--
-- PostgreSQL database dump
--

-- Dumped from database version 10.16 (Ubuntu 10.16-0ubuntu0.18.04.1)
-- Dumped by pg_dump version 12.7 (Ubuntu 12.7-0ubuntu0.20.04.1)

SET statement_timeout = 0;
SET lock_timeout = 0;
SET idle_in_transaction_session_timeout = 0;
SET client_encoding = 'UTF8';
SET standard_conforming_strings = on;
SELECT pg_catalog.set_config('search_path', '', false);
SET check_function_bodies = false;
SET xmloption = content;
SET client_min_messages = warning;
SET row_security = off;

SET default_tablespace = '';

--
-- Name: aqtmf_binder_section; Type: TABLE; Schema: public; Owner: postgres
--

CREATE TABLE public.aqtmf_binder_section (
    serial_num integer,
    binder_serial_num integer,
    binder_section_id character varying(50),
    parent_section_id character varying(50),
    binder_name character varying(50),
    index_id character varying(50),
    parent_index_id character varying(50),
    status character varying(50),
    creation_time timestamp without time zone,
    parent_index_name character varying(500),
    index_name character varying(500)
);


ALTER TABLE public.aqtmf_binder_section OWNER TO postgres;

--
-- Name: aqtmf_document; Type: TABLE; Schema: public; Owner: postgres
--

CREATE TABLE public.aqtmf_document (
    serial_num integer,
    batch_id_fk integer,
    file_name character varying(500),
    vault_doc_id integer,
    external_id character varying(500),
    doc_link_id character varying(200),
    status character varying(50),
    doc_link_status character varying(50),
    checksum_status character varying(50),
    linking_time timestamp without time zone,
    md5_comparison_time timestamp without time zone
);


ALTER TABLE public.aqtmf_document OWNER TO postgres;

--
-- Name: playground; Type: TABLE; Schema: public; Owner: postgres
--

CREATE TABLE public.playground (
    equip_id integer NOT NULL,
    type character varying(50) NOT NULL,
    color character varying(25) NOT NULL,
    location character varying(25),
    install_date date,
    CONSTRAINT playground_location_check CHECK (((location)::text = ANY ((ARRAY['north'::character varying, 'south'::character varying, 'west'::character varying, 'east'::character varying, 'northeast'::character varying, 'southeast'::character varying, 'southwest'::character varying, 'northwest'::character varying])::text[])))
);


ALTER TABLE public.playground OWNER TO postgres;

--
-- Name: playground_equip_id_seq; Type: SEQUENCE; Schema: public; Owner: postgres
--

CREATE SEQUENCE public.playground_equip_id_seq
    AS integer
    START WITH 1
    INCREMENT BY 1
    NO MINVALUE
    NO MAXVALUE
    CACHE 1;


ALTER TABLE public.playground_equip_id_seq OWNER TO postgres;

--
-- Name: playground_equip_id_seq; Type: SEQUENCE OWNED BY; Schema: public; Owner: postgres
--

ALTER SEQUENCE public.playground_equip_id_seq OWNED BY public.playground.equip_id;


--
-- Name: playground equip_id; Type: DEFAULT; Schema: public; Owner: postgres
--

ALTER TABLE ONLY public.playground ALTER COLUMN equip_id SET DEFAULT nextval('public.playground_equip_id_seq'::regclass);


--
-- Data for Name: aqtmf_binder_section; Type: TABLE DATA; Schema: public; Owner: postgres
--

COPY public.aqtmf_binder_section (serial_num, binder_serial_num, binder_section_id, parent_section_id, binder_name, index_id, parent_index_id, status, creation_time, parent_index_name, index_name) FROM stdin;
1202	51	1559200538842:-1768967831	1559200538057:1026801084	CV181-085	239	238	CREATE	2019-05-30 09:15:39.017	\N	\N
1204	51	1559200540486:1083156261	1559200538842:-1768967831	CV181-085	241	239	CREATE	2019-05-30 09:15:40.674	\N	\N
1207	51	1559200542764:-69277325	1559200538057:1026801084	CV181-085	244	238	CREATE	2019-05-30 09:15:42.943	\N	\N
1210	51	1559200545037:-86031066	1559200538057:1026801084	CV181-085	247	238	CREATE	2019-05-30 09:15:45.286	\N	\N
1212	51	1559200546674:-420907187	1559200538057:1026801084	CV181-085	249	238	CREATE	2019-05-30 09:15:46.909	\N	\N
1215	51	1559200549123:-2032960965	1559200548243:999810838	CV181-085	252	251	CREATE	2019-05-30 09:15:49.381	\N	\N
1218	51	1559200551538:1728702436	1559200548243:999810838	CV181-085	255	251	CREATE	2019-05-30 09:15:51.707	\N	\N
1220	51	1559200553060:-1853104876	1559200548243:999810838	CV181-085	257	251	CREATE	2019-05-30 09:15:53.248	\N	\N
5	2	\N	\N	ACQSIT01	1	0	NEW	\N	\N	\N
6	2	\N	\N	ACQSIT01	2	1	NEW	\N	\N	\N
7	2	\N	\N	ACQSIT01	3	2	NEW	\N	\N	\N
8	2	\N	\N	ACQSIT01	4	3	NEW	\N	\N	\N
9	2	\N	\N	ACQSIT01	5	4	NEW	\N	\N	\N
10	2	\N	\N	ACQSIT01	6	0	NEW	\N	\N	\N
11	2	\N	\N	ACQSIT01	7	6	NEW	\N	\N	\N
12	2	\N	\N	ACQSIT01	8	7	NEW	\N	\N	\N
13	2	\N	\N	ACQSIT01	9	8	NEW	\N	\N	\N
14	2	\N	\N	ACQSIT01	10	9	NEW	\N	\N	\N
15	3	\N	\N	ACQSIT02	1	0	NEW	\N	\N	\N
16	3	\N	\N	ACQSIT02	2	1	NEW	\N	\N	\N
17	3	\N	\N	ACQSIT02	3	2	NEW	\N	\N	\N
18	3	\N	\N	ACQSIT02	4	3	NEW	\N	\N	\N
19	3	\N	\N	ACQSIT02	5	4	NEW	\N	\N	\N
20	3	\N	\N	ACQSIT02	6	0	NEW	\N	\N	\N
21	3	\N	\N	ACQSIT02	7	6	NEW	\N	\N	\N
22	3	\N	\N	ACQSIT02	8	7	NEW	\N	\N	\N
23	3	\N	\N	ACQSIT02	9	8	NEW	\N	\N	\N
24	3	\N	\N	ACQSIT02	10	9	NEW	\N	\N	\N
25	4	\N	\N	ACQSIT03	1	0	NEW	\N	\N	\N
26	4	\N	\N	ACQSIT03	2	1	NEW	\N	\N	\N
27	4	\N	\N	ACQSIT03	3	2	NEW	\N	\N	\N
28	4	\N	\N	ACQSIT03	4	3	NEW	\N	\N	\N
29	4	\N	\N	ACQSIT03	5	4	NEW	\N	\N	\N
30	4	\N	\N	ACQSIT03	6	0	NEW	\N	\N	\N
31	4	\N	\N	ACQSIT03	7	6	NEW	\N	\N	\N
32	4	\N	\N	ACQSIT03	8	7	NEW	\N	\N	\N
33	4	\N	\N	ACQSIT03	9	8	NEW	\N	\N	\N
34	4	\N	\N	ACQSIT03	10	9	NEW	\N	\N	\N
35	5	\N	\N	ACQSIT04	1	0	NEW	\N	\N	\N
36	5	\N	\N	ACQSIT04	2	1	NEW	\N	\N	\N
37	5	\N	\N	ACQSIT04	3	2	NEW	\N	\N	\N
38	5	\N	\N	ACQSIT04	4	3	NEW	\N	\N	\N
39	5	\N	\N	ACQSIT04	5	4	NEW	\N	\N	\N
40	5	\N	\N	ACQSIT04	6	0	NEW	\N	\N	\N
41	5	\N	\N	ACQSIT04	7	6	NEW	\N	\N	\N
42	5	\N	\N	ACQSIT04	8	7	NEW	\N	\N	\N
43	5	\N	\N	ACQSIT04	9	8	NEW	\N	\N	\N
44	5	\N	\N	ACQSIT04	10	9	NEW	\N	\N	\N
1223	51	1559200555766:-1869858617	1559200548243:999810838	CV181-085	260	251	CREATE	2019-05-30 09:15:55.982	\N	\N
1225	51	1559200557439:2090232352	1559200548243:999810838	CV181-085	262	251	CREATE	2019-05-30 09:15:57.689	\N	\N
1228	51	1559200559903:-1814664050	1559200559030:972820386	CV181-085	265	264	CREATE	2019-05-30 09:16:00.077	\N	\N
1231	51	1559200562227:-1405573604	1559200559030:972820386	CV181-085	268	264	CREATE	2019-05-30 09:16:02.625	\N	\N
1234	51	1559200564785:934227197	rootNode	CV181-085	271	0	CREATE	2019-05-30 09:16:05.044	\N	\N
1236	51	1559200566574:1558359032	1559200565678:829886557	CV181-085	273	272	CREATE	2019-05-30 09:16:06.791	\N	\N
1374	51	1559200688100:561086736	1559200678910:745305569	CV181-085	411	401	CREATE	2019-05-30 09:18:08.319	\N	\N
1377	51	1559200690538:1449294558	1559200678910:745305569	CV181-085	414	401	CREATE	2019-05-30 09:18:10.712	\N	\N
49	7	1557765713070:1964599573	rootNode	TestStudy	1	0	CREATE	2019-05-13 18:41:53.24	\N	\N
50	7	1557765713855:963495632	1557765713070:1964599573	TestStudy	2	1	CREATE	2019-05-13 18:41:54.007	\N	\N
51	7	1557765714477:1737896235	rootNode	TestStudy	3	0	CREATE	2019-05-13 18:41:54.637	\N	\N
52	7	1557765715266:-732209292	1557765714477:1737896235	TestStudy	4	3	CREATE	2019-05-13 18:41:55.414	\N	\N
1379	51	1559200692174:-1738567739	1559200678910:745305569	CV181-085	416	401	CREATE	2019-05-30 09:18:12.428	\N	\N
527	31	1558106284754:1734541215	1558106283950:-1714634729	ATMF_500Secstudy	290	289	CREATE	2019-05-17 17:18:04.91	\N	\N
73	10	\N	\N	ACQSIT02	1	0	NEW	\N	\N	\N
74	10	\N	\N	ACQSIT02	2	1	NEW	\N	\N	\N
75	10	\N	\N	ACQSIT02	3	2	NEW	\N	\N	\N
76	10	\N	\N	ACQSIT02	4	3	NEW	\N	\N	\N
77	10	\N	\N	ACQSIT02	5	4	NEW	\N	\N	\N
78	10	\N	\N	ACQSIT02	6	0	NEW	\N	\N	\N
63	9	1557817990994:-1639768299	rootNode	ACQSIT01	1	0	CREATE	2019-05-14 09:13:11.16	\N	\N
64	9	1557817991751:160174226	1557817990994:-1639768299	ACQSIT01	2	1	CREATE	2019-05-14 09:13:12.246	\N	\N
65	9	1557817992877:-1886403891	1557817991751:160174226	ACQSIT01	3	2	CREATE	2019-05-14 09:13:13.059	\N	\N
66	9	1557817993674:283509292	1557817992877:-1886403891	ACQSIT01	4	3	CREATE	2019-05-14 09:13:13.824	\N	\N
67	9	1557817994470:474848396	1557817993674:283509292	ACQSIT01	5	4	CREATE	2019-05-14 09:13:14.674	\N	\N
68	9	1557817995183:-1666759060	rootNode	ACQSIT01	6	0	CREATE	2019-05-14 09:13:15.394	\N	\N
70	9	1557817996821:-1058661586	1557817996010:1150905025	ACQSIT01	8	7	CREATE	2019-05-14 09:13:16.999	\N	\N
71	9	1557817997537:-1058849400	1557817996821:-1058661586	ACQSIT01	9	8	CREATE	2019-05-14 09:13:17.715	\N	\N
79	10	\N	\N	ACQSIT02	7	6	NEW	\N	\N	\N
80	10	\N	\N	ACQSIT02	8	7	NEW	\N	\N	\N
81	10	\N	\N	ACQSIT02	9	8	NEW	\N	\N	\N
82	10	\N	\N	ACQSIT02	10	9	NEW	\N	\N	\N
69	9	1557817996010:1150905025	1557817995183:-1666759060	ACQSIT01	7	6	CREATE	2019-05-14 09:13:16.217	\N	\N
72	9	1557817998290:-1906070481	1557817997537:-1058849400	ACQSIT01	10	9	CREATE	2019-05-14 09:13:18.492	\N	\N
83	11	1557818812265:-363585913	rootNode	ACQSIT03	1	0	CREATE	2019-05-14 09:26:52.815	\N	\N
84	11	1557818813403:452008230	1557818812265:-363585913	ACQSIT03	2	1	CREATE	2019-05-14 09:26:53.764	\N	\N
85	11	1557818814387:-986540447	1557818813403:452008230	ACQSIT03	3	2	CREATE	2019-05-14 09:26:54.705	\N	\N
86	11	1557818815311:226605570	1557818814387:-986540447	ACQSIT03	4	3	CREATE	2019-05-14 09:26:55.805	\N	\N
87	11	1557818816399:703596510	1557818815311:226605570	ACQSIT03	5	4	CREATE	2019-05-14 09:26:56.706	\N	\N
88	11	1557818817214:-390576880	rootNode	ACQSIT03	6	0	CREATE	2019-05-14 09:26:57.491	\N	\N
89	11	1557818818087:21507250	1557818817214:-390576880	ACQSIT03	7	6	CREATE	2019-05-14 09:26:58.386	\N	\N
90	11	1557818818964:-100157847	1557818818087:21507250	ACQSIT03	8	7	CREATE	2019-05-14 09:26:59.285	\N	\N
91	11	1557818819935:-1198546218	1557818818964:-100157847	ACQSIT03	9	8	CREATE	2019-05-14 09:27:00.33	\N	\N
92	11	1557818820942:996576951	1557818819935:-1198546218	ACQSIT03	10	9	CREATE	2019-05-14 09:27:01.199	\N	\N
93	12	1557818864122:-1994628766	rootNode	ACQSIT04	1	0	CREATE	2019-05-14 09:27:44.293	\N	\N
94	12	1557818864894:1624168513	1557818864122:-1994628766	ACQSIT04	2	1	CREATE	2019-05-14 09:27:45.243	\N	\N
95	12	1557818865839:-87538557	1557818864894:1624168513	ACQSIT04	3	2	CREATE	2019-05-14 09:27:46.336	\N	\N
96	12	1557818866928:1736039931	1557818865839:-87538557	ACQSIT04	4	3	CREATE	2019-05-14 09:27:47.256	\N	\N
97	12	1557818867911:906294136	1557818866928:1736039931	ACQSIT04	5	4	CREATE	2019-05-14 09:27:48.16	\N	\N
98	12	1557818868704:245839970	rootNode	ACQSIT04	6	0	CREATE	2019-05-14 09:27:48.947	\N	\N
99	12	1557818869557:1733286104	1557818868704:245839970	ACQSIT04	7	6	CREATE	2019-05-14 09:27:49.72	\N	\N
100	12	1557818870291:-1062843859	1557818869557:1733286104	ACQSIT04	8	7	CREATE	2019-05-14 09:27:50.455	\N	\N
101	12	1557818871024:-1213167867	1557818870291:-1062843859	ACQSIT04	9	8	CREATE	2019-05-14 09:27:51.599	\N	\N
102	12	1557818872299:901973385	1557818871024:-1213167867	ACQSIT04	10	9	CREATE	2019-05-14 09:27:52.522	\N	\N
103	13	\N	\N	ACQSIT02	1	0	NEW	\N	\N	\N
104	13	\N	\N	ACQSIT02	2	1	NEW	\N	\N	\N
105	13	\N	\N	ACQSIT02	3	2	NEW	\N	\N	\N
106	13	\N	\N	ACQSIT02	4	3	NEW	\N	\N	\N
107	13	\N	\N	ACQSIT02	5	4	NEW	\N	\N	\N
108	13	\N	\N	ACQSIT02	6	0	NEW	\N	\N	\N
109	13	\N	\N	ACQSIT02	7	6	NEW	\N	\N	\N
110	13	\N	\N	ACQSIT02	8	7	NEW	\N	\N	\N
111	13	\N	\N	ACQSIT02	9	8	NEW	\N	\N	\N
112	13	\N	\N	ACQSIT02	10	9	NEW	\N	\N	\N
113	14	1557833410589:1865545757	rootNode	ACQSIT02	1	0	CREATE	2019-05-14 13:30:10.823	\N	\N
114	14	1557833411441:-1379761490	1557833410589:1865545757	ACQSIT02	2	1	CREATE	2019-05-14 13:30:11.667	\N	\N
115	14	1557833412273:-2120435175	1557833411441:-1379761490	ACQSIT02	3	2	CREATE	2019-05-14 13:30:12.42	\N	\N
116	14	1557833412972:83048018	1557833412273:-2120435175	ACQSIT02	4	3	CREATE	2019-05-14 13:30:13.141	\N	\N
117	14	1557833413709:-2021670964	1557833412972:83048018	ACQSIT02	5	4	CREATE	2019-05-14 13:30:13.895	\N	\N
118	14	1557833414368:1838554893	rootNode	ACQSIT02	6	0	CREATE	2019-05-14 13:30:14.656	\N	\N
119	14	1557833415245:-1882031264	1557833414368:1838554893	ACQSIT02	7	6	CREATE	2019-05-14 13:30:15.51	\N	\N
120	14	1557833416081:792013972	1557833415245:-1882031264	ACQSIT02	8	7	CREATE	2019-05-14 13:30:16.311	\N	\N
121	14	1557833416849:-1669847316	1557833416081:792013972	ACQSIT02	9	8	CREATE	2019-05-14 13:30:17.085	\N	\N
122	14	1557833417635:-1693120621	1557833416849:-1669847316	ACQSIT02	10	9	CREATE	2019-05-14 13:30:17.803	\N	\N
1382	51	1559200694482:1476679781	rootNode	CV181-085	419	0	CREATE	2019-05-30 09:18:14.68	\N	\N
123	15	1557923196996:1069245717	rootNode	ATMF_Int0001	1	0	CREATE	2019-05-15 14:26:37.253	\N	\N
124	15	1557923197896:1158435399	1557923196996:1069245717	ATMF_Int0001	2	1	CREATE	2019-05-15 14:26:38.071	\N	\N
125	15	1557923198611:1260268135	1557923197896:1158435399	ATMF_Int0001	3	2	CREATE	2019-05-15 14:26:38.895	\N	\N
126	15	1557923199479:-900144836	1557923198611:1260268135	ATMF_Int0001	4	3	CREATE	2019-05-15 14:26:39.644	\N	\N
127	15	1557923200143:1042254647	rootNode	ATMF_Int0001	5	0	CREATE	2019-05-15 14:26:40.653	\N	\N
128	15	1557923201261:-1653279897	1557923200143:1042254647	ATMF_Int0001	6	5	CREATE	2019-05-15 14:26:41.52	\N	\N
129	15	1557923202121:-1252197259	rootNode	ATMF_Int0001	7	0	CREATE	2019-05-15 14:26:42.399	\N	\N
130	15	1557923203014:597222324	1557923202121:-1252197259	ATMF_Int0001	8	7	CREATE	2019-05-15 14:26:43.235	\N	\N
131	15	1557923203813:-892097127	1557923203014:597222324	ATMF_Int0001	9	8	CREATE	2019-05-15 14:26:44.12	\N	\N
132	16	1557924201316:-718390658	rootNode	ATMFE2EStudy	1	0	CREATE	2019-05-15 14:43:21.766	\N	\N
133	16	1557924202407:-167411044	1557924201316:-718390658	ATMFE2EStudy	2	1	CREATE	2019-05-15 14:43:22.558	\N	\N
134	16	1557924203126:486029066	1557924202407:-167411044	ATMFE2EStudy	3	2	CREATE	2019-05-15 14:43:23.324	\N	\N
135	16	1557924203862:-1329490624	1557924203126:486029066	ATMFE2EStudy	4	3	CREATE	2019-05-15 14:43:24.014	\N	\N
136	16	1557924204560:2075345493	1557924201316:-718390658	ATMFE2EStudy	5	1	CREATE	2019-05-15 14:43:24.79	\N	\N
137	16	1557924205404:-1660157403	1557924204560:2075345493	ATMFE2EStudy	6	5	CREATE	2019-05-15 14:43:25.636	\N	\N
138	16	1557924206193:1718492388	1557924201316:-718390658	ATMFE2EStudy	7	1	CREATE	2019-05-15 14:43:26.372	\N	\N
139	16	1557924211628:1522079623	rootNode	ATMFE2EStudy	8	0	CREATE	2019-05-15 14:43:31.882	\N	\N
140	16	1557924212500:1101857758	1557924211628:1522079623	ATMFE2EStudy	9	8	CREATE	2019-05-15 14:43:32.702	\N	\N
141	17	1557923196996:1069245717	rootNode	ATMF_Int0001	1	0	ALREADY AVAILABLE	2019-05-16 12:12:10.025	\N	\N
145	17	1557923200143:1042254647	rootNode	ATMF_Int0001	5	0	ALREADY AVAILABLE	2019-05-16 12:12:10.025	\N	\N
147	17	1557923202121:-1252197259	rootNode	ATMF_Int0001	7	0	ALREADY AVAILABLE	2019-05-16 12:12:10.025	\N	\N
142	17	1557923197896:1158435399	1557923196996:1069245717	ATMF_Int0001	2	1	ALREADY AVAILABLE	2019-05-16 12:12:10.025	\N	\N
146	17	1557923201261:-1653279897	1557923200143:1042254647	ATMF_Int0001	6	5	ALREADY AVAILABLE	2019-05-16 12:12:10.025	\N	\N
148	17	1557923203014:597222324	1557923202121:-1252197259	ATMF_Int0001	8	7	ALREADY AVAILABLE	2019-05-16 12:12:10.025	\N	\N
143	17	1557923198611:1260268135	1557923197896:1158435399	ATMF_Int0001	3	2	ALREADY AVAILABLE	2019-05-16 12:12:10.025	\N	\N
149	17	1557923203813:-892097127	1557923203014:597222324	ATMF_Int0001	9	8	ALREADY AVAILABLE	2019-05-16 12:12:10.025	\N	\N
144	17	1557923199479:-900144836	1557923198611:1260268135	ATMF_Int0001	4	3	ALREADY AVAILABLE	2019-05-16 12:12:10.025	\N	\N
150	18	1558009604580:1838276896	rootNode	ATMF_INT0002	1	0	CREATE	2019-05-16 14:26:44.771	\N	\N
151	18	1558009605418:1205179447	1558009604580:1838276896	ATMF_INT0002	2	1	CREATE	2019-05-16 14:26:45.587	\N	\N
152	18	1558009606147:129149986	1558009605418:1205179447	ATMF_INT0002	3	2	CREATE	2019-05-16 14:26:46.367	\N	\N
153	18	1558009606979:1792202441	rootNode	ATMF_INT0002	4	0	CREATE	2019-05-16 14:26:47.162	\N	\N
154	18	1558009607741:-155396988	1558009606979:1792202441	ATMF_INT0002	5	4	CREATE	2019-05-16 14:26:47.999	\N	\N
155	18	1558009608685:-967513578	1558009607741:-155396988	ATMF_INT0002	6	5	CREATE	2019-05-16 14:26:48.964	\N	\N
156	18	1558009609422:1629155021	rootNode	ATMF_INT0002	7	0	CREATE	2019-05-16 14:26:49.669	\N	\N
157	18	1558009610246:-920948028	1558009609422:1629155021	ATMF_INT0002	8	7	CREATE	2019-05-16 14:26:50.418	\N	\N
158	18	1558009610955:-408259031	1558009610246:-920948028	ATMF_INT0002	9	8	CREATE	2019-05-16 14:26:51.122	\N	\N
159	19	1558070038155:519392156	rootNode	ATMF_INT0003	1	0	CREATE	2019-05-17 07:13:58.313	\N	\N
160	19	1558070038898:2069902013	1558070038155:519392156	ATMF_INT0003	2	1	CREATE	2019-05-17 07:13:59.21	\N	\N
161	19	1558070039803:26359883	1558070038898:2069902013	ATMF_INT0003	3	2	CREATE	2019-05-17 07:13:59.962	\N	\N
162	19	1558070040511:-570232946	1558070039803:26359883	ATMF_INT0003	4	3	CREATE	2019-05-17 07:14:00.665	\N	\N
163	19	1558070041345:-935838564	1558070040511:-570232946	ATMF_INT0003	5	4	CREATE	2019-05-17 07:14:01.5	\N	\N
164	19	1558070041986:-866367939	rootNode	ATMF_INT0003	6	0	CREATE	2019-05-17 07:14:02.184	\N	\N
165	19	1558070042793:-819012024	1558070041986:-866367939	ATMF_INT0003	7	6	CREATE	2019-05-17 07:14:02.944	\N	\N
166	19	1558070044372:-174996549	1558070042793:-819012024	ATMF_INT0003	8	7	CREATE	2019-05-17 07:14:04.781	\N	\N
167	19	1558070045437:-1626314472	1558070044372:-174996549	ATMF_INT0003	9	8	CREATE	2019-05-17 07:14:05.587	\N	\N
168	19	1558070046260:818085485	1558070045437:-1626314472	ATMF_INT0003	10	9	CREATE	2019-05-17 07:14:06.413	\N	\N
169	19	1558070046921:310270487	rootNode	ATMF_INT0003	11	0	CREATE	2019-05-17 07:14:07.136	\N	\N
170	19	1558070047759:1725505225	1558070046921:310270487	ATMF_INT0003	12	11	CREATE	2019-05-17 07:14:07.934	\N	\N
171	19	1558070048471:-192772740	1558070047759:1725505225	ATMF_INT0003	13	12	CREATE	2019-05-17 07:14:08.649	\N	\N
172	19	1558070049199:-1195016254	1558070048471:-192772740	ATMF_INT0003	14	13	CREATE	2019-05-17 07:14:09.354	\N	\N
173	19	1558070050001:245365382	1558070049199:-1195016254	ATMF_INT0003	15	14	CREATE	2019-05-17 07:14:10.166	\N	\N
179	21	1558076279020:-1751695131	rootNode	YETMF	1	0	CREATE	2019-05-17 08:57:59.173	\N	\N
180	21	1558076279749:812065369	1558076279020:-1751695131	YETMF	2	1	CREATE	2019-05-17 08:57:59.907	\N	\N
181	21	1558076280452:-1433333228	1558076279749:812065369	YETMF	3	2	CREATE	2019-05-17 08:58:00.6	\N	\N
182	21	1558076281140:23371039	1558076280452:-1433333228	YETMF	4	3	CREATE	2019-05-17 08:58:01.306	\N	\N
183	21	1558076281903:813156617	1558076281140:23371039	YETMF	5	4	CREATE	2019-05-17 08:58:02.085	\N	\N
184	22	1558076329734:821182926	rootNode	AETMF	1	0	CREATE	2019-05-17 08:58:49.947	\N	\N
185	22	1558076330576:-143741752	1558076329734:821182926	AETMF	2	1	CREATE	2019-05-17 08:58:50.724	\N	\N
186	22	1558076331351:928272444	1558076330576:-143741752	AETMF	3	2	CREATE	2019-05-17 08:58:51.497	\N	\N
174	20	1558078992500:2112877434	rootNode	SETMF	1	0	CREATE	2019-05-17 09:43:12.775	\N	\N
175	20	1558078993394:1303967338	1558078992500:2112877434	SETMF	2	1	CREATE	2019-05-17 09:43:13.59	\N	\N
176	20	1558078994166:1917531556	1558078993394:1303967338	SETMF	3	2	CREATE	2019-05-17 09:43:14.379	\N	\N
177	20	1558078994968:556401783	1558078994166:1917531556	SETMF	4	3	CREATE	2019-05-17 09:43:15.126	\N	\N
178	20	1558078995911:74308294	1558078994968:556401783	SETMF	5	4	CREATE	2019-05-17 09:43:16.297	\N	\N
530	31	1558106286983:804956048	1558106286210:237379465	ATMF_500Secstudy	293	292	CREATE	2019-05-17 17:18:07.191	\N	\N
533	31	1558106289381:-2106366492	rootNode	ATMF_500Secstudy	296	0	CREATE	2019-05-17 17:18:09.561	\N	\N
535	31	1558106290857:-1838182699	1558106290147:1765907887	ATMF_500Secstudy	298	297	CREATE	2019-05-17 17:18:11.043	\N	\N
537	31	1558106292409:-1024474009	1558106291651:1694475243	ATMF_500Secstudy	300	299	CREATE	2019-05-17 17:18:12.592	\N	\N
540	31	1558106295520:-1115358761	1558106294827:78356752	ATMF_500Secstudy	303	302	CREATE	2019-05-17 17:18:15.691	\N	\N
541	31	1558106296265:593739706	1558106295520:-1115358761	ATMF_500Secstudy	304	303	CREATE	2019-05-17 17:18:16.417	\N	\N
544	31	1558106298492:-930802559	1558106297734:2134618973	ATMF_500Secstudy	307	306	CREATE	2019-05-17 17:18:18.643	\N	\N
546	31	1558106299949:2034662489	1558106299218:-755350377	ATMF_500Secstudy	309	308	CREATE	2019-05-17 17:18:20.304	\N	\N
549	31	1558106302362:-471329849	1558106301610:-847654165	ATMF_500Secstudy	312	311	CREATE	2019-05-17 17:18:22.517	\N	\N
551	31	1558106303849:425853857	1558106303141:1109824842	ATMF_500Secstudy	314	313	CREATE	2019-05-17 17:18:24.029	\N	\N
554	31	1558106306150:1405552659	1558106305296:-874644926	ATMF_500Secstudy	317	316	CREATE	2019-05-17 17:18:26.301	\N	\N
556	31	1558106307705:-1097853502	1558106306931:-1032594898	ATMF_500Secstudy	319	318	CREATE	2019-05-17 17:18:28.075	\N	\N
559	31	1558106310123:-770035585	1558106309314:-901635687	ATMF_500Secstudy	322	321	CREATE	2019-05-17 17:18:30.296	\N	\N
187	22	1558076332044:261611103	1558076331351:928272444	AETMF	4	3	CREATE	2019-05-17 08:58:52.195	\N	\N
188	22	1558076332744:-708945923	1558076332044:261611103	AETMF	5	4	CREATE	2019-05-17 08:58:53.116	\N	\N
189	23	1558076329734:821182926	rootNode	AETMF	1	0	ALREADY AVAILABLE	2019-05-17 09:43:49.496	\N	\N
190	23	1558076330576:-143741752	1558076329734:821182926	AETMF	2	1	ALREADY AVAILABLE	2019-05-17 09:43:49.497	\N	\N
191	23	1558076331351:928272444	1558076330576:-143741752	AETMF	3	2	ALREADY AVAILABLE	2019-05-17 09:43:49.497	\N	\N
192	23	1558076332044:261611103	1558076331351:928272444	AETMF	4	3	ALREADY AVAILABLE	2019-05-17 09:43:49.497	\N	\N
193	23	1558076332744:-708945923	1558076332044:261611103	AETMF	5	4	ALREADY AVAILABLE	2019-05-17 09:43:49.497	\N	\N
199	25	1558076279020:-1751695131	rootNode	YETMF	1	0	ALREADY AVAILABLE	2019-05-17 09:44:18.185	\N	\N
200	25	1558076279749:812065369	1558076279020:-1751695131	YETMF	2	1	ALREADY AVAILABLE	2019-05-17 09:44:18.185	\N	\N
201	25	1558076280452:-1433333228	1558076279749:812065369	YETMF	3	2	ALREADY AVAILABLE	2019-05-17 09:44:18.185	\N	\N
202	25	1558076281140:23371039	1558076280452:-1433333228	YETMF	4	3	ALREADY AVAILABLE	2019-05-17 09:44:18.185	\N	\N
203	25	1558076281903:813156617	1558076281140:23371039	YETMF	5	4	ALREADY AVAILABLE	2019-05-17 09:44:18.185	\N	\N
194	24	1558078992500:2112877434	rootNode	SETMF	1	0	ALREADY AVAILABLE	2019-05-17 10:12:51.068	\N	\N
195	24	1558078993394:1303967338	1558078992500:2112877434	SETMF	2	1	ALREADY AVAILABLE	2019-05-17 10:12:51.068	\N	\N
196	24	1558078994166:1917531556	1558078993394:1303967338	SETMF	3	2	ALREADY AVAILABLE	2019-05-17 10:12:51.068	\N	\N
197	24	1558078994968:556401783	1558078994166:1917531556	SETMF	4	3	ALREADY AVAILABLE	2019-05-17 10:12:51.068	\N	\N
198	24	1558078995911:74308294	1558078994968:556401783	SETMF	5	4	ALREADY AVAILABLE	2019-05-17 10:12:51.068	\N	\N
204	26	1558076329734:821182926	rootNode	AETMF	1	0	ALREADY AVAILABLE	2019-05-17 12:12:33.435	\N	\N
205	26	1558076330576:-143741752	1558076329734:821182926	AETMF	2	1	ALREADY AVAILABLE	2019-05-17 12:12:33.434	\N	\N
206	26	1558076331351:928272444	1558076330576:-143741752	AETMF	3	2	ALREADY AVAILABLE	2019-05-17 12:12:33.435	\N	\N
207	26	1558076332044:261611103	1558076331351:928272444	AETMF	4	3	ALREADY AVAILABLE	2019-05-17 12:12:33.435	\N	\N
208	26	1558076332744:-708945923	1558076332044:261611103	AETMF	5	4	ALREADY AVAILABLE	2019-05-17 12:12:33.435	\N	\N
209	27	1558078992500:2112877434	rootNode	SETMF	1	0	ALREADY AVAILABLE	2019-05-17 12:26:39.698	\N	\N
210	27	1558078993394:1303967338	1558078992500:2112877434	SETMF	2	1	ALREADY AVAILABLE	2019-05-17 12:26:39.698	\N	\N
211	27	1558078994166:1917531556	1558078993394:1303967338	SETMF	3	2	ALREADY AVAILABLE	2019-05-17 12:26:39.698	\N	\N
212	27	1558078994968:556401783	1558078994166:1917531556	SETMF	4	3	ALREADY AVAILABLE	2019-05-17 12:26:39.698	\N	\N
213	27	1558078995911:74308294	1558078994968:556401783	SETMF	5	4	ALREADY AVAILABLE	2019-05-17 12:26:39.698	\N	\N
214	28	1558076279020:-1751695131	rootNode	YETMF	1	0	ALREADY AVAILABLE	2019-05-17 12:27:23.533	\N	\N
215	28	1558076279749:812065369	1558076279020:-1751695131	YETMF	2	1	ALREADY AVAILABLE	2019-05-17 12:27:23.533	\N	\N
216	28	1558076280452:-1433333228	1558076279749:812065369	YETMF	3	2	ALREADY AVAILABLE	2019-05-17 12:27:23.534	\N	\N
217	28	1558076281140:23371039	1558076280452:-1433333228	YETMF	4	3	ALREADY AVAILABLE	2019-05-17 12:27:23.534	\N	\N
218	28	1558076281903:813156617	1558076281140:23371039	YETMF	5	4	ALREADY AVAILABLE	2019-05-17 12:27:23.534	\N	\N
219	29	1558088876853:1770250132	rootNode	ATMF_INT0002	1	0	CREATE	2019-05-17 12:27:57.348	\N	\N
220	29	1558088878046:-960854999	1558088876853:1770250132	ATMF_INT0002	2	1	CREATE	2019-05-17 12:27:58.212	\N	\N
221	29	1558088878797:1659524525	1558088878046:-960854999	ATMF_INT0002	3	2	CREATE	2019-05-17 12:27:58.951	\N	\N
222	29	1558088879586:919800898	1558088878797:1659524525	ATMF_INT0002	4	3	CREATE	2019-05-17 12:27:59.753	\N	\N
223	29	1558088880300:-1740456082	rootNode	ATMF_INT0002	5	0	CREATE	2019-05-17 12:28:00.453	\N	\N
224	29	1558088881064:779054437	1558088880300:-1740456082	ATMF_INT0002	6	5	CREATE	2019-05-17 12:28:01.223	\N	\N
225	29	1558088881918:-792387211	1558088881064:779054437	ATMF_INT0002	7	6	CREATE	2019-05-17 12:28:02.093	\N	\N
226	30	1558070038155:519392156	rootNode	ATMF_INT0003	1	0	ALREADY AVAILABLE	2019-05-17 14:26:48.524	\N	\N
231	30	1558070041986:-866367939	rootNode	ATMF_INT0003	6	0	ALREADY AVAILABLE	2019-05-17 14:26:48.525	\N	\N
233	30	1558070046921:310270487	rootNode	ATMF_INT0003	8	0	ALREADY AVAILABLE	2019-05-17 14:26:48.525	\N	\N
227	30	1558070038898:2069902013	1558070038155:519392156	ATMF_INT0003	2	1	ALREADY AVAILABLE	2019-05-17 14:26:48.525	\N	\N
232	30	1558070042793:-819012024	1558070041986:-866367939	ATMF_INT0003	7	6	ALREADY AVAILABLE	2019-05-17 14:26:48.525	\N	\N
234	30	1558070047759:1725505225	1558070046921:310270487	ATMF_INT0003	9	8	ALREADY AVAILABLE	2019-05-17 14:26:48.525	\N	\N
228	30	1558070039803:26359883	1558070038898:2069902013	ATMF_INT0003	3	2	ALREADY AVAILABLE	2019-05-17 14:26:48.525	\N	\N
235	30	1558070048471:-192772740	1558070047759:1725505225	ATMF_INT0003	10	9	ALREADY AVAILABLE	2019-05-17 14:26:48.525	\N	\N
229	30	1558070040511:-570232946	1558070039803:26359883	ATMF_INT0003	4	3	ALREADY AVAILABLE	2019-05-17 14:26:48.525	\N	\N
236	30	1558070049199:-1195016254	1558070048471:-192772740	ATMF_INT0003	11	10	ALREADY AVAILABLE	2019-05-17 14:26:48.525	\N	\N
230	30	1558070041345:-935838564	1558070040511:-570232946	ATMF_INT0003	5	4	ALREADY AVAILABLE	2019-05-17 14:26:48.525	\N	\N
237	30	1558070050001:245365382	1558070049199:-1195016254	ATMF_INT0003	12	11	ALREADY AVAILABLE	2019-05-17 14:26:48.525	\N	\N
1404	53	\N	\N	ACQSIT02	1	0	NEW	\N	\N	\N
240	31	1558106042621:-1512592502	1558106041846:-803107606	ATMF_500Secstudy	3	2	CREATE	2019-05-17 17:14:02.798	\N	\N
242	31	1558106044193:-200757467	1558106043375:335112201	ATMF_500Secstudy	5	4	CREATE	2019-05-17 17:14:04.367	\N	\N
243	31	1558106044861:853466674	rootNode	ATMF_500Secstudy	6	0	CREATE	2019-05-17 17:14:05.031	\N	\N
245	31	1558106046368:-1052977442	1558106045636:-1575889553	ATMF_500Secstudy	8	7	CREATE	2019-05-17 17:14:06.571	\N	\N
247	31	1558106047925:1031169766	1558106047148:-817698127	ATMF_500Secstudy	10	9	CREATE	2019-05-17 17:14:08.111	\N	\N
248	31	1558106048588:-202153780	rootNode	ATMF_500Secstudy	11	0	CREATE	2019-05-17 17:14:08.775	\N	\N
561	31	1558106311654:10801968	1558106310927:1136714601	ATMF_500Secstudy	324	323	CREATE	2019-05-17 17:18:31.958	\N	\N
251	31	1558106050901:1875601594	1558106050126:298457950	ATMF_500Secstudy	14	13	CREATE	2019-05-17 17:14:11.079	\N	\N
253	31	1558106052358:892009829	rootNode	ATMF_500Secstudy	16	0	CREATE	2019-05-17 17:14:12.549	\N	\N
254	31	1558106053226:-239547935	1558106052358:892009829	ATMF_500Secstudy	17	16	CREATE	2019-05-17 17:14:13.401	\N	\N
358	31	1558106145735:211139206	rootNode	ATMF_500Secstudy	121	0	CREATE	2019-05-17 17:15:45.89	\N	\N
256	31	1558106054756:558828909	1558106053982:1711073953	ATMF_500Secstudy	19	18	CREATE	2019-05-17 17:14:14.922	\N	\N
258	31	1558106056219:865018759	rootNode	ATMF_500Secstudy	21	0	CREATE	2019-05-17 17:14:16.373	\N	\N
259	31	1558106057019:1316350821	1558106056219:865018759	ATMF_500Secstudy	22	21	CREATE	2019-05-17 17:14:17.171	\N	\N
261	31	1558106058466:-981678066	1558106057734:2044718885	ATMF_500Secstudy	24	23	CREATE	2019-05-17 17:14:18.677	\N	\N
263	31	1558106059879:-2117255821	rootNode	ATMF_500Secstudy	26	0	CREATE	2019-05-17 17:14:20.042	\N	\N
264	31	1558106060709:304674559	1558106059879:-2117255821	ATMF_500Secstudy	27	26	CREATE	2019-05-17 17:14:20.908	\N	\N
266	31	1558106062274:-1752604892	1558106061482:1394749499	ATMF_500Secstudy	29	28	CREATE	2019-05-17 17:14:22.433	\N	\N
267	31	1558106063008:-1319645450	1558106062274:-1752604892	ATMF_500Secstudy	30	29	CREATE	2019-05-17 17:14:23.18	\N	\N
269	31	1558106064446:1301066494	1558106063653:811036825	ATMF_500Secstudy	32	31	CREATE	2019-05-17 17:14:24.613	\N	\N
271	31	1558106066004:-1580541266	1558106065183:-2137240293	ATMF_500Secstudy	34	33	CREATE	2019-05-17 17:14:26.213	\N	\N
273	31	1558106067452:2123729953	rootNode	ATMF_500Secstudy	36	0	CREATE	2019-05-17 17:14:27.619	\N	\N
274	31	1558106068243:124608026	1558106067452:2123729953	ATMF_500Secstudy	37	36	CREATE	2019-05-17 17:14:28.391	\N	\N
276	31	1558106069744:2119834467	1558106068965:-1806475381	ATMF_500Secstudy	39	38	CREATE	2019-05-17 17:14:29.927	\N	\N
278	31	1558106071398:2096738986	rootNode	ATMF_500Secstudy	41	0	CREATE	2019-05-17 17:14:31.562	\N	\N
279	31	1558106072215:-25862764	1558106071398:2096738986	ATMF_500Secstudy	42	41	CREATE	2019-05-17 17:14:32.396	\N	\N
281	31	1558106073822:-1713094612	1558106073024:-37276044	ATMF_500Secstudy	44	43	CREATE	2019-05-17 17:14:34.057	\N	\N
283	31	1558106075290:2069748019	rootNode	ATMF_500Secstudy	46	0	CREATE	2019-05-17 17:14:35.446	\N	\N
284	31	1558106076044:-1851771346	1558106075290:2069748019	ATMF_500Secstudy	47	46	CREATE	2019-05-17 17:14:36.194	\N	\N
286	31	1558106077767:-676234931	1558106076754:-1706860598	ATMF_500Secstudy	49	48	CREATE	2019-05-17 17:14:37.923	\N	\N
288	31	1558106079188:703073060	rootNode	ATMF_500Secstudy	51	0	CREATE	2019-05-17 17:14:39.374	\N	\N
289	31	1558106079990:-63987421	1558106079188:703073060	ATMF_500Secstudy	52	51	CREATE	2019-05-17 17:14:40.152	\N	\N
291	31	1558106086858:-333046063	1558106086108:959061542	ATMF_500Secstudy	54	53	CREATE	2019-05-17 17:14:47.025	\N	\N
293	31	1558106088315:2015766085	rootNode	ATMF_500Secstudy	56	0	CREATE	2019-05-17 17:14:48.49	\N	\N
294	31	1558106089106:-241269754	1558106088315:2015766085	ATMF_500Secstudy	57	56	CREATE	2019-05-17 17:14:49.406	\N	\N
296	31	1558106090929:-669157813	1558106090050:-811444488	ATMF_500Secstudy	59	58	CREATE	2019-05-17 17:14:51.131	\N	\N
297	31	1558106091720:630899882	1558106090929:-669157813	ATMF_500Secstudy	60	59	CREATE	2019-05-17 17:14:51.907	\N	\N
299	31	1558106093154:-1407344743	1558106092383:1337177159	ATMF_500Secstudy	62	61	CREATE	2019-05-17 17:14:53.415	\N	\N
301	31	1558106095239:-269171463	1558106094434:1035353093	ATMF_500Secstudy	64	63	CREATE	2019-05-17 17:14:55.406	\N	\N
303	31	1558106096633:2042706297	rootNode	ATMF_500Secstudy	66	0	CREATE	2019-05-17 17:14:56.801	\N	\N
304	31	1558106097461:1786584351	1558106096633:2042706297	ATMF_500Secstudy	67	66	CREATE	2019-05-17 17:14:57.659	\N	\N
306	31	1558106098934:1944948156	1558106098207:-1576066672	ATMF_500Secstudy	69	68	CREATE	2019-05-17 17:14:59.114	\N	\N
308	31	1558106100418:2015715227	rootNode	ATMF_500Secstudy	71	0	CREATE	2019-05-17 17:15:00.583	\N	\N
309	31	1558106101183:1655894444	1558106100418:2015715227	ATMF_500Secstudy	72	71	CREATE	2019-05-17 17:15:01.35	\N	\N
311	31	1558106102726:1722279736	1558106101976:-1074151030	ATMF_500Secstudy	74	73	CREATE	2019-05-17 17:15:02.887	\N	\N
313	31	1558106104146:1988724363	rootNode	ATMF_500Secstudy	76	0	CREATE	2019-05-17 17:15:04.298	\N	\N
314	31	1558106104936:-1518422025	1558106104146:1988724363	ATMF_500Secstudy	77	76	CREATE	2019-05-17 17:15:05.107	\N	\N
316	31	1558106106360:1421436472	1558106105657:-999341738	ATMF_500Secstudy	79	78	CREATE	2019-05-17 17:15:06.536	\N	\N
318	31	1558106107859:1961733499	rootNode	ATMF_500Secstudy	81	0	CREATE	2019-05-17 17:15:08.069	\N	\N
319	31	1558106108670:-993153771	1558106107859:1961733499	ATMF_500Secstudy	82	81	CREATE	2019-05-17 17:15:08.859	\N	\N
321	31	1558106110258:-1939049668	1558106109472:-879158395	ATMF_500Secstudy	84	83	CREATE	2019-05-17 17:15:10.428	\N	\N
323	31	1558106111687:1934753038	rootNode	ATMF_500Secstudy	86	0	CREATE	2019-05-17 17:15:11.862	\N	\N
324	31	1558106112647:-1838897690	1558106111687:1934753038	ATMF_500Secstudy	87	86	CREATE	2019-05-17 17:15:12.814	\N	\N
326	31	1558106114148:-2087694856	1558106113436:-1507103020	ATMF_500Secstudy	89	88	CREATE	2019-05-17 17:15:14.359	\N	\N
328	31	1558106115724:-1047521233	rootNode	ATMF_500Secstudy	91	0	CREATE	2019-05-17 17:15:15.921	\N	\N
329	31	1558106116566:-422245180	1558106115724:-1047521233	ATMF_500Secstudy	92	91	CREATE	2019-05-17 17:15:16.727	\N	\N
331	31	1558106118096:1568748531	1558106117367:1829056699	ATMF_500Secstudy	94	93	CREATE	2019-05-17 17:15:18.273	\N	\N
333	31	1558106119587:-1074511994	rootNode	ATMF_500Secstudy	96	0	CREATE	2019-05-17 17:15:19.794	\N	\N
334	31	1558106120394:610516613	1558106119587:-1074511994	ATMF_500Secstudy	97	96	CREATE	2019-05-17 17:15:20.912	\N	\N
336	31	1558106122524:821551738	1558106121495:878824752	ATMF_500Secstudy	99	98	CREATE	2019-05-17 17:15:22.674	\N	\N
337	31	1558106123228:1960753067	1558106122524:821551738	ATMF_500Secstudy	100	99	CREATE	2019-05-17 17:15:23.424	\N	\N
339	31	1558106125364:-1512355022	1558106124524:1853780137	ATMF_500Secstudy	102	101	CREATE	2019-05-17 17:15:25.515	\N	\N
341	31	1558106126850:625403838	1558106126136:-293386120	ATMF_500Secstudy	104	103	CREATE	2019-05-17 17:15:27.031	\N	\N
343	31	1558106128323:1826789376	rootNode	ATMF_500Secstudy	106	0	CREATE	2019-05-17 17:15:28.472	\N	\N
344	31	1558106129061:1075235551	1558106128323:1826789376	ATMF_500Secstudy	107	106	CREATE	2019-05-17 17:15:29.226	\N	\N
564	31	1558106314031:1152902316	1558106313197:-928626448	ATMF_500Secstudy	327	326	CREATE	2019-05-17 17:18:34.184	\N	\N
348	31	1558106137939:-1155484998	rootNode	ATMF_500Secstudy	111	0	CREATE	2019-05-17 17:15:38.341	\N	\N
349	31	1558106138929:1403405649	1558106137939:-1155484998	ATMF_500Secstudy	112	111	CREATE	2019-05-17 17:15:39.099	\N	\N
351	31	1558106140432:478235459	1558106139667:-326058310	ATMF_500Secstudy	114	113	CREATE	2019-05-17 17:15:40.594	\N	\N
353	31	1558106141942:1137784336	rootNode	ATMF_500Secstudy	116	0	CREATE	2019-05-17 17:15:42.209	\N	\N
354	31	1558106142805:-1412225768	1558106141942:1137784336	ATMF_500Secstudy	117	116	CREATE	2019-05-17 17:15:42.966	\N	\N
356	31	1558106144220:-329773662	1558106143519:1069067593	ATMF_500Secstudy	119	118	CREATE	2019-05-17 17:15:44.406	\N	\N
359	31	1558106146529:156078982	1558106145735:211139206	ATMF_500Secstudy	122	121	CREATE	2019-05-17 17:15:46.701	\N	\N
361	31	1558106148101:124520775	1558106147262:-1890042304	ATMF_500Secstudy	124	123	CREATE	2019-05-17 17:15:48.288	\N	\N
363	31	1558106149567:184148342	rootNode	ATMF_500Secstudy	126	0	CREATE	2019-05-17 17:15:49.745	\N	\N
364	31	1558106150339:874825947	1558106149567:184148342	ATMF_500Secstudy	127	126	CREATE	2019-05-17 17:15:50.517	\N	\N
366	31	1558106151880:-1008321839	1558106151162:-842805861	ATMF_500Secstudy	129	128	CREATE	2019-05-17 17:15:52.341	\N	\N
368	31	1558106153595:-1182526514	rootNode	ATMF_500Secstudy	131	0	CREATE	2019-05-17 17:15:53.749	\N	\N
369	31	1558106154356:-1427090832	1558106153595:-1182526514	ATMF_500Secstudy	132	131	CREATE	2019-05-17 17:15:54.515	\N	\N
371	31	1558106155841:-1817196547	1558106155055:345171574	ATMF_500Secstudy	134	133	CREATE	2019-05-17 17:15:55.997	\N	\N
373	31	1558106157248:130166408	rootNode	ATMF_500Secstudy	136	0	CREATE	2019-05-17 17:15:57.432	\N	\N
374	31	1558106158009:1938361	1558106157248:130166408	ATMF_500Secstudy	137	136	CREATE	2019-05-17 17:15:58.232	\N	\N
376	31	1558106159664:-764662128	1558106158871:-1905736111	ATMF_500Secstudy	139	138	CREATE	2019-05-17 17:15:59.811	\N	\N
378	31	1558106161074:-1236508345	rootNode	ATMF_500Secstudy	141	0	CREATE	2019-05-17 17:16:01.259	\N	\N
379	31	1558106161889:2090075482	1558106161074:-1236508345	ATMF_500Secstudy	142	141	CREATE	2019-05-17 17:16:02.08	\N	\N
381	31	1558106163452:-1709026437	1558106162704:-178991037	ATMF_500Secstudy	144	143	CREATE	2019-05-17 17:16:03.618	\N	\N
383	31	1558106164899:76184371	rootNode	ATMF_500Secstudy	146	0	CREATE	2019-05-17 17:16:05.427	\N	\N
384	31	1558106166040:-1145009529	1558106164899:76184371	ATMF_500Secstudy	147	146	CREATE	2019-05-17 17:16:06.209	\N	\N
386	31	1558106167619:-2058737966	1558106166807:219697469	ATMF_500Secstudy	149	148	CREATE	2019-05-17 17:16:07.799	\N	\N
388	31	1558106169040:-1290489970	rootNode	ATMF_500Secstudy	151	0	CREATE	2019-05-17 17:16:09.293	\N	\N
389	31	1558106169960:-775784756	1558106169040:-1290489970	ATMF_500Secstudy	152	151	CREATE	2019-05-17 17:16:10.126	\N	\N
391	31	1558106171429:2131815328	1558106170683:-2083847462	ATMF_500Secstudy	154	153	CREATE	2019-05-17 17:16:11.643	\N	\N
393	31	1558106172917:22202334	rootNode	ATMF_500Secstudy	156	0	CREATE	2019-05-17 17:16:13.093	\N	\N
394	31	1558106173685:746253919	1558106172917:22202334	ATMF_500Secstudy	157	156	CREATE	2019-05-17 17:16:13.872	\N	\N
396	31	1558106175670:-1466619245	1558106174473:272595044	ATMF_500Secstudy	159	158	CREATE	2019-05-17 17:16:15.981	\N	\N
397	31	1558106176609:1336404910	1558106175670:-1466619245	ATMF_500Secstudy	160	159	CREATE	2019-05-17 17:16:16.765	\N	\N
399	31	1558106178215:-2015901293	1558106177305:-1344471492	ATMF_500Secstudy	162	161	CREATE	2019-05-17 17:16:18.429	\N	\N
401	31	1558106179693:-79944863	1558106178985:-1201521058	ATMF_500Secstudy	164	163	CREATE	2019-05-17 17:16:19.866	\N	\N
403	31	1558106181075:-31779703	rootNode	ATMF_500Secstudy	166	0	CREATE	2019-05-17 17:16:21.228	\N	\N
404	31	1558106181846:425463756	1558106181075:-31779703	ATMF_500Secstudy	167	166	CREATE	2019-05-17 17:16:22.344	\N	\N
406	31	1558106183656:1701928437	1558106182937:-1321281172	ATMF_500Secstudy	169	168	CREATE	2019-05-17 17:16:23.897	\N	\N
408	31	1558106185194:-677219026	rootNode	ATMF_500Secstudy	171	0	CREATE	2019-05-17 17:16:25.346	\N	\N
409	31	1558106185968:-335076266	1558106185194:-677219026	ATMF_500Secstudy	172	171	CREATE	2019-05-17 17:16:26.127	\N	\N
411	31	1558106187456:1405231082	1558106186698:-887120670	ATMF_500Secstudy	174	173	CREATE	2019-05-17 17:16:27.616	\N	\N
413	31	1558106188855:1334844398	rootNode	ATMF_500Secstudy	176	0	CREATE	2019-05-17 17:16:29.03	\N	\N
414	31	1558106189642:-1210243255	1558106188855:1334844398	ATMF_500Secstudy	177	176	CREATE	2019-05-17 17:16:29.805	\N	\N
416	31	1558106191131:1639016813	1558106190400:106428213	ATMF_500Secstudy	179	178	CREATE	2019-05-17 17:16:31.326	\N	\N
418	31	1558106192647:1307853534	rootNode	ATMF_500Secstudy	181	0	CREATE	2019-05-17 17:16:32.886	\N	\N
419	31	1558106193481:-11401822	1558106192647:1307853534	ATMF_500Secstudy	182	181	CREATE	2019-05-17 17:16:33.732	\N	\N
421	31	1558106195052:2039079723	1558106194279:-2019843871	ATMF_500Secstudy	184	183	CREATE	2019-05-17 17:16:35.215	\N	\N
423	31	1558106196375:-58820086	rootNode	ATMF_500Secstudy	186	0	CREATE	2019-05-17 17:16:36.529	\N	\N
424	31	1558106197172:-195688096	1558106196375:-58820086	ATMF_500Secstudy	187	186	CREATE	2019-05-17 17:16:37.324	\N	\N
426	31	1558106198718:665630442	1558106197902:1402025647	ATMF_500Secstudy	189	188	CREATE	2019-05-17 17:16:38.944	\N	\N
427	31	1558106199542:2088719503	1558106198718:665630442	ATMF_500Secstudy	190	189	CREATE	2019-05-17 17:16:39.698	\N	\N
429	31	1558106200941:-898654345	1558106200189:-85811053	ATMF_500Secstudy	192	191	CREATE	2019-05-17 17:16:41.161	\N	\N
431	31	1558106202462:-1660122091	1558106201717:432857670	ATMF_500Secstudy	194	193	CREATE	2019-05-17 17:16:42.624	\N	\N
433	31	1558106203871:-112802020	rootNode	ATMF_500Secstudy	196	0	CREATE	2019-05-17 17:16:44.071	\N	\N
434	31	1558106204678:-1519251887	1558106203871:-112802020	ATMF_500Secstudy	197	196	CREATE	2019-05-17 17:16:44.914	\N	\N
436	31	1558106206211:1072491087	1558106205520:1128135262	ATMF_500Secstudy	199	198	CREATE	2019-05-17 17:16:46.362	\N	\N
438	31	1558106208300:1199889872	rootNode	ATMF_500Secstudy	201	0	CREATE	2019-05-17 17:16:48.529	\N	\N
439	31	1558106209218:2103633211	1558106208300:1199889872	ATMF_500Secstudy	202	201	CREATE	2019-05-17 17:16:49.373	\N	\N
441	31	1558106210710:-173333509	1558106210003:-690431507	ATMF_500Secstudy	204	203	CREATE	2019-05-17 17:16:50.867	\N	\N
526	31	1558106283950:-1714634729	1558106282848:800746674	ATMF_500Secstudy	289	288	CREATE	2019-05-17 17:18:04.107	\N	\N
528	31	1558106285383:-739690400	rootNode	ATMF_500Secstudy	291	0	CREATE	2019-05-17 17:18:05.594	\N	\N
529	31	1558106286210:237379465	1558106285383:-739690400	ATMF_500Secstudy	292	291	CREATE	2019-05-17 17:18:06.433	\N	\N
531	31	1558106287819:252520907	1558106286983:804956048	ATMF_500Secstudy	294	293	CREATE	2019-05-17 17:18:08.042	\N	\N
532	31	1558106288661:1340720732	1558106287819:252520907	ATMF_500Secstudy	295	294	CREATE	2019-05-17 17:18:08.886	\N	\N
534	31	1558106290147:1765907887	1558106289381:-2106366492	ATMF_500Secstudy	297	296	CREATE	2019-05-17 17:18:10.305	\N	\N
536	31	1558106291651:1694475243	1558106290857:-1838182699	ATMF_500Secstudy	299	298	CREATE	2019-05-17 17:18:11.81	\N	\N
538	31	1558106293723:-2133357562	rootNode	ATMF_500Secstudy	301	0	CREATE	2019-05-17 17:18:14.163	\N	\N
539	31	1558106294827:78356752	1558106293723:-2133357562	ATMF_500Secstudy	302	301	CREATE	2019-05-17 17:18:14.977	\N	\N
11552	86	\N	\N	D5170C00002	3	2	NEW	\N	\N	\N
445	31	1558106213647:-344314355	1558106212929:1117453972	ATMF_500Secstudy	208	207	CREATE	2019-05-17 17:16:53.815	\N	\N
447	31	1558106215420:-1339118781	1558106214454:1015864155	ATMF_500Secstudy	210	209	CREATE	2019-05-17 17:16:55.587	\N	\N
448	31	1558106216123:1145908041	rootNode	ATMF_500Secstudy	211	0	CREATE	2019-05-17 17:16:56.32	\N	\N
450	31	1558106217745:885631587	1558106216997:-724696861	ATMF_500Secstudy	213	212	CREATE	2019-05-17 17:16:57.92	\N	\N
452	31	1558106219271:-1149802577	1558106218505:1535498318	ATMF_500Secstudy	215	214	CREATE	2019-05-17 17:16:59.485	\N	\N
453	31	1558106219958:1118917383	rootNode	ATMF_500Secstudy	216	0	CREATE	2019-05-17 17:17:00.115	\N	\N
455	31	1558106221460:471398737	1558106220707:796348264	ATMF_500Secstudy	218	217	CREATE	2019-05-17 17:17:01.698	\N	\N
457	31	1558106223095:-1955968025	1558106222315:1846345547	ATMF_500Secstudy	220	219	CREATE	2019-05-17 17:17:03.241	\N	\N
458	31	1558106223758:-247756855	rootNode	ATMF_500Secstudy	221	0	CREATE	2019-05-17 17:17:03.913	\N	\N
460	31	1558106225476:-302449313	1558106224540:84592556	ATMF_500Secstudy	223	222	CREATE	2019-05-17 17:17:05.694	\N	\N
462	31	1558106227067:468229918	1558106226330:1861850324	ATMF_500Secstudy	225	224	CREATE	2019-05-17 17:17:07.275	\N	\N
463	31	1558106227743:463062049	rootNode	ATMF_500Secstudy	226	0	CREATE	2019-05-17 17:17:07.969	\N	\N
465	31	1558106229658:1710065290	1558106228594:-1750890886	ATMF_500Secstudy	228	227	CREATE	2019-05-17 17:17:09.838	\N	\N
467	31	1558106231129:229350304	1558106230375:-1813699271	ATMF_500Secstudy	230	229	CREATE	2019-05-17 17:17:11.285	\N	\N
468	31	1558106231791:-1836416470	rootNode	ATMF_500Secstudy	231	0	CREATE	2019-05-17 17:17:11.957	\N	\N
470	31	1558106233273:-1960081921	1558106232555:-1189990778	ATMF_500Secstudy	233	232	CREATE	2019-05-17 17:17:13.424	\N	\N
471	31	1558106233986:-1668214939	1558106233273:-1960081921	ATMF_500Secstudy	234	233	CREATE	2019-05-17 17:17:14.135	\N	\N
473	31	1558106235411:-1863407334	rootNode	ATMF_500Secstudy	236	0	CREATE	2019-05-17 17:17:15.59	\N	\N
475	31	1558106236971:-1574951622	1558106236196:-100121452	ATMF_500Secstudy	238	237	CREATE	2019-05-17 17:17:17.219	\N	\N
476	31	1558106237873:-1032721091	1558106236971:-1574951622	ATMF_500Secstudy	239	238	CREATE	2019-05-17 17:17:18.032	\N	\N
478	31	1558106239607:1064885106	rootNode	ATMF_500Secstudy	241	0	CREATE	2019-05-17 17:17:19.804	\N	\N
480	31	1558106241185:1336504161	1558106240472:544206950	ATMF_500Secstudy	243	242	CREATE	2019-05-17 17:17:21.352	\N	\N
481	31	1558106241895:1569292178	1558106241185:1336504161	ATMF_500Secstudy	244	243	CREATE	2019-05-17 17:17:22.046	\N	\N
483	31	1558106243319:-1917388959	rootNode	ATMF_500Secstudy	246	0	CREATE	2019-05-17 17:17:23.478	\N	\N
485	31	1558106244848:854216955	1558106244077:-1686258741	ATMF_500Secstudy	248	247	CREATE	2019-05-17 17:17:25.014	\N	\N
486	31	1558106245575:-906438556	1558106244848:854216955	ATMF_500Secstudy	249	248	CREATE	2019-05-17 17:17:26.173	\N	\N
488	31	1558106247497:1010903172	rootNode	ATMF_500Secstudy	251	0	CREATE	2019-05-17 17:17:27.762	\N	\N
490	31	1558106249549:1299435683	1558106248417:-1702765393	ATMF_500Secstudy	253	252	CREATE	2019-05-17 17:17:29.807	\N	\N
491	31	1558106250394:-489441476	1558106249549:1299435683	ATMF_500Secstudy	254	253	CREATE	2019-05-17 17:17:30.628	\N	\N
493	31	1558106251867:-1971370790	rootNode	ATMF_500Secstudy	256	0	CREATE	2019-05-17 17:17:32.033	\N	\N
494	31	1558106252653:248883723	1558106251867:-1971370790	ATMF_500Secstudy	257	256	CREATE	2019-05-17 17:17:32.82	\N	\N
496	31	1558106254190:2042298893	1558106253434:1182570273	ATMF_500Secstudy	259	258	CREATE	2019-05-17 17:17:34.355	\N	\N
498	31	1558106255650:-1998361654	rootNode	ATMF_500Secstudy	261	0	CREATE	2019-05-17 17:17:35.848	\N	\N
499	31	1558106256453:166618590	1558106255650:-1998361654	ATMF_500Secstudy	262	261	CREATE	2019-05-17 17:17:36.606	\N	\N
501	31	1558106257873:1729892589	1558106257158:-1439522183	ATMF_500Secstudy	264	263	CREATE	2019-05-17 17:17:38.041	\N	\N
503	31	1558106259346:-2025341909	rootNode	ATMF_500Secstudy	266	0	CREATE	2019-05-17 17:17:39.501	\N	\N
504	31	1558106260170:-287973767	1558106259346:-2025341909	ATMF_500Secstudy	267	266	CREATE	2019-05-17 17:17:40.558	\N	\N
506	31	1558106261973:1726455575	1558106261196:-1368905796	ATMF_500Secstudy	269	268	CREATE	2019-05-17 17:17:42.16	\N	\N
508	31	1558106263439:-2052332670	rootNode	ATMF_500Secstudy	271	0	CREATE	2019-05-17 17:17:49.848	\N	\N
509	31	1558106270511:-1245120921	1558106263439:-2052332670	ATMF_500Secstudy	272	271	CREATE	2019-05-17 17:17:50.683	\N	\N
511	31	1558106272112:-903501714	1558106271335:-481798401	ATMF_500Secstudy	274	273	CREATE	2019-05-17 17:17:52.271	\N	\N
513	31	1558106273564:875948131	rootNode	ATMF_500Secstudy	276	0	CREATE	2019-05-17 17:17:53.725	\N	\N
514	31	1558106274361:1203686609	1558106273564:875948131	ATMF_500Secstudy	277	276	CREATE	2019-05-17 17:17:54.537	\N	\N
516	31	1558106275873:-201082201	1558106275083:-862134929	ATMF_500Secstudy	279	278	CREATE	2019-05-17 17:17:56.033	\N	\N
518	31	1558106277215:263658205	rootNode	ATMF_500Secstudy	281	0	CREATE	2019-05-17 17:17:57.413	\N	\N
519	31	1558106278050:1410213691	1558106277215:263658205	ATMF_500Secstudy	282	281	CREATE	2019-05-17 17:17:58.238	\N	\N
521	31	1558106279894:1131530011	1558106278916:-1325016904	ATMF_500Secstudy	284	283	CREATE	2019-05-17 17:18:00.067	\N	\N
523	31	1558106281230:-712699639	rootNode	ATMF_500Secstudy	286	0	CREATE	2019-05-17 17:18:01.388	\N	\N
524	31	1558106282062:-1678404217	1558106281230:-712699639	ATMF_500Secstudy	287	286	CREATE	2019-05-17 17:18:02.295	\N	\N
11553	86	\N	\N	D5170C00002	4	3	NEW	\N	\N	\N
542	31	1558106297011:245191508	1558106296265:593739706	ATMF_500Secstudy	305	304	CREATE	2019-05-17 17:18:17.173	\N	\N
543	31	1558106297734:2134618973	rootNode	ATMF_500Secstudy	306	0	CREATE	2019-05-17 17:18:17.89	\N	\N
545	31	1558106299218:-755350377	1558106298492:-930802559	ATMF_500Secstudy	308	307	CREATE	2019-05-17 17:18:19.365	\N	\N
547	31	1558106300987:1609240493	1558106299949:2034662489	ATMF_500Secstudy	310	309	CREATE	2019-05-17 17:18:21.145	\N	\N
548	31	1558106301610:-847654165	rootNode	ATMF_500Secstudy	311	0	CREATE	2019-05-17 17:18:21.779	\N	\N
550	31	1558106303141:1109824842	1558106302362:-471329849	ATMF_500Secstudy	313	312	CREATE	2019-05-17 17:18:23.297	\N	\N
552	31	1558106304583:-1553890632	1558106303849:425853857	ATMF_500Secstudy	315	314	CREATE	2019-05-17 17:18:24.733	\N	\N
553	31	1558106305296:-874644926	rootNode	ATMF_500Secstudy	316	0	CREATE	2019-05-17 17:18:25.538	\N	\N
555	31	1558106306931:-1032594898	1558106306150:1405552659	ATMF_500Secstudy	318	317	CREATE	2019-05-17 17:18:27.161	\N	\N
557	31	1558106308668:1146674799	1558106307705:-1097853502	ATMF_500Secstudy	320	319	CREATE	2019-05-17 17:18:28.814	\N	\N
558	31	1558106309314:-901635687	rootNode	ATMF_500Secstudy	321	0	CREATE	2019-05-17 17:18:29.492	\N	\N
560	31	1558106310927:1136714601	1558106310123:-770035585	ATMF_500Secstudy	323	322	CREATE	2019-05-17 17:18:31.083	\N	\N
562	31	1558106312575:1546335889	1558106311654:10801968	ATMF_500Secstudy	325	324	CREATE	2019-05-17 17:18:32.73	\N	\N
563	31	1558106313197:-928626448	rootNode	ATMF_500Secstudy	326	0	CREATE	2019-05-17 17:18:33.364	\N	\N
565	31	1558106314760:1600824318	1558106314031:1152902316	ATMF_500Secstudy	328	327	CREATE	2019-05-17 17:18:35.067	\N	\N
567	31	1558106316560:-1165065293	1558106315659:11490092	ATMF_500Secstudy	330	329	CREATE	2019-05-17 17:18:36.783	\N	\N
568	31	1558106317321:1999664241	rootNode	ATMF_500Secstudy	331	0	CREATE	2019-05-17 17:18:37.476	\N	\N
570	31	1558106318857:198092454	1558106318073:1927728829	ATMF_500Secstudy	333	332	CREATE	2019-05-17 17:18:39.063	\N	\N
572	31	1558106320354:1706141123	1558106319630:1314216253	ATMF_500Secstudy	335	334	CREATE	2019-05-17 17:18:40.514	\N	\N
573	31	1558106321038:1403949168	rootNode	ATMF_500Secstudy	336	0	CREATE	2019-05-17 17:18:41.244	\N	\N
575	31	1558106322575:-1648826486	1558106321833:-2033249594	ATMF_500Secstudy	338	337	CREATE	2019-05-17 17:18:42.789	\N	\N
577	31	1558106324336:-416380402	1558106323377:-1142956750	ATMF_500Secstudy	340	339	CREATE	2019-05-17 17:18:44.501	\N	\N
578	31	1558106325040:411006274	rootNode	ATMF_500Secstudy	341	0	CREATE	2019-05-17 17:18:45.206	\N	\N
580	31	1558106326501:-263178352	1558106325794:-1578013945	ATMF_500Secstudy	343	342	CREATE	2019-05-17 17:18:46.651	\N	\N
582	31	1558106328008:311683824	1558106327220:-1925881447	ATMF_500Secstudy	345	344	CREATE	2019-05-17 17:18:48.159	\N	\N
583	31	1558106328625:-955669612	rootNode	ATMF_500Secstudy	346	0	CREATE	2019-05-17 17:18:49.088	\N	\N
585	31	1558106330561:-203959303	1558106329707:542431936	ATMF_500Secstudy	348	347	CREATE	2019-05-17 17:18:50.804	\N	\N
587	31	1558106332074:1581626296	1558106331360:-1226145618	ATMF_500Secstudy	350	349	CREATE	2019-05-17 17:18:52.247	\N	\N
588	31	1558106332707:-982660476	rootNode	ATMF_500Secstudy	351	0	CREATE	2019-05-17 17:18:52.878	\N	\N
590	31	1558106334317:-1615284018	1558106333526:-222743871	ATMF_500Secstudy	353	352	CREATE	2019-05-17 17:18:54.482	\N	\N
591	31	1558106335032:-407666135	1558106334317:-1615284018	ATMF_500Secstudy	354	353	CREATE	2019-05-17 17:18:55.179	\N	\N
593	31	1558106336428:-1009651237	rootNode	ATMF_500Secstudy	356	0	CREATE	2019-05-17 17:18:56.596	\N	\N
595	31	1558106337888:-1816441324	1558106337188:-1588699772	ATMF_500Secstudy	358	357	CREATE	2019-05-17 17:18:58.036	\N	\N
596	31	1558106338645:-1782153951	1558106337888:-1816441324	ATMF_500Secstudy	359	358	CREATE	2019-05-17 17:18:58.819	\N	\N
598	31	1558106340129:303042509	rootNode	ATMF_500Secstudy	361	0	CREATE	2019-05-17 17:19:00.53	\N	\N
600	31	1558106341949:1586701590	1558106341135:-1349355614	ATMF_500Secstudy	363	362	CREATE	2019-05-17 17:19:02.136	\N	\N
601	31	1558106342734:1946685357	1558106341949:1586701590	ATMF_500Secstudy	364	363	CREATE	2019-05-17 17:19:02.928	\N	\N
603	31	1558106344120:-1063633068	rootNode	ATMF_500Secstudy	366	0	CREATE	2019-05-17 17:19:04.277	\N	\N
605	31	1558106345629:-39713730	1558106344923:77712752	ATMF_500Secstudy	368	367	CREATE	2019-05-17 17:19:06.09	\N	\N
606	31	1558106346685:-920288430	1558106345629:-39713730	ATMF_500Secstudy	369	368	CREATE	2019-05-17 17:19:06.887	\N	\N
608	31	1558106348300:249060472	rootNode	ATMF_500Secstudy	371	0	CREATE	2019-05-17 17:19:08.492	\N	\N
610	31	1558106349890:863312386	1558106349107:-1799038688	ATMF_500Secstudy	373	372	CREATE	2019-05-17 17:19:10.051	\N	\N
611	31	1558106350587:2039607883	1558106349890:863312386	ATMF_500Secstudy	374	373	CREATE	2019-05-17 17:19:10.738	\N	\N
613	31	1558106352000:222069608	rootNode	ATMF_500Secstudy	376	0	CREATE	2019-05-17 17:19:12.157	\N	\N
614	31	1558106352760:-1615602641	1558106352000:222069608	ATMF_500Secstudy	377	376	CREATE	2019-05-17 17:19:12.969	\N	\N
616	31	1558106354300:-1065939095	1558106353532:-596517286	ATMF_500Secstudy	379	378	CREATE	2019-05-17 17:19:14.476	\N	\N
618	31	1558106355721:-1144605660	rootNode	ATMF_500Secstudy	381	0	CREATE	2019-05-17 17:19:15.906	\N	\N
619	31	1558106356616:1270565465	1558106355721:-1144605660	ATMF_500Secstudy	382	381	CREATE	2019-05-17 17:19:16.783	\N	\N
621	31	1558106358165:-2046674919	1558106357345:1890020067	ATMF_500Secstudy	384	383	CREATE	2019-05-17 17:19:18.327	\N	\N
623	31	1558106359562:168087674	rootNode	ATMF_500Secstudy	386	0	CREATE	2019-05-17 17:19:19.738	\N	\N
624	31	1558106360321:-692395302	1558106359562:168087674	ATMF_500Secstudy	387	386	CREATE	2019-05-17 17:19:20.491	\N	\N
626	31	1558106361850:1704540070	1558106361052:-604765242	ATMF_500Secstudy	389	388	CREATE	2019-05-17 17:19:22.013	\N	\N
628	31	1558106363224:-411052546	rootNode	ATMF_500Secstudy	391	0	CREATE	2019-05-17 17:19:23.403	\N	\N
629	31	1558106364073:49837412	1558106363224:-411052546	ATMF_500Secstudy	392	391	CREATE	2019-05-17 17:19:24.257	\N	\N
631	31	1558106365541:1513942882	1558106364813:993265664	ATMF_500Secstudy	394	393	CREATE	2019-05-17 17:19:25.707	\N	\N
633	31	1558106366902:195027474	rootNode	ATMF_500Secstudy	396	0	CREATE	2019-05-17 17:19:27.083	\N	\N
634	31	1558106367680:544232541	1558106366902:195027474	ATMF_500Secstudy	397	396	CREATE	2019-05-17 17:19:27.833	\N	\N
636	31	1558106369170:1957457467	1558106368433:-1791619042	ATMF_500Secstudy	399	398	CREATE	2019-05-17 17:19:29.349	\N	\N
1405	53	\N	\N	ACQSIT02	2	1	NEW	\N	\N	\N
639	31	1558106373700:1618799960	1558106372945:1507720911	ATMF_500Secstudy	402	401	CREATE	2019-05-17 17:19:33.886	\N	\N
641	31	1558106375262:1914706043	1558106374453:1939507307	ATMF_500Secstudy	404	403	CREATE	2019-05-17 17:19:35.413	\N	\N
642	31	1558106376045:2112130487	1558106375262:1914706043	ATMF_500Secstudy	405	404	CREATE	2019-05-17 17:19:36.2	\N	\N
644	31	1558106377564:-1845507061	1558106376726:141045437	ATMF_500Secstudy	407	406	CREATE	2019-05-17 17:19:37.803	\N	\N
646	31	1558106379089:-1938275476	1558106378363:-1448342169	ATMF_500Secstudy	409	408	CREATE	2019-05-17 17:19:39.301	\N	\N
648	31	1558106380513:1453739183	rootNode	ATMF_500Secstudy	411	0	CREATE	2019-05-17 17:19:40.701	\N	\N
649	31	1558106381292:-826766703	1558106380513:1453739183	ATMF_500Secstudy	412	411	CREATE	2019-05-17 17:19:41.444	\N	\N
651	31	1558106382722:-1174880869	1558106382008:1759667089	ATMF_500Secstudy	414	413	CREATE	2019-05-17 17:19:42.886	\N	\N
653	31	1558106384168:1426748319	rootNode	ATMF_500Secstudy	416	0	CREATE	2019-05-17 17:19:44.473	\N	\N
654	31	1558106385125:-1503146226	1558106384168:1426748319	ATMF_500Secstudy	417	416	CREATE	2019-05-17 17:19:45.309	\N	\N
656	31	1558106386625:1989786221	1558106385858:1498311834	ATMF_500Secstudy	419	418	CREATE	2019-05-17 17:19:46.799	\N	\N
658	31	1558106387987:60072742	rootNode	ATMF_500Secstudy	421	0	CREATE	2019-05-17 17:19:48.135	\N	\N
659	31	1558106388736:2127497680	1558106387987:60072742	ATMF_500Secstudy	422	421	CREATE	2019-05-17 17:19:49.006	\N	\N
661	31	1558106390429:-1865152407	1558106389674:1885869080	ATMF_500Secstudy	424	423	CREATE	2019-05-17 17:19:50.596	\N	\N
663	31	1558106391781:1372766591	rootNode	ATMF_500Secstudy	426	0	CREATE	2019-05-17 17:19:51.964	\N	\N
664	31	1558106392610:780711173	1558106391781:1372766591	ATMF_500Secstudy	427	426	CREATE	2019-05-17 17:19:52.762	\N	\N
666	31	1558106394075:204580112	1558106393310:1464481687	ATMF_500Secstudy	429	428	CREATE	2019-05-17 17:19:54.265	\N	\N
668	31	1558106395438:1345775624	rootNode	ATMF_500Secstudy	431	0	CREATE	2019-05-17 17:19:55.62	\N	\N
669	31	1558106396250:-1442452664	1558106395438:1345775624	ATMF_500Secstudy	432	431	CREATE	2019-05-17 17:19:56.415	\N	\N
671	31	1558106397701:-1108832876	1558106396977:-165025419	ATMF_500Secstudy	434	433	CREATE	2019-05-17 17:19:57.892	\N	\N
672	31	1558106398463:931764111	1558106397701:-1108832876	ATMF_500Secstudy	435	434	CREATE	2019-05-17 17:19:58.699	\N	\N
674	31	1558106400060:699824707	1558106399185:1318784863	ATMF_500Secstudy	437	436	CREATE	2019-05-17 17:20:00.297	\N	\N
676	31	1558106401994:1138418107	1558106400827:-1535537195	ATMF_500Secstudy	439	438	CREATE	2019-05-17 17:20:02.615	\N	\N
678	31	1558106404250:-47891023	rootNode	ATMF_500Secstudy	441	0	CREATE	2019-05-17 17:20:04.43	\N	\N
679	31	1558106405076:-1623753711	1558106404250:-47891023	ATMF_500Secstudy	442	441	CREATE	2019-05-17 17:20:05.232	\N	\N
681	31	1558106406644:-142757630	1558106405914:2032570101	ATMF_500Secstudy	444	443	CREATE	2019-05-17 17:20:06.945	\N	\N
683	31	1558106408308:729228220	rootNode	ATMF_500Secstudy	446	0	CREATE	2019-05-17 17:20:08.55	\N	\N
684	31	1558106409138:-572845083	1558106408308:729228220	ATMF_500Secstudy	447	446	CREATE	2019-05-17 17:20:09.673	\N	\N
686	31	1558106411082:-1286522226	1558106410296:-226792650	ATMF_500Secstudy	449	448	CREATE	2019-05-17 17:20:11.237	\N	\N
688	31	1558106412523:-1636549196	rootNode	ATMF_500Secstudy	451	0	CREATE	2019-05-17 17:20:12.685	\N	\N
689	31	1558106413279:-1009262458	1558106412523:-1636549196	ATMF_500Secstudy	452	451	CREATE	2019-05-17 17:20:13.44	\N	\N
691	31	1558106414826:-1933349611	1558106414034:-100503637	ATMF_500Secstudy	454	453	CREATE	2019-05-17 17:20:15.287	\N	\N
693	31	1558106416499:1291742111	rootNode	ATMF_500Secstudy	456	0	CREATE	2019-05-17 17:20:16.666	\N	\N
694	31	1558106417347:1234325873	1558106416499:1291742111	ATMF_500Secstudy	457	456	CREATE	2019-05-17 17:20:17.574	\N	\N
696	31	1558106418811:-1285820873	1558106418121:-754031935	ATMF_500Secstudy	459	458	CREATE	2019-05-17 17:20:18.981	\N	\N
698	31	1558106420304:1264751144	rootNode	ATMF_500Secstudy	461	0	CREATE	2019-05-17 17:20:20.484	\N	\N
699	31	1558106421082:2100213991	1558106420304:1264751144	ATMF_500Secstudy	462	461	CREATE	2019-05-17 17:20:21.231	\N	\N
701	31	1558106422632:-1095886731	1558106421904:704474210	ATMF_500Secstudy	464	463	CREATE	2019-05-17 17:20:22.782	\N	\N
702	31	1558106423317:-357930266	1558106422632:-1095886731	ATMF_500Secstudy	465	464	CREATE	2019-05-17 17:20:23.474	\N	\N
704	31	1558106424813:-2006560753	1558106424037:-1717511591	ATMF_500Secstudy	467	466	CREATE	2019-05-17 17:20:24.962	\N	\N
706	31	1558106426372:-1432098096	1558106425609:1359589921	ATMF_500Secstudy	469	468	CREATE	2019-05-17 17:20:26.534	\N	\N
708	31	1558106427834:-1744502352	rootNode	ATMF_500Secstudy	471	0	CREATE	2019-05-17 17:20:28.274	\N	\N
709	31	1558106428865:1775370744	1558106427834:-1744502352	ATMF_500Secstudy	472	471	CREATE	2019-05-17 17:20:29.041	\N	\N
711	31	1558106430401:1300868013	1558106429656:-1169669996	ATMF_500Secstudy	474	473	CREATE	2019-05-17 17:20:30.85	\N	\N
713	31	1558106432208:-1771493216	rootNode	ATMF_500Secstudy	476	0	CREATE	2019-05-17 17:20:32.359	\N	\N
714	31	1558106432948:-9373110	1558106432208:-1771493216	ATMF_500Secstudy	477	476	CREATE	2019-05-17 17:20:33.107	\N	\N
716	31	1558106434373:546342800	1558106433679:-1716241849	ATMF_500Secstudy	479	478	CREATE	2019-05-17 17:20:34.558	\N	\N
718	31	1558106435851:-1798483977	rootNode	ATMF_500Secstudy	481	0	CREATE	2019-05-17 17:20:36.019	\N	\N
719	31	1558106436616:-431604393	1558106435851:-1798483977	ATMF_500Secstudy	482	481	CREATE	2019-05-17 17:20:36.771	\N	\N
721	31	1558106438158:1303251032	1558106437445:238585739	ATMF_500Secstudy	484	483	CREATE	2019-05-17 17:20:38.355	\N	\N
723	31	1558106439547:1129796206	rootNode	ATMF_500Secstudy	486	0	CREATE	2019-05-17 17:20:39.707	\N	\N
724	31	1558106440303:386049724	1558106439547:1129796206	ATMF_500Secstudy	487	486	CREATE	2019-05-17 17:20:40.451	\N	\N
726	31	1558106441743:-1115950362	1558106441007:-2134230308	ATMF_500Secstudy	489	488	CREATE	2019-05-17 17:20:41.905	\N	\N
728	31	1558106443161:-1852465705	rootNode	ATMF_500Secstudy	491	0	CREATE	2019-05-17 17:20:43.577	\N	\N
729	31	1558106444198:974349546	1558106443161:-1852465705	ATMF_500Secstudy	492	491	CREATE	2019-05-17 17:20:44.379	\N	\N
731	31	1558106445624:793166518	1558106444920:-1893422226	ATMF_500Secstudy	494	493	CREATE	2019-05-17 17:20:45.782	\N	\N
732	31	1558106446373:-3199960	1558106445624:793166518	ATMF_500Secstudy	495	494	CREATE	2019-05-17 17:20:46.542	\N	\N
1401	52	1559564825325:237206177	rootNode	ATMF_Unicode	1	0	CREATE	2019-06-03 14:27:05.53	\N	\N
238	31	1558106041022:1746963128	rootNode	ATMF_500Secstudy	1	0	CREATE	2019-05-17 17:14:01.198	\N	\N
239	31	1558106041846:-803107606	1558106041022:1746963128	ATMF_500Secstudy	2	1	CREATE	2019-05-17 17:14:02.044	\N	\N
241	31	1558106043375:335112201	1558106042621:-1512592502	ATMF_500Secstudy	4	3	CREATE	2019-05-17 17:14:03.627	\N	\N
244	31	1558106045636:-1575889553	1558106044861:853466674	ATMF_500Secstudy	7	6	CREATE	2019-05-17 17:14:05.804	\N	\N
246	31	1558106047148:-817698127	1558106046368:-1052977442	ATMF_500Secstudy	9	8	CREATE	2019-05-17 17:14:07.314	\N	\N
249	31	1558106049402:-971586618	1558106048588:-202153780	ATMF_500Secstudy	12	11	CREATE	2019-05-17 17:14:09.575	\N	\N
250	31	1558106050126:298457950	1558106049402:-971586618	ATMF_500Secstudy	13	12	CREATE	2019-05-17 17:14:10.292	\N	\N
252	31	1558106051657:-2014294710	1558106050901:1875601594	ATMF_500Secstudy	15	14	CREATE	2019-05-17 17:14:11.866	\N	\N
255	31	1558106053982:1711073953	1558106053226:-239547935	ATMF_500Secstudy	18	17	CREATE	2019-05-17 17:14:14.149	\N	\N
257	31	1558106055485:-1554028952	1558106054756:558828909	ATMF_500Secstudy	20	19	CREATE	2019-05-17 17:14:15.638	\N	\N
260	31	1558106057734:2044718885	1558106057019:1316350821	ATMF_500Secstudy	23	22	CREATE	2019-05-17 17:14:17.888	\N	\N
262	31	1558106059253:1642030210	1558106058466:-981678066	ATMF_500Secstudy	25	24	CREATE	2019-05-17 17:14:19.412	\N	\N
265	31	1558106061482:1394749499	1558106060709:304674559	ATMF_500Secstudy	28	27	CREATE	2019-05-17 17:14:21.654	\N	\N
268	31	1558106063653:811036825	rootNode	ATMF_500Secstudy	31	0	CREATE	2019-05-17 17:14:23.808	\N	\N
270	31	1558106065183:-2137240293	1558106064446:1301066494	ATMF_500Secstudy	33	32	CREATE	2019-05-17 17:14:25.355	\N	\N
272	31	1558106066789:700541302	1558106066004:-1580541266	ATMF_500Secstudy	35	34	CREATE	2019-05-17 17:14:26.954	\N	\N
275	31	1558106068965:-1806475381	1558106068243:124608026	ATMF_500Secstudy	38	37	CREATE	2019-05-17 17:14:29.165	\N	\N
277	31	1558106070481:1626734186	1558106069744:2119834467	ATMF_500Secstudy	40	39	CREATE	2019-05-17 17:14:30.846	\N	\N
944	50	\N	\N	PT001002	27	0	NEW	\N		02 Central Trial Documents
280	31	1558106073024:-37276044	1558106072215:-25862764	ATMF_500Secstudy	43	42	CREATE	2019-05-17 17:14:33.208	\N	\N
282	31	1558106074606:-1823319366	1558106073822:-1713094612	ATMF_500Secstudy	45	44	CREATE	2019-05-17 17:14:34.77	\N	\N
285	31	1558106076754:-1706860598	1558106076044:-1851771346	ATMF_500Secstudy	48	47	CREATE	2019-05-17 17:14:37.157	\N	\N
287	31	1558106078548:-574177437	1558106077767:-676234931	ATMF_500Secstudy	50	49	CREATE	2019-05-17 17:14:38.706	\N	\N
290	31	1558106086108:959061542	1558106079990:-63987421	ATMF_500Secstudy	53	52	CREATE	2019-05-17 17:14:46.27	\N	\N
292	31	1558106087662:1260940655	1558106086858:-333046063	ATMF_500Secstudy	55	54	CREATE	2019-05-17 17:14:47.839	\N	\N
295	31	1558106090050:-811444488	1558106089106:-241269754	ATMF_500Secstudy	58	57	CREATE	2019-05-17 17:14:50.289	\N	\N
298	31	1558106092383:1337177159	rootNode	ATMF_500Secstudy	61	0	CREATE	2019-05-17 17:14:52.538	\N	\N
300	31	1558106094434:1035353093	1558106093154:-1407344743	ATMF_500Secstudy	63	62	CREATE	2019-05-17 17:14:54.597	\N	\N
302	31	1558106095982:-484595727	1558106095239:-269171463	ATMF_500Secstudy	65	64	CREATE	2019-05-17 17:14:56.131	\N	\N
305	31	1558106098207:-1576066672	1558106097461:1786584351	ATMF_500Secstudy	68	67	CREATE	2019-05-17 17:14:58.388	\N	\N
307	31	1558106099757:621011709	1558106098934:1944948156	ATMF_500Secstudy	70	69	CREATE	2019-05-17 17:14:59.938	\N	\N
310	31	1558106101976:-1074151030	1558106101183:1655894444	ATMF_500Secstudy	73	72	CREATE	2019-05-17 17:15:02.145	\N	\N
312	31	1558106103450:1804657911	1558106102726:1722279736	ATMF_500Secstudy	75	74	CREATE	2019-05-17 17:15:03.613	\N	\N
315	31	1558106105657:-999341738	1558106104936:-1518422025	ATMF_500Secstudy	78	77	CREATE	2019-05-17 17:15:05.814	\N	\N
317	31	1558106107165:1492404108	1558106106360:1421436472	ATMF_500Secstudy	80	79	CREATE	2019-05-17 17:15:07.391	\N	\N
320	31	1558106109472:-879158395	1558106108670:-993153771	ATMF_500Secstudy	83	82	CREATE	2019-05-17 17:15:09.689	\N	\N
322	31	1558106111030:-292953092	1558106110258:-1939049668	ATMF_500Secstudy	85	84	CREATE	2019-05-17 17:15:11.197	\N	\N
325	31	1558106113436:-1507103020	1558106112647:-1838897690	ATMF_500Secstudy	88	87	CREATE	2019-05-17 17:15:13.588	\N	\N
327	31	1558106115040:-451099819	1558106114148:-2087694856	ATMF_500Secstudy	90	89	CREATE	2019-05-17 17:15:15.207	\N	\N
330	31	1558106117367:1829056699	1558106116566:-422245180	ATMF_500Secstudy	93	92	CREATE	2019-05-17 17:15:17.535	\N	\N
332	31	1558106118840:-1521706949	1558106118096:1568748531	ATMF_500Secstudy	95	94	CREATE	2019-05-17 17:15:19.1	\N	\N
335	31	1558106121495:878824752	1558106120394:610516613	ATMF_500Secstudy	98	97	CREATE	2019-05-17 17:15:21.804	\N	\N
338	31	1558106124524:1853780137	rootNode	ATMF_500Secstudy	101	0	CREATE	2019-05-17 17:15:24.698	\N	\N
340	31	1558106126136:-293386120	1558106125364:-1512355022	ATMF_500Secstudy	103	102	CREATE	2019-05-17 17:15:26.289	\N	\N
342	31	1558106127603:1722438367	1558106126850:625403838	ATMF_500Secstudy	105	104	CREATE	2019-05-17 17:15:27.819	\N	\N
345	31	1558106129798:1903781748	1558106129061:1075235551	ATMF_500Secstudy	108	107	CREATE	2019-05-17 17:15:30.241	\N	\N
346	31	1558106130899:-1186436101	1558106129798:1903781748	ATMF_500Secstudy	109	108	CREATE	2019-05-17 17:15:31.05	\N	\N
347	31	1558106137131:2090845825	1558106130899:-1186436101	ATMF_500Secstudy	110	109	CREATE	2019-05-17 17:15:37.342	\N	\N
350	31	1558106139667:-326058310	1558106138929:1403405649	ATMF_500Secstudy	113	112	CREATE	2019-05-17 17:15:39.876	\N	\N
352	31	1558106141152:276096188	1558106140432:478235459	ATMF_500Secstudy	115	114	CREATE	2019-05-17 17:15:41.316	\N	\N
355	31	1558106143519:1069067593	1558106142805:-1412225768	ATMF_500Secstudy	118	117	CREATE	2019-05-17 17:15:43.672	\N	\N
357	31	1558106144976:746358668	1558106144220:-329773662	ATMF_500Secstudy	120	119	CREATE	2019-05-17 17:15:45.131	\N	\N
360	31	1558106147262:-1890042304	1558106146529:156078982	ATMF_500Secstudy	123	122	CREATE	2019-05-17 17:15:47.492	\N	\N
362	31	1558106148873:-195584126	1558106148101:124520775	ATMF_500Secstudy	125	124	CREATE	2019-05-17 17:15:49.086	\N	\N
365	31	1558106151162:-842805861	1558106150339:874825947	ATMF_500Secstudy	128	127	CREATE	2019-05-17 17:15:51.325	\N	\N
367	31	1558106152955:1705438833	1558106151880:-1008321839	ATMF_500Secstudy	130	129	CREATE	2019-05-17 17:15:53.123	\N	\N
370	31	1558106155055:345171574	1558106154356:-1427090832	ATMF_500Secstudy	133	132	CREATE	2019-05-17 17:15:55.239	\N	\N
735	31	1558106455723:28747854	1558106447880:-344866830	ATMF_500Secstudy	498	497	CREATE	2019-05-17 17:20:56.024	\N	\N
736	31	1558106456691:-351309031	1558106455723:28747854	ATMF_500Secstudy	499	498	CREATE	2019-05-17 17:20:56.845	\N	\N
372	31	1558106156580:-613215660	1558106155841:-1817196547	ATMF_500Secstudy	135	134	CREATE	2019-05-17 17:15:56.741	\N	\N
375	31	1558106158871:-1905736111	1558106158009:1938361	ATMF_500Secstudy	138	137	CREATE	2019-05-17 17:15:59.109	\N	\N
377	31	1558106160366:-884221597	1558106159664:-764662128	ATMF_500Secstudy	140	139	CREATE	2019-05-17 17:16:00.533	\N	\N
380	31	1558106162704:-178991037	1558106161889:2090075482	ATMF_500Secstudy	143	142	CREATE	2019-05-17 17:16:02.87	\N	\N
382	31	1558106164241:-274000282	1558106163452:-1709026437	ATMF_500Secstudy	145	144	CREATE	2019-05-17 17:16:04.405	\N	\N
385	31	1558106166807:219697469	1558106166040:-1145009529	ATMF_500Secstudy	148	147	CREATE	2019-05-17 17:16:07.047	\N	\N
387	31	1558106168389:-735347783	1558106167619:-2058737966	ATMF_500Secstudy	150	149	CREATE	2019-05-17 17:16:08.562	\N	\N
390	31	1558106170683:-2083847462	1558106169960:-775784756	ATMF_500Secstudy	153	152	CREATE	2019-05-17 17:16:10.885	\N	\N
392	31	1558106172264:1245800994	1558106171429:2131815328	ATMF_500Secstudy	155	154	CREATE	2019-05-17 17:16:12.44	\N	\N
395	31	1558106174473:272595044	1558106173685:746253919	ATMF_500Secstudy	158	157	CREATE	2019-05-17 17:16:15.035	\N	\N
398	31	1558106177305:-1344471492	rootNode	ATMF_500Secstudy	161	0	CREATE	2019-05-17 17:16:17.571	\N	\N
400	31	1558106178985:-1201521058	1558106178215:-2015901293	ATMF_500Secstudy	163	162	CREATE	2019-05-17 17:16:19.141	\N	\N
402	31	1558106180421:-11621411	1558106179693:-79944863	ATMF_500Secstudy	165	164	CREATE	2019-05-17 17:16:20.57	\N	\N
405	31	1558106182937:-1321281172	1558106181846:425463756	ATMF_500Secstudy	168	167	CREATE	2019-05-17 17:16:23.091	\N	\N
407	31	1558106184479:-758005607	1558106183656:1701928437	ATMF_500Secstudy	170	169	CREATE	2019-05-17 17:16:24.634	\N	\N
410	31	1558106186698:-887120670	1558106185968:-335076266	ATMF_500Secstudy	173	172	CREATE	2019-05-17 17:16:26.849	\N	\N
412	31	1558106188169:429709785	1558106187456:1405231082	ATMF_500Secstudy	175	174	CREATE	2019-05-17 17:16:28.328	\N	\N
415	31	1558106190400:106428213	1558106189642:-1210243255	ATMF_500Secstudy	178	177	CREATE	2019-05-17 17:16:30.56	\N	\N
417	31	1558106191882:-1093242332	1558106191131:1639016813	ATMF_500Secstudy	180	179	CREATE	2019-05-17 17:16:32.119	\N	\N
420	31	1558106194279:-2019843871	1558106193481:-11401822	ATMF_500Secstudy	183	182	CREATE	2019-05-17 17:16:34.449	\N	\N
422	31	1558106195772:-1441532906	1558106195052:2039079723	ATMF_500Secstudy	185	184	CREATE	2019-05-17 17:16:35.921	\N	\N
425	31	1558106197902:1402025647	1558106197172:-195688096	ATMF_500Secstudy	188	187	CREATE	2019-05-17 17:16:38.071	\N	\N
428	31	1558106200189:-85811053	rootNode	ATMF_500Secstudy	191	0	CREATE	2019-05-17 17:16:40.344	\N	\N
430	31	1558106201717:432857670	1558106200941:-898654345	ATMF_500Secstudy	193	192	CREATE	2019-05-17 17:16:41.88	\N	\N
432	31	1558106203216:1307026975	1558106202462:-1660122091	ATMF_500Secstudy	195	194	CREATE	2019-05-17 17:16:43.398	\N	\N
435	31	1558106205520:1128135262	1558106204678:-1519251887	ATMF_500Secstudy	198	197	CREATE	2019-05-17 17:16:45.669	\N	\N
437	31	1558106206921:203438355	1558106206211:1072491087	ATMF_500Secstudy	200	199	CREATE	2019-05-17 17:16:47.138	\N	\N
440	31	1558106210003:-690431507	1558106209218:2103633211	ATMF_500Secstudy	203	202	CREATE	2019-05-17 17:16:50.164	\N	\N
442	31	1558106211430:-1119174860	1558106210710:-173333509	ATMF_500Secstudy	205	204	CREATE	2019-05-17 17:16:51.58	\N	\N
443	31	1558106212112:1172899008	rootNode	ATMF_500Secstudy	206	0	CREATE	2019-05-17 17:16:52.275	\N	\N
444	31	1558106212929:1117453972	1558106212112:1172899008	ATMF_500Secstudy	207	206	CREATE	2019-05-17 17:16:53.083	\N	\N
446	31	1558106214454:1015864155	1558106213647:-344314355	ATMF_500Secstudy	209	208	CREATE	2019-05-17 17:16:54.832	\N	\N
449	31	1558106216997:-724696861	1558106216123:1145908041	ATMF_500Secstudy	212	211	CREATE	2019-05-17 17:16:57.179	\N	\N
451	31	1558106218505:1535498318	1558106217745:885631587	ATMF_500Secstudy	214	213	CREATE	2019-05-17 17:16:58.693	\N	\N
454	31	1558106220707:796348264	1558106219958:1118917383	ATMF_500Secstudy	217	216	CREATE	2019-05-17 17:17:00.857	\N	\N
456	31	1558106222315:1846345547	1558106221460:471398737	ATMF_500Secstudy	219	218	CREATE	2019-05-17 17:17:02.478	\N	\N
459	31	1558106224540:84592556	1558106223758:-247756855	ATMF_500Secstudy	222	221	CREATE	2019-05-17 17:17:04.889	\N	\N
461	31	1558106226330:1861850324	1558106225476:-302449313	ATMF_500Secstudy	224	223	CREATE	2019-05-17 17:17:06.501	\N	\N
464	31	1558106228594:-1750890886	1558106227743:463062049	ATMF_500Secstudy	227	226	CREATE	2019-05-17 17:17:09.027	\N	\N
466	31	1558106230375:-1813699271	1558106229658:1710065290	ATMF_500Secstudy	229	228	CREATE	2019-05-17 17:17:10.535	\N	\N
469	31	1558106232555:-1189990778	1558106231791:-1836416470	ATMF_500Secstudy	232	231	CREATE	2019-05-17 17:17:12.704	\N	\N
472	31	1558106234762:194302131	1558106233986:-1668214939	ATMF_500Secstudy	235	234	CREATE	2019-05-17 17:17:14.949	\N	\N
474	31	1558106236196:-100121452	1558106235411:-1863407334	ATMF_500Secstudy	237	236	CREATE	2019-05-17 17:17:16.411	\N	\N
477	31	1558106238622:-1383600399	1558106237873:-1032721091	ATMF_500Secstudy	240	239	CREATE	2019-05-17 17:17:19.076	\N	\N
479	31	1558106240472:544206950	1558106239607:1064885106	ATMF_500Secstudy	242	241	CREATE	2019-05-17 17:17:20.622	\N	\N
482	31	1558106242681:540724424	1558106241895:1569292178	ATMF_500Secstudy	245	244	CREATE	2019-05-17 17:17:22.848	\N	\N
484	31	1558106244077:-1686258741	1558106243319:-1917388959	ATMF_500Secstudy	247	246	CREATE	2019-05-17 17:17:24.239	\N	\N
487	31	1558106246760:-2011488714	1558106245575:-906438556	ATMF_500Secstudy	250	249	CREATE	2019-05-17 17:17:27.045	\N	\N
489	31	1558106248417:-1702765393	1558106247497:1010903172	ATMF_500Secstudy	252	251	CREATE	2019-05-17 17:17:28.923	\N	\N
492	31	1558106251199:13828197	1558106250394:-489441476	ATMF_500Secstudy	255	254	CREATE	2019-05-17 17:17:31.4	\N	\N
495	31	1558106253434:1182570273	1558106252653:248883723	ATMF_500Secstudy	258	257	CREATE	2019-05-17 17:17:33.624	\N	\N
497	31	1558106254925:201896800	1558106254190:2042298893	ATMF_500Secstudy	260	259	CREATE	2019-05-17 17:17:35.09	\N	\N
500	31	1558106257158:-1439522183	1558106256453:166618590	ATMF_500Secstudy	263	262	CREATE	2019-05-17 17:17:37.326	\N	\N
502	31	1558106258655:286596703	1558106257873:1729892589	ATMF_500Secstudy	265	264	CREATE	2019-05-17 17:17:38.856	\N	\N
505	31	1558106261196:-1368905796	1558106260170:-287973767	ATMF_500Secstudy	268	267	CREATE	2019-05-17 17:17:41.375	\N	\N
507	31	1558106262711:646147194	1558106261973:1726455575	ATMF_500Secstudy	270	269	CREATE	2019-05-17 17:17:42.929	\N	\N
510	31	1558106271335:-481798401	1558106270511:-1245120921	ATMF_500Secstudy	273	272	CREATE	2019-05-17 17:17:51.508	\N	\N
512	31	1558106272892:-1543479220	1558106272112:-903501714	ATMF_500Secstudy	275	274	CREATE	2019-05-17 17:17:53.054	\N	\N
1406	53	\N	\N	ACQSIT02	3	2	NEW	\N	\N	\N
515	31	1558106275083:-862134929	1558106274361:1203686609	ATMF_500Secstudy	278	277	CREATE	2019-05-17 17:17:55.258	\N	\N
517	31	1558106276582:2111138126	1558106275873:-201082201	ATMF_500Secstudy	280	279	CREATE	2019-05-17 17:17:56.739	\N	\N
520	31	1558106278916:-1325016904	1558106278050:1410213691	ATMF_500Secstudy	283	282	CREATE	2019-05-17 17:17:59.306	\N	\N
522	31	1558106280599:1934222637	1558106279894:1131530011	ATMF_500Secstudy	285	284	CREATE	2019-05-17 17:18:00.75	\N	\N
525	31	1558106282848:800746674	1558106282062:-1678404217	ATMF_500Secstudy	288	287	CREATE	2019-05-17 17:18:03.35	\N	\N
566	31	1558106315659:11490092	1558106314760:1600824318	ATMF_500Secstudy	329	328	CREATE	2019-05-17 17:18:35.873	\N	\N
569	31	1558106318073:1927728829	1558106317321:1999664241	ATMF_500Secstudy	332	331	CREATE	2019-05-17 17:18:38.243	\N	\N
571	31	1558106319630:1314216253	1558106318857:198092454	ATMF_500Secstudy	334	333	CREATE	2019-05-17 17:18:39.784	\N	\N
574	31	1558106321833:-2033249594	1558106321038:1403949168	ATMF_500Secstudy	337	336	CREATE	2019-05-17 17:18:42.021	\N	\N
576	31	1558106323377:-1142956750	1558106322575:-1648826486	ATMF_500Secstudy	339	338	CREATE	2019-05-17 17:18:43.702	\N	\N
579	31	1558106325794:-1578013945	1558106325040:411006274	ATMF_500Secstudy	342	341	CREATE	2019-05-17 17:18:45.956	\N	\N
581	31	1558106327220:-1925881447	1558106326501:-263178352	ATMF_500Secstudy	344	343	CREATE	2019-05-17 17:18:47.418	\N	\N
584	31	1558106329707:542431936	1558106328625:-955669612	ATMF_500Secstudy	347	346	CREATE	2019-05-17 17:18:49.921	\N	\N
586	31	1558106331360:-1226145618	1558106330561:-203959303	ATMF_500Secstudy	349	348	CREATE	2019-05-17 17:18:51.518	\N	\N
589	31	1558106333526:-222743871	1558106332707:-982660476	ATMF_500Secstudy	352	351	CREATE	2019-05-17 17:18:53.685	\N	\N
592	31	1558106335743:-1711727200	1558106335032:-407666135	ATMF_500Secstudy	355	354	CREATE	2019-05-17 17:18:55.894	\N	\N
594	31	1558106337188:-1588699772	1558106336428:-1009651237	ATMF_500Secstudy	357	356	CREATE	2019-05-17 17:18:57.339	\N	\N
597	31	1558106339370:-939355477	1558106338645:-1782153951	ATMF_500Secstudy	360	359	CREATE	2019-05-17 17:18:59.534	\N	\N
599	31	1558106341135:-1349355614	1558106340129:303042509	ATMF_500Secstudy	362	361	CREATE	2019-05-17 17:19:01.376	\N	\N
602	31	1558106343477:-1432008009	1558106342734:1946685357	ATMF_500Secstudy	365	364	CREATE	2019-05-17 17:19:03.644	\N	\N
604	31	1558106344923:77712752	1558106344120:-1063633068	ATMF_500Secstudy	367	366	CREATE	2019-05-17 17:19:05.084	\N	\N
607	31	1558106347467:582248678	1558106346685:-920288430	ATMF_500Secstudy	370	369	CREATE	2019-05-17 17:19:07.689	\N	\N
609	31	1558106349107:-1799038688	1558106348300:249060472	ATMF_500Secstudy	372	371	CREATE	2019-05-17 17:19:09.273	\N	\N
612	31	1558106351302:-131177344	1558106350587:2039607883	ATMF_500Secstudy	375	374	CREATE	2019-05-17 17:19:11.454	\N	\N
615	31	1558106353532:-596517286	1558106352760:-1615602641	ATMF_500Secstudy	378	377	CREATE	2019-05-17 17:19:13.697	\N	\N
617	31	1558106355073:-921192381	1558106354300:-1065939095	ATMF_500Secstudy	380	379	CREATE	2019-05-17 17:19:15.234	\N	\N
620	31	1558106357345:1890020067	1558106356616:1270565465	ATMF_500Secstudy	383	382	CREATE	2019-05-17 17:19:17.614	\N	\N
622	31	1558106358914:751477581	1558106358165:-2046674919	ATMF_500Secstudy	385	384	CREATE	2019-05-17 17:19:19.078	\N	\N
625	31	1558106361052:-604765242	1558106360321:-692395302	ATMF_500Secstudy	388	387	CREATE	2019-05-17 17:19:21.306	\N	\N
627	31	1558106362572:-182766043	1558106361850:1704540070	ATMF_500Secstudy	390	389	CREATE	2019-05-17 17:19:22.738	\N	\N
630	31	1558106364813:993265664	1558106364073:49837412	ATMF_500Secstudy	393	392	CREATE	2019-05-17 17:19:24.958	\N	\N
632	31	1558106366265:-693531261	1558106365541:1513942882	ATMF_500Secstudy	395	394	CREATE	2019-05-17 17:19:26.438	\N	\N
635	31	1558106368433:-1791619042	1558106367680:544232541	ATMF_500Secstudy	398	397	CREATE	2019-05-17 17:19:28.585	\N	\N
637	31	1558106371525:-164819796	1558106369170:1957457467	ATMF_500Secstudy	400	399	CREATE	2019-05-17 17:19:31.679	\N	\N
638	31	1558106372945:1507720911	rootNode	ATMF_500Secstudy	401	0	CREATE	2019-05-17 17:19:33.115	\N	\N
640	31	1558106374453:1939507307	1558106373700:1618799960	ATMF_500Secstudy	403	402	CREATE	2019-05-17 17:19:34.688	\N	\N
643	31	1558106376726:141045437	rootNode	ATMF_500Secstudy	406	0	CREATE	2019-05-17 17:19:36.907	\N	\N
645	31	1558106378363:-1448342169	1558106377564:-1845507061	ATMF_500Secstudy	408	407	CREATE	2019-05-17 17:19:38.541	\N	\N
647	31	1558106379905:-532922536	1558106379089:-1938275476	ATMF_500Secstudy	410	409	CREATE	2019-05-17 17:19:40.061	\N	\N
650	31	1558106382008:1759667089	1558106381292:-826766703	ATMF_500Secstudy	413	412	CREATE	2019-05-17 17:19:42.177	\N	\N
652	31	1558106383482:-559446930	1558106382722:-1174880869	ATMF_500Secstudy	415	414	CREATE	2019-05-17 17:19:43.677	\N	\N
655	31	1558106385858:1498311834	1558106385125:-1503146226	ATMF_500Secstudy	418	417	CREATE	2019-05-17 17:19:46.069	\N	\N
657	31	1558106387356:-67976875	1558106386625:1989786221	ATMF_500Secstudy	420	419	CREATE	2019-05-17 17:19:47.532	\N	\N
660	31	1558106389674:1885869080	1558106388736:2127497680	ATMF_500Secstudy	423	422	CREATE	2019-05-17 17:19:49.844	\N	\N
662	31	1558106391133:-1337863478	1558106390429:-1865152407	ATMF_500Secstudy	425	424	CREATE	2019-05-17 17:19:51.312	\N	\N
665	31	1558106393310:1464481687	1558106392610:780711173	ATMF_500Secstudy	428	427	CREATE	2019-05-17 17:19:53.46	\N	\N
667	31	1558106394805:-1265803815	1558106394075:204580112	ATMF_500Secstudy	430	429	CREATE	2019-05-17 17:19:54.967	\N	\N
670	31	1558106396977:-165025419	1558106396250:-1442452664	ATMF_500Secstudy	433	432	CREATE	2019-05-17 17:19:57.157	\N	\N
673	31	1558106399185:1318784863	rootNode	ATMF_500Secstudy	436	0	CREATE	2019-05-17 17:19:59.428	\N	\N
675	31	1558106400827:-1535537195	1558106400060:699824707	ATMF_500Secstudy	438	437	CREATE	2019-05-17 17:20:01.334	\N	\N
677	31	1558106403238:1447094376	1558106401994:1138418107	ATMF_500Secstudy	440	439	CREATE	2019-05-17 17:20:03.678	\N	\N
680	31	1558106405914:2032570101	1558106405076:-1623753711	ATMF_500Secstudy	443	442	CREATE	2019-05-17 17:20:06.102	\N	\N
682	31	1558106407532:164505907	1558106406644:-142757630	ATMF_500Secstudy	445	444	CREATE	2019-05-17 17:20:07.787	\N	\N
685	31	1558106410296:-226792650	1558106409138:-572845083	ATMF_500Secstudy	448	447	CREATE	2019-05-17 17:20:10.442	\N	\N
687	31	1558106411814:-447468647	1558106411082:-1286522226	ATMF_500Secstudy	450	449	CREATE	2019-05-17 17:20:11.994	\N	\N
690	31	1558106414034:-100503637	1558106413279:-1009262458	ATMF_500Secstudy	453	452	CREATE	2019-05-17 17:20:14.203	\N	\N
692	31	1558106415879:248388563	1558106414826:-1933349611	ATMF_500Secstudy	455	454	CREATE	2019-05-17 17:20:16.036	\N	\N
695	31	1558106418121:-754031935	1558106417347:1234325873	ATMF_500Secstudy	458	457	CREATE	2019-05-17 17:20:18.268	\N	\N
1407	53	\N	\N	ACQSIT02	4	3	NEW	\N	\N	\N
697	31	1558106419618:-2115798161	1558106418811:-1285820873	ATMF_500Secstudy	460	459	CREATE	2019-05-17 17:20:19.823	\N	\N
700	31	1558106421904:704474210	1558106421082:2100213991	ATMF_500Secstudy	463	462	CREATE	2019-05-17 17:20:22.056	\N	\N
703	31	1558106424037:-1717511591	rootNode	ATMF_500Secstudy	466	0	CREATE	2019-05-17 17:20:24.219	\N	\N
705	31	1558106425609:1359589921	1558106424813:-2006560753	ATMF_500Secstudy	468	467	CREATE	2019-05-17 17:20:25.764	\N	\N
707	31	1558106427189:2042383192	1558106426372:-1432098096	ATMF_500Secstudy	470	469	CREATE	2019-05-17 17:20:27.359	\N	\N
710	31	1558106429656:-1169669996	1558106428865:1775370744	ATMF_500Secstudy	473	472	CREATE	2019-05-17 17:20:29.828	\N	\N
712	31	1558106431449:1618414074	1558106430401:1300868013	ATMF_500Secstudy	475	474	CREATE	2019-05-17 17:20:31.691	\N	\N
715	31	1558106433679:-1716241849	1558106432948:-9373110	ATMF_500Secstudy	478	477	CREATE	2019-05-17 17:20:33.826	\N	\N
717	31	1558106435153:-185391260	1558106434373:546342800	ATMF_500Secstudy	480	479	CREATE	2019-05-17 17:20:35.384	\N	\N
720	31	1558106437445:238585739	1558106436616:-431604393	ATMF_500Secstudy	483	482	CREATE	2019-05-17 17:20:37.608	\N	\N
722	31	1558106438901:-1525689552	1558106438158:1303251032	ATMF_500Secstudy	485	484	CREATE	2019-05-17 17:20:39.052	\N	\N
725	31	1558106441007:-2134230308	1558106440303:386049724	ATMF_500Secstudy	488	487	CREATE	2019-05-17 17:20:41.203	\N	\N
727	31	1558106442436:-1632727401	1558106441743:-1115950362	ATMF_500Secstudy	490	489	CREATE	2019-05-17 17:20:42.626	\N	\N
730	31	1558106444920:-1893422226	1558106444198:974349546	ATMF_500Secstudy	493	492	CREATE	2019-05-17 17:20:45.076	\N	\N
733	31	1558106447086:-1879456363	rootNode	ATMF_500Secstudy	496	0	CREATE	2019-05-17 17:20:47.275	\N	\N
734	31	1558106447880:-344866830	1558106447086:-1879456363	ATMF_500Secstudy	497	496	CREATE	2019-05-17 17:20:55.018	\N	\N
737	31	1558106457447:-1571555173	1558106456691:-351309031	ATMF_500Secstudy	500	499	CREATE	2019-05-17 17:20:57.68	\N	\N
738	32	1558131234649:-2256577	rootNode	ATMF_5000docs	1	0	CREATE	2019-05-18 00:13:54.802	\N	\N
739	32	1558131235317:-519956932	rootNode	ATMF_5000docs	2	0	CREATE	2019-05-18 00:13:55.468	\N	\N
740	32	1558131236004:302031134	rootNode	ATMF_5000docs	3	0	CREATE	2019-05-18 00:13:56.198	\N	\N
741	32	1558131236842:-1831259881	rootNode	ATMF_5000docs	4	0	CREATE	2019-05-18 00:13:56.99	\N	\N
742	32	1558131237501:1946007163	rootNode	ATMF_5000docs	5	0	CREATE	2019-05-18 00:13:57.658	\N	\N
1238	51	1559200568368:-846723928	1559200564785:934227197	CV181-085	275	271	CREATE	2019-05-30 09:16:08.546	\N	\N
815	43	1558526276004:987481047	rootNode	ATMF_BigFile	1	0	CREATE	2019-05-22 13:57:56.195	\N	\N
861	47	1558635115835:-87069370	1558635114957:-1280948793	ATMF_SNL2	2	1	CREATE	2019-05-23 20:11:56.004	\N	\N
862	47	1558635116573:904362506	1558635115835:-87069370	ATMF_SNL2	3	2	CREATE	2019-05-23 20:11:56.841	\N	\N
863	47	1558635117594:-1654672868	1558635116573:904362506	ATMF_SNL2	4	3	CREATE	2019-05-23 20:11:57.748	\N	\N
864	47	1558635118449:801205834	1558635117594:-1654672868	ATMF_SNL2	5	4	CREATE	2019-05-23 20:11:58.844	\N	\N
865	47	1558635119391:-1307939554	rootNode	ATMF_SNL2	6	0	CREATE	2019-05-23 20:11:59.548	\N	\N
866	47	1558635120162:-606427559	1558635119391:-1307939554	ATMF_SNL2	7	6	CREATE	2019-05-23 20:12:00.328	\N	\N
867	47	1558635120898:344401337	1558635120162:-606427559	ATMF_SNL2	8	7	CREATE	2019-05-23 20:12:01.06	\N	\N
868	47	1558635121857:-1009418490	1558635120898:344401337	ATMF_SNL2	9	8	CREATE	2019-05-23 20:12:02.026	\N	\N
869	47	1558635122753:-88616914	1558635121857:-1009418490	ATMF_SNL2	10	9	CREATE	2019-05-23 20:12:02.941	\N	\N
1241	51	1559200570813:-360173046	1559200564785:934227197	CV181-085	278	271	CREATE	2019-05-30 09:16:11.02	\N	\N
1244	51	1559200573196:-1524616268	1559200564785:934227197	CV181-085	281	271	CREATE	2019-05-30 09:16:13.362	\N	\N
1247	51	1559200575700:1948712226	1559200564785:934227197	CV181-085	284	271	CREATE	2019-05-30 09:16:15.964	\N	\N
1249	51	1559200577375:183100331	1559200564785:934227197	CV181-085	286	271	CREATE	2019-05-30 09:16:17.634	\N	\N
1253	51	1559200580439:1790295873	1559200578977:760891089	CV181-085	290	288	CREATE	2019-05-30 09:16:20.635	\N	\N
1255	51	1559200582083:-1308877727	1559200578977:760891089	CV181-085	292	288	CREATE	2019-05-30 09:16:22.655	\N	\N
1258	51	1559200584871:-1754460708	1559200578977:760891089	CV181-085	295	288	CREATE	2019-05-30 09:16:25.115	\N	\N
1259	51	1559200585696:-424057552	1559200578977:760891089	CV181-085	296	288	CREATE	2019-05-30 09:16:25.927	\N	\N
1262	51	1559200588664:227587606	1559200578174:907236539	CV181-085	299	287	CREATE	2019-05-30 09:16:28.828	\N	\N
1264	51	1559200590969:-1834385289	1559200578174:907236539	CV181-085	301	287	CREATE	2019-05-30 09:16:31.147	\N	\N
1267	51	1559200593373:-1527508753	1559200578174:907236539	CV181-085	304	287	CREATE	2019-05-30 09:16:38.428	\N	\N
1269	51	1559200599975:-1815837123	1559200578174:907236539	CV181-085	306	287	CREATE	2019-05-30 09:16:40.147	\N	\N
1272	51	1559200602408:-1291112221	1559200578174:907236539	CV181-085	309	287	CREATE	2019-05-30 09:16:42.581	\N	\N
1275	51	1559200604612:-995019640	1559200603805:-1894885762	CV181-085	312	311	CREATE	2019-05-30 09:16:44.781	\N	\N
1277	51	1559200606240:-749936482	1559200604612:-995019640	CV181-085	314	312	CREATE	2019-05-30 09:16:46.477	\N	\N
1280	51	1559200608735:-497264390	1559200604612:-995019640	CV181-085	317	312	CREATE	2019-05-30 09:16:48.919	\N	\N
1283	51	1559200611530:-273788718	1559200604612:-995019640	CV181-085	320	312	CREATE	2019-05-30 09:16:51.69	\N	\N
1286	51	1559200613939:-1542903346	1559200603805:-1894885762	CV181-085	323	311	CREATE	2019-05-30 09:16:54.102	\N	\N
1288	51	1559200615551:1782019546	1559200603805:-1894885762	CV181-085	325	311	CREATE	2019-05-30 09:16:55.726	\N	\N
1290	51	1559200617085:-508287221	1559200603805:-1894885762	CV181-085	327	311	CREATE	2019-05-30 09:16:57.249	\N	\N
1293	51	1559200619862:1758258912	1559200603805:-1894885762	CV181-085	330	311	CREATE	2019-05-30 09:17:00.027	\N	\N
1295	51	1559200621364:357304561	1559200603805:-1894885762	CV181-085	332	311	CREATE	2019-05-30 09:17:01.54	\N	\N
1299	51	1559200624719:-1138860802	1559200623151:-629929397	CV181-085	336	334	CREATE	2019-05-30 09:17:04.881	\N	\N
1301	51	1559200626517:-1163233292	1559200622018:853256459	CV181-085	338	333	CREATE	2019-05-30 09:17:06.682	\N	\N
743	33	1558338185044:-875990928	rootNode	ATMF_INT0004	1	0	CREATE	2019-05-20 09:43:05.252	\N	\N
744	33	1558338185928:111291129	1558338185044:-875990928	ATMF_INT0004	2	1	CREATE	2019-05-20 09:43:06.305	\N	\N
745	33	1558338186923:-415768304	1558338185928:111291129	ATMF_INT0004	3	2	CREATE	2019-05-20 09:43:07.212	\N	\N
746	33	1558338187873:853939295	1558338186923:-415768304	ATMF_INT0004	4	3	CREATE	2019-05-20 09:43:08.416	\N	\N
747	33	1558338188958:-902981792	rootNode	ATMF_INT0004	5	0	CREATE	2019-05-20 09:43:09.238	\N	\N
748	33	1558338190001:-477122531	1558338188958:-902981792	ATMF_INT0004	6	5	CREATE	2019-05-20 09:43:10.711	\N	\N
749	33	1558338191245:2025309824	rootNode	ATMF_INT0004	7	0	CREATE	2019-05-20 09:43:11.755	\N	\N
750	33	1558338192366:-341051119	1558338191245:2025309824	ATMF_INT0004	8	7	CREATE	2019-05-20 09:43:12.693	\N	\N
751	33	1558338193318:-660713272	1558338192366:-341051119	ATMF_INT0004	9	8	CREATE	2019-05-20 09:43:13.575	\N	\N
788	40	1558510106087:-549403887	rootNode	ATMF_SplChar	1	0	CREATE	2019-05-22 09:28:26.305	\N	\N
789	40	1558510106912:-612187219	1558510106087:-549403887	ATMF_SplChar	2	1	CREATE	2019-05-22 09:28:27.165	\N	\N
790	40	1558510107828:-614961055	1558510106912:-612187219	ATMF_SplChar	3	2	CREATE	2019-05-22 09:28:27.996	\N	\N
791	40	1558510108566:1218935549	1558510107828:-614961055	ATMF_SplChar	4	3	CREATE	2019-05-22 09:28:28.804	\N	\N
792	40	1558510109276:-1916080906	rootNode	ATMF_SplChar	5	0	CREATE	2019-05-22 09:28:29.451	\N	\N
793	40	1558510110037:62353524	1558510109276:-1916080906	ATMF_SplChar	6	5	CREATE	2019-05-22 09:28:30.275	\N	\N
794	40	1558510110757:-1943071873	rootNode	ATMF_SplChar	7	0	CREATE	2019-05-22 09:28:30.921	\N	\N
795	40	1558510111671:-433042914	1558510110757:-1943071873	ATMF_SplChar	8	7	CREATE	2019-05-22 09:28:31.861	\N	\N
796	40	1558510112434:1545721057	1558510111671:-433042914	ATMF_SplChar	9	8	CREATE	2019-05-22 09:28:32.661	\N	\N
816	44	1558526313704:-1339049608	rootNode	ATMF_Documents	1	0	CREATE	2019-05-22 13:58:34.181	\N	\N
817	44	1558526314774:209094521	1558526313704:-1339049608	ATMF_Documents	2	1	CREATE	2019-05-22 13:58:35.035	\N	\N
818	44	1558526315734:2069819503	1558526314774:209094521	ATMF_Documents	3	2	CREATE	2019-05-22 13:58:36.014	\N	\N
819	44	1558526316620:783192848	1558526315734:2069819503	ATMF_Documents	4	3	CREATE	2019-05-22 13:58:37.214	\N	\N
820	44	1558526317766:-1366040472	rootNode	ATMF_Documents	5	0	CREATE	2019-05-22 13:58:38.057	\N	\N
821	44	1558526318693:-1017686845	1558526317766:-1366040472	ATMF_Documents	6	5	CREATE	2019-05-22 13:58:39.458	\N	\N
822	44	1558526319993:1562252071	rootNode	ATMF_Documents	7	0	CREATE	2019-05-22 13:58:40.336	\N	\N
823	44	1558526321014:1106172565	1558526319993:1562252071	ATMF_Documents	8	7	CREATE	2019-05-22 13:58:41.202	\N	\N
824	44	1558526321774:-706408215	1558526321014:1106172565	ATMF_Documents	9	8	CREATE	2019-05-22 13:58:41.976	\N	\N
860	47	1558635114957:-1280948793	rootNode	ATMF_SNL2	1	0	CREATE	2019-05-23 20:11:55.131	\N	\N
1303	51	1559200628066:1069761212	1559200622018:853256459	CV181-085	340	333	CREATE	2019-05-30 09:17:08.237	\N	\N
1306	51	1559200630308:-143197184	1559200622018:853256459	CV181-085	343	333	CREATE	2019-05-30 09:17:10.482	\N	\N
1309	51	1559200632751:-2030120902	1559200622018:853256459	CV181-085	346	333	CREATE	2019-05-30 09:17:13.015	\N	\N
1311	51	1559200634372:93199039	1559200622018:853256459	CV181-085	348	333	CREATE	2019-05-30 09:17:14.631	\N	\N
1314	51	1559200636729:1847961122	1559200635880:826266213	CV181-085	351	350	CREATE	2019-05-30 09:17:16.904	\N	\N
1317	51	1559200639166:-1856751058	1559200636729:1847961122	CV181-085	354	351	CREATE	2019-05-30 09:17:19.417	\N	\N
1319	51	1559200640816:1314657433	1559200635880:826266213	CV181-085	356	350	CREATE	2019-05-30 09:17:20.988	\N	\N
1322	51	1559200643146:330033012	1559200635880:826266213	CV181-085	359	350	CREATE	2019-05-30 09:17:23.968	\N	\N
1408	53	\N	\N	ACQSIT02	5	4	NEW	\N	\N	\N
965	51	1559200327796:784341167	1559200326561:-1304902220	CV181-085	2	1	CREATE	2019-05-30 09:12:08.064	\N	\N
966	51	1559200328776:1653889162	1559200327796:784341167	CV181-085	3	2	CREATE	2019-05-30 09:12:09.032	\N	\N
967	51	1559200329797:-1846218990	1559200326561:-1304902220	CV181-085	4	1	CREATE	2019-05-30 09:12:10.128	\N	\N
968	51	1559200330774:-54827969	1559200326561:-1304902220	CV181-085	5	1	CREATE	2019-05-30 09:12:10.977	\N	\N
969	51	1559200331544:1026777378	1559200326561:-1304902220	CV181-085	6	1	CREATE	2019-05-30 09:12:11.87	\N	\N
970	51	1559200332568:2061816949	1559200326561:-1304902220	CV181-085	7	1	CREATE	2019-05-30 09:12:13.043	\N	\N
971	51	1559200333702:1666120334	1559200326561:-1304902220	CV181-085	8	1	CREATE	2019-05-30 09:12:13.939	\N	\N
972	51	1559200334431:-1331892981	rootNode	CV181-085	9	0	CREATE	2019-05-30 09:12:14.915	\N	\N
973	51	1559200335563:822813004	1559200334431:-1331892981	CV181-085	10	9	CREATE	2019-05-30 09:12:15.946	\N	\N
974	51	1559200338617:838467869	1559200335563:822813004	CV181-085	11	10	CREATE	2019-05-30 09:12:18.78	\N	\N
975	51	1559200339341:1987331523	1559200335563:822813004	CV181-085	12	10	CREATE	2019-05-30 09:12:19.524	\N	\N
976	51	1559200340092:666037039	1559200334431:-1331892981	CV181-085	13	9	CREATE	2019-05-30 09:12:20.279	\N	\N
977	51	1559200340833:-1080425020	1559200334431:-1331892981	CV181-085	14	9	CREATE	2019-05-30 09:12:21.023	\N	\N
978	51	1559200341657:1680146176	1559200334431:-1331892981	CV181-085	15	9	CREATE	2019-05-30 09:12:21.816	\N	\N
979	51	1559200342379:-367246599	1559200334431:-1331892981	CV181-085	16	9	CREATE	2019-05-30 09:12:22.598	\N	\N
980	51	1559200343155:710101875	1559200334431:-1331892981	CV181-085	17	9	CREATE	2019-05-30 09:12:23.422	\N	\N
981	51	1559200344069:-1465606202	1559200334431:-1331892981	CV181-085	18	9	CREATE	2019-05-30 09:12:24.244	\N	\N
982	51	1559200344837:-1531689924	1559200334431:-1331892981	CV181-085	19	9	CREATE	2019-05-30 09:12:25.375	\N	\N
983	51	1559200346022:-1753934675	1559200334431:-1331892981	CV181-085	20	9	CREATE	2019-05-30 09:12:26.199	\N	\N
984	51	1559200346777:942437376	1559200334431:-1331892981	CV181-085	21	9	CREATE	2019-05-30 09:12:27.077	\N	\N
985	51	1559200347721:686322083	1559200334431:-1331892981	CV181-085	22	9	CREATE	2019-05-30 09:12:27.984	\N	\N
753	34	1558344443470:-429968669	1558344442549:329987330	Char_val1	2	1	CREATE	2019-05-20 11:27:23.705	\N	\N
754	34	1558344444320:-539606721	1558344443470:-429968669	Char_val1	3	2	CREATE	2019-05-20 11:27:24.575	\N	\N
755	34	1558344445190:3199587	1558344444320:-539606721	Char_val1	4	3	CREATE	2019-05-20 11:27:25.655	\N	\N
1324	51	1559200645606:-440439132	1559200635880:826266213	CV181-085	361	350	CREATE	2019-05-30 09:17:25.842	\N	\N
1327	51	1559200647932:1967604343	1559200635880:826266213	CV181-085	364	350	CREATE	2019-05-30 09:17:28.118	\N	\N
1329	51	1559200649492:-204042188	1559200635880:826266213	CV181-085	366	350	CREATE	2019-05-30 09:17:30.058	\N	\N
1332	51	1559200652229:-428799041	1559200651417:-1975856500	CV181-085	369	368	CREATE	2019-05-30 09:17:32.406	\N	\N
1335	51	1559200654891:2092587031	1559200652229:-428799041	CV181-085	372	369	CREATE	2019-05-30 09:17:35.076	\N	\N
1202	51	1559200538842:-1768967831	1559200538057:1026801084	CV181-085	239	238	CREATE	2019-05-30 09:15:39.017	017	Correspondence
1204	51	1559200540486:1083156261	1559200538842:-1768967831	CV181-085	241	239	CREATE	2019-05-30 09:15:40.674	Correspondence	Other (specify)
1207	51	1559200542764:-69277325	1559200538057:1026801084	CV181-085	244	238	CREATE	2019-05-30 09:15:42.943	017	Financial and Legal
1210	51	1559200545037:-86031066	1559200538057:1026801084	CV181-085	247	238	CREATE	2019-05-30 09:15:45.286	017	Monitoring
1212	51	1559200546674:-420907187	1559200538057:1026801084	CV181-085	249	238	CREATE	2019-05-30 09:15:46.909	017	Regulatory
1215	51	1559200549123:-2032960965	1559200548243:999810838	CV181-085	252	251	CREATE	2019-05-30 09:15:49.381	018	Correspondence
1218	51	1559200551538:1728702436	1559200548243:999810838	CV181-085	255	251	CREATE	2019-05-30 09:15:51.707	018	Data Handling
1220	51	1559200553060:-1853104876	1559200548243:999810838	CV181-085	257	251	CREATE	2019-05-30 09:15:53.248	018	Financial and Legal
5	2	\N	\N	ACQSIT01	1	0	NEW	\N		001
6	2	\N	\N	ACQSIT01	2	1	NEW	\N	001	Correspondence
7	2	\N	\N	ACQSIT01	3	2	NEW	\N	Correspondence	GeneralAdmin
8	2	\N	\N	ACQSIT01	4	3	NEW	\N	GeneralAdmin	Management
9	2	\N	\N	ACQSIT01	5	4	NEW	\N	Management	DrugManagement
10	2	\N	\N	ACQSIT01	6	0	NEW	\N		002
11	2	\N	\N	ACQSIT01	7	6	NEW	\N	002	Correspondence
12	2	\N	\N	ACQSIT01	8	7	NEW	\N	Correspondence	GeneralAdmin
13	2	\N	\N	ACQSIT01	9	8	NEW	\N	GeneralAdmin	Data Handling
14	2	\N	\N	ACQSIT01	10	9	NEW	\N	Data Handling	Drug Supply
15	3	\N	\N	ACQSIT02	1	0	NEW	\N		001
16	3	\N	\N	ACQSIT02	2	1	NEW	\N	001	Correspondence
17	3	\N	\N	ACQSIT02	3	2	NEW	\N	Correspondence	GeneralAdmin
18	3	\N	\N	ACQSIT02	4	3	NEW	\N	GeneralAdmin	Management
19	3	\N	\N	ACQSIT02	5	4	NEW	\N	Management	DrugManagement
20	3	\N	\N	ACQSIT02	6	0	NEW	\N		002
21	3	\N	\N	ACQSIT02	7	6	NEW	\N	002	Correspondence
22	3	\N	\N	ACQSIT02	8	7	NEW	\N	Correspondence	GeneralAdmin
23	3	\N	\N	ACQSIT02	9	8	NEW	\N	GeneralAdmin	Data Handling
24	3	\N	\N	ACQSIT02	10	9	NEW	\N	Data Handling	Drug Supply
25	4	\N	\N	ACQSIT03	1	0	NEW	\N		001
26	4	\N	\N	ACQSIT03	2	1	NEW	\N	001	Correspondence
27	4	\N	\N	ACQSIT03	3	2	NEW	\N	Correspondence	GeneralAdmin
28	4	\N	\N	ACQSIT03	4	3	NEW	\N	GeneralAdmin	Management
29	4	\N	\N	ACQSIT03	5	4	NEW	\N	Management	DrugManagement
30	4	\N	\N	ACQSIT03	6	0	NEW	\N		002
31	4	\N	\N	ACQSIT03	7	6	NEW	\N	002	Correspondence
32	4	\N	\N	ACQSIT03	8	7	NEW	\N	Correspondence	Monitoring
33	4	\N	\N	ACQSIT03	9	8	NEW	\N	Monitoring	Regulatory
34	4	\N	\N	ACQSIT03	10	9	NEW	\N	Regulatory	Protocol
35	5	\N	\N	ACQSIT04	1	0	NEW	\N		001
36	5	\N	\N	ACQSIT04	2	1	NEW	\N	001	Finance and Legal
37	5	\N	\N	ACQSIT04	3	2	NEW	\N	Finance and Legal	Informed Consent
38	5	\N	\N	ACQSIT04	4	3	NEW	\N	Informed Consent	IRB IEB SC
39	5	\N	\N	ACQSIT04	5	4	NEW	\N	IRB IEB SC	Laboratory and Clinical
40	5	\N	\N	ACQSIT04	6	0	NEW	\N		002
41	5	\N	\N	ACQSIT04	7	6	NEW	\N	002	Correspondence
42	5	\N	\N	ACQSIT04	8	7	NEW	\N	Correspondence	GeneralAdmin
43	5	\N	\N	ACQSIT04	9	8	NEW	\N	GeneralAdmin	Data Handling
44	5	\N	\N	ACQSIT04	10	9	NEW	\N	Data Handling	Drug Supply
1223	51	1559200555766:-1869858617	1559200548243:999810838	CV181-085	260	251	CREATE	2019-05-30 09:15:55.982	018	Monitoring
1225	51	1559200557439:2090232352	1559200548243:999810838	CV181-085	262	251	CREATE	2019-05-30 09:15:57.689	018	Regulatory
1228	51	1559200559903:-1814664050	1559200559030:972820386	CV181-085	265	264	CREATE	2019-05-30 09:16:00.077	019	Correspondence
1231	51	1559200562227:-1405573604	1559200559030:972820386	CV181-085	268	264	CREATE	2019-05-30 09:16:02.625	019	Financial and Legal
1234	51	1559200564785:934227197	rootNode	CV181-085	271	0	CREATE	2019-05-30 09:16:05.044		020
1236	51	1559200566574:1558359032	1559200565678:829886557	CV181-085	273	272	CREATE	2019-05-30 09:16:06.791	Correspondence	General Administration
1374	51	1559200688100:561086736	1559200678910:745305569	CV181-085	411	401	CREATE	2019-05-30 09:18:08.319	027	IRB   IEC   SC
1377	51	1559200690538:1449294558	1559200678910:745305569	CV181-085	414	401	CREATE	2019-05-30 09:18:10.712	027	Protocol
6427	84	\N	\N	D5170C00002	212	156	NEW	\N	Site	2001825 De Vos, Martine
49	7	1557765713070:1964599573	rootNode	TestStudy	1	0	CREATE	2019-05-13 18:41:53.24		New_sec
50	7	1557765713855:963495632	1557765713070:1964599573	TestStudy	2	1	CREATE	2019-05-13 18:41:54.007	New_sec	New
51	7	1557765714477:1737896235	rootNode	TestStudy	3	0	CREATE	2019-05-13 18:41:54.637		testing
52	7	1557765715266:-732209292	1557765714477:1737896235	TestStudy	4	3	CREATE	2019-05-13 18:41:55.414	testing	new_sec1
1379	51	1559200692174:-1738567739	1559200678910:745305569	CV181-085	416	401	CREATE	2019-05-30 09:18:12.428	027	SFM Cover Sheet
527	31	1558106284754:1734541215	1558106283950:-1714634729	ATMF_500Secstudy	290	289	CREATE	2019-05-17 17:18:04.91	1004	1005
73	10	\N	\N	ACQSIT02	1	0	NEW	\N		001
74	10	\N	\N	ACQSIT02	2	1	NEW	\N	001	Correspondence
75	10	\N	\N	ACQSIT02	3	2	NEW	\N	Correspondence	GeneralAdmin
76	10	\N	\N	ACQSIT02	4	3	NEW	\N	GeneralAdmin	Management
77	10	\N	\N	ACQSIT02	5	4	NEW	\N	Management	DrugManagement
78	10	\N	\N	ACQSIT02	6	0	NEW	\N		002
63	9	1557817990994:-1639768299	rootNode	ACQSIT01	1	0	CREATE	2019-05-14 09:13:11.16		001
64	9	1557817991751:160174226	1557817990994:-1639768299	ACQSIT01	2	1	CREATE	2019-05-14 09:13:12.246	001	Correspondence
65	9	1557817992877:-1886403891	1557817991751:160174226	ACQSIT01	3	2	CREATE	2019-05-14 09:13:13.059	Correspondence	GeneralAdmin
66	9	1557817993674:283509292	1557817992877:-1886403891	ACQSIT01	4	3	CREATE	2019-05-14 09:13:13.824	GeneralAdmin	Management
67	9	1557817994470:474848396	1557817993674:283509292	ACQSIT01	5	4	CREATE	2019-05-14 09:13:14.674	Management	DrugManagement
68	9	1557817995183:-1666759060	rootNode	ACQSIT01	6	0	CREATE	2019-05-14 09:13:15.394		002
70	9	1557817996821:-1058661586	1557817996010:1150905025	ACQSIT01	8	7	CREATE	2019-05-14 09:13:16.999	Correspondence	GeneralAdmin
71	9	1557817997537:-1058849400	1557817996821:-1058661586	ACQSIT01	9	8	CREATE	2019-05-14 09:13:17.715	GeneralAdmin	Data Handling
79	10	\N	\N	ACQSIT02	7	6	NEW	\N	002	Correspondence
80	10	\N	\N	ACQSIT02	8	7	NEW	\N	Correspondence	GeneralAdmin
81	10	\N	\N	ACQSIT02	9	8	NEW	\N	GeneralAdmin	Data Handling
82	10	\N	\N	ACQSIT02	10	9	NEW	\N	Data Handling	Drug Supply
69	9	1557817996010:1150905025	1557817995183:-1666759060	ACQSIT01	7	6	CREATE	2019-05-14 09:13:16.217	002	Correspondence
72	9	1557817998290:-1906070481	1557817997537:-1058849400	ACQSIT01	10	9	CREATE	2019-05-14 09:13:18.492	Data Handling	Drug Supply
83	11	1557818812265:-363585913	rootNode	ACQSIT03	1	0	CREATE	2019-05-14 09:26:52.815		001
84	11	1557818813403:452008230	1557818812265:-363585913	ACQSIT03	2	1	CREATE	2019-05-14 09:26:53.764	001	Correspondence
85	11	1557818814387:-986540447	1557818813403:452008230	ACQSIT03	3	2	CREATE	2019-05-14 09:26:54.705	Correspondence	GeneralAdmin
86	11	1557818815311:226605570	1557818814387:-986540447	ACQSIT03	4	3	CREATE	2019-05-14 09:26:55.805	GeneralAdmin	Management
87	11	1557818816399:703596510	1557818815311:226605570	ACQSIT03	5	4	CREATE	2019-05-14 09:26:56.706	Management	DrugManagement
88	11	1557818817214:-390576880	rootNode	ACQSIT03	6	0	CREATE	2019-05-14 09:26:57.491		002
89	11	1557818818087:21507250	1557818817214:-390576880	ACQSIT03	7	6	CREATE	2019-05-14 09:26:58.386	002	Correspondence
90	11	1557818818964:-100157847	1557818818087:21507250	ACQSIT03	8	7	CREATE	2019-05-14 09:26:59.285	Correspondence	Monitoring
91	11	1557818819935:-1198546218	1557818818964:-100157847	ACQSIT03	9	8	CREATE	2019-05-14 09:27:00.33	Monitoring	Regulatory
92	11	1557818820942:996576951	1557818819935:-1198546218	ACQSIT03	10	9	CREATE	2019-05-14 09:27:01.199	Regulatory	Protocol
93	12	1557818864122:-1994628766	rootNode	ACQSIT04	1	0	CREATE	2019-05-14 09:27:44.293		001
94	12	1557818864894:1624168513	1557818864122:-1994628766	ACQSIT04	2	1	CREATE	2019-05-14 09:27:45.243	001	Finance and Legal
95	12	1557818865839:-87538557	1557818864894:1624168513	ACQSIT04	3	2	CREATE	2019-05-14 09:27:46.336	Finance and Legal	Informed Consent
96	12	1557818866928:1736039931	1557818865839:-87538557	ACQSIT04	4	3	CREATE	2019-05-14 09:27:47.256	Informed Consent	IRB IEB SC
97	12	1557818867911:906294136	1557818866928:1736039931	ACQSIT04	5	4	CREATE	2019-05-14 09:27:48.16	IRB IEB SC	Laboratory and Clinical
98	12	1557818868704:245839970	rootNode	ACQSIT04	6	0	CREATE	2019-05-14 09:27:48.947		002
99	12	1557818869557:1733286104	1557818868704:245839970	ACQSIT04	7	6	CREATE	2019-05-14 09:27:49.72	002	Correspondence
100	12	1557818870291:-1062843859	1557818869557:1733286104	ACQSIT04	8	7	CREATE	2019-05-14 09:27:50.455	Correspondence	GeneralAdmin
101	12	1557818871024:-1213167867	1557818870291:-1062843859	ACQSIT04	9	8	CREATE	2019-05-14 09:27:51.599	GeneralAdmin	Data Handling
102	12	1557818872299:901973385	1557818871024:-1213167867	ACQSIT04	10	9	CREATE	2019-05-14 09:27:52.522	Data Handling	Drug Supply
103	13	\N	\N	ACQSIT02	1	0	NEW	\N		001
104	13	\N	\N	ACQSIT02	2	1	NEW	\N	001	Correspondence
105	13	\N	\N	ACQSIT02	3	2	NEW	\N	Correspondence	GeneralAdmin
106	13	\N	\N	ACQSIT02	4	3	NEW	\N	GeneralAdmin	Management
107	13	\N	\N	ACQSIT02	5	4	NEW	\N	Management	DrugManagement
108	13	\N	\N	ACQSIT02	6	0	NEW	\N		002
109	13	\N	\N	ACQSIT02	7	6	NEW	\N	002	Correspondence
110	13	\N	\N	ACQSIT02	8	7	NEW	\N	Correspondence	GeneralAdmin
111	13	\N	\N	ACQSIT02	9	8	NEW	\N	GeneralAdmin	Data Handling
112	13	\N	\N	ACQSIT02	10	9	NEW	\N	Data Handling	Drug Supply
113	14	1557833410589:1865545757	rootNode	ACQSIT02	1	0	CREATE	2019-05-14 13:30:10.823		001
114	14	1557833411441:-1379761490	1557833410589:1865545757	ACQSIT02	2	1	CREATE	2019-05-14 13:30:11.667	001	Correspondence
115	14	1557833412273:-2120435175	1557833411441:-1379761490	ACQSIT02	3	2	CREATE	2019-05-14 13:30:12.42	Correspondence	GeneralAdmin
116	14	1557833412972:83048018	1557833412273:-2120435175	ACQSIT02	4	3	CREATE	2019-05-14 13:30:13.141	GeneralAdmin	Management
117	14	1557833413709:-2021670964	1557833412972:83048018	ACQSIT02	5	4	CREATE	2019-05-14 13:30:13.895	Management	DrugManagement
118	14	1557833414368:1838554893	rootNode	ACQSIT02	6	0	CREATE	2019-05-14 13:30:14.656		002
119	14	1557833415245:-1882031264	1557833414368:1838554893	ACQSIT02	7	6	CREATE	2019-05-14 13:30:15.51	002	Correspondence
120	14	1557833416081:792013972	1557833415245:-1882031264	ACQSIT02	8	7	CREATE	2019-05-14 13:30:16.311	Correspondence	GeneralAdmin
121	14	1557833416849:-1669847316	1557833416081:792013972	ACQSIT02	9	8	CREATE	2019-05-14 13:30:17.085	GeneralAdmin	Data Handling
122	14	1557833417635:-1693120621	1557833416849:-1669847316	ACQSIT02	10	9	CREATE	2019-05-14 13:30:17.803	Data Handling	Drug Supply
1382	51	1559200694482:1476679781	rootNode	CV181-085	419	0	CREATE	2019-05-30 09:18:14.68		Correspondence
123	15	1557923196996:1069245717	rootNode	ATMF_Int0001	1	0	CREATE	2019-05-15 14:26:37.253		001
124	15	1557923197896:1158435399	1557923196996:1069245717	ATMF_Int0001	2	1	CREATE	2019-05-15 14:26:38.071	001	Correspondence
125	15	1557923198611:1260268135	1557923197896:1158435399	ATMF_Int0001	3	2	CREATE	2019-05-15 14:26:38.895	Correspondence	General Admin
126	15	1557923199479:-900144836	1557923198611:1260268135	ATMF_Int0001	4	3	CREATE	2019-05-15 14:26:39.644	General Admin	Management
127	15	1557923200143:1042254647	rootNode	ATMF_Int0001	5	0	CREATE	2019-05-15 14:26:40.653		002
128	15	1557923201261:-1653279897	1557923200143:1042254647	ATMF_Int0001	6	5	CREATE	2019-05-15 14:26:41.52	002	IREB
129	15	1557923202121:-1252197259	rootNode	ATMF_Int0001	7	0	CREATE	2019-05-15 14:26:42.399		003
130	15	1557923203014:597222324	1557923202121:-1252197259	ATMF_Int0001	8	7	CREATE	2019-05-15 14:26:43.235	003	FinancialandLegal
131	15	1557923203813:-892097127	1557923203014:597222324	ATMF_Int0001	9	8	CREATE	2019-05-15 14:26:44.12	FinancialandLegal	Monitoring
132	16	1557924201316:-718390658	rootNode	ATMFE2EStudy	1	0	CREATE	2019-05-15 14:43:21.766		001
133	16	1557924202407:-167411044	1557924201316:-718390658	ATMFE2EStudy	2	1	CREATE	2019-05-15 14:43:22.558	001	Correspondence
134	16	1557924203126:486029066	1557924202407:-167411044	ATMFE2EStudy	3	2	CREATE	2019-05-15 14:43:23.324	Correspondence	General Admin
135	16	1557924203862:-1329490624	1557924203126:486029066	ATMFE2EStudy	4	3	CREATE	2019-05-15 14:43:24.014	General Admin	Management
136	16	1557924204560:2075345493	1557924201316:-718390658	ATMFE2EStudy	5	1	CREATE	2019-05-15 14:43:24.79	001	FinancialandLegal
137	16	1557924205404:-1660157403	1557924204560:2075345493	ATMFE2EStudy	6	5	CREATE	2019-05-15 14:43:25.636	FinancialandLegal	Monitoring
138	16	1557924206193:1718492388	1557924201316:-718390658	ATMFE2EStudy	7	1	CREATE	2019-05-15 14:43:26.372	001	IREB
139	16	1557924211628:1522079623	rootNode	ATMFE2EStudy	8	0	CREATE	2019-05-15 14:43:31.882		002
140	16	1557924212500:1101857758	1557924211628:1522079623	ATMFE2EStudy	9	8	CREATE	2019-05-15 14:43:32.702	002	IREB
141	17	1557923196996:1069245717	rootNode	ATMF_Int0001	1	0	ALREADY AVAILABLE	2019-05-16 12:12:10.025		001
145	17	1557923200143:1042254647	rootNode	ATMF_Int0001	5	0	ALREADY AVAILABLE	2019-05-16 12:12:10.025		002
147	17	1557923202121:-1252197259	rootNode	ATMF_Int0001	7	0	ALREADY AVAILABLE	2019-05-16 12:12:10.025		003
142	17	1557923197896:1158435399	1557923196996:1069245717	ATMF_Int0001	2	1	ALREADY AVAILABLE	2019-05-16 12:12:10.025	001	Correspondence
146	17	1557923201261:-1653279897	1557923200143:1042254647	ATMF_Int0001	6	5	ALREADY AVAILABLE	2019-05-16 12:12:10.025	002	IREB
148	17	1557923203014:597222324	1557923202121:-1252197259	ATMF_Int0001	8	7	ALREADY AVAILABLE	2019-05-16 12:12:10.025	003	FinancialandLegal
143	17	1557923198611:1260268135	1557923197896:1158435399	ATMF_Int0001	3	2	ALREADY AVAILABLE	2019-05-16 12:12:10.025	Correspondence	General Admin
149	17	1557923203813:-892097127	1557923203014:597222324	ATMF_Int0001	9	8	ALREADY AVAILABLE	2019-05-16 12:12:10.025	FinancialandLegal	Monitoring
144	17	1557923199479:-900144836	1557923198611:1260268135	ATMF_Int0001	4	3	ALREADY AVAILABLE	2019-05-16 12:12:10.025	General Admin	Management
150	18	1558009604580:1838276896	rootNode	ATMF_INT0002	1	0	CREATE	2019-05-16 14:26:44.771		00001
151	18	1558009605418:1205179447	1558009604580:1838276896	ATMF_INT0002	2	1	CREATE	2019-05-16 14:26:45.587	00001	00002
152	18	1558009606147:129149986	1558009605418:1205179447	ATMF_INT0002	3	2	CREATE	2019-05-16 14:26:46.367	00002	00003
153	18	1558009606979:1792202441	rootNode	ATMF_INT0002	4	0	CREATE	2019-05-16 14:26:47.162		0001
154	18	1558009607741:-155396988	1558009606979:1792202441	ATMF_INT0002	5	4	CREATE	2019-05-16 14:26:47.999	0001	0002
155	18	1558009608685:-967513578	1558009607741:-155396988	ATMF_INT0002	6	5	CREATE	2019-05-16 14:26:48.964	0002	0003
156	18	1558009609422:1629155021	rootNode	ATMF_INT0002	7	0	CREATE	2019-05-16 14:26:49.669		001
157	18	1558009610246:-920948028	1558009609422:1629155021	ATMF_INT0002	8	7	CREATE	2019-05-16 14:26:50.418	001	002
158	18	1558009610955:-408259031	1558009610246:-920948028	ATMF_INT0002	9	8	CREATE	2019-05-16 14:26:51.122	002	003
159	19	1558070038155:519392156	rootNode	ATMF_INT0003	1	0	CREATE	2019-05-17 07:13:58.313		00001
160	19	1558070038898:2069902013	1558070038155:519392156	ATMF_INT0003	2	1	CREATE	2019-05-17 07:13:59.21	00001	00002
161	19	1558070039803:26359883	1558070038898:2069902013	ATMF_INT0003	3	2	CREATE	2019-05-17 07:13:59.962	00002	00003
162	19	1558070040511:-570232946	1558070039803:26359883	ATMF_INT0003	4	3	CREATE	2019-05-17 07:14:00.665	00003	00004
163	19	1558070041345:-935838564	1558070040511:-570232946	ATMF_INT0003	5	4	CREATE	2019-05-17 07:14:01.5	00004	00005
164	19	1558070041986:-866367939	rootNode	ATMF_INT0003	6	0	CREATE	2019-05-17 07:14:02.184		0001
165	19	1558070042793:-819012024	1558070041986:-866367939	ATMF_INT0003	7	6	CREATE	2019-05-17 07:14:02.944	0001	0002
166	19	1558070044372:-174996549	1558070042793:-819012024	ATMF_INT0003	8	7	CREATE	2019-05-17 07:14:04.781	0002	0003
167	19	1558070045437:-1626314472	1558070044372:-174996549	ATMF_INT0003	9	8	CREATE	2019-05-17 07:14:05.587	0003	0004
168	19	1558070046260:818085485	1558070045437:-1626314472	ATMF_INT0003	10	9	CREATE	2019-05-17 07:14:06.413	0004	0005
169	19	1558070046921:310270487	rootNode	ATMF_INT0003	11	0	CREATE	2019-05-17 07:14:07.136		001
170	19	1558070047759:1725505225	1558070046921:310270487	ATMF_INT0003	12	11	CREATE	2019-05-17 07:14:07.934	001	002
171	19	1558070048471:-192772740	1558070047759:1725505225	ATMF_INT0003	13	12	CREATE	2019-05-17 07:14:08.649	002	003
172	19	1558070049199:-1195016254	1558070048471:-192772740	ATMF_INT0003	14	13	CREATE	2019-05-17 07:14:09.354	003	004
173	19	1558070050001:245365382	1558070049199:-1195016254	ATMF_INT0003	15	14	CREATE	2019-05-17 07:14:10.166	004	005
179	21	1558076279020:-1751695131	rootNode	YETMF	1	0	CREATE	2019-05-17 08:57:59.173		Z001
180	21	1558076279749:812065369	1558076279020:-1751695131	YETMF	2	1	CREATE	2019-05-17 08:57:59.907	Z001	Correspondence
181	21	1558076280452:-1433333228	1558076279749:812065369	YETMF	3	2	CREATE	2019-05-17 08:58:00.6	Correspondence	Monitoring
182	21	1558076281140:23371039	1558076280452:-1433333228	YETMF	4	3	CREATE	2019-05-17 08:58:01.306	Monitoring	Regulatory
183	21	1558076281903:813156617	1558076281140:23371039	YETMF	5	4	CREATE	2019-05-17 08:58:02.085	Regulatory	DrugManagement
184	22	1558076329734:821182926	rootNode	AETMF	1	0	CREATE	2019-05-17 08:58:49.947		A001
185	22	1558076330576:-143741752	1558076329734:821182926	AETMF	2	1	CREATE	2019-05-17 08:58:50.724	A001	FinancialandLegal
186	22	1558076331351:928272444	1558076330576:-143741752	AETMF	3	2	CREATE	2019-05-17 08:58:51.497	FinancialandLegal	IREB
174	20	1558078992500:2112877434	rootNode	SETMF	1	0	CREATE	2019-05-17 09:43:12.775		S001
175	20	1558078993394:1303967338	1558078992500:2112877434	SETMF	2	1	CREATE	2019-05-17 09:43:13.59	S001	FinancialandLegal
176	20	1558078994166:1917531556	1558078993394:1303967338	SETMF	3	2	CREATE	2019-05-17 09:43:14.379	FinancialandLegal	IREB
177	20	1558078994968:556401783	1558078994166:1917531556	SETMF	4	3	CREATE	2019-05-17 09:43:15.126	IREB	Monitoring
178	20	1558078995911:74308294	1558078994968:556401783	SETMF	5	4	CREATE	2019-05-17 09:43:16.297	Monitoring	StaffingQualifications
530	31	1558106286983:804956048	1558106286210:237379465	ATMF_500Secstudy	293	292	CREATE	2019-05-17 17:18:07.191	1002	1003
533	31	1558106289381:-2106366492	rootNode	ATMF_500Secstudy	296	0	CREATE	2019-05-17 17:18:09.561		Sec62
535	31	1558106290857:-1838182699	1558106290147:1765907887	ATMF_500Secstudy	298	297	CREATE	2019-05-17 17:18:11.043	1002	1003
537	31	1558106292409:-1024474009	1558106291651:1694475243	ATMF_500Secstudy	300	299	CREATE	2019-05-17 17:18:12.592	1004	1005
540	31	1558106295520:-1115358761	1558106294827:78356752	ATMF_500Secstudy	303	302	CREATE	2019-05-17 17:18:15.691	1002	1003
541	31	1558106296265:593739706	1558106295520:-1115358761	ATMF_500Secstudy	304	303	CREATE	2019-05-17 17:18:16.417	1003	1004
544	31	1558106298492:-930802559	1558106297734:2134618973	ATMF_500Secstudy	307	306	CREATE	2019-05-17 17:18:18.643	Sec64	1002
546	31	1558106299949:2034662489	1558106299218:-755350377	ATMF_500Secstudy	309	308	CREATE	2019-05-17 17:18:20.304	1003	1004
549	31	1558106302362:-471329849	1558106301610:-847654165	ATMF_500Secstudy	312	311	CREATE	2019-05-17 17:18:22.517	Sec65	1002
551	31	1558106303849:425853857	1558106303141:1109824842	ATMF_500Secstudy	314	313	CREATE	2019-05-17 17:18:24.029	1003	1004
554	31	1558106306150:1405552659	1558106305296:-874644926	ATMF_500Secstudy	317	316	CREATE	2019-05-17 17:18:26.301	Sec66	1002
556	31	1558106307705:-1097853502	1558106306931:-1032594898	ATMF_500Secstudy	319	318	CREATE	2019-05-17 17:18:28.075	1003	1004
559	31	1558106310123:-770035585	1558106309314:-901635687	ATMF_500Secstudy	322	321	CREATE	2019-05-17 17:18:30.296	Sec67	1002
187	22	1558076332044:261611103	1558076331351:928272444	AETMF	4	3	CREATE	2019-05-17 08:58:52.195	IREB	Monitoring
188	22	1558076332744:-708945923	1558076332044:261611103	AETMF	5	4	CREATE	2019-05-17 08:58:53.116	Monitoring	StaffingQualifications
189	23	1558076329734:821182926	rootNode	AETMF	1	0	ALREADY AVAILABLE	2019-05-17 09:43:49.496		A001
190	23	1558076330576:-143741752	1558076329734:821182926	AETMF	2	1	ALREADY AVAILABLE	2019-05-17 09:43:49.497	A001	FinancialandLegal
191	23	1558076331351:928272444	1558076330576:-143741752	AETMF	3	2	ALREADY AVAILABLE	2019-05-17 09:43:49.497	FinancialandLegal	IREB
192	23	1558076332044:261611103	1558076331351:928272444	AETMF	4	3	ALREADY AVAILABLE	2019-05-17 09:43:49.497	IREB	Monitoring
193	23	1558076332744:-708945923	1558076332044:261611103	AETMF	5	4	ALREADY AVAILABLE	2019-05-17 09:43:49.497	Monitoring	StaffingQualifications
199	25	1558076279020:-1751695131	rootNode	YETMF	1	0	ALREADY AVAILABLE	2019-05-17 09:44:18.185		Z001
200	25	1558076279749:812065369	1558076279020:-1751695131	YETMF	2	1	ALREADY AVAILABLE	2019-05-17 09:44:18.185	Z001	Correspondence
201	25	1558076280452:-1433333228	1558076279749:812065369	YETMF	3	2	ALREADY AVAILABLE	2019-05-17 09:44:18.185	Correspondence	Monitoring
202	25	1558076281140:23371039	1558076280452:-1433333228	YETMF	4	3	ALREADY AVAILABLE	2019-05-17 09:44:18.185	Monitoring	Regulatory
203	25	1558076281903:813156617	1558076281140:23371039	YETMF	5	4	ALREADY AVAILABLE	2019-05-17 09:44:18.185	Regulatory	DrugManagement
194	24	1558078992500:2112877434	rootNode	SETMF	1	0	ALREADY AVAILABLE	2019-05-17 10:12:51.068		S001
195	24	1558078993394:1303967338	1558078992500:2112877434	SETMF	2	1	ALREADY AVAILABLE	2019-05-17 10:12:51.068	S001	FinancialandLegal
196	24	1558078994166:1917531556	1558078993394:1303967338	SETMF	3	2	ALREADY AVAILABLE	2019-05-17 10:12:51.068	FinancialandLegal	IREB
197	24	1558078994968:556401783	1558078994166:1917531556	SETMF	4	3	ALREADY AVAILABLE	2019-05-17 10:12:51.068	IREB	Monitoring
198	24	1558078995911:74308294	1558078994968:556401783	SETMF	5	4	ALREADY AVAILABLE	2019-05-17 10:12:51.068	Monitoring	StaffingQualifications
204	26	1558076329734:821182926	rootNode	AETMF	1	0	ALREADY AVAILABLE	2019-05-17 12:12:33.435		A001
205	26	1558076330576:-143741752	1558076329734:821182926	AETMF	2	1	ALREADY AVAILABLE	2019-05-17 12:12:33.434	A001	FinancialandLegal
206	26	1558076331351:928272444	1558076330576:-143741752	AETMF	3	2	ALREADY AVAILABLE	2019-05-17 12:12:33.435	FinancialandLegal	IREB
207	26	1558076332044:261611103	1558076331351:928272444	AETMF	4	3	ALREADY AVAILABLE	2019-05-17 12:12:33.435	IREB	Monitoring
208	26	1558076332744:-708945923	1558076332044:261611103	AETMF	5	4	ALREADY AVAILABLE	2019-05-17 12:12:33.435	Monitoring	StaffingQualifications
209	27	1558078992500:2112877434	rootNode	SETMF	1	0	ALREADY AVAILABLE	2019-05-17 12:26:39.698		S001
210	27	1558078993394:1303967338	1558078992500:2112877434	SETMF	2	1	ALREADY AVAILABLE	2019-05-17 12:26:39.698	S001	FinancialandLegal
211	27	1558078994166:1917531556	1558078993394:1303967338	SETMF	3	2	ALREADY AVAILABLE	2019-05-17 12:26:39.698	FinancialandLegal	IREB
212	27	1558078994968:556401783	1558078994166:1917531556	SETMF	4	3	ALREADY AVAILABLE	2019-05-17 12:26:39.698	IREB	Monitoring
213	27	1558078995911:74308294	1558078994968:556401783	SETMF	5	4	ALREADY AVAILABLE	2019-05-17 12:26:39.698	Monitoring	StaffingQualifications
214	28	1558076279020:-1751695131	rootNode	YETMF	1	0	ALREADY AVAILABLE	2019-05-17 12:27:23.533		Z001
215	28	1558076279749:812065369	1558076279020:-1751695131	YETMF	2	1	ALREADY AVAILABLE	2019-05-17 12:27:23.533	Z001	Correspondence
216	28	1558076280452:-1433333228	1558076279749:812065369	YETMF	3	2	ALREADY AVAILABLE	2019-05-17 12:27:23.534	Correspondence	Monitoring
217	28	1558076281140:23371039	1558076280452:-1433333228	YETMF	4	3	ALREADY AVAILABLE	2019-05-17 12:27:23.534	Monitoring	Regulatory
218	28	1558076281903:813156617	1558076281140:23371039	YETMF	5	4	ALREADY AVAILABLE	2019-05-17 12:27:23.534	Regulatory	DrugManagement
219	29	1558088876853:1770250132	rootNode	ATMF_INT0002	1	0	CREATE	2019-05-17 12:27:57.348		01-New
220	29	1558088878046:-960854999	1558088876853:1770250132	ATMF_INT0002	2	1	CREATE	2019-05-17 12:27:58.212	01-New	02
221	29	1558088878797:1659524525	1558088878046:-960854999	ATMF_INT0002	3	2	CREATE	2019-05-17 12:27:58.951	02	03
222	29	1558088879586:919800898	1558088878797:1659524525	ATMF_INT0002	4	3	CREATE	2019-05-17 12:27:59.753	03	04
223	29	1558088880300:-1740456082	rootNode	ATMF_INT0002	5	0	CREATE	2019-05-17 12:28:00.453		1-New
224	29	1558088881064:779054437	1558088880300:-1740456082	ATMF_INT0002	6	5	CREATE	2019-05-17 12:28:01.223	1-New	1-2
225	29	1558088881918:-792387211	1558088881064:779054437	ATMF_INT0002	7	6	CREATE	2019-05-17 12:28:02.093	1-2	1-3
226	30	1558070038155:519392156	rootNode	ATMF_INT0003	1	0	ALREADY AVAILABLE	2019-05-17 14:26:48.524		00001
231	30	1558070041986:-866367939	rootNode	ATMF_INT0003	6	0	ALREADY AVAILABLE	2019-05-17 14:26:48.525		0001
233	30	1558070046921:310270487	rootNode	ATMF_INT0003	8	0	ALREADY AVAILABLE	2019-05-17 14:26:48.525		001
227	30	1558070038898:2069902013	1558070038155:519392156	ATMF_INT0003	2	1	ALREADY AVAILABLE	2019-05-17 14:26:48.525	00001	00002
232	30	1558070042793:-819012024	1558070041986:-866367939	ATMF_INT0003	7	6	ALREADY AVAILABLE	2019-05-17 14:26:48.525	0001	0002
234	30	1558070047759:1725505225	1558070046921:310270487	ATMF_INT0003	9	8	ALREADY AVAILABLE	2019-05-17 14:26:48.525	001	002
228	30	1558070039803:26359883	1558070038898:2069902013	ATMF_INT0003	3	2	ALREADY AVAILABLE	2019-05-17 14:26:48.525	00002	00003
235	30	1558070048471:-192772740	1558070047759:1725505225	ATMF_INT0003	10	9	ALREADY AVAILABLE	2019-05-17 14:26:48.525	002	003
229	30	1558070040511:-570232946	1558070039803:26359883	ATMF_INT0003	4	3	ALREADY AVAILABLE	2019-05-17 14:26:48.525	00003	00004
236	30	1558070049199:-1195016254	1558070048471:-192772740	ATMF_INT0003	11	10	ALREADY AVAILABLE	2019-05-17 14:26:48.525	003	004
230	30	1558070041345:-935838564	1558070040511:-570232946	ATMF_INT0003	5	4	ALREADY AVAILABLE	2019-05-17 14:26:48.525	00004	00005
237	30	1558070050001:245365382	1558070049199:-1195016254	ATMF_INT0003	12	11	ALREADY AVAILABLE	2019-05-17 14:26:48.525	004	005
1404	53	\N	\N	ACQSIT02	1	0	NEW	\N		001
240	31	1558106042621:-1512592502	1558106041846:-803107606	ATMF_500Secstudy	3	2	CREATE	2019-05-17 17:14:02.798	1002	1003
242	31	1558106044193:-200757467	1558106043375:335112201	ATMF_500Secstudy	5	4	CREATE	2019-05-17 17:14:04.367	1004	1005
243	31	1558106044861:853466674	rootNode	ATMF_500Secstudy	6	0	CREATE	2019-05-17 17:14:05.031		Sec10
245	31	1558106046368:-1052977442	1558106045636:-1575889553	ATMF_500Secstudy	8	7	CREATE	2019-05-17 17:14:06.571	1002	1003
247	31	1558106047925:1031169766	1558106047148:-817698127	ATMF_500Secstudy	10	9	CREATE	2019-05-17 17:14:08.111	1004	1005
248	31	1558106048588:-202153780	rootNode	ATMF_500Secstudy	11	0	CREATE	2019-05-17 17:14:08.775		Sec100
561	31	1558106311654:10801968	1558106310927:1136714601	ATMF_500Secstudy	324	323	CREATE	2019-05-17 17:18:31.958	1003	1004
251	31	1558106050901:1875601594	1558106050126:298457950	ATMF_500Secstudy	14	13	CREATE	2019-05-17 17:14:11.079	1003	1004
253	31	1558106052358:892009829	rootNode	ATMF_500Secstudy	16	0	CREATE	2019-05-17 17:14:12.549		Sec11
254	31	1558106053226:-239547935	1558106052358:892009829	ATMF_500Secstudy	17	16	CREATE	2019-05-17 17:14:13.401	Sec11	1002
256	31	1558106054756:558828909	1558106053982:1711073953	ATMF_500Secstudy	19	18	CREATE	2019-05-17 17:14:14.922	1003	1004
258	31	1558106056219:865018759	rootNode	ATMF_500Secstudy	21	0	CREATE	2019-05-17 17:14:16.373		Sec12
259	31	1558106057019:1316350821	1558106056219:865018759	ATMF_500Secstudy	22	21	CREATE	2019-05-17 17:14:17.171	Sec12	1002
261	31	1558106058466:-981678066	1558106057734:2044718885	ATMF_500Secstudy	24	23	CREATE	2019-05-17 17:14:18.677	1003	1004
263	31	1558106059879:-2117255821	rootNode	ATMF_500Secstudy	26	0	CREATE	2019-05-17 17:14:20.042		Sec13
264	31	1558106060709:304674559	1558106059879:-2117255821	ATMF_500Secstudy	27	26	CREATE	2019-05-17 17:14:20.908	Sec13	1002
266	31	1558106062274:-1752604892	1558106061482:1394749499	ATMF_500Secstudy	29	28	CREATE	2019-05-17 17:14:22.433	1003	1004
267	31	1558106063008:-1319645450	1558106062274:-1752604892	ATMF_500Secstudy	30	29	CREATE	2019-05-17 17:14:23.18	1004	1005
269	31	1558106064446:1301066494	1558106063653:811036825	ATMF_500Secstudy	32	31	CREATE	2019-05-17 17:14:24.613	Sec14	1002
271	31	1558106066004:-1580541266	1558106065183:-2137240293	ATMF_500Secstudy	34	33	CREATE	2019-05-17 17:14:26.213	1003	1004
273	31	1558106067452:2123729953	rootNode	ATMF_500Secstudy	36	0	CREATE	2019-05-17 17:14:27.619		Sec15
274	31	1558106068243:124608026	1558106067452:2123729953	ATMF_500Secstudy	37	36	CREATE	2019-05-17 17:14:28.391	Sec15	1002
276	31	1558106069744:2119834467	1558106068965:-1806475381	ATMF_500Secstudy	39	38	CREATE	2019-05-17 17:14:29.927	1003	1004
278	31	1558106071398:2096738986	rootNode	ATMF_500Secstudy	41	0	CREATE	2019-05-17 17:14:31.562		Sec16
279	31	1558106072215:-25862764	1558106071398:2096738986	ATMF_500Secstudy	42	41	CREATE	2019-05-17 17:14:32.396	Sec16	1002
281	31	1558106073822:-1713094612	1558106073024:-37276044	ATMF_500Secstudy	44	43	CREATE	2019-05-17 17:14:34.057	1003	1004
283	31	1558106075290:2069748019	rootNode	ATMF_500Secstudy	46	0	CREATE	2019-05-17 17:14:35.446		Sec17
284	31	1558106076044:-1851771346	1558106075290:2069748019	ATMF_500Secstudy	47	46	CREATE	2019-05-17 17:14:36.194	Sec17	1002
286	31	1558106077767:-676234931	1558106076754:-1706860598	ATMF_500Secstudy	49	48	CREATE	2019-05-17 17:14:37.923	1003	1004
288	31	1558106079188:703073060	rootNode	ATMF_500Secstudy	51	0	CREATE	2019-05-17 17:14:39.374		Sec18
289	31	1558106079990:-63987421	1558106079188:703073060	ATMF_500Secstudy	52	51	CREATE	2019-05-17 17:14:40.152	Sec18	1002
291	31	1558106086858:-333046063	1558106086108:959061542	ATMF_500Secstudy	54	53	CREATE	2019-05-17 17:14:47.025	1003	1004
293	31	1558106088315:2015766085	rootNode	ATMF_500Secstudy	56	0	CREATE	2019-05-17 17:14:48.49		Sec19
294	31	1558106089106:-241269754	1558106088315:2015766085	ATMF_500Secstudy	57	56	CREATE	2019-05-17 17:14:49.406	Sec19	1002
296	31	1558106090929:-669157813	1558106090050:-811444488	ATMF_500Secstudy	59	58	CREATE	2019-05-17 17:14:51.131	1003	1004
297	31	1558106091720:630899882	1558106090929:-669157813	ATMF_500Secstudy	60	59	CREATE	2019-05-17 17:14:51.907	1004	1005
299	31	1558106093154:-1407344743	1558106092383:1337177159	ATMF_500Secstudy	62	61	CREATE	2019-05-17 17:14:53.415	Sec2	1002
301	31	1558106095239:-269171463	1558106094434:1035353093	ATMF_500Secstudy	64	63	CREATE	2019-05-17 17:14:55.406	1003	1004
303	31	1558106096633:2042706297	rootNode	ATMF_500Secstudy	66	0	CREATE	2019-05-17 17:14:56.801		Sec20
304	31	1558106097461:1786584351	1558106096633:2042706297	ATMF_500Secstudy	67	66	CREATE	2019-05-17 17:14:57.659	Sec20	1002
306	31	1558106098934:1944948156	1558106098207:-1576066672	ATMF_500Secstudy	69	68	CREATE	2019-05-17 17:14:59.114	1003	1004
308	31	1558106100418:2015715227	rootNode	ATMF_500Secstudy	71	0	CREATE	2019-05-17 17:15:00.583		Sec21
309	31	1558106101183:1655894444	1558106100418:2015715227	ATMF_500Secstudy	72	71	CREATE	2019-05-17 17:15:01.35	Sec21	1002
311	31	1558106102726:1722279736	1558106101976:-1074151030	ATMF_500Secstudy	74	73	CREATE	2019-05-17 17:15:02.887	1003	1004
313	31	1558106104146:1988724363	rootNode	ATMF_500Secstudy	76	0	CREATE	2019-05-17 17:15:04.298		Sec22
314	31	1558106104936:-1518422025	1558106104146:1988724363	ATMF_500Secstudy	77	76	CREATE	2019-05-17 17:15:05.107	Sec22	1002
316	31	1558106106360:1421436472	1558106105657:-999341738	ATMF_500Secstudy	79	78	CREATE	2019-05-17 17:15:06.536	1003	1004
318	31	1558106107859:1961733499	rootNode	ATMF_500Secstudy	81	0	CREATE	2019-05-17 17:15:08.069		Sec23
319	31	1558106108670:-993153771	1558106107859:1961733499	ATMF_500Secstudy	82	81	CREATE	2019-05-17 17:15:08.859	Sec23	1002
321	31	1558106110258:-1939049668	1558106109472:-879158395	ATMF_500Secstudy	84	83	CREATE	2019-05-17 17:15:10.428	1003	1004
323	31	1558106111687:1934753038	rootNode	ATMF_500Secstudy	86	0	CREATE	2019-05-17 17:15:11.862		Sec24
324	31	1558106112647:-1838897690	1558106111687:1934753038	ATMF_500Secstudy	87	86	CREATE	2019-05-17 17:15:12.814	Sec24	1002
326	31	1558106114148:-2087694856	1558106113436:-1507103020	ATMF_500Secstudy	89	88	CREATE	2019-05-17 17:15:14.359	1003	1004
328	31	1558106115724:-1047521233	rootNode	ATMF_500Secstudy	91	0	CREATE	2019-05-17 17:15:15.921		Sec25
329	31	1558106116566:-422245180	1558106115724:-1047521233	ATMF_500Secstudy	92	91	CREATE	2019-05-17 17:15:16.727	Sec25	1002
331	31	1558106118096:1568748531	1558106117367:1829056699	ATMF_500Secstudy	94	93	CREATE	2019-05-17 17:15:18.273	1003	1004
333	31	1558106119587:-1074511994	rootNode	ATMF_500Secstudy	96	0	CREATE	2019-05-17 17:15:19.794		Sec26
334	31	1558106120394:610516613	1558106119587:-1074511994	ATMF_500Secstudy	97	96	CREATE	2019-05-17 17:15:20.912	Sec26	1002
336	31	1558106122524:821551738	1558106121495:878824752	ATMF_500Secstudy	99	98	CREATE	2019-05-17 17:15:22.674	1003	1004
337	31	1558106123228:1960753067	1558106122524:821551738	ATMF_500Secstudy	100	99	CREATE	2019-05-17 17:15:23.424	1004	1005
339	31	1558106125364:-1512355022	1558106124524:1853780137	ATMF_500Secstudy	102	101	CREATE	2019-05-17 17:15:25.515	Sec27	1002
341	31	1558106126850:625403838	1558106126136:-293386120	ATMF_500Secstudy	104	103	CREATE	2019-05-17 17:15:27.031	1003	1004
343	31	1558106128323:1826789376	rootNode	ATMF_500Secstudy	106	0	CREATE	2019-05-17 17:15:28.472		Sec28
344	31	1558106129061:1075235551	1558106128323:1826789376	ATMF_500Secstudy	107	106	CREATE	2019-05-17 17:15:29.226	Sec28	1002
564	31	1558106314031:1152902316	1558106313197:-928626448	ATMF_500Secstudy	327	326	CREATE	2019-05-17 17:18:34.184	Sec68	1002
348	31	1558106137939:-1155484998	rootNode	ATMF_500Secstudy	111	0	CREATE	2019-05-17 17:15:38.341		Sec29
349	31	1558106138929:1403405649	1558106137939:-1155484998	ATMF_500Secstudy	112	111	CREATE	2019-05-17 17:15:39.099	Sec29	1002
351	31	1558106140432:478235459	1558106139667:-326058310	ATMF_500Secstudy	114	113	CREATE	2019-05-17 17:15:40.594	1003	1004
353	31	1558106141942:1137784336	rootNode	ATMF_500Secstudy	116	0	CREATE	2019-05-17 17:15:42.209		Sec3
354	31	1558106142805:-1412225768	1558106141942:1137784336	ATMF_500Secstudy	117	116	CREATE	2019-05-17 17:15:42.966	Sec3	1002
356	31	1558106144220:-329773662	1558106143519:1069067593	ATMF_500Secstudy	119	118	CREATE	2019-05-17 17:15:44.406	1003	1004
358	31	1558106145735:211139206	rootNode	ATMF_500Secstudy	121	0	CREATE	2019-05-17 17:15:45.89		Sec30
359	31	1558106146529:156078982	1558106145735:211139206	ATMF_500Secstudy	122	121	CREATE	2019-05-17 17:15:46.701	Sec30	1002
361	31	1558106148101:124520775	1558106147262:-1890042304	ATMF_500Secstudy	124	123	CREATE	2019-05-17 17:15:48.288	1003	1004
363	31	1558106149567:184148342	rootNode	ATMF_500Secstudy	126	0	CREATE	2019-05-17 17:15:49.745		Sec31
364	31	1558106150339:874825947	1558106149567:184148342	ATMF_500Secstudy	127	126	CREATE	2019-05-17 17:15:50.517	Sec31	1002
366	31	1558106151880:-1008321839	1558106151162:-842805861	ATMF_500Secstudy	129	128	CREATE	2019-05-17 17:15:52.341	1003	1004
368	31	1558106153595:-1182526514	rootNode	ATMF_500Secstudy	131	0	CREATE	2019-05-17 17:15:53.749		Sec32
369	31	1558106154356:-1427090832	1558106153595:-1182526514	ATMF_500Secstudy	132	131	CREATE	2019-05-17 17:15:54.515	Sec32	1002
371	31	1558106155841:-1817196547	1558106155055:345171574	ATMF_500Secstudy	134	133	CREATE	2019-05-17 17:15:55.997	1003	1004
373	31	1558106157248:130166408	rootNode	ATMF_500Secstudy	136	0	CREATE	2019-05-17 17:15:57.432		Sec33
374	31	1558106158009:1938361	1558106157248:130166408	ATMF_500Secstudy	137	136	CREATE	2019-05-17 17:15:58.232	Sec33	1002
376	31	1558106159664:-764662128	1558106158871:-1905736111	ATMF_500Secstudy	139	138	CREATE	2019-05-17 17:15:59.811	1003	1004
378	31	1558106161074:-1236508345	rootNode	ATMF_500Secstudy	141	0	CREATE	2019-05-17 17:16:01.259		Sec34
379	31	1558106161889:2090075482	1558106161074:-1236508345	ATMF_500Secstudy	142	141	CREATE	2019-05-17 17:16:02.08	Sec34	1002
381	31	1558106163452:-1709026437	1558106162704:-178991037	ATMF_500Secstudy	144	143	CREATE	2019-05-17 17:16:03.618	1003	1004
383	31	1558106164899:76184371	rootNode	ATMF_500Secstudy	146	0	CREATE	2019-05-17 17:16:05.427		Sec35
384	31	1558106166040:-1145009529	1558106164899:76184371	ATMF_500Secstudy	147	146	CREATE	2019-05-17 17:16:06.209	Sec35	1002
386	31	1558106167619:-2058737966	1558106166807:219697469	ATMF_500Secstudy	149	148	CREATE	2019-05-17 17:16:07.799	1003	1004
388	31	1558106169040:-1290489970	rootNode	ATMF_500Secstudy	151	0	CREATE	2019-05-17 17:16:09.293		Sec36
389	31	1558106169960:-775784756	1558106169040:-1290489970	ATMF_500Secstudy	152	151	CREATE	2019-05-17 17:16:10.126	Sec36	1002
391	31	1558106171429:2131815328	1558106170683:-2083847462	ATMF_500Secstudy	154	153	CREATE	2019-05-17 17:16:11.643	1003	1004
393	31	1558106172917:22202334	rootNode	ATMF_500Secstudy	156	0	CREATE	2019-05-17 17:16:13.093		Sec37
394	31	1558106173685:746253919	1558106172917:22202334	ATMF_500Secstudy	157	156	CREATE	2019-05-17 17:16:13.872	Sec37	1002
396	31	1558106175670:-1466619245	1558106174473:272595044	ATMF_500Secstudy	159	158	CREATE	2019-05-17 17:16:15.981	1003	1004
397	31	1558106176609:1336404910	1558106175670:-1466619245	ATMF_500Secstudy	160	159	CREATE	2019-05-17 17:16:16.765	1004	1005
399	31	1558106178215:-2015901293	1558106177305:-1344471492	ATMF_500Secstudy	162	161	CREATE	2019-05-17 17:16:18.429	Sec38	1002
401	31	1558106179693:-79944863	1558106178985:-1201521058	ATMF_500Secstudy	164	163	CREATE	2019-05-17 17:16:19.866	1003	1004
403	31	1558106181075:-31779703	rootNode	ATMF_500Secstudy	166	0	CREATE	2019-05-17 17:16:21.228		Sec39
404	31	1558106181846:425463756	1558106181075:-31779703	ATMF_500Secstudy	167	166	CREATE	2019-05-17 17:16:22.344	Sec39	1002
406	31	1558106183656:1701928437	1558106182937:-1321281172	ATMF_500Secstudy	169	168	CREATE	2019-05-17 17:16:23.897	1003	1004
408	31	1558106185194:-677219026	rootNode	ATMF_500Secstudy	171	0	CREATE	2019-05-17 17:16:25.346		Sec4
409	31	1558106185968:-335076266	1558106185194:-677219026	ATMF_500Secstudy	172	171	CREATE	2019-05-17 17:16:26.127	Sec4	1002
411	31	1558106187456:1405231082	1558106186698:-887120670	ATMF_500Secstudy	174	173	CREATE	2019-05-17 17:16:27.616	1003	1004
413	31	1558106188855:1334844398	rootNode	ATMF_500Secstudy	176	0	CREATE	2019-05-17 17:16:29.03		Sec40
414	31	1558106189642:-1210243255	1558106188855:1334844398	ATMF_500Secstudy	177	176	CREATE	2019-05-17 17:16:29.805	Sec40	1002
416	31	1558106191131:1639016813	1558106190400:106428213	ATMF_500Secstudy	179	178	CREATE	2019-05-17 17:16:31.326	1003	1004
418	31	1558106192647:1307853534	rootNode	ATMF_500Secstudy	181	0	CREATE	2019-05-17 17:16:32.886		Sec41
419	31	1558106193481:-11401822	1558106192647:1307853534	ATMF_500Secstudy	182	181	CREATE	2019-05-17 17:16:33.732	Sec41	1002
421	31	1558106195052:2039079723	1558106194279:-2019843871	ATMF_500Secstudy	184	183	CREATE	2019-05-17 17:16:35.215	1003	1004
423	31	1558106196375:-58820086	rootNode	ATMF_500Secstudy	186	0	CREATE	2019-05-17 17:16:36.529		Sec42
424	31	1558106197172:-195688096	1558106196375:-58820086	ATMF_500Secstudy	187	186	CREATE	2019-05-17 17:16:37.324	Sec42	1002
426	31	1558106198718:665630442	1558106197902:1402025647	ATMF_500Secstudy	189	188	CREATE	2019-05-17 17:16:38.944	1003	1004
427	31	1558106199542:2088719503	1558106198718:665630442	ATMF_500Secstudy	190	189	CREATE	2019-05-17 17:16:39.698	1004	1005
429	31	1558106200941:-898654345	1558106200189:-85811053	ATMF_500Secstudy	192	191	CREATE	2019-05-17 17:16:41.161	Sec43	1002
431	31	1558106202462:-1660122091	1558106201717:432857670	ATMF_500Secstudy	194	193	CREATE	2019-05-17 17:16:42.624	1003	1004
433	31	1558106203871:-112802020	rootNode	ATMF_500Secstudy	196	0	CREATE	2019-05-17 17:16:44.071		Sec44
434	31	1558106204678:-1519251887	1558106203871:-112802020	ATMF_500Secstudy	197	196	CREATE	2019-05-17 17:16:44.914	Sec44	1002
436	31	1558106206211:1072491087	1558106205520:1128135262	ATMF_500Secstudy	199	198	CREATE	2019-05-17 17:16:46.362	1003	1004
438	31	1558106208300:1199889872	rootNode	ATMF_500Secstudy	201	0	CREATE	2019-05-17 17:16:48.529		Sec45
439	31	1558106209218:2103633211	1558106208300:1199889872	ATMF_500Secstudy	202	201	CREATE	2019-05-17 17:16:49.373	Sec45	1002
441	31	1558106210710:-173333509	1558106210003:-690431507	ATMF_500Secstudy	204	203	CREATE	2019-05-17 17:16:50.867	1003	1004
526	31	1558106283950:-1714634729	1558106282848:800746674	ATMF_500Secstudy	289	288	CREATE	2019-05-17 17:18:04.107	1003	1004
528	31	1558106285383:-739690400	rootNode	ATMF_500Secstudy	291	0	CREATE	2019-05-17 17:18:05.594		Sec61
529	31	1558106286210:237379465	1558106285383:-739690400	ATMF_500Secstudy	292	291	CREATE	2019-05-17 17:18:06.433	Sec61	1002
531	31	1558106287819:252520907	1558106286983:804956048	ATMF_500Secstudy	294	293	CREATE	2019-05-17 17:18:08.042	1003	1004
532	31	1558106288661:1340720732	1558106287819:252520907	ATMF_500Secstudy	295	294	CREATE	2019-05-17 17:18:08.886	1004	1005
534	31	1558106290147:1765907887	1558106289381:-2106366492	ATMF_500Secstudy	297	296	CREATE	2019-05-17 17:18:10.305	Sec62	1002
536	31	1558106291651:1694475243	1558106290857:-1838182699	ATMF_500Secstudy	299	298	CREATE	2019-05-17 17:18:11.81	1003	1004
538	31	1558106293723:-2133357562	rootNode	ATMF_500Secstudy	301	0	CREATE	2019-05-17 17:18:14.163		Sec63
539	31	1558106294827:78356752	1558106293723:-2133357562	ATMF_500Secstudy	302	301	CREATE	2019-05-17 17:18:14.977	Sec63	1002
11552	86	\N	\N	D5170C00002	3	2	NEW	\N	Quintiles IQVIA	eTMF
445	31	1558106213647:-344314355	1558106212929:1117453972	ATMF_500Secstudy	208	207	CREATE	2019-05-17 17:16:53.815	1002	1003
447	31	1558106215420:-1339118781	1558106214454:1015864155	ATMF_500Secstudy	210	209	CREATE	2019-05-17 17:16:55.587	1004	1005
448	31	1558106216123:1145908041	rootNode	ATMF_500Secstudy	211	0	CREATE	2019-05-17 17:16:56.32		Sec47
450	31	1558106217745:885631587	1558106216997:-724696861	ATMF_500Secstudy	213	212	CREATE	2019-05-17 17:16:57.92	1002	1003
452	31	1558106219271:-1149802577	1558106218505:1535498318	ATMF_500Secstudy	215	214	CREATE	2019-05-17 17:16:59.485	1004	1005
453	31	1558106219958:1118917383	rootNode	ATMF_500Secstudy	216	0	CREATE	2019-05-17 17:17:00.115		Sec48
455	31	1558106221460:471398737	1558106220707:796348264	ATMF_500Secstudy	218	217	CREATE	2019-05-17 17:17:01.698	1002	1003
457	31	1558106223095:-1955968025	1558106222315:1846345547	ATMF_500Secstudy	220	219	CREATE	2019-05-17 17:17:03.241	1004	1005
458	31	1558106223758:-247756855	rootNode	ATMF_500Secstudy	221	0	CREATE	2019-05-17 17:17:03.913		Sec49
460	31	1558106225476:-302449313	1558106224540:84592556	ATMF_500Secstudy	223	222	CREATE	2019-05-17 17:17:05.694	1002	1003
462	31	1558106227067:468229918	1558106226330:1861850324	ATMF_500Secstudy	225	224	CREATE	2019-05-17 17:17:07.275	1004	1005
463	31	1558106227743:463062049	rootNode	ATMF_500Secstudy	226	0	CREATE	2019-05-17 17:17:07.969		Sec5
465	31	1558106229658:1710065290	1558106228594:-1750890886	ATMF_500Secstudy	228	227	CREATE	2019-05-17 17:17:09.838	1002	1003
467	31	1558106231129:229350304	1558106230375:-1813699271	ATMF_500Secstudy	230	229	CREATE	2019-05-17 17:17:11.285	1004	1005
468	31	1558106231791:-1836416470	rootNode	ATMF_500Secstudy	231	0	CREATE	2019-05-17 17:17:11.957		Sec50
470	31	1558106233273:-1960081921	1558106232555:-1189990778	ATMF_500Secstudy	233	232	CREATE	2019-05-17 17:17:13.424	1002	1003
471	31	1558106233986:-1668214939	1558106233273:-1960081921	ATMF_500Secstudy	234	233	CREATE	2019-05-17 17:17:14.135	1003	1004
473	31	1558106235411:-1863407334	rootNode	ATMF_500Secstudy	236	0	CREATE	2019-05-17 17:17:15.59		Sec51
475	31	1558106236971:-1574951622	1558106236196:-100121452	ATMF_500Secstudy	238	237	CREATE	2019-05-17 17:17:17.219	1002	1003
476	31	1558106237873:-1032721091	1558106236971:-1574951622	ATMF_500Secstudy	239	238	CREATE	2019-05-17 17:17:18.032	1003	1004
478	31	1558106239607:1064885106	rootNode	ATMF_500Secstudy	241	0	CREATE	2019-05-17 17:17:19.804		Sec52
480	31	1558106241185:1336504161	1558106240472:544206950	ATMF_500Secstudy	243	242	CREATE	2019-05-17 17:17:21.352	1002	1003
481	31	1558106241895:1569292178	1558106241185:1336504161	ATMF_500Secstudy	244	243	CREATE	2019-05-17 17:17:22.046	1003	1004
483	31	1558106243319:-1917388959	rootNode	ATMF_500Secstudy	246	0	CREATE	2019-05-17 17:17:23.478		Sec53
485	31	1558106244848:854216955	1558106244077:-1686258741	ATMF_500Secstudy	248	247	CREATE	2019-05-17 17:17:25.014	1002	1003
486	31	1558106245575:-906438556	1558106244848:854216955	ATMF_500Secstudy	249	248	CREATE	2019-05-17 17:17:26.173	1003	1004
488	31	1558106247497:1010903172	rootNode	ATMF_500Secstudy	251	0	CREATE	2019-05-17 17:17:27.762		Sec54
490	31	1558106249549:1299435683	1558106248417:-1702765393	ATMF_500Secstudy	253	252	CREATE	2019-05-17 17:17:29.807	1002	1003
491	31	1558106250394:-489441476	1558106249549:1299435683	ATMF_500Secstudy	254	253	CREATE	2019-05-17 17:17:30.628	1003	1004
493	31	1558106251867:-1971370790	rootNode	ATMF_500Secstudy	256	0	CREATE	2019-05-17 17:17:32.033		Sec55
494	31	1558106252653:248883723	1558106251867:-1971370790	ATMF_500Secstudy	257	256	CREATE	2019-05-17 17:17:32.82	Sec55	1002
496	31	1558106254190:2042298893	1558106253434:1182570273	ATMF_500Secstudy	259	258	CREATE	2019-05-17 17:17:34.355	1003	1004
498	31	1558106255650:-1998361654	rootNode	ATMF_500Secstudy	261	0	CREATE	2019-05-17 17:17:35.848		Sec56
499	31	1558106256453:166618590	1558106255650:-1998361654	ATMF_500Secstudy	262	261	CREATE	2019-05-17 17:17:36.606	Sec56	1002
501	31	1558106257873:1729892589	1558106257158:-1439522183	ATMF_500Secstudy	264	263	CREATE	2019-05-17 17:17:38.041	1003	1004
503	31	1558106259346:-2025341909	rootNode	ATMF_500Secstudy	266	0	CREATE	2019-05-17 17:17:39.501		Sec57
504	31	1558106260170:-287973767	1558106259346:-2025341909	ATMF_500Secstudy	267	266	CREATE	2019-05-17 17:17:40.558	Sec57	1002
506	31	1558106261973:1726455575	1558106261196:-1368905796	ATMF_500Secstudy	269	268	CREATE	2019-05-17 17:17:42.16	1003	1004
508	31	1558106263439:-2052332670	rootNode	ATMF_500Secstudy	271	0	CREATE	2019-05-17 17:17:49.848		Sec58
509	31	1558106270511:-1245120921	1558106263439:-2052332670	ATMF_500Secstudy	272	271	CREATE	2019-05-17 17:17:50.683	Sec58	1002
511	31	1558106272112:-903501714	1558106271335:-481798401	ATMF_500Secstudy	274	273	CREATE	2019-05-17 17:17:52.271	1003	1004
513	31	1558106273564:875948131	rootNode	ATMF_500Secstudy	276	0	CREATE	2019-05-17 17:17:53.725		Sec59
514	31	1558106274361:1203686609	1558106273564:875948131	ATMF_500Secstudy	277	276	CREATE	2019-05-17 17:17:54.537	Sec59	1002
516	31	1558106275873:-201082201	1558106275083:-862134929	ATMF_500Secstudy	279	278	CREATE	2019-05-17 17:17:56.033	1003	1004
518	31	1558106277215:263658205	rootNode	ATMF_500Secstudy	281	0	CREATE	2019-05-17 17:17:57.413		Sec6
519	31	1558106278050:1410213691	1558106277215:263658205	ATMF_500Secstudy	282	281	CREATE	2019-05-17 17:17:58.238	Sec6	1002
521	31	1558106279894:1131530011	1558106278916:-1325016904	ATMF_500Secstudy	284	283	CREATE	2019-05-17 17:18:00.067	1003	1004
523	31	1558106281230:-712699639	rootNode	ATMF_500Secstudy	286	0	CREATE	2019-05-17 17:18:01.388		Sec60
524	31	1558106282062:-1678404217	1558106281230:-712699639	ATMF_500Secstudy	287	286	CREATE	2019-05-17 17:18:02.295	Sec60	1002
11553	86	\N	\N	D5170C00002	4	3	NEW	\N	eTMF	contents
542	31	1558106297011:245191508	1558106296265:593739706	ATMF_500Secstudy	305	304	CREATE	2019-05-17 17:18:17.173	1004	1005
543	31	1558106297734:2134618973	rootNode	ATMF_500Secstudy	306	0	CREATE	2019-05-17 17:18:17.89		Sec64
545	31	1558106299218:-755350377	1558106298492:-930802559	ATMF_500Secstudy	308	307	CREATE	2019-05-17 17:18:19.365	1002	1003
547	31	1558106300987:1609240493	1558106299949:2034662489	ATMF_500Secstudy	310	309	CREATE	2019-05-17 17:18:21.145	1004	1005
548	31	1558106301610:-847654165	rootNode	ATMF_500Secstudy	311	0	CREATE	2019-05-17 17:18:21.779		Sec65
550	31	1558106303141:1109824842	1558106302362:-471329849	ATMF_500Secstudy	313	312	CREATE	2019-05-17 17:18:23.297	1002	1003
552	31	1558106304583:-1553890632	1558106303849:425853857	ATMF_500Secstudy	315	314	CREATE	2019-05-17 17:18:24.733	1004	1005
553	31	1558106305296:-874644926	rootNode	ATMF_500Secstudy	316	0	CREATE	2019-05-17 17:18:25.538		Sec66
555	31	1558106306931:-1032594898	1558106306150:1405552659	ATMF_500Secstudy	318	317	CREATE	2019-05-17 17:18:27.161	1002	1003
557	31	1558106308668:1146674799	1558106307705:-1097853502	ATMF_500Secstudy	320	319	CREATE	2019-05-17 17:18:28.814	1004	1005
558	31	1558106309314:-901635687	rootNode	ATMF_500Secstudy	321	0	CREATE	2019-05-17 17:18:29.492		Sec67
560	31	1558106310927:1136714601	1558106310123:-770035585	ATMF_500Secstudy	323	322	CREATE	2019-05-17 17:18:31.083	1002	1003
562	31	1558106312575:1546335889	1558106311654:10801968	ATMF_500Secstudy	325	324	CREATE	2019-05-17 17:18:32.73	1004	1005
563	31	1558106313197:-928626448	rootNode	ATMF_500Secstudy	326	0	CREATE	2019-05-17 17:18:33.364		Sec68
565	31	1558106314760:1600824318	1558106314031:1152902316	ATMF_500Secstudy	328	327	CREATE	2019-05-17 17:18:35.067	1002	1003
567	31	1558106316560:-1165065293	1558106315659:11490092	ATMF_500Secstudy	330	329	CREATE	2019-05-17 17:18:36.783	1004	1005
568	31	1558106317321:1999664241	rootNode	ATMF_500Secstudy	331	0	CREATE	2019-05-17 17:18:37.476		Sec69
570	31	1558106318857:198092454	1558106318073:1927728829	ATMF_500Secstudy	333	332	CREATE	2019-05-17 17:18:39.063	1002	1003
572	31	1558106320354:1706141123	1558106319630:1314216253	ATMF_500Secstudy	335	334	CREATE	2019-05-17 17:18:40.514	1004	1005
573	31	1558106321038:1403949168	rootNode	ATMF_500Secstudy	336	0	CREATE	2019-05-17 17:18:41.244		Sec7
575	31	1558106322575:-1648826486	1558106321833:-2033249594	ATMF_500Secstudy	338	337	CREATE	2019-05-17 17:18:42.789	1002	1003
577	31	1558106324336:-416380402	1558106323377:-1142956750	ATMF_500Secstudy	340	339	CREATE	2019-05-17 17:18:44.501	1004	1005
578	31	1558106325040:411006274	rootNode	ATMF_500Secstudy	341	0	CREATE	2019-05-17 17:18:45.206		Sec70
580	31	1558106326501:-263178352	1558106325794:-1578013945	ATMF_500Secstudy	343	342	CREATE	2019-05-17 17:18:46.651	1002	1003
582	31	1558106328008:311683824	1558106327220:-1925881447	ATMF_500Secstudy	345	344	CREATE	2019-05-17 17:18:48.159	1004	1005
583	31	1558106328625:-955669612	rootNode	ATMF_500Secstudy	346	0	CREATE	2019-05-17 17:18:49.088		Sec71
585	31	1558106330561:-203959303	1558106329707:542431936	ATMF_500Secstudy	348	347	CREATE	2019-05-17 17:18:50.804	1002	1003
587	31	1558106332074:1581626296	1558106331360:-1226145618	ATMF_500Secstudy	350	349	CREATE	2019-05-17 17:18:52.247	1004	1005
588	31	1558106332707:-982660476	rootNode	ATMF_500Secstudy	351	0	CREATE	2019-05-17 17:18:52.878		Sec72
590	31	1558106334317:-1615284018	1558106333526:-222743871	ATMF_500Secstudy	353	352	CREATE	2019-05-17 17:18:54.482	1002	1003
591	31	1558106335032:-407666135	1558106334317:-1615284018	ATMF_500Secstudy	354	353	CREATE	2019-05-17 17:18:55.179	1003	1004
593	31	1558106336428:-1009651237	rootNode	ATMF_500Secstudy	356	0	CREATE	2019-05-17 17:18:56.596		Sec73
595	31	1558106337888:-1816441324	1558106337188:-1588699772	ATMF_500Secstudy	358	357	CREATE	2019-05-17 17:18:58.036	1002	1003
596	31	1558106338645:-1782153951	1558106337888:-1816441324	ATMF_500Secstudy	359	358	CREATE	2019-05-17 17:18:58.819	1003	1004
598	31	1558106340129:303042509	rootNode	ATMF_500Secstudy	361	0	CREATE	2019-05-17 17:19:00.53		Sec74
600	31	1558106341949:1586701590	1558106341135:-1349355614	ATMF_500Secstudy	363	362	CREATE	2019-05-17 17:19:02.136	1002	1003
601	31	1558106342734:1946685357	1558106341949:1586701590	ATMF_500Secstudy	364	363	CREATE	2019-05-17 17:19:02.928	1003	1004
603	31	1558106344120:-1063633068	rootNode	ATMF_500Secstudy	366	0	CREATE	2019-05-17 17:19:04.277		Sec75
605	31	1558106345629:-39713730	1558106344923:77712752	ATMF_500Secstudy	368	367	CREATE	2019-05-17 17:19:06.09	1002	1003
606	31	1558106346685:-920288430	1558106345629:-39713730	ATMF_500Secstudy	369	368	CREATE	2019-05-17 17:19:06.887	1003	1004
608	31	1558106348300:249060472	rootNode	ATMF_500Secstudy	371	0	CREATE	2019-05-17 17:19:08.492		Sec76
610	31	1558106349890:863312386	1558106349107:-1799038688	ATMF_500Secstudy	373	372	CREATE	2019-05-17 17:19:10.051	1002	1003
611	31	1558106350587:2039607883	1558106349890:863312386	ATMF_500Secstudy	374	373	CREATE	2019-05-17 17:19:10.738	1003	1004
613	31	1558106352000:222069608	rootNode	ATMF_500Secstudy	376	0	CREATE	2019-05-17 17:19:12.157		Sec77
614	31	1558106352760:-1615602641	1558106352000:222069608	ATMF_500Secstudy	377	376	CREATE	2019-05-17 17:19:12.969	Sec77	1002
616	31	1558106354300:-1065939095	1558106353532:-596517286	ATMF_500Secstudy	379	378	CREATE	2019-05-17 17:19:14.476	1003	1004
618	31	1558106355721:-1144605660	rootNode	ATMF_500Secstudy	381	0	CREATE	2019-05-17 17:19:15.906		Sec78
619	31	1558106356616:1270565465	1558106355721:-1144605660	ATMF_500Secstudy	382	381	CREATE	2019-05-17 17:19:16.783	Sec78	1002
621	31	1558106358165:-2046674919	1558106357345:1890020067	ATMF_500Secstudy	384	383	CREATE	2019-05-17 17:19:18.327	1003	1004
623	31	1558106359562:168087674	rootNode	ATMF_500Secstudy	386	0	CREATE	2019-05-17 17:19:19.738		Sec79
624	31	1558106360321:-692395302	1558106359562:168087674	ATMF_500Secstudy	387	386	CREATE	2019-05-17 17:19:20.491	Sec79	1002
626	31	1558106361850:1704540070	1558106361052:-604765242	ATMF_500Secstudy	389	388	CREATE	2019-05-17 17:19:22.013	1003	1004
628	31	1558106363224:-411052546	rootNode	ATMF_500Secstudy	391	0	CREATE	2019-05-17 17:19:23.403		Sec8
629	31	1558106364073:49837412	1558106363224:-411052546	ATMF_500Secstudy	392	391	CREATE	2019-05-17 17:19:24.257	Sec8	1002
631	31	1558106365541:1513942882	1558106364813:993265664	ATMF_500Secstudy	394	393	CREATE	2019-05-17 17:19:25.707	1003	1004
633	31	1558106366902:195027474	rootNode	ATMF_500Secstudy	396	0	CREATE	2019-05-17 17:19:27.083		Sec80
634	31	1558106367680:544232541	1558106366902:195027474	ATMF_500Secstudy	397	396	CREATE	2019-05-17 17:19:27.833	Sec80	1002
636	31	1558106369170:1957457467	1558106368433:-1791619042	ATMF_500Secstudy	399	398	CREATE	2019-05-17 17:19:29.349	1003	1004
1405	53	\N	\N	ACQSIT02	2	1	NEW	\N	001	Correspondence
639	31	1558106373700:1618799960	1558106372945:1507720911	ATMF_500Secstudy	402	401	CREATE	2019-05-17 17:19:33.886	Sec81	1002
641	31	1558106375262:1914706043	1558106374453:1939507307	ATMF_500Secstudy	404	403	CREATE	2019-05-17 17:19:35.413	1003	1004
642	31	1558106376045:2112130487	1558106375262:1914706043	ATMF_500Secstudy	405	404	CREATE	2019-05-17 17:19:36.2	1004	1005
644	31	1558106377564:-1845507061	1558106376726:141045437	ATMF_500Secstudy	407	406	CREATE	2019-05-17 17:19:37.803	Sec82	1002
646	31	1558106379089:-1938275476	1558106378363:-1448342169	ATMF_500Secstudy	409	408	CREATE	2019-05-17 17:19:39.301	1003	1004
648	31	1558106380513:1453739183	rootNode	ATMF_500Secstudy	411	0	CREATE	2019-05-17 17:19:40.701		Sec83
649	31	1558106381292:-826766703	1558106380513:1453739183	ATMF_500Secstudy	412	411	CREATE	2019-05-17 17:19:41.444	Sec83	1002
651	31	1558106382722:-1174880869	1558106382008:1759667089	ATMF_500Secstudy	414	413	CREATE	2019-05-17 17:19:42.886	1003	1004
653	31	1558106384168:1426748319	rootNode	ATMF_500Secstudy	416	0	CREATE	2019-05-17 17:19:44.473		Sec84
654	31	1558106385125:-1503146226	1558106384168:1426748319	ATMF_500Secstudy	417	416	CREATE	2019-05-17 17:19:45.309	Sec84	1002
656	31	1558106386625:1989786221	1558106385858:1498311834	ATMF_500Secstudy	419	418	CREATE	2019-05-17 17:19:46.799	1003	1004
658	31	1558106387987:60072742	rootNode	ATMF_500Secstudy	421	0	CREATE	2019-05-17 17:19:48.135		Sec85
659	31	1558106388736:2127497680	1558106387987:60072742	ATMF_500Secstudy	422	421	CREATE	2019-05-17 17:19:49.006	Sec85	1002
661	31	1558106390429:-1865152407	1558106389674:1885869080	ATMF_500Secstudy	424	423	CREATE	2019-05-17 17:19:50.596	1003	1004
663	31	1558106391781:1372766591	rootNode	ATMF_500Secstudy	426	0	CREATE	2019-05-17 17:19:51.964		Sec86
664	31	1558106392610:780711173	1558106391781:1372766591	ATMF_500Secstudy	427	426	CREATE	2019-05-17 17:19:52.762	Sec86	1002
666	31	1558106394075:204580112	1558106393310:1464481687	ATMF_500Secstudy	429	428	CREATE	2019-05-17 17:19:54.265	1003	1004
668	31	1558106395438:1345775624	rootNode	ATMF_500Secstudy	431	0	CREATE	2019-05-17 17:19:55.62		Sec87
669	31	1558106396250:-1442452664	1558106395438:1345775624	ATMF_500Secstudy	432	431	CREATE	2019-05-17 17:19:56.415	Sec87	1002
671	31	1558106397701:-1108832876	1558106396977:-165025419	ATMF_500Secstudy	434	433	CREATE	2019-05-17 17:19:57.892	1003	1004
672	31	1558106398463:931764111	1558106397701:-1108832876	ATMF_500Secstudy	435	434	CREATE	2019-05-17 17:19:58.699	1004	1005
674	31	1558106400060:699824707	1558106399185:1318784863	ATMF_500Secstudy	437	436	CREATE	2019-05-17 17:20:00.297	Sec88	1002
676	31	1558106401994:1138418107	1558106400827:-1535537195	ATMF_500Secstudy	439	438	CREATE	2019-05-17 17:20:02.615	1003	1004
678	31	1558106404250:-47891023	rootNode	ATMF_500Secstudy	441	0	CREATE	2019-05-17 17:20:04.43		Sec89
679	31	1558106405076:-1623753711	1558106404250:-47891023	ATMF_500Secstudy	442	441	CREATE	2019-05-17 17:20:05.232	Sec89	1002
681	31	1558106406644:-142757630	1558106405914:2032570101	ATMF_500Secstudy	444	443	CREATE	2019-05-17 17:20:06.945	1003	1004
683	31	1558106408308:729228220	rootNode	ATMF_500Secstudy	446	0	CREATE	2019-05-17 17:20:08.55		Sec9
684	31	1558106409138:-572845083	1558106408308:729228220	ATMF_500Secstudy	447	446	CREATE	2019-05-17 17:20:09.673	Sec9	1002
686	31	1558106411082:-1286522226	1558106410296:-226792650	ATMF_500Secstudy	449	448	CREATE	2019-05-17 17:20:11.237	1003	1004
688	31	1558106412523:-1636549196	rootNode	ATMF_500Secstudy	451	0	CREATE	2019-05-17 17:20:12.685		Sec90
689	31	1558106413279:-1009262458	1558106412523:-1636549196	ATMF_500Secstudy	452	451	CREATE	2019-05-17 17:20:13.44	Sec90	1002
691	31	1558106414826:-1933349611	1558106414034:-100503637	ATMF_500Secstudy	454	453	CREATE	2019-05-17 17:20:15.287	1003	1004
693	31	1558106416499:1291742111	rootNode	ATMF_500Secstudy	456	0	CREATE	2019-05-17 17:20:16.666		Sec91
694	31	1558106417347:1234325873	1558106416499:1291742111	ATMF_500Secstudy	457	456	CREATE	2019-05-17 17:20:17.574	Sec91	1002
696	31	1558106418811:-1285820873	1558106418121:-754031935	ATMF_500Secstudy	459	458	CREATE	2019-05-17 17:20:18.981	1003	1004
698	31	1558106420304:1264751144	rootNode	ATMF_500Secstudy	461	0	CREATE	2019-05-17 17:20:20.484		Sec92
699	31	1558106421082:2100213991	1558106420304:1264751144	ATMF_500Secstudy	462	461	CREATE	2019-05-17 17:20:21.231	Sec92	1002
701	31	1558106422632:-1095886731	1558106421904:704474210	ATMF_500Secstudy	464	463	CREATE	2019-05-17 17:20:22.782	1003	1004
702	31	1558106423317:-357930266	1558106422632:-1095886731	ATMF_500Secstudy	465	464	CREATE	2019-05-17 17:20:23.474	1004	1005
704	31	1558106424813:-2006560753	1558106424037:-1717511591	ATMF_500Secstudy	467	466	CREATE	2019-05-17 17:20:24.962	Sec93	1002
706	31	1558106426372:-1432098096	1558106425609:1359589921	ATMF_500Secstudy	469	468	CREATE	2019-05-17 17:20:26.534	1003	1004
708	31	1558106427834:-1744502352	rootNode	ATMF_500Secstudy	471	0	CREATE	2019-05-17 17:20:28.274		Sec94
709	31	1558106428865:1775370744	1558106427834:-1744502352	ATMF_500Secstudy	472	471	CREATE	2019-05-17 17:20:29.041	Sec94	1002
711	31	1558106430401:1300868013	1558106429656:-1169669996	ATMF_500Secstudy	474	473	CREATE	2019-05-17 17:20:30.85	1003	1004
713	31	1558106432208:-1771493216	rootNode	ATMF_500Secstudy	476	0	CREATE	2019-05-17 17:20:32.359		Sec95
714	31	1558106432948:-9373110	1558106432208:-1771493216	ATMF_500Secstudy	477	476	CREATE	2019-05-17 17:20:33.107	Sec95	1002
716	31	1558106434373:546342800	1558106433679:-1716241849	ATMF_500Secstudy	479	478	CREATE	2019-05-17 17:20:34.558	1003	1004
718	31	1558106435851:-1798483977	rootNode	ATMF_500Secstudy	481	0	CREATE	2019-05-17 17:20:36.019		Sec96
719	31	1558106436616:-431604393	1558106435851:-1798483977	ATMF_500Secstudy	482	481	CREATE	2019-05-17 17:20:36.771	Sec96	1002
721	31	1558106438158:1303251032	1558106437445:238585739	ATMF_500Secstudy	484	483	CREATE	2019-05-17 17:20:38.355	1003	1004
723	31	1558106439547:1129796206	rootNode	ATMF_500Secstudy	486	0	CREATE	2019-05-17 17:20:39.707		Sec97
724	31	1558106440303:386049724	1558106439547:1129796206	ATMF_500Secstudy	487	486	CREATE	2019-05-17 17:20:40.451	Sec97	1002
726	31	1558106441743:-1115950362	1558106441007:-2134230308	ATMF_500Secstudy	489	488	CREATE	2019-05-17 17:20:41.905	1003	1004
728	31	1558106443161:-1852465705	rootNode	ATMF_500Secstudy	491	0	CREATE	2019-05-17 17:20:43.577		Sec98
729	31	1558106444198:974349546	1558106443161:-1852465705	ATMF_500Secstudy	492	491	CREATE	2019-05-17 17:20:44.379	Sec98	1002
731	31	1558106445624:793166518	1558106444920:-1893422226	ATMF_500Secstudy	494	493	CREATE	2019-05-17 17:20:45.782	1003	1004
732	31	1558106446373:-3199960	1558106445624:793166518	ATMF_500Secstudy	495	494	CREATE	2019-05-17 17:20:46.542	1004	1005
1401	52	1559564825325:237206177	rootNode	ATMF_Unicode	1	0	CREATE	2019-06-03 14:27:05.53		001
238	31	1558106041022:1746963128	rootNode	ATMF_500Secstudy	1	0	CREATE	2019-05-17 17:14:01.198		Sec1
239	31	1558106041846:-803107606	1558106041022:1746963128	ATMF_500Secstudy	2	1	CREATE	2019-05-17 17:14:02.044	Sec1	1002
241	31	1558106043375:335112201	1558106042621:-1512592502	ATMF_500Secstudy	4	3	CREATE	2019-05-17 17:14:03.627	1003	1004
244	31	1558106045636:-1575889553	1558106044861:853466674	ATMF_500Secstudy	7	6	CREATE	2019-05-17 17:14:05.804	Sec10	1002
246	31	1558106047148:-817698127	1558106046368:-1052977442	ATMF_500Secstudy	9	8	CREATE	2019-05-17 17:14:07.314	1003	1004
249	31	1558106049402:-971586618	1558106048588:-202153780	ATMF_500Secstudy	12	11	CREATE	2019-05-17 17:14:09.575	Sec100	1002
250	31	1558106050126:298457950	1558106049402:-971586618	ATMF_500Secstudy	13	12	CREATE	2019-05-17 17:14:10.292	1002	1003
252	31	1558106051657:-2014294710	1558106050901:1875601594	ATMF_500Secstudy	15	14	CREATE	2019-05-17 17:14:11.866	1004	1005
255	31	1558106053982:1711073953	1558106053226:-239547935	ATMF_500Secstudy	18	17	CREATE	2019-05-17 17:14:14.149	1002	1003
257	31	1558106055485:-1554028952	1558106054756:558828909	ATMF_500Secstudy	20	19	CREATE	2019-05-17 17:14:15.638	1004	1005
260	31	1558106057734:2044718885	1558106057019:1316350821	ATMF_500Secstudy	23	22	CREATE	2019-05-17 17:14:17.888	1002	1003
262	31	1558106059253:1642030210	1558106058466:-981678066	ATMF_500Secstudy	25	24	CREATE	2019-05-17 17:14:19.412	1004	1005
265	31	1558106061482:1394749499	1558106060709:304674559	ATMF_500Secstudy	28	27	CREATE	2019-05-17 17:14:21.654	1002	1003
268	31	1558106063653:811036825	rootNode	ATMF_500Secstudy	31	0	CREATE	2019-05-17 17:14:23.808		Sec14
270	31	1558106065183:-2137240293	1558106064446:1301066494	ATMF_500Secstudy	33	32	CREATE	2019-05-17 17:14:25.355	1002	1003
272	31	1558106066789:700541302	1558106066004:-1580541266	ATMF_500Secstudy	35	34	CREATE	2019-05-17 17:14:26.954	1004	1005
275	31	1558106068965:-1806475381	1558106068243:124608026	ATMF_500Secstudy	38	37	CREATE	2019-05-17 17:14:29.165	1002	1003
277	31	1558106070481:1626734186	1558106069744:2119834467	ATMF_500Secstudy	40	39	CREATE	2019-05-17 17:14:30.846	1004	1005
280	31	1558106073024:-37276044	1558106072215:-25862764	ATMF_500Secstudy	43	42	CREATE	2019-05-17 17:14:33.208	1002	1003
282	31	1558106074606:-1823319366	1558106073822:-1713094612	ATMF_500Secstudy	45	44	CREATE	2019-05-17 17:14:34.77	1004	1005
285	31	1558106076754:-1706860598	1558106076044:-1851771346	ATMF_500Secstudy	48	47	CREATE	2019-05-17 17:14:37.157	1002	1003
287	31	1558106078548:-574177437	1558106077767:-676234931	ATMF_500Secstudy	50	49	CREATE	2019-05-17 17:14:38.706	1004	1005
290	31	1558106086108:959061542	1558106079990:-63987421	ATMF_500Secstudy	53	52	CREATE	2019-05-17 17:14:46.27	1002	1003
292	31	1558106087662:1260940655	1558106086858:-333046063	ATMF_500Secstudy	55	54	CREATE	2019-05-17 17:14:47.839	1004	1005
295	31	1558106090050:-811444488	1558106089106:-241269754	ATMF_500Secstudy	58	57	CREATE	2019-05-17 17:14:50.289	1002	1003
298	31	1558106092383:1337177159	rootNode	ATMF_500Secstudy	61	0	CREATE	2019-05-17 17:14:52.538		Sec2
300	31	1558106094434:1035353093	1558106093154:-1407344743	ATMF_500Secstudy	63	62	CREATE	2019-05-17 17:14:54.597	1002	1003
302	31	1558106095982:-484595727	1558106095239:-269171463	ATMF_500Secstudy	65	64	CREATE	2019-05-17 17:14:56.131	1004	1005
305	31	1558106098207:-1576066672	1558106097461:1786584351	ATMF_500Secstudy	68	67	CREATE	2019-05-17 17:14:58.388	1002	1003
307	31	1558106099757:621011709	1558106098934:1944948156	ATMF_500Secstudy	70	69	CREATE	2019-05-17 17:14:59.938	1004	1005
310	31	1558106101976:-1074151030	1558106101183:1655894444	ATMF_500Secstudy	73	72	CREATE	2019-05-17 17:15:02.145	1002	1003
312	31	1558106103450:1804657911	1558106102726:1722279736	ATMF_500Secstudy	75	74	CREATE	2019-05-17 17:15:03.613	1004	1005
315	31	1558106105657:-999341738	1558106104936:-1518422025	ATMF_500Secstudy	78	77	CREATE	2019-05-17 17:15:05.814	1002	1003
317	31	1558106107165:1492404108	1558106106360:1421436472	ATMF_500Secstudy	80	79	CREATE	2019-05-17 17:15:07.391	1004	1005
320	31	1558106109472:-879158395	1558106108670:-993153771	ATMF_500Secstudy	83	82	CREATE	2019-05-17 17:15:09.689	1002	1003
322	31	1558106111030:-292953092	1558106110258:-1939049668	ATMF_500Secstudy	85	84	CREATE	2019-05-17 17:15:11.197	1004	1005
325	31	1558106113436:-1507103020	1558106112647:-1838897690	ATMF_500Secstudy	88	87	CREATE	2019-05-17 17:15:13.588	1002	1003
327	31	1558106115040:-451099819	1558106114148:-2087694856	ATMF_500Secstudy	90	89	CREATE	2019-05-17 17:15:15.207	1004	1005
330	31	1558106117367:1829056699	1558106116566:-422245180	ATMF_500Secstudy	93	92	CREATE	2019-05-17 17:15:17.535	1002	1003
332	31	1558106118840:-1521706949	1558106118096:1568748531	ATMF_500Secstudy	95	94	CREATE	2019-05-17 17:15:19.1	1004	1005
335	31	1558106121495:878824752	1558106120394:610516613	ATMF_500Secstudy	98	97	CREATE	2019-05-17 17:15:21.804	1002	1003
338	31	1558106124524:1853780137	rootNode	ATMF_500Secstudy	101	0	CREATE	2019-05-17 17:15:24.698		Sec27
340	31	1558106126136:-293386120	1558106125364:-1512355022	ATMF_500Secstudy	103	102	CREATE	2019-05-17 17:15:26.289	1002	1003
342	31	1558106127603:1722438367	1558106126850:625403838	ATMF_500Secstudy	105	104	CREATE	2019-05-17 17:15:27.819	1004	1005
345	31	1558106129798:1903781748	1558106129061:1075235551	ATMF_500Secstudy	108	107	CREATE	2019-05-17 17:15:30.241	1002	1003
346	31	1558106130899:-1186436101	1558106129798:1903781748	ATMF_500Secstudy	109	108	CREATE	2019-05-17 17:15:31.05	1003	1004
347	31	1558106137131:2090845825	1558106130899:-1186436101	ATMF_500Secstudy	110	109	CREATE	2019-05-17 17:15:37.342	1004	1005
350	31	1558106139667:-326058310	1558106138929:1403405649	ATMF_500Secstudy	113	112	CREATE	2019-05-17 17:15:39.876	1002	1003
352	31	1558106141152:276096188	1558106140432:478235459	ATMF_500Secstudy	115	114	CREATE	2019-05-17 17:15:41.316	1004	1005
355	31	1558106143519:1069067593	1558106142805:-1412225768	ATMF_500Secstudy	118	117	CREATE	2019-05-17 17:15:43.672	1002	1003
357	31	1558106144976:746358668	1558106144220:-329773662	ATMF_500Secstudy	120	119	CREATE	2019-05-17 17:15:45.131	1004	1005
360	31	1558106147262:-1890042304	1558106146529:156078982	ATMF_500Secstudy	123	122	CREATE	2019-05-17 17:15:47.492	1002	1003
362	31	1558106148873:-195584126	1558106148101:124520775	ATMF_500Secstudy	125	124	CREATE	2019-05-17 17:15:49.086	1004	1005
365	31	1558106151162:-842805861	1558106150339:874825947	ATMF_500Secstudy	128	127	CREATE	2019-05-17 17:15:51.325	1002	1003
367	31	1558106152955:1705438833	1558106151880:-1008321839	ATMF_500Secstudy	130	129	CREATE	2019-05-17 17:15:53.123	1004	1005
370	31	1558106155055:345171574	1558106154356:-1427090832	ATMF_500Secstudy	133	132	CREATE	2019-05-17 17:15:55.239	1002	1003
735	31	1558106455723:28747854	1558106447880:-344866830	ATMF_500Secstudy	498	497	CREATE	2019-05-17 17:20:56.024	1002	1003
736	31	1558106456691:-351309031	1558106455723:28747854	ATMF_500Secstudy	499	498	CREATE	2019-05-17 17:20:56.845	1003	1004
372	31	1558106156580:-613215660	1558106155841:-1817196547	ATMF_500Secstudy	135	134	CREATE	2019-05-17 17:15:56.741	1004	1005
375	31	1558106158871:-1905736111	1558106158009:1938361	ATMF_500Secstudy	138	137	CREATE	2019-05-17 17:15:59.109	1002	1003
377	31	1558106160366:-884221597	1558106159664:-764662128	ATMF_500Secstudy	140	139	CREATE	2019-05-17 17:16:00.533	1004	1005
380	31	1558106162704:-178991037	1558106161889:2090075482	ATMF_500Secstudy	143	142	CREATE	2019-05-17 17:16:02.87	1002	1003
382	31	1558106164241:-274000282	1558106163452:-1709026437	ATMF_500Secstudy	145	144	CREATE	2019-05-17 17:16:04.405	1004	1005
385	31	1558106166807:219697469	1558106166040:-1145009529	ATMF_500Secstudy	148	147	CREATE	2019-05-17 17:16:07.047	1002	1003
387	31	1558106168389:-735347783	1558106167619:-2058737966	ATMF_500Secstudy	150	149	CREATE	2019-05-17 17:16:08.562	1004	1005
390	31	1558106170683:-2083847462	1558106169960:-775784756	ATMF_500Secstudy	153	152	CREATE	2019-05-17 17:16:10.885	1002	1003
392	31	1558106172264:1245800994	1558106171429:2131815328	ATMF_500Secstudy	155	154	CREATE	2019-05-17 17:16:12.44	1004	1005
395	31	1558106174473:272595044	1558106173685:746253919	ATMF_500Secstudy	158	157	CREATE	2019-05-17 17:16:15.035	1002	1003
398	31	1558106177305:-1344471492	rootNode	ATMF_500Secstudy	161	0	CREATE	2019-05-17 17:16:17.571		Sec38
400	31	1558106178985:-1201521058	1558106178215:-2015901293	ATMF_500Secstudy	163	162	CREATE	2019-05-17 17:16:19.141	1002	1003
402	31	1558106180421:-11621411	1558106179693:-79944863	ATMF_500Secstudy	165	164	CREATE	2019-05-17 17:16:20.57	1004	1005
405	31	1558106182937:-1321281172	1558106181846:425463756	ATMF_500Secstudy	168	167	CREATE	2019-05-17 17:16:23.091	1002	1003
407	31	1558106184479:-758005607	1558106183656:1701928437	ATMF_500Secstudy	170	169	CREATE	2019-05-17 17:16:24.634	1004	1005
410	31	1558106186698:-887120670	1558106185968:-335076266	ATMF_500Secstudy	173	172	CREATE	2019-05-17 17:16:26.849	1002	1003
412	31	1558106188169:429709785	1558106187456:1405231082	ATMF_500Secstudy	175	174	CREATE	2019-05-17 17:16:28.328	1004	1005
415	31	1558106190400:106428213	1558106189642:-1210243255	ATMF_500Secstudy	178	177	CREATE	2019-05-17 17:16:30.56	1002	1003
417	31	1558106191882:-1093242332	1558106191131:1639016813	ATMF_500Secstudy	180	179	CREATE	2019-05-17 17:16:32.119	1004	1005
420	31	1558106194279:-2019843871	1558106193481:-11401822	ATMF_500Secstudy	183	182	CREATE	2019-05-17 17:16:34.449	1002	1003
422	31	1558106195772:-1441532906	1558106195052:2039079723	ATMF_500Secstudy	185	184	CREATE	2019-05-17 17:16:35.921	1004	1005
425	31	1558106197902:1402025647	1558106197172:-195688096	ATMF_500Secstudy	188	187	CREATE	2019-05-17 17:16:38.071	1002	1003
428	31	1558106200189:-85811053	rootNode	ATMF_500Secstudy	191	0	CREATE	2019-05-17 17:16:40.344		Sec43
430	31	1558106201717:432857670	1558106200941:-898654345	ATMF_500Secstudy	193	192	CREATE	2019-05-17 17:16:41.88	1002	1003
432	31	1558106203216:1307026975	1558106202462:-1660122091	ATMF_500Secstudy	195	194	CREATE	2019-05-17 17:16:43.398	1004	1005
435	31	1558106205520:1128135262	1558106204678:-1519251887	ATMF_500Secstudy	198	197	CREATE	2019-05-17 17:16:45.669	1002	1003
437	31	1558106206921:203438355	1558106206211:1072491087	ATMF_500Secstudy	200	199	CREATE	2019-05-17 17:16:47.138	1004	1005
440	31	1558106210003:-690431507	1558106209218:2103633211	ATMF_500Secstudy	203	202	CREATE	2019-05-17 17:16:50.164	1002	1003
442	31	1558106211430:-1119174860	1558106210710:-173333509	ATMF_500Secstudy	205	204	CREATE	2019-05-17 17:16:51.58	1004	1005
443	31	1558106212112:1172899008	rootNode	ATMF_500Secstudy	206	0	CREATE	2019-05-17 17:16:52.275		Sec46
444	31	1558106212929:1117453972	1558106212112:1172899008	ATMF_500Secstudy	207	206	CREATE	2019-05-17 17:16:53.083	Sec46	1002
446	31	1558106214454:1015864155	1558106213647:-344314355	ATMF_500Secstudy	209	208	CREATE	2019-05-17 17:16:54.832	1003	1004
449	31	1558106216997:-724696861	1558106216123:1145908041	ATMF_500Secstudy	212	211	CREATE	2019-05-17 17:16:57.179	Sec47	1002
451	31	1558106218505:1535498318	1558106217745:885631587	ATMF_500Secstudy	214	213	CREATE	2019-05-17 17:16:58.693	1003	1004
454	31	1558106220707:796348264	1558106219958:1118917383	ATMF_500Secstudy	217	216	CREATE	2019-05-17 17:17:00.857	Sec48	1002
456	31	1558106222315:1846345547	1558106221460:471398737	ATMF_500Secstudy	219	218	CREATE	2019-05-17 17:17:02.478	1003	1004
459	31	1558106224540:84592556	1558106223758:-247756855	ATMF_500Secstudy	222	221	CREATE	2019-05-17 17:17:04.889	Sec49	1002
461	31	1558106226330:1861850324	1558106225476:-302449313	ATMF_500Secstudy	224	223	CREATE	2019-05-17 17:17:06.501	1003	1004
464	31	1558106228594:-1750890886	1558106227743:463062049	ATMF_500Secstudy	227	226	CREATE	2019-05-17 17:17:09.027	Sec5	1002
466	31	1558106230375:-1813699271	1558106229658:1710065290	ATMF_500Secstudy	229	228	CREATE	2019-05-17 17:17:10.535	1003	1004
469	31	1558106232555:-1189990778	1558106231791:-1836416470	ATMF_500Secstudy	232	231	CREATE	2019-05-17 17:17:12.704	Sec50	1002
472	31	1558106234762:194302131	1558106233986:-1668214939	ATMF_500Secstudy	235	234	CREATE	2019-05-17 17:17:14.949	1004	1005
474	31	1558106236196:-100121452	1558106235411:-1863407334	ATMF_500Secstudy	237	236	CREATE	2019-05-17 17:17:16.411	Sec51	1002
477	31	1558106238622:-1383600399	1558106237873:-1032721091	ATMF_500Secstudy	240	239	CREATE	2019-05-17 17:17:19.076	1004	1005
479	31	1558106240472:544206950	1558106239607:1064885106	ATMF_500Secstudy	242	241	CREATE	2019-05-17 17:17:20.622	Sec52	1002
482	31	1558106242681:540724424	1558106241895:1569292178	ATMF_500Secstudy	245	244	CREATE	2019-05-17 17:17:22.848	1004	1005
484	31	1558106244077:-1686258741	1558106243319:-1917388959	ATMF_500Secstudy	247	246	CREATE	2019-05-17 17:17:24.239	Sec53	1002
487	31	1558106246760:-2011488714	1558106245575:-906438556	ATMF_500Secstudy	250	249	CREATE	2019-05-17 17:17:27.045	1004	1005
489	31	1558106248417:-1702765393	1558106247497:1010903172	ATMF_500Secstudy	252	251	CREATE	2019-05-17 17:17:28.923	Sec54	1002
492	31	1558106251199:13828197	1558106250394:-489441476	ATMF_500Secstudy	255	254	CREATE	2019-05-17 17:17:31.4	1004	1005
495	31	1558106253434:1182570273	1558106252653:248883723	ATMF_500Secstudy	258	257	CREATE	2019-05-17 17:17:33.624	1002	1003
497	31	1558106254925:201896800	1558106254190:2042298893	ATMF_500Secstudy	260	259	CREATE	2019-05-17 17:17:35.09	1004	1005
500	31	1558106257158:-1439522183	1558106256453:166618590	ATMF_500Secstudy	263	262	CREATE	2019-05-17 17:17:37.326	1002	1003
502	31	1558106258655:286596703	1558106257873:1729892589	ATMF_500Secstudy	265	264	CREATE	2019-05-17 17:17:38.856	1004	1005
505	31	1558106261196:-1368905796	1558106260170:-287973767	ATMF_500Secstudy	268	267	CREATE	2019-05-17 17:17:41.375	1002	1003
507	31	1558106262711:646147194	1558106261973:1726455575	ATMF_500Secstudy	270	269	CREATE	2019-05-17 17:17:42.929	1004	1005
510	31	1558106271335:-481798401	1558106270511:-1245120921	ATMF_500Secstudy	273	272	CREATE	2019-05-17 17:17:51.508	1002	1003
512	31	1558106272892:-1543479220	1558106272112:-903501714	ATMF_500Secstudy	275	274	CREATE	2019-05-17 17:17:53.054	1004	1005
1406	53	\N	\N	ACQSIT02	3	2	NEW	\N	Correspondence	GeneralAdmin
515	31	1558106275083:-862134929	1558106274361:1203686609	ATMF_500Secstudy	278	277	CREATE	2019-05-17 17:17:55.258	1002	1003
517	31	1558106276582:2111138126	1558106275873:-201082201	ATMF_500Secstudy	280	279	CREATE	2019-05-17 17:17:56.739	1004	1005
520	31	1558106278916:-1325016904	1558106278050:1410213691	ATMF_500Secstudy	283	282	CREATE	2019-05-17 17:17:59.306	1002	1003
522	31	1558106280599:1934222637	1558106279894:1131530011	ATMF_500Secstudy	285	284	CREATE	2019-05-17 17:18:00.75	1004	1005
525	31	1558106282848:800746674	1558106282062:-1678404217	ATMF_500Secstudy	288	287	CREATE	2019-05-17 17:18:03.35	1002	1003
566	31	1558106315659:11490092	1558106314760:1600824318	ATMF_500Secstudy	329	328	CREATE	2019-05-17 17:18:35.873	1003	1004
569	31	1558106318073:1927728829	1558106317321:1999664241	ATMF_500Secstudy	332	331	CREATE	2019-05-17 17:18:38.243	Sec69	1002
571	31	1558106319630:1314216253	1558106318857:198092454	ATMF_500Secstudy	334	333	CREATE	2019-05-17 17:18:39.784	1003	1004
574	31	1558106321833:-2033249594	1558106321038:1403949168	ATMF_500Secstudy	337	336	CREATE	2019-05-17 17:18:42.021	Sec7	1002
576	31	1558106323377:-1142956750	1558106322575:-1648826486	ATMF_500Secstudy	339	338	CREATE	2019-05-17 17:18:43.702	1003	1004
579	31	1558106325794:-1578013945	1558106325040:411006274	ATMF_500Secstudy	342	341	CREATE	2019-05-17 17:18:45.956	Sec70	1002
581	31	1558106327220:-1925881447	1558106326501:-263178352	ATMF_500Secstudy	344	343	CREATE	2019-05-17 17:18:47.418	1003	1004
584	31	1558106329707:542431936	1558106328625:-955669612	ATMF_500Secstudy	347	346	CREATE	2019-05-17 17:18:49.921	Sec71	1002
586	31	1558106331360:-1226145618	1558106330561:-203959303	ATMF_500Secstudy	349	348	CREATE	2019-05-17 17:18:51.518	1003	1004
589	31	1558106333526:-222743871	1558106332707:-982660476	ATMF_500Secstudy	352	351	CREATE	2019-05-17 17:18:53.685	Sec72	1002
592	31	1558106335743:-1711727200	1558106335032:-407666135	ATMF_500Secstudy	355	354	CREATE	2019-05-17 17:18:55.894	1004	1005
594	31	1558106337188:-1588699772	1558106336428:-1009651237	ATMF_500Secstudy	357	356	CREATE	2019-05-17 17:18:57.339	Sec73	1002
597	31	1558106339370:-939355477	1558106338645:-1782153951	ATMF_500Secstudy	360	359	CREATE	2019-05-17 17:18:59.534	1004	1005
599	31	1558106341135:-1349355614	1558106340129:303042509	ATMF_500Secstudy	362	361	CREATE	2019-05-17 17:19:01.376	Sec74	1002
602	31	1558106343477:-1432008009	1558106342734:1946685357	ATMF_500Secstudy	365	364	CREATE	2019-05-17 17:19:03.644	1004	1005
604	31	1558106344923:77712752	1558106344120:-1063633068	ATMF_500Secstudy	367	366	CREATE	2019-05-17 17:19:05.084	Sec75	1002
607	31	1558106347467:582248678	1558106346685:-920288430	ATMF_500Secstudy	370	369	CREATE	2019-05-17 17:19:07.689	1004	1005
609	31	1558106349107:-1799038688	1558106348300:249060472	ATMF_500Secstudy	372	371	CREATE	2019-05-17 17:19:09.273	Sec76	1002
612	31	1558106351302:-131177344	1558106350587:2039607883	ATMF_500Secstudy	375	374	CREATE	2019-05-17 17:19:11.454	1004	1005
615	31	1558106353532:-596517286	1558106352760:-1615602641	ATMF_500Secstudy	378	377	CREATE	2019-05-17 17:19:13.697	1002	1003
617	31	1558106355073:-921192381	1558106354300:-1065939095	ATMF_500Secstudy	380	379	CREATE	2019-05-17 17:19:15.234	1004	1005
620	31	1558106357345:1890020067	1558106356616:1270565465	ATMF_500Secstudy	383	382	CREATE	2019-05-17 17:19:17.614	1002	1003
622	31	1558106358914:751477581	1558106358165:-2046674919	ATMF_500Secstudy	385	384	CREATE	2019-05-17 17:19:19.078	1004	1005
625	31	1558106361052:-604765242	1558106360321:-692395302	ATMF_500Secstudy	388	387	CREATE	2019-05-17 17:19:21.306	1002	1003
627	31	1558106362572:-182766043	1558106361850:1704540070	ATMF_500Secstudy	390	389	CREATE	2019-05-17 17:19:22.738	1004	1005
630	31	1558106364813:993265664	1558106364073:49837412	ATMF_500Secstudy	393	392	CREATE	2019-05-17 17:19:24.958	1002	1003
632	31	1558106366265:-693531261	1558106365541:1513942882	ATMF_500Secstudy	395	394	CREATE	2019-05-17 17:19:26.438	1004	1005
635	31	1558106368433:-1791619042	1558106367680:544232541	ATMF_500Secstudy	398	397	CREATE	2019-05-17 17:19:28.585	1002	1003
637	31	1558106371525:-164819796	1558106369170:1957457467	ATMF_500Secstudy	400	399	CREATE	2019-05-17 17:19:31.679	1004	1005
638	31	1558106372945:1507720911	rootNode	ATMF_500Secstudy	401	0	CREATE	2019-05-17 17:19:33.115		Sec81
640	31	1558106374453:1939507307	1558106373700:1618799960	ATMF_500Secstudy	403	402	CREATE	2019-05-17 17:19:34.688	1002	1003
643	31	1558106376726:141045437	rootNode	ATMF_500Secstudy	406	0	CREATE	2019-05-17 17:19:36.907		Sec82
645	31	1558106378363:-1448342169	1558106377564:-1845507061	ATMF_500Secstudy	408	407	CREATE	2019-05-17 17:19:38.541	1002	1003
647	31	1558106379905:-532922536	1558106379089:-1938275476	ATMF_500Secstudy	410	409	CREATE	2019-05-17 17:19:40.061	1004	1005
650	31	1558106382008:1759667089	1558106381292:-826766703	ATMF_500Secstudy	413	412	CREATE	2019-05-17 17:19:42.177	1002	1003
652	31	1558106383482:-559446930	1558106382722:-1174880869	ATMF_500Secstudy	415	414	CREATE	2019-05-17 17:19:43.677	1004	1005
655	31	1558106385858:1498311834	1558106385125:-1503146226	ATMF_500Secstudy	418	417	CREATE	2019-05-17 17:19:46.069	1002	1003
657	31	1558106387356:-67976875	1558106386625:1989786221	ATMF_500Secstudy	420	419	CREATE	2019-05-17 17:19:47.532	1004	1005
660	31	1558106389674:1885869080	1558106388736:2127497680	ATMF_500Secstudy	423	422	CREATE	2019-05-17 17:19:49.844	1002	1003
662	31	1558106391133:-1337863478	1558106390429:-1865152407	ATMF_500Secstudy	425	424	CREATE	2019-05-17 17:19:51.312	1004	1005
665	31	1558106393310:1464481687	1558106392610:780711173	ATMF_500Secstudy	428	427	CREATE	2019-05-17 17:19:53.46	1002	1003
667	31	1558106394805:-1265803815	1558106394075:204580112	ATMF_500Secstudy	430	429	CREATE	2019-05-17 17:19:54.967	1004	1005
670	31	1558106396977:-165025419	1558106396250:-1442452664	ATMF_500Secstudy	433	432	CREATE	2019-05-17 17:19:57.157	1002	1003
673	31	1558106399185:1318784863	rootNode	ATMF_500Secstudy	436	0	CREATE	2019-05-17 17:19:59.428		Sec88
675	31	1558106400827:-1535537195	1558106400060:699824707	ATMF_500Secstudy	438	437	CREATE	2019-05-17 17:20:01.334	1002	1003
677	31	1558106403238:1447094376	1558106401994:1138418107	ATMF_500Secstudy	440	439	CREATE	2019-05-17 17:20:03.678	1004	1005
680	31	1558106405914:2032570101	1558106405076:-1623753711	ATMF_500Secstudy	443	442	CREATE	2019-05-17 17:20:06.102	1002	1003
682	31	1558106407532:164505907	1558106406644:-142757630	ATMF_500Secstudy	445	444	CREATE	2019-05-17 17:20:07.787	1004	1005
685	31	1558106410296:-226792650	1558106409138:-572845083	ATMF_500Secstudy	448	447	CREATE	2019-05-17 17:20:10.442	1002	1003
687	31	1558106411814:-447468647	1558106411082:-1286522226	ATMF_500Secstudy	450	449	CREATE	2019-05-17 17:20:11.994	1004	1005
690	31	1558106414034:-100503637	1558106413279:-1009262458	ATMF_500Secstudy	453	452	CREATE	2019-05-17 17:20:14.203	1002	1003
692	31	1558106415879:248388563	1558106414826:-1933349611	ATMF_500Secstudy	455	454	CREATE	2019-05-17 17:20:16.036	1004	1005
695	31	1558106418121:-754031935	1558106417347:1234325873	ATMF_500Secstudy	458	457	CREATE	2019-05-17 17:20:18.268	1002	1003
1407	53	\N	\N	ACQSIT02	4	3	NEW	\N	GeneralAdmin	Management
697	31	1558106419618:-2115798161	1558106418811:-1285820873	ATMF_500Secstudy	460	459	CREATE	2019-05-17 17:20:19.823	1004	1005
700	31	1558106421904:704474210	1558106421082:2100213991	ATMF_500Secstudy	463	462	CREATE	2019-05-17 17:20:22.056	1002	1003
703	31	1558106424037:-1717511591	rootNode	ATMF_500Secstudy	466	0	CREATE	2019-05-17 17:20:24.219		Sec93
705	31	1558106425609:1359589921	1558106424813:-2006560753	ATMF_500Secstudy	468	467	CREATE	2019-05-17 17:20:25.764	1002	1003
707	31	1558106427189:2042383192	1558106426372:-1432098096	ATMF_500Secstudy	470	469	CREATE	2019-05-17 17:20:27.359	1004	1005
710	31	1558106429656:-1169669996	1558106428865:1775370744	ATMF_500Secstudy	473	472	CREATE	2019-05-17 17:20:29.828	1002	1003
712	31	1558106431449:1618414074	1558106430401:1300868013	ATMF_500Secstudy	475	474	CREATE	2019-05-17 17:20:31.691	1004	1005
715	31	1558106433679:-1716241849	1558106432948:-9373110	ATMF_500Secstudy	478	477	CREATE	2019-05-17 17:20:33.826	1002	1003
717	31	1558106435153:-185391260	1558106434373:546342800	ATMF_500Secstudy	480	479	CREATE	2019-05-17 17:20:35.384	1004	1005
720	31	1558106437445:238585739	1558106436616:-431604393	ATMF_500Secstudy	483	482	CREATE	2019-05-17 17:20:37.608	1002	1003
722	31	1558106438901:-1525689552	1558106438158:1303251032	ATMF_500Secstudy	485	484	CREATE	2019-05-17 17:20:39.052	1004	1005
725	31	1558106441007:-2134230308	1558106440303:386049724	ATMF_500Secstudy	488	487	CREATE	2019-05-17 17:20:41.203	1002	1003
727	31	1558106442436:-1632727401	1558106441743:-1115950362	ATMF_500Secstudy	490	489	CREATE	2019-05-17 17:20:42.626	1004	1005
730	31	1558106444920:-1893422226	1558106444198:974349546	ATMF_500Secstudy	493	492	CREATE	2019-05-17 17:20:45.076	1002	1003
733	31	1558106447086:-1879456363	rootNode	ATMF_500Secstudy	496	0	CREATE	2019-05-17 17:20:47.275		Sec99
734	31	1558106447880:-344866830	1558106447086:-1879456363	ATMF_500Secstudy	497	496	CREATE	2019-05-17 17:20:55.018	Sec99	1002
737	31	1558106457447:-1571555173	1558106456691:-351309031	ATMF_500Secstudy	500	499	CREATE	2019-05-17 17:20:57.68	1004	1005
738	32	1558131234649:-2256577	rootNode	ATMF_5000docs	1	0	CREATE	2019-05-18 00:13:54.802		0001_Index
739	32	1558131235317:-519956932	rootNode	ATMF_5000docs	2	0	CREATE	2019-05-18 00:13:55.468		0002_Index
740	32	1558131236004:302031134	rootNode	ATMF_5000docs	3	0	CREATE	2019-05-18 00:13:56.198		0003_Index
741	32	1558131236842:-1831259881	rootNode	ATMF_5000docs	4	0	CREATE	2019-05-18 00:13:56.99		0004_Index
742	32	1558131237501:1946007163	rootNode	ATMF_5000docs	5	0	CREATE	2019-05-18 00:13:57.658		0005_Index
1238	51	1559200568368:-846723928	1559200564785:934227197	CV181-085	275	271	CREATE	2019-05-30 09:16:08.546	020	Country and Site Selection Tools
815	43	1558526276004:987481047	rootNode	ATMF_BigFile	1	0	CREATE	2019-05-22 13:57:56.195		Index1
861	47	1558635115835:-87069370	1558635114957:-1280948793	ATMF_SNL2	2	1	CREATE	2019-05-23 20:11:56.004	001	Finance and Legal
862	47	1558635116573:904362506	1558635115835:-87069370	ATMF_SNL2	3	2	CREATE	2019-05-23 20:11:56.841	Finance and Legal	Informed Consent
863	47	1558635117594:-1654672868	1558635116573:904362506	ATMF_SNL2	4	3	CREATE	2019-05-23 20:11:57.748	Informed Consent	IRB IEB SC
864	47	1558635118449:801205834	1558635117594:-1654672868	ATMF_SNL2	5	4	CREATE	2019-05-23 20:11:58.844	IRB IEB SC	Laboratory and Clinical
865	47	1558635119391:-1307939554	rootNode	ATMF_SNL2	6	0	CREATE	2019-05-23 20:11:59.548		002
866	47	1558635120162:-606427559	1558635119391:-1307939554	ATMF_SNL2	7	6	CREATE	2019-05-23 20:12:00.328	002	Correspondence
867	47	1558635120898:344401337	1558635120162:-606427559	ATMF_SNL2	8	7	CREATE	2019-05-23 20:12:01.06	Correspondence	GeneralAdmin
868	47	1558635121857:-1009418490	1558635120898:344401337	ATMF_SNL2	9	8	CREATE	2019-05-23 20:12:02.026	GeneralAdmin	Data Handling
869	47	1558635122753:-88616914	1558635121857:-1009418490	ATMF_SNL2	10	9	CREATE	2019-05-23 20:12:02.941	Data Handling	Drug Supply
1241	51	1559200570813:-360173046	1559200564785:934227197	CV181-085	278	271	CREATE	2019-05-30 09:16:11.02	020	Financial and Legal
1244	51	1559200573196:-1524616268	1559200564785:934227197	CV181-085	281	271	CREATE	2019-05-30 09:16:13.362	020	Laboratory Clinical   Analytical
1247	51	1559200575700:1948712226	1559200564785:934227197	CV181-085	284	271	CREATE	2019-05-30 09:16:15.964	020	Regulatory
1249	51	1559200577375:183100331	1559200564785:934227197	CV181-085	286	271	CREATE	2019-05-30 09:16:17.634	020	Staffing Qualifications
1253	51	1559200580439:1790295873	1559200578977:760891089	CV181-085	290	288	CREATE	2019-05-30 09:16:20.635	Correspondence	Data Handling
1255	51	1559200582083:-1308877727	1559200578977:760891089	CV181-085	292	288	CREATE	2019-05-30 09:16:22.655	Correspondence	IB Updates   Safety Updates
1258	51	1559200584871:-1754460708	1559200578977:760891089	CV181-085	295	288	CREATE	2019-05-30 09:16:25.115	Correspondence	Other (specify)
1259	51	1559200585696:-424057552	1559200578977:760891089	CV181-085	296	288	CREATE	2019-05-30 09:16:25.927	Correspondence	Prot   Amend   Admin Ltr
1262	51	1559200588664:227587606	1559200578174:907236539	CV181-085	299	287	CREATE	2019-05-30 09:16:28.828	021	Data Handling
1264	51	1559200590969:-1834385289	1559200578174:907236539	CV181-085	301	287	CREATE	2019-05-30 09:16:31.147	021	Financial and Legal
1267	51	1559200593373:-1527508753	1559200578174:907236539	CV181-085	304	287	CREATE	2019-05-30 09:16:38.428	021	IRB   IEC   SC
1269	51	1559200599975:-1815837123	1559200578174:907236539	CV181-085	306	287	CREATE	2019-05-30 09:16:40.147	021	Monitoring
1272	51	1559200602408:-1291112221	1559200578174:907236539	CV181-085	309	287	CREATE	2019-05-30 09:16:42.581	021	Staffing Qualifications
1275	51	1559200604612:-995019640	1559200603805:-1894885762	CV181-085	312	311	CREATE	2019-05-30 09:16:44.781	022	Correspondence
1277	51	1559200606240:-749936482	1559200604612:-995019640	CV181-085	314	312	CREATE	2019-05-30 09:16:46.477	Correspondence	Data Handling
1280	51	1559200608735:-497264390	1559200604612:-995019640	CV181-085	317	312	CREATE	2019-05-30 09:16:48.919	Correspondence	IRB   IEC Correspondence
1283	51	1559200611530:-273788718	1559200604612:-995019640	CV181-085	320	312	CREATE	2019-05-30 09:16:51.69	Correspondence	Regulatory
1286	51	1559200613939:-1542903346	1559200603805:-1894885762	CV181-085	323	311	CREATE	2019-05-30 09:16:54.102	022	Drug Supply
1288	51	1559200615551:1782019546	1559200603805:-1894885762	CV181-085	325	311	CREATE	2019-05-30 09:16:55.726	022	Informed Consent
1290	51	1559200617085:-508287221	1559200603805:-1894885762	CV181-085	327	311	CREATE	2019-05-30 09:16:57.249	022	IRB   IEC   SC
1293	51	1559200619862:1758258912	1559200603805:-1894885762	CV181-085	330	311	CREATE	2019-05-30 09:17:00.027	022	Regulatory
1295	51	1559200621364:357304561	1559200603805:-1894885762	CV181-085	332	311	CREATE	2019-05-30 09:17:01.54	022	Training Materials and Guidelines
1299	51	1559200624719:-1138860802	1559200623151:-629929397	CV181-085	336	334	CREATE	2019-05-30 09:17:04.881	Correspondence	Other (specify)
1301	51	1559200626517:-1163233292	1559200622018:853256459	CV181-085	338	333	CREATE	2019-05-30 09:17:06.682	023	Data Handling
743	33	1558338185044:-875990928	rootNode	ATMF_INT0004	1	0	CREATE	2019-05-20 09:43:05.252		001
744	33	1558338185928:111291129	1558338185044:-875990928	ATMF_INT0004	2	1	CREATE	2019-05-20 09:43:06.305	001	Correspondence
745	33	1558338186923:-415768304	1558338185928:111291129	ATMF_INT0004	3	2	CREATE	2019-05-20 09:43:07.212	Correspondence	General Admin
746	33	1558338187873:853939295	1558338186923:-415768304	ATMF_INT0004	4	3	CREATE	2019-05-20 09:43:08.416	General Admin	Management
747	33	1558338188958:-902981792	rootNode	ATMF_INT0004	5	0	CREATE	2019-05-20 09:43:09.238		002
748	33	1558338190001:-477122531	1558338188958:-902981792	ATMF_INT0004	6	5	CREATE	2019-05-20 09:43:10.711	002	IREB
749	33	1558338191245:2025309824	rootNode	ATMF_INT0004	7	0	CREATE	2019-05-20 09:43:11.755		003
750	33	1558338192366:-341051119	1558338191245:2025309824	ATMF_INT0004	8	7	CREATE	2019-05-20 09:43:12.693	003	FinancialandLegal
751	33	1558338193318:-660713272	1558338192366:-341051119	ATMF_INT0004	9	8	CREATE	2019-05-20 09:43:13.575	FinancialandLegal	Monitoring
788	40	1558510106087:-549403887	rootNode	ATMF_SplChar	1	0	CREATE	2019-05-22 09:28:26.305		001
789	40	1558510106912:-612187219	1558510106087:-549403887	ATMF_SplChar	2	1	CREATE	2019-05-22 09:28:27.165	001	Correspondence
790	40	1558510107828:-614961055	1558510106912:-612187219	ATMF_SplChar	3	2	CREATE	2019-05-22 09:28:27.996	Correspondence	General Admin
791	40	1558510108566:1218935549	1558510107828:-614961055	ATMF_SplChar	4	3	CREATE	2019-05-22 09:28:28.804	General Admin	Management
792	40	1558510109276:-1916080906	rootNode	ATMF_SplChar	5	0	CREATE	2019-05-22 09:28:29.451		002
793	40	1558510110037:62353524	1558510109276:-1916080906	ATMF_SplChar	6	5	CREATE	2019-05-22 09:28:30.275	002	IREB
794	40	1558510110757:-1943071873	rootNode	ATMF_SplChar	7	0	CREATE	2019-05-22 09:28:30.921		003
795	40	1558510111671:-433042914	1558510110757:-1943071873	ATMF_SplChar	8	7	CREATE	2019-05-22 09:28:31.861	003	FinancialandLegal
796	40	1558510112434:1545721057	1558510111671:-433042914	ATMF_SplChar	9	8	CREATE	2019-05-22 09:28:32.661	FinancialandLegal	Monitoring
816	44	1558526313704:-1339049608	rootNode	ATMF_Documents	1	0	CREATE	2019-05-22 13:58:34.181		001
817	44	1558526314774:209094521	1558526313704:-1339049608	ATMF_Documents	2	1	CREATE	2019-05-22 13:58:35.035	001	Correspondence
818	44	1558526315734:2069819503	1558526314774:209094521	ATMF_Documents	3	2	CREATE	2019-05-22 13:58:36.014	Correspondence	General Admin
819	44	1558526316620:783192848	1558526315734:2069819503	ATMF_Documents	4	3	CREATE	2019-05-22 13:58:37.214	General Admin	Management
820	44	1558526317766:-1366040472	rootNode	ATMF_Documents	5	0	CREATE	2019-05-22 13:58:38.057		002
821	44	1558526318693:-1017686845	1558526317766:-1366040472	ATMF_Documents	6	5	CREATE	2019-05-22 13:58:39.458	002	IREB
822	44	1558526319993:1562252071	rootNode	ATMF_Documents	7	0	CREATE	2019-05-22 13:58:40.336		003
823	44	1558526321014:1106172565	1558526319993:1562252071	ATMF_Documents	8	7	CREATE	2019-05-22 13:58:41.202	003	FinancialandLegal
824	44	1558526321774:-706408215	1558526321014:1106172565	ATMF_Documents	9	8	CREATE	2019-05-22 13:58:41.976	FinancialandLegal	Monitoring
860	47	1558635114957:-1280948793	rootNode	ATMF_SNL2	1	0	CREATE	2019-05-23 20:11:55.131		001
1303	51	1559200628066:1069761212	1559200622018:853256459	CV181-085	340	333	CREATE	2019-05-30 09:17:08.237	023	Financial and Legal
1306	51	1559200630308:-143197184	1559200622018:853256459	CV181-085	343	333	CREATE	2019-05-30 09:17:10.482	023	IRB   IEC   SC
1309	51	1559200632751:-2030120902	1559200622018:853256459	CV181-085	346	333	CREATE	2019-05-30 09:17:13.015	023	Protocol
1311	51	1559200634372:93199039	1559200622018:853256459	CV181-085	348	333	CREATE	2019-05-30 09:17:14.631	023	Staffing Qualifications
1314	51	1559200636729:1847961122	1559200635880:826266213	CV181-085	351	350	CREATE	2019-05-30 09:17:16.904	024	Correspondence
1317	51	1559200639166:-1856751058	1559200636729:1847961122	CV181-085	354	351	CREATE	2019-05-30 09:17:19.417	Correspondence	Other (specify)
1319	51	1559200640816:1314657433	1559200635880:826266213	CV181-085	356	350	CREATE	2019-05-30 09:17:20.988	024	Data Handling
1322	51	1559200643146:330033012	1559200635880:826266213	CV181-085	359	350	CREATE	2019-05-30 09:17:23.968	024	Informed Consent
1408	53	\N	\N	ACQSIT02	5	4	NEW	\N	Management	DrugManagement
965	51	1559200327796:784341167	1559200326561:-1304902220	CV181-085	2	1	CREATE	2019-05-30 09:12:08.064	001	Correspondence
966	51	1559200328776:1653889162	1559200327796:784341167	CV181-085	3	2	CREATE	2019-05-30 09:12:09.032	Correspondence	General Administration
967	51	1559200329797:-1846218990	1559200326561:-1304902220	CV181-085	4	1	CREATE	2019-05-30 09:12:10.128	001	Financial and Legal
968	51	1559200330774:-54827969	1559200326561:-1304902220	CV181-085	5	1	CREATE	2019-05-30 09:12:10.977	001	IRB   IEC   SC
969	51	1559200331544:1026777378	1559200326561:-1304902220	CV181-085	6	1	CREATE	2019-05-30 09:12:11.87	001	Monitoring
970	51	1559200332568:2061816949	1559200326561:-1304902220	CV181-085	7	1	CREATE	2019-05-30 09:12:13.043	001	Regulatory
971	51	1559200333702:1666120334	1559200326561:-1304902220	CV181-085	8	1	CREATE	2019-05-30 09:12:13.939	001	Staffing Qualifications
972	51	1559200334431:-1331892981	rootNode	CV181-085	9	0	CREATE	2019-05-30 09:12:14.915		002
973	51	1559200335563:822813004	1559200334431:-1331892981	CV181-085	10	9	CREATE	2019-05-30 09:12:15.946	002	Correspondence
974	51	1559200338617:838467869	1559200335563:822813004	CV181-085	11	10	CREATE	2019-05-30 09:12:18.78	Correspondence	General Administration
975	51	1559200339341:1987331523	1559200335563:822813004	CV181-085	12	10	CREATE	2019-05-30 09:12:19.524	Correspondence	IB Updates   Safety Updates
945	50	\N	\N	PT001002	28	27	NEW	\N	02 Central Trial Documents	02.01 Product and Trial Documentation
976	51	1559200340092:666037039	1559200334431:-1331892981	CV181-085	13	9	CREATE	2019-05-30 09:12:20.279	002	Country and Site Selection Tools
977	51	1559200340833:-1080425020	1559200334431:-1331892981	CV181-085	14	9	CREATE	2019-05-30 09:12:21.023	002	Data Handling
978	51	1559200341657:1680146176	1559200334431:-1331892981	CV181-085	15	9	CREATE	2019-05-30 09:12:21.816	002	Drug Supply
979	51	1559200342379:-367246599	1559200334431:-1331892981	CV181-085	16	9	CREATE	2019-05-30 09:12:22.598	002	Financial and Legal
980	51	1559200343155:710101875	1559200334431:-1331892981	CV181-085	17	9	CREATE	2019-05-30 09:12:23.422	002	Informed Consent
981	51	1559200344069:-1465606202	1559200334431:-1331892981	CV181-085	18	9	CREATE	2019-05-30 09:12:24.244	002	IRB   IEC   SC
982	51	1559200344837:-1531689924	1559200334431:-1331892981	CV181-085	19	9	CREATE	2019-05-30 09:12:25.375	002	Laboratory Clinical   Analytical
983	51	1559200346022:-1753934675	1559200334431:-1331892981	CV181-085	20	9	CREATE	2019-05-30 09:12:26.199	002	Monitoring
984	51	1559200346777:942437376	1559200334431:-1331892981	CV181-085	21	9	CREATE	2019-05-30 09:12:27.077	002	Protocol
985	51	1559200347721:686322083	1559200334431:-1331892981	CV181-085	22	9	CREATE	2019-05-30 09:12:27.984	002	Regulatory
753	34	1558344443470:-429968669	1558344442549:329987330	Char_val1	2	1	CREATE	2019-05-20 11:27:23.705	001	Correspondence
754	34	1558344444320:-539606721	1558344443470:-429968669	Char_val1	3	2	CREATE	2019-05-20 11:27:24.575	Correspondence	General Admin
755	34	1558344445190:3199587	1558344444320:-539606721	Char_val1	4	3	CREATE	2019-05-20 11:27:25.655	General Admin	Management
1324	51	1559200645606:-440439132	1559200635880:826266213	CV181-085	361	350	CREATE	2019-05-30 09:17:25.842	024	IRB   IEC   SC
1327	51	1559200647932:1967604343	1559200635880:826266213	CV181-085	364	350	CREATE	2019-05-30 09:17:28.118	024	Protocol
1329	51	1559200649492:-204042188	1559200635880:826266213	CV181-085	366	350	CREATE	2019-05-30 09:17:30.058	024	Staffing Qualifications
1332	51	1559200652229:-428799041	1559200651417:-1975856500	CV181-085	369	368	CREATE	2019-05-30 09:17:32.406	025	Correspondence
1335	51	1559200654891:2092587031	1559200652229:-428799041	CV181-085	372	369	CREATE	2019-05-30 09:17:35.076	Correspondence	Monitoring
1337	51	1559200656405:1842342703	1559200652229:-428799041	CV181-085	374	369	CREATE	2019-05-30 09:17:36.572	Correspondence	Prot   Amend   Admin Ltr
1340	51	1559200659105:1270891465	1559200651417:-1975856500	CV181-085	377	368	CREATE	2019-05-30 09:17:39.266	025	Financial and Legal
1343	51	1559200661426:57933275	1559200651417:-1975856500	CV181-085	380	368	CREATE	2019-05-30 09:17:41.642	025	IRB   IEC   SC
1345	51	1559200662986:-230395095	1559200651417:-1975856500	CV181-085	382	368	CREATE	2019-05-30 09:17:43.204	025	Monitoring
825	45	1558600032183:-875333600	rootNode	ATMF_SNL1	1	0	CREATE	2019-05-23 10:27:12.799		001
826	45	1558600034254:1290092348	1558600032183:-875333600	ATMF_SNL1	2	1	CREATE	2019-05-23 10:27:14.771	001	Finance and Legal
827	45	1558600036005:2084405586	1558600034254:1290092348	ATMF_SNL1	3	2	CREATE	2019-05-23 10:27:16.645	Finance and Legal	Informed Consent
828	45	1558600037981:-926119722	1558600036005:2084405586	ATMF_SNL1	4	3	CREATE	2019-05-23 10:27:18.474	Informed Consent	IRB IEB SC
829	45	1558600039737:241193430	1558600037981:-926119722	ATMF_SNL1	5	4	CREATE	2019-05-23 10:27:20.161	IRB IEB SC	Laboratory and Clinical
830	45	1558600041451:-902324567	rootNode	ATMF_SNL1	6	0	CREATE	2019-05-23 10:27:21.891		002
831	45	1558600043095:1112758926	1558600041451:-902324567	ATMF_SNL1	7	6	CREATE	2019-05-23 10:27:24.052	002	Correspondence
832	45	1558600045387:943752141	1558600043095:1112758926	ATMF_SNL1	8	7	CREATE	2019-05-23 10:27:25.995	Correspondence	GeneralAdmin
833	45	1558600047152:-2010576426	1558600045387:943752141	ATMF_SNL1	9	8	CREATE	2019-05-23 10:27:27.956	GeneralAdmin	Data Handling
834	45	1558600049255:-695784489	1558600047152:-2010576426	ATMF_SNL1	10	9	CREATE	2019-05-23 10:27:29.774	Data Handling	Drug Supply
858	46	1558680217784:-281215624	rootNode	ATMF_25kdocs	24	0	CREATE	2019-05-24 08:43:38.177		0008_Index
859	46	1558680219341:540772442	rootNode	ATMF_25kdocs	25	0	CREATE	2019-05-24 08:43:39.593		0009_Index
918	50	\N	\N	PT001002	1	0	NEW	\N		01 Trial Management
919	50	\N	\N	PT001002	2	1	NEW	\N	01 Trial Management	01.01 Trial Oversight
920	50	\N	\N	PT001002	3	2	NEW	\N	01.01 Trial Oversight	01.01.01 Trial Master File Plan
921	50	\N	\N	PT001002	4	2	NEW	\N	01.01 Trial Oversight	01.01.012 Trial Status Report
922	50	\N	\N	PT001002	5	2	NEW	\N	01.01 Trial Oversight	01.01.013 Investigator Newsletter
923	50	\N	\N	PT001002	6	2	NEW	\N	01.01 Trial Oversight	01.01.016 Risk Management Plan
924	50	\N	\N	PT001002	7	2	NEW	\N	01.01 Trial Oversight	01.01.017 Vendor Management Plan
925	50	\N	\N	PT001002	8	2	NEW	\N	01.01 Trial Oversight	01.01.023 Project Plan
926	50	\N	\N	PT001002	9	2	NEW	\N	01.01 Trial Oversight	01.01.025 Monitoring Visit Guidelines
927	50	\N	\N	PT001002	10	2	NEW	\N	01.01 Trial Oversight	01.01.04 List of SOPs Current During Trial
928	50	\N	\N	PT001002	11	2	NEW	\N	01.01 Trial Oversight	01.01.05 Operational Procedure Manual
929	50	\N	\N	PT001002	12	2	NEW	\N	01.01 Trial Oversight	01.01.08 Monitoring Plan
930	50	\N	\N	PT001002	13	1	NEW	\N	01 Trial Management	01.02 Trial Team
931	50	\N	\N	PT001002	14	13	NEW	\N	01.02 Trial Team	01.02.01 Trial Team Details
932	50	\N	\N	PT001002	15	1	NEW	\N	01 Trial Management	01.03 Trial Committee
933	50	\N	\N	PT001002	16	15	NEW	\N	01.03 Trial Committee	01.03.02 Committee Member List
934	50	\N	\N	PT001002	17	15	NEW	\N	01.03 Trial Committee	01.03.08 Committee Member Confidentiality Disclosure Agreement
935	50	\N	\N	PT001002	18	1	NEW	\N	01 Trial Management	01.04 Meetings
936	50	\N	\N	PT001002	19	18	NEW	\N	01.04 Meetings	01.04.02 Trial Team Training Material
937	50	\N	\N	PT001002	20	18	NEW	\N	01.04 Meetings	01.04.03 Investigators Meeting Material
938	50	\N	\N	PT001002	21	18	NEW	\N	01.04 Meetings	01.04.04 Trial Team Evidence of Training
939	50	\N	\N	PT001002	22	1	NEW	\N	01 Trial Management	01.05 General
940	50	\N	\N	PT001002	23	22	NEW	\N	01.05 General	01.05.01 Relevant Communications
941	50	\N	\N	PT001002	24	22	NEW	\N	01.05 General	01.05.02 Tracking Information
942	50	\N	\N	PT001002	25	22	NEW	\N	01.05 General	01.05.03 Meeting Minutes
943	50	\N	\N	PT001002	26	22	NEW	\N	01.05 General	01.05.04 Agenda
946	50	\N	\N	PT001002	29	28	NEW	\N	02.01 Product and Trial Documentation	02.01.01 Investigator Brochure
947	50	\N	\N	PT001002	30	28	NEW	\N	02.01 Product and Trial Documentation	02.01.02 Protocol
948	50	\N	\N	PT001002	31	28	NEW	\N	02.01 Product and Trial Documentation	02.01.03 Protocol Synopsis
949	50	\N	\N	PT001002	32	28	NEW	\N	02.01 Product and Trial Documentation	02.01.04 Protocol Amendment
950	50	\N	\N	PT001002	33	28	NEW	\N	02.01 Product and Trial Documentation	02.01.06 Insurance
951	50	\N	\N	PT001002	34	28	NEW	\N	02.01 Product and Trial Documentation	02.01.07 Blank Sample Forms and Templates
952	50	\N	\N	PT001002	35	28	NEW	\N	02.01 Product and Trial Documentation	02.01.09 Marketed Product Material
953	50	\N	\N	PT001002	36	27	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
954	50	\N	\N	PT001002	37	36	NEW	\N	02.02 Subject Documents	02.02.010 Blank Sample Forms and Templates
1347	51	1559200664609:-2085105633	1559200651417:-1975856500	CV181-085	384	368	CREATE	2019-05-30 09:17:45.17	025	Regulatory
1349	51	1559200666470:-710917526	1559200651417:-1975856500	CV181-085	386	368	CREATE	2019-05-30 09:17:46.644	025	Training Materials and Guidelines
752	34	1558344442549:329987330	rootNode	Char_val1	1	0	CREATE	2019-05-20 11:27:22.766		001
760	36	1558344484861:-1988879536	rootNode	Char_val3	1	0	CREATE	2019-05-20 11:28:05.276		001
761	36	1558344485894:1033473042	1558344484861:-1988879536	Char_val3	2	1	CREATE	2019-05-20 11:28:06.175	001	Correspondence
762	36	1558344486740:986573101	1558344485894:1033473042	Char_val3	3	2	CREATE	2019-05-20 11:28:06.982	Correspondence	General Admin
763	36	1558344487590:-1318479437	1558344486740:986573101	Char_val3	4	3	CREATE	2019-05-20 11:28:08.037	General Admin	Management
756	35	1558345401312:-2055732918	rootNode	Char_val2	1	0	CREATE	2019-05-20 11:43:21.47		001
757	35	1558345402108:-417257637	1558345401312:-2055732918	Char_val2	2	1	CREATE	2019-05-20 11:43:22.265	001	Correspondence
758	35	1558345402960:-1379797157	1558345402108:-417257637	Char_val2	3	2	CREATE	2019-05-20 11:43:23.109	Correspondence	General Admin
759	35	1558345403683:-1076413549	1558345402960:-1379797157	Char_val2	4	3	CREATE	2019-05-20 11:43:23.85	General Admin	Management
764	37	1558425431916:-1509055075	rootNode	ATMF_CheckSumVal	1	0	CREATE	2019-05-21 09:57:12.414		001
765	37	1558425433817:-2074666392	1558425431916:-1509055075	ATMF_CheckSumVal	2	1	CREATE	2019-05-21 09:57:14.428	001	Correspondence
766	37	1558425435869:-1104990474	1558425433817:-2074666392	ATMF_CheckSumVal	3	2	CREATE	2019-05-21 09:57:16.313	Correspondence	General Admin
767	37	1558425437736:1331541387	1558425435869:-1104990474	ATMF_CheckSumVal	4	3	CREATE	2019-05-21 09:57:18.172	General Admin	Management
768	37	1558425440356:1419236644	rootNode	ATMF_CheckSumVal	5	0	CREATE	2019-05-21 09:57:20.776		002
769	37	1558425442197:622040784	1558425440356:1419236644	ATMF_CheckSumVal	6	5	CREATE	2019-05-21 09:57:22.648	002	Correspondence
770	37	1558425444042:-899898794	1558425442197:622040784	ATMF_CheckSumVal	7	6	CREATE	2019-05-21 09:57:24.568	Correspondence	General Admin
771	37	1558425446009:1918928978	1558425444042:-899898794	ATMF_CheckSumVal	8	7	CREATE	2019-05-21 09:57:26.435	General Admin	Management
772	38	1558432657009:697298571	rootNode	ATMF_Unicode	1	0	CREATE	2019-05-21 11:57:37.421		Index$#
773	38	1558432658753:195934824	1558432657009:697298571	ATMF_Unicode	2	1	CREATE	2019-05-21 11:57:39.158	Index$#	001=
774	38	1558432660546:1772144172	1558432658753:195934824	ATMF_Unicode	3	2	CREATE	2019-05-21 11:57:40.967	001=	Uniµ
775	38	1558432662294:-1245883250	rootNode	ATMF_Unicode	4	0	CREATE	2019-05-21 11:57:42.595		Index@-
776	38	1558432663921:-513076712	1558432662294:-1245883250	ATMF_Unicode	5	4	CREATE	2019-05-21 11:57:44.28	Index@-	002ÄÄ
777	38	1558432665578:-987344119	rootNode	ATMF_Unicode	6	0	CREATE	2019-05-21 11:57:45.973		Index{}
778	38	1558432667344:-1949907556	1558432665578:-987344119	ATMF_Unicode	7	6	CREATE	2019-05-21 11:57:47.743	Index{}	003ð
1353	51	1559200669616:-2113965532	1559200668016:-950140689	CV181-085	390	388	CREATE	2019-05-30 09:17:49.791	Correspondence	IB Updates   Safety Updates
835	46	1558680184491:813651335	rootNode	ATMF_25kdocs	1	0	CREATE	2019-05-24 08:43:04.861		00010_Index
836	46	1558680186203:1251598161	rootNode	ATMF_25kdocs	2	0	CREATE	2019-05-24 08:43:06.486		00011_Index
837	46	1558680187602:2073586227	rootNode	ATMF_25kdocs	3	0	CREATE	2019-05-24 08:43:07.877		00012_Index
838	46	1558680188975:-1399393003	rootNode	ATMF_25kdocs	4	0	CREATE	2019-05-24 08:43:09.254		00013_Index
839	46	1558680190352:-577404937	rootNode	ATMF_25kdocs	5	0	CREATE	2019-05-24 08:43:10.624		00014_Index
840	46	1558680191863:244583129	rootNode	ATMF_25kdocs	6	0	CREATE	2019-05-24 08:43:12.128		00015_Index
841	46	1558680193213:1450611920	rootNode	ATMF_25kdocs	7	0	CREATE	2019-05-24 08:43:13.515		00016_Index
842	46	1558680194611:-2022367310	rootNode	ATMF_25kdocs	8	0	CREATE	2019-05-24 08:43:14.893		00017_Index
843	46	1558680196017:-1200379244	rootNode	ATMF_25kdocs	9	0	CREATE	2019-05-24 08:43:16.292		00018_Index
844	46	1558680197653:-762432212	rootNode	ATMF_25kdocs	10	0	CREATE	2019-05-24 08:43:18.008		00019_Index
845	46	1558680199146:-1581532599	rootNode	ATMF_25kdocs	11	0	CREATE	2019-05-24 08:43:19.422		0001_Index
846	46	1558680200456:2101863285	rootNode	ATMF_25kdocs	12	0	CREATE	2019-05-24 08:43:20.701		00020_Index
847	46	1558680201743:-987075014	rootNode	ATMF_25kdocs	13	0	CREATE	2019-05-24 08:43:22.135		00021_Index
848	46	1558680203181:-165086948	rootNode	ATMF_25kdocs	14	0	CREATE	2019-05-24 08:43:23.47		00022_Index
849	46	1558680204637:272859981	rootNode	ATMF_25kdocs	15	0	CREATE	2019-05-24 08:43:24.884		00023_Index
850	46	1558680206106:1478889081	rootNode	ATMF_25kdocs	16	0	CREATE	2019-05-24 08:43:26.371		00024_Index
851	46	1558680207483:1916836010	rootNode	ATMF_25kdocs	17	0	CREATE	2019-05-24 08:43:27.761		00025_Index
852	46	1558680208742:-1302217346	rootNode	ATMF_25kdocs	18	0	CREATE	2019-05-24 08:43:29.102		0002_Index
853	46	1558680210188:-480229280	rootNode	ATMF_25kdocs	19	0	CREATE	2019-05-24 08:43:30.424		0003_Index
854	46	1558680211584:725799614	rootNode	ATMF_25kdocs	20	0	CREATE	2019-05-24 08:43:31.879		0004_Index
855	46	1558680213014:1163746749	rootNode	ATMF_25kdocs	21	0	CREATE	2019-05-24 08:43:33.286		0005_Index
856	46	1558680214474:1985734815	rootNode	ATMF_25kdocs	22	0	CREATE	2019-05-24 08:43:34.764		0006_Index
857	46	1558680216018:-1103203690	rootNode	ATMF_25kdocs	23	0	CREATE	2019-05-24 08:43:36.292		0007_Index
870	48	1558680194611:-2022367310	rootNode	ATMF_25kdocs	1	0	ALREADY AVAILABLE	2019-05-28 10:55:57.767		00017_Index
871	48	1558680204637:272859981	rootNode	ATMF_25kdocs	2	0	ALREADY AVAILABLE	2019-05-28 10:55:57.768		00023_Index
955	50	\N	\N	PT001002	38	36	NEW	\N	02.02 Subject Documents	02.02.03 Informed Consent Form
956	50	\N	\N	PT001002	39	36	NEW	\N	02.02 Subject Documents	02.02.06 Diary Labels
957	50	\N	\N	PT001002	40	36	NEW	\N	02.02 Subject Documents	02.02.08 Quick Reference Guide
958	50	\N	\N	PT001002	41	27	NEW	\N	02 Central Trial Documents	02.03 Reports
959	50	\N	\N	PT001002	42	41	NEW	\N	02.03 Reports	02.03.01 Clinical Study Report
960	50	\N	\N	PT001002	43	27	NEW	\N	02 Central Trial Documents	02.04 General
961	50	\N	\N	PT001002	44	43	NEW	\N	02.04 General	02.04.02 Tracking Information
962	50	\N	\N	PT001002	45	43	NEW	\N	02.04 General	02.04.03 Meeting Material
963	50	\N	\N	PT001002	46	43	NEW	\N	02.04 General	02.04.04 Filenote
987	51	1559200349286:-1358883433	rootNode	CV181-085	24	0	CREATE	2019-05-30 09:12:29.504		003
989	51	1559200351033:1667875210	1559200350103:-1949973293	CV181-085	26	25	CREATE	2019-05-30 09:12:31.338	Correspondence	General Administration
991	51	1559200352790:1291250844	1559200350103:-1949973293	CV181-085	28	25	CREATE	2019-05-30 09:12:32.952	Correspondence	Monitoring
993	51	1559200354431:-586933175	1559200349286:-1358883433	CV181-085	30	24	CREATE	2019-05-30 09:12:34.869	003	Country and Site Selection Tools
1409	53	\N	\N	ACQSIT02	6	0	NEW	\N		005testmorethan255fharacters
996	51	1559200357681:-1620216813	1559200349286:-1358883433	CV181-085	33	24	CREATE	2019-05-30 09:12:38.108	003	Financial and Legal
998	51	1559200359574:-1822694963	1559200349286:-1358883433	CV181-085	35	24	CREATE	2019-05-30 09:12:39.766	003	Investigator Meeting
1000	51	1559200361148:-1379443054	1559200349286:-1358883433	CV181-085	37	24	CREATE	2019-05-30 09:12:41.816	003	Laboratory Clinical   Analytical
1001	51	1559200362445:1173463717	1559200349286:-1358883433	CV181-085	38	24	CREATE	2019-05-30 09:12:42.87	003	Monitoring
1003	51	1559200364211:2093904186	1559200349286:-1358883433	CV181-085	40	24	CREATE	2019-05-30 09:12:44.455	003	Regulatory
1005	51	1559200365890:1389277637	rootNode	CV181-085	42	0	CREATE	2019-05-30 09:12:46.155		004
1006	51	1559200366748:955132241	1559200365890:1389277637	CV181-085	43	42	CREATE	2019-05-30 09:12:46.948	004	Correspondence
1008	51	1559200368293:-944202021	1559200366748:955132241	CV181-085	45	43	CREATE	2019-05-30 09:12:48.609	Correspondence	IB Updates   Safety Updates
1009	51	1559200369217:-1214354705	1559200366748:955132241	CV181-085	46	43	CREATE	2019-05-30 09:12:49.604	Correspondence	Monitoring
1011	51	1559200371335:307229553	1559200365890:1389277637	CV181-085	48	42	CREATE	2019-05-30 09:12:51.768	004	Data Handling
1013	51	1559200373362:-1754743342	1559200365890:1389277637	CV181-085	50	42	CREATE	2019-05-30 09:12:53.594	004	Financial and Legal
1014	51	1559200374185:-677394868	1559200365890:1389277637	CV181-085	51	42	CREATE	2019-05-30 09:12:54.431	004	Informed Consent
1016	51	1559200376263:1375780732	1559200365890:1389277637	CV181-085	53	42	CREATE	2019-05-30 09:12:56.528	004	Laboratory Clinical   Analytical
1018	51	1559200377968:-1964875141	1559200365890:1389277637	CV181-085	55	42	CREATE	2019-05-30 09:12:58.164	004	Protocol
1019	51	1559200378732:2073976862	1559200365890:1389277637	CV181-085	56	42	CREATE	2019-05-30 09:12:59.239	004	Regulatory
1021	51	1559200380781:673022511	1559200365890:1389277637	CV181-085	58	42	CREATE	2019-05-30 09:13:01.042	004	Training Materials and Guidelines
1022	51	1559200381546:-1412864234	rootNode	CV181-085	59	0	CREATE	2019-05-30 09:13:01.745		005
1024	51	1559200383334:-753408327	1559200382385:76569261	CV181-085	61	60	CREATE	2019-05-30 09:13:03.605	Correspondence	General Administration
1026	51	1559200385407:125303261	1559200382385:76569261	CV181-085	63	60	CREATE	2019-05-30 09:13:05.668	Correspondence	Monitoring
1027	51	1559200386254:1439608761	1559200381546:-1412864234	CV181-085	64	59	CREATE	2019-05-30 09:13:06.42	005	Country and Site Selection Tools
1029	51	1559200387775:-1841249398	1559200381546:-1412864234	CV181-085	66	59	CREATE	2019-05-30 09:13:08.035	005	Drug Supply
1031	51	1559200389533:-36141868	1559200381546:-1412864234	CV181-085	68	59	CREATE	2019-05-30 09:13:09.792	005	Informed Consent
1032	51	1559200390427:563301577	1559200381546:-1412864234	CV181-085	69	59	CREATE	2019-05-30 09:13:10.663	005	IRB   IEC   SC
1034	51	1559200392306:274973104	1559200381546:-1412864234	CV181-085	71	59	CREATE	2019-05-30 09:13:12.487	005	Monitoring
1035	51	1559200393052:196193015	1559200381546:-1412864234	CV181-085	72	59	CREATE	2019-05-30 09:13:13.47	005	Protocol
1037	51	1559200394930:-216517142	1559200381546:-1412864234	CV181-085	74	59	CREATE	2019-05-30 09:13:15.133	005	SFM Cover Sheet
1039	51	1559200396427:1335297454	rootNode	CV181-085	76	0	CREATE	2019-05-30 09:13:16.703		006
1040	51	1559200397318:-1583479460	1559200396427:1335297454	CV181-085	77	76	CREATE	2019-05-30 09:13:17.578	006	Correspondence
1042	51	1559200399354:-1787894190	1559200397318:-1583479460	CV181-085	79	77	CREATE	2019-05-30 09:13:19.542	Correspondence	IB Updates   Safety Updates
1043	51	1559200400109:-538231924	1559200397318:-1583479460	CV181-085	80	77	CREATE	2019-05-30 09:13:20.308	Correspondence	Monitoring
1045	51	1559200401745:2063585972	1559200396427:1335297454	CV181-085	82	76	CREATE	2019-05-30 09:13:21.905	006	Data Handling
1046	51	1559200402513:-726146288	1559200396427:1335297454	CV181-085	83	76	CREATE	2019-05-30 09:13:22.732	006	Drug Supply
1048	51	1559200404495:1078961448	1559200396427:1335297454	CV181-085	85	76	CREATE	2019-05-30 09:13:24.772	006	Informed Consent
1050	51	1559200406227:-1162830248	1559200396427:1335297454	CV181-085	87	76	CREATE	2019-05-30 09:13:26.489	006	Laboratory Clinical   Analytical
1051	51	1559200407169:1390076523	1559200396427:1335297454	CV181-085	88	76	CREATE	2019-05-30 09:13:27.412	006	Monitoring
1053	51	1559200408817:1055180729	1559200396427:1335297454	CV181-085	90	76	CREATE	2019-05-30 09:13:29.008	006	Regulatory
1055	51	1559200410395:544886454	1559200396427:1335297454	CV181-085	92	76	CREATE	2019-05-30 09:13:30.723	006	Staffing Qualifications
1056	51	1559200411287:1308307414	rootNode	CV181-085	93	0	CREATE	2019-05-30 09:13:31.523		007
1058	51	1559200412976:-1018294741	1559200412168:395995592	CV181-085	95	94	CREATE	2019-05-30 09:13:33.214	Correspondence	Consent
1060	51	1559200414885:2014369067	1559200412168:395995592	CV181-085	97	94	CREATE	2019-05-30 09:13:35.146	Correspondence	IB Updates   Safety Updates
1061	51	1559200415767:278166147	1559200412168:395995592	CV181-085	98	94	CREATE	2019-05-30 09:13:35.952	Correspondence	Other (specify)
1063	51	1559200417350:-2084683744	1559200411287:1308307414	CV181-085	100	93	CREATE	2019-05-30 09:13:37.692	007	Financial and Legal
1064	51	1559200419105:-1007335270	1559200411287:1308307414	CV181-085	101	93	CREATE	2019-05-30 09:13:39.361	007	Informed Consent
1066	51	1559200421248:-473974517	1559200411287:1308307414	CV181-085	103	93	CREATE	2019-05-30 09:13:41.444	007	Laboratory Clinical   Analytical
1067	51	1559200422045:-696220298	1559200411287:1308307414	CV181-085	104	93	CREATE	2019-05-30 09:13:42.239	007	Monitoring
1069	51	1559200423648:1744036460	1559200411287:1308307414	CV181-085	106	93	CREATE	2019-05-30 09:13:43.903	007	Regulatory
1071	51	1559200425582:-1541410264	1559200411287:1308307414	CV181-085	108	93	CREATE	2019-05-30 09:13:45.76	007	Staffing Qualifications
1072	51	1559200426280:-1493835281	rootNode	CV181-085	109	0	CREATE	2019-05-30 09:13:46.464		008
1074	51	1559200427935:1196798125	1559200427167:-1421044297	CV181-085	111	110	CREATE	2019-05-30 09:13:48.125	Correspondence	General Administration
1076	51	1559200430056:-1577820262	1559200426280:-1493835281	CV181-085	113	109	CREATE	2019-05-30 09:13:50.243	008	Country and Site Selection Tools
1077	51	1559200430840:-549131005	1559200426280:-1493835281	CV181-085	114	109	CREATE	2019-05-30 09:13:51.019	008	Data Handling
1079	51	1559200432466:-1091288744	1559200426280:-1493835281	CV181-085	116	109	CREATE	2019-05-30 09:13:52.706	008	Financial and Legal
1080	51	1559200433313:-1533755529	1559200426280:-1493835281	CV181-085	117	109	CREATE	2019-05-30 09:13:53.655	008	Informed Consent
1082	51	1559200435043:519420071	1559200426280:-1493835281	CV181-085	119	109	CREATE	2019-05-30 09:13:55.205	008	Laboratory Clinical   Analytical
1355	51	1559200671179:-1189623242	1559200668016:-950140689	CV181-085	392	388	CREATE	2019-05-30 09:17:51.359	Correspondence	Other (specify)
1085	51	1559200437598:1217616201	1559200426280:-1493835281	CV181-085	122	109	CREATE	2019-05-30 09:13:57.763	008	Regulatory
1087	51	1559200439027:1254326510	rootNode	CV181-085	124	0	CREATE	2019-05-30 09:13:59.285		009
1088	51	1559200439939:1903274018	1559200439027:1254326510	CV181-085	125	124	CREATE	2019-05-30 09:14:00.13	009	Correspondence
1090	51	1559200441599:1441778834	1559200439939:1903274018	CV181-085	127	125	CREATE	2019-05-30 09:14:01.947	Correspondence	IB Updates   Safety Updates
1091	51	1559200442543:1746498053	1559200439027:1254326510	CV181-085	128	124	CREATE	2019-05-30 09:14:02.812	009	Country and Site Selection Tools
1092	51	1559200443438:34655	1559200439027:1254326510	CV181-085	129	124	CREATE	2019-05-30 09:14:03.636	009	Data Handling
1094	51	1559200445271:-2061938240	1559200439027:1254326510	CV181-085	131	124	CREATE	2019-05-30 09:14:05.446	009	Financial and Legal
1096	51	1559200446925:-1904961065	1559200439027:1254326510	CV181-085	133	124	CREATE	2019-05-30 09:14:07.155	009	IRB   IEC   SC
1098	51	1559200448532:-673475000	1559200439027:1254326510	CV181-085	135	124	CREATE	2019-05-30 09:14:08.713	009	Monitoring
1099	51	1559200449270:2022897051	1559200439027:1254326510	CV181-085	136	124	CREATE	2019-05-30 09:14:09.472	009	Protocol
1101	51	1559200450928:-148729498	1559200439027:1254326510	CV181-085	138	124	CREATE	2019-05-30 09:14:11.123	009	Staffing Qualifications
1102	51	1559200451617:1215734042	rootNode	CV181-085	139	0	CREATE	2019-05-30 09:14:11.88		010
1104	51	1559200453665:1871186897	1559200452478:-1647247579	CV181-085	141	140	CREATE	2019-05-30 09:14:13.859	Correspondence	General Administration
1106	51	1559200455255:-1545067575	1559200452478:-1647247579	CV181-085	143	140	CREATE	2019-05-30 09:14:15.479	Correspondence	Monitoring
1107	51	1559200456041:-284209315	1559200451617:1215734042	CV181-085	144	139	CREATE	2019-05-30 09:14:16.323	010	Country and Site Selection Tools
1108	51	1559200456862:744479942	1559200451617:1215734042	CV181-085	145	139	CREATE	2019-05-30 09:14:17.072	010	Data Handling
1110	51	1559200458843:-1317492953	1559200451617:1215734042	CV181-085	147	139	CREATE	2019-05-30 09:14:19.009	010	Financial and Legal
1112	51	1559200460841:-1519969249	1559200451617:1215734042	CV181-085	149	139	CREATE	2019-05-30 09:14:21.033	010	Investigator Meeting
1113	51	1559200461589:1764516050	1559200451617:1215734042	CV181-085	150	139	CREATE	2019-05-30 09:14:21.778	010	IRB   IEC   SC
1115	51	1559200463348:1476187577	1559200451617:1215734042	CV181-085	152	139	CREATE	2019-05-30 09:14:23.526	010	Monitoring
1116	51	1559200464195:-122407668	1559200451617:1215734042	CV181-085	153	139	CREATE	2019-05-30 09:14:24.382	010	Protocol
1118	51	1559200466042:984697434	1559200451617:1215734042	CV181-085	155	139	CREATE	2019-05-30 09:14:26.214	010	SFM Cover Sheet
1120	51	1559200467492:-1586408962	rootNode	CV181-085	157	0	CREATE	2019-05-30 09:14:27.833		011
1121	51	1559200468452:-1601301961	1559200467492:-1586408962	CV181-085	158	157	CREATE	2019-05-30 09:14:28.621	011	Correspondence
1123	51	1559200469972:-1750275925	1559200468452:-1601301961	CV181-085	160	158	CREATE	2019-05-30 09:14:30.161	Correspondence	Monitoring
1124	51	1559200470753:1582921570	1559200467492:-1586408962	CV181-085	161	157	CREATE	2019-05-30 09:14:31.018	011	Financial and Legal
1126	51	1559200472277:-1613399826	rootNode	CV181-085	163	0	CREATE	2019-05-30 09:14:32.497		012
1127	51	1559200473124:-1161375476	1559200472277:-1613399826	CV181-085	164	163	CREATE	2019-05-30 09:14:33.305	012	Correspondence
1129	51	1559200474687:400585812	1559200473124:-1161375476	CV181-085	166	164	CREATE	2019-05-30 09:14:35.061	Correspondence	IB Updates   Safety Updates
1131	51	1559200476545:1230352251	1559200472277:-1613399826	CV181-085	168	163	CREATE	2019-05-30 09:14:36.736	012	Data Handling
1132	51	1559200477297:-304042201	1559200472277:-1613399826	CV181-085	169	163	CREATE	2019-05-30 09:14:37.476	012	Drug Supply
1134	51	1559200478898:-1274086502	1559200472277:-1613399826	CV181-085	171	163	CREATE	2019-05-30 09:14:39.1	012	Informed Consent
1135	51	1559200479703:-674643057	1559200472277:-1613399826	CV181-085	172	163	CREATE	2019-05-30 09:14:39.871	012	IRB   IEC   SC
1137	51	1559200481362:-962971427	1559200472277:-1613399826	CV181-085	174	163	CREATE	2019-05-30 09:14:41.552	012	Monitoring
1138	51	1559200482224:-1041752855	1559200472277:-1613399826	CV181-085	175	163	CREATE	2019-05-30 09:14:42.446	012	Protocol
1140	51	1559200483983:65352247	1559200472277:-1613399826	CV181-085	177	163	CREATE	2019-05-30 09:14:44.265	012	SFM Cover Sheet
1142	51	1559200485613:1481547858	1559200472277:-1613399826	CV181-085	179	163	CREATE	2019-05-30 09:14:46.144	012	Training Materials and Guidelines
1143	51	1559200486651:1134762892	rootNode	CV181-085	180	0	CREATE	2019-05-30 09:14:46.831		013
1145	51	1559200488284:292377715	1559200487473:132721430	CV181-085	182	181	CREATE	2019-05-30 09:14:48.451	Correspondence	General Administration
1147	51	1559200489760:-24054535	1559200486651:1134762892	CV181-085	184	180	CREATE	2019-05-30 09:14:50.017	013	Country and Site Selection Tools
1148	51	1559200490579:1004634722	1559200486651:1134762892	CV181-085	185	180	CREATE	2019-05-30 09:14:50.804	013	Data Handling
1149	51	1559200491468:-529759524	1559200486651:1134762892	CV181-085	186	180	CREATE	2019-05-30 09:14:51.716	013	Drug Supply
1151	51	1559200493005:20010301	1559200486651:1134762892	CV181-085	188	180	CREATE	2019-05-30 09:14:53.229	013	Informed Consent
1153	51	1559200494616:2024670933	1559200486651:1134762892	CV181-085	190	180	CREATE	2019-05-30 09:14:55.127	013	IRB   IEC   SC
1154	51	1559200495756:-816564208	1559200486651:1134762892	CV181-085	191	180	CREATE	2019-05-30 09:14:56.043	013	Laboratory Clinical   Analytical
1156	51	1559200497409:-1382067426	1559200486651:1134762892	CV181-085	193	180	CREATE	2019-05-30 09:14:57.586	013	Protocol
1157	51	1559200498180:-1638182719	1559200486651:1134762892	CV181-085	194	180	CREATE	2019-05-30 09:14:58.358	013	Regulatory
1159	51	1559200499770:1255830329	1559200486651:1134762892	CV181-085	196	180	CREATE	2019-05-30 09:15:00.032	013	Training Materials and Guidelines
1160	51	1559200500550:1107772440	rootNode	CV181-085	197	0	CREATE	2019-05-30 09:15:00.832		014
1162	51	1559200502484:356704335	1559200501497:1570652599	CV181-085	199	198	CREATE	2019-05-30 09:15:02.741	Correspondence	General Administration
1164	51	1559200504798:-482465628	1559200500550:1107772440	CV181-085	201	197	CREATE	2019-05-30 09:15:05.069	014	Data Handling
1165	51	1559200505735:1022768584	1559200500550:1107772440	CV181-085	202	197	CREATE	2019-05-30 09:15:05.99	014	Drug Supply
1167	51	1559200507331:-1467090152	1559200500550:1107772440	CV181-085	204	197	CREATE	2019-05-30 09:15:07.502	014	Informed Consent
1169	51	1559200508862:2105899677	1559200500550:1107772440	CV181-085	206	197	CREATE	2019-05-30 09:15:09.044	014	Laboratory Clinical   Analytical
1200	51	1559200537315:-1220327951	1559200526634:1053791639	CV181-085	237	225	CREATE	2019-05-30 09:15:37.507	016	Staffing Qualifications
1201	51	1559200538057:1026801084	rootNode	CV181-085	238	0	CREATE	2019-05-30 09:15:38.249		017
1203	51	1559200539609:1564041046	1559200538842:-1768967831	CV181-085	240	239	CREATE	2019-05-30 09:15:39.798	Correspondence	IB Updates   Safety Updates
1205	51	1559200541225:-782437000	1559200538057:1026801084	CV181-085	242	238	CREATE	2019-05-30 09:15:41.388	017	Data Handling
1206	51	1559200541932:1978115450	1559200538057:1026801084	CV181-085	243	238	CREATE	2019-05-30 09:15:42.092	017	Drug Supply
1208	51	1559200543517:-1767061524	1559200538057:1026801084	CV181-085	245	238	CREATE	2019-05-30 09:15:43.71	017	Informed Consent
1209	51	1559200544277:1607514491	1559200538057:1026801084	CV181-085	246	238	CREATE	2019-05-30 09:15:44.449	017	IRB   IEC   SC
1211	51	1559200545878:-1684626311	1559200538057:1026801084	CV181-085	248	238	CREATE	2019-05-30 09:15:46.08	017	Protocol
1213	51	1559200547496:1958528974	1559200538057:1026801084	CV181-085	250	238	CREATE	2019-05-30 09:15:47.682	017	Staffing Qualifications
1214	51	1559200548243:999810838	rootNode	CV181-085	251	0	CREATE	2019-05-30 09:15:48.505		018
1216	51	1559200549912:-540280350	1559200549123:-2032960965	CV181-085	253	252	CREATE	2019-05-30 09:15:50.118	Correspondence	IB Updates   Safety Updates
1217	51	1559200550691:2018504008	1559200549123:-2032960965	CV181-085	254	252	CREATE	2019-05-30 09:15:50.932	Correspondence	Other (specify)
11554	86	\N	\N	D5170C00002	5	4	NEW	\N	contents	UNITED STATES
1171	51	1559200510709:1540396871	1559200500550:1107772440	CV181-085	208	197	CREATE	2019-05-30 09:15:10.889	014	Protocol
1173	51	1559200512294:-1647465323	1559200500550:1107772440	CV181-085	210	197	CREATE	2019-05-30 09:15:12.461	014	SFM Cover Sheet
1175	51	1559200513827:-1694371079	rootNode	CV181-085	212	0	CREATE	2019-05-30 09:15:14.063		015
1176	51	1559200514756:717253384	1559200513827:-1694371079	CV181-085	213	212	CREATE	2019-05-30 09:15:15.014	015	Correspondence
1178	51	1559200518670:-1456037463	1559200514756:717253384	CV181-085	215	213	CREATE	2019-05-30 09:15:18.928	Correspondence	Other (specify)
1179	51	1559200519485:1703784215	1559200513827:-1694371079	CV181-085	216	212	CREATE	2019-05-30 09:15:19.654	015	Data Handling
1181	51	1559200521006:-358188577	1559200513827:-1694371079	CV181-085	218	212	CREATE	2019-05-30 09:15:21.199	015	Financial and Legal
1182	51	1559200521826:-800675138	1559200513827:-1694371079	CV181-085	219	212	CREATE	2019-05-30 09:15:22.05	015	Informed Consent
1184	51	1559200523409:-374942318	1559200513827:-1694371079	CV181-085	221	212	CREATE	2019-05-30 09:15:23.599	015	Monitoring
1186	51	1559200525124:545479302	1559200513827:-1694371079	CV181-085	223	212	CREATE	2019-05-30 09:15:25.322	015	Regulatory
1188	51	1559200526634:1053791639	rootNode	CV181-085	225	0	CREATE	2019-05-30 09:15:27.193		016
1189	51	1559200527790:-652857357	1559200526634:1053791639	CV181-085	226	225	CREATE	2019-05-30 09:15:27.971	016	Correspondence
1191	51	1559200529324:625619336	1559200527790:-652857357	CV181-085	228	226	CREATE	2019-05-30 09:15:29.489	Correspondence	Other (specify)
1192	51	1559200530071:1588971112	1559200526634:1053791639	CV181-085	229	225	CREATE	2019-05-30 09:15:30.254	016	Data Handling
1193	51	1559200530865:1574391095	1559200526634:1053791639	CV181-085	230	225	CREATE	2019-05-30 09:15:31.053	016	Drug Supply
1195	51	1559200532342:2124181520	1559200526634:1053791639	CV181-085	232	225	CREATE	2019-05-30 09:15:32.582	016	Informed Consent
1197	51	1559200534106:1030079305	1559200526634:1053791639	CV181-085	234	225	CREATE	2019-05-30 09:15:34.873	016	Monitoring
1198	51	1559200535478:-2088350769	1559200526634:1053791639	CV181-085	235	225	CREATE	2019-05-30 09:15:35.71	016	Protocol
1219	51	1559200552288:194287899	1559200548243:999810838	CV181-085	256	251	CREATE	2019-05-30 09:15:52.459	018	Drug Supply
1221	51	1559200553848:-775756402	1559200548243:999810838	CV181-085	258	251	CREATE	2019-05-30 09:15:54.372	018	Informed Consent
1222	51	1559200555009:1343521254	1559200548243:999810838	CV181-085	259	251	CREATE	2019-05-30 09:15:55.171	018	IRB   IEC   SC
1224	51	1559200556597:-1948619651	1559200548243:999810838	CV181-085	261	251	CREATE	2019-05-30 09:15:56.773	018	Protocol
1226	51	1559200558342:174701320	1559200548243:999810838	CV181-085	263	251	CREATE	2019-05-30 09:15:58.574	018	Staffing Qualifications
1227	51	1559200559030:972820386	rootNode	CV181-085	264	0	CREATE	2019-05-30 09:15:59.278		019
1229	51	1559200560688:-2132701149	1559200559903:-1814664050	CV181-085	266	265	CREATE	2019-05-30 09:16:00.859	Correspondence	General Administration
1230	51	1559200561428:-1139391180	1559200559903:-1814664050	CV181-085	267	265	CREATE	2019-05-30 09:16:01.608	Correspondence	Monitoring
1232	51	1559200563241:-1133998872	1559200559030:972820386	CV181-085	269	264	CREATE	2019-05-30 09:16:03.443	019	IRB   IEC   SC
1233	51	1559200564064:-52411653	1559200559030:972820386	CV181-085	270	264	CREATE	2019-05-30 09:16:04.283	019	Monitoring
1235	51	1559200565678:829886557	1559200564785:934227197	CV181-085	272	271	CREATE	2019-05-30 09:16:05.948	020	Correspondence
1237	51	1559200567430:-67928424	1559200565678:829886557	CV181-085	274	272	CREATE	2019-05-30 09:16:07.655	Correspondence	IB Updates   Safety Updates
1239	51	1559200569183:181965329	1559200564785:934227197	CV181-085	276	271	CREATE	2019-05-30 09:16:09.389	020	Data Handling
1240	51	1559200569973:1687219729	1559200564785:934227197	CV181-085	277	271	CREATE	2019-05-30 09:16:10.146	020	Drug Supply
1242	51	1559200571605:717175428	1559200564785:934227197	CV181-085	279	271	CREATE	2019-05-30 09:16:11.786	020	Informed Consent
1243	51	1559200572412:1316618873	1559200564785:934227197	CV181-085	280	271	CREATE	2019-05-30 09:16:12.629	020	IRB   IEC   SC
1245	51	1559200574030:-491544429	1559200564785:934227197	CV181-085	282	271	CREATE	2019-05-30 09:16:14.238	020	Monitoring
1246	51	1559200574817:-570304845	1559200564785:934227197	CV181-085	283	271	CREATE	2019-05-30 09:16:15	020	Protocol
1248	51	1559200576534:536800154	1559200564785:934227197	CV181-085	285	271	CREATE	2019-05-30 09:16:16.778	020	SFM Cover Sheet
1250	51	1559200578174:907236539	rootNode	CV181-085	287	0	CREATE	2019-05-30 09:16:18.372		021
1251	51	1559200578977:760891089	1559200578174:907236539	CV181-085	288	287	CREATE	2019-05-30 09:16:19.152	021	Correspondence
1252	51	1559200579720:1323341247	1559200578977:760891089	CV181-085	289	288	CREATE	2019-05-30 09:16:19.881	Correspondence	Consent
1254	51	1559200581293:-464729709	1559200578977:760891089	CV181-085	291	288	CREATE	2019-05-30 09:16:21.496	Correspondence	File Retention   Destruction
1256	51	1559200583232:2042968068	1559200578977:760891089	CV181-085	293	288	CREATE	2019-05-30 09:16:23.468	Correspondence	IRB   IEC Correspondence
1257	51	1559200584035:-173813327	1559200578977:760891089	CV181-085	294	288	CREATE	2019-05-30 09:16:24.256	Correspondence	Monitoring
11555	86	\N	\N	D5170C00002	6	5	NEW	\N	UNITED STATES	Site
1260	51	1559200587070:-623306678	1559200578977:760891089	CV181-085	297	288	CREATE	2019-05-30 09:16:27.241	Correspondence	Regulatory
1261	51	1559200587818:446841830	1559200578977:760891089	CV181-085	298	288	CREATE	2019-05-30 09:16:27.983	Correspondence	Study Start
1263	51	1559200589483:1732842315	1559200578174:907236539	CV181-085	300	287	CREATE	2019-05-30 09:16:29.656	021	Drug Supply
1265	51	1559200591726:762797911	1559200578174:907236539	CV181-085	302	287	CREATE	2019-05-30 09:16:31.943	021	Informed Consent
1266	51	1559200592508:1002787576	1559200578174:907236539	CV181-085	303	287	CREATE	2019-05-30 09:16:32.769	021	Investigator Meeting
1268	51	1559200599161:-73776598	1559200578174:907236539	CV181-085	305	287	CREATE	2019-05-30 09:16:39.36	021	Laboratory Clinical   Analytical
1270	51	1559200600733:-639300313	1559200578174:907236539	CV181-085	307	287	CREATE	2019-05-30 09:16:40.963	021	Protocol
1271	51	1559200601585:-895415606	1559200578174:907236539	CV181-085	308	287	CREATE	2019-05-30 09:16:41.773	021	Regulatory
1273	51	1559200603130:1998597442	1559200578174:907236539	CV181-085	310	287	CREATE	2019-05-30 09:16:43.29	021	Training Materials and Guidelines
1274	51	1559200603805:-1894885762	rootNode	CV181-085	311	0	CREATE	2019-05-30 09:16:43.976		022
1276	51	1559200605368:302943824	1559200604612:-995019640	CV181-085	313	312	CREATE	2019-05-30 09:16:45.588	Correspondence	Consent
1278	51	1559200607077:-1485127235	1559200604612:-995019640	CV181-085	315	312	CREATE	2019-05-30 09:16:47.245	Correspondence	File Retention   Destruction
1279	51	1559200607855:445857523	1559200604612:-995019640	CV181-085	316	312	CREATE	2019-05-30 09:16:48.048	Correspondence	IB Updates   Safety Updates
1281	51	1559200609530:-1404942645	1559200604612:-995019640	CV181-085	318	312	CREATE	2019-05-30 09:16:49.717	Correspondence	Other (specify)
1282	51	1559200610309:-1594374524	1559200604612:-995019640	CV181-085	319	312	CREATE	2019-05-30 09:16:50.845	Correspondence	Prot   Amend   Admin Ltr
1284	51	1559200612273:-1978772574	1559200604612:-995019640	CV181-085	321	312	CREATE	2019-05-30 09:16:52.446	Correspondence	Study Start
1285	51	1559200613046:-1528323329	1559200603805:-1894885762	CV181-085	322	311	CREATE	2019-05-30 09:16:53.211	022	Data Handling
1287	51	1559200614798:-2070461189	1559200603805:-1894885762	CV181-085	324	311	CREATE	2019-05-30 09:16:54.975	022	Financial and Legal
1289	51	1559200616272:-753123153	1559200603805:-1894885762	CV181-085	326	311	CREATE	2019-05-30 09:16:56.481	022	Investigator Meeting
1291	51	1559200617903:-681997846	1559200603805:-1894885762	CV181-085	328	311	CREATE	2019-05-30 09:16:58.492	022	Monitoring
1292	51	1559200619133:2014374205	1559200603805:-1894885762	CV181-085	329	311	CREATE	2019-05-30 09:16:59.306	022	Protocol
1294	51	1559200620569:-157272944	1559200603805:-1894885762	CV181-085	331	311	CREATE	2019-05-30 09:17:00.742	022	Staffing Qualifications
1296	51	1559200622018:853256459	rootNode	CV181-085	333	0	CREATE	2019-05-30 09:17:02.48		023
1297	51	1559200623151:-629929397	1559200622018:853256459	CV181-085	334	333	CREATE	2019-05-30 09:17:03.334	023	Correspondence
1298	51	1559200623949:-880205039	1559200623151:-629929397	CV181-085	335	334	CREATE	2019-05-30 09:17:04.11	Correspondence	Consent
1300	51	1559200625429:191542354	1559200623151:-629929397	CV181-085	337	334	CREATE	2019-05-30 09:17:05.897	Correspondence	Prot   Amend   Admin Ltr
1302	51	1559200627295:-1177813309	1559200622018:853256459	CV181-085	339	333	CREATE	2019-05-30 09:17:07.457	023	Drug Supply
1304	51	1559200628823:627274239	1559200622018:853256459	CV181-085	341	333	CREATE	2019-05-30 09:17:08.982	023	Informed Consent
1305	51	1559200629571:867263904	1559200622018:853256459	CV181-085	342	333	CREATE	2019-05-30 09:17:09.73	023	Investigator Meeting
1307	51	1559200631088:-209300373	1559200622018:853256459	CV181-085	344	333	CREATE	2019-05-30 09:17:11.357	023	Laboratory Clinical   Analytical
1308	51	1559200631984:-431525657	1559200622018:853256459	CV181-085	345	333	CREATE	2019-05-30 09:17:12.173	023	Monitoring
1310	51	1559200633574:488895654	1559200622018:853256459	CV181-085	347	333	CREATE	2019-05-30 09:17:13.759	023	Regulatory
1312	51	1559200635171:-912058594	1559200622018:853256459	CV181-085	349	333	CREATE	2019-05-30 09:17:15.381	023	Training Materials and Guidelines
1313	51	1559200635880:826266213	rootNode	CV181-085	350	0	CREATE	2019-05-30 09:17:16.083		024
1315	51	1559200637497:-228180427	1559200636729:1847961122	CV181-085	352	351	CREATE	2019-05-30 09:17:17.671	Correspondence	Consent
1316	51	1559200638334:1243731255	1559200636729:1847961122	CV181-085	353	351	CREATE	2019-05-30 09:17:18.583	Correspondence	Monitoring
1318	51	1559200640007:-526347902	1559200636729:1847961122	CV181-085	355	351	CREATE	2019-05-30 09:17:20.256	Correspondence	Prot   Amend   Admin Ltr
1320	51	1559200641601:1300077416	1559200635880:826266213	CV181-085	357	350	CREATE	2019-05-30 09:17:21.773	024	Drug Supply
1321	51	1559200642339:772519161	1559200635880:826266213	CV181-085	358	350	CREATE	2019-05-30 09:17:22.563	024	Financial and Legal
1323	51	1559200644663:2089857197	1559200635880:826266213	CV181-085	360	350	CREATE	2019-05-30 09:17:24.978	024	Investigator Meeting
1325	51	1559200646409:-506541703	1559200635880:826266213	CV181-085	362	350	CREATE	2019-05-30 09:17:26.576	024	Laboratory Clinical   Analytical
1326	51	1559200647170:2046365068	1559200635880:826266213	CV181-085	363	350	CREATE	2019-05-30 09:17:27.339	024	Monitoring
1328	51	1559200648725:191654427	1559200635880:826266213	CV181-085	365	350	CREATE	2019-05-30 09:17:28.904	024	Regulatory
1330	51	1559200650723:310534596	1559200635880:826266213	CV181-085	367	350	CREATE	2019-05-30 09:17:30.898	024	Training Materials and Guidelines
1331	51	1559200651417:-1975856500	rootNode	CV181-085	368	0	CREATE	2019-05-30 09:17:31.583		025
1333	51	1559200653009:-2039839476	1559200652229:-428799041	CV181-085	370	369	CREATE	2019-05-30 09:17:33.472	Correspondence	Consent
1334	51	1559200654109:-1932227581	1559200652229:-428799041	CV181-085	371	369	CREATE	2019-05-30 09:17:34.311	Correspondence	IB Updates   Safety Updates
1336	51	1559200655644:2031774273	1559200652229:-428799041	CV181-085	373	369	CREATE	2019-05-30 09:17:35.853	Correspondence	Other (specify)
1338	51	1559200657142:1813029840	1559200651417:-1975856500	CV181-085	375	368	CREATE	2019-05-30 09:17:37.717	025	Data Handling
1339	51	1559200658358:1798460226	1559200651417:-1975856500	CV181-085	376	368	CREATE	2019-05-30 09:17:38.524	025	Drug Supply
1341	51	1559200659899:-1946727357	1559200651417:-1975856500	CV181-085	378	368	CREATE	2019-05-30 09:17:40.065	025	Informed Consent
1342	51	1559200660666:-1706737692	1559200651417:-1975856500	CV181-085	379	368	CREATE	2019-05-30 09:17:40.851	025	Investigator Meeting
1344	51	1559200662233:1511665430	1559200651417:-1975856500	CV181-085	381	368	CREATE	2019-05-30 09:17:42.398	025	Laboratory Clinical   Analytical
2890	64	1572952350418:1750951035	rootNode	Risk_study	1	0	CREATE	2019-11-05 12:12:30.611		003
964	51	1559200326561:-1304902220	rootNode	CV181-085	1	0	CREATE	2019-05-30 09:12:07.018		001
986	51	1559200348595:-1229190615	1559200334431:-1331892981	CV181-085	23	9	CREATE	2019-05-30 09:12:28.787	002	Staffing Qualifications
988	51	1559200350103:-1949973293	1559200349286:-1358883433	CV181-085	25	24	CREATE	2019-05-30 09:12:30.366	003	Correspondence
990	51	1559200352006:41587754	1559200350103:-1949973293	CV181-085	27	25	CREATE	2019-05-30 09:12:32.202	Correspondence	IB Updates   Safety Updates
992	51	1559200353549:-289396537	1559200350103:-1949973293	CV181-085	29	25	CREATE	2019-05-30 09:12:33.817	Correspondence	Other (specify)
994	51	1559200355834:-1078060001	1559200349286:-1358883433	CV181-085	31	24	CREATE	2019-05-30 09:12:36.126	003	Data Handling
995	51	1559200356889:427175962	1559200349286:-1358883433	CV181-085	32	24	CREATE	2019-05-30 09:12:37.091	003	Drug Supply
997	51	1559200358809:-542868339	1559200349286:-1358883433	CV181-085	34	24	CREATE	2019-05-30 09:12:38.974	003	Informed Consent
999	51	1559200360313:-58023996	1559200349286:-1358883433	CV181-085	36	24	CREATE	2019-05-30 09:12:40.487	003	IRB   IEC   SC
1002	51	1559200363468:-1944947817	1559200349286:-1358883433	CV181-085	39	24	CREATE	2019-05-30 09:12:43.659	003	Protocol
1004	51	1559200365046:1698207571	1559200349286:-1358883433	CV181-085	41	24	CREATE	2019-05-30 09:12:45.358	003	Staffing Qualifications
1007	51	1559200367540:-2093065778	1559200366748:955132241	CV181-085	44	43	CREATE	2019-05-30 09:12:47.748	Correspondence	General Administration
1010	51	1559200370220:798356276	1559200365890:1389277637	CV181-085	47	42	CREATE	2019-05-30 09:12:50.651	004	Country and Site Selection Tools
1012	51	1559200372421:1812465413	1559200365890:1389277637	CV181-085	49	42	CREATE	2019-05-30 09:12:52.723	004	Drug Supply
1015	51	1559200374997:-77951423	1559200365890:1389277637	CV181-085	52	42	CREATE	2019-05-30 09:12:55.581	004	IRB   IEC   SC
1017	51	1559200377116:1153535775	1559200365890:1389277637	CV181-085	54	42	CREATE	2019-05-30 09:12:57.358	004	Monitoring
1020	51	1559200379887:-1096871584	1559200365890:1389277637	CV181-085	57	42	CREATE	2019-05-30 09:13:00.08	004	Staffing Qualifications
1023	51	1559200382385:76569261	1559200381546:-1412864234	CV181-085	60	59	CREATE	2019-05-30 09:13:02.688	005	Correspondence
1025	51	1559200384271:395455945	1559200382385:76569261	CV181-085	62	60	CREATE	2019-05-30 09:13:04.766	Correspondence	IB Updates   Safety Updates
1028	51	1559200386991:948482553	1559200381546:-1412864234	CV181-085	65	59	CREATE	2019-05-30 09:13:07.174	005	Data Handling
1346	51	1559200663856:-1828990340	1559200651417:-1975856500	CV181-085	383	368	CREATE	2019-05-30 09:17:44.02	025	Protocol
1348	51	1559200665769:1814165048	1559200651417:-1975856500	CV181-085	385	368	CREATE	2019-05-30 09:17:45.936	025	Staffing Qualifications
1350	51	1559200667114:772296124	rootNode	CV181-085	387	0	CREATE	2019-05-30 09:17:47.296		026
1351	51	1559200668016:-950140689	1559200667114:772296124	CV181-085	388	387	CREATE	2019-05-30 09:17:48.175	026	Correspondence
1352	51	1559200668781:-966269695	1559200668016:-950140689	CV181-085	389	388	CREATE	2019-05-30 09:17:49.001	Correspondence	Consent
1354	51	1559200670349:1910849080	1559200668016:-950140689	CV181-085	391	388	CREATE	2019-05-30 09:17:50.508	Correspondence	Monitoring
1356	51	1559200671992:1660604752	1559200668016:-950140689	CV181-085	393	388	CREATE	2019-05-30 09:17:52.23	Correspondence	Prot   Amend   Admin Ltr
1357	51	1559200672827:1126296938	1559200668016:-950140689	CV181-085	394	388	CREATE	2019-05-30 09:17:52.998	Correspondence	Study Start
1359	51	1559200674365:2146204000	1559200667114:772296124	CV181-085	396	387	CREATE	2019-05-30 09:17:54.527	026	Investigator Meeting
1360	51	1559200675207:-1903917373	1559200667114:772296124	CV181-085	397	387	CREATE	2019-05-30 09:17:55.37	026	IRB   IEC   SC
1362	51	1559200676701:618733959	1559200667114:772296124	CV181-085	399	387	CREATE	2019-05-30 09:17:56.87	026	Protocol
1363	51	1559200677430:362618666	1559200667114:772296124	CV181-085	400	387	CREATE	2019-05-30 09:17:57.643	026	Regulatory
1365	51	1559200679825:-40263840	1559200678910:745305569	CV181-085	402	401	CREATE	2019-05-30 09:18:00.04	027	Correspondence
1367	51	1559200682249:-1598927935	1559200679825:-40263840	CV181-085	404	402	CREATE	2019-05-30 09:18:02.44	Correspondence	IRB   IEC Correspondence
1368	51	1559200683161:1734565904	1559200679825:-40263840	CV181-085	405	402	CREATE	2019-05-30 09:18:03.327	Correspondence	Monitoring
1370	51	1559200684677:1322785136	1559200678910:745305569	CV181-085	407	401	CREATE	2019-05-30 09:18:04.905	027	Country and Site Selection Tools
1372	51	1559200686272:-1443573896	1559200678910:745305569	CV181-085	409	401	CREATE	2019-05-30 09:18:06.483	027	Informed Consent
1373	51	1559200687052:-1203584231	1559200678910:745305569	CV181-085	410	401	CREATE	2019-05-30 09:18:07.518	027	Investigator Meeting
1375	51	1559200688924:494983135	1559200678910:745305569	CV181-085	412	401	CREATE	2019-05-30 09:18:09.097	027	Laboratory Clinical   Analytical
1376	51	1559200689691:272758263	1559200678910:745305569	CV181-085	413	401	CREATE	2019-05-30 09:18:09.944	027	Monitoring
1378	51	1559200691362:-1581952378	1559200678910:745305569	CV181-085	415	401	CREATE	2019-05-30 09:18:11.545	027	Regulatory
1380	51	1559200693014:-572431909	1559200678910:745305569	CV181-085	417	401	CREATE	2019-05-30 09:18:13.271	027	Staffing Qualifications
1381	51	1559200693783:-1190494567	rootNode	CV181-085	418	0	CREATE	2019-05-30 09:18:13.974		Committees
1383	51	1559200695297:1968829954	1559200694482:1476679781	CV181-085	420	419	CREATE	2019-05-30 09:18:15.537	Correspondence	IB Updates   Safety Updates
1385	51	1559200698564:1923656039	1559200694482:1476679781	CV181-085	422	419	CREATE	2019-05-30 09:18:19.033	Correspondence	Laboratory
1386	51	1559200699732:3411114	1559200694482:1476679781	CV181-085	423	419	CREATE	2019-05-30 09:18:19.9	Correspondence	Other (specify)
1388	51	1559200701163:-426538467	rootNode	CV181-085	425	0	CREATE	2019-05-30 09:18:21.346		Data Handling
1389	51	1559200701914:-1118596906	rootNode	CV181-085	426	0	CREATE	2019-05-30 09:18:22.094		Financial and Legal
1390	51	1559200702641:-41248432	rootNode	CV181-085	427	0	CREATE	2019-05-30 09:18:22.821		Informed Consent
1392	51	1559200704310:-811719649	rootNode	CV181-085	429	0	CREATE	2019-05-30 09:18:24.498		IRB   IEC   SC
1393	51	1559200705016:-1893123540	rootNode	CV181-085	430	0	CREATE	2019-05-30 09:18:25.197		ISR
1395	51	1559200706639:1385399956	1559200705888:2021375967	CV181-085	432	431	CREATE	2019-05-30 09:18:26.884	Correspondence	Other (specify)
1396	51	1559200707484:2102598833	1559200705016:-1893123540	CV181-085	433	430	CREATE	2019-05-30 09:18:27.73	ISR	Informed Consent
1398	51	1559200709100:106365486	rootNode	CV181-085	435	0	CREATE	2019-05-30 09:18:29.264		Plans
1399	51	1559200709818:-1293426077	rootNode	CV181-085	436	0	CREATE	2019-05-30 09:18:29.98		Protocol
1030	51	1559200388741:-1113490342	1559200381546:-1412864234	CV181-085	67	59	CREATE	2019-05-30 09:13:08.917	005	Financial and Legal
1033	51	1559200391221:-758118408	1559200381546:-1412864234	CV181-085	70	59	CREATE	2019-05-30 09:13:11.676	005	Laboratory Clinical   Analytical
1036	51	1559200394048:-1579737537	1559200381546:-1412864234	CV181-085	73	59	CREATE	2019-05-30 09:13:14.263	005	Regulatory
1038	51	1559200395715:949598088	1559200381546:-1412864234	CV181-085	75	59	CREATE	2019-05-30 09:13:15.966	005	Staffing Qualifications
1041	51	1559200398161:-161606734	1559200397318:-1583479460	CV181-085	78	77	CREATE	2019-05-30 09:13:18.71	Correspondence	General Administration
1044	51	1559200400885:-1740255425	1559200396427:1335297454	CV181-085	81	76	CREATE	2019-05-30 09:13:21.155	006	Country and Site Selection Tools
1047	51	1559200403309:1521428233	1559200396427:1335297454	CV181-085	84	76	CREATE	2019-05-30 09:13:23.844	006	Financial and Legal
1049	51	1559200405365:1678404893	1559200396427:1335297454	CV181-085	86	76	CREATE	2019-05-30 09:13:25.653	006	IRB   IEC   SC
1052	51	1559200408053:-208518722	1559200396427:1335297454	CV181-085	89	76	CREATE	2019-05-30 09:13:28.235	006	Protocol
1054	51	1559200409582:898586277	1559200396427:1335297454	CV181-085	91	76	CREATE	2019-05-30 09:13:29.764	006	SFM Cover Sheet
1057	51	1559200412168:395995592	1559200411287:1308307414	CV181-085	94	93	CREATE	2019-05-30 09:13:32.356	007	Correspondence
1059	51	1559200413802:865503662	1559200412168:395995592	CV181-085	96	94	CREATE	2019-05-30 09:13:34.206	Correspondence	General Administration
1062	51	1559200416549:1759034165	1559200411287:1308307414	CV181-085	99	93	CREATE	2019-05-30 09:13:36.773	007	Country and Site Selection Tools
1065	51	1559200420034:-407891825	1559200411287:1308307414	CV181-085	102	93	CREATE	2019-05-30 09:13:40.611	007	IRB   IEC   SC
1068	51	1559200422788:2000151753	1559200411287:1308307414	CV181-085	105	93	CREATE	2019-05-30 09:13:43.04	007	Protocol
1070	51	1559200424459:-1187710441	1559200411287:1308307414	CV181-085	107	93	CREATE	2019-05-30 09:13:44.906	007	SFM Cover Sheet
1073	51	1559200427167:-1421044297	1559200426280:-1493835281	CV181-085	110	109	CREATE	2019-05-30 09:13:47.339	008	Correspondence
1075	51	1559200428716:1090325825	1559200427167:-1421044297	CV181-085	112	110	CREATE	2019-05-30 09:13:49.417	Correspondence	IB Updates   Safety Updates
1078	51	1559200431676:956104031	1559200426280:-1493835281	CV181-085	115	109	CREATE	2019-05-30 09:13:51.865	008	Drug Supply
1081	51	1559200434291:-934312084	1559200426280:-1493835281	CV181-085	118	109	CREATE	2019-05-30 09:13:54.471	008	IRB   IEC   SC
1083	51	1559200435826:297174496	1559200426280:-1493835281	CV181-085	120	109	CREATE	2019-05-30 09:13:56.183	008	Monitoring
1084	51	1559200436828:1473731494	1559200426280:-1493835281	CV181-085	121	109	CREATE	2019-05-30 09:13:57.013	008	Protocol
1086	51	1559200438344:-1953232863	1559200426280:-1493835281	CV181-085	123	109	CREATE	2019-05-30 09:13:58.531	008	Staffing Qualifications
1089	51	1559200440740:292913841	1559200439939:1903274018	CV181-085	126	125	CREATE	2019-05-30 09:14:00.981	Correspondence	General Administration
1093	51	1559200444218:-1534360106	1559200439027:1254326510	CV181-085	130	124	CREATE	2019-05-30 09:14:04.682	009	Drug Supply
1095	51	1559200446047:1790562786	1559200439027:1254326510	CV181-085	132	124	CREATE	2019-05-30 09:14:06.288	009	Informed Consent
1097	51	1559200447751:-451228910	1559200439027:1254326510	CV181-085	134	124	CREATE	2019-05-30 09:14:07.928	009	Laboratory Clinical   Analytical
1100	51	1559200450028:246967117	1559200439027:1254326510	CV181-085	137	124	CREATE	2019-05-30 09:14:10.286	009	Regulatory
1103	51	1559200452478:-1647247579	1559200451617:1215734042	CV181-085	140	139	CREATE	2019-05-30 09:14:13.072	010	Correspondence
1105	51	1559200454497:-1274914891	1559200452478:-1647247579	CV181-085	142	140	CREATE	2019-05-30 09:14:14.713	Correspondence	IB Updates   Safety Updates
1109	51	1559200457640:-789914407	1559200451617:1215734042	CV181-085	146	139	CREATE	2019-05-30 09:14:18.192	010	Drug Supply
1111	51	1559200459587:-240144479	1559200451617:1215734042	CV181-085	148	139	CREATE	2019-05-30 09:14:20.21	010	Informed Consent
1114	51	1559200462422:1698433770	1559200451617:1215734042	CV181-085	151	139	CREATE	2019-05-30 09:14:22.721	010	Laboratory Clinical   Analytical
1117	51	1559200464969:-378522961	1559200451617:1215734042	CV181-085	154	139	CREATE	2019-05-30 09:14:25.448	010	Regulatory
1119	51	1559200466806:-888817133	1559200451617:1215734042	CV181-085	156	139	CREATE	2019-05-30 09:14:27.002	010	Staffing Qualifications
1122	51	1559200469201:31566864	1559200468452:-1601301961	CV181-085	159	158	CREATE	2019-05-30 09:14:29.363	Correspondence	General Administration
1125	51	1559200471602:-920656456	1559200467492:-1586408962	CV181-085	162	157	CREATE	2019-05-30 09:14:31.804	011	IRB   IEC   SC
1128	51	1559200473947:2026873268	1559200473124:-1161375476	CV181-085	165	164	CREATE	2019-05-30 09:14:34.127	Correspondence	General Administration
1130	51	1559200475711:-1318151338	1559200472277:-1613399826	CV181-085	167	163	CREATE	2019-05-30 09:14:35.966	012	Country and Site Selection Tools
1133	51	1559200478128:1943532320	1559200472277:-1613399826	CV181-085	170	163	CREATE	2019-05-30 09:14:38.339	012	Financial and Legal
1136	51	1559200480454:779089098	1559200472277:-1613399826	CV181-085	173	163	CREATE	2019-05-30 09:14:40.733	012	Laboratory Clinical   Analytical
1139	51	1559200483086:-1297868148	1559200472277:-1613399826	CV181-085	176	163	CREATE	2019-05-30 09:14:43.341	012	Regulatory
1141	51	1559200484860:-288347576	1559200472277:-1613399826	CV181-085	178	163	CREATE	2019-05-30 09:14:45.062	012	Staffing Qualifications
1144	51	1559200487473:132721430	1559200486651:1134762892	CV181-085	181	180	CREATE	2019-05-30 09:14:47.726	013	Correspondence
1146	51	1559200489039:185904179	1559200487473:132721430	CV181-085	183	181	CREATE	2019-05-30 09:14:49.206	Correspondence	IB Updates   Safety Updates
1150	51	1559200492284:-1057338173	1559200486651:1134762892	CV181-085	187	180	CREATE	2019-05-30 09:14:52.456	013	Financial and Legal
1152	51	1559200493790:259999966	1559200486651:1134762892	CV181-085	189	180	CREATE	2019-05-30 09:14:54.044	013	Investigator Meeting
1155	51	1559200496594:1736342563	1559200486651:1134762892	CV181-085	192	180	CREATE	2019-05-30 09:14:56.829	013	Monitoring
1158	51	1559200498983:-2033879334	1559200486651:1134762892	CV181-085	195	180	CREATE	2019-05-30 09:14:59.191	013	Staffing Qualifications
1161	51	1559200501497:1570652599	1559200500550:1107772440	CV181-085	198	197	CREATE	2019-05-30 09:15:01.805	014	Correspondence
1163	51	1559200503342:250231108	1559200501497:1570652599	CV181-085	200	198	CREATE	2019-05-30 09:15:03.525	Correspondence	IB Updates   Safety Updates
1166	51	1559200506584:-1024624191	1559200500550:1107772440	CV181-085	203	197	CREATE	2019-05-30 09:15:06.752	014	Financial and Legal
1168	51	1559200508053:-867646707	1559200500550:1107772440	CV181-085	205	197	CREATE	2019-05-30 09:15:08.22	014	IRB   IEC   SC
1170	51	1559200509623:-1155975180	1559200500550:1107772440	CV181-085	207	197	CREATE	2019-05-30 09:15:10.093	014	Monitoring
1172	51	1559200511479:1284281578	1559200500550:1107772440	CV181-085	209	197	CREATE	2019-05-30 09:15:11.729	014	Regulatory
1174	51	1559200513091:-481351226	1559200500550:1107772440	CV181-085	211	197	CREATE	2019-05-30 09:15:13.324	014	Staffing Qualifications
1177	51	1559200515689:-975173381	1559200514756:717253384	CV181-085	214	213	CREATE	2019-05-30 09:15:15.889	Correspondence	IB Updates   Safety Updates
1180	51	1559200520237:1689204198	1559200513827:-1694371079	CV181-085	217	212	CREATE	2019-05-30 09:15:20.42	015	Drug Supply
1183	51	1559200522618:1318603239	1559200513827:-1694371079	CV181-085	220	212	CREATE	2019-05-30 09:15:22.831	015	IRB   IEC   SC
1185	51	1559200524218:801594595	1559200513827:-1694371079	CV181-085	222	212	CREATE	2019-05-30 09:15:24.515	015	Protocol
1187	51	1559200525916:149782687	1559200513827:-1694371079	CV181-085	224	212	CREATE	2019-05-30 09:15:26.117	015	Staffing Qualifications
1190	51	1559200528565:-413330708	1559200527790:-652857357	CV181-085	227	226	CREATE	2019-05-30 09:15:28.765	Correspondence	IB Updates   Safety Updates
1194	51	1559200531606:-473001680	1559200526634:1053791639	CV181-085	231	225	CREATE	2019-05-30 09:15:31.777	016	Financial and Legal
1196	51	1559200533239:1203790136	1559200526634:1053791639	CV181-085	233	225	CREATE	2019-05-30 09:15:33.499	016	IRB   IEC   SC
1199	51	1559200536274:-824631336	1559200526634:1053791639	CV181-085	236	225	CREATE	2019-05-30 09:15:36.663	016	Regulatory
1358	51	1559200673574:-2060884248	1559200667114:772296124	CV181-085	395	387	CREATE	2019-05-30 09:17:53.739	026	Financial and Legal
1361	51	1559200675932:697504366	1559200667114:772296124	CV181-085	398	387	CREATE	2019-05-30 09:17:56.112	026	Monitoring
1364	51	1559200678910:745305569	rootNode	CV181-085	401	0	CREATE	2019-05-30 09:17:59.132		027
1366	51	1559200680647:599501504	1559200679825:-40263840	CV181-085	403	402	CREATE	2019-05-30 09:18:00.914	Correspondence	IB Updates   Safety Updates
1369	51	1559200683929:1673743258	1559200679825:-40263840	CV181-085	406	402	CREATE	2019-05-30 09:18:04.091	Correspondence	Other (specify)
1371	51	1559200685472:1774044926	1559200678910:745305569	CV181-085	408	401	CREATE	2019-05-30 09:18:05.658	027	Financial and Legal
1384	51	1559200696098:1025707217	1559200694482:1476679781	CV181-085	421	419	CREATE	2019-05-30 09:18:16.28	Correspondence	IRB   IEC Correspondence
1387	51	1559200700422:1319903919	rootNode	CV181-085	424	0	CREATE	2019-05-30 09:18:20.594		Country and Site Selection Tools
1391	51	1559200703397:198741233	rootNode	CV181-085	428	0	CREATE	2019-05-30 09:18:23.744		Investigator Meeting
1394	51	1559200705888:2021375967	1559200705016:-1893123540	CV181-085	431	430	CREATE	2019-05-30 09:18:26.047	ISR	Correspondence
1397	51	1559200708336:527394246	rootNode	CV181-085	434	0	CREATE	2019-05-30 09:18:28.55		Laboratory Clinical   Analytical
1400	51	1559200710515:-1465962696	rootNode	CV181-085	437	0	CREATE	2019-05-30 09:18:30.682		Training Materials and Guidelines
1402	52	1559564826675:2120845002	1559564825325:237206177	ATMF_Unicode	2	1	CREATE	2019-06-03 14:27:06.852	001	Correspondence
1403	52	1559564827675:514182567	1559564826675:2120845002	ATMF_Unicode	3	2	CREATE	2019-06-03 14:27:08.164	Correspondence	General Administration
1410	53	\N	\N	ACQSIT02	7	6	NEW	\N	005testmorethan255fharacters	Staffing qualificationsHiringprocess
1411	53	\N	\N	ACQSIT02	8	7	NEW	\N	Staffing qualificationsHiringprocess	correspondenceRecruting
1412	53	\N	\N	ACQSIT02	9	8	NEW	\N	correspondenceRecruting	protocolstaffing
1413	53	\N	\N	ACQSIT02	10	9	NEW	\N	protocolstaffing	ManagementQualityITstaffingadfdlfdlfjdlfjdlfjdlfjdlfjeorere,nf
2862	59	1558680191863:244583129	rootNode	ATMF_25kdocs	1	0	ALREADY AVAILABLE	2019-07-02 13:46:38.087		00015_Index
1415	54	1561985140124:-1311183939	rootNode	ATMF_25kdocs	2	0	CREATE	2019-07-01 14:45:40.385		Perf22
1417	54	1561985141805:-622608546	1561985141098:-238015638	ATMF_25kdocs	4	3	CREATE	2019-07-01 14:45:41.921	1002	1003
1419	54	1561985143403:-1321632124	1561985142563:-1989707401	ATMF_25kdocs	6	5	CREATE	2019-07-01 14:45:43.691	1004	1005
1420	55	1561986778192:12019265	rootNode	CV181-086	1	0	CREATE	2019-07-01 15:12:58.401		001
1422	55	1561986779836:-912031897	1561986779024:-2104297147	CV181-086	3	2	CREATE	2019-07-01 15:13:00.012	Correspondence	General Administration
1424	55	1561986781444:-818208158	1561986778192:12019265	CV181-086	5	1	CREATE	2019-07-01 15:13:01.688	001	IRB   IEC   SC
1425	55	1561986782287:1783213581	1561986778192:12019265	CV181-086	6	1	CREATE	2019-07-01 15:13:02.822	001	Monitoring
1427	55	1561986784201:297298000	1561986778192:12019265	CV181-086	8	1	CREATE	2019-07-01 15:13:04.414	001	Staffing Qualifications
1428	55	1561986785129:-14971599	rootNode	CV181-086	9	0	CREATE	2019-07-01 15:13:05.367		002
1431	55	1561986787982:-840932416	1561986786006:-1762573756	CV181-086	12	10	CREATE	2019-07-01 15:13:08.188	Correspondence	IB Updates   Safety Updates
1432	55	1561986788853:-1919349618	1561986785129:-14971599	CV181-086	13	9	CREATE	2019-07-01 15:13:09.038	002	Country and Site Selection Tools
1434	55	1561986790521:1220017438	1561986785129:-14971599	CV181-086	15	9	CREATE	2019-07-01 15:13:10.708	002	Drug Supply
1435	55	1561986791274:1342334040	1561986785129:-14971599	CV181-086	16	9	CREATE	2019-07-01 15:13:11.562	002	Financial and Legal
1437	55	1561986793065:849416479	1561986785129:-14971599	CV181-086	18	9	CREATE	2019-07-01 15:13:13.26	002	IRB   IEC   SC
1439	55	1561986794642:561088006	1561986785129:-14971599	CV181-086	20	9	CREATE	2019-07-01 15:13:14.898	002	Monitoring
1440	55	1561986795490:1132202035	1561986785129:-14971599	CV181-086	21	9	CREATE	2019-07-01 15:13:16.117	002	Protocol
1442	55	1561986797595:-1689319353	1561986785129:-14971599	CV181-086	23	9	CREATE	2019-07-01 15:13:17.786	002	Staffing Qualifications
1443	55	1561986798256:-41961742	rootNode	CV181-086	24	0	CREATE	2019-07-01 15:13:18.449		003
1445	55	1561986799854:435014510	1561986799075:-820822092	CV181-086	26	25	CREATE	2019-07-01 15:13:20.105	Correspondence	General Administration
1447	55	1561986801461:708283541	1561986799075:-820822092	CV181-086	28	25	CREATE	2019-07-01 15:13:21.678	Correspondence	Monitoring
1448	55	1561986802266:-872363840	1561986799075:-820822092	CV181-086	29	25	CREATE	2019-07-01 15:13:22.578	Correspondence	Other (specify)
1450	55	1561986803964:-2074166719	1561986798256:-41961742	CV181-086	31	24	CREATE	2019-07-01 15:13:24.236	003	Data Handling
1451	55	1561986804867:36511183	1561986798256:-41961742	CV181-086	32	24	CREATE	2019-07-01 15:13:25.051	003	Drug Supply
1453	55	1561986806437:-933533221	1561986798256:-41961742	CV181-086	34	24	CREATE	2019-07-01 15:13:26.668	003	Informed Consent
1455	55	1561986808397:1071127308	1561986798256:-41961742	CV181-086	36	24	CREATE	2019-07-01 15:13:28.592	003	IRB   IEC   SC
1456	55	1561986809254:-1770107833	1561986798256:-41961742	CV181-086	37	24	CREATE	2019-07-01 15:13:29.568	003	Laboratory Clinical   Analytical
1458	55	1561986811158:-815796410	1561986798256:-41961742	CV181-086	39	24	CREATE	2019-07-01 15:13:31.494	003	Protocol
1459	55	1561986812138:-1071911703	1561986798256:-41961742	CV181-086	40	24	CREATE	2019-07-01 15:13:32.353	003	Regulatory
2863	59	1562067999908:831822768	rootNode	ATMF_25kdocs	2	0	CREATE	2019-07-02 13:46:40.201		Perf23
11556	86	\N	\N	D5170C00002	7	6	NEW	\N	Site	2001700 Idarraga, Samuel
1465	55	1561986816932:-2087307689	1561986814513:-637244901	CV181-086	46	43	CREATE	2019-07-01 15:13:37.117	Correspondence	Monitoring
1466	55	1561986817687:-794020763	1561986813695:-68952091	CV181-086	47	42	CREATE	2019-07-01 15:13:37.869	004	Country and Site Selection Tools
1468	55	1561986819240:220088477	1561986813695:-68952091	CV181-086	49	42	CREATE	2019-07-01 15:13:39.439	004	Drug Supply
1469	55	1561986820034:-1827304298	1561986813695:-68952091	CV181-086	50	42	CREATE	2019-07-01 15:13:40.22	004	Financial and Legal
1471	55	1561986821946:2019196277	1561986813695:-68952091	CV181-086	52	42	CREATE	2019-07-01 15:13:42.22	004	IRB   IEC   SC
1473	55	1561986823564:1730867804	1561986813695:-68952091	CV181-086	54	42	CREATE	2019-07-01 15:13:43.93	004	Monitoring
1474	55	1561986824532:-2037436303	1561986813695:-68952091	CV181-086	55	42	CREATE	2019-07-01 15:13:44.765	004	Protocol
1476	55	1561986826180:1605718982	1561986813695:-68952091	CV181-086	57	42	CREATE	2019-07-01 15:13:46.383	004	Staffing Qualifications
1478	55	1561986827672:-95942543	rootNode	CV181-086	59	0	CREATE	2019-07-01 15:13:47.877		005
1479	55	1561986828558:108208695	1561986827672:-95942543	CV181-086	60	59	CREATE	2019-07-01 15:13:48.825	005	Correspondence
1481	55	1561986830429:-38602909	1561986828558:108208695	CV181-086	62	60	CREATE	2019-07-01 15:13:50.643	Correspondence	IB Updates   Safety Updates
1482	55	1561986831408:1816502429	1561986828558:108208695	CV181-086	63	60	CREATE	2019-07-01 15:13:51.935	Correspondence	Monitoring
1484	55	1561986833675:-1189587081	1561986827672:-95942543	CV181-086	65	59	CREATE	2019-07-01 15:13:53.867	005	Data Handling
1485	55	1561986834564:-1204167098	1561986827672:-95942543	CV181-086	66	59	CREATE	2019-07-01 15:13:54.751	005	Drug Supply
1487	55	1561986836100:2120755794	1561986827672:-95942543	CV181-086	68	59	CREATE	2019-07-01 15:13:56.33	005	Informed Consent
1488	55	1561986836901:-1574768057	1561986827672:-95942543	CV181-086	69	59	CREATE	2019-07-01 15:13:57.094	005	IRB   IEC   SC
1490	55	1561986838447:306612332	1561986827672:-95942543	CV181-086	71	59	CREATE	2019-07-01 15:13:58.673	005	Monitoring
1491	55	1561986839210:-1291982913	1561986827672:-95942543	CV181-086	72	59	CREATE	2019-07-01 15:13:59.396	005	Protocol
1493	55	1561986840732:-184877811	1561986827672:-95942543	CV181-086	74	59	CREATE	2019-07-01 15:14:00.91	005	SFM Cover Sheet
1495	55	1561986842265:-122932583	rootNode	CV181-086	76	0	CREATE	2019-07-01 15:14:02.538		006
1496	55	1561986843180:1532816407	1561986842265:-122932583	CV181-086	77	76	CREATE	2019-07-01 15:14:03.41	006	Correspondence
1498	55	1561986844809:534328113	1561986843180:1532816407	CV181-086	79	77	CREATE	2019-07-01 15:14:05.002	Correspondence	IB Updates   Safety Updates
1500	55	1561986846399:-749217374	1561986842265:-122932583	CV181-086	81	76	CREATE	2019-07-01 15:14:08.449	006	Country and Site Selection Tools
1501	55	1561986849065:-1890237700	1561986842265:-122932583	CV181-086	82	76	CREATE	2019-07-01 15:14:09.283	006	Data Handling
1503	55	1561986850604:-1782501012	1561986842265:-122932583	CV181-086	84	76	CREATE	2019-07-01 15:14:10.777	006	Financial and Legal
1505	55	1561986852200:-105709093	1561986842265:-122932583	CV181-086	86	76	CREATE	2019-07-01 15:14:12.493	006	IRB   IEC   SC
1507	55	1561986853905:-394037566	1561986842265:-122932583	CV181-086	88	76	CREATE	2019-07-01 15:14:14.103	006	Monitoring
1508	55	1561986854832:132624593	1561986842265:-122932583	CV181-086	89	76	CREATE	2019-07-01 15:14:15.6	006	Protocol
1509	55	1561986856211:2046219089	1561986842265:-122932583	CV181-086	90	76	CREATE	2019-07-01 15:14:16.426	006	Regulatory
1511	55	1561986857818:886029769	1561986842265:-122932583	CV181-086	92	76	CREATE	2019-07-01 15:14:18.033	006	Staffing Qualifications
1512	55	1561986858580:-149922726	rootNode	CV181-086	93	0	CREATE	2019-07-01 15:14:18.844		007
1514	55	1561986860308:-2083294053	1561986859494:-1249613699	CV181-086	95	94	CREATE	2019-07-01 15:14:20.686	Correspondence	Consent
1516	55	1561986862035:-1220340137	1561986859494:-1249613699	CV181-086	97	94	CREATE	2019-07-01 15:14:22.24	Correspondence	IB Updates   Safety Updates
1518	55	1561986863602:-1406389561	1561986858580:-149922726	CV181-086	99	93	CREATE	2019-07-01 15:14:23.789	007	Country and Site Selection Tools
1519	55	1561986864398:1170117127	1561986858580:-149922726	CV181-086	100	93	CREATE	2019-07-01 15:14:24.672	007	Financial and Legal
1521	55	1561986866836:-1448058250	1561986858580:-149922726	CV181-086	102	93	CREATE	2019-07-01 15:14:27.036	007	IRB   IEC   SC
1523	55	1561986868626:433322963	1561986858580:-149922726	CV181-086	104	93	CREATE	2019-07-01 15:14:28.806	007	Monitoring
1524	55	1561986869418:-1165272282	1561986858580:-149922726	CV181-086	105	93	CREATE	2019-07-01 15:14:29.595	007	Protocol
1525	55	1561986870209:-1421387575	1561986858580:-149922726	CV181-086	106	93	CREATE	2019-07-01 15:14:30.389	007	Regulatory
1527	55	1561986871837:1713390298	1561986858580:-149922726	CV181-086	108	93	CREATE	2019-07-01 15:14:32.032	007	Staffing Qualifications
1528	55	1561986872531:1948344432	rootNode	CV181-086	109	0	CREATE	2019-07-01 15:14:32.719		008
1530	55	1561986874159:-1107493888	1561986873360:-1547847525	CV181-086	111	110	CREATE	2019-07-01 15:14:34.351	Correspondence	General Administration
1532	55	1561986876033:465086093	1561986872531:1948344432	CV181-086	113	109	CREATE	2019-07-01 15:14:36.233	008	Country and Site Selection Tools
1533	55	1561986877016:1493775350	1561986872531:1948344432	CV181-086	114	109	CREATE	2019-07-01 15:14:37.257	008	Data Handling
1535	55	1561986878691:1557060065	1561986872531:1948344432	CV181-086	116	109	CREATE	2019-07-01 15:14:38.911	008	Financial and Legal
1536	55	1561986879581:509150929	1561986872531:1948344432	CV181-086	117	109	CREATE	2019-07-01 15:14:39.756	008	Informed Consent
1538	55	1561986881231:392616740	1561986872531:1948344432	CV181-086	119	109	CREATE	2019-07-01 15:14:41.427	008	Laboratory Clinical   Analytical
1540	55	1561986882840:-778329447	1561986872531:1948344432	CV181-086	121	109	CREATE	2019-07-01 15:14:43.03	008	Protocol
1541	55	1561986883606:1090812767	1561986872531:1948344432	CV181-086	122	109	CREATE	2019-07-01 15:14:43.833	008	Regulatory
1543	55	1561986885138:-203903424	rootNode	CV181-086	124	0	CREATE	2019-07-01 15:14:45.327		009
1544	55	1561986885948:1001778705	1561986885138:-203903424	CV181-086	125	124	CREATE	2019-07-01 15:14:46.175	009	Correspondence
1546	55	1561986887640:-956504153	1561986885948:1001778705	CV181-086	127	125	CREATE	2019-07-01 15:14:47.827	Correspondence	IB Updates   Safety Updates
1548	55	1561986889226:-251565716	1561986885138:-203903424	CV181-086	129	124	CREATE	2019-07-01 15:14:49.406	009	Data Handling
1549	55	1561986889992:-266145733	1561986885138:-203903424	CV181-086	130	124	CREATE	2019-07-01 15:14:50.194	009	Drug Supply
2864	59	1562068000913:-2142491793	1562067999908:831822768	ATMF_25kdocs	3	2	CREATE	2019-07-02 13:46:41.29	Perf23	1002
1552	55	1561986892423:-636746589	1561986885138:-203903424	CV181-086	133	124	CREATE	2019-07-01 15:14:52.632	009	IRB   IEC   SC
1554	55	1561986894389:1200182342	1561986885138:-203903424	CV181-086	135	124	CREATE	2019-07-01 15:14:54.596	009	Monitoring
1555	55	1561986895266:-398412903	1561986885138:-203903424	CV181-086	136	124	CREATE	2019-07-01 15:14:55.489	009	Protocol
1557	55	1561986896872:1119484772	1561986885138:-203903424	CV181-086	138	124	CREATE	2019-07-01 15:14:57.092	009	Staffing Qualifications
1558	55	1561986897566:-242496201	rootNode	CV181-086	139	0	CREATE	2019-07-01 15:14:57.889		010
1560	55	1561986899414:-754090702	1561986898592:573195486	CV181-086	141	140	CREATE	2019-07-01 15:14:59.633	Correspondence	General Administration
1562	55	1561986901059:1644436454	1561986898592:573195486	CV181-086	143	140	CREATE	2019-07-01 15:15:01.279	Correspondence	Monitoring
1564	55	1561986902757:1445108572	1561986897566:-242496201	CV181-086	145	139	CREATE	2019-07-01 15:15:02.965	010	Data Handling
1565	55	1561986903516:-694728746	1561986897566:-242496201	CV181-086	146	139	CREATE	2019-07-01 15:15:03.721	010	Drug Supply
1567	55	1561986905079:460484151	1561986897566:-242496201	CV181-086	148	139	CREATE	2019-07-01 15:15:05.301	010	Informed Consent
1568	55	1561986905946:700473816	1561986897566:-242496201	CV181-086	149	139	CREATE	2019-07-01 15:15:06.162	010	Investigator Meeting
1570	55	1561986907774:1793619431	1561986897566:-242496201	CV181-086	151	139	CREATE	2019-07-01 15:15:08.107	010	Laboratory Clinical   Analytical
1571	55	1561986908824:51558906	1561986897566:-242496201	CV181-086	152	139	CREATE	2019-07-01 15:15:09.103	010	Monitoring
1573	55	1561986910731:-1803151632	1561986897566:-242496201	CV181-086	154	139	CREATE	2019-07-01 15:15:11.324	010	Regulatory
1575	55	1561986912840:-793631163	1561986897566:-242496201	CV181-086	156	139	CREATE	2019-07-01 15:15:13.055	010	Staffing Qualifications
1576	55	1561986913546:1855770854	rootNode	CV181-086	157	0	CREATE	2019-07-01 15:15:13.805		011
1578	55	1561986915177:1868923631	1561986914412:1379605979	CV181-086	159	158	CREATE	2019-07-01 15:15:15.375	Correspondence	General Administration
1579	55	1561986915940:-1432733696	1561986914412:1379605979	CV181-086	160	158	CREATE	2019-07-01 15:15:16.131	Correspondence	Monitoring
1581	55	1561986918751:-1584820252	1561986913546:1855770854	CV181-086	162	157	CREATE	2019-07-01 15:15:19.014	011	IRB   IEC   SC
1582	55	1561986919521:1828780093	rootNode	CV181-086	163	0	CREATE	2019-07-01 15:15:19.725		012
1584	55	1561986921173:1217621922	1561986920410:1988489180	CV181-086	165	164	CREATE	2019-07-01 15:15:21.358	Correspondence	General Administration
1586	55	1561986922827:1831713215	1561986919521:1828780093	CV181-086	167	163	CREATE	2019-07-01 15:15:23.022	012	Country and Site Selection Tools
1587	55	1561986923566:690692168	1561986919521:1828780093	CV181-086	168	163	CREATE	2019-07-01 15:15:23.753	012	Data Handling
1589	55	1561986925122:-1371280727	1561986919521:1828780093	CV181-086	170	163	CREATE	2019-07-01 15:15:25.387	012	Financial and Legal
1590	55	1561986925999:-293932253	1561986919521:1828780093	CV181-086	171	163	CREATE	2019-07-01 15:15:26.308	012	Informed Consent
1592	55	1561986927831:1759243244	1561986919521:1828780093	CV181-086	173	163	CREATE	2019-07-01 15:15:28.025	012	Laboratory Clinical   Analytical
1594	55	1561986929533:588297469	1561986919521:1828780093	CV181-086	175	163	CREATE	2019-07-01 15:15:29.718	012	Protocol
1595	55	1561986930276:-1837527922	1561986919521:1828780093	CV181-086	176	163	CREATE	2019-07-01 15:15:30.8	012	Regulatory
1597	55	1561986932309:1341702542	1561986919521:1828780093	CV181-086	178	163	CREATE	2019-07-01 15:15:32.522	012	Staffing Qualifications
1599	55	1561986934221:-323467454	rootNode	CV181-086	180	0	CREATE	2019-07-01 15:15:34.488		013
1600	55	1561986935113:-670015267	1561986934221:-323467454	CV181-086	181	180	CREATE	2019-07-01 15:15:35.318	013	Correspondence
1602	55	1561986936665:-84346471	1561986935113:-670015267	CV181-086	183	181	CREATE	2019-07-01 15:15:36.921	Correspondence	IB Updates   Safety Updates
1603	55	1561986937544:-826791232	1561986934221:-323467454	CV181-086	184	180	CREATE	2019-07-01 15:15:37.755	013	Country and Site Selection Tools
1604	55	1561986938354:-1967791473	1561986934221:-323467454	CV181-086	185	180	CREATE	2019-07-01 15:15:38.535	013	Data Handling
1606	55	1561986940256:265202928	1561986934221:-323467454	CV181-086	187	180	CREATE	2019-07-01 15:15:40.523	013	Financial and Legal
1608	55	1561986942049:1582540964	1561986934221:-323467454	CV181-086	189	180	CREATE	2019-07-01 15:15:42.565	013	Investigator Meeting
1610	55	1561986943989:505976790	1561986934221:-323467454	CV181-086	191	180	CREATE	2019-07-01 15:15:44.174	013	Laboratory Clinical   Analytical
1611	55	1561986944743:-1236083735	1561986934221:-323467454	CV181-086	192	180	CREATE	2019-07-01 15:15:44.933	013	Monitoring
1613	55	1561986946438:1204172920	1561986934221:-323467454	CV181-086	194	180	CREATE	2019-07-01 15:15:46.635	013	Regulatory
1615	55	1561986948008:-196781431	1561986934221:-323467454	CV181-086	196	180	CREATE	2019-07-01 15:15:48.202	013	Training Materials and Guidelines
1616	55	1561986948691:-350457803	rootNode	CV181-086	197	0	CREATE	2019-07-01 15:15:48.874		014
1618	55	1561986950821:169454888	1561986949501:592828684	CV181-086	199	198	CREATE	2019-07-01 15:15:51.037	Correspondence	General Administration
1619	55	1561986951625:-1456832568	1561986949501:592828684	CV181-086	200	198	CREATE	2019-07-01 15:15:51.9	Correspondence	IB Updates   Safety Updates
1621	55	1561986953919:44944875	1561986948691:-350457803	CV181-086	202	197	CREATE	2019-07-01 15:15:54.182	014	Drug Supply
1623	55	1561986955512:1200178166	1561986948691:-350457803	CV181-086	204	197	CREATE	2019-07-01 15:15:55.765	014	Informed Consent
1624	55	1561986956329:-325656187	1561986948691:-350457803	CV181-086	205	197	CREATE	2019-07-01 15:15:56.558	014	IRB   IEC   SC
1626	55	1561986957956:1511293138	1561986948691:-350457803	CV181-086	207	197	CREATE	2019-07-01 15:15:58.192	014	Monitoring
1627	55	1561986958809:2082387288	1561986948691:-350457803	CV181-086	208	197	CREATE	2019-07-01 15:15:59.033	014	Protocol
1629	55	1561986960477:1019802892	1561986948691:-350457803	CV181-086	210	197	CREATE	2019-07-01 15:16:00.678	014	SFM Cover Sheet
1631	55	1561986962007:1747829955	rootNode	CV181-086	212	0	CREATE	2019-07-01 15:16:02.279		015
1632	55	1561986962910:1778387403	1561986962007:1747829955	CV181-086	213	212	CREATE	2019-07-01 15:16:03.406	015	Correspondence
1634	55	1561986964852:-1689268393	1561986962910:1778387403	CV181-086	215	213	CREATE	2019-07-01 15:16:05.04	Correspondence	Other (specify)
1635	55	1561986965591:1245083611	1561986962007:1747829955	CV181-086	216	212	CREATE	2019-07-01 15:16:05.786	015	Data Handling
1637	55	1561986967082:-816889181	1561986962007:1747829955	CV181-086	218	212	CREATE	2019-07-01 15:16:07.278	015	Financial and Legal
2865	59	1562068001946:-793624111	1562068000913:-2142491793	ATMF_25kdocs	4	3	CREATE	2019-07-02 13:46:42.161	1002	1003
1640	55	1561986972596:1336045443	1561986962007:1747829955	CV181-086	221	212	CREATE	2019-07-01 15:16:12.807	015	Monitoring
1641	55	1561986973573:-262549802	1561986962007:1747829955	CV181-086	222	212	CREATE	2019-07-01 15:16:13.799	015	Protocol
1643	55	1561986975352:1210917118	1561986962007:1747829955	CV181-086	224	212	CREATE	2019-07-01 15:16:15.644	015	Staffing Qualifications
1644	55	1561986976178:1720839915	rootNode	CV181-086	225	0	CREATE	2019-07-01 15:16:16.387		016
1646	55	1561986977713:1836687414	1561986976964:654386175	CV181-086	227	226	CREATE	2019-07-01 15:16:18.225	Correspondence	IB Updates   Safety Updates
1648	55	1561986979589:121082177	1561986976178:1720839915	CV181-086	229	225	CREATE	2019-07-01 15:16:19.947	016	Data Handling
1649	55	1561986980582:-2063185999	1561986976178:1720839915	CV181-086	230	225	CREATE	2019-07-01 15:16:21.02	016	Drug Supply
1651	55	1561986982414:1261736996	1561986976178:1720839915	CV181-086	232	225	CREATE	2019-07-01 15:16:22.636	016	Informed Consent
1652	55	1561986983186:1861180441	1561986976178:1720839915	CV181-086	233	225	CREATE	2019-07-01 15:16:23.379	016	IRB   IEC   SC
1654	55	1561986984801:-1430960464	1561986976178:1720839915	CV181-086	235	225	CREATE	2019-07-01 15:16:24.99	016	Protocol
1656	55	1561986986641:86915272	1561986976178:1720839915	CV181-086	237	225	CREATE	2019-07-01 15:16:27.069	016	Staffing Qualifications
1657	55	1561986987588:1693849669	rootNode	CV181-086	238	0	CREATE	2019-07-01 15:16:27.889		017
1659	55	1561986989365:37693880	1561986988545:-713512188	CV181-086	240	239	CREATE	2019-07-01 15:16:29.564	Correspondence	IB Updates   Safety Updates
1661	55	1561986990916:-1246815980	1561986987588:1693849669	CV181-086	242	238	CREATE	2019-07-01 15:16:31.302	017	Data Handling
1662	55	1561986991969:908291235	1561986987588:1693849669	CV181-086	243	238	CREATE	2019-07-01 15:16:32.173	017	Drug Supply
1664	55	1561986993757:-61753066	1561986987588:1693849669	CV181-086	245	238	CREATE	2019-07-01 15:16:34.016	017	Informed Consent
1665	55	1561986994602:537690379	1561986987588:1693849669	CV181-086	246	238	CREATE	2019-07-01 15:16:34.806	017	IRB   IEC   SC
1667	55	1561986996225:-629170771	1561986987588:1693849669	CV181-086	248	238	CREATE	2019-07-01 15:16:36.574	017	Protocol
1669	55	1561986998382:-1280982782	1561986987588:1693849669	CV181-086	250	238	CREATE	2019-07-01 15:16:38.678	017	Staffing Qualifications
1670	55	1561986999380:-458420538	rootNode	CV181-086	251	0	CREATE	2019-07-01 15:16:39.722		018
1672	55	1561987001875:492763613	1561987000593:-1302360148	CV181-086	253	252	CREATE	2019-07-01 15:16:42.391	Correspondence	IB Updates   Safety Updates
1673	55	1561987003315:1531713657	1561987000593:-1302360148	CV181-086	254	252	CREATE	2019-07-01 15:16:43.611	Correspondence	Other (specify)
1675	55	1561987005671:-1850244266	1561986999380:-458420538	CV181-086	256	251	CREATE	2019-07-01 15:16:45.998	018	Drug Supply
1677	55	1561987007994:1474678626	1561986999380:-458420538	CV181-086	258	251	CREATE	2019-07-01 15:16:48.519	018	Informed Consent
1678	55	1561987009299:-95565367	1561986999380:-458420538	CV181-086	259	251	CREATE	2019-07-01 15:16:49.575	018	IRB   IEC   SC
1680	55	1561987017183:-1218018937	1561986999380:-458420538	CV181-086	261	251	CREATE	2019-07-01 15:16:57.524	018	Protocol
1682	55	1561987019480:255449116	1561986999380:-458420538	CV181-086	263	251	CREATE	2019-07-01 15:16:59.686	018	Staffing Qualifications
1683	55	1561987020320:-485411196	rootNode	CV181-086	264	0	CREATE	2019-07-01 15:17:00.495		019
1685	55	1561987021872:585373998	1561987021131:1997055721	CV181-086	266	265	CREATE	2019-07-01 15:17:02.158	Correspondence	General Administration
1686	55	1561987022765:1578683967	1561987021131:1997055721	CV181-086	267	265	CREATE	2019-07-01 15:17:02.942	Correspondence	Monitoring
1688	55	1561987024291:-967393376	1561987020320:-485411196	CV181-086	269	264	CREATE	2019-07-01 15:17:04.474	019	IRB   IEC   SC
1690	55	1561987026248:-524004076	rootNode	CV181-086	271	0	CREATE	2019-07-01 15:17:08.97		020
1691	55	1561987029620:1404434715	1561987026248:-524004076	CV181-086	272	271	CREATE	2019-07-01 15:17:09.932	020	Correspondence
1693	55	1561987031415:128640626	1561987029620:1404434715	CV181-086	274	272	CREATE	2019-07-01 15:17:11.628	Correspondence	IB Updates   Safety Updates
1694	55	1561987032211:1247658750	1561987026248:-524004076	CV181-086	275	271	CREATE	2019-07-01 15:17:12.742	020	Country and Site Selection Tools
1696	55	1561987034196:92080037	1561987026248:-524004076	CV181-086	277	271	CREATE	2019-07-01 15:17:14.47	020	Drug Supply
1698	55	1561987035888:-877964367	1561987026248:-524004076	CV181-086	279	271	CREATE	2019-07-01 15:17:16.084	020	Informed Consent
1699	55	1561987036685:-278520922	1561987026248:-524004076	CV181-086	280	271	CREATE	2019-07-01 15:17:16.916	020	IRB   IEC   SC
1701	55	1561987038360:1602838352	1561987026248:-524004076	CV181-086	282	271	CREATE	2019-07-01 15:17:18.68	020	Monitoring
1702	55	1561987039352:4243107	1561987026248:-524004076	CV181-086	283	271	CREATE	2019-07-01 15:17:19.57	020	Protocol
1704	55	1561987041032:-1058339744	1561987026248:-524004076	CV181-086	285	271	CREATE	2019-07-01 15:17:21.24	020	SFM Cover Sheet
1706	55	1561987042742:-550994322	rootNode	CV181-086	287	0	CREATE	2019-07-01 15:17:22.947		021
1707	55	1561987043568:1287121714	1561987042742:-550994322	CV181-086	288	287	CREATE	2019-07-01 15:17:23.756	021	Correspondence
1708	55	1561987044333:-302912752	1561987043568:1287121714	CV181-086	289	288	CREATE	2019-07-01 15:17:24.696	Correspondence	Consent
1710	55	1561987046287:-2090983708	1561987043568:1287121714	CV181-086	291	288	CREATE	2019-07-01 15:17:26.942	Correspondence	File Retention   Destruction
1712	55	1561987048389:-1752974193	1561987043568:1287121714	CV181-086	293	288	CREATE	2019-07-01 15:17:29.003	Correspondence	IRB   IEC Correspondence
1713	55	1561987049639:975065347	1561987043568:1287121714	CV181-086	294	288	CREATE	2019-07-01 15:17:29.879	Correspondence	Monitoring
1715	55	1561987051438:724821122	1561987043568:1287121714	CV181-086	296	288	CREATE	2019-07-01 15:17:32.097	Correspondence	Prot   Amend   Admin Ltr
1716	55	1561987052711:-1644116472	1561987043568:1287121714	CV181-086	297	288	CREATE	2019-07-01 15:17:32.888	Correspondence	Regulatory
1718	55	1561987054548:-1415869928	1561987042742:-550994322	CV181-086	299	287	CREATE	2019-07-01 15:17:34.795	021	Data Handling
1720	55	1561987056944:817124576	1561987042742:-550994322	CV181-086	301	287	CREATE	2019-07-01 15:17:37.14	021	Financial and Legal
1721	55	1561987057835:-230806293	1561987042742:-550994322	CV181-086	302	287	CREATE	2019-07-01 15:17:38.016	021	Informed Consent
1723	55	1561987059495:-395833820	1561987042742:-550994322	CV181-086	304	287	CREATE	2019-07-01 15:17:39.703	021	IRB   IEC   SC
1725	55	1561987061612:1485525763	1561987042742:-550994322	CV181-086	306	287	CREATE	2019-07-01 15:17:41.917	021	Monitoring
2866	59	1562068002739:-1105476147	1562068001946:-793624111	ATMF_25kdocs	5	4	CREATE	2019-07-02 13:46:42.93	1003	1004
1728	55	1561987064217:-764881493	1561987042742:-550994322	CV181-086	309	287	CREATE	2019-07-01 15:17:44.413	021	Staffing Qualifications
1730	55	1561987065726:1547294981	rootNode	CV181-086	311	0	CREATE	2019-07-01 15:17:45.949		022
1731	55	1561987066543:-1326309726	1561987065726:1547294981	CV181-086	312	311	CREATE	2019-07-01 15:17:46.761	022	Correspondence
1733	55	1561987068080:862199250	1561987066543:-1326309726	CV181-086	314	312	CREATE	2019-07-01 15:17:48.268	Correspondence	Data Handling
1734	55	1561987068824:776861930	1561987066543:-1326309726	CV181-086	315	312	CREATE	2019-07-01 15:17:49.068	Correspondence	File Retention   Destruction
1736	55	1561987070582:-1010407486	1561987066543:-1326309726	CV181-086	317	312	CREATE	2019-07-01 15:17:50.83	Correspondence	IRB   IEC Correspondence
1737	55	1561987071384:857046623	1561987066543:-1326309726	CV181-086	318	312	CREATE	2019-07-01 15:17:51.597	Correspondence	Other (specify)
1739	55	1561987073008:1988200550	1561987066543:-1326309726	CV181-086	320	312	CREATE	2019-07-01 15:17:53.19	Correspondence	Regulatory
1740	55	1561987073824:-1886471980	1561987066543:-1326309726	CV181-086	321	312	CREATE	2019-07-01 15:17:54.199	Correspondence	Study Start
1742	55	1561987076458:251085499	1561987065726:1547294981	CV181-086	323	311	CREATE	2019-07-01 15:17:56.684	022	Drug Supply
1744	55	1561987078204:-718958905	1561987065726:1547294981	CV181-086	325	311	CREATE	2019-07-01 15:17:58.426	022	Informed Consent
1745	55	1561987078987:-478969240	1561987065726:1547294981	CV181-086	326	311	CREATE	2019-07-01 15:17:59.64	022	Investigator Meeting
1747	55	1561987081112:-407843830	1561987065726:1547294981	CV181-086	328	311	CREATE	2019-07-01 15:18:01.291	022	Monitoring
1749	55	1561987082674:2032412825	1561987065726:1547294981	CV181-086	330	311	CREATE	2019-07-01 15:18:02.846	022	Regulatory
1751	55	1561987084289:631458474	1561987065726:1547294981	CV181-086	332	311	CREATE	2019-07-01 15:18:04.897	022	Training Materials and Guidelines
1752	55	1561987085449:1520304941	rootNode	CV181-086	333	0	CREATE	2019-07-01 15:18:05.631		023
1753	55	1561987086361:-201794540	1561987085449:1520304941	CV181-086	334	333	CREATE	2019-07-01 15:18:06.558	023	Correspondence
1755	55	1561987087907:-324227775	1561987086361:-201794540	CV181-086	336	334	CREATE	2019-07-01 15:18:08.156	Correspondence	Other (specify)
1757	55	1561987089688:1390180599	1561987085449:1520304941	CV181-086	338	333	CREATE	2019-07-01 15:18:09.891	023	Data Handling
1758	55	1561987090471:-749678452	1561987085449:1520304941	CV181-086	339	333	CREATE	2019-07-01 15:18:10.693	023	Drug Supply
1760	55	1561987092312:-1719722856	1561987085449:1520304941	CV181-086	341	333	CREATE	2019-07-01 15:18:12.571	023	Informed Consent
1762	55	1561987094061:284937776	1561987085449:1520304941	CV181-086	343	333	CREATE	2019-07-01 15:18:14.254	023	IRB   IEC   SC
1763	55	1561987094841:-431018640	1561987085449:1520304941	CV181-086	344	333	CREATE	2019-07-01 15:18:15.125	023	Laboratory Clinical   Analytical
1765	55	1561987096536:523292886	1561987085449:1520304941	CV181-086	346	333	CREATE	2019-07-01 15:18:16.858	023	Protocol
1766	55	1561987097483:267177593	1561987085449:1520304941	CV181-086	347	333	CREATE	2019-07-01 15:18:17.653	023	Regulatory
1768	55	1561987099046:-1133776655	1561987085449:1520304941	CV181-086	349	333	CREATE	2019-07-01 15:18:19.256	023	Training Materials and Guidelines
1769	55	1561987099800:-631964545	rootNode	CV181-086	350	0	CREATE	2019-07-01 15:18:20.008		024
1771	55	1561987101518:10520191	1561987100612:1006689133	CV181-086	352	351	CREATE	2019-07-01 15:18:21.772	Correspondence	Consent
1773	55	1561987103189:551637513	1561987100612:1006689133	CV181-086	354	351	CREATE	2019-07-01 15:18:23.409	Correspondence	Other (specify)
1775	55	1561987104757:-1651893899	1561987099800:-631964545	CV181-086	356	350	CREATE	2019-07-01 15:18:24.989	024	Data Handling
1776	55	1561987105620:-1666473916	1561987099800:-631964545	CV181-086	357	350	CREATE	2019-07-01 15:18:26.335	024	Drug Supply
1778	55	1561987108079:1658449079	1561987099800:-631964545	CV181-086	359	350	CREATE	2019-07-01 15:18:28.295	024	Informed Consent
1779	55	1561987109386:1898438744	1561987099800:-631964545	CV181-086	360	350	CREATE	2019-07-01 15:18:30.726	024	Investigator Meeting
1781	55	1561987112327:-1347814207	1561987099800:-631964545	CV181-086	362	350	CREATE	2019-07-01 15:18:32.531	024	Laboratory Clinical   Analytical
1782	55	1561987113120:1205092564	1561987099800:-631964545	CV181-086	363	350	CREATE	2019-07-01 15:18:33.335	024	Monitoring
1784	55	1561987115485:1520081000	1561987099800:-631964545	CV181-086	365	350	CREATE	2019-07-01 15:18:35.692	024	Regulatory
1786	55	1561987117215:119126649	1561987099800:-631964545	CV181-086	367	350	CREATE	2019-07-01 15:18:37.431	024	Training Materials and Guidelines
1787	55	1561987117971:-658943976	rootNode	CV181-086	368	0	CREATE	2019-07-01 15:18:38.163		025
1789	55	1561987120210:114340935	1561987118875:-1192631755	CV181-086	370	369	CREATE	2019-07-01 15:18:40.499	Correspondence	Consent
1791	55	1561987121973:-653633141	1561987118875:-1192631755	CV181-086	372	369	CREATE	2019-07-01 15:18:42.17	Correspondence	Monitoring
1792	55	1561987122748:-109002106	1561987118875:-1192631755	CV181-086	373	369	CREATE	2019-07-01 15:18:42.951	Correspondence	Other (specify)
1794	55	1561987124352:399342869	1561987117971:-658943976	CV181-086	375	368	CREATE	2019-07-01 15:18:45.012	025	Data Handling
1795	55	1561987125656:-1740515667	1561987117971:-658943976	CV181-086	376	368	CREATE	2019-07-01 15:18:45.938	025	Drug Supply
1797	55	1561987127476:1584407328	1561987117971:-658943976	CV181-086	378	368	CREATE	2019-07-01 15:18:47.777	025	Informed Consent
1798	55	1561987128424:1824396993	1561987117971:-658943976	CV181-086	379	368	CREATE	2019-07-01 15:18:48.69	025	Investigator Meeting
1800	55	1561987130148:747832819	1561987117971:-658943976	CV181-086	381	368	CREATE	2019-07-01 15:18:50.337	025	Laboratory Clinical   Analytical
1802	55	1561987131880:-467545050	1561987117971:-658943976	CV181-086	383	368	CREATE	2019-07-01 15:18:52.117	025	Protocol
1803	55	1561987132734:-723660343	1561987117971:-658943976	CV181-086	384	368	CREATE	2019-07-01 15:18:53.308	025	Regulatory
1805	55	1561987134860:45074392	1561987117971:-658943976	CV181-086	386	368	CREATE	2019-07-01 15:18:55.078	025	Training Materials and Guidelines
1806	55	1561987135575:-685934016	rootNode	CV181-086	387	0	CREATE	2019-07-01 15:18:56.019		026
1808	55	1561987137752:1216542555	1561987136735:-2076894653	CV181-086	389	388	CREATE	2019-07-01 15:18:58.031	Correspondence	Consent
1810	55	1561987139785:448558385	1561987136735:-2076894653	CV181-086	391	388	CREATE	2019-07-01 15:19:00.127	Correspondence	Monitoring
1811	55	1561987140769:-1132088996	1561987136735:-2076894653	CV181-086	392	388	CREATE	2019-07-01 15:19:00.999	Correspondence	Other (specify)
1813	55	1561987142663:1183831287	1561987136735:-2076894653	CV181-086	394	388	CREATE	2019-07-01 15:19:02.96	Correspondence	Study Start
1814	55	1561987143593:1107329187	1561987135575:-685934016	CV181-086	395	387	CREATE	2019-07-01 15:19:03.975	026	Financial and Legal
1815	55	1561987144613:-1150239462	1561987135575:-685934016	CV181-086	396	387	CREATE	2019-07-01 15:19:04.956	026	Investigator Meeting
1816	55	1561987145602:614431505	1561987135575:-685934016	CV181-086	397	387	CREATE	2019-07-01 15:19:05.88	026	IRB   IEC   SC
1817	55	1561987146498:-1079114052	1561987135575:-685934016	CV181-086	398	387	CREATE	2019-07-01 15:19:06.689	026	Monitoring
1818	55	1561987147279:-508020005	1561987135575:-685934016	CV181-086	399	387	CREATE	2019-07-01 15:19:07.997	026	Protocol
1819	55	1561987148729:-764135298	1561987135575:-685934016	CV181-086	400	387	CREATE	2019-07-01 15:19:08.962	026	Regulatory
1820	55	1561987150083:-712924262	rootNode	CV181-086	401	0	CREATE	2019-07-01 15:19:10.289		027
2950	74	\N	\N	CV181-369	48	5	NEW	\N	Site Set-up	Sub-Investigator Curriculum Vitae
1821	55	1561987150885:-28005024	1561987150083:-712924262	CV181-086	402	401	CREATE	2019-07-01 15:19:11.072	027	Correspondence
1822	55	1561987151630:1633543032	1561987150885:-28005024	CV181-086	403	402	CREATE	2019-07-01 15:19:17.469	Correspondence	IB Updates   Safety Updates
1823	55	1561987158178:-2084711142	1561987150885:-28005024	CV181-086	404	402	CREATE	2019-07-01 15:19:18.443	Correspondence	IRB   IEC Correspondence
1824	55	1561987159185:643329737	1561987150885:-28005024	CV181-086	405	402	CREATE	2019-07-01 15:19:19.386	Correspondence	Monitoring
1825	55	1561987160013:-937317644	1561987150885:-28005024	CV181-086	406	402	CREATE	2019-07-01 15:19:20.249	Correspondence	Other (specify)
1826	55	1561987160909:-184780886	1561987150083:-712924262	CV181-086	407	401	CREATE	2019-07-01 15:19:21.086	027	Country and Site Selection Tools
1827	55	1561987161672:-1903221306	1561987150083:-712924262	CV181-086	408	401	CREATE	2019-07-01 15:19:21.858	027	Financial and Legal
1828	55	1561987162470:1343816872	1561987150083:-712924262	CV181-086	409	401	CREATE	2019-07-01 15:19:22.664	027	Informed Consent
1829	55	1561987163282:-585883270	1561987150083:-712924262	CV181-086	410	401	CREATE	2019-07-01 15:19:23.485	027	Investigator Meeting
1830	55	1561987164102:1178787697	1561987150083:-712924262	CV181-086	411	401	CREATE	2019-07-01 15:19:24.302	027	IRB   IEC   SC
1831	55	1561987164868:-1662447444	1561987150083:-712924262	CV181-086	412	401	CREATE	2019-07-01 15:19:25.051	027	Laboratory Clinical   Analytical
1832	55	1561987165755:-1234818471	1561987150083:-712924262	CV181-086	413	401	CREATE	2019-07-01 15:19:25.954	027	Monitoring
1833	55	1561987166540:1461553580	1561987150083:-712924262	CV181-086	414	401	CREATE	2019-07-01 15:19:26.772	027	Protocol
1834	55	1561987167375:-964251417	1561987150083:-712924262	CV181-086	415	401	CREATE	2019-07-01 15:19:27.606	027	Regulatory
1835	55	1561987168254:398968978	1561987150083:-712924262	CV181-086	416	401	CREATE	2019-07-01 15:19:28.719	027	SFM Cover Sheet
1836	55	1561987169391:-2080008643	1561987150083:-712924262	CV181-086	417	401	CREATE	2019-07-01 15:19:29.683	027	Staffing Qualifications
1837	55	1561987170231:126407348	rootNode	CV181-086	418	0	CREATE	2019-07-01 15:19:30.416		Committees
1838	55	1561987170968:2143727851	rootNode	CV181-086	419	0	CREATE	2019-07-01 15:19:31.262		Correspondence
1839	55	1561987171908:-2142100507	1561987170968:2143727851	CV181-086	420	419	CREATE	2019-07-01 15:19:32.086	Correspondence	IB Updates   Safety Updates
1840	55	1561987172732:604302113	1561987170968:2143727851	CV181-086	421	419	CREATE	2019-07-01 15:19:32.966	Correspondence	IRB   IEC Correspondence
1841	55	1561987173512:2107692874	1561987170968:2143727851	CV181-086	422	419	CREATE	2019-07-01 15:19:33.728	Correspondence	Laboratory
1842	55	1561987174288:1707283808	1561987170968:2143727851	CV181-086	423	419	CREATE	2019-07-01 15:19:34.611	Correspondence	Other (specify)
1843	55	1561987175144:1986952092	rootNode	CV181-086	424	0	CREATE	2019-07-01 15:19:35.324		Country and Site Selection Tools
1844	55	1561987175865:-1279325947	rootNode	CV181-086	425	0	CREATE	2019-07-01 15:19:36.262		Data Handling
1845	55	1561987176895:-451548630	rootNode	CV181-086	426	0	CREATE	2019-07-01 15:19:37.082		Financial and Legal
1846	55	1561987177595:-1499478366	rootNode	CV181-086	427	0	CREATE	2019-07-01 15:19:37.819		Informed Consent
1847	55	1561987178371:865789406	rootNode	CV181-086	428	0	CREATE	2019-07-01 15:19:38.603		Investigator Meeting
1848	55	1561987179185:505182163	rootNode	CV181-086	429	0	CREATE	2019-07-01 15:19:39.397		IRB   IEC   SC
1849	55	1561987179984:-1226075367	rootNode	CV181-086	430	0	CREATE	2019-07-01 15:19:40.167		ISR
1850	55	1561987180781:-1281633825	1561987179984:-1226075367	CV181-086	431	430	CREATE	2019-07-01 15:19:40.965	ISR	Correspondence
1851	55	1561987181527:1905783232	1561987180781:-1281633825	CV181-086	432	431	CREATE	2019-07-01 15:19:42.085	Correspondence	Other (specify)
1852	55	1561987182749:-550557320	1561987179984:-1226075367	CV181-086	433	430	CREATE	2019-07-01 15:19:42.934	ISR	Informed Consent
1853	55	1561987183553:-930835688	rootNode	CV181-086	434	0	CREATE	2019-07-01 15:19:43.742		Laboratory Clinical   Analytical
1854	55	1561987184264:1423267401	rootNode	CV181-086	435	0	CREATE	2019-07-01 15:19:44.473		Plans
1855	55	1561987185016:23475838	rootNode	CV181-086	436	0	CREATE	2019-07-01 15:19:45.205		Protocol
1856	55	1561987185715:1976217017	rootNode	CV181-086	437	0	CREATE	2019-07-01 15:19:45.895		Training Materials and Guidelines
2867	59	1562068003596:1279909438	1562068002739:-1105476147	ATMF_25kdocs	6	5	CREATE	2019-07-02 13:46:43.834	1004	1005
2891	64	1572952351607:-2102863892	1572952350418:1750951035	Risk_study	2	1	CREATE	2019-11-05 12:12:35.53	003	Correspondence3
2892	64	1572952356358:1847073217	1572952351607:-2102863892	Risk_study	3	2	CREATE	2019-11-05 12:12:36.571	Correspondence3	Monitoring3
2378	58	1558106053226:-239547935	1558106052358:892009829	ATMF_500Secstudy	17	16	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec11	1002
2383	58	1558106057019:1316350821	1558106056219:865018759	ATMF_500Secstudy	22	21	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec12	1002
2388	58	1558106060709:304674559	1558106059879:-2117255821	ATMF_500Secstudy	27	26	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec13	1002
2379	58	1558106053982:1711073953	1558106053226:-239547935	ATMF_500Secstudy	18	17	ALREADY AVAILABLE	2019-07-02 09:27:15.23	1002	1003
2384	58	1558106057734:2044718885	1558106057019:1316350821	ATMF_500Secstudy	23	22	ALREADY AVAILABLE	2019-07-02 09:27:15.23	1002	1003
2380	58	1558106054756:558828909	1558106053982:1711073953	ATMF_500Secstudy	19	18	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1003	1004
2385	58	1558106058466:-981678066	1558106057734:2044718885	ATMF_500Secstudy	24	23	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1003	1004
2381	58	1558106055485:-1554028952	1558106054756:558828909	ATMF_500Secstudy	20	19	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2386	58	1558106059253:1642030210	1558106058466:-981678066	ATMF_500Secstudy	25	24	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
1414	54	1558680196017:-1200379244	rootNode	ATMF_25kdocs	1	0	ALREADY AVAILABLE	2019-07-01 14:45:38.424		00018_Index
1416	54	1561985141098:-238015638	1561985140124:-1311183939	ATMF_25kdocs	3	2	CREATE	2019-07-01 14:45:41.236	Perf22	1002
1418	54	1561985142563:-1989707401	1561985141805:-622608546	ATMF_25kdocs	5	4	CREATE	2019-07-01 14:45:42.722	1003	1004
1857	56	1561985191354:875416206	rootNode	ACQSIT03	1	0	CREATE	2019-07-01 14:46:31.479		003
1858	56	1561985192089:1205403022	1561985191354:875416206	ACQSIT03	2	1	CREATE	2019-07-01 14:46:32.278	003	Correspondence3
1859	56	1561985192899:1574065539	1561985192089:1205403022	ACQSIT03	3	2	CREATE	2019-07-01 14:46:33.088	Correspondence3	Monitoring3
1860	56	1561985193770:1196170551	1561985192899:1574065539	ACQSIT03	4	3	CREATE	2019-07-01 14:46:34.293	Monitoring3	Regulatory3
1861	56	1561985195014:-1889234018	1561985193770:1196170551	ACQSIT03	5	4	CREATE	2019-07-01 14:46:35.132	Regulatory3	Protocol3
1421	55	1561986779024:-2104297147	1561986778192:12019265	CV181-086	2	1	CREATE	2019-07-01 15:12:59.22	001	Correspondence
1423	55	1561986780656:-1089782890	1561986778192:12019265	CV181-086	4	1	CREATE	2019-07-01 15:13:00.829	001	Financial and Legal
1426	55	1561986783445:-1476714144	1561986778192:12019265	CV181-086	7	1	CREATE	2019-07-01 15:13:03.641	001	Regulatory
1429	55	1561986786006:-1762573756	1561986785129:-14971599	CV181-086	10	9	CREATE	2019-07-01 15:13:06.533	002	Correspondence
1430	55	1561986787176:785355040	1561986786006:-1762573756	CV181-086	11	10	CREATE	2019-07-01 15:13:07.391	Correspondence	General Administration
1433	55	1561986789690:-890660361	1561986785129:-14971599	CV181-086	14	9	CREATE	2019-07-01 15:13:09.904	002	Data Handling
1436	55	1561986792203:249973034	1561986785129:-14971599	CV181-086	17	9	CREATE	2019-07-01 15:13:12.414	002	Informed Consent
1438	55	1561986793877:177890612	1561986785129:-14971599	CV181-086	19	9	CREATE	2019-07-01 15:13:14.07	002	Laboratory Clinical   Analytical
1441	55	1561986796738:876086742	1561986785129:-14971599	CV181-086	22	9	CREATE	2019-07-01 15:13:16.949	002	Regulatory
1444	55	1561986799075:-820822092	1561986798256:-41961742	CV181-086	25	24	CREATE	2019-07-01 15:13:19.289	003	Correspondence
1446	55	1561986800686:-1191272946	1561986799075:-820822092	CV181-086	27	25	CREATE	2019-07-01 15:13:20.899	Correspondence	IB Updates   Safety Updates
1449	55	1561986803217:-977597954	1561986798256:-41961742	CV181-086	30	24	CREATE	2019-07-01 15:13:23.41	003	Country and Site Selection Tools
1452	55	1561986805642:158827682	1561986798256:-41961742	CV181-086	33	24	CREATE	2019-07-01 15:13:25.848	003	Financial and Legal
1454	55	1561986807247:1476165718	1561986798256:-41961742	CV181-086	35	24	CREATE	2019-07-01 15:13:27.774	003	Investigator Meeting
1457	55	1561986810209:-1342459187	1561986798256:-41961742	CV181-086	38	24	CREATE	2019-07-01 15:13:30.521	003	Monitoring
1460	55	1561986812926:702100750	1561986798256:-41961742	CV181-086	41	24	CREATE	2019-07-01 15:13:33.118	003	Staffing Qualifications
1461	55	1561986813695:-68952091	rootNode	CV181-086	42	0	CREATE	2019-07-01 15:13:33.886		004
1462	55	1561986814513:-637244901	1561986813695:-68952091	CV181-086	43	42	CREATE	2019-07-01 15:13:34.705	004	Correspondence
1463	55	1561986815284:-190867446	1561986814513:-637244901	CV181-086	44	43	CREATE	2019-07-01 15:13:35.504	Correspondence	General Administration
1464	55	1561986816125:352554166	1561986814513:-637244901	CV181-086	45	43	CREATE	2019-07-01 15:13:36.336	Correspondence	IB Updates   Safety Updates
1467	55	1561986818456:234668494	1561986813695:-68952091	CV181-086	48	42	CREATE	2019-07-01 15:13:38.644	004	Data Handling
1470	55	1561986820855:1419752832	1561986813695:-68952091	CV181-086	51	42	CREATE	2019-07-01 15:13:41.304	004	Informed Consent
1472	55	1561986822809:1303219570	1561986813695:-68952091	CV181-086	53	42	CREATE	2019-07-01 15:13:43	004	Laboratory Clinical   Analytical
1475	55	1561986825435:-123842837	1561986813695:-68952091	CV181-086	56	42	CREATE	2019-07-01 15:13:45.626	004	Regulatory
1477	55	1561986826973:-1524797188	1561986813695:-68952091	CV181-086	58	42	CREATE	2019-07-01 15:13:47.176	004	Training Materials and Guidelines
1480	55	1561986829518:1587684547	1561986828558:108208695	CV181-086	61	60	CREATE	2019-07-01 15:13:49.716	Correspondence	General Administration
1483	55	1561986832749:2076690958	1561986827672:-95942543	CV181-086	64	59	CREATE	2019-07-01 15:13:52.948	005	Country and Site Selection Tools
1486	55	1561986835333:-1081851011	1561986827672:-95942543	CV181-086	67	59	CREATE	2019-07-01 15:13:55.558	005	Financial and Legal
1489	55	1561986837639:2048672857	1561986827672:-95942543	CV181-086	70	59	CREATE	2019-07-01 15:13:57.878	005	Laboratory Clinical   Analytical
1492	55	1561986839947:-1548098206	1561986827672:-95942543	CV181-086	73	59	CREATE	2019-07-01 15:14:00.132	005	Regulatory
1494	55	1561986841469:-538577634	1561986827672:-95942543	CV181-086	75	59	CREATE	2019-07-01 15:14:01.714	005	Staffing Qualifications
1497	55	1561986843978:-2134351727	1561986843180:1532816407	CV181-086	78	77	CREATE	2019-07-01 15:14:04.191	Correspondence	General Administration
1499	55	1561986845568:-1905534154	1561986843180:1532816407	CV181-086	80	77	CREATE	2019-07-01 15:14:05.801	Correspondence	Monitoring
1502	55	1561986849857:264891763	1561986842265:-122932583	CV181-086	83	76	CREATE	2019-07-01 15:14:10.052	006	Drug Supply
1504	55	1561986851342:-705152538	1561986842265:-122932583	CV181-086	85	76	CREATE	2019-07-01 15:14:11.543	006	Informed Consent
1506	55	1561986853136:-821686830	1561986842265:-122932583	CV181-086	87	76	CREATE	2019-07-01 15:14:13.352	006	Laboratory Clinical   Analytical
1510	55	1561986857041:1239729592	1561986842265:-122932583	CV181-086	91	76	CREATE	2019-07-01 15:14:17.234	006	SFM Cover Sheet
1513	55	1561986859494:-1249613699	1561986858580:-149922726	CV181-086	94	93	CREATE	2019-07-01 15:14:19.676	007	Correspondence
1515	55	1561986861284:405947319	1561986859494:-1249613699	CV181-086	96	94	CREATE	2019-07-01 15:14:21.478	Correspondence	General Administration
1517	55	1561986862798:1988319696	1561986859494:-1249613699	CV181-086	98	94	CREATE	2019-07-01 15:14:22.987	Correspondence	Other (specify)
1520	55	1561986865950:-2047501695	1561986858580:-149922726	CV181-086	101	93	CREATE	2019-07-01 15:14:26.15	007	Informed Consent
1522	55	1561986867628:5673905	1561986858580:-149922726	CV181-086	103	93	CREATE	2019-07-01 15:14:27.986	007	Laboratory Clinical   Analytical
1526	55	1561986871046:-58167180	1561986858580:-149922726	CV181-086	107	93	CREATE	2019-07-01 15:14:31.239	007	SFM Cover Sheet
1529	55	1561986873360:-1547847525	1561986872531:1948344432	CV181-086	110	109	CREATE	2019-07-01 15:14:33.566	008	Correspondence
1531	55	1561986875014:1561185952	1561986873360:-1547847525	CV181-086	112	110	CREATE	2019-07-01 15:14:35.39	Correspondence	IB Updates   Safety Updates
1534	55	1561986877886:1479195333	1561986872531:1948344432	CV181-086	115	109	CREATE	2019-07-01 15:14:38.113	008	Drug Supply
1537	55	1561986880325:-1061115415	1561986872531:1948344432	CV181-086	118	109	CREATE	2019-07-01 15:14:40.622	008	IRB   IEC   SC
1539	55	1561986881995:820265798	1561986872531:1948344432	CV181-086	120	109	CREATE	2019-07-01 15:14:42.208	008	Monitoring
8830	84	\N	\N	D5170C00002	2615	2326	NEW	\N	Site	2001787 Israeli, Eran
1542	55	1561986884437:-1430141458	1561986872531:1948344432	CV181-086	123	109	CREATE	2019-07-01 15:14:44.636	008	Staffing Qualifications
1545	55	1561986886822:669783303	1561986885948:1001778705	CV181-086	126	125	CREATE	2019-07-01 15:14:47.085	Correspondence	General Administration
1547	55	1561986888423:845002843	1561986885138:-203903424	CV181-086	128	124	CREATE	2019-07-01 15:14:48.62	009	Country and Site Selection Tools
1550	55	1561986890880:1981428788	1561986885138:-203903424	CV181-086	131	124	CREATE	2019-07-01 15:14:51.078	009	Financial and Legal
1551	55	1561986891652:-1236190034	1561986885138:-203903424	CV181-086	132	124	CREATE	2019-07-01 15:14:51.84	009	Informed Consent
1553	55	1561986893223:-1352724429	1561986885138:-203903424	CV181-086	134	124	CREATE	2019-07-01 15:14:53.776	009	Laboratory Clinical   Analytical
1556	55	1561986896080:-654528196	1561986885138:-203903424	CV181-086	137	124	CREATE	2019-07-01 15:14:56.291	009	Regulatory
1559	55	1561986898592:573195486	1561986897566:-242496201	CV181-086	140	139	CREATE	2019-07-01 15:14:58.794	010	Correspondence
1561	55	1561986900264:1914589138	1561986898592:573195486	CV181-086	142	140	CREATE	2019-07-01 15:15:00.464	Correspondence	IB Updates   Safety Updates
1563	55	1561986901898:-1708837883	1561986897566:-242496201	CV181-086	144	139	CREATE	2019-07-01 15:15:02.105	010	Country and Site Selection Tools
1566	55	1561986904279:-616864323	1561986897566:-242496201	CV181-086	147	139	CREATE	2019-07-01 15:15:04.487	010	Financial and Legal
1569	55	1561986906864:339887276	1561986897566:-242496201	CV181-086	150	139	CREATE	2019-07-01 15:15:07.058	010	IRB   IEC   SC
1572	55	1561986909883:-1547036339	1561986897566:-242496201	CV181-086	153	139	CREATE	2019-07-01 15:15:10.086	010	Protocol
1574	55	1561986911953:1685325755	1561986897566:-242496201	CV181-086	155	139	CREATE	2019-07-01 15:15:12.238	010	SFM Cover Sheet
1577	55	1561986914412:1379605979	1561986913546:1855770854	CV181-086	158	157	CREATE	2019-07-01 15:15:14.617	011	Correspondence
1580	55	1561986916742:-1856394984	1561986913546:1855770854	CV181-086	161	157	CREATE	2019-07-01 15:15:18.15	011	Financial and Legal
1583	55	1561986920410:1988489180	1561986919521:1828780093	CV181-086	164	163	CREATE	2019-07-01 15:15:20.6	012	Correspondence
1585	55	1561986921983:1716591458	1561986920410:1988489180	CV181-086	166	164	CREATE	2019-07-01 15:15:22.245	Correspondence	IB Updates   Safety Updates
1588	55	1561986924307:-1449144944	1561986919521:1828780093	CV181-086	169	163	CREATE	2019-07-01 15:15:24.509	012	Drug Supply
1591	55	1561986926963:-1819746006	1561986919521:1828780093	CV181-086	172	163	CREATE	2019-07-01 15:15:27.243	012	IRB   IEC   SC
1593	55	1561986928643:17182719	1561986919521:1828780093	CV181-086	174	163	CREATE	2019-07-01 15:15:28.847	012	Monitoring
1596	55	1561986931390:-474286824	1561986919521:1828780093	CV181-086	177	163	CREATE	2019-07-01 15:15:31.684	012	SFM Cover Sheet
1598	55	1561986933124:-1833244383	1561986919521:1828780093	CV181-086	179	163	CREATE	2019-07-01 15:15:33.676	012	Training Materials and Guidelines
1601	55	1561986935891:-583336813	1561986935113:-670015267	CV181-086	182	181	CREATE	2019-07-01 15:15:36.12	Correspondence	General Administration
1605	55	1561986939087:187317905	1561986934221:-323467454	CV181-086	186	180	CREATE	2019-07-01 15:15:39.604	013	Drug Supply
1607	55	1561986941071:-782726499	1561986934221:-323467454	CV181-086	188	180	CREATE	2019-07-01 15:15:41.387	013	Informed Consent
1609	55	1561986943194:-947755365	1561986934221:-323467454	CV181-086	190	180	CREATE	2019-07-01 15:15:43.399	013	IRB   IEC   SC
1612	55	1561986945526:-664989894	1561986934221:-323467454	CV181-086	193	180	CREATE	2019-07-01 15:15:45.808	013	Protocol
1614	55	1561986947230:-1316801905	1561986934221:-323467454	CV181-086	195	180	CREATE	2019-07-01 15:15:47.422	013	Staffing Qualifications
1617	55	1561986949501:592828684	1561986948691:-350457803	CV181-086	198	197	CREATE	2019-07-01 15:15:49.801	014	Correspondence
1620	55	1561986953157:59524892	1561986948691:-350457803	CV181-086	201	197	CREATE	2019-07-01 15:15:53.342	014	Data Handling
1622	55	1561986954760:122829692	1561986948691:-350457803	CV181-086	203	197	CREATE	2019-07-01 15:15:54.941	014	Financial and Legal
1625	55	1561986957162:-1041613633	1561986948691:-350457803	CV181-086	206	197	CREATE	2019-07-01 15:15:57.392	014	Laboratory Clinical   Analytical
1628	55	1561986959639:-343417503	1561986948691:-350457803	CV181-086	209	197	CREATE	2019-07-01 15:15:59.87	014	Regulatory
1630	55	1561986961260:666103069	1561986948691:-350457803	CV181-086	211	197	CREATE	2019-07-01 15:16:01.51	014	Staffing Qualifications
1633	55	1561986964014:1566748859	1561986962910:1778387403	CV181-086	214	213	CREATE	2019-07-01 15:16:04.198	Correspondence	IB Updates   Safety Updates
1636	55	1561986966328:1230503594	1561986962007:1747829955	CV181-086	217	212	CREATE	2019-07-01 15:16:06.51	015	Drug Supply
1638	55	1561986967861:260459293	1561986962007:1747829955	CV181-086	219	212	CREATE	2019-07-01 15:16:08.047	015	Informed Consent
1639	55	1561986968689:859902738	1561986962007:1747829955	CV181-086	220	212	CREATE	2019-07-01 15:16:08.864	015	IRB   IEC   SC
1642	55	1561986974543:1606613733	1561986962007:1747829955	CV181-086	223	212	CREATE	2019-07-01 15:16:14.749	015	Regulatory
1645	55	1561986976964:654386175	1561986976178:1720839915	CV181-086	226	225	CREATE	2019-07-01 15:16:17.168	016	Correspondence
1647	55	1561986978823:-1419329838	1561986976964:654386175	CV181-086	228	226	CREATE	2019-07-01 15:16:19.044	Correspondence	Other (specify)
1650	55	1561986981606:184388522	1561986976178:1720839915	CV181-086	231	225	CREATE	2019-07-01 15:16:21.857	016	Financial and Legal
1653	55	1561986984016:-1957644665	1561986976178:1720839915	CV181-086	234	225	CREATE	2019-07-01 15:16:24.231	016	Monitoring
1655	55	1561986985564:-1687075757	1561986976178:1720839915	CV181-086	236	225	CREATE	2019-07-01 15:16:26.034	016	Regulatory
1658	55	1561986988545:-713512188	1561986987588:1693849669	CV181-086	239	238	CREATE	2019-07-01 15:16:28.756	017	Correspondence
1660	55	1561986990150:1076643924	1561986988545:-713512188	CV181-086	241	239	CREATE	2019-07-01 15:16:30.33	Correspondence	Other (specify)
1663	55	1561986992743:-1139101540	1561986987588:1693849669	CV181-086	244	238	CREATE	2019-07-01 15:16:33.12	017	Financial and Legal
1666	55	1561986995396:969424474	1561986987588:1693849669	CV181-086	247	238	CREATE	2019-07-01 15:16:35.596	017	Monitoring
1668	55	1561986997297:1284401374	1561986987588:1693849669	CV181-086	249	238	CREATE	2019-07-01 15:16:37.547	017	Regulatory
1671	55	1561987000593:-1302360148	1561986999380:-458420538	CV181-086	252	251	CREATE	2019-07-01 15:16:40.96	018	Correspondence
1674	55	1561987004476:289615712	1561986999380:-458420538	CV181-086	255	251	CREATE	2019-07-01 15:16:44.787	018	Data Handling
1676	55	1561987006898:-1772357183	1561986999380:-458420538	CV181-086	257	251	CREATE	2019-07-01 15:16:47.174	018	Financial and Legal
1679	55	1561987010361:-1789110924	1561986999380:-458420538	CV181-086	260	251	CREATE	2019-07-01 15:16:56.317	018	Monitoring
1681	55	1561987018445:651145731	1561986999380:-458420538	CV181-086	262	251	CREATE	2019-07-01 15:16:58.852	018	Regulatory
1684	55	1561987021131:1997055721	1561987020320:-485411196	CV181-086	265	264	CREATE	2019-07-01 15:17:01.313	019	Correspondence
1687	55	1561987023517:-1238968108	1561987020320:-485411196	CV181-086	268	264	CREATE	2019-07-01 15:17:03.702	019	Financial and Legal
1689	55	1561987025054:1634028363	1561987020320:-485411196	CV181-086	270	264	CREATE	2019-07-01 15:17:05.724	019	Monitoring
1692	55	1561987030568:-370351261	1561987029620:1404434715	CV181-086	273	272	CREATE	2019-07-01 15:17:10.796	Correspondence	General Administration
1695	55	1561987033387:106660054	1561987026248:-524004076	CV181-086	276	271	CREATE	2019-07-01 15:17:13.588	020	Data Handling
1697	55	1561987035113:214375009	1561987026248:-524004076	CV181-086	278	271	CREATE	2019-07-01 15:17:15.332	020	Financial and Legal
1700	55	1561987037523:-950068419	1561987026248:-524004076	CV181-086	281	271	CREATE	2019-07-01 15:17:17.75	020	Laboratory Clinical   Analytical
1703	55	1561987040285:1873407157	1561987026248:-524004076	CV181-086	284	271	CREATE	2019-07-01 15:17:20.484	020	Regulatory
1705	55	1561987041808:757648180	1561987026248:-524004076	CV181-086	286	271	CREATE	2019-07-01 15:17:22.103	020	Staffing Qualifications
1709	55	1561987045320:164041874	1561987043568:1287121714	CV181-086	290	288	CREATE	2019-07-01 15:17:25.59	Correspondence	Data Handling
1711	55	1561987047594:1965279981	1561987043568:1287121714	CV181-086	292	288	CREATE	2019-07-01 15:17:27.809	Correspondence	IB Updates   Safety Updates
1714	55	1561987050558:-605582034	1561987043568:1287121714	CV181-086	295	288	CREATE	2019-07-01 15:17:30.833	Correspondence	Other (specify)
1717	55	1561987053524:945866968	1561987043568:1287121714	CV181-086	298	288	CREATE	2019-07-01 15:17:33.917	Correspondence	Study Start
1719	55	1561987055414:-1430449945	1561987042742:-550994322	CV181-086	300	287	CREATE	2019-07-01 15:17:35.64	021	Drug Supply
1722	55	1561987058693:9183372	1561987042742:-550994322	CV181-086	303	287	CREATE	2019-07-01 15:17:38.897	021	Investigator Meeting
1724	55	1561987060319:1057898335	1561987042742:-550994322	CV181-086	305	287	CREATE	2019-07-01 15:17:40.899	021	Laboratory Clinical   Analytical
1726	55	1561987062645:2012209758	1561987042742:-550994322	CV181-086	307	287	CREATE	2019-07-01 15:17:42.841	021	Protocol
1727	55	1561987063453:-369184878	1561987042742:-550994322	CV181-086	308	287	CREATE	2019-07-01 15:17:43.638	021	Regulatory
1729	55	1561987065015:-1770139126	1561987042742:-550994322	CV181-086	310	287	CREATE	2019-07-01 15:17:45.197	021	Training Materials and Guidelines
1732	55	1561987067338:-1730034307	1561987066543:-1326309726	CV181-086	313	312	CREATE	2019-07-01 15:17:47.517	Correspondence	Consent
1735	55	1561987069772:-1587120608	1561987066543:-1326309726	CV181-086	316	312	CREATE	2019-07-01 15:17:49.972	Correspondence	IB Updates   Safety Updates
1738	55	1561987072187:17761105	1561987066543:-1326309726	CV181-086	319	312	CREATE	2019-07-01 15:17:52.383	Correspondence	Prot   Amend   Admin Ltr
1741	55	1561987074831:-1859613106	1561987065726:1547294981	CV181-086	322	311	CREATE	2019-07-01 15:17:55.823	022	Data Handling
1743	55	1561987077368:373381295	1561987065726:1547294981	CV181-086	324	311	CREATE	2019-07-01 15:17:57.619	022	Financial and Legal
1746	55	1561987080334:1285701727	1561987065726:1547294981	CV181-086	327	311	CREATE	2019-07-01 15:18:00.539	022	IRB   IEC   SC
1748	55	1561987081899:163249187	1561987065726:1547294981	CV181-086	329	311	CREATE	2019-07-01 15:18:02.09	022	Protocol
1750	55	1561987083493:-488562824	1561987065726:1547294981	CV181-086	331	311	CREATE	2019-07-01 15:18:03.707	022	Staffing Qualifications
1754	55	1561987087122:539871781	1561987086361:-201794540	CV181-086	335	334	CREATE	2019-07-01 15:18:07.32	Correspondence	Consent
1756	55	1561987088767:1006175381	1561987086361:-201794540	CV181-086	337	334	CREATE	2019-07-01 15:18:09.018	Correspondence	Prot   Amend   Admin Ltr
1759	55	1561987091293:-671792296	1561987085449:1520304941	CV181-086	340	333	CREATE	2019-07-01 15:18:11.7	023	Financial and Legal
1761	55	1561987093151:-1479733191	1561987085449:1520304941	CV181-086	342	333	CREATE	2019-07-01 15:18:13.457	023	Investigator Meeting
1764	55	1561987095721:2121888131	1561987085449:1520304941	CV181-086	345	333	CREATE	2019-07-01 15:18:15.924	023	Monitoring
1767	55	1561987098252:-128519022	1561987085449:1520304941	CV181-086	348	333	CREATE	2019-07-01 15:18:18.461	023	Staffing Qualifications
1770	55	1561987100612:1006689133	1561987099800:-631964545	CV181-086	351	350	CREATE	2019-07-01 15:18:20.873	024	Correspondence
1772	55	1561987102419:2132284894	1561987100612:1006689133	CV181-086	353	351	CREATE	2019-07-01 15:18:22.619	Correspondence	Monitoring
1774	55	1561987103965:1882040669	1561987100612:1006689133	CV181-086	355	351	CREATE	2019-07-01 15:18:24.15	Correspondence	Prot   Amend   Admin Ltr
1777	55	1561987106994:581100605	1561987099800:-631964545	CV181-086	358	350	CREATE	2019-07-01 15:18:27.301	024	Financial and Legal
1780	55	1561987111498:-631857585	1561987099800:-631964545	CV181-086	361	350	CREATE	2019-07-01 15:18:31.708	024	IRB   IEC   SC
1783	55	1561987113909:1776185890	1561987099800:-631964545	CV181-086	364	350	CREATE	2019-07-01 15:18:34.724	024	Protocol
1785	55	1561987116269:-1045314795	1561987099800:-631964545	CV181-086	366	350	CREATE	2019-07-01 15:18:36.611	024	Staffing Qualifications
1788	55	1561987118875:-1192631755	1561987117971:-658943976	CV181-086	369	368	CREATE	2019-07-01 15:18:39.548	025	Correspondence
1790	55	1561987121121:1741798062	1561987118875:-1192631755	CV181-086	371	369	CREATE	2019-07-01 15:18:41.383	Correspondence	IB Updates   Safety Updates
1793	55	1561987123614:-903877469	1561987118875:-1192631755	CV181-086	374	369	CREATE	2019-07-01 15:18:43.807	Correspondence	Prot   Amend   Admin Ltr
1796	55	1561987126534:507058854	1561987117971:-658943976	CV181-086	377	368	CREATE	2019-07-01 15:18:46.811	025	Financial and Legal
1799	55	1561987129247:-705899336	1561987117971:-658943976	CV181-086	380	368	CREATE	2019-07-01 15:18:49.49	025	IRB   IEC   SC
1801	55	1561987130924:1131050195	1561987117971:-658943976	CV181-086	382	368	CREATE	2019-07-01 15:18:51.278	025	Monitoring
1804	55	1561987133916:-1119356958	1561987117971:-658943976	CV181-086	385	368	CREATE	2019-07-01 15:18:54.207	025	Staffing Qualifications
1807	55	1561987136735:-2076894653	1561987135575:-685934016	CV181-086	388	387	CREATE	2019-07-01 15:18:57.108	026	Correspondence
1809	55	1561987138686:-1450978017	1561987136735:-2076894653	CV181-086	390	388	CREATE	2019-07-01 15:18:59.099	Correspondence	IB Updates   Safety Updates
1812	55	1561987141588:198314160	1561987136735:-2076894653	CV181-086	393	388	CREATE	2019-07-01 15:19:01.933	Correspondence	Prot   Amend   Admin Ltr
2871	60	1562148781501:465884334	1562148780285:-1554740098	ACQSIT02	4	3	CREATE	2019-07-03 12:13:01.879	1003	1004
2403	58	1558106072215:-25862764	1558106071398:2096738986	ATMF_500Secstudy	42	41	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec16	1002
2399	58	1558106068965:-1806475381	1558106068243:124608026	ATMF_500Secstudy	38	37	ALREADY AVAILABLE	2019-07-02 09:27:15.23	1002	1003
2400	58	1558106069744:2119834467	1558106068965:-1806475381	ATMF_500Secstudy	39	38	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1003	1004
2401	58	1558106070481:1626734186	1558106069744:2119834467	ATMF_500Secstudy	40	39	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2872	60	1562148782494:-1894761516	1562148781501:465884334	ACQSIT02	5	4	CREATE	2019-07-03 12:13:02.789	1004	1005
2895	65	1573028176330:1175735279	rootNode	Many_study	1	0	CREATE	2019-11-06 09:16:16.594		003
2896	65	1573028177248:301185050	1573028176330:1175735279	Many_study	2	1	CREATE	2019-11-06 09:16:17.385	003	Correspondence3
2897	65	1573028178022:-1377440080	1573028177248:301185050	Many_study	3	2	CREATE	2019-11-06 09:16:18.166	Correspondence3	Monitoring3
2898	65	1573028178938:-1258825809	1573028178022:-1377440080	Many_study	4	3	CREATE	2019-11-06 09:16:19.143	Monitoring3	Regulatory3
2899	65	1573028179813:55075272	1573028178938:-1258825809	Many_study	5	4	CREATE	2019-11-06 09:16:19.966	Regulatory3	Protocol3
2900	66	1582285469975:771852111	rootNode	Acquiredstudy1	1	0	CREATE	2020-02-21 12:44:30.041		003
2901	66	1582285471097:917020755	1582285469975:771852111	Acquiredstudy1	2	1	CREATE	2020-02-21 12:44:31.184	003	Correspondence3
2902	66	1582285472141:1312331977	1582285471097:917020755	Acquiredstudy1	3	2	CREATE	2020-02-21 12:44:32.234	Correspondence3	Monitoring3
2932	72	1582535643279:1470954139	1582535641787:-1512878045	TS02eTMFUAT	4	3	CREATE	2020-02-24 10:14:03.495	Monitoring3	Regulatory3
2933	72	1582535644760:408360058	1582535643279:1470954139	TS02eTMFUAT	5	4	CREATE	2020-02-24 10:14:04.98	Regulatory3	Protocol3
3022	74	\N	\N	CV181-369	89	88	NEW	\N	General	Relevant Communications
2413	58	1558106079990:-63987421	1558106079188:703073060	ATMF_500Secstudy	52	51	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec18	1002
2418	58	1558106089106:-241269754	1558106088315:2015766085	ATMF_500Secstudy	57	56	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec19	1002
2423	58	1558106093154:-1407344743	1558106092383:1337177159	ATMF_500Secstudy	62	61	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec2	1002
2428	58	1558106097461:1786584351	1558106096633:2042706297	ATMF_500Secstudy	67	66	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec20	1002
2433	58	1558106101183:1655894444	1558106100418:2015715227	ATMF_500Secstudy	72	71	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec21	1002
2438	58	1558106104936:-1518422025	1558106104146:1988724363	ATMF_500Secstudy	77	76	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec22	1002
2443	58	1558106108670:-993153771	1558106107859:1961733499	ATMF_500Secstudy	82	81	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec23	1002
2448	58	1558106112647:-1838897690	1558106111687:1934753038	ATMF_500Secstudy	87	86	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec24	1002
2453	58	1558106116566:-422245180	1558106115724:-1047521233	ATMF_500Secstudy	92	91	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec25	1002
2458	58	1558106120394:610516613	1558106119587:-1074511994	ATMF_500Secstudy	97	96	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec26	1002
2409	58	1558106076754:-1706860598	1558106076044:-1851771346	ATMF_500Secstudy	48	47	ALREADY AVAILABLE	2019-07-02 09:27:15.23	1002	1003
2414	58	1558106086108:959061542	1558106079990:-63987421	ATMF_500Secstudy	53	52	ALREADY AVAILABLE	2019-07-02 09:27:15.23	1002	1003
2419	58	1558106090050:-811444488	1558106089106:-241269754	ATMF_500Secstudy	58	57	ALREADY AVAILABLE	2019-07-02 09:27:15.23	1002	1003
2424	58	1558106094434:1035353093	1558106093154:-1407344743	ATMF_500Secstudy	63	62	ALREADY AVAILABLE	2019-07-02 09:27:15.23	1002	1003
2429	58	1558106098207:-1576066672	1558106097461:1786584351	ATMF_500Secstudy	68	67	ALREADY AVAILABLE	2019-07-02 09:27:15.23	1002	1003
2434	58	1558106101976:-1074151030	1558106101183:1655894444	ATMF_500Secstudy	73	72	ALREADY AVAILABLE	2019-07-02 09:27:15.23	1002	1003
2439	58	1558106105657:-999341738	1558106104936:-1518422025	ATMF_500Secstudy	78	77	ALREADY AVAILABLE	2019-07-02 09:27:15.23	1002	1003
2444	58	1558106109472:-879158395	1558106108670:-993153771	ATMF_500Secstudy	83	82	ALREADY AVAILABLE	2019-07-02 09:27:15.23	1002	1003
2449	58	1558106113436:-1507103020	1558106112647:-1838897690	ATMF_500Secstudy	88	87	ALREADY AVAILABLE	2019-07-02 09:27:15.23	1002	1003
2454	58	1558106117367:1829056699	1558106116566:-422245180	ATMF_500Secstudy	93	92	ALREADY AVAILABLE	2019-07-02 09:27:15.23	1002	1003
2410	58	1558106077767:-676234931	1558106076754:-1706860598	ATMF_500Secstudy	49	48	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1003	1004
2415	58	1558106086858:-333046063	1558106086108:959061542	ATMF_500Secstudy	54	53	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1003	1004
2420	58	1558106090929:-669157813	1558106090050:-811444488	ATMF_500Secstudy	59	58	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1003	1004
2425	58	1558106095239:-269171463	1558106094434:1035353093	ATMF_500Secstudy	64	63	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1003	1004
2430	58	1558106098934:1944948156	1558106098207:-1576066672	ATMF_500Secstudy	69	68	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1003	1004
2435	58	1558106102726:1722279736	1558106101976:-1074151030	ATMF_500Secstudy	74	73	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2440	58	1558106106360:1421436472	1558106105657:-999341738	ATMF_500Secstudy	79	78	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2445	58	1558106110258:-1939049668	1558106109472:-879158395	ATMF_500Secstudy	84	83	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2450	58	1558106114148:-2087694856	1558106113436:-1507103020	ATMF_500Secstudy	89	88	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2455	58	1558106118096:1568748531	1558106117367:1829056699	ATMF_500Secstudy	94	93	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2460	58	1558106122524:821551738	1558106121495:878824752	ATMF_500Secstudy	99	98	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2411	58	1558106078548:-574177437	1558106077767:-676234931	ATMF_500Secstudy	50	49	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2416	58	1558106087662:1260940655	1558106086858:-333046063	ATMF_500Secstudy	55	54	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2421	58	1558106091720:630899882	1558106090929:-669157813	ATMF_500Secstudy	60	59	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2426	58	1558106095982:-484595727	1558106095239:-269171463	ATMF_500Secstudy	65	64	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2431	58	1558106099757:621011709	1558106098934:1944948156	ATMF_500Secstudy	70	69	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2436	58	1558106103450:1804657911	1558106102726:1722279736	ATMF_500Secstudy	75	74	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2441	58	1558106107165:1492404108	1558106106360:1421436472	ATMF_500Secstudy	80	79	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2446	58	1558106111030:-292953092	1558106110258:-1939049668	ATMF_500Secstudy	85	84	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2451	58	1558106115040:-451099819	1558106114148:-2087694856	ATMF_500Secstudy	90	89	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2456	58	1558106118840:-1521706949	1558106118096:1568748531	ATMF_500Secstudy	95	94	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2461	58	1558106123228:1960753067	1558106122524:821551738	ATMF_500Secstudy	100	99	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2868	60	1562148778069:-151890601	rootNode	ACQSIT02	1	0	CREATE	2019-07-03 12:12:58.464		Perf23
2869	60	1562148779127:1054915037	1562148778069:-151890601	ACQSIT02	2	1	CREATE	2019-07-03 12:12:59.61	Perf23	1002
2870	60	1562148780285:-1554740098	1562148779127:1054915037	ACQSIT02	3	2	CREATE	2019-07-03 12:13:00.833	1002	1003
2903	66	1582285473250:-515890331	1582285472141:1312331977	Acquiredstudy1	4	3	CREATE	2020-02-21 12:44:33.309	Monitoring3	Regulatory3
2915	69	1582534778498:523049040	1582534776616:804141793	ArchivingeTMFRegression	2	1	CREATE	2020-02-24 09:59:38.802	003	Correspondence3
2918	69	1582534783816:-1051955988	1582534782054:-1381377805	ArchivingeTMFRegression	5	4	CREATE	2020-02-24 09:59:44.15	Regulatory3	Protocol3
2922	70	1582534858766:-599043248	1582534857112:-385731040	AcqeTMFRegression2	4	3	CREATE	2020-02-24 10:00:59.098	Monitoring3	Regulatory3
2936	73	1582721092630:-744495178	1582721091750:825813289	Teststudy	3	2	CREATE	2020-02-26 13:44:52.7	Correspondence3	Monitoring3
2937	73	1582721093411:-1574357403	1582721092630:-744495178	Teststudy	4	3	CREATE	2020-02-26 13:44:53.486	Monitoring3	Regulatory3
2938	73	1582721094301:1089979896	1582721093411:-1574357403	Teststudy	5	4	CREATE	2020-02-26 13:44:54.37	Regulatory3	Protocol3
2942	74	\N	\N	CV181-369	4	3	NEW	\N	Site Selection	Pre Trial Monitoring Report
2943	74	\N	\N	CV181-369	84	3	NEW	\N	Site Selection	Confidentiality Agreement
2944	74	\N	\N	CV181-369	5	2	NEW	\N	Site Management	Site Set-up
2508	58	1558106166040:-1145009529	1558106164899:76184371	ATMF_500Secstudy	147	146	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec35	1002
2513	58	1558106169960:-775784756	1558106169040:-1290489970	ATMF_500Secstudy	152	151	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec36	1002
2518	58	1558106173685:746253919	1558106172917:22202334	ATMF_500Secstudy	157	156	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec37	1002
2523	58	1558106178215:-2015901293	1558106177305:-1344471492	ATMF_500Secstudy	162	161	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec38	1002
2528	58	1558106181846:425463756	1558106181075:-31779703	ATMF_500Secstudy	167	166	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec39	1002
2533	58	1558106185968:-335076266	1558106185194:-677219026	ATMF_500Secstudy	172	171	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec4	1002
2538	58	1558106189642:-1210243255	1558106188855:1334844398	ATMF_500Secstudy	177	176	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec40	1002
2543	58	1558106193481:-11401822	1558106192647:1307853534	ATMF_500Secstudy	182	181	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec41	1002
2548	58	1558106197172:-195688096	1558106196375:-58820086	ATMF_500Secstudy	187	186	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec42	1002
2553	58	1558106200941:-898654345	1558106200189:-85811053	ATMF_500Secstudy	192	191	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec43	1002
2509	58	1558106166807:219697469	1558106166040:-1145009529	ATMF_500Secstudy	148	147	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2514	58	1558106170683:-2083847462	1558106169960:-775784756	ATMF_500Secstudy	153	152	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2519	58	1558106174473:272595044	1558106173685:746253919	ATMF_500Secstudy	158	157	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2524	58	1558106178985:-1201521058	1558106178215:-2015901293	ATMF_500Secstudy	163	162	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2529	58	1558106182937:-1321281172	1558106181846:425463756	ATMF_500Secstudy	168	167	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2534	58	1558106186698:-887120670	1558106185968:-335076266	ATMF_500Secstudy	173	172	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2539	58	1558106190400:106428213	1558106189642:-1210243255	ATMF_500Secstudy	178	177	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2544	58	1558106194279:-2019843871	1558106193481:-11401822	ATMF_500Secstudy	183	182	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2549	58	1558106197902:1402025647	1558106197172:-195688096	ATMF_500Secstudy	188	187	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2554	58	1558106201717:432857670	1558106200941:-898654345	ATMF_500Secstudy	193	192	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2559	58	1558106205520:1128135262	1558106204678:-1519251887	ATMF_500Secstudy	198	197	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2510	58	1558106167619:-2058737966	1558106166807:219697469	ATMF_500Secstudy	149	148	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2515	58	1558106171429:2131815328	1558106170683:-2083847462	ATMF_500Secstudy	154	153	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2520	58	1558106175670:-1466619245	1558106174473:272595044	ATMF_500Secstudy	159	158	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2525	58	1558106179693:-79944863	1558106178985:-1201521058	ATMF_500Secstudy	164	163	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2530	58	1558106183656:1701928437	1558106182937:-1321281172	ATMF_500Secstudy	169	168	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2535	58	1558106187456:1405231082	1558106186698:-887120670	ATMF_500Secstudy	174	173	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2951	74	\N	\N	CV181-369	63	5	NEW	\N	Site Set-up	Acceptance of Investigator Brochure
2540	58	1558106191131:1639016813	1558106190400:106428213	ATMF_500Secstudy	179	178	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2545	58	1558106195052:2039079723	1558106194279:-2019843871	ATMF_500Secstudy	184	183	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2550	58	1558106198718:665630442	1558106197902:1402025647	ATMF_500Secstudy	189	188	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2555	58	1558106202462:-1660122091	1558106201717:432857670	ATMF_500Secstudy	194	193	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2506	58	1558106164241:-274000282	1558106163452:-1709026437	ATMF_500Secstudy	145	144	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2511	58	1558106168389:-735347783	1558106167619:-2058737966	ATMF_500Secstudy	150	149	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2516	58	1558106172264:1245800994	1558106171429:2131815328	ATMF_500Secstudy	155	154	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2521	58	1558106176609:1336404910	1558106175670:-1466619245	ATMF_500Secstudy	160	159	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2526	58	1558106180421:-11621411	1558106179693:-79944863	ATMF_500Secstudy	165	164	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2531	58	1558106184479:-758005607	1558106183656:1701928437	ATMF_500Secstudy	170	169	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2536	58	1558106188169:429709785	1558106187456:1405231082	ATMF_500Secstudy	175	174	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2541	58	1558106191882:-1093242332	1558106191131:1639016813	ATMF_500Secstudy	180	179	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2546	58	1558106195772:-1441532906	1558106195052:2039079723	ATMF_500Secstudy	185	184	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2551	58	1558106199542:2088719503	1558106198718:665630442	ATMF_500Secstudy	190	189	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2904	67	1582301674395:-877342942	rootNode	AcqeTMFRegression1	1	0	CREATE	2020-02-21 17:14:34.498		003
2905	67	1582301675307:-1206049022	1582301674395:-877342942	AcqeTMFRegression1	2	1	CREATE	2020-02-21 17:14:35.392	003	Correspondence3
2906	67	1582301676132:1313850423	1582301675307:-1206049022	AcqeTMFRegression1	3	2	CREATE	2020-02-21 17:14:36.212	Correspondence3	Monitoring3
2907	67	1582301677044:1959950069	1582301676132:1313850423	AcqeTMFRegression1	4	3	CREATE	2020-02-21 17:14:37.148	Monitoring3	Regulatory3
2908	67	1582301678003:1274223850	1582301677044:1959950069	AcqeTMFRegression1	5	4	CREATE	2020-02-21 17:14:38.098	Regulatory3	Protocol3
2929	72	1582535638174:-1944164916	rootNode	TS02eTMFUAT	1	0	CREATE	2020-02-24 10:13:58.511		003
2930	72	1582535639895:551347553	1582535638174:-1944164916	TS02eTMFUAT	2	1	CREATE	2020-02-24 10:14:00.205	003	Correspondence3
2931	72	1582535641787:-1512878045	1582535639895:551347553	TS02eTMFUAT	3	2	CREATE	2020-02-24 10:14:01.988	Correspondence3	Monitoring3
2939	74	\N	\N	CV181-369	1	0	NEW	\N		Site
2940	74	\N	\N	CV181-369	2	1	NEW	\N	Site	Site Management
2941	74	\N	\N	CV181-369	3	2	NEW	\N	Site Management	Site Selection
2603	58	1558106240472:544206950	1558106239607:1064885106	ATMF_500Secstudy	242	241	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec52	1002
2608	58	1558106244077:-1686258741	1558106243319:-1917388959	ATMF_500Secstudy	247	246	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec53	1002
2613	58	1558106248417:-1702765393	1558106247497:1010903172	ATMF_500Secstudy	252	251	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec54	1002
2618	58	1558106252653:248883723	1558106251867:-1971370790	ATMF_500Secstudy	257	256	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec55	1002
2623	58	1558106256453:166618590	1558106255650:-1998361654	ATMF_500Secstudy	262	261	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec56	1002
2628	58	1558106260170:-287973767	1558106259346:-2025341909	ATMF_500Secstudy	267	266	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec57	1002
2633	58	1558106270511:-1245120921	1558106263439:-2052332670	ATMF_500Secstudy	272	271	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec58	1002
2638	58	1558106274361:1203686609	1558106273564:875948131	ATMF_500Secstudy	277	276	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec59	1002
2643	58	1558106278050:1410213691	1558106277215:263658205	ATMF_500Secstudy	282	281	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec6	1002
2648	58	1558106282062:-1678404217	1558106281230:-712699639	ATMF_500Secstudy	287	286	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec60	1002
2653	58	1558106286210:237379465	1558106285383:-739690400	ATMF_500Secstudy	292	291	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec61	1002
2604	58	1558106241185:1336504161	1558106240472:544206950	ATMF_500Secstudy	243	242	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2609	58	1558106244848:854216955	1558106244077:-1686258741	ATMF_500Secstudy	248	247	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2614	58	1558106249549:1299435683	1558106248417:-1702765393	ATMF_500Secstudy	253	252	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2619	58	1558106253434:1182570273	1558106252653:248883723	ATMF_500Secstudy	258	257	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2624	58	1558106257158:-1439522183	1558106256453:166618590	ATMF_500Secstudy	263	262	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2629	58	1558106261196:-1368905796	1558106260170:-287973767	ATMF_500Secstudy	268	267	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2634	58	1558106271335:-481798401	1558106270511:-1245120921	ATMF_500Secstudy	273	272	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2639	58	1558106275083:-862134929	1558106274361:1203686609	ATMF_500Secstudy	278	277	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2644	58	1558106278916:-1325016904	1558106278050:1410213691	ATMF_500Secstudy	283	282	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2649	58	1558106282848:800746674	1558106282062:-1678404217	ATMF_500Secstudy	288	287	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2654	58	1558106286983:804956048	1558106286210:237379465	ATMF_500Secstudy	293	292	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2605	58	1558106241895:1569292178	1558106241185:1336504161	ATMF_500Secstudy	244	243	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2610	58	1558106245575:-906438556	1558106244848:854216955	ATMF_500Secstudy	249	248	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2615	58	1558106250394:-489441476	1558106249549:1299435683	ATMF_500Secstudy	254	253	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2620	58	1558106254190:2042298893	1558106253434:1182570273	ATMF_500Secstudy	259	258	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2952	74	\N	\N	CV181-369	68	5	NEW	\N	Site Set-up	Site Staff Qualification Supporting Information
2625	58	1558106257873:1729892589	1558106257158:-1439522183	ATMF_500Secstudy	264	263	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2630	58	1558106261973:1726455575	1558106261196:-1368905796	ATMF_500Secstudy	269	268	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2635	58	1558106272112:-903501714	1558106271335:-481798401	ATMF_500Secstudy	274	273	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2640	58	1558106275873:-201082201	1558106275083:-862134929	ATMF_500Secstudy	279	278	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2645	58	1558106279894:1131530011	1558106278916:-1325016904	ATMF_500Secstudy	284	283	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2650	58	1558106283950:-1714634729	1558106282848:800746674	ATMF_500Secstudy	289	288	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2606	58	1558106242681:540724424	1558106241895:1569292178	ATMF_500Secstudy	245	244	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2611	58	1558106246760:-2011488714	1558106245575:-906438556	ATMF_500Secstudy	250	249	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2616	58	1558106251199:13828197	1558106250394:-489441476	ATMF_500Secstudy	255	254	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2621	58	1558106254925:201896800	1558106254190:2042298893	ATMF_500Secstudy	260	259	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2626	58	1558106258655:286596703	1558106257873:1729892589	ATMF_500Secstudy	265	264	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2631	58	1558106262711:646147194	1558106261973:1726455575	ATMF_500Secstudy	270	269	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2636	58	1558106272892:-1543479220	1558106272112:-903501714	ATMF_500Secstudy	275	274	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2641	58	1558106276582:2111138126	1558106275873:-201082201	ATMF_500Secstudy	280	279	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2646	58	1558106280599:1934222637	1558106279894:1131530011	ATMF_500Secstudy	285	284	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2651	58	1558106284754:1734541215	1558106283950:-1714634729	ATMF_500Secstudy	290	289	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2656	58	1558106288661:1340720732	1558106287819:252520907	ATMF_500Secstudy	295	294	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2879	62	1558680203181:-165086948	rootNode	ATMF_25kdocs	1	0	ALREADY AVAILABLE	2019-07-03 14:01:42.272		00022_Index
2880	62	1562155304090:-1835135213	rootNode	ATMF_25kdocs	2	0	CREATE	2019-07-03 14:01:44.499		Perf24
2881	62	1562155305111:-1996460118	1562155304090:-1835135213	ATMF_25kdocs	3	2	CREATE	2019-07-03 14:01:45.319	Perf24	1002
2882	62	1562155305911:-391220447	1562155305111:-1996460118	ATMF_25kdocs	4	3	CREATE	2019-07-03 14:01:46.089	1002	1003
2883	62	1562155306651:174656952	1562155305911:-391220447	ATMF_25kdocs	5	4	CREATE	2019-07-03 14:01:47.141	1003	1004
2884	62	1562155307829:773955086	1562155306651:174656952	ATMF_25kdocs	6	5	CREATE	2019-07-03 14:01:48.11	1004	1005
2909	68	\N	\N	AcqeTMFRegression2	1	0	NEW	\N		003
2910	68	\N	\N	AcqeTMFRegression2	2	1	NEW	\N	003	Correspondence3
2911	68	\N	\N	AcqeTMFRegression2	3	2	NEW	\N	Correspondence3	Monitoring3
2912	68	\N	\N	AcqeTMFRegression2	4	3	NEW	\N	Monitoring3	Regulatory3
2913	68	\N	\N	AcqeTMFRegression2	5	4	NEW	\N	Regulatory3	Protocol3
4028	82	1611633574460:-545679261	rootNode	D5136C00008	1	0	CREATE	2021-01-26 04:59:34.564		01 Trial Management
4029	82	1611633575093:-524477315	1611633574460:-545679261	D5136C00008	2	1	CREATE	2021-01-26 04:59:35.179	01 Trial Management	01.01 Trial Oversight
4032	82	1611633577077:-797196868	1611633575093:-524477315	D5136C00008	5	2	CREATE	2021-01-26 04:59:37.164	01.01 Trial Oversight	01.01.03 Quality Plan
2703	58	1558106325794:-1578013945	1558106325040:411006274	ATMF_500Secstudy	342	341	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec70	1002
2708	58	1558106329707:542431936	1558106328625:-955669612	ATMF_500Secstudy	347	346	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec71	1002
2713	58	1558106333526:-222743871	1558106332707:-982660476	ATMF_500Secstudy	352	351	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec72	1002
2718	58	1558106337188:-1588699772	1558106336428:-1009651237	ATMF_500Secstudy	357	356	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec73	1002
2723	58	1558106341135:-1349355614	1558106340129:303042509	ATMF_500Secstudy	362	361	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec74	1002
2728	58	1558106344923:77712752	1558106344120:-1063633068	ATMF_500Secstudy	367	366	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec75	1002
2733	58	1558106349107:-1799038688	1558106348300:249060472	ATMF_500Secstudy	372	371	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec76	1002
2738	58	1558106352760:-1615602641	1558106352000:222069608	ATMF_500Secstudy	377	376	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec77	1002
2743	58	1558106356616:1270565465	1558106355721:-1144605660	ATMF_500Secstudy	382	381	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec78	1002
2748	58	1558106360321:-692395302	1558106359562:168087674	ATMF_500Secstudy	387	386	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec79	1002
2704	58	1558106326501:-263178352	1558106325794:-1578013945	ATMF_500Secstudy	343	342	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2709	58	1558106330561:-203959303	1558106329707:542431936	ATMF_500Secstudy	348	347	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2714	58	1558106334317:-1615284018	1558106333526:-222743871	ATMF_500Secstudy	353	352	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2719	58	1558106337888:-1816441324	1558106337188:-1588699772	ATMF_500Secstudy	358	357	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2724	58	1558106341949:1586701590	1558106341135:-1349355614	ATMF_500Secstudy	363	362	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2729	58	1558106345629:-39713730	1558106344923:77712752	ATMF_500Secstudy	368	367	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2734	58	1558106349890:863312386	1558106349107:-1799038688	ATMF_500Secstudy	373	372	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2739	58	1558106353532:-596517286	1558106352760:-1615602641	ATMF_500Secstudy	378	377	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2744	58	1558106357345:1890020067	1558106356616:1270565465	ATMF_500Secstudy	383	382	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2749	58	1558106361052:-604765242	1558106360321:-692395302	ATMF_500Secstudy	388	387	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2700	58	1558106323377:-1142956750	1558106322575:-1648826486	ATMF_500Secstudy	339	338	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2953	74	\N	\N	CV181-369	83	5	NEW	\N	Site Set-up	Clinical Trial Agreement
2705	58	1558106327220:-1925881447	1558106326501:-263178352	ATMF_500Secstudy	344	343	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2710	58	1558106331360:-1226145618	1558106330561:-203959303	ATMF_500Secstudy	349	348	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2715	58	1558106335032:-407666135	1558106334317:-1615284018	ATMF_500Secstudy	354	353	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2720	58	1558106338645:-1782153951	1558106337888:-1816441324	ATMF_500Secstudy	359	358	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2725	58	1558106342734:1946685357	1558106341949:1586701590	ATMF_500Secstudy	364	363	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2730	58	1558106346685:-920288430	1558106345629:-39713730	ATMF_500Secstudy	369	368	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2735	58	1558106350587:2039607883	1558106349890:863312386	ATMF_500Secstudy	374	373	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2740	58	1558106354300:-1065939095	1558106353532:-596517286	ATMF_500Secstudy	379	378	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2745	58	1558106358165:-2046674919	1558106357345:1890020067	ATMF_500Secstudy	384	383	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2701	58	1558106324336:-416380402	1558106323377:-1142956750	ATMF_500Secstudy	340	339	ALREADY AVAILABLE	2019-07-02 09:27:15.234	1004	1005
2706	58	1558106328008:311683824	1558106327220:-1925881447	ATMF_500Secstudy	345	344	ALREADY AVAILABLE	2019-07-02 09:27:15.234	1004	1005
2711	58	1558106332074:1581626296	1558106331360:-1226145618	ATMF_500Secstudy	350	349	ALREADY AVAILABLE	2019-07-02 09:27:15.234	1004	1005
2716	58	1558106335743:-1711727200	1558106335032:-407666135	ATMF_500Secstudy	355	354	ALREADY AVAILABLE	2019-07-02 09:27:15.234	1004	1005
2721	58	1558106339370:-939355477	1558106338645:-1782153951	ATMF_500Secstudy	360	359	ALREADY AVAILABLE	2019-07-02 09:27:15.234	1004	1005
2726	58	1558106343477:-1432008009	1558106342734:1946685357	ATMF_500Secstudy	365	364	ALREADY AVAILABLE	2019-07-02 09:27:15.234	1004	1005
2731	58	1558106347467:582248678	1558106346685:-920288430	ATMF_500Secstudy	370	369	ALREADY AVAILABLE	2019-07-02 09:27:15.234	1004	1005
2736	58	1558106351302:-131177344	1558106350587:2039607883	ATMF_500Secstudy	375	374	ALREADY AVAILABLE	2019-07-02 09:27:15.234	1004	1005
2741	58	1558106355073:-921192381	1558106354300:-1065939095	ATMF_500Secstudy	380	379	ALREADY AVAILABLE	2019-07-02 09:27:15.234	1004	1005
2746	58	1558106358914:751477581	1558106358165:-2046674919	ATMF_500Secstudy	385	384	ALREADY AVAILABLE	2019-07-02 09:27:15.234	1004	1005
2751	58	1558106362572:-182766043	1558106361850:1704540070	ATMF_500Secstudy	390	389	ALREADY AVAILABLE	2019-07-02 09:27:15.234	1004	1005
2885	63	\N	\N	Risk_study	1	0	NEW	\N		003
2886	63	\N	\N	Risk_study	2	1	NEW	\N	003	Correspondence3
2887	63	\N	\N	Risk_study	3	2	NEW	\N	Correspondence3	Monitoring3
2888	63	\N	\N	Risk_study	4	3	NEW	\N	Monitoring3	Regulatory3
2889	63	\N	\N	Risk_study	5	4	NEW	\N	Regulatory3	Protocol3
2914	69	1582534776616:804141793	rootNode	ArchivingeTMFRegression	1	0	CREATE	2020-02-24 09:59:36.906		003
2916	69	1582534780343:-55940106	1582534778498:523049040	ArchivingeTMFRegression	3	2	CREATE	2020-02-24 09:59:40.614	Correspondence3	Monitoring3
2917	69	1582534782054:-1381377805	1582534780343:-55940106	ArchivingeTMFRegression	4	3	CREATE	2020-02-24 09:59:42.359	Monitoring3	Regulatory3
2934	73	1582721090857:502700395	rootNode	Teststudy	1	0	CREATE	2020-02-26 13:44:50.955		003
3021	74	\N	\N	CV181-369	88	54	NEW	\N	IRB/IEC and other Approvals	General
2362	58	1558106041022:1746963128	rootNode	ATMF_500Secstudy	1	0	ALREADY AVAILABLE	2019-07-02 09:27:15.228		Sec1
2367	58	1558106044861:853466674	rootNode	ATMF_500Secstudy	6	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec10
2372	58	1558106048588:-202153780	rootNode	ATMF_500Secstudy	11	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec100
2377	58	1558106052358:892009829	rootNode	ATMF_500Secstudy	16	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec11
2382	58	1558106056219:865018759	rootNode	ATMF_500Secstudy	21	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec12
2387	58	1558106059879:-2117255821	rootNode	ATMF_500Secstudy	26	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec13
2392	58	1558106063653:811036825	rootNode	ATMF_500Secstudy	31	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec14
2397	58	1558106067452:2123729953	rootNode	ATMF_500Secstudy	36	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec15
2402	58	1558106071398:2096738986	rootNode	ATMF_500Secstudy	41	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec16
2407	58	1558106075290:2069748019	rootNode	ATMF_500Secstudy	46	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec17
2412	58	1558106079188:703073060	rootNode	ATMF_500Secstudy	51	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec18
2417	58	1558106088315:2015766085	rootNode	ATMF_500Secstudy	56	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec19
2422	58	1558106092383:1337177159	rootNode	ATMF_500Secstudy	61	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec2
2427	58	1558106096633:2042706297	rootNode	ATMF_500Secstudy	66	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec20
2432	58	1558106100418:2015715227	rootNode	ATMF_500Secstudy	71	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec21
2437	58	1558106104146:1988724363	rootNode	ATMF_500Secstudy	76	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec22
2442	58	1558106107859:1961733499	rootNode	ATMF_500Secstudy	81	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec23
2447	58	1558106111687:1934753038	rootNode	ATMF_500Secstudy	86	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec24
2452	58	1558106115724:-1047521233	rootNode	ATMF_500Secstudy	91	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec25
2457	58	1558106119587:-1074511994	rootNode	ATMF_500Secstudy	96	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec26
2807	58	1558106408308:729228220	rootNode	ATMF_500Secstudy	446	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec9
2798	58	1558106400060:699824707	1558106399185:1318784863	ATMF_500Secstudy	437	436	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec88	1002
2803	58	1558106405076:-1623753711	1558106404250:-47891023	ATMF_500Secstudy	442	441	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec89	1002
2808	58	1558106409138:-572845083	1558106408308:729228220	ATMF_500Secstudy	447	446	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec9	1002
2813	58	1558106413279:-1009262458	1558106412523:-1636549196	ATMF_500Secstudy	452	451	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec90	1002
2818	58	1558106417347:1234325873	1558106416499:1291742111	ATMF_500Secstudy	457	456	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec91	1002
2823	58	1558106421082:2100213991	1558106420304:1264751144	ATMF_500Secstudy	462	461	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec92	1002
2799	58	1558106400827:-1535537195	1558106400060:699824707	ATMF_500Secstudy	438	437	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2804	58	1558106405914:2032570101	1558106405076:-1623753711	ATMF_500Secstudy	443	442	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2809	58	1558106410296:-226792650	1558106409138:-572845083	ATMF_500Secstudy	448	447	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2814	58	1558106414034:-100503637	1558106413279:-1009262458	ATMF_500Secstudy	453	452	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2819	58	1558106418121:-754031935	1558106417347:1234325873	ATMF_500Secstudy	458	457	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2824	58	1558106421904:704474210	1558106421082:2100213991	ATMF_500Secstudy	463	462	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2829	58	1558106425609:1359589921	1558106424813:-2006560753	ATMF_500Secstudy	468	467	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2834	58	1558106429656:-1169669996	1558106428865:1775370744	ATMF_500Secstudy	473	472	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2800	58	1558106401994:1138418107	1558106400827:-1535537195	ATMF_500Secstudy	439	438	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2805	58	1558106406644:-142757630	1558106405914:2032570101	ATMF_500Secstudy	444	443	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2810	58	1558106411082:-1286522226	1558106410296:-226792650	ATMF_500Secstudy	449	448	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2815	58	1558106414826:-1933349611	1558106414034:-100503637	ATMF_500Secstudy	454	453	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2820	58	1558106418811:-1285820873	1558106418121:-754031935	ATMF_500Secstudy	459	458	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2825	58	1558106422632:-1095886731	1558106421904:704474210	ATMF_500Secstudy	464	463	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2830	58	1558106426372:-1432098096	1558106425609:1359589921	ATMF_500Secstudy	469	468	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2801	58	1558106403238:1447094376	1558106401994:1138418107	ATMF_500Secstudy	440	439	ALREADY AVAILABLE	2019-07-02 09:27:15.234	1004	1005
2806	58	1558106407532:164505907	1558106406644:-142757630	ATMF_500Secstudy	445	444	ALREADY AVAILABLE	2019-07-02 09:27:15.234	1004	1005
2811	58	1558106411814:-447468647	1558106411082:-1286522226	ATMF_500Secstudy	450	449	ALREADY AVAILABLE	2019-07-02 09:27:15.234	1004	1005
2816	58	1558106415879:248388563	1558106414826:-1933349611	ATMF_500Secstudy	455	454	ALREADY AVAILABLE	2019-07-02 09:27:15.235	1004	1005
2821	58	1558106419618:-2115798161	1558106418811:-1285820873	ATMF_500Secstudy	460	459	ALREADY AVAILABLE	2019-07-02 09:27:15.235	1004	1005
2826	58	1558106423317:-357930266	1558106422632:-1095886731	ATMF_500Secstudy	465	464	ALREADY AVAILABLE	2019-07-02 09:27:15.235	1004	1005
2831	58	1558106427189:2042383192	1558106426372:-1432098096	ATMF_500Secstudy	470	469	ALREADY AVAILABLE	2019-07-02 09:27:15.235	1004	1005
2462	58	1558106124524:1853780137	rootNode	ATMF_500Secstudy	101	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec27
2467	58	1558106128323:1826789376	rootNode	ATMF_500Secstudy	106	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec28
2472	58	1558106137939:-1155484998	rootNode	ATMF_500Secstudy	111	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec29
2477	58	1558106141942:1137784336	rootNode	ATMF_500Secstudy	116	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec3
2482	58	1558106145735:211139206	rootNode	ATMF_500Secstudy	121	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec30
2487	58	1558106149567:184148342	rootNode	ATMF_500Secstudy	126	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec31
2492	58	1558106153595:-1182526514	rootNode	ATMF_500Secstudy	131	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec32
2497	58	1558106157248:130166408	rootNode	ATMF_500Secstudy	136	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec33
2502	58	1558106161074:-1236508345	rootNode	ATMF_500Secstudy	141	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec34
2507	58	1558106164899:76184371	rootNode	ATMF_500Secstudy	146	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec35
2512	58	1558106169040:-1290489970	rootNode	ATMF_500Secstudy	151	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec36
2517	58	1558106172917:22202334	rootNode	ATMF_500Secstudy	156	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec37
2522	58	1558106177305:-1344471492	rootNode	ATMF_500Secstudy	161	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec38
2527	58	1558106181075:-31779703	rootNode	ATMF_500Secstudy	166	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec39
2532	58	1558106185194:-677219026	rootNode	ATMF_500Secstudy	171	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec4
2537	58	1558106188855:1334844398	rootNode	ATMF_500Secstudy	176	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec40
2542	58	1558106192647:1307853534	rootNode	ATMF_500Secstudy	181	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec41
2547	58	1558106196375:-58820086	rootNode	ATMF_500Secstudy	186	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec42
2552	58	1558106200189:-85811053	rootNode	ATMF_500Secstudy	191	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec43
2557	58	1558106203871:-112802020	rootNode	ATMF_500Secstudy	196	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec44
2562	58	1558106208300:1199889872	rootNode	ATMF_500Secstudy	201	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec45
2567	58	1558106212112:1172899008	rootNode	ATMF_500Secstudy	206	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec46
2572	58	1558106216123:1145908041	rootNode	ATMF_500Secstudy	211	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec47
2577	58	1558106219958:1118917383	rootNode	ATMF_500Secstudy	216	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec48
2582	58	1558106223758:-247756855	rootNode	ATMF_500Secstudy	221	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec49
2587	58	1558106227743:463062049	rootNode	ATMF_500Secstudy	226	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec5
2592	58	1558106231791:-1836416470	rootNode	ATMF_500Secstudy	231	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec50
2597	58	1558106235411:-1863407334	rootNode	ATMF_500Secstudy	236	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec51
2602	58	1558106239607:1064885106	rootNode	ATMF_500Secstudy	241	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec52
2607	58	1558106243319:-1917388959	rootNode	ATMF_500Secstudy	246	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec53
2612	58	1558106247497:1010903172	rootNode	ATMF_500Secstudy	251	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec54
2617	58	1558106251867:-1971370790	rootNode	ATMF_500Secstudy	256	0	ALREADY AVAILABLE	2019-07-02 09:27:15.229		Sec55
2622	58	1558106255650:-1998361654	rootNode	ATMF_500Secstudy	261	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec56
2627	58	1558106259346:-2025341909	rootNode	ATMF_500Secstudy	266	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec57
2632	58	1558106263439:-2052332670	rootNode	ATMF_500Secstudy	271	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec58
2637	58	1558106273564:875948131	rootNode	ATMF_500Secstudy	276	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec59
2642	58	1558106277215:263658205	rootNode	ATMF_500Secstudy	281	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec6
2647	58	1558106281230:-712699639	rootNode	ATMF_500Secstudy	286	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec60
2652	58	1558106285383:-739690400	rootNode	ATMF_500Secstudy	291	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec61
2657	58	1558106289381:-2106366492	rootNode	ATMF_500Secstudy	296	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec62
2662	58	1558106293723:-2133357562	rootNode	ATMF_500Secstudy	301	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec63
2667	58	1558106297734:2134618973	rootNode	ATMF_500Secstudy	306	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec64
2672	58	1558106301610:-847654165	rootNode	ATMF_500Secstudy	311	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec65
2677	58	1558106305296:-874644926	rootNode	ATMF_500Secstudy	316	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec66
2682	58	1558106309314:-901635687	rootNode	ATMF_500Secstudy	321	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec67
2687	58	1558106313197:-928626448	rootNode	ATMF_500Secstudy	326	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec68
2692	58	1558106317321:1999664241	rootNode	ATMF_500Secstudy	331	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec69
2697	58	1558106321038:1403949168	rootNode	ATMF_500Secstudy	336	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec7
2702	58	1558106325040:411006274	rootNode	ATMF_500Secstudy	341	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec70
2707	58	1558106328625:-955669612	rootNode	ATMF_500Secstudy	346	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec71
2712	58	1558106332707:-982660476	rootNode	ATMF_500Secstudy	351	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec72
2717	58	1558106336428:-1009651237	rootNode	ATMF_500Secstudy	356	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec73
2722	58	1558106340129:303042509	rootNode	ATMF_500Secstudy	361	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec74
2727	58	1558106344120:-1063633068	rootNode	ATMF_500Secstudy	366	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec75
2732	58	1558106348300:249060472	rootNode	ATMF_500Secstudy	371	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec76
2737	58	1558106352000:222069608	rootNode	ATMF_500Secstudy	376	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec77
2742	58	1558106355721:-1144605660	rootNode	ATMF_500Secstudy	381	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec78
2747	58	1558106359562:168087674	rootNode	ATMF_500Secstudy	386	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec79
2752	58	1558106363224:-411052546	rootNode	ATMF_500Secstudy	391	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec8
2757	58	1558106366902:195027474	rootNode	ATMF_500Secstudy	396	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec80
2762	58	1558106372945:1507720911	rootNode	ATMF_500Secstudy	401	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec81
2767	58	1558106376726:141045437	rootNode	ATMF_500Secstudy	406	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec82
2772	58	1558106380513:1453739183	rootNode	ATMF_500Secstudy	411	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec83
2777	58	1558106384168:1426748319	rootNode	ATMF_500Secstudy	416	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec84
2782	58	1558106387987:60072742	rootNode	ATMF_500Secstudy	421	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec85
2787	58	1558106391781:1372766591	rootNode	ATMF_500Secstudy	426	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec86
2792	58	1558106395438:1345775624	rootNode	ATMF_500Secstudy	431	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec87
2797	58	1558106399185:1318784863	rootNode	ATMF_500Secstudy	436	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec88
2802	58	1558106404250:-47891023	rootNode	ATMF_500Secstudy	441	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec89
2812	58	1558106412523:-1636549196	rootNode	ATMF_500Secstudy	451	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec90
2817	58	1558106416499:1291742111	rootNode	ATMF_500Secstudy	456	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec91
2822	58	1558106420304:1264751144	rootNode	ATMF_500Secstudy	461	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec92
2827	58	1558106424037:-1717511591	rootNode	ATMF_500Secstudy	466	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec93
2832	58	1558106427834:-1744502352	rootNode	ATMF_500Secstudy	471	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec94
2837	58	1558106432208:-1771493216	rootNode	ATMF_500Secstudy	476	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec95
2842	58	1558106435851:-1798483977	rootNode	ATMF_500Secstudy	481	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec96
2847	58	1558106439547:1129796206	rootNode	ATMF_500Secstudy	486	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec97
2852	58	1558106443161:-1852465705	rootNode	ATMF_500Secstudy	491	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec98
2857	58	1558106447086:-1879456363	rootNode	ATMF_500Secstudy	496	0	ALREADY AVAILABLE	2019-07-02 09:27:15.23		Sec99
2363	58	1558106041846:-803107606	1558106041022:1746963128	ATMF_500Secstudy	2	1	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec1	1002
2368	58	1558106045636:-1575889553	1558106044861:853466674	ATMF_500Secstudy	7	6	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec10	1002
2373	58	1558106049402:-971586618	1558106048588:-202153780	ATMF_500Secstudy	12	11	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec100	1002
2393	58	1558106064446:1301066494	1558106063653:811036825	ATMF_500Secstudy	32	31	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec14	1002
2398	58	1558106068243:124608026	1558106067452:2123729953	ATMF_500Secstudy	37	36	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec15	1002
2408	58	1558106076044:-1851771346	1558106075290:2069748019	ATMF_500Secstudy	47	46	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec17	1002
2463	58	1558106125364:-1512355022	1558106124524:1853780137	ATMF_500Secstudy	102	101	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec27	1002
2468	58	1558106129061:1075235551	1558106128323:1826789376	ATMF_500Secstudy	107	106	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec28	1002
2954	74	\N	\N	CV181-369	95	5	NEW	\N	Site Set-up	Other Curriculum Vitae
2473	58	1558106138929:1403405649	1558106137939:-1155484998	ATMF_500Secstudy	112	111	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec29	1002
2478	58	1558106142805:-1412225768	1558106141942:1137784336	ATMF_500Secstudy	117	116	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec3	1002
2483	58	1558106146529:156078982	1558106145735:211139206	ATMF_500Secstudy	122	121	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec30	1002
2488	58	1558106150339:874825947	1558106149567:184148342	ATMF_500Secstudy	127	126	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec31	1002
2493	58	1558106154356:-1427090832	1558106153595:-1182526514	ATMF_500Secstudy	132	131	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec32	1002
2498	58	1558106158009:1938361	1558106157248:130166408	ATMF_500Secstudy	137	136	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec33	1002
2503	58	1558106161889:2090075482	1558106161074:-1236508345	ATMF_500Secstudy	142	141	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec34	1002
2558	58	1558106204678:-1519251887	1558106203871:-112802020	ATMF_500Secstudy	197	196	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec44	1002
2563	58	1558106209218:2103633211	1558106208300:1199889872	ATMF_500Secstudy	202	201	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec45	1002
2568	58	1558106212929:1117453972	1558106212112:1172899008	ATMF_500Secstudy	207	206	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec46	1002
2573	58	1558106216997:-724696861	1558106216123:1145908041	ATMF_500Secstudy	212	211	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec47	1002
2578	58	1558106220707:796348264	1558106219958:1118917383	ATMF_500Secstudy	217	216	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec48	1002
2583	58	1558106224540:84592556	1558106223758:-247756855	ATMF_500Secstudy	222	221	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec49	1002
2588	58	1558106228594:-1750890886	1558106227743:463062049	ATMF_500Secstudy	227	226	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec5	1002
2593	58	1558106232555:-1189990778	1558106231791:-1836416470	ATMF_500Secstudy	232	231	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec50	1002
2598	58	1558106236196:-100121452	1558106235411:-1863407334	ATMF_500Secstudy	237	236	ALREADY AVAILABLE	2019-07-02 09:27:15.229	Sec51	1002
2658	58	1558106290147:1765907887	1558106289381:-2106366492	ATMF_500Secstudy	297	296	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec62	1002
2663	58	1558106294827:78356752	1558106293723:-2133357562	ATMF_500Secstudy	302	301	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec63	1002
2668	58	1558106298492:-930802559	1558106297734:2134618973	ATMF_500Secstudy	307	306	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec64	1002
2673	58	1558106302362:-471329849	1558106301610:-847654165	ATMF_500Secstudy	312	311	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec65	1002
2678	58	1558106306150:1405552659	1558106305296:-874644926	ATMF_500Secstudy	317	316	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec66	1002
2683	58	1558106310123:-770035585	1558106309314:-901635687	ATMF_500Secstudy	322	321	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec67	1002
2688	58	1558106314031:1152902316	1558106313197:-928626448	ATMF_500Secstudy	327	326	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec68	1002
2693	58	1558106318073:1927728829	1558106317321:1999664241	ATMF_500Secstudy	332	331	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec69	1002
2698	58	1558106321833:-2033249594	1558106321038:1403949168	ATMF_500Secstudy	337	336	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec7	1002
2753	58	1558106364073:49837412	1558106363224:-411052546	ATMF_500Secstudy	392	391	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec8	1002
2758	58	1558106367680:544232541	1558106366902:195027474	ATMF_500Secstudy	397	396	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec80	1002
2763	58	1558106373700:1618799960	1558106372945:1507720911	ATMF_500Secstudy	402	401	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec81	1002
2768	58	1558106377564:-1845507061	1558106376726:141045437	ATMF_500Secstudy	407	406	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec82	1002
2773	58	1558106381292:-826766703	1558106380513:1453739183	ATMF_500Secstudy	412	411	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec83	1002
2778	58	1558106385125:-1503146226	1558106384168:1426748319	ATMF_500Secstudy	417	416	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec84	1002
2783	58	1558106388736:2127497680	1558106387987:60072742	ATMF_500Secstudy	422	421	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec85	1002
2788	58	1558106392610:780711173	1558106391781:1372766591	ATMF_500Secstudy	427	426	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec86	1002
2793	58	1558106396250:-1442452664	1558106395438:1345775624	ATMF_500Secstudy	432	431	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec87	1002
2828	58	1558106424813:-2006560753	1558106424037:-1717511591	ATMF_500Secstudy	467	466	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec93	1002
2833	58	1558106428865:1775370744	1558106427834:-1744502352	ATMF_500Secstudy	472	471	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec94	1002
2838	58	1558106432948:-9373110	1558106432208:-1771493216	ATMF_500Secstudy	477	476	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec95	1002
2843	58	1558106436616:-431604393	1558106435851:-1798483977	ATMF_500Secstudy	482	481	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec96	1002
2848	58	1558106440303:386049724	1558106439547:1129796206	ATMF_500Secstudy	487	486	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec97	1002
2853	58	1558106444198:974349546	1558106443161:-1852465705	ATMF_500Secstudy	492	491	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec98	1002
2858	58	1558106447880:-344866830	1558106447086:-1879456363	ATMF_500Secstudy	497	496	ALREADY AVAILABLE	2019-07-02 09:27:15.23	Sec99	1002
2364	58	1558106042621:-1512592502	1558106041846:-803107606	ATMF_500Secstudy	3	2	ALREADY AVAILABLE	2019-07-02 09:27:15.23	1002	1003
2369	58	1558106046368:-1052977442	1558106045636:-1575889553	ATMF_500Secstudy	8	7	ALREADY AVAILABLE	2019-07-02 09:27:15.23	1002	1003
2374	58	1558106050126:298457950	1558106049402:-971586618	ATMF_500Secstudy	13	12	ALREADY AVAILABLE	2019-07-02 09:27:15.23	1002	1003
2389	58	1558106061482:1394749499	1558106060709:304674559	ATMF_500Secstudy	28	27	ALREADY AVAILABLE	2019-07-02 09:27:15.23	1002	1003
2394	58	1558106065183:-2137240293	1558106064446:1301066494	ATMF_500Secstudy	33	32	ALREADY AVAILABLE	2019-07-02 09:27:15.23	1002	1003
2404	58	1558106073024:-37276044	1558106072215:-25862764	ATMF_500Secstudy	43	42	ALREADY AVAILABLE	2019-07-02 09:27:15.23	1002	1003
2459	58	1558106121495:878824752	1558106120394:610516613	ATMF_500Secstudy	98	97	ALREADY AVAILABLE	2019-07-02 09:27:15.23	1002	1003
2464	58	1558106126136:-293386120	1558106125364:-1512355022	ATMF_500Secstudy	103	102	ALREADY AVAILABLE	2019-07-02 09:27:15.23	1002	1003
2955	74	\N	\N	CV181-369	96	5	NEW	\N	Site Set-up	Financial Disclosure Form
2469	58	1558106129798:1903781748	1558106129061:1075235551	ATMF_500Secstudy	108	107	ALREADY AVAILABLE	2019-07-02 09:27:15.23	1002	1003
2474	58	1558106139667:-326058310	1558106138929:1403405649	ATMF_500Secstudy	113	112	ALREADY AVAILABLE	2019-07-02 09:27:15.23	1002	1003
2479	58	1558106143519:1069067593	1558106142805:-1412225768	ATMF_500Secstudy	118	117	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2484	58	1558106147262:-1890042304	1558106146529:156078982	ATMF_500Secstudy	123	122	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2489	58	1558106151162:-842805861	1558106150339:874825947	ATMF_500Secstudy	128	127	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2494	58	1558106155055:345171574	1558106154356:-1427090832	ATMF_500Secstudy	133	132	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2499	58	1558106158871:-1905736111	1558106158009:1938361	ATMF_500Secstudy	138	137	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2504	58	1558106162704:-178991037	1558106161889:2090075482	ATMF_500Secstudy	143	142	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2564	58	1558106210003:-690431507	1558106209218:2103633211	ATMF_500Secstudy	203	202	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2569	58	1558106213647:-344314355	1558106212929:1117453972	ATMF_500Secstudy	208	207	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2574	58	1558106217745:885631587	1558106216997:-724696861	ATMF_500Secstudy	213	212	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2579	58	1558106221460:471398737	1558106220707:796348264	ATMF_500Secstudy	218	217	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2584	58	1558106225476:-302449313	1558106224540:84592556	ATMF_500Secstudy	223	222	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2589	58	1558106229658:1710065290	1558106228594:-1750890886	ATMF_500Secstudy	228	227	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2594	58	1558106233273:-1960081921	1558106232555:-1189990778	ATMF_500Secstudy	233	232	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2599	58	1558106236971:-1574951622	1558106236196:-100121452	ATMF_500Secstudy	238	237	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2659	58	1558106290857:-1838182699	1558106290147:1765907887	ATMF_500Secstudy	298	297	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2664	58	1558106295520:-1115358761	1558106294827:78356752	ATMF_500Secstudy	303	302	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2669	58	1558106299218:-755350377	1558106298492:-930802559	ATMF_500Secstudy	308	307	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2674	58	1558106303141:1109824842	1558106302362:-471329849	ATMF_500Secstudy	313	312	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2679	58	1558106306931:-1032594898	1558106306150:1405552659	ATMF_500Secstudy	318	317	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2684	58	1558106310927:1136714601	1558106310123:-770035585	ATMF_500Secstudy	323	322	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2689	58	1558106314760:1600824318	1558106314031:1152902316	ATMF_500Secstudy	328	327	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2694	58	1558106318857:198092454	1558106318073:1927728829	ATMF_500Secstudy	333	332	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2699	58	1558106322575:-1648826486	1558106321833:-2033249594	ATMF_500Secstudy	338	337	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2754	58	1558106364813:993265664	1558106364073:49837412	ATMF_500Secstudy	393	392	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2759	58	1558106368433:-1791619042	1558106367680:544232541	ATMF_500Secstudy	398	397	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2764	58	1558106374453:1939507307	1558106373700:1618799960	ATMF_500Secstudy	403	402	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2769	58	1558106378363:-1448342169	1558106377564:-1845507061	ATMF_500Secstudy	408	407	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2774	58	1558106382008:1759667089	1558106381292:-826766703	ATMF_500Secstudy	413	412	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2779	58	1558106385858:1498311834	1558106385125:-1503146226	ATMF_500Secstudy	418	417	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2784	58	1558106389674:1885869080	1558106388736:2127497680	ATMF_500Secstudy	423	422	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2789	58	1558106393310:1464481687	1558106392610:780711173	ATMF_500Secstudy	428	427	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2794	58	1558106396977:-165025419	1558106396250:-1442452664	ATMF_500Secstudy	433	432	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2839	58	1558106433679:-1716241849	1558106432948:-9373110	ATMF_500Secstudy	478	477	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2844	58	1558106437445:238585739	1558106436616:-431604393	ATMF_500Secstudy	483	482	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2849	58	1558106441007:-2134230308	1558106440303:386049724	ATMF_500Secstudy	488	487	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2854	58	1558106444920:-1893422226	1558106444198:974349546	ATMF_500Secstudy	493	492	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2859	58	1558106455723:28747854	1558106447880:-344866830	ATMF_500Secstudy	498	497	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1002	1003
2365	58	1558106043375:335112201	1558106042621:-1512592502	ATMF_500Secstudy	4	3	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1003	1004
2370	58	1558106047148:-817698127	1558106046368:-1052977442	ATMF_500Secstudy	9	8	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1003	1004
2375	58	1558106050901:1875601594	1558106050126:298457950	ATMF_500Secstudy	14	13	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1003	1004
2390	58	1558106062274:-1752604892	1558106061482:1394749499	ATMF_500Secstudy	29	28	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1003	1004
2395	58	1558106066004:-1580541266	1558106065183:-2137240293	ATMF_500Secstudy	34	33	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1003	1004
2405	58	1558106073822:-1713094612	1558106073024:-37276044	ATMF_500Secstudy	44	43	ALREADY AVAILABLE	2019-07-02 09:27:15.231	1003	1004
2465	58	1558106126850:625403838	1558106126136:-293386120	ATMF_500Secstudy	104	103	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2470	58	1558106130899:-1186436101	1558106129798:1903781748	ATMF_500Secstudy	109	108	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2475	58	1558106140432:478235459	1558106139667:-326058310	ATMF_500Secstudy	114	113	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2480	58	1558106144220:-329773662	1558106143519:1069067593	ATMF_500Secstudy	119	118	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2956	74	\N	\N	CV181-369	97	5	NEW	\N	Site Set-up	Form FDA 1572
2485	58	1558106148101:124520775	1558106147262:-1890042304	ATMF_500Secstudy	124	123	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2490	58	1558106151880:-1008321839	1558106151162:-842805861	ATMF_500Secstudy	129	128	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2495	58	1558106155841:-1817196547	1558106155055:345171574	ATMF_500Secstudy	134	133	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2500	58	1558106159664:-764662128	1558106158871:-1905736111	ATMF_500Secstudy	139	138	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2505	58	1558106163452:-1709026437	1558106162704:-178991037	ATMF_500Secstudy	144	143	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2560	58	1558106206211:1072491087	1558106205520:1128135262	ATMF_500Secstudy	199	198	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2565	58	1558106210710:-173333509	1558106210003:-690431507	ATMF_500Secstudy	204	203	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2570	58	1558106214454:1015864155	1558106213647:-344314355	ATMF_500Secstudy	209	208	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2575	58	1558106218505:1535498318	1558106217745:885631587	ATMF_500Secstudy	214	213	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2580	58	1558106222315:1846345547	1558106221460:471398737	ATMF_500Secstudy	219	218	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2585	58	1558106226330:1861850324	1558106225476:-302449313	ATMF_500Secstudy	224	223	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2590	58	1558106230375:-1813699271	1558106229658:1710065290	ATMF_500Secstudy	229	228	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2595	58	1558106233986:-1668214939	1558106233273:-1960081921	ATMF_500Secstudy	234	233	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2600	58	1558106237873:-1032721091	1558106236971:-1574951622	ATMF_500Secstudy	239	238	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2655	58	1558106287819:252520907	1558106286983:804956048	ATMF_500Secstudy	294	293	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2660	58	1558106291651:1694475243	1558106290857:-1838182699	ATMF_500Secstudy	299	298	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2665	58	1558106296265:593739706	1558106295520:-1115358761	ATMF_500Secstudy	304	303	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2670	58	1558106299949:2034662489	1558106299218:-755350377	ATMF_500Secstudy	309	308	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2675	58	1558106303849:425853857	1558106303141:1109824842	ATMF_500Secstudy	314	313	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2680	58	1558106307705:-1097853502	1558106306931:-1032594898	ATMF_500Secstudy	319	318	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2685	58	1558106311654:10801968	1558106310927:1136714601	ATMF_500Secstudy	324	323	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2690	58	1558106315659:11490092	1558106314760:1600824318	ATMF_500Secstudy	329	328	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2695	58	1558106319630:1314216253	1558106318857:198092454	ATMF_500Secstudy	334	333	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2750	58	1558106361850:1704540070	1558106361052:-604765242	ATMF_500Secstudy	389	388	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2755	58	1558106365541:1513942882	1558106364813:993265664	ATMF_500Secstudy	394	393	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2760	58	1558106369170:1957457467	1558106368433:-1791619042	ATMF_500Secstudy	399	398	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2765	58	1558106375262:1914706043	1558106374453:1939507307	ATMF_500Secstudy	404	403	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2770	58	1558106379089:-1938275476	1558106378363:-1448342169	ATMF_500Secstudy	409	408	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2775	58	1558106382722:-1174880869	1558106382008:1759667089	ATMF_500Secstudy	414	413	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2780	58	1558106386625:1989786221	1558106385858:1498311834	ATMF_500Secstudy	419	418	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2785	58	1558106390429:-1865152407	1558106389674:1885869080	ATMF_500Secstudy	424	423	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2790	58	1558106394075:204580112	1558106393310:1464481687	ATMF_500Secstudy	429	428	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2795	58	1558106397701:-1108832876	1558106396977:-165025419	ATMF_500Secstudy	434	433	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2835	58	1558106430401:1300868013	1558106429656:-1169669996	ATMF_500Secstudy	474	473	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2840	58	1558106434373:546342800	1558106433679:-1716241849	ATMF_500Secstudy	479	478	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2845	58	1558106438158:1303251032	1558106437445:238585739	ATMF_500Secstudy	484	483	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2850	58	1558106441743:-1115950362	1558106441007:-2134230308	ATMF_500Secstudy	489	488	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2855	58	1558106445624:793166518	1558106444920:-1893422226	ATMF_500Secstudy	494	493	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2860	58	1558106456691:-351309031	1558106455723:28747854	ATMF_500Secstudy	499	498	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1003	1004
2366	58	1558106044193:-200757467	1558106043375:335112201	ATMF_500Secstudy	5	4	ALREADY AVAILABLE	2019-07-02 09:27:15.232	1004	1005
2371	58	1558106047925:1031169766	1558106047148:-817698127	ATMF_500Secstudy	10	9	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2376	58	1558106051657:-2014294710	1558106050901:1875601594	ATMF_500Secstudy	15	14	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2391	58	1558106063008:-1319645450	1558106062274:-1752604892	ATMF_500Secstudy	30	29	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2396	58	1558106066789:700541302	1558106066004:-1580541266	ATMF_500Secstudy	35	34	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2406	58	1558106074606:-1823319366	1558106073822:-1713094612	ATMF_500Secstudy	45	44	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2466	58	1558106127603:1722438367	1558106126850:625403838	ATMF_500Secstudy	105	104	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2471	58	1558106137131:2090845825	1558106130899:-1186436101	ATMF_500Secstudy	110	109	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2476	58	1558106141152:276096188	1558106140432:478235459	ATMF_500Secstudy	115	114	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2481	58	1558106144976:746358668	1558106144220:-329773662	ATMF_500Secstudy	120	119	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2957	74	\N	\N	CV181-369	108	5	NEW	\N	Site Set-up	IP Site Release Documentation
2486	58	1558106148873:-195584126	1558106148101:124520775	ATMF_500Secstudy	125	124	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2491	58	1558106152955:1705438833	1558106151880:-1008321839	ATMF_500Secstudy	130	129	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2496	58	1558106156580:-613215660	1558106155841:-1817196547	ATMF_500Secstudy	135	134	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2501	58	1558106160366:-884221597	1558106159664:-764662128	ATMF_500Secstudy	140	139	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2556	58	1558106203216:1307026975	1558106202462:-1660122091	ATMF_500Secstudy	195	194	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2561	58	1558106206921:203438355	1558106206211:1072491087	ATMF_500Secstudy	200	199	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2566	58	1558106211430:-1119174860	1558106210710:-173333509	ATMF_500Secstudy	205	204	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2571	58	1558106215420:-1339118781	1558106214454:1015864155	ATMF_500Secstudy	210	209	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2576	58	1558106219271:-1149802577	1558106218505:1535498318	ATMF_500Secstudy	215	214	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2581	58	1558106223095:-1955968025	1558106222315:1846345547	ATMF_500Secstudy	220	219	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2586	58	1558106227067:468229918	1558106226330:1861850324	ATMF_500Secstudy	225	224	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2591	58	1558106231129:229350304	1558106230375:-1813699271	ATMF_500Secstudy	230	229	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2596	58	1558106234762:194302131	1558106233986:-1668214939	ATMF_500Secstudy	235	234	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2601	58	1558106238622:-1383600399	1558106237873:-1032721091	ATMF_500Secstudy	240	239	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2661	58	1558106292409:-1024474009	1558106291651:1694475243	ATMF_500Secstudy	300	299	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2666	58	1558106297011:245191508	1558106296265:593739706	ATMF_500Secstudy	305	304	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2671	58	1558106300987:1609240493	1558106299949:2034662489	ATMF_500Secstudy	310	309	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2676	58	1558106304583:-1553890632	1558106303849:425853857	ATMF_500Secstudy	315	314	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2681	58	1558106308668:1146674799	1558106307705:-1097853502	ATMF_500Secstudy	320	319	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2686	58	1558106312575:1546335889	1558106311654:10801968	ATMF_500Secstudy	325	324	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2691	58	1558106316560:-1165065293	1558106315659:11490092	ATMF_500Secstudy	330	329	ALREADY AVAILABLE	2019-07-02 09:27:15.233	1004	1005
2696	58	1558106320354:1706141123	1558106319630:1314216253	ATMF_500Secstudy	335	334	ALREADY AVAILABLE	2019-07-02 09:27:15.234	1004	1005
2756	58	1558106366265:-693531261	1558106365541:1513942882	ATMF_500Secstudy	395	394	ALREADY AVAILABLE	2019-07-02 09:27:15.234	1004	1005
2761	58	1558106371525:-164819796	1558106369170:1957457467	ATMF_500Secstudy	400	399	ALREADY AVAILABLE	2019-07-02 09:27:15.234	1004	1005
2766	58	1558106376045:2112130487	1558106375262:1914706043	ATMF_500Secstudy	405	404	ALREADY AVAILABLE	2019-07-02 09:27:15.234	1004	1005
2771	58	1558106379905:-532922536	1558106379089:-1938275476	ATMF_500Secstudy	410	409	ALREADY AVAILABLE	2019-07-02 09:27:15.234	1004	1005
2776	58	1558106383482:-559446930	1558106382722:-1174880869	ATMF_500Secstudy	415	414	ALREADY AVAILABLE	2019-07-02 09:27:15.234	1004	1005
2781	58	1558106387356:-67976875	1558106386625:1989786221	ATMF_500Secstudy	420	419	ALREADY AVAILABLE	2019-07-02 09:27:15.234	1004	1005
2786	58	1558106391133:-1337863478	1558106390429:-1865152407	ATMF_500Secstudy	425	424	ALREADY AVAILABLE	2019-07-02 09:27:15.234	1004	1005
2791	58	1558106394805:-1265803815	1558106394075:204580112	ATMF_500Secstudy	430	429	ALREADY AVAILABLE	2019-07-02 09:27:15.234	1004	1005
2796	58	1558106398463:931764111	1558106397701:-1108832876	ATMF_500Secstudy	435	434	ALREADY AVAILABLE	2019-07-02 09:27:15.234	1004	1005
2836	58	1558106431449:1618414074	1558106430401:1300868013	ATMF_500Secstudy	475	474	ALREADY AVAILABLE	2019-07-02 09:27:15.235	1004	1005
2841	58	1558106435153:-185391260	1558106434373:546342800	ATMF_500Secstudy	480	479	ALREADY AVAILABLE	2019-07-02 09:27:15.235	1004	1005
2846	58	1558106438901:-1525689552	1558106438158:1303251032	ATMF_500Secstudy	485	484	ALREADY AVAILABLE	2019-07-02 09:27:15.235	1004	1005
2851	58	1558106442436:-1632727401	1558106441743:-1115950362	ATMF_500Secstudy	490	489	ALREADY AVAILABLE	2019-07-02 09:27:15.235	1004	1005
2856	58	1558106446373:-3199960	1558106445624:793166518	ATMF_500Secstudy	495	494	ALREADY AVAILABLE	2019-07-02 09:27:15.235	1004	1005
2861	58	1558106457447:-1571555173	1558106456691:-351309031	ATMF_500Secstudy	500	499	ALREADY AVAILABLE	2019-07-02 09:27:15.235	1004	1005
2893	64	1572952357295:-688074842	1572952356358:1847073217	Risk_study	4	3	CREATE	2019-11-05 12:12:37.424	Monitoring3	Regulatory3
2894	64	1572952358128:-1003415648	1572952357295:-688074842	Risk_study	5	4	CREATE	2019-11-05 12:12:38.275	Regulatory3	Protocol3
2924	71	\N	\N	TS02eTMFUAT	1	0	NEW	\N		003
2925	71	\N	\N	TS02eTMFUAT	2	1	NEW	\N	003	Correspondence3
2926	71	\N	\N	TS02eTMFUAT	3	2	NEW	\N	Correspondence3	Monitoring3
2927	71	\N	\N	TS02eTMFUAT	4	3	NEW	\N	Monitoring3	Regulatory3
2928	71	\N	\N	TS02eTMFUAT	5	4	NEW	\N	Regulatory3	Protocol3
2919	70	1582534853695:831317197	rootNode	AcqeTMFRegression2	1	0	CREATE	2020-02-24 10:00:53.934		003
2920	70	1582534855272:-573757019	1582534853695:831317197	AcqeTMFRegression2	2	1	CREATE	2020-02-24 10:00:55.543	003	Correspondence3
2921	70	1582534857112:-385731040	1582534855272:-573757019	AcqeTMFRegression2	3	2	CREATE	2020-02-24 10:00:57.429	Correspondence3	Monitoring3
2923	70	1582534860462:-630552930	1582534858766:-599043248	AcqeTMFRegression2	5	4	CREATE	2020-02-24 10:01:00.721	Regulatory3	Protocol3
2935	73	1582721091750:825813289	1582721090857:502700395	Teststudy	2	1	CREATE	2020-02-26 13:44:51.825	003	Correspondence3
2945	74	\N	\N	CV181-369	6	5	NEW	\N	Site Set-up	Principal Investigator Curriculum Vitae
2946	74	\N	\N	CV181-369	7	5	NEW	\N	Site Set-up	Protocol Amendment Signature Page
2947	74	\N	\N	CV181-369	8	5	NEW	\N	Site Set-up	Protocol Signature Page
2948	74	\N	\N	CV181-369	39	5	NEW	\N	Site Set-up	Data Privacy Agreement
2949	74	\N	\N	CV181-369	42	5	NEW	\N	Site Set-up	Site Signature Sheet
2958	74	\N	\N	CV181-369	116	5	NEW	\N	Site Set-up	Other Financial Agreement
2959	74	\N	\N	CV181-369	137	5	NEW	\N	Site Set-up	Indemnity
2960	74	\N	\N	CV181-369	27	2	NEW	\N	Site Management	Site Management
2961	74	\N	\N	CV181-369	28	27	NEW	\N	Site Management	Subject Log
2962	74	\N	\N	CV181-369	44	27	NEW	\N	Site Management	Visit Log
2963	74	\N	\N	CV181-369	61	27	NEW	\N	Site Management	Final Trial Close Out Monitoring Report
2964	74	\N	\N	CV181-369	62	27	NEW	\N	Site Management	Monitoring Visit Follow-up Documentation
2965	74	\N	\N	CV181-369	71	27	NEW	\N	Site Management	Source Data
2966	74	\N	\N	CV181-369	76	27	NEW	\N	Site Management	Monitoring Visit Report
2967	74	\N	\N	CV181-369	115	27	NEW	\N	Site Management	Notification to Investigators of Safety Information
2968	74	\N	\N	CV181-369	40	2	NEW	\N	Site Management	Site Initiation
2969	74	\N	\N	CV181-369	41	40	NEW	\N	Site Initiation	Trial Initiation Monitoring Report
2970	74	\N	\N	CV181-369	43	40	NEW	\N	Site Initiation	Site Evidence of Training
2971	74	\N	\N	CV181-369	52	2	NEW	\N	Site Management	General
2972	74	\N	\N	CV181-369	53	52	NEW	\N	General	Tracking Information
2973	74	\N	\N	CV181-369	66	52	NEW	\N	General	Relevant Communications
2974	74	\N	\N	CV181-369	75	52	NEW	\N	General	Meeting Material
2975	74	\N	\N	CV181-369	79	52	NEW	\N	General	Filenote
2976	74	\N	\N	CV181-369	13	1	NEW	\N	Site	Trial Management
2977	74	\N	\N	CV181-369	14	13	NEW	\N	Trial Management	Trial Oversight
2978	74	\N	\N	CV181-369	15	14	NEW	\N	Trial Oversight	Recruitment Plan
2979	74	\N	\N	CV181-369	67	14	NEW	\N	Trial Oversight	Debarment Statement
2980	74	\N	\N	CV181-369	80	13	NEW	\N	Trial Management	Trial Team
2981	74	\N	\N	CV181-369	81	80	NEW	\N	Trial Team	Trial Team Details
2982	74	\N	\N	CV181-369	132	13	NEW	\N	Trial Management	Trial Committee
2983	74	\N	\N	CV181-369	133	132	NEW	\N	Trial Committee	Committee Output
2984	74	\N	\N	CV181-369	17	1	NEW	\N	Site	Regulatory
2985	74	\N	\N	CV181-369	18	17	NEW	\N	Regulatory	Trial Approval
2986	74	\N	\N	CV181-369	19	18	NEW	\N	Trial Approval	Regulatory Authority Decision
2987	74	\N	\N	CV181-369	26	18	NEW	\N	Trial Approval	Regulatory Submission
2988	74	\N	\N	CV181-369	23	17	NEW	\N	Regulatory	Trial Status Reporting
2989	74	\N	\N	CV181-369	24	23	NEW	\N	Trial Status Reporting	Regulatory Progress Report
2990	74	\N	\N	CV181-369	64	17	NEW	\N	Regulatory	General
2991	74	\N	\N	CV181-369	65	64	NEW	\N	General	Relevant Communications
2992	74	\N	\N	CV181-369	29	1	NEW	\N	Site	Central Trial Documents
2993	74	\N	\N	CV181-369	30	29	NEW	\N	Central Trial Documents	Subject Documentation
2994	74	\N	\N	CV181-369	31	30	NEW	\N	Subject Documentation	Informed Consent Form
2995	74	\N	\N	CV181-369	126	30	NEW	\N	Subject Documentation	Subject Participation Card
2996	74	\N	\N	CV181-369	128	30	NEW	\N	Subject Documentation	Subject Diary
2997	74	\N	\N	CV181-369	129	30	NEW	\N	Subject Documentation	Advertisements for Subject Recruitment
2998	74	\N	\N	CV181-369	131	30	NEW	\N	Subject Documentation	Other Information Given to Subjects
2999	74	\N	\N	CV181-369	35	29	NEW	\N	Central Trial Documents	General
3000	74	\N	\N	CV181-369	36	35	NEW	\N	General	Tracking Information
3001	74	\N	\N	CV181-369	69	29	NEW	\N	Central Trial Documents	Product and Trial Documentation
3002	74	\N	\N	CV181-369	70	69	NEW	\N	Product and Trial Documentation	Insurance
3003	74	\N	\N	CV181-369	45	1	NEW	\N	Site	IP and Trial Supplies
3004	74	\N	\N	CV181-369	46	45	NEW	\N	IP and Trial Supplies	Storage
3005	74	\N	\N	CV181-369	47	46	NEW	\N	Storage	IP Storage Condition Documentation
3006	74	\N	\N	CV181-369	121	46	NEW	\N	Storage	IP Storage Condition Excursion Documentation
3007	74	\N	\N	CV181-369	72	45	NEW	\N	IP and Trial Supplies	IP Documentation
3008	74	\N	\N	CV181-369	73	72	NEW	\N	IP Documentation	IP Shipment Documentation
3009	74	\N	\N	CV181-369	74	72	NEW	\N	IP Documentation	IP Return Documentation
3010	74	\N	\N	CV181-369	82	72	NEW	\N	IP Documentation	IP Accountability Documentation
3011	74	\N	\N	CV181-369	107	72	NEW	\N	IP Documentation	IP Transfer Documentation
3012	74	\N	\N	CV181-369	77	45	NEW	\N	IP and Trial Supplies	Non-IP Documentation
3013	74	\N	\N	CV181-369	78	77	NEW	\N	Non-IP Documentation	Non-IP Shipment Documentation
3014	74	\N	\N	CV181-369	112	77	NEW	\N	Non-IP Documentation	Non-IP Return Documentation
3015	74	\N	\N	CV181-369	54	1	NEW	\N	Site	IRB/IEC and other Approvals
3016	74	\N	\N	CV181-369	55	54	NEW	\N	IRB/IEC and other Approvals	IRB or IEC Trial Approval
3017	74	\N	\N	CV181-369	56	55	NEW	\N	IRB or IEC Trial Approval	IRB or IEC Approval
3018	74	\N	\N	CV181-369	57	55	NEW	\N	IRB or IEC Trial Approval	IRB or IEC Submission
3019	74	\N	\N	CV181-369	130	55	NEW	\N	IRB or IEC Trial Approval	IRB or IEC Composition
3020	74	\N	\N	CV181-369	134	55	NEW	\N	IRB or IEC Trial Approval	IRB or IEC Compliance Documentation
3023	74	\N	\N	CV181-369	125	88	NEW	\N	General	Filenote
3024	74	\N	\N	CV181-369	113	54	NEW	\N	IRB/IEC and other Approvals	Trial Status Reporting
3025	74	\N	\N	CV181-369	114	113	NEW	\N	Trial Status Reporting	Notification to IRB or IEC of Safety Information
3026	74	\N	\N	CV181-369	135	113	NEW	\N	Trial Status Reporting	IRB or IEC Notification of Trial Termination
3027	74	\N	\N	CV181-369	136	113	NEW	\N	Trial Status Reporting	IRB or IEC Progress Report
3028	74	\N	\N	CV181-369	58	1	NEW	\N	Site	Data Management
3029	74	\N	\N	CV181-369	59	58	NEW	\N	Data Management	Database
3030	74	\N	\N	CV181-369	60	59	NEW	\N	Database	Database Lock and Unlock Approval
3031	74	\N	\N	CV181-369	92	1	NEW	\N	Site	Safety Reporting
3032	74	\N	\N	CV181-369	93	92	NEW	\N	Safety Reporting	General
3033	74	\N	\N	CV181-369	94	93	NEW	\N	General	Relevant Communications
3034	74	\N	\N	CV181-369	109	1	NEW	\N	Site	Central and Local Testing
3035	74	\N	\N	CV181-369	110	109	NEW	\N	Central and Local Testing	Facility Documentation
3036	74	\N	\N	CV181-369	111	110	NEW	\N	Facility Documentation	Laboratory Validation Documentation
3037	74	\N	\N	CV181-369	9	0	NEW	\N		Country
3038	74	\N	\N	CV181-369	10	9	NEW	\N	Country	Regulatory
3039	74	\N	\N	CV181-369	11	10	NEW	\N	Regulatory	Trial Approval
3040	74	\N	\N	CV181-369	12	11	NEW	\N	Trial Approval	Public Registration
3041	74	\N	\N	CV181-369	16	11	NEW	\N	Trial Approval	Regulatory Authority Decision
3042	74	\N	\N	CV181-369	25	11	NEW	\N	Trial Approval	Regulatory Submission
3043	74	\N	\N	CV181-369	20	10	NEW	\N	Regulatory	Trial Status Reporting
3044	74	\N	\N	CV181-369	21	20	NEW	\N	Trial Status Reporting	Regulatory Notification of Trial Termination
3045	74	\N	\N	CV181-369	22	20	NEW	\N	Trial Status Reporting	Regulatory Progress Report
3046	74	\N	\N	CV181-369	90	10	NEW	\N	Regulatory	General
3047	74	\N	\N	CV181-369	91	90	NEW	\N	General	Relevant Communications
3048	74	\N	\N	CV181-369	32	9	NEW	\N	Country	Central Trial Documents
3049	74	\N	\N	CV181-369	33	32	NEW	\N	Central Trial Documents	Subject Documentation
3050	74	\N	\N	CV181-369	34	33	NEW	\N	Subject Documentation	Informed Consent Form
3051	74	\N	\N	CV181-369	49	33	NEW	\N	Subject Documentation	Subject Diary
3052	74	\N	\N	CV181-369	50	33	NEW	\N	Subject Documentation	Subject Participation Card
3053	74	\N	\N	CV181-369	51	33	NEW	\N	Subject Documentation	Subject Questionnaire
3054	74	\N	\N	CV181-369	117	33	NEW	\N	Subject Documentation	Other Information Given to Subjects
3055	74	\N	\N	CV181-369	127	33	NEW	\N	Subject Documentation	Advertisements for Subject Recruitment
3056	74	\N	\N	CV181-369	37	32	NEW	\N	Central Trial Documents	General
3057	74	\N	\N	CV181-369	38	37	NEW	\N	General	Tracking Information
3058	74	\N	\N	CV181-369	105	32	NEW	\N	Central Trial Documents	Product and Trial Documentation
3059	74	\N	\N	CV181-369	106	105	NEW	\N	Product and Trial Documentation	Insurance
3060	74	\N	\N	CV181-369	85	9	NEW	\N	Country	IRB/IEC and other Approvals
3061	74	\N	\N	CV181-369	86	85	NEW	\N	IRB/IEC and other Approvals	General
3062	74	\N	\N	CV181-369	87	86	NEW	\N	General	Relevant Communications
3063	74	\N	\N	CV181-369	98	85	NEW	\N	IRB/IEC and other Approvals	IRB or IEC Trial Approval
3064	74	\N	\N	CV181-369	99	98	NEW	\N	IRB or IEC Trial Approval	IRB or IEC Approval
3065	74	\N	\N	CV181-369	100	98	NEW	\N	IRB or IEC Trial Approval	IRB or IEC Compliance Documentation
3066	74	\N	\N	CV181-369	103	98	NEW	\N	IRB or IEC Trial Approval	IRB or IEC Composition
3067	74	\N	\N	CV181-369	104	98	NEW	\N	IRB or IEC Trial Approval	IRB or IEC Submission
3068	74	\N	\N	CV181-369	101	85	NEW	\N	IRB/IEC and other Approvals	Trial Status Reporting
3069	74	\N	\N	CV181-369	102	101	NEW	\N	Trial Status Reporting	IRB or IEC Notification of Trial Termination
3070	74	\N	\N	CV181-369	118	9	NEW	\N	Country	Third Parties
3071	74	\N	\N	CV181-369	119	118	NEW	\N	Third Parties	Third Party Set-up
3072	74	\N	\N	CV181-369	120	119	NEW	\N	Third Party Set-up	Contractual Agreement
3073	74	\N	\N	CV181-369	122	9	NEW	\N	Country	Site Management
3074	74	\N	\N	CV181-369	123	122	NEW	\N	Site Management	General
3075	74	\N	\N	CV181-369	124	123	NEW	\N	General	Tracking Information
3078	75	1611118281819:-979575774	1611118281187:-670438690	D4190C00023	3	2	CREATE	2021-01-20 05:51:21.897	Central and Local Testing	Facility Documentation
3080	75	1611118282962:-1544706531	1611118281819:-979575774	D4190C00023	5	3	CREATE	2021-01-20 05:51:23.037	Facility Documentation	Manual
3081	75	1611118283519:-1726846093	1611118281819:-979575774	D4190C00023	6	3	CREATE	2021-01-20 05:51:23.597	Facility Documentation	Normal Ranges
3090	75	1611118284713:-1916438262	1611118280465:2047621457	D4190C00023	8	1	CREATE	2021-01-20 05:51:24.787	Study	IP and Trial Supplies
3091	75	1611118285284:169843248	1611118284713:-1916438262	D4190C00023	9	8	CREATE	2021-01-20 05:51:25.379	IP and Trial Supplies	IP Release Process Documentation
3084	75	1611118291942:-957498763	1611118281187:-670438690	D4190C00023	20	2	CREATE	2021-01-20 05:51:32.042	Central and Local Testing	General
3085	75	1611118292555:1568377054	1611118291942:-957498763	D4190C00023	21	20	CREATE	2021-01-20 05:51:32.633	General	Relevant Communications
3095	75	1611118296458:1411196334	1611118295821:1609755251	D4190C00023	26	25	CREATE	2021-01-20 05:51:36.534	General	Relevant Communications
3097	75	1611118315112:1936728942	1611118284713:-1916438262	D4190C00023	58	8	CREATE	2021-01-20 05:51:55.191	IP and Trial Supplies	IP Documentation
3096	75	1611118321800:1131931235	1611118295821:1609755251	D4190C00023	69	25	CREATE	2021-01-20 05:52:01.882	General	Filenote
3083	75	1611118351612:1427727852	1611118281819:-979575774	D4190C00023	118	3	CREATE	2021-01-20 05:52:31.689	Facility Documentation	Laboratory Results Documentation
3087	75	1611118352190:1191511035	1611118281187:-670438690	D4190C00023	119	2	CREATE	2021-01-20 05:52:32.27	Central and Local Testing	Sample Documentation
3088	75	1611118352737:-461061648	1611118352190:1191511035	D4190C00023	120	119	CREATE	2021-01-20 05:52:32.812	Sample Documentation	Shipment Records
3086	75	1611118386080:1108172662	1611118291942:-957498763	D4190C00023	175	20	CREATE	2021-01-20 05:53:06.16	General	Filenote
3108	75	1611118287159:-562415975	1611118286542:539763926	D4190C00023	12	11	CREATE	2021-01-20 05:51:27.244	Trial Management	Trial Oversight
3110	75	1611118288275:-1990479600	1611118287159:-562415975	D4190C00023	14	12	CREATE	2021-01-20 05:51:28.352	Trial Oversight	Quality Plan
3135	75	1611118288829:61613925	1611118280465:2047621457	D4190C00023	15	1	CREATE	2021-01-20 05:51:28.911	Study	Third Parties
3137	75	1611118289953:1796248299	1611118289379:792077101	D4190C00023	17	16	CREATE	2021-01-20 05:51:30.041	Third Party Set-up	Confidentiality Agreement
3120	75	1611118290802:-1374085427	1611118286542:539763926	D4190C00023	18	11	CREATE	2021-01-20 05:51:30.882	Trial Management	General
3143	75	1611118293109:756484481	1611118280465:2047621457	D4190C00023	22	1	CREATE	2021-01-20 05:51:33.187	Study	Data Management
3145	75	1611118294274:-429763887	1611118293728:2134531322	D4190C00023	24	23	CREATE	2021-01-20 05:51:34.351	General	Relevant Communications
3153	75	1611118297002:192568491	1611118280465:2047621457	D4190C00023	27	1	CREATE	2021-01-20 05:51:37.081	Study	Safety Reporting
11566	86	\N	\N	D5170C00002	17	13	NEW	\N	05.04 Site Management	05.04.04 Visit Log
3155	75	1611118298216:-248454685	1611118297570:1342007522	D4190C00023	29	28	CREATE	2021-01-20 05:51:38.293	General	Relevant Communications
3139	75	1611118298807:312405412	1611118288829:61613925	D4190C00023	30	15	CREATE	2021-01-20 05:51:38.888	Third Parties	General
3122	75	1611118299900:512778987	1611118290802:-1374085427	D4190C00023	32	18	CREATE	2021-01-20 05:51:39.975	General	Relevant Communications
3147	75	1611118301064:915929594	1611118300487:672131046	D4190C00023	34	33	CREATE	2021-01-20 05:51:41.256	Data Capture	CRF Completion Requirements
3125	75	1611118301753:1764816528	1611118286542:539763926	D4190C00023	35	11	CREATE	2021-01-20 05:51:41.829	Trial Management	Trial Team
3148	75	1611118302874:1440458347	1611118293109:756484481	D4190C00023	37	22	CREATE	2021-01-20 05:51:42.952	Data Management	Data Management Oversight
3150	75	1611118304046:1572359144	1611118293109:756484481	D4190C00023	39	22	CREATE	2021-01-20 05:51:44.124	Data Management	Database
3151	75	1611118304653:1646701375	1611118304046:1572359144	D4190C00023	40	39	CREATE	2021-01-20 05:51:44.727	Database	Approval for Database Activation
3129	75	1611118305823:-2106694305	1611118305265:-18158125	D4190C00023	42	41	CREATE	2021-01-20 05:51:45.899	Trial Committee	Committee Output
3152	75	1611118306439:-785368399	1611118304046:1572359144	D4190C00023	43	39	CREATE	2021-01-20 05:51:46.518	Database	External Data Transfer Specifications
3166	75	1611118307616:1505345382	1611118307068:1603840561	D4190C00023	45	44	CREATE	2021-01-20 05:51:47.694	Site Management	Site Selection
3168	75	1611118308807:-259378777	1611118307616:1505345382	D4190C00023	47	45	CREATE	2021-01-20 05:51:48.885	Site Selection	Feasibility Documentation
3111	75	1611118309356:-1570721772	1611118287159:-562415975	D4190C00023	48	12	CREATE	2021-01-20 05:51:49.435	Trial Oversight	Trial Master File Plan
3130	75	1611118312222:910595091	1611118286542:539763926	D4190C00023	53	11	CREATE	2021-01-20 05:51:52.301	Trial Management	Meetings
3131	75	1611118312779:1661761547	1611118312222:910595091	D4190C00023	54	53	CREATE	2021-01-20 05:51:52.856	Meetings	Investigators Meeting Material
3112	75	1611118314496:97033037	1611118287159:-562415975	D4190C00023	57	12	CREATE	2021-01-20 05:51:54.572	Trial Oversight	Investigator Newsletter
3099	75	1611118316223:-1630940376	1611118315112:1936728942	D4190C00023	60	58	CREATE	2021-01-20 05:51:56.302	IP Documentation	IP Supply Plan
3101	75	1611118317665:-1236047525	1611118317008:-1397196057	D4190C00023	62	61	CREATE	2021-01-20 05:51:57.743	Interactive Response Technology	IRT User Manual
3132	75	1611118318820:-109372340	1611118312222:910595091	D4190C00023	64	53	CREATE	2021-01-20 05:51:58.899	Meetings	Kick-off Meeting Material
3113	75	1611118319394:85391357	1611118287159:-562415975	D4190C00023	65	12	CREATE	2021-01-20 05:51:59.473	Trial Oversight	List of SOPs Current During Trial
3114	75	1611118319967:108726129	1611118287159:-562415975	D4190C00023	66	12	CREATE	2021-01-20 05:52:00.046	Trial Oversight	Monitoring Plan
3106	75	1611118321216:-2092520437	1611118320596:1809140435	D4190C00023	68	67	CREATE	2021-01-20 05:52:01.296	Non-IP Documentation	Non-IP Shipment Documentation
3156	75	1611118322352:-715044597	1611118297570:1342007522	D4190C00023	70	28	CREATE	2021-01-20 05:52:02.433	General	Filenote
3158	75	1611118324775:-1055042490	1611118297002:192568491	D4190C00023	74	27	CREATE	2021-01-20 05:52:04.852	Safety Reporting	Trial Status Reporting
3115	75	1611118325937:1991729181	1611118287159:-562415975	D4190C00023	76	12	CREATE	2021-01-20 05:52:06.013	Trial Oversight	Trial Management Plan
3127	75	1611118326557:-1236179001	1611118301753:1764816528	D4190C00023	77	35	CREATE	2021-01-20 05:52:06.638	Trial Team	Trial Team Details
3171	75	1611118329153:-1281257606	1611118328550:-961597029	D4190C00023	81	80	CREATE	2021-01-20 05:52:09.233	Site Management	Protocol Deviations
3116	75	1611118330886:-1647250873	1611118287159:-562415975	D4190C00023	84	12	CREATE	2021-01-20 05:52:10.965	Trial Oversight	Recruitment Plan
3157	75	1611118333930:1413477463	1611118297570:1342007522	D4190C00023	89	28	CREATE	2021-01-20 05:52:14.006	General	Tracking Information
3160	75	1611118334484:-1309879688	1611118324775:-1055042490	D4190C00023	90	74	CREATE	2021-01-20 05:52:14.562	Trial Status Reporting	SAE Report
3174	75	1611118337401:-361236416	1611118336855:858950831	D4190C00023	95	94	CREATE	2021-01-20 05:52:17.482	Site Initiation	Site Training Material
3161	75	1611118341451:-625582815	1611118324775:-1055042490	D4190C00023	101	74	CREATE	2021-01-20 05:52:21.531	Trial Status Reporting	Expedited Safety Report
3133	75	1611118342015:1554844807	1611118312222:910595091	D4190C00023	102	53	CREATE	2021-01-20 05:52:22.131	Meetings	Trial Team Evidence of Training
3119	75	1611118344480:1576249804	1611118287159:-562415975	D4190C00023	106	12	CREATE	2021-01-20 05:52:24.56	Trial Oversight	Vendor Management Plan
3162	75	1611118364609:-1575661861	1611118297002:192568491	D4190C00023	140	27	CREATE	2021-01-20 05:52:44.688	Safety Reporting	Safety Documentation
3103	75	1611118378363:-216779502	1611118317008:-1397196057	D4190C00023	163	61	CREATE	2021-01-20 05:52:58.441	Interactive Response Technology	IRT User Acceptance Testing (UAT) Certification
3164	75	1611118383255:1905975397	1611118364609:-1575661861	D4190C00023	170	140	CREATE	2021-01-20 05:53:03.331	Safety Documentation	Safety Management Plan
3172	75	1611118387263:-1032093659	1611118328550:-961597029	D4190C00023	177	80	CREATE	2021-01-20 05:53:07.339	Site Management	Notification to Investigators of Safety Information
3138	75	1611118389501:-1182610212	1611118289379:792077101	D4190C00023	181	16	CREATE	2021-01-20 05:53:09.582	Third Party Set-up	Contractual Agreement
3142	75	1611118404885:1689182946	1611118404331:-1276155350	D4190C00023	206	205	CREATE	2021-01-20 05:53:24.961	Third Party Oversight	Qualification and Compliance
3179	75	1611118311115:-1330951839	1611118310487:1184606184	D4190C00023	51	50	CREATE	2021-01-20 05:51:51.191	Product and Trial Documentation	Sample Case Report Form
3180	75	1611118313330:-2141006715	1611118310487:1184606184	D4190C00023	55	50	CREATE	2021-01-20 05:51:53.406	Product and Trial Documentation	Investigator's Brochure
3185	75	1611118324208:-1426969197	1611118323668:-356020335	D4190C00023	73	72	CREATE	2021-01-20 05:52:04.286	Subject Documentation	Other Information Given to Subjects
3181	75	1611118327376:-693208904	1611118310487:1184606184	D4190C00023	78	50	CREATE	2021-01-20 05:52:07.456	Product and Trial Documentation	Protocol
3183	75	1611118329715:-1556355472	1611118310487:1184606184	D4190C00023	82	50	CREATE	2021-01-20 05:52:09.793	Product and Trial Documentation	Protocol Synopsis
3190	75	1611118331445:294592306	1611118280465:2047621457	D4190C00023	85	1	CREATE	2021-01-20 05:52:11.524	Study	Regulatory
3192	75	1611118332664:-1177725826	1611118332057:947852846	D4190C00023	87	86	CREATE	2021-01-20 05:52:12.746	Trial Approval	Notification of Regulatory Identification Number
3186	75	1611118335129:1351015619	1611118323668:-356020335	D4190C00023	91	72	CREATE	2021-01-20 05:52:15.207	Subject Documentation	Informed Consent Form
3189	75	1611118336290:1315724563	1611118335742:-2120833869	D4190C00023	93	92	CREATE	2021-01-20 05:52:16.37	General	Tracking Information
3193	75	1611118338040:477918819	1611118280465:2047621457	D4190C00023	96	1	CREATE	2021-01-20 05:52:18.121	Study	Statistics
3195	75	1611118339162:-1113052693	1611118338609:2085037506	D4190C00023	98	97	CREATE	2021-01-20 05:52:19.24	Statistics Oversight	Statistical Analysis Plan
3175	75	1611118343282:-1090041104	1611118307068:1603840561	D4190C00023	104	44	CREATE	2021-01-20 05:52:23.363	Site Management	General
3176	75	1611118343860:342260013	1611118343282:-1090041104	D4190C00023	105	104	CREATE	2021-01-20 05:52:23.935	General	Tracking Information
3196	75	1611118344992:-35311861	rootNode	D4190C00023	107	0	CREATE	2021-01-20 05:52:25.07		Site
3198	75	1611118346229:46931385	1611118345634:171654942	D4190C00023	109	108	CREATE	2021-01-20 05:52:26.306	Site Management	Site Selection
3200	75	1611118347500:-1194827172	1611118346229:46931385	D4190C00023	111	109	CREATE	2021-01-20 05:52:27.583	Site Selection	Feasibility Documentation
3229	75	1611118348109:-1942566898	1611118344992:-35311861	D4190C00023	112	107	CREATE	2021-01-20 05:52:28.19	Site	Central Trial Documents
3231	75	1611118349289:-318495250	1611118348733:51885120	D4190C00023	114	113	CREATE	2021-01-20 05:52:29.366	Subject Documentation	Subject Participation Card
3236	75	1611118349852:1768392499	1611118344992:-35311861	D4190C00023	115	107	CREATE	2021-01-20 05:52:29.928	Site	IP and Trial Supplies
3238	75	1611118350998:-2078712526	1611118350421:-300690033	D4190C00023	117	116	CREATE	2021-01-20 05:52:31.075	IP Documentation	IP Accountability Documentation
3239	75	1611118353854:-790470367	1611118350421:-300690033	D4190C00023	122	116	CREATE	2021-01-20 05:52:33.931	IP Documentation	IP Certificate of Destruction
3203	75	1611118355056:-1159091477	1611118354401:-764788218	D4190C00023	124	123	CREATE	2021-01-20 05:52:35.135	Site Set-up	Clinical Trial Agreement
3216	75	1611118356154:250197465	1611118355614:-1062802421	D4190C00023	126	125	CREATE	2021-01-20 05:52:36.231	Site Management	Final Trial Close Out Monitoring Report
3217	75	1611118356704:396830353	1611118355614:-1062802421	D4190C00023	127	125	CREATE	2021-01-20 05:52:36.779	Site Management	Monitoring Visit Follow-up Documentation
3204	75	1611118357870:328591856	1611118354401:-764788218	D4190C00023	129	123	CREATE	2021-01-20 05:52:37.949	Site Set-up	Acceptance of Investigator Brochure
3245	75	1611118358470:-554892274	1611118344992:-35311861	D4190C00023	130	107	CREATE	2021-01-20 05:52:38.546	Site	IRB/IEC and other Approvals
3247	75	1611118359919:-48273714	1611118359034:847772793	D4190C00023	132	131	CREATE	2021-01-20 05:52:39.996	General	Relevant Communications
3222	75	1611118362285:228300024	1611118345634:171654942	D4190C00023	136	108	CREATE	2021-01-20 05:52:42.36	Site Management	General
3205	75	1611118363479:286315461	1611118354401:-764788218	D4190C00023	138	123	CREATE	2021-01-20 05:52:43.555	Site Set-up	Principal Investigator Curriculum Vitae
3218	75	1611118365825:821565278	1611118355614:-1062802421	D4190C00023	142	125	CREATE	2021-01-20 05:52:45.901	Site Management	Source Data
3207	75	1611118369574:645769565	1611118354401:-764788218	D4190C00023	148	123	CREATE	2021-01-20 05:52:49.649	Site Set-up	Financial Disclosure Form
3208	75	1611118371898:-1193488118	1611118354401:-764788218	D4190C00023	152	123	CREATE	2021-01-20 05:52:51.977	Site Set-up	Form FDA 1572
3219	75	1611118373058:2040418774	1611118355614:-1062802421	D4190C00023	154	125	CREATE	2021-01-20 05:52:53.134	Site Management	Subject Log
3210	75	1611118377785:-863014648	1611118354401:-764788218	D4190C00023	162	123	CREATE	2021-01-20 05:52:57.86	Site Set-up	IP Site Release Documentation
3220	75	1611118383852:-639221671	1611118355614:-1062802421	D4190C00023	171	125	CREATE	2021-01-20 05:53:03.93	Site Management	Monitoring Visit Report
3240	75	1611118384418:-544721581	1611118349852:1768392499	D4190C00023	172	115	CREATE	2021-01-20 05:53:04.497	IP and Trial Supplies	Non-IP Documentation
3242	75	1611118385508:1417647048	1611118384418:-544721581	D4190C00023	174	172	CREATE	2021-01-20 05:53:05.584	Non-IP Documentation	Non-IP Shipment Documentation
3224	75	1611118386665:-1376424946	1611118362285:228300024	D4190C00023	176	136	CREATE	2021-01-20 05:53:06.745	General	Filenote
3211	75	1611118390102:-802096744	1611118354401:-764788218	D4190C00023	182	123	CREATE	2021-01-20 05:53:10.183	Site Set-up	Protocol Amendment Signature Page
3212	75	1611118390677:455568956	1611118354401:-764788218	D4190C00023	183	123	CREATE	2021-01-20 05:53:10.755	Site Set-up	Protocol Signature Page
3234	75	1611118393701:-1366616	1611118348109:-1942566898	D4190C00023	188	112	CREATE	2021-01-20 05:53:13.783	Central Trial Documents	General
3235	75	1611118394264:-818358888	1611118393701:-1366616	D4190C00023	189	188	CREATE	2021-01-20 05:53:14.342	General	Tracking Information
3213	75	1611118394820:-416480130	1611118354401:-764788218	D4190C00023	190	123	CREATE	2021-01-20 05:53:14.895	Site Set-up	Data Privacy Agreement
3227	75	1611118397182:-230892822	1611118396597:-2077587214	D4190C00023	194	193	CREATE	2021-01-20 05:53:17.266	Site Initiation	Trial Initiation Monitoring Report
3228	75	1611118399015:-825232402	1611118396597:-2077587214	D4190C00023	197	193	CREATE	2021-01-20 05:53:19.095	Site Initiation	Site Evidence of Training
3221	75	1611118399572:696099	1611118355614:-1062802421	D4190C00023	198	125	CREATE	2021-01-20 05:53:19.653	Site Management	Visit Log
3244	75	1611118400735:-1407716948	1611118400150:-280593938	D4190C00023	200	199	CREATE	2021-01-20 05:53:20.812	Storage	IP Storage Condition Documentation
3225	75	1611118402592:570712243	1611118362285:228300024	D4190C00023	202	136	CREATE	2021-01-20 05:53:22.675	General	Tracking Information
4034	82	1611633578254:-1637656823	1611633575093:-524477315	D5136C00008	7	2	CREATE	2021-01-26 04:59:38.338	01.01 Trial Oversight	01.01.06 Recruitment Plan
4037	82	1611633580073:-458618725	1611633575093:-524477315	D5136C00008	10	2	CREATE	2021-01-26 04:59:40.159	01.01 Trial Oversight	01.01.09 Medical Monitoring Plan
4040	82	1611633585366:1488699875	1611633575093:-524477315	D5136C00008	13	2	CREATE	2021-01-26 04:59:45.452	01.01 Trial Oversight	01.01.17 Vendor Management Plan
4041	82	1611633585988:-779850671	1611633574460:-545679261	D5136C00008	14	1	CREATE	2021-01-26 04:59:46.071	01 Trial Management	01.02 Trial Team
4043	82	1611633587188:-471624673	1611633585988:-779850671	D5136C00008	16	14	CREATE	2021-01-26 04:59:47.277	01.02 Trial Team	01.02.01 Project Team Member Details
4047	82	1611633589490:-1133465099	1611633588365:-624690648	D5136C00008	20	18	CREATE	2021-01-26 04:59:49.576	01.03 Data Adjudication	01.03.03 Advisory Com_ee-Correspondence-Email
4048	82	1611633590408:417557536	1611633588365:-624690648	D5136C00008	21	18	CREATE	2021-01-26 04:59:50.494	01.03 Data Adjudication	01.03.03 Advisory Committee-Correspondence-Documents
4052	82	1611633592792:1638302567	1611633588365:-624690648	D5136C00008	25	18	CREATE	2021-01-26 04:59:52.876	01.03 Data Adjudication	01.03.04 Independent _oring Committee Meeting
4056	82	1611633595192:-1709533775	1611633593354:1728232414	D5136C00008	29	26	CREATE	2021-01-26 04:59:55.279	01.04 Meetings	01.04.02 Project Team Training Material
4057	82	1611633595778:-849370546	1611633593354:1728232414	D5136C00008	30	26	CREATE	2021-01-26 04:59:55.864	01.04 Meetings	01.04.03 Investigators Meeting Material
4062	82	1611633598760:-1484894469	1611633598188:1461789720	D5136C00008	35	34	CREATE	2021-01-26 04:59:58.846	Site Communication	7802 - Dr.Ralph Boccia
4066	82	1611633601130:230629070	1611633598188:1461789720	D5136C00008	39	34	CREATE	2021-01-26 05:00:01.508	Site Communication	Site 2804_Dr _mitri Tsitsikas
4067	82	1611633602080:1249078774	1611633598188:1461789720	D5136C00008	40	34	CREATE	2021-01-26 05:00:02.176	Site Communication	Site 4102_Pro_a De Franceschi
4069	82	1611633603292:349227860	1611633598188:1461789720	D5136C00008	42	34	CREATE	2021-01-26 05:00:03.377	Site Communication	Site 7603_Aprof.Selma Unal
4074	82	1611633606798:-726414410	1611633598188:1461789720	D5136C00008	47	34	CREATE	2021-01-26 05:00:06.883	Site Communication	Site 8503_Dr.Videlis Nduba
4075	82	1611633607389:329345973	1611633598188:1461789720	D5136C00008	48	34	CREATE	2021-01-26 05:00:07.476	Site Communication	Site 8701_Dr.Amal El-Beshlawy
4078	82	1611633609183:673574352	1611633598188:1461789720	D5136C00008	51	34	CREATE	2021-01-26 05:00:09.271	Site Communication	Site 8801_Dr.Adelette Inati
4083	82	1611633612290:-1199400603	1611633596372:-19064024	D5136C00008	56	31	CREATE	2021-01-26 05:00:12.376	01.05 General	01.05.03 Other Sponsor Meeting Material
4084	82	1611633612877:-1033698651	1611633596372:-19064024	D5136C00008	57	31	CREATE	2021-01-26 05:00:12.962	01.05 General	01.05.03 Project Management- Sponsor Meeting Material
4088	82	1611633615343:1761351401	1611633614054:756634841	D5136C00008	61	59	CREATE	2021-01-26 05:00:15.448	02.01 Trial Documents	02.01.02 Protocol
4093	82	1611633618780:-420400763	1611633613367:-1231745763	D5136C00008	66	58	CREATE	2021-01-26 05:00:18.865	02 Central Trial Documents	02.02 Subject Documents
4094	82	1611633619359:1169864761	1611633618780:-420400763	D5136C00008	67	66	CREATE	2021-01-26 05:00:19.447	02.02 Subject Documents	02.02.03 Informed Consent Form Checklists
3254	75	1611118361722:-977120586	1611118361173:-980106582	D4190C00023	135	134	CREATE	2021-01-20 05:52:41.8	General	Relevant Communications
3268	75	1611118366364:1567783348	rootNode	D4190C00023	143	0	CREATE	2021-01-20 05:52:46.441		Country
3270	75	1611118367486:-1946223830	1611118366935:-1497728851	D4190C00023	145	144	CREATE	2021-01-20 05:52:47.562	Site Management	Site Selection
3272	75	1611118368684:-416196695	1611118367486:-1946223830	D4190C00023	147	145	CREATE	2021-01-20 05:52:49.06	Site Selection	Feasibility Documentation
3257	75	1611118370189:156785711	1611118344992:-35311861	D4190C00023	149	107	CREATE	2021-01-20 05:52:50.269	Site	Trial Management
3259	75	1611118371334:2104586157	1611118370767:-289119883	D4190C00023	151	150	CREATE	2021-01-20 05:52:51.41	Trial Oversight	Debarment Statement
3249	75	1611118374184:1181559357	1611118373611:-1700142288	D4190C00023	156	155	CREATE	2021-01-20 05:52:54.263	IRB or IEC Trial Approval	IRB or IEC Approval
3251	75	1611118375320:-1482593370	1611118373611:-1700142288	D4190C00023	158	155	CREATE	2021-01-20 05:52:55.396	IRB or IEC Trial Approval	IRB or IEC Composition
3275	75	1611118375871:-1034326000	1611118366364:1567783348	D4190C00023	159	143	CREATE	2021-01-20 05:52:55.948	Country	Central Trial Documents
3277	75	1611118377089:529850012	1611118376475:1451428367	D4190C00023	161	160	CREATE	2021-01-20 05:52:57.168	Product and Trial Documentation	Insurance
3263	75	1611118380404:-516285564	1611118344992:-35311861	D4190C00023	165	107	CREATE	2021-01-20 05:53:00.486	Site	Central and Local Testing
3265	75	1611118381568:1940345949	1611118381006:-1223038678	D4190C00023	167	166	CREATE	2021-01-20 05:53:01.644	Facility Documentation	Laboratory Validation Documentation
3266	75	1611118382136:1809006837	1611118381006:-1223038678	D4190C00023	168	166	CREATE	2021-01-20 05:53:02.215	Facility Documentation	Certification or Accreditation
3279	75	1611118387813:98084225	1611118375871:-1034326000	D4190C00023	178	159	CREATE	2021-01-20 05:53:07.889	Central Trial Documents	Subject Documentation
3280	75	1611118388380:-73607634	1611118387813:98084225	D4190C00023	179	178	CREATE	2021-01-20 05:53:08.456	Subject Documentation	Other Information Given to Subjects
3256	75	1611118391813:-2026699038	1611118391250:917863747	D4190C00023	185	184	CREATE	2021-01-20 05:53:11.89	Trial Status Reporting	SAE Report
3281	75	1611118392982:998808371	1611118387813:98084225	D4190C00023	187	178	CREATE	2021-01-20 05:53:13.197	Subject Documentation	Informed Consent Form
3262	75	1611118396022:-1446774683	1611118395464:1915570502	D4190C00023	192	191	CREATE	2021-01-20 05:53:16.104	Trial Team	Trial Team Details
3260	75	1611118397788:790359467	1611118370767:-289119883	D4190C00023	195	150	CREATE	2021-01-20 05:53:17.875	Trial Oversight	Operational Procedure Manual
3273	75	1611118403164:760960628	1611118366935:-1497728851	D4190C00023	203	144	CREATE	2021-01-20 05:53:23.241	Site Management	General
3274	75	1611118403720:-2059399481	1611118403164:760960628	D4190C00023	204	203	CREATE	2021-01-20 05:53:23.797	General	Tracking Information
3284	75	1611118406004:61268278	1611118405435:424134915	D4190C00023	208	207	CREATE	2021-01-20 05:53:26.096	IRB/IEC and other Approvals	General
3285	75	1611118406573:-1912899545	1611118406004:61268278	D4190C00023	209	208	CREATE	2021-01-20 05:53:26.648	General	Relevant Communications
3287	75	1611118407724:1521323061	1611118407120:68549760	D4190C00023	211	210	CREATE	2021-01-20 05:53:27.809	Regulatory	General
3278	75	1611118409084:2128679395	1611118376475:1451428367	D4190C00023	213	160	CREATE	2021-01-20 05:53:29.18	Product and Trial Documentation	Protocol Amendment
4098	82	1611633621931:999077936	1611633613367:-1231745763	D5136C00008	71	58	CREATE	2021-01-26 05:00:22.017	02 Central Trial Documents	02.03 Reports
4102	82	1611633625790:814787781	1611633625156:219883668	D5136C00008	75	74	CREATE	2021-01-26 05:00:25.885	02.04 General	02.04.02 Tracking Information
3910	80	1611118348733:51885120	1611118348109:-1942566898	D4190C00023	73	72	ALREADY AVAILABLE	2021-01-20 18:57:21.852	Central Trial Documents	Subject Documentation
3913	80	1611118393701:-1366616	1611118348109:-1942566898	D4190C00023	76	72	ALREADY AVAILABLE	2021-01-20 18:57:21.852	Central Trial Documents	General
3887	80	1611118350421:-300690033	1611118349852:1768392499	D4190C00023	35	34	ALREADY AVAILABLE	2021-01-20 18:57:21.852	IP and Trial Supplies	IP Documentation
3893	80	1611118384418:-544721581	1611118349852:1768392499	D4190C00023	45	34	ALREADY AVAILABLE	2021-01-20 18:57:21.852	IP and Trial Supplies	Non-IP Documentation
3912	80	1611118349289:-318495250	1611118348733:51885120	D4190C00023	95	73	ALREADY AVAILABLE	2021-01-20 18:57:21.856	Subject Documentation	Subject Participation Card
3911	80	1611118392436:-2038888332	1611118348733:51885120	D4190C00023	74	73	ALREADY AVAILABLE	2021-01-20 18:57:21.856	Subject Documentation	Informed Consent Form
3914	80	1611118394264:-818358888	1611118393701:-1366616	D4190C00023	77	76	ALREADY AVAILABLE	2021-01-20 18:57:21.856	General	Tracking Information
3889	80	1611118350998:-2078712526	1611118350421:-300690033	D4190C00023	100	35	ALREADY AVAILABLE	2021-01-20 18:57:21.856	IP Documentation	IP Accountability Documentation
3890	80	1611118353854:-790470367	1611118350421:-300690033	D4190C00023	101	35	ALREADY AVAILABLE	2021-01-20 18:57:21.856	IP Documentation	IP Certificate of Destruction
3894	80	1611118384970:-851016987	1611118384418:-544721581	D4190C00023	46	45	ALREADY AVAILABLE	2021-01-20 18:57:21.856	Non-IP Documentation	Non-IP Return Documentation
3895	80	1611118385508:1417647048	1611118384418:-544721581	D4190C00023	114	45	ALREADY AVAILABLE	2021-01-20 18:57:21.856	Non-IP Documentation	Non-IP Shipment Documentation
3930	80	1611118406573:-1912899545	1611118406004:61268278	D4190C00023	108	107	ALREADY AVAILABLE	2021-01-20 18:57:21.856	General	Relevant Communications
3922	80	1611165450206:-909821005	1611118405435:424134915	D4190C00023	14	13	CREATE	2021-01-20 18:57:30.407	IRB/IEC and other Approvals	IRB or IEC Trial Approval
3923	80	1611165451545:-2141461185	1611165450206:-909821005	D4190C00023	15	14	CREATE	2021-01-20 18:57:31.713	IRB or IEC Trial Approval	IRB or IEC Approval
3926	80	1611165452831:420941654	1611118405435:424134915	D4190C00023	20	13	CREATE	2021-01-20 18:57:32.994	IRB/IEC and other Approvals	Trial Status Reporting
3927	80	1611165454121:1431610786	1611165452831:420941654	D4190C00023	21	20	CREATE	2021-01-20 18:57:34.29	Trial Status Reporting	IRB or IEC Notification of Trial Termination
3879	80	1611165455406:1394940726	1611118358470:-554892274	D4190C00023	22	16	CREATE	2021-01-20 18:57:35.567	IRB/IEC and other Approvals	Trial Status Reporting
3880	80	1611165456680:-1897923447	1611165455406:1394940726	D4190C00023	23	22	CREATE	2021-01-20 18:57:36.844	Trial Status Reporting	IRB or IEC Notification of Trial Termination
3928	80	1611165458008:710920943	1611165452831:420941654	D4190C00023	25	20	CREATE	2021-01-20 18:57:38.173	Trial Status Reporting	IRB or IEC Progress Report
3924	80	1611165459293:1331083071	1611165450206:-909821005	D4190C00023	26	14	CREATE	2021-01-20 18:57:39.478	IRB or IEC Trial Approval	IRB or IEC Submission
3878	80	1611165460614:641111340	1611118373611:-1700142288	D4190C00023	27	17	CREATE	2021-01-20 18:57:40.783	IRB or IEC Trial Approval	IRB or IEC Submission
3935	80	1611165461886:-138745589	1611118407120:68549760	D4190C00023	29	28	CREATE	2021-01-20 18:57:42.054	Regulatory	Investigational Medicinal Product
3936	80	1611165463171:1668578824	1611165461886:-138745589	D4190C00023	30	29	CREATE	2021-01-20 18:57:43.339	Investigational Medicinal Product	Import or Export Documentation
3888	80	1611165464522:-630974068	1611118350421:-300690033	D4190C00023	36	35	CREATE	2021-01-20 18:57:44.686	IP Documentation	IP Shipment Documentation
3882	80	1611165465808:-274684775	1611118359034:847772793	D4190C00023	48	47	CREATE	2021-01-20 18:57:45.975	General	Filenote
3937	80	1611165473673:-548949282	1611118407120:68549760	D4190C00023	63	28	CREATE	2021-01-20 18:57:53.84	Regulatory	Trial Approval
3938	80	1611165474968:-341403103	1611165473673:-548949282	D4190C00023	64	63	CREATE	2021-01-20 18:57:55.131	Trial Approval	Regulatory Authority Decision
3898	80	1611165482767:-620933537	1611118400150:-280593938	D4190C00023	92	90	CREATE	2021-01-20 18:58:02.933	Storage	IP Storage Condition Excursion Documentation
3891	80	1611165485392:-546156885	1611118350421:-300690033	D4190C00023	112	35	CREATE	2021-01-20 18:58:05.558	IP Documentation	IP Transfer Documentation
3892	80	1611165486671:-439236573	1611118350421:-300690033	D4190C00023	113	35	CREATE	2021-01-20 18:58:06.837	IP Documentation	IP Return Documentation
3870	80	1611165490656:1721835689	1611118370767:-289119883	D4190C00023	118	6	CREATE	2021-01-20 18:58:10.822	Trial Oversight	Recruitment Plan
3915	80	1611165491934:-502301281	1611118344992:-35311861	D4190C00023	122	1	CREATE	2021-01-20 18:58:12.102	Site	Regulatory
3916	80	1611165493237:1706574044	1611165491934:-502301281	D4190C00023	123	122	CREATE	2021-01-20 18:58:13.407	Regulatory	Trial Status Reporting
3917	80	1611165494541:-1468278328	1611165493237:1706574044	D4190C00023	124	123	CREATE	2021-01-20 18:58:14.708	Trial Status Reporting	Regulatory Notification of Trial Termination
3918	80	1611165495819:273762972	1611165491934:-502301281	D4190C00023	125	122	CREATE	2021-01-20 18:58:15.986	Regulatory	Trial Approval
3919	80	1611165497178:1658943321	1611165495819:273762972	D4190C00023	126	125	CREATE	2021-01-20 18:58:17.364	Trial Approval	Regulatory Submission
3925	80	1611165499752:-323332412	1611165450206:-909821005	D4190C00023	130	14	CREATE	2021-01-20 18:58:19.917	IRB or IEC Trial Approval	IRB or IEC Composition
3931	80	1611165501024:1973858068	1611118406004:61268278	D4190C00023	131	107	CREATE	2021-01-20 18:58:21.198	General	Filenote
3932	80	1611165502319:1605018645	1611118405435:424134915	D4190C00023	132	13	CREATE	2021-01-20 18:58:22.482	IRB/IEC and other Approvals	Other Committees
3933	80	1611165503640:-1645605823	1611165502319:1605018645	D4190C00023	133	132	CREATE	2021-01-20 18:58:23.802	Other Committees	Other Approvals
3884	80	1611165504902:-1719990510	1611118358470:-554892274	D4190C00023	134	16	CREATE	2021-01-20 18:58:25.07	IRB/IEC and other Approvals	Other Committees
3885	80	1611165506202:-1753332200	1611165504902:-1719990510	D4190C00023	135	134	CREATE	2021-01-20 18:58:26.374	Other Committees	Other Approvals
4107	82	1611633628838:1676090004	1611633628220:566797703	D5136C00008	80	79	CREATE	2021-01-26 05:00:28.924	03.04 General	03.04.01 Re_tart-Up-Email
4109	82	1611633629965:-546399387	1611633629405:1835360317	D5136C00008	82	81	CREATE	2021-01-26 05:00:30.051	Documents	EoT
4113	82	1611633632645:-1336762156	1611633628838:1676090004	D5136C00008	86	80	CREATE	2021-01-26 05:00:32.731	03.04.01 Re_tart-Up-Email	Important RSUL correpondence
4114	82	1611633633234:269799339	1611633632645:-1336762156	D5136C00008	87	86	CREATE	2021-01-26 05:00:33.319	Important RSUL correpondence	IP Release
4118	82	1611633635876:-1112329647	1611633635145:1445917995	D5136C00008	91	90	CREATE	2021-01-26 05:00:35.964	04.02 Other Committees	04.02.01 Other Submissions
4120	82	1611633637194:-1703339831	1611633636474:-1952132568	D5136C00008	93	92	CREATE	2021-01-26 05:00:37.279	04.04 General	04.04.01 Relevant Communications-IRB-IEC-Documents
4122	82	1611633638250:-130934538	1611633637688:277410375	D5136C00008	95	94	CREATE	2021-01-26 05:00:38.336	05 Site Management	05.03 Site Initiation
3076	75	1611118280465:2047621457	rootNode	D4190C00023	1	0	CREATE	2021-01-20 05:51:20.587		Study
3077	75	1611118281187:-670438690	1611118280465:2047621457	D4190C00023	2	1	CREATE	2021-01-20 05:51:21.285	Study	Central and Local Testing
3079	75	1611118282402:-2135384619	1611118281819:-979575774	D4190C00023	4	3	CREATE	2021-01-20 05:51:22.48	Facility Documentation	Head of Facility Curriculum Vitae
3082	75	1611118284137:-358549576	1611118281819:-979575774	D4190C00023	7	3	CREATE	2021-01-20 05:51:24.222	Facility Documentation	Certification or Accreditation
3092	75	1611118285861:1619693817	1611118285284:169843248	D4190C00023	10	9	CREATE	2021-01-20 05:51:25.941	IP Release Process Documentation	Certificate of Analysis
3107	75	1611118286542:539763926	1611118280465:2047621457	D4190C00023	11	1	CREATE	2021-01-20 05:51:26.623	Study	Trial Management
3109	75	1611118287721:1862814762	1611118287159:-562415975	D4190C00023	13	12	CREATE	2021-01-20 05:51:27.807	Trial Oversight	Communication Plan
3136	75	1611118289379:792077101	1611118288829:61613925	D4190C00023	16	15	CREATE	2021-01-20 05:51:29.471	Third Parties	Third Party Set-up
3121	75	1611118291362:1824840953	1611118290802:-1374085427	D4190C00023	19	18	CREATE	2021-01-20 05:51:31.439	General	Tracking Information
3144	75	1611118293728:2134531322	1611118293109:756484481	D4190C00023	23	22	CREATE	2021-01-20 05:51:33.806	Data Management	General
3094	75	1611118295821:1609755251	1611118284713:-1916438262	D4190C00023	25	8	CREATE	2021-01-20 05:51:35.922	IP and Trial Supplies	General
3154	75	1611118297570:1342007522	1611118297002:192568491	D4190C00023	28	27	CREATE	2021-01-20 05:51:37.648	Safety Reporting	General
3140	75	1611118299347:908950328	1611118298807:312405412	D4190C00023	31	30	CREATE	2021-01-20 05:51:39.426	General	Relevant Communications
3146	75	1611118300487:672131046	1611118293109:756484481	D4190C00023	33	22	CREATE	2021-01-20 05:51:40.565	Data Management	Data Capture
3126	75	1611118302290:-1621782017	1611118301753:1764816528	D4190C00023	36	35	CREATE	2021-01-20 05:51:42.369	Trial Team	Trial Team Curriculum Vitae
3149	75	1611118303419:413791687	1611118302874:1440458347	D4190C00023	38	37	CREATE	2021-01-20 05:51:43.541	Data Management Oversight	Data Management Plan
3128	75	1611118305265:-18158125	1611118286542:539763926	D4190C00023	41	11	CREATE	2021-01-20 05:51:45.343	Trial Management	Trial Committee
3165	75	1611118307068:1603840561	1611118280465:2047621457	D4190C00023	44	1	CREATE	2021-01-20 05:51:47.146	Study	Site Management
3167	75	1611118308271:1791231083	1611118307616:1505345382	D4190C00023	46	45	CREATE	2021-01-20 05:51:48.347	Site Selection	Sites Evaluated but not Selected
3177	75	1611118309925:-697737919	1611118280465:2047621457	D4190C00023	49	1	CREATE	2021-01-20 05:51:50	Study	Central Trial Documents
3178	75	1611118310487:1184606184	1611118309925:-697737919	D4190C00023	50	49	CREATE	2021-01-20 05:51:50.568	Central Trial Documents	Product and Trial Documentation
3123	75	1611118311665:-476920065	1611118290802:-1374085427	D4190C00023	52	18	CREATE	2021-01-20 05:51:51.74	General	Other Meeting Material
3169	75	1611118313902:1745306617	1611118307616:1505345382	D4190C00023	56	45	CREATE	2021-01-20 05:51:53.978	Site Selection	Site Contact Details
3098	75	1611118315659:882756560	1611118315112:1936728942	D4190C00023	59	58	CREATE	2021-01-20 05:51:55.735	IP Documentation	IP Sample Label
3100	75	1611118317008:-1397196057	1611118284713:-1916438262	D4190C00023	61	8	CREATE	2021-01-20 05:51:57.088	IP and Trial Supplies	Interactive Response Technology
3102	75	1611118318221:-1513915004	1611118317008:-1397196057	D4190C00023	63	61	CREATE	2021-01-20 05:51:58.3	Interactive Response Technology	IRT User Requirement Specification
3105	75	1611118320596:1809140435	1611118284713:-1916438262	D4190C00023	67	8	CREATE	2021-01-20 05:52:00.737	IP and Trial Supplies	Non-IP Documentation
3124	75	1611118323040:350063019	1611118290802:-1374085427	D4190C00023	71	18	CREATE	2021-01-20 05:52:03.121	General	Filenote
3184	75	1611118323668:-356020335	1611118309925:-697737919	D4190C00023	72	49	CREATE	2021-01-20 05:52:03.742	Central Trial Documents	Subject Documentation
3159	75	1611118325370:-910512289	1611118324775:-1055042490	D4190C00023	75	74	CREATE	2021-01-20 05:52:05.453	Trial Status Reporting	Pregnancy Report
3182	75	1611118328010:1442015658	1611118310487:1184606184	D4190C00023	79	50	CREATE	2021-01-20 05:52:08.089	Product and Trial Documentation	Protocol Amendment
3170	75	1611118328550:-961597029	1611118307068:1603840561	D4190C00023	80	44	CREATE	2021-01-20 05:52:08.628	Site Management	Site Management
3093	75	1611118330297:-1691555743	1611118285284:169843248	D4190C00023	83	9	CREATE	2021-01-20 05:52:10.386	IP Release Process Documentation	QP (Qualified Person) Certification
3191	75	1611118332057:947852846	1611118331445:294592306	D4190C00023	86	85	CREATE	2021-01-20 05:52:12.142	Regulatory	Trial Approval
3843	80	1611118357870:328591856	1611118354401:-764788218	D4190C00023	103	3	ALREADY AVAILABLE	2021-01-20 18:57:21.855	Site Set-up	Acceptance of Investigator Brochure
3837	80	1611118363479:286315461	1611118354401:-764788218	D4190C00023	59	3	ALREADY AVAILABLE	2021-01-20 18:57:21.856	Site Set-up	Principal Investigator Curriculum Vitae
3842	80	1611118364041:-614807915	1611118354401:-764788218	D4190C00023	93	3	ALREADY AVAILABLE	2021-01-20 18:57:21.856	Site Set-up	Sub-Investigator Curriculum Vitae
3832	80	1611118369574:645769565	1611118354401:-764788218	D4190C00023	4	3	ALREADY AVAILABLE	2021-01-20 18:57:21.856	Site Set-up	Financial Disclosure Form
3833	80	1611118371898:-1193488118	1611118354401:-764788218	D4190C00023	8	3	ALREADY AVAILABLE	2021-01-20 18:57:21.856	Site Set-up	Form FDA 1572
3834	80	1611118372455:-1133335321	1611118354401:-764788218	D4190C00023	9	3	ALREADY AVAILABLE	2021-01-20 18:57:21.856	Site Set-up	Site Staff Qualification Supporting Information
3835	80	1611118377785:-863014648	1611118354401:-764788218	D4190C00023	37	3	ALREADY AVAILABLE	2021-01-20 18:57:21.856	Site Set-up	IP Site Release Documentation
3836	80	1611165467085:-1801027003	1611118354401:-764788218	D4190C00023	51	3	CREATE	2021-01-20 18:57:47.251	Site Set-up	Other Curriculum Vitae
3117	75	1611118333263:-1805751758	1611118287159:-562415975	D4190C00023	88	12	CREATE	2021-01-20 05:52:13.342	Trial Oversight	Medical Monitoring Plan
3188	75	1611118335742:-2120833869	1611118309925:-697737919	D4190C00023	92	49	CREATE	2021-01-20 05:52:15.818	Central Trial Documents	General
3173	75	1611118336855:858950831	1611118307068:1603840561	D4190C00023	94	44	CREATE	2021-01-20 05:52:16.933	Site Management	Site Initiation
3194	75	1611118338609:2085037506	1611118338040:477918819	D4190C00023	97	96	CREATE	2021-01-20 05:52:18.684	Statistics	Statistics Oversight
3118	75	1611118339729:2118731023	1611118287159:-562415975	D4190C00023	99	12	CREATE	2021-01-20 05:52:19.808	Trial Oversight	Operational Procedure Manual
3187	75	1611118340289:-873709631	1611118323668:-356020335	D4190C00023	100	72	CREATE	2021-01-20 05:52:20.369	Subject Documentation	Subject Participation Card
3134	75	1611118342629:52906086	1611118312222:910595091	D4190C00023	103	53	CREATE	2021-01-20 05:52:22.706	Meetings	Trial Team Training Material
3197	75	1611118345634:171654942	1611118344992:-35311861	D4190C00023	108	107	CREATE	2021-01-20 05:52:25.712	Site	Site Management
3199	75	1611118346788:577427565	1611118346229:46931385	D4190C00023	110	109	CREATE	2021-01-20 05:52:26.864	Site Selection	Pre Trial Monitoring Report
3230	75	1611118348733:51885120	1611118348109:-1942566898	D4190C00023	113	112	CREATE	2021-01-20 05:52:28.809	Central Trial Documents	Subject Documentation
3237	75	1611118350421:-300690033	1611118349852:1768392499	D4190C00023	116	115	CREATE	2021-01-20 05:52:30.498	IP and Trial Supplies	IP Documentation
3089	75	1611118353283:-1699929693	1611118352190:1191511035	D4190C00023	121	119	CREATE	2021-01-20 05:52:33.363	Sample Documentation	Specimen Label
3202	75	1611118354401:-764788218	1611118345634:171654942	D4190C00023	123	108	CREATE	2021-01-20 05:52:34.479	Site Management	Site Set-up
3215	75	1611118355614:-1062802421	1611118345634:171654942	D4190C00023	125	108	CREATE	2021-01-20 05:52:35.691	Site Management	Site Management
3201	75	1611118357299:1263428656	1611118346229:46931385	D4190C00023	128	109	CREATE	2021-01-20 05:52:37.375	Site Selection	Confidentiality Agreement
3246	75	1611118359034:847772793	1611118358470:-554892274	D4190C00023	131	130	CREATE	2021-01-20 05:52:39.112	IRB/IEC and other Approvals	General
3252	75	1611118360593:1054732761	1611118344992:-35311861	D4190C00023	133	107	CREATE	2021-01-20 05:52:40.676	Site	Safety Reporting
3253	75	1611118361173:-980106582	1611118360593:1054732761	D4190C00023	134	133	CREATE	2021-01-20 05:52:41.252	Safety Reporting	General
3223	75	1611118362876:-915902284	1611118362285:228300024	D4190C00023	137	136	CREATE	2021-01-20 05:52:42.955	General	Relevant Communications
3206	75	1611118364041:-614807915	1611118354401:-764788218	D4190C00023	139	123	CREATE	2021-01-20 05:52:44.117	Site Set-up	Sub-Investigator Curriculum Vitae
3163	75	1611118365188:897585412	1611118364609:-1575661861	D4190C00023	141	140	CREATE	2021-01-20 05:52:45.269	Safety Documentation	Pharmacovigilance Database Line Listing
3269	75	1611118366935:-1497728851	1611118366364:1567783348	D4190C00023	144	143	CREATE	2021-01-20 05:52:47.01	Country	Site Management
3271	75	1611118368142:-955165673	1611118367486:-1946223830	D4190C00023	146	145	CREATE	2021-01-20 05:52:48.221	Site Selection	Sites Evaluated but not Selected
3258	75	1611118370767:-289119883	1611118370189:156785711	D4190C00023	150	149	CREATE	2021-01-20 05:52:50.842	Trial Management	Trial Oversight
3209	75	1611118372455:-1133335321	1611118354401:-764788218	D4190C00023	153	123	CREATE	2021-01-20 05:52:52.532	Site Set-up	Site Staff Qualification Supporting Information
3248	75	1611118373611:-1700142288	1611118358470:-554892274	D4190C00023	155	130	CREATE	2021-01-20 05:52:53.688	IRB/IEC and other Approvals	IRB or IEC Trial Approval
3250	75	1611118374764:2112787256	1611118373611:-1700142288	D4190C00023	157	155	CREATE	2021-01-20 05:52:54.843	IRB or IEC Trial Approval	IRB or IEC Compliance Documentation
3276	75	1611118376475:1451428367	1611118375871:-1034326000	D4190C00023	160	159	CREATE	2021-01-20 05:52:56.554	Central Trial Documents	Product and Trial Documentation
3104	75	1611118378917:88668141	1611118317008:-1397196057	D4190C00023	164	61	CREATE	2021-01-20 05:52:58.993	Interactive Response Technology	IRT Validation Certification
3264	75	1611118381006:-1223038678	1611118380404:-516285564	D4190C00023	166	165	CREATE	2021-01-20 05:53:01.084	Central and Local Testing	Facility Documentation
3267	75	1611118382703:-1903741846	1611118381006:-1223038678	D4190C00023	169	166	CREATE	2021-01-20 05:53:02.784	Facility Documentation	Normal Ranges
3241	75	1611118384970:-851016987	1611118384418:-544721581	D4190C00023	173	172	CREATE	2021-01-20 05:53:05.046	Non-IP Documentation	Non-IP Return Documentation
3232	75	1611118388941:1189528638	1611118348733:51885120	D4190C00023	180	113	CREATE	2021-01-20 05:53:09.017	Subject Documentation	Other Information Given to Subjects
3255	75	1611118391250:917863747	1611118360593:1054732761	D4190C00023	184	133	CREATE	2021-01-20 05:53:11.33	Safety Reporting	Trial Status Reporting
3233	75	1611118392436:-2038888332	1611118348733:51885120	D4190C00023	186	113	CREATE	2021-01-20 05:53:12.513	Subject Documentation	Informed Consent Form
3261	75	1611118395464:1915570502	1611118370189:156785711	D4190C00023	191	149	CREATE	2021-01-20 05:53:15.542	Trial Management	Trial Team
3226	75	1611118396597:-2077587214	1611118345634:171654942	D4190C00023	193	108	CREATE	2021-01-20 05:53:16.676	Site Management	Site Initiation
3214	75	1611118398453:-1177896454	1611118354401:-764788218	D4190C00023	196	123	CREATE	2021-01-20 05:53:18.535	Site Set-up	Site Signature Sheet
3243	75	1611118400150:-280593938	1611118349852:1768392499	D4190C00023	199	115	CREATE	2021-01-20 05:53:20.228	IP and Trial Supplies	Storage
3282	75	1611118401951:-1225874443	1611118387813:98084225	D4190C00023	201	178	CREATE	2021-01-20 05:53:22.028	Subject Documentation	Subject Participation Card
3141	75	1611118404331:-1276155350	1611118288829:61613925	D4190C00023	205	15	CREATE	2021-01-20 05:53:24.423	Third Parties	Third Party Oversight
3283	75	1611118405435:424134915	1611118366364:1567783348	D4190C00023	207	143	CREATE	2021-01-20 05:53:25.515	Country	IRB/IEC and other Approvals
3286	75	1611118407120:68549760	1611118366364:1567783348	D4190C00023	210	143	CREATE	2021-01-20 05:53:27.2	Country	Regulatory
3288	75	1611118408487:-1069630245	1611118407724:1521323061	D4190C00023	212	211	CREATE	2021-01-20 05:53:28.598	General	Relevant Communications
4123	82	1611633638975:-1139240195	1611633638250:-130934538	D5136C00008	96	95	CREATE	2021-01-26 05:00:39.061	05.03 Site Initiation	05.03.02 Site Training Material
4128	82	1611633642658:-1421657888	1611633640142:533683269	D5136C00008	101	98	CREATE	2021-01-26 05:00:42.748	05.04 Site Management	05.04.09 Inv Notification-SUSAR
4131	82	1611633644413:-257366779	1611633643846:-744493045	D5136C00008	104	103	CREATE	2021-01-26 05:00:44.497	05.05 General	05.05.01 Relevant Com_ication-Documents-Email
4132	82	1611633645058:1489862171	1611633643846:-744493045	D5136C00008	105	103	CREATE	2021-01-26 05:00:45.144	05.05 General	05.05.01 Relevant Communications-Mass Communication-Documents
5693	83	1611641655142:139909630	1611641654503:111781285	D5136C00008	646	645	CREATE	2021-01-26 07:14:15.227	2803 Davis, Bernard	02 Central Trial Documents
4138	82	1611633648608:497804235	1611633645572:-233503501	D5136C00008	111	106	CREATE	2021-01-26 05:00:48.696	06 IP and Trial Supplies	06.02 IP Release Process Documentation
4139	82	1611633649203:-1293044770	1611633648608:497804235	D5136C00008	112	111	CREATE	2021-01-26 05:00:49.295	06.02 IP Release Process Documentation	06.02.01 QP (Qualified Person) Certification
4142	82	1611633651196:415787218	1611633645572:-233503501	D5136C00008	115	106	CREATE	2021-01-26 05:00:51.288	06 IP and Trial Supplies	06.03 IP Allocation Documentation
4147	82	1611633654251:-167394712	1611633652995:-1827193367	D5136C00008	120	118	CREATE	2021-01-26 05:00:54.336	06.05 Non-IP Documentation	06.05.03 Non-IP Documentation of Return
4152	82	1611633657459:1726318288	1611633654821:838670961	D5136C00008	125	121	CREATE	2021-01-26 05:00:57.55	06.06 Interactive Response Technology	06.06.05 IRT User Notifications
4156	82	1611633659694:-271432071	1611633658524:-299226186	D5136C00008	129	127	CREATE	2021-01-26 05:00:59.778	07.01 Safety Documentation	07.01.02 Pharmacovigilance Database Line Listing
4158	82	1611633660969:-195266425	1611633657958:998844879	D5136C00008	131	126	CREATE	2021-01-26 05:01:01.057	07 Safety Reporting	07.02 Trial Status Reporting
4162	82	1611633663572:-1484878071	1611633657958:998844879	D5136C00008	135	126	CREATE	2021-01-26 05:01:03.66	07 Safety Reporting	07.03 General
4166	82	1611633671528:-1425332994	1611633664828:971975340	D5136C00008	139	137	CREATE	2021-01-26 05:01:11.615	Alert Letter _l Notifications	2016
4168	82	1611633672775:-1766462952	1611633664254:-141510675	D5136C00008	141	136	CREATE	2021-01-26 05:01:12.859	07.03.01 Re_-Safety-Email	CIOMS
4170	82	1611633674918:-350851273	1611633672775:-1766462952	D5136C00008	143	141	CREATE	2021-01-26 05:01:15.009	CIOMS	2017
3965	81	1611118345634:171654942	1611118344992:-35311861	D4190C00023	2	1	ALREADY AVAILABLE	2021-01-20 19:50:50.083	Site	Site Management
3978	81	1611118346229:46931385	1611118345634:171654942	D4190C00023	44	2	ALREADY AVAILABLE	2021-01-20 19:50:50.084	Site Management	Site Selection
3966	81	1611118354401:-764788218	1611118345634:171654942	D4190C00023	3	2	ALREADY AVAILABLE	2021-01-20 19:50:50.084	Site Management	Site Set-up
3971	81	1611118355614:-1062802421	1611118345634:171654942	D4190C00023	22	2	ALREADY AVAILABLE	2021-01-20 19:50:50.084	Site Management	Site Management
3980	81	1611118362285:228300024	1611118345634:171654942	D4190C00023	55	2	ALREADY AVAILABLE	2021-01-20 19:50:50.084	Site Management	General
3983	81	1611165495819:273762972	1611165491934:-502301281	D4190C00023	10	9	ALREADY AVAILABLE	2021-01-20 19:50:50.085	Regulatory	Trial Approval
3979	81	1611118347500:-1194827172	1611118346229:46931385	D4190C00023	45	44	ALREADY AVAILABLE	2021-01-20 19:50:50.086	Site Selection	Feasibility Documentation
3970	81	1611118364041:-614807915	1611118354401:-764788218	D4190C00023	52	3	ALREADY AVAILABLE	2021-01-20 19:50:50.086	Site Set-up	Sub-Investigator Curriculum Vitae
3967	81	1611118390677:455568956	1611118354401:-764788218	D4190C00023	4	3	ALREADY AVAILABLE	2021-01-20 19:50:50.086	Site Set-up	Protocol Signature Page
3968	81	1611118394820:-416480130	1611118354401:-764788218	D4190C00023	35	3	ALREADY AVAILABLE	2021-01-20 19:50:50.086	Site Set-up	Data Privacy Agreement
3969	81	1611118398453:-1177896454	1611118354401:-764788218	D4190C00023	43	3	ALREADY AVAILABLE	2021-01-20 19:50:50.086	Site Set-up	Site Signature Sheet
3972	81	1611118365825:821565278	1611118355614:-1062802421	D4190C00023	23	22	ALREADY AVAILABLE	2021-01-20 19:50:50.086	Site Management	Source Data
3973	81	1611118373058:2040418774	1611118355614:-1062802421	D4190C00023	24	22	ALREADY AVAILABLE	2021-01-20 19:50:50.086	Site Management	Subject Log
3974	81	1611118399572:696099	1611118355614:-1062802421	D4190C00023	47	22	ALREADY AVAILABLE	2021-01-20 19:50:50.086	Site Management	Visit Log
3981	81	1611118402592:570712243	1611118362285:228300024	D4190C00023	56	55	ALREADY AVAILABLE	2021-01-20 19:50:50.087	General	Tracking Information
3976	81	1611118397182:-230892822	1611118396597:-2077587214	D4190C00023	40	39	ALREADY AVAILABLE	2021-01-20 19:50:50.087	Site Initiation	Trial Initiation Monitoring Report
3996	81	1611118394264:-818358888	1611118393701:-1366616	D4190C00023	32	31	ALREADY AVAILABLE	2021-01-20 19:50:50.088	General	Tracking Information
4004	81	1611118400735:-1407716948	1611118400150:-280593938	D4190C00023	50	49	ALREADY AVAILABLE	2021-01-20 19:50:50.088	Storage	IP Storage Condition Documentation
4005	81	1611165482767:-620933537	1611118400150:-280593938	D4190C00023	51	49	ALREADY AVAILABLE	2021-01-20 19:50:50.088	Storage	IP Storage Condition Excursion Documentation
3990	81	1611118391813:-2026699038	1611118391250:917863747	D4190C00023	21	20	ALREADY AVAILABLE	2021-01-20 19:50:50.089	Trial Status Reporting	SAE Report
4001	81	1611118397788:790359467	1611118370767:-289119883	D4190C00023	42	41	ALREADY AVAILABLE	2021-01-20 19:50:50.089	Trial Oversight	Operational Procedure Manual
3999	81	1611118396022:-1446774683	1611118395464:1915570502	D4190C00023	38	37	ALREADY AVAILABLE	2021-01-20 19:50:50.089	Trial Team	Trial Team Details
3987	81	1611165494541:-1468278328	1611165493237:1706574044	D4190C00023	15	14	ALREADY AVAILABLE	2021-01-20 19:50:50.089	Trial Status Reporting	Regulatory Notification of Trial Termination
4009	81	1611165474968:-341403103	1611165473673:-548949282	D4190C00023	8	7	ALREADY AVAILABLE	2021-01-20 19:50:50.091	Trial Approval	Regulatory Authority Decision
4010	81	1611165478907:-1730080977	1611165473673:-548949282	D4190C00023	17	7	ALREADY AVAILABLE	2021-01-20 19:50:50.091	Trial Approval	Regulatory Submission
4012	81	1611165477594:1339314530	1611165476304:-590358146	D4190C00023	13	12	ALREADY AVAILABLE	2021-01-20 19:50:50.091	Trial Status Reporting	Regulatory Notification of Trial Termination
3984	81	1611168652020:-773634019	1611165495819:273762972	D4190C00023	11	10	CREATE	2021-01-20 19:50:52.106	Trial Approval	Regulatory Authority Decision
4013	81	1611168652590:-146963545	1611165476304:-590358146	D4190C00023	16	12	CREATE	2021-01-20 19:50:52.671	Trial Status Reporting	Regulatory Progress Report
4023	81	1611168653155:-1116095700	rootNode	D4190C00023	60	0	CREATE	2021-01-20 19:50:53.246		Generic Documents
4024	81	1611168653761:-662663759	1611168653155:-1116095700	D4190C00023	61	60	CREATE	2021-01-20 19:50:53.846	Generic Documents	Audit Trail
4025	81	1611168654303:1274097972	1611168653155:-1116095700	D4190C00023	62	60	CREATE	2021-01-20 19:50:54.385	Generic Documents	CRO eTMF Index
11567	86	\N	\N	D5170C00002	18	13	NEW	\N	05.04 Site Management	05.04.05 Additional Monitoring Activity
4026	81	1611168654873:-1380420441	1611168653155:-1116095700	D4190C00023	63	60	CREATE	2021-01-20 19:50:54.955	Generic Documents	Hash Values
4027	81	1611168655485:-944354712	1611168653155:-1116095700	D4190C00023	64	60	CREATE	2021-01-20 19:50:55.569	Generic Documents	Metadata
4174	82	1611633677425:878215908	1611633675544:-832317854	D5136C00008	147	144	CREATE	2021-01-26 05:01:17.512	eDC triggers and SAE reports	DEC_2016
4176	82	1611633678671:973917301	1611633675544:-832317854	D5136C00008	149	144	CREATE	2021-01-26 05:01:18.767	eDC triggers and SAE reports	Jan_2016
4177	82	1611633679311:1372071069	1611633675544:-832317854	D5136C00008	150	144	CREATE	2021-01-26 05:01:19.397	eDC triggers and SAE reports	Jul_2016
4181	82	1611633682027:-1481038501	1611633675544:-832317854	D5136C00008	154	144	CREATE	2021-01-26 05:01:22.113	eDC triggers and SAE reports	May_2016
4183	82	1611633683372:-1937496406	1611633675544:-832317854	D5136C00008	156	144	CREATE	2021-01-26 05:01:23.458	eDC triggers and SAE reports	Nov2016
4186	82	1611633685105:-612447916	1611633664254:-141510675	D5136C00008	159	136	CREATE	2021-01-26 05:01:25.195	07.03.01 Re_-Safety-Email	Internal Correspondence
4190	82	1611633687989:-1008667387	1611633686238:-591261556	D5136C00008	163	160	CREATE	2021-01-26 05:01:28.076	ISL	2017
4191	82	1611633695696:-377505882	1611633664254:-141510675	D5136C00008	164	136	CREATE	2021-01-26 05:01:44.462	07.03.01 Re_-Safety-Email	Sponsor SAE queries
4193	82	1611633720833:-497589883	1611633711829:-813954584	D5136C00008	166	165	CREATE	2021-01-26 05:02:00.921	Start up correspondences	2015
4198	82	1611633729816:687994357	1611633729251:949515046	D5136C00008	171	170	CREATE	2021-01-26 05:02:09.901	08.01 Facility Documentation	08.01.05 Manual
4200	82	1611633730950:-2141087264	1611633730364:1225538960	D5136C00008	173	172	CREATE	2021-01-26 05:02:11.034	08.02 Sample Documentation	08.02.05 Retained Body Fluids-Tissue Samples
4202	82	1611633732144:1841950717	1611633731495:-1800430298	D5136C00008	175	174	CREATE	2021-01-26 05:02:12.23	09 Third Party	09.01 Third Party Oversight
4206	82	1611633734707:-1456972668	1611633733990:-600357563	D5136C00008	179	178	CREATE	2021-01-26 05:02:14.794	09.02 Third Party Set-up	09.02.01 Confidentiality Agreement
4208	82	1611633735906:-541893922	1611633733990:-600357563	D5136C00008	181	178	CREATE	2021-01-26 05:02:17.424	09.02 Third Party Set-up	09.02.04 Roles and Responsibilities Matrix
4210	82	1611633738640:481580601	1611633737995:96987237	D5136C00008	183	182	CREATE	2021-01-26 05:02:18.727	09.03 General	09.03.01 Relevant Com_tions-Third Party-Email
4212	82	1611633739717:-1652999533	1611633739130:1114499820	D5136C00008	185	184	CREATE	2021-01-26 05:02:19.806	10 Data Management	10.01 Data Management Oversight
4215	82	1611633741505:967017086	1611633740845:-1237235519	D5136C00008	188	187	CREATE	2021-01-26 05:02:21.59	10.02 Data Capture	10.02.01 CRF Completion Requirements (Paper and EDC)
4221	82	1611633745025:-355202375	1611633742648:5105622	D5136C00008	194	190	CREATE	2021-01-26 05:02:25.114	10.03 Database	10.03.08 SAE Reconciliation (Paper and EDC)
4223	82	1611633763108:1191567590	1611633742648:5105622	D5136C00008	196	190	CREATE	2021-01-26 05:02:43.193	10.03 Database	10.03.11 Database Loc_pproval (Paper and EDC)
4225	82	1611633764295:1628439698	1611633739130:1114499820	D5136C00008	198	184	CREATE	2021-01-26 05:02:44.38	10 Data Management	10.04 EDC Management
4231	82	1611633769206:745005926	1611633766605:581871995	D5136C00008	204	201	CREATE	2021-01-26 05:02:49.734	10.05 General	10.05.03 Data Management-Sponsor Meeting Material
4236	82	1611633773030:-1848424021	1611633772440:2094256862	D5136C00008	209	208	CREATE	2021-01-26 05:02:53.115	11.02 Randomization	11.02.05 Randomization Sign Off
4240	82	1611633775360:1787355292	1611633774147:-1122726286	D5136C00008	213	211	CREATE	2021-01-26 05:02:55.45	11.03 Analysis	11.03.10 Final Analysis Output
3866	80	1611118370189:156785711	1611118344992:-35311861	D4190C00023	5	1	ALREADY AVAILABLE	2021-01-20 18:57:21.849	Site	Trial Management
3859	80	1611118346229:46931385	1611118345634:171654942	D4190C00023	57	2	ALREADY AVAILABLE	2021-01-20 18:57:21.852	Site Management	Site Selection
3846	80	1611118355614:-1062802421	1611118345634:171654942	D4190C00023	10	2	ALREADY AVAILABLE	2021-01-20 18:57:21.852	Site Management	Site Management
3855	80	1611118362285:228300024	1611118345634:171654942	D4190C00023	49	2	ALREADY AVAILABLE	2021-01-20 18:57:21.852	Site Management	General
3863	80	1611118396597:-2077587214	1611118345634:171654942	D4190C00023	83	2	ALREADY AVAILABLE	2021-01-20 18:57:21.852	Site Management	Site Initiation
3860	80	1611118346788:577427565	1611118346229:46931385	D4190C00023	58	57	ALREADY AVAILABLE	2021-01-20 18:57:21.855	Site Selection	Pre Trial Monitoring Report
3861	80	1611118347500:-1194827172	1611118346229:46931385	D4190C00023	87	57	ALREADY AVAILABLE	2021-01-20 18:57:21.855	Site Selection	Feasibility Documentation
3862	80	1611118357299:1263428656	1611118346229:46931385	D4190C00023	106	57	ALREADY AVAILABLE	2021-01-20 18:57:21.855	Site Selection	Confidentiality Agreement
3844	80	1611118355056:-1159091477	1611118354401:-764788218	D4190C00023	105	3	ALREADY AVAILABLE	2021-01-20 18:57:21.855	Site Set-up	Clinical Trial Agreement
3853	80	1611118356154:250197465	1611118355614:-1062802421	D4190C00023	102	10	ALREADY AVAILABLE	2021-01-20 18:57:21.856	Site Management	Final Trial Close Out Monitoring Report
3849	80	1611118356704:396830353	1611118355614:-1062802421	D4190C00023	44	10	ALREADY AVAILABLE	2021-01-20 18:57:21.856	Site Management	Monitoring Visit Follow-up Documentation
3851	80	1611118365825:821565278	1611118355614:-1062802421	D4190C00023	71	10	ALREADY AVAILABLE	2021-01-20 18:57:21.856	Site Management	Source Data
3847	80	1611118373058:2040418774	1611118355614:-1062802421	D4190C00023	11	10	ALREADY AVAILABLE	2021-01-20 18:57:21.856	Site Management	Subject Log
3848	80	1611118383852:-639221671	1611118355614:-1062802421	D4190C00023	43	10	ALREADY AVAILABLE	2021-01-20 18:57:21.856	Site Management	Monitoring Visit Report
3852	80	1611118399572:696099	1611118355614:-1062802421	D4190C00023	89	10	ALREADY AVAILABLE	2021-01-20 18:57:21.856	Site Management	Visit Log
3858	80	1611118362876:-915902284	1611118362285:228300024	D4190C00023	104	49	ALREADY AVAILABLE	2021-01-20 18:57:21.856	General	Relevant Communications
3856	80	1611118386665:-1376424946	1611118362285:228300024	D4190C00023	50	49	ALREADY AVAILABLE	2021-01-20 18:57:21.856	General	Filenote
3857	80	1611118402592:570712243	1611118362285:228300024	D4190C00023	96	49	ALREADY AVAILABLE	2021-01-20 18:57:21.856	General	Tracking Information
3864	80	1611118397182:-230892822	1611118396597:-2077587214	D4190C00023	84	83	ALREADY AVAILABLE	2021-01-20 18:57:21.856	Site Initiation	Trial Initiation Monitoring Report
3865	80	1611118399015:-825232402	1611118396597:-2077587214	D4190C00023	88	83	ALREADY AVAILABLE	2021-01-20 18:57:21.856	Site Initiation	Site Evidence of Training
3850	80	1611165472391:-1266624419	1611118355614:-1062802421	D4190C00023	61	10	CREATE	2021-01-20 18:57:52.56	Site Management	Protocol Deviations
3845	80	1611165484111:-2146662163	1611118354401:-764788218	D4190C00023	111	3	CREATE	2021-01-20 18:58:04.274	Site Set-up	Indemnity
3854	80	1611165489360:326813248	1611118355614:-1062802421	D4190C00023	117	10	CREATE	2021-01-20 18:58:09.524	Site Management	Notification to Investigators of Safety Information
3958	80	1611118366935:-1497728851	1611118366364:1567783348	D4190C00023	97	12	ALREADY AVAILABLE	2021-01-20 18:57:21.849	Country	Site Management
3945	80	1611118375871:-1034326000	1611118366364:1567783348	D4190C00023	31	12	ALREADY AVAILABLE	2021-01-20 18:57:21.849	Country	Central Trial Documents
3961	80	1611118367486:-1946223830	1611118366935:-1497728851	D4190C00023	119	97	ALREADY AVAILABLE	2021-01-20 18:57:21.853	Site Management	Site Selection
3959	80	1611118403164:760960628	1611118366935:-1497728851	D4190C00023	98	97	ALREADY AVAILABLE	2021-01-20 18:57:21.853	Site Management	General
3946	80	1611118376475:1451428367	1611118375871:-1034326000	D4190C00023	32	31	ALREADY AVAILABLE	2021-01-20 18:57:21.853	Central Trial Documents	Product and Trial Documentation
3948	80	1611118387813:98084225	1611118375871:-1034326000	D4190C00023	52	31	ALREADY AVAILABLE	2021-01-20 18:57:21.853	Central Trial Documents	Subject Documentation
3942	80	1611118407724:1521323061	1611118407120:68549760	D4190C00023	115	28	ALREADY AVAILABLE	2021-01-20 18:57:21.853	Regulatory	General
3962	80	1611118368142:-955165673	1611118367486:-1946223830	D4190C00023	120	119	ALREADY AVAILABLE	2021-01-20 18:57:21.856	Site Selection	Sites Evaluated but not Selected
3963	80	1611118368684:-416196695	1611118367486:-1946223830	D4190C00023	121	119	ALREADY AVAILABLE	2021-01-20 18:57:21.856	Site Selection	Feasibility Documentation
3960	80	1611118403720:-2059399481	1611118403164:760960628	D4190C00023	99	98	ALREADY AVAILABLE	2021-01-20 18:57:21.856	General	Tracking Information
3947	80	1611118377089:529850012	1611118376475:1451428367	D4190C00023	33	32	ALREADY AVAILABLE	2021-01-20 18:57:21.856	Product and Trial Documentation	Insurance
3949	80	1611118388380:-73607634	1611118387813:98084225	D4190C00023	53	52	ALREADY AVAILABLE	2021-01-20 18:57:21.856	Subject Documentation	Other Information Given to Subjects
3950	80	1611118392982:998808371	1611118387813:98084225	D4190C00023	75	52	ALREADY AVAILABLE	2021-01-20 18:57:21.856	Subject Documentation	Informed Consent Form
3951	80	1611118401951:-1225874443	1611118387813:98084225	D4190C00023	94	52	ALREADY AVAILABLE	2021-01-20 18:57:21.856	Subject Documentation	Subject Participation Card
3944	80	1611118408487:-1069630245	1611118407724:1521323061	D4190C00023	129	115	ALREADY AVAILABLE	2021-01-20 18:57:21.857	General	Relevant Communications
3955	80	1611165468372:2119509698	1611118366364:1567783348	D4190C00023	54	12	CREATE	2021-01-20 18:57:48.539	Country	Third Parties
3956	80	1611165469654:-940719694	1611165468372:2119509698	D4190C00023	55	54	CREATE	2021-01-20 18:57:49.819	Third Parties	Third Party Set-up
3957	80	1611165470965:1385586651	1611165469654:-940719694	D4190C00023	56	55	CREATE	2021-01-20 18:57:51.13	Third Party Set-up	Contractual Agreement
3940	80	1611165476304:-590358146	1611118407120:68549760	D4190C00023	65	28	CREATE	2021-01-20 18:57:56.47	Regulatory	Trial Status Reporting
3941	80	1611165477594:1339314530	1611165476304:-590358146	D4190C00023	66	65	CREATE	2021-01-20 18:57:57.769	Trial Status Reporting	Regulatory Notification of Trial Termination
3939	80	1611165478907:-1730080977	1611165473673:-548949282	D4190C00023	67	63	CREATE	2021-01-20 18:57:59.081	Trial Approval	Regulatory Submission
3953	80	1611165480198:-88343988	1611118375871:-1034326000	D4190C00023	78	31	CREATE	2021-01-20 18:58:00.369	Central Trial Documents	General
3954	80	1611165481476:-675102257	1611165480198:-88343988	D4190C00023	79	78	CREATE	2021-01-20 18:58:01.644	General	Tracking Information
3943	80	1611165487955:-1477553485	1611118407724:1521323061	D4190C00023	116	115	CREATE	2021-01-20 18:58:08.123	General	Filenote
3952	80	1611165498469:204700538	1611118387813:98084225	D4190C00023	127	52	CREATE	2021-01-20 18:58:18.646	Subject Documentation	Advertisements for Subject Recruitment
4247	82	1611633779372:1478779409	1611633778799:1307046762	D5136C00008	220	219	CREATE	2021-01-26 05:02:59.46	02.01 Trial Documents	02.01.03 Protocol Synopsis
4253	82	1611633782913:-1840313275	1611633781086:10116526	D5136C00008	226	223	CREATE	2021-01-26 05:03:03.004	02.02 Subject Documents	02.02.03 Informe_ent Form Templates
4257	82	1611633785292:-1423890426	1611633778165:-1580788740	D5136C00008	230	218	CREATE	2021-01-26 05:03:05.379	02 Central Trial Documents	02.04 General
4261	82	1611633787835:640698226	1611633787164:1537812839	D5136C00008	234	233	CREATE	2021-01-26 05:03:07.92	03.01 Trial Approval	03.01.01 Submission
4262	82	1611633788822:310395710	1611633787164:1537812839	D5136C00008	235	233	CREATE	2021-01-26 05:03:08.908	03.01 Trial Approval	03.01.02 Approval
4266	82	1611633791249:-2052250339	1611633789385:-545457047	D5136C00008	239	236	CREATE	2021-01-26 05:03:11.337	03.03 Trial Status Reporting	03.03.03 Notification of Trial Termination
4268	82	1611633792436:251057588	1611633791852:-1171837222	D5136C00008	241	240	CREATE	2021-01-26 05:03:12.522	03.04 General	03.04.01 Relevan_Start-Up-Documents
4270	82	1611633793882:-1149484920	1611633793297:-607882380	D5136C00008	243	242	CREATE	2021-01-26 05:03:13.968	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
4276	82	1611633799599:268451710	1611633798892:867900015	D5136C00008	249	248	CREATE	2021-01-26 05:03:19.687	05.05 General	05.05.01 Relevant Communications-Mass Communication-Documents
4281	82	1611633802722:388846497	1611633802093:1326305442	D5136C00008	254	253	CREATE	2021-01-26 05:03:22.991	09 Third Party	09.02 Third Party Set-up
4282	82	1611633803509:1449364982	1611633802722:388846497	D5136C00008	255	254	CREATE	2021-01-26 05:03:23.602	09.02 Third Party Set-up	09.02.04 Roles and Responsibilities Matrix
4286	82	1611633806925:1928517045	1611633806365:-771701492	D5136C00008	259	258	CREATE	2021-01-26 05:03:27.05	8701 El-Beshlawy, Amal	02 Central Trial Documents
4287	82	1611633807547:-1084872664	1611633806925:1928517045	D5136C00008	260	259	CREATE	2021-01-26 05:03:27.634	02 Central Trial Documents	02.02 Subject Documents
4291	82	1611633809960:-1263396366	1611633806365:-771701492	D5136C00008	264	258	CREATE	2021-01-26 05:03:30.046	8701 El-Beshlawy, Amal	03 Regulatory
4294	82	1611633811744:832936093	1611633806365:-771701492	D5136C00008	267	258	CREATE	2021-01-26 05:03:31.828	8701 El-Beshlawy, Amal	04 IRB-IEC an_other Approvals
4296	82	1611633812880:-1325356215	1611633812326:492437771	D5136C00008	269	268	CREATE	2021-01-26 05:03:32.963	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
11568	86	\N	\N	D5170C00002	19	13	NEW	\N	05.04 Site Management	05.04.05 UNBLI_itoring Activity
4300	82	1611633815247:2028128151	1611633811744:832936093	D5136C00008	273	267	CREATE	2021-01-26 05:03:35.334	04 IRB-IEC an_other Approvals	04.03 Trial Status Reporting
4304	82	1611633817724:-1563013837	1611633806365:-771701492	D5136C00008	277	258	CREATE	2021-01-26 05:03:37.813	8701 El-Beshlawy, Amal	05 Site Management
4306	82	1611633818868:-1773377010	1611633818303:-165652764	D5136C00008	279	278	CREATE	2021-01-26 05:03:38.953	05.01 Site Selection	05.01.02 Confidentiality Agreement
4308	82	1611633820041:1475246888	1611633818303:-165652764	D5136C00008	281	278	CREATE	2021-01-26 05:03:40.126	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
4309	82	1611633820621:-329722076	1611633817724:-1563013837	D5136C00008	282	277	CREATE	2021-01-26 05:03:40.711	05 Site Management	05.02 Site Se_p Documentation
4315	82	1611633824674:1620904690	1611633820621:-329722076	D5136C00008	288	282	CREATE	2021-01-26 05:03:44.759	05.02 Site Se_p Documentation	05.02.08 Form FDA1572
4317	82	1611633825917:1251847380	1611633820621:-329722076	D5136C00008	290	282	CREATE	2021-01-26 05:03:46.002	05.02 Site Se_p Documentation	05.02.12 Clinical Trial Agreement
4319	82	1611633827065:218477983	1611633820621:-329722076	D5136C00008	292	282	CREATE	2021-01-26 05:03:47.151	05.02 Site Se_p Documentation	05.02.18 Site Signature Sheet
4322	82	1611633828864:1149698196	1611633827665:94376258	D5136C00008	295	293	CREATE	2021-01-26 05:03:48.947	05.03 Site Initiation	05.03.03 Site Training-Staff
4325	82	1611633830555:-1014064244	1611633829983:-878982745	D5136C00008	298	297	CREATE	2021-01-26 05:03:50.642	05.04 Site Management	05.04.01 Subject Log
4327	82	1611633845703:594694688	1611633829983:-878982745	D5136C00008	300	297	CREATE	2021-01-26 05:04:05.792	05.04 Site Management	05.04.04 Visit Log
4330	82	1611633848209:-519182249	1611633817724:-1563013837	D5136C00008	303	277	CREATE	2021-01-26 05:04:08.296	05 Site Management	05.05 General
5697	83	1611641657477:-638622732	1611641654503:111781285	D5136C00008	650	645	CREATE	2021-01-26 07:14:17.562	2803 Davis, Bernard	04 IRB-IEC and other Approvals
5698	83	1611641658050:62901831	1611641657477:-638622732	D5136C00008	651	650	CREATE	2021-01-26 07:14:18.136	04 IRB-IEC and other Approvals	04.02 Other Committees
5703	83	1611641661049:268681067	1611641659881:-534458741	D5136C00008	656	654	CREATE	2021-01-26 07:14:21.133	05.01 Site Selection	05.01.03 Feasibility Documentation
5706	83	1611641662791:-1014888702	1611641662194:936340320	D5136C00008	659	658	CREATE	2021-01-26 07:14:22.878	05.02 Site Se_p Documentation	05.02.01 Acceptance of Investigator Brochure
5707	83	1611641663367:818940250	1611641662194:936340320	D5136C00008	660	658	CREATE	2021-01-26 07:14:23.455	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
5713	83	1611641666868:-383059296	1611641662194:936340320	D5136C00008	666	658	CREATE	2021-01-26 07:14:26.953	05.02 Site Se_p Documentation	05.02.17 IP Site Release Documentation
5716	83	1611641668864:784370543	1611641668214:-1297771867	D5136C00008	669	668	CREATE	2021-01-26 07:14:28.949	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
5719	83	1611641670584:-1830622076	1611641659215:825789058	D5136C00008	672	653	CREATE	2021-01-26 07:14:30.669	05 Site Management	05.04 Site Management
5723	83	1611641672929:-621475796	1611641672347:-1911319765	D5136C00008	676	675	CREATE	2021-01-26 07:14:33.015	05.05 General	05.05.01 Rele_nications-Email
5727	83	1611641675302:19832219	1611641674713:1149004986	D5136C00008	680	679	CREATE	2021-01-26 07:14:35.405	06.01 IP Documentation	06.01.02 IP I_ns for Handling
5728	83	1611641675923:-1368288120	1611641674713:1149004986	D5136C00008	681	679	CREATE	2021-01-26 07:14:36.007	06.01 IP Documentation	06.01.04 IP S_t Documentation
5732	83	1611641678317:-1432090032	1611641677757:751154444	D5136C00008	685	684	CREATE	2021-01-26 07:14:38.401	06.04 Storage	06.04.01 Storage Condition Documentation
5735	83	1611641681904:-2134783063	1611641679556:869327954	D5136C00008	688	687	CREATE	2021-01-26 07:14:41.995	2804 Tsitsikas, Dimitris	02 Central Trial Documents
5737	83	1611641683076:389814636	1611641682511:756325895	D5136C00008	690	689	CREATE	2021-01-26 07:14:43.161	02.02 Subject Documents	02.02.03 Info_ Form Templates
5738	83	1611641683660:-928648616	1611641682511:756325895	D5136C00008	691	689	CREATE	2021-01-26 07:14:43.745	02.02 Subject Documents	02.02.07 Othe_ven to Subjects
5742	83	1611641686009:-719571360	1611641685430:-688787497	D5136C00008	695	694	CREATE	2021-01-26 07:14:46.094	04 IRB-IEC an_other Approvals	04.02 Other Committees
5746	83	1611641688365:-682582181	1611641687778:-1221740030	D5136C00008	699	698	CREATE	2021-01-26 07:14:48.452	05.01 Site Selection	05.01.02 Confidentiality Agreement
5749	83	1611641691263:1885868851	1611641687220:-567939092	D5136C00008	702	697	CREATE	2021-01-26 07:14:51.349	05 Site Management	05.02 Site Se_p Documentation
5751	83	1611641692456:257058411	1611641691263:1885868851	D5136C00008	704	702	CREATE	2021-01-26 07:14:52.541	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
5755	83	1611641695385:-366033018	1611641691263:1885868851	D5136C00008	708	702	CREATE	2021-01-26 07:14:55.471	05.02 Site Se_p Documentation	05.02.07 Site Qualification
5757	83	1611641696576:615215688	1611641691263:1885868851	D5136C00008	710	702	CREATE	2021-01-26 07:14:56.665	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
5761	83	1611641699194:-1544533753	1611641687220:-567939092	D5136C00008	714	697	CREATE	2021-01-26 07:14:59.282	05 Site Management	05.03 Site Initiation
5765	83	1611641702363:1777095758	1611641687220:-567939092	D5136C00008	718	697	CREATE	2021-01-26 07:15:02.449	05 Site Management	05.04 Site Management
5766	83	1611641703011:1477195479	1611641702363:1777095758	D5136C00008	719	718	CREATE	2021-01-26 07:15:03.095	05.04 Site Management	05.04.01 Subject Log
5770	83	1611641705372:1101925685	1611641702363:1777095758	D5136C00008	723	718	CREATE	2021-01-26 07:15:05.458	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
5774	83	1611641707764:-376358380	1611641679556:869327954	D5136C00008	727	687	CREATE	2021-01-26 07:15:07.85	2804 Tsitsikas, Dimitris	06 IP and Trial Supplies
5775	83	1611641708356:114558887	1611641707764:-376358380	D5136C00008	728	727	CREATE	2021-01-26 07:15:08.445	06 IP and Trial Supplies	06.01 IP Documentation
5780	83	1611641711428:-2077336445	1611641710870:-157562073	D5136C00008	733	732	CREATE	2021-01-26 07:15:11.523	06.04 Storage	06.04.01 Storage Condition Documentation
5784	83	1611641713844:585681397	1611641713265:-1534972663	D5136C00008	737	736	CREATE	2021-01-26 07:15:13.944	07 Safety Reporting	07.02 Trial Status Reporting
5785	83	1611641714463:833739382	1611641713844:585681397	D5136C00008	738	737	CREATE	2021-01-26 07:15:14.549	07.02 Trial Status Reporting	07.02.02 SAE Report
5791	83	1611641718087:1922868827	1611641717512:1455942024	D5136C00008	744	743	CREATE	2021-01-26 07:15:18.175	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
5795	83	1611641720506:-381439757	1611641719838:305747085	D5136C00008	748	747	CREATE	2021-01-26 07:15:20.595	01.05 General	01.05.02 Tracking Information
5796	83	1611641721078:-746356268	1611641718590:868406125	D5136C00008	749	745	CREATE	2021-01-26 07:15:21.164	UNITED STATES	02 Central Trial Documents
5800	83	1611641727969:-52582080	1611641721078:-746356268	D5136C00008	753	749	CREATE	2021-01-26 07:15:28.053	02 Central Trial Documents	02.02 Subject Documents
5802	83	1611641729202:1987570643	1611641727969:-52582080	D5136C00008	755	753	CREATE	2021-01-26 07:15:29.289	02.02 Subject Documents	02.02.03 Informed Consent Form Templates
5804	83	1611641730420:-209916714	1611641727969:-52582080	D5136C00008	757	753	CREATE	2021-01-26 07:15:30.509	02.02 Subject Documents	02.02.05 Subject Participation Card
5810	83	1611641734636:-162194106	1611641734072:692844924	D5136C00008	763	762	CREATE	2021-01-26 07:15:34.72	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
5814	83	1611641736995:424515100	1611641734636:-162194106	D5136C00008	767	763	CREATE	2021-01-26 07:15:37.08	04.01 IRB-IEC Trial Approval	04.01.05 IRB-IEC GCP Compliance Statement
4334	82	1611633903385:1071774038	1611633849968:-1663068523	D5136C00008	307	306	CREATE	2021-01-26 05:05:03.472	06.01 IP Documentation	06.01.05 Accountability Documentation
4336	82	1611633923041:-422931646	1611633849391:1288644580	D5136C00008	309	305	CREATE	2021-01-26 05:05:23.131	06 IP and Trial Supplies	06.04 Storage
4338	82	1611633924790:-535198706	1611633923041:-422931646	D5136C00008	311	309	CREATE	2021-01-26 05:05:24.878	06.04 Storage	06.04.03 Maintenance Logs
4339	82	1611633929220:-1664536893	1611633849391:1288644580	D5136C00008	312	305	CREATE	2021-01-26 05:05:29.308	06 IP and Trial Supplies	06.05 Non-IP Documentation
4343	82	1611633931837:-1961645667	1611633931245:-1787836062	D5136C00008	316	315	CREATE	2021-01-26 05:05:31.935	07.02 Trial Status Reporting	07.02.02 SAE Report
4346	82	1611633933732:-602135589	1611633932431:-1439428462	D5136C00008	319	317	CREATE	2021-01-26 05:05:33.821	07.03 General	07.03.01 Relevant Communications-Safety-Documents
4348	82	1611633935025:-1078345831	1611633934352:-1164023789	D5136C00008	321	320	CREATE	2021-01-26 05:05:35.113	8702 Hassab, Hoda	02 Central Trial Documents
4352	82	1611633937492:142556404	1611633936745:198340305	D5136C00008	325	324	CREATE	2021-01-26 05:05:37.578	03 Regulatory	03.01 Trial Approval
4355	82	1611633939171:2064106262	1611633938622:-609262867	D5136C00008	328	327	CREATE	2021-01-26 05:05:39.258	03.04 General	03.04.01 Relevant Communications-Regulatory-Start-Up-Documents
4356	82	1611633939803:2121051122	1611633934352:-1164023789	D5136C00008	329	320	CREATE	2021-01-26 05:05:39.888	8702 Hassab, Hoda	04 IRB-IEC an_other Approvals
4361	82	1611633942907:314242916	1611633942248:-661719985	D5136C00008	334	333	CREATE	2021-01-26 05:05:42.991	04.03 Trial Status Reporting	04.03.01 IRB-_ Info-Deviation
4365	82	1611633945189:-242716665	1611633944643:2119267773	D5136C00008	338	337	CREATE	2021-01-26 05:05:45.273	05 Site Management	05.01 Site Selection
4366	82	1611633945941:-677264746	1611633945189:-242716665	D5136C00008	339	338	CREATE	2021-01-26 05:05:46.024	05.01 Site Selection	05.01.02 Confidentiality Agreement
4370	82	1611633948400:-855807439	1611633947798:1228093005	D5136C00008	343	342	CREATE	2021-01-26 05:05:48.487	05.02 Site Se_p Documentation	05.02.01 Acceptance of Investigator Brochure
4374	82	1611633950873:-46479607	1611633947798:1228093005	D5136C00008	347	342	CREATE	2021-01-26 05:05:50.957	05.02 Site Se_p Documentation	05.02.07 Staff Qualification
4377	82	1611633952618:-1598364330	1611633947798:1228093005	D5136C00008	350	342	CREATE	2021-01-26 05:05:52.702	05.02 Site Se_p Documentation	05.02.12 Clinical Trial Agreement
4381	82	1611633955085:1971049562	1611633954423:-568374818	D5136C00008	354	353	CREATE	2021-01-26 05:05:55.17	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
4382	82	1611633955663:-437618997	1611633954423:-568374818	D5136C00008	355	353	CREATE	2021-01-26 05:05:55.747	05.03 Site Initiation	05.03.03 Site Training-Staff
4386	82	1611633958110:-942802019	1611633956904:-1275822697	D5136C00008	359	357	CREATE	2021-01-26 05:05:58.197	05.04 Site Management	05.04.03 Monitoring Visit Report
4392	82	1611633961607:-220993690	1611633961045:1038632832	D5136C00008	365	364	CREATE	2021-01-26 05:06:01.716	05.05 General	05.05.02 Tracking Information
4394	82	1611634014925:-1152458415	1611633962210:90314155	D5136C00008	367	366	CREATE	2021-01-26 05:06:55.052	06 IP and Trial Supplies	06.01 IP Documentation
4395	82	1611634106120:1263620549	1611634014925:-1152458415	D5136C00008	368	367	CREATE	2021-01-26 05:08:26.207	06.01 IP Documentation	06.01.05 Accountability Documentation
4400	82	1611634109494:1268191458	1611634108900:886163943	D5136C00008	373	372	CREATE	2021-01-26 05:08:29.58	07 Safety Reporting	07.02 Trial Status Reporting
4401	82	1611634110132:-1729510726	1611634109494:1268191458	D5136C00008	374	373	CREATE	2021-01-26 05:08:30.229	07.02 Trial Status Reporting	07.02.02 SAE Report
4405	82	1611634112416:1528001080	1611634111846:-90530030	D5136C00008	378	377	CREATE	2021-01-26 05:08:32.501	8703 Elalfy, Mohsen	02 Central Trial Documents
4409	82	1611634115038:124121426	1611634113141:1265678167	D5136C00008	382	379	CREATE	2021-01-26 05:08:35.124	02.02 Subject Documents	02.02.07 Othe_ven to Subjects
4410	82	1611634115684:996197201	1611634111846:-90530030	D5136C00008	383	377	CREATE	2021-01-26 05:08:35.769	8703 Elalfy, Mohsen	03 Regulatory
4414	82	1611634118116:-2128125074	1611634117491:-7197510	D5136C00008	387	386	CREATE	2021-01-26 05:08:38.204	04 IRB-IEC an_other Approvals	04.01 IRB-IEC Trial Approval
4419	82	1611634184976:-773797878	1611634176125:1365396096	D5136C00008	392	391	CREATE	2021-01-26 05:09:45.072	04.03 Trial Status Reporting	04.03.01 IRB-_ Info-Deviation
4421	82	1611634187103:8826074	1611634176125:1365396096	D5136C00008	394	391	CREATE	2021-01-26 05:09:51.158	04.03 Trial Status Reporting	04.03.03 IRB-_rm Notification
4424	82	1611634194541:216531853	1611634193596:1676667652	D5136C00008	397	396	CREATE	2021-01-26 05:09:54.628	05.01 Site Selection	05.01.02 Confidentiality Agreement
4425	82	1611634195214:-268502053	1611634193596:1676667652	D5136C00008	398	396	CREATE	2021-01-26 05:09:55.299	05.01 Site Selection	05.01.03 Feasibility Documentation
4429	82	1611634198418:-2071038452	1611634196456:926911165	D5136C00008	402	400	CREATE	2021-01-26 05:09:58.503	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
4434	82	1611634201744:122169335	1611634196456:926911165	D5136C00008	407	400	CREATE	2021-01-26 05:10:01.84	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
4435	82	1611634202377:1602293515	1611634196456:926911165	D5136C00008	408	400	CREATE	2021-01-26 05:10:02.464	05.02 Site Se_p Documentation	05.02.12 Clinical Trial Agreement
4522	82	1611634635807:1113031843	1611634530994:1521384230	D5136C00008	495	483	CREATE	2021-01-26 05:17:15.906	05 Site Management	05.03 Site Initiation
4439	82	1611634307906:-1880150025	1611634204475:911338816	D5136C00008	412	411	CREATE	2021-01-26 05:11:48.075	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
4441	82	1611634347570:2027998032	1611634204475:911338816	D5136C00008	414	411	CREATE	2021-01-26 05:12:27.655	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
4442	82	1611634348852:377671714	1611634192599:696569121	D5136C00008	415	395	CREATE	2021-01-26 05:12:28.938	05 Site Management	05.04 Site Management
4445	82	1611634351803:-721807839	1611634348852:377671714	D5136C00008	418	415	CREATE	2021-01-26 05:12:31.896	05.04 Site Management	05.04.04 Visit Log
4446	82	1611634352429:746730183	1611634348852:377671714	D5136C00008	419	415	CREATE	2021-01-26 05:12:32.515	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
4450	82	1611634427076:-1336907711	1611634192599:696569121	D5136C00008	423	395	CREATE	2021-01-26 05:13:47.16	05 Site Management	05.05 General
4455	82	1611634436355:-1279986279	1611634428789:1055488528	D5136C00008	428	426	CREATE	2021-01-26 05:13:56.44	06.01 IP Documentation	06.01.11 Certificate of Destruction
4459	82	1611634439003:1101399665	1611634111846:-90530030	D5136C00008	432	377	CREATE	2021-01-26 05:13:59.091	8703 Elalfy, Mohsen	07 Safety Reporting
4464	82	1611634441949:-346193256	1611634441361:-2005279210	D5136C00008	437	436	CREATE	2021-01-26 05:14:02.04	02 Central Trial Documents	02.01 Trial Documents
4228	82	1611633766605:581871995	1611633739130:1114499820	D5136C00008	201	184	CREATE	2021-01-26 05:02:46.695	10 Data Management	10.05 General
4466	82	1611634443148:-2065341942	1611634441949:-346193256	D5136C00008	439	437	CREATE	2021-01-26 05:14:03.25	02.01 Trial Documents	02.01.04 Protocol Amendment
4468	82	1611634444290:431288256	1611634441361:-2005279210	D5136C00008	441	436	CREATE	2021-01-26 05:14:04.38	02 Central Trial Documents	02.02 Subject Documents
5816	83	1611641738649:1950893660	1611641738023:646123431	D5136C00008	769	768	CREATE	2021-01-26 07:15:38.738	05 Site Management	05.02 Site Set-up Documentation
5820	83	1611641741022:463540751	1611641738023:646123431	D5136C00008	773	768	CREATE	2021-01-26 07:15:41.107	05 Site Management	05.05 General
5824	83	1611641743449:20537008	1611641742789:-1683491224	D5136C00008	777	776	CREATE	2021-01-26 07:15:43.599	01 Trial Management	01.01 Trial Oversight
5825	83	1611641744081:1949818558	1611641743449:20537008	D5136C00008	778	777	CREATE	2021-01-26 07:15:44.166	01.01 Trial Oversight	01.01.06 Recruitment Plan
5827	83	1611641745288:-1594877498	1611641744682:-462625009	D5136C00008	780	779	CREATE	2021-01-26 07:15:45.375	02 Central Trial Documents	02.02 Subject Documents
5833	83	1611641748876:1080004078	1611641742207:1213330506	D5136C00008	786	775	CREATE	2021-01-26 07:15:48.96	7801 Lanzkron, Sophie	03 Regulatory
5835	83	1611641750009:-1478510096	1611641749438:-674462754	D5136C00008	788	787	CREATE	2021-01-26 07:15:50.097	03.04 General	03.04.01 Rele_rt-Up-Documents
5836	83	1611641750589:-1824265611	1611641742207:1213330506	D5136C00008	789	775	CREATE	2021-01-26 07:15:50.673	7801 Lanzkron, Sophie	04 IRB-IEC an_other Approvals
5839	83	1611641752394:-1717467548	1611641751258:-540240332	D5136C00008	792	790	CREATE	2021-01-26 07:15:52.483	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
5844	83	1611641755337:-132630099	1611641750589:-1824265611	D5136C00008	797	789	CREATE	2021-01-26 07:15:55.423	04 IRB-IEC an_other Approvals	04.04 General
5845	83	1611641755974:-842926638	1611641755337:-132630099	D5136C00008	798	797	CREATE	2021-01-26 07:15:56.06	04.04 General	04.04.01 Rele_B-IEC-Documents
5850	83	1611641758984:-1205697307	1611641757766:1260846546	D5136C00008	803	801	CREATE	2021-01-26 07:15:59.069	05.01 Site Selection	05.01.03 Feasibility Documentation
5851	83	1611641759775:1970877688	1611641757766:1260846546	D5136C00008	804	801	CREATE	2021-01-26 07:15:59.865	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
5855	83	1611641762869:-430132829	1611641761013:1091716741	D5136C00008	808	805	CREATE	2021-01-26 07:16:02.964	05.02 Site Se_p Documentation	05.02.03 Prot_ Signature Page
8230	84	\N	\N	D5170C00002	2015	2013	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
4472	82	1611634446994:-1600685588	1611634444290:431288256	D5136C00008	445	441	CREATE	2021-01-26 05:14:07.089	02.02 Subject Documents	02.02.05 Subject Participation Card
4473	82	1611634447659:1164746214	1611634444290:431288256	D5136C00008	446	441	CREATE	2021-01-26 05:14:07.769	02.02 Subject Documents	02.02.06 Advertisements for Subject Recruitment
4478	82	1611634454928:-1300482490	1611634450752:-2100573888	D5136C00008	451	450	CREATE	2021-01-26 05:14:15.017	03 Regulatory	03.01 Trial Approval
4482	82	1611634459814:-1658629794	1611634458931:-1045254387	D5136C00008	455	454	CREATE	2021-01-26 05:14:19.903	03.02 Investigational Medicinal Product	03.02.02 Import-Export License
4484	82	1611634461078:-2081990109	1611634460502:-2125430507	D5136C00008	457	456	CREATE	2021-01-26 05:14:21.165	03.03 Trial Status Reporting	03.03.03 Notification of Trial Termination
4488	82	1611634463398:1627789727	1611634440712:1089216046	D5136C00008	461	435	CREATE	2021-01-26 05:14:23.486	FRANCE	04 IRB-IEC and other Approvals
4492	82	1611634465748:-1576068504	1611634463983:-788940127	D5136C00008	465	462	CREATE	2021-01-26 05:14:25.833	04.01 IRB-IEC Trial Approval	04.01.05 IRB-IEC GCP Compliance Statement
4494	82	1611634467315:-1033457797	1611634466529:-1543998616	D5136C00008	467	466	CREATE	2021-01-26 05:14:27.401	04.02 Other Committees	04.02.01 Other Submissions
4496	82	1611634468403:-1436752022	1611634467861:-891226557	D5136C00008	469	468	CREATE	2021-01-26 05:14:28.488	04.03 Trial Status Reporting	04.03.03 IRB-IEC_ Term Notification
4502	82	1611634471933:833480202	1611634471362:-1919023201	D5136C00008	475	474	CREATE	2021-01-26 05:14:32.019	09.02 Third Party Set-up	09.02.04 Roles and Responsibilities Matrix
4506	82	1611634522297:-1881403253	1611634493847:1488478382	D5136C00008	479	478	CREATE	2021-01-26 05:15:28.612	02.04 General	02.04.01 Rele_-Contact Report
4509	82	1611634530354:-1781072068	1611634529797:2109022025	D5136C00008	482	481	CREATE	2021-01-26 05:15:30.438	03.04 General	03.04.01 Rele_rt-Up-Documents
4512	82	1611634606247:-917816169	1611634598697:-1484073697	D5136C00008	485	484	CREATE	2021-01-26 05:16:46.333	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
4516	82	1611634608648:-1722306268	1611634606822:426374829	D5136C00008	489	486	CREATE	2021-01-26 05:16:48.731	05.02 Site Se_p Documentation	05.02.04 PI C_ite Affiliation
4517	82	1611634609312:-232677690	1611634606822:426374829	D5136C00008	490	486	CREATE	2021-01-26 05:16:49.398	05.02 Site Se_p Documentation	05.02.06 Othe_ite Affiliation
4521	82	1611634635216:971869291	1611634606822:426374829	D5136C00008	494	486	CREATE	2021-01-26 05:17:15.303	05.02 Site Se_p Documentation	05.02.18 Site Signature Sheet
11636	86	\N	\N	D5170C00002	87	79	NEW	\N	2001702 Abdul-Baki, Heitham	04 IRB-IEC and other Approvals
4526	82	1611634638391:-562556523	1611634530994:1521384230	D5136C00008	499	483	CREATE	2021-01-26 05:17:18.491	05 Site Management	05.04 Site Management
4527	82	1611634639120:67405872	1611634638391:-562556523	D5136C00008	500	499	CREATE	2021-01-26 05:17:19.217	05.04 Site Management	05.04.01 Subject Log
4530	82	1611634641495:-953063210	1611634638391:-562556523	D5136C00008	503	499	CREATE	2021-01-26 05:17:21.58	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
4535	82	1611634688731:633531067	1611634688119:-944099807	D5136C00008	508	507	CREATE	2021-01-26 05:18:08.816	06 IP and Trial Supplies	06.01 IP Documentation
4536	82	1611634689290:-1220793189	1611634688731:633531067	D5136C00008	509	508	CREATE	2021-01-26 05:18:09.377	06.01 IP Documentation	06.01.05 Acco_y Documentation
4542	82	1611634693086:-360837257	1611634692486:543633225	D5136C00008	515	514	CREATE	2021-01-26 05:18:13.173	07.02 Trial Status Reporting	07.02.02 SAE Report
4545	82	1611634694769:-1440080006	1611634694194:1013062304	D5136C00008	518	517	CREATE	2021-01-26 05:18:14.856	03 Regulatory	03.04 General
4546	82	1611634695389:1768726831	1611634694769:-1440080006	D5136C00008	519	518	CREATE	2021-01-26 05:18:15.475	03.04 General	03.04.01 Rele_rt-Up-Documents
4551	82	1611634698350:1423508124	1611634697783:-2069299963	D5136C00008	524	523	CREATE	2021-01-26 05:18:18.436	05.02 Site Se_p Documentation	05.02.01 Acceptance of Investigator Brochure
4553	82	1611634699603:895454942	1611634697783:-2069299963	D5136C00008	526	523	CREATE	2021-01-26 05:18:19.691	05.02 Site Se_p Documentation	05.02.04 PI C_ite Affiliation
4555	82	1611634700828:482787404	1611634697783:-2069299963	D5136C00008	528	523	CREATE	2021-01-26 05:18:20.914	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
4560	82	1611634703845:875950559	1611634703159:-943014702	D5136C00008	533	532	CREATE	2021-01-26 05:18:23.946	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
4562	82	1611634704990:-320311838	1611634703159:-943014702	D5136C00008	535	532	CREATE	2021-01-26 05:18:25.081	05.03 Site Initiation	05.03.03 Site_umentation-Site
4566	82	1611634707338:1009059610	1611634705558:38419245	D5136C00008	539	536	CREATE	2021-01-26 05:18:27.513	05.04 Site Management	05.04.04 Visit Log
4570	82	1611634709787:-181607047	1611634709194:-1819121280	D5136C00008	543	542	CREATE	2021-01-26 05:18:29.872	05.05 General	05.05.01 Rele_nications-Email
4572	82	1611634711335:-1344226520	1611634709194:-1819121280	D5136C00008	545	542	CREATE	2021-01-26 05:18:31.421	05.05 General	05.05.02 Tracking Information
4574	82	1611634712550:1285880308	1611634711956:-1289255951	D5136C00008	547	546	CREATE	2021-01-26 05:18:32.638	06 IP and Trial Supplies	06.01 IP Documentation
4579	82	1611634716081:1581069239	1611634693647:1967015484	D5136C00008	552	516	CREATE	2021-01-26 05:18:36.167	2302 Ame, Shanti	07 Safety Reporting
4580	82	1611634716714:-544577564	1611634716081:1581069239	D5136C00008	553	552	CREATE	2021-01-26 05:18:36.799	07 Safety Reporting	07.02 Trial Status Reporting
4584	82	1611634722387:931803228	1611634721761:421910909	D5136C00008	557	556	CREATE	2021-01-26 05:18:42.472	02 Central Trial Documents	02.04 General
4588	82	1611634724644:1943627674	1611634724087:-939038561	D5136C00008	561	560	CREATE	2021-01-26 05:18:44.739	03.04 General	03.04.01 Rele_rt-Up-Documents
4589	82	1611634725215:1548299131	1611634721197:-1154770586	D5136C00008	562	555	CREATE	2021-01-26 05:18:45.3	2303 Receveur_Marie Catherine	05 Site Management
4593	82	1611634727586:-784628112	1611634727016:-744888890	D5136C00008	566	565	CREATE	2021-01-26 05:18:47.716	05.02 Site Se_p Documentation	05.02.01 Acce_igator Brochure
4597	82	1611634729975:1910514827	1611634727016:-744888890	D5136C00008	570	565	CREATE	2021-01-26 05:18:50.06	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
4598	82	1611634730529:-580764969	1611634727016:-744888890	D5136C00008	571	565	CREATE	2021-01-26 05:18:50.614	05.02 Site Se_p Documentation	05.02.12 Clin_Trial Agreement
4603	82	1611634733331:1731185786	1611634732181:1756846328	D5136C00008	576	574	CREATE	2021-01-26 05:18:53.424	05.03 Site Initiation	05.03.03 Site Training-Staff
4607	82	1611634735623:489195634	1611634734503:343784815	D5136C00008	580	578	CREATE	2021-01-26 05:18:55.706	05.04 Site Management	05.04.03 Monitoring Visit Report
4608	82	1611634736188:-2064778223	1611634734503:343784815	D5136C00008	581	578	CREATE	2021-01-26 05:18:56.279	05.04 Site Management	05.04.04 Visit Log
4612	82	1611634738512:-2092217250	1611634737938:1143287821	D5136C00008	585	584	CREATE	2021-01-26 05:18:58.598	05.05 General	05.05.01 Rele_nications-Email
4616	82	1611634742678:-2060406633	1611634742128:-513081152	D5136C00008	589	588	CREATE	2021-01-26 05:19:02.761	06.01 IP Documentation	06.01.05 Acco_y Documentation
4617	82	1611634743341:-1172924780	1611634742128:-513081152	D5136C00008	590	588	CREATE	2021-01-26 05:19:03.428	06.01 IP Documentation	06.01.11 Cert_ of Destruction
4619	82	1611634744481:-757560168	1611634743935:-905510495	D5136C00008	592	591	CREATE	2021-01-26 05:19:04.566	06.04 Storage	06.04.01 Storage Condition Documentation
4621	82	1611634745633:52604794	1611634721197:-1154770586	D5136C00008	594	555	CREATE	2021-01-26 05:19:05.717	2303 Receveur_Marie Catherine	07 Safety Reporting
4628	82	1611634750195:-1779624801	1611634749078:-347551325	D5136C00008	601	600	CREATE	2021-01-26 05:19:10.282	TBD-1-1RACHLQ Dei-Adomakoh, Yvonne	05 Site Management
4629	82	1611634750851:191243606	1611634750195:-1779624801	D5136C00008	602	601	CREATE	2021-01-26 05:19:10.937	05 Site Management	05.01 Site Selection
4631	82	1611634751972:1652014839	1611634750851:191243606	D5136C00008	604	602	CREATE	2021-01-26 05:19:12.057	05.01 Site Selection	05.01.03 Feasibility Documentation
4635	82	1611634754550:-175228917	1611634753942:-324936041	D5136C00008	608	607	CREATE	2021-01-26 05:19:14.643	02.01 Trial Documents	02.01.01 Affidavit from Sponsor
4636	82	1611634755124:679501331	1611634753942:-324936041	D5136C00008	609	607	CREATE	2021-01-26 05:19:15.211	02.01 Trial Documents	02.01.03 Protocol Synopsis
4638	82	1611634756279:12800525	1611634753081:-774219405	D5136C00008	611	606	CREATE	2021-01-26 05:19:16.365	02 Central Trial Documents	02.02 Subject Documents
4640	82	1611634757568:-348620135	1611634756279:12800525	D5136C00008	613	611	CREATE	2021-01-26 05:19:17.653	02.02 Subject Documents	02.02.02 Subject Questionnaire
4641	82	1611634758265:-609880483	1611634756279:12800525	D5136C00008	614	611	CREATE	2021-01-26 05:19:18.352	02.02 Subject Documents	02.02.03 Informe_ent Form Templates
5859	83	1611641788036:-322479468	1611641761013:1091716741	D5136C00008	812	805	CREATE	2021-01-26 07:16:28.121	05.02 Site Se_p Documentation	05.02.08 Form FDA1572
5860	83	1611641788713:1591367391	1611641761013:1091716741	D5136C00008	813	805	CREATE	2021-01-26 07:16:28.799	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
5865	83	1611641791735:-1152043815	1611641791165:-1139191528	D5136C00008	818	817	CREATE	2021-01-26 07:16:31.819	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
5869	83	1611641794957:-1632419560	1611641794384:-2112550531	D5136C00008	822	821	CREATE	2021-01-26 07:16:35.043	05.04 Site Management	05.04.01 Subject Log
5873	83	1611641797363:-1972454648	1611641794384:-2112550531	D5136C00008	826	821	CREATE	2021-01-26 07:16:37.449	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
5874	83	1611641797937:2137788641	1611641794384:-2112550531	D5136C00008	827	821	CREATE	2021-01-26 07:16:42.834	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
5877	83	1611641804677:-682800165	1611641803433:902267177	D5136C00008	830	828	CREATE	2021-01-26 07:16:44.794	05.05 General	05.05.01 Rele_tions-Documents
5879	83	1611641805884:-59936057	1611641803433:902267177	D5136C00008	832	828	CREATE	2021-01-26 07:16:45.969	05.05 General	05.05.03 Meeting Material
5883	83	1611641808322:-1460575618	1611641807104:444092009	D5136C00008	836	834	CREATE	2021-01-26 07:16:48.52	06.01 IP Documentation	06.01.05 Accountability Documentation
5885	83	1611641809681:-616021753	1611641807104:444092009	D5136C00008	838	834	CREATE	2021-01-26 07:16:49.77	06.01 IP Documentation	06.01.11 Certificate of Destruction
5887	83	1611641810867:-1595695852	1611641810260:-1905283911	D5136C00008	840	839	CREATE	2021-01-26 07:16:50.952	06.04 Storage	06.04.01 Storage Condition Documentation
5893	83	1611641814480:-1327299701	1611641813889:1498893027	D5136C00008	846	845	CREATE	2021-01-26 07:16:54.586	07 Safety Reporting	07.02 Trial Status Reporting
5897	83	1611641816956:-636931721	1611641816352:547764742	D5136C00008	850	849	CREATE	2021-01-26 07:16:57.041	01 Trial Management	01.01 Trial Oversight
5898	83	1611641817561:2063509694	1611641816956:-636931721	D5136C00008	851	850	CREATE	2021-01-26 07:16:57.646	01.01 Trial Oversight	01.01.06 Recruitment Plan
5902	83	1611641820621:-1203481022	1611641818196:-135193323	D5136C00008	855	852	CREATE	2021-01-26 07:17:00.708	02 Central Trial Documents	02.04 General
5906	83	1611641822980:522407819	1611641822384:-667750441	D5136C00008	859	858	CREATE	2021-01-26 07:17:03.067	03 Regulatory	03.04 General
5907	83	1611641823632:-2002089796	1611641822980:522407819	D5136C00008	860	859	CREATE	2021-01-26 07:17:03.718	03.04 General	03.04.01 Rele_rt-Up-Documents
5909	83	1611641824765:1420293699	1611641824207:989038643	D5136C00008	862	861	CREATE	2021-01-26 07:17:04.85	04 IRB-IEC an_other Approvals	04.01 IRB-IEC Trial Approval
5913	83	1611641827179:-1925639085	1611641826509:883517444	D5136C00008	866	865	CREATE	2021-01-26 07:17:07.27	04.03 Trial Status Reporting	04.03.01 IRB-_ Info-Deviation
5916	83	1611641828877:-967378521	1611641815710:-328278205	D5136C00008	869	848	CREATE	2021-01-26 07:17:08.963	7802 Boccia, Ralph	05 Site Management
5921	83	1611641833440:-27058349	1611641828877:-967378521	D5136C00008	874	869	CREATE	2021-01-26 07:17:13.528	05 Site Management	05.02 Site Se_p Documentation
5922	83	1611641834005:1614724350	1611641833440:-27058349	D5136C00008	875	874	CREATE	2021-01-26 07:17:14.091	05.02 Site Se_p Documentation	05.02.01 Acceptance of Investigator Brochure
5925	83	1611641835745:621538623	1611641833440:-27058349	D5136C00008	878	874	CREATE	2021-01-26 07:17:15.84	05.02 Site Se_p Documentation	05.02.06 Othe_ite Affiliation
5927	83	1611641836860:469446528	1611641833440:-27058349	D5136C00008	880	874	CREATE	2021-01-26 07:17:16.948	05.02 Site Se_p Documentation	05.02.07 Staff Qualification
5934	83	1611641840881:-692014651	1611641840311:397050594	D5136C00008	887	886	CREATE	2021-01-26 07:17:20.975	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
5938	83	1611641843159:-1821003805	1611641842622:130323689	D5136C00008	891	890	CREATE	2021-01-26 07:17:23.244	05.04 Site Management	05.04.01 Subject Log
5941	83	1611641844887:-1165195214	1611641842622:130323689	D5136C00008	894	890	CREATE	2021-01-26 07:17:24.973	05.04 Site Management	05.04.05 Additional Monitoring Activity
5946	83	1611641847664:1837016720	1611641846524:490134794	D5136C00008	899	897	CREATE	2021-01-26 07:17:27.75	05.05 General	05.05.01 Rele_tions-Documents
5947	83	1611641848238:1573199888	1611641846524:490134794	D5136C00008	900	897	CREATE	2021-01-26 07:17:28.328	05.05 General	05.05.02 Tracking Information
5950	83	1611641850007:-1992430678	1611641849443:-1160745370	D5136C00008	903	902	CREATE	2021-01-26 07:17:30.093	06.01 IP Documentation	06.01.05 Accountability Documentation
4448	82	1611634422074:1525186683	1611634348852:377671714	D5136C00008	421	415	CREATE	2021-01-26 05:13:42.165	05.04 Site Management	05.04.09 Inv _o-Dr-HCP Letter
4647	82	1611634778649:768420291	1611634752450:778372697	D5136C00008	620	605	CREATE	2021-01-26 05:19:38.734	ITALY	03 Regulatory
4648	82	1611634779223:478497030	1611634778649:768420291	D5136C00008	621	620	CREATE	2021-01-26 05:19:39.31	03 Regulatory	03.01 Trial Approval
4650	82	1611634780459:-775619454	1611634779223:478497030	D5136C00008	623	621	CREATE	2021-01-26 05:19:40.544	03.01 Trial Approval	03.01.02 Approval
4655	82	1611634785355:1218985931	1611634782936:-1169326093	D5136C00008	628	627	CREATE	2021-01-26 05:19:45.442	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
4657	82	1611634786551:-21112414	1611634782936:-1169326093	D5136C00008	630	627	CREATE	2021-01-26 05:19:46.638	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
4659	82	1611634787747:498162568	1611634786551:-21112414	D5136C00008	632	630	CREATE	2021-01-26 05:19:47.833	04.03 Trial Status Reporting	04.03.03 IRB-IEC_ Term Notification
4665	82	1611634809988:936545905	1611634790707:1239281399	D5136C00008	638	637	CREATE	2021-01-26 05:20:10.317	06.07 General	06.07.01 Relevan_onal Product-Email
4666	82	1611634811520:1860553942	1611634790707:1239281399	D5136C00008	639	637	CREATE	2021-01-26 05:20:11.607	06.07 General	06.07.02 Tracking Information
4670	82	1611634813907:1400154817	1611634813341:-282849748	D5136C00008	643	642	CREATE	2021-01-26 05:20:13.995	02.02 Subject Documents	02.02.03 Info_ Form Templates
4674	82	1611634864617:1471197104	1611634863909:-1009365273	D5136C00008	647	646	CREATE	2021-01-26 05:21:04.702	02.04 General	02.04.01 Rele_tions-Documents
4675	82	1611634865168:-1597911788	1611634812168:-338813646	D5136C00008	648	640	CREATE	2021-01-26 05:21:05.254	4101 Forni, Gianluca	04 IRB-IEC an_other Approvals
4679	82	1611634867477:-347630410	1611634865168:-1597911788	D5136C00008	652	648	CREATE	2021-01-26 05:21:07.563	04 IRB-IEC an_other Approvals	04.03 Trial Status Reporting
4684	82	1611634870418:-1616134385	1611634869848:-234217722	D5136C00008	657	656	CREATE	2021-01-26 05:21:10.506	05.01 Site Selection	05.01.02 Confidentiality Agreement
4685	82	1611634871080:412882313	1611634869848:-234217722	D5136C00008	658	656	CREATE	2021-01-26 05:21:11.166	05.01 Site Selection	05.01.03 Feasibility Documentation
4688	82	1611634888735:499030595	1611634872212:1236581339	D5136C00008	661	660	CREATE	2021-01-26 05:21:28.822	05.02 Site Se_p Documentation	05.02.01 Acceptance of Investigator Brochure
4693	82	1611634891709:1692855610	1611634872212:1236581339	D5136C00008	666	660	CREATE	2021-01-26 05:21:31.794	05.02 Site Se_p Documentation	05.02.07 Staff Qualification
4694	82	1611634892256:-1721560503	1611634872212:1236581339	D5136C00008	667	660	CREATE	2021-01-26 05:21:32.344	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
4698	82	1611634918669:-558783148	1611634869278:-1918516378	D5136C00008	671	655	CREATE	2021-01-26 05:21:58.796	05 Site Management	05.03 Site Initiation
4702	82	1611634921359:-1265286826	1611634869278:-1918516378	D5136C00008	675	655	CREATE	2021-01-26 05:22:01.445	05 Site Management	05.04 Site Management
4706	82	1611634967661:-1172341655	1611634869278:-1918516378	D5136C00008	679	655	CREATE	2021-01-26 05:22:47.751	05 Site Management	05.05 General
4707	82	1611634968215:750042994	1611634967661:-1172341655	D5136C00008	680	679	CREATE	2021-01-26 05:22:48.299	05.05 General	05.05.01 Rele_nications-Email
4712	82	1611634971123:-1302542566	1611634969903:2071976112	D5136C00008	685	683	CREATE	2021-01-26 05:22:51.207	06.01 IP Documentation	06.01.05 Accountability Documentation
4715	82	1611634972925:1192866083	1611634972255:-1913212382	D5136C00008	688	687	CREATE	2021-01-26 05:22:53.012	06.04 Storage	06.04.01 Storage Condition Documentation
4716	82	1611634973489:-732522044	1611634972255:-1913212382	D5136C00008	689	687	CREATE	2021-01-26 05:22:53.575	06.04 Storage	06.04.03 Maintenance Logs
4720	82	1611634975872:-1339940573	1611634969322:932176620	D5136C00008	693	682	CREATE	2021-01-26 05:22:55.956	06 IP and Trial Supplies	06.07 General
4723	82	1611634981490:1690815957	1611634980918:-492476095	D5136C00008	696	695	CREATE	2021-01-26 05:23:01.588	07 Safety Reporting	07.02 Trial Status Reporting
4724	82	1611634982064:1706368272	1611634981490:1690815957	D5136C00008	697	696	CREATE	2021-01-26 05:23:02.173	07.02 Trial Status Reporting	07.02.02 SAE Report
4728	82	1611634990852:1753571129	1611634989056:-1584236725	D5136C00008	701	699	CREATE	2021-01-26 05:23:10.94	08.01 Facility Documentation	08.01.04 Norm_nd Alert Values
4732	82	1611634993259:-516063643	1611634992685:1252850792	D5136C00008	705	704	CREATE	2021-01-26 05:23:13.346	4102 De Franceschi, Lucia	02 Central Trial Documents
4733	82	1611634993832:1513901308	1611634993259:-516063643	D5136C00008	706	705	CREATE	2021-01-26 05:23:13.92	02 Central Trial Documents	02.02 Subject Documents
4737	82	1611634996260:-357027335	1611634995697:-92423588	D5136C00008	710	709	CREATE	2021-01-26 05:23:16.345	04 IRB-IEC an_other Approvals	04.01 IRB-IEC Trial Approval
4742	82	1611634999116:-792924899	1611634998016:-1280203450	D5136C00008	715	713	CREATE	2021-01-26 05:23:19.2	04.03 Trial Status Reporting	04.03.03 IRB-_rm Notification
4743	82	1611634999665:-1342325353	1611634992685:1252850792	D5136C00008	716	704	CREATE	2021-01-26 05:23:19.749	4102 De Franceschi, Lucia	05 Site Management
4747	82	1611635002046:424130711	1611635000232:601968163	D5136C00008	720	717	CREATE	2021-01-26 05:23:22.134	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
4751	82	1611635004327:-1917522803	1611635002613:1633128368	D5136C00008	724	721	CREATE	2021-01-26 05:23:24.413	05.02 Site Se_p Documentation	05.02.03 Prot_ Signature Page
4752	82	1611635004926:-2104243879	1611635002613:1633128368	D5136C00008	725	721	CREATE	2021-01-26 05:23:25.01	05.02 Site Se_p Documentation	05.02.04 PI C_ite Affiliation
4756	82	1611635007412:-217976916	1611635002613:1633128368	D5136C00008	729	721	CREATE	2021-01-26 05:23:27.495	05.02 Site Se_p Documentation	05.02.12 Clinical Trial Agreement
4760	82	1611635009780:-1933797769	1611635009234:-1798112347	D5136C00008	733	732	CREATE	2021-01-26 05:23:29.864	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
4762	82	1611635011359:-787710975	1611635009234:-1798112347	D5136C00008	735	732	CREATE	2021-01-26 05:23:31.444	05.03 Site Initiation	05.03.03 Site_umentation-Site
4766	82	1611635024885:1455181237	1611635012017:-551934266	D5136C00008	739	736	CREATE	2021-01-26 05:23:44.971	05.04 Site Management	05.04.04 Visit Log
4770	82	1611635027263:-954133956	1611635026080:-192123161	D5136C00008	743	741	CREATE	2021-01-26 05:23:47.349	05.05 General	05.05.02 Tracking Information
4771	82	1611635027829:-1857302476	1611634992685:1252850792	D5136C00008	744	704	CREATE	2021-01-26 05:23:47.916	4102 De Franceschi, Lucia	06 IP and Trial Supplies
4776	82	1611635031525:-208492443	1611635027829:-1857302476	D5136C00008	749	744	CREATE	2021-01-26 05:23:51.609	06 IP and Trial Supplies	06.04 Storage
4230	82	1611633768515:752554144	1611633766605:581871995	D5136C00008	203	201	CREATE	2021-01-26 05:02:48.6	10.05 General	10.05.01 Relevant Communications-Data Management-Documents
4780	82	1611635033901:-2030656299	1611635033309:502520415	D5136C00008	753	752	CREATE	2021-01-26 05:23:53.987	06.05 Non-IP Documentation	06.05.03 Non-_ation of Return
4781	82	1611635034464:241946041	1611635027829:-1857302476	D5136C00008	754	744	CREATE	2021-01-26 05:23:54.549	06 IP and Trial Supplies	06.07 General
4785	82	1611635036973:1797479166	1611635036250:1013022714	D5136C00008	758	757	CREATE	2021-01-26 05:23:57.057	07 Safety Reporting	07.02 Trial Status Reporting
4787	82	1611635038110:-1709568982	1611635036250:1013022714	D5136C00008	760	757	CREATE	2021-01-26 05:23:58.196	07 Safety Reporting	07.03 General
4789	82	1611635039309:-1576908759	1611635038110:-1709568982	D5136C00008	762	760	CREATE	2021-01-26 05:23:59.397	07.03 General	07.03.01 Rele_ns-Safety-Email
4794	82	1611635042296:1579870611	1611635040435:-1481630305	D5136C00008	767	764	CREATE	2021-01-26 05:24:02.382	08.01 Facility Documentation	08.01.07 Head of Facility CV
4796	82	1611635043526:-553468064	1611635042855:165472658	D5136C00008	769	768	CREATE	2021-01-26 05:24:03.611	08.02 Sample Documentation	08.02.03 Samp_e Condition Log
4798	82	1611635044640:-525120202	1611635044087:-1271912187	D5136C00008	771	770	CREATE	2021-01-26 05:24:04.759	08.03 General	08.03.01 Rele_l Lab-Documents
4804	82	1611635048181:-1368068921	1611635047615:196962608	D5136C00008	777	776	CREATE	2021-01-26 05:24:08.266	02 Central Trial Documents	02.04 General
4806	82	1611635049319:-1015188693	1611635045240:488517972	D5136C00008	779	772	CREATE	2021-01-26 05:24:09.405	4103 Maggio, Aurelio	04 IRB-IEC an_other Approvals
4807	82	1611635049907:144511447	1611635049319:-1015188693	D5136C00008	780	779	CREATE	2021-01-26 05:24:09.993	04 IRB-IEC an_other Approvals	04.01 IRB-IEC Trial Approval
4813	82	1611635053406:1762957859	1611635045240:488517972	D5136C00008	786	772	CREATE	2021-01-26 05:24:13.491	4103 Maggio, Aurelio	05 Site Management
4815	82	1611635054664:1225538559	1611635054074:-1900825982	D5136C00008	788	787	CREATE	2021-01-26 05:24:14.75	05.01 Site Selection	05.01.02 Confidentiality Agreement
4816	82	1611635055376:-1746991092	1611635054074:-1900825982	D5136C00008	789	787	CREATE	2021-01-26 05:24:15.466	05.01 Site Selection	05.01.03 Feasibility Documentation
4817	82	1611635055959:1427324186	1611635054074:-1900825982	D5136C00008	790	787	CREATE	2021-01-26 05:24:16.045	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
4819	82	1611635057184:1990678936	1611635056623:1912290443	D5136C00008	792	791	CREATE	2021-01-26 05:24:17.269	05.02 Site Se_p Documentation	05.02.01 Acceptance of Investigator Brochure
4823	82	1611635059554:847102143	1611635056623:1912290443	D5136C00008	796	791	CREATE	2021-01-26 05:24:19.638	05.02 Site Se_p Documentation	05.02.06 Othe_ite Affiliation
4825	82	1611635060772:-1383581646	1611635056623:1912290443	D5136C00008	798	791	CREATE	2021-01-26 05:24:20.857	05.02 Site Se_p Documentation	05.02.07 Staff Qualification
4827	82	1611635061930:1364692394	1611635056623:1912290443	D5136C00008	800	791	CREATE	2021-01-26 05:24:22.014	05.02 Site Se_p Documentation	05.02.12 Clinical Trial Agreement
4833	82	1611635066010:1138095803	1611635064264:2069480407	D5136C00008	806	803	CREATE	2021-01-26 05:24:26.095	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
4837	82	1611635068302:919334443	1611635066559:1363061601	D5136C00008	810	807	CREATE	2021-01-26 05:24:28.388	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
4839	82	1611635069486:-1122552518	1611635068943:1722862097	D5136C00008	812	811	CREATE	2021-01-26 05:24:29.571	05.05 General	05.05.01 Rele_nications-Email
4841	82	1611635070649:2005424397	1611635068943:1722862097	D5136C00008	814	811	CREATE	2021-01-26 05:24:30.735	05.05 General	05.05.02 Tracking Information
4845	82	1611635072896:1912606987	1611635071760:1132662206	D5136C00008	818	816	CREATE	2021-01-26 05:24:32.982	06.01 IP Documentation	06.01.10 IP Documentation Return
4849	82	1611635075295:1569676311	1611635071223:-2073499137	D5136C00008	822	815	CREATE	2021-01-26 05:24:35.381	06 IP and Trial Supplies	06.05 Non-IP Documentation
4850	82	1611635075886:-93405248	1611635075295:1569676311	D5136C00008	823	822	CREATE	2021-01-26 05:24:36.014	06.05 Non-IP Documentation	06.05.03 Non-_ation of Return
4854	82	1611635078231:1230985592	1611635077665:529885856	D5136C00008	827	826	CREATE	2021-01-26 05:24:38.316	07 Safety Reporting	07.02 Trial Status Reporting
4858	82	1611635080569:-1079021881	1611635080024:1468909366	D5136C00008	831	830	CREATE	2021-01-26 05:24:40.664	08.01 Facility Documentation	08.01.01 Cert_r Accreditation
4860	82	1611635081692:-912025379	1611635079459:-692151942	D5136C00008	833	829	CREATE	2021-01-26 05:24:41.784	08 Centralized Testing	08.02 Sample Documentation
4865	82	1611635084687:1142185195	1611635083928:-79353286	D5136C00008	838	837	CREATE	2021-01-26 05:24:44.772	01.05 General	01.05.02 Tracking Information
4869	82	1611635087126:1714063451	1611635085337:379127416	D5136C00008	842	839	CREATE	2021-01-26 05:24:47.302	02 Central Trial Documents	02.02 Subject Documents
4870	82	1611635087801:-516298708	1611635087126:1714063451	D5136C00008	843	842	CREATE	2021-01-26 05:24:56.257	02.02 Subject Documents	02.02.01 Subject Diary
4873	82	1611635179051:1878025536	1611635087126:1714063451	D5136C00008	846	842	CREATE	2021-01-26 05:26:19.151	02.02 Subject Documents	02.02.03 Informed Consent Form Checklists
4878	82	1611635232727:-1205186428	1611635232038:-1354748220	D5136C00008	851	850	CREATE	2021-01-26 05:27:12.811	02.04 General	02.04.01 Relevant Communications-Clinical Operations-Documents
4879	82	1611635233293:1558791006	1611635232038:-1354748220	D5136C00008	852	850	CREATE	2021-01-26 05:27:13.38	02.04 General	02.04.02 Tracking Information
4883	82	1611635236525:-1243994196	1611635234569:598329682	D5136C00008	856	854	CREATE	2021-01-26 05:27:16.614	03.01 Trial Approval	03.01.02 Approval
4887	82	1611635238984:-1419080457	1611635238416:1727145542	D5136C00008	860	859	CREATE	2021-01-26 05:27:19.153	03.03 Trial Status Reporting	03.03.02 Progress Report
4890	82	1611635240828:-1972852746	1611635240183:-1921798044	D5136C00008	863	862	CREATE	2021-01-26 05:27:20.914	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
4892	82	1611635241934:973810207	1611635240828:-1972852746	D5136C00008	865	863	CREATE	2021-01-26 05:27:22.019	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
4896	82	1611635257761:727214764	1611635257148:-993382180	D5136C00008	869	868	CREATE	2021-01-26 05:27:37.846	04.03 Trial Status Reporting	04.03.02 IRB-IEC Progress Report
4900	82	1611635277197:537419571	1611635269768:-361370040	D5136C00008	873	872	CREATE	2021-01-26 05:27:57.286	06.02 IP Release Process Documentation	06.02.02 IP Regulatory Release Documentation
4901	82	1611635284327:-2056777458	1611635082806:-1894530611	D5136C00008	874	835	CREATE	2021-01-26 05:28:04.413	KENYA	09 Third Party
4903	82	1611635295497:-1365904520	1611635285003:-1295722191	D5136C00008	876	875	CREATE	2021-01-26 05:28:15.586	09.02 Third Party Set-up	09.02.04 Roles and Responsibilities Matrix
4234	82	1611633771866:1527846712	1611633771235:-2048636475	D5136C00008	207	206	CREATE	2021-01-26 05:02:51.951	11.01 Statistics Oversight	11.01.01 Statistical Analysis Plan
4910	82	1611635305692:-414272022	1611635296374:708461817	D5136C00008	883	877	CREATE	2021-01-26 05:28:25.777	8502 Ogutu, Bernhards	03 Regulatory
4912	82	1611635307165:1662699400	1611635306403:547419586	D5136C00008	885	884	CREATE	2021-01-26 05:28:27.254	03.01 Trial Approval	03.01.01 Submission
4914	82	1611635308568:1714214786	1611635305692:-414272022	D5136C00008	887	883	CREATE	2021-01-26 05:28:28.654	03 Regulatory	03.02 Investi_dicinal Product
4917	82	1611635313319:-118391846	1611635312669:-1099842738	D5136C00008	890	889	CREATE	2021-01-26 05:28:33.407	04 IRB-IEC an_other Approvals	04.01 IRB-IEC Trial Approval
4918	82	1611635321706:1636212930	1611635313319:-118391846	D5136C00008	891	890	CREATE	2021-01-26 05:28:41.792	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
4919	82	1611635322296:-1247437630	1611635313319:-118391846	D5136C00008	892	890	CREATE	2021-01-26 05:28:42.381	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
4923	82	1611635327636:-706171261	1611635325881:1300728185	D5136C00008	896	893	CREATE	2021-01-26 05:28:47.723	04.03 Trial Status Reporting	04.03.03 IRB-_rm Notification
4928	82	1611635331549:-562817611	1611635328861:68431599	D5136C00008	901	898	CREATE	2021-01-26 05:28:51.634	05.01 Site Selection	05.01.03 Feasibility Documentation
4931	82	1611635334712:-929445568	1611635333181:-413398054	D5136C00008	904	903	CREATE	2021-01-26 05:28:54.799	05.02 Site Se_p Documentation	05.02.01 Acceptance of Investigator Brochure
4933	82	1611635336024:-2035844497	1611635333181:-413398054	D5136C00008	906	903	CREATE	2021-01-26 05:28:56.17	05.02 Site Se_p Documentation	05.02.04 PI C_ite Affiliation
4938	82	1611635339752:406652889	1611635333181:-413398054	D5136C00008	911	903	CREATE	2021-01-26 05:28:59.842	05.02 Site Se_p Documentation	05.02.12 Clinical Trial Agreement
4940	82	1611635340874:2033361197	1611635333181:-413398054	D5136C00008	913	903	CREATE	2021-01-26 05:29:00.958	05.02 Site Se_p Documentation	05.02.18 Site Signature Sheet
4942	82	1611635342103:-2085649724	1611635341509:-692674855	D5136C00008	915	914	CREATE	2021-01-26 05:29:02.196	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
4948	82	1611635346693:1840139756	1611635343851:-1226341957	D5136C00008	921	918	CREATE	2021-01-26 05:29:06.779	05.04 Site Management	05.04.04 Visit Log
5955	83	1611641853561:-1384650024	1611641853016:-125391627	D5136C00008	908	907	CREATE	2021-01-26 07:17:33.795	07 Safety Reporting	07.02 Trial Status Reporting
5956	83	1611641854265:-1334913610	1611641853561:-1384650024	D5136C00008	909	908	CREATE	2021-01-26 07:17:34.351	07.02 Trial Status Reporting	07.02.02 SAE Report
5960	83	1611641856549:-1614870835	1611641855992:-1347429425	D5136C00008	913	912	CREATE	2021-01-26 07:17:36.636	08 Centralized Testing	08.01 Facility Documentation
5964	83	1611641858821:1916082264	1611641858278:-1927931879	D5136C00008	917	916	CREATE	2021-01-26 07:17:38.906	7803 Chen, Ian	02 Central Trial Documents
5969	83	1611641863359:1876023154	1611641862740:1013851629	D5136C00008	922	921	CREATE	2021-01-26 07:17:43.444	02.04 General	02.04.01 Rele_-Contact Report
5971	83	1611641864494:-836255945	1611641858278:-1927931879	D5136C00008	924	916	CREATE	2021-01-26 07:17:44.581	7803 Chen, Ian	03 Regulatory
5973	83	1611641865587:1836212945	1611641865032:1513460493	D5136C00008	926	925	CREATE	2021-01-26 07:17:45.709	03.04 General	03.04.01 Rele_-Start-Up-Email
5974	83	1611641866186:-1841936032	1611641865032:1513460493	D5136C00008	927	925	CREATE	2021-01-26 07:17:46.281	03.04 General	03.04.01 Rele_rt-Up-Documents
5978	83	1611641868514:1306691595	1611641867323:112979452	D5136C00008	931	929	CREATE	2021-01-26 07:17:48.602	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
5985	83	1611641875861:1476439184	1611641874687:885376812	D5136C00008	938	936	CREATE	2021-01-26 07:17:55.948	05.01 Site Selection	05.01.03 Feasibility Documentation
5986	83	1611641876402:1234831480	1611641874687:885376812	D5136C00008	939	936	CREATE	2021-01-26 07:17:56.486	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
5990	83	1611641879681:1165583010	1611641877922:281074540	D5136C00008	943	940	CREATE	2021-01-26 07:17:59.765	05.02 Site Se_p Documentation	05.02.03 Protocol Amendment Signature Page
5992	83	1611641880829:1037656376	1611641877922:281074540	D5136C00008	945	940	CREATE	2021-01-26 07:18:00.915	05.02 Site Se_p Documentation	05.02.06 Other CV-Site Affiliation
5996	83	1611641883347:-218564428	1611641877922:281074540	D5136C00008	949	940	CREATE	2021-01-26 07:18:03.432	05.02 Site Se_p Documentation	05.02.12 Clinical Trial Agreement
6000	83	1611641885656:398328306	1611641885102:705183483	D5136C00008	953	952	CREATE	2021-01-26 07:18:05.74	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
6005	83	1611641888519:1670265798	1611641886849:1367467310	D5136C00008	958	955	CREATE	2021-01-26 07:18:08.605	05.04 Site Management	05.04.05 Additional Monitoring Activity
6006	83	1611641889181:-66309522	1611641886849:1367467310	D5136C00008	959	955	CREATE	2021-01-26 07:18:09.278	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
6010	83	1611641891454:643340897	1611641889731:91624976	D5136C00008	963	960	CREATE	2021-01-26 07:18:11.541	05.05 General	05.05.02 Tracking Information
6014	83	1611641893734:-331669559	1611641892587:-928009258	D5136C00008	967	965	CREATE	2021-01-26 07:18:13.82	06.01 IP Documentation	06.01.05 Accountability Documentation
6015	83	1611641894374:663551206	1611641892587:-928009258	D5136C00008	968	965	CREATE	2021-01-26 07:18:14.463	06.01 IP Documentation	06.01.11 Certificate of Destruction
6019	83	1611641896673:1172479281	1611641895482:1014769913	D5136C00008	972	970	CREATE	2021-01-26 07:18:16.758	08.01 Facility Documentation	08.01.04 Normal Ranges and Alert Values
6025	83	1611641900074:2073531444	1611641897787:584577030	D5136C00008	978	974	CREATE	2021-01-26 07:18:20.164	7804 Kanter Washko, Julie	02 Central Trial Documents
6027	83	1611641901270:-689921189	1611641900718:-628926654	D5136C00008	980	979	CREATE	2021-01-26 07:18:21.355	02.02 Subject Documents	02.02.03 Info_ Form Templates
6029	83	1611641902435:1036645038	1611641900074:2073531444	D5136C00008	982	978	CREATE	2021-01-26 07:18:22.52	02 Central Trial Documents	02.04 General
6035	83	1611641905826:977950492	1611641897787:584577030	D5136C00008	988	974	CREATE	2021-01-26 07:18:25.913	7804 Kanter Washko, Julie	04 IRB-IEC an_other Approvals
6036	83	1611641906419:-702978421	1611641905826:977950492	D5136C00008	989	988	CREATE	2021-01-26 07:18:26.505	04 IRB-IEC an_other Approvals	04.01 IRB-IEC Trial Approval
6038	83	1611641907549:-497433040	1611641906419:-702978421	D5136C00008	991	989	CREATE	2021-01-26 07:18:27.635	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
6042	83	1611641909850:1106937592	1611641908756:-1236540149	D5136C00008	995	993	CREATE	2021-01-26 07:18:29.933	04.03 Trial Status Reporting	04.03.03 IRB-_rm Notification
14312	88	1617049781649:846308156	1617049777304:1085508340	D5170C00001	2	1	ALREADY AVAILABLE	2021-03-30 07:19:37.236	eTMF	Acquisition Assessments
4950	82	1611635348255:2108207667	1611635343851:-1226341957	D5136C00008	923	918	CREATE	2021-01-26 05:29:08.341	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
4952	82	1611635350144:-1091244429	1611635349334:-1306233362	D5136C00008	925	924	CREATE	2021-01-26 05:29:10.241	05.05 General	05.05.01 Rele_tions-Documents
4956	82	1611635353063:-2107995233	1611635352447:1124608392	D5136C00008	929	928	CREATE	2021-01-26 05:29:13.152	06.01 IP Documentation	06.01.04 IP Shipment Documentation
4960	82	1611635363826:757049518	1611635363047:-1224778137	D5136C00008	933	932	CREATE	2021-01-26 05:29:38.422	06.04 Storage	06.04.01 Storage Condition Documentation
4961	82	1611635379426:-250113872	1611635351882:-786034451	D5136C00008	934	927	CREATE	2021-01-26 05:29:39.658	06 IP and Trial Supplies	06.05 Non-IP Documentation
4965	82	1611635382706:978631184	1611635381946:-1712443188	D5136C00008	938	937	CREATE	2021-01-26 05:29:42.791	07.02 Trial Status Reporting	07.02.02 SAE Report
4969	82	1611635401312:1561610362	1611635385557:422497386	D5136C00008	942	941	CREATE	2021-01-26 05:30:01.412	08 Centralized Testing	08.01 Facility Documentation
4970	82	1611635401948:-1242661883	1611635401312:1561610362	D5136C00008	943	942	CREATE	2021-01-26 05:30:02.039	08.01 Facility Documentation	08.01.02 Lab _cation Document
4975	82	1611635407019:-341956019	1611635404231:-555768457	D5136C00008	948	946	CREATE	2021-01-26 05:30:07.118	08.02 Sample Documentation	08.02.03 Samp_e Condition Log
4980	82	1611635425151:-1632139843	1611635423215:407261501	D5136C00008	953	950	CREATE	2021-01-26 05:30:25.238	02 Central Trial Documents	02.02 Subject Documents
18405	91	1625578788152:-1490134762	1625578787595:-65419865	D5160C00019	9	8	CREATE	2021-07-06 15:39:48.255	contents	01 Trial Management
4981	82	1611635425730:-1436818173	1611635425151:-1632139843	D5136C00008	954	953	CREATE	2021-01-26 05:30:25.816	02.02 Subject Documents	02.02.03 Info_ Form Templates
4986	82	1611635465746:-334904021	1611635464762:-2081542000	D5136C00008	959	958	CREATE	2021-01-26 05:31:05.833	03 Regulatory	03.01 Trial Approval
4989	82	1611635468196:1821835600	1611635464762:-2081542000	D5136C00008	962	958	CREATE	2021-01-26 05:31:08.286	03 Regulatory	03.02 Investigational Medicinal Product
4990	82	1611635468774:-618757814	1611635468196:1821835600	D5136C00008	963	962	CREATE	2021-01-26 05:31:08.959	03.02 Investigational Medicinal Product	03.02.02 Import-Export License
4995	82	1611635472028:730231795	1611635471392:-1128075006	D5136C00008	968	967	CREATE	2021-01-26 05:31:12.119	04 IRB-IEC an_other Approvals	04.01 IRB-IEC Trial Approval
4999	82	1611635475859:-1442250944	1611635471392:-1128075006	D5136C00008	972	967	CREATE	2021-01-26 05:31:16.032	04 IRB-IEC an_other Approvals	04.03 Trial Status Reporting
5000	82	1611635478039:-1727530256	1611635475859:-1442250944	D5136C00008	973	972	CREATE	2021-01-26 05:31:18.125	04.03 Trial Status Reporting	04.03.01 IRB-_ Info-Deviation
5004	82	1611635480419:156813326	1611635479845:1450478222	D5136C00008	977	976	CREATE	2021-01-26 05:31:20.507	04.04 General	04.04.01 Rele_B-IEC-Documents
5008	82	1611635483168:-15088701	1611635481647:-1827529987	D5136C00008	981	979	CREATE	2021-01-26 05:31:23.257	05.01 Site Selection	05.01.02 Confidentiality Agreement
5009	82	1611635483831:-1302045199	1611635481647:-1827529987	D5136C00008	982	979	CREATE	2021-01-26 05:31:23.916	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
5013	82	1611635486445:768355333	1611635484407:-1992490455	D5136C00008	986	983	CREATE	2021-01-26 05:31:26.534	05.02 Site Se_p Documentation	05.02.04 PI CV-Site Affiliation
5016	82	1611635488404:-788628304	1611635484407:-1992490455	D5136C00008	989	983	CREATE	2021-01-26 05:31:28.49	05.02 Site Se_p Documentation	05.02.07 Staff Qualification
5018	82	1611635489850:-1086057372	1611635484407:-1992490455	D5136C00008	991	983	CREATE	2021-01-26 05:31:29.941	05.02 Site Se_p Documentation	05.02.12 Clinical Trial Agreement
5021	82	1611635492128:-1568402730	1611635481045:-428477712	D5136C00008	994	978	CREATE	2021-01-26 05:31:32.216	05 Site Management	05.03 Site Initiation
5024	82	1611635494450:1182044354	1611635492128:-1568402730	D5136C00008	997	994	CREATE	2021-01-26 05:31:34.537	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
5030	82	1611635501070:-322336917	1611635495407:1753205563	D5136C00008	1003	998	CREATE	2021-01-26 05:31:41.159	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
5031	82	1611635506396:-106446153	1611635481045:-428477712	D5136C00008	1004	978	CREATE	2021-01-26 05:31:46.482	05 Site Management	05.05 General
5034	82	1611635508553:-233735518	1611635407656:1770977111	D5136C00008	1007	949	CREATE	2021-01-26 05:31:48.763	8503 Nduba, Videlis	06 IP and Trial Supplies
5035	82	1611635509263:374373782	1611635508553:-233735518	D5136C00008	1008	1007	CREATE	2021-01-26 05:31:49.349	06 IP and Trial Supplies	06.01 IP Documentation
5038	82	1611635511176:512585597	1611635509263:374373782	D5136C00008	1011	1008	CREATE	2021-01-26 05:31:51.261	06.01 IP Documentation	06.01.11 Certificate of Destruction
5042	82	1611635513591:-405486703	1611635512945:-227597760	D5136C00008	1015	1014	CREATE	2021-01-26 05:31:53.723	Generic Documents	Audit Trail
5046	82	1611635516763:74842625	1611635515530:-1013398044	D5136C00008	1019	1018	CREATE	2021-01-26 05:31:56.894	Hash Values	Hash Value Software
6046	83	1611641912274:-1286239609	1611641911014:-1279628076	D5136C00008	999	997	CREATE	2021-01-26 07:18:32.36	05.01 Site Selection	05.01.03 Feasibility Documentation
6050	83	1611641914558:-604049874	1611641913429:191192203	D5136C00008	1003	1001	CREATE	2021-01-26 07:18:34.649	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
6054	83	1611641917376:992703442	1611641913429:191192203	D5136C00008	1007	1001	CREATE	2021-01-26 07:18:37.462	05.02 Site Se_p Documentation	05.02.07 Site Qualification
6056	83	1611641918547:-90444912	1611641913429:191192203	D5136C00008	1009	1001	CREATE	2021-01-26 07:18:38.633	05.02 Site Se_p Documentation	05.02.08 Form FDA1572
6060	83	1611641921090:-1053360071	1611641913429:191192203	D5136C00008	1013	1001	CREATE	2021-01-26 07:18:41.181	05.02 Site Se_p Documentation	05.02.18 Site Signature Sheet
6064	83	1611641932634:-9104203	1611641930683:-1727026827	D5136C00008	1017	1014	CREATE	2021-01-26 07:18:52.719	05.03 Site Initiation	05.03.03 Site_umentation-Site
6065	83	1611641933291:1594581466	1611641910396:-271802747	D5136C00008	1018	996	CREATE	2021-01-26 07:18:53.378	05 Site Management	05.04 Site Management
6069	83	1611641935636:-71975119	1611641933291:1594581466	D5136C00008	1022	1018	CREATE	2021-01-26 07:18:55.722	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
6075	83	1611641939187:-80222035	1611641897787:584577030	D5136C00008	1028	974	CREATE	2021-01-26 07:18:59.274	7804 Kanter Washko, Julie	06 IP and Trial Supplies
6077	83	1611641940370:-1014065280	1611641939789:462620448	D5136C00008	1030	1029	CREATE	2021-01-26 07:19:00.457	06.01 IP Documentation	06.01.04 IP S_t Documentation
6079	83	1611641941623:510145087	1611641939789:462620448	D5136C00008	1032	1029	CREATE	2021-01-26 07:19:01.712	06.01 IP Documentation	06.01.10 IP Documentation Return
6084	83	1611641944584:682895240	1611641943980:-1770206341	D5136C00008	1037	1036	CREATE	2021-01-26 07:19:04.676	06.04 Storage	06.04.01 Stor_n Documentation
4501	82	1611634471362:-1919023201	1611634470778:-409900022	D5136C00008	474	473	CREATE	2021-01-26 05:14:31.447	09 Third Party	09.02 Third Party Set-up
5050	83	1611635508553:-233735518	1611635407656:1770977111	D5136C00008	3	2	ALREADY AVAILABLE	2021-01-26 07:05:00.997	8503 Nduba, Videlis	06 IP and Trial Supplies
5052	83	1611641113741:-1004197534	1611635511774:1613375496	D5136C00008	5	4	CREATE	2021-01-26 07:05:13.844	06.04 Storage	06.04.03 Maintenance Logs
5055	83	1611641115499:-412359119	1611641114313:-1202754132	D5136C00008	8	6	CREATE	2021-01-26 07:05:15.585	06.05 Non-IP Documentation	06.05.03 Non-_ation of Return
5056	83	1611641116099:42796999	1611635407656:1770977111	D5136C00008	9	2	CREATE	2021-01-26 07:05:16.195	8503 Nduba, Videlis	07 Safety Reporting
5060	83	1611641118435:-957626241	1611641116099:42796999	D5136C00008	13	9	CREATE	2021-01-26 07:05:18.519	07 Safety Reporting	07.03 General
5064	83	1611641120711:993411845	1611641120162:342802980	D5136C00008	17	16	CREATE	2021-01-26 07:05:20.799	08.01 Facility Documentation	08.01.01 Cert_r Accreditation
5065	83	1611641121367:-1658590423	1611641120162:342802980	D5136C00008	18	16	CREATE	2021-01-26 07:05:21.455	08.01 Facility Documentation	08.01.04 Norm_nd Alert Values
5069	83	1611641124854:608995483	1611641124203:619314964	D5136C00008	22	21	CREATE	2021-01-26 07:05:24.945	10 Data Management	10.02 Data Capture
8367	84	\N	\N	D5170C00002	2152	2001	NEW	\N	Site	2002292 Tulassay, Zsolt
5073	83	1611641130852:-444519198	1611641126518:-1296583142	D5136C00008	26	25	CREATE	2021-01-26 07:05:30.938	02 Central Trial Documents	02.01 Trial Documents
5074	83	1611641131460:1915684886	1611641130852:-444519198	D5136C00008	27	26	CREATE	2021-01-26 07:05:31.547	02.01 Trial Documents	02.01.04 Protocol Amendment
5078	83	1611641135390:1630733315	1611641134791:-1832216870	D5136C00008	31	30	CREATE	2021-01-26 07:05:35.477	03 Regulatory	03.01 Trial Approval
5082	83	1611641137720:103577153	1611641134791:-1832216870	D5136C00008	35	30	CREATE	2021-01-26 07:05:37.822	03 Regulatory	03.03 Trial Status Reporting
5083	83	1611641138359:1355811535	1611641137720:103577153	D5136C00008	36	35	CREATE	2021-01-26 07:05:38.444	03.03 Trial Status Reporting	03.03.02 Progress Report
5087	83	1611641140629:1717486555	1611641139504:-299483099	D5136C00008	40	38	CREATE	2021-01-26 07:05:40.715	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
5089	83	1611641141859:2046833069	1611641141269:1119647541	D5136C00008	42	41	CREATE	2021-01-26 07:05:41.946	04.03 Trial Status Reporting	04.03.01 IRB-_ Info-Deviation
5091	83	1611641145535:419840345	1611641138917:1902813811	D5136C00008	44	37	CREATE	2021-01-26 07:05:45.621	04 IRB-IEC an_other Approvals	04.04 General
5095	83	1611641147805:-1618829832	1611641147252:921451337	D5136C00008	48	47	CREATE	2021-01-26 07:05:47.889	05.01 Site Selection	05.01.01 Site Contact Details
5099	83	1611641155108:752353359	1611641146631:210546677	D5136C00008	52	46	CREATE	2021-01-26 07:05:55.194	05 Site Management	05.02 Site Se_p Documentation
5100	83	1611641155767:1062104931	1611641155108:752353359	D5136C00008	53	52	CREATE	2021-01-26 07:05:55.854	05.02 Site Se_p Documentation	05.02.01 Acce_igator Brochure
5105	83	1611641158616:-480513523	1611641155108:752353359	D5136C00008	58	52	CREATE	2021-01-26 07:05:58.701	05.02 Site Se_p Documentation	05.02.07 Staff Qualification
5106	83	1611641159163:133734003	1611641155108:752353359	D5136C00008	59	52	CREATE	2021-01-26 07:05:59.248	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
5110	83	1611641161682:-1478597346	1611641146631:210546677	D5136C00008	63	46	CREATE	2021-01-26 07:06:01.776	05 Site Management	05.03 Site Initiation
5114	83	1611641169363:-2013654227	1611641146631:210546677	D5136C00008	67	46	CREATE	2021-01-26 07:06:09.449	05 Site Management	05.04 Site Management
5118	83	1611641171642:800024689	1611641169363:-2013654227	D5136C00008	71	67	CREATE	2021-01-26 07:06:11.726	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
5119	83	1611641172196:-77226329	1611641169363:-2013654227	D5136C00008	72	67	CREATE	2021-01-26 07:06:12.283	05.04 Site Management	05.04.08 Fina_nitoring Report
5124	83	1611641175298:-1847480691	1611641174673:141149450	D5136C00008	77	76	CREATE	2021-01-26 07:06:15.383	06 IP and Trial Supplies	06.01 IP Documentation
5126	83	1611641176435:-1309203325	1611641175298:-1847480691	D5136C00008	79	77	CREATE	2021-01-26 07:06:16.52	06.01 IP Documentation	06.01.05 Acco_y Documentation
5128	83	1611641177645:-1856629220	1611641174673:141149450	D5136C00008	81	76	CREATE	2021-01-26 07:06:17.732	06 IP and Trial Supplies	06.04 Storage
5133	83	1611641180523:-1460102051	1611641179903:-883324184	D5136C00008	86	85	CREATE	2021-01-26 07:06:20.609	07.02 Trial Status Reporting	07.02.02 SAE Report
5137	83	1611641183456:1789426233	1611641125971:-2109224039	D5136C00008	90	24	CREATE	2021-01-26 07:06:23.543	TBD-1-1RACHEE Nduba, Videlis	08 Centralized Testing
5138	83	1611641184005:1485148585	1611641183456:1789426233	D5136C00008	91	90	CREATE	2021-01-26 07:06:24.093	08 Centralized Testing	08.01 Facility Documentation
5142	83	1611641186299:658710670	1611641185742:739824843	D5136C00008	95	94	CREATE	2021-01-26 07:06:26.394	08.02 Sample Documentation	08.02.03 Samp_e Condition Log
5143	83	1611641186875:491352654	1611641125971:-2109224039	D5136C00008	96	24	CREATE	2021-01-26 07:06:26.963	TBD-1-1RACHEE Nduba, Videlis	10 Data Management
5145	83	1611641188036:-325941744	1611641187430:1528821284	D5136C00008	98	97	CREATE	2021-01-26 07:06:28.126	10.02 Data Capture	10.02.03 Completed CRFs (Paper)
5147	83	1611641189205:-1645362497	1611641188634:1011967195	D5136C00008	100	99	CREATE	2021-01-26 07:06:29.291	TBD-1-1RACHJN Oyieko, Janet	05 Site Management
5149	83	1611641190333:-213574758	1611641189764:732813343	D5136C00008	102	101	CREATE	2021-01-26 07:06:30.418	05.01 Site Selection	05.01.02 Confidentiality Agreement
5154	83	1611641193753:-53242902	1611641193206:-1448325700	D5136C00008	107	106	CREATE	2021-01-26 07:06:33.84	02 Central Trial Documents	02.01 Trial Documents
5155	83	1611641194294:-1169250433	1611641193753:-53242902	D5136C00008	108	107	CREATE	2021-01-26 07:06:34.379	02.01 Trial Documents	02.01.06 Insurance
5158	83	1611641201701:-1770587503	1611641194952:724217392	D5136C00008	111	109	CREATE	2021-01-26 07:06:41.787	02.02 Subject Documents	02.02.02 Subject Questionnaire
5162	83	1611641205734:-1758079252	1611641194952:724217392	D5136C00008	115	109	CREATE	2021-01-26 07:06:45.821	02.02 Subject Documents	02.02.06 Adverti_ubject Recruitment
5163	83	1611641207750:-342018837	1611641194952:724217392	D5136C00008	116	109	CREATE	2021-01-26 07:06:47.835	02.02 Subject Documents	02.02.07 Other W_ Given to Subjects
5168	83	1611641210602:1906549998	1611641210051:-2123461994	D5136C00008	121	120	CREATE	2021-01-26 07:06:50.764	03 Regulatory	03.01 Trial Approval
5173	83	1611641213536:-179229825	1611641212925:1313737179	D5136C00008	126	125	CREATE	2021-01-26 07:06:53.621	05 Site Management	05.05 General
5176	83	1611641215217:1210344784	1611641214649:-2085192152	D5136C00008	129	128	CREATE	2021-01-26 07:06:55.305	06 IP and Trial Supplies	06.01 IP Documentation
5177	83	1611641215762:1621691564	1611641215217:1210344784	D5136C00008	130	129	CREATE	2021-01-26 07:06:55.845	06.01 IP Documentation	06.01.03 IP Sample Label
4237	82	1611633773590:-1013107688	1611633772440:2094256862	D5136C00008	210	208	CREATE	2021-01-26 05:02:53.674	11.02 Randomization	11.02.06 End of Trial-Interim Unblinding
5181	83	1611641217984:-1338634650	1611641216891:-215026989	D5136C00008	134	132	CREATE	2021-01-26 07:06:58.069	06.07 General	06.07.01 Relevant Communications-Investigational Product-Documents
5182	83	1611641218597:1342993808	1611641192586:-1906583418	D5136C00008	135	105	CREATE	2021-01-26 07:06:58.684	LEBANON	09 Third Party
5184	83	1611641219698:674724421	1611641219153:2031669099	D5136C00008	137	136	CREATE	2021-01-26 07:06:59.782	09.02 Third Party Set-up	09.02.04 Roles and Responsibilities Matrix
5193	83	1611641224898:-1787264290	1611641224326:-1469787599	D5136C00008	146	145	CREATE	2021-01-26 07:07:04.984	03 Regulatory	03.02 Investi_dicinal Product
5194	83	1611641225555:1208711332	1611641224898:-1787264290	D5136C00008	147	146	CREATE	2021-01-26 07:07:05.648	03.02 Investi_dicinal Product	03.02.02 Impo_-Export License
11637	86	\N	\N	D5170C00002	88	87	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
5196	83	1611641226684:-1843904240	1611641226118:-186216529	D5136C00008	149	148	CREATE	2021-01-26 07:07:06.769	03.03 Trial Status Reporting	03.03.01 Reg _o and Deviation
5202	83	1611641230216:1525345913	1611641229044:167385129	D5136C00008	155	153	CREATE	2021-01-26 07:07:10.302	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
5203	83	1611641230770:1586505160	1611641228476:450048179	D5136C00008	156	152	CREATE	2021-01-26 07:07:10.856	04 IRB-IEC an_other Approvals	04.03 Trial Status Reporting
5206	83	1611641232432:-1769405070	1611641220259:1485242300	D5136C00008	159	138	CREATE	2021-01-26 07:07:12.548	8801 Inati, Adlette	05 Site Management
5211	83	1611641235488:136088595	1611641232432:-1769405070	D5136C00008	164	159	CREATE	2021-01-26 07:07:15.574	05 Site Management	05.02 Site Se_p Documentation
5213	83	1611641236616:2061605481	1611641235488:136088595	D5136C00008	166	164	CREATE	2021-01-26 07:07:16.702	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
5215	83	1611641237830:32633499	1611641235488:136088595	D5136C00008	168	164	CREATE	2021-01-26 07:07:17.915	05.02 Site Se_p Documentation	05.02.06 Other CV-Site Affiliation
5220	83	1611641240721:-1807657729	1611641235488:136088595	D5136C00008	173	164	CREATE	2021-01-26 07:07:20.807	05.02 Site Se_p Documentation	05.02.17 IP Site Release Documentation
5223	83	1611641242493:-377107087	1611641241923:297161453	D5136C00008	176	175	CREATE	2021-01-26 07:07:22.581	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
5225	83	1611641243600:1541578440	1611641232432:-1769405070	D5136C00008	178	159	CREATE	2021-01-26 07:07:23.685	05 Site Management	05.04 Site Management
5229	83	1611641246282:-1331468644	1611641243600:1541578440	D5136C00008	182	178	CREATE	2021-01-26 07:07:26.369	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
5235	83	1611641259987:-2019425879	1611641220259:1485242300	D5136C00008	188	138	CREATE	2021-01-26 07:07:40.077	8801 Inati, Adlette	06 IP and Trial Supplies
5236	83	1611641260592:-276369822	1611641259987:-2019425879	D5136C00008	189	188	CREATE	2021-01-26 07:07:40.678	06 IP and Trial Supplies	06.01 IP Documentation
5238	83	1611641261739:1647529877	1611641260592:-276369822	D5136C00008	191	189	CREATE	2021-01-26 07:07:41.826	06.01 IP Documentation	06.01.05 Accountability Documentation
5244	83	1611641265734:122400131	1611641265128:-1466345627	D5136C00008	197	196	CREATE	2021-01-26 07:07:45.82	07.02 Trial Status Reporting	07.02.02 SAE Report
5245	83	1611641266317:-941441346	1611641264375:1555441436	D5136C00008	198	195	CREATE	2021-01-26 07:07:46.403	07 Safety Reporting	07.03 General
5246	83	1611641266912:-617425789	1611641266317:-941441346	D5136C00008	199	198	CREATE	2021-01-26 07:07:47	07.03 General	07.03.01 Rele_ns-Safety-Email
5247	83	1611641267579:-1313159054	1611641266317:-941441346	D5136C00008	200	198	CREATE	2021-01-26 07:07:47.666	07.03 General	07.03.01 Relevant Communications-Safety-Documents
5252	83	1611641273996:-1226266543	1611641272075:-25702648	D5136C00008	205	203	CREATE	2021-01-26 07:07:54.085	02.02 Subject Documents	02.02.03 Info_Form Checklists
5255	83	1611641275829:-2044286765	1611641268190:2064345550	D5136C00008	208	201	CREATE	2021-01-26 07:07:55.918	8802 Abboud, Miguel	03 Regulatory
5256	83	1611641276514:-1133967190	1611641275829:-2044286765	D5136C00008	209	208	CREATE	2021-01-26 07:07:56.603	03 Regulatory	03.02 Investi_dicinal Product
5260	83	1611641279025:1689619362	1611641268190:2064345550	D5136C00008	213	201	CREATE	2021-01-26 07:07:59.123	8802 Abboud, Miguel	04 IRB-IEC an_other Approvals
5261	83	1611641279667:-351148005	1611641279025:1689619362	D5136C00008	214	213	CREATE	2021-01-26 07:07:59.869	04 IRB-IEC an_other Approvals	04.01 IRB-IEC Trial Approval
5265	83	1611641282200:-1874462522	1611641281637:-567607150	D5136C00008	218	217	CREATE	2021-01-26 07:08:02.287	04.03 Trial Status Reporting	04.03.01 IRB-_ Info-Deviation
5269	83	1611641285923:1450063667	1611641284084:762640707	D5136C00008	222	221	CREATE	2021-01-26 07:08:06.011	05.01 Site Selection	05.01.02 Confidentiality Agreement
5271	83	1611641287156:-1936602603	1611641284084:762640707	D5136C00008	224	221	CREATE	2021-01-26 07:08:07.247	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
5276	83	1611641291627:-668840281	1611641287732:-1798491443	D5136C00008	229	225	CREATE	2021-01-26 07:08:11.728	05.02 Site Se_p Documentation	05.02.06 Other CV-Site Affiliation
5279	83	1611641293413:-1183229329	1611641287732:-1798491443	D5136C00008	232	225	CREATE	2021-01-26 07:08:13.501	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
6086	83	1611641945863:419086585	1611641945226:-936657210	D5136C00008	1039	1038	CREATE	2021-01-26 07:19:05.952	06.05 Non-IP Documentation	06.05.02 Non-_ion of Shipment
6088	83	1611641947062:1027654787	1611641946480:1022570725	D5136C00008	1041	1040	CREATE	2021-01-26 07:19:07.149	06.07 General	06.07.01 Rele_l Product-Email
6093	83	1611641950038:810834671	1611641948287:-1504874750	D5136C00008	1046	1043	CREATE	2021-01-26 07:19:10.129	07 Safety Reporting	07.03 General
6095	83	1611641951219:-774262616	1611641897787:584577030	D5136C00008	1048	974	CREATE	2021-01-26 07:19:11.304	7804 Kanter Washko, Julie	08 Centralized Testing
6097	83	1611641952360:535506801	1611641951808:381159402	D5136C00008	1050	1049	CREATE	2021-01-26 07:19:12.444	08.01 Facility Documentation	08.01.01 Cert_r Accreditation
6101	83	1611641954666:711893372	1611641954086:-1630766501	D5136C00008	1054	1053	CREATE	2021-01-26 07:19:14.752	10 Data Management	10.05 General
6106	83	1611641958251:-817942400	1611641957694:1871115465	D5136C00008	1059	1058	CREATE	2021-01-26 07:19:18.337	01.01 Trial Oversight	01.01.06 Recruitment Plan
6107	83	1611641958876:1498581014	1611641956364:-1352316942	D5136C00008	1060	1056	CREATE	2021-01-26 07:19:18.961	7805 Harrington, Thomas	02 Central Trial Documents
6115	83	1611641963428:374651675	1611641962887:-1253767804	D5136C00008	1068	1067	CREATE	2021-01-26 07:19:23.663	03 Regulatory	03.04 General
6119	83	1611641965897:-738152005	1611641965340:403031889	D5136C00008	1072	1071	CREATE	2021-01-26 07:19:25.985	04 IRB-IEC an_other Approvals	04.01 IRB-IEC Trial Approval
5280	83	1611641293967:-953260493	1611641287732:-1798491443	D5136C00008	233	225	CREATE	2021-01-26 07:08:14.052	05.02 Site Se_p Documentation	05.02.12 Clinical Trial Agreement
5281	83	1611641294737:-168957163	1611641287732:-1798491443	D5136C00008	234	225	CREATE	2021-01-26 07:08:14.823	05.02 Site Se_p Documentation	05.02.17 IP Site Release Documentation
5284	83	1611641296480:-240300201	1611641295900:-1374361282	D5136C00008	237	236	CREATE	2021-01-26 07:08:16.567	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
5285	83	1611641297109:1645998536	1611641295900:-1374361282	D5136C00008	238	236	CREATE	2021-01-26 07:08:17.196	05.03 Site Initiation	05.03.03 Site Training-Staff
5290	83	1611641300106:-666888707	1611641298339:1242683668	D5136C00008	243	240	CREATE	2021-01-26 07:08:20.192	05.04 Site Management	05.04.04 Visit Log
5293	83	1611641301766:-406112845	1611641298339:1242683668	D5136C00008	246	240	CREATE	2021-01-26 07:08:21.851	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
5294	83	1611641302386:477775054	1611641298339:1242683668	D5136C00008	247	240	CREATE	2021-01-26 07:08:22.473	05.04 Site Management	05.04.09 Inv Notification-SUSAR
5299	83	1611641305244:511713447	1611641304679:2142590727	D5136C00008	252	251	CREATE	2021-01-26 07:08:25.329	06 IP and Trial Supplies	06.01 IP Documentation
5304	83	1611641308064:-1780896329	rootNode	D5136C00008	257	0	CREATE	2021-01-26 07:08:28.155		TURKEY
5305	83	1611641308631:539102919	1611641308064:-1780896329	D5136C00008	258	257	CREATE	2021-01-26 07:08:28.726	TURKEY	02 Central Trial Documents
5308	83	1611641310387:-1054202436	1611641309220:199223105	D5136C00008	261	259	CREATE	2021-01-26 07:08:30.473	02.01 Trial Documents	02.01.06 Insurance
5312	83	1611641312716:-1094976088	1611641310956:976683399	D5136C00008	265	262	CREATE	2021-01-26 07:08:32.805	02.02 Subject Documents	02.02.05 Subject Participation Card
5313	83	1611641313282:1494786535	1611641310956:976683399	D5136C00008	266	262	CREATE	2021-01-26 07:08:33.374	02.02 Subject Documents	02.02.06 Advertisements for Subject Recruitment
5317	83	1611641315688:1640300229	1611641308064:-1780896329	D5136C00008	270	257	CREATE	2021-01-26 07:08:35.774	TURKEY	03 Regulatory
5322	83	1611641318770:-572483746	1611641318033:420781695	D5136C00008	275	274	CREATE	2021-01-26 07:08:38.856	03.03 Trial Status Reporting	03.03.02 Progress Report
5323	83	1611641319347:768658155	1611641318033:420781695	D5136C00008	276	274	CREATE	2021-01-26 07:08:39.436	03.03 Trial Status Reporting	03.03.03 Notification of Trial Termination
5327	83	1611641324713:1711953080	1611641323555:-1313666846	D5136C00008	280	278	CREATE	2021-01-26 07:08:44.798	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
5328	83	1611641325529:2060224917	1611641322936:2095054813	D5136C00008	281	277	CREATE	2021-01-26 07:08:45.614	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
5331	83	1611641327240:2029484938	1611641325529:2060224917	D5136C00008	284	281	CREATE	2021-01-26 07:08:47.327	04.03 Trial Status Reporting	04.03.03 IRB-IEC_ Term Notification
5337	83	1611641331503:-103421796	1611641308064:-1780896329	D5136C00008	290	257	CREATE	2021-01-26 07:08:51.589	TURKEY	06 IP and Trial Supplies
5341	83	1611641339594:169244912	1611641339019:-1528095729	D5136C00008	294	293	CREATE	2021-01-26 07:08:59.679	07 Safety Reporting	07.03 General
5342	83	1611641340234:-907397247	1611641339594:169244912	D5136C00008	295	294	CREATE	2021-01-26 07:09:00.32	07.03 General	07.03.01 Relevan_tions-Safety-Email
5345	83	1611641375003:1172743110	1611641341381:-633744407	D5136C00008	298	297	CREATE	2021-01-26 07:09:35.092	08.01 Facility Documentation	08.01.04 Normal Ranges and Alert Values
5348	83	1611641377284:414246044	1611641376330:1360373821	D5136C00008	301	300	CREATE	2021-01-26 07:09:37.374	08.03 General	08.03.01 Relevan_tral Lab-Documents
5350	83	1611641378514:1644563501	1611641377844:-32509700	D5136C00008	303	302	CREATE	2021-01-26 07:09:38.608	09 Third Party	09.02 Third Party Set-up
5353	83	1611641381022:1907539791	1611641308064:-1780896329	D5136C00008	306	257	CREATE	2021-01-26 07:09:41.107	TURKEY	7601 Antmen, Ali Bulent
5357	83	1611641383413:-1154639148	1611641381582:-90037019	D5136C00008	310	307	CREATE	2021-01-26 07:09:43.498	02 Central Trial Documents	02.04 General
5359	83	1611641384590:-1039035536	1611641381022:1907539791	D5136C00008	312	306	CREATE	2021-01-26 07:09:44.715	7601 Antmen, Ali Bulent	04 IRB-IEC an_other Approvals
5360	83	1611641385243:1841533869	1611641384590:-1039035536	D5136C00008	313	312	CREATE	2021-01-26 07:09:45.33	04 IRB-IEC an_other Approvals	04.01 IRB-IEC Trial Approval
5366	83	1611641388789:2009800360	1611641386972:687809263	D5136C00008	319	316	CREATE	2021-01-26 07:09:48.875	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
5368	83	1611641390599:118463534	1611641389332:-1873206188	D5136C00008	321	320	CREATE	2021-01-26 07:09:50.683	05.02 Site Se_p Documentation	05.02.01 Acce_igator Brochure
5370	83	1611641391767:877752142	1611641389332:-1873206188	D5136C00008	323	320	CREATE	2021-01-26 07:09:51.938	05.02 Site Se_p Documentation	05.02.03 Prot_ Signature Page
5374	83	1611641394113:-1511394127	1611641389332:-1873206188	D5136C00008	327	320	CREATE	2021-01-26 07:09:54.258	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
5378	83	1611641398777:-1449076027	1611641386398:1299514596	D5136C00008	331	315	CREATE	2021-01-26 07:09:58.863	05 Site Management	05.03 Site Initiation
5379	83	1611641399373:1506369950	1611641398777:-1449076027	D5136C00008	332	331	CREATE	2021-01-26 07:09:59.457	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
5385	83	1611641402948:941136206	1611641401135:1872542875	D5136C00008	338	335	CREATE	2021-01-26 07:10:03.034	05.04 Site Management	05.04.04 Visit Log
5387	83	1611641404120:307386469	1611641401135:1872542875	D5136C00008	340	335	CREATE	2021-01-26 07:10:04.208	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
5390	83	1611641405889:1530983946	1611641386398:1299514596	D5136C00008	343	315	CREATE	2021-01-26 07:10:05.975	05 Site Management	05.05 General
5394	83	1611641408382:1231310022	1611641407680:1491095308	D5136C00008	347	346	CREATE	2021-01-26 07:10:08.469	06 IP and Trial Supplies	06.01 IP Documentation
5395	83	1611641408933:700967656	1611641408382:1231310022	D5136C00008	348	347	CREATE	2021-01-26 07:10:09.017	06.01 IP Documentation	06.01.05 Accountability Documentation
5397	83	1611641411160:2070791939	1611641408382:1231310022	D5136C00008	350	347	CREATE	2021-01-26 07:10:11.251	06.01 IP Documentation	06.01.11 Cert_ of Destruction
5402	83	1611641414122:-1615780276	1611641413561:-720813788	D5136C00008	355	354	CREATE	2021-01-26 07:10:14.207	06.05 Non-IP Documentation	06.05.02 Non-_ion of Shipment
5404	83	1611641415401:-634916832	1611641381022:1907539791	D5136C00008	357	306	CREATE	2021-01-26 07:10:15.489	7601 Antmen, Ali Bulent	07 Safety Reporting
5407	83	1611641417121:801226331	1611641415401:-634916832	D5136C00008	360	357	CREATE	2021-01-26 07:10:17.215	07 Safety Reporting	07.03 General
5412	83	1611641420111:-423346641	1611641418943:518296229	D5136C00008	365	363	CREATE	2021-01-26 07:10:20.202	08.01 Facility Documentation	08.01.07 Head of Facility CV
4241	82	1611633775952:1880085546	1611633770606:-736878236	D5136C00008	214	205	CREATE	2021-01-26 05:02:56.038	11 Statistics	11.05 General
4862	82	1611635082806:-1894530611	rootNode	D5136C00008	835	0	CREATE	2021-01-26 05:24:42.894		KENYA
5413	83	1611641420778:-1862627907	1611641418332:-1418801034	D5136C00008	366	362	CREATE	2021-01-26 07:10:20.873	08 Centralized Testing	08.02 Sample Documentation
5416	83	1611641423550:-57369794	1611641381022:1907539791	D5136C00008	369	306	CREATE	2021-01-26 07:10:23.635	7601 Antmen, Ali Bulent	10 Data Management
5422	83	1611641427013:-138210426	1611641426413:1544408119	D5136C00008	375	374	CREATE	2021-01-26 07:10:27.101	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
5423	83	1611641427590:-1279760116	1611641425855:-2079925699	D5136C00008	376	373	CREATE	2021-01-26 07:10:27.675	05 Site Management	05.02 Site Se_p Documentation
5427	83	1611641430005:-554911708	1611641429413:-215726209	D5136C00008	380	379	CREATE	2021-01-26 07:10:30.09	02 Central Trial Documents	02.04 General
5431	83	1611641437572:-1070718334	1611641437014:355969895	D5136C00008	384	383	CREATE	2021-01-26 07:10:37.659	05 Site Management	05.01 Site Selection
5432	83	1611641438199:1822402793	1611641437572:-1070718334	D5136C00008	385	384	CREATE	2021-01-26 07:10:38.285	05.01 Site Selection	05.01.02 Confidentiality Agreement
5434	83	1611641439348:-1564263477	1611641437572:-1070718334	D5136C00008	387	384	CREATE	2021-01-26 07:10:39.436	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
5439	83	1611641442271:766323456	1611641439922:-38030433	D5136C00008	392	388	CREATE	2021-01-26 07:10:42.357	05.02 Site Se_p Documentation	05.02.04 PI CV-Site Affiliation
5441	83	1611641444246:-670000842	1611641439922:-38030433	D5136C00008	394	388	CREATE	2021-01-26 07:10:44.334	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
5442	83	1611641444928:-1582738336	1611641439922:-38030433	D5136C00008	395	388	CREATE	2021-01-26 07:10:45.014	05.02 Site Se_p Documentation	05.02.12 Clinical Trial Agreement
5443	83	1611641445489:-798435006	1611641439922:-38030433	D5136C00008	396	388	CREATE	2021-01-26 07:10:45.576	05.02 Site Se_p Documentation	05.02.17 IP Site Release Documentation
5449	83	1611641450803:-149148115	1611641437014:355969895	D5136C00008	402	383	CREATE	2021-01-26 07:10:50.901	05 Site Management	05.04 Site Management
5453	83	1611641453873:2063170127	1611641450803:-149148115	D5136C00008	406	402	CREATE	2021-01-26 07:10:53.961	05.04 Site Management	05.04.05 Additional Monitoring Activity
5454	83	1611641454480:-713250756	1611641450803:-149148115	D5136C00008	407	402	CREATE	2021-01-26 07:10:54.583	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
5460	83	1611641458298:-16868745	1611641457701:1248793333	D5136C00008	413	412	CREATE	2021-01-26 07:10:58.395	06 IP and Trial Supplies	06.01 IP Documentation
5461	83	1611641458926:1565717885	1611641458298:-16868745	D5136C00008	414	413	CREATE	2021-01-26 07:10:59.012	06.01 IP Documentation	06.01.05 Accountability Documentation
5464	83	1611641460811:-1928091069	1611641457701:1248793333	D5136C00008	417	412	CREATE	2021-01-26 07:11:00.896	06 IP and Trial Supplies	06.04 Storage
5467	83	1611641462736:1125260371	1611641457701:1248793333	D5136C00008	420	412	CREATE	2021-01-26 07:11:02.823	06 IP and Trial Supplies	06.05 Non-IP Documentation
5471	83	1611641465393:-671198915	1611641464739:1778965395	D5136C00008	424	423	CREATE	2021-01-26 07:11:05.481	07 Safety Reporting	07.02 Trial Status Reporting
5473	83	1611641466584:-1522126515	1611641464739:1778965395	D5136C00008	426	423	CREATE	2021-01-26 07:11:06.672	07 Safety Reporting	07.03 General
5476	83	1611641468416:-937483898	1611641467748:-1397939616	D5136C00008	429	428	CREATE	2021-01-26 07:11:08.501	08 Centralized Testing	08.01 Facility Documentation
5481	83	1611641471444:-1836261277	1611641470797:976569871	D5136C00008	434	433	CREATE	2021-01-26 07:11:11.54	08.02 Sample Documentation	08.02.03 Sample Storage Condition Log
5482	83	1611641472020:-1013138150	1611641470797:976569871	D5136C00008	435	433	CREATE	2021-01-26 07:11:12.105	08.02 Sample Documentation	08.02.05 Reta_-Tissue Samples
5486	83	1611641474385:-1858612203	1611641473794:134747435	D5136C00008	439	438	CREATE	2021-01-26 07:11:14.517	02.04 General	02.04.01 Rele_-Contact Report
5490	83	1611641476799:554249780	1611641472621:1691274514	D5136C00008	443	436	CREATE	2021-01-26 07:11:16.885	7604 Demir, Cengiz	05 Site Management
5491	83	1611641477381:1251585694	1611641476799:554249780	D5136C00008	444	443	CREATE	2021-01-26 07:11:17.47	05 Site Management	05.01 Site Selection
5495	83	1611641479662:-1134365291	1611641476799:554249780	D5136C00008	448	443	CREATE	2021-01-26 07:11:19.747	05 Site Management	05.02 Site Se_p Documentation
5496	83	1611641480300:1980143402	1611641479662:-1134365291	D5136C00008	449	448	CREATE	2021-01-26 07:11:20.386	05.02 Site Se_p Documentation	05.02.01 Acceptance of Investigator Brochure
5499	83	1611641483629:548778303	1611641479662:-1134365291	D5136C00008	452	448	CREATE	2021-01-26 07:11:23.733	05.02 Site Se_p Documentation	05.02.04 PI CV-Site Affiliation
5504	83	1611641501884:-198145866	1611641479662:-1134365291	D5136C00008	457	448	CREATE	2021-01-26 07:11:41.972	05.02 Site Se_p Documentation	05.02.17 IP Site Release Documentation
5508	83	1611641504128:-1553291034	1611641503042:-710235130	D5136C00008	461	459	CREATE	2021-01-26 07:11:44.214	05.03 Site Initiation	05.03.03 Site Training-Staff
5510	83	1611641505332:536430965	1611641476799:554249780	D5136C00008	463	443	CREATE	2021-01-26 07:11:45.437	05 Site Management	05.04 Site Management
5514	83	1611641507661:1198540101	1611641505332:536430965	D5136C00008	467	463	CREATE	2021-01-26 07:11:47.747	05.04 Site Management	05.04.05 Additional Monitoring Activity
5519	83	1611641512240:199006238	1611641509907:-1060778770	D5136C00008	472	471	CREATE	2021-01-26 07:11:52.327	05.05 General	05.05.02 Tracking Information
5520	83	1611641513158:-1472072806	1611641472621:1691274514	D5136C00008	473	436	CREATE	2021-01-26 07:11:53.247	7604 Demir, Cengiz	06 IP and Trial Supplies
5524	83	1611641515456:-2103154508	1611641513722:-1060499336	D5136C00008	477	474	CREATE	2021-01-26 07:11:55.543	06.01 IP Documentation	06.01.11 Certificate of Destruction
5526	83	1611641516576:-489879245	1611641516019:183849314	D5136C00008	479	478	CREATE	2021-01-26 07:11:56.666	06.04 Storage	06.04.01 Storage Condition Documentation
5528	83	1611641517788:-356545034	1611641513158:-1472072806	D5136C00008	481	473	CREATE	2021-01-26 07:11:57.873	06 IP and Trial Supplies	06.05 Non-IP Documentation
5533	83	1611641520614:1424952952	1611641520047:-1027127638	D5136C00008	486	485	CREATE	2021-01-26 07:12:00.706	08.01 Facility Documentation	08.01.04 Norm_nd Alert Values
5535	83	1611641521722:-1330966558	1611641519431:-2017504633	D5136C00008	488	484	CREATE	2021-01-26 07:12:01.819	08 Centralized Testing	08.02 Sample Documentation
5537	83	1611641522913:-1506298855	1611641521722:-1330966558	D5136C00008	490	488	CREATE	2021-01-26 07:12:02.998	08.02 Sample Documentation	08.02.05 Reta_-Tissue Samples
5540	83	1611641524639:733074266	1611641523954:-1587146496	D5136C00008	493	492	CREATE	2021-01-26 07:12:04.725	02 Central Trial Documents	02.01 Trial Documents
5544	83	1611641526976:-399648384	1611641526425:-2077853683	D5136C00008	497	496	CREATE	2021-01-26 07:12:07.06	02.02 Subject Documents	02.02.03 Informed Consent Form Checklists
5545	83	1611641527535:-1101511052	1611641526425:-2077853683	D5136C00008	498	496	CREATE	2021-01-26 07:12:07.621	02.02 Subject Documents	02.02.03 Informed Consent Form Templates
5549	83	1611641529878:652041537	1611641529289:-851687449	D5136C00008	502	501	CREATE	2021-01-26 07:12:09.965	02.04 General	02.04.02 Tracking Information
5553	83	1611641532988:1146852924	1611641531177:396075957	D5136C00008	506	504	CREATE	2021-01-26 07:12:13.072	03.01 Trial Approval	03.01.02 Approval
5556	83	1611641544879:-1855560865	1611641533599:1095748928	D5136C00008	509	507	CREATE	2021-01-26 07:12:24.97	03.03 Trial Status Reporting	03.03.03 Notification of Trial Termination
5558	83	1611641546875:-1271742766	1611641545490:-676817329	D5136C00008	511	510	CREATE	2021-01-26 07:12:26.964	03.04 General	03.04.01 Rele_-Start-Up-Email
5562	83	1611641549125:2141911536	1611641548568:1779650611	D5136C00008	515	514	CREATE	2021-01-26 07:12:29.212	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
5566	83	1611641551528:-733925120	1611641548568:1779650611	D5136C00008	519	514	CREATE	2021-01-26 07:12:31.615	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
5567	83	1611641552102:-1817957802	1611641551528:-733925120	D5136C00008	520	519	CREATE	2021-01-26 07:12:32.189	04.03 Trial Status Reporting	04.03.02 IRB-IEC Progress Report
5571	83	1611641554404:-697799806	1611641553264:-1430602661	D5136C00008	524	522	CREATE	2021-01-26 07:12:34.489	04.04 General	04.04.01 Relevan_l Committees-Email
5575	83	1611641557930:-1325271446	1611641557387:-1261198909	D5136C00008	528	527	CREATE	2021-01-26 07:12:38.015	05.04 Site Management	05.04.09 Inv Notification-SUSAR
5577	83	1611641559140:-180137484	1611641558567:-1608051729	D5136C00008	530	529	CREATE	2021-01-26 07:12:39.228	05.05 General	05.05.01 Relevant Communications-Mass Communication-Documents-Email
5581	83	1611641561537:-1021457304	1611641523376:-1327162297	D5136C00008	534	491	CREATE	2021-01-26 07:12:41.624	UNITED KINGDOM	09 Third Party
6125	83	1611641969258:2060696725	1611641965340:403031889	D5136C00008	1078	1071	CREATE	2021-01-26 07:19:29.345	04 IRB-IEC an_other Approvals	04.04 General
6129	83	1611641971525:-1450581034	1611641970955:-330671972	D5136C00008	1082	1081	CREATE	2021-01-26 07:19:31.61	05.01 Site Selection	05.01.02 Confidentiality Agreement
6133	83	1611641974084:-1702144362	1611641973521:-1519367121	D5136C00008	1086	1085	CREATE	2021-01-26 07:19:34.212	05.02 Site Se_p Documentation	05.02.01 Acce_igator Brochure
6138	83	1611641976913:1052411152	1611641973521:-1519367121	D5136C00008	1091	1085	CREATE	2021-01-26 07:19:36.998	05.02 Site Se_p Documentation	05.02.07 Staff Qualification
6139	83	1611641977462:-397600465	1611641973521:-1519367121	D5136C00008	1092	1085	CREATE	2021-01-26 07:19:37.549	05.02 Site Se_p Documentation	05.02.08 Form FDA1572
6145	83	1611641980937:1688093627	1611641980352:-1095258178	D5136C00008	1098	1097	CREATE	2021-01-26 07:19:46.022	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
6147	83	1611641987092:-1143663074	1611641980352:-1095258178	D5136C00008	1100	1097	CREATE	2021-01-26 07:19:47.179	05.03 Site Initiation	05.03.03 Site_umentation-Site
6149	83	1611641988263:1105100611	1611641987649:-1628946498	D5136C00008	1102	1101	CREATE	2021-01-26 07:19:48.354	05.04 Site Management	05.04.01 Subject Log
6154	83	1611641991649:847504502	1611641987649:-1628946498	D5136C00008	1107	1101	CREATE	2021-01-26 07:19:51.734	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
6158	83	1611641993925:155619764	1611641992242:-1269135393	D5136C00008	1111	1108	CREATE	2021-01-26 07:19:54.033	05.05 General	05.05.02 Tracking Information
6163	83	1611642008753:-1165953299	1611641995045:2075773630	D5136C00008	1116	1113	CREATE	2021-01-26 07:20:08.838	06.01 IP Documentation	06.01.05 Accountability Documentation
6168	83	1611642011582:1241347032	1611641956364:-1352316942	D5136C00008	1121	1056	CREATE	2021-01-26 07:20:11.668	7805 Harrington, Thomas	07 Safety Reporting
6173	83	1611642014418:150174786	1611642013879:-1072796387	D5136C00008	1126	1125	CREATE	2021-01-26 07:20:14.503	08.01 Facility Documentation	08.01.01 Cert_r Accreditation
5586	83	1611641565908:-893255450	1611641563860:-1812593903	D5136C00008	539	538	CREATE	2021-01-26 07:12:45.995	02 Central Trial Documents	02.02 Subject Documents
5588	83	1611641567201:211159172	1611641565908:-893255450	D5136C00008	541	539	CREATE	2021-01-26 07:12:54.8	02.02 Subject Documents	02.02.07 Othe_ven to Subjects
5590	83	1611641577204:636997282	1611641576614:1969678168	D5136C00008	543	542	CREATE	2021-01-26 07:12:57.294	02.04 General	02.04.01 Rele_-Contact Report
5595	83	1611641580037:1616070392	1611641579484:-1158501418	D5136C00008	548	547	CREATE	2021-01-26 07:13:00.123	04.04 General	04.04.01 Rele_ommittees-Email
5597	83	1611641581189:-1159841738	1611641580609:1971994231	D5136C00008	550	549	CREATE	2021-01-26 07:13:01.276	05 Site Management	05.01 Site Selection
5600	83	1611641582950:276271563	1611641581189:-1159841738	D5136C00008	553	550	CREATE	2021-01-26 07:13:03.036	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
5603	83	1611641584608:-1314360925	1611641583518:310957323	D5136C00008	556	554	CREATE	2021-01-26 07:13:04.695	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
5604	83	1611641585186:1989782068	1611641583518:310957323	D5136C00008	557	554	CREATE	2021-01-26 07:13:05.274	05.02 Site Se_p Documentation	05.02.04 PI C_ite Affiliation
5610	83	1611641589423:-395837128	1611641583518:310957323	D5136C00008	563	554	CREATE	2021-01-26 07:13:09.509	05.02 Site Se_p Documentation	05.02.17 IP S_e Documentation
5614	83	1611641591790:332998237	1611641590634:735045048	D5136C00008	567	565	CREATE	2021-01-26 07:13:11.874	05.03 Site Initiation	05.03.03 Site Training-Staff
5616	83	1611641592944:1838866742	1611641580609:1971994231	D5136C00008	569	549	CREATE	2021-01-26 07:13:13.03	05 Site Management	05.04 Site Management
5618	83	1611641598320:-2121179909	1611641592944:1838866742	D5136C00008	571	569	CREATE	2021-01-26 07:13:18.409	05.04 Site Management	05.04.03 Monitoring Visit Report
5624	83	1611641602082:-1882309800	1611641601462:-2096289449	D5136C00008	577	576	CREATE	2021-01-26 07:13:22.169	05.05 General	05.05.01 Rele_nications-Email
5625	83	1611641602753:-821749636	1611641601462:-2096289449	D5136C00008	578	576	CREATE	2021-01-26 07:13:22.837	05.05 General	05.05.02 Tracking Information
5627	83	1611641604056:-1028150333	1611641603355:-2131402962	D5136C00008	580	579	CREATE	2021-01-26 07:13:24.143	06 IP and Trial Supplies	06.01 IP Documentation
5632	83	1611641607417:-1720531801	1611641606569:917430434	D5136C00008	585	584	CREATE	2021-01-26 07:13:27.503	06.04 Storage	06.04.01 Storage Condition Documentation
5634	83	1611641608795:939406174	1611641608143:-1407972852	D5136C00008	587	586	CREATE	2021-01-26 07:13:28.88	06.07 General	06.07.01 Rele_l Product-Email
5636	83	1611641609999:-813435372	1611641609390:-1212698631	D5136C00008	589	588	CREATE	2021-01-26 07:13:30.088	07 Safety Reporting	07.03 General
5638	83	1611641611208:-2139773700	1611641523376:-1327162297	D5136C00008	591	491	CREATE	2021-01-26 07:13:31.3	UNITED KINGDOM	2802 Kaya, Banu
5641	83	1611641613116:1780182803	1611641612464:1839687067	D5136C00008	594	593	CREATE	2021-01-26 07:13:33.212	02.02 Subject Documents	02.02.03 Info_ Form Templates
5643	83	1611641614358:161217309	1611641611208:-2139773700	D5136C00008	596	591	CREATE	2021-01-26 07:13:34.443	2802 Kaya, Banu	04 IRB-IEC an_other Approvals
5645	83	1611641620856:-617258690	1611641620277:-1785751022	D5136C00008	598	597	CREATE	2021-01-26 07:13:40.952	04.02 Other Committees	04.02.02 Other Approvals
5650	83	1611641623836:-56339076	1611641623233:-1795168028	D5136C00008	603	602	CREATE	2021-01-26 07:13:43.923	05 Site Management	05.01 Site Selection
5651	83	1611641624460:1687184358	1611641623836:-56339076	D5136C00008	604	603	CREATE	2021-01-26 07:13:44.545	05.01 Site Selection	05.01.02 Confidentiality Agreement
5656	83	1611641628091:-1596626499	1611641626833:-803284178	D5136C00008	609	607	CREATE	2021-01-26 07:13:48.178	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
5659	83	1611641629939:-990214087	1611641626833:-803284178	D5136C00008	612	607	CREATE	2021-01-26 07:13:50.024	05.02 Site Se_p Documentation	05.02.06 Other CV-Site Affiliation
5660	83	1611641630545:-583024807	1611641626833:-803284178	D5136C00008	613	607	CREATE	2021-01-26 07:13:50.632	05.02 Site Se_p Documentation	05.02.07 Site Qualification
5664	83	1611641632983:-928792226	1611641626833:-803284178	D5136C00008	617	607	CREATE	2021-01-26 07:13:53.148	05.02 Site Se_p Documentation	05.02.17 IP Site Release Documentation
5669	83	1611641636551:1048684875	1611641634195:-819684029	D5136C00008	622	619	CREATE	2021-01-26 07:13:56.636	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
5671	83	1611641637833:-1884333248	1611641637093:-1086410934	D5136C00008	624	623	CREATE	2021-01-26 07:13:57.919	05.04 Site Management	05.04.01 Subject Log
5672	83	1611641638472:-58645150	1611641637093:-1086410934	D5136C00008	625	623	CREATE	2021-01-26 07:13:58.558	05.04 Site Management	05.04.03 Monitoring Visit Report
5674	83	1611641639641:754597930	1611641637093:-1086410934	D5136C00008	627	623	CREATE	2021-01-26 07:13:59.727	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
5675	83	1611641644410:1769304604	1611641637093:-1086410934	D5136C00008	628	623	CREATE	2021-01-26 07:14:04.5	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
5680	83	1611641647393:-1337485230	1611641611208:-2139773700	D5136C00008	633	591	CREATE	2021-01-26 07:14:07.478	2802 Kaya, Banu	06 IP and Trial Supplies
5684	83	1611641649726:-65413379	1611641648039:-2071648837	D5136C00008	637	634	CREATE	2021-01-26 07:14:09.906	06.01 IP Documentation	06.01.11 Certificate of Destruction
5688	83	1611641652164:1920405322	1611641651566:-1744828649	D5136C00008	641	640	CREATE	2021-01-26 07:14:12.249	06.07 General	06.07.01 Rele_l Product-Email
5689	83	1611641652796:1532818742	1611641611208:-2139773700	D5136C00008	642	591	CREATE	2021-01-26 07:14:12.882	2802 Kaya, Banu	07 Safety Reporting
6179	83	1611642026170:729958990	1611642025610:-1407555123	D5136C00008	1132	1131	CREATE	2021-01-26 07:20:26.259	7806 Harrington, Thomas	02 Central Trial Documents
6184	83	1611642029087:-1035675319	1611642028456:-1696256659	D5136C00008	1137	1136	CREATE	2021-01-26 07:20:29.174	02.04 General	02.04.01 Rele_tions-Documents
6189	83	1611642031900:-1089089567	1611642031302:1854159129	D5136C00008	1142	1141	CREATE	2021-01-26 07:20:31.984	04 IRB-IEC an_other Approvals	04.01 IRB-IEC Trial Approval
6193	83	1611642034708:-2054897358	1611642025610:-1407555123	D5136C00008	1146	1131	CREATE	2021-01-26 07:20:34.794	7806 Harrington, Thomas	05 Site Management
6198	83	1611642040513:-53309673	1611642036355:2028077891	D5136C00008	1151	1149	CREATE	2021-01-26 07:20:40.669	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
6202	83	1611642044240:1259357540	1611642036355:2028077891	D5136C00008	1155	1149	CREATE	2021-01-26 07:20:44.324	05.02 Site Se_p Documentation	05.02.07 Staff Qualification
6206	83	1611642046695:-1842780462	1611642034708:-2054897358	D5136C00008	1159	1146	CREATE	2021-01-26 07:20:46.784	05 Site Management	05.03 Site Initiation
6210	83	1611642049155:1954797713	1611642048539:1282302423	D5136C00008	1163	1162	CREATE	2021-01-26 07:20:49.241	05.05 General	05.05.01 Rele_nications-Email
5039	82	1611635511774:1613375496	1611635508553:-233735518	D5136C00008	1012	1007	CREATE	2021-01-26 05:31:51.86	06 IP and Trial Supplies	06.04 Storage
14334	88	1617049796982:-2116394566	1617049777304:1085508340	D5170C00001	24	1	ALREADY AVAILABLE	2021-03-30 07:19:37.237	eTMF	AstraZeneca
3829	80	1611118344992:-35311861	rootNode	D4190C00023	1	0	ALREADY AVAILABLE	2021-01-20 18:57:21.848		Site
3920	80	1611118366364:1567783348	rootNode	D4190C00023	12	0	ALREADY AVAILABLE	2021-01-20 18:57:21.848		Country
3830	80	1611118345634:171654942	1611118344992:-35311861	D4190C00023	2	1	ALREADY AVAILABLE	2021-01-20 18:57:21.849	Site	Site Management
3909	80	1611118348109:-1942566898	1611118344992:-35311861	D4190C00023	72	1	ALREADY AVAILABLE	2021-01-20 18:57:21.849	Site	Central Trial Documents
3886	80	1611118349852:1768392499	1611118344992:-35311861	D4190C00023	34	1	ALREADY AVAILABLE	2021-01-20 18:57:21.849	Site	IP and Trial Supplies
3873	80	1611118358470:-554892274	1611118344992:-35311861	D4190C00023	16	1	ALREADY AVAILABLE	2021-01-20 18:57:21.849	Site	IRB/IEC and other Approvals
3904	80	1611118360593:1054732761	1611118344992:-35311861	D4190C00023	68	1	ALREADY AVAILABLE	2021-01-20 18:57:21.849	Site	Safety Reporting
3899	80	1611118380404:-516285564	1611118344992:-35311861	D4190C00023	38	1	ALREADY AVAILABLE	2021-01-20 18:57:21.849	Site	Central and Local Testing
3921	80	1611118405435:424134915	1611118366364:1567783348	D4190C00023	13	12	ALREADY AVAILABLE	2021-01-20 18:57:21.849	Country	IRB/IEC and other Approvals
3934	80	1611118407120:68549760	1611118366364:1567783348	D4190C00023	28	12	ALREADY AVAILABLE	2021-01-20 18:57:21.849	Country	Regulatory
3831	80	1611118354401:-764788218	1611118345634:171654942	D4190C00023	3	2	ALREADY AVAILABLE	2021-01-20 18:57:21.852	Site Management	Site Set-up
3896	80	1611118400150:-280593938	1611118349852:1768392499	D4190C00023	90	34	ALREADY AVAILABLE	2021-01-20 18:57:21.852	IP and Trial Supplies	Storage
3881	80	1611118359034:847772793	1611118358470:-554892274	D4190C00023	47	16	ALREADY AVAILABLE	2021-01-20 18:57:21.852	IRB/IEC and other Approvals	General
3874	80	1611118373611:-1700142288	1611118358470:-554892274	D4190C00023	17	16	ALREADY AVAILABLE	2021-01-20 18:57:21.852	IRB/IEC and other Approvals	IRB or IEC Trial Approval
3907	80	1611118361173:-980106582	1611118360593:1054732761	D4190C00023	109	68	ALREADY AVAILABLE	2021-01-20 18:57:21.852	Safety Reporting	General
3905	80	1611118391250:917863747	1611118360593:1054732761	D4190C00023	69	68	ALREADY AVAILABLE	2021-01-20 18:57:21.852	Safety Reporting	Trial Status Reporting
3867	80	1611118370767:-289119883	1611118370189:156785711	D4190C00023	6	5	ALREADY AVAILABLE	2021-01-20 18:57:21.852	Trial Management	Trial Oversight
3871	80	1611118395464:1915570502	1611118370189:156785711	D4190C00023	81	5	ALREADY AVAILABLE	2021-01-20 18:57:21.852	Trial Management	Trial Team
3900	80	1611118381006:-1223038678	1611118380404:-516285564	D4190C00023	39	38	ALREADY AVAILABLE	2021-01-20 18:57:21.852	Central and Local Testing	Facility Documentation
3929	80	1611118406004:61268278	1611118405435:424134915	D4190C00023	107	13	ALREADY AVAILABLE	2021-01-20 18:57:21.853	IRB/IEC and other Approvals	General
3838	80	1611118390102:-802096744	1611118354401:-764788218	D4190C00023	60	3	ALREADY AVAILABLE	2021-01-20 18:57:21.856	Site Set-up	Protocol Amendment Signature Page
3839	80	1611118390677:455568956	1611118354401:-764788218	D4190C00023	62	3	ALREADY AVAILABLE	2021-01-20 18:57:21.856	Site Set-up	Protocol Signature Page
3840	80	1611118394820:-416480130	1611118354401:-764788218	D4190C00023	80	3	ALREADY AVAILABLE	2021-01-20 18:57:21.856	Site Set-up	Data Privacy Agreement
3841	80	1611118398453:-1177896454	1611118354401:-764788218	D4190C00023	86	3	ALREADY AVAILABLE	2021-01-20 18:57:21.856	Site Set-up	Site Signature Sheet
3897	80	1611118400735:-1407716948	1611118400150:-280593938	D4190C00023	91	90	ALREADY AVAILABLE	2021-01-20 18:57:21.856	Storage	IP Storage Condition Documentation
3883	80	1611118359919:-48273714	1611118359034:847772793	D4190C00023	128	47	ALREADY AVAILABLE	2021-01-20 18:57:21.856	General	Relevant Communications
3875	80	1611118374184:1181559357	1611118373611:-1700142288	D4190C00023	18	17	ALREADY AVAILABLE	2021-01-20 18:57:21.856	IRB or IEC Trial Approval	IRB or IEC Approval
3876	80	1611118374764:2112787256	1611118373611:-1700142288	D4190C00023	19	17	ALREADY AVAILABLE	2021-01-20 18:57:21.856	IRB or IEC Trial Approval	IRB or IEC Compliance Documentation
3877	80	1611118375320:-1482593370	1611118373611:-1700142288	D4190C00023	24	17	ALREADY AVAILABLE	2021-01-20 18:57:21.856	IRB or IEC Trial Approval	IRB or IEC Composition
3908	80	1611118361722:-977120586	1611118361173:-980106582	D4190C00023	110	109	ALREADY AVAILABLE	2021-01-20 18:57:21.856	General	Relevant Communications
3906	80	1611118391813:-2026699038	1611118391250:917863747	D4190C00023	70	69	ALREADY AVAILABLE	2021-01-20 18:57:21.856	Trial Status Reporting	SAE Report
3868	80	1611118371334:2104586157	1611118370767:-289119883	D4190C00023	7	6	ALREADY AVAILABLE	2021-01-20 18:57:21.856	Trial Oversight	Debarment Statement
3869	80	1611118397788:790359467	1611118370767:-289119883	D4190C00023	85	6	ALREADY AVAILABLE	2021-01-20 18:57:21.856	Trial Oversight	Operational Procedure Manual
3872	80	1611118396022:-1446774683	1611118395464:1915570502	D4190C00023	82	81	ALREADY AVAILABLE	2021-01-20 18:57:21.856	Trial Team	Trial Team Details
3901	80	1611118381568:1940345949	1611118381006:-1223038678	D4190C00023	40	39	ALREADY AVAILABLE	2021-01-20 18:57:21.856	Facility Documentation	Laboratory Validation Documentation
3902	80	1611118382136:1809006837	1611118381006:-1223038678	D4190C00023	41	39	ALREADY AVAILABLE	2021-01-20 18:57:21.856	Facility Documentation	Certification or Accreditation
3903	80	1611118382703:-1903741846	1611118381006:-1223038678	D4190C00023	42	39	ALREADY AVAILABLE	2021-01-20 18:57:21.856	Facility Documentation	Normal Ranges
3964	81	1611118344992:-35311861	rootNode	D4190C00023	1	0	ALREADY AVAILABLE	2021-01-20 19:50:50.083		Site
4006	81	1611118366364:1567783348	rootNode	D4190C00023	5	0	ALREADY AVAILABLE	2021-01-20 19:50:50.083		Country
3991	81	1611118348109:-1942566898	1611118344992:-35311861	D4190C00023	25	1	ALREADY AVAILABLE	2021-01-20 19:50:50.083	Site	Central Trial Documents
4002	81	1611118349852:1768392499	1611118344992:-35311861	D4190C00023	48	1	ALREADY AVAILABLE	2021-01-20 19:50:50.083	Site	IP and Trial Supplies
3988	81	1611118360593:1054732761	1611118344992:-35311861	D4190C00023	19	1	ALREADY AVAILABLE	2021-01-20 19:50:50.083	Site	Safety Reporting
3997	81	1611118370189:156785711	1611118344992:-35311861	D4190C00023	36	1	ALREADY AVAILABLE	2021-01-20 19:50:50.083	Site	Trial Management
3982	81	1611165491934:-502301281	1611118344992:-35311861	D4190C00023	9	1	ALREADY AVAILABLE	2021-01-20 19:50:50.083	Site	Regulatory
4020	81	1611118366935:-1497728851	1611118366364:1567783348	D4190C00023	57	5	ALREADY AVAILABLE	2021-01-20 19:50:50.083	Country	Site Management
4014	81	1611118375871:-1034326000	1611118366364:1567783348	D4190C00023	28	5	ALREADY AVAILABLE	2021-01-20 19:50:50.084	Country	Central Trial Documents
4007	81	1611118407120:68549760	1611118366364:1567783348	D4190C00023	6	5	ALREADY AVAILABLE	2021-01-20 19:50:50.084	Country	Regulatory
3975	81	1611118396597:-2077587214	1611118345634:171654942	D4190C00023	39	2	ALREADY AVAILABLE	2021-01-20 19:50:50.085	Site Management	Site Initiation
3992	81	1611118348733:51885120	1611118348109:-1942566898	D4190C00023	26	25	ALREADY AVAILABLE	2021-01-20 19:50:50.085	Central Trial Documents	Subject Documentation
3995	81	1611118393701:-1366616	1611118348109:-1942566898	D4190C00023	31	25	ALREADY AVAILABLE	2021-01-20 19:50:50.085	Central Trial Documents	General
4003	81	1611118400150:-280593938	1611118349852:1768392499	D4190C00023	49	48	ALREADY AVAILABLE	2021-01-20 19:50:50.085	IP and Trial Supplies	Storage
3989	81	1611118391250:917863747	1611118360593:1054732761	D4190C00023	20	19	ALREADY AVAILABLE	2021-01-20 19:50:50.085	Safety Reporting	Trial Status Reporting
4000	81	1611118370767:-289119883	1611118370189:156785711	D4190C00023	41	36	ALREADY AVAILABLE	2021-01-20 19:50:50.085	Trial Management	Trial Oversight
3998	81	1611118395464:1915570502	1611118370189:156785711	D4190C00023	37	36	ALREADY AVAILABLE	2021-01-20 19:50:50.085	Trial Management	Trial Team
3986	81	1611165493237:1706574044	1611165491934:-502301281	D4190C00023	14	9	ALREADY AVAILABLE	2021-01-20 19:50:50.085	Regulatory	Trial Status Reporting
4021	81	1611118403164:760960628	1611118366935:-1497728851	D4190C00023	58	57	ALREADY AVAILABLE	2021-01-20 19:50:50.085	Site Management	General
4015	81	1611118387813:98084225	1611118375871:-1034326000	D4190C00023	29	28	ALREADY AVAILABLE	2021-01-20 19:50:50.085	Central Trial Documents	Subject Documentation
4018	81	1611165480198:-88343988	1611118375871:-1034326000	D4190C00023	33	28	ALREADY AVAILABLE	2021-01-20 19:50:50.085	Central Trial Documents	General
4008	81	1611165473673:-548949282	1611118407120:68549760	D4190C00023	7	6	ALREADY AVAILABLE	2021-01-20 19:50:50.085	Regulatory	Trial Approval
4011	81	1611165476304:-590358146	1611118407120:68549760	D4190C00023	12	6	ALREADY AVAILABLE	2021-01-20 19:50:50.085	Regulatory	Trial Status Reporting
3977	81	1611118399015:-825232402	1611118396597:-2077587214	D4190C00023	46	39	ALREADY AVAILABLE	2021-01-20 19:50:50.087	Site Initiation	Site Evidence of Training
3994	81	1611118349289:-318495250	1611118348733:51885120	D4190C00023	54	26	ALREADY AVAILABLE	2021-01-20 19:50:50.087	Subject Documentation	Subject Participation Card
3993	81	1611118392436:-2038888332	1611118348733:51885120	D4190C00023	27	26	ALREADY AVAILABLE	2021-01-20 19:50:50.088	Subject Documentation	Informed Consent Form
3985	81	1611165497178:1658943321	1611165495819:273762972	D4190C00023	18	10	ALREADY AVAILABLE	2021-01-20 19:50:50.089	Trial Approval	Regulatory Submission
4022	81	1611118403720:-2059399481	1611118403164:760960628	D4190C00023	59	58	ALREADY AVAILABLE	2021-01-20 19:50:50.09	General	Tracking Information
4016	81	1611118392982:998808371	1611118387813:98084225	D4190C00023	30	29	ALREADY AVAILABLE	2021-01-20 19:50:50.09	Subject Documentation	Informed Consent Form
4017	81	1611118401951:-1225874443	1611118387813:98084225	D4190C00023	53	29	ALREADY AVAILABLE	2021-01-20 19:50:50.09	Subject Documentation	Subject Participation Card
4019	81	1611165481476:-675102257	1611165480198:-88343988	D4190C00023	34	33	ALREADY AVAILABLE	2021-01-20 19:50:50.09	General	Tracking Information
4039	82	1611633581256:-1853038975	1611633575093:-524477315	D5136C00008	12	2	CREATE	2021-01-26 04:59:41.393	01.01 Trial Oversight	01.01.16 Risk Management
6217	84	\N	\N	D5170C00002	2	1	NEW	\N	eTMF	Quintiles IQVIA
4105	82	1611633627544:721508756	1611633626853:-901970401	D5136C00008	78	77	CREATE	2021-01-26 05:00:27.636	03.01 Trial Approval	03.01.04 Public Registration
6248	84	\N	\N	D5170C00002	33	6	NEW	\N	Site	2002539 Weltman, Martin
4451	82	1611634427655:-1424448048	1611634427076:-1336907711	D5136C00008	424	423	CREATE	2021-01-26 05:13:47.74	05.05 General	05.05.02 Tracking Information
6378	84	\N	\N	D5170C00002	163	162	NEW	\N	03 Regulatory	03.04 General
4454	82	1611634429420:-370077857	1611634428789:1055488528	D5136C00008	427	426	CREATE	2021-01-26 05:13:55.74	06.01 IP Documentation	06.01.05 Accountability Documentation
4457	82	1611634437597:1503572016	1611634437033:926668156	D5136C00008	430	429	CREATE	2021-01-26 05:13:57.681	06.04 Storage	06.04.01 Storage Condition Documentation
6574	84	\N	\N	D5170C00002	359	337	NEW	\N	05 Site Management	05.04 Site Management
5958	83	1611641855448:-499227367	1611641854830:1623156305	D5136C00008	911	910	CREATE	2021-01-26 07:17:35.535	07.03 General	07.03.01 Rele_ns-Safety-Email
6672	84	\N	\N	D5170C00002	457	4	NEW	\N	contents	CANADA
5190	83	1611641223222:1529462479	1611641222606:-136010939	D5136C00008	143	142	CREATE	2021-01-26 07:07:03.307	02.04 General	02.04.01 Rele_-Contact Report
6699	84	\N	\N	D5170C00002	484	480	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
6759	84	\N	\N	D5170C00002	544	526	NEW	\N	05 Site Management	05.03 Site Initiation
18383	90	1620235104478:506816	1620234969089:-1826863465	ACE-ST-209	206	1	CREATE	2021-05-05 19:18:24.567	eTMF	011 Statistics
18384	90	1620235105075:-1059358353	1620235104478:506816	ACE-ST-209	207	206	CREATE	2021-05-05 19:18:25.163	011 Statistics	011.03 Analysis
18385	90	1620235105668:266375940	1620235105075:-1059358353	ACE-ST-209	208	207	CREATE	2021-05-05 19:18:25.774	011.03 Analysis	011.03.011 Subject Evaluability Criteria & Subject Classification
18387	90	1620235186180:-709103714	1620235104478:506816	ACE-ST-209	331	206	CREATE	2021-05-05 19:19:46.268	011 Statistics	011.02 Randomization
18388	90	1620235186796:-1847009837	1620235186180:-709103714	ACE-ST-209	332	331	CREATE	2021-05-05 19:19:46.88	011.02 Randomization	011.02.03 Master Randomization List
18380	90	1620235202653:1619493531	1620235202047:102780812	ACE-ST-209	357	356	CREATE	2021-05-05 19:20:02.742	010.04 EDC Management	010.04.01 System Account Management 
18381	90	1620235203250:-1018415051	1620235202047:102780812	ACE-ST-209	358	356	CREATE	2021-05-05 19:20:04.01	010.04 EDC Management	010.04.03 Validation Document 
18386	90	1620235205145:-1839587695	1620235105075:-1059358353	ACE-ST-209	360	207	CREATE	2021-05-05 19:20:05.231	011.03 Analysis	011.03.06 Interim Analysis Output
18389	90	1620235206306:603103498	1620235104478:506816	ACE-ST-209	362	206	CREATE	2021-05-05 19:20:06.389	011 Statistics	011.01 Statistics Oversight
18390	90	1620235206893:1618239720	1620235206306:603103498	ACE-ST-209	363	362	CREATE	2021-05-05 19:20:06.975	011.01 Statistics Oversight	011.01.01 Statistical Analysis Plan
18382	90	1620235207537:-656555429	1620235202047:102780812	ACE-ST-209	364	356	CREATE	2021-05-05 19:20:07.638	010.04 EDC Management	010.04.02 Technical Design Document
18391	90	1620235341996:650625948	1620234969089:-1826863465	ACE-ST-209	568	1	CREATE	2021-05-05 19:22:22.078	eTMF	09 Third parties
18392	90	1620235342650:-1459116704	1620235341996:650625948	ACE-ST-209	569	568	CREATE	2021-05-05 19:22:22.735	09 Third parties	09.03 Covance
18393	90	1620235344108:1385288991	1620235342650:-1459116704	ACE-ST-209	570	569	CREATE	2021-05-05 19:22:24.255	09.03 Covance	09.03.03 General
18394	90	1620235344760:1770958140	1620235344108:1385288991	ACE-ST-209	571	570	CREATE	2021-05-05 19:22:24.847	09.03.03 General	09.03.03.01 Relevant Communications
18395	90	1620235347309:-1930900144	rootNode	ACE-ST-209	575	0	CREATE	2021-05-05 19:22:27.396		Generic Documents
18396	90	1620235347873:997629302	1620235347309:-1930900144	ACE-ST-209	576	575	CREATE	2021-05-05 19:22:27.961	Generic Documents	Metadata
4243	82	1611633777117:-958855996	1611633775952:1880085546	D5136C00008	216	214	CREATE	2021-01-26 05:02:57.207	11.05 General	11.05.01 Relevant Communications-Biostatistics-Documents
6823	84	\N	\N	D5170C00002	608	601	NEW	\N	05.04 Site Management	05.04.08 UNBLI_onitoring Report
17821	90	1620234969089:-1826863465	rootNode	ACE-ST-209	1	0	CREATE	2021-05-05 19:16:09.189		eTMF
17822	90	1620234969795:395460105	1620234969089:-1826863465	ACE-ST-209	2	1	CREATE	2021-05-05 19:16:09.894	eTMF	bin
17823	90	1620234970475:-1191996394	1620234969089:-1826863465	ACE-ST-209	3	1	CREATE	2021-05-05 19:16:10.593	eTMF	05 Site Management
17824	90	1620234971111:-1802480856	1620234970475:-1191996394	ACE-ST-209	4	3	CREATE	2021-05-05 19:16:11.342	05 Site Management	05.015 Site 0055 David Cosgrove
17825	90	1620234971872:173820211	1620234971111:-1802480856	ACE-ST-209	5	4	CREATE	2021-05-05 19:16:11.965	05.015 Site 0055 David Cosgrove	05.015.04 IRB/IEC and other Approvals
17826	90	1620234972464:-1150989718	1620234971872:173820211	ACE-ST-209	6	5	CREATE	2021-05-05 19:16:12.555	05.015.04 IRB/IEC and other Approvals	05.015.04.01 IRB/IEC Trial Approvals
17827	90	1620234973063:-805561567	1620234972464:-1150989718	ACE-ST-209	7	6	CREATE	2021-05-05 19:16:13.15	05.015.04.01 IRB/IEC Trial Approvals	05.015.04.01.02 IRB/IEC Approval
17833	90	1620234973659:-1193361541	1620234971111:-1802480856	ACE-ST-209	8	4	CREATE	2021-05-05 19:16:13.746	05.015 Site 0055 David Cosgrove	05.015.02 Site  Set-up
17834	90	1620234974273:1009531349	1620234973659:-1193361541	ACE-ST-209	9	8	CREATE	2021-05-05 19:16:14.364	05.015.02 Site  Set-up	05.015.02.04 Principal Investigator Curriculum Vitae
17835	90	1620234974849:1494030102	1620234973659:-1193361541	ACE-ST-209	10	8	CREATE	2021-05-05 19:16:14.936	05.015.02 Site  Set-up	05.015.02.03 Protocol Amendment Signature Page
17836	90	1620234975468:-227161414	1620234973659:-1193361541	ACE-ST-209	11	8	CREATE	2021-05-05 19:16:15.563	05.015.02 Site  Set-up	05.015.02.018 Site Signature Sheet
18271	90	1620234976122:207009065	1620234969089:-1826863465	ACE-ST-209	12	1	CREATE	2021-05-05 19:16:16.204	eTMF	01 Trial Management
18272	90	1620234976754:-497068908	1620234976122:207009065	ACE-ST-209	13	12	CREATE	2021-05-05 19:16:16.842	01 Trial Management	01.04 Meetings
18273	90	1620234977363:1555532521	1620234976754:-497068908	ACE-ST-209	14	13	CREATE	2021-05-05 19:16:17.454	01.04 Meetings	01.04.04 Trial Team Evidence of Training
18274	90	1620234977969:-1964455933	1620234976754:-497068908	ACE-ST-209	15	13	CREATE	2021-05-05 19:16:18.058	01.04 Meetings	01.04.02 Trial Team Training Material
17870	90	1620234978635:-1970050106	1620234970475:-1191996394	ACE-ST-209	16	3	CREATE	2021-05-05 19:16:19.17	05 Site Management	05.012 Site  Samuael Goldlust
17871	90	1620234979718:-2027306979	1620234978635:-1970050106	ACE-ST-209	17	16	CREATE	2021-05-05 19:16:19.806	05.012 Site  Samuael Goldlust	05.012.06 General
17872	90	1620234980380:1822211424	1620234979718:-2027306979	ACE-ST-209	18	17	CREATE	2021-05-05 19:16:20.472	05.012.06 General	05.012.06.04 Filenote
17895	90	1620234980940:-109158258	1620234970475:-1191996394	ACE-ST-209	19	3	CREATE	2021-05-05 19:16:21.028	05 Site Management	05.017 Site 0588 Lawrence Recht
17896	90	1620234981545:891425982	1620234980940:-109158258	ACE-ST-209	20	19	CREATE	2021-05-05 19:16:21.636	05.017 Site 0588 Lawrence Recht	05.017.02 Site  Set-up
17897	90	1620234982106:-1534022644	1620234981545:891425982	ACE-ST-209	21	20	CREATE	2021-05-05 19:16:22.196	05.017.02 Site  Set-up	05.017.02.05 Sub-Investigator Curriculum Vitae
17936	90	1620234982700:-567252818	1620234970475:-1191996394	ACE-ST-209	22	3	CREATE	2021-05-05 19:16:22.783	05 Site Management	05.016 Site 0586 Patrick Wen
17937	90	1620234983276:771387598	1620234982700:-567252818	ACE-ST-209	23	22	CREATE	2021-05-05 19:16:23.362	05.016 Site 0586 Patrick Wen	05.016.05 Site Management
17938	90	1620234983942:1021223641	1620234983276:771387598	ACE-ST-209	24	23	CREATE	2021-05-05 19:16:24.031	05.016.05 Site Management	05.016.05.03 Monitoring Visit Report
17908	90	1620234984524:1528573619	1620234980940:-109158258	ACE-ST-209	25	19	CREATE	2021-05-05 19:16:24.613	05.017 Site 0588 Lawrence Recht	05.017.05 Site Management
17909	90	1620234985117:1672203465	1620234984524:1528573619	ACE-ST-209	26	25	CREATE	2021-05-05 19:16:25.21	05.017.05 Site Management	05.017.05.03 Monitoring Visit Report
18299	90	1620234985730:-1852071393	1620234969089:-1826863465	ACE-ST-209	27	1	CREATE	2021-05-05 19:16:25.814	eTMF	02 Central Trial Documents
18300	90	1620234986339:450639273	1620234985730:-1852071393	ACE-ST-209	28	27	CREATE	2021-05-05 19:16:26.429	02 Central Trial Documents	02.01 Product and Trial Documentation 
18301	90	1620234986964:1424637959	1620234986339:450639273	ACE-ST-209	29	28	CREATE	2021-05-05 19:16:27.05	02.01 Product and Trial Documentation 	02.01.06 Insurance
17846	90	1620234987599:-370760942	1620234971111:-1802480856	ACE-ST-209	30	4	CREATE	2021-05-05 19:16:27.682	05.015 Site 0055 David Cosgrove	05.015.05 Site Management
17847	90	1620234988215:-1411691233	1620234987599:-370760942	ACE-ST-209	31	30	CREATE	2021-05-05 19:16:28.303	05.015.05 Site Management	05.015.05.011 Site Investigational Product Documentation
17848	90	1620234988792:-578901955	1620234988215:-1411691233	ACE-ST-209	32	31	CREATE	2021-05-05 19:16:28.874	05.015.05.011 Site Investigational Product Documentation	05.015.05.011.01 Site Logs
18318	90	1620234989907:878397219	1620234969089:-1826863465	ACE-ST-209	33	1	CREATE	2021-05-05 19:16:29.995	eTMF	06 IP and Trial Supplies
18319	90	1620234990523:-1385566267	1620234989907:878397219	ACE-ST-209	34	33	CREATE	2021-05-05 19:16:30.616	06 IP and Trial Supplies	06.02 IP Release Process Documentation
18320	90	1620234991114:-1983334898	1620234990523:-1385566267	ACE-ST-209	35	34	CREATE	2021-05-05 19:16:31.203	06.02 IP Release Process Documentation	06.02.01 QP (Qualified Person) Certification
18321	90	1620234991694:-1493108290	1620234990523:-1385566267	ACE-ST-209	36	34	CREATE	2021-05-05 19:16:31.782	06.02 IP Release Process Documentation	06.02.03 IP Verification Statements
17939	90	1620234992294:474176864	1620234983276:771387598	ACE-ST-209	37	23	CREATE	2021-05-05 19:16:32.381	05.016.05 Site Management	05.016.05.011 Site Investigational Product Documentation
17940	90	1620234992893:115058048	1620234992294:474176864	ACE-ST-209	38	37	CREATE	2021-05-05 19:16:32.993	05.016.05.011 Site Investigational Product Documentation	05.016.05.011.03 Shipment Receipts/Packing List
17941	90	1620234993579:-1488279081	1620234992294:474176864	ACE-ST-209	39	37	CREATE	2021-05-05 19:16:33.672	05.016.05.011 Site Investigational Product Documentation	05.016.05.011.01 Site Logs
17849	90	1620234994212:-236516165	1620234988215:-1411691233	ACE-ST-209	40	31	CREATE	2021-05-05 19:16:34.306	05.015.05.011 Site Investigational Product Documentation	05.015.05.011.03 Shipment Receipts/Packing List
17984	90	1620234994824:-751491923	1620234970475:-1191996394	ACE-ST-209	41	3	CREATE	2021-05-05 19:16:34.919	05 Site Management	05.020 Site 0668 Jorg Dietrich
17985	90	1620234995426:2074962944	1620234994824:-751491923	ACE-ST-209	42	41	CREATE	2021-05-05 19:16:35.518	05.020 Site 0668 Jorg Dietrich	05.020.05 Site Management
17986	90	1620234996005:-1440550496	1620234995426:2074962944	ACE-ST-209	43	42	CREATE	2021-05-05 19:16:36.092	05.020.05 Site Management	05.020.05.011 Site Investigational Product Documentation
17987	90	1620234996589:1012515592	1620234996005:-1440550496	ACE-ST-209	44	43	CREATE	2021-05-05 19:16:36.686	05.020.05.011 Site Investigational Product Documentation	05.020.05.011.03 Shipment Receipts/Packing List
18323	90	1620234997236:-1640925509	1620234989907:878397219	ACE-ST-209	45	33	CREATE	2021-05-05 19:16:37.321	06 IP and Trial Supplies	06.01 IP Documentation
18324	90	1620234997803:-1724451756	1620234997236:-1640925509	ACE-ST-209	46	45	CREATE	2021-05-05 19:16:37.909	06.01 IP Documentation	06.01.05 IP Accountability Documentation
18017	90	1620234998654:-1244079717	1620234970475:-1191996394	ACE-ST-209	47	3	CREATE	2021-05-05 19:16:38.742	05 Site Management	05.019 Site 0667 Eric Wong
18018	90	1620234999266:-1639035036	1620234998654:-1244079717	ACE-ST-209	48	47	CREATE	2021-05-05 19:16:39.354	05.019 Site 0667 Eric Wong	05.019.05 Site Management
18019	90	1620235000379:1139753674	1620234999266:-1639035036	ACE-ST-209	49	48	CREATE	2021-05-05 19:16:40.476	05.019.05 Site Management	05.019.05.011 Site Investigational Product Documentation
18020	90	1620235001073:-1745532853	1620235000379:1139753674	ACE-ST-209	50	49	CREATE	2021-05-05 19:16:41.161	05.019.05.011 Site Investigational Product Documentation	05.019.05.011.03 Shipment Receipts/Packing List
17910	90	1620235001679:-459530292	1620234984524:1528573619	ACE-ST-209	51	25	CREATE	2021-05-05 19:16:41.777	05.017.05 Site Management	05.017.05.011 Site Investigational Product Documentation
17911	90	1620235002295:-272759121	1620235001679:-459530292	ACE-ST-209	52	51	CREATE	2021-05-05 19:16:42.388	05.017.05.011 Site Investigational Product Documentation	05.017.05.011.03 Shipment Receipts/Packing List
18044	90	1620235002898:1277184787	1620234970475:-1191996394	ACE-ST-209	53	3	CREATE	2021-05-05 19:16:42.988	05 Site Management	05.02 Site  Carlos Taboada
18045	90	1620235003508:838102417	1620235002898:1277184787	ACE-ST-209	54	53	CREATE	2021-05-05 19:16:43.608	05.02 Site  Carlos Taboada	05.02.05 Site Management
18046	90	1620235004167:385345127	1620235003508:838102417	ACE-ST-209	55	54	CREATE	2021-05-05 19:16:44.257	05.02.05 Site Management	05.02.05.011 Site Investigational Product Documentation
18047	90	1620235004808:-1062779049	1620235004167:385345127	ACE-ST-209	56	55	CREATE	2021-05-05 19:16:44.894	05.02.05.011 Site Investigational Product Documentation	05.02.05.011.03 Shipment Receipts/Packing List
18325	90	1620235005384:-677334553	1620234997236:-1640925509	ACE-ST-209	57	45	CREATE	2021-05-05 19:16:45.472	06.01 IP Documentation	06.01.04 IP Shipment Documentation
18052	90	1620235005982:-695400115	1620234970475:-1191996394	ACE-ST-209	58	3	CREATE	2021-05-05 19:16:46.069	05 Site Management	05.018 Site 0589 Howard Fine
18053	90	1620235006570:469001643	1620235005982:-695400115	ACE-ST-209	59	58	CREATE	2021-05-05 19:16:46.659	05.018 Site 0589 Howard Fine	05.018.05 Site Management
18054	90	1620235007149:1351512464	1620235006570:469001643	ACE-ST-209	60	59	CREATE	2021-05-05 19:16:47.233	05.018.05 Site Management	05.018.05.011 Site Investigational Product Documentation
18055	90	1620235007723:1191720905	1620235007149:1351512464	ACE-ST-209	61	60	CREATE	2021-05-05 19:16:47.805	05.018.05.011 Site Investigational Product Documentation	05.018.05.011.03 Shipment Receipts/Packing List
18100	90	1620235008383:498417270	1620234970475:-1191996394	ACE-ST-209	62	3	CREATE	2021-05-05 19:16:48.472	05 Site Management	05.01 Site  Allen Cohn
18101	90	1620235009008:860283858	1620235008383:498417270	ACE-ST-209	63	62	CREATE	2021-05-05 19:16:49.099	05.01 Site  Allen Cohn	05.01.05 Site Management
18102	90	1620235009619:-1166841877	1620235009008:860283858	ACE-ST-209	64	63	CREATE	2021-05-05 19:16:49.719	05.01.05 Site Management	05.01.05.011 Site Investigational Product Documentation
18103	90	1620235010211:-1327019234	1620235009619:-1166841877	ACE-ST-209	65	64	CREATE	2021-05-05 19:16:50.308	05.01.05.011 Site Investigational Product Documentation	05.01.05.011.03 Shipment Receipts/Packing List
18120	90	1620235011440:404816477	1620234970475:-1191996394	ACE-ST-209	66	3	CREATE	2021-05-05 19:16:51.742	05 Site Management	05.013 Site  Timothy  Cloughesey
18121	90	1620235012307:-1543109431	1620235011440:404816477	ACE-ST-209	67	66	CREATE	2021-05-05 19:16:52.396	05.013 Site  Timothy  Cloughesey	05.013.05 Site Management
18122	90	1620235012979:300423137	1620235012307:-1543109431	ACE-ST-209	68	67	CREATE	2021-05-05 19:16:53.07	05.013.05 Site Management	05.013.05.011 Site Investigational Product Documentation
18123	90	1620235013576:-256241343	1620235012979:300423137	ACE-ST-209	69	68	CREATE	2021-05-05 19:16:53.665	05.013.05.011 Site Investigational Product Documentation	05.013.05.011.03 Shipment Receipts/Packing List
18059	90	1620235014192:1263787962	1620235006570:469001643	ACE-ST-209	70	59	CREATE	2021-05-05 19:16:54.274	05.018.05 Site Management	05.018.05.06 Protocol Deviations
18024	90	1620235014753:242899700	1620234999266:-1639035036	ACE-ST-209	71	48	CREATE	2021-05-05 19:16:54.846	05.019.05 Site Management	05.019.05.03 Monitoring Visit Report
18277	90	1620235015362:-1535134244	1620234976122:207009065	ACE-ST-209	72	12	CREATE	2021-05-05 19:16:55.464	01 Trial Management	01.05 General
18278	90	1620235016035:1829505885	1620235015362:-1535134244	ACE-ST-209	73	72	CREATE	2021-05-05 19:16:56.122	01.05 General	01.05.02 Tracking Information
17851	90	1620235016633:305236915	1620234987599:-370760942	ACE-ST-209	74	30	CREATE	2021-05-05 19:16:56.717	05.015.05 Site Management	05.015.05.03 Monitoring Visit Report
18060	90	1620235017225:247165509	1620235006570:469001643	ACE-ST-209	75	59	CREATE	2021-05-05 19:16:57.311	05.018.05 Site Management	05.018.05.03 Monitoring Visit Report
18124	90	1620235017832:465010778	1620235012979:300423137	ACE-ST-209	76	68	CREATE	2021-05-05 19:16:57.919	05.013.05.011 Site Investigational Product Documentation	05.013.05.011.04 Temperature Monitoring
17949	90	1620235018469:1402389940	1620234982700:-567252818	ACE-ST-209	77	22	CREATE	2021-05-05 19:16:58.556	05.016 Site 0586 Patrick Wen	05.016.06 General
17950	90	1620235019046:1491116837	1620235018469:1402389940	ACE-ST-209	78	77	CREATE	2021-05-05 19:16:59.134	05.016.06 General	05.016.06.04 Filenote
18302	90	1620235019716:-261900890	1620234986339:450639273	ACE-ST-209	79	28	CREATE	2021-05-05 19:16:59.806	02.01 Product and Trial Documentation 	02.01.01 Investigator Brochure
17952	90	1620235020291:1661858014	1620234982700:-567252818	ACE-ST-209	80	22	CREATE	2021-05-05 19:17:00.378	05.016 Site 0586 Patrick Wen	05.016.03 Site Initiation
17953	90	1620235020893:-149604061	1620235020291:1661858014	ACE-ST-209	81	80	CREATE	2021-05-05 19:17:00.981	05.016.03 Site Initiation	05.016.03.03 Site Evidence of Training 
18131	90	1620235022062:-769283627	1620235011440:404816477	ACE-ST-209	82	66	CREATE	2021-05-05 19:17:02.15	05.013 Site  Timothy  Cloughesey	05.013.03 Site Initiation
18132	90	1620235022675:-699376203	1620235022062:-769283627	ACE-ST-209	83	82	CREATE	2021-05-05 19:17:02.762	05.013.03 Site Initiation	05.013.03.03 Site Evidence of Training 
17990	90	1620235023335:-440098583	1620234995426:2074962944	ACE-ST-209	84	42	CREATE	2021-05-05 19:17:03.424	05.020.05 Site Management	05.020.05.03 Monitoring Visit Report
6949	84	\N	\N	D5170C00002	734	712	NEW	\N	05 Site Management	05.04 Site Management
17988	90	1620235023967:328443608	1620234996005:-1440550496	ACE-ST-209	85	43	CREATE	2021-05-05 19:17:04.062	05.020.05.011 Site Investigational Product Documentation	05.020.05.011.01 Site Logs
17850	90	1620235024549:-1036959083	1620234988215:-1411691233	ACE-ST-209	86	31	CREATE	2021-05-05 19:17:04.634	05.015.05.011 Site Investigational Product Documentation	05.015.05.011.04 Temperature Monitoring
17995	90	1620235025099:861432581	1620234994824:-751491923	ACE-ST-209	87	41	CREATE	2021-05-05 19:17:05.185	05.020 Site 0668 Jorg Dietrich	05.020.02 Site  Set-up
17996	90	1620235025677:2002973652	1620235025099:861432581	ACE-ST-209	88	87	CREATE	2021-05-05 19:17:05.763	05.020.02 Site  Set-up	05.020.02.05 Sub-Investigator Curriculum Vitae
17997	90	1620235026324:-653191274	1620235025099:861432581	ACE-ST-209	89	87	CREATE	2021-05-05 19:17:06.419	05.020.02 Site  Set-up	05.020.02.07 Site and Staff Qualification Supporting Information 
17918	90	1620235026905:-1973411326	1620234980940:-109158258	ACE-ST-209	90	19	CREATE	2021-05-05 19:17:06.992	05.017 Site 0588 Lawrence Recht	05.017.06 General
11638	86	\N	\N	D5170C00002	89	88	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
17919	90	1620235027495:1251633732	1620235026905:-1973411326	ACE-ST-209	91	90	CREATE	2021-05-05 19:17:07.58	05.017.06 General	05.017.06.04 Filenote
17998	90	1620235028061:1851926427	1620235025099:861432581	ACE-ST-209	92	87	CREATE	2021-05-05 19:17:08.148	05.020.02 Site  Set-up	05.020.02.015 Local Laboratory Certification or Accreditation
18137	90	1620235028810:1708636542	1620235011440:404816477	ACE-ST-209	93	66	CREATE	2021-05-05 19:17:08.893	05.013 Site  Timothy  Cloughesey	05.013.02 Site  Set-up
18138	90	1620235029462:-920057319	1620235028810:1708636542	ACE-ST-209	94	93	CREATE	2021-05-05 19:17:09.559	05.013.02 Site  Set-up	05.013.02.018 Site Signature Sheet
18326	90	1620235030042:-1822304227	1620234997236:-1640925509	ACE-ST-209	95	45	CREATE	2021-05-05 19:17:10.139	06.01 IP Documentation	06.01.06 IP Transfer Documentation 
18327	90	1620235030641:-1917559929	1620234997236:-1640925509	ACE-ST-209	96	45	CREATE	2021-05-05 19:17:10.741	06.01 IP Documentation	06.01.010 IP Return Documentation 
18021	90	1620235031232:919676038	1620235000379:1139753674	ACE-ST-209	97	49	CREATE	2021-05-05 19:17:11.314	05.019.05.011 Site Investigational Product Documentation	05.019.05.011.01 Site Logs
18022	90	1620235034757:980632684	1620235000379:1139753674	ACE-ST-209	98	49	CREATE	2021-05-05 19:17:14.845	05.019.05.011 Site Investigational Product Documentation	05.019.05.011.04 Temperature Monitoring
18125	90	1620235035361:-70713073	1620235012979:300423137	ACE-ST-209	99	68	CREATE	2021-05-05 19:17:15.455	05.013.05.011 Site Investigational Product Documentation	05.013.05.011.01 Site Logs
17912	90	1620235035962:1761095357	1620235001679:-459530292	ACE-ST-209	100	51	CREATE	2021-05-05 19:17:16.047	05.017.05.011 Site Investigational Product Documentation	05.017.05.011.04 Temperature Monitoring
18336	90	1620235037072:2103103251	1620234969089:-1826863465	ACE-ST-209	101	1	CREATE	2021-05-05 19:17:17.161	eTMF	07 Safety Reporting
18337	90	1620235037711:1765455008	1620235037072:2103103251	ACE-ST-209	102	101	CREATE	2021-05-05 19:17:17.797	07 Safety Reporting	07.01 Safety Documentation
18338	90	1620235038305:-1448280882	1620235037711:1765455008	ACE-ST-209	103	102	CREATE	2021-05-05 19:17:18.392	07.01 Safety Documentation	07.01.01 Safety Management Plan
18331	90	1620235038883:304782566	1620234989907:878397219	ACE-ST-209	104	33	CREATE	2021-05-05 19:17:18.969	06 IP and Trial Supplies	06.04 Storage
18332	90	1620235039488:1167688749	1620235038883:304782566	ACE-ST-209	105	104	CREATE	2021-05-05 19:17:19.573	06.04 Storage	06.04.01 IP Storage Condition Documentation
17958	90	1620235040062:-1315485005	1620234982700:-567252818	ACE-ST-209	106	22	CREATE	2021-05-05 19:17:20.145	05.016 Site 0586 Patrick Wen	05.016.02 Site  Set-up
17959	90	1620235040705:692540867	1620235040062:-1315485005	ACE-ST-209	107	106	CREATE	2021-05-05 19:17:20.789	05.016.02 Site  Set-up	05.016.02.07 Site and Staff Qualification Supporting Information 
17837	90	1620235041302:-1758334424	1620234973659:-1193361541	ACE-ST-209	108	8	CREATE	2021-05-05 19:17:21.391	05.015.02 Site  Set-up	05.015.02.08 Form FDA1572
17838	90	1620235041904:82756412	1620234973659:-1193361541	ACE-ST-209	109	8	CREATE	2021-05-05 19:17:21.99	05.015.02 Site  Set-up	05.015.02.07 Site and Staff Qualification Supporting Information 
17839	90	1620235042481:-1232951388	1620234973659:-1193361541	ACE-ST-209	110	8	CREATE	2021-05-05 19:17:22.564	05.015.02 Site  Set-up	05.015.02.010 Financial Disclosure Form
17840	90	1620235043075:-2132336215	1620234973659:-1193361541	ACE-ST-209	111	8	CREATE	2021-05-05 19:17:23.163	05.015.02 Site  Set-up	05.015.02.05 Sub-Investigator Curriculum Vitae
17856	90	1620235043682:-857473916	1620234971111:-1802480856	ACE-ST-209	112	4	CREATE	2021-05-05 19:17:23.77	05.015 Site 0055 David Cosgrove	05.015.03 Site Initiation
17857	90	1620235044317:-990334474	1620235043682:-857473916	ACE-ST-209	113	112	CREATE	2021-05-05 19:17:24.407	05.015.03 Site Initiation	05.015.03.03 Site Evidence of Training 
17841	90	1620235045312:-1993236357	1620234973659:-1193361541	ACE-ST-209	114	8	CREATE	2021-05-05 19:17:25.402	05.015.02 Site  Set-up	05.015.02.01 Acceptance of Investigator Brochure
18279	90	1620235045890:-1399127458	1620235015362:-1535134244	ACE-ST-209	115	72	CREATE	2021-05-05 19:17:25.978	01.05 General	01.05.01 Relevant Communications
18280	90	1620235046459:970761061	1620235015362:-1535134244	ACE-ST-209	116	72	CREATE	2021-05-05 19:17:26.545	01.05 General	01.05.03 Other Meeting Material
18281	90	1620235047061:-1229795144	1620235046459:970761061	ACE-ST-209	117	116	CREATE	2021-05-05 19:17:27.149	01.05.03 Other Meeting Material	01.05.03.01 Internal SMT Meetings (Agenda / Minutes)
18307	90	1620235047704:1670208559	1620234985730:-1852071393	ACE-ST-209	118	27	CREATE	2021-05-05 19:17:27.791	02 Central Trial Documents	02.02 Subject Documentation 
18308	90	1620235048302:-483315648	1620235047704:1670208559	ACE-ST-209	119	118	CREATE	2021-05-05 19:17:28.394	02.02 Subject Documentation 	02.02.03 Informed Consent Form
18284	90	1620235048910:1457913569	1620234976122:207009065	ACE-ST-209	120	12	CREATE	2021-05-05 19:17:28.999	01 Trial Management	01.01 Trial Oversight
18285	90	1620235049471:230411767	1620235048910:1457913569	ACE-ST-209	121	120	CREATE	2021-05-05 19:17:29.555	01.01 Trial Oversight	01.01.08 Monitoring Plan
17999	90	1620235050037:-172727132	1620235025099:861432581	ACE-ST-209	122	87	CREATE	2021-05-05 19:17:30.12	05.020.02 Site  Set-up	05.020.02.010 Financial Disclosure Form
18006	90	1620235050615:-1329449064	1620234994824:-751491923	ACE-ST-209	123	41	CREATE	2021-05-05 19:17:30.703	05.020 Site 0668 Jorg Dietrich	05.020.03 Site Initiation
18007	90	1620235051253:-635746156	1620235050615:-1329449064	ACE-ST-209	124	123	CREATE	2021-05-05 19:17:31.352	05.020.03 Site Initiation	05.020.03.03 Site Evidence of Training
4246	82	1611633778799:1307046762	1611633778165:-1580788740	D5136C00008	219	218	CREATE	2021-01-26 05:02:58.883	02 Central Trial Documents	02.01 Trial Documents
17960	90	1620235051858:87257343	1620235040062:-1315485005	ACE-ST-209	125	106	CREATE	2021-05-05 19:17:31.947	05.016.02 Site  Set-up	05.016.02.010 Financial Disclosure Form
18008	90	1620235052481:366015184	1620235050615:-1329449064	ACE-ST-209	126	123	CREATE	2021-05-05 19:17:32.563	05.020.03 Site Initiation	05.020.03.03 Site Evidence of Training 
17991	90	1620235053040:-1961762747	1620234995426:2074962944	ACE-ST-209	127	42	CREATE	2021-05-05 19:17:33.126	05.020.05 Site Management	05.020.05.01 Subject Log
17992	90	1620235053658:1569640658	1620234995426:2074962944	ACE-ST-209	128	42	CREATE	2021-05-05 19:17:33.749	05.020.05 Site Management	05.020.05.04 Visit Log
18000	90	1620235054251:1528149092	1620235025099:861432581	ACE-ST-209	129	87	CREATE	2021-05-05 19:17:34.335	05.020.02 Site  Set-up	05.020.02.018 Site Signature Sheet
17944	90	1620235054880:1834568222	1620234983276:771387598	ACE-ST-209	130	23	CREATE	2021-05-05 19:17:34.963	05.016.05 Site Management	05.016.05.07 Final Trial Close Out Monitoring Report
17863	90	1620235055870:1764401331	1620234971111:-1802480856	ACE-ST-209	131	4	CREATE	2021-05-05 19:17:35.955	05.015 Site 0055 David Cosgrove	05.015.06 General
17864	90	1620235056456:-1560260897	1620235055870:1764401331	ACE-ST-209	132	131	CREATE	2021-05-05 19:17:36.543	05.015.06 General	05.015.06.01 Relevant Communications
18167	90	1620235057063:298634074	1620234970475:-1191996394	ACE-ST-209	133	3	CREATE	2021-05-05 19:17:37.153	05 Site Management	05.03 Site  Charles Conrad
18168	90	1620235057670:361764368	1620235057063:298634074	ACE-ST-209	134	133	CREATE	2021-05-05 19:17:37.759	05.03 Site  Charles Conrad	05.03.05 Site Management
18169	90	1620235058239:1579327864	1620235057670:361764368	ACE-ST-209	135	134	CREATE	2021-05-05 19:17:38.326	05.03.05 Site Management	05.03.05.01 Subject Log
17828	90	1620235059002:-393985068	1620234972464:-1150989718	ACE-ST-209	136	6	CREATE	2021-05-05 19:17:39.105	05.015.04.01 IRB/IEC Trial Approvals	05.015.04.01.06 Approved ICF
17898	90	1620235059581:1080527099	1620234981545:891425982	ACE-ST-209	137	20	CREATE	2021-05-05 19:17:39.664	05.017.02 Site  Set-up	05.017.02.01 Acceptance of Investigator Brochure
18341	90	1620235060165:1623100032	1620234969089:-1826863465	ACE-ST-209	138	1	CREATE	2021-05-05 19:17:40.255	eTMF	04 IRB or IEC and Other Approvals
18342	90	1620235060777:-1015712217	1620235060165:1623100032	ACE-ST-209	139	138	CREATE	2021-05-05 19:17:40.867	04 IRB or IEC and Other Approvals	04.01 IRB or IEC Trial Approvals
18343	90	1620235061384:-1666191163	1620235060777:-1015712217	ACE-ST-209	140	139	CREATE	2021-05-05 19:17:41.48	04.01 IRB or IEC Trial Approvals	04.01.03 IRB or IEC Composition 
17829	90	1620235061972:-853442494	1620234972464:-1150989718	ACE-ST-209	141	6	CREATE	2021-05-05 19:17:42.068	05.015.04.01 IRB/IEC Trial Approvals	05.015.04.01.01 IRB/IEC Submission
18286	90	1620235062601:774344090	1620235048910:1457913569	ACE-ST-209	142	120	CREATE	2021-05-05 19:17:42.691	01.01 Trial Oversight	01.01.01 Trial Master File Plan
18139	90	1620235063177:540063833	1620235028810:1708636542	ACE-ST-209	143	93	CREATE	2021-05-05 19:17:43.264	05.013.02 Site  Set-up	05.013.02.01 Acceptance of Investigator Brochure
17915	90	1620235063748:-898168119	1620234984524:1528573619	ACE-ST-209	144	25	CREATE	2021-05-05 19:17:43.854	05.017.05 Site Management	05.017.05.04 Visit Log
17961	90	1620235064368:-1267063725	1620235040062:-1315485005	ACE-ST-209	145	106	CREATE	2021-05-05 19:17:44.463	05.016.02 Site  Set-up	05.016.02.018 Site Signature Sheet
17945	90	1620235064972:855624287	1620234983276:771387598	ACE-ST-209	146	23	CREATE	2021-05-05 19:17:45.059	05.016.05 Site Management	05.016.05.01 Subject Log
17899	90	1620235066004:-347555459	1620234981545:891425982	ACE-ST-209	147	20	CREATE	2021-05-05 19:17:46.091	05.017.02 Site  Set-up	05.017.02.018 Site Signature Sheet
17913	90	1620235066621:974814718	1620235001679:-459530292	ACE-ST-209	148	51	CREATE	2021-05-05 19:17:46.713	05.017.05.011 Site Investigational Product Documentation	05.017.05.011.01 Site Logs
18065	90	1620235067217:1044761536	1620235005982:-695400115	ACE-ST-209	149	58	CREATE	2021-05-05 19:17:47.305	05.018 Site 0589 Howard Fine	05.018.02 Site  Set-up
18066	90	1620235067800:-1772391147	1620235067217:1044761536	ACE-ST-209	150	149	CREATE	2021-05-05 19:17:47.886	05.018.02 Site  Set-up	05.018.02.010 Financial Disclosure Form
18027	90	1620235068347:2113620094	1620234998654:-1244079717	ACE-ST-209	151	47	CREATE	2021-05-05 19:17:48.428	05.019 Site 0667 Eric Wong	05.019.02 Site  Set-up
18028	90	1620235068928:679591099	1620235068347:2113620094	ACE-ST-209	152	151	CREATE	2021-05-05 19:17:49.023	05.019.02 Site  Set-up	05.019.02.018 Site Signature Sheet
18025	90	1620235069572:976836370	1620234999266:-1639035036	ACE-ST-209	153	48	CREATE	2021-05-05 19:17:49.659	05.019.05 Site Management	05.019.05.04 Visit Log
18029	90	1620235070165:1057270279	1620235068347:2113620094	ACE-ST-209	154	151	CREATE	2021-05-05 19:17:50.254	05.019.02 Site  Set-up	05.019.02.010 Financial Disclosure Form
18036	90	1620235070769:-363346323	1620234998654:-1244079717	ACE-ST-209	155	47	CREATE	2021-05-05 19:17:50.857	05.019 Site 0667 Eric Wong	05.019.03 Site Initiation
18037	90	1620235071344:-987965797	1620235070769:-363346323	ACE-ST-209	156	155	CREATE	2021-05-05 19:17:51.43	05.019.03 Site Initiation	05.019.03.03 Site Evidence of Training
18038	90	1620235071948:1175132441	1620235070769:-363346323	ACE-ST-209	157	155	CREATE	2021-05-05 19:17:52.039	05.019.03 Site Initiation	05.019.03.03 Site Evidence of Training 
18067	90	1620235072529:2097863065	1620235067217:1044761536	ACE-ST-209	158	149	CREATE	2021-05-05 19:17:52.618	05.018.02 Site  Set-up	05.018.02.07 Site and Staff Qualification Supporting Information 
17921	90	1620235073278:-1490651919	1620234980940:-109158258	ACE-ST-209	159	19	CREATE	2021-05-05 19:17:53.369	05.017 Site 0588 Lawrence Recht	05.017.03 Site Initiation
17922	90	1620235073861:-1599270904	1620235073278:-1490651919	ACE-ST-209	160	159	CREATE	2021-05-05 19:17:53.948	05.017.03 Site Initiation	05.017.03.03 Site Evidence of Training 
18294	90	1620235074436:-1666486287	1620234976122:207009065	ACE-ST-209	161	12	CREATE	2021-05-05 19:17:54.521	01 Trial Management	01.03 Trial Committee
18295	90	1620235074999:743508476	1620235074436:-1666486287	ACE-ST-209	162	161	CREATE	2021-05-05 19:17:55.083	01.03 Trial Committee	01.03.01 Committee Process
17946	90	1620235075606:-441122305	1620234983276:771387598	ACE-ST-209	163	23	CREATE	2021-05-05 19:17:55.693	05.016.05 Site Management	05.016.05.04 Visit Log
18348	90	1620235076737:-1651415284	1620234969089:-1826863465	ACE-ST-209	164	1	CREATE	2021-05-05 19:17:56.825	eTMF	08 Centralized Testing
18349	90	1620235077353:-1752616330	1620235076737:-1651415284	ACE-ST-209	165	164	CREATE	2021-05-05 19:17:57.441	08 Centralized Testing	08.01 Facility Documentation
18350	90	1620235077976:-1453058616	1620235077353:-1752616330	ACE-ST-209	166	165	CREATE	2021-05-05 19:17:58.065	08.01 Facility Documentation	08.01.01 Certification or Accreditation
8340	84	\N	\N	D5170C00002	2125	2122	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
18287	90	1620235078546:-327607548	1620235048910:1457913569	ACE-ST-209	167	120	CREATE	2021-05-05 19:17:58.634	01.01 Trial Oversight	01.01.02 Trial Management Plan
18351	90	1620235079156:-186561114	1620235077353:-1752616330	ACE-ST-209	168	165	CREATE	2021-05-05 19:17:59.25	08.01 Facility Documentation	08.01.05 Manual
18353	90	1620235079783:1802925044	1620234969089:-1826863465	ACE-ST-209	169	1	CREATE	2021-05-05 19:17:59.872	eTMF	03 Regulatory
18354	90	1620235080433:-2024430066	1620235079783:1802925044	ACE-ST-209	170	169	CREATE	2021-05-05 19:18:00.521	03 Regulatory	03.02 United States
18355	90	1620235081041:-1583032995	1620235080433:-2024430066	ACE-ST-209	171	170	CREATE	2021-05-05 19:18:01.128	03.02 United States	03.02.01 Trial Approval
11639	86	\N	\N	D5170C00002	90	87	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
18356	90	1620235081634:-824133785	1620235081041:-1583032995	ACE-ST-209	172	171	CREATE	2021-05-05 19:18:01.728	03.02.01 Trial Approval	03.02.01.04 Public Registration
18296	90	1620235082260:1319206043	1620234976122:207009065	ACE-ST-209	173	12	CREATE	2021-05-05 19:18:02.348	01 Trial Management	01.02 Trial Team
18297	90	1620235082875:-2123975540	1620235082260:1319206043	ACE-ST-209	174	173	CREATE	2021-05-05 19:18:02.962	01.02 Trial Team	01.02.03 Trial Team Training Material
18303	90	1620235083494:851379847	1620234986339:450639273	ACE-ST-209	175	28	CREATE	2021-05-05 19:18:03.588	02.01 Product and Trial Documentation 	02.01.04 Protocol Amendment
17842	90	1620235084087:-825590617	1620234973659:-1193361541	ACE-ST-209	176	8	CREATE	2021-05-05 19:18:04.178	05.015.02 Site  Set-up	05.015.02.015 Local Laboratory Certification or Accreditation
17852	90	1620235084742:704388379	1620234987599:-370760942	ACE-ST-209	177	30	CREATE	2021-05-05 19:18:04.832	05.015.05 Site Management	05.015.05.01 Subject Log
17962	90	1620235085350:-281699979	1620235040062:-1315485005	ACE-ST-209	178	106	CREATE	2021-05-05 19:18:05.445	05.016.02 Site  Set-up	05.016.02.06 Other Curriculum Vitae
17963	90	1620235085973:775928220	1620235040062:-1315485005	ACE-ST-209	179	106	CREATE	2021-05-05 19:18:06.06	05.016.02 Site  Set-up	05.016.02.05 Sub-Investigator Curriculum Vitae
17951	90	1620235087094:-1820590403	1620235018469:1402389940	ACE-ST-209	180	77	CREATE	2021-05-05 19:18:07.184	05.016.06 General	05.016.06.01 Relevant Communications
18358	90	1620235087740:-357532094	1620234969089:-1826863465	ACE-ST-209	181	1	CREATE	2021-05-05 19:18:07.827	eTMF	010 Data Management.
18359	90	1620235088393:-2145248301	1620235087740:-357532094	ACE-ST-209	182	181	CREATE	2021-05-05 19:18:08.479	010 Data Management.	010.03 Database
18360	90	1620235088984:1131768547	1620235088393:-2145248301	ACE-ST-209	183	182	CREATE	2021-05-05 19:18:09.069	010.03 Database	010.03.011 Database Lock and Unlock Approval 
17858	90	1620235089588:-966156148	1620235043682:-857473916	ACE-ST-209	184	112	CREATE	2021-05-05 19:18:09.672	05.015.03 Site Initiation	05.015.03.03 Site Evidence of Training
18361	90	1620235090207:1800512387	1620235088393:-2145248301	ACE-ST-209	185	182	CREATE	2021-05-05 19:18:10.296	010.03 Database	010.03.010 Data QC / QA Plan & Results 
18362	90	1620235090804:-636428934	1620235088393:-2145248301	ACE-ST-209	186	182	CREATE	2021-05-05 19:18:10.893	010.03 Database	010.03.012 Database Change Control 
18363	90	1620235091413:-1284661553	1620235088393:-2145248301	ACE-ST-209	187	182	CREATE	2021-05-05 19:18:11.503	010.03 Database	010.03.01 Database Specifications 
17865	90	1620235092045:-938198612	1620235055870:1764401331	ACE-ST-209	188	131	CREATE	2021-05-05 19:18:12.131	05.015.06 General	05.015.06.02 Tracking Information
18370	90	1620235092634:-633377047	1620235087740:-357532094	ACE-ST-209	189	181	CREATE	2021-05-05 19:18:12.717	010 Data Management.	010.05 General
18371	90	1620235093232:1529334442	1620235092634:-633377047	ACE-ST-209	190	189	CREATE	2021-05-05 19:18:13.319	010.05 General	010.05.02 Tracking Information
18282	90	1620235093851:-652436304	1620235046459:970761061	ACE-ST-209	191	116	CREATE	2021-05-05 19:18:13.939	01.05.03 Other Meeting Material	01.05.03.02 Protocol and Amendment Training
17866	90	1620235094428:1824200081	1620235055870:1764401331	ACE-ST-209	192	131	CREATE	2021-05-05 19:18:14.512	05.015.06 General	05.015.06.04 Filenote
18140	90	1620235095005:-1509595287	1620235028810:1708636542	ACE-ST-209	193	93	CREATE	2021-05-05 19:18:15.093	05.013.02 Site  Set-up	05.013.02.05 Sub-Investigator Curriculum Vitae
18141	90	1620235095615:1700128496	1620235028810:1708636542	ACE-ST-209	194	93	CREATE	2021-05-05 19:18:15.709	05.013.02 Site  Set-up	05.013.02.04 Principal Investigator Curriculum Vitae
18077	90	1620235096181:1359663021	1620235005982:-695400115	ACE-ST-209	195	58	CREATE	2021-05-05 19:18:16.268	05.018 Site 0589 Howard Fine	05.018.03 Site Initiation
18078	90	1620235096786:-10010676	1620235096181:1359663021	ACE-ST-209	196	195	CREATE	2021-05-05 19:18:16.88	05.018.03 Site Initiation	05.018.03.03 Site Evidence of Training 
17843	90	1620235097919:1888642885	1620234973659:-1193361541	ACE-ST-209	197	8	CREATE	2021-05-05 19:18:18.008	05.015.02 Site  Set-up	05.015.02.016 Local Laboratory Normal Ranges
18104	90	1620235098559:-560788738	1620235008383:498417270	ACE-ST-209	198	62	CREATE	2021-05-05 19:18:18.645	05.01 Site  Allen Cohn	05.01.02 Site  Set-up
18105	90	1620235099158:-905171010	1620235098559:-560788738	ACE-ST-209	199	198	CREATE	2021-05-05 19:18:19.248	05.01.02 Site  Set-up	05.01.02.015 Local Laboratory Certification or Accreditation
18009	90	1620235099755:-502507968	1620234994824:-751491923	ACE-ST-209	200	41	CREATE	2021-05-05 19:18:19.842	05.020 Site 0668 Jorg Dietrich	05.020.01 Site Selection
18010	90	1620235101326:-1443430077	1620235099755:-502507968	ACE-ST-209	201	200	CREATE	2021-05-05 19:18:21.416	05.020.01 Site Selection	05.020.01.05 Subject Eligibility Verification Forms and Worksheets
17830	90	1620235101929:-830225201	1620234972464:-1150989718	ACE-ST-209	202	6	CREATE	2021-05-05 19:18:22.127	05.015.04.01 IRB/IEC Trial Approvals	05.015.04.01.07 IRB/IEC Correspondence - Site
17853	90	1620235102666:534022656	1620234987599:-370760942	ACE-ST-209	203	30	CREATE	2021-05-05 19:18:22.761	05.015.05 Site Management	05.015.05.09 Site Specific SOPs
17867	90	1620235103257:-349891518	1620234971111:-1802480856	ACE-ST-209	204	4	CREATE	2021-05-05 19:18:23.342	05.015 Site 0055 David Cosgrove	05.015.01 Site Selection
17868	90	1620235103845:975287128	1620235103257:-349891518	ACE-ST-209	205	204	CREATE	2021-05-05 19:18:23.933	05.015.01 Site Selection	05.015.01.03 Feasibility Documentation
18373	90	1620235106294:-1561806854	1620235087740:-357532094	ACE-ST-209	209	181	CREATE	2021-05-05 19:18:26.381	010 Data Management.	010.01 Data Management Oversight
18374	90	1620235106880:-1497293188	1620235106294:-1561806854	ACE-ST-209	210	209	CREATE	2021-05-05 19:18:26.965	010.01 Data Management Oversight	010.01.01 Data Management Plan
17969	90	1620235107466:-1343191039	1620234982700:-567252818	ACE-ST-209	211	22	CREATE	2021-05-05 19:18:28.044	05.016 Site 0586 Patrick Wen	05.016.04 IRB/IEC and other Approvals
4249	82	1611633780524:-179877480	1611633778799:1307046762	D5136C00008	222	219	CREATE	2021-01-26 05:03:00.608	02.01 Trial Documents	02.01.06 Insurance
17970	90	1620235108665:1104499339	1620235107466:-1343191039	ACE-ST-209	212	211	CREATE	2021-05-05 19:18:28.754	05.016.04 IRB/IEC and other Approvals	05.016.04.03 Trial Status Reporting
7141	84	\N	\N	D5170C00002	926	918	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
17971	90	1620235109278:-393306950	1620235108665:1104499339	ACE-ST-209	213	212	CREATE	2021-05-05 19:18:29.364	05.016.04.03 Trial Status Reporting	05.016.04.03.02 IRB/IEC Progress Report
17844	90	1620235109838:223932222	1620234973659:-1193361541	ACE-ST-209	214	8	CREATE	2021-05-05 19:18:29.924	05.015.02 Site  Set-up	05.015.02.07 Site and Staff Qualification Supporting Information
17854	90	1620235110432:989696650	1620234987599:-370760942	ACE-ST-209	215	30	CREATE	2021-05-05 19:18:30.517	05.015.05 Site Management	05.015.05.04 Visit Log
18375	90	1620235111038:-1564414597	1620235087740:-357532094	ACE-ST-209	216	181	CREATE	2021-05-05 19:18:31.125	010 Data Management.	010.02 Data Capture
18376	90	1620235111623:547972958	1620235111038:-1564414597	ACE-ST-209	217	216	CREATE	2021-05-05 19:18:31.715	010.02 Data Capture	010.02.05 Final Subject Data 
18377	90	1620235112291:-1575607149	1620235111038:-1564414597	ACE-ST-209	218	216	CREATE	2021-05-05 19:18:32.378	010.02 Data Capture	010.02.02 Annotated CRF 
18304	90	1620235112896:-795732158	1620234986339:450639273	ACE-ST-209	219	28	CREATE	2021-05-05 19:18:32.984	02.01 Product and Trial Documentation 	02.01.07 Sample Case Report Form
18288	90	1620235113482:-1672644564	1620235048910:1457913569	ACE-ST-209	220	120	CREATE	2021-05-05 19:18:33.568	01.01 Trial Oversight	01.01.013 Investigator Newsletter
17964	90	1620235114022:-1367673487	1620235040062:-1315485005	ACE-ST-209	221	106	CREATE	2021-05-05 19:18:34.112	05.016.02 Site  Set-up	05.016.02.01 Acceptance of Investigator Brochure
17973	90	1620235114635:-1039491666	1620235107466:-1343191039	ACE-ST-209	222	211	CREATE	2021-05-05 19:18:34.721	05.016.04 IRB/IEC and other Approvals	05.016.04.01 IRB/IEC Trial Approvals
17974	90	1620235115218:-406078528	1620235114635:-1039491666	ACE-ST-209	223	222	CREATE	2021-05-05 19:18:35.302	05.016.04.01 IRB/IEC Trial Approvals	05.016.04.01.01 IRB/IEC Submission
17975	90	1620235115850:-1950601033	1620235114635:-1039491666	ACE-ST-209	224	222	CREATE	2021-05-05 19:18:35.934	05.016.04.01 IRB/IEC Trial Approvals	05.016.04.01.02 IRB/IEC Approval
17874	90	1620235116462:-1001870599	1620234978635:-1970050106	ACE-ST-209	225	16	CREATE	2021-05-05 19:18:36.556	05.012 Site  Samuael Goldlust	05.012.02 Site  Set-up
17875	90	1620235117059:-479093063	1620235116462:-1001870599	ACE-ST-209	226	225	CREATE	2021-05-05 19:18:37.145	05.012.02 Site  Set-up	05.012.02.015 Local Laboratory Certification or Accreditation
18061	90	1620235117634:1212050405	1620235006570:469001643	ACE-ST-209	227	59	CREATE	2021-05-05 19:18:37.722	05.018.05 Site Management	05.018.05.07 Final Trial Close Out Monitoring Report
18026	90	1620235118740:2088690275	1620234999266:-1639035036	ACE-ST-209	228	48	CREATE	2021-05-05 19:18:38.83	05.019.05 Site Management	05.019.05.07 Final Trial Close Out Monitoring Report
18011	90	1620235119411:111477188	1620234994824:-751491923	ACE-ST-209	229	41	CREATE	2021-05-05 19:18:39.513	05.020 Site 0668 Jorg Dietrich	05.020.04 IRB/IEC and other Approvals
18012	90	1620235120142:-2021137329	1620235119411:111477188	ACE-ST-209	230	229	CREATE	2021-05-05 19:18:40.23	05.020.04 IRB/IEC and other Approvals	05.020.04.03 Trial Status Reporting
18013	90	1620235120730:-96718791	1620235120142:-2021137329	ACE-ST-209	231	230	CREATE	2021-05-05 19:18:40.816	05.020.04.03 Trial Status Reporting	05.020.04.03.03 IRB/IEC Notification of Trial Termination
17925	90	1620235121322:-2060365173	1620234980940:-109158258	ACE-ST-209	232	19	CREATE	2021-05-05 19:18:41.412	05.017 Site 0588 Lawrence Recht	05.017.04 IRB/IEC and other Approvals
17926	90	1620235121905:1736106139	1620235121322:-2060365173	ACE-ST-209	233	232	CREATE	2021-05-05 19:18:41.993	05.017.04 IRB/IEC and other Approvals	05.017.04.01 IRB/IEC Trial Approvals
17927	90	1620235122501:-1142151532	1620235121905:1736106139	ACE-ST-209	234	233	CREATE	2021-05-05 19:18:42.589	05.017.04.01 IRB/IEC Trial Approvals	05.017.04.01.01 IRB/IEC Submission
17900	90	1620235123168:2138237237	1620234981545:891425982	ACE-ST-209	235	20	CREATE	2021-05-05 19:18:43.259	05.017.02 Site  Set-up	05.017.02.07 Site and Staff Qualification Supporting Information 
17928	90	1620235123763:-1351094484	1620235121905:1736106139	ACE-ST-209	236	233	CREATE	2021-05-05 19:18:43.852	05.017.04.01 IRB/IEC Trial Approvals	05.017.04.01.06 Approved ICF
17901	90	1620235124366:-133111656	1620234981545:891425982	ACE-ST-209	237	20	CREATE	2021-05-05 19:18:44.469	05.017.02 Site  Set-up	05.017.02.015 Local Laboratory Certification or Accreditation
18283	90	1620235125003:-1484994093	1620235015362:-1535134244	ACE-ST-209	238	72	CREATE	2021-05-05 19:18:45.091	01.05 General	01.05.04 Filenote
18311	90	1620235125600:757715893	1620234985730:-1852071393	ACE-ST-209	239	27	CREATE	2021-05-05 19:18:45.686	02 Central Trial Documents	02.03 Reports
18312	90	1620235126248:-1163307003	1620235125600:757715893	ACE-ST-209	240	239	CREATE	2021-05-05 19:18:46.343	02.03 Reports	02.03.01 Clinical Study Report
18083	90	1620235126824:720663600	1620235005982:-695400115	ACE-ST-209	241	58	CREATE	2021-05-05 19:18:46.909	05.018 Site 0589 Howard Fine	05.018.06 General
18084	90	1620235127427:-1011225902	1620235126824:720663600	ACE-ST-209	242	241	CREATE	2021-05-05 19:18:47.536	05.018.06 General	05.018.06.01 Relevant Communications
17859	90	1620235128020:-254407786	1620235043682:-857473916	ACE-ST-209	243	112	CREATE	2021-05-05 19:18:48.106	05.015.03 Site Initiation	05.015.03.02 Site Training Material
17982	90	1620235128622:-1503949533	1620234982700:-567252818	ACE-ST-209	244	22	CREATE	2021-05-05 19:18:49.201	05.016 Site 0586 Patrick Wen	05.016.01 Site Selection
17983	90	1620235129749:-854884980	1620235128622:-1503949533	ACE-ST-209	245	244	CREATE	2021-05-05 19:18:49.85	05.016.01 Site Selection	05.016.01.05 Subject Eligibility Verification Forms and Worksheets
18056	90	1620235130385:2108800000	1620235007149:1351512464	ACE-ST-209	246	60	CREATE	2021-05-05 19:18:50.476	05.018.05.011 Site Investigational Product Documentation	05.018.05.011.04 Temperature Monitoring
18057	90	1620235130986:560281462	1620235007149:1351512464	ACE-ST-209	247	60	CREATE	2021-05-05 19:18:51.071	05.018.05.011 Site Investigational Product Documentation	05.018.05.011.01 Site Logs
17845	90	1620235131591:754477637	1620234973659:-1193361541	ACE-ST-209	248	8	CREATE	2021-05-05 19:18:51.682	05.015.02 Site  Set-up	05.015.02.017 IP Site Release Documentation
18068	90	1620235132173:-1733635027	1620235067217:1044761536	ACE-ST-209	249	149	CREATE	2021-05-05 19:18:52.261	05.018.02 Site  Set-up	05.018.02.01 Acceptance of Investigator Brochure
18298	90	1620235132739:1524106034	1620235082260:1319206043	ACE-ST-209	250	173	CREATE	2021-05-05 19:18:52.825	01.02 Trial Team	01.02.01 Trial Team Details
17855	90	1620235133405:-287954835	1620234987599:-370760942	ACE-ST-209	251	30	CREATE	2021-05-05 19:18:53.497	05.015.05 Site Management	05.015.05.07 Final Trial Close Out Monitoring Report
18364	90	1620235134008:-1789715335	1620235088393:-2145248301	ACE-ST-209	252	182	CREATE	2021-05-05 19:18:54.1	010.03 Database	010.03.04 Edit Check Testing 
7203	84	\N	\N	D5170C00002	988	985	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
18328	90	1620235134618:114346157	1620234997236:-1640925509	ACE-ST-209	253	45	CREATE	2021-05-05 19:18:54.704	06.01 IP Documentation	06.01.09 IP Quality Complaint Form
18033	90	1620235218990:-313644394	1620235068347:2113620094	ACE-ST-209	378	151	CREATE	2021-05-05 19:20:19.077	05.019.02 Site  Set-up	05.019.02.06 Other Curriculum Vitae
18322	90	1620235135212:1033282677	1620234990523:-1385566267	ACE-ST-209	254	34	CREATE	2021-05-05 19:18:55.298	06.02 IP Release Process Documentation	06.02.04 Certificate of Analysis
18289	90	1620235135798:1053173248	1620235048910:1457913569	ACE-ST-209	255	120	CREATE	2021-05-05 19:18:55.882	01.01 Trial Oversight	01.01.019 Operational Oversight
18365	90	1620235136389:-1000709345	1620235088393:-2145248301	ACE-ST-209	256	182	CREATE	2021-05-05 19:18:56.477	010.03 Database	010.03.09 Dictionary Coding 
18039	90	1620235137024:872286686	1620234998654:-1244079717	ACE-ST-209	257	47	CREATE	2021-05-05 19:18:57.112	05.019 Site 0667 Eric Wong	05.019.06 General
18040	90	1620235137599:714366570	1620235137024:872286686	ACE-ST-209	258	257	CREATE	2021-05-05 19:18:57.682	05.019.06 General	05.019.06.01 Relevant Communications
17947	90	1620235138208:1834425370	1620234983276:771387598	ACE-ST-209	259	23	CREATE	2021-05-05 19:18:58.295	05.016.05 Site Management	05.016.05.09 Site Specific SOPs
17965	90	1620235138810:-1610165682	1620235040062:-1315485005	ACE-ST-209	260	106	CREATE	2021-05-05 19:18:58.9	05.016.02 Site  Set-up	05.016.02.08 Form FDA1572
17902	90	1620235139936:-1383573365	1620234981545:891425982	ACE-ST-209	261	20	CREATE	2021-05-05 19:19:00.025	05.017.02 Site  Set-up	05.017.02.010 Financial Disclosure Form
17903	90	1620235140663:147607109	1620234981545:891425982	ACE-ST-209	262	20	CREATE	2021-05-05 19:19:00.819	05.017.02 Site  Set-up	05.017.02.08 Form FDA1572
17929	90	1620235141331:1428177325	1620235121905:1736106139	ACE-ST-209	263	233	CREATE	2021-05-05 19:19:01.423	05.017.04.01 IRB/IEC Trial Approvals	05.017.04.01.02 IRB/IEC Approval
18344	90	1620235141935:1325284399	1620235060777:-1015712217	ACE-ST-209	264	139	CREATE	2021-05-05 19:19:02.036	04.01 IRB or IEC Trial Approvals	04.01.01 IRB or IEC Submission
18346	90	1620235142532:628765211	1620235060165:1623100032	ACE-ST-209	265	138	CREATE	2021-05-05 19:19:02.624	04 IRB or IEC and Other Approvals	04.04 General
18347	90	1620235143091:228200418	1620235142532:628765211	ACE-ST-209	266	265	CREATE	2021-05-05 19:19:03.176	04.04 General	04.04.01 Relevant Communications
18314	90	1620235143720:-950330173	1620234985730:-1852071393	ACE-ST-209	267	27	CREATE	2021-05-05 19:19:03.808	02 Central Trial Documents	02.04 General
18315	90	1620235144375:-1472551956	1620235143720:-950330173	ACE-ST-209	268	267	CREATE	2021-05-05 19:19:04.47	02.04 General	02.04.04 Filenote
18290	90	1620235144993:1325154129	1620235048910:1457913569	ACE-ST-209	269	120	CREATE	2021-05-05 19:19:05.084	01.01 Trial Oversight	01.01.011 Debarment Statement
18014	90	1620235145555:-1438031672	1620234994824:-751491923	ACE-ST-209	270	41	CREATE	2021-05-05 19:19:05.642	05.020 Site 0668 Jorg Dietrich	05.020.06 General
18015	90	1620235146122:1881269555	1620235145555:-1438031672	ACE-ST-209	271	270	CREATE	2021-05-05 19:19:06.204	05.020.06 General	05.020.06.04 Filenote
18001	90	1620235146715:-791933241	1620235025099:861432581	ACE-ST-209	272	87	CREATE	2021-05-05 19:19:06.797	05.020.02 Site  Set-up	05.020.02.06 Other Curriculum Vitae
17993	90	1620235147303:1191704456	1620234995426:2074962944	ACE-ST-209	273	42	CREATE	2021-05-05 19:19:07.387	05.020.05 Site Management	05.020.05.09 Site Specific SOPs
18086	90	1620235147944:-127309930	1620235005982:-695400115	ACE-ST-209	274	58	CREATE	2021-05-05 19:19:08.029	05.018 Site 0589 Howard Fine	05.018.04 IRB/IEC and other Approvals
18087	90	1620235148537:-1069360250	1620235147944:-127309930	ACE-ST-209	275	274	CREATE	2021-05-05 19:19:08.626	05.018.04 IRB/IEC and other Approvals	05.018.04.01 IRB/IEC Trial Approvals
18088	90	1620235149163:383631387	1620235148537:-1069360250	ACE-ST-209	276	275	CREATE	2021-05-05 19:19:09.252	05.018.04.01 IRB/IEC Trial Approvals	05.018.04.01.02 IRB/IEC Approval
18089	90	1620235149766:1751256446	1620235148537:-1069360250	ACE-ST-209	277	275	CREATE	2021-05-05 19:19:10.446	05.018.04.01 IRB/IEC Trial Approvals	05.018.04.01.01 IRB/IEC Submission
18142	90	1620235150993:-571573296	1620235028810:1708636542	ACE-ST-209	278	93	CREATE	2021-05-05 19:19:11.094	05.013.02 Site  Set-up	05.013.02.07 Site and Staff Qualification Supporting Information 
18149	90	1620235151645:936724088	1620235011440:404816477	ACE-ST-209	279	66	CREATE	2021-05-05 19:19:11.737	05.013 Site  Timothy  Cloughesey	05.013.06 General
18150	90	1620235152277:1999319394	1620235151645:936724088	ACE-ST-209	280	279	CREATE	2021-05-05 19:19:12.368	05.013.06 General	05.013.06.01 Relevant Communications
18143	90	1620235152885:1599312055	1620235028810:1708636542	ACE-ST-209	281	93	CREATE	2021-05-05 19:19:12.975	05.013.02 Site  Set-up	05.013.02.015 Local Laboratory Certification or Accreditation
17904	90	1620235153492:615081183	1620234981545:891425982	ACE-ST-209	282	20	CREATE	2021-05-05 19:19:13.592	05.017.02 Site  Set-up	05.017.02.016 Local Laboratory Normal Ranges
18069	90	1620235154086:-1076765028	1620235067217:1044761536	ACE-ST-209	283	149	CREATE	2021-05-05 19:19:14.175	05.018.02 Site  Set-up	05.018.02.015 Local Laboratory Certification or Accreditation
17920	90	1620235154656:-948645817	1620235026905:-1973411326	ACE-ST-209	284	90	CREATE	2021-05-05 19:19:14.744	05.017.06 General	05.017.06.01 Relevant Communications
18352	90	1620235155283:70997647	1620235077353:-1752616330	ACE-ST-209	285	165	CREATE	2021-05-05 19:19:15.374	08.01 Facility Documentation	08.01.03 Laboratory Results Documentation  
18316	90	1620235155889:-1315002546	1620235143720:-950330173	ACE-ST-209	286	267	CREATE	2021-05-05 19:19:15.98	02.04 General	02.04.03 Meeting Material
18151	90	1620235156479:668520446	1620235151645:936724088	ACE-ST-209	287	279	CREATE	2021-05-05 19:19:16.564	05.013.06 General	05.013.06.03 Meeting Material
18127	90	1620235157094:1754824846	1620235012307:-1543109431	ACE-ST-209	288	67	CREATE	2021-05-05 19:19:17.218	05.013.05 Site Management	05.013.05.03 Monitoring Visit Report
18329	90	1620235157743:-1382316385	1620234997236:-1640925509	ACE-ST-209	289	45	CREATE	2021-05-05 19:19:17.83	06.01 IP Documentation	06.01.02 IP Instructions for Handling
18309	90	1620235158315:438194449	1620235047704:1670208559	ACE-ST-209	290	118	CREATE	2021-05-05 19:19:18.403	02.02 Subject Documentation 	02.02.01 Subject Diary
18090	90	1620235158955:430734475	1620235148537:-1069360250	ACE-ST-209	291	275	CREATE	2021-05-05 19:19:19.044	05.018.04.01 IRB/IEC Trial Approvals	05.018.04.01.06 Approved ICF
18030	90	1620235159586:148037328	1620235068347:2113620094	ACE-ST-209	292	151	CREATE	2021-05-05 19:19:19.676	05.019.02 Site  Set-up	05.019.02.01 Acceptance of Investigator Brochure
4252	82	1611633782331:-1577938982	1611633781086:10116526	D5136C00008	225	223	CREATE	2021-01-26 05:03:02.426	02.02 Subject Documents	02.02.02 Subject Questionnaire
8344	84	\N	\N	D5170C00002	2129	2126	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
18153	90	1620235160223:1384205549	1620235011440:404816477	ACE-ST-209	293	66	CREATE	2021-05-05 19:19:20.311	05.013 Site  Timothy  Cloughesey	05.013.04 IRB/IEC and other Approvals
18154	90	1620235161441:-1445563814	1620235160223:1384205549	ACE-ST-209	294	293	CREATE	2021-05-05 19:19:21.529	05.013.04 IRB/IEC and other Approvals	05.013.04.01 IRB/IEC Trial Approvals
18155	90	1620235162007:-1452411046	1620235161441:-1445563814	ACE-ST-209	295	294	CREATE	2021-05-05 19:19:22.095	05.013.04.01 IRB/IEC Trial Approvals	05.013.04.01.06 Approved ICF
18156	90	1620235162656:1291675225	1620235161441:-1445563814	ACE-ST-209	296	294	CREATE	2021-05-05 19:19:22.744	05.013.04.01 IRB/IEC Trial Approvals	05.013.04.01.02 IRB/IEC Approval
18031	90	1620235163256:-773748823	1620235068347:2113620094	ACE-ST-209	297	151	CREATE	2021-05-05 19:19:23.347	05.019.02 Site  Set-up	05.019.02.015 Local Laboratory Certification or Accreditation
17976	90	1620235163825:-323217732	1620235114635:-1039491666	ACE-ST-209	298	222	CREATE	2021-05-05 19:19:23.912	05.016.04.01 IRB/IEC Trial Approvals	05.016.04.01.06 Approved ICF
18157	90	1620235164447:1039047571	1620235161441:-1445563814	ACE-ST-209	299	294	CREATE	2021-05-05 19:19:24.54	05.013.04.01 IRB/IEC Trial Approvals	05.013.04.01.03 IRB/IEC Composition
18334	90	1620235165026:-989530239	1620234989907:878397219	ACE-ST-209	300	33	CREATE	2021-05-05 19:19:25.112	06 IP and Trial Supplies	06.07 General
18335	90	1620235166205:-595263642	1620235165026:-989530239	ACE-ST-209	301	300	CREATE	2021-05-05 19:19:26.292	06.07 General	06.07.04 IP and Trial Supplies Filenote
18133	90	1620235166788:-343013575	1620235022062:-769283627	ACE-ST-209	302	82	CREATE	2021-05-05 19:19:26.869	05.013.03 Site Initiation	05.013.03.03 Site Evidence of Training
17954	90	1620235167393:-388991160	1620235020291:1661858014	ACE-ST-209	303	80	CREATE	2021-05-05 19:19:27.478	05.016.03 Site Initiation	05.016.03.03 Site Evidence of Training
18291	90	1620235168012:1095627311	1620235048910:1457913569	ACE-ST-209	304	120	CREATE	2021-05-05 19:19:28.099	01.01 Trial Oversight	01.01.04 List of SOPs Current During Trial
18042	90	1620235168630:-1185597536	1620234998654:-1244079717	ACE-ST-209	305	47	CREATE	2021-05-05 19:19:28.725	05.019 Site 0667 Eric Wong	05.019.01 Site Selection
18043	90	1620235169221:1627762179	1620235168630:-1185597536	ACE-ST-209	306	305	CREATE	2021-05-05 19:19:29.31	05.019.01 Site Selection	05.019.01.05 Subject Eligibility Verification Forms and Worksheets
17932	90	1620235169809:-1776407139	1620234980940:-109158258	ACE-ST-209	307	19	CREATE	2021-05-05 19:19:29.896	05.017 Site 0588 Lawrence Recht	05.017.01 Site Selection
17933	90	1620235170384:-1868677997	1620235169809:-1776407139	ACE-ST-209	308	307	CREATE	2021-05-05 19:19:30.471	05.017.01 Site Selection	05.017.01.05 Subject Eligibility Verification Forms and Worksheets
18016	90	1620235170957:382126030	1620235145555:-1438031672	ACE-ST-209	309	270	CREATE	2021-05-05 19:19:31.045	05.020.06 General	05.020.06.01 Relevant Communications
18079	90	1620235172402:1743668384	1620235096181:1359663021	ACE-ST-209	310	195	CREATE	2021-05-05 19:19:32.492	05.018.03 Site Initiation	05.018.03.03 Site Evidence of Training
18070	90	1620235173013:-1476903874	1620235067217:1044761536	ACE-ST-209	311	149	CREATE	2021-05-05 19:19:33.111	05.018.02 Site  Set-up	05.018.02.03 Protocol Amendment Signature Page
18002	90	1620235173623:934058911	1620235025099:861432581	ACE-ST-209	312	87	CREATE	2021-05-05 19:19:33.713	05.020.02 Site  Set-up	05.020.02.07 Site and Staff Qualification Supporting Information
18071	90	1620235174212:-867210288	1620235067217:1044761536	ACE-ST-209	313	149	CREATE	2021-05-05 19:19:34.304	05.018.02 Site  Set-up	05.018.02.04 Principal Investigator Curriculum Vitae
18003	90	1620235174807:-165926030	1620235025099:861432581	ACE-ST-209	314	87	CREATE	2021-05-05 19:19:34.897	05.020.02 Site  Set-up	05.020.02.04 Principal Investigator Curriculum Vitae
17869	90	1620235175413:-1458022503	1620235103257:-349891518	ACE-ST-209	315	204	CREATE	2021-05-05 19:19:35.505	05.015.01 Site Selection	05.015.01.05 Subject Eligibility Verification Forms and Worksheets
18162	90	1620235175986:-752306264	1620235011440:404816477	ACE-ST-209	316	66	CREATE	2021-05-05 19:19:36.07	05.013 Site  Timothy  Cloughesey	05.013.01 Site Selection
18163	90	1620235176629:-372868465	1620235175986:-752306264	ACE-ST-209	317	316	CREATE	2021-05-05 19:19:36.714	05.013.01 Site Selection	05.013.01.05 Subject Eligibility Verification Forms and Worksheets
18096	90	1620235177227:-726568115	1620235005982:-695400115	ACE-ST-209	318	58	CREATE	2021-05-05 19:19:37.323	05.018 Site 0589 Howard Fine	05.018.01 Site Selection
18097	90	1620235177836:884605787	1620235177227:-726568115	ACE-ST-209	319	318	CREATE	2021-05-05 19:19:37.919	05.018.01 Site Selection	05.018.01.05 Subject Eligibility Verification Forms and Worksheets
17873	90	1620235178390:-1252039065	1620234979718:-2027306979	ACE-ST-209	320	17	CREATE	2021-05-05 19:19:38.475	05.012.06 General	05.012.06.01 Relevant Communications
18339	90	1620235178990:933408637	1620235037072:2103103251	ACE-ST-209	321	101	CREATE	2021-05-05 19:19:39.08	07 Safety Reporting	07.02 Trial Status Reporting
18340	90	1620235179633:-1419198874	1620235178990:933408637	ACE-ST-209	322	321	CREATE	2021-05-05 19:19:39.717	07.02 Trial Status Reporting	07.02.04 Special Events of Interest
18305	90	1620235180233:-58980915	1620234986339:450639273	ACE-ST-209	323	28	CREATE	2021-05-05 19:19:40.323	02.01 Product and Trial Documentation 	02.01.02 Protocol
17942	90	1620235180805:-135988486	1620234992294:474176864	ACE-ST-209	324	37	CREATE	2021-05-05 19:19:40.889	05.016.05.011 Site Investigational Product Documentation	05.016.05.011.04 Temperature Monitoring
18292	90	1620235181615:1065502564	1620235048910:1457913569	ACE-ST-209	325	120	CREATE	2021-05-05 19:19:41.779	01.01 Trial Oversight	01.01.05 Operational Procedure Manual
18313	90	1620235182965:-509741048	1620235125600:757715893	ACE-ST-209	326	239	CREATE	2021-05-05 19:19:43.048	02.03 Reports	02.03.03 Pharmacokinetics Report
18366	90	1620235183601:2031108203	1620235088393:-2145248301	ACE-ST-209	327	182	CREATE	2021-05-05 19:19:43.685	010.03 Database	010.03.08 SAE Reconciliation
18144	90	1620235184172:-1064046346	1620235028810:1708636542	ACE-ST-209	328	93	CREATE	2021-05-05 19:19:44.26	05.013.02 Site  Set-up	05.013.02.010 Financial Disclosure Form
18330	90	1620235184820:752145400	1620234997236:-1640925509	ACE-ST-209	329	45	CREATE	2021-05-05 19:19:44.907	06.01 IP Documentation	06.01.01 IP Supply Plan
18275	90	1620235185537:328789008	1620234976754:-497068908	ACE-ST-209	330	13	CREATE	2021-05-05 19:19:45.626	01.04 Meetings	01.04.01 Kick-off Meeting Material
18333	90	1620235187399:-1228244398	1620235038883:304782566	ACE-ST-209	333	104	CREATE	2021-05-05 19:19:47.49	06.04 Storage	06.04.02 IP Storage Condition Excursion Documentation
7328	84	\N	\N	D5170C00002	1113	1084	NEW	\N	05 Site Management	05.05 General
18357	90	1620235188008:-1919000219	1620235081041:-1583032995	ACE-ST-209	334	171	CREATE	2021-05-05 19:19:48.098	03.02.01 Trial Approval	03.02.01.01 Regulatory Submission
18403	91	1625578786929:398390451	rootNode	D5160C00019	7	0	CREATE	2021-07-06 15:39:47.024		eTMF
17979	90	1620235188582:672294034	1620235107466:-1343191039	ACE-ST-209	335	211	CREATE	2021-05-05 19:19:48.667	05.016.04 IRB/IEC and other Approvals	05.016.04.02 Other Committees
17980	90	1620235189202:-1529826979	1620235188582:672294034	ACE-ST-209	336	335	CREATE	2021-05-05 19:19:49.301	05.016.04.02 Other Committees	05.016.04.02.02 Other Approvals
17886	90	1620235189886:-1527464051	1620234978635:-1970050106	ACE-ST-209	337	16	CREATE	2021-05-05 19:19:49.974	05.012 Site  Samuael Goldlust	05.012.04 IRB/IEC and other Approvals
17887	90	1620235190474:-596988181	1620235189886:-1527464051	ACE-ST-209	338	337	CREATE	2021-05-05 19:19:50.567	05.012.04 IRB/IEC and other Approvals	05.012.04.01 IRB/IEC Trial Approvals
17888	90	1620235191070:742018111	1620235190474:-596988181	ACE-ST-209	339	338	CREATE	2021-05-05 19:19:51.155	05.012.04.01 IRB/IEC Trial Approvals	05.012.04.01.01 IRB/IEC Submission
5928	83	1611641837462:-713380885	1611641833440:-27058349	D5136C00008	881	874	CREATE	2021-01-26 07:17:17.547	05.02 Site Se_p Documentation	05.02.08 Form FDA1572
5933	83	1611641840311:397050594	1611641828877:-967378521	D5136C00008	886	869	CREATE	2021-01-26 07:17:20.402	05 Site Management	05.03 Site Initiation
18345	90	1620235191656:-408091936	1620235060777:-1015712217	ACE-ST-209	340	139	CREATE	2021-05-05 19:19:51.753	04.01 IRB or IEC Trial Approvals	04.01.02 IRB or IEC Approval
17889	90	1620235192275:-1298589095	1620235190474:-596988181	ACE-ST-209	341	338	CREATE	2021-05-05 19:19:52.362	05.012.04.01 IRB/IEC Trial Approvals	05.012.04.01.02 IRB/IEC Approval
7390	84	\N	\N	D5170C00002	1175	1174	NEW	\N	2002273 Cadiot, Guilllaume	05 Site Management
18276	90	1620235193606:-1734449407	1620234976754:-497068908	ACE-ST-209	342	13	CREATE	2021-05-05 19:19:53.693	01.04 Meetings	01.04.03 Investigators Meeting Material
17966	90	1620235194178:-1362899361	1620235040062:-1315485005	ACE-ST-209	343	106	CREATE	2021-05-05 19:19:54.265	05.016.02 Site  Set-up	05.016.02.07 Site and Staff Qualification Supporting Information
18004	90	1620235194779:1244288352	1620235025099:861432581	ACE-ST-209	344	87	CREATE	2021-05-05 19:19:54.871	05.020.02 Site  Set-up	05.020.02.01 Acceptance of Investigator Brochure
18128	90	1620235195382:1049151114	1620235012307:-1543109431	ACE-ST-209	345	67	CREATE	2021-05-05 19:19:55.474	05.013.05 Site Management	05.013.05.04 Visit Log
18145	90	1620235195994:1085844738	1620235028810:1708636542	ACE-ST-209	346	93	CREATE	2021-05-05 19:19:56.084	05.013.02 Site  Set-up	05.013.02.03 Protocol Amendment Signature Page
17948	90	1620235196611:500619097	1620234983276:771387598	ACE-ST-209	347	23	CREATE	2021-05-05 19:19:56.699	05.016.05 Site Management	05.016.05.06 Protocol Deviations
18072	90	1620235197190:-91430745	1620235067217:1044761536	ACE-ST-209	348	149	CREATE	2021-05-05 19:19:57.284	05.018.02 Site  Set-up	05.018.02.018 Site Signature Sheet
18062	90	1620235197801:-1936947524	1620235006570:469001643	ACE-ST-209	349	59	CREATE	2021-05-05 19:19:57.886	05.018.05 Site Management	05.018.05.04 Visit Log
18032	90	1620235198375:-674810557	1620235068347:2113620094	ACE-ST-209	350	151	CREATE	2021-05-05 19:19:58.46	05.019.02 Site  Set-up	05.019.02.04 Principal Investigator Curriculum Vitae
17967	90	1620235198952:-259409336	1620235040062:-1315485005	ACE-ST-209	351	106	CREATE	2021-05-05 19:19:59.034	05.016.02 Site  Set-up	05.016.02.04 Principal Investigator Curriculum Vitae
17989	90	1620235199516:-1098124010	1620234996005:-1440550496	ACE-ST-209	352	43	CREATE	2021-05-05 19:19:59.603	05.020.05.011 Site Investigational Product Documentation	05.020.05.011.04 Temperature Monitoring
18378	90	1620235200150:-676821709	1620235111038:-1564414597	ACE-ST-209	353	216	CREATE	2021-05-05 19:20:00.345	010.02 Data Capture	010.02.01 CRF Completion Requirements 
18367	90	1620235200844:-353920705	1620235088393:-2145248301	ACE-ST-209	354	182	CREATE	2021-05-05 19:20:00.94	010.03 Database	010.03.05 Approval for Database Activation
18368	90	1620235201456:-1520246824	1620235088393:-2145248301	ACE-ST-209	355	182	CREATE	2021-05-05 19:20:01.545	010.03 Database	010.03.06 External Data Transfer Specifications 
18379	90	1620235202047:102780812	1620235087740:-357532094	ACE-ST-209	356	181	CREATE	2021-05-05 19:20:02.136	010 Data Management.	010.04 EDC Management
18372	90	1620235204567:1885015376	1620235092634:-633377047	ACE-ST-209	359	189	CREATE	2021-05-05 19:20:04.657	010.05 General	010.05.03 Meeting Material
18369	90	1620235205729:-1936435489	1620235088393:-2145248301	ACE-ST-209	361	182	CREATE	2021-05-05 19:20:05.815	010.03 Database	010.03.02 Edit Check Plan 
18005	90	1620235208133:1636740543	1620235025099:861432581	ACE-ST-209	365	87	CREATE	2021-05-05 19:20:08.217	05.020.02 Site  Set-up	05.020.02.017 IP Site Release Documentation
18073	90	1620235208776:-1757253799	1620235067217:1044761536	ACE-ST-209	366	149	CREATE	2021-05-05 19:20:08.864	05.018.02 Site  Set-up	05.018.02.08 Form FDA1572
18074	90	1620235209351:11695165	1620235067217:1044761536	ACE-ST-209	367	149	CREATE	2021-05-05 19:20:09.437	05.018.02 Site  Set-up	05.018.02.05 Sub-Investigator Curriculum Vitae
18058	90	1620235209963:1814063187	1620235007149:1351512464	ACE-ST-209	368	60	CREATE	2021-05-05 19:20:10.049	05.018.05.011 Site Investigational Product Documentation	05.018.05.011.02 Certificates of Destruction
18023	90	1620235210534:981219015	1620235000379:1139753674	ACE-ST-209	369	49	CREATE	2021-05-05 19:20:10.631	05.019.05.011 Site Investigational Product Documentation	05.019.05.011.02 Certificates of Destruction
18129	90	1620235211202:-1694595834	1620235012307:-1543109431	ACE-ST-209	370	67	CREATE	2021-05-05 19:20:11.288	05.013.05 Site Management	05.013.05.07 Final Trial Close Out Monitoring Report
17994	90	1620235212013:-1760140797	1620234995426:2074962944	ACE-ST-209	371	42	CREATE	2021-05-05 19:20:12.099	05.020.05 Site Management	05.020.05.07 Final Trial Close Out Monitoring Report
17916	90	1620235212616:-1803537000	1620234984524:1528573619	ACE-ST-209	372	25	CREATE	2021-05-05 19:20:12.707	05.017.05 Site Management	05.017.05.07 Final Trial Close Out Monitoring Report
18126	90	1620235213200:2060619995	1620235012979:300423137	ACE-ST-209	373	68	CREATE	2021-05-05 19:20:13.284	05.013.05.011 Site Investigational Product Documentation	05.013.05.011.02 Certificates of Destruction
18310	90	1620235213803:-141363166	1620235047704:1670208559	ACE-ST-209	374	118	CREATE	2021-05-05 19:20:13.89	02.02 Subject Documentation 	02.02.07 Other Information Given to Subjects
18158	90	1620235217182:718282497	1620235161441:-1445563814	ACE-ST-209	375	294	CREATE	2021-05-05 19:20:17.273	05.013.04.01 IRB/IEC Trial Approvals	05.013.04.01.01 IRB/IEC Submission
18160	90	1620235217799:1054265089	1620235160223:1384205549	ACE-ST-209	376	293	CREATE	2021-05-05 19:20:17.885	05.013.04 IRB/IEC and other Approvals	05.013.04.03 Trial Status Reporting
18161	90	1620235218395:1472551454	1620235217799:1054265089	ACE-ST-209	377	376	CREATE	2021-05-05 19:20:18.482	05.013.04.03 Trial Status Reporting	05.013.04.03.03 IRB/IEC Notification of Trial Termination
18041	90	1620235219581:896445581	1620235137024:872286686	ACE-ST-209	379	257	CREATE	2021-05-05 19:20:19.667	05.019.06 General	05.019.06.04 Filenote
17972	90	1620235220225:-1976269680	1620235108665:1104499339	ACE-ST-209	380	212	CREATE	2021-05-05 19:20:20.318	05.016.04.03 Trial Status Reporting	05.016.04.03.03 IRB/IEC Notification of Trial Termination
18094	90	1620235220801:-935730530	1620235147944:-127309930	ACE-ST-209	381	274	CREATE	2021-05-05 19:20:20.882	05.018.04 IRB/IEC and other Approvals	05.018.04.03 Trial Status Reporting
18095	90	1620235221386:634544189	1620235220801:-935730530	ACE-ST-209	382	381	CREATE	2021-05-05 19:20:21.473	05.018.04.03 Trial Status Reporting	05.018.04.03.03 IRB/IEC Notification of Trial Termination
17930	90	1620235221967:1628803529	1620235121905:1736106139	ACE-ST-209	383	233	CREATE	2021-05-05 19:20:22.057	05.017.04.01 IRB/IEC Trial Approvals	05.017.04.01.03 IRB/IEC Composition
5982	83	1611641874139:-1842558559	1611641858278:-1927931879	D5136C00008	935	916	CREATE	2021-01-26 07:17:54.227	7803 Chen, Ian	05 Site Management
7450	84	\N	\N	D5170C00002	1235	1232	NEW	\N	05 Site Management	05.05 General
17905	90	1620235222540:1133973057	1620234981545:891425982	ACE-ST-209	384	20	CREATE	2021-05-05 19:20:22.627	05.017.02 Site  Set-up	05.017.02.02 Protocol Signature Page
17831	90	1620235223114:-342190333	1620234972464:-1150989718	ACE-ST-209	385	6	CREATE	2021-05-05 19:20:23.208	05.015.04.01 IRB/IEC Trial Approvals	05.015.04.01.05 IRB/IEC GCP Compliance Statement
17832	90	1620235223759:-831586522	1620234972464:-1150989718	ACE-ST-209	386	6	CREATE	2021-05-05 19:20:23.847	05.015.04.01 IRB/IEC Trial Approvals	05.015.04.01.03 IRB/IEC Composition
17981	90	1620235224394:-1079610782	1620235188582:672294034	ACE-ST-209	387	335	CREATE	2021-05-05 19:20:24.479	05.016.04.02 Other Committees	05.016.04.02.01 Other Submissions
17934	90	1620235225022:-1932528415	1620235169809:-1776407139	ACE-ST-209	388	307	CREATE	2021-05-05 19:20:25.191	05.017.01 Site Selection	05.017.01.01 Site Contact Details
18187	90	1620235225656:1165803083	1620234970475:-1191996394	ACE-ST-209	389	3	CREATE	2021-05-05 19:20:25.737	05 Site Management	05.08 Site  manmeet Ahluwalia
18188	90	1620235226246:-356414356	1620235225656:1165803083	ACE-ST-209	390	389	CREATE	2021-05-05 19:20:26.334	05.08 Site  manmeet Ahluwalia	05.08.02 Site  Set-up
18189	90	1620235227324:1441881801	1620235226246:-356414356	ACE-ST-209	391	390	CREATE	2021-05-05 19:20:27.409	05.08.02 Site  Set-up	05.08.02.01 Acceptance of Investigator Brochure
18306	90	1620235227915:-398279009	1620234986339:450639273	ACE-ST-209	392	28	CREATE	2021-05-05 19:20:27.997	02.01 Product and Trial Documentation 	02.01.03 Protocol Synopsis
17860	90	1620235228473:-1519396386	1620235043682:-857473916	ACE-ST-209	393	112	CREATE	2021-05-05 19:20:28.558	05.015.03 Site Initiation	05.015.03.04 Site Initiation Confirmation Letter
17861	90	1620235229040:1135486432	1620235043682:-857473916	ACE-ST-209	394	112	CREATE	2021-05-05 19:20:29.125	05.015.03 Site Initiation	05.015.03.05 Site Initiation Follow-Up Letter
17862	90	1620235229628:1509991254	1620235043682:-857473916	ACE-ST-209	395	112	CREATE	2021-05-05 19:20:29.716	05.015.03 Site Initiation	05.015.03.01 Trial Initiation Monitoring Report
18209	90	1620235230255:2059464664	1620234970475:-1191996394	ACE-ST-209	396	3	CREATE	2021-05-05 19:20:30.344	05 Site Management	05.014 Site  William Jeffrey  Edenfield
18210	90	1620235230895:224125764	1620235230255:2059464664	ACE-ST-209	397	396	CREATE	2021-05-05 19:20:30.982	05.014 Site  William Jeffrey  Edenfield	05.014.02 Site  Set-up
18211	90	1620235231489:1764827293	1620235230895:224125764	ACE-ST-209	398	397	CREATE	2021-05-05 19:20:31.579	05.014.02 Site  Set-up	05.014.02.08 Form FDA1572
18212	90	1620235232084:-539675303	1620235230895:224125764	ACE-ST-209	399	397	CREATE	2021-05-05 19:20:32.173	05.014.02 Site  Set-up	05.014.02.05 Sub-Investigator Curriculum Vitae
18213	90	1620235232650:74246486	1620235230895:224125764	ACE-ST-209	400	397	CREATE	2021-05-05 19:20:32.751	05.014.02 Site  Set-up	05.014.02.010 Financial Disclosure Form
18214	90	1620235233811:-1735235283	1620235230895:224125764	ACE-ST-209	401	397	CREATE	2021-05-05 19:20:33.901	05.014.02 Site  Set-up	05.014.02.07 Site and Staff Qualification Supporting Information 
18215	90	1620235234392:464741064	1620235230895:224125764	ACE-ST-209	402	397	CREATE	2021-05-05 19:20:34.481	05.014.02 Site  Set-up	05.014.02.04 Principal Investigator Curriculum Vitae
18221	90	1620235234980:-1043226321	1620235230255:2059464664	ACE-ST-209	403	396	CREATE	2021-05-05 19:20:35.066	05.014 Site  William Jeffrey  Edenfield	05.014.06 General
18222	90	1620235235532:254252595	1620235234980:-1043226321	ACE-ST-209	404	403	CREATE	2021-05-05 19:20:35.617	05.014.06 General	05.014.06.01 Relevant Communications
18216	90	1620235236105:-1325558377	1620235230895:224125764	ACE-ST-209	405	397	CREATE	2021-05-05 19:20:36.196	05.014.02 Site  Set-up	05.014.02.017 IP Site Release Documentation
18217	90	1620235236702:2073750745	1620235230895:224125764	ACE-ST-209	406	397	CREATE	2021-05-05 19:20:36.8	05.014.02 Site  Set-up	05.014.02.016 Local Laboratory Normal Ranges
18218	90	1620235237322:1025742683	1620235230895:224125764	ACE-ST-209	407	397	CREATE	2021-05-05 19:20:37.659	05.014.02 Site  Set-up	05.014.02.015 Local Laboratory Certification or Accreditation
18223	90	1620235238177:-1277829491	1620235234980:-1043226321	ACE-ST-209	408	403	CREATE	2021-05-05 19:20:38.263	05.014.06 General	05.014.06.04 Filenote
18219	90	1620235238763:158529528	1620235230895:224125764	ACE-ST-209	409	397	CREATE	2021-05-05 19:20:38.846	05.014.02 Site  Set-up	05.014.02.01 Acceptance of Investigator Brochure
18317	90	1620235239335:-784632702	1620235143720:-950330173	ACE-ST-209	410	267	CREATE	2021-05-05 19:20:39.424	02.04 General	02.04.01 Relevant Communications
18293	90	1620235239912:-278059993	1620235048910:1457913569	ACE-ST-209	411	120	CREATE	2021-05-05 19:20:39.998	01.01 Trial Oversight	01.01.020 Sites Evaluated But Not Selected
18115	90	1620235240558:1710341827	1620235008383:498417270	ACE-ST-209	412	62	CREATE	2021-05-05 19:20:40.649	05.01 Site  Allen Cohn	05.01.06 General
18116	90	1620235241138:657370654	1620235240558:1710341827	ACE-ST-209	413	412	CREATE	2021-05-05 19:20:41.234	05.01.06 General	05.01.06.01 Relevant Communications
18106	90	1620235241732:1692372286	1620235098559:-560788738	ACE-ST-209	414	198	CREATE	2021-05-05 19:20:41.822	05.01.02 Site  Set-up	05.01.02.010 Financial Disclosure Form
18107	90	1620235242488:-1234486110	1620235098559:-560788738	ACE-ST-209	415	198	CREATE	2021-05-05 19:20:42.572	05.01.02 Site  Set-up	05.01.02.07 Site and Staff Qualification Supporting Information 
18108	90	1620235243059:1071145193	1620235098559:-560788738	ACE-ST-209	416	198	CREATE	2021-05-05 19:20:43.148	05.01.02 Site  Set-up	05.01.02.017 IP Site Release Documentation
18109	90	1620235243650:-1265512079	1620235098559:-560788738	ACE-ST-209	417	198	CREATE	2021-05-05 19:20:43.74	05.01.02 Site  Set-up	05.01.02.01 Acceptance of Investigator Brochure
18110	90	1620235244250:1356085720	1620235098559:-560788738	ACE-ST-209	418	198	CREATE	2021-05-05 19:20:44.339	05.01.02 Site  Set-up	05.01.02.016 Local Laboratory Normal Ranges
18117	90	1620235244858:740868107	1620235240558:1710341827	ACE-ST-209	419	412	CREATE	2021-05-05 19:20:44.945	05.01.06 General	05.01.06.04 Filenote
18111	90	1620235245446:-1305583710	1620235098559:-560788738	ACE-ST-209	420	198	CREATE	2021-05-05 19:20:45.532	05.01.02 Site  Set-up	05.01.02.03 Protocol Amendment Signature Page
18118	90	1620235246030:-1160918848	1620235008383:498417270	ACE-ST-209	421	62	CREATE	2021-05-05 19:20:46.122	05.01 Site  Allen Cohn	05.01.03 Site Initiation
18119	90	1620235246668:1572769575	1620235246030:-1160918848	ACE-ST-209	422	421	CREATE	2021-05-05 19:20:46.755	05.01.03 Site Initiation	05.01.03.04 Site Initiation Confirmation Letter
17977	90	1620235247228:2131387170	1620235114635:-1039491666	ACE-ST-209	423	222	CREATE	2021-05-05 19:20:47.313	05.016.04.01 IRB/IEC Trial Approvals	05.016.04.01.07 IRB/IEC Correspondence - Site
6047	83	1611641912844:2060445449	1611641911014:-1279628076	D5136C00008	1000	997	CREATE	2021-01-26 07:18:32.93	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
6049	83	1611641913987:-1778616054	1611641913429:191192203	D5136C00008	1002	1001	CREATE	2021-01-26 07:18:34.075	05.02 Site Se_p Documentation	05.02.01 Acce_igator Brochure
17978	90	1620235248253:1300277538	1620235114635:-1039491666	ACE-ST-209	424	222	CREATE	2021-05-05 19:20:48.341	05.016.04.01 IRB/IEC Trial Approvals	05.016.04.01.05 IRB/IEC GCP Compliance Statement
17955	90	1620235248889:1649448872	1620235020291:1661858014	ACE-ST-209	425	80	CREATE	2021-05-05 19:20:48.978	05.016.03 Site Initiation	05.016.03.05 Site Initiation Follow-Up Letter
17956	90	1620235249504:-284219271	1620235020291:1661858014	ACE-ST-209	426	80	CREATE	2021-05-05 19:20:49.592	05.016.03 Site Initiation	05.016.03.01 Trial Initiation Monitoring Report
18146	90	1620235250092:1373988382	1620235028810:1708636542	ACE-ST-209	427	93	CREATE	2021-05-05 19:20:50.177	05.013.02 Site  Set-up	05.013.02.08 Form FDA1572
18147	90	1620235250642:-1616682309	1620235028810:1708636542	ACE-ST-209	428	93	CREATE	2021-05-05 19:20:50.726	05.013.02 Site  Set-up	05.013.02.016 Local Laboratory Normal Ranges
18164	90	1620235251279:1378538906	1620235175986:-752306264	ACE-ST-209	429	316	CREATE	2021-05-05 19:20:51.367	05.013.01 Site Selection	05.013.01.02 Confidentiality Agreement
18165	90	1620235251889:-1327061157	1620235175986:-752306264	ACE-ST-209	430	316	CREATE	2021-05-05 19:20:52.192	05.013.01 Site Selection	05.013.01.03 Feasibility Documentation
18166	90	1620235252703:-1126192487	1620235175986:-752306264	ACE-ST-209	431	316	CREATE	2021-05-05 19:20:52.791	05.013.01 Site Selection	05.013.01.01 Site Contact Details
18159	90	1620235253282:1413642075	1620235161441:-1445563814	ACE-ST-209	432	294	CREATE	2021-05-05 19:20:53.367	05.013.04.01 IRB/IEC Trial Approvals	05.013.04.01.07 IRB/IEC Correspondence - Site
18152	90	1620235253893:636072172	1620235151645:936724088	ACE-ST-209	433	279	CREATE	2021-05-05 19:20:53.986	05.013.06 General	05.013.06.04 Filenote
18148	90	1620235254560:-762288216	1620235028810:1708636542	ACE-ST-209	434	93	CREATE	2021-05-05 19:20:54.66	05.013.02 Site  Set-up	05.013.02.02 Protocol Signature Page
18134	90	1620235255149:-1677669207	1620235022062:-769283627	ACE-ST-209	435	82	CREATE	2021-05-05 19:20:55.241	05.013.03 Site Initiation	05.013.03.04 Site Initiation Confirmation Letter
18135	90	1620235255731:1372324056	1620235022062:-769283627	ACE-ST-209	436	82	CREATE	2021-05-05 19:20:55.82	05.013.03 Site Initiation	05.013.03.05 Site Initiation Follow-Up Letter
18130	90	1620235256307:410151655	1620235012307:-1543109431	ACE-ST-209	437	67	CREATE	2021-05-05 19:20:56.393	05.013.05 Site Management	05.013.05.09 Site Specific SOPs
17906	90	1620235256915:-287418278	1620234981545:891425982	ACE-ST-209	438	20	CREATE	2021-05-05 19:20:57.022	05.017.02 Site  Set-up	05.017.02.04 Principal Investigator Curriculum Vitae
17917	90	1620235257547:1733438933	1620234984524:1528573619	ACE-ST-209	439	25	CREATE	2021-05-05 19:20:57.643	05.017.05 Site Management	05.017.05.09 Site Specific SOPs
17935	90	1620235258619:-1409630678	1620235169809:-1776407139	ACE-ST-209	440	307	CREATE	2021-05-05 19:20:58.707	05.017.01 Site Selection	05.017.01.03 Feasibility Documentation
17923	90	1620235259228:-1073642188	1620235073278:-1490651919	ACE-ST-209	441	159	CREATE	2021-05-05 19:20:59.314	05.017.03 Site Initiation	05.017.03.01 Trial Initiation Monitoring Report
17924	90	1620235259829:750835099	1620235073278:-1490651919	ACE-ST-209	442	159	CREATE	2021-05-05 19:20:59.917	05.017.03 Site Initiation	05.017.03.05 Site Initiation Follow-Up Letter
18224	90	1620235260427:-95707018	1620234970475:-1191996394	ACE-ST-209	443	3	CREATE	2021-05-05 19:21:00.534	05 Site Management	05.09 Site  Nicholas Butowski
18225	90	1620235261023:-1099683373	1620235260427:-95707018	ACE-ST-209	444	443	CREATE	2021-05-05 19:21:01.11	05.09 Site  Nicholas Butowski	05.09.06 General
18226	90	1620235261598:1816817268	1620235261023:-1099683373	ACE-ST-209	445	444	CREATE	2021-05-05 19:21:01.682	05.09.06 General	05.09.06.01 Relevant Communications
18227	90	1620235262314:-442790529	1620234970475:-1191996394	ACE-ST-209	446	3	CREATE	2021-05-05 19:21:02.407	05 Site Management	05.05 Site  Jethro Hu
18228	90	1620235262894:-1697657725	1620235262314:-442790529	ACE-ST-209	447	446	CREATE	2021-05-05 19:21:02.975	05.05 Site  Jethro Hu	05.05.06 General
18229	90	1620235263492:-22516238	1620235262894:-1697657725	ACE-ST-209	448	447	CREATE	2021-05-05 19:21:03.579	05.05.06 General	05.05.06.01 Relevant Communications
18230	90	1620235264088:-1841848532	1620235262314:-442790529	ACE-ST-209	449	446	CREATE	2021-05-05 19:21:04.178	05.05 Site  Jethro Hu	05.05.01 Site Selection
18231	90	1620235264668:161179007	1620235264088:-1841848532	ACE-ST-209	450	449	CREATE	2021-05-05 19:21:04.843	05.05.01 Site Selection	05.05.01.02 Confidentiality Agreement
18232	90	1620235265376:2135669056	1620235264088:-1841848532	ACE-ST-209	451	449	CREATE	2021-05-05 19:21:05.466	05.05.01 Site Selection	05.05.01.03 Feasibility Documentation
18200	90	1620235266013:-68908492	1620235225656:1165803083	ACE-ST-209	452	389	CREATE	2021-05-05 19:21:06.102	05.08 Site  manmeet Ahluwalia	05.08.06 General
18201	90	1620235266597:-831363058	1620235266013:-68908492	ACE-ST-209	453	452	CREATE	2021-05-05 19:21:06.681	05.08.06 General	05.08.06.01 Relevant Communications
18190	90	1620235267148:269481509	1620235226246:-356414356	ACE-ST-209	454	390	CREATE	2021-05-05 19:21:07.236	05.08.02 Site  Set-up	05.08.02.08 Form FDA1572
18191	90	1620235267731:-1173169008	1620235226246:-356414356	ACE-ST-209	455	390	CREATE	2021-05-05 19:21:07.818	05.08.02 Site  Set-up	05.08.02.016 Local Laboratory Normal Ranges
18192	90	1620235268387:447622355	1620235226246:-356414356	ACE-ST-209	456	390	CREATE	2021-05-05 19:21:08.484	05.08.02 Site  Set-up	05.08.02.015 Local Laboratory Certification or Accreditation
18193	90	1620235269657:-1091987994	1620235226246:-356414356	ACE-ST-209	457	390	CREATE	2021-05-05 19:21:09.746	05.08.02 Site  Set-up	05.08.02.04 Principal Investigator Curriculum Vitae
18203	90	1620235270260:600283671	1620235225656:1165803083	ACE-ST-209	458	389	CREATE	2021-05-05 19:21:10.351	05.08 Site  manmeet Ahluwalia	05.08.01 Site Selection
18204	90	1620235270876:-862622352	1620235270260:600283671	ACE-ST-209	459	458	CREATE	2021-05-05 19:21:10.971	05.08.01 Site Selection	05.08.01.02 Confidentiality Agreement
18194	90	1620235271477:-1213502963	1620235226246:-356414356	ACE-ST-209	460	390	CREATE	2021-05-05 19:21:11.568	05.08.02 Site  Set-up	05.08.02.010 Financial Disclosure Form
18205	90	1620235272065:-923086050	1620235270260:600283671	ACE-ST-209	461	458	CREATE	2021-05-05 19:21:12.181	05.08.01 Site Selection	05.08.01.03 Feasibility Documentation
18206	90	1620235272716:-1612299660	1620235225656:1165803083	ACE-ST-209	462	389	CREATE	2021-05-05 19:21:12.804	05.08 Site  manmeet Ahluwalia	05.08.04 IRB/IEC and other Approvals
18207	90	1620235273348:-1877661603	1620235272716:-1612299660	ACE-ST-209	463	462	CREATE	2021-05-05 19:21:13.451	05.08.04 IRB/IEC and other Approvals	05.08.04.01 IRB/IEC Trial Approvals
6112	83	1611641961771:-193637476	1611641961200:1409857359	D5136C00008	1065	1064	CREATE	2021-01-26 07:19:21.856	02.04 General	02.04.01 Rele_-Contact Report
6114	83	1611641962887:-1253767804	1611641956364:-1352316942	D5136C00008	1067	1056	CREATE	2021-01-26 07:19:22.972	7805 Harrington, Thomas	03 Regulatory
18208	90	1620235273958:-134428210	1620235273348:-1877661603	ACE-ST-209	464	463	CREATE	2021-05-05 19:21:14.045	05.08.04.01 IRB/IEC Trial Approvals	05.08.04.01.03 IRB/IEC Composition
7571	84	\N	\N	D5170C00002	1356	1336	NEW	\N	2002076 Schmelz, Renate	05 Site Management
18195	90	1620235274682:-399493367	1620235226246:-356414356	ACE-ST-209	465	390	CREATE	2021-05-05 19:21:14.772	05.08.02 Site  Set-up	05.08.02.05 Sub-Investigator Curriculum Vitae
18196	90	1620235275254:-674412708	1620235226246:-356414356	ACE-ST-209	466	390	CREATE	2021-05-05 19:21:15.341	05.08.02 Site  Set-up	05.08.02.07 Site and Staff Qualification Supporting Information 
18202	90	1620235275811:-511574976	1620235266013:-68908492	ACE-ST-209	467	452	CREATE	2021-05-05 19:21:15.939	05.08.06 General	05.08.06.04 Filenote
18197	90	1620235276450:-2145462325	1620235226246:-356414356	ACE-ST-209	468	390	CREATE	2021-05-05 19:21:16.536	05.08.02 Site  Set-up	05.08.02.02 Protocol Signature Page
18198	90	1620235277059:-1010873253	1620235226246:-356414356	ACE-ST-209	469	390	CREATE	2021-05-05 19:21:17.15	05.08.02 Site  Set-up	05.08.02.03 Protocol Amendment Signature Page
18199	90	1620235277660:-706419439	1620235226246:-356414356	ACE-ST-209	470	390	CREATE	2021-05-05 19:21:17.748	05.08.02 Site  Set-up	05.08.02.017 IP Site Release Documentation
17876	90	1620235278241:25591817	1620235116462:-1001870599	ACE-ST-209	471	225	CREATE	2021-05-05 19:21:18.33	05.012.02 Site  Set-up	05.012.02.08 Form FDA1572
17877	90	1620235278847:1348700461	1620235116462:-1001870599	ACE-ST-209	472	225	CREATE	2021-05-05 19:21:19.025	05.012.02 Site  Set-up	05.012.02.04 Principal Investigator Curriculum Vitae
17878	90	1620235280092:1074905809	1620235116462:-1001870599	ACE-ST-209	473	225	CREATE	2021-05-05 19:21:20.182	05.012.02 Site  Set-up	05.012.02.010 Financial Disclosure Form
17891	90	1620235280750:-744564645	1620234978635:-1970050106	ACE-ST-209	474	16	CREATE	2021-05-05 19:21:20.837	05.012 Site  Samuael Goldlust	05.012.01 Site Selection
17892	90	1620235281331:1604116631	1620235280750:-744564645	ACE-ST-209	475	474	CREATE	2021-05-05 19:21:21.413	05.012.01 Site Selection	05.012.01.03 Feasibility Documentation
17893	90	1620235281922:-688508569	1620235280750:-744564645	ACE-ST-209	476	474	CREATE	2021-05-05 19:21:22.009	05.012.01 Site Selection	05.012.01.02 Confidentiality Agreement
17879	90	1620235282484:1885020094	1620235116462:-1001870599	ACE-ST-209	477	225	CREATE	2021-05-05 19:21:22.57	05.012.02 Site  Set-up	05.012.02.01 Acceptance of Investigator Brochure
17890	90	1620235283072:268524281	1620235190474:-596988181	ACE-ST-209	478	338	CREATE	2021-05-05 19:21:23.158	05.012.04.01 IRB/IEC Trial Approvals	05.012.04.01.06 Approved ICF
17880	90	1620235283658:1239134348	1620235116462:-1001870599	ACE-ST-209	479	225	CREATE	2021-05-05 19:21:23.745	05.012.02 Site  Set-up	05.012.02.05 Sub-Investigator Curriculum Vitae
17881	90	1620235284306:-878580787	1620235116462:-1001870599	ACE-ST-209	480	225	CREATE	2021-05-05 19:21:24.394	05.012.02 Site  Set-up	05.012.02.07 Site and Staff Qualification Supporting Information 
17882	90	1620235284866:-1196105209	1620235116462:-1001870599	ACE-ST-209	481	225	CREATE	2021-05-05 19:21:24.952	05.012.02 Site  Set-up	05.012.02.06 Other Curriculum Vitae
17883	90	1620235285466:-1022055251	1620235116462:-1001870599	ACE-ST-209	482	225	CREATE	2021-05-05 19:21:25.556	05.012.02 Site  Set-up	05.012.02.03 Protocol Amendment Signature Page
17884	90	1620235286064:1029318062	1620235116462:-1001870599	ACE-ST-209	483	225	CREATE	2021-05-05 19:21:26.153	05.012.02 Site  Set-up	05.012.02.02 Protocol Signature Page
17885	90	1620235286658:-684931320	1620235116462:-1001870599	ACE-ST-209	484	225	CREATE	2021-05-05 19:21:26.748	05.012.02 Site  Set-up	05.012.02.016 Local Laboratory Normal Ranges
17894	90	1620235287235:-1407897306	1620235280750:-744564645	ACE-ST-209	485	474	CREATE	2021-05-05 19:21:27.318	05.012.01 Site Selection	05.012.01.01 Site Contact Details
18034	90	1620235287861:205040063	1620235068347:2113620094	ACE-ST-209	486	151	CREATE	2021-05-05 19:21:27.944	05.019.02 Site  Set-up	05.019.02.05 Sub-Investigator Curriculum Vitae
18035	90	1620235288439:-1818186433	1620235068347:2113620094	ACE-ST-209	487	151	CREATE	2021-05-05 19:21:28.526	05.019.02 Site  Set-up	05.019.02.07 Site and Staff Qualification Supporting Information 
18233	90	1620235289046:-916174424	1620234970475:-1191996394	ACE-ST-209	488	3	CREATE	2021-05-05 19:21:29.135	05 Site Management	05.010 Site  Paul Conkling
18234	90	1620235289655:689688409	1620235289046:-916174424	ACE-ST-209	489	488	CREATE	2021-05-05 19:21:30.145	05.010 Site  Paul Conkling	05.010.02 Site  Set-up
18235	90	1620235290920:1464020453	1620235289655:689688409	ACE-ST-209	490	489	CREATE	2021-05-05 19:21:31.011	05.010.02 Site  Set-up	05.010.02.08 Form FDA1572
18246	90	1620235291553:-1397504671	1620235289046:-916174424	ACE-ST-209	491	488	CREATE	2021-05-05 19:21:31.641	05.010 Site  Paul Conkling	05.010.06 General
18247	90	1620235292191:139874588	1620235291553:-1397504671	ACE-ST-209	492	491	CREATE	2021-05-05 19:21:32.275	05.010.06 General	05.010.06.01 Relevant Communications
18170	90	1620235292770:2105202710	1620235057063:298634074	ACE-ST-209	493	133	CREATE	2021-05-05 19:21:32.855	05.03 Site  Charles Conrad	05.03.02 Site  Set-up
18171	90	1620235293356:950826989	1620235292770:2105202710	ACE-ST-209	494	493	CREATE	2021-05-05 19:21:33.443	05.03.02 Site  Set-up	05.03.02.015 Local Laboratory Certification or Accreditation
18172	90	1620235293944:988079739	1620235292770:2105202710	ACE-ST-209	495	493	CREATE	2021-05-05 19:21:34.033	05.03.02 Site  Set-up	05.03.02.016 Local Laboratory Normal Ranges
18173	90	1620235294563:1301958094	1620235292770:2105202710	ACE-ST-209	496	493	CREATE	2021-05-05 19:21:34.655	05.03.02 Site  Set-up	05.03.02.017 IP Site Release Documentation
18174	90	1620235295174:2142174804	1620235292770:2105202710	ACE-ST-209	497	493	CREATE	2021-05-05 19:21:35.263	05.03.02 Site  Set-up	05.03.02.010 Financial Disclosure Form
18175	90	1620235295777:2000687078	1620235292770:2105202710	ACE-ST-209	498	493	CREATE	2021-05-05 19:21:35.874	05.03.02 Site  Set-up	05.03.02.01 Acceptance of Investigator Brochure
18181	90	1620235296411:667117147	1620235057063:298634074	ACE-ST-209	499	133	CREATE	2021-05-05 19:21:36.498	05.03 Site  Charles Conrad	05.03.06 General
18182	90	1620235297011:-1288687049	1620235296411:667117147	ACE-ST-209	500	499	CREATE	2021-05-05 19:21:37.097	05.03.06 General	05.03.06.04 Filenote
18176	90	1620235298214:-1243514813	1620235292770:2105202710	ACE-ST-209	501	493	CREATE	2021-05-05 19:21:38.301	05.03.02 Site  Set-up	05.03.02.03 Protocol Amendment Signature Page
18183	90	1620235298808:-1917240337	1620235296411:667117147	ACE-ST-209	502	499	CREATE	2021-05-05 19:21:38.974	05.03.06 General	05.03.06.01 Relevant Communications
5048	83	1611635082806:-1894530611	rootNode	D5136C00008	1	0	ALREADY AVAILABLE	2021-01-26 07:05:00.987		KENYA
5049	83	1611635407656:1770977111	1611635082806:-1894530611	D5136C00008	2	1	ALREADY AVAILABLE	2021-01-26 07:05:00.993	KENYA	8503 Nduba, Videlis
18254	90	1620235299535:771429778	1620234970475:-1191996394	ACE-ST-209	503	3	CREATE	2021-05-05 19:21:39.655	05 Site Management	05.07 Site  Jonathon Berkowitz
7661	84	\N	\N	D5170C00002	1446	1335	NEW	\N	Site	2002079 Sturm, Andreas
18255	90	1620235300165:-743539861	1620235299535:771429778	ACE-ST-209	504	503	CREATE	2021-05-05 19:21:40.738	05.07 Site  Jonathon Berkowitz	05.07.06 General
18256	90	1620235301311:1772767	1620235300165:-743539861	ACE-ST-209	505	504	CREATE	2021-05-05 19:21:41.404	05.07.06 General	05.07.06.01 Relevant Communications
18257	90	1620235301903:-1616788018	1620235299535:771429778	ACE-ST-209	506	503	CREATE	2021-05-05 19:21:41.986	05.07 Site  Jonathon Berkowitz	05.07.03 Site Initiation
18258	90	1620235302452:-1396105166	1620235301903:-1616788018	ACE-ST-209	507	506	CREATE	2021-05-05 19:21:42.536	05.07.03 Site Initiation	05.07.03.04 Site Initiation Confirmation Letter
18259	90	1620235303044:-1481827517	1620234970475:-1191996394	ACE-ST-209	508	3	CREATE	2021-05-05 19:21:43.129	05 Site Management	05.06 Site  John  Schwerkosk
18260	90	1620235303724:-872002532	1620235303044:-1481827517	ACE-ST-209	509	508	CREATE	2021-05-05 19:21:43.814	05.06 Site  John  Schwerkosk	05.06.03 Site Initiation
18261	90	1620235304313:-2024332138	1620235303724:-872002532	ACE-ST-209	510	509	CREATE	2021-05-05 19:21:44.4	05.06.03 Site Initiation	05.06.03.04 Site Initiation Confirmation Letter
18048	90	1620235304940:1618357275	1620235002898:1277184787	ACE-ST-209	511	53	CREATE	2021-05-05 19:21:45.03	05.02 Site  Carlos Taboada	05.02.03 Site Initiation
18049	90	1620235305527:-446236992	1620235304940:1618357275	ACE-ST-209	512	511	CREATE	2021-05-05 19:21:45.613	05.02.03 Site Initiation	05.02.03.04 Site Initiation Confirmation Letter
18264	90	1620235306114:-530821082	1620234970475:-1191996394	ACE-ST-209	513	3	CREATE	2021-05-05 19:21:46.201	05 Site Management	05.04 Site  David  Piccioni
18265	90	1620235306716:-1876576362	1620235306114:-530821082	ACE-ST-209	514	513	CREATE	2021-05-05 19:21:46.8	05.04 Site  David  Piccioni	05.04.01 Site Selection
18266	90	1620235307375:-599649954	1620235306716:-1876576362	ACE-ST-209	515	514	CREATE	2021-05-05 19:21:47.465	05.04.01 Site Selection	05.04.01.03 Feasibility Documentation
18267	90	1620235307964:-1019541478	1620235306716:-1876576362	ACE-ST-209	516	514	CREATE	2021-05-05 19:21:48.055	05.04.01 Site Selection	05.04.01.02 Confidentiality Agreement
18184	90	1620235308578:302600012	1620235057063:298634074	ACE-ST-209	517	133	CREATE	2021-05-05 19:21:48.669	05.03 Site  Charles Conrad	05.03.04 IRB/IEC and other Approvals
18185	90	1620235309178:-443296173	1620235308578:302600012	ACE-ST-209	518	517	CREATE	2021-05-05 19:21:49.268	05.03.04 IRB/IEC and other Approvals	05.03.04.01 IRB/IEC Trial Approvals
18186	90	1620235309771:-677779078	1620235309178:-443296173	ACE-ST-209	519	518	CREATE	2021-05-05 19:21:49.858	05.03.04.01 IRB/IEC Trial Approvals	05.03.04.01.02 IRB/IEC Approval
18112	90	1620235310394:864858680	1620235098559:-560788738	ACE-ST-209	520	198	CREATE	2021-05-05 19:21:50.484	05.01.02 Site  Set-up	05.01.02.04 Principal Investigator Curriculum Vitae
18113	90	1620235311487:664473887	1620235098559:-560788738	ACE-ST-209	521	198	CREATE	2021-05-05 19:21:51.659	05.01.02 Site  Set-up	05.01.02.05 Sub-Investigator Curriculum Vitae
18220	90	1620235312215:696695633	1620235230895:224125764	ACE-ST-209	522	397	CREATE	2021-05-05 19:21:52.305	05.014.02 Site  Set-up	05.014.02.03 Protocol Amendment Signature Page
18114	90	1620235312777:-392000274	1620235098559:-560788738	ACE-ST-209	523	198	CREATE	2021-05-05 19:21:52.862	05.01.02 Site  Set-up	05.01.02.08 Form FDA1572
17968	90	1620235313364:1664455293	1620235040062:-1315485005	ACE-ST-209	524	106	CREATE	2021-05-05 19:21:53.454	05.016.02 Site  Set-up	05.016.02.03 Protocol Amendment Signature Page
18136	90	1620235313996:-1093600432	1620235022062:-769283627	ACE-ST-209	525	82	CREATE	2021-05-05 19:21:54.088	05.013.03 Site Initiation	05.013.03.01 Trial Initiation Monitoring Report
18236	90	1620235314578:1702348115	1620235289655:689688409	ACE-ST-209	526	489	CREATE	2021-05-05 19:21:54.667	05.010.02 Site  Set-up	05.010.02.05 Sub-Investigator Curriculum Vitae
18237	90	1620235315160:2073246401	1620235289655:689688409	ACE-ST-209	527	489	CREATE	2021-05-05 19:21:55.248	05.010.02 Site  Set-up	05.010.02.07 Site and Staff Qualification Supporting Information 
18238	90	1620235315779:1460093030	1620235289655:689688409	ACE-ST-209	528	489	CREATE	2021-05-05 19:21:55.865	05.010.02 Site  Set-up	05.010.02.010 Financial Disclosure Form
18239	90	1620235316355:601590128	1620235289655:689688409	ACE-ST-209	529	489	CREATE	2021-05-05 19:21:56.438	05.010.02 Site  Set-up	05.010.02.04 Principal Investigator Curriculum Vitae
18240	90	1620235316993:-796136108	1620235289655:689688409	ACE-ST-209	530	489	CREATE	2021-05-05 19:21:57.078	05.010.02 Site  Set-up	05.010.02.017 IP Site Release Documentation
18241	90	1620235317598:-1420459514	1620235289655:689688409	ACE-ST-209	531	489	CREATE	2021-05-05 19:21:57.686	05.010.02 Site  Set-up	05.010.02.01 Acceptance of Investigator Brochure
18242	90	1620235318311:-1846264379	1620235289655:689688409	ACE-ST-209	532	489	CREATE	2021-05-05 19:21:58.397	05.010.02 Site  Set-up	05.010.02.015 Local Laboratory Certification or Accreditation
18243	90	1620235318878:643020389	1620235289655:689688409	ACE-ST-209	533	489	CREATE	2021-05-05 19:21:58.968	05.010.02 Site  Set-up	05.010.02.016 Local Laboratory Normal Ranges
18248	90	1620235319490:-1953051123	1620235291553:-1397504671	ACE-ST-209	534	491	CREATE	2021-05-05 19:21:59.594	05.010.06 General	05.010.06.04 Filenote
18244	90	1620235320104:-1741657504	1620235289655:689688409	ACE-ST-209	535	489	CREATE	2021-05-05 19:22:00.208	05.010.02 Site  Set-up	05.010.02.03 Protocol Amendment Signature Page
18249	90	1620235320713:-1371373195	1620235289046:-916174424	ACE-ST-209	536	488	CREATE	2021-05-05 19:22:00.813	05.010 Site  Paul Conkling	05.010.01 Site Selection
18250	90	1620235321413:-701512396	1620235320713:-1371373195	ACE-ST-209	537	536	CREATE	2021-05-05 19:22:02.006	05.010.01 Site Selection	05.010.01.02 Confidentiality Agreement
18251	90	1620235322558:329034187	1620235289046:-916174424	ACE-ST-209	538	488	CREATE	2021-05-05 19:22:02.671	05.010 Site  Paul Conkling	05.010.04 IRB/IEC and other Approvals
18252	90	1620235323213:-711313228	1620235322558:329034187	ACE-ST-209	539	538	CREATE	2021-05-05 19:22:03.322	05.010.04 IRB/IEC and other Approvals	05.010.04.01 IRB/IEC Trial Approvals
18253	90	1620235323836:2132735069	1620235323213:-711313228	ACE-ST-209	540	539	CREATE	2021-05-05 19:22:03.927	05.010.04.01 IRB/IEC Trial Approvals	05.010.04.01.01 IRB/IEC Submission
18245	90	1620235324463:1174138048	1620235289655:689688409	ACE-ST-209	541	489	CREATE	2021-05-05 19:22:04.546	05.010.02 Site  Set-up	05.010.02.012 Clinical Trial Agreement
18177	90	1620235325048:-2023510203	1620235292770:2105202710	ACE-ST-209	542	493	CREATE	2021-05-05 19:22:05.133	05.03.02 Site  Set-up	05.03.02.08 Form FDA1572
7691	84	\N	\N	D5170C00002	1476	1470	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
18178	90	1620235325632:468627409	1620235292770:2105202710	ACE-ST-209	543	493	CREATE	2021-05-05 19:22:05.722	05.03.02 Site  Set-up	05.03.02.04 Principal Investigator Curriculum Vitae
18179	90	1620235326396:1388819257	1620235292770:2105202710	ACE-ST-209	544	493	CREATE	2021-05-05 19:22:06.48	05.03.02 Site  Set-up	05.03.02.05 Sub-Investigator Curriculum Vitae
18180	90	1620235327074:180618178	1620235292770:2105202710	ACE-ST-209	545	493	CREATE	2021-05-05 19:22:07.168	05.03.02 Site  Set-up	05.03.02.07 Site and Staff Qualification Supporting Information 
18262	90	1620235327711:-2020998015	1620235303044:-1481827517	ACE-ST-209	546	508	CREATE	2021-05-05 19:22:07.801	05.06 Site  John  Schwerkosk	05.06.06 General
18263	90	1620235328406:77565932	1620235327711:-2020998015	ACE-ST-209	547	546	CREATE	2021-05-05 19:22:08.499	05.06.06 General	05.06.06.01 Relevant Communications
18050	90	1620235329017:-726562319	1620235002898:1277184787	ACE-ST-209	548	53	CREATE	2021-05-05 19:22:09.104	05.02 Site  Carlos Taboada	05.02.06 General
18051	90	1620235329603:-1221190730	1620235329017:-726562319	ACE-ST-209	549	548	CREATE	2021-05-05 19:22:09.69	05.02.06 General	05.02.06.01 Relevant Communications
17907	90	1620235330218:-1712336840	1620234981545:891425982	ACE-ST-209	550	20	CREATE	2021-05-05 19:22:10.302	05.017.02 Site  Set-up	05.017.02.03 Protocol Amendment Signature Page
17957	90	1620235330832:-708323927	1620235020291:1661858014	ACE-ST-209	551	80	CREATE	2021-05-05 19:22:11.033	05.016.03 Site Initiation	05.016.03.04 Site Initiation Confirmation Letter
17931	90	1620235331543:-502972320	1620235121905:1736106139	ACE-ST-209	552	233	CREATE	2021-05-05 19:22:11.629	05.017.04.01 IRB/IEC Trial Approvals	05.017.04.01.07 IRB/IEC Correspondence - Site
18063	90	1620235332861:-834066863	1620235006570:469001643	ACE-ST-209	553	59	CREATE	2021-05-05 19:22:12.95	05.018.05 Site Management	05.018.05.09 Site Specific SOPs
18080	90	1620235333513:1305687098	1620235096181:1359663021	ACE-ST-209	554	195	CREATE	2021-05-05 19:22:13.603	05.018.03 Site Initiation	05.018.03.04 Site Initiation Confirmation Letter
18081	90	1620235334164:259735875	1620235096181:1359663021	ACE-ST-209	555	195	CREATE	2021-05-05 19:22:14.252	05.018.03 Site Initiation	05.018.03.05 Site Initiation Follow-Up Letter
18082	90	1620235334783:-1155390366	1620235096181:1359663021	ACE-ST-209	556	195	CREATE	2021-05-05 19:22:14.871	05.018.03 Site Initiation	05.018.03.01 Trial Initiation Monitoring Report
18085	90	1620235335337:1220217770	1620235126824:720663600	ACE-ST-209	557	241	CREATE	2021-05-05 19:22:15.421	05.018.06 General	05.018.06.04 Filenote
18091	90	1620235335926:1962919509	1620235148537:-1069360250	ACE-ST-209	558	275	CREATE	2021-05-05 19:22:16.01	05.018.04.01 IRB/IEC Trial Approvals	05.018.04.01.03 IRB/IEC Composition
18092	90	1620235336532:-738078661	1620235148537:-1069360250	ACE-ST-209	559	275	CREATE	2021-05-05 19:22:16.622	05.018.04.01 IRB/IEC Trial Approvals	05.018.04.01.05 IRB/IEC GCP Compliance Statement
18093	90	1620235337124:375058982	1620235148537:-1069360250	ACE-ST-209	560	275	CREATE	2021-05-05 19:22:17.233	05.018.04.01 IRB/IEC Trial Approvals	05.018.04.01.07 IRB/IEC Correspondence - Site
18075	90	1620235337711:-1517599038	1620235067217:1044761536	ACE-ST-209	561	149	CREATE	2021-05-05 19:22:17.794	05.018.02 Site  Set-up	05.018.02.016 Local Laboratory Normal Ranges
18076	90	1620235338294:492121632	1620235067217:1044761536	ACE-ST-209	562	149	CREATE	2021-05-05 19:22:18.379	05.018.02 Site  Set-up	05.018.02.02 Protocol Signature Page
18098	90	1620235338882:79554681	1620235177227:-726568115	ACE-ST-209	563	318	CREATE	2021-05-05 19:22:18.969	05.018.01 Site Selection	05.018.01.01 Site Contact Details
18099	90	1620235339601:688264760	1620235177227:-726568115	ACE-ST-209	564	318	CREATE	2021-05-05 19:22:19.693	05.018.01 Site Selection	05.018.01.03 Feasibility Documentation
17914	90	1620235340220:1123959602	1620235001679:-459530292	ACE-ST-209	565	51	CREATE	2021-05-05 19:22:20.31	05.017.05.011 Site Investigational Product Documentation	05.017.05.011.02 Certificates of Destruction
18064	90	1620235340833:1638818918	1620235006570:469001643	ACE-ST-209	566	59	CREATE	2021-05-05 19:22:20.916	05.018.05 Site Management	05.018.05.01 Subject Log
17943	90	1620235341394:-1682753742	1620234992294:474176864	ACE-ST-209	567	37	CREATE	2021-05-05 19:22:21.481	05.016.05.011 Site Investigational Product Documentation	05.016.05.011.02 Certificates of Destruction
18268	90	1620235345471:-1672859183	1620235306114:-530821082	ACE-ST-209	572	513	CREATE	2021-05-05 19:22:25.559	05.04 Site  David  Piccioni	05.04.04 IRB/IEC and other Approvals
18269	90	1620235346111:-1558009873	1620235345471:-1672859183	ACE-ST-209	573	572	CREATE	2021-05-05 19:22:26.222	05.04.04 IRB/IEC and other Approvals	05.04.04.01 IRB/IEC Trial Approvals
18270	90	1620235346798:1987343305	1620235346111:-1558009873	ACE-ST-209	574	573	CREATE	2021-05-05 19:22:26.883	05.04.04.01 IRB/IEC Trial Approvals	05.04.04.01.01 IRB/IEC Submission
18399	91	1625578784534:1142763789	1625578772584:-1400269124	D5160C00019	3	1	CREATE	2021-07-06 15:39:44.633	Generic Documents	Document Inventory Listings
18400	91	1625578785229:-811038769	1625578772584:-1400269124	D5160C00019	4	1	CREATE	2021-07-06 15:39:45.326	Generic Documents	Hash Values
18402	91	1625578786441:1758583951	1625578772584:-1400269124	D5160C00019	6	1	CREATE	2021-07-06 15:39:46.549	Generic Documents	Metadata
18407	91	1625578789310:-198643826	1625578788740:24020017	D5160C00019	11	10	CREATE	2021-07-06 15:39:49.414	01.01 Trial Oversight	01.01.01 Trial Master File Plan
18408	91	1625578789875:1804140085	1625578788740:24020017	D5160C00019	12	10	CREATE	2021-07-06 15:39:50.015	01.01 Trial Oversight	01.01.02 Trial Management Plan
18410	91	1625578791058:825695791	1625578788740:24020017	D5160C00019	14	10	CREATE	2021-07-06 15:39:51.15	01.01 Trial Oversight	01.01.04 List of SOPs Current During Trial
18411	91	1625578791606:-1784917987	1625578788740:24020017	D5160C00019	15	10	CREATE	2021-07-06 15:39:55.851	01.01 Trial Oversight	01.01.07 Communication Plan
18413	91	1625578796926:1223678375	1625578788740:24020017	D5160C00019	17	10	CREATE	2021-07-06 15:39:57.02	01.01 Trial Oversight	01.01.09 Medical Monitoring Plan
18414	91	1625578797504:843231555	1625578788740:24020017	D5160C00019	18	10	CREATE	2021-07-06 15:39:57.604	01.01 Trial Oversight	01.01.12 Trial Status Report
18416	91	1625578798645:698945880	1625578788740:24020017	D5160C00019	20	10	CREATE	2021-07-06 15:39:58.741	01.01 Trial Oversight	01.01.16 Risk Management
18417	91	1625578799204:1119410793	1625578788740:24020017	D5160C00019	21	10	CREATE	2021-07-06 15:39:59.305	01.01 Trial Oversight	01.01.17 Vendor Management Plan
18418	91	1625578799751:1987521491	1625578788152:-1490134762	D5160C00019	22	9	CREATE	2021-07-06 15:39:59.842	01 Trial Management	01.02 Trial Team
18420	91	1625578800922:-304787835	1625578799751:1987521491	D5160C00019	24	22	CREATE	2021-07-06 15:40:01.013	01.02 Trial Team	01.02.01 Project Team Member Details
18421	91	1625578801479:785052253	1625578799751:1987521491	D5160C00019	25	22	CREATE	2021-07-06 15:40:01.571	01.02 Trial Team	01.02.02 Project Team Curriculum Vitae
18423	91	1625578802656:-1767246033	1625578802101:-1716094851	D5160C00019	27	26	CREATE	2021-07-06 15:40:02.748	01.03 Data Adjudication	01.03.04 Independent Data Monitoring Committee Meeting
18424	91	1625578803717:-116289195	1625578788152:-1490134762	D5160C00019	28	9	CREATE	2021-07-06 15:40:03.819	01 Trial Management	01.04 Meetings
18426	91	1625578811351:468640301	1625578803717:-116289195	D5160C00019	30	28	CREATE	2021-07-06 15:40:11.453	01.04 Meetings	01.04.02 Project Tea_ Training Documentation
18427	91	1625578812078:343270869	1625578803717:-116289195	D5160C00019	31	28	CREATE	2021-07-06 15:40:12.261	01.04 Meetings	01.04.02 Project Team Training Material
18429	91	1625578813320:-1863585633	1625578788152:-1490134762	D5160C00019	33	9	CREATE	2021-07-06 15:40:13.414	01 Trial Management	01.05 General
18430	91	1625578814530:275201093	1625578813320:-1863585633	D5160C00019	34	33	CREATE	2021-07-06 15:40:14.62	01.05 General	01.05.01 Relevan_t Management-Email
18431	91	1625578815136:537267555	1625578814530:275201093	D5160C00019	35	34	CREATE	2021-07-06 15:40:15.227	01.05.01 Relevan_t Management-Email	Country
18433	91	1625578816404:-156593973	1625578814530:275201093	D5160C00019	37	34	CREATE	2021-07-06 15:40:16.5	01.05.01 Relevan_t Management-Email	Deliverables
18434	91	1625578817031:544166805	1625578814530:275201093	D5160C00019	38	34	CREATE	2021-07-06 15:40:17.139	01.05.01 Relevan_t Management-Email	PMA Emails
18436	91	1625578818214:-1280658973	1625578814530:275201093	D5160C00019	40	34	CREATE	2021-07-06 15:40:18.315	01.05.01 Relevan_t Management-Email	study status from Nov-18
18437	91	1625578818818:1784840863	1625578813320:-1863585633	D5160C00019	41	33	CREATE	2021-07-06 15:40:18.94	01.05 General	01.05.01 Relevant Communications-Project Management-Documents
18439	91	1625578820009:384699763	1625578813320:-1863585633	D5160C00019	43	33	CREATE	2021-07-06 15:40:20.098	01.05 General	01.05.03 Project Management- Sponsor Meeting Material
18440	91	1625578820748:-485676911	1625578787595:-65419865	D5160C00019	44	8	CREATE	2021-07-06 15:40:20.849	contents	02 Central Trial Documents
18441	91	1625578821334:-1059768343	1625578820748:-485676911	D5160C00019	45	44	CREATE	2021-07-06 15:40:21.446	02 Central Trial Documents	02.01 Trial Documents
18443	91	1625578828447:-975848518	1625578821334:-1059768343	D5160C00019	47	45	CREATE	2021-07-06 15:40:28.552	02.01 Trial Documents	02.01.02 Protocol
18444	91	1625578829196:-237868504	1625578821334:-1059768343	D5160C00019	48	45	CREATE	2021-07-06 15:40:29.326	02.01 Trial Documents	02.01.04 Protocol Amendment
18446	91	1625578836913:727906280	1625578821334:-1059768343	D5160C00019	50	45	CREATE	2021-07-06 15:40:37.035	02.01 Trial Documents	02.01.07 Blank Case Report Form
18447	91	1625578837624:1885859091	1625578820748:-485676911	D5160C00019	51	44	CREATE	2021-07-06 15:40:37.718	02 Central Trial Documents	02.02 Subject Documents
18449	91	1625578843879:800605563	1625578837624:1885859091	D5160C00019	53	51	CREATE	2021-07-06 15:40:43.985	02.02 Subject Documents	02.02.03 Informed Consent Form Checklists
18450	91	1625578844500:364982898	1625578837624:1885859091	D5160C00019	54	51	CREATE	2021-07-06 15:40:44.61	02.02 Subject Documents	02.02.03 Informed Consent Form Templates
18452	91	1625578845765:-1572844575	1625578837624:1885859091	D5160C00019	56	51	CREATE	2021-07-06 15:40:45.88	02.02 Subject Documents	02.02.06 Advertisements for Subject Recruitment
18453	91	1625578847158:751791937	1625578837624:1885859091	D5160C00019	57	51	CREATE	2021-07-06 15:40:47.258	02.02 Subject Documents	02.02.07 Other Written Information Given to Subjects
18454	91	1625578847695:1401528364	1625578820748:-485676911	D5160C00019	58	44	CREATE	2021-07-06 15:40:47.786	02 Central Trial Documents	02.03 Reports
18456	91	1625578848877:1060428534	1625578820748:-485676911	D5160C00019	60	44	CREATE	2021-07-06 15:40:48.984	02 Central Trial Documents	02.04 General
18458	91	1625578850173:1420276777	1625578848877:1060428534	D5160C00019	62	60	CREATE	2021-07-06 15:40:50.277	02.04 General	02.04.02 Tracking Information
18459	91	1625578850782:1057005221	1625578787595:-65419865	D5160C00019	63	8	CREATE	2021-07-06 15:40:50.886	contents	03 Regulatory
18460	91	1625578851329:-1134328802	1625578850782:1057005221	D5160C00019	64	63	CREATE	2021-07-06 15:40:51.421	03 Regulatory	03.01 Trial Approval
18462	91	1625578852480:-701888584	1625578850782:1057005221	D5160C00019	66	63	CREATE	2021-07-06 15:40:52.583	03 Regulatory	03.03 Trial Status Reporting
18463	91	1625578853072:354495486	1625578852480:-701888584	D5160C00019	67	66	CREATE	2021-07-06 15:40:53.172	03.03 Trial Status Reporting	03.03.03 Notification of Trial Termination
6033	83	1611641904712:-43014382	1611641904149:1980507092	D5136C00008	986	985	CREATE	2021-01-26 07:18:24.797	03 Regulatory	03.04 General
7819	84	\N	\N	D5170C00002	1604	1603	NEW	\N	02.04 General	02.04.01 Relev_ations-Documents
18467	91	1625578855475:-1983876153	1625578854320:618729158	D5160C00019	71	69	CREATE	2021-07-06 15:40:55.566	03.04.01 Relevan_ory-Start-Up-Email	EudraCT
18468	91	1625578856035:-660004405	1625578854320:618729158	D5160C00019	72	69	CREATE	2021-07-06 15:40:56.131	03.04.01 Relevan_ory-Start-Up-Email	IB Edition 6
18470	91	1625578864297:-513196823	1625578853630:400301961	D5160C00019	74	68	CREATE	2021-07-06 15:41:04.41	03.04 General	03.04.01 Relevant Communications-Regulatory-Start-Up-Documents
18471	91	1625578864933:-1887285703	1625578787595:-65419865	D5160C00019	75	8	CREATE	2021-07-06 15:41:05.044	contents	04 IRB-IEC and other Approvals
18473	91	1625578866232:1989296241	1625578865524:-1075585151	D5160C00019	77	76	CREATE	2021-07-06 15:41:06.349	04.04 General	04.04.01 Relevant Communications-IRB-IEC-Email
18474	91	1625578866850:757366532	1625578787595:-65419865	D5160C00019	78	8	CREATE	2021-07-06 15:41:06.977	contents	05 Site Management
18476	91	1625578868876:566344155	1625578867441:495037739	D5160C00019	80	79	CREATE	2021-07-06 15:41:08.967	05.03 Site Initiation	05.03.02 Site Training Material
18477	91	1625578869406:-427687837	1625578866850:757366532	D5160C00019	81	78	CREATE	2021-07-06 15:41:21.525	05 Site Management	05.04 Site Management
18479	91	1625578882689:-410420846	1625578869406:-427687837	D5160C00019	83	81	CREATE	2021-07-06 15:41:22.781	05.04 Site Management	05.04.09 Inv Notific_fety Info-Dr-HCP Letter
18480	91	1625578888818:222910086	1625578869406:-427687837	D5160C00019	84	81	CREATE	2021-07-06 15:41:28.936	05.04 Site Management	05.04.09 Inv Notification-CIOMS
18482	91	1625578890401:1268558346	1625578866850:757366532	D5160C00019	86	78	CREATE	2021-07-06 15:41:30.521	05 Site Management	05.05 General
18483	91	1625578890987:860673989	1625578890401:1268558346	D5160C00019	87	86	CREATE	2021-07-06 15:41:31.099	05.05 General	05.05.01 Relevant Co_Communication-Documents
18484	91	1625578891792:-1479114868	1625578890401:1268558346	D5160C00019	88	86	CREATE	2021-07-06 15:41:32.385	05.05 General	05.05.01 Relevant Co_ication-Documents-Email
18486	91	1625578899388:209162548	1625578787595:-65419865	D5160C00019	90	8	CREATE	2021-07-06 15:41:39.495	contents	06 IP and Trial Supplies
18487	91	1625578899967:1926640624	1625578899388:209162548	D5160C00019	91	90	CREATE	2021-07-06 15:41:40.077	06 IP and Trial Supplies	06.01 IP Documentation
18489	91	1625578908234:-284704364	1625578899967:1926640624	D5160C00019	93	91	CREATE	2021-07-06 15:41:48.358	06.01 IP Documentation	06.01.02 IP Instructions for Handling
18490	91	1625578908843:-1504308281	1625578899967:1926640624	D5160C00019	94	91	CREATE	2021-07-06 15:41:48.94	06.01 IP Documentation	06.01.03 IP Sample Label
18492	91	1625578910124:149141191	1625578909475:-1879773687	D5160C00019	96	95	CREATE	2021-07-06 15:41:50.244	06.02 IP Release Process Documentation	06.02.01 QP (Qualified Person) Certification
18493	91	1625578918789:-297317309	1625578909475:-1879773687	D5160C00019	97	95	CREATE	2021-07-06 15:41:58.888	06.02 IP Release Process Documentation	06.02.03 IP Verification Statements
18494	91	1625578921113:-1301806660	1625578899388:209162548	D5160C00019	98	90	CREATE	2021-07-06 15:42:01.251	06 IP and Trial Supplies	06.07 General
18496	91	1625578922377:1943272215	1625578921113:-1301806660	D5160C00019	100	98	CREATE	2021-07-06 15:42:02.472	06.07 General	06.07.02 Tracking Information
18497	91	1625578923361:-475769125	1625578787595:-65419865	D5160C00019	101	8	CREATE	2021-07-06 15:42:03.46	contents	07 Safety Reporting
18499	91	1625578925187:1645965304	1625578923931:338587064	D5160C00019	103	102	CREATE	2021-07-06 15:42:05.307	07.01 Safety Documentation	07.01.01 Safety Management Plan
18500	91	1625578925763:1781864122	1625578923931:338587064	D5160C00019	104	102	CREATE	2021-07-06 15:42:05.869	07.01 Safety Documentation	07.01.02 Pharmacovigilance Database Line Listing
18501	91	1625578926458:203457721	1625578923931:338587064	D5160C00019	105	102	CREATE	2021-07-06 15:42:06.605	07.01 Safety Documentation	07.01.02 Safety Reports
18503	91	1625578927713:-1987880456	1625578927078:-893920080	D5160C00019	107	106	CREATE	2021-07-06 15:42:07.822	07.02 Trial Status Reporting	07.02.01 Expedited Safety Report- IND
18504	91	1625578928360:1895476643	1625578927078:-893920080	D5160C00019	108	106	CREATE	2021-07-06 15:42:08.469	07.02 Trial Status Reporting	07.02.01 Expedited Safety Report-CIOMS
18506	91	1625578937152:1970176406	1625578923361:-475769125	D5160C00019	110	101	CREATE	2021-07-06 15:42:17.251	07 Safety Reporting	07.03 General
18507	91	1625578937750:1075847699	1625578937152:1970176406	D5160C00019	111	110	CREATE	2021-07-06 15:42:17.844	07.03 General	07.03.01 Relevan_tions-Safety-Email
18508	91	1625578938348:773710075	1625578937750:1075847699	D5160C00019	112	111	CREATE	2021-07-06 15:42:18.446	07.03.01 Relevan_tions-Safety-Email	2015-01
18510	91	1625578939461:-2081491039	1625578937750:1075847699	D5160C00019	114	111	CREATE	2021-07-06 15:42:19.555	07.03.01 Relevan_tions-Safety-Email	2015-03
18511	91	1625578940011:-668025955	1625578937750:1075847699	D5160C00019	115	111	CREATE	2021-07-06 15:42:20.107	07.03.01 Relevan_tions-Safety-Email	2015-04
18513	91	1625578941184:-2136073692	1625578937750:1075847699	D5160C00019	117	111	CREATE	2021-07-06 15:42:21.279	07.03.01 Relevan_tions-Safety-Email	2015-06
18514	91	1625578941782:1404223375	1625578937750:1075847699	D5160C00019	118	111	CREATE	2021-07-06 15:42:21.889	07.03.01 Relevan_tions-Safety-Email	2015-07
18516	91	1625578942931:-2140012309	1625578937750:1075847699	D5160C00019	120	111	CREATE	2021-07-06 15:42:23.021	07.03.01 Relevan_tions-Safety-Email	2015-09
18517	91	1625578943481:738438434	1625578937750:1075847699	D5160C00019	121	111	CREATE	2021-07-06 15:42:23.586	07.03.01 Relevan_tions-Safety-Email	2015-10
18519	91	1625578944888:606857602	1625578937750:1075847699	D5160C00019	123	111	CREATE	2021-07-06 15:42:24.992	07.03.01 Relevan_tions-Safety-Email	2015-12
18520	91	1625578945451:-949428417	1625578937750:1075847699	D5160C00019	124	111	CREATE	2021-07-06 15:42:25.546	07.03.01 Relevan_tions-Safety-Email	2016-01
18522	91	1625578952641:1928167005	1625578937750:1075847699	D5160C00019	126	111	CREATE	2021-07-06 15:42:41.255	07.03.01 Relevan_tions-Safety-Email	2016-03
18523	91	1625578969340:383121089	1625578937750:1075847699	D5160C00019	127	111	CREATE	2021-07-06 15:42:49.456	07.03.01 Relevan_tions-Safety-Email	2016-04
18525	91	1625578970508:1822897880	1625578937750:1075847699	D5160C00019	129	111	CREATE	2021-07-06 15:42:50.609	07.03.01 Relevan_tions-Safety-Email	2016-06
18526	91	1625578971120:328527827	1625578937750:1075847699	D5160C00019	130	111	CREATE	2021-07-06 15:42:51.232	07.03.01 Relevan_tions-Safety-Email	2016-07
18528	91	1625578972288:694409902	1625578937750:1075847699	D5160C00019	132	111	CREATE	2021-07-06 15:42:52.392	07.03.01 Relevan_tions-Safety-Email	Reports
18531	91	1625578974059:1437488637	1625578937152:1970176406	D5160C00019	135	110	CREATE	2021-07-06 15:42:54.151	07.03 General	07.03.04 Filenote
18532	91	1625578974647:-1697753878	1625578787595:-65419865	D5160C00019	136	8	CREATE	2021-07-06 15:42:54.772	contents	08 Centralized Testing
18533	91	1625578975262:-53607421	1625578974647:-1697753878	D5160C00019	137	136	CREATE	2021-07-06 15:42:55.356	08 Centralized Testing	08.01 Facility Documentation
18535	91	1625578984321:-215730990	1625578974647:-1697753878	D5160C00019	139	136	CREATE	2021-07-06 15:43:04.413	08 Centralized Testing	08.02 Sample Documentation
18536	91	1625578984856:-1982674943	1625578984321:-215730990	D5160C00019	140	139	CREATE	2021-07-06 15:43:04.948	08.02 Sample Documentation	08.02.05 Retained Body Fluids-Tissue Samples
18538	91	1625578985952:-66494831	1625578985403:-1106962034	D5160C00019	142	141	CREATE	2021-07-06 15:43:06.044	09 Third Party	09.02 Third Party Set-up
18540	91	1625578987155:-888236302	1625578985952:-66494831	D5160C00019	144	142	CREATE	2021-07-06 15:43:07.264	09.02 Third Party Set-up	09.02.03 Contractual Agreement
18541	91	1625578987749:-1537274735	1625578985403:-1106962034	D5160C00019	145	141	CREATE	2021-07-06 15:43:07.847	09 Third Party	09.03 General
18542	91	1625578988316:-2072635798	1625578987749:-1537274735	D5160C00019	146	145	CREATE	2021-07-06 15:43:08.406	09.03 General	09.03.01 Relevant Communications-Third Party-Email
18544	91	1625578989561:640230263	1625578988967:1117580058	D5160C00019	148	147	CREATE	2021-07-06 15:43:09.676	10 Data Management	10.01 Data Management Oversight
18546	91	1625578990691:-1776451340	1625578988967:1117580058	D5160C00019	150	147	CREATE	2021-07-06 15:43:16.032	10 Data Management	10.02 Data Capture
18547	91	1625578996796:164050115	1625578990691:-1776451340	D5160C00019	151	150	CREATE	2021-07-06 15:43:16.906	10.02 Data Capture	10.02.01 CRF Completion Requirements (Paper and EDC)
18548	91	1625578997554:-318070808	1625578990691:-1776451340	D5160C00019	152	150	CREATE	2021-07-06 15:43:17.649	10.02 Data Capture	10.02.02 Annotated CRF (Paper and EDC)
18549	91	1625578998116:1809512072	1625578988967:1117580058	D5160C00019	153	147	CREATE	2021-07-06 15:43:27.936	10 Data Management	10.03 Database
18551	91	1625579010828:901269518	1625578998116:1809512072	D5160C00019	155	153	CREATE	2021-07-06 15:43:30.931	10.03 Database	10.03.08 SAE Reconciliation (Paper and EDC)
18552	91	1625579011380:1398454868	1625578998116:1809512072	D5160C00019	156	153	CREATE	2021-07-06 15:43:31.473	10.03 Database	10.03.09 Dictionary Coding (Paper and EDC)
18554	91	1625579012481:-811434676	1625578988967:1117580058	D5160C00019	158	147	CREATE	2021-07-06 15:43:32.572	10 Data Management	10.04 EDC Management
18555	91	1625579013029:1624636859	1625579012481:-811434676	D5160C00019	159	158	CREATE	2021-07-06 15:43:33.12	10.04 EDC Management	10.04.01 System Account Management
18556	91	1625579013622:-2120961984	1625578787595:-65419865	D5160C00019	160	8	CREATE	2021-07-06 15:43:33.713	contents	11 Statistics
18558	91	1625579014699:481782375	1625579014164:541543405	D5160C00019	162	161	CREATE	2021-07-06 15:43:34.798	11.01 Statistics Oversight	11.01.01 Statistical Analysis Plan
18559	91	1625579015301:1260310553	1625579013622:-2120961984	D5160C00019	163	160	CREATE	2021-07-06 15:43:35.409	11 Statistics	11.03 Analysis
18561	91	1625579016546:303043561	1625579015301:1260310553	D5160C00019	165	163	CREATE	2021-07-06 15:43:37.535	11.03 Analysis	11.03.02 Analysis QC Documentation
18562	91	1625579018097:498324201	1625579013622:-2120961984	D5160C00019	166	160	CREATE	2021-07-06 15:43:38.191	11 Statistics	11.05 General
18564	91	1625579025366:847779378	1625578787595:-65419865	D5160C00019	168	8	CREATE	2021-07-06 15:43:45.47	contents	CANADA
18565	91	1625579026006:-1675487980	1625579025366:847779378	D5160C00019	169	168	CREATE	2021-07-06 15:43:46.107	CANADA	05 Site Management
18566	91	1625579026592:770148067	1625579026006:-1675487980	D5160C00019	170	169	CREATE	2021-07-06 15:43:46.694	05 Site Management	05.02 Site Set-up Documentation
18568	91	1625579036587:1462507344	1625579025366:847779378	D5160C00019	172	168	CREATE	2021-07-06 15:43:56.781	CANADA	11001 Goss, Glenwood
18569	91	1625579037374:727505950	1625579036587:1462507344	D5160C00019	173	172	CREATE	2021-07-06 15:43:57.487	11001 Goss, Glenwood	02 Central Trial Documents
18570	91	1625579037989:-1232379313	1625579037374:727505950	D5160C00019	174	173	CREATE	2021-07-06 15:43:58.08	02 Central Trial Documents	02.04 General
18572	91	1625579040047:400931181	1625579036587:1462507344	D5160C00019	176	172	CREATE	2021-07-06 15:44:00.134	11001 Goss, Glenwood	05 Site Management
18573	91	1625579040722:-1245754834	1625579040047:400931181	D5160C00019	177	176	CREATE	2021-07-06 15:44:00.818	05 Site Management	05.01 Site Selection
18575	91	1625579048409:-510601586	1625578787595:-65419865	D5160C00019	179	8	CREATE	2021-07-06 15:44:08.501	contents	FRANCE
18576	91	1625579049008:-999116212	1625579048409:-510601586	D5160C00019	180	179	CREATE	2021-07-06 15:44:09.102	FRANCE	02 Central Trial Documents
18578	91	1625579051177:-1241512944	1625579049562:358124851	D5160C00019	182	181	CREATE	2021-07-06 15:44:11.29	02.01 Trial Documents	02.01.01 Investigator Brochure
18579	91	1625579051758:1888626018	1625579049562:358124851	D5160C00019	183	181	CREATE	2021-07-06 15:44:11.853	02.01 Trial Documents	02.01.03 Protocol Synopsis
18581	91	1625579053052:911434609	1625579049562:358124851	D5160C00019	185	181	CREATE	2021-07-06 15:44:13.163	02.01 Trial Documents	02.01.06 Insurance
18582	91	1625579053683:-1772313646	1625579049008:-999116212	D5160C00019	186	180	CREATE	2021-07-06 15:44:23.291	02 Central Trial Documents	02.02 Subject Documents
18583	91	1625579064430:-607397615	1625579053683:-1772313646	D5160C00019	187	186	CREATE	2021-07-06 15:44:24.527	02.02 Subject Documents	02.02.01 Subject Diary
18585	91	1625579065668:1619071208	1625579053683:-1772313646	D5160C00019	189	186	CREATE	2021-07-06 15:44:25.836	02.02 Subject Documents	02.02.03 Informed Consent Form Checklists
18586	91	1625579066314:392802399	1625579053683:-1772313646	D5160C00019	190	186	CREATE	2021-07-06 15:44:26.428	02.02 Subject Documents	02.02.05 Subject Participation Card
18588	91	1625579067519:-1933215917	1625579049008:-999116212	D5160C00019	192	180	CREATE	2021-07-06 15:44:33.375	02 Central Trial Documents	02.04 General
18589	91	1625579073875:2004016550	1625579067519:-1933215917	D5160C00019	193	192	CREATE	2021-07-06 15:44:33.968	02.04 General	02.04.02 Tracking Information
18590	91	1625579075055:1930581380	1625579048409:-510601586	D5160C00019	194	179	CREATE	2021-07-06 15:44:35.153	FRANCE	03 Regulatory
18592	91	1625579076274:-1568353622	1625579075686:-1426752179	D5160C00019	196	195	CREATE	2021-07-06 15:44:36.368	03.01 Trial Approval	03.01.02 Approval
18594	91	1625579077389:-2036231706	1625579076834:1853457585	D5160C00019	198	197	CREATE	2021-07-06 15:44:37.482	03.02 Investigational Medicinal Product	03.02.02 Import-Export License
18595	91	1625579077959:-273999111	1625579048409:-510601586	D5160C00019	199	179	CREATE	2021-07-06 15:44:38.057	FRANCE	04 IRB-IEC and other Approvals
18597	91	1625579079530:-821355658	1625579078496:869889524	D5160C00019	201	200	CREATE	2021-07-06 15:44:39.644	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
18599	91	1625579096763:1319703048	1625579078496:869889524	D5160C00019	203	200	CREATE	2021-07-06 15:45:04.375	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
18600	91	1625579110297:1211445330	1625579078496:869889524	D5160C00019	204	200	CREATE	2021-07-06 15:45:10.409	04.01 IRB-IEC Trial Approval	04.01.05 IRB-IEC GCP Compliance Statement
18602	91	1625579111556:-269643988	1625579110981:-324754776	D5160C00019	206	205	CREATE	2021-07-06 15:45:11.646	04.02 Other Committees	04.02.01 Other Submissions
18603	91	1625579112271:278822184	1625579077959:-273999111	D5160C00019	207	199	CREATE	2021-07-06 15:45:12.369	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
18604	91	1625579112839:168123980	1625579112271:278822184	D5160C00019	208	207	CREATE	2021-07-06 15:45:12.935	04.03 Trial Status Reporting	04.03.01 IRB-IEC_ety Info-Deviation
18605	91	1625579113454:243937840	1625579048409:-510601586	D5160C00019	209	179	CREATE	2021-07-06 15:45:13.556	FRANCE	05 Site Management
18607	91	1625579114540:-1532158102	1625579114012:-1847582291	D5160C00019	211	210	CREATE	2021-07-06 15:45:14.63	05.05 General	05.05.02 Tracking Information
18608	91	1625579115154:281183640	1625579048409:-510601586	D5160C00019	212	179	CREATE	2021-07-06 15:45:15.268	FRANCE	07 Safety Reporting
18610	91	1625579123942:1074640762	1625579115730:764595528	D5160C00019	214	213	CREATE	2021-07-06 15:45:24.058	07.03 General	07.03.01 Relevant Communications-Safety-Email
18612	91	1625579125147:273194469	1625579048409:-510601586	D5160C00019	216	179	CREATE	2021-07-06 15:45:25.268	FRANCE	09 Third Party
18613	91	1625579125810:471498585	1625579125147:273194469	D5160C00019	217	216	CREATE	2021-07-06 15:45:25.921	09 Third Party	09.02 Third Party Set-up
18615	91	1625579126979:-1958417080	1625579125810:471498585	D5160C00019	219	217	CREATE	2021-07-06 15:45:27.081	09.02 Third Party Set-up	09.02.04 Roles and Responsibilities Matrix
18616	91	1625579127548:-1843397400	1625579048409:-510601586	D5160C00019	220	179	CREATE	2021-07-06 15:45:28.421	FRANCE	23011 Isambert, Nicolas
18618	91	1625579130301:-664074934	1625579129675:660189935	D5160C00019	222	221	CREATE	2021-07-06 15:45:30.406	04 IRB-IEC an_other Approvals	04.01 IRB-IEC Trial Approval
18619	91	1625579130886:-403640694	1625579130301:-664074934	D5160C00019	223	222	CREATE	2021-07-06 15:45:30.998	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
18620	91	1625579131467:-1346797002	1625579127548:-1843397400	D5160C00019	224	220	CREATE	2021-07-06 15:45:42.463	23011 Isambert, Nicolas	05 Site Management
18622	91	1625579143889:445174305	1625579143026:2129589673	D5160C00019	226	225	CREATE	2021-07-06 15:45:46.893	05.01 Site Selection	05.01.02 Confidentiality Agreement
18623	91	1625579147390:1236915591	1625579143026:2129589673	D5160C00019	227	225	CREATE	2021-07-06 15:45:47.509	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
18625	91	1625579148642:-255778310	1625579147974:-694578562	D5160C00019	229	228	CREATE	2021-07-06 15:45:48.756	05.02 Site Se_p Documentation	05.02.01 Acce_igator Brochure
18626	91	1625579149196:-1596869189	1625579147974:-694578562	D5160C00019	230	228	CREATE	2021-07-06 15:45:49.293	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
18628	91	1625579151422:-428109012	1625579147974:-694578562	D5160C00019	232	228	CREATE	2021-07-06 15:45:51.529	05.02 Site Se_p Documentation	05.02.04 PI C_ite Affiliation
18629	91	1625579152104:-62915996	1625579147974:-694578562	D5160C00019	233	228	CREATE	2021-07-06 15:45:52.227	05.02 Site Se_p Documentation	05.02.06 Othe_ite Affiliation
18631	91	1625579153394:1341598211	1625579147974:-694578562	D5160C00019	235	228	CREATE	2021-07-06 15:45:53.524	05.02 Site Se_p Documentation	05.02.12 Clinical Trial Agreement
18632	91	1625579154048:789455854	1625579147974:-694578562	D5160C00019	236	228	CREATE	2021-07-06 15:45:54.139	05.02 Site Se_p Documentation	05.02.17 IP Site Release Documentation
18634	91	1625579155233:-270469619	1625579131467:-1346797002	D5160C00019	238	224	CREATE	2021-07-06 15:45:55.333	05 Site Management	05.03 Site Initiation
18635	91	1625579155974:-1240099696	1625579155233:-270469619	D5160C00019	239	238	CREATE	2021-07-06 15:45:56.076	05.03 Site Initiation	05.03.01 Tria_nitoring Report
18636	91	1625579156548:197188785	1625579155233:-270469619	D5160C00019	240	238	CREATE	2021-07-06 15:46:17.106	05.03 Site Initiation	05.03.03 Site Training-Staff
18638	91	1625579178428:-2097720097	1625579177853:-1243828622	D5160C00019	242	241	CREATE	2021-07-06 15:46:18.52	05.04 Site Management	05.04.01 Subject Log
18639	91	1625579178972:-661960411	1625579177853:-1243828622	D5160C00019	243	241	CREATE	2021-07-06 15:46:19.061	05.04 Site Management	05.04.03 Monitoring Visit Report
18641	91	1625579180182:1675197725	1625579177853:-1243828622	D5160C00019	245	241	CREATE	2021-07-06 15:46:20.298	05.04 Site Management	05.04.08 Fina_nitoring Report
18642	91	1625579180738:-884017517	1625579131467:-1346797002	D5160C00019	246	224	CREATE	2021-07-06 15:46:20.83	05 Site Management	05.05 General
18644	91	1625579182147:971467167	1625579127548:-1843397400	D5160C00019	248	220	CREATE	2021-07-06 15:46:22.244	23011 Isambert, Nicolas	06 IP and Trial Supplies
18645	91	1625579182776:-368096901	1625579182147:971467167	D5160C00019	249	248	CREATE	2021-07-06 15:46:30.538	06 IP and Trial Supplies	06.01 IP Documentation
18647	91	1625579191680:1597669818	1625579182776:-368096901	D5160C00019	251	249	CREATE	2021-07-06 15:46:31.799	06.01 IP Documentation	06.01.05 Acco_y Documentation
18648	91	1625579192402:-288004474	1625579182776:-368096901	D5160C00019	252	249	CREATE	2021-07-06 15:46:32.519	06.01 IP Documentation	06.01.10 IP D_entation Return
18649	91	1625579192961:2074202494	1625579182776:-368096901	D5160C00019	253	249	CREATE	2021-07-06 15:46:33.048	06.01 IP Documentation	06.01.11 Certificate of Destruction
18651	91	1625579194219:209604571	1625579193489:241070006	D5160C00019	255	254	CREATE	2021-07-06 15:46:34.313	06.04 Storage	06.04.01 Storage Condition Documentation
18652	91	1625579201993:-1428292173	1625579182147:971467167	D5160C00019	256	248	CREATE	2021-07-06 15:46:42.086	06 IP and Trial Supplies	06.07 General
18654	91	1625579203286:-453206766	1625579127548:-1843397400	D5160C00019	258	220	CREATE	2021-07-06 15:46:43.376	23011 Isambert, Nicolas	07 Safety Reporting
18655	91	1625579203928:1243445351	1625579203286:-453206766	D5160C00019	259	258	CREATE	2021-07-06 15:46:44.019	07 Safety Reporting	07.03 General
18657	91	1625579205065:36357806	1625579048409:-510601586	D5160C00019	261	179	CREATE	2021-07-06 15:46:45.165	FRANCE	23021 Italiano, Antoine
18658	91	1625579205605:1479488623	1625579205065:36357806	D5160C00019	262	261	CREATE	2021-07-06 15:46:45.7	23021 Italiano, Antoine	02 Central Trial Documents
18660	91	1625579207887:840429927	1625579207262:351890808	D5160C00019	264	263	CREATE	2021-07-06 15:46:47.977	02.02 Subject Documents	02.02.03 Info_ Form Templates
18662	91	1625579215718:574517881	1625579215099:270474102	D5160C00019	266	265	CREATE	2021-07-06 15:46:55.809	05 Site Management	05.01 Site Selection
18664	91	1625579216937:2116650893	1625579215718:574517881	D5160C00019	268	266	CREATE	2021-07-06 15:46:57.036	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
18665	91	1625579218454:2045316942	1625579215099:270474102	D5160C00019	269	265	CREATE	2021-07-06 15:46:58.544	05 Site Management	05.02 Site Se_p Documentation
18667	91	1625579219636:-409781919	1625579218454:2045316942	D5160C00019	271	269	CREATE	2021-07-06 15:46:59.727	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
18668	91	1625579220216:315800873	1625579218454:2045316942	D5160C00019	272	269	CREATE	2021-07-06 15:47:00.314	05.02 Site Se_p Documentation	05.02.03 Prot_ Signature Page
18670	91	1625579221465:1914483307	1625579218454:2045316942	D5160C00019	274	269	CREATE	2021-07-06 15:47:01.561	05.02 Site Se_p Documentation	05.02.06 Othe_ite Affiliation
18671	91	1625579222003:330452268	1625579218454:2045316942	D5160C00019	275	269	CREATE	2021-07-06 15:47:02.109	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
18673	91	1625579223104:-728582710	1625579218454:2045316942	D5160C00019	277	269	CREATE	2021-07-06 15:47:03.195	05.02 Site Se_p Documentation	05.02.17 IP S_e Documentation
18674	91	1625579223648:1431953860	1625579218454:2045316942	D5160C00019	278	269	CREATE	2021-07-06 15:47:03.748	05.02 Site Se_p Documentation	05.02.18 Site Signature Sheet
18675	91	1625579224272:-489148769	1625579215099:270474102	D5160C00019	279	265	CREATE	2021-07-06 15:47:04.395	05 Site Management	05.03 Site Initiation
18677	91	1625579225555:1778487570	1625579224272:-489148769	D5160C00019	281	279	CREATE	2021-07-06 15:47:05.651	05.03 Site Initiation	05.03.03 Site Training-Staff
18678	91	1625579226176:864136012	1625579224272:-489148769	D5160C00019	282	279	CREATE	2021-07-06 15:47:06.271	05.03 Site Initiation	05.03.03 Site_umentation-Site
18679	91	1625579226728:1496045664	1625579215099:270474102	D5160C00019	283	265	CREATE	2021-07-06 15:47:06.819	05 Site Management	05.04 Site Management
18681	91	1625579227893:-1516252487	1625579226728:1496045664	D5160C00019	285	283	CREATE	2021-07-06 15:47:07.988	05.04 Site Management	05.04.03 Monitoring Visit Report
18682	91	1625579235352:-1732205625	1625579226728:1496045664	D5160C00019	286	283	CREATE	2021-07-06 15:47:15.442	05.04 Site Management	05.04.04 Visit Log
18684	91	1625579236746:752206061	1625579226728:1496045664	D5160C00019	288	283	CREATE	2021-07-06 15:47:16.838	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
18685	91	1625579237331:1199468904	1625579226728:1496045664	D5160C00019	289	283	CREATE	2021-07-06 15:47:17.431	05.04 Site Management	05.04.09 Inv _o-Dr-HCP Letter
18687	91	1625579238564:-2073339268	1625579237976:-1102707276	D5160C00019	291	290	CREATE	2021-07-06 15:47:18.659	05.05 General	05.05.01 Relevant Communications-Documents
18688	91	1625579239165:-318887484	1625579237976:-1102707276	D5160C00019	292	290	CREATE	2021-07-06 15:47:19.279	05.05 General	05.05.02 Tracking Information
18690	91	1625579241429:-1840587288	1625579240865:-277698055	D5160C00019	294	293	CREATE	2021-07-06 15:47:21.524	06 IP and Trial Supplies	06.01 IP Documentation
18691	91	1625579242036:-464454131	1625579241429:-1840587288	D5160C00019	295	294	CREATE	2021-07-06 15:47:22.139	06.01 IP Documentation	06.01.04 IP Shipment Documentation
18693	91	1625579243397:386961230	1625579241429:-1840587288	D5160C00019	297	294	CREATE	2021-07-06 15:47:23.488	06.01 IP Documentation	06.01.11 Cert_ of Destruction
18694	91	1625579244028:155542034	1625579240865:-277698055	D5160C00019	298	293	CREATE	2021-07-06 15:47:24.122	06 IP and Trial Supplies	06.04 Storage
18695	91	1625579247534:-407815549	1625579244028:155542034	D5160C00019	299	298	CREATE	2021-07-06 15:47:27.635	06.04 Storage	06.04.01 Stor_n Documentation
18697	91	1625579249148:250361256	1625579240865:-277698055	D5160C00019	301	293	CREATE	2021-07-06 15:47:29.249	06 IP and Trial Supplies	06.05 Non-IP Documentation
18698	91	1625579249702:-213191288	1625579249148:250361256	D5160C00019	302	301	CREATE	2021-07-06 15:47:29.79	06.05 Non-IP Documentation	06.05.02 Non-_ion of Shipment
18700	91	1625579260028:1995795902	1625579254876:1205622284	D5160C00019	304	303	CREATE	2021-07-06 15:47:40.12	07 Safety Reporting	07.03 General
18701	91	1625579260587:470196415	1625579260028:1995795902	D5160C00019	305	304	CREATE	2021-07-06 15:47:40.683	07.03 General	07.03.01 Rele_ns-Safety-Email
18703	91	1625579262170:2001125354	1625579261144:-16415514	D5160C00019	307	306	CREATE	2021-07-06 15:47:42.261	08 Centralized Testing	08.01 Facility Documentation
18704	91	1625579262817:831194406	1625579262170:2001125354	D5160C00019	308	307	CREATE	2021-07-06 15:47:42.914	08.01 Facility Documentation	08.01.01 Cert_r Accreditation
18706	91	1625579263915:-329292663	1625579261144:-16415514	D5160C00019	310	306	CREATE	2021-07-06 15:47:44.007	08 Centralized Testing	08.02 Sample Documentation
18707	91	1625579264519:894975641	1625579263915:-329292663	D5160C00019	311	310	CREATE	2021-07-06 15:47:50.415	08.02 Sample Documentation	08.02.03 Samp_e Condition Log
18708	91	1625579270989:-749907364	1625579263915:-329292663	D5160C00019	312	310	CREATE	2021-07-06 15:47:51.081	08.02 Sample Documentation	08.02.05 Reta_-Tissue Samples
18709	91	1625579271640:734720565	1625579048409:-510601586	D5160C00019	313	179	CREATE	2021-07-06 15:47:52.223	FRANCE	23031 Lena, Hervé
18711	91	1625579273383:-32616377	1625579272768:-1232719165	D5160C00019	315	314	CREATE	2021-07-06 15:47:53.477	02 Central Trial Documents	02.04 General
18713	91	1625579274558:516798532	1625579271640:734720565	D5160C00019	317	313	CREATE	2021-07-06 15:47:54.661	23031 Lena, Hervé	05 Site Management
18714	91	1625579275150:-350631739	1625579274558:516798532	D5160C00019	318	317	CREATE	2021-07-06 15:47:55.261	05 Site Management	05.01 Site Selection
18716	91	1625579276352:-1731139951	1625579275150:-350631739	D5160C00019	320	318	CREATE	2021-07-06 15:47:56.463	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
18717	91	1625579276918:-266826920	1625579274558:516798532	D5160C00019	321	317	CREATE	2021-07-06 15:47:57.011	05 Site Management	05.02 Site Se_p Documentation
18719	91	1625579278082:1229215532	1625579276918:-266826920	D5160C00019	323	321	CREATE	2021-07-06 15:47:58.175	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
18720	91	1625579278621:-1922598035	1625579276918:-266826920	D5160C00019	324	321	CREATE	2021-07-06 15:47:58.71	05.02 Site Se_p Documentation	05.02.03 Protocol Amendment Signature Page
18721	91	1625579279149:-1892067105	1625579276918:-266826920	D5160C00019	325	321	CREATE	2021-07-06 15:47:59.24	05.02 Site Se_p Documentation	05.02.04 PI CV-Site Affiliation
18723	91	1625579280339:-1728803541	1625579276918:-266826920	D5160C00019	327	321	CREATE	2021-07-06 15:48:00.438	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
18724	91	1625579280895:-1963801700	1625579276918:-266826920	D5160C00019	328	321	CREATE	2021-07-06 15:48:00.986	05.02 Site Se_p Documentation	05.02.12 Clin_Trial Agreement
18726	91	1625579282104:-1913146036	1625579276918:-266826920	D5160C00019	330	321	CREATE	2021-07-06 15:48:21.86	05.02 Site Se_p Documentation	05.02.18 Site Signature Sheet
18728	91	1625579302895:661744442	1625579302346:207830578	D5160C00019	332	331	CREATE	2021-07-06 15:48:22.986	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
18729	91	1625579304113:379738122	1625579302346:207830578	D5160C00019	333	331	CREATE	2021-07-06 15:48:24.211	05.03 Site Initiation	05.03.03 Site Training-Staff
18731	91	1625579305459:570896044	1625579274558:516798532	D5160C00019	335	317	CREATE	2021-07-06 15:48:25.556	05 Site Management	05.04 Site Management
18732	91	1625579306007:-150766894	1625579305459:570896044	D5160C00019	336	335	CREATE	2021-07-06 15:48:26.098	05.04 Site Management	05.04.01 Subject Log
18733	91	1625579306535:1234433628	1625579305459:570896044	D5160C00019	337	335	CREATE	2021-07-06 15:48:26.624	05.04 Site Management	05.04.03 Monitoring Visit Report
18735	91	1625579307637:-220616010	1625579305459:570896044	D5160C00019	339	335	CREATE	2021-07-06 15:48:27.727	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
18737	91	1625579308950:-405696102	1625579274558:516798532	D5160C00019	341	317	CREATE	2021-07-06 15:48:29.038	05 Site Management	05.05 General
18738	91	1625579309520:988377928	1625579308950:-405696102	D5160C00019	342	341	CREATE	2021-07-06 15:48:29.623	05.05 General	05.05.02 Tracking Information
18739	91	1625579310168:708326199	1625579271640:734720565	D5160C00019	343	313	CREATE	2021-07-06 15:48:30.274	23031 Lena, Hervé	06 IP and Trial Supplies
18740	91	1625579315610:-89025629	1625579310168:708326199	D5160C00019	344	343	CREATE	2021-07-06 15:48:35.702	06 IP and Trial Supplies	06.01 IP Documentation
18742	91	1625579316717:1478697400	1625579315610:-89025629	D5160C00019	346	344	CREATE	2021-07-06 15:48:36.812	06.01 IP Documentation	06.01.05 Accountability Documentation
18743	91	1625579317307:110039757	1625579315610:-89025629	D5160C00019	347	344	CREATE	2021-07-06 15:48:37.414	06.01 IP Documentation	06.01.10 IP Documentation Return
18745	91	1625579318437:1856565747	1625579310168:708326199	D5160C00019	349	343	CREATE	2021-07-06 15:48:38.53	06 IP and Trial Supplies	06.04 Storage
18746	91	1625579318983:-807723591	1625579318437:1856565747	D5160C00019	350	349	CREATE	2021-07-06 15:48:39.08	06.04 Storage	06.04.01 Storage Condition Documentation
18748	91	1625579320163:971889310	1625579318437:1856565747	D5160C00019	352	349	CREATE	2021-07-06 15:48:40.253	06.04 Storage	06.04.03 Maintenance Logs
18749	91	1625579320706:1453028832	1625579271640:734720565	D5160C00019	353	313	CREATE	2021-07-06 15:48:40.795	23031 Lena, Hervé	07 Safety Reporting
18751	91	1625579321866:635703775	1625579321330:-2138720706	D5160C00019	355	354	CREATE	2021-07-06 15:48:41.956	07.03 General	07.03.01 Rele_ns-Safety-Email
18752	91	1625579322468:280531734	1625579271640:734720565	D5160C00019	356	313	CREATE	2021-07-06 15:48:42.557	23031 Lena, Hervé	08 Centralized Testing
18754	91	1625579323718:1032627068	1625579323101:691616285	D5160C00019	358	357	CREATE	2021-07-06 15:48:43.821	08.01 Facility Documentation	08.01.01 Cert_r Accreditation
18755	91	1625579324267:599531457	1625579323101:691616285	D5160C00019	359	357	CREATE	2021-07-06 15:48:49.252	08.01 Facility Documentation	08.01.04 Norm_nd Alert Values
18756	91	1625579329798:1269341066	1625579322468:280531734	D5160C00019	360	356	CREATE	2021-07-06 15:48:49.889	08 Centralized Testing	08.02 Sample Documentation
18758	91	1625579330925:-174697633	1625579329798:1269341066	D5160C00019	362	360	CREATE	2021-07-06 15:48:51.193	08.02 Sample Documentation	08.02.05 Reta_-Tissue Samples
18759	91	1625579331782:-1842571658	1625579048409:-510601586	D5160C00019	363	179	CREATE	2021-07-06 15:48:51.897	FRANCE	23041 Veillon, Remi
18761	91	1625579332949:1042439630	1625579332397:-1668088758	D5160C00019	365	364	CREATE	2021-07-06 15:48:53.04	02 Central Trial Documents	02.04 General
18762	91	1625579333572:1319831640	1625579332949:1042439630	D5160C00019	366	365	CREATE	2021-07-06 15:48:53.67	02.04 General	02.04.01 Rele_-Contact Report
18764	91	1625579334772:-1994578655	1625579331782:-1842571658	D5160C00019	368	363	CREATE	2021-07-06 15:48:54.862	23041 Veillon, Remi	05 Site Management
18765	91	1625579335915:-645535075	1625579334772:-1994578655	D5160C00019	369	368	CREATE	2021-07-06 15:48:56.006	05 Site Management	05.01 Site Selection
18767	91	1625579337140:299783906	1625579335915:-645535075	D5160C00019	371	369	CREATE	2021-07-06 15:48:57.243	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
18768	91	1625579337791:-1300347962	1625579334772:-1994578655	D5160C00019	372	368	CREATE	2021-07-06 15:48:57.881	05 Site Management	05.02 Site Se_p Documentation
18770	91	1625579338960:-1803744076	1625579337791:-1300347962	D5160C00019	374	372	CREATE	2021-07-06 15:48:59.061	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
18771	91	1625579339529:-2139680481	1625579337791:-1300347962	D5160C00019	375	372	CREATE	2021-07-06 15:48:59.626	05.02 Site Se_p Documentation	05.02.03 Protocol Amendment Signature Page
18772	91	1625579340065:109757106	1625579337791:-1300347962	D5160C00019	376	372	CREATE	2021-07-06 15:49:00.155	05.02 Site Se_p Documentation	05.02.04 PI CV-Site Affiliation
18774	91	1625579341186:1012625013	1625579337791:-1300347962	D5160C00019	378	372	CREATE	2021-07-06 15:49:01.292	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
18775	91	1625579341851:-201711754	1625579337791:-1300347962	D5160C00019	379	372	CREATE	2021-07-06 15:49:01.971	05.02 Site Se_p Documentation	05.02.12 Clinical Trial Agreement
18777	91	1625579343124:1424996554	1625579337791:-1300347962	D5160C00019	381	372	CREATE	2021-07-06 15:49:03.23	05.02 Site Se_p Documentation	05.02.18 Site Signature Sheet
18778	91	1625579343760:509641278	1625579334772:-1994578655	D5160C00019	382	368	CREATE	2021-07-06 15:49:03.868	05 Site Management	05.03 Site Initiation
18779	91	1625579344448:1887405707	1625579343760:509641278	D5160C00019	383	382	CREATE	2021-07-06 15:49:04.535	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
18781	91	1625579345584:-573804062	1625579343760:509641278	D5160C00019	385	382	CREATE	2021-07-06 15:49:05.674	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
18782	91	1625579346750:-1849629849	1625579334772:-1994578655	D5160C00019	386	368	CREATE	2021-07-06 15:49:06.84	05 Site Management	05.04 Site Management
18784	91	1625579347874:-979457367	1625579346750:-1849629849	D5160C00019	388	386	CREATE	2021-07-06 15:49:08.155	05.04 Site Management	05.04.03 Monitoring Visit Report
18785	91	1625579348698:-1935142156	1625579346750:-1849629849	D5160C00019	389	386	CREATE	2021-07-06 15:49:08.803	05.04 Site Management	05.04.04 Visit Log
18787	91	1625579349990:-787048849	1625579346750:-1849629849	D5160C00019	391	386	CREATE	2021-07-06 15:49:10.114	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
18788	91	1625579350574:2002017037	1625579346750:-1849629849	D5160C00019	392	386	CREATE	2021-07-06 15:49:10.694	05.04 Site Management	05.04.09 Inv Notification-SUSAR
11640	86	\N	\N	D5170C00002	91	90	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
6110	83	1611641960564:816586284	1611641959424:450864720	D5136C00008	1063	1061	CREATE	2021-01-26 07:19:20.65	02.02 Subject Documents	02.02.03 Info_Form Checklists
6111	83	1611641961200:1409857359	1611641958876:1498581014	D5136C00008	1064	1060	CREATE	2021-01-26 07:19:21.286	02 Central Trial Documents	02.04 General
6113	83	1611641962313:496667910	1611641961200:1409857359	D5136C00008	1066	1064	CREATE	2021-01-26 07:19:22.402	02.04 General	02.04.01 Rele_tions-Documents
6116	83	1611641964228:1106613463	1611641963428:374651675	D5136C00008	1069	1068	CREATE	2021-01-26 07:19:24.316	03.04 General	03.04.01 Rele_-Start-Up-Email
6118	83	1611641965340:403031889	1611641956364:-1352316942	D5136C00008	1071	1056	CREATE	2021-01-26 07:19:25.425	7805 Harrington, Thomas	04 IRB-IEC an_other Approvals
6121	83	1611641967085:1421046322	1611641965897:-738152005	D5136C00008	1074	1072	CREATE	2021-01-26 07:19:27.172	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
6124	83	1611641968723:-172427837	1611641968185:1120596273	D5136C00008	1077	1076	CREATE	2021-01-26 07:19:28.808	04.03 Trial Status Reporting	04.03.03 IRB-_rm Notification
6128	83	1611641970955:-330671972	1611641970411:-1553364057	D5136C00008	1081	1080	CREATE	2021-01-26 07:19:31.04	05 Site Management	05.01 Site Selection
6130	83	1611641972165:-2081069155	1611641970955:-330671972	D5136C00008	1083	1081	CREATE	2021-01-26 07:19:32.252	05.01 Site Selection	05.01.03 Feasibility Documentation
6134	83	1611641974678:1692415089	1611641973521:-1519367121	D5136C00008	1087	1085	CREATE	2021-01-26 07:19:34.762	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
6137	83	1611641976324:1324256296	1611641973521:-1519367121	D5136C00008	1090	1085	CREATE	2021-01-26 07:19:36.409	05.02 Site Se_p Documentation	05.02.06 Othe_ite Affiliation
6140	83	1611641978058:1342677797	1611641973521:-1519367121	D5136C00008	1093	1085	CREATE	2021-01-26 07:19:38.145	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
8138	84	\N	\N	D5170C00002	1923	1918	NEW	\N	2002284 Walldorf, Jens	05 Site Management
18790	91	1625579357699:1410074995	1625579351167:-1489808135	D5160C00019	394	393	CREATE	2021-07-06 15:49:18.018	05.05 General	05.05.02 Tracking Information
18792	91	1625579359128:291551010	1625579358543:-1852602297	D5160C00019	396	395	CREATE	2021-07-06 15:49:19.253	06 IP and Trial Supplies	06.01 IP Documentation
18793	91	1625579359794:-1540125760	1625579359128:291551010	D5160C00019	397	396	CREATE	2021-07-06 15:49:19.921	06.01 IP Documentation	06.01.04 IP Shipment Documentation
18795	91	1625579361134:1454747414	1625579359128:291551010	D5160C00019	399	396	CREATE	2021-07-06 15:49:21.254	06.01 IP Documentation	06.01.10 IP D_entation Return
18796	91	1625579361730:-1307750484	1625579359128:291551010	D5160C00019	400	396	CREATE	2021-07-06 15:49:21.864	06.01 IP Documentation	06.01.11 Certificate of Destruction
18797	91	1625579362742:-2002979710	1625579358543:-1852602297	D5160C00019	401	395	CREATE	2021-07-06 15:49:23.026	06 IP and Trial Supplies	06.04 Storage
18799	91	1625579371796:-402769431	1625579362742:-2002979710	D5160C00019	403	401	CREATE	2021-07-06 15:49:31.902	06.04 Storage	06.04.03 Maintenance Logs
18800	91	1625579372409:1072578702	1625579331782:-1842571658	D5160C00019	404	363	CREATE	2021-07-06 15:49:32.502	23041 Veillon, Remi	07 Safety Reporting
18802	91	1625579373545:1987232687	1625579373018:-985701559	D5160C00019	406	405	CREATE	2021-07-06 15:49:33.634	07.03 General	07.03.01 Rele_ns-Safety-Email
18803	91	1625579374135:1924458525	1625579331782:-1842571658	D5160C00019	407	363	CREATE	2021-07-06 15:49:34.235	23041 Veillon, Remi	08 Centralized Testing
18805	91	1625579375383:1932196341	1625579374719:922500407	D5160C00019	409	408	CREATE	2021-07-06 15:49:35.483	08.01 Facility Documentation	08.01.01 Cert_r Accreditation
18806	91	1625579375913:1501211921	1625579374719:922500407	D5160C00019	410	408	CREATE	2021-07-06 15:49:36.019	08.01 Facility Documentation	08.01.04 Norm_nd Alert Values
18808	91	1625579377113:2093565562	1625579374135:1924458525	D5160C00019	412	407	CREATE	2021-07-06 15:49:37.243	08 Centralized Testing	08.02 Sample Documentation
18809	91	1625579377852:979441567	1625579377113:2093565562	D5160C00019	413	412	CREATE	2021-07-06 15:49:38.581	08.02 Sample Documentation	08.02.03 Samp_e Condition Log
18810	91	1625579379057:303629918	1625579048409:-510601586	D5160C00019	414	179	CREATE	2021-07-06 15:49:39.148	FRANCE	23051 Cortot, Alexis
18812	91	1625579380298:1562065157	1625579379617:1323294590	D5160C00019	416	415	CREATE	2021-07-06 15:49:40.4	05 Site Management	05.01 Site Selection
18814	91	1625579381609:-2065448271	1625579380298:1562065157	D5160C00019	418	416	CREATE	2021-07-06 15:49:41.709	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
18815	91	1625579388201:1647036966	1625579379617:1323294590	D5160C00019	419	415	CREATE	2021-07-06 15:49:48.301	05 Site Management	05.02 Site Se_p Documentation
18817	91	1625579390079:-188811481	1625579388201:1647036966	D5160C00019	421	419	CREATE	2021-07-06 15:49:50.171	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
18818	91	1625579390619:809469911	1625579388201:1647036966	D5160C00019	422	419	CREATE	2021-07-06 15:49:50.712	05.02 Site Se_p Documentation	05.02.03 Protocol Amendment Signature Page
18819	91	1625579391160:-1233948607	1625579388201:1647036966	D5160C00019	423	419	CREATE	2021-07-06 15:49:51.249	05.02 Site Se_p Documentation	05.02.04 PI CV-Site Affiliation
18821	91	1625579392348:-333191891	1625579388201:1647036966	D5160C00019	425	419	CREATE	2021-07-06 15:49:52.442	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
18822	91	1625579392944:-807786398	1625579388201:1647036966	D5160C00019	426	419	CREATE	2021-07-06 15:49:53.052	05.02 Site Se_p Documentation	05.02.12 Clinical Trial Agreement
18823	91	1625579393493:-1426443087	1625579388201:1647036966	D5160C00019	427	419	CREATE	2021-07-06 15:49:53.585	05.02 Site Se_p Documentation	05.02.18 Site Signature Sheet
18825	91	1625579394836:-277127847	1625579394108:-95016130	D5160C00019	429	428	CREATE	2021-07-06 15:49:54.929	05.03 Site Initiation	05.03.01 Tria_nitoring Report
18826	91	1625579395429:-362016995	1625579394108:-95016130	D5160C00019	430	428	CREATE	2021-07-06 15:49:55.528	05.03 Site Initiation	05.03.03 Site Training-Staff
18828	91	1625579396716:1097797515	1625579379617:1323294590	D5160C00019	432	415	CREATE	2021-07-06 15:49:56.807	05 Site Management	05.04 Site Management
18829	91	1625579397285:1231376409	1625579396716:1097797515	D5160C00019	433	432	CREATE	2021-07-06 15:49:57.393	05.04 Site Management	05.04.01 Subject Log
18831	91	1625579398539:-1894354112	1625579396716:1097797515	D5160C00019	435	432	CREATE	2021-07-06 15:49:58.636	05.04 Site Management	05.04.04 Visit Log
18832	91	1625579399078:-173698359	1625579396716:1097797515	D5160C00019	436	432	CREATE	2021-07-06 15:49:59.171	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
18834	91	1625579400873:-708564028	1625579379617:1323294590	D5160C00019	438	415	CREATE	2021-07-06 15:50:07.055	05 Site Management	05.05 General
4030	82	1611633575695:2125183590	1611633575093:-524477315	D5136C00008	3	2	CREATE	2021-01-26 04:59:35.781	01.01 Trial Oversight	01.01.01 Trial Master File Plan
4031	82	1611633576341:-260924931	1611633575093:-524477315	D5136C00008	4	2	CREATE	2021-01-26 04:59:36.427	01.01 Trial Oversight	01.01.02 Trial Management Plan
4033	82	1611633577636:1194974264	1611633575093:-524477315	D5136C00008	6	2	CREATE	2021-01-26 04:59:37.723	01.01 Trial Oversight	01.01.04 List of SOPs Current During Trial
4035	82	1611633578815:827752209	1611633575093:-524477315	D5136C00008	8	2	CREATE	2021-01-26 04:59:38.9	01.01 Trial Oversight	01.01.07 Communication Plan
4036	82	1611633579389:-259714949	1611633575093:-524477315	D5136C00008	9	2	CREATE	2021-01-26 04:59:39.475	01.01 Trial Oversight	01.01.08 Monitoring Plan
4038	82	1611633580673:235707083	1611633575093:-524477315	D5136C00008	11	2	CREATE	2021-01-26 04:59:40.765	01.01 Trial Oversight	01.01.13 Investigator Newsletter
4254	82	1611633783489:-1377617256	1611633781086:10116526	D5136C00008	227	223	CREATE	2021-01-26 05:03:03.576	02.02 Subject Documents	02.02.03 Informed Consent Form Checklists
4258	82	1611633785861:583640984	1611633785292:-1423890426	D5136C00008	231	230	CREATE	2021-01-26 05:03:05.945	02.04 General	02.04.02 Tracking Information
4264	82	1611633790025:1546834266	1611633789385:-545457047	D5136C00008	237	236	CREATE	2021-01-26 05:03:10.116	03.03 Trial Status Reporting	03.03.01 Reg Auth Notificaton-Safety-Info and Deviation
4271	82	1611633794505:140517602	1611633793882:-1149484920	D5136C00008	244	243	CREATE	2021-01-26 05:03:14.592	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
4274	82	1611633798166:558428529	1611633797584:1332085920	D5136C00008	247	246	CREATE	2021-01-26 05:03:18.25	05.03 Site Initiation	05.03.02 Site Training Material
4278	82	1611633800825:440133804	1611633800166:-2100925708	D5136C00008	251	250	CREATE	2021-01-26 05:03:20.91	06 IP and Trial Supplies	06.01 IP Documentation
4284	82	1611633805757:-1388952270	1611633804708:-988231060	D5136C00008	257	256	CREATE	2021-01-26 05:03:25.842	09.03 General	09.03.01 Relevant Communications-Third Party-Documents
4290	82	1611633809347:-1754755461	1611633808779:580826336	D5136C00008	263	262	CREATE	2021-01-26 05:03:29.448	02.04 General	02.04.01 Rele_-Contact Report
4293	82	1611633811094:-1848378413	1611633810537:-1383609946	D5136C00008	266	265	CREATE	2021-01-26 05:03:31.18	03.02 Investigational Medicinal Product	03.02.02 Import-Export License
4299	82	1611633814565:387623382	1611633814005:3247970	D5136C00008	272	271	CREATE	2021-01-26 05:03:34.648	04.02 Other Committees	04.02.01 Other Submissions
4302	82	1611633816460:1310754632	1611633815247:2028128151	D5136C00008	275	273	CREATE	2021-01-26 05:03:36.545	04.03 Trial Status Reporting	04.03.02 IRB-_Progress Report
4310	82	1611633821262:872569998	1611633820621:-329722076	D5136C00008	283	282	CREATE	2021-01-26 05:03:41.346	05.02 Site Se_p Documentation	05.02.01 Acce_igator Brochure
4311	82	1611633821857:1168123691	1611633820621:-329722076	D5136C00008	284	282	CREATE	2021-01-26 05:03:41.945	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
4314	82	1611633824102:-1491235193	1611633820621:-329722076	D5136C00008	287	282	CREATE	2021-01-26 05:03:44.189	05.02 Site Se_p Documentation	05.02.07 Staff Qualification
4320	82	1611633827665:94376258	1611633817724:-1563013837	D5136C00008	293	277	CREATE	2021-01-26 05:03:47.748	05 Site Management	05.03 Site Initiation
4323	82	1611633829424:1097156986	1611633827665:94376258	D5136C00008	296	293	CREATE	2021-01-26 05:03:49.509	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
4329	82	1611633847510:-949981625	1611633829983:-878982745	D5136C00008	302	297	CREATE	2021-01-26 05:04:07.595	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
4333	82	1611633849968:-1663068523	1611633849391:1288644580	D5136C00008	306	305	CREATE	2021-01-26 05:04:40.815	06 IP and Trial Supplies	06.01 IP Documentation
4342	82	1611633931245:-1787836062	1611633930646:-2090684386	D5136C00008	315	314	CREATE	2021-01-26 05:05:31.332	07 Safety Reporting	07.02 Trial Status Reporting
4345	82	1611633933154:532409030	1611633932431:-1439428462	D5136C00008	318	317	CREATE	2021-01-26 05:05:33.239	07.03 General	07.03.01 Rele_ns-Safety-Email
4351	82	1611633936745:198340305	1611633934352:-1164023789	D5136C00008	324	320	CREATE	2021-01-26 05:05:36.846	8702 Hassab, Hoda	03 Regulatory
4354	82	1611633938622:-609262867	1611633936745:198340305	D5136C00008	327	324	CREATE	2021-01-26 05:05:38.707	03 Regulatory	03.04 General
4359	82	1611633941680:1375639059	1611633940517:579258907	D5136C00008	332	330	CREATE	2021-01-26 05:05:41.764	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
4362	82	1611633943489:-1293165651	1611633942248:-661719985	D5136C00008	335	333	CREATE	2021-01-26 05:05:43.573	04.03 Trial Status Reporting	04.03.02 IRB-_Progress Report
4368	82	1611633947242:-1843364859	1611633945189:-242716665	D5136C00008	341	338	CREATE	2021-01-26 05:05:47.327	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
4371	82	1611633949042:-1242576471	1611633947798:1228093005	D5136C00008	344	342	CREATE	2021-01-26 05:05:49.13	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
4376	82	1611633952033:511087941	1611633947798:1228093005	D5136C00008	349	342	CREATE	2021-01-26 05:05:52.12	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
4378	82	1611633953212:-814061000	1611633947798:1228093005	D5136C00008	351	342	CREATE	2021-01-26 05:05:53.299	05.02 Site Se_p Documentation	05.02.17 IP Site Release Documentation
4385	82	1611633957509:-1888406121	1611633956904:-1275822697	D5136C00008	358	357	CREATE	2021-01-26 05:05:57.593	05.04 Site Management	05.04.01 Subject Log
4388	82	1611633959308:-1641816776	1611633956904:-1275822697	D5136C00008	361	357	CREATE	2021-01-26 05:05:59.392	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
4391	82	1611633961045:1038632832	1611633944643:2119267773	D5136C00008	364	337	CREATE	2021-01-26 05:06:01.13	05 Site Management	05.05 General
4397	82	1611634107687:87646635	1611633962210:90314155	D5136C00008	370	366	CREATE	2021-01-26 05:08:27.773	06 IP and Trial Supplies	06.04 Storage
4403	82	1611634111277:-344828287	1611634110714:1790241918	D5136C00008	376	375	CREATE	2021-01-26 05:08:31.361	07.03 General	07.03.01 Rele_ns-Safety-Email
4406	82	1611634113141:1265678167	1611634112416:1528001080	D5136C00008	379	378	CREATE	2021-01-26 05:08:33.227	02 Central Trial Documents	02.02 Subject Documents
4412	82	1611634116904:-1900207261	1611634116307:-175056378	D5136C00008	385	384	CREATE	2021-01-26 05:08:36.993	03.04 General	03.04.01 Rele_rt-Up-Documents
4415	82	1611634118745:-1955395016	1611634118116:-2128125074	D5136C00008	388	387	CREATE	2021-01-26 05:08:38.83	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
4418	82	1611634176125:1365396096	1611634117491:-7197510	D5136C00008	391	386	CREATE	2021-01-26 05:09:37.016	04 IRB-IEC an_other Approvals	04.03 Trial Status Reporting
4042	82	1611633586541:567354360	1611633585988:-779850671	D5136C00008	15	14	CREATE	2021-01-26 04:59:46.627	01.02 Trial Team	01.02.01 Project Team Details
4045	82	1611633588365:-624690648	1611633574460:-545679261	D5136C00008	18	1	CREATE	2021-01-26 04:59:48.451	01 Trial Management	01.03 Data Adjudication
4046	82	1611633588916:-1603832347	1611633588365:-624690648	D5136C00008	19	18	CREATE	2021-01-26 04:59:49	01.03 Data Adjudication	01.03.01 Oversight Group Charters
4049	82	1611633591028:-476727517	1611633588365:-624690648	D5136C00008	22	18	CREATE	2021-01-26 04:59:51.112	01.03 Data Adjudication	01.03.03 Independent _ Correspondence - Email
4051	82	1611633592167:-1647108937	1611633588365:-624690648	D5136C00008	24	18	CREATE	2021-01-26 04:59:52.256	01.03 Data Adjudication	01.03.04 Advisory Committee Meeting
4053	82	1611633593354:1728232414	1611633574460:-545679261	D5136C00008	26	1	CREATE	2021-01-26 04:59:53.44	01 Trial Management	01.04 Meetings
4055	82	1611633594606:-1542049912	1611633593354:1728232414	D5136C00008	28	26	CREATE	2021-01-26 04:59:54.69	01.04 Meetings	01.04.02 Project Team Member Training Documentation
4058	82	1611633596372:-19064024	1611633574460:-545679261	D5136C00008	31	1	CREATE	2021-01-26 04:59:56.457	01 Trial Management	01.05 General
4059	82	1611633597017:206304988	1611633596372:-19064024	D5136C00008	32	31	CREATE	2021-01-26 04:59:57.103	01.05 General	01.05.01 Rele_veillance-Email
4061	82	1611633598188:1461789720	1611633597017:206304988	D5136C00008	34	32	CREATE	2021-01-26 04:59:58.275	01.05.01 Rele_veillance-Email	Site Communication
4063	82	1611633599415:1117998020	1611633598188:1461789720	D5136C00008	36	34	CREATE	2021-01-26 04:59:59.501	Site Communication	Site 2302_Dr._ti AmeNatarajan
4065	82	1611633600540:1870910623	1611633598188:1461789720	D5136C00008	38	34	CREATE	2021-01-26 05:00:00.627	Site Communication	Site 2802_Dr.Banu Kaya
4068	82	1611633602704:650077804	1611633598188:1461789720	D5136C00008	41	34	CREATE	2021-01-26 05:00:02.81	Site Communication	Site 7601_Pro_i Bulent Antmen
4071	82	1611633604614:1079809440	1611633598188:1461789720	D5136C00008	44	34	CREATE	2021-01-26 05:00:04.699	Site Communication	Site 7804_Dr._e Kanter Washko
4072	82	1611633605276:333327382	1611633598188:1461789720	D5136C00008	45	34	CREATE	2021-01-26 05:00:05.364	Site Communication	Site 8501_Dr.Videlis Nudba
4076	82	1611633607965:-275866144	1611633598188:1461789720	D5136C00008	49	34	CREATE	2021-01-26 05:00:08.049	Site Communication	Site 8702_Dr.Hoda Hassab
4077	82	1611633608530:-945966574	1611633598188:1461789720	D5136C00008	50	34	CREATE	2021-01-26 05:00:08.619	Site Communication	Site 8703_Dr.Mohsen Elafy
4080	82	1611633610336:1106954324	1611633596372:-19064024	D5136C00008	53	31	CREATE	2021-01-26 05:00:10.432	01.05 General	01.05.01 Relevant Com_roject Management-Email
4082	82	1611633611704:853362288	1611633596372:-19064024	D5136C00008	55	31	CREATE	2021-01-26 05:00:11.792	01.05 General	01.05.01 Relevant Communications-Project Management-Documents
4085	82	1611633613367:-1231745763	rootNode	D5136C00008	58	0	CREATE	2021-01-26 05:00:13.46		02 Central Trial Documents
4086	82	1611633614054:756634841	1611633613367:-1231745763	D5136C00008	59	58	CREATE	2021-01-26 05:00:14.139	02 Central Trial Documents	02.01 Trial Documents
4087	82	1611633614629:1792166228	1611633614054:756634841	D5136C00008	60	59	CREATE	2021-01-26 05:00:14.715	02.01 Trial Documents	02.01.01 Investigator Brochure
4090	82	1611633616672:222914650	1611633614054:756634841	D5136C00008	63	59	CREATE	2021-01-26 05:00:16.786	02.01 Trial Documents	02.01.04 Protocol Amendment
4092	82	1611633618120:-1030153569	1611633614054:756634841	D5136C00008	65	59	CREATE	2021-01-26 05:00:18.206	02.01 Trial Documents	02.01.07 Blank Case Report Form
4095	82	1611633619952:-1340084780	1611633618780:-420400763	D5136C00008	68	66	CREATE	2021-01-26 05:00:20.037	02.02 Subject Documents	02.02.03 Informed Consent Form Templates
4096	82	1611633620736:60155692	1611633618780:-420400763	D5136C00008	69	66	CREATE	2021-01-26 05:00:20.822	02.02 Subject Documents	02.02.05 Subject Participation Card
4099	82	1611633622791:-1448570094	1611633621931:999077936	D5136C00008	72	71	CREATE	2021-01-26 05:00:22.878	02.03 Reports	02.03.01 Clinical Study Report
4100	82	1611633624434:-2067916985	1611633621931:999077936	D5136C00008	73	71	CREATE	2021-01-26 05:00:24.52	02.03 Reports	02.03.02 Clinical Study Report Synopsis
4103	82	1611633626281:310936369	rootNode	D5136C00008	76	0	CREATE	2021-01-26 05:00:26.369		03 Regulatory
4104	82	1611633626853:-901970401	1611633626281:310936369	D5136C00008	77	76	CREATE	2021-01-26 05:00:26.94	03 Regulatory	03.01 Trial Approval
4108	82	1611633629405:1835360317	1611633628838:1676090004	D5136C00008	81	80	CREATE	2021-01-26 05:00:29.49	03.04.01 Re_tart-Up-Email	Documents
4111	82	1611633631211:299120285	1611633629405:1835360317	D5136C00008	84	81	CREATE	2021-01-26 05:00:31.312	Documents	ICF
4115	82	1611633633916:-1736951551	1611633628838:1676090004	D5136C00008	88	80	CREATE	2021-01-26 05:00:34.007	03.04.01 Re_tart-Up-Email	Other
4116	82	1611633634425:-1627531427	rootNode	D5136C00008	89	0	CREATE	2021-01-26 05:00:34.512		04 IRB-IEC and other Approvals
4119	82	1611633636474:-1952132568	1611633634425:-1627531427	D5136C00008	92	89	CREATE	2021-01-26 05:00:36.561	04 IRB-IEC and other Approvals	04.04 General
4121	82	1611633637688:277410375	rootNode	D5136C00008	94	0	CREATE	2021-01-26 05:00:37.779		05 Site Management
4422	82	1611634192599:696569121	1611634111846:-90530030	D5136C00008	395	377	CREATE	2021-01-26 05:09:52.685	8703 Elalfy, Mohsen	05 Site Management
4460	82	1611634439658:368220957	1611634439003:1101399665	D5136C00008	433	432	CREATE	2021-01-26 05:13:59.742	07 Safety Reporting	07.03 General
4463	82	1611634441361:-2005279210	1611634440712:1089216046	D5136C00008	436	435	CREATE	2021-01-26 05:14:01.466	FRANCE	02 Central Trial Documents
4469	82	1611634444950:-1134884171	1611634444290:431288256	D5136C00008	442	441	CREATE	2021-01-26 05:14:05.036	02.02 Subject Documents	02.02.01 Subject Diary
4475	82	1611634448984:-1935325879	1611634441361:-2005279210	D5136C00008	448	436	CREATE	2021-01-26 05:14:09.069	02 Central Trial Documents	02.04 General
4479	82	1611634457566:1563134671	1611634454928:-1300482490	D5136C00008	452	451	CREATE	2021-01-26 05:14:17.652	03.01 Trial Approval	03.01.01 Submission
4481	82	1611634458931:-1045254387	1611634450752:-2100573888	D5136C00008	454	450	CREATE	2021-01-26 05:14:19.016	03 Regulatory	03.02 Investigational Medicinal Product
4487	82	1611634462813:-1965065625	1611634461654:1103613239	D5136C00008	460	458	CREATE	2021-01-26 05:14:22.899	03.04 General	03.04.01 Relevant Communications-Regulatory-Start-Up-Documents
4491	82	1611634465175:-1444351727	1611634463983:-788940127	D5136C00008	464	462	CREATE	2021-01-26 05:14:25.26	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
4498	82	1611634469557:1670582390	1611634469004:-762225158	D5136C00008	471	470	CREATE	2021-01-26 05:14:29.642	05 Site Management	05.05 General
8832	84	\N	\N	D5170C00002	2617	2616	NEW	\N	05 Site Management	05.01 Site Selection
4125	82	1611633640142:533683269	1611633637688:277410375	D5136C00008	98	94	CREATE	2021-01-26 05:00:40.233	05 Site Management	05.04 Site Management
4126	82	1611633640719:1096232644	1611633640142:533683269	D5136C00008	99	98	CREATE	2021-01-26 05:00:40.803	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
4129	82	1611633643252:1657204451	1611633640142:533683269	D5136C00008	102	98	CREATE	2021-01-26 05:00:43.339	05.04 Site Management	05.04.09 Inv Notification Safety Info-Dr-HCP Letter
4130	82	1611633643846:-744493045	1611633637688:277410375	D5136C00008	103	94	CREATE	2021-01-26 05:00:43.93	05 Site Management	05.05 General
4133	82	1611633645572:-233503501	rootNode	D5136C00008	106	0	CREATE	2021-01-26 05:00:45.66		06 IP and Trial Supplies
4135	82	1611633646740:643839762	1611633646157:9261859	D5136C00008	108	107	CREATE	2021-01-26 05:00:46.826	06.01 IP Documentation	06.01.01 IP Supply Plan
4136	82	1611633647360:961802843	1611633646157:9261859	D5136C00008	109	107	CREATE	2021-01-26 05:00:47.446	06.01 IP Documentation	06.01.03 IP Sample Label
4140	82	1611633649790:-155963697	1611633648608:497804235	D5136C00008	113	111	CREATE	2021-01-26 05:00:49.875	06.02 IP Release Process Documentation	06.02.02 IP Regulatory Release Documentation
4141	82	1611633650458:-1360077189	1611633648608:497804235	D5136C00008	114	111	CREATE	2021-01-26 05:00:50.544	06.02 IP Release Process Documentation	06.02.03 IP Verification Statements
4144	82	1611633652387:508628731	1611633651196:415787218	D5136C00008	117	115	CREATE	2021-01-26 05:00:52.473	06.03 IP Allocation Documentation	06.03.03 Treatment Decoding Documentation
4145	82	1611633652995:-1827193367	1611633645572:-233503501	D5136C00008	118	106	CREATE	2021-01-26 05:00:53.081	06 IP and Trial Supplies	06.05 Non-IP Documentation
4148	82	1611633654821:838670961	1611633645572:-233503501	D5136C00008	121	106	CREATE	2021-01-26 05:00:54.905	06 IP and Trial Supplies	06.06 Interactive Response Technology
4150	82	1611633656278:-458333012	1611633654821:838670961	D5136C00008	123	121	CREATE	2021-01-26 05:00:56.366	06.06 Interactive Response Technology	06.06.02 IRT Validation Certification
4151	82	1611633656880:-880425524	1611633654821:838670961	D5136C00008	124	121	CREATE	2021-01-26 05:00:56.966	06.06 Interactive Response Technology	06.06.04 IRT User Manual
4153	82	1611633657958:998844879	rootNode	D5136C00008	126	0	CREATE	2021-01-26 05:00:58.047		07 Safety Reporting
4155	82	1611633659111:-1480942062	1611633658524:-299226186	D5136C00008	128	127	CREATE	2021-01-26 05:00:59.201	07.01 Safety Documentation	07.01.01 Safety Management Plan
4157	82	1611633660341:-1708568699	1611633658524:-299226186	D5136C00008	130	127	CREATE	2021-01-26 05:01:00.427	07.01 Safety Documentation	07.01.02 Safety Reports
4159	82	1611633661662:-1626547428	1611633660969:-195266425	D5136C00008	132	131	CREATE	2021-01-26 05:01:01.75	07.02 Trial Status Reporting	07.02.01 Expedited Safety Report- IND
4161	82	1611633662976:348109392	1611633660969:-195266425	D5136C00008	134	131	CREATE	2021-01-26 05:01:03.067	07.02 Trial Status Reporting	07.02.02 SAE Report
4163	82	1611633664254:-141510675	1611633663572:-1484878071	D5136C00008	136	135	CREATE	2021-01-26 05:01:04.339	07.03 General	07.03.01 Re_-Safety-Email
4165	82	1611633665392:-181796983	1611633664828:971975340	D5136C00008	138	137	CREATE	2021-01-26 05:01:10.73	Alert Letter _l Notifications	2015
4167	82	1611633672102:690531197	1611633664828:971975340	D5136C00008	140	137	CREATE	2021-01-26 05:01:12.278	Alert Letter _l Notifications	2017
4169	82	1611633673352:453120145	1611633672775:-1766462952	D5136C00008	142	141	CREATE	2021-01-26 05:01:13.438	CIOMS	2016
4172	82	1611633676160:-665289861	1611633675544:-832317854	D5136C00008	145	144	CREATE	2021-01-26 05:01:16.248	eDC triggers and SAE reports	Apr_2016
4178	82	1611633679862:-1746920729	1611633675544:-832317854	D5136C00008	151	144	CREATE	2021-01-26 05:01:19.959	eDC triggers and SAE reports	Jun_2016
4179	82	1611633680531:-1578986245	1611633675544:-832317854	D5136C00008	152	144	CREATE	2021-01-26 05:01:20.622	eDC triggers and SAE reports	June2017
4182	82	1611633682718:389066492	1611633675544:-832317854	D5136C00008	155	144	CREATE	2021-01-26 05:01:22.804	eDC triggers and SAE reports	May2017
4184	82	1611633683940:-955711364	1611633675544:-832317854	D5136C00008	157	144	CREATE	2021-01-26 05:01:24.026	eDC triggers and SAE reports	Oct2016
4187	82	1611633686238:-591261556	1611633664254:-141510675	D5136C00008	160	136	CREATE	2021-01-26 05:01:26.326	07.03.01 Re_-Safety-Email	ISL
4188	82	1611633686834:1164951548	1611633686238:-591261556	D5136C00008	161	160	CREATE	2021-01-26 05:01:26.919	ISL	2015
4192	82	1611633711829:-813954584	1611633664254:-141510675	D5136C00008	165	136	CREATE	2021-01-26 05:01:51.917	07.03.01 Re_-Safety-Email	Start up correspondences
4195	82	1611633722038:-1246414353	1611633663572:-1484878071	D5136C00008	168	135	CREATE	2021-01-26 05:02:02.125	07.03 General	07.03.03 Safety-Sponsor Meeting Material
4196	82	1611633722508:2120471788	rootNode	D5136C00008	169	0	CREATE	2021-01-26 05:02:08.558		08 Centralized Testing
4199	82	1611633730364:1225538960	1611633722508:2120471788	D5136C00008	172	169	CREATE	2021-01-26 05:02:10.449	08 Centralized Testing	08.02 Sample Documentation
4201	82	1611633731495:-1800430298	rootNode	D5136C00008	174	0	CREATE	2021-01-26 05:02:11.581		09 Third Party
4204	82	1611633733410:-1902785211	1611633732144:1841950717	D5136C00008	177	175	CREATE	2021-01-26 05:02:13.502	09.01 Third Party Oversight	09.01.01 Third Party Personnel
4205	82	1611633733990:-600357563	1611633731495:-1800430298	D5136C00008	178	174	CREATE	2021-01-26 05:02:14.076	09 Third Party	09.02 Third Party Set-up
4227	82	1611633765493:1478053704	1611633764295:1628439698	D5136C00008	200	198	CREATE	2021-01-26 05:02:45.58	10.04 EDC Management	10.04.03 Validation Documents
4229	82	1611633767189:-865702652	1611633766605:581871995	D5136C00008	202	201	CREATE	2021-01-26 05:02:47.275	10.05 General	10.05.01 Relevant Com_s-Data Management-Email
4232	82	1611633770606:-736878236	rootNode	D5136C00008	205	0	CREATE	2021-01-26 05:02:50.692		11 Statistics
4233	82	1611633771235:-2048636475	1611633770606:-736878236	D5136C00008	206	205	CREATE	2021-01-26 05:02:51.32	11 Statistics	11.01 Statistics Oversight
4235	82	1611633772440:2094256862	1611633770606:-736878236	D5136C00008	208	205	CREATE	2021-01-26 05:02:52.526	11 Statistics	11.02 Randomization
4238	82	1611633774147:-1122726286	1611633770606:-736878236	D5136C00008	211	205	CREATE	2021-01-26 05:02:54.232	11 Statistics	11.03 Analysis
4239	82	1611633774736:758149498	1611633774147:-1122726286	D5136C00008	212	211	CREATE	2021-01-26 05:02:54.819	11.03 Analysis	11.03.02 Analysis QC Documentation
4242	82	1611633776541:790958636	1611633775952:1880085546	D5136C00008	215	214	CREATE	2021-01-26 05:02:56.626	11.05 General	11.05.01 Relevant Com_ons-Biostatistics-Email
4428	82	1611634197768:124284249	1611634196456:926911165	D5136C00008	401	400	CREATE	2021-01-26 05:09:57.853	05.02 Site Se_p Documentation	05.02.01 Acceptance of Investigator Brochure
5929	83	1611641838009:-875749304	1611641833440:-27058349	D5136C00008	882	874	CREATE	2021-01-26 07:17:18.095	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
5932	83	1611641839742:-1676306653	1611641833440:-27058349	D5136C00008	885	874	CREATE	2021-01-26 07:17:19.827	05.02 Site Se_p Documentation	05.02.18 Site Signature Sheet
4209	82	1611633737995:96987237	1611633731495:-1800430298	D5136C00008	182	174	CREATE	2021-01-26 05:02:18.089	09 Third Party	09.03 General
4211	82	1611633739130:1114499820	rootNode	D5136C00008	184	0	CREATE	2021-01-26 05:02:19.223		10 Data Management
4214	82	1611633740845:-1237235519	1611633739130:1114499820	D5136C00008	187	184	CREATE	2021-01-26 05:02:20.932	10 Data Management	10.02 Data Capture
4216	82	1611633742071:-45166859	1611633740845:-1237235519	D5136C00008	189	187	CREATE	2021-01-26 05:02:22.161	10.02 Data Capture	10.02.02 Annotated CRF (Paper and EDC)
4218	82	1611633743229:905776812	1611633742648:5105622	D5136C00008	191	190	CREATE	2021-01-26 05:02:23.32	10.03 Database	10.03.02 Edit Check Plan (Paper)
4219	82	1611633743807:1676093351	1611633742648:5105622	D5136C00008	192	190	CREATE	2021-01-26 05:02:23.889	10.03 Database	10.03.06 External Dat_RF Data (Paper and EDC)
4222	82	1611633762209:1744467094	1611633742648:5105622	D5136C00008	195	190	CREATE	2021-01-26 05:02:42.297	10.03 Database	10.03.09 Dictionary Coding (Paper and EDC)
4224	82	1611633763716:-1626823127	1611633742648:5105622	D5136C00008	197	190	CREATE	2021-01-26 05:02:43.815	10.03 Database	10.03.12 Database Change Control (Paper and EDC)
4244	82	1611633777615:781225629	rootNode	D5136C00008	217	0	CREATE	2021-01-26 05:02:57.701		EGYPT
4245	82	1611633778165:-1580788740	1611633777615:781225629	D5136C00008	218	217	CREATE	2021-01-26 05:02:58.25	EGYPT	02 Central Trial Documents
4248	82	1611633779970:-163085122	1611633778799:1307046762	D5136C00008	221	219	CREATE	2021-01-26 05:03:00.058	02.01 Trial Documents	02.01.04 Protocol Amendment
4250	82	1611633781086:10116526	1611633778165:-1580788740	D5136C00008	223	218	CREATE	2021-01-26 05:03:01.203	02 Central Trial Documents	02.02 Subject Documents
4251	82	1611633781677:1107726334	1611633781086:10116526	D5136C00008	224	223	CREATE	2021-01-26 05:03:01.762	02.02 Subject Documents	02.02.01 Subject Diary
4255	82	1611633784060:1691081231	1611633781086:10116526	D5136C00008	228	223	CREATE	2021-01-26 05:03:04.146	02.02 Subject Documents	02.02.05 Subject Participation Card
4256	82	1611633784706:-848911936	1611633781086:10116526	D5136C00008	229	223	CREATE	2021-01-26 05:03:04.793	02.02 Subject Documents	02.02.07 Other W_ Given to Subjects
4259	82	1611633786454:1596666284	1611633777615:781225629	D5136C00008	232	217	CREATE	2021-01-26 05:03:06.539	EGYPT	03 Regulatory
4260	82	1611633787164:1537812839	1611633786454:1596666284	D5136C00008	233	232	CREATE	2021-01-26 05:03:07.251	03 Regulatory	03.01 Trial Approval
4263	82	1611633789385:-545457047	1611633786454:1596666284	D5136C00008	236	232	CREATE	2021-01-26 05:03:09.473	03 Regulatory	03.03 Trial Status Reporting
4265	82	1611633790664:1607093209	1611633789385:-545457047	D5136C00008	238	236	CREATE	2021-01-26 05:03:10.749	03.03 Trial Status Reporting	03.03.02 Progress Report
4267	82	1611633791852:-1171837222	1611633786454:1596666284	D5136C00008	240	232	CREATE	2021-01-26 05:03:11.938	03 Regulatory	03.04 General
4269	82	1611633793297:-607882380	1611633777615:781225629	D5136C00008	242	217	CREATE	2021-01-26 05:03:13.384	EGYPT	04 IRB-IEC and other Approvals
4272	82	1611633795076:1736592188	1611633777615:781225629	D5136C00008	245	217	CREATE	2021-01-26 05:03:15.162	EGYPT	05 Site Management
4273	82	1611633797584:1332085920	1611633795076:1736592188	D5136C00008	246	245	CREATE	2021-01-26 05:03:17.67	05 Site Management	05.03 Site Initiation
4275	82	1611633798892:867900015	1611633795076:1736592188	D5136C00008	248	245	CREATE	2021-01-26 05:03:18.977	05 Site Management	05.05 General
4277	82	1611633800166:-2100925708	1611633777615:781225629	D5136C00008	250	217	CREATE	2021-01-26 05:03:20.354	EGYPT	06 IP and Trial Supplies
4279	82	1611633801486:-1971309060	1611633800825:440133804	D5136C00008	252	251	CREATE	2021-01-26 05:03:21.582	06.01 IP Documentation	06.01.03 IP Sample Label
4280	82	1611633802093:1326305442	1611633777615:781225629	D5136C00008	253	217	CREATE	2021-01-26 05:03:22.187	EGYPT	09 Third Party
4283	82	1611633804708:-988231060	1611633802093:1326305442	D5136C00008	256	253	CREATE	2021-01-26 05:03:24.792	09 Third Party	09.03 General
4285	82	1611633806365:-771701492	1611633777615:781225629	D5136C00008	258	217	CREATE	2021-01-26 05:03:26.452	EGYPT	8701 El-Beshlawy, Amal
4288	82	1611633808134:1819506972	1611633807547:-1084872664	D5136C00008	261	260	CREATE	2021-01-26 05:03:28.227	02.02 Subject Documents	02.02.03 Info_ Form Templates
4289	82	1611633808779:580826336	1611633806925:1928517045	D5136C00008	262	259	CREATE	2021-01-26 05:03:28.868	02 Central Trial Documents	02.04 General
4292	82	1611633810537:-1383609946	1611633809960:-1263396366	D5136C00008	265	264	CREATE	2021-01-26 05:03:30.623	03 Regulatory	03.02 Investigational Medicinal Product
4295	82	1611633812326:492437771	1611633811744:832936093	D5136C00008	268	267	CREATE	2021-01-26 05:03:32.412	04 IRB-IEC an_other Approvals	04.01 IRB-IEC Trial Approval
4297	82	1611633813443:1527080228	1611633812326:492437771	D5136C00008	270	268	CREATE	2021-01-26 05:03:33.53	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
4298	82	1611633814005:3247970	1611633811744:832936093	D5136C00008	271	267	CREATE	2021-01-26 05:03:34.09	04 IRB-IEC an_other Approvals	04.02 Other Committees
4301	82	1611633815821:-1376804097	1611633815247:2028128151	D5136C00008	274	273	CREATE	2021-01-26 05:03:35.906	04.03 Trial Status Reporting	04.03.01 IRB-_ Info-Deviation
4303	82	1611633817040:1626396621	1611633815247:2028128151	D5136C00008	276	273	CREATE	2021-01-26 05:03:37.126	04.03 Trial Status Reporting	04.03.03 IRB-_rm Notification
4305	82	1611633818303:-165652764	1611633817724:-1563013837	D5136C00008	278	277	CREATE	2021-01-26 05:03:38.389	05 Site Management	05.01 Site Selection
4307	82	1611633819477:-184009777	1611633818303:-165652764	D5136C00008	280	278	CREATE	2021-01-26 05:03:39.561	05.01 Site Selection	05.01.03 Feasibility Documentation
4312	82	1611633822769:883910268	1611633820621:-329722076	D5136C00008	285	282	CREATE	2021-01-26 05:03:42.856	05.02 Site Se_p Documentation	05.02.04 PI C_ite Affiliation
4313	82	1611633823534:-1658880379	1611633820621:-329722076	D5136C00008	286	282	CREATE	2021-01-26 05:03:43.621	05.02 Site Se_p Documentation	05.02.06 Othe_ite Affiliation
4316	82	1611633825340:-933625209	1611633820621:-329722076	D5136C00008	289	282	CREATE	2021-01-26 05:03:45.429	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
4318	82	1611633826486:81485068	1611633820621:-329722076	D5136C00008	291	282	CREATE	2021-01-26 05:03:46.57	05.02 Site Se_p Documentation	05.02.17 IP Site Release Documentation
4321	82	1611633828306:-736600541	1611633827665:94376258	D5136C00008	294	293	CREATE	2021-01-26 05:03:48.397	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
4324	82	1611633829983:-878982745	1611633817724:-1563013837	D5136C00008	297	277	CREATE	2021-01-26 05:03:50.067	05 Site Management	05.04 Site Management
4326	82	1611633831275:810647826	1611633829983:-878982745	D5136C00008	299	297	CREATE	2021-01-26 05:03:51.361	05.04 Site Management	05.04.03 Monitoring Visit Report
4328	82	1611633846949:-327952742	1611633829983:-878982745	D5136C00008	301	297	CREATE	2021-01-26 05:04:07.036	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
4331	82	1611633848773:-327699751	1611633848209:-519182249	D5136C00008	304	303	CREATE	2021-01-26 05:04:08.858	05.05 General	05.05.02 Tracking Information
4332	82	1611633849391:1288644580	1611633806365:-771701492	D5136C00008	305	258	CREATE	2021-01-26 05:04:09.485	8701 El-Beshlawy, Amal	06 IP and Trial Supplies
4335	82	1611633922405:1533857039	1611633849968:-1663068523	D5136C00008	308	306	CREATE	2021-01-26 05:05:22.493	06.01 IP Documentation	06.01.11 Certificate of Destruction
4337	82	1611633923845:-1492807977	1611633923041:-422931646	D5136C00008	310	309	CREATE	2021-01-26 05:05:23.928	06.04 Storage	06.04.01 Storage Condition Documentation
4340	82	1611633930000:18058814	1611633929220:-1664536893	D5136C00008	313	312	CREATE	2021-01-26 05:05:30.187	06.05 Non-IP Documentation	06.05.02 Non-_ion of Shipment
4341	82	1611633930646:-2090684386	1611633806365:-771701492	D5136C00008	314	258	CREATE	2021-01-26 05:05:30.737	8701 El-Beshlawy, Amal	07 Safety Reporting
4344	82	1611633932431:-1439428462	1611633930646:-2090684386	D5136C00008	317	314	CREATE	2021-01-26 05:05:32.689	07 Safety Reporting	07.03 General
4347	82	1611633934352:-1164023789	1611633777615:781225629	D5136C00008	320	217	CREATE	2021-01-26 05:05:34.44	EGYPT	8702 Hassab, Hoda
4349	82	1611633935606:-178568786	1611633935025:-1078345831	D5136C00008	322	321	CREATE	2021-01-26 05:05:35.703	02 Central Trial Documents	02.04 General
4350	82	1611633936175:-1581696052	1611633935606:-178568786	D5136C00008	323	322	CREATE	2021-01-26 05:05:36.26	02.04 General	02.04.01 Rele_-Contact Report
4353	82	1611633938070:-1793682584	1611633937492:142556404	D5136C00008	326	325	CREATE	2021-01-26 05:05:38.157	03.01 Trial Approval	03.01.02 Approval
4357	82	1611633940517:579258907	1611633939803:2121051122	D5136C00008	330	329	CREATE	2021-01-26 05:05:40.603	04 IRB-IEC an_other Approvals	04.01 IRB-IEC Trial Approval
4358	82	1611633941099:-1940562857	1611633940517:579258907	D5136C00008	331	330	CREATE	2021-01-26 05:05:41.185	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
4360	82	1611633942248:-661719985	1611633939803:2121051122	D5136C00008	333	329	CREATE	2021-01-26 05:05:42.339	04 IRB-IEC an_other Approvals	04.03 Trial Status Reporting
4363	82	1611633944057:-1243477222	1611633942248:-661719985	D5136C00008	336	333	CREATE	2021-01-26 05:05:44.141	04.03 Trial Status Reporting	04.03.03 IRB-_rm Notification
4364	82	1611633944643:2119267773	1611633934352:-1164023789	D5136C00008	337	320	CREATE	2021-01-26 05:05:44.726	8702 Hassab, Hoda	05 Site Management
4367	82	1611633946576:1178034829	1611633945189:-242716665	D5136C00008	340	338	CREATE	2021-01-26 05:05:46.668	05.01 Site Selection	05.01.03 Feasibility Documentation
4369	82	1611633947798:1228093005	1611633944643:2119267773	D5136C00008	342	337	CREATE	2021-01-26 05:05:47.882	05 Site Management	05.02 Site Se_p Documentation
4372	82	1611633949642:1451139975	1611633947798:1228093005	D5136C00008	345	342	CREATE	2021-01-26 05:05:49.728	05.02 Site Se_p Documentation	05.02.04 PI CV-Site Affiliation
4373	82	1611633950307:1025476989	1611633947798:1228093005	D5136C00008	346	342	CREATE	2021-01-26 05:05:50.396	05.02 Site Se_p Documentation	05.02.06 Other CV-Site Affiliation
4375	82	1611633951417:-963385287	1611633947798:1228093005	D5136C00008	348	342	CREATE	2021-01-26 05:05:51.502	05.02 Site Se_p Documentation	05.02.08 Form FDA1572
4379	82	1611633953874:2102723899	1611633947798:1228093005	D5136C00008	352	342	CREATE	2021-01-26 05:05:53.958	05.02 Site Se_p Documentation	05.02.18 Site Signature Sheet
4380	82	1611633954423:-568374818	1611633944643:2119267773	D5136C00008	353	337	CREATE	2021-01-26 05:05:54.508	05 Site Management	05.03 Site Initiation
4383	82	1611633956259:-490160207	1611633954423:-568374818	D5136C00008	356	353	CREATE	2021-01-26 05:05:56.345	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
4384	82	1611633956904:-1275822697	1611633944643:2119267773	D5136C00008	357	337	CREATE	2021-01-26 05:05:56.989	05 Site Management	05.04 Site Management
4387	82	1611633958685:-719169346	1611633956904:-1275822697	D5136C00008	360	357	CREATE	2021-01-26 05:05:58.769	05.04 Site Management	05.04.04 Visit Log
4389	82	1611633959866:1765242340	1611633956904:-1275822697	D5136C00008	362	357	CREATE	2021-01-26 05:05:59.95	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
4390	82	1611633960447:308934675	1611633956904:-1275822697	D5136C00008	363	357	CREATE	2021-01-26 05:06:00.531	05.04 Site Management	05.04.09 Inv Notification-SUSAR
4393	82	1611633962210:90314155	1611633934352:-1164023789	D5136C00008	366	320	CREATE	2021-01-26 05:06:02.296	8702 Hassab, Hoda	06 IP and Trial Supplies
4396	82	1611634107005:356756910	1611634014925:-1152458415	D5136C00008	369	367	CREATE	2021-01-26 05:08:27.096	06.01 IP Documentation	06.01.11 Certificate of Destruction
4398	82	1611634108270:-403822725	1611634107687:87646635	D5136C00008	371	370	CREATE	2021-01-26 05:08:28.356	06.04 Storage	06.04.01 Storage Condition Documentation
4399	82	1611634108900:886163943	1611633934352:-1164023789	D5136C00008	372	320	CREATE	2021-01-26 05:08:28.987	8702 Hassab, Hoda	07 Safety Reporting
4402	82	1611634110714:1790241918	1611634108900:886163943	D5136C00008	375	372	CREATE	2021-01-26 05:08:30.798	07 Safety Reporting	07.03 General
4404	82	1611634111846:-90530030	1611633777615:781225629	D5136C00008	377	217	CREATE	2021-01-26 05:08:31.93	EGYPT	8703 Elalfy, Mohsen
4407	82	1611634113887:1589039805	1611634113141:1265678167	D5136C00008	380	379	CREATE	2021-01-26 05:08:33.972	02.02 Subject Documents	02.02.03 Info_ Form Templates
4408	82	1611634114474:-263039945	1611634113141:1265678167	D5136C00008	381	379	CREATE	2021-01-26 05:08:34.559	02.02 Subject Documents	02.02.03 Info_Form Checklists
4411	82	1611634116307:-175056378	1611634115684:996197201	D5136C00008	384	383	CREATE	2021-01-26 05:08:36.393	03 Regulatory	03.04 General
4508	82	1611634529797:2109022025	1611634529164:-279737144	D5136C00008	481	480	CREATE	2021-01-26 05:15:29.884	03 Regulatory	03.04 General
4413	82	1611634117491:-7197510	1611634111846:-90530030	D5136C00008	386	377	CREATE	2021-01-26 05:08:37.578	8703 Elalfy, Mohsen	04 IRB-IEC an_other Approvals
4416	82	1611634129845:-859822911	1611634118116:-2128125074	D5136C00008	389	387	CREATE	2021-01-26 05:08:49.941	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
4417	82	1611634173088:357734550	1611634118116:-2128125074	D5136C00008	390	387	CREATE	2021-01-26 05:09:33.188	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
4420	82	1611634185774:-306815915	1611634176125:1365396096	D5136C00008	393	391	CREATE	2021-01-26 05:09:45.951	04.03 Trial Status Reporting	04.03.02 IRB-_Progress Report
8833	84	\N	\N	D5170C00002	2618	2617	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
4423	82	1611634193596:1676667652	1611634192599:696569121	D5136C00008	396	395	CREATE	2021-01-26 05:09:53.681	05 Site Management	05.01 Site Selection
4426	82	1611634195888:1124832879	1611634193596:1676667652	D5136C00008	399	396	CREATE	2021-01-26 05:09:55.973	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
4427	82	1611634196456:926911165	1611634192599:696569121	D5136C00008	400	395	CREATE	2021-01-26 05:09:56.54	05 Site Management	05.02 Site Se_p Documentation
4430	82	1611634199137:1062231978	1611634196456:926911165	D5136C00008	403	400	CREATE	2021-01-26 05:09:59.222	05.02 Site Se_p Documentation	05.02.04 PI CV-Site Affiliation
4432	82	1611634200425:1079787708	1611634196456:926911165	D5136C00008	405	400	CREATE	2021-01-26 05:10:00.513	05.02 Site Se_p Documentation	05.02.07 Staff Qualification
4433	82	1611634201088:1531680142	1611634196456:926911165	D5136C00008	406	400	CREATE	2021-01-26 05:10:01.183	05.02 Site Se_p Documentation	05.02.08 Form FDA1572
4436	82	1611634203222:166020079	1611634196456:926911165	D5136C00008	409	400	CREATE	2021-01-26 05:10:03.311	05.02 Site Se_p Documentation	05.02.17 IP Site Release Documentation
4437	82	1611634203865:1008435666	1611634196456:926911165	D5136C00008	410	400	CREATE	2021-01-26 05:10:03.952	05.02 Site Se_p Documentation	05.02.18 Site Signature Sheet
4440	82	1611634346830:6148712	1611634204475:911338816	D5136C00008	413	411	CREATE	2021-01-26 05:12:26.916	05.03 Site Initiation	05.03.03 Site Training-Staff
4443	82	1611634350004:-1894237923	1611634348852:377671714	D5136C00008	416	415	CREATE	2021-01-26 05:12:30.098	05.04 Site Management	05.04.01 Subject Log
4444	82	1611634350570:-2143757248	1611634348852:377671714	D5136C00008	417	415	CREATE	2021-01-26 05:12:31.253	05.04 Site Management	05.04.03 Monitoring Visit Report
4447	82	1611634421390:124701300	1611634348852:377671714	D5136C00008	420	415	CREATE	2021-01-26 05:13:41.481	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
4449	82	1611634426435:422845313	1611634348852:377671714	D5136C00008	422	415	CREATE	2021-01-26 05:13:46.523	05.04 Site Management	05.04.09 Inv Notification-SUSAR
4452	82	1611634428213:-1332416324	1611634111846:-90530030	D5136C00008	425	377	CREATE	2021-01-26 05:13:48.298	8703 Elalfy, Mohsen	06 IP and Trial Supplies
4453	82	1611634428789:1055488528	1611634428213:-1332416324	D5136C00008	426	425	CREATE	2021-01-26 05:13:48.904	06 IP and Trial Supplies	06.01 IP Documentation
4456	82	1611634437033:926668156	1611634428213:-1332416324	D5136C00008	429	425	CREATE	2021-01-26 05:13:57.119	06 IP and Trial Supplies	06.04 Storage
4458	82	1611634438182:509528601	1611634437033:926668156	D5136C00008	431	429	CREATE	2021-01-26 05:13:58.27	06.04 Storage	06.04.03 Maintenance Logs
4461	82	1611634440242:-1679676415	1611634439658:368220957	D5136C00008	434	433	CREATE	2021-01-26 05:14:00.333	07.03 General	07.03.01 Relevant Communications-Safety-Documents
4462	82	1611634440712:1089216046	rootNode	D5136C00008	435	0	CREATE	2021-01-26 05:14:00.805		FRANCE
4465	82	1611634442552:-423477411	1611634441949:-346193256	D5136C00008	438	437	CREATE	2021-01-26 05:14:02.653	02.01 Trial Documents	02.01.03 Protocol Synopsis
4467	82	1611634443709:1943696736	1611634441949:-346193256	D5136C00008	440	437	CREATE	2021-01-26 05:14:03.801	02.01 Trial Documents	02.01.06 Insurance
4470	82	1611634445547:-1978885536	1611634444290:431288256	D5136C00008	443	441	CREATE	2021-01-26 05:14:05.634	02.02 Subject Documents	02.02.03 Informe_ent Form Templates
4471	82	1611634446405:1580397389	1611634444290:431288256	D5136C00008	444	441	CREATE	2021-01-26 05:14:06.505	02.02 Subject Documents	02.02.03 Informed Consent Form Checklists
4474	82	1611634448302:8268383	1611634444290:431288256	D5136C00008	447	441	CREATE	2021-01-26 05:14:08.392	02.02 Subject Documents	02.02.07 Other W_ Given to Subjects
4476	82	1611634449595:452513851	1611634448984:-1935325879	D5136C00008	449	448	CREATE	2021-01-26 05:14:09.681	02.04 General	02.04.02 Tracking Information
4477	82	1611634450752:-2100573888	1611634440712:1089216046	D5136C00008	450	435	CREATE	2021-01-26 05:14:10.837	FRANCE	03 Regulatory
4480	82	1611634458225:-401802820	1611634454928:-1300482490	D5136C00008	453	451	CREATE	2021-01-26 05:14:18.31	03.01 Trial Approval	03.01.02 Approval
4483	82	1611634460502:-2125430507	1611634450752:-2100573888	D5136C00008	456	450	CREATE	2021-01-26 05:14:20.588	03 Regulatory	03.03 Trial Status Reporting
4485	82	1611634461654:1103613239	1611634450752:-2100573888	D5136C00008	458	450	CREATE	2021-01-26 05:14:21.739	03 Regulatory	03.04 General
4486	82	1611634462229:-1323401318	1611634461654:1103613239	D5136C00008	459	458	CREATE	2021-01-26 05:14:22.32	03.04 General	03.04.01 Relevan_ory-Start-Up-Email
4489	82	1611634463983:-788940127	1611634463398:1627789727	D5136C00008	462	461	CREATE	2021-01-26 05:14:24.072	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
4490	82	1611634464536:2017740061	1611634463983:-788940127	D5136C00008	463	462	CREATE	2021-01-26 05:14:24.62	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
4493	82	1611634466529:-1543998616	1611634463398:1627789727	D5136C00008	466	461	CREATE	2021-01-26 05:14:26.615	04 IRB-IEC and other Approvals	04.02 Other Committees
4495	82	1611634467861:-891226557	1611634463398:1627789727	D5136C00008	468	461	CREATE	2021-01-26 05:14:27.945	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
4497	82	1611634469004:-762225158	1611634440712:1089216046	D5136C00008	470	435	CREATE	2021-01-26 05:14:29.092	FRANCE	05 Site Management
4499	82	1611634470128:-528422348	1611634469557:1670582390	D5136C00008	472	471	CREATE	2021-01-26 05:14:30.214	05.05 General	05.05.02 Tracking Information
4500	82	1611634470778:-409900022	1611634440712:1089216046	D5136C00008	473	435	CREATE	2021-01-26 05:14:30.863	FRANCE	09 Third Party
4503	82	1611634492548:315441297	1611634440712:1089216046	D5136C00008	476	435	CREATE	2021-01-26 05:14:52.634	FRANCE	2301 Arlet, Jean-Benoit
4505	82	1611634493847:1488478382	1611634493237:-1559775724	D5136C00008	478	477	CREATE	2021-01-26 05:14:53.933	02 Central Trial Documents	02.04 General
11641	86	\N	\N	D5170C00002	92	79	NEW	\N	2001702 Abdul-Baki, Heitham	05 Site Management
4511	82	1611634598697:-1484073697	1611634530994:1521384230	D5136C00008	484	483	CREATE	2021-01-26 05:16:45.649	05 Site Management	05.01 Site Selection
4514	82	1611634607506:-218365136	1611634606822:426374829	D5136C00008	487	486	CREATE	2021-01-26 05:16:47.59	05.02 Site Se_p Documentation	05.02.01 Acce_igator Brochure
4515	82	1611634608082:-1700630307	1611634606822:426374829	D5136C00008	488	486	CREATE	2021-01-26 05:16:48.166	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
4518	82	1611634633177:259458000	1611634606822:426374829	D5136C00008	491	486	CREATE	2021-01-26 05:17:13.267	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
4520	82	1611634634453:1468344425	1611634606822:426374829	D5136C00008	493	486	CREATE	2021-01-26 05:17:14.547	05.02 Site Se_p Documentation	05.02.17 IP S_e Documentation
5936	83	1611641842038:-810938883	1611641840311:397050594	D5136C00008	889	886	CREATE	2021-01-26 07:17:22.13	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
4524	82	1611634636960:-914777950	1611634635807:1113031843	D5136C00008	497	495	CREATE	2021-01-26 05:17:17.047	05.03 Site Initiation	05.03.03 Site Training-Staff
4525	82	1611634637520:-2042577961	1611634635807:1113031843	D5136C00008	498	495	CREATE	2021-01-26 05:17:17.605	05.03 Site Initiation	05.03.03 Site_umentation-Site
4528	82	1611634640400:1452606394	1611634638391:-562556523	D5136C00008	501	499	CREATE	2021-01-26 05:17:20.486	05.04 Site Management	05.04.03 Monitoring Visit Report
4531	82	1611634642071:-1840711619	1611634530994:1521384230	D5136C00008	504	483	CREATE	2021-01-26 05:17:22.256	05 Site Management	05.05 General
4533	82	1611634643297:-1755851796	1611634642071:-1840711619	D5136C00008	506	504	CREATE	2021-01-26 05:17:23.382	05.05 General	05.05.02 Tracking Information
4534	82	1611634688119:-944099807	1611634492548:315441297	D5136C00008	507	476	CREATE	2021-01-26 05:18:08.221	2301 Arlet, Jean-Benoit	06 IP and Trial Supplies
4537	82	1611634689979:1742118876	1611634688731:633531067	D5136C00008	510	508	CREATE	2021-01-26 05:18:10.065	06.01 IP Documentation	06.01.11 Cert_ of Destruction
4539	82	1611634691276:-846889462	1611634690687:1220915020	D5136C00008	512	511	CREATE	2021-01-26 05:18:11.363	06.05 Non-IP Documentation	06.05.03 Non-_ation of Return
4540	82	1611634691844:1926225383	1611634492548:315441297	D5136C00008	513	476	CREATE	2021-01-26 05:18:11.93	2301 Arlet, Jean-Benoit	07 Safety Reporting
4543	82	1611634693647:1967015484	1611634440712:1089216046	D5136C00008	516	435	CREATE	2021-01-26 05:18:13.731	FRANCE	2302 Ame, Shanti
4544	82	1611634694194:1013062304	1611634693647:1967015484	D5136C00008	517	516	CREATE	2021-01-26 05:18:14.28	2302 Ame, Shanti	03 Regulatory
4548	82	1611634696561:1457065808	1611634695998:157193192	D5136C00008	521	520	CREATE	2021-01-26 05:18:16.65	05 Site Management	05.01 Site Selection
4550	82	1611634697783:-2069299963	1611634695998:157193192	D5136C00008	523	520	CREATE	2021-01-26 05:18:17.869	05 Site Management	05.02 Site Se_p Documentation
4552	82	1611634699014:-1037630220	1611634697783:-2069299963	D5136C00008	525	523	CREATE	2021-01-26 05:18:19.102	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
4554	82	1611634700153:692849250	1611634697783:-2069299963	D5136C00008	527	523	CREATE	2021-01-26 05:18:20.239	05.02 Site Se_p Documentation	05.02.06 Othe_ite Affiliation
4557	82	1611634702036:1232135083	1611634697783:-2069299963	D5136C00008	530	523	CREATE	2021-01-26 05:18:22.125	05.02 Site Se_p Documentation	05.02.17 IP Site Release Documentation
4558	82	1611634702590:-3118041	1611634697783:-2069299963	D5136C00008	531	523	CREATE	2021-01-26 05:18:22.69	05.02 Site Se_p Documentation	05.02.18 Site Signature Sheet
4561	82	1611634704428:807466955	1611634703159:-943014702	D5136C00008	534	532	CREATE	2021-01-26 05:18:24.514	05.03 Site Initiation	05.03.03 Site Training-Staff
4563	82	1611634705558:38419245	1611634695998:157193192	D5136C00008	536	520	CREATE	2021-01-26 05:18:25.644	05 Site Management	05.04 Site Management
4564	82	1611634706124:1794615785	1611634705558:38419245	D5136C00008	537	536	CREATE	2021-01-26 05:18:26.209	05.04 Site Management	05.04.01 Subject Log
4567	82	1611634707978:-179456508	1611634705558:38419245	D5136C00008	540	536	CREATE	2021-01-26 05:18:28.064	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
4569	82	1611634709194:-1819121280	1611634695998:157193192	D5136C00008	542	520	CREATE	2021-01-26 05:18:29.281	05 Site Management	05.05 General
4571	82	1611634710363:756650136	1611634709194:-1819121280	D5136C00008	544	542	CREATE	2021-01-26 05:18:30.803	05.05 General	05.05.01 Relevant Communications-Documents
4573	82	1611634711956:-1289255951	1611634693647:1967015484	D5136C00008	546	516	CREATE	2021-01-26 05:18:32.04	2302 Ame, Shanti	06 IP and Trial Supplies
4577	82	1611634714957:1593473656	1611634711956:-1289255951	D5136C00008	550	546	CREATE	2021-01-26 05:18:35.045	06 IP and Trial Supplies	06.04 Storage
4578	82	1611634715517:954053728	1611634714957:1593473656	D5136C00008	551	550	CREATE	2021-01-26 05:18:35.603	06.04 Storage	06.04.01 Storage Condition Documentation
4581	82	1611634717779:-613908733	1611634716714:-544577564	D5136C00008	554	553	CREATE	2021-01-26 05:18:40.415	07.02 Trial Status Reporting	07.02.02 SAE Report
4583	82	1611634721761:421910909	1611634721197:-1154770586	D5136C00008	556	555	CREATE	2021-01-26 05:18:41.845	2303 Receveur_Marie Catherine	02 Central Trial Documents
4586	82	1611634723504:1701960098	1611634721197:-1154770586	D5136C00008	559	555	CREATE	2021-01-26 05:18:43.59	2303 Receveur_Marie Catherine	03 Regulatory
4587	82	1611634724087:-939038561	1611634723504:1701960098	D5136C00008	560	559	CREATE	2021-01-26 05:18:44.173	03 Regulatory	03.04 General
4590	82	1611634725759:124507613	1611634725215:1548299131	D5136C00008	563	562	CREATE	2021-01-26 05:18:45.843	05 Site Management	05.01 Site Selection
4592	82	1611634727016:-744888890	1611634725215:1548299131	D5136C00008	565	562	CREATE	2021-01-26 05:18:47.101	05 Site Management	05.02 Site Se_p Documentation
4595	82	1611634728771:-1971710668	1611634727016:-744888890	D5136C00008	568	565	CREATE	2021-01-26 05:18:48.854	05.02 Site Se_p Documentation	05.02.04 PI C_ite Affiliation
4596	82	1611634729326:1858071038	1611634727016:-744888890	D5136C00008	569	565	CREATE	2021-01-26 05:18:49.412	05.02 Site Se_p Documentation	05.02.06 Othe_ite Affiliation
4599	82	1611634731076:-735842316	1611634727016:-744888890	D5136C00008	572	565	CREATE	2021-01-26 05:18:51.159	05.02 Site Se_p Documentation	05.02.17 IP S_e Documentation
4601	82	1611634732181:1756846328	1611634725215:1548299131	D5136C00008	574	562	CREATE	2021-01-26 05:18:52.309	05 Site Management	05.03 Site Initiation
4602	82	1611634732788:-1093107546	1611634732181:1756846328	D5136C00008	575	574	CREATE	2021-01-26 05:18:52.873	05.03 Site Initiation	05.03.01 Tria_nitoring Report
4605	82	1611634734503:343784815	1611634725215:1548299131	D5136C00008	578	562	CREATE	2021-01-26 05:18:54.589	05 Site Management	05.04 Site Management
4606	82	1611634735082:1058819889	1611634734503:343784815	D5136C00008	579	578	CREATE	2021-01-26 05:18:55.167	05.04 Site Management	05.04.01 Subject Log
4609	82	1611634736764:-1617534812	1611634734503:343784815	D5136C00008	582	578	CREATE	2021-01-26 05:18:56.849	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
4611	82	1611634737938:1143287821	1611634725215:1548299131	D5136C00008	584	562	CREATE	2021-01-26 05:18:58.023	05 Site Management	05.05 General
4613	82	1611634741001:-449630016	1611634737938:1143287821	D5136C00008	586	584	CREATE	2021-01-26 05:19:01.086	05.05 General	05.05.02 Tracking Information
4615	82	1611634742128:-513081152	1611634741575:1037597435	D5136C00008	588	587	CREATE	2021-01-26 05:19:02.213	06 IP and Trial Supplies	06.01 IP Documentation
4618	82	1611634743935:-905510495	1611634741575:1037597435	D5136C00008	591	587	CREATE	2021-01-26 05:19:04.02	06 IP and Trial Supplies	06.04 Storage
4622	82	1611634746252:970022122	1611634745633:52604794	D5136C00008	595	594	CREATE	2021-01-26 05:19:06.338	07 Safety Reporting	07.02 Trial Status Reporting
4624	82	1611634747381:-580079449	1611634745633:52604794	D5136C00008	597	594	CREATE	2021-01-26 05:19:07.466	07 Safety Reporting	07.03 General
4625	82	1611634747949:-1730954007	1611634747381:-580079449	D5136C00008	598	597	CREATE	2021-01-26 05:19:08.033	07.03 General	07.03.01 Rele_ns-Safety-Email
4626	82	1611634748430:1715170	rootNode	D5136C00008	599	0	CREATE	2021-01-26 05:19:08.518		GHANA
4630	82	1611634751428:-1894267144	1611634750851:191243606	D5136C00008	603	602	CREATE	2021-01-26 05:19:11.514	05.01 Site Selection	05.01.02 Confidentiality Agreement
4632	82	1611634752450:778372697	rootNode	D5136C00008	605	0	CREATE	2021-01-26 05:19:12.539		ITALY
4634	82	1611634753942:-324936041	1611634753081:-774219405	D5136C00008	607	606	CREATE	2021-01-26 05:19:14.028	02 Central Trial Documents	02.01 Trial Documents
4637	82	1611634755694:-1361573377	1611634753942:-324936041	D5136C00008	610	607	CREATE	2021-01-26 05:19:15.778	02.01 Trial Documents	02.01.06 Insurance
4639	82	1611634756947:384384640	1611634756279:12800525	D5136C00008	612	611	CREATE	2021-01-26 05:19:17.032	02.02 Subject Documents	02.02.01 Subject Diary
4642	82	1611634758840:-147322381	1611634756279:12800525	D5136C00008	615	611	CREATE	2021-01-26 05:19:18.925	02.02 Subject Documents	02.02.03 Informed Consent Form Checklists
4644	82	1611634776428:1087919556	1611634756279:12800525	D5136C00008	617	611	CREATE	2021-01-26 05:19:36.523	02.02 Subject Documents	02.02.07 Other W_ Given to Subjects
4646	82	1611634778096:1469941249	1611634777066:1945503376	D5136C00008	619	618	CREATE	2021-01-26 05:19:38.182	02.04 General	02.04.02 Tracking Information
4649	82	1611634779797:484913829	1611634779223:478497030	D5136C00008	622	621	CREATE	2021-01-26 05:19:39.89	03.01 Trial Approval	03.01.01 Submission
4652	82	1611634781750:1751046153	1611634781032:-458661037	D5136C00008	625	624	CREATE	2021-01-26 05:19:41.836	03.03 Trial Status Reporting	03.03.02 Progress Report
4654	82	1611634782936:-1169326093	1611634752450:778372697	D5136C00008	627	605	CREATE	2021-01-26 05:19:43.02	ITALY	04 IRB-IEC and other Approvals
4656	82	1611634785957:147833915	1611634785355:1218985931	D5136C00008	629	628	CREATE	2021-01-26 05:19:46.039	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
4658	82	1611634787112:-802026463	1611634786551:-21112414	D5136C00008	631	630	CREATE	2021-01-26 05:19:47.196	04.03 Trial Status Reporting	04.03.02 IRB-IEC Progress Report
4660	82	1611634788327:29068483	1611634752450:778372697	D5136C00008	633	605	CREATE	2021-01-26 05:19:48.413	ITALY	05 Site Management
4662	82	1611634789470:1388289722	1611634788883:1521383636	D5136C00008	635	634	CREATE	2021-01-26 05:19:49.558	05.05 General	05.05.01 Relevan_on-Documents-Email
4664	82	1611634790707:1239281399	1611634790047:660277442	D5136C00008	637	636	CREATE	2021-01-26 05:19:50.793	06 IP and Trial Supplies	06.07 General
4667	82	1611634812168:-338813646	1611634752450:778372697	D5136C00008	640	605	CREATE	2021-01-26 05:20:12.253	ITALY	4101 Forni, Gianluca
4668	82	1611634812724:-385771096	1611634812168:-338813646	D5136C00008	641	640	CREATE	2021-01-26 05:20:12.809	4101 Forni, Gianluca	02 Central Trial Documents
4671	82	1611634815141:1181840104	1611634813341:-282849748	D5136C00008	644	642	CREATE	2021-01-26 05:20:15.228	02.02 Subject Documents	02.02.03 Info_Form Checklists
4673	82	1611634863909:-1009365273	1611634812724:-385771096	D5136C00008	646	641	CREATE	2021-01-26 05:21:03.995	02 Central Trial Documents	02.04 General
4676	82	1611634865724:-1060224433	1611634865168:-1597911788	D5136C00008	649	648	CREATE	2021-01-26 05:21:05.812	04 IRB-IEC an_other Approvals	04.01 IRB-IEC Trial Approval
4677	82	1611634866301:-1705645985	1611634865724:-1060224433	D5136C00008	650	649	CREATE	2021-01-26 05:21:06.387	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
4680	82	1611634868097:1920143435	1611634867477:-347630410	D5136C00008	653	652	CREATE	2021-01-26 05:21:08.182	04.03 Trial Status Reporting	04.03.02 IRB-_Progress Report
4682	82	1611634869278:-1918516378	1611634812168:-338813646	D5136C00008	655	640	CREATE	2021-01-26 05:21:09.366	4101 Forni, Gianluca	05 Site Management
4683	82	1611634869848:-234217722	1611634869278:-1918516378	D5136C00008	656	655	CREATE	2021-01-26 05:21:09.933	05 Site Management	05.01 Site Selection
4686	82	1611634871645:-707833359	1611634869848:-234217722	D5136C00008	659	656	CREATE	2021-01-26 05:21:11.732	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
4689	82	1611634889342:380199006	1611634872212:1236581339	D5136C00008	662	660	CREATE	2021-01-26 05:21:29.429	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
4691	82	1611634890561:-931782836	1611634872212:1236581339	D5136C00008	664	660	CREATE	2021-01-26 05:21:30.666	05.02 Site Se_p Documentation	05.02.04 PI CV-Site Affiliation
4692	82	1611634891142:1697877256	1611634872212:1236581339	D5136C00008	665	660	CREATE	2021-01-26 05:21:31.227	05.02 Site Se_p Documentation	05.02.06 Othe_ite Affiliation
4695	82	1611634892804:1831967570	1611634872212:1236581339	D5136C00008	668	660	CREATE	2021-01-26 05:21:32.889	05.02 Site Se_p Documentation	05.02.12 Clinical Trial Agreement
4696	82	1611634893423:-1411862289	1611634872212:1236581339	D5136C00008	669	660	CREATE	2021-01-26 05:21:33.517	05.02 Site Se_p Documentation	05.02.17 IP Site Release Documentation
4699	82	1611634919268:1216649019	1611634918669:-558783148	D5136C00008	672	671	CREATE	2021-01-26 05:21:59.604	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
4701	82	1611634920802:1097767223	1611634918669:-558783148	D5136C00008	674	671	CREATE	2021-01-26 05:22:00.887	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
4703	82	1611634921917:1713862508	1611634921359:-1265286826	D5136C00008	676	675	CREATE	2021-01-26 05:22:02.004	05.04 Site Management	05.04.01 Subject Log
4705	82	1611634923239:-1819751747	1611634921359:-1265286826	D5136C00008	678	675	CREATE	2021-01-26 05:22:38.014	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
4708	82	1611634968770:1686051175	1611634967661:-1172341655	D5136C00008	681	679	CREATE	2021-01-26 05:22:48.855	05.05 General	05.05.02 Tracking Information
4710	82	1611634969903:2071976112	1611634969322:932176620	D5136C00008	683	682	CREATE	2021-01-26 05:22:49.987	06 IP and Trial Supplies	06.01 IP Documentation
4713	82	1611634971688:1183508413	1611634969903:2071976112	D5136C00008	686	683	CREATE	2021-01-26 05:22:51.781	06.01 IP Documentation	06.01.10 IP Documentation Return
4714	82	1611634972255:-1913212382	1611634969322:932176620	D5136C00008	687	682	CREATE	2021-01-26 05:22:52.339	06 IP and Trial Supplies	06.04 Storage
4718	82	1611634974604:-63391416	1611634974057:-1519026273	D5136C00008	691	690	CREATE	2021-01-26 05:22:54.689	06.05 Non-IP Documentation	06.05.02 Non-_ion of Shipment
4719	82	1611634975301:-178024695	1611634974057:-1519026273	D5136C00008	692	690	CREATE	2021-01-26 05:22:55.387	06.05 Non-IP Documentation	06.05.03 Non-_ation of Return
5939	83	1611641843710:1784062680	1611641842622:130323689	D5136C00008	892	890	CREATE	2021-01-26 07:17:23.794	05.04 Site Management	05.04.03 Monitoring Visit Report
4722	82	1611634980918:-492476095	1611634812168:-338813646	D5136C00008	695	640	CREATE	2021-01-26 05:23:01.003	4101 Forni, Gianluca	07 Safety Reporting
4725	82	1611634982797:-1714513893	1611634812168:-338813646	D5136C00008	698	640	CREATE	2021-01-26 05:23:02.881	4101 Forni, Gianluca	08 Centralized Testing
4726	82	1611634989056:-1584236725	1611634982797:-1714513893	D5136C00008	699	698	CREATE	2021-01-26 05:23:09.142	08 Centralized Testing	08.01 Facility Documentation
4729	82	1611634991443:1965576573	1611634982797:-1714513893	D5136C00008	702	698	CREATE	2021-01-26 05:23:11.533	08 Centralized Testing	08.02 Sample Documentation
4731	82	1611634992685:1252850792	1611634752450:778372697	D5136C00008	704	605	CREATE	2021-01-26 05:23:12.773	ITALY	4102 De Franceschi, Lucia
4734	82	1611634994388:-794273823	1611634993832:1513901308	D5136C00008	707	706	CREATE	2021-01-26 05:23:14.473	02.02 Subject Documents	02.02.03 Info_ Form Templates
4735	82	1611634995037:-39217812	1611634993832:1513901308	D5136C00008	708	706	CREATE	2021-01-26 05:23:15.122	02.02 Subject Documents	02.02.03 Info_Form Checklists
4738	82	1611634996819:-416480738	1611634996260:-357027335	D5136C00008	711	710	CREATE	2021-01-26 05:23:16.905	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
4740	82	1611634998016:-1280203450	1611634995697:-92423588	D5136C00008	713	709	CREATE	2021-01-26 05:23:18.101	04 IRB-IEC an_other Approvals	04.03 Trial Status Reporting
4741	82	1611634998566:-1108566888	1611634998016:-1280203450	D5136C00008	714	713	CREATE	2021-01-26 05:23:18.65	04.03 Trial Status Reporting	04.03.02 IRB-_Progress Report
4744	82	1611635000232:601968163	1611634999665:-1342325353	D5136C00008	717	716	CREATE	2021-01-26 05:23:20.318	05 Site Management	05.01 Site Selection
4745	82	1611635000800:-484170315	1611635000232:601968163	D5136C00008	718	717	CREATE	2021-01-26 05:23:20.885	05.01 Site Selection	05.01.02 Confidentiality Agreement
4748	82	1611635002613:1633128368	1611634999665:-1342325353	D5136C00008	721	716	CREATE	2021-01-26 05:23:22.699	05 Site Management	05.02 Site Se_p Documentation
4750	82	1611635003740:-1936590196	1611635002613:1633128368	D5136C00008	723	721	CREATE	2021-01-26 05:23:23.825	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
4753	82	1611635005494:-352067230	1611635002613:1633128368	D5136C00008	726	721	CREATE	2021-01-26 05:23:25.579	05.02 Site Se_p Documentation	05.02.06 Othe_ite Affiliation
4754	82	1611635006063:-1330438382	1611635002613:1633128368	D5136C00008	727	721	CREATE	2021-01-26 05:23:26.151	05.02 Site Se_p Documentation	05.02.07 Staff Qualification
4757	82	1611635007976:1200812927	1611635002613:1633128368	D5136C00008	730	721	CREATE	2021-01-26 05:23:28.059	05.02 Site Se_p Documentation	05.02.17 IP S_e Documentation
4758	82	1611635008546:1408731392	1611635002613:1633128368	D5136C00008	731	721	CREATE	2021-01-26 05:23:28.631	05.02 Site Se_p Documentation	05.02.18 Site Signature Sheet
4761	82	1611635010338:-47499032	1611635009234:-1798112347	D5136C00008	734	732	CREATE	2021-01-26 05:23:30.422	05.03 Site Initiation	05.03.03 Site Training-Staff
4763	82	1611635012017:-551934266	1611634999665:-1342325353	D5136C00008	736	716	CREATE	2021-01-26 05:23:32.105	05 Site Management	05.04 Site Management
4764	82	1611635012584:552874050	1611635012017:-551934266	D5136C00008	737	736	CREATE	2021-01-26 05:23:32.667	05.04 Site Management	05.04.01 Subject Log
4767	82	1611635025502:-143261994	1611635012017:-551934266	D5136C00008	740	736	CREATE	2021-01-26 05:23:45.59	05.04 Site Management	05.04.08 Fina_nitoring Report
4768	82	1611635026080:-192123161	1611634999665:-1342325353	D5136C00008	741	716	CREATE	2021-01-26 05:23:46.164	05 Site Management	05.05 General
4772	82	1611635028412:1434357469	1611635027829:-1857302476	D5136C00008	745	744	CREATE	2021-01-26 05:23:48.5	06 IP and Trial Supplies	06.01 IP Documentation
4773	82	1611635028990:45272176	1611635028412:1434357469	D5136C00008	746	745	CREATE	2021-01-26 05:23:49.076	06.01 IP Documentation	06.01.04 IP S_t Documentation
4777	82	1611635032112:-1956908869	1611635031525:-208492443	D5136C00008	750	749	CREATE	2021-01-26 05:23:52.198	06.04 Storage	06.04.01 Stor_n Documentation
4779	82	1611635033309:502520415	1611635027829:-1857302476	D5136C00008	752	744	CREATE	2021-01-26 05:23:53.395	06 IP and Trial Supplies	06.05 Non-IP Documentation
4782	82	1611635035041:-1383776908	1611635034464:241946041	D5136C00008	755	754	CREATE	2021-01-26 05:23:55.128	06.07 General	06.07.01 Rele_l Product-Email
4783	82	1611635035684:-906183356	1611635034464:241946041	D5136C00008	756	754	CREATE	2021-01-26 05:23:55.768	06.07 General	06.07.01 Rele_oduct-Documents
4786	82	1611635037538:2086388217	1611635036973:1797479166	D5136C00008	759	758	CREATE	2021-01-26 05:23:57.624	07.02 Trial Status Reporting	07.02.02 SAE Report
4788	82	1611635038660:-1543296528	1611635038110:-1709568982	D5136C00008	761	760	CREATE	2021-01-26 05:23:58.744	07.03 General	07.03.01 Rele_afety-Documents
4791	82	1611635040435:-1481630305	1611635039857:230602554	D5136C00008	764	763	CREATE	2021-01-26 05:24:00.52	08 Centralized Testing	08.01 Facility Documentation
4792	82	1611635041112:1161712459	1611635040435:-1481630305	D5136C00008	765	764	CREATE	2021-01-26 05:24:01.199	08.01 Facility Documentation	08.01.01 Cert_r Accreditation
4795	82	1611635042855:165472658	1611635039857:230602554	D5136C00008	768	763	CREATE	2021-01-26 05:24:03.064	08 Centralized Testing	08.02 Sample Documentation
4797	82	1611635044087:-1271912187	1611635039857:230602554	D5136C00008	770	763	CREATE	2021-01-26 05:24:04.172	08 Centralized Testing	08.03 General
11642	86	\N	\N	D5170C00002	93	92	NEW	\N	05 Site Management	05.01 Site Selection
4799	82	1611635045240:488517972	1611634752450:778372697	D5136C00008	772	605	CREATE	2021-01-26 05:24:05.326	ITALY	4103 Maggio, Aurelio
4801	82	1611635046405:232440667	1611635045817:1319411003	D5136C00008	774	773	CREATE	2021-01-26 05:24:06.491	01 Trial Management	01.01 Trial Oversight
4802	82	1611635046958:2071167032	1611635046405:232440667	D5136C00008	775	774	CREATE	2021-01-26 05:24:07.041	01.01 Trial Oversight	01.01.06 Recruitment Plan
4805	82	1611635048727:-177019833	1611635048181:-1368068921	D5136C00008	778	777	CREATE	2021-01-26 05:24:08.811	02.04 General	02.04.01 Rele_tions-Documents
4808	82	1611635050468:1985256860	1611635049907:144511447	D5136C00008	781	780	CREATE	2021-01-26 05:24:10.554	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
4810	82	1611635051695:1563631478	1611635049319:-1015188693	D5136C00008	783	779	CREATE	2021-01-26 05:24:11.781	04 IRB-IEC an_other Approvals	04.03 Trial Status Reporting
4811	82	1611635052285:1595849892	1611635051695:1563631478	D5136C00008	784	783	CREATE	2021-01-26 05:24:12.373	04.03 Trial Status Reporting	04.03.02 IRB-_Progress Report
4814	82	1611635054074:-1900825982	1611635053406:1762957859	D5136C00008	787	786	CREATE	2021-01-26 05:24:14.159	05 Site Management	05.01 Site Selection
5942	83	1611641845432:-1456517986	1611641842622:130323689	D5136C00008	895	890	CREATE	2021-01-26 07:17:25.517	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
4820	82	1611635057737:1482169306	1611635056623:1912290443	D5136C00008	793	791	CREATE	2021-01-26 05:24:17.822	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
4822	82	1611635059008:-1515607143	1611635056623:1912290443	D5136C00008	795	791	CREATE	2021-01-26 05:24:19.093	05.02 Site Se_p Documentation	05.02.04 PI CV-Site Affiliation
4824	82	1611635060101:-1360512252	1611635056623:1912290443	D5136C00008	797	791	CREATE	2021-01-26 05:24:20.193	05.02 Site Se_p Documentation	05.02.07 Site Qualification
4826	82	1611635061378:1135964811	1611635056623:1912290443	D5136C00008	799	791	CREATE	2021-01-26 05:24:21.47	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
4829	82	1611635063704:-1570506791	1611635056623:1912290443	D5136C00008	802	791	CREATE	2021-01-26 05:24:23.79	05.02 Site Se_p Documentation	05.02.18 Site Signature Sheet
4830	82	1611635064264:2069480407	1611635053406:1762957859	D5136C00008	803	786	CREATE	2021-01-26 05:24:24.349	05 Site Management	05.03 Site Initiation
4832	82	1611635065454:-761970483	1611635064264:2069480407	D5136C00008	805	803	CREATE	2021-01-26 05:24:25.538	05.03 Site Initiation	05.03.03 Site Training-Staff
4834	82	1611635066559:1363061601	1611635053406:1762957859	D5136C00008	807	786	CREATE	2021-01-26 05:24:26.644	05 Site Management	05.04 Site Management
4836	82	1611635067736:190498989	1611635066559:1363061601	D5136C00008	809	807	CREATE	2021-01-26 05:24:27.821	05.04 Site Management	05.04.04 Visit Log
4838	82	1611635068943:1722862097	1611635053406:1762957859	D5136C00008	811	786	CREATE	2021-01-26 05:24:29.027	05 Site Management	05.05 General
4842	82	1611635071223:-2073499137	1611635045240:488517972	D5136C00008	815	772	CREATE	2021-01-26 05:24:31.307	4103 Maggio, Aurelio	06 IP and Trial Supplies
4843	82	1611635071760:1132662206	1611635071223:-2073499137	D5136C00008	816	815	CREATE	2021-01-26 05:24:31.843	06 IP and Trial Supplies	06.01 IP Documentation
4846	82	1611635073474:-1483685738	1611635071223:-2073499137	D5136C00008	819	815	CREATE	2021-01-26 05:24:33.561	06 IP and Trial Supplies	06.04 Storage
4848	82	1611635074728:-805093563	1611635073474:-1483685738	D5136C00008	821	819	CREATE	2021-01-26 05:24:34.815	06.04 Storage	06.04.03 Maintenance Logs
4851	82	1611635076489:1576020916	1611635071223:-2073499137	D5136C00008	824	815	CREATE	2021-01-26 05:24:36.575	06 IP and Trial Supplies	06.07 General
4852	82	1611635077065:1412577435	1611635076489:1576020916	D5136C00008	825	824	CREATE	2021-01-26 05:24:37.15	06.07 General	06.07.01 Rele_l Product-Email
4855	82	1611635078800:-218077126	1611635078231:1230985592	D5136C00008	828	827	CREATE	2021-01-26 05:24:38.886	07.02 Trial Status Reporting	07.02.02 SAE Report
4856	82	1611635079459:-692151942	1611635045240:488517972	D5136C00008	829	772	CREATE	2021-01-26 05:24:39.545	4103 Maggio, Aurelio	08 Centralized Testing
4859	82	1611635081149:-1511561328	1611635080024:1468909366	D5136C00008	832	830	CREATE	2021-01-26 05:24:41.237	08.01 Facility Documentation	08.01.04 Norm_nd Alert Values
4861	82	1611635082281:1019371911	1611635081692:-912025379	D5136C00008	834	833	CREATE	2021-01-26 05:24:42.392	08.02 Sample Documentation	08.02.03 Samp_e Condition Log
4863	82	1611635083352:1938063794	1611635082806:-1894530611	D5136C00008	836	835	CREATE	2021-01-26 05:24:43.437	KENYA	01 Trial Management
4867	82	1611635085907:-1015951294	1611635085337:379127416	D5136C00008	840	839	CREATE	2021-01-26 05:24:46.002	02 Central Trial Documents	02.01 Trial Documents
4868	82	1611635086476:428830246	1611635085907:-1015951294	D5136C00008	841	840	CREATE	2021-01-26 05:24:46.562	02.01 Trial Documents	02.01.06 Insurance
4871	82	1611635096901:1096196581	1611635087126:1714063451	D5136C00008	844	842	CREATE	2021-01-26 05:24:56.991	02.02 Subject Documents	02.02.02 Subject Questionnaire
4874	82	1611635229166:651756727	1611635087126:1714063451	D5136C00008	847	842	CREATE	2021-01-26 05:27:09.331	02.02 Subject Documents	02.02.05 Subject Participation Card
4876	82	1611635231486:-132670817	1611635087126:1714063451	D5136C00008	849	842	CREATE	2021-01-26 05:27:11.573	02.02 Subject Documents	02.02.07 Other W_ Given to Subjects
4877	82	1611635232038:-1354748220	1611635085337:379127416	D5136C00008	850	839	CREATE	2021-01-26 05:27:12.123	02 Central Trial Documents	02.04 General
4880	82	1611635233882:-1933550719	1611635082806:-1894530611	D5136C00008	853	835	CREATE	2021-01-26 05:27:13.972	KENYA	03 Regulatory
4881	82	1611635234569:598329682	1611635233882:-1933550719	D5136C00008	854	853	CREATE	2021-01-26 05:27:14.656	03 Regulatory	03.01 Trial Approval
4884	82	1611635237073:852496885	1611635233882:-1933550719	D5136C00008	857	853	CREATE	2021-01-26 05:27:17.159	03 Regulatory	03.02 Investigational Medicinal Product
4886	82	1611635238416:1727145542	1611635233882:-1933550719	D5136C00008	859	853	CREATE	2021-01-26 05:27:18.502	03 Regulatory	03.03 Trial Status Reporting
4889	82	1611635240183:-1921798044	1611635082806:-1894530611	D5136C00008	862	835	CREATE	2021-01-26 05:27:20.271	KENYA	04 IRB-IEC and other Approvals
4891	82	1611635241370:139873799	1611635240828:-1972852746	D5136C00008	864	863	CREATE	2021-01-26 05:27:21.455	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
4893	82	1611635242615:-2103599628	1611635240828:-1972852746	D5136C00008	866	863	CREATE	2021-01-26 05:27:22.7	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
4894	82	1611635243186:-1382560858	1611635240828:-1972852746	D5136C00008	867	863	CREATE	2021-01-26 05:27:23.27	04.01 IRB-IEC Trial Approval	04.01.05 IRB-IEC GCP Compliance Statement
4897	82	1611635258390:-562327109	1611635257148:-993382180	D5136C00008	870	868	CREATE	2021-01-26 05:27:38.475	04.03 Trial Status Reporting	04.03.03 IRB-IEC Trial Term Notification
4899	82	1611635269768:-361370040	1611635258949:58090467	D5136C00008	872	871	CREATE	2021-01-26 05:27:49.854	06 IP and Trial Supplies	06.02 IP Release Process Documentation
4902	82	1611635285003:-1295722191	1611635284327:-2056777458	D5136C00008	875	874	CREATE	2021-01-26 05:28:05.089	09 Third Party	09.02 Third Party Set-up
4904	82	1611635296374:708461817	1611635082806:-1894530611	D5136C00008	877	835	CREATE	2021-01-26 05:28:16.625	KENYA	8502 Ogutu, Bernhards
4906	82	1611635298532:1924316446	1611635297677:1634691052	D5136C00008	879	878	CREATE	2021-01-26 05:28:18.618	02 Central Trial Documents	02.02 Subject Documents
4908	82	1611635303974:-441141308	1611635297677:1634691052	D5136C00008	881	878	CREATE	2021-01-26 05:28:24.309	02 Central Trial Documents	02.04 General
4911	82	1611635306403:547419586	1611635305692:-414272022	D5136C00008	884	883	CREATE	2021-01-26 05:28:26.49	03 Regulatory	03.01 Trial Approval
4913	82	1611635307965:-1817360358	1611635306403:547419586	D5136C00008	886	884	CREATE	2021-01-26 05:28:28.05	03.01 Trial Approval	03.01.02 Approval
4916	82	1611635312669:-1099842738	1611635296374:708461817	D5136C00008	889	877	CREATE	2021-01-26 05:28:32.828	8502 Ogutu, Bernhards	04 IRB-IEC an_other Approvals
4920	82	1611635325881:1300728185	1611635312669:-1099842738	D5136C00008	893	889	CREATE	2021-01-26 05:28:45.969	04 IRB-IEC an_other Approvals	04.03 Trial Status Reporting
4922	82	1611635327040:-582089522	1611635325881:1300728185	D5136C00008	895	893	CREATE	2021-01-26 05:28:47.125	04.03 Trial Status Reporting	04.03.02 IRB-_Progress Report
4924	82	1611635328226:1238707394	1611635296374:708461817	D5136C00008	897	877	CREATE	2021-01-26 05:28:48.311	8502 Ogutu, Bernhards	05 Site Management
4926	82	1611635329427:-1862957668	1611635328861:68431599	D5136C00008	899	898	CREATE	2021-01-26 05:28:49.513	05.01 Site Selection	05.01.01 Site Contact Details
4929	82	1611635332218:-1243873209	1611635328861:68431599	D5136C00008	902	898	CREATE	2021-01-26 05:28:52.303	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
4930	82	1611635333181:-413398054	1611635328226:1238707394	D5136C00008	903	897	CREATE	2021-01-26 05:28:54.166	05 Site Management	05.02 Site Se_p Documentation
4932	82	1611635335402:-1751631074	1611635333181:-413398054	D5136C00008	905	903	CREATE	2021-01-26 05:28:55.499	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
4935	82	1611635337962:-2051622169	1611635333181:-413398054	D5136C00008	908	903	CREATE	2021-01-26 05:28:58.069	05.02 Site Se_p Documentation	05.02.07 Site Qualification
4936	82	1611635338586:264400665	1611635333181:-413398054	D5136C00008	909	903	CREATE	2021-01-26 05:28:58.672	05.02 Site Se_p Documentation	05.02.07 Staff Qualification
4939	82	1611635340323:-887688520	1611635333181:-413398054	D5136C00008	912	903	CREATE	2021-01-26 05:29:00.408	05.02 Site Se_p Documentation	05.02.17 IP Site Release Documentation
4941	82	1611635341509:-692674855	1611635328226:1238707394	D5136C00008	914	897	CREATE	2021-01-26 05:29:01.6	05 Site Management	05.03 Site Initiation
4943	82	1611635342655:-1838314434	1611635341509:-692674855	D5136C00008	916	914	CREATE	2021-01-26 05:29:02.749	05.03 Site Initiation	05.03.03 Site Training-Staff
4945	82	1611635343851:-1226341957	1611635328226:1238707394	D5136C00008	918	897	CREATE	2021-01-26 05:29:03.94	05 Site Management	05.04 Site Management
4946	82	1611635344589:-1545430185	1611635343851:-1226341957	D5136C00008	919	918	CREATE	2021-01-26 05:29:05.297	05.04 Site Management	05.04.01 Subject Log
4949	82	1611635347352:-1301068730	1611635343851:-1226341957	D5136C00008	922	918	CREATE	2021-01-26 05:29:07.437	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
4951	82	1611635349334:-1306233362	1611635328226:1238707394	D5136C00008	924	897	CREATE	2021-01-26 05:29:09.524	05 Site Management	05.05 General
4953	82	1611635351091:1040601189	1611635349334:-1306233362	D5136C00008	926	924	CREATE	2021-01-26 05:29:11.179	05.05 General	05.05.02 Tracking Information
4955	82	1611635352447:1124608392	1611635351882:-786034451	D5136C00008	928	927	CREATE	2021-01-26 05:29:12.531	06 IP and Trial Supplies	06.01 IP Documentation
4958	82	1611635355656:-1995383615	1611635352447:1124608392	D5136C00008	931	928	CREATE	2021-01-26 05:29:15.745	06.01 IP Documentation	06.01.11 Certificate of Destruction
4959	82	1611635363047:-1224778137	1611635351882:-786034451	D5136C00008	932	927	CREATE	2021-01-26 05:29:23.132	06 IP and Trial Supplies	06.04 Storage
4962	82	1611635380493:-1972469822	1611635379426:-250113872	D5136C00008	935	934	CREATE	2021-01-26 05:29:40.578	06.05 Non-IP Documentation	06.05.03 Non-_ation of Return
4963	82	1611635381289:2084311957	1611635296374:708461817	D5136C00008	936	877	CREATE	2021-01-26 05:29:41.377	8502 Ogutu, Bernhards	07 Safety Reporting
4966	82	1611635383288:1291724254	1611635381289:2084311957	D5136C00008	939	936	CREATE	2021-01-26 05:29:43.372	07 Safety Reporting	07.03 General
4968	82	1611635385557:422497386	1611635296374:708461817	D5136C00008	941	877	CREATE	2021-01-26 05:30:00.605	8502 Ogutu, Bernhards	08 Centralized Testing
4971	82	1611635402624:-1733471900	1611635401312:1561610362	D5136C00008	944	942	CREATE	2021-01-26 05:30:02.714	08.01 Facility Documentation	08.01.04 Norm_nd Alert Values
4973	82	1611635404231:-555768457	1611635385557:422497386	D5136C00008	946	941	CREATE	2021-01-26 05:30:04.318	08 Centralized Testing	08.02 Sample Documentation
4976	82	1611635407656:1770977111	1611635082806:-1894530611	D5136C00008	949	835	CREATE	2021-01-26 05:30:07.762	KENYA	8503 Nduba, Videlis
4978	82	1611635423864:1182055678	1611635423215:407261501	D5136C00008	951	950	CREATE	2021-01-26 05:30:23.956	02 Central Trial Documents	02.01 Trial Documents
4979	82	1611635424430:-1390987370	1611635423864:1182055678	D5136C00008	952	951	CREATE	2021-01-26 05:30:24.515	02.01 Trial Documents	02.01.02 Protocol
4982	82	1611635426376:337980281	1611635425151:-1632139843	D5136C00008	955	953	CREATE	2021-01-26 05:30:26.462	02.02 Subject Documents	02.02.03 Informed Consent Form Checklists
4983	82	1611635426998:-1109316917	1611635423215:407261501	D5136C00008	956	950	CREATE	2021-01-26 05:31:02.701	02 Central Trial Documents	02.04 General
4985	82	1611635464762:-2081542000	1611635407656:1770977111	D5136C00008	958	949	CREATE	2021-01-26 05:31:04.87	8503 Nduba, Videlis	03 Regulatory
4988	82	1611635467373:1333232293	1611635465746:-334904021	D5136C00008	961	959	CREATE	2021-01-26 05:31:07.607	03.01 Trial Approval	03.01.02 Approval
4991	82	1611635469486:354177502	1611635464762:-2081542000	D5136C00008	964	958	CREATE	2021-01-26 05:31:09.572	03 Regulatory	03.03 Trial Status Reporting
4993	82	1611635470766:1337800746	1611635469486:354177502	D5136C00008	966	964	CREATE	2021-01-26 05:31:10.867	03.03 Trial Status Reporting	03.03.02 Progress Report
4994	82	1611635471392:-1128075006	1611635407656:1770977111	D5136C00008	967	949	CREATE	2021-01-26 05:31:11.479	8503 Nduba, Videlis	04 IRB-IEC an_other Approvals
4997	82	1611635474425:-1445586667	1611635472028:730231795	D5136C00008	970	968	CREATE	2021-01-26 05:31:14.51	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
4998	82	1611635475194:-228029206	1611635472028:730231795	D5136C00008	971	968	CREATE	2021-01-26 05:31:15.281	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
5001	82	1611635478612:-1695964767	1611635475859:-1442250944	D5136C00008	974	972	CREATE	2021-01-26 05:31:18.782	04.03 Trial Status Reporting	04.03.02 IRB-_Progress Report
5003	82	1611635479845:1450478222	1611635471392:-1128075006	D5136C00008	976	967	CREATE	2021-01-26 05:31:19.93	04 IRB-IEC an_other Approvals	04.04 General
5005	82	1611635481045:-428477712	1611635407656:1770977111	D5136C00008	978	949	CREATE	2021-01-26 05:31:21.13	8503 Nduba, Videlis	05 Site Management
5007	82	1611635482199:1241133190	1611635481647:-1827529987	D5136C00008	980	979	CREATE	2021-01-26 05:31:22.286	05.01 Site Selection	05.01.01 Site Contact Details
5010	82	1611635484407:-1992490455	1611635481045:-428477712	D5136C00008	983	978	CREATE	2021-01-26 05:31:24.497	05 Site Management	05.02 Site Se_p Documentation
5012	82	1611635485823:1930052199	1611635484407:-1992490455	D5136C00008	985	983	CREATE	2021-01-26 05:31:25.911	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
8835	84	\N	\N	D5170C00002	2620	2619	NEW	\N	05.05 General	05.05.01 Relev_unications-Email
4044	82	1611633587776:618215415	1611633585988:-779850671	D5136C00008	17	14	CREATE	2021-01-26 04:59:47.859	01.02 Trial Team	01.02.02 Project Team Curriculum Vitae
4050	82	1611633591611:-1435402098	1611633588365:-624690648	D5136C00008	23	18	CREATE	2021-01-26 04:59:51.694	01.03 Data Adjudication	01.03.03 Independent _respondence - Documents
4054	82	1611633594018:-1381531751	1611633593354:1728232414	D5136C00008	27	26	CREATE	2021-01-26 04:59:54.104	01.04 Meetings	01.04.01 External Kick-off Meeting Material
4060	82	1611633597591:1726647664	1611633597017:206304988	D5136C00008	33	32	CREATE	2021-01-26 04:59:57.675	01.05.01 Rele_veillance-Email	D5136C00008_Lab _ntact spreadsheet_
4064	82	1611633599986:-1326620345	1611633598188:1461789720	D5136C00008	37	34	CREATE	2021-01-26 05:00:00.074	Site Communication	Site 2801_Dr.Fateha Chowdhury
4070	82	1611633603879:-888530765	1611633598188:1461789720	D5136C00008	43	34	CREATE	2021-01-26 05:00:03.963	Site Communication	Site 7604_Pro_Ahmed Faik Oner
4073	82	1611633606179:-574572261	1611633598188:1461789720	D5136C00008	46	34	CREATE	2021-01-26 05:00:06.276	Site Communication	Site 8502_Dr.Bernhards Ogutu
4079	82	1611633609763:-985274586	1611633598188:1461789720	D5136C00008	52	34	CREATE	2021-01-26 05:00:09.855	Site Communication	Site 8802_Dr.Miguel Abbound
4081	82	1611633611076:1709170751	1611633610336:1106954324	D5136C00008	54	53	CREATE	2021-01-26 05:00:11.165	01.05.01 Relevant Com_roject Management-Email	Recruitment
4089	82	1611633616061:1428535205	1611633614054:756634841	D5136C00008	62	59	CREATE	2021-01-26 05:00:16.174	02.01 Trial Documents	02.01.03 Protocol Synopsis
4091	82	1611633617412:-935703491	1611633614054:756634841	D5136C00008	64	59	CREATE	2021-01-26 05:00:17.609	02.01 Trial Documents	02.01.06 Insurance
4097	82	1611633621340:1744201828	1611633618780:-420400763	D5136C00008	70	66	CREATE	2021-01-26 05:00:21.431	02.02 Subject Documents	02.02.07 Other Written Information Given to Subjects
4101	82	1611633625156:219883668	1611633613367:-1231745763	D5136C00008	74	58	CREATE	2021-01-26 05:00:25.247	02 Central Trial Documents	02.04 General
4106	82	1611633628220:566797703	1611633626281:310936369	D5136C00008	79	76	CREATE	2021-01-26 05:00:28.309	03 Regulatory	03.04 General
4110	82	1611633630642:1570516710	1611633629405:1835360317	D5136C00008	83	81	CREATE	2021-01-26 05:00:30.73	Documents	IB
4112	82	1611633631817:516422816	1611633629405:1835360317	D5136C00008	85	81	CREATE	2021-01-26 05:00:32.131	Documents	Protocol
4117	82	1611633635145:1445917995	1611633634425:-1627531427	D5136C00008	90	89	CREATE	2021-01-26 05:00:35.252	04 IRB-IEC and other Approvals	04.02 Other Committees
4124	82	1611633639549:-2126848257	1611633638250:-130934538	D5136C00008	97	95	CREATE	2021-01-26 05:00:39.644	05.03 Site Initiation	05.03.03 Site Training Documentation
4127	82	1611633641271:1504738540	1611633640142:533683269	D5136C00008	100	98	CREATE	2021-01-26 05:00:41.357	05.04 Site Management	05.04.09 Inv Notification-CIOMS
4134	82	1611633646157:9261859	1611633645572:-233503501	D5136C00008	107	106	CREATE	2021-01-26 05:00:46.246	06 IP and Trial Supplies	06.01 IP Documentation
4137	82	1611633648039:-586575931	1611633646157:9261859	D5136C00008	110	107	CREATE	2021-01-26 05:00:48.125	06.01 IP Documentation	06.01.11 Certificate of Destruction
4143	82	1611633651802:-1080508168	1611633651196:415787218	D5136C00008	116	115	CREATE	2021-01-26 05:00:51.889	06.03 IP Allocation Documentation	06.03.02 Unblinding Plan
4146	82	1611633653647:1064923796	1611633652995:-1827193367	D5136C00008	119	118	CREATE	2021-01-26 05:00:53.733	06.05 Non-IP Documentation	06.05.02 Non-IP Documentation of Shipment
4149	82	1611633655673:-1734096482	1611633654821:838670961	D5136C00008	122	121	CREATE	2021-01-26 05:00:55.763	06.06 Interactive Response Technology	06.06.01 IRT User Requirement Specification
4154	82	1611633658524:-299226186	1611633657958:998844879	D5136C00008	127	126	CREATE	2021-01-26 05:00:58.612	07 Safety Reporting	07.01 Safety Documentation
4160	82	1611633662245:1393968070	1611633660969:-195266425	D5136C00008	133	131	CREATE	2021-01-26 05:01:02.333	07.02 Trial Status Reporting	07.02.01 Expedited Safety Report-SUSAR
4164	82	1611633664828:971975340	1611633664254:-141510675	D5136C00008	137	136	CREATE	2021-01-26 05:01:04.914	07.03.01 Re_-Safety-Email	Alert Letter _l Notifications
4171	82	1611633675544:-832317854	1611633664254:-141510675	D5136C00008	144	136	CREATE	2021-01-26 05:01:15.64	07.03.01 Re_-Safety-Email	eDC triggers and SAE reports
4173	82	1611633676750:1479983608	1611633675544:-832317854	D5136C00008	146	144	CREATE	2021-01-26 05:01:16.842	eDC triggers and SAE reports	Aug_2016
5014	82	1611635487175:-1336707426	1611635484407:-1992490455	D5136C00008	987	983	CREATE	2021-01-26 05:31:27.264	05.02 Site Se_p Documentation	05.02.06 Othe_ite Affiliation
5017	82	1611635489137:-171696701	1611635484407:-1992490455	D5136C00008	990	983	CREATE	2021-01-26 05:31:29.224	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
5019	82	1611635490514:401610484	1611635484407:-1992490455	D5136C00008	992	983	CREATE	2021-01-26 05:31:30.599	05.02 Site Se_p Documentation	05.02.17 IP Site Release Documentation
5020	82	1611635491177:540650936	1611635484407:-1992490455	D5136C00008	993	983	CREATE	2021-01-26 05:31:31.271	05.02 Site Se_p Documentation	05.02.18 Site Signature Sheet
5023	82	1611635493723:1498215753	1611635492128:-1568402730	D5136C00008	996	994	CREATE	2021-01-26 05:31:33.809	05.03 Site Initiation	05.03.03 Site Training-Staff
5026	82	1611635496077:-1316767002	1611635495407:1753205563	D5136C00008	999	998	CREATE	2021-01-26 05:31:36.162	05.04 Site Management	05.04.01 Subject Log
5027	82	1611635496725:68433520	1611635495407:1753205563	D5136C00008	1000	998	CREATE	2021-01-26 05:31:36.811	05.04 Site Management	05.04.03 Monitoring Visit Report
5029	82	1611635500362:1006271019	1611635495407:1753205563	D5136C00008	1002	998	CREATE	2021-01-26 05:31:40.45	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
5032	82	1611635507225:-138624537	1611635506396:-106446153	D5136C00008	1005	1004	CREATE	2021-01-26 05:31:47.313	05.05 General	05.05.01 Rele_tions-Documents
5033	82	1611635507901:-1331526364	1611635506396:-106446153	D5136C00008	1006	1004	CREATE	2021-01-26 05:31:47.988	05.05 General	05.05.02 Tracking Information
5036	82	1611635509912:-306594465	1611635509263:374373782	D5136C00008	1009	1008	CREATE	2021-01-26 05:31:49.999	06.01 IP Documentation	06.01.04 IP Shipment Documentation
5040	82	1611635512342:-653002586	1611635511774:1613375496	D5136C00008	1013	1012	CREATE	2021-01-26 05:31:52.428	06.04 Storage	06.04.01 Storage Condition Documentation
5041	82	1611635512945:-227597760	rootNode	D5136C00008	1014	0	CREATE	2021-01-26 05:31:53.036		Generic Documents
5044	82	1611635514943:-1186427469	1611635512945:-227597760	D5136C00008	1017	1014	CREATE	2021-01-26 05:31:55.027	Generic Documents	Document Inventory Listings
5047	82	1611635517414:-837462632	1611635512945:-227597760	D5136C00008	1020	1014	CREATE	2021-01-26 05:31:57.501	Generic Documents	Metadata
18846	91	1625579414482:268563924	1625579413951:-556274802	D5160C00019	450	449	CREATE	2021-07-06 15:50:14.574	23061 Tosi, Diego	02 Central Trial Documents
4175	82	1611633678017:535559860	1611633675544:-832317854	D5136C00008	148	144	CREATE	2021-01-26 05:01:18.102	eDC triggers and SAE reports	Feb_2016
4180	82	1611633681185:819492975	1611633675544:-832317854	D5136C00008	153	144	CREATE	2021-01-26 05:01:21.272	eDC triggers and SAE reports	Mar_2016
4185	82	1611633684523:-1854189322	1611633675544:-832317854	D5136C00008	158	144	CREATE	2021-01-26 05:01:24.607	eDC triggers and SAE reports	Sep_2016
4189	82	1611633687389:-1982599705	1611633686238:-591261556	D5136C00008	162	160	CREATE	2021-01-26 05:01:27.474	ISL	2016
4194	82	1611633721450:649826160	1611633711829:-813954584	D5136C00008	167	165	CREATE	2021-01-26 05:02:01.553	Start up correspondences	2016
4197	82	1611633729251:949515046	1611633722508:2120471788	D5136C00008	170	169	CREATE	2021-01-26 05:02:09.337	08 Centralized Testing	08.01 Facility Documentation
4203	82	1611633732816:-1396364655	1611633732144:1841950717	D5136C00008	176	175	CREATE	2021-01-26 05:02:12.902	09.01 Third Party Oversight	09.01.01 Qualification and Compliance
4207	82	1611633735344:435424579	1611633733990:-600357563	D5136C00008	180	178	CREATE	2021-01-26 05:02:15.43	09.02 Third Party Set-up	09.02.03 Contractual Agreement
4213	82	1611633740275:-1388934339	1611633739717:-1652999533	D5136C00008	186	185	CREATE	2021-01-26 05:02:20.364	10.01 Data Management Oversight	10.01.01 Data Management Plan (Paper and EDC)
4217	82	1611633742648:5105622	1611633739130:1114499820	D5136C00008	190	184	CREATE	2021-01-26 05:02:22.75	10 Data Management	10.03 Database
4220	82	1611633744398:-771284634	1611633742648:5105622	D5136C00008	193	190	CREATE	2021-01-26 05:02:24.489	10.03 Database	10.03.07 Data Entry Guidelines (Paper)
4226	82	1611633764928:1099997739	1611633764295:1628439698	D5136C00008	199	198	CREATE	2021-01-26 05:02:45.013	10.04 EDC Management	10.04.01 System Account Management
4431	82	1611634199794:1351632852	1611634196456:926911165	D5136C00008	404	400	CREATE	2021-01-26 05:09:59.878	05.02 Site Se_p Documentation	05.02.06 Othe_ite Affiliation
4438	82	1611634204475:911338816	1611634192599:696569121	D5136C00008	411	395	CREATE	2021-01-26 05:10:04.563	05 Site Management	05.03 Site Initiation
4504	82	1611634493237:-1559775724	1611634492548:315441297	D5136C00008	477	476	CREATE	2021-01-26 05:14:53.322	2301 Arlet, Jean-Benoit	02 Central Trial Documents
4507	82	1611634529164:-279737144	1611634492548:315441297	D5136C00008	480	476	CREATE	2021-01-26 05:15:29.25	2301 Arlet, Jean-Benoit	03 Regulatory
4510	82	1611634530994:1521384230	1611634492548:315441297	D5136C00008	483	476	CREATE	2021-01-26 05:15:31.078	2301 Arlet, Jean-Benoit	05 Site Management
4513	82	1611634606822:426374829	1611634530994:1521384230	D5136C00008	486	483	CREATE	2021-01-26 05:16:46.906	05 Site Management	05.02 Site Se_p Documentation
4519	82	1611634633879:47390346	1611634606822:426374829	D5136C00008	492	486	CREATE	2021-01-26 05:17:13.969	05.02 Site Se_p Documentation	05.02.12 Clinical Trial Agreement
4523	82	1611634636380:1493890609	1611634635807:1113031843	D5136C00008	496	495	CREATE	2021-01-26 05:17:16.465	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
4529	82	1611634640944:-1103574135	1611634638391:-562556523	D5136C00008	502	499	CREATE	2021-01-26 05:17:21.029	05.04 Site Management	05.04.04 Visit Log
4532	82	1611634642738:-739252481	1611634642071:-1840711619	D5136C00008	505	504	CREATE	2021-01-26 05:17:22.823	05.05 General	05.05.01 Rele_nications-Email
4538	82	1611634690687:1220915020	1611634688119:-944099807	D5136C00008	511	507	CREATE	2021-01-26 05:18:10.775	06 IP and Trial Supplies	06.05 Non-IP Documentation
4541	82	1611634692486:543633225	1611634691844:1926225383	D5136C00008	514	513	CREATE	2021-01-26 05:18:12.573	07 Safety Reporting	07.02 Trial Status Reporting
4547	82	1611634695998:157193192	1611634693647:1967015484	D5136C00008	520	516	CREATE	2021-01-26 05:18:16.084	2302 Ame, Shanti	05 Site Management
4549	82	1611634697215:858456113	1611634696561:1457065808	D5136C00008	522	521	CREATE	2021-01-26 05:18:17.303	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
4556	82	1611634701477:8192897	1611634697783:-2069299963	D5136C00008	529	523	CREATE	2021-01-26 05:18:21.569	05.02 Site Se_p Documentation	05.02.12 Clinical Trial Agreement
4559	82	1611634703159:-943014702	1611634695998:157193192	D5136C00008	532	520	CREATE	2021-01-26 05:18:23.256	05 Site Management	05.03 Site Initiation
4565	82	1611634706772:1225012748	1611634705558:38419245	D5136C00008	538	536	CREATE	2021-01-26 05:18:26.857	05.04 Site Management	05.04.03 Monitoring Visit Report
4568	82	1611634708577:-1503714754	1611634705558:38419245	D5136C00008	541	536	CREATE	2021-01-26 05:18:28.688	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
4575	82	1611634713102:1493373809	1611634712550:1285880308	D5136C00008	548	547	CREATE	2021-01-26 05:18:33.189	06.01 IP Documentation	06.01.05 Accountability Documentation
4576	82	1611634713690:266585593	1611634712550:1285880308	D5136C00008	549	547	CREATE	2021-01-26 05:18:34.427	06.01 IP Documentation	06.01.11 Certificate of Destruction
4582	82	1611634721197:-1154770586	1611634440712:1089216046	D5136C00008	555	435	CREATE	2021-01-26 05:18:41.284	FRANCE	2303 Receveur_Marie Catherine
4585	82	1611634722954:-600517854	1611634722387:931803228	D5136C00008	558	557	CREATE	2021-01-26 05:18:43.038	02.04 General	02.04.01 Rele_-Contact Report
4591	82	1611634726311:-1028317704	1611634725759:124507613	D5136C00008	564	563	CREATE	2021-01-26 05:18:46.526	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
4594	82	1611634728191:-1687497245	1611634727016:-744888890	D5136C00008	567	565	CREATE	2021-01-26 05:18:48.276	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
4600	82	1611634731627:-792667985	1611634727016:-744888890	D5136C00008	573	565	CREATE	2021-01-26 05:18:51.713	05.02 Site Se_p Documentation	05.02.18 Site Signature Sheet
4604	82	1611634733891:988777780	1611634732181:1756846328	D5136C00008	577	574	CREATE	2021-01-26 05:18:53.974	05.03 Site Initiation	05.03.03 Site_umentation-Site
4610	82	1611634737325:604219928	1611634734503:343784815	D5136C00008	583	578	CREATE	2021-01-26 05:18:57.41	05.04 Site Management	05.04.08 Fina_nitoring Report
4614	82	1611634741575:1037597435	1611634721197:-1154770586	D5136C00008	587	555	CREATE	2021-01-26 05:19:01.663	2303 Receveur_Marie Catherine	06 IP and Trial Supplies
4620	82	1611634745082:203242412	1611634743935:-905510495	D5136C00008	593	591	CREATE	2021-01-26 05:19:05.169	06.04 Storage	06.04.03 Maintenance Logs
4623	82	1611634746811:-174012145	1611634746252:970022122	D5136C00008	596	595	CREATE	2021-01-26 05:19:06.896	07.02 Trial Status Reporting	07.02.02 SAE Report
4627	82	1611634749078:-347551325	1611634748430:1715170	D5136C00008	600	599	CREATE	2021-01-26 05:19:09.164	GHANA	TBD-1-1RACHLQ Dei-Adomakoh, Yvonne
4633	82	1611634753081:-774219405	1611634752450:778372697	D5136C00008	606	605	CREATE	2021-01-26 05:19:13.166	ITALY	02 Central Trial Documents
4643	82	1611634759409:-667054573	1611634756279:12800525	D5136C00008	616	611	CREATE	2021-01-26 05:19:19.494	02.02 Subject Documents	02.02.05 Subject Participation Card
4645	82	1611634777066:1945503376	1611634753081:-774219405	D5136C00008	618	606	CREATE	2021-01-26 05:19:37.484	02 Central Trial Documents	02.04 General
4651	82	1611634781032:-458661037	1611634778649:768420291	D5136C00008	624	620	CREATE	2021-01-26 05:19:41.119	03 Regulatory	03.03 Trial Status Reporting
4653	82	1611634782317:-1202779242	1611634781032:-458661037	D5136C00008	626	624	CREATE	2021-01-26 05:19:42.404	03.03 Trial Status Reporting	03.03.03 Notification of Trial Termination
4661	82	1611634788883:1521383636	1611634788327:29068483	D5136C00008	634	633	CREATE	2021-01-26 05:19:48.967	05 Site Management	05.05 General
4663	82	1611634790047:660277442	1611634752450:778372697	D5136C00008	636	605	CREATE	2021-01-26 05:19:50.134	ITALY	06 IP and Trial Supplies
4669	82	1611634813341:-282849748	1611634812724:-385771096	D5136C00008	642	641	CREATE	2021-01-26 05:20:13.427	02 Central Trial Documents	02.02 Subject Documents
4672	82	1611634815697:1569001475	1611634813341:-282849748	D5136C00008	645	642	CREATE	2021-01-26 05:20:15.784	02.02 Subject Documents	02.02.07 Othe_ven to Subjects
4678	82	1611634866877:1344634198	1611634865724:-1060224433	D5136C00008	651	649	CREATE	2021-01-26 05:21:06.962	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
4681	82	1611634868693:1529259416	1611634867477:-347630410	D5136C00008	654	652	CREATE	2021-01-26 05:21:08.779	04.03 Trial Status Reporting	04.03.03 IRB-_rm Notification
4687	82	1611634872212:1236581339	1611634869278:-1918516378	D5136C00008	660	655	CREATE	2021-01-26 05:21:26.32	05 Site Management	05.02 Site Se_p Documentation
4690	82	1611634889909:-1236535566	1611634872212:1236581339	D5136C00008	663	660	CREATE	2021-01-26 05:21:30.008	05.02 Site Se_p Documentation	05.02.03 Prot_ Signature Page
4697	82	1611634918017:-569446702	1611634872212:1236581339	D5136C00008	670	660	CREATE	2021-01-26 05:21:58.104	05.02 Site Se_p Documentation	05.02.18 Site Signature Sheet
4700	82	1611634920154:443782425	1611634918669:-558783148	D5136C00008	673	671	CREATE	2021-01-26 05:22:00.242	05.03 Site Initiation	05.03.03 Site Training-Staff
4704	82	1611634922485:547055504	1611634921359:-1265286826	D5136C00008	677	675	CREATE	2021-01-26 05:22:02.571	05.04 Site Management	05.04.04 Visit Log
4709	82	1611634969322:932176620	1611634812168:-338813646	D5136C00008	682	640	CREATE	2021-01-26 05:22:49.408	4101 Forni, Gianluca	06 IP and Trial Supplies
4711	82	1611634970554:1655178523	1611634969903:2071976112	D5136C00008	684	683	CREATE	2021-01-26 05:22:50.639	06.01 IP Documentation	06.01.04 IP Shipment Documentation
4717	82	1611634974057:-1519026273	1611634969322:932176620	D5136C00008	690	682	CREATE	2021-01-26 05:22:54.143	06 IP and Trial Supplies	06.05 Non-IP Documentation
4721	82	1611634976445:437468567	1611634975872:-1339940573	D5136C00008	694	693	CREATE	2021-01-26 05:23:00.283	06.07 General	06.07.01 Rele_l Product-Email
4727	82	1611634989660:110606101	1611634989056:-1584236725	D5136C00008	700	699	CREATE	2021-01-26 05:23:09.746	08.01 Facility Documentation	08.01.01 Cert_r Accreditation
4730	82	1611634992007:-2124205964	1611634991443:1965576573	D5136C00008	703	702	CREATE	2021-01-26 05:23:12.093	08.02 Sample Documentation	08.02.03 Samp_e Condition Log
4736	82	1611634995697:-92423588	1611634992685:1252850792	D5136C00008	709	704	CREATE	2021-01-26 05:23:15.784	4102 De Franceschi, Lucia	04 IRB-IEC an_other Approvals
4739	82	1611634997387:-25376495	1611634996260:-357027335	D5136C00008	712	710	CREATE	2021-01-26 05:23:17.475	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
4746	82	1611635001478:1811712317	1611635000232:601968163	D5136C00008	719	717	CREATE	2021-01-26 05:23:21.563	05.01 Site Selection	05.01.03 Feasibility Documentation
4749	82	1611635003180:-719016114	1611635002613:1633128368	D5136C00008	722	721	CREATE	2021-01-26 05:23:23.267	05.02 Site Se_p Documentation	05.02.01 Acce_igator Brochure
4755	82	1611635006761:-10280170	1611635002613:1633128368	D5136C00008	728	721	CREATE	2021-01-26 05:23:26.845	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
4759	82	1611635009234:-1798112347	1611634999665:-1342325353	D5136C00008	732	716	CREATE	2021-01-26 05:23:29.321	05 Site Management	05.03 Site Initiation
4765	82	1611635024186:1231516737	1611635012017:-551934266	D5136C00008	738	736	CREATE	2021-01-26 05:23:44.272	05.04 Site Management	05.04.03 Monitoring Visit Report
4769	82	1611635026714:-204443011	1611635026080:-192123161	D5136C00008	742	741	CREATE	2021-01-26 05:23:46.8	05.05 General	05.05.01 Rele_nications-Email
4774	82	1611635029613:986417733	1611635028412:1434357469	D5136C00008	747	745	CREATE	2021-01-26 05:23:49.698	06.01 IP Documentation	06.01.05 Accountability Documentation
4775	82	1611635030173:-505661226	1611635028412:1434357469	D5136C00008	748	745	CREATE	2021-01-26 05:23:50.258	06.01 IP Documentation	06.01.10 IP Documentation Return
4778	82	1611635032676:-248679969	1611635031525:-208492443	D5136C00008	751	749	CREATE	2021-01-26 05:23:52.761	06.04 Storage	06.04.03 Maintenance Logs
4784	82	1611635036250:1013022714	1611634992685:1252850792	D5136C00008	757	704	CREATE	2021-01-26 05:23:56.506	4102 De Franceschi, Lucia	07 Safety Reporting
4790	82	1611635039857:230602554	1611634992685:1252850792	D5136C00008	763	704	CREATE	2021-01-26 05:23:59.941	4102 De Franceschi, Lucia	08 Centralized Testing
4793	82	1611635041731:-783742583	1611635040435:-1481630305	D5136C00008	766	764	CREATE	2021-01-26 05:24:01.816	08.01 Facility Documentation	08.01.04 Norm_nd Alert Values
4800	82	1611635045817:1319411003	1611635045240:488517972	D5136C00008	773	772	CREATE	2021-01-26 05:24:05.903	4103 Maggio, Aurelio	01 Trial Management
4803	82	1611635047615:196962608	1611635045240:488517972	D5136C00008	776	772	CREATE	2021-01-26 05:24:07.703	4103 Maggio, Aurelio	02 Central Trial Documents
4809	82	1611635051120:740569747	1611635049907:144511447	D5136C00008	782	780	CREATE	2021-01-26 05:24:11.207	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
4812	82	1611635052858:275668698	1611635051695:1563631478	D5136C00008	785	783	CREATE	2021-01-26 05:24:12.942	04.03 Trial Status Reporting	04.03.03 IRB-_rm Notification
4818	82	1611635056623:1912290443	1611635053406:1762957859	D5136C00008	791	786	CREATE	2021-01-26 05:24:16.708	05 Site Management	05.02 Site Se_p Documentation
4821	82	1611635058320:-451413233	1611635056623:1912290443	D5136C00008	794	791	CREATE	2021-01-26 05:24:18.407	05.02 Site Se_p Documentation	05.02.03 Prot_ Signature Page
4828	82	1611635063134:-2145971572	1611635056623:1912290443	D5136C00008	801	791	CREATE	2021-01-26 05:24:23.219	05.02 Site Se_p Documentation	05.02.17 IP Site Release Documentation
4831	82	1611635064821:1379779097	1611635064264:2069480407	D5136C00008	804	803	CREATE	2021-01-26 05:24:24.906	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
4835	82	1611635067138:-862178046	1611635066559:1363061601	D5136C00008	808	807	CREATE	2021-01-26 05:24:27.225	05.04 Site Management	05.04.01 Subject Log
18849	91	1625579422804:1812538854	1625579414482:268563924	D5160C00019	453	450	CREATE	2021-07-06 15:50:22.909	02 Central Trial Documents	02.04 General
4840	82	1611635070061:-390083237	1611635068943:1722862097	D5136C00008	813	811	CREATE	2021-01-26 05:24:30.145	05.05 General	05.05.01 Rele_tions-Documents
4844	82	1611635072311:-2064242747	1611635071760:1132662206	D5136C00008	817	816	CREATE	2021-01-26 05:24:32.397	06.01 IP Documentation	06.01.04 IP Shipment Documentation
4847	82	1611635074142:-2031701177	1611635073474:-1483685738	D5136C00008	820	819	CREATE	2021-01-26 05:24:34.227	06.04 Storage	06.04.01 Storage Condition Documentation
4853	82	1611635077665:529885856	1611635045240:488517972	D5136C00008	826	772	CREATE	2021-01-26 05:24:37.75	4103 Maggio, Aurelio	07 Safety Reporting
4857	82	1611635080024:1468909366	1611635079459:-692151942	D5136C00008	830	829	CREATE	2021-01-26 05:24:40.111	08 Centralized Testing	08.01 Facility Documentation
4864	82	1611635083928:-79353286	1611635083352:1938063794	D5136C00008	837	836	CREATE	2021-01-26 05:24:44.014	01 Trial Management	01.05 General
4866	82	1611635085337:379127416	1611635082806:-1894530611	D5136C00008	839	835	CREATE	2021-01-26 05:24:45.424	KENYA	02 Central Trial Documents
4872	82	1611635097501:-1680217707	1611635087126:1714063451	D5136C00008	845	842	CREATE	2021-01-26 05:24:57.587	02.02 Subject Documents	02.02.03 Informe_ent Form Templates
4875	82	1611635230885:1110603843	1611635087126:1714063451	D5136C00008	848	842	CREATE	2021-01-26 05:27:10.974	02.02 Subject Documents	02.02.06 Adverti_ubject Recruitment
4882	82	1611635235807:-915866525	1611635234569:598329682	D5136C00008	855	854	CREATE	2021-01-26 05:27:15.892	03.01 Trial Approval	03.01.01 Submission
4885	82	1611635237868:-591867228	1611635237073:852496885	D5136C00008	858	857	CREATE	2021-01-26 05:27:17.952	03.02 Investigational Medicinal Product	03.02.02 Import-Export License
4888	82	1611635239635:185776505	1611635238416:1727145542	D5136C00008	861	859	CREATE	2021-01-26 05:27:19.721	03.03 Trial Status Reporting	03.03.03 Notification of Trial Termination
4895	82	1611635257148:-993382180	1611635240183:-1921798044	D5136C00008	868	862	CREATE	2021-01-26 05:27:37.235	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
4898	82	1611635258949:58090467	1611635082806:-1894530611	D5136C00008	871	835	CREATE	2021-01-26 05:27:39.035	KENYA	06 IP and Trial Supplies
4905	82	1611635297677:1634691052	1611635296374:708461817	D5136C00008	878	877	CREATE	2021-01-26 05:28:17.763	8502 Ogutu, Bernhards	02 Central Trial Documents
4907	82	1611635299205:-914952745	1611635298532:1924316446	D5136C00008	880	879	CREATE	2021-01-26 05:28:19.291	02.02 Subject Documents	02.02.03 Info_ Form Templates
4909	82	1611635304966:-2093234427	1611635303974:-441141308	D5136C00008	882	881	CREATE	2021-01-26 05:28:25.052	02.04 General	02.04.01 Rele_tions-Documents
4915	82	1611635311773:-227412643	1611635308568:1714214786	D5136C00008	888	887	CREATE	2021-01-26 05:28:32.008	03.02 Investi_dicinal Product	03.02.02 Impo_-Export License
4921	82	1611635326477:1025319045	1611635325881:1300728185	D5136C00008	894	893	CREATE	2021-01-26 05:28:46.562	04.03 Trial Status Reporting	04.03.01 IRB-_ Info-Deviation
4925	82	1611635328861:68431599	1611635328226:1238707394	D5136C00008	898	897	CREATE	2021-01-26 05:28:48.944	05 Site Management	05.01 Site Selection
4927	82	1611635330263:1439428535	1611635328861:68431599	D5136C00008	900	898	CREATE	2021-01-26 05:28:50.35	05.01 Site Selection	05.01.02 Confidentiality Agreement
4934	82	1611635336690:-1922641904	1611635333181:-413398054	D5136C00008	907	903	CREATE	2021-01-26 05:28:56.775	05.02 Site Se_p Documentation	05.02.06 Othe_ite Affiliation
4937	82	1611635339186:-1197386734	1611635333181:-413398054	D5136C00008	910	903	CREATE	2021-01-26 05:28:59.276	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
4944	82	1611635343301:-1890855644	1611635341509:-692674855	D5136C00008	917	914	CREATE	2021-01-26 05:29:03.39	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
4947	82	1611635345892:2056092894	1611635343851:-1226341957	D5136C00008	920	918	CREATE	2021-01-26 05:29:06.097	05.04 Site Management	05.04.03 Monitoring Visit Report
4954	82	1611635351882:-786034451	1611635296374:708461817	D5136C00008	927	877	CREATE	2021-01-26 05:29:11.973	8502 Ogutu, Bernhards	06 IP and Trial Supplies
4957	82	1611635353667:2011323893	1611635352447:1124608392	D5136C00008	930	928	CREATE	2021-01-26 05:29:13.751	06.01 IP Documentation	06.01.05 Accountability Documentation
4964	82	1611635381946:-1712443188	1611635381289:2084311957	D5136C00008	937	936	CREATE	2021-01-26 05:29:42.12	07 Safety Reporting	07.02 Trial Status Reporting
4967	82	1611635384904:1146473094	1611635383288:1291724254	D5136C00008	940	939	CREATE	2021-01-26 05:29:44.99	07.03 General	07.03.01 Rele_ns-Safety-Email
4972	82	1611635403506:1069907458	1611635401312:1561610362	D5136C00008	945	942	CREATE	2021-01-26 05:30:03.609	08.01 Facility Documentation	08.01.07 Head of Facility CV
4974	82	1611635405242:-977567361	1611635404231:-555768457	D5136C00008	947	946	CREATE	2021-01-26 05:30:05.33	08.02 Sample Documentation	08.02.02 Shipment Records
4977	82	1611635423215:407261501	1611635407656:1770977111	D5136C00008	950	949	CREATE	2021-01-26 05:30:23.328	8503 Nduba, Videlis	02 Central Trial Documents
4984	82	1611635463954:1693968317	1611635426998:-1109316917	D5136C00008	957	956	CREATE	2021-01-26 05:31:04.04	02.04 General	02.04.01 Rele_-Contact Report
4987	82	1611635466561:-680968009	1611635465746:-334904021	D5136C00008	960	959	CREATE	2021-01-26 05:31:06.651	03.01 Trial Approval	03.01.01 Submission
4992	82	1611635470103:-1883047821	1611635469486:354177502	D5136C00008	965	964	CREATE	2021-01-26 05:31:10.2	03.03 Trial Status Reporting	03.03.01 Reg _o and Deviation
4996	82	1611635473668:-200899554	1611635472028:730231795	D5136C00008	969	968	CREATE	2021-01-26 05:31:13.777	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
5002	82	1611635479250:1275659853	1611635475859:-1442250944	D5136C00008	975	972	CREATE	2021-01-26 05:31:19.357	04.03 Trial Status Reporting	04.03.03 IRB-_rm Notification
5006	82	1611635481647:-1827529987	1611635481045:-428477712	D5136C00008	979	978	CREATE	2021-01-26 05:31:21.734	05 Site Management	05.01 Site Selection
5011	82	1611635485142:359864045	1611635484407:-1992490455	D5136C00008	984	983	CREATE	2021-01-26 05:31:25.228	05.02 Site Se_p Documentation	05.02.01 Acceptance of Investigator Brochure
5015	82	1611635487830:1190390421	1611635484407:-1992490455	D5136C00008	988	983	CREATE	2021-01-26 05:31:27.916	05.02 Site Se_p Documentation	05.02.07 Site Qualification
5022	82	1611635492867:-1091436901	1611635492128:-1568402730	D5136C00008	995	994	CREATE	2021-01-26 05:31:32.953	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
5025	82	1611635495407:1753205563	1611635481045:-428477712	D5136C00008	998	978	CREATE	2021-01-26 05:31:35.496	05 Site Management	05.04 Site Management
5028	82	1611635499675:-2100180159	1611635495407:1753205563	D5136C00008	1001	998	CREATE	2021-01-26 05:31:39.767	05.04 Site Management	05.04.04 Visit Log
5949	83	1611641849443:-1160745370	1611641848838:-775808418	D5136C00008	902	901	CREATE	2021-01-26 07:17:29.528	06 IP and Trial Supplies	06.01 IP Documentation
5952	83	1611641851913:1062281413	1611641848838:-775808418	D5136C00008	905	901	CREATE	2021-01-26 07:17:32	06 IP and Trial Supplies	06.05 Non-IP Documentation
5037	82	1611635510477:1737230795	1611635509263:374373782	D5136C00008	1010	1008	CREATE	2021-01-26 05:31:50.564	06.01 IP Documentation	06.01.05 Accountability Documentation
5043	82	1611635514272:817992185	1611635512945:-227597760	D5136C00008	1016	1014	CREATE	2021-01-26 05:31:54.449	Generic Documents	CRO eTMF Index
5045	82	1611635515530:-1013398044	1611635512945:-227597760	D5136C00008	1018	1014	CREATE	2021-01-26 05:31:55.616	Generic Documents	Hash Values
5057	83	1611641116729:596941719	1611641116099:42796999	D5136C00008	10	9	CREATE	2021-01-26 07:05:16.814	07 Safety Reporting	07.02 Trial Status Reporting
5059	83	1611641117847:618972343	1611641116729:596941719	D5136C00008	12	10	CREATE	2021-01-26 07:05:17.933	07.02 Trial Status Reporting	07.02.03 Pregnancy Report
5062	83	1611641119608:1475797631	1611635407656:1770977111	D5136C00008	15	2	CREATE	2021-01-26 07:05:19.695	8503 Nduba, Videlis	08 Centralized Testing
5063	83	1611641120162:342802980	1611641119608:1475797631	D5136C00008	16	15	CREATE	2021-01-26 07:05:20.252	08 Centralized Testing	08.01 Facility Documentation
5066	83	1611641121935:40141659	1611641119608:1475797631	D5136C00008	19	15	CREATE	2021-01-26 07:05:22.022	08 Centralized Testing	08.02 Sample Documentation
5068	83	1611641124203:619314964	1611635407656:1770977111	D5136C00008	21	2	CREATE	2021-01-26 07:05:24.29	8503 Nduba, Videlis	10 Data Management
5070	83	1611641125422:1770888672	1611641124854:608995483	D5136C00008	23	22	CREATE	2021-01-26 07:05:25.509	10.02 Data Capture	10.02.03 Completed CRFs (Paper)
5072	83	1611641126518:-1296583142	1611641125971:-2109224039	D5136C00008	25	24	CREATE	2021-01-26 07:05:26.603	TBD-1-1RACHEE Nduba, Videlis	02 Central Trial Documents
5075	83	1611641131999:-1619634573	1611641126518:-1296583142	D5136C00008	28	25	CREATE	2021-01-26 07:05:32.087	02 Central Trial Documents	02.02 Subject Documents
5076	83	1611641132612:-410153458	1611641131999:-1619634573	D5136C00008	29	28	CREATE	2021-01-26 07:05:32.711	02.02 Subject Documents	02.02.03 Info_ Form Templates
5079	83	1611641136013:1141084786	1611641135390:1630733315	D5136C00008	32	31	CREATE	2021-01-26 07:05:36.099	03.01 Trial Approval	03.01.02 Approval
5081	83	1611641137146:-312399979	1611641136573:719286918	D5136C00008	34	33	CREATE	2021-01-26 07:05:37.233	03.02 Investi_dicinal Product	03.02.02 Impo_-Export License
5084	83	1611641138917:1902813811	1611641125971:-2109224039	D5136C00008	37	24	CREATE	2021-01-26 07:05:39	TBD-1-1RACHEE Nduba, Videlis	04 IRB-IEC an_other Approvals
5085	83	1611641139504:-299483099	1611641138917:1902813811	D5136C00008	38	37	CREATE	2021-01-26 07:05:39.59	04 IRB-IEC an_other Approvals	04.01 IRB-IEC Trial Approval
5088	83	1611641141269:1119647541	1611641138917:1902813811	D5136C00008	41	37	CREATE	2021-01-26 07:05:41.356	04 IRB-IEC an_other Approvals	04.03 Trial Status Reporting
5090	83	1611641144981:1076819482	1611641141269:1119647541	D5136C00008	43	41	CREATE	2021-01-26 07:05:45.066	04.03 Trial Status Reporting	04.03.03 IRB-_rm Notification
5092	83	1611641146084:-885547857	1611641145535:419840345	D5136C00008	45	44	CREATE	2021-01-26 07:05:46.17	04.04 General	04.04.01 Rele_B-IEC-Documents
5094	83	1611641147252:921451337	1611641146631:210546677	D5136C00008	47	46	CREATE	2021-01-26 07:05:47.339	05 Site Management	05.01 Site Selection
5097	83	1611641148914:1322469735	1611641147252:921451337	D5136C00008	50	47	CREATE	2021-01-26 07:05:48.999	05.01 Site Selection	05.01.03 Feasibility Documentation
5098	83	1611641154522:375099871	1611641147252:921451337	D5136C00008	51	47	CREATE	2021-01-26 07:05:54.608	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
5102	83	1611641156884:882855925	1611641155108:752353359	D5136C00008	55	52	CREATE	2021-01-26 07:05:56.97	05.02 Site Se_p Documentation	05.02.03 Prot_ Signature Page
5103	83	1611641157454:1629527098	1611641155108:752353359	D5136C00008	56	52	CREATE	2021-01-26 07:05:57.541	05.02 Site Se_p Documentation	05.02.04 PI C_ite Affiliation
5104	83	1611641158005:-474961427	1611641155108:752353359	D5136C00008	57	52	CREATE	2021-01-26 07:05:58.09	05.02 Site Se_p Documentation	05.02.06 Othe_ite Affiliation
5107	83	1611641159743:-74567456	1611641155108:752353359	D5136C00008	60	52	CREATE	2021-01-26 07:05:59.828	05.02 Site Se_p Documentation	05.02.12 Clinical Trial Agreement
5109	83	1611641161023:1552140852	1611641155108:752353359	D5136C00008	62	52	CREATE	2021-01-26 07:06:01.109	05.02 Site Se_p Documentation	05.02.18 Site Signature Sheet
5111	83	1611641167399:-1413714738	1611641161682:-1478597346	D5136C00008	64	63	CREATE	2021-01-26 07:06:07.491	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
5113	83	1611641168816:-974313087	1611641161682:-1478597346	D5136C00008	66	63	CREATE	2021-01-26 07:06:08.901	05.03 Site Initiation	05.03.03 Site_umentation-Site
5116	83	1611641170533:-16496572	1611641169363:-2013654227	D5136C00008	69	67	CREATE	2021-01-26 07:06:10.618	05.04 Site Management	05.04.03 Monitoring Visit Report
5117	83	1611641171080:-232449710	1611641169363:-2013654227	D5136C00008	70	67	CREATE	2021-01-26 07:06:11.165	05.04 Site Management	05.04.04 Visit Log
5120	83	1611641172981:-1650639204	1611641146631:210546677	D5136C00008	73	46	CREATE	2021-01-26 07:06:13.069	05 Site Management	05.05 General
5122	83	1611641174101:1726733722	1611641172981:-1650639204	D5136C00008	75	73	CREATE	2021-01-26 07:06:14.186	05.05 General	05.05.02 Tracking Information
5125	83	1611641175884:-717569356	1611641175298:-1847480691	D5136C00008	78	77	CREATE	2021-01-26 07:06:15.971	06.01 IP Documentation	06.01.04 IP S_t Documentation
5127	83	1611641177014:1268545601	1611641175298:-1847480691	D5136C00008	80	77	CREATE	2021-01-26 07:06:17.099	06.01 IP Documentation	06.01.11 Certificate of Destruction
5129	83	1611641178199:-2041473554	1611641177645:-1856629220	D5136C00008	82	81	CREATE	2021-01-26 07:06:18.287	06.04 Storage	06.04.01 Stor_n Documentation
5131	83	1611641179338:934272725	1611641125971:-2109224039	D5136C00008	84	24	CREATE	2021-01-26 07:06:19.425	TBD-1-1RACHEE Nduba, Videlis	07 Safety Reporting
5134	83	1611641181087:-1888861576	1611641179903:-883324184	D5136C00008	87	85	CREATE	2021-01-26 07:06:21.173	07.02 Trial Status Reporting	07.02.03 Pregnancy Report
5136	83	1611641182800:630115234	1611641181647:1981775661	D5136C00008	89	88	CREATE	2021-01-26 07:06:22.886	07.03 General	07.03.01 Rele_ns-Safety-Email
5139	83	1611641184571:1041411636	1611641184005:1485148585	D5136C00008	92	91	CREATE	2021-01-26 07:06:24.659	08.01 Facility Documentation	08.01.01 Cert_r Accreditation
5140	83	1611641185139:466579456	1611641184005:1485148585	D5136C00008	93	91	CREATE	2021-01-26 07:06:25.227	08.01 Facility Documentation	08.01.04 Norm_nd Alert Values
5146	83	1611641188634:1011967195	1611635082806:-1894530611	D5136C00008	99	1	CREATE	2021-01-26 07:06:28.721	KENYA	TBD-1-1RACHJN Oyieko, Janet
5148	83	1611641189764:732813343	1611641189205:-1645362497	D5136C00008	101	100	CREATE	2021-01-26 07:06:29.85	05 Site Management	05.01 Site Selection
5151	83	1611641191515:431711401	1611641189764:732813343	D5136C00008	104	101	CREATE	2021-01-26 07:06:31.601	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
5152	83	1611641192586:-1906583418	rootNode	D5136C00008	105	0	CREATE	2021-01-26 07:06:32.679		LEBANON
5153	83	1611641193206:-1448325700	1611641192586:-1906583418	D5136C00008	106	105	CREATE	2021-01-26 07:06:33.292	LEBANON	02 Central Trial Documents
5156	83	1611641194952:724217392	1611641193206:-1448325700	D5136C00008	109	106	CREATE	2021-01-26 07:06:35.036	02 Central Trial Documents	02.02 Subject Documents
5160	83	1611641204543:648348324	1611641194952:724217392	D5136C00008	113	109	CREATE	2021-01-26 07:06:44.631	02.02 Subject Documents	02.02.03 Informed Consent Form Checklists
5161	83	1611641205161:2081414590	1611641194952:724217392	D5136C00008	114	109	CREATE	2021-01-26 07:06:45.246	02.02 Subject Documents	02.02.05 Subject Participation Card
5164	83	1611641208351:-4419933	1611641193206:-1448325700	D5136C00008	117	106	CREATE	2021-01-26 07:06:48.437	02 Central Trial Documents	02.04 General
5165	83	1611641208962:-332617816	1611641208351:-4419933	D5136C00008	118	117	CREATE	2021-01-26 07:06:49.045	02.04 General	02.04.01 Relevant Communications-Clinical Operations-Documents
5167	83	1611641210051:-2123461994	1611641192586:-1906583418	D5136C00008	120	105	CREATE	2021-01-26 07:06:50.137	LEBANON	03 Regulatory
5170	83	1611641211799:-2077340250	1611641210051:-2123461994	D5136C00008	123	120	CREATE	2021-01-26 07:06:51.883	03 Regulatory	03.03 Trial Status Reporting
5172	83	1611641212925:1313737179	1611641192586:-1906583418	D5136C00008	125	105	CREATE	2021-01-26 07:06:53.011	LEBANON	05 Site Management
5174	83	1611641214098:-1725102497	1611641213536:-179229825	D5136C00008	127	126	CREATE	2021-01-26 07:06:54.183	05.05 General	05.05.01 Relevan_on-Documents-Email
5175	83	1611641214649:-2085192152	1611641192586:-1906583418	D5136C00008	128	105	CREATE	2021-01-26 07:06:54.732	LEBANON	06 IP and Trial Supplies
5179	83	1611641216891:-215026989	1611641214649:-2085192152	D5136C00008	132	128	CREATE	2021-01-26 07:06:56.974	06 IP and Trial Supplies	06.07 General
5180	83	1611641217432:-1398219073	1611641216891:-215026989	D5136C00008	133	132	CREATE	2021-01-26 07:06:57.518	06.07 General	06.07.01 Relevan_onal Product-Email
5183	83	1611641219153:2031669099	1611641218597:1342993808	D5136C00008	136	135	CREATE	2021-01-26 07:06:59.239	09 Third Party	09.02 Third Party Set-up
5185	83	1611641220259:1485242300	1611641192586:-1906583418	D5136C00008	138	105	CREATE	2021-01-26 07:07:00.344	LEBANON	8801 Inati, Adlette
5187	83	1611641221456:978039609	1611641220889:1545586695	D5136C00008	140	139	CREATE	2021-01-26 07:07:01.543	02 Central Trial Documents	02.02 Subject Documents
5192	83	1611641224326:-1469787599	1611641220259:1485242300	D5136C00008	145	138	CREATE	2021-01-26 07:07:04.413	8801 Inati, Adlette	03 Regulatory
5195	83	1611641226118:-186216529	1611641224326:-1469787599	D5136C00008	148	145	CREATE	2021-01-26 07:07:06.219	03 Regulatory	03.03 Trial Status Reporting
5197	83	1611641227257:-547566127	1611641224326:-1469787599	D5136C00008	150	145	CREATE	2021-01-26 07:07:07.354	03 Regulatory	03.04 General
5199	83	1611641228476:450048179	1611641220259:1485242300	D5136C00008	152	138	CREATE	2021-01-26 07:07:08.571	8801 Inati, Adlette	04 IRB-IEC an_other Approvals
5201	83	1611641229587:-1261866358	1611641229044:167385129	D5136C00008	154	153	CREATE	2021-01-26 07:07:09.672	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
5204	83	1611641231316:-1098672775	1611641230770:1586505160	D5136C00008	157	156	CREATE	2021-01-26 07:07:11.404	04.03 Trial Status Reporting	04.03.02 IRB-_Progress Report
5205	83	1611641231880:-783030786	1611641230770:1586505160	D5136C00008	158	156	CREATE	2021-01-26 07:07:11.964	04.03 Trial Status Reporting	04.03.03 IRB-_rm Notification
5208	83	1611641233767:879539323	1611641233060:-1334710466	D5136C00008	161	160	CREATE	2021-01-26 07:07:13.854	05.01 Site Selection	05.01.02 Confidentiality Agreement
5209	83	1611641234325:391704641	1611641233060:-1334710466	D5136C00008	162	160	CREATE	2021-01-26 07:07:14.411	05.01 Site Selection	05.01.03 Feasibility Documentation
5212	83	1611641236068:-213814383	1611641235488:136088595	D5136C00008	165	164	CREATE	2021-01-26 07:07:16.155	05.02 Site Se_p Documentation	05.02.01 Acceptance of Investigator Brochure
5214	83	1611641237275:1162934091	1611641235488:136088595	D5136C00008	167	164	CREATE	2021-01-26 07:07:17.362	05.02 Site Se_p Documentation	05.02.04 PI CV-Site Affiliation
5217	83	1611641238973:1633273411	1611641235488:136088595	D5136C00008	170	164	CREATE	2021-01-26 07:07:19.06	05.02 Site Se_p Documentation	05.02.08 Form FDA1572
5218	83	1611641239604:222871448	1611641235488:136088595	D5136C00008	171	164	CREATE	2021-01-26 07:07:19.693	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
5221	83	1611641241301:670347643	1611641235488:136088595	D5136C00008	174	164	CREATE	2021-01-26 07:07:21.388	05.02 Site Se_p Documentation	05.02.18 Site Signature Sheet
5222	83	1611641241923:297161453	1611641232432:-1769405070	D5136C00008	175	159	CREATE	2021-01-26 07:07:22.01	05 Site Management	05.03 Site Initiation
5224	83	1611641243053:1509191650	1611641241923:297161453	D5136C00008	177	175	CREATE	2021-01-26 07:07:23.142	05.03 Site Initiation	05.03.03 Site Training-Staff
5226	83	1611641244164:1347188210	1611641243600:1541578440	D5136C00008	179	178	CREATE	2021-01-26 07:07:24.293	05.04 Site Management	05.04.01 Subject Log
5228	83	1611641245691:298627777	1611641243600:1541578440	D5136C00008	181	178	CREATE	2021-01-26 07:07:25.776	05.04 Site Management	05.04.04 Visit Log
5231	83	1611641247438:1367411241	1611641243600:1541578440	D5136C00008	184	178	CREATE	2021-01-26 07:07:27.523	05.04 Site Management	05.04.09 Inv _ification-SUSAR
5232	83	1611641248043:1901410763	1611641232432:-1769405070	D5136C00008	185	159	CREATE	2021-01-26 07:07:28.128	05 Site Management	05.05 General
5233	83	1611641248676:-1553834374	1611641248043:1901410763	D5136C00008	186	185	CREATE	2021-01-26 07:07:28.776	05.05 General	05.05.01 Rele_nications-Email
5237	83	1611641261155:308108825	1611641260592:-276369822	D5136C00008	190	189	CREATE	2021-01-26 07:07:41.243	06.01 IP Documentation	06.01.04 IP Shipment Documentation
5239	83	1611641262364:-407969752	1611641259987:-2019425879	D5136C00008	192	188	CREATE	2021-01-26 07:07:42.449	06 IP and Trial Supplies	06.04 Storage
5241	83	1611641263609:-1542244877	1611641262364:-407969752	D5136C00008	194	192	CREATE	2021-01-26 07:07:43.734	06.04 Storage	06.04.02 Stor_n Documentation
5242	83	1611641264375:1555441436	1611641220259:1485242300	D5136C00008	195	138	CREATE	2021-01-26 07:07:44.51	8801 Inati, Adlette	07 Safety Reporting
5961	83	1611641857109:-132823061	1611641856549:-1614870835	D5136C00008	914	913	CREATE	2021-01-26 07:17:37.197	08.01 Facility Documentation	08.01.01 Cert_r Accreditation
5248	83	1611641268190:2064345550	1611641192586:-1906583418	D5136C00008	201	105	CREATE	2021-01-26 07:07:48.277	LEBANON	8802 Abboud, Miguel
5250	83	1611641272075:-25702648	1611641268812:-1246752115	D5136C00008	203	202	CREATE	2021-01-26 07:07:52.163	02 Central Trial Documents	02.02 Subject Documents
5253	83	1611641274588:1463436017	1611641268812:-1246752115	D5136C00008	206	202	CREATE	2021-01-26 07:07:54.674	02 Central Trial Documents	02.04 General
5254	83	1611641275211:679151201	1611641274588:1463436017	D5136C00008	207	206	CREATE	2021-01-26 07:07:55.299	02.04 General	02.04.01 Rele_-Contact Report
5258	83	1611641277809:1943953574	1611641275829:-2044286765	D5136C00008	211	208	CREATE	2021-01-26 07:07:57.894	03 Regulatory	03.04 General
5259	83	1611641278421:-1893956753	1611641277809:1943953574	D5136C00008	212	211	CREATE	2021-01-26 07:07:58.532	03.04 General	03.04.01 Rele_rt-Up-Documents
5262	83	1611641280407:-925427464	1611641279667:-351148005	D5136C00008	215	214	CREATE	2021-01-26 07:08:00.493	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
5264	83	1611641281637:-567607150	1611641279025:1689619362	D5136C00008	217	213	CREATE	2021-01-26 07:08:01.724	04 IRB-IEC an_other Approvals	04.03 Trial Status Reporting
5267	83	1611641283462:-708346278	1611641268190:2064345550	D5136C00008	220	201	CREATE	2021-01-26 07:08:03.549	8802 Abboud, Miguel	05 Site Management
5268	83	1611641284084:762640707	1611641283462:-708346278	D5136C00008	221	220	CREATE	2021-01-26 07:08:04.171	05 Site Management	05.01 Site Selection
5270	83	1611641286599:-550973053	1611641284084:762640707	D5136C00008	223	221	CREATE	2021-01-26 07:08:06.686	05.01 Site Selection	05.01.03 Feasibility Documentation
5273	83	1611641288279:-210714211	1611641287732:-1798491443	D5136C00008	226	225	CREATE	2021-01-26 07:08:08.364	05.02 Site Se_p Documentation	05.02.01 Acceptance of Investigator Brochure
5274	83	1611641288937:-717070214	1611641287732:-1798491443	D5136C00008	227	225	CREATE	2021-01-26 07:08:09.032	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
5277	83	1611641292192:479026650	1611641287732:-1798491443	D5136C00008	230	225	CREATE	2021-01-26 07:08:12.297	05.02 Site Se_p Documentation	05.02.07 Staff Qualification
5278	83	1611641292852:1636362974	1611641287732:-1798491443	D5136C00008	231	225	CREATE	2021-01-26 07:08:12.937	05.02 Site Se_p Documentation	05.02.08 Form FDA1572
5282	83	1611641295357:-1666737140	1611641287732:-1798491443	D5136C00008	235	225	CREATE	2021-01-26 07:08:15.442	05.02 Site Se_p Documentation	05.02.18 Site Signature Sheet
5283	83	1611641295900:-1374361282	1611641283462:-708346278	D5136C00008	236	220	CREATE	2021-01-26 07:08:15.985	05 Site Management	05.03 Site Initiation
5286	83	1611641297768:1593457326	1611641295900:-1374361282	D5136C00008	239	236	CREATE	2021-01-26 07:08:17.853	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
5287	83	1611641298339:1242683668	1611641283462:-708346278	D5136C00008	240	220	CREATE	2021-01-26 07:08:18.426	05 Site Management	05.04 Site Management
5289	83	1611641299470:1503846772	1611641298339:1242683668	D5136C00008	242	240	CREATE	2021-01-26 07:08:19.557	05.04 Site Management	05.04.03 Monitoring Visit Report
5292	83	1611641301221:1851569477	1611641298339:1242683668	D5136C00008	245	240	CREATE	2021-01-26 07:08:21.309	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
5295	83	1611641302932:-33137448	1611641283462:-708346278	D5136C00008	248	220	CREATE	2021-01-26 07:08:23.017	05 Site Management	05.05 General
5296	83	1611641303507:-1796499208	1611641302932:-33137448	D5136C00008	249	248	CREATE	2021-01-26 07:08:23.593	05.05 General	05.05.01 Rele_nications-Email
5297	83	1611641304060:1481868773	1611641302932:-33137448	D5136C00008	250	248	CREATE	2021-01-26 07:08:24.145	05.05 General	05.05.02 Tracking Information
5301	83	1611641306455:-1236844329	1611641268190:2064345550	D5136C00008	254	201	CREATE	2021-01-26 07:08:26.539	8802 Abboud, Miguel	07 Safety Reporting
5302	83	1611641307035:269218627	1611641306455:-1236844329	D5136C00008	255	254	CREATE	2021-01-26 07:08:27.121	07 Safety Reporting	07.03 General
5303	83	1611641307582:1790260342	1611641307035:269218627	D5136C00008	256	255	CREATE	2021-01-26 07:08:27.67	07.03 General	07.03.01 Rele_ns-Safety-Email
5306	83	1611641309220:199223105	1611641308631:539102919	D5136C00008	259	258	CREATE	2021-01-26 07:08:29.306	02 Central Trial Documents	02.01 Trial Documents
5309	83	1611641310956:976683399	1611641308631:539102919	D5136C00008	262	258	CREATE	2021-01-26 07:08:31.04	02 Central Trial Documents	02.02 Subject Documents
5311	83	1611641312161:-310149665	1611641310956:976683399	D5136C00008	264	262	CREATE	2021-01-26 07:08:32.249	02.02 Subject Documents	02.02.03 Informed Consent Form Checklists
5314	83	1611641313845:1039689347	1611641310956:976683399	D5136C00008	267	262	CREATE	2021-01-26 07:08:33.945	02.02 Subject Documents	02.02.07 Other W_ Given to Subjects
5315	83	1611641314509:125753808	1611641308631:539102919	D5136C00008	268	258	CREATE	2021-01-26 07:08:34.594	02 Central Trial Documents	02.04 General
5316	83	1611641315117:-203512239	1611641314509:125753808	D5136C00008	269	268	CREATE	2021-01-26 07:08:35.205	02.04 General	02.04.02 Tracking Information
5319	83	1611641316832:-191506941	1611641316277:-594826869	D5136C00008	272	271	CREATE	2021-01-26 07:08:36.917	03.01 Trial Approval	03.01.01 Submission
5324	83	1611641322936:2095054813	1611641308064:-1780896329	D5136C00008	277	257	CREATE	2021-01-26 07:08:43.022	TURKEY	04 IRB-IEC and other Approvals
5326	83	1611641324136:738747504	1611641323555:-1313666846	D5136C00008	279	278	CREATE	2021-01-26 07:08:44.22	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
5329	83	1611641326090:-921021130	1611641325529:2060224917	D5136C00008	282	281	CREATE	2021-01-26 07:08:46.176	04.03 Trial Status Reporting	04.03.01 IRB-IEC_ety Info-Deviation
5330	83	1611641326676:-1932054878	1611641325529:2060224917	D5136C00008	283	281	CREATE	2021-01-26 07:08:46.76	04.03 Trial Status Reporting	04.03.02 IRB-IEC Progress Report
5333	83	1611641328432:1255199303	1611641327869:-294928245	D5136C00008	286	285	CREATE	2021-01-26 07:08:48.518	05 Site Management	05.03 Site Initiation
5334	83	1611641329012:-1832564854	1611641328432:1255199303	D5136C00008	287	286	CREATE	2021-01-26 07:08:49.097	05.03 Site Initiation	05.03.02 Site Training Material
5336	83	1611641330945:518958315	1611641329592:-1110519338	D5136C00008	289	288	CREATE	2021-01-26 07:08:51.03	05.05 General	05.05.01 Relevan_on-Documents-Email
5339	83	1611641332638:981413674	1611641332061:1168507137	D5136C00008	292	291	CREATE	2021-01-26 07:08:52.725	06.07 General	06.07.01 Relevan_onal Product-Email
5340	83	1611641339019:-1528095729	1611641308064:-1780896329	D5136C00008	293	257	CREATE	2021-01-26 07:08:59.108	TURKEY	07 Safety Reporting
5343	83	1611641340822:-1114575569	1611641308064:-1780896329	D5136C00008	296	257	CREATE	2021-01-26 07:09:00.909	TURKEY	08 Centralized Testing
5965	83	1611641859355:-212282778	1611641858821:1916082264	D5136C00008	918	917	CREATE	2021-01-26 07:17:39.44	02 Central Trial Documents	02.02 Subject Documents
5347	83	1611641376330:1360373821	1611641340822:-1114575569	D5136C00008	300	296	CREATE	2021-01-26 07:09:36.418	08 Centralized Testing	08.03 General
5349	83	1611641377844:-32509700	1611641308064:-1780896329	D5136C00008	302	257	CREATE	2021-01-26 07:09:37.93	TURKEY	09 Third Party
5351	83	1611641379072:-440432803	1611641378514:1644563501	D5136C00008	304	303	CREATE	2021-01-26 07:09:39.159	09.02 Third Party Set-up	09.02.03 Contractual Agreement
5354	83	1611641381582:-90037019	1611641381022:1907539791	D5136C00008	307	306	CREATE	2021-01-26 07:09:41.669	7601 Antmen, Ali Bulent	02 Central Trial Documents
5355	83	1611641382155:1914193741	1611641381582:-90037019	D5136C00008	308	307	CREATE	2021-01-26 07:09:42.241	02 Central Trial Documents	02.02 Subject Documents
5358	83	1611641384027:1561460059	1611641383413:-1154639148	D5136C00008	311	310	CREATE	2021-01-26 07:09:44.115	02.04 General	02.04.01 Rele_tions-Documents
5361	83	1611641385819:-189809981	1611641385243:1841533869	D5136C00008	314	313	CREATE	2021-01-26 07:09:45.904	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
5363	83	1611641386972:687809263	1611641386398:1299514596	D5136C00008	316	315	CREATE	2021-01-26 07:09:47.058	05 Site Management	05.01 Site Selection
5364	83	1611641387616:1098295416	1611641386972:687809263	D5136C00008	317	316	CREATE	2021-01-26 07:09:47.703	05.01 Site Selection	05.01.02 Confidentiality Agreement
5367	83	1611641389332:-1873206188	1611641386398:1299514596	D5136C00008	320	315	CREATE	2021-01-26 07:09:50.073	05 Site Management	05.02 Site Se_p Documentation
5369	83	1611641391188:853539384	1611641389332:-1873206188	D5136C00008	322	320	CREATE	2021-01-26 07:09:51.273	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
5372	83	1611641393001:-2120100166	1611641389332:-1873206188	D5136C00008	325	320	CREATE	2021-01-26 07:09:53.086	05.02 Site Se_p Documentation	05.02.06 Othe_ite Affiliation
5373	83	1611641393551:2052665429	1611641389332:-1873206188	D5136C00008	326	320	CREATE	2021-01-26 07:09:53.634	05.02 Site Se_p Documentation	05.02.09 Inve_atory Agreement
5376	83	1611641395303:-938532520	1611641389332:-1873206188	D5136C00008	329	320	CREATE	2021-01-26 07:09:55.39	05.02 Site Se_p Documentation	05.02.17 IP Site Release Documentation
5377	83	1611641395891:-797486967	1611641389332:-1873206188	D5136C00008	330	320	CREATE	2021-01-26 07:09:55.977	05.02 Site Se_p Documentation	05.02.18 Site Signature Sheet
5380	83	1611641399973:-1165493829	1611641398777:-1449076027	D5136C00008	333	331	CREATE	2021-01-26 07:10:00.057	05.03 Site Initiation	05.03.03 Site Training-Staff
5382	83	1611641401135:1872542875	1611641386398:1299514596	D5136C00008	335	315	CREATE	2021-01-26 07:10:01.221	05 Site Management	05.04 Site Management
5383	83	1611641401686:210116681	1611641401135:1872542875	D5136C00008	336	335	CREATE	2021-01-26 07:10:01.771	05.04 Site Management	05.04.01 Subject Log
5386	83	1611641403505:-1211159944	1611641401135:1872542875	D5136C00008	339	335	CREATE	2021-01-26 07:10:03.591	05.04 Site Management	05.04.05 Additional Monitoring Activity
5389	83	1611641405310:2085799967	1611641401135:1872542875	D5136C00008	342	335	CREATE	2021-01-26 07:10:05.396	05.04 Site Management	05.04.09 Inv Notification-SUSAR
5391	83	1611641406448:-1140865811	1611641405889:1530983946	D5136C00008	344	343	CREATE	2021-01-26 07:10:06.534	05.05 General	05.05.01 Rele_nications-Email
5393	83	1611641407680:1491095308	1611641381022:1907539791	D5136C00008	346	306	CREATE	2021-01-26 07:10:07.886	7601 Antmen, Ali Bulent	06 IP and Trial Supplies
5396	83	1611641410550:1440487346	1611641408382:1231310022	D5136C00008	349	347	CREATE	2021-01-26 07:10:10.638	06.01 IP Documentation	06.01.10 IP D_entation Return
5399	83	1611641412382:-681335063	1611641411735:958976882	D5136C00008	352	351	CREATE	2021-01-26 07:10:12.482	06.04 Storage	06.04.01 Storage Condition Documentation
5400	83	1611641412958:-1236195809	1611641411735:958976882	D5136C00008	353	351	CREATE	2021-01-26 07:10:13.043	06.04 Storage	06.04.03 Maintenance Logs
14781	88	1617050182170:-1429529666	1617050181568:-159398468	D5170C00001	471	470	ALREADY AVAILABLE	2021-03-30 07:19:37.313	Site	Canada
5403	83	1611641414719:1049473910	1611641413561:-720813788	D5136C00008	356	354	CREATE	2021-01-26 07:10:14.803	06.05 Non-IP Documentation	06.05.03 Non-_ation of Return
5405	83	1611641415986:1652206976	1611641415401:-634916832	D5136C00008	358	357	CREATE	2021-01-26 07:10:16.077	07 Safety Reporting	07.02 Trial Status Reporting
5406	83	1611641416554:-1897050423	1611641415986:1652206976	D5136C00008	359	358	CREATE	2021-01-26 07:10:16.642	07.02 Trial Status Reporting	07.02.02 SAE Report
5409	83	1611641418332:-1418801034	1611641381022:1907539791	D5136C00008	362	306	CREATE	2021-01-26 07:10:18.435	7601 Antmen, Ali Bulent	08 Centralized Testing
5411	83	1611641419539:-1148049433	1611641418943:518296229	D5136C00008	364	363	CREATE	2021-01-26 07:10:19.635	08.01 Facility Documentation	08.01.04 Norm_nd Alert Values
5414	83	1611641422297:-172926705	1611641420778:-1862627907	D5136C00008	367	366	CREATE	2021-01-26 07:10:22.383	08.02 Sample Documentation	08.02.03 Samp_e Condition Log
5415	83	1611641422929:1736549884	1611641420778:-1862627907	D5136C00008	368	366	CREATE	2021-01-26 07:10:23.016	08.02 Sample Documentation	08.02.05 Reta_-Tissue Samples
5418	83	1611641424658:991556839	1611641424103:1728944826	D5136C00008	371	370	CREATE	2021-01-26 07:10:24.747	10.02 Data Capture	10.02.03 Completed CRFs (Paper)
5419	83	1611641425234:-1793389510	1611641308064:-1780896329	D5136C00008	372	257	CREATE	2021-01-26 07:10:25.32	TURKEY	7602 Ilgen Sasmaz, Hatice
5421	83	1611641426413:1544408119	1611641425855:-2079925699	D5136C00008	374	373	CREATE	2021-01-26 07:10:26.498	05 Site Management	05.01 Site Selection
5424	83	1611641428247:-273022431	1611641427590:-1279760116	D5136C00008	377	376	CREATE	2021-01-26 07:10:28.334	05.02 Site Se_p Documentation	05.02.04 PI C_ite Affiliation
5425	83	1611641428841:1078425869	1611641308064:-1780896329	D5136C00008	378	257	CREATE	2021-01-26 07:10:28.925	TURKEY	7603 Unal, Selma
5428	83	1611641430665:45538764	1611641430005:-554911708	D5136C00008	381	380	CREATE	2021-01-26 07:10:30.751	02.04 General	02.04.01 Rele_-Contact Report
5430	83	1611641437014:355969895	1611641428841:1078425869	D5136C00008	383	378	CREATE	2021-01-26 07:10:37.103	7603 Unal, Selma	05 Site Management
5433	83	1611641438786:-445075501	1611641437572:-1070718334	D5136C00008	386	384	CREATE	2021-01-26 07:10:38.872	05.01 Site Selection	05.01.03 Feasibility Documentation
5436	83	1611641440584:-285499936	1611641439922:-38030433	D5136C00008	389	388	CREATE	2021-01-26 07:10:40.676	05.02 Site Se_p Documentation	05.02.01 Acceptance of Investigator Brochure
5437	83	1611641441156:1548329016	1611641439922:-38030433	D5136C00008	390	388	CREATE	2021-01-26 07:10:41.242	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
5440	83	1611641443704:-1999535094	1611641439922:-38030433	D5136C00008	393	388	CREATE	2021-01-26 07:10:43.794	05.02 Site Se_p Documentation	05.02.06 Other CV-Site Affiliation
5968	83	1611641862740:1013851629	1611641858821:1916082264	D5136C00008	921	917	CREATE	2021-01-26 07:17:42.825	02 Central Trial Documents	02.04 General
5444	83	1611641446050:745233916	1611641439922:-38030433	D5136C00008	397	388	CREATE	2021-01-26 07:10:46.136	05.02 Site Se_p Documentation	05.02.18 Site Signature Sheet
5446	83	1611641447317:-1978687773	1611641446591:1087342454	D5136C00008	399	398	CREATE	2021-01-26 07:10:47.404	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
5447	83	1611641449540:345722124	1611641446591:1087342454	D5136C00008	400	398	CREATE	2021-01-26 07:10:49.624	05.03 Site Initiation	05.03.03 Site Training-Staff
5450	83	1611641451405:-810520544	1611641450803:-149148115	D5136C00008	403	402	CREATE	2021-01-26 07:10:51.501	05.04 Site Management	05.04.01 Subject Log
5452	83	1611641453300:621826579	1611641450803:-149148115	D5136C00008	405	402	CREATE	2021-01-26 07:10:53.385	05.04 Site Management	05.04.04 Visit Log
5456	83	1611641455896:-1866401008	1611641437014:355969895	D5136C00008	409	383	CREATE	2021-01-26 07:10:55.981	05 Site Management	05.05 General
5457	83	1611641456518:-352781817	1611641455896:-1866401008	D5136C00008	410	409	CREATE	2021-01-26 07:10:56.604	05.05 General	05.05.01 Relevant Communications-Email
5458	83	1611641457112:-1279161020	1611641455896:-1866401008	D5136C00008	411	409	CREATE	2021-01-26 07:10:57.204	05.05 General	05.05.02 Tracking Information
5462	83	1611641459494:929533002	1611641458298:-16868745	D5136C00008	415	413	CREATE	2021-01-26 07:10:59.582	06.01 IP Documentation	06.01.10 IP D_entation Return
5463	83	1611641460203:333207752	1611641458298:-16868745	D5136C00008	416	413	CREATE	2021-01-26 07:11:00.288	06.01 IP Documentation	06.01.11 Certificate of Destruction
5466	83	1611641462152:1296314442	1611641460811:-1928091069	D5136C00008	419	417	CREATE	2021-01-26 07:11:02.242	06.04 Storage	06.04.03 Maintenance Logs
5469	83	1611641464023:217446638	1611641462736:1125260371	D5136C00008	422	420	CREATE	2021-01-26 07:11:04.111	06.05 Non-IP Documentation	06.05.03 Non-IP Documentation of Return
5470	83	1611641464739:1778965395	1611641428841:1078425869	D5136C00008	423	378	CREATE	2021-01-26 07:11:04.85	7603 Unal, Selma	07 Safety Reporting
5472	83	1611641466026:1604772268	1611641465393:-671198915	D5136C00008	425	424	CREATE	2021-01-26 07:11:06.124	07.02 Trial Status Reporting	07.02.02 SAE Report
5474	83	1611641467185:-309915757	1611641466584:-1522126515	D5136C00008	427	426	CREATE	2021-01-26 07:11:07.278	07.03 General	07.03.01 Rele_ns-Safety-Email
5477	83	1611641468995:-2087969518	1611641468416:-937483898	D5136C00008	430	429	CREATE	2021-01-26 07:11:09.086	08.01 Facility Documentation	08.01.01 Cert_r Accreditation
5479	83	1611641470217:1217312933	1611641468416:-937483898	D5136C00008	432	429	CREATE	2021-01-26 07:11:10.305	08.01 Facility Documentation	08.01.07 Head of Facility CV
5480	83	1611641470797:976569871	1611641467748:-1397939616	D5136C00008	433	428	CREATE	2021-01-26 07:11:10.882	08 Centralized Testing	08.02 Sample Documentation
5483	83	1611641472621:1691274514	1611641308064:-1780896329	D5136C00008	436	257	CREATE	2021-01-26 07:11:12.704	TURKEY	7604 Demir, Cengiz
5484	83	1611641473200:1765871668	1611641472621:1691274514	D5136C00008	437	436	CREATE	2021-01-26 07:11:13.286	7604 Demir, Cengiz	02 Central Trial Documents
5487	83	1611641475002:-1249598107	1611641472621:1691274514	D5136C00008	440	436	CREATE	2021-01-26 07:11:15.088	7604 Demir, Cengiz	03 Regulatory
5489	83	1611641476189:1158618627	1611641475593:-1117694739	D5136C00008	442	441	CREATE	2021-01-26 07:11:16.277	03.01 Trial Approval	03.01.02 Approval
5492	83	1611641477927:-492535828	1611641477381:1251585694	D5136C00008	445	444	CREATE	2021-01-26 07:11:18.012	05.01 Site Selection	05.01.02 Confidentiality Agreement
5494	83	1611641479105:-1804302336	1611641477381:1251585694	D5136C00008	447	444	CREATE	2021-01-26 07:11:19.192	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
9416	85	1616043114723:-1860584359	1616043032792:2030519844	D5170C00002	432	317	CREATE	2021-03-18 05:51:54.81	Site	2002360 Kim, Hyun-Soo
5497	83	1611641480866:1155687570	1611641479662:-1134365291	D5136C00008	450	448	CREATE	2021-01-26 07:11:20.958	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
5498	83	1611641481416:518247373	1611641479662:-1134365291	D5136C00008	451	448	CREATE	2021-01-26 07:11:23.01	05.02 Site Se_p Documentation	05.02.03 Protocol Amendment Signature Page
5501	83	1611641499280:-1676969070	1611641479662:-1134365291	D5136C00008	454	448	CREATE	2021-01-26 07:11:39.371	05.02 Site Se_p Documentation	05.02.09 Inve_atory Agreement
5502	83	1611641500772:-507844080	1611641479662:-1134365291	D5136C00008	455	448	CREATE	2021-01-26 07:11:40.857	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
5505	83	1611641502430:-1430683086	1611641479662:-1134365291	D5136C00008	458	448	CREATE	2021-01-26 07:11:42.515	05.02 Site Se_p Documentation	05.02.18 Site Signature Sheet
5506	83	1611641503042:-710235130	1611641476799:554249780	D5136C00008	459	443	CREATE	2021-01-26 07:11:43.127	05 Site Management	05.03 Site Initiation
5509	83	1611641504761:-340874263	1611641503042:-710235130	D5136C00008	462	459	CREATE	2021-01-26 07:11:44.846	05.03 Site Initiation	05.03.03 Site_umentation-Site
5511	83	1611641505916:104482433	1611641505332:536430965	D5136C00008	464	463	CREATE	2021-01-26 07:11:46.004	05.04 Site Management	05.04.01 Subject Log
5512	83	1611641506462:-2104041615	1611641505332:536430965	D5136C00008	465	463	CREATE	2021-01-26 07:11:46.549	05.04 Site Management	05.04.03 Monitoring Visit Report
5515	83	1611641508213:-1434951509	1611641505332:536430965	D5136C00008	468	463	CREATE	2021-01-26 07:11:48.303	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
5517	83	1611641509332:-1876594936	1611641505332:536430965	D5136C00008	470	463	CREATE	2021-01-26 07:11:49.418	05.04 Site Management	05.04.09 Inv Notification-SUSAR
5521	83	1611641513722:-1060499336	1611641513158:-1472072806	D5136C00008	474	473	CREATE	2021-01-26 07:11:53.807	06 IP and Trial Supplies	06.01 IP Documentation
5523	83	1611641514832:-1506829258	1611641513722:-1060499336	D5136C00008	476	474	CREATE	2021-01-26 07:11:54.919	06.01 IP Documentation	06.01.10 IP D_entation Return
5525	83	1611641516019:183849314	1611641513158:-1472072806	D5136C00008	478	473	CREATE	2021-01-26 07:11:56.107	06 IP and Trial Supplies	06.04 Storage
5527	83	1611641517140:1874374206	1611641516019:183849314	D5136C00008	480	478	CREATE	2021-01-26 07:11:57.225	06.04 Storage	06.04.03 Maintenance Logs
5530	83	1611641518863:672269602	1611641517788:-356545034	D5136C00008	483	481	CREATE	2021-01-26 07:11:58.965	06.05 Non-IP Documentation	06.05.03 Non-IP Documentation of Return
5531	83	1611641519431:-2017504633	1611641472621:1691274514	D5136C00008	484	436	CREATE	2021-01-26 07:11:59.516	7604 Demir, Cengiz	08 Centralized Testing
5534	83	1611641521168:200146076	1611641520047:-1027127638	D5136C00008	487	485	CREATE	2021-01-26 07:12:01.253	08.01 Facility Documentation	08.01.07 Head of Facility CV
5536	83	1611641522371:-931632143	1611641521722:-1330966558	D5136C00008	489	488	CREATE	2021-01-26 07:12:02.458	08.02 Sample Documentation	08.02.03 Samp_e Condition Log
8202	84	\N	\N	D5170C00002	1987	1335	NEW	\N	Site	TBD-1-1RDPHRT Witthoeft, Thomas
5538	83	1611641523376:-1327162297	rootNode	D5136C00008	491	0	CREATE	2021-01-26 07:12:03.465		UNITED KINGDOM
5541	83	1611641525244:-1662980217	1611641524639:733074266	D5136C00008	494	493	CREATE	2021-01-26 07:12:05.33	02.01 Trial Documents	02.01.03 Protocol Synopsis
5543	83	1611641526425:-2077853683	1611641523954:-1587146496	D5136C00008	496	492	CREATE	2021-01-26 07:12:06.51	02 Central Trial Documents	02.02 Subject Documents
5546	83	1611641528172:-1509357453	1611641526425:-2077853683	D5136C00008	499	496	CREATE	2021-01-26 07:12:08.258	02.02 Subject Documents	02.02.05 Subject Participation Card
5547	83	1611641528734:245616676	1611641526425:-2077853683	D5136C00008	500	496	CREATE	2021-01-26 07:12:08.819	02.02 Subject Documents	02.02.07 Other W_ Given to Subjects
5550	83	1611641530548:1907082232	1611641523376:-1327162297	D5136C00008	503	491	CREATE	2021-01-26 07:12:10.634	UNITED KINGDOM	03 Regulatory
5552	83	1611641532439:771616069	1611641531177:396075957	D5136C00008	505	504	CREATE	2021-01-26 07:12:12.525	03.01 Trial Approval	03.01.01 Submission
5555	83	1611641534196:-978863122	1611641533599:1095748928	D5136C00008	508	507	CREATE	2021-01-26 07:12:14.283	03.03 Trial Status Reporting	03.03.02 Progress Report
5557	83	1611641545490:-676817329	1611641530548:1907082232	D5136C00008	510	503	CREATE	2021-01-26 07:12:25.581	03 Regulatory	03.04 General
5559	83	1611641547427:1140382926	1611641546875:-1271742766	D5136C00008	512	511	CREATE	2021-01-26 07:12:27.516	03.04.01 Rele_-Start-Up-Email	applicant change- Nov2015
5561	83	1611641548568:1779650611	1611641523376:-1327162297	D5136C00008	514	491	CREATE	2021-01-26 07:12:28.653	UNITED KINGDOM	04 IRB-IEC and other Approvals
5564	83	1611641550350:289415099	1611641549125:2141911536	D5136C00008	517	515	CREATE	2021-01-26 07:12:30.436	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
5565	83	1611641550946:-1151237961	1611641549125:2141911536	D5136C00008	518	515	CREATE	2021-01-26 07:12:31.035	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
5568	83	1611641552719:-624905288	1611641551528:-733925120	D5136C00008	521	519	CREATE	2021-01-26 07:12:32.803	04.03 Trial Status Reporting	04.03.03 IRB-IEC Trial Term Notification
5569	83	1611641553264:-1430602661	1611641548568:1779650611	D5136C00008	522	514	CREATE	2021-01-26 07:12:33.349	04 IRB-IEC and other Approvals	04.04 General
5572	83	1611641555041:-645532323	1611641553264:-1430602661	D5136C00008	525	522	CREATE	2021-01-26 07:12:35.127	04.04 General	04.04.01 Relevant Communications-IRB-IEC-Documents
5573	83	1611641555612:-1050735151	1611641523376:-1327162297	D5136C00008	526	491	CREATE	2021-01-26 07:12:35.699	UNITED KINGDOM	05 Site Management
5576	83	1611641558567:-1608051729	1611641555612:-1050735151	D5136C00008	529	526	CREATE	2021-01-26 07:12:38.655	05 Site Management	05.05 General
5578	83	1611641559725:1894483703	1611641523376:-1327162297	D5136C00008	531	491	CREATE	2021-01-26 07:12:39.823	UNITED KINGDOM	07 Safety Reporting
5579	83	1611641560331:823359296	1611641559725:1894483703	D5136C00008	532	531	CREATE	2021-01-26 07:12:40.422	07 Safety Reporting	07.03 General
5582	83	1611641562108:1256030504	1611641561537:-1021457304	D5136C00008	535	534	CREATE	2021-01-26 07:12:42.193	09 Third Party	09.02 Third Party Set-up
5587	83	1611641566469:-1254275243	1611641565908:-893255450	D5136C00008	540	539	CREATE	2021-01-26 07:12:46.559	02.02 Subject Documents	02.02.03 Info_ Form Templates
5589	83	1611641576614:1969678168	1611641563860:-1812593903	D5136C00008	542	538	CREATE	2021-01-26 07:12:56.727	02 Central Trial Documents	02.04 General
5592	83	1611641578304:1659707529	1611641577760:-366555901	D5136C00008	545	544	CREATE	2021-01-26 07:12:58.39	04 IRB-IEC an_other Approvals	04.02 Other Committees
5593	83	1611641578852:203423623	1611641578304:1659707529	D5136C00008	546	545	CREATE	2021-01-26 07:12:58.938	04.02 Other Committees	04.02.02 Other Approvals
5596	83	1611641580609:1971994231	1611641563305:1950187595	D5136C00008	549	537	CREATE	2021-01-26 07:13:00.695	2801 Chowdhury, Fateha	05 Site Management
5598	83	1611641581773:-632029463	1611641581189:-1159841738	D5136C00008	551	550	CREATE	2021-01-26 07:13:01.87	05.01 Site Selection	05.01.02 Confidentiality Agreement
5601	83	1611641583518:310957323	1611641580609:1971994231	D5136C00008	554	549	CREATE	2021-01-26 07:13:03.604	05 Site Management	05.02 Site Se_p Documentation
5602	83	1611641584061:1979279909	1611641583518:310957323	D5136C00008	555	554	CREATE	2021-01-26 07:13:04.147	05.02 Site Se_p Documentation	05.02.01 Acce_igator Brochure
5605	83	1611641585801:153591692	1611641583518:310957323	D5136C00008	558	554	CREATE	2021-01-26 07:13:05.885	05.02 Site Se_p Documentation	05.02.06 Othe_ite Affiliation
5607	83	1611641586907:-1693712	1611641583518:310957323	D5136C00008	560	554	CREATE	2021-01-26 07:13:07.741	05.02 Site Se_p Documentation	05.02.07 Staff Qualification
5608	83	1611641588279:612585641	1611641583518:310957323	D5136C00008	561	554	CREATE	2021-01-26 07:13:08.367	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
5611	83	1611641589994:1764699442	1611641583518:310957323	D5136C00008	564	554	CREATE	2021-01-26 07:13:10.079	05.02 Site Se_p Documentation	05.02.18 Site Signature Sheet
5612	83	1611641590634:735045048	1611641580609:1971994231	D5136C00008	565	549	CREATE	2021-01-26 07:13:10.772	05 Site Management	05.03 Site Initiation
5615	83	1611641592345:280457027	1611641590634:735045048	D5136C00008	568	565	CREATE	2021-01-26 07:13:12.431	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
5617	83	1611641593529:-1869602438	1611641592944:1838866742	D5136C00008	570	569	CREATE	2021-01-26 07:13:13.618	05.04 Site Management	05.04.01 Subject Log
5620	83	1611641599450:1444416674	1611641592944:1838866742	D5136C00008	573	569	CREATE	2021-01-26 07:13:19.536	05.04 Site Management	05.04.05 Additional Monitoring Activity
5621	83	1611641600180:885888480	1611641592944:1838866742	D5136C00008	574	569	CREATE	2021-01-26 07:13:20.267	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
5623	83	1611641601462:-2096289449	1611641580609:1971994231	D5136C00008	576	549	CREATE	2021-01-26 07:13:21.549	05 Site Management	05.05 General
5626	83	1611641603355:-2131402962	1611641563305:1950187595	D5136C00008	579	537	CREATE	2021-01-26 07:13:23.441	2801 Chowdhury, Fateha	06 IP and Trial Supplies
5629	83	1611641605277:1338442806	1611641604056:-1028150333	D5136C00008	582	580	CREATE	2021-01-26 07:13:25.367	06.01 IP Documentation	06.01.05 Accountability Documentation
5630	83	1611641605932:429711983	1611641604056:-1028150333	D5136C00008	583	580	CREATE	2021-01-26 07:13:26.017	06.01 IP Documentation	06.01.11 Certificate of Destruction
5633	83	1611641608143:-1407972852	1611641603355:-2131402962	D5136C00008	586	579	CREATE	2021-01-26 07:13:28.23	06 IP and Trial Supplies	06.07 General
5635	83	1611641609390:-1212698631	1611641563305:1950187595	D5136C00008	588	537	CREATE	2021-01-26 07:13:29.476	2801 Chowdhury, Fateha	07 Safety Reporting
5692	83	1611641654503:111781285	1611641523376:-1327162297	D5136C00008	645	491	CREATE	2021-01-26 07:14:14.593	UNITED KINGDOM	2803 Davis, Bernard
5695	83	1611641656279:-1479920435	1611641655726:-998739994	D5136C00008	648	647	CREATE	2021-01-26 07:14:16.364	02.02 Subject Documents	02.02.03 Info_ Form Templates
5696	83	1611641656836:-721096900	1611641655726:-998739994	D5136C00008	649	647	CREATE	2021-01-26 07:14:16.924	02.02 Subject Documents	02.02.07 Othe_ven to Subjects
5699	83	1611641658636:394717282	1611641658050:62901831	D5136C00008	652	651	CREATE	2021-01-26 07:14:18.72	04.02 Other Committees	04.02.02 Other Approvals
5701	83	1611641659881:-534458741	1611641659215:825789058	D5136C00008	654	653	CREATE	2021-01-26 07:14:19.966	05 Site Management	05.01 Site Selection
5704	83	1611641661617:-412374531	1611641659881:-534458741	D5136C00008	657	654	CREATE	2021-01-26 07:14:21.701	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
5705	83	1611641662194:936340320	1611641659215:825789058	D5136C00008	658	653	CREATE	2021-01-26 07:14:22.28	05 Site Management	05.02 Site Se_p Documentation
5708	83	1611641663937:363864873	1611641662194:936340320	D5136C00008	661	658	CREATE	2021-01-26 07:14:24.022	05.02 Site Se_p Documentation	05.02.04 PI CV-Site Affiliation
5710	83	1611641665084:-1839431997	1611641662194:936340320	D5136C00008	663	658	CREATE	2021-01-26 07:14:25.169	05.02 Site Se_p Documentation	05.02.07 Staff Qualification
5711	83	1611641665650:-1399389608	1611641662194:936340320	D5136C00008	664	658	CREATE	2021-01-26 07:14:25.735	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
5714	83	1611641667483:193222378	1611641662194:936340320	D5136C00008	667	658	CREATE	2021-01-26 07:14:27.569	05.02 Site Se_p Documentation	05.02.18 Site Signature Sheet
5715	83	1611641668214:-1297771867	1611641659215:825789058	D5136C00008	668	653	CREATE	2021-01-26 07:14:28.3	05 Site Management	05.03 Site Initiation
5717	83	1611641669414:-917676527	1611641668214:-1297771867	D5136C00008	670	668	CREATE	2021-01-26 07:14:29.499	05.03 Site Initiation	05.03.03 Site Training-Staff
5639	83	1611641611836:932923470	1611641611208:-2139773700	D5136C00008	592	591	CREATE	2021-01-26 07:13:31.953	2802 Kaya, Banu	02 Central Trial Documents
5642	83	1611641613727:587406697	1611641612464:1839687067	D5136C00008	595	593	CREATE	2021-01-26 07:13:33.824	02.02 Subject Documents	02.02.07 Othe_ven to Subjects
5644	83	1611641620277:-1785751022	1611641614358:161217309	D5136C00008	597	596	CREATE	2021-01-26 07:13:40.365	04 IRB-IEC an_other Approvals	04.02 Other Committees
5647	83	1611641622064:-796291784	1611641621465:1768134979	D5136C00008	600	599	CREATE	2021-01-26 07:13:42.158	04.04 General	04.04.01 Rele_s-IRB-IEC-Email
5649	83	1611641623233:-1795168028	1611641611208:-2139773700	D5136C00008	602	591	CREATE	2021-01-26 07:13:43.319	2802 Kaya, Banu	05 Site Management
5653	83	1611641626242:-1699481912	1611641623836:-56339076	D5136C00008	606	603	CREATE	2021-01-26 07:13:46.328	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
5654	83	1611641626833:-803284178	1611641623233:-1795168028	D5136C00008	607	602	CREATE	2021-01-26 07:13:46.918	05 Site Management	05.02 Site Se_p Documentation
5657	83	1611641628708:-1035590825	1611641626833:-803284178	D5136C00008	610	607	CREATE	2021-01-26 07:13:48.795	05.02 Site Se_p Documentation	05.02.03 Protocol Amendment Signature Page
5658	83	1611641629345:-1005059895	1611641626833:-803284178	D5136C00008	611	607	CREATE	2021-01-26 07:13:49.434	05.02 Site Se_p Documentation	05.02.04 PI CV-Site Affiliation
5661	83	1611641631115:1909823587	1611641626833:-803284178	D5136C00008	614	607	CREATE	2021-01-26 07:13:51.201	05.02 Site Se_p Documentation	05.02.07 Staff Qualification
5663	83	1611641632373:-403144998	1611641626833:-803284178	D5136C00008	616	607	CREATE	2021-01-26 07:13:52.458	05.02 Site Se_p Documentation	05.02.12 Clin_Trial Agreement
5666	83	1611641634195:-819684029	1611641623233:-1795168028	D5136C00008	619	602	CREATE	2021-01-26 07:13:54.292	05 Site Management	05.03 Site Initiation
5667	83	1611641635297:-785062043	1611641634195:-819684029	D5136C00008	620	619	CREATE	2021-01-26 07:13:55.384	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
5668	83	1611641635986:-1556995045	1611641634195:-819684029	D5136C00008	621	619	CREATE	2021-01-26 07:13:56.073	05.03 Site Initiation	05.03.03 Site Training-Staff
5670	83	1611641637093:-1086410934	1611641623233:-1795168028	D5136C00008	623	602	CREATE	2021-01-26 07:13:57.18	05 Site Management	05.04 Site Management
5673	83	1611641639040:-274598288	1611641637093:-1086410934	D5136C00008	626	623	CREATE	2021-01-26 07:13:59.173	05.04 Site Management	05.04.04 Visit Log
5676	83	1611641644983:-992723133	1611641623233:-1795168028	D5136C00008	629	602	CREATE	2021-01-26 07:14:05.069	05 Site Management	05.05 General
5677	83	1611641645626:265325876	1611641644983:-992723133	D5136C00008	630	629	CREATE	2021-01-26 07:14:05.712	05.05 General	05.05.01 Rele_nications-Email
5678	83	1611641646232:1465293019	1611641644983:-992723133	D5136C00008	631	629	CREATE	2021-01-26 07:14:06.32	05.05 General	05.05.01 Relevant Communications-Documents
5681	83	1611641648039:-2071648837	1611641647393:-1337485230	D5136C00008	634	633	CREATE	2021-01-26 07:14:08.124	06 IP and Trial Supplies	06.01 IP Documentation
5683	83	1611641649149:843338662	1611641648039:-2071648837	D5136C00008	636	634	CREATE	2021-01-26 07:14:09.236	06.01 IP Documentation	06.01.05 Accountability Documentation
5686	83	1611641651000:-1719738376	1611641650427:1510667487	D5136C00008	639	638	CREATE	2021-01-26 07:14:11.086	06.04 Storage	06.04.03 Maintenance Logs
5687	83	1611641651566:-1744828649	1611641647393:-1337485230	D5136C00008	640	633	CREATE	2021-01-26 07:14:11.65	06 IP and Trial Supplies	06.07 General
5690	83	1611641653359:1363717645	1611641652796:1532818742	D5136C00008	643	642	CREATE	2021-01-26 07:14:13.445	07 Safety Reporting	07.03 General
5720	83	1611641671206:1948763560	1611641670584:-1830622076	D5136C00008	673	672	CREATE	2021-01-26 07:14:31.291	05.04 Site Management	05.04.04 Visit Log
5722	83	1611641672347:-1911319765	1611641659215:825789058	D5136C00008	675	653	CREATE	2021-01-26 07:14:32.434	05 Site Management	05.05 General
5724	83	1611641673504:-2078573296	1611641672347:-1911319765	D5136C00008	677	675	CREATE	2021-01-26 07:14:33.599	05.05 General	05.05.02 Tracking Information
5726	83	1611641674713:1149004986	1611641674147:1017359161	D5136C00008	679	678	CREATE	2021-01-26 07:14:34.81	06 IP and Trial Supplies	06.01 IP Documentation
5729	83	1611641676572:818885880	1611641674713:1149004986	D5136C00008	682	679	CREATE	2021-01-26 07:14:36.661	06.01 IP Documentation	06.01.05 Accountability Documentation
5731	83	1611641677757:751154444	1611641674147:1017359161	D5136C00008	684	678	CREATE	2021-01-26 07:14:37.842	06 IP and Trial Supplies	06.04 Storage
5733	83	1611641678908:-209503229	1611641677757:751154444	D5136C00008	686	684	CREATE	2021-01-26 07:14:38.994	06.04 Storage	06.04.03 Maintenance Logs
5976	83	1611641867323:112979452	1611641866767:113847996	D5136C00008	929	928	CREATE	2021-01-26 07:17:47.42	04 IRB-IEC an_other Approvals	04.01 IRB-IEC Trial Approval
5736	83	1611641682511:756325895	1611641681904:-2134783063	D5136C00008	689	688	CREATE	2021-01-26 07:14:42.597	02 Central Trial Documents	02.02 Subject Documents
5739	83	1611641684238:1275870640	1611641681904:-2134783063	D5136C00008	692	688	CREATE	2021-01-26 07:14:44.324	02 Central Trial Documents	02.04 General
5741	83	1611641685430:-688787497	1611641679556:869327954	D5136C00008	694	687	CREATE	2021-01-26 07:14:45.515	2804 Tsitsikas, Dimitris	04 IRB-IEC an_other Approvals
5744	83	1611641687220:-567939092	1611641679556:869327954	D5136C00008	697	687	CREATE	2021-01-26 07:14:47.304	2804 Tsitsikas, Dimitris	05 Site Management
5745	83	1611641687778:-1221740030	1611641687220:-567939092	D5136C00008	698	697	CREATE	2021-01-26 07:14:47.862	05 Site Management	05.01 Site Selection
5747	83	1611641688949:1347240801	1611641687778:-1221740030	D5136C00008	700	698	CREATE	2021-01-26 07:14:49.035	05.01 Site Selection	05.01.03 Feasibility Documentation
5750	83	1611641691836:-478017439	1611641691263:1885868851	D5136C00008	703	702	CREATE	2021-01-26 07:14:51.92	05.02 Site Se_p Documentation	05.02.01 Acce_igator Brochure
5753	83	1611641694238:-1862205522	1611641691263:1885868851	D5136C00008	706	702	CREATE	2021-01-26 07:14:54.324	05.02 Site Se_p Documentation	05.02.04 PI C_ite Affiliation
5754	83	1611641694820:1841581377	1611641691263:1885868851	D5136C00008	707	702	CREATE	2021-01-26 07:14:54.904	05.02 Site Se_p Documentation	05.02.06 Othe_ite Affiliation
5756	83	1611641695975:-531448190	1611641691263:1885868851	D5136C00008	709	702	CREATE	2021-01-26 07:14:56.058	05.02 Site Se_p Documentation	05.02.07 Staff Qualification
5759	83	1611641697751:-1096603434	1611641691263:1885868851	D5136C00008	712	702	CREATE	2021-01-26 07:14:57.852	05.02 Site Se_p Documentation	05.02.17 IP S_e Documentation
5760	83	1611641698569:1063933136	1611641691263:1885868851	D5136C00008	713	702	CREATE	2021-01-26 07:14:58.661	05.02 Site Se_p Documentation	05.02.18 Site Signature Sheet
5763	83	1611641700479:-455081830	1611641699194:-1544533753	D5136C00008	716	714	CREATE	2021-01-26 07:15:00.564	05.03 Site Initiation	05.03.03 Site Training-Staff
5764	83	1611641701729:-1319930628	1611641699194:-1544533753	D5136C00008	717	714	CREATE	2021-01-26 07:15:01.835	05.03 Site Initiation	05.03.03 Site_umentation-Site
5767	83	1611641703591:-1869886780	1611641702363:1777095758	D5136C00008	720	718	CREATE	2021-01-26 07:15:03.678	05.04 Site Management	05.04.03 Monitoring Visit Report
5768	83	1611641704166:569156076	1611641702363:1777095758	D5136C00008	721	718	CREATE	2021-01-26 07:15:04.253	05.04 Site Management	05.04.04 Visit Log
5771	83	1611641705972:1699612596	1611641687220:-567939092	D5136C00008	724	697	CREATE	2021-01-26 07:15:06.059	05 Site Management	05.05 General
5773	83	1611641707203:-988149914	1611641705972:1699612596	D5136C00008	726	724	CREATE	2021-01-26 07:15:07.291	05.05 General	05.05.02 Tracking Information
5776	83	1611641708975:1635779421	1611641708356:114558887	D5136C00008	729	728	CREATE	2021-01-26 07:15:09.126	06.01 IP Documentation	06.01.04 IP S_t Documentation
5777	83	1611641709633:602618194	1611641708356:114558887	D5136C00008	730	728	CREATE	2021-01-26 07:15:09.719	06.01 IP Documentation	06.01.05 Acco_y Documentation
5779	83	1611641710870:-157562073	1611641707764:-376358380	D5136C00008	732	727	CREATE	2021-01-26 07:15:10.954	06 IP and Trial Supplies	06.04 Storage
5783	83	1611641713265:-1534972663	1611641679556:869327954	D5136C00008	736	687	CREATE	2021-01-26 07:15:13.35	2804 Tsitsikas, Dimitris	07 Safety Reporting
5786	83	1611641715146:2076943853	1611641713265:-1534972663	D5136C00008	739	736	CREATE	2021-01-26 07:15:15.233	07 Safety Reporting	07.03 General
5788	83	1611641716336:-525926880	1611641523376:-1327162297	D5136C00008	741	491	CREATE	2021-01-26 07:15:16.424	UNITED KINGDOM	TBD-1-1RBSZVO Hill, Quentin
5789	83	1611641716899:1092634339	1611641716336:-525926880	D5136C00008	742	741	CREATE	2021-01-26 07:15:16.984	TBD-1-1RBSZVO Hill, Quentin	05 Site Management
5792	83	1611641718590:868406125	rootNode	D5136C00008	745	0	CREATE	2021-01-26 07:15:18.68		UNITED STATES
5794	83	1611641719838:305747085	1611641719184:376092127	D5136C00008	747	746	CREATE	2021-01-26 07:15:19.923	01 Trial Management	01.05 General
5797	83	1611641721663:-1533385682	1611641721078:-746356268	D5136C00008	750	749	CREATE	2021-01-26 07:15:21.752	02 Central Trial Documents	02.01 Trial Documents
5798	83	1611641726738:96577373	1611641721663:-1533385682	D5136C00008	751	750	CREATE	2021-01-26 07:15:26.824	02.01 Trial Documents	02.01.01 Investigator Brochure
5801	83	1611641728543:-1696924364	1611641727969:-52582080	D5136C00008	754	753	CREATE	2021-01-26 07:15:28.629	02.02 Subject Documents	02.02.01 Subject Diary
5803	83	1611641729770:-700247780	1611641727969:-52582080	D5136C00008	756	753	CREATE	2021-01-26 07:15:29.855	02.02 Subject Documents	02.02.04 Subject Information Sheet
5805	83	1611641731028:953228520	1611641727969:-52582080	D5136C00008	758	753	CREATE	2021-01-26 07:15:31.114	02.02 Subject Documents	02.02.06 Adverti_ubject Recruitment
5807	83	1611641732857:-1169730456	1611641721078:-746356268	D5136C00008	760	749	CREATE	2021-01-26 07:15:32.942	02 Central Trial Documents	02.04 General
5808	83	1611641733486:-682019503	1611641732857:-1169730456	D5136C00008	761	760	CREATE	2021-01-26 07:15:33.574	02.04 General	02.04.02 Tracking Information
5811	83	1611641735222:1243595840	1611641734636:-162194106	D5136C00008	764	763	CREATE	2021-01-26 07:15:35.31	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
5813	83	1611641736433:1216455579	1611641734636:-162194106	D5136C00008	766	763	CREATE	2021-01-26 07:15:36.52	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
5815	83	1611641738023:646123431	1611641718590:868406125	D5136C00008	768	745	CREATE	2021-01-26 07:15:38.109	UNITED STATES	05 Site Management
5817	83	1611641739220:-1451690548	1611641738649:1950893660	D5136C00008	770	769	CREATE	2021-01-26 07:15:39.307	05.02 Site Set-up Documentation	05.02.12 Investigator Clinical Trial Agreement Template
5818	83	1611641739811:-333543403	1611641738023:646123431	D5136C00008	771	768	CREATE	2021-01-26 07:15:39.9	05 Site Management	05.04 Site Management
5821	83	1611641741602:-1500399181	1611641741022:463540751	D5136C00008	774	773	CREATE	2021-01-26 07:15:41.687	05.05 General	05.05.01 Relevan_on-Documents-Email
5823	83	1611641742789:-1683491224	1611641742207:1213330506	D5136C00008	776	775	CREATE	2021-01-26 07:15:42.874	7801 Lanzkron, Sophie	01 Trial Management
5826	83	1611641744682:-462625009	1611641742207:1213330506	D5136C00008	779	775	CREATE	2021-01-26 07:15:44.767	7801 Lanzkron, Sophie	02 Central Trial Documents
5829	83	1611641746498:-862143584	1611641745288:-1594877498	D5136C00008	782	780	CREATE	2021-01-26 07:15:46.584	02.02 Subject Documents	02.02.03 Info_Form Checklists
5830	83	1611641747065:68551176	1611641744682:-462625009	D5136C00008	783	779	CREATE	2021-01-26 07:15:47.151	02 Central Trial Documents	02.04 General
5831	83	1611641747628:58096024	1611641747065:68551176	D5136C00008	784	783	CREATE	2021-01-26 07:15:47.713	02.04 General	02.04.01 Rele_-Contact Report
5834	83	1611641749438:-674462754	1611641748876:1080004078	D5136C00008	787	786	CREATE	2021-01-26 07:15:49.525	03 Regulatory	03.04 General
5838	83	1611641751827:1870576611	1611641751258:-540240332	D5136C00008	791	790	CREATE	2021-01-26 07:15:51.913	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
5841	83	1611641753622:878890308	1611641750589:-1824265611	D5136C00008	794	789	CREATE	2021-01-26 07:15:53.709	04 IRB-IEC an_other Approvals	04.03 Trial Status Reporting
5842	83	1611641754194:1101007548	1611641753622:878890308	D5136C00008	795	794	CREATE	2021-01-26 07:15:54.28	04.03 Trial Status Reporting	04.03.01 IRB-_ Info-Deviation
5843	83	1611641754769:1644291480	1611641753622:878890308	D5136C00008	796	794	CREATE	2021-01-26 07:15:54.858	04.03 Trial Status Reporting	04.03.03 IRB-_rm Notification
5846	83	1611641756554:-1940861454	1611641755337:-132630099	D5136C00008	799	797	CREATE	2021-01-26 07:15:56.64	04.04 General	04.04.04 Filenote
5848	83	1611641757766:1260846546	1611641757161:76937209	D5136C00008	801	800	CREATE	2021-01-26 07:15:57.852	05 Site Management	05.01 Site Selection
5852	83	1611641761013:1091716741	1611641757161:76937209	D5136C00008	805	800	CREATE	2021-01-26 07:16:01.11	05 Site Management	05.02 Site Se_p Documentation
5854	83	1611641762200:-718389527	1611641761013:1091716741	D5136C00008	807	805	CREATE	2021-01-26 07:16:02.293	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
5856	83	1611641763471:-619972951	1611641761013:1091716741	D5136C00008	809	805	CREATE	2021-01-26 07:16:03.557	05.02 Site Se_p Documentation	05.02.04 PI C_ite Affiliation
5858	83	1611641787467:156951592	1611641761013:1091716741	D5136C00008	811	805	CREATE	2021-01-26 07:16:27.556	05.02 Site Se_p Documentation	05.02.07 Staff Qualification
5861	83	1611641789270:-960513903	1611641761013:1091716741	D5136C00008	814	805	CREATE	2021-01-26 07:16:29.359	05.02 Site Se_p Documentation	05.02.12 Clinical Trial Agreement
5862	83	1611641789915:-1494331556	1611641761013:1091716741	D5136C00008	815	805	CREATE	2021-01-26 07:16:29.999	05.02 Site Se_p Documentation	05.02.17 IP S_e Documentation
5864	83	1611641791165:-1139191528	1611641757161:76937209	D5136C00008	817	800	CREATE	2021-01-26 07:16:31.253	05 Site Management	05.03 Site Initiation
5866	83	1611641793182:468142227	1611641791165:-1139191528	D5136C00008	819	817	CREATE	2021-01-26 07:16:33.268	05.03 Site Initiation	05.03.03 Site Training-Staff
5868	83	1611641794384:-2112550531	1611641757161:76937209	D5136C00008	821	800	CREATE	2021-01-26 07:16:34.471	05 Site Management	05.04 Site Management
5871	83	1611641796124:1754508333	1611641794384:-2112550531	D5136C00008	824	821	CREATE	2021-01-26 07:16:36.21	05.04 Site Management	05.04.04 Visit Log
5872	83	1611641796786:-1413926454	1611641794384:-2112550531	D5136C00008	825	821	CREATE	2021-01-26 07:16:36.872	05.04 Site Management	05.04.05 Additional Monitoring Activity
5875	83	1611641803433:902267177	1611641757161:76937209	D5136C00008	828	800	CREATE	2021-01-26 07:16:43.52	05 Site Management	05.05 General
5876	83	1611641804060:269400607	1611641803433:902267177	D5136C00008	829	828	CREATE	2021-01-26 07:16:44.163	05.05 General	05.05.01 Rele_nications-Email
5878	83	1611641805292:1448759010	1611641803433:902267177	D5136C00008	831	828	CREATE	2021-01-26 07:16:45.382	05.05 General	05.05.02 Tracking Information
5881	83	1611641807104:444092009	1611641806484:707997642	D5136C00008	834	833	CREATE	2021-01-26 07:16:47.189	06 IP and Trial Supplies	06.01 IP Documentation
5884	83	1611641809042:1341294255	1611641807104:444092009	D5136C00008	837	834	CREATE	2021-01-26 07:16:49.129	06.01 IP Documentation	06.01.10 IP Documentation Return
5886	83	1611641810260:-1905283911	1611641806484:707997642	D5136C00008	839	833	CREATE	2021-01-26 07:16:50.345	06 IP and Trial Supplies	06.04 Storage
5888	83	1611641811427:1148067529	1611641806484:707997642	D5136C00008	841	833	CREATE	2021-01-26 07:16:51.512	06 IP and Trial Supplies	06.05 Non-IP Documentation
5890	83	1611641812671:-1455885109	1611641806484:707997642	D5136C00008	843	833	CREATE	2021-01-26 07:16:52.756	06 IP and Trial Supplies	06.07 General
5891	83	1611641813299:1132246936	1611641812671:-1455885109	D5136C00008	844	843	CREATE	2021-01-26 07:16:53.386	06.07 General	06.07.01 Rele_l Product-Email
5894	83	1611641815113:401557928	1611641814480:-1327299701	D5136C00008	847	846	CREATE	2021-01-26 07:16:55.201	07.02 Trial Status Reporting	07.02.02 SAE Report
5896	83	1611641816352:547764742	1611641815710:-328278205	D5136C00008	849	848	CREATE	2021-01-26 07:16:56.438	7802 Boccia, Ralph	01 Trial Management
5899	83	1611641818196:-135193323	1611641815710:-328278205	D5136C00008	852	848	CREATE	2021-01-26 07:16:58.282	7802 Boccia, Ralph	02 Central Trial Documents
5900	83	1611641818789:1865351867	1611641818196:-135193323	D5136C00008	853	852	CREATE	2021-01-26 07:16:58.876	02 Central Trial Documents	02.02 Subject Documents
5903	83	1611641821254:-2134255637	1611641820621:-1203481022	D5136C00008	856	855	CREATE	2021-01-26 07:17:01.342	02.04 General	02.04.01 Rele_-Contact Report
5905	83	1611641822384:-667750441	1611641815710:-328278205	D5136C00008	858	848	CREATE	2021-01-26 07:17:02.476	7802 Boccia, Ralph	03 Regulatory
5908	83	1611641824207:989038643	1611641815710:-328278205	D5136C00008	861	848	CREATE	2021-01-26 07:17:04.293	7802 Boccia, Ralph	04 IRB-IEC an_other Approvals
5911	83	1611641825959:208215329	1611641824765:1420293699	D5136C00008	864	862	CREATE	2021-01-26 07:17:06.048	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
5912	83	1611641826509:883517444	1611641824207:989038643	D5136C00008	865	861	CREATE	2021-01-26 07:17:06.598	04 IRB-IEC an_other Approvals	04.03 Trial Status Reporting
5914	83	1611641827736:1201378147	1611641826509:883517444	D5136C00008	867	865	CREATE	2021-01-26 07:17:07.838	04.03 Trial Status Reporting	04.03.02 IRB-_Progress Report
5918	83	1611641831679:-778431963	1611641831105:-794461057	D5136C00008	871	870	CREATE	2021-01-26 07:17:11.765	05.01 Site Selection	05.01.02 Confidentiality Agreement
5920	83	1611641832881:-1505805594	1611641831105:-794461057	D5136C00008	873	870	CREATE	2021-01-26 07:17:12.967	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
5923	83	1611641834574:-1549810347	1611641833440:-27058349	D5136C00008	876	874	CREATE	2021-01-26 07:17:14.663	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
5924	83	1611641835198:-2008121469	1611641833440:-27058349	D5136C00008	877	874	CREATE	2021-01-26 07:17:15.284	05.02 Site Se_p Documentation	05.02.04 PI CV-Site Affiliation
5930	83	1611641838570:-1350343811	1611641833440:-27058349	D5136C00008	883	874	CREATE	2021-01-26 07:17:18.655	05.02 Site Se_p Documentation	05.02.12 Clinical Trial Agreement
5931	83	1611641839111:-566040481	1611641833440:-27058349	D5136C00008	884	874	CREATE	2021-01-26 07:17:19.197	05.02 Site Se_p Documentation	05.02.17 IP Site Release Documentation
5979	83	1611641872329:-1064033097	1611641867323:112979452	D5136C00008	932	929	CREATE	2021-01-26 07:17:52.415	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
5935	83	1611641841435:-758397673	1611641840311:397050594	D5136C00008	888	886	CREATE	2021-01-26 07:17:21.522	05.03 Site Initiation	05.03.03 Site Training-Staff
5937	83	1611641842622:130323689	1611641828877:-967378521	D5136C00008	890	869	CREATE	2021-01-26 07:17:22.707	05 Site Management	05.04 Site Management
5940	83	1611641844338:1568109542	1611641842622:130323689	D5136C00008	893	890	CREATE	2021-01-26 07:17:24.423	05.04 Site Management	05.04.04 Visit Log
5943	83	1611641845974:1949204396	1611641842622:130323689	D5136C00008	896	890	CREATE	2021-01-26 07:17:26.059	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
5944	83	1611641846524:490134794	1611641828877:-967378521	D5136C00008	897	869	CREATE	2021-01-26 07:17:26.61	05 Site Management	05.05 General
5945	83	1611641847062:-1382269330	1611641846524:490134794	D5136C00008	898	897	CREATE	2021-01-26 07:17:27.147	05.05 General	05.05.01 Rele_nications-Email
5948	83	1611641848838:-775808418	1611641815710:-328278205	D5136C00008	901	848	CREATE	2021-01-26 07:17:28.983	7802 Boccia, Ralph	06 IP and Trial Supplies
5951	83	1611641850586:-1971100478	1611641849443:-1160745370	D5136C00008	904	902	CREATE	2021-01-26 07:17:30.672	06.01 IP Documentation	06.01.11 Certificate of Destruction
5953	83	1611641852465:-2142046191	1611641851913:1062281413	D5136C00008	906	905	CREATE	2021-01-26 07:17:32.55	06.05 Non-IP Documentation	06.05.03 Non-_ation of Return
5954	83	1611641853016:-125391627	1611641815710:-328278205	D5136C00008	907	848	CREATE	2021-01-26 07:17:33.102	7802 Boccia, Ralph	07 Safety Reporting
5957	83	1611641854830:1623156305	1611641853016:-125391627	D5136C00008	910	907	CREATE	2021-01-26 07:17:34.914	07 Safety Reporting	07.03 General
5959	83	1611641855992:-1347429425	1611641815710:-328278205	D5136C00008	912	848	CREATE	2021-01-26 07:17:36.076	7802 Boccia, Ralph	08 Centralized Testing
5962	83	1611641857734:-125500863	1611641856549:-1614870835	D5136C00008	915	913	CREATE	2021-01-26 07:17:37.819	08.01 Facility Documentation	08.01.04 Norm_nd Alert Values
5963	83	1611641858278:-1927931879	1611641718590:868406125	D5136C00008	916	745	CREATE	2021-01-26 07:17:38.363	UNITED STATES	7803 Chen, Ian
5966	83	1611641859955:219014054	1611641859355:-212282778	D5136C00008	919	918	CREATE	2021-01-26 07:17:40.768	02.02 Subject Documents	02.02.03 Info_ Form Templates
5967	83	1611641862204:707246567	1611641859355:-212282778	D5136C00008	920	918	CREATE	2021-01-26 07:17:42.29	02.02 Subject Documents	02.02.03 Info_Form Checklists
5970	83	1611641863932:-1728596320	1611641862740:1013851629	D5136C00008	923	921	CREATE	2021-01-26 07:17:44.017	02.04 General	02.04.01 Rele_tions-Documents
5972	83	1611641865032:1513460493	1611641864494:-836255945	D5136C00008	925	924	CREATE	2021-01-26 07:17:45.121	03 Regulatory	03.04 General
5975	83	1611641866767:113847996	1611641858278:-1927931879	D5136C00008	928	916	CREATE	2021-01-26 07:17:46.858	7803 Chen, Ian	04 IRB-IEC an_other Approvals
5977	83	1611641867889:-1036892836	1611641867323:112979452	D5136C00008	930	929	CREATE	2021-01-26 07:17:47.975	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
5980	83	1611641872993:13322831	1611641866767:113847996	D5136C00008	933	928	CREATE	2021-01-26 07:17:53.079	04 IRB-IEC an_other Approvals	04.04 General
5984	83	1611641875288:593757094	1611641874687:885376812	D5136C00008	937	936	CREATE	2021-01-26 07:17:55.374	05.01 Site Selection	05.01.02 Confidentiality Agreement
5987	83	1611641877922:281074540	1611641874139:-1842558559	D5136C00008	940	935	CREATE	2021-01-26 07:17:58.008	05 Site Management	05.02 Site Se_p Documentation
5988	83	1611641878529:674648754	1611641877922:281074540	D5136C00008	941	940	CREATE	2021-01-26 07:17:58.646	05.02 Site Se_p Documentation	05.02.01 Acceptance of Investigator Brochure
5991	83	1611641880260:756655437	1611641877922:281074540	D5136C00008	944	940	CREATE	2021-01-26 07:18:00.347	05.02 Site Se_p Documentation	05.02.04 PI CV-Site Affiliation
5993	83	1611641881612:-1180507520	1611641877922:281074540	D5136C00008	946	940	CREATE	2021-01-26 07:18:01.711	05.02 Site Se_p Documentation	05.02.07 Staff Qualification
5994	83	1611641882201:295957706	1611641877922:281074540	D5136C00008	947	940	CREATE	2021-01-26 07:18:02.306	05.02 Site Se_p Documentation	05.02.08 Form FDA1572
5997	83	1611641883978:-1509373040	1611641877922:281074540	D5136C00008	950	940	CREATE	2021-01-26 07:18:04.063	05.02 Site Se_p Documentation	05.02.17 IP Site Release Documentation
5999	83	1611641885102:705183483	1611641874139:-1842558559	D5136C00008	952	935	CREATE	2021-01-26 07:18:05.192	05 Site Management	05.03 Site Initiation
6001	83	1611641886211:-1743113613	1611641885102:705183483	D5136C00008	954	952	CREATE	2021-01-26 07:18:06.297	05.03 Site Initiation	05.03.03 Site Training-Staff
6003	83	1611641887392:324556396	1611641886849:1367467310	D5136C00008	956	955	CREATE	2021-01-26 07:18:07.479	05.04 Site Management	05.04.03 Monitoring Visit Report
6004	83	1611641887958:1744246088	1611641886849:1367467310	D5136C00008	957	955	CREATE	2021-01-26 07:18:08.044	05.04 Site Management	05.04.04 Visit Log
6007	83	1611641889731:91624976	1611641874139:-1842558559	D5136C00008	960	935	CREATE	2021-01-26 07:18:09.818	05 Site Management	05.05 General
6008	83	1611641890281:-798926283	1611641889731:91624976	D5136C00008	961	960	CREATE	2021-01-26 07:18:10.369	05.05 General	05.05.01 Rele_nications-Email
6011	83	1611641892006:-944324531	1611641858278:-1927931879	D5136C00008	964	916	CREATE	2021-01-26 07:18:12.109	7803 Chen, Ian	06 IP and Trial Supplies
6013	83	1611641893163:-1791377776	1611641892587:-928009258	D5136C00008	966	965	CREATE	2021-01-26 07:18:13.248	06.01 IP Documentation	06.01.04 IP Shipment Documentation
6016	83	1611641894929:-1754967288	1611641858278:-1927931879	D5136C00008	969	916	CREATE	2021-01-26 07:18:15.014	7803 Chen, Ian	08 Centralized Testing
6017	83	1611641895482:1014769913	1611641894929:-1754967288	D5136C00008	970	969	CREATE	2021-01-26 07:18:15.567	08 Centralized Testing	08.01 Facility Documentation
6020	83	1611641897229:-17868839	1611641895482:1014769913	D5136C00008	973	970	CREATE	2021-01-26 07:18:17.315	08.01 Facility Documentation	08.01.07 Head of Facility CV
6021	83	1611641897787:584577030	1611641718590:868406125	D5136C00008	974	745	CREATE	2021-01-26 07:18:17.871	UNITED STATES	7804 Kanter Washko, Julie
6023	83	1611641898966:216856431	1611641898339:-1098976848	D5136C00008	976	975	CREATE	2021-01-26 07:18:19.052	01 Trial Management	01.01 Trial Oversight
6026	83	1611641900718:-628926654	1611641900074:2073531444	D5136C00008	979	978	CREATE	2021-01-26 07:18:20.806	02 Central Trial Documents	02.02 Subject Documents
6028	83	1611641901828:2018177287	1611641900718:-628926654	D5136C00008	981	979	CREATE	2021-01-26 07:18:21.914	02.02 Subject Documents	02.02.03 Info_Form Checklists
6030	83	1611641902973:-1783086598	1611641902435:1036645038	D5136C00008	983	982	CREATE	2021-01-26 07:18:23.059	02.04 General	02.04.01 Rele_-Contact Report
6032	83	1611641904149:1980507092	1611641897787:584577030	D5136C00008	985	974	CREATE	2021-01-26 07:18:24.235	7804 Kanter Washko, Julie	03 Regulatory
6037	83	1611641906987:747254073	1611641906419:-702978421	D5136C00008	990	989	CREATE	2021-01-26 07:18:27.073	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
6040	83	1611641908756:-1236540149	1611641905826:977950492	D5136C00008	993	988	CREATE	2021-01-26 07:18:28.84	04 IRB-IEC an_other Approvals	04.03 Trial Status Reporting
6041	83	1611641909296:440194404	1611641908756:-1236540149	D5136C00008	994	993	CREATE	2021-01-26 07:18:29.382	04.03 Trial Status Reporting	04.03.01 IRB-_ Info-Deviation
6044	83	1611641911014:-1279628076	1611641910396:-271802747	D5136C00008	997	996	CREATE	2021-01-26 07:18:31.099	05 Site Management	05.01 Site Selection
6045	83	1611641911563:1419360454	1611641911014:-1279628076	D5136C00008	998	997	CREATE	2021-01-26 07:18:31.65	05.01 Site Selection	05.01.02 Confidentiality Agreement
6052	83	1611641916279:1448151797	1611641913429:191192203	D5136C00008	1005	1001	CREATE	2021-01-26 07:18:36.365	05.02 Site Se_p Documentation	05.02.04 PI C_ite Affiliation
6053	83	1611641916835:980473092	1611641913429:191192203	D5136C00008	1006	1001	CREATE	2021-01-26 07:18:36.92	05.02 Site Se_p Documentation	05.02.06 Othe_ite Affiliation
6055	83	1611641917929:1092382501	1611641913429:191192203	D5136C00008	1008	1001	CREATE	2021-01-26 07:18:38.014	05.02 Site Se_p Documentation	05.02.07 Staff Qualification
6058	83	1611641919674:908160729	1611641913429:191192203	D5136C00008	1011	1001	CREATE	2021-01-26 07:18:39.761	05.02 Site Se_p Documentation	05.02.12 Clinical Trial Agreement
6059	83	1611641920262:813854624	1611641913429:191192203	D5136C00008	1012	1001	CREATE	2021-01-26 07:18:40.557	05.02 Site Se_p Documentation	05.02.17 IP S_e Documentation
6062	83	1611641931433:747646646	1611641930683:-1727026827	D5136C00008	1015	1014	CREATE	2021-01-26 07:18:51.521	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
6063	83	1611641932034:-1661021913	1611641930683:-1727026827	D5136C00008	1016	1014	CREATE	2021-01-26 07:18:52.122	05.03 Site Initiation	05.03.03 Site Training-Staff
6066	83	1611641933883:-492196715	1611641933291:1594581466	D5136C00008	1019	1018	CREATE	2021-01-26 07:18:53.97	05.04 Site Management	05.04.01 Subject Log
6068	83	1611641935040:1116540999	1611641933291:1594581466	D5136C00008	1021	1018	CREATE	2021-01-26 07:18:55.124	05.04 Site Management	05.04.04 Visit Log
6071	83	1611641936814:1742639	1611641910396:-271802747	D5136C00008	1024	996	CREATE	2021-01-26 07:18:56.898	05 Site Management	05.05 General
6072	83	1611641937370:492221143	1611641936814:1742639	D5136C00008	1025	1024	CREATE	2021-01-26 07:18:57.455	05.05 General	05.05.01 Rele_nications-Email
6073	83	1611641937969:-728182297	1611641936814:1742639	D5136C00008	1026	1024	CREATE	2021-01-26 07:18:58.055	05.05 General	05.05.01 Rele_tions-Documents
6076	83	1611641939789:462620448	1611641939187:-80222035	D5136C00008	1029	1028	CREATE	2021-01-26 07:18:59.876	06 IP and Trial Supplies	06.01 IP Documentation
6078	83	1611641940993:27906653	1611641939789:462620448	D5136C00008	1031	1029	CREATE	2021-01-26 07:19:01.078	06.01 IP Documentation	06.01.05 Acco_y Documentation
6081	83	1611641942794:1330470052	1611641939187:-80222035	D5136C00008	1034	1028	CREATE	2021-01-26 07:19:02.88	06 IP and Trial Supplies	06.03 IP Allo_n Documentation
6082	83	1611641943389:1655733036	1611641942794:1330470052	D5136C00008	1035	1034	CREATE	2021-01-26 07:19:03.475	06.03 IP Allo_n Documentation	06.03.01 Trea_n Documentation
6085	83	1611641945226:-936657210	1611641939187:-80222035	D5136C00008	1038	1028	CREATE	2021-01-26 07:19:05.312	06 IP and Trial Supplies	06.05 Non-IP Documentation
6087	83	1611641946480:1022570725	1611641939187:-80222035	D5136C00008	1040	1028	CREATE	2021-01-26 07:19:06.566	06 IP and Trial Supplies	06.07 General
6090	83	1611641948287:-1504874750	1611641897787:584577030	D5136C00008	1043	974	CREATE	2021-01-26 07:19:08.373	7804 Kanter Washko, Julie	07 Safety Reporting
6091	83	1611641948881:729664320	1611641948287:-1504874750	D5136C00008	1044	1043	CREATE	2021-01-26 07:19:08.967	07 Safety Reporting	07.02 Trial Status Reporting
6094	83	1611641950624:-736160859	1611641950038:810834671	D5136C00008	1047	1046	CREATE	2021-01-26 07:19:10.71	07.03 General	07.03.01 Rele_ns-Safety-Email
6096	83	1611641951808:381159402	1611641951219:-774262616	D5136C00008	1049	1048	CREATE	2021-01-26 07:19:11.894	08 Centralized Testing	08.01 Facility Documentation
6099	83	1611641953539:-525789623	1611641952918:342520803	D5136C00008	1052	1051	CREATE	2021-01-26 07:19:13.626	08.02 Sample Documentation	08.02.03 Samp_e Condition Log
6100	83	1611641954086:-1630766501	1611641897787:584577030	D5136C00008	1053	974	CREATE	2021-01-26 07:19:14.184	7804 Kanter Washko, Julie	10 Data Management
6103	83	1611641956364:-1352316942	1611641718590:868406125	D5136C00008	1056	745	CREATE	2021-01-26 07:19:16.533	UNITED STATES	7805 Harrington, Thomas
6105	83	1611641957694:1871115465	1611641957151:-1941058437	D5136C00008	1058	1057	CREATE	2021-01-26 07:19:17.779	01 Trial Management	01.01 Trial Oversight
6108	83	1611641959424:450864720	1611641958876:1498581014	D5136C00008	1061	1060	CREATE	2021-01-26 07:19:19.511	02 Central Trial Documents	02.02 Subject Documents
6109	83	1611641960003:1963879902	1611641959424:450864720	D5136C00008	1062	1061	CREATE	2021-01-26 07:19:20.091	02.02 Subject Documents	02.02.03 Info_ Form Templates
6117	83	1611641964769:-618853755	1611641963428:374651675	D5136C00008	1070	1068	CREATE	2021-01-26 07:19:24.854	03.04 General	03.04.01 Rele_rt-Up-Documents
6120	83	1611641966453:713072894	1611641965897:-738152005	D5136C00008	1073	1072	CREATE	2021-01-26 07:19:26.541	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
6122	83	1611641967625:685932633	1611641965897:-738152005	D5136C00008	1075	1072	CREATE	2021-01-26 07:19:27.709	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
6123	83	1611641968185:1120596273	1611641965340:403031889	D5136C00008	1076	1071	CREATE	2021-01-26 07:19:28.271	04 IRB-IEC an_other Approvals	04.03 Trial Status Reporting
6126	83	1611641969875:81666076	1611641969258:2060696725	D5136C00008	1079	1078	CREATE	2021-01-26 07:19:29.96	04.04 General	04.04.01 Rele_s-IRB-IEC-Email
6127	83	1611641970411:-1553364057	1611641956364:-1352316942	D5136C00008	1080	1056	CREATE	2021-01-26 07:19:30.496	7805 Harrington, Thomas	05 Site Management
6131	83	1611641972934:1532842543	1611641970955:-330671972	D5136C00008	1084	1081	CREATE	2021-01-26 07:19:33.019	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
6132	83	1611641973521:-1519367121	1611641970411:-1553364057	D5136C00008	1085	1080	CREATE	2021-01-26 07:19:33.609	05 Site Management	05.02 Site Se_p Documentation
6135	83	1611641975234:465316122	1611641973521:-1519367121	D5136C00008	1088	1085	CREATE	2021-01-26 07:19:35.32	05.02 Site Se_p Documentation	05.02.03 Prot_ Signature Page
6136	83	1611641975780:-695083339	1611641973521:-1519367121	D5136C00008	1089	1085	CREATE	2021-01-26 07:19:35.866	05.02 Site Se_p Documentation	05.02.04 PI C_ite Affiliation
5781	83	1611641712035:2081339768	1611641707764:-376358380	D5136C00008	734	727	CREATE	2021-01-26 07:15:12.121	06 IP and Trial Supplies	06.07 General
6141	83	1611641978612:1307743364	1611641973521:-1519367121	D5136C00008	1094	1085	CREATE	2021-01-26 07:19:38.697	05.02 Site Se_p Documentation	05.02.12 Clinical Trial Agreement
6142	83	1611641979166:-1301228667	1611641973521:-1519367121	D5136C00008	1095	1085	CREATE	2021-01-26 07:19:39.251	05.02 Site Se_p Documentation	05.02.17 IP S_e Documentation
6144	83	1611641980352:-1095258178	1611641970411:-1553364057	D5136C00008	1097	1080	CREATE	2021-01-26 07:19:40.44	05 Site Management	05.03 Site Initiation
6146	83	1611641986532:-13762481	1611641980352:-1095258178	D5136C00008	1099	1097	CREATE	2021-01-26 07:19:46.619	05.03 Site Initiation	05.03.03 Site Training-Staff
6148	83	1611641987649:-1628946498	1611641970411:-1553364057	D5136C00008	1101	1080	CREATE	2021-01-26 07:19:47.734	05 Site Management	05.04 Site Management
5051	83	1611635511774:1613375496	1611635508553:-233735518	D5136C00008	4	3	ALREADY AVAILABLE	2021-01-26 07:05:01.001	06 IP and Trial Supplies	06.04 Storage
5053	83	1611641114313:-1202754132	1611635508553:-233735518	D5136C00008	6	3	CREATE	2021-01-26 07:05:14.407	06 IP and Trial Supplies	06.05 Non-IP Documentation
5054	83	1611641114913:-34827672	1611641114313:-1202754132	D5136C00008	7	6	CREATE	2021-01-26 07:05:15.001	06.05 Non-IP Documentation	06.05.02 Non-_ion of Shipment
5058	83	1611641117277:-591072444	1611641116729:596941719	D5136C00008	11	10	CREATE	2021-01-26 07:05:17.364	07.02 Trial Status Reporting	07.02.02 SAE Report
5061	83	1611641119061:890439361	1611641118435:-957626241	D5136C00008	14	13	CREATE	2021-01-26 07:05:19.148	07.03 General	07.03.01 Rele_ns-Safety-Email
5067	83	1611641123647:333525040	1611641121935:40141659	D5136C00008	20	19	CREATE	2021-01-26 07:05:23.74	08.02 Sample Documentation	08.02.03 Samp_e Condition Log
5071	83	1611641125971:-2109224039	1611635082806:-1894530611	D5136C00008	24	1	CREATE	2021-01-26 07:05:26.056	KENYA	TBD-1-1RACHEE Nduba, Videlis
5077	83	1611641134791:-1832216870	1611641125971:-2109224039	D5136C00008	30	24	CREATE	2021-01-26 07:05:34.876	TBD-1-1RACHEE Nduba, Videlis	03 Regulatory
5080	83	1611641136573:719286918	1611641134791:-1832216870	D5136C00008	33	30	CREATE	2021-01-26 07:05:36.657	03 Regulatory	03.02 Investi_dicinal Product
5086	83	1611641140059:-630277822	1611641139504:-299483099	D5136C00008	39	38	CREATE	2021-01-26 07:05:40.145	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
6151	83	1611641989405:199172399	1611641987649:-1628946498	D5136C00008	1104	1101	CREATE	2021-01-26 07:19:49.491	05.04 Site Management	05.04.04 Visit Log
6152	83	1611641990523:2028061579	1611641987649:-1628946498	D5136C00008	1105	1101	CREATE	2021-01-26 07:19:50.61	05.04 Site Management	05.04.05 Additional Monitoring Activity
6155	83	1611641992242:-1269135393	1611641970411:-1553364057	D5136C00008	1108	1080	CREATE	2021-01-26 07:19:52.338	05 Site Management	05.05 General
6157	83	1611641993361:-20074952	1611641992242:-1269135393	D5136C00008	1110	1108	CREATE	2021-01-26 07:19:53.462	05.05 General	05.05.01 Rele_tions-Documents
6160	83	1611641995045:2075773630	1611641994485:-1628956940	D5136C00008	1113	1112	CREATE	2021-01-26 07:19:55.138	06 IP and Trial Supplies	06.01 IP Documentation
6161	83	1611642007604:733159721	1611641995045:2075773630	D5136C00008	1114	1113	CREATE	2021-01-26 07:20:07.692	06.01 IP Documentation	06.01.02 IP Instructions for Handling
6164	83	1611642009379:-437959174	1611641995045:2075773630	D5136C00008	1117	1113	CREATE	2021-01-26 07:20:09.466	06.01 IP Documentation	06.01.11 Certificate of Destruction
6165	83	1611642009940:1946178801	1611641994485:-1628956940	D5136C00008	1118	1112	CREATE	2021-01-26 07:20:10.029	06 IP and Trial Supplies	06.04 Storage
6167	83	1611642011040:1056377489	1611642009940:1946178801	D5136C00008	1120	1118	CREATE	2021-01-26 07:20:11.127	06.04 Storage	06.04.03 Maintenance Logs
6170	83	1611642012673:-1757310772	1611642012129:401904389	D5136C00008	1123	1122	CREATE	2021-01-26 07:20:12.76	07.03 General	07.03.01 Rele_ns-Safety-Email
6171	83	1611642013335:19319843	1611641956364:-1352316942	D5136C00008	1124	1056	CREATE	2021-01-26 07:20:13.422	7805 Harrington, Thomas	08 Centralized Testing
6174	83	1611642014958:161018001	1611642013879:-1072796387	D5136C00008	1127	1125	CREATE	2021-01-26 07:20:15.044	08.01 Facility Documentation	08.01.05 Manual
6178	83	1611642025610:-1407555123	1611641718590:868406125	D5136C00008	1131	745	CREATE	2021-01-26 07:20:25.696	UNITED STATES	7806 Harrington, Thomas
6181	83	1611642027340:348848184	1611642026715:-580073702	D5136C00008	1134	1133	CREATE	2021-01-26 07:20:27.43	02.02 Subject Documents	02.02.03 Info_ Form Templates
6182	83	1611642027912:837080697	1611642026715:-580073702	D5136C00008	1135	1133	CREATE	2021-01-26 07:20:27.998	02.02 Subject Documents	02.02.03 Info_Form Checklists
6185	83	1611642029643:-1755248060	1611642025610:-1407555123	D5136C00008	1138	1131	CREATE	2021-01-26 07:20:29.727	7806 Harrington, Thomas	03 Regulatory
6187	83	1611642030760:-1282932404	1611642030206:-820853829	D5136C00008	1140	1139	CREATE	2021-01-26 07:20:30.846	03.04 General	03.04.01 Rele_-Start-Up-Email
6190	83	1611642032450:-1943593706	1611642031900:-1089089567	D5136C00008	1143	1142	CREATE	2021-01-26 07:20:32.538	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
6192	83	1611642033869:-1970733967	1611642031900:-1089089567	D5136C00008	1145	1142	CREATE	2021-01-26 07:20:34.03	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
6195	83	1611642035815:1022862703	1611642035262:117555102	D5136C00008	1148	1147	CREATE	2021-01-26 07:20:35.9	05.01 Site Selection	05.01.02 Confidentiality Agreement
6196	83	1611642036355:2028077891	1611642034708:-2054897358	D5136C00008	1149	1146	CREATE	2021-01-26 07:20:36.442	05 Site Management	05.02 Site Se_p Documentation
6199	83	1611642041212:2004794268	1611642036355:2028077891	D5136C00008	1152	1149	CREATE	2021-01-26 07:20:41.297	05.02 Site Se_p Documentation	05.02.04 PI C_ite Affiliation
6201	83	1611642043642:1282182927	1611642036355:2028077891	D5136C00008	1154	1149	CREATE	2021-01-26 07:20:43.775	05.02 Site Se_p Documentation	05.02.07 Site Qualification
6203	83	1611642044881:-1876130414	1611642036355:2028077891	D5136C00008	1156	1149	CREATE	2021-01-26 07:20:44.967	05.02 Site Se_p Documentation	05.02.08 Form FDA1572
6205	83	1611642046127:496946396	1611642036355:2028077891	D5136C00008	1158	1149	CREATE	2021-01-26 07:20:46.212	05.02 Site Se_p Documentation	05.02.17 IP Site Release Documentation
6208	83	1611642047901:1151936514	1611642046695:-1842780462	D5136C00008	1161	1159	CREATE	2021-01-26 07:20:47.985	05.03 Site Initiation	05.03.03 Site Training-Staff
6209	83	1611642048539:1282302423	1611642034708:-2054897358	D5136C00008	1162	1146	CREATE	2021-01-26 07:20:48.627	05 Site Management	05.05 General
6212	83	1611642050370:-1155173365	1611642025610:-1407555123	D5136C00008	1165	1131	CREATE	2021-01-26 07:20:50.457	7806 Harrington, Thomas	08 Centralized Testing
6214	83	1611642051717:-411185947	1611642051105:-1292787135	D5136C00008	1167	1166	CREATE	2021-01-26 07:20:51.803	08.01 Facility Documentation	08.01.01 Cert_r Accreditation
6215	83	1611642052312:845388659	1611642051105:-1292787135	D5136C00008	1168	1166	CREATE	2021-01-26 07:20:52.399	08.01 Facility Documentation	08.01.05 Manual
5093	83	1611641146631:210546677	1611641125971:-2109224039	D5136C00008	46	24	CREATE	2021-01-26 07:05:46.715	TBD-1-1RACHEE Nduba, Videlis	05 Site Management
5096	83	1611641148365:-266897498	1611641147252:921451337	D5136C00008	49	47	CREATE	2021-01-26 07:05:48.456	05.01 Site Selection	05.01.02 Confidentiality Agreement
5101	83	1611641156326:1797180781	1611641155108:752353359	D5136C00008	54	52	CREATE	2021-01-26 07:05:56.413	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
5108	83	1611641160328:-1313012106	1611641155108:752353359	D5136C00008	61	52	CREATE	2021-01-26 07:06:00.532	05.02 Site Se_p Documentation	05.02.17 IP S_e Documentation
5112	83	1611641168064:472583999	1611641161682:-1478597346	D5136C00008	65	63	CREATE	2021-01-26 07:06:08.317	05.03 Site Initiation	05.03.03 Site Training-Staff
5115	83	1611641169923:819314641	1611641169363:-2013654227	D5136C00008	68	67	CREATE	2021-01-26 07:06:10.007	05.04 Site Management	05.04.01 Subject Log
5121	83	1611641173548:-405684782	1611641172981:-1650639204	D5136C00008	74	73	CREATE	2021-01-26 07:06:13.633	05.05 General	05.05.01 Rele_tions-Documents
5123	83	1611641174673:141149450	1611641125971:-2109224039	D5136C00008	76	24	CREATE	2021-01-26 07:06:14.757	TBD-1-1RACHEE Nduba, Videlis	06 IP and Trial Supplies
5130	83	1611641178774:-158646984	1611641177645:-1856629220	D5136C00008	83	81	CREATE	2021-01-26 07:06:18.857	06.04 Storage	06.04.03 Maintenance Logs
5132	83	1611641179903:-883324184	1611641179338:934272725	D5136C00008	85	84	CREATE	2021-01-26 07:06:19.988	07 Safety Reporting	07.02 Trial Status Reporting
5135	83	1611641181647:1981775661	1611641179338:934272725	D5136C00008	88	84	CREATE	2021-01-26 07:06:21.734	07 Safety Reporting	07.03 General
5141	83	1611641185742:739824843	1611641183456:1789426233	D5136C00008	94	90	CREATE	2021-01-26 07:06:25.835	08 Centralized Testing	08.02 Sample Documentation
5144	83	1611641187430:1528821284	1611641186875:491352654	D5136C00008	97	96	CREATE	2021-01-26 07:06:27.516	10 Data Management	10.02 Data Capture
5150	83	1611641190942:671197305	1611641189764:732813343	D5136C00008	103	101	CREATE	2021-01-26 07:06:31.03	05.01 Site Selection	05.01.03 Feasibility Documentation
5157	83	1611641195499:915077813	1611641194952:724217392	D5136C00008	110	109	CREATE	2021-01-26 07:06:35.584	02.02 Subject Documents	02.02.01 Subject Diary
5159	83	1611641203981:-253944115	1611641194952:724217392	D5136C00008	112	109	CREATE	2021-01-26 07:06:44.072	02.02 Subject Documents	02.02.03 Informe_ent Form Templates
5166	83	1611641209501:792364344	1611641208351:-4419933	D5136C00008	119	117	CREATE	2021-01-26 07:06:49.586	02.04 General	02.04.02 Tracking Information
5169	83	1611641211251:-466593241	1611641210602:1906549998	D5136C00008	122	121	CREATE	2021-01-26 07:06:51.338	03.01 Trial Approval	03.01.01 Submission
5171	83	1611641212347:742861545	1611641211799:-2077340250	D5136C00008	124	123	CREATE	2021-01-26 07:06:52.433	03.03 Trial Status Reporting	03.03.03 Notification of Trial Termination
5178	83	1611641216343:1588594192	1611641215217:1210344784	D5136C00008	131	129	CREATE	2021-01-26 07:06:56.428	06.01 IP Documentation	06.01.11 Certificate of Destruction
5186	83	1611641220889:1545586695	1611641220259:1485242300	D5136C00008	139	138	CREATE	2021-01-26 07:07:00.974	8801 Inati, Adlette	02 Central Trial Documents
5188	83	1611641222026:408594091	1611641221456:978039609	D5136C00008	141	140	CREATE	2021-01-26 07:07:02.129	02.02 Subject Documents	02.02.03 Info_ Form Templates
5189	83	1611641222606:-136010939	1611641220889:1545586695	D5136C00008	142	139	CREATE	2021-01-26 07:07:02.69	02 Central Trial Documents	02.04 General
5191	83	1611641223772:-45053	1611641222606:-136010939	D5136C00008	144	142	CREATE	2021-01-26 07:07:03.856	02.04 General	02.04.01 Rele_tions-Documents
5198	83	1611641227902:-1909566043	1611641227257:-547566127	D5136C00008	151	150	CREATE	2021-01-26 07:07:07.989	03.04 General	03.04.01 Rele_rt-Up-Documents
5200	83	1611641229044:167385129	1611641228476:450048179	D5136C00008	153	152	CREATE	2021-01-26 07:07:09.129	04 IRB-IEC an_other Approvals	04.01 IRB-IEC Trial Approval
5207	83	1611641233060:-1334710466	1611641232432:-1769405070	D5136C00008	160	159	CREATE	2021-01-26 07:07:13.145	05 Site Management	05.01 Site Selection
5210	83	1611641234936:-289350957	1611641233060:-1334710466	D5136C00008	163	160	CREATE	2021-01-26 07:07:15.02	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
5216	83	1611641238384:1180511039	1611641235488:136088595	D5136C00008	169	164	CREATE	2021-01-26 07:07:18.47	05.02 Site Se_p Documentation	05.02.07 Staff Qualification
5219	83	1611641240179:-514769753	1611641235488:136088595	D5136C00008	172	164	CREATE	2021-01-26 07:07:20.265	05.02 Site Se_p Documentation	05.02.12 Clinical Trial Agreement
5227	83	1611641244756:-1562578564	1611641243600:1541578440	D5136C00008	180	178	CREATE	2021-01-26 07:07:25.182	05.04 Site Management	05.04.03 Monitoring Visit Report
5230	83	1611641246833:-1511927833	1611641243600:1541578440	D5136C00008	183	178	CREATE	2021-01-26 07:07:26.92	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
5234	83	1611641255315:-2128863995	1611641248043:1901410763	D5136C00008	187	185	CREATE	2021-01-26 07:07:35.403	05.05 General	05.05.02 Tracking Information
5240	83	1611641262991:-96794948	1611641262364:-407969752	D5136C00008	193	192	CREATE	2021-01-26 07:07:43.078	06.04 Storage	06.04.01 Storage Condition Documentation
5243	83	1611641265128:-1466345627	1611641264375:1555441436	D5136C00008	196	195	CREATE	2021-01-26 07:07:45.214	07 Safety Reporting	07.02 Trial Status Reporting
5249	83	1611641268812:-1246752115	1611641268190:2064345550	D5136C00008	202	201	CREATE	2021-01-26 07:07:48.897	8802 Abboud, Miguel	02 Central Trial Documents
5251	83	1611641272799:944878455	1611641272075:-25702648	D5136C00008	204	203	CREATE	2021-01-26 07:07:52.884	02.02 Subject Documents	02.02.03 Info_ Form Templates
5257	83	1611641277218:-1443912937	1611641276514:-1133967190	D5136C00008	210	209	CREATE	2021-01-26 07:07:57.307	03.02 Investi_dicinal Product	03.02.02 Impo_-Export License
5263	83	1611641281018:-1907110319	1611641279667:-351148005	D5136C00008	216	214	CREATE	2021-01-26 07:08:01.104	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
5266	83	1611641282816:1012167847	1611641281637:-567607150	D5136C00008	219	217	CREATE	2021-01-26 07:08:02.901	04.03 Trial Status Reporting	04.03.03 IRB-_rm Notification
5272	83	1611641287732:-1798491443	1611641283462:-708346278	D5136C00008	225	220	CREATE	2021-01-26 07:08:07.815	05 Site Management	05.02 Site Se_p Documentation
5275	83	1611641289511:-243177295	1611641287732:-1798491443	D5136C00008	228	225	CREATE	2021-01-26 07:08:11.094	05.02 Site Se_p Documentation	05.02.04 PI CV-Site Affiliation
5288	83	1611641298915:1754299689	1611641298339:1242683668	D5136C00008	241	240	CREATE	2021-01-26 07:08:19.001	05.04 Site Management	05.04.01 Subject Log
5291	83	1611641300660:-1180306282	1611641298339:1242683668	D5136C00008	244	240	CREATE	2021-01-26 07:08:20.745	05.04 Site Management	05.04.05 Additional Monitoring Activity
5298	83	1611641304679:2142590727	1611641268190:2064345550	D5136C00008	251	201	CREATE	2021-01-26 07:08:24.764	8802 Abboud, Miguel	06 IP and Trial Supplies
5300	83	1611641305840:-1227547908	1611641305244:511713447	D5136C00008	253	252	CREATE	2021-01-26 07:08:25.925	06.01 IP Documentation	06.01.05 Accountability Documentation
5307	83	1611641309828:722022048	1611641309220:199223105	D5136C00008	260	259	CREATE	2021-01-26 07:08:29.913	02.01 Trial Documents	02.01.03 Protocol Synopsis
5310	83	1611641311574:-507846934	1611641310956:976683399	D5136C00008	263	262	CREATE	2021-01-26 07:08:31.659	02.02 Subject Documents	02.02.03 Informe_ent Form Templates
5318	83	1611641316277:-594826869	1611641315688:1640300229	D5136C00008	271	270	CREATE	2021-01-26 07:08:36.364	03 Regulatory	03.01 Trial Approval
5320	83	1611641317463:-79412261	1611641316277:-594826869	D5136C00008	273	271	CREATE	2021-01-26 07:08:37.551	03.01 Trial Approval	03.01.02 Approval
5321	83	1611641318033:420781695	1611641315688:1640300229	D5136C00008	274	270	CREATE	2021-01-26 07:08:38.264	03 Regulatory	03.03 Trial Status Reporting
5325	83	1611641323555:-1313666846	1611641322936:2095054813	D5136C00008	278	277	CREATE	2021-01-26 07:08:43.641	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
5332	83	1611641327869:-294928245	1611641308064:-1780896329	D5136C00008	285	257	CREATE	2021-01-26 07:08:47.953	TURKEY	05 Site Management
5335	83	1611641329592:-1110519338	1611641327869:-294928245	D5136C00008	288	285	CREATE	2021-01-26 07:08:50.349	05 Site Management	05.05 General
5338	83	1611641332061:1168507137	1611641331503:-103421796	D5136C00008	291	290	CREATE	2021-01-26 07:08:52.147	06 IP and Trial Supplies	06.07 General
5344	83	1611641341381:-633744407	1611641340822:-1114575569	D5136C00008	297	296	CREATE	2021-01-26 07:09:01.475	08 Centralized Testing	08.01 Facility Documentation
5346	83	1611641375745:-479246741	1611641341381:-633744407	D5136C00008	299	297	CREATE	2021-01-26 07:09:35.836	08.01 Facility Documentation	08.01.06 Supply Import Documentation
5352	83	1611641380445:-1680914697	1611641378514:1644563501	D5136C00008	305	303	CREATE	2021-01-26 07:09:40.529	09.02 Third Party Set-up	09.02.04 Roles and Responsibilities Matrix
5356	83	1611641382842:-135325419	1611641382155:1914193741	D5136C00008	309	308	CREATE	2021-01-26 07:09:42.927	02.02 Subject Documents	02.02.06 Adve_ect Recruitment
5362	83	1611641386398:1299514596	1611641381022:1907539791	D5136C00008	315	306	CREATE	2021-01-26 07:09:46.482	7601 Antmen, Ali Bulent	05 Site Management
5365	83	1611641388184:-1604111338	1611641386972:687809263	D5136C00008	318	316	CREATE	2021-01-26 07:09:48.275	05.01 Site Selection	05.01.03 Feasibility Documentation
5371	83	1611641392421:-15473724	1611641389332:-1873206188	D5136C00008	324	320	CREATE	2021-01-26 07:09:52.507	05.02 Site Se_p Documentation	05.02.04 PI C_ite Affiliation
5375	83	1611641394745:-146783206	1611641389332:-1873206188	D5136C00008	328	320	CREATE	2021-01-26 07:09:54.829	05.02 Site Se_p Documentation	05.02.12 Clin_Trial Agreement
5381	83	1611641400551:-1218035039	1611641398777:-1449076027	D5136C00008	334	331	CREATE	2021-01-26 07:10:00.637	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
5384	83	1611641402355:1858491205	1611641401135:1872542875	D5136C00008	337	335	CREATE	2021-01-26 07:10:02.441	05.04 Site Management	05.04.03 Monitoring Visit Report
5388	83	1611641404704:-752859664	1611641401135:1872542875	D5136C00008	341	335	CREATE	2021-01-26 07:10:04.792	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
5392	83	1611641407121:-518575942	1611641405889:1530983946	D5136C00008	345	343	CREATE	2021-01-26 07:10:07.208	05.05 General	05.05.02 Tracking Information
5398	83	1611641411735:958976882	1611641407680:1491095308	D5136C00008	351	346	CREATE	2021-01-26 07:10:11.83	06 IP and Trial Supplies	06.04 Storage
5401	83	1611641413561:-720813788	1611641407680:1491095308	D5136C00008	354	346	CREATE	2021-01-26 07:10:13.651	06 IP and Trial Supplies	06.05 Non-IP Documentation
5408	83	1611641417769:-2058464979	1611641417121:801226331	D5136C00008	361	360	CREATE	2021-01-26 07:10:17.865	07.03 General	07.03.01 Rele_ns-Safety-Email
5410	83	1611641418943:518296229	1611641418332:-1418801034	D5136C00008	363	362	CREATE	2021-01-26 07:10:19.047	08 Centralized Testing	08.01 Facility Documentation
5417	83	1611641424103:1728944826	1611641423550:-57369794	D5136C00008	370	369	CREATE	2021-01-26 07:10:24.19	10 Data Management	10.02 Data Capture
5420	83	1611641425855:-2079925699	1611641425234:-1793389510	D5136C00008	373	372	CREATE	2021-01-26 07:10:25.94	7602 Ilgen Sasmaz, Hatice	05 Site Management
5426	83	1611641429413:-215726209	1611641428841:1078425869	D5136C00008	379	378	CREATE	2021-01-26 07:10:29.499	7603 Unal, Selma	02 Central Trial Documents
5429	83	1611641431280:-1045846999	1611641430005:-554911708	D5136C00008	382	380	CREATE	2021-01-26 07:10:31.365	02.04 General	02.04.01 Rele_tions-Documents
5435	83	1611641439922:-38030433	1611641437014:355969895	D5136C00008	388	383	CREATE	2021-01-26 07:10:40.009	05 Site Management	05.02 Site Se_p Documentation
5438	83	1611641441711:-1604392429	1611641439922:-38030433	D5136C00008	391	388	CREATE	2021-01-26 07:10:41.802	05.02 Site Se_p Documentation	05.02.03 Protocol Amendment Signature Page
5445	83	1611641446591:1087342454	1611641437014:355969895	D5136C00008	398	383	CREATE	2021-01-26 07:10:46.751	05 Site Management	05.03 Site Initiation
5448	83	1611641450099:293180914	1611641446591:1087342454	D5136C00008	401	398	CREATE	2021-01-26 07:10:50.199	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
5451	83	1611641451992:-1502415847	1611641450803:-149148115	D5136C00008	404	402	CREATE	2021-01-26 07:10:52.09	05.04 Site Management	05.04.03 Monitoring Visit Report
5455	83	1611641455269:882602441	1611641450803:-149148115	D5136C00008	408	402	CREATE	2021-01-26 07:10:55.355	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
5459	83	1611641457701:1248793333	1611641428841:1078425869	D5136C00008	412	378	CREATE	2021-01-26 07:10:57.786	7603 Unal, Selma	06 IP and Trial Supplies
5465	83	1611641461372:-366738719	1611641460811:-1928091069	D5136C00008	418	417	CREATE	2021-01-26 07:11:01.464	06.04 Storage	06.04.01 Storage Condition Documentation
5468	83	1611641463356:-1208798916	1611641462736:1125260371	D5136C00008	421	420	CREATE	2021-01-26 07:11:03.443	06.05 Non-IP Documentation	06.05.02 Non-_ion of Shipment
5475	83	1611641467748:-1397939616	1611641428841:1078425869	D5136C00008	428	378	CREATE	2021-01-26 07:11:07.835	7603 Unal, Selma	08 Centralized Testing
5478	83	1611641469611:-445004490	1611641468416:-937483898	D5136C00008	431	429	CREATE	2021-01-26 07:11:09.697	08.01 Facility Documentation	08.01.04 Norm_nd Alert Values
8208	84	\N	\N	D5170C00002	1993	1992	NEW	\N	TBD-1-1RDPHSG Buening, Carsten	05 Site Management
5485	83	1611641473794:134747435	1611641473200:1765871668	D5136C00008	438	437	CREATE	2021-01-26 07:11:13.879	02 Central Trial Documents	02.04 General
5488	83	1611641475593:-1117694739	1611641475002:-1249598107	D5136C00008	441	440	CREATE	2021-01-26 07:11:15.683	03 Regulatory	03.01 Trial Approval
5493	83	1611641478548:-1123246738	1611641477381:1251585694	D5136C00008	446	444	CREATE	2021-01-26 07:11:18.64	05.01 Site Selection	05.01.03 Feasibility Documentation
5500	83	1611641484210:-1554767369	1611641479662:-1134365291	D5136C00008	453	448	CREATE	2021-01-26 07:11:38.683	05.02 Site Se_p Documentation	05.02.06 Othe_ite Affiliation
5503	83	1611641501330:-1420666446	1611641479662:-1134365291	D5136C00008	456	448	CREATE	2021-01-26 07:11:41.416	05.02 Site Se_p Documentation	05.02.12 Clinical Trial Agreement
5507	83	1611641503572:-1219564673	1611641503042:-710235130	D5136C00008	460	459	CREATE	2021-01-26 07:11:43.655	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
5513	83	1611641507046:1273719208	1611641505332:536430965	D5136C00008	466	463	CREATE	2021-01-26 07:11:47.139	05.04 Site Management	05.04.04 Visit Log
5516	83	1611641508780:17972415	1611641505332:536430965	D5136C00008	469	463	CREATE	2021-01-26 07:11:48.864	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
5518	83	1611641509907:-1060778770	1611641476799:554249780	D5136C00008	471	443	CREATE	2021-01-26 07:11:49.99	05 Site Management	05.05 General
5522	83	1611641514280:1787640409	1611641513722:-1060499336	D5136C00008	475	474	CREATE	2021-01-26 07:11:54.367	06.01 IP Documentation	06.01.05 Accountability Documentation
5529	83	1611641518320:1458612237	1611641517788:-356545034	D5136C00008	482	481	CREATE	2021-01-26 07:11:58.405	06.05 Non-IP Documentation	06.05.02 Non-_ion of Shipment
5532	83	1611641520047:-1027127638	1611641519431:-2017504633	D5136C00008	485	484	CREATE	2021-01-26 07:12:00.133	08 Centralized Testing	08.01 Facility Documentation
5539	83	1611641523954:-1587146496	1611641523376:-1327162297	D5136C00008	492	491	CREATE	2021-01-26 07:12:04.038	UNITED KINGDOM	02 Central Trial Documents
5542	83	1611641525805:591527693	1611641524639:733074266	D5136C00008	495	493	CREATE	2021-01-26 07:12:05.893	02.01 Trial Documents	02.01.06 Insurance
5548	83	1611641529289:-851687449	1611641523954:-1587146496	D5136C00008	501	492	CREATE	2021-01-26 07:12:09.377	02 Central Trial Documents	02.04 General
5551	83	1611641531177:396075957	1611641530548:1907082232	D5136C00008	504	503	CREATE	2021-01-26 07:12:11.263	03 Regulatory	03.01 Trial Approval
10360	85	1616043814946:718636409	1616043707500:1826778313	D5170C00002	1376	1234	CREATE	2021-03-18 06:03:35.033	Site	2001831 Pesegova, Marina
5554	83	1611641533599:1095748928	1611641530548:1907082232	D5136C00008	507	503	CREATE	2021-01-26 07:12:13.695	03 Regulatory	03.03 Trial Status Reporting
5560	83	1611641548030:1663225670	1611641545490:-676817329	D5136C00008	513	510	CREATE	2021-01-26 07:12:28.118	03.04 General	03.04.01 Relevant Communications-Regulatory-Start-Up-Documents
5563	83	1611641549710:-683705605	1611641549125:2141911536	D5136C00008	516	515	CREATE	2021-01-26 07:12:29.796	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
5570	83	1611641553830:-1100663654	1611641553264:-1430602661	D5136C00008	523	522	CREATE	2021-01-26 07:12:33.915	04.04 General	04.04.01 Relevan_ions-IRB-IEC-Email
5574	83	1611641557387:-1261198909	1611641555612:-1050735151	D5136C00008	527	526	CREATE	2021-01-26 07:12:37.473	05 Site Management	05.04 Site Management
5580	83	1611641560963:1841356753	1611641560331:823359296	D5136C00008	533	532	CREATE	2021-01-26 07:12:41.049	07.03 General	07.03.01 Relevan_tions-Safety-Email
5583	83	1611641562670:960527147	1611641562108:1256030504	D5136C00008	536	535	CREATE	2021-01-26 07:12:42.755	09.02 Third Party Set-up	09.02.04 Roles and Responsibilities Matrix
5584	83	1611641563305:1950187595	1611641523376:-1327162297	D5136C00008	537	491	CREATE	2021-01-26 07:12:43.392	UNITED KINGDOM	2801 Chowdhury, Fateha
5585	83	1611641563860:-1812593903	1611641563305:1950187595	D5136C00008	538	537	CREATE	2021-01-26 07:12:43.947	2801 Chowdhury, Fateha	02 Central Trial Documents
5591	83	1611641577760:-366555901	1611641563305:1950187595	D5136C00008	544	537	CREATE	2021-01-26 07:12:57.844	2801 Chowdhury, Fateha	04 IRB-IEC an_other Approvals
5594	83	1611641579484:-1158501418	1611641577760:-366555901	D5136C00008	547	544	CREATE	2021-01-26 07:12:59.569	04 IRB-IEC an_other Approvals	04.04 General
5599	83	1611641582355:1663938041	1611641581189:-1159841738	D5136C00008	552	550	CREATE	2021-01-26 07:13:02.442	05.01 Site Selection	05.01.03 Feasibility Documentation
5606	83	1611641586348:1974672763	1611641583518:310957323	D5136C00008	559	554	CREATE	2021-01-26 07:13:06.433	05.02 Site Se_p Documentation	05.02.07 Site Qualification
5609	83	1611641588833:1980304999	1611641583518:310957323	D5136C00008	562	554	CREATE	2021-01-26 07:13:08.918	05.02 Site Se_p Documentation	05.02.12 Clin_Trial Agreement
5613	83	1611641591235:-1553300500	1611641590634:735045048	D5136C00008	566	565	CREATE	2021-01-26 07:13:11.32	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
5619	83	1611641598879:1957834249	1611641592944:1838866742	D5136C00008	572	569	CREATE	2021-01-26 07:13:18.964	05.04 Site Management	05.04.04 Visit Log
5622	83	1611641600853:-1953958829	1611641592944:1838866742	D5136C00008	575	569	CREATE	2021-01-26 07:13:20.938	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
5628	83	1611641604637:-848699367	1611641604056:-1028150333	D5136C00008	581	580	CREATE	2021-01-26 07:13:24.722	06.01 IP Documentation	06.01.04 IP S_t Documentation
5631	83	1611641606569:917430434	1611641603355:-2131402962	D5136C00008	584	579	CREATE	2021-01-26 07:13:26.654	06 IP and Trial Supplies	06.04 Storage
5637	83	1611641610613:-945134034	1611641609999:-813435372	D5136C00008	590	589	CREATE	2021-01-26 07:13:30.702	07.03 General	07.03.01 Rele_ns-Safety-Email
5640	83	1611641612464:1839687067	1611641611836:932923470	D5136C00008	593	592	CREATE	2021-01-26 07:13:32.565	02 Central Trial Documents	02.02 Subject Documents
5646	83	1611641621465:1768134979	1611641614358:161217309	D5136C00008	599	596	CREATE	2021-01-26 07:13:41.553	04 IRB-IEC an_other Approvals	04.04 General
5648	83	1611641622664:2057660103	1611641621465:1768134979	D5136C00008	601	599	CREATE	2021-01-26 07:13:42.749	04.04 General	04.04.01 Relevant Communications-IRB-IEC-Documents
5652	83	1611641625613:-1458935108	1611641623836:-56339076	D5136C00008	605	603	CREATE	2021-01-26 07:13:45.701	05.01 Site Selection	05.01.03 Feasibility Documentation
5655	83	1611641627442:-1087087796	1611641626833:-803284178	D5136C00008	608	607	CREATE	2021-01-26 07:13:47.528	05.02 Site Se_p Documentation	05.02.01 Acceptance of Investigator Brochure
5662	83	1611641631712:-1945111929	1611641626833:-803284178	D5136C00008	615	607	CREATE	2021-01-26 07:13:51.799	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
5665	83	1611641633626:-86376639	1611641626833:-803284178	D5136C00008	618	607	CREATE	2021-01-26 07:13:53.715	05.02 Site Se_p Documentation	05.02.18 Site Signature Sheet
5694	83	1611641655726:-998739994	1611641655142:139909630	D5136C00008	647	646	CREATE	2021-01-26 07:14:15.821	02 Central Trial Documents	02.02 Subject Documents
5700	83	1611641659215:825789058	1611641654503:111781285	D5136C00008	653	645	CREATE	2021-01-26 07:14:19.303	2803 Davis, Bernard	05 Site Management
5702	83	1611641660455:-1320686166	1611641659881:-534458741	D5136C00008	655	654	CREATE	2021-01-26 07:14:20.541	05.01 Site Selection	05.01.02 Confidentiality Agreement
5679	83	1611641646817:1582988028	1611641644983:-992723133	D5136C00008	632	629	CREATE	2021-01-26 07:14:06.902	05.05 General	05.05.02 Tracking Information
5682	83	1611641648581:-2129635247	1611641648039:-2071648837	D5136C00008	635	634	CREATE	2021-01-26 07:14:08.666	06.01 IP Documentation	06.01.04 IP Shipment Documentation
5685	83	1611641650427:1510667487	1611641647393:-1337485230	D5136C00008	638	633	CREATE	2021-01-26 07:14:10.515	06 IP and Trial Supplies	06.04 Storage
5691	83	1611641653927:-543877997	1611641653359:1363717645	D5136C00008	644	643	CREATE	2021-01-26 07:14:14.012	07.03 General	07.03.01 Rele_ns-Safety-Email
5709	83	1611641664483:-1301442331	1611641662194:936340320	D5136C00008	662	658	CREATE	2021-01-26 07:14:24.567	05.02 Site Se_p Documentation	05.02.06 Othe_ite Affiliation
5712	83	1611641666289:-1433485930	1611641662194:936340320	D5136C00008	665	658	CREATE	2021-01-26 07:14:26.375	05.02 Site Se_p Documentation	05.02.12 Clinical Trial Agreement
5718	83	1611641670003:-1676849835	1611641668214:-1297771867	D5136C00008	671	668	CREATE	2021-01-26 07:14:30.091	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
5721	83	1611641671757:1973184197	1611641670584:-1830622076	D5136C00008	674	672	CREATE	2021-01-26 07:14:31.843	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
5725	83	1611641674147:1017359161	1611641654503:111781285	D5136C00008	678	645	CREATE	2021-01-26 07:14:34.238	2803 Davis, Bernard	06 IP and Trial Supplies
5730	83	1611641677156:-89961642	1611641674713:1149004986	D5136C00008	683	679	CREATE	2021-01-26 07:14:37.243	06.01 IP Documentation	06.01.11 Certificate of Destruction
5734	83	1611641679556:869327954	1611641523376:-1327162297	D5136C00008	687	491	CREATE	2021-01-26 07:14:39.643	UNITED KINGDOM	2804 Tsitsikas, Dimitris
5740	83	1611641684859:-580550936	1611641684238:1275870640	D5136C00008	693	692	CREATE	2021-01-26 07:14:44.943	02.04 General	02.04.01 Rele_-Contact Report
5743	83	1611641686576:2137916345	1611641686009:-719571360	D5136C00008	696	695	CREATE	2021-01-26 07:14:46.66	04.02 Other Committees	04.02.02 Other Approvals
5748	83	1611641689589:-1411090975	1611641687778:-1221740030	D5136C00008	701	698	CREATE	2021-01-26 07:14:49.675	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
5752	83	1611641693599:982641203	1611641691263:1885868851	D5136C00008	705	702	CREATE	2021-01-26 07:14:53.686	05.02 Site Se_p Documentation	05.02.03 Prot_ Signature Page
5758	83	1611641697168:-125502123	1611641691263:1885868851	D5136C00008	711	702	CREATE	2021-01-26 07:14:57.267	05.02 Site Se_p Documentation	05.02.12 Clinical Trial Agreement
5762	83	1611641699757:1953586729	1611641699194:-1544533753	D5136C00008	715	714	CREATE	2021-01-26 07:14:59.844	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
5769	83	1611641704800:1020600651	1611641702363:1777095758	D5136C00008	722	718	CREATE	2021-01-26 07:15:04.888	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
5772	83	1611641706562:465743668	1611641705972:1699612596	D5136C00008	725	724	CREATE	2021-01-26 07:15:06.648	05.05 General	05.05.01 Rele_nications-Email
5778	83	1611641710226:962591130	1611641708356:114558887	D5136C00008	731	728	CREATE	2021-01-26 07:15:10.317	06.01 IP Documentation	06.01.11 Certificate of Destruction
5782	83	1611641712604:1448128198	1611641712035:2081339768	D5136C00008	735	734	CREATE	2021-01-26 07:15:12.74	06.07 General	06.07.01 Rele_l Product-Email
5787	83	1611641715748:500085640	1611641715146:2076943853	D5136C00008	740	739	CREATE	2021-01-26 07:15:15.835	07.03 General	07.03.01 Rele_ns-Safety-Email
5790	83	1611641717512:1455942024	1611641716899:1092634339	D5136C00008	743	742	CREATE	2021-01-26 07:15:17.598	05 Site Management	05.01 Site Selection
5793	83	1611641719184:376092127	1611641718590:868406125	D5136C00008	746	745	CREATE	2021-01-26 07:15:19.272	UNITED STATES	01 Trial Management
5799	83	1611641727330:2016405446	1611641721663:-1533385682	D5136C00008	752	750	CREATE	2021-01-26 07:15:27.415	02.01 Trial Documents	02.01.06 Insurance
5806	83	1611641732278:1661617155	1611641727969:-52582080	D5136C00008	759	753	CREATE	2021-01-26 07:15:32.364	02.02 Subject Documents	02.02.07 Other W_ Given to Subjects
5809	83	1611641734072:692844924	1611641718590:868406125	D5136C00008	762	745	CREATE	2021-01-26 07:15:34.159	UNITED STATES	04 IRB-IEC and other Approvals
5812	83	1611641735849:-1641030748	1611641734636:-162194106	D5136C00008	765	763	CREATE	2021-01-26 07:15:35.932	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
5819	83	1611641740397:438374486	1611641739811:-333543403	D5136C00008	772	771	CREATE	2021-01-26 07:15:40.483	05.04 Site Management	05.04.09 Inv Notification Safety Info-Dr-HCP Letter
5822	83	1611641742207:1213330506	1611641718590:868406125	D5136C00008	775	745	CREATE	2021-01-26 07:15:42.294	UNITED STATES	7801 Lanzkron, Sophie
5828	83	1611641745852:-1350376097	1611641745288:-1594877498	D5136C00008	781	780	CREATE	2021-01-26 07:15:45.936	02.02 Subject Documents	02.02.03 Info_ Form Templates
5832	83	1611641748223:-1471411508	1611641747065:68551176	D5136C00008	785	783	CREATE	2021-01-26 07:15:48.31	02.04 General	02.04.01 Rele_tions-Documents
5837	83	1611641751258:-540240332	1611641750589:-1824265611	D5136C00008	790	789	CREATE	2021-01-26 07:15:51.346	04 IRB-IEC an_other Approvals	04.01 IRB-IEC Trial Approval
5840	83	1611641752997:1577355482	1611641751258:-540240332	D5136C00008	793	790	CREATE	2021-01-26 07:15:53.082	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
5847	83	1611641757161:76937209	1611641742207:1213330506	D5136C00008	800	775	CREATE	2021-01-26 07:15:57.249	7801 Lanzkron, Sophie	05 Site Management
5849	83	1611641758363:1062576662	1611641757766:1260846546	D5136C00008	802	801	CREATE	2021-01-26 07:15:58.45	05.01 Site Selection	05.01.02 Confidentiality Agreement
5853	83	1611641761621:1305433332	1611641761013:1091716741	D5136C00008	806	805	CREATE	2021-01-26 07:16:01.711	05.02 Site Se_p Documentation	05.02.01 Acceptance of Investigator Brochure
5857	83	1611641764066:1132203698	1611641761013:1091716741	D5136C00008	810	805	CREATE	2021-01-26 07:16:04.154	05.02 Site Se_p Documentation	05.02.06 Othe_ite Affiliation
5863	83	1611641790473:-1285405236	1611641761013:1091716741	D5136C00008	816	805	CREATE	2021-01-26 07:16:30.559	05.02 Site Se_p Documentation	05.02.18 Site Signature Sheet
5867	83	1611641793779:-1661675161	1611641791165:-1139191528	D5136C00008	820	817	CREATE	2021-01-26 07:16:33.864	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
5870	83	1611641795543:-247219038	1611641794384:-2112550531	D5136C00008	823	821	CREATE	2021-01-26 07:16:35.629	05.04 Site Management	05.04.03 Monitoring Visit Report
5880	83	1611641806484:707997642	1611641742207:1213330506	D5136C00008	833	775	CREATE	2021-01-26 07:16:46.57	7801 Lanzkron, Sophie	06 IP and Trial Supplies
5882	83	1611641807693:1106417139	1611641807104:444092009	D5136C00008	835	834	CREATE	2021-01-26 07:16:47.812	06.01 IP Documentation	06.01.04 IP Shipment Documentation
5889	83	1611641812040:139446362	1611641811427:1148067529	D5136C00008	842	841	CREATE	2021-01-26 07:16:52.161	06.05 Non-IP Documentation	06.05.02 Non-_ion of Shipment
5892	83	1611641813889:1498893027	1611641742207:1213330506	D5136C00008	845	775	CREATE	2021-01-26 07:16:53.974	7801 Lanzkron, Sophie	07 Safety Reporting
5895	83	1611641815710:-328278205	1611641718590:868406125	D5136C00008	848	745	CREATE	2021-01-26 07:16:55.797	UNITED STATES	7802 Boccia, Ralph
5901	83	1611641819850:-651326768	1611641818789:1865351867	D5136C00008	854	853	CREATE	2021-01-26 07:16:59.937	02.02 Subject Documents	02.02.03 Info_ Form Templates
5904	83	1611641821825:1070683848	1611641820621:-1203481022	D5136C00008	857	855	CREATE	2021-01-26 07:17:01.913	02.04 General	02.04.01 Rele_tions-Documents
5910	83	1611641825308:-2138647283	1611641824765:1420293699	D5136C00008	863	862	CREATE	2021-01-26 07:17:05.397	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
5915	83	1611641828300:1517020136	1611641826509:883517444	D5136C00008	868	865	CREATE	2021-01-26 07:17:08.385	04.03 Trial Status Reporting	04.03.03 IRB-_rm Notification
5917	83	1611641831105:-794461057	1611641828877:-967378521	D5136C00008	870	869	CREATE	2021-01-26 07:17:11.192	05 Site Management	05.01 Site Selection
5919	83	1611641832245:810935270	1611641831105:-794461057	D5136C00008	872	870	CREATE	2021-01-26 07:17:12.336	05.01 Site Selection	05.01.03 Feasibility Documentation
5926	83	1611641836316:2005484562	1611641833440:-27058349	D5136C00008	879	874	CREATE	2021-01-26 07:17:16.404	05.02 Site Se_p Documentation	05.02.07 Site Qualification
5981	83	1611641873577:-2042339487	1611641872993:13322831	D5136C00008	934	933	CREATE	2021-01-26 07:17:53.664	04.04 General	04.04.01 Rele_s-IRB-IEC-Email
5983	83	1611641874687:885376812	1611641874139:-1842558559	D5136C00008	936	935	CREATE	2021-01-26 07:17:54.772	05 Site Management	05.01 Site Selection
5989	83	1611641879135:1801792563	1611641877922:281074540	D5136C00008	942	940	CREATE	2021-01-26 07:17:59.222	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
5995	83	1611641882793:523267328	1611641877922:281074540	D5136C00008	948	940	CREATE	2021-01-26 07:18:02.878	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
5998	83	1611641884545:1675370520	1611641877922:281074540	D5136C00008	951	940	CREATE	2021-01-26 07:18:04.631	05.02 Site Se_p Documentation	05.02.18 Site Signature Sheet
6002	83	1611641886849:1367467310	1611641874139:-1842558559	D5136C00008	955	935	CREATE	2021-01-26 07:18:06.935	05 Site Management	05.04 Site Management
6009	83	1611641890826:-1378326918	1611641889731:91624976	D5136C00008	962	960	CREATE	2021-01-26 07:18:10.914	05.05 General	05.05.01 Relevant Communications-Documents
6012	83	1611641892587:-928009258	1611641892006:-944324531	D5136C00008	965	964	CREATE	2021-01-26 07:18:12.674	06 IP and Trial Supplies	06.01 IP Documentation
6018	83	1611641896056:-1691787368	1611641895482:1014769913	D5136C00008	971	970	CREATE	2021-01-26 07:18:16.144	08.01 Facility Documentation	08.01.01 Certification or Accreditation
6022	83	1611641898339:-1098976848	1611641897787:584577030	D5136C00008	975	974	CREATE	2021-01-26 07:18:18.426	7804 Kanter Washko, Julie	01 Trial Management
6024	83	1611641899510:-1350629628	1611641898966:216856431	D5136C00008	977	976	CREATE	2021-01-26 07:18:19.596	01.01 Trial Oversight	01.01.06 Recruitment Plan
6031	83	1611641903524:-1092738776	1611641902435:1036645038	D5136C00008	984	982	CREATE	2021-01-26 07:18:23.61	02.04 General	02.04.01 Rele_tions-Documents
6034	83	1611641905251:1211433708	1611641904712:-43014382	D5136C00008	987	986	CREATE	2021-01-26 07:18:25.336	03.04 General	03.04.01 Rele_rt-Up-Documents
6039	83	1611641908141:-1354976912	1611641906419:-702978421	D5136C00008	992	989	CREATE	2021-01-26 07:18:28.227	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
6043	83	1611641910396:-271802747	1611641897787:584577030	D5136C00008	996	974	CREATE	2021-01-26 07:18:30.481	7804 Kanter Washko, Julie	05 Site Management
6048	83	1611641913429:191192203	1611641910396:-271802747	D5136C00008	1001	996	CREATE	2021-01-26 07:18:33.514	05 Site Management	05.02 Site Se_p Documentation
6051	83	1611641915132:121532918	1611641913429:191192203	D5136C00008	1004	1001	CREATE	2021-01-26 07:18:35.217	05.02 Site Se_p Documentation	05.02.03 Prot_ Signature Page
6057	83	1611641919105:2089504033	1611641913429:191192203	D5136C00008	1010	1001	CREATE	2021-01-26 07:18:39.191	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
6061	83	1611641930683:-1727026827	1611641910396:-271802747	D5136C00008	1014	996	CREATE	2021-01-26 07:18:50.772	05 Site Management	05.03 Site Initiation
6067	83	1611641934471:893003807	1611641933291:1594581466	D5136C00008	1020	1018	CREATE	2021-01-26 07:18:54.559	05.04 Site Management	05.04.03 Monitoring Visit Report
6070	83	1611641936206:-694004002	1611641933291:1594581466	D5136C00008	1023	1018	CREATE	2021-01-26 07:18:56.292	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
6074	83	1611641938603:1667325337	1611641936814:1742639	D5136C00008	1027	1024	CREATE	2021-01-26 07:18:58.689	05.05 General	05.05.02 Tracking Information
6080	83	1611641942226:504449938	1611641939789:462620448	D5136C00008	1033	1029	CREATE	2021-01-26 07:19:02.314	06.01 IP Documentation	06.01.11 Certificate of Destruction
6083	83	1611641943980:-1770206341	1611641939187:-80222035	D5136C00008	1036	1028	CREATE	2021-01-26 07:19:04.067	06 IP and Trial Supplies	06.04 Storage
6089	83	1611641947691:1065641310	1611641946480:1022570725	D5136C00008	1042	1040	CREATE	2021-01-26 07:19:07.778	06.07 General	06.07.01 Rele_oduct-Documents
6092	83	1611641949429:-258870374	1611641948881:729664320	D5136C00008	1045	1044	CREATE	2021-01-26 07:19:09.514	07.02 Trial Status Reporting	07.02.02 SAE Report
6098	83	1611641952918:342520803	1611641951219:-774262616	D5136C00008	1051	1048	CREATE	2021-01-26 07:19:13.021	08 Centralized Testing	08.02 Sample Documentation
6102	83	1611641955251:-541468181	1611641954666:711893372	D5136C00008	1055	1054	CREATE	2021-01-26 07:19:15.337	10.05 General	10.05.01 Rele_anagement-Email
6104	83	1611641957151:-1941058437	1611641956364:-1352316942	D5136C00008	1057	1056	CREATE	2021-01-26 07:19:17.238	7805 Harrington, Thomas	01 Trial Management
6143	83	1611641979780:-1360515624	1611641973521:-1519367121	D5136C00008	1096	1085	CREATE	2021-01-26 07:19:39.865	05.02 Site Se_p Documentation	05.02.18 Site Signature Sheet
6150	83	1611641988839:-1537524395	1611641987649:-1628946498	D5136C00008	1103	1101	CREATE	2021-01-26 07:19:48.924	05.04 Site Management	05.04.03 Monitoring Visit Report
6153	83	1611641991056:1469533385	1611641987649:-1628946498	D5136C00008	1106	1101	CREATE	2021-01-26 07:19:51.146	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
6156	83	1611641992806:615978047	1611641992242:-1269135393	D5136C00008	1109	1108	CREATE	2021-01-26 07:19:52.897	05.05 General	05.05.01 Rele_nications-Email
6159	83	1611641994485:-1628956940	1611641956364:-1352316942	D5136C00008	1112	1056	CREATE	2021-01-26 07:19:54.575	7805 Harrington, Thomas	06 IP and Trial Supplies
6162	83	1611642008173:1870723421	1611641995045:2075773630	D5136C00008	1115	1113	CREATE	2021-01-26 07:20:08.263	06.01 IP Documentation	06.01.04 IP S_t Documentation
6166	83	1611642010489:-606675672	1611642009940:1946178801	D5136C00008	1119	1118	CREATE	2021-01-26 07:20:10.577	06.04 Storage	06.04.01 Storage Condition Documentation
6169	83	1611642012129:401904389	1611642011582:1241347032	D5136C00008	1122	1121	CREATE	2021-01-26 07:20:12.215	07 Safety Reporting	07.03 General
6172	83	1611642013879:-1072796387	1611642013335:19319843	D5136C00008	1125	1124	CREATE	2021-01-26 07:20:13.964	08 Centralized Testing	08.01 Facility Documentation
6175	83	1611642015521:-138224897	1611642013879:-1072796387	D5136C00008	1128	1125	CREATE	2021-01-26 07:20:23.861	08.01 Facility Documentation	08.01.07 Head of Facility CV
6176	83	1611642024412:1108356714	1611642013335:19319843	D5136C00008	1129	1124	CREATE	2021-01-26 07:20:24.499	08 Centralized Testing	08.02 Sample Documentation
6177	83	1611642025032:586724628	1611642024412:1108356714	D5136C00008	1130	1129	CREATE	2021-01-26 07:20:25.117	08.02 Sample Documentation	08.02.03 Samp_e Condition Log
6180	83	1611642026715:-580073702	1611642026170:729958990	D5136C00008	1133	1132	CREATE	2021-01-26 07:20:26.801	02 Central Trial Documents	02.02 Subject Documents
6183	83	1611642028456:-1696256659	1611642026170:729958990	D5136C00008	1136	1132	CREATE	2021-01-26 07:20:28.544	02 Central Trial Documents	02.04 General
6186	83	1611642030206:-820853829	1611642029643:-1755248060	D5136C00008	1139	1138	CREATE	2021-01-26 07:20:30.293	03 Regulatory	03.04 General
6188	83	1611642031302:1854159129	1611642025610:-1407555123	D5136C00008	1141	1131	CREATE	2021-01-26 07:20:31.387	7806 Harrington, Thomas	04 IRB-IEC an_other Approvals
6191	83	1611642033026:-968489119	1611642031900:-1089089567	D5136C00008	1144	1142	CREATE	2021-01-26 07:20:33.114	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
6194	83	1611642035262:117555102	1611642034708:-2054897358	D5136C00008	1147	1146	CREATE	2021-01-26 07:20:35.349	05 Site Management	05.01 Site Selection
6197	83	1611642036991:847066345	1611642036355:2028077891	D5136C00008	1150	1149	CREATE	2021-01-26 07:20:37.078	05.02 Site Se_p Documentation	05.02.01 Acce_igator Brochure
6200	83	1611642041767:1414642944	1611642036355:2028077891	D5136C00008	1153	1149	CREATE	2021-01-26 07:20:41.851	05.02 Site Se_p Documentation	05.02.06 Othe_ite Affiliation
6204	83	1611642045542:36655545	1611642036355:2028077891	D5136C00008	1157	1149	CREATE	2021-01-26 07:20:45.629	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
6207	83	1611642047279:-734362223	1611642046695:-1842780462	D5136C00008	1160	1159	CREATE	2021-01-26 07:20:47.365	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
6211	83	1611642049733:-1014430316	1611642048539:1282302423	D5136C00008	1164	1162	CREATE	2021-01-26 07:20:49.82	05.05 General	05.05.02 Tracking Information
6213	83	1611642051105:-1292787135	1611642050370:-1155173365	D5136C00008	1166	1165	CREATE	2021-01-26 07:20:51.191	08 Centralized Testing	08.01 Facility Documentation
18871	91	1625579447513:-1888187276	1625579446912:-1020930239	D5160C00019	475	474	CREATE	2021-07-06 15:50:47.612	05.04 Site Management	05.04.01 Subject Log
18872	91	1625579448091:-1891933052	1625579446912:-1020930239	D5160C00019	476	474	CREATE	2021-07-06 15:50:48.185	05.04 Site Management	05.04.03 Monitoring Visit Report
18874	91	1625579449254:-1907477228	1625579446912:-1020930239	D5160C00019	478	474	CREATE	2021-07-06 15:50:49.373	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
18876	91	1625579450503:-2050054823	1625579424106:-942551179	D5160C00019	480	455	CREATE	2021-07-06 15:50:50.598	05 Site Management	05.05 General
8210	84	\N	\N	D5170C00002	1995	1994	NEW	\N	05.01 Site Selection	05.01.01 Site Contact Details
18877	91	1625579451043:-1496322053	1625579450503:-2050054823	D5160C00019	481	480	CREATE	2021-07-06 15:50:51.133	05.05 General	05.05.02 Tracking Information
18878	91	1625579451751:1469909464	1625579413951:-556274802	D5160C00019	482	449	CREATE	2021-07-06 15:50:51.839	23061 Tosi, Diego	06 IP and Trial Supplies
18880	91	1625579453511:-116387047	1625579452438:1392572474	D5160C00019	484	483	CREATE	2021-07-06 15:50:53.604	06.01 IP Documentation	06.01.04 IP S_t Documentation
18881	91	1625579454171:239398024	1625579452438:1392572474	D5160C00019	485	483	CREATE	2021-07-06 15:50:54.275	06.01 IP Documentation	06.01.05 Acco_y Documentation
18883	91	1625579461488:1455757832	1625579452438:1392572474	D5160C00019	487	483	CREATE	2021-07-06 15:51:01.584	06.01 IP Documentation	06.01.11 Certificate of Destruction
18884	91	1625579462108:-956803446	1625579451751:1469909464	D5160C00019	488	482	CREATE	2021-07-06 15:51:02.207	06 IP and Trial Supplies	06.04 Storage
18886	91	1625579463525:2119301678	1625579413951:-556274802	D5160C00019	490	449	CREATE	2021-07-06 15:51:04.067	23061 Tosi, Diego	07 Safety Reporting
18887	91	1625579464569:1515069965	1625579463525:2119301678	D5160C00019	491	490	CREATE	2021-07-06 15:51:04.659	07 Safety Reporting	07.03 General
18888	91	1625579465134:-59101527	1625579464569:1515069965	D5160C00019	492	491	CREATE	2021-07-06 15:51:05.229	07.03 General	07.03.01 Rele_ns-Safety-Email
18890	91	1625579466409:1394531806	1625579465803:897253271	D5160C00019	494	493	CREATE	2021-07-06 15:51:06.537	08 Centralized Testing	08.01 Facility Documentation
18891	91	1625579466988:-734226820	1625579466409:1394531806	D5160C00019	495	494	CREATE	2021-07-06 15:51:07.107	08.01 Facility Documentation	08.01.01 Cert_r Accreditation
18893	91	1625579468207:1345836676	1625579466409:1394531806	D5160C00019	497	494	CREATE	2021-07-06 15:51:08.324	08.01 Facility Documentation	08.01.05 Manual
18894	91	1625579468907:482921971	1625579466409:1394531806	D5160C00019	498	494	CREATE	2021-07-06 15:51:09.011	08.01 Facility Documentation	08.01.07 Head of Facility CV
18896	91	1625579476241:-571870753	1625579475483:1179759100	D5160C00019	500	499	CREATE	2021-07-06 15:51:16.363	08.02 Sample Documentation	08.02.03 Samp_e Condition Log
18897	91	1625579477254:1340561251	1625579475483:1179759100	D5160C00019	501	499	CREATE	2021-07-06 15:51:17.379	08.02 Sample Documentation	08.02.05 Reta_-Tissue Samples
18898	91	1625579477872:594587882	1625578787595:-65419865	D5160C00019	502	8	CREATE	2021-07-06 15:51:17.976	contents	GERMANY
18900	91	1625579479032:1629658789	1625579478442:-1326871365	D5160C00019	504	503	CREATE	2021-07-06 15:51:19.131	03 Regulatory	03.03 Trial Status Reporting
18902	91	1625579480277:763504831	1625579477872:594587882	D5160C00019	506	502	CREATE	2021-07-06 15:51:20.369	GERMANY	04 IRB-IEC and other Approvals
18903	91	1625579480895:623547909	1625579480277:763504831	D5160C00019	507	506	CREATE	2021-07-06 15:51:21.003	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
8307	84	\N	\N	D5170C00002	2092	2001	NEW	\N	Site	2002290 Bene, Laszlo
18906	91	1625579488428:-86137317	1625579480277:763504831	D5160C00019	510	506	CREATE	2021-07-06 15:51:28.535	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
18907	91	1625579488977:-1700503273	1625579488428:-86137317	D5160C00019	511	510	CREATE	2021-07-06 15:51:29.065	04.03 Trial Status Reporting	04.03.03 IRB-IEC_ Term Notification
18908	91	1625579489513:-233588849	1625579477872:594587882	D5160C00019	512	502	CREATE	2021-07-06 15:51:29.605	GERMANY	26021 Golpon, Heiko
18910	91	1625579490929:-379050661	1625579490247:366897001	D5160C00019	514	513	CREATE	2021-07-06 15:51:31.027	04 IRB-IEC an_other Approvals	04.01 IRB-IEC Trial Approval
18911	91	1625579491455:1385205940	1625579490929:-379050661	D5160C00019	515	514	CREATE	2021-07-06 15:51:31.543	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
18913	91	1625579498822:1040069370	1625579490247:366897001	D5160C00019	517	513	CREATE	2021-07-06 15:51:39.076	04 IRB-IEC an_other Approvals	04.03 Trial Status Reporting
18914	91	1625579499613:1990520235	1625579498822:1040069370	D5160C00019	518	517	CREATE	2021-07-06 15:51:39.711	04.03 Trial Status Reporting	04.03.03 IRB-_rm Notification
18915	91	1625579500226:1965609392	1625579489513:-233588849	D5160C00019	519	512	CREATE	2021-07-06 15:51:40.326	26021 Golpon, Heiko	05 Site Management
18917	91	1625579501382:483184000	1625579500785:803025185	D5160C00019	521	520	CREATE	2021-07-06 15:51:41.473	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
18918	91	1625579501913:1125369365	1625579477872:594587882	D5160C00019	522	502	CREATE	2021-07-06 15:51:41.999	GERMANY	26031 Waller, Cornelius
18920	91	1625579503196:2008099700	1625579502631:-1998221983	D5160C00019	524	523	CREATE	2021-07-06 15:51:43.287	05 Site Management	05.01 Site Selection
18921	91	1625579503771:-1395103238	1625579503196:2008099700	D5160C00019	525	524	CREATE	2021-07-06 15:51:43.861	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
11643	86	\N	\N	D5170C00002	94	93	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
18923	91	1625579504926:-1490843975	1625579504346:-1266246792	D5160C00019	527	526	CREATE	2021-07-06 15:51:45.016	26041 Ochsenreither, Sebastian	05 Site Management
18924	91	1625579505464:-669512994	1625579504926:-1490843975	D5160C00019	528	527	CREATE	2021-07-06 15:51:45.554	05 Site Management	05.01 Site Selection
18926	91	1625579507539:-398173960	1625579477872:594587882	D5160C00019	530	502	CREATE	2021-07-06 15:51:47.632	GERMANY	26051 Grohe, Christian
18927	91	1625579508068:-443947250	1625579507539:-398173960	D5160C00019	531	530	CREATE	2021-07-06 15:51:48.184	26051 Grohe, Christian	05 Site Management
18928	91	1625579508634:1489731179	1625579508068:-443947250	D5160C00019	532	531	CREATE	2021-07-06 15:51:48.727	05 Site Management	05.01 Site Selection
18930	91	1625579509774:723492485	1625579477872:594587882	D5160C00019	534	502	CREATE	2021-07-06 15:51:49.869	GERMANY	TBD-1-1FNLC0B Bullinger, Lars
18931	91	1625579510350:1385825209	1625579509774:723492485	D5160C00019	535	534	CREATE	2021-07-06 15:51:50.438	TBD-1-1FNLC0B Bullinger, Lars	04 IRB-IEC an_other Approvals
18933	91	1625579511439:1869238646	1625579510905:1359085066	D5160C00019	537	536	CREATE	2021-07-06 15:51:51.529	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
18934	91	1625579512137:-1504243115	1625579510905:1359085066	D5160C00019	538	536	CREATE	2021-07-06 15:51:52.226	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
18936	91	1625579513294:1236255960	1625579512675:-1462086743	D5160C00019	540	539	CREATE	2021-07-06 15:51:53.4	04.03 Trial Status Reporting	04.03.03 IRB-_rm Notification
18937	91	1625579520498:812242115	1625579510350:1385825209	D5160C00019	541	535	CREATE	2021-07-06 15:52:00.611	04 IRB-IEC an_other Approvals	04.04 General
18938	91	1625579521118:-1569759037	1625579520498:812242115	D5160C00019	542	541	CREATE	2021-07-06 15:52:01.211	04.04 General	04.04.01 Rele_B-IEC-Documents
18940	91	1625579522369:624133661	1625579521723:-570591955	D5160C00019	544	543	CREATE	2021-07-06 15:52:02.469	05 Site Management	05.01 Site Selection
18941	91	1625579522981:2043663613	1625579522369:624133661	D5160C00019	545	544	CREATE	2021-07-06 15:52:03.08	05.01 Site Selection	05.01.04 Pre _nitoring Report
18942	91	1625579523523:1533419025	1625578787595:-65419865	D5160C00019	546	8	CREATE	2021-07-06 15:52:03.615	contents	SPAIN
18944	91	1625579524619:1092805660	1625579524071:-1882409801	D5160C00019	548	547	CREATE	2021-07-06 15:52:04.716	01 Trial Management	01.05 General
18946	91	1625579525786:-930760222	1625579523523:1533419025	D5160C00019	550	546	CREATE	2021-07-06 15:52:05.881	SPAIN	02 Central Trial Documents
18947	91	1625579526344:-1862470708	1625579525786:-930760222	D5160C00019	551	550	CREATE	2021-07-06 15:52:06.435	02 Central Trial Documents	02.01 Trial Documents
18948	91	1625579526882:-252635609	1625579526344:-1862470708	D5160C00019	552	551	CREATE	2021-07-06 15:52:06.971	02.01 Trial Documents	02.01.02 Protocol
18950	91	1625579529027:-1524896011	1625579526344:-1862470708	D5160C00019	554	551	CREATE	2021-07-06 15:52:09.122	02.01 Trial Documents	02.01.04 Protocol Amendment
18951	91	1625579529561:2102425621	1625579526344:-1862470708	D5160C00019	555	551	CREATE	2021-07-06 15:52:09.662	02.01 Trial Documents	02.01.06 Insurance
18953	91	1625579536175:196467926	1625579530191:249196774	D5160C00019	557	556	CREATE	2021-07-06 15:52:16.524	02.02 Subject Documents	02.02.01 Subject Diary
18954	91	1625579537041:741381032	1625579530191:249196774	D5160C00019	558	556	CREATE	2021-07-06 15:52:17.152	02.02 Subject Documents	02.02.03 Informe_ent Form Templates
18956	91	1625579538245:1157263621	1625579530191:249196774	D5160C00019	560	556	CREATE	2021-07-06 15:52:18.338	02.02 Subject Documents	02.02.05 Subject Participation Card
18957	91	1625579539563:-2122609723	1625579530191:249196774	D5160C00019	561	556	CREATE	2021-07-06 15:52:19.666	02.02 Subject Documents	02.02.07 Other W_ Given to Subjects
18958	91	1625579540206:-2079745329	1625579525786:-930760222	D5160C00019	562	550	CREATE	2021-07-06 15:52:20.31	02 Central Trial Documents	02.04 General
9023	85	1616042826860:1269305664	1616042808791:-137870481	D5170C00002	39	14	CREATE	2021-03-18 05:47:06.95	05 Site Management	05.05 General
18960	91	1625579541335:-1462229109	1625579523523:1533419025	D5160C00019	564	546	CREATE	2021-07-06 15:52:21.428	SPAIN	03 Regulatory
18961	91	1625579541948:1445963708	1625579541335:-1462229109	D5160C00019	565	564	CREATE	2021-07-06 15:52:22.043	03 Regulatory	03.01 Trial Approval
18963	91	1625579543074:524386621	1625579541948:1445963708	D5160C00019	567	565	CREATE	2021-07-06 15:52:23.18	03.01 Trial Approval	03.01.02 Approval
18964	91	1625579550187:-1586698492	1625579541335:-1462229109	D5160C00019	568	564	CREATE	2021-07-06 15:52:30.282	03 Regulatory	03.03 Trial Status Reporting
18966	91	1625579551525:914978313	1625579550187:-1586698492	D5160C00019	570	568	CREATE	2021-07-06 15:52:31.628	03.03 Trial Status Reporting	03.03.02 Progress Report
18967	91	1625579552237:921881199	1625579550187:-1586698492	D5160C00019	571	568	CREATE	2021-07-06 15:52:32.327	03.03 Trial Status Reporting	03.03.03 Notification of Trial Termination
8369	84	\N	\N	D5170C00002	2154	2153	NEW	\N	02 Central Trial Documents	02.04 General
18970	91	1625579553953:1962396711	1625579523523:1533419025	D5160C00019	574	546	CREATE	2021-07-06 15:52:34.051	SPAIN	04 IRB-IEC and other Approvals
18971	91	1625579554551:1724964884	1625579553953:1962396711	D5160C00019	575	574	CREATE	2021-07-06 15:52:34.644	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
18973	91	1625579555637:-261270210	1625579554551:1724964884	D5160C00019	577	575	CREATE	2021-07-06 15:52:35.73	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
18974	91	1625579556211:238063917	1625579553953:1962396711	D5160C00019	578	574	CREATE	2021-07-06 15:52:36.315	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
18975	91	1625579556755:1509755187	1625579556211:238063917	D5160C00019	579	578	CREATE	2021-07-06 15:52:36.848	04.03 Trial Status Reporting	04.03.01 IRB-IEC_ety Info-Deviation
18977	91	1625579558001:1178164369	1625579553953:1962396711	D5160C00019	581	574	CREATE	2021-07-06 15:52:38.105	04 IRB-IEC and other Approvals	04.04 General
18978	91	1625579558565:790162445	1625579558001:1178164369	D5160C00019	582	581	CREATE	2021-07-06 15:52:38.657	04.04 General	04.04.01 Relevant Communications-IRB-IEC-Documents
18979	91	1625579559145:-427607565	1625579523523:1533419025	D5160C00019	583	546	CREATE	2021-07-06 15:52:39.247	SPAIN	05 Site Management
18981	91	1625579561150:-2075725140	1625579559706:-2105204750	D5160C00019	585	584	CREATE	2021-07-06 15:52:41.243	05.01 Site Selection	05.01.05 Sites Evaluated but not Selected
18982	91	1625579561710:900521065	1625579559145:-427607565	D5160C00019	586	583	CREATE	2021-07-06 15:52:41.804	05 Site Management	05.05 General
18984	91	1625579562911:503757843	1625579523523:1533419025	D5160C00019	588	546	CREATE	2021-07-06 15:52:43.006	SPAIN	06 IP and Trial Supplies
18985	91	1625579563460:-65167614	1625579562911:503757843	D5160C00019	589	588	CREATE	2021-07-06 15:52:43.55	06 IP and Trial Supplies	06.01 IP Documentation
18987	91	1625579570333:1407517647	1625579523523:1533419025	D5160C00019	591	546	CREATE	2021-07-06 15:52:50.434	SPAIN	70011 Alonso Garcia, Miriam
18988	91	1625579571774:-1350265333	1625579570333:1407517647	D5160C00019	592	591	CREATE	2021-07-06 15:52:51.9	70011 Alonso Garcia, Miriam	02 Central Trial Documents
18989	91	1625579572398:-1583118447	1625579571774:-1350265333	D5160C00019	593	592	CREATE	2021-07-06 15:52:52.658	02 Central Trial Documents	02.04 General
18991	91	1625579573810:-1080348855	1625579570333:1407517647	D5160C00019	595	591	CREATE	2021-07-06 15:52:53.907	70011 Alonso Garcia, Miriam	05 Site Management
18992	91	1625579574380:-1305925445	1625579573810:-1080348855	D5160C00019	596	595	CREATE	2021-07-06 15:52:54.476	05 Site Management	05.01 Site Selection
18994	91	1625579582799:1431691396	1625579574380:-1305925445	D5160C00019	598	596	CREATE	2021-07-06 15:53:02.903	05.01 Site Selection	05.01.02 Confidentiality Agreement
18995	91	1625579583408:892189718	1625579574380:-1305925445	D5160C00019	599	596	CREATE	2021-07-06 15:53:03.508	05.01 Site Selection	05.01.03 Feasibility Documentation
18997	91	1625579585128:1553851741	1625579573810:-1080348855	D5160C00019	601	595	CREATE	2021-07-06 15:53:05.222	05 Site Management	05.02 Site Se_p Documentation
18998	91	1625579585675:38945866	1625579585128:1553851741	D5160C00019	602	601	CREATE	2021-07-06 15:53:05.772	05.02 Site Se_p Documentation	05.02.01 Acce_igator Brochure
19000	91	1625579586817:110615774	1625579585128:1553851741	D5160C00019	604	601	CREATE	2021-07-06 15:53:06.91	05.02 Site Se_p Documentation	05.02.03 Prot_ Signature Page
19001	91	1625579587377:-782610092	1625579585128:1553851741	D5160C00019	605	601	CREATE	2021-07-06 15:53:07.468	05.02 Site Se_p Documentation	05.02.04 PI C_ite Affiliation
19003	91	1625579588586:-1238047838	1625579585128:1553851741	D5160C00019	607	601	CREATE	2021-07-06 15:53:08.678	05.02 Site Se_p Documentation	05.02.07 Site Qualification
19004	91	1625579589135:963935205	1625579585128:1553851741	D5160C00019	608	601	CREATE	2021-07-06 15:53:09.262	05.02 Site Se_p Documentation	05.02.09 Inve_atory Agreement
19005	91	1625579597876:-1211199271	1625579585128:1553851741	D5160C00019	609	601	CREATE	2021-07-06 15:53:17.992	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
19007	91	1625579599166:1298287037	1625579585128:1553851741	D5160C00019	611	601	CREATE	2021-07-06 15:53:19.273	05.02 Site Se_p Documentation	05.02.13 Indemnity
19008	91	1625579599767:857612936	1625579585128:1553851741	D5160C00019	612	601	CREATE	2021-07-06 15:53:19.855	05.02 Site Se_p Documentation	05.02.17 IP S_e Documentation
19010	91	1625579601139:1977960684	1625579573810:-1080348855	D5160C00019	614	595	CREATE	2021-07-06 15:53:21.241	05 Site Management	05.03 Site Initiation
19011	91	1625579601765:1781938150	1625579601139:1977960684	D5160C00019	615	614	CREATE	2021-07-06 15:53:21.861	05.03 Site Initiation	05.03.01 Tria_nitoring Report
19012	91	1625579602323:-1817541071	1625579601139:1977960684	D5160C00019	616	614	CREATE	2021-07-06 15:53:22.42	05.03 Site Initiation	05.03.03 Site Training-Staff
19014	91	1625579603429:-384312790	1625579573810:-1080348855	D5160C00019	618	595	CREATE	2021-07-06 15:53:23.522	05 Site Management	05.04 Site Management
19015	91	1625579604926:-454128083	1625579603429:-384312790	D5160C00019	619	618	CREATE	2021-07-06 15:53:25.019	05.04 Site Management	05.04.01 Subject Log
19017	91	1625579606096:2049390143	1625579603429:-384312790	D5160C00019	621	618	CREATE	2021-07-06 15:53:26.194	05.04 Site Management	05.04.04 Visit Log
19018	91	1625579606653:-528040446	1625579603429:-384312790	D5160C00019	622	618	CREATE	2021-07-06 15:53:26.744	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
19019	91	1625579607194:1254033002	1625579603429:-384312790	D5160C00019	623	618	CREATE	2021-07-06 15:53:27.287	05.04 Site Management	05.04.08 Fina_nitoring Report
19021	91	1625579608306:1841688435	1625579607765:1364402177	D5160C00019	625	624	CREATE	2021-07-06 15:53:28.412	05.05 General	05.05.01 Rele_tions-Documents
19022	91	1625579608862:-112393638	1625579607765:1364402177	D5160C00019	626	624	CREATE	2021-07-06 15:53:28.961	05.05 General	05.05.02 Tracking Information
19024	91	1625579612936:-310694722	1625579612280:2017284682	D5160C00019	628	627	CREATE	2021-07-06 15:53:33.045	06 IP and Trial Supplies	06.01 IP Documentation
19025	91	1625579613487:-27714114	1625579612936:-310694722	D5160C00019	629	628	CREATE	2021-07-06 15:53:33.578	06.01 IP Documentation	06.01.04 IP S_t Documentation
19027	91	1625579635040:-42629217	1625579612936:-310694722	D5160C00019	631	628	CREATE	2021-07-06 15:53:55.149	06.01 IP Documentation	06.01.10 IP D_entation Return
19028	91	1625579635605:-2013780325	1625579612936:-310694722	D5160C00019	632	628	CREATE	2021-07-06 15:53:56.195	06.01 IP Documentation	06.01.11 Cert_ of Destruction
19030	91	1625579637261:-1260292702	1625579636713:245992792	D5160C00019	634	633	CREATE	2021-07-06 15:53:57.352	06.04 Storage	06.04.01 Stor_n Documentation
19031	91	1625579637864:-1985240301	1625579636713:245992792	D5160C00019	635	633	CREATE	2021-07-06 15:53:57.961	06.04 Storage	06.04.03 Maintenance Logs
8432	84	\N	\N	D5170C00002	2217	2216	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
19033	91	1625579639020:-174212346	1625579638398:647243769	D5160C00019	637	636	CREATE	2021-07-06 15:53:59.118	07 Safety Reporting	07.02 Trial Status Reporting
19034	91	1625579639581:-850940195	1625579639020:-174212346	D5160C00019	638	637	CREATE	2021-07-06 15:53:59.673	07.02 Trial Status Reporting	07.02.02 SAE Report
19036	91	1625579640898:1368767647	1625579640345:-574804638	D5160C00019	640	639	CREATE	2021-07-06 15:54:00.992	08 Centralized Testing	08.01 Facility Documentation
19037	91	1625579641501:523065004	1625579640898:1368767647	D5160C00019	641	640	CREATE	2021-07-06 15:54:01.603	08.01 Facility Documentation	08.01.01 Cert_r Accreditation
19039	91	1625579642643:-1485920325	1625579570333:1407517647	D5160C00019	643	591	CREATE	2021-07-06 15:54:02.736	70011 Alonso Garcia, Miriam	10 Data Management
19040	91	1625579643245:128585342	1625579642643:-1485920325	D5160C00019	644	643	CREATE	2021-07-06 15:54:03.346	10 Data Management	10.02 Data Capture
19042	91	1625579644481:1074217758	1625579523523:1533419025	D5160C00019	646	546	CREATE	2021-07-06 15:54:04.573	SPAIN	70021 Vicente Baz, David
19043	91	1625579645112:-1277140982	1625579644481:1074217758	D5160C00019	647	646	CREATE	2021-07-06 15:54:05.233	70021 Vicente Baz, David	02 Central Trial Documents
19044	91	1625579645841:-929441078	1625579645112:-1277140982	D5160C00019	648	647	CREATE	2021-07-06 15:54:05.954	02 Central Trial Documents	02.04 General
19046	91	1625579647463:-1601604560	1625579644481:1074217758	D5160C00019	650	646	CREATE	2021-07-06 15:54:07.555	70021 Vicente Baz, David	05 Site Management
19047	91	1625579648018:-1200493129	1625579647463:-1601604560	D5160C00019	651	650	CREATE	2021-07-06 15:54:08.129	05 Site Management	05.01 Site Selection
19049	91	1625579649319:-1381196188	1625579648018:-1200493129	D5160C00019	653	651	CREATE	2021-07-06 15:54:09.44	05.01 Site Selection	05.01.03 Feasibility Documentation
19050	91	1625579650039:843822257	1625579648018:-1200493129	D5160C00019	654	651	CREATE	2021-07-06 15:54:17.702	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
19052	91	1625579658811:-1476187190	1625579658218:270316541	D5160C00019	656	655	CREATE	2021-07-06 15:54:18.915	05.02 Site Se_p Documentation	05.02.01 Acce_igator Brochure
19053	91	1625579659356:-2075424618	1625579658218:270316541	D5160C00019	657	655	CREATE	2021-07-06 15:54:19.444	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
19055	91	1625579660508:-168990936	1625579658218:270316541	D5160C00019	659	655	CREATE	2021-07-06 15:54:20.617	05.02 Site Se_p Documentation	05.02.04 PI C_ite Affiliation
19056	91	1625579661064:258720015	1625579658218:270316541	D5160C00019	660	655	CREATE	2021-07-06 15:54:21.152	05.02 Site Se_p Documentation	05.02.05 Sub-_ite Affiliation
19057	91	1625579661604:-374341912	1625579658218:270316541	D5160C00019	661	655	CREATE	2021-07-06 15:54:21.704	05.02 Site Se_p Documentation	05.02.06 Othe_ite Affiliation
19059	91	1625579662802:-529627316	1625579658218:270316541	D5160C00019	663	655	CREATE	2021-07-06 15:54:22.89	05.02 Site Se_p Documentation	05.02.07 Staff Qualification
19060	91	1625579663462:1070857318	1625579658218:270316541	D5160C00019	664	655	CREATE	2021-07-06 15:54:23.572	05.02 Site Se_p Documentation	05.02.09 Inve_atory Agreement
19062	91	1625579664685:-7121509	1625579658218:270316541	D5160C00019	666	655	CREATE	2021-07-06 15:54:24.772	05.02 Site Se_p Documentation	05.02.12 Clinical Trial Agreement
19063	91	1625579665398:-723585498	1625579658218:270316541	D5160C00019	667	655	CREATE	2021-07-06 15:54:25.495	05.02 Site Se_p Documentation	05.02.13 Indemnity
19064	91	1625579665929:-424379422	1625579658218:270316541	D5160C00019	668	655	CREATE	2021-07-06 15:54:26.023	05.02 Site Se_p Documentation	05.02.17 IP S_e Documentation
19066	91	1625579666997:749047895	1625579647463:-1601604560	D5160C00019	670	650	CREATE	2021-07-06 15:54:27.096	05 Site Management	05.03 Site Initiation
19067	91	1625579668152:-1995648929	1625579666997:749047895	D5160C00019	671	670	CREATE	2021-07-06 15:54:28.264	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
19068	91	1625579668766:-849124279	1625579666997:749047895	D5160C00019	672	670	CREATE	2021-07-06 15:54:28.882	05.03 Site Initiation	05.03.03 Site Training-Staff
19070	91	1625579670023:1109959734	1625579647463:-1601604560	D5160C00019	674	650	CREATE	2021-07-06 15:54:30.143	05 Site Management	05.04 Site Management
19071	91	1625579670802:1513401618	1625579670023:1109959734	D5160C00019	675	674	CREATE	2021-07-06 15:54:30.924	05.04 Site Management	05.04.01 Subject Log
19073	91	1625579672002:-1612318294	1625579670023:1109959734	D5160C00019	677	674	CREATE	2021-07-06 15:54:32.105	05.04 Site Management	05.04.04 Visit Log
19074	91	1625579672614:1494132884	1625579670023:1109959734	D5160C00019	678	674	CREATE	2021-07-06 15:54:32.72	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
19076	91	1625579673740:1469802666	1625579647463:-1601604560	D5160C00019	680	650	CREATE	2021-07-06 15:54:33.855	05 Site Management	05.05 General
19077	91	1625579674628:1654499715	1625579673740:1469802666	D5160C00019	681	680	CREATE	2021-07-06 15:54:34.749	05.05 General	05.05.01 Rele_tions-Documents
19078	91	1625579675237:1921329400	1625579673740:1469802666	D5160C00019	682	680	CREATE	2021-07-06 15:54:35.347	05.05 General	05.05.02 Tracking Information
19080	91	1625579676435:-1339670252	1625579675897:-75699961	D5160C00019	684	683	CREATE	2021-07-06 15:54:36.529	06 IP and Trial Supplies	06.01 IP Documentation
19081	91	1625579683899:-498804536	1625579676435:-1339670252	D5160C00019	685	684	CREATE	2021-07-06 15:54:43.992	06.01 IP Documentation	06.01.04 IP S_t Documentation
19083	91	1625579685188:875226659	1625579676435:-1339670252	D5160C00019	687	684	CREATE	2021-07-06 15:54:45.285	06.01 IP Documentation	06.01.10 IP D_entation Return
19084	91	1625579685740:-1110076716	1625579676435:-1339670252	D5160C00019	688	684	CREATE	2021-07-06 15:54:45.83	06.01 IP Documentation	06.01.11 Certificate of Destruction
19086	91	1625579686850:949037897	1625579686276:605910515	D5160C00019	690	689	CREATE	2021-07-06 15:54:46.949	06.04 Storage	06.04.01 Storage Condition Documentation
19087	91	1625579687459:1872391234	1625579686276:605910515	D5160C00019	691	689	CREATE	2021-07-06 15:54:47.559	06.04 Storage	06.04.03 Maintenance Logs
19089	91	1625579689348:-1958798750	1625579688211:-760652852	D5160C00019	693	692	CREATE	2021-07-06 15:54:49.442	07 Safety Reporting	07.03 General
19090	91	1625579689909:-1185488920	1625579689348:-1958798750	D5160C00019	694	693	CREATE	2021-07-06 15:54:50.004	07.03 General	07.03.01 Rele_ns-Safety-Email
19092	91	1625579691022:-1240552473	1625579690475:-1982690650	D5160C00019	696	695	CREATE	2021-07-06 15:54:51.111	08 Centralized Testing	08.01 Facility Documentation
19093	91	1625579691555:-1231200249	1625579691022:-1240552473	D5160C00019	697	696	CREATE	2021-07-06 15:54:51.642	08.01 Facility Documentation	08.01.01 Cert_r Accreditation
8515	84	\N	\N	D5170C00002	2300	2273	NEW	\N	05 Site Management	05.05 General
15006	88	1617081901976:1195828666	1617050397534:-1030155443	D5170C00001	696	695	CREATE	2021-03-30 07:25:02.072	General	Tracking Information
19096	91	1625579693257:332293842	1625579692657:618825840	D5160C00019	700	699	CREATE	2021-07-06 15:54:53.353	08.02 Sample Documentation	08.02.02 Shipment Records
19098	91	1625579694915:1047762492	1625579692657:618825840	D5160C00019	702	699	CREATE	2021-07-06 15:54:55.026	08.02 Sample Documentation	08.02.05 Reta_-Tissue Samples
19099	91	1625579695477:877579486	1625579523523:1533419025	D5160C00019	703	546	CREATE	2021-07-06 15:54:55.572	SPAIN	70031 Trigo P_ez, Jose Manuel
19101	91	1625579696653:-2003305773	1625579696086:-1521331114	D5160C00019	705	704	CREATE	2021-07-06 15:54:56.751	02 Central Trial Documents	02.02 Subject Documents
19102	91	1625579697252:-1695815357	1625579696653:-2003305773	D5160C00019	706	705	CREATE	2021-07-06 15:54:57.359	02.02 Subject Documents	02.02.01 Subject Diary
19103	91	1625579697824:-777171366	1625579696086:-1521331114	D5160C00019	707	704	CREATE	2021-07-06 15:54:57.926	02 Central Trial Documents	02.04 General
19105	91	1625579699048:170638637	1625579697824:-777171366	D5160C00019	709	707	CREATE	2021-07-06 15:54:59.161	02.04 General	02.04.01 Rele_tions-Documents
19106	91	1625579700277:-511502632	1625579695477:877579486	D5160C00019	710	703	CREATE	2021-07-06 15:55:06.732	70031 Trigo P_ez, Jose Manuel	05 Site Management
19108	91	1625579708014:-1196855518	1625579707219:1138505648	D5160C00019	712	711	CREATE	2021-07-06 15:55:08.115	05.01 Site Selection	05.01.02 Confidentiality Agreement
19109	91	1625579708561:392511715	1625579707219:1138505648	D5160C00019	713	711	CREATE	2021-07-06 15:55:08.653	05.01 Site Selection	05.01.03 Feasibility Documentation
19111	91	1625579709688:1869604885	1625579700277:-511502632	D5160C00019	715	710	CREATE	2021-07-06 15:55:09.794	05 Site Management	05.02 Site Se_p Documentation
19112	91	1625579710916:-1632365666	1625579709688:1869604885	D5160C00019	716	715	CREATE	2021-07-06 15:55:11.007	05.02 Site Se_p Documentation	05.02.01 Acce_igator Brochure
19114	91	1625579712034:-223167953	1625579709688:1869604885	D5160C00019	718	715	CREATE	2021-07-06 15:55:12.126	05.02 Site Se_p Documentation	05.02.03 Prot_ Signature Page
19115	91	1625579712574:-1116393819	1625579709688:1869604885	D5160C00019	719	715	CREATE	2021-07-06 15:55:12.665	05.02 Site Se_p Documentation	05.02.04 PI C_ite Affiliation
19117	91	1625579713674:553631857	1625579709688:1869604885	D5160C00019	721	715	CREATE	2021-07-06 15:55:13.767	05.02 Site Se_p Documentation	05.02.07 Site Qualification
19118	91	1625579714226:-1539352396	1625579709688:1869604885	D5160C00019	722	715	CREATE	2021-07-06 15:55:14.321	05.02 Site Se_p Documentation	05.02.09 Inve_atory Agreement
19119	91	1625579714806:-1548186916	1625579709688:1869604885	D5160C00019	723	715	CREATE	2021-07-06 15:55:14.917	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
19121	91	1625579715981:-1164333774	1625579709688:1869604885	D5160C00019	725	715	CREATE	2021-07-06 15:55:16.071	05.02 Site Se_p Documentation	05.02.13 Indemnity
19122	91	1625579716526:469164362	1625579709688:1869604885	D5160C00019	726	715	CREATE	2021-07-06 15:55:16.618	05.02 Site Se_p Documentation	05.02.17 IP S_e Documentation
19124	91	1625579717645:-1261532426	1625579700277:-511502632	D5160C00019	728	710	CREATE	2021-07-06 15:55:17.754	05 Site Management	05.03 Site Initiation
19125	91	1625579718319:1252831044	1625579717645:-1261532426	D5160C00019	729	728	CREATE	2021-07-06 15:55:18.415	05.03 Site Initiation	05.03.01 Tria_nitoring Report
19126	91	1625579718874:2003068838	1625579717645:-1261532426	D5160C00019	730	728	CREATE	2021-07-06 15:55:18.964	05.03 Site Initiation	05.03.03 Site Training-Staff
19128	91	1625579720128:1320333607	1625579700277:-511502632	D5160C00019	732	710	CREATE	2021-07-06 15:55:20.239	05 Site Management	05.04 Site Management
19129	91	1625579721288:-1991023972	1625579720128:1320333607	D5160C00019	733	732	CREATE	2021-07-06 15:55:21.383	05.04 Site Management	05.04.01 Subject Log
19131	91	1625579722412:-821787197	1625579720128:1320333607	D5160C00019	735	732	CREATE	2021-07-06 15:55:22.51	05.04 Site Management	05.04.04 Visit Log
19132	91	1625579723028:-2074968250	1625579720128:1320333607	D5160C00019	736	732	CREATE	2021-07-06 15:55:23.136	05.04 Site Management	05.04.05 Additional Monitoring Activity
19134	91	1625579724236:-111670127	1625579720128:1320333607	D5160C00019	738	732	CREATE	2021-07-06 15:55:24.327	05.04 Site Management	05.04.08 Fina_nitoring Report
19135	91	1625579724777:839495266	1625579720128:1320333607	D5160C00019	739	732	CREATE	2021-07-06 15:55:24.874	05.04 Site Management	05.04.09 Inv _o-Dr-HCP Letter
19136	91	1625579725345:-300327174	1625579720128:1320333607	D5160C00019	740	732	CREATE	2021-07-06 15:55:25.456	05.04 Site Management	05.04.09 Inv Notification-SUSAR
19138	91	1625579726590:-430289399	1625579726021:-1875037888	D5160C00019	742	741	CREATE	2021-07-06 15:55:26.791	05.05 General	05.05.01 Rele_nications-Email
19139	91	1625579727255:569141297	1625579726021:-1875037888	D5160C00019	743	741	CREATE	2021-07-06 15:55:27.373	05.05 General	05.05.01 Rele_tions-Documents
19141	91	1625579728545:-319953747	1625579695477:877579486	D5160C00019	745	703	CREATE	2021-07-06 15:55:28.659	70031 Trigo P_ez, Jose Manuel	06 IP and Trial Supplies
19142	91	1625579729118:347810824	1625579728545:-319953747	D5160C00019	746	745	CREATE	2021-07-06 15:55:29.213	06 IP and Trial Supplies	06.01 IP Documentation
19144	91	1625579730257:900857707	1625579729118:347810824	D5160C00019	748	746	CREATE	2021-07-06 15:55:30.375	06.01 IP Documentation	06.01.05 Acco_y Documentation
19145	91	1625579730828:-117209742	1625579729118:347810824	D5160C00019	749	746	CREATE	2021-07-06 15:55:30.931	06.01 IP Documentation	06.01.11 Cert_ of Destruction
19147	91	1625579732768:954504445	1625579732052:-1950157212	D5160C00019	751	750	CREATE	2021-07-06 15:55:32.886	06.04 Storage	06.04.01 Stor_n Documentation
19148	91	1625579733324:1010061377	1625579732052:-1950157212	D5160C00019	752	750	CREATE	2021-07-06 15:55:33.426	06.04 Storage	06.04.03 Maintenance Logs
19150	91	1625579734620:-550161776	1625579733919:-1744617071	D5160C00019	754	753	CREATE	2021-07-06 15:55:34.739	07 Safety Reporting	07.02 Trial Status Reporting
19151	91	1625579735202:2103516211	1625579734620:-550161776	D5160C00019	755	754	CREATE	2021-07-06 15:55:35.299	07.02 Trial Status Reporting	07.02.02 SAE Report
19153	91	1625579741175:-622608715	1625579735750:-57440562	D5160C00019	757	756	CREATE	2021-07-06 15:55:41.29	08 Centralized Testing	08.01 Facility Documentation
19154	91	1625579741808:-181557233	1625579741175:-622608715	D5160C00019	758	757	CREATE	2021-07-06 15:55:41.901	08.01 Facility Documentation	08.01.01 Cert_r Accreditation
19155	91	1625579743141:-612679570	1625579741175:-622608715	D5160C00019	759	757	CREATE	2021-07-06 15:55:43.23	08.01 Facility Documentation	08.01.04 Norm_nd Alert Values
8560	84	\N	\N	D5170C00002	2345	2344	NEW	\N	04.03 Trial Status Reporting	04.03.01 IRB-I_y Info-Deviation
19158	91	1625579744820:-2075715286	1625579744273:-94318544	D5160C00019	762	761	CREATE	2021-07-06 15:55:44.91	08.02 Sample Documentation	08.02.02 Shipment Records
19160	91	1625579746104:1211550802	1625579695477:877579486	D5160C00019	764	703	CREATE	2021-07-06 15:55:46.199	70031 Trigo P_ez, Jose Manuel	10 Data Management
19161	91	1625579746662:1569326926	1625579746104:1211550802	D5160C00019	765	764	CREATE	2021-07-06 15:55:46.762	10 Data Management	10.02 Data Capture
19162	91	1625579747294:-1836773448	1625579746662:1569326926	D5160C00019	766	765	CREATE	2021-07-06 15:55:47.394	10.02 Data Capture	10.02.03 Completed CRFs (Paper)
19164	91	1625579748567:151884156	1625579747993:349527162	D5160C00019	768	767	CREATE	2021-07-06 15:55:48.67	70041 Insa Molla, Amelia	05 Site Management
19165	91	1625579749143:1772446402	1625579748567:151884156	D5160C00019	769	768	CREATE	2021-07-06 15:55:49.241	05 Site Management	05.01 Site Selection
19167	91	1625579750390:273948397	1625579749143:1772446402	D5160C00019	771	769	CREATE	2021-07-06 15:55:50.49	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
19168	91	1625579750949:1857503083	1625579748567:151884156	D5160C00019	772	768	CREATE	2021-07-06 15:55:51.049	05 Site Management	05.02 Site Se_p Documentation
19170	91	1625579752057:-1532431639	1625579750949:1857503083	D5160C00019	774	772	CREATE	2021-07-06 15:55:52.149	05.02 Site Se_p Documentation	05.02.06 Othe_ite Affiliation
8988	85	1615838976578:1645421407	1615838975982:177552897	D5170C00002	4	3	ALREADY AVAILABLE	2021-03-18 05:45:16.123	eTMF	contents
19171	91	1625579752605:470851300	1625579750949:1857503083	D5160C00019	775	772	CREATE	2021-07-06 15:55:52.696	05.02 Site Se_p Documentation	05.02.09 Inve_atory Agreement
19173	91	1625579754512:-662997556	1625579750949:1857503083	D5160C00019	777	772	CREATE	2021-07-06 15:55:54.619	05.02 Site Se_p Documentation	05.02.17 IP S_e Documentation
19174	91	1625579755115:-627623499	1625579748567:151884156	D5160C00019	778	768	CREATE	2021-07-06 15:56:00.264	05 Site Management	05.03 Site Initiation
19175	91	1625579760790:372678564	1625579755115:-627623499	D5160C00019	779	778	CREATE	2021-07-06 15:56:00.887	05.03 Site Initiation	05.03.03 Site Training-Staff
19176	91	1625579761351:1551472561	1625579748567:151884156	D5160C00019	780	768	CREATE	2021-07-06 15:56:01.447	05 Site Management	05.05 General
19178	91	1625579762485:-251872034	1625579523523:1533419025	D5160C00019	782	546	CREATE	2021-07-06 15:56:02.576	SPAIN	70051 Martin Jimenez, Miguel
19180	91	1625579764461:250010127	1625579763183:143957915	D5160C00019	784	783	CREATE	2021-07-06 15:56:04.55	02 Central Trial Documents	02.02 Subject Documents
19181	91	1625579765199:143603541	1625579764461:250010127	D5160C00019	785	784	CREATE	2021-07-06 15:56:05.29	02.02 Subject Documents	02.02.07 Othe_ven to Subjects
19182	91	1625579765746:-741520870	1625579763183:143957915	D5160C00019	786	783	CREATE	2021-07-06 15:56:05.843	02 Central Trial Documents	02.04 General
19184	91	1625579766810:1892428805	1625579762485:-251872034	D5160C00019	788	782	CREATE	2021-07-06 15:56:06.904	70051 Martin Jimenez, Miguel	04 IRB-IEC an_other Approvals
19185	91	1625579767360:-846636727	1625579766810:1892428805	D5160C00019	789	788	CREATE	2021-07-06 15:56:07.463	04 IRB-IEC an_other Approvals	04.03 Trial Status Reporting
19187	91	1625579768625:2013302924	1625579762485:-251872034	D5160C00019	791	782	CREATE	2021-07-06 15:56:17.042	70051 Martin Jimenez, Miguel	05 Site Management
19188	91	1625579777611:-978690974	1625579768625:2013302924	D5160C00019	792	791	CREATE	2021-07-06 15:56:17.718	05 Site Management	05.01 Site Selection
19189	91	1625579778307:109867603	1625579777611:-978690974	D5160C00019	793	792	CREATE	2021-07-06 15:56:18.417	05.01 Site Selection	05.01.01 Site Contact Details
19191	91	1625579785974:-679088637	1625579777611:-978690974	D5160C00019	795	792	CREATE	2021-07-06 15:56:26.083	05.01 Site Selection	05.01.03 Feasibility Documentation
19192	91	1625579786620:-840451667	1625579777611:-978690974	D5160C00019	796	792	CREATE	2021-07-06 15:56:26.741	05.01 Site Selection	05.01.04 Pre _nitoring Report
19194	91	1625579787745:-390681474	1625579787188:-1585215023	D5160C00019	798	797	CREATE	2021-07-06 15:56:27.84	05.02 Site Se_p Documentation	05.02.01 Acce_igator Brochure
19195	91	1625579788341:344394376	1625579787188:-1585215023	D5160C00019	799	797	CREATE	2021-07-06 15:56:28.434	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
19197	91	1625579794476:-2040924711	1625579787188:-1585215023	D5160C00019	801	797	CREATE	2021-07-06 15:56:34.573	05.02 Site Se_p Documentation	05.02.04 PI C_ite Affiliation
19198	91	1625579795007:1928906733	1625579787188:-1585215023	D5160C00019	802	797	CREATE	2021-07-06 15:56:35.105	05.02 Site Se_p Documentation	05.02.06 Othe_ite Affiliation
19200	91	1625579796710:-1808773017	1625579787188:-1585215023	D5160C00019	804	797	CREATE	2021-07-06 15:56:36.805	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
19201	91	1625579797328:-897656971	1625579787188:-1585215023	D5160C00019	805	797	CREATE	2021-07-06 15:56:37.426	05.02 Site Se_p Documentation	05.02.12 Clinical Trial Agreement
19202	91	1625579797874:12240998	1625579787188:-1585215023	D5160C00019	806	797	CREATE	2021-07-06 15:56:37.964	05.02 Site Se_p Documentation	05.02.13 Indemnity
19204	91	1625579805961:1588599691	1625579787188:-1585215023	D5160C00019	808	797	CREATE	2021-07-06 15:56:46.081	05.02 Site Se_p Documentation	05.02.18 Site Signature Sheet
19205	91	1625579806586:173239025	1625579768625:2013302924	D5160C00019	809	791	CREATE	2021-07-06 15:56:47.023	05 Site Management	05.03 Site Initiation
19207	91	1625579808493:2018363037	1625579806586:173239025	D5160C00019	811	809	CREATE	2021-07-06 15:56:48.605	05.03 Site Initiation	05.03.03 Site Training-Staff
19208	91	1625579809065:-57141973	1625579768625:2013302924	D5160C00019	812	791	CREATE	2021-07-06 15:56:49.165	05 Site Management	05.04 Site Management
19209	91	1625579809636:-1369465854	1625579809065:-57141973	D5160C00019	813	812	CREATE	2021-07-06 15:56:49.774	05.04 Site Management	05.04.01 Subject Log
19211	91	1625579810850:-1585982068	1625579809065:-57141973	D5160C00019	815	812	CREATE	2021-07-06 15:56:50.97	05.04 Site Management	05.04.04 Visit Log
19212	91	1625579811445:-1388755806	1625579809065:-57141973	D5160C00019	816	812	CREATE	2021-07-06 15:56:51.548	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
19214	91	1625579812667:-440287655	1625579768625:2013302924	D5160C00019	818	791	CREATE	2021-07-06 15:56:52.783	05 Site Management	05.05 General
19215	91	1625579813245:1684051134	1625579812667:-440287655	D5160C00019	819	818	CREATE	2021-07-06 15:57:06.904	05.05 General	05.05.01 Rele_tions-Documents
19216	91	1625579827473:527516432	1625579812667:-440287655	D5160C00019	820	818	CREATE	2021-07-06 15:57:07.601	05.05 General	05.05.02 Tracking Information
19218	91	1625579829088:-939111597	1625579828507:1461926849	D5160C00019	822	821	CREATE	2021-07-06 15:57:09.188	06 IP and Trial Supplies	06.01 IP Documentation
19219	91	1625579829638:10792207	1625579829088:-939111597	D5160C00019	823	822	CREATE	2021-07-06 15:57:09.746	06.01 IP Documentation	06.01.04 IP S_t Documentation
8625	84	\N	\N	D5170C00002	2410	2404	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Site Qualification
19222	91	1625579831561:-1902723919	1625579828507:1461926849	D5160C00019	826	821	CREATE	2021-07-06 15:57:11.661	06 IP and Trial Supplies	06.04 Storage
19223	91	1625579832173:-2048655521	1625579831561:-1902723919	D5160C00019	827	826	CREATE	2021-07-06 15:57:12.272	06.04 Storage	06.04.01 Storage Condition Documentation
19224	91	1625579832804:1000161238	1625579831561:-1902723919	D5160C00019	828	826	CREATE	2021-07-06 15:57:12.91	06.04 Storage	06.04.03 Maintenance Logs
19226	91	1625579833977:-522373630	1625579833389:-558430271	D5160C00019	830	829	CREATE	2021-07-06 15:57:14.084	08 Centralized Testing	08.01 Facility Documentation
19227	91	1625579834550:-816506159	1625579833977:-522373630	D5160C00019	831	830	CREATE	2021-07-06 15:57:14.652	08.01 Facility Documentation	08.01.01 Cert_r Accreditation
19229	91	1625579842778:-1104905842	1625579833977:-522373630	D5160C00019	833	830	CREATE	2021-07-06 15:57:22.877	08.01 Facility Documentation	08.01.07 Head of Facility CV
19230	91	1625579843375:1391680139	1625579833389:-558430271	D5160C00019	834	829	CREATE	2021-07-06 15:57:23.487	08 Centralized Testing	08.02 Sample Documentation
19232	91	1625579844594:1910676987	1625579523523:1533419025	D5160C00019	836	546	CREATE	2021-07-06 15:57:24.698	SPAIN	70061 Reguart Aransay, Noemi
19233	91	1625579853931:-1885090269	1625579844594:1910676987	D5160C00019	837	836	CREATE	2021-07-06 15:57:34.065	70061 Reguart Aransay, Noemi	02 Central Trial Documents
19234	91	1625579854583:-169047240	1625579853931:-1885090269	D5160C00019	838	837	CREATE	2021-07-06 15:57:34.703	02 Central Trial Documents	02.02 Subject Documents
19236	91	1625579855796:1057097776	1625579853931:-1885090269	D5160C00019	840	837	CREATE	2021-07-06 15:57:35.896	02 Central Trial Documents	02.04 General
19237	91	1625579856364:-804066671	1625579855796:1057097776	D5160C00019	841	840	CREATE	2021-07-06 15:57:36.461	02.04 General	02.04.01 Rele_-Contact Report
19239	91	1625579857530:-1094980586	1625579856987:1202124977	D5160C00019	843	842	CREATE	2021-07-06 15:57:37.633	05 Site Management	05.01 Site Selection
19240	91	1625579858215:-1311665921	1625579857530:-1094980586	D5160C00019	844	843	CREATE	2021-07-06 15:57:38.321	05.01 Site Selection	05.01.01 Site Contact Details
19242	91	1625579859337:-2051452776	1625579857530:-1094980586	D5160C00019	846	843	CREATE	2021-07-06 15:57:39.925	05.01 Site Selection	05.01.03 Feasibility Documentation
19243	91	1625579860577:1290004100	1625579857530:-1094980586	D5160C00019	847	843	CREATE	2021-07-06 15:57:40.68	05.01 Site Selection	05.01.04 Pre _nitoring Report
19245	91	1625579861684:1339184675	1625579861139:-365027121	D5160C00019	849	848	CREATE	2021-07-06 15:57:41.788	05.02 Site Se_p Documentation	05.02.01 Acce_igator Brochure
19246	91	1625579862250:-884144385	1625579861139:-365027121	D5160C00019	850	848	CREATE	2021-07-06 15:57:42.359	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
19248	91	1625579863376:-1051798068	1625579861139:-365027121	D5160C00019	852	848	CREATE	2021-07-06 15:57:43.472	05.02 Site Se_p Documentation	05.02.04 PI C_ite Affiliation
19249	91	1625579863932:-687538644	1625579861139:-365027121	D5160C00019	853	848	CREATE	2021-07-06 15:57:44.029	05.02 Site Se_p Documentation	05.02.06 Othe_ite Affiliation
19251	91	1625579865120:-693169996	1625579861139:-365027121	D5160C00019	855	848	CREATE	2021-07-06 15:57:45.214	05.02 Site Se_p Documentation	05.02.09 Inve_atory Agreement
19252	91	1625579865664:-2128519776	1625579861139:-365027121	D5160C00019	856	848	CREATE	2021-07-06 15:57:45.778	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
19253	91	1625579866361:-1767896626	1625579861139:-365027121	D5160C00019	857	848	CREATE	2021-07-06 15:57:46.462	05.02 Site Se_p Documentation	05.02.12 Clin_Trial Agreement
19255	91	1625579867510:533760113	1625579861139:-365027121	D5160C00019	859	848	CREATE	2021-07-06 15:57:47.618	05.02 Site Se_p Documentation	05.02.17 IP S_e Documentation
19256	91	1625579868191:-1600670613	1625579861139:-365027121	D5160C00019	860	848	CREATE	2021-07-06 15:57:48.292	05.02 Site Se_p Documentation	05.02.18 Site Signature Sheet
19258	91	1625579869303:-1527040312	1625579868762:59113649	D5160C00019	862	861	CREATE	2021-07-06 15:57:49.399	05.03 Site Initiation	05.03.01 Tria_nitoring Report
19259	91	1625579869900:-869004500	1625579868762:59113649	D5160C00019	863	861	CREATE	2021-07-06 15:57:50.002	05.03 Site Initiation	05.03.03 Site Training-Staff
19261	91	1625579871637:1992815326	1625579856987:1202124977	D5160C00019	865	842	CREATE	2021-07-06 15:57:51.727	05 Site Management	05.04 Site Management
19262	91	1625579872213:965438188	1625579871637:1992815326	D5160C00019	866	865	CREATE	2021-07-06 15:57:52.32	05.04 Site Management	05.04.01 Subject Log
19263	91	1625579872862:-1044978880	1625579871637:1992815326	D5160C00019	867	865	CREATE	2021-07-06 15:57:52.966	05.04 Site Management	05.04.02 Source Data Verification
19265	91	1625579874319:-655847195	1625579871637:1992815326	D5160C00019	869	865	CREATE	2021-07-06 15:57:54.422	05.04 Site Management	05.04.04 Visit Log
19266	91	1625579874927:1062707976	1625579871637:1992815326	D5160C00019	870	865	CREATE	2021-07-06 15:57:55.169	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
19268	91	1625579876306:-554434249	1625579856987:1202124977	D5160C00019	872	842	CREATE	2021-07-06 15:57:56.404	05 Site Management	05.05 General
19269	91	1625579876866:897507611	1625579876306:-554434249	D5160C00019	873	872	CREATE	2021-07-06 15:57:56.959	05.05 General	05.05.01 Rele_tions-Documents
19270	91	1625579877473:334684598	1625579876306:-554434249	D5160C00019	874	872	CREATE	2021-07-06 15:57:57.583	05.05 General	05.05.02 Tracking Information
19272	91	1625579883917:-2144802171	1625579878090:652891920	D5160C00019	876	875	CREATE	2021-07-06 15:58:04.047	06 IP and Trial Supplies	06.01 IP Documentation
19273	91	1625579884517:443845486	1625579883917:-2144802171	D5160C00019	877	876	CREATE	2021-07-06 15:58:04.623	06.01 IP Documentation	06.01.04 IP S_t Documentation
19275	91	1625579885676:-1733995911	1625579883917:-2144802171	D5160C00019	879	876	CREATE	2021-07-06 15:58:05.797	06.01 IP Documentation	06.01.10 IP D_entation Return
19276	91	1625579886260:-1542220725	1625579883917:-2144802171	D5160C00019	880	876	CREATE	2021-07-06 15:58:06.372	06.01 IP Documentation	06.01.11 Cert_ of Destruction
19278	91	1625579887573:147552681	1625579886814:1967025507	D5160C00019	882	881	CREATE	2021-07-06 15:58:14.807	06.04 Storage	06.04.01 Stor_n Documentation
19279	91	1625579895317:-778869155	1625579886814:1967025507	D5160C00019	883	881	CREATE	2021-07-06 15:58:15.411	06.04 Storage	06.04.02 Stor_n Documentation
19281	91	1625579896474:-30968244	1625579844594:1910676987	D5160C00019	885	836	CREATE	2021-07-06 15:58:16.572	70061 Reguart Aransay, Noemi	07 Safety Reporting
19282	91	1625579897034:-2071372747	1625579896474:-30968244	D5160C00019	886	885	CREATE	2021-07-06 15:58:17.128	07 Safety Reporting	07.03 General
14313	88	1617049782284:-654012642	1617049781649:846308156	D5170C00001	3	2	ALREADY AVAILABLE	2021-03-30 07:19:37.237	Acquisition Assessments	2. Study Lists
19285	91	1625579898740:1621347756	1625579898200:-1252995433	D5160C00019	889	888	CREATE	2021-07-06 15:58:18.839	08 Centralized Testing	08.01 Facility Documentation
19287	91	1625579899832:-991850759	1625579898740:1621347756	D5160C00019	891	889	CREATE	2021-07-06 15:58:19.93	08.01 Facility Documentation	08.01.04 Norm_nd Alert Values
19288	91	1625579900376:1371762435	1625579898740:1621347756	D5160C00019	892	889	CREATE	2021-07-06 15:58:20.484	08.01 Facility Documentation	08.01.07 Head of Facility CV
19290	91	1625579901551:2043274791	1625579900979:1457887453	D5160C00019	894	893	CREATE	2021-07-06 15:58:21.653	08.02 Sample Documentation	08.02.02 Shipment Records
19291	91	1625579902119:-1176293781	1625579900979:1457887453	D5160C00019	895	893	CREATE	2021-07-06 15:58:22.806	08.02 Sample Documentation	08.02.03 Samp_e Condition Log
19292	91	1625579903316:-1418165972	1625579523523:1533419025	D5160C00019	896	546	CREATE	2021-07-06 15:58:23.409	SPAIN	70071 Muñoz Q_a, Miguel Angel
19294	91	1625579904437:565612792	1625579903870:105005578	D5160C00019	898	897	CREATE	2021-07-06 15:58:24.531	04 IRB-IEC an_other Approvals	04.01 IRB-IEC Trial Approval
19295	91	1625579905001:115334601	1625579904437:565612792	D5160C00019	899	898	CREATE	2021-07-06 15:58:25.095	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
19297	91	1625579906614:2089635832	1625579905612:277351235	D5160C00019	901	900	CREATE	2021-07-06 15:58:26.711	05 Site Management	05.01 Site Selection
19298	91	1625579914383:782118646	1625579906614:2089635832	D5160C00019	902	901	CREATE	2021-07-06 15:58:34.483	05.01 Site Selection	05.01.02 Confidentiality Agreement
19300	91	1625579921028:6376847	1625579905612:277351235	D5160C00019	904	900	CREATE	2021-07-06 15:58:41.181	05 Site Management	05.02 Site Se_p Documentation
19301	91	1625579921772:476877217	1625579921028:6376847	D5160C00019	905	904	CREATE	2021-07-06 15:58:41.895	05.02 Site Se_p Documentation	05.02.01 Acce_igator Brochure
19303	91	1625579922950:239161200	1625579921028:6376847	D5160C00019	907	904	CREATE	2021-07-06 15:58:43.2	05.02 Site Se_p Documentation	05.02.07 Site Qualification
19304	91	1625579924335:312317768	1625579921028:6376847	D5160C00019	908	904	CREATE	2021-07-06 15:58:44.434	05.02 Site Se_p Documentation	05.02.09 Inve_atory Agreement
19305	91	1625579930690:1197529817	1625579921028:6376847	D5160C00019	909	904	CREATE	2021-07-06 15:58:50.808	05.02 Site Se_p Documentation	05.02.14 Othe_ncial Agreement
19307	91	1625579931983:1562388226	1625579523523:1533419025	D5160C00019	911	546	CREATE	2021-07-06 15:58:52.076	SPAIN	TBD-1-1FD9W8M Lo_rtin, Jose Antonio
19308	91	1625579932531:-289120925	1625579931983:1562388226	D5160C00019	912	911	CREATE	2021-07-06 15:58:52.639	TBD-1-1FD9W8M Lo_rtin, Jose Antonio	05 Site Management
19309	91	1625579933249:-550208776	1625579932531:-289120925	D5160C00019	913	912	CREATE	2021-07-06 15:58:53.353	05 Site Management	05.01 Site Selection
19311	91	1625579934358:-182833767	1625579523523:1533419025	D5160C00019	915	546	CREATE	2021-07-06 15:58:55.127	SPAIN	TBD-1-1FD9W94 Taus Garcia, Alvaro
19312	91	1625579935640:792720258	1625579934358:-182833767	D5160C00019	916	915	CREATE	2021-07-06 15:58:55.75	TBD-1-1FD9W94 Taus Garcia, Alvaro	05 Site Management
19314	91	1625579936760:-1346696726	1625579936235:1330568430	D5160C00019	918	917	CREATE	2021-07-06 15:58:56.85	05.01 Site Selection	05.01.02 Confidentiality Agreement
19315	91	1625579937316:690727696	1625578787595:-65419865	D5160C00019	919	8	CREATE	2021-07-06 15:58:57.421	contents	UNITED STATES
19317	91	1625579938422:-1463876480	1625579937899:16576795	D5160C00019	921	920	CREATE	2021-07-06 15:58:58.511	02 Central Trial Documents	02.01 Trial Documents
19318	91	1625579939017:-1368686515	1625579938422:-1463876480	D5160C00019	922	921	CREATE	2021-07-06 15:58:59.11	02.01 Trial Documents	02.01.01 Investigator Brochure
19320	91	1625579940102:1562095725	1625579938422:-1463876480	D5160C00019	924	921	CREATE	2021-07-06 15:59:00.273	02.01 Trial Documents	02.01.04 Protocol Amendment
19321	91	1625579940718:-1381911610	1625579938422:-1463876480	D5160C00019	925	921	CREATE	2021-07-06 15:59:00.814	02.01 Trial Documents	02.01.06 Insurance
19323	91	1625579942111:-249749037	1625579941464:1386928549	D5160C00019	927	926	CREATE	2021-07-06 15:59:02.233	02.02 Subject Documents	02.02.01 Subject Diary
19324	91	1625579942741:1024343519	1625579941464:1386928549	D5160C00019	928	926	CREATE	2021-07-06 15:59:02.854	02.02 Subject Documents	02.02.03 Informed Consent Form Checklists
19326	91	1625579943863:655586136	1625579941464:1386928549	D5160C00019	930	926	CREATE	2021-07-06 15:59:03.954	02.02 Subject Documents	02.02.05 Subject Participation Card
19327	91	1625579944391:1641589408	1625579941464:1386928549	D5160C00019	931	926	CREATE	2021-07-06 15:59:04.483	02.02 Subject Documents	02.02.06 Adverti_ubject Recruitment
19329	91	1625579946188:-1681893731	1625579937899:16576795	D5160C00019	933	920	CREATE	2021-07-06 15:59:06.286	02 Central Trial Documents	02.04 General
19330	91	1625579946728:-452692058	1625579946188:-1681893731	D5160C00019	934	933	CREATE	2021-07-06 15:59:06.823	02.04 General	02.04.02 Tracking Information
19331	91	1625579947278:-606934939	1625579937316:690727696	D5160C00019	935	919	CREATE	2021-07-06 15:59:14.185	UNITED STATES	03 Regulatory
19332	91	1625579954823:-919228590	1625579947278:-606934939	D5160C00019	936	935	CREATE	2021-07-06 15:59:14.915	03 Regulatory	03.01 Trial Approval
19334	91	1625579955963:1384965787	1625579954823:-919228590	D5160C00019	938	936	CREATE	2021-07-06 15:59:16.057	03.01 Trial Approval	03.01.02 Approval
19335	91	1625579957205:742457744	1625579937316:690727696	D5160C00019	939	919	CREATE	2021-07-06 15:59:17.297	UNITED STATES	04 IRB-IEC and other Approvals
19337	91	1625579958302:-1223707035	1625579957762:-1458823435	D5160C00019	941	940	CREATE	2021-07-06 15:59:18.395	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
19338	91	1625579958852:-6149574	1625579957762:-1458823435	D5160C00019	942	940	CREATE	2021-07-06 15:59:18.945	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
19340	91	1625579959955:-39703404	1625579957205:742457744	D5160C00019	944	939	CREATE	2021-07-06 15:59:20.046	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
19341	91	1625579960473:1159319905	1625579959955:-39703404	D5160C00019	945	944	CREATE	2021-07-06 15:59:20.567	04.03 Trial Status Reporting	04.03.02 IRB-IEC Progress Report
19342	91	1625579961060:-1647546532	1625579937316:690727696	D5160C00019	946	919	CREATE	2021-07-06 15:59:21.164	UNITED STATES	05 Site Management
19344	91	1625579962237:1107203173	1625579961701:363020584	D5160C00019	948	947	CREATE	2021-07-06 15:59:22.344	05.02 Site Set-up Documentation	05.02.12 Investi_Agreement Template
19345	91	1625579962775:1246768928	1625579961060:-1647546532	D5160C00019	949	946	CREATE	2021-07-06 15:59:22.864	05 Site Management	05.05 General
19346	91	1625579963301:1538059781	1625579962775:1246768928	D5160C00019	950	949	CREATE	2021-07-06 15:59:23.401	05.05 General	05.05.01 Relevan_on-Documents-Email
8750	84	\N	\N	D5170C00002	2535	2528	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
19349	91	1625579964922:2121739424	1625579964382:-1682329672	D5160C00019	953	952	CREATE	2021-07-06 15:59:25.015	07.03 General	07.03.01 Rele_ns-Safety-Email
19350	91	1625579965532:1076226041	1625579964922:2121739424	D5160C00019	954	953	CREATE	2021-07-06 15:59:25.628	07.03.01 Rele_ns-Safety-Email	2015-02
19352	91	1625579966666:816628646	1625579937316:690727696	D5160C00019	956	919	CREATE	2021-07-06 15:59:26.783	UNITED STATES	08 Centralized Testing
19353	91	1625579967866:703291178	1625579966666:816628646	D5160C00019	957	956	CREATE	2021-07-06 15:59:27.982	08 Centralized Testing	08.01 Facility Documentation
19355	91	1625579976867:-1657722098	1625579937316:690727696	D5160C00019	959	919	CREATE	2021-07-06 15:59:37.02	UNITED STATES	78011 Shehadeh, Nasfat
19356	91	1625579977471:-1664699373	1625579976867:-1657722098	D5160C00019	960	959	CREATE	2021-07-06 15:59:37.941	78011 Shehadeh, Nasfat	02 Central Trial Documents
19358	91	1625579978976:819185363	1625579978424:873834880	D5160C00019	962	961	CREATE	2021-07-06 15:59:39.08	02.02 Subject Documents	02.02.03 Info_ Form Templates
19359	91	1625579979559:-1655177589	1625579978424:873834880	D5160C00019	963	961	CREATE	2021-07-06 15:59:39.66	02.02 Subject Documents	02.02.03 Info_Form Checklists
19361	91	1625579981075:229269394	1625579980260:-862604960	D5160C00019	965	964	CREATE	2021-07-06 15:59:41.176	02.04 General	02.04.01 Rele_perations-Email
19362	91	1625579981677:1265772676	1625579976867:-1657722098	D5160C00019	966	959	CREATE	2021-07-06 15:59:41.776	78011 Shehadeh, Nasfat	03 Regulatory
19363	91	1625579982220:-771090342	1625579981677:1265772676	D5160C00019	967	966	CREATE	2021-07-06 15:59:42.321	03 Regulatory	03.04 General
19365	91	1625579983292:1590147493	1625579976867:-1657722098	D5160C00019	969	959	CREATE	2021-07-06 15:59:43.387	78011 Shehadeh, Nasfat	04 IRB-IEC an_other Approvals
19367	91	1625579984582:-894133433	1625579983819:-2009173875	D5160C00019	971	970	CREATE	2021-07-06 15:59:44.679	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
19368	91	1625579991627:-1805423665	1625579983819:-2009173875	D5160C00019	972	970	CREATE	2021-07-06 15:59:51.728	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
19370	91	1625579992822:-590053844	1625579983292:1590147493	D5160C00019	974	969	CREATE	2021-07-06 15:59:52.913	04 IRB-IEC an_other Approvals	04.03 Trial Status Reporting
19371	91	1625579993361:-282806910	1625579992822:-590053844	D5160C00019	975	974	CREATE	2021-07-06 15:59:53.45	04.03 Trial Status Reporting	04.03.03 IRB-_rm Notification
19372	91	1625579993932:-1871565344	1625579983292:1590147493	D5160C00019	976	969	CREATE	2021-07-06 15:59:54.033	04 IRB-IEC an_other Approvals	04.04 General
19374	91	1625579995071:-366237844	1625579976867:-1657722098	D5160C00019	978	959	CREATE	2021-07-06 15:59:55.162	78011 Shehadeh, Nasfat	05 Site Management
19375	91	1625579995601:-2535266	1625579995071:-366237844	D5160C00019	979	978	CREATE	2021-07-06 15:59:55.707	05 Site Management	05.01 Site Selection
19377	91	1625579996739:743981161	1625579995601:-2535266	D5160C00019	981	979	CREATE	2021-07-06 15:59:56.843	05.01 Site Selection	05.01.03 Feasibility Documentation
19378	91	1625579997305:62925563	1625579995601:-2535266	D5160C00019	982	979	CREATE	2021-07-06 15:59:57.402	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
19379	91	1625579997887:-1438849930	1625579995071:-366237844	D5160C00019	983	978	CREATE	2021-07-06 15:59:57.982	05 Site Management	05.02 Site Se_p Documentation
19381	91	1625579999515:-839685511	1625579997887:-1438849930	D5160C00019	985	983	CREATE	2021-07-06 15:59:59.623	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
19382	91	1625580000186:-382915421	1625579997887:-1438849930	D5160C00019	986	983	CREATE	2021-07-06 16:00:00.321	05.02 Site Se_p Documentation	05.02.04 PI C_ite Affiliation
19384	91	1625580001470:-975960478	1625579997887:-1438849930	D5160C00019	988	983	CREATE	2021-07-06 16:00:01.569	05.02 Site Se_p Documentation	05.02.07 Staff Qualification
19385	91	1625580002008:2136179405	1625579997887:-1438849930	D5160C00019	989	983	CREATE	2021-07-06 16:00:02.106	05.02 Site Se_p Documentation	05.02.08 Form FDA1572
19387	91	1625580003133:878906551	1625579997887:-1438849930	D5160C00019	991	983	CREATE	2021-07-06 16:00:03.234	05.02 Site Se_p Documentation	05.02.12 Clinical Trial Agreement
19388	91	1625580003692:-1042775282	1625579997887:-1438849930	D5160C00019	992	983	CREATE	2021-07-06 16:00:03.801	05.02 Site Se_p Documentation	05.02.17 IP S_e Documentation
19390	91	1625580004917:1892383347	1625579995071:-366237844	D5160C00019	994	978	CREATE	2021-07-06 16:00:05.009	05 Site Management	05.03 Site Initiation
19391	91	1625580005478:1451998557	1625580004917:1892383347	D5160C00019	995	994	CREATE	2021-07-06 16:00:05.569	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
19392	91	1625580012152:1264941950	1625580004917:1892383347	D5160C00019	996	994	CREATE	2021-07-06 16:00:12.967	05.03 Site Initiation	05.03.03 Site Training-Staff
19394	91	1625580022877:974516693	1625579995071:-366237844	D5160C00019	998	978	CREATE	2021-07-06 16:00:22.98	05 Site Management	05.04 Site Management
19395	91	1625580023527:311186859	1625580022877:974516693	D5160C00019	999	998	CREATE	2021-07-06 16:00:23.656	05.04 Site Management	05.04.04 Visit Log
19396	91	1625580024151:1529167962	1625580022877:974516693	D5160C00019	1000	998	CREATE	2021-07-06 16:00:24.262	05.04 Site Management	05.04.08 Fina_nitoring Report
19398	91	1625580025796:-13087588	1625580025107:-887305372	D5160C00019	1002	1001	CREATE	2021-07-06 16:00:25.918	05.05 General	05.05.01 Rele_nications-Email
19399	91	1625580026400:-1770712852	1625580025107:-887305372	D5160C00019	1003	1001	CREATE	2021-07-06 16:00:26.531	05.05 General	05.05.02 Tracking Information
19401	91	1625580027625:-494811565	1625580027065:1898666385	D5160C00019	1005	1004	CREATE	2021-07-06 16:00:28.235	06 IP and Trial Supplies	06.01 IP Documentation
19402	91	1625580028800:-748898373	1625580027625:-494811565	D5160C00019	1006	1005	CREATE	2021-07-06 16:00:28.894	06.01 IP Documentation	06.01.04 IP Shipment Documentation
19404	91	1625580030176:-2024119108	1625580027625:-494811565	D5160C00019	1008	1005	CREATE	2021-07-06 16:00:30.278	06.01 IP Documentation	06.01.11 Certificate of Destruction
19405	91	1625580031472:1450779811	1625580027065:1898666385	D5160C00019	1009	1004	CREATE	2021-07-06 16:00:31.573	06 IP and Trial Supplies	06.04 Storage
19407	91	1625580032779:1301514517	1625579976867:-1657722098	D5160C00019	1011	959	CREATE	2021-07-06 16:00:32.872	78011 Shehadeh, Nasfat	08 Centralized Testing
19408	91	1625580033438:-1580028882	1625580032779:1301514517	D5160C00019	1012	1011	CREATE	2021-07-06 16:00:33.542	08 Centralized Testing	08.01 Facility Documentation
19410	91	1625580034541:-1922199966	1625580033438:-1580028882	D5160C00019	1014	1012	CREATE	2021-07-06 16:00:34.636	08.01 Facility Documentation	08.01.04 Norm_nd Alert Values
14314	88	1617049782868:655599704	1617049781649:846308156	D5170C00001	4	2	ALREADY AVAILABLE	2021-03-30 07:19:37.237	Acquisition Assessments	6. Assessment Team Documentation
19412	91	1625580036241:1596494027	1625580032779:1301514517	D5160C00019	1016	1011	CREATE	2021-07-06 16:00:36.355	08 Centralized Testing	08.03 General
19414	91	1625580045946:-2111844087	1625579937316:690727696	D5160C00019	1018	919	CREATE	2021-07-06 16:00:46.053	UNITED STATES	78021 Gadgeel, Shirish
19415	91	1625580046584:-1744970457	1625580045946:-2111844087	D5160C00019	1019	1018	CREATE	2021-07-06 16:00:46.683	78021 Gadgeel, Shirish	05 Site Management
19416	91	1625580047124:598163529	1625580046584:-1744970457	D5160C00019	1020	1019	CREATE	2021-07-06 16:00:47.237	05 Site Management	05.01 Site Selection
19418	91	1625580048430:-747779433	1625579937316:690727696	D5160C00019	1022	919	CREATE	2021-07-06 16:00:48.535	UNITED STATES	78031 Cetnar, Jeremy
8989	85	1615840755001:1663782495	1615838976578:1645421407	D5170C00002	5	4	ALREADY AVAILABLE	2021-03-18 05:45:16.136	contents	ITALY
19419	91	1625580048994:1767892404	1625580048430:-747779433	D5160C00019	1023	1022	CREATE	2021-07-06 16:00:49.099	78031 Cetnar, Jeremy	05 Site Management
19421	91	1625580050228:-2131602693	1625580049572:-1639494596	D5160C00019	1025	1024	CREATE	2021-07-06 16:00:50.351	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
19422	91	1625580050810:-1362614089	1625579937316:690727696	D5160C00019	1026	919	CREATE	2021-07-06 16:00:50.915	UNITED STATES	78041 Spira, Alexander
19424	91	1625580052022:1190720311	1625580051393:-566092581	D5160C00019	1028	1027	CREATE	2021-07-06 16:00:52.126	02 Central Trial Documents	02.02 Subject Documents
19425	91	1625580053309:-271389903	1625580052022:1190720311	D5160C00019	1029	1028	CREATE	2021-07-06 16:00:53.416	02.02 Subject Documents	02.02.03 Info_ Form Templates
19427	91	1625580054539:1084493496	1625580051393:-566092581	D5160C00019	1031	1027	CREATE	2021-07-06 16:00:54.648	02 Central Trial Documents	02.04 General
19428	91	1625580055098:346113068	1625580054539:1084493496	D5160C00019	1032	1031	CREATE	2021-07-06 16:00:55.2	02.04 General	02.04.01 Rele_-Contact Report
19429	91	1625580055740:-1113468043	1625580054539:1084493496	D5160C00019	1033	1031	CREATE	2021-07-06 16:00:55.85	02.04 General	02.04.01 Rele_perations-Email
19431	91	1625580056968:163947651	1625580056385:-1189604315	D5160C00019	1035	1034	CREATE	2021-07-06 16:00:57.074	03 Regulatory	03.04 General
19433	91	1625580058131:-1661684142	1625580050810:-1362614089	D5160C00019	1037	1026	CREATE	2021-07-06 16:00:58.249	78041 Spira, Alexander	04 IRB-IEC an_other Approvals
19434	91	1625580058784:-1144296019	1625580058131:-1661684142	D5160C00019	1038	1037	CREATE	2021-07-06 16:00:58.91	04 IRB-IEC an_other Approvals	04.01 IRB-IEC Trial Approval
19436	91	1625580081057:274834621	1625580058131:-1661684142	D5160C00019	1040	1037	CREATE	2021-07-06 16:01:21.175	04 IRB-IEC an_other Approvals	04.03 Trial Status Reporting
19437	91	1625580081683:-1220434126	1625580081057:274834621	D5160C00019	1041	1040	CREATE	2021-07-06 16:01:21.831	04.03 Trial Status Reporting	04.03.01 IRB-_ Info-Deviation
19439	91	1625580082892:1782755983	1625580081057:274834621	D5160C00019	1043	1040	CREATE	2021-07-06 16:01:22.998	04.03 Trial Status Reporting	04.03.03 IRB-_rm Notification
19440	91	1625580083469:1214935073	1625580058131:-1661684142	D5160C00019	1044	1037	CREATE	2021-07-06 16:01:23.577	04 IRB-IEC an_other Approvals	04.04 General
19441	91	1625580084054:-245224463	1625580083469:1214935073	D5160C00019	1045	1044	CREATE	2021-07-06 16:01:24.164	04.04 General	04.04.01 Rele_s-IRB-IEC-Email
19443	91	1625580086005:-676775514	1625580084594:732358339	D5160C00019	1047	1046	CREATE	2021-07-06 16:01:26.112	05 Site Management	05.01 Site Selection
19444	91	1625580086581:728600093	1625580086005:-676775514	D5160C00019	1048	1047	CREATE	2021-07-06 16:01:26.688	05.01 Site Selection	05.01.02 Confidentiality Agreement
19446	91	1625580087789:-529218484	1625580086005:-676775514	D5160C00019	1050	1047	CREATE	2021-07-06 16:01:27.902	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
19447	91	1625580088433:738531198	1625580084594:732358339	D5160C00019	1051	1046	CREATE	2021-07-06 16:01:28.543	05 Site Management	05.02 Site Se_p Documentation
19449	91	1625580089836:-828879014	1625580088433:738531198	D5160C00019	1053	1051	CREATE	2021-07-06 16:01:29.963	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
19450	91	1625580090440:-844300953	1625580088433:738531198	D5160C00019	1054	1051	CREATE	2021-07-06 16:01:30.549	05.02 Site Se_p Documentation	05.02.03 Prot_ Signature Page
19451	91	1625580091110:-996532697	1625580088433:738531198	D5160C00019	1055	1051	CREATE	2021-07-06 16:01:31.218	05.02 Site Se_p Documentation	05.02.04 PI C_ite Affiliation
19453	91	1625580092224:131198961	1625580088433:738531198	D5160C00019	1057	1051	CREATE	2021-07-06 16:01:32.331	05.02 Site Se_p Documentation	05.02.06 Othe_ite Affiliation
19454	91	1625580092814:-140646183	1625580088433:738531198	D5160C00019	1058	1051	CREATE	2021-07-06 16:01:32.927	05.02 Site Se_p Documentation	05.02.07 Staff Qualification
19456	91	1625580093991:856475349	1625580088433:738531198	D5160C00019	1060	1051	CREATE	2021-07-06 16:01:34.095	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
19457	91	1625580094612:-1006036383	1625580088433:738531198	D5160C00019	1061	1051	CREATE	2021-07-06 16:01:34.713	05.02 Site Se_p Documentation	05.02.12 Clinical Trial Agreement
19459	91	1625580095744:-1545426460	1625580088433:738531198	D5160C00019	1063	1051	CREATE	2021-07-06 16:01:35.905	05.02 Site Se_p Documentation	05.02.18 Site Signature Sheet
19460	91	1625580097215:1218111272	1625580084594:732358339	D5160C00019	1064	1046	CREATE	2021-07-06 16:01:37.309	05 Site Management	05.03 Site Initiation
19461	91	1625580097776:-1313789121	1625580097215:1218111272	D5160C00019	1065	1064	CREATE	2021-07-06 16:01:37.871	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
19463	91	1625580098900:244762878	1625580084594:732358339	D5160C00019	1067	1046	CREATE	2021-07-06 16:01:38.992	05 Site Management	05.04 Site Management
19464	91	1625580099447:-1908685913	1625580098900:244762878	D5160C00019	1068	1067	CREATE	2021-07-06 16:01:39.54	05.04 Site Management	05.04.01 Subject Log
19466	91	1625580100776:592943911	1625580098900:244762878	D5160C00019	1070	1067	CREATE	2021-07-06 16:01:40.89	05.04 Site Management	05.04.04 Visit Log
19467	91	1625580101351:-1983489432	1625580098900:244762878	D5160C00019	1071	1067	CREATE	2021-07-06 16:01:48.459	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
19468	91	1625580108959:-476649404	1625580098900:244762878	D5160C00019	1072	1067	CREATE	2021-07-06 16:01:49.059	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
19470	91	1625580110255:1693989855	1625580109494:604573983	D5160C00019	1074	1073	CREATE	2021-07-06 16:01:50.348	05.05 General	05.05.01 Relevant Communications-Documents
19471	91	1625580110792:192704632	1625580109494:604573983	D5160C00019	1075	1073	CREATE	2021-07-06 16:01:50.892	05.05 General	05.05.01 Relevant Communications-Email
8929	84	\N	\N	D5170C00002	2714	2630	NEW	\N	Site	2002047 Basilisco, Guido
15086	88	1617050481669:-1199531501	1617050481011:-855896347	D5170C00001	776	775	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Site Management	General
19473	91	1625580112296:-1297672901	1625580050810:-1362614089	D5160C00019	1077	1026	CREATE	2021-07-06 16:01:52.402	78041 Spira, Alexander	06 IP and Trial Supplies
19474	91	1625580112987:-370560227	1625580112296:-1297672901	D5160C00019	1078	1077	CREATE	2021-07-06 16:01:53.082	06 IP and Trial Supplies	06.01 IP Documentation
19475	91	1625580113599:1272139079	1625580112987:-370560227	D5160C00019	1079	1078	CREATE	2021-07-06 16:01:53.708	06.01 IP Documentation	06.01.04 IP S_t Documentation
19476	91	1625580114233:-502005661	1625580112987:-370560227	D5160C00019	1080	1078	CREATE	2021-07-06 16:01:54.327	06.01 IP Documentation	06.01.05 Acco_y Documentation
11644	86	\N	\N	D5170C00002	95	93	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
19477	91	1625580114796:-830497481	1625580112987:-370560227	D5160C00019	1081	1078	CREATE	2021-07-06 16:01:54.894	06.01 IP Documentation	06.01.11 Cert_ of Destruction
19478	91	1625580115414:1575020540	1625580112296:-1297672901	D5160C00019	1082	1077	CREATE	2021-07-06 16:01:55.511	06 IP and Trial Supplies	06.04 Storage
19479	91	1625580116008:1064899744	1625580115414:1575020540	D5160C00019	1083	1082	CREATE	2021-07-06 16:01:56.108	06.04 Storage	06.04.01 Storage Condition Documentation
19480	91	1625580116544:-500756100	1625580050810:-1362614089	D5160C00019	1084	1026	CREATE	2021-07-06 16:01:56.633	78041 Spira, Alexander	07 Safety Reporting
19481	91	1625580117101:1421684504	1625580116544:-500756100	D5160C00019	1085	1084	CREATE	2021-07-06 16:01:57.222	07 Safety Reporting	07.03 General
19482	91	1625580117684:866104574	1625580117101:1421684504	D5160C00019	1086	1085	CREATE	2021-07-06 16:01:57.788	07.03 General	07.03.01 Rele_ns-Safety-Email
19483	91	1625580119191:-1722804507	1625580050810:-1362614089	D5160C00019	1087	1026	CREATE	2021-07-06 16:01:59.281	78041 Spira, Alexander	08 Centralized Testing
19484	91	1625580119766:22704519	1625580119191:-1722804507	D5160C00019	1088	1087	CREATE	2021-07-06 16:01:59.856	08 Centralized Testing	08.01 Facility Documentation
19485	91	1625580120352:-619264479	1625580119766:22704519	D5160C00019	1089	1088	CREATE	2021-07-06 16:02:00.445	08.01 Facility Documentation	08.01.01 Cert_r Accreditation
19486	91	1625580120921:-1938852480	1625580119766:22704519	D5160C00019	1090	1088	CREATE	2021-07-06 16:02:01.014	08.01 Facility Documentation	08.01.04 Norm_nd Alert Values
19487	91	1625580121483:-963209556	1625580119766:22704519	D5160C00019	1091	1088	CREATE	2021-07-06 16:02:01.598	08.01 Facility Documentation	08.01.07 Head of Facility CV
19488	91	1625580122070:-970259956	1625580119191:-1722804507	D5160C00019	1092	1087	CREATE	2021-07-06 16:02:02.194	08 Centralized Testing	08.02 Sample Documentation
19489	91	1625580122660:1939537057	1625580122070:-970259956	D5160C00019	1093	1092	CREATE	2021-07-06 16:02:02.758	08.02 Sample Documentation	08.02.02 Shipment Records
19490	91	1625580123242:-1424514514	1625579937316:690727696	D5160C00019	1094	919	CREATE	2021-07-06 16:02:03.338	UNITED STATES	78051 Moore, Daniel
19491	91	1625580123858:871711643	1625580123242:-1424514514	D5160C00019	1095	1094	CREATE	2021-07-06 16:02:03.959	78051 Moore, Daniel	05 Site Management
19492	91	1625580124494:1761037948	1625580123858:871711643	D5160C00019	1096	1095	CREATE	2021-07-06 16:02:04.59	05 Site Management	05.01 Site Selection
19493	91	1625580125047:1412050536	1625580124494:1761037948	D5160C00019	1097	1096	CREATE	2021-07-06 16:02:05.141	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
19494	91	1625580125614:-1040557241	1625579937316:690727696	D5160C00019	1098	919	CREATE	2021-07-06 16:02:05.789	UNITED STATES	78061 Edenfield, William
19495	91	1625580126295:-344792398	1625580125614:-1040557241	D5160C00019	1099	1098	CREATE	2021-07-06 16:02:06.39	78061 Edenfield, William	05 Site Management
19496	91	1625580126855:-1206689652	1625580126295:-344792398	D5160C00019	1100	1099	CREATE	2021-07-06 16:02:06.953	05 Site Management	05.01 Site Selection
19497	91	1625580127876:818358643	1625580126855:-1206689652	D5160C00019	1101	1100	CREATE	2021-07-06 16:02:07.969	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
19498	91	1625580128438:1418318634	1625579937316:690727696	D5160C00019	1102	919	CREATE	2021-07-06 16:02:08.546	UNITED STATES	78071 Smith, Pamela
19499	91	1625580130082:-1871435044	1625580128438:1418318634	D5160C00019	1103	1102	CREATE	2021-07-06 16:02:10.183	78071 Smith, Pamela	05 Site Management
19500	91	1625580130665:592771400	1625580130082:-1871435044	D5160C00019	1104	1103	CREATE	2021-07-06 16:02:10.755	05 Site Management	05.01 Site Selection
19501	91	1625580131206:1226018921	1625580130665:592771400	D5160C00019	1105	1104	CREATE	2021-07-06 16:02:11.3	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
19502	91	1625580131827:1946324073	1625579937316:690727696	D5160C00019	1106	919	CREATE	2021-07-06 16:02:11.921	UNITED STATES	78081 Acle, Eduardo
19504	91	1625580132925:596416379	1625580132378:480509004	D5160C00019	1108	1107	CREATE	2021-07-06 16:02:13.015	05 Site Management	05.01 Site Selection
19506	91	1625580134061:760834398	1625580132378:480509004	D5160C00019	1110	1107	CREATE	2021-07-06 16:02:14.158	05 Site Management	05.02 Site Set-up Documentation
19507	91	1625580134604:-211573181	1625580134061:760834398	D5160C00019	1111	1110	CREATE	2021-07-06 16:02:14.694	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
19508	91	1625580135144:-577459771	1625579937316:690727696	D5160C00019	1112	919	CREATE	2021-07-06 16:02:15.233	UNITED STATES	78091 Call, Justin
19510	91	1625580143381:1459104504	1625580142777:-1151687511	D5160C00019	1114	1113	CREATE	2021-07-06 16:02:23.481	02 Central Trial Documents	02.04 General
19511	91	1625580143943:804874594	1625580143381:1459104504	D5160C00019	1115	1114	CREATE	2021-07-06 16:02:24.047	02.04 General	02.04.01 Rele_perations-Email
19513	91	1625580145159:1372341463	1625580144606:-141869638	D5160C00019	1117	1116	CREATE	2021-07-06 16:02:25.248	05 Site Management	05.01 Site Selection
19514	91	1625580145700:-1894386278	1625580145159:1372341463	D5160C00019	1118	1117	CREATE	2021-07-06 16:02:25.84	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
19515	91	1625580146331:617140338	1625579937316:690727696	D5160C00019	1119	919	CREATE	2021-07-06 16:02:26.427	UNITED STATES	78101 Cho, Daniel
19517	91	1625580147424:772093940	1625580146868:2034593237	D5160C00019	1121	1120	CREATE	2021-07-06 16:02:27.516	05 Site Management	05.01 Site Selection
19519	91	1625580148602:-846182881	1625579937316:690727696	D5160C00019	1123	919	CREATE	2021-07-06 16:02:28.696	UNITED STATES	TBD-1-1MRFMWU_emunaitis, John
19520	91	1625580149161:402332827	1625580148602:-846182881	D5160C00019	1124	1123	CREATE	2021-07-06 16:02:29.276	TBD-1-1MRFMWU_emunaitis, John	05 Site Management
19521	91	1625580149748:1542716225	1625580149161:402332827	D5160C00019	1125	1124	CREATE	2021-07-06 16:02:29.865	05 Site Management	05.01 Site Selection
18397	91	1625578772584:-1400269124	rootNode	D5160C00019	1	0	CREATE	2021-07-06 15:39:37.508		Generic Documents
18398	91	1625578778132:-86557079	1625578772584:-1400269124	D5160C00019	2	1	CREATE	2021-07-06 15:39:38.262	Generic Documents	Audit Trail
6216	84	\N	\N	D5170C00002	1	0	NEW	\N		eTMF
18401	91	1625578785830:-513253073	1625578785229:-811038769	D5160C00019	5	4	CREATE	2021-07-06 15:39:45.965	Hash Values	Hash Value Software
18404	91	1625578787595:-65419865	1625578786929:398390451	D5160C00019	8	7	CREATE	2021-07-06 15:39:47.687	eTMF	contents
18406	91	1625578788740:24020017	1625578788152:-1490134762	D5160C00019	10	9	CREATE	2021-07-06 15:39:48.842	01 Trial Management	01.01 Trial Oversight
18409	91	1625578790480:1704080297	1625578788740:24020017	D5160C00019	13	10	CREATE	2021-07-06 15:39:50.572	01.01 Trial Oversight	01.01.03 Quality Plan
18412	91	1625578796358:-2119246521	1625578788740:24020017	D5160C00019	16	10	CREATE	2021-07-06 15:39:56.47	01.01 Trial Oversight	01.01.08 Monitoring Plan
18415	91	1625578798100:-1557972439	1625578788740:24020017	D5160C00019	19	10	CREATE	2021-07-06 15:39:58.197	01.01 Trial Oversight	01.01.13 Investigator Newsletter
18419	91	1625578800361:786781177	1625578799751:1987521491	D5160C00019	23	22	CREATE	2021-07-06 15:40:00.471	01.02 Trial Team	01.02.01 Project Team Details
18422	91	1625578802101:-1716094851	1625578788152:-1490134762	D5160C00019	26	9	CREATE	2021-07-06 15:40:02.197	01 Trial Management	01.03 Data Adjudication
18425	91	1625578810101:1410972717	1625578803717:-116289195	D5160C00019	29	28	CREATE	2021-07-06 15:40:10.75	01.04 Meetings	01.04.01 External Kick-off Meeting Material
18428	91	1625578812771:1203434098	1625578803717:-116289195	D5160C00019	32	28	CREATE	2021-07-06 15:40:12.875	01.04 Meetings	01.04.03 Investigators Meeting Material
18432	91	1625578815723:2082939499	1625578814530:275201093	D5160C00019	36	34	CREATE	2021-07-06 15:40:15.833	01.05.01 Relevan_t Management-Email	CRA Resources
18435	91	1625578817623:942829226	1625578814530:275201093	D5160C00019	39	34	CREATE	2021-07-06 15:40:17.719	01.05.01 Relevan_t Management-Email	Sonia Harris Emails
18438	91	1625578819465:-1101462116	1625578813320:-1863585633	D5160C00019	42	33	CREATE	2021-07-06 15:40:19.566	01.05 General	01.05.03 Other Sponsor Meeting Material
18442	91	1625578821897:-894347219	1625578821334:-1059768343	D5160C00019	46	45	CREATE	2021-07-06 15:40:21.985	02.01 Trial Documents	02.01.01 Investigator Brochure
18445	91	1625578829789:1258600334	1625578821334:-1059768343	D5160C00019	49	45	CREATE	2021-07-06 15:40:29.902	02.01 Trial Documents	02.01.06 Insurance
18448	91	1625578838182:-1267904709	1625578837624:1885859091	D5160C00019	52	51	CREATE	2021-07-06 15:40:38.438	02.02 Subject Documents	02.02.01 Subject Diary
18451	91	1625578845113:-309092897	1625578837624:1885859091	D5160C00019	55	51	CREATE	2021-07-06 15:40:45.217	02.02 Subject Documents	02.02.05 Subject Participation Card
18455	91	1625578848286:1190987408	1625578847695:1401528364	D5160C00019	59	58	CREATE	2021-07-06 15:40:48.416	02.03 Reports	02.03.01 Clinical Study Report
18457	91	1625578849503:-937076491	1625578848877:1060428534	D5160C00019	61	60	CREATE	2021-07-06 15:40:49.626	02.04 General	02.04.01 Relevant Communications-Clinical Operations-Email
18461	91	1625578851887:-120823892	1625578851329:-1134328802	D5160C00019	65	64	CREATE	2021-07-06 15:40:51.979	03.01 Trial Approval	03.01.01 Submission
18464	91	1625578853630:400301961	1625578850782:1057005221	D5160C00019	68	63	CREATE	2021-07-06 15:40:53.726	03 Regulatory	03.04 General
18465	91	1625578854320:618729158	1625578853630:400301961	D5160C00019	69	68	CREATE	2021-07-06 15:40:54.409	03.04 General	03.04.01 Relevan_ory-Start-Up-Email
18466	91	1625578854921:236446947	1625578854320:618729158	D5160C00019	70	69	CREATE	2021-07-06 15:40:55.028	03.04.01 Relevan_ory-Start-Up-Email	EoT
18469	91	1625578856577:-384407249	1625578854320:618729158	D5160C00019	73	69	CREATE	2021-07-06 15:41:03.757	03.04.01 Relevan_ory-Start-Up-Email	Prot Admt Q1 2016
18472	91	1625578865524:-1075585151	1625578864933:-1887285703	D5160C00019	76	75	CREATE	2021-07-06 15:41:05.634	04 IRB-IEC and other Approvals	04.04 General
18475	91	1625578867441:495037739	1625578866850:757366532	D5160C00019	79	78	CREATE	2021-07-06 15:41:07.542	05 Site Management	05.03 Site Initiation
18478	91	1625578882087:-160864559	1625578869406:-427687837	D5160C00019	82	81	CREATE	2021-07-06 15:41:22.19	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
18481	91	1625578889441:2121660675	1625578869406:-427687837	D5160C00019	85	81	CREATE	2021-07-06 15:41:29.548	05.04 Site Management	05.04.09 Inv Notification-SUSAR
18485	91	1625578898659:1848942306	1625578890401:1268558346	D5160C00019	89	86	CREATE	2021-07-06 15:41:38.766	05.05 General	05.05.02 Tracking Information
18488	91	1625578900513:279990683	1625578899967:1926640624	D5160C00019	92	91	CREATE	2021-07-06 15:41:47.638	06.01 IP Documentation	06.01.01 IP Supply Plan
18491	91	1625578909475:-1879773687	1625578899388:209162548	D5160C00019	95	90	CREATE	2021-07-06 15:41:49.583	06 IP and Trial Supplies	06.02 IP Release Process Documentation
18495	91	1625578921761:-755441554	1625578921113:-1301806660	D5160C00019	99	98	CREATE	2021-07-06 15:42:01.874	06.07 General	06.07.01 Relevant Communications-Investigational Product-Email
18498	91	1625578923931:338587064	1625578923361:-475769125	D5160C00019	102	101	CREATE	2021-07-06 15:42:04.617	07 Safety Reporting	07.01 Safety Documentation
18502	91	1625578927078:-893920080	1625578923361:-475769125	D5160C00019	106	101	CREATE	2021-07-06 15:42:07.178	07 Safety Reporting	07.02 Trial Status Reporting
18505	91	1625578929048:-1663232745	1625578927078:-893920080	D5160C00019	109	106	CREATE	2021-07-06 15:42:09.144	07.02 Trial Status Reporting	07.02.02 SAE Report
18509	91	1625578938915:800011173	1625578937750:1075847699	D5160C00019	113	111	CREATE	2021-07-06 15:42:19.009	07.03.01 Relevan_tions-Safety-Email	2015-02
18512	91	1625578940594:2132571288	1625578937750:1075847699	D5160C00019	116	111	CREATE	2021-07-06 15:42:20.697	07.03.01 Relevan_tions-Safety-Email	2015-05
18515	91	1625578942402:-1477278837	1625578937750:1075847699	D5160C00019	119	111	CREATE	2021-07-06 15:42:22.501	07.03.01 Relevan_tions-Safety-Email	2015-08
18518	91	1625578944296:-806607482	1625578937750:1075847699	D5160C00019	122	111	CREATE	2021-07-06 15:42:24.398	07.03.01 Relevan_tions-Safety-Email	2015-11
18521	91	1625578945994:514701921	1625578937750:1075847699	D5160C00019	125	111	CREATE	2021-07-06 15:42:26.087	07.03.01 Relevan_tions-Safety-Email	2016-02
18524	91	1625578969948:409432796	1625578937750:1075847699	D5160C00019	128	111	CREATE	2021-07-06 15:42:50.046	07.03.01 Relevan_tions-Safety-Email	2016-05
18527	91	1625578971678:-1531854596	1625578937750:1075847699	D5160C00019	131	111	CREATE	2021-07-06 15:42:51.774	07.03.01 Relevan_tions-Safety-Email	2016-12
18529	91	1625578972890:-1148655518	1625578972288:694409902	D5160C00019	133	132	CREATE	2021-07-06 15:42:52.985	Reports	Compliance
18530	91	1625578973463:1252033852	1625578937152:1970176406	D5160C00019	134	110	CREATE	2021-07-06 15:42:53.562	07.03 General	07.03.01 Relevant Communications-Safety-Documents
18534	91	1625578975882:-432312728	1625578975262:-53607421	D5160C00019	138	137	CREATE	2021-07-06 15:43:03.705	08.01 Facility Documentation	08.01.05 Manual
18537	91	1625578985403:-1106962034	1625578787595:-65419865	D5160C00019	141	8	CREATE	2021-07-06 15:43:05.497	contents	09 Third Party
18539	91	1625578986546:-2075083569	1625578985952:-66494831	D5160C00019	143	142	CREATE	2021-07-06 15:43:06.675	09.02 Third Party Set-up	09.02.01 Confidentiality Agreement
18543	91	1625578988967:1117580058	1625578787595:-65419865	D5160C00019	147	8	CREATE	2021-07-06 15:43:09.069	contents	10 Data Management
18545	91	1625578990140:-1380321394	1625578989561:640230263	D5160C00019	149	148	CREATE	2021-07-06 15:43:10.229	10.01 Data Management Oversight	10.01.01 Data Manage_nt Plan (Paper and EDC)
18550	91	1625579010134:-1910114303	1625578998116:1809512072	D5160C00019	154	153	CREATE	2021-07-06 15:43:30.229	10.03 Database	10.03.06 External Dat_F Data (Paper and EDC)
18553	91	1625579011936:1317242334	1625578998116:1809512072	D5160C00019	157	153	CREATE	2021-07-06 15:43:32.04	10.03 Database	10.03.11 Database Lock and Unlock Approval (Paper and EDC)
18557	91	1625579014164:541543405	1625579013622:-2120961984	D5160C00019	161	160	CREATE	2021-07-06 15:43:34.254	11 Statistics	11.01 Statistics Oversight
18560	91	1625579015965:-750988495	1625579015301:1260310553	D5160C00019	164	163	CREATE	2021-07-06 15:43:36.054	11.03 Analysis	11.03.01 Data Definitions for Analysis Datasets
18563	91	1625579024710:-1132849465	1625579018097:498324201	D5160C00019	167	166	CREATE	2021-07-06 15:43:44.822	11.05 General	11.05.01 Relevant Com_Pharmacokinetics-Email
18567	91	1625579027150:1392974495	1625579026592:770148067	D5160C00019	171	170	CREATE	2021-07-06 15:43:47.243	05.02 Site Set-up Documentation	05.02.12 Investi_Agreement Template
18571	91	1625579038531:-252391526	1625579037989:-1232379313	D5160C00019	175	174	CREATE	2021-07-06 15:43:59.558	02.04 General	02.04.01 Rele_-Contact Report
18574	91	1625579041284:-1853376132	1625579040722:-1245754834	D5160C00019	178	177	CREATE	2021-07-06 15:44:01.382	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
18577	91	1625579049562:358124851	1625579049008:-999116212	D5160C00019	181	180	CREATE	2021-07-06 15:44:10.524	02 Central Trial Documents	02.01 Trial Documents
18580	91	1625579052301:297416132	1625579049562:358124851	D5160C00019	184	181	CREATE	2021-07-06 15:44:12.393	02.01 Trial Documents	02.01.04 Protocol Amendment
18584	91	1625579065075:-1451398980	1625579053683:-1772313646	D5160C00019	188	186	CREATE	2021-07-06 15:44:25.189	02.02 Subject Documents	02.02.03 Informe_ent Form Templates
18587	91	1625579066964:-2147190768	1625579053683:-1772313646	D5160C00019	191	186	CREATE	2021-07-06 15:44:27.056	02.02 Subject Documents	02.02.07 Other W_ Given to Subjects
18591	91	1625579075686:-1426752179	1625579075055:1930581380	D5160C00019	195	194	CREATE	2021-07-06 15:44:35.777	03 Regulatory	03.01 Trial Approval
18593	91	1625579076834:1853457585	1625579075055:1930581380	D5160C00019	197	194	CREATE	2021-07-06 15:44:36.943	03 Regulatory	03.02 Investigational Medicinal Product
18596	91	1625579078496:869889524	1625579077959:-273999111	D5160C00019	200	199	CREATE	2021-07-06 15:44:38.595	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
18598	91	1625579086448:-2066042771	1625579078496:869889524	D5160C00019	202	200	CREATE	2021-07-06 15:44:56.209	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
18601	91	1625579110981:-324754776	1625579077959:-273999111	D5160C00019	205	199	CREATE	2021-07-06 15:45:11.113	04 IRB-IEC and other Approvals	04.02 Other Committees
18606	91	1625579114012:-1847582291	1625579113454:243937840	D5160C00019	210	209	CREATE	2021-07-06 15:45:14.104	05 Site Management	05.05 General
18609	91	1625579115730:764595528	1625579115154:281183640	D5160C00019	213	212	CREATE	2021-07-06 15:45:23.403	07 Safety Reporting	07.03 General
18611	91	1625579124574:114836887	1625579123942:1074640762	D5160C00019	215	214	CREATE	2021-07-06 15:45:24.698	07.03.01 Relevant Communications-Safety-Email	2016-03
18614	91	1625579126373:405916881	1625579125810:471498585	D5160C00019	218	217	CREATE	2021-07-06 15:45:26.51	09.02 Third Party Set-up	09.02.03 Contractual Agreement
18617	91	1625579129675:660189935	1625579127548:-1843397400	D5160C00019	221	220	CREATE	2021-07-06 15:45:29.771	23011 Isambert, Nicolas	04 IRB-IEC an_other Approvals
18621	91	1625579143026:2129589673	1625579131467:-1346797002	D5160C00019	225	224	CREATE	2021-07-06 15:45:43.119	05 Site Management	05.01 Site Selection
18624	91	1625579147974:-694578562	1625579131467:-1346797002	D5160C00019	228	224	CREATE	2021-07-06 15:45:48.074	05 Site Management	05.02 Site Se_p Documentation
18627	91	1625579149859:1204869723	1625579147974:-694578562	D5160C00019	231	228	CREATE	2021-07-06 15:45:49.978	05.02 Site Se_p Documentation	05.02.03 Prot_ Signature Page
18630	91	1625579152767:1816192718	1625579147974:-694578562	D5160C00019	234	228	CREATE	2021-07-06 15:45:52.884	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
18633	91	1625579154654:-586939735	1625579147974:-694578562	D5160C00019	237	228	CREATE	2021-07-06 15:45:54.751	05.02 Site Se_p Documentation	05.02.18 Site Signature Sheet
6255	84	\N	\N	D5170C00002	40	39	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
18637	91	1625579177853:-1243828622	1625579131467:-1346797002	D5160C00019	241	224	CREATE	2021-07-06 15:46:17.946	05 Site Management	05.04 Site Management
18640	91	1625579179582:458500311	1625579177853:-1243828622	D5160C00019	244	241	CREATE	2021-07-06 15:46:19.68	05.04 Site Management	05.04.04 Visit Log
18643	91	1625579181393:1821389994	1625579180738:-884017517	D5160C00019	247	246	CREATE	2021-07-06 15:46:21.611	05.05 General	05.05.02 Tracking Information
18646	91	1625579191109:-327701173	1625579182776:-368096901	D5160C00019	250	249	CREATE	2021-07-06 15:46:31.233	06.01 IP Documentation	06.01.04 IP S_t Documentation
18650	91	1625579193489:241070006	1625579182147:971467167	D5160C00019	254	248	CREATE	2021-07-06 15:46:33.578	06 IP and Trial Supplies	06.04 Storage
18653	91	1625579202745:-1168641057	1625579201993:-1428292173	D5160C00019	257	256	CREATE	2021-07-06 15:46:42.836	06.07 General	06.07.02 Tracking Information
18656	91	1625579204459:1723401808	1625579203928:1243445351	D5160C00019	260	259	CREATE	2021-07-06 15:46:44.551	07.03 General	07.03.01 Relevant Communications-Safety-Documents
18659	91	1625579207262:351890808	1625579205605:1479488623	D5160C00019	263	262	CREATE	2021-07-06 15:46:47.365	02 Central Trial Documents	02.02 Subject Documents
18661	91	1625579215099:270474102	1625579205065:36357806	D5160C00019	265	261	CREATE	2021-07-06 15:46:55.194	23021 Italiano, Antoine	05 Site Management
18663	91	1625579216342:2064662476	1625579215718:574517881	D5160C00019	267	266	CREATE	2021-07-06 15:46:56.437	05.01 Site Selection	05.01.02 Confidentiality Agreement
18666	91	1625579219057:-405104900	1625579218454:2045316942	D5160C00019	270	269	CREATE	2021-07-06 15:46:59.159	05.02 Site Se_p Documentation	05.02.01 Acce_igator Brochure
18669	91	1625579220853:162306658	1625579218454:2045316942	D5160C00019	273	269	CREATE	2021-07-06 15:47:00.952	05.02 Site Se_p Documentation	05.02.04 PI C_ite Affiliation
18672	91	1625579222571:-194765057	1625579218454:2045316942	D5160C00019	276	269	CREATE	2021-07-06 15:47:02.665	05.02 Site Se_p Documentation	05.02.12 Clinical Trial Agreement
18676	91	1625579225001:-1045805762	1625579224272:-489148769	D5160C00019	280	279	CREATE	2021-07-06 15:47:05.098	05.03 Site Initiation	05.03.01 Tria_nitoring Report
18680	91	1625579227315:-774684680	1625579226728:1496045664	D5160C00019	284	283	CREATE	2021-07-06 15:47:07.42	05.04 Site Management	05.04.01 Subject Log
18683	91	1625579236205:1424815326	1625579226728:1496045664	D5160C00019	287	283	CREATE	2021-07-06 15:47:16.3	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
18686	91	1625579237976:-1102707276	1625579215099:270474102	D5160C00019	290	265	CREATE	2021-07-06 15:47:18.092	05 Site Management	05.05 General
18689	91	1625579240865:-277698055	1625579205065:36357806	D5160C00019	293	261	CREATE	2021-07-06 15:47:20.967	23021 Italiano, Antoine	06 IP and Trial Supplies
18692	91	1625579242785:1456425954	1625579241429:-1840587288	D5160C00019	296	294	CREATE	2021-07-06 15:47:22.874	06.01 IP Documentation	06.01.05 Acco_y Documentation
18696	91	1625579248138:-1093242130	1625579244028:155542034	D5160C00019	300	298	CREATE	2021-07-06 15:47:28.233	06.04 Storage	06.04.03 Maintenance Logs
18699	91	1625579254876:1205622284	1625579205065:36357806	D5160C00019	303	261	CREATE	2021-07-06 15:47:39.526	23021 Italiano, Antoine	07 Safety Reporting
18702	91	1625579261144:-16415514	1625579205065:36357806	D5160C00019	306	261	CREATE	2021-07-06 15:47:41.663	23021 Italiano, Antoine	08 Centralized Testing
18705	91	1625579263384:-1081086820	1625579262170:2001125354	D5160C00019	309	307	CREATE	2021-07-06 15:47:43.475	08.01 Facility Documentation	08.01.04 Norm_nd Alert Values
18710	91	1625579272768:-1232719165	1625579271640:734720565	D5160C00019	314	313	CREATE	2021-07-06 15:47:52.886	23031 Lena, Hervé	02 Central Trial Documents
18712	91	1625579273965:-1932544783	1625579273383:-32616377	D5160C00019	316	315	CREATE	2021-07-06 15:47:54.068	02.04 General	02.04.01 Rele_-Contact Report
18715	91	1625579275742:385091817	1625579275150:-350631739	D5160C00019	319	318	CREATE	2021-07-06 15:47:55.837	05.01 Site Selection	05.01.02 Confidentiality Agreement
18718	91	1625579277468:1563691637	1625579276918:-266826920	D5160C00019	322	321	CREATE	2021-07-06 15:47:57.573	05.02 Site Se_p Documentation	05.02.01 Acceptance of Investigator Brochure
18722	91	1625579279730:687055041	1625579276918:-266826920	D5160C00019	326	321	CREATE	2021-07-06 15:47:59.821	05.02 Site Se_p Documentation	05.02.06 Othe_ite Affiliation
18725	91	1625579281510:-679426721	1625579276918:-266826920	D5160C00019	329	321	CREATE	2021-07-06 15:48:01.615	05.02 Site Se_p Documentation	05.02.17 IP Site Release Documentation
18727	91	1625579302346:207830578	1625579274558:516798532	D5160C00019	331	317	CREATE	2021-07-06 15:48:22.436	05 Site Management	05.03 Site Initiation
18730	91	1625579304824:327196912	1625579302346:207830578	D5160C00019	334	331	CREATE	2021-07-06 15:48:24.925	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
18734	91	1625579307062:1018480490	1625579305459:570896044	D5160C00019	338	335	CREATE	2021-07-06 15:48:27.153	05.04 Site Management	05.04.04 Visit Log
18736	91	1625579308166:-792075120	1625579305459:570896044	D5160C00019	340	335	CREATE	2021-07-06 15:48:28.257	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
18741	91	1625579316184:2094069298	1625579315610:-89025629	D5160C00019	345	344	CREATE	2021-07-06 15:48:36.283	06.01 IP Documentation	06.01.04 IP Shipment Documentation
18744	91	1625579317899:104344608	1625579315610:-89025629	D5160C00019	348	344	CREATE	2021-07-06 15:48:37.995	06.01 IP Documentation	06.01.11 Certificate of Destruction
18747	91	1625579319510:2091355694	1625579318437:1856565747	D5160C00019	351	349	CREATE	2021-07-06 15:48:39.599	06.04 Storage	06.04.02 Stor_n Documentation
18750	91	1625579321330:-2138720706	1625579320706:1453028832	D5160C00019	354	353	CREATE	2021-07-06 15:48:41.433	07 Safety Reporting	07.03 General
18753	91	1625579323101:691616285	1625579322468:280531734	D5160C00019	357	356	CREATE	2021-07-06 15:48:43.201	08 Centralized Testing	08.01 Facility Documentation
18757	91	1625579330339:-1991851045	1625579329798:1269341066	D5160C00019	361	360	CREATE	2021-07-06 15:48:50.431	08.02 Sample Documentation	08.02.03 Samp_e Condition Log
18760	91	1625579332397:-1668088758	1625579331782:-1842571658	D5160C00019	364	363	CREATE	2021-07-06 15:48:52.504	23041 Veillon, Remi	02 Central Trial Documents
18763	91	1625579334229:1959668847	1625579332949:1042439630	D5160C00019	367	365	CREATE	2021-07-06 15:48:54.32	02.04 General	02.04.01 Rele_tions-Documents
18766	91	1625579336524:-1877816459	1625579335915:-645535075	D5160C00019	370	369	CREATE	2021-07-06 15:48:56.619	05.01 Site Selection	05.01.02 Confidentiality Agreement
18769	91	1625579338355:1756147370	1625579337791:-1300347962	D5160C00019	373	372	CREATE	2021-07-06 15:48:58.452	05.02 Site Se_p Documentation	05.02.01 Acce_igator Brochure
18773	91	1625579340599:-1555550098	1625579337791:-1300347962	D5160C00019	377	372	CREATE	2021-07-06 15:49:00.688	05.02 Site Se_p Documentation	05.02.06 Othe_ite Affiliation
18776	91	1625579342480:1322323227	1625579337791:-1300347962	D5160C00019	380	372	CREATE	2021-07-06 15:49:02.582	05.02 Site Se_p Documentation	05.02.17 IP Site Release Documentation
6414	84	\N	\N	D5170C00002	199	198	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
18780	91	1625579344985:-521262852	1625579343760:509641278	D5160C00019	384	382	CREATE	2021-07-06 15:49:05.072	05.03 Site Initiation	05.03.03 Site Training-Staff
18783	91	1625579347294:-195302541	1625579346750:-1849629849	D5160C00019	387	386	CREATE	2021-07-06 15:49:07.385	05.04 Site Management	05.04.01 Subject Log
18786	91	1625579349269:1171309022	1625579346750:-1849629849	D5160C00019	390	386	CREATE	2021-07-06 15:49:09.48	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
18789	91	1625579351167:-1489808135	1625579334772:-1994578655	D5160C00019	393	368	CREATE	2021-07-06 15:49:17.181	05 Site Management	05.05 General
18791	91	1625579358543:-1852602297	1625579331782:-1842571658	D5160C00019	395	363	CREATE	2021-07-06 15:49:18.67	23041 Veillon, Remi	06 IP and Trial Supplies
18794	91	1625579360395:-1784283160	1625579359128:291551010	D5160C00019	398	396	CREATE	2021-07-06 15:49:20.625	06.01 IP Documentation	06.01.05 Acco_y Documentation
18798	91	1625579363478:-2065822592	1625579362742:-2002979710	D5160C00019	402	401	CREATE	2021-07-06 15:49:23.576	06.04 Storage	06.04.01 Storage Condition Documentation
18801	91	1625579373018:-985701559	1625579372409:1072578702	D5160C00019	405	404	CREATE	2021-07-06 15:49:33.11	07 Safety Reporting	07.03 General
18804	91	1625579374719:922500407	1625579374135:1924458525	D5160C00019	408	407	CREATE	2021-07-06 15:49:34.813	08 Centralized Testing	08.01 Facility Documentation
18807	91	1625579376517:-485008599	1625579374719:922500407	D5160C00019	411	408	CREATE	2021-07-06 15:49:36.611	08.01 Facility Documentation	08.01.07 Head of Facility CV
18811	91	1625579379617:1323294590	1625579379057:303629918	D5160C00019	415	414	CREATE	2021-07-06 15:49:39.715	23051 Cortot, Alexis	05 Site Management
18813	91	1625579380893:-2114211552	1625579380298:1562065157	D5160C00019	417	416	CREATE	2021-07-06 15:49:40.989	05.01 Site Selection	05.01.02 Confidentiality Agreement
18816	91	1625579389473:-2077475024	1625579388201:1647036966	D5160C00019	420	419	CREATE	2021-07-06 15:49:49.57	05.02 Site Se_p Documentation	05.02.01 Acceptance of Investigator Brochure
18820	91	1625579391717:1340855676	1625579388201:1647036966	D5160C00019	424	419	CREATE	2021-07-06 15:49:51.808	05.02 Site Se_p Documentation	05.02.06 Othe_ite Affiliation
18824	91	1625579394108:-95016130	1625579379617:1323294590	D5160C00019	428	415	CREATE	2021-07-06 15:49:54.239	05 Site Management	05.03 Site Initiation
18827	91	1625579396161:328441018	1625579394108:-95016130	D5160C00019	431	428	CREATE	2021-07-06 15:49:56.265	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
18830	91	1625579397908:1230781506	1625579396716:1097797515	D5160C00019	434	432	CREATE	2021-07-06 15:49:58.02	05.04 Site Management	05.04.03 Monitoring Visit Report
18833	91	1625579400336:1333046188	1625579396716:1097797515	D5160C00019	437	432	CREATE	2021-07-06 15:50:00.429	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
18835	91	1625579407585:-1419273337	1625579400873:-708564028	D5160C00019	439	438	CREATE	2021-07-06 15:50:07.68	05.05 General	05.05.01 Rele_tions-Documents
18836	91	1625579408146:976234297	1625579400873:-708564028	D5160C00019	440	438	CREATE	2021-07-06 15:50:08.24	05.05 General	05.05.02 Tracking Information
18837	91	1625579408698:1569656848	1625579379057:303629918	D5160C00019	441	414	CREATE	2021-07-06 15:50:08.791	23051 Cortot, Alexis	06 IP and Trial Supplies
18838	91	1625579409237:-210814555	1625579408698:1569656848	D5160C00019	442	441	CREATE	2021-07-06 15:50:09.332	06 IP and Trial Supplies	06.01 IP Documentation
18839	91	1625579409816:-1469778001	1625579409237:-210814555	D5160C00019	443	442	CREATE	2021-07-06 15:50:09.926	06.01 IP Documentation	06.01.04 IP Shipment Documentation
18840	91	1625579411040:-1248406778	1625579379057:303629918	D5160C00019	444	414	CREATE	2021-07-06 15:50:11.131	23051 Cortot, Alexis	08 Centralized Testing
18841	91	1625579411645:-723875187	1625579411040:-1248406778	D5160C00019	445	444	CREATE	2021-07-06 15:50:11.764	08 Centralized Testing	08.01 Facility Documentation
18842	91	1625579412286:1341467777	1625579411645:-723875187	D5160C00019	446	445	CREATE	2021-07-06 15:50:12.396	08.01 Facility Documentation	08.01.01 Cert_r Accreditation
18843	91	1625579412872:39866316	1625579411645:-723875187	D5160C00019	447	445	CREATE	2021-07-06 15:50:12.965	08.01 Facility Documentation	08.01.02 Lab _cation Document
18844	91	1625579413404:1715239556	1625579411645:-723875187	D5160C00019	448	445	CREATE	2021-07-06 15:50:13.503	08.01 Facility Documentation	08.01.04 Norm_nd Alert Values
18845	91	1625579413951:-556274802	1625579048409:-510601586	D5160C00019	449	179	CREATE	2021-07-06 15:50:14.047	FRANCE	23061 Tosi, Diego
18847	91	1625579415012:-1487608655	1625579414482:268563924	D5160C00019	451	450	CREATE	2021-07-06 15:50:15.104	02 Central Trial Documents	02.02 Subject Documents
18848	91	1625579422173:-843430010	1625579415012:-1487608655	D5160C00019	452	451	CREATE	2021-07-06 15:50:22.269	02.02 Subject Documents	02.02.07 Othe_ven to Subjects
18850	91	1625579423414:135941415	1625579422804:1812538854	D5160C00019	454	453	CREATE	2021-07-06 15:50:23.551	02.04 General	02.04.01 Rele_-Contact Report
18851	91	1625579424106:-942551179	1625579413951:-556274802	D5160C00019	455	449	CREATE	2021-07-06 15:50:24.209	23061 Tosi, Diego	05 Site Management
18852	91	1625579424752:963562976	1625579424106:-942551179	D5160C00019	456	455	CREATE	2021-07-06 15:50:24.843	05 Site Management	05.01 Site Selection
18853	91	1625579425378:266195145	1625579424752:963562976	D5160C00019	457	456	CREATE	2021-07-06 15:50:25.481	05.01 Site Selection	05.01.02 Confidentiality Agreement
18854	91	1625579426080:-273056230	1625579424752:963562976	D5160C00019	458	456	CREATE	2021-07-06 15:50:26.193	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
18855	91	1625579426708:268178780	1625579424106:-942551179	D5160C00019	459	455	CREATE	2021-07-06 15:50:26.804	05 Site Management	05.02 Site Se_p Documentation
18856	91	1625579429988:-1568837908	1625579426708:268178780	D5160C00019	460	459	CREATE	2021-07-06 15:50:30.084	05.02 Site Se_p Documentation	05.02.01 Acce_igator Brochure
18857	91	1625579430653:-90720399	1625579426708:268178780	D5160C00019	461	459	CREATE	2021-07-06 15:50:30.753	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
18858	91	1625579431253:634862393	1625579426708:268178780	D5160C00019	462	459	CREATE	2021-07-06 15:50:31.354	05.02 Site Se_p Documentation	05.02.03 Prot_ Signature Page
18859	91	1625579431821:1030304514	1625579426708:268178780	D5160C00019	463	459	CREATE	2021-07-06 15:50:32.293	05.02 Site Se_p Documentation	05.02.04 PI CV-Site Affiliation
18860	91	1625579432801:-580252971	1625579426708:268178780	D5160C00019	464	459	CREATE	2021-07-06 15:50:32.896	05.02 Site Se_p Documentation	05.02.06 Othe_ite Affiliation
18861	91	1625579433349:1452339602	1625579426708:268178780	D5160C00019	465	459	CREATE	2021-07-06 15:50:33.442	05.02 Site Se_p Documentation	05.02.07 Site Qualification
18862	91	1625579433887:28442459	1625579426708:268178780	D5160C00019	466	459	CREATE	2021-07-06 15:50:33.978	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
18863	91	1625579434528:884819395	1625579426708:268178780	D5160C00019	467	459	CREATE	2021-07-06 15:50:34.629	05.02 Site Se_p Documentation	05.02.12 Clinical Trial Agreement
18864	91	1625579435084:283380345	1625579426708:268178780	D5160C00019	468	459	CREATE	2021-07-06 15:50:35.186	05.02 Site Se_p Documentation	05.02.17 IP Site Release Documentation
18865	91	1625579435718:-1040387325	1625579426708:268178780	D5160C00019	469	459	CREATE	2021-07-06 15:50:35.809	05.02 Site Se_p Documentation	05.02.18 Site Signature Sheet
18866	91	1625579436267:-1436496316	1625579424106:-942551179	D5160C00019	470	455	CREATE	2021-07-06 15:50:36.358	05 Site Management	05.03 Site Initiation
18867	91	1625579436884:-903920306	1625579436267:-1436496316	D5160C00019	471	470	CREATE	2021-07-06 15:50:45.254	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
18868	91	1625579445760:1725430699	1625579436267:-1436496316	D5160C00019	472	470	CREATE	2021-07-06 15:50:45.858	05.03 Site Initiation	05.03.03 Site Training-Staff
18869	91	1625579446323:1672889489	1625579436267:-1436496316	D5160C00019	473	470	CREATE	2021-07-06 15:50:46.431	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
18870	91	1625579446912:-1020930239	1625579424106:-942551179	D5160C00019	474	455	CREATE	2021-07-06 15:50:47.014	05 Site Management	05.04 Site Management
18873	91	1625579448643:20908458	1625579446912:-1020930239	D5160C00019	477	474	CREATE	2021-07-06 15:50:48.737	05.04 Site Management	05.04.04 Visit Log
18875	91	1625579449852:1765461185	1625579446912:-1020930239	D5160C00019	479	474	CREATE	2021-07-06 15:50:50.054	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
18879	91	1625579452438:1392572474	1625579451751:1469909464	D5160C00019	483	482	CREATE	2021-07-06 15:50:52.539	06 IP and Trial Supplies	06.01 IP Documentation
18882	91	1625579454910:721636458	1625579452438:1392572474	D5160C00019	486	483	CREATE	2021-07-06 15:51:00.981	06.01 IP Documentation	06.01.10 IP Documentation Return
18885	91	1625579462653:1784485383	1625579462108:-956803446	D5160C00019	489	488	CREATE	2021-07-06 15:51:02.997	06.04 Storage	06.04.01 Storage Condition Documentation
18889	91	1625579465803:897253271	1625579413951:-556274802	D5160C00019	493	449	CREATE	2021-07-06 15:51:05.914	23061 Tosi, Diego	08 Centralized Testing
18892	91	1625579467648:-1997250963	1625579466409:1394531806	D5160C00019	496	494	CREATE	2021-07-06 15:51:07.761	08.01 Facility Documentation	08.01.04 Norm_nd Alert Values
18895	91	1625579475483:1179759100	1625579465803:897253271	D5160C00019	499	493	CREATE	2021-07-06 15:51:15.587	08 Centralized Testing	08.02 Sample Documentation
18899	91	1625579478442:-1326871365	1625579477872:594587882	D5160C00019	503	502	CREATE	2021-07-06 15:51:18.558	GERMANY	03 Regulatory
18901	91	1625579479700:-1407711637	1625579479032:1629658789	D5160C00019	505	504	CREATE	2021-07-06 15:51:19.811	03.03 Trial Status Reporting	03.03.03 Notification of Trial Termination
18904	91	1625579481450:-734381780	1625579480895:623547909	D5160C00019	508	507	CREATE	2021-07-06 15:51:21.538	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
18905	91	1625579487730:95018472	1625579480895:623547909	D5160C00019	509	507	CREATE	2021-07-06 15:51:27.922	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
18909	91	1625579490247:366897001	1625579489513:-233588849	D5160C00019	513	512	CREATE	2021-07-06 15:51:30.346	26021 Golpon, Heiko	04 IRB-IEC an_other Approvals
18912	91	1625579492095:-2080361104	1625579490929:-379050661	D5160C00019	516	514	CREATE	2021-07-06 15:51:32.189	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
18916	91	1625579500785:803025185	1625579500226:1965609392	D5160C00019	520	519	CREATE	2021-07-06 15:51:40.874	05 Site Management	05.01 Site Selection
18919	91	1625579502631:-1998221983	1625579501913:1125369365	D5160C00019	523	522	CREATE	2021-07-06 15:51:42.738	26031 Waller, Cornelius	05 Site Management
18922	91	1625579504346:-1266246792	1625579477872:594587882	D5160C00019	526	502	CREATE	2021-07-06 15:51:44.447	GERMANY	26041 Ochsenreither, Sebastian
18925	91	1625579506917:-1696002592	1625579505464:-669512994	D5160C00019	529	528	CREATE	2021-07-06 15:51:47.02	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
18929	91	1625579509194:2099394910	1625579508634:1489731179	D5160C00019	533	532	CREATE	2021-07-06 15:51:49.288	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
18932	91	1625579510905:1359085066	1625579510350:1385825209	D5160C00019	536	535	CREATE	2021-07-06 15:51:50.994	04 IRB-IEC an_other Approvals	04.01 IRB-IEC Trial Approval
18935	91	1625579512675:-1462086743	1625579510350:1385825209	D5160C00019	539	535	CREATE	2021-07-06 15:51:52.764	04 IRB-IEC an_other Approvals	04.03 Trial Status Reporting
18939	91	1625579521723:-570591955	1625579509774:723492485	D5160C00019	543	534	CREATE	2021-07-06 15:52:01.828	TBD-1-1FNLC0B Bullinger, Lars	05 Site Management
18943	91	1625579524071:-1882409801	1625579523523:1533419025	D5160C00019	547	546	CREATE	2021-07-06 15:52:04.169	SPAIN	01 Trial Management
18945	91	1625579525162:-1083923800	1625579524619:1092805660	D5160C00019	549	548	CREATE	2021-07-06 15:52:05.251	01.05 General	01.05.01 Relevant Communications-Project Management-Documents
18949	91	1625579527413:171697021	1625579526344:-1862470708	D5160C00019	553	551	CREATE	2021-07-06 15:52:07.504	02.01 Trial Documents	02.01.03 Protocol Synopsis
18952	91	1625579530191:249196774	1625579525786:-930760222	D5160C00019	556	550	CREATE	2021-07-06 15:52:15.615	02 Central Trial Documents	02.02 Subject Documents
18955	91	1625579537622:254748391	1625579530191:249196774	D5160C00019	559	556	CREATE	2021-07-06 15:52:17.743	02.02 Subject Documents	02.02.03 Informed Consent Form Checklists
18959	91	1625579540804:-1601989681	1625579540206:-2079745329	D5160C00019	563	562	CREATE	2021-07-06 15:52:20.901	02.04 General	02.04.02 Tracking Information
18962	91	1625579542550:-2071719556	1625579541948:1445963708	D5160C00019	566	565	CREATE	2021-07-06 15:52:22.645	03.01 Trial Approval	03.01.01 Submission
18965	91	1625579550802:457165573	1625579550187:-1586698492	D5160C00019	569	568	CREATE	2021-07-06 15:52:30.948	03.03 Trial Status Reporting	03.03.01 Reg Aut_Info and Deviation
18968	91	1625579552790:1642345254	1625579541335:-1462229109	D5160C00019	572	564	CREATE	2021-07-06 15:52:32.882	03 Regulatory	03.04 General
18969	91	1625579553354:1793582996	1625579552790:1642345254	D5160C00019	573	572	CREATE	2021-07-06 15:52:33.447	03.04 General	03.04.01 Relevan_ory-Start-Up-Email
18972	91	1625579555088:-1145367136	1625579554551:1724964884	D5160C00019	576	575	CREATE	2021-07-06 15:52:35.183	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
18976	91	1625579557384:48734219	1625579556211:238063917	D5160C00019	580	578	CREATE	2021-07-06 15:52:37.484	04.03 Trial Status Reporting	04.03.03 IRB-IEC_ Term Notification
18980	91	1625579559706:-2105204750	1625579559145:-427607565	D5160C00019	584	583	CREATE	2021-07-06 15:52:39.795	05 Site Management	05.01 Site Selection
18983	91	1625579562331:-1450622706	1625579561710:900521065	D5160C00019	587	586	CREATE	2021-07-06 15:52:42.43	05.05 General	05.05.01 Relevan_on-Documents-Email
18986	91	1625579564021:-1451599490	1625579563460:-65167614	D5160C00019	590	589	CREATE	2021-07-06 15:52:44.123	06.01 IP Documentation	06.01.02 IP Instructions for Handling
18990	91	1625579573214:477889890	1625579572398:-1583118447	D5160C00019	594	593	CREATE	2021-07-06 15:52:53.325	02.04 General	02.04.01 Rele_-Contact Report
18993	91	1625579574965:1684392312	1625579574380:-1305925445	D5160C00019	597	596	CREATE	2021-07-06 15:52:55.066	05.01 Site Selection	05.01.01 Site Contact Details
18996	91	1625579584021:730985823	1625579574380:-1305925445	D5160C00019	600	596	CREATE	2021-07-06 15:53:04.166	05.01 Site Selection	05.01.04 Pre _nitoring Report
18999	91	1625579586248:-614967018	1625579585128:1553851741	D5160C00019	603	601	CREATE	2021-07-06 15:53:06.339	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
19002	91	1625579588016:969566557	1625579585128:1553851741	D5160C00019	606	601	CREATE	2021-07-06 15:53:08.109	05.02 Site Se_p Documentation	05.02.06 Othe_ite Affiliation
19006	91	1625579598516:1220237829	1625579585128:1553851741	D5160C00019	610	601	CREATE	2021-07-06 15:53:18.611	05.02 Site Se_p Documentation	05.02.12 Clinical Trial Agreement
19009	91	1625579600374:-1331461419	1625579585128:1553851741	D5160C00019	613	601	CREATE	2021-07-06 15:53:20.466	05.02 Site Se_p Documentation	05.02.18 Site Signature Sheet
19013	91	1625579602875:1523670348	1625579601139:1977960684	D5160C00019	617	614	CREATE	2021-07-06 15:53:22.968	05.03 Site Initiation	05.03.03 Site_umentation-Site
19016	91	1625579605501:-613786814	1625579603429:-384312790	D5160C00019	620	618	CREATE	2021-07-06 15:53:25.595	05.04 Site Management	05.04.03 Moni_ng Visit Report
19020	91	1625579607765:1364402177	1625579573810:-1080348855	D5160C00019	624	595	CREATE	2021-07-06 15:53:27.86	05 Site Management	05.05 General
19023	91	1625579612280:2017284682	1625579570333:1407517647	D5160C00019	627	591	CREATE	2021-07-06 15:53:32.374	70011 Alonso Garcia, Miriam	06 IP and Trial Supplies
19026	91	1625579634410:-1060875341	1625579612936:-310694722	D5160C00019	630	628	CREATE	2021-07-06 15:53:54.506	06.01 IP Documentation	06.01.05 Acco_y Documentation
19029	91	1625579636713:245992792	1625579612280:2017284682	D5160C00019	633	627	CREATE	2021-07-06 15:53:56.804	06 IP and Trial Supplies	06.04 Storage
19032	91	1625579638398:647243769	1625579570333:1407517647	D5160C00019	636	591	CREATE	2021-07-06 15:53:58.489	70011 Alonso Garcia, Miriam	07 Safety Reporting
19035	91	1625579640345:-574804638	1625579570333:1407517647	D5160C00019	639	591	CREATE	2021-07-06 15:54:00.436	70011 Alonso Garcia, Miriam	08 Centralized Testing
19038	91	1625579642039:831769799	1625579640898:1368767647	D5160C00019	642	640	CREATE	2021-07-06 15:54:02.132	08.01 Facility Documentation	08.01.04 Norm_nd Alert Values
19041	91	1625579643925:-1051727601	1625579643245:128585342	D5160C00019	645	644	CREATE	2021-07-06 15:54:04.025	10.02 Data Capture	10.02.03 Completed CRFs (Paper)
19045	91	1625579646866:1085980107	1625579645841:-929441078	D5160C00019	649	648	CREATE	2021-07-06 15:54:06.966	02.04 General	02.04.01 Rele_-Contact Report
19048	91	1625579648610:1324403875	1625579648018:-1200493129	D5160C00019	652	651	CREATE	2021-07-06 15:54:08.719	05.01 Site Selection	05.01.02 Confidentiality Agreement
19051	91	1625579658218:270316541	1625579647463:-1601604560	D5160C00019	655	650	CREATE	2021-07-06 15:54:18.33	05 Site Management	05.02 Site Se_p Documentation
19054	91	1625579659918:-1404421801	1625579658218:270316541	D5160C00019	658	655	CREATE	2021-07-06 15:54:20.021	05.02 Site Se_p Documentation	05.02.03 Prot_ Signature Page
19058	91	1625579662265:1658420405	1625579658218:270316541	D5160C00019	662	655	CREATE	2021-07-06 15:54:22.361	05.02 Site Se_p Documentation	05.02.07 Site Qualification
19061	91	1625579664132:1801765058	1625579658218:270316541	D5160C00019	665	655	CREATE	2021-07-06 15:54:24.237	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
19065	91	1625579666470:1736157148	1625579658218:270316541	D5160C00019	669	655	CREATE	2021-07-06 15:54:26.559	05.02 Site Se_p Documentation	05.02.18 Site Signature Sheet
19069	91	1625579669344:-1025611370	1625579666997:749047895	D5160C00019	673	670	CREATE	2021-07-06 15:54:29.455	05.03 Site Initiation	05.03.03 Site_umentation-Site
19072	91	1625579671428:-1396365156	1625579670023:1109959734	D5160C00019	676	674	CREATE	2021-07-06 15:54:31.529	05.04 Site Management	05.04.03 Monitoring Visit Report
19075	91	1625579673167:-279050531	1625579670023:1109959734	D5160C00019	679	674	CREATE	2021-07-06 15:54:33.27	05.04 Site Management	05.04.08 Fina_nitoring Report
19079	91	1625579675897:-75699961	1625579644481:1074217758	D5160C00019	683	646	CREATE	2021-07-06 15:54:35.994	70021 Vicente Baz, David	06 IP and Trial Supplies
19082	91	1625579684597:-197641876	1625579676435:-1339670252	D5160C00019	686	684	CREATE	2021-07-06 15:54:44.697	06.01 IP Documentation	06.01.05 Acco_y Documentation
19085	91	1625579686276:605910515	1625579675897:-75699961	D5160C00019	689	683	CREATE	2021-07-06 15:54:46.366	06 IP and Trial Supplies	06.04 Storage
19088	91	1625579688211:-760652852	1625579644481:1074217758	D5160C00019	692	646	CREATE	2021-07-06 15:54:48.309	70021 Vicente Baz, David	07 Safety Reporting
19091	91	1625579690475:-1982690650	1625579644481:1074217758	D5160C00019	695	646	CREATE	2021-07-06 15:54:50.578	70021 Vicente Baz, David	08 Centralized Testing
19094	91	1625579692117:1746078057	1625579691022:-1240552473	D5160C00019	698	696	CREATE	2021-07-06 15:54:52.214	08.01 Facility Documentation	08.01.04 Norm_nd Alert Values
19095	91	1625579692657:618825840	1625579690475:-1982690650	D5160C00019	699	695	CREATE	2021-07-06 15:54:52.746	08 Centralized Testing	08.02 Sample Documentation
19097	91	1625579694335:-813251019	1625579692657:618825840	D5160C00019	701	699	CREATE	2021-07-06 15:54:54.443	08.02 Sample Documentation	08.02.03 Samp_e Condition Log
19100	91	1625579696086:-1521331114	1625579695477:877579486	D5160C00019	704	703	CREATE	2021-07-06 15:54:56.187	70031 Trigo P_ez, Jose Manuel	02 Central Trial Documents
19104	91	1625579698378:314393180	1625579697824:-777171366	D5160C00019	708	707	CREATE	2021-07-06 15:54:58.495	02.04 General	02.04.01 Rele_-Contact Report
19107	91	1625579707219:1138505648	1625579700277:-511502632	D5160C00019	711	710	CREATE	2021-07-06 15:55:07.49	05 Site Management	05.01 Site Selection
19110	91	1625579709103:271921565	1625579707219:1138505648	D5160C00019	714	711	CREATE	2021-07-06 15:55:09.199	05.01 Site Selection	05.01.04 Pre _nitoring Report
19113	91	1625579711496:-897289816	1625579709688:1869604885	D5160C00019	717	715	CREATE	2021-07-06 15:55:11.585	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
19116	91	1625579713122:-1533721044	1625579709688:1869604885	D5160C00019	720	715	CREATE	2021-07-06 15:55:13.212	05.02 Site Se_p Documentation	05.02.06 Othe_ite Affiliation
19120	91	1625579715361:-1781052666	1625579709688:1869604885	D5160C00019	724	715	CREATE	2021-07-06 15:55:15.449	05.02 Site Se_p Documentation	05.02.12 Clin_Trial Agreement
19123	91	1625579717054:-1613837262	1625579709688:1869604885	D5160C00019	727	715	CREATE	2021-07-06 15:55:17.143	05.02 Site Se_p Documentation	05.02.18 Site Signature Sheet
19127	91	1625579719530:-1130932007	1625579717645:-1261532426	D5160C00019	731	728	CREATE	2021-07-06 15:55:19.63	05.03 Site Initiation	05.03.03 Site_umentation-Site
19130	91	1625579721874:1615088308	1625579720128:1320333607	D5160C00019	734	732	CREATE	2021-07-06 15:55:21.967	05.04 Site Management	05.04.03 Monitoring Visit Report
19133	91	1625579723663:-1893743575	1625579720128:1320333607	D5160C00019	737	732	CREATE	2021-07-06 15:55:23.783	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
19137	91	1625579726021:-1875037888	1625579700277:-511502632	D5160C00019	741	710	CREATE	2021-07-06 15:55:26.132	05 Site Management	05.05 General
19140	91	1625579727937:55424015	1625579726021:-1875037888	D5160C00019	744	741	CREATE	2021-07-06 15:55:28.067	05.05 General	05.05.02 Tracking Information
19143	91	1625579729679:1934018934	1625579729118:347810824	D5160C00019	747	746	CREATE	2021-07-06 15:55:29.795	06.01 IP Documentation	06.01.04 IP S_t Documentation
19146	91	1625579732052:-1950157212	1625579728545:-319953747	D5160C00019	750	745	CREATE	2021-07-06 15:55:32.171	06 IP and Trial Supplies	06.04 Storage
19149	91	1625579733919:-1744617071	1625579695477:877579486	D5160C00019	753	703	CREATE	2021-07-06 15:55:34.026	70031 Trigo P_ez, Jose Manuel	07 Safety Reporting
19152	91	1625579735750:-57440562	1625579695477:877579486	D5160C00019	756	703	CREATE	2021-07-06 15:55:35.854	70031 Trigo P_ez, Jose Manuel	08 Centralized Testing
19156	91	1625579743708:-1209709785	1625579741175:-622608715	D5160C00019	760	757	CREATE	2021-07-06 15:55:43.816	08.01 Facility Documentation	08.01.07 Head of Facility CV
19157	91	1625579744273:-94318544	1625579735750:-57440562	D5160C00019	761	756	CREATE	2021-07-06 15:55:44.366	08 Centralized Testing	08.02 Sample Documentation
19159	91	1625579745379:1073749585	1625579744273:-94318544	D5160C00019	763	761	CREATE	2021-07-06 15:55:45.57	08.02 Sample Documentation	08.02.03 Samp_e Condition Log
19163	91	1625579747993:349527162	1625579523523:1533419025	D5160C00019	767	546	CREATE	2021-07-06 15:55:48.106	SPAIN	70041 Insa Molla, Amelia
19166	91	1625579749715:-1257535149	1625579749143:1772446402	D5160C00019	770	769	CREATE	2021-07-06 15:55:49.823	05.01 Site Selection	05.01.02 Confidentiality Agreement
19169	91	1625579751504:1061756283	1625579750949:1857503083	D5160C00019	773	772	CREATE	2021-07-06 15:55:51.593	05.02 Site Se_p Documentation	05.02.04 PI C_ite Affiliation
19172	91	1625579753924:1201759040	1625579750949:1857503083	D5160C00019	776	772	CREATE	2021-07-06 15:55:54.027	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
19177	91	1625579761909:-1505009654	1625579761351:1551472561	D5160C00019	781	780	CREATE	2021-07-06 15:56:02.007	05.05 General	05.05.01 Rele_tions-Documents
19179	91	1625579763183:143957915	1625579762485:-251872034	D5160C00019	783	782	CREATE	2021-07-06 15:56:03.279	70051 Martin Jimenez, Miguel	02 Central Trial Documents
19183	91	1625579766277:-539004703	1625579765746:-741520870	D5160C00019	787	786	CREATE	2021-07-06 15:56:06.366	02.04 General	02.04.01 Rele_-Contact Report
19186	91	1625579768020:-587440625	1625579767360:-846636727	D5160C00019	790	789	CREATE	2021-07-06 15:56:08.168	04.03 Trial Status Reporting	04.03.03 IRB-_rm Notification
19190	91	1625579778905:-882713490	1625579777611:-978690974	D5160C00019	794	792	CREATE	2021-07-06 15:56:19.025	05.01 Site Selection	05.01.02 Confidentiality Agreement
19193	91	1625579787188:-1585215023	1625579768625:2013302924	D5160C00019	797	791	CREATE	2021-07-06 15:56:27.281	05 Site Management	05.02 Site Se_p Documentation
19196	91	1625579793138:1018569284	1625579787188:-1585215023	D5160C00019	800	797	CREATE	2021-07-06 15:56:33.572	05.02 Site Se_p Documentation	05.02.03 Prot_ Signature Page
19199	91	1625579795683:1798594230	1625579787188:-1585215023	D5160C00019	803	797	CREATE	2021-07-06 15:56:35.776	05.02 Site Se_p Documentation	05.02.07 Site Qualification
19203	91	1625579798453:-1314914884	1625579787188:-1585215023	D5160C00019	807	797	CREATE	2021-07-06 15:56:45.433	05.02 Site Se_p Documentation	05.02.17 IP S_e Documentation
19206	91	1625579807893:528414810	1625579806586:173239025	D5160C00019	810	809	CREATE	2021-07-06 15:56:47.997	05.03 Site Initiation	05.03.01 Tria_nitoring Report
19210	91	1625579810260:-1370028930	1625579809065:-57141973	D5160C00019	814	812	CREATE	2021-07-06 15:56:50.387	05.04 Site Management	05.04.03 Monitoring Visit Report
19213	91	1625579812014:393317642	1625579809065:-57141973	D5160C00019	817	812	CREATE	2021-07-06 15:56:52.114	05.04 Site Management	05.04.08 Fina_nitoring Report
19217	91	1625579828507:1461926849	1625579762485:-251872034	D5160C00019	821	782	CREATE	2021-07-06 15:57:08.626	70051 Martin Jimenez, Miguel	06 IP and Trial Supplies
19220	91	1625579830220:1143877891	1625579829088:-939111597	D5160C00019	824	822	CREATE	2021-07-06 15:57:10.324	06.01 IP Documentation	06.01.05 Acco_y Documentation
19221	91	1625579830789:1503850827	1625579829088:-939111597	D5160C00019	825	822	CREATE	2021-07-06 15:57:11.031	06.01 IP Documentation	06.01.11 Certificate of Destruction
19225	91	1625579833389:-558430271	1625579762485:-251872034	D5160C00019	829	782	CREATE	2021-07-06 15:57:13.508	70051 Martin Jimenez, Miguel	08 Centralized Testing
19228	91	1625579842123:-1302261516	1625579833977:-522373630	D5160C00019	832	830	CREATE	2021-07-06 15:57:22.239	08.01 Facility Documentation	08.01.04 Norm_nd Alert Values
19231	91	1625579843957:631606631	1625579843375:1391680139	D5160C00019	835	834	CREATE	2021-07-06 15:57:24.055	08.02 Sample Documentation	08.02.02 Shipment Records
19235	91	1625579855229:1121926209	1625579854583:-169047240	D5160C00019	839	838	CREATE	2021-07-06 15:57:35.332	02.02 Subject Documents	02.02.03 Info_ Form Templates
19238	91	1625579856987:1202124977	1625579844594:1910676987	D5160C00019	842	836	CREATE	2021-07-06 15:57:37.087	70061 Reguart Aransay, Noemi	05 Site Management
19241	91	1625579858804:-1563390809	1625579857530:-1094980586	D5160C00019	845	843	CREATE	2021-07-06 15:57:38.904	05.01 Site Selection	05.01.02 Confidentiality Agreement
19244	91	1625579861139:-365027121	1625579856987:1202124977	D5160C00019	848	842	CREATE	2021-07-06 15:57:41.243	05 Site Management	05.02 Site Se_p Documentation
19247	91	1625579862817:-1546478818	1625579861139:-365027121	D5160C00019	851	848	CREATE	2021-07-06 15:57:42.908	05.02 Site Se_p Documentation	05.02.03 Prot_ Signature Page
19250	91	1625579864564:1399814257	1625579861139:-365027121	D5160C00019	854	848	CREATE	2021-07-06 15:57:44.659	05.02 Site Se_p Documentation	05.02.07 Site Qualification
19254	91	1625579866917:1858645669	1625579861139:-365027121	D5160C00019	858	848	CREATE	2021-07-06 15:57:47.005	05.02 Site Se_p Documentation	05.02.13 Indemnity
19257	91	1625579868762:59113649	1625579856987:1202124977	D5160C00019	861	842	CREATE	2021-07-06 15:57:48.855	05 Site Management	05.03 Site Initiation
19260	91	1625579871079:-1785308114	1625579868762:59113649	D5160C00019	864	861	CREATE	2021-07-06 15:57:51.176	05.03 Site Initiation	05.03.03 Site_umentation-Site
19264	91	1625579873420:300930321	1625579871637:1992815326	D5160C00019	868	865	CREATE	2021-07-06 15:57:53.526	05.04 Site Management	05.04.03 Monitoring Visit Report
19267	91	1625579875738:-62300474	1625579871637:1992815326	D5160C00019	871	865	CREATE	2021-07-06 15:57:55.836	05.04 Site Management	05.04.08 Fina_nitoring Report
19271	91	1625579878090:652891920	1625579844594:1910676987	D5160C00019	875	836	CREATE	2021-07-06 15:58:03.351	70061 Reguart Aransay, Noemi	06 IP and Trial Supplies
19274	91	1625579885131:-589315741	1625579883917:-2144802171	D5160C00019	878	876	CREATE	2021-07-06 15:58:05.225	06.01 IP Documentation	06.01.05 Acco_y Documentation
19277	91	1625579886814:1967025507	1625579878090:652891920	D5160C00019	881	875	CREATE	2021-07-06 15:58:06.951	06 IP and Trial Supplies	06.04 Storage
19280	91	1625579895869:-1848763012	1625579886814:1967025507	D5160C00019	884	881	CREATE	2021-07-06 15:58:15.961	06.04 Storage	06.04.03 Maintenance Logs
19283	91	1625579897594:-743124922	1625579897034:-2071372747	D5160C00019	887	886	CREATE	2021-07-06 15:58:17.688	07.03 General	07.03.01 Rele_ns-Safety-Email
19284	91	1625579898200:-1252995433	1625579844594:1910676987	D5160C00019	888	836	CREATE	2021-07-06 15:58:18.294	70061 Reguart Aransay, Noemi	08 Centralized Testing
19286	91	1625579899282:1660151509	1625579898740:1621347756	D5160C00019	890	889	CREATE	2021-07-06 15:58:19.372	08.01 Facility Documentation	08.01.01 Cert_r Accreditation
19289	91	1625579900979:1457887453	1625579898200:-1252995433	D5160C00019	893	888	CREATE	2021-07-06 15:58:21.081	08 Centralized Testing	08.02 Sample Documentation
19293	91	1625579903870:105005578	1625579903316:-1418165972	D5160C00019	897	896	CREATE	2021-07-06 15:58:23.98	70071 Muñoz Q_a, Miguel Angel	04 IRB-IEC an_other Approvals
19296	91	1625579905612:277351235	1625579903316:-1418165972	D5160C00019	900	896	CREATE	2021-07-06 15:58:25.708	70071 Muñoz Q_a, Miguel Angel	05 Site Management
19299	91	1625579920361:-35146667	1625579906614:2089635832	D5160C00019	903	901	CREATE	2021-07-06 15:58:40.517	05.01 Site Selection	05.01.04 Pre _nitoring Report
19302	91	1625579922369:1211953067	1625579921028:6376847	D5160C00019	906	904	CREATE	2021-07-06 15:58:42.491	05.02 Site Se_p Documentation	05.02.02 Protocol Signature Page
19306	91	1625579931324:-26285870	1625579921028:6376847	D5160C00019	910	904	CREATE	2021-07-06 15:58:51.446	05.02 Site Se_p Documentation	05.02.17 IP S_e Documentation
19310	91	1625579933801:267691088	1625579933249:-550208776	D5160C00019	914	913	CREATE	2021-07-06 15:58:53.893	05.01 Site Selection	05.01.02 Confidentiality Agreement
19313	91	1625579936235:1330568430	1625579935640:792720258	D5160C00019	917	916	CREATE	2021-07-06 15:58:56.326	05 Site Management	05.01 Site Selection
19316	91	1625579937899:16576795	1625579937316:690727696	D5160C00019	920	919	CREATE	2021-07-06 15:58:57.991	UNITED STATES	02 Central Trial Documents
19319	91	1625579939551:-11658380	1625579938422:-1463876480	D5160C00019	923	921	CREATE	2021-07-06 15:58:59.646	02.01 Trial Documents	02.01.02 Protocol
19322	91	1625579941464:1386928549	1625579937899:16576795	D5160C00019	926	920	CREATE	2021-07-06 15:59:01.572	02 Central Trial Documents	02.02 Subject Documents
19325	91	1625579943299:-799143326	1625579941464:1386928549	D5160C00019	929	926	CREATE	2021-07-06 15:59:03.395	02.02 Subject Documents	02.02.03 Informed Consent Form Templates
19328	91	1625579944917:382847277	1625579941464:1386928549	D5160C00019	932	926	CREATE	2021-07-06 15:59:05.011	02.02 Subject Documents	02.02.07 Other Written Information Given to Subjects
19333	91	1625579955353:1009728932	1625579954823:-919228590	D5160C00019	937	936	CREATE	2021-07-06 15:59:15.449	03.01 Trial Approval	03.01.01 Submission
19336	91	1625579957762:-1458823435	1625579957205:742457744	D5160C00019	940	939	CREATE	2021-07-06 15:59:17.855	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
19339	91	1625579959386:1405669755	1625579957762:-1458823435	D5160C00019	943	940	CREATE	2021-07-06 15:59:19.479	04.01 IRB-IEC Trial Approval	04.01.05 IRB-IEC GCP Compliance Statement
19343	91	1625579961701:363020584	1625579961060:-1647546532	D5160C00019	947	946	CREATE	2021-07-06 15:59:21.794	05 Site Management	05.02 Site Set-up Documentation
19347	91	1625579963840:2038677053	1625579937316:690727696	D5160C00019	951	919	CREATE	2021-07-06 15:59:23.93	UNITED STATES	07 Safety Reporting
19348	91	1625579964382:-1682329672	1625579963840:2038677053	D5160C00019	952	951	CREATE	2021-07-06 15:59:24.476	07 Safety Reporting	07.03 General
19351	91	1625579966077:-1233360743	1625579964382:-1682329672	D5160C00019	955	952	CREATE	2021-07-06 15:59:26.174	07.03 General	07.03.01 Relevant Communications-Safety-Documents
19354	91	1625579976257:563376898	1625579967866:703291178	D5160C00019	958	957	CREATE	2021-07-06 15:59:36.361	08.01 Facility Documentation	08.01.05 Manual
19357	91	1625579978424:873834880	1625579977471:-1664699373	D5160C00019	961	960	CREATE	2021-07-06 15:59:38.537	02 Central Trial Documents	02.02 Subject Documents
19360	91	1625579980260:-862604960	1625579977471:-1664699373	D5160C00019	964	960	CREATE	2021-07-06 15:59:40.542	02 Central Trial Documents	02.04 General
19364	91	1625579982760:-734858594	1625579982220:-771090342	D5160C00019	968	967	CREATE	2021-07-06 15:59:42.85	03.04 General	03.04.01 Rele_-Start-Up-Email
19366	91	1625579983819:-2009173875	1625579983292:1590147493	D5160C00019	970	969	CREATE	2021-07-06 15:59:43.91	04 IRB-IEC an_other Approvals	04.01 IRB-IEC Trial Approval
19369	91	1625579992277:-348976738	1625579983819:-2009173875	D5160C00019	973	970	CREATE	2021-07-06 15:59:52.374	04.01 IRB-IEC Trial Approval	04.01.05 IRB-_iance Statement
19373	91	1625579994537:1025714249	1625579993932:-1871565344	D5160C00019	977	976	CREATE	2021-07-06 15:59:54.634	04.04 General	04.04.01 Rele_s-IRB-IEC-Email
19376	91	1625579996166:1320754749	1625579995601:-2535266	D5160C00019	980	979	CREATE	2021-07-06 15:59:56.262	05.01 Site Selection	05.01.02 Confidentiality Agreement
19380	91	1625579998494:1332362973	1625579997887:-1438849930	D5160C00019	984	983	CREATE	2021-07-06 15:59:58.587	05.02 Site Se_p Documentation	05.02.01 Acce_igator Brochure
19383	91	1625580000912:2118893504	1625579997887:-1438849930	D5160C00019	987	983	CREATE	2021-07-06 16:00:01.013	05.02 Site Se_p Documentation	05.02.05 Sub-_ite Affiliation
19386	91	1625580002549:21161054	1625579997887:-1438849930	D5160C00019	990	983	CREATE	2021-07-06 16:00:02.642	05.02 Site Se_p Documentation	05.02.10 Fina_tigator Consent
19389	91	1625580004343:1117761288	1625579997887:-1438849930	D5160C00019	993	983	CREATE	2021-07-06 16:00:04.451	05.02 Site Se_p Documentation	05.02.18 Site Signature Sheet
19393	91	1625580013478:-1873100924	1625580004917:1892383347	D5160C00019	997	994	CREATE	2021-07-06 16:00:13.588	05.03 Site Initiation	05.03.03 Site_umentation-Site
19397	91	1625580025107:-887305372	1625579995071:-366237844	D5160C00019	1001	978	CREATE	2021-07-06 16:00:25.271	05 Site Management	05.05 General
19400	91	1625580027065:1898666385	1625579976867:-1657722098	D5160C00019	1004	959	CREATE	2021-07-06 16:00:27.171	78011 Shehadeh, Nasfat	06 IP and Trial Supplies
19403	91	1625580029347:1910875252	1625580027625:-494811565	D5160C00019	1007	1005	CREATE	2021-07-06 16:00:29.652	06.01 IP Documentation	06.01.05 Acco_y Documentation
19406	91	1625580032136:-391836485	1625580031472:1450779811	D5160C00019	1010	1009	CREATE	2021-07-06 16:00:32.248	06.04 Storage	06.04.01 Storage Condition Documentation
19409	91	1625580034012:729802302	1625580033438:-1580028882	D5160C00019	1013	1012	CREATE	2021-07-06 16:00:34.107	08.01 Facility Documentation	08.01.01 Cert_r Accreditation
19411	91	1625580035097:1773753232	1625580033438:-1580028882	D5160C00019	1015	1012	CREATE	2021-07-06 16:00:35.53	08.01 Facility Documentation	08.01.07 Head of Facility CV
19413	91	1625580045292:172697607	1625580036241:1596494027	D5160C00019	1017	1016	CREATE	2021-07-06 16:00:45.419	08.03 General	08.03.01 Rele_Local Lab-Email
19417	91	1625580047736:2079732342	1625580047124:598163529	D5160C00019	1021	1020	CREATE	2021-07-06 16:00:47.87	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
19420	91	1625580049572:-1639494596	1625580048994:1767892404	D5160C00019	1024	1023	CREATE	2021-07-06 16:00:49.685	05 Site Management	05.01 Site Selection
19423	91	1625580051393:-566092581	1625580050810:-1362614089	D5160C00019	1027	1026	CREATE	2021-07-06 16:00:51.496	78041 Spira, Alexander	02 Central Trial Documents
19426	91	1625580053974:-524162121	1625580052022:1190720311	D5160C00019	1030	1028	CREATE	2021-07-06 16:00:54.091	02.02 Subject Documents	02.02.03 Info_Form Checklists
19430	91	1625580056385:-1189604315	1625580050810:-1362614089	D5160C00019	1034	1026	CREATE	2021-07-06 16:00:56.497	78041 Spira, Alexander	03 Regulatory
19432	91	1625580057573:1170132735	1625580056968:163947651	D5160C00019	1036	1035	CREATE	2021-07-06 16:00:57.685	03.04 General	03.04.01 Rele_-Start-Up-Email
19435	91	1625580059378:-1854765486	1625580058784:-1144296019	D5160C00019	1039	1038	CREATE	2021-07-06 16:00:59.49	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
19438	91	1625580082290:-698995000	1625580081057:274834621	D5160C00019	1042	1040	CREATE	2021-07-06 16:01:22.401	04.03 Trial Status Reporting	04.03.02 IRB-_Progress Report
19442	91	1625580084594:732358339	1625580050810:-1362614089	D5160C00019	1046	1026	CREATE	2021-07-06 16:01:24.695	78041 Spira, Alexander	05 Site Management
19445	91	1625580087188:-589135790	1625580086005:-676775514	D5160C00019	1049	1047	CREATE	2021-07-06 16:01:27.3	05.01 Site Selection	05.01.03 Feasibility Documentation
19448	91	1625580089139:-1563954864	1625580088433:738531198	D5160C00019	1052	1051	CREATE	2021-07-06 16:01:29.294	05.02 Site Se_p Documentation	05.02.01 Acce_igator Brochure
19452	91	1625580091661:-568121552	1625580088433:738531198	D5160C00019	1056	1051	CREATE	2021-07-06 16:01:31.765	05.02 Site Se_p Documentation	05.02.05 Sub-_ite Affiliation
19455	91	1625580093395:-1323473596	1625580088433:738531198	D5160C00019	1059	1051	CREATE	2021-07-06 16:01:33.51	05.02 Site Se_p Documentation	05.02.08 Form FDA1572
19458	91	1625580095163:-1539854036	1625580088433:738531198	D5160C00019	1062	1051	CREATE	2021-07-06 16:01:35.274	05.02 Site Se_p Documentation	05.02.17 IP S_e Documentation
19462	91	1625580098309:-1500888164	1625580097215:1218111272	D5160C00019	1066	1064	CREATE	2021-07-06 16:01:38.403	05.03 Site Initiation	05.03.03 Site Training-Staff
19465	91	1625580100165:808897049	1625580098900:244762878	D5160C00019	1069	1067	CREATE	2021-07-06 16:01:40.271	05.04 Site Management	05.04.03 Monitoring Visit Report
19469	91	1625580109494:604573983	1625580084594:732358339	D5160C00019	1073	1046	CREATE	2021-07-06 16:01:49.59	05 Site Management	05.05 General
19472	91	1625580111398:602416523	1625580109494:604573983	D5160C00019	1076	1073	CREATE	2021-07-06 16:01:51.754	05.05 General	05.05.02 Tracking Information
19503	91	1625580132378:480509004	1625580131827:1946324073	D5160C00019	1107	1106	CREATE	2021-07-06 16:02:12.471	78081 Acle, Eduardo	05 Site Management
19505	91	1625580133463:-170746386	1625580132925:596416379	D5160C00019	1109	1108	CREATE	2021-07-06 16:02:13.567	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
19509	91	1625580142777:-1151687511	1625580135144:-577459771	D5160C00019	1113	1112	CREATE	2021-07-06 16:02:22.883	78091 Call, Justin	02 Central Trial Documents
19512	91	1625580144606:-141869638	1625580135144:-577459771	D5160C00019	1116	1112	CREATE	2021-07-06 16:02:24.719	78091 Call, Justin	05 Site Management
19516	91	1625580146868:2034593237	1625580146331:617140338	D5160C00019	1120	1119	CREATE	2021-07-06 16:02:26.96	78101 Cho, Daniel	05 Site Management
19518	91	1625580147989:-989633548	1625580147424:772093940	D5160C00019	1122	1121	CREATE	2021-07-06 16:02:28.078	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
19522	91	1625580150356:-923291632	1625580149748:1542716225	D5160C00019	1126	1125	CREATE	2021-07-06 16:02:30.463	05.01 Site Selection	05.01.04 Pre _nitoring Report
7244	84	\N	\N	D5170C00002	1029	1028	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
7550	84	\N	\N	D5170C00002	1335	1334	NEW	\N	GERMANY	Site
7690	84	\N	\N	D5170C00002	1475	1470	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
7967	84	\N	\N	D5170C00002	1752	1718	NEW	\N	05 Site Management	05.05 General
8127	84	\N	\N	D5170C00002	1912	1910	NEW	\N	05.04 Site Management	05.04.04 Visit Log
8606	84	\N	\N	D5170C00002	2391	2390	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
14331	88	1617049794992:-1581935803	1617049781649:846308156	D5170C00001	21	2	ALREADY AVAILABLE	2021-03-30 07:19:37.237	Acquisition Assessments	8. Remediation Tracker
14335	88	1617049797574:1150734763	1617049796982:-2116394566	D5170C00001	25	24	ALREADY AVAILABLE	2021-03-30 07:19:37.237	AstraZeneca	ANGEL System CSR Transfer
14337	88	1617049800076:760783756	1617049796982:-2116394566	D5170C00001	27	24	ALREADY AVAILABLE	2021-03-30 07:19:37.237	AstraZeneca	Delta Transfer x2 (06 Oct 2017)
14339	88	1617049801368:-1129006037	1617049796982:-2116394566	D5170C00001	29	24	ALREADY AVAILABLE	2021-03-30 07:19:37.237	AstraZeneca	eTMF
14315	88	1617049783428:-1367925901	1617049782868:655599704	D5170C00001	5	4	ALREADY AVAILABLE	2021-03-30 07:19:37.237	6. Assessment Team Documentation	Brazikumab - MedImmune
14332	88	1617049795702:1517803028	1617049794992:-1581935803	D5170C00001	22	21	ALREADY AVAILABLE	2021-03-30 07:19:37.237	8. Remediation Tracker	Brazikumab
14336	88	1617049798173:-1840562327	1617049797574:1150734763	D5170C00001	26	25	ALREADY AVAILABLE	2021-03-30 07:19:37.237	ANGEL System CSR Transfer	0903882083145bf4
14338	88	1617049800748:-1267559343	1617049800076:760783756	D5170C00001	28	27	ALREADY AVAILABLE	2021-03-30 07:19:37.237	Delta Transfer x2 (06 Oct 2017)	Documents
14340	88	1617049801974:-542363185	1617049801368:-1129006037	D5170C00001	30	29	ALREADY AVAILABLE	2021-03-30 07:19:37.237	eTMF	Delivery
14316	88	1617049784091:-1315261634	1617049783428:-1367925901	D5170C00001	6	5	ALREADY AVAILABLE	2021-03-30 07:19:37.237	Brazikumab - MedImmune	D5170C00001
14333	88	1617049796323:-1028941208	1617049795702:1517803028	D5170C00001	23	22	ALREADY AVAILABLE	2021-03-30 07:19:37.237	Brazikumab	D5170C00001
14341	88	1617049802668:1612179485	1617049801974:-542363185	D5170C00001	31	30	ALREADY AVAILABLE	2021-03-30 07:19:37.237	Delivery	Country
14457	88	1617049913203:1419096663	1617049802668:1612179485	D5170C00001	147	31	ALREADY AVAILABLE	2021-03-30 07:19:37.312	Country	France
14502	88	1617049947855:2112136971	1617049802668:1612179485	D5170C00001	192	31	ALREADY AVAILABLE	2021-03-30 07:19:37.312	Country	Germany
14547	88	1617049984850:1605378607	1617049802668:1612179485	D5170C00001	237	31	ALREADY AVAILABLE	2021-03-30 07:19:37.312	Country	Hungary
14590	88	1617050019241:-1950023577	1617049802668:1612179485	D5170C00001	280	31	ALREADY AVAILABLE	2021-03-30 07:19:37.312	Country	Italy
14630	88	1617050058407:1840928122	1617049802668:1612179485	D5170C00001	320	31	ALREADY AVAILABLE	2021-03-30 07:19:37.312	Country	Poland
14678	88	1617050098551:-1298331324	1617049802668:1612179485	D5170C00001	368	31	ALREADY AVAILABLE	2021-03-30 07:19:37.312	Country	Spain
14736	88	1617050144863:-122430637	1617049802668:1612179485	D5170C00001	426	31	ALREADY AVAILABLE	2021-03-30 07:19:37.313	Country	United States of America
15233	88	1617050627586:-1316449834	1617050181568:-159398468	D5170C00001	923	470	ALREADY AVAILABLE	2021-03-30 07:19:37.313	Site	Czech Republic
15415	88	1617050813308:-388381196	1617050181568:-159398468	D5170C00001	1105	470	ALREADY AVAILABLE	2021-03-30 07:19:37.313	Site	France
15574	88	1617050947418:307056746	1617050181568:-159398468	D5170C00001	1264	470	ALREADY AVAILABLE	2021-03-30 07:19:37.313	Site	Germany
15661	88	1617051021606:95161147	1617050181568:-159398468	D5170C00001	1351	470	ALREADY AVAILABLE	2021-03-30 07:19:37.313	Site	Hungary
15831	88	1617051196990:749950322	1617050181568:-159398468	D5170C00001	1521	470	ALREADY AVAILABLE	2021-03-30 07:19:37.313	Site	Italy
16148	88	1617051459985:-355373043	1617050181568:-159398468	D5170C00001	1838	470	ALREADY AVAILABLE	2021-03-30 07:19:37.313	Site	Poland
16347	88	1617051622299:1003976290	1617050181568:-159398468	D5170C00001	2037	470	ALREADY AVAILABLE	2021-03-30 07:19:37.313	Site	Spain
16772	88	1617051980305:1976405238	1617050181568:-159398468	D5170C00001	2462	470	ALREADY AVAILABLE	2021-03-30 07:19:37.313	Site	United States of America
14324	88	1617049790524:-1430369879	1617049789824:-639278170	D5170C00001	14	13	ALREADY AVAILABLE	2021-03-30 07:19:37.313	Site Level	D5170C00001-Site 1002
14343	88	1617049803910:1860048973	1617049803271:1189358325	D5170C00001	33	32	ALREADY AVAILABLE	2021-03-30 07:19:37.314	Canada	Central Trial Documents
14352	88	1617049809621:1949893672	1617049803271:1189358325	D5170C00001	42	32	ALREADY AVAILABLE	2021-03-30 07:19:37.314	Canada	IP and Trial Supplies
14355	88	1617049812776:504308022	1617049803271:1189358325	D5170C00001	45	32	ALREADY AVAILABLE	2021-03-30 07:19:37.314	Canada	IRB or IEC and other Approvals
14364	88	1617049818425:-1215525259	1617049803271:1189358325	D5170C00001	54	32	ALREADY AVAILABLE	2021-03-30 07:19:37.314	Canada	Regulatory
14367	88	1617049820221:-1421706041	1617049803271:1189358325	D5170C00001	57	32	ALREADY AVAILABLE	2021-03-30 07:19:37.314	Canada	Site Management
14380	88	1617049843874:1787270063	1617049803271:1189358325	D5170C00001	70	32	ALREADY AVAILABLE	2021-03-30 07:19:37.314	Canada	Trial Management
14396	88	1617049864704:-1654436179	1617049864147:396645261	D5170C00001	86	85	ALREADY AVAILABLE	2021-03-30 07:19:37.314	Czech Republic	Central Trial Documents
14409	88	1617049873884:1745461580	1617049864147:396645261	D5170C00001	99	85	ALREADY AVAILABLE	2021-03-30 07:19:37.314	Czech Republic	IP and Trial Supplies
14415	88	1617049878901:1691951506	1617049864147:396645261	D5170C00001	105	85	ALREADY AVAILABLE	2021-03-30 07:19:37.314	Czech Republic	IRB or IEC and other Approvals
14433	88	1617049891080:1261850085	1617049864147:396645261	D5170C00001	123	85	ALREADY AVAILABLE	2021-03-30 07:19:37.314	Czech Republic	Safety Reporting
14436	88	1617049892866:-1621887577	1617049864147:396645261	D5170C00001	126	85	ALREADY AVAILABLE	2021-03-30 07:19:37.314	Czech Republic	Site Management
14445	88	1617049904841:1897140590	1617049864147:396645261	D5170C00001	135	85	ALREADY AVAILABLE	2021-03-30 07:19:37.315	Czech Republic	Trial Management
14458	88	1617049913771:-1842981418	1617049913203:1419096663	D5170C00001	148	147	ALREADY AVAILABLE	2021-03-30 07:19:37.315	France	Central Trial Documents
14468	88	1617049920071:1274410035	1617049913203:1419096663	D5170C00001	158	147	ALREADY AVAILABLE	2021-03-30 07:19:37.315	France	IRB or IEC and other Approvals
14477	88	1617049926694:-247839502	1617049913203:1419096663	D5170C00001	167	147	ALREADY AVAILABLE	2021-03-30 07:19:37.315	France	Regulatory
14482	88	1617049929835:-1845968552	1617049913203:1419096663	D5170C00001	172	147	ALREADY AVAILABLE	2021-03-30 07:19:37.315	France	Site Management
14490	88	1617049939516:-1834757542	1617049913203:1419096663	D5170C00001	180	147	ALREADY AVAILABLE	2021-03-30 07:19:37.315	France	Trial Management
14503	88	1617049948426:-1605761680	1617049947855:2112136971	D5170C00001	193	192	ALREADY AVAILABLE	2021-03-30 07:19:37.315	Germany	Central Trial Documents
14515	88	1617049958230:2116406684	1617049947855:2112136971	D5170C00001	205	192	ALREADY AVAILABLE	2021-03-30 07:19:37.315	Germany	IRB or IEC and other Approvals
14521	88	1617049962100:396573403	1617049947855:2112136971	D5170C00001	211	192	ALREADY AVAILABLE	2021-03-30 07:19:37.315	Germany	Regulatory
14529	88	1617049968468:-709172792	1617049947855:2112136971	D5170C00001	219	192	ALREADY AVAILABLE	2021-03-30 07:19:37.315	Germany	Site Management
14535	88	1617049972272:-2089920659	1617049947855:2112136971	D5170C00001	225	192	ALREADY AVAILABLE	2021-03-30 07:19:37.315	Germany	Trial Management
14548	88	1617049985434:-626374300	1617049984850:1605378607	D5170C00001	238	237	ALREADY AVAILABLE	2021-03-30 07:19:37.315	Hungary	Central Trial Documents
14559	88	1617049993597:-2098685600	1617049984850:1605378607	D5170C00001	249	237	ALREADY AVAILABLE	2021-03-30 07:19:37.315	Hungary	IRB or IEC and other Approvals
14571	88	1617050006076:1963700365	1617049984850:1605378607	D5170C00001	261	237	ALREADY AVAILABLE	2021-03-30 07:19:37.317	Hungary	Safety Reporting
14575	88	1617050008582:-1117695304	1617049984850:1605378607	D5170C00001	265	237	ALREADY AVAILABLE	2021-03-30 07:19:37.317	Hungary	Site Management
14580	88	1617050012922:-1893538952	1617049984850:1605378607	D5170C00001	270	237	ALREADY AVAILABLE	2021-03-30 07:19:37.317	Hungary	Trial Management
14591	88	1617050019842:696592341	1617050019241:-1950023577	D5170C00001	281	280	ALREADY AVAILABLE	2021-03-30 07:19:37.317	Italy	Central Trial Documents
14605	88	1617050036640:-283389149	1617050019241:-1950023577	D5170C00001	295	280	ALREADY AVAILABLE	2021-03-30 07:19:37.317	Italy	IRB or IEC and other Approvals
14608	88	1617050038332:-1595997436	1617050019241:-1950023577	D5170C00001	298	280	ALREADY AVAILABLE	2021-03-30 07:19:37.317	Italy	Regulatory
14614	88	1617050043494:693562771	1617050019241:-1950023577	D5170C00001	304	280	ALREADY AVAILABLE	2021-03-30 07:19:37.317	Italy	Site Management
14622	88	1617050048274:704794999	1617050019241:-1950023577	D5170C00001	312	280	ALREADY AVAILABLE	2021-03-30 07:19:37.317	Italy	Trial Management
14631	88	1617050058982:436847938	1617050058407:1840928122	D5170C00001	321	320	ALREADY AVAILABLE	2021-03-30 07:19:37.317	Poland	Central Trial Documents
14643	88	1617050067736:933811541	1617050058407:1840928122	D5170C00001	333	320	ALREADY AVAILABLE	2021-03-30 07:19:37.317	Poland	IP and Trial Supplies
14646	88	1617050069542:-426520767	1617050058407:1840928122	D5170C00001	336	320	ALREADY AVAILABLE	2021-03-30 07:19:37.317	Poland	IRB or IEC and other Approvals
14652	88	1617050074483:1656198566	1617050058407:1840928122	D5170C00001	342	320	ALREADY AVAILABLE	2021-03-30 07:19:37.317	Poland	Regulatory
9036	85	1616042835603:107281433	1616042830147:-1028747214	D5170C00002	52	44	CREATE	2021-03-18 05:47:15.709	2002049 Danese, Silvio	04 IRB-IEC and other Approvals
9037	85	1616042836549:-726187771	1616042835603:107281433	D5170C00002	53	52	CREATE	2021-03-18 05:47:16.647	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
9039	85	1616042837799:1820532493	1616042836549:-726187771	D5170C00002	55	53	CREATE	2021-03-18 05:47:17.888	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
9040	85	1616042838443:-559920065	1616042835603:107281433	D5170C00002	56	52	CREATE	2021-03-18 05:47:18.531	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
9042	85	1616042839842:-462799596	1616042830147:-1028747214	D5170C00002	58	44	CREATE	2021-03-18 05:47:19.933	2002049 Danese, Silvio	05 Site Management
9043	85	1616042840447:-1408974558	1616042839842:-462799596	D5170C00002	59	58	CREATE	2021-03-18 05:47:20.544	05 Site Management	05.01 Site Selection
9045	85	1616042841655:1797218173	1616042840447:-1408974558	D5170C00002	61	59	CREATE	2021-03-18 05:47:21.77	05.01 Site Selection	05.01.02 Confidentiality Agreement
9046	85	1616042843131:-908381890	1616042840447:-1408974558	D5170C00002	62	59	CREATE	2021-03-18 05:47:23.223	05.01 Site Selection	05.01.03 Feasibility Documentation
9048	85	1616042844320:831226125	1616042839842:-462799596	D5170C00002	64	58	CREATE	2021-03-18 05:47:24.436	05 Site Management	05.02 Site Set-up Documentation
9049	85	1616042844913:-1142338510	1616042844320:831226125	D5170C00002	65	64	CREATE	2021-03-18 05:47:25.001	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
9051	85	1616042846368:-1692440584	1616042844320:831226125	D5170C00002	67	64	CREATE	2021-03-18 05:47:26.461	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
9052	85	1616042846946:399834315	1616042844320:831226125	D5170C00002	68	64	CREATE	2021-03-18 05:47:27.039	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
9053	85	1616042847564:1887576697	1616042844320:831226125	D5170C00002	69	64	CREATE	2021-03-18 05:47:27.656	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
9055	85	1616042848666:-1620921709	1616042844320:831226125	D5170C00002	71	64	CREATE	2021-03-18 05:47:28.752	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
9056	85	1616042849291:-1884884792	1616042844320:831226125	D5170C00002	72	64	CREATE	2021-03-18 05:47:29.382	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
9058	85	1616042850470:-1480389426	1616042844320:831226125	D5170C00002	74	64	CREATE	2021-03-18 05:47:30.561	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
9059	85	1616042851029:485954664	1616042839842:-462799596	D5170C00002	75	58	CREATE	2021-03-18 05:47:31.121	05 Site Management	05.03 Site Initiation
9061	85	1616042852222:-957546644	1616042851029:485954664	D5170C00002	77	75	CREATE	2021-03-18 05:47:32.309	05.03 Site Initiation	05.03.03 Site Training-Staff
9062	85	1616042852756:2031984681	1616042851029:485954664	D5170C00002	78	75	CREATE	2021-03-18 05:47:33.481	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
9063	85	1616042854311:-633244236	1616042839842:-462799596	D5170C00002	79	58	CREATE	2021-03-18 05:47:34.408	05 Site Management	05.04 Site Management
9065	85	1616042855524:1586794255	1616042854311:-633244236	D5170C00002	81	79	CREATE	2021-03-18 05:47:35.631	05.04 Site Management	05.04.03 Monitoring Visit Report
9067	85	1616042856835:-92104091	1616042854311:-633244236	D5170C00002	83	79	CREATE	2021-03-18 05:47:36.934	05.04 Site Management	05.04.04 UNBLINDED Visit Log
9068	85	1616042857448:1603971206	1616042854311:-633244236	D5170C00002	84	79	CREATE	2021-03-18 05:47:37.541	05.04 Site Management	05.04.04 Visit Log
9069	85	1616042858062:-1489999367	1616042854311:-633244236	D5170C00002	85	79	CREATE	2021-03-18 05:47:38.158	05.04 Site Management	05.04.05 UNBLI_itoring Activity
9071	85	1616042859421:-1342919425	1616042854311:-633244236	D5170C00002	87	79	CREATE	2021-03-18 05:47:39.518	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
9072	85	1616042860106:1427962790	1616042854311:-633244236	D5170C00002	88	79	CREATE	2021-03-18 05:47:40.21	05.04 Site Management	05.04.08 UNBLI_onitoring Report
9074	85	1616042861309:144055242	1616042860709:-1495593028	D5170C00002	90	89	CREATE	2021-03-18 05:47:41.401	05.05 General	05.05.02 Tracking Information
9075	85	1616042861904:-271261320	1616042830147:-1028747214	D5170C00002	91	44	CREATE	2021-03-18 05:47:41.989	2002049 Danese, Silvio	06 IP and Trial Supplies
9077	85	1616042863020:764697566	1616042862458:863372248	D5170C00002	93	92	CREATE	2021-03-18 05:47:43.107	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
9078	85	1616042864528:-1759853332	1616042862458:863372248	D5170C00002	94	92	CREATE	2021-03-18 05:47:44.618	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
9080	85	1616042865768:1293467976	1616042862458:863372248	D5170C00002	96	92	CREATE	2021-03-18 05:47:45.873	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
9081	85	1616042866343:-916614050	1616042862458:863372248	D5170C00002	97	92	CREATE	2021-03-18 05:47:46.43	06.01 IP Documentation	06.01.10 UNBLI_mentation Return
9083	85	1616042867489:1524547460	1616042866903:333877139	D5170C00002	99	98	CREATE	2021-03-18 05:47:50.665	06.04 Storage	06.04.01 UNBLI_on Documentation
9084	85	1616042871311:-96069467	1616042866903:333877139	D5170C00002	100	98	CREATE	2021-03-18 05:47:51.402	06.04 Storage	06.04.02 UNBLI_on Documentation
9086	85	1616042872495:383084682	1615840756146:-740604444	D5170C00002	102	6	CREATE	2021-03-18 05:47:52.588	Site	2002050 Dinelli, Marco
9087	85	1616042873077:-1201337596	1616042872495:383084682	D5170C00002	103	102	CREATE	2021-03-18 05:47:53.167	2002050 Dinelli, Marco	04 IRB-IEC and other Approvals
9089	85	1616042874406:-1839756739	1616042873807:-1623057563	D5170C00002	105	104	CREATE	2021-03-18 05:47:54.496	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
9090	85	1616042875570:-157465741	1616042873807:-1623057563	D5170C00002	106	104	CREATE	2021-03-18 05:47:55.663	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
9092	85	1616042877046:-1696790869	1616042876162:2071593391	D5170C00002	108	107	CREATE	2021-03-18 05:47:57.141	05 Site Management	05.01 Site Selection
9093	85	1616042877753:1330088868	1616042877046:-1696790869	D5170C00002	109	108	CREATE	2021-03-18 05:47:57.841	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
9095	85	1616042879512:2096448935	1616042878842:1375590686	D5170C00002	111	110	CREATE	2021-03-18 05:47:59.603	2002051 Cosintino, Rocco	02 Central Trial Documents
9096	85	1616042880147:621463369	1616042879512:2096448935	D5170C00002	112	111	CREATE	2021-03-18 05:48:00.237	02 Central Trial Documents	02.02 Subject Documents
9098	85	1616042881405:-1194485368	1616042879512:2096448935	D5170C00002	114	111	CREATE	2021-03-18 05:48:01.499	02 Central Trial Documents	02.04 General
9099	85	1616042882012:1522523635	1616042881405:-1194485368	D5170C00002	115	114	CREATE	2021-03-18 05:48:02.112	02.04 General	02.04.01 UNBLI_s-Contact Report
14655	88	1617050076340:845134783	1617050058407:1840928122	D5170C00001	345	320	ALREADY AVAILABLE	2021-03-30 07:19:37.317	Poland	Site Management
9102	85	1616042883796:1032491711	1616042883163:-786565090	D5170C00002	118	117	CREATE	2021-03-18 05:48:03.892	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
9103	85	1616042884561:-1465111381	1616042883163:-786565090	D5170C00002	119	117	CREATE	2021-03-18 05:48:04.652	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
9105	85	1616042886442:918851384	1616042885128:-589604956	D5170C00002	121	120	CREATE	2021-03-18 05:48:06.532	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
9106	85	1616042887016:-1072098312	1616042878842:1375590686	D5170C00002	122	110	CREATE	2021-03-18 05:48:07.106	2002051 Cosintino, Rocco	05 Site Management
9107	85	1616042887640:-1940424832	1616042887016:-1072098312	D5170C00002	123	122	CREATE	2021-03-18 05:48:07.728	05 Site Management	05.01 Site Selection
9109	85	1616042888800:319352618	1616042887640:-1940424832	D5170C00002	125	123	CREATE	2021-03-18 05:48:08.89	05.01 Site Selection	05.01.02 Confidentiality Agreement
9111	85	1616042889943:1081856183	1616042887640:-1940424832	D5170C00002	127	123	CREATE	2021-03-18 05:48:10.028	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
9112	85	1616042890583:1698521118	1616042887016:-1072098312	D5170C00002	128	122	CREATE	2021-03-18 05:48:10.672	05 Site Management	05.02 Site Set-up Documentation
9114	85	1616042891761:1268006843	1616042890583:1698521118	D5170C00002	130	128	CREATE	2021-03-18 05:48:11.849	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
9115	85	1616042892354:1444324625	1616042890583:1698521118	D5170C00002	131	128	CREATE	2021-03-18 05:48:12.46	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
9116	85	1616042892933:-904165233	1616042890583:1698521118	D5170C00002	132	128	CREATE	2021-03-18 05:48:13.025	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
9118	85	1616042894104:-1593004	1616042890583:1698521118	D5170C00002	134	128	CREATE	2021-03-18 05:48:14.19	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
9119	85	1616042894668:-2119006339	1616042890583:1698521118	D5170C00002	135	128	CREATE	2021-03-18 05:48:14.911	05.02 Site Set-up Documentation	05.02.09 Investigator Regulatory Agreement
9121	85	1616042896008:146216606	1616042890583:1698521118	D5170C00002	137	128	CREATE	2021-03-18 05:48:16.723	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
9122	85	1616042897346:-437426813	1616042890583:1698521118	D5170C00002	138	128	CREATE	2021-03-18 05:48:17.438	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
9124	85	1616042898629:1207409760	1616042887016:-1072098312	D5170C00002	140	122	CREATE	2021-03-18 05:48:18.722	05 Site Management	05.03 Site Initiation
9125	85	1616042899307:2054701667	1616042898629:1207409760	D5170C00002	141	140	CREATE	2021-03-18 05:48:19.397	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
9126	85	1616042899878:719701392	1616042898629:1207409760	D5170C00002	142	140	CREATE	2021-03-18 05:48:19.962	05.03 Site Initiation	05.03.03 Site _cumentation-Site
9128	85	1616042901004:1456200045	1616042887016:-1072098312	D5170C00002	144	122	CREATE	2021-03-18 05:48:21.09	05 Site Management	05.04 Site Management
9129	85	1616042901589:-49996804	1616042901004:1456200045	D5170C00002	145	144	CREATE	2021-03-18 05:48:21.692	05.04 Site Management	05.04.04 Visit Log
9131	85	1616042902756:-2006318048	1616042901004:1456200045	D5170C00002	147	144	CREATE	2021-03-18 05:48:23.113	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
9132	85	1616042903667:1816021759	1616042887016:-1072098312	D5170C00002	148	122	CREATE	2021-03-18 05:48:23.754	05 Site Management	05.05 General
9133	85	1616042904261:2019835806	1616042903667:1816021759	D5170C00002	149	148	CREATE	2021-03-18 05:48:24.361	05.05 General	05.05.01 Relev_ations-Documents
9135	85	1616042905465:803471939	1615840756146:-740604444	D5170C00002	151	6	CREATE	2021-03-18 05:48:25.558	Site	2002052 Ricci, Chiara
9136	85	1616042906068:1238408799	1616042905465:803471939	D5170C00002	152	151	CREATE	2021-03-18 05:48:26.156	2002052 Ricci, Chiara	02 Central Trial Documents
9138	85	1616042908033:209378484	1616042906640:-1833453036	D5170C00002	154	153	CREATE	2021-03-18 05:48:28.132	02.02 Subject Documents	02.02.03 Infor_ Form Checklists
9139	85	1616042908665:-1505533471	1616042906640:-1833453036	D5170C00002	155	153	CREATE	2021-03-18 05:48:28.754	02.02 Subject Documents	02.02.03 Infor_t Form Templates
9141	85	1616042909853:-1858216597	1616042909228:-1975212333	D5170C00002	157	156	CREATE	2021-03-18 05:48:29.947	02.04 General	02.04.01 Relev_s-Contact Report
9142	85	1616042910444:-1715169375	1616042909228:-1975212333	D5170C00002	158	156	CREATE	2021-03-18 05:48:30.533	02.04 General	02.04.01 UNBLI_s-Contact Report
9144	85	1616042911665:-505828296	1616042911034:1712856070	D5170C00002	160	159	CREATE	2021-03-18 05:48:31.758	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
9146	85	1616042912767:-356122516	1616042911665:-505828296	D5170C00002	162	160	CREATE	2021-03-18 05:48:32.862	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
9147	85	1616042913315:-1613683367	1616042911665:-505828296	D5170C00002	163	160	CREATE	2021-03-18 05:48:33.419	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
9148	85	1616042913878:-1561805359	1616042911034:1712856070	D5170C00002	164	159	CREATE	2021-03-18 05:48:33.979	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
9150	85	1616042915150:544958646	1616042905465:803471939	D5170C00002	166	151	CREATE	2021-03-18 05:48:35.244	2002052 Ricci, Chiara	05 Site Management
9151	85	1616042915719:-1294345713	1616042915150:544958646	D5170C00002	167	166	CREATE	2021-03-18 05:48:35.815	05 Site Management	05.01 Site Selection
9153	85	1616042917036:-517705457	1616042915719:-1294345713	D5170C00002	169	167	CREATE	2021-03-18 05:48:37.13	05.01 Site Selection	05.01.02 Confidentiality Agreement
9154	85	1616042918473:1071661776	1616042915719:-1294345713	D5170C00002	170	167	CREATE	2021-03-18 05:48:38.568	05.01 Site Selection	05.01.03 Feasibility Documentation
9156	85	1616042919743:-161305984	1616042915150:544958646	D5170C00002	172	166	CREATE	2021-03-18 05:48:39.938	05 Site Management	05.02 Site Set-up Documentation
9157	85	1616042920490:-744452283	1616042919743:-161305984	D5170C00002	173	172	CREATE	2021-03-18 05:48:40.577	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
9159	85	1616042921924:-72330806	1616042919743:-161305984	D5170C00002	175	172	CREATE	2021-03-18 05:48:42.017	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
9160	85	1616042922578:2019944093	1616042919743:-161305984	D5170C00002	176	172	CREATE	2021-03-18 05:48:42.685	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
9161	85	1616042923235:-335399804	1616042919743:-161305984	D5170C00002	177	172	CREATE	2021-03-18 05:48:43.327	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
8990	85	1615840756146:-740604444	1615840755001:1663782495	D5170C00002	6	5	ALREADY AVAILABLE	2021-03-18 05:45:16.143	ITALY	Site
9163	85	1616042924753:1106253542	1616042919743:-161305984	D5170C00002	179	172	CREATE	2021-03-18 05:48:45.01	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
14666	88	1617050084444:561652772	1617050058407:1840928122	D5170C00001	356	320	ALREADY AVAILABLE	2021-03-30 07:19:37.317	Poland	Trial Management
9165	85	1616042926533:-848482087	1616042919743:-161305984	D5170C00002	181	172	CREATE	2021-03-18 05:48:46.624	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
9167	85	1616042928108:-652417342	1616042915150:544958646	D5170C00002	183	166	CREATE	2021-03-18 05:48:48.198	05 Site Management	05.03 Site Initiation
9168	85	1616042929836:-1085909212	1616042928108:-652417342	D5170C00002	184	183	CREATE	2021-03-18 05:48:49.94	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
9170	85	1616042931916:-372786103	1616042915150:544958646	D5170C00002	186	166	CREATE	2021-03-18 05:48:52.022	05 Site Management	05.04 Site Management
9171	85	1616042932609:659647414	1616042931916:-372786103	D5170C00002	187	186	CREATE	2021-03-18 05:48:52.704	05.04 Site Management	05.04.04 Visit Log
9173	85	1616042934380:-12985607	1616042915150:544958646	D5170C00002	189	166	CREATE	2021-03-18 05:48:54.478	05 Site Management	05.05 General
9174	85	1616042935131:1789116811	1616042934380:-12985607	D5170C00002	190	189	CREATE	2021-03-18 05:48:55.224	05.05 General	05.05.02 Tracking Information
9175	85	1616042935779:1077307827	1615840756146:-740604444	D5170C00002	191	6	CREATE	2021-03-18 05:48:55.869	Site	2002053 Vecchi, Maurizio
9177	85	1616042937092:37464914	1616042936422:994025982	D5170C00002	193	192	CREATE	2021-03-18 05:48:57.184	02 Central Trial Documents	02.02 Subject Documents
9178	85	1616042937845:-898824166	1616042937092:37464914	D5170C00002	194	193	CREATE	2021-03-18 05:48:57.935	02.02 Subject Documents	02.02.03 Infor_ Form Checklists
9180	85	1616042939244:1238183852	1616042937092:37464914	D5170C00002	196	193	CREATE	2021-03-18 05:48:59.333	02.02 Subject Documents	02.02.07 Other_iven to Subjects
9181	85	1616042941236:-1357295234	1616042936422:994025982	D5170C00002	197	192	CREATE	2021-03-18 05:49:01.33	02 Central Trial Documents	02.04 General
9182	85	1616042941969:-533137774	1616042941236:-1357295234	D5170C00002	198	197	CREATE	2021-03-18 05:49:02.062	02.04 General	02.04.01 Relev_s-Contact Report
9184	85	1616042943334:215472402	1616042935779:1077307827	D5170C00002	200	191	CREATE	2021-03-18 05:49:03.423	2002053 Vecchi, Maurizio	04 IRB-IEC and other Approvals
9186	85	1616042944673:-2098597993	1616042943981:1085676217	D5170C00002	202	201	CREATE	2021-03-18 05:49:04.767	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
9187	85	1616042945445:-1669222974	1616042943981:1085676217	D5170C00002	203	201	CREATE	2021-03-18 05:49:05.533	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
9188	85	1616042946154:286349297	1616042943334:215472402	D5170C00002	204	200	CREATE	2021-03-18 05:49:06.251	04 IRB-IEC and other Approvals	04.04 General
9190	85	1616042947609:-354661672	1616042935779:1077307827	D5170C00002	206	191	CREATE	2021-03-18 05:49:07.706	2002053 Vecchi, Maurizio	05 Site Management
9191	85	1616042948243:-260277017	1616042947609:-354661672	D5170C00002	207	206	CREATE	2021-03-18 05:49:08.332	05 Site Management	05.01 Site Selection
9193	85	1616042949501:-192772380	1616042948243:-260277017	D5170C00002	209	207	CREATE	2021-03-18 05:49:09.588	05.01 Site Selection	05.01.02 Confidentiality Agreement
9194	85	1616042952223:-277488497	1616042948243:-260277017	D5170C00002	210	207	CREATE	2021-03-18 05:49:12.315	05.01 Site Selection	05.01.03 Feasibility Documentation
9196	85	1616042953687:-916255927	1616042947609:-354661672	D5170C00002	212	206	CREATE	2021-03-18 05:49:13.781	05 Site Management	05.02 Site Set-up Documentation
9198	85	1616042955310:1096941012	1616042953687:-916255927	D5170C00002	214	212	CREATE	2021-03-18 05:49:15.399	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
9199	85	1616042956184:1127471942	1616042953687:-916255927	D5170C00002	215	212	CREATE	2021-03-18 05:49:16.278	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
9200	85	1616042956892:146822743	1616042953687:-916255927	D5170C00002	216	212	CREATE	2021-03-18 05:49:16.982	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
9202	85	1616042958179:-1992529037	1616042953687:-916255927	D5170C00002	218	212	CREATE	2021-03-18 05:49:18.269	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
9203	85	1616042958838:751904884	1616042953687:-916255927	D5170C00002	219	212	CREATE	2021-03-18 05:49:18.928	05.02 Site Set-up Documentation	05.02.09 Investigator Regulatory Agreement
9205	85	1616042960292:1197268236	1616042953687:-916255927	D5170C00002	221	212	CREATE	2021-03-18 05:49:20.402	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
9206	85	1616042960952:-639312380	1616042953687:-916255927	D5170C00002	222	212	CREATE	2021-03-18 05:49:21.039	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
9207	85	1616042961562:203103207	1616042953687:-916255927	D5170C00002	223	212	CREATE	2021-03-18 05:49:21.65	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
9209	85	1616042964230:1261024695	1616042963451:-1407346067	D5170C00002	225	224	CREATE	2021-03-18 05:49:24.322	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
9210	85	1616042964900:1894343799	1616042963451:-1407346067	D5170C00002	226	224	CREATE	2021-03-18 05:49:24.987	05.03 Site Initiation	05.03.03 Site Training-Staff
9212	85	1616042966259:-1158672481	1616042947609:-354661672	D5170C00002	228	206	CREATE	2021-03-18 05:49:26.345	05 Site Management	05.04 Site Management
9213	85	1616042966931:-699149028	1616042966259:-1158672481	D5170C00002	229	228	CREATE	2021-03-18 05:49:27.018	05.04 Site Management	05.04.04 Visit Log
9215	85	1616042968549:1931102555	1616042966259:-1158672481	D5170C00002	231	228	CREATE	2021-03-18 05:49:28.741	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
9216	85	1616042969251:-653010870	1616042947609:-354661672	D5170C00002	232	206	CREATE	2021-03-18 05:49:29.342	05 Site Management	05.05 General
9217	85	1616042970233:-241998324	1616042969251:-653010870	D5170C00002	233	232	CREATE	2021-03-18 05:49:30.32	05.05 General	05.05.02 Tracking Information
9219	85	1616042971858:-1258531835	1616042970964:-163080960	D5170C00002	235	234	CREATE	2021-03-18 05:49:31.949	06 IP and Trial Supplies	06.04 Storage
9220	85	1616042972535:-1596721133	1616042971858:-1258531835	D5170C00002	236	235	CREATE	2021-03-18 05:49:32.865	06.04 Storage	06.04.03 Maintenance Logs
9222	85	1616042976620:-237636268	1616042975293:1368593647	D5170C00002	238	237	CREATE	2021-03-18 05:49:36.714	08 Centralized Testing	08.02 Sample Documentation
9224	85	1616042978107:1562038103	1615840756146:-740604444	D5170C00002	240	6	CREATE	2021-03-18 05:49:38.197	Site	2002295 Rogai, Francesca
11645	86	\N	\N	D5170C00002	96	93	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
9225	85	1616042978842:1099230100	1616042978107:1562038103	D5170C00002	241	240	CREATE	2021-03-18 05:49:38.932	2002295 Rogai, Francesca	02 Central Trial Documents
9226	85	1616042979519:-131284349	1616042978842:1099230100	D5170C00002	242	241	CREATE	2021-03-18 05:49:39.647	02 Central Trial Documents	02.02 Subject Documents
9228	85	1616042981450:122259214	1616042979519:-131284349	D5170C00002	244	242	CREATE	2021-03-18 05:49:41.541	02.02 Subject Documents	02.02.03 Infor_t Form Templates
14679	88	1617050099210:955631137	1617050098551:-1298331324	D5170C00001	369	368	ALREADY AVAILABLE	2021-03-30 07:19:37.317	Spain	Central Trial Documents
9231	85	1616042983660:806550622	1616042982922:124756227	D5170C00002	247	246	CREATE	2021-03-18 05:49:43.748	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
9232	85	1616042984288:-292296594	1616042982922:124756227	D5170C00002	248	246	CREATE	2021-03-18 05:49:44.38	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
9233	85	1616042984890:-2069338365	1616042978107:1562038103	D5170C00002	249	240	CREATE	2021-03-18 05:49:45.94	2002295 Rogai, Francesca	05 Site Management
9235	85	1616042987118:433389654	1616042986465:1276850479	D5170C00002	251	250	CREATE	2021-03-18 05:49:47.207	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
9236	85	1616042987772:-777958570	1616042984890:-2069338365	D5170C00002	252	249	CREATE	2021-03-18 05:49:47.883	05 Site Management	05.02 Site Set-up Documentation
9238	85	1616042989087:-1063431615	1616042987772:-777958570	D5170C00002	254	252	CREATE	2021-03-18 05:49:49.195	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
9240	85	1616042990313:-657485548	1616042987772:-777958570	D5170C00002	256	252	CREATE	2021-03-18 05:49:50.426	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
9241	85	1616042990955:126817782	1616042987772:-777958570	D5170C00002	257	252	CREATE	2021-03-18 05:49:51.047	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
9242	85	1616042991563:-1269080537	1616042984890:-2069338365	D5170C00002	258	249	CREATE	2021-03-18 05:49:51.664	05 Site Management	05.03 Site Initiation
9244	85	1616042992854:1637881845	1615840756146:-740604444	D5170C00002	260	6	CREATE	2021-03-18 05:49:52.938	Site	2002296 Petruzzellis, Carlo
9245	85	1616042993479:-486166747	1616042992854:1637881845	D5170C00002	261	260	CREATE	2021-03-18 05:49:53.563	2002296 Petruzzellis, Carlo	02 Central Trial Documents
9247	85	1616042994704:2033745197	1616042994090:786736660	D5170C00002	263	262	CREATE	2021-03-18 05:49:54.802	02.02 Subject Documents	02.02.03 Infor_t Form Templates
9248	85	1616042995315:790838478	1616042993479:-486166747	D5170C00002	264	261	CREATE	2021-03-18 05:49:55.405	02 Central Trial Documents	02.04 General
9249	85	1616042997170:-259144980	1616042995315:790838478	D5170C00002	265	264	CREATE	2021-03-18 05:49:57.263	02.04 General	02.04.01 Relev_ations-Documents
9251	85	1616042998439:-1994293975	1616042995315:790838478	D5170C00002	267	264	CREATE	2021-03-18 05:49:58.529	02.04 General	02.04.01 UNBLI_s-Contact Report
9252	85	1616042999036:-1985546541	1616042992854:1637881845	D5170C00002	268	260	CREATE	2021-03-18 05:49:59.126	2002296 Petruzzellis, Carlo	03 Regulatory
9254	85	1616043000329:842435629	1616042999695:1931325858	D5170C00002	270	269	CREATE	2021-03-18 05:50:00.421	03.04 General	03.04.01 Relev_art-Up-Documents
9256	85	1616043001603:1261339491	1616043001019:-1148139369	D5170C00002	272	271	CREATE	2021-03-18 05:50:01.693	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
9257	85	1616043002206:464923970	1616043001603:1261339491	D5170C00002	273	272	CREATE	2021-03-18 05:50:02.325	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
9259	85	1616043003536:1805656195	1616043001603:1261339491	D5170C00002	275	272	CREATE	2021-03-18 05:50:03.625	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
9260	85	1616043004144:-1614486556	1616043001019:-1148139369	D5170C00002	276	271	CREATE	2021-03-18 05:50:04.247	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
9262	85	1616043005337:756802433	1616042992854:1637881845	D5170C00002	278	260	CREATE	2021-03-18 05:50:05.424	2002296 Petruzzellis, Carlo	05 Site Management
9263	85	1616043005950:402571786	1616043005337:756802433	D5170C00002	279	278	CREATE	2021-03-18 05:50:06.038	05 Site Management	05.01 Site Selection
9264	85	1616043006657:-1353725577	1616043005950:402571786	D5170C00002	280	279	CREATE	2021-03-18 05:50:06.756	05.01 Site Selection	05.01.01 Site Contact Details
9266	85	1616043008984:-902811161	1616043005950:402571786	D5170C00002	282	279	CREATE	2021-03-18 05:50:09.073	05.01 Site Selection	05.01.03 Feasibility Documentation
9267	85	1616043009613:236077706	1616043005950:402571786	D5170C00002	283	279	CREATE	2021-03-18 05:50:09.714	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
9269	85	1616043010800:371991659	1616043010205:1420686835	D5170C00002	285	284	CREATE	2021-03-18 05:50:10.891	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
9270	85	1616043011381:-1009300621	1616043010205:1420686835	D5170C00002	286	284	CREATE	2021-03-18 05:50:11.468	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
9272	85	1616043012660:515504089	1616043010205:1420686835	D5170C00002	288	284	CREATE	2021-03-18 05:50:12.746	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
9273	85	1616043013235:781044138	1616043010205:1420686835	D5170C00002	289	284	CREATE	2021-03-18 05:50:13.324	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
9275	85	1616043014376:1775653987	1616043010205:1420686835	D5170C00002	291	284	CREATE	2021-03-18 05:50:14.468	05.02 Site Set-up Documentation	05.02.09 Investigator Regulatory Agreement
9276	85	1616043014970:1117118545	1616043010205:1420686835	D5170C00002	292	284	CREATE	2021-03-18 05:50:15.062	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
9278	85	1616043016205:-2090564890	1616043010205:1420686835	D5170C00002	294	284	CREATE	2021-03-18 05:50:16.293	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
9279	85	1616043016777:1226841701	1616043010205:1420686835	D5170C00002	295	284	CREATE	2021-03-18 05:50:16.883	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
9280	85	1616043017404:929564868	1616043005337:756802433	D5170C00002	296	278	CREATE	2021-03-18 05:50:17.566	05 Site Management	05.03 Site Initiation
9282	85	1616043019863:-1607851962	1616043017404:929564868	D5170C00002	298	296	CREATE	2021-03-18 05:50:19.955	05.03 Site Initiation	05.03.03 Site Training-Staff
9283	85	1616043020516:1324142005	1616043005337:756802433	D5170C00002	299	278	CREATE	2021-03-18 05:50:20.608	05 Site Management	05.04 Site Management
9285	85	1616043021688:1414343894	1616043020516:1324142005	D5170C00002	301	299	CREATE	2021-03-18 05:50:21.775	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
9286	85	1616043022276:-936941445	1616043005337:756802433	D5170C00002	302	278	CREATE	2021-03-18 05:50:22.455	05 Site Management	05.05 General
9288	85	1616043023596:-1597709658	1615840756146:-740604444	D5170C00002	304	6	CREATE	2021-03-18 05:50:23.688	Site	TBD-1-1QNSNRM Privitera, Antonino
9289	85	1616043024197:-794954001	1616043023596:-1597709658	D5170C00002	305	304	CREATE	2021-03-18 05:50:24.287	TBD-1-1QNSNRM Privitera, Antonino	05 Site Management
9291	85	1616043025316:-579557904	1616043024773:998046271	D5170C00002	307	306	CREATE	2021-03-18 05:50:25.417	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
9292	85	1616043025914:-915551249	1615840756146:-740604444	D5170C00002	308	6	CREATE	2021-03-18 05:50:26.005	Site	TBD-1-25G8KT4 Romano, Marco
8836	84	\N	\N	D5170C00002	2621	2326	NEW	\N	Site	TBD-1-1QG2E8P Nimer, Assy
9295	85	1616043028184:-366279271	1616043027530:704457932	D5170C00002	311	310	CREATE	2021-03-18 05:50:28.273	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
9297	85	1616043029403:-591537099	1616043028775:-496339678	D5170C00002	313	312	CREATE	2021-03-18 05:50:29.495	TBD-1-27OAC50 _eleone, Giovanni	05 Site Management
9298	85	1616043030993:-601812489	1616043029403:-591537099	D5170C00002	314	313	CREATE	2021-03-18 05:50:31.1	05 Site Management	05.01 Site Selection
9300	85	1616043032210:355705415	1615838976578:1645421407	D5170C00002	316	4	CREATE	2021-03-18 05:50:32.302	contents	KOREA, REPUBLIC OF
9301	85	1616043032792:2030519844	1616043032210:355705415	D5170C00002	317	316	CREATE	2021-03-18 05:50:32.883	KOREA, REPUBLIC OF	Site
9303	85	1616043033970:-2024926725	1616043033408:-338850020	D5170C00002	319	318	CREATE	2021-03-18 05:50:34.06	2002355 Ye, Byong Duk	02 Central Trial Documents
9304	85	1616043034518:1133706409	1616043033970:-2024926725	D5170C00002	320	319	CREATE	2021-03-18 05:50:34.605	02 Central Trial Documents	02.02 Subject Documents
9306	85	1616043035632:951078280	1616043034518:1133706409	D5170C00002	322	320	CREATE	2021-03-18 05:50:35.718	02.02 Subject Documents	02.02.03 Infor_t Form Templates
9307	85	1616043036245:-682136238	1616043033970:-2024926725	D5170C00002	323	319	CREATE	2021-03-18 05:50:36.337	02 Central Trial Documents	02.04 General
9309	85	1616043037494:-1129418173	1616043033408:-338850020	D5170C00002	325	318	CREATE	2021-03-18 05:50:37.589	2002355 Ye, Byong Duk	04 IRB-IEC and other Approvals
9311	85	1616043038680:-815012764	1616043038091:-869470640	D5170C00002	327	326	CREATE	2021-03-18 05:50:38.771	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
9312	85	1616043039277:867320670	1616043038091:-869470640	D5170C00002	328	326	CREATE	2021-03-18 05:50:39.381	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
9313	85	1616043039932:-842153025	1616043038091:-869470640	D5170C00002	329	326	CREATE	2021-03-18 05:50:40.022	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
9315	85	1616043042360:-1035653020	1616043040500:549670609	D5170C00002	331	330	CREATE	2021-03-18 05:50:42.449	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
9316	85	1616043042910:1343825074	1616043037494:-1129418173	D5170C00002	332	325	CREATE	2021-03-18 05:50:42.994	04 IRB-IEC and other Approvals	04.04 General
9318	85	1616043044105:2028513871	1616043033408:-338850020	D5170C00002	334	318	CREATE	2021-03-18 05:50:44.195	2002355 Ye, Byong Duk	05 Site Management
9319	85	1616043044682:-1249689044	1616043044105:2028513871	D5170C00002	335	334	CREATE	2021-03-18 05:50:44.767	05 Site Management	05.01 Site Selection
9321	85	1616043045825:230081047	1616043044682:-1249689044	D5170C00002	337	335	CREATE	2021-03-18 05:50:45.911	05.01 Site Selection	05.01.03 Feasibility Documentation
9322	85	1616043046388:-305039173	1616043044682:-1249689044	D5170C00002	338	335	CREATE	2021-03-18 05:50:46.479	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
9324	85	1616043047581:-448830899	1616043047013:1136330318	D5170C00002	340	339	CREATE	2021-03-18 05:50:47.674	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
9325	85	1616043048130:192770257	1616043047013:1136330318	D5170C00002	341	339	CREATE	2021-03-18 05:50:48.23	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
9327	85	1616043049248:-2022348700	1616043047013:1136330318	D5170C00002	343	339	CREATE	2021-03-18 05:50:49.339	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
9328	85	1616043049903:-460913964	1616043047013:1136330318	D5170C00002	344	339	CREATE	2021-03-18 05:50:49.992	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
9329	85	1616043050467:1398267504	1616043047013:1136330318	D5170C00002	345	339	CREATE	2021-03-18 05:50:50.552	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
9331	85	1616043051575:727712933	1616043047013:1136330318	D5170C00002	347	339	CREATE	2021-03-18 05:50:51.663	05.02 Site Set-up Documentation	05.02.11 Data Privacy
9332	85	1616043055832:1546130159	1616043047013:1136330318	D5170C00002	348	339	CREATE	2021-03-18 05:50:55.939	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
9334	85	1616043056955:1804849282	1616043047013:1136330318	D5170C00002	350	339	CREATE	2021-03-18 05:50:57.047	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
9335	85	1616043057519:-1174746723	1616043044105:2028513871	D5170C00002	351	334	CREATE	2021-03-18 05:50:57.611	05 Site Management	05.03 Site Initiation
9337	85	1616043058787:-393149172	1616043057519:-1174746723	D5170C00002	353	351	CREATE	2021-03-18 05:50:58.875	05.03 Site Initiation	05.03.03 Site Training-Staff
9338	85	1616043059371:924839590	1616043044105:2028513871	D5170C00002	354	334	CREATE	2021-03-18 05:50:59.461	05 Site Management	05.04 Site Management
9339	85	1616043059967:-391300926	1616043059371:924839590	D5170C00002	355	354	CREATE	2021-03-18 05:51:00.062	05.04 Site Management	05.04.01 Subject Log
9341	85	1616043061207:1997804202	1616043059371:924839590	D5170C00002	357	354	CREATE	2021-03-18 05:51:01.331	05.04 Site Management	05.04.04 Visit Log
9342	85	1616043061872:1890665144	1616043059371:924839590	D5170C00002	358	354	CREATE	2021-03-18 05:51:01.96	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
9344	85	1616043062966:2033242205	1616043062408:31681671	D5170C00002	360	359	CREATE	2021-03-18 05:51:03.06	05.05 General	05.05.02 Tracking Information
9345	85	1616043063556:-2072772131	1616043033408:-338850020	D5170C00002	361	318	CREATE	2021-03-18 05:51:03.645	2002355 Ye, Byong Duk	06 IP and Trial Supplies
9347	85	1616043064740:1235136024	1616043064126:-1611552785	D5170C00002	363	362	CREATE	2021-03-18 05:51:04.831	06.01 IP Documentation	06.01.11 Certi_e of Destruction
9348	85	1616043065323:230932601	1616043063556:-2072772131	D5170C00002	364	361	CREATE	2021-03-18 05:51:05.414	06 IP and Trial Supplies	06.05 Non-IP Documentation
9350	85	1616043067133:-1284753815	1616043063556:-2072772131	D5170C00002	366	361	CREATE	2021-03-18 05:51:07.227	06 IP and Trial Supplies	06.07 General
9351	85	1616043067697:-914814453	1616043067133:-1284753815	D5170C00002	367	366	CREATE	2021-03-18 05:51:07.784	06.07 General	06.07.01 Relev_roduct-Documents
9353	85	1616043068876:-448852043	1616043068335:701629456	D5170C00002	369	368	CREATE	2021-03-18 05:51:08.962	2002359 Jung, Sung-Ae	02 Central Trial Documents
9354	85	1616043069450:967591264	1616043068876:-448852043	D5170C00002	370	369	CREATE	2021-03-18 05:51:09.539	02 Central Trial Documents	02.02 Subject Documents
9356	85	1616043070613:-2101241625	1616043068876:-448852043	D5170C00002	372	369	CREATE	2021-03-18 05:51:10.705	02 Central Trial Documents	02.04 General
9357	85	1616043071256:689553104	1616043070613:-2101241625	D5170C00002	373	372	CREATE	2021-03-18 05:51:11.349	02.04 General	02.04.01 Relev_Operations-Email
9359	85	1616043072399:-1037064413	1616043070613:-2101241625	D5170C00002	375	372	CREATE	2021-03-18 05:51:12.488	02.04 General	02.04.01 UNBLI_s-Contact Report
14697	88	1617050111601:-202515461	1617050098551:-1298331324	D5170C00001	387	368	ALREADY AVAILABLE	2021-03-30 07:19:37.318	Spain	IRB or IEC and other Approvals
9362	85	1616043074136:133286268	1616043073514:754811658	D5170C00002	378	377	CREATE	2021-03-18 05:51:14.23	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
9363	85	1616043074687:562629460	1616043073514:754811658	D5170C00002	379	377	CREATE	2021-03-18 05:51:14.774	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
9365	85	1616043075789:-2121014389	1616043072959:592591887	D5170C00002	381	376	CREATE	2021-03-18 05:51:15.873	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
9366	85	1616043076925:-2074040961	1616043075789:-2121014389	D5170C00002	382	381	CREATE	2021-03-18 05:51:17.012	04.03 Trial Status Reporting	04.03.01 IRB-I_y Info-Deviation
9368	85	1616043078139:1543877424	1616043075789:-2121014389	D5170C00002	384	381	CREATE	2021-03-18 05:51:18.23	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
9369	85	1616043078714:1439991227	1616043072959:592591887	D5170C00002	385	376	CREATE	2021-03-18 05:51:18.803	04 IRB-IEC and other Approvals	04.04 General
9370	85	1616043079350:843870886	1616043078714:1439991227	D5170C00002	386	385	CREATE	2021-03-18 05:51:19.443	04.04 General	04.04.02 Tracking Information
9372	85	1616043080537:1037922969	1616043079954:-542332174	D5170C00002	388	387	CREATE	2021-03-18 05:51:20.629	05 Site Management	05.01 Site Selection
9373	85	1616043081106:-1093343386	1616043080537:1037922969	D5170C00002	389	388	CREATE	2021-03-18 05:51:21.194	05.01 Site Selection	05.01.02 Confidentiality Agreement
9375	85	1616043082380:-185042360	1616043080537:1037922969	D5170C00002	391	388	CREATE	2021-03-18 05:51:22.469	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
9376	85	1616043082965:-2090914536	1616043079954:-542332174	D5170C00002	392	387	CREATE	2021-03-18 05:51:23.052	05 Site Management	05.02 Site Set-up Documentation
9378	85	1616043084175:1884707311	1616043082965:-2090914536	D5170C00002	394	392	CREATE	2021-03-18 05:51:24.279	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
9379	85	1616043084791:-559752763	1616043082965:-2090914536	D5170C00002	395	392	CREATE	2021-03-18 05:51:24.882	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
9381	85	1616043086020:-1175408318	1616043082965:-2090914536	D5170C00002	397	392	CREATE	2021-03-18 05:51:26.108	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
9382	85	1616043086609:1456169678	1616043082965:-2090914536	D5170C00002	398	392	CREATE	2021-03-18 05:51:27.167	05.02 Site Set-up Documentation	05.02.09 Investigator Regulatory Agreement
9384	85	1616043088305:-1728331640	1616043082965:-2090914536	D5170C00002	400	392	CREATE	2021-03-18 05:51:28.398	05.02 Site Set-up Documentation	05.02.11 Data Privacy
9385	85	1616043088954:617130222	1616043082965:-2090914536	D5170C00002	401	392	CREATE	2021-03-18 05:51:29.039	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
9387	85	1616043090197:-1904121879	1616043082965:-2090914536	D5170C00002	403	392	CREATE	2021-03-18 05:51:34.942	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
9388	85	1616043095483:457861187	1616043079954:-542332174	D5170C00002	404	387	CREATE	2021-03-18 05:51:35.583	05 Site Management	05.03 Site Initiation
9389	85	1616043096134:1323040798	1616043095483:457861187	D5170C00002	405	404	CREATE	2021-03-18 05:51:36.224	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
9391	85	1616043097906:-1138168971	1616043095483:457861187	D5170C00002	407	404	CREATE	2021-03-18 05:51:37.992	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
9392	85	1616043098549:1959482579	1616043079954:-542332174	D5170C00002	408	387	CREATE	2021-03-18 05:51:38.641	05 Site Management	05.04 Site Management
9394	85	1616043100329:-504563496	1616043098549:1959482579	D5170C00002	410	408	CREATE	2021-03-18 05:51:40.422	05.04 Site Management	05.04.04 Visit Log
9395	85	1616043101094:-1211757448	1616043098549:1959482579	D5170C00002	411	408	CREATE	2021-03-18 05:51:41.186	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
9396	85	1616043101674:-1975673612	1616043079954:-542332174	D5170C00002	412	387	CREATE	2021-03-18 05:51:41.762	05 Site Management	05.05 General
9398	85	1616043102891:679451638	1616043101674:-1975673612	D5170C00002	414	412	CREATE	2021-03-18 05:51:42.99	05.05 General	05.05.01 Relevant Communications-Documents
9399	85	1616043103476:-641121258	1616043101674:-1975673612	D5170C00002	415	412	CREATE	2021-03-18 05:51:43.585	05.05 General	05.05.02 Tracking Information
9401	85	1616043104806:-1567719674	1616043104210:1016134387	D5170C00002	417	416	CREATE	2021-03-18 05:51:44.903	06 IP and Trial Supplies	06.01 IP Documentation
9403	85	1616043106008:-904229335	1616043104806:-1567719674	D5170C00002	419	417	CREATE	2021-03-18 05:51:46.098	06.01 IP Documentation	06.01.02 UNBLINDED IP Instructions for Handling
9404	85	1616043106620:-989099019	1616043104210:1016134387	D5170C00002	420	416	CREATE	2021-03-18 05:51:46.708	06 IP and Trial Supplies	06.04 Storage
9405	85	1616043107278:1338808083	1616043106620:-989099019	D5170C00002	421	420	CREATE	2021-03-18 05:51:47.368	06.04 Storage	06.04.03 Maintenance Logs
9407	85	1616043108978:1531086415	1616043107856:-1010751041	D5170C00002	423	422	CREATE	2021-03-18 05:51:49.068	06.05 Non-IP Documentation	06.05.02 Non-IP Documentation of Shipment
9408	85	1616043109642:1180880709	1616043068335:701629456	D5170C00002	424	368	CREATE	2021-03-18 05:51:49.734	2002359 Jung, Sung-Ae	08 Centralized Testing
9410	85	1616043110912:-52809894	1616043110297:1943856845	D5170C00002	426	425	CREATE	2021-03-18 05:51:50.999	08.01 Facility Documentation	08.01.01 Certi_or Accreditation
9411	85	1616043111614:-430701891	1616043109642:1180880709	D5170C00002	427	424	CREATE	2021-03-18 05:51:51.709	08 Centralized Testing	08.02 Sample Documentation
9413	85	1616043112808:1691294500	1616043068335:701629456	D5170C00002	429	368	CREATE	2021-03-18 05:51:52.92	2002359 Jung, Sung-Ae	10 Data Management
9414	85	1616043113419:-1821644234	1616043112808:1691294500	D5170C00002	430	429	CREATE	2021-03-18 05:51:53.518	10 Data Management	10.05 General
9417	85	1616043115330:-835844106	1616043114723:-1860584359	D5170C00002	433	432	CREATE	2021-03-18 05:51:55.428	2002360 Kim, Hyun-Soo	02 Central Trial Documents
9419	85	1616043116648:933419467	1616043116052:944554280	D5170C00002	435	434	CREATE	2021-03-18 05:51:56.738	02.02 Subject Documents	02.02.03 Infor_ Form Checklists
9420	85	1616043117217:-640914655	1616043116052:944554280	D5170C00002	436	434	CREATE	2021-03-18 05:51:57.307	02.02 Subject Documents	02.02.03 Infor_t Form Templates
9422	85	1616043118392:1441132026	1616043117784:-448126504	D5170C00002	438	437	CREATE	2021-03-18 05:51:58.504	02.04 General	02.04.01 Relev_s-Contact Report
9423	85	1616043120138:218354299	1616043117784:-448126504	D5170C00002	439	437	CREATE	2021-03-18 05:52:00.242	02.04 General	02.04.01 UNBLI_s-Contact Report
8838	84	\N	\N	D5170C00002	2623	2622	NEW	\N	05 Site Management	05.01 Site Selection
8839	84	\N	\N	D5170C00002	2624	2623	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
9426	85	1616043122041:-1995527670	1616043121383:2080778767	D5170C00002	442	441	CREATE	2021-03-18 05:52:02.136	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
9427	85	1616043122862:1657493619	1616043114723:-1860584359	D5170C00002	443	432	CREATE	2021-03-18 05:52:02.952	2002360 Kim, Hyun-Soo	05 Site Management
9429	85	1616043124537:-1417255800	1616043123633:1238623466	D5170C00002	445	444	CREATE	2021-03-18 05:52:04.628	05.01 Site Selection	05.01.02 Confidentiality Agreement
9431	85	1616043125787:-1760852289	1616043123633:1238623466	D5170C00002	447	444	CREATE	2021-03-18 05:52:05.878	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
9432	85	1616043126363:-670313859	1616043122862:1657493619	D5170C00002	448	443	CREATE	2021-03-18 05:52:06.453	05 Site Management	05.02 Site Set-up Documentation
9434	85	1616043127621:1441136579	1616043126363:-670313859	D5170C00002	450	448	CREATE	2021-03-18 05:52:07.722	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
9435	85	1616043128380:1612319605	1616043126363:-670313859	D5170C00002	451	448	CREATE	2021-03-18 05:52:08.468	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
9436	85	1616043128963:-1432211617	1616043126363:-670313859	D5170C00002	452	448	CREATE	2021-03-18 05:52:09.061	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
9438	85	1616043131080:201273438	1616043126363:-670313859	D5170C00002	454	448	CREATE	2021-03-18 05:52:11.172	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
9439	85	1616043131750:1859498297	1616043126363:-670313859	D5170C00002	455	448	CREATE	2021-03-18 05:52:11.847	05.02 Site Set-up Documentation	05.02.11 Data Privacy
9441	85	1616043132951:-1913853102	1616043132347:676620788	D5170C00002	457	456	CREATE	2021-03-18 05:52:13.038	05.04 Site Management	05.04.03 Monitoring Visit Report
9442	85	1616043133558:2071216429	1616043032792:2030519844	D5170C00002	458	317	CREATE	2021-03-18 05:52:13.66	Site	2002361 Kim, YoungHo
9444	85	1616043134820:168566753	1616043134166:-1446026205	D5170C00002	460	459	CREATE	2021-03-18 05:52:14.91	02 Central Trial Documents	02.02 Subject Documents
9445	85	1616043135531:-711503296	1616043134820:168566753	D5170C00002	461	460	CREATE	2021-03-18 05:52:15.631	02.02 Subject Documents	02.02.03 Infor_ Form Checklists
9447	85	1616043136808:-281429727	1616043134166:-1446026205	D5170C00002	463	459	CREATE	2021-03-18 05:52:16.901	02 Central Trial Documents	02.04 General
9448	85	1616043137394:-1742285367	1616043136808:-281429727	D5170C00002	464	463	CREATE	2021-03-18 05:52:17.498	02.04 General	02.04.01 Relev_s-Contact Report
9450	85	1616043138640:2070408729	1616043133558:2071216429	D5170C00002	466	458	CREATE	2021-03-18 05:52:18.731	2002361 Kim, YoungHo	04 IRB-IEC and other Approvals
9451	85	1616043139234:631197058	1616043138640:2070408729	D5170C00002	467	466	CREATE	2021-03-18 05:52:19.325	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
9453	85	1616043141328:2074898546	1616043139234:631197058	D5170C00002	469	467	CREATE	2021-03-18 05:52:21.418	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
9454	85	1616043142020:223764900	1616043139234:631197058	D5170C00002	470	467	CREATE	2021-03-18 05:52:22.111	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
9456	85	1616043143227:55186030	1616043142634:2050317089	D5170C00002	472	471	CREATE	2021-03-18 05:52:23.315	04.03 Trial Status Reporting	04.03.01 IRB-I_y Info-Deviation
9457	85	1616043143981:983689523	1616043142634:2050317089	D5170C00002	473	471	CREATE	2021-03-18 05:52:24.068	04.03 Trial Status Reporting	04.03.02 IRB-I_ Progress Report
9459	85	1616043145199:-1304539146	1616043138640:2070408729	D5170C00002	475	466	CREATE	2021-03-18 05:52:25.29	04 IRB-IEC and other Approvals	04.04 General
9460	85	1616043145797:2140828951	1616043145199:-1304539146	D5170C00002	476	475	CREATE	2021-03-18 05:52:25.883	04.04 General	04.04.02 Tracking Information
9461	85	1616043146378:1047364565	1616043133558:2071216429	D5170C00002	477	458	CREATE	2021-03-18 05:52:26.465	2002361 Kim, YoungHo	05 Site Management
9463	85	1616043147800:-1939380239	1616043146982:1835201218	D5170C00002	479	478	CREATE	2021-03-18 05:52:27.906	05.01 Site Selection	05.01.02 Confidentiality Agreement
9465	85	1616043149179:195228803	1616043146982:1835201218	D5170C00002	481	478	CREATE	2021-03-18 05:52:29.269	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
9466	85	1616043149777:1743015049	1616043146378:1047364565	D5170C00002	482	477	CREATE	2021-03-18 05:52:29.863	05 Site Management	05.02 Site Set-up Documentation
9467	85	1616043150363:1861661256	1616043149777:1743015049	D5170C00002	483	482	CREATE	2021-03-18 05:52:30.449	05.02 Site Set-up Documentation	05.02.01 Accep_tigator Brochure
9469	85	1616043152747:1457211731	1616043149777:1743015049	D5170C00002	485	482	CREATE	2021-03-18 05:52:32.837	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
9470	85	1616043153350:-2037110535	1616043149777:1743015049	D5170C00002	486	482	CREATE	2021-03-18 05:52:33.438	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
9472	85	1616043154520:-709932009	1616043149777:1743015049	D5170C00002	488	482	CREATE	2021-03-18 05:52:34.612	05.02 Site Set-up Documentation	05.02.09 Investigator Regulatory Agreement
9473	85	1616043155135:-146403035	1616043149777:1743015049	D5170C00002	489	482	CREATE	2021-03-18 05:52:35.231	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
9475	85	1616043156368:1385432946	1616043149777:1743015049	D5170C00002	491	482	CREATE	2021-03-18 05:52:36.457	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
9476	85	1616043156961:943396433	1616043149777:1743015049	D5170C00002	492	482	CREATE	2021-03-18 05:52:37.05	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
9478	85	1616043158111:-564836856	1616043146378:1047364565	D5170C00002	494	477	CREATE	2021-03-18 05:52:38.199	05 Site Management	05.03 Site Initiation
9479	85	1616043158928:-68727786	1616043158111:-564836856	D5170C00002	495	494	CREATE	2021-03-18 05:52:39.019	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
9480	85	1616043159522:1817570951	1616043158111:-564836856	D5170C00002	496	494	CREATE	2021-03-18 05:52:39.609	05.03 Site Initiation	05.03.03 Site Training-Staff
9482	85	1616043161703:278534079	1616043146378:1047364565	D5170C00002	498	477	CREATE	2021-03-18 05:52:41.794	05 Site Management	05.04 Site Management
9483	85	1616043162348:-1013460790	1616043161703:278534079	D5170C00002	499	498	CREATE	2021-03-18 05:52:42.443	05.04 Site Management	05.04.04 Visit Log
9485	85	1616043164548:398321198	1616043161703:278534079	D5170C00002	501	498	CREATE	2021-03-18 05:52:44.637	05.04 Site Management	05.04.08 UNBLI_onitoring Report
9486	85	1616043165142:-1037753876	1616043146378:1047364565	D5170C00002	502	477	CREATE	2021-03-18 05:52:45.239	05 Site Management	05.05 General
9487	85	1616043165716:432212052	1616043165142:-1037753876	D5170C00002	503	502	CREATE	2021-03-18 05:52:45.805	05.05 General	05.05.01 Relev_unications-Email
14710	88	1617050125486:-1922316915	1617050098551:-1298331324	D5170C00001	400	368	ALREADY AVAILABLE	2021-03-30 07:19:37.318	Spain	Regulatory
9490	85	1616043167615:648366174	1616043166986:1098293181	D5170C00002	506	505	CREATE	2021-03-18 05:52:47.713	06 IP and Trial Supplies	06.04 Storage
9492	85	1616043168813:-1110993456	1616043166986:1098293181	D5170C00002	508	505	CREATE	2021-03-18 05:52:48.904	06 IP and Trial Supplies	06.07 General
9493	85	1616043169439:-578968721	1616043168813:-1110993456	D5170C00002	509	508	CREATE	2021-03-18 05:52:49.539	06.07 General	06.07.01 Relev_roduct-Documents
9495	85	1616043171261:740114206	1616043170636:-1664978290	D5170C00002	511	510	CREATE	2021-03-18 05:52:51.349	08 Centralized Testing	08.01 Facility Documentation
9496	85	1616043171995:347572337	1616043171261:740114206	D5170C00002	512	511	CREATE	2021-03-18 05:52:52.082	08.01 Facility Documentation	08.01.01 Certi_or Accreditation
9498	85	1616043173248:532369708	1616043172604:1287133600	D5170C00002	514	513	CREATE	2021-03-18 05:52:53.352	08.02 Sample Documentation	08.02.03 Sampl_ge Condition Log
9499	85	1616043174911:255942202	1616043032792:2030519844	D5170C00002	515	317	CREATE	2021-03-18 05:52:55.002	Site	2002362 Kim, Hyo-Jong
9501	85	1616043176193:-1093692696	1616043175514:2080354096	D5170C00002	517	516	CREATE	2021-03-18 05:52:56.286	02 Central Trial Documents	02.02 Subject Documents
9502	85	1616043176793:-1801726640	1616043176193:-1093692696	D5170C00002	518	517	CREATE	2021-03-18 05:52:56.879	02.02 Subject Documents	02.02.03 Infor_t Form Templates
9504	85	1616043178035:273786161	1616043177446:-8167949	D5170C00002	520	519	CREATE	2021-03-18 05:52:58.316	02.04 General	02.04.01 Relev_s-Contact Report
9505	85	1616043178933:1529224574	1616043177446:-8167949	D5170C00002	521	519	CREATE	2021-03-18 05:52:59.025	02.04 General	02.04.01 UNBLI_s-Contact Report
9507	85	1616043180175:860390378	1616043179558:-1741301092	D5170C00002	523	522	CREATE	2021-03-18 05:53:00.267	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
9508	85	1616043180778:-1232464825	1616043180175:860390378	D5170C00002	524	523	CREATE	2021-03-18 05:53:00.867	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
9510	85	1616043183231:-1400193528	1616043180175:860390378	D5170C00002	526	523	CREATE	2021-03-18 05:53:03.347	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
9511	85	1616043183883:-198779994	1616043179558:-1741301092	D5170C00002	527	522	CREATE	2021-03-18 05:53:03.974	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
9513	85	1616043186527:631316165	1616043183883:-198779994	D5170C00002	529	527	CREATE	2021-03-18 05:53:06.633	04.03 Trial Status Reporting	04.03.02 IRB-I_ Progress Report
9514	85	1616043187191:248942122	1616043183883:-198779994	D5170C00002	530	527	CREATE	2021-03-18 05:53:07.295	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
9515	85	1616043187874:1390097252	1616043174911:255942202	D5170C00002	531	515	CREATE	2021-03-18 05:53:07.963	2002362 Kim, Hyo-Jong	05 Site Management
9517	85	1616043189115:1005737655	1616043188485:664926241	D5170C00002	533	532	CREATE	2021-03-18 05:53:09.207	05.01 Site Selection	05.01.02 Confidentiality Agreement
9519	85	1616043190375:1914038681	1616043188485:664926241	D5170C00002	535	532	CREATE	2021-03-18 05:53:10.464	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
9520	85	1616043191053:1683953664	1616043187874:1390097252	D5170C00002	536	531	CREATE	2021-03-18 05:53:11.149	05 Site Management	05.02 Site Set-up Documentation
9522	85	1616043192289:1093841510	1616043191053:1683953664	D5170C00002	538	536	CREATE	2021-03-18 05:53:12.377	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
9523	85	1616043192907:-692304453	1616043191053:1683953664	D5170C00002	539	536	CREATE	2021-03-18 05:53:12.994	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
9524	85	1616043193507:-1117967439	1616043191053:1683953664	D5170C00002	540	536	CREATE	2021-03-18 05:53:13.629	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
9526	85	1616043194877:-710907099	1616043191053:1683953664	D5170C00002	542	536	CREATE	2021-03-18 05:53:14.968	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
9527	85	1616043195557:1512203228	1616043191053:1683953664	D5170C00002	543	536	CREATE	2021-03-18 05:53:15.646	05.02 Site Set-up Documentation	05.02.11 Data Privacy
9529	85	1616043197944:1745884308	1616043191053:1683953664	D5170C00002	545	536	CREATE	2021-03-18 05:53:18.037	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
9530	85	1616043198556:-480263904	1616043191053:1683953664	D5170C00002	546	536	CREATE	2021-03-18 05:53:18.647	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
9531	85	1616043199143:-1735164878	1616043187874:1390097252	D5170C00002	547	531	CREATE	2021-03-18 05:53:19.232	05 Site Management	05.03 Site Initiation
9533	85	1616043200419:879213388	1616043199143:-1735164878	D5170C00002	549	547	CREATE	2021-03-18 05:53:20.511	05.03 Site Initiation	05.03.03 Site Training-Staff
9534	85	1616043201043:-425225337	1616043199143:-1735164878	D5170C00002	550	547	CREATE	2021-03-18 05:53:21.13	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
9536	85	1616043202206:341390023	1616043201619:-1032392994	D5170C00002	552	551	CREATE	2021-03-18 05:53:22.297	05.04 Site Management	05.04.04 Visit Log
9537	85	1616043202849:1342281857	1616043201619:-1032392994	D5170C00002	553	551	CREATE	2021-03-18 05:53:22.938	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
9539	85	1616043204172:476414562	1616043203436:579294408	D5170C00002	555	554	CREATE	2021-03-18 05:53:24.257	05.05 General	05.05.01 Relev_unications-Email
9540	85	1616043204771:-707203661	1616043203436:579294408	D5170C00002	556	554	CREATE	2021-03-18 05:53:24.859	05.05 General	05.05.02 Tracking Information
9542	85	1616043206032:1961641066	1616043205362:355242640	D5170C00002	558	557	CREATE	2021-03-18 05:53:26.121	06 IP and Trial Supplies	06.01 IP Documentation
9543	85	1616043206754:1840305791	1616043206032:1961641066	D5170C00002	559	558	CREATE	2021-03-18 05:53:26.842	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
9545	85	1616043209050:1332835044	1616043208463:2090523722	D5170C00002	561	560	CREATE	2021-03-18 05:53:29.144	06.04 Storage	06.04.03 Maintenance Logs
9546	85	1616043209670:-377463804	1616043205362:355242640	D5170C00002	562	557	CREATE	2021-03-18 05:53:29.762	06 IP and Trial Supplies	06.05 Non-IP Documentation
9548	85	1616043210911:1886938465	1616043174911:255942202	D5170C00002	564	515	CREATE	2021-03-18 05:53:31.003	2002362 Kim, Hyo-Jong	08 Centralized Testing
9549	85	1616043211493:-871343730	1616043210911:1886938465	D5170C00002	565	564	CREATE	2021-03-18 05:53:31.587	08 Centralized Testing	08.01 Facility Documentation
9551	85	1616043212719:-596000106	1616043211493:-871343730	D5170C00002	567	565	CREATE	2021-03-18 05:53:32.815	08.01 Facility Documentation	08.01.05 Manual
9552	85	1616043213322:1042699430	1616043210911:1886938465	D5170C00002	568	564	CREATE	2021-03-18 05:53:33.408	08 Centralized Testing	08.02 Sample Documentation
8841	84	\N	\N	D5170C00002	2626	2625	NEW	\N	TBD-1-1QG2E97 Delgado, Shmuel	05 Site Management
9556	85	1616043215974:967251282	1616043215380:710637040	D5170C00002	572	571	CREATE	2021-03-18 05:53:36.062	10.05 General	10.05.02 Tracking Information
9557	85	1616043216587:1433691790	1616043032792:2030519844	D5170C00002	573	317	CREATE	2021-03-18 05:53:36.682	Site	2002363 Cheon, Jae Hee
9559	85	1616043217798:-581266830	1616043217168:-781665764	D5170C00002	575	574	CREATE	2021-03-18 05:53:37.885	02 Central Trial Documents	02.02 Subject Documents
9560	85	1616043219626:-576154718	1616043217798:-581266830	D5170C00002	576	575	CREATE	2021-03-18 05:53:39.718	02.02 Subject Documents	02.02.03 Infor_t Form Templates
9562	85	1616043220820:1622052357	1616043220220:644878186	D5170C00002	578	577	CREATE	2021-03-18 05:53:40.905	02.04 General	02.04.01 Relev_s-Contact Report
9563	85	1616043221492:-1276866866	1616043220220:644878186	D5170C00002	579	577	CREATE	2021-03-18 05:53:41.579	02.04 General	02.04.01 UNBLI_s-Contact Report
9565	85	1616043223086:1044014200	1616043222445:-1700797177	D5170C00002	581	580	CREATE	2021-03-18 05:53:43.175	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
9566	85	1616043223765:-320199650	1616043223086:1044014200	D5170C00002	582	581	CREATE	2021-03-18 05:53:43.853	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
9568	85	1616043225060:-347339911	1616043223086:1044014200	D5170C00002	584	581	CREATE	2021-03-18 05:53:45.157	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
9569	85	1616043225714:-1831811847	1616043222445:-1700797177	D5170C00002	585	580	CREATE	2021-03-18 05:53:45.805	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
9571	85	1616043226940:1564931111	1616043225714:-1831811847	D5170C00002	587	585	CREATE	2021-03-18 05:53:47.026	04.03 Trial Status Reporting	04.03.02 IRB-I_ Progress Report
9572	85	1616043227545:-1719998534	1616043225714:-1831811847	D5170C00002	588	585	CREATE	2021-03-18 05:53:47.633	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
9574	85	1616043228822:888472171	1616043228197:2020916999	D5170C00002	590	589	CREATE	2021-03-18 05:53:48.912	05 Site Management	05.01 Site Selection
9575	85	1616043230639:713442921	1616043228822:888472171	D5170C00002	591	590	CREATE	2021-03-18 05:53:50.743	05.01 Site Selection	05.01.02 Confidentiality Agreement
9577	85	1616043231853:-997113680	1616043228822:888472171	D5170C00002	593	590	CREATE	2021-03-18 05:53:51.964	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
9578	85	1616043232497:1907510203	1616043228197:2020916999	D5170C00002	594	589	CREATE	2021-03-18 05:53:52.588	05 Site Management	05.02 Site Set-up Documentation
9580	85	1616043233783:68314179	1616043232497:1907510203	D5170C00002	596	594	CREATE	2021-03-18 05:53:53.888	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
9581	85	1616043234408:-411389686	1616043232497:1907510203	D5170C00002	597	594	CREATE	2021-03-18 05:53:54.513	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
9582	85	1616043235092:-976822947	1616043232497:1907510203	D5170C00002	598	594	CREATE	2021-03-18 05:53:58.887	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
9584	85	1616043240194:81583630	1616043232497:1907510203	D5170C00002	600	594	CREATE	2021-03-18 05:54:00.283	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
9585	85	1616043241995:1035895576	1616043232497:1907510203	D5170C00002	601	594	CREATE	2021-03-18 05:54:02.096	05.02 Site Set-up Documentation	05.02.09 Investigator Regulatory Agreement
9587	85	1616043243276:2005730676	1616043232497:1907510203	D5170C00002	603	594	CREATE	2021-03-18 05:54:03.365	05.02 Site Set-up Documentation	05.02.11 Data Privacy
9588	85	1616043243847:2020046939	1616043232497:1907510203	D5170C00002	604	594	CREATE	2021-03-18 05:54:03.934	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
9590	85	1616043245015:603664248	1616043232497:1907510203	D5170C00002	606	594	CREATE	2021-03-18 05:54:05.108	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
9591	85	1616043245603:-1652271044	1616043228197:2020916999	D5170C00002	607	589	CREATE	2021-03-18 05:54:05.704	05 Site Management	05.03 Site Initiation
9592	85	1616043246287:1775535952	1616043245603:-1652271044	D5170C00002	608	607	CREATE	2021-03-18 05:54:06.373	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
9594	85	1616043247986:1792457451	1616043245603:-1652271044	D5170C00002	610	607	CREATE	2021-03-18 05:54:08.08	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
9595	85	1616043248649:443071669	1616043228197:2020916999	D5170C00002	611	589	CREATE	2021-03-18 05:54:08.758	05 Site Management	05.04 Site Management
9597	85	1616043249978:-7889720	1616043248649:443071669	D5170C00002	613	611	CREATE	2021-03-18 05:54:10.086	05.04 Site Management	05.04.02 Source Data Verification
9598	85	1616043250573:637962400	1616043248649:443071669	D5170C00002	614	611	CREATE	2021-03-18 05:54:10.67	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
9600	85	1616043252428:-448982914	1616043228197:2020916999	D5170C00002	616	589	CREATE	2021-03-18 05:54:12.519	05 Site Management	05.05 General
9601	85	1616043253101:247259754	1616043252428:-448982914	D5170C00002	617	616	CREATE	2021-03-18 05:54:13.187	05.05 General	05.05.01 Relev_unications-Email
9603	85	1616043254214:536334997	1616043216587:1433691790	D5170C00002	619	573	CREATE	2021-03-18 05:54:14.415	2002363 Cheon, Jae Hee	06 IP and Trial Supplies
9604	85	1616043254881:1968873285	1616043254214:536334997	D5170C00002	620	619	CREATE	2021-03-18 05:54:14.969	06 IP and Trial Supplies	06.01 IP Documentation
11646	86	\N	\N	D5170C00002	97	92	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
9606	85	1616043256054:-239850539	1616043254214:536334997	D5170C00002	622	619	CREATE	2021-03-18 05:54:16.14	06 IP and Trial Supplies	06.04 Storage
9607	85	1616043256615:-765639028	1616043256054:-239850539	D5170C00002	623	622	CREATE	2021-03-18 05:54:16.705	06.04 Storage	06.04.03 Maintenance Logs
9609	85	1616043257718:-1037705805	1616043257168:-1481466395	D5170C00002	625	624	CREATE	2021-03-18 05:54:17.805	06.05 Non-IP Documentation	06.05.03 Non-I_tation of Return
9610	85	1616043258303:-65878055	1616043254214:536334997	D5170C00002	626	619	CREATE	2021-03-18 05:54:18.391	06 IP and Trial Supplies	06.07 General
9612	85	1616043259433:2068041431	1616043216587:1433691790	D5170C00002	628	573	CREATE	2021-03-18 05:54:19.524	2002363 Cheon, Jae Hee	08 Centralized Testing
9613	85	1616043259989:1038700100	1616043259433:2068041431	D5170C00002	629	628	CREATE	2021-03-18 05:54:20.097	08 Centralized Testing	08.02 Sample Documentation
9615	85	1616043261240:2061080188	1616043032792:2030519844	D5170C00002	631	317	CREATE	2021-03-18 05:54:21.333	Site	2002364 Im, JongPil
9616	85	1616043261823:-1716773635	1616043261240:2061080188	D5170C00002	632	631	CREATE	2021-03-18 05:54:21.907	2002364 Im, JongPil	01 Trial Management
9617	85	1616043262348:1699985694	1616043261823:-1716773635	D5170C00002	633	632	CREATE	2021-03-18 05:54:22.915	01 Trial Management	01.05 General
9619	85	1616043263981:1455745266	1616043261240:2061080188	D5170C00002	635	631	CREATE	2021-03-18 05:54:24.069	2002364 Im, JongPil	02 Central Trial Documents
9622	85	1616043265747:-1849936871	1616043263981:1455745266	D5170C00002	638	635	CREATE	2021-03-18 05:54:25.839	02 Central Trial Documents	02.04 General
9623	85	1616043266300:-1797152874	1616043265747:-1849936871	D5170C00002	639	638	CREATE	2021-03-18 05:54:26.389	02.04 General	02.04.01 Relev_s-Contact Report
9624	85	1616043266866:-401104801	1616043265747:-1849936871	D5170C00002	640	638	CREATE	2021-03-18 05:54:26.951	02.04 General	02.04.01 UNBLI_s-Contact Report
9626	85	1616043268019:156840162	1616043267467:677223513	D5170C00002	642	641	CREATE	2021-03-18 05:54:28.108	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
9627	85	1616043268576:120255329	1616043268019:156840162	D5170C00002	643	642	CREATE	2021-03-18 05:54:28.662	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
9629	85	1616043269772:93115068	1616043268019:156840162	D5170C00002	645	642	CREATE	2021-03-18 05:54:29.861	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
9630	85	1616043270337:324168768	1616043267467:677223513	D5170C00002	646	641	CREATE	2021-03-18 05:54:30.428	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
9632	85	1616043271493:379785179	1616043270337:324168768	D5170C00002	648	646	CREATE	2021-03-18 05:54:31.581	04.03 Trial Status Reporting	04.03.02 IRB-I_ Progress Report
9633	85	1616043272056:1389748567	1616043270337:324168768	D5170C00002	649	646	CREATE	2021-03-18 05:54:32.146	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
9635	85	1616043273950:1608903389	1616043272617:-460999947	D5170C00002	651	650	CREATE	2021-03-18 05:54:34.04	05 Site Management	05.01 Site Selection
9636	85	1616043274534:926122779	1616043273950:1608903389	D5170C00002	652	651	CREATE	2021-03-18 05:54:34.633	05.01 Site Selection	05.01.02 Confidentiality Agreement
9638	85	1616043275702:-1208773284	1616043273950:1608903389	D5170C00002	654	651	CREATE	2021-03-18 05:54:35.792	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
9639	85	1616043276246:-1976239086	1616043272617:-460999947	D5170C00002	655	650	CREATE	2021-03-18 05:54:36.335	05 Site Management	05.02 Site Set-up Documentation
9641	85	1616043277477:1897847431	1616043276246:-1976239086	D5170C00002	657	655	CREATE	2021-03-18 05:54:37.565	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
9642	85	1616043278139:822189984	1616043276246:-1976239086	D5170C00002	658	655	CREATE	2021-03-18 05:54:38.231	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
9643	85	1616043278707:-373534057	1616043276246:-1976239086	D5170C00002	659	655	CREATE	2021-03-18 05:54:38.797	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
9645	85	1616043279880:-566908296	1616043276246:-1976239086	D5170C00002	661	655	CREATE	2021-03-18 05:54:39.968	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
9646	85	1616043280552:-417492804	1616043276246:-1976239086	D5170C00002	662	655	CREATE	2021-03-18 05:54:40.652	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
9648	85	1616043281701:-1788191207	1616043276246:-1976239086	D5170C00002	664	655	CREATE	2021-03-18 05:54:41.788	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
9649	85	1616043282264:363082844	1616043276246:-1976239086	D5170C00002	665	655	CREATE	2021-03-18 05:54:42.357	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
9651	85	1616043283756:460635522	1616043272617:-460999947	D5170C00002	667	650	CREATE	2021-03-18 05:54:43.845	05 Site Management	05.03 Site Initiation
9652	85	1616043285043:-210231594	1616043283756:460635522	D5170C00002	668	667	CREATE	2021-03-18 05:54:45.134	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
9653	85	1616043285594:-942716221	1616043283756:460635522	D5170C00002	669	667	CREATE	2021-03-18 05:54:45.683	05.03 Site Initiation	05.03.03 Site Training-Staff
9655	85	1616043286729:-512723481	1616043272617:-460999947	D5170C00002	671	650	CREATE	2021-03-18 05:54:46.816	05 Site Management	05.04 Site Management
9656	85	1616043287298:495064428	1616043286729:-512723481	D5170C00002	672	671	CREATE	2021-03-18 05:54:47.383	05.04 Site Management	05.04.01 Subject Log
9658	85	1616043288406:1805069998	1616043286729:-512723481	D5170C00002	674	671	CREATE	2021-03-18 05:54:48.494	05.04 Site Management	05.04.04 Visit Log
9659	85	1616043288971:-262824756	1616043286729:-512723481	D5170C00002	675	671	CREATE	2021-03-18 05:54:49.056	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
9661	85	1616043290107:-1947511612	1616043289532:1214068954	D5170C00002	677	676	CREATE	2021-03-18 05:54:50.195	05.05 General	05.05.01 Relev_ations-Documents
9662	85	1616043290742:1029067210	1616043289532:1214068954	D5170C00002	678	676	CREATE	2021-03-18 05:54:50.836	05.05 General	05.05.01 Relev_unications-Email
9664	85	1616043291887:-269429844	1616043261240:2061080188	D5170C00002	680	631	CREATE	2021-03-18 05:54:51.977	2002364 Im, JongPil	06 IP and Trial Supplies
9665	85	1616043292438:-382075652	1616043291887:-269429844	D5170C00002	681	680	CREATE	2021-03-18 05:54:52.526	06 IP and Trial Supplies	06.01 IP Documentation
9667	85	1616043293786:-1055278249	1616043291887:-269429844	D5170C00002	683	680	CREATE	2021-03-18 05:54:53.874	06 IP and Trial Supplies	06.04 Storage
9668	85	1616043294355:1053758505	1616043293786:-1055278249	D5170C00002	684	683	CREATE	2021-03-18 05:54:54.443	06.04 Storage	06.04.03 Maintenance Logs
11647	86	\N	\N	D5170C00002	98	97	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Accep_tigator Brochure
9670	85	1616043296283:583251433	1616043295730:1998073191	D5170C00002	686	685	CREATE	2021-03-18 05:54:56.366	06.05 Non-IP Documentation	06.05.02 Non-IP Documentation of Shipment
9671	85	1616043296920:518695017	1616043295730:1998073191	D5170C00002	687	685	CREATE	2021-03-18 05:54:57.007	06.05 Non-IP Documentation	06.05.03 Non-I_tation of Return
9673	85	1616043298054:641753554	1616043297486:-1665741203	D5170C00002	689	688	CREATE	2021-03-18 05:54:58.143	08 Centralized Testing	08.01 Facility Documentation
9674	85	1616043298637:-309640647	1616043298054:641753554	D5170C00002	690	689	CREATE	2021-03-18 05:54:58.722	08.01 Facility Documentation	08.01.01 Certi_or Accreditation
9676	85	1616043300014:531226769	1616043299214:1188794166	D5170C00002	692	691	CREATE	2021-03-18 05:55:00.105	08.02 Sample Documentation	08.02.03 Sampl_ge Condition Log
9677	85	1616043300592:2030041035	1616043032792:2030519844	D5170C00002	693	317	CREATE	2021-03-18 05:55:00.681	Site	2002365 Huh, Kyu Chan
9679	85	1616043301758:-50785164	1616043301155:1537126143	D5170C00002	695	694	CREATE	2021-03-18 05:55:01.856	02 Central Trial Documents	02.02 Subject Documents
9680	85	1616043302331:-818097345	1616043301758:-50785164	D5170C00002	696	695	CREATE	2021-03-18 05:55:02.433	02.02 Subject Documents	02.02.03 Infor_ Form Checklists
9682	85	1616043303494:1175359852	1616043301155:1537126143	D5170C00002	698	694	CREATE	2021-03-18 05:55:03.586	02 Central Trial Documents	02.04 General
9683	85	1616043304072:196253619	1616043303494:1175359852	D5170C00002	699	698	CREATE	2021-03-18 05:55:04.17	02.04 General	02.04.01 Relev_s-Contact Report
9684	85	1616043304646:1733059878	1616043303494:1175359852	D5170C00002	700	698	CREATE	2021-03-18 05:55:04.732	02.04 General	02.04.01 UNBLI_s-Contact Report
14741	88	1617050148100:-552850351	1617050144863:-122430637	D5170C00001	431	426	ALREADY AVAILABLE	2021-03-30 07:19:37.318	United States of America	Central Trial Documents
9687	85	1616043307438:846357548	1616043306716:271309321	D5170C00002	703	702	CREATE	2021-03-18 05:55:07.525	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
9688	85	1616043308173:-398329565	1616043306716:271309321	D5170C00002	704	702	CREATE	2021-03-18 05:55:08.262	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
9690	85	1616043309339:1831187538	1616043305211:2010321552	D5170C00002	706	701	CREATE	2021-03-18 05:55:09.43	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
9691	85	1616043309920:-242177118	1616043309339:1831187538	D5170C00002	707	706	CREATE	2021-03-18 05:55:10.014	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
9692	85	1616043310565:-379693333	1616043300592:2030041035	D5170C00002	708	693	CREATE	2021-03-18 05:55:10.657	2002365 Huh, Kyu Chan	05 Site Management
9694	85	1616043312250:-622372500	1616043311153:1606724768	D5170C00002	710	709	CREATE	2021-03-18 05:55:12.336	05.01 Site Selection	05.01.02 Confidentiality Agreement
9696	85	1616043313408:-1390319060	1616043311153:1606724768	D5170C00002	712	709	CREATE	2021-03-18 05:55:13.5	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
9697	85	1616043313962:1064758164	1616043310565:-379693333	D5170C00002	713	708	CREATE	2021-03-18 05:55:14.05	05 Site Management	05.02 Site Set-up Documentation
9699	85	1616043315099:186613658	1616043313962:1064758164	D5170C00002	715	713	CREATE	2021-03-18 05:55:15.188	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
9700	85	1616043315722:-1149847351	1616043313962:1064758164	D5170C00002	716	713	CREATE	2021-03-18 05:55:15.823	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
9701	85	1616043316281:1467686752	1616043313962:1064758164	D5170C00002	717	713	CREATE	2021-03-18 05:55:16.372	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
9703	85	1616043318290:57964109	1616043313962:1064758164	D5170C00002	719	713	CREATE	2021-03-18 05:55:18.381	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
9704	85	1616043318854:-761995345	1616043313962:1064758164	D5170C00002	720	713	CREATE	2021-03-18 05:55:18.942	05.02 Site Set-up Documentation	05.02.11 Data Privacy
9706	85	1616043320051:-413241059	1616043313962:1064758164	D5170C00002	722	713	CREATE	2021-03-18 05:55:20.139	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
9707	85	1616043320606:429174528	1616043313962:1064758164	D5170C00002	723	713	CREATE	2021-03-18 05:55:20.693	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
9708	85	1616043321169:-793313306	1616043310565:-379693333	D5170C00002	724	708	CREATE	2021-03-18 05:55:21.258	05 Site Management	05.03 Site Initiation
9710	85	1616043322334:1098994460	1616043321169:-793313306	D5170C00002	726	724	CREATE	2021-03-18 05:55:22.437	05.03 Site Initiation	05.03.03 Site Training-Staff
9711	85	1616043322930:-629751900	1616043321169:-793313306	D5170C00002	727	724	CREATE	2021-03-18 05:55:23.019	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
9713	85	1616043324102:-2061524133	1616043323531:-1766672309	D5170C00002	729	728	CREATE	2021-03-18 05:55:24.188	05.04 Site Management	05.04.01 Subject Log
9714	85	1616043324638:-1905662463	1616043323531:-1766672309	D5170C00002	730	728	CREATE	2021-03-18 05:55:24.722	05.04 Site Management	05.04.02 Source Data Verification
9716	85	1616043325914:1475564588	1616043323531:-1766672309	D5170C00002	732	728	CREATE	2021-03-18 05:55:25.999	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
9717	85	1616043326478:-1406861204	1616043310565:-379693333	D5170C00002	733	708	CREATE	2021-03-18 05:55:26.565	05 Site Management	05.05 General
9719	85	1616043328631:446944834	1616043326478:-1406861204	D5170C00002	735	733	CREATE	2021-03-18 05:55:28.719	05.05 General	05.05.01 Relev_ations-Documents
9720	85	1616043329197:1673300033	1616043326478:-1406861204	D5170C00002	736	733	CREATE	2021-03-18 05:55:29.288	05.05 General	05.05.02 Tracking Information
9722	85	1616043330336:1322747374	1616043329763:1038078696	D5170C00002	738	737	CREATE	2021-03-18 05:55:30.428	06 IP and Trial Supplies	06.04 Storage
9723	85	1616043330948:601235482	1616043330336:1322747374	D5170C00002	739	738	CREATE	2021-03-18 05:55:31.037	06.04 Storage	06.04.03 Maintenance Logs
9725	85	1616043332153:814293213	1616043331556:91749343	D5170C00002	741	740	CREATE	2021-03-18 05:55:32.238	08 Centralized Testing	08.01 Facility Documentation
9727	85	1616043333364:-1566641532	1616043331556:91749343	D5170C00002	743	740	CREATE	2021-03-18 05:55:33.45	08 Centralized Testing	08.02 Sample Documentation
9728	85	1616043333934:703659279	1616043333364:-1566641532	D5170C00002	744	743	CREATE	2021-03-18 05:55:34.019	08.02 Sample Documentation	08.02.05 Retai_s-Tissue Samples
9729	85	1616043334514:703678621	1616043032792:2030519844	D5170C00002	745	317	CREATE	2021-03-18 05:55:34.603	Site	2002366 Jeen, Yoon-Tae
9731	85	1616043335678:-312013812	1616043335117:-532055847	D5170C00002	747	746	CREATE	2021-03-18 05:55:35.767	02 Central Trial Documents	02.02 Subject Documents
9732	85	1616043336300:-1241945318	1616043335678:-312013812	D5170C00002	748	747	CREATE	2021-03-18 05:55:36.392	02.02 Subject Documents	02.02.03 Infor_t Form Templates
9734	85	1616043337410:-332758636	1616043336857:56382512	D5170C00002	750	749	CREATE	2021-03-18 05:55:37.498	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
9735	85	1616043338193:-967257362	1616043337410:-332758636	D5170C00002	751	750	CREATE	2021-03-18 05:55:39.044	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
9736	85	1616043339549:-657512095	1616043334514:703678621	D5170C00002	752	745	CREATE	2021-03-18 05:55:39.636	2002366 Jeen, Yoon-Tae	05 Site Management
9738	85	1616043340747:-1148999810	1616043340168:1605366631	D5170C00002	754	753	CREATE	2021-03-18 05:55:40.833	05.01 Site Selection	05.01.03 Feasibility Documentation
9740	85	1616043342124:-1529751402	1616043339549:-657512095	D5170C00002	756	752	CREATE	2021-03-18 05:55:42.216	05 Site Management	05.02 Site Set-up Documentation
9741	85	1616043342709:97999600	1616043342124:-1529751402	D5170C00002	757	756	CREATE	2021-03-18 05:55:42.804	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
9743	85	1616043343903:2079116068	1616043342124:-1529751402	D5170C00002	759	756	CREATE	2021-03-18 05:55:43.988	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
9744	85	1616043344467:-2044498458	1616043342124:-1529751402	D5170C00002	760	756	CREATE	2021-03-18 05:55:44.553	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
9745	85	1616043345023:545793053	1616043032792:2030519844	D5170C00002	761	317	CREATE	2021-03-18 05:55:45.107	Site	2002367 Song, Geun Am
9747	85	1616043346199:1833481351	1616043345594:-1744758221	D5170C00002	763	762	CREATE	2021-03-18 05:55:46.288	02 Central Trial Documents	02.02 Subject Documents
9748	85	1616043346770:473400825	1616043346199:1833481351	D5170C00002	764	763	CREATE	2021-03-18 05:55:46.855	02.02 Subject Documents	02.02.03 Infor_t Form Templates
14747	88	1617050158041:-1565671489	1617050144863:-122430637	D5170C00001	437	426	ALREADY AVAILABLE	2021-03-30 07:19:37.318	United States of America	IP and Trial Supplies
9751	85	1616043348487:-1368998937	1616043347322:128436483	D5170C00002	767	765	CREATE	2021-03-18 05:55:48.583	02.04 General	02.04.01 UNBLI_s-Contact Report
9753	85	1616043350490:-1989311962	1616043349098:1771655495	D5170C00002	769	768	CREATE	2021-03-18 05:55:50.583	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
9754	85	1616043351088:1379326484	1616043350490:-1989311962	D5170C00002	770	769	CREATE	2021-03-18 05:55:51.178	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
9756	85	1616043352256:97190880	1616043350490:-1989311962	D5170C00002	772	769	CREATE	2021-03-18 05:55:52.346	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
9757	85	1616043352901:-1937194479	1616043349098:1771655495	D5170C00002	773	768	CREATE	2021-03-18 05:55:52.99	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
9759	85	1616043354038:1391296594	1616043352901:-1937194479	D5170C00002	775	773	CREATE	2021-03-18 05:55:54.124	04.03 Trial Status Reporting	04.03.02 IRB-I_ Progress Report
9760	85	1616043354584:-217502164	1616043352901:-1937194479	D5170C00002	776	773	CREATE	2021-03-18 05:55:54.669	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
9762	85	1616043355766:-608489152	1616043355130:-618369999	D5170C00002	778	777	CREATE	2021-03-18 05:55:55.853	05 Site Management	05.01 Site Selection
9763	85	1616043356320:2099418981	1616043355766:-608489152	D5170C00002	779	778	CREATE	2021-03-18 05:55:56.408	05.01 Site Selection	05.01.02 Confidentiality Agreement
9765	85	1616043357467:-1143232140	1616043355766:-608489152	D5170C00002	781	778	CREATE	2021-03-18 05:55:57.576	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
9766	85	1616043358063:-1294481514	1616043355130:-618369999	D5170C00002	782	777	CREATE	2021-03-18 05:55:58.155	05 Site Management	05.02 Site Set-up Documentation
9768	85	1616043359232:-1386999647	1616043358063:-1294481514	D5170C00002	784	782	CREATE	2021-03-18 05:55:59.321	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
9769	85	1616043359807:1832310202	1616043358063:-1294481514	D5170C00002	785	782	CREATE	2021-03-18 05:55:59.894	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
9770	85	1616043361325:1862841132	1616043358063:-1294481514	D5170C00002	786	782	CREATE	2021-03-18 05:56:01.415	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
9772	85	1616043362567:-1373708978	1616043358063:-1294481514	D5170C00002	788	782	CREATE	2021-03-18 05:56:02.673	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
9773	85	1616043363176:1847654584	1616043358063:-1294481514	D5170C00002	789	782	CREATE	2021-03-18 05:56:03.269	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
9775	85	1616043364349:-774814026	1616043358063:-1294481514	D5170C00002	791	782	CREATE	2021-03-18 05:56:04.453	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
9776	85	1616043365026:1232487312	1616043358063:-1294481514	D5170C00002	792	782	CREATE	2021-03-18 05:56:05.118	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
9778	85	1616043366256:1286418852	1616043355130:-618369999	D5170C00002	794	777	CREATE	2021-03-18 05:56:06.359	05 Site Management	05.03 Site Initiation
9779	85	1616043366895:-197946256	1616043366256:1286418852	D5170C00002	795	794	CREATE	2021-03-18 05:56:06.996	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
9780	85	1616043367530:-1239686530	1616043366256:1286418852	D5170C00002	796	794	CREATE	2021-03-18 05:56:07.643	05.03 Site Initiation	05.03.03 Site Training-Staff
9782	85	1616043368881:1332379371	1616043368299:1680009352	D5170C00002	798	797	CREATE	2021-03-18 05:56:08.97	05.04 Site Management	05.04.01 Subject Log
9783	85	1616043369496:-1909910890	1616043368299:1680009352	D5170C00002	799	797	CREATE	2021-03-18 05:56:09.583	05.04 Site Management	05.04.04 Visit Log
9785	85	1616043370686:609774682	1616043368299:1680009352	D5170C00002	801	797	CREATE	2021-03-18 05:56:10.774	05.04 Site Management	05.04.08 UNBLI_onitoring Report
9786	85	1616043372521:672870954	1616043355130:-618369999	D5170C00002	802	777	CREATE	2021-03-18 05:56:12.614	05 Site Management	05.05 General
9788	85	1616043373716:1233116060	1616043372521:672870954	D5170C00002	804	802	CREATE	2021-03-18 05:56:13.805	05.05 General	05.05.01 Relev_ations-Documents
9789	85	1616043374367:-1385482204	1616043372521:672870954	D5170C00002	805	802	CREATE	2021-03-18 05:56:14.455	05.05 General	05.05.02 Tracking Information
9791	85	1616043375658:646576004	1616043374962:-282784747	D5170C00002	807	806	CREATE	2021-03-18 05:56:15.746	06 IP and Trial Supplies	06.01 IP Documentation
9792	85	1616043376282:-1751408717	1616043375658:646576004	D5170C00002	808	807	CREATE	2021-03-18 05:56:16.371	06.01 IP Documentation	06.01.11 Certificate of Destruction
11648	86	\N	\N	D5170C00002	99	97	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
9794	85	1616043378529:1071040571	1616043376906:-26700856	D5170C00002	810	809	CREATE	2021-03-18 05:56:18.623	06.04 Storage	06.04.03 Maintenance Logs
9795	85	1616043379143:-1268316712	1616043374962:-282784747	D5170C00002	811	806	CREATE	2021-03-18 05:56:19.236	06 IP and Trial Supplies	06.05 Non-IP Documentation
9797	85	1616043380455:-2027397936	1616043379143:-1268316712	D5170C00002	813	811	CREATE	2021-03-18 05:56:20.544	06.05 Non-IP Documentation	06.05.03 Non-I_tation of Return
9798	85	1616043381078:-118070252	1616043345023:545793053	D5170C00002	814	761	CREATE	2021-03-18 05:56:21.185	2002367 Song, Geun Am	08 Centralized Testing
9800	85	1616043383607:1648241901	1616043381762:-32497933	D5170C00002	816	815	CREATE	2021-03-18 05:56:23.702	08.01 Facility Documentation	08.01.01 Certi_or Accreditation
9801	85	1616043384230:514563897	1616043381078:-118070252	D5170C00002	817	814	CREATE	2021-03-18 05:56:24.408	08 Centralized Testing	08.02 Sample Documentation
9803	85	1616043385668:392407193	1616043345023:545793053	D5170C00002	819	761	CREATE	2021-03-18 05:56:25.758	2002367 Song, Geun Am	10 Data Management
9804	85	1616043386277:-752701010	1616043385668:392407193	D5170C00002	820	819	CREATE	2021-03-18 05:56:26.368	10 Data Management	10.05 General
9805	85	1616043386929:568867108	1616043386277:-752701010	D5170C00002	821	820	CREATE	2021-03-18 05:56:27.02	10.05 General	10.05.02 Tracking Information
9807	85	1616043388161:-231994293	1616043387512:-1915588046	D5170C00002	823	822	CREATE	2021-03-18 05:56:28.252	2002368 Lee, Kang-Moon	02 Central Trial Documents
9809	85	1616043389414:1197448471	1616043388768:1598094545	D5170C00002	825	824	CREATE	2021-03-18 05:56:29.504	02.02 Subject Documents	02.02.03 Infor_t Form Templates
9810	85	1616043390059:-1470738344	1616043388161:-231994293	D5170C00002	826	823	CREATE	2021-03-18 05:56:30.148	02 Central Trial Documents	02.04 General
9811	85	1616043390669:-2138140510	1616043390059:-1470738344	D5170C00002	827	826	CREATE	2021-03-18 05:56:30.758	02.04 General	02.04.01 Relev_ations-Documents
9813	85	1616043391917:-686374319	1616043390059:-1470738344	D5170C00002	829	826	CREATE	2021-03-18 05:56:32.008	02.04 General	02.04.01 UNBLI_s-Contact Report
14750	88	1617050159901:1484582691	1617050144863:-122430637	D5170C00001	440	426	ALREADY AVAILABLE	2021-03-30 07:19:37.318	United States of America	IRB or IEC and other Approvals
9817	85	1616043395450:620658428	1616043393192:1078251389	D5170C00002	833	831	CREATE	2021-03-18 05:56:35.538	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
9818	85	1616043396054:1694179522	1616043393192:1078251389	D5170C00002	834	831	CREATE	2021-03-18 05:56:36.145	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
9820	85	1616043397367:-699915884	1616043396679:22518333	D5170C00002	836	835	CREATE	2021-03-18 05:56:37.457	04.03 Trial Status Reporting	04.03.01 IRB-I_y Info-Deviation
9821	85	1616043398023:886668322	1616043396679:22518333	D5170C00002	837	835	CREATE	2021-03-18 05:56:38.116	04.03 Trial Status Reporting	04.03.02 IRB-I_ Progress Report
9822	85	1616043398630:750389389	1616043387512:-1915588046	D5170C00002	838	822	CREATE	2021-03-18 05:56:38.721	2002368 Lee, Kang-Moon	05 Site Management
9824	85	1616043399850:783821869	1616043399191:-1934593837	D5170C00002	840	839	CREATE	2021-03-18 05:56:39.936	05.01 Site Selection	05.01.02 Confidentiality Agreement
9825	85	1616043400423:-2065803952	1616043399191:-1934593837	D5170C00002	841	839	CREATE	2021-03-18 05:56:40.509	05.01 Site Selection	05.01.03 Feasibility Documentation
9827	85	1616043401575:307420985	1616043398630:750389389	D5170C00002	843	838	CREATE	2021-03-18 05:56:41.665	05 Site Management	05.02 Site Set-up Documentation
9829	85	1616043402904:-1701800083	1616043401575:307420985	D5170C00002	845	843	CREATE	2021-03-18 05:56:42.989	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
9830	85	1616043403503:947609692	1616043401575:307420985	D5170C00002	846	843	CREATE	2021-03-18 05:56:43.593	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
9831	85	1616043404064:377931557	1616043401575:307420985	D5170C00002	847	843	CREATE	2021-03-18 05:56:44.152	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
9833	85	1616043406255:1564457987	1616043401575:307420985	D5170C00002	849	843	CREATE	2021-03-18 05:56:46.341	05.02 Site Set-up Documentation	05.02.09 Investigator Regulatory Agreement
9834	85	1616043406831:2127986961	1616043401575:307420985	D5170C00002	850	843	CREATE	2021-03-18 05:56:46.919	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
9835	85	1616043407460:85061326	1616043401575:307420985	D5170C00002	851	843	CREATE	2021-03-18 05:56:47.549	05.02 Site Set-up Documentation	05.02.11 Data Privacy
9837	85	1616043408712:-933144500	1616043401575:307420985	D5170C00002	853	843	CREATE	2021-03-18 05:56:48.804	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
9838	85	1616043409345:-90728913	1616043401575:307420985	D5170C00002	854	843	CREATE	2021-03-18 05:56:49.437	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
9840	85	1616043410635:-1516561207	1616043409960:-39675224	D5170C00002	856	855	CREATE	2021-03-18 05:56:50.721	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
9841	85	1616043411310:2045772936	1616043409960:-39675224	D5170C00002	857	855	CREATE	2021-03-18 05:56:51.397	05.03 Site Initiation	05.03.03 Site Training-Staff
9843	85	1616043412541:-1157049376	1616043398630:750389389	D5170C00002	859	838	CREATE	2021-03-18 05:56:52.628	05 Site Management	05.04 Site Management
9844	85	1616043413172:-1640847071	1616043412541:-1157049376	D5170C00002	860	859	CREATE	2021-03-18 05:56:53.263	05.04 Site Management	05.04.02 Source Data Verification
9845	85	1616043413799:-1879443744	1616043412541:-1157049376	D5170C00002	861	859	CREATE	2021-03-18 05:56:53.89	05.04 Site Management	05.04.04 Visit Log
9847	85	1616043414906:784235759	1616043412541:-1157049376	D5170C00002	863	859	CREATE	2021-03-18 05:56:54.994	05.04 Site Management	05.04.08 UNBLI_onitoring Report
9848	85	1616043416545:-797248880	1616043398630:750389389	D5170C00002	864	838	CREATE	2021-03-18 05:56:56.635	05 Site Management	05.05 General
9850	85	1616043417935:-1117034276	1616043416545:-797248880	D5170C00002	866	864	CREATE	2021-03-18 05:56:58.023	05.05 General	05.05.02 Tracking Information
9851	85	1616043418573:1085964032	1616043387512:-1915588046	D5170C00002	867	822	CREATE	2021-03-18 05:56:58.664	2002368 Lee, Kang-Moon	06 IP and Trial Supplies
9853	85	1616043423553:-783532736	1616043419194:-239559611	D5170C00002	869	868	CREATE	2021-03-18 05:57:03.641	06.04 Storage	06.04.03 Maintenance Logs
9854	85	1616043424209:1673162052	1616043032792:2030519844	D5170C00002	870	317	CREATE	2021-03-18 05:57:04.296	Site	2002369 Lee, Bo In
9856	85	1616043425553:933271639	1616043424821:-1785648185	D5170C00002	872	871	CREATE	2021-03-18 05:57:05.642	02 Central Trial Documents	02.02 Subject Documents
9857	85	1616043426176:-937140773	1616043425553:933271639	D5170C00002	873	872	CREATE	2021-03-18 05:57:06.264	02.02 Subject Documents	02.02.03 Infor_ Form Checklists
9859	85	1616043428097:-2135561250	1616043424821:-1785648185	D5170C00002	875	871	CREATE	2021-03-18 05:57:08.181	02 Central Trial Documents	02.04 General
9860	85	1616043428710:-1075797535	1616043428097:-2135561250	D5170C00002	876	875	CREATE	2021-03-18 05:57:08.794	02.04 General	02.04.01 Relev_s-Contact Report
9862	85	1616043430073:507809959	1616043424209:1673162052	D5170C00002	878	870	CREATE	2021-03-18 05:57:10.17	2002369 Lee, Bo In	04 IRB-IEC and other Approvals
9863	85	1616043430702:2085232792	1616043430073:507809959	D5170C00002	879	878	CREATE	2021-03-18 05:57:10.792	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
9865	85	1616043432009:-1682334126	1616043430702:2085232792	D5170C00002	881	879	CREATE	2021-03-18 05:57:12.102	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
9866	85	1616043432566:-1716706007	1616043430702:2085232792	D5170C00002	882	879	CREATE	2021-03-18 05:57:12.661	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
9868	85	1616043433704:2132412930	1616043433165:576324421	D5170C00002	884	883	CREATE	2021-03-18 05:57:13.794	04.03 Trial Status Reporting	04.03.01 IRB-I_y Info-Deviation
9869	85	1616043434253:1384955280	1616043433165:576324421	D5170C00002	885	883	CREATE	2021-03-18 05:57:14.339	04.03 Trial Status Reporting	04.03.02 IRB-I_ Progress Report
9871	85	1616043435419:-485091902	1616043434789:-1102432754	D5170C00002	887	886	CREATE	2021-03-18 05:57:15.507	04.04 General	04.04.01 Relev_RB-IEC-Documents
9872	85	1616043435988:-1882183708	1616043424209:1673162052	D5170C00002	888	870	CREATE	2021-03-18 05:57:16.077	2002369 Lee, Bo In	05 Site Management
9874	85	1616043437107:-782488936	1616043436552:-87006701	D5170C00002	890	889	CREATE	2021-03-18 05:57:17.748	05.01 Site Selection	05.01.02 Confidentiality Agreement
9875	85	1616043438302:806878297	1616043436552:-87006701	D5170C00002	891	889	CREATE	2021-03-18 05:57:18.391	05.01 Site Selection	05.01.03 Feasibility Documentation
9877	85	1616043439429:-769848190	1616043435988:-1882183708	D5170C00002	893	888	CREATE	2021-03-18 05:57:19.519	05 Site Management	05.02 Site Set-up Documentation
9878	85	1616043439988:-1351487029	1616043439429:-769848190	D5170C00002	894	893	CREATE	2021-03-18 05:57:20.079	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
9881	85	1616043441916:-1105028538	1616043439429:-769848190	D5170C00002	897	893	CREATE	2021-03-18 05:57:22.005	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
9882	85	1616043442501:2055097649	1616043439429:-769848190	D5170C00002	898	893	CREATE	2021-03-18 05:57:22.59	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
9884	85	1616043443802:-721954464	1616043439429:-769848190	D5170C00002	900	893	CREATE	2021-03-18 05:57:23.898	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
9885	85	1616043444408:-174953806	1616043439429:-769848190	D5170C00002	901	893	CREATE	2021-03-18 05:57:24.504	05.02 Site Set-up Documentation	05.02.11 Data Privacy
9886	85	1616043444990:950544222	1616043439429:-769848190	D5170C00002	902	893	CREATE	2021-03-18 05:57:25.085	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
9888	85	1616043446147:1325291361	1616043439429:-769848190	D5170C00002	904	893	CREATE	2021-03-18 05:57:26.372	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
9889	85	1616043451758:-1120105881	1616043435988:-1882183708	D5170C00002	905	888	CREATE	2021-03-18 05:57:31.847	05 Site Management	05.03 Site Initiation
9891	85	1616043453038:-528921490	1616043451758:-1120105881	D5170C00002	907	905	CREATE	2021-03-18 05:57:33.145	05.03 Site Initiation	05.03.03 Site Training-Staff
9892	85	1616043453603:644611918	1616043451758:-1120105881	D5170C00002	908	905	CREATE	2021-03-18 05:57:33.696	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
9893	85	1616043454223:834552909	1616043435988:-1882183708	D5170C00002	909	888	CREATE	2021-03-18 05:57:34.314	05 Site Management	05.04 Site Management
9895	85	1616043455955:-1471086821	1616043454223:834552909	D5170C00002	911	909	CREATE	2021-03-18 05:57:36.043	05.04 Site Management	05.04.04 Visit Log
9897	85	1616043457094:-212770971	1616043454223:834552909	D5170C00002	913	909	CREATE	2021-03-18 05:57:37.185	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
9898	85	1616043457728:-1874518055	1616043435988:-1882183708	D5170C00002	914	888	CREATE	2021-03-18 05:57:37.814	05 Site Management	05.05 General
9899	85	1616043458439:7266721	1616043457728:-1874518055	D5170C00002	915	914	CREATE	2021-03-18 05:57:39.187	05.05 General	05.05.01 Rel_cations-Email
9901	85	1616043460354:1483706943	1616043457728:-1874518055	D5170C00002	917	914	CREATE	2021-03-18 05:57:40.445	05.05 General	05.05.02 Tracking Information
9902	85	1616043460963:-464507160	1616043424209:1673162052	D5170C00002	918	870	CREATE	2021-03-18 05:57:41.048	2002369 Lee, Bo In	06 IP and Trial Supplies
9903	85	1616043461566:1535808464	1616043460963:-464507160	D5170C00002	919	918	CREATE	2021-03-18 05:57:41.658	06 IP and Trial Supplies	06.01 IP Documentation
9905	85	1616043462760:-813588674	1616043460963:-464507160	D5170C00002	921	918	CREATE	2021-03-18 05:57:42.849	06 IP and Trial Supplies	06.04 Storage
9906	85	1616043463537:-904606821	1616043462760:-813588674	D5170C00002	922	921	CREATE	2021-03-18 05:57:43.625	06.04 Storage	06.04.03 Maintenance Logs
9908	85	1616043464646:-547300955	1616043464098:987759161	D5170C00002	924	923	CREATE	2021-03-18 05:57:44.735	06.05 Non-IP Documentation	06.05.02 Non-IP Documentation of Shipment
9909	85	1616043465302:-158907171	1616043424209:1673162052	D5170C00002	925	870	CREATE	2021-03-18 05:57:45.393	2002369 Lee, Bo In	08 Centralized Testing
9911	85	1616043466586:-89827820	1616043465983:-1370879171	D5170C00002	927	926	CREATE	2021-03-18 05:57:46.675	08.02 Sample Documentation	08.02.03 Sample Storage Condition Log
9912	85	1616043467162:2024493087	1615838976578:1645421407	D5170C00002	928	4	CREATE	2021-03-18 05:57:47.25	contents	NETHERLANDS
9914	85	1616043468320:2059636529	1616043467753:1424116701	D5170C00002	930	929	CREATE	2021-03-18 05:57:48.409	Site	2001763 van _oude, Janneke
9916	85	1616043470340:-268014748	1616043468972:1956668992	D5170C00002	932	931	CREATE	2021-03-18 05:57:50.436	02 Central Trial Documents	02.02 Subject Documents
9917	85	1616043470947:-1428752557	1616043470340:-268014748	D5170C00002	933	932	CREATE	2021-03-18 05:57:51.036	02.02 Subject Documents	02.02.03 Infor_t Form Templates
9918	85	1616043471510:-293894555	1616043468972:1956668992	D5170C00002	934	931	CREATE	2021-03-18 05:57:51.605	02 Central Trial Documents	02.04 General
9920	85	1616043472749:1252802652	1616043471510:-293894555	D5170C00002	936	934	CREATE	2021-03-18 05:57:52.842	02.04 General	02.04.01 UNBLI_s-Contact Report
11649	86	\N	\N	D5170C00002	100	97	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
9922	85	1616043473942:-790108260	1616043473348:-1864837670	D5170C00002	938	937	CREATE	2021-03-18 05:57:54.031	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
9923	85	1616043474533:-878155378	1616043473942:-790108260	D5170C00002	939	938	CREATE	2021-03-18 05:57:54.626	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
9924	85	1616043475104:-1211899473	1616043468320:2059636529	D5170C00002	940	930	CREATE	2021-03-18 05:57:55.194	2001763 van _oude, Janneke	05 Site Management
9926	85	1616043476323:222976545	1616043475738:1742136313	D5170C00002	942	941	CREATE	2021-03-18 05:57:56.414	05.01 Site Selection	05.01.01 Site Contact Details
9928	85	1616043482991:-118674493	1616043475738:1742136313	D5170C00002	944	941	CREATE	2021-03-18 05:58:03.085	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
9929	85	1616043483742:-1418815226	1616043475104:-1211899473	D5170C00002	945	940	CREATE	2021-03-18 05:58:03.833	05 Site Management	05.02 Site Set-up Documentation
9931	85	1616043484945:-1353445023	1616043483742:-1418815226	D5170C00002	947	945	CREATE	2021-03-18 05:58:05.044	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
9932	85	1616043485557:-1918899502	1616043483742:-1418815226	D5170C00002	948	945	CREATE	2021-03-18 05:58:05.645	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
9933	85	1616043486204:173375397	1616043483742:-1418815226	D5170C00002	949	945	CREATE	2021-03-18 05:58:06.29	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
9935	85	1616043487346:-1261435105	1616043483742:-1418815226	D5170C00002	951	945	CREATE	2021-03-18 05:58:07.435	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
9936	85	1616043487949:-627362836	1616043483742:-1418815226	D5170C00002	952	945	CREATE	2021-03-18 05:58:08.037	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
9938	85	1616043489351:890584174	1616043483742:-1418815226	D5170C00002	954	945	CREATE	2021-03-18 05:58:09.443	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
9939	85	1616043489932:-481579545	1616043483742:-1418815226	D5170C00002	955	945	CREATE	2021-03-18 05:58:10.019	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
9941	85	1616043492284:1145128763	1616043483742:-1418815226	D5170C00002	957	945	CREATE	2021-03-18 05:58:12.378	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
9942	85	1616043492879:568141030	1616043475104:-1211899473	D5170C00002	958	940	CREATE	2021-03-18 05:58:12.97	05 Site Management	05.03 Site Initiation
10073	85	1616043584535:-2097377763	1616043550459:1372147956	D5170C00002	1089	1043	CREATE	2021-03-18 05:59:44.623	2001765 Pierik, Marieke	06 IP and Trial Supplies
8842	84	\N	\N	D5170C00002	2627	2626	NEW	\N	05 Site Management	05.01 Site Selection
8844	84	\N	\N	D5170C00002	2629	4	NEW	\N	contents	ITALY
8845	84	\N	\N	D5170C00002	2630	2629	NEW	\N	ITALY	Site
9944	85	1616043494205:-143106357	1616043492879:568141030	D5170C00002	960	958	CREATE	2021-03-18 05:58:14.294	05.03 Site Initiation	05.03.03 Site Training-Staff
9946	85	1616043495451:-1631281982	1616043475104:-1211899473	D5170C00002	962	940	CREATE	2021-03-18 05:58:15.544	05 Site Management	05.04 Site Management
9947	85	1616043496076:1207731259	1616043495451:-1631281982	D5170C00002	963	962	CREATE	2021-03-18 05:58:16.17	05.04 Site Management	05.04.01 Subject Log
9949	85	1616043497335:1909557225	1616043495451:-1631281982	D5170C00002	965	962	CREATE	2021-03-18 05:58:17.428	05.04 Site Management	05.04.04 UNBLINDED Visit Log
9950	85	1616043497987:1126663143	1616043495451:-1631281982	D5170C00002	966	962	CREATE	2021-03-18 05:58:18.077	05.04 Site Management	05.04.04 Visit Log
9951	85	1616043498556:-600442799	1616043495451:-1631281982	D5170C00002	967	962	CREATE	2021-03-18 05:58:18.648	05.04 Site Management	05.04.05 UNBLI_itoring Activity
9953	85	1616043499747:978799721	1616043495451:-1631281982	D5170C00002	969	962	CREATE	2021-03-18 05:58:19.837	05.04 Site Management	05.04.08 UNBLI_onitoring Report
9954	85	1616043500401:-45406868	1616043475104:-1211899473	D5170C00002	970	940	CREATE	2021-03-18 05:58:20.491	05 Site Management	05.05 General
9956	85	1616043501639:-179572246	1616043500401:-45406868	D5170C00002	972	970	CREATE	2021-03-18 05:58:21.738	05.05 General	05.05.02 Tracking Information
9957	85	1616043503128:1598538866	1616043468320:2059636529	D5170C00002	973	930	CREATE	2021-03-18 05:58:23.22	2001763 van _oude, Janneke	06 IP and Trial Supplies
9959	85	1616043504412:-2065965447	1616043503819:1066045526	D5170C00002	975	974	CREATE	2021-03-18 05:58:24.572	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
9960	85	1616043505037:-1240333935	1616043503819:1066045526	D5170C00002	976	974	CREATE	2021-03-18 05:58:25.126	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
9962	85	1616043506187:-1910087950	1616043503819:1066045526	D5170C00002	978	974	CREATE	2021-03-18 05:58:26.276	06.01 IP Documentation	06.01.11 UNBLI_e of Destruction
9963	85	1616043506819:-57298212	1616043503128:1598538866	D5170C00002	979	973	CREATE	2021-03-18 05:58:26.907	06 IP and Trial Supplies	06.04 Storage
9965	85	1616043507955:-312239710	1616043506819:-57298212	D5170C00002	981	979	CREATE	2021-03-18 05:58:28.04	06.04 Storage	06.04.02 UNBLI_on Documentation
9966	85	1616043508511:626649369	1616043506819:-57298212	D5170C00002	982	979	CREATE	2021-03-18 05:58:28.601	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
9968	85	1616043509794:505715298	1616043509101:1392855105	D5170C00002	984	983	CREATE	2021-03-18 05:58:29.896	06.07 General	06.07.01 UNBLI_al Product-Email
9969	85	1616043510377:503914846	1616043509101:1392855105	D5170C00002	985	983	CREATE	2021-03-18 05:58:30.469	06.07 General	06.07.01 UNBLI_roduct-Documents
9971	85	1616043511523:11790088	1616043510953:1763391278	D5170C00002	987	986	CREATE	2021-03-18 05:58:31.613	08 Centralized Testing	08.01 Facility Documentation
9972	85	1616043512079:-1228956664	1616043511523:11790088	D5170C00002	988	987	CREATE	2021-03-18 05:58:32.169	08.01 Facility Documentation	08.01.01 Certi_or Accreditation
9974	85	1616043514232:1821964700	1616043467753:1424116701	D5170C00002	990	929	CREATE	2021-03-18 05:58:34.318	Site	2001764 Kubben, Francois
9975	85	1616043514844:-255850501	1616043514232:1821964700	D5170C00002	991	990	CREATE	2021-03-18 05:58:34.935	2001764 Kubben, Francois	02 Central Trial Documents
9977	85	1616043516021:1576966339	1616043515464:553764480	D5170C00002	993	992	CREATE	2021-03-18 05:58:36.109	02.02 Subject Documents	02.02.03 Infor_t Form Templates
9978	85	1616043516594:-1641387733	1616043514232:1821964700	D5170C00002	994	990	CREATE	2021-03-18 05:58:36.681	2001764 Kubben, Francois	03 Regulatory
9980	85	1616043517736:1479426361	1616043517155:245931013	D5170C00002	996	995	CREATE	2021-03-18 05:58:37.823	03.04 General	03.04.01 Relev_art-Up-Documents
9982	85	1616043519008:-370532889	1616043518391:308156014	D5170C00002	998	997	CREATE	2021-03-18 05:58:39.098	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
9983	85	1616043519578:-313938751	1616043519008:-370532889	D5170C00002	999	998	CREATE	2021-03-18 05:58:39.667	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
9984	85	1616043520148:-306590432	1616043519008:-370532889	D5170C00002	1000	998	CREATE	2021-03-18 05:58:40.239	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
9986	85	1616043521342:-588261507	1616043520752:-1941047640	D5170C00002	1002	1001	CREATE	2021-03-18 05:58:41.43	05 Site Management	05.01 Site Selection
9987	85	1616043522000:-895703811	1616043521342:-588261507	D5170C00002	1003	1002	CREATE	2021-03-18 05:58:42.088	05.01 Site Selection	05.01.01 Site Contact Details
9989	85	1616043523154:927040248	1616043521342:-588261507	D5170C00002	1005	1002	CREATE	2021-03-18 05:58:43.24	05.01 Site Selection	05.01.03 Feasibility Documentation
9990	85	1616043523887:-979994487	1616043521342:-588261507	D5170C00002	1006	1002	CREATE	2021-03-18 05:58:44.729	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
9992	85	1616043526036:1261038532	1616043525396:121637577	D5170C00002	1008	1007	CREATE	2021-03-18 05:58:46.126	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
9993	85	1616043526687:-1487065334	1616043525396:121637577	D5170C00002	1009	1007	CREATE	2021-03-18 05:58:46.777	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
9995	85	1616043528496:-410386055	1616043525396:121637577	D5170C00002	1011	1007	CREATE	2021-03-18 05:58:48.586	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
9996	85	1616043529097:-2080615257	1616043525396:121637577	D5170C00002	1012	1007	CREATE	2021-03-18 05:58:49.188	05.02 Site Set-up Documentation	05.02.07 Site Qualification
9998	85	1616043530405:-1625227161	1616043525396:121637577	D5170C00002	1014	1007	CREATE	2021-03-18 05:58:50.497	05.02 Site Set-up Documentation	05.02.09 Investigator Regulatory Agreement
9999	85	1616043531051:2007300581	1616043525396:121637577	D5170C00002	1015	1007	CREATE	2021-03-18 05:58:51.272	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
10000	85	1616043531780:-1983816246	1616043525396:121637577	D5170C00002	1016	1007	CREATE	2021-03-18 05:58:51.87	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
10002	85	1616043533008:-369484390	1616043520752:-1941047640	D5170C00002	1018	1001	CREATE	2021-03-18 05:58:53.094	05 Site Management	05.03 Site Initiation
10003	85	1616043533601:138735842	1616043533008:-369484390	D5170C00002	1019	1018	CREATE	2021-03-18 05:58:53.687	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
10005	85	1616043534822:-1483654624	1616043520752:-1941047640	D5170C00002	1021	1001	CREATE	2021-03-18 05:58:55.694	05 Site Management	05.04 Site Management
10006	85	1616043536296:-1058619327	1616043534822:-1483654624	D5170C00002	1022	1021	CREATE	2021-03-18 05:58:56.385	05.04 Site Management	05.04.01 Subject Log
14756	88	1617050164909:258256819	1617050144863:-122430637	D5170C00001	446	426	ALREADY AVAILABLE	2021-03-30 07:19:37.318	United States of America	Regulatory
10011	85	1616043539772:-1404121214	1616043534822:-1483654624	D5170C00002	1027	1021	CREATE	2021-03-18 05:58:59.857	05.04 Site Management	05.04.08 UNBLI_onitoring Report
10012	85	1616043540343:-1123854128	1616043520752:-1941047640	D5170C00002	1028	1001	CREATE	2021-03-18 05:59:00.431	05 Site Management	05.05 General
10013	85	1616043540927:-391071210	1616043540343:-1123854128	D5170C00002	1029	1028	CREATE	2021-03-18 05:59:01.019	05.05 General	05.05.01 Relev_ations-Documents
10015	85	1616043542133:-1526139013	1616043540343:-1123854128	D5170C00002	1031	1028	CREATE	2021-03-18 05:59:02.22	05.05 General	05.05.02 Tracking Information
10016	85	1616043542733:-1890320595	1616043514232:1821964700	D5170C00002	1032	990	CREATE	2021-03-18 05:59:02.823	2001764 Kubben, Francois	06 IP and Trial Supplies
10018	85	1616043543884:638111501	1616043543301:732779521	D5170C00002	1034	1033	CREATE	2021-03-18 05:59:03.971	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
10019	85	1616043544490:943018751	1616043542733:-1890320595	D5170C00002	1035	1032	CREATE	2021-03-18 05:59:04.58	06 IP and Trial Supplies	06.07 General
10021	85	1616043545745:-541368869	1616043544490:943018751	D5170C00002	1037	1035	CREATE	2021-03-18 05:59:06.764	06.07 General	06.07.01 UNBLI_al Product-Email
10022	85	1616043547349:-217813539	1616043514232:1821964700	D5170C00002	1038	990	CREATE	2021-03-18 05:59:07.473	2001764 Kubben, Francois	08 Centralized Testing
10024	85	1616043548611:926102118	1616043548012:-1329219092	D5170C00002	1040	1039	CREATE	2021-03-18 05:59:08.691	08.01 Facility Documentation	08.01.01 Certi_or Accreditation
10025	85	1616043549217:1648632802	1616043548012:-1329219092	D5170C00002	1041	1039	CREATE	2021-03-18 05:59:09.305	08.01 Facility Documentation	08.01.04 Norma_and Alert Values
10027	85	1616043550459:1372147956	1616043467753:1424116701	D5170C00002	1043	929	CREATE	2021-03-18 05:59:10.546	Site	2001765 Pierik, Marieke
10028	85	1616043551063:738841195	1616043550459:1372147956	D5170C00002	1044	1043	CREATE	2021-03-18 05:59:11.161	2001765 Pierik, Marieke	02 Central Trial Documents
10030	85	1616043552278:544705337	1616043551679:-1563348389	D5170C00002	1046	1045	CREATE	2021-03-18 05:59:12.368	02.02 Subject Documents	02.02.03 Infor_t Form Templates
10031	85	1616043552898:-2013323651	1616043551063:738841195	D5170C00002	1047	1044	CREATE	2021-03-18 05:59:12.986	02 Central Trial Documents	02.04 General
10032	85	1616043553520:217881562	1616043552898:-2013323651	D5170C00002	1048	1047	CREATE	2021-03-18 05:59:13.606	02.04 General	02.04.01 Relev_s-Contact Report
10034	85	1616043554892:-1343876684	1616043552898:-2013323651	D5170C00002	1050	1047	CREATE	2021-03-18 05:59:14.985	02.04 General	02.04.04 Filenote
10036	85	1616043556381:460876392	1616043555742:-1265712740	D5170C00002	1052	1051	CREATE	2021-03-18 05:59:16.472	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
10037	85	1616043557951:906442826	1616043556381:460876392	D5170C00002	1053	1052	CREATE	2021-03-18 05:59:18.045	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
10038	85	1616043558637:-733789126	1616043555742:-1265712740	D5170C00002	1054	1051	CREATE	2021-03-18 05:59:18.725	04 IRB-IEC and other Approvals	04.02 Other Committees
10040	85	1616043559912:639229062	1616043550459:1372147956	D5170C00002	1056	1043	CREATE	2021-03-18 05:59:20.002	2001765 Pierik, Marieke	05 Site Management
10041	85	1616043560570:597624834	1616043559912:639229062	D5170C00002	1057	1056	CREATE	2021-03-18 05:59:20.679	05 Site Management	05.01 Site Selection
10043	85	1616043561945:632789860	1616043560570:597624834	D5170C00002	1059	1057	CREATE	2021-03-18 05:59:22.037	05.01 Site Selection	05.01.02 Confidentiality Agreement
10044	85	1616043562576:172463887	1616043560570:597624834	D5170C00002	1060	1057	CREATE	2021-03-18 05:59:22.673	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
10046	85	1616043563949:995937915	1616043563221:1616853828	D5170C00002	1062	1061	CREATE	2021-03-18 05:59:24.047	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
10047	85	1616043564620:385461203	1616043563221:1616853828	D5170C00002	1063	1061	CREATE	2021-03-18 05:59:24.712	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
10049	85	1616043566017:832146754	1616043563221:1616853828	D5170C00002	1065	1061	CREATE	2021-03-18 05:59:26.107	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
10050	85	1616043566673:-838082448	1616043563221:1616853828	D5170C00002	1066	1061	CREATE	2021-03-18 05:59:26.775	05.02 Site Set-up Documentation	05.02.07 Site Qualification
10052	85	1616043568955:-523537410	1616043563221:1616853828	D5170C00002	1068	1061	CREATE	2021-03-18 05:59:29.043	05.02 Site Set-up Documentation	05.02.09 Investigator Regulatory Agreement
10053	85	1616043569647:39991564	1616043563221:1616853828	D5170C00002	1069	1061	CREATE	2021-03-18 05:59:29.748	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
10055	85	1616043571093:1154233485	1616043563221:1616853828	D5170C00002	1071	1061	CREATE	2021-03-18 05:59:31.183	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
10056	85	1616043571756:744592422	1616043563221:1616853828	D5170C00002	1072	1061	CREATE	2021-03-18 05:59:31.844	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
10057	85	1616043572436:-1943245689	1616043559912:639229062	D5170C00002	1073	1056	CREATE	2021-03-18 05:59:32.538	05 Site Management	05.03 Site Initiation
10059	85	1616043573775:-1021450826	1616043572436:-1943245689	D5170C00002	1075	1073	CREATE	2021-03-18 05:59:33.876	05.03 Site Initiation	05.03.03 Site Training-Staff
10060	85	1616043574439:-1073992036	1616043572436:-1943245689	D5170C00002	1076	1073	CREATE	2021-03-18 05:59:34.53	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
10061	85	1616043575092:-1099651965	1616043559912:639229062	D5170C00002	1077	1056	CREATE	2021-03-18 05:59:35.191	05 Site Management	05.04 Site Management
10063	85	1616043576440:-1492101963	1616043575092:-1099651965	D5170C00002	1079	1077	CREATE	2021-03-18 05:59:36.534	05.04 Site Management	05.04.03 UNBLINDED Monitoring Visit Report
10064	85	1616043577197:1480647312	1616043575092:-1099651965	D5170C00002	1080	1077	CREATE	2021-03-18 05:59:37.295	05.04 Site Management	05.04.04 UNBLINDED Visit Log
10066	85	1616043578730:55836412	1616043575092:-1099651965	D5170C00002	1082	1077	CREATE	2021-03-18 05:59:38.836	05.04 Site Management	05.04.05 UNBLI_itoring Activity
10068	85	1616043581120:229831978	1616043575092:-1099651965	D5170C00002	1084	1077	CREATE	2021-03-18 05:59:41.213	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
10069	85	1616043581834:-726375897	1616043575092:-1099651965	D5170C00002	1085	1077	CREATE	2021-03-18 05:59:41.921	05.04 Site Management	05.04.08 UNBLI_onitoring Report
10070	85	1616043582509:-739830251	1616043559912:639229062	D5170C00002	1086	1056	CREATE	2021-03-18 05:59:42.597	05 Site Management	05.05 General
10072	85	1616043583835:-1383454927	1616043582509:-739830251	D5170C00002	1088	1086	CREATE	2021-03-18 05:59:43.929	05.05 General	05.05.02 Tracking Information
16068	88	1617082427470:-323588963	1617051398365:442414412	D5170C00001	1758	1757	CREATE	2021-03-30 07:33:47.554	Other Committees	Other Submissions
10076	85	1616043586936:-1940627011	1616043585201:-191295877	D5170C00002	1092	1090	CREATE	2021-03-18 05:59:47.025	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
10077	85	1616043587643:996123948	1616043585201:-191295877	D5170C00002	1093	1090	CREATE	2021-03-18 05:59:47.736	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
10079	85	1616043588965:-723708461	1616043584535:-2097377763	D5170C00002	1095	1089	CREATE	2021-03-18 05:59:49.053	06 IP and Trial Supplies	06.04 Storage
10080	85	1616043589621:-1128917607	1616043588965:-723708461	D5170C00002	1096	1095	CREATE	2021-03-18 05:59:49.711	06.04 Storage	06.04.01 UNBLINDED Storage Condition Documentation
10082	85	1616043592032:1544435470	1616043588965:-723708461	D5170C00002	1098	1095	CREATE	2021-03-18 05:59:52.121	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
10083	85	1616043592738:135524311	1616043584535:-2097377763	D5170C00002	1099	1089	CREATE	2021-03-18 05:59:52.938	06 IP and Trial Supplies	06.07 General
10084	85	1616043593471:-1725343239	1616043592738:135524311	D5170C00002	1100	1099	CREATE	2021-03-18 05:59:53.562	06.07 General	06.07.01 UNBLI_roduct-Documents
10086	85	1616043594800:-1483379208	1616043594121:-1296617415	D5170C00002	1102	1101	CREATE	2021-03-18 05:59:54.883	2001766 Dijkstra, Gerard	02 Central Trial Documents
10088	85	1616043596126:-35181449	1616043595486:470346733	D5170C00002	1104	1103	CREATE	2021-03-18 06:00:00.117	02.02 Subject Documents	02.02.03 Infor_ Form Checklists
10089	85	1616043600795:-1750093404	1616043595486:470346733	D5170C00002	1105	1103	CREATE	2021-03-18 06:00:00.894	02.02 Subject Documents	02.02.03 Infor_t Form Templates
10090	85	1616043606235:473674094	1616043594800:-1483379208	D5170C00002	1106	1102	CREATE	2021-03-18 06:00:06.339	02 Central Trial Documents	02.04 General
10092	85	1616043607404:-585770074	1616043594121:-1296617415	D5170C00002	1108	1101	CREATE	2021-03-18 06:00:07.509	2001766 Dijkstra, Gerard	04 IRB-IEC and other Approvals
10093	85	1616043608098:-956033575	1616043607404:-585770074	D5170C00002	1109	1108	CREATE	2021-03-18 06:00:08.184	04 IRB-IEC and other Approvals	04.02 Other Committees
10095	85	1616043610009:-357001595	1616043594121:-1296617415	D5170C00002	1111	1101	CREATE	2021-03-18 06:00:10.104	2001766 Dijkstra, Gerard	05 Site Management
10096	85	1616043610593:1189547592	1616043610009:-357001595	D5170C00002	1112	1111	CREATE	2021-03-18 06:00:10.684	05 Site Management	05.01 Site Selection
10098	85	1616043611725:-328805975	1616043610593:1189547592	D5170C00002	1114	1112	CREATE	2021-03-18 06:00:11.936	05.01 Site Selection	05.01.02 Confidentiality Agreement
10099	85	1616043612388:1260561258	1616043610593:1189547592	D5170C00002	1115	1112	CREATE	2021-03-18 06:00:12.48	05.01 Site Selection	05.01.03 Feasibility Documentation
10101	85	1616043613528:1758624836	1616043610009:-357001595	D5170C00002	1117	1111	CREATE	2021-03-18 06:00:13.62	05 Site Management	05.02 Site Set-up Documentation
10102	85	1616043614075:-2033733304	1616043613528:1758624836	D5170C00002	1118	1117	CREATE	2021-03-18 06:00:14.218	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
10104	85	1616043615247:-2043300757	1616043613528:1758624836	D5170C00002	1120	1117	CREATE	2021-03-18 06:00:15.336	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
10105	85	1616043615791:1373720668	1616043613528:1758624836	D5170C00002	1121	1117	CREATE	2021-03-18 06:00:16.443	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
10106	85	1616043617102:-828971729	1616043613528:1758624836	D5170C00002	1122	1117	CREATE	2021-03-18 06:00:17.203	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
10108	85	1616043618360:1229311992	1616043613528:1758624836	D5170C00002	1124	1117	CREATE	2021-03-18 06:00:18.453	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
10303	85	1616043767232:-2038246709	1616043707500:1826778313	D5170C00002	1319	1234	CREATE	2021-03-18 06:02:47.549	Site	2001830 Tsibin, Andrey
10109	85	1616043618915:1301639057	1616043613528:1758624836	D5170C00002	1125	1117	CREATE	2021-03-18 06:00:19.006	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
10111	85	1616043621218:312459811	1616043613528:1758624836	D5170C00002	1127	1117	CREATE	2021-03-18 06:00:21.304	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
10112	85	1616043621827:192182998	1616043613528:1758624836	D5170C00002	1128	1117	CREATE	2021-03-18 06:00:21.916	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
10113	85	1616043622407:976486328	1616043613528:1758624836	D5170C00002	1129	1117	CREATE	2021-03-18 06:00:22.495	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
10115	85	1616043623613:1267502869	1616043610009:-357001595	D5170C00002	1131	1111	CREATE	2021-03-18 06:00:23.703	05 Site Management	05.03 Site Initiation
10116	85	1616043624241:506056183	1616043623613:1267502869	D5170C00002	1132	1131	CREATE	2021-03-18 06:00:24.329	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
10118	85	1616043625449:-591556527	1616043623613:1267502869	D5170C00002	1134	1131	CREATE	2021-03-18 06:00:25.536	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
10119	85	1616043626060:-928695007	1616043610009:-357001595	D5170C00002	1135	1111	CREATE	2021-03-18 06:00:26.15	05 Site Management	05.04 Site Management
10120	85	1616043627320:-897982384	1616043626060:-928695007	D5170C00002	1136	1135	CREATE	2021-03-18 06:00:27.436	05.04 Site Management	05.04.01 Subject Log
10122	85	1616043628646:1458229803	1616043626060:-928695007	D5170C00002	1138	1135	CREATE	2021-03-18 06:00:28.752	05.04 Site Management	05.04.05 Additional Monitoring Activity
10124	85	1616043629959:-1398543033	1616043626060:-928695007	D5170C00002	1140	1135	CREATE	2021-03-18 06:00:30.053	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
10125	85	1616043630598:-568883902	1616043610009:-357001595	D5170C00002	1141	1111	CREATE	2021-03-18 06:00:30.703	05 Site Management	05.05 General
10126	85	1616043631268:1904742258	1616043630598:-568883902	D5170C00002	1142	1141	CREATE	2021-03-18 06:00:31.362	05.05 General	05.05.01 Relev_unications-Email
10128	85	1616043632515:-2090323409	1616043630598:-568883902	D5170C00002	1144	1141	CREATE	2021-03-18 06:00:32.606	05.05 General	05.05.02 Tracking Information
10129	85	1616043633091:1510741831	1616043594121:-1296617415	D5170C00002	1145	1101	CREATE	2021-03-18 06:00:33.187	2001766 Dijkstra, Gerard	06 IP and Trial Supplies
10131	85	1616043634291:1055773757	1616043633692:-135474222	D5170C00002	1147	1146	CREATE	2021-03-18 06:00:34.381	06.04 Storage	06.04.01 Stora_on Documentation
10132	85	1616043634859:2069352813	1616043594121:-1296617415	D5170C00002	1148	1101	CREATE	2021-03-18 06:00:34.948	2001766 Dijkstra, Gerard	10 Data Management
10134	85	1616043635938:-785416609	1616043635393:1281555922	D5170C00002	1150	1149	CREATE	2021-03-18 06:00:36.025	10.04 EDC Management	10.04.01 System Account Management
10135	85	1616043636475:45205761	1615838976578:1645421407	D5170C00002	1151	4	CREATE	2021-03-18 06:00:36.564	contents	POLAND
10137	85	1616043638391:-1922604572	1616043637081:1888909623	D5170C00002	1153	1152	CREATE	2021-03-18 06:00:38.483	Site	2002173 Hartleb, Marek
15746	88	1617051090042:1240630777	1617051079236:111814508	D5170C00001	1436	1420	ALREADY AVAILABLE	2021-03-30 07:19:37.332	3303	Site Management
10141	85	1616043640737:-1360665539	1616043639522:-914848551	D5170C00002	1157	1155	CREATE	2021-03-18 06:00:40.848	02.04 General	02.04.01 Relev_s-Contact Report
10142	85	1616043641335:-105418088	1616043639522:-914848551	D5170C00002	1158	1155	CREATE	2021-03-18 06:00:41.445	02.04 General	02.04.01 UNBLI_s-Contact Report
10144	85	1616043642595:1616725266	1616043642029:1731761045	D5170C00002	1160	1159	CREATE	2021-03-18 06:00:42.696	05 Site Management	05.01 Site Selection
10145	85	1616043643166:-2003198819	1616043642595:1616725266	D5170C00002	1161	1160	CREATE	2021-03-18 06:00:43.257	05.01 Site Selection	05.01.02 Confidentiality Agreement
10147	85	1616043644386:1977273066	1616043642595:1616725266	D5170C00002	1163	1160	CREATE	2021-03-18 06:00:44.491	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
10148	85	1616043644961:-433002072	1616043642029:1731761045	D5170C00002	1164	1159	CREATE	2021-03-18 06:00:45.066	05 Site Management	05.02 Site Set-up Documentation
10150	85	1616043646099:-1514525695	1616043644961:-433002072	D5170C00002	1166	1164	CREATE	2021-03-18 06:00:46.192	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
10151	85	1616043646646:1555818053	1616043644961:-433002072	D5170C00002	1167	1164	CREATE	2021-03-18 06:00:46.733	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
10153	85	1616043648921:301594946	1616043644961:-433002072	D5170C00002	1169	1164	CREATE	2021-03-18 06:00:49.016	05.02 Site Set-up Documentation	05.02.07 Site Qualification
10154	85	1616043649514:-264774555	1616043644961:-433002072	D5170C00002	1170	1164	CREATE	2021-03-18 06:00:49.611	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
10155	85	1616043650079:1171096524	1616043644961:-433002072	D5170C00002	1171	1164	CREATE	2021-03-18 06:00:50.168	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
10157	85	1616043651242:303483236	1616043644961:-433002072	D5170C00002	1173	1164	CREATE	2021-03-18 06:00:51.341	05.02 Site Set-up Documentation	05.02.12 Clini_ Trial Agreement
10158	85	1616043651818:-1997820672	1616043644961:-433002072	D5170C00002	1174	1164	CREATE	2021-03-18 06:00:51.907	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
10160	85	1616043652936:-783344635	1616043642029:1731761045	D5170C00002	1176	1159	CREATE	2021-03-18 06:00:53.028	05 Site Management	05.03 Site Initiation
10161	85	1616043653579:-1581408111	1616043652936:-783344635	D5170C00002	1177	1176	CREATE	2021-03-18 06:00:53.668	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
10163	85	1616043654702:1928607611	1616043652936:-783344635	D5170C00002	1179	1176	CREATE	2021-03-18 06:00:54.788	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
10164	85	1616043655239:-78281207	1616043642029:1731761045	D5170C00002	1180	1159	CREATE	2021-03-18 06:00:55.328	05 Site Management	05.04 Site Management
10165	85	1616043655800:-607112750	1616043655239:-78281207	D5170C00002	1181	1180	CREATE	2021-03-18 06:00:55.903	05.04 Site Management	05.04.04 Visit Log
10167	85	1616043656981:-1396903142	1616043642029:1731761045	D5170C00002	1183	1159	CREATE	2021-03-18 06:00:57.071	05 Site Management	05.05 General
10168	85	1616043657546:-1825529325	1616043656981:-1396903142	D5170C00002	1184	1183	CREATE	2021-03-18 06:00:57.634	05.05 General	05.05.01 Relev_ations-Documents
10170	85	1616043658660:1923288712	1616043638391:-1922604572	D5170C00002	1186	1153	CREATE	2021-03-18 06:00:58.745	2002173 Hartleb, Marek	06 IP and Trial Supplies
10171	85	1616043660093:1336689441	1616043658660:1923288712	D5170C00002	1187	1186	CREATE	2021-03-18 06:01:00.18	06 IP and Trial Supplies	06.01 IP Documentation
11650	86	\N	\N	D5170C00002	101	97	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
10173	85	1616043661230:555179677	1616043637081:1888909623	D5170C00002	1189	1152	CREATE	2021-03-18 06:01:01.325	Site	2002174 Woznia_olarska, Barbara
10174	85	1616043676835:1059986138	1616043661230:555179677	D5170C00002	1190	1189	CREATE	2021-03-18 06:01:16.932	2002174 Woznia_olarska, Barbara	02 Central Trial Documents
10175	85	1616043677618:-929655048	1616043676835:1059986138	D5170C00002	1191	1190	CREATE	2021-03-18 06:01:17.706	02 Central Trial Documents	02.04 General
10177	85	1616043678854:-1640883993	1616043677618:-929655048	D5170C00002	1193	1191	CREATE	2021-03-18 06:01:18.943	02.04 General	02.04.01 Relev_s-Contact Report
10178	85	1616043679485:-99781089	1616043677618:-929655048	D5170C00002	1194	1191	CREATE	2021-03-18 06:01:19.618	02.04 General	02.04.01 UNBLI_s-Contact Report
10180	85	1616043681593:-812757175	1616043680146:-1692352071	D5170C00002	1196	1195	CREATE	2021-03-18 06:01:21.686	03 Regulatory	03.04 General
10182	85	1616043682856:-2108561109	1616043661230:555179677	D5170C00002	1198	1189	CREATE	2021-03-18 06:01:22.946	2002174 Woznia_olarska, Barbara	05 Site Management
10183	85	1616043683437:1407330710	1616043682856:-2108561109	D5170C00002	1199	1198	CREATE	2021-03-18 06:01:23.538	05 Site Management	05.01 Site Selection
10185	85	1616043684588:1745875517	1616043683437:1407330710	D5170C00002	1201	1199	CREATE	2021-03-18 06:01:24.688	05.01 Site Selection	05.01.03 Feasibility Documentation
10186	85	1616043685262:-158029563	1616043683437:1407330710	D5170C00002	1202	1199	CREATE	2021-03-18 06:01:25.371	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
10187	85	1616043685889:751341191	1616043682856:-2108561109	D5170C00002	1203	1198	CREATE	2021-03-18 06:01:25.993	05 Site Management	05.02 Site Set-up Documentation
10189	85	1616043687090:1276361494	1616043685889:751341191	D5170C00002	1205	1203	CREATE	2021-03-18 06:01:27.204	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
10190	85	1616043687728:1104926639	1616043685889:751341191	D5170C00002	1206	1203	CREATE	2021-03-18 06:01:27.829	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
10192	85	1616043688963:-297331634	1616043685889:751341191	D5170C00002	1208	1203	CREATE	2021-03-18 06:01:29.054	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
10193	85	1616043689541:-1967560836	1616043685889:751341191	D5170C00002	1209	1203	CREATE	2021-03-18 06:01:29.63	05.02 Site Set-up Documentation	05.02.07 Site Qualification
10195	85	1616043691341:154920375	1616043685889:751341191	D5170C00002	1211	1203	CREATE	2021-03-18 06:01:31.434	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
10196	85	1616043692880:304335867	1616043685889:751341191	D5170C00002	1212	1203	CREATE	2021-03-18 06:01:32.976	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
10197	85	1616043693471:-1021152885	1616043685889:751341191	D5170C00002	1213	1203	CREATE	2021-03-18 06:01:33.57	05.02 Site Set-up Documentation	05.02.12 Clini_ Trial Agreement
10199	85	1616043694817:414801653	1616043685889:751341191	D5170C00002	1215	1203	CREATE	2021-03-18 06:01:34.917	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
10200	85	1616043695416:260261660	1616043682856:-2108561109	D5170C00002	1216	1198	CREATE	2021-03-18 06:01:35.512	05 Site Management	05.03 Site Initiation
10779	85	1616044119677:-655064285	1616044119105:840225381	D5170C00002	1795	1794	CREATE	2021-03-18 06:08:39.765	Site	2002254 Gonen, Can
14761	88	1617050168065:-847521203	1617050144863:-122430637	D5170C00001	451	426	ALREADY AVAILABLE	2021-03-30 07:19:37.318	United States of America	Site Management
10204	85	1616043697921:-713076125	1616043682856:-2108561109	D5170C00002	1220	1198	CREATE	2021-03-18 06:01:38.011	05 Site Management	05.04 Site Management
10205	85	1616043698549:670133173	1616043697921:-713076125	D5170C00002	1221	1220	CREATE	2021-03-18 06:01:38.642	05.04 Site Management	05.04.04 Visit Log
10207	85	1616043699761:1014501376	1616043682856:-2108561109	D5170C00002	1223	1198	CREATE	2021-03-18 06:01:39.849	05 Site Management	05.05 General
10208	85	1616043700361:-16356369	1616043699761:1014501376	D5170C00002	1224	1223	CREATE	2021-03-18 06:01:40.635	05.05 General	05.05.01 Relev_ations-Documents
10210	85	1616043701808:-1771978611	1616043661230:555179677	D5170C00002	1226	1189	CREATE	2021-03-18 06:01:41.899	2002174 Woznia_olarska, Barbara	06 IP and Trial Supplies
10211	85	1616043702401:-1951205186	1616043701808:-1771978611	D5170C00002	1227	1226	CREATE	2021-03-18 06:01:42.495	06 IP and Trial Supplies	06.07 General
10213	85	1616043704481:-1317194054	1616043637081:1888909623	D5170C00002	1229	1152	CREATE	2021-03-18 06:01:44.575	Site	TBD-1-1UAZ81B Gapys, Monika
10214	85	1616043705106:701722373	1616043704481:-1317194054	D5170C00002	1230	1229	CREATE	2021-03-18 06:01:45.221	TBD-1-1UAZ81B Gapys, Monika	05 Site Management
10215	85	1616043705687:535278543	1616043705106:701722373	D5170C00002	1231	1230	CREATE	2021-03-18 06:01:45.8	05 Site Management	05.01 Site Selection
10217	85	1616043706902:-426051787	1615838976578:1645421407	D5170C00002	1233	4	CREATE	2021-03-18 06:01:47.011	contents	RUSSIAN FEDERATION
10218	85	1616043707500:1826778313	1616043706902:-426051787	D5170C00002	1234	1233	CREATE	2021-03-18 06:01:47.593	RUSSIAN FEDERATION	Site
10220	85	1616043708984:1155630674	1616043708256:827276628	D5170C00002	1236	1235	CREATE	2021-03-18 06:01:49.074	103 Simanenkov, Vladimir	05 Site Management
10221	85	1616043709605:2070953195	1616043708984:1155630674	D5170C00002	1237	1236	CREATE	2021-03-18 06:01:49.721	05 Site Management	05.01 Site Selection
10223	85	1616043710785:1690140416	1616043707500:1826778313	D5170C00002	1239	1234	CREATE	2021-03-18 06:01:50.873	Site	2001828 Yakovlev, Alexey
10224	85	1616043711372:-1445248576	1616043710785:1690140416	D5170C00002	1240	1239	CREATE	2021-03-18 06:01:51.462	2001828 Yakovlev, Alexey	02 Central Trial Documents
10226	85	1616043712585:1810482997	1616043711970:-1526657338	D5170C00002	1242	1241	CREATE	2021-03-18 06:01:52.675	02.04 General	02.04.01 Relev_s-Contact Report
10227	85	1616043713223:1350413189	1616043710785:1690140416	D5170C00002	1243	1239	CREATE	2021-03-18 06:01:53.314	2001828 Yakovlev, Alexey	03 Regulatory
10229	85	1616043715496:562928885	1616043714873:1852310734	D5170C00002	1245	1244	CREATE	2021-03-18 06:01:55.589	03.01 Trial Approval	03.01.01 Submission
10230	85	1616043716090:-854177911	1616043710785:1690140416	D5170C00002	1246	1239	CREATE	2021-03-18 06:01:56.201	2001828 Yakovlev, Alexey	04 IRB-IEC and other Approvals
10232	85	1616043717339:-831551036	1616043716703:-1918363954	D5170C00002	1248	1247	CREATE	2021-03-18 06:01:57.437	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
10233	85	1616043717939:-1931204536	1616043716703:-1918363954	D5170C00002	1249	1247	CREATE	2021-03-18 06:01:58.038	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
10235	85	1616043719156:-1752329646	1616043716090:-854177911	D5170C00002	1251	1246	CREATE	2021-03-18 06:01:59.248	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
10236	85	1616043719797:166925814	1616043719156:-1752329646	D5170C00002	1252	1251	CREATE	2021-03-18 06:02:00.071	04.03 Trial Status Reporting	04.03.01 IRB-I_y Info-Deviation
10238	85	1616043721153:-2021502449	1616043710785:1690140416	D5170C00002	1254	1239	CREATE	2021-03-18 06:02:01.251	2001828 Yakovlev, Alexey	05 Site Management
10239	85	1616043721847:-746688907	1616043721153:-2021502449	D5170C00002	1255	1254	CREATE	2021-03-18 06:02:01.945	05 Site Management	05.01 Site Selection
10241	85	1616043723227:2130148137	1616043721847:-746688907	D5170C00002	1257	1255	CREATE	2021-03-18 06:02:03.318	05.01 Site Selection	05.01.03 Feasibility Documentation
10242	85	1616043723850:-370109296	1616043721847:-746688907	D5170C00002	1258	1255	CREATE	2021-03-18 06:02:03.95	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
10243	85	1616043724564:-836435006	1616043721153:-2021502449	D5170C00002	1259	1254	CREATE	2021-03-18 06:02:05.531	05 Site Management	05.02 Site Set-up Documentation
10245	85	1616043726762:-2083996815	1616043724564:-836435006	D5170C00002	1261	1259	CREATE	2021-03-18 06:02:06.851	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
10246	85	1616043727533:-2053465885	1616043724564:-836435006	D5170C00002	1262	1259	CREATE	2021-03-18 06:02:07.624	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
10248	85	1616043728878:-1631430797	1616043724564:-836435006	D5170C00002	1264	1259	CREATE	2021-03-18 06:02:08.97	05.02 Site Set-up Documentation	05.02.07 Site Qualification
10249	85	1616043729488:-2131574682	1616043724564:-836435006	D5170C00002	1265	1259	CREATE	2021-03-18 06:02:09.606	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
10251	85	1616043730904:2095265374	1616043724564:-836435006	D5170C00002	1267	1259	CREATE	2021-03-18 06:02:11.004	05.02 Site Set-up Documentation	05.02.12 Clini_ Trial Agreement
10252	85	1616043731540:1611136982	1616043724564:-836435006	D5170C00002	1268	1259	CREATE	2021-03-18 06:02:11.634	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
10253	85	1616043732191:-473722594	1616043724564:-836435006	D5170C00002	1269	1259	CREATE	2021-03-18 06:02:12.281	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
10255	85	1616043733439:-147154668	1616043732789:1148219097	D5170C00002	1271	1270	CREATE	2021-03-18 06:02:13.531	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
10256	85	1616043734046:1739144069	1616043732789:1148219097	D5170C00002	1272	1270	CREATE	2021-03-18 06:02:14.137	05.03 Site Initiation	05.03.03 Site Training-Staff
10258	85	1616043735234:319872489	1616043721153:-2021502449	D5170C00002	1274	1254	CREATE	2021-03-18 06:02:15.324	05 Site Management	05.04 Site Management
10259	85	1616043736883:-1259233027	1616043735234:319872489	D5170C00002	1275	1274	CREATE	2021-03-18 06:02:16.976	05.04 Site Management	05.04.04 Visit Log
10261	85	1616043738116:534649981	1616043721153:-2021502449	D5170C00002	1277	1254	CREATE	2021-03-18 06:02:18.224	05 Site Management	05.05 General
10262	85	1616043738687:-1263102155	1616043738116:534649981	D5170C00002	1278	1277	CREATE	2021-03-18 06:02:18.859	05.05 General	05.05.01 Relevant Communications-Documents
10263	85	1616043739338:491349629	1616043738116:534649981	D5170C00002	1279	1277	CREATE	2021-03-18 06:02:19.426	05.05 General	05.05.02 Tracking Information
10265	85	1616043740683:1178372729	1616043740135:1754069876	D5170C00002	1281	1280	CREATE	2021-03-18 06:02:20.769	2001829 Bogdanov, Roman	03 Regulatory
10266	85	1616043741256:141038977	1616043740683:1178372729	D5170C00002	1282	1281	CREATE	2021-03-18 06:02:21.368	03 Regulatory	03.01 Trial Approval
14772	88	1617050176477:-1705672544	1617050144863:-122430637	D5170C00001	462	426	ALREADY AVAILABLE	2021-03-30 07:19:37.318	United States of America	Trial Management
10270	85	1616043743738:1906214287	1616043742967:1899842701	D5170C00002	1286	1285	CREATE	2021-03-18 06:02:23.831	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
10271	85	1616043744312:2029229916	1616043742967:1899842701	D5170C00002	1287	1285	CREATE	2021-03-18 06:02:24.401	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
10272	85	1616043744963:1879074026	1616043742967:1899842701	D5170C00002	1288	1285	CREATE	2021-03-18 06:02:25.06	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
10274	85	1616043746121:-107474262	1616043745558:-1121048786	D5170C00002	1290	1289	CREATE	2021-03-18 06:02:26.209	04.03 Trial Status Reporting	04.03.01 IRB-I_y Info-Deviation
10275	85	1616043746675:1573865655	1616043745558:-1121048786	D5170C00002	1291	1289	CREATE	2021-03-18 06:02:26.766	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
10277	85	1616043748992:-1680961788	1616043748314:-1742033207	D5170C00002	1293	1292	CREATE	2021-03-18 06:02:29.082	05 Site Management	05.01 Site Selection
10278	85	1616043749869:235200743	1616043748992:-1680961788	D5170C00002	1294	1293	CREATE	2021-03-18 06:02:29.963	05.01 Site Selection	05.01.02 Confidentiality Agreement
10280	85	1616043751056:-109562736	1616043748992:-1680961788	D5170C00002	1296	1293	CREATE	2021-03-18 06:02:31.149	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
10281	85	1616043751686:2072770925	1616043748314:-1742033207	D5170C00002	1297	1292	CREATE	2021-03-18 06:02:31.778	05 Site Management	05.02 Site Set-up Documentation
10283	85	1616043753010:-1970198116	1616043751686:2072770925	D5170C00002	1299	1297	CREATE	2021-03-18 06:02:33.109	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
10284	85	1616043753616:-571953835	1616043751686:2072770925	D5170C00002	1300	1297	CREATE	2021-03-18 06:02:33.708	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
10286	85	1616043754763:1524260084	1616043751686:2072770925	D5170C00002	1302	1297	CREATE	2021-03-18 06:02:34.857	05.02 Site Set-up Documentation	05.02.07 Site Qualification
10287	85	1616043755358:457915215	1616043751686:2072770925	D5170C00002	1303	1297	CREATE	2021-03-18 06:02:35.453	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
10288	85	1616043756029:-615306595	1616043751686:2072770925	D5170C00002	1304	1297	CREATE	2021-03-18 06:02:36.131	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
10290	85	1616043757188:1931789702	1616043751686:2072770925	D5170C00002	1306	1297	CREATE	2021-03-18 06:02:37.279	05.02 Site Set-up Documentation	05.02.13 Indemnity
10291	85	1616043757807:1841484812	1616043751686:2072770925	D5170C00002	1307	1297	CREATE	2021-03-18 06:02:37.902	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
10293	85	1616043760121:213956825	1616043748314:-1742033207	D5170C00002	1309	1292	CREATE	2021-03-18 06:02:40.252	05 Site Management	05.03 Site Initiation
10294	85	1616043761267:-232880297	1616043760121:213956825	D5170C00002	1310	1309	CREATE	2021-03-18 06:02:41.36	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
10295	85	1616043761894:-822272758	1616043760121:213956825	D5170C00002	1311	1309	CREATE	2021-03-18 06:02:41.981	05.03 Site Initiation	05.03.03 Site Training-Staff
11651	86	\N	\N	D5170C00002	102	97	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
10297	85	1616043763329:-759402178	1616043748314:-1742033207	D5170C00002	1313	1292	CREATE	2021-03-18 06:02:43.448	05 Site Management	05.04 Site Management
10298	85	1616043763944:-338071143	1616043763329:-759402178	D5170C00002	1314	1313	CREATE	2021-03-18 06:02:44.038	05.04 Site Management	05.04.04 Visit Log
10300	85	1616043765188:823035620	1616043748314:-1742033207	D5170C00002	1316	1292	CREATE	2021-03-18 06:02:45.275	05 Site Management	05.05 General
10301	85	1616043765869:598077626	1616043765188:823035620	D5170C00002	1317	1316	CREATE	2021-03-18 06:02:45.961	05.05 General	05.05.01 Relevant Communications-Documents
10302	85	1616043766681:-719811193	1616043765188:823035620	D5170C00002	1318	1316	CREATE	2021-03-18 06:02:46.771	05.05 General	05.05.02 Tracking Information
10304	85	1616043768112:-182117116	1616043767232:-2038246709	D5170C00002	1320	1319	CREATE	2021-03-18 06:02:48.203	2001830 Tsibin, Andrey	02 Central Trial Documents
10305	85	1616043768904:-512936083	1616043768112:-182117116	D5170C00002	1321	1320	CREATE	2021-03-18 06:02:48.999	02 Central Trial Documents	02.04 General
10307	85	1616043771385:1045192040	1616043768904:-512936083	D5170C00002	1323	1321	CREATE	2021-03-18 06:02:51.484	02.04 General	02.04.01 UNBLI_s-Contact Report
10308	85	1616043771993:-7190771	1616043767232:-2038246709	D5170C00002	1324	1319	CREATE	2021-03-18 06:02:52.095	2001830 Tsibin, Andrey	03 Regulatory
10310	85	1616043773199:1064485191	1616043772584:-1476962255	D5170C00002	1326	1325	CREATE	2021-03-18 06:02:53.288	03.01 Trial Approval	03.01.01 Submission
10312	85	1616043774345:60549639	1616043773771:2083185425	D5170C00002	1328	1327	CREATE	2021-03-18 06:02:54.741	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
10313	85	1616043775269:710259704	1616043774345:60549639	D5170C00002	1329	1328	CREATE	2021-03-18 06:02:55.356	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
10315	85	1616043776487:-991091215	1616043774345:60549639	D5170C00002	1331	1328	CREATE	2021-03-18 06:02:56.588	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
10316	85	1616043777124:1487677761	1616043774345:60549639	D5170C00002	1332	1328	CREATE	2021-03-18 06:02:57.222	04.01 IRB-IEC Trial Approval	04.01.05 IRB-I_liance Statement
10318	85	1616043778250:651880136	1616043777699:253828450	D5170C00002	1334	1333	CREATE	2021-03-18 06:02:58.34	04.03 Trial Status Reporting	04.03.01 IRB-I_y Info-Deviation
10319	85	1616043778815:-1819938766	1616043777699:253828450	D5170C00002	1335	1333	CREATE	2021-03-18 06:02:58.91	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
10320	85	1616043779375:1060852064	1616043767232:-2038246709	D5170C00002	1336	1319	CREATE	2021-03-18 06:02:59.464	2001830 Tsibin, Andrey	05 Site Management
10322	85	1616043781748:-39839046	1616043780007:-1552015885	D5170C00002	1338	1337	CREATE	2021-03-18 06:03:01.861	05.01 Site Selection	05.01.02 Confidentiality Agreement
10323	85	1616043782381:-1071260278	1616043780007:-1552015885	D5170C00002	1339	1337	CREATE	2021-03-18 06:03:02.474	05.01 Site Selection	05.01.03 Feasibility Documentation
10325	85	1616043783621:2087110418	1616043779375:1060852064	D5170C00002	1341	1336	CREATE	2021-03-18 06:03:03.726	05 Site Management	05.02 Site Set-up Documentation
10327	85	1616043784825:1180609454	1616043783621:2087110418	D5170C00002	1343	1341	CREATE	2021-03-18 06:03:04.913	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
10328	85	1616043785433:1069278862	1616043783621:2087110418	D5170C00002	1344	1341	CREATE	2021-03-18 06:03:05.523	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
10329	85	1616043786050:-1133413535	1616043783621:2087110418	D5170C00002	1345	1341	CREATE	2021-03-18 06:03:13.367	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
8847	84	\N	\N	D5170C00002	2632	2631	NEW	\N	2002045 Andriulli, Angelo	02 Central Trial Documents
10332	85	1616043795289:-1901296016	1616043783621:2087110418	D5170C00002	1348	1341	CREATE	2021-03-18 06:03:15.389	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
10334	85	1616043796568:438935651	1616043783621:2087110418	D5170C00002	1350	1341	CREATE	2021-03-18 06:03:16.664	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
10335	85	1616043797163:55488800	1616043783621:2087110418	D5170C00002	1351	1341	CREATE	2021-03-18 06:03:17.265	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
10336	85	1616043797788:-1331297321	1616043779375:1060852064	D5170C00002	1352	1336	CREATE	2021-03-18 06:03:17.879	05 Site Management	05.03 Site Initiation
10338	85	1616043799228:-888229855	1616043797788:-1331297321	D5170C00002	1354	1352	CREATE	2021-03-18 06:03:19.363	05.03 Site Initiation	05.03.03 Site Training-Staff
10339	85	1616043799989:2128344402	1616043797788:-1331297321	D5170C00002	1355	1352	CREATE	2021-03-18 06:03:20.114	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
10341	85	1616043801334:1654363097	1616043800624:1990310972	D5170C00002	1357	1356	CREATE	2021-03-18 06:03:21.427	05.04 Site Management	05.04.01 Subject Log
10342	85	1616043802125:1154578116	1616043800624:1990310972	D5170C00002	1358	1356	CREATE	2021-03-18 06:03:22.225	05.04 Site Management	05.04.04 UNBLINDED Visit Log
10344	85	1616043803932:-1842987131	1616043800624:1990310972	D5170C00002	1360	1356	CREATE	2021-03-18 06:03:24.028	05.04 Site Management	05.04.05 Additional Monitoring Activity
10346	85	1616043805171:2010011711	1616043800624:1990310972	D5170C00002	1362	1356	CREATE	2021-03-18 06:03:25.268	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
10347	85	1616043805776:-183041823	1616043800624:1990310972	D5170C00002	1363	1356	CREATE	2021-03-18 06:03:25.905	05.04 Site Management	05.04.06 UNBLINDED Protocol Deviations and Waivers
10348	85	1616043806428:1504553177	1616043800624:1990310972	D5170C00002	1364	1356	CREATE	2021-03-18 06:03:26.516	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
10349	85	1616043807083:-270687606	1616043779375:1060852064	D5170C00002	1365	1336	CREATE	2021-03-18 06:03:27.168	05 Site Management	05.05 General
10351	85	1616043808342:-1488640100	1616043807083:-270687606	D5170C00002	1367	1365	CREATE	2021-03-18 06:03:28.428	05.05 General	05.05.02 Tracking Information
10352	85	1616043809012:-1368376907	1616043767232:-2038246709	D5170C00002	1368	1319	CREATE	2021-03-18 06:03:29.104	2001830 Tsibin, Andrey	06 IP and Trial Supplies
10354	85	1616043810568:1029082219	1616043809845:208576053	D5170C00002	1370	1369	CREATE	2021-03-18 06:03:30.661	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
10355	85	1616043811192:-1582272886	1616043809845:208576053	D5170C00002	1371	1369	CREATE	2021-03-18 06:03:31.278	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
10357	85	1616043812488:-915001083	1616043809012:-1368376907	D5170C00002	1373	1368	CREATE	2021-03-18 06:03:32.59	06 IP and Trial Supplies	06.04 Storage
10358	85	1616043813120:1374787676	1616043812488:-915001083	D5170C00002	1374	1373	CREATE	2021-03-18 06:03:33.209	06.04 Storage	06.04.01 UNBLI_on Documentation
10361	85	1616043815603:-639664129	1616043814946:718636409	D5170C00002	1377	1376	CREATE	2021-03-18 06:03:35.692	2001831 Pesegova, Marina	02 Central Trial Documents
10363	85	1616043816999:-973722647	1616043816271:463501640	D5170C00002	1379	1378	CREATE	2021-03-18 06:03:37.089	02.04 General	02.04.01 Relev_s-Contact Report
10364	85	1616043817563:-1717834116	1616043814946:718636409	D5170C00002	1380	1376	CREATE	2021-03-18 06:03:37.662	2001831 Pesegova, Marina	03 Regulatory
10366	85	1616043818855:-1458317580	1616043818221:1471761501	D5170C00002	1382	1381	CREATE	2021-03-18 06:03:38.942	03.01 Trial Approval	03.01.01 Submission
10367	85	1616043819470:372552689	1616043814946:718636409	D5170C00002	1383	1376	CREATE	2021-03-18 06:03:39.558	2001831 Pesegova, Marina	04 IRB-IEC and other Approvals
10369	85	1616043820793:1453158	1616043820161:370770102	D5170C00002	1385	1384	CREATE	2021-03-18 06:03:46.728	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
10370	85	1616043827359:572785180	1616043820161:370770102	D5170C00002	1386	1384	CREATE	2021-03-18 06:03:47.447	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
10372	85	1616043828697:564048913	1616043819470:372552689	D5170C00002	1388	1383	CREATE	2021-03-18 06:03:48.924	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
10373	85	1616043829473:-430825758	1616043828697:564048913	D5170C00002	1389	1388	CREATE	2021-03-18 06:03:49.563	04.03 Trial Status Reporting	04.03.01 IRB-I_y Info-Deviation
10375	85	1616043830612:-1423178843	1616043819470:372552689	D5170C00002	1391	1383	CREATE	2021-03-18 06:03:50.699	04 IRB-IEC and other Approvals	04.04 General
10376	85	1616043831153:-676424888	1616043830612:-1423178843	D5170C00002	1392	1391	CREATE	2021-03-18 06:03:51.244	04.04 General	04.04.01 Relev_RB-IEC-Documents
10377	85	1616043831728:-2017430369	1616043814946:718636409	D5170C00002	1393	1376	CREATE	2021-03-18 06:03:52.063	2001831 Pesegova, Marina	05 Site Management
10379	85	1616043833221:113340058	1616043832649:-399068200	D5170C00002	1395	1394	CREATE	2021-03-18 06:03:53.312	05.01 Site Selection	05.01.02 Confidentiality Agreement
10380	85	1616043833971:-1224620917	1616043832649:-399068200	D5170C00002	1396	1394	CREATE	2021-03-18 06:03:54.058	05.01 Site Selection	05.01.03 Feasibility Documentation
10382	85	1616043835119:1845142685	1616043831728:-2017430369	D5170C00002	1398	1393	CREATE	2021-03-18 06:03:55.218	05 Site Management	05.02 Site Set-up Documentation
10384	85	1616043836220:97757623	1616043835119:1845142685	D5170C00002	1400	1398	CREATE	2021-03-18 06:03:56.408	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
10385	85	1616043836895:-1687783627	1616043835119:1845142685	D5170C00002	1401	1398	CREATE	2021-03-18 06:03:56.985	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
10386	85	1616043837478:404491272	1616043835119:1845142685	D5170C00002	1402	1398	CREATE	2021-03-18 06:03:57.572	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
10387	85	1616043838090:1803366928	1616043835119:1845142685	D5170C00002	1403	1398	CREATE	2021-03-18 06:03:58.18	05.02 Site Set-up Documentation	05.02.07 Site Qualification
10389	85	1616043839310:1452649144	1616043835119:1845142685	D5170C00002	1405	1398	CREATE	2021-03-18 06:03:59.398	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
10390	85	1616043839960:-1240637831	1616043835119:1845142685	D5170C00002	1406	1398	CREATE	2021-03-18 06:04:00.047	05.02 Site Set-up Documentation	05.02.12 Clini_ Trial Agreement
10392	85	1616043841209:340329102	1616043835119:1845142685	D5170C00002	1408	1398	CREATE	2021-03-18 06:04:01.297	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
10393	85	1616043841860:128179498	1616043831728:-2017430369	D5170C00002	1409	1393	CREATE	2021-03-18 06:04:01.945	05 Site Management	05.03 Site Initiation
8848	84	\N	\N	D5170C00002	2633	2632	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
10395	85	1616043848879:1489570401	1616043841860:128179498	D5170C00002	1411	1409	CREATE	2021-03-18 06:04:08.993	05.03 Site Initiation	05.03.03 Site Training-Staff
10396	85	1616043849519:1437029191	1616043841860:128179498	D5170C00002	1412	1409	CREATE	2021-03-18 06:04:09.609	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
10398	85	1616043850807:631353783	1616043850113:522470192	D5170C00002	1414	1413	CREATE	2021-03-18 06:04:10.896	05.04 Site Management	05.04.01 Subject Log
10399	85	1616043851467:763500409	1616043850113:522470192	D5170C00002	1415	1413	CREATE	2021-03-18 06:04:11.552	05.04 Site Management	05.04.03 Monitoring Visit Report
10401	85	1616043852718:-1151954560	1616043850113:522470192	D5170C00002	1417	1413	CREATE	2021-03-18 06:04:12.802	05.04 Site Management	05.04.04 Visit Log
10402	85	1616043853328:190818813	1616043850113:522470192	D5170C00002	1418	1413	CREATE	2021-03-18 06:04:13.422	05.04 Site Management	05.04.05 UNBLI_itoring Activity
10404	85	1616043854601:-121997176	1616043850113:522470192	D5170C00002	1420	1413	CREATE	2021-03-18 06:04:14.686	05.04 Site Management	05.04.06 UNBLINDED Protocol Deviations and Waivers
10405	85	1616043855260:1707363865	1616043850113:522470192	D5170C00002	1421	1413	CREATE	2021-03-18 06:04:15.344	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
10406	85	1616043855906:635520507	1616043850113:522470192	D5170C00002	1422	1413	CREATE	2021-03-18 06:04:15.993	05.04 Site Management	05.04.08 UNBLI_onitoring Report
10408	85	1616043857188:-936740461	1616043856526:740515256	D5170C00002	1424	1423	CREATE	2021-03-18 06:04:17.28	05.05 General	05.05.01 Relevant Communications-Documents
10409	85	1616043857835:959466755	1616043856526:740515256	D5170C00002	1425	1423	CREATE	2021-03-18 06:04:17.93	05.05 General	05.05.02 Tracking Information
10411	85	1616043858998:91110559	1616043858408:794843327	D5170C00002	1427	1426	CREATE	2021-03-18 06:04:19.086	06 IP and Trial Supplies	06.01 IP Documentation
10412	85	1616043859760:373178167	1616043858998:91110559	D5170C00002	1428	1427	CREATE	2021-03-18 06:04:19.85	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
10414	85	1616043861060:1245655170	1616043858998:91110559	D5170C00002	1430	1427	CREATE	2021-03-18 06:04:21.151	06.01 IP Documentation	06.01.10 UNBLI_mentation Return
10415	85	1616043861685:2036691326	1616043858408:794843327	D5170C00002	1431	1426	CREATE	2021-03-18 06:04:21.768	06 IP and Trial Supplies	06.04 Storage
10417	85	1616043862895:1121024365	1616043861685:2036691326	D5170C00002	1433	1431	CREATE	2021-03-18 06:04:22.981	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
10418	85	1616043863525:1528635901	1616043707500:1826778313	D5170C00002	1434	1234	CREATE	2021-03-18 06:04:23.608	Site	2001863 Ballyuzek, Marina
10420	85	1616043864768:-1670719050	1616043864171:-735557284	D5170C00002	1436	1435	CREATE	2021-03-18 06:04:24.85	02 Central Trial Documents	02.04 General
10421	85	1616043865365:576943389	1616043864768:-1670719050	D5170C00002	1437	1436	CREATE	2021-03-18 06:04:25.454	02.04 General	02.04.01 Relev_s-Contact Report
11652	86	\N	\N	D5170C00002	103	97	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
10423	85	1616043866748:1385528023	1616043866131:-1813674226	D5170C00002	1439	1438	CREATE	2021-03-18 06:04:26.834	03 Regulatory	03.01 Trial Approval
10424	85	1616043867365:110379416	1616043866748:1385528023	D5170C00002	1440	1439	CREATE	2021-03-18 06:04:27.498	03.01 Trial Approval	03.01.01 Submission
10426	85	1616043868688:436075958	1616043868049:-1539285338	D5170C00002	1442	1441	CREATE	2021-03-18 06:04:28.775	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
10427	85	1616043869310:-962754997	1616043868688:436075958	D5170C00002	1443	1442	CREATE	2021-03-18 06:04:29.396	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
10429	85	1616043870564:-1131618863	1616043868688:436075958	D5170C00002	1445	1442	CREATE	2021-03-18 06:04:30.651	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
10430	85	1616043871235:1488841891	1616043868688:436075958	D5170C00002	1446	1442	CREATE	2021-03-18 06:04:31.326	04.01 IRB-IEC Trial Approval	04.01.05 IRB-I_liance Statement
10432	85	1616043872816:-357686861	1616043871901:629238070	D5170C00002	1448	1447	CREATE	2021-03-18 06:04:32.902	04.03 Trial Status Reporting	04.03.01 IRB-I_y Info-Deviation
10433	85	1616043873537:70609769	1616043871901:629238070	D5170C00002	1449	1447	CREATE	2021-03-18 06:04:33.622	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
10434	85	1616043874185:-860269628	1616043863525:1528635901	D5170C00002	1450	1434	CREATE	2021-03-18 06:04:34.273	2001863 Ballyuzek, Marina	05 Site Management
10436	85	1616043875468:490197399	1616043874855:-1193583964	D5170C00002	1452	1451	CREATE	2021-03-18 06:04:35.558	05.01 Site Selection	05.01.02 Confidentiality Agreement
10437	85	1616043876128:853617322	1616043874855:-1193583964	D5170C00002	1453	1451	CREATE	2021-03-18 06:04:36.217	05.01 Site Selection	05.01.03 Feasibility Documentation
10439	85	1616043877405:-1428268195	1616043874185:-860269628	D5170C00002	1455	1450	CREATE	2021-03-18 06:04:37.492	05 Site Management	05.02 Site Set-up Documentation
10440	85	1616043878091:1273304082	1616043877405:-1428268195	D5170C00002	1456	1455	CREATE	2021-03-18 06:04:38.187	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
10442	85	1616043879331:-675278034	1616043877405:-1428268195	D5170C00002	1458	1455	CREATE	2021-03-18 06:04:39.416	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
10443	85	1616043879915:-399001052	1616043877405:-1428268195	D5170C00002	1459	1455	CREATE	2021-03-18 06:04:40.004	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
10445	85	1616043881255:1752731570	1616043877405:-1428268195	D5170C00002	1461	1455	CREATE	2021-03-18 06:04:41.345	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
10446	85	1616043881842:649103775	1616043877405:-1428268195	D5170C00002	1462	1455	CREATE	2021-03-18 06:04:41.928	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
10447	85	1616043882435:576499175	1616043877405:-1428268195	D5170C00002	1463	1455	CREATE	2021-03-18 06:04:42.526	05.02 Site Set-up Documentation	05.02.12 Clini_ Trial Agreement
10449	85	1616043884005:2015731894	1616043877405:-1428268195	D5170C00002	1465	1455	CREATE	2021-03-18 06:04:44.093	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
10450	85	1616043885270:-1919368944	1616043874185:-860269628	D5170C00002	1466	1450	CREATE	2021-03-18 06:04:45.353	05 Site Management	05.03 Site Initiation
10452	85	1616043886526:1560744533	1616043885270:-1919368944	D5170C00002	1468	1466	CREATE	2021-03-18 06:04:46.625	05.03 Site Initiation	05.03.03 Site Training-Staff
10453	85	1616043887201:-1533741904	1616043885270:-1919368944	D5170C00002	1469	1466	CREATE	2021-03-18 06:04:47.29	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
10454	85	1616043887879:-1639684660	1616043874185:-860269628	D5170C00002	1470	1450	CREATE	2021-03-18 06:04:47.974	05 Site Management	05.04 Site Management
10456	85	1616043888997:815271756	1616043887879:-1639684660	D5170C00002	1472	1470	CREATE	2021-03-18 06:04:49.1	05.04 Site Management	05.04.05 Additional Monitoring Activity
14782	88	1617050182770:-212915113	1617050182170:-1429529666	D5170C00001	472	471	ALREADY AVAILABLE	2021-03-30 07:19:37.318	Canada	1001, 1002, 1006, 1007, 1011, 1016
10458	85	1616043890329:1762061063	1616043874185:-860269628	D5170C00002	1474	1450	CREATE	2021-03-18 06:04:50.417	05 Site Management	05.05 General
10460	85	1616043891569:-1978620291	1616043890329:1762061063	D5170C00002	1476	1474	CREATE	2021-03-18 06:04:51.657	05.05 General	05.05.02 Tracking Information
10461	85	1616043892121:-2001710502	1616043707500:1826778313	D5170C00002	1477	1234	CREATE	2021-03-18 06:04:52.214	Site	TBD-1-1RP9EIE Baranovsky, Andrey
10463	85	1616043893267:1361380746	1616043892696:948916065	D5170C00002	1479	1478	CREATE	2021-03-18 06:04:53.355	05 Site Management	05.01 Site Selection
10464	85	1616043893946:1701340962	1616043893267:1361380746	D5170C00002	1480	1479	CREATE	2021-03-18 06:04:54.031	05.01 Site Selection	05.01.02 Confidentiality Agreement
10465	85	1616043894518:-1586424078	1616043707500:1826778313	D5170C00002	1481	1234	CREATE	2021-03-18 06:04:54.61	Site	TBD-1-1RPCQZW Lakhin, Alexander
10467	85	1616043896539:898080664	1616043895896:1415575075	D5170C00002	1483	1482	CREATE	2021-03-18 06:04:56.628	05 Site Management	05.01 Site Selection
10468	85	1616043897126:-477093878	1616043896539:898080664	D5170C00002	1484	1483	CREATE	2021-03-18 06:04:57.214	05.01 Site Selection	05.01.02 Confidentiality Agreement
10470	85	1616043898419:966892902	1616043897832:-699334386	D5170C00002	1486	1485	CREATE	2021-03-18 06:04:58.508	TBD-1-1RPDC9V Dvorkin, Mikhail	05 Site Management
10471	85	1616043899032:1328068321	1616043898419:966892902	D5170C00002	1487	1486	CREATE	2021-03-18 06:04:59.115	05 Site Management	05.01 Site Selection
10473	85	1616043900269:-1147156722	1616043707500:1826778313	D5170C00002	1489	1234	CREATE	2021-03-18 06:05:06.755	Site	TBD-1-1RS0TV7 Kucheryaviy, Yuriy
10474	85	1616043907282:1352736424	1616043900269:-1147156722	D5170C00002	1490	1489	CREATE	2021-03-18 06:05:07.369	TBD-1-1RS0TV7 Kucheryaviy, Yuriy	05 Site Management
10476	85	1616043908678:-1340991116	1616043907906:761474353	D5170C00002	1492	1491	CREATE	2021-03-18 06:05:08.765	05.01 Site Selection	05.01.02 Confidentiality Agreement
10477	85	1616043909305:1922671647	1616043907906:761474353	D5170C00002	1493	1491	CREATE	2021-03-18 06:05:09.459	05.01 Site Selection	05.01.03 Feasibility Documentation
10479	85	1616043911000:-1979662181	1616043707500:1826778313	D5170C00002	1495	1234	CREATE	2021-03-18 06:05:11.086	Site	TBD-1-1RS0TVX Pershko, Anatoly
10480	85	1616043911779:-374032577	1616043911000:-1979662181	D5170C00002	1496	1495	CREATE	2021-03-18 06:05:11.935	TBD-1-1RS0TVX Pershko, Anatoly	05 Site Management
10481	85	1616043912486:-1589475664	1616043911779:-374032577	D5170C00002	1497	1496	CREATE	2021-03-18 06:05:12.571	05 Site Management	05.01 Site Selection
10483	85	1616043913929:654344100	1615838976578:1645421407	D5170C00002	1499	4	CREATE	2021-03-18 06:05:14.014	contents	SPAIN
10484	85	1616043914564:1825605212	1616043913929:654344100	D5170C00002	1500	1499	CREATE	2021-03-18 06:05:14.652	SPAIN	Site
10486	85	1616043915878:1698168066	1616043915203:1635453748	D5170C00002	1502	1501	CREATE	2021-03-18 06:05:15.965	2002056 Guardiola Capon, Jordi	01 Trial Management
10487	85	1616043916595:1168470070	1616043915878:1698168066	D5170C00002	1503	1502	CREATE	2021-03-18 06:05:17.609	01 Trial Management	01.01 Trial Oversight
10489	85	1616043918956:575709062	1616043915203:1635453748	D5170C00002	1505	1501	CREATE	2021-03-18 06:05:19.056	2002056 Guardiola Capon, Jordi	02 Central Trial Documents
10490	85	1616043919624:-758896115	1616043918956:575709062	D5170C00002	1506	1505	CREATE	2021-03-18 06:05:19.716	02 Central Trial Documents	02.04 General
10492	85	1616043921472:672879351	1616043919624:-758896115	D5170C00002	1508	1506	CREATE	2021-03-18 06:05:21.56	02.04 General	02.04.01 Relev_s-Contact Report
10493	85	1616043922152:812637783	1616043919624:-758896115	D5170C00002	1509	1506	CREATE	2021-03-18 06:05:22.238	02.04 General	02.04.01 UNBLI_s-Contact Report
10495	85	1616043923999:1322743105	1616043923352:1161558825	D5170C00002	1511	1510	CREATE	2021-03-18 06:05:24.089	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
10496	85	1616043924719:-958863759	1616043923999:1322743105	D5170C00002	1512	1511	CREATE	2021-03-18 06:05:24.805	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
10498	85	1616043926043:-2064561391	1616043925383:-2093977400	D5170C00002	1514	1513	CREATE	2021-03-18 06:05:26.125	04.04 General	04.04.01 Relev_RB-IEC-Documents
10499	85	1616043926723:-1228445451	1616043915203:1635453748	D5170C00002	1515	1501	CREATE	2021-03-18 06:05:26.81	2002056 Guardiola Capon, Jordi	05 Site Management
10501	85	1616043929493:1795443596	1616043927394:697930674	D5170C00002	1517	1516	CREATE	2021-03-18 06:05:29.591	05.01 Site Selection	05.01.02 Confidentiality Agreement
10502	85	1616043930192:-1707782414	1616043927394:697930674	D5170C00002	1518	1516	CREATE	2021-03-18 06:05:30.284	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
10504	85	1616043931494:1799631902	1616043930859:463246443	D5170C00002	1520	1519	CREATE	2021-03-18 06:05:31.728	05.02 Site Set-up Documentation	05.02.01 Accep_tigator Brochure
10505	85	1616043932280:-1767369484	1616043930859:463246443	D5170C00002	1521	1519	CREATE	2021-03-18 06:05:32.365	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
10507	85	1616043933552:1482460686	1616043930859:463246443	D5170C00002	1523	1519	CREATE	2021-03-18 06:05:33.642	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
10508	85	1616043934165:-720231711	1616043930859:463246443	D5170C00002	1524	1519	CREATE	2021-03-18 06:05:34.249	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
10510	85	1616043935444:-1495763643	1616043930859:463246443	D5170C00002	1526	1519	CREATE	2021-03-18 06:05:35.532	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
10511	85	1616043936062:-946210130	1616043930859:463246443	D5170C00002	1527	1519	CREATE	2021-03-18 06:05:36.157	05.02 Site Set-up Documentation	05.02.09 Inves_latory Agreement
10512	85	1616043936662:-1371554452	1616043930859:463246443	D5170C00002	1528	1519	CREATE	2021-03-18 06:05:36.846	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
10514	85	1616043938032:1205958439	1616043930859:463246443	D5170C00002	1530	1519	CREATE	2021-03-18 06:05:38.121	05.02 Site Set-up Documentation	05.02.13 Indemnity
10515	85	1616043938887:2145406869	1616043930859:463246443	D5170C00002	1531	1519	CREATE	2021-03-18 06:05:40.327	05.02 Site Set-up Documentation	05.02.14 Other_ancial Agreement
10517	85	1616043941810:-2109010191	1616043930859:463246443	D5170C00002	1533	1519	CREATE	2021-03-18 06:05:41.898	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
10518	85	1616043942524:-1702139227	1616043926723:-1228445451	D5170C00002	1534	1515	CREATE	2021-03-18 06:05:42.611	05 Site Management	05.03 Site Initiation
10520	85	1616043944479:816135393	1616043942524:-1702139227	D5170C00002	1536	1534	CREATE	2021-03-18 06:05:44.572	05.03 Site Initiation	05.03.03 Site Training-Staff
10521	85	1616043945239:-1052424952	1616043942524:-1702139227	D5170C00002	1537	1534	CREATE	2021-03-18 06:05:45.328	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
14786	88	1617050191494:-1593718706	1617050182170:-1429529666	D5170C00001	476	471	ALREADY AVAILABLE	2021-03-30 07:19:37.318	Canada	1001
10524	85	1616043947243:33435895	1616043945994:1477724243	D5170C00002	1540	1538	CREATE	2021-03-18 06:05:47.328	05.04 Site Management	05.04.03 Monitoring Visit Report
10526	85	1616043948776:-207702326	1616043945994:1477724243	D5170C00002	1542	1538	CREATE	2021-03-18 06:05:48.898	05.04 Site Management	05.04.04 Visit Log
10527	85	1616043949460:993294397	1616043945994:1477724243	D5170C00002	1543	1538	CREATE	2021-03-18 06:05:49.576	05.04 Site Management	05.04.05 UNBLI_itoring Activity
10529	85	1616043952188:822265667	1616043945994:1477724243	D5170C00002	1545	1538	CREATE	2021-03-18 06:05:52.276	05.04 Site Management	05.04.06 UNBLINDED Protocol Deviations and Waivers
10530	85	1616043952852:756323612	1616043945994:1477724243	D5170C00002	1546	1538	CREATE	2021-03-18 06:05:52.937	05.04 Site Management	05.04.08 Final_onitoring Report
10531	85	1616043953587:1979280171	1616043926723:-1228445451	D5170C00002	1547	1515	CREATE	2021-03-18 06:05:53.675	05 Site Management	05.05 General
10533	85	1616043955180:637367137	1616043915203:1635453748	D5170C00002	1549	1501	CREATE	2021-03-18 06:05:55.269	2002056 Guardiola Capon, Jordi	06 IP and Trial Supplies
10534	85	1616043955957:467668828	1616043955180:637367137	D5170C00002	1550	1549	CREATE	2021-03-18 06:05:56.066	06 IP and Trial Supplies	06.01 IP Documentation
10536	85	1616043957439:211216148	1616043955957:467668828	D5170C00002	1552	1550	CREATE	2021-03-18 06:05:57.529	06.01 IP Documentation	06.01.04 IP Sh_nt Documentation
10537	85	1616043958743:-43250497	1616043955957:467668828	D5170C00002	1553	1550	CREATE	2021-03-18 06:05:58.831	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
10538	85	1616043959318:-37074100	1616043955957:467668828	D5170C00002	1554	1550	CREATE	2021-03-18 06:05:59.404	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
10540	85	1616043960596:-517303749	1616043955180:637367137	D5170C00002	1556	1549	CREATE	2021-03-18 06:06:00.679	06 IP and Trial Supplies	06.04 Storage
10541	85	1616043961243:6851083	1616043960596:-517303749	D5170C00002	1557	1556	CREATE	2021-03-18 06:06:01.345	06.04 Storage	06.04.01 UNBLI_on Documentation
10543	85	1616043963721:-461843061	1616043955180:637367137	D5170C00002	1559	1549	CREATE	2021-03-18 06:06:03.81	06 IP and Trial Supplies	06.07 General
10544	85	1616043964360:-1978720974	1616043963721:-461843061	D5170C00002	1560	1559	CREATE	2021-03-18 06:06:04.448	06.07 General	06.07.01 UNBLI_roduct-Documents
10546	85	1616043965644:333654042	1616043965020:-1419698331	D5170C00002	1562	1561	CREATE	2021-03-18 06:06:05.733	2002057 Taxonera, Carlos	01 Trial Management
10547	85	1616043966237:-1103272243	1616043965644:333654042	D5170C00002	1563	1562	CREATE	2021-03-18 06:06:06.326	01 Trial Management	01.01 Trial Oversight
10549	85	1616043967537:-788794353	1616043965020:-1419698331	D5170C00002	1565	1561	CREATE	2021-03-18 06:06:07.643	2002057 Taxonera, Carlos	02 Central Trial Documents
10550	85	1616043968145:-2057983635	1616043967537:-788794353	D5170C00002	1566	1565	CREATE	2021-03-18 06:06:08.236	02 Central Trial Documents	02.04 General
10552	85	1616043969335:-885584657	1616043968145:-2057983635	D5170C00002	1568	1566	CREATE	2021-03-18 06:06:09.428	02.04 General	02.04.01 Relev_s-Contact Report
10553	85	1616043969888:-2110293222	1616043968145:-2057983635	D5170C00002	1569	1566	CREATE	2021-03-18 06:06:10.027	02.04 General	02.04.01 UNBLI_s-Contact Report
10555	85	1616043974490:-1416466667	1616043970568:-1143411650	D5170C00002	1571	1570	CREATE	2021-03-18 06:06:14.578	05 Site Management	05.01 Site Selection
10557	85	1616043975636:-965780730	1616043974490:-1416466667	D5170C00002	1573	1571	CREATE	2021-03-18 06:06:15.72	05.01 Site Selection	05.01.02 Confidentiality Agreement
10558	85	1616043976182:-1990037361	1616043974490:-1416466667	D5170C00002	1574	1571	CREATE	2021-03-18 06:06:16.267	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
10560	85	1616043977352:528811926	1616043976782:-1651193334	D5170C00002	1576	1575	CREATE	2021-03-18 06:06:17.437	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
10561	85	1616043977965:688398393	1616043976782:-1651193334	D5170C00002	1577	1575	CREATE	2021-03-18 06:06:18.055	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
10563	85	1616043979098:-356738733	1616043976782:-1651193334	D5170C00002	1579	1575	CREATE	2021-03-18 06:06:19.185	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
10564	85	1616043979785:371079778	1616043976782:-1651193334	D5170C00002	1580	1575	CREATE	2021-03-18 06:06:19.875	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
10565	85	1616043980478:65296355	1616043976782:-1651193334	D5170C00002	1581	1575	CREATE	2021-03-18 06:06:20.572	05.02 Site Set-up Documentation	05.02.07 Site Qualification
10567	85	1616043981684:145111968	1616043976782:-1651193334	D5170C00002	1583	1575	CREATE	2021-03-18 06:06:21.772	05.02 Site Set-up Documentation	05.02.09 Inves_latory Agreement
10568	85	1616043982404:942415557	1616043976782:-1651193334	D5170C00002	1584	1575	CREATE	2021-03-18 06:06:22.494	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
10570	85	1616043983530:447609063	1616043976782:-1651193334	D5170C00002	1586	1575	CREATE	2021-03-18 06:06:23.616	05.02 Site Set-up Documentation	05.02.13 Indemnity
10571	85	1616043984751:920226976	1616043976782:-1651193334	D5170C00002	1587	1575	CREATE	2021-03-18 06:06:24.832	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
10572	85	1616043985426:88421296	1616043976782:-1651193334	D5170C00002	1588	1575	CREATE	2021-03-18 06:06:25.513	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
10574	85	1616043986523:490149751	1616043985987:478451946	D5170C00002	1590	1589	CREATE	2021-03-18 06:06:26.613	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
10575	85	1616043987086:-665411867	1616043985987:478451946	D5170C00002	1591	1589	CREATE	2021-03-18 06:06:27.176	05.03 Site Initiation	05.03.03 Site Training-Staff
10577	85	1616043988247:1081910034	1616043987647:1182496910	D5170C00002	1593	1592	CREATE	2021-03-18 06:06:28.337	05.04 Site Management	05.04.04 Visit Log
10578	85	1616043988811:710258500	1616043987647:1182496910	D5170C00002	1594	1592	CREATE	2021-03-18 06:06:28.904	05.04 Site Management	05.04.05 Additional Monitoring Activity
10580	85	1616043990106:1542297406	1616043970568:-1143411650	D5170C00002	1596	1570	CREATE	2021-03-18 06:06:30.193	05 Site Management	05.05 General
10581	85	1616043990678:-491750607	1616043990106:1542297406	D5170C00002	1597	1596	CREATE	2021-03-18 06:06:30.769	05.05 General	05.05.02 Tracking Information
10583	85	1616043991789:-1333409467	1616043991226:2089997590	D5170C00002	1599	1598	CREATE	2021-03-18 06:06:31.878	06 IP and Trial Supplies	06.01 IP Documentation
10584	85	1616043992328:1520537221	1616043991789:-1333409467	D5170C00002	1600	1599	CREATE	2021-03-18 06:06:32.418	06.01 IP Documentation	06.01.02 IP Instructions for Handling
10585	85	1616043992959:1976595861	1616043991226:2089997590	D5170C00002	1601	1598	CREATE	2021-03-18 06:06:33.045	06 IP and Trial Supplies	06.04 Storage
14845	88	1617050246297:-889170302	1617050182170:-1429529666	D5170C00001	535	471	ALREADY AVAILABLE	2021-03-30 07:19:37.318	Canada	1002, 1003, 1006, 1010
10588	85	1616043994655:1027175165	1616043994064:-1346591113	D5170C00002	1604	1603	CREATE	2021-03-18 06:06:34.743	2002058 Domenech Morral, Eugeni	01 Trial Management
10590	85	1616043996433:1854043167	1616043995898:1928736265	D5170C00002	1606	1605	CREATE	2021-03-18 06:06:36.525	01.01 Trial Oversight	01.01.06 Recruitment Plan
10591	85	1616043996995:1157812493	1616043994064:-1346591113	D5170C00002	1607	1603	CREATE	2021-03-18 06:06:37.082	2002058 Domenech Morral, Eugeni	02 Central Trial Documents
10593	85	1616043998192:-978291609	1616043997615:862683754	D5170C00002	1609	1608	CREATE	2021-03-18 06:06:38.278	02.04 General	02.04.01 Relev_ations-Documents
10594	85	1616043999271:328029726	1616043997615:862683754	D5170C00002	1610	1608	CREATE	2021-03-18 06:06:39.358	02.04 General	02.04.01 Relev_s-Contact Report
10596	85	1616044000510:476181151	1616043997615:862683754	D5170C00002	1612	1608	CREATE	2021-03-18 06:06:40.598	02.04 General	02.04.01 UNBLI_s-Contact Report
10597	85	1616044001075:914544643	1616043994064:-1346591113	D5170C00002	1613	1603	CREATE	2021-03-18 06:06:41.167	2002058 Domenech Morral, Eugeni	05 Site Management
10599	85	1616044002177:-186062576	1616044001626:-797469454	D5170C00002	1615	1614	CREATE	2021-03-18 06:06:42.271	05.01 Site Selection	05.01.02 Confidentiality Agreement
10600	85	1616044002745:180614310	1616044001626:-797469454	D5170C00002	1616	1614	CREATE	2021-03-18 06:06:42.836	05.01 Site Selection	05.01.03 Feasibility Documentation
10602	85	1616044003953:365880779	1616044001075:914544643	D5170C00002	1618	1613	CREATE	2021-03-18 06:06:44.043	05 Site Management	05.02 Site Set-up Documentation
10603	85	1616044004536:717485423	1616044003953:365880779	D5170C00002	1619	1618	CREATE	2021-03-18 06:06:44.625	05.02 Site Set-up Documentation	05.02.01 Accep_tigator Brochure
10605	85	1616044006384:1419262271	1616044003953:365880779	D5170C00002	1621	1618	CREATE	2021-03-18 06:06:46.474	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
10606	85	1616044007002:-2075408818	1616044003953:365880779	D5170C00002	1622	1618	CREATE	2021-03-18 06:06:47.089	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
10607	85	1616044007555:-1660569713	1616044003953:365880779	D5170C00002	1623	1618	CREATE	2021-03-18 06:06:47.642	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
10609	85	1616044008620:1575333569	1616044003953:365880779	D5170C00002	1625	1618	CREATE	2021-03-18 06:06:48.704	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
10610	85	1616044009217:1043994603	1616044003953:365880779	D5170C00002	1626	1618	CREATE	2021-03-18 06:06:49.305	05.02 Site Set-up Documentation	05.02.09 Inves_latory Agreement
10612	85	1616044010326:-897719549	1616044003953:365880779	D5170C00002	1628	1618	CREATE	2021-03-18 06:06:50.412	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
10613	85	1616044010893:-1129305590	1616044003953:365880779	D5170C00002	1629	1618	CREATE	2021-03-18 06:06:50.977	05.02 Site Set-up Documentation	05.02.13 Indemnity
10614	85	1616044011455:-159376912	1616044003953:365880779	D5170C00002	1630	1618	CREATE	2021-03-18 06:06:51.543	05.02 Site Set-up Documentation	05.02.14 Other_ancial Agreement
10616	85	1616044012745:-260560890	1616044003953:365880779	D5170C00002	1632	1618	CREATE	2021-03-18 06:06:52.834	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
10617	85	1616044013278:-1378337520	1616044001075:914544643	D5170C00002	1633	1613	CREATE	2021-03-18 06:06:53.362	05 Site Management	05.03 Site Initiation
10619	85	1616044014420:-1833203559	1616044013278:-1378337520	D5170C00002	1635	1633	CREATE	2021-03-18 06:06:54.509	05.03 Site Initiation	05.03.03 Site _cumentation-Site
10620	85	1616044014977:251707387	1616044013278:-1378337520	D5170C00002	1636	1633	CREATE	2021-03-18 06:06:55.067	05.03 Site Initiation	05.03.03 Site Training-Staff
10621	85	1616044015516:1943270773	1616044001075:914544643	D5170C00002	1637	1613	CREATE	2021-03-18 06:06:55.647	05 Site Management	05.04 Site Management
10623	85	1616044017392:142440405	1616044015516:1943270773	D5170C00002	1639	1637	CREATE	2021-03-18 06:06:57.482	05.04 Site Management	05.04.03 Monitoring Visit Report
10624	85	1616044017936:1274108956	1616044015516:1943270773	D5170C00002	1640	1637	CREATE	2021-03-18 06:06:58.02	05.04 Site Management	05.04.04 UNBLINDED Visit Log
10626	85	1616044019044:1244033121	1616044015516:1943270773	D5170C00002	1642	1637	CREATE	2021-03-18 06:06:59.133	05.04 Site Management	05.04.05 UNBLI_itoring Activity
10628	85	1616044020158:928034432	1616044015516:1943270773	D5170C00002	1644	1637	CREATE	2021-03-18 06:07:00.248	05.04 Site Management	05.04.06 UNBLINDED Protocol Deviations and Waivers
10629	85	1616044020718:865328122	1616044015516:1943270773	D5170C00002	1645	1637	CREATE	2021-03-18 06:07:00.805	05.04 Site Management	05.04.08 Final_onitoring Report
10630	85	1616044021256:483901261	1616044001075:914544643	D5170C00002	1646	1613	CREATE	2021-03-18 06:07:01.351	05 Site Management	05.05 General
10632	85	1616044022619:36184499	1616044021256:483901261	D5170C00002	1648	1646	CREATE	2021-03-18 06:07:02.709	05.05 General	05.05.02 Tracking Information
10633	85	1616044023171:1106114746	1616043994064:-1346591113	D5170C00002	1649	1603	CREATE	2021-03-18 06:07:03.257	2002058 Domenech Morral, Eugeni	06 IP and Trial Supplies
10635	85	1616044024299:-1282860048	1616044023734:503736290	D5170C00002	1651	1650	CREATE	2021-03-18 06:07:04.389	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
10636	85	1616044024946:1653890911	1616044023734:503736290	D5170C00002	1652	1650	CREATE	2021-03-18 06:07:05.034	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
10638	85	1616044026130:-1063713267	1616044023734:503736290	D5170C00002	1654	1650	CREATE	2021-03-18 06:07:06.214	06.01 IP Documentation	06.01.11 Certi_e of Destruction
10639	85	1616044026794:-1719473365	1616044023734:503736290	D5170C00002	1655	1650	CREATE	2021-03-18 06:07:06.879	06.01 IP Documentation	06.01.11 UNBLI_e of Destruction
10640	85	1616044028195:1081677969	1616044023171:1106114746	D5170C00002	1656	1649	CREATE	2021-03-18 06:07:08.284	06 IP and Trial Supplies	06.04 Storage
10642	85	1616044029415:1697717429	1616044028195:1081677969	D5170C00002	1658	1656	CREATE	2021-03-18 06:07:09.504	06.04 Storage	06.04.02 UNBLI_on Documentation
10643	85	1616044030030:1270823995	1616044028195:1081677969	D5170C00002	1659	1656	CREATE	2021-03-18 06:07:10.12	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
10645	85	1616044031474:-1793072383	1616044030603:830577696	D5170C00002	1661	1660	CREATE	2021-03-18 06:07:11.564	06.07 General	06.07.01 UNBLI_roduct-Documents
10646	85	1616044032148:-899601491	1616043914564:1825605212	D5170C00002	1662	1500	CREATE	2021-03-18 06:07:12.234	Site	2002059 Sierra Ausin, Monica
10648	85	1616044033440:-39018954	1616044032810:-1199154755	D5170C00002	1664	1663	CREATE	2021-03-18 06:07:13.533	01 Trial Management	01.01 Trial Oversight
10649	85	1616044034026:1271987013	1616044033440:-39018954	D5170C00002	1665	1664	CREATE	2021-03-18 06:07:14.119	01.01 Trial Oversight	01.01.06 Recruitment Plan
8850	84	\N	\N	D5170C00002	2635	2633	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
10652	85	1616044035874:641235398	1616044035249:927120712	D5170C00002	1668	1667	CREATE	2021-03-18 06:07:15.957	02.04 General	02.04.01 Relev_ations-Documents
10654	85	1616044037064:1979190854	1616044035249:927120712	D5170C00002	1670	1667	CREATE	2021-03-18 06:07:17.154	02.04 General	02.04.01 UNBLI_s-Contact Report
10655	85	1616044037647:-1456829499	1616044032148:-899601491	D5170C00002	1671	1662	CREATE	2021-03-18 06:07:17.748	2002059 Sierra Ausin, Monica	05 Site Management
10657	85	1616044039772:1952575411	1616044039184:2102042207	D5170C00002	1673	1672	CREATE	2021-03-18 06:07:19.858	05.01 Site Selection	05.01.01 Site Contact Details
10658	85	1616044040355:-714216340	1616044039184:2102042207	D5170C00002	1674	1672	CREATE	2021-03-18 06:07:20.443	05.01 Site Selection	05.01.02 Confidentiality Agreement
10660	85	1616044041497:1868284735	1616044039184:2102042207	D5170C00002	1676	1672	CREATE	2021-03-18 06:07:21.588	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
10661	85	1616044042116:-1029500593	1616044037647:-1456829499	D5170C00002	1677	1671	CREATE	2021-03-18 06:07:22.203	05 Site Management	05.02 Site Set-up Documentation
10663	85	1616044043273:1094759913	1616044042116:-1029500593	D5170C00002	1679	1677	CREATE	2021-03-18 06:07:23.361	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
10664	85	1616044043903:-2003790970	1616044042116:-1029500593	D5170C00002	1680	1677	CREATE	2021-03-18 06:07:23.99	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
10666	85	1616044045179:-899930842	1616044042116:-1029500593	D5170C00002	1682	1677	CREATE	2021-03-18 06:07:25.267	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
10667	85	1616044045807:-1347586396	1616044042116:-1029500593	D5170C00002	1683	1677	CREATE	2021-03-18 06:07:25.895	05.02 Site Set-up Documentation	05.02.07 Site Qualification
10668	85	1616044046403:-1817228815	1616044042116:-1029500593	D5170C00002	1684	1677	CREATE	2021-03-18 06:07:26.493	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
10670	85	1616044047589:-328679935	1616044042116:-1029500593	D5170C00002	1686	1677	CREATE	2021-03-18 06:07:27.68	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
10671	85	1616044048209:-1202733248	1616044042116:-1029500593	D5170C00002	1687	1677	CREATE	2021-03-18 06:07:28.295	05.02 Site Set-up Documentation	05.02.12 Clini_ Trial Agreement
10673	85	1616044050193:1120132776	1616044042116:-1029500593	D5170C00002	1689	1677	CREATE	2021-03-18 06:07:30.28	05.02 Site Set-up Documentation	05.02.17 IP Si_se Documentation
10674	85	1616044050784:494793425	1616044042116:-1029500593	D5170C00002	1690	1677	CREATE	2021-03-18 06:07:30.97	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
10675	85	1616044051460:-153025908	1616044037647:-1456829499	D5170C00002	1691	1671	CREATE	2021-03-18 06:07:31.548	05 Site Management	05.03 Site Initiation
10677	85	1616044052718:1999391815	1616044051460:-153025908	D5170C00002	1693	1691	CREATE	2021-03-18 06:07:32.807	05.03 Site Initiation	05.03.03 Site Training-Staff
10678	85	1616044053285:-980541257	1616044051460:-153025908	D5170C00002	1694	1691	CREATE	2021-03-18 06:07:33.377	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
10680	85	1616044054582:666892060	1616044053980:1801006951	D5170C00002	1696	1695	CREATE	2021-03-18 06:07:34.669	05.04 Site Management	05.04.04 Visit Log
10681	85	1616044055179:-2125167434	1616044053980:1801006951	D5170C00002	1697	1695	CREATE	2021-03-18 06:07:35.267	05.04 Site Management	05.04.05 UNBLI_on Visits (CCOV)
10683	85	1616044056368:-766584415	1616044037647:-1456829499	D5170C00002	1699	1671	CREATE	2021-03-18 06:07:36.453	05 Site Management	05.05 General
10684	85	1616044056929:1645040135	1616044056368:-766584415	D5170C00002	1700	1699	CREATE	2021-03-18 06:07:37.014	05.05 General	05.05.02 Tracking Information
10686	85	1616044058098:965262709	1616044057512:-1265259396	D5170C00002	1702	1701	CREATE	2021-03-18 06:07:38.188	06 IP and Trial Supplies	06.01 IP Documentation
10687	85	1616044058788:-83380679	1616044058098:965262709	D5170C00002	1703	1702	CREATE	2021-03-18 06:07:38.886	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
10688	85	1616044059376:-396114037	1616043914564:1825605212	D5170C00002	1704	1500	CREATE	2021-03-18 06:07:39.465	Site	2002060 Argüel_ Arias, Federico
10690	85	1616044061310:1828632862	1616044060729:-619125260	D5170C00002	1706	1705	CREATE	2021-03-18 06:07:41.395	01 Trial Management	01.01 Trial Oversight
10691	85	1616044061933:-701584516	1616044061310:1828632862	D5170C00002	1707	1706	CREATE	2021-03-18 06:07:42.017	01.01 Trial Oversight	01.01.06 Recruitment Plan
10693	85	1616044063121:1438189014	1616044062562:879140547	D5170C00002	1709	1708	CREATE	2021-03-18 06:07:43.204	02 Central Trial Documents	02.04 General
10694	85	1616044064338:-1932656396	1616044063121:1438189014	D5170C00002	1710	1709	CREATE	2021-03-18 06:07:44.422	02.04 General	02.04.01 Relev_ations-Documents
10696	85	1616044065428:-1847839708	1616044063121:1438189014	D5170C00002	1712	1709	CREATE	2021-03-18 06:07:45.512	02.04 General	02.04.01 UNBLI_s-Contact Report
10697	85	1616044065975:-1266999076	1616044059376:-396114037	D5170C00002	1713	1704	CREATE	2021-03-18 06:07:46.062	2002060 Argüel_ Arias, Federico	04 IRB-IEC and other Approvals
10699	85	1616044067086:1795086509	1616044066504:-1547710995	D5170C00002	1715	1714	CREATE	2021-03-18 06:07:47.177	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
10700	85	1616044067675:-615185433	1616044059376:-396114037	D5170C00002	1716	1704	CREATE	2021-03-18 06:07:47.762	2002060 Argüel_ Arias, Federico	05 Site Management
10702	85	1616044068738:1961332264	1616044068206:-1811828080	D5170C00002	1718	1717	CREATE	2021-03-18 06:07:48.823	05.01 Site Selection	05.01.01 Site Contact Details
10703	85	1616044069292:-2073098575	1616044068206:-1811828080	D5170C00002	1719	1717	CREATE	2021-03-18 06:07:49.377	05.01 Site Selection	05.01.02 Confidentiality Agreement
10705	85	1616044071246:-1164786940	1616044068206:-1811828080	D5170C00002	1721	1717	CREATE	2021-03-18 06:07:51.333	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
10706	85	1616044071842:429189496	1616044067675:-615185433	D5170C00002	1722	1716	CREATE	2021-03-18 06:07:51.926	05 Site Management	05.02 Site Set-up Documentation
10708	85	1616044073141:-1391446697	1616044071842:429189496	D5170C00002	1724	1722	CREATE	2021-03-18 06:07:53.227	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
10709	85	1616044073683:1741823733	1616044071842:429189496	D5170C00002	1725	1722	CREATE	2021-03-18 06:07:53.77	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
10710	85	1616044074233:-2135153585	1616044071842:429189496	D5170C00002	1726	1722	CREATE	2021-03-18 06:07:54.32	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
10712	85	1616044075391:-125027869	1616044071842:429189496	D5170C00002	1728	1722	CREATE	2021-03-18 06:07:55.478	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
10713	85	1616044075981:-686857692	1616044071842:429189496	D5170C00002	1729	1722	CREATE	2021-03-18 06:07:56.065	05.02 Site Set-up Documentation	05.02.09 Inves_latory Agreement
14849	88	1617050248804:838258556	1617050182170:-1429529666	D5170C00001	539	471	ALREADY AVAILABLE	2021-03-30 07:19:37.318	Canada	1002
10716	85	1616044077684:-1607029726	1616044071842:429189496	D5170C00002	1732	1722	CREATE	2021-03-18 06:07:57.767	05.02 Site Set-up Documentation	05.02.13 Indemnity
10717	85	1616044078218:1932070025	1616044071842:429189496	D5170C00002	1733	1722	CREATE	2021-03-18 06:07:58.308	05.02 Site Set-up Documentation	05.02.14 Other Financial Agreement
10719	85	1616044079378:629279799	1616044071842:429189496	D5170C00002	1735	1722	CREATE	2021-03-18 06:07:59.468	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
10720	85	1616044080069:1757354236	1616044067675:-615185433	D5170C00002	1736	1716	CREATE	2021-03-18 06:08:00.156	05 Site Management	05.03 Site Initiation
10722	85	1616044081217:484956690	1616044080069:1757354236	D5170C00002	1738	1736	CREATE	2021-03-18 06:08:02.852	05.03 Site Initiation	05.03.03 Site _cumentation-Site
10723	85	1616044083433:-499375139	1616044080069:1757354236	D5170C00002	1739	1736	CREATE	2021-03-18 06:08:03.521	05.03 Site Initiation	05.03.03 Site Training-Staff
10724	85	1616044083985:783995233	1616044067675:-615185433	D5170C00002	1740	1716	CREATE	2021-03-18 06:08:04.084	05 Site Management	05.04 Site Management
10726	85	1616044085293:-226789210	1616044083985:783995233	D5170C00002	1742	1740	CREATE	2021-03-18 06:08:05.386	05.04 Site Management	05.04.08 Final_onitoring Report
10727	85	1616044086069:1143806338	1616044067675:-615185433	D5170C00002	1743	1716	CREATE	2021-03-18 06:08:06.159	05 Site Management	05.05 General
10729	85	1616044087248:-423604721	1616044059376:-396114037	D5170C00002	1745	1704	CREATE	2021-03-18 06:08:07.335	2002060 Argüel_ Arias, Federico	06 IP and Trial Supplies
10730	85	1616044087880:1104321046	1616044087248:-423604721	D5170C00002	1746	1745	CREATE	2021-03-18 06:08:07.97	06 IP and Trial Supplies	06.01 IP Documentation
10732	85	1616044089030:1803336123	1616043914564:1825605212	D5170C00002	1748	1500	CREATE	2021-03-18 06:08:09.413	Site	2002061 Calvet Calvo, Xavier
10733	85	1616044089942:-1568546846	1616044089030:1803336123	D5170C00002	1749	1748	CREATE	2021-03-18 06:08:10.026	2002061 Calvet Calvo, Xavier	01 Trial Management
10735	85	1616044091145:1339872979	1616044090506:-131521138	D5170C00002	1751	1750	CREATE	2021-03-18 06:08:11.232	01.01 Trial Oversight	01.01.06 Recruitment Plan
11653	86	\N	\N	D5170C00002	104	97	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
10736	85	1616044091761:378194489	1616044089030:1803336123	D5170C00002	1752	1748	CREATE	2021-03-18 06:08:11.847	2002061 Calvet Calvo, Xavier	02 Central Trial Documents
10738	85	1616044092862:-899834614	1616044092324:417277298	D5170C00002	1754	1753	CREATE	2021-03-18 06:08:12.946	02.04 General	02.04.01 Relev_ations-Documents
10739	85	1616044094391:409584549	1616044092324:417277298	D5170C00002	1755	1753	CREATE	2021-03-18 06:08:14.486	02.04 General	02.04.01 Relev_s-Contact Report
10741	85	1616044095595:1388012362	1616044089030:1803336123	D5170C00002	1757	1748	CREATE	2021-03-18 06:08:15.688	2002061 Calvet Calvo, Xavier	05 Site Management
10742	85	1616044096182:2003204663	1616044095595:1388012362	D5170C00002	1758	1757	CREATE	2021-03-18 06:08:16.272	05 Site Management	05.01 Site Selection
10744	85	1616044097315:356562552	1616044096182:2003204663	D5170C00002	1760	1758	CREATE	2021-03-18 06:08:17.405	05.01 Site Selection	05.01.02 Confidentiality Agreement
10745	85	1616044097956:1148303838	1616044096182:2003204663	D5170C00002	1761	1758	CREATE	2021-03-18 06:08:18.043	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
10747	85	1616044099069:1648709479	1616044098495:236075815	D5170C00002	1763	1762	CREATE	2021-03-18 06:08:19.159	05.02 Site Set-up Documentation	05.02.01 Accep_tigator Brochure
10748	85	1616044099619:-1324782766	1616044098495:236075815	D5170C00002	1764	1762	CREATE	2021-03-18 06:08:19.708	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
10750	85	1616044100776:108932788	1616044098495:236075815	D5170C00002	1766	1762	CREATE	2021-03-18 06:08:20.862	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
10751	85	1616044101339:-277644993	1616044098495:236075815	D5170C00002	1767	1762	CREATE	2021-03-18 06:08:21.426	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
10752	85	1616044101888:672776353	1616044098495:236075815	D5170C00002	1768	1762	CREATE	2021-03-18 06:08:21.978	05.02 Site Set-up Documentation	05.02.07 Site Qualification
10754	85	1616044103061:1975218659	1616044098495:236075815	D5170C00002	1770	1762	CREATE	2021-03-18 06:08:23.171	05.02 Site Set-up Documentation	05.02.09 Inves_latory Agreement
10755	85	1616044103826:1691682814	1616044098495:236075815	D5170C00002	1771	1762	CREATE	2021-03-18 06:08:23.915	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
10757	85	1616044105890:-170741550	1616044098495:236075815	D5170C00002	1773	1762	CREATE	2021-03-18 06:08:25.982	05.02 Site Set-up Documentation	05.02.13 Indemnity
10758	85	1616044106460:-1154482380	1616044098495:236075815	D5170C00002	1774	1762	CREATE	2021-03-18 06:08:26.547	05.02 Site Set-up Documentation	05.02.17 IP Si_se Documentation
10759	85	1616044107029:-1924749254	1616044098495:236075815	D5170C00002	1775	1762	CREATE	2021-03-18 06:08:27.116	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
10761	85	1616044108249:-1721272333	1616044107648:-396844020	D5170C00002	1777	1776	CREATE	2021-03-18 06:08:28.337	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
10762	85	1616044108802:165026404	1616044107648:-396844020	D5170C00002	1778	1776	CREATE	2021-03-18 06:08:28.89	05.03 Site Initiation	05.03.03 Site Training-Staff
10764	85	1616044110047:445911593	1616044095595:1388012362	D5170C00002	1780	1757	CREATE	2021-03-18 06:08:30.135	05 Site Management	05.04 Site Management
10765	85	1616044110637:-434771106	1616044110047:445911593	D5170C00002	1781	1780	CREATE	2021-03-18 06:08:30.724	05.04 Site Management	05.04.04 Visit Log
10767	85	1616044111735:805712089	1616044095595:1388012362	D5170C00002	1783	1757	CREATE	2021-03-18 06:08:31.817	05 Site Management	05.05 General
10768	85	1616044112289:1583596211	1616044111735:805712089	D5170C00002	1784	1783	CREATE	2021-03-18 06:08:32.375	05.05 General	05.05.02 Tracking Information
10769	85	1616044112844:-1678553762	1616043914564:1825605212	D5170C00002	1785	1500	CREATE	2021-03-18 06:08:32.937	Site	TBD-1-1R0JLPR Garcia Planella, Esther
10771	85	1616044114128:-282822733	1616044113447:-1884088784	D5170C00002	1787	1786	CREATE	2021-03-18 06:08:34.229	05 Site Management	05.01 Site Selection
10772	85	1616044114669:1137232890	1616044114128:-282822733	D5170C00002	1788	1787	CREATE	2021-03-18 06:08:34.755	05.01 Site Selection	05.01.02 Confidentiality Agreement
10774	85	1616044116734:231804830	1616044116185:-1141306314	D5170C00002	1790	1789	CREATE	2021-03-18 06:08:36.886	TBD-1-1WXVYHU And_ Garcia, Montserrat	05 Site Management
10775	85	1616044117385:918232179	1616044116734:231804830	D5170C00002	1791	1790	CREATE	2021-03-18 06:08:37.475	05 Site Management	05.01 Site Selection
10777	85	1616044118517:1962719730	1615838976578:1645421407	D5170C00002	1793	4	CREATE	2021-03-18 06:08:38.609	contents	TURKEY
10778	85	1616044119105:840225381	1616044118517:1962719730	D5170C00002	1794	1793	CREATE	2021-03-18 06:08:39.191	TURKEY	Site
14894	88	1617050284193:-2043116348	1617050182170:-1429529666	D5170C00001	584	471	ALREADY AVAILABLE	2021-03-30 07:19:37.319	Canada	1003
10781	85	1616044120829:2141606761	1616044120264:1383864152	D5170C00002	1797	1796	CREATE	2021-03-18 06:08:40.919	01 Trial Management	01.01 Trial Oversight
10783	85	1616044122029:261405148	1616044119677:-655064285	D5170C00002	1799	1795	CREATE	2021-03-18 06:08:42.116	2002254 Gonen, Can	02 Central Trial Documents
10785	85	1616044123251:-1807929086	1616044122601:1658375096	D5170C00002	1801	1800	CREATE	2021-03-18 06:08:43.341	02.02 Subject Documents	02.02.01 Subject Diary
10786	85	1616044123841:1027129242	1616044122601:1658375096	D5170C00002	1802	1800	CREATE	2021-03-18 06:08:43.928	02.02 Subject Documents	02.02.02 Subject Questionnaire
10787	85	1616044124385:-184680227	1616044122029:261405148	D5170C00002	1803	1799	CREATE	2021-03-18 06:08:44.469	02 Central Trial Documents	02.04 General
10789	85	1616044125548:2665575	1616044124385:-184680227	D5170C00002	1805	1803	CREATE	2021-03-18 06:08:45.635	02.04 General	02.04.01 Relev_s-Contact Report
10790	85	1616044126182:1398713648	1616044124385:-184680227	D5170C00002	1806	1803	CREATE	2021-03-18 06:08:47.124	02.04 General	02.04.01 UNBLI_s-Contact Report
10792	85	1616044128263:1949488369	1616044127636:1271223021	D5170C00002	1808	1807	CREATE	2021-03-18 06:08:48.354	05 Site Management	05.01 Site Selection
10793	85	1616044128853:-1388132866	1616044128263:1949488369	D5170C00002	1809	1808	CREATE	2021-03-18 06:08:48.943	05.01 Site Selection	05.01.01 Site Contact Details
10795	85	1616044130741:-791357335	1616044128263:1949488369	D5170C00002	1811	1808	CREATE	2021-03-18 06:08:50.827	05.01 Site Selection	05.01.03 Feasibility Documentation
10796	85	1616044131346:1455031974	1616044128263:1949488369	D5170C00002	1812	1808	CREATE	2021-03-18 06:08:51.432	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
10798	85	1616044132537:1552302437	1616044131965:1408073433	D5170C00002	1814	1813	CREATE	2021-03-18 06:08:52.624	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
10800	85	1616044133718:550096557	1616044131965:1408073433	D5170C00002	1816	1813	CREATE	2021-03-18 06:08:53.809	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
10801	85	1616044134430:-17343079	1616044131965:1408073433	D5170C00002	1817	1813	CREATE	2021-03-18 06:08:54.518	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
10802	85	1616044135062:1608503134	1616044131965:1408073433	D5170C00002	1818	1813	CREATE	2021-03-18 06:08:55.156	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
10804	85	1616044136230:693185806	1616044131965:1408073433	D5170C00002	1820	1813	CREATE	2021-03-18 06:08:56.313	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
10805	85	1616044136815:1477489136	1616044131965:1408073433	D5170C00002	1821	1813	CREATE	2021-03-18 06:08:56.9	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
10806	85	1616044138380:-1975062573	1616044131965:1408073433	D5170C00002	1822	1813	CREATE	2021-03-18 06:08:58.465	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
10808	85	1616044139632:1491849685	1616044139056:916962075	D5170C00002	1824	1823	CREATE	2021-03-18 06:08:59.719	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
10809	85	1616044140236:308916256	1616044139056:916962075	D5170C00002	1825	1823	CREATE	2021-03-18 06:09:00.323	05.03 Site Initiation	05.03.03 Site Training-Staff
10811	85	1616044141422:-56386319	1616044127636:1271223021	D5170C00002	1827	1807	CREATE	2021-03-18 06:09:01.703	05 Site Management	05.04 Site Management
10812	85	1616044142270:1410442014	1616044141422:-56386319	D5170C00002	1828	1827	CREATE	2021-03-18 06:09:02.361	05.04 Site Management	05.04.04 Visit Log
10814	85	1616044143503:-400113596	1616044141422:-56386319	D5170C00002	1830	1827	CREATE	2021-03-18 06:09:03.592	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
10815	85	1616044144189:161626918	1616044127636:1271223021	D5170C00002	1831	1807	CREATE	2021-03-18 06:09:04.287	05 Site Management	05.05 General
10816	85	1616044144761:1400807725	1616044144189:161626918	D5170C00002	1832	1831	CREATE	2021-03-18 06:09:04.845	05.05 General	05.05.01 Relevant Communications-Documents
10818	85	1616044146028:-1023137438	1616044144189:161626918	D5170C00002	1834	1831	CREATE	2021-03-18 06:09:06.114	05.05 General	05.05.02 Tracking Information
10819	85	1616044146628:-1572197061	1616044119105:840225381	D5170C00002	1835	1794	CREATE	2021-03-18 06:09:06.728	Site	2002255 Senates, Ebubekir
10821	85	1616044147904:2128472873	1616044147203:1675189478	D5170C00002	1837	1836	CREATE	2021-03-18 06:09:07.996	01 Trial Management	01.01 Trial Oversight
10822	85	1616044149559:1333906838	1616044147904:2128472873	D5170C00002	1838	1837	CREATE	2021-03-18 06:09:09.66	01.01 Trial Oversight	01.01.06 Recruitment Plan
10824	85	1616044150809:-466183998	1616044150214:-669811347	D5170C00002	1840	1839	CREATE	2021-03-18 06:09:10.898	02 Central Trial Documents	02.02 Subject Documents
10825	85	1616044151397:-812197280	1616044150809:-466183998	D5170C00002	1841	1840	CREATE	2021-03-18 06:09:11.482	02.02 Subject Documents	02.02.01 Subject Diary
10827	85	1616044152685:-604357453	1616044150214:-669811347	D5170C00002	1843	1839	CREATE	2021-03-18 06:09:12.776	02 Central Trial Documents	02.04 General
10828	85	1616044153333:47982517	1616044152685:-604357453	D5170C00002	1844	1843	CREATE	2021-03-18 06:09:16.998	02.04 General	02.04.01 Relev_ations-Documents
10829	85	1616044157575:1775396960	1616044152685:-604357453	D5170C00002	1845	1843	CREATE	2021-03-18 06:09:17.659	02.04 General	02.04.01 Relev_s-Contact Report
10831	85	1616044158744:1562548347	1616044146628:-1572197061	D5170C00002	1847	1835	CREATE	2021-03-18 06:09:18.83	2002255 Senates, Ebubekir	05 Site Management
10832	85	1616044159349:1644746838	1616044158744:1562548347	D5170C00002	1848	1847	CREATE	2021-03-18 06:09:20.028	05 Site Management	05.01 Site Selection
10834	85	1616044161273:-1737638446	1616044159349:1644746838	D5170C00002	1850	1848	CREATE	2021-03-18 06:09:21.365	05.01 Site Selection	05.01.02 Confidentiality Agreement
10835	85	1616044161913:-148271213	1616044159349:1644746838	D5170C00002	1851	1848	CREATE	2021-03-18 06:09:22.001	05.01 Site Selection	05.01.03 Feasibility Documentation
10837	85	1616044163195:-405977746	1616044158744:1562548347	D5170C00002	1853	1847	CREATE	2021-03-18 06:09:23.282	05 Site Management	05.02 Site Set-up Documentation
10838	85	1616044163840:317851959	1616044163195:-405977746	D5170C00002	1854	1853	CREATE	2021-03-18 06:09:23.926	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
10840	85	1616044165145:-374366253	1616044163195:-405977746	D5170C00002	1856	1853	CREATE	2021-03-18 06:09:25.237	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
10841	85	1616044165795:1717908646	1616044163195:-405977746	D5170C00002	1857	1853	CREATE	2021-03-18 06:09:25.889	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
10842	85	1616044166413:1906560927	1616044163195:-405977746	D5170C00002	1858	1853	CREATE	2021-03-18 06:09:26.505	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
8851	84	\N	\N	D5170C00002	2636	2632	NEW	\N	02 Central Trial Documents	02.04 General
10845	85	1616044168232:243028049	1616044163195:-405977746	D5170C00002	1861	1853	CREATE	2021-03-18 06:09:28.318	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
10846	85	1616044168853:1085443636	1616044163195:-405977746	D5170C00002	1862	1853	CREATE	2021-03-18 06:09:28.94	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
10848	85	1616044170172:-768699700	1616044169516:-755280627	D5170C00002	1864	1863	CREATE	2021-03-18 06:09:30.777	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
10849	85	1616044171371:1769930206	1616044169516:-755280627	D5170C00002	1865	1863	CREATE	2021-03-18 06:09:31.456	05.03 Site Initiation	05.03.03 Site _cumentation-Site
10851	85	1616044173110:1201998586	1616044158744:1562548347	D5170C00002	1867	1847	CREATE	2021-03-18 06:09:33.202	05 Site Management	05.04 Site Management
10852	85	1616044173782:-507501948	1616044173110:1201998586	D5170C00002	1868	1867	CREATE	2021-03-18 06:09:33.878	05.04 Site Management	05.04.04 Visit Log
10854	85	1616044175068:1561799082	1616044158744:1562548347	D5170C00002	1870	1847	CREATE	2021-03-18 06:09:35.157	05 Site Management	05.05 General
10855	85	1616044175796:885817930	1616044175068:1561799082	D5170C00002	1871	1870	CREATE	2021-03-18 06:09:35.883	05.05 General	05.05.01 Relevant Communications-Documents
10856	85	1616044176383:-1654697582	1616044175068:1561799082	D5170C00002	1872	1870	CREATE	2021-03-18 06:09:36.467	05.05 General	05.05.02 Tracking Information
10858	85	1616044177689:-753885674	1616044176991:1754065405	D5170C00002	1874	1873	CREATE	2021-03-18 06:09:37.775	06 IP and Trial Supplies	06.01 IP Documentation
10860	85	1616044178983:1310440696	1616044119105:840225381	D5170C00002	1876	1794	CREATE	2021-03-18 06:09:39.073	Site	2002256 Purnak, Tugrul
10861	85	1616044179669:-257843779	1616044178983:1310440696	D5170C00002	1877	1876	CREATE	2021-03-18 06:09:39.757	2002256 Purnak, Tugrul	01 Trial Management
10862	85	1616044180307:2046590206	1616044179669:-257843779	D5170C00002	1878	1877	CREATE	2021-03-18 06:09:40.395	01 Trial Management	01.01 Trial Oversight
10864	85	1616044182267:-1380292174	1616044178983:1310440696	D5170C00002	1880	1876	CREATE	2021-03-18 06:09:42.355	2002256 Purnak, Tugrul	02 Central Trial Documents
10865	85	1616044182864:1607874792	1616044182267:-1380292174	D5170C00002	1881	1880	CREATE	2021-03-18 06:09:42.952	02 Central Trial Documents	02.02 Subject Documents
10867	85	1616044184136:-1838781848	1616044182864:1607874792	D5170C00002	1883	1881	CREATE	2021-03-18 06:09:44.229	02.02 Subject Documents	02.02.02 Subject Questionnaire
10868	85	1616044184788:1469690728	1616044182267:-1380292174	D5170C00002	1884	1880	CREATE	2021-03-18 06:09:44.878	02 Central Trial Documents	02.04 General
10870	85	1616044185991:2048387776	1616044184788:1469690728	D5170C00002	1886	1884	CREATE	2021-03-18 06:09:46.077	02.04 General	02.04.01 Relev_s-Contact Report
10871	85	1616044186662:405811239	1616044184788:1469690728	D5170C00002	1887	1884	CREATE	2021-03-18 06:09:46.754	02.04 General	02.04.01 UNBLI_s-Contact Report
10873	85	1616044187889:-1752725371	1616044187263:852014475	D5170C00002	1889	1888	CREATE	2021-03-18 06:09:47.977	05 Site Management	05.01 Site Selection
10874	85	1616044188494:38318460	1616044187889:-1752725371	D5170C00002	1890	1889	CREATE	2021-03-18 06:09:48.578	05.01 Site Selection	05.01.01 Site Contact Details
10876	85	1616044189811:1059946211	1616044187889:-1752725371	D5170C00002	1892	1889	CREATE	2021-03-18 06:09:49.894	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
10877	85	1616044190425:633304600	1616044187263:852014475	D5170C00002	1893	1888	CREATE	2021-03-18 06:09:50.512	05 Site Management	05.02 Site Set-up Documentation
10879	85	1616044192285:-326828403	1616044190425:633304600	D5170C00002	1895	1893	CREATE	2021-03-18 06:09:52.374	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
10880	85	1616044192921:-1552661377	1616044190425:633304600	D5170C00002	1896	1893	CREATE	2021-03-18 06:09:53.004	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
10882	85	1616044194214:762098495	1616044190425:633304600	D5170C00002	1898	1893	CREATE	2021-03-18 06:09:54.306	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
10883	85	1616044194865:-2019166665	1616044190425:633304600	D5170C00002	1899	1893	CREATE	2021-03-18 06:09:54.964	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
10884	85	1616044195501:-463227719	1616044190425:633304600	D5170C00002	1900	1893	CREATE	2021-03-18 06:09:55.597	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
10886	85	1616044196710:-1457180568	1616044190425:633304600	D5170C00002	1902	1893	CREATE	2021-03-18 06:09:56.793	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
10887	85	1616044197302:-1080306143	1616044187263:852014475	D5170C00002	1903	1888	CREATE	2021-03-18 06:09:57.395	05 Site Management	05.03 Site Initiation
10889	85	1616044198534:-879757013	1616044197302:-1080306143	D5170C00002	1905	1903	CREATE	2021-03-18 06:09:58.62	05.03 Site Initiation	05.03.03 Site Training-Staff
10890	85	1616044199133:1688362934	1616044197302:-1080306143	D5170C00002	1906	1903	CREATE	2021-03-18 06:09:59.219	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
10891	85	1616044199693:984959464	1616044187263:852014475	D5170C00002	1907	1888	CREATE	2021-03-18 06:09:59.776	05 Site Management	05.04 Site Management
10893	85	1616044200934:-730604081	1616044199693:984959464	D5170C00002	1909	1907	CREATE	2021-03-18 06:10:01.028	05.04 Site Management	05.04.04 Visit Log
10894	85	1616044202159:572135396	1616044199693:984959464	D5170C00002	1910	1907	CREATE	2021-03-18 06:10:02.883	05.04 Site Management	05.04.05 Additional Monitoring Activity
10896	85	1616044204245:-329535570	1616044187263:852014475	D5170C00002	1912	1888	CREATE	2021-03-18 06:10:04.337	05 Site Management	05.05 General
10897	85	1616044204844:-142903361	1616044204245:-329535570	D5170C00002	1913	1912	CREATE	2021-03-18 06:10:05.028	05.05 General	05.05.01 Relevant Communications-Documents
10898	85	1616044205523:-204629847	1616044204245:-329535570	D5170C00002	1914	1912	CREATE	2021-03-18 06:10:05.626	05.05 General	05.05.02 Tracking Information
10900	85	1616044206817:899380528	1616044206205:1150244426	D5170C00002	1916	1915	CREATE	2021-03-18 06:10:06.899	2002257 Altintas, Engin	01 Trial Management
10901	85	1616044207420:-1194366348	1616044206817:899380528	D5170C00002	1917	1916	CREATE	2021-03-18 06:10:07.508	01 Trial Management	01.01 Trial Oversight
10903	85	1616044208695:-364950607	1616044206205:1150244426	D5170C00002	1919	1915	CREATE	2021-03-18 06:10:08.784	2002257 Altintas, Engin	02 Central Trial Documents
10904	85	1616044209369:1707016773	1616044208695:-364950607	D5170C00002	1920	1919	CREATE	2021-03-18 06:10:09.458	02 Central Trial Documents	02.02 Subject Documents
10906	85	1616044210575:-548933376	1616044209369:1707016773	D5170C00002	1922	1920	CREATE	2021-03-18 06:10:10.667	02.02 Subject Documents	02.02.02 Subject Questionnaire
10907	85	1616044211168:2544791	1616044208695:-364950607	D5170C00002	1923	1919	CREATE	2021-03-18 06:10:11.265	02 Central Trial Documents	02.04 General
14898	88	1617050292282:-1037937158	1617050182170:-1429529666	D5170C00001	588	471	ALREADY AVAILABLE	2021-03-30 07:19:37.319	Canada	1004
10910	85	1616044213730:-983135873	1616044211168:2544791	D5170C00002	1926	1923	CREATE	2021-03-18 06:10:13.82	02.04 General	02.04.01 UNBLI_s-Contact Report
10911	85	1616044214406:-577600292	1616044206205:1150244426	D5170C00002	1927	1915	CREATE	2021-03-18 06:10:14.498	2002257 Altintas, Engin	05 Site Management
10913	85	1616044215743:122397681	1616044215083:-495377138	D5170C00002	1929	1928	CREATE	2021-03-18 06:10:15.83	05.01 Site Selection	05.01.01 Site Contact Details
10915	85	1616044216991:-537169474	1616044215083:-495377138	D5170C00002	1931	1928	CREATE	2021-03-18 06:10:17.078	05.01 Site Selection	05.01.03 Feasibility Documentation
10916	85	1616044217611:38117614	1616044215083:-495377138	D5170C00002	1932	1928	CREATE	2021-03-18 06:10:17.701	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
10917	85	1616044218207:1890642224	1616044214406:-577600292	D5170C00002	1933	1927	CREATE	2021-03-18 06:10:18.296	05 Site Management	05.02 Site Set-up Documentation
10919	85	1616044219482:-1381343186	1616044218207:1890642224	D5170C00002	1935	1933	CREATE	2021-03-18 06:10:19.57	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
10920	85	1616044220060:1928423866	1616044218207:1890642224	D5170C00002	1936	1933	CREATE	2021-03-18 06:10:20.154	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
10922	85	1616044221190:-85701122	1616044218207:1890642224	D5170C00002	1938	1933	CREATE	2021-03-18 06:10:21.278	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
10923	85	1616044221748:63714370	1616044218207:1890642224	D5170C00002	1939	1933	CREATE	2021-03-18 06:10:21.839	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
10924	85	1616044222371:442948351	1616044218207:1890642224	D5170C00002	1940	1933	CREATE	2021-03-18 06:10:22.466	05.02 Site Set-up Documentation	05.02.12 Clini_ Trial Agreement
10926	85	1616044223528:-1048605672	1616044218207:1890642224	D5170C00002	1942	1933	CREATE	2021-03-18 06:10:23.631	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
10927	85	1616044224858:-1221183336	1616044214406:-577600292	D5170C00002	1943	1927	CREATE	2021-03-18 06:10:24.957	05 Site Management	05.03 Site Initiation
10929	85	1616044226132:343950137	1616044224858:-1221183336	D5170C00002	1945	1943	CREATE	2021-03-18 06:10:26.22	05.03 Site Initiation	05.03.03 Site Training-Staff
10930	85	1616044226724:149526187	1616044224858:-1221183336	D5170C00002	1946	1943	CREATE	2021-03-18 06:10:26.809	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
10931	85	1616044227289:284289123	1616044214406:-577600292	D5170C00002	1947	1927	CREATE	2021-03-18 06:10:27.383	05 Site Management	05.04 Site Management
10933	85	1616044228479:1982263024	1616044227289:284289123	D5170C00002	1949	1947	CREATE	2021-03-18 06:10:28.566	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
10934	85	1616044229106:-578377939	1616044214406:-577600292	D5170C00002	1950	1927	CREATE	2021-03-18 06:10:29.197	05 Site Management	05.05 General
10936	85	1616044230239:612385030	1616044229106:-578377939	D5170C00002	1952	1950	CREATE	2021-03-18 06:10:30.33	05.05 General	05.05.02 Tracking Information
10937	85	1616044230848:-688811429	1616044119105:840225381	D5170C00002	1953	1794	CREATE	2021-03-18 06:10:30.937	Site	2002258 Ormeci, Necati
10939	85	1616044232040:-1942512492	1616044231437:1474862809	D5170C00002	1955	1954	CREATE	2021-03-18 06:10:32.13	01 Trial Management	01.01 Trial Oversight
10940	85	1616044232712:-1489764089	1616044232040:-1942512492	D5170C00002	1956	1955	CREATE	2021-03-18 06:10:32.808	01.01 Trial Oversight	01.01.06 Recruitment Plan
10942	85	1616044234047:2079926146	1616044233311:-1011957102	D5170C00002	1958	1957	CREATE	2021-03-18 06:10:34.137	02 Central Trial Documents	02.02 Subject Documents
10943	85	1616044235372:-213838130	1616044234047:2079926146	D5170C00002	1959	1958	CREATE	2021-03-18 06:10:35.469	02.02 Subject Documents	02.02.01 Subject Diary
10945	85	1616044236676:685335742	1616044233311:-1011957102	D5170C00002	1961	1957	CREATE	2021-03-18 06:10:36.768	02 Central Trial Documents	02.04 General
10946	85	1616044237280:-1527824359	1616044236676:685335742	D5170C00002	1962	1961	CREATE	2021-03-18 06:10:37.378	02.04 General	02.04.01 Relev_ations-Documents
10948	85	1616044238719:-1443007671	1616044236676:685335742	D5170C00002	1964	1961	CREATE	2021-03-18 06:10:38.814	02.04 General	02.04.01 UNBLI_s-Contact Report
10949	85	1616044239296:1362232287	1616044230848:-688811429	D5170C00002	1965	1953	CREATE	2021-03-18 06:10:39.392	2002258 Ormeci, Necati	05 Site Management
10951	85	1616044240517:-1858806038	1616044239893:-675556019	D5170C00002	1967	1966	CREATE	2021-03-18 06:10:40.607	05.01 Site Selection	05.01.01 Site Contact Details
10952	85	1616044241181:-1628951400	1616044239893:-675556019	D5170C00002	1968	1966	CREATE	2021-03-18 06:10:41.272	05.01 Site Selection	05.01.02 Confidentiality Agreement
10954	85	1616044242369:-720650374	1616044239893:-675556019	D5170C00002	1970	1966	CREATE	2021-03-18 06:10:42.46	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
10955	85	1616044242944:-105683100	1616044239296:1362232287	D5170C00002	1971	1965	CREATE	2021-03-18 06:10:43.03	05 Site Management	05.02 Site Set-up Documentation
10957	85	1616044244106:-1363291666	1616044242944:-105683100	D5170C00002	1973	1971	CREATE	2021-03-18 06:10:44.207	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
10958	85	1616044244797:1597856262	1616044242944:-105683100	D5170C00002	1974	1971	CREATE	2021-03-18 06:10:44.897	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
10960	85	1616044246822:1403081635	1616044242944:-105683100	D5170C00002	1976	1971	CREATE	2021-03-18 06:10:46.91	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
10961	85	1616044247431:1552497127	1616044242944:-105683100	D5170C00002	1977	1971	CREATE	2021-03-18 06:10:47.529	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
10962	85	1616044247998:-1186531223	1616044242944:-105683100	D5170C00002	1978	1971	CREATE	2021-03-18 06:10:48.084	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
10964	85	1616044249122:-1237301145	1616044242944:-105683100	D5170C00002	1980	1971	CREATE	2021-03-18 06:10:49.22	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
10965	85	1616044249707:-1819262016	1616044239296:1362232287	D5170C00002	1981	1965	CREATE	2021-03-18 06:10:49.795	05 Site Management	05.03 Site Initiation
10967	85	1616044250917:914889359	1616044249707:-1819262016	D5170C00002	1983	1981	CREATE	2021-03-18 06:10:51.037	05.03 Site Initiation	05.03.03 Site Training-Staff
10968	85	1616044251543:862348149	1616044249707:-1819262016	D5170C00002	1984	1981	CREATE	2021-03-18 06:10:51.663	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
10969	85	1616044252166:249207509	1616044239296:1362232287	D5170C00002	1985	1965	CREATE	2021-03-18 06:10:52.271	05 Site Management	05.04 Site Management
10971	85	1616044253364:1125254540	1616044252166:249207509	D5170C00002	1987	1985	CREATE	2021-03-18 06:10:53.454	05.04 Site Management	05.04.04 Visit Log
14902	88	1617050294808:783803211	1617050182170:-1429529666	D5170C00001	592	471	ALREADY AVAILABLE	2021-03-30 07:19:37.319	Canada	1005
10973	85	1616044254605:-2049661977	1616044252166:249207509	D5170C00002	1989	1985	CREATE	2021-03-18 06:10:54.695	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
10974	85	1616044255207:1862157382	1616044239296:1362232287	D5170C00002	1990	1965	CREATE	2021-03-18 06:10:55.301	05 Site Management	05.05 General
10976	85	1616044257305:1608469440	1616044255207:1862157382	D5170C00002	1992	1990	CREATE	2021-03-18 06:10:57.391	05.05 General	05.05.02 Tracking Information
10977	85	1616044257937:-1063718503	1616044230848:-688811429	D5170C00002	1993	1953	CREATE	2021-03-18 06:10:58.02	2002258 Ormeci, Necati	06 IP and Trial Supplies
10979	85	1616044259097:-2106939104	1616044258514:556717357	D5170C00002	1995	1994	CREATE	2021-03-18 06:10:59.198	06.07 General	06.07.01 Relev_roduct-Documents
10980	85	1616044259681:628615123	1616044119105:840225381	D5170C00002	1996	1794	CREATE	2021-03-18 06:10:59.782	Site	2002259 Kalkan, Ismail
10982	85	1616044260929:-2039038508	1616044260293:-1433159409	D5170C00002	1998	1997	CREATE	2021-03-18 06:11:01.026	01 Trial Management	01.01 Trial Oversight
10983	85	1616044261512:-1978172361	1616044260929:-2039038508	D5170C00002	1999	1998	CREATE	2021-03-18 06:11:01.611	01.01 Trial Oversight	01.01.06 Recruitment Plan
10985	85	1616044262710:-1917380588	1616044262095:486210115	D5170C00002	2001	2000	CREATE	2021-03-18 06:11:02.804	02 Central Trial Documents	02.02 Subject Documents
10986	85	1616044263284:-1015668224	1616044262710:-1917380588	D5170C00002	2002	2001	CREATE	2021-03-18 06:11:03.378	02.02 Subject Documents	02.02.01 Subject Diary
10988	85	1616044264596:-691235572	1616044262095:486210115	D5170C00002	2004	2000	CREATE	2021-03-18 06:11:04.893	02 Central Trial Documents	02.04 General
10989	85	1616044265420:620299418	1616044264596:-691235572	D5170C00002	2005	2004	CREATE	2021-03-18 06:11:05.522	02.04 General	02.04.01 Relev_s-Contact Report
10991	85	1616044266647:1472554315	1616044266043:-181429024	D5170C00002	2007	2006	CREATE	2021-03-18 06:11:06.734	05 Site Management	05.01 Site Selection
10992	85	1616044268286:-365086179	1616044266647:1472554315	D5170C00002	2008	2007	CREATE	2021-03-18 06:11:08.375	05.01 Site Selection	05.01.01 Site Contact Details
10994	85	1616044270008:1596082086	1616044266647:1472554315	D5170C00002	2010	2007	CREATE	2021-03-18 06:11:10.11	05.01 Site Selection	05.01.03 Feasibility Documentation
10995	85	1616044270587:-1702515623	1616044266647:1472554315	D5170C00002	2011	2007	CREATE	2021-03-18 06:11:10.671	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
10997	85	1616044271853:1145060926	1616044271229:1382977960	D5170C00002	2013	2012	CREATE	2021-03-18 06:11:11.947	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
10998	85	1616044272431:1786662082	1616044271229:1382977960	D5170C00002	2014	2012	CREATE	2021-03-18 06:11:12.516	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
11000	85	1616044273581:-1229216003	1616044271229:1382977960	D5170C00002	2016	2012	CREATE	2021-03-18 06:11:13.667	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
11001	85	1616044274142:254864169	1616044271229:1382977960	D5170C00002	2017	2012	CREATE	2021-03-18 06:11:14.229	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
11002	85	1616044274712:-1269962824	1616044271229:1382977960	D5170C00002	2018	2012	CREATE	2021-03-18 06:11:14.799	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
11004	85	1616044275842:-1550466577	1616044271229:1382977960	D5170C00002	2020	2012	CREATE	2021-03-18 06:11:15.929	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
11005	85	1616044276456:1912684430	1616044271229:1382977960	D5170C00002	2021	2012	CREATE	2021-03-18 06:11:16.549	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
11006	85	1616044277076:-927536804	1616044266043:-181429024	D5170C00002	2022	2006	CREATE	2021-03-18 06:11:17.176	05 Site Management	05.03 Site Initiation
11008	85	1616044279063:1945556616	1616044277076:-927536804	D5170C00002	2024	2022	CREATE	2021-03-18 06:11:19.149	05.03 Site Initiation	05.03.03 Site Training-Staff
11009	85	1616044279655:1893015406	1616044277076:-927536804	D5170C00002	2025	2022	CREATE	2021-03-18 06:11:19.745	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
11011	85	1616044280991:921883845	1616044280338:-1900874589	D5170C00002	2027	2026	CREATE	2021-03-18 06:11:21.081	05.04 Site Management	05.04.04 Visit Log
11012	85	1616044281583:247843609	1616044280338:-1900874589	D5170C00002	2028	2026	CREATE	2021-03-18 06:11:21.668	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
11014	85	1616044283748:1531393818	1616044266043:-181429024	D5170C00002	2030	2006	CREATE	2021-03-18 06:11:23.835	05 Site Management	05.05 General
11015	85	1616044284364:-814292336	1616044283748:1531393818	D5170C00002	2031	2030	CREATE	2021-03-18 06:11:24.45	05.05 General	05.05.01 Relevant Communications-Email
11017	85	1616044285585:-405333406	1616044119105:840225381	D5170C00002	2033	1794	CREATE	2021-03-18 06:11:25.676	Site	2002260 Yesil, Atakan
11018	85	1616044286185:-507938384	1616044285585:-405333406	D5170C00002	2034	2033	CREATE	2021-03-18 06:11:26.28	2002260 Yesil, Atakan	01 Trial Management
11020	85	1616044287561:121413654	1616044286766:-709861104	D5170C00002	2036	2035	CREATE	2021-03-18 06:11:27.645	01.01 Trial Oversight	01.01.06 Recruitment Plan
11021	85	1616044288205:-1630397388	1616044285585:-405333406	D5170C00002	2037	2033	CREATE	2021-03-18 06:11:28.298	2002260 Yesil, Atakan	02 Central Trial Documents
11023	85	1616044290178:99764792	1616044289540:1887817615	D5170C00002	2039	2038	CREATE	2021-03-18 06:11:30.264	02.02 Subject Documents	02.02.01 Subject Diary
11024	85	1616044290775:-766528945	1616044289540:1887817615	D5170C00002	2040	2038	CREATE	2021-03-18 06:11:30.858	02.02 Subject Documents	02.02.02 Subject Questionnaire
11026	85	1616044292061:825316464	1616044291412:1891463246	D5170C00002	2042	2041	CREATE	2021-03-18 06:11:32.147	02.04 General	02.04.01 UNBLI_s-Contact Report
11027	85	1616044292676:-765740436	1616044285585:-405333406	D5170C00002	2043	2033	CREATE	2021-03-18 06:11:32.763	2002260 Yesil, Atakan	05 Site Management
11029	85	1616044293898:-78408693	1616044293286:1658097072	D5170C00002	2045	2044	CREATE	2021-03-18 06:11:33.987	05.01 Site Selection	05.01.01 Site Contact Details
11030	85	1616044294483:-1070989786	1616044293286:1658097072	D5170C00002	2046	2044	CREATE	2021-03-18 06:11:34.576	05.01 Site Selection	05.01.02 Confidentiality Agreement
11032	85	1616044295814:-1530359675	1616044293286:1658097072	D5170C00002	2048	2044	CREATE	2021-03-18 06:11:35.902	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
11033	85	1616044296434:-250850862	1616044292676:-765740436	D5170C00002	2049	2043	CREATE	2021-03-18 06:11:36.525	05 Site Management	05.02 Site Set-up Documentation
11035	85	1616044297758:-859393376	1616044296434:-250850862	D5170C00002	2051	2049	CREATE	2021-03-18 06:11:37.853	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
14949	88	1617050337587:1587186884	1617050182170:-1429529666	D5170C00001	639	471	ALREADY AVAILABLE	2021-03-30 07:19:37.319	Canada	1006
11038	85	1616044300584:-1774519491	1616044296434:-250850862	D5170C00002	2054	2049	CREATE	2021-03-18 06:11:40.673	05.02 Site Set-up Documentation	05.02.07 Site Qualification
11039	85	1616044301242:2020282702	1616044296434:-250850862	D5170C00002	2055	2049	CREATE	2021-03-18 06:11:41.341	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
11041	85	1616044302476:1906286779	1616044296434:-250850862	D5170C00002	2057	2049	CREATE	2021-03-18 06:11:42.57	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
11042	85	1616044303059:-1459237484	1616044296434:-250850862	D5170C00002	2058	2049	CREATE	2021-03-18 06:11:43.149	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
11043	85	1616044303680:-761972209	1616044296434:-250850862	D5170C00002	2059	2049	CREATE	2021-03-18 06:11:43.768	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
11045	85	1616044304963:-1613271786	1616044304335:-596790690	D5170C00002	2061	2060	CREATE	2021-03-18 06:11:45.05	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
11046	85	1616044305606:1640719084	1616044304335:-596790690	D5170C00002	2062	2060	CREATE	2021-03-18 06:11:45.69	05.03 Site Initiation	05.03.03 Site Training-Staff
11048	85	1616044306781:-1570128475	1616044292676:-765740436	D5170C00002	2064	2043	CREATE	2021-03-18 06:11:46.867	05 Site Management	05.04 Site Management
11049	85	1616044307358:145123360	1616044306781:-1570128475	D5170C00002	2065	2064	CREATE	2021-03-18 06:11:47.444	05.04 Site Management	05.04.04 Visit Log
11051	85	1616044308715:1555674704	1616044306781:-1570128475	D5170C00002	2067	2064	CREATE	2021-03-18 06:11:48.801	05.04 Site Management	05.04.08 UNBLI_onitoring Report
11052	85	1616044309373:463819025	1616044292676:-765740436	D5170C00002	2068	2043	CREATE	2021-03-18 06:11:49.456	05 Site Management	05.05 General
11053	85	1616044309984:1911070267	1616044309373:463819025	D5170C00002	2069	2068	CREATE	2021-03-18 06:11:50.069	05.05 General	05.05.02 Tracking Information
11055	85	1616044312022:2106415203	1616044310634:246082852	D5170C00002	2071	2070	CREATE	2021-03-18 06:11:52.108	2002261 Boyacioglu, Sedat	01 Trial Management
11056	85	1616044312676:1139745326	1616044312022:2106415203	D5170C00002	2072	2071	CREATE	2021-03-18 06:11:52.758	01 Trial Management	01.01 Trial Oversight
11058	85	1616044313898:-1943329573	1616044310634:246082852	D5170C00002	2074	2070	CREATE	2021-03-18 06:11:53.982	2002261 Boyacioglu, Sedat	02 Central Trial Documents
11060	85	1616044315100:-838119348	1616044314484:-590538057	D5170C00002	2076	2075	CREATE	2021-03-18 06:11:55.188	02.02 Subject Documents	02.02.01 Subject Diary
11061	85	1616044315739:-451337971	1616044314484:-590538057	D5170C00002	2077	2075	CREATE	2021-03-18 06:11:55.83	02.02 Subject Documents	02.02.02 Subject Questionnaire
11062	85	1616044316349:635606959	1616044313898:-1943329573	D5170C00002	2078	2074	CREATE	2021-03-18 06:11:56.436	02 Central Trial Documents	02.04 General
11064	85	1616044317494:1511734321	1616044316349:635606959	D5170C00002	2080	2078	CREATE	2021-03-18 06:11:57.581	02.04 General	02.04.01 Relev_s-Contact Report
11065	85	1616044318206:-19545814	1616044316349:635606959	D5170C00002	2081	2078	CREATE	2021-03-18 06:11:58.315	02.04 General	02.04.01 UNBLI_s-Contact Report
11067	85	1616044319473:-1650652766	1616044318842:-933501091	D5170C00002	2083	2082	CREATE	2021-03-18 06:11:59.564	05 Site Management	05.01 Site Selection
11068	85	1616044320046:-931146646	1616044319473:-1650652766	D5170C00002	2084	2083	CREATE	2021-03-18 06:12:00.311	05.01 Site Selection	05.01.01 Site Contact Details
11070	85	1616044321409:-189199585	1616044319473:-1650652766	D5170C00002	2086	2083	CREATE	2021-03-18 06:12:02.365	05.01 Site Selection	05.01.03 Feasibility Documentation
11071	85	1616044322913:803870603	1616044319473:-1650652766	D5170C00002	2087	2083	CREATE	2021-03-18 06:12:02.998	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
11073	85	1616044324116:1691883258	1616044323530:-517803999	D5170C00002	2089	2088	CREATE	2021-03-18 06:12:04.203	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
11074	85	1616044324702:-1961482882	1616044323530:-517803999	D5170C00002	2090	2088	CREATE	2021-03-18 06:12:04.789	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
11076	85	1616044325983:161312338	1616044323530:-517803999	D5170C00002	2092	2088	CREATE	2021-03-18 06:12:06.07	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
11077	85	1616044326605:349890356	1616044323530:-517803999	D5170C00002	2093	2088	CREATE	2021-03-18 06:12:06.693	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
11079	85	1616044327744:2100986169	1616044323530:-517803999	D5170C00002	2095	2088	CREATE	2021-03-18 06:12:07.831	05.02 Site Set-up Documentation	05.02.12 Clini_ Trial Agreement
11080	85	1616044328350:1976709131	1616044323530:-517803999	D5170C00002	2096	2088	CREATE	2021-03-18 06:12:08.443	05.02 Site Set-up Documentation	05.02.17 IP Si_se Documentation
11081	85	1616044328957:-467853273	1616044323530:-517803999	D5170C00002	2097	2088	CREATE	2021-03-18 06:12:09.047	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
11083	85	1616044330163:261501074	1616044329537:244265847	D5170C00002	2099	2098	CREATE	2021-03-18 06:12:10.255	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
11084	85	1616044330767:780160723	1616044329537:244265847	D5170C00002	2100	2098	CREATE	2021-03-18 06:12:10.86	05.03 Site Initiation	05.03.03 Site Training-Staff
11086	85	1616044332062:-1982295578	1616044318842:-933501091	D5170C00002	2102	2082	CREATE	2021-03-18 06:12:12.149	05 Site Management	05.04 Site Management
11087	85	1616044333516:-1573900476	1616044332062:-1982295578	D5170C00002	2103	2102	CREATE	2021-03-18 06:12:13.601	05.04 Site Management	05.04.04 Visit Log
11089	85	1616044334670:853153680	1616044318842:-933501091	D5170C00002	2105	2082	CREATE	2021-03-18 06:12:14.755	05 Site Management	05.05 General
11090	85	1616044335254:-1711764031	1616044334670:853153680	D5170C00002	2106	2105	CREATE	2021-03-18 06:12:15.34	05.05 General	05.05.01 Relevant Communications-Documents
11091	85	1616044335898:-1179758587	1616044334670:853153680	D5170C00002	2107	2105	CREATE	2021-03-18 06:12:15.982	05.05 General	05.05.02 Tracking Information
11093	85	1616044337148:184549392	1616044336475:932162971	D5170C00002	2109	2108	CREATE	2021-03-18 06:12:17.241	06 IP and Trial Supplies	06.01 IP Documentation
11094	85	1616044341083:1947161851	1616044337148:184549392	D5170C00002	2110	2109	CREATE	2021-03-18 06:12:21.172	06.01 IP Documentation	06.01.11 Certificate of Destruction
11096	85	1616044342237:-1961719993	1616044341663:1198874892	D5170C00002	2112	2111	CREATE	2021-03-18 06:12:22.395	2003204 Celik, Aykut Ferhat	05 Site Management
11097	85	1616044342904:-1153426605	1616044342237:-1961719993	D5170C00002	2113	2112	CREATE	2021-03-18 06:12:22.995	05 Site Management	05.01 Site Selection
11099	85	1616044344556:-441543638	1616044342237:-1961719993	D5170C00002	2115	2112	CREATE	2021-03-18 06:12:24.645	05 Site Management	05.02 Site Set-up Documentation
14998	88	1617050386532:-683947474	1617050182170:-1429529666	D5170C00001	688	471	ALREADY AVAILABLE	2021-03-30 07:19:37.319	Canada	1007
11101	85	1616044345684:-1541510787	1616044344556:-441543638	D5170C00002	2117	2115	CREATE	2021-03-18 06:12:25.783	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
11102	85	1616044346280:1503739465	1616044119105:840225381	D5170C00002	2118	1794	CREATE	2021-03-18 06:12:26.418	Site	TBD-1-1ROJI0A Karakan, Tarkan
11104	85	1616044347456:-139065716	1616044346881:-1340603638	D5170C00002	2120	2119	CREATE	2021-03-18 06:12:27.557	05 Site Management	05.01 Site Selection
11105	85	1616044348017:1214394969	1616044347456:-139065716	D5170C00002	2121	2120	CREATE	2021-03-18 06:12:28.107	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
11107	85	1616044349283:87005257	1616044348722:816596348	D5170C00002	2123	2122	CREATE	2021-03-18 06:12:29.368	TBD-1-1XK1D9U Yalniz, Mehmet	05 Site Management
11108	85	1616044349959:-457875896	1616044349283:87005257	D5170C00002	2124	2123	CREATE	2021-03-18 06:12:30.042	05 Site Management	05.01 Site Selection
11110	85	1616044351094:-1850568280	1615838976578:1645421407	D5170C00002	2126	4	CREATE	2021-03-18 06:12:31.177	contents	UKRAINE
11111	85	1616044351640:-2073699292	1616044351094:-1850568280	D5170C00002	2127	2126	CREATE	2021-03-18 06:12:31.724	UKRAINE	Site
11113	85	1616044352775:-1628533852	1616044352179:205722499	D5170C00002	2129	2128	CREATE	2021-03-18 06:12:32.859	TBD-1-25PODT3 Hospodarskyy, Ihor	05 Site Management
11114	85	1616044353319:877913662	1616044352775:-1628533852	D5170C00002	2130	2129	CREATE	2021-03-18 06:12:33.402	05 Site Management	05.01 Site Selection
11116	85	1616044354909:-343853202	1616044351640:-2073699292	D5170C00002	2132	2127	CREATE	2021-03-18 06:12:34.995	Site	TBD-1-26H5ZET Zhdan, Vyacheslav
11117	85	1616044355443:-400900292	1616044354909:-343853202	D5170C00002	2133	2132	CREATE	2021-03-18 06:12:35.527	TBD-1-26H5ZET Zhdan, Vyacheslav	05 Site Management
11119	85	1616044356607:209274419	1616044356052:1172108087	D5170C00002	2135	2134	CREATE	2021-03-18 06:12:36.697	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
11120	85	1616044357172:1865320547	1615838976578:1645421407	D5170C00002	2136	4	CREATE	2021-03-18 06:12:37.256	contents	UNITED KINGDOM
11122	85	1616044358287:-1168622510	1616044357746:1825771779	D5170C00002	2138	2137	CREATE	2021-03-18 06:12:38.372	Site	2002042 Hoque, Syed
11124	85	1616044359430:1760335989	1616044358881:189925105	D5170C00002	2140	2139	CREATE	2021-03-18 06:12:39.516	02 Central Trial Documents	02.02 Subject Documents
11125	85	1616044359997:-725174493	1616044359430:1760335989	D5170C00002	2141	2140	CREATE	2021-03-18 06:12:40.083	02.02 Subject Documents	02.02.03 Infor_t Form Templates
11127	85	1616044361086:-937013230	1616044359430:1760335989	D5170C00002	2143	2140	CREATE	2021-03-18 06:12:41.172	02.02 Subject Documents	02.02.07 Other_iven to Subjects
11128	85	1616044361636:-1453710866	1616044358881:189925105	D5170C00002	2144	2139	CREATE	2021-03-18 06:12:41.722	02 Central Trial Documents	02.04 General
11129	85	1616044362580:-1828619156	1616044361636:-1453710866	D5170C00002	2145	2144	CREATE	2021-03-18 06:12:42.667	02.04 General	02.04.01 Relev_ations-Documents
11131	85	1616044363763:1886967242	1616044358287:-1168622510	D5170C00002	2147	2138	CREATE	2021-03-18 06:12:43.847	2002042 Hoque, Syed	04 IRB-IEC and other Approvals
11132	85	1616044364312:-1404737046	1616044363763:1886967242	D5170C00002	2148	2147	CREATE	2021-03-18 06:12:44.4	04 IRB-IEC and other Approvals	04.02 Other Committees
11134	85	1616044366001:205936392	1616044364312:-1404737046	D5170C00002	2150	2148	CREATE	2021-03-18 06:12:46.086	04.02 Other Committees	04.02.02 Other Approvals
11135	85	1616044366540:-357854895	1616044358287:-1168622510	D5170C00002	2151	2138	CREATE	2021-03-18 06:12:46.627	2002042 Hoque, Syed	05 Site Management
11137	85	1616044367654:443012709	1616044367082:917823081	D5170C00002	2153	2152	CREATE	2021-03-18 06:12:47.74	05.01 Site Selection	05.01.01 Site Contact Details
11138	85	1616044368197:-694792959	1616044367082:917823081	D5170C00002	2154	2152	CREATE	2021-03-18 06:12:48.283	05.01 Site Selection	05.01.02 Confidentiality Agreement
11140	85	1616044369387:358722033	1616044367082:917823081	D5170C00002	2156	2152	CREATE	2021-03-18 06:12:49.475	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
11141	85	1616044369974:1936192746	1616044366540:-357854895	D5170C00002	2157	2151	CREATE	2021-03-18 06:12:50.058	05 Site Management	05.02 Site Set-up Documentation
11143	85	1616044404221:-598143126	1616044369974:1936192746	D5170C00002	2159	2157	CREATE	2021-03-18 06:13:24.309	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
11144	85	1616044404802:2053176269	1616044369974:1936192746	D5170C00002	2160	2157	CREATE	2021-03-18 06:13:24.889	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
11145	85	1616044405399:259852977	1616044369974:1936192746	D5170C00002	2161	2157	CREATE	2021-03-18 06:13:25.498	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
11147	85	1616044406605:-1135076645	1616044369974:1936192746	D5170C00002	2163	2157	CREATE	2021-03-18 06:13:26.692	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
11148	85	1616044407633:1977063238	1616044369974:1936192746	D5170C00002	2164	2157	CREATE	2021-03-18 06:13:27.723	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
11150	85	1616044408815:989867875	1616044369974:1936192746	D5170C00002	2166	2157	CREATE	2021-03-18 06:13:28.909	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
11151	85	1616044409405:726403415	1616044369974:1936192746	D5170C00002	2167	2157	CREATE	2021-03-18 06:13:29.49	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
11153	85	1616044410624:-1796641607	1616044369974:1936192746	D5170C00002	2169	2157	CREATE	2021-03-18 06:13:30.793	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
11154	85	1616044411281:1445113215	1616044366540:-357854895	D5170C00002	2170	2151	CREATE	2021-03-18 06:13:31.539	05 Site Management	05.03 Site Initiation
11155	85	1616044412030:-1141034000	1616044411281:1445113215	D5170C00002	2171	2170	CREATE	2021-03-18 06:13:32.121	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
11157	85	1616044413190:692712918	1616044411281:1445113215	D5170C00002	2173	2170	CREATE	2021-03-18 06:13:33.272	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
11158	85	1616044413755:-781395165	1616044366540:-357854895	D5170C00002	2174	2151	CREATE	2021-03-18 06:13:33.838	05 Site Management	05.04 Site Management
11159	85	1616044414314:810388321	1616044413755:-781395165	D5170C00002	2175	2174	CREATE	2021-03-18 06:13:34.396	05.04 Site Management	05.04.04 Visit Log
11161	85	1616044415619:-94309322	1616044413755:-781395165	D5170C00002	2177	2174	CREATE	2021-03-18 06:13:35.702	05.04 Site Management	05.04.09 Inv Notification-SUSAR
11162	85	1616044416238:2057162530	1616044366540:-357854895	D5170C00002	2178	2151	CREATE	2021-03-18 06:13:36.325	05 Site Management	05.05 General
11164	85	1616044417959:1202942121	1616044416238:2057162530	D5170C00002	2180	2178	CREATE	2021-03-18 06:13:38.042	05.05 General	05.05.01 Relevant Communications-Documents
15047	88	1617050448058:729655527	1617050182170:-1429529666	D5170C00001	737	471	ALREADY AVAILABLE	2021-03-30 07:19:37.319	Canada	1008
11167	85	1616044419861:1264690622	1616044419222:-308294840	D5170C00002	2183	2182	CREATE	2021-03-18 06:13:39.946	06 IP and Trial Supplies	06.05 Non-IP Documentation
11169	85	1616044421021:1414552527	1616044357746:1825771779	D5170C00002	2185	2137	CREATE	2021-03-18 06:13:41.105	Site	2002043 Nwokolo, Chukwuka
11170	85	1616044421578:-1500793567	1616044421021:1414552527	D5170C00002	2186	2185	CREATE	2021-03-18 06:13:41.674	2002043 Nwokolo, Chukwuka	02 Central Trial Documents
11171	85	1616044422177:-1078049900	1616044421578:-1500793567	D5170C00002	2187	2186	CREATE	2021-03-18 06:13:42.263	02 Central Trial Documents	02.02 Subject Documents
11173	85	1616044423382:1531273450	1616044422177:-1078049900	D5170C00002	2189	2187	CREATE	2021-03-18 06:13:43.47	02.02 Subject Documents	02.02.05 Subject Participation Card
11174	85	1616044423936:658577006	1616044422177:-1078049900	D5170C00002	2190	2187	CREATE	2021-03-18 06:13:44.025	02.02 Subject Documents	02.02.06 Adver_ject Recruitment
11176	85	1616044425047:-1105064870	1616044421578:-1500793567	D5170C00002	2192	2186	CREATE	2021-03-18 06:13:45.133	02 Central Trial Documents	02.04 General
11177	85	1616044425658:-1492152804	1616044425047:-1105064870	D5170C00002	2193	2192	CREATE	2021-03-18 06:13:45.746	02.04 General	02.04.01 Relev_s-Contact Report
11784	86	\N	\N	D5170C00002	235	233	NEW	\N	02.02 Subject Documents	02.02.07 Other_iven to Subjects
11179	85	1616044426888:99321168	1616044426290:-1053707498	D5170C00002	2195	2194	CREATE	2021-03-18 06:13:46.978	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
11180	85	1616044427468:-1326381860	1616044426888:99321168	D5170C00002	2196	2195	CREATE	2021-03-18 06:13:47.556	04.01 IRB-IEC Trial Approval	04.01.05 IRB-I_liance Statement
11182	85	1616044429553:1555740910	1616044428767:-1095344350	D5170C00002	2198	2197	CREATE	2021-03-18 06:13:49.641	04.02 Other Committees	04.02.02 Other Approvals
11183	85	1616044430159:-374362909	1616044421021:1414552527	D5170C00002	2199	2185	CREATE	2021-03-18 06:13:50.245	2002043 Nwokolo, Chukwuka	05 Site Management
11184	85	1616044430731:1665082690	1616044430159:-374362909	D5170C00002	2200	2199	CREATE	2021-03-18 06:13:50.82	05 Site Management	05.01 Site Selection
11186	85	1616044431965:845603812	1616044430731:1665082690	D5170C00002	2202	2200	CREATE	2021-03-18 06:13:52.051	05.01 Site Selection	05.01.02 Confidentiality Agreement
11187	85	1616044432528:1181779232	1616044430731:1665082690	D5170C00002	2203	2200	CREATE	2021-03-18 06:13:52.613	05.01 Site Selection	05.01.03 Feasibility Documentation
11189	85	1616044433958:-1469462457	1616044430159:-374362909	D5170C00002	2205	2199	CREATE	2021-03-18 06:13:54.042	05 Site Management	05.02 Site Set-up Documentation
11190	85	1616044434525:-1362703550	1616044433958:-1469462457	D5170C00002	2206	2205	CREATE	2021-03-18 06:13:54.608	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
11192	85	1616044435689:565803049	1616044433958:-1469462457	D5170C00002	2208	2205	CREATE	2021-03-18 06:13:55.783	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
11193	85	1616044436334:-1636889348	1616044433958:-1469462457	D5170C00002	2209	2205	CREATE	2021-03-18 06:13:56.423	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
11194	85	1616044437811:-1371349299	1616044433958:-1469462457	D5170C00002	2210	2205	CREATE	2021-03-18 06:13:57.899	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
11196	85	1616044439625:-1040485185	1616044433958:-1469462457	D5170C00002	2212	2205	CREATE	2021-03-18 06:13:59.715	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
11198	85	1616044440814:-1320957111	1616044433958:-1469462457	D5170C00002	2214	2205	CREATE	2021-03-18 06:14:00.9	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
11199	85	1616044441388:777854207	1616044433958:-1469462457	D5170C00002	2215	2205	CREATE	2021-03-18 06:14:01.477	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
11200	85	1616044442019:1081201668	1616044430159:-374362909	D5170C00002	2216	2199	CREATE	2021-03-18 06:14:02.104	05 Site Management	05.03 Site Initiation
11202	85	1616044443204:1434637027	1616044442019:1081201668	D5170C00002	2218	2216	CREATE	2021-03-18 06:14:03.287	05.03 Site Initiation	05.03.03 Site Training-Staff
11203	85	1616044443806:159723740	1616044442019:1081201668	D5170C00002	2219	2216	CREATE	2021-03-18 06:14:03.889	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
11204	85	1616044444375:-1708356823	1616044430159:-374362909	D5170C00002	2220	2199	CREATE	2021-03-18 06:14:04.465	05 Site Management	05.04 Site Management
11206	85	1616044445753:27844455	1616044444375:-1708356823	D5170C00002	2222	2220	CREATE	2021-03-18 06:14:05.84	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
11207	85	1616044446338:-1428463210	1616044444375:-1708356823	D5170C00002	2223	2220	CREATE	2021-03-18 06:14:06.427	05.04 Site Management	05.04.09 Inv Notification-SUSAR
11209	85	1616044447501:1591075776	1616044446934:1724049501	D5170C00002	2225	2224	CREATE	2021-03-18 06:14:07.588	05.05 General	05.05.01 Relev_unications-Email
11211	85	1616044448791:-587843448	1616044446934:1724049501	D5170C00002	2227	2224	CREATE	2021-03-18 06:14:08.879	05.05 General	05.05.02 Tracking Information
11212	85	1616044449957:959156689	1616044357746:1825771779	D5170C00002	2228	2137	CREATE	2021-03-18 06:14:10.045	Site	2002161 Harbord, Marcus
11214	85	1616044451230:-361333536	1616044450600:1815465417	D5170C00002	2230	2229	CREATE	2021-03-18 06:14:11.323	02 Central Trial Documents	02.02 Subject Documents
11215	85	1616044451806:1319293801	1616044451230:-361333536	D5170C00002	2231	2230	CREATE	2021-03-18 06:14:11.892	02.02 Subject Documents	02.02.03 Infor_t Form Templates
11217	85	1616044452972:549575171	1616044451230:-361333536	D5170C00002	2233	2230	CREATE	2021-03-18 06:14:13.06	02.02 Subject Documents	02.02.06 Adver_ject Recruitment
11218	85	1616044453536:-1400051842	1616044451230:-361333536	D5170C00002	2234	2230	CREATE	2021-03-18 06:14:13.643	02.02 Subject Documents	02.02.07 Other_iven to Subjects
11219	85	1616044454186:-499464555	1616044450600:1815465417	D5170C00002	2235	2229	CREATE	2021-03-18 06:14:14.275	02 Central Trial Documents	02.04 General
11221	85	1616044455404:-219505112	1616044449957:959156689	D5170C00002	2237	2228	CREATE	2021-03-18 06:14:15.489	2002161 Harbord, Marcus	04 IRB-IEC and other Approvals
11222	85	1616044455972:1943697658	1616044455404:-219505112	D5170C00002	2238	2237	CREATE	2021-03-18 06:14:16.061	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
11224	85	1616044457156:-506567609	1616044455972:1943697658	D5170C00002	2240	2238	CREATE	2021-03-18 06:14:17.246	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
11225	85	1616044457926:-1353071221	1616044449957:959156689	D5170C00002	2241	2228	CREATE	2021-03-18 06:14:18.014	2002161 Harbord, Marcus	05 Site Management
11226	85	1616044458513:-1779638327	1616044457926:-1353071221	D5170C00002	2242	2241	CREATE	2021-03-18 06:14:18.662	05 Site Management	05.01 Site Selection
11228	85	1616044459798:1532461986	1616044458513:-1779638327	D5170C00002	2244	2242	CREATE	2021-03-18 06:14:20.519	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
15051	88	1617050451849:1532848238	1617050182170:-1429529666	D5170C00001	741	471	ALREADY AVAILABLE	2021-03-30 07:19:37.319	Canada	1009
15055	88	1617050454157:318201465	1617050182170:-1429529666	D5170C00001	745	471	ALREADY AVAILABLE	2021-03-30 07:19:37.319	Canada	1010
11231	85	1616044462224:1025232017	1616044461045:-1067850841	D5170C00002	2247	2245	CREATE	2021-03-18 06:14:22.31	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
11232	85	1616044462792:599877966	1616044461045:-1067850841	D5170C00002	2248	2245	CREATE	2021-03-18 06:14:22.874	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
11234	85	1616044463966:-80814997	1616044461045:-1067850841	D5170C00002	2250	2245	CREATE	2021-03-18 06:14:24.051	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
11235	85	1616044464528:1774854892	1616044461045:-1067850841	D5170C00002	2251	2245	CREATE	2021-03-18 06:14:24.61	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
11237	85	1616044465750:-814768575	1616044461045:-1067850841	D5170C00002	2253	2245	CREATE	2021-03-18 06:14:25.837	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
11238	85	1616044466358:1225983531	1616044461045:-1067850841	D5170C00002	2254	2245	CREATE	2021-03-18 06:14:26.445	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
11239	85	1616044466947:115280286	1616044457926:-1353071221	D5170C00002	2255	2241	CREATE	2021-03-18 06:14:27.039	05 Site Management	05.03 Site Initiation
11241	85	1616044468088:398370059	1616044457926:-1353071221	D5170C00002	2257	2241	CREATE	2021-03-18 06:14:28.174	05 Site Management	05.04 Site Management
11242	85	1616044468723:766302096	1616044468088:398370059	D5170C00002	2258	2257	CREATE	2021-03-18 06:14:28.807	05.04 Site Management	05.04.09 Inv N_fo-Dr-HCP Letter
11244	85	1616044469876:2122425372	1616044457926:-1353071221	D5170C00002	2260	2241	CREATE	2021-03-18 06:14:29.961	05 Site Management	05.05 General
11245	85	1616044470441:121759522	1616044469876:2122425372	D5170C00002	2261	2260	CREATE	2021-03-18 06:14:30.526	05.05 General	05.05.01 Relev_unications-Email
11247	85	1616044472364:421650542	1616044469876:2122425372	D5170C00002	2263	2260	CREATE	2021-03-18 06:14:32.451	05.05 General	05.05.02 Tracking Information
11248	85	1616044472925:1045618028	1616044357746:1825771779	D5170C00002	2264	2137	CREATE	2021-03-18 06:14:33.011	Site	TBD-1-1PTCU1R Hart, Ailsa
11249	85	1616044473520:161802953	1616044472925:1045618028	D5170C00002	2265	2264	CREATE	2021-03-18 06:14:33.611	TBD-1-1PTCU1R Hart, Ailsa	05 Site Management
11251	85	1616044474667:-1813593120	1616044474093:-1298139862	D5170C00002	2267	2266	CREATE	2021-03-18 06:14:34.766	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
11252	85	1616044475289:-1695620963	1616044357746:1825771779	D5170C00002	2268	2137	CREATE	2021-03-18 06:14:35.378	Site	TBD-1-1PTCU4D Arnott, Ian
11254	85	1616044476588:1292447884	1616044476014:-947596401	D5170C00002	2270	2269	CREATE	2021-03-18 06:14:36.674	05 Site Management	05.01 Site Selection
11256	85	1616044477692:600526286	1616044357746:1825771779	D5170C00002	2272	2137	CREATE	2021-03-18 06:14:37.781	Site	TBD-1-2A19J9E Brown, Matthew
11257	85	1616044478318:-1890130093	1616044477692:600526286	D5170C00002	2273	2272	CREATE	2021-03-18 06:14:38.406	TBD-1-2A19J9E Brown, Matthew	05 Site Management
11258	85	1616044478896:-948110432	1616044478318:-1890130093	D5170C00002	2274	2273	CREATE	2021-03-18 06:14:38.985	05 Site Management	05.01 Site Selection
11260	85	1616044480024:-16493200	1616044478318:-1890130093	D5170C00002	2276	2273	CREATE	2021-03-18 06:14:40.113	05 Site Management	05.05 General
11261	85	1616044480628:-866532208	1616044480024:-16493200	D5170C00002	2277	2276	CREATE	2021-03-18 06:14:40.718	05.05 General	05.05.01 Relev_unications-Email
11262	85	1616044481211:1022147660	1615838976578:1645421407	D5170C00002	2278	4	CREATE	2021-03-18 06:14:41.301	contents	UNITED STATES
11264	85	1616044483116:885994259	1616044482556:-1401552591	D5170C00002	2280	2279	CREATE	2021-03-18 06:14:43.203	Site	2001691 Connor, Michael
11266	85	1616044484302:-909630057	1616044483715:239655172	D5170C00002	2282	2281	CREATE	2021-03-18 06:14:44.485	02 Central Trial Documents	02.02 Subject Documents
11267	85	1616044485012:-701496774	1616044484302:-909630057	D5170C00002	2283	2282	CREATE	2021-03-18 06:14:45.097	02.02 Subject Documents	02.02.01 Subject Diary
11269	85	1616044486132:954939539	1616044484302:-909630057	D5170C00002	2285	2282	CREATE	2021-03-18 06:14:46.217	02.02 Subject Documents	02.02.03 Infor_t Form Templates
11270	85	1616044486715:-1605602534	1616044484302:-909630057	D5170C00002	2286	2282	CREATE	2021-03-18 06:14:46.803	02.02 Subject Documents	02.02.06 Adver_ject Recruitment
11272	85	1616044487894:1990757444	1616044483715:239655172	D5170C00002	2288	2281	CREATE	2021-03-18 06:14:47.98	02 Central Trial Documents	02.04 General
11273	85	1616044488470:-294444150	1616044487894:1990757444	D5170C00002	2289	2288	CREATE	2021-03-18 06:14:48.558	02.04 General	02.04.01 Relev_s-Contact Report
11274	85	1616044489081:-1971129213	1616044487894:1990757444	D5170C00002	2290	2288	CREATE	2021-03-18 06:14:49.167	02.04 General	02.04.01 UNBLI_s-Contact Report
11276	85	1616044490276:-22270548	1616044489650:825409454	D5170C00002	2292	2291	CREATE	2021-03-18 06:14:50.363	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
11277	85	1616044490883:-1859467595	1616044490276:-22270548	D5170C00002	2293	2292	CREATE	2021-03-18 06:14:50.972	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
11279	85	1616044492078:898069841	1616044491483:1396860092	D5170C00002	2295	2294	CREATE	2021-03-18 06:14:52.165	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
11280	85	1616044493365:-1564616040	1616044483116:885994259	D5170C00002	2296	2280	CREATE	2021-03-18 06:14:53.466	2001691 Connor, Michael	05 Site Management
11282	85	1616044494631:-428181981	1616044494018:-693385720	D5170C00002	2298	2297	CREATE	2021-03-18 06:14:54.719	05.01 Site Selection	05.01.02 Confidentiality Agreement
11283	85	1616044495200:1161185252	1616044494018:-693385720	D5170C00002	2299	2297	CREATE	2021-03-18 06:14:55.287	05.01 Site Selection	05.01.03 Feasibility Documentation
11285	85	1616044496415:1692633642	1616044493365:-1564616040	D5170C00002	2301	2296	CREATE	2021-03-18 06:14:56.504	05 Site Management	05.02 Site Set-up Documentation
11286	85	1616044497027:753795282	1616044496415:1692633642	D5170C00002	2302	2301	CREATE	2021-03-18 06:14:57.112	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
11288	85	1616044498213:1369935521	1616044496415:1692633642	D5170C00002	2304	2301	CREATE	2021-03-18 06:14:58.301	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
11289	85	1616044498779:-1078269530	1616044496415:1692633642	D5170C00002	2305	2301	CREATE	2021-03-18 06:14:58.863	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
11291	85	1616044499959:-536707115	1616044496415:1692633642	D5170C00002	2307	2301	CREATE	2021-03-18 06:15:00.05	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
11292	85	1616044500525:-1719534528	1616044496415:1692633642	D5170C00002	2308	2301	CREATE	2021-03-18 06:15:00.613	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
15110	88	1617050503960:1241532802	1617050182170:-1429529666	D5170C00001	800	471	ALREADY AVAILABLE	2021-03-30 07:19:37.319	Canada	1011
11296	85	1616044504416:-335636052	1616044496415:1692633642	D5170C00002	2312	2301	CREATE	2021-03-18 06:15:04.504	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
11297	85	1616044505009:1871055570	1616044496415:1692633642	D5170C00002	2313	2301	CREATE	2021-03-18 06:15:05.098	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
11299	85	1616044506461:2097225651	1616044505612:-1871125980	D5170C00002	2315	2314	CREATE	2021-03-18 06:15:06.551	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
11300	85	1616044507044:1504745971	1616044505612:-1871125980	D5170C00002	2316	2314	CREATE	2021-03-18 06:15:07.129	05.03 Site Initiation	05.03.03 Site Training-Staff
11302	85	1616044508250:1592449925	1616044493365:-1564616040	D5170C00002	2318	2296	CREATE	2021-03-18 06:15:08.338	05 Site Management	05.04 Site Management
11303	85	1616044508859:-1527285951	1616044508250:1592449925	D5170C00002	2319	2318	CREATE	2021-03-18 06:15:08.957	05.04 Site Management	05.04.01 Subject Log
11305	85	1616044510056:-1835022829	1616044508250:1592449925	D5170C00002	2321	2318	CREATE	2021-03-18 06:15:10.147	05.04 Site Management	05.04.03 UNBLINDED Monitoring Visit Report
11306	85	1616044510702:1248099865	1616044508250:1592449925	D5170C00002	2322	2318	CREATE	2021-03-18 06:15:10.789	05.04 Site Management	05.04.04 UNBLINDED Visit Log
11307	85	1616044511288:-1347248728	1616044508250:1592449925	D5170C00002	2323	2318	CREATE	2021-03-18 06:15:11.379	05.04 Site Management	05.04.04 Visit Log
11309	85	1616044512448:-1054939680	1616044508250:1592449925	D5170C00002	2325	2318	CREATE	2021-03-18 06:15:12.533	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
11311	85	1616044513713:113833662	1616044508250:1592449925	D5170C00002	2327	2318	CREATE	2021-03-18 06:15:13.797	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
11312	85	1616044515134:-668453172	1616044493365:-1564616040	D5170C00002	2328	2296	CREATE	2021-03-18 06:15:15.217	05 Site Management	05.05 General
11313	85	1616044515727:912885003	1616044515134:-668453172	D5170C00002	2329	2328	CREATE	2021-03-18 06:15:15.811	05.05 General	05.05.02 Tracking Information
11315	85	1616044516904:957490106	1616044516299:-1515055985	D5170C00002	2331	2330	CREATE	2021-03-18 06:15:16.988	06 IP and Trial Supplies	06.01 IP Documentation
11316	85	1616044517540:-644603351	1616044516904:957490106	D5170C00002	2332	2331	CREATE	2021-03-18 06:15:17.63	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
11318	85	1616044518806:77425243	1616044516904:957490106	D5170C00002	2334	2331	CREATE	2021-03-18 06:15:18.895	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
11319	85	1616044519425:40184585	1616044516904:957490106	D5170C00002	2335	2331	CREATE	2021-03-18 06:15:19.511	06.01 IP Documentation	06.01.11 UNBLINDED Certificate of Destruction
11320	85	1616044520046:-1448412557	1616044516299:-1515055985	D5170C00002	2336	2330	CREATE	2021-03-18 06:15:20.154	06 IP and Trial Supplies	06.03 IP Alloc_on Documentation
11322	85	1616044521264:1345388128	1616044516299:-1515055985	D5170C00002	2338	2330	CREATE	2021-03-18 06:15:21.356	06 IP and Trial Supplies	06.04 Storage
11323	85	1616044521986:-283743996	1616044521264:1345388128	D5170C00002	2339	2338	CREATE	2021-03-18 06:15:22.072	06.04 Storage	06.04.01 UNBLI_on Documentation
11325	85	1616044523236:-415361281	1616044516299:-1515055985	D5170C00002	2341	2330	CREATE	2021-03-18 06:15:23.326	06 IP and Trial Supplies	06.07 General
11326	85	1616044523846:1428038919	1616044523236:-415361281	D5170C00002	2342	2341	CREATE	2021-03-18 06:15:23.937	06.07 General	06.07.01 UNBLI_roduct-Documents
11328	85	1616044525899:1760537561	1616044524433:781555588	D5170C00002	2344	2343	CREATE	2021-03-18 06:15:25.989	2001692 Seminerio, Jennifer	05 Site Management
11329	85	1616044526466:1948545428	1616044525899:1760537561	D5170C00002	2345	2344	CREATE	2021-03-18 06:15:26.554	05 Site Management	05.01 Site Selection
11331	85	1616044527731:-1361686045	1616044482556:-1401552591	D5170C00002	2347	2279	CREATE	2021-03-18 06:15:27.821	Site	2001694 Houghton, Jean Marie
11332	85	1616044528321:1235587192	1616044527731:-1361686045	D5170C00002	2348	2347	CREATE	2021-03-18 06:15:28.41	2001694 Houghton, Jean Marie	02 Central Trial Documents
11334	85	1616044529563:-287581980	1616044528968:1840531848	D5170C00002	2350	2349	CREATE	2021-03-18 06:15:29.65	02.02 Subject Documents	02.02.03 Infor_t Form Templates
11335	85	1616044530167:457033612	1616044527731:-1361686045	D5170C00002	2351	2347	CREATE	2021-03-18 06:15:30.257	2001694 Houghton, Jean Marie	04 IRB-IEC and other Approvals
11337	85	1616044531356:915775280	1616044530751:1273563743	D5170C00002	2353	2352	CREATE	2021-03-18 06:15:31.445	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
11338	85	1616044531981:1035364202	1616044530751:1273563743	D5170C00002	2354	2352	CREATE	2021-03-18 06:15:32.124	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
11339	85	1616044532595:-367856193	1616044530751:1273563743	D5170C00002	2355	2352	CREATE	2021-03-18 06:15:32.682	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
11341	85	1616044533737:-1932981273	1616044527731:-1361686045	D5170C00002	2357	2347	CREATE	2021-03-18 06:15:33.826	2001694 Houghton, Jean Marie	05 Site Management
11342	85	1616044534330:504922225	1616044533737:-1932981273	D5170C00002	2358	2357	CREATE	2021-03-18 06:15:34.417	05 Site Management	05.01 Site Selection
11344	85	1616044535598:-492699764	1616044534330:504922225	D5170C00002	2360	2358	CREATE	2021-03-18 06:15:35.698	05.01 Site Selection	05.01.03 Feasibility Documentation
11345	85	1616044537208:500444687	1616044534330:504922225	D5170C00002	2361	2358	CREATE	2021-03-18 06:15:37.293	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
11346	85	1616044537795:1216741538	1616044533737:-1932981273	D5170C00002	2362	2357	CREATE	2021-03-18 06:15:37.881	05 Site Management	05.02 Site Set-up Documentation
11348	85	1616044539003:-726228114	1616044537795:1216741538	D5170C00002	2364	2362	CREATE	2021-03-18 06:15:39.094	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
11349	85	1616044539643:1213501375	1616044537795:1216741538	D5170C00002	2365	2362	CREATE	2021-03-18 06:15:39.728	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
11351	85	1616044540834:-638688291	1616044533737:-1932981273	D5170C00002	2367	2357	CREATE	2021-03-18 06:15:40.923	05 Site Management	05.03 Site Initiation
11352	85	1616044541433:1037048430	1616044540834:-638688291	D5170C00002	2368	2367	CREATE	2021-03-18 06:15:41.529	05.03 Site Initiation	05.03.03 Site Training-Staff
11353	85	1616044542041:1326287762	1616044482556:-1401552591	D5170C00002	2369	2279	CREATE	2021-03-18 06:15:42.13	Site	2001695 Bassan, Isaac
11355	85	1616044543422:-290154688	1616044542686:-157025006	D5170C00002	2371	2370	CREATE	2021-03-18 06:15:43.511	02 Central Trial Documents	02.02 Subject Documents
11357	85	1616044544798:951583884	1616044543422:-290154688	D5170C00002	2373	2371	CREATE	2021-03-18 06:15:44.901	02.02 Subject Documents	02.02.02 Subject Questionnaire
15170	88	1617050558890:67223276	1617050182170:-1429529666	D5170C00001	860	471	ALREADY AVAILABLE	2021-03-30 07:19:37.319	Canada	1013
11359	85	1616044546028:112418629	1616044543422:-290154688	D5170C00002	2375	2371	CREATE	2021-03-18 06:15:46.117	02.02 Subject Documents	02.02.06 Adver_ject Recruitment
11361	85	1616044548225:-1994679715	1616044542686:-157025006	D5170C00002	2377	2370	CREATE	2021-03-18 06:15:48.327	02 Central Trial Documents	02.04 General
11362	85	1616044548828:759024197	1616044548225:-1994679715	D5170C00002	2378	2377	CREATE	2021-03-18 06:15:48.93	02.04 General	02.04.01 Relev_s-Contact Report
11363	85	1616044549410:-462533495	1616044548225:-1994679715	D5170C00002	2379	2377	CREATE	2021-03-18 06:15:49.499	02.04 General	02.04.01 UNBLI_s-Contact Report
11365	85	1616044550736:1428041103	1616044550071:-935557368	D5170C00002	2381	2380	CREATE	2021-03-18 06:15:50.828	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
16098	88	1617051422295:1689434483	1617051196990:749950322	D5170C00001	1788	1521	ALREADY AVAILABLE	2021-03-30 07:19:37.32	Italy	4107
11367	85	1616044551899:1624926974	1616044550071:-935557368	D5170C00002	2383	2380	CREATE	2021-03-18 06:15:51.984	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
11368	85	1616044552538:-61909562	1616044551899:1624926974	D5170C00002	2384	2383	CREATE	2021-03-18 06:15:52.626	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
11369	85	1616044553185:969405652	1616044542041:1326287762	D5170C00002	2385	2369	CREATE	2021-03-18 06:15:58.722	2001695 Bassan, Isaac	05 Site Management
11371	85	1616044559948:1907669570	1616044559288:1995840739	D5170C00002	2387	2386	CREATE	2021-03-18 06:16:00.09	05.01 Site Selection	05.01.02 Confidentiality Agreement
11372	85	1616044560636:-797930493	1616044559288:1995840739	D5170C00002	2388	2386	CREATE	2021-03-18 06:16:00.798	05.01 Site Selection	05.01.03 Feasibility Documentation
11374	85	1616044562163:-55180897	1616044553185:969405652	D5170C00002	2390	2385	CREATE	2021-03-18 06:16:02.255	05 Site Management	05.02 Site Set-up Documentation
11375	85	1616044562843:-43718416	1616044562163:-55180897	D5170C00002	2391	2390	CREATE	2021-03-18 06:16:02.933	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
11377	85	1616044564057:-624916060	1616044562163:-55180897	D5170C00002	2393	2390	CREATE	2021-03-18 06:16:04.143	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
11378	85	1616044564691:-1050579046	1616044562163:-55180897	D5170C00002	2394	2390	CREATE	2021-03-18 06:16:04.782	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
11380	85	1616044565943:-1127311274	1616044562163:-55180897	D5170C00002	2396	2390	CREATE	2021-03-18 06:16:06.04	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
11381	85	1616044566548:699465749	1616044562163:-55180897	D5170C00002	2397	2390	CREATE	2021-03-18 06:16:06.636	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
11382	85	1616044567217:435948244	1616044562163:-55180897	D5170C00002	2398	2390	CREATE	2021-03-18 06:16:07.308	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
11384	85	1616044568397:-412864902	1616044562163:-55180897	D5170C00002	2400	2390	CREATE	2021-03-18 06:16:08.482	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
11385	85	1616044569900:1273164196	1616044553185:969405652	D5170C00002	2401	2385	CREATE	2021-03-18 06:16:09.985	05 Site Management	05.03 Site Initiation
11387	85	1616044571307:1319411041	1616044569900:1273164196	D5170C00002	2403	2401	CREATE	2021-03-18 06:16:11.391	05.03 Site Initiation	05.03.03 Site Training-Staff
11388	85	1616044571905:1266869831	1616044569900:1273164196	D5170C00002	2404	2401	CREATE	2021-03-18 06:16:11.99	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
11389	85	1616044572490:-1374384247	1616044553185:969405652	D5170C00002	2405	2385	CREATE	2021-03-18 06:16:12.577	05 Site Management	05.04 Site Management
11391	85	1616044573746:-2069567077	1616044572490:-1374384247	D5170C00002	2407	2405	CREATE	2021-03-18 06:16:13.832	05.04 Site Management	05.04.05 Additional Monitoring Activity
11392	85	1616044574414:-293971976	1616044572490:-1374384247	D5170C00002	2408	2405	CREATE	2021-03-18 06:16:14.503	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
11393	85	1616044575122:-1159850762	1616044553185:969405652	D5170C00002	2409	2385	CREATE	2021-03-18 06:16:15.211	05 Site Management	05.05 General
11395	85	1616044577064:1160933319	1616044542041:1326287762	D5170C00002	2411	2369	CREATE	2021-03-18 06:16:17.15	2001695 Bassan, Isaac	06 IP and Trial Supplies
11397	85	1616044578295:-1506390136	1616044577699:2117301680	D5170C00002	2413	2412	CREATE	2021-03-18 06:16:18.381	06.01 IP Documentation	06.01.11 Certificate of Destruction
11398	85	1616044578921:-1112983243	1616044482556:-1401552591	D5170C00002	2414	2279	CREATE	2021-03-18 06:16:19.01	Site	2001696 Headstrom, Peggy
11400	85	1616044581281:-1873013556	1616044579537:655268407	D5170C00002	2416	2415	CREATE	2021-03-18 06:16:21.371	02 Central Trial Documents	02.02 Subject Documents
11401	85	1616044581875:1502368561	1616044581281:-1873013556	D5170C00002	2417	2416	CREATE	2021-03-18 06:16:21.965	02.02 Subject Documents	02.02.01 Subject Diary
11403	85	1616044583015:1905485753	1616044581281:-1873013556	D5170C00002	2419	2416	CREATE	2021-03-18 06:16:23.102	02.02 Subject Documents	02.02.03 Infor_t Form Templates
11404	85	1616044583612:1556550723	1616044581281:-1873013556	D5170C00002	2420	2416	CREATE	2021-03-18 06:16:23.699	02.02 Subject Documents	02.02.05 Subject Participation Card
11405	85	1616044584214:-683721155	1616044581281:-1873013556	D5170C00002	2421	2416	CREATE	2021-03-18 06:16:24.302	02.02 Subject Documents	02.02.06 Adver_ject Recruitment
11407	85	1616044585399:575333793	1616044579537:655268407	D5170C00002	2423	2415	CREATE	2021-03-18 06:16:25.484	02 Central Trial Documents	02.04 General
11408	85	1616044586162:-767517937	1616044585399:575333793	D5170C00002	2424	2423	CREATE	2021-03-18 06:16:26.251	02.04 General	02.04.01 Relev_s-Contact Report
11410	85	1616044587308:-268530966	1616044578921:-1112983243	D5170C00002	2426	2414	CREATE	2021-03-18 06:16:27.393	2001696 Headstrom, Peggy	04 IRB-IEC and other Approvals
11411	85	1616044587984:-1371054014	1616044587308:-268530966	D5170C00002	2427	2426	CREATE	2021-03-18 06:16:28.071	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
11413	85	1616044589229:1717218551	1616044587984:-1371054014	D5170C00002	2429	2427	CREATE	2021-03-18 06:16:29.316	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
11414	85	1616044589806:-1205253104	1616044587308:-268530966	D5170C00002	2430	2426	CREATE	2021-03-18 06:16:29.891	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
11416	85	1616044592018:414219112	1616044578921:-1112983243	D5170C00002	2432	2414	CREATE	2021-03-18 06:16:32.107	2001696 Headstrom, Peggy	05 Site Management
11417	85	1616044592605:1277571825	1616044592018:414219112	D5170C00002	2433	2432	CREATE	2021-03-18 06:16:32.698	05 Site Management	05.01 Site Selection
11419	85	1616044593796:-662326649	1616044592605:1277571825	D5170C00002	2435	2433	CREATE	2021-03-18 06:16:33.883	05.01 Site Selection	05.01.03 Feasibility Documentation
11420	85	1616044594436:-1343382247	1616044592605:1277571825	D5170C00002	2436	2433	CREATE	2021-03-18 06:16:34.524	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
15174	88	1617050567026:1680584866	1617050182170:-1429529666	D5170C00001	864	471	ALREADY AVAILABLE	2021-03-30 07:19:37.319	Canada	1014
11422	85	1616044595609:1307025914	1616044595020:1042823940	D5170C00002	2438	2437	CREATE	2021-03-18 06:16:35.696	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
11424	85	1616044596797:390965543	1616044595020:1042823940	D5170C00002	2440	2437	CREATE	2021-03-18 06:16:36.888	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
11425	85	1616044597402:-945941044	1616044595020:1042823940	D5170C00002	2441	2437	CREATE	2021-03-18 06:16:37.489	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
11561	86	\N	\N	D5170C00002	12	9	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
11426	85	1616044598118:-106995875	1616044595020:1042823940	D5170C00002	2442	2437	CREATE	2021-03-18 06:16:38.202	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
11428	85	1616044599298:1596462790	1616044595020:1042823940	D5170C00002	2444	2437	CREATE	2021-03-18 06:16:39.382	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
11429	85	1616044599869:1298919657	1616044595020:1042823940	D5170C00002	2445	2437	CREATE	2021-03-18 06:16:39.953	05.02 Site Set-up Documentation	05.02.09 Investigator Regulatory Agreement
11431	85	1616044601096:2050928842	1616044595020:1042823940	D5170C00002	2447	2437	CREATE	2021-03-18 06:16:41.185	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
11432	85	1616044601685:1581891833	1616044595020:1042823940	D5170C00002	2448	2437	CREATE	2021-03-18 06:16:42.599	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
11433	85	1616044603178:-1122476858	1616044592018:414219112	D5170C00002	2449	2432	CREATE	2021-03-18 06:16:43.268	05 Site Management	05.03 Site Initiation
11435	85	1616044604388:1826787335	1616044603178:-1122476858	D5170C00002	2451	2449	CREATE	2021-03-18 06:16:44.481	05.03 Site Initiation	05.03.03 Site Training-Staff
11436	85	1616044605042:2053843206	1616044592018:414219112	D5170C00002	2452	2432	CREATE	2021-03-18 06:16:45.135	05 Site Management	05.04 Site Management
11438	85	1616044606332:-518796215	1616044605042:2053843206	D5170C00002	2454	2452	CREATE	2021-03-18 06:16:46.441	05.04 Site Management	05.04.05 UNBLI_itoring Activity
11439	85	1616044607051:-602829378	1616044605042:2053843206	D5170C00002	2455	2452	CREATE	2021-03-18 06:16:47.142	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
11440	85	1616044607710:-1881323594	1616044592018:414219112	D5170C00002	2456	2432	CREATE	2021-03-18 06:16:47.808	05 Site Management	05.05 General
11442	85	1616044608953:878588026	1616044482556:-1401552591	D5170C00002	2458	2279	CREATE	2021-03-18 06:16:49.048	Site	2001698 Khurana, Sunil
11444	85	1616044610219:-1261421386	1616044609586:-236281463	D5170C00002	2460	2459	CREATE	2021-03-18 06:16:50.305	02 Central Trial Documents	02.02 Subject Documents
11445	85	1616044610888:2117654873	1616044610219:-1261421386	D5170C00002	2461	2460	CREATE	2021-03-18 06:16:50.976	02.02 Subject Documents	02.02.03 Infor_t Form Templates
11446	85	1616044611622:109980032	1616044609586:-236281463	D5170C00002	2462	2459	CREATE	2021-03-18 06:16:51.714	02 Central Trial Documents	02.04 General
11448	85	1616044613986:534983491	1616044611622:109980032	D5170C00002	2464	2462	CREATE	2021-03-18 06:16:54.074	02.04 General	02.04.01 UNBLI_s-Contact Report
11450	85	1616044615176:1352645478	1616044614577:2026781305	D5170C00002	2466	2465	CREATE	2021-03-18 06:16:55.264	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
11451	85	1616044615786:-635731425	1616044615176:1352645478	D5170C00002	2467	2466	CREATE	2021-03-18 06:16:55.88	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
11453	85	1616044617057:1001378201	1616044616377:-301052499	D5170C00002	2469	2468	CREATE	2021-03-18 06:16:57.15	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
11454	85	1616044617866:-2037412411	1616044608953:878588026	D5170C00002	2470	2458	CREATE	2021-03-18 06:16:57.957	2001698 Khurana, Sunil	05 Site Management
11455	85	1616044618460:-270994340	1616044617866:-2037412411	D5170C00002	2471	2470	CREATE	2021-03-18 06:16:58.545	05 Site Management	05.01 Site Selection
11457	85	1616044619680:1004306310	1616044618460:-270994340	D5170C00002	2473	2471	CREATE	2021-03-18 06:16:59.763	05.01 Site Selection	05.01.03 Feasibility Documentation
11458	85	1616044620279:-1496216348	1616044618460:-270994340	D5170C00002	2474	2471	CREATE	2021-03-18 06:17:00.367	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
11460	85	1616044621558:-679803573	1616044620960:295579180	D5170C00002	2476	2475	CREATE	2021-03-18 06:17:01.649	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
11461	85	1616044622201:1299281781	1616044620960:295579180	D5170C00002	2477	2475	CREATE	2021-03-18 06:17:02.291	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
11463	85	1616044623474:-1113303471	1616044620960:295579180	D5170C00002	2479	2475	CREATE	2021-03-18 06:17:03.564	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
11464	85	1616044625363:-1948558351	1616044620960:295579180	D5170C00002	2480	2475	CREATE	2021-03-18 06:17:05.452	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
11465	85	1616044625995:-1683018302	1616044620960:295579180	D5170C00002	2481	2475	CREATE	2021-03-18 06:17:06.086	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
11467	85	1616044627219:1433259453	1616044620960:295579180	D5170C00002	2483	2475	CREATE	2021-03-18 06:17:07.322	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
11468	85	1616044628021:1766996066	1616044620960:295579180	D5170C00002	2484	2475	CREATE	2021-03-18 06:17:08.111	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
11470	85	1616044629313:466185204	1616044620960:295579180	D5170C00002	2486	2475	CREATE	2021-03-18 06:17:09.399	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
11471	85	1616044629984:-195510960	1616044617866:-2037412411	D5170C00002	2487	2470	CREATE	2021-03-18 06:17:10.067	05 Site Management	05.03 Site Initiation
11473	85	1616044631181:1008505571	1616044629984:-195510960	D5170C00002	2489	2487	CREATE	2021-03-18 06:17:11.268	05.03 Site Initiation	05.03.03 Site Training-Staff
11474	85	1616044631861:-1971554809	1616044629984:-195510960	D5170C00002	2490	2487	CREATE	2021-03-18 06:17:12.013	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
11475	85	1616044632530:1903905609	1616044617866:-2037412411	D5170C00002	2491	2470	CREATE	2021-03-18 06:17:12.618	05 Site Management	05.04 Site Management
11477	85	1616044633726:491229468	1616044632530:1903905609	D5170C00002	2493	2491	CREATE	2021-03-18 06:17:13.812	05.04 Site Management	05.04.03 Monitoring Visit Report
11478	85	1616044634363:1202038309	1616044632530:1903905609	D5170C00002	2494	2491	CREATE	2021-03-18 06:17:14.45	05.04 Site Management	05.04.04 UNBLINDED Visit Log
11480	85	1616044636652:-1535289889	1616044632530:1903905609	D5170C00002	2496	2491	CREATE	2021-03-18 06:17:16.738	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
11481	85	1616044637275:-663813065	1616044617866:-2037412411	D5170C00002	2497	2470	CREATE	2021-03-18 06:17:17.364	05 Site Management	05.05 General
15178	88	1617050569625:-794594117	1617050182170:-1429529666	D5170C00001	868	471	ALREADY AVAILABLE	2021-03-30 07:19:37.319	Canada	1015
11484	85	1616044639114:195840278	1616044638521:-171705913	D5170C00002	2500	2499	CREATE	2021-03-18 06:17:19.201	06 IP and Trial Supplies	06.01 IP Documentation
11486	85	1616044640375:-314403321	1616044639114:195840278	D5170C00002	2502	2500	CREATE	2021-03-18 06:17:20.464	06.01 IP Documentation	06.01.10 UNBLI_mentation Return
11487	85	1616044640978:606902512	1616044639114:195840278	D5170C00002	2503	2500	CREATE	2021-03-18 06:17:21.067	06.01 IP Documentation	06.01.11 UNBLINDED Certificate of Destruction
11488	85	1616044641579:321985812	1616044638521:-171705913	D5170C00002	2504	2499	CREATE	2021-03-18 06:17:21.667	06 IP and Trial Supplies	06.04 Storage
11490	85	1616044642831:448096473	1616044641579:321985812	D5170C00002	2506	2504	CREATE	2021-03-18 06:17:22.916	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
11491	85	1616044643477:900868466	1616044482556:-1401552591	D5170C00002	2507	2279	CREATE	2021-03-18 06:17:23.565	Site	2001699 Mehta, Nilesh
11493	85	1616044644683:734799504	1616044644085:-1545034686	D5170C00002	2509	2508	CREATE	2021-03-18 06:17:24.766	02 Central Trial Documents	02.02 Subject Documents
11494	85	1616044645927:-1105784439	1616044644683:734799504	D5170C00002	2510	2509	CREATE	2021-03-18 06:17:26.016	02.02 Subject Documents	02.02.01 Subject Diary
11496	85	1616044648295:550641265	1616044644683:734799504	D5170C00002	2512	2509	CREATE	2021-03-18 06:17:28.379	02.02 Subject Documents	02.02.03 Infor_t Form Templates
11497	85	1616044648895:201780498	1616044644683:734799504	D5170C00002	2513	2509	CREATE	2021-03-18 06:17:28.979	02.02 Subject Documents	02.02.05 Subject Participation Card
11499	85	1616044650279:-912266211	1616044644683:734799504	D5170C00002	2515	2509	CREATE	2021-03-18 06:17:30.363	02.02 Subject Documents	02.02.07 Other_iven to Subjects
11500	85	1616044650880:2116646041	1616044643477:900868466	D5170C00002	2516	2507	CREATE	2021-03-18 06:17:30.966	2001699 Mehta, Nilesh	04 IRB-IEC and other Approvals
11502	85	1616044652097:922858276	1616044651477:-1618086227	D5170C00002	2518	2517	CREATE	2021-03-18 06:17:32.181	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
11503	85	1616044652754:-480415164	1616044651477:-1618086227	D5170C00002	2519	2517	CREATE	2021-03-18 06:17:32.838	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
11504	85	1616044653352:-1640880624	1616044643477:900868466	D5170C00002	2520	2507	CREATE	2021-03-18 06:17:33.44	2001699 Mehta, Nilesh	05 Site Management
11506	85	1616044654535:1643191967	1616044653957:-674022655	D5170C00002	2522	2521	CREATE	2021-03-18 06:17:34.62	05.01 Site Selection	05.01.02 Confidentiality Agreement
11507	85	1616044655142:-1062408096	1616044653957:-674022655	D5170C00002	2523	2521	CREATE	2021-03-18 06:17:35.226	05.01 Site Selection	05.01.03 Feasibility Documentation
11509	85	1616044656446:-1360736429	1616044653352:-1640880624	D5170C00002	2525	2520	CREATE	2021-03-18 06:17:36.533	05 Site Management	05.02 Site Set-up Documentation
11510	85	1616044657037:-212015264	1616044656446:-1360736429	D5170C00002	2526	2525	CREATE	2021-03-18 06:17:37.124	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
11512	85	1616044659595:-895890927	1616044656446:-1360736429	D5170C00002	2528	2525	CREATE	2021-03-18 06:17:39.684	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
11513	85	1616044660206:-1859802503	1616044656446:-1360736429	D5170C00002	2529	2525	CREATE	2021-03-18 06:17:40.293	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
11515	85	1616044661467:-32423163	1616044653352:-1640880624	D5170C00002	2531	2520	CREATE	2021-03-18 06:17:41.556	05 Site Management	05.03 Site Initiation
11516	85	1616044662103:-1272528666	1616044661467:-32423163	D5170C00002	2532	2531	CREATE	2021-03-18 06:17:42.192	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
11517	85	1616044662740:613770071	1616044661467:-32423163	D5170C00002	2533	2531	CREATE	2021-03-18 06:17:42.825	05.03 Site Initiation	05.03.03 Site Training-Staff
11518	85	1616044663418:490724666	1616044653352:-1640880624	D5170C00002	2534	2520	CREATE	2021-03-18 06:17:43.512	05 Site Management	05.05 General
11520	85	1616044664709:197344214	1616044482556:-1401552591	D5170C00002	2536	2279	CREATE	2021-03-18 06:17:44.792	Site	2001700 Idarraga, Samuel
11522	85	1616044665901:-1961068847	1616044665301:-1609575163	D5170C00002	2538	2537	CREATE	2021-03-18 06:17:45.982	02 Central Trial Documents	02.02 Subject Documents
11523	85	1616044666540:-2077953845	1616044665901:-1961068847	D5170C00002	2539	2538	CREATE	2021-03-18 06:17:46.626	02.02 Subject Documents	02.02.03 Infor_t Form Templates
11524	85	1616044667198:518331636	1616044665301:-1609575163	D5170C00002	2540	2537	CREATE	2021-03-18 06:17:47.283	02 Central Trial Documents	02.04 General
11526	85	1616044668555:278183261	1616044667198:518331636	D5170C00002	2542	2540	CREATE	2021-03-18 06:17:49.654	02.04 General	02.04.01 UNBLI_s-Contact Report
11528	85	1616044670872:283029740	1616044670243:539358600	D5170C00002	2544	2543	CREATE	2021-03-18 06:17:50.964	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
11529	85	1616044671468:-2069229902	1616044670872:283029740	D5170C00002	2545	2544	CREATE	2021-03-18 06:17:51.59	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
11531	85	1616044672713:-283210415	1616044672096:1556935805	D5170C00002	2547	2546	CREATE	2021-03-18 06:17:52.799	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
11532	85	1616044673332:-628390298	1616044664709:197344214	D5170C00002	2548	2536	CREATE	2021-03-18 06:17:53.417	2001700 Idarraga, Samuel	05 Site Management
11533	85	1616044674021:1868588612	1616044673332:-628390298	D5170C00002	2549	2548	CREATE	2021-03-18 06:17:54.111	05 Site Management	05.01 Site Selection
11535	85	1616044675288:760885985	1616044674021:1868588612	D5170C00002	2551	2549	CREATE	2021-03-18 06:17:55.373	05.01 Site Selection	05.01.03 Feasibility Documentation
11536	85	1616044675908:79830387	1616044674021:1868588612	D5170C00002	2552	2549	CREATE	2021-03-18 06:17:55.992	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
11538	85	1616044677218:1366328901	1616044676540:-40359322	D5170C00002	2554	2553	CREATE	2021-03-18 06:17:57.304	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
11539	85	1616044677856:-949606086	1616044676540:-40359322	D5170C00002	2555	2553	CREATE	2021-03-18 06:17:57.943	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
11541	85	1616044679084:-320543163	1616044676540:-40359322	D5170C00002	2557	2553	CREATE	2021-03-18 06:17:59.17	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
11542	85	1616044679710:-1269980093	1616044676540:-40359322	D5170C00002	2558	2553	CREATE	2021-03-18 06:18:00.858	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
11543	85	1616044681498:217836552	1616044676540:-40359322	D5170C00002	2559	2553	CREATE	2021-03-18 06:18:01.605	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
11545	85	1616044682964:-2037862574	1616044676540:-40359322	D5170C00002	2561	2553	CREATE	2021-03-18 06:18:03.056	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
8985	85	1615838974550:1174697746	rootNode	D5170C00002	1	0	ALREADY AVAILABLE	2021-03-18 05:45:16.122		eTMF
8986	85	1615838975337:1872112979	1615838974550:1174697746	D5170C00002	2	1	ALREADY AVAILABLE	2021-03-18 05:45:16.122	eTMF	Quintiles IQVIA
8987	85	1615838975982:177552897	1615838975337:1872112979	D5170C00002	3	2	ALREADY AVAILABLE	2021-03-18 05:45:16.123	Quintiles IQVIA	eTMF
11562	86	\N	\N	D5170C00002	13	8	NEW	\N	05 Site Management	05.04 Site Management
8991	85	1615840838514:1383351227	1615840756146:-740604444	D5170C00002	7	6	ALREADY AVAILABLE	2021-03-18 05:45:16.144	Site	2002048 Cicala, Michele
8992	85	1615840843327:-426312646	1615840838514:1383351227	D5170C00002	8	7	ALREADY AVAILABLE	2021-03-18 05:45:16.147	2002048 Cicala, Michele	04 IRB-IEC and other Approvals
8993	85	1615840844038:701879462	1615840843327:-426312646	D5170C00002	9	8	ALREADY AVAILABLE	2021-03-18 05:45:16.152	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
8994	85	1616042805772:1656528689	1615840844038:701879462	D5170C00002	10	9	CREATE	2021-03-18 05:46:45.918	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
8995	85	1616042806487:-810435020	1615840844038:701879462	D5170C00002	11	9	CREATE	2021-03-18 05:46:46.616	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
8996	85	1616042807276:-1265735559	1615840843327:-426312646	D5170C00002	12	8	CREATE	2021-03-18 05:46:47.4	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
8997	85	1616042808086:234435910	1616042807276:-1265735559	D5170C00002	13	12	CREATE	2021-03-18 05:46:48.178	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
8998	85	1616042808791:-137870481	1615840838514:1383351227	D5170C00002	14	7	CREATE	2021-03-18 05:46:48.881	2002048 Cicala, Michele	05 Site Management
8999	85	1616042809542:-12054442	1616042808791:-137870481	D5170C00002	15	14	CREATE	2021-03-18 05:46:49.701	05 Site Management	05.01 Site Selection
9000	85	1616042810991:-347211787	1616042809542:-12054442	D5170C00002	16	15	CREATE	2021-03-18 05:46:51.097	05.01 Site Selection	05.01.01 Site Contact Details
9001	85	1616042811675:28270568	1616042809542:-12054442	D5170C00002	17	15	CREATE	2021-03-18 05:46:51.777	05.01 Site Selection	05.01.02 Confidentiality Agreement
9002	85	1616042812399:249563744	1616042809542:-12054442	D5170C00002	18	15	CREATE	2021-03-18 05:46:52.494	05.01 Site Selection	05.01.03 Feasibility Documentation
9003	85	1616042813099:936571594	1616042809542:-12054442	D5170C00002	19	15	CREATE	2021-03-18 05:46:53.189	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
9004	85	1616042813745:-2066799837	1616042808791:-137870481	D5170C00002	20	14	CREATE	2021-03-18 05:46:53.84	05 Site Management	05.02 Site Set-up Documentation
9005	85	1616042814409:1530222528	1616042813745:-2066799837	D5170C00002	21	20	CREATE	2021-03-18 05:46:54.504	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
9006	85	1616042815107:-1219154418	1616042813745:-2066799837	D5170C00002	22	20	CREATE	2021-03-18 05:46:55.2	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
9007	85	1616042815838:-418529332	1616042813745:-2066799837	D5170C00002	23	20	CREATE	2021-03-18 05:46:55.925	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
9008	85	1616042816468:1673745567	1616042813745:-2066799837	D5170C00002	24	20	CREATE	2021-03-18 05:46:56.554	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
9009	85	1616042817107:-1102903618	1616042813745:-2066799837	D5170C00002	25	20	CREATE	2021-03-18 05:46:57.199	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
9010	85	1616042817799:2009236265	1616042813745:-2066799837	D5170C00002	26	20	CREATE	2021-03-18 05:46:57.9	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
9011	85	1616042818459:905852477	1616042813745:-2066799837	D5170C00002	27	20	CREATE	2021-03-18 05:46:58.548	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
9012	85	1616042819143:641846958	1616042813745:-2066799837	D5170C00002	28	20	CREATE	2021-03-18 05:46:59.242	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
9013	85	1616042819775:1426150288	1616042813745:-2066799837	D5170C00002	29	20	CREATE	2021-03-18 05:46:59.863	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
9014	85	1616042820355:1046310497	1616042813745:-2066799837	D5170C00002	30	20	CREATE	2021-03-18 05:47:00.447	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
9015	85	1616042821606:1882853562	1616042808791:-137870481	D5170C00002	31	14	CREATE	2021-03-18 05:47:01.696	05 Site Management	05.03 Site Initiation
9016	85	1616042822258:1929756448	1616042821606:1882853562	D5170C00002	32	31	CREATE	2021-03-18 05:47:02.351	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
9017	85	1616042822963:743322049	1616042821606:1882853562	D5170C00002	33	31	CREATE	2021-03-18 05:47:03.058	05.03 Site Initiation	05.03.03 Site Training-Staff
9018	85	1616042823628:-531463930	1616042821606:1882853562	D5170C00002	34	31	CREATE	2021-03-18 05:47:03.719	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
9019	85	1616042824245:909494559	1616042808791:-137870481	D5170C00002	35	14	CREATE	2021-03-18 05:47:04.433	05 Site Management	05.04 Site Management
9020	85	1616042824949:-1732021159	1616042824245:909494559	D5170C00002	36	35	CREATE	2021-03-18 05:47:05.041	05.04 Site Management	05.04.03 UNBLINDED Monitoring Visit Report
9021	85	1616042825544:1566107659	1616042824245:909494559	D5170C00002	37	35	CREATE	2021-03-18 05:47:05.652	05.04 Site Management	05.04.04 Visit Log
9022	85	1616042826175:-361007691	1616042824245:909494559	D5170C00002	38	35	CREATE	2021-03-18 05:47:06.263	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
9024	85	1616042827452:1492477105	1616042826860:1269305664	D5170C00002	40	39	CREATE	2021-03-18 05:47:07.541	05.05 General	05.05.02 Tracking Information
9025	85	1616042828110:-1168555756	1615840838514:1383351227	D5170C00002	41	7	CREATE	2021-03-18 05:47:08.2	2002048 Cicala, Michele	06 IP and Trial Supplies
9026	85	1616042828780:1575787389	1616042828110:-1168555756	D5170C00002	42	41	CREATE	2021-03-18 05:47:08.872	06 IP and Trial Supplies	06.01 IP Documentation
9027	85	1616042829502:618578083	1616042828780:1575787389	D5170C00002	43	42	CREATE	2021-03-18 05:47:09.593	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
9028	85	1616042830147:-1028747214	1615840756146:-740604444	D5170C00002	44	6	CREATE	2021-03-18 05:47:10.241	Site	2002049 Danese, Silvio
11547	85	1616044684253:-950918201	1616044676540:-40359322	D5170C00002	2563	2553	CREATE	2021-03-18 06:18:04.337	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
11548	85	1616044684884:-676674037	1616044673332:-628390298	D5170C00002	2564	2548	CREATE	2021-03-18 06:18:04.973	05 Site Management	05.03 Site Initiation
11557	86	\N	\N	D5170C00002	8	7	NEW	\N	2001700 Idarraga, Samuel	05 Site Management
11558	86	\N	\N	D5170C00002	9	8	NEW	\N	05 Site Management	05.03 Site Initiation
9029	85	1616042830778:-1589209036	1616042830147:-1028747214	D5170C00002	45	44	CREATE	2021-03-18 05:47:10.866	2002049 Danese, Silvio	02 Central Trial Documents
9030	85	1616042832090:299422097	1616042830778:-1589209036	D5170C00002	46	45	CREATE	2021-03-18 05:47:12.183	02 Central Trial Documents	02.02 Subject Documents
11563	86	\N	\N	D5170C00002	14	13	NEW	\N	05.04 Site Management	05.04.01 Subject Log
9031	85	1616042832713:1916265881	1616042832090:299422097	D5170C00002	47	46	CREATE	2021-03-18 05:47:12.797	02.02 Subject Documents	02.02.03 Infor_ Form Checklists
9032	85	1616042833261:2021277173	1616042832090:299422097	D5170C00002	48	46	CREATE	2021-03-18 05:47:13.348	02.02 Subject Documents	02.02.03 Infor_t Form Templates
9033	85	1616042833847:1525556504	1616042830778:-1589209036	D5170C00002	49	45	CREATE	2021-03-18 05:47:13.939	02 Central Trial Documents	02.04 General
9034	85	1616042834427:1914093230	1616042833847:1525556504	D5170C00002	50	49	CREATE	2021-03-18 05:47:14.515	02.04 General	02.04.01 Relev_s-Contact Report
9035	85	1616042834986:1636036735	1616042833847:1525556504	D5170C00002	51	49	CREATE	2021-03-18 05:47:15.076	02.04 General	02.04.01 UNBLI_s-Contact Report
9038	85	1616042837197:1843049100	1616042836549:-726187771	D5170C00002	54	53	CREATE	2021-03-18 05:47:17.285	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
9041	85	1616042839013:974836666	1616042838443:-559920065	D5170C00002	57	56	CREATE	2021-03-18 05:47:19.274	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
9044	85	1616042841056:-1650986709	1616042840447:-1408974558	D5170C00002	60	59	CREATE	2021-03-18 05:47:21.141	05.01 Site Selection	05.01.01 Site Contact Details
9047	85	1616042843757:-1589437488	1616042840447:-1408974558	D5170C00002	63	59	CREATE	2021-03-18 05:47:23.846	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
9050	85	1616042845711:-354908066	1616042844320:831226125	D5170C00002	66	64	CREATE	2021-03-18 05:47:25.826	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
9054	85	1616042848130:850578572	1616042844320:831226125	D5170C00002	70	64	CREATE	2021-03-18 05:47:28.219	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
9057	85	1616042849887:1972162283	1616042844320:831226125	D5170C00002	73	64	CREATE	2021-03-18 05:47:29.976	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
9060	85	1616042851605:1451121915	1616042851029:485954664	D5170C00002	76	75	CREATE	2021-03-18 05:47:31.694	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
9064	85	1616042854918:1423796066	1616042854311:-633244236	D5170C00002	80	79	CREATE	2021-03-18 05:47:35.006	05.04 Site Management	05.04.01 Subject Log
9066	85	1616042856251:2015802069	1616042854311:-633244236	D5170C00002	82	79	CREATE	2021-03-18 05:47:36.342	05.04 Site Management	05.04.03 UNBLI_ing Visit Report
9070	85	1616042858670:1264452871	1616042854311:-633244236	D5170C00002	86	79	CREATE	2021-03-18 05:47:38.759	05.04 Site Management	05.04.06 UNBLINDED Protocol Deviations and Waivers
9073	85	1616042860709:-1495593028	1616042839842:-462799596	D5170C00002	89	58	CREATE	2021-03-18 05:47:40.815	05 Site Management	05.05 General
9076	85	1616042862458:863372248	1616042861904:-271261320	D5170C00002	92	91	CREATE	2021-03-18 05:47:42.546	06 IP and Trial Supplies	06.01 IP Documentation
9079	85	1616042865141:1105286380	1616042862458:863372248	D5170C00002	95	92	CREATE	2021-03-18 05:47:45.232	06.01 IP Documentation	06.01.05 Accountability Documentation
9082	85	1616042866903:333877139	1616042861904:-271261320	D5170C00002	98	91	CREATE	2021-03-18 05:47:46.988	06 IP and Trial Supplies	06.04 Storage
9085	85	1616042871919:-408059439	1616042866903:333877139	D5170C00002	101	98	CREATE	2021-03-18 05:47:52.009	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
9088	85	1616042873807:-1623057563	1616042873077:-1201337596	D5170C00002	104	103	CREATE	2021-03-18 05:47:53.897	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
9091	85	1616042876162:2071593391	1616042872495:383084682	D5170C00002	107	102	CREATE	2021-03-18 05:47:56.251	2002050 Dinelli, Marco	05 Site Management
9094	85	1616042878842:1375590686	1615840756146:-740604444	D5170C00002	110	6	CREATE	2021-03-18 05:47:58.932	Site	2002051 Cosintino, Rocco
9097	85	1616042880807:-739542289	1616042880147:621463369	D5170C00002	113	112	CREATE	2021-03-18 05:48:00.897	02.02 Subject Documents	02.02.03 Informed Consent Form Templates
9100	85	1616042882583:-1754901435	1616042878842:1375590686	D5170C00002	116	110	CREATE	2021-03-18 05:48:02.671	2002051 Cosintino, Rocco	04 IRB-IEC and other Approvals
9101	85	1616042883163:-786565090	1616042882583:-1754901435	D5170C00002	117	116	CREATE	2021-03-18 05:48:03.254	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
9104	85	1616042885128:-589604956	1616042882583:-1754901435	D5170C00002	120	116	CREATE	2021-03-18 05:48:05.874	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
9108	85	1616042888228:-55991820	1616042887640:-1940424832	D5170C00002	124	123	CREATE	2021-03-18 05:48:08.333	05.01 Site Selection	05.01.01 Site Contact Details
9110	85	1616042889357:1762911781	1616042887640:-1940424832	D5170C00002	126	123	CREATE	2021-03-18 05:48:09.445	05.01 Site Selection	05.01.03 Feasibility Documentation
9113	85	1616042891188:772203148	1616042890583:1698521118	D5170C00002	129	128	CREATE	2021-03-18 05:48:11.277	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
9117	85	1616042893547:-638625184	1616042890583:1698521118	D5170C00002	133	128	CREATE	2021-03-18 05:48:13.636	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
9120	85	1616042895398:1517308816	1616042890583:1698521118	D5170C00002	136	128	CREATE	2021-03-18 05:48:15.491	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
9123	85	1616042897928:-847959032	1616042890583:1698521118	D5170C00002	139	128	CREATE	2021-03-18 05:48:18.018	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
9127	85	1616042900443:-237407152	1616042898629:1207409760	D5170C00002	143	140	CREATE	2021-03-18 05:48:20.532	05.03 Site Initiation	05.03.03 Site Training-Staff
9130	85	1616042902190:-709190622	1616042901004:1456200045	D5170C00002	146	144	CREATE	2021-03-18 05:48:22.28	05.04 Site Management	05.04.05 Additional Monitoring Activity
9134	85	1616042904903:768208263	1616042903667:1816021759	D5170C00002	150	148	CREATE	2021-03-18 05:48:24.99	05.05 General	05.05.02 Tracking Information
9137	85	1616042906640:-1833453036	1616042906068:1238408799	D5170C00002	153	152	CREATE	2021-03-18 05:48:26.728	02 Central Trial Documents	02.02 Subject Documents
9140	85	1616042909228:-1975212333	1616042906068:1238408799	D5170C00002	156	152	CREATE	2021-03-18 05:48:29.332	02 Central Trial Documents	02.04 General
9143	85	1616042911034:1712856070	1616042905465:803471939	D5170C00002	159	151	CREATE	2021-03-18 05:48:31.131	2002052 Ricci, Chiara	04 IRB-IEC and other Approvals
9145	85	1616042912229:-1586543106	1616042911665:-505828296	D5170C00002	161	160	CREATE	2021-03-18 05:48:32.316	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
9149	85	1616042914495:135632610	1616042913878:-1561805359	D5170C00002	165	164	CREATE	2021-03-18 05:48:34.585	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
11564	86	\N	\N	D5170C00002	15	13	NEW	\N	05.04 Site Management	05.04.03 UNBLINDED Monitoring Visit Report
9152	85	1616042916297:1842769340	1616042915719:-1294345713	D5170C00002	168	167	CREATE	2021-03-18 05:48:36.385	05.01 Site Selection	05.01.01 Site Contact Details
11559	86	\N	\N	D5170C00002	10	9	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
9155	85	1616042919156:390606178	1616042915719:-1294345713	D5170C00002	171	167	CREATE	2021-03-18 05:48:39.247	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
9158	85	1616042921099:1571242832	1616042919743:-161305984	D5170C00002	174	172	CREATE	2021-03-18 05:48:41.21	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
9162	85	1616042923999:-265247584	1616042919743:-161305984	D5170C00002	178	172	CREATE	2021-03-18 05:48:44.103	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
9164	85	1616042925545:1440096245	1616042919743:-161305984	D5170C00002	180	172	CREATE	2021-03-18 05:48:45.643	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
9166	85	1616042927323:-6066500	1616042919743:-161305984	D5170C00002	182	172	CREATE	2021-03-18 05:48:47.419	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
9169	85	1616042931052:654613282	1616042928108:-652417342	D5170C00002	185	183	CREATE	2021-03-18 05:48:51.232	05.03 Site Initiation	05.03.03 Site Training-Staff
9172	85	1616042933269:406615414	1616042931916:-372786103	D5170C00002	188	186	CREATE	2021-03-18 05:48:53.359	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
9176	85	1616042936422:994025982	1616042935779:1077307827	D5170C00002	192	191	CREATE	2021-03-18 05:48:56.511	2002053 Vecchi, Maurizio	02 Central Trial Documents
9179	85	1616042938585:7158434	1616042937092:37464914	D5170C00002	195	193	CREATE	2021-03-18 05:48:58.689	02.02 Subject Documents	02.02.03 Infor_t Form Templates
9183	85	1616042942622:-2064163293	1616042941236:-1357295234	D5170C00002	199	197	CREATE	2021-03-18 05:49:02.716	02.04 General	02.04.01 UNBLI_s-Contact Report
9185	85	1616042943981:1085676217	1616042943334:215472402	D5170C00002	201	200	CREATE	2021-03-18 05:49:04.068	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
9189	85	1616042946924:-1234970976	1616042946154:286349297	D5170C00002	205	204	CREATE	2021-03-18 05:49:07.016	04.04 General	04.04.01 Relev_RB-IEC-Documents
9192	85	1616042948871:-874264028	1616042948243:-260277017	D5170C00002	208	207	CREATE	2021-03-18 05:49:08.961	05.01 Site Selection	05.01.01 Site Contact Details
9195	85	1616042952944:715528646	1616042948243:-260277017	D5170C00002	211	207	CREATE	2021-03-18 05:49:13.032	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
9197	85	1616042954381:455339856	1616042953687:-916255927	D5170C00002	213	212	CREATE	2021-03-18 05:49:14.472	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
9201	85	1616042957535:-2062681257	1616042953687:-916255927	D5170C00002	217	212	CREATE	2021-03-18 05:49:17.629	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
9204	85	1616042959457:-358670710	1616042953687:-916255927	D5170C00002	220	212	CREATE	2021-03-18 05:49:19.766	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
9208	85	1616042963451:-1407346067	1616042947609:-354661672	D5170C00002	224	206	CREATE	2021-03-18 05:49:23.55	05 Site Management	05.03 Site Initiation
9211	85	1616042965526:-1200195683	1616042963451:-1407346067	D5170C00002	227	224	CREATE	2021-03-18 05:49:25.618	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
9214	85	1616042967734:501847695	1616042966259:-1158672481	D5170C00002	230	228	CREATE	2021-03-18 05:49:27.824	05.04 Site Management	05.04.05 UNBLI_itoring Activity
9218	85	1616042970964:-163080960	1616042935779:1077307827	D5170C00002	234	191	CREATE	2021-03-18 05:49:31.053	2002053 Vecchi, Maurizio	06 IP and Trial Supplies
9221	85	1616042975293:1368593647	1616042935779:1077307827	D5170C00002	237	191	CREATE	2021-03-18 05:49:35.391	2002053 Vecchi, Maurizio	08 Centralized Testing
9223	85	1616042977401:1333523337	1616042976620:-237636268	D5170C00002	239	238	CREATE	2021-03-18 05:49:37.49	08.02 Sample Documentation	08.02.03 Sampl_ge Condition Log
9227	85	1616042980422:584223363	1616042979519:-131284349	D5170C00002	243	242	CREATE	2021-03-18 05:49:40.518	02.02 Subject Documents	02.02.03 Infor_ Form Checklists
9229	85	1616042982093:-932271286	1616042978107:1562038103	D5170C00002	245	240	CREATE	2021-03-18 05:49:42.18	2002295 Rogai, Francesca	04 IRB-IEC and other Approvals
9230	85	1616042982922:124756227	1616042982093:-932271286	D5170C00002	246	245	CREATE	2021-03-18 05:49:43.027	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
9234	85	1616042986465:1276850479	1616042984890:-2069338365	D5170C00002	250	249	CREATE	2021-03-18 05:49:46.571	05 Site Management	05.01 Site Selection
9237	85	1616042988419:-1936782510	1616042987772:-777958570	D5170C00002	253	252	CREATE	2021-03-18 05:49:48.526	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
9239	85	1616042989676:-1438350530	1616042987772:-777958570	D5170C00002	255	252	CREATE	2021-03-18 05:49:49.768	05.02 Site Set-up Documentation	05.02.09 Investigator Regulatory Agreement
9243	85	1616042992213:-303075975	1616042991563:-1269080537	D5170C00002	259	258	CREATE	2021-03-18 05:49:52.299	05.03 Site Initiation	05.03.03 Site Training-Staff
9246	85	1616042994090:786736660	1616042993479:-486166747	D5170C00002	262	261	CREATE	2021-03-18 05:49:54.178	02 Central Trial Documents	02.02 Subject Documents
9250	85	1616042997815:1050465145	1616042995315:790838478	D5170C00002	266	264	CREATE	2021-03-18 05:49:57.907	02.04 General	02.04.01 Relev_s-Contact Report
9253	85	1616042999695:1931325858	1616042999036:-1985546541	D5170C00002	269	268	CREATE	2021-03-18 05:49:59.788	03 Regulatory	03.04 General
9255	85	1616043001019:-1148139369	1616042992854:1637881845	D5170C00002	271	260	CREATE	2021-03-18 05:50:01.108	2002296 Petruzzellis, Carlo	04 IRB-IEC and other Approvals
9258	85	1616043002876:588098734	1616043001603:1261339491	D5170C00002	274	272	CREATE	2021-03-18 05:50:02.968	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
9261	85	1616043004732:-2115331031	1616043004144:-1614486556	D5170C00002	277	276	CREATE	2021-03-18 05:50:04.822	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
9265	85	1616043008327:1802788902	1616043005950:402571786	D5170C00002	281	279	CREATE	2021-03-18 05:50:08.417	05.01 Site Selection	05.01.02 Confidentiality Agreement
9268	85	1616043010205:1420686835	1616043005337:756802433	D5170C00002	284	278	CREATE	2021-03-18 05:50:10.302	05 Site Management	05.02 Site Set-up Documentation
9271	85	1616043012074:1044123745	1616043010205:1420686835	D5170C00002	287	284	CREATE	2021-03-18 05:50:12.177	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
9274	85	1616043013790:-2075877234	1616043010205:1420686835	D5170C00002	290	284	CREATE	2021-03-18 05:50:13.88	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
9277	85	1616043015558:-253973665	1616043010205:1420686835	D5170C00002	293	284	CREATE	2021-03-18 05:50:15.649	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
9281	85	1616043018068:2053775012	1616043017404:929564868	D5170C00002	297	296	CREATE	2021-03-18 05:50:18.161	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
9284	85	1616043021114:2119426655	1616043020516:1324142005	D5170C00002	300	299	CREATE	2021-03-18 05:50:21.206	05.04 Site Management	05.04.04 Visit Log
9287	85	1616043022951:1862233188	1616043022276:-936941445	D5170C00002	303	302	CREATE	2021-03-18 05:50:23.035	05.05 General	05.05.02 Tracking Information
9290	85	1616043024773:998046271	1616043024197:-794954001	D5170C00002	306	305	CREATE	2021-03-18 05:50:24.863	05 Site Management	05.01 Site Selection
9293	85	1616043026490:1599968718	1616043025914:-915551249	D5170C00002	309	308	CREATE	2021-03-18 05:50:26.577	TBD-1-25G8KT4 Romano, Marco	05 Site Management
9294	85	1616043027530:704457932	1616043026490:1599968718	D5170C00002	310	309	CREATE	2021-03-18 05:50:27.635	05 Site Management	05.01 Site Selection
9296	85	1616043028775:-496339678	1615840756146:-740604444	D5170C00002	312	6	CREATE	2021-03-18 05:50:28.867	Site	TBD-1-27OAC50 _eleone, Giovanni
9299	85	1616043031604:927952571	1616043030993:-601812489	D5170C00002	315	314	CREATE	2021-03-18 05:50:31.7	05.01 Site Selection	05.01.04 Pre T_onitoring Report
9302	85	1616043033408:-338850020	1616043032792:2030519844	D5170C00002	318	317	CREATE	2021-03-18 05:50:33.499	Site	2002355 Ye, Byong Duk
9305	85	1616043035074:-1483062901	1616043034518:1133706409	D5170C00002	321	320	CREATE	2021-03-18 05:50:35.161	02.02 Subject Documents	02.02.03 Infor_ Form Checklists
9308	85	1616043036940:-933934712	1616043036245:-682136238	D5170C00002	324	323	CREATE	2021-03-18 05:50:37.029	02.04 General	02.04.01 UNBLI_s-Contact Report
9310	85	1616043038091:-869470640	1616043037494:-1129418173	D5170C00002	326	325	CREATE	2021-03-18 05:50:38.19	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
9314	85	1616043040500:549670609	1616043037494:-1129418173	D5170C00002	330	325	CREATE	2021-03-18 05:50:40.59	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
9317	85	1616043043498:1542333605	1616043042910:1343825074	D5170C00002	333	332	CREATE	2021-03-18 05:50:43.589	04.04 General	04.04.02 Tracking Information
9320	85	1616043045259:-1359286186	1616043044682:-1249689044	D5170C00002	336	335	CREATE	2021-03-18 05:50:45.346	05.01 Site Selection	05.01.02 Confidentiality Agreement
9323	85	1616043047013:1136330318	1616043044105:2028513871	D5170C00002	339	334	CREATE	2021-03-18 05:50:47.103	05 Site Management	05.02 Site Set-up Documentation
9326	85	1616043048692:223301187	1616043047013:1136330318	D5170C00002	342	339	CREATE	2021-03-18 05:50:48.78	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
9330	85	1616043051011:-126368527	1616043047013:1136330318	D5170C00002	346	339	CREATE	2021-03-18 05:50:51.1	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
9333	85	1616043056391:-1964533807	1616043047013:1136330318	D5170C00002	349	339	CREATE	2021-03-18 05:50:56.485	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
9336	85	1616043058185:-911448115	1616043057519:-1174746723	D5170C00002	352	351	CREATE	2021-03-18 05:50:58.275	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
9340	85	1616043060551:-235439256	1616043059371:924839590	D5170C00002	356	354	CREATE	2021-03-18 05:51:00.643	05.04 Site Management	05.04.02 Source Data Verification
9343	85	1616043062408:31681671	1616043044105:2028513871	D5170C00002	359	334	CREATE	2021-03-18 05:51:02.494	05 Site Management	05.05 General
9346	85	1616043064126:-1611552785	1616043063556:-2072772131	D5170C00002	362	361	CREATE	2021-03-18 05:51:04.214	06 IP and Trial Supplies	06.01 IP Documentation
9349	85	1616043066419:1076246360	1616043065323:230932601	D5170C00002	365	364	CREATE	2021-03-18 05:51:06.51	06.05 Non-IP Documentation	06.05.02 Non-IP Documentation of Shipment
9352	85	1616043068335:701629456	1616043032792:2030519844	D5170C00002	368	317	CREATE	2021-03-18 05:51:08.423	Site	2002359 Jung, Sung-Ae
9355	85	1616043070044:-11951835	1616043069450:967591264	D5170C00002	371	370	CREATE	2021-03-18 05:51:10.134	02.02 Subject Documents	02.02.03 Infor_t Form Templates
9358	85	1616043071841:1861854810	1616043070613:-2101241625	D5170C00002	374	372	CREATE	2021-03-18 05:51:11.928	02.04 General	02.04.01 Relev_s-Contact Report
9360	85	1616043072959:592591887	1616043068335:701629456	D5170C00002	376	368	CREATE	2021-03-18 05:51:13.046	2002359 Jung, Sung-Ae	04 IRB-IEC and other Approvals
9361	85	1616043073514:754811658	1616043072959:592591887	D5170C00002	377	376	CREATE	2021-03-18 05:51:13.612	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
9364	85	1616043075229:1780186921	1616043073514:754811658	D5170C00002	380	377	CREATE	2021-03-18 05:51:15.325	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
9367	85	1616043077559:1332668063	1616043075789:-2121014389	D5170C00002	383	381	CREATE	2021-03-18 05:51:17.655	04.03 Trial Status Reporting	04.03.02 IRB-I_ Progress Report
9371	85	1616043079954:-542332174	1616043068335:701629456	D5170C00002	387	368	CREATE	2021-03-18 05:51:20.044	2002359 Jung, Sung-Ae	05 Site Management
9374	85	1616043081700:-723886942	1616043080537:1037922969	D5170C00002	390	388	CREATE	2021-03-18 05:51:21.792	05.01 Site Selection	05.01.03 Feasibility Documentation
9377	85	1616043083588:1389041533	1616043082965:-2090914536	D5170C00002	393	392	CREATE	2021-03-18 05:51:23.678	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
9380	85	1616043085420:1489564646	1616043082965:-2090914536	D5170C00002	396	392	CREATE	2021-03-18 05:51:25.511	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
9383	85	1616043087720:764618437	1616043082965:-2090914536	D5170C00002	399	392	CREATE	2021-03-18 05:51:27.809	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
9386	85	1616043089546:1548429830	1616043082965:-2090914536	D5170C00002	402	392	CREATE	2021-03-18 05:51:29.649	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
9390	85	1616043096693:-1085627761	1616043095483:457861187	D5170C00002	406	404	CREATE	2021-03-18 05:51:36.781	05.03 Site Initiation	05.03.03 Site Training-Staff
9393	85	1616043099139:-150999707	1616043098549:1959482579	D5170C00002	409	408	CREATE	2021-03-18 05:51:39.239	05.04 Site Management	05.04.02 Source Data Verification
9397	85	1616043102293:-941012278	1616043101674:-1975673612	D5170C00002	413	412	CREATE	2021-03-18 05:51:42.388	05.05 General	05.05.01 Relev_unications-Email
9400	85	1616043104210:1016134387	1616043068335:701629456	D5170C00002	416	368	CREATE	2021-03-18 05:51:44.304	2002359 Jung, Sung-Ae	06 IP and Trial Supplies
9402	85	1616043105398:1544223055	1616043104806:-1567719674	D5170C00002	418	417	CREATE	2021-03-18 05:51:45.502	06.01 IP Documentation	06.01.02 IP Instructions for Handling
9406	85	1616043107856:-1010751041	1616043104210:1016134387	D5170C00002	422	416	CREATE	2021-03-18 05:51:48.454	06 IP and Trial Supplies	06.05 Non-IP Documentation
9409	85	1616043110297:1943856845	1616043109642:1180880709	D5170C00002	425	424	CREATE	2021-03-18 05:51:50.383	08 Centralized Testing	08.01 Facility Documentation
9412	85	1616043112220:1706809190	1616043111614:-430701891	D5170C00002	428	427	CREATE	2021-03-18 05:51:52.311	08.02 Sample Documentation	08.02.03 Sampl_ge Condition Log
9415	85	1616043114128:-2120394832	1616043113419:-1821644234	D5170C00002	431	430	CREATE	2021-03-18 05:51:54.223	10.05 General	10.05.02 Tracking Information
9418	85	1616043116052:944554280	1616043115330:-835844106	D5170C00002	434	433	CREATE	2021-03-18 05:51:56.143	02 Central Trial Documents	02.02 Subject Documents
9421	85	1616043117784:-448126504	1616043115330:-835844106	D5170C00002	437	433	CREATE	2021-03-18 05:51:57.872	02 Central Trial Documents	02.04 General
9424	85	1616043120751:-1614397686	1616043114723:-1860584359	D5170C00002	440	432	CREATE	2021-03-18 05:52:00.866	2002360 Kim, Hyun-Soo	04 IRB-IEC and other Approvals
9967	85	1616043509101:1392855105	1616043503128:1598538866	D5170C00002	983	973	CREATE	2021-03-18 05:58:29.202	06 IP and Trial Supplies	06.07 General
9425	85	1616043121383:2080778767	1616043120751:-1614397686	D5170C00002	441	440	CREATE	2021-03-18 05:52:01.49	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
9428	85	1616043123633:1238623466	1616043122862:1657493619	D5170C00002	444	443	CREATE	2021-03-18 05:52:03.966	05 Site Management	05.01 Site Selection
9430	85	1616043125210:1539071545	1616043123633:1238623466	D5170C00002	446	444	CREATE	2021-03-18 05:52:05.301	05.01 Site Selection	05.01.03 Feasibility Documentation
9433	85	1616043126950:-1678659499	1616043126363:-670313859	D5170C00002	449	448	CREATE	2021-03-18 05:52:07.035	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
9437	85	1616043130432:1303734243	1616043126363:-670313859	D5170C00002	453	448	CREATE	2021-03-18 05:52:10.524	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
9440	85	1616043132347:676620788	1616043122862:1657493619	D5170C00002	456	443	CREATE	2021-03-18 05:52:12.437	05 Site Management	05.04 Site Management
9443	85	1616043134166:-1446026205	1616043133558:2071216429	D5170C00002	459	458	CREATE	2021-03-18 05:52:14.263	2002361 Kim, YoungHo	02 Central Trial Documents
9446	85	1616043136209:642233420	1616043134820:168566753	D5170C00002	462	460	CREATE	2021-03-18 05:52:16.304	02.02 Subject Documents	02.02.03 Infor_t Form Templates
9449	85	1616043138056:905649612	1616043136808:-281429727	D5170C00002	465	463	CREATE	2021-03-18 05:52:18.15	02.04 General	02.04.01 UNBLI_s-Contact Report
9452	85	1616043139842:2067688144	1616043139234:631197058	D5170C00002	468	467	CREATE	2021-03-18 05:52:19.927	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
9455	85	1616043142634:2050317089	1616043138640:2070408729	D5170C00002	471	466	CREATE	2021-03-18 05:52:22.725	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
9458	85	1616043144562:1993727174	1616043142634:2050317089	D5170C00002	474	471	CREATE	2021-03-18 05:52:24.649	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
9462	85	1616043146982:1835201218	1616043146378:1047364565	D5170C00002	478	477	CREATE	2021-03-18 05:52:27.069	05 Site Management	05.01 Site Selection
9464	85	1616043148561:876284401	1616043146982:1835201218	D5170C00002	480	478	CREATE	2021-03-18 05:52:28.671	05.01 Site Selection	05.01.03 Feasibility Documentation
9468	85	1616043150961:-1501305165	1616043149777:1743015049	D5170C00002	484	482	CREATE	2021-03-18 05:52:31.049	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
9471	85	1616043153940:-553030363	1616043149777:1743015049	D5170C00002	487	482	CREATE	2021-03-18 05:52:34.029	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
9474	85	1616043155785:709715353	1616043149777:1743015049	D5170C00002	490	482	CREATE	2021-03-18 05:52:35.872	05.02 Site Set-up Documentation	05.02.11 Data Privacy
9477	85	1616043157529:-1142173946	1616043149777:1743015049	D5170C00002	493	482	CREATE	2021-03-18 05:52:37.62	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
9481	85	1616043160082:1765029741	1616043158111:-564836856	D5170C00002	497	494	CREATE	2021-03-18 05:52:40.171	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
9484	85	1616043163938:102493641	1616043161703:278534079	D5170C00002	500	498	CREATE	2021-03-18 05:52:44.028	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
9488	85	1616043166274:615543332	1616043165142:-1037753876	D5170C00002	504	502	CREATE	2021-03-18 05:52:46.404	05.05 General	05.05.02 Tracking Information
9489	85	1616043166986:1098293181	1616043133558:2071216429	D5170C00002	505	458	CREATE	2021-03-18 05:52:47.075	2002361 Kim, YoungHo	06 IP and Trial Supplies
9491	85	1616043168233:410964448	1616043167615:648366174	D5170C00002	507	506	CREATE	2021-03-18 05:52:48.324	06.04 Storage	06.04.03 Maintenance Logs
9494	85	1616043170636:-1664978290	1616043133558:2071216429	D5170C00002	510	458	CREATE	2021-03-18 05:52:50.758	2002361 Kim, YoungHo	08 Centralized Testing
9497	85	1616043172604:1287133600	1616043170636:-1664978290	D5170C00002	513	510	CREATE	2021-03-18 05:52:52.697	08 Centralized Testing	08.02 Sample Documentation
9500	85	1616043175514:2080354096	1616043174911:255942202	D5170C00002	516	515	CREATE	2021-03-18 05:52:55.609	2002362 Kim, Hyo-Jong	02 Central Trial Documents
9503	85	1616043177446:-8167949	1616043175514:2080354096	D5170C00002	519	516	CREATE	2021-03-18 05:52:57.543	02 Central Trial Documents	02.04 General
9506	85	1616043179558:-1741301092	1616043174911:255942202	D5170C00002	522	515	CREATE	2021-03-18 05:52:59.66	2002362 Kim, Hyo-Jong	04 IRB-IEC and other Approvals
9509	85	1616043181403:1677216307	1616043180175:860390378	D5170C00002	525	523	CREATE	2021-03-18 05:53:01.492	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
9512	85	1616043184561:1519574437	1616043183883:-198779994	D5170C00002	528	527	CREATE	2021-03-18 05:53:05.59	04.03 Trial Status Reporting	04.03.01 IRB-I_y Info-Deviation
9516	85	1616043188485:664926241	1616043187874:1390097252	D5170C00002	532	531	CREATE	2021-03-18 05:53:08.577	05 Site Management	05.01 Site Selection
9518	85	1616043189747:1343217982	1616043188485:664926241	D5170C00002	534	532	CREATE	2021-03-18 05:53:09.835	05.01 Site Selection	05.01.03 Feasibility Documentation
9521	85	1616043191685:452240354	1616043191053:1683953664	D5170C00002	537	536	CREATE	2021-03-18 05:53:11.774	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
9525	85	1616043194215:-860322591	1616043191053:1683953664	D5170C00002	541	536	CREATE	2021-03-18 05:53:14.307	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
9528	85	1616043197264:-290295319	1616043191053:1683953664	D5170C00002	544	536	CREATE	2021-03-18 05:53:17.354	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
9532	85	1616043199788:219339366	1616043199143:-1735164878	D5170C00002	548	547	CREATE	2021-03-18 05:53:19.873	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
9535	85	1616043201619:-1032392994	1616043187874:1390097252	D5170C00002	551	531	CREATE	2021-03-18 05:53:21.708	05 Site Management	05.04 Site Management
9538	85	1616043203436:579294408	1616043187874:1390097252	D5170C00002	554	531	CREATE	2021-03-18 05:53:23.528	05 Site Management	05.05 General
9541	85	1616043205362:355242640	1616043174911:255942202	D5170C00002	557	515	CREATE	2021-03-18 05:53:25.449	2002362 Kim, Hyo-Jong	06 IP and Trial Supplies
9544	85	1616043208463:2090523722	1616043205362:355242640	D5170C00002	560	557	CREATE	2021-03-18 05:53:28.554	06 IP and Trial Supplies	06.04 Storage
9547	85	1616043210249:-1597330035	1616043209670:-377463804	D5170C00002	563	562	CREATE	2021-03-18 05:53:30.337	06.05 Non-IP Documentation	06.05.02 Non-IP Documentation of Shipment
9550	85	1616043212119:570438767	1616043211493:-871343730	D5170C00002	566	565	CREATE	2021-03-18 05:53:32.208	08.01 Facility Documentation	08.01.01 Certi_or Accreditation
9553	85	1616043214157:-87438597	1616043213322:1042699430	D5170C00002	569	568	CREATE	2021-03-18 05:53:34.256	08.02 Sample Documentation	08.02.03 Sampl_ge Condition Log
9554	85	1616043214755:-221462935	1616043174911:255942202	D5170C00002	570	515	CREATE	2021-03-18 05:53:34.841	2002362 Kim, Hyo-Jong	10 Data Management
9555	85	1616043215380:710637040	1616043214755:-221462935	D5170C00002	571	570	CREATE	2021-03-18 05:53:35.47	10 Data Management	10.05 General
11560	86	\N	\N	D5170C00002	11	9	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
9558	85	1616043217168:-781665764	1616043216587:1433691790	D5170C00002	574	573	CREATE	2021-03-18 05:53:37.262	2002363 Cheon, Jae Hee	02 Central Trial Documents
9561	85	1616043220220:644878186	1616043217168:-781665764	D5170C00002	577	574	CREATE	2021-03-18 05:53:40.313	02 Central Trial Documents	02.04 General
9564	85	1616043222445:-1700797177	1616043216587:1433691790	D5170C00002	580	573	CREATE	2021-03-18 05:53:42.535	2002363 Cheon, Jae Hee	04 IRB-IEC and other Approvals
9567	85	1616043224436:1363120421	1616043223086:1044014200	D5170C00002	583	581	CREATE	2021-03-18 05:53:44.529	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
9570	85	1616043226337:-589891007	1616043225714:-1831811847	D5170C00002	586	585	CREATE	2021-03-18 05:53:46.428	04.03 Trial Status Reporting	04.03.01 IRB-I_y Info-Deviation
9573	85	1616043228197:2020916999	1616043216587:1433691790	D5170C00002	589	573	CREATE	2021-03-18 05:53:48.285	2002363 Cheon, Jae Hee	05 Site Management
9576	85	1616043231267:-1992157142	1616043228822:888472171	D5170C00002	592	590	CREATE	2021-03-18 05:53:51.355	05.01 Site Selection	05.01.03 Feasibility Documentation
9579	85	1616043233153:-513638476	1616043232497:1907510203	D5170C00002	595	594	CREATE	2021-03-18 05:53:53.245	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
9583	85	1616043239591:-150630854	1616043232497:1907510203	D5170C00002	599	594	CREATE	2021-03-18 05:53:59.685	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
9586	85	1616043242644:1599424550	1616043232497:1907510203	D5170C00002	602	594	CREATE	2021-03-18 05:54:02.733	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
9589	85	1616043244411:-238751339	1616043232497:1907510203	D5170C00002	605	594	CREATE	2021-03-18 05:54:04.503	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
9593	85	1616043246856:-633132607	1616043245603:-1652271044	D5170C00002	609	607	CREATE	2021-03-18 05:54:06.942	05.03 Site Initiation	05.03.03 Site Training-Staff
9596	85	1616043249241:-304403486	1616043248649:443071669	D5170C00002	612	611	CREATE	2021-03-18 05:54:09.332	05.04 Site Management	05.04.01 Subject Log
9599	85	1616043251189:933789957	1616043248649:443071669	D5170C00002	615	611	CREATE	2021-03-18 05:54:11.286	05.04 Site Management	05.04.08 UNBLI_onitoring Report
9602	85	1616043253650:-1245603507	1616043252428:-448982914	D5170C00002	618	616	CREATE	2021-03-18 05:54:13.74	05.05 General	05.05.02 Tracking Information
9605	85	1616043255463:953442567	1616043254881:1968873285	D5170C00002	621	620	CREATE	2021-03-18 05:54:15.578	06.01 IP Documentation	06.01.11 Certi_e of Destruction
9608	85	1616043257168:-1481466395	1616043254214:536334997	D5170C00002	624	619	CREATE	2021-03-18 05:54:17.256	06 IP and Trial Supplies	06.05 Non-IP Documentation
9611	85	1616043258877:1098105416	1616043258303:-65878055	D5170C00002	627	626	CREATE	2021-03-18 05:54:18.965	06.07 General	06.07.01 Relev_roduct-Documents
9614	85	1616043260573:403689729	1616043259989:1038700100	D5170C00002	630	629	CREATE	2021-03-18 05:54:20.683	08.02 Sample Documentation	08.02.03 Sampl_ge Condition Log
9618	85	1616043263436:1213687397	1616043262348:1699985694	D5170C00002	634	633	CREATE	2021-03-18 05:54:23.524	01.05 General	01.05.01 Relev_tions-CEVA-Email
9620	85	1616043264591:-597982446	1616043263981:1455745266	D5170C00002	636	635	CREATE	2021-03-18 05:54:24.679	02 Central Trial Documents	02.02 Subject Documents
9621	85	1616043265156:-403450087	1616043264591:-597982446	D5170C00002	637	636	CREATE	2021-03-18 05:54:25.247	02.02 Subject Documents	02.02.03 Infor_t Form Templates
9625	85	1616043267467:677223513	1616043261240:2061080188	D5170C00002	641	631	CREATE	2021-03-18 05:54:27.55	2002364 Im, JongPil	04 IRB-IEC and other Approvals
9628	85	1616043269149:-1265158143	1616043268019:156840162	D5170C00002	644	642	CREATE	2021-03-18 05:54:29.24	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
9631	85	1616043270945:-1775132420	1616043270337:324168768	D5170C00002	647	646	CREATE	2021-03-18 05:54:31.038	04.03 Trial Status Reporting	04.03.01 IRB-I_y Info-Deviation
9634	85	1616043272617:-460999947	1616043261240:2061080188	D5170C00002	650	631	CREATE	2021-03-18 05:54:32.707	2002364 Im, JongPil	05 Site Management
9637	85	1616043275129:839274253	1616043273950:1608903389	D5170C00002	653	651	CREATE	2021-03-18 05:54:35.22	05.01 Site Selection	05.01.03 Feasibility Documentation
9640	85	1616043276854:1880981815	1616043276246:-1976239086	D5170C00002	656	655	CREATE	2021-03-18 05:54:36.944	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
9644	85	1616043279268:567784287	1616043276246:-1976239086	D5170C00002	660	655	CREATE	2021-03-18 05:54:39.356	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
9647	85	1616043281136:14307340	1616043276246:-1976239086	D5170C00002	663	655	CREATE	2021-03-18 05:54:41.227	05.02 Site Set-up Documentation	05.02.11 Data Privacy
9650	85	1616043283106:1205498431	1616043276246:-1976239086	D5170C00002	666	655	CREATE	2021-03-18 05:54:43.202	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
9654	85	1616043286149:-995257431	1616043283756:460635522	D5170C00002	670	667	CREATE	2021-03-18 05:54:46.238	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
9657	85	1616043287847:-1827067253	1616043286729:-512723481	D5170C00002	673	671	CREATE	2021-03-18 05:54:47.94	05.04 Site Management	05.04.02 Source Data Verification
9660	85	1616043289532:1214068954	1616043272617:-460999947	D5170C00002	676	650	CREATE	2021-03-18 05:54:49.622	05 Site Management	05.05 General
9663	85	1616043291293:-39392935	1616043289532:1214068954	D5170C00002	679	676	CREATE	2021-03-18 05:54:51.384	05.05 General	05.05.02 Tracking Information
9666	85	1616043292983:1819529227	1616043292438:-382075652	D5170C00002	682	681	CREATE	2021-03-18 05:54:53.186	06.01 IP Documentation	06.01.02 UNBLINDED IP Instructions for Handling
9669	85	1616043295730:1998073191	1616043291887:-269429844	D5170C00002	685	680	CREATE	2021-03-18 05:54:55.817	06 IP and Trial Supplies	06.05 Non-IP Documentation
9672	85	1616043297486:-1665741203	1616043261240:2061080188	D5170C00002	688	631	CREATE	2021-03-18 05:54:57.574	2002364 Im, JongPil	08 Centralized Testing
9675	85	1616043299214:1188794166	1616043297486:-1665741203	D5170C00002	691	688	CREATE	2021-03-18 05:54:59.308	08 Centralized Testing	08.02 Sample Documentation
9678	85	1616043301155:1537126143	1616043300592:2030041035	D5170C00002	694	693	CREATE	2021-03-18 05:55:01.266	2002365 Huh, Kyu Chan	02 Central Trial Documents
9681	85	1616043302917:-55079603	1616043301758:-50785164	D5170C00002	697	695	CREATE	2021-03-18 05:55:03.006	02.02 Subject Documents	02.02.03 Infor_t Form Templates
9685	85	1616043305211:2010321552	1616043300592:2030041035	D5170C00002	701	693	CREATE	2021-03-18 05:55:05.303	2002365 Huh, Kyu Chan	04 IRB-IEC and other Approvals
9686	85	1616043306716:271309321	1616043305211:2010321552	D5170C00002	702	701	CREATE	2021-03-18 05:55:06.962	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
9689	85	1616043308762:-407016466	1616043306716:271309321	D5170C00002	705	702	CREATE	2021-03-18 05:55:08.851	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
9693	85	1616043311153:1606724768	1616043310565:-379693333	D5170C00002	709	708	CREATE	2021-03-18 05:55:11.239	05 Site Management	05.01 Site Selection
9695	85	1616043312855:-850011039	1616043311153:1606724768	D5170C00002	711	709	CREATE	2021-03-18 05:55:12.94	05.01 Site Selection	05.01.03 Feasibility Documentation
9698	85	1616043314547:-1821968828	1616043313962:1064758164	D5170C00002	714	713	CREATE	2021-03-18 05:55:14.638	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
9702	85	1616043317710:1134761152	1616043313962:1064758164	D5170C00002	718	713	CREATE	2021-03-18 05:55:17.803	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
9705	85	1616043319466:1730473404	1616043313962:1064758164	D5170C00002	721	713	CREATE	2021-03-18 05:55:19.555	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
9709	85	1616043321774:1831468478	1616043321169:-793313306	D5170C00002	725	724	CREATE	2021-03-18 05:55:21.862	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
9712	85	1616043323531:-1766672309	1616043310565:-379693333	D5170C00002	728	708	CREATE	2021-03-18 05:55:23.633	05 Site Management	05.04 Site Management
9715	85	1616043325265:-2118457457	1616043323531:-1766672309	D5170C00002	731	728	CREATE	2021-03-18 05:55:25.351	05.04 Site Management	05.04.04 Visit Log
9718	85	1616043327072:196785548	1616043326478:-1406861204	D5170C00002	734	733	CREATE	2021-03-18 05:55:27.159	05.05 General	05.05.01 Rel_cations-Email
9721	85	1616043329763:1038078696	1616043300592:2030041035	D5170C00002	737	693	CREATE	2021-03-18 05:55:29.853	2002365 Huh, Kyu Chan	06 IP and Trial Supplies
9724	85	1616043331556:91749343	1616043300592:2030041035	D5170C00002	740	693	CREATE	2021-03-18 05:55:31.665	2002365 Huh, Kyu Chan	08 Centralized Testing
9726	85	1616043332722:-1088623294	1616043332153:814293213	D5170C00002	742	741	CREATE	2021-03-18 05:55:32.808	08.01 Facility Documentation	08.01.01 Certi_or Accreditation
9730	85	1616043335117:-532055847	1616043334514:703678621	D5170C00002	746	745	CREATE	2021-03-18 05:55:35.208	2002366 Jeen, Yoon-Tae	02 Central Trial Documents
9733	85	1616043336857:56382512	1616043334514:703678621	D5170C00002	749	745	CREATE	2021-03-18 05:55:36.952	2002366 Jeen, Yoon-Tae	04 IRB-IEC and other Approvals
9737	85	1616043340168:1605366631	1616043339549:-657512095	D5170C00002	753	752	CREATE	2021-03-18 05:55:40.257	05 Site Management	05.01 Site Selection
9739	85	1616043341513:-1830055408	1616043340168:1605366631	D5170C00002	755	753	CREATE	2021-03-18 05:55:41.605	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
9742	85	1616043343285:676801382	1616043342124:-1529751402	D5170C00002	758	756	CREATE	2021-03-18 05:55:43.371	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
9746	85	1616043345594:-1744758221	1616043345023:545793053	D5170C00002	762	761	CREATE	2021-03-18 05:55:45.68	2002367 Song, Geun Am	02 Central Trial Documents
9749	85	1616043347322:128436483	1616043345594:-1744758221	D5170C00002	765	762	CREATE	2021-03-18 05:55:47.408	02 Central Trial Documents	02.04 General
9750	85	1616043347922:-1092066996	1616043347322:128436483	D5170C00002	766	765	CREATE	2021-03-18 05:55:48.008	02.04 General	02.04.01 Relev_s-Contact Report
9752	85	1616043349098:1771655495	1616043345023:545793053	D5170C00002	768	761	CREATE	2021-03-18 05:55:49.963	2002367 Song, Geun Am	04 IRB-IEC and other Approvals
9755	85	1616043351685:-1120366581	1616043350490:-1989311962	D5170C00002	771	769	CREATE	2021-03-18 05:55:51.778	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
9758	85	1616043353485:-760406478	1616043352901:-1937194479	D5170C00002	774	773	CREATE	2021-03-18 05:55:53.575	04.03 Trial Status Reporting	04.03.01 IRB-I_y Info-Deviation
9761	85	1616043355130:-618369999	1616043345023:545793053	D5170C00002	777	761	CREATE	2021-03-18 05:55:55.216	2002367 Song, Geun Am	05 Site Management
9764	85	1616043356898:-1829136654	1616043355766:-608489152	D5170C00002	780	778	CREATE	2021-03-18 05:55:56.986	05.01 Site Selection	05.01.03 Feasibility Documentation
9767	85	1616043358668:1074138697	1616043358063:-1294481514	D5170C00002	783	782	CREATE	2021-03-18 05:55:58.757	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
9771	85	1616043361924:1437178146	1616043358063:-1294481514	D5170C00002	787	782	CREATE	2021-03-18 05:56:02.011	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
9774	85	1616043363781:-227321431	1616043358063:-1294481514	D5170C00002	790	782	CREATE	2021-03-18 05:56:03.868	05.02 Site Set-up Documentation	05.02.11 Data Privacy
9777	85	1616043365584:-403122279	1616043358063:-1294481514	D5170C00002	793	782	CREATE	2021-03-18 05:56:05.676	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
9781	85	1616043368299:1680009352	1616043355130:-618369999	D5170C00002	797	777	CREATE	2021-03-18 05:56:08.394	05 Site Management	05.04 Site Management
9784	85	1616043370082:-909029665	1616043368299:1680009352	D5170C00002	800	797	CREATE	2021-03-18 05:56:10.173	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
9787	85	1616043373117:-268877087	1616043372521:672870954	D5170C00002	803	802	CREATE	2021-03-18 05:56:13.204	05.05 General	05.05.01 Rel_cations-Email
9790	85	1616043374962:-282784747	1616043345023:545793053	D5170C00002	806	761	CREATE	2021-03-18 05:56:15.06	2002367 Song, Geun Am	06 IP and Trial Supplies
9793	85	1616043376906:-26700856	1616043374962:-282784747	D5170C00002	809	806	CREATE	2021-03-18 05:56:16.996	06 IP and Trial Supplies	06.04 Storage
9796	85	1616043379802:1109085332	1616043379143:-1268316712	D5170C00002	812	811	CREATE	2021-03-18 05:56:19.9	06.05 Non-IP Documentation	06.05.02 Non-IP Documentation of Shipment
9799	85	1616043381762:-32497933	1616043381078:-118070252	D5170C00002	815	814	CREATE	2021-03-18 05:56:21.855	08 Centralized Testing	08.01 Facility Documentation
9802	85	1616043384962:-1256695384	1616043384230:514563897	D5170C00002	818	817	CREATE	2021-03-18 05:56:25.053	08.02 Sample Documentation	08.02.03 Sampl_ge Condition Log
9806	85	1616043387512:-1915588046	1616043032792:2030519844	D5170C00002	822	317	CREATE	2021-03-18 05:56:27.609	Site	2002368 Lee, Kang-Moon
9808	85	1616043388768:1598094545	1616043388161:-231994293	D5170C00002	824	823	CREATE	2021-03-18 05:56:28.854	02 Central Trial Documents	02.02 Subject Documents
9812	85	1616043391302:845606010	1616043390059:-1470738344	D5170C00002	828	826	CREATE	2021-03-18 05:56:31.394	02.04 General	02.04.01 Relev_s-Contact Report
9814	85	1616043392562:1917480529	1616043387512:-1915588046	D5170C00002	830	822	CREATE	2021-03-18 05:56:32.653	2002368 Lee, Kang-Moon	04 IRB-IEC and other Approvals
9815	85	1616043393192:1078251389	1616043392562:1917480529	D5170C00002	831	830	CREATE	2021-03-18 05:56:34.221	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
9816	85	1616043394824:498417256	1616043393192:1078251389	D5170C00002	832	831	CREATE	2021-03-18 05:56:34.914	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
9819	85	1616043396679:22518333	1616043392562:1917480529	D5170C00002	835	830	CREATE	2021-03-18 05:56:36.766	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
9823	85	1616043399191:-1934593837	1616043398630:750389389	D5170C00002	839	838	CREATE	2021-03-18 05:56:39.28	05 Site Management	05.01 Site Selection
9826	85	1616043401000:325162783	1616043399191:-1934593837	D5170C00002	842	839	CREATE	2021-03-18 05:56:41.092	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
10932	85	1616044227877:-2059842016	1616044227289:284289123	D5170C00002	1948	1947	CREATE	2021-03-18 06:10:27.961	05.04 Site Management	05.04.04 Visit Log
9828	85	1616043402144:-1091450679	1616043401575:307420985	D5170C00002	844	843	CREATE	2021-03-18 05:56:42.236	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
9832	85	1616043405713:2006016269	1616043401575:307420985	D5170C00002	848	843	CREATE	2021-03-18 05:56:45.801	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
9836	85	1616043408065:-350487718	1616043401575:307420985	D5170C00002	852	843	CREATE	2021-03-18 05:56:48.152	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
9839	85	1616043409960:-39675224	1616043398630:750389389	D5170C00002	855	838	CREATE	2021-03-18 05:56:50.05	05 Site Management	05.03 Site Initiation
9842	85	1616043411964:-1049774401	1616043409960:-39675224	D5170C00002	858	855	CREATE	2021-03-18 05:56:52.051	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
9846	85	1616043414353:488408202	1616043412541:-1157049376	D5170C00002	862	859	CREATE	2021-03-18 05:56:54.442	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
9849	85	1616043417289:1368070532	1616043416545:-797248880	D5170C00002	865	864	CREATE	2021-03-18 05:56:57.377	05.05 General	05.05.01 Rel_cations-Email
9852	85	1616043419194:-239559611	1616043418573:1085964032	D5170C00002	868	867	CREATE	2021-03-18 05:57:02.899	06 IP and Trial Supplies	06.04 Storage
9855	85	1616043424821:-1785648185	1616043424209:1673162052	D5170C00002	871	870	CREATE	2021-03-18 05:57:04.909	2002369 Lee, Bo In	02 Central Trial Documents
9858	85	1616043427420:419937778	1616043425553:933271639	D5170C00002	874	872	CREATE	2021-03-18 05:57:07.511	02.02 Subject Documents	02.02.03 Infor_t Form Templates
9861	85	1616043429384:320250538	1616043428097:-2135561250	D5170C00002	877	875	CREATE	2021-03-18 05:57:09.48	02.04 General	02.04.01 UNBLI_s-Contact Report
9864	85	1616043431297:929291881	1616043430702:2085232792	D5170C00002	880	879	CREATE	2021-03-18 05:57:11.388	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
9867	85	1616043433165:576324421	1616043430073:507809959	D5170C00002	883	878	CREATE	2021-03-18 05:57:13.255	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
9870	85	1616043434789:-1102432754	1616043430073:507809959	D5170C00002	886	878	CREATE	2021-03-18 05:57:14.875	04 IRB-IEC and other Approvals	04.04 General
9873	85	1616043436552:-87006701	1616043435988:-1882183708	D5170C00002	889	888	CREATE	2021-03-18 05:57:16.641	05 Site Management	05.01 Site Selection
9876	85	1616043438861:125822699	1616043436552:-87006701	D5170C00002	892	889	CREATE	2021-03-18 05:57:18.948	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
9879	85	1616043440648:-709885873	1616043439429:-769848190	D5170C00002	895	893	CREATE	2021-03-18 05:57:20.743	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
9880	85	1616043441259:-820208610	1616043439429:-769848190	D5170C00002	896	893	CREATE	2021-03-18 05:57:21.345	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
9883	85	1616043443126:-1285483438	1616043439429:-769848190	D5170C00002	899	893	CREATE	2021-03-18 05:57:23.217	05.02 Site Set-up Documentation	05.02.09 Investigator Regulatory Agreement
9887	85	1616043445573:1734847552	1616043439429:-769848190	D5170C00002	903	893	CREATE	2021-03-18 05:57:25.678	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
9890	85	1616043452377:627796509	1616043451758:-1120105881	D5170C00002	906	905	CREATE	2021-03-18 05:57:32.478	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
9894	85	1616043455395:1810494761	1616043454223:834552909	D5170C00002	910	909	CREATE	2021-03-18 05:57:35.497	05.04 Site Management	05.04.02 Source Data Verification
9896	85	1616043456512:18953473	1616043454223:834552909	D5170C00002	912	909	CREATE	2021-03-18 05:57:36.601	05.04 Site Management	05.04.05 UNBLINDED Additional Monitoring Activity
9900	85	1616043459741:-1496819459	1616043457728:-1874518055	D5170C00002	916	914	CREATE	2021-03-18 05:57:39.833	05.05 General	05.05.01 Relevant Communications-Documents
9904	85	1616043462166:-1519822736	1616043461566:1535808464	D5170C00002	920	919	CREATE	2021-03-18 05:57:42.254	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
9907	85	1616043464098:987759161	1616043460963:-464507160	D5170C00002	923	918	CREATE	2021-03-18 05:57:44.187	06 IP and Trial Supplies	06.05 Non-IP Documentation
9910	85	1616043465983:-1370879171	1616043465302:-158907171	D5170C00002	926	925	CREATE	2021-03-18 05:57:46.078	08 Centralized Testing	08.02 Sample Documentation
9913	85	1616043467753:1424116701	1616043467162:2024493087	D5170C00002	929	928	CREATE	2021-03-18 05:57:47.839	NETHERLANDS	Site
9915	85	1616043468972:1956668992	1616043468320:2059636529	D5170C00002	931	930	CREATE	2021-03-18 05:57:49.059	2001763 van _oude, Janneke	02 Central Trial Documents
9919	85	1616043472098:-1819344481	1616043471510:-293894555	D5170C00002	935	934	CREATE	2021-03-18 05:57:52.187	02.04 General	02.04.01 Relev_s-Contact Report
9921	85	1616043473348:-1864837670	1616043468320:2059636529	D5170C00002	937	930	CREATE	2021-03-18 05:57:53.438	2001763 van _oude, Janneke	04 IRB-IEC and other Approvals
9925	85	1616043475738:1742136313	1616043475104:-1211899473	D5170C00002	941	940	CREATE	2021-03-18 05:57:55.83	05 Site Management	05.01 Site Selection
9927	85	1616043476971:-769604548	1616043475738:1742136313	D5170C00002	943	941	CREATE	2021-03-18 05:57:57.06	05.01 Site Selection	05.01.02 Confidentiality Agreement
9930	85	1616043484354:989440534	1616043483742:-1418815226	D5170C00002	946	945	CREATE	2021-03-18 05:58:04.447	05.02 Site Set-up Documentation	05.02.01 Accep_tigator Brochure
9934	85	1616043486787:981192591	1616043483742:-1418815226	D5170C00002	950	945	CREATE	2021-03-18 05:58:06.874	05.02 Site Set-up Documentation	05.02.07 Site Qualification
9937	85	1616043488536:-924905969	1616043483742:-1418815226	D5170C00002	953	945	CREATE	2021-03-18 05:58:08.731	05.02 Site Set-up Documentation	05.02.09 Investigator Regulatory Agreement
9940	85	1616043490577:970854758	1616043483742:-1418815226	D5170C00002	956	945	CREATE	2021-03-18 05:58:10.665	05.02 Site Set-up Documentation	05.02.17 IP Si_se Documentation
9943	85	1616043493518:1039487584	1616043492879:568141030	D5170C00002	959	958	CREATE	2021-03-18 05:58:13.611	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
9945	85	1616043494826:-1421732794	1616043492879:568141030	D5170C00002	961	958	CREATE	2021-03-18 05:58:14.937	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
9948	85	1616043496724:2005764282	1616043495451:-1631281982	D5170C00002	964	962	CREATE	2021-03-18 05:58:16.813	05.04 Site Management	05.04.03 UNBLINDED Monitoring Visit Report
9952	85	1616043499143:-683892467	1616043495451:-1631281982	D5170C00002	968	962	CREATE	2021-03-18 05:58:19.236	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
9955	85	1616043501024:1373735877	1616043500401:-45406868	D5170C00002	971	970	CREATE	2021-03-18 05:58:21.112	05.05 General	05.05.01 Re_ications-Email
9958	85	1616043503819:1066045526	1616043503128:1598538866	D5170C00002	974	973	CREATE	2021-03-18 05:58:23.909	06 IP and Trial Supplies	06.01 IP Documentation
9961	85	1616043505601:-120493267	1616043503819:1066045526	D5170C00002	977	974	CREATE	2021-03-18 05:58:25.689	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
9964	85	1616043507399:1338189098	1616043506819:-57298212	D5170C00002	980	979	CREATE	2021-03-18 05:58:27.491	06.04 Storage	06.04.01 UNBLI_on Documentation
9970	85	1616043510953:1763391278	1616043468320:2059636529	D5170C00002	986	930	CREATE	2021-03-18 05:58:31.043	2001763 van _oude, Janneke	08 Centralized Testing
9973	85	1616043512724:-506457807	1616043511523:11790088	D5170C00002	989	987	CREATE	2021-03-18 05:58:32.824	08.01 Facility Documentation	08.01.04 Norma_and Alert Values
9976	85	1616043515464:553764480	1616043514844:-255850501	D5170C00002	992	991	CREATE	2021-03-18 05:58:35.553	02 Central Trial Documents	02.02 Subject Documents
9979	85	1616043517155:245931013	1616043516594:-1641387733	D5170C00002	995	994	CREATE	2021-03-18 05:58:37.241	03 Regulatory	03.04 General
9981	85	1616043518391:308156014	1616043514232:1821964700	D5170C00002	997	990	CREATE	2021-03-18 05:58:38.479	2001764 Kubben, Francois	04 IRB-IEC and other Approvals
9985	85	1616043520752:-1941047640	1616043514232:1821964700	D5170C00002	1001	990	CREATE	2021-03-18 05:58:40.84	2001764 Kubben, Francois	05 Site Management
9988	85	1616043522587:1154636351	1616043521342:-588261507	D5170C00002	1004	1002	CREATE	2021-03-18 05:58:42.673	05.01 Site Selection	05.01.02 Confidentiality Agreement
9991	85	1616043525396:121637577	1616043520752:-1941047640	D5170C00002	1007	1001	CREATE	2021-03-18 05:58:45.487	05 Site Management	05.02 Site Set-up Documentation
9994	85	1616043527906:566359032	1616043525396:121637577	D5170C00002	1010	1007	CREATE	2021-03-18 05:58:47.993	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
9997	85	1616043529762:-1254244185	1616043525396:121637577	D5170C00002	1013	1007	CREATE	2021-03-18 05:58:49.852	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
10001	85	1616043532407:1278522871	1616043525396:121637577	D5170C00002	1017	1007	CREATE	2021-03-18 05:58:52.493	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
10004	85	1616043534217:348914301	1616043533008:-369484390	D5170C00002	1020	1018	CREATE	2021-03-18 05:58:54.302	05.03 Site Initiation	05.03.03 Site Training-Staff
10007	85	1616043536910:1670156768	1616043534822:-1483654624	D5170C00002	1023	1021	CREATE	2021-03-18 05:58:56.998	05.04 Site Management	05.04.04 Visit Log
10008	85	1616043537866:-171757155	1616043534822:-1483654624	D5170C00002	1024	1021	CREATE	2021-03-18 05:58:57.963	05.04 Site Management	05.04.05 UNBLI_itoring Activity
10009	85	1616043538580:-1077909279	1616043534822:-1483654624	D5170C00002	1025	1021	CREATE	2021-03-18 05:58:58.67	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
10010	85	1616043539185:-23839102	1616043534822:-1483654624	D5170C00002	1026	1021	CREATE	2021-03-18 05:58:59.271	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
10014	85	1616043541508:-342658707	1616043540343:-1123854128	D5170C00002	1030	1028	CREATE	2021-03-18 05:59:01.607	05.05 General	05.05.01 Relev_unications-Email
10017	85	1616043543301:732779521	1616043542733:-1890320595	D5170C00002	1033	1032	CREATE	2021-03-18 05:59:03.387	06 IP and Trial Supplies	06.01 IP Documentation
10020	85	1616043545107:-2055787743	1616043544490:943018751	D5170C00002	1036	1035	CREATE	2021-03-18 05:59:05.196	06.07 General	06.07.01 Relev_roduct-Documents
10023	85	1616043548012:-1329219092	1616043547349:-217813539	D5170C00002	1039	1038	CREATE	2021-03-18 05:59:08.102	08 Centralized Testing	08.01 Facility Documentation
10026	85	1616043549843:-816066871	1616043548012:-1329219092	D5170C00002	1042	1039	CREATE	2021-03-18 05:59:09.93	08.01 Facility Documentation	08.01.07 Head of Facility CV
10029	85	1616043551679:-1563348389	1616043551063:738841195	D5170C00002	1045	1044	CREATE	2021-03-18 05:59:11.769	02 Central Trial Documents	02.02 Subject Documents
10033	85	1616043554206:-62180034	1616043552898:-2013323651	D5170C00002	1049	1047	CREATE	2021-03-18 05:59:14.294	02.04 General	02.04.01 UNBLI_s-Contact Report
10035	85	1616043555742:-1265712740	1616043550459:1372147956	D5170C00002	1051	1043	CREATE	2021-03-18 05:59:15.836	2001765 Pierik, Marieke	04 IRB-IEC and other Approvals
10039	85	1616043559242:1221306440	1616043558637:-733789126	D5170C00002	1055	1054	CREATE	2021-03-18 05:59:19.335	04.02 Other Committees	04.02.02 Other Approvals
10042	85	1616043561252:-1302784757	1616043560570:597624834	D5170C00002	1058	1057	CREATE	2021-03-18 05:59:21.432	05.01 Site Selection	05.01.01 Site Contact Details
10045	85	1616043563221:1616853828	1616043559912:639229062	D5170C00002	1061	1056	CREATE	2021-03-18 05:59:23.327	05 Site Management	05.02 Site Set-up Documentation
10048	85	1616043565269:-1260128145	1616043563221:1616853828	D5170C00002	1064	1061	CREATE	2021-03-18 05:59:25.362	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
10051	85	1616043567330:-1404621693	1616043563221:1616853828	D5170C00002	1067	1061	CREATE	2021-03-18 05:59:27.416	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
10054	85	1616043570407:-882115886	1616043563221:1616853828	D5170C00002	1070	1061	CREATE	2021-03-18 05:59:30.497	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
10058	85	1616043573128:-288891936	1616043572436:-1943245689	D5170C00002	1074	1073	CREATE	2021-03-18 05:59:33.218	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
10062	85	1616043575748:1864021079	1616043575092:-1099651965	D5170C00002	1078	1077	CREATE	2021-03-18 05:59:35.838	05.04 Site Management	05.04.01 Subject Log
10065	85	1616043578005:671803025	1616043575092:-1099651965	D5170C00002	1081	1077	CREATE	2021-03-18 05:59:38.106	05.04 Site Management	05.04.04 Visit Log
10067	85	1616043580396:851860861	1616043575092:-1099651965	D5170C00002	1083	1077	CREATE	2021-03-18 05:59:40.506	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
10071	85	1616043583152:109387116	1616043582509:-739830251	D5170C00002	1087	1086	CREATE	2021-03-18 05:59:43.239	05.05 General	05.05.01 Relev_unications-Email
10074	85	1616043585201:-191295877	1616043584535:-2097377763	D5170C00002	1090	1089	CREATE	2021-03-18 05:59:45.324	06 IP and Trial Supplies	06.01 IP Documentation
10075	85	1616043586256:1952783010	1616043585201:-191295877	D5170C00002	1091	1090	CREATE	2021-03-18 05:59:46.344	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
10078	85	1616043588292:-1384401889	1616043585201:-191295877	D5170C00002	1094	1090	CREATE	2021-03-18 05:59:48.383	06.01 IP Documentation	06.01.11 UNBLI_e of Destruction
10081	85	1616043591340:-622977407	1616043588965:-723708461	D5170C00002	1097	1095	CREATE	2021-03-18 05:59:51.445	06.04 Storage	06.04.02 UNBLINDED Storage Condition Excursion Documentation
10085	85	1616043594121:-1296617415	1616043467753:1424116701	D5170C00002	1101	929	CREATE	2021-03-18 05:59:54.209	Site	2001766 Dijkstra, Gerard
10087	85	1616043595486:470346733	1616043594800:-1483379208	D5170C00002	1103	1102	CREATE	2021-03-18 05:59:55.573	02 Central Trial Documents	02.02 Subject Documents
10091	85	1616043606830:-1583599524	1616043606235:473674094	D5170C00002	1107	1106	CREATE	2021-03-18 06:00:06.916	02.04 General	02.04.01 Relev_s-Contact Report
10094	85	1616043609273:2089666975	1616043608098:-956033575	D5170C00002	1110	1109	CREATE	2021-03-18 06:00:09.36	04.02 Other Committees	04.02.02 Other Approvals
10097	85	1616043611160:663775118	1616043610593:1189547592	D5170C00002	1113	1112	CREATE	2021-03-18 06:00:11.258	05.01 Site Selection	05.01.01 Site Contact Details
10100	85	1616043612983:-643354431	1616043610593:1189547592	D5170C00002	1116	1112	CREATE	2021-03-18 06:00:13.081	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
10103	85	1616043614663:-199904352	1616043613528:1758624836	D5170C00002	1119	1117	CREATE	2021-03-18 06:00:14.751	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
10107	85	1616043617790:1654997570	1616043613528:1758624836	D5170C00002	1123	1117	CREATE	2021-03-18 06:00:17.88	05.02 Site Set-up Documentation	05.02.07 Site Qualification
10110	85	1616043620567:-251069163	1616043613528:1758624836	D5170C00002	1126	1117	CREATE	2021-03-18 06:00:20.672	05.02 Site Set-up Documentation	05.02.09 Investigator Regulatory Agreement
10114	85	1616043623025:455273029	1616043613528:1758624836	D5170C00002	1130	1117	CREATE	2021-03-18 06:00:23.121	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
10117	85	1616043624834:1137189833	1616043623613:1267502869	D5170C00002	1133	1131	CREATE	2021-03-18 06:00:24.93	05.03 Site Initiation	05.03.03 Site Training-Staff
10121	85	1616043628011:154694651	1616043626060:-928695007	D5170C00002	1137	1135	CREATE	2021-03-18 06:00:28.109	05.04 Site Management	05.04.04 Visit Log
10123	85	1616043629292:249401632	1616043626060:-928695007	D5170C00002	1139	1135	CREATE	2021-03-18 06:00:29.392	05.04 Site Management	05.04.05 UNBLI_itoring Activity
10127	85	1616043631900:450192103	1616043630598:-568883902	D5170C00002	1143	1141	CREATE	2021-03-18 06:00:32	05.05 General	05.05.01 Relevant Communications-Documents
10130	85	1616043633692:-135474222	1616043633091:1510741831	D5170C00002	1146	1145	CREATE	2021-03-18 06:00:33.789	06 IP and Trial Supplies	06.04 Storage
10133	85	1616043635393:1281555922	1616043634859:2069352813	D5170C00002	1149	1148	CREATE	2021-03-18 06:00:35.482	10 Data Management	10.04 EDC Management
10136	85	1616043637081:1888909623	1616043636475:45205761	D5170C00002	1152	1151	CREATE	2021-03-18 06:00:37.171	POLAND	Site
10138	85	1616043638938:-533179479	1616043638391:-1922604572	D5170C00002	1154	1153	CREATE	2021-03-18 06:00:39.048	2002173 Hartleb, Marek	02 Central Trial Documents
10139	85	1616043639522:-914848551	1616043638938:-533179479	D5170C00002	1155	1154	CREATE	2021-03-18 06:00:39.625	02 Central Trial Documents	02.04 General
10140	85	1616043640100:-1413020604	1616043639522:-914848551	D5170C00002	1156	1155	CREATE	2021-03-18 06:00:40.206	02.04 General	02.04.01 Relev_ations-Documents
10143	85	1616043642029:1731761045	1616043638391:-1922604572	D5170C00002	1159	1153	CREATE	2021-03-18 06:00:42.121	2002173 Hartleb, Marek	05 Site Management
10146	85	1616043643726:-413831586	1616043642595:1616725266	D5170C00002	1162	1160	CREATE	2021-03-18 06:00:43.819	05.01 Site Selection	05.01.03 Feasibility Documentation
10149	85	1616043645530:-933309196	1616043644961:-433002072	D5170C00002	1165	1164	CREATE	2021-03-18 06:00:45.625	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
10152	85	1616043647427:-646874344	1616043644961:-433002072	D5170C00002	1168	1164	CREATE	2021-03-18 06:00:47.515	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
10156	85	1616043650694:-1298197085	1616043644961:-433002072	D5170C00002	1172	1164	CREATE	2021-03-18 06:00:50.779	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
10159	85	1616043652361:1884450169	1616043644961:-433002072	D5170C00002	1175	1164	CREATE	2021-03-18 06:00:52.447	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
10162	85	1616043654137:-1058706433	1616043652936:-783344635	D5170C00002	1178	1176	CREATE	2021-03-18 06:00:54.23	05.03 Site Initiation	05.03.03 Site Training-Staff
10166	85	1616043656376:-715015656	1616043655239:-78281207	D5170C00002	1182	1180	CREATE	2021-03-18 06:00:56.465	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
10169	85	1616043658096:-460622612	1616043656981:-1396903142	D5170C00002	1185	1183	CREATE	2021-03-18 06:00:58.184	05.05 General	05.05.02 Tracking Information
10172	85	1616043660659:-97965056	1616043660093:1336689441	D5170C00002	1188	1187	CREATE	2021-03-18 06:01:00.749	06.01 IP Documentation	06.01.02 IP Instructions for Handling
10176	85	1616043678185:-329663217	1616043677618:-929655048	D5170C00002	1192	1191	CREATE	2021-03-18 06:01:18.275	02.04 General	02.04.01 Relev_ations-Documents
10179	85	1616043680146:-1692352071	1616043661230:555179677	D5170C00002	1195	1189	CREATE	2021-03-18 06:01:20.237	2002174 Woznia_olarska, Barbara	03 Regulatory
10181	85	1616043682216:1240067668	1616043681593:-812757175	D5170C00002	1197	1196	CREATE	2021-03-18 06:01:22.313	03.04 General	03.04.01 Relev_art-Up-Documents
10184	85	1616043684025:156508284	1616043683437:1407330710	D5170C00002	1200	1199	CREATE	2021-03-18 06:01:24.115	05.01 Site Selection	05.01.02 Confidentiality Agreement
10188	85	1616043686470:1625988664	1616043685889:751341191	D5170C00002	1204	1203	CREATE	2021-03-18 06:01:26.564	05.02 Site Set-up Documentation	05.02.01 Accep_tigator Brochure
10191	85	1616043688376:-1136616291	1616043685889:751341191	D5170C00002	1207	1203	CREATE	2021-03-18 06:01:28.472	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
10194	85	1616043690659:1337747788	1616043685889:751341191	D5170C00002	1210	1203	CREATE	2021-03-18 06:01:30.773	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
10198	85	1616043694088:-1435603239	1616043685889:751341191	D5170C00002	1214	1203	CREATE	2021-03-18 06:01:34.253	05.02 Site Set-up Documentation	05.02.17 IP Si_se Documentation
10201	85	1616043696015:-828251803	1616043695416:260261660	D5170C00002	1217	1216	CREATE	2021-03-18 06:01:36.143	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
10202	85	1616043696644:-309761898	1616043695416:260261660	D5170C00002	1218	1216	CREATE	2021-03-18 06:01:36.736	05.03 Site Initiation	05.03.03 Site Training-Staff
10203	85	1616043697225:-362303108	1616043695416:260261660	D5170C00002	1219	1216	CREATE	2021-03-18 06:01:37.323	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
10206	85	1616043699154:-531507417	1616043697921:-713076125	D5170C00002	1222	1220	CREATE	2021-03-18 06:01:39.257	05.04 Site Management	05.04.08 Final_onitoring Report
10209	85	1616043701205:-1267983912	1616043699761:1014501376	D5170C00002	1225	1223	CREATE	2021-03-18 06:01:41.294	05.05 General	05.05.02 Tracking Information
10212	85	1616043703886:1301230395	1616043702401:-1951205186	D5170C00002	1228	1227	CREATE	2021-03-18 06:01:43.992	06.07 General	06.07.01 Relev_roduct-Documents
10216	85	1616043706328:-1718289814	1616043705687:535278543	D5170C00002	1232	1231	CREATE	2021-03-18 06:01:46.425	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
10219	85	1616043708256:827276628	1616043707500:1826778313	D5170C00002	1235	1234	CREATE	2021-03-18 06:01:48.348	Site	103 Simanenkov, Vladimir
10222	85	1616043710236:1185706507	1616043709605:2070953195	D5170C00002	1238	1237	CREATE	2021-03-18 06:01:50.326	05.01 Site Selection	05.01.02 Confidentiality Agreement
10225	85	1616043711970:-1526657338	1616043711372:-1445248576	D5170C00002	1241	1240	CREATE	2021-03-18 06:01:52.059	02 Central Trial Documents	02.04 General
10228	85	1616043714873:1852310734	1616043713223:1350413189	D5170C00002	1244	1243	CREATE	2021-03-18 06:01:54.995	03 Regulatory	03.01 Trial Approval
10231	85	1616043716703:-1918363954	1616043716090:-854177911	D5170C00002	1247	1246	CREATE	2021-03-18 06:01:56.821	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
10234	85	1616043718541:-2081381644	1616043716703:-1918363954	D5170C00002	1250	1247	CREATE	2021-03-18 06:01:58.641	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
10237	85	1616043720568:-772554561	1616043719156:-1752329646	D5170C00002	1253	1251	CREATE	2021-03-18 06:02:00.665	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
10240	85	1616043722528:1793866627	1616043721847:-746688907	D5170C00002	1256	1255	CREATE	2021-03-18 06:02:02.627	05.01 Site Selection	05.01.02 Confidentiality Agreement
10244	85	1616043726100:316315429	1616043724564:-836435006	D5170C00002	1260	1259	CREATE	2021-03-18 06:02:06.191	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
10247	85	1616043728208:1406511756	1616043724564:-836435006	D5170C00002	1263	1259	CREATE	2021-03-18 06:02:08.319	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
10250	85	1616043730164:493585053	1616043724564:-836435006	D5170C00002	1266	1259	CREATE	2021-03-18 06:02:10.259	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
10254	85	1616043732789:1148219097	1616043721153:-2021502449	D5170C00002	1270	1254	CREATE	2021-03-18 06:02:12.879	05 Site Management	05.03 Site Initiation
10257	85	1616043734667:433495918	1616043732789:1148219097	D5170C00002	1273	1270	CREATE	2021-03-18 06:02:14.773	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
10260	85	1616043737512:-1512180155	1616043735234:319872489	D5170C00002	1276	1274	CREATE	2021-03-18 06:02:17.602	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
10264	85	1616043740135:1754069876	1616043707500:1826778313	D5170C00002	1280	1234	CREATE	2021-03-18 06:02:20.222	Site	2001829 Bogdanov, Roman
10267	85	1616043741827:1265205221	1616043741256:141038977	D5170C00002	1283	1282	CREATE	2021-03-18 06:02:21.922	03.01 Trial Approval	03.01.01 Submission
10268	85	1616043742393:647992287	1616043740135:1754069876	D5170C00002	1284	1280	CREATE	2021-03-18 06:02:22.484	2001829 Bogdanov, Roman	04 IRB-IEC and other Approvals
10269	85	1616043742967:1899842701	1616043742393:647992287	D5170C00002	1285	1284	CREATE	2021-03-18 06:02:23.247	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
10273	85	1616043745558:-1121048786	1616043742393:647992287	D5170C00002	1289	1284	CREATE	2021-03-18 06:02:25.663	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
10276	85	1616043748314:-1742033207	1616043740135:1754069876	D5170C00002	1292	1280	CREATE	2021-03-18 06:02:28.406	2001829 Bogdanov, Roman	05 Site Management
10279	85	1616043750494:571492862	1616043748992:-1680961788	D5170C00002	1295	1293	CREATE	2021-03-18 06:02:30.585	05.01 Site Selection	05.01.03 Feasibility Documentation
10282	85	1616043752335:-1244075312	1616043751686:2072770925	D5170C00002	1298	1297	CREATE	2021-03-18 06:02:32.454	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
10285	85	1616043754188:1520321064	1616043751686:2072770925	D5170C00002	1301	1297	CREATE	2021-03-18 06:02:34.276	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
10289	85	1616043756614:-266690779	1616043751686:2072770925	D5170C00002	1305	1297	CREATE	2021-03-18 06:02:36.703	05.02 Site Set-up Documentation	05.02.12 Clini_ Trial Agreement
10292	85	1616043759528:-388450813	1616043751686:2072770925	D5170C00002	1308	1297	CREATE	2021-03-18 06:02:39.618	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
10296	85	1616043762440:1600866621	1616043760121:213956825	D5170C00002	1312	1309	CREATE	2021-03-18 06:02:42.795	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
10299	85	1616043764543:-1042570409	1616043763329:-759402178	D5170C00002	1315	1313	CREATE	2021-03-18 06:02:44.634	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
11565	86	\N	\N	D5170C00002	16	13	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
10306	85	1616043770724:-350856033	1616043768904:-512936083	D5170C00002	1322	1321	CREATE	2021-03-18 06:02:50.856	02.04 General	02.04.01 Relev_s-Contact Report
10309	85	1616043772584:-1476962255	1616043771993:-7190771	D5170C00002	1325	1324	CREATE	2021-03-18 06:02:52.679	03 Regulatory	03.01 Trial Approval
10311	85	1616043773771:2083185425	1616043767232:-2038246709	D5170C00002	1327	1319	CREATE	2021-03-18 06:02:53.878	2001830 Tsibin, Andrey	04 IRB-IEC and other Approvals
10314	85	1616043775888:718658314	1616043774345:60549639	D5170C00002	1330	1328	CREATE	2021-03-18 06:02:55.984	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
10317	85	1616043777699:253828450	1616043773771:2083185425	D5170C00002	1333	1327	CREATE	2021-03-18 06:02:57.792	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
10321	85	1616043780007:-1552015885	1616043779375:1060852064	D5170C00002	1337	1336	CREATE	2021-03-18 06:03:00.098	05 Site Management	05.01 Site Selection
10324	85	1616043782968:-1752315876	1616043780007:-1552015885	D5170C00002	1340	1337	CREATE	2021-03-18 06:03:03.057	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
10326	85	1616043784219:539008298	1616043783621:2087110418	D5170C00002	1342	1341	CREATE	2021-03-18 06:03:04.311	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
10330	85	1616043794027:1491324559	1616043783621:2087110418	D5170C00002	1346	1341	CREATE	2021-03-18 06:03:14.132	05.02 Site Set-up Documentation	05.02.07 Site Qualification
10331	85	1616043794653:1018403959	1616043783621:2087110418	D5170C00002	1347	1341	CREATE	2021-03-18 06:03:14.743	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
10333	85	1616043795939:-1525478133	1616043783621:2087110418	D5170C00002	1349	1341	CREATE	2021-03-18 06:03:16.032	05.02 Site Set-up Documentation	05.02.12 Clini_ Trial Agreement
10337	85	1616043798405:294597484	1616043797788:-1331297321	D5170C00002	1353	1352	CREATE	2021-03-18 06:03:18.505	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
10340	85	1616043800624:1990310972	1616043779375:1060852064	D5170C00002	1356	1336	CREATE	2021-03-18 06:03:20.724	05 Site Management	05.04 Site Management
10343	85	1616043802758:1597758652	1616043800624:1990310972	D5170C00002	1359	1356	CREATE	2021-03-18 06:03:22.854	05.04 Site Management	05.04.04 Visit Log
10345	85	1616043804531:134288409	1616043800624:1990310972	D5170C00002	1361	1356	CREATE	2021-03-18 06:03:24.626	05.04 Site Management	05.04.05 UNBLINDED Additional Monitoring Activity
10350	85	1616043807685:1051875412	1616043807083:-270687606	D5170C00002	1366	1365	CREATE	2021-03-18 06:03:27.771	05.05 General	05.05.01 Relevant Communications-Documents
10353	85	1616043809845:208576053	1616043809012:-1368376907	D5170C00002	1369	1368	CREATE	2021-03-18 06:03:29.936	06 IP and Trial Supplies	06.01 IP Documentation
10356	85	1616043811827:648431063	1616043809845:208576053	D5170C00002	1372	1369	CREATE	2021-03-18 06:03:31.929	06.01 IP Documentation	06.01.10 UNBLI_mentation Return
10359	85	1616043814245:995842711	1616043812488:-915001083	D5170C00002	1375	1373	CREATE	2021-03-18 06:03:34.331	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
10362	85	1616043816271:463501640	1616043815603:-639664129	D5170C00002	1378	1377	CREATE	2021-03-18 06:03:36.361	02 Central Trial Documents	02.04 General
10365	85	1616043818221:1471761501	1616043817563:-1717834116	D5170C00002	1381	1380	CREATE	2021-03-18 06:03:38.307	03 Regulatory	03.01 Trial Approval
10368	85	1616043820161:370770102	1616043819470:372552689	D5170C00002	1384	1383	CREATE	2021-03-18 06:03:40.252	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
10371	85	1616043828078:1790342641	1616043820161:370770102	D5170C00002	1387	1384	CREATE	2021-03-18 06:03:48.167	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
10374	85	1616043830042:-2582173	1616043828697:564048913	D5170C00002	1390	1388	CREATE	2021-03-18 06:03:50.132	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
10378	85	1616043832649:-399068200	1616043831728:-2017430369	D5170C00002	1394	1393	CREATE	2021-03-18 06:03:52.74	05 Site Management	05.01 Site Selection
10381	85	1616043834527:-2047506210	1616043832649:-399068200	D5170C00002	1397	1394	CREATE	2021-03-18 06:03:54.614	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
10383	85	1616043835670:-543843533	1616043835119:1845142685	D5170C00002	1399	1398	CREATE	2021-03-18 06:03:55.76	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
10388	85	1616043838727:-371019442	1616043835119:1845142685	D5170C00002	1404	1398	CREATE	2021-03-18 06:03:58.818	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
10391	85	1616043840559:2118617108	1616043835119:1845142685	D5170C00002	1407	1398	CREATE	2021-03-18 06:04:00.648	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
10394	85	1616043843002:-396728336	1616043841860:128179498	D5170C00002	1410	1409	CREATE	2021-03-18 06:04:08.249	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
10397	85	1616043850113:522470192	1616043831728:-2017430369	D5170C00002	1413	1393	CREATE	2021-03-18 06:04:10.269	05 Site Management	05.04 Site Management
10400	85	1616043852087:220937084	1616043850113:522470192	D5170C00002	1416	1413	CREATE	2021-03-18 06:04:12.176	05.04 Site Management	05.04.04 UNBLINDED Visit Log
10403	85	1616043853965:2071056358	1616043850113:522470192	D5170C00002	1419	1413	CREATE	2021-03-18 06:04:14.05	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
10407	85	1616043856526:740515256	1616043831728:-2017430369	D5170C00002	1423	1393	CREATE	2021-03-18 06:04:16.609	05 Site Management	05.05 General
10410	85	1616043858408:794843327	1616043814946:718636409	D5170C00002	1426	1376	CREATE	2021-03-18 06:04:18.495	2001831 Pesegova, Marina	06 IP and Trial Supplies
10413	85	1616043860383:240866704	1616043858998:91110559	D5170C00002	1429	1427	CREATE	2021-03-18 06:04:20.47	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
10416	85	1616043862277:695274263	1616043861685:2036691326	D5170C00002	1432	1431	CREATE	2021-03-18 06:04:22.362	06.04 Storage	06.04.01 UNBLI_on Documentation
10419	85	1616043864171:-735557284	1616043863525:1528635901	D5170C00002	1435	1434	CREATE	2021-03-18 06:04:24.255	2001863 Ballyuzek, Marina	02 Central Trial Documents
10422	85	1616043866131:-1813674226	1616043863525:1528635901	D5170C00002	1438	1434	CREATE	2021-03-18 06:04:26.217	2001863 Ballyuzek, Marina	03 Regulatory
10425	85	1616043868049:-1539285338	1616043863525:1528635901	D5170C00002	1441	1434	CREATE	2021-03-18 06:04:28.139	2001863 Ballyuzek, Marina	04 IRB-IEC and other Approvals
10428	85	1616043869945:-533189016	1616043868688:436075958	D5170C00002	1444	1442	CREATE	2021-03-18 06:04:30.033	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
10431	85	1616043871901:629238070	1616043868049:-1539285338	D5170C00002	1447	1441	CREATE	2021-03-18 06:04:31.986	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
10435	85	1616043874855:-1193583964	1616043874185:-860269628	D5170C00002	1451	1450	CREATE	2021-03-18 06:04:34.943	05 Site Management	05.01 Site Selection
10438	85	1616043876782:172561724	1616043874855:-1193583964	D5170C00002	1454	1451	CREATE	2021-03-18 06:04:36.871	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
10441	85	1616043878738:-107988198	1616043877405:-1428268195	D5170C00002	1457	1455	CREATE	2021-03-18 06:04:38.829	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
10444	85	1616043880537:-253242946	1616043877405:-1428268195	D5170C00002	1460	1455	CREATE	2021-03-18 06:04:40.624	05.02 Site Set-up Documentation	05.02.07 Site Qualification
10448	85	1616043883228:-52599176	1616043877405:-1428268195	D5170C00002	1464	1455	CREATE	2021-03-18 06:04:43.318	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
10451	85	1616043885874:-1999828516	1616043885270:-1919368944	D5170C00002	1467	1466	CREATE	2021-03-18 06:04:45.961	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
10455	85	1616043888454:1328689331	1616043887879:-1639684660	D5170C00002	1471	1470	CREATE	2021-03-18 06:04:48.541	05.04 Site Management	05.04.04 Visit Log
10457	85	1616043889579:774359708	1616043887879:-1639684660	D5170C00002	1473	1470	CREATE	2021-03-18 06:04:49.679	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
10459	85	1616043890965:703640044	1616043890329:1762061063	D5170C00002	1475	1474	CREATE	2021-03-18 06:04:51.048	05.05 General	05.05.01 Relevant Communications-Documents
10462	85	1616043892696:948916065	1616043892121:-2001710502	D5170C00002	1478	1477	CREATE	2021-03-18 06:04:52.782	TBD-1-1RP9EIE Baranovsky, Andrey	05 Site Management
10466	85	1616043895896:1415575075	1616043894518:-1586424078	D5170C00002	1482	1481	CREATE	2021-03-18 06:04:55.98	TBD-1-1RPCQZW Lakhin, Alexander	05 Site Management
10469	85	1616043897832:-699334386	1616043707500:1826778313	D5170C00002	1485	1234	CREATE	2021-03-18 06:04:57.921	Site	TBD-1-1RPDC9V Dvorkin, Mikhail
10472	85	1616043899653:2109529534	1616043899032:1328068321	D5170C00002	1488	1487	CREATE	2021-03-18 06:04:59.74	05.01 Site Selection	05.01.02 Confidentiality Agreement
10475	85	1616043907906:761474353	1616043907282:1352736424	D5170C00002	1491	1490	CREATE	2021-03-18 06:05:08.146	05 Site Management	05.01 Site Selection
10478	85	1616043910139:-574445522	1616043907906:761474353	D5170C00002	1494	1491	CREATE	2021-03-18 06:05:10.228	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
10482	85	1616043913097:-1334042039	1616043912486:-1589475664	D5170C00002	1498	1497	CREATE	2021-03-18 06:05:13.184	05.01 Site Selection	05.01.02 Confidentiality Agreement
10485	85	1616043915203:1635453748	1616043914564:1825605212	D5170C00002	1501	1500	CREATE	2021-03-18 06:05:15.298	Site	2002056 Guardiola Capon, Jordi
10488	85	1616043918339:413874227	1616043916595:1168470070	D5170C00002	1504	1503	CREATE	2021-03-18 06:05:18.427	01.01 Trial Oversight	01.01.06 Recruitment Plan
10491	85	1616043920576:1984100127	1616043919624:-758896115	D5170C00002	1507	1506	CREATE	2021-03-18 06:05:20.668	02.04 General	02.04.01 Relev_ations-Documents
10494	85	1616043923352:1161558825	1616043915203:1635453748	D5170C00002	1510	1501	CREATE	2021-03-18 06:05:23.44	2002056 Guardiola Capon, Jordi	04 IRB-IEC and other Approvals
10497	85	1616043925383:-2093977400	1616043923352:1161558825	D5170C00002	1513	1510	CREATE	2021-03-18 06:05:25.475	04 IRB-IEC and other Approvals	04.04 General
10500	85	1616043927394:697930674	1616043926723:-1228445451	D5170C00002	1516	1515	CREATE	2021-03-18 06:05:27.483	05 Site Management	05.01 Site Selection
10503	85	1616043930859:463246443	1616043926723:-1228445451	D5170C00002	1519	1515	CREATE	2021-03-18 06:05:30.947	05 Site Management	05.02 Site Set-up Documentation
10506	85	1616043932922:-1793558546	1616043930859:463246443	D5170C00002	1522	1519	CREATE	2021-03-18 06:05:33.008	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
10509	85	1616043934739:-574420560	1616043930859:463246443	D5170C00002	1525	1519	CREATE	2021-03-18 06:05:34.825	05.02 Site Set-up Documentation	05.02.07 Site Qualification
10513	85	1616043937365:184384494	1616043930859:463246443	D5170C00002	1529	1519	CREATE	2021-03-18 06:05:37.453	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
10516	85	1616043940993:-1028819303	1616043930859:463246443	D5170C00002	1532	1519	CREATE	2021-03-18 06:05:41.084	05.02 Site Set-up Documentation	05.02.17 IP Si_se Documentation
10519	85	1616043943809:186168733	1616043942524:-1702139227	D5170C00002	1535	1534	CREATE	2021-03-18 06:05:43.899	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
10522	85	1616043945994:1477724243	1616043926723:-1228445451	D5170C00002	1538	1515	CREATE	2021-03-18 06:05:46.083	05 Site Management	05.04 Site Management
10523	85	1616043946623:1578831153	1616043945994:1477724243	D5170C00002	1539	1538	CREATE	2021-03-18 06:05:46.713	05.04 Site Management	05.04.01 Subject Log
10525	85	1616043948037:-509127430	1616043945994:1477724243	D5170C00002	1541	1538	CREATE	2021-03-18 06:05:48.187	05.04 Site Management	05.04.04 UNBLINDED Visit Log
10528	85	1616043950307:-1279648095	1616043945994:1477724243	D5170C00002	1544	1538	CREATE	2021-03-18 06:05:50.395	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
10532	85	1616043954341:165787572	1616043953587:1979280171	D5170C00002	1548	1547	CREATE	2021-03-18 06:05:54.552	05.05 General	05.05.02 Tracking Information
10535	85	1616043956636:2055028827	1616043955957:467668828	D5170C00002	1551	1550	CREATE	2021-03-18 06:05:56.725	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
10539	85	1616043959987:651398831	1616043955957:467668828	D5170C00002	1555	1550	CREATE	2021-03-18 06:06:00.073	06.01 IP Documentation	06.01.11 UNBLI_e of Destruction
10542	85	1616043963055:-965454497	1616043960596:-517303749	D5170C00002	1558	1556	CREATE	2021-03-18 06:06:03.142	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
10545	85	1616043965020:-1419698331	1616043914564:1825605212	D5170C00002	1561	1500	CREATE	2021-03-18 06:06:05.108	Site	2002057 Taxonera, Carlos
10548	85	1616043966895:551271687	1616043966237:-1103272243	D5170C00002	1564	1563	CREATE	2021-03-18 06:06:06.987	01.01 Trial Oversight	01.01.06 Recruitment Plan
10551	85	1616043968750:283880687	1616043968145:-2057983635	D5170C00002	1567	1566	CREATE	2021-03-18 06:06:08.843	02.04 General	02.04.01 Relev_ations-Documents
10554	85	1616043970568:-1143411650	1616043965020:-1419698331	D5170C00002	1570	1561	CREATE	2021-03-18 06:06:13.94	2002057 Taxonera, Carlos	05 Site Management
10556	85	1616043975098:1283121831	1616043974490:-1416466667	D5170C00002	1572	1571	CREATE	2021-03-18 06:06:15.186	05.01 Site Selection	05.01.01 Site Contact Details
10559	85	1616043976782:-1651193334	1616043970568:-1143411650	D5170C00002	1575	1570	CREATE	2021-03-18 06:06:16.866	05 Site Management	05.02 Site Set-up Documentation
10562	85	1616043978536:1743038156	1616043976782:-1651193334	D5170C00002	1578	1575	CREATE	2021-03-18 06:06:18.625	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
10566	85	1616043981078:-546218195	1616043976782:-1651193334	D5170C00002	1582	1575	CREATE	2021-03-18 06:06:21.167	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
10569	85	1616043982960:-1796612793	1616043976782:-1651193334	D5170C00002	1585	1575	CREATE	2021-03-18 06:06:23.046	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
10573	85	1616043985987:478451946	1616043970568:-1143411650	D5170C00002	1589	1570	CREATE	2021-03-18 06:06:26.072	05 Site Management	05.03 Site Initiation
10576	85	1616043987647:1182496910	1616043970568:-1143411650	D5170C00002	1592	1570	CREATE	2021-03-18 06:06:27.732	05 Site Management	05.04 Site Management
10579	85	1616043989383:-728645576	1616043987647:1182496910	D5170C00002	1595	1592	CREATE	2021-03-18 06:06:29.471	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
10582	85	1616043991226:2089997590	1616043965020:-1419698331	D5170C00002	1598	1561	CREATE	2021-03-18 06:06:31.316	2002057 Taxonera, Carlos	06 IP and Trial Supplies
10586	85	1616043993506:602806096	1616043992959:1976595861	D5170C00002	1602	1601	CREATE	2021-03-18 06:06:33.604	06.04 Storage	06.04.03 Maintenance Logs
10587	85	1616043994064:-1346591113	1616043914564:1825605212	D5170C00002	1603	1500	CREATE	2021-03-18 06:06:34.17	Site	2002058 Domenech Morral, Eugeni
10589	85	1616043995898:1928736265	1616043994655:1027175165	D5170C00002	1605	1604	CREATE	2021-03-18 06:06:35.981	01 Trial Management	01.01 Trial Oversight
10592	85	1616043997615:862683754	1616043996995:1157812493	D5170C00002	1608	1607	CREATE	2021-03-18 06:06:37.703	02 Central Trial Documents	02.04 General
10595	85	1616043999936:1787401927	1616043997615:862683754	D5170C00002	1611	1608	CREATE	2021-03-18 06:06:40.023	02.04 General	02.04.01 UNBLI_ations-Documents
10598	85	1616044001626:-797469454	1616044001075:914544643	D5170C00002	1614	1613	CREATE	2021-03-18 06:06:41.711	05 Site Management	05.01 Site Selection
10601	85	1616044003351:-1753548229	1616044001626:-797469454	D5170C00002	1617	1614	CREATE	2021-03-18 06:06:43.445	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
10604	85	1616044005138:1587270419	1616044003953:365880779	D5170C00002	1620	1618	CREATE	2021-03-18 06:06:45.227	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
10608	85	1616044008087:822391731	1616044003953:365880779	D5170C00002	1624	1618	CREATE	2021-03-18 06:06:48.171	05.02 Site Set-up Documentation	05.02.07 Site Qualification
10611	85	1616044009787:1841308801	1616044003953:365880779	D5170C00002	1627	1618	CREATE	2021-03-18 06:06:49.874	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
10615	85	1616044012054:-888286044	1616044003953:365880779	D5170C00002	1631	1618	CREATE	2021-03-18 06:06:52.142	05.02 Site Set-up Documentation	05.02.17 IP Si_se Documentation
10618	85	1616044013862:-386758356	1616044013278:-1378337520	D5170C00002	1634	1633	CREATE	2021-03-18 06:06:53.948	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
10622	85	1616044016140:-1242760117	1616044015516:1943270773	D5170C00002	1638	1637	CREATE	2021-03-18 06:06:56.229	05.04 Site Management	05.04.01 Subject Log
10625	85	1616044018518:1717289492	1616044015516:1943270773	D5170C00002	1641	1637	CREATE	2021-03-18 06:06:58.605	05.04 Site Management	05.04.04 Visit Log
10627	85	1616044019609:-1028909371	1616044015516:1943270773	D5170C00002	1643	1637	CREATE	2021-03-18 06:06:59.707	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
10631	85	1616044022026:1220481698	1616044021256:483901261	D5170C00002	1647	1646	CREATE	2021-03-18 06:07:02.125	05.05 General	05.05.01 Relev_unications-Email
10634	85	1616044023734:503736290	1616044023171:1106114746	D5170C00002	1650	1649	CREATE	2021-03-18 06:07:03.826	06 IP and Trial Supplies	06.01 IP Documentation
10637	85	1616044025527:1263838222	1616044023734:503736290	D5170C00002	1653	1650	CREATE	2021-03-18 06:07:05.623	06.01 IP Documentation	06.01.10 UNBLI_mentation Return
10641	85	1616044028844:2096132023	1616044028195:1081677969	D5170C00002	1657	1656	CREATE	2021-03-18 06:07:08.929	06.04 Storage	06.04.01 UNBLI_on Documentation
10644	85	1616044030603:830577696	1616044023171:1106114746	D5170C00002	1660	1649	CREATE	2021-03-18 06:07:10.686	06 IP and Trial Supplies	06.07 General
10647	85	1616044032810:-1199154755	1616044032148:-899601491	D5170C00002	1663	1662	CREATE	2021-03-18 06:07:12.897	2002059 Sierra Ausin, Monica	01 Trial Management
10650	85	1616044034682:1973353537	1616044032148:-899601491	D5170C00002	1666	1662	CREATE	2021-03-18 06:07:14.768	2002059 Sierra Ausin, Monica	02 Central Trial Documents
10651	85	1616044035249:927120712	1616044034682:1973353537	D5170C00002	1667	1666	CREATE	2021-03-18 06:07:15.336	02 Central Trial Documents	02.04 General
10653	85	1616044036462:583142781	1616044035249:927120712	D5170C00002	1669	1667	CREATE	2021-03-18 06:07:16.552	02.04 General	02.04.01 Relev_s-Contact Report
10656	85	1616044039184:2102042207	1616044037647:-1456829499	D5170C00002	1672	1671	CREATE	2021-03-18 06:07:19.273	05 Site Management	05.01 Site Selection
10659	85	1616044040949:-492477586	1616044039184:2102042207	D5170C00002	1675	1672	CREATE	2021-03-18 06:07:21.033	05.01 Site Selection	05.01.03 Feasibility Documentation
10662	85	1616044042690:-1452418441	1616044042116:-1029500593	D5170C00002	1678	1677	CREATE	2021-03-18 06:07:22.778	05.02 Site Set-up Documentation	05.02.01 Accep_tigator Brochure
10665	85	1616044044505:-1769621484	1616044042116:-1029500593	D5170C00002	1681	1677	CREATE	2021-03-18 06:07:24.593	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
10669	85	1616044047000:1915908658	1616044042116:-1029500593	D5170C00002	1685	1677	CREATE	2021-03-18 06:07:27.088	05.02 Site Set-up Documentation	05.02.09 Inves_latory Agreement
10672	85	1616044049522:-823497038	1616044042116:-1029500593	D5170C00002	1688	1677	CREATE	2021-03-18 06:07:29.613	05.02 Site Set-up Documentation	05.02.13 Indemnity
10676	85	1616044052140:1335709162	1616044051460:-153025908	D5170C00002	1692	1691	CREATE	2021-03-18 06:07:32.225	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
10679	85	1616044053980:1801006951	1616044037647:-1456829499	D5170C00002	1695	1671	CREATE	2021-03-18 06:07:34.07	05 Site Management	05.04 Site Management
10682	85	1616044055820:675548894	1616044053980:1801006951	D5170C00002	1698	1695	CREATE	2021-03-18 06:07:35.903	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
10685	85	1616044057512:-1265259396	1616044032148:-899601491	D5170C00002	1701	1662	CREATE	2021-03-18 06:07:37.601	2002059 Sierra Ausin, Monica	06 IP and Trial Supplies
10689	85	1616044060729:-619125260	1616044059376:-396114037	D5170C00002	1705	1704	CREATE	2021-03-18 06:07:40.817	2002060 Argüel_ Arias, Federico	01 Trial Management
10692	85	1616044062562:879140547	1616044059376:-396114037	D5170C00002	1708	1704	CREATE	2021-03-18 06:07:42.646	2002060 Argüel_ Arias, Federico	02 Central Trial Documents
10695	85	1616044064892:-768154147	1616044063121:1438189014	D5170C00002	1711	1709	CREATE	2021-03-18 06:07:44.976	02.04 General	02.04.01 Relev_s-Contact Report
10698	85	1616044066504:-1547710995	1616044065975:-1266999076	D5170C00002	1714	1713	CREATE	2021-03-18 06:07:46.589	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
10701	85	1616044068206:-1811828080	1616044067675:-615185433	D5170C00002	1717	1716	CREATE	2021-03-18 06:07:48.292	05 Site Management	05.01 Site Selection
10704	85	1616044069905:-483731342	1616044068206:-1811828080	D5170C00002	1720	1717	CREATE	2021-03-18 06:07:49.991	05.01 Site Selection	05.01.03 Feasibility Documentation
10707	85	1616044072409:356342245	1616044071842:429189496	D5170C00002	1723	1722	CREATE	2021-03-18 06:07:52.495	05.02 Site Set-up Documentation	05.02.01 Accep_tigator Brochure
10711	85	1616044074834:-877969707	1616044071842:429189496	D5170C00002	1727	1722	CREATE	2021-03-18 06:07:54.927	05.02 Site Set-up Documentation	05.02.07 Site Qualification
10714	85	1616044076533:140947363	1616044071842:429189496	D5170C00002	1730	1722	CREATE	2021-03-18 06:07:56.619	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
10715	85	1616044077085:-1230558598	1616044071842:429189496	D5170C00002	1731	1722	CREATE	2021-03-18 06:07:57.171	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
10718	85	1616044078795:-1362944179	1616044071842:429189496	D5170C00002	1734	1722	CREATE	2021-03-18 06:07:58.89	05.02 Site Set-up Documentation	05.02.17 IP Si_se Documentation
10721	85	1616044080643:1792733680	1616044080069:1757354236	D5170C00002	1737	1736	CREATE	2021-03-18 06:08:00.739	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
10725	85	1616044084677:-699422932	1616044083985:783995233	D5170C00002	1741	1740	CREATE	2021-03-18 06:08:04.77	05.04 Site Management	05.04.04 Visit Log
10728	85	1616044086672:1019849090	1616044086069:1143806338	D5170C00002	1744	1743	CREATE	2021-03-18 06:08:06.755	05.05 General	05.05.02 Tracking Information
10731	85	1616044088458:-810508277	1616044087880:1104321046	D5170C00002	1747	1746	CREATE	2021-03-18 06:08:08.543	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
10734	85	1616044090506:-131521138	1616044089942:-1568546846	D5170C00002	1750	1749	CREATE	2021-03-18 06:08:10.597	01 Trial Management	01.01 Trial Oversight
10737	85	1616044092324:417277298	1616044091761:378194489	D5170C00002	1753	1752	CREATE	2021-03-18 06:08:12.411	02 Central Trial Documents	02.04 General
10740	85	1616044095021:-815017926	1616044092324:417277298	D5170C00002	1756	1753	CREATE	2021-03-18 06:08:15.108	02.04 General	02.04.01 UNBLI_s-Contact Report
10743	85	1616044096738:1349143645	1616044096182:2003204663	D5170C00002	1759	1758	CREATE	2021-03-18 06:08:16.827	05.01 Site Selection	05.01.01 Site Contact Details
10746	85	1616044098495:236075815	1616044095595:1388012362	D5170C00002	1762	1757	CREATE	2021-03-18 06:08:18.595	05 Site Management	05.02 Site Set-up Documentation
10749	85	1616044100167:-128366353	1616044098495:236075815	D5170C00002	1765	1762	CREATE	2021-03-18 06:08:20.253	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
10753	85	1616044102479:-1194942966	1616044098495:236075815	D5170C00002	1769	1762	CREATE	2021-03-18 06:08:22.568	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
10756	85	1616044105293:-1189164622	1616044098495:236075815	D5170C00002	1772	1762	CREATE	2021-03-18 06:08:25.38	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
10760	85	1616044107648:-396844020	1616044095595:1388012362	D5170C00002	1776	1757	CREATE	2021-03-18 06:08:27.735	05 Site Management	05.03 Site Initiation
10763	85	1616044109390:1338262760	1616044107648:-396844020	D5170C00002	1779	1776	CREATE	2021-03-18 06:08:29.478	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
10766	85	1616044111188:707282056	1616044110047:445911593	D5170C00002	1782	1780	CREATE	2021-03-18 06:08:31.281	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
10770	85	1616044113447:-1884088784	1616044112844:-1678553762	D5170C00002	1786	1785	CREATE	2021-03-18 06:08:33.535	TBD-1-1R0JLPR Garcia Planella, Esther	05 Site Management
10773	85	1616044116185:-1141306314	1616043914564:1825605212	D5170C00002	1789	1500	CREATE	2021-03-18 06:08:36.274	Site	TBD-1-1WXVYHU And_ Garcia, Montserrat
10776	85	1616044117956:-644375285	1616044117385:918232179	D5170C00002	1792	1791	CREATE	2021-03-18 06:08:38.046	05.01 Site Selection	05.01.02 Confidentiality Agreement
10780	85	1616044120264:1383864152	1616044119677:-655064285	D5170C00002	1796	1795	CREATE	2021-03-18 06:08:40.349	2002254 Gonen, Can	01 Trial Management
10782	85	1616044121389:673579579	1616044120829:2141606761	D5170C00002	1798	1797	CREATE	2021-03-18 06:08:41.477	01.01 Trial Oversight	01.01.06 Recruitment Plan
10784	85	1616044122601:1658375096	1616044122029:261405148	D5170C00002	1800	1799	CREATE	2021-03-18 06:08:42.689	02 Central Trial Documents	02.02 Subject Documents
10788	85	1616044124950:88119394	1616044124385:-184680227	D5170C00002	1804	1803	CREATE	2021-03-18 06:08:45.036	02.04 General	02.04.01 Relev_ations-Documents
10791	85	1616044127636:1271223021	1616044119677:-655064285	D5170C00002	1807	1795	CREATE	2021-03-18 06:08:47.735	2002254 Gonen, Can	05 Site Management
10794	85	1616044130113:546730948	1616044128263:1949488369	D5170C00002	1810	1808	CREATE	2021-03-18 06:08:50.202	05.01 Site Selection	05.01.02 Confidentiality Agreement
10797	85	1616044131965:1408073433	1616044127636:1271223021	D5170C00002	1813	1807	CREATE	2021-03-18 06:08:52.048	05 Site Management	05.02 Site Set-up Documentation
10799	85	1616044133116:-847946153	1616044131965:1408073433	D5170C00002	1815	1813	CREATE	2021-03-18 06:08:53.204	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
10803	85	1616044135644:390385628	1616044131965:1408073433	D5170C00002	1819	1813	CREATE	2021-03-18 06:08:55.733	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
10807	85	1616044139056:916962075	1616044127636:1271223021	D5170C00002	1823	1807	CREATE	2021-03-18 06:08:59.145	05 Site Management	05.03 Site Initiation
10810	85	1616044140793:398151696	1616044139056:916962075	D5170C00002	1826	1823	CREATE	2021-03-18 06:09:00.882	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
10813	85	1616044142932:2122759569	1616044141422:-56386319	D5170C00002	1829	1827	CREATE	2021-03-18 06:09:03.017	05.04 Site Management	05.04.05 Additional Monitoring Activity
10817	85	1616044145364:2121134454	1616044144189:161626918	D5170C00002	1833	1831	CREATE	2021-03-18 06:09:05.451	05.05 General	05.05.01 Relevant Communications-Email
10820	85	1616044147203:1675189478	1616044146628:-1572197061	D5170C00002	1836	1835	CREATE	2021-03-18 06:09:07.293	2002255 Senates, Ebubekir	01 Trial Management
10823	85	1616044150214:-669811347	1616044146628:-1572197061	D5170C00002	1839	1835	CREATE	2021-03-18 06:09:10.314	2002255 Senates, Ebubekir	02 Central Trial Documents
10826	85	1616044151997:-1019020525	1616044150809:-466183998	D5170C00002	1842	1840	CREATE	2021-03-18 06:09:12.195	02.02 Subject Documents	02.02.02 Subject Questionnaire
10830	85	1616044158148:1497085849	1616044152685:-604357453	D5170C00002	1846	1843	CREATE	2021-03-18 06:09:18.239	02.04 General	02.04.01 UNBLI_s-Contact Report
10833	85	1616044160639:929291222	1616044159349:1644746838	D5170C00002	1849	1848	CREATE	2021-03-18 06:09:20.743	05.01 Site Selection	05.01.01 Site Contact Details
10836	85	1616044162495:-829326811	1616044159349:1644746838	D5170C00002	1852	1848	CREATE	2021-03-18 06:09:22.675	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
10839	85	1616044164422:-404897183	1616044163195:-405977746	D5170C00002	1855	1853	CREATE	2021-03-18 06:09:24.509	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
10843	85	1616044167036:833455816	1616044163195:-405977746	D5170C00002	1859	1853	CREATE	2021-03-18 06:09:27.126	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
10844	85	1616044167636:1178782842	1616044163195:-405977746	D5170C00002	1860	1853	CREATE	2021-03-18 06:09:27.727	05.02 Site Set-up Documentation	05.02.12 Clini_ Trial Agreement
10847	85	1616044169516:-755280627	1616044158744:1562548347	D5170C00002	1863	1847	CREATE	2021-03-18 06:09:29.604	05 Site Management	05.03 Site Initiation
10850	85	1616044172106:-1804476442	1616044169516:-755280627	D5170C00002	1866	1863	CREATE	2021-03-18 06:09:32.193	05.03 Site Initiation	05.03.03 Site Training-Staff
10853	85	1616044174440:2002179693	1616044173110:1201998586	D5170C00002	1869	1867	CREATE	2021-03-18 06:09:34.53	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
10857	85	1616044176991:1754065405	1616044146628:-1572197061	D5170C00002	1873	1835	CREATE	2021-03-18 06:09:37.074	2002255 Senates, Ebubekir	06 IP and Trial Supplies
10859	85	1616044178320:272993708	1616044177689:-753885674	D5170C00002	1875	1874	CREATE	2021-03-18 06:09:38.408	06.01 IP Documentation	06.01.11 Certificate of Destruction
10863	85	1616044181521:-30360994	1616044180307:2046590206	D5170C00002	1879	1878	CREATE	2021-03-18 06:09:41.609	01.01 Trial Oversight	01.01.06 Recruitment Plan
10866	85	1616044183488:988734381	1616044182864:1607874792	D5170C00002	1882	1881	CREATE	2021-03-18 06:09:43.579	02.02 Subject Documents	02.02.01 Subject Diary
10869	85	1616044185392:-935358744	1616044184788:1469690728	D5170C00002	1885	1884	CREATE	2021-03-18 06:09:45.478	02.04 General	02.04.01 Relev_ations-Documents
10872	85	1616044187263:852014475	1616044178983:1310440696	D5170C00002	1888	1876	CREATE	2021-03-18 06:09:47.353	2002256 Purnak, Tugrul	05 Site Management
10875	85	1616044189096:2084340759	1616044187889:-1752725371	D5170C00002	1891	1889	CREATE	2021-03-18 06:09:49.179	05.01 Site Selection	05.01.02 Confidentiality Agreement
10878	85	1616044191028:395878303	1616044190425:633304600	D5170C00002	1894	1893	CREATE	2021-03-18 06:09:51.113	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
10881	85	1616044193598:-1978324363	1616044190425:633304600	D5170C00002	1897	1893	CREATE	2021-03-18 06:09:53.684	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
10885	85	1616044196094:321075611	1616044190425:633304600	D5170C00002	1901	1893	CREATE	2021-03-18 06:09:56.186	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
10888	85	1616044197922:-145383984	1616044197302:-1080306143	D5170C00002	1904	1903	CREATE	2021-03-18 06:09:58.013	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
10892	85	1616044200332:-1737107892	1616044199693:984959464	D5170C00002	1908	1907	CREATE	2021-03-18 06:10:00.417	05.04 Site Management	05.04.03 Monitoring Visit Report
10895	85	1616044203475:1895658518	1616044199693:984959464	D5170C00002	1911	1907	CREATE	2021-03-18 06:10:03.57	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
10899	85	1616044206205:1150244426	1616044119105:840225381	D5170C00002	1915	1794	CREATE	2021-03-18 06:10:06.296	Site	2002257 Altintas, Engin
10902	85	1616044208093:-1922613534	1616044207420:-1194366348	D5170C00002	1918	1917	CREATE	2021-03-18 06:10:08.18	01.01 Trial Oversight	01.01.06 Recruitment Plan
10905	85	1616044209979:462468237	1616044209369:1707016773	D5170C00002	1921	1920	CREATE	2021-03-18 06:10:10.066	02.02 Subject Documents	02.02.01 Subject Diary
10908	85	1616044211830:748215100	1616044211168:2544791	D5170C00002	1924	1923	CREATE	2021-03-18 06:10:11.913	02.04 General	02.04.01 Relev_ations-Documents
10909	85	1616044212416:1915783350	1616044211168:2544791	D5170C00002	1925	1923	CREATE	2021-03-18 06:10:12.503	02.04 General	02.04.01 Relev_s-Contact Report
10912	85	1616044215083:-495377138	1616044214406:-577600292	D5170C00002	1928	1927	CREATE	2021-03-18 06:10:15.172	05 Site Management	05.01 Site Selection
10914	85	1616044216377:-870183412	1616044215083:-495377138	D5170C00002	1930	1928	CREATE	2021-03-18 06:10:16.472	05.01 Site Selection	05.01.02 Confidentiality Agreement
10918	85	1616044218835:-1674304000	1616044218207:1890642224	D5170C00002	1934	1933	CREATE	2021-03-18 06:10:18.925	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
10921	85	1616044220634:1502760880	1616044218207:1890642224	D5170C00002	1937	1933	CREATE	2021-03-18 06:10:20.723	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
10925	85	1616044222938:1395956732	1616044218207:1890642224	D5170C00002	1941	1933	CREATE	2021-03-18 06:10:23.03	05.02 Site Set-up Documentation	05.02.17 IP Si_se Documentation
10928	85	1616044225452:1388300225	1616044224858:-1221183336	D5170C00002	1944	1943	CREATE	2021-03-18 06:10:25.549	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
11550	86	\N	\N	D5170C00002	1	0	NEW	\N		eTMF
10935	85	1616044229682:532207558	1616044229106:-578377939	D5170C00002	1951	1950	CREATE	2021-03-18 06:10:29.771	05.05 General	05.05.01 Relevant Communications-Documents
10938	85	1616044231437:1474862809	1616044230848:-688811429	D5170C00002	1954	1953	CREATE	2021-03-18 06:10:31.525	2002258 Ormeci, Necati	01 Trial Management
10941	85	1616044233311:-1011957102	1616044230848:-688811429	D5170C00002	1957	1953	CREATE	2021-03-18 06:10:33.408	2002258 Ormeci, Necati	02 Central Trial Documents
10944	85	1616044236012:1253549283	1616044234047:2079926146	D5170C00002	1960	1958	CREATE	2021-03-18 06:10:36.214	02.02 Subject Documents	02.02.02 Subject Questionnaire
10947	85	1616044238083:199558257	1616044236676:685335742	D5170C00002	1963	1961	CREATE	2021-03-18 06:10:38.212	02.04 General	02.04.01 Relev_s-Contact Report
10950	85	1616044239893:-675556019	1616044239296:1362232287	D5170C00002	1966	1965	CREATE	2021-03-18 06:10:39.979	05 Site Management	05.01 Site Selection
10953	85	1616044241792:1779766194	1616044239893:-675556019	D5170C00002	1969	1966	CREATE	2021-03-18 06:10:41.881	05.01 Site Selection	05.01.03 Feasibility Documentation
10956	85	1616044243502:925734785	1616044242944:-105683100	D5170C00002	1972	1971	CREATE	2021-03-18 06:10:43.588	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
10959	85	1616044246203:-1900327680	1616044242944:-105683100	D5170C00002	1975	1971	CREATE	2021-03-18 06:10:46.293	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
10963	85	1616044248570:-1410217198	1616044242944:-105683100	D5170C00002	1979	1971	CREATE	2021-03-18 06:10:48.656	05.02 Site Set-up Documentation	05.02.17 IP Si_se Documentation
10966	85	1616044250315:706079461	1616044249707:-1819262016	D5170C00002	1982	1981	CREATE	2021-03-18 06:10:50.405	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
10970	85	1616044252780:1199303720	1616044252166:249207509	D5170C00002	1986	1985	CREATE	2021-03-18 06:10:52.881	05.04 Site Management	05.04.03 Monitoring Visit Report
10972	85	1616044254001:-752534551	1616044252166:249207509	D5170C00002	1988	1985	CREATE	2021-03-18 06:10:54.095	05.04 Site Management	05.04.05 Additional Monitoring Activity
10975	85	1616044255790:1531495886	1616044255207:1862157382	D5170C00002	1991	1990	CREATE	2021-03-18 06:10:55.88	05.05 General	05.05.01 Relevant Communications-Documents
10978	85	1616044258514:556717357	1616044257937:-1063718503	D5170C00002	1994	1993	CREATE	2021-03-18 06:10:58.604	06 IP and Trial Supplies	06.07 General
10981	85	1616044260293:-1433159409	1616044259681:628615123	D5170C00002	1997	1996	CREATE	2021-03-18 06:11:00.379	2002259 Kalkan, Ismail	01 Trial Management
10984	85	1616044262095:486210115	1616044259681:628615123	D5170C00002	2000	1996	CREATE	2021-03-18 06:11:02.191	2002259 Kalkan, Ismail	02 Central Trial Documents
10987	85	1616044264018:735537714	1616044262710:-1917380588	D5170C00002	2003	2001	CREATE	2021-03-18 06:11:04.108	02.02 Subject Documents	02.02.02 Subject Questionnaire
10990	85	1616044266043:-181429024	1616044259681:628615123	D5170C00002	2006	1996	CREATE	2021-03-18 06:11:06.136	2002259 Kalkan, Ismail	05 Site Management
10993	85	1616044268904:6714853	1616044266647:1472554315	D5170C00002	2009	2007	CREATE	2021-03-18 06:11:09	05.01 Site Selection	05.01.02 Confidentiality Agreement
10996	85	1616044271229:1382977960	1616044266043:-181429024	D5170C00002	2012	2006	CREATE	2021-03-18 06:11:11.313	05 Site Management	05.02 Site Set-up Documentation
10999	85	1616044272988:1817193012	1616044271229:1382977960	D5170C00002	2015	2012	CREATE	2021-03-18 06:11:13.076	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
11003	85	1616044275283:331717497	1616044271229:1382977960	D5170C00002	2019	2012	CREATE	2021-03-18 06:11:15.371	05.02 Site Set-up Documentation	05.02.12 Clini_ Trial Agreement
11007	85	1616044277698:204450627	1616044277076:-927536804	D5170C00002	2023	2022	CREATE	2021-03-18 06:11:17.794	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
11010	85	1616044280338:-1900874589	1616044266043:-181429024	D5170C00002	2026	2006	CREATE	2021-03-18 06:11:20.428	05 Site Management	05.04 Site Management
11013	85	1616044282162:1911331472	1616044280338:-1900874589	D5170C00002	2029	2026	CREATE	2021-03-18 06:11:22.25	05.04 Site Management	05.04.08 UNBLI_onitoring Report
11016	85	1616044285008:1558881235	1616044283748:1531393818	D5170C00002	2032	2030	CREATE	2021-03-18 06:11:25.091	05.05 General	05.05.02 Tracking Information
11019	85	1616044286766:-709861104	1616044286185:-507938384	D5170C00002	2035	2034	CREATE	2021-03-18 06:11:26.851	01 Trial Management	01.01 Trial Oversight
11022	85	1616044289540:1887817615	1616044288205:-1630397388	D5170C00002	2038	2037	CREATE	2021-03-18 06:11:29.626	02 Central Trial Documents	02.02 Subject Documents
11025	85	1616044291412:1891463246	1616044288205:-1630397388	D5170C00002	2041	2037	CREATE	2021-03-18 06:11:31.5	02 Central Trial Documents	02.04 General
11028	85	1616044293286:1658097072	1616044292676:-765740436	D5170C00002	2044	2043	CREATE	2021-03-18 06:11:33.373	05 Site Management	05.01 Site Selection
11031	85	1616044295169:518377447	1616044293286:1658097072	D5170C00002	2047	2044	CREATE	2021-03-18 06:11:35.255	05.01 Site Selection	05.01.03 Feasibility Documentation
11034	85	1616044297143:-1646144844	1616044296434:-250850862	D5170C00002	2050	2049	CREATE	2021-03-18 06:11:37.238	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
11036	85	1616044298424:-974023367	1616044296434:-250850862	D5170C00002	2052	2049	CREATE	2021-03-18 06:11:38.549	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
11037	85	1616044299056:-1399686353	1616044296434:-250850862	D5170C00002	2053	2049	CREATE	2021-03-18 06:11:39.147	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
11040	85	1616044301841:495498145	1616044296434:-250850862	D5170C00002	2056	2049	CREATE	2021-03-18 06:11:41.928	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
11044	85	1616044304335:-596790690	1616044292676:-765740436	D5170C00002	2060	2043	CREATE	2021-03-18 06:11:44.425	05 Site Management	05.03 Site Initiation
11047	85	1616044306208:1588177874	1616044304335:-596790690	D5170C00002	2063	2060	CREATE	2021-03-18 06:11:46.295	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
11050	85	1616044307965:-1781991990	1616044306781:-1570128475	D5170C00002	2066	2064	CREATE	2021-03-18 06:11:48.229	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
11054	85	1616044310634:246082852	1616044119105:840225381	D5170C00002	2070	1794	CREATE	2021-03-18 06:11:51.429	Site	2002261 Boyacioglu, Sedat
11057	85	1616044313289:-1282392709	1616044312676:1139745326	D5170C00002	2073	2072	CREATE	2021-03-18 06:11:53.376	01.01 Trial Oversight	01.01.06 Recruitment Plan
11059	85	1616044314484:-590538057	1616044313898:-1943329573	D5170C00002	2075	2074	CREATE	2021-03-18 06:11:54.571	02 Central Trial Documents	02.02 Subject Documents
11063	85	1616044316924:-1472012199	1616044316349:635606959	D5170C00002	2079	2078	CREATE	2021-03-18 06:11:57.01	02.04 General	02.04.01 Relev_ations-Documents
11066	85	1616044318842:-933501091	1616044310634:246082852	D5170C00002	2082	2070	CREATE	2021-03-18 06:11:58.934	2002261 Boyacioglu, Sedat	05 Site Management
11069	85	1616044320823:1148761390	1616044319473:-1650652766	D5170C00002	2085	2083	CREATE	2021-03-18 06:12:00.91	05.01 Site Selection	05.01.02 Confidentiality Agreement
11072	85	1616044323530:-517803999	1616044318842:-933501091	D5170C00002	2088	2082	CREATE	2021-03-18 06:12:03.614	05 Site Management	05.02 Site Set-up Documentation
11075	85	1616044325309:1110823531	1616044323530:-517803999	D5170C00002	2091	2088	CREATE	2021-03-18 06:12:05.395	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
11078	85	1616044327179:499305848	1616044323530:-517803999	D5170C00002	2094	2088	CREATE	2021-03-18 06:12:07.265	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
11082	85	1616044329537:244265847	1616044318842:-933501091	D5170C00002	2098	2082	CREATE	2021-03-18 06:12:09.624	05 Site Management	05.03 Site Initiation
11085	85	1616044331344:727619513	1616044329537:244265847	D5170C00002	2101	2098	CREATE	2021-03-18 06:12:11.432	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
11088	85	1616044334091:-573677009	1616044332062:-1982295578	D5170C00002	2104	2102	CREATE	2021-03-18 06:12:14.176	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
11092	85	1616044336475:932162971	1616044310634:246082852	D5170C00002	2108	2070	CREATE	2021-03-18 06:12:16.558	2002261 Boyacioglu, Sedat	06 IP and Trial Supplies
11095	85	1616044341663:1198874892	1616044119105:840225381	D5170C00002	2111	1794	CREATE	2021-03-18 06:12:21.75	Site	2003204 Celik, Aykut Ferhat
11098	85	1616044343929:59943529	1616044342904:-1153426605	D5170C00002	2114	2113	CREATE	2021-03-18 06:12:24.017	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
11100	85	1616044345103:-158089488	1616044344556:-441543638	D5170C00002	2116	2115	CREATE	2021-03-18 06:12:25.201	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
11103	85	1616044346881:-1340603638	1616044346280:1503739465	D5170C00002	2119	2118	CREATE	2021-03-18 06:12:26.989	TBD-1-1ROJI0A Karakan, Tarkan	05 Site Management
11106	85	1616044348722:816596348	1616044119105:840225381	D5170C00002	2122	1794	CREATE	2021-03-18 06:12:28.803	Site	TBD-1-1XK1D9U Yalniz, Mehmet
11109	85	1616044350541:-1336764421	1616044349959:-457875896	D5170C00002	2125	2124	CREATE	2021-03-18 06:12:30.629	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
11112	85	1616044352179:205722499	1616044351640:-2073699292	D5170C00002	2128	2127	CREATE	2021-03-18 06:12:32.264	Site	TBD-1-25PODT3 Hospodarskyy, Ihor
11115	85	1616044353886:-1105942691	1616044353319:877913662	D5170C00002	2131	2130	CREATE	2021-03-18 06:12:34.381	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
11118	85	1616044356052:1172108087	1616044355443:-400900292	D5170C00002	2134	2133	CREATE	2021-03-18 06:12:36.137	05 Site Management	05.01 Site Selection
11121	85	1616044357746:1825771779	1616044357172:1865320547	D5170C00002	2137	2136	CREATE	2021-03-18 06:12:37.833	UNITED KINGDOM	Site
11123	85	1616044358881:189925105	1616044358287:-1168622510	D5170C00002	2139	2138	CREATE	2021-03-18 06:12:38.963	2002042 Hoque, Syed	02 Central Trial Documents
11126	85	1616044360542:-507791840	1616044359430:1760335989	D5170C00002	2142	2140	CREATE	2021-03-18 06:12:40.629	02.02 Subject Documents	02.02.05 Subject Participation Card
11130	85	1616044363183:-607212831	1616044361636:-1453710866	D5170C00002	2146	2144	CREATE	2021-03-18 06:12:43.269	02.04 General	02.04.01 UNBLI_s-Contact Report
11133	85	1616044365373:-428879835	1616044364312:-1404737046	D5170C00002	2149	2148	CREATE	2021-03-18 06:12:45.461	04.02 Other Committees	04.02.01 Other Submissions
11136	85	1616044367082:917823081	1616044366540:-357854895	D5170C00002	2152	2151	CREATE	2021-03-18 06:12:47.169	05 Site Management	05.01 Site Selection
11139	85	1616044368811:-1581010834	1616044367082:917823081	D5170C00002	2155	2152	CREATE	2021-03-18 06:12:48.899	05.01 Site Selection	05.01.03 Feasibility Documentation
11142	85	1616044403605:13405095	1616044369974:1936192746	D5170C00002	2158	2157	CREATE	2021-03-18 06:13:23.694	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
11146	85	1616044405984:-1964991123	1616044369974:1936192746	D5170C00002	2162	2157	CREATE	2021-03-18 06:13:26.074	05.02 Site Set-up Documentation	05.02.07 Site Qualification
11149	85	1616044408232:1679520105	1616044369974:1936192746	D5170C00002	2165	2157	CREATE	2021-03-18 06:13:28.329	05.02 Site Set-up Documentation	05.02.09 Investigator Regulatory Agreement
11152	85	1616044410027:-964867754	1616044369974:1936192746	D5170C00002	2168	2157	CREATE	2021-03-18 06:13:30.119	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
11156	85	1616044412591:-1070955969	1616044411281:1445113215	D5170C00002	2172	2170	CREATE	2021-03-18 06:13:32.679	05.03 Site Initiation	05.03.03 Site Training-Staff
11160	85	1616044415025:1361998343	1616044413755:-781395165	D5170C00002	2176	2174	CREATE	2021-03-18 06:13:35.11	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
11163	85	1616044416813:-1495475581	1616044416238:2057162530	D5170C00002	2179	2178	CREATE	2021-03-18 06:13:36.9	05.05 General	05.05.01 Relev_unications-Email
11165	85	1616044418600:1731754256	1616044416238:2057162530	D5170C00002	2181	2178	CREATE	2021-03-18 06:13:38.688	05.05 General	05.05.02 Tracking Information
11166	85	1616044419222:-308294840	1616044358287:-1168622510	D5170C00002	2182	2138	CREATE	2021-03-18 06:13:39.31	2002042 Hoque, Syed	06 IP and Trial Supplies
11168	85	1616044420424:-67798525	1616044419861:1264690622	D5170C00002	2184	2183	CREATE	2021-03-18 06:13:40.51	06.05 Non-IP Documentation	06.05.02 Non-IP Documentation of Shipment
11172	85	1616044422818:1286349242	1616044422177:-1078049900	D5170C00002	2188	2187	CREATE	2021-03-18 06:13:42.905	02.02 Subject Documents	02.02.03 Infor_t Form Templates
11175	85	1616044424486:1639620036	1616044422177:-1078049900	D5170C00002	2191	2187	CREATE	2021-03-18 06:13:44.58	02.02 Subject Documents	02.02.07 Other_iven to Subjects
11178	85	1616044426290:-1053707498	1616044421021:1414552527	D5170C00002	2194	2185	CREATE	2021-03-18 06:13:46.384	2002043 Nwokolo, Chukwuka	04 IRB-IEC and other Approvals
11181	85	1616044428767:-1095344350	1616044426290:-1053707498	D5170C00002	2197	2194	CREATE	2021-03-18 06:13:49.004	04 IRB-IEC and other Approvals	04.02 Other Committees
11185	85	1616044431290:585003701	1616044430731:1665082690	D5170C00002	2201	2200	CREATE	2021-03-18 06:13:51.452	05.01 Site Selection	05.01.01 Site Contact Details
11188	85	1616044433300:1753904838	1616044430731:1665082690	D5170C00002	2204	2200	CREATE	2021-03-18 06:13:53.386	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
11191	85	1616044435105:1757676023	1616044433958:-1469462457	D5170C00002	2207	2205	CREATE	2021-03-18 06:13:55.197	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
11195	85	1616044438388:484373635	1616044433958:-1469462457	D5170C00002	2211	2205	CREATE	2021-03-18 06:13:58.474	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
11197	85	1616044440204:515453761	1616044433958:-1469462457	D5170C00002	2213	2205	CREATE	2021-03-18 06:14:00.292	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
11201	85	1616044442642:-309715316	1616044442019:1081201668	D5170C00002	2217	2216	CREATE	2021-03-18 06:14:02.727	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
11205	85	1616044444990:732598337	1616044444375:-1708356823	D5170C00002	2221	2220	CREATE	2021-03-18 06:14:05.075	05.04 Site Management	05.04.04 Visit Log
11208	85	1616044446934:1724049501	1616044430159:-374362909	D5170C00002	2224	2199	CREATE	2021-03-18 06:14:07.02	05 Site Management	05.05 General
11210	85	1616044448160:278418970	1616044446934:1724049501	D5170C00002	2226	2224	CREATE	2021-03-18 06:14:08.247	05.05 General	05.05.01 Relevant Communications-Documents
11213	85	1616044450600:1815465417	1616044449957:959156689	D5170C00002	2229	2228	CREATE	2021-03-18 06:14:10.689	2002161 Harbord, Marcus	02 Central Trial Documents
11216	85	1616044452413:-1505120247	1616044451230:-361333536	D5170C00002	2232	2230	CREATE	2021-03-18 06:14:12.5	02.02 Subject Documents	02.02.05 Subject Participation Card
11220	85	1616044454787:-297401066	1616044454186:-499464555	D5170C00002	2236	2235	CREATE	2021-03-18 06:14:14.875	02.04 General	02.04.01 Relev_ations-Documents
11223	85	1616044456549:738119504	1616044455972:1943697658	D5170C00002	2239	2238	CREATE	2021-03-18 06:14:16.639	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
11227	85	1616044459159:2104996735	1616044458513:-1779638327	D5170C00002	2243	2242	CREATE	2021-03-18 06:14:19.249	05.01 Site Selection	05.01.02 Confidentiality Agreement
11229	85	1616044461045:-1067850841	1616044457926:-1353071221	D5170C00002	2245	2241	CREATE	2021-03-18 06:14:21.136	05 Site Management	05.02 Site Set-up Documentation
11230	85	1616044461621:1184237092	1616044461045:-1067850841	D5170C00002	2246	2245	CREATE	2021-03-18 06:14:21.706	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
11233	85	1616044463358:174214980	1616044461045:-1067850841	D5170C00002	2249	2245	CREATE	2021-03-18 06:14:23.445	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
11236	85	1616044465180:250017290	1616044461045:-1067850841	D5170C00002	2252	2245	CREATE	2021-03-18 06:14:25.269	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
11240	85	1616044467511:2085255157	1616044466947:115280286	D5170C00002	2256	2255	CREATE	2021-03-18 06:14:27.596	05.03 Site Initiation	05.03.03 Site Training-Staff
11243	85	1616044469302:-383769679	1616044468088:398370059	D5170C00002	2259	2257	CREATE	2021-03-18 06:14:29.388	05.04 Site Management	05.04.09 Inv Notification-SUSAR
11246	85	1616044471743:-1474800681	1616044469876:2122425372	D5170C00002	2262	2260	CREATE	2021-03-18 06:14:31.83	05.05 General	05.05.01 Relevant Communications-Documents
11250	85	1616044474093:-1298139862	1616044473520:161802953	D5170C00002	2266	2265	CREATE	2021-03-18 06:14:34.183	05 Site Management	05.01 Site Selection
11253	85	1616044476014:-947596401	1616044475289:-1695620963	D5170C00002	2269	2268	CREATE	2021-03-18 06:14:36.102	TBD-1-1PTCU4D Arnott, Ian	05 Site Management
11255	85	1616044477146:-4599808	1616044476588:1292447884	D5170C00002	2271	2270	CREATE	2021-03-18 06:14:37.231	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
11259	85	1616044479469:-1754474385	1616044478896:-948110432	D5170C00002	2275	2274	CREATE	2021-03-18 06:14:39.557	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
11263	85	1616044482556:-1401552591	1616044481211:1022147660	D5170C00002	2279	2278	CREATE	2021-03-18 06:14:42.649	UNITED STATES	Site
11265	85	1616044483715:239655172	1616044483116:885994259	D5170C00002	2281	2280	CREATE	2021-03-18 06:14:43.806	2001691 Connor, Michael	02 Central Trial Documents
11268	85	1616044485571:907805206	1616044484302:-909630057	D5170C00002	2284	2282	CREATE	2021-03-18 06:14:45.658	02.02 Subject Documents	02.02.02 Subject Questionnaire
11271	85	1616044487283:1996197134	1616044484302:-909630057	D5170C00002	2287	2282	CREATE	2021-03-18 06:14:47.368	02.02 Subject Documents	02.02.07 Other_iven to Subjects
11275	85	1616044489650:825409454	1616044483116:885994259	D5170C00002	2291	2280	CREATE	2021-03-18 06:14:49.766	2001691 Connor, Michael	04 IRB-IEC and other Approvals
11278	85	1616044491483:1396860092	1616044489650:825409454	D5170C00002	2294	2291	CREATE	2021-03-18 06:14:51.577	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
11281	85	1616044494018:-693385720	1616044493365:-1564616040	D5170C00002	2297	2296	CREATE	2021-03-18 06:14:54.11	05 Site Management	05.01 Site Selection
11284	85	1616044495804:480129654	1616044494018:-693385720	D5170C00002	2300	2297	CREATE	2021-03-18 06:14:55.899	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
11287	85	1616044497605:1223316372	1616044496415:1692633642	D5170C00002	2303	2301	CREATE	2021-03-18 06:14:57.692	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
11290	85	1616044499346:-1503932516	1616044496415:1692633642	D5170C00002	2306	2301	CREATE	2021-03-18 06:14:59.431	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
11293	85	1616044501168:1055581212	1616044496415:1692633642	D5170C00002	2309	2301	CREATE	2021-03-18 06:15:01.258	05.02 Site Set-up Documentation	05.02.09 Investigator Regulatory Agreement
11294	85	1616044502377:-1453559296	1616044496415:1692633642	D5170C00002	2310	2301	CREATE	2021-03-18 06:15:02.468	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
11295	85	1616044502997:102379650	1616044496415:1692633642	D5170C00002	2311	2301	CREATE	2021-03-18 06:15:03.791	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
11298	85	1616044505612:-1871125980	1616044493365:-1564616040	D5170C00002	2314	2296	CREATE	2021-03-18 06:15:05.768	05 Site Management	05.03 Site Initiation
11301	85	1616044507688:1452204761	1616044505612:-1871125980	D5170C00002	2317	2314	CREATE	2021-03-18 06:15:07.772	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
11304	85	1616044509470:-1364425679	1616044508250:1592449925	D5170C00002	2320	2318	CREATE	2021-03-18 06:15:09.562	05.04 Site Management	05.04.03 Monitoring Visit Report
11308	85	1616044511879:-146252005	1616044508250:1592449925	D5170C00002	2324	2318	CREATE	2021-03-18 06:15:11.966	05.04 Site Management	05.04.05 UNBLI_itoring Activity
11310	85	1616044513043:-317291344	1616044508250:1592449925	D5170C00002	2326	2318	CREATE	2021-03-18 06:15:13.13	05.04 Site Management	05.04.06 UNBLINDED Protocol Deviations and Waivers
11314	85	1616044516299:-1515055985	1616044483116:885994259	D5170C00002	2330	2280	CREATE	2021-03-18 06:15:16.396	2001691 Connor, Michael	06 IP and Trial Supplies
11317	85	1616044518122:-1495039072	1616044516904:957490106	D5170C00002	2333	2331	CREATE	2021-03-18 06:15:18.208	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
11321	85	1616044520665:2112603817	1616044520046:-1448412557	D5170C00002	2337	2336	CREATE	2021-03-18 06:15:20.754	06.03 IP Alloc_on Documentation	06.03.01 Treat_on Documentation
11324	85	1616044522586:-1222269929	1616044521264:1345388128	D5170C00002	2340	2338	CREATE	2021-03-18 06:15:22.673	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
11327	85	1616044524433:781555588	1616044482556:-1401552591	D5170C00002	2343	2279	CREATE	2021-03-18 06:15:24.52	Site	2001692 Seminerio, Jennifer
11330	85	1616044527131:887624858	1616044526466:1948545428	D5170C00002	2346	2345	CREATE	2021-03-18 06:15:27.219	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
11333	85	1616044528968:1840531848	1616044528321:1235587192	D5170C00002	2349	2348	CREATE	2021-03-18 06:15:29.055	02 Central Trial Documents	02.02 Subject Documents
11336	85	1616044530751:1273563743	1616044530167:457033612	D5170C00002	2352	2351	CREATE	2021-03-18 06:15:30.838	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
11340	85	1616044533155:-816383598	1616044530751:1273563743	D5170C00002	2356	2352	CREATE	2021-03-18 06:15:33.246	04.01 IRB-IEC Trial Approval	04.01.05 IRB-I_liance Statement
11343	85	1616044534931:-2082066997	1616044534330:504922225	D5170C00002	2359	2358	CREATE	2021-03-18 06:15:35.018	05.01 Site Selection	05.01.02 Confidentiality Agreement
11347	85	1616044538394:112167030	1616044537795:1216741538	D5170C00002	2363	2362	CREATE	2021-03-18 06:15:38.482	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
11350	85	1616044540225:-313364831	1616044537795:1216741538	D5170C00002	2366	2362	CREATE	2021-03-18 06:15:40.315	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
11354	85	1616044542686:-157025006	1616044542041:1326287762	D5170C00002	2370	2369	CREATE	2021-03-18 06:15:42.882	2001695 Bassan, Isaac	02 Central Trial Documents
11356	85	1616044544155:-2021994131	1616044543422:-290154688	D5170C00002	2372	2371	CREATE	2021-03-18 06:15:44.245	02.02 Subject Documents	02.02.01 Subject Diary
11358	85	1616044545383:-1618866330	1616044543422:-290154688	D5170C00002	2374	2371	CREATE	2021-03-18 06:15:45.473	02.02 Subject Documents	02.02.03 Infor_t Form Templates
11360	85	1616044546632:-722822701	1616044543422:-290154688	D5170C00002	2376	2371	CREATE	2021-03-18 06:15:47.627	02.02 Subject Documents	02.02.07 Other_iven to Subjects
11364	85	1616044550071:-935557368	1616044542041:1326287762	D5170C00002	2380	2369	CREATE	2021-03-18 06:15:50.155	2001695 Bassan, Isaac	04 IRB-IEC and other Approvals
11366	85	1616044551310:1613327960	1616044550736:1428041103	D5170C00002	2382	2381	CREATE	2021-03-18 06:15:51.395	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
11370	85	1616044559288:1995840739	1616044553185:969405652	D5170C00002	2386	2385	CREATE	2021-03-18 06:15:59.38	05 Site Management	05.01 Site Selection
11373	85	1616044561296:198354222	1616044559288:1995840739	D5170C00002	2389	2386	CREATE	2021-03-18 06:16:01.386	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
11376	85	1616044563451:1790110536	1616044562163:-55180897	D5170C00002	2392	2390	CREATE	2021-03-18 06:16:03.539	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
11379	85	1616044565306:-86557563	1616044562163:-55180897	D5170C00002	2395	2390	CREATE	2021-03-18 06:16:05.397	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
11383	85	1616044567833:1365518585	1616044562163:-55180897	D5170C00002	2399	2390	CREATE	2021-03-18 06:16:07.929	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
11386	85	1616044570538:1908623149	1616044569900:1273164196	D5170C00002	2402	2401	CREATE	2021-03-18 06:16:10.725	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
11390	85	1616044573108:-1737471460	1616044572490:-1374384247	D5170C00002	2406	2405	CREATE	2021-03-18 06:16:13.195	05.04 Site Management	05.04.04 UNBLINDED Visit Log
11394	85	1616044576346:47142393	1616044575122:-1159850762	D5170C00002	2410	2409	CREATE	2021-03-18 06:16:16.432	05.05 General	05.05.02 Tracking Information
11396	85	1616044577699:2117301680	1616044577064:1160933319	D5170C00002	2412	2411	CREATE	2021-03-18 06:16:17.787	06 IP and Trial Supplies	06.01 IP Documentation
11399	85	1616044579537:655268407	1616044578921:-1112983243	D5170C00002	2415	2414	CREATE	2021-03-18 06:16:20.67	2001696 Headstrom, Peggy	02 Central Trial Documents
11402	85	1616044582449:1858351420	1616044581281:-1873013556	D5170C00002	2418	2416	CREATE	2021-03-18 06:16:22.534	02.02 Subject Documents	02.02.02 Subject Questionnaire
11406	85	1616044584830:-1231632381	1616044581281:-1873013556	D5170C00002	2422	2416	CREATE	2021-03-18 06:16:24.918	02.02 Subject Documents	02.02.07 Other_iven to Subjects
11409	85	1616044586731:1995988871	1616044585399:575333793	D5170C00002	2425	2423	CREATE	2021-03-18 06:16:26.818	02.04 General	02.04.01 UNBLI_s-Contact Report
11412	85	1616044588620:-722530634	1616044587984:-1371054014	D5170C00002	2428	2427	CREATE	2021-03-18 06:16:28.719	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
11415	85	1616044590407:1739025712	1616044589806:-1205253104	D5170C00002	2431	2430	CREATE	2021-03-18 06:16:30.494	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
11418	85	1616044593201:789954293	1616044592605:1277571825	D5170C00002	2434	2433	CREATE	2021-03-18 06:16:33.288	05.01 Site Selection	05.01.02 Confidentiality Agreement
11421	85	1616044595020:1042823940	1616044592018:414219112	D5170C00002	2437	2432	CREATE	2021-03-18 06:16:35.107	05 Site Management	05.02 Site Set-up Documentation
11423	85	1616044596210:1321387806	1616044595020:1042823940	D5170C00002	2439	2437	CREATE	2021-03-18 06:16:36.301	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
11427	85	1616044598714:-1515677093	1616044595020:1042823940	D5170C00002	2443	2437	CREATE	2021-03-18 06:16:38.801	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
11430	85	1616044600449:494989896	1616044595020:1042823940	D5170C00002	2446	2437	CREATE	2021-03-18 06:16:40.54	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
11434	85	1616044603779:-1426948919	1616044603178:-1122476858	D5170C00002	2450	2449	CREATE	2021-03-18 06:16:43.868	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
11437	85	1616044605643:-675591422	1616044605042:2053843206	D5170C00002	2453	2452	CREATE	2021-03-18 06:16:45.735	05.04 Site Management	05.04.05 Additional Monitoring Activity
11441	85	1616044608311:-658982899	1616044607710:-1881323594	D5170C00002	2457	2456	CREATE	2021-03-18 06:16:48.433	05.05 General	05.05.02 Tracking Information
11443	85	1616044609586:-236281463	1616044608953:878588026	D5170C00002	2459	2458	CREATE	2021-03-18 06:16:49.676	2001698 Khurana, Sunil	02 Central Trial Documents
11447	85	1616044612241:958391869	1616044611622:109980032	D5170C00002	2463	2462	CREATE	2021-03-18 06:16:52.334	02.04 General	02.04.01 Relev_s-Contact Report
11449	85	1616044614577:2026781305	1616044608953:878588026	D5170C00002	2465	2458	CREATE	2021-03-18 06:16:54.66	2001698 Khurana, Sunil	04 IRB-IEC and other Approvals
11452	85	1616044616377:-301052499	1616044614577:2026781305	D5170C00002	2468	2465	CREATE	2021-03-18 06:16:56.464	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
11456	85	1616044619079:668300634	1616044618460:-270994340	D5170C00002	2472	2471	CREATE	2021-03-18 06:16:59.165	05.01 Site Selection	05.01.02 Confidentiality Agreement
11459	85	1616044620960:295579180	1616044617866:-2037412411	D5170C00002	2475	2470	CREATE	2021-03-18 06:17:01.05	05 Site Management	05.02 Site Set-up Documentation
11462	85	1616044622845:78357323	1616044620960:295579180	D5170C00002	2478	2475	CREATE	2021-03-18 06:17:02.943	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
11466	85	1616044626616:1283843961	1616044620960:295579180	D5170C00002	2482	2475	CREATE	2021-03-18 06:17:06.706	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
11469	85	1616044628677:1297927230	1616044620960:295579180	D5170C00002	2485	2475	CREATE	2021-03-18 06:17:08.762	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
11472	85	1616044630557:344419776	1616044629984:-195510960	D5170C00002	2488	2487	CREATE	2021-03-18 06:17:10.644	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
11476	85	1616044633129:1581614054	1616044632530:1903905609	D5170C00002	2492	2491	CREATE	2021-03-18 06:17:13.215	05.04 Site Management	05.04.01 Subject Log
11479	85	1616044635003:-343130353	1616044632530:1903905609	D5170C00002	2495	2491	CREATE	2021-03-18 06:17:16.11	05.04 Site Management	05.04.05 UNBLI_itoring Activity
11482	85	1616044637929:-2092745316	1616044637275:-663813065	D5170C00002	2498	2497	CREATE	2021-03-18 06:17:18.015	05.05 General	05.05.02 Tracking Information
11551	86	\N	\N	D5170C00002	2	1	NEW	\N	eTMF	Quintiles IQVIA
11483	85	1616044638521:-171705913	1616044608953:878588026	D5170C00002	2499	2458	CREATE	2021-03-18 06:17:18.608	2001698 Khurana, Sunil	06 IP and Trial Supplies
11485	85	1616044639768:1749860026	1616044639114:195840278	D5170C00002	2501	2500	CREATE	2021-03-18 06:17:19.869	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
11489	85	1616044642155:-1515261986	1616044641579:321985812	D5170C00002	2505	2504	CREATE	2021-03-18 06:17:22.244	06.04 Storage	06.04.01 UNBLINDED Storage Condition Documentation
11492	85	1616044644085:-1545034686	1616044643477:900868466	D5170C00002	2508	2507	CREATE	2021-03-18 06:17:24.169	2001699 Mehta, Nilesh	02 Central Trial Documents
11495	85	1616044647675:-1170640072	1616044644683:734799504	D5170C00002	2511	2509	CREATE	2021-03-18 06:17:27.782	02.02 Subject Documents	02.02.02 Subject Questionnaire
11498	85	1616044649635:1034220538	1616044644683:734799504	D5170C00002	2514	2509	CREATE	2021-03-18 06:17:29.724	02.02 Subject Documents	02.02.06 Adver_ject Recruitment
11501	85	1616044651477:-1618086227	1616044650880:2116646041	D5170C00002	2517	2516	CREATE	2021-03-18 06:17:31.569	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
11505	85	1616044653957:-674022655	1616044653352:-1640880624	D5170C00002	2521	2520	CREATE	2021-03-18 06:17:34.044	05 Site Management	05.01 Site Selection
11508	85	1616044655758:732057760	1616044653957:-674022655	D5170C00002	2524	2521	CREATE	2021-03-18 06:17:35.846	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
11511	85	1616044658919:1837853813	1616044656446:-1360736429	D5170C00002	2527	2525	CREATE	2021-03-18 06:17:39.009	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
11514	85	1616044660831:1400032890	1616044656446:-1360736429	D5170C00002	2530	2525	CREATE	2021-03-18 06:17:40.928	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
11519	85	1616044664073:-1597350212	1616044663418:490724666	D5170C00002	2535	2534	CREATE	2021-03-18 06:17:44.157	05.05 General	05.05.02 Tracking Information
11521	85	1616044665301:-1609575163	1616044664709:197344214	D5170C00002	2537	2536	CREATE	2021-03-18 06:17:45.388	2001700 Idarraga, Samuel	02 Central Trial Documents
11525	85	1616044667929:104411784	1616044667198:518331636	D5170C00002	2541	2540	CREATE	2021-03-18 06:17:48.026	02.04 General	02.04.01 Relev_s-Contact Report
11527	85	1616044670243:539358600	1616044664709:197344214	D5170C00002	2543	2536	CREATE	2021-03-18 06:17:50.336	2001700 Idarraga, Samuel	04 IRB-IEC and other Approvals
11530	85	1616044672096:1556935805	1616044670243:539358600	D5170C00002	2546	2543	CREATE	2021-03-18 06:17:52.199	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
11534	85	1616044674638:424816655	1616044674021:1868588612	D5170C00002	2550	2549	CREATE	2021-03-18 06:17:54.786	05.01 Site Selection	05.01.02 Confidentiality Agreement
11537	85	1616044676540:-40359322	1616044673332:-628390298	D5170C00002	2553	2548	CREATE	2021-03-18 06:17:56.626	05 Site Management	05.02 Site Set-up Documentation
11540	85	1616044678458:1920999767	1616044676540:-40359322	D5170C00002	2556	2553	CREATE	2021-03-18 06:17:58.543	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
11544	85	1616044682300:2107689230	1616044676540:-40359322	D5170C00002	2560	2553	CREATE	2021-03-18 06:18:02.391	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
11546	85	1616044683626:740342359	1616044676540:-40359322	D5170C00002	2562	2553	CREATE	2021-03-18 06:18:03.725	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
11549	85	1616044685601:1654000482	1616044684884:-676674037	D5170C00002	2565	2564	CREATE	2021-03-18 06:18:05.688	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
15182	88	1617050572356:212547738	1617050182170:-1429529666	D5170C00001	872	471	ALREADY AVAILABLE	2021-03-30 07:19:37.319	Canada	1016
15234	88	1617050629316:-980367197	1617050627586:-1316449834	D5170C00001	924	923	ALREADY AVAILABLE	2021-03-30 07:19:37.319	Czech Republic	1901
15278	88	1617050667990:-173100630	1617050627586:-1316449834	D5170C00001	968	923	ALREADY AVAILABLE	2021-03-30 07:19:37.319	Czech Republic	1902
15314	88	1617050709337:1440483749	1617050627586:-1316449834	D5170C00001	1004	923	ALREADY AVAILABLE	2021-03-30 07:19:37.319	Czech Republic	1903
15359	88	1617050752425:-1641031668	1617050627586:-1316449834	D5170C00001	1049	923	ALREADY AVAILABLE	2021-03-30 07:19:37.319	Czech Republic	1904
15363	88	1617050757043:-227566584	1617050627586:-1316449834	D5170C00001	1053	923	ALREADY AVAILABLE	2021-03-30 07:19:37.319	Czech Republic	1905
15411	88	1617050809522:1185993981	1617050627586:-1316449834	D5170C00001	1101	923	ALREADY AVAILABLE	2021-03-30 07:19:37.319	Czech Republic	1906
15416	88	1617050813994:-966217426	1617050813308:-388381196	D5170C00001	1106	1105	ALREADY AVAILABLE	2021-03-30 07:19:37.319	France	2301
15456	88	1617050848789:447364357	1617050813308:-388381196	D5170C00001	1146	1105	ALREADY AVAILABLE	2021-03-30 07:19:37.319	France	2302
15491	88	1617050879782:1860882486	1617050813308:-388381196	D5170C00001	1181	1105	ALREADY AVAILABLE	2021-03-30 07:19:37.319	France	2303
15503	88	1617050887704:-1310750877	1617050813308:-388381196	D5170C00001	1193	1105	ALREADY AVAILABLE	2021-03-30 07:19:37.319	France	2304
15575	88	1617050948026:-1563471959	1617050947418:307056746	D5170C00001	1265	1264	ALREADY AVAILABLE	2021-03-30 07:19:37.319	Germany	2601, 2602
15579	88	1617050950392:-865869964	1617050947418:307056746	D5170C00001	1269	1264	ALREADY AVAILABLE	2021-03-30 07:19:37.319	Germany	2601
15598	88	1617050964476:-57606151	1617050947418:307056746	D5170C00001	1288	1264	ALREADY AVAILABLE	2021-03-30 07:19:37.319	Germany	2602
15629	88	1617051000367:-1036916876	1617050947418:307056746	D5170C00001	1319	1264	ALREADY AVAILABLE	2021-03-30 07:19:37.319	Germany	2604
15662	88	1617051027993:1087214165	1617051021606:95161147	D5170C00001	1352	1351	ALREADY AVAILABLE	2021-03-30 07:19:37.319	Hungary	3301
15698	88	1617051052456:-1794171348	1617051021606:95161147	D5170C00001	1388	1351	ALREADY AVAILABLE	2021-03-30 07:19:37.32	Hungary	3302
15730	88	1617051079236:111814508	1617051021606:95161147	D5170C00001	1420	1351	ALREADY AVAILABLE	2021-03-30 07:19:37.32	Hungary	3303
15766	88	1617051108777:1327366969	1617051021606:95161147	D5170C00001	1456	1351	ALREADY AVAILABLE	2021-03-30 07:19:37.32	Hungary	3304
15797	88	1617051168428:-1356074094	1617051021606:95161147	D5170C00001	1487	1351	ALREADY AVAILABLE	2021-03-30 07:19:37.32	Hungary	3305
15832	88	1617051197667:-2006859691	1617051196990:749950322	D5170C00001	1522	1521	ALREADY AVAILABLE	2021-03-30 07:19:37.32	Italy	4101
15886	88	1617051238334:-593288517	1617051196990:749950322	D5170C00001	1576	1521	ALREADY AVAILABLE	2021-03-30 07:19:37.32	Italy	4102
15936	88	1617051282034:330095865	1617051196990:749950322	D5170C00001	1626	1521	ALREADY AVAILABLE	2021-03-30 07:19:37.32	Italy	4103
15987	88	1617051328560:2039166344	1617051196990:749950322	D5170C00001	1677	1521	ALREADY AVAILABLE	2021-03-30 07:19:37.32	Italy	4104
16044	88	1617051382807:-1137591166	1617051196990:749950322	D5170C00001	1734	1521	ALREADY AVAILABLE	2021-03-30 07:19:37.32	Italy	4105
16094	88	1617051419745:1177635394	1617051196990:749950322	D5170C00001	1784	1521	ALREADY AVAILABLE	2021-03-30 07:19:37.32	Italy	4106
11569	86	\N	\N	D5170C00002	20	13	NEW	\N	05.04 Site Management	05.04.06 UNBLINDED Protocol Deviations and Waivers
11570	86	\N	\N	D5170C00002	21	13	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
11571	86	\N	\N	D5170C00002	22	8	NEW	\N	05 Site Management	05.05 General
11572	86	\N	\N	D5170C00002	23	22	NEW	\N	05.05 General	05.05.01 Relev_ations-Documents
11573	86	\N	\N	D5170C00002	24	22	NEW	\N	05.05 General	05.05.02 Tracking Information
11574	86	\N	\N	D5170C00002	25	7	NEW	\N	2001700 Idarraga, Samuel	06 IP and Trial Supplies
11575	86	\N	\N	D5170C00002	26	25	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
11576	86	\N	\N	D5170C00002	27	26	NEW	\N	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
11577	86	\N	\N	D5170C00002	28	26	NEW	\N	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
11578	86	\N	\N	D5170C00002	29	26	NEW	\N	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
11579	86	\N	\N	D5170C00002	30	26	NEW	\N	06.01 IP Documentation	06.01.10 UNBLI_mentation Return
11580	86	\N	\N	D5170C00002	31	25	NEW	\N	06 IP and Trial Supplies	06.04 Storage
11581	86	\N	\N	D5170C00002	32	31	NEW	\N	06.04 Storage	06.04.01 UNBLI_on Documentation
11582	86	\N	\N	D5170C00002	33	31	NEW	\N	06.04 Storage	06.04.02 UNBLI_on Documentation
11583	86	\N	\N	D5170C00002	34	31	NEW	\N	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
11584	86	\N	\N	D5170C00002	35	6	NEW	\N	Site	2001701 Narayen, Vijay
11585	86	\N	\N	D5170C00002	36	35	NEW	\N	2001701 Narayen, Vijay	02 Central Trial Documents
11586	86	\N	\N	D5170C00002	37	36	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
11587	86	\N	\N	D5170C00002	38	37	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
11588	86	\N	\N	D5170C00002	39	36	NEW	\N	02 Central Trial Documents	02.04 General
11589	86	\N	\N	D5170C00002	40	39	NEW	\N	02.04 General	02.04.01 Relev_ations-Documents
11590	86	\N	\N	D5170C00002	41	39	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
11591	86	\N	\N	D5170C00002	42	39	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
11592	86	\N	\N	D5170C00002	43	35	NEW	\N	2001701 Narayen, Vijay	04 IRB-IEC and other Approvals
11593	86	\N	\N	D5170C00002	44	43	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
11594	86	\N	\N	D5170C00002	45	44	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
11595	86	\N	\N	D5170C00002	46	44	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
11596	86	\N	\N	D5170C00002	47	43	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
11597	86	\N	\N	D5170C00002	48	47	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
11598	86	\N	\N	D5170C00002	49	43	NEW	\N	04 IRB-IEC and other Approvals	04.04 General
11599	86	\N	\N	D5170C00002	50	49	NEW	\N	04.04 General	04.04.01 Relev_RB-IEC-Documents
11600	86	\N	\N	D5170C00002	51	35	NEW	\N	2001701 Narayen, Vijay	05 Site Management
11601	86	\N	\N	D5170C00002	52	51	NEW	\N	05 Site Management	05.01 Site Selection
11602	86	\N	\N	D5170C00002	53	52	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
11603	86	\N	\N	D5170C00002	54	52	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
11604	86	\N	\N	D5170C00002	55	52	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
11605	86	\N	\N	D5170C00002	56	51	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
11606	86	\N	\N	D5170C00002	57	56	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
11607	86	\N	\N	D5170C00002	58	56	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
11608	86	\N	\N	D5170C00002	59	56	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
11609	86	\N	\N	D5170C00002	60	56	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
11610	86	\N	\N	D5170C00002	61	56	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
11611	86	\N	\N	D5170C00002	62	56	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Site Qualification
11612	86	\N	\N	D5170C00002	63	56	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
11613	86	\N	\N	D5170C00002	64	56	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
11614	86	\N	\N	D5170C00002	65	56	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
11615	86	\N	\N	D5170C00002	66	56	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
11616	86	\N	\N	D5170C00002	67	56	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
11617	86	\N	\N	D5170C00002	68	51	NEW	\N	05 Site Management	05.03 Site Initiation
11618	86	\N	\N	D5170C00002	69	68	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
11619	86	\N	\N	D5170C00002	70	68	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
11620	86	\N	\N	D5170C00002	71	51	NEW	\N	05 Site Management	05.04 Site Management
11621	86	\N	\N	D5170C00002	72	71	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
11622	86	\N	\N	D5170C00002	73	71	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
11623	86	\N	\N	D5170C00002	74	51	NEW	\N	05 Site Management	05.05 General
11624	86	\N	\N	D5170C00002	75	74	NEW	\N	05.05 General	05.05.02 Tracking Information
11625	86	\N	\N	D5170C00002	76	35	NEW	\N	2001701 Narayen, Vijay	06 IP and Trial Supplies
11626	86	\N	\N	D5170C00002	77	76	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
11627	86	\N	\N	D5170C00002	78	77	NEW	\N	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
11628	86	\N	\N	D5170C00002	79	6	NEW	\N	Site	2001702 Abdul-Baki, Heitham
11629	86	\N	\N	D5170C00002	80	79	NEW	\N	2001702 Abdul-Baki, Heitham	02 Central Trial Documents
11630	86	\N	\N	D5170C00002	81	80	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
11631	86	\N	\N	D5170C00002	82	81	NEW	\N	02.02 Subject Documents	02.02.03 Infor_ Form Checklists
11632	86	\N	\N	D5170C00002	83	81	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
11633	86	\N	\N	D5170C00002	84	80	NEW	\N	02 Central Trial Documents	02.04 General
11634	86	\N	\N	D5170C00002	85	84	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
11635	86	\N	\N	D5170C00002	86	84	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
11654	86	\N	\N	D5170C00002	105	97	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Investigator Regulatory Agreement
11655	86	\N	\N	D5170C00002	106	97	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
11656	86	\N	\N	D5170C00002	107	97	NEW	\N	05.02 Site Set-up Documentation	05.02.11 Data Privacy
11657	86	\N	\N	D5170C00002	108	97	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
11658	86	\N	\N	D5170C00002	109	97	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
11659	86	\N	\N	D5170C00002	110	97	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
11660	86	\N	\N	D5170C00002	111	92	NEW	\N	05 Site Management	05.03 Site Initiation
11661	86	\N	\N	D5170C00002	112	111	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
11662	86	\N	\N	D5170C00002	113	111	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
11663	86	\N	\N	D5170C00002	114	92	NEW	\N	05 Site Management	05.04 Site Management
11664	86	\N	\N	D5170C00002	115	114	NEW	\N	05.04 Site Management	05.04.04 Visit Log
11665	86	\N	\N	D5170C00002	116	114	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
11666	86	\N	\N	D5170C00002	117	92	NEW	\N	05 Site Management	05.05 General
11667	86	\N	\N	D5170C00002	118	117	NEW	\N	05.05 General	05.05.02 Tracking Information
11668	86	\N	\N	D5170C00002	119	79	NEW	\N	2001702 Abdul-Baki, Heitham	06 IP and Trial Supplies
11669	86	\N	\N	D5170C00002	120	119	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
11670	86	\N	\N	D5170C00002	121	120	NEW	\N	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
11671	86	\N	\N	D5170C00002	122	119	NEW	\N	06 IP and Trial Supplies	06.05 Non-IP Documentation
11672	86	\N	\N	D5170C00002	123	122	NEW	\N	06.05 Non-IP Documentation	06.05.02 Non-I_tion of Shipment
11673	86	\N	\N	D5170C00002	124	122	NEW	\N	06.05 Non-IP Documentation	06.05.03 Non-I_tation of Return
11674	86	\N	\N	D5170C00002	125	6	NEW	\N	Site	2001703 Phillips, Raymond
11675	86	\N	\N	D5170C00002	126	125	NEW	\N	2001703 Phillips, Raymond	05 Site Management
11676	86	\N	\N	D5170C00002	127	126	NEW	\N	05 Site Management	05.01 Site Selection
11677	86	\N	\N	D5170C00002	128	127	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
11678	86	\N	\N	D5170C00002	129	6	NEW	\N	Site	2001704 Silvers, David
11679	86	\N	\N	D5170C00002	130	129	NEW	\N	2001704 Silvers, David	02 Central Trial Documents
11680	86	\N	\N	D5170C00002	131	130	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
11681	86	\N	\N	D5170C00002	132	131	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
11682	86	\N	\N	D5170C00002	133	130	NEW	\N	02 Central Trial Documents	02.04 General
11683	86	\N	\N	D5170C00002	134	133	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
11684	86	\N	\N	D5170C00002	135	133	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
11685	86	\N	\N	D5170C00002	136	129	NEW	\N	2001704 Silvers, David	04 IRB-IEC and other Approvals
11686	86	\N	\N	D5170C00002	137	136	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
11687	86	\N	\N	D5170C00002	138	137	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
11688	86	\N	\N	D5170C00002	139	137	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
11689	86	\N	\N	D5170C00002	140	129	NEW	\N	2001704 Silvers, David	05 Site Management
11690	86	\N	\N	D5170C00002	141	140	NEW	\N	05 Site Management	05.01 Site Selection
11691	86	\N	\N	D5170C00002	142	141	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
11692	86	\N	\N	D5170C00002	143	141	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
11693	86	\N	\N	D5170C00002	144	141	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
11694	86	\N	\N	D5170C00002	145	140	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
11695	86	\N	\N	D5170C00002	146	145	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
11696	86	\N	\N	D5170C00002	147	145	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
11697	86	\N	\N	D5170C00002	148	145	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
11698	86	\N	\N	D5170C00002	149	145	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
11699	86	\N	\N	D5170C00002	150	145	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
11700	86	\N	\N	D5170C00002	151	145	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
11701	86	\N	\N	D5170C00002	152	145	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
11702	86	\N	\N	D5170C00002	153	145	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
11703	86	\N	\N	D5170C00002	154	145	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
11704	86	\N	\N	D5170C00002	155	145	NEW	\N	05.02 Site Set-up Documentation	05.02.13 Indemnity
11705	86	\N	\N	D5170C00002	156	145	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
11706	86	\N	\N	D5170C00002	157	145	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
11707	86	\N	\N	D5170C00002	158	140	NEW	\N	05 Site Management	05.03 Site Initiation
11708	86	\N	\N	D5170C00002	159	158	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
11709	86	\N	\N	D5170C00002	160	158	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
11710	86	\N	\N	D5170C00002	161	158	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
11711	86	\N	\N	D5170C00002	162	140	NEW	\N	05 Site Management	05.04 Site Management
11712	86	\N	\N	D5170C00002	163	162	NEW	\N	05.04 Site Management	05.04.01 Subject Log
11713	86	\N	\N	D5170C00002	164	162	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
11714	86	\N	\N	D5170C00002	165	162	NEW	\N	05.04 Site Management	05.04.04 Visit Log
11715	86	\N	\N	D5170C00002	166	162	NEW	\N	05.04 Site Management	05.04.05 Additional Monitoring Activity
11716	86	\N	\N	D5170C00002	167	162	NEW	\N	05.04 Site Management	05.04.05 UNBLI_itoring Activity
11717	86	\N	\N	D5170C00002	168	162	NEW	\N	05.04 Site Management	05.04.06 UNBLINDED Protocol Deviations and Waivers
11785	86	\N	\N	D5170C00002	236	232	NEW	\N	02 Central Trial Documents	02.04 General
11718	86	\N	\N	D5170C00002	169	162	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
11719	86	\N	\N	D5170C00002	170	140	NEW	\N	05 Site Management	05.05 General
11720	86	\N	\N	D5170C00002	171	170	NEW	\N	05.05 General	05.05.01 Relevant Communications-Documents
11721	86	\N	\N	D5170C00002	172	170	NEW	\N	05.05 General	05.05.02 Tracking Information
11722	86	\N	\N	D5170C00002	173	129	NEW	\N	2001704 Silvers, David	06 IP and Trial Supplies
11723	86	\N	\N	D5170C00002	174	173	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
11724	86	\N	\N	D5170C00002	175	174	NEW	\N	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
11725	86	\N	\N	D5170C00002	176	174	NEW	\N	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
11726	86	\N	\N	D5170C00002	177	174	NEW	\N	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
11727	86	\N	\N	D5170C00002	178	174	NEW	\N	06.01 IP Documentation	06.01.10 UNBLI_mentation Return
11728	86	\N	\N	D5170C00002	179	173	NEW	\N	06 IP and Trial Supplies	06.04 Storage
11729	86	\N	\N	D5170C00002	180	179	NEW	\N	06.04 Storage	06.04.01 Storage Condition Documentation
11730	86	\N	\N	D5170C00002	181	179	NEW	\N	06.04 Storage	06.04.01 UNBLINDED Storage Condition Documentation
11731	86	\N	\N	D5170C00002	182	179	NEW	\N	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
11732	86	\N	\N	D5170C00002	183	173	NEW	\N	06 IP and Trial Supplies	06.05 Non-IP Documentation
11733	86	\N	\N	D5170C00002	184	183	NEW	\N	06.05 Non-IP Documentation	06.05.03 Non-I_tation of Return
11734	86	\N	\N	D5170C00002	185	173	NEW	\N	06 IP and Trial Supplies	06.07 General
11735	86	\N	\N	D5170C00002	186	185	NEW	\N	06.07 General	06.07.01 UNBLI_roduct-Documents
11736	86	\N	\N	D5170C00002	187	6	NEW	\N	Site	2001705 Haq, Mahmudul
11737	86	\N	\N	D5170C00002	188	187	NEW	\N	2001705 Haq, Mahmudul	02 Central Trial Documents
11738	86	\N	\N	D5170C00002	189	188	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
11739	86	\N	\N	D5170C00002	190	189	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
11740	86	\N	\N	D5170C00002	191	189	NEW	\N	02.02 Subject Documents	02.02.07 Other_iven to Subjects
11741	86	\N	\N	D5170C00002	192	188	NEW	\N	02 Central Trial Documents	02.04 General
11742	86	\N	\N	D5170C00002	193	192	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
11743	86	\N	\N	D5170C00002	194	192	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
11744	86	\N	\N	D5170C00002	195	187	NEW	\N	2001705 Haq, Mahmudul	04 IRB-IEC and other Approvals
11745	86	\N	\N	D5170C00002	196	195	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
11746	86	\N	\N	D5170C00002	197	196	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
11747	86	\N	\N	D5170C00002	198	195	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
11748	86	\N	\N	D5170C00002	199	198	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
11749	86	\N	\N	D5170C00002	200	187	NEW	\N	2001705 Haq, Mahmudul	05 Site Management
11750	86	\N	\N	D5170C00002	201	200	NEW	\N	05 Site Management	05.01 Site Selection
11751	86	\N	\N	D5170C00002	202	201	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
11752	86	\N	\N	D5170C00002	203	201	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
11753	86	\N	\N	D5170C00002	204	201	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
11754	86	\N	\N	D5170C00002	205	200	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
11755	86	\N	\N	D5170C00002	206	205	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
11756	86	\N	\N	D5170C00002	207	205	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
11757	86	\N	\N	D5170C00002	208	205	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
11758	86	\N	\N	D5170C00002	209	205	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
11759	86	\N	\N	D5170C00002	210	205	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
11760	86	\N	\N	D5170C00002	211	205	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
11761	86	\N	\N	D5170C00002	212	205	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
11762	86	\N	\N	D5170C00002	213	205	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
11763	86	\N	\N	D5170C00002	214	205	NEW	\N	05.02 Site Set-up Documentation	05.02.13 Indemnity
11764	86	\N	\N	D5170C00002	215	205	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
11765	86	\N	\N	D5170C00002	216	205	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
11766	86	\N	\N	D5170C00002	217	200	NEW	\N	05 Site Management	05.03 Site Initiation
11767	86	\N	\N	D5170C00002	218	217	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
11768	86	\N	\N	D5170C00002	219	217	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
11769	86	\N	\N	D5170C00002	220	217	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
11770	86	\N	\N	D5170C00002	221	200	NEW	\N	05 Site Management	05.04 Site Management
11771	86	\N	\N	D5170C00002	222	221	NEW	\N	05.04 Site Management	05.04.01 Subject Log
11772	86	\N	\N	D5170C00002	223	221	NEW	\N	05.04 Site Management	05.04.04 Visit Log
11773	86	\N	\N	D5170C00002	224	221	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
11774	86	\N	\N	D5170C00002	225	200	NEW	\N	05 Site Management	05.05 General
11775	86	\N	\N	D5170C00002	226	225	NEW	\N	05.05 General	05.05.02 Tracking Information
11776	86	\N	\N	D5170C00002	227	6	NEW	\N	Site	2001706 Barnett, Cody
11777	86	\N	\N	D5170C00002	228	227	NEW	\N	2001706 Barnett, Cody	05 Site Management
11778	86	\N	\N	D5170C00002	229	228	NEW	\N	05 Site Management	05.01 Site Selection
11779	86	\N	\N	D5170C00002	230	229	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
11780	86	\N	\N	D5170C00002	231	6	NEW	\N	Site	2001707 Ginzburg, Lev
11781	86	\N	\N	D5170C00002	232	231	NEW	\N	2001707 Ginzburg, Lev	02 Central Trial Documents
11782	86	\N	\N	D5170C00002	233	232	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
11783	86	\N	\N	D5170C00002	234	233	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
11786	86	\N	\N	D5170C00002	237	236	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
11787	86	\N	\N	D5170C00002	238	236	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
11788	86	\N	\N	D5170C00002	239	231	NEW	\N	2001707 Ginzburg, Lev	04 IRB-IEC and other Approvals
11789	86	\N	\N	D5170C00002	240	239	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
11790	86	\N	\N	D5170C00002	241	240	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
11791	86	\N	\N	D5170C00002	242	240	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
11792	86	\N	\N	D5170C00002	243	240	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
11793	86	\N	\N	D5170C00002	244	239	NEW	\N	04 IRB-IEC and other Approvals	04.04 General
11794	86	\N	\N	D5170C00002	245	244	NEW	\N	04.04 General	04.04.01 Relevant Communications-IRB-IEC-Documents
11795	86	\N	\N	D5170C00002	246	231	NEW	\N	2001707 Ginzburg, Lev	05 Site Management
11796	86	\N	\N	D5170C00002	247	246	NEW	\N	05 Site Management	05.01 Site Selection
11797	86	\N	\N	D5170C00002	248	247	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
11798	86	\N	\N	D5170C00002	249	247	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
11799	86	\N	\N	D5170C00002	250	247	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
11800	86	\N	\N	D5170C00002	251	246	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
11801	86	\N	\N	D5170C00002	252	251	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
11802	86	\N	\N	D5170C00002	253	251	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
11803	86	\N	\N	D5170C00002	254	251	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
11804	86	\N	\N	D5170C00002	255	251	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
11805	86	\N	\N	D5170C00002	256	251	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
11806	86	\N	\N	D5170C00002	257	251	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
11807	86	\N	\N	D5170C00002	258	251	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
11808	86	\N	\N	D5170C00002	259	251	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Investigator Regulatory Agreement
11809	86	\N	\N	D5170C00002	260	251	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
11810	86	\N	\N	D5170C00002	261	251	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
11811	86	\N	\N	D5170C00002	262	251	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
11812	86	\N	\N	D5170C00002	263	251	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
11813	86	\N	\N	D5170C00002	264	246	NEW	\N	05 Site Management	05.03 Site Initiation
11814	86	\N	\N	D5170C00002	265	264	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
11815	86	\N	\N	D5170C00002	266	264	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
11816	86	\N	\N	D5170C00002	267	264	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
11817	86	\N	\N	D5170C00002	268	246	NEW	\N	05 Site Management	05.04 Site Management
11818	86	\N	\N	D5170C00002	269	268	NEW	\N	05.04 Site Management	05.04.01 Subject Log
11819	86	\N	\N	D5170C00002	270	268	NEW	\N	05.04 Site Management	05.04.03 UNBLINDED Monitoring Visit Report
11820	86	\N	\N	D5170C00002	271	268	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
11821	86	\N	\N	D5170C00002	272	268	NEW	\N	05.04 Site Management	05.04.04 Visit Log
11822	86	\N	\N	D5170C00002	273	268	NEW	\N	05.04 Site Management	05.04.05 Additional Monitoring Activity
11823	86	\N	\N	D5170C00002	274	268	NEW	\N	05.04 Site Management	05.04.05 UNBLINDED Additional Monitoring Activity
11824	86	\N	\N	D5170C00002	275	268	NEW	\N	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
11825	86	\N	\N	D5170C00002	276	268	NEW	\N	05.04 Site Management	05.04.06 UNBLINDED Protocol Deviations and Waivers
11826	86	\N	\N	D5170C00002	277	268	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
11827	86	\N	\N	D5170C00002	278	246	NEW	\N	05 Site Management	05.05 General
11828	86	\N	\N	D5170C00002	279	278	NEW	\N	05.05 General	05.05.02 Tracking Information
11829	86	\N	\N	D5170C00002	280	231	NEW	\N	2001707 Ginzburg, Lev	06 IP and Trial Supplies
11830	86	\N	\N	D5170C00002	281	280	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
11831	86	\N	\N	D5170C00002	282	281	NEW	\N	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
11832	86	\N	\N	D5170C00002	283	281	NEW	\N	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
11833	86	\N	\N	D5170C00002	284	281	NEW	\N	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
11834	86	\N	\N	D5170C00002	285	281	NEW	\N	06.01 IP Documentation	06.01.11 Certificate of Destruction
11835	86	\N	\N	D5170C00002	286	281	NEW	\N	06.01 IP Documentation	06.01.11 UNBLINDED Certificate of Destruction
11836	86	\N	\N	D5170C00002	287	280	NEW	\N	06 IP and Trial Supplies	06.04 Storage
11837	86	\N	\N	D5170C00002	288	287	NEW	\N	06.04 Storage	06.04.01 Storage Condition Documentation
11838	86	\N	\N	D5170C00002	289	287	NEW	\N	06.04 Storage	06.04.01 UNBLI_on Documentation
11839	86	\N	\N	D5170C00002	290	287	NEW	\N	06.04 Storage	06.04.02 UNBLINDED Storage Condition Excursion Documentation
11840	86	\N	\N	D5170C00002	291	287	NEW	\N	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
11841	86	\N	\N	D5170C00002	292	280	NEW	\N	06 IP and Trial Supplies	06.05 Non-IP Documentation
11842	86	\N	\N	D5170C00002	293	292	NEW	\N	06.05 Non-IP Documentation	06.05.03 Non-I_tation of Return
11843	86	\N	\N	D5170C00002	294	6	NEW	\N	Site	2001708 Sedghi, Shahriar
11844	86	\N	\N	D5170C00002	295	294	NEW	\N	2001708 Sedghi, Shahriar	02 Central Trial Documents
11845	86	\N	\N	D5170C00002	296	295	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
11846	86	\N	\N	D5170C00002	297	296	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
11847	86	\N	\N	D5170C00002	298	295	NEW	\N	02 Central Trial Documents	02.04 General
11848	86	\N	\N	D5170C00002	299	298	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
11849	86	\N	\N	D5170C00002	300	298	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
11850	86	\N	\N	D5170C00002	301	294	NEW	\N	2001708 Sedghi, Shahriar	04 IRB-IEC and other Approvals
11851	86	\N	\N	D5170C00002	302	301	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
11852	86	\N	\N	D5170C00002	303	302	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
11853	86	\N	\N	D5170C00002	304	301	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
11854	86	\N	\N	D5170C00002	305	304	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
11855	86	\N	\N	D5170C00002	306	294	NEW	\N	2001708 Sedghi, Shahriar	05 Site Management
11856	86	\N	\N	D5170C00002	307	306	NEW	\N	05 Site Management	05.01 Site Selection
11857	86	\N	\N	D5170C00002	308	307	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
11858	86	\N	\N	D5170C00002	309	307	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
11859	86	\N	\N	D5170C00002	310	307	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
11860	86	\N	\N	D5170C00002	311	306	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
11861	86	\N	\N	D5170C00002	312	311	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
11862	86	\N	\N	D5170C00002	313	311	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
11863	86	\N	\N	D5170C00002	314	311	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
11864	86	\N	\N	D5170C00002	315	311	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
11865	86	\N	\N	D5170C00002	316	311	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
11866	86	\N	\N	D5170C00002	317	311	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
11867	86	\N	\N	D5170C00002	318	311	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
11868	86	\N	\N	D5170C00002	319	311	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
11869	86	\N	\N	D5170C00002	320	311	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
11870	86	\N	\N	D5170C00002	321	311	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
11871	86	\N	\N	D5170C00002	322	311	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
11872	86	\N	\N	D5170C00002	323	306	NEW	\N	05 Site Management	05.03 Site Initiation
11873	86	\N	\N	D5170C00002	324	323	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
11874	86	\N	\N	D5170C00002	325	323	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
11875	86	\N	\N	D5170C00002	326	306	NEW	\N	05 Site Management	05.04 Site Management
11876	86	\N	\N	D5170C00002	327	326	NEW	\N	05.04 Site Management	05.04.01 Subject Log
11877	86	\N	\N	D5170C00002	328	326	NEW	\N	05.04 Site Management	05.04.04 Visit Log
11878	86	\N	\N	D5170C00002	329	326	NEW	\N	05.04 Site Management	05.04.05 Additional Monitoring Activity
11879	86	\N	\N	D5170C00002	330	326	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
11880	86	\N	\N	D5170C00002	331	306	NEW	\N	05 Site Management	05.05 General
11881	86	\N	\N	D5170C00002	332	331	NEW	\N	05.05 General	05.05.02 Tracking Information
11882	86	\N	\N	D5170C00002	333	294	NEW	\N	2001708 Sedghi, Shahriar	06 IP and Trial Supplies
11883	86	\N	\N	D5170C00002	334	333	NEW	\N	06 IP and Trial Supplies	06.05 Non-IP Documentation
11884	86	\N	\N	D5170C00002	335	334	NEW	\N	06.05 Non-IP Documentation	06.05.03 Non-I_tation of Return
11885	86	\N	\N	D5170C00002	336	6	NEW	\N	Site	2001709 Salzberg, Bruce
11886	86	\N	\N	D5170C00002	337	336	NEW	\N	2001709 Salzberg, Bruce	02 Central Trial Documents
11887	86	\N	\N	D5170C00002	338	337	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
11888	86	\N	\N	D5170C00002	339	338	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
11889	86	\N	\N	D5170C00002	340	337	NEW	\N	02 Central Trial Documents	02.04 General
11890	86	\N	\N	D5170C00002	341	340	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
11891	86	\N	\N	D5170C00002	342	340	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
11892	86	\N	\N	D5170C00002	343	336	NEW	\N	2001709 Salzberg, Bruce	04 IRB-IEC and other Approvals
11893	86	\N	\N	D5170C00002	344	343	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
11894	86	\N	\N	D5170C00002	345	344	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
11895	86	\N	\N	D5170C00002	346	344	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
11896	86	\N	\N	D5170C00002	347	343	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
11897	86	\N	\N	D5170C00002	348	347	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
11898	86	\N	\N	D5170C00002	349	336	NEW	\N	2001709 Salzberg, Bruce	05 Site Management
11899	86	\N	\N	D5170C00002	350	349	NEW	\N	05 Site Management	05.01 Site Selection
11900	86	\N	\N	D5170C00002	351	350	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
11901	86	\N	\N	D5170C00002	352	350	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
11902	86	\N	\N	D5170C00002	353	350	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
11903	86	\N	\N	D5170C00002	354	349	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
11904	86	\N	\N	D5170C00002	355	354	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
11905	86	\N	\N	D5170C00002	356	354	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
11906	86	\N	\N	D5170C00002	357	354	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
11907	86	\N	\N	D5170C00002	358	354	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
11908	86	\N	\N	D5170C00002	359	354	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
11909	86	\N	\N	D5170C00002	360	354	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
11910	86	\N	\N	D5170C00002	361	354	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
11911	86	\N	\N	D5170C00002	362	354	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
11912	86	\N	\N	D5170C00002	363	354	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
11913	86	\N	\N	D5170C00002	364	349	NEW	\N	05 Site Management	05.03 Site Initiation
11914	86	\N	\N	D5170C00002	365	364	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
11915	86	\N	\N	D5170C00002	366	364	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
11916	86	\N	\N	D5170C00002	367	349	NEW	\N	05 Site Management	05.04 Site Management
11917	86	\N	\N	D5170C00002	368	367	NEW	\N	05.04 Site Management	05.04.01 Subject Log
11918	86	\N	\N	D5170C00002	369	367	NEW	\N	05.04 Site Management	05.04.04 Visit Log
11919	86	\N	\N	D5170C00002	370	367	NEW	\N	05.04 Site Management	05.04.05 Additional Monitoring Activity
11920	86	\N	\N	D5170C00002	371	367	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
11921	86	\N	\N	D5170C00002	372	349	NEW	\N	05 Site Management	05.05 General
11922	86	\N	\N	D5170C00002	373	372	NEW	\N	05.05 General	05.05.02 Tracking Information
11923	86	\N	\N	D5170C00002	374	336	NEW	\N	2001709 Salzberg, Bruce	06 IP and Trial Supplies
11924	86	\N	\N	D5170C00002	375	374	NEW	\N	06 IP and Trial Supplies	06.05 Non-IP Documentation
11925	86	\N	\N	D5170C00002	376	375	NEW	\N	06.05 Non-IP Documentation	06.05.03 Non-I_tation of Return
11926	86	\N	\N	D5170C00002	377	6	NEW	\N	Site	2001710 Rodriguez, Miguel
11927	86	\N	\N	D5170C00002	378	377	NEW	\N	2001710 Rodriguez, Miguel	02 Central Trial Documents
11928	86	\N	\N	D5170C00002	379	378	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
11929	86	\N	\N	D5170C00002	380	379	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
11930	86	\N	\N	D5170C00002	381	379	NEW	\N	02.02 Subject Documents	02.02.07 Other_iven to Subjects
11931	86	\N	\N	D5170C00002	382	378	NEW	\N	02 Central Trial Documents	02.04 General
11932	86	\N	\N	D5170C00002	383	382	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
11933	86	\N	\N	D5170C00002	384	382	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
11934	86	\N	\N	D5170C00002	385	377	NEW	\N	2001710 Rodriguez, Miguel	04 IRB-IEC and other Approvals
11935	86	\N	\N	D5170C00002	386	385	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
11936	86	\N	\N	D5170C00002	387	386	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
11937	86	\N	\N	D5170C00002	388	385	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
11938	86	\N	\N	D5170C00002	389	388	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
11939	86	\N	\N	D5170C00002	390	377	NEW	\N	2001710 Rodriguez, Miguel	05 Site Management
11940	86	\N	\N	D5170C00002	391	390	NEW	\N	05 Site Management	05.01 Site Selection
11941	86	\N	\N	D5170C00002	392	391	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
11942	86	\N	\N	D5170C00002	393	391	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
11943	86	\N	\N	D5170C00002	394	391	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
11944	86	\N	\N	D5170C00002	395	390	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
11945	86	\N	\N	D5170C00002	396	395	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
11946	86	\N	\N	D5170C00002	397	395	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
11947	86	\N	\N	D5170C00002	398	395	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
11948	86	\N	\N	D5170C00002	399	395	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
11949	86	\N	\N	D5170C00002	400	395	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
11950	86	\N	\N	D5170C00002	401	395	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
11951	86	\N	\N	D5170C00002	402	395	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
11952	86	\N	\N	D5170C00002	403	395	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
11953	86	\N	\N	D5170C00002	404	395	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
11954	86	\N	\N	D5170C00002	405	395	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Si_se Documentation
11955	86	\N	\N	D5170C00002	406	390	NEW	\N	05 Site Management	05.03 Site Initiation
11956	86	\N	\N	D5170C00002	407	406	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
11957	86	\N	\N	D5170C00002	408	390	NEW	\N	05 Site Management	05.04 Site Management
11958	86	\N	\N	D5170C00002	409	408	NEW	\N	05.04 Site Management	05.04.03 Monitoring Visit Report
11959	86	\N	\N	D5170C00002	410	408	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
11960	86	\N	\N	D5170C00002	411	408	NEW	\N	05.04 Site Management	05.04.05 UNBLI_itoring Activity
11961	86	\N	\N	D5170C00002	412	408	NEW	\N	05.04 Site Management	05.04.06 UNBLINDED Protocol Deviations and Waivers
11962	86	\N	\N	D5170C00002	413	408	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
11963	86	\N	\N	D5170C00002	414	408	NEW	\N	05.04 Site Management	05.04.08 UNBLI_onitoring Report
11964	86	\N	\N	D5170C00002	415	390	NEW	\N	05 Site Management	05.05 General
11965	86	\N	\N	D5170C00002	416	415	NEW	\N	05.05 General	05.05.02 Tracking Information
11966	86	\N	\N	D5170C00002	417	377	NEW	\N	2001710 Rodriguez, Miguel	06 IP and Trial Supplies
11967	86	\N	\N	D5170C00002	418	417	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
11968	86	\N	\N	D5170C00002	419	418	NEW	\N	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
11969	86	\N	\N	D5170C00002	420	418	NEW	\N	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
11970	86	\N	\N	D5170C00002	421	418	NEW	\N	06.01 IP Documentation	06.01.10 UNBLI_mentation Return
11971	86	\N	\N	D5170C00002	422	417	NEW	\N	06 IP and Trial Supplies	06.04 Storage
11972	86	\N	\N	D5170C00002	423	422	NEW	\N	06.04 Storage	06.04.01 UNBLI_on Documentation
11973	86	\N	\N	D5170C00002	424	422	NEW	\N	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
11974	86	\N	\N	D5170C00002	425	6	NEW	\N	Site	2001711 Esfandyari, Tuba
11975	86	\N	\N	D5170C00002	426	425	NEW	\N	2001711 Esfandyari, Tuba	05 Site Management
11976	86	\N	\N	D5170C00002	427	426	NEW	\N	05 Site Management	05.01 Site Selection
11977	86	\N	\N	D5170C00002	428	427	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
11978	86	\N	\N	D5170C00002	429	427	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
11979	86	\N	\N	D5170C00002	430	427	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
11980	86	\N	\N	D5170C00002	431	6	NEW	\N	Site	2001712 Gordon, Glenn
11981	86	\N	\N	D5170C00002	432	431	NEW	\N	2001712 Gordon, Glenn	05 Site Management
11982	86	\N	\N	D5170C00002	433	432	NEW	\N	05 Site Management	05.01 Site Selection
11983	86	\N	\N	D5170C00002	434	433	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
11984	86	\N	\N	D5170C00002	435	433	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
11985	86	\N	\N	D5170C00002	436	433	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
11986	86	\N	\N	D5170C00002	437	431	NEW	\N	2001712 Gordon, Glenn	06 IP and Trial Supplies
11987	86	\N	\N	D5170C00002	438	437	NEW	\N	06 IP and Trial Supplies	06.05 Non-IP Documentation
11988	86	\N	\N	D5170C00002	439	438	NEW	\N	06.05 Non-IP Documentation	06.05.03 Non-I_tation of Return
11989	86	\N	\N	D5170C00002	440	6	NEW	\N	Site	2001719 Chen, Stuart
11990	86	\N	\N	D5170C00002	441	440	NEW	\N	2001719 Chen, Stuart	02 Central Trial Documents
11991	86	\N	\N	D5170C00002	442	441	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
11992	86	\N	\N	D5170C00002	443	442	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
11993	86	\N	\N	D5170C00002	444	442	NEW	\N	02.02 Subject Documents	02.02.03 Informed Consent Form Checklists
11994	86	\N	\N	D5170C00002	445	441	NEW	\N	02 Central Trial Documents	02.04 General
11995	86	\N	\N	D5170C00002	446	445	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
11996	86	\N	\N	D5170C00002	447	440	NEW	\N	2001719 Chen, Stuart	04 IRB-IEC and other Approvals
11997	86	\N	\N	D5170C00002	448	447	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
11998	86	\N	\N	D5170C00002	449	448	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
11999	86	\N	\N	D5170C00002	450	448	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
12000	86	\N	\N	D5170C00002	451	447	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
12001	86	\N	\N	D5170C00002	452	451	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
12002	86	\N	\N	D5170C00002	453	440	NEW	\N	2001719 Chen, Stuart	05 Site Management
12003	86	\N	\N	D5170C00002	454	453	NEW	\N	05 Site Management	05.01 Site Selection
12004	86	\N	\N	D5170C00002	455	454	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
12005	86	\N	\N	D5170C00002	456	454	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
12006	86	\N	\N	D5170C00002	457	454	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
12007	86	\N	\N	D5170C00002	458	453	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
12008	86	\N	\N	D5170C00002	459	458	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
12009	86	\N	\N	D5170C00002	460	458	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
12010	86	\N	\N	D5170C00002	461	458	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
12011	86	\N	\N	D5170C00002	462	458	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
12012	86	\N	\N	D5170C00002	463	458	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
12013	86	\N	\N	D5170C00002	464	458	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
12014	86	\N	\N	D5170C00002	465	458	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
12015	86	\N	\N	D5170C00002	466	458	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Investigator Regulatory Agreement
12016	86	\N	\N	D5170C00002	467	458	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
12017	86	\N	\N	D5170C00002	468	458	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
12018	86	\N	\N	D5170C00002	469	458	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
12019	86	\N	\N	D5170C00002	470	458	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
12020	86	\N	\N	D5170C00002	471	453	NEW	\N	05 Site Management	05.03 Site Initiation
12021	86	\N	\N	D5170C00002	472	471	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
12022	86	\N	\N	D5170C00002	473	471	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
12023	86	\N	\N	D5170C00002	474	471	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
12024	86	\N	\N	D5170C00002	475	453	NEW	\N	05 Site Management	05.04 Site Management
12025	86	\N	\N	D5170C00002	476	475	NEW	\N	05.04 Site Management	05.04.01 Subject Log
12026	86	\N	\N	D5170C00002	477	475	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
12027	86	\N	\N	D5170C00002	478	475	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
12028	86	\N	\N	D5170C00002	479	453	NEW	\N	05 Site Management	05.05 General
12029	86	\N	\N	D5170C00002	480	479	NEW	\N	05.05 General	05.05.01 Relevant Communications-Documents
12030	86	\N	\N	D5170C00002	481	479	NEW	\N	05.05 General	05.05.02 Tracking Information
12031	86	\N	\N	D5170C00002	482	6	NEW	\N	Site	2001721 Brettholz, Edward
12032	86	\N	\N	D5170C00002	483	482	NEW	\N	2001721 Brettholz, Edward	02 Central Trial Documents
12033	86	\N	\N	D5170C00002	484	483	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
12034	86	\N	\N	D5170C00002	485	484	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
12035	86	\N	\N	D5170C00002	486	483	NEW	\N	02 Central Trial Documents	02.04 General
12036	86	\N	\N	D5170C00002	487	486	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
12037	86	\N	\N	D5170C00002	488	486	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
12038	86	\N	\N	D5170C00002	489	482	NEW	\N	2001721 Brettholz, Edward	04 IRB-IEC and other Approvals
12039	86	\N	\N	D5170C00002	490	489	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
12040	86	\N	\N	D5170C00002	491	490	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
12041	86	\N	\N	D5170C00002	492	490	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
12042	86	\N	\N	D5170C00002	493	489	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
12043	86	\N	\N	D5170C00002	494	493	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
12044	86	\N	\N	D5170C00002	495	482	NEW	\N	2001721 Brettholz, Edward	05 Site Management
12045	86	\N	\N	D5170C00002	496	495	NEW	\N	05 Site Management	05.01 Site Selection
12046	86	\N	\N	D5170C00002	497	496	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
12047	86	\N	\N	D5170C00002	498	496	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
12048	86	\N	\N	D5170C00002	499	496	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
12049	86	\N	\N	D5170C00002	500	495	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
12050	86	\N	\N	D5170C00002	501	500	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
12051	86	\N	\N	D5170C00002	502	500	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
12052	86	\N	\N	D5170C00002	503	500	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
12053	86	\N	\N	D5170C00002	504	500	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
12054	86	\N	\N	D5170C00002	505	500	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
12055	86	\N	\N	D5170C00002	506	500	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
12056	86	\N	\N	D5170C00002	507	500	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
12057	86	\N	\N	D5170C00002	508	500	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
12058	86	\N	\N	D5170C00002	509	500	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
12059	86	\N	\N	D5170C00002	510	500	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Si_se Documentation
12060	86	\N	\N	D5170C00002	511	500	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
12061	86	\N	\N	D5170C00002	512	495	NEW	\N	05 Site Management	05.03 Site Initiation
12062	86	\N	\N	D5170C00002	513	512	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
12063	86	\N	\N	D5170C00002	514	512	NEW	\N	05.03 Site Initiation	05.03.03 Site _cumentation-Site
12064	86	\N	\N	D5170C00002	515	512	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
12065	86	\N	\N	D5170C00002	516	495	NEW	\N	05 Site Management	05.04 Site Management
12066	86	\N	\N	D5170C00002	517	516	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
12067	86	\N	\N	D5170C00002	518	516	NEW	\N	05.04 Site Management	05.04.04 Visit Log
12068	86	\N	\N	D5170C00002	519	516	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
12069	86	\N	\N	D5170C00002	520	495	NEW	\N	05 Site Management	05.05 General
12070	86	\N	\N	D5170C00002	521	520	NEW	\N	05.05 General	05.05.02 Tracking Information
12071	86	\N	\N	D5170C00002	522	6	NEW	\N	Site	2001722 Dassop_os, Themistocles
12072	86	\N	\N	D5170C00002	523	522	NEW	\N	2001722 Dassop_os, Themistocles	02 Central Trial Documents
12073	86	\N	\N	D5170C00002	524	523	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
12074	86	\N	\N	D5170C00002	525	524	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
12075	86	\N	\N	D5170C00002	526	523	NEW	\N	02 Central Trial Documents	02.04 General
12076	86	\N	\N	D5170C00002	527	526	NEW	\N	02.04 General	02.04.01 Relev_ations-Documents
12077	86	\N	\N	D5170C00002	528	526	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
12078	86	\N	\N	D5170C00002	529	526	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
12079	86	\N	\N	D5170C00002	530	522	NEW	\N	2001722 Dassop_os, Themistocles	04 IRB-IEC and other Approvals
12080	86	\N	\N	D5170C00002	531	530	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
12081	86	\N	\N	D5170C00002	532	531	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
12082	86	\N	\N	D5170C00002	533	531	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
12083	86	\N	\N	D5170C00002	534	531	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
12084	86	\N	\N	D5170C00002	535	530	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
12085	86	\N	\N	D5170C00002	536	535	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
12086	86	\N	\N	D5170C00002	537	530	NEW	\N	04 IRB-IEC and other Approvals	04.04 General
12087	86	\N	\N	D5170C00002	538	537	NEW	\N	04.04 General	04.04.01 Relev_RB-IEC-Documents
12088	86	\N	\N	D5170C00002	539	522	NEW	\N	2001722 Dassop_os, Themistocles	05 Site Management
12089	86	\N	\N	D5170C00002	540	539	NEW	\N	05 Site Management	05.01 Site Selection
12090	86	\N	\N	D5170C00002	541	540	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
12091	86	\N	\N	D5170C00002	542	540	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
12092	86	\N	\N	D5170C00002	543	540	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
12093	86	\N	\N	D5170C00002	544	539	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
12094	86	\N	\N	D5170C00002	545	544	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Accep_tigator Brochure
12095	86	\N	\N	D5170C00002	546	544	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
12096	86	\N	\N	D5170C00002	547	544	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
12097	86	\N	\N	D5170C00002	548	544	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
12098	86	\N	\N	D5170C00002	549	544	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
12099	86	\N	\N	D5170C00002	550	544	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Site Qualification
12100	86	\N	\N	D5170C00002	551	544	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
12101	86	\N	\N	D5170C00002	552	544	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
12102	86	\N	\N	D5170C00002	553	544	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
12103	86	\N	\N	D5170C00002	554	544	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
12104	86	\N	\N	D5170C00002	555	544	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Si_se Documentation
12105	86	\N	\N	D5170C00002	556	544	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
12106	86	\N	\N	D5170C00002	557	539	NEW	\N	05 Site Management	05.03 Site Initiation
12107	86	\N	\N	D5170C00002	558	557	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
12108	86	\N	\N	D5170C00002	559	557	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
12109	86	\N	\N	D5170C00002	560	539	NEW	\N	05 Site Management	05.04 Site Management
12110	86	\N	\N	D5170C00002	561	560	NEW	\N	05.04 Site Management	05.04.01 Subject Log
12111	86	\N	\N	D5170C00002	562	560	NEW	\N	05.04 Site Management	05.04.04 Visit Log
12112	86	\N	\N	D5170C00002	563	560	NEW	\N	05.04 Site Management	05.04.05 Additional Monitoring Activity
12113	86	\N	\N	D5170C00002	564	560	NEW	\N	05.04 Site Management	05.04.08 Final_onitoring Report
12114	86	\N	\N	D5170C00002	565	539	NEW	\N	05 Site Management	05.05 General
12115	86	\N	\N	D5170C00002	566	565	NEW	\N	05.05 General	05.05.01 Relev_ations-Documents
12116	86	\N	\N	D5170C00002	567	565	NEW	\N	05.05 General	05.05.02 Tracking Information
12117	86	\N	\N	D5170C00002	568	522	NEW	\N	2001722 Dassop_os, Themistocles	06 IP and Trial Supplies
12118	86	\N	\N	D5170C00002	569	568	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
12119	86	\N	\N	D5170C00002	570	569	NEW	\N	06.01 IP Documentation	06.01.02 IP In_ons for Handling
12120	86	\N	\N	D5170C00002	571	6	NEW	\N	Site	2001723 Moparty, Ravi
12121	86	\N	\N	D5170C00002	572	571	NEW	\N	2001723 Moparty, Ravi	02 Central Trial Documents
12122	86	\N	\N	D5170C00002	573	572	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
12123	86	\N	\N	D5170C00002	574	573	NEW	\N	02.02 Subject Documents	02.02.01 Subject Diary
12124	86	\N	\N	D5170C00002	575	573	NEW	\N	02.02 Subject Documents	02.02.02 Subject Questionnaire
12125	86	\N	\N	D5170C00002	576	573	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
12126	86	\N	\N	D5170C00002	577	572	NEW	\N	02 Central Trial Documents	02.04 General
12127	86	\N	\N	D5170C00002	578	577	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
12128	86	\N	\N	D5170C00002	579	577	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
12129	86	\N	\N	D5170C00002	580	571	NEW	\N	2001723 Moparty, Ravi	04 IRB-IEC and other Approvals
12130	86	\N	\N	D5170C00002	581	580	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
12131	86	\N	\N	D5170C00002	582	581	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
12132	86	\N	\N	D5170C00002	583	581	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
12133	86	\N	\N	D5170C00002	584	580	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
12134	86	\N	\N	D5170C00002	585	584	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
12135	86	\N	\N	D5170C00002	586	571	NEW	\N	2001723 Moparty, Ravi	05 Site Management
12136	86	\N	\N	D5170C00002	587	586	NEW	\N	05 Site Management	05.01 Site Selection
12137	86	\N	\N	D5170C00002	588	587	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
12138	86	\N	\N	D5170C00002	589	587	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
12139	86	\N	\N	D5170C00002	590	587	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
12140	86	\N	\N	D5170C00002	591	586	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
12141	86	\N	\N	D5170C00002	592	591	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
12142	86	\N	\N	D5170C00002	593	591	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
12143	86	\N	\N	D5170C00002	594	591	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
12144	86	\N	\N	D5170C00002	595	591	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
12145	86	\N	\N	D5170C00002	596	591	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
12146	86	\N	\N	D5170C00002	597	591	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
12147	86	\N	\N	D5170C00002	598	591	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
12148	86	\N	\N	D5170C00002	599	591	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
12149	86	\N	\N	D5170C00002	600	591	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
12150	86	\N	\N	D5170C00002	601	586	NEW	\N	05 Site Management	05.03 Site Initiation
12151	86	\N	\N	D5170C00002	602	601	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
12152	86	\N	\N	D5170C00002	603	601	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
12153	86	\N	\N	D5170C00002	604	586	NEW	\N	05 Site Management	05.04 Site Management
12154	86	\N	\N	D5170C00002	605	604	NEW	\N	05.04 Site Management	05.04.05 Additional Monitoring Activity
12155	86	\N	\N	D5170C00002	606	604	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
12156	86	\N	\N	D5170C00002	607	586	NEW	\N	05 Site Management	05.05 General
12157	86	\N	\N	D5170C00002	608	607	NEW	\N	05.05 General	05.05.02 Tracking Information
12158	86	\N	\N	D5170C00002	609	571	NEW	\N	2001723 Moparty, Ravi	06 IP and Trial Supplies
12159	86	\N	\N	D5170C00002	610	609	NEW	\N	06 IP and Trial Supplies	06.04 Storage
12160	86	\N	\N	D5170C00002	611	610	NEW	\N	06.04 Storage	06.04.01 Storage Condition Documentation
12161	86	\N	\N	D5170C00002	612	571	NEW	\N	2001723 Moparty, Ravi	08 Centralized Testing
12162	86	\N	\N	D5170C00002	613	612	NEW	\N	08 Centralized Testing	08.02 Sample Documentation
12163	86	\N	\N	D5170C00002	614	613	NEW	\N	08.02 Sample Documentation	08.02.03 Sampl_ge Condition Log
12164	86	\N	\N	D5170C00002	615	6	NEW	\N	Site	2001724 Dupont, Andrew
12165	86	\N	\N	D5170C00002	616	615	NEW	\N	2001724 Dupont, Andrew	02 Central Trial Documents
12166	86	\N	\N	D5170C00002	617	616	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
12167	86	\N	\N	D5170C00002	618	617	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
12168	86	\N	\N	D5170C00002	619	616	NEW	\N	02 Central Trial Documents	02.04 General
12169	86	\N	\N	D5170C00002	620	619	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
12170	86	\N	\N	D5170C00002	621	619	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
12171	86	\N	\N	D5170C00002	622	615	NEW	\N	2001724 Dupont, Andrew	04 IRB-IEC and other Approvals
12172	86	\N	\N	D5170C00002	623	622	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
12173	86	\N	\N	D5170C00002	624	623	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
12174	86	\N	\N	D5170C00002	625	623	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
12175	86	\N	\N	D5170C00002	626	622	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
12176	86	\N	\N	D5170C00002	627	626	NEW	\N	04.03 Trial Status Reporting	04.03.01 IRB-I_y Info-Deviation
12177	86	\N	\N	D5170C00002	628	626	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
12178	86	\N	\N	D5170C00002	629	615	NEW	\N	2001724 Dupont, Andrew	05 Site Management
12179	86	\N	\N	D5170C00002	630	629	NEW	\N	05 Site Management	05.01 Site Selection
12180	86	\N	\N	D5170C00002	631	630	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
12181	86	\N	\N	D5170C00002	632	630	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
12182	86	\N	\N	D5170C00002	633	630	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
12183	86	\N	\N	D5170C00002	634	629	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
12184	86	\N	\N	D5170C00002	635	634	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
12185	86	\N	\N	D5170C00002	636	634	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
12186	86	\N	\N	D5170C00002	637	634	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
12187	86	\N	\N	D5170C00002	638	634	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
12188	86	\N	\N	D5170C00002	639	634	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
12189	86	\N	\N	D5170C00002	640	634	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
12190	86	\N	\N	D5170C00002	641	634	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
12191	86	\N	\N	D5170C00002	642	634	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
12192	86	\N	\N	D5170C00002	643	634	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
12193	86	\N	\N	D5170C00002	644	634	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
12194	86	\N	\N	D5170C00002	645	629	NEW	\N	05 Site Management	05.03 Site Initiation
12195	86	\N	\N	D5170C00002	646	645	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
12196	86	\N	\N	D5170C00002	647	645	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
12197	86	\N	\N	D5170C00002	648	629	NEW	\N	05 Site Management	05.04 Site Management
12198	86	\N	\N	D5170C00002	649	648	NEW	\N	05.04 Site Management	05.04.03 Monitoring Visit Report
12199	86	\N	\N	D5170C00002	650	648	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
12200	86	\N	\N	D5170C00002	651	648	NEW	\N	05.04 Site Management	05.04.05 UNBLI_itoring Activity
12201	86	\N	\N	D5170C00002	652	648	NEW	\N	05.04 Site Management	05.04.06 UNBLINDED Protocol Deviations and Waivers
12202	86	\N	\N	D5170C00002	653	648	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
12203	86	\N	\N	D5170C00002	654	629	NEW	\N	05 Site Management	05.05 General
12204	86	\N	\N	D5170C00002	655	654	NEW	\N	05.05 General	05.05.02 Tracking Information
12205	86	\N	\N	D5170C00002	656	615	NEW	\N	2001724 Dupont, Andrew	06 IP and Trial Supplies
12206	86	\N	\N	D5170C00002	657	656	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
12207	86	\N	\N	D5170C00002	658	657	NEW	\N	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
12208	86	\N	\N	D5170C00002	659	657	NEW	\N	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
12209	86	\N	\N	D5170C00002	660	657	NEW	\N	06.01 IP Documentation	06.01.10 UNBLI_mentation Return
12210	86	\N	\N	D5170C00002	661	656	NEW	\N	06 IP and Trial Supplies	06.04 Storage
12211	86	\N	\N	D5170C00002	662	661	NEW	\N	06.04 Storage	06.04.01 UNBLINDED Storage Condition Documentation
12212	86	\N	\N	D5170C00002	663	661	NEW	\N	06.04 Storage	06.04.03 UNBLINDED Maintenance Logs
12213	86	\N	\N	D5170C00002	664	6	NEW	\N	Site	2001726 Weiss, L. Michael
12214	86	\N	\N	D5170C00002	665	664	NEW	\N	2001726 Weiss, L. Michael	02 Central Trial Documents
12215	86	\N	\N	D5170C00002	666	665	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
12216	86	\N	\N	D5170C00002	667	666	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
12217	86	\N	\N	D5170C00002	668	665	NEW	\N	02 Central Trial Documents	02.04 General
12218	86	\N	\N	D5170C00002	669	668	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
12219	86	\N	\N	D5170C00002	670	668	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
12220	86	\N	\N	D5170C00002	671	664	NEW	\N	2001726 Weiss, L. Michael	03 Regulatory
12221	86	\N	\N	D5170C00002	672	671	NEW	\N	03 Regulatory	03.04 General
12222	86	\N	\N	D5170C00002	673	672	NEW	\N	03.04 General	03.04.01 Relev_art-Up-Documents
12223	86	\N	\N	D5170C00002	674	664	NEW	\N	2001726 Weiss, L. Michael	04 IRB-IEC and other Approvals
12224	86	\N	\N	D5170C00002	675	674	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
12225	86	\N	\N	D5170C00002	676	675	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
12226	86	\N	\N	D5170C00002	677	674	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
12227	86	\N	\N	D5170C00002	678	677	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
12228	86	\N	\N	D5170C00002	679	664	NEW	\N	2001726 Weiss, L. Michael	05 Site Management
12229	86	\N	\N	D5170C00002	680	679	NEW	\N	05 Site Management	05.01 Site Selection
12230	86	\N	\N	D5170C00002	681	680	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
12231	86	\N	\N	D5170C00002	682	680	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
12232	86	\N	\N	D5170C00002	683	680	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
12233	86	\N	\N	D5170C00002	684	679	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
12234	86	\N	\N	D5170C00002	685	684	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
12235	86	\N	\N	D5170C00002	686	684	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
12236	86	\N	\N	D5170C00002	687	684	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
12237	86	\N	\N	D5170C00002	688	684	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
12238	86	\N	\N	D5170C00002	689	684	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
12239	86	\N	\N	D5170C00002	690	684	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
12240	86	\N	\N	D5170C00002	691	684	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
12241	86	\N	\N	D5170C00002	692	684	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
12242	86	\N	\N	D5170C00002	693	684	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
12243	86	\N	\N	D5170C00002	694	684	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Si_se Documentation
12244	86	\N	\N	D5170C00002	695	679	NEW	\N	05 Site Management	05.03 Site Initiation
12245	86	\N	\N	D5170C00002	696	695	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
12246	86	\N	\N	D5170C00002	697	695	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
12247	86	\N	\N	D5170C00002	698	679	NEW	\N	05 Site Management	05.04 Site Management
12248	86	\N	\N	D5170C00002	699	698	NEW	\N	05.04 Site Management	05.04.03 Monitoring Visit Report
12249	86	\N	\N	D5170C00002	700	698	NEW	\N	05.04 Site Management	05.04.03 UNBLINDED Monitoring Visit Report
12250	86	\N	\N	D5170C00002	701	698	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
12251	86	\N	\N	D5170C00002	702	698	NEW	\N	05.04 Site Management	05.04.05 UNBLI_itoring Activity
12252	86	\N	\N	D5170C00002	703	698	NEW	\N	05.04 Site Management	05.04.06 UNBLINDED Protocol Deviations and Waivers
12253	86	\N	\N	D5170C00002	704	698	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
12254	86	\N	\N	D5170C00002	705	698	NEW	\N	05.04 Site Management	05.04.08 UNBLI_onitoring Report
12255	86	\N	\N	D5170C00002	706	679	NEW	\N	05 Site Management	05.05 General
12256	86	\N	\N	D5170C00002	707	706	NEW	\N	05.05 General	05.05.02 Tracking Information
12257	86	\N	\N	D5170C00002	708	664	NEW	\N	2001726 Weiss, L. Michael	06 IP and Trial Supplies
12258	86	\N	\N	D5170C00002	709	708	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
12259	86	\N	\N	D5170C00002	710	709	NEW	\N	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
12260	86	\N	\N	D5170C00002	711	709	NEW	\N	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
12261	86	\N	\N	D5170C00002	712	709	NEW	\N	06.01 IP Documentation	06.01.10 UNBLI_mentation Return
12262	86	\N	\N	D5170C00002	713	708	NEW	\N	06 IP and Trial Supplies	06.04 Storage
12263	86	\N	\N	D5170C00002	714	713	NEW	\N	06.04 Storage	06.04.01 UNBLI_on Documentation
12264	86	\N	\N	D5170C00002	715	713	NEW	\N	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
12265	86	\N	\N	D5170C00002	716	708	NEW	\N	06 IP and Trial Supplies	06.05 Non-IP Documentation
12266	86	\N	\N	D5170C00002	717	716	NEW	\N	06.05 Non-IP Documentation	06.05.03 Non-I_tation of Return
12267	86	\N	\N	D5170C00002	718	708	NEW	\N	06 IP and Trial Supplies	06.07 General
12268	86	\N	\N	D5170C00002	719	718	NEW	\N	06.07 General	06.07.01 UNBLI_roduct-Documents
12269	86	\N	\N	D5170C00002	720	6	NEW	\N	Site	2001727 Kaur, Manreet
12270	86	\N	\N	D5170C00002	721	720	NEW	\N	2001727 Kaur, Manreet	02 Central Trial Documents
12271	86	\N	\N	D5170C00002	722	721	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
12272	86	\N	\N	D5170C00002	723	722	NEW	\N	02.02 Subject Documents	02.02.03 Infor_ Form Checklists
12273	86	\N	\N	D5170C00002	724	722	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
12274	86	\N	\N	D5170C00002	725	721	NEW	\N	02 Central Trial Documents	02.04 General
12275	86	\N	\N	D5170C00002	726	725	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
12276	86	\N	\N	D5170C00002	727	720	NEW	\N	2001727 Kaur, Manreet	03 Regulatory
12277	86	\N	\N	D5170C00002	728	727	NEW	\N	03 Regulatory	03.04 General
12278	86	\N	\N	D5170C00002	729	728	NEW	\N	03.04 General	03.04.01 Relev_art-Up-Documents
12279	86	\N	\N	D5170C00002	730	720	NEW	\N	2001727 Kaur, Manreet	04 IRB-IEC and other Approvals
12280	86	\N	\N	D5170C00002	731	730	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
12281	86	\N	\N	D5170C00002	732	731	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
12282	86	\N	\N	D5170C00002	733	731	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
12283	86	\N	\N	D5170C00002	734	731	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
12284	86	\N	\N	D5170C00002	735	731	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.05 IRB-I_liance Statement
12285	86	\N	\N	D5170C00002	736	720	NEW	\N	2001727 Kaur, Manreet	05 Site Management
12286	86	\N	\N	D5170C00002	737	736	NEW	\N	05 Site Management	05.01 Site Selection
12287	86	\N	\N	D5170C00002	738	737	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
12288	86	\N	\N	D5170C00002	739	737	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
12289	86	\N	\N	D5170C00002	740	737	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
12290	86	\N	\N	D5170C00002	741	736	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
12291	86	\N	\N	D5170C00002	742	741	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
12292	86	\N	\N	D5170C00002	743	741	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
12293	86	\N	\N	D5170C00002	744	741	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
12294	86	\N	\N	D5170C00002	745	741	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
12295	86	\N	\N	D5170C00002	746	741	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
12296	86	\N	\N	D5170C00002	747	741	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
12297	86	\N	\N	D5170C00002	748	741	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
12298	86	\N	\N	D5170C00002	749	741	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
12299	86	\N	\N	D5170C00002	750	741	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
12300	86	\N	\N	D5170C00002	751	741	NEW	\N	05.02 Site Set-up Documentation	05.02.13 Indemnity
12301	86	\N	\N	D5170C00002	752	741	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
12302	86	\N	\N	D5170C00002	753	736	NEW	\N	05 Site Management	05.03 Site Initiation
12303	86	\N	\N	D5170C00002	754	753	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
12304	86	\N	\N	D5170C00002	755	753	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
12305	86	\N	\N	D5170C00002	756	736	NEW	\N	05 Site Management	05.04 Site Management
12306	86	\N	\N	D5170C00002	757	756	NEW	\N	05.04 Site Management	05.04.05 Additional Monitoring Activity
12307	86	\N	\N	D5170C00002	758	756	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
12308	86	\N	\N	D5170C00002	759	736	NEW	\N	05 Site Management	05.05 General
12309	86	\N	\N	D5170C00002	760	759	NEW	\N	05.05 General	05.05.02 Tracking Information
12310	86	\N	\N	D5170C00002	761	720	NEW	\N	2001727 Kaur, Manreet	06 IP and Trial Supplies
12311	86	\N	\N	D5170C00002	762	761	NEW	\N	06 IP and Trial Supplies	06.04 Storage
12312	86	\N	\N	D5170C00002	763	762	NEW	\N	06.04 Storage	06.04.03 Maintenance Logs
12313	86	\N	\N	D5170C00002	764	6	NEW	\N	Site	2001728 Shafran, Ira
12314	86	\N	\N	D5170C00002	765	764	NEW	\N	2001728 Shafran, Ira	02 Central Trial Documents
12315	86	\N	\N	D5170C00002	766	765	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
12316	86	\N	\N	D5170C00002	767	766	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
12317	86	\N	\N	D5170C00002	768	765	NEW	\N	02 Central Trial Documents	02.04 General
12318	86	\N	\N	D5170C00002	769	768	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
12319	86	\N	\N	D5170C00002	770	768	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
12320	86	\N	\N	D5170C00002	771	764	NEW	\N	2001728 Shafran, Ira	04 IRB-IEC and other Approvals
12321	86	\N	\N	D5170C00002	772	771	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
12322	86	\N	\N	D5170C00002	773	772	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
12323	86	\N	\N	D5170C00002	774	772	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
12324	86	\N	\N	D5170C00002	775	772	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
12325	86	\N	\N	D5170C00002	776	771	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
12326	86	\N	\N	D5170C00002	777	776	NEW	\N	04.03 Trial Status Reporting	04.03.01 IRB-I_y Info-Deviation
12327	86	\N	\N	D5170C00002	778	764	NEW	\N	2001728 Shafran, Ira	05 Site Management
12328	86	\N	\N	D5170C00002	779	778	NEW	\N	05 Site Management	05.01 Site Selection
12329	86	\N	\N	D5170C00002	780	779	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
12330	86	\N	\N	D5170C00002	781	779	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
12331	86	\N	\N	D5170C00002	782	779	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
12332	86	\N	\N	D5170C00002	783	778	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
12333	86	\N	\N	D5170C00002	784	783	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
12334	86	\N	\N	D5170C00002	785	783	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
12335	86	\N	\N	D5170C00002	786	783	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
12336	86	\N	\N	D5170C00002	787	783	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
12337	86	\N	\N	D5170C00002	788	783	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
12338	86	\N	\N	D5170C00002	789	783	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
12339	86	\N	\N	D5170C00002	790	783	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
12340	86	\N	\N	D5170C00002	791	783	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
12341	86	\N	\N	D5170C00002	792	783	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
12342	86	\N	\N	D5170C00002	793	783	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
12343	86	\N	\N	D5170C00002	794	783	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
12344	86	\N	\N	D5170C00002	795	778	NEW	\N	05 Site Management	05.03 Site Initiation
12345	86	\N	\N	D5170C00002	796	795	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
12346	86	\N	\N	D5170C00002	797	795	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
12347	86	\N	\N	D5170C00002	798	778	NEW	\N	05 Site Management	05.04 Site Management
12348	86	\N	\N	D5170C00002	799	798	NEW	\N	05.04 Site Management	05.04.01 Subject Log
12349	86	\N	\N	D5170C00002	800	798	NEW	\N	05.04 Site Management	05.04.04 Visit Log
12350	86	\N	\N	D5170C00002	801	798	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
12351	86	\N	\N	D5170C00002	802	778	NEW	\N	05 Site Management	05.05 General
12352	86	\N	\N	D5170C00002	803	802	NEW	\N	05.05 General	05.05.02 Tracking Information
12353	86	\N	\N	D5170C00002	804	764	NEW	\N	2001728 Shafran, Ira	06 IP and Trial Supplies
12354	86	\N	\N	D5170C00002	805	804	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
12355	86	\N	\N	D5170C00002	806	805	NEW	\N	06.01 IP Documentation	06.01.10 IP Documentation Return
12356	86	\N	\N	D5170C00002	807	6	NEW	\N	Site	2001729 Sheikh, Aasim
12357	86	\N	\N	D5170C00002	808	807	NEW	\N	2001729 Sheikh, Aasim	05 Site Management
12358	86	\N	\N	D5170C00002	809	808	NEW	\N	05 Site Management	05.01 Site Selection
12359	86	\N	\N	D5170C00002	810	809	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
12360	86	\N	\N	D5170C00002	811	6	NEW	\N	Site	2001731 Colman, Ronald
12361	86	\N	\N	D5170C00002	812	811	NEW	\N	2001731 Colman, Ronald	02 Central Trial Documents
12362	86	\N	\N	D5170C00002	813	812	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
12363	86	\N	\N	D5170C00002	814	813	NEW	\N	02.02 Subject Documents	02.02.01 Subject Diary
12364	86	\N	\N	D5170C00002	815	813	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
12365	86	\N	\N	D5170C00002	816	813	NEW	\N	02.02 Subject Documents	02.02.05 Subject Participation Card
12366	86	\N	\N	D5170C00002	817	813	NEW	\N	02.02 Subject Documents	02.02.06 Adver_ject Recruitment
12367	86	\N	\N	D5170C00002	818	813	NEW	\N	02.02 Subject Documents	02.02.07 Other_iven to Subjects
12368	86	\N	\N	D5170C00002	819	812	NEW	\N	02 Central Trial Documents	02.04 General
12369	86	\N	\N	D5170C00002	820	819	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
12370	86	\N	\N	D5170C00002	821	819	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
12371	86	\N	\N	D5170C00002	822	811	NEW	\N	2001731 Colman, Ronald	04 IRB-IEC and other Approvals
12372	86	\N	\N	D5170C00002	823	822	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
12373	86	\N	\N	D5170C00002	824	823	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
12374	86	\N	\N	D5170C00002	825	823	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
12375	86	\N	\N	D5170C00002	826	822	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
12376	86	\N	\N	D5170C00002	827	826	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
12377	86	\N	\N	D5170C00002	828	822	NEW	\N	04 IRB-IEC and other Approvals	04.04 General
12378	86	\N	\N	D5170C00002	829	828	NEW	\N	04.04 General	04.04.01 Relev_RB-IEC-Documents
12379	86	\N	\N	D5170C00002	830	811	NEW	\N	2001731 Colman, Ronald	05 Site Management
12380	86	\N	\N	D5170C00002	831	830	NEW	\N	05 Site Management	05.01 Site Selection
12381	86	\N	\N	D5170C00002	832	831	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
12382	86	\N	\N	D5170C00002	833	831	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
12383	86	\N	\N	D5170C00002	834	831	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
12384	86	\N	\N	D5170C00002	835	830	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
12385	86	\N	\N	D5170C00002	836	835	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
12386	86	\N	\N	D5170C00002	837	835	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
12387	86	\N	\N	D5170C00002	838	835	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
12388	86	\N	\N	D5170C00002	839	835	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
12389	86	\N	\N	D5170C00002	840	835	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
12390	86	\N	\N	D5170C00002	841	835	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
12391	86	\N	\N	D5170C00002	842	835	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
12392	86	\N	\N	D5170C00002	843	835	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
12393	86	\N	\N	D5170C00002	844	835	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
12394	86	\N	\N	D5170C00002	845	835	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
12395	86	\N	\N	D5170C00002	846	830	NEW	\N	05 Site Management	05.03 Site Initiation
12396	86	\N	\N	D5170C00002	847	846	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
12397	86	\N	\N	D5170C00002	848	846	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
12398	86	\N	\N	D5170C00002	849	846	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
12399	86	\N	\N	D5170C00002	850	830	NEW	\N	05 Site Management	05.04 Site Management
12400	86	\N	\N	D5170C00002	851	850	NEW	\N	05.04 Site Management	05.04.01 Subject Log
12401	86	\N	\N	D5170C00002	852	850	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
12402	86	\N	\N	D5170C00002	853	850	NEW	\N	05.04 Site Management	05.04.04 Visit Log
12403	86	\N	\N	D5170C00002	854	850	NEW	\N	05.04 Site Management	05.04.05 Additional Monitoring Activity
12404	86	\N	\N	D5170C00002	855	850	NEW	\N	05.04 Site Management	05.04.05 UNBLI_itoring Activity
12405	86	\N	\N	D5170C00002	856	850	NEW	\N	05.04 Site Management	05.04.06 UNBLINDED Protocol Deviations and Waivers
12406	86	\N	\N	D5170C00002	857	850	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
12407	86	\N	\N	D5170C00002	858	830	NEW	\N	05 Site Management	05.05 General
12408	86	\N	\N	D5170C00002	859	858	NEW	\N	05.05 General	05.05.02 Tracking Information
12409	86	\N	\N	D5170C00002	860	811	NEW	\N	2001731 Colman, Ronald	06 IP and Trial Supplies
12410	86	\N	\N	D5170C00002	861	860	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
12411	86	\N	\N	D5170C00002	862	861	NEW	\N	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
12412	86	\N	\N	D5170C00002	863	861	NEW	\N	06.01 IP Documentation	06.01.10 UNBLI_mentation Return
12413	86	\N	\N	D5170C00002	864	860	NEW	\N	06 IP and Trial Supplies	06.04 Storage
12414	86	\N	\N	D5170C00002	865	864	NEW	\N	06.04 Storage	06.04.02 UNBLINDED Storage Condition Excursion Documentation
12415	86	\N	\N	D5170C00002	866	864	NEW	\N	06.04 Storage	06.04.03 UNBLINDED Maintenance Logs
12416	86	\N	\N	D5170C00002	867	6	NEW	\N	Site	2001732 Mutlu, Ece
12417	86	\N	\N	D5170C00002	868	867	NEW	\N	2001732 Mutlu, Ece	02 Central Trial Documents
12418	86	\N	\N	D5170C00002	869	868	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
12419	86	\N	\N	D5170C00002	870	869	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
12420	86	\N	\N	D5170C00002	871	869	NEW	\N	02.02 Subject Documents	02.02.03 Informed Consent Form Checklists
12421	86	\N	\N	D5170C00002	872	868	NEW	\N	02 Central Trial Documents	02.04 General
12422	86	\N	\N	D5170C00002	873	872	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
12423	86	\N	\N	D5170C00002	874	872	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
12424	86	\N	\N	D5170C00002	875	867	NEW	\N	2001732 Mutlu, Ece	03 Regulatory
12425	86	\N	\N	D5170C00002	876	875	NEW	\N	03 Regulatory	03.04 General
12426	86	\N	\N	D5170C00002	877	876	NEW	\N	03.04 General	03.04.01 Relev_art-Up-Documents
12427	86	\N	\N	D5170C00002	878	867	NEW	\N	2001732 Mutlu, Ece	04 IRB-IEC and other Approvals
12428	86	\N	\N	D5170C00002	879	878	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
12429	86	\N	\N	D5170C00002	880	879	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
12430	86	\N	\N	D5170C00002	881	867	NEW	\N	2001732 Mutlu, Ece	05 Site Management
12431	86	\N	\N	D5170C00002	882	881	NEW	\N	05 Site Management	05.01 Site Selection
12432	86	\N	\N	D5170C00002	883	882	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
12433	86	\N	\N	D5170C00002	884	882	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
12434	86	\N	\N	D5170C00002	885	882	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
12435	86	\N	\N	D5170C00002	886	881	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
12436	86	\N	\N	D5170C00002	887	886	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
12437	86	\N	\N	D5170C00002	888	886	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
12438	86	\N	\N	D5170C00002	889	886	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
12439	86	\N	\N	D5170C00002	890	886	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
12440	86	\N	\N	D5170C00002	891	886	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
12441	86	\N	\N	D5170C00002	892	881	NEW	\N	05 Site Management	05.03 Site Initiation
12442	86	\N	\N	D5170C00002	893	892	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
12443	86	\N	\N	D5170C00002	894	6	NEW	\N	Site	2001733 Poulos, John
12444	86	\N	\N	D5170C00002	895	894	NEW	\N	2001733 Poulos, John	05 Site Management
12445	86	\N	\N	D5170C00002	896	895	NEW	\N	05 Site Management	05.01 Site Selection
12446	86	\N	\N	D5170C00002	897	896	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
12447	86	\N	\N	D5170C00002	898	6	NEW	\N	Site	2001735 Rausher, David
12448	86	\N	\N	D5170C00002	899	898	NEW	\N	2001735 Rausher, David	02 Central Trial Documents
12449	86	\N	\N	D5170C00002	900	899	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
12450	86	\N	\N	D5170C00002	901	900	NEW	\N	02.02 Subject Documents	02.02.01 Subject Diary
12451	86	\N	\N	D5170C00002	902	900	NEW	\N	02.02 Subject Documents	02.02.02 Subject Questionnaire
12452	86	\N	\N	D5170C00002	903	900	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
12453	86	\N	\N	D5170C00002	904	900	NEW	\N	02.02 Subject Documents	02.02.05 Subje_rticipation Card
12454	86	\N	\N	D5170C00002	905	900	NEW	\N	02.02 Subject Documents	02.02.06 Adver_ject Recruitment
12455	86	\N	\N	D5170C00002	906	900	NEW	\N	02.02 Subject Documents	02.02.07 Other_iven to Subjects
12456	86	\N	\N	D5170C00002	907	899	NEW	\N	02 Central Trial Documents	02.04 General
12457	86	\N	\N	D5170C00002	908	907	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
12458	86	\N	\N	D5170C00002	909	907	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
12459	86	\N	\N	D5170C00002	910	898	NEW	\N	2001735 Rausher, David	04 IRB-IEC and other Approvals
12460	86	\N	\N	D5170C00002	911	910	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
12461	86	\N	\N	D5170C00002	912	911	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
12462	86	\N	\N	D5170C00002	913	898	NEW	\N	2001735 Rausher, David	05 Site Management
12463	86	\N	\N	D5170C00002	914	913	NEW	\N	05 Site Management	05.01 Site Selection
12464	86	\N	\N	D5170C00002	915	914	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
12465	86	\N	\N	D5170C00002	916	914	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
12466	86	\N	\N	D5170C00002	917	914	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
12467	86	\N	\N	D5170C00002	918	913	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
12468	86	\N	\N	D5170C00002	919	918	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
12469	86	\N	\N	D5170C00002	920	918	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
12470	86	\N	\N	D5170C00002	921	918	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
12471	86	\N	\N	D5170C00002	922	918	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
12472	86	\N	\N	D5170C00002	923	918	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
12473	86	\N	\N	D5170C00002	924	918	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
12474	86	\N	\N	D5170C00002	925	918	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
12475	86	\N	\N	D5170C00002	926	918	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
12476	86	\N	\N	D5170C00002	927	918	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
12477	86	\N	\N	D5170C00002	928	918	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
12478	86	\N	\N	D5170C00002	929	918	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
12479	86	\N	\N	D5170C00002	930	913	NEW	\N	05 Site Management	05.03 Site Initiation
12480	86	\N	\N	D5170C00002	931	930	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
12481	86	\N	\N	D5170C00002	932	930	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
12482	86	\N	\N	D5170C00002	933	930	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
12483	86	\N	\N	D5170C00002	934	913	NEW	\N	05 Site Management	05.04 Site Management
12484	86	\N	\N	D5170C00002	935	934	NEW	\N	05.04 Site Management	05.04.01 Subject Log
12485	86	\N	\N	D5170C00002	936	934	NEW	\N	05.04 Site Management	05.04.04 Visit Log
12486	86	\N	\N	D5170C00002	937	934	NEW	\N	05.04 Site Management	05.04.05 Additional Monitoring Activity
12487	86	\N	\N	D5170C00002	938	934	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
12488	86	\N	\N	D5170C00002	939	913	NEW	\N	05 Site Management	05.05 General
12489	86	\N	\N	D5170C00002	940	939	NEW	\N	05.05 General	05.05.02 Tracking Information
12490	86	\N	\N	D5170C00002	941	6	NEW	\N	Site	2001736 Cohen, Russell
12491	86	\N	\N	D5170C00002	942	941	NEW	\N	2001736 Cohen, Russell	02 Central Trial Documents
12492	86	\N	\N	D5170C00002	943	942	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
12493	86	\N	\N	D5170C00002	944	943	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
12494	86	\N	\N	D5170C00002	945	943	NEW	\N	02.02 Subject Documents	02.02.07 Other_iven to Subjects
12495	86	\N	\N	D5170C00002	946	942	NEW	\N	02 Central Trial Documents	02.04 General
12496	86	\N	\N	D5170C00002	947	946	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
12497	86	\N	\N	D5170C00002	948	946	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
12498	86	\N	\N	D5170C00002	949	941	NEW	\N	2001736 Cohen, Russell	03 Regulatory
12499	86	\N	\N	D5170C00002	950	949	NEW	\N	03 Regulatory	03.04 General
12500	86	\N	\N	D5170C00002	951	950	NEW	\N	03.04 General	03.04.01 Relev_y-Start-Up-Email
12501	86	\N	\N	D5170C00002	952	941	NEW	\N	2001736 Cohen, Russell	04 IRB-IEC and other Approvals
12502	86	\N	\N	D5170C00002	953	952	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
12503	86	\N	\N	D5170C00002	954	953	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
12504	86	\N	\N	D5170C00002	955	953	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
12505	86	\N	\N	D5170C00002	956	953	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
12506	86	\N	\N	D5170C00002	957	952	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
12507	86	\N	\N	D5170C00002	958	957	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
12508	86	\N	\N	D5170C00002	959	941	NEW	\N	2001736 Cohen, Russell	05 Site Management
12509	86	\N	\N	D5170C00002	960	959	NEW	\N	05 Site Management	05.01 Site Selection
12510	86	\N	\N	D5170C00002	961	960	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
12511	86	\N	\N	D5170C00002	962	960	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
12512	86	\N	\N	D5170C00002	963	960	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
12513	86	\N	\N	D5170C00002	964	959	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
12514	86	\N	\N	D5170C00002	965	964	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
12515	86	\N	\N	D5170C00002	966	964	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
12516	86	\N	\N	D5170C00002	967	964	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
12517	86	\N	\N	D5170C00002	968	964	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
12518	86	\N	\N	D5170C00002	969	964	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
12519	86	\N	\N	D5170C00002	970	964	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
12520	86	\N	\N	D5170C00002	971	964	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Investigator Regulatory Agreement
12521	86	\N	\N	D5170C00002	972	964	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
12522	86	\N	\N	D5170C00002	973	964	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
12523	86	\N	\N	D5170C00002	974	964	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
12524	86	\N	\N	D5170C00002	975	964	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
12525	86	\N	\N	D5170C00002	976	959	NEW	\N	05 Site Management	05.03 Site Initiation
12526	86	\N	\N	D5170C00002	977	976	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
12527	86	\N	\N	D5170C00002	978	976	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
12528	86	\N	\N	D5170C00002	979	976	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
12529	86	\N	\N	D5170C00002	980	959	NEW	\N	05 Site Management	05.04 Site Management
12530	86	\N	\N	D5170C00002	981	980	NEW	\N	05.04 Site Management	05.04.03 UNBLINDED Monitoring Visit Report
12531	86	\N	\N	D5170C00002	982	980	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
12532	86	\N	\N	D5170C00002	983	980	NEW	\N	05.04 Site Management	05.04.04 Visit Log
12533	86	\N	\N	D5170C00002	984	980	NEW	\N	05.04 Site Management	05.04.05 UNBLI_itoring Activity
12534	86	\N	\N	D5170C00002	985	980	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
12535	86	\N	\N	D5170C00002	986	959	NEW	\N	05 Site Management	05.05 General
12536	86	\N	\N	D5170C00002	987	986	NEW	\N	05.05 General	05.05.01 Relevant Communications-Documents
12537	86	\N	\N	D5170C00002	988	986	NEW	\N	05.05 General	05.05.02 Tracking Information
12538	86	\N	\N	D5170C00002	989	941	NEW	\N	2001736 Cohen, Russell	06 IP and Trial Supplies
12539	86	\N	\N	D5170C00002	990	989	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
12540	86	\N	\N	D5170C00002	991	990	NEW	\N	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
12541	86	\N	\N	D5170C00002	992	990	NEW	\N	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
12542	86	\N	\N	D5170C00002	993	990	NEW	\N	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
12543	86	\N	\N	D5170C00002	994	990	NEW	\N	06.01 IP Documentation	06.01.11 UNBLINDED Certificate of Destruction
12544	86	\N	\N	D5170C00002	995	989	NEW	\N	06 IP and Trial Supplies	06.04 Storage
12545	86	\N	\N	D5170C00002	996	995	NEW	\N	06.04 Storage	06.04.01 UNBLI_on Documentation
12546	86	\N	\N	D5170C00002	997	995	NEW	\N	06.04 Storage	06.04.03 UNBLINDED Maintenance Logs
12547	86	\N	\N	D5170C00002	998	6	NEW	\N	Site	2001737 Fogel, Ronald
12548	86	\N	\N	D5170C00002	999	998	NEW	\N	2001737 Fogel, Ronald	05 Site Management
12549	86	\N	\N	D5170C00002	1000	999	NEW	\N	05 Site Management	05.01 Site Selection
12550	86	\N	\N	D5170C00002	1001	1000	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
12551	86	\N	\N	D5170C00002	1002	6	NEW	\N	Site	2001738 Georgetson, Michael
12552	86	\N	\N	D5170C00002	1003	1002	NEW	\N	2001738 Georgetson, Michael	02 Central Trial Documents
12553	86	\N	\N	D5170C00002	1004	1003	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
12554	86	\N	\N	D5170C00002	1005	1004	NEW	\N	02.02 Subject Documents	02.02.01 Subject Diary
12555	86	\N	\N	D5170C00002	1006	1004	NEW	\N	02.02 Subject Documents	02.02.02 Subject Questionnaire
12556	86	\N	\N	D5170C00002	1007	1004	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
12557	86	\N	\N	D5170C00002	1008	1004	NEW	\N	02.02 Subject Documents	02.02.05 Subject Participation Card
12558	86	\N	\N	D5170C00002	1009	1004	NEW	\N	02.02 Subject Documents	02.02.06 Adver_ject Recruitment
12559	86	\N	\N	D5170C00002	1010	1004	NEW	\N	02.02 Subject Documents	02.02.07 Other_iven to Subjects
12560	86	\N	\N	D5170C00002	1011	1003	NEW	\N	02 Central Trial Documents	02.04 General
12561	86	\N	\N	D5170C00002	1012	1011	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
12562	86	\N	\N	D5170C00002	1013	1011	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
12563	86	\N	\N	D5170C00002	1014	1002	NEW	\N	2001738 Georgetson, Michael	04 IRB-IEC and other Approvals
12564	86	\N	\N	D5170C00002	1015	1014	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
12565	86	\N	\N	D5170C00002	1016	1015	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
12566	86	\N	\N	D5170C00002	1017	1015	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
12567	86	\N	\N	D5170C00002	1018	1015	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
12568	86	\N	\N	D5170C00002	1019	1015	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.05 IRB-I_liance Statement
12569	86	\N	\N	D5170C00002	1020	1014	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
12570	86	\N	\N	D5170C00002	1021	1020	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
12571	86	\N	\N	D5170C00002	1022	1002	NEW	\N	2001738 Georgetson, Michael	05 Site Management
12572	86	\N	\N	D5170C00002	1023	1022	NEW	\N	05 Site Management	05.01 Site Selection
12573	86	\N	\N	D5170C00002	1024	1023	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
12574	86	\N	\N	D5170C00002	1025	1023	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
12575	86	\N	\N	D5170C00002	1026	1023	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
12576	86	\N	\N	D5170C00002	1027	1022	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
12577	86	\N	\N	D5170C00002	1028	1027	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Accep_tigator Brochure
12578	86	\N	\N	D5170C00002	1029	1027	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
12579	86	\N	\N	D5170C00002	1030	1027	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
12580	86	\N	\N	D5170C00002	1031	1027	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
12581	86	\N	\N	D5170C00002	1032	1027	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
12582	86	\N	\N	D5170C00002	1033	1027	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
12583	86	\N	\N	D5170C00002	1034	1027	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
12584	86	\N	\N	D5170C00002	1035	1027	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
12585	86	\N	\N	D5170C00002	1036	1027	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
12586	86	\N	\N	D5170C00002	1037	1027	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Si_se Documentation
12587	86	\N	\N	D5170C00002	1038	1027	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
12588	86	\N	\N	D5170C00002	1039	1022	NEW	\N	05 Site Management	05.03 Site Initiation
12589	86	\N	\N	D5170C00002	1040	1039	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
12590	86	\N	\N	D5170C00002	1041	1039	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
12591	86	\N	\N	D5170C00002	1042	1039	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
12592	86	\N	\N	D5170C00002	1043	1022	NEW	\N	05 Site Management	05.04 Site Management
12593	86	\N	\N	D5170C00002	1044	1043	NEW	\N	05.04 Site Management	05.04.01 Subject Log
12594	86	\N	\N	D5170C00002	1045	1043	NEW	\N	05.04 Site Management	05.04.03 UNBLINDED Monitoring Visit Report
12595	86	\N	\N	D5170C00002	1046	1043	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
12596	86	\N	\N	D5170C00002	1047	1043	NEW	\N	05.04 Site Management	05.04.04 Visit Log
12597	86	\N	\N	D5170C00002	1048	1043	NEW	\N	05.04 Site Management	05.04.05 Additional Monitoring Activity
12598	86	\N	\N	D5170C00002	1049	1043	NEW	\N	05.04 Site Management	05.04.05 UNBLI_itoring Activity
12599	86	\N	\N	D5170C00002	1050	1043	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
12600	86	\N	\N	D5170C00002	1051	1022	NEW	\N	05 Site Management	05.05 General
12601	86	\N	\N	D5170C00002	1052	1051	NEW	\N	05.05 General	05.05.01 Relev_ations-Documents
12602	86	\N	\N	D5170C00002	1053	1051	NEW	\N	05.05 General	05.05.02 Tracking Information
12603	86	\N	\N	D5170C00002	1054	1002	NEW	\N	2001738 Georgetson, Michael	06 IP and Trial Supplies
12604	86	\N	\N	D5170C00002	1055	1054	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
12605	86	\N	\N	D5170C00002	1056	1055	NEW	\N	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
12606	86	\N	\N	D5170C00002	1057	1055	NEW	\N	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
12607	86	\N	\N	D5170C00002	1058	1055	NEW	\N	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
12608	86	\N	\N	D5170C00002	1059	1055	NEW	\N	06.01 IP Documentation	06.01.11 UNBLI_e of Destruction
12609	86	\N	\N	D5170C00002	1060	1054	NEW	\N	06 IP and Trial Supplies	06.04 Storage
12610	86	\N	\N	D5170C00002	1061	1060	NEW	\N	06.04 Storage	06.04.01 UNBLI_on Documentation
12611	86	\N	\N	D5170C00002	1062	1060	NEW	\N	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
12612	86	\N	\N	D5170C00002	1063	1054	NEW	\N	06 IP and Trial Supplies	06.07 General
12613	86	\N	\N	D5170C00002	1064	1063	NEW	\N	06.07 General	06.07.01 UNBLI_roduct-Documents
12614	86	\N	\N	D5170C00002	1065	6	NEW	\N	Site	2001739 Goff, John
12615	86	\N	\N	D5170C00002	1066	1065	NEW	\N	2001739 Goff, John	05 Site Management
12616	86	\N	\N	D5170C00002	1067	1066	NEW	\N	05 Site Management	05.01 Site Selection
12617	86	\N	\N	D5170C00002	1068	1067	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
12618	86	\N	\N	D5170C00002	1069	6	NEW	\N	Site	2001740 Fleisher, Mark
12619	86	\N	\N	D5170C00002	1070	1069	NEW	\N	2001740 Fleisher, Mark	02 Central Trial Documents
12620	86	\N	\N	D5170C00002	1071	1070	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
12621	86	\N	\N	D5170C00002	1072	1071	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
12622	86	\N	\N	D5170C00002	1073	1070	NEW	\N	02 Central Trial Documents	02.04 General
12623	86	\N	\N	D5170C00002	1074	1073	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
12624	86	\N	\N	D5170C00002	1075	1073	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
12625	86	\N	\N	D5170C00002	1076	1069	NEW	\N	2001740 Fleisher, Mark	04 IRB-IEC and other Approvals
12626	86	\N	\N	D5170C00002	1077	1076	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
12627	86	\N	\N	D5170C00002	1078	1077	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
12628	86	\N	\N	D5170C00002	1079	1077	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
12629	86	\N	\N	D5170C00002	1080	1069	NEW	\N	2001740 Fleisher, Mark	05 Site Management
12630	86	\N	\N	D5170C00002	1081	1080	NEW	\N	05 Site Management	05.01 Site Selection
12631	86	\N	\N	D5170C00002	1082	1081	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
12632	86	\N	\N	D5170C00002	1083	1081	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
12633	86	\N	\N	D5170C00002	1084	1081	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
12634	86	\N	\N	D5170C00002	1085	1080	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
12635	86	\N	\N	D5170C00002	1086	1085	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
12636	86	\N	\N	D5170C00002	1087	1085	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
12637	86	\N	\N	D5170C00002	1088	1085	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
12638	86	\N	\N	D5170C00002	1089	1085	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
12639	86	\N	\N	D5170C00002	1090	1085	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
12640	86	\N	\N	D5170C00002	1091	1085	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
12641	86	\N	\N	D5170C00002	1092	1085	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
12642	86	\N	\N	D5170C00002	1093	1085	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
12643	86	\N	\N	D5170C00002	1094	1085	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
12644	86	\N	\N	D5170C00002	1095	1085	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
12645	86	\N	\N	D5170C00002	1096	1085	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
12646	86	\N	\N	D5170C00002	1097	1080	NEW	\N	05 Site Management	05.03 Site Initiation
12647	86	\N	\N	D5170C00002	1098	1097	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
12648	86	\N	\N	D5170C00002	1099	1080	NEW	\N	05 Site Management	05.04 Site Management
12649	86	\N	\N	D5170C00002	1100	1099	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
12650	86	\N	\N	D5170C00002	1101	1099	NEW	\N	05.04 Site Management	05.04.05 UNBLI_itoring Activity
12651	86	\N	\N	D5170C00002	1102	1099	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
12652	86	\N	\N	D5170C00002	1103	1080	NEW	\N	05 Site Management	05.05 General
12653	86	\N	\N	D5170C00002	1104	1103	NEW	\N	05.05 General	05.05.02 Tracking Information
12654	86	\N	\N	D5170C00002	1105	1069	NEW	\N	2001740 Fleisher, Mark	06 IP and Trial Supplies
12655	86	\N	\N	D5170C00002	1106	1105	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
12656	86	\N	\N	D5170C00002	1107	1106	NEW	\N	06.01 IP Documentation	06.01.02 IP Instructions for Handling
12657	86	\N	\N	D5170C00002	1108	1105	NEW	\N	06 IP and Trial Supplies	06.07 General
12658	86	\N	\N	D5170C00002	1109	1108	NEW	\N	06.07 General	06.07.01 UNBLI_roduct-Documents
12659	86	\N	\N	D5170C00002	1110	6	NEW	\N	Site	2001742 Hanauer, Stephen
12660	86	\N	\N	D5170C00002	1111	1110	NEW	\N	2001742 Hanauer, Stephen	02 Central Trial Documents
12661	86	\N	\N	D5170C00002	1112	1111	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
12662	86	\N	\N	D5170C00002	1113	1112	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
12663	86	\N	\N	D5170C00002	1114	1111	NEW	\N	02 Central Trial Documents	02.04 General
12664	86	\N	\N	D5170C00002	1115	1114	NEW	\N	02.04 General	02.04.01 Relev_ations-Documents
12665	86	\N	\N	D5170C00002	1116	1114	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
12666	86	\N	\N	D5170C00002	1117	1114	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
12667	86	\N	\N	D5170C00002	1118	1110	NEW	\N	2001742 Hanauer, Stephen	04 IRB-IEC and other Approvals
12668	86	\N	\N	D5170C00002	1119	1118	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
12669	86	\N	\N	D5170C00002	1120	1119	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
12670	86	\N	\N	D5170C00002	1121	1119	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
12671	86	\N	\N	D5170C00002	1122	1118	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
12672	86	\N	\N	D5170C00002	1123	1122	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
12673	86	\N	\N	D5170C00002	1124	1110	NEW	\N	2001742 Hanauer, Stephen	05 Site Management
12674	86	\N	\N	D5170C00002	1125	1124	NEW	\N	05 Site Management	05.01 Site Selection
12675	86	\N	\N	D5170C00002	1126	1125	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
12676	86	\N	\N	D5170C00002	1127	1125	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
12677	86	\N	\N	D5170C00002	1128	1125	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
12678	86	\N	\N	D5170C00002	1129	1124	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
12679	86	\N	\N	D5170C00002	1130	1129	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
12680	86	\N	\N	D5170C00002	1131	1129	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
12681	86	\N	\N	D5170C00002	1132	1129	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
12682	86	\N	\N	D5170C00002	1133	1129	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
12683	86	\N	\N	D5170C00002	1134	1129	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
12684	86	\N	\N	D5170C00002	1135	1129	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
12685	86	\N	\N	D5170C00002	1136	1129	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
12686	86	\N	\N	D5170C00002	1137	1129	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
12687	86	\N	\N	D5170C00002	1138	1129	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
12688	86	\N	\N	D5170C00002	1139	1129	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
12689	86	\N	\N	D5170C00002	1140	1129	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
12690	86	\N	\N	D5170C00002	1141	1124	NEW	\N	05 Site Management	05.03 Site Initiation
12691	86	\N	\N	D5170C00002	1142	1141	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
12692	86	\N	\N	D5170C00002	1143	1141	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
12693	86	\N	\N	D5170C00002	1144	1141	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
12694	86	\N	\N	D5170C00002	1145	1124	NEW	\N	05 Site Management	05.04 Site Management
12695	86	\N	\N	D5170C00002	1146	1145	NEW	\N	05.04 Site Management	05.04.04 Visit Log
12696	86	\N	\N	D5170C00002	1147	1145	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
12697	86	\N	\N	D5170C00002	1148	1124	NEW	\N	05 Site Management	05.05 General
12698	86	\N	\N	D5170C00002	1149	1148	NEW	\N	05.05 General	05.05.01 Relevant Communications-Documents
12699	86	\N	\N	D5170C00002	1150	1148	NEW	\N	05.05 General	05.05.01 Relevant Communications-Email
12700	86	\N	\N	D5170C00002	1151	1148	NEW	\N	05.05 General	05.05.02 Tracking Information
12701	86	\N	\N	D5170C00002	1152	1110	NEW	\N	2001742 Hanauer, Stephen	06 IP and Trial Supplies
12702	86	\N	\N	D5170C00002	1153	1152	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
12703	86	\N	\N	D5170C00002	1154	1153	NEW	\N	06.01 IP Documentation	06.01.11 UNBLI_e of Destruction
12704	86	\N	\N	D5170C00002	1155	6	NEW	\N	Site	2001746 Fischer, Monika
12705	86	\N	\N	D5170C00002	1156	1155	NEW	\N	2001746 Fischer, Monika	02 Central Trial Documents
12706	86	\N	\N	D5170C00002	1157	1156	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
12707	86	\N	\N	D5170C00002	1158	1157	NEW	\N	02.02 Subject Documents	02.02.03 Infor_ Form Checklists
12708	86	\N	\N	D5170C00002	1159	1157	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
12709	86	\N	\N	D5170C00002	1160	1156	NEW	\N	02 Central Trial Documents	02.04 General
12710	86	\N	\N	D5170C00002	1161	1160	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
12711	86	\N	\N	D5170C00002	1162	1160	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
12712	86	\N	\N	D5170C00002	1163	1155	NEW	\N	2001746 Fischer, Monika	04 IRB-IEC and other Approvals
12713	86	\N	\N	D5170C00002	1164	1163	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
12714	86	\N	\N	D5170C00002	1165	1164	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
12715	86	\N	\N	D5170C00002	1166	1164	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
12716	86	\N	\N	D5170C00002	1167	1164	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
12717	86	\N	\N	D5170C00002	1168	1163	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
12718	86	\N	\N	D5170C00002	1169	1168	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
12719	86	\N	\N	D5170C00002	1170	1155	NEW	\N	2001746 Fischer, Monika	05 Site Management
12720	86	\N	\N	D5170C00002	1171	1170	NEW	\N	05 Site Management	05.01 Site Selection
12721	86	\N	\N	D5170C00002	1172	1171	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
12722	86	\N	\N	D5170C00002	1173	1171	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
12723	86	\N	\N	D5170C00002	1174	1171	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
12724	86	\N	\N	D5170C00002	1175	1170	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
12725	86	\N	\N	D5170C00002	1176	1175	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
12726	86	\N	\N	D5170C00002	1177	1175	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
12727	86	\N	\N	D5170C00002	1178	1175	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
12728	86	\N	\N	D5170C00002	1179	1175	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
12729	86	\N	\N	D5170C00002	1180	1175	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
12730	86	\N	\N	D5170C00002	1181	1175	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
12731	86	\N	\N	D5170C00002	1182	1175	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
12732	86	\N	\N	D5170C00002	1183	1175	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Investigator Regulatory Agreement
12733	86	\N	\N	D5170C00002	1184	1175	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
12734	86	\N	\N	D5170C00002	1185	1175	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
12735	86	\N	\N	D5170C00002	1186	1175	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
12736	86	\N	\N	D5170C00002	1187	1175	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
12737	86	\N	\N	D5170C00002	1188	1170	NEW	\N	05 Site Management	05.03 Site Initiation
12738	86	\N	\N	D5170C00002	1189	1188	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
12739	86	\N	\N	D5170C00002	1190	1188	NEW	\N	05.03 Site Initiation	05.03.02 Site Training Material
12740	86	\N	\N	D5170C00002	1191	1188	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
12741	86	\N	\N	D5170C00002	1192	1188	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
12742	86	\N	\N	D5170C00002	1193	1170	NEW	\N	05 Site Management	05.04 Site Management
12743	86	\N	\N	D5170C00002	1194	1193	NEW	\N	05.04 Site Management	05.04.01 Subject Log
12744	86	\N	\N	D5170C00002	1195	1193	NEW	\N	05.04 Site Management	05.04.03 Monitoring Visit Report
12745	86	\N	\N	D5170C00002	1196	1193	NEW	\N	05.04 Site Management	05.04.03 UNBLINDED Monitoring Visit Report
12746	86	\N	\N	D5170C00002	1197	1193	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
12747	86	\N	\N	D5170C00002	1198	1193	NEW	\N	05.04 Site Management	05.04.04 Visit Log
12748	86	\N	\N	D5170C00002	1199	1193	NEW	\N	05.04 Site Management	05.04.05 Additional Monitoring Activity
12749	86	\N	\N	D5170C00002	1200	1193	NEW	\N	05.04 Site Management	05.04.05 UNBLI_itoring Activity
12750	86	\N	\N	D5170C00002	1201	1193	NEW	\N	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
12751	86	\N	\N	D5170C00002	1202	1193	NEW	\N	05.04 Site Management	05.04.06 UNBLINDED Protocol Deviations and Waivers
12752	86	\N	\N	D5170C00002	1203	1193	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
12753	86	\N	\N	D5170C00002	1204	1170	NEW	\N	05 Site Management	05.05 General
12754	86	\N	\N	D5170C00002	1205	1204	NEW	\N	05.05 General	05.05.01 Relev_ations-Documents
12755	86	\N	\N	D5170C00002	1206	1204	NEW	\N	05.05 General	05.05.02 Tracking Information
12756	86	\N	\N	D5170C00002	1207	1155	NEW	\N	2001746 Fischer, Monika	06 IP and Trial Supplies
12757	86	\N	\N	D5170C00002	1208	1207	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
12758	86	\N	\N	D5170C00002	1209	1208	NEW	\N	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
12759	86	\N	\N	D5170C00002	1210	1208	NEW	\N	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
12760	86	\N	\N	D5170C00002	1211	1208	NEW	\N	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
12761	86	\N	\N	D5170C00002	1212	1208	NEW	\N	06.01 IP Documentation	06.01.11 UNBLINDED Certificate of Destruction
12762	86	\N	\N	D5170C00002	1213	1207	NEW	\N	06 IP and Trial Supplies	06.03 IP Alloc_on Documentation
12763	86	\N	\N	D5170C00002	1214	1213	NEW	\N	06.03 IP Alloc_on Documentation	06.03.01 UNBLI_on Documentation
12764	86	\N	\N	D5170C00002	1215	1207	NEW	\N	06 IP and Trial Supplies	06.04 Storage
12765	86	\N	\N	D5170C00002	1216	1215	NEW	\N	06.04 Storage	06.04.01 UNBLI_on Documentation
12766	86	\N	\N	D5170C00002	1217	1215	NEW	\N	06.04 Storage	06.04.02 UNBLINDED Storage Condition Excursion Documentation
12767	86	\N	\N	D5170C00002	1218	1215	NEW	\N	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
12768	86	\N	\N	D5170C00002	1219	1207	NEW	\N	06 IP and Trial Supplies	06.05 Non-IP Documentation
12769	86	\N	\N	D5170C00002	1220	1219	NEW	\N	06.05 Non-IP Documentation	06.05.03 Non-I_tation of Return
12770	86	\N	\N	D5170C00002	1221	1207	NEW	\N	06 IP and Trial Supplies	06.07 General
12771	86	\N	\N	D5170C00002	1222	1221	NEW	\N	06.07 General	06.07.01 UNBLI_roduct-Documents
12772	86	\N	\N	D5170C00002	1223	1155	NEW	\N	2001746 Fischer, Monika	08 Centralized Testing
12773	86	\N	\N	D5170C00002	1224	1223	NEW	\N	08 Centralized Testing	08.02 Sample Documentation
12774	86	\N	\N	D5170C00002	1225	1224	NEW	\N	08.02 Sample Documentation	08.02.03 Sampl_ge Condition Log
12775	86	\N	\N	D5170C00002	1226	6	NEW	\N	Site	2001748 Higgins, Peter
12776	86	\N	\N	D5170C00002	1227	1226	NEW	\N	2001748 Higgins, Peter	02 Central Trial Documents
12777	86	\N	\N	D5170C00002	1228	1227	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
12778	86	\N	\N	D5170C00002	1229	1228	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
12779	86	\N	\N	D5170C00002	1230	1227	NEW	\N	02 Central Trial Documents	02.04 General
12780	86	\N	\N	D5170C00002	1231	1230	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
12781	86	\N	\N	D5170C00002	1232	1230	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
12782	86	\N	\N	D5170C00002	1233	1226	NEW	\N	2001748 Higgins, Peter	03 Regulatory
12783	86	\N	\N	D5170C00002	1234	1233	NEW	\N	03 Regulatory	03.04 General
12784	86	\N	\N	D5170C00002	1235	1234	NEW	\N	03.04 General	03.04.01 Relev_y-Start-Up-Email
12785	86	\N	\N	D5170C00002	1236	1226	NEW	\N	2001748 Higgins, Peter	04 IRB-IEC and other Approvals
12786	86	\N	\N	D5170C00002	1237	1236	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
12787	86	\N	\N	D5170C00002	1238	1237	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
12788	86	\N	\N	D5170C00002	1239	1236	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
12789	86	\N	\N	D5170C00002	1240	1239	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
12790	86	\N	\N	D5170C00002	1241	1226	NEW	\N	2001748 Higgins, Peter	05 Site Management
12791	86	\N	\N	D5170C00002	1242	1241	NEW	\N	05 Site Management	05.01 Site Selection
12792	86	\N	\N	D5170C00002	1243	1242	NEW	\N	05.01 Site Selection	05.01.01 Site Contact Details
12793	86	\N	\N	D5170C00002	1244	1242	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
12794	86	\N	\N	D5170C00002	1245	1242	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
12795	86	\N	\N	D5170C00002	1246	1242	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
12796	86	\N	\N	D5170C00002	1247	1241	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
12797	86	\N	\N	D5170C00002	1248	1247	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
12798	86	\N	\N	D5170C00002	1249	1247	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
12799	86	\N	\N	D5170C00002	1250	1247	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
12800	86	\N	\N	D5170C00002	1251	1247	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
12801	86	\N	\N	D5170C00002	1252	1247	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
12802	86	\N	\N	D5170C00002	1253	1247	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Site Qualification
12803	86	\N	\N	D5170C00002	1254	1247	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
12804	86	\N	\N	D5170C00002	1255	1247	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
12805	86	\N	\N	D5170C00002	1256	1247	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Investigator Regulatory Agreement
12806	86	\N	\N	D5170C00002	1257	1247	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
12807	86	\N	\N	D5170C00002	1258	1247	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
12808	86	\N	\N	D5170C00002	1259	1247	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
12809	86	\N	\N	D5170C00002	1260	1247	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
12810	86	\N	\N	D5170C00002	1261	1241	NEW	\N	05 Site Management	05.03 Site Initiation
12811	86	\N	\N	D5170C00002	1262	1261	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
12812	86	\N	\N	D5170C00002	1263	1261	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
12813	86	\N	\N	D5170C00002	1264	1261	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
12814	86	\N	\N	D5170C00002	1265	1241	NEW	\N	05 Site Management	05.04 Site Management
12815	86	\N	\N	D5170C00002	1266	1265	NEW	\N	05.04 Site Management	05.04.01 Subject Log
12816	86	\N	\N	D5170C00002	1267	1265	NEW	\N	05.04 Site Management	05.04.03 Monitoring Visit Report
12817	86	\N	\N	D5170C00002	1268	1265	NEW	\N	05.04 Site Management	05.04.03 UNBLINDED Monitoring Visit Report
12818	86	\N	\N	D5170C00002	1269	1265	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
12819	86	\N	\N	D5170C00002	1270	1265	NEW	\N	05.04 Site Management	05.04.04 Visit Log
12820	86	\N	\N	D5170C00002	1271	1265	NEW	\N	05.04 Site Management	05.04.05 UNBLI_itoring Activity
12821	86	\N	\N	D5170C00002	1272	1265	NEW	\N	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
12822	86	\N	\N	D5170C00002	1273	1265	NEW	\N	05.04 Site Management	05.04.06 UNBLINDED Protocol Deviations and Waivers
12823	86	\N	\N	D5170C00002	1274	1265	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
12824	86	\N	\N	D5170C00002	1275	1241	NEW	\N	05 Site Management	05.05 General
12825	86	\N	\N	D5170C00002	1276	1275	NEW	\N	05.05 General	05.05.01 Relev_ations-Documents
12826	86	\N	\N	D5170C00002	1277	1275	NEW	\N	05.05 General	05.05.01 Relev_unications-Email
12827	86	\N	\N	D5170C00002	1278	1275	NEW	\N	05.05 General	05.05.02 Tracking Information
12828	86	\N	\N	D5170C00002	1279	1226	NEW	\N	2001748 Higgins, Peter	06 IP and Trial Supplies
12829	86	\N	\N	D5170C00002	1280	1279	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
12830	86	\N	\N	D5170C00002	1281	1280	NEW	\N	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
12831	86	\N	\N	D5170C00002	1282	1280	NEW	\N	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
12832	86	\N	\N	D5170C00002	1283	1280	NEW	\N	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
12833	86	\N	\N	D5170C00002	1284	1280	NEW	\N	06.01 IP Documentation	06.01.11 UNBLINDED Certificate of Destruction
12834	86	\N	\N	D5170C00002	1285	1279	NEW	\N	06 IP and Trial Supplies	06.04 Storage
12835	86	\N	\N	D5170C00002	1286	1285	NEW	\N	06.04 Storage	06.04.01 UNBLI_on Documentation
12836	86	\N	\N	D5170C00002	1287	1285	NEW	\N	06.04 Storage	06.04.02 UNBLI_on Documentation
12837	86	\N	\N	D5170C00002	1288	1285	NEW	\N	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
12838	86	\N	\N	D5170C00002	1289	1279	NEW	\N	06 IP and Trial Supplies	06.07 General
12839	86	\N	\N	D5170C00002	1290	1289	NEW	\N	06.07 General	06.07.01 UNBLI_roduct-Documents
12840	86	\N	\N	D5170C00002	1291	1226	NEW	\N	2001748 Higgins, Peter	08 Centralized Testing
12841	86	\N	\N	D5170C00002	1292	1291	NEW	\N	08 Centralized Testing	08.03 General
12842	86	\N	\N	D5170C00002	1293	1292	NEW	\N	08.03 General	08.03.01 Relev_al Lab-Documents
12843	86	\N	\N	D5170C00002	1294	6	NEW	\N	Site	2001749 Soloman, Nehad
12844	86	\N	\N	D5170C00002	1295	1294	NEW	\N	2001749 Soloman, Nehad	02 Central Trial Documents
12845	86	\N	\N	D5170C00002	1296	1295	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
12846	86	\N	\N	D5170C00002	1297	1296	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
12847	86	\N	\N	D5170C00002	1298	1295	NEW	\N	02 Central Trial Documents	02.04 General
12848	86	\N	\N	D5170C00002	1299	1298	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
12849	86	\N	\N	D5170C00002	1300	1298	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
12850	86	\N	\N	D5170C00002	1301	1294	NEW	\N	2001749 Soloman, Nehad	04 IRB-IEC and other Approvals
12851	86	\N	\N	D5170C00002	1302	1301	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
12852	86	\N	\N	D5170C00002	1303	1302	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
12853	86	\N	\N	D5170C00002	1304	1302	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
12854	86	\N	\N	D5170C00002	1305	1294	NEW	\N	2001749 Soloman, Nehad	05 Site Management
12855	86	\N	\N	D5170C00002	1306	1305	NEW	\N	05 Site Management	05.01 Site Selection
12856	86	\N	\N	D5170C00002	1307	1306	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
12857	86	\N	\N	D5170C00002	1308	1306	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
12858	86	\N	\N	D5170C00002	1309	1306	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
12859	86	\N	\N	D5170C00002	1310	1305	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
12860	86	\N	\N	D5170C00002	1311	1310	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
12861	86	\N	\N	D5170C00002	1312	1310	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
12862	86	\N	\N	D5170C00002	1313	1310	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
12863	86	\N	\N	D5170C00002	1314	1310	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
12864	86	\N	\N	D5170C00002	1315	1310	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
12865	86	\N	\N	D5170C00002	1316	1310	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
12866	86	\N	\N	D5170C00002	1317	1310	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
12867	86	\N	\N	D5170C00002	1318	1310	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Investigator Regulatory Agreement
12868	86	\N	\N	D5170C00002	1319	1310	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
12869	86	\N	\N	D5170C00002	1320	1310	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
12870	86	\N	\N	D5170C00002	1321	1310	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
12871	86	\N	\N	D5170C00002	1322	1305	NEW	\N	05 Site Management	05.03 Site Initiation
12872	86	\N	\N	D5170C00002	1323	1322	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
12873	86	\N	\N	D5170C00002	1324	1322	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
12874	86	\N	\N	D5170C00002	1325	1305	NEW	\N	05 Site Management	05.04 Site Management
12875	86	\N	\N	D5170C00002	1326	1325	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
12876	86	\N	\N	D5170C00002	1327	1325	NEW	\N	05.04 Site Management	05.04.05 Additional Monitoring Activity
12877	86	\N	\N	D5170C00002	1328	1325	NEW	\N	05.04 Site Management	05.04.05 UNBLI_itoring Activity
12878	86	\N	\N	D5170C00002	1329	1325	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
12879	86	\N	\N	D5170C00002	1330	1305	NEW	\N	05 Site Management	05.05 General
12880	86	\N	\N	D5170C00002	1331	1330	NEW	\N	05.05 General	05.05.02 Tracking Information
12881	86	\N	\N	D5170C00002	1332	1294	NEW	\N	2001749 Soloman, Nehad	06 IP and Trial Supplies
12882	86	\N	\N	D5170C00002	1333	1332	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
12883	86	\N	\N	D5170C00002	1334	1333	NEW	\N	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
12884	86	\N	\N	D5170C00002	1335	1333	NEW	\N	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
12885	86	\N	\N	D5170C00002	1336	1333	NEW	\N	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
12886	86	\N	\N	D5170C00002	1337	1333	NEW	\N	06.01 IP Documentation	06.01.11 UNBLINDED Certificate of Destruction
12887	86	\N	\N	D5170C00002	1338	1332	NEW	\N	06 IP and Trial Supplies	06.04 Storage
12888	86	\N	\N	D5170C00002	1339	1338	NEW	\N	06.04 Storage	06.04.01 UNBLI_on Documentation
12889	86	\N	\N	D5170C00002	1340	1338	NEW	\N	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
12890	86	\N	\N	D5170C00002	1341	6	NEW	\N	Site	2001750 Lee, Scott
12891	86	\N	\N	D5170C00002	1342	1341	NEW	\N	2001750 Lee, Scott	02 Central Trial Documents
12892	86	\N	\N	D5170C00002	1343	1342	NEW	\N	02 Central Trial Documents	02.04 General
12893	86	\N	\N	D5170C00002	1344	1343	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
12894	86	\N	\N	D5170C00002	1345	1341	NEW	\N	2001750 Lee, Scott	05 Site Management
12895	86	\N	\N	D5170C00002	1346	1345	NEW	\N	05 Site Management	05.01 Site Selection
12896	86	\N	\N	D5170C00002	1347	1346	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
12897	86	\N	\N	D5170C00002	1348	1346	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
12898	86	\N	\N	D5170C00002	1349	1346	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
12899	86	\N	\N	D5170C00002	1350	1345	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
12900	86	\N	\N	D5170C00002	1351	1350	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
12901	86	\N	\N	D5170C00002	1352	1345	NEW	\N	05 Site Management	05.03 Site Initiation
12902	86	\N	\N	D5170C00002	1353	1352	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
12903	86	\N	\N	D5170C00002	1354	1352	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
12904	86	\N	\N	D5170C00002	1355	1345	NEW	\N	05 Site Management	05.04 Site Management
12905	86	\N	\N	D5170C00002	1356	1355	NEW	\N	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
12906	86	\N	\N	D5170C00002	1357	1345	NEW	\N	05 Site Management	05.05 General
12907	86	\N	\N	D5170C00002	1358	1357	NEW	\N	05.05 General	05.05.01 Relevant Communications-Documents
12908	86	\N	\N	D5170C00002	1359	1357	NEW	\N	05.05 General	05.05.02 Tracking Information
12909	86	\N	\N	D5170C00002	1360	6	NEW	\N	Site	2001752 Loftus, Edward
12910	86	\N	\N	D5170C00002	1361	1360	NEW	\N	2001752 Loftus, Edward	02 Central Trial Documents
12911	86	\N	\N	D5170C00002	1362	1361	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
12912	86	\N	\N	D5170C00002	1363	1362	NEW	\N	02.02 Subject Documents	02.02.03 Infor_ Form Checklists
12913	86	\N	\N	D5170C00002	1364	1362	NEW	\N	02.02 Subject Documents	02.02.03 Informed Consent Form Templates
12914	86	\N	\N	D5170C00002	1365	1361	NEW	\N	02 Central Trial Documents	02.04 General
12915	86	\N	\N	D5170C00002	1366	1365	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
12916	86	\N	\N	D5170C00002	1367	1365	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
12917	86	\N	\N	D5170C00002	1368	1360	NEW	\N	2001752 Loftus, Edward	04 IRB-IEC and other Approvals
12918	86	\N	\N	D5170C00002	1369	1368	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
12919	86	\N	\N	D5170C00002	1370	1369	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
12920	86	\N	\N	D5170C00002	1371	1369	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
12921	86	\N	\N	D5170C00002	1372	1368	NEW	\N	04 IRB-IEC and other Approvals	04.04 General
12922	86	\N	\N	D5170C00002	1373	1372	NEW	\N	04.04 General	04.04.01 Relev_ns-IRB-IEC-Email
12923	86	\N	\N	D5170C00002	1374	1360	NEW	\N	2001752 Loftus, Edward	05 Site Management
12924	86	\N	\N	D5170C00002	1375	1374	NEW	\N	05 Site Management	05.01 Site Selection
12925	86	\N	\N	D5170C00002	1376	1375	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
12926	86	\N	\N	D5170C00002	1377	1375	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
12927	86	\N	\N	D5170C00002	1378	1375	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
12928	86	\N	\N	D5170C00002	1379	1374	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
12929	86	\N	\N	D5170C00002	1380	1379	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
12930	86	\N	\N	D5170C00002	1381	1379	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
12931	86	\N	\N	D5170C00002	1382	1379	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
12932	86	\N	\N	D5170C00002	1383	1379	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
12933	86	\N	\N	D5170C00002	1384	1379	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
12934	86	\N	\N	D5170C00002	1385	1379	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Site Qualification
12935	86	\N	\N	D5170C00002	1386	1379	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
12936	86	\N	\N	D5170C00002	1387	1379	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
12937	86	\N	\N	D5170C00002	1388	1379	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Investigator Regulatory Agreement
12938	86	\N	\N	D5170C00002	1389	1379	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
12939	86	\N	\N	D5170C00002	1390	1379	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
12940	86	\N	\N	D5170C00002	1391	1379	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
12941	86	\N	\N	D5170C00002	1392	1379	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
12942	86	\N	\N	D5170C00002	1393	1374	NEW	\N	05 Site Management	05.03 Site Initiation
12943	86	\N	\N	D5170C00002	1394	1393	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
12944	86	\N	\N	D5170C00002	1395	1393	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
12945	86	\N	\N	D5170C00002	1396	1393	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
12946	86	\N	\N	D5170C00002	1397	1374	NEW	\N	05 Site Management	05.04 Site Management
12947	86	\N	\N	D5170C00002	1398	1397	NEW	\N	05.04 Site Management	05.04.01 Subject Log
12948	86	\N	\N	D5170C00002	1399	1397	NEW	\N	05.04 Site Management	05.04.03 Monitoring Visit Report
12949	86	\N	\N	D5170C00002	1400	1397	NEW	\N	05.04 Site Management	05.04.03 UNBLINDED Monitoring Visit Report
12950	86	\N	\N	D5170C00002	1401	1397	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
12951	86	\N	\N	D5170C00002	1402	1397	NEW	\N	05.04 Site Management	05.04.04 Visit Log
12952	86	\N	\N	D5170C00002	1403	1397	NEW	\N	05.04 Site Management	05.04.05 UNBLI_itoring Activity
12953	86	\N	\N	D5170C00002	1404	1397	NEW	\N	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
12954	86	\N	\N	D5170C00002	1405	1397	NEW	\N	05.04 Site Management	05.04.06 UNBLINDED Protocol Deviations and Waivers
12955	86	\N	\N	D5170C00002	1406	1397	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
12956	86	\N	\N	D5170C00002	1407	1374	NEW	\N	05 Site Management	05.05 General
12957	86	\N	\N	D5170C00002	1408	1407	NEW	\N	05.05 General	05.05.01 Relevant Communications-Documents
12958	86	\N	\N	D5170C00002	1409	1407	NEW	\N	05.05 General	05.05.01 Relevant Communications-Email
12959	86	\N	\N	D5170C00002	1410	1407	NEW	\N	05.05 General	05.05.02 Tracking Information
12960	86	\N	\N	D5170C00002	1411	1360	NEW	\N	2001752 Loftus, Edward	06 IP and Trial Supplies
12961	86	\N	\N	D5170C00002	1412	1411	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
12962	86	\N	\N	D5170C00002	1413	1412	NEW	\N	06.01 IP Documentation	06.01.02 UNBLINDED IP Instructions for Handling
12963	86	\N	\N	D5170C00002	1414	1412	NEW	\N	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
12964	86	\N	\N	D5170C00002	1415	1412	NEW	\N	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
12965	86	\N	\N	D5170C00002	1416	1412	NEW	\N	06.01 IP Documentation	06.01.11 UNBLINDED Certificate of Destruction
12966	86	\N	\N	D5170C00002	1417	1411	NEW	\N	06 IP and Trial Supplies	06.04 Storage
12967	86	\N	\N	D5170C00002	1418	1417	NEW	\N	06.04 Storage	06.04.01 UNBLI_on Documentation
12968	86	\N	\N	D5170C00002	1419	1417	NEW	\N	06.04 Storage	06.04.03 Maintenance Logs
12969	86	\N	\N	D5170C00002	1420	1417	NEW	\N	06.04 Storage	06.04.03 UNBLINDED Maintenance Logs
12970	86	\N	\N	D5170C00002	1421	1411	NEW	\N	06 IP and Trial Supplies	06.07 General
12971	86	\N	\N	D5170C00002	1422	1421	NEW	\N	06.07 General	06.07.01 UNBLI_roduct-Documents
12972	86	\N	\N	D5170C00002	1423	1360	NEW	\N	2001752 Loftus, Edward	08 Centralized Testing
12973	86	\N	\N	D5170C00002	1424	1423	NEW	\N	08 Centralized Testing	08.01 Facility Documentation
12974	86	\N	\N	D5170C00002	1425	1424	NEW	\N	08.01 Facility Documentation	08.01.01 Certification or Accreditation
12975	86	\N	\N	D5170C00002	1426	1424	NEW	\N	08.01 Facility Documentation	08.01.04 Normal Ranges and Alert Values
12976	86	\N	\N	D5170C00002	1427	1423	NEW	\N	08 Centralized Testing	08.02 Sample Documentation
12977	86	\N	\N	D5170C00002	1428	1427	NEW	\N	08.02 Sample Documentation	08.02.03 Sampl_ge Condition Log
12978	86	\N	\N	D5170C00002	1429	6	NEW	\N	Site	2001753 Abreu, Maria
12979	86	\N	\N	D5170C00002	1430	1429	NEW	\N	2001753 Abreu, Maria	05 Site Management
12980	86	\N	\N	D5170C00002	1431	1430	NEW	\N	05 Site Management	05.01 Site Selection
12981	86	\N	\N	D5170C00002	1432	1431	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
12982	86	\N	\N	D5170C00002	1433	6	NEW	\N	Site	2001754 Zhang, Cheng
12983	86	\N	\N	D5170C00002	1434	1433	NEW	\N	2001754 Zhang, Cheng	02 Central Trial Documents
12984	86	\N	\N	D5170C00002	1435	1434	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
12985	86	\N	\N	D5170C00002	1436	1435	NEW	\N	02.02 Subject Documents	02.02.03 Infor_ Form Checklists
12986	86	\N	\N	D5170C00002	1437	1435	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
12987	86	\N	\N	D5170C00002	1438	1434	NEW	\N	02 Central Trial Documents	02.04 General
12988	86	\N	\N	D5170C00002	1439	1438	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
12989	86	\N	\N	D5170C00002	1440	1438	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
12990	86	\N	\N	D5170C00002	1441	1433	NEW	\N	2001754 Zhang, Cheng	04 IRB-IEC and other Approvals
12991	86	\N	\N	D5170C00002	1442	1441	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
12992	86	\N	\N	D5170C00002	1443	1442	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
12993	86	\N	\N	D5170C00002	1444	1442	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
12994	86	\N	\N	D5170C00002	1445	1442	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.05 IRB-I_liance Statement
12995	86	\N	\N	D5170C00002	1446	1441	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
12996	86	\N	\N	D5170C00002	1447	1446	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
12997	86	\N	\N	D5170C00002	1448	1433	NEW	\N	2001754 Zhang, Cheng	05 Site Management
12998	86	\N	\N	D5170C00002	1449	1448	NEW	\N	05 Site Management	05.01 Site Selection
12999	86	\N	\N	D5170C00002	1450	1449	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
13000	86	\N	\N	D5170C00002	1451	1449	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
13001	86	\N	\N	D5170C00002	1452	1449	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
13002	86	\N	\N	D5170C00002	1453	1448	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
13003	86	\N	\N	D5170C00002	1454	1453	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
13004	86	\N	\N	D5170C00002	1455	1453	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
13005	86	\N	\N	D5170C00002	1456	1453	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
13006	86	\N	\N	D5170C00002	1457	1453	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
13007	86	\N	\N	D5170C00002	1458	1453	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
13008	86	\N	\N	D5170C00002	1459	1453	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
13009	86	\N	\N	D5170C00002	1460	1453	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
13010	86	\N	\N	D5170C00002	1461	1453	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Investigator Regulatory Agreement
13011	86	\N	\N	D5170C00002	1462	1453	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
13012	86	\N	\N	D5170C00002	1463	1453	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
13013	86	\N	\N	D5170C00002	1464	1453	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
13014	86	\N	\N	D5170C00002	1465	1453	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
13015	86	\N	\N	D5170C00002	1466	1448	NEW	\N	05 Site Management	05.03 Site Initiation
13016	86	\N	\N	D5170C00002	1467	1466	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
13017	86	\N	\N	D5170C00002	1468	1466	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
13018	86	\N	\N	D5170C00002	1469	1466	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
13019	86	\N	\N	D5170C00002	1470	1448	NEW	\N	05 Site Management	05.04 Site Management
13020	86	\N	\N	D5170C00002	1471	1470	NEW	\N	05.04 Site Management	05.04.01 Subject Log
13021	86	\N	\N	D5170C00002	1472	1470	NEW	\N	05.04 Site Management	05.04.04 Visit Log
13022	86	\N	\N	D5170C00002	1473	1470	NEW	\N	05.04 Site Management	05.04.05 Additional Monitoring Activity
13023	86	\N	\N	D5170C00002	1474	1470	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
13024	86	\N	\N	D5170C00002	1475	1448	NEW	\N	05 Site Management	05.05 General
13025	86	\N	\N	D5170C00002	1476	1475	NEW	\N	05.05 General	05.05.01 Relevant Communications-Documents
13026	86	\N	\N	D5170C00002	1477	1475	NEW	\N	05.05 General	05.05.02 Tracking Information
13027	86	\N	\N	D5170C00002	1478	1433	NEW	\N	2001754 Zhang, Cheng	06 IP and Trial Supplies
13028	86	\N	\N	D5170C00002	1479	1478	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
13029	86	\N	\N	D5170C00002	1480	1479	NEW	\N	06.01 IP Documentation	06.01.02 IP Instructions for Handling
13030	86	\N	\N	D5170C00002	1481	1479	NEW	\N	06.01 IP Documentation	06.01.02 UNBLINDED IP Instructions for Handling
13031	86	\N	\N	D5170C00002	1482	6	NEW	\N	Site	2001755 Baum, Curtis
13032	86	\N	\N	D5170C00002	1483	1482	NEW	\N	2001755 Baum, Curtis	02 Central Trial Documents
13033	86	\N	\N	D5170C00002	1484	1483	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
13034	86	\N	\N	D5170C00002	1485	1484	NEW	\N	02.02 Subject Documents	02.02.01 Subject Diary
13035	86	\N	\N	D5170C00002	1486	1484	NEW	\N	02.02 Subject Documents	02.02.02 Subject Questionnaire
13036	86	\N	\N	D5170C00002	1487	1484	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
13037	86	\N	\N	D5170C00002	1488	1484	NEW	\N	02.02 Subject Documents	02.02.06 Adver_ject Recruitment
13038	86	\N	\N	D5170C00002	1489	1484	NEW	\N	02.02 Subject Documents	02.02.07 Other_iven to Subjects
13039	86	\N	\N	D5170C00002	1490	1483	NEW	\N	02 Central Trial Documents	02.04 General
13040	86	\N	\N	D5170C00002	1491	1490	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
13041	86	\N	\N	D5170C00002	1492	1490	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
13042	86	\N	\N	D5170C00002	1493	1482	NEW	\N	2001755 Baum, Curtis	04 IRB-IEC and other Approvals
13043	86	\N	\N	D5170C00002	1494	1493	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
13044	86	\N	\N	D5170C00002	1495	1494	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
13045	86	\N	\N	D5170C00002	1496	1494	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
13046	86	\N	\N	D5170C00002	1497	1493	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
13047	86	\N	\N	D5170C00002	1498	1497	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
13048	86	\N	\N	D5170C00002	1499	1482	NEW	\N	2001755 Baum, Curtis	05 Site Management
13049	86	\N	\N	D5170C00002	1500	1499	NEW	\N	05 Site Management	05.01 Site Selection
13050	86	\N	\N	D5170C00002	1501	1500	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
13051	86	\N	\N	D5170C00002	1502	1500	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
13052	86	\N	\N	D5170C00002	1503	1500	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
13053	86	\N	\N	D5170C00002	1504	1499	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
13054	86	\N	\N	D5170C00002	1505	1504	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
13055	86	\N	\N	D5170C00002	1506	1504	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
13056	86	\N	\N	D5170C00002	1507	1504	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
13057	86	\N	\N	D5170C00002	1508	1504	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
13058	86	\N	\N	D5170C00002	1509	1504	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
13059	86	\N	\N	D5170C00002	1510	1504	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
13060	86	\N	\N	D5170C00002	1511	1504	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
13061	86	\N	\N	D5170C00002	1512	1504	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
13062	86	\N	\N	D5170C00002	1513	1504	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
13063	86	\N	\N	D5170C00002	1514	1504	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
13064	86	\N	\N	D5170C00002	1515	1504	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
13065	86	\N	\N	D5170C00002	1516	1499	NEW	\N	05 Site Management	05.03 Site Initiation
13066	86	\N	\N	D5170C00002	1517	1516	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
13067	86	\N	\N	D5170C00002	1518	1516	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
13068	86	\N	\N	D5170C00002	1519	1516	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
13069	86	\N	\N	D5170C00002	1520	1499	NEW	\N	05 Site Management	05.04 Site Management
13070	86	\N	\N	D5170C00002	1521	1520	NEW	\N	05.04 Site Management	05.04.01 Subject Log
13071	86	\N	\N	D5170C00002	1522	1520	NEW	\N	05.04 Site Management	05.04.03 UNBLINDED Monitoring Visit Report
13072	86	\N	\N	D5170C00002	1523	1520	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
13073	86	\N	\N	D5170C00002	1524	1520	NEW	\N	05.04 Site Management	05.04.05 Additional Monitoring Activity
13074	86	\N	\N	D5170C00002	1525	1520	NEW	\N	05.04 Site Management	05.04.05 UNBLINDED Additional Monitoring Activity
13075	86	\N	\N	D5170C00002	1526	1520	NEW	\N	05.04 Site Management	05.04.06 UNBLINDED Protocol Deviations and Waivers
13076	86	\N	\N	D5170C00002	1527	1520	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
13077	86	\N	\N	D5170C00002	1528	1499	NEW	\N	05 Site Management	05.05 General
13078	86	\N	\N	D5170C00002	1529	1528	NEW	\N	05.05 General	05.05.02 Tracking Information
13079	86	\N	\N	D5170C00002	1530	1482	NEW	\N	2001755 Baum, Curtis	06 IP and Trial Supplies
13080	86	\N	\N	D5170C00002	1531	1530	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
13081	86	\N	\N	D5170C00002	1532	1531	NEW	\N	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
13082	86	\N	\N	D5170C00002	1533	1531	NEW	\N	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
13083	86	\N	\N	D5170C00002	1534	1531	NEW	\N	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
13084	86	\N	\N	D5170C00002	1535	1531	NEW	\N	06.01 IP Documentation	06.01.11 UNBLINDED Certificate of Destruction
13085	86	\N	\N	D5170C00002	1536	1530	NEW	\N	06 IP and Trial Supplies	06.04 Storage
13086	86	\N	\N	D5170C00002	1537	1536	NEW	\N	06.04 Storage	06.04.01 UNBLI_on Documentation
13087	86	\N	\N	D5170C00002	1538	1536	NEW	\N	06.04 Storage	06.04.02 UNBLI_on Documentation
13088	86	\N	\N	D5170C00002	1539	1536	NEW	\N	06.04 Storage	06.04.03 UNBLINDED Maintenance Logs
13089	86	\N	\N	D5170C00002	1540	6	NEW	\N	Site	2001756 Behm, Brian
13090	86	\N	\N	D5170C00002	1541	1540	NEW	\N	2001756 Behm, Brian	05 Site Management
13091	86	\N	\N	D5170C00002	1542	1541	NEW	\N	05 Site Management	05.01 Site Selection
13092	86	\N	\N	D5170C00002	1543	1542	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
13093	86	\N	\N	D5170C00002	1544	6	NEW	\N	Site	2001757 Bekal, Pradeep
13094	86	\N	\N	D5170C00002	1545	1544	NEW	\N	2001757 Bekal, Pradeep	02 Central Trial Documents
13095	86	\N	\N	D5170C00002	1546	1545	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
13096	86	\N	\N	D5170C00002	1547	1546	NEW	\N	02.02 Subject Documents	02.02.01 Subject Diary
13097	86	\N	\N	D5170C00002	1548	1546	NEW	\N	02.02 Subject Documents	02.02.02 Subject Questionnaire
13098	86	\N	\N	D5170C00002	1549	1546	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
13099	86	\N	\N	D5170C00002	1550	1546	NEW	\N	02.02 Subject Documents	02.02.04 Subject Information Sheet
13100	86	\N	\N	D5170C00002	1551	1546	NEW	\N	02.02 Subject Documents	02.02.06 Adver_ject Recruitment
13101	86	\N	\N	D5170C00002	1552	1545	NEW	\N	02 Central Trial Documents	02.04 General
13102	86	\N	\N	D5170C00002	1553	1552	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
13103	86	\N	\N	D5170C00002	1554	1552	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
13104	86	\N	\N	D5170C00002	1555	1544	NEW	\N	2001757 Bekal, Pradeep	04 IRB-IEC and other Approvals
13105	86	\N	\N	D5170C00002	1556	1555	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
13106	86	\N	\N	D5170C00002	1557	1556	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
13107	86	\N	\N	D5170C00002	1558	1555	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
13108	86	\N	\N	D5170C00002	1559	1558	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
13109	86	\N	\N	D5170C00002	1560	1544	NEW	\N	2001757 Bekal, Pradeep	05 Site Management
13110	86	\N	\N	D5170C00002	1561	1560	NEW	\N	05 Site Management	05.01 Site Selection
13111	86	\N	\N	D5170C00002	1562	1561	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
13112	86	\N	\N	D5170C00002	1563	1561	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
13113	86	\N	\N	D5170C00002	1564	1561	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
13114	86	\N	\N	D5170C00002	1565	1560	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
13115	86	\N	\N	D5170C00002	1566	1565	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
13116	86	\N	\N	D5170C00002	1567	1565	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
13117	86	\N	\N	D5170C00002	1568	1565	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
13118	86	\N	\N	D5170C00002	1569	1565	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
13119	86	\N	\N	D5170C00002	1570	1565	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
13120	86	\N	\N	D5170C00002	1571	1565	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
13121	86	\N	\N	D5170C00002	1572	1565	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
13122	86	\N	\N	D5170C00002	1573	1565	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
13123	86	\N	\N	D5170C00002	1574	1565	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
13124	86	\N	\N	D5170C00002	1575	1565	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
13125	86	\N	\N	D5170C00002	1576	1565	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
13126	86	\N	\N	D5170C00002	1577	1560	NEW	\N	05 Site Management	05.03 Site Initiation
13127	86	\N	\N	D5170C00002	1578	1577	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
13128	86	\N	\N	D5170C00002	1579	1577	NEW	\N	05.03 Site Initiation	05.03.02 Site Training Material
13129	86	\N	\N	D5170C00002	1580	1577	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
13130	86	\N	\N	D5170C00002	1581	1577	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
13131	86	\N	\N	D5170C00002	1582	1560	NEW	\N	05 Site Management	05.04 Site Management
13132	86	\N	\N	D5170C00002	1583	1582	NEW	\N	05.04 Site Management	05.04.01 Subject Log
13133	86	\N	\N	D5170C00002	1584	1582	NEW	\N	05.04 Site Management	05.04.04 Visit Log
13134	86	\N	\N	D5170C00002	1585	1582	NEW	\N	05.04 Site Management	05.04.05 Additional Monitoring Activity
13135	86	\N	\N	D5170C00002	1586	1582	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
13136	86	\N	\N	D5170C00002	1587	1560	NEW	\N	05 Site Management	05.05 General
13137	86	\N	\N	D5170C00002	1588	1587	NEW	\N	05.05 General	05.05.01 Relev_ations-Documents
13138	86	\N	\N	D5170C00002	1589	1587	NEW	\N	05.05 General	05.05.01 Relevant Communications-Email
13139	86	\N	\N	D5170C00002	1590	1587	NEW	\N	05.05 General	05.05.02 Tracking Information
13140	86	\N	\N	D5170C00002	1591	1544	NEW	\N	2001757 Bekal, Pradeep	06 IP and Trial Supplies
13141	86	\N	\N	D5170C00002	1592	1591	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
13142	86	\N	\N	D5170C00002	1593	1592	NEW	\N	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
13143	86	\N	\N	D5170C00002	1594	1592	NEW	\N	06.01 IP Documentation	06.01.11 UNBLINDED Certificate of Destruction
13144	86	\N	\N	D5170C00002	1595	1591	NEW	\N	06 IP and Trial Supplies	06.04 Storage
13145	86	\N	\N	D5170C00002	1596	1595	NEW	\N	06.04 Storage	06.04.01 UNBLINDED Storage Condition Documentation
13146	86	\N	\N	D5170C00002	1597	6	NEW	\N	Site	2001758 Weber, John
13147	86	\N	\N	D5170C00002	1598	1597	NEW	\N	2001758 Weber, John	02 Central Trial Documents
13148	86	\N	\N	D5170C00002	1599	1598	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
13149	86	\N	\N	D5170C00002	1600	1599	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
13150	86	\N	\N	D5170C00002	1601	1598	NEW	\N	02 Central Trial Documents	02.04 General
13151	86	\N	\N	D5170C00002	1602	1601	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
13152	86	\N	\N	D5170C00002	1603	1601	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
13153	86	\N	\N	D5170C00002	1604	1597	NEW	\N	2001758 Weber, John	04 IRB-IEC and other Approvals
13154	86	\N	\N	D5170C00002	1605	1604	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
13155	86	\N	\N	D5170C00002	1606	1605	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
13156	86	\N	\N	D5170C00002	1607	1605	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.05 IRB-I_liance Statement
13157	86	\N	\N	D5170C00002	1608	1604	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
13158	86	\N	\N	D5170C00002	1609	1608	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
13159	86	\N	\N	D5170C00002	1610	1597	NEW	\N	2001758 Weber, John	05 Site Management
13160	86	\N	\N	D5170C00002	1611	1610	NEW	\N	05 Site Management	05.01 Site Selection
13161	86	\N	\N	D5170C00002	1612	1611	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
13162	86	\N	\N	D5170C00002	1613	1611	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
13163	86	\N	\N	D5170C00002	1614	1611	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
13164	86	\N	\N	D5170C00002	1615	1610	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
13165	86	\N	\N	D5170C00002	1616	1615	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
13166	86	\N	\N	D5170C00002	1617	1615	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
13167	86	\N	\N	D5170C00002	1618	1615	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
13168	86	\N	\N	D5170C00002	1619	1615	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
13169	86	\N	\N	D5170C00002	1620	1615	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
13170	86	\N	\N	D5170C00002	1621	1615	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
13171	86	\N	\N	D5170C00002	1622	1615	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
13172	86	\N	\N	D5170C00002	1623	1615	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
13173	86	\N	\N	D5170C00002	1624	1615	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
13174	86	\N	\N	D5170C00002	1625	1615	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
13175	86	\N	\N	D5170C00002	1626	1610	NEW	\N	05 Site Management	05.03 Site Initiation
13176	86	\N	\N	D5170C00002	1627	1626	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
13177	86	\N	\N	D5170C00002	1628	1626	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
13178	86	\N	\N	D5170C00002	1629	1626	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
13179	86	\N	\N	D5170C00002	1630	1610	NEW	\N	05 Site Management	05.04 Site Management
13180	86	\N	\N	D5170C00002	1631	1630	NEW	\N	05.04 Site Management	05.04.05 Additional Monitoring Activity
13181	86	\N	\N	D5170C00002	1632	1630	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
13182	86	\N	\N	D5170C00002	1633	1610	NEW	\N	05 Site Management	05.05 General
13183	86	\N	\N	D5170C00002	1634	1633	NEW	\N	05.05 General	05.05.01 Relevant Communications-Documents
13184	86	\N	\N	D5170C00002	1635	1633	NEW	\N	05.05 General	05.05.01 Relevant Communications-Email
13185	86	\N	\N	D5170C00002	1636	1633	NEW	\N	05.05 General	05.05.02 Tracking Information
13186	86	\N	\N	D5170C00002	1637	1597	NEW	\N	2001758 Weber, John	06 IP and Trial Supplies
13187	86	\N	\N	D5170C00002	1638	1637	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
13188	86	\N	\N	D5170C00002	1639	1638	NEW	\N	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
13189	86	\N	\N	D5170C00002	1640	6	NEW	\N	Site	2001759 Patil, Seema
13190	86	\N	\N	D5170C00002	1641	1640	NEW	\N	2001759 Patil, Seema	02 Central Trial Documents
13191	86	\N	\N	D5170C00002	1642	1641	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
13192	86	\N	\N	D5170C00002	1643	1642	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
13193	86	\N	\N	D5170C00002	1644	1641	NEW	\N	02 Central Trial Documents	02.04 General
13194	86	\N	\N	D5170C00002	1645	1644	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
13195	86	\N	\N	D5170C00002	1646	1640	NEW	\N	2001759 Patil, Seema	04 IRB-IEC and other Approvals
13196	86	\N	\N	D5170C00002	1647	1646	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
13197	86	\N	\N	D5170C00002	1648	1647	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
13198	86	\N	\N	D5170C00002	1649	1646	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
13199	86	\N	\N	D5170C00002	1650	1649	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
13200	86	\N	\N	D5170C00002	1651	1640	NEW	\N	2001759 Patil, Seema	05 Site Management
13201	86	\N	\N	D5170C00002	1652	1651	NEW	\N	05 Site Management	05.01 Site Selection
13202	86	\N	\N	D5170C00002	1653	1652	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
13203	86	\N	\N	D5170C00002	1654	1652	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
13204	86	\N	\N	D5170C00002	1655	1652	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
13205	86	\N	\N	D5170C00002	1656	1651	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
13206	86	\N	\N	D5170C00002	1657	1656	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
13207	86	\N	\N	D5170C00002	1658	1656	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
13208	86	\N	\N	D5170C00002	1659	1656	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
13209	86	\N	\N	D5170C00002	1660	1656	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
13210	86	\N	\N	D5170C00002	1661	1656	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
13211	86	\N	\N	D5170C00002	1662	1656	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
13212	86	\N	\N	D5170C00002	1663	1656	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
13213	86	\N	\N	D5170C00002	1664	1656	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
13214	86	\N	\N	D5170C00002	1665	1656	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
13215	86	\N	\N	D5170C00002	1666	1651	NEW	\N	05 Site Management	05.03 Site Initiation
13216	86	\N	\N	D5170C00002	1667	1666	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
13217	86	\N	\N	D5170C00002	1668	1651	NEW	\N	05 Site Management	05.05 General
13218	86	\N	\N	D5170C00002	1669	1668	NEW	\N	05.05 General	05.05.01 Relev_ations-Documents
13219	86	\N	\N	D5170C00002	1670	1668	NEW	\N	05.05 General	05.05.02 Tracking Information
13220	86	\N	\N	D5170C00002	1671	6	NEW	\N	Site	2001760 Eisner, Mark
13221	86	\N	\N	D5170C00002	1672	1671	NEW	\N	2001760 Eisner, Mark	05 Site Management
13222	86	\N	\N	D5170C00002	1673	1672	NEW	\N	05 Site Management	05.01 Site Selection
13223	86	\N	\N	D5170C00002	1674	1673	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
13224	86	\N	\N	D5170C00002	1675	6	NEW	\N	Site	2001761 Eves, Matthew
13225	86	\N	\N	D5170C00002	1676	1675	NEW	\N	2001761 Eves, Matthew	02 Central Trial Documents
13226	86	\N	\N	D5170C00002	1677	1676	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
13227	86	\N	\N	D5170C00002	1678	1677	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
13228	86	\N	\N	D5170C00002	1679	1675	NEW	\N	2001761 Eves, Matthew	04 IRB-IEC and other Approvals
13229	86	\N	\N	D5170C00002	1680	1679	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
13230	86	\N	\N	D5170C00002	1681	1680	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
13231	86	\N	\N	D5170C00002	1682	1680	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
13232	86	\N	\N	D5170C00002	1683	1679	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
13233	86	\N	\N	D5170C00002	1684	1683	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
13234	86	\N	\N	D5170C00002	1685	1675	NEW	\N	2001761 Eves, Matthew	05 Site Management
13235	86	\N	\N	D5170C00002	1686	1685	NEW	\N	05 Site Management	05.01 Site Selection
13236	86	\N	\N	D5170C00002	1687	1686	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
13237	86	\N	\N	D5170C00002	1688	1686	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
13238	86	\N	\N	D5170C00002	1689	1686	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
13239	86	\N	\N	D5170C00002	1690	1685	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
13240	86	\N	\N	D5170C00002	1691	1690	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
13241	86	\N	\N	D5170C00002	1692	1690	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
13242	86	\N	\N	D5170C00002	1693	1690	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
13243	86	\N	\N	D5170C00002	1694	1690	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
13244	86	\N	\N	D5170C00002	1695	1690	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
13245	86	\N	\N	D5170C00002	1696	1690	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
13246	86	\N	\N	D5170C00002	1697	1690	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
13247	86	\N	\N	D5170C00002	1698	1690	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
13248	86	\N	\N	D5170C00002	1699	1690	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
13249	86	\N	\N	D5170C00002	1700	1690	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
13250	86	\N	\N	D5170C00002	1701	1685	NEW	\N	05 Site Management	05.03 Site Initiation
13251	86	\N	\N	D5170C00002	1702	1701	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
13252	86	\N	\N	D5170C00002	1703	1685	NEW	\N	05 Site Management	05.05 General
13253	86	\N	\N	D5170C00002	1704	1703	NEW	\N	05.05 General	05.05.02 Tracking Information
13254	86	\N	\N	D5170C00002	1705	6	NEW	\N	Site	2001762 Swoger, Jason
13255	86	\N	\N	D5170C00002	1706	1705	NEW	\N	2001762 Swoger, Jason	05 Site Management
13256	86	\N	\N	D5170C00002	1707	1706	NEW	\N	05 Site Management	05.01 Site Selection
13257	86	\N	\N	D5170C00002	1708	1707	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
13258	86	\N	\N	D5170C00002	1709	1707	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
13259	86	\N	\N	D5170C00002	1710	1707	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
13260	86	\N	\N	D5170C00002	1711	6	NEW	\N	Site	2001781 Sultan, Keith
13261	86	\N	\N	D5170C00002	1712	1711	NEW	\N	2001781 Sultan, Keith	05 Site Management
13262	86	\N	\N	D5170C00002	1713	1712	NEW	\N	05 Site Management	05.01 Site Selection
13263	86	\N	\N	D5170C00002	1714	1713	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
13264	86	\N	\N	D5170C00002	1715	6	NEW	\N	Site	2001797 Nichols, Matthew
13265	86	\N	\N	D5170C00002	1716	1715	NEW	\N	2001797 Nichols, Matthew	02 Central Trial Documents
13266	86	\N	\N	D5170C00002	1717	1716	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
13267	86	\N	\N	D5170C00002	1718	1717	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
13268	86	\N	\N	D5170C00002	1719	1716	NEW	\N	02 Central Trial Documents	02.04 General
13269	86	\N	\N	D5170C00002	1720	1719	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
13270	86	\N	\N	D5170C00002	1721	1715	NEW	\N	2001797 Nichols, Matthew	04 IRB-IEC and other Approvals
13271	86	\N	\N	D5170C00002	1722	1721	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
13272	86	\N	\N	D5170C00002	1723	1722	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
13273	86	\N	\N	D5170C00002	1724	1722	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
13274	86	\N	\N	D5170C00002	1725	1715	NEW	\N	2001797 Nichols, Matthew	05 Site Management
13275	86	\N	\N	D5170C00002	1726	1725	NEW	\N	05 Site Management	05.01 Site Selection
13276	86	\N	\N	D5170C00002	1727	1726	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
13277	86	\N	\N	D5170C00002	1728	1726	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
13278	86	\N	\N	D5170C00002	1729	1726	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
13279	86	\N	\N	D5170C00002	1730	1725	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
13280	86	\N	\N	D5170C00002	1731	1730	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
13281	86	\N	\N	D5170C00002	1732	1730	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
13282	86	\N	\N	D5170C00002	1733	1730	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
13283	86	\N	\N	D5170C00002	1734	1730	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
13284	86	\N	\N	D5170C00002	1735	1730	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
13285	86	\N	\N	D5170C00002	1736	1730	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
13286	86	\N	\N	D5170C00002	1737	1730	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
13287	86	\N	\N	D5170C00002	1738	1730	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
13288	86	\N	\N	D5170C00002	1739	1730	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
13289	86	\N	\N	D5170C00002	1740	1730	NEW	\N	05.02 Site Set-up Documentation	05.02.13 Indemnity
13290	86	\N	\N	D5170C00002	1741	1730	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
13291	86	\N	\N	D5170C00002	1742	1730	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
13292	86	\N	\N	D5170C00002	1743	1725	NEW	\N	05 Site Management	05.03 Site Initiation
13293	86	\N	\N	D5170C00002	1744	1743	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
13294	86	\N	\N	D5170C00002	1745	1743	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
13295	86	\N	\N	D5170C00002	1746	1743	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
13296	86	\N	\N	D5170C00002	1747	1725	NEW	\N	05 Site Management	05.04 Site Management
13297	86	\N	\N	D5170C00002	1748	1747	NEW	\N	05.04 Site Management	05.04.01 Subject Log
13298	86	\N	\N	D5170C00002	1749	1747	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
13299	86	\N	\N	D5170C00002	1750	1747	NEW	\N	05.04 Site Management	05.04.05 UNBLI_itoring Activity
13300	86	\N	\N	D5170C00002	1751	1747	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
13301	86	\N	\N	D5170C00002	1752	1747	NEW	\N	05.04 Site Management	05.04.08 UNBLI_onitoring Report
13302	86	\N	\N	D5170C00002	1753	1725	NEW	\N	05 Site Management	05.05 General
13303	86	\N	\N	D5170C00002	1754	1753	NEW	\N	05.05 General	05.05.02 Tracking Information
13304	86	\N	\N	D5170C00002	1755	1715	NEW	\N	2001797 Nichols, Matthew	06 IP and Trial Supplies
13305	86	\N	\N	D5170C00002	1756	1755	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
13306	86	\N	\N	D5170C00002	1757	1756	NEW	\N	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
13307	86	\N	\N	D5170C00002	1758	1756	NEW	\N	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
13308	86	\N	\N	D5170C00002	1759	1756	NEW	\N	06.01 IP Documentation	06.01.11 Certificate of Destruction
13309	86	\N	\N	D5170C00002	1760	1756	NEW	\N	06.01 IP Documentation	06.01.11 UNBLINDED Certificate of Destruction
13310	86	\N	\N	D5170C00002	1761	1755	NEW	\N	06 IP and Trial Supplies	06.04 Storage
13311	86	\N	\N	D5170C00002	1762	1761	NEW	\N	06.04 Storage	06.04.01 UNBLI_on Documentation
13312	86	\N	\N	D5170C00002	1763	1761	NEW	\N	06.04 Storage	06.04.03 UNBLINDED Maintenance Logs
13313	86	\N	\N	D5170C00002	1764	1755	NEW	\N	06 IP and Trial Supplies	06.07 General
13314	86	\N	\N	D5170C00002	1765	1764	NEW	\N	06.07 General	06.07.01 Relev_roduct-Documents
13315	86	\N	\N	D5170C00002	1766	6	NEW	\N	Site	2001798 Lee, Brent Younghoon
13316	86	\N	\N	D5170C00002	1767	1766	NEW	\N	2001798 Lee, Brent Younghoon	05 Site Management
13317	86	\N	\N	D5170C00002	1768	1767	NEW	\N	05 Site Management	05.01 Site Selection
13318	86	\N	\N	D5170C00002	1769	1768	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
13319	86	\N	\N	D5170C00002	1770	1767	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
13320	86	\N	\N	D5170C00002	1771	1770	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
13321	86	\N	\N	D5170C00002	1772	6	NEW	\N	Site	2001799 Kim, Suzy
13322	86	\N	\N	D5170C00002	1773	1772	NEW	\N	2001799 Kim, Suzy	05 Site Management
13323	86	\N	\N	D5170C00002	1774	1773	NEW	\N	05 Site Management	05.01 Site Selection
13324	86	\N	\N	D5170C00002	1775	1774	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
13325	86	\N	\N	D5170C00002	1776	6	NEW	\N	Site	2001881 Geronilla, Giovanni
13326	86	\N	\N	D5170C00002	1777	1776	NEW	\N	2001881 Geronilla, Giovanni	02 Central Trial Documents
13327	86	\N	\N	D5170C00002	1778	1777	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
13328	86	\N	\N	D5170C00002	1779	1778	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
13329	86	\N	\N	D5170C00002	1780	1777	NEW	\N	02 Central Trial Documents	02.04 General
13330	86	\N	\N	D5170C00002	1781	1780	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
13331	86	\N	\N	D5170C00002	1782	1780	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
13332	86	\N	\N	D5170C00002	1783	1776	NEW	\N	2001881 Geronilla, Giovanni	04 IRB-IEC and other Approvals
13333	86	\N	\N	D5170C00002	1784	1783	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
13334	86	\N	\N	D5170C00002	1785	1784	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
13335	86	\N	\N	D5170C00002	1786	1784	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
13336	86	\N	\N	D5170C00002	1787	1783	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
13337	86	\N	\N	D5170C00002	1788	1787	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
13338	86	\N	\N	D5170C00002	1789	1776	NEW	\N	2001881 Geronilla, Giovanni	05 Site Management
13339	86	\N	\N	D5170C00002	1790	1789	NEW	\N	05 Site Management	05.01 Site Selection
13340	86	\N	\N	D5170C00002	1791	1790	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
13341	86	\N	\N	D5170C00002	1792	1790	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
13342	86	\N	\N	D5170C00002	1793	1790	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
13343	86	\N	\N	D5170C00002	1794	1789	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
13344	86	\N	\N	D5170C00002	1795	1794	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Accep_tigator Brochure
13345	86	\N	\N	D5170C00002	1796	1794	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
13346	86	\N	\N	D5170C00002	1797	1794	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
13347	86	\N	\N	D5170C00002	1798	1794	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
13348	86	\N	\N	D5170C00002	1799	1794	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
13349	86	\N	\N	D5170C00002	1800	1794	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
13350	86	\N	\N	D5170C00002	1801	1794	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
13351	86	\N	\N	D5170C00002	1802	1794	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
13352	86	\N	\N	D5170C00002	1803	1794	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
13353	86	\N	\N	D5170C00002	1804	1794	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Si_se Documentation
13354	86	\N	\N	D5170C00002	1805	1789	NEW	\N	05 Site Management	05.03 Site Initiation
13355	86	\N	\N	D5170C00002	1806	1805	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
13356	86	\N	\N	D5170C00002	1807	1805	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
13357	86	\N	\N	D5170C00002	1808	1805	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
13358	86	\N	\N	D5170C00002	1809	1789	NEW	\N	05 Site Management	05.04 Site Management
13359	86	\N	\N	D5170C00002	1810	1809	NEW	\N	05.04 Site Management	05.04.03 Monitoring Visit Report
13360	86	\N	\N	D5170C00002	1811	1809	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
13361	86	\N	\N	D5170C00002	1812	1809	NEW	\N	05.04 Site Management	05.04.04 Visit Log
13362	86	\N	\N	D5170C00002	1813	1809	NEW	\N	05.04 Site Management	05.04.05 UNBLI_itoring Activity
13363	86	\N	\N	D5170C00002	1814	1809	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
13364	86	\N	\N	D5170C00002	1815	1809	NEW	\N	05.04 Site Management	05.04.08 UNBLI_onitoring Report
13365	86	\N	\N	D5170C00002	1816	1789	NEW	\N	05 Site Management	05.05 General
13366	86	\N	\N	D5170C00002	1817	1816	NEW	\N	05.05 General	05.05.02 Tracking Information
13367	86	\N	\N	D5170C00002	1818	1776	NEW	\N	2001881 Geronilla, Giovanni	06 IP and Trial Supplies
13368	86	\N	\N	D5170C00002	1819	1818	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
13369	86	\N	\N	D5170C00002	1820	1819	NEW	\N	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
13370	86	\N	\N	D5170C00002	1821	1819	NEW	\N	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
13371	86	\N	\N	D5170C00002	1822	1819	NEW	\N	06.01 IP Documentation	06.01.10 UNBLI_mentation Return
13372	86	\N	\N	D5170C00002	1823	1818	NEW	\N	06 IP and Trial Supplies	06.04 Storage
13373	86	\N	\N	D5170C00002	1824	1823	NEW	\N	06.04 Storage	06.04.01 UNBLI_on Documentation
13374	86	\N	\N	D5170C00002	1825	1823	NEW	\N	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
13375	86	\N	\N	D5170C00002	1826	1818	NEW	\N	06 IP and Trial Supplies	06.05 Non-IP Documentation
13376	86	\N	\N	D5170C00002	1827	1826	NEW	\N	06.05 Non-IP Documentation	06.05.02 Non-I_tion of Shipment
13377	86	\N	\N	D5170C00002	1828	1826	NEW	\N	06.05 Non-IP Documentation	06.05.03 Non-I_tation of Return
13378	86	\N	\N	D5170C00002	1829	6	NEW	\N	Site	2001928 Yen, Eugene
13379	86	\N	\N	D5170C00002	1830	1829	NEW	\N	2001928 Yen, Eugene	02 Central Trial Documents
13380	86	\N	\N	D5170C00002	1831	1830	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
13381	86	\N	\N	D5170C00002	1832	1831	NEW	\N	02.02 Subject Documents	02.02.03 Infor_ Form Checklists
13382	86	\N	\N	D5170C00002	1833	1831	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
13383	86	\N	\N	D5170C00002	1834	1830	NEW	\N	02 Central Trial Documents	02.04 General
13384	86	\N	\N	D5170C00002	1835	1834	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
13385	86	\N	\N	D5170C00002	1836	1834	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
13386	86	\N	\N	D5170C00002	1837	1829	NEW	\N	2001928 Yen, Eugene	04 IRB-IEC and other Approvals
13387	86	\N	\N	D5170C00002	1838	1837	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
13388	86	\N	\N	D5170C00002	1839	1838	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
13389	86	\N	\N	D5170C00002	1840	1837	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
13390	86	\N	\N	D5170C00002	1841	1840	NEW	\N	04.03 Trial Status Reporting	04.03.01 IRB-I_y Info-Deviation
13391	86	\N	\N	D5170C00002	1842	1840	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
13392	86	\N	\N	D5170C00002	1843	1829	NEW	\N	2001928 Yen, Eugene	05 Site Management
13393	86	\N	\N	D5170C00002	1844	1843	NEW	\N	05 Site Management	05.01 Site Selection
13394	86	\N	\N	D5170C00002	1845	1844	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
13395	86	\N	\N	D5170C00002	1846	1844	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
13396	86	\N	\N	D5170C00002	1847	1844	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
13397	86	\N	\N	D5170C00002	1848	1843	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
13398	86	\N	\N	D5170C00002	1849	1848	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
13399	86	\N	\N	D5170C00002	1850	1848	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
13400	86	\N	\N	D5170C00002	1851	1848	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
13401	86	\N	\N	D5170C00002	1852	1848	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
13402	86	\N	\N	D5170C00002	1853	1848	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
13403	86	\N	\N	D5170C00002	1854	1848	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
13404	86	\N	\N	D5170C00002	1855	1848	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Investigator Regulatory Agreement
13405	86	\N	\N	D5170C00002	1856	1848	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
13406	86	\N	\N	D5170C00002	1857	1848	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
13407	86	\N	\N	D5170C00002	1858	1848	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
13408	86	\N	\N	D5170C00002	1859	1848	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
13409	86	\N	\N	D5170C00002	1860	1843	NEW	\N	05 Site Management	05.03 Site Initiation
13410	86	\N	\N	D5170C00002	1861	1860	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
13411	86	\N	\N	D5170C00002	1862	1860	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
13412	86	\N	\N	D5170C00002	1863	1860	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
13413	86	\N	\N	D5170C00002	1864	1843	NEW	\N	05 Site Management	05.04 Site Management
13414	86	\N	\N	D5170C00002	1865	1864	NEW	\N	05.04 Site Management	05.04.01 Subject Log
13415	86	\N	\N	D5170C00002	1866	1864	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
13416	86	\N	\N	D5170C00002	1867	1864	NEW	\N	05.04 Site Management	05.04.04 Visit Log
13417	86	\N	\N	D5170C00002	1868	1864	NEW	\N	05.04 Site Management	05.04.05 Additional Monitoring Activity
13418	86	\N	\N	D5170C00002	1869	1864	NEW	\N	05.04 Site Management	05.04.05 UNBLINDED Additional Monitoring Activity
13419	86	\N	\N	D5170C00002	1870	1864	NEW	\N	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
13420	86	\N	\N	D5170C00002	1871	1864	NEW	\N	05.04 Site Management	05.04.06 UNBLINDED Protocol Deviations and Waivers
13421	86	\N	\N	D5170C00002	1872	1864	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
13422	86	\N	\N	D5170C00002	1873	1843	NEW	\N	05 Site Management	05.05 General
13423	86	\N	\N	D5170C00002	1874	1873	NEW	\N	05.05 General	05.05.02 Tracking Information
13424	86	\N	\N	D5170C00002	1875	1829	NEW	\N	2001928 Yen, Eugene	06 IP and Trial Supplies
13425	86	\N	\N	D5170C00002	1876	1875	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
13426	86	\N	\N	D5170C00002	1877	1876	NEW	\N	06.01 IP Documentation	06.01.02 UNBLINDED IP Instructions for Handling
13427	86	\N	\N	D5170C00002	1878	1876	NEW	\N	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
13428	86	\N	\N	D5170C00002	1879	1876	NEW	\N	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
13429	86	\N	\N	D5170C00002	1880	1876	NEW	\N	06.01 IP Documentation	06.01.11 UNBLINDED Certificate of Destruction
13430	86	\N	\N	D5170C00002	1881	1875	NEW	\N	06 IP and Trial Supplies	06.04 Storage
13431	86	\N	\N	D5170C00002	1882	1881	NEW	\N	06.04 Storage	06.04.01 UNBLI_on Documentation
13432	86	\N	\N	D5170C00002	1883	1881	NEW	\N	06.04 Storage	06.04.02 UNBLI_on Documentation
13433	86	\N	\N	D5170C00002	1884	1881	NEW	\N	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
13434	86	\N	\N	D5170C00002	1885	1829	NEW	\N	2001928 Yen, Eugene	08 Centralized Testing
13435	86	\N	\N	D5170C00002	1886	1885	NEW	\N	08 Centralized Testing	08.02 Sample Documentation
13436	86	\N	\N	D5170C00002	1887	1886	NEW	\N	08.02 Sample Documentation	08.02.03 Sampl_ge Condition Log
13437	86	\N	\N	D5170C00002	1888	6	NEW	\N	Site	2001929 Emslie, Robert
13438	86	\N	\N	D5170C00002	1889	1888	NEW	\N	2001929 Emslie, Robert	02 Central Trial Documents
13439	86	\N	\N	D5170C00002	1890	1889	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
13440	86	\N	\N	D5170C00002	1891	1890	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
13441	86	\N	\N	D5170C00002	1892	1889	NEW	\N	02 Central Trial Documents	02.04 General
13442	86	\N	\N	D5170C00002	1893	1892	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
13443	86	\N	\N	D5170C00002	1894	1888	NEW	\N	2001929 Emslie, Robert	04 IRB-IEC and other Approvals
13444	86	\N	\N	D5170C00002	1895	1894	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
13445	86	\N	\N	D5170C00002	1896	1895	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
13446	86	\N	\N	D5170C00002	1897	1894	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
13447	86	\N	\N	D5170C00002	1898	1897	NEW	\N	04.03 Trial Status Reporting	04.03.01 IRB-I_y Info-Deviation
13448	86	\N	\N	D5170C00002	1899	1894	NEW	\N	04 IRB-IEC and other Approvals	04.04 General
13449	86	\N	\N	D5170C00002	1900	1899	NEW	\N	04.04 General	04.04.01 Relevant Communications-IRB-IEC-Documents
13450	86	\N	\N	D5170C00002	1901	1888	NEW	\N	2001929 Emslie, Robert	05 Site Management
13451	86	\N	\N	D5170C00002	1902	1901	NEW	\N	05 Site Management	05.01 Site Selection
13452	86	\N	\N	D5170C00002	1903	1902	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
13453	86	\N	\N	D5170C00002	1904	1902	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
13454	86	\N	\N	D5170C00002	1905	1902	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
13455	86	\N	\N	D5170C00002	1906	1901	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
13456	86	\N	\N	D5170C00002	1907	1906	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
13457	86	\N	\N	D5170C00002	1908	1906	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
13458	86	\N	\N	D5170C00002	1909	1906	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
13459	86	\N	\N	D5170C00002	1910	1906	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
13460	86	\N	\N	D5170C00002	1911	1906	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
13461	86	\N	\N	D5170C00002	1912	1906	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
13462	86	\N	\N	D5170C00002	1913	1906	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
13463	86	\N	\N	D5170C00002	1914	1906	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
13464	86	\N	\N	D5170C00002	1915	1906	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
13465	86	\N	\N	D5170C00002	1916	1906	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
13466	86	\N	\N	D5170C00002	1917	1906	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
13467	86	\N	\N	D5170C00002	1918	1901	NEW	\N	05 Site Management	05.03 Site Initiation
13468	86	\N	\N	D5170C00002	1919	1918	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
13469	86	\N	\N	D5170C00002	1920	1918	NEW	\N	05.03 Site Initiation	05.03.01 UNBLI_onitoring Report
13470	86	\N	\N	D5170C00002	1921	1918	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
13471	86	\N	\N	D5170C00002	1922	1918	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
13472	86	\N	\N	D5170C00002	1923	1901	NEW	\N	05 Site Management	05.04 Site Management
13473	86	\N	\N	D5170C00002	1924	1923	NEW	\N	05.04 Site Management	05.04.01 Subject Log
13474	86	\N	\N	D5170C00002	1925	1923	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
13475	86	\N	\N	D5170C00002	1926	1923	NEW	\N	05.04 Site Management	05.04.04 Visit Log
13476	86	\N	\N	D5170C00002	1927	1923	NEW	\N	05.04 Site Management	05.04.05 Additional Monitoring Activity
13477	86	\N	\N	D5170C00002	1928	1923	NEW	\N	05.04 Site Management	05.04.05 UNBLI_itoring Activity
13478	86	\N	\N	D5170C00002	1929	1923	NEW	\N	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
13479	86	\N	\N	D5170C00002	1930	1923	NEW	\N	05.04 Site Management	05.04.06 UNBLINDED Protocol Deviations and Waivers
13480	86	\N	\N	D5170C00002	1931	1923	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
13481	86	\N	\N	D5170C00002	1932	1901	NEW	\N	05 Site Management	05.05 General
13482	86	\N	\N	D5170C00002	1933	1932	NEW	\N	05.05 General	05.05.02 Tracking Information
13483	86	\N	\N	D5170C00002	1934	1888	NEW	\N	2001929 Emslie, Robert	06 IP and Trial Supplies
13484	86	\N	\N	D5170C00002	1935	1934	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
13485	86	\N	\N	D5170C00002	1936	1935	NEW	\N	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
13486	86	\N	\N	D5170C00002	1937	1935	NEW	\N	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
13487	86	\N	\N	D5170C00002	1938	1935	NEW	\N	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
13488	86	\N	\N	D5170C00002	1939	1935	NEW	\N	06.01 IP Documentation	06.01.10 UNBLI_mentation Return
13489	86	\N	\N	D5170C00002	1940	1935	NEW	\N	06.01 IP Documentation	06.01.11 UNBLINDED Certificate of Destruction
13490	86	\N	\N	D5170C00002	1941	1934	NEW	\N	06 IP and Trial Supplies	06.04 Storage
13491	86	\N	\N	D5170C00002	1942	1941	NEW	\N	06.04 Storage	06.04.01 UNBLI_on Documentation
13492	86	\N	\N	D5170C00002	1943	1941	NEW	\N	06.04 Storage	06.04.02 UNBLI_on Documentation
13493	86	\N	\N	D5170C00002	1944	1941	NEW	\N	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
13494	86	\N	\N	D5170C00002	1945	1934	NEW	\N	06 IP and Trial Supplies	06.07 General
13495	86	\N	\N	D5170C00002	1946	1945	NEW	\N	06.07 General	06.07.01 UNBLI_roduct-Documents
13496	86	\N	\N	D5170C00002	1947	1888	NEW	\N	2001929 Emslie, Robert	08 Centralized Testing
13497	86	\N	\N	D5170C00002	1948	1947	NEW	\N	08 Centralized Testing	08.01 Facility Documentation
13498	86	\N	\N	D5170C00002	1949	1948	NEW	\N	08.01 Facility Documentation	08.01.01 Certi_or Accreditation
13499	86	\N	\N	D5170C00002	1950	6	NEW	\N	Site	2002036 Rai, Rudrajit
13500	86	\N	\N	D5170C00002	1951	1950	NEW	\N	2002036 Rai, Rudrajit	02 Central Trial Documents
13501	86	\N	\N	D5170C00002	1952	1951	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
13502	86	\N	\N	D5170C00002	1953	1952	NEW	\N	02.02 Subject Documents	02.02.01 Subject Diary
13503	86	\N	\N	D5170C00002	1954	1952	NEW	\N	02.02 Subject Documents	02.02.02 Subject Questionnaire
13504	86	\N	\N	D5170C00002	1955	1952	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
13505	86	\N	\N	D5170C00002	1956	1952	NEW	\N	02.02 Subject Documents	02.02.05 Subject Participation Card
13506	86	\N	\N	D5170C00002	1957	1952	NEW	\N	02.02 Subject Documents	02.02.06 Adver_ject Recruitment
13507	86	\N	\N	D5170C00002	1958	1952	NEW	\N	02.02 Subject Documents	02.02.07 Other_iven to Subjects
13508	86	\N	\N	D5170C00002	1959	1951	NEW	\N	02 Central Trial Documents	02.04 General
13509	86	\N	\N	D5170C00002	1960	1959	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
13510	86	\N	\N	D5170C00002	1961	1950	NEW	\N	2002036 Rai, Rudrajit	04 IRB-IEC and other Approvals
13511	86	\N	\N	D5170C00002	1962	1961	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
13512	86	\N	\N	D5170C00002	1963	1962	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
13513	86	\N	\N	D5170C00002	1964	1950	NEW	\N	2002036 Rai, Rudrajit	05 Site Management
13514	86	\N	\N	D5170C00002	1965	1964	NEW	\N	05 Site Management	05.01 Site Selection
13515	86	\N	\N	D5170C00002	1966	1965	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
13516	86	\N	\N	D5170C00002	1967	1965	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
13517	86	\N	\N	D5170C00002	1968	1965	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
13518	86	\N	\N	D5170C00002	1969	1964	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
13519	86	\N	\N	D5170C00002	1970	1969	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
13520	86	\N	\N	D5170C00002	1971	1969	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
13521	86	\N	\N	D5170C00002	1972	1969	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
13522	86	\N	\N	D5170C00002	1973	1969	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
13523	86	\N	\N	D5170C00002	1974	1969	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
13524	86	\N	\N	D5170C00002	1975	1969	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
13525	86	\N	\N	D5170C00002	1976	1969	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
13526	86	\N	\N	D5170C00002	1977	1969	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
13527	86	\N	\N	D5170C00002	1978	1969	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
13528	86	\N	\N	D5170C00002	1979	1969	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
13529	86	\N	\N	D5170C00002	1980	1969	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
13530	86	\N	\N	D5170C00002	1981	1964	NEW	\N	05 Site Management	05.03 Site Initiation
13531	86	\N	\N	D5170C00002	1982	1981	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
13532	86	\N	\N	D5170C00002	1983	1981	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
13533	86	\N	\N	D5170C00002	1984	1964	NEW	\N	05 Site Management	05.04 Site Management
13534	86	\N	\N	D5170C00002	1985	1984	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
13535	86	\N	\N	D5170C00002	1986	1984	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
13536	86	\N	\N	D5170C00002	1987	1964	NEW	\N	05 Site Management	05.05 General
13537	86	\N	\N	D5170C00002	1988	1987	NEW	\N	05.05 General	05.05.02 Tracking Information
13538	86	\N	\N	D5170C00002	1989	6	NEW	\N	Site	2002037 Inamdar, Nikhil
13539	86	\N	\N	D5170C00002	1990	1989	NEW	\N	2002037 Inamdar, Nikhil	02 Central Trial Documents
13540	86	\N	\N	D5170C00002	1991	1990	NEW	\N	02 Central Trial Documents	02.04 General
13541	86	\N	\N	D5170C00002	1992	1991	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
13542	86	\N	\N	D5170C00002	1993	1989	NEW	\N	2002037 Inamdar, Nikhil	05 Site Management
13543	86	\N	\N	D5170C00002	1994	1993	NEW	\N	05 Site Management	05.01 Site Selection
13544	86	\N	\N	D5170C00002	1995	1994	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
13545	86	\N	\N	D5170C00002	1996	1994	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
13546	86	\N	\N	D5170C00002	1997	1994	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
13547	86	\N	\N	D5170C00002	1998	6	NEW	\N	Site	2002038 Serje, Jorge
13548	86	\N	\N	D5170C00002	1999	1998	NEW	\N	2002038 Serje, Jorge	05 Site Management
13549	86	\N	\N	D5170C00002	2000	1999	NEW	\N	05 Site Management	05.01 Site Selection
13550	86	\N	\N	D5170C00002	2001	2000	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
13551	86	\N	\N	D5170C00002	2002	6	NEW	\N	Site	2002039 Kessler, Steven
13552	86	\N	\N	D5170C00002	2003	2002	NEW	\N	2002039 Kessler, Steven	02 Central Trial Documents
13553	86	\N	\N	D5170C00002	2004	2003	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
13554	86	\N	\N	D5170C00002	2005	2004	NEW	\N	02.02 Subject Documents	02.02.03 Infor_ Form Checklists
13555	86	\N	\N	D5170C00002	2006	2004	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
13556	86	\N	\N	D5170C00002	2007	2003	NEW	\N	02 Central Trial Documents	02.04 General
13557	86	\N	\N	D5170C00002	2008	2007	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
13558	86	\N	\N	D5170C00002	2009	2007	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
13559	86	\N	\N	D5170C00002	2010	2002	NEW	\N	2002039 Kessler, Steven	03 Regulatory
13560	86	\N	\N	D5170C00002	2011	2010	NEW	\N	03 Regulatory	03.04 General
13561	86	\N	\N	D5170C00002	2012	2011	NEW	\N	03.04 General	03.04.01 Relev_art-Up-Documents
13562	86	\N	\N	D5170C00002	2013	2002	NEW	\N	2002039 Kessler, Steven	04 IRB-IEC and other Approvals
13563	86	\N	\N	D5170C00002	2014	2013	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
13564	86	\N	\N	D5170C00002	2015	2014	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
13565	86	\N	\N	D5170C00002	2016	2014	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
13566	86	\N	\N	D5170C00002	2017	2013	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
13567	86	\N	\N	D5170C00002	2018	2017	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
13568	86	\N	\N	D5170C00002	2019	2002	NEW	\N	2002039 Kessler, Steven	05 Site Management
13569	86	\N	\N	D5170C00002	2020	2019	NEW	\N	05 Site Management	05.01 Site Selection
13570	86	\N	\N	D5170C00002	2021	2020	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
13571	86	\N	\N	D5170C00002	2022	2020	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
13572	86	\N	\N	D5170C00002	2023	2020	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
13573	86	\N	\N	D5170C00002	2024	2019	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
13574	86	\N	\N	D5170C00002	2025	2024	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
13575	86	\N	\N	D5170C00002	2026	2024	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
13576	86	\N	\N	D5170C00002	2027	2024	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
13577	86	\N	\N	D5170C00002	2028	2024	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
13578	86	\N	\N	D5170C00002	2029	2024	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
13579	86	\N	\N	D5170C00002	2030	2024	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
13580	86	\N	\N	D5170C00002	2031	2024	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
13581	86	\N	\N	D5170C00002	2032	2024	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
13582	86	\N	\N	D5170C00002	2033	2024	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
13583	86	\N	\N	D5170C00002	2034	2024	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
13584	86	\N	\N	D5170C00002	2035	2024	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
13585	86	\N	\N	D5170C00002	2036	2019	NEW	\N	05 Site Management	05.03 Site Initiation
13586	86	\N	\N	D5170C00002	2037	2036	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
13587	86	\N	\N	D5170C00002	2038	2036	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
13588	86	\N	\N	D5170C00002	2039	2036	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
13589	86	\N	\N	D5170C00002	2040	2019	NEW	\N	05 Site Management	05.04 Site Management
13590	86	\N	\N	D5170C00002	2041	2040	NEW	\N	05.04 Site Management	05.04.01 Subject Log
13591	86	\N	\N	D5170C00002	2042	2040	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
13592	86	\N	\N	D5170C00002	2043	2040	NEW	\N	05.04 Site Management	05.04.04 Visit Log
13593	86	\N	\N	D5170C00002	2044	2040	NEW	\N	05.04 Site Management	05.04.05 UNBLI_itoring Activity
13594	86	\N	\N	D5170C00002	2045	2040	NEW	\N	05.04 Site Management	05.04.06 UNBLINDED Protocol Deviations and Waivers
13595	86	\N	\N	D5170C00002	2046	2040	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
13596	86	\N	\N	D5170C00002	2047	2019	NEW	\N	05 Site Management	05.05 General
13597	86	\N	\N	D5170C00002	2048	2047	NEW	\N	05.05 General	05.05.02 Tracking Information
13598	86	\N	\N	D5170C00002	2049	2002	NEW	\N	2002039 Kessler, Steven	06 IP and Trial Supplies
13599	86	\N	\N	D5170C00002	2050	2049	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
13600	86	\N	\N	D5170C00002	2051	2050	NEW	\N	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
13601	86	\N	\N	D5170C00002	2052	2050	NEW	\N	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
13602	86	\N	\N	D5170C00002	2053	2050	NEW	\N	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
13603	86	\N	\N	D5170C00002	2054	2050	NEW	\N	06.01 IP Documentation	06.01.10 UNBLI_mentation Return
13604	86	\N	\N	D5170C00002	2055	2049	NEW	\N	06 IP and Trial Supplies	06.04 Storage
13605	86	\N	\N	D5170C00002	2056	2055	NEW	\N	06.04 Storage	06.04.01 Storage Condition Documentation
13606	86	\N	\N	D5170C00002	2057	2055	NEW	\N	06.04 Storage	06.04.01 UNBLINDED Storage Condition Documentation
13607	86	\N	\N	D5170C00002	2058	2055	NEW	\N	06.04 Storage	06.04.03 UNBLINDED Maintenance Logs
13608	86	\N	\N	D5170C00002	2059	2002	NEW	\N	2002039 Kessler, Steven	08 Centralized Testing
13609	86	\N	\N	D5170C00002	2060	2059	NEW	\N	08 Centralized Testing	08.01 Facility Documentation
13610	86	\N	\N	D5170C00002	2061	2060	NEW	\N	08.01 Facility Documentation	08.01.01 Certification or Accreditation
13611	86	\N	\N	D5170C00002	2062	2059	NEW	\N	08 Centralized Testing	08.02 Sample Documentation
13612	86	\N	\N	D5170C00002	2063	2062	NEW	\N	08.02 Sample Documentation	08.02.03 Sampl_ge Condition Log
13613	86	\N	\N	D5170C00002	2064	6	NEW	\N	Site	2002040 Gaffney, Mary
13614	86	\N	\N	D5170C00002	2065	2064	NEW	\N	2002040 Gaffney, Mary	02 Central Trial Documents
13615	86	\N	\N	D5170C00002	2066	2065	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
13616	86	\N	\N	D5170C00002	2067	2066	NEW	\N	02.02 Subject Documents	02.02.01 Subject Diary
13617	86	\N	\N	D5170C00002	2068	2066	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
13618	86	\N	\N	D5170C00002	2069	2066	NEW	\N	02.02 Subject Documents	02.02.05 Subject Participation Card
13619	86	\N	\N	D5170C00002	2070	2066	NEW	\N	02.02 Subject Documents	02.02.06 Adver_ject Recruitment
13620	86	\N	\N	D5170C00002	2071	2066	NEW	\N	02.02 Subject Documents	02.02.07 Other_iven to Subjects
13621	86	\N	\N	D5170C00002	2072	2065	NEW	\N	02 Central Trial Documents	02.04 General
13622	86	\N	\N	D5170C00002	2073	2072	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
13623	86	\N	\N	D5170C00002	2074	2072	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
13624	86	\N	\N	D5170C00002	2075	2064	NEW	\N	2002040 Gaffney, Mary	04 IRB-IEC and other Approvals
13625	86	\N	\N	D5170C00002	2076	2075	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
13626	86	\N	\N	D5170C00002	2077	2076	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
13627	86	\N	\N	D5170C00002	2078	2076	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
13628	86	\N	\N	D5170C00002	2079	2075	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
13629	86	\N	\N	D5170C00002	2080	2079	NEW	\N	04.03 Trial Status Reporting	04.03.02 IRB-I_ Progress Report
13630	86	\N	\N	D5170C00002	2081	2079	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
13631	86	\N	\N	D5170C00002	2082	2075	NEW	\N	04 IRB-IEC and other Approvals	04.04 General
13632	86	\N	\N	D5170C00002	2083	2082	NEW	\N	04.04 General	04.04.01 Relev_RB-IEC-Documents
13633	86	\N	\N	D5170C00002	2084	2064	NEW	\N	2002040 Gaffney, Mary	05 Site Management
13634	86	\N	\N	D5170C00002	2085	2084	NEW	\N	05 Site Management	05.01 Site Selection
13635	86	\N	\N	D5170C00002	2086	2085	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
13636	86	\N	\N	D5170C00002	2087	2085	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
13637	86	\N	\N	D5170C00002	2088	2085	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
13638	86	\N	\N	D5170C00002	2089	2084	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
13639	86	\N	\N	D5170C00002	2090	2089	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
13640	86	\N	\N	D5170C00002	2091	2089	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
13641	86	\N	\N	D5170C00002	2092	2089	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
13642	86	\N	\N	D5170C00002	2093	2089	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
13643	86	\N	\N	D5170C00002	2094	2089	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
13644	86	\N	\N	D5170C00002	2095	2089	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
13645	86	\N	\N	D5170C00002	2096	2089	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
13646	86	\N	\N	D5170C00002	2097	2089	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
13647	86	\N	\N	D5170C00002	2098	2089	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
13648	86	\N	\N	D5170C00002	2099	2089	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
13649	86	\N	\N	D5170C00002	2100	2089	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
13650	86	\N	\N	D5170C00002	2101	2084	NEW	\N	05 Site Management	05.03 Site Initiation
13651	86	\N	\N	D5170C00002	2102	2101	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
13652	86	\N	\N	D5170C00002	2103	2101	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
13653	86	\N	\N	D5170C00002	2104	2101	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
13654	86	\N	\N	D5170C00002	2105	2084	NEW	\N	05 Site Management	05.04 Site Management
13655	86	\N	\N	D5170C00002	2106	2105	NEW	\N	05.04 Site Management	05.04.01 Subject Log
13656	86	\N	\N	D5170C00002	2107	2105	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
13657	86	\N	\N	D5170C00002	2108	2105	NEW	\N	05.04 Site Management	05.04.04 Visit Log
13658	86	\N	\N	D5170C00002	2109	2105	NEW	\N	05.04 Site Management	05.04.05 Additional Monitoring Activity
13659	86	\N	\N	D5170C00002	2110	2105	NEW	\N	05.04 Site Management	05.04.05 UNBLINDED Additional Monitoring Activity
13660	86	\N	\N	D5170C00002	2111	2105	NEW	\N	05.04 Site Management	05.04.06 UNBLINDED Protocol Deviations and Waivers
13661	86	\N	\N	D5170C00002	2112	2105	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
13662	86	\N	\N	D5170C00002	2113	2084	NEW	\N	05 Site Management	05.05 General
13663	86	\N	\N	D5170C00002	2114	2113	NEW	\N	05.05 General	05.05.01 Relev_ations-Documents
13664	86	\N	\N	D5170C00002	2115	2113	NEW	\N	05.05 General	05.05.02 Tracking Information
13665	86	\N	\N	D5170C00002	2116	2064	NEW	\N	2002040 Gaffney, Mary	06 IP and Trial Supplies
13666	86	\N	\N	D5170C00002	2117	2116	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
13667	86	\N	\N	D5170C00002	2118	2117	NEW	\N	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
13668	86	\N	\N	D5170C00002	2119	2117	NEW	\N	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
13669	86	\N	\N	D5170C00002	2120	2117	NEW	\N	06.01 IP Documentation	06.01.10 UNBLI_mentation Return
13670	86	\N	\N	D5170C00002	2121	2116	NEW	\N	06 IP and Trial Supplies	06.04 Storage
13671	86	\N	\N	D5170C00002	2122	2121	NEW	\N	06.04 Storage	06.04.01 UNBLINDED Storage Condition Documentation
13672	86	\N	\N	D5170C00002	2123	2121	NEW	\N	06.04 Storage	06.04.02 UNBLI_on Documentation
13673	86	\N	\N	D5170C00002	2124	2121	NEW	\N	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
13674	86	\N	\N	D5170C00002	2125	2116	NEW	\N	06 IP and Trial Supplies	06.05 Non-IP Documentation
13675	86	\N	\N	D5170C00002	2126	2125	NEW	\N	06.05 Non-IP Documentation	06.05.02 Non-IP Documentation of Shipment
13676	86	\N	\N	D5170C00002	2127	2125	NEW	\N	06.05 Non-IP Documentation	06.05.03 Non-I_tation of Return
13677	86	\N	\N	D5170C00002	2128	2116	NEW	\N	06 IP and Trial Supplies	06.07 General
13678	86	\N	\N	D5170C00002	2129	2128	NEW	\N	06.07 General	06.07.01 UNBLI_roduct-Documents
13679	86	\N	\N	D5170C00002	2130	6	NEW	\N	Site	2002110 Mattar, Mark
13680	86	\N	\N	D5170C00002	2131	2130	NEW	\N	2002110 Mattar, Mark	02 Central Trial Documents
13681	86	\N	\N	D5170C00002	2132	2131	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
13682	86	\N	\N	D5170C00002	2133	2132	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
13683	86	\N	\N	D5170C00002	2134	2131	NEW	\N	02 Central Trial Documents	02.04 General
13684	86	\N	\N	D5170C00002	2135	2134	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
13685	86	\N	\N	D5170C00002	2136	2134	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
13686	86	\N	\N	D5170C00002	2137	2130	NEW	\N	2002110 Mattar, Mark	04 IRB-IEC and other Approvals
13687	86	\N	\N	D5170C00002	2138	2137	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
13688	86	\N	\N	D5170C00002	2139	2138	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
13689	86	\N	\N	D5170C00002	2140	2138	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
13690	86	\N	\N	D5170C00002	2141	2130	NEW	\N	2002110 Mattar, Mark	05 Site Management
13691	86	\N	\N	D5170C00002	2142	2141	NEW	\N	05 Site Management	05.01 Site Selection
13692	86	\N	\N	D5170C00002	2143	2142	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
13693	86	\N	\N	D5170C00002	2144	2142	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
13694	86	\N	\N	D5170C00002	2145	2142	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
13695	86	\N	\N	D5170C00002	2146	2141	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
13696	86	\N	\N	D5170C00002	2147	2146	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
13697	86	\N	\N	D5170C00002	2148	2146	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
13698	86	\N	\N	D5170C00002	2149	2146	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
13699	86	\N	\N	D5170C00002	2150	2146	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
13700	86	\N	\N	D5170C00002	2151	2146	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
13701	86	\N	\N	D5170C00002	2152	2146	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
13702	86	\N	\N	D5170C00002	2153	2146	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
13703	86	\N	\N	D5170C00002	2154	2146	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
13704	86	\N	\N	D5170C00002	2155	2146	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
13705	86	\N	\N	D5170C00002	2156	2141	NEW	\N	05 Site Management	05.03 Site Initiation
13706	86	\N	\N	D5170C00002	2157	2156	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
13707	86	\N	\N	D5170C00002	2158	2156	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
13708	86	\N	\N	D5170C00002	2159	2156	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
13709	86	\N	\N	D5170C00002	2160	2141	NEW	\N	05 Site Management	05.04 Site Management
13710	86	\N	\N	D5170C00002	2161	2160	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
13711	86	\N	\N	D5170C00002	2162	2160	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
13712	86	\N	\N	D5170C00002	2163	2141	NEW	\N	05 Site Management	05.05 General
13713	86	\N	\N	D5170C00002	2164	2163	NEW	\N	05.05 General	05.05.02 Tracking Information
13714	86	\N	\N	D5170C00002	2165	2130	NEW	\N	2002110 Mattar, Mark	06 IP and Trial Supplies
13715	86	\N	\N	D5170C00002	2166	2165	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
13716	86	\N	\N	D5170C00002	2167	2166	NEW	\N	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
13717	86	\N	\N	D5170C00002	2168	6	NEW	\N	Site	2002111 Siddiqui, Firdous
13718	86	\N	\N	D5170C00002	2169	2168	NEW	\N	2002111 Siddiqui, Firdous	02 Central Trial Documents
13719	86	\N	\N	D5170C00002	2170	2169	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
13720	86	\N	\N	D5170C00002	2171	2170	NEW	\N	02.02 Subject Documents	02.02.01 Subject Diary
13721	86	\N	\N	D5170C00002	2172	2170	NEW	\N	02.02 Subject Documents	02.02.02 Subject Questionnaire
13722	86	\N	\N	D5170C00002	2173	2170	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
13723	86	\N	\N	D5170C00002	2174	2170	NEW	\N	02.02 Subject Documents	02.02.05 Subject Participation Card
13724	86	\N	\N	D5170C00002	2175	2170	NEW	\N	02.02 Subject Documents	02.02.06 Adver_ject Recruitment
13725	86	\N	\N	D5170C00002	2176	2170	NEW	\N	02.02 Subject Documents	02.02.07 Other_iven to Subjects
13726	86	\N	\N	D5170C00002	2177	2169	NEW	\N	02 Central Trial Documents	02.04 General
13727	86	\N	\N	D5170C00002	2178	2177	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
13728	86	\N	\N	D5170C00002	2179	2177	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
13729	86	\N	\N	D5170C00002	2180	2168	NEW	\N	2002111 Siddiqui, Firdous	04 IRB-IEC and other Approvals
13730	86	\N	\N	D5170C00002	2181	2180	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
13731	86	\N	\N	D5170C00002	2182	2181	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
13732	86	\N	\N	D5170C00002	2183	2181	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
13733	86	\N	\N	D5170C00002	2184	2180	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
13734	86	\N	\N	D5170C00002	2185	2184	NEW	\N	04.03 Trial Status Reporting	04.03.01 IRB-I_y Info-Deviation
13735	86	\N	\N	D5170C00002	2186	2184	NEW	\N	04.03 Trial Status Reporting	04.03.02 IRB-I_ Progress Report
13736	86	\N	\N	D5170C00002	2187	2184	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
13737	86	\N	\N	D5170C00002	2188	2168	NEW	\N	2002111 Siddiqui, Firdous	05 Site Management
13738	86	\N	\N	D5170C00002	2189	2188	NEW	\N	05 Site Management	05.01 Site Selection
13739	86	\N	\N	D5170C00002	2190	2189	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
13740	86	\N	\N	D5170C00002	2191	2189	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
13741	86	\N	\N	D5170C00002	2192	2189	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
13742	86	\N	\N	D5170C00002	2193	2188	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
13743	86	\N	\N	D5170C00002	2194	2193	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
13744	86	\N	\N	D5170C00002	2195	2193	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
13745	86	\N	\N	D5170C00002	2196	2193	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
13746	86	\N	\N	D5170C00002	2197	2193	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
13747	86	\N	\N	D5170C00002	2198	2193	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
13748	86	\N	\N	D5170C00002	2199	2193	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
13749	86	\N	\N	D5170C00002	2200	2193	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Investigator Regulatory Agreement
13750	86	\N	\N	D5170C00002	2201	2193	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
13751	86	\N	\N	D5170C00002	2202	2193	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
13752	86	\N	\N	D5170C00002	2203	2193	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Si_se Documentation
13753	86	\N	\N	D5170C00002	2204	2193	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
13754	86	\N	\N	D5170C00002	2205	2188	NEW	\N	05 Site Management	05.03 Site Initiation
13755	86	\N	\N	D5170C00002	2206	2205	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
13756	86	\N	\N	D5170C00002	2207	2205	NEW	\N	05.03 Site Initiation	05.03.03 Site _cumentation-Site
13757	86	\N	\N	D5170C00002	2208	2205	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
13758	86	\N	\N	D5170C00002	2209	2188	NEW	\N	05 Site Management	05.04 Site Management
13759	86	\N	\N	D5170C00002	2210	2209	NEW	\N	05.04 Site Management	05.04.01 Subject Log
13760	86	\N	\N	D5170C00002	2211	2209	NEW	\N	05.04 Site Management	05.04.03 Monitoring Visit Report
13761	86	\N	\N	D5170C00002	2212	2209	NEW	\N	05.04 Site Management	05.04.03 UNBLINDED Monitoring Visit Report
13762	86	\N	\N	D5170C00002	2213	2209	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
13763	86	\N	\N	D5170C00002	2214	2209	NEW	\N	05.04 Site Management	05.04.05 Additional Monitoring Activity
13764	86	\N	\N	D5170C00002	2215	2209	NEW	\N	05.04 Site Management	05.04.05 UNBLI_itoring Activity
13765	86	\N	\N	D5170C00002	2216	2209	NEW	\N	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
13766	86	\N	\N	D5170C00002	2217	2209	NEW	\N	05.04 Site Management	05.04.06 UNBLINDED Protocol Deviations and Waivers
13767	86	\N	\N	D5170C00002	2218	2209	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
13768	86	\N	\N	D5170C00002	2219	2188	NEW	\N	05 Site Management	05.05 General
13769	86	\N	\N	D5170C00002	2220	2219	NEW	\N	05.05 General	05.05.01 Relevant Communications-Email
13770	86	\N	\N	D5170C00002	2221	2219	NEW	\N	05.05 General	05.05.02 Tracking Information
13771	86	\N	\N	D5170C00002	2222	2168	NEW	\N	2002111 Siddiqui, Firdous	06 IP and Trial Supplies
13772	86	\N	\N	D5170C00002	2223	2222	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
13773	86	\N	\N	D5170C00002	2224	2223	NEW	\N	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
13774	86	\N	\N	D5170C00002	2225	2223	NEW	\N	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
13775	86	\N	\N	D5170C00002	2226	2223	NEW	\N	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
13776	86	\N	\N	D5170C00002	2227	2223	NEW	\N	06.01 IP Documentation	06.01.10 UNBLI_mentation Return
13777	86	\N	\N	D5170C00002	2228	2222	NEW	\N	06 IP and Trial Supplies	06.04 Storage
13778	86	\N	\N	D5170C00002	2229	2228	NEW	\N	06.04 Storage	06.04.01 UNBLI_on Documentation
13779	86	\N	\N	D5170C00002	2230	2228	NEW	\N	06.04 Storage	06.04.02 UNBLI_on Documentation
13780	86	\N	\N	D5170C00002	2231	2228	NEW	\N	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
13781	86	\N	\N	D5170C00002	2232	6	NEW	\N	Site	2002158 Dryden, Gerald
13782	86	\N	\N	D5170C00002	2233	2232	NEW	\N	2002158 Dryden, Gerald	02 Central Trial Documents
13783	86	\N	\N	D5170C00002	2234	2233	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
13784	86	\N	\N	D5170C00002	2235	2234	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
13785	86	\N	\N	D5170C00002	2236	2233	NEW	\N	02 Central Trial Documents	02.04 General
13786	86	\N	\N	D5170C00002	2237	2236	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
13787	86	\N	\N	D5170C00002	2238	2236	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
13788	86	\N	\N	D5170C00002	2239	2232	NEW	\N	2002158 Dryden, Gerald	04 IRB-IEC and other Approvals
13789	86	\N	\N	D5170C00002	2240	2239	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
13790	86	\N	\N	D5170C00002	2241	2240	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
13791	86	\N	\N	D5170C00002	2242	2240	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
13792	86	\N	\N	D5170C00002	2243	2240	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
13793	86	\N	\N	D5170C00002	2244	2239	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
13794	86	\N	\N	D5170C00002	2245	2244	NEW	\N	04.03 Trial Status Reporting	04.03.01 IRB-I_y Info-Deviation
13795	86	\N	\N	D5170C00002	2246	2244	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
13796	86	\N	\N	D5170C00002	2247	2232	NEW	\N	2002158 Dryden, Gerald	05 Site Management
13797	86	\N	\N	D5170C00002	2248	2247	NEW	\N	05 Site Management	05.01 Site Selection
13798	86	\N	\N	D5170C00002	2249	2248	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
13799	86	\N	\N	D5170C00002	2250	2248	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
13800	86	\N	\N	D5170C00002	2251	2248	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
13801	86	\N	\N	D5170C00002	2252	2247	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
13802	86	\N	\N	D5170C00002	2253	2252	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
13803	86	\N	\N	D5170C00002	2254	2252	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
13804	86	\N	\N	D5170C00002	2255	2252	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
13805	86	\N	\N	D5170C00002	2256	2252	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
13806	86	\N	\N	D5170C00002	2257	2252	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
13807	86	\N	\N	D5170C00002	2258	2252	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Site Qualification
13808	86	\N	\N	D5170C00002	2259	2252	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
13809	86	\N	\N	D5170C00002	2260	2252	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
13810	86	\N	\N	D5170C00002	2261	2252	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
13811	86	\N	\N	D5170C00002	2262	2252	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
13812	86	\N	\N	D5170C00002	2263	2252	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
13813	86	\N	\N	D5170C00002	2264	2252	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
13814	86	\N	\N	D5170C00002	2265	2247	NEW	\N	05 Site Management	05.03 Site Initiation
13815	86	\N	\N	D5170C00002	2266	2265	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
13816	86	\N	\N	D5170C00002	2267	2265	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
13817	86	\N	\N	D5170C00002	2268	2265	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
13818	86	\N	\N	D5170C00002	2269	2247	NEW	\N	05 Site Management	05.04 Site Management
13819	86	\N	\N	D5170C00002	2270	2269	NEW	\N	05.04 Site Management	05.04.03 Monitoring Visit Report
13820	86	\N	\N	D5170C00002	2271	2269	NEW	\N	05.04 Site Management	05.04.03 UNBLINDED Monitoring Visit Report
13821	86	\N	\N	D5170C00002	2272	2269	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
13822	86	\N	\N	D5170C00002	2273	2269	NEW	\N	05.04 Site Management	05.04.04 Visit Log
13823	86	\N	\N	D5170C00002	2274	2269	NEW	\N	05.04 Site Management	05.04.05 UNBLI_itoring Activity
13824	86	\N	\N	D5170C00002	2275	2269	NEW	\N	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
13825	86	\N	\N	D5170C00002	2276	2269	NEW	\N	05.04 Site Management	05.04.06 UNBLINDED Protocol Deviations and Waivers
13826	86	\N	\N	D5170C00002	2277	2269	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
13827	86	\N	\N	D5170C00002	2278	2247	NEW	\N	05 Site Management	05.05 General
13828	86	\N	\N	D5170C00002	2279	2278	NEW	\N	05.05 General	05.05.01 Relevant Communications-Documents
13829	86	\N	\N	D5170C00002	2280	2278	NEW	\N	05.05 General	05.05.01 Relevant Communications-Email
13830	86	\N	\N	D5170C00002	2281	2278	NEW	\N	05.05 General	05.05.02 Tracking Information
13831	86	\N	\N	D5170C00002	2282	2232	NEW	\N	2002158 Dryden, Gerald	06 IP and Trial Supplies
13832	86	\N	\N	D5170C00002	2283	2282	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
13833	86	\N	\N	D5170C00002	2284	2283	NEW	\N	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
13834	86	\N	\N	D5170C00002	2285	2283	NEW	\N	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
13835	86	\N	\N	D5170C00002	2286	2283	NEW	\N	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
13836	86	\N	\N	D5170C00002	2287	2283	NEW	\N	06.01 IP Documentation	06.01.11 UNBLINDED Certificate of Destruction
13837	86	\N	\N	D5170C00002	2288	2282	NEW	\N	06 IP and Trial Supplies	06.03 IP Alloc_on Documentation
13838	86	\N	\N	D5170C00002	2289	2288	NEW	\N	06.03 IP Alloc_on Documentation	06.03.01 UNBLI_on Documentation
13839	86	\N	\N	D5170C00002	2290	2282	NEW	\N	06 IP and Trial Supplies	06.04 Storage
13840	86	\N	\N	D5170C00002	2291	2290	NEW	\N	06.04 Storage	06.04.01 Storage Condition Documentation
13841	86	\N	\N	D5170C00002	2292	2290	NEW	\N	06.04 Storage	06.04.01 UNBLI_on Documentation
13842	86	\N	\N	D5170C00002	2293	2290	NEW	\N	06.04 Storage	06.04.02 UNBLINDED Storage Condition Excursion Documentation
13843	86	\N	\N	D5170C00002	2294	2290	NEW	\N	06.04 Storage	06.04.03 Maintenance Logs
13844	86	\N	\N	D5170C00002	2295	2290	NEW	\N	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
13845	86	\N	\N	D5170C00002	2296	2282	NEW	\N	06 IP and Trial Supplies	06.07 General
13846	86	\N	\N	D5170C00002	2297	2296	NEW	\N	06.07 General	06.07.01 UNBLI_roduct-Documents
13847	86	\N	\N	D5170C00002	2298	2232	NEW	\N	2002158 Dryden, Gerald	08 Centralized Testing
13848	86	\N	\N	D5170C00002	2299	2298	NEW	\N	08 Centralized Testing	08.02 Sample Documentation
13849	86	\N	\N	D5170C00002	2300	2299	NEW	\N	08.02 Sample Documentation	08.02.03 Sampl_ge Condition Log
13850	86	\N	\N	D5170C00002	2301	6	NEW	\N	Site	2002159 Kaur, Nirmal
13851	86	\N	\N	D5170C00002	2302	2301	NEW	\N	2002159 Kaur, Nirmal	05 Site Management
13852	86	\N	\N	D5170C00002	2303	2302	NEW	\N	05 Site Management	05.01 Site Selection
13853	86	\N	\N	D5170C00002	2304	2303	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
13854	86	\N	\N	D5170C00002	2305	6	NEW	\N	Site	2002160 Casey, Kevin
13855	86	\N	\N	D5170C00002	2306	2305	NEW	\N	2002160 Casey, Kevin	02 Central Trial Documents
13856	86	\N	\N	D5170C00002	2307	2306	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
13857	86	\N	\N	D5170C00002	2308	2307	NEW	\N	02.02 Subject Documents	02.02.03 Infor_ Form Checklists
13858	86	\N	\N	D5170C00002	2309	2307	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
13859	86	\N	\N	D5170C00002	2310	2306	NEW	\N	02 Central Trial Documents	02.04 General
13860	86	\N	\N	D5170C00002	2311	2310	NEW	\N	02.04 General	02.04.01 Relev_ations-Documents
13861	86	\N	\N	D5170C00002	2312	2310	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
13862	86	\N	\N	D5170C00002	2313	2310	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
13863	86	\N	\N	D5170C00002	2314	2305	NEW	\N	2002160 Casey, Kevin	04 IRB-IEC and other Approvals
13864	86	\N	\N	D5170C00002	2315	2314	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
13865	86	\N	\N	D5170C00002	2316	2315	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
13866	86	\N	\N	D5170C00002	2317	2315	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
13867	86	\N	\N	D5170C00002	2318	2315	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.05 IRB-I_liance Statement
13868	86	\N	\N	D5170C00002	2319	2314	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
13869	86	\N	\N	D5170C00002	2320	2319	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
13870	86	\N	\N	D5170C00002	2321	2305	NEW	\N	2002160 Casey, Kevin	05 Site Management
13871	86	\N	\N	D5170C00002	2322	2321	NEW	\N	05 Site Management	05.01 Site Selection
13872	86	\N	\N	D5170C00002	2323	2322	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
13873	86	\N	\N	D5170C00002	2324	2322	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
13874	86	\N	\N	D5170C00002	2325	2322	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
13875	86	\N	\N	D5170C00002	2326	2321	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
13876	86	\N	\N	D5170C00002	2327	2326	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
13877	86	\N	\N	D5170C00002	2328	2326	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
13878	86	\N	\N	D5170C00002	2329	2326	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
13879	86	\N	\N	D5170C00002	2330	2326	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
13880	86	\N	\N	D5170C00002	2331	2326	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
13881	86	\N	\N	D5170C00002	2332	2326	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
13882	86	\N	\N	D5170C00002	2333	2326	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
13883	86	\N	\N	D5170C00002	2334	2326	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
13884	86	\N	\N	D5170C00002	2335	2326	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
13885	86	\N	\N	D5170C00002	2336	2326	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
13886	86	\N	\N	D5170C00002	2337	2321	NEW	\N	05 Site Management	05.03 Site Initiation
13887	86	\N	\N	D5170C00002	2338	2337	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
13888	86	\N	\N	D5170C00002	2339	2337	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
13889	86	\N	\N	D5170C00002	2340	2321	NEW	\N	05 Site Management	05.04 Site Management
13890	86	\N	\N	D5170C00002	2341	2340	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
13891	86	\N	\N	D5170C00002	2342	2340	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
13892	86	\N	\N	D5170C00002	2343	2321	NEW	\N	05 Site Management	05.05 General
13893	86	\N	\N	D5170C00002	2344	2343	NEW	\N	05.05 General	05.05.01 Relevant Communications-Documents
13894	86	\N	\N	D5170C00002	2345	2343	NEW	\N	05.05 General	05.05.02 Tracking Information
13895	86	\N	\N	D5170C00002	2346	6	NEW	\N	Site	2002162 Hemaidan, Ammar
13896	86	\N	\N	D5170C00002	2347	2346	NEW	\N	2002162 Hemaidan, Ammar	02 Central Trial Documents
13897	86	\N	\N	D5170C00002	2348	2347	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
13898	86	\N	\N	D5170C00002	2349	2348	NEW	\N	02.02 Subject Documents	02.02.01 Subject Diary
13899	86	\N	\N	D5170C00002	2350	2348	NEW	\N	02.02 Subject Documents	02.02.02 Subject Questionnaire
13900	86	\N	\N	D5170C00002	2351	2348	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
13901	86	\N	\N	D5170C00002	2352	2348	NEW	\N	02.02 Subject Documents	02.02.05 Subject Participation Card
13902	86	\N	\N	D5170C00002	2353	2348	NEW	\N	02.02 Subject Documents	02.02.06 Adver_ject Recruitment
13903	86	\N	\N	D5170C00002	2354	2348	NEW	\N	02.02 Subject Documents	02.02.07 Other_iven to Subjects
13904	86	\N	\N	D5170C00002	2355	2347	NEW	\N	02 Central Trial Documents	02.04 General
13905	86	\N	\N	D5170C00002	2356	2355	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
13906	86	\N	\N	D5170C00002	2357	2355	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
13907	86	\N	\N	D5170C00002	2358	2346	NEW	\N	2002162 Hemaidan, Ammar	04 IRB-IEC and other Approvals
13908	86	\N	\N	D5170C00002	2359	2358	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
13909	86	\N	\N	D5170C00002	2360	2359	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
13910	86	\N	\N	D5170C00002	2361	2358	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
13911	86	\N	\N	D5170C00002	2362	2361	NEW	\N	04.03 Trial Status Reporting	04.03.02 IRB-I_ Progress Report
13912	86	\N	\N	D5170C00002	2363	2361	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
13913	86	\N	\N	D5170C00002	2364	2346	NEW	\N	2002162 Hemaidan, Ammar	05 Site Management
13914	86	\N	\N	D5170C00002	2365	2364	NEW	\N	05 Site Management	05.01 Site Selection
13915	86	\N	\N	D5170C00002	2366	2365	NEW	\N	05.01 Site Selection	05.01.01 Site Contact Details
13916	86	\N	\N	D5170C00002	2367	2365	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
13917	86	\N	\N	D5170C00002	2368	2365	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
13918	86	\N	\N	D5170C00002	2369	2365	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
13919	86	\N	\N	D5170C00002	2370	2364	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
13920	86	\N	\N	D5170C00002	2371	2370	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
13921	86	\N	\N	D5170C00002	2372	2370	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
13922	86	\N	\N	D5170C00002	2373	2370	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
13923	86	\N	\N	D5170C00002	2374	2370	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
13924	86	\N	\N	D5170C00002	2375	2370	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
13925	86	\N	\N	D5170C00002	2376	2370	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
13926	86	\N	\N	D5170C00002	2377	2370	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
13927	86	\N	\N	D5170C00002	2378	2370	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
13928	86	\N	\N	D5170C00002	2379	2370	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
13929	86	\N	\N	D5170C00002	2380	2370	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
13930	86	\N	\N	D5170C00002	2381	2364	NEW	\N	05 Site Management	05.03 Site Initiation
13931	86	\N	\N	D5170C00002	2382	2381	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
13932	86	\N	\N	D5170C00002	2383	2381	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
13933	86	\N	\N	D5170C00002	2384	2364	NEW	\N	05 Site Management	05.04 Site Management
13934	86	\N	\N	D5170C00002	2385	2384	NEW	\N	05.04 Site Management	05.04.04 Visit Log
13935	86	\N	\N	D5170C00002	2386	2384	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
13936	86	\N	\N	D5170C00002	2387	2364	NEW	\N	05 Site Management	05.05 General
13937	86	\N	\N	D5170C00002	2388	2387	NEW	\N	05.05 General	05.05.02 Tracking Information
13938	86	\N	\N	D5170C00002	2389	2346	NEW	\N	2002162 Hemaidan, Ammar	06 IP and Trial Supplies
13939	86	\N	\N	D5170C00002	2390	2389	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
13940	86	\N	\N	D5170C00002	2391	2390	NEW	\N	06.01 IP Documentation	06.01.02 IP In_ons for Handling
13941	86	\N	\N	D5170C00002	2392	2389	NEW	\N	06 IP and Trial Supplies	06.05 Non-IP Documentation
13942	86	\N	\N	D5170C00002	2393	2392	NEW	\N	06.05 Non-IP Documentation	06.05.03 Non-I_tation of Return
13943	86	\N	\N	D5170C00002	2394	2346	NEW	\N	2002162 Hemaidan, Ammar	08 Centralized Testing
13944	86	\N	\N	D5170C00002	2395	2394	NEW	\N	08 Centralized Testing	08.03 General
13945	86	\N	\N	D5170C00002	2396	2395	NEW	\N	08.03 General	08.03.01 Relev_al Lab-Documents
13946	86	\N	\N	D5170C00002	2397	6	NEW	\N	Site	2002198 Ananthakrishnan, Ashwin
13947	86	\N	\N	D5170C00002	2398	2397	NEW	\N	2002198 Ananthakrishnan, Ashwin	02 Central Trial Documents
13948	86	\N	\N	D5170C00002	2399	2398	NEW	\N	02 Central Trial Documents	02.04 General
13949	86	\N	\N	D5170C00002	2400	2399	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
13950	86	\N	\N	D5170C00002	2401	2397	NEW	\N	2002198 Ananthakrishnan, Ashwin	05 Site Management
13951	86	\N	\N	D5170C00002	2402	2401	NEW	\N	05 Site Management	05.01 Site Selection
13952	86	\N	\N	D5170C00002	2403	2402	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
13953	86	\N	\N	D5170C00002	2404	2402	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
13954	86	\N	\N	D5170C00002	2405	2402	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
13955	86	\N	\N	D5170C00002	2406	2401	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
13956	86	\N	\N	D5170C00002	2407	2406	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
13957	86	\N	\N	D5170C00002	2408	2401	NEW	\N	05 Site Management	05.05 General
13958	86	\N	\N	D5170C00002	2409	2408	NEW	\N	05.05 General	05.05.02 Tracking Information
13959	86	\N	\N	D5170C00002	2410	6	NEW	\N	Site	2002199 Oza, Amita
13960	86	\N	\N	D5170C00002	2411	2410	NEW	\N	2002199 Oza, Amita	02 Central Trial Documents
13961	86	\N	\N	D5170C00002	2412	2411	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
13962	86	\N	\N	D5170C00002	2413	2412	NEW	\N	02.02 Subject Documents	02.02.01 Subject Diary
13963	86	\N	\N	D5170C00002	2414	2412	NEW	\N	02.02 Subject Documents	02.02.02 Subject Questionnaire
13964	86	\N	\N	D5170C00002	2415	2412	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
13965	86	\N	\N	D5170C00002	2416	2412	NEW	\N	02.02 Subject Documents	02.02.05 Subject Participation Card
13966	86	\N	\N	D5170C00002	2417	2412	NEW	\N	02.02 Subject Documents	02.02.06 Adver_ject Recruitment
13967	86	\N	\N	D5170C00002	2418	2412	NEW	\N	02.02 Subject Documents	02.02.07 Other_iven to Subjects
13968	86	\N	\N	D5170C00002	2419	2411	NEW	\N	02 Central Trial Documents	02.04 General
13969	86	\N	\N	D5170C00002	2420	2419	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
13970	86	\N	\N	D5170C00002	2421	2419	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
13971	86	\N	\N	D5170C00002	2422	2410	NEW	\N	2002199 Oza, Amita	04 IRB-IEC and other Approvals
13972	86	\N	\N	D5170C00002	2423	2422	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
13973	86	\N	\N	D5170C00002	2424	2423	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
13974	86	\N	\N	D5170C00002	2425	2423	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
13975	86	\N	\N	D5170C00002	2426	2422	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
13976	86	\N	\N	D5170C00002	2427	2426	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
13977	86	\N	\N	D5170C00002	2428	2410	NEW	\N	2002199 Oza, Amita	05 Site Management
13978	86	\N	\N	D5170C00002	2429	2428	NEW	\N	05 Site Management	05.01 Site Selection
13979	86	\N	\N	D5170C00002	2430	2429	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
13980	86	\N	\N	D5170C00002	2431	2429	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
13981	86	\N	\N	D5170C00002	2432	2429	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
13982	86	\N	\N	D5170C00002	2433	2428	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
13983	86	\N	\N	D5170C00002	2434	2433	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
13984	86	\N	\N	D5170C00002	2435	2433	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
13985	86	\N	\N	D5170C00002	2436	2433	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
13986	86	\N	\N	D5170C00002	2437	2433	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
13987	86	\N	\N	D5170C00002	2438	2433	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Site Qualification
13988	86	\N	\N	D5170C00002	2439	2433	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
13989	86	\N	\N	D5170C00002	2440	2433	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
13990	86	\N	\N	D5170C00002	2441	2433	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Investigator Regulatory Agreement
13991	86	\N	\N	D5170C00002	2442	2433	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
13992	86	\N	\N	D5170C00002	2443	2433	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
13993	86	\N	\N	D5170C00002	2444	2433	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
13994	86	\N	\N	D5170C00002	2445	2428	NEW	\N	05 Site Management	05.03 Site Initiation
13995	86	\N	\N	D5170C00002	2446	2445	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
13996	86	\N	\N	D5170C00002	2447	2445	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
13997	86	\N	\N	D5170C00002	2448	2445	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
13998	86	\N	\N	D5170C00002	2449	2428	NEW	\N	05 Site Management	05.04 Site Management
13999	86	\N	\N	D5170C00002	2450	2449	NEW	\N	05.04 Site Management	05.04.01 Subject Log
14000	86	\N	\N	D5170C00002	2451	2449	NEW	\N	05.04 Site Management	05.04.03 UNBLINDED Monitoring Visit Report
14001	86	\N	\N	D5170C00002	2452	2449	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
14002	86	\N	\N	D5170C00002	2453	2449	NEW	\N	05.04 Site Management	05.04.04 Visit Log
14003	86	\N	\N	D5170C00002	2454	2449	NEW	\N	05.04 Site Management	05.04.05 Additional Monitoring Activity
14004	86	\N	\N	D5170C00002	2455	2449	NEW	\N	05.04 Site Management	05.04.05 UNBLINDED Additional Monitoring Activity
14005	86	\N	\N	D5170C00002	2456	2449	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
14006	86	\N	\N	D5170C00002	2457	2428	NEW	\N	05 Site Management	05.05 General
14007	86	\N	\N	D5170C00002	2458	2457	NEW	\N	05.05 General	05.05.01 Relevant Communications-Documents
14008	86	\N	\N	D5170C00002	2459	2457	NEW	\N	05.05 General	05.05.02 Tracking Information
14009	86	\N	\N	D5170C00002	2460	2410	NEW	\N	2002199 Oza, Amita	06 IP and Trial Supplies
14010	86	\N	\N	D5170C00002	2461	2460	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
14011	86	\N	\N	D5170C00002	2462	2461	NEW	\N	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
14012	86	\N	\N	D5170C00002	2463	2461	NEW	\N	06.01 IP Documentation	06.01.04 UNBLINDED IP Shipment Documentation
14013	86	\N	\N	D5170C00002	2464	2461	NEW	\N	06.01 IP Documentation	06.01.05 UNBLINDED Accountability Documentation
14014	86	\N	\N	D5170C00002	2465	2461	NEW	\N	06.01 IP Documentation	06.01.11 UNBLINDED Certificate of Destruction
14015	86	\N	\N	D5170C00002	2466	2460	NEW	\N	06 IP and Trial Supplies	06.04 Storage
14016	86	\N	\N	D5170C00002	2467	2466	NEW	\N	06.04 Storage	06.04.01 UNBLI_on Documentation
14017	86	\N	\N	D5170C00002	2468	2466	NEW	\N	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
14018	86	\N	\N	D5170C00002	2469	2460	NEW	\N	06 IP and Trial Supplies	06.07 General
14019	86	\N	\N	D5170C00002	2470	2469	NEW	\N	06.07 General	06.07.01 UNBLI_roduct-Documents
14020	86	\N	\N	D5170C00002	2471	2410	NEW	\N	2002199 Oza, Amita	08 Centralized Testing
14021	86	\N	\N	D5170C00002	2472	2471	NEW	\N	08 Centralized Testing	08.01 Facility Documentation
14022	86	\N	\N	D5170C00002	2473	2472	NEW	\N	08.01 Facility Documentation	08.01.01 Certification or Accreditation
14023	86	\N	\N	D5170C00002	2474	6	NEW	\N	Site	2002534 Arce-Nunez, Esperanza
14024	86	\N	\N	D5170C00002	2475	2474	NEW	\N	2002534 Arce-Nunez, Esperanza	02 Central Trial Documents
14025	86	\N	\N	D5170C00002	2476	2475	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
14026	86	\N	\N	D5170C00002	2477	2476	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
14027	86	\N	\N	D5170C00002	2478	2475	NEW	\N	02 Central Trial Documents	02.04 General
14028	86	\N	\N	D5170C00002	2479	2478	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
14029	86	\N	\N	D5170C00002	2480	2478	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
14030	86	\N	\N	D5170C00002	2481	2474	NEW	\N	2002534 Arce-Nunez, Esperanza	03 Regulatory
14031	86	\N	\N	D5170C00002	2482	2481	NEW	\N	03 Regulatory	03.04 General
14032	86	\N	\N	D5170C00002	2483	2482	NEW	\N	03.04 General	03.04.01 Relev_art-Up-Documents
14033	86	\N	\N	D5170C00002	2484	2474	NEW	\N	2002534 Arce-Nunez, Esperanza	04 IRB-IEC and other Approvals
14034	86	\N	\N	D5170C00002	2485	2484	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
14035	86	\N	\N	D5170C00002	2486	2485	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
14036	86	\N	\N	D5170C00002	2487	2485	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
14037	86	\N	\N	D5170C00002	2488	2484	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
14038	86	\N	\N	D5170C00002	2489	2488	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
14039	86	\N	\N	D5170C00002	2490	2474	NEW	\N	2002534 Arce-Nunez, Esperanza	05 Site Management
14040	86	\N	\N	D5170C00002	2491	2490	NEW	\N	05 Site Management	05.01 Site Selection
14041	86	\N	\N	D5170C00002	2492	2491	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
14042	86	\N	\N	D5170C00002	2493	2491	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
14043	86	\N	\N	D5170C00002	2494	2491	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
14044	86	\N	\N	D5170C00002	2495	2490	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
14045	86	\N	\N	D5170C00002	2496	2495	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Accep_tigator Brochure
14046	86	\N	\N	D5170C00002	2497	2495	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
14047	86	\N	\N	D5170C00002	2498	2495	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
14048	86	\N	\N	D5170C00002	2499	2495	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
14049	86	\N	\N	D5170C00002	2500	2495	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Site Qualification
14050	86	\N	\N	D5170C00002	2501	2495	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
14051	86	\N	\N	D5170C00002	2502	2495	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
14052	86	\N	\N	D5170C00002	2503	2495	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
14053	86	\N	\N	D5170C00002	2504	2495	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
14054	86	\N	\N	D5170C00002	2505	2495	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Si_se Documentation
14055	86	\N	\N	D5170C00002	2506	2495	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
14056	86	\N	\N	D5170C00002	2507	2490	NEW	\N	05 Site Management	05.03 Site Initiation
14057	86	\N	\N	D5170C00002	2508	2507	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
14058	86	\N	\N	D5170C00002	2509	2507	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
14059	86	\N	\N	D5170C00002	2510	2490	NEW	\N	05 Site Management	05.04 Site Management
14060	86	\N	\N	D5170C00002	2511	2510	NEW	\N	05.04 Site Management	05.04.01 Subject Log
14061	86	\N	\N	D5170C00002	2512	2510	NEW	\N	05.04 Site Management	05.04.04 Visit Log
14062	86	\N	\N	D5170C00002	2513	2510	NEW	\N	05.04 Site Management	05.04.08 Final_onitoring Report
14063	86	\N	\N	D5170C00002	2514	2490	NEW	\N	05 Site Management	05.05 General
14064	86	\N	\N	D5170C00002	2515	2514	NEW	\N	05.05 General	05.05.02 Tracking Information
14065	86	\N	\N	D5170C00002	2516	2474	NEW	\N	2002534 Arce-Nunez, Esperanza	08 Centralized Testing
14066	86	\N	\N	D5170C00002	2517	2516	NEW	\N	08 Centralized Testing	08.01 Facility Documentation
14067	86	\N	\N	D5170C00002	2518	2517	NEW	\N	08.01 Facility Documentation	08.01.01 Certi_or Accreditation
14068	86	\N	\N	D5170C00002	2519	2517	NEW	\N	08.01 Facility Documentation	08.01.08 Stand_dization Methods
14069	86	\N	\N	D5170C00002	2520	6	NEW	\N	Site	2002535 McCall, Ricardo
14070	86	\N	\N	D5170C00002	2521	2520	NEW	\N	2002535 McCall, Ricardo	02 Central Trial Documents
14071	86	\N	\N	D5170C00002	2522	2521	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
14072	86	\N	\N	D5170C00002	2523	2522	NEW	\N	02.02 Subject Documents	02.02.01 Subject Diary
14073	86	\N	\N	D5170C00002	2524	2522	NEW	\N	02.02 Subject Documents	02.02.02 Subject Questionnaire
14074	86	\N	\N	D5170C00002	2525	2522	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
14075	86	\N	\N	D5170C00002	2526	2522	NEW	\N	02.02 Subject Documents	02.02.05 Subje_rticipation Card
14076	86	\N	\N	D5170C00002	2527	2522	NEW	\N	02.02 Subject Documents	02.02.06 Adver_ject Recruitment
14077	86	\N	\N	D5170C00002	2528	2522	NEW	\N	02.02 Subject Documents	02.02.07 Other_iven to Subjects
14078	86	\N	\N	D5170C00002	2529	2521	NEW	\N	02 Central Trial Documents	02.04 General
14079	86	\N	\N	D5170C00002	2530	2529	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
14080	86	\N	\N	D5170C00002	2531	2529	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
14081	86	\N	\N	D5170C00002	2532	2520	NEW	\N	2002535 McCall, Ricardo	03 Regulatory
14082	86	\N	\N	D5170C00002	2533	2532	NEW	\N	03 Regulatory	03.04 General
14083	86	\N	\N	D5170C00002	2534	2533	NEW	\N	03.04 General	03.04.01 Relev_art-Up-Documents
14084	86	\N	\N	D5170C00002	2535	2520	NEW	\N	2002535 McCall, Ricardo	04 IRB-IEC and other Approvals
14085	86	\N	\N	D5170C00002	2536	2535	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
14086	86	\N	\N	D5170C00002	2537	2536	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
14087	86	\N	\N	D5170C00002	2538	2536	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
14088	86	\N	\N	D5170C00002	2539	2536	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
14089	86	\N	\N	D5170C00002	2540	2535	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
14090	86	\N	\N	D5170C00002	2541	2540	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
14091	86	\N	\N	D5170C00002	2542	2520	NEW	\N	2002535 McCall, Ricardo	05 Site Management
14092	86	\N	\N	D5170C00002	2543	2542	NEW	\N	05 Site Management	05.01 Site Selection
14093	86	\N	\N	D5170C00002	2544	2543	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
14094	86	\N	\N	D5170C00002	2545	2543	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
14095	86	\N	\N	D5170C00002	2546	2543	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
14096	86	\N	\N	D5170C00002	2547	2542	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
14097	86	\N	\N	D5170C00002	2548	2547	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
14098	86	\N	\N	D5170C00002	2549	2547	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
14099	86	\N	\N	D5170C00002	2550	2547	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
14100	86	\N	\N	D5170C00002	2551	2547	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
14101	86	\N	\N	D5170C00002	2552	2547	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
14102	86	\N	\N	D5170C00002	2553	2547	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
14103	86	\N	\N	D5170C00002	2554	2547	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
14104	86	\N	\N	D5170C00002	2555	2547	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
14105	86	\N	\N	D5170C00002	2556	2547	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
14106	86	\N	\N	D5170C00002	2557	2547	NEW	\N	05.02 Site Set-up Documentation	05.02.13 Indemnity
14107	86	\N	\N	D5170C00002	2558	2547	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
14108	86	\N	\N	D5170C00002	2559	2547	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
14109	86	\N	\N	D5170C00002	2560	2542	NEW	\N	05 Site Management	05.03 Site Initiation
14110	86	\N	\N	D5170C00002	2561	2560	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
14111	86	\N	\N	D5170C00002	2562	2560	NEW	\N	05.03 Site Initiation	05.03.03 Site _cumentation-Site
14112	86	\N	\N	D5170C00002	2563	2560	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
14113	86	\N	\N	D5170C00002	2564	2542	NEW	\N	05 Site Management	05.04 Site Management
14114	86	\N	\N	D5170C00002	2565	2564	NEW	\N	05.04 Site Management	05.04.01 Subject Log
14115	86	\N	\N	D5170C00002	2566	2564	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
14116	86	\N	\N	D5170C00002	2567	2564	NEW	\N	05.04 Site Management	05.04.04 Visit Log
14117	86	\N	\N	D5170C00002	2568	2564	NEW	\N	05.04 Site Management	05.04.05 Additional Monitoring Activity
14118	86	\N	\N	D5170C00002	2569	2564	NEW	\N	05.04 Site Management	05.04.05 UNBLI_itoring Activity
14119	86	\N	\N	D5170C00002	2570	2564	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
14120	86	\N	\N	D5170C00002	2571	2542	NEW	\N	05 Site Management	05.05 General
14121	86	\N	\N	D5170C00002	2572	2571	NEW	\N	05.05 General	05.05.02 Tracking Information
14122	86	\N	\N	D5170C00002	2573	2520	NEW	\N	2002535 McCall, Ricardo	06 IP and Trial Supplies
14123	86	\N	\N	D5170C00002	2574	2573	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
14124	86	\N	\N	D5170C00002	2575	2574	NEW	\N	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
14125	86	\N	\N	D5170C00002	2576	2574	NEW	\N	06.01 IP Documentation	06.01.04 IP Shipment Documentation
14126	86	\N	\N	D5170C00002	2577	2574	NEW	\N	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
14127	86	\N	\N	D5170C00002	2578	2574	NEW	\N	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
14128	86	\N	\N	D5170C00002	2579	2574	NEW	\N	06.01 IP Documentation	06.01.10 UNBLI_mentation Return
14129	86	\N	\N	D5170C00002	2580	2574	NEW	\N	06.01 IP Documentation	06.01.11 Certificate of Destruction
14130	86	\N	\N	D5170C00002	2581	2573	NEW	\N	06 IP and Trial Supplies	06.04 Storage
14131	86	\N	\N	D5170C00002	2582	2581	NEW	\N	06.04 Storage	06.04.01 Storage Condition Documentation
14132	86	\N	\N	D5170C00002	2583	2581	NEW	\N	06.04 Storage	06.04.01 UNBLINDED Storage Condition Documentation
14133	86	\N	\N	D5170C00002	2584	2581	NEW	\N	06.04 Storage	06.04.03 Maintenance Logs
14134	86	\N	\N	D5170C00002	2585	2581	NEW	\N	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
14135	86	\N	\N	D5170C00002	2586	2573	NEW	\N	06 IP and Trial Supplies	06.05 Non-IP Documentation
14136	86	\N	\N	D5170C00002	2587	2586	NEW	\N	06.05 Non-IP Documentation	06.05.02 Non-I_tion of Shipment
14137	86	\N	\N	D5170C00002	2588	2586	NEW	\N	06.05 Non-IP Documentation	06.05.03 Non-I_tation of Return
14138	86	\N	\N	D5170C00002	2589	2573	NEW	\N	06 IP and Trial Supplies	06.07 General
14139	86	\N	\N	D5170C00002	2590	2589	NEW	\N	06.07 General	06.07.01 Relev_roduct-Documents
14140	86	\N	\N	D5170C00002	2591	2520	NEW	\N	2002535 McCall, Ricardo	08 Centralized Testing
14141	86	\N	\N	D5170C00002	2592	2591	NEW	\N	08 Centralized Testing	08.01 Facility Documentation
14142	86	\N	\N	D5170C00002	2593	2592	NEW	\N	08.01 Facility Documentation	08.01.01 Certification or Accreditation
14143	86	\N	\N	D5170C00002	2594	2592	NEW	\N	08.01 Facility Documentation	08.01.04 Norma_and Alert Values
14144	86	\N	\N	D5170C00002	2595	2592	NEW	\N	08.01 Facility Documentation	08.01.07 Head of Facility CV
14145	86	\N	\N	D5170C00002	2596	2591	NEW	\N	08 Centralized Testing	08.02 Sample Documentation
14146	86	\N	\N	D5170C00002	2597	2596	NEW	\N	08.02 Sample Documentation	08.02.03 Sampl_ge Condition Log
14147	86	\N	\N	D5170C00002	2598	6	NEW	\N	Site	2002600 Chiorean, Michael
14148	86	\N	\N	D5170C00002	2599	2598	NEW	\N	2002600 Chiorean, Michael	02 Central Trial Documents
14149	86	\N	\N	D5170C00002	2600	2599	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
14150	86	\N	\N	D5170C00002	2601	2600	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
14151	86	\N	\N	D5170C00002	2602	2599	NEW	\N	02 Central Trial Documents	02.04 General
14152	86	\N	\N	D5170C00002	2603	2602	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
14153	86	\N	\N	D5170C00002	2604	2602	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
14154	86	\N	\N	D5170C00002	2605	2598	NEW	\N	2002600 Chiorean, Michael	04 IRB-IEC and other Approvals
14155	86	\N	\N	D5170C00002	2606	2605	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
14156	86	\N	\N	D5170C00002	2607	2606	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
14157	86	\N	\N	D5170C00002	2608	2606	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
14158	86	\N	\N	D5170C00002	2609	2605	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
14159	86	\N	\N	D5170C00002	2610	2609	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
14160	86	\N	\N	D5170C00002	2611	2598	NEW	\N	2002600 Chiorean, Michael	05 Site Management
14161	86	\N	\N	D5170C00002	2612	2611	NEW	\N	05 Site Management	05.01 Site Selection
14162	86	\N	\N	D5170C00002	2613	2612	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
14163	86	\N	\N	D5170C00002	2614	2612	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
14164	86	\N	\N	D5170C00002	2615	2612	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
14165	86	\N	\N	D5170C00002	2616	2611	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
14166	86	\N	\N	D5170C00002	2617	2616	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
14167	86	\N	\N	D5170C00002	2618	2616	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
14168	86	\N	\N	D5170C00002	2619	2616	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
14169	86	\N	\N	D5170C00002	2620	2616	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
14170	86	\N	\N	D5170C00002	2621	2616	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
14171	86	\N	\N	D5170C00002	2622	2616	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
14172	86	\N	\N	D5170C00002	2623	2616	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
14173	86	\N	\N	D5170C00002	2624	2616	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
14174	86	\N	\N	D5170C00002	2625	2616	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
14175	86	\N	\N	D5170C00002	2626	2611	NEW	\N	05 Site Management	05.03 Site Initiation
14176	86	\N	\N	D5170C00002	2627	2626	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
14177	86	\N	\N	D5170C00002	2628	2626	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
14178	86	\N	\N	D5170C00002	2629	2611	NEW	\N	05 Site Management	05.04 Site Management
14179	86	\N	\N	D5170C00002	2630	2629	NEW	\N	05.04 Site Management	05.04.05 Additional Monitoring Activity
14180	86	\N	\N	D5170C00002	2631	2629	NEW	\N	05.04 Site Management	05.04.05 UNBLI_itoring Activity
14181	86	\N	\N	D5170C00002	2632	2629	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
14182	86	\N	\N	D5170C00002	2633	2611	NEW	\N	05 Site Management	05.05 General
14183	86	\N	\N	D5170C00002	2634	2633	NEW	\N	05.05 General	05.05.01 Relev_ations-Documents
14184	86	\N	\N	D5170C00002	2635	2633	NEW	\N	05.05 General	05.05.02 Tracking Information
14185	86	\N	\N	D5170C00002	2636	2598	NEW	\N	2002600 Chiorean, Michael	06 IP and Trial Supplies
14186	86	\N	\N	D5170C00002	2637	2636	NEW	\N	06 IP and Trial Supplies	06.07 General
14187	86	\N	\N	D5170C00002	2638	2637	NEW	\N	06.07 General	06.07.01 Relev_roduct-Documents
14188	86	\N	\N	D5170C00002	2639	2598	NEW	\N	2002600 Chiorean, Michael	08 Centralized Testing
14189	86	\N	\N	D5170C00002	2640	2639	NEW	\N	08 Centralized Testing	08.01 Facility Documentation
14190	86	\N	\N	D5170C00002	2641	2640	NEW	\N	08.01 Facility Documentation	08.01.07 Head of Facility CV
14191	86	\N	\N	D5170C00002	2642	2639	NEW	\N	08 Centralized Testing	08.03 General
14192	86	\N	\N	D5170C00002	2643	2642	NEW	\N	08.03 General	08.03.01 Relev_al Lab-Documents
14193	86	\N	\N	D5170C00002	2644	6	NEW	\N	Site	2002601 Jamal, Mazen
14194	86	\N	\N	D5170C00002	2645	2644	NEW	\N	2002601 Jamal, Mazen	02 Central Trial Documents
14195	86	\N	\N	D5170C00002	2646	2645	NEW	\N	02 Central Trial Documents	02.04 General
14196	86	\N	\N	D5170C00002	2647	2646	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
14197	86	\N	\N	D5170C00002	2648	2644	NEW	\N	2002601 Jamal, Mazen	05 Site Management
14198	86	\N	\N	D5170C00002	2649	2648	NEW	\N	05 Site Management	05.01 Site Selection
14199	86	\N	\N	D5170C00002	2650	2649	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
14200	86	\N	\N	D5170C00002	2651	2649	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
14201	86	\N	\N	D5170C00002	2652	2649	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
14202	86	\N	\N	D5170C00002	2653	2648	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
14203	86	\N	\N	D5170C00002	2654	2653	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
14204	86	\N	\N	D5170C00002	2655	6	NEW	\N	Site	2002602 May, Elizabeth
14205	86	\N	\N	D5170C00002	2656	2655	NEW	\N	2002602 May, Elizabeth	05 Site Management
14206	86	\N	\N	D5170C00002	2657	2656	NEW	\N	05 Site Management	05.01 Site Selection
14207	86	\N	\N	D5170C00002	2658	2657	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
14208	86	\N	\N	D5170C00002	2659	2657	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
14209	86	\N	\N	D5170C00002	2660	2657	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
14210	86	\N	\N	D5170C00002	2661	6	NEW	\N	Site	2002603 Gancayco, John
14211	86	\N	\N	D5170C00002	2662	2661	NEW	\N	2002603 Gancayco, John	05 Site Management
14212	86	\N	\N	D5170C00002	2663	2662	NEW	\N	05 Site Management	05.01 Site Selection
14213	86	\N	\N	D5170C00002	2664	2663	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
14214	86	\N	\N	D5170C00002	2665	2663	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
14215	86	\N	\N	D5170C00002	2666	6	NEW	\N	Site	2002604 Kurtz, Michael
14216	86	\N	\N	D5170C00002	2667	2666	NEW	\N	2002604 Kurtz, Michael	02 Central Trial Documents
14217	86	\N	\N	D5170C00002	2668	2667	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
14218	86	\N	\N	D5170C00002	2669	2668	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
14219	86	\N	\N	D5170C00002	2670	2667	NEW	\N	02 Central Trial Documents	02.04 General
14220	86	\N	\N	D5170C00002	2671	2670	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
14221	86	\N	\N	D5170C00002	2672	2670	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
14222	86	\N	\N	D5170C00002	2673	2666	NEW	\N	2002604 Kurtz, Michael	04 IRB-IEC and other Approvals
14223	86	\N	\N	D5170C00002	2674	2673	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
14224	86	\N	\N	D5170C00002	2675	2674	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
14225	86	\N	\N	D5170C00002	2676	2673	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
14226	86	\N	\N	D5170C00002	2677	2676	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
14227	86	\N	\N	D5170C00002	2678	2666	NEW	\N	2002604 Kurtz, Michael	05 Site Management
14228	86	\N	\N	D5170C00002	2679	2678	NEW	\N	05 Site Management	05.01 Site Selection
14229	86	\N	\N	D5170C00002	2680	2679	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
14230	86	\N	\N	D5170C00002	2681	2679	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
14231	86	\N	\N	D5170C00002	2682	2679	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
14232	86	\N	\N	D5170C00002	2683	2678	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
14233	86	\N	\N	D5170C00002	2684	2683	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
14234	86	\N	\N	D5170C00002	2685	2683	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
14235	86	\N	\N	D5170C00002	2686	2683	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
14236	86	\N	\N	D5170C00002	2687	2683	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
14237	86	\N	\N	D5170C00002	2688	2683	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Site Qualification
14238	86	\N	\N	D5170C00002	2689	2683	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
14239	86	\N	\N	D5170C00002	2690	2683	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
14240	86	\N	\N	D5170C00002	2691	2683	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
14241	86	\N	\N	D5170C00002	2692	2683	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
14242	86	\N	\N	D5170C00002	2693	2683	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
14243	86	\N	\N	D5170C00002	2694	2678	NEW	\N	05 Site Management	05.03 Site Initiation
14244	86	\N	\N	D5170C00002	2695	2694	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
14245	86	\N	\N	D5170C00002	2696	2694	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
14246	86	\N	\N	D5170C00002	2697	2678	NEW	\N	05 Site Management	05.04 Site Management
14247	86	\N	\N	D5170C00002	2698	2697	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
14248	86	\N	\N	D5170C00002	2699	2678	NEW	\N	05 Site Management	05.05 General
14249	86	\N	\N	D5170C00002	2700	2699	NEW	\N	05.05 General	05.05.02 Tracking Information
14250	86	\N	\N	D5170C00002	2701	6	NEW	\N	Site	2002605 Singla, Manish
14251	86	\N	\N	D5170C00002	2702	2701	NEW	\N	2002605 Singla, Manish	05 Site Management
14252	86	\N	\N	D5170C00002	2703	2702	NEW	\N	05 Site Management	05.01 Site Selection
14253	86	\N	\N	D5170C00002	2704	2703	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
14254	86	\N	\N	D5170C00002	2705	2703	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
14255	86	\N	\N	D5170C00002	2706	6	NEW	\N	Site	2002677 Herring, Robert
14256	86	\N	\N	D5170C00002	2707	2706	NEW	\N	2002677 Herring, Robert	02 Central Trial Documents
14257	86	\N	\N	D5170C00002	2708	2707	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
14258	86	\N	\N	D5170C00002	2709	2708	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
14259	86	\N	\N	D5170C00002	2710	2707	NEW	\N	02 Central Trial Documents	02.04 General
14260	86	\N	\N	D5170C00002	2711	2710	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
14261	86	\N	\N	D5170C00002	2712	2706	NEW	\N	2002677 Herring, Robert	04 IRB-IEC and other Approvals
14262	86	\N	\N	D5170C00002	2713	2712	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
14263	86	\N	\N	D5170C00002	2714	2713	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
14264	86	\N	\N	D5170C00002	2715	2712	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
14265	86	\N	\N	D5170C00002	2716	2715	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
14266	86	\N	\N	D5170C00002	2717	2706	NEW	\N	2002677 Herring, Robert	05 Site Management
14267	86	\N	\N	D5170C00002	2718	2717	NEW	\N	05 Site Management	05.01 Site Selection
14268	86	\N	\N	D5170C00002	2719	2718	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
14269	86	\N	\N	D5170C00002	2720	2718	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
14270	86	\N	\N	D5170C00002	2721	2718	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
14271	86	\N	\N	D5170C00002	2722	2717	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
14272	86	\N	\N	D5170C00002	2723	2722	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
14273	86	\N	\N	D5170C00002	2724	2722	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
14274	86	\N	\N	D5170C00002	2725	2722	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
14275	86	\N	\N	D5170C00002	2726	2722	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
14276	86	\N	\N	D5170C00002	2727	2722	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Site Qualification
14277	86	\N	\N	D5170C00002	2728	2722	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
14278	86	\N	\N	D5170C00002	2729	2722	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
14279	86	\N	\N	D5170C00002	2730	2722	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Investigator Regulatory Agreement
14280	86	\N	\N	D5170C00002	2731	2722	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
14281	86	\N	\N	D5170C00002	2732	2722	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
14282	86	\N	\N	D5170C00002	2733	2722	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
14283	86	\N	\N	D5170C00002	2734	2717	NEW	\N	05 Site Management	05.03 Site Initiation
14284	86	\N	\N	D5170C00002	2735	2734	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
14285	86	\N	\N	D5170C00002	2736	2734	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
14286	86	\N	\N	D5170C00002	2737	2717	NEW	\N	05 Site Management	05.04 Site Management
14287	86	\N	\N	D5170C00002	2738	2737	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
14288	86	\N	\N	D5170C00002	2739	2717	NEW	\N	05 Site Management	05.05 General
14289	86	\N	\N	D5170C00002	2740	2739	NEW	\N	05.05 General	05.05.02 Tracking Information
14290	86	\N	\N	D5170C00002	2741	2706	NEW	\N	2002677 Herring, Robert	06 IP and Trial Supplies
14291	86	\N	\N	D5170C00002	2742	2741	NEW	\N	06 IP and Trial Supplies	06.04 Storage
14292	86	\N	\N	D5170C00002	2743	2742	NEW	\N	06.04 Storage	06.04.03 Maintenance Logs
14293	86	\N	\N	D5170C00002	2744	6	NEW	\N	Site	2002678 Vincent, Jennifer
14294	86	\N	\N	D5170C00002	2745	2744	NEW	\N	2002678 Vincent, Jennifer	02 Central Trial Documents
14295	86	\N	\N	D5170C00002	2746	2745	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
14296	86	\N	\N	D5170C00002	2747	2746	NEW	\N	02.02 Subject Documents	02.02.03 Informed Consent Form Templates
14297	86	\N	\N	D5170C00002	2748	2746	NEW	\N	02.02 Subject Documents	02.02.06 Adver_ject Recruitment
14298	86	\N	\N	D5170C00002	2749	2746	NEW	\N	02.02 Subject Documents	02.02.07 Other_iven to Subjects
14299	86	\N	\N	D5170C00002	2750	2745	NEW	\N	02 Central Trial Documents	02.04 General
14300	86	\N	\N	D5170C00002	2751	2750	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
16149	88	1617051460559:2040566660	1617051459985:-355373043	D5170C00001	1839	1838	ALREADY AVAILABLE	2021-03-30 07:19:37.32	Poland	5701
16197	88	1617051498893:-432490523	1617051459985:-355373043	D5170C00001	1887	1838	ALREADY AVAILABLE	2021-03-30 07:19:37.32	Poland	5702
14305	87	1616511588396:1424696994	1616511587687:131730181	123456789	5	4	ALREADY AVAILABLE	2021-03-24 08:54:40.237	folder 4	folder 5
14310	87	1616572482143:-898480514	1616511590817:-1363343296	123456789	10	9	CREATE	2021-03-24 08:54:42.255	folder 9	folder 10
14301	87	1616511585300:1528111882	rootNode	123456789	1	0	ALREADY AVAILABLE	2021-03-24 08:54:40.237		folder 1
14302	87	1616511586067:1968930110	1616511585300:1528111882	123456789	2	1	ALREADY AVAILABLE	2021-03-24 08:54:40.237	folder 1	folder 2
14303	87	1616511587082:-1657200326	1616511586067:1968930110	123456789	3	2	ALREADY AVAILABLE	2021-03-24 08:54:40.237	folder 2	folder 3
14304	87	1616511587687:131730181	1616511587082:-1657200326	123456789	4	3	ALREADY AVAILABLE	2021-03-24 08:54:40.237	folder 3	folder 4
14306	87	1616511589018:1576393203	1616511588396:1424696994	123456789	6	5	ALREADY AVAILABLE	2021-03-24 08:54:40.237	folder 5	folder 6
14307	87	1616511589625:286791388	1616511589018:1576393203	123456789	7	6	ALREADY AVAILABLE	2021-03-24 08:54:40.237	folder 6	folder 7
14308	87	1616511590221:923961195	1616511589625:286791388	123456789	8	7	ALREADY AVAILABLE	2021-03-24 08:54:40.238	folder 7	folder 8
14309	87	1616511590817:-1363343296	1616511590221:923961195	123456789	9	8	ALREADY AVAILABLE	2021-03-24 08:54:40.238	folder 8	folder 9
16201	88	1617051507100:374680563	1617051459985:-355373043	D5170C00001	1891	1838	ALREADY AVAILABLE	2021-03-30 07:19:37.32	Poland	5703
16237	88	1617051537945:1496073049	1617051459985:-355373043	D5170C00001	1927	1838	ALREADY AVAILABLE	2021-03-30 07:19:37.32	Poland	5704
16280	88	1617051570075:-895125672	1617051459985:-355373043	D5170C00001	1970	1838	ALREADY AVAILABLE	2021-03-30 07:19:37.32	Poland	5705
16339	88	1617051616486:-1950569652	1617051459985:-355373043	D5170C00001	2029	1838	ALREADY AVAILABLE	2021-03-30 07:19:37.32	Poland	5707
16343	88	1617051619941:-1439714764	1617051459985:-355373043	D5170C00001	2033	1838	ALREADY AVAILABLE	2021-03-30 07:19:37.32	Poland	5708
16348	88	1617051622858:-848511232	1617051622299:1003976290	D5170C00001	2038	2037	ALREADY AVAILABLE	2021-03-30 07:19:37.32	Spain	7001
16476	88	1617051733842:-2020942965	1617051622299:1003976290	D5170C00001	2166	2037	ALREADY AVAILABLE	2021-03-30 07:19:37.32	Spain	7003
16541	88	1617051781196:-410329106	1617051622299:1003976290	D5170C00001	2231	2037	ALREADY AVAILABLE	2021-03-30 07:19:37.32	Spain	7004
16603	88	1617051828718:514201048	1617051622299:1003976290	D5170C00001	2293	2037	ALREADY AVAILABLE	2021-03-30 07:19:37.32	Spain	7005
16607	88	1617051836208:-1467894886	1617051622299:1003976290	D5170C00001	2297	2037	ALREADY AVAILABLE	2021-03-30 07:19:37.32	Spain	7006
16676	88	1617051895119:-661583129	1617051622299:1003976290	D5170C00001	2366	2037	ALREADY AVAILABLE	2021-03-30 07:19:37.32	Spain	7007
16727	88	1617051939091:952255866	1617051622299:1003976290	D5170C00001	2417	2037	ALREADY AVAILABLE	2021-03-30 07:19:37.32	Spain	7008
16773	88	1617051980881:-120376759	1617051980305:1976405238	D5170C00001	2463	2462	ALREADY AVAILABLE	2021-03-30 07:19:37.32	United States of America	7801
16831	88	1617052027253:1001206689	1617051980305:1976405238	D5170C00001	2521	2462	ALREADY AVAILABLE	2021-03-30 07:19:37.32	United States of America	7802
16879	88	1617052074281:-90943670	1617051980305:1976405238	D5170C00001	2569	2462	ALREADY AVAILABLE	2021-03-30 07:19:37.32	United States of America	7804
16922	88	1617052111853:830308303	1617051980305:1976405238	D5170C00001	2612	2462	ALREADY AVAILABLE	2021-03-30 07:19:37.32	United States of America	7805
16968	88	1617052144915:-1558768618	1617051980305:1976405238	D5170C00001	2658	2462	ALREADY AVAILABLE	2021-03-30 07:19:37.32	United States of America	7806
16974	88	1617052155871:-637654562	1617051980305:1976405238	D5170C00001	2664	2462	ALREADY AVAILABLE	2021-03-30 07:19:37.32	United States of America	7807
17024	88	1617052197208:1678537417	1617051980305:1976405238	D5170C00001	2714	2462	ALREADY AVAILABLE	2021-03-30 07:19:37.32	United States of America	7808
17070	88	1617052234097:-1810160558	1617051980305:1976405238	D5170C00001	2760	2462	ALREADY AVAILABLE	2021-03-30 07:19:37.32	United States of America	7809
17125	88	1617052296101:1068428102	1617051980305:1976405238	D5170C00001	2815	2462	ALREADY AVAILABLE	2021-03-30 07:19:37.32	United States of America	7810
17173	88	1617052335404:780821450	1617051980305:1976405238	D5170C00001	2863	2462	ALREADY AVAILABLE	2021-03-30 07:19:37.32	United States of America	7813
17213	88	1617052368447:-1900328069	1617051980305:1976405238	D5170C00001	2903	2462	ALREADY AVAILABLE	2021-03-30 07:19:37.321	United States of America	7814
17254	88	1617052398111:-486756895	1617051980305:1976405238	D5170C00001	2944	2462	ALREADY AVAILABLE	2021-03-30 07:19:37.321	United States of America	7815
17258	88	1617052406953:434219244	1617051980305:1976405238	D5170C00001	2948	2462	ALREADY AVAILABLE	2021-03-30 07:19:37.321	United States of America	7816
17303	88	1617052436931:-1544354502	1617051980305:1976405238	D5170C00001	2993	2462	ALREADY AVAILABLE	2021-03-30 07:19:37.321	United States of America	7817
17341	88	1617052474834:-1033595095	1617051980305:1976405238	D5170C00001	3031	2462	ALREADY AVAILABLE	2021-03-30 07:19:37.321	United States of America	7818
17386	88	1617052508239:872433197	1617051980305:1976405238	D5170C00001	3076	2462	ALREADY AVAILABLE	2021-03-30 07:19:37.321	United States of America	7819
14353	88	1617049811589:2092292068	1617049809621:1949893672	D5170C00001	43	42	ALREADY AVAILABLE	2021-03-30 07:19:37.321	IP and Trial Supplies	General
14358	88	1617049814651:-719237161	1617049812776:504308022	D5170C00001	48	45	ALREADY AVAILABLE	2021-03-30 07:19:37.321	IRB or IEC and other Approvals	IRB or IEC Trial Approval
14372	88	1617049831710:-29400867	1617049820221:-1421706041	D5170C00001	62	57	ALREADY AVAILABLE	2021-03-30 07:19:37.322	Site Management	Site Management
14374	88	1617049834186:-586533418	1617049820221:-1421706041	D5170C00001	64	57	ALREADY AVAILABLE	2021-03-30 07:19:37.322	Site Management	Site Selection
14397	88	1617049865285:-949512337	1617049864704:-1654436179	D5170C00001	87	86	ALREADY AVAILABLE	2021-03-30 07:19:37.322	Central Trial Documents	General
14403	88	1617049870019:245753741	1617049864704:-1654436179	D5170C00001	93	86	ALREADY AVAILABLE	2021-03-30 07:19:37.322	Central Trial Documents	Subject Documentation
14421	88	1617049882644:215896033	1617049878901:1691951506	D5170C00001	111	105	ALREADY AVAILABLE	2021-03-30 07:19:37.323	IRB or IEC and other Approvals	Trial Status Reporting
14425	88	1617049885217:-607421981	1617049884622:-632679904	D5170C00001	115	114	ALREADY AVAILABLE	2021-03-30 07:19:37.323	Regulatory	General
14428	88	1617049887081:1855593420	1617049884622:-632679904	D5170C00001	118	114	ALREADY AVAILABLE	2021-03-30 07:19:37.323	Regulatory	Trial Approval
14449	88	1617049907247:-1928664089	1617049904841:1897140590	D5170C00001	139	135	ALREADY AVAILABLE	2021-03-30 07:19:37.323	Trial Management	Meetings
14452	88	1617049909235:1256286141	1617049904841:1897140590	D5170C00001	142	135	ALREADY AVAILABLE	2021-03-30 07:19:37.323	Trial Management	Trial Oversight
14459	88	1617049914415:1966474462	1617049913771:-1842981418	D5170C00001	149	148	ALREADY AVAILABLE	2021-03-30 07:19:37.323	Central Trial Documents	General
14461	88	1617049915594:-679394982	1617049913771:-1842981418	D5170C00001	151	148	ALREADY AVAILABLE	2021-03-30 07:19:37.323	Central Trial Documents	Product and Trial Documentation
14463	88	1617049917006:-1738035494	1617049913771:-1842981418	D5170C00001	153	148	ALREADY AVAILABLE	2021-03-30 07:19:37.323	Central Trial Documents	Subject Documentation
14469	88	1617049920673:-1246644968	1617049920071:1274410035	D5170C00001	159	158	ALREADY AVAILABLE	2021-03-30 07:19:37.323	IRB or IEC and other Approvals	General
14471	88	1617049923071:-1975640652	1617049920071:1274410035	D5170C00001	161	158	ALREADY AVAILABLE	2021-03-30 07:19:37.323	IRB or IEC and other Approvals	IRB or IEC Trial Approval
14474	88	1617049924900:1667312597	1617049920071:1274410035	D5170C00001	164	158	ALREADY AVAILABLE	2021-03-30 07:19:37.324	IRB or IEC and other Approvals	Trial Status Reporting
14478	88	1617049927269:2007966018	1617049926694:-247839502	D5170C00001	168	167	ALREADY AVAILABLE	2021-03-30 07:19:37.324	Regulatory	General
14480	88	1617049928470:2018761972	1617049926694:-247839502	D5170C00001	170	167	ALREADY AVAILABLE	2021-03-30 07:19:37.324	Regulatory	Investigational Medicinal Product
14483	88	1617049930557:1774117388	1617049929835:-1845968552	D5170C00001	173	172	ALREADY AVAILABLE	2021-03-30 07:19:37.324	Site Management	General
14485	88	1617049931776:1572682713	1617049929835:-1845968552	D5170C00001	175	172	ALREADY AVAILABLE	2021-03-30 07:19:37.324	Site Management	Site Selection
14487	88	1617049937670:1247310542	1617049929835:-1845968552	D5170C00001	177	172	ALREADY AVAILABLE	2021-03-30 07:19:37.324	Site Management	Site Set-up
14491	88	1617049940120:1191110238	1617049939516:-1834757542	D5170C00001	181	180	ALREADY AVAILABLE	2021-03-30 07:19:37.324	Trial Management	General
14494	88	1617049941923:-944906594	1617049939516:-1834757542	D5170C00001	184	180	ALREADY AVAILABLE	2021-03-30 07:19:37.324	Trial Management	Meetings
14497	88	1617049944862:-1647719884	1617049939516:-1834757542	D5170C00001	187	180	ALREADY AVAILABLE	2021-03-30 07:19:37.324	Trial Management	Trial Oversight
14504	88	1617049949297:632083578	1617049948426:-1605761680	D5170C00001	194	193	ALREADY AVAILABLE	2021-03-30 07:19:37.324	Central Trial Documents	General
14507	88	1617049951131:-1311878460	1617049948426:-1605761680	D5170C00001	197	193	ALREADY AVAILABLE	2021-03-30 07:19:37.324	Central Trial Documents	Product and Trial Documentation
14509	88	1617049952578:1024957174	1617049948426:-1605761680	D5170C00001	199	193	ALREADY AVAILABLE	2021-03-30 07:19:37.324	Central Trial Documents	Subject Documentation
14516	88	1617049958868:-509134877	1617049958230:2116406684	D5170C00001	206	205	ALREADY AVAILABLE	2021-03-30 07:19:37.324	IRB or IEC and other Approvals	IRB or IEC Trial Approval
14519	88	1617049960864:1629454830	1617049958230:2116406684	D5170C00001	209	205	ALREADY AVAILABLE	2021-03-30 07:19:37.324	IRB or IEC and other Approvals	Trial Status Reporting
14522	88	1617049962684:-617016717	1617049962100:396573403	D5170C00001	212	211	ALREADY AVAILABLE	2021-03-30 07:19:37.324	Regulatory	General
14525	88	1617049964566:833975561	1617049962100:396573403	D5170C00001	215	211	ALREADY AVAILABLE	2021-03-30 07:19:37.324	Regulatory	Trial Approval
14527	88	1617049967232:792566697	1617049962100:396573403	D5170C00001	217	211	ALREADY AVAILABLE	2021-03-30 07:19:37.324	Regulatory	Trial Status Reporting
14530	88	1617049969314:1540707118	1617049968468:-709172792	D5170C00001	220	219	ALREADY AVAILABLE	2021-03-30 07:19:37.324	Site Management	Site Selection
14532	88	1617049970504:722983919	1617049968468:-709172792	D5170C00001	222	219	ALREADY AVAILABLE	2021-03-30 07:19:37.325	Site Management	Site Set-up
14536	88	1617049972823:-300097928	1617049972272:-2089920659	D5170C00001	226	225	ALREADY AVAILABLE	2021-03-30 07:19:37.325	Trial Management	General
14539	88	1617049980004:1071776660	1617049972272:-2089920659	D5170C00001	229	225	ALREADY AVAILABLE	2021-03-30 07:19:37.325	Trial Management	Meetings
14572	88	1617050006666:-784742218	1617050006076:1963700365	D5170C00001	262	261	ALREADY AVAILABLE	2021-03-30 07:19:37.325	Safety Reporting	General
8897	84	\N	\N	D5170C00002	2682	2678	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
14578	88	1617050010438:689346162	1617050008582:-1117695304	D5170C00001	268	265	ALREADY AVAILABLE	2021-03-30 07:19:37.325	Site Management	Site Set-up
14581	88	1617050013595:-846737349	1617050012922:-1893538952	D5170C00001	271	270	ALREADY AVAILABLE	2021-03-30 07:19:37.325	Trial Management	General
14583	88	1617050014859:610189010	1617050012922:-1893538952	D5170C00001	273	270	ALREADY AVAILABLE	2021-03-30 07:19:37.325	Trial Management	Meetings
14585	88	1617050016194:-584943481	1617050012922:-1893538952	D5170C00001	275	270	ALREADY AVAILABLE	2021-03-30 07:19:37.325	Trial Management	Trial Oversight
14596	88	1617050031241:1587904752	1617050019842:696592341	D5170C00001	286	281	ALREADY AVAILABLE	2021-03-30 07:19:37.325	Central Trial Documents	Product and Trial Documentation
14606	88	1617050037206:-2021869274	1617050036640:-283389149	D5170C00001	296	295	ALREADY AVAILABLE	2021-03-30 07:19:37.325	IRB or IEC and other Approvals	IRB or IEC Trial Approval
14609	88	1617050039892:-616636994	1617050038332:-1595997436	D5170C00001	299	298	ALREADY AVAILABLE	2021-03-30 07:19:37.325	Regulatory	General
14611	88	1617050041637:2044089459	1617050038332:-1595997436	D5170C00001	301	298	ALREADY AVAILABLE	2021-03-30 07:19:37.325	Regulatory	Trial Approval
14615	88	1617050044086:441716742	1617050043494:693562771	D5170C00001	305	304	ALREADY AVAILABLE	2021-03-30 07:19:37.325	Site Management	General
14617	88	1617050045264:-1660721073	1617050043494:693562771	D5170C00001	307	304	ALREADY AVAILABLE	2021-03-30 07:19:37.325	Site Management	Site Initiation
14619	88	1617050046469:-379793734	1617050043494:693562771	D5170C00001	309	304	ALREADY AVAILABLE	2021-03-30 07:19:37.325	Site Management	Site Set-up
14625	88	1617050055025:-41458515	1617050048274:704794999	D5170C00001	315	312	ALREADY AVAILABLE	2021-03-30 07:19:37.325	Trial Management	Trial Oversight
14632	88	1617050059679:1952071395	1617050058982:436847938	D5170C00001	322	321	ALREADY AVAILABLE	2021-03-30 07:19:37.325	Central Trial Documents	General
14636	88	1617050063206:-399030765	1617050058982:436847938	D5170C00001	326	321	ALREADY AVAILABLE	2021-03-30 07:19:37.326	Central Trial Documents	Product and Trial Documentation
14638	88	1617050064713:-1752417343	1617050058982:436847938	D5170C00001	328	321	ALREADY AVAILABLE	2021-03-30 07:19:37.326	Central Trial Documents	Subject Documentation
14644	88	1617050068364:-524072122	1617050067736:933811541	D5170C00001	334	333	ALREADY AVAILABLE	2021-03-30 07:19:37.326	IP and Trial Supplies	General
14647	88	1617050070204:-1562773554	1617050069542:-426520767	D5170C00001	337	336	ALREADY AVAILABLE	2021-03-30 07:19:37.326	IRB or IEC and other Approvals	IRB or IEC Trial Approval
14650	88	1617050073281:1475370957	1617050069542:-426520767	D5170C00001	340	336	ALREADY AVAILABLE	2021-03-30 07:19:37.326	IRB or IEC and other Approvals	Trial Status Reporting
14653	88	1617050075145:-1568961585	1617050074483:1656198566	D5170C00001	343	342	ALREADY AVAILABLE	2021-03-30 07:19:37.326	Regulatory	General
14656	88	1617050076899:2072348370	1617050076340:845134783	D5170C00001	346	345	ALREADY AVAILABLE	2021-03-30 07:19:37.326	Site Management	General
14658	88	1617050078211:-720140916	1617050076340:845134783	D5170C00001	348	345	ALREADY AVAILABLE	2021-03-30 07:19:37.326	Site Management	Site Initiation
14660	88	1617050079550:1952755909	1617050076340:845134783	D5170C00001	350	345	ALREADY AVAILABLE	2021-03-30 07:19:37.326	Site Management	Site Set-up
14667	88	1617050085081:-756019195	1617050084444:561652772	D5170C00001	357	356	ALREADY AVAILABLE	2021-03-30 07:19:37.326	Trial Management	General
14671	88	1617050093283:503280984	1617050084444:561652772	D5170C00001	361	356	ALREADY AVAILABLE	2021-03-30 07:19:37.326	Trial Management	Meetings
14673	88	1617050095551:-199521697	1617050084444:561652772	D5170C00001	363	356	ALREADY AVAILABLE	2021-03-30 07:19:37.326	Trial Management	Trial Oversight
14686	88	1617050103459:1438998616	1617050099210:955631137	D5170C00001	376	369	ALREADY AVAILABLE	2021-03-30 07:19:37.326	Central Trial Documents	Subject Documentation
8853	84	\N	\N	D5170C00002	2638	2636	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
8854	84	\N	\N	D5170C00002	2639	2631	NEW	\N	2002045 Andriulli, Angelo	04 IRB-IEC and other Approvals
14693	88	1617050109066:-952572892	1617050108375:1157838065	D5170C00001	383	382	ALREADY AVAILABLE	2021-03-30 07:19:37.326	IP and Trial Supplies	General
14695	88	1617050110306:-1230492811	1617050108375:1157838065	D5170C00001	385	382	ALREADY AVAILABLE	2021-03-30 07:19:37.326	IP and Trial Supplies	IP Documentation
14698	88	1617050118042:288436627	1617050111601:-202515461	D5170C00001	388	387	ALREADY AVAILABLE	2021-03-30 07:19:37.327	IRB or IEC and other Approvals	General
14705	88	1617050122435:-1961205912	1617050111601:-202515461	D5170C00001	395	387	ALREADY AVAILABLE	2021-03-30 07:19:37.327	IRB or IEC and other Approvals	Other Committees
14718	88	1617050132250:1119209526	1617050131693:777650986	D5170C00001	408	407	ALREADY AVAILABLE	2021-03-30 07:19:37.327	Site Management	General
14723	88	1617050135480:103191916	1617050131693:777650986	D5170C00001	413	407	ALREADY AVAILABLE	2021-03-30 07:19:37.327	Site Management	Site Set-up
14728	88	1617050138890:-446708846	1617050138174:588116770	D5170C00001	418	417	ALREADY AVAILABLE	2021-03-30 07:19:37.327	Trial Management	General
14757	88	1617050165512:856853127	1617050164909:258256819	D5170C00001	447	446	ALREADY AVAILABLE	2021-03-30 07:19:37.327	Regulatory	Trial Approval
14759	88	1617050166769:1223687721	1617050164909:258256819	D5170C00001	449	446	ALREADY AVAILABLE	2021-03-30 07:19:37.327	Regulatory	Trial Status Reporting
14762	88	1617050168767:-1382863374	1617050168065:-847521203	D5170C00001	452	451	ALREADY AVAILABLE	2021-03-30 07:19:37.327	Site Management	General
14765	88	1617050170621:-1500179870	1617050168065:-847521203	D5170C00001	455	451	ALREADY AVAILABLE	2021-03-30 07:19:37.327	Site Management	Site Selection
14769	88	1617050174612:2014445176	1617050172551:-1515127504	D5170C00001	459	458	ALREADY AVAILABLE	2021-03-30 07:19:37.327	Third Parties	Third Party Set-up
14773	88	1617050177152:1601897760	1617050176477:-1705672544	D5170C00001	463	462	ALREADY AVAILABLE	2021-03-30 07:19:37.327	Trial Management	General
14783	88	1617050183385:1344982314	1617050182770:-212915113	D5170C00001	473	472	ALREADY AVAILABLE	2021-03-30 07:19:37.327	1001, 1002, 1006, 1007, 1011, 1016	Site Management
14815	88	1617050220998:959732678	1617050191494:-1593718706	D5170C00001	505	476	ALREADY AVAILABLE	2021-03-30 07:19:37.327	1001	Safety Reporting
14818	88	1617050222793:-1515687263	1617050191494:-1593718706	D5170C00001	508	476	ALREADY AVAILABLE	2021-03-30 07:19:37.327	1001	Site Management
14842	88	1617050244270:1889864730	1617050191494:-1593718706	D5170C00001	532	476	ALREADY AVAILABLE	2021-03-30 07:19:37.327	1001	Trial Management
14846	88	1617050246923:-341419747	1617050246297:-889170302	D5170C00001	536	535	ALREADY AVAILABLE	2021-03-30 07:19:37.327	1002, 1003, 1006, 1010	Central Trial Documents
14850	88	1617050249401:-1315940313	1617050248804:838258556	D5170C00001	540	539	ALREADY AVAILABLE	2021-03-30 07:19:37.328	1002	Central and Local Testing
14853	88	1617050251421:1843977330	1617050248804:838258556	D5170C00001	543	539	ALREADY AVAILABLE	2021-03-30 07:19:37.328	1002	Central Trial Documents
14856	88	1617050254588:-738412591	1617050248804:838258556	D5170C00001	546	539	ALREADY AVAILABLE	2021-03-30 07:19:37.328	1002	Data Management
14859	88	1617050256531:1966157500	1617050248804:838258556	D5170C00001	549	539	ALREADY AVAILABLE	2021-03-30 07:19:37.328	1002	IP and Trial Supplies
14864	88	1617050259524:402852076	1617050248804:838258556	D5170C00001	554	539	ALREADY AVAILABLE	2021-03-30 07:19:37.328	1002	IRB or IEC and other Approvals
14869	88	1617050262674:662880042	1617050248804:838258556	D5170C00001	559	539	ALREADY AVAILABLE	2021-03-30 07:19:37.328	1002	Safety Reporting
14872	88	1617050268885:1872176242	1617050248804:838258556	D5170C00001	562	539	ALREADY AVAILABLE	2021-03-30 07:19:37.328	1002	Site Management
14895	88	1617050284810:-1027482747	1617050284193:-2043116348	D5170C00001	585	584	ALREADY AVAILABLE	2021-03-30 07:19:37.328	1003	Site Management
14899	88	1617050292850:1678689241	1617050292282:-1037937158	D5170C00001	589	588	ALREADY AVAILABLE	2021-03-30 07:19:37.328	1004	Site Management
14903	88	1617050295416:147132828	1617050294808:783803211	D5170C00001	593	592	ALREADY AVAILABLE	2021-03-30 07:19:37.328	1005	Central Trial Documents
14906	88	1617050297345:-1825080201	1617050294808:783803211	D5170C00001	596	592	ALREADY AVAILABLE	2021-03-30 07:19:37.328	1005	Data Management
14909	88	1617050300673:-138972896	1617050294808:783803211	D5170C00001	599	592	ALREADY AVAILABLE	2021-03-30 07:19:37.328	1005	IP and Trial Supplies
14914	88	1617050304469:-1294003035	1617050294808:783803211	D5170C00001	604	592	ALREADY AVAILABLE	2021-03-30 07:19:37.328	1005	IRB or IEC and other Approvals
14923	88	1617050314587:-1033953851	1617050294808:783803211	D5170C00001	613	592	ALREADY AVAILABLE	2021-03-30 07:19:37.328	1005	Safety Reporting
14926	88	1617050316365:377275783	1617050294808:783803211	D5170C00001	616	592	ALREADY AVAILABLE	2021-03-30 07:19:37.328	1005	Site Management
14950	88	1617050338275:426524344	1617050337587:1587186884	D5170C00001	640	639	ALREADY AVAILABLE	2021-03-30 07:19:37.328	1006	Central and Local Testing
14953	88	1617050340141:108057088	1617050337587:1587186884	D5170C00001	643	639	ALREADY AVAILABLE	2021-03-30 07:19:37.329	1006	Central Trial Documents
14958	88	1617050344730:-1196528987	1617050337587:1587186884	D5170C00001	648	639	ALREADY AVAILABLE	2021-03-30 07:19:37.329	1006	IP and Trial Supplies
14964	88	1617050353989:-1857945627	1617050337587:1587186884	D5170C00001	654	639	ALREADY AVAILABLE	2021-03-30 07:19:37.329	1006	IRB or IEC and other Approvals
14973	88	1617050361333:1327386498	1617050337587:1587186884	D5170C00001	663	639	ALREADY AVAILABLE	2021-03-30 07:19:37.329	1006	Regulatory
14976	88	1617050363344:-680259090	1617050337587:1587186884	D5170C00001	666	639	ALREADY AVAILABLE	2021-03-30 07:19:37.329	1006	Site Management
14999	88	1617050387132:-222193713	1617050386532:-683947474	D5170C00001	689	688	ALREADY AVAILABLE	2021-03-30 07:19:37.329	1007	Central Trial Documents
15004	88	1617050396747:1692295878	1617050386532:-683947474	D5170C00001	694	688	ALREADY AVAILABLE	2021-03-30 07:19:37.329	1007	Data Management
15013	88	1617050410716:-1461396142	1617050386532:-683947474	D5170C00001	703	688	ALREADY AVAILABLE	2021-03-30 07:19:37.329	1007	IRB or IEC and other Approvals
15021	88	1617050424754:793235850	1617050386532:-683947474	D5170C00001	711	688	ALREADY AVAILABLE	2021-03-30 07:19:37.329	1007	Site Management
15052	88	1617050452446:1129717580	1617050451849:1532848238	D5170C00001	742	741	ALREADY AVAILABLE	2021-03-30 07:19:37.329	1009	Site Management
15056	88	1617050454755:-359275543	1617050454157:318201465	D5170C00001	746	745	ALREADY AVAILABLE	2021-03-30 07:19:37.329	1010	Central and Local Testing
15061	88	1617050457712:-592563720	1617050454157:318201465	D5170C00001	751	745	ALREADY AVAILABLE	2021-03-30 07:19:37.329	1010	Central Trial Documents
15064	88	1617050466805:1321936480	1617050454157:318201465	D5170C00001	754	745	ALREADY AVAILABLE	2021-03-30 07:19:37.329	1010	Data Management
15067	88	1617050468677:-878648226	1617050454157:318201465	D5170C00001	757	745	ALREADY AVAILABLE	2021-03-30 07:19:37.329	1010	IP and Trial Supplies
15075	88	1617050474720:-2033667756	1617050454157:318201465	D5170C00001	765	745	ALREADY AVAILABLE	2021-03-30 07:19:37.329	1010	IRB or IEC and other Approvals
15082	88	1617050479111:2027851924	1617050454157:318201465	D5170C00001	772	745	ALREADY AVAILABLE	2021-03-30 07:19:37.329	1010	Safety Reporting
15085	88	1617050481011:-855896347	1617050454157:318201465	D5170C00001	775	745	ALREADY AVAILABLE	2021-03-30 07:19:37.329	1010	Site Management
15107	88	1617050502162:-1333832447	1617050454157:318201465	D5170C00001	797	745	ALREADY AVAILABLE	2021-03-30 07:19:37.329	1010	Trial Management
15111	88	1617050505235:-560829044	1617050503960:1241532802	D5170C00001	801	800	ALREADY AVAILABLE	2021-03-30 07:19:37.329	1011	Central and Local Testing
15114	88	1617050508488:-1287592803	1617050503960:1241532802	D5170C00001	804	800	ALREADY AVAILABLE	2021-03-30 07:19:37.329	1011	Central Trial Documents
15117	88	1617050510246:626907397	1617050503960:1241532802	D5170C00001	807	800	ALREADY AVAILABLE	2021-03-30 07:19:37.33	1011	Data Management
15120	88	1617050512108:1821544221	1617050503960:1241532802	D5170C00001	810	800	ALREADY AVAILABLE	2021-03-30 07:19:37.33	1011	IP and Trial Supplies
15130	88	1617050519626:1358729789	1617050503960:1241532802	D5170C00001	820	800	ALREADY AVAILABLE	2021-03-30 07:19:37.33	1011	IRB or IEC and other Approvals
15139	88	1617050534119:1220184778	1617050503960:1241532802	D5170C00001	829	800	ALREADY AVAILABLE	2021-03-30 07:19:37.33	1011	Safety Reporting
15142	88	1617050535856:-1463709423	1617050503960:1241532802	D5170C00001	832	800	ALREADY AVAILABLE	2021-03-30 07:19:37.33	1011	Site Management
15171	88	1617050559669:1445364575	1617050558890:67223276	D5170C00001	861	860	ALREADY AVAILABLE	2021-03-30 07:19:37.33	1013	Site Management
15175	88	1617050567816:1510033362	1617050567026:1680584866	D5170C00001	865	864	ALREADY AVAILABLE	2021-03-30 07:19:37.33	1014	Site Management
15179	88	1617050570244:-448758501	1617050569625:-794594117	D5170C00001	869	868	ALREADY AVAILABLE	2021-03-30 07:19:37.33	1015	Site Management
15183	88	1617050573081:-1674932892	1617050572356:212547738	D5170C00001	873	872	ALREADY AVAILABLE	2021-03-30 07:19:37.33	1016	Central and Local Testing
15186	88	1617050576997:1486947416	1617050572356:212547738	D5170C00001	876	872	ALREADY AVAILABLE	2021-03-30 07:19:37.33	1016	Central Trial Documents
15191	88	1617050580357:-1093437404	1617050572356:212547738	D5170C00001	881	872	ALREADY AVAILABLE	2021-03-30 07:19:37.33	1016	Data Management
15194	88	1617050582514:707376719	1617050572356:212547738	D5170C00001	884	872	ALREADY AVAILABLE	2021-03-30 07:19:37.33	1016	IP and Trial Supplies
15201	88	1617050595422:654078825	1617050572356:212547738	D5170C00001	891	872	ALREADY AVAILABLE	2021-03-30 07:19:37.33	1016	IRB or IEC and other Approvals
15207	88	1617050600754:712194575	1617050572356:212547738	D5170C00001	897	872	ALREADY AVAILABLE	2021-03-30 07:19:37.33	1016	Safety Reporting
15210	88	1617050602815:1223614789	1617050572356:212547738	D5170C00001	900	872	ALREADY AVAILABLE	2021-03-30 07:19:37.33	1016	Site Management
15230	88	1617050625502:1235939744	1617050572356:212547738	D5170C00001	920	872	ALREADY AVAILABLE	2021-03-30 07:19:37.33	1016	Trial Management
15235	88	1617050630036:1972484496	1617050629316:-980367197	D5170C00001	925	924	ALREADY AVAILABLE	2021-03-30 07:19:37.33	1901	Data Management
15238	88	1617050632004:-228110819	1617050629316:-980367197	D5170C00001	928	924	ALREADY AVAILABLE	2021-03-30 07:19:37.33	1901	IP and Trial Supplies
15249	88	1617050641824:-1587562580	1617050629316:-980367197	D5170C00001	939	924	ALREADY AVAILABLE	2021-03-30 07:19:37.33	1901	IRB or IEC and other Approvals
15258	88	1617050653361:-728263127	1617050629316:-980367197	D5170C00001	948	924	ALREADY AVAILABLE	2021-03-30 07:19:37.33	1901	Site Management
15282	88	1617050670849:-2009750966	1617050667990:-173100630	D5170C00001	972	968	ALREADY AVAILABLE	2021-03-30 07:19:37.33	1902	IP and Trial Supplies
15296	88	1617050687375:1785042804	1617050667990:-173100630	D5170C00001	986	968	ALREADY AVAILABLE	2021-03-30 07:19:37.33	1902	Site Management
15315	88	1617050710016:843282234	1617050709337:1440483749	D5170C00001	1005	1004	ALREADY AVAILABLE	2021-03-30 07:19:37.33	1903	Central Trial Documents
15318	88	1617050712046:1857909360	1617050709337:1440483749	D5170C00001	1008	1004	ALREADY AVAILABLE	2021-03-30 07:19:37.331	1903	Data Management
15321	88	1617050714212:150895717	1617050709337:1440483749	D5170C00001	1011	1004	ALREADY AVAILABLE	2021-03-30 07:19:37.331	1903	IP and Trial Supplies
15332	88	1617050723574:-395930804	1617050709337:1440483749	D5170C00001	1022	1004	ALREADY AVAILABLE	2021-03-30 07:19:37.331	1903	IRB or IEC and other Approvals
15341	88	1617050729850:350475970	1617050709337:1440483749	D5170C00001	1031	1004	ALREADY AVAILABLE	2021-03-30 07:19:37.331	1903	Site Management
15360	88	1617050753016:841413619	1617050752425:-1641031668	D5170C00001	1050	1049	ALREADY AVAILABLE	2021-03-30 07:19:37.331	1904	Site Management
15364	88	1617050757628:2044852040	1617050757043:-227566584	D5170C00001	1054	1053	ALREADY AVAILABLE	2021-03-30 07:19:37.331	1905	Central Trial Documents
15367	88	1617050759635:-535734351	1617050757043:-227566584	D5170C00001	1057	1053	ALREADY AVAILABLE	2021-03-30 07:19:37.331	1905	Data Management
15370	88	1617050761850:1758735707	1617050757043:-227566584	D5170C00001	1060	1053	ALREADY AVAILABLE	2021-03-30 07:19:37.331	1905	IP and Trial Supplies
15381	88	1617050775453:605540925	1617050757043:-227566584	D5170C00001	1071	1053	ALREADY AVAILABLE	2021-03-30 07:19:37.331	1905	IRB or IEC and other Approvals
15390	88	1617050788902:-1730293684	1617050757043:-227566584	D5170C00001	1080	1053	ALREADY AVAILABLE	2021-03-30 07:19:37.331	1905	Site Management
15420	88	1617050816912:1583696798	1617050813994:-966217426	D5170C00001	1110	1106	ALREADY AVAILABLE	2021-03-30 07:19:37.331	2301	IP and Trial Supplies
15434	88	1617050827407:978394460	1617050813994:-966217426	D5170C00001	1124	1106	ALREADY AVAILABLE	2021-03-30 07:19:37.331	2301	Safety Reporting
15437	88	1617050829333:1783277051	1617050813994:-966217426	D5170C00001	1127	1106	ALREADY AVAILABLE	2021-03-30 07:19:37.332	2301	Site Management
15457	88	1617050849382:-1265092320	1617050848789:447364357	D5170C00001	1147	1146	ALREADY AVAILABLE	2021-03-30 07:19:37.332	2302	Data Management
15460	88	1617050851258:539084856	1617050848789:447364357	D5170C00001	1150	1146	ALREADY AVAILABLE	2021-03-30 07:19:37.332	2302	IP and Trial Supplies
15472	88	1617050860225:1721896167	1617050848789:447364357	D5170C00001	1162	1146	ALREADY AVAILABLE	2021-03-30 07:19:37.332	2302	Site Management
15492	88	1617050880411:-618614854	1617050879782:1860882486	D5170C00001	1182	1181	ALREADY AVAILABLE	2021-03-30 07:19:37.332	2303	Site Management
15504	88	1617050888318:-156966807	1617050887704:-1310750877	D5170C00001	1194	1193	ALREADY AVAILABLE	2021-03-30 07:19:37.332	2304	Data Management
8856	84	\N	\N	D5170C00002	2641	2640	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
8857	84	\N	\N	D5170C00002	2642	2640	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
15543	88	1617050921240:-718435360	1617050918835:393025711	D5170C00001	1233	1229	ALREADY AVAILABLE	2021-03-30 07:19:37.332	2305	IP and Trial Supplies
15553	88	1617050928710:1665277302	1617050918835:393025711	D5170C00001	1243	1229	ALREADY AVAILABLE	2021-03-30 07:19:37.332	2305	Safety Reporting
15556	88	1617050930395:-318767639	1617050918835:393025711	D5170C00001	1246	1229	ALREADY AVAILABLE	2021-03-30 07:19:37.332	2305	Site Management
15576	88	1617050948680:2001569956	1617050948026:-1563471959	D5170C00001	1266	1265	ALREADY AVAILABLE	2021-03-30 07:19:37.332	2601, 2602	Regulatory
15580	88	1617050951058:291884327	1617050950392:-865869964	D5170C00001	1270	1269	ALREADY AVAILABLE	2021-03-30 07:19:37.332	2601	Regulatory
15583	88	1617050952867:-813893695	1617050950392:-865869964	D5170C00001	1273	1269	ALREADY AVAILABLE	2021-03-30 07:19:37.332	2601	Site Management
15599	88	1617050974852:459003653	1617050964476:-57606151	D5170C00001	1289	1288	ALREADY AVAILABLE	2021-03-30 07:19:37.332	2602	Data Management
15602	88	1617050976877:1948121318	1617050964476:-57606151	D5170C00001	1292	1288	ALREADY AVAILABLE	2021-03-30 07:19:37.332	2602	IP and Trial Supplies
15607	88	1617050979777:-1135891685	1617050964476:-57606151	D5170C00001	1297	1288	ALREADY AVAILABLE	2021-03-30 07:19:37.332	2602	Regulatory
15633	88	1617051002881:-1857730589	1617051000367:-1036916876	D5170C00001	1323	1319	ALREADY AVAILABLE	2021-03-30 07:19:37.332	2604	IP and Trial Supplies
15636	88	1617051004695:1682073843	1617051000367:-1036916876	D5170C00001	1326	1319	ALREADY AVAILABLE	2021-03-30 07:19:37.332	2604	IRB or IEC and other Approvals
15642	88	1617051009046:-1636058232	1617051000367:-1036916876	D5170C00001	1332	1319	ALREADY AVAILABLE	2021-03-30 07:19:37.332	2604	Site Management
15663	88	1617051029400:1934203216	1617051027993:1087214165	D5170C00001	1353	1352	ALREADY AVAILABLE	2021-03-30 07:19:37.332	3301	Data Management
15666	88	1617051031256:140875331	1617051027993:1087214165	D5170C00001	1356	1352	ALREADY AVAILABLE	2021-03-30 07:19:37.332	3301	IP and Trial Supplies
15675	88	1617051036840:-1475887853	1617051027993:1087214165	D5170C00001	1365	1352	ALREADY AVAILABLE	2021-03-30 07:19:37.332	3301	Safety Reporting
15678	88	1617051038795:-359170887	1617051027993:1087214165	D5170C00001	1368	1352	ALREADY AVAILABLE	2021-03-30 07:19:37.332	3301	Site Management
15699	88	1617051053025:502982541	1617051052456:-1794171348	D5170C00001	1389	1388	ALREADY AVAILABLE	2021-03-30 07:19:37.332	3302	IP and Trial Supplies
15707	88	1617051057888:-1000994054	1617051052456:-1794171348	D5170C00001	1397	1388	ALREADY AVAILABLE	2021-03-30 07:19:37.332	3302	Safety Reporting
15710	88	1617051059720:902650262	1617051052456:-1794171348	D5170C00001	1400	1388	ALREADY AVAILABLE	2021-03-30 07:19:37.332	3302	Site Management
15731	88	1617051079795:-1547836721	1617051079236:111814508	D5170C00001	1421	1420	ALREADY AVAILABLE	2021-03-30 07:19:37.332	3303	Data Management
15734	88	1617051081683:1446217372	1617051079236:111814508	D5170C00001	1424	1420	ALREADY AVAILABLE	2021-03-30 07:19:37.332	3303	IP and Trial Supplies
15743	88	1617051088166:27430465	1617051079236:111814508	D5170C00001	1433	1420	ALREADY AVAILABLE	2021-03-30 07:19:37.332	3303	Safety Reporting
15774	88	1617051146697:-2060794445	1617051108777:1327366969	D5170C00001	1464	1456	ALREADY AVAILABLE	2021-03-30 07:19:37.332	3304	Safety Reporting
15777	88	1617051148521:-44352931	1617051108777:1327366969	D5170C00001	1467	1456	ALREADY AVAILABLE	2021-03-30 07:19:37.332	3304	Site Management
15798	88	1617051168992:-1885562869	1617051168428:-1356074094	D5170C00001	1488	1487	ALREADY AVAILABLE	2021-03-30 07:19:37.332	3305	Data Management
15801	88	1617051176367:10854053	1617051168428:-1356074094	D5170C00001	1491	1487	ALREADY AVAILABLE	2021-03-30 07:19:37.332	3305	IP and Trial Supplies
15808	88	1617051180542:-1295188701	1617051168428:-1356074094	D5170C00001	1498	1487	ALREADY AVAILABLE	2021-03-30 07:19:37.332	3305	Safety Reporting
15811	88	1617051182931:608455615	1617051168428:-1356074094	D5170C00001	1501	1487	ALREADY AVAILABLE	2021-03-30 07:19:37.332	3305	Site Management
15833	88	1617051198257:1896236507	1617051197667:-2006859691	D5170C00001	1523	1522	ALREADY AVAILABLE	2021-03-30 07:19:37.332	4101	Central and Local Testing
15836	88	1617051200141:971496471	1617051197667:-2006859691	D5170C00001	1526	1522	ALREADY AVAILABLE	2021-03-30 07:19:37.332	4101	Central Trial Documents
15843	88	1617051210063:-1701244794	1617051197667:-2006859691	D5170C00001	1533	1522	ALREADY AVAILABLE	2021-03-30 07:19:37.332	4101	Data Management
15846	88	1617051211925:883377633	1617051197667:-2006859691	D5170C00001	1536	1522	ALREADY AVAILABLE	2021-03-30 07:19:37.333	4101	IP and Trial Supplies
15861	88	1617051222038:1690238521	1617051197667:-2006859691	D5170C00001	1551	1522	ALREADY AVAILABLE	2021-03-30 07:19:37.333	4101	Site Management
15894	88	1617051244541:338362176	1617051238334:-593288517	D5170C00001	1584	1576	ALREADY AVAILABLE	2021-03-30 07:19:37.333	4102	Data Management
15897	88	1617051254873:-1570001406	1617051238334:-593288517	D5170C00001	1587	1576	ALREADY AVAILABLE	2021-03-30 07:19:37.333	4102	IP and Trial Supplies
15906	88	1617051260612:1771879794	1617051238334:-593288517	D5170C00001	1596	1576	ALREADY AVAILABLE	2021-03-30 07:19:37.333	4102	IRB or IEC and other Approvals
15944	88	1617051288265:-1441080999	1617051282034:330095865	D5170C00001	1634	1626	ALREADY AVAILABLE	2021-03-30 07:19:37.333	4103	Data Management
15947	88	1617051290023:1146692301	1617051282034:330095865	D5170C00001	1637	1626	ALREADY AVAILABLE	2021-03-30 07:19:37.333	4103	IP and Trial Supplies
15956	88	1617051303404:193606205	1617051282034:330095865	D5170C00001	1646	1626	ALREADY AVAILABLE	2021-03-30 07:19:37.333	4103	IRB or IEC and other Approvals
15962	88	1617051309968:1546370631	1617051282034:330095865	D5170C00001	1652	1626	ALREADY AVAILABLE	2021-03-30 07:19:37.333	4103	Site Management
15991	88	1617051332369:1869742645	1617051328560:2039166344	D5170C00001	1681	1677	ALREADY AVAILABLE	2021-03-30 07:19:37.333	4104	Central Trial Documents
16001	88	1617051338492:1288169443	1617051328560:2039166344	D5170C00001	1691	1677	ALREADY AVAILABLE	2021-03-30 07:19:37.334	4104	IP and Trial Supplies
16008	88	1617051350504:335083347	1617051328560:2039166344	D5170C00001	1698	1677	ALREADY AVAILABLE	2021-03-30 07:19:37.334	4104	IRB or IEC and other Approvals
16014	88	1617051354772:688645357	1617051328560:2039166344	D5170C00001	1704	1677	ALREADY AVAILABLE	2021-03-30 07:19:37.334	4104	Safety Reporting
16017	88	1617051356725:1804396904	1617051328560:2039166344	D5170C00001	1707	1677	ALREADY AVAILABLE	2021-03-30 07:19:37.334	4104	Site Management
16045	88	1617051383401:902099672	1617051382807:-1137591166	D5170C00001	1735	1734	ALREADY AVAILABLE	2021-03-30 07:19:37.334	4105	Central and Local Testing
16048	88	1617051385239:175335913	1617051382807:-1137591166	D5170C00001	1738	1734	ALREADY AVAILABLE	2021-03-30 07:19:37.334	4105	Central Trial Documents
16053	88	1617051388251:-1711931435	1617051382807:-1137591166	D5170C00001	1743	1734	ALREADY AVAILABLE	2021-03-30 07:19:37.334	4105	Data Management
16056	88	1617051390063:-110780420	1617051382807:-1137591166	D5170C00001	1746	1734	ALREADY AVAILABLE	2021-03-30 07:19:37.334	4105	IP and Trial Supplies
16063	88	1617051394569:-162242957	1617051382807:-1137591166	D5170C00001	1753	1734	ALREADY AVAILABLE	2021-03-30 07:19:37.334	4105	IRB or IEC and other Approvals
16069	88	1617051399678:1190532078	1617051382807:-1137591166	D5170C00001	1759	1734	ALREADY AVAILABLE	2021-03-30 07:19:37.334	4105	Site Management
16095	88	1617051420418:1160130113	1617051419745:1177635394	D5170C00001	1785	1784	ALREADY AVAILABLE	2021-03-30 07:19:37.334	4106	Site Management
16099	88	1617051422865:-302201633	1617051422295:1689434483	D5170C00001	1789	1788	ALREADY AVAILABLE	2021-03-30 07:19:37.334	4107	Central and Local Testing
16102	88	1617051424711:-1522239403	1617051422295:1689434483	D5170C00001	1792	1788	ALREADY AVAILABLE	2021-03-30 07:19:37.334	4107	Central Trial Documents
16111	88	1617051432103:-1512973130	1617051422295:1689434483	D5170C00001	1801	1788	ALREADY AVAILABLE	2021-03-30 07:19:37.334	4107	IP and Trial Supplies
16124	88	1617051439945:-1113294800	1617051422295:1689434483	D5170C00001	1814	1788	ALREADY AVAILABLE	2021-03-30 07:19:37.335	4107	Site Management
16150	88	1617051461198:-493718346	1617051460559:2040566660	D5170C00001	1840	1839	ALREADY AVAILABLE	2021-03-30 07:19:37.335	5701	Central and Local Testing
16153	88	1617051462939:-727186876	1617051460559:2040566660	D5170C00001	1843	1839	ALREADY AVAILABLE	2021-03-30 07:19:37.335	5701	Central Trial Documents
16157	88	1617051466692:989379483	1617051460559:2040566660	D5170C00001	1847	1839	ALREADY AVAILABLE	2021-03-30 07:19:37.335	5701	Data Management
16160	88	1617051468525:-1211205223	1617051460559:2040566660	D5170C00001	1850	1839	ALREADY AVAILABLE	2021-03-30 07:19:37.335	5701	IP and Trial Supplies
16170	88	1617051480142:-321919943	1617051460559:2040566660	D5170C00001	1860	1839	ALREADY AVAILABLE	2021-03-30 07:19:37.335	5701	Site Management
16198	88	1617051499559:1757789079	1617051498893:-432490523	D5170C00001	1888	1887	ALREADY AVAILABLE	2021-03-30 07:19:37.335	5702	Site Management
16238	88	1617051538521:1136432634	1617051537945:1496073049	D5170C00001	1928	1927	ALREADY AVAILABLE	2021-03-30 07:19:37.335	5704	Central and Local Testing
16241	88	1617051540274:409679484	1617051537945:1496073049	D5170C00001	1931	1927	ALREADY AVAILABLE	2021-03-30 07:19:37.335	5704	Central Trial Documents
16244	88	1617051542055:-1562554763	1617051537945:1496073049	D5170C00001	1934	1927	ALREADY AVAILABLE	2021-03-30 07:19:37.335	5704	Data Management
16255	88	1617051549268:814903981	1617051537945:1496073049	D5170C00001	1945	1927	ALREADY AVAILABLE	2021-03-30 07:19:37.335	5704	Site Management
16281	88	1617051570626:2016539822	1617051570075:-895125672	D5170C00001	1971	1970	ALREADY AVAILABLE	2021-03-30 07:19:37.336	5705	IP and Trial Supplies
16288	88	1617051575574:-1503063946	1617051570075:-895125672	D5170C00001	1978	1970	ALREADY AVAILABLE	2021-03-30 07:19:37.336	5705	Site Management
16319	88	1617051596016:-246562775	1617051591205:320405571	D5170C00001	2009	2001	ALREADY AVAILABLE	2021-03-30 07:19:37.336	5706	Site Management
16349	88	1617051623515:-610352553	1617051622858:-848511232	D5170C00001	2039	2038	ALREADY AVAILABLE	2021-03-30 07:19:37.336	7001	Central and Local Testing
16354	88	1617051626763:-1337105703	1617051622858:-848511232	D5170C00001	2044	2038	ALREADY AVAILABLE	2021-03-30 07:19:37.336	7001	Central Trial Documents
16379	88	1617051650732:1308315124	1617051622858:-848511232	D5170C00001	2069	2038	ALREADY AVAILABLE	2021-03-30 07:19:37.336	7001	IRB or IEC and other Approvals
16384	88	1617051654910:-411539375	1617051622858:-848511232	D5170C00001	2074	2038	ALREADY AVAILABLE	2021-03-30 07:19:37.336	7001	Regulatory
16387	88	1617051656781:1893345263	1617051622858:-848511232	D5170C00001	2077	2038	ALREADY AVAILABLE	2021-03-30 07:19:37.336	7001	Safety Reporting
16390	88	1617051658601:-1400747048	1617051622858:-848511232	D5170C00001	2080	2038	ALREADY AVAILABLE	2021-03-30 07:19:37.336	7001	Site Management
16416	88	1617051680333:159582786	1617051679777:1057410970	D5170C00001	2106	2105	ALREADY AVAILABLE	2021-03-30 07:19:37.336	7002	Central and Local Testing
16421	88	1617051683273:-567170364	1617051679777:1057410970	D5170C00001	2111	2105	ALREADY AVAILABLE	2021-03-30 07:19:37.336	7002	Central Trial Documents
16426	88	1617051687370:936985796	1617051679777:1057410970	D5170C00001	2116	2105	ALREADY AVAILABLE	2021-03-30 07:19:37.336	7002	Data Management
16431	88	1617051695619:-1755896893	1617051679777:1057410970	D5170C00001	2121	2105	ALREADY AVAILABLE	2021-03-30 07:19:37.336	7002	IP and Trial Supplies
16446	88	1617051706416:-1806330357	1617051679777:1057410970	D5170C00001	2136	2105	ALREADY AVAILABLE	2021-03-30 07:19:37.337	7002	IRB or IEC and other Approvals
16453	88	1617051711732:-1356218563	1617051679777:1057410970	D5170C00001	2143	2105	ALREADY AVAILABLE	2021-03-30 07:19:37.337	7002	Site Management
16477	88	1617051734408:-462767479	1617051733842:-2020942965	D5170C00001	2167	2166	ALREADY AVAILABLE	2021-03-30 07:19:37.337	7003	Central and Local Testing
16481	88	1617051736766:-1189510020	1617051733842:-2020942965	D5170C00001	2171	2166	ALREADY AVAILABLE	2021-03-30 07:19:37.337	7003	Central Trial Documents
16487	88	1617051740336:921969211	1617051733842:-2020942965	D5170C00001	2177	2166	ALREADY AVAILABLE	2021-03-30 07:19:37.337	7003	Data Management
16492	88	1617051744204:-1278615495	1617051733842:-2020942965	D5170C00001	2182	2166	ALREADY AVAILABLE	2021-03-30 07:19:37.337	7003	IP and Trial Supplies
16507	88	1617051754183:1570914677	1617051733842:-2020942965	D5170C00001	2197	2166	ALREADY AVAILABLE	2021-03-30 07:19:37.337	7003	IRB or IEC and other Approvals
16514	88	1617051759057:753734028	1617051733842:-2020942965	D5170C00001	2204	2166	ALREADY AVAILABLE	2021-03-30 07:19:37.337	7003	Regulatory
16517	88	1617051760741:-762366816	1617051733842:-2020942965	D5170C00001	2207	2166	ALREADY AVAILABLE	2021-03-30 07:19:37.337	7003	Site Management
16542	88	1617051781827:1009552632	1617051781196:-410329106	D5170C00001	2232	2231	ALREADY AVAILABLE	2021-03-30 07:19:37.337	7004	Central and Local Testing
16546	88	1617051784501:282788873	1617051781196:-410329106	D5170C00001	2236	2231	ALREADY AVAILABLE	2021-03-30 07:19:37.337	7004	Central Trial Documents
16551	88	1617051788334:-1900699192	1617051781196:-410329106	D5170C00001	2241	2231	ALREADY AVAILABLE	2021-03-30 07:19:37.337	7004	Data Management
16556	88	1617051797523:193694007	1617051781196:-410329106	D5170C00001	2246	2231	ALREADY AVAILABLE	2021-03-30 07:19:37.337	7004	IP and Trial Supplies
16569	88	1617051805400:-759370871	1617051781196:-410329106	D5170C00001	2259	2231	ALREADY AVAILABLE	2021-03-30 07:19:37.337	7004	IRB or IEC and other Approvals
16576	88	1617051811032:1815773753	1617051781196:-410329106	D5170C00001	2266	2231	ALREADY AVAILABLE	2021-03-30 07:19:37.337	7004	Regulatory
14780	88	1617050181568:-159398468	1617049801974:-542363185	D5170C00001	470	30	ALREADY AVAILABLE	2021-03-30 07:19:37.237	Delivery	Site
16579	88	1617051812847:709985122	1617051781196:-410329106	D5170C00001	2269	2231	ALREADY AVAILABLE	2021-03-30 07:19:37.337	7004	Site Management
16613	88	1617051841553:-444954540	1617051836208:-1467894886	D5170C00001	2303	2297	ALREADY AVAILABLE	2021-03-30 07:19:37.337	7006	Central Trial Documents
16619	88	1617051845408:980345505	1617051836208:-1467894886	D5170C00001	2309	2297	ALREADY AVAILABLE	2021-03-30 07:19:37.338	7006	Data Management
16624	88	1617051848710:-320832923	1617051836208:-1467894886	D5170C00001	2314	2297	ALREADY AVAILABLE	2021-03-30 07:19:37.338	7006	IP and Trial Supplies
16639	88	1617051866008:-1273908410	1617051836208:-1467894886	D5170C00001	2329	2297	ALREADY AVAILABLE	2021-03-30 07:19:37.338	7006	IRB or IEC and other Approvals
16646	88	1617051870298:890998264	1617051836208:-1467894886	D5170C00001	2336	2297	ALREADY AVAILABLE	2021-03-30 07:19:37.338	7006	Regulatory
16649	88	1617051872103:-211586449	1617051836208:-1467894886	D5170C00001	2339	2297	ALREADY AVAILABLE	2021-03-30 07:19:37.338	7006	Site Management
16673	88	1617051893192:-1185088104	1617051836208:-1467894886	D5170C00001	2363	2297	ALREADY AVAILABLE	2021-03-30 07:19:37.338	7006	Trial Management
16677	88	1617051895712:-696943926	1617051895119:-661583129	D5170C00001	2367	2366	ALREADY AVAILABLE	2021-03-30 07:19:37.338	7007	Central Trial Documents
16682	88	1617051904629:-1099619999	1617051895119:-661583129	D5170C00001	2372	2366	ALREADY AVAILABLE	2021-03-30 07:19:37.338	7007	IP and Trial Supplies
16693	88	1617051911438:-2049470350	1617051895119:-661583129	D5170C00001	2383	2366	ALREADY AVAILABLE	2021-03-30 07:19:37.338	7007	IRB or IEC and other Approvals
16700	88	1617051916721:-1991354600	1617051895119:-661583129	D5170C00001	2390	2366	ALREADY AVAILABLE	2021-03-30 07:19:37.338	7007	Safety Reporting
16703	88	1617051922463:-990437179	1617051895119:-661583129	D5170C00001	2393	2366	ALREADY AVAILABLE	2021-03-30 07:19:37.338	7007	Site Management
16728	88	1617051939690:225203587	1617051939091:952255866	D5170C00001	2418	2417	ALREADY AVAILABLE	2021-03-30 07:19:37.338	7008	Central Trial Documents
16742	88	1617051953884:-1422588744	1617051939091:952255866	D5170C00001	2432	2417	ALREADY AVAILABLE	2021-03-30 07:19:37.338	7008	IRB or IEC and other Approvals
16747	88	1617051957706:-872196229	1617051939091:952255866	D5170C00001	2437	2417	ALREADY AVAILABLE	2021-03-30 07:19:37.338	7008	Safety Reporting
16750	88	1617051959552:949324400	1617051939091:952255866	D5170C00001	2440	2417	ALREADY AVAILABLE	2021-03-30 07:19:37.338	7008	Site Management
16774	88	1617051981481:-737558928	1617051980881:-120376759	D5170C00001	2464	2463	ALREADY AVAILABLE	2021-03-30 07:19:37.338	7801	Central and Local Testing
16800	88	1617052005782:1449258282	1617051980881:-120376759	D5170C00001	2490	2463	ALREADY AVAILABLE	2021-03-30 07:19:37.339	7801	Safety Reporting
16832	88	1617052035339:2044345600	1617052027253:1001206689	D5170C00001	2522	2521	ALREADY AVAILABLE	2021-03-30 07:19:37.339	7802	Central Trial Documents
16835	88	1617052037157:-336121496	1617052027253:1001206689	D5170C00001	2525	2521	ALREADY AVAILABLE	2021-03-30 07:19:37.339	7802	Data Management
16838	88	1617052039203:1758250485	1617052027253:1001206689	D5170C00001	2528	2521	ALREADY AVAILABLE	2021-03-30 07:19:37.339	7802	IP and Trial Supplies
16842	88	1617052041660:805143171	1617052027253:1001206689	D5170C00001	2532	2521	ALREADY AVAILABLE	2021-03-30 07:19:37.339	7802	IRB or IEC and other Approvals
16848	88	1617052046422:370876066	1617052027253:1001206689	D5170C00001	2538	2521	ALREADY AVAILABLE	2021-03-30 07:19:37.339	7802	Safety Reporting
16851	88	1617052048398:1782105700	1617052027253:1001206689	D5170C00001	2541	2521	ALREADY AVAILABLE	2021-03-30 07:19:37.339	7802	Site Management
16876	88	1617052072235:-2091444463	1617052027253:1001206689	D5170C00001	2566	2521	ALREADY AVAILABLE	2021-03-30 07:19:37.339	7802	Trial Management
16886	88	1617052080046:-1354812098	1617052074281:-90943670	D5170C00001	2576	2569	ALREADY AVAILABLE	2021-03-30 07:19:37.34	7804	Data Management
16889	88	1617052081883:132226203	1617052074281:-90943670	D5170C00001	2579	2569	ALREADY AVAILABLE	2021-03-30 07:19:37.34	7804	IP and Trial Supplies
16893	88	1617052089878:-820881111	1617052074281:-90943670	D5170C00001	2583	2569	ALREADY AVAILABLE	2021-03-30 07:19:37.34	7804	IRB or IEC and other Approvals
16901	88	1617052097430:729000263	1617052074281:-90943670	D5170C00001	2591	2569	ALREADY AVAILABLE	2021-03-30 07:19:37.34	7804	Site Management
16923	88	1617052113456:2039893700	1617052111853:830308303	D5170C00001	2613	2612	ALREADY AVAILABLE	2021-03-30 07:19:37.34	7805	Central Trial Documents
16927	88	1617052116002:-750864391	1617052111853:830308303	D5170C00001	2617	2612	ALREADY AVAILABLE	2021-03-30 07:19:37.34	7805	Data Management
16930	88	1617052117903:1343518199	1617052111853:830308303	D5170C00001	2620	2612	ALREADY AVAILABLE	2021-03-30 07:19:37.34	7805	IP and Trial Supplies
16936	88	1617052121840:193293937	1617052111853:830308303	D5170C00001	2626	2612	ALREADY AVAILABLE	2021-03-30 07:19:37.34	7805	IRB or IEC and other Approvals
16969	88	1617052145510:709388340	1617052144915:-1558768618	D5170C00001	2659	2658	ALREADY AVAILABLE	2021-03-30 07:19:37.34	7806	Site Management
16975	88	1617052156484:1692629743	1617052155871:-637654562	D5170C00001	2665	2664	ALREADY AVAILABLE	2021-03-30 07:19:37.34	7807	Central and Local Testing
16980	88	1617052160622:63277006	1617052155871:-637654562	D5170C00001	2670	2664	ALREADY AVAILABLE	2021-03-30 07:19:37.34	7807	Central Trial Documents
16983	88	1617052162658:-1414611721	1617052155871:-637654562	D5170C00001	2673	2664	ALREADY AVAILABLE	2021-03-30 07:19:37.34	7807	Data Management
16986	88	1617052164469:269511701	1617052155871:-637654562	D5170C00001	2676	2664	ALREADY AVAILABLE	2021-03-30 07:19:37.34	7807	IP and Trial Supplies
16992	88	1617052168040:-1172742723	1617052155871:-637654562	D5170C00001	2682	2664	ALREADY AVAILABLE	2021-03-30 07:19:37.34	7807	IRB or IEC and other Approvals
16997	88	1617052172506:-1114626973	1617052155871:-637654562	D5170C00001	2687	2664	ALREADY AVAILABLE	2021-03-30 07:19:37.341	7807	Safety Reporting
17000	88	1617052174479:1195966503	1617052155871:-637654562	D5170C00001	2690	2664	ALREADY AVAILABLE	2021-03-30 07:19:37.341	7807	Site Management
17025	88	1617052197815:-922197242	1617052197208:1678537417	D5170C00001	2715	2714	ALREADY AVAILABLE	2021-03-30 07:19:37.341	7808	Central Trial Documents
17030	88	1617052201119:503124021	1617052197208:1678537417	D5170C00001	2720	2714	ALREADY AVAILABLE	2021-03-30 07:19:37.341	7808	Data Management
17039	88	1617052208169:2133546407	1617052197208:1678537417	D5170C00001	2729	2714	ALREADY AVAILABLE	2021-03-30 07:19:37.341	7808	IRB or IEC and other Approvals
17045	88	1617052217060:1994555818	1617052197208:1678537417	D5170C00001	2735	2714	ALREADY AVAILABLE	2021-03-30 07:19:37.341	7808	Safety Reporting
17048	88	1617052219165:-889192453	1617052197208:1678537417	D5170C00001	2738	2714	ALREADY AVAILABLE	2021-03-30 07:19:37.341	7808	Site Management
17074	88	1617052238105:-552229202	1617052234097:-1810160558	D5170C00001	2764	2760	ALREADY AVAILABLE	2021-03-30 07:19:37.341	7809	Central Trial Documents
17077	88	1617052239893:462790457	1617052234097:-1810160558	D5170C00001	2767	2760	ALREADY AVAILABLE	2021-03-30 07:19:37.341	7809	Data Management
17080	88	1617052247211:-1737804858	1617052234097:-1810160558	D5170C00001	2770	2760	ALREADY AVAILABLE	2021-03-30 07:19:37.341	7809	IP and Trial Supplies
17087	88	1617052253073:1604065733	1617052234097:-1810160558	D5170C00001	2777	2760	ALREADY AVAILABLE	2021-03-30 07:19:37.341	7809	IRB or IEC and other Approvals
17095	88	1617052258119:1954328344	1617052234097:-1810160558	D5170C00001	2785	2760	ALREADY AVAILABLE	2021-03-30 07:19:37.341	7809	Safety Reporting
17098	88	1617052261315:-318903547	1617052234097:-1810160558	D5170C00001	2788	2760	ALREADY AVAILABLE	2021-03-30 07:19:37.341	7809	Site Management
17122	88	1617052289712:-1410549336	1617052234097:-1810160558	D5170C00001	2812	2760	ALREADY AVAILABLE	2021-03-30 07:19:37.341	7809	Trial Management
17126	88	1617052296723:-1930996861	1617052296101:1068428102	D5170C00001	2816	2815	ALREADY AVAILABLE	2021-03-30 07:19:37.341	7810	Central Trial Documents
17129	88	1617052298390:-216711437	1617052296101:1068428102	D5170C00001	2819	2815	ALREADY AVAILABLE	2021-03-30 07:19:37.341	7810	Data Management
17180	88	1617052340892:30784672	1617052335404:780821450	D5170C00001	2870	2863	ALREADY AVAILABLE	2021-03-30 07:19:37.342	7813	IP and Trial Supplies
17183	88	1617052342727:-430003441	1617052335404:780821450	D5170C00001	2873	2863	ALREADY AVAILABLE	2021-03-30 07:19:37.342	7813	IRB or IEC and other Approvals
17189	88	1617052346345:38530612	1617052335404:780821450	D5170C00001	2879	2863	ALREADY AVAILABLE	2021-03-30 07:19:37.342	7813	Safety Reporting
17192	88	1617052349308:1039310116	1617052335404:780821450	D5170C00001	2882	2863	ALREADY AVAILABLE	2021-03-30 07:19:37.342	7813	Site Management
17220	88	1617052374108:-2052785508	1617052368447:-1900328069	D5170C00001	2910	2903	ALREADY AVAILABLE	2021-03-30 07:19:37.342	7814	IP and Trial Supplies
17224	88	1617052376599:-2103091664	1617052368447:-1900328069	D5170C00001	2914	2903	ALREADY AVAILABLE	2021-03-30 07:19:37.342	7814	IRB or IEC and other Approvals
17230	88	1617052380208:1839626124	1617052368447:-1900328069	D5170C00001	2920	2903	ALREADY AVAILABLE	2021-03-30 07:19:37.342	7814	Safety Reporting
17233	88	1617052382004:-1241186050	1617052368447:-1900328069	D5170C00001	2923	2903	ALREADY AVAILABLE	2021-03-30 07:19:37.342	7814	Site Management
17259	88	1617052407504:1800759500	1617052406953:434219244	D5170C00001	2949	2948	ALREADY AVAILABLE	2021-03-30 07:19:37.343	7816	Central Trial Documents
17262	88	1617052409191:-1072207150	1617052406953:434219244	D5170C00001	2952	2948	ALREADY AVAILABLE	2021-03-30 07:19:37.343	7816	Data Management
17265	88	1617052410969:1022164831	1617052406953:434219244	D5170C00001	2955	2948	ALREADY AVAILABLE	2021-03-30 07:19:37.343	7816	IP and Trial Supplies
17271	88	1617052414587:364440123	1617052406953:434219244	D5170C00001	2961	2948	ALREADY AVAILABLE	2021-03-30 07:19:37.343	7816	IRB or IEC and other Approvals
17277	88	1617052419700:127162658	1617052406953:434219244	D5170C00001	2967	2948	ALREADY AVAILABLE	2021-03-30 07:19:37.343	7816	Safety Reporting
17280	88	1617052421410:1538392292	1617052406953:434219244	D5170C00001	2970	2948	ALREADY AVAILABLE	2021-03-30 07:19:37.343	7816	Site Management
17304	88	1617052437641:-338104240	1617052436931:-1544354502	D5170C00001	2994	2993	ALREADY AVAILABLE	2021-03-30 07:19:37.343	7817	Central Trial Documents
17307	88	1617052439453:-740759095	1617052436931:-1544354502	D5170C00001	2997	2993	ALREADY AVAILABLE	2021-03-30 07:19:37.343	7817	IP and Trial Supplies
17313	88	1617052445277:-1989259624	1617052436931:-1544354502	D5170C00001	3003	2993	ALREADY AVAILABLE	2021-03-30 07:19:37.343	7817	IRB or IEC and other Approvals
17322	88	1617052450649:382865700	1617052436931:-1544354502	D5170C00001	3012	2993	ALREADY AVAILABLE	2021-03-30 07:19:37.343	7817	Site Management
17342	88	1617052475368:-10509717	1617052474834:-1033595095	D5170C00001	3032	3031	ALREADY AVAILABLE	2021-03-30 07:19:37.343	7818	Central Trial Documents
17345	88	1617052477064:1296593149	1617052474834:-1033595095	D5170C00001	3035	3031	ALREADY AVAILABLE	2021-03-30 07:19:37.343	7818	Data Management
17348	88	1617052479480:-296615441	1617052474834:-1033595095	D5170C00001	3038	3031	ALREADY AVAILABLE	2021-03-30 07:19:37.343	7818	IP and Trial Supplies
17356	88	1617052484114:-1249701537	1617052474834:-1033595095	D5170C00001	3046	3031	ALREADY AVAILABLE	2021-03-30 07:19:37.343	7818	IRB or IEC and other Approvals
17362	88	1617052487489:-1798961903	1617052474834:-1033595095	D5170C00001	3052	3031	ALREADY AVAILABLE	2021-03-30 07:19:37.343	7818	Safety Reporting
17365	88	1617052490174:-387742878	1617052474834:-1033595095	D5170C00001	3055	3031	ALREADY AVAILABLE	2021-03-30 07:19:37.343	7818	Site Management
17387	88	1617052508807:655482224	1617052508239:872433197	D5170C00001	3077	3076	ALREADY AVAILABLE	2021-03-30 07:19:37.343	7819	Central Trial Documents
17392	88	1617052512629:-1724974263	1617052508239:872433197	D5170C00001	3082	3076	ALREADY AVAILABLE	2021-03-30 07:19:37.343	7819	Data Management
17403	88	1617052518861:-583677769	1617052508239:872433197	D5170C00001	3093	3076	ALREADY AVAILABLE	2021-03-30 07:19:37.343	7819	IRB or IEC and other Approvals
17412	88	1617052525623:81718616	1617052508239:872433197	D5170C00001	3102	3076	ALREADY AVAILABLE	2021-03-30 07:19:37.343	7819	Safety Reporting
17415	88	1617052527421:590104656	1617052508239:872433197	D5170C00001	3105	3076	ALREADY AVAILABLE	2021-03-30 07:19:37.343	7819	Site Management
17446	88	1617052561543:1214236868	1617052549132:-740913861	D5170C00001	3136	3129	ALREADY AVAILABLE	2021-03-30 07:19:37.344	7820	IP and Trial Supplies
17449	88	1617052568207:-31218878	1617052549132:-740913861	D5170C00001	3139	3129	ALREADY AVAILABLE	2021-03-30 07:19:37.344	7820	IRB or IEC and other Approvals
17459	88	1617052574384:1927379706	1617052549132:-740913861	D5170C00001	3149	3129	ALREADY AVAILABLE	2021-03-30 07:19:37.344	7820	Site Management
17480	88	1617052593400:-1650442343	1617052592811:380298272	D5170C00001	3170	3169	ALREADY AVAILABLE	2021-03-30 07:19:37.344	7821	Central Trial Documents
17483	88	1617052595272:264047248	1617052592811:380298272	D5170C00001	3173	3169	ALREADY AVAILABLE	2021-03-30 07:19:37.344	7821	Data Management
14348	88	1617049807047:131142780	1617049805778:546631501	D5170C00001	38	36	ALREADY AVAILABLE	2021-03-30 07:19:37.344	Subject Documentation	Informed Consent Form
14350	88	1617049808430:-1272618927	1617049805778:546631501	D5170C00001	40	36	ALREADY AVAILABLE	2021-03-30 07:19:37.344	Subject Documentation	Subject Diary
14351	88	1617049809020:1829631914	1617049805778:546631501	D5170C00001	41	36	ALREADY AVAILABLE	2021-03-30 07:19:37.344	Subject Documentation	Subject Participation Card
14354	88	1617049812189:-1746142075	1617049811589:2092292068	D5170C00001	44	43	ALREADY AVAILABLE	2021-03-30 07:19:37.344	General	Relevant Communications
14357	88	1617049814057:-1330738394	1617049813452:304504589	D5170C00001	47	46	ALREADY AVAILABLE	2021-03-30 07:19:37.344	General	Relevant Communications
14359	88	1617049815265:2125451196	1617049814651:-719237161	D5170C00001	49	48	ALREADY AVAILABLE	2021-03-30 07:19:37.344	IRB or IEC Trial Approval	IRB or IEC Approval
14360	88	1617049815946:136798017	1617049814651:-719237161	D5170C00001	50	48	ALREADY AVAILABLE	2021-03-30 07:19:37.344	IRB or IEC Trial Approval	IRB or IEC Composition
14363	88	1617049817838:-744072357	1617049817187:1565883125	D5170C00001	53	52	ALREADY AVAILABLE	2021-03-30 07:19:37.344	Other Committees	Other Submissions
14366	88	1617049819592:687135559	1617049819028:-270565087	D5170C00001	56	55	ALREADY AVAILABLE	2021-03-30 07:19:37.344	General	Filenote
14369	88	1617049822976:-854488486	1617049820773:-1110579860	D5170C00001	59	58	ALREADY AVAILABLE	2021-03-30 07:19:37.344	General	Relevant Communications
14371	88	1617049831062:-537108636	1617049823645:1179027071	D5170C00001	61	60	ALREADY AVAILABLE	2021-03-30 07:19:37.344	Site Initiation	Site Training Material
14373	88	1617049832276:-1350702339	1617049831710:-29400867	D5170C00001	63	62	ALREADY AVAILABLE	2021-03-30 07:19:37.344	Site Management	Subject Log
14375	88	1617049839642:-897096797	1617049834186:-586533418	D5170C00001	65	64	ALREADY AVAILABLE	2021-03-30 07:19:37.344	Site Selection	Feasibility Documentation
14377	88	1617049841963:-44260798	1617049840255:-1404256617	D5170C00001	67	66	ALREADY AVAILABLE	2021-03-30 07:19:37.344	Site Set-up	Clinical Study Agreement
14378	88	1617049842680:-203011127	1617049840255:-1404256617	D5170C00001	68	66	ALREADY AVAILABLE	2021-03-30 07:19:37.344	Site Set-up	Other Financial Agreement
14379	88	1617049843282:-1763361566	1617049840255:-1404256617	D5170C00001	69	66	ALREADY AVAILABLE	2021-03-30 07:19:37.344	Site Set-up	Protocol Signature Page
14382	88	1617049845918:2052673020	1617049845355:-2119944318	D5170C00001	72	71	ALREADY AVAILABLE	2021-03-30 07:19:37.344	General	Other Meeting Material
14383	88	1617049846508:-1025468731	1617049845355:-2119944318	D5170C00001	73	71	ALREADY AVAILABLE	2021-03-30 07:19:37.344	General	Relevant Communications
14384	88	1617049847065:932951914	1617049845355:-2119944318	D5170C00001	74	71	ALREADY AVAILABLE	2021-03-30 07:19:37.344	General	Tracking Information
14386	88	1617049848326:-796970772	1617049847716:-550507204	D5170C00001	76	75	ALREADY AVAILABLE	2021-03-30 07:19:37.344	Meetings	Investigators Meeting Material
14387	88	1617049849105:15470583	1617049847716:-550507204	D5170C00001	77	75	ALREADY AVAILABLE	2021-03-30 07:19:37.344	Meetings	Kick-off Meeting Material
14388	88	1617049849680:248365556	1617049847716:-550507204	D5170C00001	78	75	ALREADY AVAILABLE	2021-03-30 07:19:37.344	Meetings	Trial Team Training Material
14390	88	1617049850958:-957164890	1617049850378:-1253320494	D5170C00001	80	79	ALREADY AVAILABLE	2021-03-30 07:19:37.344	Trial Oversight	Investigator Newsletter
14391	88	1617049851521:-1648535456	1617049850378:-1253320494	D5170C00001	81	79	ALREADY AVAILABLE	2021-03-30 07:19:37.344	Trial Oversight	List of SOPs Current During Trial
14392	88	1617049862283:-1625200684	1617049850378:-1253320494	D5170C00001	82	79	ALREADY AVAILABLE	2021-03-30 07:19:37.344	Trial Oversight	Monitoring Plan
14393	88	1617049862915:-2060646820	1617049850378:-1253320494	D5170C00001	83	79	ALREADY AVAILABLE	2021-03-30 07:19:37.344	Trial Oversight	Quality Plan
14399	88	1617049867391:-969087555	1617049865285:-949512337	D5170C00001	89	87	ALREADY AVAILABLE	2021-03-30 07:19:37.344	General	Relevant Communications
14400	88	1617049868026:582182359	1617049865285:-949512337	D5170C00001	90	87	ALREADY AVAILABLE	2021-03-30 07:19:37.344	General	Tracking Information
14402	88	1617049869215:-1389010926	1617049868581:1599150928	D5170C00001	92	91	ALREADY AVAILABLE	2021-03-30 07:19:37.344	Product and Trial Documentation	Insurance
14405	88	1617049871368:-818981589	1617049870019:245753741	D5170C00001	95	93	ALREADY AVAILABLE	2021-03-30 07:19:37.344	Subject Documentation	Other Information Given to Subjects
14406	88	1617049872032:943256959	1617049870019:245753741	D5170C00001	96	93	ALREADY AVAILABLE	2021-03-30 07:19:37.344	Subject Documentation	Subject Diary
14408	88	1617049873291:1155371381	1617049870019:245753741	D5170C00001	98	93	ALREADY AVAILABLE	2021-03-30 07:19:37.344	Subject Documentation	Subject Questionnaire
14411	88	1617049875727:1500084469	1617049874554:1131675673	D5170C00001	101	100	ALREADY AVAILABLE	2021-03-30 07:19:37.344	General	Filenote
14412	88	1617049876311:-1201537355	1617049874554:1131675673	D5170C00001	102	100	ALREADY AVAILABLE	2021-03-30 07:19:37.344	General	Relevant Communications
14414	88	1617049878316:143104499	1617049876883:-1327860076	D5170C00001	104	103	ALREADY AVAILABLE	2021-03-30 07:19:37.344	Storage	IP Storage Condition Documentation
14417	88	1617049880113:-399418541	1617049879542:-1798496119	D5170C00001	107	106	ALREADY AVAILABLE	2021-03-30 07:19:37.344	General	Relevant Communications
14419	88	1617049881471:893646507	1617049880709:867899471	D5170C00001	109	108	ALREADY AVAILABLE	2021-03-30 07:19:37.344	IRB or IEC Trial Approval	IRB or IEC Approval
14420	88	1617049882052:264840543	1617049880709:867899471	D5170C00001	110	108	ALREADY AVAILABLE	2021-03-30 07:19:37.344	IRB or IEC Trial Approval	IRB or IEC Submission
14453	88	1617049909821:2136289935	1617049909235:1256286141	D5170C00001	143	142	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Trial Oversight	List of SOPs Current During Trial
14454	88	1617049911413:-1728160031	1617049909235:1256286141	D5170C00001	144	142	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Trial Oversight	Monitoring Plan
14456	88	1617049912619:1260537595	1617049909235:1256286141	D5170C00001	146	142	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Trial Oversight	Transfer of Regulatory Obligations
14462	88	1617049916336:-2106738114	1617049915594:-679394982	D5170C00001	152	151	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Product and Trial Documentation	Insurance
14464	88	1617049917592:-1405548074	1617049917006:-1738035494	D5170C00001	154	153	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Subject Documentation	Informed Consent Form
14465	88	1617049918203:1074351709	1617049917006:-1738035494	D5170C00001	155	153	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Subject Documentation	Subject Diary
14467	88	1617049919481:1371655819	1617049917006:-1738035494	D5170C00001	157	153	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Subject Documentation	Subject Questionnaire
14473	88	1617049924228:-64263364	1617049923071:-1975640652	D5170C00001	163	161	ALREADY AVAILABLE	2021-03-30 07:19:37.347	IRB or IEC Trial Approval	IRB or IEC Submission
14475	88	1617049925473:562169548	1617049924900:1667312597	D5170C00001	165	164	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Trial Status Reporting	IRB or IEC Notification of Trial Termination
14476	88	1617049926038:-465959277	1617049924900:1667312597	D5170C00001	166	164	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Trial Status Reporting	Notification to IRB or IEC of Safety Information
14479	88	1617049927852:478890474	1617049927269:2007966018	D5170C00001	169	168	ALREADY AVAILABLE	2021-03-30 07:19:37.347	General	Filenote
14481	88	1617049929124:1297152480	1617049928470:2018761972	D5170C00001	171	170	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Investigational Medicinal Product	Import or Export License
14484	88	1617049931194:-2051860323	1617049930557:1774117388	D5170C00001	174	173	ALREADY AVAILABLE	2021-03-30 07:19:37.347	General	Relevant Communications
14486	88	1617049937096:1251398348	1617049931776:1572682713	D5170C00001	176	175	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Site Selection	Feasibility Documentation
14488	88	1617049938278:-1518257044	1617049937670:1247310542	D5170C00001	178	177	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Site Set-up	Clinical Study Agreement
14489	88	1617049938941:646271851	1617049937670:1247310542	D5170C00001	179	177	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Site Set-up	Protocol Signature Page
14492	88	1617049940684:1181712998	1617049940120:1191110238	D5170C00001	182	181	ALREADY AVAILABLE	2021-03-30 07:19:37.347	General	Relevant Communications
14493	88	1617049941340:-2054346021	1617049940120:1191110238	D5170C00001	183	181	ALREADY AVAILABLE	2021-03-30 07:19:37.347	General	Tracking Information
14495	88	1617049942488:1989781045	1617049941923:-944906594	D5170C00001	185	184	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Meetings	Investigators Meeting Material
14496	88	1617049943067:-884079853	1617049941923:-944906594	D5170C00001	186	184	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Meetings	Trial Team Training Material
14498	88	1617049945435:1075153447	1617049944862:-1647719884	D5170C00001	188	187	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Trial Oversight	Investigator Newsletter
14499	88	1617049946009:980556339	1617049944862:-1647719884	D5170C00001	189	187	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Trial Oversight	Monitoring Plan
14500	88	1617049946658:-846806238	1617049944862:-1647719884	D5170C00001	190	187	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Trial Oversight	Quality Plan
14501	88	1617049947240:-523318293	1617049944862:-1647719884	D5170C00001	191	187	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Trial Oversight	Transfer of Regulatory Obligations
14505	88	1617049949938:17467590	1617049949297:632083578	D5170C00001	195	194	ALREADY AVAILABLE	2021-03-30 07:19:37.347	General	Explanation of Approvals non English language
14506	88	1617049950530:-227831456	1617049949297:632083578	D5170C00001	196	194	ALREADY AVAILABLE	2021-03-30 07:19:37.347	General	Tracking Information
14508	88	1617049951996:-1384246103	1617049951131:-1311878460	D5170C00001	198	197	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Product and Trial Documentation	Insurance
14510	88	1617049953198:-1589218125	1617049952578:1024957174	D5170C00001	200	199	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Subject Documentation	Informed Consent Form
14579	88	1617050011031:-182575997	1617050010438:689346162	D5170C00001	269	268	ALREADY AVAILABLE	2021-03-30 07:19:37.349	Site Set-up	Protocol Signature Page
14582	88	1617050014172:2090868542	1617050013595:-846737349	D5170C00001	272	271	ALREADY AVAILABLE	2021-03-30 07:19:37.349	General	Other Meeting Material
14584	88	1617050015461:-1047363884	1617050014859:610189010	D5170C00001	274	273	ALREADY AVAILABLE	2021-03-30 07:19:37.349	Meetings	Trial Team Training Material
14586	88	1617050016815:1195313608	1617050016194:-584943481	D5170C00001	276	275	ALREADY AVAILABLE	2021-03-30 07:19:37.35	Trial Oversight	Investigator Newsletter
14587	88	1617050017403:298217928	1617050016194:-584943481	D5170C00001	277	275	ALREADY AVAILABLE	2021-03-30 07:19:37.35	Trial Oversight	Monitoring Plan
14588	88	1617050017998:-431878793	1617050016194:-584943481	D5170C00001	278	275	ALREADY AVAILABLE	2021-03-30 07:19:37.35	Trial Oversight	Quality Plan
14589	88	1617050018676:-1008062351	1617050016194:-584943481	D5170C00001	279	275	ALREADY AVAILABLE	2021-03-30 07:19:37.35	Trial Oversight	Transfer of Regulatory Obligations
14593	88	1617050029446:1071343162	1617050028780:-355970993	D5170C00001	283	282	ALREADY AVAILABLE	2021-03-30 07:19:37.35	General	Explanation of Approvals non English language
14594	88	1617050030043:-1678205578	1617050028780:-355970993	D5170C00001	284	282	ALREADY AVAILABLE	2021-03-30 07:19:37.35	General	Filenote
14595	88	1617050030694:-449333803	1617050028780:-355970993	D5170C00001	285	282	ALREADY AVAILABLE	2021-03-30 07:19:37.35	General	Tracking Information
14597	88	1617050031821:-1141153444	1617050031241:1587904752	D5170C00001	287	286	ALREADY AVAILABLE	2021-03-30 07:19:37.35	Product and Trial Documentation	Insurance
14599	88	1617050033008:1872548121	1617050032373:-172791692	D5170C00001	289	288	ALREADY AVAILABLE	2021-03-30 07:19:37.35	Subject Documentation	Informed Consent Form
14621	88	1617050047645:-246189894	1617050046469:-379793734	D5170C00001	311	309	ALREADY AVAILABLE	2021-03-30 07:19:37.351	Site Set-up	Protocol Signature Page
14624	88	1617050054426:1165018883	1617050053854:-593875201	D5170C00001	314	313	ALREADY AVAILABLE	2021-03-30 07:19:37.352	General	Tracking Information
14626	88	1617050055767:1519424924	1617050055025:-41458515	D5170C00001	316	315	ALREADY AVAILABLE	2021-03-30 07:19:37.352	Trial Oversight	Investigator Newsletter
14627	88	1617050056391:1227244072	1617050055025:-41458515	D5170C00001	317	315	ALREADY AVAILABLE	2021-03-30 07:19:37.352	Trial Oversight	Monitoring Plan
14629	88	1617050057765:235985410	1617050055025:-41458515	D5170C00001	319	315	ALREADY AVAILABLE	2021-03-30 07:19:37.352	Trial Oversight	Trial Management Plan
14634	88	1617050061982:-1326398050	1617050059679:1952071395	D5170C00001	324	322	ALREADY AVAILABLE	2021-03-30 07:19:37.352	General	Explanation of Approvals non English language
14641	88	1617050066496:-1926008666	1617050064713:-1752417343	D5170C00001	331	328	ALREADY AVAILABLE	2021-03-30 07:19:37.352	Subject Documentation	Subject Participation Card
14645	88	1617050068964:774450532	1617050068364:-524072122	D5170C00001	335	334	ALREADY AVAILABLE	2021-03-30 07:19:37.353	General	Relevant Communications
14648	88	1617050070786:429193104	1617050070204:-1562773554	D5170C00001	338	337	ALREADY AVAILABLE	2021-03-30 07:19:37.353	IRB or IEC Trial Approval	IRB or IEC Approval
14651	88	1617050073874:215900661	1617050073281:1475370957	D5170C00001	341	340	ALREADY AVAILABLE	2021-03-30 07:19:37.353	Trial Status Reporting	IRB or IEC Progress Report
14654	88	1617050075725:1549708736	1617050075145:-1568961585	D5170C00001	344	343	ALREADY AVAILABLE	2021-03-30 07:19:37.353	General	Filenote
14657	88	1617050077530:-1137549258	1617050076899:2072348370	D5170C00001	347	346	ALREADY AVAILABLE	2021-03-30 07:19:37.353	General	Filenote
14659	88	1617050078814:933524147	1617050078211:-720140916	D5170C00001	349	348	ALREADY AVAILABLE	2021-03-30 07:19:37.353	Site Initiation	Site Training Material
14661	88	1617050080197:804300948	1617050079550:1952755909	D5170C00001	351	350	ALREADY AVAILABLE	2021-03-30 07:19:37.353	Site Set-up	Clinical Study Agreement
14662	88	1617050080771:-715737672	1617050079550:1952755909	D5170C00001	352	350	ALREADY AVAILABLE	2021-03-30 07:19:37.353	Site Set-up	Data Privacy Agreement
14663	88	1617050081353:1066638580	1617050079550:1952755909	D5170C00001	353	350	ALREADY AVAILABLE	2021-03-30 07:19:37.353	Site Set-up	Indemnity
14664	88	1617050081931:-20916532	1617050079550:1952755909	D5170C00001	354	350	ALREADY AVAILABLE	2021-03-30 07:19:37.353	Site Set-up	Other Financial Agreement
14665	88	1617050082711:-1088905334	1617050079550:1952755909	D5170C00001	355	350	ALREADY AVAILABLE	2021-03-30 07:19:37.353	Site Set-up	Protocol Signature Page
14668	88	1617050091401:-1682122982	1617050085081:-756019195	D5170C00001	358	357	ALREADY AVAILABLE	2021-03-30 07:19:37.353	General	Other Meeting Material
14669	88	1617050092050:-170604416	1617050085081:-756019195	D5170C00001	359	357	ALREADY AVAILABLE	2021-03-30 07:19:37.354	General	Relevant Communications
14670	88	1617050092615:1578334114	1617050085081:-756019195	D5170C00001	360	357	ALREADY AVAILABLE	2021-03-30 07:19:37.354	General	Tracking Information
14676	88	1617050097349:551489288	1617050095551:-199521697	D5170C00001	366	363	ALREADY AVAILABLE	2021-03-30 07:19:37.354	Trial Oversight	Quality Plan
14681	88	1617050100367:1689270189	1617050099793:965069189	D5170C00001	371	370	ALREADY AVAILABLE	2021-03-30 07:19:37.354	General	Certificate of Translation
14684	88	1617050102179:-2132728094	1617050099793:965069189	D5170C00001	374	370	ALREADY AVAILABLE	2021-03-30 07:19:37.354	General	Relevant Communications
14691	88	1617050107792:1392169850	1617050103459:1438998616	D5170C00001	381	376	ALREADY AVAILABLE	2021-03-30 07:19:37.355	Subject Documentation	Subject Questionnaire
8898	84	\N	\N	D5170C00002	2683	2682	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
14694	88	1617050109645:1216099701	1617050109066:-952572892	D5170C00001	384	383	ALREADY AVAILABLE	2021-03-30 07:19:37.355	General	Relevant Communications
14696	88	1617050111037:197904590	1617050110306:-1230492811	D5170C00001	386	385	ALREADY AVAILABLE	2021-03-30 07:19:37.355	IP Documentation	IP Accountability Documentation
14699	88	1617050118724:-1900893843	1617050118042:288436627	D5170C00001	389	388	ALREADY AVAILABLE	2021-03-30 07:19:37.355	General	Relevant Communications
14703	88	1617050121276:-1158737333	1617050119290:-246147404	D5170C00001	393	390	ALREADY AVAILABLE	2021-03-30 07:19:37.355	IRB or IEC Trial Approval	IRB or IEC Composition
14704	88	1617050121862:724894616	1617050119290:-246147404	D5170C00001	394	390	ALREADY AVAILABLE	2021-03-30 07:19:37.355	IRB or IEC Trial Approval	IRB or IEC Submission
14706	88	1617050123001:964545645	1617050122435:-1961205912	D5170C00001	396	395	ALREADY AVAILABLE	2021-03-30 07:19:37.355	Other Committees	Other Submissions
14709	88	1617050124936:-564456096	1617050123720:-973817301	D5170C00001	399	397	ALREADY AVAILABLE	2021-03-30 07:19:37.356	Trial Status Reporting	IRB or IEC Progress Report
14713	88	1617050129254:-873354292	1617050126744:879453851	D5170C00001	403	401	ALREADY AVAILABLE	2021-03-30 07:19:37.356	General	Relevant Communications
14716	88	1617050131010:-1972595646	1617050129827:-1162096858	D5170C00001	406	404	ALREADY AVAILABLE	2021-03-30 07:19:37.356	Trial Approval	Regulatory Submission
14719	88	1617050132838:851232611	1617050132250:1119209526	D5170C00001	409	408	ALREADY AVAILABLE	2021-03-30 07:19:37.356	General	Filenote
14724	88	1617050136183:1763875045	1617050135480:103191916	D5170C00001	414	413	ALREADY AVAILABLE	2021-03-30 07:19:37.356	Site Set-up	Clinical Study Agreement
14726	88	1617050137496:-856987199	1617050135480:103191916	D5170C00001	416	413	ALREADY AVAILABLE	2021-03-30 07:19:37.356	Site Set-up	Protocol Signature Page
14729	88	1617050140590:-1333046717	1617050138890:-446708846	D5170C00001	419	418	ALREADY AVAILABLE	2021-03-30 07:19:37.356	General	Relevant Communications
14730	88	1617050141183:20597017	1617050138890:-446708846	D5170C00001	420	418	ALREADY AVAILABLE	2021-03-30 07:19:37.356	General	Tracking Information
14732	88	1617050142454:-588000314	1617050141814:1010630798	D5170C00001	422	421	ALREADY AVAILABLE	2021-03-30 07:19:37.357	Trial Oversight	List of SOPs Current During Trial
14733	88	1617050143068:-766545931	1617050141814:1010630798	D5170C00001	423	421	ALREADY AVAILABLE	2021-03-30 07:19:37.357	Trial Oversight	Monitoring Plan
14735	88	1617050144222:-1870945821	1617050141814:1010630798	D5170C00001	425	421	ALREADY AVAILABLE	2021-03-30 07:19:37.357	Trial Oversight	Transfer of Regulatory Obligations
14740	88	1617050147447:407004823	1617050146035:-951542613	D5170C00001	430	428	ALREADY AVAILABLE	2021-03-30 07:19:37.357	Facility Documentation	Normal Ranges
14743	88	1617050155636:-893838823	1617050154966:608004575	D5170C00001	433	432	ALREADY AVAILABLE	2021-03-30 07:19:37.357	Product and Trial Documentation	Insurance
14746	88	1617050157406:-1955250787	1617050156210:-1647154088	D5170C00001	436	434	ALREADY AVAILABLE	2021-03-30 07:19:37.357	Subject Documentation	Informed Consent Form
14749	88	1617050159247:1206956570	1617050158636:-1642993631	D5170C00001	439	438	ALREADY AVAILABLE	2021-03-30 07:19:37.357	Non-IP Documentation	Non-IP Supply Plan
14752	88	1617050161094:-437945273	1617050160495:2021630989	D5170C00001	442	441	ALREADY AVAILABLE	2021-03-30 07:19:37.357	IRB or IEC Trial Approval	IRB or IEC Approval
14753	88	1617050163087:1263570715	1617050160495:2021630989	D5170C00001	443	441	ALREADY AVAILABLE	2021-03-30 07:19:37.357	IRB or IEC Trial Approval	IRB or IEC Composition
14755	88	1617050164344:-1929215757	1617050163771:1173062271	D5170C00001	445	444	ALREADY AVAILABLE	2021-03-30 07:19:37.357	Trial Status Reporting	IRB or IEC Notification of Trial Termination
14758	88	1617050166190:1704825180	1617050165512:856853127	D5170C00001	448	447	ALREADY AVAILABLE	2021-03-30 07:19:37.358	Trial Approval	Regulatory Submission
14760	88	1617050167397:-1522768569	1617050166769:1223687721	D5170C00001	450	449	ALREADY AVAILABLE	2021-03-30 07:19:37.358	Trial Status Reporting	Notification to Regulatory Authority of Safety or Trial Information
14763	88	1617050169369:1802728492	1617050168767:-1382863374	D5170C00001	453	452	ALREADY AVAILABLE	2021-03-30 07:19:37.358	General	Filenote
14764	88	1617050169995:-1447666723	1617050168767:-1382863374	D5170C00001	454	452	ALREADY AVAILABLE	2021-03-30 07:19:37.358	General	Meeting Material
14766	88	1617050171355:-827928188	1617050170621:-1500179870	D5170C00001	456	455	ALREADY AVAILABLE	2021-03-30 07:19:37.358	Site Selection	Feasibility Documentation
14767	88	1617050171983:1041458617	1617050170621:-1500179870	D5170C00001	457	455	ALREADY AVAILABLE	2021-03-30 07:19:37.358	Site Selection	Sites Evaluated but not Selected
14770	88	1617050175284:2086645966	1617050174612:2014445176	D5170C00001	460	459	ALREADY AVAILABLE	2021-03-30 07:19:37.358	Third Party Set-up	Confidentiality Agreement
14771	88	1617050175860:970413206	1617050174612:2014445176	D5170C00001	461	459	ALREADY AVAILABLE	2021-03-30 07:19:37.358	Third Party Set-up	Contractual Agreement
14774	88	1617050177747:-143302071	1617050177152:1601897760	D5170C00001	464	463	ALREADY AVAILABLE	2021-03-30 07:19:37.358	General	Other Meeting Material
14824	88	1617050226422:-1412208130	1617050222793:-1515687263	D5170C00001	514	508	ALREADY AVAILABLE	2021-03-30 07:19:37.359	Site Management	Site Management
14828	88	1617050228789:-1476894172	1617050222793:-1515687263	D5170C00001	518	508	ALREADY AVAILABLE	2021-03-30 07:19:37.359	Site Management	Site Selection
8859	84	\N	\N	D5170C00002	2644	2643	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
14843	88	1617050244913:1850471677	1617050244270:1889864730	D5170C00001	533	532	ALREADY AVAILABLE	2021-03-30 07:19:37.359	Trial Management	Trial Oversight
14847	88	1617050247559:-1859913765	1617050246923:-341419747	D5170C00001	537	536	ALREADY AVAILABLE	2021-03-30 07:19:37.359	Central Trial Documents	Subject Documentation
14851	88	1617050250113:-801955375	1617050249401:-1315940313	D5170C00001	541	540	ALREADY AVAILABLE	2021-03-30 07:19:37.36	Central and Local Testing	Facility Documentation
14854	88	1617050252021:1709909660	1617050251421:1843977330	D5170C00001	544	543	ALREADY AVAILABLE	2021-03-30 07:19:37.36	Central Trial Documents	Subject Documentation
14857	88	1617050255187:-358801213	1617050254588:-738412591	D5170C00001	547	546	ALREADY AVAILABLE	2021-03-30 07:19:37.36	Data Management	General
14860	88	1617050257100:1818332267	1617050256531:1966157500	D5170C00001	550	549	ALREADY AVAILABLE	2021-03-30 07:19:37.36	IP and Trial Supplies	IP Documentation
14862	88	1617050258264:776650488	1617050256531:1966157500	D5170C00001	552	549	ALREADY AVAILABLE	2021-03-30 07:19:37.36	IP and Trial Supplies	Non-IP Documentation
8899	84	\N	\N	D5170C00002	2684	2671	NEW	\N	2002046 Armuzzi, Alessandro	05 Site Management
14865	88	1617050260101:-1295884730	1617050259524:402852076	D5170C00001	555	554	ALREADY AVAILABLE	2021-03-30 07:19:37.36	IRB or IEC and other Approvals	IRB or IEC Trial Approval
14870	88	1617050263263:1395428792	1617050262674:662880042	D5170C00001	560	559	ALREADY AVAILABLE	2021-03-30 07:19:37.36	Safety Reporting	General
14873	88	1617050269477:1540118976	1617050268885:1872176242	D5170C00001	563	562	ALREADY AVAILABLE	2021-03-30 07:19:37.36	Site Management	General
14876	88	1617050271364:-1672498684	1617050268885:1872176242	D5170C00001	566	562	ALREADY AVAILABLE	2021-03-30 07:19:37.36	Site Management	Site Management
14880	88	1617050273944:1947605678	1617050268885:1872176242	D5170C00001	570	562	ALREADY AVAILABLE	2021-03-30 07:19:37.36	Site Management	Site Selection
14882	88	1617050276464:838276677	1617050268885:1872176242	D5170C00001	572	562	ALREADY AVAILABLE	2021-03-30 07:19:37.36	Site Management	Site Set-up
14896	88	1617050285516:-2077200952	1617050284810:-1027482747	D5170C00001	586	585	ALREADY AVAILABLE	2021-03-30 07:19:37.36	Site Management	General
14900	88	1617050293538:-772496291	1617050292850:1678689241	D5170C00001	590	589	ALREADY AVAILABLE	2021-03-30 07:19:37.36	Site Management	General
14904	88	1617050296046:963783525	1617050295416:147132828	D5170C00001	594	593	ALREADY AVAILABLE	2021-03-30 07:19:37.36	Central Trial Documents	Subject Documentation
14907	88	1617050299013:-1177326334	1617050297345:-1825080201	D5170C00001	597	596	ALREADY AVAILABLE	2021-03-30 07:19:37.36	Data Management	General
14915	88	1617050305092:654739534	1617050304469:-1294003035	D5170C00001	605	604	ALREADY AVAILABLE	2021-03-30 07:19:37.36	IRB or IEC and other Approvals	General
14917	88	1617050306625:241153458	1617050304469:-1294003035	D5170C00001	607	604	ALREADY AVAILABLE	2021-03-30 07:19:37.361	IRB or IEC and other Approvals	IRB or IEC Trial Approval
14924	88	1617050315167:-529679511	1617050314587:-1033953851	D5170C00001	614	613	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Safety Reporting	General
14927	88	1617050317024:28571891	1617050316365:377275783	D5170C00001	617	616	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Site Management	General
14930	88	1617050318967:298779374	1617050316365:377275783	D5170C00001	620	616	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Site Management	Site Management
14951	88	1617050338880:-397868299	1617050338275:426524344	D5170C00001	641	640	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Central and Local Testing	Facility Documentation
14954	88	1617050340749:1789511559	1617050340141:108057088	D5170C00001	644	643	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Central Trial Documents	Product and Trial Documentation
14974	88	1617050361999:-1924460916	1617050361333:1327386498	D5170C00001	664	663	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Regulatory	General
14984	88	1617050375518:1007244423	1617050363344:-680259090	D5170C00001	674	666	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Site Management	Site Selection
14987	88	1617050379429:189521224	1617050363344:-680259090	D5170C00001	677	666	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Site Management	Site Set-up
15011	88	1617050409583:-1942504120	1617050406160:-216704244	D5170C00001	701	697	ALREADY AVAILABLE	2021-03-30 07:19:37.361	IP and Trial Supplies	Non-IP Documentation
15014	88	1617050411368:440609173	1617050410716:-1461396142	D5170C00001	704	703	ALREADY AVAILABLE	2021-03-30 07:19:37.361	IRB or IEC and other Approvals	General
15019	88	1617050423608:2046577514	1617050410716:-1461396142	D5170C00001	709	703	ALREADY AVAILABLE	2021-03-30 07:19:37.361	IRB or IEC and other Approvals	Trial Status Reporting
15022	88	1617050425448:-2097920705	1617050424754:793235850	D5170C00001	712	711	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Site Management	General
15024	88	1617050426610:-103070449	1617050424754:793235850	D5170C00001	714	711	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Site Management	Site Initiation
15026	88	1617050429138:-1509167003	1617050424754:793235850	D5170C00001	716	711	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Site Management	Site Management
15030	88	1617050431604:-963580672	1617050424754:793235850	D5170C00001	720	711	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Site Management	Site Selection
15053	88	1617050453054:-667832096	1617050452446:1129717580	D5170C00001	743	742	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Site Management	General
8860	84	\N	\N	D5170C00002	2645	2631	NEW	\N	2002045 Andriulli, Angelo	05 Site Management
8861	84	\N	\N	D5170C00002	2646	2645	NEW	\N	05 Site Management	05.01 Site Selection
8863	84	\N	\N	D5170C00002	2648	2646	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
8864	84	\N	\N	D5170C00002	2649	2646	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
8866	84	\N	\N	D5170C00002	2651	2645	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
8867	84	\N	\N	D5170C00002	2652	2651	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
8869	84	\N	\N	D5170C00002	2654	2651	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
8870	84	\N	\N	D5170C00002	2655	2651	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
8871	84	\N	\N	D5170C00002	2656	2651	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
8873	84	\N	\N	D5170C00002	2658	2651	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
8874	84	\N	\N	D5170C00002	2659	2651	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
8876	84	\N	\N	D5170C00002	2661	2651	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
8878	84	\N	\N	D5170C00002	2663	2662	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
8880	84	\N	\N	D5170C00002	2665	2662	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
15068	88	1617050469240:-1603054838	1617050468677:-878648226	D5170C00001	758	757	ALREADY AVAILABLE	2021-03-30 07:19:37.361	IP and Trial Supplies	General
15070	88	1617050470420:-1886459610	1617050468677:-878648226	D5170C00001	760	757	ALREADY AVAILABLE	2021-03-30 07:19:37.361	IP and Trial Supplies	IP Documentation
15073	88	1617050473466:-2115988627	1617050468677:-878648226	D5170C00001	763	757	ALREADY AVAILABLE	2021-03-30 07:19:37.361	IP and Trial Supplies	Non-IP Documentation
15076	88	1617050475324:-1389923857	1617050474720:-2033667756	D5170C00001	766	765	ALREADY AVAILABLE	2021-03-30 07:19:37.361	IRB or IEC and other Approvals	IRB or IEC Trial Approval
15080	88	1617050477857:1154734463	1617050474720:-2033667756	D5170C00001	770	765	ALREADY AVAILABLE	2021-03-30 07:19:37.361	IRB or IEC and other Approvals	Trial Status Reporting
15083	88	1617050479713:796845176	1617050479111:2027851924	D5170C00001	773	772	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Safety Reporting	General
8902	84	\N	\N	D5170C00002	2687	2685	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
15089	88	1617050484731:-727337539	1617050481011:-855896347	D5170C00001	779	775	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Site Management	Site Management
15093	88	1617050487249:-1403378072	1617050481011:-855896347	D5170C00001	783	775	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Site Management	Site Selection
15095	88	1617050488400:1782292050	1617050481011:-855896347	D5170C00001	785	775	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Site Management	Site Set-up
15108	88	1617050502752:-213895435	1617050502162:-1333832447	D5170C00001	798	797	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Trial Management	General
15112	88	1617050505827:1536668770	1617050505235:-560829044	D5170C00001	802	801	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Central and Local Testing	Facility Documentation
15115	88	1617050509085:790979987	1617050508488:-1287592803	D5170C00001	805	804	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Central Trial Documents	Subject Documentation
15118	88	1617050510849:-1194401043	1617050510246:626907397	D5170C00001	808	807	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Data Management	General
15121	88	1617050512674:1353831089	1617050512108:1821544221	D5170C00001	811	810	ALREADY AVAILABLE	2021-03-30 07:19:37.361	IP and Trial Supplies	General
15123	88	1617050513835:-1957036599	1617050512108:1821544221	D5170C00001	813	810	ALREADY AVAILABLE	2021-03-30 07:19:37.361	IP and Trial Supplies	Interactive Response Technology
15125	88	1617050515152:1797300866	1617050512108:1821544221	D5170C00001	815	810	ALREADY AVAILABLE	2021-03-30 07:19:37.361	IP and Trial Supplies	IP Documentation
15128	88	1617050517020:-2029393724	1617050512108:1821544221	D5170C00001	818	810	ALREADY AVAILABLE	2021-03-30 07:19:37.361	IP and Trial Supplies	Non-IP Documentation
15131	88	1617050520197:-1862333602	1617050519626:1358729789	D5170C00001	821	820	ALREADY AVAILABLE	2021-03-30 07:19:37.361	IRB or IEC and other Approvals	General
15133	88	1617050521469:802714645	1617050519626:1358729789	D5170C00001	823	820	ALREADY AVAILABLE	2021-03-30 07:19:37.361	IRB or IEC and other Approvals	IRB or IEC Trial Approval
15205	88	1617050599407:-1617042256	1617050595422:654078825	D5170C00001	895	891	ALREADY AVAILABLE	2021-03-30 07:19:37.361	IRB or IEC and other Approvals	Trial Status Reporting
15219	88	1617050611493:-1740449440	1617050602815:1223614789	D5170C00001	909	900	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Set-up
15231	88	1617050626157:-495152021	1617050625502:1235939744	D5170C00001	921	920	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Trial Management	General
15236	88	1617050630659:680024276	1617050630036:1972484496	D5170C00001	926	925	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Data Management	General
15239	88	1617050632624:982922077	1617050632004:-228110819	D5170C00001	929	928	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IP and Trial Supplies	General
15242	88	1617050635501:-2034462016	1617050632004:-228110819	D5170C00001	932	928	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IP and Trial Supplies	Interactive Response Technology
15244	88	1617050636914:1719875449	1617050632004:-228110819	D5170C00001	934	928	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IP and Trial Supplies	IP Documentation
15247	88	1617050640427:-947623572	1617050632004:-228110819	D5170C00001	937	928	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IP and Trial Supplies	Storage
15250	88	1617050646749:1484156224	1617050641824:-1587562580	D5170C00001	940	939	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IRB or IEC and other Approvals	General
15252	88	1617050647924:460414474	1617050641824:-1587562580	D5170C00001	942	939	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IRB or IEC and other Approvals	IRB or IEC Trial Approval
15255	88	1617050649716:-796397702	1617050641824:-1587562580	D5170C00001	945	939	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IRB or IEC and other Approvals	Trial Status Reporting
15259	88	1617050654065:-1393928514	1617050653361:-728263127	D5170C00001	949	948	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	General
15261	88	1617050655270:600932351	1617050653361:-728263127	D5170C00001	951	948	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Initiation
15263	88	1617050656548:-805153594	1617050653361:-728263127	D5170C00001	953	948	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Management
15266	88	1617050658402:-1069799796	1617050653361:-728263127	D5170C00001	956	948	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Selection
15269	88	1617050660514:-1281271433	1617050653361:-728263127	D5170C00001	959	948	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Set-up
15280	88	1617050669466:-2068259233	1617050668846:190844349	D5170C00001	970	969	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Data Management	General
15291	88	1617050682226:1524840752	1617050670849:-2009750966	D5170C00001	981	972	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IP and Trial Supplies	Storage
15294	88	1617050684498:943165735	1617050683887:925817614	D5170C00001	984	983	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IRB or IEC and other Approvals	General
15297	88	1617050687982:-1250782664	1617050687375:1785042804	D5170C00001	987	986	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Initiation
15299	88	1617050689323:2044400698	1617050687375:1785042804	D5170C00001	989	986	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Management
15302	88	1617050691291:1573402036	1617050687375:1785042804	D5170C00001	992	986	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Selection
15305	88	1617050693346:555633805	1617050687375:1785042804	D5170C00001	995	986	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Set-up
15316	88	1617050710677:1150840618	1617050710016:843282234	D5170C00001	1006	1005	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Central Trial Documents	General
15330	88	1617050721975:-1222777304	1617050714212:150895717	D5170C00001	1020	1011	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IP and Trial Supplies	Storage
15333	88	1617050724360:622796162	1617050723574:-395930804	D5170C00001	1023	1022	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IRB or IEC and other Approvals	General
8881	84	\N	\N	D5170C00002	2666	2645	NEW	\N	05 Site Management	05.04 Site Management
15335	88	1617050725766:-1300797444	1617050723574:-395930804	D5170C00001	1025	1022	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IRB or IEC and other Approvals	IRB or IEC Trial Approval
15338	88	1617050727663:2030809444	1617050723574:-395930804	D5170C00001	1028	1022	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IRB or IEC and other Approvals	Trial Status Reporting
15342	88	1617050730728:-788726276	1617050729850:350475970	D5170C00001	1032	1031	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Initiation
15344	88	1617050733783:2100155075	1617050729850:350475970	D5170C00001	1034	1031	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Management
15365	88	1617050758304:-1255136860	1617050757628:2044852040	D5170C00001	1055	1054	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Central Trial Documents	General
15368	88	1617050760353:-1546652229	1617050759635:-535734351	D5170C00001	1058	1057	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Data Management	General
15371	88	1617050762541:-1956694286	1617050761850:1758735707	D5170C00001	1061	1060	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IP and Trial Supplies	General
15376	88	1617050771863:-2006742527	1617050761850:1758735707	D5170C00001	1066	1060	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IP and Trial Supplies	IP Documentation
15379	88	1617050773985:-579234412	1617050761850:1758735707	D5170C00001	1069	1060	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IP and Trial Supplies	Storage
15382	88	1617050776261:842607161	1617050775453:605540925	D5170C00001	1072	1071	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IRB or IEC and other Approvals	General
15413	88	1617050810870:-888644218	1617050810205:1600279684	D5170C00001	1103	1102	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Selection
15418	88	1617050815602:-785588476	1617050814918:-1004182592	D5170C00001	1108	1107	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Data Management	General
15421	88	1617050817548:-1721806378	1617050816912:1583696798	D5170C00001	1111	1110	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IP and Trial Supplies	General
15423	88	1617050818929:-244209970	1617050816912:1583696798	D5170C00001	1113	1110	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IP and Trial Supplies	Interactive Response Technology
15430	88	1617050824972:-1299851198	1617050816912:1583696798	D5170C00001	1120	1110	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IP and Trial Supplies	Non-IP Documentation
15432	88	1617050826251:875798403	1617050816912:1583696798	D5170C00001	1122	1110	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IP and Trial Supplies	Storage
15435	88	1617050827988:-1355656996	1617050827407:978394460	D5170C00001	1125	1124	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Safety Reporting	General
15438	88	1617050829960:-162273758	1617050829333:1783277051	D5170C00001	1128	1127	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	General
15441	88	1617050831917:313113513	1617050829333:1783277051	D5170C00001	1131	1127	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Management
15444	88	1617050833644:-654554040	1617050829333:1783277051	D5170C00001	1134	1127	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Selection
15446	88	1617050835946:-1472277239	1617050829333:1783277051	D5170C00001	1136	1127	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Set-up
15458	88	1617050850094:-439682772	1617050849382:-1265092320	D5170C00001	1148	1147	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Data Management	General
15461	88	1617050852422:1745141000	1617050851258:539084856	D5170C00001	1151	1150	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IP and Trial Supplies	Interactive Response Technology
15463	88	1617050853631:1345265953	1617050851258:539084856	D5170C00001	1153	1150	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IP and Trial Supplies	IP Allocation Documentation
15465	88	1617050854894:830841681	1617050851258:539084856	D5170C00001	1155	1150	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IP and Trial Supplies	IP Documentation
15468	88	1617050857855:689531599	1617050851258:539084856	D5170C00001	1158	1150	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IP and Trial Supplies	Non-IP Documentation
15470	88	1617050859063:-1429807314	1617050851258:539084856	D5170C00001	1160	1150	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IP and Trial Supplies	Storage
15473	88	1617050860849:-1467241283	1617050860225:1721896167	D5170C00001	1163	1162	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	General
15476	88	1617050862632:1017870028	1617050860225:1721896167	D5170C00001	1166	1162	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Initiation
15478	88	1617050870350:21205140	1617050860225:1721896167	D5170C00001	1168	1162	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Management
15481	88	1617050872260:-43470293	1617050860225:1721896167	D5170C00001	1171	1162	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Selection
15517	88	1617050898051:-1930717269	1617050891415:1530127135	D5170C00001	1207	1197	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IP and Trial Supplies	Storage
15523	88	1617050907469:-499813131	1617050899273:1813224507	D5170C00001	1213	1209	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Initiation
15546	88	1617050923048:-1193322213	1617050921240:-718435360	D5170C00001	1236	1233	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IP and Trial Supplies	IP Allocation Documentation
15548	88	1617050925655:-1707757094	1617050921240:-718435360	D5170C00001	1238	1233	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IP and Trial Supplies	IP Documentation
15551	88	1617050927454:127018451	1617050921240:-718435360	D5170C00001	1241	1233	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IP and Trial Supplies	Storage
15554	88	1617050929268:-1558118965	1617050928710:1665277302	D5170C00001	1244	1243	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Safety Reporting	General
15557	88	1617050931040:-1460771932	1617050930395:-318767639	D5170C00001	1247	1246	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	General
15560	88	1617050932897:-988577970	1617050930395:-318767639	D5170C00001	1250	1246	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Management
15563	88	1617050939311:-646007191	1617050930395:-318767639	D5170C00001	1253	1246	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Selection
15565	88	1617050940499:1931522967	1617050930395:-318767639	D5170C00001	1255	1246	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Set-up
15577	88	1617050949241:1731101429	1617050948680:2001569956	D5170C00001	1267	1266	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Regulatory	General
15581	88	1617050951668:1762534194	1617050951058:291884327	D5170C00001	1271	1270	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Regulatory	General
15584	88	1617050953546:1131839666	1617050952867:-813893695	D5170C00001	1274	1273	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Management
15586	88	1617050954709:1269426546	1617050952867:-813893695	D5170C00001	1276	1273	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Selection
8882	84	\N	\N	D5170C00002	2667	2666	NEW	\N	05.04 Site Management	05.04.04 Visit Log
15806	88	1617051179301:-1644989317	1617051176367:10854053	D5170C00001	1496	1491	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IP and Trial Supplies	Non-IP Documentation
15391	88	1617050790545:39345583	1617050788902:-1730293684	D5170C00001	1081	1080	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	General
15589	88	1617050958991:451713956	1617050952867:-813893695	D5170C00001	1279	1273	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Set-up
15600	88	1617050975449:-219285075	1617050974852:459003653	D5170C00001	1290	1289	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Data Management	General
15605	88	1617050978594:1880187333	1617050976877:1948121318	D5170C00001	1295	1292	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IP and Trial Supplies	Storage
15608	88	1617050980445:-335787479	1617050979777:-1135891685	D5170C00001	1298	1297	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Regulatory	General
15611	88	1617050982920:-362078340	1617050981791:2053286980	D5170C00001	1301	1300	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	General
15615	88	1617050986152:-265813583	1617050981791:2053286980	D5170C00001	1305	1300	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Management
15618	88	1617050987881:-330478407	1617050981791:2053286980	D5170C00001	1308	1300	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Selection
15621	88	1617050994476:-248519494	1617050981791:2053286980	D5170C00001	1311	1300	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Set-up
15647	88	1617051012081:1699682467	1617051009046:-1636058232	D5170C00001	1337	1332	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Management
15650	88	1617051013811:1635007034	1617051009046:-1636058232	D5170C00001	1340	1332	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Selection
15652	88	1617051015079:817283835	1617051009046:-1636058232	D5170C00001	1342	1332	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Set-up
15664	88	1617051030016:684328245	1617051029400:1934203216	D5170C00001	1354	1353	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Data Management	General
15684	88	1617051043188:-1288086683	1617051038795:-359170887	D5170C00001	1374	1368	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Selection
15687	88	1617051044993:-2105799273	1617051038795:-359170887	D5170C00001	1377	1368	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Set-up
15700	88	1617051053704:122453074	1617051053025:502982541	D5170C00001	1390	1389	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IP and Trial Supplies	Interactive Response Technology
15702	88	1617051054940:-1260701007	1617051053025:502982541	D5170C00001	1392	1389	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IP and Trial Supplies	Non-IP Documentation
15705	88	1617051056732:1207254590	1617051053025:502982541	D5170C00001	1395	1389	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IP and Trial Supplies	Storage
15711	88	1617051060916:-941645827	1617051059720:902650262	D5170C00001	1401	1400	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Initiation
15713	88	1617051067740:1749259247	1617051059720:902650262	D5170C00001	1403	1400	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Management
15716	88	1617051069580:1684573205	1617051059720:902650262	D5170C00001	1406	1400	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Selection
15719	88	1617051071540:1064815674	1617051059720:902650262	D5170C00001	1409	1400	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Set-up
15732	88	1617051080493:2064210449	1617051079795:-1547836721	D5170C00001	1422	1421	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Data Management	General
15735	88	1617051082307:-1396322100	1617051081683:1446217372	D5170C00001	1425	1424	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IP and Trial Supplies	Interactive Response Technology
15737	88	1617051083498:1950758544	1617051081683:1446217372	D5170C00001	1427	1424	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IP and Trial Supplies	IP Documentation
15739	88	1617051085807:1926542305	1617051081683:1446217372	D5170C00001	1429	1424	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IP and Trial Supplies	Non-IP Documentation
15741	88	1617051087000:-800130288	1617051081683:1446217372	D5170C00001	1431	1424	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IP and Trial Supplies	Storage
15744	88	1617051088796:1898037300	1617051088166:27430465	D5170C00001	1434	1433	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Safety Reporting	General
15747	88	1617051090697:-1382360068	1617051090042:1240630777	D5170C00001	1437	1436	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Initiation
15749	88	1617051091884:-1888763901	1617051090042:1240630777	D5170C00001	1439	1436	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Management
15752	88	1617051093725:1441814023	1617051090042:1240630777	D5170C00001	1442	1436	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Selection
15755	88	1617051100755:624090824	1617051090042:1240630777	D5170C00001	1445	1436	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Set-up
15768	88	1617051109933:-1229754620	1617051109350:-1343670937	D5170C00001	1458	1457	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IP and Trial Supplies	Interactive Response Technology
15775	88	1617051147345:1582108549	1617051146697:-2060794445	D5170C00001	1465	1464	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Safety Reporting	General
15778	88	1617051149238:-2048493892	1617051148521:-44352931	D5170C00001	1468	1467	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Initiation
15780	88	1617051150412:235164970	1617051148521:-44352931	D5170C00001	1470	1467	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Management
15783	88	1617051153691:775680199	1617051148521:-44352931	D5170C00001	1473	1467	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Selection
15786	88	1617051160575:-449321039	1617051148521:-44352931	D5170C00001	1476	1467	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Set-up
15799	88	1617051169677:157127917	1617051168992:-1885562869	D5170C00001	1489	1488	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Data Management	General
15802	88	1617051177009:-1165311717	1617051176367:10854053	D5170C00001	1492	1491	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IP and Trial Supplies	Interactive Response Technology
15804	88	1617051178161:-780455477	1617051176367:10854053	D5170C00001	1494	1491	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IP and Trial Supplies	IP Allocation Documentation
15809	88	1617051181098:1211537658	1617051180542:-1295188701	D5170C00001	1499	1498	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Safety Reporting	General
15812	88	1617051183487:2144028803	1617051182931:608455615	D5170C00001	1502	1501	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Initiation
15814	88	1617051185477:1230346931	1617051182931:608455615	D5170C00001	1504	1501	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Management
15820	88	1617051189275:-144455774	1617051182931:608455615	D5170C00001	1510	1501	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Set-up
15834	88	1617051198940:-944855929	1617051198257:1896236507	D5170C00001	1524	1523	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Central and Local Testing	Sample Documentation
15839	88	1617051202040:-57295690	1617051200141:971496471	D5170C00001	1529	1526	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Central Trial Documents	Subject Documentation
17504	89	1617049777304:1085508340	rootNode	D5170C00001	1	0	ALREADY AVAILABLE	2021-03-30 16:25:18.509		eTMF
15862	88	1617051222601:918287663	1617051222038:1690238521	D5170C00001	1552	1551	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	General
15870	88	1617051227319:1442344714	1617051222038:1690238521	D5170C00001	1560	1551	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Selection
15874	88	1617051231050:19452071	1617051222038:1690238521	D5170C00001	1564	1551	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Set-up
15888	88	1617051239460:-66775178	1617051238887:-1085961841	D5170C00001	1578	1577	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Central Trial Documents	General
15895	88	1617051253347:1454458511	1617051244541:338362176	D5170C00001	1585	1584	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Data Management	General
15898	88	1617051255552:-1028671313	1617051254873:-1570001406	D5170C00001	1588	1587	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IP and Trial Supplies	Interactive Response Technology
15900	88	1617051256732:2116263717	1617051254873:-1570001406	D5170C00001	1590	1587	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IP and Trial Supplies	IP Documentation
15904	88	1617051259160:-1043437806	1617051254873:-1570001406	D5170C00001	1594	1587	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IP and Trial Supplies	Storage
15907	88	1617051261395:-1705887322	1617051260612:1771879794	D5170C00001	1597	1596	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IRB or IEC and other Approvals	IRB or IEC Trial Approval
15910	88	1617051264338:672904925	1617051260612:1771879794	D5170C00001	1600	1596	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IRB or IEC and other Approvals	Other Committees
15913	88	1617051266832:-1514178003	1617051266195:-560920641	D5170C00001	1603	1602	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	General
15915	88	1617051268067:480672253	1617051266195:-560920641	D5170C00001	1605	1602	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Initiation
15918	88	1617051269881:-925424301	1617051266195:-560920641	D5170C00001	1608	1602	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Management
15921	88	1617051271795:-697836174	1617051266195:-560920641	D5170C00001	1611	1602	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Selection
15924	88	1617051274641:-906178156	1617051266195:-560920641	D5170C00001	1614	1602	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Set-up
15938	88	1617051283376:178708985	1617051282673:1432766198	D5170C00001	1628	1627	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Central Trial Documents	General
15940	88	1617051285805:652595976	1617051282673:1432766198	D5170C00001	1630	1627	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Central Trial Documents	Subject Documentation
15945	88	1617051288853:-1948171321	1617051288265:-1441080999	D5170C00001	1635	1634	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Data Management	General
15948	88	1617051298607:-2136709533	1617051290023:1146692301	D5170C00001	1638	1637	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IP and Trial Supplies	Interactive Response Technology
15950	88	1617051299779:2025892608	1617051290023:1146692301	D5170C00001	1640	1637	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IP and Trial Supplies	IP Documentation
15954	88	1617051302245:-1450958399	1617051290023:1146692301	D5170C00001	1644	1637	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IP and Trial Supplies	Storage
15957	88	1617051303998:-1566993405	1617051303404:193606205	D5170C00001	1647	1646	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IRB or IEC and other Approvals	IRB or IEC Trial Approval
15960	88	1617051305856:403491730	1617051303404:193606205	D5170C00001	1650	1646	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IRB or IEC and other Approvals	Other Committees
15963	88	1617051310609:-1343289251	1617051309968:1546370631	D5170C00001	1653	1652	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	General
15966	88	1617051312421:158138468	1617051309968:1546370631	D5170C00001	1656	1652	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Initiation
15969	88	1617051314302:-1247947477	1617051309968:1546370631	D5170C00001	1659	1652	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Management
15972	88	1617051316292:-1020391177	1617051309968:1546370631	D5170C00001	1662	1652	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Selection
15975	88	1617051318031:-2130356718	1617051309968:1546370631	D5170C00001	1665	1652	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Set-up
16009	88	1617051351150:1260822380	1617051350504:335083347	D5170C00001	1699	1698	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IRB or IEC and other Approvals	IRB or IEC Trial Approval
16021	88	1617051359155:1468148407	1617051356725:1804396904	D5170C00001	1711	1707	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Initiation
16025	88	1617051361552:62062462	1617051356725:1804396904	D5170C00001	1715	1707	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Management
16028	88	1617051363367:292833289	1617051356725:1804396904	D5170C00001	1718	1707	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Selection
16031	88	1617051365201:-524879301	1617051356725:1804396904	D5170C00001	1721	1707	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Set-up
16046	88	1617051383986:-1377720498	1617051383401:902099672	D5170C00001	1736	1735	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Central and Local Testing	Sample Documentation
16049	88	1617051385807:-462599726	1617051385239:175335913	D5170C00001	1739	1738	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Central Trial Documents	General
16054	88	1617051388846:1888496182	1617051388251:-1711931435	D5170C00001	1744	1743	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Data Management	General
16078	88	1617051405136:-233742438	1617051399678:1190532078	D5170C00001	1768	1759	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Selection
16081	88	1617051406941:-1249314606	1617051399678:1190532078	D5170C00001	1771	1759	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Set-up
16096	88	1617051421041:1808517053	1617051420418:1160130113	D5170C00001	1786	1785	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	General
16105	88	1617051426566:21106758	1617051424711:-1522239403	D5170C00001	1795	1792	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Central Trial Documents	Subject Documentation
16109	88	1617051429230:2006799232	1617051428635:392271406	D5170C00001	1799	1798	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Data Management	General
16122	88	1617051438709:-1638432524	1617051436168:1828897461	D5170C00001	1812	1808	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IRB or IEC and other Approvals	Other Committees
16125	88	1617051440530:1273505835	1617051439945:-1113294800	D5170C00001	1815	1814	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	General
16127	88	1617051446143:-828741018	1617051439945:-1113294800	D5170C00001	1817	1814	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Initiation
16130	88	1617051447941:2060129724	1617051439945:-1113294800	D5170C00001	1820	1814	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Management
16133	88	1617051449798:1502159062	1617051439945:-1113294800	D5170C00001	1823	1814	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Selection
16136	88	1617051451517:979818469	1617051439945:-1113294800	D5170C00001	1826	1814	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Set-up
16151	88	1617051461778:-2095242641	1617051461198:-493718346	D5170C00001	1841	1840	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Central and Local Testing	General
16154	88	1617051464866:-1903743660	1617051462939:-727186876	D5170C00001	1844	1843	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Central Trial Documents	General
16158	88	1617051467364:-2029712696	1617051466692:989379483	D5170C00001	1848	1847	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Data Management	General
16163	88	1617051470759:1373549070	1617051468525:-1211205223	D5170C00001	1853	1850	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IP and Trial Supplies	Interactive Response Technology
16165	88	1617051471889:1241173306	1617051468525:-1211205223	D5170C00001	1855	1850	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IP and Trial Supplies	IP Documentation
16168	88	1617051473791:-1626285875	1617051468525:-1211205223	D5170C00001	1858	1850	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IP and Trial Supplies	Storage
16174	88	1617051482517:1848509389	1617051480142:-321919943	D5170C00001	1864	1860	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Initiation
16181	88	1617051487976:377748011	1617051480142:-321919943	D5170C00001	1871	1860	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Selection
16184	88	1617051489675:-848292909	1617051480142:-321919943	D5170C00001	1874	1860	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Set-up
16203	88	1617051508350:335862163	1617051507774:432053920	D5170C00001	1893	1892	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Data Management	General
16211	88	1617051515248:-655445431	1617051510979:-1966549499	D5170C00001	1901	1895	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IP and Trial Supplies	Non-IP Documentation
16213	88	1617051516874:1320095484	1617051510979:-1966549499	D5170C00001	1903	1895	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IP and Trial Supplies	Storage
16216	88	1617051518723:1654198188	1617051518128:-1077200565	D5170C00001	1906	1905	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	General
16219	88	1617051521930:-1876364631	1617051518128:-1077200565	D5170C00001	1909	1905	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Management
16223	88	1617051524393:-1334830938	1617051518128:-1077200565	D5170C00001	1913	1905	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Selection
16225	88	1617051525539:1536193424	1617051518128:-1077200565	D5170C00001	1915	1905	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Set-up
16242	88	1617051540871:453979375	1617051540274:409679484	D5170C00001	1932	1931	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Central Trial Documents	General
16245	88	1617051543316:-1352271444	1617051542055:-1562554763	D5170C00001	1935	1934	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Data Management	General
16256	88	1617051549813:-529203249	1617051549268:814903981	D5170C00001	1946	1945	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	General
16260	88	1617051552139:59561062	1617051549268:814903981	D5170C00001	1950	1945	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Management
16265	88	1617051559484:-203133084	1617051549268:814903981	D5170C00001	1955	1945	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Selection
16268	88	1617051561626:-822837570	1617051549268:814903981	D5170C00001	1958	1945	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Set-up
16284	88	1617051572433:-218521472	1617051570626:2016539822	D5170C00001	1974	1971	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IP and Trial Supplies	IP Documentation
16286	88	1617051573651:-1142260688	1617051570626:2016539822	D5170C00001	1976	1971	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IP and Trial Supplies	Non-IP Documentation
16291	88	1617051577421:1984810468	1617051575574:-1503063946	D5170C00001	1981	1978	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Management
16296	88	1617051580719:1514087640	1617051575574:-1503063946	D5170C00001	1986	1978	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Selection
16299	88	1617051582575:204087676	1617051575574:-1503063946	D5170C00001	1989	1978	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Set-up
16313	88	1617051592376:-727863300	1617051591796:372971267	D5170C00001	2003	2002	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IP and Trial Supplies	Interactive Response Technology
16315	88	1617051593584:-1268493131	1617051591796:372971267	D5170C00001	2005	2002	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IP and Trial Supplies	IP Documentation
16317	88	1617051594747:-1900085486	1617051591796:372971267	D5170C00001	2007	2002	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IP and Trial Supplies	Non-IP Documentation
16320	88	1617051597487:-392127918	1617051596016:-246562775	D5170C00001	2010	2009	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Initiation
16322	88	1617051598904:-1798224472	1617051596016:-246562775	D5170C00001	2012	2009	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Management
16326	88	1617051607218:-1862910514	1617051596016:-246562775	D5170C00001	2016	2009	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Selection
16329	88	1617051610102:1204000152	1617051596016:-246562775	D5170C00001	2019	2009	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Set-up
16341	88	1617051617715:-55469056	1617051617147:-588691388	D5170C00001	2031	2030	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Selection
16368	88	1617051644252:-1864444558	1617051634105:2061260707	D5170C00001	2058	2054	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IP and Trial Supplies	Interactive Response Technology
16370	88	1617051645462:-1502442975	1617051634105:2061260707	D5170C00001	2060	2054	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IP and Trial Supplies	IP Documentation
16374	88	1617051647838:1950696612	1617051634105:2061260707	D5170C00001	2064	2054	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IP and Trial Supplies	Non-IP Documentation
16377	88	1617051649575:-565645146	1617051634105:2061260707	D5170C00001	2067	2054	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IP and Trial Supplies	Storage
16380	88	1617051651360:-655738977	1617051650732:1308315124	D5170C00001	2070	2069	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IRB or IEC and other Approvals	General
16385	88	1617051655510:-961442356	1617051654910:-411539375	D5170C00001	2075	2074	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Regulatory	General
6490	84	\N	\N	D5170C00002	275	273	NEW	\N	05.05 General	05.05.02 Tracking Information
16394	88	1617051661159:2122344217	1617051658601:-1400747048	D5170C00001	2084	2080	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Initiation
16397	88	1617051663157:716247663	1617051658601:-1400747048	D5170C00001	2087	2080	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Management
16401	88	1617051669750:1061884443	1617051658601:-1400747048	D5170C00001	2091	2080	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Selection
16404	88	1617051671572:-658448952	1617051658601:-1400747048	D5170C00001	2094	2080	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Set-up
16417	88	1617051680876:-590282257	1617051680333:159582786	D5170C00001	2107	2106	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Central and Local Testing	General
16419	88	1617051682054:474583948	1617051680333:159582786	D5170C00001	2109	2106	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Central and Local Testing	Sample Documentation
16422	88	1617051683853:-2050834138	1617051683273:-567170364	D5170C00001	2112	2111	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Central Trial Documents	General
16427	88	1617051693079:1351726709	1617051687370:936985796	D5170C00001	2117	2116	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Data Management	EDC Management
16429	88	1617051694262:-2058771409	1617051687370:936985796	D5170C00001	2119	2116	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Data Management	General
16457	88	1617051721482:1197692574	1617051711732:-1356218563	D5170C00001	2147	2143	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Initiation
16463	88	1617051725178:-273100631	1617051711732:-1356218563	D5170C00001	2153	2143	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Selection
16466	88	1617051726989:-680554053	1617051711732:-1356218563	D5170C00001	2156	2143	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Set-up
16482	88	1617051737342:-1500149096	1617051736766:-1189510020	D5170C00001	2172	2171	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Central Trial Documents	General
16485	88	1617051739139:443705431	1617051736766:-1189510020	D5170C00001	2175	2171	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Central Trial Documents	Product and Trial Documentation
16488	88	1617051740919:-176552001	1617051740336:921969211	D5170C00001	2178	2177	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Data Management	EDC Management
16496	88	1617051746527:1542196342	1617051744204:-1278615495	D5170C00001	2186	2182	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IP and Trial Supplies	Interactive Response Technology
16502	88	1617051750158:865454839	1617051744204:-1278615495	D5170C00001	2192	2182	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IP and Trial Supplies	Non-IP Documentation
16508	88	1617051754774:1457307700	1617051754183:1570914677	D5170C00001	2198	2197	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IRB or IEC and other Approvals	General
16515	88	1617051759631:476919452	1617051759057:753734028	D5170C00001	2205	2204	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Regulatory	General
16518	88	1617051761376:-1887528791	1617051760741:-762366816	D5170C00001	2208	2207	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	General
16521	88	1617051768377:714623318	1617051760741:-762366816	D5170C00001	2211	2207	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Initiation
16524	88	1617051770192:-1298785698	1617051760741:-762366816	D5170C00001	2214	2207	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Management
16527	88	1617051771975:-756148669	1617051760741:-762366816	D5170C00001	2217	2207	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Selection
16530	88	1617051773702:1818442796	1617051760741:-762366816	D5170C00001	2220	2207	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Set-up
16543	88	1617051782466:-1895893737	1617051781827:1009552632	D5170C00001	2233	2232	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Central and Local Testing	General
16547	88	1617051786000:-455772204	1617051784501:282788873	D5170C00001	2237	2236	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Central Trial Documents	General
16549	88	1617051787207:1783411884	1617051784501:282788873	D5170C00001	2239	2236	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Central Trial Documents	Product and Trial Documentation
16552	88	1617051788894:1799614986	1617051788334:-1900699192	D5170C00001	2242	2241	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Data Management	EDC Management
16554	88	1617051795480:2076771702	1617051788334:-1900699192	D5170C00001	2244	2241	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Data Management	General
16557	88	1617051798192:1749476784	1617051797523:193694007	D5170C00001	2247	2246	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IP and Trial Supplies	General
16560	88	1617051800011:1584003966	1617051797523:193694007	D5170C00001	2250	2246	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IP and Trial Supplies	IP Documentation
16564	88	1617051802416:1152552124	1617051797523:193694007	D5170C00001	2254	2246	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IP and Trial Supplies	Non-IP Documentation
16567	88	1617051804121:-1166853039	1617051797523:193694007	D5170C00001	2257	2246	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IP and Trial Supplies	Storage
16570	88	1617051806140:-1242465374	1617051805400:-759370871	D5170C00001	2260	2259	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IRB or IEC and other Approvals	General
16572	88	1617051808411:1831685660	1617051805400:-759370871	D5170C00001	2262	2259	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IRB or IEC and other Approvals	IRB or IEC Trial Approval
16574	88	1617051809813:116616543	1617051805400:-759370871	D5170C00001	2264	2259	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IRB or IEC and other Approvals	Other Committees
16577	88	1617051811681:2100458680	1617051811032:1815773753	D5170C00001	2267	2266	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Regulatory	General
16580	88	1617051813448:-628229041	1617051812847:709985122	D5170C00001	2270	2269	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	General
16583	88	1617051815406:-2025746494	1617051812847:709985122	D5170C00001	2273	2269	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Initiation
16586	88	1617051817282:452875689	1617051812847:709985122	D5170C00001	2276	2269	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Management
16589	88	1617051820206:388189647	1617051812847:709985122	D5170C00001	2279	2269	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Selection
16617	88	1617051844090:511004515	1617051841553:-444954540	D5170C00001	2307	2303	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Central Trial Documents	Product and Trial Documentation
16620	88	1617051846041:1388766875	1617051845408:980345505	D5170C00001	2310	2309	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Data Management	EDC Management
16628	88	1617051851399:576968967	1617051848710:-320832923	D5170C00001	2318	2314	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IP and Trial Supplies	Interactive Response Technology
16634	88	1617051856001:-1294540202	1617051848710:-320832923	D5170C00001	2324	2314	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IP and Trial Supplies	Non-IP Documentation
16637	88	1617051864799:681000713	1617051848710:-320832923	D5170C00001	2327	2314	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IP and Trial Supplies	Storage
16640	88	1617051866650:-151019709	1617051866008:-1273908410	D5170C00001	2330	2329	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IRB or IEC and other Approvals	General
16642	88	1617051867869:-764555336	1617051866008:-1273908410	D5170C00001	2332	2329	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IRB or IEC and other Approvals	IRB or IEC Trial Approval
16644	88	1617051869119:1208030381	1617051866008:-1273908410	D5170C00001	2334	2329	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IRB or IEC and other Approvals	Other Committees
16647	88	1617051870881:-894193012	1617051870298:890998264	D5170C00001	2337	2336	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Regulatory	General
16650	88	1617051872679:143709618	1617051872103:-211586449	D5170C00001	2340	2339	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	General
16653	88	1617051875818:1239132378	1617051872103:-211586449	D5170C00001	2343	2339	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	Site Initiation
16656	88	1617051877638:125140249	1617051872103:-211586449	D5170C00001	2346	2339	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	Site Management
16659	88	1617051879521:667777278	1617051872103:-211586449	D5170C00001	2349	2339	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	Site Selection
16662	88	1617051881424:-556958735	1617051872103:-211586449	D5170C00001	2352	2339	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	Site Set-up
16674	88	1617051893802:721860238	1617051893192:-1185088104	D5170C00001	2364	2363	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Trial Management	General
16678	88	1617051902152:617116802	1617051895712:-696943926	D5170C00001	2368	2367	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Central Trial Documents	General
16680	88	1617051903448:-1733995967	1617051895712:-696943926	D5170C00001	2370	2367	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Central Trial Documents	Product and Trial Documentation
16683	88	1617051905385:922826437	1617051904629:-1099619999	D5170C00001	2373	2372	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IP and Trial Supplies	General
16685	88	1617051906657:1249736474	1617051904629:-1099619999	D5170C00001	2375	2372	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IP and Trial Supplies	IP Documentation
16688	88	1617051908471:-81121646	1617051904629:-1099619999	D5170C00001	2378	2372	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IP and Trial Supplies	Non-IP Documentation
16691	88	1617051910172:1894419269	1617051904629:-1099619999	D5170C00001	2381	2372	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IP and Trial Supplies	Storage
16694	88	1617051912086:714379135	1617051911438:-2049470350	D5170C00001	2384	2383	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IRB or IEC and other Approvals	General
16696	88	1617051914213:-801692425	1617051911438:-2049470350	D5170C00001	2386	2383	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IRB or IEC and other Approvals	IRB or IEC Trial Approval
16698	88	1617051915400:-1614161955	1617051911438:-2049470350	D5170C00001	2388	2383	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IRB or IEC and other Approvals	Other Committees
16701	88	1617051917303:-1394328483	1617051916721:-1991354600	D5170C00001	2391	2390	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Safety Reporting	General
16704	88	1617051923017:910496300	1617051922463:-990437179	D5170C00001	2394	2393	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	General
16707	88	1617051925572:2002725751	1617051922463:-990437179	D5170C00001	2397	2393	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	Site Initiation
16710	88	1617051927290:888680577	1617051922463:-990437179	D5170C00001	2400	2393	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	Site Management
16729	88	1617051940357:-610164440	1617051939690:225203587	D5170C00001	2419	2418	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Central Trial Documents	General
16731	88	1617051947299:1625730858	1617051939690:225203587	D5170C00001	2421	2418	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Central Trial Documents	Product and Trial Documentation
16734	88	1617051949087:-1979556020	1617051948429:-469502648	D5170C00001	2424	2423	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IP and Trial Supplies	General
16736	88	1617051950238:-1944697363	1617051948429:-469502648	D5170C00001	2426	2423	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IP and Trial Supplies	IP Documentation
16739	88	1617051952037:-2084129652	1617051948429:-469502648	D5170C00001	2429	2423	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IP and Trial Supplies	Non-IP Documentation
16743	88	1617051954436:1318013755	1617051953884:-1422588744	D5170C00001	2433	2432	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IRB or IEC and other Approvals	General
16745	88	1617051955610:1196839765	1617051953884:-1422588744	D5170C00001	2435	2432	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IRB or IEC and other Approvals	IRB or IEC Trial Approval
16748	88	1617051958332:1202718462	1617051957706:-872196229	D5170C00001	2438	2437	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Safety Reporting	General
16751	88	1617051960115:1642261440	1617051959552:949324400	D5170C00001	2441	2440	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	General
16753	88	1617051961288:-657855600	1617051959552:949324400	D5170C00001	2443	2440	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	Site Initiation
16756	88	1617051963011:-1571685998	1617051959552:949324400	D5170C00001	2446	2440	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	Site Management
16759	88	1617051971556:-1226059827	1617051959552:949324400	D5170C00001	2449	2440	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	Site Selection
16762	88	1617051973346:1348595292	1617051959552:949324400	D5170C00001	2452	2440	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	Site Set-up
16833	88	1617052035945:-246890470	1617052035339:2044345600	D5170C00001	2523	2522	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Central Trial Documents	Subject Documentation
16836	88	1617052037940:743038637	1617052037157:-336121496	D5170C00001	2526	2525	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Data Management	General
16855	88	1617052050799:-385507727	1617052048398:1782105700	D5170C00001	2545	2541	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	Site Initiation
16857	88	1617052052073:-1988784883	1617052048398:1782105700	D5170C00001	2547	2541	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	Site Management
16860	88	1617052053847:1946304727	1617052048398:1782105700	D5170C00001	2550	2541	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	Site Selection
16864	88	1617052057507:1423773172	1617052048398:1782105700	D5170C00001	2554	2541	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	Site Set-up
16877	88	1617052073027:1819467264	1617052072235:-2091444463	D5170C00001	2567	2566	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Trial Management	Trial Oversight
16881	88	1617052075531:-1260041289	1617052074879:1752429366	D5170C00001	2571	2570	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Central and Local Testing	Facility Documentation
16884	88	1617052077420:71147089	1617052076801:123119065	D5170C00001	2574	2573	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Central Trial Documents	Subject Documentation
16887	88	1617052080702:787241645	1617052080046:-1354812098	D5170C00001	2577	2576	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Data Management	General
16890	88	1617052082532:-1070486015	1617052081883:132226203	D5170C00001	2580	2579	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IP and Trial Supplies	IP Documentation
16894	88	1617052091843:-1938637842	1617052089878:-820881111	D5170C00001	2584	2583	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IRB or IEC and other Approvals	IRB or IEC Trial Approval
16899	88	1617052096128:804283198	1617052089878:-820881111	D5170C00001	2589	2583	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IRB or IEC and other Approvals	Trial Status Reporting
16902	88	1617052098024:666055170	1617052097430:729000263	D5170C00001	2592	2591	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	General
16904	88	1617052099206:1745572203	1617052097430:729000263	D5170C00001	2594	2591	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	Site Management
16907	88	1617052101116:1680886161	1617052097430:729000263	D5170C00001	2597	2591	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	Site Selection
16909	88	1617052103517:863173571	1617052097430:729000263	D5170C00001	2599	2591	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	Site Set-up
16924	88	1617052114134:-175040892	1617052113456:2039893700	D5170C00001	2614	2613	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Central Trial Documents	Subject Documentation
16928	88	1617052116580:-88006519	1617052116002:-750864391	D5170C00001	2618	2617	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Data Management	General
16931	88	1617052118488:-697672242	1617052117903:1343518199	D5170C00001	2621	2620	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IP and Trial Supplies	General
16933	88	1617052120069:-1273361792	1617052117903:1343518199	D5170C00001	2623	2620	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IP and Trial Supplies	IP Documentation
16939	88	1617052125009:1008845714	1617052121840:193293937	D5170C00001	2629	2626	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IRB or IEC and other Approvals	IRB or IEC Trial Approval
16951	88	1617052133144:700993632	1617052130628:1662639321	D5170C00001	2641	2637	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	Site Management
16970	88	1617052147273:1431985492	1617052145510:709388340	D5170C00001	2660	2659	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	General
16987	88	1617052165048:-1251433130	1617052164469:269511701	D5170C00001	2677	2676	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IP and Trial Supplies	General
16989	88	1617052166248:-921340393	1617052164469:269511701	D5170C00001	2679	2676	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IP and Trial Supplies	IP Documentation
16998	88	1617052173178:-426181613	1617052172506:-1114626973	D5170C00001	2688	2687	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Safety Reporting	General
17001	88	1617052175222:304882754	1617052174479:1195966503	D5170C00001	2691	2690	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	General
17004	88	1617052176983:-1585017554	1617052174479:1195966503	D5170C00001	2694	2690	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	Site Initiation
17006	88	1617052178200:404478737	1617052174479:1195966503	D5170C00001	2696	2690	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	Site Management
17010	88	1617052186543:828939805	1617052174479:1195966503	D5170C00001	2700	2690	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	Site Selection
17012	88	1617052188373:-477941113	1617052174479:1195966503	D5170C00001	2702	2690	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	Site Set-up
17034	88	1617052204961:-2124480324	1617052204288:-798043798	D5170C00001	2724	2723	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IP and Trial Supplies	General
17040	88	1617052208732:-1462452139	1617052208169:2133546407	D5170C00001	2730	2729	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IRB or IEC and other Approvals	IRB or IEC Trial Approval
17043	88	1617052210642:1575692372	1617052208169:2133546407	D5170C00001	2733	2729	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IRB or IEC and other Approvals	Trial Status Reporting
17046	88	1617052217799:558939653	1617052217060:1994555818	D5170C00001	2736	2735	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Safety Reporting	General
17049	88	1617052219841:-434680426	1617052219165:-889192453	D5170C00001	2739	2738	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	General
17052	88	1617052221721:644868434	1617052219165:-889192453	D5170C00001	2742	2738	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	Site Management
17056	88	1617052224236:-27183115	1617052219165:-889192453	D5170C00001	2746	2738	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	Site Selection
17058	88	1617052226758:-844895705	1617052219165:-889192453	D5170C00001	2748	2738	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	Site Set-up
17081	88	1617052249172:-1210357819	1617052247211:-1737804858	D5170C00001	2771	2770	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IP and Trial Supplies	General
17083	88	1617052250611:-1494006598	1617052247211:-1737804858	D5170C00001	2773	2770	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IP and Trial Supplies	IP Documentation
17088	88	1617052253661:113346992	1617052253073:1604065733	D5170C00001	2778	2777	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IRB or IEC and other Approvals	General
17093	88	1617052256900:-1875113118	1617052253073:1604065733	D5170C00001	2783	2777	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IRB or IEC and other Approvals	Trial Status Reporting
17096	88	1617052260044:-531955583	1617052258119:1954328344	D5170C00001	2786	2785	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Safety Reporting	General
17099	88	1617052261919:1685251453	1617052261315:-318903547	D5170C00001	2789	2788	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	General
17102	88	1617052263817:-614865587	1617052261315:-318903547	D5170C00001	2792	2788	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	Site Initiation
17104	88	1617052277702:-2020962141	1617052261315:-318903547	D5170C00001	2794	2788	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	Site Management
17108	88	1617052280045:1716978694	1617052261315:-318903547	D5170C00001	2798	2788	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	Site Selection
17110	88	1617052281159:1391595914	1617052261315:-318903547	D5170C00001	2800	2788	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	Site Set-up
17123	88	1617052294962:-227010689	1617052289712:-1410549336	D5170C00001	2813	2812	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Trial Management	Trial Oversight
17127	88	1617052297295:-7015142	1617052296723:-1930996861	D5170C00001	2817	2816	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Central Trial Documents	Subject Documentation
17130	88	1617052299003:-869605419	1617052298390:-216711437	D5170C00001	2820	2819	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Data Management	General
17133	88	1617052300857:-944269136	1617052300163:1877660544	D5170C00001	2823	2822	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IP and Trial Supplies	General
17135	88	1617052302041:-1227886088	1617052300163:1877660544	D5170C00001	2825	2822	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IP and Trial Supplies	IP Documentation
17139	88	1617052305313:6491038	1617052304706:632395760	D5170C00001	2829	2828	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IRB or IEC and other Approvals	IRB or IEC Trial Approval
17142	88	1617052307191:-1050170016	1617052304706:632395760	D5170C00001	2832	2828	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IRB or IEC and other Approvals	Trial Status Reporting
17145	88	1617052308977:2000768062	1617052308434:1593185360	D5170C00001	2835	2834	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Safety Reporting	General
17148	88	1617052310759:1407892748	1617052310176:-1290552302	D5170C00001	2838	2837	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	General
17190	88	1617052346899:-311508770	1617052346345:38530612	D5170C00001	2880	2879	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Safety Reporting	General
17193	88	1617052349908:-1671940381	1617052349308:1039310116	D5170C00001	2883	2882	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	General
17221	88	1617052374783:-1479937613	1617052374108:-2052785508	D5170C00001	2911	2910	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IP and Trial Supplies	IP Documentation
17234	88	1617052383971:-2096296941	1617052382004:-1241186050	D5170C00001	2924	2923	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	General
17237	88	1617052385879:-1213780157	1617052382004:-1241186050	D5170C00001	2927	2923	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	Site Management
17241	88	1617052388263:-1885884751	1617052382004:-1241186050	D5170C00001	2931	2923	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	Site Selection
17243	88	1617052389524:1591359346	1617052382004:-1241186050	D5170C00001	2933	2923	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	Site Set-up
17260	88	1617052408057:671714097	1617052407504:1800759500	D5170C00001	2950	2949	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Central Trial Documents	Subject Documentation
17263	88	1617052409766:-157007580	1617052409191:-1072207150	D5170C00001	2953	2952	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Data Management	General
17266	88	1617052411575:842770780	1617052410969:1022164831	D5170C00001	2956	2955	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IP and Trial Supplies	General
17268	88	1617052412840:677181263	1617052410969:1022164831	D5170C00001	2958	2955	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IP and Trial Supplies	IP Documentation
17272	88	1617052415150:-951067260	1617052414587:364440123	D5170C00001	2962	2961	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IRB or IEC and other Approvals	IRB or IEC Trial Approval
17275	88	1617052418513:2087077251	1617052414587:364440123	D5170C00001	2965	2961	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IRB or IEC and other Approvals	Trial Status Reporting
17278	88	1617052420258:-1947535890	1617052419700:127162658	D5170C00001	2968	2967	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Safety Reporting	General
17281	88	1617052422075:1231131625	1617052421410:1538392292	D5170C00001	2971	2970	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	General
17284	88	1617052423900:-1561453142	1617052421410:1538392292	D5170C00001	2974	2970	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	Site Initiation
17286	88	1617052425099:1819885327	1617052421410:1538392292	D5170C00001	2976	2970	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	Site Management
17290	88	1617052427438:1262742167	1617052421410:1538392292	D5170C00001	2980	2970	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	Site Selection
17292	88	1617052430313:937497304	1617052421410:1538392292	D5170C00001	2982	2970	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	Site Set-up
17310	88	1617052442936:-1058772421	1617052439453:-740759095	D5170C00001	3000	2997	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IP and Trial Supplies	IP Documentation
17317	88	1617052447646:243971903	1617052445277:-1989259624	D5170C00001	3007	3003	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IRB or IEC and other Approvals	Trial Status Reporting
17323	88	1617052451217:-1316900603	1617052450649:382865700	D5170C00001	3013	3012	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	General
17325	88	1617052454137:-549313426	1617052450649:382865700	D5170C00001	3015	3012	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	Site Management
17331	88	1617052457633:-824335942	1617052450649:382865700	D5170C00001	3021	3012	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	Site Set-up
17343	88	1617052475910:1123804712	1617052475368:-10509717	D5170C00001	3033	3032	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Central Trial Documents	Subject Documentation
17346	88	1617052478386:915132062	1617052477064:1296593149	D5170C00001	3036	3035	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Data Management	General
17396	88	1617052514916:-264826285	1617052514364:566366140	D5170C00001	3086	3085	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IP and Trial Supplies	General
17401	88	1617052517762:1489581258	1617052514364:566366140	D5170C00001	3091	3085	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IP and Trial Supplies	Storage
17404	88	1617052519495:-2073008828	1617052518861:-583677769	D5170C00001	3094	3093	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IRB or IEC and other Approvals	General
17406	88	1617052520597:1198206109	1617052518861:-583677769	D5170C00001	3096	3093	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IRB or IEC and other Approvals	IRB or IEC Trial Approval
17410	88	1617052523845:-58616676	1617052518861:-583677769	D5170C00001	3100	3093	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IRB or IEC and other Approvals	Trial Status Reporting
17413	88	1617052526267:1602848431	1617052525623:81718616	D5170C00001	3103	3102	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Safety Reporting	General
17416	88	1617052528072:1933751190	1617052527421:590104656	D5170C00001	3106	3105	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	General
17419	88	1617052529725:-1281762727	1617052527421:590104656	D5170C00001	3109	3105	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	Site Management
17423	88	1617052532083:-1953729404	1617052527421:590104656	D5170C00001	3113	3105	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	Site Selection
17425	88	1617052534244:1720408852	1617052527421:590104656	D5170C00001	3115	3105	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	Site Set-up
17441	88	1617052558654:-927996579	1617052549741:1204800851	D5170C00001	3131	3130	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Central Trial Documents	Subject Documentation
15912	88	1617051266195:-560920641	1617051238334:-593288517	D5170C00001	1602	1576	ALREADY AVAILABLE	2021-03-30 07:19:37.333	4102	Site Management
17444	88	1617052560354:1456838545	1617052559748:-272854478	D5170C00001	3134	3133	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Data Management	General
17463	88	1617052577752:1181948729	1617052574384:1927379706	D5170C00001	3153	3149	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	Site Management
17465	88	1617052578989:1524381591	1617052574384:1927379706	D5170C00001	3155	3149	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	Site Selection
17467	88	1617052580110:299539488	1617052574384:1927379706	D5170C00001	3157	3149	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	Site Set-up
17487	88	1617052597849:-1774507897	1617052597203:-1936537458	D5170C00001	3177	3176	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IP and Trial Supplies	General
17493	88	1617052602756:191533864	1617052602169:794880407	D5170C00001	3183	3182	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IRB or IEC and other Approvals	IRB or IEC Trial Approval
17496	88	1617052604486:-1065288921	1617052602169:794880407	D5170C00001	3186	3182	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IRB or IEC and other Approvals	Trial Status Reporting
17499	88	1617052606275:1790585508	1617052605658:1053104843	D5170C00001	3189	3188	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Safety Reporting	General
14887	88	1617081843550:-1622162167	1617050276464:838276677	D5170C00001	577	572	CREATE	2021-03-30 07:24:03.639	Site Set-up	Other Financial Agreement
14891	88	1617081845882:691944938	1617050276464:838276677	D5170C00001	581	572	CREATE	2021-03-30 07:24:05.964	Site Set-up	Site Signature Sheet
14905	88	1617081849476:878193021	1617050296046:963783525	D5170C00001	595	594	CREATE	2021-03-30 07:24:09.562	Subject Documentation	Informed Consent Form
14908	88	1617081850065:933082277	1617050299013:-1177326334	D5170C00001	598	597	CREATE	2021-03-30 07:24:10.151	General	Tracking Information
14935	88	1617081862447:377897521	1617050322829:436069202	D5170C00001	625	624	CREATE	2021-03-30 07:24:22.533	Site Selection	Confidentiality Agreement
14941	88	1617081866449:-1104149615	1617050324770:26621288	D5170C00001	631	627	CREATE	2021-03-30 07:24:26.534	Site Set-up	Investigator Regulatory Agreement
14957	88	1617081872245:-319742714	1617050342048:1046354918	D5170C00001	647	646	CREATE	2021-03-30 07:24:32.333	Subject Documentation	Informed Consent Form
14966	88	1617081875646:-1613932592	1617050356086:1799449075	D5170C00001	656	655	CREATE	2021-03-30 07:24:35.73	General	Relevant Communications
14969	88	1617081877404:1598258925	1617050357411:775707325	D5170C00001	659	657	CREATE	2021-03-30 07:24:37.491	IRB or IEC Trial Approval	IRB or IEC Composition
14979	88	1617081880380:-1389753693	1617050364013:599747112	D5170C00001	669	667	CREATE	2021-03-30 07:24:40.469	General	Relevant Communications
14982	88	1617081881626:-1717644008	1617050372860:663591526	D5170C00001	672	670	CREATE	2021-03-30 07:24:41.71	Site Management	Protocol Deviations
14983	88	1617081882179:1547020864	1617050372860:663591526	D5170C00001	673	670	CREATE	2021-03-30 07:24:42.266	Site Management	Visit Log
14990	88	1617081886331:1008584308	1617050379429:189521224	D5170C00001	680	677	CREATE	2021-03-30 07:24:46.419	Site Set-up	Financial Disclosure Form
14991	88	1617081887007:2114821848	1617050379429:189521224	D5170C00001	681	677	CREATE	2021-03-30 07:24:47.096	Site Set-up	Investigator Regulatory Agreement
14995	88	1617081898890:827984872	1617050379429:189521224	D5170C00001	685	677	CREATE	2021-03-30 07:24:58.974	Site Set-up	Protocol Signature Page
15001	88	1617081900722:1042924497	1617050387773:-339061386	D5170C00001	691	690	CREATE	2021-03-30 07:25:00.812	General	Relevant Communications
15009	88	1617081902551:1859798101	1617050406925:-1919454871	D5170C00001	699	698	CREATE	2021-03-30 07:25:02.637	IP Documentation	IP Accountability Documentation
15017	88	1617081904813:-1830198286	1617050421645:-991566997	D5170C00001	707	706	CREATE	2021-03-30 07:25:04.897	IRB or IEC Trial Approval	IRB or IEC Approval
15028	88	1617081909660:-167951087	1617050429138:-1509167003	D5170C00001	718	716	CREATE	2021-03-30 07:25:09.744	Site Management	Protocol Deviations
15081	88	1617081927559:-1808265991	1617050477857:1154734463	D5170C00001	771	770	CREATE	2021-03-30 07:25:27.646	Trial Status Reporting	IRB or IEC Notification of Trial Termination
15090	88	1617081931024:-442906555	1617050484731:-727337539	D5170C00001	780	779	CREATE	2021-03-30 07:25:31.112	Site Management	Monitoring Visit Report
15094	88	1617081932852:1731002283	1617050487249:-1403378072	D5170C00001	784	783	CREATE	2021-03-30 07:25:32.939	Site Selection	Confidentiality Agreement
15103	88	1617081937635:1278068580	1617050488400:1782292050	D5170C00001	793	785	CREATE	2021-03-30 07:25:37.721	Site Set-up	Protocol Signature Page
15126	88	1617081945009:-283137364	1617050515152:1797300866	D5170C00001	816	815	CREATE	2021-03-30 07:25:54.883	IP Documentation	IP Accountability Documentation
15138	88	1617081958935:1067860459	1617050532914:-254243461	D5170C00001	828	827	CREATE	2021-03-30 07:25:59.03	Trial Status Reporting	Notification to IRB or IEC of Safety Information
15141	88	1617081959561:1035426501	1617050534700:614575278	D5170C00001	831	830	CREATE	2021-03-30 07:25:59.646	General	Relevant Communications
15147	88	1617081961385:635714955	1617050538563:-2137484447	D5170C00001	837	836	CREATE	2021-03-30 07:26:01.476	Site Management	Monitoring Visit Report
15911	88	1617082357495:922334948	1617051264338:672904925	D5170C00001	1601	1600	CREATE	2021-03-30 07:32:37.582	Other Committees	Other Submissions
8884	84	\N	\N	D5170C00002	2669	2645	NEW	\N	05 Site Management	05.05 General
8885	84	\N	\N	D5170C00002	2670	2669	NEW	\N	05.05 General	05.05.02 Tracking Information
8886	84	\N	\N	D5170C00002	2671	2630	NEW	\N	Site	2002046 Armuzzi, Alessandro
8888	84	\N	\N	D5170C00002	2673	2672	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
8889	84	\N	\N	D5170C00002	2674	2673	NEW	\N	02.02 Subject Documents	02.02.03 Infor_ Form Checklists
8891	84	\N	\N	D5170C00002	2676	2672	NEW	\N	02 Central Trial Documents	02.04 General
8892	84	\N	\N	D5170C00002	2677	2676	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
8894	84	\N	\N	D5170C00002	2679	2678	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
8895	84	\N	\N	D5170C00002	2680	2679	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
15154	88	1617081966248:1368539724	1617050544090:1275073608	D5170C00001	844	842	CREATE	2021-03-30 07:26:06.331	Site Set-up	Clinical Study Agreement
15162	88	1617081977812:-35959718	1617050544090:1275073608	D5170C00001	852	842	CREATE	2021-03-30 07:26:17.992	Site Set-up	Sub-Investigator Curriculum Vitae
15185	88	1617081981491:505918890	1617050573787:-2094104714	D5170C00001	875	874	CREATE	2021-03-30 07:26:21.579	Facility Documentation	Laboratory Validation Documentation
15229	88	1617081998366:985814508	1617050611493:-1740449440	D5170C00001	919	909	CREATE	2021-03-30 07:26:38.454	Site Set-up	Sub-Investigator Curriculum Vitae
15245	88	1617082001851:266990823	1617050636914:1719875449	D5170C00001	935	934	CREATE	2021-03-30 07:26:41.935	IP Documentation	IP Accountability Documentation
15253	88	1617082004132:830503616	1617050647924:460414474	D5170C00001	943	942	CREATE	2021-03-30 07:26:44.217	IRB or IEC Trial Approval	IRB or IEC Approval
15262	88	1617082015271:-648151965	1617050655270:600932351	D5170C00001	952	951	CREATE	2021-03-30 07:26:55.355	Site Initiation	Trial Initiation Monitoring Report
15268	88	1617082017559:714683323	1617050658402:-1069799796	D5170C00001	958	956	CREATE	2021-03-30 07:26:57.648	Site Selection	Site Contact Details
15272	88	1617082020474:-1006491102	1617050660514:-1281271433	D5170C00001	962	959	CREATE	2021-03-30 07:27:00.561	Site Set-up	Other Curriculum Vitae
15323	88	1617082039218:-1381302115	1617050714815:1001124632	D5170C00001	1013	1012	CREATE	2021-03-30 07:27:19.304	General	Filenote
15331	88	1617082043518:1907770563	1617050721975:-1222777304	D5170C00001	1021	1020	CREATE	2021-03-30 07:27:23.607	Storage	IP Storage Condition Documentation
15339	88	1617082046437:-644564803	1617050727663:2030809444	D5170C00001	1029	1028	CREATE	2021-03-30 07:27:26.523	Trial Status Reporting	IRB or IEC Notification of Trial Termination
15353	88	1617082052031:1464411050	1617050745959:2117512818	D5170C00001	1043	1040	CREATE	2021-03-30 07:27:32.12	Site Set-up	Other Curriculum Vitae
15355	88	1617082054546:1394025674	1617050745959:2117512818	D5170C00001	1045	1040	CREATE	2021-03-30 07:27:34.658	Site Set-up	Protocol Amendment Signature Page
15357	88	1617082055685:1015738222	1617050745959:2117512818	D5170C00001	1047	1040	CREATE	2021-03-30 07:27:35.77	Site Set-up	Site Signature Sheet
15373	88	1617082059642:-2035459862	1617050762541:-1956694286	D5170C00001	1063	1061	CREATE	2021-03-30 07:27:39.726	General	Relevant Communications
15377	88	1617082060919:397458923	1617050771863:-2006742527	D5170C00001	1067	1066	CREATE	2021-03-30 07:27:41.005	IP Documentation	IP Accountability Documentation
15378	88	1617082061493:-887233305	1617050771863:-2006742527	D5170C00001	1068	1066	CREATE	2021-03-30 07:27:41.576	IP Documentation	IP Certificate of Destruction
15386	88	1617082068853:1470637923	1617050779584:425212454	D5170C00001	1076	1074	CREATE	2021-03-30 07:27:48.94	IRB or IEC Trial Approval	IRB or IEC Submission
15393	88	1617082104296:-600212954	1617050790545:39345583	D5170C00001	1083	1081	CREATE	2021-03-30 07:28:24.381	General	Relevant Communications
15443	88	1617082123492:1359552827	1617050831917:313113513	D5170C00001	1133	1131	CREATE	2021-03-30 07:28:43.582	Site Management	Visit Log
15449	88	1617082125768:1151581003	1617050835946:-1472277239	D5170C00001	1139	1136	CREATE	2021-03-30 07:28:52.082	Site Set-up	Other Curriculum Vitae
15452	88	1617082135471:-2137512058	1617050835946:-1472277239	D5170C00001	1142	1136	CREATE	2021-03-30 07:28:55.556	Site Set-up	Protocol Signature Page
15459	88	1617082137810:739308999	1617050850094:-439682772	D5170C00001	1149	1148	CREATE	2021-03-30 07:28:57.892	General	Tracking Information
15471	88	1617082141408:-305403908	1617050859063:-1429807314	D5170C00001	1161	1160	CREATE	2021-03-30 07:29:01.507	Storage	IP Storage Condition Documentation
15479	88	1617082143990:-1788791894	1617050870350:21205140	D5170C00001	1169	1168	CREATE	2021-03-30 07:29:04.073	Site Management	Monitoring Visit Report
15485	88	1617082147760:330681828	1617050873391:-1270625158	D5170C00001	1175	1173	CREATE	2021-03-30 07:29:07.846	Site Set-up	Clinical Study Agreement
15490	88	1617082150782:-1828377239	1617050873391:-1270625158	D5170C00001	1180	1173	CREATE	2021-03-30 07:29:10.872	Site Set-up	Sub-Investigator Curriculum Vitae
15498	88	1617082152660:-1515212131	1617050883626:-1294971027	D5170C00001	1188	1187	CREATE	2021-03-30 07:29:12.751	Site Selection	Confidentiality Agreement
15506	88	1617082155290:-1089605263	1617050888961:1714730018	D5170C00001	1196	1195	CREATE	2021-03-30 07:29:15.46	General	Tracking Information
15509	88	1617082156006:-510397490	1617050891997:634754347	D5170C00001	1199	1198	CREATE	2021-03-30 07:29:16.091	Interactive Response Technology	IRT User Account Management
15533	88	1617082172674:646019517	1617050911732:-1888658032	D5170C00001	1223	1220	CREATE	2021-03-30 07:29:32.757	Site Set-up	Other Curriculum Vitae
15537	88	1617082175237:-1956505509	1617050911732:-1888658032	D5170C00001	1227	1220	CREATE	2021-03-30 07:29:35.323	Site Set-up	Site Staff Qualification Supporting Information
15558	88	1617082187034:1080165135	1617050931040:-1460771932	D5170C00001	1248	1247	CREATE	2021-03-30 07:29:47.12	General	Filenote
15566	88	1617082189956:-1437522801	1617050940499:1931522967	D5170C00001	1256	1255	CREATE	2021-03-30 07:29:50.044	Site Set-up	Acceptance of Investigator Brochure
15572	88	1617082193492:-873638606	1617050940499:1931522967	D5170C00001	1262	1255	CREATE	2021-03-30 07:29:53.576	Site Set-up	Site Staff Qualification Supporting Information
15593	88	1617082199690:-93970806	1617050958991:451713956	D5170C00001	1283	1279	CREATE	2021-03-30 07:29:59.775	Site Set-up	Other Financial Agreement
15623	88	1617082209433:-7919117	1617050994476:-248519494	D5170C00001	1313	1311	CREATE	2021-03-30 07:30:09.674	Site Set-up	Clinical Study Agreement
15682	88	1617082235738:1353366394	1617051041434:-1828570085	D5170C00001	1372	1371	CREATE	2021-03-30 07:30:35.825	Site Management	Monitoring Visit Report
15688	88	1617082238143:-1787992005	1617051044993:-2105799273	D5170C00001	1378	1377	CREATE	2021-03-30 07:30:38.229	Site Set-up	Acceptance of Investigator Brochure
15694	88	1617082243818:1032688011	1617051044993:-2105799273	D5170C00001	1384	1377	CREATE	2021-03-30 07:30:43.901	Site Set-up	Protocol Amendment Signature Page
15703	88	1617082248305:-2005590136	1617051054940:-1260701007	D5170C00001	1393	1392	CREATE	2021-03-30 07:30:48.389	Non-IP Documentation	Non-IP Return Documentation
15714	88	1617082251372:670022061	1617051067740:1749259247	D5170C00001	1404	1403	CREATE	2021-03-30 07:30:51.456	Site Management	Monitoring Visit Report
15720	88	1617082253774:-186239531	1617051071540:1064815674	D5170C00001	1410	1409	CREATE	2021-03-30 07:30:53.857	Site Set-up	Acceptance of Investigator Brochure
15725	88	1617082258129:-187069394	1617051071540:1064815674	D5170C00001	1415	1409	CREATE	2021-03-30 07:30:58.216	Site Set-up	Principal Investigator Curriculum Vitae
8901	84	\N	\N	D5170C00002	2686	2685	NEW	\N	05.01 Site Selection	05.01.01 Site Contact Details
16061	88	1617051393329:566567928	1617051390063:-110780420	D5170C00001	1751	1746	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IP and Trial Supplies	Storage
15729	88	1617082260630:-534735248	1617051071540:1064815674	D5170C00001	1419	1409	CREATE	2021-03-30 07:31:00.72	Site Set-up	Sub-Investigator Curriculum Vitae
15742	88	1617082263729:359492694	1617051087000:-800130288	D5170C00001	1432	1431	CREATE	2021-03-30 07:31:03.815	Storage	IP Storage Condition Documentation
15745	88	1617082264357:1487776000	1617051088796:1898037300	D5170C00001	1435	1434	CREATE	2021-03-30 07:31:04.456	General	Tracking Information
15785	88	1617082281793:1718970579	1617051153691:775680199	D5170C00001	1475	1473	CREATE	2021-03-30 07:31:21.886	Site Selection	Pre Trial Monitoring Report
15794	88	1617082296467:-135688392	1617051160575:-449321039	D5170C00001	1484	1476	CREATE	2021-03-30 07:31:36.553	Site Set-up	Protocol Signature Page
15795	88	1617082297102:1510802286	1617051160575:-449321039	D5170C00001	1485	1476	CREATE	2021-03-30 07:31:37.188	Site Set-up	Site Signature Sheet
15803	88	1617082298891:1362513071	1617051177009:-1165311717	D5170C00001	1493	1492	CREATE	2021-03-30 07:31:38.975	Interactive Response Technology	IRT User Account Management
15815	88	1617082301912:474214016	1617051185477:1230346931	D5170C00001	1505	1504	CREATE	2021-03-30 07:31:41.996	Site Management	Monitoring Visit Report
15821	88	1617082306020:-232280460	1617051189275:-144455774	D5170C00001	1511	1510	CREATE	2021-03-30 07:31:46.107	Site Set-up	Acceptance of Investigator Brochure
15826	88	1617082309275:-117141034	1617051189275:-144455774	D5170C00001	1516	1510	CREATE	2021-03-30 07:31:49.36	Site Set-up	Principal Investigator Curriculum Vitae
15830	88	1617082311676:-662624030	1617051189275:-144455774	D5170C00001	1520	1510	CREATE	2021-03-30 07:31:51.762	Site Set-up	Sub-Investigator Curriculum Vitae
15842	88	1617082316344:1521582872	1617051202040:-57295690	D5170C00001	1532	1529	CREATE	2021-03-30 07:31:56.431	Subject Documentation	Subject Information Sheet
15845	88	1617082316930:86391434	1617051210639:-1668625502	D5170C00001	1535	1534	CREATE	2021-03-30 07:31:57.017	General	Tracking Information
15876	88	1617082330354:-406722874	1617051231050:19452071	D5170C00001	1566	1564	CREATE	2021-03-30 07:32:10.439	Site Set-up	Clinical Study Agreement
15877	88	1617082330993:-615865404	1617051231050:19452071	D5170C00001	1567	1564	CREATE	2021-03-30 07:32:11.08	Site Set-up	Data Privacy Agreement
15879	88	1617082332204:844451552	1617051231050:19452071	D5170C00001	1569	1564	CREATE	2021-03-30 07:32:12.287	Site Set-up	Investigator Regulatory Agreement
15880	88	1617082332816:1943948915	1617051231050:19452071	D5170C00001	1570	1564	CREATE	2021-03-30 07:32:12.9	Site Set-up	Other Curriculum Vitae
15882	88	1617082334021:-1715645284	1617051231050:19452071	D5170C00001	1572	1564	CREATE	2021-03-30 07:32:14.105	Site Set-up	Protocol Amendment Signature Page
15884	88	1617082335252:1495265478	1617051231050:19452071	D5170C00001	1574	1564	CREATE	2021-03-30 07:32:15.341	Site Set-up	Site Signature Sheet
15889	88	1617082336616:1179994962	1617051239460:-66775178	D5170C00001	1579	1578	CREATE	2021-03-30 07:32:23.657	General	Explanation of Approvals non English language
15891	88	1617082344210:-1460012364	1617051242085:-4346172	D5170C00001	1581	1580	CREATE	2021-03-30 07:32:24.294	Subject Documentation	Informed Consent Form
15899	88	1617082346701:1799381661	1617051255552:-1028671313	D5170C00001	1589	1588	CREATE	2021-03-30 07:32:26.788	Interactive Response Technology	IRT User Account Management
15903	88	1617082354799:-525595794	1617051256732:2116263717	D5170C00001	1593	1590	CREATE	2021-03-30 07:32:34.883	IP Documentation	IP Shipment Documentation
15909	88	1617082356604:-185465042	1617051261395:-1705887322	D5170C00001	1599	1597	CREATE	2021-03-30 07:32:36.688	IRB or IEC Trial Approval	IRB or IEC Submission
15914	88	1617082358218:1689720888	1617051266832:-1514178003	D5170C00001	1604	1603	CREATE	2021-03-30 07:32:38.302	General	Relevant Communications
15916	88	1617082358768:803711064	1617051268067:480672253	D5170C00001	1606	1605	CREATE	2021-03-30 07:32:38.85	Site Initiation	Site Evidence of Training
15919	88	1617082359974:-420064253	1617051269881:-925424301	D5170C00001	1609	1608	CREATE	2021-03-30 07:32:40.062	Site Management	Monitoring Visit Report
15922	88	1617082361221:862266425	1617051271795:-697836174	D5170C00001	1612	1611	CREATE	2021-03-30 07:32:41.304	Site Selection	Confidentiality Agreement
15939	88	1617082369850:-1449484990	1617051283376:178708985	D5170C00001	1629	1628	CREATE	2021-03-30 07:32:49.935	General	Explanation of Approvals non English language
15942	88	1617082371064:95345730	1617051285805:652595976	D5170C00001	1632	1630	CREATE	2021-03-30 07:32:51.153	Subject Documentation	Other Information Given to Subjects
15946	88	1617082372197:-2079088069	1617051288853:-1948171321	D5170C00001	1636	1635	CREATE	2021-03-30 07:32:52.282	General	Tracking Information
15951	88	1617082373404:1562592451	1617051299779:2025892608	D5170C00001	1641	1640	CREATE	2021-03-30 07:32:53.488	IP Documentation	IP Accountability Documentation
15955	88	1617082376189:1400298149	1617051302245:-1450958399	D5170C00001	1645	1644	CREATE	2021-03-30 07:32:56.273	Storage	IP Storage Condition Documentation
15961	88	1617082377870:-1559965347	1617051305856:403491730	D5170C00001	1651	1650	CREATE	2021-03-30 07:32:57.954	Other Committees	Other Submissions
15964	88	1617082378480:-1476084600	1617051310609:-1343289251	D5170C00001	1654	1653	CREATE	2021-03-30 07:32:58.564	General	Filenote
15968	88	1617082380278:702103192	1617051312421:158138468	D5170C00001	1658	1656	CREATE	2021-03-30 07:33:00.367	Site Initiation	Trial Initiation Monitoring Report
15973	88	1617082382068:-1237464634	1617051316292:-1020391177	D5170C00001	1663	1662	CREATE	2021-03-30 07:33:02.152	Site Selection	Confidentiality Agreement
15977	88	1617082383928:-1564686322	1617051318031:-2130356718	D5170C00001	1667	1665	CREATE	2021-03-30 07:33:04.011	Site Set-up	Clinical Study Agreement
15978	88	1617082384521:1124012984	1617051318031:-2130356718	D5170C00001	1668	1665	CREATE	2021-03-30 07:33:04.606	Site Set-up	Data Privacy Agreement
15980	88	1617082386788:-1710637356	1617051318031:-2130356718	D5170C00001	1670	1665	CREATE	2021-03-30 07:33:06.872	Site Set-up	Investigator Regulatory Agreement
15982	88	1617082388117:-2105994660	1617051318031:-2130356718	D5170C00001	1672	1665	CREATE	2021-03-30 07:33:08.2	Site Set-up	Principal Investigator Curriculum Vitae
15983	88	1617082388718:927882982	1617051318031:-2130356718	D5170C00001	1673	1665	CREATE	2021-03-30 07:33:08.804	Site Set-up	Protocol Amendment Signature Page
15984	88	1617082389336:1593989515	1617051318031:-2130356718	D5170C00001	1674	1665	CREATE	2021-03-30 07:33:09.419	Site Set-up	Protocol Signature Page
16034	88	1617082413851:650737349	1617051365201:-524879301	D5170C00001	1724	1721	CREATE	2021-03-30 07:33:34.065	Site Set-up	Data Privacy Agreement
16038	88	1617082416661:877778418	1617051365201:-524879301	D5170C00001	1728	1721	CREATE	2021-03-30 07:33:36.744	Site Set-up	Other Financial Agreement
16039	88	1617082417233:1045138429	1617051365201:-524879301	D5170C00001	1729	1721	CREATE	2021-03-30 07:33:37.32	Site Set-up	Principal Investigator Curriculum Vitae
16041	88	1617082418553:743808647	1617051365201:-524879301	D5170C00001	1731	1721	CREATE	2021-03-30 07:33:38.643	Site Set-up	Protocol Signature Page
16050	88	1617082422150:-397805603	1617051385807:-462599726	D5170C00001	1740	1739	CREATE	2021-03-30 07:33:42.233	General	Explanation of Approvals non English language
16055	88	1617082423366:-1601850863	1617051388846:1888496182	D5170C00001	1745	1744	CREATE	2021-03-30 07:33:43.449	General	Tracking Information
16060	88	1617082425129:942318131	1617051390648:-452537594	D5170C00001	1750	1747	CREATE	2021-03-30 07:33:45.218	IP Documentation	IP Shipment Documentation
16062	88	1617082425760:1134006740	1617051393329:566567928	D5170C00001	1752	1751	CREATE	2021-03-30 07:33:45.846	Storage	IP Storage Condition Documentation
16065	88	1617082426358:-253787670	1617051395212:1959655778	D5170C00001	1755	1754	CREATE	2021-03-30 07:33:46.449	IRB or IEC Trial Approval	IRB or IEC Approval
16076	88	1617082431457:-24139601	1617051403323:239356806	D5170C00001	1766	1765	CREATE	2021-03-30 07:33:51.54	Site Management	Monitoring Visit Report
16080	88	1617082433472:-1249667962	1617051405136:-233742438	D5170C00001	1770	1768	CREATE	2021-03-30 07:33:53.556	Site Selection	Pre Trial Monitoring Report
16084	88	1617082435388:-1745325959	1617051406941:-1249314606	D5170C00001	1774	1771	CREATE	2021-03-30 07:33:55.472	Site Set-up	Data Privacy Agreement
16086	88	1617082437742:-695236344	1617051406941:-1249314606	D5170C00001	1776	1771	CREATE	2021-03-30 07:33:57.828	Site Set-up	Investigator Regulatory Agreement
16088	88	1617082439272:-1634827065	1617051406941:-1249314606	D5170C00001	1778	1771	CREATE	2021-03-30 07:33:59.355	Site Set-up	Other Financial Agreement
16091	88	1617082441252:2032694878	1617051406941:-1249314606	D5170C00001	1781	1771	CREATE	2021-03-30 07:34:01.38	Site Set-up	Protocol Signature Page
16104	88	1617082446066:1205298077	1617051425299:-452780233	D5170C00001	1794	1793	CREATE	2021-03-30 07:34:06.15	General	Explanation of Approvals non English language
16113	88	1617082448757:733597958	1617051432683:-589143661	D5170C00001	1803	1802	CREATE	2021-03-30 07:34:08.84	Interactive Response Technology	IRT User Account Management
16120	88	1617082461839:425737871	1617051436825:-121233594	D5170C00001	1810	1809	CREATE	2021-03-30 07:34:21.978	IRB or IEC Trial Approval	IRB or IEC Approval
16129	88	1617082466417:428242913	1617051446143:-828741018	D5170C00001	1819	1817	CREATE	2021-03-30 07:34:26.606	Site Initiation	Trial Initiation Monitoring Report
16132	88	1617082467794:1480950756	1617051447941:2060129724	D5170C00001	1822	1820	CREATE	2021-03-30 07:34:27.882	Site Management	Visit Log
16138	88	1617082470692:-338391875	1617051451517:979818469	D5170C00001	1828	1826	CREATE	2021-03-30 07:34:30.775	Site Set-up	Clinical Study Agreement
16141	88	1617082472728:9111455	1617051451517:979818469	D5170C00001	1831	1826	CREATE	2021-03-30 07:34:32.813	Site Set-up	Investigator Regulatory Agreement
16179	88	1617082489673:1134290921	1617051483668:34126941	D5170C00001	1869	1866	CREATE	2021-03-30 07:34:49.759	Site Management	Subject Log
16191	88	1617082496605:678180373	1617051489675:-848292909	D5170C00001	1881	1874	CREATE	2021-03-30 07:34:56.689	Site Set-up	Principal Investigator Curriculum Vitae
16194	88	1617082499696:2018036769	1617051489675:-848292909	D5170C00001	1884	1874	CREATE	2021-03-30 07:34:59.784	Site Set-up	Site Signature Sheet
16209	88	1617082503526:-606811473	1617051512807:71420844	D5170C00001	1899	1898	CREATE	2021-03-30 07:35:03.617	IP Documentation	IP Accountability Documentation
16220	88	1617082507293:-1161511125	1617051521930:-1876364631	D5170C00001	1910	1909	CREATE	2021-03-30 07:35:07.377	Site Management	Monitoring Visit Report
16229	88	1617082521015:1131808827	1617051525539:1536193424	D5170C00001	1919	1915	CREATE	2021-03-30 07:35:21.101	Site Set-up	Financial Disclosure Form
16246	88	1617082528430:-2023183389	1617051543316:-1352271444	D5170C00001	1936	1935	CREATE	2021-03-30 07:35:28.519	General	Tracking Information
16264	88	1617082541420:682851790	1617051552139:59561062	D5170C00001	1954	1950	CREATE	2021-03-30 07:35:41.511	Site Management	Visit Log
16273	88	1617082546551:-648163448	1617051561626:-822837570	D5170C00001	1963	1958	CREATE	2021-03-30 07:35:46.637	Site Set-up	Other Curriculum Vitae
16279	88	1617082550069:819301784	1617051561626:-822837570	D5170C00001	1969	1958	CREATE	2021-03-30 07:35:50.156	Site Set-up	Sub-Investigator Curriculum Vitae
16290	88	1617082552681:1841979361	1617051576203:-904060274	D5170C00001	1980	1979	CREATE	2021-03-30 07:35:52.8	Site Initiation	Site Evidence of Training
16295	88	1617082556559:374794152	1617051577421:1984810468	D5170C00001	1985	1981	CREATE	2021-03-30 07:35:56.649	Site Management	Visit Log
16300	88	1617082558346:-1237784130	1617051582575:204087676	D5170C00001	1990	1989	CREATE	2021-03-30 07:35:58.43	Site Set-up	Acceptance of Investigator Brochure
16302	88	1617082559547:-1287342402	1617051582575:204087676	D5170C00001	1992	1989	CREATE	2021-03-30 07:35:59.634	Site Set-up	Data Privacy Agreement
16306	88	1617082561938:-515961826	1617051582575:204087676	D5170C00001	1996	1989	CREATE	2021-03-30 07:36:02.023	Site Set-up	Principal Investigator Curriculum Vitae
16308	88	1617082563086:-1310820235	1617051582575:204087676	D5170C00001	1998	1989	CREATE	2021-03-30 07:36:03.18	Site Set-up	Protocol Signature Page
16314	88	1617082565193:1410027371	1617051592376:-727863300	D5170C00001	2004	2003	CREATE	2021-03-30 07:36:05.278	Interactive Response Technology	IRT User Account Management
16324	88	1617082569557:-1429473375	1617051598904:-1798224472	D5170C00001	2014	2012	CREATE	2021-03-30 07:36:09.642	Site Management	Monitoring Visit Report
16328	88	1617082571518:665868275	1617051607218:-1862910514	D5170C00001	2018	2016	CREATE	2021-03-30 07:36:11.602	Site Selection	Feasibility Documentation
16331	88	1617082572686:-1450739038	1617051610102:1204000152	D5170C00001	2021	2019	CREATE	2021-03-30 07:36:12.769	Site Set-up	Data Privacy Agreement
16333	88	1617082573842:1402806536	1617051610102:1204000152	D5170C00001	2023	2019	CREATE	2021-03-30 07:36:13.925	Site Set-up	Other Curriculum Vitae
16334	88	1617082574379:-995772272	1617051610102:1204000152	D5170C00001	2024	2019	CREATE	2021-03-30 07:36:14.462	Site Set-up	Principal Investigator Curriculum Vitae
16336	88	1617082575523:-1297049009	1617051610102:1204000152	D5170C00001	2026	2019	CREATE	2021-03-30 07:36:15.612	Site Set-up	Protocol Signature Page
16353	88	1617082584615:-1472918257	1617051625577:-2078306383	D5170C00001	2043	2042	CREATE	2021-03-30 07:36:24.696	Sample Documentation	Sample Storage Condition Log
6493	84	\N	\N	D5170C00002	278	277	NEW	\N	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
16369	88	1617082590420:1482038213	1617051644252:-1864444558	D5170C00001	2059	2058	CREATE	2021-03-30 07:36:30.503	Interactive Response Technology	IRT User Account Management
16386	88	1617082595710:-737778624	1617051655510:-961442356	D5170C00001	2076	2075	CREATE	2021-03-30 07:36:35.795	General	Relevant Communications
16208	88	1617051512807:71420844	1617051510979:-1966549499	D5170C00001	1898	1895	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IP and Trial Supplies	IP Documentation
16425	88	1617082612545:1657407899	1617051685011:500343460	D5170C00001	2115	2114	CREATE	2021-03-30 07:36:52.634	Product and Trial Documentation	Insurance
16440	88	1617082617476:835375814	1617051700568:-1174541574	D5170C00001	2130	2127	CREATE	2021-03-30 07:36:57.559	IP Documentation	IP Shipment Documentation
16452	88	1617082620859:231917084	1617051710572:679115478	D5170C00001	2142	2141	CREATE	2021-03-30 07:37:00.945	Other Committees	Other Submissions
16458	88	1617082623792:-120230225	1617051721482:1197692574	D5170C00001	2148	2147	CREATE	2021-03-30 07:37:03.877	Site Initiation	Site Evidence of Training
16464	88	1617082626154:-1149330226	1617051725178:-273100631	D5170C00001	2154	2153	CREATE	2021-03-30 07:37:06.238	Site Selection	Confidentiality Agreement
16469	88	1617082628439:-1721565170	1617051726989:-680554053	D5170C00001	2159	2156	CREATE	2021-03-30 07:37:08.528	Site Set-up	Financial Disclosure Form
16571	88	1617082680364:-720318872	1617051806140:-1242465374	D5170C00001	2261	2260	CREATE	2021-03-30 07:38:00.447	General	Relevant Communications
16581	88	1617082682782:-1523915717	1617051813448:-628229041	D5170C00001	2271	2270	CREATE	2021-03-30 07:38:02.872	General	Filenote
16588	88	1617082685950:1010646016	1617051817282:452875689	D5170C00001	2278	2276	CREATE	2021-03-30 07:38:06.037	Site Management	Visit Log
8904	84	\N	\N	D5170C00002	2689	2685	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
8905	84	\N	\N	D5170C00002	2690	2684	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
8907	84	\N	\N	D5170C00002	2692	2690	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
8908	84	\N	\N	D5170C00002	2693	2690	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
8910	84	\N	\N	D5170C00002	2695	2690	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
8911	84	\N	\N	D5170C00002	2696	2690	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
8912	84	\N	\N	D5170C00002	2697	2690	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
8914	84	\N	\N	D5170C00002	2699	2690	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
8915	84	\N	\N	D5170C00002	2700	2690	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
8916	84	\N	\N	D5170C00002	2701	2684	NEW	\N	05 Site Management	05.03 Site Initiation
8918	84	\N	\N	D5170C00002	2703	2701	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
8919	84	\N	\N	D5170C00002	2704	2701	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
8921	84	\N	\N	D5170C00002	2706	2705	NEW	\N	05.04 Site Management	05.04.03 UNBLINDED Monitoring Visit Report
8922	84	\N	\N	D5170C00002	2707	2705	NEW	\N	05.04 Site Management	05.04.04 Visit Log
8924	84	\N	\N	D5170C00002	2709	2684	NEW	\N	05 Site Management	05.05 General
8925	84	\N	\N	D5170C00002	2710	2709	NEW	\N	05.05 General	05.05.02 Tracking Information
8926	84	\N	\N	D5170C00002	2711	2671	NEW	\N	2002046 Armuzzi, Alessandro	06 IP and Trial Supplies
8928	84	\N	\N	D5170C00002	2713	2712	NEW	\N	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
8931	84	\N	\N	D5170C00002	2716	2715	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
8932	84	\N	\N	D5170C00002	2717	2716	NEW	\N	02.02 Subject Documents	02.02.03 Infor_ Form Checklists
8934	84	\N	\N	D5170C00002	2719	2716	NEW	\N	02.02 Subject Documents	02.02.07 Other_iven to Subjects
8935	84	\N	\N	D5170C00002	2720	2715	NEW	\N	02 Central Trial Documents	02.04 General
8937	84	\N	\N	D5170C00002	2722	2720	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
8938	84	\N	\N	D5170C00002	2723	2714	NEW	\N	2002047 Basilisco, Guido	04 IRB-IEC and other Approvals
6218	84	\N	\N	D5170C00002	3	2	NEW	\N	Quintiles IQVIA	eTMF
6220	84	\N	\N	D5170C00002	5	4	NEW	\N	contents	AUSTRALIA
6223	84	\N	\N	D5170C00002	8	7	NEW	\N	2002538 Moore, Gregory	02 Central Trial Documents
6225	84	\N	\N	D5170C00002	10	9	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
6228	84	\N	\N	D5170C00002	13	7	NEW	\N	2002538 Moore, Gregory	04 IRB-IEC and other Approvals
6232	84	\N	\N	D5170C00002	17	16	NEW	\N	05 Site Management	05.01 Site Selection
6234	84	\N	\N	D5170C00002	19	16	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
6237	84	\N	\N	D5170C00002	22	19	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
6241	84	\N	\N	D5170C00002	26	19	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
6244	84	\N	\N	D5170C00002	29	19	NEW	\N	05.02 Site Set-up Documentation	05.02.13 Indemnity
6247	84	\N	\N	D5170C00002	32	31	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
6249	84	\N	\N	D5170C00002	34	33	NEW	\N	2002539 Weltman, Martin	05 Site Management
6252	84	\N	\N	D5170C00002	37	6	NEW	\N	Site	2002540 Holtmann, Gerald
8941	84	\N	\N	D5170C00002	2726	2724	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
8943	84	\N	\N	D5170C00002	2728	2727	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
8944	84	\N	\N	D5170C00002	2729	2714	NEW	\N	2002047 Basilisco, Guido	05 Site Management
8945	84	\N	\N	D5170C00002	2730	2729	NEW	\N	05 Site Management	05.01 Site Selection
8947	84	\N	\N	D5170C00002	2732	2730	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
8948	84	\N	\N	D5170C00002	2733	2730	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
8950	84	\N	\N	D5170C00002	2735	2729	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
8951	84	\N	\N	D5170C00002	2736	2735	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
8953	84	\N	\N	D5170C00002	2738	2735	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
8954	84	\N	\N	D5170C00002	2739	2735	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
8955	84	\N	\N	D5170C00002	2740	2735	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
8957	84	\N	\N	D5170C00002	2742	2735	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
16289	88	1617051576203:-904060274	1617051575574:-1503063946	D5170C00001	1979	1978	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Initiation
16735	88	1617082757828:-1180133576	1617051949087:-1979556020	D5170C00001	2425	2424	CREATE	2021-03-30 07:39:17.915	General	Filenote
16738	88	1617082759201:1072533862	1617051950238:-1944697363	D5170C00001	2428	2426	CREATE	2021-03-30 07:39:19.287	IP Documentation	IP Certificate of Destruction
16746	88	1617082763597:-713285204	1617051955610:1196839765	D5170C00001	2436	2435	CREATE	2021-03-30 07:39:23.684	IRB or IEC Trial Approval	IRB or IEC Submission
16757	88	1617082766674:-188828479	1617051963011:-1571685998	D5170C00001	2447	2446	CREATE	2021-03-30 07:39:26.757	Site Management	Final Trial Close Out Monitoring Report
16758	88	1617082767292:-1514904832	1617051963011:-1571685998	D5170C00001	2448	2446	CREATE	2021-03-30 07:39:27.379	Site Management	Visit Log
16765	88	1617082770356:-1527941787	1617051973346:1348595292	D5170C00001	2455	2452	CREATE	2021-03-30 07:39:30.439	Site Set-up	Financial Disclosure Form
16766	88	1617082770900:67708088	1617051973346:1348595292	D5170C00001	2456	2452	CREATE	2021-03-30 07:39:30.982	Site Set-up	Investigator Regulatory Agreement
16768	88	1617082772020:-408807484	1617051973346:1348595292	D5170C00001	2458	2452	CREATE	2021-03-30 07:39:32.103	Site Set-up	Principal Investigator Curriculum Vitae
16776	88	1617082775522:2036494523	1617051982085:1003926316	D5170C00001	2466	2465	CREATE	2021-03-30 07:39:35.605	Facility Documentation	Certification or Accreditation
16787	88	1617082778562:-1436664720	1617051996289:1165390347	D5170C00001	2477	2476	CREATE	2021-03-30 07:39:38.65	General	Relevant Communications
16790	88	1617082789298:227462220	1617051997454:1492300384	D5170C00001	2480	2478	CREATE	2021-03-30 07:39:49.388	IP Documentation	IP Certificate of Destruction
16792	88	1617082789901:-1223694833	1617051999397:-1174880367	D5170C00001	2482	2481	CREATE	2021-03-30 07:39:49.988	Storage	IP Storage Condition Documentation
16795	88	1617082790514:1210892202	1617052002324:-1851246732	D5170C00001	2485	2484	CREATE	2021-03-30 07:39:50.599	IRB or IEC Trial Approval	IRB or IEC Approval
16796	88	1617082791136:-1663424251	1617052002324:-1851246732	D5170C00001	2486	2484	CREATE	2021-03-30 07:39:51.239	IRB or IEC Trial Approval	IRB or IEC Compliance Documentation
16799	88	1617082792314:-782371449	1617052004642:1679195762	D5170C00001	2489	2488	CREATE	2021-03-30 07:39:52.406	Trial Status Reporting	IRB or IEC Notification of Trial Termination
16802	88	1617082792923:-1520424181	1617052006431:-1772093969	D5170C00001	2492	2491	CREATE	2021-03-30 07:39:53.016	General	Tracking Information
16868	88	1617082821254:1255633108	1617052057507:1423773172	D5170C00001	2558	2554	CREATE	2021-03-30 07:40:21.339	Site Set-up	Form FDA 1572
16878	88	1617082826896:-1257990782	1617052073027:1819467264	D5170C00001	2568	2567	CREATE	2021-03-30 07:40:26.984	Trial Oversight	Recruitment Plan
16896	88	1617082832263:-495680637	1617052091843:-1938637842	D5170C00001	2586	2584	CREATE	2021-03-30 07:40:32.348	IRB or IEC Trial Approval	IRB or IEC Compliance Documentation
16914	88	1617082845822:860119006	1617052103517:863173571	D5170C00001	2604	2599	CREATE	2021-03-30 07:40:45.907	Site Set-up	Form FDA 1572
16920	88	1617082849421:-882464808	1617052103517:863173571	D5170C00001	2610	2599	CREATE	2021-03-30 07:40:49.505	Site Set-up	Site Staff Qualification Supporting Information
16938	88	1617082855956:-50393858	1617052122585:2032598073	D5170C00001	2628	2627	CREATE	2021-03-30 07:40:56.052	General	Relevant Communications
16953	88	1617082860979:-527192632	1617052133144:700993632	D5170C00001	2643	2641	CREATE	2021-03-30 07:41:01.068	Site Management	Subject Log
16956	88	1617082862239:-703656380	1617052136927:833392711	D5170C00001	2646	2645	CREATE	2021-03-30 07:41:02.324	Site Selection	Confidentiality Agreement
16959	88	1617082864888:-661198951	1617052138141:425928680	D5170C00001	2649	2647	CREATE	2021-03-30 07:41:04.973	Site Set-up	Clinical Study Agreement
16973	88	1617082871147:-748604730	1617052148515:1722912454	D5170C00001	2663	2662	CREATE	2021-03-30 07:41:11.252	Site Selection	Confidentiality Agreement
16988	88	1617082876484:-2055104166	1617052165048:-1251433130	D5170C00001	2678	2677	CREATE	2021-03-30 07:41:16.573	General	Filenote
17005	88	1617082882209:-1259523332	1617052176983:-1585017554	D5170C00001	2695	2694	CREATE	2021-03-30 07:41:22.293	Site Initiation	Site Evidence of Training
17011	88	1617082884690:524037811	1617052186543:828939805	D5170C00001	2701	2700	CREATE	2021-03-30 07:41:24.777	Site Selection	Confidentiality Agreement
17019	88	1617082890517:438251176	1617052188373:-477941113	D5170C00001	2709	2702	CREATE	2021-03-30 07:41:30.601	Site Set-up	Protocol Amendment Signature Page
17062	88	1617082922867:-1990603207	1617052226758:-844895705	D5170C00001	2752	2748	CREATE	2021-03-30 07:42:02.965	Site Set-up	Form FDA 1572
17097	88	1617082934721:-1829795783	1617052260044:-531955583	D5170C00001	2787	2786	CREATE	2021-03-30 07:42:14.812	General	Tracking Information
17100	88	1617082935398:-1827167116	1617052261919:1685251453	D5170C00001	2790	2789	CREATE	2021-03-30 07:42:15.487	General	Filenote
17106	88	1617082937775:-1425756	1617052277702:-2020962141	D5170C00001	2796	2794	CREATE	2021-03-30 07:42:17.864	Site Management	Monitoring Visit Report
17114	88	1617082941229:-274046922	1617052281159:1391595914	D5170C00001	2804	2800	CREATE	2021-03-30 07:42:21.312	Site Set-up	Form FDA 1572
17117	88	1617082942975:298633842	1617052281159:1391595914	D5170C00001	2807	2800	CREATE	2021-03-30 07:42:23.061	Site Set-up	Protocol Amendment Signature Page
17120	88	1617082946136:-1721884670	1617052281159:1391595914	D5170C00001	2810	2800	CREATE	2021-03-30 07:42:26.221	Site Set-up	Site Staff Qualification Supporting Information
17131	88	1617082981761:445420102	1617052299003:-869605419	D5170C00001	2821	2820	CREATE	2021-03-30 07:43:01.844	General	Tracking Information
17136	88	1617082983093:1211228062	1617052302041:-1227886088	D5170C00001	2826	2825	CREATE	2021-03-30 07:43:03.18	IP Documentation	IP Accountability Documentation
17143	88	1617082986150:1980631878	1617052307191:-1050170016	D5170C00001	2833	2832	CREATE	2021-03-30 07:43:06.242	Trial Status Reporting	IRB or IEC Notification of Trial Termination
17149	88	1617082987431:-453846010	1617052310759:1407892748	D5170C00001	2839	2838	CREATE	2021-03-30 07:43:07.521	General	Filenote
17154	88	1617082990638:-1255695624	1617052313486:-1395615169	D5170C00001	2844	2843	CREATE	2021-03-30 07:43:10.723	Site Management	Monitoring Visit Report
17158	88	1617082992597:-602102943	1617052316990:-1460290602	D5170C00001	2848	2847	CREATE	2021-03-30 07:43:12.694	Site Selection	Confidentiality Agreement
17161	88	1617082993848:1832663153	1617052326585:1114215991	D5170C00001	2851	2849	CREATE	2021-03-30 07:43:13.934	Site Set-up	Clinical Study Agreement
17166	88	1617082997287:1070129707	1617052326585:1114215991	D5170C00001	2856	2849	CREATE	2021-03-30 07:43:17.37	Site Set-up	Protocol Signature Page
17167	88	1617082998038:-1578463610	1617052326585:1114215991	D5170C00001	2857	2849	CREATE	2021-03-30 07:43:18.125	Site Set-up	Site Signature Sheet
16415	88	1617051679777:1057410970	1617051622299:1003976290	D5170C00001	2105	2037	ALREADY AVAILABLE	2021-03-30 07:19:37.32	Spain	7002
16358	88	1617082586410:-103951493	1617051628720:-1340553915	D5170C00001	2048	2047	CREATE	2021-03-30 07:36:26.493	Product and Trial Documentation	Insurance
17172	88	1617083000066:-1006310086	1617052334243:1378768945	D5170C00001	2862	2861	CREATE	2021-03-30 07:43:20.153	General	Filenote
17185	88	1617083004380:681670603	1617052343327:93551715	D5170C00001	2875	2874	CREATE	2021-03-30 07:43:24.465	IRB or IEC Trial Approval	IRB or IEC Approval
17188	88	1617083005873:-1493264797	1617052345201:-1163271070	D5170C00001	2878	2877	CREATE	2021-03-30 07:43:25.958	Trial Status Reporting	IRB or IEC Notification of Trial Termination
17191	88	1617083006531:-1935293304	1617052346899:-311508770	D5170C00001	2881	2880	CREATE	2021-03-30 07:43:26.616	General	Tracking Information
17194	88	1617083007198:-1948688162	1617052349908:-1671940381	D5170C00001	2884	2883	CREATE	2021-03-30 07:43:27.297	General	Filenote
17201	88	1617083010795:-613333405	1617052354278:-1067453430	D5170C00001	2891	2890	CREATE	2021-03-30 07:43:30.882	Site Selection	Confidentiality Agreement
17209	88	1617083017622:-747435554	1617052355513:-1474768935	D5170C00001	2899	2892	CREATE	2021-03-30 07:43:37.705	Site Set-up	Protocol Amendment Signature Page
17226	88	1617083025172:315666429	1617052377227:-1191611985	D5170C00001	2916	2915	CREATE	2021-03-30 07:43:45.26	IRB or IEC Trial Approval	IRB or IEC Approval
17238	88	1617083029790:1196783737	1617052385879:-1213780157	D5170C00001	2928	2927	CREATE	2021-03-30 07:43:49.878	Site Management	Monitoring Visit Report
17246	88	1617083042511:575503540	1617052389524:1591359346	D5170C00001	2936	2933	CREATE	2021-03-30 07:44:02.598	Site Set-up	Financial Disclosure Form
8958	84	\N	\N	D5170C00002	2743	2735	NEW	\N	05.02 Site Set-up Documentation	05.02.11 Data Privacy
8960	84	\N	\N	D5170C00002	2745	2735	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
8961	84	\N	\N	D5170C00002	2746	2735	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
8963	84	\N	\N	D5170C00002	2748	2747	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
8964	84	\N	\N	D5170C00002	2749	2747	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
8966	84	\N	\N	D5170C00002	2751	2729	NEW	\N	05 Site Management	05.04 Site Management
8967	84	\N	\N	D5170C00002	2752	2751	NEW	\N	05.04 Site Management	05.04.03 UNBLINDED Monitoring Visit Report
8968	84	\N	\N	D5170C00002	2753	2751	NEW	\N	05.04 Site Management	05.04.04 Visit Log
8970	84	\N	\N	D5170C00002	2755	2729	NEW	\N	05 Site Management	05.05 General
8971	84	\N	\N	D5170C00002	2756	2755	NEW	\N	05.05 General	05.05.02 Tracking Information
8972	84	\N	\N	D5170C00002	2757	2714	NEW	\N	2002047 Basilisco, Guido	06 IP and Trial Supplies
8974	84	\N	\N	D5170C00002	2759	2758	NEW	\N	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
8975	84	\N	\N	D5170C00002	2760	2630	NEW	\N	Site	2002048 Cicala, Michele
8977	84	\N	\N	D5170C00002	2762	2761	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
8978	84	\N	\N	D5170C00002	2763	2762	NEW	\N	02.02 Subject Documents	02.02.03 Informed Consent Form Templates
8980	84	\N	\N	D5170C00002	2765	2764	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
8981	84	\N	\N	D5170C00002	2766	2764	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
8983	84	\N	\N	D5170C00002	2768	2767	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
8984	84	\N	\N	D5170C00002	2769	2768	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
6258	84	\N	\N	D5170C00002	43	41	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
6261	84	\N	\N	D5170C00002	46	45	NEW	\N	03.03 Trial Status Reporting	03.03.03 Notif_rial Termination
6264	84	\N	\N	D5170C00002	49	48	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
6267	84	\N	\N	D5170C00002	52	51	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
6270	84	\N	\N	D5170C00002	55	54	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
6274	84	\N	\N	D5170C00002	59	54	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
6277	84	\N	\N	D5170C00002	62	54	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
6280	84	\N	\N	D5170C00002	65	54	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
6283	84	\N	\N	D5170C00002	68	66	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
6287	84	\N	\N	D5170C00002	72	70	NEW	\N	05.04 Site Management	05.04.03 Monitoring Visit Report
6290	84	\N	\N	D5170C00002	75	70	NEW	\N	05.04 Site Management	05.04.05 UNBLI_itoring Activity
6293	84	\N	\N	D5170C00002	78	77	NEW	\N	05.05 General	05.05.01 Relevant Communications-Documents
6296	84	\N	\N	D5170C00002	81	80	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
6299	84	\N	\N	D5170C00002	84	81	NEW	\N	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
6302	84	\N	\N	D5170C00002	87	86	NEW	\N	06.04 Storage	06.04.01 UNBLINDED Storage Condition Documentation
6305	84	\N	\N	D5170C00002	90	89	NEW	\N	06.05 Non-IP Documentation	06.05.02 Non-IP Documentation of Shipment
6308	84	\N	\N	D5170C00002	93	92	NEW	\N	08.01 Facility Documentation	08.01.01 Certi_or Accreditation
6312	84	\N	\N	D5170C00002	97	96	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
6314	84	\N	\N	D5170C00002	99	98	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
6317	84	\N	\N	D5170C00002	102	98	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
6321	84	\N	\N	D5170C00002	106	105	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
6324	84	\N	\N	D5170C00002	109	108	NEW	\N	05 Site Management	05.01 Site Selection
6327	84	\N	\N	D5170C00002	112	111	NEW	\N	2002543 Leong, Rupert	02 Central Trial Documents
6329	84	\N	\N	D5170C00002	114	113	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
6333	84	\N	\N	D5170C00002	118	111	NEW	\N	2002543 Leong, Rupert	04 IRB-IEC and other Approvals
6336	84	\N	\N	D5170C00002	121	119	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
16437	88	1617051700568:-1174541574	1617051695619:-1755896893	D5170C00001	2127	2121	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IP and Trial Supplies	IP Documentation
17251	88	1617083047842:-2080966522	1617052389524:1591359346	D5170C00001	2941	2933	CREATE	2021-03-30 07:44:07.926	Site Set-up	Site Signature Sheet
17367	88	1617083099086:-1973233915	1617052495749:1459276251	D5170C00001	3057	3056	CREATE	2021-03-30 07:44:59.169	General	Filenote
17371	88	1617083101180:2078859584	1617052497460:-1953174261	D5170C00001	3061	3059	CREATE	2021-03-30 07:45:01.269	Site Management	Subject Log
17372	88	1617083102051:2056662167	1617052497460:-1953174261	D5170C00001	3062	3059	CREATE	2021-03-30 07:45:02.139	Site Management	Visit Log
17376	88	1617083103822:-942735255	1617052501784:1459373185	D5170C00001	3066	3065	CREATE	2021-03-30 07:45:03.915	Site Set-up	Acceptance of Investigator Brochure
17379	88	1617083107587:1421869826	1617052501784:1459373185	D5170C00001	3069	3065	CREATE	2021-03-30 07:45:07.681	Site Set-up	Form FDA 1572
17383	88	1617083119914:1495862940	1617052501784:1459373185	D5170C00001	3073	3065	CREATE	2021-03-30 07:45:20.006	Site Set-up	Site Signature Sheet
17390	88	1617083122836:601685499	1617052509377:2052844832	D5170C00001	3080	3078	CREATE	2021-03-30 07:45:22.922	Subject Documentation	Informed Consent Form
17405	88	1617083130028:1782544086	1617052519495:-2073008828	D5170C00001	3095	3094	CREATE	2021-03-30 07:45:30.117	General	Relevant Communications
17408	88	1617083131524:2145850337	1617052520597:1198206109	D5170C00001	3098	3096	CREATE	2021-03-30 07:45:31.609	IRB or IEC Trial Approval	IRB or IEC Compliance Documentation
17418	88	1617083134788:-572959055	1617052528072:1933751190	D5170C00001	3108	3106	CREATE	2021-03-30 07:45:34.87	General	Relevant Communications
17421	88	1617083136173:-1160955485	1617052529725:-1281762727	D5170C00001	3111	3109	CREATE	2021-03-30 07:45:36.305	Site Management	Subject Log
17424	88	1617083137451:-676422333	1617052532083:-1953729404	D5170C00001	3114	3113	CREATE	2021-03-30 07:45:37.535	Site Selection	Confidentiality Agreement
17430	88	1617083144899:1040039421	1617052534244:1720408852	D5170C00001	3120	3115	CREATE	2021-03-30 07:45:44.983	Site Set-up	IP Site Release Documentation
17431	88	1617083145572:-2022037890	1617052534244:1720408852	D5170C00001	3121	3115	CREATE	2021-03-30 07:45:45.661	Site Set-up	Principal Investigator Curriculum Vitae
17451	88	1617083151662:-1271420439	1617052568773:57779536	D5170C00001	3141	3140	CREATE	2021-03-30 07:45:51.745	IRB or IEC Trial Approval	IRB or IEC Approval
17461	88	1617083156827:-1359711399	1617052574964:509646081	D5170C00001	3151	3150	CREATE	2021-03-30 07:45:56.913	General	Filenote
17469	88	1617083160268:1443301927	1617052580110:299539488	D5170C00001	3159	3157	CREATE	2021-03-30 07:46:00.356	Site Set-up	Clinical Study Agreement
17475	88	1617083164345:-571580527	1617052580110:299539488	D5170C00001	3165	3157	CREATE	2021-03-30 07:46:04.433	Site Set-up	Protocol Amendment Signature Page
17503	88	1617083176554:-241606451	1617052608083:-67683498	D5170C00001	3193	3192	CREATE	2021-03-30 07:46:16.663	General	Filenote
6339	84	\N	\N	D5170C00002	124	111	NEW	\N	2002543 Leong, Rupert	05 Site Management
6342	84	\N	\N	D5170C00002	127	125	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
6344	84	\N	\N	D5170C00002	129	128	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
6348	84	\N	\N	D5170C00002	133	128	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
6351	84	\N	\N	D5170C00002	136	128	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
6354	84	\N	\N	D5170C00002	139	128	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
6358	84	\N	\N	D5170C00002	143	124	NEW	\N	05 Site Management	05.04 Site Management
6361	84	\N	\N	D5170C00002	146	145	NEW	\N	05.05 General	05.05.02 Tracking Information
6364	84	\N	\N	D5170C00002	149	148	NEW	\N	05 Site Management	05.01 Site Selection
6367	84	\N	\N	D5170C00002	152	151	NEW	\N	TBD-1-1ZSMQVQ Sparrow, Miles	05 Site Management
6371	84	\N	\N	D5170C00002	156	155	NEW	\N	BELGIUM	Site
6373	84	\N	\N	D5170C00002	158	157	NEW	\N	2001824 Van Assche, Gert	02 Central Trial Documents
6376	84	\N	\N	D5170C00002	161	159	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
6377	84	\N	\N	D5170C00002	162	157	NEW	\N	2001824 Van Assche, Gert	03 Regulatory
6379	84	\N	\N	D5170C00002	164	163	NEW	\N	03.04 General	03.04.01 Relev_art-Up-Documents
6381	84	\N	\N	D5170C00002	166	165	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
6385	84	\N	\N	D5170C00002	170	169	NEW	\N	05.01 Site Selection	05.01.01 Site Contact Details
6388	84	\N	\N	D5170C00002	173	169	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
6390	84	\N	\N	D5170C00002	175	174	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
6394	84	\N	\N	D5170C00002	179	174	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Site Qualification
6397	84	\N	\N	D5170C00002	182	174	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
6400	84	\N	\N	D5170C00002	185	174	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
6404	84	\N	\N	D5170C00002	189	186	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
6407	84	\N	\N	D5170C00002	192	190	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
6410	84	\N	\N	D5170C00002	195	190	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
6417	84	\N	\N	D5170C00002	202	199	NEW	\N	06.01 IP Documentation	06.01.11 UNBLI_e of Destruction
6420	84	\N	\N	D5170C00002	205	203	NEW	\N	06.04 Storage	06.04.01 UNBLI_on Documentation
6423	84	\N	\N	D5170C00002	208	203	NEW	\N	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
6426	84	\N	\N	D5170C00002	211	210	NEW	\N	08.02 Sample Documentation	08.02.03 Sampl_ge Condition Log
6429	84	\N	\N	D5170C00002	214	213	NEW	\N	03 Regulatory	03.04 General
6432	84	\N	\N	D5170C00002	217	216	NEW	\N	05 Site Management	05.01 Site Selection
6434	84	\N	\N	D5170C00002	219	217	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
6438	84	\N	\N	D5170C00002	223	222	NEW	\N	05.05 General	05.05.02 Tracking Information
6441	84	\N	\N	D5170C00002	226	225	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
6443	84	\N	\N	D5170C00002	228	225	NEW	\N	02 Central Trial Documents	02.04 General
16510	88	1617051756036:-58795687	1617051754183:1570914677	D5170C00001	2200	2197	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IRB or IEC and other Approvals	IRB or IEC Trial Approval
17505	89	1617049796982:-2116394566	1617049777304:1085508340	D5170C00001	2	1	ALREADY AVAILABLE	2021-03-30 16:25:18.51	eTMF	AstraZeneca
17509	89	1617051980305:1976405238	1617050181568:-159398468	D5170C00001	6	5	ALREADY AVAILABLE	2021-03-30 16:25:18.804	Site	United States of America
17510	89	1617052592811:380298272	1617051980305:1976405238	D5170C00001	7	6	ALREADY AVAILABLE	2021-03-30 16:25:18.806	United States of America	7821
17511	89	1617052607516:-1420320606	1617052592811:380298272	D5170C00001	8	7	ALREADY AVAILABLE	2021-03-30 16:25:18.831	7821	Site Management
17513	89	1617114372719:714228245	1617052608083:-67683498	D5170C00001	10	9	CREATE	2021-03-30 16:26:12.839	General	Relevant Communications
17514	89	1617114373319:-1384424025	1617052607516:-1420320606	D5170C00001	11	8	CREATE	2021-03-30 16:26:13.411	Site Management	Site Initiation
17516	89	1617114374532:1094251203	1617052607516:-1420320606	D5170C00001	13	8	CREATE	2021-03-30 16:26:14.63	Site Management	Site Management
17517	89	1617114375223:-886348649	1617114374532:1094251203	D5170C00001	14	13	CREATE	2021-03-30 16:26:15.312	Site Management	Monitoring Visit Report
17519	89	1617114376418:1804508315	1617114374532:1094251203	D5170C00001	16	13	CREATE	2021-03-30 16:26:16.507	Site Management	Visit Log
17520	89	1617114376988:1439771284	1617052607516:-1420320606	D5170C00001	17	8	CREATE	2021-03-30 16:26:17.073	Site Management	Site Selection
17522	89	1617114378194:12412252	1617052607516:-1420320606	D5170C00001	19	8	CREATE	2021-03-30 16:26:19.23	Site Management	Site Set-up
17524	89	1617114380487:-1807710408	1617114378194:12412252	D5170C00001	21	19	CREATE	2021-03-30 16:26:20.58	Site Set-up	Clinical Study Agreement
17525	89	1617114381077:1611973547	1617114378194:12412252	D5170C00001	22	19	CREATE	2021-03-30 16:26:21.166	Site Set-up	Financial Disclosure Form
17526	89	1617114381637:195048102	1617114378194:12412252	D5170C00001	23	19	CREATE	2021-03-30 16:26:21.747	Site Set-up	Form FDA 1572
17528	89	1617114382803:1829399419	1617114378194:12412252	D5170C00001	25	19	CREATE	2021-03-30 16:26:22.891	Site Set-up	Principal Investigator Curriculum Vitae
17529	89	1617114383373:767718257	1617114378194:12412252	D5170C00001	26	19	CREATE	2021-03-30 16:26:23.462	Site Set-up	Protocol Amendment Signature Page
17531	89	1617114384527:2022731880	1617114378194:12412252	D5170C00001	28	19	CREATE	2021-03-30 16:26:24.61	Site Set-up	Site Staff Qualification Supporting Information
17532	89	1617114385103:1893541647	1617114378194:12412252	D5170C00001	29	19	CREATE	2021-03-30 16:26:25.187	Site Set-up	Sub-Investigator Curriculum Vitae
17534	89	1617114386298:113383799	1617114385706:-830451826	D5170C00001	31	30	CREATE	2021-03-30 16:26:34.277	7823	Central Trial Documents
17535	89	1617114394847:453771359	1617114386298:113383799	D5170C00001	32	31	CREATE	2021-03-30 16:26:34.949	Central Trial Documents	Subject Documentation
17537	89	1617114396071:884990809	1617114394847:453771359	D5170C00001	34	32	CREATE	2021-03-30 16:26:36.166	Subject Documentation	Informed Consent Form
17538	89	1617114396712:-289292274	1617114385706:-830451826	D5170C00001	35	30	CREATE	2021-03-30 16:26:36.811	7823	IP and Trial Supplies
17540	89	1617114397923:-975913762	1617114397326:1609685598	D5170C00001	37	36	CREATE	2021-03-30 16:26:38.017	IP Documentation	IP Accountability Documentation
17541	89	1617114398528:-1848840344	1617114397326:1609685598	D5170C00001	38	36	CREATE	2021-03-30 16:26:38.864	IP Documentation	IP Certificate of Destruction
17543	89	1617114400031:1557752653	1617114399454:-632753146	D5170C00001	40	39	CREATE	2021-03-30 16:26:40.13	IRB or IEC and other Approvals	IRB or IEC Trial Approval
17544	89	1617114401706:1387118128	1617114400031:1557752653	D5170C00001	41	40	CREATE	2021-03-30 16:26:41.811	IRB or IEC Trial Approval	IRB or IEC Approval
17546	89	1617114403082:594498335	1617114399454:-632753146	D5170C00001	43	39	CREATE	2021-03-30 16:26:43.176	IRB or IEC and other Approvals	Trial Status Reporting
17547	89	1617114403674:364218881	1617114403082:594498335	D5170C00001	44	43	CREATE	2021-03-30 16:26:43.758	Trial Status Reporting	IRB or IEC Notification of Trial Termination
17548	89	1617114404295:720000671	1617114385706:-830451826	D5170C00001	45	30	CREATE	2021-03-30 16:26:44.388	7823	Site Management
17550	89	1617114405703:806546725	1617114404891:-1207956496	D5170C00001	47	46	CREATE	2021-03-30 16:26:45.791	General	Filenote
17552	89	1617114406870:-935139199	1617114404295:720000671	D5170C00001	49	45	CREATE	2021-03-30 16:26:46.959	Site Management	Site Management
17553	89	1617114407432:536978345	1617114406870:-935139199	D5170C00001	50	49	CREATE	2021-03-30 16:26:47.52	Site Management	Final Trial Close Out Monitoring Report
17555	89	1617114408681:-1293383099	1617114404295:720000671	D5170C00001	52	45	CREATE	2021-03-30 16:26:48.766	Site Management	Site Selection
17557	89	1617114409929:1245864365	1617114408681:-1293383099	D5170C00001	54	52	CREATE	2021-03-30 16:26:50.022	Site Selection	Pre Trial Monitoring Report
17558	89	1617114410504:-1618192993	1617114404295:720000671	D5170C00001	55	45	CREATE	2021-03-30 16:26:50.593	Site Management	Site Set-up
17560	89	1617114412921:-10185346	1617114410504:-1618192993	D5170C00001	57	55	CREATE	2021-03-30 16:26:53.01	Site Set-up	Clinical Study Agreement
17561	89	1617114413489:-1788662378	1617114410504:-1618192993	D5170C00001	58	55	CREATE	2021-03-30 16:26:53.577	Site Set-up	Financial Disclosure Form
17562	89	1617114414263:479775467	1617114410504:-1618192993	D5170C00001	59	55	CREATE	2021-03-30 16:26:54.358	Site Set-up	Form FDA 1572
17564	89	1617114415435:-668042815	1617114410504:-1618192993	D5170C00001	61	55	CREATE	2021-03-30 16:26:55.522	Site Set-up	Principal Investigator Curriculum Vitae
17565	89	1617114416043:1346014089	1617114410504:-1618192993	D5170C00001	62	55	CREATE	2021-03-30 16:26:56.133	Site Set-up	Protocol Amendment Signature Page
17567	89	1617114417695:-674118846	1617114410504:-1618192993	D5170C00001	64	55	CREATE	2021-03-30 16:26:57.784	Site Set-up	Site Staff Qualification Supporting Information
17569	89	1617114418923:1192755181	1617051980305:1976405238	D5170C00001	66	6	CREATE	2021-03-30 16:26:59.016	United States of America	7824
17570	89	1617114419587:-1524941523	1617114418923:1192755181	D5170C00001	67	66	CREATE	2021-03-30 16:26:59.673	7824	Central Trial Documents
17571	89	1617114420170:-571199935	1617114419587:-1524941523	D5170C00001	68	67	CREATE	2021-03-30 16:27:00.26	Central Trial Documents	Subject Documentation
17573	89	1617114421386:1707963032	1617114418923:1192755181	D5170C00001	70	66	CREATE	2021-03-30 16:27:01.475	7824	IRB or IEC and other Approvals
17574	89	1617114422031:1886890913	1617114421386:1707963032	D5170C00001	71	70	CREATE	2021-03-30 16:27:02.119	IRB or IEC and other Approvals	IRB or IEC Trial Approval
17642	89	1617114505630:-836441117	1617114505054:-1816874419	D5170C00001	139	138	CREATE	2021-03-30 16:28:25.719	General	Filenote
16585	88	1617082684709:-1329593109	1617051815406:-2025746494	D5170C00001	2275	2273	CREATE	2021-03-30 07:38:04.796	Site Initiation	Trial Initiation Monitoring Report
17575	89	1617114422638:232398932	1617114422031:1886890913	D5170C00001	72	71	CREATE	2021-03-30 16:27:03.787	IRB or IEC Trial Approval	IRB or IEC Approval
17577	89	1617114424929:630068128	1617114421386:1707963032	D5170C00001	74	70	CREATE	2021-03-30 16:27:05.023	IRB or IEC and other Approvals	Trial Status Reporting
17578	89	1617114425561:1101604946	1617114424929:630068128	D5170C00001	75	74	CREATE	2021-03-30 16:27:05.658	Trial Status Reporting	IRB or IEC Notification of Trial Termination
17579	89	1617114426186:-1843875671	1617114418923:1192755181	D5170C00001	76	66	CREATE	2021-03-30 16:27:06.275	7824	Site Management
17581	89	1617114427640:-844337402	1617114426939:1912847229	D5170C00001	78	77	CREATE	2021-03-30 16:27:07.755	Site Set-up	Acceptance of Investigator Brochure
17583	89	1617114428906:1401755883	1617114426939:1912847229	D5170C00001	80	77	CREATE	2021-03-30 16:27:09.085	Site Set-up	Form FDA 1572
17584	89	1617114429612:-472204927	1617114426939:1912847229	D5170C00001	81	77	CREATE	2021-03-30 16:27:09.706	Site Set-up	Principal Investigator Curriculum Vitae
17586	89	1617114430765:14805744	1617114426939:1912847229	D5170C00001	83	77	CREATE	2021-03-30 16:27:11.038	Site Set-up	Site Staff Qualification Supporting Information
17587	89	1617114431643:-524590612	1617114426939:1912847229	D5170C00001	84	77	CREATE	2021-03-30 16:27:11.728	Site Set-up	Sub-Investigator Curriculum Vitae
17589	89	1617114432813:1942153944	1617114432206:-1688662159	D5170C00001	86	85	CREATE	2021-03-30 16:27:12.904	7825	Central Trial Documents
17590	89	1617114433429:-356783449	1617114432813:1942153944	D5170C00001	87	86	CREATE	2021-03-30 16:27:13.515	Central Trial Documents	Subject Documentation
17592	89	1617114435952:1738790882	1617114432206:-1688662159	D5170C00001	89	85	CREATE	2021-03-30 16:27:16.039	7825	IP and Trial Supplies
17593	89	1617114436515:-1626467945	1617114435952:1738790882	D5170C00001	90	89	CREATE	2021-03-30 16:27:16.604	IP and Trial Supplies	General
17594	89	1617114437161:-1943203762	1617114436515:-1626467945	D5170C00001	91	90	CREATE	2021-03-30 16:27:17.25	General	Filenote
17596	89	1617114438345:-1266332753	1617114437779:-1299557908	D5170C00001	93	92	CREATE	2021-03-30 16:27:18.432	IP Documentation	IP Accountability Documentation
17598	89	1617114439622:586381166	1617114432206:-1688662159	D5170C00001	95	85	CREATE	2021-03-30 16:27:19.848	7825	IRB or IEC and other Approvals
17599	89	1617114440331:-860330077	1617114439622:586381166	D5170C00001	96	95	CREATE	2021-03-30 16:27:20.415	IRB or IEC and other Approvals	IRB or IEC Trial Approval
17601	89	1617114441591:682442493	1617114440331:-860330077	D5170C00001	98	96	CREATE	2021-03-30 16:27:21.681	IRB or IEC Trial Approval	IRB or IEC Composition
17602	89	1617114442181:-1213853081	1617114439622:586381166	D5170C00001	99	95	CREATE	2021-03-30 16:27:22.269	IRB or IEC and other Approvals	Trial Status Reporting
17604	89	1617114443407:644518134	1617114432206:-1688662159	D5170C00001	101	85	CREATE	2021-03-30 16:27:23.494	7825	Safety Reporting
17605	89	1617114444092:124880741	1617114443407:644518134	D5170C00001	102	101	CREATE	2021-03-30 16:27:24.183	Safety Reporting	General
17606	89	1617114444680:-68566704	1617114444092:124880741	D5170C00001	103	102	CREATE	2021-03-30 16:27:24.767	General	Tracking Information
17608	89	1617114447196:1987922844	1617114446455:1762062602	D5170C00001	105	104	CREATE	2021-03-30 16:27:27.282	Site Management	General
17609	89	1617114447867:-1835226917	1617114447196:1987922844	D5170C00001	106	105	CREATE	2021-03-30 16:27:27.953	General	Relevant Communications
17611	89	1617114449085:-452300059	1617114448472:-312194196	D5170C00001	108	107	CREATE	2021-03-30 16:27:29.172	Site Initiation	Site Evidence of Training
17613	89	1617114450888:929313522	1617114449665:-1718280141	D5170C00001	110	109	CREATE	2021-03-30 16:27:31.013	Site Management	Final Trial Close Out Monitoring Report
17614	89	1617114451523:2050431693	1617114449665:-1718280141	D5170C00001	111	109	CREATE	2021-03-30 16:27:31.612	Site Management	Monitoring Visit Report
17616	89	1617114452675:2101604028	1617114446455:1762062602	D5170C00001	113	104	CREATE	2021-03-30 16:27:32.761	Site Management	Site Selection
17617	89	1617114453358:1543714935	1617114452675:2101604028	D5170C00001	114	113	CREATE	2021-03-30 16:27:33.452	Site Selection	Confidentiality Agreement
17619	89	1617114454686:1323679781	1617114454108:1694277914	D5170C00001	116	115	CREATE	2021-03-30 16:27:34.769	Site Set-up	Acceptance of Investigator Brochure
17620	89	1617114455291:-1907416839	1617114454108:1694277914	D5170C00001	117	115	CREATE	2021-03-30 16:27:35.448	Site Set-up	Clinical Study Agreement
17622	89	1617114457834:-514272944	1617114454108:1694277914	D5170C00001	119	115	CREATE	2021-03-30 16:27:37.927	Site Set-up	Form FDA 1572
17623	89	1617114458628:86098257	1617114454108:1694277914	D5170C00001	120	115	CREATE	2021-03-30 16:27:38.714	Site Set-up	IP Site Release Documentation
17625	89	1617114459820:-235330391	1617114454108:1694277914	D5170C00001	122	115	CREATE	2021-03-30 16:27:39.912	Site Set-up	Protocol Amendment Signature Page
17626	89	1617114460476:-731938677	1617114454108:1694277914	D5170C00001	123	115	CREATE	2021-03-30 16:27:40.567	Site Set-up	Site Signature Sheet
17628	89	1617114495690:1184209992	1617114454108:1694277914	D5170C00001	125	115	CREATE	2021-03-30 16:28:15.794	Site Set-up	Sub-Investigator Curriculum Vitae
17629	89	1617114496297:-2110691886	1617114432206:-1688662159	D5170C00001	126	85	CREATE	2021-03-30 16:28:16.385	7825	Trial Management
17631	89	1617114497539:1753034368	1617114496878:-1987700060	D5170C00001	128	127	CREATE	2021-03-30 16:28:17.63	Trial Oversight	Recruitment Plan
17632	89	1617114498116:-998406171	1617049801974:-542363185	D5170C00001	129	4	CREATE	2021-03-30 16:28:18.208	Delivery	Study
17634	89	1617114499367:-111636337	1617114498695:-1963164418	D5170C00001	131	130	CREATE	2021-03-30 16:28:19.453	Central and Local Testing	Facility Documentation
17635	89	1617114499942:2031238817	1617114499367:-111636337	D5170C00001	132	131	CREATE	2021-03-30 16:28:20.03	Facility Documentation	Certification or Accreditation
17637	89	1617114501113:-1788586435	1617114499367:-111636337	D5170C00001	134	131	CREATE	2021-03-30 16:28:21.202	Facility Documentation	Laboratory Validation Documentation
17638	89	1617114501762:940928417	1617114499367:-111636337	D5170C00001	135	131	CREATE	2021-03-30 16:28:21.852	Facility Documentation	Manual
17640	89	1617114504372:1740505689	1617114499367:-111636337	D5170C00001	137	131	CREATE	2021-03-30 16:28:24.46	Facility Documentation	Standardization Methods
17641	89	1617114505054:-1816874419	1617114498695:-1963164418	D5170C00001	138	130	CREATE	2021-03-30 16:28:25.146	Central and Local Testing	General
16658	88	1617082721291:188052124	1617051877638:125140249	D5170C00001	2348	2346	CREATE	2021-03-30 07:38:41.378	Site Management	Visit Log
16660	88	1617082721886:-814104331	1617051879521:667777278	D5170C00001	2350	2349	CREATE	2021-03-30 07:38:41.969	Site Selection	Confidentiality Agreement
17644	89	1617114506973:-26090709	1617114505054:-1816874419	D5170C00001	141	138	CREATE	2021-03-30 16:28:27.06	General	Relevant Communications
17645	89	1617114507647:758126624	1617114498695:-1963164418	D5170C00001	142	130	CREATE	2021-03-30 16:28:27.732	Central and Local Testing	Sample Documentation
17646	89	1617114508230:-1006165309	1617114507647:758126624	D5170C00001	143	142	CREATE	2021-03-30 16:28:28.322	Sample Documentation	Record of Retained Samples
17648	89	1617114509360:-517684071	1617114507647:758126624	D5170C00001	145	142	CREATE	2021-03-30 16:28:29.448	Sample Documentation	Shipment Records
17649	89	1617114510005:997556913	1617114498116:-998406171	D5170C00001	146	129	CREATE	2021-03-30 16:28:30.095	Study	Central Trial Documents
17651	89	1617114511145:147204536	1617114510572:1321856745	D5170C00001	148	147	CREATE	2021-03-30 16:28:31.233	General	Filenote
17652	89	1617114511798:233449344	1617114510572:1321856745	D5170C00001	149	147	CREATE	2021-03-30 16:28:31.884	General	Relevant Communications
17654	89	1617114516291:822274972	1617114512372:-1029256024	D5170C00001	151	150	CREATE	2021-03-30 16:28:36.38	Product and Trial Documentation	Investigator's Brochure
17655	89	1617114516967:-607740128	1617114512372:-1029256024	D5170C00001	152	150	CREATE	2021-03-30 16:28:37.059	Product and Trial Documentation	Protocol Amendment
17657	89	1617114518198:1688203550	1617114512372:-1029256024	D5170C00001	154	150	CREATE	2021-03-30 16:28:38.283	Product and Trial Documentation	Sample Case Report Form
17658	89	1617114518800:1423538290	1617114510005:997556913	D5170C00001	155	146	CREATE	2021-03-30 16:28:38.912	Central Trial Documents	Subject Documentation
17660	89	1617114520189:-216218966	1617114518800:1423538290	D5170C00001	157	155	CREATE	2021-03-30 16:28:40.277	Subject Documentation	Subject Diary
17661	89	1617114520801:-1117308401	1617114518800:1423538290	D5170C00001	158	155	CREATE	2021-03-30 16:28:40.907	Subject Documentation	Subject Participation Card
17663	89	1617114522085:-1185750799	1617114498116:-998406171	D5170C00001	160	129	CREATE	2021-03-30 16:28:42.179	Study	Data Management
17664	89	1617114522916:1088795663	1617114522085:-1185750799	D5170C00001	161	160	CREATE	2021-03-30 16:28:43.001	Data Management	Data Capture
17665	89	1617114523533:-537862558	1617114522916:1088795663	D5170C00001	162	161	CREATE	2021-03-30 16:28:43.619	Data Capture	Annotated CRF
17667	89	1617114524823:1675886619	1617114522085:-1185750799	D5170C00001	164	160	CREATE	2021-03-30 16:28:46.274	Data Management	Data Management Oversight
17668	89	1617114526843:-824118019	1617114524823:1675886619	D5170C00001	165	164	CREATE	2021-03-30 16:28:46.951	Data Management Oversight	Data Management Plan
17670	89	1617114528276:640706566	1617114527602:-365411959	D5170C00001	167	166	CREATE	2021-03-30 16:28:48.36	Database	Approval for Database Activation
17671	89	1617114528838:673010851	1617114527602:-365411959	D5170C00001	168	166	CREATE	2021-03-30 16:28:48.927	Database	Data QC or QA Plan and Results
17673	89	1617114530059:1495991799	1617114527602:-365411959	D5170C00001	170	166	CREATE	2021-03-30 16:28:50.151	Database	Database Lock and Unlock Approval
17674	89	1617114530626:-890309814	1617114527602:-365411959	D5170C00001	171	166	CREATE	2021-03-30 16:28:50.717	Database	Dictionary Coding
17676	89	1617114531845:-167205812	1617114527602:-365411959	D5170C00001	173	166	CREATE	2021-03-30 16:28:51.933	Database	External Data Transfer Specifications
17677	89	1617114532564:-251691246	1617114527602:-365411959	D5170C00001	174	166	CREATE	2021-03-30 16:28:52.649	Database	SAE Reconciliation
17679	89	1617114533695:-2046303439	1617114533132:-1405894619	D5170C00001	176	175	CREATE	2021-03-30 16:28:53.783	EDC Management	System Account Management
17681	89	1617114534964:-757277648	1617114533132:-1405894619	D5170C00001	178	175	CREATE	2021-03-30 16:28:55.056	EDC Management	Validation Documents
17682	89	1617114535554:-1830952970	1617114522085:-1185750799	D5170C00001	179	160	CREATE	2021-03-30 16:28:55.643	Data Management	General
17683	89	1617114536136:-893060789	1617114535554:-1830952970	D5170C00001	180	179	CREATE	2021-03-30 16:28:56.224	General	Filenote
17685	89	1617114545089:-82720990	1617114535554:-1830952970	D5170C00001	182	179	CREATE	2021-03-30 16:29:05.173	General	Relevant Communications
17687	89	1617114546336:-1887931292	1617114545748:711525452	D5170C00001	184	183	CREATE	2021-03-30 16:29:06.439	IP and Trial Supplies	General
17688	89	1617114547035:-170917790	1617114546336:-1887931292	D5170C00001	185	184	CREATE	2021-03-30 16:29:07.129	General	Filenote
17690	89	1617114549405:-903831684	1617114545748:711525452	D5170C00001	187	183	CREATE	2021-03-30 16:29:09.508	IP and Trial Supplies	Interactive Response Technology
17692	89	1617114550688:316821627	1617114549405:-903831684	D5170C00001	189	187	CREATE	2021-03-30 16:29:10.776	Interactive Response Technology	IRT User Acceptance Testing (UAT) Certification
17693	89	1617114551263:954201985	1617114549405:-903831684	D5170C00001	190	187	CREATE	2021-03-30 16:29:11.35	Interactive Response Technology	IRT User Account Management
17694	89	1617114551900:1065137630	1617114549405:-903831684	D5170C00001	191	187	CREATE	2021-03-30 16:29:11.986	Interactive Response Technology	IRT User Manual
17696	89	1617114553080:742946885	1617114549405:-903831684	D5170C00001	193	187	CREATE	2021-03-30 16:29:13.165	Interactive Response Technology	IRT Validation Certification
17697	89	1617114553631:-836926264	1617114545748:711525452	D5170C00001	194	183	CREATE	2021-03-30 16:29:13.717	IP and Trial Supplies	IP Documentation
17699	89	1617114554909:1627203320	1617114553631:-836926264	D5170C00001	196	194	CREATE	2021-03-30 16:29:14.996	IP Documentation	IP Certificate of Destruction
17700	89	1617114555493:1004591874	1617114553631:-836926264	D5170C00001	197	194	CREATE	2021-03-30 16:29:15.58	IP Documentation	IP Instructions for Handling
17701	89	1617114556053:631214060	1617114553631:-836926264	D5170C00001	198	194	CREATE	2021-03-30 16:29:16.147	IP Documentation	IP Sample Label
17703	89	1617114557279:1448634935	1617114553631:-836926264	D5170C00001	200	194	CREATE	2021-03-30 16:29:17.366	IP Documentation	IP Supply Plan
17704	89	1617114558032:149654487	1617114553631:-836926264	D5170C00001	201	194	CREATE	2021-03-30 16:29:18.129	IP Documentation	IP Transfer Documentation
17706	89	1617114560470:-647104256	1617114558623:1853668880	D5170C00001	203	202	CREATE	2021-03-30 16:29:20.561	IP Release Process Documentation	Certificate of Analysis
17707	89	1617114561151:-1767847758	1617114558623:1853668880	D5170C00001	204	202	CREATE	2021-03-30 16:29:21.245	IP Release Process Documentation	IP Regulatory Release Documentation
16732	88	1617082757248:-1835152756	1617051947299:1625730858	D5170C00001	2422	2421	CREATE	2021-03-30 07:39:17.357	Product and Trial Documentation	Insurance
17709	89	1617114562339:-241550035	1617114498116:-998406171	D5170C00001	206	129	CREATE	2021-03-30 16:29:22.43	Study	IRB or IEC and other Approvals
17711	89	1617114563580:-1817866884	1617114562930:116364977	D5170C00001	208	207	CREATE	2021-03-30 16:29:23.673	General	Tracking Information
17712	89	1617114564138:-1764170887	1617114498116:-998406171	D5170C00001	209	129	CREATE	2021-03-30 16:29:24.224	Study	Regulatory
17713	89	1617114565349:938159686	1617114564138:-1764170887	D5170C00001	210	209	CREATE	2021-03-30 16:29:25.438	Regulatory	General
17715	89	1617114566589:1125333467	1617114565349:938159686	D5170C00001	212	210	CREATE	2021-03-30 16:29:26.69	General	Relevant Communications
17717	89	1617114567821:540660706	1617114498116:-998406171	D5170C00001	214	129	CREATE	2021-03-30 16:29:27.913	Study	Safety Reporting
17718	89	1617114568395:-18341145	1617114567821:540660706	D5170C00001	215	214	CREATE	2021-03-30 16:29:28.484	Safety Reporting	General
17720	89	1617114569569:-912333159	1617114568395:-18341145	D5170C00001	217	215	CREATE	2021-03-30 16:29:29.694	General	Meeting Material
17721	89	1617114571296:-327988552	1617114568395:-18341145	D5170C00001	218	215	CREATE	2021-03-30 16:29:31.453	General	Relevant Communications
17723	89	1617114572619:-557874053	1617114572003:-1076837938	D5170C00001	220	219	CREATE	2021-03-30 16:29:32.711	Safety Documentation	Safety Management Plan
17725	89	1617114573970:576283092	1617114573377:1585728185	D5170C00001	222	221	CREATE	2021-03-30 16:29:34.059	Trial Status Reporting	SAE Report
17726	89	1617114574535:1951922167	1617114498116:-998406171	D5170C00001	223	129	CREATE	2021-03-30 16:29:34.632	Study	Site Management
17727	89	1617114575211:819097842	1617114574535:1951922167	D5170C00001	224	223	CREATE	2021-03-30 16:29:35.303	Site Management	General
17729	89	1617114576514:-1364581088	1617114575211:819097842	D5170C00001	226	224	CREATE	2021-03-30 16:29:36.604	General	Relevant Communications
17731	89	1617114577772:1551419683	1617114577097:-581803882	D5170C00001	228	227	CREATE	2021-03-30 16:29:37.886	Site Initiation	Site Training Material
17732	89	1617114578401:1699510391	1617114574535:1951922167	D5170C00001	229	223	CREATE	2021-03-30 16:29:38.489	Site Management	Site Management
17734	89	1617114579674:1684049312	1617114578401:1699510391	D5170C00001	231	229	CREATE	2021-03-30 16:29:47.238	Site Management	Protocol Deviations
17735	89	1617114587774:1414152978	1617114578401:1699510391	D5170C00001	232	229	CREATE	2021-03-30 16:29:47.862	Site Management	Source Data Verification
17737	89	1617114589335:690893900	1617114588561:1343144284	D5170C00001	234	233	CREATE	2021-03-30 16:29:49.426	Site Selection	Feasibility Documentation
17738	89	1617114589928:1424657619	1617114574535:1951922167	D5170C00001	235	223	CREATE	2021-03-30 16:29:50.013	Site Management	Site Set-up
17740	89	1617114591160:-1528971848	1617114498116:-998406171	D5170C00001	237	129	CREATE	2021-03-30 16:29:51.248	Study	Statistics
17741	89	1617114591812:-1183478421	1617114591160:-1528971848	D5170C00001	238	237	CREATE	2021-03-30 16:29:51.924	Statistics	Analysis
17743	89	1617114594187:771852010	1617114591812:-1183478421	D5170C00001	240	238	CREATE	2021-03-30 16:29:54.274	Analysis	Final Analysis Datasets
17744	89	1617114594919:1254926786	1617114591812:-1183478421	D5170C00001	241	238	CREATE	2021-03-30 16:29:55.011	Analysis	Final Analysis Output
17746	89	1617114596059:1615206047	1617114591812:-1183478421	D5170C00001	243	238	CREATE	2021-03-30 16:29:56.147	Analysis	Final Analysis Raw Datasets
17747	89	1617114596650:-646144655	1617114591812:-1183478421	D5170C00001	244	238	CREATE	2021-03-30 16:29:56.737	Analysis	Validation Plan
17749	89	1617114597913:-379550713	1617114591160:-1528971848	D5170C00001	246	237	CREATE	2021-03-30 16:29:58.036	Statistics	General
17750	89	1617114598539:-2091001871	1617114597913:-379550713	D5170C00001	247	246	CREATE	2021-03-30 16:29:58.626	General	Relevant Communications
17752	89	1617114599863:-24448065	1617114599173:1217651056	D5170C00001	249	248	CREATE	2021-03-30 16:29:59.948	Randomization	End of Trial or Interim Unblinding
17754	89	1617114601052:1035065541	1617114599173:1217651056	D5170C00001	251	248	CREATE	2021-03-30 16:30:01.145	Randomization	Randomization Plan
17755	89	1617114601678:-903094878	1617114591160:-1528971848	D5170C00001	252	237	CREATE	2021-03-30 16:30:01.774	Statistics	Statistics Oversight
17757	89	1617114603087:-255793184	1617114601678:-903094878	D5170C00001	254	252	CREATE	2021-03-30 16:30:03.185	Statistics Oversight	Statistical Analysis Plan
17758	89	1617114603706:385107506	1617114498116:-998406171	D5170C00001	255	129	CREATE	2021-03-30 16:30:03.795	Study	Third Parties
17759	89	1617114605471:1632239223	1617114603706:385107506	D5170C00001	256	255	CREATE	2021-03-30 16:30:05.713	Third Parties	General
17761	89	1617114606912:660744729	1617114603706:385107506	D5170C00001	258	255	CREATE	2021-03-30 16:30:07.001	Third Parties	Third Party Set-up
17762	89	1617114607502:696221437	1617114606912:660744729	D5170C00001	259	258	CREATE	2021-03-30 16:30:07.591	Third Party Set-up	Contractual Agreement
17764	89	1617114608748:1159922748	1617114608159:1704007719	D5170C00001	261	260	CREATE	2021-03-30 16:30:08.855	Trial Management	General
17765	89	1617114609347:843253922	1617114608748:1159922748	D5170C00001	262	261	CREATE	2021-03-30 16:30:09.436	General	Filenote
17767	89	1617114610667:1456381292	1617114608748:1159922748	D5170C00001	264	261	CREATE	2021-03-30 16:30:10.762	General	Relevant Communications
17769	89	1617114611805:-1073617112	1617114608159:1704007719	D5170C00001	266	260	CREATE	2021-03-30 16:30:11.904	Trial Management	Meetings
17770	89	1617114612466:1701596797	1617114611805:-1073617112	D5170C00001	267	266	CREATE	2021-03-30 16:30:12.564	Meetings	Investigators Meeting Material
17772	89	1617114613696:-1350832351	1617114611805:-1073617112	D5170C00001	269	266	CREATE	2021-03-30 16:30:13.787	Meetings	Trial Team Training Material
17773	89	1617114614322:-1177638636	1617114608159:1704007719	D5170C00001	270	260	CREATE	2021-03-30 16:30:14.407	Trial Management	Trial Committee
17775	89	1617114620202:1513168399	1617114614322:-1177638636	D5170C00001	272	270	CREATE	2021-03-30 16:30:20.289	Trial Committee	Committee Member Contract
17776	89	1617114620897:598989093	1617114614322:-1177638636	D5170C00001	273	270	CREATE	2021-03-30 16:30:20.984	Trial Committee	Committee Member Curriculum Vitae
17777	89	1617114621515:1364508030	1617114614322:-1177638636	D5170C00001	274	270	CREATE	2021-03-30 16:30:21.607	Trial Committee	Committee Output
17779	89	1617114622728:-1857072482	1617114608159:1704007719	D5170C00001	276	260	CREATE	2021-03-30 16:30:22.816	Trial Management	Trial Oversight
6326	84	\N	\N	D5170C00002	111	6	NEW	\N	Site	2002543 Leong, Rupert
17780	89	1617114623389:2074797514	1617114622728:-1857072482	D5170C00001	277	276	CREATE	2021-03-30 16:30:23.488	Trial Oversight	Communication Plan
16806	88	1617052009490:-1902472164	1617052007615:-1234169123	D5170C00001	2496	2493	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	Site Initiation
17782	89	1617114624564:490436836	1617114622728:-1857072482	D5170C00001	279	276	CREATE	2021-03-30 16:30:24.653	Trial Oversight	List of SOPs Current During Trial
17783	89	1617114625204:1834380398	1617114622728:-1857072482	D5170C00001	280	276	CREATE	2021-03-30 16:30:25.288	Trial Oversight	Operational Procedure Manual
17784	89	1617114625765:-1171514584	1617114622728:-1857072482	D5170C00001	281	276	CREATE	2021-03-30 16:30:25.85	Trial Oversight	Recruitment Plan
17785	89	1617114626370:1133906565	1617114622728:-1857072482	D5170C00001	282	276	CREATE	2021-03-30 16:30:26.458	Trial Oversight	Risk Management Plan
17786	89	1617114628351:-1283526618	1617114622728:-1857072482	D5170C00001	283	276	CREATE	2021-03-30 16:30:28.442	Trial Oversight	Transfer of Regulatory Obligations
17787	89	1617114628925:-162380255	1617114622728:-1857072482	D5170C00001	284	276	CREATE	2021-03-30 16:30:29.015	Trial Oversight	Trial Master File Plan
17788	89	1617114629485:955100109	1617114608159:1704007719	D5170C00001	285	260	CREATE	2021-03-30 16:30:29.572	Trial Management	Trial Team
17789	89	1617114630099:-592847267	1617114629485:955100109	D5170C00001	286	285	CREATE	2021-03-30 16:30:30.188	Trial Team	Trial Team Details
17790	89	1617114630752:1394584142	1617049796982:-2116394566	D5170C00001	287	2	CREATE	2021-03-30 16:30:30.836	AstraZeneca	Monitoring Visit Reports
17791	89	1617114631402:-403823234	1617114630752:1394584142	D5170C00001	288	287	CREATE	2021-03-30 16:30:31.493	Monitoring Visit Reports	eTMF QC
17792	89	1617114632019:-23801077	1617049796982:-2116394566	D5170C00001	289	2	CREATE	2021-03-30 16:30:32.109	AstraZeneca	Safety
17793	89	1617114632664:948643316	1617049777304:1085508340	D5170C00001	290	1	CREATE	2021-03-30 16:30:32.755	eTMF	Statistical Sciences and Programming
17794	89	1617114633312:-196285203	1617114632664:948643316	D5170C00001	291	290	CREATE	2021-03-30 16:30:33.401	Statistical Sciences and Programming	medi2070_d5170c00001_to_allergan_appendix_f_files
17795	89	1617114633947:1590695760	1617114633312:-196285203	D5170C00001	292	291	CREATE	2021-03-30 16:30:34.05	medi2070_d5170c00001_to_allergan_appendix_f_files	Analysis_data
17796	89	1617114634529:-668179756	1617114633947:1590695760	D5170C00001	293	292	CREATE	2021-03-30 16:30:34.618	Analysis_data	data
17797	89	1617114635152:1986149421	1617114633947:1590695760	D5170C00001	294	292	CREATE	2021-03-30 16:30:35.245	Analysis_data	doc
17798	89	1617114635802:581180130	1617114633312:-196285203	D5170C00001	295	291	CREATE	2021-03-30 16:30:35.893	medi2070_d5170c00001_to_allergan_appendix_f_files	Pharmacokinetic_data
17799	89	1617114636410:630000192	1617114635802:581180130	D5170C00001	296	295	CREATE	2021-03-30 16:30:36.679	Pharmacokinetic_data	data
17800	89	1617114637178:1997713229	1617114636410:630000192	D5170C00001	297	296	CREATE	2021-03-30 16:30:37.268	data	new
17801	89	1617114637774:-205922074	1617114635802:581180130	D5170C00001	298	295	CREATE	2021-03-30 16:30:37.859	Pharmacokinetic_data	doc
17802	89	1617114639846:1166509746	1617114633312:-196285203	D5170C00001	299	291	CREATE	2021-03-30 16:30:39.936	medi2070_d5170c00001_to_allergan_appendix_f_files	Raw_clinical_data
17803	89	1617114640430:1931513420	1617114639846:1166509746	D5170C00001	300	299	CREATE	2021-03-30 16:30:40.518	Raw_clinical_data	data
17804	89	1617114642429:1505956412	1617114639846:1166509746	D5170C00001	301	299	CREATE	2021-03-30 16:30:42.533	Raw_clinical_data	doc
17805	89	1617114643122:-1786503483	1617114633312:-196285203	D5170C00001	302	291	CREATE	2021-03-30 16:30:43.213	medi2070_d5170c00001_to_allergan_appendix_f_files	SAS_programs
17806	89	1617114643849:-488913148	1617114643122:-1786503483	D5170C00001	303	302	CREATE	2021-03-30 16:30:43.934	SAS_programs	ads
17807	89	1617114644489:-858074382	1617114643122:-1786503483	D5170C00001	304	302	CREATE	2021-03-30 16:30:44.58	SAS_programs	doc
17808	89	1617114645088:200761598	1617114643122:-1786503483	D5170C00001	305	302	CREATE	2021-03-30 16:30:45.176	SAS_programs	figures
17809	89	1617114645752:-836339096	1617114643122:-1786503483	D5170C00001	306	302	CREATE	2021-03-30 16:30:45.838	SAS_programs	listings
17810	89	1617114646336:932144847	1617114643122:-1786503483	D5170C00001	307	302	CREATE	2021-03-30 16:30:46.426	SAS_programs	macros
17811	89	1617114646896:804919142	1617114643122:-1786503483	D5170C00001	308	302	CREATE	2021-03-30 16:30:46.982	SAS_programs	sdtm
17812	89	1617114647499:29708767	1617114643122:-1786503483	D5170C00001	309	302	CREATE	2021-03-30 16:30:47.589	SAS_programs	tables
17813	89	1617114648708:2080394343	1617114633312:-196285203	D5170C00001	310	291	CREATE	2021-03-30 16:30:48.797	medi2070_d5170c00001_to_allergan_appendix_f_files	SDTM_data
17814	89	1617114650935:2086409776	1617114648708:2080394343	D5170C00001	311	310	CREATE	2021-03-30 16:30:51.032	SDTM_data	data
17815	89	1617114651584:1542220620	1617114648708:2080394343	D5170C00001	312	310	CREATE	2021-03-30 16:30:51.669	SDTM_data	doc
17816	89	1617114652155:1485406086	1617114633312:-196285203	D5170C00001	313	291	CREATE	2021-03-30 16:30:52.264	medi2070_d5170c00001_to_allergan_appendix_f_files	Stat_doc
17817	89	1617114652763:-581668660	1617114633312:-196285203	D5170C00001	314	291	CREATE	2021-03-30 16:30:52.868	medi2070_d5170c00001_to_allergan_appendix_f_files	Validation
17818	89	1617114653419:1423696661	1617114652763:-581668660	D5170C00001	315	314	CREATE	2021-03-30 16:30:53.508	Validation	doc
17819	89	1617114653915:1806245382	rootNode	D5170C00001	316	0	CREATE	2021-03-30 16:30:54.043		Generic Documents
17820	89	1617114654575:-807115430	1617114653915:1806245382	D5170C00001	317	316	CREATE	2021-03-30 16:30:54.665	Generic Documents	Metadata
6445	84	\N	\N	D5170C00002	230	228	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
6448	84	\N	\N	D5170C00002	233	232	NEW	\N	03.04 General	03.04.01 Relev_art-Up-Documents
6451	84	\N	\N	D5170C00002	236	235	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
6454	84	\N	\N	D5170C00002	239	238	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
6457	84	\N	\N	D5170C00002	242	241	NEW	\N	05.01 Site Selection	05.01.01 Site Contact Details
6460	84	\N	\N	D5170C00002	245	241	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
6463	84	\N	\N	D5170C00002	248	246	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
6467	84	\N	\N	D5170C00002	252	246	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
6470	84	\N	\N	D5170C00002	255	246	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
6474	84	\N	\N	D5170C00002	259	258	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
6477	84	\N	\N	D5170C00002	262	240	NEW	\N	05 Site Management	05.04 Site Management
16880	88	1617052074879:1752429366	1617052074281:-90943670	D5170C00001	2570	2569	ALREADY AVAILABLE	2021-03-30 07:19:37.339	7804	Central and Local Testing
16883	88	1617052076801:123119065	1617052074281:-90943670	D5170C00001	2573	2569	ALREADY AVAILABLE	2021-03-30 07:19:37.34	7804	Central Trial Documents
17506	89	1617049801368:-1129006037	1617049796982:-2116394566	D5170C00001	3	2	ALREADY AVAILABLE	2021-03-30 16:25:18.51	AstraZeneca	eTMF
17507	89	1617049801974:-542363185	1617049801368:-1129006037	D5170C00001	4	3	ALREADY AVAILABLE	2021-03-30 16:25:18.51	eTMF	Delivery
17508	89	1617050181568:-159398468	1617049801974:-542363185	D5170C00001	5	4	ALREADY AVAILABLE	2021-03-30 16:25:18.51	Delivery	Site
17512	89	1617052608083:-67683498	1617052607516:-1420320606	D5170C00001	9	8	ALREADY AVAILABLE	2021-03-30 16:25:18.851	Site Management	General
17515	89	1617114373978:-1054886141	1617114373319:-1384424025	D5170C00001	12	11	CREATE	2021-03-30 16:26:14.06	Site Initiation	Site Evidence of Training
17518	89	1617114375799:2026506757	1617114374532:1094251203	D5170C00001	15	13	CREATE	2021-03-30 16:26:15.893	Site Management	Subject Log
17521	89	1617114377586:-151763329	1617114376988:1439771284	D5170C00001	18	17	CREATE	2021-03-30 16:26:17.675	Site Selection	Confidentiality Agreement
17523	89	1617114379861:930621433	1617114378194:12412252	D5170C00001	20	19	CREATE	2021-03-30 16:26:19.95	Site Set-up	Acceptance of Investigator Brochure
17527	89	1617114382219:185963823	1617114378194:12412252	D5170C00001	24	19	CREATE	2021-03-30 16:26:22.306	Site Set-up	IP Site Release Documentation
17530	89	1617114383957:-22607022	1617114378194:12412252	D5170C00001	27	19	CREATE	2021-03-30 16:26:24.047	Site Set-up	Site Signature Sheet
17533	89	1617114385706:-830451826	1617051980305:1976405238	D5170C00001	30	6	CREATE	2021-03-30 16:26:25.795	United States of America	7823
17536	89	1617114395464:1550391974	1617114394847:453771359	D5170C00001	33	32	CREATE	2021-03-30 16:26:35.559	Subject Documentation	Advertisements for Subject Recruitment
17539	89	1617114397326:1609685598	1617114396712:-289292274	D5170C00001	36	35	CREATE	2021-03-30 16:26:37.42	IP and Trial Supplies	IP Documentation
17542	89	1617114399454:-632753146	1617114385706:-830451826	D5170C00001	39	30	CREATE	2021-03-30 16:26:39.551	7823	IRB or IEC and other Approvals
17545	89	1617114402429:-1499901647	1617114400031:1557752653	D5170C00001	42	40	CREATE	2021-03-30 16:26:42.533	IRB or IEC Trial Approval	IRB or IEC Composition
17549	89	1617114404891:-1207956496	1617114404295:720000671	D5170C00001	46	45	CREATE	2021-03-30 16:26:44.977	Site Management	General
17551	89	1617114406292:1090046398	1617114404891:-1207956496	D5170C00001	48	46	CREATE	2021-03-30 16:26:46.378	General	Relevant Communications
17554	89	1617114408019:114647351	1617114406870:-935139199	D5170C00001	51	49	CREATE	2021-03-30 16:26:48.121	Site Management	Visit Log
17556	89	1617114409274:1582111973	1617114408681:-1293383099	D5170C00001	53	52	CREATE	2021-03-30 16:26:49.377	Site Selection	Confidentiality Agreement
17559	89	1617114411166:-1882909385	1617114410504:-1618192993	D5170C00001	56	55	CREATE	2021-03-30 16:26:51.258	Site Set-up	Acceptance of Investigator Brochure
17563	89	1617114414869:1784069784	1617114410504:-1618192993	D5170C00001	60	55	CREATE	2021-03-30 16:26:54.965	Site Set-up	IP Site Release Documentation
17566	89	1617114416726:755012430	1617114410504:-1618192993	D5170C00001	63	55	CREATE	2021-03-30 16:26:57.15	Site Set-up	Site Signature Sheet
17568	89	1617114418310:-2116719502	1617114410504:-1618192993	D5170C00001	65	55	CREATE	2021-03-30 16:26:58.404	Site Set-up	Sub-Investigator Curriculum Vitae
17572	89	1617114420758:999071382	1617114420170:-571199935	D5170C00001	69	68	CREATE	2021-03-30 16:27:00.845	Subject Documentation	Informed Consent Form
17576	89	1617114424357:-1751427152	1617114422031:1886890913	D5170C00001	73	71	CREATE	2021-03-30 16:27:04.452	IRB or IEC Trial Approval	IRB or IEC Composition
17580	89	1617114426939:1912847229	1617114426186:-1843875671	D5170C00001	77	76	CREATE	2021-03-30 16:27:07.137	Site Management	Site Set-up
17582	89	1617114428253:36575383	1617114426939:1912847229	D5170C00001	79	77	CREATE	2021-03-30 16:27:08.344	Site Set-up	Financial Disclosure Form
17585	89	1617114430184:-1533854262	1617114426939:1912847229	D5170C00001	82	77	CREATE	2021-03-30 16:27:10.271	Site Set-up	Protocol Amendment Signature Page
17588	89	1617114432206:-1688662159	1617051980305:1976405238	D5170C00001	85	6	CREATE	2021-03-30 16:27:12.294	United States of America	7825
17591	89	1617114435229:1756789754	1617114433429:-356783449	D5170C00001	88	87	CREATE	2021-03-30 16:27:15.319	Subject Documentation	Informed Consent Form
17595	89	1617114437779:-1299557908	1617114435952:1738790882	D5170C00001	92	89	CREATE	2021-03-30 16:27:17.864	IP and Trial Supplies	IP Documentation
17597	89	1617114438954:1053126996	1617114437779:-1299557908	D5170C00001	94	92	CREATE	2021-03-30 16:27:19.041	IP Documentation	IP Certificate of Destruction
17600	89	1617114440921:-1019073495	1617114440331:-860330077	D5170C00001	97	96	CREATE	2021-03-30 16:27:21.009	IRB or IEC Trial Approval	IRB or IEC Approval
17603	89	1617114442820:-997565685	1617114442181:-1213853081	D5170C00001	100	99	CREATE	2021-03-30 16:27:22.916	Trial Status Reporting	IRB or IEC Notification of Trial Termination
17607	89	1617114446455:1762062602	1617114432206:-1688662159	D5170C00001	104	85	CREATE	2021-03-30 16:27:26.543	7825	Site Management
17610	89	1617114448472:-312194196	1617114446455:1762062602	D5170C00001	107	104	CREATE	2021-03-30 16:27:28.558	Site Management	Site Initiation
17612	89	1617114449665:-1718280141	1617114446455:1762062602	D5170C00001	109	104	CREATE	2021-03-30 16:27:29.757	Site Management	Site Management
17615	89	1617114452116:-279683250	1617114449665:-1718280141	D5170C00001	112	109	CREATE	2021-03-30 16:27:32.208	Site Management	Visit Log
17618	89	1617114454108:1694277914	1617114446455:1762062602	D5170C00001	115	104	CREATE	2021-03-30 16:27:34.21	Site Management	Site Set-up
17621	89	1617114456015:1711516473	1617114454108:1694277914	D5170C00001	118	115	CREATE	2021-03-30 16:27:36.104	Site Set-up	Financial Disclosure Form
17624	89	1617114459225:-1955638475	1617114454108:1694277914	D5170C00001	121	115	CREATE	2021-03-30 16:27:39.314	Site Set-up	Principal Investigator Curriculum Vitae
6480	84	\N	\N	D5170C00002	265	262	NEW	\N	05.04 Site Management	05.04.03 UNBLINDED Monitoring Visit Report
6483	84	\N	\N	D5170C00002	268	262	NEW	\N	05.04 Site Management	05.04.05 Additional Monitoring Activity
6486	84	\N	\N	D5170C00002	271	262	NEW	\N	05.04 Site Management	05.04.06 UNBLINDED Protocol Deviations and Waivers
6496	84	\N	\N	D5170C00002	281	277	NEW	\N	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
6499	84	\N	\N	D5170C00002	284	276	NEW	\N	06 IP and Trial Supplies	06.04 Storage
16952	88	1617082860397:563345283	1617052133144:700993632	D5170C00001	2642	2641	CREATE	2021-03-30 07:41:00.481	Site Management	Monitoring Visit Report
17627	89	1617114494996:1922866314	1617114454108:1694277914	D5170C00001	124	115	CREATE	2021-03-30 16:28:15.131	Site Set-up	Site Staff Qualification Supporting Information
17630	89	1617114496878:-1987700060	1617114496297:-2110691886	D5170C00001	127	126	CREATE	2021-03-30 16:28:16.967	Trial Management	Trial Oversight
17633	89	1617114498695:-1963164418	1617114498116:-998406171	D5170C00001	130	129	CREATE	2021-03-30 16:28:18.78	Study	Central and Local Testing
17636	89	1617114500515:-1633782377	1617114499367:-111636337	D5170C00001	133	131	CREATE	2021-03-30 16:28:20.602	Facility Documentation	Head of Facility Curriculum Vitae
17639	89	1617114503750:-1716198144	1617114499367:-111636337	D5170C00001	136	131	CREATE	2021-03-30 16:28:23.859	Facility Documentation	Normal Ranges
17643	89	1617114506237:-200112494	1617114505054:-1816874419	D5170C00001	140	138	CREATE	2021-03-30 16:28:26.33	General	Meeting Material
17647	89	1617114508798:1991712291	1617114507647:758126624	D5170C00001	144	142	CREATE	2021-03-30 16:28:28.883	Sample Documentation	Sample Storage Condition Log
17650	89	1617114510572:1321856745	1617114510005:997556913	D5170C00001	147	146	CREATE	2021-03-30 16:28:30.657	Central Trial Documents	General
17653	89	1617114512372:-1029256024	1617114510005:997556913	D5170C00001	150	146	CREATE	2021-03-30 16:28:35.752	Central Trial Documents	Product and Trial Documentation
17656	89	1617114517557:1597807882	1617114512372:-1029256024	D5170C00001	153	150	CREATE	2021-03-30 16:28:37.649	Product and Trial Documentation	Protocol
17659	89	1617114519486:1598402969	1617114518800:1423538290	D5170C00001	156	155	CREATE	2021-03-30 16:28:39.576	Subject Documentation	Informed Consent Form
17662	89	1617114521417:487875169	1617114518800:1423538290	D5170C00001	159	155	CREATE	2021-03-30 16:28:41.504	Subject Documentation	Subject Questionnaire
17666	89	1617114524147:-1869456003	1617114522916:1088795663	D5170C00001	163	161	CREATE	2021-03-30 16:28:44.234	Data Capture	CRF Completion Requirements
17669	89	1617114527602:-365411959	1617114522085:-1185750799	D5170C00001	166	160	CREATE	2021-03-30 16:28:47.702	Data Management	Database
17672	89	1617114529417:594720285	1617114527602:-365411959	D5170C00001	169	166	CREATE	2021-03-30 16:28:49.514	Database	Database Change Control
17675	89	1617114531233:-243765334	1617114527602:-365411959	D5170C00001	172	166	CREATE	2021-03-30 16:28:51.324	Database	Edit Check Plan
17678	89	1617114533132:-1405894619	1617114522085:-1185750799	D5170C00001	175	160	CREATE	2021-03-30 16:28:53.22	Data Management	EDC Management
17680	89	1617114534301:-795866879	1617114533132:-1405894619	D5170C00001	177	175	CREATE	2021-03-30 16:28:54.391	EDC Management	Technical Design Document
17684	89	1617114544445:-453923377	1617114535554:-1830952970	D5170C00001	181	179	CREATE	2021-03-30 16:29:04.539	General	Meeting Material
17686	89	1617114545748:711525452	1617114498116:-998406171	D5170C00001	183	129	CREATE	2021-03-30 16:29:05.838	Study	IP and Trial Supplies
17689	89	1617114547627:-376342438	1617114546336:-1887931292	D5170C00001	186	184	CREATE	2021-03-30 16:29:07.713	General	Relevant Communications
17691	89	1617114550124:1632202108	1617114549405:-903831684	D5170C00001	188	187	CREATE	2021-03-30 16:29:10.211	Interactive Response Technology	IRT Maintenance Plan
17695	89	1617114552492:-934009519	1617114549405:-903831684	D5170C00001	192	187	CREATE	2021-03-30 16:29:12.582	Interactive Response Technology	IRT User Requirement Specification
17698	89	1617114554284:-1185212170	1617114553631:-836926264	D5170C00001	195	194	CREATE	2021-03-30 16:29:14.369	IP Documentation	IP Accountability Documentation
17702	89	1617114556711:1962795724	1617114553631:-836926264	D5170C00001	199	194	CREATE	2021-03-30 16:29:16.792	IP Documentation	IP Shipment Documentation
17705	89	1617114558623:1853668880	1617114545748:711525452	D5170C00001	202	183	CREATE	2021-03-30 16:29:18.707	IP and Trial Supplies	IP Release Process Documentation
17708	89	1617114561756:941853534	1617114558623:1853668880	D5170C00001	205	202	CREATE	2021-03-30 16:29:21.842	IP Release Process Documentation	QP (Qualified Person) Certification
17710	89	1617114562930:116364977	1617114562339:-241550035	D5170C00001	207	206	CREATE	2021-03-30 16:29:23.02	IRB or IEC and other Approvals	General
17714	89	1617114565942:723222864	1617114565349:938159686	D5170C00001	211	210	CREATE	2021-03-30 16:29:26.039	General	Filenote
17716	89	1617114567213:-1326705068	1617114565349:938159686	D5170C00001	213	210	CREATE	2021-03-30 16:29:27.323	General	Tracking Information
17719	89	1617114568978:-1138328351	1617114568395:-18341145	D5170C00001	216	215	CREATE	2021-03-30 16:29:29.065	General	Filenote
17722	89	1617114572003:-1076837938	1617114567821:540660706	D5170C00001	219	214	CREATE	2021-03-30 16:29:32.108	Safety Reporting	Safety Documentation
17724	89	1617114573377:1585728185	1617114567821:540660706	D5170C00001	221	214	CREATE	2021-03-30 16:29:33.462	Safety Reporting	Trial Status Reporting
17728	89	1617114575895:2039404329	1617114575211:819097842	D5170C00001	225	224	CREATE	2021-03-30 16:29:35.995	General	Filenote
17730	89	1617114577097:-581803882	1617114574535:1951922167	D5170C00001	227	223	CREATE	2021-03-30 16:29:37.199	Site Management	Site Initiation
17733	89	1617114578981:-1479105606	1617114578401:1699510391	D5170C00001	230	229	CREATE	2021-03-30 16:29:39.088	Site Management	Financial Documentation
17736	89	1617114588561:1343144284	1617114574535:1951922167	D5170C00001	233	223	CREATE	2021-03-30 16:29:48.725	Site Management	Site Selection
17739	89	1617114590566:2127872896	1617114589928:1424657619	D5170C00001	236	235	CREATE	2021-03-30 16:29:50.673	Site Set-up	Clinical Study Agreement
17742	89	1617114592410:436993235	1617114591812:-1183478421	D5170C00001	239	238	CREATE	2021-03-30 16:29:52.501	Analysis	Data Definitions for Analysis Datasets
17745	89	1617114595483:950430495	1617114591812:-1183478421	D5170C00001	242	238	CREATE	2021-03-30 16:29:55.576	Analysis	Final Analysis Programs
17748	89	1617114597320:-1845263213	1617114591812:-1183478421	D5170C00001	245	238	CREATE	2021-03-30 16:29:57.412	Analysis	Validation Report
17751	89	1617114599173:1217651056	1617114591160:-1528971848	D5170C00001	248	237	CREATE	2021-03-30 16:29:59.277	Statistics	Randomization
17753	89	1617114600452:-1214185288	1617114599173:1217651056	D5170C00001	250	248	CREATE	2021-03-30 16:30:00.54	Randomization	Master Randomization List
17756	89	1617114602358:-1778364044	1617114601678:-903094878	D5170C00001	253	252	CREATE	2021-03-30 16:30:02.596	Statistics Oversight	Statistical Analysis Plan Signature Page
17760	89	1617114606289:1721979980	1617114605471:1632239223	D5170C00001	257	256	CREATE	2021-03-30 16:30:06.382	General	Relevant Communications
17763	89	1617114608159:1704007719	1617114498116:-998406171	D5170C00001	260	129	CREATE	2021-03-30 16:30:08.253	Study	Trial Management
17766	89	1617114609952:239555747	1617114608748:1159922748	D5170C00001	263	261	CREATE	2021-03-30 16:30:10.047	General	Other Meeting Material
17029	88	1617082901939:-165788857	1617052199761:1574272098	D5170C00001	2719	2718	CREATE	2021-03-30 07:41:42.024	Subject Documentation	Informed Consent Form
17768	89	1617114611241:-1090114270	1617114608748:1159922748	D5170C00001	265	261	CREATE	2021-03-30 16:30:11.333	General	Tracking Information
17771	89	1617114613093:-2072619818	1617114611805:-1073617112	D5170C00001	268	266	CREATE	2021-03-30 16:30:13.194	Meetings	Kick-off Meeting Material
17774	89	1617114614963:314786491	1617114614322:-1177638636	D5170C00001	271	270	CREATE	2021-03-30 16:30:19.621	Trial Committee	Committee Member Confidentiality Disclosure Agreement
17778	89	1617114622102:-1896637004	1617114614322:-1177638636	D5170C00001	275	270	CREATE	2021-03-30 16:30:22.193	Trial Committee	Committee Process
17781	89	1617114623990:279027462	1617114622728:-1857072482	D5170C00001	278	276	CREATE	2021-03-30 16:30:24.075	Trial Oversight	Investigator Newsletter
6502	84	\N	\N	D5170C00002	287	284	NEW	\N	06.04 Storage	06.04.02 UNBLINDED Storage Condition Excursion Documentation
6505	84	\N	\N	D5170C00002	290	276	NEW	\N	06 IP and Trial Supplies	06.05 Non-IP Documentation
6507	84	\N	\N	D5170C00002	292	276	NEW	\N	06 IP and Trial Supplies	06.07 General
6508	84	\N	\N	D5170C00002	293	292	NEW	\N	06.07 General	06.07.01 UNBLI_roduct-Documents
6511	84	\N	\N	D5170C00002	296	295	NEW	\N	08.02 Sample Documentation	08.02.03 Sampl_ge Condition Log
6514	84	\N	\N	D5170C00002	299	298	NEW	\N	05 Site Management	05.01 Site Selection
6517	84	\N	\N	D5170C00002	302	301	NEW	\N	TBD-1-1PPS6HE Baert, Filip	05 Site Management
6520	84	\N	\N	D5170C00002	305	156	NEW	\N	Site	TBD-1-1PPSYYV Macken, Elisabeth
6523	84	\N	\N	D5170C00002	308	307	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
6526	84	\N	\N	D5170C00002	311	310	NEW	\N	02 Central Trial Documents	02.04 General
6529	84	\N	\N	D5170C00002	314	313	NEW	\N	05 Site Management	05.01 Site Selection
6532	84	\N	\N	D5170C00002	317	316	NEW	\N	BULGARIA	Site
6534	84	\N	\N	D5170C00002	319	318	NEW	\N	2002264 Mirchev, Milko	05 Site Management
6538	84	\N	\N	D5170C00002	323	322	NEW	\N	2002265 Petrov, Plamen	05 Site Management
6540	84	\N	\N	D5170C00002	325	324	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
6544	84	\N	\N	D5170C00002	329	328	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
6546	84	\N	\N	D5170C00002	331	326	NEW	\N	2002266 Vladimirov, Borislav	04 IRB-IEC and other Approvals
6550	84	\N	\N	D5170C00002	335	331	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
6553	84	\N	\N	D5170C00002	338	337	NEW	\N	05 Site Management	05.01 Site Selection
6556	84	\N	\N	D5170C00002	341	338	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
6559	84	\N	\N	D5170C00002	344	343	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Accep_tigator Brochure
6562	84	\N	\N	D5170C00002	347	343	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
6565	84	\N	\N	D5170C00002	350	343	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Inves_latory Agreement
6568	84	\N	\N	D5170C00002	353	343	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Si_se Documentation
6571	84	\N	\N	D5170C00002	356	355	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
6573	84	\N	\N	D5170C00002	358	355	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
6576	84	\N	\N	D5170C00002	361	359	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
6580	84	\N	\N	D5170C00002	365	364	NEW	\N	2002267 Draganova, Raina	02 Central Trial Documents
6583	84	\N	\N	D5170C00002	368	366	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
6586	84	\N	\N	D5170C00002	371	370	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
6590	84	\N	\N	D5170C00002	375	374	NEW	\N	05.01 Site Selection	05.01.01 Site Contact Details
6592	84	\N	\N	D5170C00002	377	374	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
6596	84	\N	\N	D5170C00002	381	379	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
6599	84	\N	\N	D5170C00002	384	379	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Site Qualification
6602	84	\N	\N	D5170C00002	387	379	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
6606	84	\N	\N	D5170C00002	391	373	NEW	\N	05 Site Management	05.03 Site Initiation
6609	84	\N	\N	D5170C00002	394	391	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
6613	84	\N	\N	D5170C00002	398	395	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
6617	84	\N	\N	D5170C00002	402	401	NEW	\N	2002268 Petrov, Asen	02 Central Trial Documents
6620	84	\N	\N	D5170C00002	405	403	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
6623	84	\N	\N	D5170C00002	408	407	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
6626	84	\N	\N	D5170C00002	411	410	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
6630	84	\N	\N	D5170C00002	415	414	NEW	\N	05 Site Management	05.01 Site Selection
6632	84	\N	\N	D5170C00002	417	415	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
6635	84	\N	\N	D5170C00002	420	414	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
6638	84	\N	\N	D5170C00002	423	420	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
6641	84	\N	\N	D5170C00002	426	420	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
6644	84	\N	\N	D5170C00002	429	420	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
6648	84	\N	\N	D5170C00002	433	432	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
6652	84	\N	\N	D5170C00002	437	436	NEW	\N	05.04 Site Management	05.04.04 Visit Log
6655	84	\N	\N	D5170C00002	440	439	NEW	\N	05.05 General	05.05.02 Tracking Information
6658	84	\N	\N	D5170C00002	443	442	NEW	\N	05 Site Management	05.01 Site Selection
6661	84	\N	\N	D5170C00002	446	445	NEW	\N	TBD-1-1Q34X7Y Stoinov, Simeon	05 Site Management
6665	84	\N	\N	D5170C00002	450	449	NEW	\N	TBD-1-2OQDQEF Naydenova, Totka	05 Site Management
6668	84	\N	\N	D5170C00002	453	317	NEW	\N	Site	TBD-1-2P5VCT5 _Peneva, Mariyana
17103	88	1617082936590:-530884260	1617052263817:-614865587	D5170C00001	2793	2792	CREATE	2021-03-30 07:42:16.675	Site Initiation	Site Evidence of Training
17107	88	1617082938325:1670006656	1617052277702:-2020962141	D5170C00001	2797	2794	CREATE	2021-03-30 07:42:18.412	Site Management	Visit Log
8604	84	\N	\N	D5170C00002	2389	2388	NEW	\N	03.01 Trial Approval	03.01.02 Approval
8840	84	\N	\N	D5170C00002	2625	2326	NEW	\N	Site	TBD-1-1QG2E97 Delgado, Shmuel
8232	84	\N	\N	D5170C00002	2017	2012	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
8233	84	\N	\N	D5170C00002	2018	2017	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
8235	84	\N	\N	D5170C00002	2020	2017	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
8236	84	\N	\N	D5170C00002	2021	2017	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
8237	84	\N	\N	D5170C00002	2022	2017	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
8239	84	\N	\N	D5170C00002	2024	2017	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
8240	84	\N	\N	D5170C00002	2025	2017	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clini_ Trial Agreement
8242	84	\N	\N	D5170C00002	2027	2017	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
8243	84	\N	\N	D5170C00002	2028	2012	NEW	\N	05 Site Management	05.03 Site Initiation
8244	84	\N	\N	D5170C00002	2029	2028	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
8246	84	\N	\N	D5170C00002	2031	2028	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
8247	84	\N	\N	D5170C00002	2032	2012	NEW	\N	05 Site Management	05.04 Site Management
8249	84	\N	\N	D5170C00002	2034	2032	NEW	\N	05.04 Site Management	05.04.04 Visit Log
8250	84	\N	\N	D5170C00002	2035	2032	NEW	\N	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
8252	84	\N	\N	D5170C00002	2037	2012	NEW	\N	05 Site Management	05.05 General
8253	84	\N	\N	D5170C00002	2038	2037	NEW	\N	05.05 General	05.05.02 Tracking Information
8254	84	\N	\N	D5170C00002	2039	2002	NEW	\N	2002286 Salamon, Agnes	06 IP and Trial Supplies
8256	84	\N	\N	D5170C00002	2041	2040	NEW	\N	06.04 Storage	06.04.03 Maintenance Logs
8257	84	\N	\N	D5170C00002	2042	2039	NEW	\N	06 IP and Trial Supplies	06.05 Non-IP Documentation
8259	84	\N	\N	D5170C00002	2044	2039	NEW	\N	06 IP and Trial Supplies	06.07 General
8260	84	\N	\N	D5170C00002	2045	2044	NEW	\N	06.07 General	06.07.01 Relev_roduct-Documents
8261	84	\N	\N	D5170C00002	2046	2001	NEW	\N	Site	2002288 Schnabel, Robert
8263	84	\N	\N	D5170C00002	2048	2047	NEW	\N	02 Central Trial Documents	02.04 General
8264	84	\N	\N	D5170C00002	2049	2048	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
8266	84	\N	\N	D5170C00002	2051	2046	NEW	\N	2002288 Schnabel, Robert	04 IRB-IEC and other Approvals
8267	84	\N	\N	D5170C00002	2052	2051	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
8316	84	\N	\N	D5170C00002	2101	2096	NEW	\N	2002291 Toth, Gabor Tamas	04 IRB-IEC and other Approvals
8272	84	\N	\N	D5170C00002	2057	2056	NEW	\N	05 Site Management	05.01 Site Selection
8274	84	\N	\N	D5170C00002	2059	2057	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
8275	84	\N	\N	D5170C00002	2060	2057	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
8276	84	\N	\N	D5170C00002	2061	2056	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
8278	84	\N	\N	D5170C00002	2063	2061	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
8279	84	\N	\N	D5170C00002	2064	2061	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
8281	84	\N	\N	D5170C00002	2066	2061	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
8282	84	\N	\N	D5170C00002	2067	2061	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Investigator Regulatory Agreement
8283	84	\N	\N	D5170C00002	2068	2061	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
8285	84	\N	\N	D5170C00002	2070	2061	NEW	\N	05.02 Site Set-up Documentation	05.02.14 Other_ancial Agreement
8286	84	\N	\N	D5170C00002	2071	2061	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
8287	84	\N	\N	D5170C00002	2072	2061	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
8289	84	\N	\N	D5170C00002	2074	2073	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
8290	84	\N	\N	D5170C00002	2075	2073	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
8292	84	\N	\N	D5170C00002	2077	2056	NEW	\N	05 Site Management	05.04 Site Management
8296	84	\N	\N	D5170C00002	2081	2077	NEW	\N	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
8297	84	\N	\N	D5170C00002	2082	2077	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
8298	84	\N	\N	D5170C00002	2083	2056	NEW	\N	05 Site Management	05.05 General
8300	84	\N	\N	D5170C00002	2085	2046	NEW	\N	2002288 Schnabel, Robert	06 IP and Trial Supplies
6219	84	\N	\N	D5170C00002	4	3	NEW	\N	eTMF	contents
6221	84	\N	\N	D5170C00002	6	5	NEW	\N	AUSTRALIA	Site
6222	84	\N	\N	D5170C00002	7	6	NEW	\N	Site	2002538 Moore, Gregory
6224	84	\N	\N	D5170C00002	9	8	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
6226	84	\N	\N	D5170C00002	11	8	NEW	\N	02 Central Trial Documents	02.04 General
6227	84	\N	\N	D5170C00002	12	11	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
6229	84	\N	\N	D5170C00002	14	13	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
6230	84	\N	\N	D5170C00002	15	14	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
6231	84	\N	\N	D5170C00002	16	7	NEW	\N	2002538 Moore, Gregory	05 Site Management
6233	84	\N	\N	D5170C00002	18	17	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
6671	84	\N	\N	D5170C00002	456	455	NEW	\N	05.01 Site Selection	05.01.04 Pre T_onitoring Report
17177	88	1617052339066:-1160849805	1617052335404:780821450	D5170C00001	2867	2863	ALREADY AVAILABLE	2021-03-30 07:19:37.342	7813	Data Management
17179	88	1617083003048:814275398	1617052339726:941460990	D5170C00001	2869	2868	CREATE	2021-03-30 07:43:23.138	General	Tracking Information
6235	84	\N	\N	D5170C00002	20	19	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
6236	84	\N	\N	D5170C00002	21	19	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
6238	84	\N	\N	D5170C00002	23	19	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
6239	84	\N	\N	D5170C00002	24	19	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
6240	84	\N	\N	D5170C00002	25	19	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
6242	84	\N	\N	D5170C00002	27	19	NEW	\N	05.02 Site Set-up Documentation	05.02.11 Data Privacy
6243	84	\N	\N	D5170C00002	28	19	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
6245	84	\N	\N	D5170C00002	30	19	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
6246	84	\N	\N	D5170C00002	31	16	NEW	\N	05 Site Management	05.03 Site Initiation
6250	84	\N	\N	D5170C00002	35	34	NEW	\N	05 Site Management	05.01 Site Selection
6251	84	\N	\N	D5170C00002	36	35	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
6253	84	\N	\N	D5170C00002	38	37	NEW	\N	2002540 Holtmann, Gerald	02 Central Trial Documents
6254	84	\N	\N	D5170C00002	39	38	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
6256	84	\N	\N	D5170C00002	41	38	NEW	\N	02 Central Trial Documents	02.04 General
6257	84	\N	\N	D5170C00002	42	41	NEW	\N	02.04 General	02.04.01 Relev_ations-Documents
6259	84	\N	\N	D5170C00002	44	37	NEW	\N	2002540 Holtmann, Gerald	03 Regulatory
6260	84	\N	\N	D5170C00002	45	44	NEW	\N	03 Regulatory	03.03 Trial Status Reporting
6262	84	\N	\N	D5170C00002	47	37	NEW	\N	2002540 Holtmann, Gerald	04 IRB-IEC and other Approvals
6263	84	\N	\N	D5170C00002	48	47	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
6265	84	\N	\N	D5170C00002	50	37	NEW	\N	2002540 Holtmann, Gerald	05 Site Management
6266	84	\N	\N	D5170C00002	51	50	NEW	\N	05 Site Management	05.01 Site Selection
6268	84	\N	\N	D5170C00002	53	51	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
6269	84	\N	\N	D5170C00002	54	50	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
6271	84	\N	\N	D5170C00002	56	54	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
6272	84	\N	\N	D5170C00002	57	54	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
6273	84	\N	\N	D5170C00002	58	54	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
6275	84	\N	\N	D5170C00002	60	54	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
6276	84	\N	\N	D5170C00002	61	54	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
6278	84	\N	\N	D5170C00002	63	54	NEW	\N	05.02 Site Set-up Documentation	05.02.13 Indemnity
6279	84	\N	\N	D5170C00002	64	54	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
6281	84	\N	\N	D5170C00002	66	50	NEW	\N	05 Site Management	05.03 Site Initiation
6282	84	\N	\N	D5170C00002	67	66	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
6284	84	\N	\N	D5170C00002	69	66	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
6285	84	\N	\N	D5170C00002	70	50	NEW	\N	05 Site Management	05.04 Site Management
6286	84	\N	\N	D5170C00002	71	70	NEW	\N	05.04 Site Management	05.04.01 Subject Log
6288	84	\N	\N	D5170C00002	73	70	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
6289	84	\N	\N	D5170C00002	74	70	NEW	\N	05.04 Site Management	05.04.04 Visit Log
6291	84	\N	\N	D5170C00002	76	70	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
6292	84	\N	\N	D5170C00002	77	50	NEW	\N	05 Site Management	05.05 General
6294	84	\N	\N	D5170C00002	79	77	NEW	\N	05.05 General	05.05.02 Tracking Information
6295	84	\N	\N	D5170C00002	80	37	NEW	\N	2002540 Holtmann, Gerald	06 IP and Trial Supplies
6297	84	\N	\N	D5170C00002	82	81	NEW	\N	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
6298	84	\N	\N	D5170C00002	83	81	NEW	\N	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
6300	84	\N	\N	D5170C00002	85	81	NEW	\N	06.01 IP Documentation	06.01.11 UNBLINDED Certificate of Destruction
6301	84	\N	\N	D5170C00002	86	80	NEW	\N	06 IP and Trial Supplies	06.04 Storage
6303	84	\N	\N	D5170C00002	88	86	NEW	\N	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
6304	84	\N	\N	D5170C00002	89	80	NEW	\N	06 IP and Trial Supplies	06.05 Non-IP Documentation
6306	84	\N	\N	D5170C00002	91	37	NEW	\N	2002540 Holtmann, Gerald	08 Centralized Testing
6307	84	\N	\N	D5170C00002	92	91	NEW	\N	08 Centralized Testing	08.01 Facility Documentation
6309	84	\N	\N	D5170C00002	94	6	NEW	\N	Site	2002541 Debinski, Henry
6310	84	\N	\N	D5170C00002	95	94	NEW	\N	2002541 Debinski, Henry	05 Site Management
6311	84	\N	\N	D5170C00002	96	95	NEW	\N	05 Site Management	05.01 Site Selection
8320	84	\N	\N	D5170C00002	2105	2104	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
6313	84	\N	\N	D5170C00002	98	95	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
6315	84	\N	\N	D5170C00002	100	98	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
6316	84	\N	\N	D5170C00002	101	98	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
6318	84	\N	\N	D5170C00002	103	98	NEW	\N	05.02 Site Set-up Documentation	05.02.13 Indemnity
6319	84	\N	\N	D5170C00002	104	98	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
6320	84	\N	\N	D5170C00002	105	95	NEW	\N	05 Site Management	05.03 Site Initiation
6322	84	\N	\N	D5170C00002	107	6	NEW	\N	Site	2002542 Subramaniam, Kavitha
17255	88	1617052398862:-541467014	1617052398111:-486756895	D5170C00001	2945	2944	ALREADY AVAILABLE	2021-03-30 07:19:37.342	7815	Site Management
17252	88	1617083048557:176803797	1617052389524:1591359346	D5170C00001	2942	2933	CREATE	2021-03-30 07:44:08.643	Site Set-up	Site Staff Qualification Supporting Information
6323	84	\N	\N	D5170C00002	108	107	NEW	\N	2002542 Subramaniam, Kavitha	05 Site Management
6325	84	\N	\N	D5170C00002	110	109	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
6328	84	\N	\N	D5170C00002	113	112	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
6330	84	\N	\N	D5170C00002	115	112	NEW	\N	02 Central Trial Documents	02.04 General
6331	84	\N	\N	D5170C00002	116	115	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
6332	84	\N	\N	D5170C00002	117	115	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
6334	84	\N	\N	D5170C00002	119	118	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
6335	84	\N	\N	D5170C00002	120	119	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
6337	84	\N	\N	D5170C00002	122	118	NEW	\N	04 IRB-IEC and other Approvals	04.02 Other Committees
6338	84	\N	\N	D5170C00002	123	122	NEW	\N	04.02 Other Committees	04.02.02 Other Approvals
6340	84	\N	\N	D5170C00002	125	124	NEW	\N	05 Site Management	05.01 Site Selection
6341	84	\N	\N	D5170C00002	126	125	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
6343	84	\N	\N	D5170C00002	128	124	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
6345	84	\N	\N	D5170C00002	130	128	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
6346	84	\N	\N	D5170C00002	131	128	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
6347	84	\N	\N	D5170C00002	132	128	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
6349	84	\N	\N	D5170C00002	134	128	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Investigator Regulatory Agreement
6350	84	\N	\N	D5170C00002	135	128	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
6352	84	\N	\N	D5170C00002	137	128	NEW	\N	05.02 Site Set-up Documentation	05.02.13 Indemnity
6353	84	\N	\N	D5170C00002	138	128	NEW	\N	05.02 Site Set-up Documentation	05.02.14 Other Financial Agreement
6355	84	\N	\N	D5170C00002	140	124	NEW	\N	05 Site Management	05.03 Site Initiation
6356	84	\N	\N	D5170C00002	141	140	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
6357	84	\N	\N	D5170C00002	142	140	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
6359	84	\N	\N	D5170C00002	144	143	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
6360	84	\N	\N	D5170C00002	145	124	NEW	\N	05 Site Management	05.05 General
6362	84	\N	\N	D5170C00002	147	6	NEW	\N	Site	TBD-1-1QAHU3S Leong, Rupert
6363	84	\N	\N	D5170C00002	148	147	NEW	\N	TBD-1-1QAHU3S Leong, Rupert	05 Site Management
6365	84	\N	\N	D5170C00002	150	149	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
6366	84	\N	\N	D5170C00002	151	6	NEW	\N	Site	TBD-1-1ZSMQVQ Sparrow, Miles
6368	84	\N	\N	D5170C00002	153	152	NEW	\N	05 Site Management	05.01 Site Selection
6369	84	\N	\N	D5170C00002	154	153	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
6370	84	\N	\N	D5170C00002	155	4	NEW	\N	contents	BELGIUM
6372	84	\N	\N	D5170C00002	157	156	NEW	\N	Site	2001824 Van Assche, Gert
6374	84	\N	\N	D5170C00002	159	158	NEW	\N	02 Central Trial Documents	02.04 General
6375	84	\N	\N	D5170C00002	160	159	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
6380	84	\N	\N	D5170C00002	165	157	NEW	\N	2001824 Van Assche, Gert	04 IRB-IEC and other Approvals
6382	84	\N	\N	D5170C00002	167	166	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
6383	84	\N	\N	D5170C00002	168	157	NEW	\N	2001824 Van Assche, Gert	05 Site Management
6384	84	\N	\N	D5170C00002	169	168	NEW	\N	05 Site Management	05.01 Site Selection
6386	84	\N	\N	D5170C00002	171	169	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
6387	84	\N	\N	D5170C00002	172	169	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
6389	84	\N	\N	D5170C00002	174	168	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
6391	84	\N	\N	D5170C00002	176	174	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
6392	84	\N	\N	D5170C00002	177	174	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
6393	84	\N	\N	D5170C00002	178	174	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
6395	84	\N	\N	D5170C00002	180	174	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
6396	84	\N	\N	D5170C00002	181	174	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Investigator Regulatory Agreement
6398	84	\N	\N	D5170C00002	183	174	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
6399	84	\N	\N	D5170C00002	184	174	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
6401	84	\N	\N	D5170C00002	186	168	NEW	\N	05 Site Management	05.03 Site Initiation
6402	84	\N	\N	D5170C00002	187	186	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
6403	84	\N	\N	D5170C00002	188	186	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
6405	84	\N	\N	D5170C00002	190	168	NEW	\N	05 Site Management	05.04 Site Management
6406	84	\N	\N	D5170C00002	191	190	NEW	\N	05.04 Site Management	05.04.01 Subject Log
6408	84	\N	\N	D5170C00002	193	190	NEW	\N	05.04 Site Management	05.04.04 Visit Log
6409	84	\N	\N	D5170C00002	194	190	NEW	\N	05.04 Site Management	05.04.05 UNBLI_itoring Activity
6411	84	\N	\N	D5170C00002	196	168	NEW	\N	05 Site Management	05.05 General
6412	84	\N	\N	D5170C00002	197	196	NEW	\N	05.05 General	05.05.02 Tracking Information
6413	84	\N	\N	D5170C00002	198	157	NEW	\N	2001824 Van Assche, Gert	06 IP and Trial Supplies
17326	88	1617083076421:628062749	1617052454137:-549313426	D5170C00001	3016	3015	CREATE	2021-03-30 07:44:40.579	Site Management	Final Trial Close Out Monitoring Report
6415	84	\N	\N	D5170C00002	200	199	NEW	\N	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
6416	84	\N	\N	D5170C00002	201	199	NEW	\N	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
6418	84	\N	\N	D5170C00002	203	198	NEW	\N	06 IP and Trial Supplies	06.04 Storage
6419	84	\N	\N	D5170C00002	204	203	NEW	\N	06.04 Storage	06.04.01 Storage Condition Documentation
6421	84	\N	\N	D5170C00002	206	203	NEW	\N	06.04 Storage	06.04.02 UNBLINDED Storage Condition Excursion Documentation
6422	84	\N	\N	D5170C00002	207	203	NEW	\N	06.04 Storage	06.04.03 Maintenance Logs
6424	84	\N	\N	D5170C00002	209	157	NEW	\N	2001824 Van Assche, Gert	08 Centralized Testing
6425	84	\N	\N	D5170C00002	210	209	NEW	\N	08 Centralized Testing	08.02 Sample Documentation
6428	84	\N	\N	D5170C00002	213	212	NEW	\N	2001825 De Vos, Martine	03 Regulatory
6430	84	\N	\N	D5170C00002	215	214	NEW	\N	03.04 General	03.04.01 Relev_art-Up-Documents
6431	84	\N	\N	D5170C00002	216	212	NEW	\N	2001825 De Vos, Martine	05 Site Management
6433	84	\N	\N	D5170C00002	218	217	NEW	\N	05.01 Site Selection	05.01.01 Site Contact Details
6435	84	\N	\N	D5170C00002	220	217	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
6436	84	\N	\N	D5170C00002	221	217	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
6437	84	\N	\N	D5170C00002	222	216	NEW	\N	05 Site Management	05.05 General
6439	84	\N	\N	D5170C00002	224	156	NEW	\N	Site	2001826 Bossuyt, Peter
6440	84	\N	\N	D5170C00002	225	224	NEW	\N	2001826 Bossuyt, Peter	02 Central Trial Documents
6442	84	\N	\N	D5170C00002	227	226	NEW	\N	02.02 Subject Documents	02.02.05 Subject Participation Card
8323	84	\N	\N	D5170C00002	2108	2107	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
6444	84	\N	\N	D5170C00002	229	228	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
6446	84	\N	\N	D5170C00002	231	224	NEW	\N	2001826 Bossuyt, Peter	03 Regulatory
6447	84	\N	\N	D5170C00002	232	231	NEW	\N	03 Regulatory	03.04 General
6449	84	\N	\N	D5170C00002	234	224	NEW	\N	2001826 Bossuyt, Peter	04 IRB-IEC and other Approvals
6450	84	\N	\N	D5170C00002	235	234	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
6452	84	\N	\N	D5170C00002	237	235	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
6453	84	\N	\N	D5170C00002	238	234	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
6455	84	\N	\N	D5170C00002	240	224	NEW	\N	2001826 Bossuyt, Peter	05 Site Management
6456	84	\N	\N	D5170C00002	241	240	NEW	\N	05 Site Management	05.01 Site Selection
6458	84	\N	\N	D5170C00002	243	241	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
6459	84	\N	\N	D5170C00002	244	241	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
6461	84	\N	\N	D5170C00002	246	240	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
6462	84	\N	\N	D5170C00002	247	246	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
6464	84	\N	\N	D5170C00002	249	246	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
6465	84	\N	\N	D5170C00002	250	246	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
6466	84	\N	\N	D5170C00002	251	246	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
6468	84	\N	\N	D5170C00002	253	246	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Investigator Regulatory Agreement
6469	84	\N	\N	D5170C00002	254	246	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
6471	84	\N	\N	D5170C00002	256	246	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
6472	84	\N	\N	D5170C00002	257	246	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
6473	84	\N	\N	D5170C00002	258	240	NEW	\N	05 Site Management	05.03 Site Initiation
6475	84	\N	\N	D5170C00002	260	258	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
6476	84	\N	\N	D5170C00002	261	258	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
6478	84	\N	\N	D5170C00002	263	262	NEW	\N	05.04 Site Management	05.04.01 Subject Log
6479	84	\N	\N	D5170C00002	264	262	NEW	\N	05.04 Site Management	05.04.03 Monitoring Visit Report
6481	84	\N	\N	D5170C00002	266	262	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
6482	84	\N	\N	D5170C00002	267	262	NEW	\N	05.04 Site Management	05.04.04 Visit Log
6484	84	\N	\N	D5170C00002	269	262	NEW	\N	05.04 Site Management	05.04.05 UNBLI_itoring Activity
6485	84	\N	\N	D5170C00002	270	262	NEW	\N	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
6487	84	\N	\N	D5170C00002	272	262	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
6488	84	\N	\N	D5170C00002	273	240	NEW	\N	05 Site Management	05.05 General
6489	84	\N	\N	D5170C00002	274	273	NEW	\N	05.05 General	05.05.01 Relevant Communications-Documents
6491	84	\N	\N	D5170C00002	276	224	NEW	\N	2001826 Bossuyt, Peter	06 IP and Trial Supplies
6492	84	\N	\N	D5170C00002	277	276	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
6494	84	\N	\N	D5170C00002	279	277	NEW	\N	06.01 IP Documentation	06.01.04 IP Shipment Documentation
6495	84	\N	\N	D5170C00002	280	277	NEW	\N	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
6497	84	\N	\N	D5170C00002	282	277	NEW	\N	06.01 IP Documentation	06.01.11 Certificate of Destruction
6498	84	\N	\N	D5170C00002	283	277	NEW	\N	06.01 IP Documentation	06.01.11 UNBLI_e of Destruction
6500	84	\N	\N	D5170C00002	285	284	NEW	\N	06.04 Storage	06.04.01 Storage Condition Documentation
6501	84	\N	\N	D5170C00002	286	284	NEW	\N	06.04 Storage	06.04.01 UNBLI_on Documentation
6503	84	\N	\N	D5170C00002	288	284	NEW	\N	06.04 Storage	06.04.03 Maintenance Logs
17399	88	1617083125534:1790561333	1617052516047:357604275	D5170C00001	3089	3088	CREATE	2021-03-30 07:45:25.649	IP Documentation	IP Accountability Documentation
6504	84	\N	\N	D5170C00002	289	284	NEW	\N	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
6506	84	\N	\N	D5170C00002	291	290	NEW	\N	06.05 Non-IP Documentation	06.05.02 Non-IP Documentation of Shipment
8327	84	\N	\N	D5170C00002	2112	2111	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
6509	84	\N	\N	D5170C00002	294	224	NEW	\N	2001826 Bossuyt, Peter	08 Centralized Testing
6510	84	\N	\N	D5170C00002	295	294	NEW	\N	08 Centralized Testing	08.02 Sample Documentation
6512	84	\N	\N	D5170C00002	297	156	NEW	\N	Site	TBD-1-1PPR8W5 D'Heygere, François
6513	84	\N	\N	D5170C00002	298	297	NEW	\N	TBD-1-1PPR8W5 D'Heygere, François	05 Site Management
6515	84	\N	\N	D5170C00002	300	299	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
6516	84	\N	\N	D5170C00002	301	156	NEW	\N	Site	TBD-1-1PPS6HE Baert, Filip
6518	84	\N	\N	D5170C00002	303	302	NEW	\N	05 Site Management	05.01 Site Selection
6519	84	\N	\N	D5170C00002	304	303	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
6521	84	\N	\N	D5170C00002	306	305	NEW	\N	TBD-1-1PPSYYV Macken, Elisabeth	05 Site Management
6522	84	\N	\N	D5170C00002	307	306	NEW	\N	05 Site Management	05.01 Site Selection
6524	84	\N	\N	D5170C00002	309	156	NEW	\N	Site	TBD-1-2KODZJF Willandt, Barbara
6525	84	\N	\N	D5170C00002	310	309	NEW	\N	TBD-1-2KODZJF Willandt, Barbara	02 Central Trial Documents
6527	84	\N	\N	D5170C00002	312	311	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
6528	84	\N	\N	D5170C00002	313	309	NEW	\N	TBD-1-2KODZJF Willandt, Barbara	05 Site Management
6530	84	\N	\N	D5170C00002	315	314	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
6531	84	\N	\N	D5170C00002	316	4	NEW	\N	contents	BULGARIA
6533	84	\N	\N	D5170C00002	318	317	NEW	\N	Site	2002264 Mirchev, Milko
6535	84	\N	\N	D5170C00002	320	319	NEW	\N	05 Site Management	05.01 Site Selection
6536	84	\N	\N	D5170C00002	321	320	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
6537	84	\N	\N	D5170C00002	322	317	NEW	\N	Site	2002265 Petrov, Plamen
6539	84	\N	\N	D5170C00002	324	323	NEW	\N	05 Site Management	05.01 Site Selection
6541	84	\N	\N	D5170C00002	326	317	NEW	\N	Site	2002266 Vladimirov, Borislav
6542	84	\N	\N	D5170C00002	327	326	NEW	\N	2002266 Vladimirov, Borislav	02 Central Trial Documents
6543	84	\N	\N	D5170C00002	328	327	NEW	\N	02 Central Trial Documents	02.04 General
6545	84	\N	\N	D5170C00002	330	328	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
6547	84	\N	\N	D5170C00002	332	331	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
6548	84	\N	\N	D5170C00002	333	332	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
6549	84	\N	\N	D5170C00002	334	332	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
6551	84	\N	\N	D5170C00002	336	335	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
6552	84	\N	\N	D5170C00002	337	326	NEW	\N	2002266 Vladimirov, Borislav	05 Site Management
6554	84	\N	\N	D5170C00002	339	338	NEW	\N	05.01 Site Selection	05.01.01 Site Contact Details
6555	84	\N	\N	D5170C00002	340	338	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
6557	84	\N	\N	D5170C00002	342	338	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
6558	84	\N	\N	D5170C00002	343	337	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
6560	84	\N	\N	D5170C00002	345	343	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
6561	84	\N	\N	D5170C00002	346	343	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
6563	84	\N	\N	D5170C00002	348	343	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Site Qualification
6564	84	\N	\N	D5170C00002	349	343	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
6566	84	\N	\N	D5170C00002	351	343	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
6567	84	\N	\N	D5170C00002	352	343	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
6569	84	\N	\N	D5170C00002	354	343	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
6570	84	\N	\N	D5170C00002	355	337	NEW	\N	05 Site Management	05.03 Site Initiation
6572	84	\N	\N	D5170C00002	357	355	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
6575	84	\N	\N	D5170C00002	360	359	NEW	\N	05.04 Site Management	05.04.04 Visit Log
6577	84	\N	\N	D5170C00002	362	337	NEW	\N	05 Site Management	05.05 General
6578	84	\N	\N	D5170C00002	363	362	NEW	\N	05.05 General	05.05.02 Tracking Information
6579	84	\N	\N	D5170C00002	364	317	NEW	\N	Site	2002267 Draganova, Raina
6581	84	\N	\N	D5170C00002	366	365	NEW	\N	02 Central Trial Documents	02.04 General
6582	84	\N	\N	D5170C00002	367	366	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
6584	84	\N	\N	D5170C00002	369	364	NEW	\N	2002267 Draganova, Raina	04 IRB-IEC and other Approvals
6585	84	\N	\N	D5170C00002	370	369	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
6587	84	\N	\N	D5170C00002	372	370	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
6588	84	\N	\N	D5170C00002	373	364	NEW	\N	2002267 Draganova, Raina	05 Site Management
6589	84	\N	\N	D5170C00002	374	373	NEW	\N	05 Site Management	05.01 Site Selection
6591	84	\N	\N	D5170C00002	376	374	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
6593	84	\N	\N	D5170C00002	378	374	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
6594	84	\N	\N	D5170C00002	379	373	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
6595	84	\N	\N	D5170C00002	380	379	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Accep_tigator Brochure
6597	84	\N	\N	D5170C00002	382	379	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
6598	84	\N	\N	D5170C00002	383	379	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
14311	88	1617049777304:1085508340	rootNode	D5170C00001	1	0	ALREADY AVAILABLE	2021-03-30 07:19:37.236		eTMF
6600	84	\N	\N	D5170C00002	385	379	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
6601	84	\N	\N	D5170C00002	386	379	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Investigator Regulatory Agreement
6603	84	\N	\N	D5170C00002	388	379	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
6604	84	\N	\N	D5170C00002	389	379	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
6605	84	\N	\N	D5170C00002	390	379	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
6607	84	\N	\N	D5170C00002	392	391	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
6608	84	\N	\N	D5170C00002	393	391	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
6610	84	\N	\N	D5170C00002	395	373	NEW	\N	05 Site Management	05.04 Site Management
6611	84	\N	\N	D5170C00002	396	395	NEW	\N	05.04 Site Management	05.04.04 Visit Log
6612	84	\N	\N	D5170C00002	397	395	NEW	\N	05.04 Site Management	05.04.05 Additional Monitoring Activity
6614	84	\N	\N	D5170C00002	399	373	NEW	\N	05 Site Management	05.05 General
6615	84	\N	\N	D5170C00002	400	399	NEW	\N	05.05 General	05.05.02 Tracking Information
6616	84	\N	\N	D5170C00002	401	317	NEW	\N	Site	2002268 Petrov, Asen
6618	84	\N	\N	D5170C00002	403	402	NEW	\N	02 Central Trial Documents	02.04 General
6619	84	\N	\N	D5170C00002	404	403	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
6621	84	\N	\N	D5170C00002	406	401	NEW	\N	2002268 Petrov, Asen	04 IRB-IEC and other Approvals
6622	84	\N	\N	D5170C00002	407	406	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
6624	84	\N	\N	D5170C00002	409	407	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
6625	84	\N	\N	D5170C00002	410	406	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
6627	84	\N	\N	D5170C00002	412	406	NEW	\N	04 IRB-IEC and other Approvals	04.04 General
6628	84	\N	\N	D5170C00002	413	412	NEW	\N	04.04 General	04.04.01 Relev_RB-IEC-Documents
6629	84	\N	\N	D5170C00002	414	401	NEW	\N	2002268 Petrov, Asen	05 Site Management
6631	84	\N	\N	D5170C00002	416	415	NEW	\N	05.01 Site Selection	05.01.01 Site Contact Details
6633	84	\N	\N	D5170C00002	418	415	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
6634	84	\N	\N	D5170C00002	419	415	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
6636	84	\N	\N	D5170C00002	421	420	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
8330	84	\N	\N	D5170C00002	2115	2111	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
6637	84	\N	\N	D5170C00002	422	420	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
6639	84	\N	\N	D5170C00002	424	420	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
6640	84	\N	\N	D5170C00002	425	420	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Site Qualification
6642	84	\N	\N	D5170C00002	427	420	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Investigator Regulatory Agreement
6643	84	\N	\N	D5170C00002	428	420	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
6645	84	\N	\N	D5170C00002	430	420	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
6646	84	\N	\N	D5170C00002	431	420	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
6647	84	\N	\N	D5170C00002	432	414	NEW	\N	05 Site Management	05.03 Site Initiation
6649	84	\N	\N	D5170C00002	434	432	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
6650	84	\N	\N	D5170C00002	435	432	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
6651	84	\N	\N	D5170C00002	436	414	NEW	\N	05 Site Management	05.04 Site Management
6653	84	\N	\N	D5170C00002	438	436	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
6654	84	\N	\N	D5170C00002	439	414	NEW	\N	05 Site Management	05.05 General
6656	84	\N	\N	D5170C00002	441	317	NEW	\N	Site	2002989 Popov, Georgi
6657	84	\N	\N	D5170C00002	442	441	NEW	\N	2002989 Popov, Georgi	05 Site Management
6659	84	\N	\N	D5170C00002	444	443	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
6660	84	\N	\N	D5170C00002	445	317	NEW	\N	Site	TBD-1-1Q34X7Y Stoinov, Simeon
6662	84	\N	\N	D5170C00002	447	446	NEW	\N	05 Site Management	05.01 Site Selection
6663	84	\N	\N	D5170C00002	448	447	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
6664	84	\N	\N	D5170C00002	449	317	NEW	\N	Site	TBD-1-2OQDQEF Naydenova, Totka
6666	84	\N	\N	D5170C00002	451	450	NEW	\N	05 Site Management	05.01 Site Selection
6667	84	\N	\N	D5170C00002	452	451	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
6669	84	\N	\N	D5170C00002	454	453	NEW	\N	TBD-1-2P5VCT5 _Peneva, Mariyana	05 Site Management
6670	84	\N	\N	D5170C00002	455	454	NEW	\N	05 Site Management	05.01 Site Selection
6673	84	\N	\N	D5170C00002	458	457	NEW	\N	CANADA	Site
6674	84	\N	\N	D5170C00002	459	458	NEW	\N	Site	2001741 Dhalla, Sonny
6676	84	\N	\N	D5170C00002	461	460	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
6678	84	\N	\N	D5170C00002	463	460	NEW	\N	02 Central Trial Documents	02.04 General
6679	84	\N	\N	D5170C00002	464	463	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
6680	84	\N	\N	D5170C00002	465	463	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
6682	84	\N	\N	D5170C00002	467	466	NEW	\N	03 Regulatory	03.01 Trial Approval
6683	84	\N	\N	D5170C00002	468	467	NEW	\N	03.01 Trial Approval	03.01.02 Approval
6685	84	\N	\N	D5170C00002	470	469	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
6686	84	\N	\N	D5170C00002	471	470	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
6688	84	\N	\N	D5170C00002	473	469	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
6689	84	\N	\N	D5170C00002	474	473	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
6691	84	\N	\N	D5170C00002	476	475	NEW	\N	05 Site Management	05.01 Site Selection
15925	88	1617082362382:-2067824277	1617051274641:-906178156	D5170C00001	1615	1614	CREATE	2021-03-30 07:32:42.467	Site Set-up	Acceptance of Investigator Brochure
6692	84	\N	\N	D5170C00002	477	476	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
6694	84	\N	\N	D5170C00002	479	476	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
6695	84	\N	\N	D5170C00002	480	475	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
8301	84	\N	\N	D5170C00002	2086	2085	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
6700	84	\N	\N	D5170C00002	485	480	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
6701	84	\N	\N	D5170C00002	486	480	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
6703	84	\N	\N	D5170C00002	488	480	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Inves_latory Agreement
6704	84	\N	\N	D5170C00002	489	480	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
6706	84	\N	\N	D5170C00002	491	480	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
6707	84	\N	\N	D5170C00002	492	480	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
6708	84	\N	\N	D5170C00002	493	475	NEW	\N	05 Site Management	05.03 Site Initiation
6710	84	\N	\N	D5170C00002	495	493	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
6711	84	\N	\N	D5170C00002	496	493	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
6712	84	\N	\N	D5170C00002	497	475	NEW	\N	05 Site Management	05.04 Site Management
6714	84	\N	\N	D5170C00002	499	497	NEW	\N	05.04 Site Management	05.04.04 Visit Log
6715	84	\N	\N	D5170C00002	500	497	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
6717	84	\N	\N	D5170C00002	502	501	NEW	\N	05.05 General	05.05.01 Relev_unications-Email
6718	84	\N	\N	D5170C00002	503	501	NEW	\N	05.05 General	05.05.02 Tracking Information
6720	84	\N	\N	D5170C00002	505	504	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
6721	84	\N	\N	D5170C00002	506	505	NEW	\N	06.01 IP Documentation	06.01.02 IP Instructions for Handling
6723	84	\N	\N	D5170C00002	508	507	NEW	\N	06.04 Storage	06.04.03 UNBLINDED Maintenance Logs
6724	84	\N	\N	D5170C00002	509	458	NEW	\N	Site	2001743 Ropeleski, Mark
6726	84	\N	\N	D5170C00002	511	510	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
6727	84	\N	\N	D5170C00002	512	511	NEW	\N	02.02 Subject Documents	02.02.03 Infor_ Form Checklists
6729	84	\N	\N	D5170C00002	514	510	NEW	\N	02 Central Trial Documents	02.04 General
6730	84	\N	\N	D5170C00002	515	514	NEW	\N	02.04 General	02.04.01 Relev_ations-Documents
6732	84	\N	\N	D5170C00002	517	514	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
6733	84	\N	\N	D5170C00002	518	509	NEW	\N	2001743 Ropeleski, Mark	04 IRB-IEC and other Approvals
6735	84	\N	\N	D5170C00002	520	519	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
6736	84	\N	\N	D5170C00002	521	519	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
6737	84	\N	\N	D5170C00002	522	519	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
6739	84	\N	\N	D5170C00002	524	523	NEW	\N	04.03 Trial Status Reporting	04.03.01 IRB-I_y Info-Deviation
6740	84	\N	\N	D5170C00002	525	523	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
6742	84	\N	\N	D5170C00002	527	526	NEW	\N	05 Site Management	05.01 Site Selection
6743	84	\N	\N	D5170C00002	528	527	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
6745	84	\N	\N	D5170C00002	530	527	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
6746	84	\N	\N	D5170C00002	531	526	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
6748	84	\N	\N	D5170C00002	533	531	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
6749	84	\N	\N	D5170C00002	534	531	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
6750	84	\N	\N	D5170C00002	535	531	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
6752	84	\N	\N	D5170C00002	537	531	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
6753	84	\N	\N	D5170C00002	538	531	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
6754	84	\N	\N	D5170C00002	539	531	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Inves_latory Agreement
6756	84	\N	\N	D5170C00002	541	531	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
6757	84	\N	\N	D5170C00002	542	531	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
6760	84	\N	\N	D5170C00002	545	544	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
6762	84	\N	\N	D5170C00002	547	544	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
6763	84	\N	\N	D5170C00002	548	526	NEW	\N	05 Site Management	05.04 Site Management
6765	84	\N	\N	D5170C00002	550	548	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
6766	84	\N	\N	D5170C00002	551	548	NEW	\N	05.04 Site Management	05.04.04 Visit Log
6768	84	\N	\N	D5170C00002	553	526	NEW	\N	05 Site Management	05.05 General
6769	84	\N	\N	D5170C00002	554	553	NEW	\N	05.05 General	05.05.01 Relev_unications-Email
6770	84	\N	\N	D5170C00002	555	553	NEW	\N	05.05 General	05.05.01 Relevant Communications-Documents
6772	84	\N	\N	D5170C00002	557	509	NEW	\N	2001743 Ropeleski, Mark	06 IP and Trial Supplies
6773	84	\N	\N	D5170C00002	558	557	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
6775	84	\N	\N	D5170C00002	560	558	NEW	\N	06.01 IP Documentation	06.01.10 IP Documentation Return
6776	84	\N	\N	D5170C00002	561	557	NEW	\N	06 IP and Trial Supplies	06.05 Non-IP Documentation
6778	84	\N	\N	D5170C00002	563	458	NEW	\N	Site	2001744 Ponich, Terry
6779	84	\N	\N	D5170C00002	564	563	NEW	\N	2001744 Ponich, Terry	02 Central Trial Documents
6780	84	\N	\N	D5170C00002	565	564	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
6782	84	\N	\N	D5170C00002	567	565	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
6783	84	\N	\N	D5170C00002	568	564	NEW	\N	02 Central Trial Documents	02.04 General
6785	84	\N	\N	D5170C00002	570	568	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
6786	84	\N	\N	D5170C00002	571	563	NEW	\N	2001744 Ponich, Terry	03 Regulatory
6787	84	\N	\N	D5170C00002	572	571	NEW	\N	03 Regulatory	03.01 Trial Approval
6789	84	\N	\N	D5170C00002	574	571	NEW	\N	03 Regulatory	03.04 General
6791	84	\N	\N	D5170C00002	576	563	NEW	\N	2001744 Ponich, Terry	04 IRB-IEC and other Approvals
6792	84	\N	\N	D5170C00002	577	576	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
6794	84	\N	\N	D5170C00002	579	577	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
6795	84	\N	\N	D5170C00002	580	576	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
6797	84	\N	\N	D5170C00002	582	563	NEW	\N	2001744 Ponich, Terry	05 Site Management
6798	84	\N	\N	D5170C00002	583	582	NEW	\N	05 Site Management	05.01 Site Selection
6799	84	\N	\N	D5170C00002	584	583	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
6801	84	\N	\N	D5170C00002	586	582	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
6802	84	\N	\N	D5170C00002	587	586	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
6804	84	\N	\N	D5170C00002	589	586	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
6805	84	\N	\N	D5170C00002	590	586	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
6806	84	\N	\N	D5170C00002	591	586	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
6808	84	\N	\N	D5170C00002	593	586	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Inves_latory Agreement
6809	84	\N	\N	D5170C00002	594	586	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
6811	84	\N	\N	D5170C00002	596	586	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
6812	84	\N	\N	D5170C00002	597	582	NEW	\N	05 Site Management	05.03 Site Initiation
6813	84	\N	\N	D5170C00002	598	597	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
6815	84	\N	\N	D5170C00002	600	597	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
6816	84	\N	\N	D5170C00002	601	582	NEW	\N	05 Site Management	05.04 Site Management
6818	84	\N	\N	D5170C00002	603	601	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
6819	84	\N	\N	D5170C00002	604	601	NEW	\N	05.04 Site Management	05.04.05 UNBLINDED Additional Monitoring Activity
6820	84	\N	\N	D5170C00002	605	601	NEW	\N	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
6824	84	\N	\N	D5170C00002	609	582	NEW	\N	05 Site Management	05.05 General
6825	84	\N	\N	D5170C00002	610	609	NEW	\N	05.05 General	05.05.01 Relev_ations-Documents
6827	84	\N	\N	D5170C00002	612	609	NEW	\N	05.05 General	05.05.02 Tracking Information
6828	84	\N	\N	D5170C00002	613	563	NEW	\N	2001744 Ponich, Terry	06 IP and Trial Supplies
6830	84	\N	\N	D5170C00002	615	614	NEW	\N	06.01 IP Documentation	06.01.02 IP Instructions for Handling
6831	84	\N	\N	D5170C00002	616	614	NEW	\N	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
6833	84	\N	\N	D5170C00002	618	614	NEW	\N	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
6834	84	\N	\N	D5170C00002	619	614	NEW	\N	06.01 IP Documentation	06.01.11 UNBLINDED Certificate of Destruction
6836	84	\N	\N	D5170C00002	621	620	NEW	\N	06.04 Storage	06.04.01 UNBLINDED Storage Condition Documentation
6837	84	\N	\N	D5170C00002	622	620	NEW	\N	06.04 Storage	06.04.02 UNBLINDED Storage Condition Excursion Documentation
6839	84	\N	\N	D5170C00002	624	613	NEW	\N	06 IP and Trial Supplies	06.07 General
6840	84	\N	\N	D5170C00002	625	624	NEW	\N	06.07 General	06.07.01 Relev_al Product-Email
6842	84	\N	\N	D5170C00002	627	458	NEW	\N	Site	2001745 Bitton, Alain
6843	84	\N	\N	D5170C00002	628	627	NEW	\N	2001745 Bitton, Alain	02 Central Trial Documents
6844	84	\N	\N	D5170C00002	629	628	NEW	\N	02 Central Trial Documents	02.04 General
6846	84	\N	\N	D5170C00002	631	627	NEW	\N	2001745 Bitton, Alain	05 Site Management
6847	84	\N	\N	D5170C00002	632	631	NEW	\N	05 Site Management	05.01 Site Selection
6849	84	\N	\N	D5170C00002	634	631	NEW	\N	05 Site Management	05.05 General
6850	84	\N	\N	D5170C00002	635	634	NEW	\N	05.05 General	05.05.01 Relev_unications-Email
6851	84	\N	\N	D5170C00002	636	458	NEW	\N	Site	2001779 Desai, Milind
6853	84	\N	\N	D5170C00002	638	637	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
6854	84	\N	\N	D5170C00002	639	638	NEW	\N	02.02 Subject Documents	02.02.03 Infor_ Form Checklists
6856	84	\N	\N	D5170C00002	641	637	NEW	\N	02 Central Trial Documents	02.04 General
6857	84	\N	\N	D5170C00002	642	641	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
6859	84	\N	\N	D5170C00002	644	636	NEW	\N	2001779 Desai, Milind	03 Regulatory
6860	84	\N	\N	D5170C00002	645	644	NEW	\N	03 Regulatory	03.01 Trial Approval
6862	84	\N	\N	D5170C00002	647	636	NEW	\N	2001779 Desai, Milind	04 IRB-IEC and other Approvals
6863	84	\N	\N	D5170C00002	648	647	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
6865	84	\N	\N	D5170C00002	650	648	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
6866	84	\N	\N	D5170C00002	651	648	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.05 IRB-I_liance Statement
6868	84	\N	\N	D5170C00002	653	652	NEW	\N	05 Site Management	05.01 Site Selection
6869	84	\N	\N	D5170C00002	654	653	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
6871	84	\N	\N	D5170C00002	656	653	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
6872	84	\N	\N	D5170C00002	657	652	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
6874	84	\N	\N	D5170C00002	659	657	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
6875	84	\N	\N	D5170C00002	660	657	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
6876	84	\N	\N	D5170C00002	661	657	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
6878	84	\N	\N	D5170C00002	663	657	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
6879	84	\N	\N	D5170C00002	664	657	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
6880	84	\N	\N	D5170C00002	665	657	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Inves_latory Agreement
14649	88	1617050071349:-397196604	1617050070204:-1562773554	D5170C00001	339	337	ALREADY AVAILABLE	2021-03-30 07:19:37.353	IRB or IEC Trial Approval	IRB or IEC Submission
6882	84	\N	\N	D5170C00002	667	657	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
8302	84	\N	\N	D5170C00002	2087	2086	NEW	\N	06.01 IP Documentation	06.01.02 IP In_ons for Handling
8334	84	\N	\N	D5170C00002	2119	2111	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
6884	84	\N	\N	D5170C00002	669	652	NEW	\N	05 Site Management	05.03 Site Initiation
6886	84	\N	\N	D5170C00002	671	669	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
6887	84	\N	\N	D5170C00002	672	652	NEW	\N	05 Site Management	05.04 Site Management
6889	84	\N	\N	D5170C00002	674	672	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
6890	84	\N	\N	D5170C00002	675	652	NEW	\N	05 Site Management	05.05 General
6891	84	\N	\N	D5170C00002	676	675	NEW	\N	05.05 General	05.05.01 Relev_unications-Email
6893	84	\N	\N	D5170C00002	678	675	NEW	\N	05.05 General	05.05.02 Tracking Information
6894	84	\N	\N	D5170C00002	679	636	NEW	\N	2001779 Desai, Milind	06 IP and Trial Supplies
6895	84	\N	\N	D5170C00002	680	679	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
6897	84	\N	\N	D5170C00002	682	458	NEW	\N	Site	2001780 Sy, Richmond
6898	84	\N	\N	D5170C00002	683	682	NEW	\N	2001780 Sy, Richmond	05 Site Management
6900	84	\N	\N	D5170C00002	685	684	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
6901	84	\N	\N	D5170C00002	686	683	NEW	\N	05 Site Management	05.05 General
6903	84	\N	\N	D5170C00002	688	458	NEW	\N	Site	2001801 Jones, Jennifer
6904	84	\N	\N	D5170C00002	689	688	NEW	\N	2001801 Jones, Jennifer	05 Site Management
6906	84	\N	\N	D5170C00002	691	690	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
6907	84	\N	\N	D5170C00002	692	458	NEW	\N	Site	2001802 Feagan, Brian
6909	84	\N	\N	D5170C00002	694	693	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
6910	84	\N	\N	D5170C00002	695	694	NEW	\N	02.02 Subject Documents	02.02.03 Infor_ Form Checklists
6912	84	\N	\N	D5170C00002	697	693	NEW	\N	02 Central Trial Documents	02.04 General
6913	84	\N	\N	D5170C00002	698	697	NEW	\N	02.04 General	02.04.01 Relev_ations-Documents
6915	84	\N	\N	D5170C00002	700	697	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
6916	84	\N	\N	D5170C00002	701	692	NEW	\N	2001802 Feagan, Brian	04 IRB-IEC and other Approvals
6918	84	\N	\N	D5170C00002	703	702	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
6919	84	\N	\N	D5170C00002	704	702	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
6920	84	\N	\N	D5170C00002	705	702	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
6922	84	\N	\N	D5170C00002	707	706	NEW	\N	04.02 Other Committees	04.02.02 Other Approvals
6923	84	\N	\N	D5170C00002	708	701	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
6925	84	\N	\N	D5170C00002	710	701	NEW	\N	04 IRB-IEC and other Approvals	04.04 General
6926	84	\N	\N	D5170C00002	711	710	NEW	\N	04.04 General	04.04.01 Relev_RB-IEC-Documents
6927	84	\N	\N	D5170C00002	712	692	NEW	\N	2001802 Feagan, Brian	05 Site Management
6929	84	\N	\N	D5170C00002	714	713	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
6931	84	\N	\N	D5170C00002	716	713	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
6932	84	\N	\N	D5170C00002	717	712	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
6934	84	\N	\N	D5170C00002	719	717	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
6935	84	\N	\N	D5170C00002	720	717	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
6936	84	\N	\N	D5170C00002	721	717	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
6938	84	\N	\N	D5170C00002	723	717	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
6939	84	\N	\N	D5170C00002	724	717	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
6940	84	\N	\N	D5170C00002	725	717	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Inves_latory Agreement
6942	84	\N	\N	D5170C00002	727	717	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
6943	84	\N	\N	D5170C00002	728	717	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
6945	84	\N	\N	D5170C00002	730	712	NEW	\N	05 Site Management	05.03 Site Initiation
6946	84	\N	\N	D5170C00002	731	730	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
6950	84	\N	\N	D5170C00002	735	734	NEW	\N	05.04 Site Management	05.04.01 Subject Log
6952	84	\N	\N	D5170C00002	737	734	NEW	\N	05.04 Site Management	05.04.04 Visit Log
6953	84	\N	\N	D5170C00002	738	734	NEW	\N	05.04 Site Management	05.04.05 Additional Monitoring Activity
6955	84	\N	\N	D5170C00002	740	734	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
6956	84	\N	\N	D5170C00002	741	734	NEW	\N	05.04 Site Management	05.04.08 UNBLI_onitoring Report
6957	84	\N	\N	D5170C00002	742	712	NEW	\N	05 Site Management	05.05 General
6959	84	\N	\N	D5170C00002	744	742	NEW	\N	05.05 General	05.05.02 Tracking Information
6960	84	\N	\N	D5170C00002	745	692	NEW	\N	2001802 Feagan, Brian	06 IP and Trial Supplies
6962	84	\N	\N	D5170C00002	747	746	NEW	\N	06.01 IP Documentation	06.01.02 IP Instructions for Handling
6963	84	\N	\N	D5170C00002	748	746	NEW	\N	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
6965	84	\N	\N	D5170C00002	750	746	NEW	\N	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
6966	84	\N	\N	D5170C00002	751	746	NEW	\N	06.01 IP Documentation	06.01.11 UNBLINDED Certificate of Destruction
6967	84	\N	\N	D5170C00002	752	745	NEW	\N	06 IP and Trial Supplies	06.04 Storage
6969	84	\N	\N	D5170C00002	754	752	NEW	\N	06.04 Storage	06.04.01 UNBLINDED Storage Condition Documentation
6970	84	\N	\N	D5170C00002	755	752	NEW	\N	06.04 Storage	06.04.02 UNBLI_on Documentation
6972	84	\N	\N	D5170C00002	757	745	NEW	\N	06 IP and Trial Supplies	06.05 Non-IP Documentation
6973	84	\N	\N	D5170C00002	758	757	NEW	\N	06.05 Non-IP Documentation	06.05.03 Non-I_tation of Return
6974	84	\N	\N	D5170C00002	759	458	NEW	\N	Site	2001803 Ptak, Theadore
6976	84	\N	\N	D5170C00002	761	760	NEW	\N	05 Site Management	05.01 Site Selection
6978	84	\N	\N	D5170C00002	763	458	NEW	\N	Site	2001804 Plamondon, Sophie
6979	84	\N	\N	D5170C00002	764	763	NEW	\N	2001804 Plamondon, Sophie	05 Site Management
6980	84	\N	\N	D5170C00002	765	764	NEW	\N	05 Site Management	05.01 Site Selection
6982	84	\N	\N	D5170C00002	767	764	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
6983	84	\N	\N	D5170C00002	768	767	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
6984	84	\N	\N	D5170C00002	769	458	NEW	\N	Site	2001805 Aumais, Guy
6986	84	\N	\N	D5170C00002	771	770	NEW	\N	02 Central Trial Documents	02.04 General
6988	84	\N	\N	D5170C00002	773	769	NEW	\N	2001805 Aumais, Guy	05 Site Management
6989	84	\N	\N	D5170C00002	774	773	NEW	\N	05 Site Management	05.01 Site Selection
6991	84	\N	\N	D5170C00002	776	773	NEW	\N	05 Site Management	05.05 General
6992	84	\N	\N	D5170C00002	777	776	NEW	\N	05.05 General	05.05.01 Relev_unications-Email
6993	84	\N	\N	D5170C00002	778	458	NEW	\N	Site	2002041 Fowler, Sharyle
6995	84	\N	\N	D5170C00002	780	779	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
6996	84	\N	\N	D5170C00002	781	780	NEW	\N	02.02 Subject Documents	02.02.03 Infor_ Form Checklists
6998	84	\N	\N	D5170C00002	783	779	NEW	\N	02 Central Trial Documents	02.04 General
6999	84	\N	\N	D5170C00002	784	783	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
7001	84	\N	\N	D5170C00002	786	778	NEW	\N	2002041 Fowler, Sharyle	03 Regulatory
7002	84	\N	\N	D5170C00002	787	786	NEW	\N	03 Regulatory	03.01 Trial Approval
7003	84	\N	\N	D5170C00002	788	787	NEW	\N	03.01 Trial Approval	03.01.01 Submission
7005	84	\N	\N	D5170C00002	790	789	NEW	\N	03.03 Trial Status Reporting	03.03.01 Reg A_fo and Deviation
7007	84	\N	\N	D5170C00002	792	791	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
7008	84	\N	\N	D5170C00002	793	792	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
7009	84	\N	\N	D5170C00002	794	792	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
7011	84	\N	\N	D5170C00002	796	791	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
7012	84	\N	\N	D5170C00002	797	796	NEW	\N	04.03 Trial Status Reporting	04.03.01 IRB-I_y Info-Deviation
8337	84	\N	\N	D5170C00002	2122	2106	NEW	\N	05 Site Management	05.03 Site Initiation
7014	84	\N	\N	D5170C00002	799	778	NEW	\N	2002041 Fowler, Sharyle	05 Site Management
7016	84	\N	\N	D5170C00002	801	800	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
7018	84	\N	\N	D5170C00002	803	799	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
7019	84	\N	\N	D5170C00002	804	803	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
7020	84	\N	\N	D5170C00002	805	803	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
7022	84	\N	\N	D5170C00002	807	803	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
7023	84	\N	\N	D5170C00002	808	803	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
7025	84	\N	\N	D5170C00002	810	803	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
7026	84	\N	\N	D5170C00002	811	803	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Inves_latory Agreement
7028	84	\N	\N	D5170C00002	813	803	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
7029	84	\N	\N	D5170C00002	814	803	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Tax Documentation
7030	84	\N	\N	D5170C00002	815	803	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
7032	84	\N	\N	D5170C00002	817	799	NEW	\N	05 Site Management	05.03 Site Initiation
7033	84	\N	\N	D5170C00002	818	817	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
7034	84	\N	\N	D5170C00002	819	817	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
7036	84	\N	\N	D5170C00002	821	799	NEW	\N	05 Site Management	05.04 Site Management
7037	84	\N	\N	D5170C00002	822	821	NEW	\N	05.04 Site Management	05.04.01 Subject Log
7039	84	\N	\N	D5170C00002	824	821	NEW	\N	05.04 Site Management	05.04.04 Visit Log
7040	84	\N	\N	D5170C00002	825	821	NEW	\N	05.04 Site Management	05.04.05 Additional Monitoring Activity
7041	84	\N	\N	D5170C00002	826	821	NEW	\N	05.04 Site Management	05.04.05 UNBLI_itoring Activity
7043	84	\N	\N	D5170C00002	828	821	NEW	\N	05.04 Site Management	05.04.09 Inv N_fo-Dr-HCP Letter
7044	84	\N	\N	D5170C00002	829	799	NEW	\N	05 Site Management	05.05 General
7046	84	\N	\N	D5170C00002	831	829	NEW	\N	05.05 General	05.05.01 Relev_unications-Email
7047	84	\N	\N	D5170C00002	832	829	NEW	\N	05.05 General	05.05.02 Tracking Information
7049	84	\N	\N	D5170C00002	834	833	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
7050	84	\N	\N	D5170C00002	835	834	NEW	\N	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
7052	84	\N	\N	D5170C00002	837	834	NEW	\N	06.01 IP Documentation	06.01.11 UNBLINDED Certificate of Destruction
7053	84	\N	\N	D5170C00002	838	833	NEW	\N	06 IP and Trial Supplies	06.04 Storage
7055	84	\N	\N	D5170C00002	840	838	NEW	\N	06.04 Storage	06.04.03 Maintenance Logs
7056	84	\N	\N	D5170C00002	841	838	NEW	\N	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
7057	84	\N	\N	D5170C00002	842	458	NEW	\N	Site	2002109 Pesant, Yves
7059	84	\N	\N	D5170C00002	844	843	NEW	\N	02 Central Trial Documents	02.04 General
7060	84	\N	\N	D5170C00002	845	844	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
7061	84	\N	\N	D5170C00002	846	842	NEW	\N	2002109 Pesant, Yves	05 Site Management
7063	84	\N	\N	D5170C00002	848	847	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
7065	84	\N	\N	D5170C00002	850	849	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
7066	84	\N	\N	D5170C00002	851	846	NEW	\N	05 Site Management	05.05 General
7067	84	\N	\N	D5170C00002	852	851	NEW	\N	05.05 General	05.05.01 Relev_unications-Email
7069	84	\N	\N	D5170C00002	854	853	NEW	\N	2002144 Orlicka, Katarzyna	02 Central Trial Documents
7070	84	\N	\N	D5170C00002	855	854	NEW	\N	02 Central Trial Documents	02.04 General
7072	84	\N	\N	D5170C00002	857	853	NEW	\N	2002144 Orlicka, Katarzyna	05 Site Management
7073	84	\N	\N	D5170C00002	858	857	NEW	\N	05 Site Management	05.01 Site Selection
7075	84	\N	\N	D5170C00002	860	857	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
7078	84	\N	\N	D5170C00002	863	862	NEW	\N	05.05 General	05.05.01 Relev_unications-Email
7079	84	\N	\N	D5170C00002	864	458	NEW	\N	Site	TBD-1-1YHPC70 Fraser, Hughie
7081	84	\N	\N	D5170C00002	866	865	NEW	\N	05 Site Management	05.01 Site Selection
7082	84	\N	\N	D5170C00002	867	866	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
7083	84	\N	\N	D5170C00002	868	4	NEW	\N	contents	CZECH REPUBLIC
7085	84	\N	\N	D5170C00002	870	869	NEW	\N	Site	2001930 Drastich, Pavel
7087	84	\N	\N	D5170C00002	872	871	NEW	\N	02 Central Trial Documents	02.04 General
7088	84	\N	\N	D5170C00002	873	872	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
7090	84	\N	\N	D5170C00002	875	870	NEW	\N	2001930 Drastich, Pavel	05 Site Management
7091	84	\N	\N	D5170C00002	876	875	NEW	\N	05 Site Management	05.01 Site Selection
7093	84	\N	\N	D5170C00002	878	876	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
7094	84	\N	\N	D5170C00002	879	876	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
7095	84	\N	\N	D5170C00002	880	875	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
7097	84	\N	\N	D5170C00002	882	880	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
7098	84	\N	\N	D5170C00002	883	880	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
7100	84	\N	\N	D5170C00002	885	880	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
7101	84	\N	\N	D5170C00002	886	880	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
7102	84	\N	\N	D5170C00002	887	880	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clini_ Trial Agreement
7104	84	\N	\N	D5170C00002	889	880	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
7105	84	\N	\N	D5170C00002	890	875	NEW	\N	05 Site Management	05.03 Site Initiation
7107	84	\N	\N	D5170C00002	892	890	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
7108	84	\N	\N	D5170C00002	893	890	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
7109	84	\N	\N	D5170C00002	894	875	NEW	\N	05 Site Management	05.04 Site Management
7111	84	\N	\N	D5170C00002	896	894	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
7112	84	\N	\N	D5170C00002	897	875	NEW	\N	05 Site Management	05.05 General
7114	84	\N	\N	D5170C00002	899	870	NEW	\N	2001930 Drastich, Pavel	06 IP and Trial Supplies
7115	84	\N	\N	D5170C00002	900	899	NEW	\N	06 IP and Trial Supplies	06.04 Storage
7116	84	\N	\N	D5170C00002	901	900	NEW	\N	06.04 Storage	06.04.03 Maintenance Logs
7118	84	\N	\N	D5170C00002	903	902	NEW	\N	2001931 Nemecek, Zdenek	02 Central Trial Documents
7120	84	\N	\N	D5170C00002	905	904	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
7121	84	\N	\N	D5170C00002	906	904	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
7123	84	\N	\N	D5170C00002	908	907	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
7124	84	\N	\N	D5170C00002	909	908	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
7126	84	\N	\N	D5170C00002	911	907	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
7127	84	\N	\N	D5170C00002	912	911	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
7128	84	\N	\N	D5170C00002	913	902	NEW	\N	2001931 Nemecek, Zdenek	05 Site Management
7130	84	\N	\N	D5170C00002	915	914	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
7132	84	\N	\N	D5170C00002	917	914	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
7133	84	\N	\N	D5170C00002	918	913	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
7135	84	\N	\N	D5170C00002	920	918	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
7136	84	\N	\N	D5170C00002	921	918	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
7137	84	\N	\N	D5170C00002	922	918	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
7138	84	\N	\N	D5170C00002	923	918	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
7143	84	\N	\N	D5170C00002	928	913	NEW	\N	05 Site Management	05.03 Site Initiation
7144	84	\N	\N	D5170C00002	929	928	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
7146	84	\N	\N	D5170C00002	931	913	NEW	\N	05 Site Management	05.04 Site Management
7147	84	\N	\N	D5170C00002	932	931	NEW	\N	05.04 Site Management	05.04.04 Visit Log
7148	84	\N	\N	D5170C00002	933	931	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
7149	84	\N	\N	D5170C00002	934	913	NEW	\N	05 Site Management	05.05 General
7151	84	\N	\N	D5170C00002	936	869	NEW	\N	Site	2001932 Lukas, Milan
7152	84	\N	\N	D5170C00002	937	936	NEW	\N	2001932 Lukas, Milan	02 Central Trial Documents
7154	84	\N	\N	D5170C00002	939	938	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
7155	84	\N	\N	D5170C00002	940	938	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
7157	84	\N	\N	D5170C00002	942	941	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
7158	84	\N	\N	D5170C00002	943	942	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
7160	84	\N	\N	D5170C00002	945	942	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
7161	84	\N	\N	D5170C00002	946	941	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
7163	84	\N	\N	D5170C00002	948	936	NEW	\N	2001932 Lukas, Milan	05 Site Management
7164	84	\N	\N	D5170C00002	949	948	NEW	\N	05 Site Management	05.01 Site Selection
7166	84	\N	\N	D5170C00002	951	949	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
7167	84	\N	\N	D5170C00002	952	949	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
14798	88	1617050200777:-2031925333	1617050191494:-1593718706	D5170C00001	488	476	ALREADY AVAILABLE	2021-03-30 07:19:37.327	1001	IP and Trial Supplies
7168	84	\N	\N	D5170C00002	953	948	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
7170	84	\N	\N	D5170C00002	955	953	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
7171	84	\N	\N	D5170C00002	956	953	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
7173	84	\N	\N	D5170C00002	958	953	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
7174	84	\N	\N	D5170C00002	959	953	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
7176	84	\N	\N	D5170C00002	961	953	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
7177	84	\N	\N	D5170C00002	962	953	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
7178	84	\N	\N	D5170C00002	963	948	NEW	\N	05 Site Management	05.03 Site Initiation
7180	84	\N	\N	D5170C00002	965	963	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
7181	84	\N	\N	D5170C00002	966	948	NEW	\N	05 Site Management	05.04 Site Management
7182	84	\N	\N	D5170C00002	967	966	NEW	\N	05.04 Site Management	05.04.01 Subject Log
7184	84	\N	\N	D5170C00002	969	966	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
7185	84	\N	\N	D5170C00002	970	948	NEW	\N	05 Site Management	05.05 General
7187	84	\N	\N	D5170C00002	972	869	NEW	\N	Site	2001933 Volfova, Miroslava
7188	84	\N	\N	D5170C00002	973	972	NEW	\N	2001933 Volfova, Miroslava	02 Central Trial Documents
7190	84	\N	\N	D5170C00002	975	974	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
7191	84	\N	\N	D5170C00002	976	974	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
7193	84	\N	\N	D5170C00002	978	977	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
7194	84	\N	\N	D5170C00002	979	978	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
7195	84	\N	\N	D5170C00002	980	978	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
7197	84	\N	\N	D5170C00002	982	977	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
7198	84	\N	\N	D5170C00002	983	982	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
7200	84	\N	\N	D5170C00002	985	984	NEW	\N	05 Site Management	05.01 Site Selection
7201	84	\N	\N	D5170C00002	986	985	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
7204	84	\N	\N	D5170C00002	989	984	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
7206	84	\N	\N	D5170C00002	991	989	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
7207	84	\N	\N	D5170C00002	992	989	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
7209	84	\N	\N	D5170C00002	994	989	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
7210	84	\N	\N	D5170C00002	995	989	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
7212	84	\N	\N	D5170C00002	997	989	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Si_se Documentation
7213	84	\N	\N	D5170C00002	998	989	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
7214	84	\N	\N	D5170C00002	999	984	NEW	\N	05 Site Management	05.03 Site Initiation
7216	84	\N	\N	D5170C00002	1001	999	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
7217	84	\N	\N	D5170C00002	1002	999	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
7218	84	\N	\N	D5170C00002	1003	984	NEW	\N	05 Site Management	05.04 Site Management
7220	84	\N	\N	D5170C00002	1005	1003	NEW	\N	05.04 Site Management	05.04.04 Visit Log
7222	84	\N	\N	D5170C00002	1007	984	NEW	\N	05 Site Management	05.05 General
7223	84	\N	\N	D5170C00002	1008	1007	NEW	\N	05.05 General	05.05.02 Tracking Information
7224	84	\N	\N	D5170C00002	1009	972	NEW	\N	2001933 Volfova, Miroslava	06 IP and Trial Supplies
7225	84	\N	\N	D5170C00002	1010	1009	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
7227	84	\N	\N	D5170C00002	1012	1009	NEW	\N	06 IP and Trial Supplies	06.04 Storage
7228	84	\N	\N	D5170C00002	1013	1012	NEW	\N	06.04 Storage	06.04.03 Maintenance Logs
7229	84	\N	\N	D5170C00002	1014	869	NEW	\N	Site	TBD-1-1QGPG0F Svoboda, Pavel
7231	84	\N	\N	D5170C00002	1016	1015	NEW	\N	05 Site Management	05.01 Site Selection
7233	84	\N	\N	D5170C00002	1018	869	NEW	\N	Site	TBD-1-1QGPG2O Kopecka, Daniela
7234	84	\N	\N	D5170C00002	1019	1018	NEW	\N	TBD-1-1QGPG2O Kopecka, Daniela	05 Site Management
7235	84	\N	\N	D5170C00002	1020	1019	NEW	\N	05 Site Management	05.01 Site Selection
7237	84	\N	\N	D5170C00002	1022	869	NEW	\N	Site	TBD-1-1QGPG9A Urbanek, Petr
7238	84	\N	\N	D5170C00002	1023	1022	NEW	\N	TBD-1-1QGPG9A Urbanek, Petr	05 Site Management
7239	84	\N	\N	D5170C00002	1024	1023	NEW	\N	05 Site Management	05.01 Site Selection
7241	84	\N	\N	D5170C00002	1026	869	NEW	\N	Site	TBD-1-1QGPGAU Stehlik, Jiri
7242	84	\N	\N	D5170C00002	1027	1026	NEW	\N	TBD-1-1QGPGAU Stehlik, Jiri	05 Site Management
7243	84	\N	\N	D5170C00002	1028	1027	NEW	\N	05 Site Management	05.01 Site Selection
7245	84	\N	\N	D5170C00002	1030	869	NEW	\N	Site	TBD-1-1QGPGMA Hegyi, Peter
7246	84	\N	\N	D5170C00002	1031	1030	NEW	\N	TBD-1-1QGPGMA Hegyi, Peter	05 Site Management
7248	84	\N	\N	D5170C00002	1033	1032	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
7249	84	\N	\N	D5170C00002	1034	869	NEW	\N	Site	TBD-1-1TTR6OF Pesta, Martin
7250	84	\N	\N	D5170C00002	1035	1034	NEW	\N	TBD-1-1TTR6OF Pesta, Martin	05 Site Management
7252	84	\N	\N	D5170C00002	1037	1036	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
7253	84	\N	\N	D5170C00002	1038	1036	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
7255	84	\N	\N	D5170C00002	1040	1039	NEW	\N	TBD-1-2K4LDCM Brabec, Tomas	05 Site Management
7256	84	\N	\N	D5170C00002	1041	1040	NEW	\N	05 Site Management	05.01 Site Selection
7258	84	\N	\N	D5170C00002	1043	4	NEW	\N	contents	FRANCE
7259	84	\N	\N	D5170C00002	1044	1043	NEW	\N	FRANCE	Site
7260	84	\N	\N	D5170C00002	1045	1044	NEW	\N	Site	2002270 Bouhnik, Yoram
7262	84	\N	\N	D5170C00002	1047	1046	NEW	\N	02 Central Trial Documents	02.04 General
7263	84	\N	\N	D5170C00002	1048	1047	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
7265	84	\N	\N	D5170C00002	1050	1045	NEW	\N	2002270 Bouhnik, Yoram	05 Site Management
7266	84	\N	\N	D5170C00002	1051	1050	NEW	\N	05 Site Management	05.01 Site Selection
7269	84	\N	\N	D5170C00002	1054	1050	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
7270	84	\N	\N	D5170C00002	1055	1054	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
7272	84	\N	\N	D5170C00002	1057	1054	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
7273	84	\N	\N	D5170C00002	1058	1054	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
7274	84	\N	\N	D5170C00002	1059	1054	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
7276	84	\N	\N	D5170C00002	1061	1054	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
7277	84	\N	\N	D5170C00002	1062	1054	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
7278	84	\N	\N	D5170C00002	1063	1054	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
7280	84	\N	\N	D5170C00002	1065	1064	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
7281	84	\N	\N	D5170C00002	1066	1064	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
7283	84	\N	\N	D5170C00002	1068	1067	NEW	\N	05.04 Site Management	05.04.01 Subject Log
7284	84	\N	\N	D5170C00002	1069	1067	NEW	\N	05.04 Site Management	05.04.04 Visit Log
7286	84	\N	\N	D5170C00002	1071	1067	NEW	\N	05.04 Site Management	05.04.09 Inv Notification-SUSAR
7287	84	\N	\N	D5170C00002	1072	1050	NEW	\N	05 Site Management	05.05 General
7288	84	\N	\N	D5170C00002	1073	1072	NEW	\N	05.05 General	05.05.01 Relev_unications-Email
7290	84	\N	\N	D5170C00002	1075	1074	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
7291	84	\N	\N	D5170C00002	1076	1075	NEW	\N	06.01 IP Documentation	06.01.02 IP In_ons for Handling
7293	84	\N	\N	D5170C00002	1078	1077	NEW	\N	06.05 Non-IP Documentation	06.05.03 Non-I_tation of Return
7294	84	\N	\N	D5170C00002	1079	1044	NEW	\N	Site	2002271 Moreau, Jacques
7296	84	\N	\N	D5170C00002	1081	1080	NEW	\N	02 Central Trial Documents	02.04 General
7297	84	\N	\N	D5170C00002	1082	1081	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
7298	84	\N	\N	D5170C00002	1083	1081	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
7300	84	\N	\N	D5170C00002	1085	1084	NEW	\N	05 Site Management	05.01 Site Selection
7301	84	\N	\N	D5170C00002	1086	1085	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
7303	84	\N	\N	D5170C00002	1088	1084	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
7304	84	\N	\N	D5170C00002	1089	1088	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Accep_tigator Brochure
7306	84	\N	\N	D5170C00002	1091	1088	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
7307	84	\N	\N	D5170C00002	1092	1088	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
7308	84	\N	\N	D5170C00002	1093	1088	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
7310	84	\N	\N	D5170C00002	1095	1088	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
7311	84	\N	\N	D5170C00002	1096	1088	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
7313	84	\N	\N	D5170C00002	1098	1084	NEW	\N	05 Site Management	05.03 Site Initiation
7314	84	\N	\N	D5170C00002	1099	1098	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
7315	84	\N	\N	D5170C00002	1100	1098	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
7317	84	\N	\N	D5170C00002	1102	1084	NEW	\N	05 Site Management	05.04 Site Management
7318	84	\N	\N	D5170C00002	1103	1102	NEW	\N	05.04 Site Management	05.04.01 Subject Log
7320	84	\N	\N	D5170C00002	1105	1102	NEW	\N	05.04 Site Management	05.04.03 UNBLI_ing Visit Report
7321	84	\N	\N	D5170C00002	1106	1102	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
7322	84	\N	\N	D5170C00002	1107	1102	NEW	\N	05.04 Site Management	05.04.04 Visit Log
7324	84	\N	\N	D5170C00002	1109	1102	NEW	\N	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
7325	84	\N	\N	D5170C00002	1110	1102	NEW	\N	05.04 Site Management	05.04.06 UNBLINDED Protocol Deviations and Waivers
7330	84	\N	\N	D5170C00002	1115	1113	NEW	\N	05.05 General	05.05.02 Tracking Information
7331	84	\N	\N	D5170C00002	1116	1079	NEW	\N	2002271 Moreau, Jacques	06 IP and Trial Supplies
7333	84	\N	\N	D5170C00002	1118	1117	NEW	\N	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
7334	84	\N	\N	D5170C00002	1119	1117	NEW	\N	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
7335	84	\N	\N	D5170C00002	1120	1117	NEW	\N	06.01 IP Documentation	06.01.05 Accou_ty Documentation
7337	84	\N	\N	D5170C00002	1122	1117	NEW	\N	06.01 IP Documentation	06.01.11 UNBLI_e of Destruction
7338	84	\N	\N	D5170C00002	1123	1116	NEW	\N	06 IP and Trial Supplies	06.04 Storage
7340	84	\N	\N	D5170C00002	1125	1123	NEW	\N	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
7341	84	\N	\N	D5170C00002	1126	1079	NEW	\N	2002271 Moreau, Jacques	08 Centralized Testing
7342	84	\N	\N	D5170C00002	1127	1126	NEW	\N	08 Centralized Testing	08.02 Sample Documentation
7344	84	\N	\N	D5170C00002	1129	1044	NEW	\N	Site	2002272 Peyrin_iroulet, Laurent
7345	84	\N	\N	D5170C00002	1130	1129	NEW	\N	2002272 Peyrin_iroulet, Laurent	02 Central Trial Documents
7347	84	\N	\N	D5170C00002	1132	1131	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
7348	84	\N	\N	D5170C00002	1133	1131	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
7350	84	\N	\N	D5170C00002	1135	1134	NEW	\N	05 Site Management	05.01 Site Selection
7351	84	\N	\N	D5170C00002	1136	1135	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
7353	84	\N	\N	D5170C00002	1138	1134	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
7354	84	\N	\N	D5170C00002	1139	1138	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Accep_tigator Brochure
7355	84	\N	\N	D5170C00002	1140	1138	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
7357	84	\N	\N	D5170C00002	1142	1138	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
7358	84	\N	\N	D5170C00002	1143	1138	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Inves_latory Agreement
7360	84	\N	\N	D5170C00002	1145	1138	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clini_ Trial Agreement
7361	84	\N	\N	D5170C00002	1146	1138	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Si_se Documentation
7362	84	\N	\N	D5170C00002	1147	1134	NEW	\N	05 Site Management	05.03 Site Initiation
7364	84	\N	\N	D5170C00002	1149	1147	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
7365	84	\N	\N	D5170C00002	1150	1134	NEW	\N	05 Site Management	05.04 Site Management
7366	84	\N	\N	D5170C00002	1151	1150	NEW	\N	05.04 Site Management	05.04.03 Monitoring Visit Report
7368	84	\N	\N	D5170C00002	1153	1150	NEW	\N	05.04 Site Management	05.04.04 Visit Log
7369	84	\N	\N	D5170C00002	1154	1150	NEW	\N	05.04 Site Management	05.04.05 UNBLI_itoring Activity
7371	84	\N	\N	D5170C00002	1156	1150	NEW	\N	05.04 Site Management	05.04.08 Final_onitoring Report
7372	84	\N	\N	D5170C00002	1157	1150	NEW	\N	05.04 Site Management	05.04.09 Inv Notification-SUSAR
7373	84	\N	\N	D5170C00002	1158	1134	NEW	\N	05 Site Management	05.05 General
7375	84	\N	\N	D5170C00002	1160	1158	NEW	\N	05.05 General	05.05.02 Tracking Information
7376	84	\N	\N	D5170C00002	1161	1129	NEW	\N	2002272 Peyrin_iroulet, Laurent	06 IP and Trial Supplies
7378	84	\N	\N	D5170C00002	1163	1162	NEW	\N	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
7379	84	\N	\N	D5170C00002	1164	1162	NEW	\N	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
7381	84	\N	\N	D5170C00002	1166	1162	NEW	\N	06.01 IP Documentation	06.01.10 UNBLI_mentation Return
7382	84	\N	\N	D5170C00002	1167	1161	NEW	\N	06 IP and Trial Supplies	06.03 IP Alloc_on Documentation
7383	84	\N	\N	D5170C00002	1168	1167	NEW	\N	06.03 IP Alloc_on Documentation	06.03.01 UNBLI_on Documentation
7385	84	\N	\N	D5170C00002	1170	1169	NEW	\N	06.04 Storage	06.04.01 UNBLI_on Documentation
7386	84	\N	\N	D5170C00002	1171	1169	NEW	\N	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
7388	84	\N	\N	D5170C00002	1173	1172	NEW	\N	06.05 Non-IP Documentation	06.05.03 Non-I_tation of Return
7389	84	\N	\N	D5170C00002	1174	1044	NEW	\N	Site	2002273 Cadiot, Guilllaume
7391	84	\N	\N	D5170C00002	1176	1175	NEW	\N	05 Site Management	05.01 Site Selection
7392	84	\N	\N	D5170C00002	1177	1176	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
7394	84	\N	\N	D5170C00002	1179	1178	NEW	\N	05.05 General	05.05.01 Relev_unications-Email
7395	84	\N	\N	D5170C00002	1180	1044	NEW	\N	Site	2002275 Bouguen, Guillaume
7397	84	\N	\N	D5170C00002	1182	1181	NEW	\N	02 Central Trial Documents	02.04 General
7398	84	\N	\N	D5170C00002	1183	1182	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
7400	84	\N	\N	D5170C00002	1185	1180	NEW	\N	2002275 Bouguen, Guillaume	04 IRB-IEC and other Approvals
7401	84	\N	\N	D5170C00002	1186	1185	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
7403	84	\N	\N	D5170C00002	1188	1180	NEW	\N	2002275 Bouguen, Guillaume	05 Site Management
7404	84	\N	\N	D5170C00002	1189	1188	NEW	\N	05 Site Management	05.01 Site Selection
7405	84	\N	\N	D5170C00002	1190	1189	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
7407	84	\N	\N	D5170C00002	1192	1191	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
7408	84	\N	\N	D5170C00002	1193	1191	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
7410	84	\N	\N	D5170C00002	1195	1191	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
7411	84	\N	\N	D5170C00002	1196	1191	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
7413	84	\N	\N	D5170C00002	1198	1191	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
7414	84	\N	\N	D5170C00002	1199	1191	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Si_se Documentation
7415	84	\N	\N	D5170C00002	1200	1191	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
7417	84	\N	\N	D5170C00002	1202	1201	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
7418	84	\N	\N	D5170C00002	1203	1201	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
7420	84	\N	\N	D5170C00002	1205	1188	NEW	\N	05 Site Management	05.04 Site Management
7421	84	\N	\N	D5170C00002	1206	1205	NEW	\N	05.04 Site Management	05.04.01 Subject Log
7422	84	\N	\N	D5170C00002	1207	1205	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
7424	84	\N	\N	D5170C00002	1209	1205	NEW	\N	05.04 Site Management	05.04.05 UNBLI_itoring Activity
7425	84	\N	\N	D5170C00002	1210	1205	NEW	\N	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
7427	84	\N	\N	D5170C00002	1212	1205	NEW	\N	05.04 Site Management	05.04.09 Inv Notification-SUSAR
7428	84	\N	\N	D5170C00002	1213	1188	NEW	\N	05 Site Management	05.05 General
7429	84	\N	\N	D5170C00002	1214	1213	NEW	\N	05.05 General	05.05.01 Relev_unications-Email
7431	84	\N	\N	D5170C00002	1216	1213	NEW	\N	05.05 General	05.05.02 Tracking Information
7432	84	\N	\N	D5170C00002	1217	1180	NEW	\N	2002275 Bouguen, Guillaume	06 IP and Trial Supplies
7434	84	\N	\N	D5170C00002	1219	1218	NEW	\N	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
7435	84	\N	\N	D5170C00002	1220	1218	NEW	\N	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
7437	84	\N	\N	D5170C00002	1222	1218	NEW	\N	06.01 IP Documentation	06.01.11 UNBLI_e of Destruction
7438	84	\N	\N	D5170C00002	1223	1217	NEW	\N	06 IP and Trial Supplies	06.04 Storage
7439	84	\N	\N	D5170C00002	1224	1223	NEW	\N	06.04 Storage	06.04.01 Storage Condition Documentation
7441	84	\N	\N	D5170C00002	1226	1223	NEW	\N	06.04 Storage	06.04.03 Maintenance Logs
7442	84	\N	\N	D5170C00002	1227	1223	NEW	\N	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
7443	84	\N	\N	D5170C00002	1228	1044	NEW	\N	Site	2002276 Allez, Matthieu
7445	84	\N	\N	D5170C00002	1230	1229	NEW	\N	02 Central Trial Documents	02.04 General
7446	84	\N	\N	D5170C00002	1231	1230	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
7448	84	\N	\N	D5170C00002	1233	1232	NEW	\N	05 Site Management	05.01 Site Selection
15928	88	1617082365127:-1563427845	1617051274641:-906178156	D5170C00001	1618	1614	CREATE	2021-03-30 07:32:45.212	Site Set-up	Financial Disclosure Form
7451	84	\N	\N	D5170C00002	1236	1235	NEW	\N	05.05 General	05.05.01 Relev_unications-Email
7452	84	\N	\N	D5170C00002	1237	1044	NEW	\N	Site	2002277 Altwegg, Romain
7454	84	\N	\N	D5170C00002	1239	1238	NEW	\N	02 Central Trial Documents	02.04 General
7455	84	\N	\N	D5170C00002	1240	1239	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
7457	84	\N	\N	D5170C00002	1242	1237	NEW	\N	2002277 Altwegg, Romain	05 Site Management
7458	84	\N	\N	D5170C00002	1243	1242	NEW	\N	05 Site Management	05.01 Site Selection
7460	84	\N	\N	D5170C00002	1245	1242	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
7461	84	\N	\N	D5170C00002	1246	1245	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
7463	84	\N	\N	D5170C00002	1248	1245	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
7464	84	\N	\N	D5170C00002	1249	1245	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
7465	84	\N	\N	D5170C00002	1250	1245	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
7467	84	\N	\N	D5170C00002	1252	1245	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
7468	84	\N	\N	D5170C00002	1253	1245	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
7469	84	\N	\N	D5170C00002	1254	1242	NEW	\N	05 Site Management	05.03 Site Initiation
7471	84	\N	\N	D5170C00002	1256	1254	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
7472	84	\N	\N	D5170C00002	1257	1242	NEW	\N	05 Site Management	05.04 Site Management
7474	84	\N	\N	D5170C00002	1259	1257	NEW	\N	05.04 Site Management	05.04.09 Inv Notification-SUSAR
7475	84	\N	\N	D5170C00002	1260	1242	NEW	\N	05 Site Management	05.05 General
7476	84	\N	\N	D5170C00002	1261	1260	NEW	\N	05.05 General	05.05.01 Relev_unications-Email
7478	84	\N	\N	D5170C00002	1263	1262	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
7479	84	\N	\N	D5170C00002	1264	1263	NEW	\N	06.01 IP Documentation	06.01.02 UNBLINDED IP Instructions for Handling
7480	84	\N	\N	D5170C00002	1265	1044	NEW	\N	Site	2002278 Roblin, Xavier
7482	84	\N	\N	D5170C00002	1267	1266	NEW	\N	02 Central Trial Documents	02.04 General
7484	84	\N	\N	D5170C00002	1269	1267	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
7485	84	\N	\N	D5170C00002	1270	1265	NEW	\N	2002278 Roblin, Xavier	05 Site Management
7487	84	\N	\N	D5170C00002	1272	1271	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
7488	84	\N	\N	D5170C00002	1273	1271	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
7490	84	\N	\N	D5170C00002	1275	1274	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
7491	84	\N	\N	D5170C00002	1276	1274	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
7493	84	\N	\N	D5170C00002	1278	1274	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
7494	84	\N	\N	D5170C00002	1279	1274	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
7495	84	\N	\N	D5170C00002	1280	1274	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
7497	84	\N	\N	D5170C00002	1282	1274	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
7498	84	\N	\N	D5170C00002	1283	1274	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
7499	84	\N	\N	D5170C00002	1284	1274	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
7501	84	\N	\N	D5170C00002	1286	1285	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
7502	84	\N	\N	D5170C00002	1287	1285	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
7504	84	\N	\N	D5170C00002	1289	1270	NEW	\N	05 Site Management	05.04 Site Management
7505	84	\N	\N	D5170C00002	1290	1289	NEW	\N	05.04 Site Management	05.04.01 Subject Log
7507	84	\N	\N	D5170C00002	1292	1289	NEW	\N	05.04 Site Management	05.04.03 UNBLI_ing Visit Report
7508	84	\N	\N	D5170C00002	1293	1289	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
8347	84	\N	\N	D5170C00002	2132	2126	NEW	\N	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
7509	84	\N	\N	D5170C00002	1294	1289	NEW	\N	05.04 Site Management	05.04.04 Visit Log
7510	84	\N	\N	D5170C00002	1295	1289	NEW	\N	05.04 Site Management	05.04.05 UNBLI_itoring Activity
7511	84	\N	\N	D5170C00002	1296	1289	NEW	\N	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
7512	84	\N	\N	D5170C00002	1297	1289	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
7514	84	\N	\N	D5170C00002	1299	1270	NEW	\N	05 Site Management	05.05 General
7515	84	\N	\N	D5170C00002	1300	1299	NEW	\N	05.05 General	05.05.02 Tracking Information
7516	84	\N	\N	D5170C00002	1301	1265	NEW	\N	2002278 Roblin, Xavier	06 IP and Trial Supplies
7518	84	\N	\N	D5170C00002	1303	1302	NEW	\N	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
7519	84	\N	\N	D5170C00002	1304	1302	NEW	\N	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
7521	84	\N	\N	D5170C00002	1306	1302	NEW	\N	06.01 IP Documentation	06.01.11 Certificate of Destruction
7522	84	\N	\N	D5170C00002	1307	1302	NEW	\N	06.01 IP Documentation	06.01.11 UNBLI_e of Destruction
7523	84	\N	\N	D5170C00002	1308	1301	NEW	\N	06 IP and Trial Supplies	06.04 Storage
7525	84	\N	\N	D5170C00002	1310	1308	NEW	\N	06.04 Storage	06.04.02 UNBLINDED Storage Condition Excursion Documentation
7526	84	\N	\N	D5170C00002	1311	1308	NEW	\N	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
7528	84	\N	\N	D5170C00002	1313	1312	NEW	\N	06.07 General	06.07.01 UNBLI_roduct-Documents
7529	84	\N	\N	D5170C00002	1314	1044	NEW	\N	Site	TBD-1-1Q4YZAR Amil, Morgane
7531	84	\N	\N	D5170C00002	1316	1315	NEW	\N	05 Site Management	05.01 Site Selection
7532	84	\N	\N	D5170C00002	1317	1316	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
7534	84	\N	\N	D5170C00002	1319	1318	NEW	\N	TBD-1-1Q4YZCR Bonaz, Bruno	05 Site Management
7535	84	\N	\N	D5170C00002	1320	1319	NEW	\N	05 Site Management	05.01 Site Selection
7537	84	\N	\N	D5170C00002	1322	1044	NEW	\N	Site	TBD-1-1Q4YZDR Hebuterne, Xavier
7538	84	\N	\N	D5170C00002	1323	1322	NEW	\N	TBD-1-1Q4YZDR Hebuterne, Xavier	05 Site Management
7539	84	\N	\N	D5170C00002	1324	1323	NEW	\N	05 Site Management	05.01 Site Selection
7541	84	\N	\N	D5170C00002	1326	1044	NEW	\N	Site	TBD-1-1Q4YZG1 Bourreille, Arnaud
7542	84	\N	\N	D5170C00002	1327	1326	NEW	\N	TBD-1-1Q4YZG1 Bourreille, Arnaud	05 Site Management
7544	84	\N	\N	D5170C00002	1329	1328	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
7545	84	\N	\N	D5170C00002	1330	1044	NEW	\N	Site	TBD-1-1Q4ZNLB Beaugerie, Laurent
7547	84	\N	\N	D5170C00002	1332	1331	NEW	\N	05 Site Management	05.01 Site Selection
7548	84	\N	\N	D5170C00002	1333	1332	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
7549	84	\N	\N	D5170C00002	1334	4	NEW	\N	contents	GERMANY
7551	84	\N	\N	D5170C00002	1336	1335	NEW	\N	Site	2002076 Schmelz, Renate
7553	84	\N	\N	D5170C00002	1338	1337	NEW	\N	01 Trial Management	01.01 Trial Oversight
7555	84	\N	\N	D5170C00002	1340	1336	NEW	\N	2002076 Schmelz, Renate	02 Central Trial Documents
7556	84	\N	\N	D5170C00002	1341	1340	NEW	\N	02 Central Trial Documents	02.04 General
7557	84	\N	\N	D5170C00002	1342	1341	NEW	\N	02.04 General	02.04.01 Relev_ations-Documents
7559	84	\N	\N	D5170C00002	1344	1341	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
7560	84	\N	\N	D5170C00002	1345	1336	NEW	\N	2002076 Schmelz, Renate	03 Regulatory
7562	84	\N	\N	D5170C00002	1347	1346	NEW	\N	03.01 Trial Approval	03.01.01 Submission
7563	84	\N	\N	D5170C00002	1348	1345	NEW	\N	03 Regulatory	03.03 Trial Status Reporting
7565	84	\N	\N	D5170C00002	1350	1336	NEW	\N	2002076 Schmelz, Renate	04 IRB-IEC and other Approvals
7566	84	\N	\N	D5170C00002	1351	1350	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
7568	84	\N	\N	D5170C00002	1353	1351	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
7569	84	\N	\N	D5170C00002	1354	1350	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
7572	84	\N	\N	D5170C00002	1357	1356	NEW	\N	05 Site Management	05.01 Site Selection
7573	84	\N	\N	D5170C00002	1358	1357	NEW	\N	05.01 Site Selection	05.01.01 Site Contact Details
7575	84	\N	\N	D5170C00002	1360	1357	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
7576	84	\N	\N	D5170C00002	1361	1357	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
7578	84	\N	\N	D5170C00002	1363	1362	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
7579	84	\N	\N	D5170C00002	1364	1362	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
7581	84	\N	\N	D5170C00002	1366	1362	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
7582	84	\N	\N	D5170C00002	1367	1362	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
7583	84	\N	\N	D5170C00002	1368	1362	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Site Qualification
7585	84	\N	\N	D5170C00002	1370	1362	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Inves_latory Agreement
7586	84	\N	\N	D5170C00002	1371	1362	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
7588	84	\N	\N	D5170C00002	1373	1362	NEW	\N	05.02 Site Set-up Documentation	05.02.14 Other Financial Agreement
7589	84	\N	\N	D5170C00002	1374	1362	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
7590	84	\N	\N	D5170C00002	1375	1362	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
7591	84	\N	\N	D5170C00002	1376	1356	NEW	\N	05 Site Management	05.03 Site Initiation
7593	84	\N	\N	D5170C00002	1378	1376	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
7594	84	\N	\N	D5170C00002	1379	1376	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
7596	84	\N	\N	D5170C00002	1381	1380	NEW	\N	05.04 Site Management	05.04.01 Subject Log
7597	84	\N	\N	D5170C00002	1382	1380	NEW	\N	05.04 Site Management	05.04.04 Visit Log
7599	84	\N	\N	D5170C00002	1384	1356	NEW	\N	05 Site Management	05.05 General
7600	84	\N	\N	D5170C00002	1385	1384	NEW	\N	05.05 General	05.05.01 Relev_unications-Email
7601	84	\N	\N	D5170C00002	1386	1384	NEW	\N	05.05 General	05.05.02 Tracking Information
7603	84	\N	\N	D5170C00002	1388	1387	NEW	\N	06 IP and Trial Supplies	06.04 Storage
7604	84	\N	\N	D5170C00002	1389	1388	NEW	\N	06.04 Storage	06.04.03 Maintenance Logs
7606	84	\N	\N	D5170C00002	1391	1390	NEW	\N	08 Centralized Testing	08.02 Sample Documentation
7607	84	\N	\N	D5170C00002	1392	1391	NEW	\N	08.02 Sample Documentation	08.02.03 Sampl_ge Condition Log
7608	84	\N	\N	D5170C00002	1393	1335	NEW	\N	Site	2002077 Ebert, Mathias
7610	84	\N	\N	D5170C00002	1395	1394	NEW	\N	01 Trial Management	01.01 Trial Oversight
7611	84	\N	\N	D5170C00002	1396	1395	NEW	\N	01.01 Trial Oversight	01.01.06 Recruitment Plan
7613	84	\N	\N	D5170C00002	1398	1397	NEW	\N	02 Central Trial Documents	02.04 General
7614	84	\N	\N	D5170C00002	1399	1398	NEW	\N	02.04 General	02.04.01 Relev_ations-Documents
7616	84	\N	\N	D5170C00002	1401	1398	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
7617	84	\N	\N	D5170C00002	1402	1393	NEW	\N	2002077 Ebert, Mathias	03 Regulatory
7619	84	\N	\N	D5170C00002	1404	1403	NEW	\N	03.01 Trial Approval	03.01.01 Submission
7620	84	\N	\N	D5170C00002	1405	1402	NEW	\N	03 Regulatory	03.03 Trial Status Reporting
7622	84	\N	\N	D5170C00002	1407	1393	NEW	\N	2002077 Ebert, Mathias	04 IRB-IEC and other Approvals
7623	84	\N	\N	D5170C00002	1408	1407	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
7625	84	\N	\N	D5170C00002	1410	1408	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
7626	84	\N	\N	D5170C00002	1411	1393	NEW	\N	2002077 Ebert, Mathias	05 Site Management
7627	84	\N	\N	D5170C00002	1412	1411	NEW	\N	05 Site Management	05.01 Site Selection
8351	84	\N	\N	D5170C00002	2136	2135	NEW	\N	05.05 General	05.05.02 Tracking Information
7630	84	\N	\N	D5170C00002	1415	1412	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
7631	84	\N	\N	D5170C00002	1416	1412	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
15931	88	1617082366887:-1545877261	1617051274641:-906178156	D5170C00001	1621	1614	CREATE	2021-03-30 07:32:46.975	Site Set-up	Principal Investigator Curriculum Vitae
7633	84	\N	\N	D5170C00002	1418	1417	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
7634	84	\N	\N	D5170C00002	1419	1417	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
7636	84	\N	\N	D5170C00002	1421	1417	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
7637	84	\N	\N	D5170C00002	1422	1417	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
7638	84	\N	\N	D5170C00002	1423	1417	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Site Qualification
7640	84	\N	\N	D5170C00002	1425	1417	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Inves_latory Agreement
7641	84	\N	\N	D5170C00002	1426	1417	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
7643	84	\N	\N	D5170C00002	1428	1417	NEW	\N	05.02 Site Set-up Documentation	05.02.14 Other Financial Agreement
7644	84	\N	\N	D5170C00002	1429	1417	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
7645	84	\N	\N	D5170C00002	1430	1417	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
7647	84	\N	\N	D5170C00002	1432	1431	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
7648	84	\N	\N	D5170C00002	1433	1431	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
7650	84	\N	\N	D5170C00002	1435	1411	NEW	\N	05 Site Management	05.04 Site Management
7651	84	\N	\N	D5170C00002	1436	1435	NEW	\N	05.04 Site Management	05.04.01 Subject Log
7652	84	\N	\N	D5170C00002	1437	1435	NEW	\N	05.04 Site Management	05.04.04 Visit Log
7654	84	\N	\N	D5170C00002	1439	1435	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
7655	84	\N	\N	D5170C00002	1440	1411	NEW	\N	05 Site Management	05.05 General
7657	84	\N	\N	D5170C00002	1442	1440	NEW	\N	05.05 General	05.05.02 Tracking Information
7658	84	\N	\N	D5170C00002	1443	1393	NEW	\N	2002077 Ebert, Mathias	06 IP and Trial Supplies
7659	84	\N	\N	D5170C00002	1444	1443	NEW	\N	06 IP and Trial Supplies	06.07 General
7662	84	\N	\N	D5170C00002	1447	1446	NEW	\N	2002079 Sturm, Andreas	01 Trial Management
7664	84	\N	\N	D5170C00002	1449	1448	NEW	\N	01.01 Trial Oversight	01.01.06 Recruitment Plan
7665	84	\N	\N	D5170C00002	1450	1446	NEW	\N	2002079 Sturm, Andreas	02 Central Trial Documents
7667	84	\N	\N	D5170C00002	1452	1451	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
7668	84	\N	\N	D5170C00002	1453	1446	NEW	\N	2002079 Sturm, Andreas	03 Regulatory
7670	84	\N	\N	D5170C00002	1455	1454	NEW	\N	03.01 Trial Approval	03.01.01 Submission
7671	84	\N	\N	D5170C00002	1456	1453	NEW	\N	03 Regulatory	03.03 Trial Status Reporting
7673	84	\N	\N	D5170C00002	1458	1446	NEW	\N	2002079 Sturm, Andreas	04 IRB-IEC and other Approvals
7674	84	\N	\N	D5170C00002	1459	1458	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
7676	84	\N	\N	D5170C00002	1461	1459	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
7677	84	\N	\N	D5170C00002	1462	1458	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
7679	84	\N	\N	D5170C00002	1464	1446	NEW	\N	2002079 Sturm, Andreas	05 Site Management
7680	84	\N	\N	D5170C00002	1465	1464	NEW	\N	05 Site Management	05.01 Site Selection
7681	84	\N	\N	D5170C00002	1466	1465	NEW	\N	05.01 Site Selection	05.01.01 Site Contact Details
7683	84	\N	\N	D5170C00002	1468	1465	NEW	\N	05.01 Site Selection	05.01.03 Feasi_ty Documentation
7684	84	\N	\N	D5170C00002	1469	1465	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
7686	84	\N	\N	D5170C00002	1471	1470	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
7687	84	\N	\N	D5170C00002	1472	1470	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
7692	84	\N	\N	D5170C00002	1477	1470	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
7694	84	\N	\N	D5170C00002	1479	1470	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
7695	84	\N	\N	D5170C00002	1480	1470	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
7696	84	\N	\N	D5170C00002	1481	1470	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
7698	84	\N	\N	D5170C00002	1483	1464	NEW	\N	05 Site Management	05.03 Site Initiation
7699	84	\N	\N	D5170C00002	1484	1483	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
7701	84	\N	\N	D5170C00002	1486	1483	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
7702	84	\N	\N	D5170C00002	1487	1464	NEW	\N	05 Site Management	05.04 Site Management
7703	84	\N	\N	D5170C00002	1488	1487	NEW	\N	05.04 Site Management	05.04.01 Subject Log
7705	84	\N	\N	D5170C00002	1490	1487	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
7706	84	\N	\N	D5170C00002	1491	1464	NEW	\N	05 Site Management	05.05 General
7708	84	\N	\N	D5170C00002	1493	1491	NEW	\N	05.05 General	05.05.01 Relev_unications-Email
7709	84	\N	\N	D5170C00002	1494	1491	NEW	\N	05.05 General	05.05.02 Tracking Information
7711	84	\N	\N	D5170C00002	1496	1495	NEW	\N	06 IP and Trial Supplies	06.04 Storage
7712	84	\N	\N	D5170C00002	1497	1496	NEW	\N	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
7714	84	\N	\N	D5170C00002	1499	1498	NEW	\N	06.05 Non-IP Documentation	06.05.02 Non-I_tion of Shipment
7715	84	\N	\N	D5170C00002	1500	1446	NEW	\N	2002079 Sturm, Andreas	08 Centralized Testing
7717	84	\N	\N	D5170C00002	1502	1501	NEW	\N	08.02 Sample Documentation	08.02.03 Sampl_ge Condition Log
7718	84	\N	\N	D5170C00002	1503	1335	NEW	\N	Site	2002080 Meyer, Ralf
7720	84	\N	\N	D5170C00002	1505	1504	NEW	\N	01 Trial Management	01.01 Trial Oversight
7721	84	\N	\N	D5170C00002	1506	1505	NEW	\N	01.01 Trial Oversight	01.01.06 Recruitment Plan
7723	84	\N	\N	D5170C00002	1508	1507	NEW	\N	02 Central Trial Documents	02.04 General
7724	84	\N	\N	D5170C00002	1509	1508	NEW	\N	02.04 General	02.04.01 Relev_ations-Documents
7726	84	\N	\N	D5170C00002	1511	1503	NEW	\N	2002080 Meyer, Ralf	03 Regulatory
15000	88	1617050387773:-339061386	1617050387132:-222193713	D5170C00001	690	689	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Central Trial Documents	General
7727	84	\N	\N	D5170C00002	1512	1511	NEW	\N	03 Regulatory	03.01 Trial Approval
7729	84	\N	\N	D5170C00002	1514	1511	NEW	\N	03 Regulatory	03.03 Trial Status Reporting
7730	84	\N	\N	D5170C00002	1515	1514	NEW	\N	03.03 Trial Status Reporting	03.03.03 Notification of Trial Termination
7732	84	\N	\N	D5170C00002	1517	1516	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
7733	84	\N	\N	D5170C00002	1518	1517	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
7735	84	\N	\N	D5170C00002	1520	1516	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
7736	84	\N	\N	D5170C00002	1521	1520	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
7738	84	\N	\N	D5170C00002	1523	1522	NEW	\N	05 Site Management	05.01 Site Selection
7739	84	\N	\N	D5170C00002	1524	1523	NEW	\N	05.01 Site Selection	05.01.01 Site Contact Details
7741	84	\N	\N	D5170C00002	1526	1523	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
7742	84	\N	\N	D5170C00002	1527	1523	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
7744	84	\N	\N	D5170C00002	1529	1528	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
7745	84	\N	\N	D5170C00002	1530	1528	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
7747	84	\N	\N	D5170C00002	1532	1528	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
7748	84	\N	\N	D5170C00002	1533	1528	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
7749	84	\N	\N	D5170C00002	1534	1528	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
7751	84	\N	\N	D5170C00002	1536	1528	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
7752	84	\N	\N	D5170C00002	1537	1528	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
8353	84	\N	\N	D5170C00002	2138	2137	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
7755	84	\N	\N	D5170C00002	1540	1522	NEW	\N	05 Site Management	05.03 Site Initiation
7756	84	\N	\N	D5170C00002	1541	1540	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
7758	84	\N	\N	D5170C00002	1543	1540	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
7759	84	\N	\N	D5170C00002	1544	1522	NEW	\N	05 Site Management	05.04 Site Management
7760	84	\N	\N	D5170C00002	1545	1544	NEW	\N	05.04 Site Management	05.04.01 Subject Log
7762	84	\N	\N	D5170C00002	1547	1544	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
7763	84	\N	\N	D5170C00002	1548	1544	NEW	\N	05.04 Site Management	05.04.04 Visit Log
7765	84	\N	\N	D5170C00002	1550	1544	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
7766	84	\N	\N	D5170C00002	1551	1544	NEW	\N	05.04 Site Management	05.04.09 Inv Notification Safety Info-Dr-HCP Letter
7767	84	\N	\N	D5170C00002	1552	1522	NEW	\N	05 Site Management	05.05 General
7769	84	\N	\N	D5170C00002	1554	1552	NEW	\N	05.05 General	05.05.02 Tracking Information
7771	84	\N	\N	D5170C00002	1556	1555	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
7772	84	\N	\N	D5170C00002	1557	1556	NEW	\N	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
7774	84	\N	\N	D5170C00002	1559	1556	NEW	\N	06.01 IP Documentation	06.01.05 UNBLINDED Accountability Documentation
7775	84	\N	\N	D5170C00002	1560	1556	NEW	\N	06.01 IP Documentation	06.01.11 UNBLI_e of Destruction
7776	84	\N	\N	D5170C00002	1561	1555	NEW	\N	06 IP and Trial Supplies	06.04 Storage
7778	84	\N	\N	D5170C00002	1563	1561	NEW	\N	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
7779	84	\N	\N	D5170C00002	1564	1503	NEW	\N	2002080 Meyer, Ralf	08 Centralized Testing
7781	84	\N	\N	D5170C00002	1566	1565	NEW	\N	08.01 Facility Documentation	08.01.04 Normal Ranges and Alert Values
7782	84	\N	\N	D5170C00002	1567	1335	NEW	\N	Site	2002081 Benten, Daniel
7784	84	\N	\N	D5170C00002	1569	1568	NEW	\N	03 Regulatory	03.01 Trial Approval
7785	84	\N	\N	D5170C00002	1570	1569	NEW	\N	03.01 Trial Approval	03.01.01 Submission
7787	84	\N	\N	D5170C00002	1572	1571	NEW	\N	03.03 Trial Status Reporting	03.03.03 Notification of Trial Termination
7789	84	\N	\N	D5170C00002	1574	1573	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
7790	84	\N	\N	D5170C00002	1575	1574	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
7791	84	\N	\N	D5170C00002	1576	1574	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
7793	84	\N	\N	D5170C00002	1578	1577	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
7794	84	\N	\N	D5170C00002	1579	1567	NEW	\N	2002081 Benten, Daniel	05 Site Management
7796	84	\N	\N	D5170C00002	1581	1580	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
7797	84	\N	\N	D5170C00002	1582	1579	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
7799	84	\N	\N	D5170C00002	1584	1582	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
7800	84	\N	\N	D5170C00002	1585	1582	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
7802	84	\N	\N	D5170C00002	1587	1582	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
7803	84	\N	\N	D5170C00002	1588	1579	NEW	\N	05 Site Management	05.03 Site Initiation
7805	84	\N	\N	D5170C00002	1590	1588	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
7806	84	\N	\N	D5170C00002	1591	1588	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
7807	84	\N	\N	D5170C00002	1592	1579	NEW	\N	05 Site Management	05.04 Site Management
7809	84	\N	\N	D5170C00002	1594	1592	NEW	\N	05.04 Site Management	05.04.04 Visit Log
7810	84	\N	\N	D5170C00002	1595	1592	NEW	\N	05.04 Site Management	05.04.09 Inv N_fo-Dr-HCP Letter
7812	84	\N	\N	D5170C00002	1597	1596	NEW	\N	05.05 General	05.05.01 Relev_unications-Email
7813	84	\N	\N	D5170C00002	1598	1335	NEW	\N	Site	2002082 Hasselblatt, Peter
7815	84	\N	\N	D5170C00002	1600	1599	NEW	\N	01 Trial Management	01.01 Trial Oversight
7816	84	\N	\N	D5170C00002	1601	1600	NEW	\N	01.01 Trial Oversight	01.01.06 Recruitment Plan
7821	84	\N	\N	D5170C00002	1606	1603	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
7822	84	\N	\N	D5170C00002	1607	1598	NEW	\N	2002082 Hasselblatt, Peter	03 Regulatory
7823	84	\N	\N	D5170C00002	1608	1607	NEW	\N	03 Regulatory	03.01 Trial Approval
7825	84	\N	\N	D5170C00002	1610	1607	NEW	\N	03 Regulatory	03.03 Trial Status Reporting
7827	84	\N	\N	D5170C00002	1612	1598	NEW	\N	2002082 Hasselblatt, Peter	04 IRB-IEC and other Approvals
7828	84	\N	\N	D5170C00002	1613	1612	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
7830	84	\N	\N	D5170C00002	1615	1613	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
7831	84	\N	\N	D5170C00002	1616	1612	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
7832	84	\N	\N	D5170C00002	1617	1616	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
7834	84	\N	\N	D5170C00002	1619	1618	NEW	\N	05 Site Management	05.01 Site Selection
7835	84	\N	\N	D5170C00002	1620	1619	NEW	\N	05.01 Site Selection	05.01.01 Site Contact Details
7837	84	\N	\N	D5170C00002	1622	1619	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
7838	84	\N	\N	D5170C00002	1623	1619	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
7840	84	\N	\N	D5170C00002	1625	1624	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Accep_tigator Brochure
7841	84	\N	\N	D5170C00002	1626	1624	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
7843	84	\N	\N	D5170C00002	1628	1624	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
7844	84	\N	\N	D5170C00002	1629	1624	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
7845	84	\N	\N	D5170C00002	1630	1624	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Site Qualification
7847	84	\N	\N	D5170C00002	1632	1624	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Inves_latory Agreement
7848	84	\N	\N	D5170C00002	1633	1624	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
7850	84	\N	\N	D5170C00002	1635	1624	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Si_se Documentation
7851	84	\N	\N	D5170C00002	1636	1624	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
7852	84	\N	\N	D5170C00002	1637	1618	NEW	\N	05 Site Management	05.03 Site Initiation
7854	84	\N	\N	D5170C00002	1639	1637	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
7855	84	\N	\N	D5170C00002	1640	1637	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
7857	84	\N	\N	D5170C00002	1642	1641	NEW	\N	05.04 Site Management	05.04.04 Visit Log
7858	84	\N	\N	D5170C00002	1643	1641	NEW	\N	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
7860	84	\N	\N	D5170C00002	1645	1618	NEW	\N	05 Site Management	05.05 General
7861	84	\N	\N	D5170C00002	1646	1645	NEW	\N	05.05 General	05.05.01 Relev_unications-Email
7862	84	\N	\N	D5170C00002	1647	1645	NEW	\N	05.05 General	05.05.02 Tracking Information
7864	84	\N	\N	D5170C00002	1649	1648	NEW	\N	2002083 Brandt, Wolfgang	01 Trial Management
7866	84	\N	\N	D5170C00002	1651	1650	NEW	\N	01.01 Trial Oversight	01.01.06 Recruitment Plan
7867	84	\N	\N	D5170C00002	1652	1648	NEW	\N	2002083 Brandt, Wolfgang	02 Central Trial Documents
7868	84	\N	\N	D5170C00002	1653	1652	NEW	\N	02 Central Trial Documents	02.04 General
7870	84	\N	\N	D5170C00002	1655	1653	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
7871	84	\N	\N	D5170C00002	1656	1648	NEW	\N	2002083 Brandt, Wolfgang	03 Regulatory
7873	84	\N	\N	D5170C00002	1658	1657	NEW	\N	03.01 Trial Approval	03.01.01 Submission
7875	84	\N	\N	D5170C00002	1660	1659	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
7876	84	\N	\N	D5170C00002	1661	1660	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
7878	84	\N	\N	D5170C00002	1663	1648	NEW	\N	2002083 Brandt, Wolfgang	05 Site Management
7879	84	\N	\N	D5170C00002	1664	1663	NEW	\N	05 Site Management	05.01 Site Selection
7880	84	\N	\N	D5170C00002	1665	1664	NEW	\N	05.01 Site Selection	05.01.01 Site Contact Details
8357	84	\N	\N	D5170C00002	2142	2137	NEW	\N	06 IP and Trial Supplies	06.04 Storage
7883	84	\N	\N	D5170C00002	1668	1664	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
7884	84	\N	\N	D5170C00002	1669	1663	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
7886	84	\N	\N	D5170C00002	1671	1669	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
7887	84	\N	\N	D5170C00002	1672	1669	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
7888	84	\N	\N	D5170C00002	1673	1669	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
7890	84	\N	\N	D5170C00002	1675	1669	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Site Qualification
7891	84	\N	\N	D5170C00002	1676	1669	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
7893	84	\N	\N	D5170C00002	1678	1669	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
7894	84	\N	\N	D5170C00002	1679	1669	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
7895	84	\N	\N	D5170C00002	1680	1669	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
7897	84	\N	\N	D5170C00002	1682	1663	NEW	\N	05 Site Management	05.03 Site Initiation
7898	84	\N	\N	D5170C00002	1683	1682	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
7900	84	\N	\N	D5170C00002	1685	1682	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
7901	84	\N	\N	D5170C00002	1686	1663	NEW	\N	05 Site Management	05.04 Site Management
7902	84	\N	\N	D5170C00002	1687	1686	NEW	\N	05.04 Site Management	05.04.01 Subject Log
7904	84	\N	\N	D5170C00002	1689	1686	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
7905	84	\N	\N	D5170C00002	1690	1663	NEW	\N	05 Site Management	05.05 General
7907	84	\N	\N	D5170C00002	1692	1690	NEW	\N	05.05 General	05.05.01 Relev_unications-Email
7908	84	\N	\N	D5170C00002	1693	1690	NEW	\N	05.05 General	05.05.02 Tracking Information
7910	84	\N	\N	D5170C00002	1695	1694	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
7911	84	\N	\N	D5170C00002	1696	1695	NEW	\N	06.01 IP Documentation	06.01.05 Accountability Documentation
16424	88	1617051685011:500343460	1617051683273:-567170364	D5170C00001	2114	2111	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Central Trial Documents	Product and Trial Documentation
16430	88	1617082613714:1727933738	1617051694262:-2058771409	D5170C00001	2120	2119	CREATE	2021-03-30 07:36:53.897	General	Tracking Information
7913	84	\N	\N	D5170C00002	1698	1697	NEW	\N	06.04 Storage	06.04.01 Storage Condition Documentation
7914	84	\N	\N	D5170C00002	1699	1335	NEW	\N	Site	2002279 Seidler, Ursula
7916	84	\N	\N	D5170C00002	1701	1700	NEW	\N	01 Trial Management	01.01 Trial Oversight
7917	84	\N	\N	D5170C00002	1702	1701	NEW	\N	01.01 Trial Oversight	01.01.06 Recruitment Plan
7919	84	\N	\N	D5170C00002	1704	1703	NEW	\N	02 Central Trial Documents	02.04 General
7920	84	\N	\N	D5170C00002	1705	1704	NEW	\N	02.04 General	02.04.01 Relev_ations-Documents
7922	84	\N	\N	D5170C00002	1707	1704	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
7923	84	\N	\N	D5170C00002	1708	1699	NEW	\N	2002279 Seidler, Ursula	03 Regulatory
7925	84	\N	\N	D5170C00002	1710	1709	NEW	\N	03.01 Trial Approval	03.01.01 Submission
7926	84	\N	\N	D5170C00002	1711	1708	NEW	\N	03 Regulatory	03.03 Trial Status Reporting
7928	84	\N	\N	D5170C00002	1713	1699	NEW	\N	2002279 Seidler, Ursula	04 IRB-IEC and other Approvals
7929	84	\N	\N	D5170C00002	1714	1713	NEW	\N	04 IRB-IEC and other Approvals	04.02 Other Committees
7931	84	\N	\N	D5170C00002	1716	1713	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
7932	84	\N	\N	D5170C00002	1717	1716	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
7934	84	\N	\N	D5170C00002	1719	1718	NEW	\N	05 Site Management	05.01 Site Selection
7935	84	\N	\N	D5170C00002	1720	1719	NEW	\N	05.01 Site Selection	05.01.01 Site Contact Details
7937	84	\N	\N	D5170C00002	1722	1719	NEW	\N	05.01 Site Selection	05.01.03 Feasi_ty Documentation
7938	84	\N	\N	D5170C00002	1723	1719	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
7940	84	\N	\N	D5170C00002	1725	1724	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
7941	84	\N	\N	D5170C00002	1726	1724	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
7943	84	\N	\N	D5170C00002	1728	1724	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
7944	84	\N	\N	D5170C00002	1729	1724	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
8360	84	\N	\N	D5170C00002	2145	2142	NEW	\N	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
7946	84	\N	\N	D5170C00002	1731	1724	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
7948	84	\N	\N	D5170C00002	1733	1724	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
7949	84	\N	\N	D5170C00002	1734	1724	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
7951	84	\N	\N	D5170C00002	1736	1724	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
7952	84	\N	\N	D5170C00002	1737	1718	NEW	\N	05 Site Management	05.03 Site Initiation
7953	84	\N	\N	D5170C00002	1738	1737	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
7955	84	\N	\N	D5170C00002	1740	1737	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
7956	84	\N	\N	D5170C00002	1741	1718	NEW	\N	05 Site Management	05.04 Site Management
7958	84	\N	\N	D5170C00002	1743	1741	NEW	\N	05.04 Site Management	05.04.03 Monitoring Visit Report
7959	84	\N	\N	D5170C00002	1744	1741	NEW	\N	05.04 Site Management	05.04.03 UNBLINDED Monitoring Visit Report
7961	84	\N	\N	D5170C00002	1746	1741	NEW	\N	05.04 Site Management	05.04.04 Visit Log
7962	84	\N	\N	D5170C00002	1747	1741	NEW	\N	05.04 Site Management	05.04.05 UNBLI_itoring Activity
7964	84	\N	\N	D5170C00002	1749	1741	NEW	\N	05.04 Site Management	05.04.06 UNBLINDED Protocol Deviations and Waivers
7965	84	\N	\N	D5170C00002	1750	1741	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
7966	84	\N	\N	D5170C00002	1751	1741	NEW	\N	05.04 Site Management	05.04.09 Inv N_fo-Dr-HCP Letter
7968	84	\N	\N	D5170C00002	1753	1752	NEW	\N	05.05 General	05.05.01 Relev_unications-Email
7969	84	\N	\N	D5170C00002	1754	1752	NEW	\N	05.05 General	05.05.02 Tracking Information
7971	84	\N	\N	D5170C00002	1756	1755	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
7972	84	\N	\N	D5170C00002	1757	1756	NEW	\N	06.01 IP Documentation	06.01.02 IP In_ons for Handling
7974	84	\N	\N	D5170C00002	1759	1756	NEW	\N	06.01 IP Documentation	06.01.04 IP Shipment Documentation
7975	84	\N	\N	D5170C00002	1760	1756	NEW	\N	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
7977	84	\N	\N	D5170C00002	1762	1756	NEW	\N	06.01 IP Documentation	06.01.11 UNBLI_e of Destruction
7978	84	\N	\N	D5170C00002	1763	1755	NEW	\N	06 IP and Trial Supplies	06.04 Storage
7979	84	\N	\N	D5170C00002	1764	1763	NEW	\N	06.04 Storage	06.04.01 UNBLI_on Documentation
7981	84	\N	\N	D5170C00002	1766	1763	NEW	\N	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
7983	84	\N	\N	D5170C00002	1768	1767	NEW	\N	06.05 Non-IP Documentation	06.05.02 Non-I_tion of Shipment
7984	84	\N	\N	D5170C00002	1769	1335	NEW	\N	Site	2002280 Siegmund, Britta
7986	84	\N	\N	D5170C00002	1771	1770	NEW	\N	01 Trial Management	01.01 Trial Oversight
7987	84	\N	\N	D5170C00002	1772	1771	NEW	\N	01.01 Trial Oversight	01.01.06 Recruitment Plan
7989	84	\N	\N	D5170C00002	1774	1773	NEW	\N	02 Central Trial Documents	02.04 General
7990	84	\N	\N	D5170C00002	1775	1774	NEW	\N	02.04 General	02.04.01 Relev_ations-Documents
7991	84	\N	\N	D5170C00002	1776	1774	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
7993	84	\N	\N	D5170C00002	1778	1769	NEW	\N	2002280 Siegmund, Britta	03 Regulatory
7994	84	\N	\N	D5170C00002	1779	1778	NEW	\N	03 Regulatory	03.01 Trial Approval
7996	84	\N	\N	D5170C00002	1781	1769	NEW	\N	2002280 Siegmund, Britta	04 IRB-IEC and other Approvals
7998	84	\N	\N	D5170C00002	1783	1782	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
7999	84	\N	\N	D5170C00002	1784	1769	NEW	\N	2002280 Siegmund, Britta	05 Site Management
8000	84	\N	\N	D5170C00002	1785	1784	NEW	\N	05 Site Management	05.01 Site Selection
8002	84	\N	\N	D5170C00002	1787	1785	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
8003	84	\N	\N	D5170C00002	1788	1785	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
8005	84	\N	\N	D5170C00002	1790	1784	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
8006	84	\N	\N	D5170C00002	1791	1790	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
8008	84	\N	\N	D5170C00002	1793	1790	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
8362	84	\N	\N	D5170C00002	2147	2146	NEW	\N	06.05 Non-IP Documentation	06.05.02 Non-I_tion of Shipment
8010	84	\N	\N	D5170C00002	1795	1790	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
8012	84	\N	\N	D5170C00002	1797	1790	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
8013	84	\N	\N	D5170C00002	1798	1790	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
8015	84	\N	\N	D5170C00002	1800	1790	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
8016	84	\N	\N	D5170C00002	1801	1790	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
8017	84	\N	\N	D5170C00002	1802	1790	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
8018	84	\N	\N	D5170C00002	1803	1784	NEW	\N	05 Site Management	05.03 Site Initiation
8020	84	\N	\N	D5170C00002	1805	1803	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
8021	84	\N	\N	D5170C00002	1806	1784	NEW	\N	05 Site Management	05.04 Site Management
8023	84	\N	\N	D5170C00002	1808	1784	NEW	\N	05 Site Management	05.05 General
8024	84	\N	\N	D5170C00002	1809	1808	NEW	\N	05.05 General	05.05.02 Tracking Information
8026	84	\N	\N	D5170C00002	1811	1810	NEW	\N	06 IP and Trial Supplies	06.07 General
8027	84	\N	\N	D5170C00002	1812	1811	NEW	\N	06.07 General	06.07.01 Relev_roduct-Documents
8028	84	\N	\N	D5170C00002	1813	1335	NEW	\N	Site	2002281 Zeuzem, Stefan
8030	84	\N	\N	D5170C00002	1815	1814	NEW	\N	01 Trial Management	01.01 Trial Oversight
8031	84	\N	\N	D5170C00002	1816	1815	NEW	\N	01.01 Trial Oversight	01.01.06 Recruitment Plan
8033	84	\N	\N	D5170C00002	1818	1817	NEW	\N	02 Central Trial Documents	02.04 General
8034	84	\N	\N	D5170C00002	1819	1818	NEW	\N	02.04 General	02.04.01 Relev_ations-Documents
8036	84	\N	\N	D5170C00002	1821	1813	NEW	\N	2002281 Zeuzem, Stefan	03 Regulatory
8037	84	\N	\N	D5170C00002	1822	1821	NEW	\N	03 Regulatory	03.01 Trial Approval
8039	84	\N	\N	D5170C00002	1824	1813	NEW	\N	2002281 Zeuzem, Stefan	04 IRB-IEC and other Approvals
8041	84	\N	\N	D5170C00002	1826	1825	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
8042	84	\N	\N	D5170C00002	1827	1824	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
8043	84	\N	\N	D5170C00002	1828	1827	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
8045	84	\N	\N	D5170C00002	1830	1829	NEW	\N	05 Site Management	05.01 Site Selection
8046	84	\N	\N	D5170C00002	1831	1830	NEW	\N	05.01 Site Selection	05.01.01 Site Contact Details
8048	84	\N	\N	D5170C00002	1833	1830	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
8049	84	\N	\N	D5170C00002	1834	1830	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
8051	84	\N	\N	D5170C00002	1836	1835	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
8052	84	\N	\N	D5170C00002	1837	1835	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
8054	84	\N	\N	D5170C00002	1839	1835	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
8055	84	\N	\N	D5170C00002	1840	1835	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
8056	84	\N	\N	D5170C00002	1841	1835	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Site Qualification
8058	84	\N	\N	D5170C00002	1843	1835	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Inves_latory Agreement
8059	84	\N	\N	D5170C00002	1844	1835	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
8061	84	\N	\N	D5170C00002	1846	1835	NEW	\N	05.02 Site Set-up Documentation	05.02.14 Other Financial Agreement
8062	84	\N	\N	D5170C00002	1847	1835	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
8064	84	\N	\N	D5170C00002	1849	1829	NEW	\N	05 Site Management	05.03 Site Initiation
8065	84	\N	\N	D5170C00002	1850	1849	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
8066	84	\N	\N	D5170C00002	1851	1849	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
8068	84	\N	\N	D5170C00002	1853	1829	NEW	\N	05 Site Management	05.04 Site Management
8069	84	\N	\N	D5170C00002	1854	1853	NEW	\N	05.04 Site Management	05.04.01 Subject Log
8071	84	\N	\N	D5170C00002	1856	1853	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
8366	84	\N	\N	D5170C00002	2151	2150	NEW	\N	08.02 Sample Documentation	08.02.03 Sampl_ge Condition Log
8074	84	\N	\N	D5170C00002	1859	1857	NEW	\N	05.05 General	05.05.02 Tracking Information
8075	84	\N	\N	D5170C00002	1860	1813	NEW	\N	2002281 Zeuzem, Stefan	06 IP and Trial Supplies
8077	84	\N	\N	D5170C00002	1862	1861	NEW	\N	06.01 IP Documentation	06.01.02 IP Instructions for Handling
8078	84	\N	\N	D5170C00002	1863	1861	NEW	\N	06.01 IP Documentation	06.01.10 IP Documentation Return
8080	84	\N	\N	D5170C00002	1865	1864	NEW	\N	06.04 Storage	06.04.03 Maintenance Logs
8081	84	\N	\N	D5170C00002	1866	1860	NEW	\N	06 IP and Trial Supplies	06.07 General
8083	84	\N	\N	D5170C00002	1868	1335	NEW	\N	Site	2002283 Schreiber, Stefan
8084	84	\N	\N	D5170C00002	1869	1868	NEW	\N	2002283 Schreiber, Stefan	01 Trial Management
8086	84	\N	\N	D5170C00002	1871	1870	NEW	\N	01.01 Trial Oversight	01.01.06 Recruitment Plan
8087	84	\N	\N	D5170C00002	1872	1868	NEW	\N	2002283 Schreiber, Stefan	02 Central Trial Documents
8089	84	\N	\N	D5170C00002	1874	1873	NEW	\N	02.04 General	02.04.01 Relev_ations-Documents
8090	84	\N	\N	D5170C00002	1875	1873	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
8092	84	\N	\N	D5170C00002	1877	1876	NEW	\N	03 Regulatory	03.01 Trial Approval
15934	88	1617082368710:603893398	1617051274641:-906178156	D5170C00001	1624	1614	CREATE	2021-03-30 07:32:48.793	Site Set-up	Site Signature Sheet
8093	84	\N	\N	D5170C00002	1878	1877	NEW	\N	03.01 Trial Approval	03.01.01 Submission
8095	84	\N	\N	D5170C00002	1880	1879	NEW	\N	03.03 Trial Status Reporting	03.03.03 Notif_rial Termination
8096	84	\N	\N	D5170C00002	1881	1868	NEW	\N	2002283 Schreiber, Stefan	04 IRB-IEC and other Approvals
8098	84	\N	\N	D5170C00002	1883	1882	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
8099	84	\N	\N	D5170C00002	1884	1882	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
8101	84	\N	\N	D5170C00002	1886	1885	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
8102	84	\N	\N	D5170C00002	1887	1868	NEW	\N	2002283 Schreiber, Stefan	05 Site Management
8103	84	\N	\N	D5170C00002	1888	1887	NEW	\N	05 Site Management	05.01 Site Selection
8105	84	\N	\N	D5170C00002	1890	1888	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
8106	84	\N	\N	D5170C00002	1891	1888	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
8108	84	\N	\N	D5170C00002	1893	1887	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
8109	84	\N	\N	D5170C00002	1894	1893	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
8111	84	\N	\N	D5170C00002	1896	1893	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
8112	84	\N	\N	D5170C00002	1897	1893	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
8114	84	\N	\N	D5170C00002	1899	1893	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Site Qualification
8115	84	\N	\N	D5170C00002	1900	1893	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
8116	84	\N	\N	D5170C00002	1901	1893	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Inves_latory Agreement
8118	84	\N	\N	D5170C00002	1903	1893	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
8119	84	\N	\N	D5170C00002	1904	1893	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Si_se Documentation
8121	84	\N	\N	D5170C00002	1906	1887	NEW	\N	05 Site Management	05.03 Site Initiation
8122	84	\N	\N	D5170C00002	1907	1906	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
8123	84	\N	\N	D5170C00002	1908	1906	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
8125	84	\N	\N	D5170C00002	1910	1887	NEW	\N	05 Site Management	05.04 Site Management
8126	84	\N	\N	D5170C00002	1911	1910	NEW	\N	05.04 Site Management	05.04.01 Subject Log
8128	84	\N	\N	D5170C00002	1913	1910	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
8129	84	\N	\N	D5170C00002	1914	1887	NEW	\N	05 Site Management	05.05 General
8131	84	\N	\N	D5170C00002	1916	1914	NEW	\N	05.05 General	05.05.01 Relevant Communications-Documents
8132	84	\N	\N	D5170C00002	1917	1914	NEW	\N	05.05 General	05.05.02 Tracking Information
8134	84	\N	\N	D5170C00002	1919	1918	NEW	\N	2002284 Walldorf, Jens	04 IRB-IEC and other Approvals
8135	84	\N	\N	D5170C00002	1920	1919	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
8137	84	\N	\N	D5170C00002	1922	1920	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
8139	84	\N	\N	D5170C00002	1924	1923	NEW	\N	05 Site Management	05.01 Site Selection
8140	84	\N	\N	D5170C00002	1925	1924	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
8141	84	\N	\N	D5170C00002	1926	1335	NEW	\N	Site	TBD-1-1Q4HLJV Baumgart, Daniel
8142	84	\N	\N	D5170C00002	1927	1926	NEW	\N	TBD-1-1Q4HLJV Baumgart, Daniel	05 Site Management
8143	84	\N	\N	D5170C00002	1928	1927	NEW	\N	05 Site Management	05.01 Site Selection
8144	84	\N	\N	D5170C00002	1929	1928	NEW	\N	05.01 Site Selection	05.01.01 Site Contact Details
8145	84	\N	\N	D5170C00002	1930	1335	NEW	\N	Site	TBD-1-1Q4LTT4 Fellermann, Klaus
8146	84	\N	\N	D5170C00002	1931	1930	NEW	\N	TBD-1-1Q4LTT4 Fellermann, Klaus	05 Site Management
8147	84	\N	\N	D5170C00002	1932	1931	NEW	\N	05 Site Management	05.01 Site Selection
8148	84	\N	\N	D5170C00002	1933	1932	NEW	\N	05.01 Site Selection	05.01.01 Site Contact Details
8149	84	\N	\N	D5170C00002	1934	1335	NEW	\N	Site	TBD-1-1Q4LVD6 Howaldt, Stefanie
8150	84	\N	\N	D5170C00002	1935	1934	NEW	\N	TBD-1-1Q4LVD6 Howaldt, Stefanie	05 Site Management
8151	84	\N	\N	D5170C00002	1936	1935	NEW	\N	05 Site Management	05.01 Site Selection
8152	84	\N	\N	D5170C00002	1937	1936	NEW	\N	05.01 Site Selection	05.01.01 Site Contact Details
8153	84	\N	\N	D5170C00002	1938	1335	NEW	\N	Site	TBD-1-1Q4LVEG Rahman, Khan Fareed
8154	84	\N	\N	D5170C00002	1939	1938	NEW	\N	TBD-1-1Q4LVEG Rahman, Khan Fareed	05 Site Management
8155	84	\N	\N	D5170C00002	1940	1939	NEW	\N	05 Site Management	05.01 Site Selection
8156	84	\N	\N	D5170C00002	1941	1940	NEW	\N	05.01 Site Selection	05.01.01 Site Contact Details
8157	84	\N	\N	D5170C00002	1942	1335	NEW	\N	Site	TBD-1-1Q4LVSK Stremmel, Wolfgang
8158	84	\N	\N	D5170C00002	1943	1942	NEW	\N	TBD-1-1Q4LVSK Stremmel, Wolfgang	05 Site Management
8159	84	\N	\N	D5170C00002	1944	1943	NEW	\N	05 Site Management	05.01 Site Selection
8160	84	\N	\N	D5170C00002	1945	1944	NEW	\N	05.01 Site Selection	05.01.01 Site Contact Details
8162	84	\N	\N	D5170C00002	1947	1335	NEW	\N	Site	TBD-1-1Q4LVT2 Aldinger, Volker
8163	84	\N	\N	D5170C00002	1948	1947	NEW	\N	TBD-1-1Q4LVT2 Aldinger, Volker	05 Site Management
8164	84	\N	\N	D5170C00002	1949	1948	NEW	\N	05 Site Management	05.01 Site Selection
8166	84	\N	\N	D5170C00002	1951	1335	NEW	\N	Site	TBD-1-1Q4LVVC Miehlke, Stephan
8167	84	\N	\N	D5170C00002	1952	1951	NEW	\N	TBD-1-1Q4LVVC Miehlke, Stephan	05 Site Management
8169	84	\N	\N	D5170C00002	1954	1953	NEW	\N	05.01 Site Selection	05.01.01 Site Contact Details
8170	84	\N	\N	D5170C00002	1955	1953	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
8172	84	\N	\N	D5170C00002	1957	1956	NEW	\N	TBD-1-1RBL8PS _ertheiner, Peter	05 Site Management
8173	84	\N	\N	D5170C00002	1958	1957	NEW	\N	05 Site Management	05.01 Site Selection
8368	84	\N	\N	D5170C00002	2153	2152	NEW	\N	2002292 Tulassay, Zsolt	02 Central Trial Documents
15937	88	1617051282673:1432766198	1617051282034:330095865	D5170C00001	1627	1626	ALREADY AVAILABLE	2021-03-30 07:19:37.333	4103	Central Trial Documents
8370	84	\N	\N	D5170C00002	2155	2154	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
8373	84	\N	\N	D5170C00002	2158	2157	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
8376	84	\N	\N	D5170C00002	2161	2160	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
8379	84	\N	\N	D5170C00002	2164	2159	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
8382	84	\N	\N	D5170C00002	2167	2164	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
8386	84	\N	\N	D5170C00002	2171	2164	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Investigator Regulatory Agreement
8389	84	\N	\N	D5170C00002	2174	2164	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
8393	84	\N	\N	D5170C00002	2178	2176	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
8396	84	\N	\N	D5170C00002	2181	2180	NEW	\N	05.04 Site Management	05.04.01 Subject Log
8399	84	\N	\N	D5170C00002	2184	2180	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
8402	84	\N	\N	D5170C00002	2187	2180	NEW	\N	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
8406	84	\N	\N	D5170C00002	2191	2189	NEW	\N	05.05 General	05.05.02 Tracking Information
8409	84	\N	\N	D5170C00002	2194	2193	NEW	\N	06.01 IP Documentation	06.01.02 IP In_ons for Handling
8211	84	\N	\N	D5170C00002	1996	1335	NEW	\N	Site	TBD-1-1RDPHST Konturek, Jan
8212	84	\N	\N	D5170C00002	1997	1996	NEW	\N	TBD-1-1RDPHST Konturek, Jan	05 Site Management
8213	84	\N	\N	D5170C00002	1998	1997	NEW	\N	05 Site Management	05.01 Site Selection
8214	84	\N	\N	D5170C00002	1999	1998	NEW	\N	05.01 Site Selection	05.01.01 Site Contact Details
8215	84	\N	\N	D5170C00002	2000	4	NEW	\N	contents	HUNGARY
8216	84	\N	\N	D5170C00002	2001	2000	NEW	\N	HUNGARY	Site
8217	84	\N	\N	D5170C00002	2002	2001	NEW	\N	Site	2002286 Salamon, Agnes
8218	84	\N	\N	D5170C00002	2003	2002	NEW	\N	2002286 Salamon, Agnes	02 Central Trial Documents
8219	84	\N	\N	D5170C00002	2004	2003	NEW	\N	02 Central Trial Documents	02.04 General
8220	84	\N	\N	D5170C00002	2005	2004	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
8221	84	\N	\N	D5170C00002	2006	2004	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
8222	84	\N	\N	D5170C00002	2007	2002	NEW	\N	2002286 Salamon, Agnes	04 IRB-IEC and other Approvals
8223	84	\N	\N	D5170C00002	2008	2007	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
8224	84	\N	\N	D5170C00002	2009	2008	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
8412	84	\N	\N	D5170C00002	2197	2193	NEW	\N	06.01 IP Documentation	06.01.10 UNBLI_mentation Return
8416	84	\N	\N	D5170C00002	2201	2199	NEW	\N	06.04 Storage	06.04.03 Maintenance Logs
8419	84	\N	\N	D5170C00002	2204	2203	NEW	\N	06.05 Non-IP Documentation	06.05.02 Non-I_tion of Shipment
8422	84	\N	\N	D5170C00002	2207	2206	NEW	\N	2002293 Zsigmond, Ferenc	02 Central Trial Documents
8425	84	\N	\N	D5170C00002	2210	2206	NEW	\N	2002293 Zsigmond, Ferenc	04 IRB-IEC and other Approvals
8428	84	\N	\N	D5170C00002	2213	2210	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
8431	84	\N	\N	D5170C00002	2216	2215	NEW	\N	05 Site Management	05.01 Site Selection
8433	84	\N	\N	D5170C00002	2218	2216	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
8436	84	\N	\N	D5170C00002	2221	2220	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
8317	84	\N	\N	D5170C00002	2102	2101	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
8318	84	\N	\N	D5170C00002	2103	2102	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
8319	84	\N	\N	D5170C00002	2104	2101	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
8321	84	\N	\N	D5170C00002	2106	2096	NEW	\N	2002291 Toth, Gabor Tamas	05 Site Management
8322	84	\N	\N	D5170C00002	2107	2106	NEW	\N	05 Site Management	05.01 Site Selection
8305	84	\N	\N	D5170C00002	2090	2085	NEW	\N	06 IP and Trial Supplies	06.05 Non-IP Documentation
8306	84	\N	\N	D5170C00002	2091	2090	NEW	\N	06.05 Non-IP Documentation	06.05.03 Non-I_tation of Return
8309	84	\N	\N	D5170C00002	2094	2093	NEW	\N	05 Site Management	05.01 Site Selection
8311	84	\N	\N	D5170C00002	2096	2001	NEW	\N	Site	2002291 Toth, Gabor Tamas
8312	84	\N	\N	D5170C00002	2097	2096	NEW	\N	2002291 Toth, Gabor Tamas	02 Central Trial Documents
8313	84	\N	\N	D5170C00002	2098	2097	NEW	\N	02 Central Trial Documents	02.04 General
8315	84	\N	\N	D5170C00002	2100	2098	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
8324	84	\N	\N	D5170C00002	2109	2107	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
8325	84	\N	\N	D5170C00002	2110	2107	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
8326	84	\N	\N	D5170C00002	2111	2106	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
8328	84	\N	\N	D5170C00002	2113	2111	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
8329	84	\N	\N	D5170C00002	2114	2111	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
8331	84	\N	\N	D5170C00002	2116	2111	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
8332	84	\N	\N	D5170C00002	2117	2111	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
8333	84	\N	\N	D5170C00002	2118	2111	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
8335	84	\N	\N	D5170C00002	2120	2111	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
8336	84	\N	\N	D5170C00002	2121	2111	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
8338	84	\N	\N	D5170C00002	2123	2122	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
8339	84	\N	\N	D5170C00002	2124	2122	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
8341	84	\N	\N	D5170C00002	2126	2106	NEW	\N	05 Site Management	05.04 Site Management
8342	84	\N	\N	D5170C00002	2127	2126	NEW	\N	05.04 Site Management	05.04.01 Subject Log
8343	84	\N	\N	D5170C00002	2128	2126	NEW	\N	05.04 Site Management	05.04.03 Monitoring Visit Report
16947	88	1617052130628:1662639321	1617052111853:830308303	D5170C00001	2637	2612	ALREADY AVAILABLE	2021-03-30 07:19:37.34	7805	Site Management
16937	88	1617052122585:2032598073	1617052121840:193293937	D5170C00001	2627	2626	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IRB or IEC and other Approvals	General
16925	88	1617082850815:1849874469	1617052114134:-175040892	D5170C00001	2615	2614	CREATE	2021-03-30 07:40:50.898	Subject Documentation	Advertisements for Subject Recruitment
16929	88	1617082853564:-1513067832	1617052116580:-88006519	D5170C00001	2619	2618	CREATE	2021-03-30 07:40:53.647	General	Tracking Information
16932	88	1617082854125:-2090339164	1617052118488:-697672242	D5170C00001	2622	2621	CREATE	2021-03-30 07:40:54.21	General	Filenote
16934	88	1617082854747:386864756	1617052120069:-1273361792	D5170C00001	2624	2623	CREATE	2021-03-30 07:40:54.835	IP Documentation	IP Accountability Documentation
16940	88	1617082856612:-1107349246	1617052125009:1008845714	D5170C00001	2630	2629	CREATE	2021-03-30 07:40:56.704	IRB or IEC Trial Approval	IRB or IEC Approval
16943	88	1617082857803:2103398236	1617052127055:359409654	D5170C00001	2633	2632	CREATE	2021-03-30 07:40:57.898	Trial Status Reporting	IRB or IEC Notification of Trial Termination
8345	84	\N	\N	D5170C00002	2130	2126	NEW	\N	05.04 Site Management	05.04.04 Visit Log
8346	84	\N	\N	D5170C00002	2131	2126	NEW	\N	05.04 Site Management	05.04.05 UNBLI_itoring Activity
8348	84	\N	\N	D5170C00002	2133	2126	NEW	\N	05.04 Site Management	05.04.06 UNBLINDED Protocol Deviations and Waivers
8349	84	\N	\N	D5170C00002	2134	2126	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
8350	84	\N	\N	D5170C00002	2135	2106	NEW	\N	05 Site Management	05.05 General
8352	84	\N	\N	D5170C00002	2137	2096	NEW	\N	2002291 Toth, Gabor Tamas	06 IP and Trial Supplies
8354	84	\N	\N	D5170C00002	2139	2138	NEW	\N	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
8355	84	\N	\N	D5170C00002	2140	2138	NEW	\N	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
8356	84	\N	\N	D5170C00002	2141	2138	NEW	\N	06.01 IP Documentation	06.01.11 UNBLI_e of Destruction
8358	84	\N	\N	D5170C00002	2143	2142	NEW	\N	06.04 Storage	06.04.01 UNBLI_on Documentation
8359	84	\N	\N	D5170C00002	2144	2142	NEW	\N	06.04 Storage	06.04.03 Maintenance Logs
8361	84	\N	\N	D5170C00002	2146	2137	NEW	\N	06 IP and Trial Supplies	06.05 Non-IP Documentation
8363	84	\N	\N	D5170C00002	2148	2146	NEW	\N	06.05 Non-IP Documentation	06.05.03 Non-I_tation of Return
8364	84	\N	\N	D5170C00002	2149	2096	NEW	\N	2002291 Toth, Gabor Tamas	08 Centralized Testing
8365	84	\N	\N	D5170C00002	2150	2149	NEW	\N	08 Centralized Testing	08.02 Sample Documentation
8371	84	\N	\N	D5170C00002	2156	2152	NEW	\N	2002292 Tulassay, Zsolt	04 IRB-IEC and other Approvals
8372	84	\N	\N	D5170C00002	2157	2156	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
8374	84	\N	\N	D5170C00002	2159	2152	NEW	\N	2002292 Tulassay, Zsolt	05 Site Management
8375	84	\N	\N	D5170C00002	2160	2159	NEW	\N	05 Site Management	05.01 Site Selection
8377	84	\N	\N	D5170C00002	2162	2160	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
8378	84	\N	\N	D5170C00002	2163	2160	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
8380	84	\N	\N	D5170C00002	2165	2164	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
8381	84	\N	\N	D5170C00002	2166	2164	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
8383	84	\N	\N	D5170C00002	2168	2164	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
8384	84	\N	\N	D5170C00002	2169	2164	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
8385	84	\N	\N	D5170C00002	2170	2164	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
8387	84	\N	\N	D5170C00002	2172	2164	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
8388	84	\N	\N	D5170C00002	2173	2164	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clini_ Trial Agreement
8390	84	\N	\N	D5170C00002	2175	2164	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
8391	84	\N	\N	D5170C00002	2176	2159	NEW	\N	05 Site Management	05.03 Site Initiation
8392	84	\N	\N	D5170C00002	2177	2176	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
8394	84	\N	\N	D5170C00002	2179	2176	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
8395	84	\N	\N	D5170C00002	2180	2159	NEW	\N	05 Site Management	05.04 Site Management
8397	84	\N	\N	D5170C00002	2182	2180	NEW	\N	05.04 Site Management	05.04.03 Monitoring Visit Report
8398	84	\N	\N	D5170C00002	2183	2180	NEW	\N	05.04 Site Management	05.04.03 UNBLINDED Monitoring Visit Report
8400	84	\N	\N	D5170C00002	2185	2180	NEW	\N	05.04 Site Management	05.04.04 Visit Log
8401	84	\N	\N	D5170C00002	2186	2180	NEW	\N	05.04 Site Management	05.04.05 UNBLI_itoring Activity
8403	84	\N	\N	D5170C00002	2188	2180	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
8404	84	\N	\N	D5170C00002	2189	2159	NEW	\N	05 Site Management	05.05 General
8405	84	\N	\N	D5170C00002	2190	2189	NEW	\N	05.05 General	05.05.01 Relevant Communications-Documents
8407	84	\N	\N	D5170C00002	2192	2152	NEW	\N	2002292 Tulassay, Zsolt	06 IP and Trial Supplies
8408	84	\N	\N	D5170C00002	2193	2192	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
8410	84	\N	\N	D5170C00002	2195	2193	NEW	\N	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
8411	84	\N	\N	D5170C00002	2196	2193	NEW	\N	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
8413	84	\N	\N	D5170C00002	2198	2193	NEW	\N	06.01 IP Documentation	06.01.11 Certificate of Destruction
16965	88	1617082868439:514268602	1617052138141:425928680	D5170C00001	2655	2647	CREATE	2021-03-30 07:41:08.533	Site Set-up	Site Signature Sheet
8414	84	\N	\N	D5170C00002	2199	2192	NEW	\N	06 IP and Trial Supplies	06.04 Storage
8415	84	\N	\N	D5170C00002	2200	2199	NEW	\N	06.04 Storage	06.04.01 UNBLINDED Storage Condition Documentation
8417	84	\N	\N	D5170C00002	2202	2199	NEW	\N	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
8418	84	\N	\N	D5170C00002	2203	2192	NEW	\N	06 IP and Trial Supplies	06.05 Non-IP Documentation
8420	84	\N	\N	D5170C00002	2205	2203	NEW	\N	06.05 Non-IP Documentation	06.05.03 Non-I_tation of Return
8421	84	\N	\N	D5170C00002	2206	2001	NEW	\N	Site	2002293 Zsigmond, Ferenc
8423	84	\N	\N	D5170C00002	2208	2207	NEW	\N	02 Central Trial Documents	02.04 General
8424	84	\N	\N	D5170C00002	2209	2208	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
8426	84	\N	\N	D5170C00002	2211	2210	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
8427	84	\N	\N	D5170C00002	2212	2211	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
8429	84	\N	\N	D5170C00002	2214	2213	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
8430	84	\N	\N	D5170C00002	2215	2206	NEW	\N	2002293 Zsigmond, Ferenc	05 Site Management
8434	84	\N	\N	D5170C00002	2219	2216	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
8435	84	\N	\N	D5170C00002	2220	2215	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
8437	84	\N	\N	D5170C00002	2222	2220	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
8438	84	\N	\N	D5170C00002	2223	2220	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
8439	84	\N	\N	D5170C00002	2224	2220	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
8441	84	\N	\N	D5170C00002	2226	2220	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
8442	84	\N	\N	D5170C00002	2227	2220	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Investigator Regulatory Agreement
8444	84	\N	\N	D5170C00002	2229	2220	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
8445	84	\N	\N	D5170C00002	2230	2220	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
8446	84	\N	\N	D5170C00002	2231	2220	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
8448	84	\N	\N	D5170C00002	2233	2232	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
8449	84	\N	\N	D5170C00002	2234	2232	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
8451	84	\N	\N	D5170C00002	2236	2215	NEW	\N	05 Site Management	05.04 Site Management
8452	84	\N	\N	D5170C00002	2237	2236	NEW	\N	05.04 Site Management	05.04.01 Subject Log
8454	84	\N	\N	D5170C00002	2239	2236	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
8455	84	\N	\N	D5170C00002	2240	2236	NEW	\N	05.04 Site Management	05.04.04 Visit Log
8457	84	\N	\N	D5170C00002	2242	2236	NEW	\N	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
8458	84	\N	\N	D5170C00002	2243	2236	NEW	\N	05.04 Site Management	05.04.06 UNBLINDED Protocol Deviations and Waivers
8460	84	\N	\N	D5170C00002	2245	2215	NEW	\N	05 Site Management	05.05 General
8461	84	\N	\N	D5170C00002	2246	2245	NEW	\N	05.05 General	05.05.02 Tracking Information
8462	84	\N	\N	D5170C00002	2247	2206	NEW	\N	2002293 Zsigmond, Ferenc	06 IP and Trial Supplies
8464	84	\N	\N	D5170C00002	2249	2248	NEW	\N	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
8465	84	\N	\N	D5170C00002	2250	2248	NEW	\N	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
8467	84	\N	\N	D5170C00002	2252	2248	NEW	\N	06.01 IP Documentation	06.01.11 UNBLINDED Certificate of Destruction
8468	84	\N	\N	D5170C00002	2253	2247	NEW	\N	06 IP and Trial Supplies	06.04 Storage
8469	84	\N	\N	D5170C00002	2254	2253	NEW	\N	06.04 Storage	06.04.01 UNBLI_on Documentation
8471	84	\N	\N	D5170C00002	2256	2253	NEW	\N	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
8473	84	\N	\N	D5170C00002	2258	2257	NEW	\N	06.05 Non-IP Documentation	06.05.02 Non-I_tion of Shipment
8474	84	\N	\N	D5170C00002	2259	2257	NEW	\N	06.05 Non-IP Documentation	06.05.03 Non-I_tation of Return
8475	84	\N	\N	D5170C00002	2260	2206	NEW	\N	2002293 Zsigmond, Ferenc	08 Centralized Testing
8477	84	\N	\N	D5170C00002	2262	2261	NEW	\N	08.02 Sample Documentation	08.02.03 Sampl_ge Condition Log
8478	84	\N	\N	D5170C00002	2263	2001	NEW	\N	Site	2002294 Racz, Ferenc
8480	84	\N	\N	D5170C00002	2265	2264	NEW	\N	02 Central Trial Documents	02.04 General
8481	84	\N	\N	D5170C00002	2266	2265	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
8483	84	\N	\N	D5170C00002	2268	2263	NEW	\N	2002294 Racz, Ferenc	04 IRB-IEC and other Approvals
8485	84	\N	\N	D5170C00002	2270	2269	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
8486	84	\N	\N	D5170C00002	2271	2268	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
8487	84	\N	\N	D5170C00002	2272	2271	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
8489	84	\N	\N	D5170C00002	2274	2273	NEW	\N	05 Site Management	05.01 Site Selection
8490	84	\N	\N	D5170C00002	2275	2274	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
8492	84	\N	\N	D5170C00002	2277	2274	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
8493	84	\N	\N	D5170C00002	2278	2273	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
8495	84	\N	\N	D5170C00002	2280	2278	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
8497	84	\N	\N	D5170C00002	2282	2278	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
8498	84	\N	\N	D5170C00002	2283	2278	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
8499	84	\N	\N	D5170C00002	2284	2278	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
8501	84	\N	\N	D5170C00002	2286	2278	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
8502	84	\N	\N	D5170C00002	2287	2278	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clini_ Trial Agreement
8503	84	\N	\N	D5170C00002	2288	2278	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
8505	84	\N	\N	D5170C00002	2290	2273	NEW	\N	05 Site Management	05.03 Site Initiation
8506	84	\N	\N	D5170C00002	2291	2290	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
8508	84	\N	\N	D5170C00002	2293	2290	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
8509	84	\N	\N	D5170C00002	2294	2273	NEW	\N	05 Site Management	05.04 Site Management
8510	84	\N	\N	D5170C00002	2295	2294	NEW	\N	05.04 Site Management	05.04.01 Subject Log
8512	84	\N	\N	D5170C00002	2297	2294	NEW	\N	05.04 Site Management	05.04.04 Visit Log
8513	84	\N	\N	D5170C00002	2298	2294	NEW	\N	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
8516	84	\N	\N	D5170C00002	2301	2300	NEW	\N	05.05 General	05.05.02 Tracking Information
8517	84	\N	\N	D5170C00002	2302	2263	NEW	\N	2002294 Racz, Ferenc	06 IP and Trial Supplies
8519	84	\N	\N	D5170C00002	2304	2303	NEW	\N	06.01 IP Documentation	06.01.02 IP Instructions for Handling
8520	84	\N	\N	D5170C00002	2305	2302	NEW	\N	06 IP and Trial Supplies	06.04 Storage
8522	84	\N	\N	D5170C00002	2307	2302	NEW	\N	06 IP and Trial Supplies	06.05 Non-IP Documentation
8523	84	\N	\N	D5170C00002	2308	2307	NEW	\N	06.05 Non-IP Documentation	06.05.03 Non-I_tation of Return
8525	84	\N	\N	D5170C00002	2310	2309	NEW	\N	2002988 Patai, Arpad	05 Site Management
8526	84	\N	\N	D5170C00002	2311	2310	NEW	\N	05 Site Management	05.01 Site Selection
8528	84	\N	\N	D5170C00002	2313	2001	NEW	\N	Site	TBD-1-1PKBSWW Fejes, Roland
8529	84	\N	\N	D5170C00002	2314	2313	NEW	\N	TBD-1-1PKBSWW Fejes, Roland	05 Site Management
8531	84	\N	\N	D5170C00002	2316	2315	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
8532	84	\N	\N	D5170C00002	2317	2001	NEW	\N	Site	TBD-1-1PKBT2O G.Kiss, Gyula
8534	84	\N	\N	D5170C00002	2319	2318	NEW	\N	05 Site Management	05.01 Site Selection
8535	84	\N	\N	D5170C00002	2320	2319	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
8536	84	\N	\N	D5170C00002	2321	2001	NEW	\N	Site	TBD-1-1QRMIHV Lakatos, Peter
8538	84	\N	\N	D5170C00002	2323	2322	NEW	\N	05 Site Management	05.01 Site Selection
8540	84	\N	\N	D5170C00002	2325	4	NEW	\N	contents	ISRAEL
8541	84	\N	\N	D5170C00002	2326	2325	NEW	\N	ISRAEL	Site
8542	84	\N	\N	D5170C00002	2327	2326	NEW	\N	Site	2001782 Konikoff, Fred
8544	84	\N	\N	D5170C00002	2329	2328	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
8545	84	\N	\N	D5170C00002	2330	2329	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
8547	84	\N	\N	D5170C00002	2332	2328	NEW	\N	02 Central Trial Documents	02.04 General
8548	84	\N	\N	D5170C00002	2333	2332	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
8550	84	\N	\N	D5170C00002	2335	2327	NEW	\N	2001782 Konikoff, Fred	03 Regulatory
8551	84	\N	\N	D5170C00002	2336	2335	NEW	\N	03 Regulatory	03.01 Trial Approval
8553	84	\N	\N	D5170C00002	2338	2327	NEW	\N	2001782 Konikoff, Fred	04 IRB-IEC and other Approvals
8554	84	\N	\N	D5170C00002	2339	2338	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
8556	84	\N	\N	D5170C00002	2341	2339	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
8557	84	\N	\N	D5170C00002	2342	2339	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
8562	84	\N	\N	D5170C00002	2347	2327	NEW	\N	2001782 Konikoff, Fred	05 Site Management
8563	84	\N	\N	D5170C00002	2348	2347	NEW	\N	05 Site Management	05.01 Site Selection
8564	84	\N	\N	D5170C00002	2349	2348	NEW	\N	05.01 Site Selection	05.01.01 Site Contact Details
8566	84	\N	\N	D5170C00002	2351	2348	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
8567	84	\N	\N	D5170C00002	2352	2348	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
8569	84	\N	\N	D5170C00002	2354	2353	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
8570	84	\N	\N	D5170C00002	2355	2353	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
8572	84	\N	\N	D5170C00002	2357	2353	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
8573	84	\N	\N	D5170C00002	2358	2353	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
8574	84	\N	\N	D5170C00002	2359	2353	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Site Qualification
8576	84	\N	\N	D5170C00002	2361	2353	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Inves_latory Agreement
8577	84	\N	\N	D5170C00002	2362	2353	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
8579	84	\N	\N	D5170C00002	2364	2353	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
8580	84	\N	\N	D5170C00002	2365	2353	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
8581	84	\N	\N	D5170C00002	2366	2347	NEW	\N	05 Site Management	05.03 Site Initiation
8583	84	\N	\N	D5170C00002	2368	2366	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
8584	84	\N	\N	D5170C00002	2369	2366	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
8586	84	\N	\N	D5170C00002	2371	2370	NEW	\N	05.04 Site Management	05.04.04 Visit Log
8587	84	\N	\N	D5170C00002	2372	2370	NEW	\N	05.04 Site Management	05.04.05 Additional Monitoring Activity
8589	84	\N	\N	D5170C00002	2374	2347	NEW	\N	05 Site Management	05.05 General
8590	84	\N	\N	D5170C00002	2375	2374	NEW	\N	05.05 General	05.05.01 Relev_unications-Email
8591	84	\N	\N	D5170C00002	2376	2374	NEW	\N	05.05 General	05.05.02 Tracking Information
8593	84	\N	\N	D5170C00002	2378	2377	NEW	\N	06 IP and Trial Supplies	06.05 Non-IP Documentation
8594	84	\N	\N	D5170C00002	2379	2378	NEW	\N	06.05 Non-IP Documentation	06.05.02 Non-I_tion of Shipment
8596	84	\N	\N	D5170C00002	2381	2380	NEW	\N	2001783 Lahat, Adi	02 Central Trial Documents
8598	84	\N	\N	D5170C00002	2383	2382	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
8599	84	\N	\N	D5170C00002	2384	2381	NEW	\N	02 Central Trial Documents	02.04 General
8600	84	\N	\N	D5170C00002	2385	2384	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
8602	84	\N	\N	D5170C00002	2387	2380	NEW	\N	2001783 Lahat, Adi	03 Regulatory
8603	84	\N	\N	D5170C00002	2388	2387	NEW	\N	03 Regulatory	03.01 Trial Approval
17031	88	1617052201794:-760556033	1617052201119:503124021	D5170C00001	2721	2720	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Data Management	General
8605	84	\N	\N	D5170C00002	2390	2380	NEW	\N	2001783 Lahat, Adi	04 IRB-IEC and other Approvals
8607	84	\N	\N	D5170C00002	2392	2391	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
8608	84	\N	\N	D5170C00002	2393	2391	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
8610	84	\N	\N	D5170C00002	2395	2391	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.05 IRB-I_liance Statement
8611	84	\N	\N	D5170C00002	2396	2390	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
8613	84	\N	\N	D5170C00002	2398	2396	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
8614	84	\N	\N	D5170C00002	2399	2380	NEW	\N	2001783 Lahat, Adi	05 Site Management
8615	84	\N	\N	D5170C00002	2400	2399	NEW	\N	05 Site Management	05.01 Site Selection
8617	84	\N	\N	D5170C00002	2402	2400	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
8618	84	\N	\N	D5170C00002	2403	2400	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
8620	84	\N	\N	D5170C00002	2405	2404	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
8621	84	\N	\N	D5170C00002	2406	2404	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
8624	84	\N	\N	D5170C00002	2409	2404	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
8626	84	\N	\N	D5170C00002	2411	2404	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
8628	84	\N	\N	D5170C00002	2413	2404	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Inves_latory Agreement
8629	84	\N	\N	D5170C00002	2414	2404	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
8631	84	\N	\N	D5170C00002	2416	2404	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
8632	84	\N	\N	D5170C00002	2417	2404	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
8633	84	\N	\N	D5170C00002	2418	2399	NEW	\N	05 Site Management	05.03 Site Initiation
8635	84	\N	\N	D5170C00002	2420	2418	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
8636	84	\N	\N	D5170C00002	2421	2418	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
8638	84	\N	\N	D5170C00002	2423	2422	NEW	\N	05.04 Site Management	05.04.04 Visit Log
8639	84	\N	\N	D5170C00002	2424	2422	NEW	\N	05.04 Site Management	05.04.05 Additional Monitoring Activity
8641	84	\N	\N	D5170C00002	2426	2399	NEW	\N	05 Site Management	05.05 General
8642	84	\N	\N	D5170C00002	2427	2426	NEW	\N	05.05 General	05.05.01 Relev_unications-Email
8643	84	\N	\N	D5170C00002	2428	2426	NEW	\N	05.05 General	05.05.02 Tracking Information
8645	84	\N	\N	D5170C00002	2430	2429	NEW	\N	06 IP and Trial Supplies	06.04 Storage
8646	84	\N	\N	D5170C00002	2431	2430	NEW	\N	06.04 Storage	06.04.03 Maintenance Logs
8648	84	\N	\N	D5170C00002	2433	2432	NEW	\N	06.05 Non-IP Documentation	06.05.02 Non-I_tion of Shipment
8649	84	\N	\N	D5170C00002	2434	2326	NEW	\N	Site	2001784 Melzer, Ehud
8651	84	\N	\N	D5170C00002	2436	2435	NEW	\N	01 Trial Management	01.01 Trial Oversight
8652	84	\N	\N	D5170C00002	2437	2436	NEW	\N	01.01 Trial Oversight	01.01.14 Audit Certificate
8654	84	\N	\N	D5170C00002	2439	2438	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
8655	84	\N	\N	D5170C00002	2440	2439	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
8657	84	\N	\N	D5170C00002	2442	2441	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
8658	84	\N	\N	D5170C00002	2443	2434	NEW	\N	2001784 Melzer, Ehud	04 IRB-IEC and other Approvals
8660	84	\N	\N	D5170C00002	2445	2444	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
8661	84	\N	\N	D5170C00002	2446	2444	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
8663	84	\N	\N	D5170C00002	2448	2444	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.05 IRB-I_liance Statement
8664	84	\N	\N	D5170C00002	2449	2443	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
8666	84	\N	\N	D5170C00002	2451	2449	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
8667	84	\N	\N	D5170C00002	2452	2434	NEW	\N	2001784 Melzer, Ehud	05 Site Management
8668	84	\N	\N	D5170C00002	2453	2452	NEW	\N	05 Site Management	05.01 Site Selection
8670	84	\N	\N	D5170C00002	2455	2453	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
8671	84	\N	\N	D5170C00002	2456	2453	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
8673	84	\N	\N	D5170C00002	2458	2452	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
8674	84	\N	\N	D5170C00002	2459	2458	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
8676	84	\N	\N	D5170C00002	2461	2458	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
8677	84	\N	\N	D5170C00002	2462	2458	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
8679	84	\N	\N	D5170C00002	2464	2458	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Site Qualification
8680	84	\N	\N	D5170C00002	2465	2458	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
8681	84	\N	\N	D5170C00002	2466	2458	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
8683	84	\N	\N	D5170C00002	2468	2458	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
8684	84	\N	\N	D5170C00002	2469	2458	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
8686	84	\N	\N	D5170C00002	2471	2458	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
8688	84	\N	\N	D5170C00002	2473	2472	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
8689	84	\N	\N	D5170C00002	2474	2472	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
8691	84	\N	\N	D5170C00002	2476	2452	NEW	\N	05 Site Management	05.04 Site Management
8692	84	\N	\N	D5170C00002	2477	2476	NEW	\N	05.04 Site Management	05.04.01 Subject Log
8694	84	\N	\N	D5170C00002	2479	2476	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
8695	84	\N	\N	D5170C00002	2480	2476	NEW	\N	05.04 Site Management	05.04.04 Visit Log
17395	88	1617052514364:566366140	1617052508239:872433197	D5170C00001	3085	3076	ALREADY AVAILABLE	2021-03-30 07:19:37.343	7819	IP and Trial Supplies
17388	88	1617052509377:2052844832	1617052508807:655482224	D5170C00001	3078	3077	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Central Trial Documents	Subject Documentation
17398	88	1617052516047:357604275	1617052514364:566366140	D5170C00001	3088	3085	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IP and Trial Supplies	IP Documentation
17382	88	1617083119128:-2008779077	1617052501784:1459373185	D5170C00001	3072	3065	CREATE	2021-03-30 07:45:19.225	Site Set-up	Protocol Amendment Signature Page
17385	88	1617083121512:-882945078	1617052501784:1459373185	D5170C00001	3075	3065	CREATE	2021-03-30 07:45:21.604	Site Set-up	Sub-Investigator Curriculum Vitae
17391	88	1617083123562:-2053528076	1617052509377:2052844832	D5170C00001	3081	3078	CREATE	2021-03-30 07:45:23.648	Subject Documentation	Other Information Given to Subjects
17397	88	1617083124932:-1780896697	1617052514916:-264826285	D5170C00001	3087	3086	CREATE	2021-03-30 07:45:25.015	General	Filenote
17400	88	1617083126200:505678143	1617052516047:357604275	D5170C00001	3090	3088	CREATE	2021-03-30 07:45:26.462	IP Documentation	IP Certificate of Destruction
8697	84	\N	\N	D5170C00002	2482	2476	NEW	\N	05.04 Site Management	05.04.05 UNBLINDED Additional Monitoring Activity
8698	84	\N	\N	D5170C00002	2483	2476	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
8699	84	\N	\N	D5170C00002	2484	2452	NEW	\N	05 Site Management	05.05 General
8701	84	\N	\N	D5170C00002	2486	2484	NEW	\N	05.05 General	05.05.01 Relevant Communications-Documents
8702	84	\N	\N	D5170C00002	2487	2484	NEW	\N	05.05 General	05.05.02 Tracking Information
8704	84	\N	\N	D5170C00002	2489	2488	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
8705	84	\N	\N	D5170C00002	2490	2489	NEW	\N	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
8707	84	\N	\N	D5170C00002	2492	2489	NEW	\N	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
8708	84	\N	\N	D5170C00002	2493	2489	NEW	\N	06.01 IP Documentation	06.01.10 UNBLI_mentation Return
8710	84	\N	\N	D5170C00002	2495	2494	NEW	\N	06.04 Storage	06.04.01 Storage Condition Documentation
8711	84	\N	\N	D5170C00002	2496	2494	NEW	\N	06.04 Storage	06.04.01 UNBLI_on Documentation
8713	84	\N	\N	D5170C00002	2498	2494	NEW	\N	06.04 Storage	06.04.03 UNBLI_Maintenance Logs
8714	84	\N	\N	D5170C00002	2499	2488	NEW	\N	06 IP and Trial Supplies	06.05 Non-IP Documentation
8716	84	\N	\N	D5170C00002	2501	2488	NEW	\N	06 IP and Trial Supplies	06.07 General
8717	84	\N	\N	D5170C00002	2502	2501	NEW	\N	06.07 General	06.07.01 UNBLI_roduct-Documents
8718	84	\N	\N	D5170C00002	2503	2326	NEW	\N	Site	2001785 Waterman, Matti
8720	84	\N	\N	D5170C00002	2505	2504	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
8722	84	\N	\N	D5170C00002	2507	2504	NEW	\N	02 Central Trial Documents	02.04 General
8723	84	\N	\N	D5170C00002	2508	2507	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
8724	84	\N	\N	D5170C00002	2509	2507	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
8726	84	\N	\N	D5170C00002	2511	2510	NEW	\N	03 Regulatory	03.04 General
8728	84	\N	\N	D5170C00002	2513	2503	NEW	\N	2001785 Waterman, Matti	04 IRB-IEC and other Approvals
8729	84	\N	\N	D5170C00002	2514	2513	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
8730	84	\N	\N	D5170C00002	2515	2514	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
8732	84	\N	\N	D5170C00002	2517	2514	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
8733	84	\N	\N	D5170C00002	2518	2514	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.05 IRB-I_liance Statement
8735	84	\N	\N	D5170C00002	2520	2519	NEW	\N	04.03 Trial Status Reporting	04.03.01 IRB-I_y Info-Deviation
8736	84	\N	\N	D5170C00002	2521	2519	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
8738	84	\N	\N	D5170C00002	2523	2522	NEW	\N	05 Site Management	05.01 Site Selection
8739	84	\N	\N	D5170C00002	2524	2523	NEW	\N	05.01 Site Selection	05.01.01 Site Contact Details
8741	84	\N	\N	D5170C00002	2526	2523	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
8742	84	\N	\N	D5170C00002	2527	2523	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
8743	84	\N	\N	D5170C00002	2528	2522	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
8745	84	\N	\N	D5170C00002	2530	2528	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
8746	84	\N	\N	D5170C00002	2531	2528	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
8748	84	\N	\N	D5170C00002	2533	2528	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
8752	84	\N	\N	D5170C00002	2537	2528	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Inves_latory Agreement
8753	84	\N	\N	D5170C00002	2538	2528	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
8755	84	\N	\N	D5170C00002	2540	2528	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
8756	84	\N	\N	D5170C00002	2541	2528	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
8757	84	\N	\N	D5170C00002	2542	2522	NEW	\N	05 Site Management	05.03 Site Initiation
8759	84	\N	\N	D5170C00002	2544	2542	NEW	\N	05.03 Site Initiation	05.03.03 Site _cumentation-Site
8760	84	\N	\N	D5170C00002	2545	2542	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
8762	84	\N	\N	D5170C00002	2547	2546	NEW	\N	05.04 Site Management	05.04.05 Additional Monitoring Activity
8764	84	\N	\N	D5170C00002	2549	2522	NEW	\N	05 Site Management	05.05 General
8765	84	\N	\N	D5170C00002	2550	2549	NEW	\N	05.05 General	05.05.01 Relev_unications-Email
16340	88	1617051617147:-588691388	1617051616486:-1950569652	D5170C00001	2030	2029	ALREADY AVAILABLE	2021-03-30 07:19:37.336	5707	Site Management
16359	88	1617051630952:-325247526	1617051622858:-848511232	D5170C00001	2049	2038	ALREADY AVAILABLE	2021-03-30 07:19:37.336	7001	Data Management
16364	88	1617051634105:2061260707	1617051622858:-848511232	D5170C00001	2054	2038	ALREADY AVAILABLE	2021-03-30 07:19:37.336	7001	IP and Trial Supplies
15989	88	1617051331158:1313932754	1617051329150:-1092230548	D5170C00001	1679	1678	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Central and Local Testing	General
15992	88	1617051332956:1076439076	1617051332369:1869742645	D5170C00001	1682	1681	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Central Trial Documents	General
15994	88	1617051334245:1550326067	1617051332369:1869742645	D5170C00001	1684	1681	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Central Trial Documents	Subject Documentation
16057	88	1617051390648:-452537594	1617051390063:-110780420	D5170C00001	1747	1746	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IP and Trial Supplies	IP Documentation
16100	88	1617051423419:-626527195	1617051422865:-302201633	D5170C00001	1790	1789	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Central and Local Testing	Sample Documentation
16103	88	1617051425299:-452780233	1617051424711:-1522239403	D5170C00001	1793	1792	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Central Trial Documents	General
16345	88	1617051621114:-2037951771	1617051620557:1614627265	D5170C00001	2035	2034	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Selection
16357	88	1617051628720:-1340553915	1617051626763:-1337105703	D5170C00001	2047	2044	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Central Trial Documents	Product and Trial Documentation
15986	88	1617082390537:1443624961	1617051318031:-2130356718	D5170C00001	1676	1665	CREATE	2021-03-30 07:33:10.756	Site Set-up	Sub-Investigator Curriculum Vitae
15997	88	1617082398932:361426141	1617051334245:1550326067	D5170C00001	1687	1684	CREATE	2021-03-30 07:33:19.017	Subject Documentation	Subject Information Sheet
16003	88	1617082400172:-546611143	1617051346680:210981169	D5170C00001	1693	1692	CREATE	2021-03-30 07:33:20.26	IP Documentation	IP Accountability Documentation
16007	88	1617082402005:-1282284863	1617051349306:1032237722	D5170C00001	1697	1696	CREATE	2021-03-30 07:33:22.094	Storage	IP Storage Condition Documentation
16013	88	1617082404291:1228399873	1617051353549:152004825	D5170C00001	1703	1702	CREATE	2021-03-30 07:33:24.375	Other Committees	Other Submissions
16016	88	1617082404867:528345130	1617051355380:1233902396	D5170C00001	1706	1705	CREATE	2021-03-30 07:33:24.952	General	Relevant Communications
16019	88	1617082405428:1929458686	1617051357300:375017191	D5170C00001	1709	1708	CREATE	2021-03-30 07:33:25.51	General	Filenote
16024	88	1617082407838:-1934985284	1617051359155:1468148407	D5170C00001	1714	1711	CREATE	2021-03-30 07:33:29.001	Site Initiation	Trial Initiation Monitoring Report
16030	88	1617082411965:1556133260	1617051363367:292833289	D5170C00001	1720	1718	CREATE	2021-03-30 07:33:32.049	Site Selection	Pre Trial Monitoring Report
16033	88	1617082413178:1763540366	1617051365201:-524879301	D5170C00001	1723	1721	CREATE	2021-03-30 07:33:33.271	Site Set-up	Clinical Study Agreement
16036	88	1617082415375:1817369139	1617051365201:-524879301	D5170C00001	1726	1721	CREATE	2021-03-30 07:33:35.469	Site Set-up	Investigator Regulatory Agreement
16042	88	1617082420278:-1299912278	1617051365201:-524879301	D5170C00001	1732	1721	CREATE	2021-03-30 07:33:40.363	Site Set-up	Site Signature Sheet
16047	88	1617082421487:675637871	1617051383986:-1377720498	D5170C00001	1737	1736	CREATE	2021-03-30 07:33:41.573	Sample Documentation	Sample Storage Condition Log
16058	88	1617082423915:-1562321724	1617051390648:-452537594	D5170C00001	1748	1747	CREATE	2021-03-30 07:33:43.996	IP Documentation	IP Accountability Documentation
16059	88	1617082424547:640076009	1617051390648:-452537594	D5170C00001	1749	1747	CREATE	2021-03-30 07:33:44.634	IP Documentation	IP Certificate of Destruction
16071	88	1617082428099:-440061799	1617051400266:-757810098	D5170C00001	1761	1760	CREATE	2021-03-30 07:33:48.183	General	Relevant Communications
16173	88	1617082485714:-1397772304	1617051480747:-146340867	D5170C00001	1863	1861	CREATE	2021-03-30 07:34:45.797	General	Relevant Communications
16074	88	1617082429695:376134736	1617051401513:1039201798	D5170C00001	1764	1762	CREATE	2021-03-30 07:33:49.781	Site Initiation	Trial Initiation Monitoring Report
16077	88	1617082432099:1940182302	1617051403323:239356806	D5170C00001	1767	1765	CREATE	2021-03-30 07:33:52.19	Site Management	Visit Log
16083	88	1617082434751:-1042739674	1617051406941:-1249314606	D5170C00001	1773	1771	CREATE	2021-03-30 07:33:54.838	Site Set-up	Clinical Study Agreement
16089	88	1617082439968:-1467467054	1617051406941:-1249314606	D5170C00001	1779	1771	CREATE	2021-03-30 07:34:00.051	Site Set-up	Principal Investigator Curriculum Vitae
16092	88	1617082443159:892634440	1617051406941:-1249314606	D5170C00001	1782	1771	CREATE	2021-03-30 07:34:03.245	Site Set-up	Site Signature Sheet
16097	88	1617082444580:-1425722043	1617051421041:1808517053	D5170C00001	1787	1786	CREATE	2021-03-30 07:34:04.671	General	Filenote
16117	88	1617082461201:-208575730	1617051433837:-1425145489	D5170C00001	1807	1804	CREATE	2021-03-30 07:34:21.29	IP Documentation	IP Shipment Documentation
16123	88	1617082463137:617284219	1617051438709:-1638432524	D5170C00001	1813	1812	CREATE	2021-03-30 07:34:23.222	Other Committees	Other Submissions
16126	88	1617082463747:-61498549	1617051440530:1273505835	D5170C00001	1816	1815	CREATE	2021-03-30 07:34:23.834	General	Relevant Communications
16131	88	1617082467170:-73175633	1617051447941:2060129724	D5170C00001	1821	1820	CREATE	2021-03-30 07:34:27.27	Site Management	Monitoring Visit Report
16139	88	1617082471375:-547523796	1617051451517:979818469	D5170C00001	1829	1826	CREATE	2021-03-30 07:34:31.466	Site Set-up	Data Privacy Agreement
16144	88	1617082474701:2037667081	1617051451517:979818469	D5170C00001	1834	1826	CREATE	2021-03-30 07:34:34.786	Site Set-up	Protocol Amendment Signature Page
16147	88	1617082478257:-521480286	1617051451517:979818469	D5170C00001	1837	1826	CREATE	2021-03-30 07:34:38.346	Site Set-up	Sub-Investigator Curriculum Vitae
16337	88	1617082576153:1857751759	1617051610102:1204000152	D5170C00001	2027	2019	CREATE	2021-03-30 07:36:16.238	Site Set-up	Site Signature Sheet
16342	88	1617082577266:-1801405302	1617051617715:-55469056	D5170C00001	2032	2031	CREATE	2021-03-30 07:36:18.322	Site Selection	Confidentiality Agreement
16351	88	1617082584041:621409294	1617051624314:249184512	D5170C00001	2041	2040	CREATE	2021-03-30 07:36:24.127	General	Relevant Communications
16361	88	1617082586963:-861729065	1617051631540:626925415	D5170C00001	2051	2050	CREATE	2021-03-30 07:36:27.047	EDC Management	System Account Management
16367	88	1617082589837:-1221087403	1617051634735:1738569991	D5170C00001	2057	2055	CREATE	2021-03-30 07:36:29.921	General	Relevant Communications
16509	88	1617082653626:1683472277	1617051754774:1457307700	D5170C00001	2199	2198	CREATE	2021-03-30 07:37:33.713	General	Relevant Communications
14318	88	1617049785224:-1294741372	1617049784091:-1315261634	D5170C00001	8	6	ALREADY AVAILABLE	2021-03-30 07:19:37.312	D5170C00001	Country Level
14323	88	1617049789824:-639278170	1617049784091:-1315261634	D5170C00001	13	6	ALREADY AVAILABLE	2021-03-30 07:19:37.312	D5170C00001	Site Level
14342	88	1617049803271:1189358325	1617049802668:1612179485	D5170C00001	32	31	ALREADY AVAILABLE	2021-03-30 07:19:37.312	Country	Canada
14395	88	1617049864147:396645261	1617049802668:1612179485	D5170C00001	85	31	ALREADY AVAILABLE	2021-03-30 07:19:37.312	Country	Czech Republic
14319	88	1617049785800:1684354094	1617049785224:-1294741372	D5170C00001	9	8	ALREADY AVAILABLE	2021-03-30 07:19:37.313	Country Level	Canada
14321	88	1617049788418:-1233910153	1617049785224:-1294741372	D5170C00001	11	8	ALREADY AVAILABLE	2021-03-30 07:19:37.313	Country Level	Hungary
14326	88	1617049791864:188818634	1617049789824:-639278170	D5170C00001	16	13	ALREADY AVAILABLE	2021-03-30 07:19:37.313	Site Level	D5170C00001-Site 1901
14327	88	1617049792462:-2000703671	1617049789824:-639278170	D5170C00001	17	13	ALREADY AVAILABLE	2021-03-30 07:19:37.314	Site Level	D5170C00001-Site 1903
14329	88	1617049793841:-1101300116	1617049789824:-639278170	D5170C00001	19	13	ALREADY AVAILABLE	2021-03-30 07:19:37.314	Site Level	D5170C00001-Site 3303
14356	88	1617049813452:304504589	1617049812776:504308022	D5170C00001	46	45	ALREADY AVAILABLE	2021-03-30 07:19:37.321	IRB or IEC and other Approvals	General
14362	88	1617049817187:1565883125	1617049812776:504308022	D5170C00001	52	45	ALREADY AVAILABLE	2021-03-30 07:19:37.321	IRB or IEC and other Approvals	Other Committees
14365	88	1617049819028:-270565087	1617049818425:-1215525259	D5170C00001	55	54	ALREADY AVAILABLE	2021-03-30 07:19:37.322	Regulatory	General
14368	88	1617049820773:-1110579860	1617049820221:-1421706041	D5170C00001	58	57	ALREADY AVAILABLE	2021-03-30 07:19:37.322	Site Management	General
14370	88	1617049823645:1179027071	1617049820221:-1421706041	D5170C00001	60	57	ALREADY AVAILABLE	2021-03-30 07:19:37.322	Site Management	Site Initiation
14376	88	1617049840255:-1404256617	1617049820221:-1421706041	D5170C00001	66	57	ALREADY AVAILABLE	2021-03-30 07:19:37.322	Site Management	Site Set-up
14381	88	1617049845355:-2119944318	1617049843874:1787270063	D5170C00001	71	70	ALREADY AVAILABLE	2021-03-30 07:19:37.322	Trial Management	General
14389	88	1617049850378:-1253320494	1617049843874:1787270063	D5170C00001	79	70	ALREADY AVAILABLE	2021-03-30 07:19:37.322	Trial Management	Trial Oversight
14345	88	1617049805179:1624144370	1617049804489:72744510	D5170C00001	35	34	ALREADY AVAILABLE	2021-03-30 07:19:37.344	General	Tracking Information
14347	88	1617049806382:1094865244	1617049805778:546631501	D5170C00001	37	36	ALREADY AVAILABLE	2021-03-30 07:19:37.344	Subject Documentation	Advertisements for Subject Recruitment
14422	88	1617049883325:-1385727971	1617049882644:215896033	D5170C00001	112	111	ALREADY AVAILABLE	2021-03-30 07:19:37.344	Trial Status Reporting	IRB or IEC Notification of Trial Termination
16161	88	1617051469535:191536839	1617051468525:-1211205223	D5170C00001	1851	1850	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IP and Trial Supplies	General
16171	88	1617051480747:-146340867	1617051480142:-321919943	D5170C00001	1861	1860	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	General
16176	88	1617051483668:34126941	1617051480142:-321919943	D5170C00001	1866	1860	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Management
16156	88	1617082480240:-1444487841	1617051464866:-1903743660	D5170C00001	1846	1844	CREATE	2021-03-30 07:34:40.333	General	Relevant Communications
16159	88	1617082480940:379313880	1617051467364:-2029712696	D5170C00001	1849	1848	CREATE	2021-03-30 07:34:41.026	General	Tracking Information
16164	88	1617082482273:-999748287	1617051470759:1373549070	D5170C00001	1854	1853	CREATE	2021-03-30 07:34:42.358	Interactive Response Technology	IRT User Account Management
16167	88	1617082483586:-172842175	1617051471889:1241173306	D5170C00001	1857	1855	CREATE	2021-03-30 07:34:43.669	IP Documentation	IP Certificate of Destruction
16182	88	1617082490878:-2011087203	1617051487976:377748011	D5170C00001	1872	1871	CREATE	2021-03-30 07:34:50.964	Site Selection	Confidentiality Agreement
16950	88	1617082859814:164878112	1617052131236:228799670	D5170C00001	2640	2638	CREATE	2021-03-30 07:40:59.899	General	Relevant Communications
14424	88	1617049884622:-632679904	1617049864147:396645261	D5170C00001	114	85	ALREADY AVAILABLE	2021-03-30 07:19:37.314	Czech Republic	Regulatory
14431	88	1617049889852:914566098	1617049884622:-632679904	D5170C00001	121	114	ALREADY AVAILABLE	2021-03-30 07:19:37.323	Regulatory	Trial Status Reporting
14434	88	1617049891719:1141184952	1617049891080:1261850085	D5170C00001	124	123	ALREADY AVAILABLE	2021-03-30 07:19:37.323	Safety Reporting	General
14437	88	1617049893530:-39355784	1617049892866:-1621887577	D5170C00001	127	126	ALREADY AVAILABLE	2021-03-30 07:19:37.323	Site Management	General
14440	88	1617049901772:1955494472	1617049892866:-1621887577	D5170C00001	130	126	ALREADY AVAILABLE	2021-03-30 07:19:37.323	Site Management	Site Initiation
14442	88	1617049902958:-566141412	1617049892866:-1621887577	D5170C00001	132	126	ALREADY AVAILABLE	2021-03-30 07:19:37.323	Site Management	Site Set-up
14446	88	1617049905414:502109418	1617049904841:1897140590	D5170C00001	136	135	ALREADY AVAILABLE	2021-03-30 07:19:37.323	Trial Management	General
14423	88	1617049884031:1893718544	1617049882644:215896033	D5170C00001	113	111	ALREADY AVAILABLE	2021-03-30 07:19:37.344	Trial Status Reporting	IRB or IEC Progress Report
14426	88	1617049885908:-889770097	1617049885217:-607421981	D5170C00001	116	115	ALREADY AVAILABLE	2021-03-30 07:19:37.344	General	Filenote
14427	88	1617049886507:-688404720	1617049885217:-607421981	D5170C00001	117	115	ALREADY AVAILABLE	2021-03-30 07:19:37.344	General	Relevant Communications
14429	88	1617049887754:534057530	1617049887081:1855593420	D5170C00001	119	118	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Trial Approval	Regulatory Approval Notification
14432	88	1617049890412:-865061000	1617049889852:914566098	D5170C00001	122	121	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Trial Status Reporting	Regulatory Notification of Trial Termination
14435	88	1617049892272:215521196	1617049891719:1141184952	D5170C00001	125	124	ALREADY AVAILABLE	2021-03-30 07:19:37.347	General	Relevant Communications
14438	88	1617049894112:1744502232	1617049893530:-39355784	D5170C00001	128	127	ALREADY AVAILABLE	2021-03-30 07:19:37.347	General	Filenote
14443	88	1617049903642:925518678	1617049902958:-566141412	D5170C00001	133	132	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Site Set-up	Clinical Study Agreement
14448	88	1617049906664:-1662198797	1617049905414:502109418	D5170C00001	138	136	ALREADY AVAILABLE	2021-03-30 07:19:37.347	General	Relevant Communications
14451	88	1617049908556:-1557086538	1617049907247:-1928664089	D5170C00001	141	139	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Meetings	Trial Team Training Material
14511	88	1617049954482:342215661	1617049952578:1024957174	D5170C00001	201	199	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Subject Documentation	Other Information Given to Subjects
14512	88	1617049956179:1906859856	1617049952578:1024957174	D5170C00001	202	199	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Subject Documentation	Subject Diary
14514	88	1617049957635:1304619771	1617049952578:1024957174	D5170C00001	204	199	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Subject Documentation	Subject Questionnaire
14517	88	1617049959517:-405572370	1617049958868:-509134877	D5170C00001	207	206	ALREADY AVAILABLE	2021-03-30 07:19:37.347	IRB or IEC Trial Approval	IRB or IEC Approval
14518	88	1617049960083:-1526750580	1617049958868:-509134877	D5170C00001	208	206	ALREADY AVAILABLE	2021-03-30 07:19:37.347	IRB or IEC Trial Approval	IRB or IEC Submission
14520	88	1617049961510:850024107	1617049960864:1629454830	D5170C00001	210	209	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Trial Status Reporting	IRB or IEC Notification of Trial Termination
14523	88	1617049963355:-1683159578	1617049962684:-617016717	D5170C00001	213	212	ALREADY AVAILABLE	2021-03-30 07:19:37.347	General	Filenote
14524	88	1617049963976:-1888966150	1617049962684:-617016717	D5170C00001	214	212	ALREADY AVAILABLE	2021-03-30 07:19:37.347	General	Relevant Communications
14526	88	1617049965145:-1415898054	1617049964566:833975561	D5170C00001	216	215	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Trial Approval	Regulatory Approval Notification
14528	88	1617049967883:1382750116	1617049967232:792566697	D5170C00001	218	217	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Trial Status Reporting	Regulatory Notification of Trial Termination
14531	88	1617049969905:-132507217	1617049969314:1540707118	D5170C00001	221	220	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Site Selection	Feasibility Documentation
14534	88	1617049971715:-120232650	1617049970504:722983919	D5170C00001	224	222	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Site Set-up	Protocol Signature Page
14537	88	1617049978778:264428895	1617049972823:-300097928	D5170C00001	227	226	ALREADY AVAILABLE	2021-03-30 07:19:37.347	General	Other Meeting Material
14538	88	1617049979394:1888511261	1617049972823:-300097928	D5170C00001	228	226	ALREADY AVAILABLE	2021-03-30 07:19:37.347	General	Relevant Communications
14564	88	1617050001821:476427197	1617049984850:1605378607	D5170C00001	254	237	ALREADY AVAILABLE	2021-03-30 07:19:37.316	Hungary	Regulatory
14542	88	1617049981849:368963370	1617049972272:-2089920659	D5170C00001	232	225	ALREADY AVAILABLE	2021-03-30 07:19:37.325	Trial Management	Trial Oversight
14549	88	1617049986103:-1233249355	1617049985434:-626374300	D5170C00001	239	238	ALREADY AVAILABLE	2021-03-30 07:19:37.325	Central Trial Documents	General
14552	88	1617049987882:1610181194	1617049985434:-626374300	D5170C00001	242	238	ALREADY AVAILABLE	2021-03-30 07:19:37.325	Central Trial Documents	Product and Trial Documentation
14554	88	1617049990405:256784007	1617049985434:-626374300	D5170C00001	244	238	ALREADY AVAILABLE	2021-03-30 07:19:37.325	Central Trial Documents	Subject Documentation
14560	88	1617049994185:-285304511	1617049993597:-2098685600	D5170C00001	250	249	ALREADY AVAILABLE	2021-03-30 07:19:37.325	IRB or IEC and other Approvals	General
14565	88	1617050002395:-1226272963	1617050001821:476427197	D5170C00001	255	254	ALREADY AVAILABLE	2021-03-30 07:19:37.325	Regulatory	General
14540	88	1617049980579:1083222329	1617049980004:1071776660	D5170C00001	230	229	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Meetings	Investigators Meeting Material
14543	88	1617049982448:-1485983017	1617049981849:368963370	D5170C00001	233	232	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Trial Oversight	Investigator Newsletter
14551	88	1617049987282:2056289411	1617049986103:-1233249355	D5170C00001	241	239	ALREADY AVAILABLE	2021-03-30 07:19:37.348	General	Explanation of Approvals non English language
14555	88	1617049991117:1756913035	1617049990405:256784007	D5170C00001	245	244	ALREADY AVAILABLE	2021-03-30 07:19:37.348	Subject Documentation	Informed Consent Form
6921	84	\N	\N	D5170C00002	706	701	NEW	\N	04 IRB-IEC and other Approvals	04.02 Other Committees
14557	88	1617049992414:56004346	1617049990405:256784007	D5170C00001	247	244	ALREADY AVAILABLE	2021-03-30 07:19:37.349	Subject Documentation	Subject Participation Card
14558	88	1617049993016:1053673883	1617049990405:256784007	D5170C00001	248	244	ALREADY AVAILABLE	2021-03-30 07:19:37.349	Subject Documentation	Subject Questionnaire
14561	88	1617049994789:822275816	1617049994185:-285304511	D5170C00001	251	250	ALREADY AVAILABLE	2021-03-30 07:19:37.349	General	Filenote
14563	88	1617049996049:1118786833	1617049995375:-1111462517	D5170C00001	253	252	ALREADY AVAILABLE	2021-03-30 07:19:37.349	IRB or IEC Trial Approval	IRB or IEC Approval
14567	88	1617050003633:-22932757	1617050002395:-1226272963	D5170C00001	257	255	ALREADY AVAILABLE	2021-03-30 07:19:37.349	General	Relevant Communications
14569	88	1617050004829:1663911847	1617050004228:1236816701	D5170C00001	259	258	ALREADY AVAILABLE	2021-03-30 07:19:37.349	Trial Approval	Regulatory Approval Notification
14570	88	1617050005404:1674263616	1617050004228:1236816701	D5170C00001	260	258	ALREADY AVAILABLE	2021-03-30 07:19:37.349	Trial Approval	Regulatory Submission
14573	88	1617050007250:1664538820	1617050006666:-784742218	D5170C00001	263	262	ALREADY AVAILABLE	2021-03-30 07:19:37.349	General	Filenote
14577	88	1617050009767:146623778	1617050009177:1704716759	D5170C00001	267	266	ALREADY AVAILABLE	2021-03-30 07:19:37.349	Site Selection	Feasibility Documentation
14601	88	1617050034165:666348940	1617050032373:-172791692	D5170C00001	291	288	ALREADY AVAILABLE	2021-03-30 07:19:37.351	Subject Documentation	Subject Diary
14602	88	1617050034819:1969325937	1617050032373:-172791692	D5170C00001	292	288	ALREADY AVAILABLE	2021-03-30 07:19:37.351	Subject Documentation	Subject Information Sheet
14603	88	1617050035377:-409797166	1617050032373:-172791692	D5170C00001	293	288	ALREADY AVAILABLE	2021-03-30 07:19:37.351	Subject Documentation	Subject Participation Card
14613	88	1617050042921:-1846413318	1617050041637:2044089459	D5170C00001	303	301	ALREADY AVAILABLE	2021-03-30 07:19:37.351	Trial Approval	Regulatory Submission
14620	88	1617050047064:1294788202	1617050046469:-379793734	D5170C00001	310	309	ALREADY AVAILABLE	2021-03-30 07:19:37.351	Site Set-up	Clinical Study Agreement
14628	88	1617050056994:-800542602	1617050055025:-41458515	D5170C00001	318	315	ALREADY AVAILABLE	2021-03-30 07:19:37.352	Trial Oversight	Transfer of Regulatory Obligations
14633	88	1617050060243:734620054	1617050059679:1952071395	D5170C00001	323	322	ALREADY AVAILABLE	2021-03-30 07:19:37.352	General	Certificate of Translation
14635	88	1617050062569:1090912628	1617050059679:1952071395	D5170C00001	325	322	ALREADY AVAILABLE	2021-03-30 07:19:37.352	General	Relevant Communications
14637	88	1617050063940:424390786	1617050063206:-399030765	D5170C00001	327	326	ALREADY AVAILABLE	2021-03-30 07:19:37.352	Product and Trial Documentation	Insurance
14639	88	1617050065291:589403056	1617050064713:-1752417343	D5170C00001	329	328	ALREADY AVAILABLE	2021-03-30 07:19:37.352	Subject Documentation	Informed Consent Form
14640	88	1617050065916:-326056608	1617050064713:-1752417343	D5170C00001	330	328	ALREADY AVAILABLE	2021-03-30 07:19:37.352	Subject Documentation	Subject Diary
14642	88	1617050067101:-1420743202	1617050064713:-1752417343	D5170C00001	332	328	ALREADY AVAILABLE	2021-03-30 07:19:37.353	Subject Documentation	Subject Questionnaire
16185	88	1617082492141:-653670297	1617051489675:-848292909	D5170C00001	1875	1874	CREATE	2021-03-30 07:34:52.228	Site Set-up	Acceptance of Investigator Brochure
14692	88	1617050108375:1157838065	1617050098551:-1298331324	D5170C00001	382	368	ALREADY AVAILABLE	2021-03-30 07:19:37.317	Spain	IP and Trial Supplies
14717	88	1617050131693:777650986	1617050098551:-1298331324	D5170C00001	407	368	ALREADY AVAILABLE	2021-03-30 07:19:37.318	Spain	Site Management
14727	88	1617050138174:588116770	1617050098551:-1298331324	D5170C00001	417	368	ALREADY AVAILABLE	2021-03-30 07:19:37.318	Spain	Trial Management
14680	88	1617050099793:965069189	1617050099210:955631137	D5170C00001	370	369	ALREADY AVAILABLE	2021-03-30 07:19:37.326	Central Trial Documents	General
14700	88	1617050119290:-246147404	1617050111601:-202515461	D5170C00001	390	387	ALREADY AVAILABLE	2021-03-30 07:19:37.327	IRB or IEC and other Approvals	IRB or IEC Trial Approval
14707	88	1617050123720:-973817301	1617050111601:-202515461	D5170C00001	397	387	ALREADY AVAILABLE	2021-03-30 07:19:37.327	IRB or IEC and other Approvals	Trial Status Reporting
14711	88	1617050126744:879453851	1617050125486:-1922316915	D5170C00001	401	400	ALREADY AVAILABLE	2021-03-30 07:19:37.327	Regulatory	General
14714	88	1617050129827:-1162096858	1617050125486:-1922316915	D5170C00001	404	400	ALREADY AVAILABLE	2021-03-30 07:19:37.327	Regulatory	Trial Approval
14721	88	1617050134148:-1180907514	1617050131693:777650986	D5170C00001	411	407	ALREADY AVAILABLE	2021-03-30 07:19:37.327	Site Management	Site Initiation
14738	88	1617050146035:-951542613	1617050145432:-727837459	D5170C00001	428	427	ALREADY AVAILABLE	2021-03-30 07:19:37.327	Central and Local Testing	Facility Documentation
14744	88	1617050156210:-1647154088	1617050148100:-552850351	D5170C00001	434	431	ALREADY AVAILABLE	2021-03-30 07:19:37.327	Central Trial Documents	Subject Documentation
14748	88	1617050158636:-1642993631	1617050158041:-1565671489	D5170C00001	438	437	ALREADY AVAILABLE	2021-03-30 07:19:37.327	IP and Trial Supplies	Non-IP Documentation
14754	88	1617050163771:1173062271	1617050159901:1484582691	D5170C00001	444	440	ALREADY AVAILABLE	2021-03-30 07:19:37.327	IRB or IEC and other Approvals	Trial Status Reporting
14672	88	1617050093924:849629824	1617050093283:503280984	D5170C00001	362	361	ALREADY AVAILABLE	2021-03-30 07:19:37.354	Meetings	Trial Team Training Material
14674	88	1617050096117:1279095058	1617050095551:-199521697	D5170C00001	364	363	ALREADY AVAILABLE	2021-03-30 07:19:37.354	Trial Oversight	Investigator Newsletter
14675	88	1617050096784:1281639054	1617050095551:-199521697	D5170C00001	365	363	ALREADY AVAILABLE	2021-03-30 07:19:37.354	Trial Oversight	Monitoring Plan
14677	88	1617050097980:580220558	1617050095551:-199521697	D5170C00001	367	363	ALREADY AVAILABLE	2021-03-30 07:19:37.354	Trial Oversight	Transfer of Regulatory Obligations
14682	88	1617050101003:-76970022	1617050099793:965069189	D5170C00001	372	370	ALREADY AVAILABLE	2021-03-30 07:19:37.354	General	Explanation of Approvals non English language
14683	88	1617050101592:1468448534	1617050099793:965069189	D5170C00001	373	370	ALREADY AVAILABLE	2021-03-30 07:19:37.354	General	Filenote
14685	88	1617050102814:-383874436	1617050099793:965069189	D5170C00001	375	370	ALREADY AVAILABLE	2021-03-30 07:19:37.354	General	Tracking Information
14687	88	1617050104168:-1617212975	1617050103459:1438998616	D5170C00001	377	376	ALREADY AVAILABLE	2021-03-30 07:19:37.354	Subject Documentation	Informed Consent Form
14688	88	1617050104748:19400482	1617050103459:1438998616	D5170C00001	378	376	ALREADY AVAILABLE	2021-03-30 07:19:37.355	Subject Documentation	Other Information Given to Subjects
14689	88	1617050106554:-1811314770	1617050103459:1438998616	D5170C00001	379	376	ALREADY AVAILABLE	2021-03-30 07:19:37.355	Subject Documentation	Subject Diary
14777	88	1617050179725:-210367500	1617050178389:-1648259386	D5170C00001	467	465	ALREADY AVAILABLE	2021-03-30 07:19:37.358	Trial Oversight	Quality Plan
14779	88	1617050180918:-65076490	1617050178389:-1648259386	D5170C00001	469	465	ALREADY AVAILABLE	2021-03-30 07:19:37.358	Trial Oversight	Transfer of Regulatory Obligations
14784	88	1617050184125:-1720550498	1617050183385:1344982314	D5170C00001	474	473	ALREADY AVAILABLE	2021-03-30 07:19:37.358	Site Management	General
14788	88	1617050192768:-833416571	1617050192159:-1019077068	D5170C00001	478	477	ALREADY AVAILABLE	2021-03-30 07:19:37.358	Central and Local Testing	General
14789	88	1617081807304:47349128	1617050192768:-833416571	D5170C00001	479	478	CREATE	2021-03-30 07:23:27.396	General	Filenote
14795	88	1617050198833:-733165757	1617050191494:-1593718706	D5170C00001	485	476	ALREADY AVAILABLE	2021-03-30 07:19:37.327	1001	Data Management
14808	88	1617050214790:699704712	1617050191494:-1593718706	D5170C00001	498	476	ALREADY AVAILABLE	2021-03-30 07:19:37.327	1001	IRB or IEC and other Approvals
14791	88	1617050194692:1373710432	1617050194062:-1745830218	D5170C00001	481	480	ALREADY AVAILABLE	2021-03-30 07:19:37.359	Central Trial Documents	Subject Documentation
14799	88	1617050201387:-1351963810	1617050200777:-2031925333	D5170C00001	489	488	ALREADY AVAILABLE	2021-03-30 07:19:37.359	IP and Trial Supplies	General
14803	88	1617050203873:-1810329772	1617050200777:-2031925333	D5170C00001	493	488	ALREADY AVAILABLE	2021-03-30 07:19:37.359	IP and Trial Supplies	IP Documentation
14806	88	1617050205784:2053175073	1617050200777:-2031925333	D5170C00001	496	488	ALREADY AVAILABLE	2021-03-30 07:19:37.359	IP and Trial Supplies	Non-IP Documentation
14809	88	1617050215517:358800250	1617050214790:699704712	D5170C00001	499	498	ALREADY AVAILABLE	2021-03-30 07:19:37.359	IRB or IEC and other Approvals	IRB or IEC Trial Approval
14822	88	1617050225243:604139579	1617050222793:-1515687263	D5170C00001	512	508	ALREADY AVAILABLE	2021-03-30 07:19:37.359	Site Management	Site Initiation
14830	88	1617050231189:2000360534	1617050222793:-1515687263	D5170C00001	520	508	ALREADY AVAILABLE	2021-03-30 07:19:37.359	Site Management	Site Set-up
14793	88	1617081809470:-439317505	1617050194692:1373710432	D5170C00001	483	481	CREATE	2021-03-30 07:23:29.559	Subject Documentation	Informed Consent Form
14794	88	1617081810048:1492116281	1617050194692:1373710432	D5170C00001	484	481	CREATE	2021-03-30 07:23:30.135	Subject Documentation	Other Information Given to Subjects
14797	88	1617081810637:399183018	1617050199411:-26332705	D5170C00001	487	486	CREATE	2021-03-30 07:23:30.728	General	Tracking Information
14800	88	1617081811216:1630993083	1617050201387:-1351963810	D5170C00001	490	489	CREATE	2021-03-30 07:23:31.304	General	Relevant Communications
14802	88	1617081811793:141786339	1617050202609:-1269710550	D5170C00001	492	491	CREATE	2021-03-30 07:23:31.875	Interactive Response Technology	IRT User Account Management
14805	88	1617081812948:-802653557	1617050203873:-1810329772	D5170C00001	495	493	CREATE	2021-03-30 07:23:33.036	IP Documentation	IP Certificate of Destruction
14811	88	1617081814627:-295215020	1617050215517:358800250	D5170C00001	501	499	CREATE	2021-03-30 07:23:34.714	IRB or IEC Trial Approval	IRB or IEC Compliance Documentation
14812	88	1617081815263:394696214	1617050215517:358800250	D5170C00001	502	499	CREATE	2021-03-30 07:23:35.359	IRB or IEC Trial Approval	IRB or IEC Composition
14814	88	1617081815877:-482274856	1617050218759:-404546953	D5170C00001	504	503	CREATE	2021-03-30 07:23:35.972	Trial Status Reporting	IRB or IEC Notification of Trial Termination
14817	88	1617081816465:2122691641	1617050221589:-454196918	D5170C00001	507	506	CREATE	2021-03-30 07:23:36.551	General	Tracking Information
14820	88	1617081817074:818003522	1617050223431:2002452707	D5170C00001	510	509	CREATE	2021-03-30 07:23:37.169	General	Filenote
14823	88	1617081818235:-911409161	1617050225243:604139579	D5170C00001	513	512	CREATE	2021-03-30 07:23:38.324	Site Initiation	Site Evidence of Training
14825	88	1617081819827:246695393	1617050226422:-1412208130	D5170C00001	515	514	CREATE	2021-03-30 07:23:39.913	Site Management	Monitoring Visit Report
14826	88	1617081820434:165418866	1617050226422:-1412208130	D5170C00001	516	514	CREATE	2021-03-30 07:23:40.523	Site Management	Protocol Deviations
14831	88	1617081822208:793779484	1617050231189:2000360534	D5170C00001	521	520	CREATE	2021-03-30 07:23:42.302	Site Set-up	Acceptance of Investigator Brochure
14833	88	1617081823445:984690190	1617050231189:2000360534	D5170C00001	523	520	CREATE	2021-03-30 07:23:43.533	Site Set-up	Financial Disclosure Form
14834	88	1617081823990:1795545124	1617050231189:2000360534	D5170C00001	524	520	CREATE	2021-03-30 07:23:44.074	Site Set-up	Investigator Regulatory Agreement
14836	88	1617081825091:1809460351	1617050231189:2000360534	D5170C00001	526	520	CREATE	2021-03-30 07:23:45.185	Site Set-up	Principal Investigator Curriculum Vitae
14838	88	1617081826224:607122332	1617050231189:2000360534	D5170C00001	528	520	CREATE	2021-03-30 07:23:46.328	Site Set-up	Protocol Signature Page
14839	88	1617081826951:-1438327860	1617050231189:2000360534	D5170C00001	529	520	CREATE	2021-03-30 07:23:47.052	Site Set-up	Site Signature Sheet
14841	88	1617081828093:1380537095	1617050231189:2000360534	D5170C00001	531	520	CREATE	2021-03-30 07:23:48.187	Site Set-up	Sub-Investigator Curriculum Vitae
14848	88	1617081829329:-1969304119	1617050247559:-1859913765	D5170C00001	538	537	CREATE	2021-03-30 07:23:49.419	Subject Documentation	Patient Engagement Materials
14858	88	1617081831905:-1635877968	1617050255187:-358801213	D5170C00001	548	547	CREATE	2021-03-30 07:23:51.992	General	Tracking Information
14863	88	1617081833073:-558934702	1617050258264:776650488	D5170C00001	553	552	CREATE	2021-03-30 07:23:53.388	Non-IP Documentation	Non-IP Shipment Documentation
14866	88	1617081833916:-626949455	1617050260101:-1295884730	D5170C00001	556	555	CREATE	2021-03-30 07:23:54	IRB or IEC Trial Approval	IRB or IEC Approval
14868	88	1617081835210:-1944134321	1617050260101:-1295884730	D5170C00001	558	555	CREATE	2021-03-30 07:23:55.3	IRB or IEC Trial Approval	IRB or IEC Submission
14871	88	1617081835812:-1526542624	1617050263263:1395428792	D5170C00001	561	560	CREATE	2021-03-30 07:23:55.898	General	Tracking Information
14874	88	1617081836398:-511609249	1617050269477:1540118976	D5170C00001	564	563	CREATE	2021-03-30 07:23:56.484	General	Filenote
14877	88	1617081837571:-2023677052	1617050271364:-1672498684	D5170C00001	567	566	CREATE	2021-03-30 07:23:57.657	Site Management	Monitoring Visit Report
14879	88	1617081838900:-350328064	1617050271364:-1672498684	D5170C00001	569	566	CREATE	2021-03-30 07:23:58.987	Site Management	Visit Log
14883	88	1617081840041:-1863223606	1617050276464:838276677	D5170C00001	573	572	CREATE	2021-03-30 07:24:00.125	Site Set-up	Acceptance of Investigator Brochure
14885	88	1617081842258:-1672249246	1617050276464:838276677	D5170C00001	575	572	CREATE	2021-03-30 07:24:02.351	Site Set-up	Financial Disclosure Form
14888	88	1617081844146:-1454802156	1617050276464:838276677	D5170C00001	578	572	CREATE	2021-03-30 07:24:04.24	Site Set-up	Principal Investigator Curriculum Vitae
14890	88	1617081845253:-1852954772	1617050276464:838276677	D5170C00001	580	572	CREATE	2021-03-30 07:24:05.339	Site Set-up	Protocol Signature Page
14893	88	1617081847529:-1686863080	1617050276464:838276677	D5170C00001	583	572	CREATE	2021-03-30 07:24:07.617	Site Set-up	Sub-Investigator Curriculum Vitae
14897	88	1617081848144:-2141164181	1617050285516:-2077200952	D5170C00001	587	586	CREATE	2021-03-30 07:24:08.231	General	Filenote
16188	88	1617082493920:50516551	1617051489675:-848292909	D5170C00001	1878	1874	CREATE	2021-03-30 07:34:54.005	Site Set-up	Financial Disclosure Form
14910	88	1617050301255:1808431316	1617050300673:-138972896	D5170C00001	600	599	ALREADY AVAILABLE	2021-03-30 07:19:37.36	IP and Trial Supplies	IP Documentation
14912	88	1617050303160:1376968865	1617050300673:-138972896	D5170C00001	602	599	ALREADY AVAILABLE	2021-03-30 07:19:37.36	IP and Trial Supplies	Non-IP Documentation
14921	88	1617050313303:-1015637500	1617050304469:-1294003035	D5170C00001	611	604	ALREADY AVAILABLE	2021-03-30 07:19:37.361	IRB or IEC and other Approvals	Trial Status Reporting
14934	88	1617050322829:436069202	1617050316365:377275783	D5170C00001	624	616	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Site Management	Site Selection
14937	88	1617050324770:26621288	1617050316365:377275783	D5170C00001	627	616	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Site Management	Site Set-up
14956	88	1617050342048:1046354918	1617050340141:108057088	D5170C00001	646	643	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Central Trial Documents	Subject Documentation
14959	88	1617050350410:-1593081825	1617050344730:-1196528987	D5170C00001	649	648	ALREADY AVAILABLE	2021-03-30 07:19:37.361	IP and Trial Supplies	IP Documentation
14961	88	1617050351825:-1732885429	1617050344730:-1196528987	D5170C00001	651	648	ALREADY AVAILABLE	2021-03-30 07:19:37.361	IP and Trial Supplies	Non-IP Documentation
14965	88	1617050356086:1799449075	1617050353989:-1857945627	D5170C00001	655	654	ALREADY AVAILABLE	2021-03-30 07:19:37.361	IRB or IEC and other Approvals	General
14967	88	1617050357411:775707325	1617050353989:-1857945627	D5170C00001	657	654	ALREADY AVAILABLE	2021-03-30 07:19:37.361	IRB or IEC and other Approvals	IRB or IEC Trial Approval
14913	88	1617081851300:-2017597040	1617050303160:1376968865	D5170C00001	603	602	CREATE	2021-03-30 07:24:11.383	Non-IP Documentation	Non-IP Shipment Documentation
14916	88	1617081853184:1252481315	1617050305092:654739534	D5170C00001	606	605	CREATE	2021-03-30 07:24:13.275	General	Relevant Communications
14918	88	1617081853784:1061361951	1617050306625:241153458	D5170C00001	608	607	CREATE	2021-03-30 07:24:13.868	IRB or IEC Trial Approval	IRB or IEC Approval
14919	88	1617081854346:-1121702881	1617050306625:241153458	D5170C00001	609	607	CREATE	2021-03-30 07:24:14.43	IRB or IEC Trial Approval	IRB or IEC Composition
14922	88	1617081855560:-1536223884	1617050313303:-1015637500	D5170C00001	612	611	CREATE	2021-03-30 07:24:15.645	Trial Status Reporting	Notification to IRB or IEC of Safety Information
14925	88	1617081858775:-853359356	1617050315167:-529679511	D5170C00001	615	614	CREATE	2021-03-30 07:24:18.858	General	Tracking Information
14932	88	1617081861187:1011525254	1617050318967:298779374	D5170C00001	622	620	CREATE	2021-03-30 07:24:21.274	Site Management	Protocol Deviations
14936	88	1617081864106:-2034446941	1617050322829:436069202	D5170C00001	626	624	CREATE	2021-03-30 07:24:24.19	Site Selection	Feasibility Documentation
14939	88	1617081865287:-1335093205	1617050324770:26621288	D5170C00001	629	627	CREATE	2021-03-30 07:24:25.376	Site Set-up	Clinical Study Agreement
14940	88	1617081865897:1181863855	1617050324770:26621288	D5170C00001	630	627	CREATE	2021-03-30 07:24:25.98	Site Set-up	Financial Disclosure Form
14942	88	1617081866998:-4790169	1617050324770:26621288	D5170C00001	632	627	CREATE	2021-03-30 07:24:27.081	Site Set-up	Other Curriculum Vitae
14943	88	1617081867607:1399289727	1617050324770:26621288	D5170C00001	633	627	CREATE	2021-03-30 07:24:27.691	Site Set-up	Principal Investigator Curriculum Vitae
14945	88	1617081868702:1707022892	1617050324770:26621288	D5170C00001	635	627	CREATE	2021-03-30 07:24:28.788	Site Set-up	Protocol Signature Page
14946	88	1617081869254:-945771589	1617050324770:26621288	D5170C00001	636	627	CREATE	2021-03-30 07:24:29.338	Site Set-up	Site Signature Sheet
14948	88	1617081870425:1462675063	1617050324770:26621288	D5170C00001	638	627	CREATE	2021-03-30 07:24:30.511	Site Set-up	Sub-Investigator Curriculum Vitae
14952	88	1617081871010:1978044031	1617050338880:-397868299	D5170C00001	642	641	CREATE	2021-03-30 07:24:31.096	Facility Documentation	Laboratory Validation Documentation
14955	88	1617081871646:-821602464	1617050340749:1789511559	D5170C00001	645	644	CREATE	2021-03-30 07:24:31.728	Product and Trial Documentation	Financial Disclosure Summary
14962	88	1617081873377:1186860659	1617050351825:-1732885429	D5170C00001	652	651	CREATE	2021-03-30 07:24:33.466	Non-IP Documentation	Non-IP Return Documentation
14970	88	1617081878018:-1712599399	1617050357411:775707325	D5170C00001	660	657	CREATE	2021-03-30 07:24:38.107	IRB or IEC Trial Approval	IRB or IEC Submission
14972	88	1617081878595:1662672534	1617050359979:-939361792	D5170C00001	662	661	CREATE	2021-03-30 07:24:38.687	Other Committees	Other Submissions
14978	88	1617081879831:1722328870	1617050364013:599747112	D5170C00001	668	667	CREATE	2021-03-30 07:24:39.918	General	Filenote
14981	88	1617081881055:-441514943	1617050372860:663591526	D5170C00001	671	670	CREATE	2021-03-30 07:24:41.144	Site Management	Monitoring Visit Report
14986	88	1617081883349:174257596	1617050375518:1007244423	D5170C00001	676	674	CREATE	2021-03-30 07:24:43.434	Site Selection	Feasibility Documentation
14989	88	1617081884530:-1803734140	1617050379429:189521224	D5170C00001	679	677	CREATE	2021-03-30 07:24:44.613	Site Set-up	Clinical Study Agreement
14992	88	1617081887650:-962493342	1617050379429:189521224	D5170C00001	682	677	CREATE	2021-03-30 07:24:57.182	Site Set-up	Other Curriculum Vitae
14993	88	1617081897714:1226020789	1617050379429:189521224	D5170C00001	683	677	CREATE	2021-03-30 07:24:57.802	Site Set-up	Principal Investigator Curriculum Vitae
14996	88	1617081899527:1416902571	1617050379429:189521224	D5170C00001	686	677	CREATE	2021-03-30 07:24:59.611	Site Set-up	Site Staff Qualification Supporting Information
14997	88	1617081900129:680537793	1617050379429:189521224	D5170C00001	687	677	CREATE	2021-03-30 07:25:00.219	Site Set-up	Sub-Investigator Curriculum Vitae
15003	88	1617081901291:-2105195074	1617050390581:134836214	D5170C00001	693	692	CREATE	2021-03-30 07:25:01.405	Subject Documentation	Informed Consent Form
15012	88	1617081903673:1109163616	1617050409583:-1942504120	D5170C00001	702	701	CREATE	2021-03-30 07:25:03.756	Non-IP Documentation	Non-IP Shipment Documentation
15015	88	1617081904278:1386357211	1617050411368:440609173	D5170C00001	705	704	CREATE	2021-03-30 07:25:04.361	General	Relevant Communications
15018	88	1617081905372:-128682298	1617050421645:-991566997	D5170C00001	708	706	CREATE	2021-03-30 07:25:05.456	IRB or IEC Trial Approval	IRB or IEC Composition
15020	88	1617081905962:-1084747499	1617050423608:2046577514	D5170C00001	710	709	CREATE	2021-03-30 07:25:06.048	Trial Status Reporting	IRB or IEC Progress Report
15023	88	1617081906618:5710101	1617050425448:-2097920705	D5170C00001	713	712	CREATE	2021-03-30 07:25:06.701	General	Filenote
15029	88	1617081910208:-298794188	1617050429138:-1509167003	D5170C00001	719	716	CREATE	2021-03-30 07:25:10.295	Site Management	Visit Log
15044	88	1617050446118:-589739907	1617050386532:-683947474	D5170C00001	734	688	ALREADY AVAILABLE	2021-03-30 07:19:37.329	1007	Trial Management
15032	88	1617050432720:2105218396	1617050424754:793235850	D5170C00001	722	711	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Site Management	Site Set-up
15045	88	1617050446697:-348579006	1617050446118:-589739907	D5170C00001	735	734	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Trial Management	General
15049	88	1617050449227:1110710828	1617050448655:-1821619583	D5170C00001	739	738	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Site Management	General
15057	88	1617050455335:-1779896179	1617050454755:-359275543	D5170C00001	747	746	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Central and Local Testing	General
15059	88	1617050456525:187590831	1617050454755:-359275543	D5170C00001	749	746	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Central and Local Testing	Sample Documentation
15062	88	1617050458405:1487211606	1617050457712:-592563720	D5170C00001	752	751	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Central Trial Documents	Subject Documentation
15065	88	1617050467378:1309946974	1617050466805:1321936480	D5170C00001	755	754	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Data Management	General
15140	88	1617050534700:614575278	1617050534119:1220184778	D5170C00001	830	829	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Safety Reporting	General
15150	88	1617050542882:-1302435332	1617050535856:-1463709423	D5170C00001	840	832	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Site Management	Site Selection
15152	88	1617050544090:1275073608	1617050535856:-1463709423	D5170C00001	842	832	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Site Management	Site Set-up
15031	88	1617081910838:-681618521	1617050431604:-963580672	D5170C00001	721	720	CREATE	2021-03-30 07:25:10.923	Site Selection	Confidentiality Agreement
15034	88	1617081912036:-1407290291	1617050432720:2105218396	D5170C00001	724	722	CREATE	2021-03-30 07:25:12.124	Site Set-up	Clinical Study Agreement
15035	88	1617081912638:-1990394944	1617050432720:2105218396	D5170C00001	725	722	CREATE	2021-03-30 07:25:12.725	Site Set-up	Financial Disclosure Form
15037	88	1617081913871:822535722	1617050432720:2105218396	D5170C00001	727	722	CREATE	2021-03-30 07:25:13.953	Site Set-up	Other Curriculum Vitae
15038	88	1617081914412:-1165677828	1617050432720:2105218396	D5170C00001	728	722	CREATE	2021-03-30 07:25:14.495	Site Set-up	Principal Investigator Curriculum Vitae
15040	88	1617081915594:2123941089	1617050432720:2105218396	D5170C00001	730	722	CREATE	2021-03-30 07:25:15.681	Site Set-up	Protocol Signature Page
15041	88	1617081916179:784228152	1617050432720:2105218396	D5170C00001	731	722	CREATE	2021-03-30 07:25:16.263	Site Set-up	Site Signature Sheet
15043	88	1617081917397:1800875062	1617050432720:2105218396	D5170C00001	733	722	CREATE	2021-03-30 07:25:17.486	Site Set-up	Sub-Investigator Curriculum Vitae
15050	88	1617081919898:-1941537007	1617050449227:1110710828	D5170C00001	740	739	CREATE	2021-03-30 07:25:19.985	General	Filenote
15054	88	1617081920507:651087679	1617050453054:-667832096	D5170C00001	744	743	CREATE	2021-03-30 07:25:20.598	General	Filenote
15060	88	1617081921669:-1299070183	1617050456525:187590831	D5170C00001	750	749	CREATE	2021-03-30 07:25:21.752	Sample Documentation	Record of Retained Samples
15071	88	1617081924034:13860933	1617050470420:-1886459610	D5170C00001	761	760	CREATE	2021-03-30 07:25:24.116	IP Documentation	IP Accountability Documentation
15077	88	1617081925818:1920734607	1617050475324:-1389923857	D5170C00001	767	766	CREATE	2021-03-30 07:25:25.902	IRB or IEC Trial Approval	IRB or IEC Approval
15079	88	1617081926991:1699998704	1617050475324:-1389923857	D5170C00001	769	766	CREATE	2021-03-30 07:25:27.08	IRB or IEC Trial Approval	IRB or IEC Submission
15091	88	1617081931660:-817475715	1617050484731:-727337539	D5170C00001	781	779	CREATE	2021-03-30 07:25:31.743	Site Management	Protocol Deviations
15096	88	1617081933450:855270252	1617050488400:1782292050	D5170C00001	786	785	CREATE	2021-03-30 07:25:33.536	Site Set-up	Acceptance of Investigator Brochure
15098	88	1617081934659:1655636438	1617050488400:1782292050	D5170C00001	788	785	CREATE	2021-03-30 07:25:34.741	Site Set-up	Financial Disclosure Form
15099	88	1617081935214:1860197374	1617050488400:1782292050	D5170C00001	789	785	CREATE	2021-03-30 07:25:35.317	Site Set-up	Investigator Regulatory Agreement
15101	88	1617081936454:1464797634	1617050488400:1782292050	D5170C00001	791	785	CREATE	2021-03-30 07:25:36.54	Site Set-up	Principal Investigator Curriculum Vitae
15102	88	1617081937056:-407657120	1617050488400:1782292050	D5170C00001	792	785	CREATE	2021-03-30 07:25:37.155	Site Set-up	Protocol Amendment Signature Page
15104	88	1617081938268:-1081422659	1617050488400:1782292050	D5170C00001	794	785	CREATE	2021-03-30 07:25:38.36	Site Set-up	Site Signature Sheet
15106	88	1617081939455:834736619	1617050488400:1782292050	D5170C00001	796	785	CREATE	2021-03-30 07:25:39.542	Site Set-up	Sub-Investigator Curriculum Vitae
15113	88	1617081940690:424732064	1617050505827:1536668770	D5170C00001	803	802	CREATE	2021-03-30 07:25:40.774	Facility Documentation	Laboratory Validation Documentation
15116	88	1617081942646:1277424349	1617050509085:790979987	D5170C00001	806	805	CREATE	2021-03-30 07:25:42.731	Subject Documentation	Informed Consent Form
15119	88	1617081943218:1322242810	1617050510849:-1194401043	D5170C00001	809	808	CREATE	2021-03-30 07:25:43.307	General	Tracking Information
15122	88	1617081943815:-1104873115	1617050512674:1353831089	D5170C00001	812	811	CREATE	2021-03-30 07:25:43.908	General	Relevant Communications
15124	88	1617081944436:-408150489	1617050513835:-1957036599	D5170C00001	814	813	CREATE	2021-03-30 07:25:44.521	Interactive Response Technology	IRT User Account Management
15127	88	1617081955452:-1272266633	1617050515152:1797300866	D5170C00001	817	815	CREATE	2021-03-30 07:25:55.548	IP Documentation	IP Certificate of Destruction
15129	88	1617081956055:430154474	1617050517020:-2029393724	D5170C00001	819	818	CREATE	2021-03-30 07:25:56.141	Non-IP Documentation	Non-IP Shipment Documentation
15135	88	1617081957825:2067996119	1617050521469:802714645	D5170C00001	825	823	CREATE	2021-03-30 07:25:57.909	IRB or IEC Trial Approval	IRB or IEC Composition
15136	88	1617081958384:-836782983	1617050521469:802714645	D5170C00001	826	823	CREATE	2021-03-30 07:25:58.472	IRB or IEC Trial Approval	IRB or IEC Submission
15144	88	1617081960116:-1827378140	1617050536529:1978899790	D5170C00001	834	833	CREATE	2021-03-30 07:26:00.2	General	Filenote
15145	88	1617081960709:-1743011125	1617050536529:1978899790	D5170C00001	835	833	CREATE	2021-03-30 07:26:00.794	General	Relevant Communications
15149	88	1617081963180:-769188456	1617050538563:-2137484447	D5170C00001	839	836	CREATE	2021-03-30 07:26:03.263	Site Management	Visit Log
15153	88	1617081965645:-388024064	1617050544090:1275073608	D5170C00001	843	842	CREATE	2021-03-30 07:26:05.729	Site Set-up	Acceptance of Investigator Brochure
15166	88	1617050555794:-1639799666	1617050182170:-1429529666	D5170C00001	856	471	ALREADY AVAILABLE	2021-03-30 07:19:37.319	Canada	1012
15163	88	1617050553763:-1538526212	1617050503960:1241532802	D5170C00001	853	800	ALREADY AVAILABLE	2021-03-30 07:19:37.33	1011	Trial Management
15167	88	1617050556535:-1406149573	1617050555794:-1639799666	D5170C00001	857	856	ALREADY AVAILABLE	2021-03-30 07:19:37.33	1012	Site Management
15172	88	1617050565643:516265672	1617050559669:1445364575	D5170C00001	862	861	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Site Management	General
15184	88	1617050573787:-2094104714	1617050573081:-1674932892	D5170C00001	874	873	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Central and Local Testing	Facility Documentation
15187	88	1617050577614:1879887020	1617050576997:1486947416	D5170C00001	877	876	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Central Trial Documents	General
15195	88	1617050583237:-426870287	1617050582514:707376719	D5170C00001	885	884	ALREADY AVAILABLE	2021-03-30 07:19:37.361	IP and Trial Supplies	General
15208	88	1617050601472:-607356572	1617050600754:712194575	D5170C00001	898	897	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Safety Reporting	General
15211	88	1617050604313:-1330202334	1617050602815:1223614789	D5170C00001	901	900	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	General
15213	88	1617050606807:-1757817792	1617050602815:1223614789	D5170C00001	903	900	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Management
16199	88	1617051500118:196725134	1617051499559:1757789079	D5170C00001	1889	1888	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Management
15155	88	1617081966886:901489232	1617050544090:1275073608	D5170C00001	845	842	CREATE	2021-03-30 07:26:06.969	Site Set-up	Financial Disclosure Form
15157	88	1617081973820:-1386865210	1617050544090:1275073608	D5170C00001	847	842	CREATE	2021-03-30 07:26:13.907	Site Set-up	Other Curriculum Vitae
15158	88	1617081974446:509523278	1617050544090:1275073608	D5170C00001	848	842	CREATE	2021-03-30 07:26:14.534	Site Set-up	Principal Investigator Curriculum Vitae
15160	88	1617081976605:-1342716561	1617050544090:1275073608	D5170C00001	850	842	CREATE	2021-03-30 07:26:16.688	Site Set-up	Site Signature Sheet
15161	88	1617081977166:211151860	1617050544090:1275073608	D5170C00001	851	842	CREATE	2021-03-30 07:26:17.25	Site Set-up	Site Staff Qualification Supporting Information
15169	88	1617081979077:-1705036491	1617050557160:1598817252	D5170C00001	859	858	CREATE	2021-03-30 07:26:19.166	General	Filenote
15177	88	1617081980298:1620656847	1617050568392:1189138179	D5170C00001	867	866	CREATE	2021-03-30 07:26:20.384	General	Filenote
15181	88	1617081980916:-1180677479	1617050571186:1563151006	D5170C00001	871	870	CREATE	2021-03-30 07:26:21.002	General	Filenote
15188	88	1617081982065:596356572	1617050577614:1879887020	D5170C00001	878	877	CREATE	2021-03-30 07:26:22.33	General	Relevant Communications
15190	88	1617081982813:-1001286644	1617050579042:-1041394474	D5170C00001	880	879	CREATE	2021-03-30 07:26:22.895	Subject Documentation	Informed Consent Form
15193	88	1617081983464:-1247073525	1617050581203:677600109	D5170C00001	883	882	CREATE	2021-03-30 07:26:23.55	General	Tracking Information
15196	88	1617081984059:1634668647	1617050583237:-426870287	D5170C00001	886	885	CREATE	2021-03-30 07:26:24.145	General	Relevant Communications
15198	88	1617081984619:-1702412396	1617050584617:306362979	D5170C00001	888	887	CREATE	2021-03-30 07:26:24.72	IP Documentation	IP Certificate of Destruction
15200	88	1617081985195:-1757565599	1617050585823:-125099472	D5170C00001	890	889	CREATE	2021-03-30 07:26:25.279	Non-IP Documentation	Non-IP Shipment Documentation
15203	88	1617081985844:679406956	1617050597307:133224284	D5170C00001	893	892	CREATE	2021-03-30 07:26:26.823	IRB or IEC Trial Approval	IRB or IEC Approval
15204	88	1617081987349:-1712949029	1617050597307:133224284	D5170C00001	894	892	CREATE	2021-03-30 07:26:27.433	IRB or IEC Trial Approval	IRB or IEC Composition
15206	88	1617081987919:1667864781	1617050599407:-1617042256	D5170C00001	896	895	CREATE	2021-03-30 07:26:28.004	Trial Status Reporting	IRB or IEC Notification of Trial Termination
15215	88	1617081990254:1262396881	1617050606807:-1757817792	D5170C00001	905	903	CREATE	2021-03-30 07:26:30.338	Site Management	Protocol Deviations
15216	88	1617081990885:-261338689	1617050606807:-1757817792	D5170C00001	906	903	CREATE	2021-03-30 07:26:30.968	Site Management	Visit Log
15218	88	1617081991462:-1414780288	1617050609786:-1528999021	D5170C00001	908	907	CREATE	2021-03-30 07:26:31.545	Site Selection	Confidentiality Agreement
15221	88	1617081992610:-1499656242	1617050611493:-1740449440	D5170C00001	911	909	CREATE	2021-03-30 07:26:32.694	Site Set-up	Clinical Study Agreement
15222	88	1617081993227:1511794864	1617050611493:-1740449440	D5170C00001	912	909	CREATE	2021-03-30 07:26:33.311	Site Set-up	Financial Disclosure Form
15224	88	1617081994347:-167157143	1617050611493:-1740449440	D5170C00001	914	909	CREATE	2021-03-30 07:26:34.433	Site Set-up	Other Curriculum Vitae
15226	88	1617081995528:-140008882	1617050611493:-1740449440	D5170C00001	916	909	CREATE	2021-03-30 07:26:35.62	Site Set-up	Protocol Amendment Signature Page
15227	88	1617081996171:-930334161	1617050611493:-1740449440	D5170C00001	917	909	CREATE	2021-03-30 07:26:36.258	Site Set-up	Site Signature Sheet
15241	88	1617082000671:96663717	1617050632624:982922077	D5170C00001	931	929	CREATE	2021-03-30 07:26:40.755	General	Relevant Communications
15248	88	1617082002937:-2073006416	1617050640427:-947623572	D5170C00001	938	937	CREATE	2021-03-30 07:26:43.022	Storage	IP Storage Condition Documentation
15251	88	1617082003517:290417676	1617050646749:1484156224	D5170C00001	941	940	CREATE	2021-03-30 07:26:43.603	General	Relevant Communications
6924	84	\N	\N	D5170C00002	709	708	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
15256	88	1617082005289:-150351640	1617050649716:-796397702	D5170C00001	946	945	CREATE	2021-03-30 07:26:45.377	Trial Status Reporting	IRB or IEC Notification of Trial Termination
15260	88	1617082014703:-1058548386	1617050654065:-1393928514	D5170C00001	950	949	CREATE	2021-03-30 07:26:54.789	General	Relevant Communications
15264	88	1617082015814:-194443694	1617050656548:-805153594	D5170C00001	954	953	CREATE	2021-03-30 07:26:55.897	Site Management	Monitoring Visit Report
15265	88	1617082016379:1969668625	1617050656548:-805153594	D5170C00001	955	953	CREATE	2021-03-30 07:26:56.462	Site Management	Visit Log
15267	88	1617082016992:1845100648	1617050658402:-1069799796	D5170C00001	957	956	CREATE	2021-03-30 07:26:57.075	Site Selection	Confidentiality Agreement
15270	88	1617082018114:517754302	1617050660514:-1281271433	D5170C00001	960	959	CREATE	2021-03-30 07:26:58.203	Site Set-up	Acceptance of Investigator Brochure
15273	88	1617082021034:1791489118	1617050660514:-1281271433	D5170C00001	963	959	CREATE	2021-03-30 07:27:01.13	Site Set-up	Principal Investigator Curriculum Vitae
16196	88	1617082500998:-360771249	1617051489675:-848292909	D5170C00001	1886	1874	CREATE	2021-03-30 07:35:01.084	Site Set-up	Sub-Investigator Curriculum Vitae
15279	88	1617050668846:190844349	1617050667990:-173100630	D5170C00001	969	968	ALREADY AVAILABLE	2021-03-30 07:19:37.33	1902	Data Management
15293	88	1617050683887:925817614	1617050667990:-173100630	D5170C00001	983	968	ALREADY AVAILABLE	2021-03-30 07:19:37.33	1902	IRB or IEC and other Approvals
16202	88	1617051507774:432053920	1617051507100:374680563	D5170C00001	1892	1891	ALREADY AVAILABLE	2021-03-30 07:19:37.335	5703	Data Management
17033	88	1617052204288:-798043798	1617052197208:1678537417	D5170C00001	2723	2714	ALREADY AVAILABLE	2021-03-30 07:19:37.341	7808	IP and Trial Supplies
15283	88	1617050676774:-1245967778	1617050670849:-2009750966	D5170C00001	973	972	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IP and Trial Supplies	General
15286	88	1617050678743:31668470	1617050670849:-2009750966	D5170C00001	976	972	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IP and Trial Supplies	Interactive Response Technology
15288	88	1617050680316:-308990592	1617050670849:-2009750966	D5170C00001	978	972	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IP and Trial Supplies	IP Documentation
15319	88	1617050712818:1078849195	1617050712046:1857909360	D5170C00001	1009	1008	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Data Management	General
15322	88	1617050714815:1001124632	1617050714212:150895717	D5170C00001	1012	1011	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IP and Trial Supplies	General
15327	88	1617050718334:1644671268	1617050714212:150895717	D5170C00001	1017	1011	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IP and Trial Supplies	IP Documentation
15275	88	1617082022190:590360525	1617050660514:-1281271433	D5170C00001	965	959	CREATE	2021-03-30 07:27:02.294	Site Set-up	Protocol Signature Page
15276	88	1617082022845:-553561589	1617050660514:-1281271433	D5170C00001	966	959	CREATE	2021-03-30 07:27:02.945	Site Set-up	Site Signature Sheet
15281	88	1617082024064:1606816936	1617050669466:-2068259233	D5170C00001	971	970	CREATE	2021-03-30 07:27:04.149	General	Tracking Information
15284	88	1617082024766:-1122802422	1617050676774:-1245967778	D5170C00001	974	973	CREATE	2021-03-30 07:27:04.849	General	Filenote
15289	88	1617082026517:-1908242621	1617050680316:-308990592	D5170C00001	979	978	CREATE	2021-03-30 07:27:06.603	IP Documentation	IP Accountability Documentation
15290	88	1617082027162:1199629738	1617050680316:-308990592	D5170C00001	980	978	CREATE	2021-03-30 07:27:07.254	IP Documentation	IP Certificate of Destruction
15292	88	1617082027722:1996897429	1617050682226:1524840752	D5170C00001	982	981	CREATE	2021-03-30 07:27:07.809	Storage	IP Storage Condition Documentation
15295	88	1617082028297:2008028426	1617050684498:943165735	D5170C00001	985	984	CREATE	2021-03-30 07:27:08.38	General	Relevant Communications
15298	88	1617082028913:-1655544470	1617050687982:-1250782664	D5170C00001	988	987	CREATE	2021-03-30 07:27:08.998	Site Initiation	Trial Initiation Monitoring Report
15300	88	1617082029477:-1831263110	1617050689323:2044400698	D5170C00001	990	989	CREATE	2021-03-30 07:27:09.562	Site Management	Monitoring Visit Report
15301	88	1617082030038:741060840	1617050689323:2044400698	D5170C00001	991	989	CREATE	2021-03-30 07:27:10.123	Site Management	Visit Log
15303	88	1617082031654:1587475300	1617050691291:1573402036	D5170C00001	993	992	CREATE	2021-03-30 07:27:11.739	Site Selection	Confidentiality Agreement
15304	88	1617082032289:1063214056	1617050691291:1573402036	D5170C00001	994	992	CREATE	2021-03-30 07:27:12.372	Site Selection	Site Contact Details
15306	88	1617082032999:-1726514113	1617050693346:555633805	D5170C00001	996	995	CREATE	2021-03-30 07:27:13.085	Site Set-up	Acceptance of Investigator Brochure
15308	88	1617082034291:1537577271	1617050693346:555633805	D5170C00001	998	995	CREATE	2021-03-30 07:27:14.38	Site Set-up	Other Curriculum Vitae
15309	88	1617082034872:-1058945987	1617050693346:555633805	D5170C00001	999	995	CREATE	2021-03-30 07:27:14.958	Site Set-up	Principal Investigator Curriculum Vitae
15311	88	1617082036070:-1949364759	1617050693346:555633805	D5170C00001	1001	995	CREATE	2021-03-30 07:27:16.157	Site Set-up	Protocol Signature Page
15312	88	1617082036645:1088893834	1617050693346:555633805	D5170C00001	1002	995	CREATE	2021-03-30 07:27:16.727	Site Set-up	Site Signature Sheet
15324	88	1617082039797:-687522056	1617050714815:1001124632	D5170C00001	1014	1012	CREATE	2021-03-30 07:27:19.88	General	Relevant Communications
15326	88	1617082040421:1424541485	1617050717017:1691730036	D5170C00001	1016	1015	CREATE	2021-03-30 07:27:20.504	Interactive Response Technology	IRT User Account Management
15329	88	1617082042876:188849326	1617050718334:1644671268	D5170C00001	1019	1017	CREATE	2021-03-30 07:27:22.966	IP Documentation	IP Certificate of Destruction
15336	88	1617082045306:-1725495468	1617050725766:-1300797444	D5170C00001	1026	1025	CREATE	2021-03-30 07:27:25.39	IRB or IEC Trial Approval	IRB or IEC Approval
15340	88	1617082047029:-1365265255	1617050727663:2030809444	D5170C00001	1030	1028	CREATE	2021-03-30 07:27:27.115	Trial Status Reporting	IRB or IEC Progress Report
15345	88	1617082048191:1914692031	1617050733783:2100155075	D5170C00001	1035	1034	CREATE	2021-03-30 07:27:28.28	Site Management	Monitoring Visit Report
15346	88	1617082048760:-18260932	1617050733783:2100155075	D5170C00001	1036	1034	CREATE	2021-03-30 07:27:28.841	Site Management	Visit Log
15348	88	1617082049474:1472416081	1617050736013:2035469033	D5170C00001	1038	1037	CREATE	2021-03-30 07:27:29.558	Site Selection	Confidentiality Agreement
15349	88	1617082050026:46531278	1617050736013:2035469033	D5170C00001	1039	1037	CREATE	2021-03-30 07:27:30.111	Site Selection	Site Contact Details
15351	88	1617082050580:-700154761	1617050745959:2117512818	D5170C00001	1041	1040	CREATE	2021-03-30 07:27:30.664	Site Set-up	Acceptance of Investigator Brochure
15354	88	1617082053948:-934167758	1617050745959:2117512818	D5170C00001	1044	1040	CREATE	2021-03-30 07:27:34.036	Site Set-up	Principal Investigator Curriculum Vitae
15356	88	1617082055124:-923016016	1617050745959:2117512818	D5170C00001	1046	1040	CREATE	2021-03-30 07:27:35.208	Site Set-up	Protocol Signature Page
15362	88	1617082056916:-1390478192	1617050753738:1984501310	D5170C00001	1052	1051	CREATE	2021-03-30 07:27:37.004	Site Selection	Site Contact Details
15369	88	1617082058345:-841464877	1617050760353:-1546652229	D5170C00001	1059	1058	CREATE	2021-03-30 07:27:38.439	General	Tracking Information
15375	88	1617082060314:-2063717889	1617050764793:-972584069	D5170C00001	1065	1064	CREATE	2021-03-30 07:27:40.403	Interactive Response Technology	IRT User Account Management
15380	88	1617082062131:442120727	1617050773985:-579234412	D5170C00001	1070	1069	CREATE	2021-03-30 07:27:42.215	Storage	IP Storage Condition Documentation
15383	88	1617082062711:866977025	1617050776261:842607161	D5170C00001	1073	1072	CREATE	2021-03-30 07:27:42.794	General	Relevant Communications
15385	88	1617082063352:-1997939665	1617050779584:425212454	D5170C00001	1075	1074	CREATE	2021-03-30 07:27:48.24	IRB or IEC Trial Approval	IRB or IEC Approval
15412	88	1617050810205:1600279684	1617050809522:1185993981	D5170C00001	1102	1101	ALREADY AVAILABLE	2021-03-30 07:19:37.331	1906	Site Management
15417	88	1617050814918:-1004182592	1617050813994:-966217426	D5170C00001	1107	1106	ALREADY AVAILABLE	2021-03-30 07:19:37.331	2301	Data Management
16205	88	1617051510979:-1966549499	1617051507100:374680563	D5170C00001	1895	1891	ALREADY AVAILABLE	2021-03-30 07:19:37.335	5703	IP and Trial Supplies
15394	88	1617050792560:-1767264048	1617050788902:-1730293684	D5170C00001	1084	1080	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Initiation
15396	88	1617050794138:1527855660	1617050788902:-1730293684	D5170C00001	1086	1080	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Management
15425	88	1617050820263:-353964475	1617050816912:1583696798	D5170C00001	1115	1110	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IP and Trial Supplies	IP Allocation Documentation
15427	88	1617050821859:-868388747	1617050816912:1583696798	D5170C00001	1117	1110	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IP and Trial Supplies	IP Documentation
15483	88	1617050873391:-1270625158	1617050860225:1721896167	D5170C00001	1173	1162	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Set-up
15495	88	1617050882368:-1028012063	1617050880411:-618614854	D5170C00001	1185	1182	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Management
15497	88	1617050883626:-1294971027	1617050880411:-618614854	D5170C00001	1187	1182	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Selection
15388	88	1617082069417:-1416240064	1617050781684:-1731387924	D5170C00001	1078	1077	CREATE	2021-03-30 07:27:49.501	Trial Status Reporting	IRB or IEC Notification of Trial Termination
15392	88	1617082103740:-392358845	1617050790545:39345583	D5170C00001	1082	1081	CREATE	2021-03-30 07:28:23.823	General	Filenote
15397	88	1617082105512:-578059987	1617050794138:1527855660	D5170C00001	1087	1086	CREATE	2021-03-30 07:28:25.595	Site Management	Monitoring Visit Report
15398	88	1617082106113:1586052332	1617050794138:1527855660	D5170C00001	1088	1086	CREATE	2021-03-30 07:28:26.2	Site Management	Visit Log
15400	88	1617082106690:1968628703	1617050796424:1463169618	D5170C00001	1090	1089	CREATE	2021-03-30 07:28:26.775	Site Selection	Confidentiality Agreement
15401	88	1617082107320:1444367459	1617050796424:1463169618	D5170C00001	1091	1089	CREATE	2021-03-30 07:28:27.407	Site Selection	Site Contact Details
15403	88	1617082107973:754896393	1617050798623:645457028	D5170C00001	1093	1092	CREATE	2021-03-30 07:28:28.056	Site Set-up	Acceptance of Investigator Brochure
15405	88	1617082109144:-1375483874	1617050798623:645457028	D5170C00001	1095	1092	CREATE	2021-03-30 07:28:29.231	Site Set-up	Other Curriculum Vitae
15406	88	1617082111156:718753583	1617050798623:645457028	D5170C00001	1096	1092	CREATE	2021-03-30 07:28:31.239	Site Set-up	Principal Investigator Curriculum Vitae
15408	88	1617082112324:-74078507	1617050798623:645457028	D5170C00001	1098	1092	CREATE	2021-03-30 07:28:32.426	Site Set-up	Protocol Signature Page
15409	88	1617082112918:-1626307733	1617050798623:645457028	D5170C00001	1099	1092	CREATE	2021-03-30 07:28:33.01	Site Set-up	Site Signature Sheet
15414	88	1617082114156:1282091798	1617050810870:-888644218	D5170C00001	1104	1103	CREATE	2021-03-30 07:28:34.24	Site Selection	Site Contact Details
15419	88	1617082114713:379391970	1617050815602:-785588476	D5170C00001	1109	1108	CREATE	2021-03-30 07:28:34.805	General	Tracking Information
15422	88	1617082115308:814320566	1617050817548:-1721806378	D5170C00001	1112	1111	CREATE	2021-03-30 07:28:35.391	General	Relevant Communications
15424	88	1617082115945:-353494051	1617050818929:-244209970	D5170C00001	1114	1113	CREATE	2021-03-30 07:28:36.029	Interactive Response Technology	IRT User Account Management
15428	88	1617082117081:813235228	1617050821859:-868388747	D5170C00001	1118	1117	CREATE	2021-03-30 07:28:37.17	IP Documentation	IP Accountability Documentation
15429	88	1617082117735:-964815883	1617050821859:-868388747	D5170C00001	1119	1117	CREATE	2021-03-30 07:28:37.818	IP Documentation	IP Certificate of Destruction
15431	88	1617082118285:-1490913808	1617050824972:-1299851198	D5170C00001	1121	1120	CREATE	2021-03-30 07:28:38.369	Non-IP Documentation	Non-IP Shipment Documentation
15440	88	1617082120679:232399059	1617050829960:-162273758	D5170C00001	1130	1128	CREATE	2021-03-30 07:28:40.764	General	Relevant Communications
15442	88	1617082122792:-606668087	1617050831917:313113513	D5170C00001	1132	1131	CREATE	2021-03-30 07:28:42.876	Site Management	Monitoring Visit Report
15445	88	1617082124066:-296446413	1617050833644:-654554040	D5170C00001	1135	1134	CREATE	2021-03-30 07:28:44.151	Site Selection	Confidentiality Agreement
15448	88	1617082125190:250060962	1617050835946:-1472277239	D5170C00001	1138	1136	CREATE	2021-03-30 07:28:45.28	Site Set-up	Clinical Study Agreement
15451	88	1617082134872:1081142582	1617050835946:-1472277239	D5170C00001	1141	1136	CREATE	2021-03-30 07:28:54.956	Site Set-up	Protocol Amendment Signature Page
15454	88	1617082136637:-1136514096	1617050835946:-1472277239	D5170C00001	1144	1136	CREATE	2021-03-30 07:28:56.722	Site Set-up	Site Staff Qualification Supporting Information
15455	88	1617082137225:-1069860461	1617050835946:-1472277239	D5170C00001	1145	1136	CREATE	2021-03-30 07:28:57.309	Site Set-up	Sub-Investigator Curriculum Vitae
15462	88	1617082138428:1527419969	1617050852422:1745141000	D5170C00001	1152	1151	CREATE	2021-03-30 07:28:58.513	Interactive Response Technology	IRT User Account Management
15467	88	1617082140255:1188435946	1617050854894:830841681	D5170C00001	1157	1155	CREATE	2021-03-30 07:29:00.341	IP Documentation	IP Certificate of Destruction
15474	88	1617082142122:-351299580	1617050860849:-1467241283	D5170C00001	1164	1163	CREATE	2021-03-30 07:29:02.221	General	Filenote
15477	88	1617082143287:-590182161	1617050862632:1017870028	D5170C00001	1167	1166	CREATE	2021-03-30 07:29:03.381	Site Initiation	Site Evidence of Training
15480	88	1617082144536:-118091503	1617050870350:21205140	D5170C00001	1170	1168	CREATE	2021-03-30 07:29:06.026	Site Management	Visit Log
15482	88	1617082146552:-1819650470	1617050872260:-43470293	D5170C00001	1172	1171	CREATE	2021-03-30 07:29:06.639	Site Selection	Confidentiality Agreement
15486	88	1617082148334:-1282904852	1617050873391:-1270625158	D5170C00001	1176	1173	CREATE	2021-03-30 07:29:08.429	Site Set-up	Principal Investigator Curriculum Vitae
15488	88	1617082149626:1156470161	1617050873391:-1270625158	D5170C00001	1178	1173	CREATE	2021-03-30 07:29:09.726	Site Set-up	Site Signature Sheet
15494	88	1617082151515:-1883469527	1617050881086:-1500195416	D5170C00001	1184	1183	CREATE	2021-03-30 07:29:11.607	General	Relevant Communications
15500	88	1617082153239:-1899205374	1617050885051:1892088874	D5170C00001	1190	1189	CREATE	2021-03-30 07:29:13.425	Site Set-up	Clinical Study Agreement
15502	88	1617082154715:12460588	1617050885051:1892088874	D5170C00001	1192	1189	CREATE	2021-03-30 07:29:14.814	Site Set-up	Protocol Amendment Signature Page
15539	88	1617050918835:393025711	1617050813308:-388381196	D5170C00001	1229	1105	ALREADY AVAILABLE	2021-03-30 07:19:37.319	France	2305
15519	88	1617050899273:1813224507	1617050887704:-1310750877	D5170C00001	1209	1193	ALREADY AVAILABLE	2021-03-30 07:19:37.332	2304	Site Management
15540	88	1617050919521:872725693	1617050918835:393025711	D5170C00001	1230	1229	ALREADY AVAILABLE	2021-03-30 07:19:37.332	2305	Data Management
15508	88	1617050891997:634754347	1617050891415:1530127135	D5170C00001	1198	1197	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IP and Trial Supplies	Interactive Response Technology
15510	88	1617050893196:725129746	1617050891415:1530127135	D5170C00001	1200	1197	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IP and Trial Supplies	IP Allocation Documentation
15512	88	1617050895010:-79499940	1617050891415:1530127135	D5170C00001	1202	1197	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IP and Trial Supplies	IP Documentation
15515	88	1617050896871:-220778195	1617050891415:1530127135	D5170C00001	1205	1197	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IP and Trial Supplies	Non-IP Documentation
16206	88	1617051511569:-255478584	1617051510979:-1966549499	D5170C00001	1896	1895	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IP and Trial Supplies	General
15511	88	1617082164298:276682510	1617050893196:725129746	D5170C00001	1201	1200	CREATE	2021-03-30 07:29:24.386	IP Allocation Documentation	IP Treatment Decoding Documentation
15514	88	1617082166167:-1593101526	1617050895010:-79499940	D5170C00001	1204	1202	CREATE	2021-03-30 07:29:26.251	IP Documentation	IP Certificate of Destruction
15518	88	1617082167284:876807119	1617050898051:-1930717269	D5170C00001	1208	1207	CREATE	2021-03-30 07:29:27.369	Storage	IP Storage Condition Documentation
15521	88	1617082167919:1894723012	1617050899861:-2002248705	D5170C00001	1211	1210	CREATE	2021-03-30 07:29:28.003	General	Filenote
15524	88	1617082169050:1605893161	1617050907469:-499813131	D5170C00001	1214	1213	CREATE	2021-03-30 07:29:29.153	Site Initiation	Site Evidence of Training
15526	88	1617082169638:-1625117090	1617050908654:-1615746707	D5170C00001	1216	1215	CREATE	2021-03-30 07:29:29.721	Site Management	Monitoring Visit Report
15527	88	1617082170250:-362596503	1617050908654:-1615746707	D5170C00001	1217	1215	CREATE	2021-03-30 07:29:30.334	Site Management	Visit Log
15529	88	1617082170809:-544422639	1617050910519:-1680422140	D5170C00001	1219	1218	CREATE	2021-03-30 07:29:30.892	Site Selection	Confidentiality Agreement
15531	88	1617082171466:1972394734	1617050911732:-1888658032	D5170C00001	1221	1220	CREATE	2021-03-30 07:29:31.556	Site Set-up	Acceptance of Investigator Brochure
15532	88	1617082172065:-453402538	1617050911732:-1888658032	D5170C00001	1222	1220	CREATE	2021-03-30 07:29:32.148	Site Set-up	Clinical Study Agreement
15534	88	1617082173321:-1344390096	1617050911732:-1888658032	D5170C00001	1224	1220	CREATE	2021-03-30 07:29:33.408	Site Set-up	Principal Investigator Curriculum Vitae
15535	88	1617082174022:673231432	1617050911732:-1888658032	D5170C00001	1225	1220	CREATE	2021-03-30 07:29:34.114	Site Set-up	Protocol Amendment Signature Page
15542	88	1617082176471:83953670	1617050920113:-1905380160	D5170C00001	1232	1231	CREATE	2021-03-30 07:29:36.56	General	Tracking Information
15545	88	1617082177023:-1954353616	1617050921897:1941594811	D5170C00001	1235	1234	CREATE	2021-03-30 07:29:37.107	General	Filenote
15547	88	1617082177582:397516851	1617050923048:-1193322213	D5170C00001	1237	1236	CREATE	2021-03-30 07:29:37.664	IP Allocation Documentation	IP Treatment Decoding Documentation
15550	88	1617082185271:-312768041	1617050925655:-1707757094	D5170C00001	1240	1238	CREATE	2021-03-30 07:29:45.357	IP Documentation	IP Certificate of Destruction
15552	88	1617082185835:-1307178282	1617050927454:127018451	D5170C00001	1242	1241	CREATE	2021-03-30 07:29:45.92	Storage	IP Storage Condition Documentation
15559	88	1617082187588:1365722954	1617050931040:-1460771932	D5170C00001	1249	1247	CREATE	2021-03-30 07:29:47.672	General	Relevant Communications
15562	88	1617082188810:-395912203	1617050932897:-988577970	D5170C00001	1252	1250	CREATE	2021-03-30 07:29:48.893	Site Management	Visit Log
15567	88	1617082190572:-470018772	1617050940499:1931522967	D5170C00001	1257	1255	CREATE	2021-03-30 07:29:50.655	Site Set-up	Clinical Study Agreement
15568	88	1617082191137:1333199091	1617050940499:1931522967	D5170C00001	1258	1255	CREATE	2021-03-30 07:29:51.225	Site Set-up	Other Curriculum Vitae
15570	88	1617082192264:-2130657330	1617050940499:1931522967	D5170C00001	1260	1255	CREATE	2021-03-30 07:29:52.347	Site Set-up	Protocol Amendment Signature Page
15571	88	1617082192903:472339910	1617050940499:1931522967	D5170C00001	1261	1255	CREATE	2021-03-30 07:29:52.985	Site Set-up	Site Signature Sheet
15573	88	1617082194100:-1610873322	1617050940499:1931522967	D5170C00001	1263	1255	CREATE	2021-03-30 07:29:54.187	Site Set-up	Sub-Investigator Curriculum Vitae
15582	88	1617082195372:-1897035058	1617050951668:1762534194	D5170C00001	1272	1271	CREATE	2021-03-30 07:29:55.455	General	Relevant Communications
15585	88	1617082196075:34108826	1617050953546:1131839666	D5170C00001	1275	1274	CREATE	2021-03-30 07:29:56.158	Site Management	Monitoring Visit Report
15588	88	1617082197312:-1810315953	1617050954709:1269426546	D5170C00001	1278	1276	CREATE	2021-03-30 07:29:57.395	Site Selection	Pre Trial Monitoring Report
15591	88	1617082198483:-53827754	1617050958991:451713956	D5170C00001	1281	1279	CREATE	2021-03-30 07:29:58.571	Site Set-up	Clinical Study Agreement
15592	88	1617082199066:-929111095	1617050958991:451713956	D5170C00001	1282	1279	CREATE	2021-03-30 07:29:59.151	Site Set-up	Financial Disclosure Form
15594	88	1617082200308:-828244963	1617050958991:451713956	D5170C00001	1284	1279	CREATE	2021-03-30 07:30:00.393	Site Set-up	Principal Investigator Curriculum Vitae
15596	88	1617082201591:-1423228084	1617050958991:451713956	D5170C00001	1286	1279	CREATE	2021-03-30 07:30:01.676	Site Set-up	Protocol Signature Page
15597	88	1617082202173:-1490277090	1617050958991:451713956	D5170C00001	1287	1279	CREATE	2021-03-30 07:30:02.264	Site Set-up	Sub-Investigator Curriculum Vitae
15604	88	1617082203370:1014544632	1617050977437:452668609	D5170C00001	1294	1293	CREATE	2021-03-30 07:30:03.456	IP Documentation	IP Certificate of Destruction
15609	88	1617082204634:-866487303	1617050980445:-335787479	D5170C00001	1299	1298	CREATE	2021-03-30 07:30:04.724	General	Relevant Communications
15612	88	1617082205206:1008172239	1617050982920:-362078340	D5170C00001	1302	1301	CREATE	2021-03-30 07:30:05.3	General	Filenote
15617	88	1617082206961:1859491758	1617050986152:-265813583	D5170C00001	1307	1305	CREATE	2021-03-30 07:30:07.046	Site Management	Visit Log
15620	88	1617082208173:-1711569462	1617050987881:-330478407	D5170C00001	1310	1308	CREATE	2021-03-30 07:30:08.265	Site Selection	Pre Trial Monitoring Report
15624	88	1617082210197:-1081072645	1617050994476:-248519494	D5170C00001	1314	1311	CREATE	2021-03-30 07:30:10.286	Site Set-up	Financial Disclosure Form
15630	88	1617051000936:540809176	1617051000367:-1036916876	D5170C00001	1320	1319	ALREADY AVAILABLE	2021-03-30 07:19:37.332	2604	Data Management
15634	88	1617051003463:-1377870757	1617051002881:-1857730589	D5170C00001	1324	1323	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IP and Trial Supplies	IP Documentation
15637	88	1617051005276:506850142	1617051004695:1682073843	D5170C00001	1327	1326	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IRB or IEC and other Approvals	General
15640	88	1617051007893:1968343678	1617051006452:-530269601	D5170C00001	1330	1329	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Regulatory	General
15643	88	1617051009711:505801757	1617051009046:-1636058232	D5170C00001	1333	1332	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	General
15671	88	1617051034169:1859202067	1617051031256:140875331	D5170C00001	1361	1356	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IP and Trial Supplies	Non-IP Documentation
15673	88	1617051035468:-952692041	1617051031256:140875331	D5170C00001	1363	1356	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IP and Trial Supplies	Storage
15679	88	1617051039367:-224539690	1617051038795:-359170887	D5170C00001	1369	1368	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Initiation
15626	88	1617082211417:2132965866	1617050994476:-248519494	D5170C00001	1316	1311	CREATE	2021-03-30 07:30:11.5	Site Set-up	Protocol Amendment Signature Page
15627	88	1617082212188:-1493900405	1617050994476:-248519494	D5170C00001	1317	1311	CREATE	2021-03-30 07:30:12.271	Site Set-up	Protocol Signature Page
15632	88	1617082213384:-891072332	1617051001542:-798495734	D5170C00001	1322	1321	CREATE	2021-03-30 07:30:13.469	General	Tracking Information
15635	88	1617082214006:-1239048335	1617051003463:-1377870757	D5170C00001	1325	1324	CREATE	2021-03-30 07:30:14.09	IP Documentation	IP Certificate of Destruction
15638	88	1617082214571:-1456816101	1617051005276:506850142	D5170C00001	1328	1327	CREATE	2021-03-30 07:30:14.653	General	Relevant Communications
15641	88	1617082215136:-858345736	1617051007893:1968343678	D5170C00001	1331	1330	CREATE	2021-03-30 07:30:15.223	General	Relevant Communications
15644	88	1617082215715:-1630501501	1617051009711:505801757	D5170C00001	1334	1333	CREATE	2021-03-30 07:30:15.802	General	Filenote
15646	88	1617082216399:642061672	1617051010852:-1596402660	D5170C00001	1336	1335	CREATE	2021-03-30 07:30:16.499	Site Initiation	Site Evidence of Training
15648	88	1617082217025:1417108605	1617051012081:1699682467	D5170C00001	1338	1337	CREATE	2021-03-30 07:30:17.115	Site Management	Monitoring Visit Report
15649	88	1617082217638:-107653945	1617051012081:1699682467	D5170C00001	1339	1337	CREATE	2021-03-30 07:30:17.742	Site Management	Visit Log
15651	88	1617082218202:1365080440	1617051013811:1635007034	D5170C00001	1341	1340	CREATE	2021-03-30 07:30:18.287	Site Selection	Confidentiality Agreement
15654	88	1617082219489:-466761950	1617051015079:817283835	D5170C00001	1344	1342	CREATE	2021-03-30 07:30:19.584	Site Set-up	Clinical Study Agreement
15655	88	1617082220136:-735942255	1617051015079:817283835	D5170C00001	1345	1342	CREATE	2021-03-30 07:30:20.219	Site Set-up	Financial Disclosure Form
15657	88	1617082221395:1265932620	1617051015079:817283835	D5170C00001	1347	1342	CREATE	2021-03-30 07:30:21.484	Site Set-up	Protocol Amendment Signature Page
15658	88	1617082222049:-1952722020	1617051015079:817283835	D5170C00001	1348	1342	CREATE	2021-03-30 07:30:22.141	Site Set-up	Protocol Signature Page
15660	88	1617082223297:-1903211286	1617051015079:817283835	D5170C00001	1350	1342	CREATE	2021-03-30 07:30:23.391	Site Set-up	Sub-Investigator Curriculum Vitae
15665	88	1617082223968:136284356	1617051030016:684328245	D5170C00001	1355	1354	CREATE	2021-03-30 07:30:24.054	General	Tracking Information
15668	88	1617082224556:633344126	1617051031832:-1956130065	D5170C00001	1358	1357	CREATE	2021-03-30 07:30:24.642	Interactive Response Technology	IRT User Account Management
15670	88	1617082225293:1213630539	1617051033038:2092720068	D5170C00001	1360	1359	CREATE	2021-03-30 07:30:25.376	IP Documentation	IP Certificate of Destruction
15674	88	1617082226493:-1909986940	1617051035468:-952692041	D5170C00001	1364	1363	CREATE	2021-03-30 07:30:26.577	Storage	IP Storage Condition Documentation
15677	88	1617082227045:333675494	1617051037418:792754053	D5170C00001	1367	1366	CREATE	2021-03-30 07:30:27.129	General	Tracking Information
15680	88	1617082227626:722473846	1617051039367:-224539690	D5170C00001	1370	1369	CREATE	2021-03-30 07:30:35.188	Site Initiation	Trial Initiation Monitoring Report
15683	88	1617082236333:-1185742650	1617051041434:-1828570085	D5170C00001	1373	1371	CREATE	2021-03-30 07:30:36.418	Site Management	Visit Log
15685	88	1617082236901:799135590	1617051043188:-1288086683	D5170C00001	1375	1374	CREATE	2021-03-30 07:30:36.982	Site Selection	Confidentiality Agreement
15691	88	1617082239946:-1889698609	1617051044993:-2105799273	D5170C00001	1381	1377	CREATE	2021-03-30 07:30:40.036	Site Set-up	Financial Disclosure Form
15692	88	1617082240612:1215859976	1617051044993:-2105799273	D5170C00001	1382	1377	CREATE	2021-03-30 07:30:41.935	Site Set-up	Other Curriculum Vitae
15695	88	1617082244475:1911151698	1617051044993:-2105799273	D5170C00001	1385	1377	CREATE	2021-03-30 07:30:44.562	Site Set-up	Protocol Signature Page
15697	88	1617082247110:1960673041	1617051044993:-2105799273	D5170C00001	1387	1377	CREATE	2021-03-30 07:30:47.2	Site Set-up	Sub-Investigator Curriculum Vitae
15706	88	1617082249449:-959223278	1617051056732:1207254590	D5170C00001	1396	1395	CREATE	2021-03-30 07:30:49.537	Storage	IP Storage Condition Documentation
15709	88	1617082250073:314821279	1617051058549:1904363532	D5170C00001	1399	1398	CREATE	2021-03-30 07:30:50.163	General	Tracking Information
15715	88	1617082252013:-562392057	1617051067740:1749259247	D5170C00001	1405	1403	CREATE	2021-03-30 07:30:52.098	Site Management	Visit Log
15717	88	1617082252601:976758378	1617051069580:1684573205	D5170C00001	1407	1406	CREATE	2021-03-30 07:30:52.686	Site Selection	Confidentiality Agreement
15721	88	1617082254363:668605217	1617051071540:1064815674	D5170C00001	1411	1409	CREATE	2021-03-30 07:30:54.525	Site Set-up	Clinical Study Agreement
15723	88	1617082255607:-90118384	1617051071540:1064815674	D5170C00001	1413	1409	CREATE	2021-03-30 07:30:55.69	Site Set-up	Financial Disclosure Form
15726	88	1617082258778:2144243084	1617051071540:1064815674	D5170C00001	1416	1409	CREATE	2021-03-30 07:30:58.863	Site Set-up	Protocol Amendment Signature Page
15728	88	1617082260054:1960643119	1617051071540:1064815674	D5170C00001	1418	1409	CREATE	2021-03-30 07:31:00.141	Site Set-up	Site Signature Sheet
15736	88	1617082261803:619810736	1617051082307:-1396322100	D5170C00001	1426	1425	CREATE	2021-03-30 07:31:01.892	Interactive Response Technology	IRT User Account Management
15740	88	1617082263104:-434966429	1617051085807:1926542305	D5170C00001	1430	1429	CREATE	2021-03-30 07:31:03.192	Non-IP Documentation	Non-IP Shipment Documentation
15767	88	1617051109350:-1343670937	1617051108777:1327366969	D5170C00001	1457	1456	ALREADY AVAILABLE	2021-03-30 07:19:37.332	3304	IP and Trial Supplies
15887	88	1617051238887:-1085961841	1617051238334:-593288517	D5170C00001	1577	1576	ALREADY AVAILABLE	2021-03-30 07:19:37.333	4102	Central Trial Documents
15770	88	1617051111167:-1713184153	1617051109350:-1343670937	D5170C00001	1460	1457	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IP and Trial Supplies	Non-IP Documentation
15772	88	1617051112435:-342886945	1617051109350:-1343670937	D5170C00001	1462	1457	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IP and Trial Supplies	Storage
15890	88	1617051242085:-4346172	1617051238887:-1085961841	D5170C00001	1580	1577	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Central Trial Documents	Subject Documentation
15748	88	1617082264953:1501928698	1617051090697:-1382360068	D5170C00001	1438	1437	CREATE	2021-03-30 07:31:05.042	Site Initiation	Trial Initiation Monitoring Report
15750	88	1617082265574:6624947	1617051091884:-1888763901	D5170C00001	1440	1439	CREATE	2021-03-30 07:31:05.665	Site Management	Monitoring Visit Report
15751	88	1617082266157:-1518211866	1617051091884:-1888763901	D5170C00001	1441	1439	CREATE	2021-03-30 07:31:06.242	Site Management	Visit Log
15753	88	1617082266739:675054103	1617051093725:1441814023	D5170C00001	1443	1442	CREATE	2021-03-30 07:31:06.827	Site Selection	Confidentiality Agreement
15754	88	1617082267373:338806495	1617051093725:1441814023	D5170C00001	1444	1442	CREATE	2021-03-30 07:31:07.464	Site Selection	Pre Trial Monitoring Report
15756	88	1617082268040:-541048425	1617051100755:624090824	D5170C00001	1446	1445	CREATE	2021-03-30 07:31:08.128	Site Set-up	Acceptance of Investigator Brochure
15757	88	1617082269998:429648913	1617051100755:624090824	D5170C00001	1447	1445	CREATE	2021-03-30 07:31:10.085	Site Set-up	Clinical Study Agreement
15759	88	1617082271215:161080277	1617051100755:624090824	D5170C00001	1449	1445	CREATE	2021-03-30 07:31:11.304	Site Set-up	Financial Disclosure Form
15761	88	1617082272376:64203530	1617051100755:624090824	D5170C00001	1451	1445	CREATE	2021-03-30 07:31:12.465	Site Set-up	Principal Investigator Curriculum Vitae
15762	88	1617082273016:-1409338759	1617051100755:624090824	D5170C00001	1452	1445	CREATE	2021-03-30 07:31:13.1	Site Set-up	Protocol Amendment Signature Page
15764	88	1617082274358:2014109510	1617051100755:624090824	D5170C00001	1454	1445	CREATE	2021-03-30 07:31:14.446	Site Set-up	Site Signature Sheet
15769	88	1617082275578:-783240483	1617051109933:-1229754620	D5170C00001	1459	1458	CREATE	2021-03-30 07:31:15.661	Interactive Response Technology	IRT User Account Management
15773	88	1617082276751:-1543940078	1617051112435:-342886945	D5170C00001	1463	1462	CREATE	2021-03-30 07:31:16.841	Storage	IP Storage Condition Documentation
15781	88	1617082278601:-132272397	1617051150412:235164970	D5170C00001	1471	1470	CREATE	2021-03-30 07:31:18.688	Site Management	Monitoring Visit Report
15782	88	1617082279200:1739449054	1617051150412:235164970	D5170C00001	1472	1470	CREATE	2021-03-30 07:31:19.284	Site Management	Visit Log
15784	88	1617082281214:-1633752163	1617051153691:775680199	D5170C00001	1474	1473	CREATE	2021-03-30 07:31:21.304	Site Selection	Confidentiality Agreement
15787	88	1617082282395:-751943563	1617051160575:-449321039	D5170C00001	1477	1476	CREATE	2021-03-30 07:31:22.483	Site Set-up	Acceptance of Investigator Brochure
15789	88	1617082293142:-601615938	1617051160575:-449321039	D5170C00001	1479	1476	CREATE	2021-03-30 07:31:33.235	Site Set-up	Data Privacy Agreement
15790	88	1617082293821:-247525913	1617051160575:-449321039	D5170C00001	1480	1476	CREATE	2021-03-30 07:31:33.907	Site Set-up	Financial Disclosure Form
15792	88	1617082295021:51019444	1617051160575:-449321039	D5170C00001	1482	1476	CREATE	2021-03-30 07:31:35.105	Site Set-up	Principal Investigator Curriculum Vitae
15793	88	1617082295794:-1212001048	1617051160575:-449321039	D5170C00001	1483	1476	CREATE	2021-03-30 07:31:35.971	Site Set-up	Protocol Amendment Signature Page
15796	88	1617082297672:-494463552	1617051160575:-449321039	D5170C00001	1486	1476	CREATE	2021-03-30 07:31:37.757	Site Set-up	Sub-Investigator Curriculum Vitae
15800	88	1617082298270:-259660151	1617051169677:157127917	D5170C00001	1490	1489	CREATE	2021-03-30 07:31:38.355	General	Tracking Information
15805	88	1617082299472:408884831	1617051178161:-780455477	D5170C00001	1495	1494	CREATE	2021-03-30 07:31:39.555	IP Allocation Documentation	IP Unblinding Plan
15810	88	1617082300766:-1928655565	1617051181098:1211537658	D5170C00001	1500	1499	CREATE	2021-03-30 07:31:40.852	General	Tracking Information
15816	88	1617082302502:-1854341404	1617051185477:1230346931	D5170C00001	1506	1504	CREATE	2021-03-30 07:31:42.59	Site Management	Visit Log
15818	88	1617082304811:1516075324	1617051187373:673246207	D5170C00001	1508	1507	CREATE	2021-03-30 07:31:44.897	Site Selection	Confidentiality Agreement
15823	88	1617082307257:-81952835	1617051189275:-144455774	D5170C00001	1513	1510	CREATE	2021-03-30 07:31:47.343	Site Set-up	Data Privacy Agreement
15824	88	1617082307825:-218007166	1617051189275:-144455774	D5170C00001	1514	1510	CREATE	2021-03-30 07:31:47.91	Site Set-up	Financial Disclosure Form
15827	88	1617082309854:-1494942607	1617051189275:-144455774	D5170C00001	1517	1510	CREATE	2021-03-30 07:31:49.947	Site Set-up	Protocol Amendment Signature Page
15829	88	1617082311081:-1972068603	1617051189275:-144455774	D5170C00001	1519	1510	CREATE	2021-03-30 07:31:51.166	Site Set-up	Site Signature Sheet
16418	88	1617082609586:1272458023	1617051680876:-590282257	D5170C00001	2108	2107	CREATE	2021-03-30 07:36:49.675	General	Relevant Communications
15835	88	1617082312361:1862111645	1617051198940:-944855929	D5170C00001	1525	1524	CREATE	2021-03-30 07:31:52.449	Sample Documentation	Sample Storage Condition Log
15840	88	1617082313592:840592553	1617051202040:-57295690	D5170C00001	1530	1529	CREATE	2021-03-30 07:31:53.677	Subject Documentation	Informed Consent Form
15875	88	1617082329758:-1176452197	1617051231050:19452071	D5170C00001	1565	1564	CREATE	2021-03-30 07:32:09.841	Site Set-up	Acceptance of Investigator Brochure
15878	88	1617082331625:-1165446475	1617051231050:19452071	D5170C00001	1568	1564	CREATE	2021-03-30 07:32:11.711	Site Set-up	Financial Disclosure Form
15881	88	1617082333386:-948020603	1617051231050:19452071	D5170C00001	1571	1564	CREATE	2021-03-30 07:32:13.517	Site Set-up	Principal Investigator Curriculum Vitae
15883	88	1617082334621:-1543003724	1617051231050:19452071	D5170C00001	1573	1564	CREATE	2021-03-30 07:32:14.717	Site Set-up	Protocol Signature Page
15885	88	1617082336004:-1493492990	1617051231050:19452071	D5170C00001	1575	1564	CREATE	2021-03-30 07:32:16.088	Site Set-up	Sub-Investigator Curriculum Vitae
15892	88	1617082344809:61130427	1617051242085:-4346172	D5170C00001	1582	1580	CREATE	2021-03-30 07:32:24.898	Subject Documentation	Other Information Given to Subjects
15893	88	1617082345414:-1976166127	1617051242085:-4346172	D5170C00001	1583	1580	CREATE	2021-03-30 07:32:25.507	Subject Documentation	Subject Information Sheet
16207	88	1617082502880:122452491	1617051511569:-255478584	D5170C00001	1897	1896	CREATE	2021-03-30 07:35:02.963	General	Relevant Communications
15849	88	1617051213717:1973607632	1617051211925:883377633	D5170C00001	1539	1536	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IP and Trial Supplies	IP Documentation
15854	88	1617051216753:1821140270	1617051216147:-267716567	D5170C00001	1544	1543	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IRB or IEC and other Approvals	General
15864	88	1617051223845:2015694306	1617051222038:1690238521	D5170C00001	1554	1551	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Initiation
15867	88	1617051225616:1099805762	1617051222038:1690238521	D5170C00001	1557	1551	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Management
15848	88	1617082317564:1320792920	1617051212494:-1175528562	D5170C00001	1538	1537	CREATE	2021-03-30 07:31:57.65	Interactive Response Technology	IRT User Account Management
15851	88	1617082318738:1448056124	1617051213717:1973607632	D5170C00001	1541	1539	CREATE	2021-03-30 07:31:58.831	IP Documentation	IP Certificate of Destruction
15852	88	1617082319445:1844002034	1617051213717:1973607632	D5170C00001	1542	1539	CREATE	2021-03-30 07:31:59.533	IP Documentation	IP Shipment Documentation
15855	88	1617082320086:-2002341432	1617051216753:1821140270	D5170C00001	1545	1544	CREATE	2021-03-30 07:32:00.174	General	Relevant Communications
15857	88	1617082320939:824908618	1617051218992:797387911	D5170C00001	1547	1546	CREATE	2021-03-30 07:32:01.034	IRB or IEC Trial Approval	IRB or IEC Approval
15858	88	1617082321559:-1481090	1617051218992:797387911	D5170C00001	1548	1546	CREATE	2021-03-30 07:32:01.65	IRB or IEC Trial Approval	IRB or IEC Submission
15860	88	1617082322221:-1185627312	1617051220732:-427473196	D5170C00001	1550	1549	CREATE	2021-03-30 07:32:02.308	Other Committees	Other Submissions
15863	88	1617082322791:1224896726	1617051222601:918287663	D5170C00001	1553	1552	CREATE	2021-03-30 07:32:02.873	General	Relevant Communications
15866	88	1617082324657:-37697975	1617051223845:2015694306	D5170C00001	1556	1554	CREATE	2021-03-30 07:32:04.747	Site Initiation	Trial Initiation Monitoring Report
15869	88	1617082325848:718654126	1617051225616:1099805762	D5170C00001	1559	1557	CREATE	2021-03-30 07:32:05.932	Site Management	Visit Log
15872	88	1617082328534:992855108	1617051227319:1442344714	D5170C00001	1562	1560	CREATE	2021-03-30 07:32:08.618	Site Selection	Feasibility Documentation
15873	88	1617082329121:-1309320273	1617051227319:1442344714	D5170C00001	1563	1560	CREATE	2021-03-30 07:32:09.208	Site Selection	Pre Trial Monitoring Report
15896	88	1617082346102:441649817	1617051253347:1454458511	D5170C00001	1586	1585	CREATE	2021-03-30 07:32:26.195	General	Tracking Information
15901	88	1617082353470:1264805910	1617051256732:2116263717	D5170C00001	1591	1590	CREATE	2021-03-30 07:32:33.582	IP Documentation	IP Accountability Documentation
15902	88	1617082354187:-827933397	1617051256732:2116263717	D5170C00001	1592	1590	CREATE	2021-03-30 07:32:34.275	IP Documentation	IP Certificate of Destruction
15905	88	1617082355379:-2063914683	1617051259160:-1043437806	D5170C00001	1595	1594	CREATE	2021-03-30 07:32:35.464	Storage	IP Storage Condition Documentation
15908	88	1617082356050:441049378	1617051261395:-1705887322	D5170C00001	1598	1597	CREATE	2021-03-30 07:32:36.14	IRB or IEC Trial Approval	IRB or IEC Approval
15917	88	1617082359340:1743290066	1617051268067:480672253	D5170C00001	1607	1605	CREATE	2021-03-30 07:32:39.426	Site Initiation	Trial Initiation Monitoring Report
15920	88	1617082360578:1943902136	1617051269881:-925424301	D5170C00001	1610	1608	CREATE	2021-03-30 07:32:40.662	Site Management	Visit Log
15923	88	1617082361819:1019388309	1617051271795:-697836174	D5170C00001	1613	1611	CREATE	2021-03-30 07:32:41.903	Site Selection	Pre Trial Monitoring Report
15926	88	1617082363024:-1004579532	1617051274641:-906178156	D5170C00001	1616	1614	CREATE	2021-03-30 07:32:43.113	Site Set-up	Clinical Study Agreement
15927	88	1617082363606:-2117382549	1617051274641:-906178156	D5170C00001	1617	1614	CREATE	2021-03-30 07:32:44.596	Site Set-up	Data Privacy Agreement
15929	88	1617082365683:-950591624	1617051274641:-906178156	D5170C00001	1619	1614	CREATE	2021-03-30 07:32:45.767	Site Set-up	Investigator Regulatory Agreement
15930	88	1617082366300:1462836003	1617051274641:-906178156	D5170C00001	1620	1614	CREATE	2021-03-30 07:32:46.384	Site Set-up	Other Curriculum Vitae
15932	88	1617082367471:1077804867	1617051274641:-906178156	D5170C00001	1622	1614	CREATE	2021-03-30 07:32:47.559	Site Set-up	Protocol Amendment Signature Page
15933	88	1617082368054:-2140849773	1617051274641:-906178156	D5170C00001	1623	1614	CREATE	2021-03-30 07:32:48.144	Site Set-up	Protocol Signature Page
15935	88	1617082369290:-1481236410	1617051274641:-906178156	D5170C00001	1625	1614	CREATE	2021-03-30 07:32:49.374	Site Set-up	Sub-Investigator Curriculum Vitae
15941	88	1617082370408:-1636223377	1617051285805:652595976	D5170C00001	1631	1630	CREATE	2021-03-30 07:32:50.491	Subject Documentation	Informed Consent Form
15943	88	1617082371643:-1448570723	1617051285805:652595976	D5170C00001	1633	1630	CREATE	2021-03-30 07:32:51.73	Subject Documentation	Subject Information Sheet
15949	88	1617082372843:916264885	1617051298607:-2136709533	D5170C00001	1639	1638	CREATE	2021-03-30 07:32:52.924	Interactive Response Technology	IRT User Account Management
15952	88	1617082373958:80040645	1617051299779:2025892608	D5170C00001	1642	1640	CREATE	2021-03-30 07:32:54.042	IP Documentation	IP Certificate of Destruction
15953	88	1617082374636:-227777426	1617051299779:2025892608	D5170C00001	1643	1640	CREATE	2021-03-30 07:32:55.616	IP Documentation	IP Shipment Documentation
15958	88	1617082376737:473042774	1617051303998:-1566993405	D5170C00001	1648	1647	CREATE	2021-03-30 07:32:56.819	IRB or IEC Trial Approval	IRB or IEC Approval
15959	88	1617082377298:-553211613	1617051303998:-1566993405	D5170C00001	1649	1647	CREATE	2021-03-30 07:32:57.386	IRB or IEC Trial Approval	IRB or IEC Submission
15965	88	1617082379034:-782304541	1617051310609:-1343289251	D5170C00001	1655	1653	CREATE	2021-03-30 07:32:59.118	General	Relevant Communications
15967	88	1617082379627:56018394	1617051312421:158138468	D5170C00001	1657	1656	CREATE	2021-03-30 07:32:59.717	Site Initiation	Site Evidence of Training
15970	88	1617082380834:489635417	1617051314302:-1247947477	D5170C00001	1660	1659	CREATE	2021-03-30 07:33:00.919	Site Management	Monitoring Visit Report
15971	88	1617082381437:-1841084239	1617051314302:-1247947477	D5170C00001	1661	1659	CREATE	2021-03-30 07:33:01.532	Site Management	Visit Log
15974	88	1617082382650:-1773576921	1617051316292:-1020391177	D5170C00001	1664	1662	CREATE	2021-03-30 07:33:02.736	Site Selection	Pre Trial Monitoring Report
15976	88	1617082383204:1467150332	1617051318031:-2130356718	D5170C00001	1666	1665	CREATE	2021-03-30 07:33:03.29	Site Set-up	Acceptance of Investigator Brochure
15979	88	1617082385110:1771682085	1617051318031:-2130356718	D5170C00001	1669	1665	CREATE	2021-03-30 07:33:05.197	Site Set-up	Financial Disclosure Form
15981	88	1617082387533:92730078	1617051318031:-2130356718	D5170C00001	1671	1665	CREATE	2021-03-30 07:33:07.632	Site Set-up	Other Curriculum Vitae
15988	88	1617051329150:-1092230548	1617051328560:2039166344	D5170C00001	1678	1677	ALREADY AVAILABLE	2021-03-30 07:19:37.333	4104	Central and Local Testing
15998	88	1617051336664:-806223756	1617051328560:2039166344	D5170C00001	1688	1677	ALREADY AVAILABLE	2021-03-30 07:19:37.333	4104	Data Management
15999	88	1617051337249:1582041782	1617051336664:-806223756	D5170C00001	1689	1688	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Data Management	General
16002	88	1617051346680:210981169	1617051338492:1288169443	D5170C00001	1692	1691	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IP and Trial Supplies	IP Documentation
16006	88	1617051349306:1032237722	1617051338492:1288169443	D5170C00001	1696	1691	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IP and Trial Supplies	Storage
16012	88	1617051353549:152004825	1617051350504:335083347	D5170C00001	1702	1698	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IRB or IEC and other Approvals	Other Committees
16015	88	1617051355380:1233902396	1617051354772:688645357	D5170C00001	1705	1704	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Safety Reporting	General
16018	88	1617051357300:375017191	1617051356725:1804396904	D5170C00001	1708	1707	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	General
16051	88	1617051386949:-186529877	1617051385239:175335913	D5170C00001	1741	1738	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Central Trial Documents	Subject Documentation
16064	88	1617051395212:1959655778	1617051394569:-162242957	D5170C00001	1754	1753	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IRB or IEC and other Approvals	IRB or IEC Trial Approval
16067	88	1617051398365:442414412	1617051394569:-162242957	D5170C00001	1757	1753	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IRB or IEC and other Approvals	Other Committees
16070	88	1617051400266:-757810098	1617051399678:1190532078	D5170C00001	1760	1759	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	General
16072	88	1617051401513:1039201798	1617051399678:1190532078	D5170C00001	1762	1759	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Initiation
16075	88	1617051403323:239356806	1617051399678:1190532078	D5170C00001	1765	1759	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Management
15985	88	1617082389957:-649543044	1617051318031:-2130356718	D5170C00001	1675	1665	CREATE	2021-03-30 07:33:10.042	Site Set-up	Site Signature Sheet
15990	88	1617082391228:779678857	1617051331158:1313932754	D5170C00001	1680	1679	CREATE	2021-03-30 07:33:11.312	General	Filenote
15993	88	1617082391809:1666776855	1617051332956:1076439076	D5170C00001	1683	1682	CREATE	2021-03-30 07:33:11.892	General	Explanation of Approvals non English language
15995	88	1617082392445:-929741070	1617051334245:1550326067	D5170C00001	1685	1684	CREATE	2021-03-30 07:33:17.805	Subject Documentation	Informed Consent Form
15996	88	1617082398369:1495136471	1617051334245:1550326067	D5170C00001	1686	1684	CREATE	2021-03-30 07:33:18.453	Subject Documentation	Other Information Given to Subjects
16000	88	1617082399521:-1180959746	1617051337249:1582041782	D5170C00001	1690	1689	CREATE	2021-03-30 07:33:19.611	General	Tracking Information
16004	88	1617082400779:-2029162949	1617051346680:210981169	D5170C00001	1694	1692	CREATE	2021-03-30 07:33:20.867	IP Documentation	IP Certificate of Destruction
16005	88	1617082401396:-1926700634	1617051346680:210981169	D5170C00001	1695	1692	CREATE	2021-03-30 07:33:21.486	IP Documentation	IP Shipment Documentation
16010	88	1617082402596:726060502	1617051351150:1260822380	D5170C00001	1700	1699	CREATE	2021-03-30 07:33:23.047	IRB or IEC Trial Approval	IRB or IEC Approval
16011	88	1617082403608:509709769	1617051351150:1260822380	D5170C00001	1701	1699	CREATE	2021-03-30 07:33:23.696	IRB or IEC Trial Approval	IRB or IEC Submission
16020	88	1617082406060:-1871561403	1617051357300:375017191	D5170C00001	1710	1708	CREATE	2021-03-30 07:33:26.149	General	Relevant Communications
16022	88	1617082406676:987309108	1617051359155:1468148407	D5170C00001	1712	1711	CREATE	2021-03-30 07:33:26.777	Site Initiation	Site Evidence of Training
16023	88	1617082407276:-905810876	1617051359155:1468148407	D5170C00001	1713	1711	CREATE	2021-03-30 07:33:27.369	Site Initiation	Site Training Material
16026	88	1617082410161:-419106619	1617051361552:62062462	D5170C00001	1716	1715	CREATE	2021-03-30 07:33:30.245	Site Management	Monitoring Visit Report
16027	88	1617082410750:1134956116	1617051361552:62062462	D5170C00001	1717	1715	CREATE	2021-03-30 07:33:30.839	Site Management	Visit Log
16029	88	1617082411388:1692590452	1617051363367:292833289	D5170C00001	1719	1718	CREATE	2021-03-30 07:33:31.482	Site Selection	Confidentiality Agreement
16032	88	1617082412532:700221358	1617051365201:-524879301	D5170C00001	1722	1721	CREATE	2021-03-30 07:33:32.618	Site Set-up	Acceptance of Investigator Brochure
16035	88	1617082414746:711131599	1617051365201:-524879301	D5170C00001	1725	1721	CREATE	2021-03-30 07:33:34.83	Site Set-up	Financial Disclosure Form
16037	88	1617082416097:-474344826	1617051365201:-524879301	D5170C00001	1727	1721	CREATE	2021-03-30 07:33:36.181	Site Set-up	Other Curriculum Vitae
16040	88	1617082417904:-626146739	1617051365201:-524879301	D5170C00001	1730	1721	CREATE	2021-03-30 07:33:37.987	Site Set-up	Protocol Amendment Signature Page
6928	84	\N	\N	D5170C00002	713	712	NEW	\N	05 Site Management	05.01 Site Selection
16043	88	1617082420909:793319381	1617051365201:-524879301	D5170C00001	1733	1721	CREATE	2021-03-30 07:33:40.998	Site Set-up	Sub-Investigator Curriculum Vitae
16052	88	1617082422732:504607987	1617051386949:-186529877	D5170C00001	1742	1741	CREATE	2021-03-30 07:33:42.816	Subject Documentation	Informed Consent Form
16066	88	1617082426918:-1373841326	1617051395212:1959655778	D5170C00001	1756	1754	CREATE	2021-03-30 07:33:47.004	IRB or IEC Trial Approval	IRB or IEC Submission
16073	88	1617082428696:-879957210	1617051401513:1039201798	D5170C00001	1763	1762	CREATE	2021-03-30 07:33:49.145	Site Initiation	Site Evidence of Training
16079	88	1617082432784:-1323637086	1617051405136:-233742438	D5170C00001	1769	1768	CREATE	2021-03-30 07:33:52.867	Site Selection	Confidentiality Agreement
16082	88	1617082434116:1495642616	1617051406941:-1249314606	D5170C00001	1772	1771	CREATE	2021-03-30 07:33:54.201	Site Set-up	Acceptance of Investigator Brochure
16085	88	1617082437068:2000039048	1617051406941:-1249314606	D5170C00001	1775	1771	CREATE	2021-03-30 07:33:57.157	Site Set-up	Financial Disclosure Form
16087	88	1617082438594:321087041	1617051406941:-1249314606	D5170C00001	1777	1771	CREATE	2021-03-30 07:33:58.68	Site Set-up	Other Curriculum Vitae
16090	88	1617082440613:956382222	1617051406941:-1249314606	D5170C00001	1780	1771	CREATE	2021-03-30 07:34:00.701	Site Set-up	Protocol Amendment Signature Page
16093	88	1617082443858:1788541664	1617051406941:-1249314606	D5170C00001	1783	1771	CREATE	2021-03-30 07:34:03.944	Site Set-up	Sub-Investigator Curriculum Vitae
16101	88	1617082445374:577961810	1617051423419:-626527195	D5170C00001	1791	1790	CREATE	2021-03-30 07:34:05.458	Sample Documentation	Sample Storage Condition Log
16108	88	1617051428635:392271406	1617051422295:1689434483	D5170C00001	1798	1788	ALREADY AVAILABLE	2021-03-30 07:19:37.334	4107	Data Management
16118	88	1617051436168:1828897461	1617051422295:1689434483	D5170C00001	1808	1788	ALREADY AVAILABLE	2021-03-30 07:19:37.335	4107	IRB or IEC and other Approvals
16112	88	1617051432683:-589143661	1617051432103:-1512973130	D5170C00001	1802	1801	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IP and Trial Supplies	Interactive Response Technology
16114	88	1617051433837:-1425145489	1617051432103:-1512973130	D5170C00001	1804	1801	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IP and Trial Supplies	IP Documentation
16119	88	1617051436825:-121233594	1617051436168:1828897461	D5170C00001	1809	1808	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IRB or IEC and other Approvals	IRB or IEC Trial Approval
16106	88	1617082446758:1234158491	1617051426566:21106758	D5170C00001	1796	1795	CREATE	2021-03-30 07:34:06.844	Subject Documentation	Informed Consent Form
16107	88	1617082447442:1505105475	1617051426566:21106758	D5170C00001	1797	1795	CREATE	2021-03-30 07:34:07.528	Subject Documentation	Subject Information Sheet
16110	88	1617082448081:-1848195210	1617051429230:2006799232	D5170C00001	1800	1799	CREATE	2021-03-30 07:34:08.165	General	Tracking Information
16115	88	1617082449466:1171524370	1617051433837:-1425145489	D5170C00001	1805	1804	CREATE	2021-03-30 07:34:09.555	IP Documentation	IP Accountability Documentation
16116	88	1617082450051:-111215802	1617051433837:-1425145489	D5170C00001	1806	1804	CREATE	2021-03-30 07:34:20.472	IP Documentation	IP Certificate of Destruction
16121	88	1617082462516:-1010627158	1617051436825:-121233594	D5170C00001	1811	1809	CREATE	2021-03-30 07:34:22.604	IRB or IEC Trial Approval	IRB or IEC Submission
16128	88	1617082465713:685839820	1617051446143:-828741018	D5170C00001	1818	1817	CREATE	2021-03-30 07:34:25.798	Site Initiation	Site Evidence of Training
16134	88	1617082468527:1265755726	1617051449798:1502159062	D5170C00001	1824	1823	CREATE	2021-03-30 07:34:28.637	Site Selection	Confidentiality Agreement
16135	88	1617082469232:1539472830	1617051449798:1502159062	D5170C00001	1825	1823	CREATE	2021-03-30 07:34:29.316	Site Selection	Pre Trial Monitoring Report
16137	88	1617082470035:-1601522517	1617051451517:979818469	D5170C00001	1827	1826	CREATE	2021-03-30 07:34:30.121	Site Set-up	Acceptance of Investigator Brochure
16140	88	1617082472106:-193433771	1617051451517:979818469	D5170C00001	1830	1826	CREATE	2021-03-30 07:34:32.19	Site Set-up	Financial Disclosure Form
16142	88	1617082473314:-1872385778	1617051451517:979818469	D5170C00001	1832	1826	CREATE	2021-03-30 07:34:33.404	Site Set-up	Other Curriculum Vitae
16143	88	1617082474031:-879689604	1617051451517:979818469	D5170C00001	1833	1826	CREATE	2021-03-30 07:34:34.119	Site Set-up	Principal Investigator Curriculum Vitae
16145	88	1617082476804:-570991020	1617051451517:979818469	D5170C00001	1835	1826	CREATE	2021-03-30 07:34:36.902	Site Set-up	Protocol Signature Page
16146	88	1617082477629:1070216376	1617051451517:979818469	D5170C00001	1836	1826	CREATE	2021-03-30 07:34:37.72	Site Set-up	Site Signature Sheet
16152	88	1617082478971:-819991067	1617051461778:-2095242641	D5170C00001	1842	1841	CREATE	2021-03-30 07:34:39.068	General	Relevant Communications
16155	88	1617082479570:1746472055	1617051464866:-1903743660	D5170C00001	1845	1844	CREATE	2021-03-30 07:34:39.655	General	Filenote
16162	88	1617082481623:1896835236	1617051469535:191536839	D5170C00001	1852	1851	CREATE	2021-03-30 07:34:41.705	General	Relevant Communications
16166	88	1617082482928:816265876	1617051471889:1241173306	D5170C00001	1856	1855	CREATE	2021-03-30 07:34:43.013	IP Documentation	IP Accountability Documentation
16169	88	1617082484254:168599992	1617051473791:-1626285875	D5170C00001	1859	1858	CREATE	2021-03-30 07:34:44.348	Storage	IP Storage Condition Documentation
16172	88	1617082485029:2003635126	1617051480747:-146340867	D5170C00001	1862	1861	CREATE	2021-03-30 07:34:45.117	General	Filenote
16175	88	1617082486406:-466414261	1617051482517:1848509389	D5170C00001	1865	1864	CREATE	2021-03-30 07:34:46.49	Site Initiation	Site Evidence of Training
16177	88	1617082488433:1394738033	1617051483668:34126941	D5170C00001	1867	1866	CREATE	2021-03-30 07:34:48.521	Site Management	Additional Monitoring Activity
16178	88	1617082489025:-1778564485	1617051483668:34126941	D5170C00001	1868	1866	CREATE	2021-03-30 07:34:49.109	Site Management	Monitoring Visit Report
16180	88	1617082490267:502118183	1617051483668:34126941	D5170C00001	1870	1866	CREATE	2021-03-30 07:34:50.35	Site Management	Visit Log
16183	88	1617082491435:-1032177901	1617051487976:377748011	D5170C00001	1873	1871	CREATE	2021-03-30 07:34:51.519	Site Selection	Feasibility Documentation
16186	88	1617082492757:315796397	1617051489675:-848292909	D5170C00001	1876	1874	CREATE	2021-03-30 07:34:52.84	Site Set-up	Clinical Study Agreement
16187	88	1617082493345:-303573474	1617051489675:-848292909	D5170C00001	1877	1874	CREATE	2021-03-30 07:34:53.428	Site Set-up	Data Privacy Agreement
16189	88	1617082494566:-1744995196	1617051489675:-848292909	D5170C00001	1879	1874	CREATE	2021-03-30 07:34:54.65	Site Set-up	Other Curriculum Vitae
16423	88	1617082611938:-1227343714	1617051683853:-2050834138	D5170C00001	2113	2112	CREATE	2021-03-30 07:36:52.022	General	Filenote
16190	88	1617082495981:100603630	1617051489675:-848292909	D5170C00001	1880	1874	CREATE	2021-03-30 07:34:56.066	Site Set-up	Other Financial Agreement
16192	88	1617082497176:-993104795	1617051489675:-848292909	D5170C00001	1882	1874	CREATE	2021-03-30 07:34:57.261	Site Set-up	Protocol Amendment Signature Page
16193	88	1617082497754:-327030089	1617051489675:-848292909	D5170C00001	1883	1874	CREATE	2021-03-30 07:34:57.838	Site Set-up	Protocol Signature Page
16195	88	1617082500397:178625107	1617051489675:-848292909	D5170C00001	1885	1874	CREATE	2021-03-30 07:35:00.489	Site Set-up	Site Staff Qualification Supporting Information
16200	88	1617082501604:1556942514	1617051500118:196725134	D5170C00001	1890	1889	CREATE	2021-03-30 07:35:01.704	Site Management	Additional Monitoring Activity
16204	88	1617082502306:-972286154	1617051508350:335862163	D5170C00001	1894	1893	CREATE	2021-03-30 07:35:02.396	General	Tracking Information
16210	88	1617082504176:-2089363279	1617051512807:71420844	D5170C00001	1900	1898	CREATE	2021-03-30 07:35:04.265	IP Documentation	IP Certificate of Destruction
16214	88	1617082505336:-1674862692	1617051516874:1320095484	D5170C00001	1904	1903	CREATE	2021-03-30 07:35:05.424	Storage	IP Storage Condition Documentation
16217	88	1617082505904:-558996988	1617051518723:1654198188	D5170C00001	1907	1906	CREATE	2021-03-30 07:35:05.991	General	Filenote
16221	88	1617082507983:1751344281	1617051521930:-1876364631	D5170C00001	1911	1909	CREATE	2021-03-30 07:35:08.069	Site Management	Subject Log
16222	88	1617082508634:1529377666	1617051521930:-1876364631	D5170C00001	1912	1909	CREATE	2021-03-30 07:35:17.948	Site Management	Visit Log
16227	88	1617082519715:1690731403	1617051525539:1536193424	D5170C00001	1917	1915	CREATE	2021-03-30 07:35:19.807	Site Set-up	Clinical Study Agreement
16247	88	1617051544589:-366591814	1617051537945:1496073049	D5170C00001	1937	1927	ALREADY AVAILABLE	2021-03-30 07:19:37.335	5704	IP and Trial Supplies
16312	88	1617051591796:372971267	1617051591205:320405571	D5170C00001	2002	2001	ALREADY AVAILABLE	2021-03-30 07:19:37.336	5706	IP and Trial Supplies
16344	88	1617051620557:1614627265	1617051619941:-1439714764	D5170C00001	2034	2033	ALREADY AVAILABLE	2021-03-30 07:19:37.336	5708	Site Management
16239	88	1617051539086:-1314893089	1617051538521:1136432634	D5170C00001	1929	1928	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Central and Local Testing	General
16250	88	1617051546343:175744749	1617051544589:-366591814	D5170C00001	1940	1937	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IP and Trial Supplies	IP Documentation
16253	88	1617051548066:997022520	1617051544589:-366591814	D5170C00001	1943	1937	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IP and Trial Supplies	Storage
16228	88	1617082520351:577928386	1617051525539:1536193424	D5170C00001	1918	1915	CREATE	2021-03-30 07:35:20.442	Site Set-up	Data Privacy Agreement
16230	88	1617082522955:-663702920	1617051525539:1536193424	D5170C00001	1920	1915	CREATE	2021-03-30 07:35:23.039	Site Set-up	Other Curriculum Vitae
16231	88	1617082523534:1181895906	1617051525539:1536193424	D5170C00001	1921	1915	CREATE	2021-03-30 07:35:23.617	Site Set-up	Other Financial Agreement
16233	88	1617082524891:-322029251	1617051525539:1536193424	D5170C00001	1923	1915	CREATE	2021-03-30 07:35:24.975	Site Set-up	Protocol Amendment Signature Page
16234	88	1617082525457:754283405	1617051525539:1536193424	D5170C00001	1924	1915	CREATE	2021-03-30 07:35:25.542	Site Set-up	Protocol Signature Page
16236	88	1617082526678:803794139	1617051525539:1536193424	D5170C00001	1926	1915	CREATE	2021-03-30 07:35:26.761	Site Set-up	Sub-Investigator Curriculum Vitae
16240	88	1617082527255:-1608711319	1617051539086:-1314893089	D5170C00001	1930	1929	CREATE	2021-03-30 07:35:27.338	General	Relevant Communications
16243	88	1617082527833:-1841238025	1617051540871:453979375	D5170C00001	1933	1932	CREATE	2021-03-30 07:35:27.918	General	Relevant Communications
16249	88	1617082529092:1043358828	1617051545157:110154845	D5170C00001	1939	1938	CREATE	2021-03-30 07:35:29.18	Interactive Response Technology	IRT User Account Management
16251	88	1617082529668:-687185094	1617051546343:175744749	D5170C00001	1941	1940	CREATE	2021-03-30 07:35:29.752	IP Documentation	IP Accountability Documentation
16254	88	1617082530899:-1438370390	1617051548066:997022520	D5170C00001	1944	1943	CREATE	2021-03-30 07:35:30.985	Storage	IP Storage Condition Documentation
16257	88	1617082531542:-1736836999	1617051549813:-529203249	D5170C00001	1947	1946	CREATE	2021-03-30 07:35:31.626	General	Relevant Communications
16259	88	1617082532141:1738152158	1617051550969:975492042	D5170C00001	1949	1948	CREATE	2021-03-30 07:35:32.237	Site Initiation	Site Evidence of Training
16262	88	1617082540291:-1797674339	1617051552139:59561062	D5170C00001	1952	1950	CREATE	2021-03-30 07:35:40.379	Site Management	Monitoring Visit Report
16263	88	1617082540859:1315024528	1617051552139:59561062	D5170C00001	1953	1950	CREATE	2021-03-30 07:35:40.943	Site Management	Subject Log
16266	88	1617082542066:745096075	1617051559484:-203133084	D5170C00001	1956	1955	CREATE	2021-03-30 07:35:42.156	Site Selection	Confidentiality Agreement
16269	88	1617082543233:443087188	1617051561626:-822837570	D5170C00001	1959	1958	CREATE	2021-03-30 07:35:43.328	Site Set-up	Acceptance of Investigator Brochure
16271	88	1617082545277:793258274	1617051561626:-822837570	D5170C00001	1961	1958	CREATE	2021-03-30 07:35:45.372	Site Set-up	Data Privacy Agreement
16272	88	1617082545941:1147348299	1617051561626:-822837570	D5170C00001	1962	1958	CREATE	2021-03-30 07:35:46.053	Site Set-up	Financial Disclosure Form
16274	88	1617082547111:703832488	1617051561626:-822837570	D5170C00001	1964	1958	CREATE	2021-03-30 07:35:47.206	Site Set-up	Other Financial Agreement
16276	88	1617082548333:-506396894	1617051561626:-822837570	D5170C00001	1966	1958	CREATE	2021-03-30 07:35:48.422	Site Set-up	Protocol Amendment Signature Page
16277	88	1617082548884:769791050	1617051561626:-822837570	D5170C00001	1967	1958	CREATE	2021-03-30 07:35:48.974	Site Set-up	Protocol Signature Page
16278	88	1617082549484:-1180162433	1617051561626:-822837570	D5170C00001	1968	1958	CREATE	2021-03-30 07:35:49.571	Site Set-up	Site Signature Sheet
16287	88	1617082552022:1901218655	1617051573651:-1142260688	D5170C00001	1977	1976	CREATE	2021-03-30 07:35:52.108	Non-IP Documentation	Non-IP Shipment Documentation
16292	88	1617082553344:973707618	1617051577421:1984810468	D5170C00001	1982	1981	CREATE	2021-03-30 07:35:53.428	Site Management	Additional Monitoring Activity
16293	88	1617082554141:-1905877907	1617051577421:1984810468	D5170C00001	1983	1981	CREATE	2021-03-30 07:35:54.228	Site Management	Monitoring Visit Report
16298	88	1617082557778:-1849160169	1617051580719:1514087640	D5170C00001	1988	1986	CREATE	2021-03-30 07:35:57.864	Site Selection	Feasibility Documentation
16301	88	1617082558922:-174539385	1617051582575:204087676	D5170C00001	1991	1989	CREATE	2021-03-30 07:35:59.007	Site Set-up	Clinical Study Agreement
16304	88	1617082560724:1566192563	1617051582575:204087676	D5170C00001	1994	1989	CREATE	2021-03-30 07:36:00.812	Site Set-up	Other Curriculum Vitae
16307	88	1617082562494:2107720302	1617051582575:204087676	D5170C00001	1997	1989	CREATE	2021-03-30 07:36:02.579	Site Set-up	Protocol Amendment Signature Page
16309	88	1617082563697:1234079475	1617051582575:204087676	D5170C00001	1999	1989	CREATE	2021-03-30 07:36:03.785	Site Set-up	Site Signature Sheet
16310	88	1617082564250:-1061434213	1617051582575:204087676	D5170C00001	2000	1989	CREATE	2021-03-30 07:36:04.335	Site Set-up	Sub-Investigator Curriculum Vitae
16318	88	1617082567691:836891822	1617051594747:-1900085486	D5170C00001	2008	2007	CREATE	2021-03-30 07:36:07.777	Non-IP Documentation	Non-IP Shipment Documentation
16321	88	1617082568301:-124924336	1617051597487:-392127918	D5170C00001	2011	2010	CREATE	2021-03-30 07:36:08.385	Site Initiation	Site Evidence of Training
16325	88	1617082570099:1144643496	1617051598904:-1798224472	D5170C00001	2015	2012	CREATE	2021-03-30 07:36:10.184	Site Management	Visit Log
16327	88	1617082570806:-723088015	1617051607218:-1862910514	D5170C00001	2017	2016	CREATE	2021-03-30 07:36:10.89	Site Selection	Confidentiality Agreement
16330	88	1617082572143:-44187201	1617051610102:1204000152	D5170C00001	2020	2019	CREATE	2021-03-30 07:36:12.229	Site Set-up	Clinical Study Agreement
16332	88	1617082573232:-1096649013	1617051610102:1204000152	D5170C00001	2022	2019	CREATE	2021-03-30 07:36:13.316	Site Set-up	Financial Disclosure Form
16335	88	1617082574948:2121523355	1617051610102:1204000152	D5170C00001	2025	2019	CREATE	2021-03-30 07:36:15.031	Site Set-up	Protocol Amendment Signature Page
16338	88	1617082576727:-637626608	1617051610102:1204000152	D5170C00001	2028	2019	CREATE	2021-03-30 07:36:16.811	Site Set-up	Sub-Investigator Curriculum Vitae
16350	88	1617051624314:249184512	1617051623515:-610352553	D5170C00001	2040	2039	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Central and Local Testing	General
16352	88	1617051625577:-2078306383	1617051623515:-610352553	D5170C00001	2042	2039	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Central and Local Testing	Sample Documentation
16355	88	1617051627401:1420945330	1617051626763:-1337105703	D5170C00001	2045	2044	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Central Trial Documents	General
16360	88	1617051631540:626925415	1617051630952:-325247526	D5170C00001	2050	2049	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Data Management	EDC Management
16362	88	1617051632788:690695904	1617051630952:-325247526	D5170C00001	2052	2049	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Data Management	General
16365	88	1617051634735:1738569991	1617051634105:2061260707	D5170C00001	2055	2054	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IP and Trial Supplies	General
16441	88	1617051703339:-1803046710	1617051695619:-1755896893	D5170C00001	2131	2121	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IP and Trial Supplies	Non-IP Documentation
16444	88	1617051705171:779849103	1617051695619:-1755896893	D5170C00001	2134	2121	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IP and Trial Supplies	Storage
16447	88	1617051706969:-384668705	1617051706416:-1806330357	D5170C00001	2137	2136	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IRB or IEC and other Approvals	General
16449	88	1617051708240:-1408421064	1617051706416:-1806330357	D5170C00001	2139	2136	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IRB or IEC and other Approvals	IRB or IEC Trial Approval
16460	88	1617051723370:-405478492	1617051711732:-1356218563	D5170C00001	2150	2143	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Management
16346	88	1617082578873:2021795487	1617051621114:-2037951771	D5170C00001	2036	2035	CREATE	2021-03-30 07:36:23.46	Site Selection	Confidentiality Agreement
16356	88	1617082585860:-269692272	1617051627401:1420945330	D5170C00001	2046	2045	CREATE	2021-03-30 07:36:25.945	General	Filenote
16363	88	1617082587587:971919871	1617051632788:690695904	D5170C00001	2053	2052	CREATE	2021-03-30 07:36:27.672	General	Tracking Information
16366	88	1617082588145:1476428738	1617051634735:1738569991	D5170C00001	2056	2055	CREATE	2021-03-30 07:36:28.23	General	Filenote
16371	88	1617082591011:90714646	1617051645462:-1502442975	D5170C00001	2061	2060	CREATE	2021-03-30 07:36:31.097	IP Documentation	IP Accountability Documentation
16372	88	1617082591563:-1391837160	1617051645462:-1502442975	D5170C00001	2062	2060	CREATE	2021-03-30 07:36:31.645	IP Documentation	IP Certificate of Destruction
16375	88	1617082592714:-1158211272	1617051647838:1950696612	D5170C00001	2065	2064	CREATE	2021-03-30 07:36:32.87	Non-IP Documentation	Non-IP Return Documentation
16378	88	1617082593961:-454021919	1617051649575:-565645146	D5170C00001	2068	2067	CREATE	2021-03-30 07:36:34.044	Storage	IP Storage Condition Documentation
16381	88	1617082594517:-89820391	1617051651360:-655738977	D5170C00001	2071	2070	CREATE	2021-03-30 07:36:34.605	General	Relevant Communications
16383	88	1617082595102:-2007470012	1617051653617:-1974873942	D5170C00001	2073	2072	CREATE	2021-03-30 07:36:35.194	IRB or IEC Trial Approval	IRB or IEC Submission
16389	88	1617082596298:428145130	1617051657410:-1879270653	D5170C00001	2079	2078	CREATE	2021-03-30 07:36:36.386	General	Relevant Communications
16392	88	1617082596881:-2048327704	1617051659308:-364804022	D5170C00001	2082	2081	CREATE	2021-03-30 07:36:36.964	General	Filenote
16393	88	1617082597470:-860891710	1617051659308:-364804022	D5170C00001	2083	2081	CREATE	2021-03-30 07:36:37.554	General	Relevant Communications
16395	88	1617082598023:-838413523	1617051661159:2122344217	D5170C00001	2085	2084	CREATE	2021-03-30 07:36:38.109	Site Initiation	Site Evidence of Training
16398	88	1617082599166:-491703201	1617051663157:716247663	D5170C00001	2088	2087	CREATE	2021-03-30 07:36:39.259	Site Management	Monitoring Visit Report
16399	88	1617082601040:-1475685405	1617051663157:716247663	D5170C00001	2089	2087	CREATE	2021-03-30 07:36:41.125	Site Management	Protocol Deviations
16403	88	1617082602783:-265306906	1617051669750:1061884443	D5170C00001	2093	2091	CREATE	2021-03-30 07:36:42.929	Site Selection	Pre Trial Monitoring Report
16406	88	1617082604055:-1265952558	1617051671572:-658448952	D5170C00001	2096	2094	CREATE	2021-03-30 07:36:44.272	Site Set-up	Clinical Study Agreement
16407	88	1617082604757:-2141235899	1617051671572:-658448952	D5170C00001	2097	2094	CREATE	2021-03-30 07:36:44.839	Site Set-up	Financial Disclosure Form
16409	88	1617082605971:768464556	1617051671572:-658448952	D5170C00001	2099	2094	CREATE	2021-03-30 07:36:46.057	Site Set-up	Other Curriculum Vitae
16410	88	1617082606569:-1974599689	1617051671572:-658448952	D5170C00001	2100	2094	CREATE	2021-03-30 07:36:46.66	Site Set-up	Other Financial Agreement
16412	88	1617082607789:-2024097531	1617051671572:-658448952	D5170C00001	2102	2094	CREATE	2021-03-30 07:36:47.873	Site Set-up	Protocol Signature Page
16413	88	1617082608366:319791728	1617051671572:-658448952	D5170C00001	2103	2094	CREATE	2021-03-30 07:36:48.457	Site Set-up	Site Signature Sheet
16428	88	1617082613128:-1036232047	1617051693079:1351726709	D5170C00001	2118	2117	CREATE	2021-03-30 07:36:53.213	EDC Management	System Account Management
16438	88	1617082616175:2017711817	1617051700568:-1174541574	D5170C00001	2128	2127	CREATE	2021-03-30 07:36:56.267	IP Documentation	IP Accountability Documentation
16443	88	1617082618606:-917767019	1617051703339:-1803046710	D5170C00001	2133	2131	CREATE	2021-03-30 07:36:58.69	Non-IP Documentation	Non-IP Shipment Documentation
16450	88	1617082620302:-112854655	1617051708240:-1408421064	D5170C00001	2140	2139	CREATE	2021-03-30 07:37:00.386	IRB or IEC Trial Approval	IRB or IEC Submission
16455	88	1617082621493:1714372112	1617051716545:-1289498101	D5170C00001	2145	2144	CREATE	2021-03-30 07:37:01.581	General	Filenote
16456	88	1617082623195:1918803490	1617051716545:-1289498101	D5170C00001	2146	2144	CREATE	2021-03-30 07:37:03.278	General	Relevant Communications
16461	88	1617082625027:1004173706	1617051723370:-405478492	D5170C00001	2151	2150	CREATE	2021-03-30 07:37:05.111	Site Management	Monitoring Visit Report
16462	88	1617082625592:-2025122130	1617051723370:-405478492	D5170C00001	2152	2150	CREATE	2021-03-30 07:37:05.674	Site Management	Visit Log
16465	88	1617082626707:-1485577834	1617051725178:-273100631	D5170C00001	2155	2153	CREATE	2021-03-30 07:37:06.834	Site Selection	Pre Trial Monitoring Report
16467	88	1617082627299:-1911605938	1617051726989:-680554053	D5170C00001	2157	2156	CREATE	2021-03-30 07:37:07.386	Site Set-up	Acceptance of Investigator Brochure
16478	88	1617051735053:-1326550545	1617051734408:-462767479	D5170C00001	2168	2167	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Central and Local Testing	General
16490	88	1617051743021:494562777	1617051740336:921969211	D5170C00001	2180	2177	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Data Management	General
16493	88	1617051744852:1460728148	1617051744204:-1278615495	D5170C00001	2183	2182	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IP and Trial Supplies	General
16498	88	1617051747756:1904208534	1617051744204:-1278615495	D5170C00001	2188	2182	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IP and Trial Supplies	IP Documentation
16505	88	1617051752120:-846690907	1617051744204:-1278615495	D5170C00001	2195	2182	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IP and Trial Supplies	Storage
16512	88	1617051757812:-1773854195	1617051754183:1570914677	D5170C00001	2202	2197	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IRB or IEC and other Approvals	Other Committees
16470	88	1617082629089:-8450137	1617051726989:-680554053	D5170C00001	2160	2156	CREATE	2021-03-30 07:37:09.174	Site Set-up	Investigator Regulatory Agreement
16472	88	1617082630236:-1795660228	1617051726989:-680554053	D5170C00001	2162	2156	CREATE	2021-03-30 07:37:10.322	Site Set-up	Principal Investigator Curriculum Vitae
16473	88	1617082630799:-1608804666	1617051726989:-680554053	D5170C00001	2163	2156	CREATE	2021-03-30 07:37:10.888	Site Set-up	Protocol Signature Page
16475	88	1617082632057:-1968407328	1617051726989:-680554053	D5170C00001	2165	2156	CREATE	2021-03-30 07:37:12.141	Site Set-up	Sub-Investigator Curriculum Vitae
16479	88	1617082632643:1616526845	1617051735053:-1326550545	D5170C00001	2169	2168	CREATE	2021-03-30 07:37:12.727	General	Filenote
16483	88	1617082635036:-1714838759	1617051737342:-1500149096	D5170C00001	2173	2172	CREATE	2021-03-30 07:37:15.119	General	Filenote
16484	88	1617082635630:-1218854624	1617051737342:-1500149096	D5170C00001	2174	2172	CREATE	2021-03-30 07:37:26.025	General	Relevant Communications
16486	88	1617082646577:-1349489372	1617051739139:443705431	D5170C00001	2176	2175	CREATE	2021-03-30 07:37:26.664	Product and Trial Documentation	Insurance
16489	88	1617082647150:-650240494	1617051740919:-176552001	D5170C00001	2179	2178	CREATE	2021-03-30 07:37:27.234	EDC Management	System Account Management
16495	88	1617082648900:-1927247234	1617051744852:1460728148	D5170C00001	2185	2183	CREATE	2021-03-30 07:37:28.986	General	Relevant Communications
16497	88	1617082649485:-1202400466	1617051746527:1542196342	D5170C00001	2187	2186	CREATE	2021-03-30 07:37:29.572	Interactive Response Technology	IRT User Account Management
16500	88	1617082650659:1755565914	1617051747756:1904208534	D5170C00001	2190	2188	CREATE	2021-03-30 07:37:30.742	IP Documentation	IP Certificate of Destruction
16501	88	1617082651246:1448883006	1617051747756:1904208534	D5170C00001	2191	2188	CREATE	2021-03-30 07:37:31.329	IP Documentation	IP Shipment Documentation
16503	88	1617082651795:-1386624797	1617051750158:865454839	D5170C00001	2193	2192	CREATE	2021-03-30 07:37:31.882	Non-IP Documentation	Non-IP Return Documentation
16504	88	1617082652409:882039238	1617051750158:865454839	D5170C00001	2194	2192	CREATE	2021-03-30 07:37:32.493	Non-IP Documentation	Non-IP Shipment Documentation
16513	88	1617082655012:1580045598	1617051757812:-1773854195	D5170C00001	2203	2202	CREATE	2021-03-30 07:37:35.096	Other Committees	Other Submissions
16516	88	1617082655587:65297317	1617051759631:476919452	D5170C00001	2206	2205	CREATE	2021-03-30 07:37:35.672	General	Relevant Communications
16519	88	1617082657509:1846812486	1617051761376:-1887528791	D5170C00001	2209	2208	CREATE	2021-03-30 07:37:37.593	General	Filenote
16522	88	1617082658692:284883939	1617051768377:714623318	D5170C00001	2212	2211	CREATE	2021-03-30 07:37:38.775	Site Initiation	Site Evidence of Training
16525	88	1617082659821:83568680	1617051770192:-1298785698	D5170C00001	2215	2214	CREATE	2021-03-30 07:37:39.917	Site Management	Monitoring Visit Report
16528	88	1617082660986:1809747279	1617051771975:-756148669	D5170C00001	2218	2217	CREATE	2021-03-30 07:37:41.07	Site Selection	Confidentiality Agreement
16531	88	1617082662376:1962427750	1617051773702:1818442796	D5170C00001	2221	2220	CREATE	2021-03-30 07:37:42.465	Site Set-up	Acceptance of Investigator Brochure
16533	88	1617082664320:1448534793	1617051773702:1818442796	D5170C00001	2223	2220	CREATE	2021-03-30 07:37:44.43	Site Set-up	Financial Disclosure Form
16534	88	1617082664978:-1250814455	1617051773702:1818442796	D5170C00001	2224	2220	CREATE	2021-03-30 07:37:45.062	Site Set-up	Investigator Regulatory Agreement
16536	88	1617082666233:-1778077253	1617051773702:1818442796	D5170C00001	2226	2220	CREATE	2021-03-30 07:37:46.316	Site Set-up	Other Financial Agreement
16538	88	1617082668742:1070977544	1617051773702:1818442796	D5170C00001	2228	2220	CREATE	2021-03-30 07:37:48.826	Site Set-up	Protocol Signature Page
16539	88	1617082669333:-679090042	1617051773702:1818442796	D5170C00001	2229	2220	CREATE	2021-03-30 07:37:49.424	Site Set-up	Site Signature Sheet
16540	88	1617082669932:2022196709	1617051773702:1818442796	D5170C00001	2230	2220	CREATE	2021-03-30 07:37:50.014	Site Set-up	Sub-Investigator Curriculum Vitae
16544	88	1617082670491:658566706	1617051782466:-1895893737	D5170C00001	2234	2233	CREATE	2021-03-30 07:37:50.583	General	Filenote
16545	88	1617082671083:1764674688	1617051782466:-1895893737	D5170C00001	2235	2233	CREATE	2021-03-30 07:37:51.194	General	Relevant Communications
16548	88	1617082671712:-1374699226	1617051786000:-455772204	D5170C00001	2238	2237	CREATE	2021-03-30 07:37:51.8	General	Filenote
16550	88	1617082672285:-338712973	1617051787207:1783411884	D5170C00001	2240	2239	CREATE	2021-03-30 07:37:52.509	Product and Trial Documentation	Insurance
16553	88	1617082673001:883621628	1617051788894:1799614986	D5170C00001	2243	2242	CREATE	2021-03-30 07:37:53.084	EDC Management	System Account Management
16559	88	1617082674779:-244525536	1617051798192:1749476784	D5170C00001	2249	2247	CREATE	2021-03-30 07:37:54.868	General	Relevant Communications
16561	88	1617082675386:-1937977301	1617051800011:1584003966	D5170C00001	2251	2250	CREATE	2021-03-30 07:37:55.474	IP Documentation	IP Accountability Documentation
16562	88	1617082676006:1484583254	1617051800011:1584003966	D5170C00001	2252	2250	CREATE	2021-03-30 07:37:56.098	IP Documentation	IP Certificate of Destruction
16565	88	1617082677134:31097450	1617051802416:1152552124	D5170C00001	2255	2254	CREATE	2021-03-30 07:37:57.217	Non-IP Documentation	Non-IP Return Documentation
16568	88	1617082678352:-72896359	1617051804121:-1166853039	D5170C00001	2258	2257	CREATE	2021-03-30 07:37:58.437	Storage	IP Storage Condition Documentation
16573	88	1617082680944:1211127994	1617051808411:1831685660	D5170C00001	2263	2262	CREATE	2021-03-30 07:38:01.034	IRB or IEC Trial Approval	IRB or IEC Submission
16582	88	1617082683524:-219979984	1617051813448:-628229041	D5170C00001	2272	2270	CREATE	2021-03-30 07:38:03.607	General	Relevant Communications
16604	88	1617051830489:-1128209151	1617051828718:514201048	D5170C00001	2294	2293	ALREADY AVAILABLE	2021-03-30 07:19:37.337	7005	Site Management
16592	88	1617051822095:-19295602	1617051812847:709985122	D5170C00001	2282	2269	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	Site Set-up
16605	88	1617051831070:-1627531118	1617051830489:-1128209151	D5170C00001	2295	2294	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	General
16609	88	1617051837467:381823121	1617051836859:84724098	D5170C00001	2299	2298	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Central and Local Testing	General
16622	88	1617051847384:-2139949640	1617051845408:980345505	D5170C00001	2312	2309	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Data Management	General
16625	88	1617051849447:-407130641	1617051848710:-320832923	D5170C00001	2315	2314	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IP and Trial Supplies	General
16630	88	1617051853567:-863088360	1617051848710:-320832923	D5170C00001	2320	2314	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IP and Trial Supplies	IP Documentation
16590	88	1617082686617:-366438112	1617051820206:388189647	D5170C00001	2280	2279	CREATE	2021-03-30 07:38:06.704	Site Selection	Confidentiality Agreement
16594	88	1617082688511:1639101134	1617051822095:-19295602	D5170C00001	2284	2282	CREATE	2021-03-30 07:38:08.602	Site Set-up	Clinical Study Agreement
16595	88	1617082689179:1373962858	1617051822095:-19295602	D5170C00001	2285	2282	CREATE	2021-03-30 07:38:09.267	Site Set-up	Financial Disclosure Form
16597	88	1617082691971:-304978540	1617051822095:-19295602	D5170C00001	2287	2282	CREATE	2021-03-30 07:38:12.056	Site Set-up	Other Curriculum Vitae
16598	88	1617082692590:1128239318	1617051822095:-19295602	D5170C00001	2288	2282	CREATE	2021-03-30 07:38:12.674	Site Set-up	Other Financial Agreement
16600	88	1617082693739:94675960	1617051822095:-19295602	D5170C00001	2290	2282	CREATE	2021-03-30 07:38:13.823	Site Set-up	Protocol Signature Page
16601	88	1617082694345:-1655391626	1617051822095:-19295602	D5170C00001	2291	2282	CREATE	2021-03-30 07:38:14.432	Site Set-up	Site Signature Sheet
16610	88	1617082696226:269354156	1617051837467:381823121	D5170C00001	2300	2299	CREATE	2021-03-30 07:38:16.312	General	Relevant Communications
16612	88	1617082696798:-406388638	1617051839214:-1945667774	D5170C00001	2302	2301	CREATE	2021-03-30 07:38:16.887	Sample Documentation	Sample Storage Condition Log
16615	88	1617082697421:-1229278176	1617051842205:-1629913915	D5170C00001	2305	2304	CREATE	2021-03-30 07:38:17.507	General	Filenote
16616	88	1617082698088:-46138827	1617051842205:-1629913915	D5170C00001	2306	2304	CREATE	2021-03-30 07:38:18.172	General	Relevant Communications
16618	88	1617082698650:-227501659	1617051844090:511004515	D5170C00001	2308	2307	CREATE	2021-03-30 07:38:18.732	Product and Trial Documentation	Insurance
16621	88	1617082699216:261587766	1617051846041:1388766875	D5170C00001	2311	2310	CREATE	2021-03-30 07:38:19.303	EDC Management	System Account Management
16627	88	1617082701031:1560558450	1617051849447:-407130641	D5170C00001	2317	2315	CREATE	2021-03-30 07:38:21.121	General	Relevant Communications
16629	88	1617082703147:537706748	1617051851399:576968967	D5170C00001	2319	2318	CREATE	2021-03-30 07:38:23.236	Interactive Response Technology	IRT User Account Management
16632	88	1617082704389:1964249192	1617051853567:-863088360	D5170C00001	2322	2320	CREATE	2021-03-30 07:38:24.472	IP Documentation	IP Certificate of Destruction
16633	88	1617082704974:2066711507	1617051853567:-863088360	D5170C00001	2323	2320	CREATE	2021-03-30 07:38:25.059	IP Documentation	IP Shipment Documentation
16635	88	1617082705768:-1911996194	1617051856001:-1294540202	D5170C00001	2325	2324	CREATE	2021-03-30 07:38:25.857	Non-IP Documentation	Non-IP Return Documentation
16636	88	1617082706336:966770470	1617051856001:-1294540202	D5170C00001	2326	2324	CREATE	2021-03-30 07:38:26.419	Non-IP Documentation	Non-IP Shipment Documentation
16638	88	1617082706909:41594476	1617051864799:681000713	D5170C00001	2328	2327	CREATE	2021-03-30 07:38:26.994	Storage	IP Storage Condition Documentation
16641	88	1617082707534:-1492818812	1617051866650:-151019709	D5170C00001	2331	2330	CREATE	2021-03-30 07:38:27.617	General	Relevant Communications
16645	88	1617082717060:1503243802	1617051869119:1208030381	D5170C00001	2335	2334	CREATE	2021-03-30 07:38:37.145	Other Committees	Other Submissions
16648	88	1617082717719:-178621196	1617051870881:-894193012	D5170C00001	2338	2337	CREATE	2021-03-30 07:38:37.801	General	Relevant Communications
16651	88	1617082718303:20553912	1617051872679:143709618	D5170C00001	2341	2340	CREATE	2021-03-30 07:38:38.388	General	Filenote
16655	88	1617082720091:131946932	1617051875818:1239132378	D5170C00001	2345	2343	CREATE	2021-03-30 07:38:40.175	Site Initiation	Trial Initiation Monitoring Report
16663	88	1617082729554:1064282637	1617051881424:-556958735	D5170C00001	2353	2352	CREATE	2021-03-30 07:38:49.639	Site Set-up	Acceptance of Investigator Brochure
16665	88	1617082730716:1864447252	1617051881424:-556958735	D5170C00001	2355	2352	CREATE	2021-03-30 07:38:50.8	Site Set-up	Financial Disclosure Form
16666	88	1617082731521:-1736610427	1617051881424:-556958735	D5170C00001	2356	2352	CREATE	2021-03-30 07:38:51.606	Site Set-up	Investigator Regulatory Agreement
16668	88	1617082732740:1618766148	1617051881424:-556958735	D5170C00001	2358	2352	CREATE	2021-03-30 07:38:52.828	Site Set-up	Other Financial Agreement
16669	88	1617082733315:-2096534432	1617051881424:-556958735	D5170C00001	2359	2352	CREATE	2021-03-30 07:38:53.401	Site Set-up	Principal Investigator Curriculum Vitae
16671	88	1617082734416:-1164939059	1617051881424:-556958735	D5170C00001	2361	2352	CREATE	2021-03-30 07:38:54.5	Site Set-up	Site Signature Sheet
16675	88	1617082735600:48228770	1617051893802:721860238	D5170C00001	2365	2364	CREATE	2021-03-30 07:38:55.683	General	Filenote
16679	88	1617082736166:769409248	1617051902152:617116802	D5170C00001	2369	2368	CREATE	2021-03-30 07:38:56.251	General	Relevant Communications
16687	88	1617082738497:-751877741	1617051906657:1249736474	D5170C00001	2377	2375	CREATE	2021-03-30 07:38:58.585	IP Documentation	IP Certificate of Destruction
16690	88	1617082740697:-468591692	1617051908471:-81121646	D5170C00001	2380	2378	CREATE	2021-03-30 07:39:00.789	Non-IP Documentation	Non-IP Shipment Documentation
16692	88	1617082741298:1456154529	1617051910172:1894419269	D5170C00001	2382	2381	CREATE	2021-03-30 07:39:01.383	Storage	IP Storage Condition Documentation
16695	88	1617082741873:-308741876	1617051912086:714379135	D5170C00001	2385	2384	CREATE	2021-03-30 07:39:01.956	General	Relevant Communications
16697	88	1617082742488:466735779	1617051914213:-801692425	D5170C00001	2387	2386	CREATE	2021-03-30 07:39:02.574	IRB or IEC Trial Approval	IRB or IEC Submission
16706	88	1617082744816:2085213012	1617051923017:910496300	D5170C00001	2396	2394	CREATE	2021-03-30 07:39:04.902	General	Relevant Communications
16708	88	1617082745387:201800487	1617051925572:2002725751	D5170C00001	2398	2397	CREATE	2021-03-30 07:39:05.474	Site Initiation	Site Evidence of Training
16733	88	1617051948429:-469502648	1617051939091:952255866	D5170C00001	2423	2417	ALREADY AVAILABLE	2021-03-30 07:19:37.338	7008	IP and Trial Supplies
16782	88	1617051986747:450177513	1617051980881:-120376759	D5170C00001	2472	2463	ALREADY AVAILABLE	2021-03-30 07:19:37.339	7801	Data Management
16785	88	1617051988458:-1950728059	1617051980881:-120376759	D5170C00001	2475	2463	ALREADY AVAILABLE	2021-03-30 07:19:37.339	7801	IP and Trial Supplies
16793	88	1617052001755:1591452789	1617051980881:-120376759	D5170C00001	2483	2463	ALREADY AVAILABLE	2021-03-30 07:19:37.339	7801	IRB or IEC and other Approvals
16714	88	1617051930381:824005144	1617051922463:-990437179	D5170C00001	2404	2393	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	Site Selection
16717	88	1617051932104:-285780044	1617051922463:-990437179	D5170C00001	2407	2393	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	Site Set-up
16779	88	1617051984476:-56360106	1617051983895:-1464322687	D5170C00001	2469	2468	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Central Trial Documents	Subject Documentation
16791	88	1617051999397:-1174880367	1617051988458:-1950728059	D5170C00001	2481	2475	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IP and Trial Supplies	Storage
16798	88	1617052004642:1679195762	1617052001755:1591452789	D5170C00001	2488	2483	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IRB or IEC and other Approvals	Trial Status Reporting
16808	88	1617052010629:1186708835	1617052007615:-1234169123	D5170C00001	2498	2493	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	Site Management
16709	88	1617082746625:1045744863	1617051925572:2002725751	D5170C00001	2399	2397	CREATE	2021-03-30 07:39:06.709	Site Initiation	Trial Initiation Monitoring Report
16711	88	1617082747159:1016204183	1617051927290:888680577	D5170C00001	2401	2400	CREATE	2021-03-30 07:39:07.243	Site Management	Final Trial Close Out Monitoring Report
16712	88	1617082747737:-1945107435	1617051927290:888680577	D5170C00001	2402	2400	CREATE	2021-03-30 07:39:07.824	Site Management	Monitoring Visit Report
16715	88	1617082748877:1833048698	1617051930381:824005144	D5170C00001	2405	2404	CREATE	2021-03-30 07:39:09.165	Site Selection	Confidentiality Agreement
16718	88	1617082750259:-17561679	1617051932104:-285780044	D5170C00001	2408	2407	CREATE	2021-03-30 07:39:11.248	Site Set-up	Acceptance of Investigator Brochure
16720	88	1617082752419:1271962226	1617051932104:-285780044	D5170C00001	2410	2407	CREATE	2021-03-30 07:39:12.506	Site Set-up	Financial Disclosure Form
16721	88	1617082753097:1965914279	1617051932104:-285780044	D5170C00001	2411	2407	CREATE	2021-03-30 07:39:13.181	Site Set-up	Investigator Regulatory Agreement
16723	88	1617082754254:1489388098	1617051932104:-285780044	D5170C00001	2413	2407	CREATE	2021-03-30 07:39:14.338	Site Set-up	Principal Investigator Curriculum Vitae
16724	88	1617082754858:777845237	1617051932104:-285780044	D5170C00001	2414	2407	CREATE	2021-03-30 07:39:14.942	Site Set-up	Protocol Signature Page
16726	88	1617082756125:415070484	1617051932104:-285780044	D5170C00001	2416	2407	CREATE	2021-03-30 07:39:16.208	Site Set-up	Sub-Investigator Curriculum Vitae
16737	88	1617082758598:2142832008	1617051950238:-1944697363	D5170C00001	2427	2426	CREATE	2021-03-30 07:39:18.682	IP Documentation	IP Accountability Documentation
16740	88	1617082759790:845643392	1617051952037:-2084129652	D5170C00001	2430	2429	CREATE	2021-03-30 07:39:19.875	Non-IP Documentation	Non-IP Return Documentation
16741	88	1617082762419:-691226316	1617051952037:-2084129652	D5170C00001	2431	2429	CREATE	2021-03-30 07:39:22.503	Non-IP Documentation	Non-IP Shipment Documentation
16744	88	1617082763027:789705543	1617051954436:1318013755	D5170C00001	2434	2433	CREATE	2021-03-30 07:39:23.111	General	Relevant Communications
16752	88	1617082764905:-1766399330	1617051960115:1642261440	D5170C00001	2442	2441	CREATE	2021-03-30 07:39:24.991	General	Relevant Communications
16755	88	1617082766123:-146470133	1617051961288:-657855600	D5170C00001	2445	2443	CREATE	2021-03-30 07:39:26.207	Site Initiation	Trial Initiation Monitoring Report
16761	88	1617082768482:-1488453173	1617051971556:-1226059827	D5170C00001	2451	2449	CREATE	2021-03-30 07:39:28.568	Site Selection	Pre Trial Monitoring Report
16764	88	1617082769719:-361116298	1617051973346:1348595292	D5170C00001	2454	2452	CREATE	2021-03-30 07:39:29.807	Site Set-up	Clinical Study Agreement
16767	88	1617082771470:1088073502	1617051973346:1348595292	D5170C00001	2457	2452	CREATE	2021-03-30 07:39:31.556	Site Set-up	Other Curriculum Vitae
16770	88	1617082774326:1424538756	1617051973346:1348595292	D5170C00001	2460	2452	CREATE	2021-03-30 07:39:34.409	Site Set-up	Site Signature Sheet
16771	88	1617082774905:-1681037721	1617051973346:1348595292	D5170C00001	2461	2452	CREATE	2021-03-30 07:39:34.991	Site Set-up	Sub-Investigator Curriculum Vitae
16777	88	1617082776080:-1863483492	1617051982085:1003926316	D5170C00001	2467	2465	CREATE	2021-03-30 07:39:36.224	Facility Documentation	Normal Ranges
16781	88	1617082777273:-1337158553	1617051984476:-56360106	D5170C00001	2471	2469	CREATE	2021-03-30 07:39:37.359	Subject Documentation	Other Information Given to Subjects
16784	88	1617082777892:708204726	1617051987297:-1055646817	D5170C00001	2474	2473	CREATE	2021-03-30 07:39:38.083	General	Tracking Information
16789	88	1617082779126:1418482487	1617051997454:1492300384	D5170C00001	2479	2478	CREATE	2021-03-30 07:39:48.741	IP Documentation	IP Accountability Documentation
16809	88	1617082795854:1458548962	1617052010629:1186708835	D5170C00001	2499	2498	CREATE	2021-03-30 07:39:55.939	Site Management	Final Trial Close Out Monitoring Report
16811	88	1617082797074:2020280251	1617052010629:1186708835	D5170C00001	2501	2498	CREATE	2021-03-30 07:39:57.157	Site Management	Subject Log
16812	88	1617082797621:486367255	1617052010629:1186708835	D5170C00001	2502	2498	CREATE	2021-03-30 07:39:57.703	Site Management	Visit Log
16814	88	1617082798165:299601253	1617052015256:1122033402	D5170C00001	2504	2503	CREATE	2021-03-30 07:39:58.25	Site Selection	Confidentiality Agreement
16815	88	1617082798788:1984311464	1617052015256:1122033402	D5170C00001	2505	2503	CREATE	2021-03-30 07:39:58.873	Site Selection	Feasibility Documentation
16817	88	1617082799349:1743369534	1617052017017:-188030216	D5170C00001	2507	2506	CREATE	2021-03-30 07:39:59.432	Site Set-up	Acceptance of Investigator Brochure
16818	88	1617082799927:-876160415	1617052017017:-188030216	D5170C00001	2508	2506	CREATE	2021-03-30 07:40:00.011	Site Set-up	Clinical Study Agreement
16820	88	1617082801191:-93246457	1617052017017:-188030216	D5170C00001	2510	2506	CREATE	2021-03-30 07:40:01.28	Site Set-up	Form FDA 1572
16822	88	1617082802326:-1946335198	1617052017017:-188030216	D5170C00001	2512	2506	CREATE	2021-03-30 07:40:02.573	Site Set-up	Principal Investigator Curriculum Vitae
16823	88	1617082803211:677346930	1617052017017:-188030216	D5170C00001	2513	2506	CREATE	2021-03-30 07:40:03.305	Site Set-up	Protocol Amendment Signature Page
16825	88	1617082804464:3581391	1617052017017:-188030216	D5170C00001	2515	2506	CREATE	2021-03-30 07:40:04.558	Site Set-up	Site Signature Sheet
16828	88	1617052025501:-1912373044	1617051980881:-120376759	D5170C00001	2518	2463	ALREADY AVAILABLE	2021-03-30 07:19:37.339	7801	Trial Management
16829	88	1617052026057:-1071436199	1617052025501:-1912373044	D5170C00001	2519	2518	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Trial Management	Trial Oversight
16839	88	1617052039818:-1640177369	1617052039203:1758250485	D5170C00001	2529	2528	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IP and Trial Supplies	IP Documentation
16843	88	1617052042228:1252886643	1617052041660:805143171	D5170C00001	2533	2532	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IRB or IEC and other Approvals	IRB or IEC Trial Approval
16846	88	1617052044049:406185109	1617052041660:805143171	D5170C00001	2536	2532	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IRB or IEC and other Approvals	Trial Status Reporting
16849	88	1617052047075:-402054162	1617052046422:370876066	D5170C00001	2539	2538	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Safety Reporting	General
16852	88	1617052049021:1422247676	1617052048398:1782105700	D5170C00001	2542	2541	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	General
16826	88	1617082805061:-2033774721	1617052017017:-188030216	D5170C00001	2516	2506	CREATE	2021-03-30 07:40:05.15	Site Set-up	Site Staff Qualification Supporting Information
16834	88	1617082808046:-1827005724	1617052035945:-246890470	D5170C00001	2524	2523	CREATE	2021-03-30 07:40:08.134	Subject Documentation	Informed Consent Form
16837	88	1617082808622:758012401	1617052037940:743038637	D5170C00001	2527	2526	CREATE	2021-03-30 07:40:08.714	General	Tracking Information
16840	88	1617082809292:211741516	1617052039818:-1640177369	D5170C00001	2530	2529	CREATE	2021-03-30 07:40:09.378	IP Documentation	IP Accountability Documentation
16845	88	1617082810999:-833875814	1617052042228:1252886643	D5170C00001	2535	2533	CREATE	2021-03-30 07:40:11.084	IRB or IEC Trial Approval	IRB or IEC Composition
16850	88	1617082812244:-1241468446	1617052047075:-402054162	D5170C00001	2540	2539	CREATE	2021-03-30 07:40:12.576	General	Tracking Information
16854	88	1617082813775:-1646564643	1617052049021:1422247676	D5170C00001	2544	2542	CREATE	2021-03-30 07:40:13.859	General	Relevant Communications
16858	88	1617082815214:-574945523	1617052052073:-1988784883	D5170C00001	2548	2547	CREATE	2021-03-30 07:40:15.299	Site Management	Final Trial Close Out Monitoring Report
16861	88	1617082816329:2133427910	1617052053847:1946304727	D5170C00001	2551	2550	CREATE	2021-03-30 07:40:16.418	Site Selection	Confidentiality Agreement
16863	88	1617082818833:-1968909940	1617052053847:1946304727	D5170C00001	2553	2550	CREATE	2021-03-30 07:40:18.917	Site Selection	Pre Trial Monitoring Report
16866	88	1617082820044:-335444628	1617052057507:1423773172	D5170C00001	2556	2554	CREATE	2021-03-30 07:40:20.134	Site Set-up	Clinical Study Agreement
16867	88	1617082820672:-1502291335	1617052057507:1423773172	D5170C00001	2557	2554	CREATE	2021-03-30 07:40:20.759	Site Set-up	Financial Disclosure Form
16869	88	1617082821906:1458810502	1617052057507:1423773172	D5170C00001	2559	2554	CREATE	2021-03-30 07:40:21.993	Site Set-up	IP Site Release Documentation
16871	88	1617082823189:1338806056	1617052057507:1423773172	D5170C00001	2561	2554	CREATE	2021-03-30 07:40:23.271	Site Set-up	Protocol Amendment Signature Page
16872	88	1617082823757:-1879848584	1617052057507:1423773172	D5170C00001	2562	2554	CREATE	2021-03-30 07:40:23.839	Site Set-up	Protocol Signature Page
16874	88	1617082825603:-882828997	1617052057507:1423773172	D5170C00001	2564	2554	CREATE	2021-03-30 07:40:25.691	Site Set-up	Site Staff Qualification Supporting Information
16875	88	1617082826186:-1224291512	1617052057507:1423773172	D5170C00001	2565	2554	CREATE	2021-03-30 07:40:26.271	Site Set-up	Sub-Investigator Curriculum Vitae
16882	88	1617082827445:1986305441	1617052075531:-1260041289	D5170C00001	2572	2571	CREATE	2021-03-30 07:40:27.532	Facility Documentation	Certification or Accreditation
16885	88	1617082828108:1856052738	1617052077420:71147089	D5170C00001	2575	2574	CREATE	2021-03-30 07:40:28.197	Subject Documentation	Informed Consent Form
16891	88	1617082830555:928028318	1617052082532:-1070486015	D5170C00001	2581	2580	CREATE	2021-03-30 07:40:30.638	IP Documentation	IP Accountability Documentation
16892	88	1617082831162:-554523488	1617052082532:-1070486015	D5170C00001	2582	2580	CREATE	2021-03-30 07:40:31.248	IP Documentation	IP Certificate of Destruction
16895	88	1617082831713:-1839183414	1617052091843:-1938637842	D5170C00001	2585	2584	CREATE	2021-03-30 07:40:31.796	IRB or IEC Trial Approval	IRB or IEC Approval
16897	88	1617082832883:-219073354	1617052091843:-1938637842	D5170C00001	2587	2584	CREATE	2021-03-30 07:40:32.971	IRB or IEC Trial Approval	IRB or IEC Composition
16898	88	1617082833434:1372974011	1617052091843:-1938637842	D5170C00001	2588	2584	CREATE	2021-03-30 07:40:33.521	IRB or IEC Trial Approval	IRB or IEC Submission
16900	88	1617082834021:-182434683	1617052096128:804283198	D5170C00001	2590	2589	CREATE	2021-03-30 07:40:34.105	Trial Status Reporting	IRB or IEC Notification of Trial Termination
16906	88	1617082835784:-189184319	1617052099206:1745572203	D5170C00001	2596	2594	CREATE	2021-03-30 07:40:35.868	Site Management	Visit Log
16908	88	1617082836619:200944289	1617052101116:1680886161	D5170C00001	2598	2597	CREATE	2021-03-30 07:40:36.708	Site Selection	Confidentiality Agreement
16910	88	1617082837208:2090678050	1617052103517:863173571	D5170C00001	2600	2599	CREATE	2021-03-30 07:40:37.292	Site Set-up	Acceptance of Investigator Brochure
16912	88	1617082844455:-1152168318	1617052103517:863173571	D5170C00001	2602	2599	CREATE	2021-03-30 07:40:44.538	Site Set-up	Data Privacy Agreement
16913	88	1617082845025:-1699892814	1617052103517:863173571	D5170C00001	2603	2599	CREATE	2021-03-30 07:40:45.11	Site Set-up	Financial Disclosure Form
16915	88	1617082846466:1459164082	1617052103517:863173571	D5170C00001	2605	2599	CREATE	2021-03-30 07:40:46.549	Site Set-up	IP Site Release Documentation
16916	88	1617082847014:-1482466942	1617052103517:863173571	D5170C00001	2606	2599	CREATE	2021-03-30 07:40:47.099	Site Set-up	Principal Investigator Curriculum Vitae
16918	88	1617082848137:-2077450063	1617052103517:863173571	D5170C00001	2608	2599	CREATE	2021-03-30 07:40:48.224	Site Set-up	Protocol Signature Page
16919	88	1617082848732:759013013	1617052103517:863173571	D5170C00001	2609	2599	CREATE	2021-03-30 07:40:48.82	Site Set-up	Site Signature Sheet
16921	88	1617082850116:-1619805614	1617052103517:863173571	D5170C00001	2611	2599	CREATE	2021-03-30 07:40:50.205	Site Set-up	Sub-Investigator Curriculum Vitae
16926	88	1617082852852:572874806	1617052114134:-175040892	D5170C00001	2616	2614	CREATE	2021-03-30 07:40:52.94	Subject Documentation	Informed Consent Form
16935	88	1617082855342:-1095687050	1617052120069:-1273361792	D5170C00001	2625	2623	CREATE	2021-03-30 07:40:55.438	IP Documentation	IP Certificate of Destruction
16941	88	1617082857176:181902473	1617052125009:1008845714	D5170C00001	2631	2629	CREATE	2021-03-30 07:40:57.322	IRB or IEC Trial Approval	IRB or IEC Composition
16944	88	1617052128361:448537244	1617052111853:830308303	D5170C00001	2634	2612	ALREADY AVAILABLE	2021-03-30 07:19:37.34	7805	Safety Reporting
16942	88	1617052127055:359409654	1617052121840:193293937	D5170C00001	2632	2626	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IRB or IEC and other Approvals	Trial Status Reporting
16945	88	1617052128996:361622823	1617052128361:448537244	D5170C00001	2635	2634	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Safety Reporting	General
16948	88	1617052131236:228799670	1617052130628:1662639321	D5170C00001	2638	2637	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	General
16955	88	1617052136927:833392711	1617052130628:1662639321	D5170C00001	2645	2637	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	Site Selection
16957	88	1617052138141:425928680	1617052130628:1662639321	D5170C00001	2647	2637	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	Site Set-up
16972	88	1617052148515:1722912454	1617052145510:709388340	D5170C00001	2662	2659	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	Site Selection
16978	88	1617052159379:157648893	1617052156484:1692629743	D5170C00001	2668	2665	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Central and Local Testing	General
16981	88	1617052161330:-439978305	1617052160622:63277006	D5170C00001	2671	2670	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Central Trial Documents	Subject Documentation
16984	88	1617052163332:1632401095	1617052162658:-1414611721	D5170C00001	2674	2673	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Data Management	General
16946	88	1617082858465:-2037586466	1617052128996:361622823	D5170C00001	2636	2635	CREATE	2021-03-30 07:40:58.55	General	Tracking Information
16949	88	1617082859120:372870138	1617052131236:228799670	D5170C00001	2639	2638	CREATE	2021-03-30 07:40:59.206	General	Filenote
16954	88	1617082861655:-1450949954	1617052133144:700993632	D5170C00001	2644	2641	CREATE	2021-03-30 07:41:01.742	Site Management	Visit Log
16958	88	1617082862957:-1924329593	1617052138141:425928680	D5170C00001	2648	2647	CREATE	2021-03-30 07:41:04.368	Site Set-up	Acceptance of Investigator Brochure
16960	88	1617082865478:1856712919	1617052138141:425928680	D5170C00001	2650	2647	CREATE	2021-03-30 07:41:05.562	Site Set-up	Financial Disclosure Form
16961	88	1617082866049:319659457	1617052138141:425928680	D5170C00001	2651	2647	CREATE	2021-03-30 07:41:06.136	Site Set-up	Form FDA 1572
16963	88	1617082867202:286283274	1617052138141:425928680	D5170C00001	2653	2647	CREATE	2021-03-30 07:41:07.287	Site Set-up	Protocol Amendment Signature Page
16964	88	1617082867848:1362595930	1617052138141:425928680	D5170C00001	2654	2647	CREATE	2021-03-30 07:41:07.947	Site Set-up	Protocol Signature Page
16966	88	1617082869190:-1737428547	1617052138141:425928680	D5170C00001	2656	2647	CREATE	2021-03-30 07:41:09.28	Site Set-up	Site Staff Qualification Supporting Information
16977	88	1617082871865:1625284292	1617052158179:-2021863589	D5170C00001	2667	2666	CREATE	2021-03-30 07:41:11.952	Facility Documentation	Certification or Accreditation
16979	88	1617082872522:1037792219	1617052159379:157648893	D5170C00001	2669	2668	CREATE	2021-03-30 07:41:12.634	General	Filenote
16991	88	1617082877867:1074279401	1617052166248:-921340393	D5170C00001	2681	2679	CREATE	2021-03-30 07:41:17.949	IP Documentation	IP Certificate of Destruction
16994	88	1617082878543:-831081518	1617052169756:-1989601637	D5170C00001	2684	2683	CREATE	2021-03-30 07:41:18.626	IRB or IEC Trial Approval	IRB or IEC Approval
16995	88	1617082879169:512421259	1617052169756:-1989601637	D5170C00001	2685	2683	CREATE	2021-03-30 07:41:19.253	IRB or IEC Trial Approval	IRB or IEC Compliance Documentation
16996	88	1617082879765:986994210	1617052169756:-1989601637	D5170C00001	2686	2683	CREATE	2021-03-30 07:41:19.978	IRB or IEC Trial Approval	IRB or IEC Composition
16999	88	1617082880451:-1952480646	1617052173178:-426181613	D5170C00001	2689	2688	CREATE	2021-03-30 07:41:20.534	General	Tracking Information
17003	88	1617082881590:-2004400904	1617052175222:304882754	D5170C00001	2693	2691	CREATE	2021-03-30 07:41:21.679	General	Relevant Communications
17007	88	1617082882811:-1154546890	1617052178200:404478737	D5170C00001	2697	2696	CREATE	2021-03-30 07:41:22.898	Site Management	Monitoring Visit Report
17009	88	1617082884064:1736323279	1617052178200:404478737	D5170C00001	2699	2696	CREATE	2021-03-30 07:41:24.148	Site Management	Visit Log
17014	88	1617082885850:-2137771593	1617052188373:-477941113	D5170C00001	2704	2702	CREATE	2021-03-30 07:41:25.937	Site Set-up	Clinical Study Agreement
17015	88	1617082888088:1892110472	1617052188373:-477941113	D5170C00001	2705	2702	CREATE	2021-03-30 07:41:28.174	Site Set-up	Financial Disclosure Form
17016	88	1617082888730:-134418979	1617052188373:-477941113	D5170C00001	2706	2702	CREATE	2021-03-30 07:41:28.813	Site Set-up	Form FDA 1572
17018	88	1617082889925:1499338234	1617052188373:-477941113	D5170C00001	2708	2702	CREATE	2021-03-30 07:41:30.016	Site Set-up	Principal Investigator Curriculum Vitae
17020	88	1617082891160:904355113	1617052188373:-477941113	D5170C00001	2710	2702	CREATE	2021-03-30 07:41:31.246	Site Set-up	Protocol Signature Page
17021	88	1617082891727:-1137339493	1617052188373:-477941113	D5170C00001	2711	2702	CREATE	2021-03-30 07:41:39.463	Site Set-up	Site Signature Sheet
17023	88	1617082900619:1070425587	1617052188373:-477941113	D5170C00001	2713	2702	CREATE	2021-03-30 07:41:40.707	Site Set-up	Sub-Investigator Curriculum Vitae
17032	88	1617082902524:-1392113436	1617052201794:-760556033	D5170C00001	2722	2721	CREATE	2021-03-30 07:41:42.611	General	Tracking Information
17035	88	1617082903154:1285326632	1617052204961:-2124480324	D5170C00001	2725	2724	CREATE	2021-03-30 07:41:43.238	General	Relevant Communications
17037	88	1617082903733:1976726038	1617052206264:1597937686	D5170C00001	2727	2726	CREATE	2021-03-30 07:41:43.821	IP Documentation	IP Accountability Documentation
17042	88	1617082905576:556855287	1617052208732:-1462452139	D5170C00001	2732	2730	CREATE	2021-03-30 07:41:45.66	IRB or IEC Trial Approval	IRB or IEC Composition
17047	88	1617082906736:1656997219	1617052217799:558939653	D5170C00001	2737	2736	CREATE	2021-03-30 07:41:46.82	General	Tracking Information
17050	88	1617082907361:788079801	1617052219841:-434680426	D5170C00001	2740	2739	CREATE	2021-03-30 07:41:47.445	General	Filenote
17053	88	1617082908496:-1021048375	1617052221721:644868434	D5170C00001	2743	2742	CREATE	2021-03-30 07:41:48.582	Site Management	Monitoring Visit Report
17055	88	1617082912004:1259623684	1617052221721:644868434	D5170C00001	2745	2742	CREATE	2021-03-30 07:41:52.155	Site Management	Visit Log
17060	88	1617082920454:713371225	1617052226758:-844895705	D5170C00001	2750	2748	CREATE	2021-03-30 07:42:00.544	Site Set-up	Clinical Study Agreement
17061	88	1617082921089:-161912116	1617052226758:-844895705	D5170C00001	2751	2748	CREATE	2021-03-30 07:42:01.177	Site Set-up	Financial Disclosure Form
17064	88	1617082924023:253362725	1617052226758:-844895705	D5170C00001	2754	2748	CREATE	2021-03-30 07:42:04.111	Site Set-up	Principal Investigator Curriculum Vitae
17071	88	1617052234763:174534557	1617052234097:-1810160558	D5170C00001	2761	2760	ALREADY AVAILABLE	2021-03-30 07:19:37.341	7809	Central and Local Testing
17144	88	1617052308434:1593185360	1617052296101:1068428102	D5170C00001	2834	2815	ALREADY AVAILABLE	2021-03-30 07:19:37.342	7810	Safety Reporting
17147	88	1617052310176:-1290552302	1617052296101:1068428102	D5170C00001	2837	2815	ALREADY AVAILABLE	2021-03-30 07:19:37.342	7810	Site Management
17174	88	1617052335972:609047866	1617052335404:780821450	D5170C00001	2864	2863	ALREADY AVAILABLE	2021-03-30 07:19:37.342	7813	Central Trial Documents
17075	88	1617052238704:-1330482653	1617052238105:-552229202	D5170C00001	2765	2764	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Central Trial Documents	Subject Documentation
17078	88	1617052240579:-1473156907	1617052239893:462790457	D5170C00001	2768	2767	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Data Management	General
17151	88	1617052312400:10481385	1617052310176:-1290552302	D5170C00001	2841	2837	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	Site Initiation
17157	88	1617052316990:-1460290602	1617052310176:-1290552302	D5170C00001	2847	2837	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	Site Selection
17159	88	1617052326585:1114215991	1617052310176:-1290552302	D5170C00001	2849	2837	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	Site Set-up
17171	88	1617052334243:1378768945	1617052333677:-1771618057	D5170C00001	2861	2860	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Trial Management	General
17181	88	1617052341493:-1318961475	1617052340892:30784672	D5170C00001	2871	2870	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IP and Trial Supplies	IP Documentation
17184	88	1617052343327:93551715	1617052342727:-430003441	D5170C00001	2874	2873	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IRB or IEC and other Approvals	IRB or IEC Trial Approval
17187	88	1617052345201:-1163271070	1617052342727:-430003441	D5170C00001	2877	2873	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IRB or IEC and other Approvals	Trial Status Reporting
17066	88	1617082925219:-831149430	1617052226758:-844895705	D5170C00001	2756	2748	CREATE	2021-03-30 07:42:05.303	Site Set-up	Protocol Signature Page
17067	88	1617082925781:-2091698591	1617052226758:-844895705	D5170C00001	2757	2748	CREATE	2021-03-30 07:42:05.862	Site Set-up	Site Signature Sheet
17069	88	1617082926881:-373420109	1617052226758:-844895705	D5170C00001	2759	2748	CREATE	2021-03-30 07:42:06.975	Site Set-up	Sub-Investigator Curriculum Vitae
17073	88	1617082927530:1517914216	1617052235427:-1760664646	D5170C00001	2763	2762	CREATE	2021-03-30 07:42:07.615	General	Filenote
17076	88	1617082928173:506912563	1617052238704:-1330482653	D5170C00001	2766	2765	CREATE	2021-03-30 07:42:08.263	Subject Documentation	Informed Consent Form
17079	88	1617082928712:1170834465	1617052240579:-1473156907	D5170C00001	2769	2768	CREATE	2021-03-30 07:42:08.798	General	Tracking Information
17084	88	1617082929952:175556440	1617052250611:-1494006598	D5170C00001	2774	2773	CREATE	2021-03-30 07:42:10.04	IP Documentation	IP Certificate of Destruction
17086	88	1617082930664:-962116495	1617052251887:133695075	D5170C00001	2776	2775	CREATE	2021-03-30 07:42:10.748	Storage	IP Storage Condition Documentation
17089	88	1617082931220:991766474	1617052253661:113346992	D5170C00001	2779	2778	CREATE	2021-03-30 07:42:11.306	General	Relevant Communications
17091	88	1617082931836:199544953	1617052254963:-418086166	D5170C00001	2781	2780	CREATE	2021-03-30 07:42:11.921	IRB or IEC Trial Approval	IRB or IEC Approval
17092	88	1617082932416:-2102258117	1617052254963:-418086166	D5170C00001	2782	2780	CREATE	2021-03-30 07:42:13.578	IRB or IEC Trial Approval	IRB or IEC Composition
17094	88	1617082934096:-1187373280	1617052256900:-1875113118	D5170C00001	2784	2783	CREATE	2021-03-30 07:42:14.194	Trial Status Reporting	IRB or IEC Notification of Trial Termination
17101	88	1617082936008:-841728210	1617052261919:1685251453	D5170C00001	2791	2789	CREATE	2021-03-30 07:42:16.111	General	Relevant Communications
17105	88	1617082937228:-1733962072	1617052277702:-2020962141	D5170C00001	2795	2794	CREATE	2021-03-30 07:42:17.316	Site Management	Final Trial Close Out Monitoring Report
17111	88	1617082939562:1656336511	1617052281159:1391595914	D5170C00001	2801	2800	CREATE	2021-03-30 07:42:19.65	Site Set-up	Acceptance of Investigator Brochure
17113	88	1617082940678:-2049794251	1617052281159:1391595914	D5170C00001	2803	2800	CREATE	2021-03-30 07:42:20.762	Site Set-up	Financial Disclosure Form
17116	88	1617082942421:1969919010	1617052281159:1391595914	D5170C00001	2806	2800	CREATE	2021-03-30 07:42:22.506	Site Set-up	Principal Investigator Curriculum Vitae
17119	88	1617082945530:-83472850	1617052281159:1391595914	D5170C00001	2809	2800	CREATE	2021-03-30 07:42:25.618	Site Set-up	Site Signature Sheet
17121	88	1617082946695:1832675819	1617052281159:1391595914	D5170C00001	2811	2800	CREATE	2021-03-30 07:42:26.783	Site Set-up	Sub-Investigator Curriculum Vitae
17462	88	1617083157452:-253635244	1617052574964:509646081	D5170C00001	3152	3150	CREATE	2021-03-30 07:45:57.537	General	Relevant Communications
17128	88	1617082981114:-40422243	1617052297295:-7015142	D5170C00001	2818	2817	CREATE	2021-03-30 07:43:01.214	Subject Documentation	Informed Consent Form
17134	88	1617082982469:2081623670	1617052300857:-944269136	D5170C00001	2824	2823	CREATE	2021-03-30 07:43:02.556	General	Filenote
17137	88	1617082983795:-469130277	1617052302041:-1227886088	D5170C00001	2827	2825	CREATE	2021-03-30 07:43:03.898	IP Documentation	IP Certificate of Destruction
17140	88	1617082984458:1895216551	1617052305313:6491038	D5170C00001	2830	2829	CREATE	2021-03-30 07:43:04.588	IRB or IEC Trial Approval	IRB or IEC Approval
17146	88	1617082986732:-577128658	1617052308977:2000768062	D5170C00001	2836	2835	CREATE	2021-03-30 07:43:06.816	General	Tracking Information
17152	88	1617082988619:-2058079491	1617052312400:10481385	D5170C00001	2842	2841	CREATE	2021-03-30 07:43:08.702	Site Initiation	Site Evidence of Training
17155	88	1617082991335:1459353249	1617052313486:-1395615169	D5170C00001	2845	2843	CREATE	2021-03-30 07:43:11.431	Site Management	Subject Log
17160	88	1617082993239:274690964	1617052326585:1114215991	D5170C00001	2850	2849	CREATE	2021-03-30 07:43:13.324	Site Set-up	Acceptance of Investigator Brochure
17163	88	1617082995185:-1364001795	1617052326585:1114215991	D5170C00001	2853	2849	CREATE	2021-03-30 07:43:15.282	Site Set-up	Form FDA 1572
17165	88	1617082996560:1174795075	1617052326585:1114215991	D5170C00001	2855	2849	CREATE	2021-03-30 07:43:16.65	Site Set-up	Principal Investigator Curriculum Vitae
17168	88	1617082998679:877092024	1617052326585:1114215991	D5170C00001	2858	2849	CREATE	2021-03-30 07:43:18.779	Site Set-up	Site Staff Qualification Supporting Information
17169	88	1617082999319:629312079	1617052326585:1114215991	D5170C00001	2859	2849	CREATE	2021-03-30 07:43:19.413	Site Set-up	Sub-Investigator Curriculum Vitae
17182	88	1617083003653:1053264580	1617052341493:-1318961475	D5170C00001	2872	2871	CREATE	2021-03-30 07:43:23.736	IP Documentation	IP Accountability Documentation
17214	88	1617052369113:-1471307787	1617052368447:-1900328069	D5170C00001	2904	2903	ALREADY AVAILABLE	2021-03-30 07:19:37.342	7814	Central Trial Documents
17217	88	1617052372271:443192413	1617052368447:-1900328069	D5170C00001	2907	2903	ALREADY AVAILABLE	2021-03-30 07:19:37.342	7814	Data Management
17196	88	1617052351810:-1002788606	1617052349308:1039310116	D5170C00001	2886	2882	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	Site Management
17200	88	1617052354278:-1067453430	1617052349308:1039310116	D5170C00001	2890	2882	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	Site Selection
17202	88	1617052355513:-1474768935	1617052349308:1039310116	D5170C00001	2892	2882	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	Site Set-up
17225	88	1617052377227:-1191611985	1617052376599:-2103091664	D5170C00001	2915	2914	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IRB or IEC and other Approvals	IRB or IEC Trial Approval
17228	88	1617052378912:2141915132	1617052376599:-2103091664	D5170C00001	2918	2914	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IRB or IEC and other Approvals	Trial Status Reporting
17231	88	1617052380790:-1560644037	1617052380208:1839626124	D5170C00001	2921	2920	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Safety Reporting	General
17197	88	1617083008666:-1530801081	1617052351810:-1002788606	D5170C00001	2887	2886	CREATE	2021-03-30 07:43:28.753	Site Management	Monitoring Visit Report
17199	88	1617083009973:142982876	1617052351810:-1002788606	D5170C00001	2889	2886	CREATE	2021-03-30 07:43:30.063	Site Management	Visit Log
17204	88	1617083013893:1092305357	1617052355513:-1474768935	D5170C00001	2894	2892	CREATE	2021-03-30 07:43:33.978	Site Set-up	Clinical Study Agreement
17205	88	1617083014667:706413133	1617052355513:-1474768935	D5170C00001	2895	2892	CREATE	2021-03-30 07:43:34.752	Site Set-up	Financial Disclosure Form
17206	88	1617083015357:-1809518044	1617052355513:-1474768935	D5170C00001	2896	2892	CREATE	2021-03-30 07:43:35.44	Site Set-up	Form FDA 1572
17208	88	1617083016996:923849614	1617052355513:-1474768935	D5170C00001	2898	2892	CREATE	2021-03-30 07:43:37.083	Site Set-up	Principal Investigator Curriculum Vitae
17210	88	1617083018360:-1128721700	1617052355513:-1474768935	D5170C00001	2900	2892	CREATE	2021-03-30 07:43:38.443	Site Set-up	Site Signature Sheet
17211	88	1617083019505:1326833934	1617052355513:-1474768935	D5170C00001	2901	2892	CREATE	2021-03-30 07:43:39.589	Site Set-up	Site Staff Qualification Supporting Information
17216	88	1617083021047:-2009631594	1617052369657:1777613902	D5170C00001	2906	2905	CREATE	2021-03-30 07:43:41.136	Subject Documentation	Informed Consent Form
17219	88	1617083021755:1853491188	1617052372954:-1520366953	D5170C00001	2909	2908	CREATE	2021-03-30 07:43:41.84	General	Tracking Information
17222	88	1617083022478:1246514061	1617052374783:-1479937613	D5170C00001	2912	2911	CREATE	2021-03-30 07:43:42.566	IP Documentation	IP Accountability Documentation
17227	88	1617083025820:1527770082	1617052377227:-1191611985	D5170C00001	2917	2915	CREATE	2021-03-30 07:43:45.916	IRB or IEC Trial Approval	IRB or IEC Composition
17232	88	1617083027661:-782373389	1617052380790:-1560644037	D5170C00001	2922	2921	CREATE	2021-03-30 07:43:47.744	General	Tracking Information
17236	88	1617083029107:-1824460817	1617052383971:-2096296941	D5170C00001	2926	2924	CREATE	2021-03-30 07:43:49.195	General	Relevant Communications
17239	88	1617083030376:-185328153	1617052385879:-1213780157	D5170C00001	2929	2927	CREATE	2021-03-30 07:43:50.464	Site Management	Subject Log
17240	88	1617083030991:-817500891	1617052385879:-1213780157	D5170C00001	2930	2927	CREATE	2021-03-30 07:43:59.899	Site Management	Visit Log
17242	88	1617083040427:1674655178	1617052388263:-1885884751	D5170C00001	2932	2931	CREATE	2021-03-30 07:44:00.51	Site Selection	Confidentiality Agreement
17244	88	1617083041004:-422393345	1617052389524:1591359346	D5170C00001	2934	2933	CREATE	2021-03-30 07:44:01.093	Site Set-up	Acceptance of Investigator Brochure
17245	88	1617083041860:840737297	1617052389524:1591359346	D5170C00001	2935	2933	CREATE	2021-03-30 07:44:01.948	Site Set-up	Clinical Study Agreement
17247	88	1617083043188:-2061086104	1617052389524:1591359346	D5170C00001	2937	2933	CREATE	2021-03-30 07:44:03.278	Site Set-up	Form FDA 1572
17248	88	1617083043983:-1659964260	1617052389524:1591359346	D5170C00001	2938	2933	CREATE	2021-03-30 07:44:04.072	Site Set-up	IP Site Release Documentation
17257	88	1617083050000:-754344331	1617052399517:1961548139	D5170C00001	2947	2946	CREATE	2021-03-30 07:44:10.09	Site Selection	Confidentiality Agreement
17261	88	1617083050718:-995542797	1617052408057:671714097	D5170C00001	2951	2950	CREATE	2021-03-30 07:44:10.806	Subject Documentation	Informed Consent Form
17269	88	1617083052714:-935467980	1617052412840:677181263	D5170C00001	2959	2958	CREATE	2021-03-30 07:44:12.806	IP Documentation	IP Accountability Documentation
6905	84	\N	\N	D5170C00002	690	689	NEW	\N	05 Site Management	05.01 Site Selection
17274	88	1617083054573:628887002	1617052415150:-951067260	D5170C00001	2964	2962	CREATE	2021-03-30 07:44:14.659	IRB or IEC Trial Approval	IRB or IEC Composition
17279	88	1617083055887:-2111996545	1617052420258:-1947535890	D5170C00001	2969	2968	CREATE	2021-03-30 07:44:16.149	General	Tracking Information
17283	88	1617083057196:-959972025	1617052422075:1231131625	D5170C00001	2973	2971	CREATE	2021-03-30 07:44:17.28	General	Relevant Communications
17287	88	1617083059992:-1891154209	1617052425099:1819885327	D5170C00001	2977	2976	CREATE	2021-03-30 07:44:20.08	Site Management	Monitoring Visit Report
17289	88	1617083061280:587281947	1617052425099:1819885327	D5170C00001	2979	2976	CREATE	2021-03-30 07:44:21.365	Site Management	Visit Log
17293	88	1617083062472:-153537048	1617052430313:937497304	D5170C00001	2983	2982	CREATE	2021-03-30 07:44:22.561	Site Set-up	Acceptance of Investigator Brochure
17295	88	1617083063798:844328010	1617052430313:937497304	D5170C00001	2985	2982	CREATE	2021-03-30 07:44:23.891	Site Set-up	Financial Disclosure Form
17296	88	1617083064543:-2083909872	1617052430313:937497304	D5170C00001	2986	2982	CREATE	2021-03-30 07:44:24.63	Site Set-up	Form FDA 1572
17298	88	1617083065854:451736125	1617052430313:937497304	D5170C00001	2988	2982	CREATE	2021-03-30 07:44:25.948	Site Set-up	Principal Investigator Curriculum Vitae
17300	88	1617083067091:-2009884931	1617052430313:937497304	D5170C00001	2990	2982	CREATE	2021-03-30 07:44:27.182	Site Set-up	Site Signature Sheet
17301	88	1617083067681:643381755	1617052430313:937497304	D5170C00001	2991	2982	CREATE	2021-03-30 07:44:27.775	Site Set-up	Site Staff Qualification Supporting Information
17306	88	1617083069035:-1017041955	1617052438283:723024113	D5170C00001	2996	2995	CREATE	2021-03-30 07:44:29.122	Subject Documentation	Informed Consent Form
17309	88	1617083071427:-978967058	1617052441743:-1582735752	D5170C00001	2999	2998	CREATE	2021-03-30 07:44:31.512	General	Relevant Communications
17312	88	1617083072710:-1899797	1617052442936:-1058772421	D5170C00001	3002	3000	CREATE	2021-03-30 07:44:32.795	IP Documentation	IP Certificate of Destruction
17319	88	1617052448836:-1635740050	1617052436931:-1544354502	D5170C00001	3009	2993	ALREADY AVAILABLE	2021-03-30 07:19:37.343	7817	Safety Reporting
17320	88	1617052449427:-1814824517	1617052448836:-1635740050	D5170C00001	3010	3009	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Safety Reporting	General
17329	88	1617052456439:-909392683	1617052450649:382865700	D5170C00001	3019	3012	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	Site Selection
17349	88	1617052480120:-154523576	1617052479480:-296615441	D5170C00001	3039	3038	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IP and Trial Supplies	General
17369	88	1617052497460:-1953174261	1617052490174:-387742878	D5170C00001	3059	3055	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	Site Management
17373	88	1617052500689:1669773313	1617052490174:-387742878	D5170C00001	3063	3055	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	Site Selection
17375	88	1617052501784:1459373185	1617052490174:-387742878	D5170C00001	3065	3055	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	Site Set-up
17393	88	1617052513208:-1773076309	1617052512629:-1724974263	D5170C00001	3083	3082	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Data Management	General
17315	88	1617083073306:756301125	1617052445948:598014748	D5170C00001	3005	3004	CREATE	2021-03-30 07:44:33.397	IRB or IEC Trial Approval	IRB or IEC Approval
17316	88	1617083073895:-1837150183	1617052445948:598014748	D5170C00001	3006	3004	CREATE	2021-03-30 07:44:33.982	IRB or IEC Trial Approval	IRB or IEC Composition
17318	88	1617083074619:-1546742163	1617052447646:243971903	D5170C00001	3008	3007	CREATE	2021-03-30 07:44:34.709	Trial Status Reporting	IRB or IEC Notification of Trial Termination
17327	88	1617083082829:-2135368073	1617052454137:-549313426	D5170C00001	3017	3015	CREATE	2021-03-30 07:44:42.917	Site Management	Monitoring Visit Report
17330	88	1617083084146:18459405	1617052456439:-909392683	D5170C00001	3020	3019	CREATE	2021-03-30 07:44:44.23	Site Selection	Confidentiality Agreement
17332	88	1617083084772:-684048771	1617052457633:-824335942	D5170C00001	3022	3021	CREATE	2021-03-30 07:44:44.859	Site Set-up	Acceptance of Investigator Brochure
17333	88	1617083085479:1068451770	1617052457633:-824335942	D5170C00001	3023	3021	CREATE	2021-03-30 07:44:45.562	Site Set-up	Clinical Study Agreement
17335	88	1617083086845:-1421096753	1617052457633:-824335942	D5170C00001	3025	3021	CREATE	2021-03-30 07:44:46.928	Site Set-up	Form FDA 1572
17337	88	1617083088122:-1377261216	1617052457633:-824335942	D5170C00001	3027	3021	CREATE	2021-03-30 07:44:48.206	Site Set-up	Protocol Amendment Signature Page
17338	88	1617083088770:1637989684	1617052457633:-824335942	D5170C00001	3028	3021	CREATE	2021-03-30 07:44:48.855	Site Set-up	Site Signature Sheet
17340	88	1617083090138:-740828943	1617052457633:-824335942	D5170C00001	3030	3021	CREATE	2021-03-30 07:44:50.226	Site Set-up	Sub-Investigator Curriculum Vitae
17344	88	1617083090765:1362491182	1617052475910:1123804712	D5170C00001	3034	3033	CREATE	2021-03-30 07:44:50.848	Subject Documentation	Informed Consent Form
17347	88	1617083091369:701581095	1617052478386:915132062	D5170C00001	3037	3036	CREATE	2021-03-30 07:44:51.457	General	Tracking Information
17350	88	1617083092093:2047343405	1617052480120:-154523576	D5170C00001	3040	3039	CREATE	2021-03-30 07:44:52.181	General	Filenote
17352	88	1617083092750:1649889398	1617052481247:-123049190	D5170C00001	3042	3041	CREATE	2021-03-30 07:44:54.406	IP Documentation	IP Accountability Documentation
17353	88	1617083094938:777334131	1617052481247:-123049190	D5170C00001	3043	3041	CREATE	2021-03-30 07:44:55.026	IP Documentation	IP Certificate of Destruction
17355	88	1617083095586:1311494016	1617052482931:1599873358	D5170C00001	3045	3044	CREATE	2021-03-30 07:44:55.681	Storage	IP Storage Condition Documentation
17358	88	1617083096187:-1186752416	1617052484723:-883004005	D5170C00001	3048	3047	CREATE	2021-03-30 07:44:56.273	IRB or IEC Trial Approval	IRB or IEC Approval
17359	88	1617083096750:-95254185	1617052484723:-883004005	D5170C00001	3049	3047	CREATE	2021-03-30 07:44:56.837	IRB or IEC Trial Approval	IRB or IEC Composition
17361	88	1617083097379:1621415008	1617052486342:-1942805323	D5170C00001	3051	3050	CREATE	2021-03-30 07:44:57.462	Trial Status Reporting	IRB or IEC Notification of Trial Termination
17364	88	1617083098351:-1317472401	1617052488156:-371881247	D5170C00001	3054	3053	CREATE	2021-03-30 07:44:58.44	General	Tracking Information
17370	88	1617083100427:-636263552	1617052497460:-1953174261	D5170C00001	3060	3059	CREATE	2021-03-30 07:45:00.513	Site Management	Monitoring Visit Report
17377	88	1617083106166:518106439	1617052501784:1459373185	D5170C00001	3067	3065	CREATE	2021-03-30 07:45:06.25	Site Set-up	Clinical Study Agreement
17378	88	1617083106922:-846568019	1617052501784:1459373185	D5170C00001	3068	3065	CREATE	2021-03-30 07:45:07.008	Site Set-up	Financial Disclosure Form
17381	88	1617083118556:-629131538	1617052501784:1459373185	D5170C00001	3071	3065	CREATE	2021-03-30 07:45:18.64	Site Set-up	Principal Investigator Curriculum Vitae
17384	88	1617083120742:-343548722	1617052501784:1459373185	D5170C00001	3074	3065	CREATE	2021-03-30 07:45:20.83	Site Set-up	Site Staff Qualification Supporting Information
17389	88	1617083122215:1878589681	1617052509377:2052844832	D5170C00001	3079	3078	CREATE	2021-03-30 07:45:22.301	Subject Documentation	Advertisements for Subject Recruitment
17394	88	1617083124273:680365529	1617052513208:-1773076309	D5170C00001	3084	3083	CREATE	2021-03-30 07:45:24.357	General	Tracking Information
17402	88	1617083127659:-1760145013	1617052517762:1489581258	D5170C00001	3092	3091	CREATE	2021-03-30 07:45:27.742	Storage	IP Storage Condition Documentation
17407	88	1617083130826:1016953822	1617052520597:1198206109	D5170C00001	3097	3096	CREATE	2021-03-30 07:45:30.913	IRB or IEC Trial Approval	IRB or IEC Approval
17411	88	1617083132874:-8612719	1617052523845:-58616676	D5170C00001	3101	3100	CREATE	2021-03-30 07:45:32.959	Trial Status Reporting	IRB or IEC Notification of Trial Termination
17414	88	1617083133489:-1896639432	1617052526267:1602848431	D5170C00001	3104	3103	CREATE	2021-03-30 07:45:33.588	General	Tracking Information
17417	88	1617083134132:2126636450	1617052528072:1933751190	D5170C00001	3107	3106	CREATE	2021-03-30 07:45:34.216	General	Filenote
17422	88	1617083136872:-1380874563	1617052529725:-1281762727	D5170C00001	3112	3109	CREATE	2021-03-30 07:45:36.959	Site Management	Visit Log
17427	88	1617083138646:-1166490587	1617052534244:1720408852	D5170C00001	3117	3115	CREATE	2021-03-30 07:45:38.733	Site Set-up	Clinical Study Agreement
17428	88	1617083139320:-1629509659	1617052534244:1720408852	D5170C00001	3118	3115	CREATE	2021-03-30 07:45:39.406	Site Set-up	Financial Disclosure Form
17432	88	1617083146272:1211598341	1617052534244:1720408852	D5170C00001	3122	3115	CREATE	2021-03-30 07:45:46.433	Site Set-up	Protocol Amendment Signature Page
17433	88	1617083147037:421273062	1617052534244:1720408852	D5170C00001	3123	3115	CREATE	2021-03-30 07:45:47.12	Site Set-up	Site Signature Sheet
14317	88	1617049784665:-1037679973	1617049784091:-1315261634	D5170C00001	7	6	ALREADY AVAILABLE	2021-03-30 07:19:37.312	D5170C00001	Brazikumab_Study_Data and Monitoring Workbook
14322	88	1617049789154:-1167315032	1617049784091:-1315261634	D5170C00001	12	6	ALREADY AVAILABLE	2021-03-30 07:19:37.312	D5170C00001	Medimmune Remediation Tracker
14320	88	1617049786425:-570341204	1617049785224:-1294741372	D5170C00001	10	8	ALREADY AVAILABLE	2021-03-30 07:19:37.313	Country Level	CZ Rep
14325	88	1617049791187:228182341	1617049789824:-639278170	D5170C00001	15	13	ALREADY AVAILABLE	2021-03-30 07:19:37.313	Site Level	D5170C00001-Site 1016
14328	88	1617049793119:-9213411	1617049789824:-639278170	D5170C00001	18	13	ALREADY AVAILABLE	2021-03-30 07:19:37.314	Site Level	D5170C00001-Site 3301
14330	88	1617049794413:-362851649	1617049789824:-639278170	D5170C00001	20	13	ALREADY AVAILABLE	2021-03-30 07:19:37.314	Site Level	D5170C00001-Site 7004
17439	88	1617052549132:-740913861	1617051980305:1976405238	D5170C00001	3129	2462	ALREADY AVAILABLE	2021-03-30 07:19:37.321	United States of America	7820
17479	88	1617052592811:380298272	1617051980305:1976405238	D5170C00001	3169	2462	ALREADY AVAILABLE	2021-03-30 07:19:37.321	United States of America	7821
14344	88	1617049804489:72744510	1617049803910:1860048973	D5170C00001	34	33	ALREADY AVAILABLE	2021-03-30 07:19:37.321	Central Trial Documents	General
14346	88	1617049805778:546631501	1617049803910:1860048973	D5170C00001	36	33	ALREADY AVAILABLE	2021-03-30 07:19:37.321	Central Trial Documents	Subject Documentation
14385	88	1617049847716:-550507204	1617049843874:1787270063	D5170C00001	75	70	ALREADY AVAILABLE	2021-03-30 07:19:37.322	Trial Management	Meetings
17436	88	1617052547329:108985856	1617052508239:872433197	D5170C00001	3126	3076	ALREADY AVAILABLE	2021-03-30 07:19:37.343	7819	Trial Management
17440	88	1617052549741:1204800851	1617052549132:-740913861	D5170C00001	3130	3129	ALREADY AVAILABLE	2021-03-30 07:19:37.344	7820	Central Trial Documents
17443	88	1617052559748:-272854478	1617052549132:-740913861	D5170C00001	3133	3129	ALREADY AVAILABLE	2021-03-30 07:19:37.344	7820	Data Management
17455	88	1617052571815:26896872	1617052549132:-740913861	D5170C00001	3145	3129	ALREADY AVAILABLE	2021-03-30 07:19:37.344	7820	Safety Reporting
17498	88	1617052605658:1053104843	1617052592811:380298272	D5170C00001	3188	3169	ALREADY AVAILABLE	2021-03-30 07:19:37.344	7821	Safety Reporting
17501	88	1617052607516:-1420320606	1617052592811:380298272	D5170C00001	3191	3169	ALREADY AVAILABLE	2021-03-30 07:19:37.344	7821	Site Management
14349	88	1617049807714:1162936890	1617049805778:546631501	D5170C00001	39	36	ALREADY AVAILABLE	2021-03-30 07:19:37.344	Subject Documentation	Other Information Given to Subjects
14361	88	1617049816602:1120822117	1617049814651:-719237161	D5170C00001	51	48	ALREADY AVAILABLE	2021-03-30 07:19:37.344	IRB or IEC Trial Approval	IRB or IEC Submission
17437	88	1617052547882:-325525901	1617052547329:108985856	D5170C00001	3127	3126	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Trial Management	General
17447	88	1617052562281:-1474815141	1617052561543:1214236868	D5170C00001	3137	3136	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IP and Trial Supplies	General
17450	88	1617052568773:57779536	1617052568207:-31218878	D5170C00001	3140	3139	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IRB or IEC and other Approvals	IRB or IEC Trial Approval
17453	88	1617052570682:-1199043249	1617052568207:-31218878	D5170C00001	3143	3139	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IRB or IEC and other Approvals	Trial Status Reporting
17456	88	1617052572371:1699787381	1617052571815:26896872	D5170C00001	3146	3145	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Safety Reporting	General
17460	88	1617052574964:509646081	1617052574384:1927379706	D5170C00001	3150	3149	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	General
17435	88	1617083148266:-1957534956	1617052534244:1720408852	D5170C00001	3125	3115	CREATE	2021-03-30 07:45:48.357	Site Set-up	Sub-Investigator Curriculum Vitae
17442	88	1617083149717:-640998218	1617052558654:-927996579	D5170C00001	3132	3131	CREATE	2021-03-30 07:45:49.8	Subject Documentation	Informed Consent Form
17445	88	1617083150296:-2097326821	1617052560354:1456838545	D5170C00001	3135	3134	CREATE	2021-03-30 07:45:50.382	General	Tracking Information
17448	88	1617083151024:-432323900	1617052562281:-1474815141	D5170C00001	3138	3137	CREATE	2021-03-30 07:45:51.107	General	Filenote
17452	88	1617083152236:430095549	1617052568773:57779536	D5170C00001	3142	3140	CREATE	2021-03-30 07:45:52.324	IRB or IEC Trial Approval	IRB or IEC Composition
17457	88	1617083153566:-964014111	1617052572371:1699787381	D5170C00001	3147	3146	CREATE	2021-03-30 07:45:53.657	General	Relevant Communications
17464	88	1617083158101:-1941322252	1617052577752:1181948729	D5170C00001	3154	3153	CREATE	2021-03-30 07:45:58.187	Site Management	Visit Log
17468	88	1617083159326:-111466344	1617052580110:299539488	D5170C00001	3158	3157	CREATE	2021-03-30 07:45:59.41	Site Set-up	Acceptance of Investigator Brochure
17470	88	1617083160863:940516667	1617052580110:299539488	D5170C00001	3160	3157	CREATE	2021-03-30 07:46:01.004	Site Set-up	Data Privacy Agreement
17471	88	1617083161593:1294606692	1617052580110:299539488	D5170C00001	3161	3157	CREATE	2021-03-30 07:46:01.677	Site Set-up	Financial Disclosure Form
17474	88	1617083163735:1512032564	1617052580110:299539488	D5170C00001	3164	3157	CREATE	2021-03-30 07:46:03.821	Site Set-up	Principal Investigator Curriculum Vitae
17476	88	1617083165130:-1559638076	1617052580110:299539488	D5170C00001	3166	3157	CREATE	2021-03-30 07:46:05.217	Site Set-up	Site Signature Sheet
17477	88	1617083165803:604279929	1617052580110:299539488	D5170C00001	3167	3157	CREATE	2021-03-30 07:46:07.721	Site Set-up	Site Staff Qualification Supporting Information
17482	88	1617083169174:88486561	1617052594078:-2020655662	D5170C00001	3172	3171	CREATE	2021-03-30 07:46:09.258	Subject Documentation	Informed Consent Form
17485	88	1617083170004:1955651807	1617052595920:1801599620	D5170C00001	3175	3174	CREATE	2021-03-30 07:46:10.09	General	Tracking Information
17488	88	1617083170928:493200216	1617052597849:-1774507897	D5170C00001	3178	3177	CREATE	2021-03-30 07:46:11.01	General	Filenote
17490	88	1617083171574:992916840	1617052600217:-1647748982	D5170C00001	3180	3179	CREATE	2021-03-30 07:46:11.667	IP Documentation	IP Accountability Documentation
17491	88	1617083173067:-291923914	1617052600217:-1647748982	D5170C00001	3181	3179	CREATE	2021-03-30 07:46:13.152	IP Documentation	IP Certificate of Destruction
17494	88	1617083173971:-916550142	1617052602756:191533864	D5170C00001	3184	3183	CREATE	2021-03-30 07:46:14.054	IRB or IEC Trial Approval	IRB or IEC Approval
17500	88	1617083175923:1714608524	1617052606275:1790585508	D5170C00001	3190	3189	CREATE	2021-03-30 07:46:16.006	General	Tracking Information
14401	88	1617049868581:1599150928	1617049864704:-1654436179	D5170C00001	91	86	ALREADY AVAILABLE	2021-03-30 07:19:37.322	Central Trial Documents	Product and Trial Documentation
14410	88	1617049874554:1131675673	1617049873884:1745461580	D5170C00001	100	99	ALREADY AVAILABLE	2021-03-30 07:19:37.322	IP and Trial Supplies	General
14413	88	1617049876883:-1327860076	1617049873884:1745461580	D5170C00001	103	99	ALREADY AVAILABLE	2021-03-30 07:19:37.322	IP and Trial Supplies	Storage
14416	88	1617049879542:-1798496119	1617049878901:1691951506	D5170C00001	106	105	ALREADY AVAILABLE	2021-03-30 07:19:37.322	IRB or IEC and other Approvals	General
14418	88	1617049880709:867899471	1617049878901:1691951506	D5170C00001	108	105	ALREADY AVAILABLE	2021-03-30 07:19:37.322	IRB or IEC and other Approvals	IRB or IEC Trial Approval
14562	88	1617049995375:-1111462517	1617049993597:-2098685600	D5170C00001	252	249	ALREADY AVAILABLE	2021-03-30 07:19:37.325	IRB or IEC and other Approvals	IRB or IEC Trial Approval
14568	88	1617050004228:1236816701	1617050001821:476427197	D5170C00001	258	254	ALREADY AVAILABLE	2021-03-30 07:19:37.325	Regulatory	Trial Approval
14576	88	1617050009177:1704716759	1617050008582:-1117695304	D5170C00001	266	265	ALREADY AVAILABLE	2021-03-30 07:19:37.325	Site Management	Site Selection
14592	88	1617050028780:-355970993	1617050019842:696592341	D5170C00001	282	281	ALREADY AVAILABLE	2021-03-30 07:19:37.325	Central Trial Documents	General
14394	88	1617049863562:1363486333	1617049850378:-1253320494	D5170C00001	84	79	ALREADY AVAILABLE	2021-03-30 07:19:37.344	Trial Oversight	Transfer of Regulatory Obligations
14398	88	1617049866038:1203251475	1617049865285:-949512337	D5170C00001	88	87	ALREADY AVAILABLE	2021-03-30 07:19:37.344	General	Explanation of Approvals non English language
14404	88	1617049870752:1544551921	1617049870019:245753741	D5170C00001	94	93	ALREADY AVAILABLE	2021-03-30 07:19:37.344	Subject Documentation	Informed Consent Form
14407	88	1617049872631:157701844	1617049870019:245753741	D5170C00001	97	93	ALREADY AVAILABLE	2021-03-30 07:19:37.344	Subject Documentation	Subject Participation Card
14430	88	1617049889277:544409299	1617049887081:1855593420	D5170C00001	120	118	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Trial Approval	Regulatory Submission
14439	88	1617049894695:-1856685005	1617049893530:-39355784	D5170C00001	129	127	ALREADY AVAILABLE	2021-03-30 07:19:37.347	General	Relevant Communications
14441	88	1617049902393:1950033288	1617049901772:1955494472	D5170C00001	131	130	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Site Initiation	Site Training Material
14444	88	1617049904230:-10565808	1617049902958:-566141412	D5170C00001	134	132	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Site Set-up	Protocol Signature Page
14447	88	1617049906017:923581317	1617049905414:502109418	D5170C00001	137	136	ALREADY AVAILABLE	2021-03-30 07:19:37.347	General	Other Meeting Material
14450	88	1617049907962:-1993469662	1617049907247:-1928664089	D5170C00001	140	139	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Meetings	Investigators Meeting Material
14455	88	1617049911999:1231806325	1617049909235:1256286141	D5170C00001	145	142	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Trial Oversight	Quality Plan
14460	88	1617049915019:-1172841580	1617049914415:1966474462	D5170C00001	150	149	ALREADY AVAILABLE	2021-03-30 07:19:37.347	General	Explanation of Approvals non English language
14466	88	1617049918898:-118364746	1617049917006:-1738035494	D5170C00001	156	153	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Subject Documentation	Subject Participation Card
14470	88	1617049922505:1031673545	1617049920673:-1246644968	D5170C00001	160	159	ALREADY AVAILABLE	2021-03-30 07:19:37.347	General	Relevant Communications
14472	88	1617049923648:1056904237	1617049923071:-1975640652	D5170C00001	162	161	ALREADY AVAILABLE	2021-03-30 07:19:37.347	IRB or IEC Trial Approval	IRB or IEC Approval
14513	88	1617049957041:714143401	1617049952578:1024957174	D5170C00001	203	199	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Subject Documentation	Subject Participation Card
14533	88	1617049971078:1308160428	1617049970504:722983919	D5170C00001	223	222	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Site Set-up	Clinical Study Agreement
14541	88	1617049981186:-1794473656	1617049980004:1071776660	D5170C00001	231	229	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Meetings	Kick-off Meeting Material
14544	88	1617049983042:1617206187	1617049981849:368963370	D5170C00001	234	232	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Trial Oversight	Monitoring Plan
14545	88	1617049983631:774503230	1617049981849:368963370	D5170C00001	235	232	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Trial Oversight	Quality Plan
14546	88	1617049984272:803234500	1617049981849:368963370	D5170C00001	236	232	ALREADY AVAILABLE	2021-03-30 07:19:37.347	Trial Oversight	Transfer of Regulatory Obligations
6908	84	\N	\N	D5170C00002	693	692	NEW	\N	2001802 Feagan, Brian	02 Central Trial Documents
14550	88	1617049986670:-177755262	1617049986103:-1233249355	D5170C00001	240	239	ALREADY AVAILABLE	2021-03-30 07:19:37.347	General	Certificate of Translation
14553	88	1617049989823:-573725888	1617049987882:1610181194	D5170C00001	243	242	ALREADY AVAILABLE	2021-03-30 07:19:37.348	Product and Trial Documentation	Insurance
14556	88	1617049991839:349155388	1617049990405:256784007	D5170C00001	246	244	ALREADY AVAILABLE	2021-03-30 07:19:37.348	Subject Documentation	Subject Diary
14566	88	1617050002990:-224393615	1617050002395:-1226272963	D5170C00001	256	255	ALREADY AVAILABLE	2021-03-30 07:19:37.349	General	Filenote
14574	88	1617050007854:-1331744198	1617050006666:-784742218	D5170C00001	264	262	ALREADY AVAILABLE	2021-03-30 07:19:37.349	General	Relevant Communications
14737	88	1617050145432:-727837459	1617050144863:-122430637	D5170C00001	427	426	ALREADY AVAILABLE	2021-03-30 07:19:37.318	United States of America	Central and Local Testing
14768	88	1617050172551:-1515127504	1617050144863:-122430637	D5170C00001	458	426	ALREADY AVAILABLE	2021-03-30 07:19:37.318	United States of America	Third Parties
14598	88	1617050032373:-172791692	1617050019842:696592341	D5170C00001	288	281	ALREADY AVAILABLE	2021-03-30 07:19:37.325	Central Trial Documents	Subject Documentation
14623	88	1617050053854:-593875201	1617050048274:704794999	D5170C00001	313	312	ALREADY AVAILABLE	2021-03-30 07:19:37.325	Trial Management	General
14731	88	1617050141814:1010630798	1617050138174:588116770	D5170C00001	421	417	ALREADY AVAILABLE	2021-03-30 07:19:37.327	Trial Management	Trial Oversight
14742	88	1617050154966:608004575	1617050148100:-552850351	D5170C00001	432	431	ALREADY AVAILABLE	2021-03-30 07:19:37.327	Central Trial Documents	Product and Trial Documentation
14751	88	1617050160495:2021630989	1617050159901:1484582691	D5170C00001	441	440	ALREADY AVAILABLE	2021-03-30 07:19:37.327	IRB or IEC and other Approvals	IRB or IEC Trial Approval
14775	88	1617050178389:-1648259386	1617050176477:-1705672544	D5170C00001	465	462	ALREADY AVAILABLE	2021-03-30 07:19:37.327	Trial Management	Trial Oversight
14787	88	1617050192159:-1019077068	1617050191494:-1593718706	D5170C00001	477	476	ALREADY AVAILABLE	2021-03-30 07:19:37.327	1001	Central and Local Testing
14790	88	1617050194062:-1745830218	1617050191494:-1593718706	D5170C00001	480	476	ALREADY AVAILABLE	2021-03-30 07:19:37.327	1001	Central Trial Documents
14600	88	1617050033599:-1095932044	1617050032373:-172791692	D5170C00001	290	288	ALREADY AVAILABLE	2021-03-30 07:19:37.35	Subject Documentation	Other Information Given to Subjects
14604	88	1617050036007:587872371	1617050032373:-172791692	D5170C00001	294	288	ALREADY AVAILABLE	2021-03-30 07:19:37.351	Subject Documentation	Subject Questionnaire
14607	88	1617050037766:-1194358132	1617050037206:-2021869274	D5170C00001	297	296	ALREADY AVAILABLE	2021-03-30 07:19:37.351	IRB or IEC Trial Approval	IRB or IEC Submission
14610	88	1617050040476:-2109242399	1617050039892:-616636994	D5170C00001	300	299	ALREADY AVAILABLE	2021-03-30 07:19:37.351	General	Filenote
14612	88	1617050042334:1945829963	1617050041637:2044089459	D5170C00001	302	301	ALREADY AVAILABLE	2021-03-30 07:19:37.351	Trial Approval	Regulatory Approval Notification
14616	88	1617050044667:-1987808193	1617050044086:441716742	D5170C00001	306	305	ALREADY AVAILABLE	2021-03-30 07:19:37.351	General	Relevant Communications
14618	88	1617050045891:-457450008	1617050045264:-1660721073	D5170C00001	308	307	ALREADY AVAILABLE	2021-03-30 07:19:37.351	Site Initiation	Site Training Material
14690	88	1617050107203:686127333	1617050103459:1438998616	D5170C00001	380	376	ALREADY AVAILABLE	2021-03-30 07:19:37.355	Subject Documentation	Subject Participation Card
14701	88	1617050119851:910908023	1617050119290:-246147404	D5170C00001	391	390	ALREADY AVAILABLE	2021-03-30 07:19:37.355	IRB or IEC Trial Approval	IRB or IEC Approval
14702	88	1617050120610:-2045595771	1617050119290:-246147404	D5170C00001	392	390	ALREADY AVAILABLE	2021-03-30 07:19:37.355	IRB or IEC Trial Approval	IRB or IEC Compliance Documentation
14708	88	1617050124311:568826895	1617050123720:-973817301	D5170C00001	398	397	ALREADY AVAILABLE	2021-03-30 07:19:37.355	Trial Status Reporting	IRB or IEC Notification of Trial Termination
14712	88	1617050127348:-1275517940	1617050126744:879453851	D5170C00001	402	401	ALREADY AVAILABLE	2021-03-30 07:19:37.356	General	Filenote
14715	88	1617050130411:-1982947415	1617050129827:-1162096858	D5170C00001	405	404	ALREADY AVAILABLE	2021-03-30 07:19:37.356	Trial Approval	Regulatory Approval Notification
14720	88	1617050133565:1836618472	1617050132250:1119209526	D5170C00001	410	408	ALREADY AVAILABLE	2021-03-30 07:19:37.356	General	Relevant Communications
14722	88	1617050134842:213639940	1617050134148:-1180907514	D5170C00001	412	411	ALREADY AVAILABLE	2021-03-30 07:19:37.356	Site Initiation	Site Training Material
14725	88	1617050136851:238521316	1617050135480:103191916	D5170C00001	415	413	ALREADY AVAILABLE	2021-03-30 07:19:37.356	Site Set-up	Data Privacy Agreement
14734	88	1617050143647:-1899677091	1617050141814:1010630798	D5170C00001	424	421	ALREADY AVAILABLE	2021-03-30 07:19:37.357	Trial Oversight	Quality Plan
14739	88	1617050146662:505554778	1617050146035:-951542613	D5170C00001	429	428	ALREADY AVAILABLE	2021-03-30 07:19:37.357	Facility Documentation	Certification or Accreditation
14745	88	1617050156790:-386677149	1617050156210:-1647154088	D5170C00001	435	434	ALREADY AVAILABLE	2021-03-30 07:19:37.357	Subject Documentation	Advertisements for Subject Recruitment
14776	88	1617050179054:1124633440	1617050178389:-1648259386	D5170C00001	466	465	ALREADY AVAILABLE	2021-03-30 07:19:37.358	Trial Oversight	Monitoring Plan
14778	88	1617050180320:-1606580247	1617050178389:-1648259386	D5170C00001	468	465	ALREADY AVAILABLE	2021-03-30 07:19:37.358	Trial Oversight	Roles and Responsibility Matrix
14796	88	1617050199411:-26332705	1617050198833:-733165757	D5170C00001	486	485	ALREADY AVAILABLE	2021-03-30 07:19:37.359	Data Management	General
14785	88	1617081805425:1837187294	1617050184125:-1720550498	D5170C00001	475	474	CREATE	2021-03-30 07:23:26.766	General	Filenote
14792	88	1617081808857:636968759	1617050194692:1373710432	D5170C00001	482	481	CREATE	2021-03-30 07:23:28.947	Subject Documentation	Advertisements for Subject Recruitment
14801	88	1617050202609:-1269710550	1617050200777:-2031925333	D5170C00001	491	488	ALREADY AVAILABLE	2021-03-30 07:19:37.359	IP and Trial Supplies	Interactive Response Technology
14813	88	1617050218759:-404546953	1617050214790:699704712	D5170C00001	503	498	ALREADY AVAILABLE	2021-03-30 07:19:37.359	IRB or IEC and other Approvals	Trial Status Reporting
14816	88	1617050221589:-454196918	1617050220998:959732678	D5170C00001	506	505	ALREADY AVAILABLE	2021-03-30 07:19:37.359	Safety Reporting	General
14819	88	1617050223431:2002452707	1617050222793:-1515687263	D5170C00001	509	508	ALREADY AVAILABLE	2021-03-30 07:19:37.359	Site Management	General
6911	84	\N	\N	D5170C00002	696	694	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
14971	88	1617050359979:-939361792	1617050353989:-1857945627	D5170C00001	661	654	ALREADY AVAILABLE	2021-03-30 07:19:37.361	IRB or IEC and other Approvals	Other Committees
14977	88	1617050364013:599747112	1617050363344:-680259090	D5170C00001	667	666	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Site Management	General
14980	88	1617050372860:663591526	1617050363344:-680259090	D5170C00001	670	666	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Site Management	Site Management
14804	88	1617081812349:679898249	1617050203873:-1810329772	D5170C00001	494	493	CREATE	2021-03-30 07:23:32.434	IP Documentation	IP Accountability Documentation
14807	88	1617081813506:745618121	1617050205784:2053175073	D5170C00001	497	496	CREATE	2021-03-30 07:23:33.592	Non-IP Documentation	Non-IP Shipment Documentation
14810	88	1617081814062:-1718719684	1617050215517:358800250	D5170C00001	500	499	CREATE	2021-03-30 07:23:34.152	IRB or IEC Trial Approval	IRB or IEC Approval
14821	88	1617081817683:2119117261	1617050223431:2002452707	D5170C00001	511	509	CREATE	2021-03-30 07:23:37.774	General	Relevant Communications
14827	88	1617081821003:-1472249065	1617050226422:-1412208130	D5170C00001	517	514	CREATE	2021-03-30 07:23:41.097	Site Management	Visit Log
14829	88	1617081821586:-438904212	1617050228789:-1476894172	D5170C00001	519	518	CREATE	2021-03-30 07:23:41.673	Site Selection	Confidentiality Agreement
14832	88	1617081822853:-1827638867	1617050231189:2000360534	D5170C00001	522	520	CREATE	2021-03-30 07:23:42.937	Site Set-up	Clinical Study Agreement
14835	88	1617081824548:-497346440	1617050231189:2000360534	D5170C00001	525	520	CREATE	2021-03-30 07:23:44.64	Site Set-up	Other Curriculum Vitae
14837	88	1617081825654:-272253729	1617050231189:2000360534	D5170C00001	527	520	CREATE	2021-03-30 07:23:45.741	Site Set-up	Protocol Amendment Signature Page
14840	88	1617081827529:1509525757	1617050231189:2000360534	D5170C00001	530	520	CREATE	2021-03-30 07:23:47.621	Site Set-up	Site Staff Qualification Supporting Information
14844	88	1617081828681:-959956417	1617050244913:1850471677	D5170C00001	534	533	CREATE	2021-03-30 07:23:48.778	Trial Oversight	Recruitment Plan
14852	88	1617081830781:1165201852	1617050250113:-801955375	D5170C00001	542	541	CREATE	2021-03-30 07:23:50.868	Facility Documentation	Laboratory Validation Documentation
14855	88	1617081831331:2056102120	1617050252021:1709909660	D5170C00001	545	544	CREATE	2021-03-30 07:23:51.416	Subject Documentation	Informed Consent Form
14861	88	1617081832522:-756860747	1617050257100:1818332267	D5170C00001	551	550	CREATE	2021-03-30 07:23:52.608	IP Documentation	IP Certificate of Destruction
14867	88	1617081834628:171829029	1617050260101:-1295884730	D5170C00001	557	555	CREATE	2021-03-30 07:23:54.715	IRB or IEC Trial Approval	IRB or IEC Composition
14875	88	1617081837019:-113233014	1617050269477:1540118976	D5170C00001	565	563	CREATE	2021-03-30 07:23:57.106	General	Relevant Communications
14878	88	1617081838164:679974360	1617050271364:-1672498684	D5170C00001	568	566	CREATE	2021-03-30 07:23:58.252	Site Management	Protocol Deviations
14881	88	1617081839482:-1466207331	1617050273944:1947605678	D5170C00001	571	570	CREATE	2021-03-30 07:23:59.565	Site Selection	Confidentiality Agreement
14884	88	1617081841637:-1092369729	1617050276464:838276677	D5170C00001	574	572	CREATE	2021-03-30 07:24:01.725	Site Set-up	Clinical Study Agreement
14886	88	1617081842902:-566011706	1617050276464:838276677	D5170C00001	576	572	CREATE	2021-03-30 07:24:02.988	Site Set-up	Investigator Regulatory Agreement
14889	88	1617081844700:1365699868	1617050276464:838276677	D5170C00001	579	572	CREATE	2021-03-30 07:24:04.784	Site Set-up	Protocol Amendment Signature Page
14892	88	1617081846853:-1147466724	1617050276464:838276677	D5170C00001	582	572	CREATE	2021-03-30 07:24:06.937	Site Set-up	Site Staff Qualification Supporting Information
14901	88	1617081848719:1508544041	1617050293538:-772496291	D5170C00001	591	590	CREATE	2021-03-30 07:24:08.936	General	Filenote
14911	88	1617081850758:1622968256	1617050301255:1808431316	D5170C00001	601	600	CREATE	2021-03-30 07:24:10.842	IP Documentation	IP Certificate of Destruction
14920	88	1617081854982:-140797827	1617050306625:241153458	D5170C00001	610	607	CREATE	2021-03-30 07:24:15.068	IRB or IEC Trial Approval	IRB or IEC Submission
14928	88	1617081859391:-1449026747	1617050317024:28571891	D5170C00001	618	617	CREATE	2021-03-30 07:24:19.479	General	Filenote
14929	88	1617081860044:-558373747	1617050317024:28571891	D5170C00001	619	617	CREATE	2021-03-30 07:24:20.132	General	Relevant Communications
14931	88	1617081860632:1798634517	1617050318967:298779374	D5170C00001	621	620	CREATE	2021-03-30 07:24:20.719	Site Management	Monitoring Visit Report
14933	88	1617081861761:-511106980	1617050318967:298779374	D5170C00001	623	620	CREATE	2021-03-30 07:24:21.848	Site Management	Visit Log
14938	88	1617081864648:794027163	1617050324770:26621288	D5170C00001	628	627	CREATE	2021-03-30 07:24:24.732	Site Set-up	Acceptance of Investigator Brochure
14944	88	1617081868150:220302542	1617050324770:26621288	D5170C00001	634	627	CREATE	2021-03-30 07:24:28.236	Site Set-up	Protocol Amendment Signature Page
14947	88	1617081869868:-1882466965	1617050324770:26621288	D5170C00001	637	627	CREATE	2021-03-30 07:24:29.951	Site Set-up	Site Staff Qualification Supporting Information
14960	88	1617081872828:1634377888	1617050350410:-1593081825	D5170C00001	650	649	CREATE	2021-03-30 07:24:32.913	IP Documentation	IP Certificate of Destruction
14963	88	1617081875079:-350327319	1617050351825:-1732885429	D5170C00001	653	651	CREATE	2021-03-30 07:24:35.165	Non-IP Documentation	Non-IP Shipment Documentation
14968	88	1617081876216:-1002769431	1617050357411:775707325	D5170C00001	658	657	CREATE	2021-03-30 07:24:36.298	IRB or IEC Trial Approval	IRB or IEC Approval
14975	88	1617081879205:-760444226	1617050361999:-1924460916	D5170C00001	665	664	CREATE	2021-03-30 07:24:39.29	General	Relevant Communications
14985	88	1617081882731:-808884697	1617050375518:1007244423	D5170C00001	675	674	CREATE	2021-03-30 07:24:42.817	Site Selection	Confidentiality Agreement
14988	88	1617081883975:817726647	1617050379429:189521224	D5170C00001	678	677	CREATE	2021-03-30 07:24:44.059	Site Set-up	Acceptance of Investigator Brochure
14994	88	1617081898279:-737400631	1617050379429:189521224	D5170C00001	684	677	CREATE	2021-03-30 07:24:58.364	Site Set-up	Protocol Amendment Signature Page
15007	88	1617050406160:-216704244	1617050386532:-683947474	D5170C00001	697	688	ALREADY AVAILABLE	2021-03-30 07:19:37.329	1007	IP and Trial Supplies
15048	88	1617050448655:-1821619583	1617050448058:729655527	D5170C00001	738	737	ALREADY AVAILABLE	2021-03-30 07:19:37.329	1008	Site Management
15002	88	1617050390581:134836214	1617050387132:-222193713	D5170C00001	692	689	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Central Trial Documents	Subject Documentation
15005	88	1617050397534:-1030155443	1617050396747:1692295878	D5170C00001	695	694	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Data Management	General
15008	88	1617050406925:-1919454871	1617050406160:-216704244	D5170C00001	698	697	ALREADY AVAILABLE	2021-03-30 07:19:37.361	IP and Trial Supplies	IP Documentation
15016	88	1617050421645:-991566997	1617050410716:-1461396142	D5170C00001	706	703	ALREADY AVAILABLE	2021-03-30 07:19:37.361	IRB or IEC and other Approvals	IRB or IEC Trial Approval
15137	88	1617050532914:-254243461	1617050519626:1358729789	D5170C00001	827	820	ALREADY AVAILABLE	2021-03-30 07:19:37.361	IRB or IEC and other Approvals	Trial Status Reporting
15143	88	1617050536529:1978899790	1617050535856:-1463709423	D5170C00001	833	832	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Site Management	General
15146	88	1617050538563:-2137484447	1617050535856:-1463709423	D5170C00001	836	832	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Site Management	Site Management
15164	88	1617050554428:1661418699	1617050553763:-1538526212	D5170C00001	854	853	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Trial Management	Trial Oversight
15168	88	1617050557160:1598817252	1617050556535:-1406149573	D5170C00001	858	857	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Site Management	General
15176	88	1617050568392:1189138179	1617050567816:1510033362	D5170C00001	866	865	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Site Management	General
15180	88	1617050571186:1563151006	1617050570244:-448758501	D5170C00001	870	869	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Site Management	General
15189	88	1617050579042:-1041394474	1617050576997:1486947416	D5170C00001	879	876	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Central Trial Documents	Subject Documentation
15192	88	1617050581203:677600109	1617050580357:-1093437404	D5170C00001	882	881	ALREADY AVAILABLE	2021-03-30 07:19:37.361	Data Management	General
15010	88	1617081903121:-230066167	1617050406925:-1919454871	D5170C00001	700	698	CREATE	2021-03-30 07:25:03.208	IP Documentation	IP Certificate of Destruction
15025	88	1617081908350:-1434624630	1617050426610:-103070449	D5170C00001	715	714	CREATE	2021-03-30 07:25:08.437	Site Initiation	Site Training Material
15027	88	1617081909061:1108220414	1617050429138:-1509167003	D5170C00001	717	716	CREATE	2021-03-30 07:25:09.159	Site Management	Monitoring Visit Report
15033	88	1617081911429:1916735660	1617050432720:2105218396	D5170C00001	723	722	CREATE	2021-03-30 07:25:11.52	Site Set-up	Acceptance of Investigator Brochure
15036	88	1617081913285:-276876769	1617050432720:2105218396	D5170C00001	726	722	CREATE	2021-03-30 07:25:13.367	Site Set-up	Investigator Regulatory Agreement
15039	88	1617081915003:1047628433	1617050432720:2105218396	D5170C00001	729	722	CREATE	2021-03-30 07:25:15.087	Site Set-up	Protocol Amendment Signature Page
15042	88	1617081916746:-1662495972	1617050432720:2105218396	D5170C00001	732	722	CREATE	2021-03-30 07:25:16.831	Site Set-up	Site Staff Qualification Supporting Information
15046	88	1617081918027:-1248948444	1617050446697:-348579006	D5170C00001	736	735	CREATE	2021-03-30 07:25:18.116	General	Relevant Communications
15058	88	1617081921060:-2094007768	1617050455335:-1779896179	D5170C00001	748	747	CREATE	2021-03-30 07:25:21.146	General	Relevant Communications
15063	88	1617081922227:-1133874813	1617050458405:1487211606	D5170C00001	753	752	CREATE	2021-03-30 07:25:22.317	Subject Documentation	Informed Consent Form
15066	88	1617081922801:-428649780	1617050467378:1309946974	D5170C00001	756	755	CREATE	2021-03-30 07:25:22.884	General	Tracking Information
15069	88	1617081923421:-5003662	1617050469240:-1603054838	D5170C00001	759	758	CREATE	2021-03-30 07:25:23.507	General	Relevant Communications
15072	88	1617081924610:-567056705	1617050470420:-1886459610	D5170C00001	762	760	CREATE	2021-03-30 07:25:24.696	IP Documentation	IP Certificate of Destruction
15074	88	1617081925235:1193974978	1617050473466:-2115988627	D5170C00001	764	763	CREATE	2021-03-30 07:25:25.322	Non-IP Documentation	Non-IP Shipment Documentation
15078	88	1617081926441:228917467	1617050475324:-1389923857	D5170C00001	768	766	CREATE	2021-03-30 07:25:26.525	IRB or IEC Trial Approval	IRB or IEC Composition
15084	88	1617081928118:-327275836	1617050479713:796845176	D5170C00001	774	773	CREATE	2021-03-30 07:25:28.205	General	Tracking Information
15087	88	1617081928703:1811349397	1617050481669:-1199531501	D5170C00001	777	776	CREATE	2021-03-30 07:25:28.79	General	Filenote
15088	88	1617081929256:-1180424796	1617050481669:-1199531501	D5170C00001	778	776	CREATE	2021-03-30 07:25:29.339	General	Relevant Communications
15092	88	1617081932214:2034638445	1617050484731:-727337539	D5170C00001	782	779	CREATE	2021-03-30 07:25:32.299	Site Management	Visit Log
15097	88	1617081934071:2118400894	1617050488400:1782292050	D5170C00001	787	785	CREATE	2021-03-30 07:25:34.155	Site Set-up	Clinical Study Agreement
15100	88	1617081935828:1297437623	1617050488400:1782292050	D5170C00001	790	785	CREATE	2021-03-30 07:25:35.917	Site Set-up	Other Financial Agreement
15105	88	1617081938849:1374132975	1617050488400:1782292050	D5170C00001	795	785	CREATE	2021-03-30 07:25:38.947	Site Set-up	Site Staff Qualification Supporting Information
15109	88	1617081940035:923488262	1617050502752:-213895435	D5170C00001	799	798	CREATE	2021-03-30 07:25:40.123	General	Filenote
15132	88	1617081956639:819882164	1617050520197:-1862333602	D5170C00001	822	821	CREATE	2021-03-30 07:25:56.725	General	Relevant Communications
15134	88	1617081957255:-126953015	1617050521469:802714645	D5170C00001	824	823	CREATE	2021-03-30 07:25:57.346	IRB or IEC Trial Approval	IRB or IEC Approval
15148	88	1617081961968:-348267249	1617050538563:-2137484447	D5170C00001	838	836	CREATE	2021-03-30 07:26:02.054	Site Management	Protocol Deviations
15151	88	1617081965014:-884154766	1617050542882:-1302435332	D5170C00001	841	840	CREATE	2021-03-30 07:26:05.098	Site Selection	Confidentiality Agreement
15156	88	1617081967470:1106039559	1617050544090:1275073608	D5170C00001	846	842	CREATE	2021-03-30 07:26:13.283	Site Set-up	Investigator Regulatory Agreement
15159	88	1617081975950:-960624131	1617050544090:1275073608	D5170C00001	849	842	CREATE	2021-03-30 07:26:16.035	Site Set-up	Protocol Amendment Signature Page
15165	88	1617081978520:-1072830122	1617050554428:1661418699	D5170C00001	855	854	CREATE	2021-03-30 07:26:18.606	Trial Oversight	Recruitment Plan
15173	88	1617081979694:1642777544	1617050565643:516265672	D5170C00001	863	862	CREATE	2021-03-30 07:26:19.781	General	Filenote
15197	88	1617050584617:306362979	1617050582514:707376719	D5170C00001	887	884	ALREADY AVAILABLE	2021-03-30 07:19:37.361	IP and Trial Supplies	IP Documentation
15199	88	1617050585823:-125099472	1617050582514:707376719	D5170C00001	889	884	ALREADY AVAILABLE	2021-03-30 07:19:37.361	IP and Trial Supplies	Non-IP Documentation
15202	88	1617050597307:133224284	1617050595422:654078825	D5170C00001	892	891	ALREADY AVAILABLE	2021-03-30 07:19:37.361	IRB or IEC and other Approvals	IRB or IEC Trial Approval
15217	88	1617050609786:-1528999021	1617050602815:1223614789	D5170C00001	907	900	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Selection
15325	88	1617050717017:1691730036	1617050714212:150895717	D5170C00001	1015	1011	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IP and Trial Supplies	Interactive Response Technology
15347	88	1617050736013:2035469033	1617050729850:350475970	D5170C00001	1037	1031	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Selection
15350	88	1617050745959:2117512818	1617050729850:350475970	D5170C00001	1040	1031	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Set-up
15361	88	1617050753738:1984501310	1617050753016:841413619	D5170C00001	1051	1050	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Selection
15374	88	1617050764793:-972584069	1617050761850:1758735707	D5170C00001	1064	1060	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IP and Trial Supplies	Interactive Response Technology
15384	88	1617050779584:425212454	1617050775453:605540925	D5170C00001	1074	1071	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IRB or IEC and other Approvals	IRB or IEC Trial Approval
15387	88	1617050781684:-1731387924	1617050775453:605540925	D5170C00001	1077	1071	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IRB or IEC and other Approvals	Trial Status Reporting
15209	88	1617081988566:-1730784079	1617050601472:-607356572	D5170C00001	899	898	CREATE	2021-03-30 07:26:28.651	General	Tracking Information
15212	88	1617081989114:381487305	1617050604313:-1330202334	D5170C00001	902	901	CREATE	2021-03-30 07:26:29.202	General	Relevant Communications
15214	88	1617081989694:1752956548	1617050606807:-1757817792	D5170C00001	904	903	CREATE	2021-03-30 07:26:29.778	Site Management	Monitoring Visit Report
15220	88	1617081992023:630546244	1617050611493:-1740449440	D5170C00001	910	909	CREATE	2021-03-30 07:26:32.108	Site Set-up	Acceptance of Investigator Brochure
15223	88	1617081993793:2124609867	1617050611493:-1740449440	D5170C00001	913	909	CREATE	2021-03-30 07:26:33.875	Site Set-up	Investigator Regulatory Agreement
15225	88	1617081994897:1729231345	1617050611493:-1740449440	D5170C00001	915	909	CREATE	2021-03-30 07:26:34.98	Site Set-up	Principal Investigator Curriculum Vitae
15228	88	1617081996742:1229722168	1617050611493:-1740449440	D5170C00001	918	909	CREATE	2021-03-30 07:26:36.826	Site Set-up	Site Staff Qualification Supporting Information
15232	88	1617081998929:-357900032	1617050626157:-495152021	D5170C00001	922	921	CREATE	2021-03-30 07:26:39.013	General	Filenote
15237	88	1617081999494:1257543506	1617050630659:680024276	D5170C00001	927	926	CREATE	2021-03-30 07:26:39.578	General	Tracking Information
15240	88	1617082000098:-1498739901	1617050632624:982922077	D5170C00001	930	929	CREATE	2021-03-30 07:26:40.184	General	Filenote
15243	88	1617082001236:-950221110	1617050635501:-2034462016	D5170C00001	933	932	CREATE	2021-03-30 07:26:41.32	Interactive Response Technology	IRT User Account Management
15246	88	1617082002400:-1215560983	1617050636914:1719875449	D5170C00001	936	934	CREATE	2021-03-30 07:26:42.484	IP Documentation	IP Certificate of Destruction
15254	88	1617082004705:4113908	1617050647924:460414474	D5170C00001	944	942	CREATE	2021-03-30 07:26:44.788	IRB or IEC Trial Approval	IRB or IEC Submission
15257	88	1617082005883:-264906620	1617050649716:-796397702	D5170C00001	947	945	CREATE	2021-03-30 07:26:54.15	Trial Status Reporting	IRB or IEC Progress Report
15271	88	1617082018695:1084488123	1617050660514:-1281271433	D5170C00001	961	959	CREATE	2021-03-30 07:26:58.783	Site Set-up	Financial Disclosure Form
15274	88	1617082021624:120203950	1617050660514:-1281271433	D5170C00001	964	959	CREATE	2021-03-30 07:27:01.715	Site Set-up	Protocol Amendment Signature Page
15277	88	1617082023457:837794491	1617050660514:-1281271433	D5170C00001	967	959	CREATE	2021-03-30 07:27:03.552	Site Set-up	Sub-Investigator Curriculum Vitae
15285	88	1617082025378:-133565494	1617050676774:-1245967778	D5170C00001	975	973	CREATE	2021-03-30 07:27:05.466	General	Relevant Communications
15287	88	1617082025943:1212694313	1617050678743:31668470	D5170C00001	977	976	CREATE	2021-03-30 07:27:06.037	Interactive Response Technology	IRT User Account Management
15307	88	1617082033629:-1159812119	1617050693346:555633805	D5170C00001	997	995	CREATE	2021-03-30 07:27:13.717	Site Set-up	Financial Disclosure Form
15310	88	1617082035445:1269289881	1617050693346:555633805	D5170C00001	1000	995	CREATE	2021-03-30 07:27:15.529	Site Set-up	Protocol Amendment Signature Page
15313	88	1617082037204:-998283511	1617050693346:555633805	D5170C00001	1003	995	CREATE	2021-03-30 07:27:17.288	Site Set-up	Sub-Investigator Curriculum Vitae
15317	88	1617082037756:-1310776493	1617050710677:1150840618	D5170C00001	1007	1006	CREATE	2021-03-30 07:27:17.84	General	Explanation of Approvals non English language
15320	88	1617082038576:-1247462861	1617050712818:1078849195	D5170C00001	1010	1009	CREATE	2021-03-30 07:27:18.666	General	Tracking Information
15328	88	1617082041135:-2017378256	1617050718334:1644671268	D5170C00001	1018	1017	CREATE	2021-03-30 07:27:21.22	IP Documentation	IP Accountability Documentation
15334	88	1617082044081:-2101109359	1617050724360:622796162	D5170C00001	1024	1023	CREATE	2021-03-30 07:27:24.165	General	Relevant Communications
15337	88	1617082045873:1136894212	1617050725766:-1300797444	D5170C00001	1027	1025	CREATE	2021-03-30 07:27:25.959	IRB or IEC Trial Approval	IRB or IEC Submission
15343	88	1617082047583:-1602351146	1617050730728:-788726276	D5170C00001	1033	1032	CREATE	2021-03-30 07:27:27.669	Site Initiation	Trial Initiation Monitoring Report
15352	88	1617082051272:-1035044499	1617050745959:2117512818	D5170C00001	1042	1040	CREATE	2021-03-30 07:27:31.363	Site Set-up	Financial Disclosure Form
15358	88	1617082056240:-1281769958	1617050745959:2117512818	D5170C00001	1048	1040	CREATE	2021-03-30 07:27:36.326	Site Set-up	Sub-Investigator Curriculum Vitae
15366	88	1617082057528:-211031345	1617050758304:-1255136860	D5170C00001	1056	1055	CREATE	2021-03-30 07:27:37.617	General	Explanation of Approvals non English language
15372	88	1617082058934:-1827616362	1617050762541:-1956694286	D5170C00001	1062	1061	CREATE	2021-03-30 07:27:39.115	General	Filenote
15389	88	1617082103091:-1235327566	1617050781684:-1731387924	D5170C00001	1079	1077	CREATE	2021-03-30 07:28:23.174	Trial Status Reporting	IRB or IEC Progress Report
15395	88	1617082104862:-1622384009	1617050792560:-1767264048	D5170C00001	1085	1084	CREATE	2021-03-30 07:28:24.943	Site Initiation	Trial Initiation Monitoring Report
15507	88	1617050891415:1530127135	1617050887704:-1310750877	D5170C00001	1197	1193	ALREADY AVAILABLE	2021-03-30 07:19:37.332	2304	IP and Trial Supplies
15399	88	1617050796424:1463169618	1617050788902:-1730293684	D5170C00001	1089	1080	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Selection
15402	88	1617050798623:645457028	1617050788902:-1730293684	D5170C00001	1092	1080	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Set-up
15493	88	1617050881086:-1500195416	1617050880411:-618614854	D5170C00001	1183	1182	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	General
15499	88	1617050885051:1892088874	1617050880411:-618614854	D5170C00001	1189	1182	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Set-up
15505	88	1617050888961:1714730018	1617050888318:-156966807	D5170C00001	1195	1194	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Data Management	General
15520	88	1617050899861:-2002248705	1617050899273:1813224507	D5170C00001	1210	1209	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	General
15525	88	1617050908654:-1615746707	1617050899273:1813224507	D5170C00001	1215	1209	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Management
15528	88	1617050910519:-1680422140	1617050899273:1813224507	D5170C00001	1218	1209	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Selection
15530	88	1617050911732:-1888658032	1617050899273:1813224507	D5170C00001	1220	1209	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Set-up
15541	88	1617050920113:-1905380160	1617050919521:872725693	D5170C00001	1231	1230	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Data Management	General
15544	88	1617050921897:1941594811	1617050921240:-718435360	D5170C00001	1234	1233	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IP and Trial Supplies	General
15404	88	1617082108558:617887451	1617050798623:645457028	D5170C00001	1094	1092	CREATE	2021-03-30 07:28:28.642	Site Set-up	Financial Disclosure Form
15407	88	1617082111751:-1150391163	1617050798623:645457028	D5170C00001	1097	1092	CREATE	2021-03-30 07:28:31.836	Site Set-up	Protocol Amendment Signature Page
15410	88	1617082113563:173281196	1617050798623:645457028	D5170C00001	1100	1092	CREATE	2021-03-30 07:28:33.647	Site Set-up	Sub-Investigator Curriculum Vitae
15426	88	1617082116506:1805723453	1617050820263:-353964475	D5170C00001	1116	1115	CREATE	2021-03-30 07:28:36.59	IP Allocation Documentation	IP Treatment Decoding Documentation
15433	88	1617082118841:1794724636	1617050826251:875798403	D5170C00001	1123	1122	CREATE	2021-03-30 07:28:38.923	Storage	IP Storage Condition Documentation
15436	88	1617082119459:-431650598	1617050827988:-1355656996	D5170C00001	1126	1125	CREATE	2021-03-30 07:28:39.548	General	Filenote
15439	88	1617082120104:-263489595	1617050829960:-162273758	D5170C00001	1129	1128	CREATE	2021-03-30 07:28:40.187	General	Filenote
15447	88	1617082124635:-1421238875	1617050835946:-1472277239	D5170C00001	1137	1136	CREATE	2021-03-30 07:28:44.717	Site Set-up	Acceptance of Investigator Brochure
15450	88	1617082132802:-1246997805	1617050835946:-1472277239	D5170C00001	1140	1136	CREATE	2021-03-30 07:28:54.275	Site Set-up	Principal Investigator Curriculum Vitae
15453	88	1617082136057:407387652	1617050835946:-1472277239	D5170C00001	1143	1136	CREATE	2021-03-30 07:28:56.142	Site Set-up	Site Signature Sheet
15464	88	1617082138985:399619737	1617050853631:1345265953	D5170C00001	1154	1153	CREATE	2021-03-30 07:28:59.07	IP Allocation Documentation	IP Treatment Decoding Documentation
15466	88	1617082139655:-1623979544	1617050854894:830841681	D5170C00001	1156	1155	CREATE	2021-03-30 07:28:59.74	IP Documentation	IP Accountability Documentation
15469	88	1617082140811:1615569540	1617050857855:689531599	D5170C00001	1159	1158	CREATE	2021-03-30 07:29:00.898	Non-IP Documentation	Non-IP Shipment Documentation
15475	88	1617082142707:-559090035	1617050860849:-1467241283	D5170C00001	1165	1163	CREATE	2021-03-30 07:29:02.794	General	Relevant Communications
15484	88	1617082147193:-1538477587	1617050873391:-1270625158	D5170C00001	1174	1173	CREATE	2021-03-30 07:29:07.28	Site Set-up	Acceptance of Investigator Brochure
15487	88	1617082148944:1340777276	1617050873391:-1270625158	D5170C00001	1177	1173	CREATE	2021-03-30 07:29:09.03	Site Set-up	Protocol Amendment Signature Page
15489	88	1617082150204:-1584512015	1617050873391:-1270625158	D5170C00001	1179	1173	CREATE	2021-03-30 07:29:10.292	Site Set-up	Site Staff Qualification Supporting Information
15496	88	1617082152072:-922164668	1617050882368:-1028012063	D5170C00001	1186	1185	CREATE	2021-03-30 07:29:12.168	Site Management	Monitoring Visit Report
15501	88	1617082153994:1881605334	1617050885051:1892088874	D5170C00001	1191	1189	CREATE	2021-03-30 07:29:14.078	Site Set-up	Principal Investigator Curriculum Vitae
15513	88	1617082164894:-110549720	1617050895010:-79499940	D5170C00001	1203	1202	CREATE	2021-03-30 07:29:25.071	IP Documentation	IP Accountability Documentation
15516	88	1617082166722:696358513	1617050896871:-220778195	D5170C00001	1206	1205	CREATE	2021-03-30 07:29:26.809	Non-IP Documentation	Non-IP Shipment Documentation
15522	88	1617082168483:2095080534	1617050899861:-2002248705	D5170C00001	1212	1210	CREATE	2021-03-30 07:29:28.567	General	Relevant Communications
15536	88	1617082174627:-117093847	1617050911732:-1888658032	D5170C00001	1226	1220	CREATE	2021-03-30 07:29:34.715	Site Set-up	Site Signature Sheet
15538	88	1617082175814:1799065431	1617050911732:-1888658032	D5170C00001	1228	1220	CREATE	2021-03-30 07:29:35.955	Site Set-up	Sub-Investigator Curriculum Vitae
15549	88	1617082178211:1775812538	1617050925655:-1707757094	D5170C00001	1239	1238	CREATE	2021-03-30 07:29:44.729	IP Documentation	IP Accountability Documentation
15555	88	1617082186481:-1634900860	1617050929268:-1558118965	D5170C00001	1245	1244	CREATE	2021-03-30 07:29:46.566	General	Filenote
15561	88	1617082188224:1537115023	1617050932897:-988577970	D5170C00001	1251	1250	CREATE	2021-03-30 07:29:48.333	Site Management	Monitoring Visit Report
15564	88	1617082189377:1632977307	1617050939311:-646007191	D5170C00001	1254	1253	CREATE	2021-03-30 07:29:49.461	Site Selection	Confidentiality Agreement
15569	88	1617082191702:-1361006330	1617050940499:1931522967	D5170C00001	1259	1255	CREATE	2021-03-30 07:29:51.785	Site Set-up	Principal Investigator Curriculum Vitae
15578	88	1617082194812:1822742624	1617050949241:1731101429	D5170C00001	1268	1267	CREATE	2021-03-30 07:29:54.897	General	Relevant Communications
15587	88	1617082196660:-2080075900	1617050954709:1269426546	D5170C00001	1277	1276	CREATE	2021-03-30 07:29:56.746	Site Selection	Confidentiality Agreement
15590	88	1617082197911:-415313619	1617050958991:451713956	D5170C00001	1280	1279	CREATE	2021-03-30 07:29:57.995	Site Set-up	Acceptance of Investigator Brochure
15595	88	1617082200926:-1597906572	1617050958991:451713956	D5170C00001	1285	1279	CREATE	2021-03-30 07:30:01.01	Site Set-up	Protocol Amendment Signature Page
15601	88	1617082202801:992683926	1617050975449:-219285075	D5170C00001	1291	1290	CREATE	2021-03-30 07:30:02.884	General	Tracking Information
15610	88	1617050981791:2053286980	1617050964476:-57606151	D5170C00001	1300	1288	ALREADY AVAILABLE	2021-03-30 07:19:37.332	2602	Site Management
15639	88	1617051006452:-530269601	1617051000367:-1036916876	D5170C00001	1329	1319	ALREADY AVAILABLE	2021-03-30 07:19:37.332	2604	Regulatory
15603	88	1617050977437:452668609	1617050976877:1948121318	D5170C00001	1293	1292	ALREADY AVAILABLE	2021-03-30 07:19:37.362	IP and Trial Supplies	IP Documentation
6914	84	\N	\N	D5170C00002	699	697	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
15613	88	1617050984056:1434806248	1617050981791:2053286980	D5170C00001	1303	1300	ALREADY AVAILABLE	2021-03-30 07:19:37.362	Site Management	Site Initiation
15631	88	1617051001542:-798495734	1617051000936:540809176	D5170C00001	1321	1320	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Data Management	General
15645	88	1617051010852:-1596402660	1617051009046:-1636058232	D5170C00001	1335	1332	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Initiation
15667	88	1617051031832:-1956130065	1617051031256:140875331	D5170C00001	1357	1356	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IP and Trial Supplies	Interactive Response Technology
15669	88	1617051033038:2092720068	1617051031256:140875331	D5170C00001	1359	1356	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IP and Trial Supplies	IP Documentation
15676	88	1617051037418:792754053	1617051036840:-1475887853	D5170C00001	1366	1365	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Safety Reporting	General
15681	88	1617051041434:-1828570085	1617051038795:-359170887	D5170C00001	1371	1368	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Management
15708	88	1617051058549:1904363532	1617051057888:-1000994054	D5170C00001	1398	1397	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Safety Reporting	General
15606	88	1617082204019:302535179	1617050978594:1880187333	D5170C00001	1296	1295	CREATE	2021-03-30 07:30:04.107	Storage	IP Storage Condition Documentation
15614	88	1617082205849:-1863982269	1617050984056:1434806248	D5170C00001	1304	1303	CREATE	2021-03-30 07:30:05.934	Site Initiation	Site Evidence of Training
15616	88	1617082206402:188770149	1617050986152:-265813583	D5170C00001	1306	1305	CREATE	2021-03-30 07:30:06.494	Site Management	Monitoring Visit Report
15619	88	1617082207594:-1981382454	1617050987881:-330478407	D5170C00001	1309	1308	CREATE	2021-03-30 07:30:07.682	Site Selection	Confidentiality Agreement
15622	88	1617082208759:-1271049759	1617050994476:-248519494	D5170C00001	1312	1311	CREATE	2021-03-30 07:30:08.844	Site Set-up	Acceptance of Investigator Brochure
15625	88	1617082210810:-1392307994	1617050994476:-248519494	D5170C00001	1315	1311	CREATE	2021-03-30 07:30:10.892	Site Set-up	Principal Investigator Curriculum Vitae
15628	88	1617082212762:-2054350730	1617050994476:-248519494	D5170C00001	1318	1311	CREATE	2021-03-30 07:30:12.851	Site Set-up	Sub-Investigator Curriculum Vitae
15653	88	1617082218859:-1532033014	1617051015079:817283835	D5170C00001	1343	1342	CREATE	2021-03-30 07:30:18.942	Site Set-up	Acceptance of Investigator Brochure
15656	88	1617082220735:-1357749508	1617051015079:817283835	D5170C00001	1346	1342	CREATE	2021-03-30 07:30:20.823	Site Set-up	Principal Investigator Curriculum Vitae
15659	88	1617082222717:789994832	1617051015079:817283835	D5170C00001	1349	1342	CREATE	2021-03-30 07:30:22.8	Site Set-up	Site Signature Sheet
15672	88	1617082225939:-178766409	1617051034169:1859202067	D5170C00001	1362	1361	CREATE	2021-03-30 07:30:26.022	Non-IP Documentation	Non-IP Shipment Documentation
15686	88	1617082237562:956268083	1617051043188:-1288086683	D5170C00001	1376	1374	CREATE	2021-03-30 07:30:37.647	Site Selection	Pre Trial Monitoring Report
15689	88	1617082238720:-1426495531	1617051044993:-2105799273	D5170C00001	1379	1377	CREATE	2021-03-30 07:30:38.805	Site Set-up	Clinical Study Agreement
15690	88	1617082239367:-1637674989	1617051044993:-2105799273	D5170C00001	1380	1377	CREATE	2021-03-30 07:30:39.45	Site Set-up	Data Privacy Agreement
15693	88	1617082243237:-1788832477	1617051044993:-2105799273	D5170C00001	1383	1377	CREATE	2021-03-30 07:30:43.33	Site Set-up	Principal Investigator Curriculum Vitae
15696	88	1617082245082:161084112	1617051044993:-2105799273	D5170C00001	1386	1377	CREATE	2021-03-30 07:30:45.17	Site Set-up	Site Signature Sheet
15701	88	1617082247743:-675156852	1617051053704:122453074	D5170C00001	1391	1390	CREATE	2021-03-30 07:30:47.825	Interactive Response Technology	IRT User Account Management
15704	88	1617082248866:263073899	1617051054940:-1260701007	D5170C00001	1394	1392	CREATE	2021-03-30 07:30:48.947	Non-IP Documentation	Non-IP Shipment Documentation
15712	88	1617082250799:957105909	1617051060916:-941645827	D5170C00001	1402	1401	CREATE	2021-03-30 07:30:50.884	Site Initiation	Trial Initiation Monitoring Report
15718	88	1617082253193:150334587	1617051069580:1684573205	D5170C00001	1408	1406	CREATE	2021-03-30 07:30:53.277	Site Selection	Pre Trial Monitoring Report
15722	88	1617082255031:-642014942	1617051071540:1064815674	D5170C00001	1412	1409	CREATE	2021-03-30 07:30:55.124	Site Set-up	Data Privacy Agreement
15724	88	1617082256210:1919150373	1617051071540:1064815674	D5170C00001	1414	1409	CREATE	2021-03-30 07:30:56.293	Site Set-up	Other Curriculum Vitae
15727	88	1617082259437:-782052515	1617051071540:1064815674	D5170C00001	1417	1409	CREATE	2021-03-30 07:30:59.525	Site Set-up	Protocol Signature Page
15733	88	1617082261221:200739227	1617051080493:2064210449	D5170C00001	1423	1422	CREATE	2021-03-30 07:31:01.309	General	Tracking Information
15738	88	1617082262520:-978928157	1617051083498:1950758544	D5170C00001	1428	1427	CREATE	2021-03-30 07:31:02.606	IP Documentation	IP Certificate of Destruction
15758	88	1617082270569:-683154104	1617051100755:624090824	D5170C00001	1448	1445	CREATE	2021-03-30 07:31:10.654	Site Set-up	Data Privacy Agreement
15760	88	1617082271792:-1634431470	1617051100755:624090824	D5170C00001	1450	1445	CREATE	2021-03-30 07:31:11.885	Site Set-up	Other Curriculum Vitae
15763	88	1617082273595:75206746	1617051100755:624090824	D5170C00001	1453	1445	CREATE	2021-03-30 07:31:13.693	Site Set-up	Protocol Signature Page
15765	88	1617082274920:-773702161	1617051100755:624090824	D5170C00001	1455	1445	CREATE	2021-03-30 07:31:15.005	Site Set-up	Sub-Investigator Curriculum Vitae
15771	88	1617082276159:-1564035443	1617051111167:-1713184153	D5170C00001	1461	1460	CREATE	2021-03-30 07:31:16.242	Non-IP Documentation	Non-IP Shipment Documentation
15776	88	1617082277354:-805446030	1617051147345:1582108549	D5170C00001	1466	1465	CREATE	2021-03-30 07:31:17.447	General	Tracking Information
15779	88	1617082278010:456965034	1617051149238:-2048493892	D5170C00001	1469	1468	CREATE	2021-03-30 07:31:18.099	Site Initiation	Trial Initiation Monitoring Report
15788	88	1617082282987:511187079	1617051160575:-449321039	D5170C00001	1478	1476	CREATE	2021-03-30 07:31:32.562	Site Set-up	Clinical Study Agreement
15791	88	1617082294405:-1437093759	1617051160575:-449321039	D5170C00001	1481	1476	CREATE	2021-03-30 07:31:34.488	Site Set-up	Other Curriculum Vitae
16311	88	1617051591205:320405571	1617051459985:-355373043	D5170C00001	2001	1838	ALREADY AVAILABLE	2021-03-30 07:19:37.32	Poland	5706
15853	88	1617051216147:-267716567	1617051197667:-2006859691	D5170C00001	1543	1522	ALREADY AVAILABLE	2021-03-30 07:19:37.333	4101	IRB or IEC and other Approvals
16215	88	1617051518128:-1077200565	1617051507100:374680563	D5170C00001	1905	1891	ALREADY AVAILABLE	2021-03-30 07:19:37.335	5703	Site Management
15817	88	1617051187373:673246207	1617051182931:608455615	D5170C00001	1507	1501	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Site Management	Site Selection
15837	88	1617051200802:-333206404	1617051200141:971496471	D5170C00001	1527	1526	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Central Trial Documents	General
15844	88	1617051210639:-1668625502	1617051210063:-1701244794	D5170C00001	1534	1533	ALREADY AVAILABLE	2021-03-30 07:19:37.363	Data Management	General
15847	88	1617051212494:-1175528562	1617051211925:883377633	D5170C00001	1537	1536	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IP and Trial Supplies	Interactive Response Technology
15856	88	1617051218992:797387911	1617051216147:-267716567	D5170C00001	1546	1543	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IRB or IEC and other Approvals	IRB or IEC Trial Approval
15859	88	1617051220732:-427473196	1617051216147:-267716567	D5170C00001	1549	1543	ALREADY AVAILABLE	2021-03-30 07:19:37.363	IRB or IEC and other Approvals	Other Committees
16248	88	1617051545157:110154845	1617051544589:-366591814	D5170C00001	1938	1937	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IP and Trial Supplies	Interactive Response Technology
16258	88	1617051550969:975492042	1617051549268:814903981	D5170C00001	1948	1945	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	Site Initiation
16282	88	1617051571254:-170157797	1617051570626:2016539822	D5170C00001	1972	1971	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IP and Trial Supplies	Interactive Response Technology
15807	88	1617082300115:725182371	1617051179301:-1644989317	D5170C00001	1497	1496	CREATE	2021-03-30 07:31:40.202	Non-IP Documentation	Non-IP Shipment Documentation
15813	88	1617082301340:668188294	1617051183487:2144028803	D5170C00001	1503	1502	CREATE	2021-03-30 07:31:41.425	Site Initiation	Trial Initiation Monitoring Report
15819	88	1617082305421:982127273	1617051187373:673246207	D5170C00001	1509	1507	CREATE	2021-03-30 07:31:45.508	Site Selection	Pre Trial Monitoring Report
15822	88	1617082306692:1030850182	1617051189275:-144455774	D5170C00001	1512	1510	CREATE	2021-03-30 07:31:46.775	Site Set-up	Clinical Study Agreement
15825	88	1617082308629:-1721106827	1617051189275:-144455774	D5170C00001	1515	1510	CREATE	2021-03-30 07:31:48.724	Site Set-up	Other Curriculum Vitae
15828	88	1617082310485:-222001017	1617051189275:-144455774	D5170C00001	1518	1510	CREATE	2021-03-30 07:31:50.572	Site Set-up	Protocol Signature Page
15838	88	1617082312956:-162150933	1617051200802:-333206404	D5170C00001	1528	1527	CREATE	2021-03-30 07:31:53.043	General	Explanation of Approvals non English language
15841	88	1617082314216:-1032807210	1617051202040:-57295690	D5170C00001	1531	1529	CREATE	2021-03-30 07:31:54.301	Subject Documentation	Other Information Given to Subjects
15850	88	1617082318159:-871011092	1617051213717:1973607632	D5170C00001	1540	1539	CREATE	2021-03-30 07:31:58.247	IP Documentation	IP Accountability Documentation
15865	88	1617082324057:-483928703	1617051223845:2015694306	D5170C00001	1555	1554	CREATE	2021-03-30 07:32:04.144	Site Initiation	Site Evidence of Training
15868	88	1617082325241:-1445458193	1617051225616:1099805762	D5170C00001	1558	1557	CREATE	2021-03-30 07:32:05.326	Site Management	Monitoring Visit Report
15871	88	1617082327935:-479476731	1617051227319:1442344714	D5170C00001	1561	1560	CREATE	2021-03-30 07:32:08.034	Site Selection	Confidentiality Agreement
16212	88	1617082504757:212999816	1617051515248:-655445431	D5170C00001	1902	1901	CREATE	2021-03-30 07:35:04.845	Non-IP Documentation	Non-IP Shipment Documentation
16218	88	1617082506544:-358713729	1617051518723:1654198188	D5170C00001	1908	1906	CREATE	2021-03-30 07:35:06.631	General	Relevant Communications
16224	88	1617082518510:-59400055	1617051524393:-1334830938	D5170C00001	1914	1913	CREATE	2021-03-30 07:35:18.598	Site Selection	Confidentiality Agreement
16226	88	1617082519109:1037650345	1617051525539:1536193424	D5170C00001	1916	1915	CREATE	2021-03-30 07:35:19.198	Site Set-up	Acceptance of Investigator Brochure
16232	88	1617082524124:1349255917	1617051525539:1536193424	D5170C00001	1922	1915	CREATE	2021-03-30 07:35:24.207	Site Set-up	Principal Investigator Curriculum Vitae
16235	88	1617082526053:-1489355244	1617051525539:1536193424	D5170C00001	1925	1915	CREATE	2021-03-30 07:35:26.136	Site Set-up	Site Signature Sheet
16252	88	1617082530261:-1876041125	1617051546343:175744749	D5170C00001	1942	1940	CREATE	2021-03-30 07:35:30.35	IP Documentation	IP Certificate of Destruction
16261	88	1617082534223:1081921795	1617051552139:59561062	D5170C00001	1951	1950	CREATE	2021-03-30 07:35:34.321	Site Management	Additional Monitoring Activity
16267	88	1617082542638:-763534855	1617051559484:-203133084	D5170C00001	1957	1955	CREATE	2021-03-30 07:35:42.724	Site Selection	Feasibility Documentation
16270	88	1617082543808:-1978742318	1617051561626:-822837570	D5170C00001	1960	1958	CREATE	2021-03-30 07:35:43.897	Site Set-up	Clinical Study Agreement
16275	88	1617082547688:871192499	1617051561626:-822837570	D5170C00001	1965	1958	CREATE	2021-03-30 07:35:47.77	Site Set-up	Principal Investigator Curriculum Vitae
16283	88	1617082550695:-1824824818	1617051571254:-170157797	D5170C00001	1973	1972	CREATE	2021-03-30 07:35:50.783	Interactive Response Technology	IRT User Account Management
16285	88	1617082551400:-780048658	1617051572433:-218521472	D5170C00001	1975	1974	CREATE	2021-03-30 07:35:51.484	IP Documentation	IP Certificate of Destruction
16294	88	1617082554726:1206842178	1617051577421:1984810468	D5170C00001	1984	1981	CREATE	2021-03-30 07:35:54.824	Site Management	Subject Log
16297	88	1617082557213:69592012	1617051580719:1514087640	D5170C00001	1987	1986	CREATE	2021-03-30 07:35:57.301	Site Selection	Confidentiality Agreement
16303	88	1617082560147:-733387698	1617051582575:204087676	D5170C00001	1993	1989	CREATE	2021-03-30 07:36:00.232	Site Set-up	Financial Disclosure Form
16305	88	1617082561307:-273253631	1617051582575:204087676	D5170C00001	1995	1989	CREATE	2021-03-30 07:36:01.392	Site Set-up	Other Financial Agreement
16316	88	1617082565970:-318139526	1617051593584:-1268493131	D5170C00001	2006	2005	CREATE	2021-03-30 07:36:06.065	IP Documentation	IP Accountability Documentation
16323	88	1617082568872:1250183817	1617051598904:-1798224472	D5170C00001	2013	2012	CREATE	2021-03-30 07:36:08.955	Site Management	Additional Monitoring Activity
16373	88	1617082592148:-1489313787	1617051645462:-1502442975	D5170C00001	2063	2060	CREATE	2021-03-30 07:36:32.234	IP Documentation	IP Shipment Documentation
16376	88	1617082593365:700405775	1617051647838:1950696612	D5170C00001	2066	2064	CREATE	2021-03-30 07:36:33.463	Non-IP Documentation	Non-IP Shipment Documentation
16382	88	1617051653617:-1974873942	1617051650732:1308315124	D5170C00001	2072	2069	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IRB or IEC and other Approvals	IRB or IEC Trial Approval
16388	88	1617051657410:-1879270653	1617051656781:1893345263	D5170C00001	2078	2077	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Safety Reporting	General
16391	88	1617051659308:-364804022	1617051658601:-1400747048	D5170C00001	2081	2080	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	General
16432	88	1617051696185:-1618000742	1617051695619:-1755896893	D5170C00001	2122	2121	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IP and Trial Supplies	General
16435	88	1617051699402:-223588921	1617051695619:-1755896893	D5170C00001	2125	2121	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IP and Trial Supplies	Interactive Response Technology
16451	88	1617051710572:679115478	1617051706416:-1806330357	D5170C00001	2141	2136	ALREADY AVAILABLE	2021-03-30 07:19:37.364	IRB or IEC and other Approvals	Other Committees
16454	88	1617051716545:-1289498101	1617051711732:-1356218563	D5170C00001	2144	2143	ALREADY AVAILABLE	2021-03-30 07:19:37.364	Site Management	General
16396	88	1617082598600:711363589	1617051661159:2122344217	D5170C00001	2086	2084	CREATE	2021-03-30 07:36:38.683	Site Initiation	Trial Initiation Monitoring Report
16400	88	1617082601647:1788979467	1617051663157:716247663	D5170C00001	2090	2087	CREATE	2021-03-30 07:36:41.73	Site Management	Visit Log
16402	88	1617082602217:-832783439	1617051669750:1061884443	D5170C00001	2092	2091	CREATE	2021-03-30 07:36:42.304	Site Selection	Confidentiality Agreement
16405	88	1617082603438:-1625337841	1617051671572:-658448952	D5170C00001	2095	2094	CREATE	2021-03-30 07:36:43.521	Site Set-up	Acceptance of Investigator Brochure
16408	88	1617082605380:-540302742	1617051671572:-658448952	D5170C00001	2098	2094	CREATE	2021-03-30 07:36:45.469	Site Set-up	Investigator Regulatory Agreement
16411	88	1617082607168:-1513554512	1617051671572:-658448952	D5170C00001	2101	2094	CREATE	2021-03-30 07:36:47.258	Site Set-up	Principal Investigator Curriculum Vitae
16414	88	1617082608951:-1565579491	1617051671572:-658448952	D5170C00001	2104	2094	CREATE	2021-03-30 07:36:49.041	Site Set-up	Sub-Investigator Curriculum Vitae
16420	88	1617082610238:1645387105	1617051682054:474583948	D5170C00001	2110	2109	CREATE	2021-03-30 07:36:50.326	Sample Documentation	Sample Storage Condition Log
16433	88	1617082614410:-874349537	1617051696185:-1618000742	D5170C00001	2123	2122	CREATE	2021-03-30 07:36:54.496	General	Filenote
16434	88	1617082614965:429458888	1617051696185:-1618000742	D5170C00001	2124	2122	CREATE	2021-03-30 07:36:55.049	General	Relevant Communications
16436	88	1617082615580:805480078	1617051699402:-223588921	D5170C00001	2126	2125	CREATE	2021-03-30 07:36:55.676	Interactive Response Technology	IRT User Account Management
16439	88	1617082616748:238239100	1617051700568:-1174541574	D5170C00001	2129	2127	CREATE	2021-03-30 07:36:56.83	IP Documentation	IP Certificate of Destruction
16442	88	1617082618037:1108536242	1617051703339:-1803046710	D5170C00001	2132	2131	CREATE	2021-03-30 07:36:58.125	Non-IP Documentation	Non-IP Return Documentation
16445	88	1617082619167:-746342592	1617051705171:779849103	D5170C00001	2135	2134	CREATE	2021-03-30 07:36:59.25	Storage	IP Storage Condition Documentation
16448	88	1617082619726:2083161394	1617051706969:-384668705	D5170C00001	2138	2137	CREATE	2021-03-30 07:36:59.81	General	Relevant Communications
16459	88	1617082624382:525854573	1617051721482:1197692574	D5170C00001	2149	2147	CREATE	2021-03-30 07:37:04.467	Site Initiation	Trial Initiation Monitoring Report
16468	88	1617082627862:-1137792150	1617051726989:-680554053	D5170C00001	2158	2156	CREATE	2021-03-30 07:37:07.949	Site Set-up	Clinical Study Agreement
16471	88	1617082629668:894450119	1617051726989:-680554053	D5170C00001	2161	2156	CREATE	2021-03-30 07:37:09.755	Site Set-up	Other Curriculum Vitae
16474	88	1617082631456:936095044	1617051726989:-680554053	D5170C00001	2164	2156	CREATE	2021-03-30 07:37:11.541	Site Set-up	Site Signature Sheet
16480	88	1617082634414:-1984660392	1617051735053:-1326550545	D5170C00001	2170	2168	CREATE	2021-03-30 07:37:14.498	General	Relevant Communications
16491	88	1617082647721:-1363863633	1617051743021:494562777	D5170C00001	2181	2180	CREATE	2021-03-30 07:37:27.803	General	Tracking Information
16494	88	1617082648343:1673940003	1617051744852:1460728148	D5170C00001	2184	2183	CREATE	2021-03-30 07:37:28.43	General	Filenote
16499	88	1617082650049:-1465984190	1617051747756:1904208534	D5170C00001	2189	2188	CREATE	2021-03-30 07:37:30.134	IP Documentation	IP Accountability Documentation
16506	88	1617082653023:-147972376	1617051752120:-846690907	D5170C00001	2196	2195	CREATE	2021-03-30 07:37:33.109	Storage	IP Storage Condition Documentation
16511	88	1617082654225:-1319156526	1617051756036:-58795687	D5170C00001	2201	2200	CREATE	2021-03-30 07:37:34.312	IRB or IEC Trial Approval	IRB or IEC Submission
16520	88	1617082658120:-1754374751	1617051761376:-1887528791	D5170C00001	2210	2208	CREATE	2021-03-30 07:37:38.204	General	Relevant Communications
16523	88	1617082659258:930968737	1617051768377:714623318	D5170C00001	2213	2211	CREATE	2021-03-30 07:37:39.342	Site Initiation	Trial Initiation Monitoring Report
16526	88	1617082660417:-1634979592	1617051770192:-1298785698	D5170C00001	2216	2214	CREATE	2021-03-30 07:37:40.508	Site Management	Visit Log
16529	88	1617082661698:-1919759194	1617051771975:-756148669	D5170C00001	2219	2217	CREATE	2021-03-30 07:37:41.783	Site Selection	Pre Trial Monitoring Report
16532	88	1617082663676:-1679553969	1617051773702:1818442796	D5170C00001	2222	2220	CREATE	2021-03-30 07:37:43.763	Site Set-up	Clinical Study Agreement
16535	88	1617082665550:-230417214	1617051773702:1818442796	D5170C00001	2225	2220	CREATE	2021-03-30 07:37:45.634	Site Set-up	Other Curriculum Vitae
16537	88	1617082666829:-2023055774	1617051773702:1818442796	D5170C00001	2227	2220	CREATE	2021-03-30 07:37:46.911	Site Set-up	Principal Investigator Curriculum Vitae
16555	88	1617082673621:532933081	1617051795480:2076771702	D5170C00001	2245	2244	CREATE	2021-03-30 07:37:53.705	General	Tracking Information
16558	88	1617082674203:-448925087	1617051798192:1749476784	D5170C00001	2248	2247	CREATE	2021-03-30 07:37:54.293	General	Filenote
16563	88	1617082676567:1587045569	1617051800011:1584003966	D5170C00001	2253	2250	CREATE	2021-03-30 07:37:56.652	IP Documentation	IP Shipment Documentation
16566	88	1617082677716:-1703674272	1617051802416:1152552124	D5170C00001	2256	2254	CREATE	2021-03-30 07:37:57.801	Non-IP Documentation	Non-IP Shipment Documentation
16575	88	1617082681531:-414579268	1617051809813:116616543	D5170C00001	2265	2264	CREATE	2021-03-30 07:38:01.625	Other Committees	Other Submissions
16578	88	1617082682187:-1880363310	1617051811681:2100458680	D5170C00001	2268	2267	CREATE	2021-03-30 07:38:02.273	General	Relevant Communications
16584	88	1617082684107:-1975677907	1617051815406:-2025746494	D5170C00001	2274	2273	CREATE	2021-03-30 07:38:04.193	Site Initiation	Site Evidence of Training
16608	88	1617051836859:84724098	1617051836208:-1467894886	D5170C00001	2298	2297	ALREADY AVAILABLE	2021-03-30 07:19:37.337	7006	Central and Local Testing
16778	88	1617051983895:-1464322687	1617051980881:-120376759	D5170C00001	2468	2463	ALREADY AVAILABLE	2021-03-30 07:19:37.338	7801	Central Trial Documents
16611	88	1617051839214:-1945667774	1617051836859:84724098	D5170C00001	2301	2298	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Central and Local Testing	Sample Documentation
16614	88	1617051842205:-1629913915	1617051841553:-444954540	D5170C00001	2304	2303	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Central Trial Documents	General
16775	88	1617051982085:1003926316	1617051981481:-737558928	D5170C00001	2465	2464	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Central and Local Testing	Facility Documentation
16783	88	1617051987297:-1055646817	1617051986747:450177513	D5170C00001	2473	2472	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Data Management	General
16786	88	1617051996289:1165390347	1617051988458:-1950728059	D5170C00001	2476	2475	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IP and Trial Supplies	General
16788	88	1617051997454:1492300384	1617051988458:-1950728059	D5170C00001	2478	2475	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IP and Trial Supplies	IP Documentation
16587	88	1617082685311:-955649161	1617051817282:452875689	D5170C00001	2277	2276	CREATE	2021-03-30 07:38:05.398	Site Management	Monitoring Visit Report
16591	88	1617082687194:-92540655	1617051820206:388189647	D5170C00001	2281	2279	CREATE	2021-03-30 07:38:07.285	Site Selection	Pre Trial Monitoring Report
16593	88	1617082687799:573777025	1617051822095:-19295602	D5170C00001	2283	2282	CREATE	2021-03-30 07:38:07.882	Site Set-up	Acceptance of Investigator Brochure
16596	88	1617082689780:-1814766898	1617051822095:-19295602	D5170C00001	2286	2282	CREATE	2021-03-30 07:38:09.864	Site Set-up	Investigator Regulatory Agreement
16599	88	1617082693146:1295599329	1617051822095:-19295602	D5170C00001	2289	2282	CREATE	2021-03-30 07:38:13.229	Site Set-up	Principal Investigator Curriculum Vitae
16602	88	1617082694993:435739451	1617051822095:-19295602	D5170C00001	2292	2282	CREATE	2021-03-30 07:38:15.079	Site Set-up	Sub-Investigator Curriculum Vitae
16606	88	1617082695639:-1690629844	1617051831070:-1627531118	D5170C00001	2296	2295	CREATE	2021-03-30 07:38:15.726	General	Filenote
16623	88	1617082699836:-755755227	1617051847384:-2139949640	D5170C00001	2313	2312	CREATE	2021-03-30 07:38:19.923	General	Tracking Information
16626	88	1617082700407:1064574315	1617051849447:-407130641	D5170C00001	2316	2315	CREATE	2021-03-30 07:38:20.491	General	Filenote
16631	88	1617082703838:-848166298	1617051853567:-863088360	D5170C00001	2321	2320	CREATE	2021-03-30 07:38:23.92	IP Documentation	IP Accountability Documentation
16643	88	1617082708099:-735943518	1617051867869:-764555336	D5170C00001	2333	2332	CREATE	2021-03-30 07:38:36.472	IRB or IEC Trial Approval	IRB or IEC Submission
16652	88	1617082718950:714333971	1617051872679:143709618	D5170C00001	2342	2340	CREATE	2021-03-30 07:38:39.034	General	Relevant Communications
16654	88	1617082719517:-926455180	1617051875818:1239132378	D5170C00001	2344	2343	CREATE	2021-03-30 07:38:39.6	Site Initiation	Site Evidence of Training
16657	88	1617082720712:-1365904521	1617051877638:125140249	D5170C00001	2347	2346	CREATE	2021-03-30 07:38:40.796	Site Management	Monitoring Visit Report
16661	88	1617082722550:-1562701080	1617051879521:667777278	D5170C00001	2351	2349	CREATE	2021-03-30 07:38:47.926	Site Selection	Pre Trial Monitoring Report
16664	88	1617082730112:-1967554017	1617051881424:-556958735	D5170C00001	2354	2352	CREATE	2021-03-30 07:38:50.197	Site Set-up	Clinical Study Agreement
16667	88	1617082732120:-424671038	1617051881424:-556958735	D5170C00001	2357	2352	CREATE	2021-03-30 07:38:52.207	Site Set-up	Other Curriculum Vitae
16670	88	1617082733872:585128527	1617051881424:-556958735	D5170C00001	2360	2352	CREATE	2021-03-30 07:38:53.954	Site Set-up	Protocol Signature Page
16672	88	1617082735049:926223845	1617051881424:-556958735	D5170C00001	2362	2352	CREATE	2021-03-30 07:38:55.135	Site Set-up	Sub-Investigator Curriculum Vitae
16681	88	1617082736771:68553560	1617051903448:-1733995967	D5170C00001	2371	2370	CREATE	2021-03-30 07:38:56.855	Product and Trial Documentation	Insurance
16684	88	1617082737320:-176701464	1617051905385:922826437	D5170C00001	2374	2373	CREATE	2021-03-30 07:38:57.424	General	Filenote
16686	88	1617082737903:730674065	1617051906657:1249736474	D5170C00001	2376	2375	CREATE	2021-03-30 07:38:57.989	IP Documentation	IP Accountability Documentation
16689	88	1617082739121:-1835494251	1617051908471:-81121646	D5170C00001	2379	2378	CREATE	2021-03-30 07:39:00.167	Non-IP Documentation	Non-IP Return Documentation
16699	88	1617082743040:-1039614909	1617051915400:-1614161955	D5170C00001	2389	2388	CREATE	2021-03-30 07:39:03.123	Other Committees	Other Submissions
16702	88	1617082743617:1115757416	1617051917303:-1394328483	D5170C00001	2392	2391	CREATE	2021-03-30 07:39:03.702	General	Relevant Communications
16705	88	1617082744192:1391432953	1617051923017:910496300	D5170C00001	2395	2394	CREATE	2021-03-30 07:39:04.278	General	Filenote
16713	88	1617082748315:219004884	1617051927290:888680577	D5170C00001	2403	2400	CREATE	2021-03-30 07:39:08.402	Site Management	Visit Log
16716	88	1617082749676:1496801090	1617051930381:824005144	D5170C00001	2406	2404	CREATE	2021-03-30 07:39:09.764	Site Selection	Pre Trial Monitoring Report
16719	88	1617082751847:1245568963	1617051932104:-285780044	D5170C00001	2409	2407	CREATE	2021-03-30 07:39:11.93	Site Set-up	Clinical Study Agreement
16722	88	1617082753648:-819264659	1617051932104:-285780044	D5170C00001	2412	2407	CREATE	2021-03-30 07:39:13.736	Site Set-up	Other Curriculum Vitae
16725	88	1617082755508:-1582388632	1617051932104:-285780044	D5170C00001	2415	2407	CREATE	2021-03-30 07:39:15.594	Site Set-up	Site Signature Sheet
16730	88	1617082756674:537371346	1617051940357:-610164440	D5170C00001	2420	2419	CREATE	2021-03-30 07:39:16.757	General	Relevant Communications
16749	88	1617082764208:607746120	1617051958332:1202718462	D5170C00001	2439	2438	CREATE	2021-03-30 07:39:24.293	General	Relevant Communications
16754	88	1617082765478:-1694252753	1617051961288:-657855600	D5170C00001	2444	2443	CREATE	2021-03-30 07:39:25.563	Site Initiation	Site Evidence of Training
16760	88	1617082767911:-662772012	1617051971556:-1226059827	D5170C00001	2450	2449	CREATE	2021-03-30 07:39:27.996	Site Selection	Confidentiality Agreement
16763	88	1617082769031:-1014059439	1617051973346:1348595292	D5170C00001	2453	2452	CREATE	2021-03-30 07:39:29.117	Site Set-up	Acceptance of Investigator Brochure
16769	88	1617082773767:-1532646441	1617051973346:1348595292	D5170C00001	2459	2452	CREATE	2021-03-30 07:39:33.852	Site Set-up	Protocol Signature Page
16780	88	1617082776713:1026374957	1617051984476:-56360106	D5170C00001	2470	2469	CREATE	2021-03-30 07:39:36.797	Subject Documentation	Informed Consent Form
16803	88	1617052007615:-1234169123	1617051980881:-120376759	D5170C00001	2493	2463	ALREADY AVAILABLE	2021-03-30 07:19:37.339	7801	Site Management
16794	88	1617052002324:-1851246732	1617052001755:1591452789	D5170C00001	2484	2483	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IRB or IEC and other Approvals	IRB or IEC Trial Approval
16801	88	1617052006431:-1772093969	1617052005782:1449258282	D5170C00001	2491	2490	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Safety Reporting	General
16804	88	1617052008208:597965742	1617052007615:-1234169123	D5170C00001	2494	2493	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	General
16813	88	1617052015256:1122033402	1617052007615:-1234169123	D5170C00001	2503	2493	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	Site Selection
16816	88	1617052017017:-188030216	1617052007615:-1234169123	D5170C00001	2506	2493	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Site Management	Site Set-up
16976	88	1617052158179:-2021863589	1617052156484:1692629743	D5170C00001	2666	2665	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Central and Local Testing	Facility Documentation
16993	88	1617052169756:-1989601637	1617052168040:-1172742723	D5170C00001	2683	2682	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IRB or IEC and other Approvals	IRB or IEC Trial Approval
17026	88	1617052198440:493040818	1617052197815:-922197242	D5170C00001	2716	2715	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Central Trial Documents	General
17028	88	1617052199761:1574272098	1617052197815:-922197242	D5170C00001	2718	2715	ALREADY AVAILABLE	2021-03-30 07:19:37.365	Central Trial Documents	Subject Documentation
16797	88	1617082791734:-1265999366	1617052002324:-1851246732	D5170C00001	2487	2484	CREATE	2021-03-30 07:39:51.825	IRB or IEC Trial Approval	IRB or IEC Composition
16805	88	1617082793554:-1452304219	1617052008208:597965742	D5170C00001	2495	2494	CREATE	2021-03-30 07:39:53.639	General	Relevant Communications
16807	88	1617082794126:947943976	1617052009490:-1902472164	D5170C00001	2497	2496	CREATE	2021-03-30 07:39:54.211	Site Initiation	Site Evidence of Training
16810	88	1617082796462:-1502794483	1617052010629:1186708835	D5170C00001	2500	2498	CREATE	2021-03-30 07:39:56.548	Site Management	Monitoring Visit Report
16819	88	1617082800481:2131206226	1617052017017:-188030216	D5170C00001	2509	2506	CREATE	2021-03-30 07:40:00.572	Site Set-up	Financial Disclosure Form
16821	88	1617082801756:918094715	1617052017017:-188030216	D5170C00001	2511	2506	CREATE	2021-03-30 07:40:01.84	Site Set-up	IP Site Release Documentation
16824	88	1617082803782:-2129011614	1617052017017:-188030216	D5170C00001	2514	2506	CREATE	2021-03-30 07:40:03.869	Site Set-up	Protocol Signature Page
16827	88	1617082805714:1721796219	1617052017017:-188030216	D5170C00001	2517	2506	CREATE	2021-03-30 07:40:05.801	Site Set-up	Sub-Investigator Curriculum Vitae
16830	88	1617082807444:1982284713	1617052026057:-1071436199	D5170C00001	2520	2519	CREATE	2021-03-30 07:40:07.531	Trial Oversight	Recruitment Plan
16841	88	1617082809882:-369059423	1617052039818:-1640177369	D5170C00001	2531	2529	CREATE	2021-03-30 07:40:09.969	IP Documentation	IP Certificate of Destruction
16844	88	1617082810425:-2123095706	1617052042228:1252886643	D5170C00001	2534	2533	CREATE	2021-03-30 07:40:10.509	IRB or IEC Trial Approval	IRB or IEC Approval
16847	88	1617082811645:-589981490	1617052044049:406185109	D5170C00001	2537	2536	CREATE	2021-03-30 07:40:11.731	Trial Status Reporting	IRB or IEC Notification of Trial Termination
16853	88	1617082813134:1954622594	1617052049021:1422247676	D5170C00001	2543	2542	CREATE	2021-03-30 07:40:13.228	General	Filenote
16856	88	1617082814409:1989034337	1617052050799:-385507727	D5170C00001	2546	2545	CREATE	2021-03-30 07:40:14.508	Site Initiation	Site Evidence of Training
16859	88	1617082815782:-878517061	1617052052073:-1988784883	D5170C00001	2549	2547	CREATE	2021-03-30 07:40:15.864	Site Management	Visit Log
16862	88	1617082816905:-768424368	1617052053847:1946304727	D5170C00001	2552	2550	CREATE	2021-03-30 07:40:16.998	Site Selection	Feasibility Documentation
16865	88	1617082819447:-1598575270	1617052057507:1423773172	D5170C00001	2555	2554	CREATE	2021-03-30 07:40:19.535	Site Set-up	Acceptance of Investigator Brochure
16870	88	1617082822561:-383050942	1617052057507:1423773172	D5170C00001	2560	2554	CREATE	2021-03-30 07:40:22.647	Site Set-up	Principal Investigator Curriculum Vitae
16873	88	1617082824415:1154527115	1617052057507:1423773172	D5170C00001	2563	2554	CREATE	2021-03-30 07:40:24.498	Site Set-up	Site Signature Sheet
16888	88	1617082829981:744671660	1617052080702:787241645	D5170C00001	2578	2577	CREATE	2021-03-30 07:40:30.068	General	Tracking Information
16903	88	1617082834596:1001659412	1617052098024:666055170	D5170C00001	2593	2592	CREATE	2021-03-30 07:40:34.682	General	Relevant Communications
16905	88	1617082835212:37186108	1617052099206:1745572203	D5170C00001	2595	2594	CREATE	2021-03-30 07:40:35.295	Site Management	Final Trial Close Out Monitoring Report
16911	88	1617082837864:-649584629	1617052103517:863173571	D5170C00001	2601	2599	CREATE	2021-03-30 07:40:43.908	Site Set-up	Clinical Study Agreement
16917	88	1617082847577:1630723002	1617052103517:863173571	D5170C00001	2607	2599	CREATE	2021-03-30 07:40:47.66	Site Set-up	Protocol Amendment Signature Page
16962	88	1617082866628:-2045824879	1617052138141:425928680	D5170C00001	2652	2647	CREATE	2021-03-30 07:41:06.716	Site Set-up	Principal Investigator Curriculum Vitae
16967	88	1617082869779:1820219161	1617052138141:425928680	D5170C00001	2657	2647	CREATE	2021-03-30 07:41:09.865	Site Set-up	Sub-Investigator Curriculum Vitae
16971	88	1617082870401:-1573130068	1617052147273:1431985492	D5170C00001	2661	2660	CREATE	2021-03-30 07:41:10.496	General	Relevant Communications
16982	88	1617082873300:-1705011055	1617052161330:-439978305	D5170C00001	2672	2671	CREATE	2021-03-30 07:41:13.386	Subject Documentation	Informed Consent Form
16985	88	1617082874137:1694023299	1617052163332:1632401095	D5170C00001	2675	2674	CREATE	2021-03-30 07:41:14.225	General	Tracking Information
16990	88	1617082877087:-836353395	1617052166248:-921340393	D5170C00001	2680	2679	CREATE	2021-03-30 07:41:17.17	IP Documentation	IP Accountability Documentation
17002	88	1617082881026:1596786333	1617052175222:304882754	D5170C00001	2692	2691	CREATE	2021-03-30 07:41:21.112	General	Filenote
17008	88	1617082883398:1466723932	1617052178200:404478737	D5170C00001	2698	2696	CREATE	2021-03-30 07:41:23.483	Site Management	Subject Log
17013	88	1617082885278:1504273780	1617052188373:-477941113	D5170C00001	2703	2702	CREATE	2021-03-30 07:41:25.361	Site Set-up	Acceptance of Investigator Brochure
17017	88	1617082889349:-343516463	1617052188373:-477941113	D5170C00001	2707	2702	CREATE	2021-03-30 07:41:29.438	Site Set-up	IP Site Release Documentation
17022	88	1617082900017:-2074936634	1617052188373:-477941113	D5170C00001	2712	2702	CREATE	2021-03-30 07:41:40.103	Site Set-up	Site Staff Qualification Supporting Information
17027	88	1617082901333:-1582666855	1617052198440:493040818	D5170C00001	2717	2716	CREATE	2021-03-30 07:41:41.415	General	Filenote
17132	88	1617052300163:1877660544	1617052296101:1068428102	D5170C00001	2822	2815	ALREADY AVAILABLE	2021-03-30 07:19:37.342	7810	IP and Trial Supplies
6917	84	\N	\N	D5170C00002	702	701	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
17138	88	1617052304706:632395760	1617052296101:1068428102	D5170C00001	2828	2815	ALREADY AVAILABLE	2021-03-30 07:19:37.342	7810	IRB or IEC and other Approvals
17170	88	1617052333677:-1771618057	1617052296101:1068428102	D5170C00001	2860	2815	ALREADY AVAILABLE	2021-03-30 07:19:37.342	7810	Trial Management
17036	88	1617052206264:1597937686	1617052204288:-798043798	D5170C00001	2726	2723	ALREADY AVAILABLE	2021-03-30 07:19:37.365	IP and Trial Supplies	IP Documentation
17072	88	1617052235427:-1760664646	1617052234763:174534557	D5170C00001	2762	2761	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Central and Local Testing	General
17085	88	1617052251887:133695075	1617052247211:-1737804858	D5170C00001	2775	2770	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IP and Trial Supplies	Storage
17090	88	1617052254963:-418086166	1617052253073:1604065733	D5170C00001	2780	2777	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IRB or IEC and other Approvals	IRB or IEC Trial Approval
17153	88	1617052313486:-1395615169	1617052310176:-1290552302	D5170C00001	2843	2837	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	Site Management
17175	88	1617052336557:-1096973711	1617052335972:609047866	D5170C00001	2865	2864	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Central Trial Documents	Subject Documentation
17178	88	1617052339726:941460990	1617052339066:-1160849805	D5170C00001	2868	2867	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Data Management	General
17215	88	1617052369657:1777613902	1617052369113:-1471307787	D5170C00001	2905	2904	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Central Trial Documents	Subject Documentation
17218	88	1617052372954:-1520366953	1617052372271:443192413	D5170C00001	2908	2907	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Data Management	General
17038	88	1617082904372:1104372342	1617052206264:1597937686	D5170C00001	2728	2726	CREATE	2021-03-30 07:41:44.457	IP Documentation	IP Certificate of Destruction
17041	88	1617082904952:-242793135	1617052208732:-1462452139	D5170C00001	2731	2730	CREATE	2021-03-30 07:41:45.035	IRB or IEC Trial Approval	IRB or IEC Approval
17044	88	1617082906135:-152459023	1617052210642:1575692372	D5170C00001	2734	2733	CREATE	2021-03-30 07:41:46.221	Trial Status Reporting	IRB or IEC Notification of Trial Termination
17051	88	1617082907950:1894219610	1617052219841:-434680426	D5170C00001	2741	2739	CREATE	2021-03-30 07:41:48.033	General	Relevant Communications
17054	88	1617082911343:1281566485	1617052221721:644868434	D5170C00001	2744	2742	CREATE	2021-03-30 07:41:51.43	Site Management	Subject Log
17057	88	1617082912685:-1641897094	1617052224236:-27183115	D5170C00001	2747	2746	CREATE	2021-03-30 07:41:52.768	Site Selection	Confidentiality Agreement
17059	88	1617082919779:-351899839	1617052226758:-844895705	D5170C00001	2749	2748	CREATE	2021-03-30 07:41:59.863	Site Set-up	Acceptance of Investigator Brochure
17063	88	1617082923448:-2079010397	1617052226758:-844895705	D5170C00001	2753	2748	CREATE	2021-03-30 07:42:03.535	Site Set-up	IP Site Release Documentation
17065	88	1617082924614:-1005552084	1617052226758:-844895705	D5170C00001	2755	2748	CREATE	2021-03-30 07:42:04.697	Site Set-up	Protocol Amendment Signature Page
17068	88	1617082926326:-125671991	1617052226758:-844895705	D5170C00001	2758	2748	CREATE	2021-03-30 07:42:06.409	Site Set-up	Site Staff Qualification Supporting Information
17082	88	1617082929288:-597884049	1617052249172:-1210357819	D5170C00001	2772	2771	CREATE	2021-03-30 07:42:09.376	General	Filenote
17109	88	1617082938895:-1209451855	1617052280045:1716978694	D5170C00001	2799	2798	CREATE	2021-03-30 07:42:18.98	Site Selection	Confidentiality Agreement
17112	88	1617082940117:-1174510910	1617052281159:1391595914	D5170C00001	2802	2800	CREATE	2021-03-30 07:42:20.2	Site Set-up	Clinical Study Agreement
17115	88	1617082941854:619754829	1617052281159:1391595914	D5170C00001	2805	2800	CREATE	2021-03-30 07:42:21.936	Site Set-up	IP Site Release Documentation
17118	88	1617082943544:1666594736	1617052281159:1391595914	D5170C00001	2808	2800	CREATE	2021-03-30 07:42:24.898	Site Set-up	Protocol Signature Page
17124	88	1617082980367:600228871	1617052294962:-227010689	D5170C00001	2814	2813	CREATE	2021-03-30 07:43:00.454	Trial Oversight	Recruitment Plan
17141	88	1617082985296:-698234757	1617052305313:6491038	D5170C00001	2831	2829	CREATE	2021-03-30 07:43:05.528	IRB or IEC Trial Approval	IRB or IEC Composition
17150	88	1617082988043:534786205	1617052310759:1407892748	D5170C00001	2840	2838	CREATE	2021-03-30 07:43:08.136	General	Relevant Communications
17156	88	1617082991957:532317746	1617052313486:-1395615169	D5170C00001	2846	2843	CREATE	2021-03-30 07:43:12.039	Site Management	Visit Log
17162	88	1617082994463:662527656	1617052326585:1114215991	D5170C00001	2852	2849	CREATE	2021-03-30 07:43:14.547	Site Set-up	Financial Disclosure Form
17164	88	1617082995805:-959686642	1617052326585:1114215991	D5170C00001	2854	2849	CREATE	2021-03-30 07:43:15.891	Site Set-up	IP Site Release Documentation
17176	88	1617083002236:1024138206	1617052336557:-1096973711	D5170C00001	2866	2865	CREATE	2021-03-30 07:43:22.321	Subject Documentation	Informed Consent Form
17186	88	1617083005156:-1422368370	1617052343327:93551715	D5170C00001	2876	2874	CREATE	2021-03-30 07:43:25.243	IRB or IEC Trial Approval	IRB or IEC Composition
17195	88	1617083007951:-1254908103	1617052349908:-1671940381	D5170C00001	2885	2883	CREATE	2021-03-30 07:43:28.062	General	Relevant Communications
17198	88	1617083009329:1382054325	1617052351810:-1002788606	D5170C00001	2888	2886	CREATE	2021-03-30 07:43:29.415	Site Management	Subject Log
17203	88	1617083011641:-170825285	1617052355513:-1474768935	D5170C00001	2893	2892	CREATE	2021-03-30 07:43:33.002	Site Set-up	Acceptance of Investigator Brochure
17207	88	1617083016301:-919005083	1617052355513:-1474768935	D5170C00001	2897	2892	CREATE	2021-03-30 07:43:36.387	Site Set-up	IP Site Release Documentation
17212	88	1617083020371:787437578	1617052355513:-1474768935	D5170C00001	2902	2892	CREATE	2021-03-30 07:43:40.455	Site Set-up	Sub-Investigator Curriculum Vitae
17223	88	1617083024471:-527622329	1617052374783:-1479937613	D5170C00001	2913	2911	CREATE	2021-03-30 07:43:44.569	IP Documentation	IP Certificate of Destruction
17229	88	1617083027011:687773871	1617052378912:2141915132	D5170C00001	2919	2918	CREATE	2021-03-30 07:43:47.1	Trial Status Reporting	IRB or IEC Notification of Trial Termination
17235	88	1617083028330:-1908127638	1617052383971:-2096296941	D5170C00001	2925	2924	CREATE	2021-03-30 07:43:48.419	General	Filenote
17249	88	1617083044657:380643925	1617052389524:1591359346	D5170C00001	2939	2933	CREATE	2021-03-30 07:44:04.755	Site Set-up	Principal Investigator Curriculum Vitae
17250	88	1617083045664:-1290641243	1617052389524:1591359346	D5170C00001	2940	2933	CREATE	2021-03-30 07:44:05.758	Site Set-up	Protocol Amendment Signature Page
17256	88	1617052399517:1961548139	1617052398862:-541467014	D5170C00001	2946	2945	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	Site Selection
17305	88	1617052438283:723024113	1617052437641:-338104240	D5170C00001	2995	2994	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Central Trial Documents	Subject Documentation
17308	88	1617052441743:-1582735752	1617052439453:-740759095	D5170C00001	2998	2997	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IP and Trial Supplies	General
17314	88	1617052445948:598014748	1617052445277:-1989259624	D5170C00001	3004	3003	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IRB or IEC and other Approvals	IRB or IEC Trial Approval
17351	88	1617052481247:-123049190	1617052479480:-296615441	D5170C00001	3041	3038	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IP and Trial Supplies	IP Documentation
17354	88	1617052482931:1599873358	1617052479480:-296615441	D5170C00001	3044	3038	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IP and Trial Supplies	Storage
17357	88	1617052484723:-883004005	1617052484114:-1249701537	D5170C00001	3047	3046	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IRB or IEC and other Approvals	IRB or IEC Trial Approval
17360	88	1617052486342:-1942805323	1617052484114:-1249701537	D5170C00001	3050	3046	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IRB or IEC and other Approvals	Trial Status Reporting
17363	88	1617052488156:-371881247	1617052487489:-1798961903	D5170C00001	3053	3052	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Safety Reporting	General
17366	88	1617052495749:1459276251	1617052490174:-387742878	D5170C00001	3056	3055	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	General
17253	88	1617083049291:247435807	1617052389524:1591359346	D5170C00001	2943	2933	CREATE	2021-03-30 07:44:09.376	Site Set-up	Sub-Investigator Curriculum Vitae
17264	88	1617083051317:1010207902	1617052409766:-157007580	D5170C00001	2954	2953	CREATE	2021-03-30 07:44:11.401	General	Tracking Information
17267	88	1617083051961:-722924352	1617052411575:842770780	D5170C00001	2957	2956	CREATE	2021-03-30 07:44:12.049	General	Relevant Communications
17270	88	1617083053281:-2005744908	1617052412840:677181263	D5170C00001	2960	2958	CREATE	2021-03-30 07:44:13.369	IP Documentation	IP Certificate of Destruction
17273	88	1617083053860:-1974316199	1617052415150:-951067260	D5170C00001	2963	2962	CREATE	2021-03-30 07:44:13.954	IRB or IEC Trial Approval	IRB or IEC Approval
17276	88	1617083055289:1629645845	1617052418513:2087077251	D5170C00001	2966	2965	CREATE	2021-03-30 07:44:15.376	Trial Status Reporting	IRB or IEC Notification of Trial Termination
17282	88	1617083056628:-1241455988	1617052422075:1231131625	D5170C00001	2972	2971	CREATE	2021-03-30 07:44:16.714	General	Filenote
17285	88	1617083057843:-1457400792	1617052423900:-1561453142	D5170C00001	2975	2974	CREATE	2021-03-30 07:44:19.414	Site Initiation	Site Evidence of Training
17288	88	1617083060579:1021701197	1617052425099:1819885327	D5170C00001	2978	2976	CREATE	2021-03-30 07:44:20.666	Site Management	Subject Log
17291	88	1617083061853:-1806654917	1617052427438:1262742167	D5170C00001	2981	2980	CREATE	2021-03-30 07:44:21.937	Site Selection	Confidentiality Agreement
17294	88	1617083063156:1109593594	1617052430313:937497304	D5170C00001	2984	2982	CREATE	2021-03-30 07:44:23.245	Site Set-up	Clinical Study Agreement
17297	88	1617083065159:-1391118572	1617052430313:937497304	D5170C00001	2987	2982	CREATE	2021-03-30 07:44:25.249	Site Set-up	IP Site Release Documentation
17299	88	1617083066431:-609541895	1617052430313:937497304	D5170C00001	2989	2982	CREATE	2021-03-30 07:44:26.548	Site Set-up	Protocol Amendment Signature Page
17302	88	1617083068333:-93736262	1617052430313:937497304	D5170C00001	2992	2982	CREATE	2021-03-30 07:44:28.423	Site Set-up	Sub-Investigator Curriculum Vitae
17311	88	1617083072114:1970074953	1617052442936:-1058772421	D5170C00001	3001	3000	CREATE	2021-03-30 07:44:32.201	IP Documentation	IP Accountability Documentation
17321	88	1617083075235:-1166703815	1617052449427:-1814824517	D5170C00001	3011	3010	CREATE	2021-03-30 07:44:35.334	General	Tracking Information
17324	88	1617083075823:661979359	1617052451217:-1316900603	D5170C00001	3014	3013	CREATE	2021-03-30 07:44:35.908	General	Relevant Communications
17328	88	1617083083464:28744246	1617052454137:-549313426	D5170C00001	3018	3015	CREATE	2021-03-30 07:44:43.547	Site Management	Visit Log
17334	88	1617083086189:193168429	1617052457633:-824335942	D5170C00001	3024	3021	CREATE	2021-03-30 07:44:46.276	Site Set-up	Financial Disclosure Form
17336	88	1617083087480:-195356556	1617052457633:-824335942	D5170C00001	3026	3021	CREATE	2021-03-30 07:44:47.566	Site Set-up	Principal Investigator Curriculum Vitae
17339	88	1617083089383:287958530	1617052457633:-824335942	D5170C00001	3029	3021	CREATE	2021-03-30 07:44:49.465	Site Set-up	Site Staff Qualification Supporting Information
17368	88	1617083099707:-987816227	1617052495749:1459276251	D5170C00001	3058	3056	CREATE	2021-03-30 07:44:59.796	General	Relevant Communications
17374	88	1617083103050:-1701658447	1617052500689:1669773313	D5170C00001	3064	3063	CREATE	2021-03-30 07:45:03.141	Site Selection	Confidentiality Agreement
17380	88	1617083108329:-1570341458	1617052501784:1459373185	D5170C00001	3070	3065	CREATE	2021-03-30 07:45:18.012	Site Set-up	IP Site Release Documentation
17409	88	1617083132187:-1751628420	1617052520597:1198206109	D5170C00001	3099	3096	CREATE	2021-03-30 07:45:32.273	IRB or IEC Trial Approval	IRB or IEC Composition
17420	88	1617083135408:633420674	1617052529725:-1281762727	D5170C00001	3110	3109	CREATE	2021-03-30 07:45:35.493	Site Management	Monitoring Visit Report
17426	88	1617083138018:1375997386	1617052534244:1720408852	D5170C00001	3116	3115	CREATE	2021-03-30 07:45:38.106	Site Set-up	Acceptance of Investigator Brochure
17429	88	1617083143941:28963474	1617052534244:1720408852	D5170C00001	3119	3115	CREATE	2021-03-30 07:45:44.03	Site Set-up	Form FDA 1572
17434	88	1617083147641:-1418138600	1617052534244:1720408852	D5170C00001	3124	3115	CREATE	2021-03-30 07:45:47.731	Site Set-up	Site Staff Qualification Supporting Information
17438	88	1617083148965:949693945	1617052547882:-325525901	D5170C00001	3128	3127	CREATE	2021-03-30 07:45:49.05	General	Filenote
17454	88	1617083152904:-1859048539	1617052570682:-1199043249	D5170C00001	3144	3143	CREATE	2021-03-30 07:45:52.987	Trial Status Reporting	IRB or IEC Notification of Trial Termination
17458	88	1617083156126:174938489	1617052572371:1699787381	D5170C00001	3148	3146	CREATE	2021-03-30 07:45:56.215	General	Tracking Information
17466	88	1617083158729:-580475921	1617052578989:1524381591	D5170C00001	3156	3155	CREATE	2021-03-30 07:45:58.814	Site Selection	Confidentiality Agreement
17472	88	1617083162392:-1633609972	1617052580110:299539488	D5170C00001	3162	3157	CREATE	2021-03-30 07:46:02.49	Site Set-up	Form FDA 1572
17473	88	1617083163037:-1232488128	1617052580110:299539488	D5170C00001	3163	3157	CREATE	2021-03-30 07:46:03.122	Site Set-up	IP Site Release Documentation
17486	88	1617052597203:-1936537458	1617052592811:380298272	D5170C00001	3176	3169	ALREADY AVAILABLE	2021-03-30 07:19:37.344	7821	IP and Trial Supplies
17492	88	1617052602169:794880407	1617052592811:380298272	D5170C00001	3182	3169	ALREADY AVAILABLE	2021-03-30 07:19:37.344	7821	IRB or IEC and other Approvals
17481	88	1617052594078:-2020655662	1617052593400:-1650442343	D5170C00001	3171	3170	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Central Trial Documents	Subject Documentation
17484	88	1617052595920:1801599620	1617052595272:264047248	D5170C00001	3174	3173	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Data Management	General
17489	88	1617052600217:-1647748982	1617052597203:-1936537458	D5170C00001	3179	3176	ALREADY AVAILABLE	2021-03-30 07:19:37.366	IP and Trial Supplies	IP Documentation
17502	88	1617052608083:-67683498	1617052607516:-1420320606	D5170C00001	3192	3191	ALREADY AVAILABLE	2021-03-30 07:19:37.366	Site Management	General
17478	88	1617083168438:966549568	1617052580110:299539488	D5170C00001	3168	3157	CREATE	2021-03-30 07:46:08.589	Site Set-up	Sub-Investigator Curriculum Vitae
17495	88	1617083174653:784965846	1617052602756:191533864	D5170C00001	3185	3183	CREATE	2021-03-30 07:46:14.858	IRB or IEC Trial Approval	IRB or IEC Composition
17497	88	1617083175335:-749477307	1617052604486:-1065288921	D5170C00001	3187	3186	CREATE	2021-03-30 07:46:15.42	Trial Status Reporting	IRB or IEC Notification of Trial Termination
8766	84	\N	\N	D5170C00002	2551	2549	NEW	\N	05.05 General	05.05.02 Tracking Information
8768	84	\N	\N	D5170C00002	2553	2552	NEW	\N	06 IP and Trial Supplies	06.04 Storage
8769	84	\N	\N	D5170C00002	2554	2553	NEW	\N	06.04 Storage	06.04.03 Maintenance Logs
8770	84	\N	\N	D5170C00002	2555	2326	NEW	\N	Site	2001786 Goldin, Eran
8772	84	\N	\N	D5170C00002	2557	2556	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
8774	84	\N	\N	D5170C00002	2559	2557	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
8775	84	\N	\N	D5170C00002	2560	2557	NEW	\N	02.02 Subject Documents	02.02.07 Other_iven to Subjects
8776	84	\N	\N	D5170C00002	2561	2556	NEW	\N	02 Central Trial Documents	02.04 General
8778	84	\N	\N	D5170C00002	2563	2561	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
8779	84	\N	\N	D5170C00002	2564	2555	NEW	\N	2001786 Goldin, Eran	03 Regulatory
8781	84	\N	\N	D5170C00002	2566	2565	NEW	\N	03.01 Trial Approval	03.01.02 Approval
8782	84	\N	\N	D5170C00002	2567	2555	NEW	\N	2001786 Goldin, Eran	04 IRB-IEC and other Approvals
8784	84	\N	\N	D5170C00002	2569	2568	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
8785	84	\N	\N	D5170C00002	2570	2568	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
8787	84	\N	\N	D5170C00002	2572	2568	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.05 IRB-I_liance Statement
8788	84	\N	\N	D5170C00002	2573	2567	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
8790	84	\N	\N	D5170C00002	2575	2573	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
8791	84	\N	\N	D5170C00002	2576	2555	NEW	\N	2001786 Goldin, Eran	05 Site Management
8792	84	\N	\N	D5170C00002	2577	2576	NEW	\N	05 Site Management	05.01 Site Selection
8794	84	\N	\N	D5170C00002	2579	2577	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
8795	84	\N	\N	D5170C00002	2580	2577	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
8797	84	\N	\N	D5170C00002	2582	2576	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
8798	84	\N	\N	D5170C00002	2583	2582	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
8800	84	\N	\N	D5170C00002	2585	2582	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
8801	84	\N	\N	D5170C00002	2586	2582	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
8803	84	\N	\N	D5170C00002	2588	2582	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Site Qualification
8804	84	\N	\N	D5170C00002	2589	2582	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
8805	84	\N	\N	D5170C00002	2590	2582	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
8807	84	\N	\N	D5170C00002	2592	2582	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
8808	84	\N	\N	D5170C00002	2593	2582	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
8810	84	\N	\N	D5170C00002	2595	2582	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
8811	84	\N	\N	D5170C00002	2596	2576	NEW	\N	05 Site Management	05.03 Site Initiation
8813	84	\N	\N	D5170C00002	2598	2596	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
8815	84	\N	\N	D5170C00002	2600	2576	NEW	\N	05 Site Management	05.04 Site Management
8816	84	\N	\N	D5170C00002	2601	2600	NEW	\N	05.04 Site Management	05.04.04 Visit Log
8817	84	\N	\N	D5170C00002	2602	2600	NEW	\N	05.04 Site Management	05.04.05 Additional Monitoring Activity
8819	84	\N	\N	D5170C00002	2604	2576	NEW	\N	05 Site Management	05.05 General
8820	84	\N	\N	D5170C00002	2605	2604	NEW	\N	05.05 General	05.05.01 Relev_unications-Email
8821	84	\N	\N	D5170C00002	2606	2604	NEW	\N	05.05 General	05.05.02 Tracking Information
8823	84	\N	\N	D5170C00002	2608	2607	NEW	\N	06 IP and Trial Supplies	06.04 Storage
8824	84	\N	\N	D5170C00002	2609	2608	NEW	\N	06.04 Storage	06.04.03 Maintenance Logs
8826	84	\N	\N	D5170C00002	2611	2610	NEW	\N	06.05 Non-IP Documentation	06.05.02 Non-I_tion of Shipment
8827	84	\N	\N	D5170C00002	2612	2555	NEW	\N	2001786 Goldin, Eran	08 Centralized Testing
8829	84	\N	\N	D5170C00002	2614	2613	NEW	\N	08.02 Sample Documentation	08.02.03 Sampl_ge Condition Log
6675	84	\N	\N	D5170C00002	460	459	NEW	\N	2001741 Dhalla, Sonny	02 Central Trial Documents
6677	84	\N	\N	D5170C00002	462	461	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
6681	84	\N	\N	D5170C00002	466	459	NEW	\N	2001741 Dhalla, Sonny	03 Regulatory
6684	84	\N	\N	D5170C00002	469	459	NEW	\N	2001741 Dhalla, Sonny	04 IRB-IEC and other Approvals
6687	84	\N	\N	D5170C00002	472	470	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
6690	84	\N	\N	D5170C00002	475	459	NEW	\N	2001741 Dhalla, Sonny	05 Site Management
6693	84	\N	\N	D5170C00002	478	476	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
6696	84	\N	\N	D5170C00002	481	480	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
6697	84	\N	\N	D5170C00002	482	480	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
6698	84	\N	\N	D5170C00002	483	480	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
6702	84	\N	\N	D5170C00002	487	480	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
6705	84	\N	\N	D5170C00002	490	480	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
6709	84	\N	\N	D5170C00002	494	493	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
6713	84	\N	\N	D5170C00002	498	497	NEW	\N	05.04 Site Management	05.04.01 Subject Log
6716	84	\N	\N	D5170C00002	501	475	NEW	\N	05 Site Management	05.05 General
6719	84	\N	\N	D5170C00002	504	459	NEW	\N	2001741 Dhalla, Sonny	06 IP and Trial Supplies
6722	84	\N	\N	D5170C00002	507	504	NEW	\N	06 IP and Trial Supplies	06.04 Storage
6725	84	\N	\N	D5170C00002	510	509	NEW	\N	2001743 Ropeleski, Mark	02 Central Trial Documents
6728	84	\N	\N	D5170C00002	513	511	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
6731	84	\N	\N	D5170C00002	516	514	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
6734	84	\N	\N	D5170C00002	519	518	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
6738	84	\N	\N	D5170C00002	523	518	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
6741	84	\N	\N	D5170C00002	526	509	NEW	\N	2001743 Ropeleski, Mark	05 Site Management
6744	84	\N	\N	D5170C00002	529	527	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
6747	84	\N	\N	D5170C00002	532	531	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
6751	84	\N	\N	D5170C00002	536	531	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
6755	84	\N	\N	D5170C00002	540	531	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
6758	84	\N	\N	D5170C00002	543	531	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
6761	84	\N	\N	D5170C00002	546	544	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
6764	84	\N	\N	D5170C00002	549	548	NEW	\N	05.04 Site Management	05.04.01 Subject Log
6767	84	\N	\N	D5170C00002	552	548	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
6771	84	\N	\N	D5170C00002	556	553	NEW	\N	05.05 General	05.05.02 Tracking Information
6774	84	\N	\N	D5170C00002	559	558	NEW	\N	06.01 IP Documentation	06.01.02 IP Instructions for Handling
6777	84	\N	\N	D5170C00002	562	561	NEW	\N	06.05 Non-IP Documentation	06.05.03 Non-I_tation of Return
6781	84	\N	\N	D5170C00002	566	565	NEW	\N	02.02 Subject Documents	02.02.03 Infor_ Form Checklists
6784	84	\N	\N	D5170C00002	569	568	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
6788	84	\N	\N	D5170C00002	573	572	NEW	\N	03.01 Trial Approval	03.01.01 Submission
6790	84	\N	\N	D5170C00002	575	574	NEW	\N	03.04 General	03.04.01 Relev_art-Up-Documents
6793	84	\N	\N	D5170C00002	578	577	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
6796	84	\N	\N	D5170C00002	581	580	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
6800	84	\N	\N	D5170C00002	585	583	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
6803	84	\N	\N	D5170C00002	588	586	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
6807	84	\N	\N	D5170C00002	592	586	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
6810	84	\N	\N	D5170C00002	595	586	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
6814	84	\N	\N	D5170C00002	599	597	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
6817	84	\N	\N	D5170C00002	602	601	NEW	\N	05.04 Site Management	05.04.03 Monitoring Visit Report
6821	84	\N	\N	D5170C00002	606	601	NEW	\N	05.04 Site Management	05.04.06 UNBLINDED Protocol Deviations and Waivers
6822	84	\N	\N	D5170C00002	607	601	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
6826	84	\N	\N	D5170C00002	611	609	NEW	\N	05.05 General	05.05.01 Relev_unications-Email
6829	84	\N	\N	D5170C00002	614	613	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
6832	84	\N	\N	D5170C00002	617	614	NEW	\N	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
6835	84	\N	\N	D5170C00002	620	613	NEW	\N	06 IP and Trial Supplies	06.04 Storage
6838	84	\N	\N	D5170C00002	623	620	NEW	\N	06.04 Storage	06.04.03 UNBLINDED Maintenance Logs
6841	84	\N	\N	D5170C00002	626	624	NEW	\N	06.07 General	06.07.01 UNBLI_roduct-Documents
6845	84	\N	\N	D5170C00002	630	629	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
6848	84	\N	\N	D5170C00002	633	632	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
6852	84	\N	\N	D5170C00002	637	636	NEW	\N	2001779 Desai, Milind	02 Central Trial Documents
6855	84	\N	\N	D5170C00002	640	638	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
6858	84	\N	\N	D5170C00002	643	641	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
6861	84	\N	\N	D5170C00002	646	645	NEW	\N	03.01 Trial Approval	03.01.02 Approval
6864	84	\N	\N	D5170C00002	649	648	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
6867	84	\N	\N	D5170C00002	652	636	NEW	\N	2001779 Desai, Milind	05 Site Management
6870	84	\N	\N	D5170C00002	655	653	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
6873	84	\N	\N	D5170C00002	658	657	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
6877	84	\N	\N	D5170C00002	662	657	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
6881	84	\N	\N	D5170C00002	666	657	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
6883	84	\N	\N	D5170C00002	668	657	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
6885	84	\N	\N	D5170C00002	670	669	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
6888	84	\N	\N	D5170C00002	673	672	NEW	\N	05.04 Site Management	05.04.05 UNBLINDED Additional Monitoring Activity
6892	84	\N	\N	D5170C00002	677	675	NEW	\N	05.05 General	05.05.01 Relevant Communications-Documents
6896	84	\N	\N	D5170C00002	681	680	NEW	\N	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
6899	84	\N	\N	D5170C00002	684	683	NEW	\N	05 Site Management	05.01 Site Selection
6902	84	\N	\N	D5170C00002	687	686	NEW	\N	05.05 General	05.05.01 Relev_unications-Email
6930	84	\N	\N	D5170C00002	715	713	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
6933	84	\N	\N	D5170C00002	718	717	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
6937	84	\N	\N	D5170C00002	722	717	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
6941	84	\N	\N	D5170C00002	726	717	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
6944	84	\N	\N	D5170C00002	729	717	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
6947	84	\N	\N	D5170C00002	732	730	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
6948	84	\N	\N	D5170C00002	733	730	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
6951	84	\N	\N	D5170C00002	736	734	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
6954	84	\N	\N	D5170C00002	739	734	NEW	\N	05.04 Site Management	05.04.05 UNBLINDED Additional Monitoring Activity
6958	84	\N	\N	D5170C00002	743	742	NEW	\N	05.05 General	05.05.01 Relev_unications-Email
6961	84	\N	\N	D5170C00002	746	745	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
6964	84	\N	\N	D5170C00002	749	746	NEW	\N	06.01 IP Documentation	06.01.04 UNBLINDED IP Shipment Documentation
6968	84	\N	\N	D5170C00002	753	752	NEW	\N	06.04 Storage	06.04.01 Storage Condition Documentation
6971	84	\N	\N	D5170C00002	756	752	NEW	\N	06.04 Storage	06.04.03 UNBLINDED Maintenance Logs
6975	84	\N	\N	D5170C00002	760	759	NEW	\N	2001803 Ptak, Theadore	05 Site Management
6977	84	\N	\N	D5170C00002	762	761	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
6981	84	\N	\N	D5170C00002	766	765	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
6985	84	\N	\N	D5170C00002	770	769	NEW	\N	2001805 Aumais, Guy	02 Central Trial Documents
6987	84	\N	\N	D5170C00002	772	771	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
6990	84	\N	\N	D5170C00002	775	774	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
6994	84	\N	\N	D5170C00002	779	778	NEW	\N	2002041 Fowler, Sharyle	02 Central Trial Documents
6997	84	\N	\N	D5170C00002	782	780	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
7000	84	\N	\N	D5170C00002	785	783	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
7004	84	\N	\N	D5170C00002	789	786	NEW	\N	03 Regulatory	03.03 Trial Status Reporting
7006	84	\N	\N	D5170C00002	791	778	NEW	\N	2002041 Fowler, Sharyle	04 IRB-IEC and other Approvals
7010	84	\N	\N	D5170C00002	795	792	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
7013	84	\N	\N	D5170C00002	798	796	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
7015	84	\N	\N	D5170C00002	800	799	NEW	\N	05 Site Management	05.01 Site Selection
7017	84	\N	\N	D5170C00002	802	800	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
7021	84	\N	\N	D5170C00002	806	803	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
7024	84	\N	\N	D5170C00002	809	803	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
7027	84	\N	\N	D5170C00002	812	803	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
7031	84	\N	\N	D5170C00002	816	803	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
7035	84	\N	\N	D5170C00002	820	817	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
7038	84	\N	\N	D5170C00002	823	821	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
7042	84	\N	\N	D5170C00002	827	821	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
7045	84	\N	\N	D5170C00002	830	829	NEW	\N	05.05 General	05.05.01 Relev_ations-Documents
7048	84	\N	\N	D5170C00002	833	778	NEW	\N	2002041 Fowler, Sharyle	06 IP and Trial Supplies
7051	84	\N	\N	D5170C00002	836	834	NEW	\N	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
7054	84	\N	\N	D5170C00002	839	838	NEW	\N	06.04 Storage	06.04.01 UNBLINDED Storage Condition Documentation
7058	84	\N	\N	D5170C00002	843	842	NEW	\N	2002109 Pesant, Yves	02 Central Trial Documents
7062	84	\N	\N	D5170C00002	847	846	NEW	\N	05 Site Management	05.01 Site Selection
7064	84	\N	\N	D5170C00002	849	846	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
7068	84	\N	\N	D5170C00002	853	458	NEW	\N	Site	2002144 Orlicka, Katarzyna
7071	84	\N	\N	D5170C00002	856	855	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
7074	84	\N	\N	D5170C00002	859	858	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
7076	84	\N	\N	D5170C00002	861	860	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
7077	84	\N	\N	D5170C00002	862	857	NEW	\N	05 Site Management	05.05 General
7080	84	\N	\N	D5170C00002	865	864	NEW	\N	TBD-1-1YHPC70 Fraser, Hughie	05 Site Management
7084	84	\N	\N	D5170C00002	869	868	NEW	\N	CZECH REPUBLIC	Site
7086	84	\N	\N	D5170C00002	871	870	NEW	\N	2001930 Drastich, Pavel	02 Central Trial Documents
7089	84	\N	\N	D5170C00002	874	872	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
7092	84	\N	\N	D5170C00002	877	876	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
7240	84	\N	\N	D5170C00002	1025	1024	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
7096	84	\N	\N	D5170C00002	881	880	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
7099	84	\N	\N	D5170C00002	884	880	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
7103	84	\N	\N	D5170C00002	888	880	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
7106	84	\N	\N	D5170C00002	891	890	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
7110	84	\N	\N	D5170C00002	895	894	NEW	\N	05.04 Site Management	05.04.04 Visit Log
7113	84	\N	\N	D5170C00002	898	897	NEW	\N	05.05 General	05.05.02 Tracking Information
7117	84	\N	\N	D5170C00002	902	869	NEW	\N	Site	2001931 Nemecek, Zdenek
7119	84	\N	\N	D5170C00002	904	903	NEW	\N	02 Central Trial Documents	02.04 General
7122	84	\N	\N	D5170C00002	907	902	NEW	\N	2001931 Nemecek, Zdenek	04 IRB-IEC and other Approvals
7125	84	\N	\N	D5170C00002	910	908	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
7129	84	\N	\N	D5170C00002	914	913	NEW	\N	05 Site Management	05.01 Site Selection
7131	84	\N	\N	D5170C00002	916	914	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
7134	84	\N	\N	D5170C00002	919	918	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
7139	84	\N	\N	D5170C00002	924	918	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
7140	84	\N	\N	D5170C00002	925	918	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
7142	84	\N	\N	D5170C00002	927	918	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
7145	84	\N	\N	D5170C00002	930	928	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
7150	84	\N	\N	D5170C00002	935	934	NEW	\N	05.05 General	05.05.02 Tracking Information
7153	84	\N	\N	D5170C00002	938	937	NEW	\N	02 Central Trial Documents	02.04 General
7156	84	\N	\N	D5170C00002	941	936	NEW	\N	2001932 Lukas, Milan	04 IRB-IEC and other Approvals
7159	84	\N	\N	D5170C00002	944	942	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
7162	84	\N	\N	D5170C00002	947	946	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
7165	84	\N	\N	D5170C00002	950	949	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
7169	84	\N	\N	D5170C00002	954	953	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
7172	84	\N	\N	D5170C00002	957	953	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other CV-Site Affiliation
7175	84	\N	\N	D5170C00002	960	953	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
7179	84	\N	\N	D5170C00002	964	963	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
7183	84	\N	\N	D5170C00002	968	966	NEW	\N	05.04 Site Management	05.04.04 Visit Log
7186	84	\N	\N	D5170C00002	971	970	NEW	\N	05.05 General	05.05.02 Tracking Information
7189	84	\N	\N	D5170C00002	974	973	NEW	\N	02 Central Trial Documents	02.04 General
7192	84	\N	\N	D5170C00002	977	972	NEW	\N	2001933 Volfova, Miroslava	04 IRB-IEC and other Approvals
7196	84	\N	\N	D5170C00002	981	978	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
7199	84	\N	\N	D5170C00002	984	972	NEW	\N	2001933 Volfova, Miroslava	05 Site Management
7202	84	\N	\N	D5170C00002	987	985	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
7205	84	\N	\N	D5170C00002	990	989	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Accep_tigator Brochure
7208	84	\N	\N	D5170C00002	993	989	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
7211	84	\N	\N	D5170C00002	996	989	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
7215	84	\N	\N	D5170C00002	1000	999	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
7219	84	\N	\N	D5170C00002	1004	1003	NEW	\N	05.04 Site Management	05.04.01 Subject Log
7221	84	\N	\N	D5170C00002	1006	1003	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
7226	84	\N	\N	D5170C00002	1011	1010	NEW	\N	06.01 IP Documentation	06.01.02 IP Instructions for Handling
7230	84	\N	\N	D5170C00002	1015	1014	NEW	\N	TBD-1-1QGPG0F Svoboda, Pavel	05 Site Management
7232	84	\N	\N	D5170C00002	1017	1016	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
7236	84	\N	\N	D5170C00002	1021	1020	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
7393	84	\N	\N	D5170C00002	1178	1175	NEW	\N	05 Site Management	05.05 General
7247	84	\N	\N	D5170C00002	1032	1031	NEW	\N	05 Site Management	05.01 Site Selection
7251	84	\N	\N	D5170C00002	1036	1035	NEW	\N	05 Site Management	05.01 Site Selection
7254	84	\N	\N	D5170C00002	1039	869	NEW	\N	Site	TBD-1-2K4LDCM Brabec, Tomas
7257	84	\N	\N	D5170C00002	1042	1041	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
7261	84	\N	\N	D5170C00002	1046	1045	NEW	\N	2002270 Bouhnik, Yoram	02 Central Trial Documents
7264	84	\N	\N	D5170C00002	1049	1047	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
7267	84	\N	\N	D5170C00002	1052	1051	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
7268	84	\N	\N	D5170C00002	1053	1051	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
7271	84	\N	\N	D5170C00002	1056	1054	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
7275	84	\N	\N	D5170C00002	1060	1054	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
7279	84	\N	\N	D5170C00002	1064	1050	NEW	\N	05 Site Management	05.03 Site Initiation
7282	84	\N	\N	D5170C00002	1067	1050	NEW	\N	05 Site Management	05.04 Site Management
7285	84	\N	\N	D5170C00002	1070	1067	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
7289	84	\N	\N	D5170C00002	1074	1045	NEW	\N	2002270 Bouhnik, Yoram	06 IP and Trial Supplies
7292	84	\N	\N	D5170C00002	1077	1074	NEW	\N	06 IP and Trial Supplies	06.05 Non-IP Documentation
7295	84	\N	\N	D5170C00002	1080	1079	NEW	\N	2002271 Moreau, Jacques	02 Central Trial Documents
7299	84	\N	\N	D5170C00002	1084	1079	NEW	\N	2002271 Moreau, Jacques	05 Site Management
7302	84	\N	\N	D5170C00002	1087	1085	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
7305	84	\N	\N	D5170C00002	1090	1088	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
7309	84	\N	\N	D5170C00002	1094	1088	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
7312	84	\N	\N	D5170C00002	1097	1088	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
7316	84	\N	\N	D5170C00002	1101	1098	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
7319	84	\N	\N	D5170C00002	1104	1102	NEW	\N	05.04 Site Management	05.04.03 Monitoring Visit Report
7323	84	\N	\N	D5170C00002	1108	1102	NEW	\N	05.04 Site Management	05.04.05 UNBLI_itoring Activity
7326	84	\N	\N	D5170C00002	1111	1102	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
7327	84	\N	\N	D5170C00002	1112	1102	NEW	\N	05.04 Site Management	05.04.09 Inv Notification-SUSAR
7329	84	\N	\N	D5170C00002	1114	1113	NEW	\N	05.05 General	05.05.01 Relev_unications-Email
7332	84	\N	\N	D5170C00002	1117	1116	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
7336	84	\N	\N	D5170C00002	1121	1117	NEW	\N	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
7339	84	\N	\N	D5170C00002	1124	1123	NEW	\N	06.04 Storage	06.04.01 UNBLI_on Documentation
7343	84	\N	\N	D5170C00002	1128	1127	NEW	\N	08.02 Sample Documentation	08.02.03 Sampl_ge Condition Log
7346	84	\N	\N	D5170C00002	1131	1130	NEW	\N	02 Central Trial Documents	02.04 General
7349	84	\N	\N	D5170C00002	1134	1129	NEW	\N	2002272 Peyrin_iroulet, Laurent	05 Site Management
7352	84	\N	\N	D5170C00002	1137	1135	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
7356	84	\N	\N	D5170C00002	1141	1138	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
7359	84	\N	\N	D5170C00002	1144	1138	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
7363	84	\N	\N	D5170C00002	1148	1147	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
7367	84	\N	\N	D5170C00002	1152	1150	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
7370	84	\N	\N	D5170C00002	1155	1150	NEW	\N	05.04 Site Management	05.04.06 UNBLI_ions and Waivers
7374	84	\N	\N	D5170C00002	1159	1158	NEW	\N	05.05 General	05.05.01 Relev_unications-Email
7377	84	\N	\N	D5170C00002	1162	1161	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
7380	84	\N	\N	D5170C00002	1165	1162	NEW	\N	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
7384	84	\N	\N	D5170C00002	1169	1161	NEW	\N	06 IP and Trial Supplies	06.04 Storage
7387	84	\N	\N	D5170C00002	1172	1161	NEW	\N	06 IP and Trial Supplies	06.05 Non-IP Documentation
7396	84	\N	\N	D5170C00002	1181	1180	NEW	\N	2002275 Bouguen, Guillaume	02 Central Trial Documents
7399	84	\N	\N	D5170C00002	1184	1182	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
7402	84	\N	\N	D5170C00002	1187	1186	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
7406	84	\N	\N	D5170C00002	1191	1188	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
7409	84	\N	\N	D5170C00002	1194	1191	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
7412	84	\N	\N	D5170C00002	1197	1191	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
7416	84	\N	\N	D5170C00002	1201	1188	NEW	\N	05 Site Management	05.03 Site Initiation
7419	84	\N	\N	D5170C00002	1204	1201	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
7423	84	\N	\N	D5170C00002	1208	1205	NEW	\N	05.04 Site Management	05.04.04 Visit Log
7426	84	\N	\N	D5170C00002	1211	1205	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
7430	84	\N	\N	D5170C00002	1215	1213	NEW	\N	05.05 General	05.05.01 Relevant Communications-Documents
7433	84	\N	\N	D5170C00002	1218	1217	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
7436	84	\N	\N	D5170C00002	1221	1218	NEW	\N	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
7440	84	\N	\N	D5170C00002	1225	1223	NEW	\N	06.04 Storage	06.04.01 UNBLI_on Documentation
7444	84	\N	\N	D5170C00002	1229	1228	NEW	\N	2002276 Allez, Matthieu	02 Central Trial Documents
7447	84	\N	\N	D5170C00002	1232	1228	NEW	\N	2002276 Allez, Matthieu	05 Site Management
7449	84	\N	\N	D5170C00002	1234	1233	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
7453	84	\N	\N	D5170C00002	1238	1237	NEW	\N	2002277 Altwegg, Romain	02 Central Trial Documents
7456	84	\N	\N	D5170C00002	1241	1239	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
7459	84	\N	\N	D5170C00002	1244	1243	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
7462	84	\N	\N	D5170C00002	1247	1245	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
7466	84	\N	\N	D5170C00002	1251	1245	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
7470	84	\N	\N	D5170C00002	1255	1254	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
7473	84	\N	\N	D5170C00002	1258	1257	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
7477	84	\N	\N	D5170C00002	1262	1237	NEW	\N	2002277 Altwegg, Romain	06 IP and Trial Supplies
7481	84	\N	\N	D5170C00002	1266	1265	NEW	\N	2002278 Roblin, Xavier	02 Central Trial Documents
7483	84	\N	\N	D5170C00002	1268	1267	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
7486	84	\N	\N	D5170C00002	1271	1270	NEW	\N	05 Site Management	05.01 Site Selection
7489	84	\N	\N	D5170C00002	1274	1270	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
7492	84	\N	\N	D5170C00002	1277	1274	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
7496	84	\N	\N	D5170C00002	1281	1274	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
7500	84	\N	\N	D5170C00002	1285	1270	NEW	\N	05 Site Management	05.03 Site Initiation
7503	84	\N	\N	D5170C00002	1288	1285	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
7506	84	\N	\N	D5170C00002	1291	1289	NEW	\N	05.04 Site Management	05.04.03 Monitoring Visit Report
7513	84	\N	\N	D5170C00002	1298	1289	NEW	\N	05.04 Site Management	05.04.09 Inv Notification-SUSAR
7517	84	\N	\N	D5170C00002	1302	1301	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
7520	84	\N	\N	D5170C00002	1305	1302	NEW	\N	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
7524	84	\N	\N	D5170C00002	1309	1308	NEW	\N	06.04 Storage	06.04.01 UNBLI_on Documentation
7527	84	\N	\N	D5170C00002	1312	1301	NEW	\N	06 IP and Trial Supplies	06.07 General
7530	84	\N	\N	D5170C00002	1315	1314	NEW	\N	TBD-1-1Q4YZAR Amil, Morgane	05 Site Management
7533	84	\N	\N	D5170C00002	1318	1044	NEW	\N	Site	TBD-1-1Q4YZCR Bonaz, Bruno
7536	84	\N	\N	D5170C00002	1321	1320	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
7540	84	\N	\N	D5170C00002	1325	1324	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
7543	84	\N	\N	D5170C00002	1328	1327	NEW	\N	05 Site Management	05.01 Site Selection
7546	84	\N	\N	D5170C00002	1331	1330	NEW	\N	TBD-1-1Q4ZNLB Beaugerie, Laurent	05 Site Management
7552	84	\N	\N	D5170C00002	1337	1336	NEW	\N	2002076 Schmelz, Renate	01 Trial Management
7554	84	\N	\N	D5170C00002	1339	1338	NEW	\N	01.01 Trial Oversight	01.01.06 Recruitment Plan
7558	84	\N	\N	D5170C00002	1343	1341	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
7561	84	\N	\N	D5170C00002	1346	1345	NEW	\N	03 Regulatory	03.01 Trial Approval
7564	84	\N	\N	D5170C00002	1349	1348	NEW	\N	03.03 Trial Status Reporting	03.03.03 Notif_rial Termination
7567	84	\N	\N	D5170C00002	1352	1351	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
7570	84	\N	\N	D5170C00002	1355	1354	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
7574	84	\N	\N	D5170C00002	1359	1357	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
7577	84	\N	\N	D5170C00002	1362	1356	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
7580	84	\N	\N	D5170C00002	1365	1362	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
7584	84	\N	\N	D5170C00002	1369	1362	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
7587	84	\N	\N	D5170C00002	1372	1362	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
7592	84	\N	\N	D5170C00002	1377	1376	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
7595	84	\N	\N	D5170C00002	1380	1356	NEW	\N	05 Site Management	05.04 Site Management
7598	84	\N	\N	D5170C00002	1383	1380	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
7602	84	\N	\N	D5170C00002	1387	1336	NEW	\N	2002076 Schmelz, Renate	06 IP and Trial Supplies
7605	84	\N	\N	D5170C00002	1390	1336	NEW	\N	2002076 Schmelz, Renate	08 Centralized Testing
7609	84	\N	\N	D5170C00002	1394	1393	NEW	\N	2002077 Ebert, Mathias	01 Trial Management
7612	84	\N	\N	D5170C00002	1397	1393	NEW	\N	2002077 Ebert, Mathias	02 Central Trial Documents
7615	84	\N	\N	D5170C00002	1400	1398	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
7618	84	\N	\N	D5170C00002	1403	1402	NEW	\N	03 Regulatory	03.01 Trial Approval
7621	84	\N	\N	D5170C00002	1406	1405	NEW	\N	03.03 Trial Status Reporting	03.03.03 Notif_rial Termination
7624	84	\N	\N	D5170C00002	1409	1408	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
7628	84	\N	\N	D5170C00002	1413	1412	NEW	\N	05.01 Site Selection	05.01.01 Site Contact Details
7629	84	\N	\N	D5170C00002	1414	1412	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
7632	84	\N	\N	D5170C00002	1417	1411	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
7635	84	\N	\N	D5170C00002	1420	1417	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
7639	84	\N	\N	D5170C00002	1424	1417	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
7642	84	\N	\N	D5170C00002	1427	1417	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
7646	84	\N	\N	D5170C00002	1431	1411	NEW	\N	05 Site Management	05.03 Site Initiation
7649	84	\N	\N	D5170C00002	1434	1431	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
7653	84	\N	\N	D5170C00002	1438	1435	NEW	\N	05.04 Site Management	05.04.05 Additional Monitoring Activity
7656	84	\N	\N	D5170C00002	1441	1440	NEW	\N	05.05 General	05.05.01 Relev_unications-Email
7660	84	\N	\N	D5170C00002	1445	1444	NEW	\N	06.07 General	06.07.01 Relev_roduct-Documents
7663	84	\N	\N	D5170C00002	1448	1447	NEW	\N	01 Trial Management	01.01 Trial Oversight
7666	84	\N	\N	D5170C00002	1451	1450	NEW	\N	02 Central Trial Documents	02.04 General
7669	84	\N	\N	D5170C00002	1454	1453	NEW	\N	03 Regulatory	03.01 Trial Approval
7672	84	\N	\N	D5170C00002	1457	1456	NEW	\N	03.03 Trial Status Reporting	03.03.03 Notification of Trial Termination
7675	84	\N	\N	D5170C00002	1460	1459	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
7678	84	\N	\N	D5170C00002	1463	1462	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
7682	84	\N	\N	D5170C00002	1467	1465	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
7685	84	\N	\N	D5170C00002	1470	1464	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
7688	84	\N	\N	D5170C00002	1473	1470	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
7689	84	\N	\N	D5170C00002	1474	1470	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
7693	84	\N	\N	D5170C00002	1478	1470	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Inves_latory Agreement
7697	84	\N	\N	D5170C00002	1482	1470	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
7700	84	\N	\N	D5170C00002	1485	1483	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
7704	84	\N	\N	D5170C00002	1489	1487	NEW	\N	05.04 Site Management	05.04.04 Visit Log
7707	84	\N	\N	D5170C00002	1492	1491	NEW	\N	05.05 General	05.05.01 Relev_ations-Documents
7710	84	\N	\N	D5170C00002	1495	1446	NEW	\N	2002079 Sturm, Andreas	06 IP and Trial Supplies
7713	84	\N	\N	D5170C00002	1498	1495	NEW	\N	06 IP and Trial Supplies	06.05 Non-IP Documentation
7716	84	\N	\N	D5170C00002	1501	1500	NEW	\N	08 Centralized Testing	08.02 Sample Documentation
7719	84	\N	\N	D5170C00002	1504	1503	NEW	\N	2002080 Meyer, Ralf	01 Trial Management
7722	84	\N	\N	D5170C00002	1507	1503	NEW	\N	2002080 Meyer, Ralf	02 Central Trial Documents
7725	84	\N	\N	D5170C00002	1510	1508	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
7728	84	\N	\N	D5170C00002	1513	1512	NEW	\N	03.01 Trial Approval	03.01.01 Submission
7731	84	\N	\N	D5170C00002	1516	1503	NEW	\N	2002080 Meyer, Ralf	04 IRB-IEC and other Approvals
7734	84	\N	\N	D5170C00002	1519	1517	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
7737	84	\N	\N	D5170C00002	1522	1503	NEW	\N	2002080 Meyer, Ralf	05 Site Management
7740	84	\N	\N	D5170C00002	1525	1523	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
7743	84	\N	\N	D5170C00002	1528	1522	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
7746	84	\N	\N	D5170C00002	1531	1528	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
7750	84	\N	\N	D5170C00002	1535	1528	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Inves_latory Agreement
7753	84	\N	\N	D5170C00002	1538	1528	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
7754	84	\N	\N	D5170C00002	1539	1528	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
7757	84	\N	\N	D5170C00002	1542	1540	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
7761	84	\N	\N	D5170C00002	1546	1544	NEW	\N	05.04 Site Management	05.04.03 UNBLINDED Monitoring Visit Report
7764	84	\N	\N	D5170C00002	1549	1544	NEW	\N	05.04 Site Management	05.04.05 UNBLINDED Additional Monitoring Activity
7768	84	\N	\N	D5170C00002	1553	1552	NEW	\N	05.05 General	05.05.01 Relev_unications-Email
7770	84	\N	\N	D5170C00002	1555	1503	NEW	\N	2002080 Meyer, Ralf	06 IP and Trial Supplies
7773	84	\N	\N	D5170C00002	1558	1556	NEW	\N	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
7777	84	\N	\N	D5170C00002	1562	1561	NEW	\N	06.04 Storage	06.04.01 UNBLI_on Documentation
7780	84	\N	\N	D5170C00002	1565	1564	NEW	\N	08 Centralized Testing	08.01 Facility Documentation
7783	84	\N	\N	D5170C00002	1568	1567	NEW	\N	2002081 Benten, Daniel	03 Regulatory
7786	84	\N	\N	D5170C00002	1571	1568	NEW	\N	03 Regulatory	03.03 Trial Status Reporting
7788	84	\N	\N	D5170C00002	1573	1567	NEW	\N	2002081 Benten, Daniel	04 IRB-IEC and other Approvals
7792	84	\N	\N	D5170C00002	1577	1573	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
7795	84	\N	\N	D5170C00002	1580	1579	NEW	\N	05 Site Management	05.01 Site Selection
7798	84	\N	\N	D5170C00002	1583	1582	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
7801	84	\N	\N	D5170C00002	1586	1582	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
7804	84	\N	\N	D5170C00002	1589	1588	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
7808	84	\N	\N	D5170C00002	1593	1592	NEW	\N	05.04 Site Management	05.04.01 Subject Log
7811	84	\N	\N	D5170C00002	1596	1579	NEW	\N	05 Site Management	05.05 General
7814	84	\N	\N	D5170C00002	1599	1598	NEW	\N	2002082 Hasselblatt, Peter	01 Trial Management
7817	84	\N	\N	D5170C00002	1602	1598	NEW	\N	2002082 Hasselblatt, Peter	02 Central Trial Documents
7818	84	\N	\N	D5170C00002	1603	1602	NEW	\N	02 Central Trial Documents	02.04 General
7820	84	\N	\N	D5170C00002	1605	1603	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
7824	84	\N	\N	D5170C00002	1609	1608	NEW	\N	03.01 Trial Approval	03.01.01 Submission
7826	84	\N	\N	D5170C00002	1611	1610	NEW	\N	03.03 Trial Status Reporting	03.03.03 Notif_rial Termination
7829	84	\N	\N	D5170C00002	1614	1613	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
7833	84	\N	\N	D5170C00002	1618	1598	NEW	\N	2002082 Hasselblatt, Peter	05 Site Management
7836	84	\N	\N	D5170C00002	1621	1619	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
7839	84	\N	\N	D5170C00002	1624	1618	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
7842	84	\N	\N	D5170C00002	1627	1624	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
7846	84	\N	\N	D5170C00002	1631	1624	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
7849	84	\N	\N	D5170C00002	1634	1624	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
7853	84	\N	\N	D5170C00002	1638	1637	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
7856	84	\N	\N	D5170C00002	1641	1618	NEW	\N	05 Site Management	05.04 Site Management
7859	84	\N	\N	D5170C00002	1644	1641	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
7863	84	\N	\N	D5170C00002	1648	1335	NEW	\N	Site	2002083 Brandt, Wolfgang
7865	84	\N	\N	D5170C00002	1650	1649	NEW	\N	01 Trial Management	01.01 Trial Oversight
7869	84	\N	\N	D5170C00002	1654	1653	NEW	\N	02.04 General	02.04.01 Relev_ations-Documents
7872	84	\N	\N	D5170C00002	1657	1656	NEW	\N	03 Regulatory	03.01 Trial Approval
7874	84	\N	\N	D5170C00002	1659	1648	NEW	\N	2002083 Brandt, Wolfgang	04 IRB-IEC and other Approvals
7877	84	\N	\N	D5170C00002	1662	1660	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
7881	84	\N	\N	D5170C00002	1666	1664	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
7882	84	\N	\N	D5170C00002	1667	1664	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
7885	84	\N	\N	D5170C00002	1670	1669	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
7889	84	\N	\N	D5170C00002	1674	1669	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
7892	84	\N	\N	D5170C00002	1677	1669	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Inves_latory Agreement
7896	84	\N	\N	D5170C00002	1681	1669	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
7899	84	\N	\N	D5170C00002	1684	1682	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
7903	84	\N	\N	D5170C00002	1688	1686	NEW	\N	05.04 Site Management	05.04.04 Visit Log
7906	84	\N	\N	D5170C00002	1691	1690	NEW	\N	05.05 General	05.05.01 Relev_ations-Documents
7909	84	\N	\N	D5170C00002	1694	1648	NEW	\N	2002083 Brandt, Wolfgang	06 IP and Trial Supplies
7912	84	\N	\N	D5170C00002	1697	1694	NEW	\N	06 IP and Trial Supplies	06.04 Storage
7915	84	\N	\N	D5170C00002	1700	1699	NEW	\N	2002279 Seidler, Ursula	01 Trial Management
7918	84	\N	\N	D5170C00002	1703	1699	NEW	\N	2002279 Seidler, Ursula	02 Central Trial Documents
7921	84	\N	\N	D5170C00002	1706	1704	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
7924	84	\N	\N	D5170C00002	1709	1708	NEW	\N	03 Regulatory	03.01 Trial Approval
7927	84	\N	\N	D5170C00002	1712	1711	NEW	\N	03.03 Trial Status Reporting	03.03.03 Notif_rial Termination
7930	84	\N	\N	D5170C00002	1715	1714	NEW	\N	04.02 Other Committees	04.02.01 Other Submissions
7933	84	\N	\N	D5170C00002	1718	1699	NEW	\N	2002279 Seidler, Ursula	05 Site Management
7936	84	\N	\N	D5170C00002	1721	1719	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
7939	84	\N	\N	D5170C00002	1724	1718	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
7942	84	\N	\N	D5170C00002	1727	1724	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
7945	84	\N	\N	D5170C00002	1730	1724	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Site Qualification
7947	84	\N	\N	D5170C00002	1732	1724	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Inves_latory Agreement
7950	84	\N	\N	D5170C00002	1735	1724	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
7954	84	\N	\N	D5170C00002	1739	1737	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
7957	84	\N	\N	D5170C00002	1742	1741	NEW	\N	05.04 Site Management	05.04.01 Subject Log
7960	84	\N	\N	D5170C00002	1745	1741	NEW	\N	05.04 Site Management	05.04.04 UNBLINDED Visit Log
7963	84	\N	\N	D5170C00002	1748	1741	NEW	\N	05.04 Site Management	05.04.06 Protocol Deviations and Waivers
7970	84	\N	\N	D5170C00002	1755	1699	NEW	\N	2002279 Seidler, Ursula	06 IP and Trial Supplies
7973	84	\N	\N	D5170C00002	1758	1756	NEW	\N	06.01 IP Documentation	06.01.02 UNBLI_ons for Handling
7976	84	\N	\N	D5170C00002	1761	1756	NEW	\N	06.01 IP Documentation	06.01.05 UNBLI_ty Documentation
7980	84	\N	\N	D5170C00002	1765	1763	NEW	\N	06.04 Storage	06.04.03 Maintenance Logs
7982	84	\N	\N	D5170C00002	1767	1755	NEW	\N	06 IP and Trial Supplies	06.05 Non-IP Documentation
7985	84	\N	\N	D5170C00002	1770	1769	NEW	\N	2002280 Siegmund, Britta	01 Trial Management
7988	84	\N	\N	D5170C00002	1773	1769	NEW	\N	2002280 Siegmund, Britta	02 Central Trial Documents
7992	84	\N	\N	D5170C00002	1777	1774	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
7995	84	\N	\N	D5170C00002	1780	1779	NEW	\N	03.01 Trial Approval	03.01.01 Submission
7997	84	\N	\N	D5170C00002	1782	1781	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
8001	84	\N	\N	D5170C00002	1786	1785	NEW	\N	05.01 Site Selection	05.01.01 Site Contact Details
8004	84	\N	\N	D5170C00002	1789	1785	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
8007	84	\N	\N	D5170C00002	1792	1790	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
8009	84	\N	\N	D5170C00002	1794	1790	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
8011	84	\N	\N	D5170C00002	1796	1790	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Site Qualification
8014	84	\N	\N	D5170C00002	1799	1790	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Inves_latory Agreement
8019	84	\N	\N	D5170C00002	1804	1803	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
8022	84	\N	\N	D5170C00002	1807	1806	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
8025	84	\N	\N	D5170C00002	1810	1769	NEW	\N	2002280 Siegmund, Britta	06 IP and Trial Supplies
8029	84	\N	\N	D5170C00002	1814	1813	NEW	\N	2002281 Zeuzem, Stefan	01 Trial Management
8032	84	\N	\N	D5170C00002	1817	1813	NEW	\N	2002281 Zeuzem, Stefan	02 Central Trial Documents
8035	84	\N	\N	D5170C00002	1820	1818	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
8038	84	\N	\N	D5170C00002	1823	1822	NEW	\N	03.01 Trial Approval	03.01.01 Submission
8040	84	\N	\N	D5170C00002	1825	1824	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
8044	84	\N	\N	D5170C00002	1829	1813	NEW	\N	2002281 Zeuzem, Stefan	05 Site Management
8047	84	\N	\N	D5170C00002	1832	1830	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
8050	84	\N	\N	D5170C00002	1835	1829	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
8053	84	\N	\N	D5170C00002	1838	1835	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
8057	84	\N	\N	D5170C00002	1842	1835	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
8060	84	\N	\N	D5170C00002	1845	1835	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
8063	84	\N	\N	D5170C00002	1848	1835	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
8067	84	\N	\N	D5170C00002	1852	1849	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
8070	84	\N	\N	D5170C00002	1855	1853	NEW	\N	05.04 Site Management	05.04.04 Visit Log
8072	84	\N	\N	D5170C00002	1857	1829	NEW	\N	05 Site Management	05.05 General
8073	84	\N	\N	D5170C00002	1858	1857	NEW	\N	05.05 General	05.05.01 Relev_unications-Email
8076	84	\N	\N	D5170C00002	1861	1860	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
8079	84	\N	\N	D5170C00002	1864	1860	NEW	\N	06 IP and Trial Supplies	06.04 Storage
8082	84	\N	\N	D5170C00002	1867	1866	NEW	\N	06.07 General	06.07.01 Relev_roduct-Documents
8085	84	\N	\N	D5170C00002	1870	1869	NEW	\N	01 Trial Management	01.01 Trial Oversight
8088	84	\N	\N	D5170C00002	1873	1872	NEW	\N	02 Central Trial Documents	02.04 General
8091	84	\N	\N	D5170C00002	1876	1868	NEW	\N	2002283 Schreiber, Stefan	03 Regulatory
8094	84	\N	\N	D5170C00002	1879	1876	NEW	\N	03 Regulatory	03.03 Trial Status Reporting
8097	84	\N	\N	D5170C00002	1882	1881	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
8100	84	\N	\N	D5170C00002	1885	1881	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
8104	84	\N	\N	D5170C00002	1889	1888	NEW	\N	05.01 Site Selection	05.01.01 Site Contact Details
8107	84	\N	\N	D5170C00002	1892	1888	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
8110	84	\N	\N	D5170C00002	1895	1893	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
8113	84	\N	\N	D5170C00002	1898	1893	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
8117	84	\N	\N	D5170C00002	1902	1893	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
8120	84	\N	\N	D5170C00002	1905	1893	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
8124	84	\N	\N	D5170C00002	1909	1906	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
8130	84	\N	\N	D5170C00002	1915	1914	NEW	\N	05.05 General	05.05.01 Relev_unications-Email
8133	84	\N	\N	D5170C00002	1918	1335	NEW	\N	Site	2002284 Walldorf, Jens
8136	84	\N	\N	D5170C00002	1921	1920	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
8161	84	\N	\N	D5170C00002	1946	1944	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
8165	84	\N	\N	D5170C00002	1950	1949	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
8168	84	\N	\N	D5170C00002	1953	1952	NEW	\N	05 Site Management	05.01 Site Selection
8171	84	\N	\N	D5170C00002	1956	1335	NEW	\N	Site	TBD-1-1RBL8PS _ertheiner, Peter
8174	84	\N	\N	D5170C00002	1959	1958	NEW	\N	05.01 Site Selection	05.01.04 Pre T_onitoring Report
8175	84	\N	\N	D5170C00002	1960	1335	NEW	\N	Site	TBD-1-1RDPHN5 Sauter, Joachim
8176	84	\N	\N	D5170C00002	1961	1960	NEW	\N	TBD-1-1RDPHN5 Sauter, Joachim	05 Site Management
8177	84	\N	\N	D5170C00002	1962	1961	NEW	\N	05 Site Management	05.01 Site Selection
8178	84	\N	\N	D5170C00002	1963	1962	NEW	\N	05.01 Site Selection	05.01.01 Site Contact Details
8179	84	\N	\N	D5170C00002	1964	1335	NEW	\N	Site	TBD-1-1RDPHNL Mueller, Joachim
8180	84	\N	\N	D5170C00002	1965	1964	NEW	\N	TBD-1-1RDPHNL Mueller, Joachim	05 Site Management
8181	84	\N	\N	D5170C00002	1966	1965	NEW	\N	05 Site Management	05.01 Site Selection
8182	84	\N	\N	D5170C00002	1967	1966	NEW	\N	05.01 Site Selection	05.01.01 Site Contact Details
8183	84	\N	\N	D5170C00002	1968	1335	NEW	\N	Site	TBD-1-1RDPHOA Krummenerl, Annette
8184	84	\N	\N	D5170C00002	1969	1968	NEW	\N	TBD-1-1RDPHOA Krummenerl, Annette	05 Site Management
8185	84	\N	\N	D5170C00002	1970	1969	NEW	\N	05 Site Management	05.01 Site Selection
8186	84	\N	\N	D5170C00002	1971	1970	NEW	\N	05.01 Site Selection	05.01.01 Site Contact Details
8187	84	\N	\N	D5170C00002	1972	1335	NEW	\N	Site	TBD-1-1RDPHOP _ummenerl, Thomas
8188	84	\N	\N	D5170C00002	1973	1972	NEW	\N	TBD-1-1RDPHOP _ummenerl, Thomas	04 IRB-IEC and other Approvals
8189	84	\N	\N	D5170C00002	1974	1973	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
8190	84	\N	\N	D5170C00002	1975	1974	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
8191	84	\N	\N	D5170C00002	1976	1972	NEW	\N	TBD-1-1RDPHOP _ummenerl, Thomas	05 Site Management
8192	84	\N	\N	D5170C00002	1977	1976	NEW	\N	05 Site Management	05.01 Site Selection
8193	84	\N	\N	D5170C00002	1978	1977	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
8194	84	\N	\N	D5170C00002	1979	1335	NEW	\N	Site	TBD-1-1RDPHP2 von Herbay, Alexandra
8195	84	\N	\N	D5170C00002	1980	1979	NEW	\N	TBD-1-1RDPHP2 von Herbay, Alexandra	05 Site Management
8196	84	\N	\N	D5170C00002	1981	1980	NEW	\N	05 Site Management	05.01 Site Selection
8197	84	\N	\N	D5170C00002	1982	1981	NEW	\N	05.01 Site Selection	05.01.01 Site Contact Details
8198	84	\N	\N	D5170C00002	1983	1335	NEW	\N	Site	TBD-1-1RDPHPP Ochsenkuehn, Thomas
8199	84	\N	\N	D5170C00002	1984	1983	NEW	\N	TBD-1-1RDPHPP Ochsenkuehn, Thomas	05 Site Management
8200	84	\N	\N	D5170C00002	1985	1984	NEW	\N	05 Site Management	05.01 Site Selection
8201	84	\N	\N	D5170C00002	1986	1985	NEW	\N	05.01 Site Selection	05.01.01 Site Contact Details
8203	84	\N	\N	D5170C00002	1988	1987	NEW	\N	TBD-1-1RDPHRT Witthoeft, Thomas	05 Site Management
8204	84	\N	\N	D5170C00002	1989	1988	NEW	\N	05 Site Management	05.01 Site Selection
8205	84	\N	\N	D5170C00002	1990	1989	NEW	\N	05.01 Site Selection	05.01.01 Site Contact Details
8206	84	\N	\N	D5170C00002	1991	1989	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
8207	84	\N	\N	D5170C00002	1992	1335	NEW	\N	Site	TBD-1-1RDPHSG Buening, Carsten
8209	84	\N	\N	D5170C00002	1994	1993	NEW	\N	05 Site Management	05.01 Site Selection
8225	84	\N	\N	D5170C00002	2010	2007	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
8226	84	\N	\N	D5170C00002	2011	2010	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
8227	84	\N	\N	D5170C00002	2012	2002	NEW	\N	2002286 Salamon, Agnes	05 Site Management
8228	84	\N	\N	D5170C00002	2013	2012	NEW	\N	05 Site Management	05.01 Site Selection
8229	84	\N	\N	D5170C00002	2014	2013	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
8231	84	\N	\N	D5170C00002	2016	2013	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
8234	84	\N	\N	D5170C00002	2019	2017	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
8238	84	\N	\N	D5170C00002	2023	2017	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
8241	84	\N	\N	D5170C00002	2026	2017	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
8245	84	\N	\N	D5170C00002	2030	2028	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
8248	84	\N	\N	D5170C00002	2033	2032	NEW	\N	05.04 Site Management	05.04.01 Subject Log
8251	84	\N	\N	D5170C00002	2036	2032	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
8255	84	\N	\N	D5170C00002	2040	2039	NEW	\N	06 IP and Trial Supplies	06.04 Storage
8258	84	\N	\N	D5170C00002	2043	2042	NEW	\N	06.05 Non-IP Documentation	06.05.03 Non-I_tation of Return
8262	84	\N	\N	D5170C00002	2047	2046	NEW	\N	2002288 Schnabel, Robert	02 Central Trial Documents
8265	84	\N	\N	D5170C00002	2050	2048	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
8268	84	\N	\N	D5170C00002	2053	2052	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
8269	84	\N	\N	D5170C00002	2054	2051	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
8270	84	\N	\N	D5170C00002	2055	2054	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
8271	84	\N	\N	D5170C00002	2056	2046	NEW	\N	2002288 Schnabel, Robert	05 Site Management
8273	84	\N	\N	D5170C00002	2058	2057	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
8277	84	\N	\N	D5170C00002	2062	2061	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
8280	84	\N	\N	D5170C00002	2065	2061	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
8284	84	\N	\N	D5170C00002	2069	2061	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
8288	84	\N	\N	D5170C00002	2073	2056	NEW	\N	05 Site Management	05.03 Site Initiation
8291	84	\N	\N	D5170C00002	2076	2073	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
8293	84	\N	\N	D5170C00002	2078	2077	NEW	\N	05.04 Site Management	05.04.01 Subject Log
8294	84	\N	\N	D5170C00002	2079	2077	NEW	\N	05.04 Site Management	05.04.03 Monitoring Visit Report
8295	84	\N	\N	D5170C00002	2080	2077	NEW	\N	05.04 Site Management	05.04.04 Visit Log
8299	84	\N	\N	D5170C00002	2084	2083	NEW	\N	05.05 General	05.05.02 Tracking Information
8303	84	\N	\N	D5170C00002	2088	2085	NEW	\N	06 IP and Trial Supplies	06.04 Storage
8304	84	\N	\N	D5170C00002	2089	2088	NEW	\N	06.04 Storage	06.04.03 Maintenance Logs
8308	84	\N	\N	D5170C00002	2093	2092	NEW	\N	2002290 Bene, Laszlo	05 Site Management
8310	84	\N	\N	D5170C00002	2095	2094	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
8314	84	\N	\N	D5170C00002	2099	2098	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
8440	84	\N	\N	D5170C00002	2225	2220	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Staff Qualification
8443	84	\N	\N	D5170C00002	2228	2220	NEW	\N	05.02 Site Set-up Documentation	05.02.10 Finan_stigator Consent
8447	84	\N	\N	D5170C00002	2232	2215	NEW	\N	05 Site Management	05.03 Site Initiation
8450	84	\N	\N	D5170C00002	2235	2232	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
8453	84	\N	\N	D5170C00002	2238	2236	NEW	\N	05.04 Site Management	05.04.03 Monitoring Visit Report
8456	84	\N	\N	D5170C00002	2241	2236	NEW	\N	05.04 Site Management	05.04.05 UNBLI_itoring Activity
8459	84	\N	\N	D5170C00002	2244	2236	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
8463	84	\N	\N	D5170C00002	2248	2247	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
8466	84	\N	\N	D5170C00002	2251	2248	NEW	\N	06.01 IP Documentation	06.01.10 UNBLI_mentation Return
8470	84	\N	\N	D5170C00002	2255	2253	NEW	\N	06.04 Storage	06.04.03 Maintenance Logs
8472	84	\N	\N	D5170C00002	2257	2247	NEW	\N	06 IP and Trial Supplies	06.05 Non-IP Documentation
8476	84	\N	\N	D5170C00002	2261	2260	NEW	\N	08 Centralized Testing	08.02 Sample Documentation
8479	84	\N	\N	D5170C00002	2264	2263	NEW	\N	2002294 Racz, Ferenc	02 Central Trial Documents
8482	84	\N	\N	D5170C00002	2267	2265	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
8484	84	\N	\N	D5170C00002	2269	2268	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
8488	84	\N	\N	D5170C00002	2273	2263	NEW	\N	2002294 Racz, Ferenc	05 Site Management
8491	84	\N	\N	D5170C00002	2276	2274	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
8494	84	\N	\N	D5170C00002	2279	2278	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
8496	84	\N	\N	D5170C00002	2281	2278	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
8500	84	\N	\N	D5170C00002	2285	2278	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Investigator Regulatory Agreement
8504	84	\N	\N	D5170C00002	2289	2278	NEW	\N	05.02 Site Set-up Documentation	05.02.18 Site Signature Sheet
8507	84	\N	\N	D5170C00002	2292	2290	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
8511	84	\N	\N	D5170C00002	2296	2294	NEW	\N	05.04 Site Management	05.04.03 Monitoring Visit Report
8514	84	\N	\N	D5170C00002	2299	2294	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
8518	84	\N	\N	D5170C00002	2303	2302	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
8521	84	\N	\N	D5170C00002	2306	2305	NEW	\N	06.04 Storage	06.04.03 Maintenance Logs
8524	84	\N	\N	D5170C00002	2309	2001	NEW	\N	Site	2002988 Patai, Arpad
8527	84	\N	\N	D5170C00002	2312	2311	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
8530	84	\N	\N	D5170C00002	2315	2314	NEW	\N	05 Site Management	05.01 Site Selection
8533	84	\N	\N	D5170C00002	2318	2317	NEW	\N	TBD-1-1PKBT2O G.Kiss, Gyula	05 Site Management
8537	84	\N	\N	D5170C00002	2322	2321	NEW	\N	TBD-1-1QRMIHV Lakatos, Peter	05 Site Management
8539	84	\N	\N	D5170C00002	2324	2323	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
8543	84	\N	\N	D5170C00002	2328	2327	NEW	\N	2001782 Konikoff, Fred	02 Central Trial Documents
8546	84	\N	\N	D5170C00002	2331	2329	NEW	\N	02.02 Subject Documents	02.02.04 Subje_nformation Sheet
8549	84	\N	\N	D5170C00002	2334	2332	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
8552	84	\N	\N	D5170C00002	2337	2336	NEW	\N	03.01 Trial Approval	03.01.02 Approval
8555	84	\N	\N	D5170C00002	2340	2339	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
8558	84	\N	\N	D5170C00002	2343	2339	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.05 IRB-I_liance Statement
8559	84	\N	\N	D5170C00002	2344	2338	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
8561	84	\N	\N	D5170C00002	2346	2344	NEW	\N	04.03 Trial Status Reporting	04.03.03 IRB-I_erm Notification
8565	84	\N	\N	D5170C00002	2350	2348	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
8568	84	\N	\N	D5170C00002	2353	2347	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
8571	84	\N	\N	D5170C00002	2356	2353	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
8575	84	\N	\N	D5170C00002	2360	2353	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
8578	84	\N	\N	D5170C00002	2363	2353	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clini_ Trial Agreement
8582	84	\N	\N	D5170C00002	2367	2366	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
8585	84	\N	\N	D5170C00002	2370	2347	NEW	\N	05 Site Management	05.04 Site Management
8588	84	\N	\N	D5170C00002	2373	2370	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
8592	84	\N	\N	D5170C00002	2377	2327	NEW	\N	2001782 Konikoff, Fred	06 IP and Trial Supplies
8595	84	\N	\N	D5170C00002	2380	2326	NEW	\N	Site	2001783 Lahat, Adi
8597	84	\N	\N	D5170C00002	2382	2381	NEW	\N	02 Central Trial Documents	02.02 Subject Documents
8601	84	\N	\N	D5170C00002	2386	2384	NEW	\N	02.04 General	02.04.01 UNBLI_s-Contact Report
8609	84	\N	\N	D5170C00002	2394	2391	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
8612	84	\N	\N	D5170C00002	2397	2396	NEW	\N	04.03 Trial Status Reporting	04.03.01 IRB-I_y Info-Deviation
8616	84	\N	\N	D5170C00002	2401	2400	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
8619	84	\N	\N	D5170C00002	2404	2399	NEW	\N	05 Site Management	05.02 Site Set-up Documentation
8622	84	\N	\N	D5170C00002	2407	2404	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Protocol Amendment Signature Page
8623	84	\N	\N	D5170C00002	2408	2404	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
8627	84	\N	\N	D5170C00002	2412	2404	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
8630	84	\N	\N	D5170C00002	2415	2404	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
8634	84	\N	\N	D5170C00002	2419	2418	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
8637	84	\N	\N	D5170C00002	2422	2399	NEW	\N	05 Site Management	05.04 Site Management
8640	84	\N	\N	D5170C00002	2425	2422	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
8644	84	\N	\N	D5170C00002	2429	2380	NEW	\N	2001783 Lahat, Adi	06 IP and Trial Supplies
8647	84	\N	\N	D5170C00002	2432	2429	NEW	\N	06 IP and Trial Supplies	06.05 Non-IP Documentation
8650	84	\N	\N	D5170C00002	2435	2434	NEW	\N	2001784 Melzer, Ehud	01 Trial Management
8653	84	\N	\N	D5170C00002	2438	2434	NEW	\N	2001784 Melzer, Ehud	02 Central Trial Documents
8656	84	\N	\N	D5170C00002	2441	2438	NEW	\N	02 Central Trial Documents	02.04 General
8659	84	\N	\N	D5170C00002	2444	2443	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
8662	84	\N	\N	D5170C00002	2447	2444	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
8665	84	\N	\N	D5170C00002	2450	2449	NEW	\N	04.03 Trial Status Reporting	04.03.01 IRB-I_y Info-Deviation
8669	84	\N	\N	D5170C00002	2454	2453	NEW	\N	05.01 Site Selection	05.01.01 Site Contact Details
8672	84	\N	\N	D5170C00002	2457	2453	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
8675	84	\N	\N	D5170C00002	2460	2458	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
8678	84	\N	\N	D5170C00002	2463	2458	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
8682	84	\N	\N	D5170C00002	2467	2458	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Inves_latory Agreement
8685	84	\N	\N	D5170C00002	2470	2458	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Si_se Documentation
8687	84	\N	\N	D5170C00002	2472	2452	NEW	\N	05 Site Management	05.03 Site Initiation
8690	84	\N	\N	D5170C00002	2475	2472	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
8693	84	\N	\N	D5170C00002	2478	2476	NEW	\N	05.04 Site Management	05.04.03 Monitoring Visit Report
8696	84	\N	\N	D5170C00002	2481	2476	NEW	\N	05.04 Site Management	05.04.05 Additional Monitoring Activity
8700	84	\N	\N	D5170C00002	2485	2484	NEW	\N	05.05 General	05.05.01 Relev_unications-Email
8703	84	\N	\N	D5170C00002	2488	2434	NEW	\N	2001784 Melzer, Ehud	06 IP and Trial Supplies
8706	84	\N	\N	D5170C00002	2491	2489	NEW	\N	06.01 IP Documentation	06.01.04 UNBLI_nt Documentation
8709	84	\N	\N	D5170C00002	2494	2488	NEW	\N	06 IP and Trial Supplies	06.04 Storage
8712	84	\N	\N	D5170C00002	2497	2494	NEW	\N	06.04 Storage	06.04.02 UNBLI_on Documentation
8715	84	\N	\N	D5170C00002	2500	2499	NEW	\N	06.05 Non-IP Documentation	06.05.02 Non-I_tion of Shipment
8719	84	\N	\N	D5170C00002	2504	2503	NEW	\N	2001785 Waterman, Matti	02 Central Trial Documents
8721	84	\N	\N	D5170C00002	2506	2505	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
8725	84	\N	\N	D5170C00002	2510	2503	NEW	\N	2001785 Waterman, Matti	03 Regulatory
8727	84	\N	\N	D5170C00002	2512	2511	NEW	\N	03.04 General	03.04.01 Relevant Communications-Regulatory-Start-Up-Documents
8731	84	\N	\N	D5170C00002	2516	2514	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
8734	84	\N	\N	D5170C00002	2519	2513	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
8737	84	\N	\N	D5170C00002	2522	2503	NEW	\N	2001785 Waterman, Matti	05 Site Management
8740	84	\N	\N	D5170C00002	2525	2523	NEW	\N	05.01 Site Selection	05.01.02 Confidentiality Agreement
8744	84	\N	\N	D5170C00002	2529	2528	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
8747	84	\N	\N	D5170C00002	2532	2528	NEW	\N	05.02 Site Set-up Documentation	05.02.04 PI CV-Site Affiliation
8749	84	\N	\N	D5170C00002	2534	2528	NEW	\N	05.02 Site Set-up Documentation	05.02.07 Site Qualification
8751	84	\N	\N	D5170C00002	2536	2528	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
8754	84	\N	\N	D5170C00002	2539	2528	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
8758	84	\N	\N	D5170C00002	2543	2542	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
8761	84	\N	\N	D5170C00002	2546	2522	NEW	\N	05 Site Management	05.04 Site Management
8763	84	\N	\N	D5170C00002	2548	2546	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
8767	84	\N	\N	D5170C00002	2552	2503	NEW	\N	2001785 Waterman, Matti	06 IP and Trial Supplies
8771	84	\N	\N	D5170C00002	2556	2555	NEW	\N	2001786 Goldin, Eran	02 Central Trial Documents
8773	84	\N	\N	D5170C00002	2558	2557	NEW	\N	02.02 Subject Documents	02.02.03 Infor_ Form Checklists
8777	84	\N	\N	D5170C00002	2562	2561	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
8780	84	\N	\N	D5170C00002	2565	2564	NEW	\N	03 Regulatory	03.01 Trial Approval
8783	84	\N	\N	D5170C00002	2568	2567	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
8786	84	\N	\N	D5170C00002	2571	2568	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.03 IRB-IEC Composition
8789	84	\N	\N	D5170C00002	2574	2573	NEW	\N	04.03 Trial Status Reporting	04.03.01 IRB-I_y Info-Deviation
8793	84	\N	\N	D5170C00002	2578	2577	NEW	\N	05.01 Site Selection	05.01.01 Site Contact Details
8796	84	\N	\N	D5170C00002	2581	2577	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
8799	84	\N	\N	D5170C00002	2584	2582	NEW	\N	05.02 Site Set-up Documentation	05.02.02 Protocol Signature Page
8802	84	\N	\N	D5170C00002	2587	2582	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
8806	84	\N	\N	D5170C00002	2591	2582	NEW	\N	05.02 Site Set-up Documentation	05.02.09 Inves_latory Agreement
8809	84	\N	\N	D5170C00002	2594	2582	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
8812	84	\N	\N	D5170C00002	2597	2596	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
8814	84	\N	\N	D5170C00002	2599	2596	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
8818	84	\N	\N	D5170C00002	2603	2600	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
8822	84	\N	\N	D5170C00002	2607	2555	NEW	\N	2001786 Goldin, Eran	06 IP and Trial Supplies
8825	84	\N	\N	D5170C00002	2610	2607	NEW	\N	06 IP and Trial Supplies	06.05 Non-IP Documentation
8828	84	\N	\N	D5170C00002	2613	2612	NEW	\N	08 Centralized Testing	08.02 Sample Documentation
8831	84	\N	\N	D5170C00002	2616	2615	NEW	\N	2001787 Israeli, Eran	05 Site Management
8834	84	\N	\N	D5170C00002	2619	2616	NEW	\N	05 Site Management	05.05 General
8837	84	\N	\N	D5170C00002	2622	2621	NEW	\N	TBD-1-1QG2E8P Nimer, Assy	05 Site Management
8843	84	\N	\N	D5170C00002	2628	2627	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
8846	84	\N	\N	D5170C00002	2631	2630	NEW	\N	Site	2002045 Andriulli, Angelo
8849	84	\N	\N	D5170C00002	2634	2633	NEW	\N	02.02 Subject Documents	02.02.03 Infor_ Form Checklists
8852	84	\N	\N	D5170C00002	2637	2636	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
8855	84	\N	\N	D5170C00002	2640	2639	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
8858	84	\N	\N	D5170C00002	2643	2639	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
8862	84	\N	\N	D5170C00002	2647	2646	NEW	\N	05.01 Site Selection	05.01.01 Site Contact Details
8865	84	\N	\N	D5170C00002	2650	2646	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
8868	84	\N	\N	D5170C00002	2653	2651	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
8872	84	\N	\N	D5170C00002	2657	2651	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
8875	84	\N	\N	D5170C00002	2660	2651	NEW	\N	05.02 Site Set-up Documentation	05.02.17 IP Site Release Documentation
8877	84	\N	\N	D5170C00002	2662	2645	NEW	\N	05 Site Management	05.03 Site Initiation
8879	84	\N	\N	D5170C00002	2664	2662	NEW	\N	05.03 Site Initiation	05.03.03 Site Training-Staff
8883	84	\N	\N	D5170C00002	2668	2666	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
8887	84	\N	\N	D5170C00002	2672	2671	NEW	\N	2002046 Armuzzi, Alessandro	02 Central Trial Documents
8890	84	\N	\N	D5170C00002	2675	2673	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
8893	84	\N	\N	D5170C00002	2678	2671	NEW	\N	2002046 Armuzzi, Alessandro	04 IRB-IEC and other Approvals
8896	84	\N	\N	D5170C00002	2681	2679	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.02 IRB-IEC Approval
8900	84	\N	\N	D5170C00002	2685	2684	NEW	\N	05 Site Management	05.01 Site Selection
8903	84	\N	\N	D5170C00002	2688	2685	NEW	\N	05.01 Site Selection	05.01.03 Feasibility Documentation
8906	84	\N	\N	D5170C00002	2691	2690	NEW	\N	05.02 Site Set-up Documentation	05.02.01 Acceptance of Investigator Brochure
8909	84	\N	\N	D5170C00002	2694	2690	NEW	\N	05.02 Site Set-up Documentation	05.02.06 Other_Site Affiliation
8913	84	\N	\N	D5170C00002	2698	2690	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
8917	84	\N	\N	D5170C00002	2702	2701	NEW	\N	05.03 Site Initiation	05.03.01 Trial Initiation Monitoring Report
8920	84	\N	\N	D5170C00002	2705	2684	NEW	\N	05 Site Management	05.04 Site Management
8923	84	\N	\N	D5170C00002	2708	2705	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
8927	84	\N	\N	D5170C00002	2712	2711	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
8930	84	\N	\N	D5170C00002	2715	2714	NEW	\N	2002047 Basilisco, Guido	02 Central Trial Documents
8933	84	\N	\N	D5170C00002	2718	2716	NEW	\N	02.02 Subject Documents	02.02.03 Infor_t Form Templates
8936	84	\N	\N	D5170C00002	2721	2720	NEW	\N	02.04 General	02.04.01 Relev_s-Contact Report
8939	84	\N	\N	D5170C00002	2724	2723	NEW	\N	04 IRB-IEC and other Approvals	04.01 IRB-IEC Trial Approval
8940	84	\N	\N	D5170C00002	2725	2724	NEW	\N	04.01 IRB-IEC Trial Approval	04.01.01 IRB-IEC Submission
8942	84	\N	\N	D5170C00002	2727	2723	NEW	\N	04 IRB-IEC and other Approvals	04.03 Trial Status Reporting
8946	84	\N	\N	D5170C00002	2731	2730	NEW	\N	05.01 Site Selection	05.01.01 Site Contact Details
8949	84	\N	\N	D5170C00002	2734	2730	NEW	\N	05.01 Site Selection	05.01.04 Pre Trial Monitoring Report
8952	84	\N	\N	D5170C00002	2737	2735	NEW	\N	05.02 Site Set-up Documentation	05.02.03 Proto_t Signature Page
8956	84	\N	\N	D5170C00002	2741	2735	NEW	\N	05.02 Site Set-up Documentation	05.02.08 Form FDA1572
8959	84	\N	\N	D5170C00002	2744	2735	NEW	\N	05.02 Site Set-up Documentation	05.02.12 Clinical Trial Agreement
8962	84	\N	\N	D5170C00002	2747	2729	NEW	\N	05 Site Management	05.03 Site Initiation
8965	84	\N	\N	D5170C00002	2750	2747	NEW	\N	05.03 Site Initiation	05.03.03 Site Training Documentation-Site
8969	84	\N	\N	D5170C00002	2754	2751	NEW	\N	05.04 Site Management	05.04.08 Final Trial Close Out Monitoring Report
8973	84	\N	\N	D5170C00002	2758	2757	NEW	\N	06 IP and Trial Supplies	06.01 IP Documentation
8976	84	\N	\N	D5170C00002	2761	2760	NEW	\N	2002048 Cicala, Michele	02 Central Trial Documents
8979	84	\N	\N	D5170C00002	2764	2761	NEW	\N	02 Central Trial Documents	02.04 General
8982	84	\N	\N	D5170C00002	2767	2760	NEW	\N	2002048 Cicala, Michele	04 IRB-IEC and other Approvals
\.


--
-- Data for Name: aqtmf_document; Type: TABLE DATA; Schema: public; Owner: postgres
--

COPY public.aqtmf_document (serial_num, batch_id_fk, file_name, vault_doc_id, external_id, doc_link_id, status, doc_link_status, checksum_status, linking_time, md5_comparison_time) FROM stdin;
82689	79	D5170C00002/tiny.path.1/file-1299.pdf	\N	D5170C00002-002b9f2c-8316-11eb-be00-adb8dcab4582-1299	\N	NEW	\N	\N	\N	\N
82690	79	D5170C00002/tiny.path.1/file-1300.pdf	\N	D5170C00002-004c468d-8316-11eb-be00-e76bb421a0c4-1300	\N	NEW	\N	\N	\N	\N
85641	79	D5170C00002/tiny.path.1/file-4251.pdf	\N	D5170C00002-0067ac64-8318-11eb-be00-4f9b7f8e01ee-4251	\N	NEW	\N	\N	\N	\N
84083	79	D5170C00002/tiny.path.1/file-2693.pdf	\N	D5170C00002-00781c7e-8317-11eb-be00-43a5e74cd867-2693	\N	NEW	\N	\N	\N	\N
85642	79	D5170C00002/tiny.path.1/file-4252.pdf	\N	D5170C00002-00784e35-8318-11eb-be00-9b730fa783db-4252	\N	NEW	\N	\N	\N	\N
82691	79	D5170C00002/tiny.path.1/file-1301.pdf	\N	D5170C00002-0086695e-8316-11eb-be00-27fbeb126970-1301	\N	NEW	\N	\N	\N	\N
82692	79	D5170C00002/tiny.path.1/file-1302.pdf	\N	D5170C00002-0098b8df-8316-11eb-be00-f3b7fd169e02-1302	\N	NEW	\N	\N	\N	\N
85643	79	D5170C00002/tiny.path.1/file-4253.pdf	\N	D5170C00002-00b38276-8318-11eb-be00-bf6ab33660f7-4253	\N	NEW	\N	\N	\N	\N
84084	79	D5170C00002/tiny.path.1/file-2694.pdf	\N	D5170C00002-00d334cf-8317-11eb-be00-7f79c630f14f-2694	\N	NEW	\N	\N	\N	\N
85644	79	D5170C00002/tiny.path.1/file-4254.pdf	\N	D5170C00002-00d3b4a7-8318-11eb-be00-0bae0a682de5-4254	\N	NEW	\N	\N	\N	\N
87009	79	D5170C00002/tiny.path.1/file-5619.pdf	\N	D5170C00002-0100c1fc-8319-11eb-be00-ed014db6e66b-5619	\N	NEW	\N	\N	\N	\N
82693	79	D5170C00002/tiny.path.1/file-1303.pdf	\N	D5170C00002-011080f0-8316-11eb-be00-e9f51447dcfd-1303	\N	NEW	\N	\N	\N	\N
85645	79	D5170C00002/tiny.path.1/file-4255.pdf	\N	D5170C00002-01300578-8318-11eb-be00-8b72bb32e9e6-4255	\N	NEW	\N	\N	\N	\N
87010	79	D5170C00002/tiny.path.1/file-5620.pdf	\N	D5170C00002-014e6ccd-8319-11eb-be00-aff6a3496b23-5620	\N	NEW	\N	\N	\N	\N
85646	79	D5170C00002/tiny.path.1/file-4256.pdf	\N	D5170C00002-014eff29-8318-11eb-be00-cf20f8af7189-4256	\N	NEW	\N	\N	\N	\N
87011	79	D5170C00002/tiny.path.1/file-5621.pdf	\N	D5170C00002-015d39de-8319-11eb-be00-e356441332e2-5621	\N	NEW	\N	\N	\N	\N
82694	79	D5170C00002/tiny.path.1/file-1304.pdf	\N	D5170C00002-016b7231-8316-11eb-be00-7b4aea993bb5-1304	\N	NEW	\N	\N	\N	\N
85647	79	D5170C00002/tiny.path.1/file-4257.pdf	\N	D5170C00002-017a2dda-8318-11eb-be00-d1f8fd3ad336-4257	\N	NEW	\N	\N	\N	\N
87012	79	D5170C00002/tiny.path.1/file-5622.pdf	\N	D5170C00002-017c338f-8319-11eb-be00-378882c5f0ff-5622	\N	NEW	\N	\N	\N	\N
85648	79	D5170C00002/tiny.path.1/file-4258.pdf	\N	D5170C00002-01999cbb-8318-11eb-be00-0d6d95e3718c-4258	\N	NEW	\N	\N	\N	\N
87013	79	D5170C00002/tiny.path.1/file-5623.pdf	\N	D5170C00002-0199a6a0-8319-11eb-be00-0f1e92506d77-5623	\N	NEW	\N	\N	\N	\N
82695	79	D5170C00002/tiny.path.1/file-1305.pdf	\N	D5170C00002-019a7172-8316-11eb-be00-5953934ae9ab-1305	\N	NEW	\N	\N	\N	\N
87014	79	D5170C00002/tiny.path.1/file-5624.pdf	\N	D5170C00002-01a8c1d1-8319-11eb-be00-f52b7284a4cb-5624	\N	NEW	\N	\N	\N	\N
84085	79	D5170C00002/tiny.path.1/file-2695.pdf	\N	D5170C00002-01a94980-8317-11eb-be00-650b5b9310d5-2695	\N	NEW	\N	\N	\N	\N
87015	79	D5170C00002/tiny.path.1/file-5625.pdf	\N	D5170C00002-01b740c2-8319-11eb-be00-dfd62cb2531c-5625	\N	NEW	\N	\N	\N	\N
87016	79	D5170C00002/tiny.path.1/file-5626.pdf	\N	D5170C00002-01c6f833-8319-11eb-be00-7b793a0f3df3-5626	\N	NEW	\N	\N	\N	\N
85649	79	D5170C00002/tiny.path.1/file-4259.pdf	\N	D5170C00002-01c9112c-8318-11eb-be00-bb9a29421978-4259	\N	NEW	\N	\N	\N	\N
82696	79	D5170C00002/tiny.path.1/file-1306.pdf	\N	D5170C00002-01d5f3d3-8316-11eb-be00-c74e0c3e8df9-1306	\N	NEW	\N	\N	\N	\N
87017	79	D5170C00002/tiny.path.1/file-5627.pdf	\N	D5170C00002-01e6b534-8319-11eb-be00-1f3523789fff-5627	\N	NEW	\N	\N	\N	\N
84086	79	D5170C00002/tiny.path.1/file-2696.pdf	\N	D5170C00002-01f43531-8317-11eb-be00-190438d8cf78-2696	\N	NEW	\N	\N	\N	\N
85650	79	D5170C00002/tiny.path.1/file-4260.pdf	\N	D5170C00002-01f4dc1d-8318-11eb-be00-1ff7a7571e22-4260	\N	NEW	\N	\N	\N	\N
87018	79	D5170C00002/tiny.path.1/file-5628.pdf	\N	D5170C00002-0212ce45-8319-11eb-be00-e9beae15aea3-5628	\N	NEW	\N	\N	\N	\N
85651	79	D5170C00002/tiny.path.1/file-4261.pdf	\N	D5170C00002-0212eb6e-8318-11eb-be00-7da35aac8062-4261	\N	NEW	\N	\N	\N	\N
87019	79	D5170C00002/tiny.path.1/file-5629.pdf	\N	D5170C00002-0222fae6-8319-11eb-be00-8d273d9ca5dc-5629	\N	NEW	\N	\N	\N	\N
87020	79	D5170C00002/tiny.path.1/file-5630.pdf	\N	D5170C00002-0231ef07-8319-11eb-be00-778ddfb95b21-5630	\N	NEW	\N	\N	\N	\N
82697	79	D5170C00002/tiny.path.1/file-1307.pdf	\N	D5170C00002-0232b9d4-8316-11eb-be00-6de6494c0ca2-1307	\N	NEW	\N	\N	\N	\N
85652	79	D5170C00002/tiny.path.1/file-4262.pdf	\N	D5170C00002-02408b1f-8318-11eb-be00-2ba78d367cce-4262	\N	NEW	\N	\N	\N	\N
85653	79	D5170C00002/tiny.path.1/file-4263.pdf	\N	D5170C00002-024f7f40-8318-11eb-be00-35a3ec4efd37-4263	\N	NEW	\N	\N	\N	\N
87021	79	D5170C00002/tiny.path.1/file-5631.pdf	\N	D5170C00002-024ffe58-8319-11eb-be00-7f169de479f6-5631	\N	NEW	\N	\N	\N	\N
82698	79	D5170C00002/tiny.path.1/file-1308.pdf	\N	D5170C00002-025228b5-8316-11eb-be00-396b21a75f41-1308	\N	NEW	\N	\N	\N	\N
85654	79	D5170C00002/tiny.path.1/file-4264.pdf	\N	D5170C00002-025ee891-8318-11eb-be00-4b7cfa14c3c5-4264	\N	NEW	\N	\N	\N	\N
87022	79	D5170C00002/tiny.path.1/file-5632.pdf	\N	D5170C00002-025f4099-8319-11eb-be00-6104bd75222e-5632	\N	NEW	\N	\N	\N	\N
84087	79	D5170C00002/tiny.path.1/file-2697.pdf	\N	D5170C00002-026ee372-8317-11eb-be00-2fc30897b5d8-2697	\N	NEW	\N	\N	\N	\N
87023	79	D5170C00002/tiny.path.1/file-5633.pdf	\N	D5170C00002-027dec2a-8319-11eb-be00-d1197c55ffb0-5633	\N	NEW	\N	\N	\N	\N
85655	79	D5170C00002/tiny.path.1/file-4265.pdf	\N	D5170C00002-028cfd72-8318-11eb-be00-bba7587608c3-4265	\N	NEW	\N	\N	\N	\N
87024	79	D5170C00002/tiny.path.1/file-5634.pdf	\N	D5170C00002-028f514b-8319-11eb-be00-3dd6f4fd8464-5634	\N	NEW	\N	\N	\N	\N
85656	79	D5170C00002/tiny.path.1/file-4266.pdf	\N	D5170C00002-029c8dd3-8318-11eb-be00-11b88760bb7d-4266	\N	NEW	\N	\N	\N	\N
84088	79	D5170C00002/tiny.path.1/file-2698.pdf	\N	D5170C00002-029ea603-8317-11eb-be00-018517a94e3f-2698	\N	NEW	\N	\N	\N	\N
82699	79	D5170C00002/tiny.path.1/file-1309.pdf	\N	D5170C00002-02abba66-8316-11eb-be00-238fb7d2362b-1309	\N	NEW	\N	\N	\N	\N
87025	79	D5170C00002/tiny.path.1/file-5635.pdf	\N	D5170C00002-02ca5e7c-8319-11eb-be00-91b264e645ef-5635	\N	NEW	\N	\N	\N	\N
84089	79	D5170C00002/tiny.path.1/file-2699.pdf	\N	D5170C00002-02ca70f4-8317-11eb-be00-232a835c1d1e-2699	\N	NEW	\N	\N	\N	\N
82700	79	D5170C00002/tiny.path.1/file-1310.pdf	\N	D5170C00002-02da4477-8316-11eb-be00-29a204d701f7-1310	\N	NEW	\N	\N	\N	\N
87026	79	D5170C00002/tiny.path.1/file-5636.pdf	\N	D5170C00002-02db4e6d-8319-11eb-be00-8db9ececa308-5636	\N	NEW	\N	\N	\N	\N
85657	79	D5170C00002/tiny.path.1/file-4267.pdf	\N	D5170C00002-02e88af4-8318-11eb-be00-432f1a890080-4267	\N	NEW	\N	\N	\N	\N
84090	79	D5170C00002/tiny.path.1/file-2700.pdf	\N	D5170C00002-02e91c85-8317-11eb-be00-c3659c115371-2700	\N	NEW	\N	\N	\N	\N
84091	79	D5170C00002/tiny.path.1/file-2701.pdf	\N	D5170C00002-02fa0c76-8317-11eb-be00-118ee3671802-2701	\N	NEW	\N	\N	\N	\N
84092	79	D5170C00002/tiny.path.1/file-2702.pdf	\N	D5170C00002-03088b67-8317-11eb-be00-235d2aef52f0-2702	\N	NEW	\N	\N	\N	\N
85658	79	D5170C00002/tiny.path.1/file-4268.pdf	\N	D5170C00002-0309ce95-8318-11eb-be00-63110ed7ebd4-4268	\N	NEW	\N	\N	\N	\N
82701	79	D5170C00002/tiny.path.1/file-1311.pdf	\N	D5170C00002-0316ff58-8316-11eb-be00-9fdc34004a52-1311	\N	NEW	\N	\N	\N	\N
82702	79	D5170C00002/tiny.path.1/file-1312.pdf	\N	D5170C00002-03261a89-8316-11eb-be00-f51619cff45d-1312	\N	NEW	\N	\N	\N	\N
82703	79	D5170C00002/tiny.path.1/file-1313.pdf	\N	D5170C00002-03272bfa-8316-11eb-be00-b52c2afb8fe8-1313	\N	NEW	\N	\N	\N	\N
82704	79	D5170C00002/tiny.path.1/file-1314.pdf	\N	D5170C00002-03370a7b-8316-11eb-be00-5949b3ccd84f-1314	\N	NEW	\N	\N	\N	\N
87027	79	D5170C00002/tiny.path.1/file-5637.pdf	\N	D5170C00002-0353d9ce-8319-11eb-be00-8149ac2e2ca1-5637	\N	NEW	\N	\N	\N	\N
84093	79	D5170C00002/tiny.path.1/file-2703.pdf	\N	D5170C00002-03543a68-8317-11eb-be00-a9edd8167fab-2703	\N	NEW	\N	\N	\N	\N
82705	79	D5170C00002/tiny.path.1/file-1315.pdf	\N	D5170C00002-0364aa2c-8316-11eb-be00-f5d69a5394fd-1315	\N	NEW	\N	\N	\N	\N
84094	79	D5170C00002/tiny.path.1/file-2704.pdf	\N	D5170C00002-03820129-8317-11eb-be00-877b67a8f3be-2704	\N	NEW	\N	\N	\N	\N
87028	79	D5170C00002/tiny.path.1/file-5638.pdf	\N	D5170C00002-0383001f-8319-11eb-be00-a5fb5c3892be-5638	\N	NEW	\N	\N	\N	\N
82706	79	D5170C00002/tiny.path.1/file-1316.pdf	\N	D5170C00002-039249dd-8316-11eb-be00-85d4f230a674-1316	\N	NEW	\N	\N	\N	\N
84095	79	D5170C00002/tiny.path.1/file-2705.pdf	\N	D5170C00002-03a20c4a-8317-11eb-be00-9b12e54f9e7f-2705	\N	NEW	\N	\N	\N	\N
84096	79	D5170C00002/tiny.path.1/file-2706.pdf	\N	D5170C00002-03cdd73b-8317-11eb-be00-196e8396654a-2706	\N	NEW	\N	\N	\N	\N
82708	79	D5170C00002/tiny.path.1/file-1318.pdf	\N	D5170C00002-03dd358e-8316-11eb-be00-45bd488b6e98-1317	\N	NEW	\N	\N	\N	\N
87029	79	D5170C00002/tiny.path.1/file-5639.pdf	\N	D5170C00002-03fb8b80-8319-11eb-be00-2fa87538cca2-5639	\N	NEW	\N	\N	\N	\N
85659	79	D5170C00002/tiny.path.1/file-4269.pdf	\N	D5170C00002-03fce126-8318-11eb-be00-81c90bd19a61-4269	\N	NEW	\N	\N	\N	\N
87030	79	D5170C00002/tiny.path.1/file-5640.pdf	\N	D5170C00002-040c7b71-8319-11eb-be00-a5bdd73b2ec4-5640	\N	NEW	\N	\N	\N	\N
87031	79	D5170C00002/tiny.path.1/file-5641.pdf	\N	D5170C00002-041afa62-8319-11eb-be00-810d7497013a-5641	\N	NEW	\N	\N	\N	\N
82709	79	D5170C00002/tiny.path.1/file-1319.pdf	\N	D5170C00002-041b770f-8316-11eb-be00-75b32813646d-1318	\N	NEW	\N	\N	\N	\N
84097	79	D5170C00002/tiny.path.1/file-2707.pdf	\N	D5170C00002-041cba8c-8317-11eb-be00-6f71110820ef-2707	\N	NEW	\N	\N	\N	\N
87032	79	D5170C00002/tiny.path.1/file-5642.pdf	\N	D5170C00002-04378313-8319-11eb-be00-13df9b46577e-5642	\N	NEW	\N	\N	\N	\N
82710	79	D5170C00002/tiny.path.1/file-1320.pdf	\N	D5170C00002-043874f0-8316-11eb-be00-dd5fd3be9f54-1319	\N	NEW	\N	\N	\N	\N
85660	79	D5170C00002/tiny.path.1/file-4270.pdf	\N	D5170C00002-043a8667-8318-11eb-be00-7399617339df-4270	\N	NEW	\N	\N	\N	\N
87033	79	D5170C00002/tiny.path.1/file-5643.pdf	\N	D5170C00002-04471374-8319-11eb-be00-85f29853aaf9-5643	\N	NEW	\N	\N	\N	\N
87034	79	D5170C00002/tiny.path.1/file-5644.pdf	\N	D5170C00002-04490f45-8319-11eb-be00-612a58248a3f-5644	\N	NEW	\N	\N	\N	\N
82707	79	D5170C00002/tiny.path.1/file-1317.pdf	\N	D5170C00002-0459dfa1-8316-11eb-be00-6955fedcc441-1320	\N	NEW	\N	\N	\N	\N
87035	79	D5170C00002/tiny.path.1/file-5645.pdf	\N	D5170C00002-046549d6-8319-11eb-be00-a5954caa7295-5645	\N	NEW	\N	\N	\N	\N
85661	79	D5170C00002/tiny.path.1/file-4271.pdf	\N	D5170C00002-04673bb8-8318-11eb-be00-03f2ccb7c050-4271	\N	NEW	\N	\N	\N	\N
84098	79	D5170C00002/tiny.path.1/file-2708.pdf	\N	D5170C00002-0468698d-8317-11eb-be00-754e3e226ec7-2708	\N	NEW	\N	\N	\N	\N
87036	79	D5170C00002/tiny.path.1/file-5646.pdf	\N	D5170C00002-0474b327-8319-11eb-be00-c143a3baf38e-5646	\N	NEW	\N	\N	\N	\N
84099	79	D5170C00002/tiny.path.1/file-2709.pdf	\N	D5170C00002-0484cb2e-8317-11eb-be00-9b2db2386d6e-2709	\N	NEW	\N	\N	\N	\N
82711	79	D5170C00002/tiny.path.1/file-1321.pdf	\N	D5170C00002-04873132-8316-11eb-be00-4914ab058701-1321	\N	NEW	\N	\N	\N	\N
87037	79	D5170C00002/tiny.path.1/file-5647.pdf	\N	D5170C00002-0495cfb8-8319-11eb-be00-1f389769c034-5647	\N	NEW	\N	\N	\N	\N
82712	79	D5170C00002/tiny.path.1/file-1322.pdf	\N	D5170C00002-04a392d3-8316-11eb-be00-ad52d7884da9-1322	\N	NEW	\N	\N	\N	\N
87038	79	D5170C00002/tiny.path.1/file-5648.pdf	\N	D5170C00002-04b2f4a9-8319-11eb-be00-f9ff5e1009fc-5648	\N	NEW	\N	\N	\N	\N
87039	79	D5170C00002/tiny.path.1/file-5649.pdf	\N	D5170C00002-04c1e8ca-8319-11eb-be00-857798e93742-5649	\N	NEW	\N	\N	\N	\N
82713	79	D5170C00002/tiny.path.1/file-1323.pdf	\N	D5170C00002-04c23e64-8316-11eb-be00-473492d8341b-1323	\N	NEW	\N	\N	\N	\N
84100	79	D5170C00002/tiny.path.1/file-2710.pdf	\N	D5170C00002-04d227df-8317-11eb-be00-5d6c3d75cee7-2710	\N	NEW	\N	\N	\N	\N
82714	79	D5170C00002/tiny.path.1/file-1324.pdf	\N	D5170C00002-050058d5-8316-11eb-be00-610d916c769c-1324	\N	NEW	\N	\N	\N	\N
84101	79	D5170C00002/tiny.path.1/file-2711.pdf	\N	D5170C00002-05014e30-8317-11eb-be00-13eafc574e47-2711	\N	NEW	\N	\N	\N	\N
87040	79	D5170C00002/tiny.path.1/file-5650.pdf	\N	D5170C00002-050162cb-8319-11eb-be00-a7ccbd30f61a-5650	\N	NEW	\N	\N	\N	\N
85662	79	D5170C00002/tiny.path.1/file-4272.pdf	\N	D5170C00002-050db4e9-8318-11eb-be00-cd68fc70b8e9-4272	\N	NEW	\N	\N	\N	\N
87041	79	D5170C00002/tiny.path.1/file-5651.pdf	\N	D5170C00002-051f23fc-8319-11eb-be00-4db8f1c834d3-5651	\N	NEW	\N	\N	\N	\N
87042	79	D5170C00002/tiny.path.1/file-5652.pdf	\N	D5170C00002-055a583d-8319-11eb-be00-1754e77b6be0-5652	\N	NEW	\N	\N	\N	\N
84102	79	D5170C00002/tiny.path.1/file-2712.pdf	\N	D5170C00002-055b5511-8317-11eb-be00-db65b978b014-2712	\N	NEW	\N	\N	\N	\N
85663	79	D5170C00002/tiny.path.1/file-4273.pdf	\N	D5170C00002-055c983a-8318-11eb-be00-c3e246c65013-4273	\N	NEW	\N	\N	\N	\N
85664	79	D5170C00002/tiny.path.1/file-4274.pdf	\N	D5170C00002-0588d85b-8318-11eb-be00-9323b0544063-4274	\N	NEW	\N	\N	\N	\N
82715	79	D5170C00002/tiny.path.1/file-1325.pdf	\N	D5170C00002-0599d9b6-8316-11eb-be00-53e50e7c2c1f-1325	\N	NEW	\N	\N	\N	\N
85665	79	D5170C00002/tiny.path.1/file-4275.pdf	\N	D5170C00002-05b58dac-8318-11eb-be00-6f58fec6db05-4275	\N	NEW	\N	\N	\N	\N
87043	79	D5170C00002/tiny.path.1/file-5653.pdf	\N	D5170C00002-05c6125e-8319-11eb-be00-4bd094da9505-5653	\N	NEW	\N	\N	\N	\N
84103	79	D5170C00002/tiny.path.1/file-2713.pdf	\N	D5170C00002-05d42e92-8317-11eb-be00-a9dbd9fa38db-2713	\N	NEW	\N	\N	\N	\N
82716	79	D5170C00002/tiny.path.1/file-1326.pdf	\N	D5170C00002-05d4e6e7-8316-11eb-be00-abb7f0ba0839-1326	\N	NEW	\N	\N	\N	\N
85671	79	D5170C00002/tiny.path.1/file-4281.pdf	\N	D5170C00002-05e5c56d-8318-11eb-be00-433537d5ec04-4276	\N	NEW	\N	\N	\N	\N
84104	79	D5170C00002/tiny.path.1/file-2714.pdf	\N	D5170C00002-05f412a3-8317-11eb-be00-1f7ef02de90a-2714	\N	NEW	\N	\N	\N	\N
87044	79	D5170C00002/tiny.path.1/file-5654.pdf	\N	D5170C00002-05f4273f-8319-11eb-be00-ad747218a42d-5654	\N	NEW	\N	\N	\N	\N
85672	79	D5170C00002/tiny.path.1/file-4282.pdf	\N	D5170C00002-0603fbce-8318-11eb-be00-4786a29bdf91-4277	\N	NEW	\N	\N	\N	\N
82717	79	D5170C00002/tiny.path.1/file-1327.pdf	\N	D5170C00002-06045b58-8316-11eb-be00-83d7a5769d9e-1327	\N	NEW	\N	\N	\N	\N
84105	79	D5170C00002/tiny.path.1/file-2715.pdf	\N	D5170C00002-06129724-8317-11eb-be00-d95fbe0cdd76-2715	\N	NEW	\N	\N	\N	\N
85666	79	D5170C00002/tiny.path.1/file-4276.pdf	\N	D5170C00002-06216edf-8318-11eb-be00-e77f97cb70ae-4278	\N	NEW	\N	\N	\N	\N
82718	79	D5170C00002/tiny.path.1/file-1328.pdf	\N	D5170C00002-063f6889-8316-11eb-be00-d7741031f8e5-1328	\N	NEW	\N	\N	\N	\N
84106	79	D5170C00002/tiny.path.1/file-2716.pdf	\N	D5170C00002-0640d315-8317-11eb-be00-699a6dcfbbac-2716	\N	NEW	\N	\N	\N	\N
85667	79	D5170C00002/tiny.path.1/file-4277.pdf	\N	D5170C00002-064fd1e0-8318-11eb-be00-475256a0ef10-4279	\N	NEW	\N	\N	\N	\N
87045	79	D5170C00002/tiny.path.1/file-5655.pdf	\N	D5170C00002-065cfb30-8319-11eb-be00-ed9f3c61b0b4-5655	\N	NEW	\N	\N	\N	\N
87046	79	D5170C00002/tiny.path.1/file-5656.pdf	\N	D5170C00002-066d27d1-8319-11eb-be00-7dec33eded0b-5656	\N	NEW	\N	\N	\N	\N
85668	79	D5170C00002/tiny.path.1/file-4278.pdf	\N	D5170C00002-066e2f51-8318-11eb-be00-91afb2613387-4280	\N	NEW	\N	\N	\N	\N
85669	79	D5170C00002/tiny.path.1/file-4279.pdf	\N	D5170C00002-068dc542-8318-11eb-be00-7f4fa0ffe7a8-4281	\N	NEW	\N	\N	\N	\N
85670	79	D5170C00002/tiny.path.1/file-4280.pdf	\N	D5170C00002-069c4433-8318-11eb-be00-a75a2f37c22d-4282	\N	NEW	\N	\N	\N	\N
82719	79	D5170C00002/tiny.path.1/file-1329.pdf	\N	D5170C00002-06aa384a-8316-11eb-be00-6b75f62592ea-1329	\N	NEW	\N	\N	\N	\N
87047	79	D5170C00002/tiny.path.1/file-5657.pdf	\N	D5170C00002-06c88e42-8319-11eb-be00-51397793fbef-5657	\N	NEW	\N	\N	\N	\N
85673	79	D5170C00002/tiny.path.1/file-4283.pdf	\N	D5170C00002-06c8d274-8318-11eb-be00-5ff09805496c-4283	\N	NEW	\N	\N	\N	\N
84107	79	D5170C00002/tiny.path.1/file-2717.pdf	\N	D5170C00002-06cb5fd6-8317-11eb-be00-ebc4f273af5d-2717	\N	NEW	\N	\N	\N	\N
87048	79	D5170C00002/tiny.path.1/file-5658.pdf	\N	D5170C00002-06e6c4a3-8319-11eb-be00-77e3d29d739c-5658	\N	NEW	\N	\N	\N	\N
85674	79	D5170C00002/tiny.path.1/file-4284.pdf	\N	D5170C00002-06e8dd95-8318-11eb-be00-f7875337b72c-4284	\N	NEW	\N	\N	\N	\N
84108	79	D5170C00002/tiny.path.1/file-2718.pdf	\N	D5170C00002-07069417-8317-11eb-be00-6faa6634a142-2718	\N	NEW	\N	\N	\N	\N
82720	79	D5170C00002/tiny.path.1/file-1330.pdf	\N	D5170C00002-071751fb-8316-11eb-be00-176a09503a5b-1330	\N	NEW	\N	\N	\N	\N
85675	79	D5170C00002/tiny.path.1/file-4285.pdf	\N	D5170C00002-07237596-8318-11eb-be00-73fd88dd02aa-4285	\N	NEW	\N	\N	\N	\N
87049	79	D5170C00002/tiny.path.1/file-5659.pdf	\N	D5170C00002-0732c1c4-8319-11eb-be00-63834ee18715-5659	\N	NEW	\N	\N	\N	\N
85676	79	D5170C00002/tiny.path.1/file-4286.pdf	\N	D5170C00002-0733a237-8318-11eb-be00-f7144141e390-4286	\N	NEW	\N	\N	\N	\N
84109	79	D5170C00002/tiny.path.1/file-2719.pdf	\N	D5170C00002-0742b2b8-8317-11eb-be00-6bb6089d8f24-2719	\N	NEW	\N	\N	\N	\N
87050	79	D5170C00002/tiny.path.1/file-5660.pdf	\N	D5170C00002-0743b1b5-8319-11eb-be00-059c1b869a60-5660	\N	NEW	\N	\N	\N	\N
85677	79	D5170C00002/tiny.path.1/file-4287.pdf	\N	D5170C00002-07450758-8318-11eb-be00-976191c7ef43-4287	\N	NEW	\N	\N	\N	\N
85678	79	D5170C00002/tiny.path.1/file-4288.pdf	\N	D5170C00002-076141e9-8318-11eb-be00-5b35a6d3e5f7-4288	\N	NEW	\N	\N	\N	\N
84110	79	D5170C00002/tiny.path.1/file-2720.pdf	\N	D5170C00002-07729c59-8317-11eb-be00-239205270446-2720	\N	NEW	\N	\N	\N	\N
85679	79	D5170C00002/tiny.path.1/file-4289.pdf	\N	D5170C00002-078e455a-8318-11eb-be00-295ebd837312-4289	\N	NEW	\N	\N	\N	\N
87051	79	D5170C00002/tiny.path.1/file-5661.pdf	\N	D5170C00002-079ef116-8319-11eb-be00-ad4f8b51a043-5661	\N	NEW	\N	\N	\N	\N
84111	79	D5170C00002/tiny.path.1/file-2721.pdf	\N	D5170C00002-07ad0d4a-8317-11eb-be00-470ee358bc6e-2721	\N	NEW	\N	\N	\N	\N
82721	79	D5170C00002/tiny.path.1/file-1331.pdf	\N	D5170C00002-07aed70c-8316-11eb-be00-fbb6b138480b-1331	\N	NEW	\N	\N	\N	\N
85680	79	D5170C00002/tiny.path.1/file-4290.msg	\N	D5170C00002-07afb00b-8318-11eb-be00-af14463421cb-4290	\N	NEW	\N	\N	\N	\N
84112	79	D5170C00002/tiny.path.1/file-2722.pdf	\N	D5170C00002-07bf35bb-8317-11eb-be00-170f47bb0a99-2722	\N	NEW	\N	\N	\N	\N
85681	79	D5170C00002/tiny.path.1/file-4291.msg	\N	D5170C00002-07cdbf5c-8318-11eb-be00-03b78ae548a1-4291	\N	NEW	\N	\N	\N	\N
85682	79	D5170C00002/tiny.path.1/file-4292.msg	\N	D5170C00002-07eb326d-8318-11eb-be00-cfc0b27ef92a-4292	\N	NEW	\N	\N	\N	\N
84113	79	D5170C00002/tiny.path.1/file-2723.pdf	\N	D5170C00002-07f9317c-8317-11eb-be00-8189c19cad64-2723	\N	NEW	\N	\N	\N	\N
84114	79	D5170C00002/tiny.path.1/file-2724.pdf	\N	D5170C00002-07fb545d-8317-11eb-be00-7545295f5605-2724	\N	NEW	\N	\N	\N	\N
87052	79	D5170C00002/tiny.path.1/file-5662.pdf	\N	D5170C00002-08086147-8319-11eb-be00-95acb28a5c8c-5662	\N	NEW	\N	\N	\N	\N
85683	79	D5170C00002/tiny.path.1/file-4293.msg	\N	D5170C00002-08098fde-8318-11eb-be00-01f36eeb4f57-4293	\N	NEW	\N	\N	\N	\N
84115	79	D5170C00002/tiny.path.1/file-2725.pdf	\N	D5170C00002-0809ac3e-8317-11eb-be00-cb3bf32a5314-2725	\N	NEW	\N	\N	\N	\N
84116	79	D5170C00002/tiny.path.1/file-2726.pdf	\N	D5170C00002-0818794f-8317-11eb-be00-05c8ca71c1b6-2726	\N	NEW	\N	\N	\N	\N
82722	79	D5170C00002/tiny.path.1/file-1332.msg	\N	D5170C00002-0819f4ed-8316-11eb-be00-ddaa08c36bcd-1332	\N	NEW	\N	\N	\N	\N
85684	79	D5170C00002/tiny.path.1/file-4294.msg	\N	D5170C00002-0828d7af-8318-11eb-be00-9163cfe1096b-4294	\N	NEW	\N	\N	\N	\N
84117	79	D5170C00002/tiny.path.1/file-2727.pdf	\N	D5170C00002-0837c120-8317-11eb-be00-37133881c5bc-2727	\N	NEW	\N	\N	\N	\N
87053	79	D5170C00002/tiny.path.1/file-5663.pdf	\N	D5170C00002-083871f8-8319-11eb-be00-2758e0a16ac3-5663	\N	NEW	\N	\N	\N	\N
85685	79	D5170C00002/tiny.path.1/file-4295.msg	\N	D5170C00002-08458770-8318-11eb-be00-53f0fa692fd8-4295	\N	NEW	\N	\N	\N	\N
84118	79	D5170C00002/tiny.path.1/file-2728.pdf	\N	D5170C00002-0854bf01-8317-11eb-be00-b30b4e571d9e-2728	\N	NEW	\N	\N	\N	\N
82723	79	D5170C00002/tiny.path.1/file-1333.msg	\N	D5170C00002-0856d6de-8316-11eb-be00-931977567200-1333	\N	NEW	\N	\N	\N	\N
85686	79	D5170C00002/tiny.path.1/file-4296.msg	\N	D5170C00002-08645a11-8318-11eb-be00-b90333712306-4296	\N	NEW	\N	\N	\N	\N
87054	79	D5170C00002/tiny.path.1/file-5664.pdf	\N	D5170C00002-08733109-8319-11eb-be00-a70a5f2985b8-5664	\N	NEW	\N	\N	\N	\N
84119	79	D5170C00002/tiny.path.1/file-2729.pdf	\N	D5170C00002-0882acd2-8317-11eb-be00-ede4ea7201b2-2729	\N	NEW	\N	\N	\N	\N
82724	79	D5170C00002/tiny.path.1/file-1334.msg	\N	D5170C00002-088587ff-8316-11eb-be00-11039de149c5-1334	\N	NEW	\N	\N	\N	\N
85687	79	D5170C00002/tiny.path.1/file-4297.pdf	\N	D5170C00002-08a22662-8318-11eb-be00-2d742baaefb4-4297	\N	NEW	\N	\N	\N	\N
84120	79	D5170C00002/tiny.path.1/file-2730.pdf	\N	D5170C00002-08a41783-8317-11eb-be00-e7690e69f594-2730	\N	NEW	\N	\N	\N	\N
85688	79	D5170C00002/tiny.path.1/file-4298.pdf	\N	D5170C00002-08c27fa3-8318-11eb-be00-e34679ca8a6a-4298	\N	NEW	\N	\N	\N	\N
82725	79	D5170C00002/tiny.path.1/file-1335.msg	\N	D5170C00002-08d15e10-8316-11eb-be00-4dc566e7c370-1335	\N	NEW	\N	\N	\N	\N
84121	79	D5170C00002/tiny.path.1/file-2731.pdf	\N	D5170C00002-08de1344-8317-11eb-be00-3b3ce09a8282-2731	\N	NEW	\N	\N	\N	\N
85689	79	D5170C00002/tiny.path.1/file-4299.pdf	\N	D5170C00002-08e0dd14-8318-11eb-be00-678c633409bb-4299	\N	NEW	\N	\N	\N	\N
87055	79	D5170C00002/tiny.path.1/file-5665.pdf	\N	D5170C00002-08fc854a-8319-11eb-be00-f1adf7bc142e-5665	\N	NEW	\N	\N	\N	\N
82726	79	D5170C00002/tiny.path.1/file-1336.msg	\N	D5170C00002-08fd2901-8316-11eb-be00-c19c93acd799-1336	\N	NEW	\N	\N	\N	\N
82727	79	D5170C00002/tiny.path.1/file-1337.msg	\N	D5170C00002-091f2ff2-8316-11eb-be00-053953d40d3b-1337	\N	NEW	\N	\N	\N	\N
82728	79	D5170C00002/tiny.path.1/file-1338.msg	\N	D5170C00002-093cf123-8316-11eb-be00-312e997e2651-1338	\N	NEW	\N	\N	\N	\N
85690	79	D5170C00002/tiny.path.1/file-4300.pdf	\N	D5170C00002-09587e15-8318-11eb-be00-8b7cc79f9809-4300	\N	NEW	\N	\N	\N	\N
82729	79	D5170C00002/tiny.path.1/file-1339.msg	\N	D5170C00002-09689504-8316-11eb-be00-0532f851e62d-1339	\N	NEW	\N	\N	\N	\N
87056	79	D5170C00002/tiny.path.1/file-5666.pdf	\N	D5170C00002-096950db-8319-11eb-be00-97f5600ad58c-5666	\N	NEW	\N	\N	\N	\N
85691	79	D5170C00002/tiny.path.1/file-4301.pdf	\N	D5170C00002-0969e336-8318-11eb-be00-5531a32ef30c-4301	\N	NEW	\N	\N	\N	\N
84122	79	D5170C00002/tiny.path.1/file-2732.pdf	\N	D5170C00002-09776d15-8317-11eb-be00-c77e038c5ea8-2732	\N	NEW	\N	\N	\N	\N
85692	79	D5170C00002/tiny.path.1/file-4302.pdf	\N	D5170C00002-09794c87-8318-11eb-be00-7be213855000-4302	\N	NEW	\N	\N	\N	\N
84123	79	D5170C00002/tiny.path.1/file-2733.pdf	\N	D5170C00002-098835f6-8317-11eb-be00-47b30cc09c1a-2733	\N	NEW	\N	\N	\N	\N
87057	79	D5170C00002/tiny.path.1/file-5667.pdf	\N	D5170C00002-0996a26c-8319-11eb-be00-d3f858ee6ee7-5667	\N	NEW	\N	\N	\N	\N
82730	79	D5170C00002/tiny.path.1/file-1340.msg	\N	D5170C00002-09a61335-8316-11eb-be00-e1f465c95d70-1340	\N	NEW	\N	\N	\N	\N
85693	79	D5170C00002/tiny.path.1/file-4303.pdf	\N	D5170C00002-09a64ff8-8318-11eb-be00-630ee3d6de4d-4303	\N	NEW	\N	\N	\N	\N
82731	79	D5170C00002/tiny.path.1/file-1341.msg	\N	D5170C00002-09c35f36-8316-11eb-be00-f996d8ea72e2-1341	\N	NEW	\N	\N	\N	\N
84124	79	D5170C00002/tiny.path.1/file-2734.pdf	\N	D5170C00002-09d48137-8317-11eb-be00-7b426f462c52-2734	\N	NEW	\N	\N	\N	\N
87058	79	D5170C00002/tiny.path.1/file-5668.pdf	\N	D5170C00002-09e18e1d-8319-11eb-be00-b7801cbbcc33-5668	\N	NEW	\N	\N	\N	\N
85694	79	D5170C00002/tiny.path.1/file-4304.pdf	\N	D5170C00002-09e1d259-8318-11eb-be00-3924dcc99f8f-4304	\N	NEW	\N	\N	\N	\N
82732	79	D5170C00002/tiny.path.1/file-1342.msg	\N	D5170C00002-0a026407-8316-11eb-be00-8527a69aa43e-1342	\N	NEW	\N	\N	\N	\N
85695	79	D5170C00002/tiny.path.1/file-4305.pdf	\N	D5170C00002-0a0fe73a-8318-11eb-be00-b15ed1b7a604-4305	\N	NEW	\N	\N	\N	\N
85696	79	D5170C00002/tiny.path.1/file-4306.pdf	\N	D5170C00002-0a116ddb-8318-11eb-be00-e71a403fc0bf-4306	\N	NEW	\N	\N	\N	\N
87059	79	D5170C00002/tiny.path.1/file-5669.pdf	\N	D5170C00002-0a1ebe2e-8319-11eb-be00-3bf55009aae3-5669	\N	NEW	\N	\N	\N	\N
85697	79	D5170C00002/tiny.path.1/file-4307.pdf	\N	D5170C00002-0a20b01c-8318-11eb-be00-a3514032f8a9-4307	\N	NEW	\N	\N	\N	\N
85698	79	D5170C00002/tiny.path.1/file-4308.pdf	\N	D5170C00002-0a2da86d-8318-11eb-be00-57f612927ca6-4308	\N	NEW	\N	\N	\N	\N
85699	79	D5170C00002/tiny.path.1/file-4309.pdf	\N	D5170C00002-0a3e232e-8318-11eb-be00-8550c2e6e152-4309	\N	NEW	\N	\N	\N	\N
85700	79	D5170C00002/tiny.path.1/file-4310.pdf	\N	D5170C00002-0a3fd0df-8318-11eb-be00-d7f135bf666f-4310	\N	NEW	\N	\N	\N	\N
87060	79	D5170C00002/tiny.path.1/file-5670.pdf	\N	D5170C00002-0a4de47f-8319-11eb-be00-7d8be0ddaaef-5670	\N	NEW	\N	\N	\N	\N
82733	79	D5170C00002/tiny.path.1/file-1343.msg	\N	D5170C00002-0a5c91f8-8316-11eb-be00-2f27555eba54-1343	\N	NEW	\N	\N	\N	\N
85701	79	D5170C00002/tiny.path.1/file-4311.pdf	\N	D5170C00002-0a5e0640-8318-11eb-be00-7bf9bcaf23d7-4311	\N	NEW	\N	\N	\N	\N
85702	79	D5170C00002/tiny.path.1/file-4312.pdf	\N	D5170C00002-0a7c1591-8318-11eb-be00-6948e93dc9e1-4312	\N	NEW	\N	\N	\N	\N
84125	79	D5170C00002/tiny.path.1/file-2735.pdf	\N	D5170C00002-0a7c8108-8317-11eb-be00-2335f19c2714-2735	\N	NEW	\N	\N	\N	\N
85703	79	D5170C00002/tiny.path.1/file-4313.pdf	\N	D5170C00002-0a7cd8e2-8318-11eb-be00-a16f8786419f-4313	\N	NEW	\N	\N	\N	\N
85704	79	D5170C00002/tiny.path.1/file-4314.pdf	\N	D5170C00002-0a8a4663-8318-11eb-be00-6d461e3ece8f-4314	\N	NEW	\N	\N	\N	\N
87061	79	D5170C00002/tiny.path.1/file-5671.pdf	\N	D5170C00002-0a98a920-8319-11eb-be00-7374f92e45fb-5671	\N	NEW	\N	\N	\N	\N
85705	79	D5170C00002/tiny.path.1/file-4315.pdf	\N	D5170C00002-0a9988a4-8318-11eb-be00-4b19ccdf0d7d-4315	\N	NEW	\N	\N	\N	\N
85706	79	D5170C00002/tiny.path.1/file-4316.pdf	\N	D5170C00002-0aa8f1f5-8318-11eb-be00-f79d11893d9a-4316	\N	NEW	\N	\N	\N	\N
82734	79	D5170C00002/tiny.path.1/file-1344.msg	\N	D5170C00002-0aa95269-8316-11eb-be00-a1252bb42728-1344	\N	NEW	\N	\N	\N	\N
84126	79	D5170C00002/tiny.path.1/file-2736.pdf	\N	D5170C00002-0ac85719-8317-11eb-be00-47b12862a5c8-2736	\N	NEW	\N	\N	\N	\N
87062	79	D5170C00002/tiny.path.1/file-5672.pdf	\N	D5170C00002-0ad5b221-8319-11eb-be00-39ce4ab1e14a-5672	\N	NEW	\N	\N	\N	\N
82735	79	D5170C00002/tiny.path.1/file-1345.msg	\N	D5170C00002-0ad5e0aa-8316-11eb-be00-9f86b1f1fa43-1345	\N	NEW	\N	\N	\N	\N
85707	79	D5170C00002/tiny.path.1/file-4317.pdf	\N	D5170C00002-0ae55eb6-8318-11eb-be00-259783d90986-4317	\N	NEW	\N	\N	\N	\N
84127	79	D5170C00002/tiny.path.1/file-2737.pdf	\N	D5170C00002-0b131bba-8317-11eb-be00-990203d9a15e-2737	\N	NEW	\N	\N	\N	\N
85708	79	D5170C00002/tiny.path.1/file-4318.pdf	\N	D5170C00002-0b132577-8318-11eb-be00-cf5cf99e2b6c-4318	\N	NEW	\N	\N	\N	\N
82736	79	D5170C00002/tiny.path.1/file-1346.msg	\N	D5170C00002-0b15a8cb-8316-11eb-be00-ff563ebfcc52-1346	\N	NEW	\N	\N	\N	\N
87063	79	D5170C00002/tiny.path.1/file-5673.pdf	\N	D5170C00002-0b227292-8319-11eb-be00-e7b8c99870d2-5673	\N	NEW	\N	\N	\N	\N
85709	79	D5170C00002/tiny.path.1/file-4319.pdf	\N	D5170C00002-0b24b1a8-8318-11eb-be00-238289c2acb1-4319	\N	NEW	\N	\N	\N	\N
84128	79	D5170C00002/tiny.path.1/file-2738.pdf	\N	D5170C00002-0b40bb6b-8317-11eb-be00-0b1c80c4f3dd-2738	\N	NEW	\N	\N	\N	\N
82737	79	D5170C00002/tiny.path.1/file-1347.msg	\N	D5170C00002-0b5067dc-8316-11eb-be00-bdf02ae0c623-1347	\N	NEW	\N	\N	\N	\N
87064	79	D5170C00002/tiny.path.1/file-5674.pdf	\N	D5170C00002-0b520e13-8319-11eb-be00-5f28fd5a4895-5674	\N	NEW	\N	\N	\N	\N
87065	79	D5170C00002/tiny.path.1/file-5675.pdf	\N	D5170C00002-0b6e96c4-8319-11eb-be00-874300f20ef0-5675	\N	NEW	\N	\N	\N	\N
82738	79	D5170C00002/tiny.path.1/file-1348.msg	\N	D5170C00002-0b6eec5d-8316-11eb-be00-b12e62418485-1348	\N	NEW	\N	\N	\N	\N
84129	79	D5170C00002/tiny.path.1/file-2739.pdf	\N	D5170C00002-0b7056ec-8317-11eb-be00-91250bc1fa92-2739	\N	NEW	\N	\N	\N	\N
85710	79	D5170C00002/tiny.path.1/file-4320.pdf	\N	D5170C00002-0b7123f9-8318-11eb-be00-73fe11d78c3e-4320	\N	NEW	\N	\N	\N	\N
85711	79	D5170C00002/tiny.path.1/file-4321.pdf	\N	D5170C00002-0b9c2b9a-8318-11eb-be00-a7bee849ab22-4321	\N	NEW	\N	\N	\N	\N
87066	79	D5170C00002/tiny.path.1/file-5676.pdf	\N	D5170C00002-0b9c8495-8319-11eb-be00-8f51d780d121-5676	\N	NEW	\N	\N	\N	\N
82739	79	D5170C00002/tiny.path.1/file-1349.msg	\N	D5170C00002-0b9d284e-8316-11eb-be00-b11ce781ea3d-1349	\N	NEW	\N	\N	\N	\N
84130	79	D5170C00002/tiny.path.1/file-2740.pdf	\N	D5170C00002-0b9e1dad-8317-11eb-be00-27349ca192f6-2740	\N	NEW	\N	\N	\N	\N
87067	79	D5170C00002/tiny.path.1/file-5677.pdf	\N	D5170C00002-0bad9b96-8319-11eb-be00-8b1dec3cd1e3-5677	\N	NEW	\N	\N	\N	\N
82740	79	D5170C00002/tiny.path.1/file-1350.msg	\N	D5170C00002-0bcc007f-8316-11eb-be00-b3edd7d9cbb9-1350	\N	NEW	\N	\N	\N	\N
87068	79	D5170C00002/tiny.path.1/file-5678.pdf	\N	D5170C00002-0be8a8c7-8319-11eb-be00-29beb53b4464-5678	\N	NEW	\N	\N	\N	\N
84131	79	D5170C00002/tiny.path.1/file-2741.pdf	\N	D5170C00002-0bf95d0e-8317-11eb-be00-cf9948073ee2-2741	\N	NEW	\N	\N	\N	\N
87069	79	D5170C00002/tiny.path.1/file-5679.pdf	\N	D5170C00002-0c070638-8319-11eb-be00-b7f80c618a3d-5679	\N	NEW	\N	\N	\N	\N
87070	79	D5170C00002/tiny.path.1/file-5680.pdf	\N	D5170C00002-0c17cf19-8319-11eb-be00-c9545f9e2e4f-5680	\N	NEW	\N	\N	\N	\N
85712	79	D5170C00002/tiny.path.1/file-4322.pdf	\N	D5170C00002-0c18ae9b-8318-11eb-be00-cf3206994cb4-4322	\N	NEW	\N	\N	\N	\N
87071	79	D5170C00002/tiny.path.1/file-5681.pdf	\N	D5170C00002-0c26c33a-8319-11eb-be00-75c293b5d91e-5681	\N	NEW	\N	\N	\N	\N
84132	79	D5170C00002/tiny.path.1/file-2742.pdf	\N	D5170C00002-0c2723cf-8317-11eb-be00-2390f0a3f057-2742	\N	NEW	\N	\N	\N	\N
82741	79	D5170C00002/tiny.path.1/file-1351.msg	\N	D5170C00002-0c3549a0-8316-11eb-be00-3588805b7f64-1351	\N	NEW	\N	\N	\N	\N
87072	79	D5170C00002/tiny.path.1/file-5682.pdf	\N	D5170C00002-0c362c8b-8319-11eb-be00-398dd8ef822d-5682	\N	NEW	\N	\N	\N	\N
87073	79	D5170C00002/tiny.path.1/file-5683.pdf	\N	D5170C00002-0c53edbc-8319-11eb-be00-f138c3c67369-5683	\N	NEW	\N	\N	\N	\N
84133	79	D5170C00002/tiny.path.1/file-2743.pdf	\N	D5170C00002-0c549c70-8317-11eb-be00-ab81c1cb3a85-2743	\N	NEW	\N	\N	\N	\N
87074	79	D5170C00002/tiny.path.1/file-5684.pdf	\N	D5170C00002-0c71aeed-8319-11eb-be00-f361f86de7c3-5684	\N	NEW	\N	\N	\N	\N
82742	79	D5170C00002/tiny.path.1/file-1352.msg	\N	D5170C00002-0c7315f1-8316-11eb-be00-5f02a7c37832-1352	\N	NEW	\N	\N	\N	\N
87075	79	D5170C00002/tiny.path.1/file-5685.pdf	\N	D5170C00002-0c905a7e-8319-11eb-be00-eba53a390f12-5685	\N	NEW	\N	\N	\N	\N
84134	79	D5170C00002/tiny.path.1/file-2744.pdf	\N	D5170C00002-0c909401-8317-11eb-be00-93c93a8a0750-2744	\N	NEW	\N	\N	\N	\N
85713	79	D5170C00002/tiny.path.1/file-4323.pdf	\N	D5170C00002-0c9139fc-8318-11eb-be00-6796c7205ef8-4323	\N	NEW	\N	\N	\N	\N
87076	79	D5170C00002/tiny.path.1/file-5686.pdf	\N	D5170C00002-0c916bef-8319-11eb-be00-ed4a9a634dd1-5686	\N	NEW	\N	\N	\N	\N
87077	79	D5170C00002/tiny.path.1/file-5687.pdf	\N	D5170C00002-0c92a470-8319-11eb-be00-5f1a46edbe8d-5687	\N	NEW	\N	\N	\N	\N
87078	79	D5170C00002/tiny.path.1/file-5688.pdf	\N	D5170C00002-0ca12361-8319-11eb-be00-efcbcb460005-5688	\N	NEW	\N	\N	\N	\N
84135	79	D5170C00002/tiny.path.1/file-2745.pdf	\N	D5170C00002-0ca1d212-8317-11eb-be00-a5d890b9edbb-2745	\N	NEW	\N	\N	\N	\N
82743	79	D5170C00002/tiny.path.1/file-1353.msg	\N	D5170C00002-0ca26352-8316-11eb-be00-03814c7c15df-1353	\N	NEW	\N	\N	\N	\N
87079	79	D5170C00002/tiny.path.1/file-5689.pdf	\N	D5170C00002-0caf2d22-8319-11eb-be00-b5587588a5f0-5689	\N	NEW	\N	\N	\N	\N
84136	79	D5170C00002/tiny.path.1/file-2746.pdf	\N	D5170C00002-0cc0a4b3-8317-11eb-be00-d5e4f1e44811-2746	\N	NEW	\N	\N	\N	\N
87080	79	D5170C00002/tiny.path.1/file-5690.pdf	\N	D5170C00002-0ccd3c73-8319-11eb-be00-13e80ea75893-5690	\N	NEW	\N	\N	\N	\N
85714	79	D5170C00002/tiny.path.1/file-4324.pdf	\N	D5170C00002-0ccdcdcd-8318-11eb-be00-537698ea34b5-4324	\N	NEW	\N	\N	\N	\N
82744	79	D5170C00002/tiny.path.1/file-1354.msg	\N	D5170C00002-0cdef723-8316-11eb-be00-91a66d2e7bf3-1354	\N	NEW	\N	\N	\N	\N
84137	79	D5170C00002/tiny.path.1/file-2747.pdf	\N	D5170C00002-0ceeb994-8317-11eb-be00-75c5f7eea787-2747	\N	NEW	\N	\N	\N	\N
82745	79	D5170C00002/tiny.path.1/file-1355.msg	\N	D5170C00002-0cfb58c4-8316-11eb-be00-7bf33fe5cc4e-1355	\N	NEW	\N	\N	\N	\N
87081	79	D5170C00002/tiny.path.1/file-5691.pdf	\N	D5170C00002-0d1c94f4-8319-11eb-be00-8dabc1887d00-5691	\N	NEW	\N	\N	\N	\N
85715	79	D5170C00002/tiny.path.1/file-4325.pdf	\N	D5170C00002-0d2ba53e-8318-11eb-be00-158c6edc5eb7-4325	\N	NEW	\N	\N	\N	\N
84138	79	D5170C00002/tiny.path.1/file-2748.pdf	\N	D5170C00002-0d38e1f5-8317-11eb-be00-57c4528e1054-2748	\N	NEW	\N	\N	\N	\N
82746	79	D5170C00002/tiny.path.1/file-1356.pdf	\N	D5170C00002-0d3b20e5-8316-11eb-be00-697055a70aa8-1356	\N	NEW	\N	\N	\N	\N
84139	79	D5170C00002/tiny.path.1/file-2749.pdf	\N	D5170C00002-0d57b496-8317-11eb-be00-23974b58d3d2-2749	\N	NEW	\N	\N	\N	\N
82747	79	D5170C00002/tiny.path.1/file-1357.pdf	\N	D5170C00002-0d690eb6-8316-11eb-be00-bf81cea36caf-1357	\N	NEW	\N	\N	\N	\N
84140	79	D5170C00002/tiny.path.1/file-2750.pdf	\N	D5170C00002-0d93fa47-8317-11eb-be00-813deef72e1a-2750	\N	NEW	\N	\N	\N	\N
82748	79	D5170C00002/tiny.path.1/file-1358.pdf	\N	D5170C00002-0d94d9a7-8316-11eb-be00-6f7ef73eb43a-1358	\N	NEW	\N	\N	\N	\N
85716	79	D5170C00002/tiny.path.1/file-4326.pdf	\N	D5170C00002-0db2af8f-8318-11eb-be00-57fb8348699a-4326	\N	NEW	\N	\N	\N	\N
82749	79	D5170C00002/tiny.path.1/file-1359.pdf	\N	D5170C00002-0db4bdb8-8316-11eb-be00-9b4d3956f1a1-1359	\N	NEW	\N	\N	\N	\N
87082	79	D5170C00002/tiny.path.1/file-5692.pdf	\N	D5170C00002-0dc1d5a5-8319-11eb-be00-032c5b9a7724-5692	\N	NEW	\N	\N	\N	\N
84141	79	D5170C00002/tiny.path.1/file-2751.pdf	\N	D5170C00002-0dd19f88-8317-11eb-be00-dfbde5d296de-2751	\N	NEW	\N	\N	\N	\N
85717	79	D5170C00002/tiny.path.1/file-4327.pdf	\N	D5170C00002-0defb890-8318-11eb-be00-c78c9ee99025-4327	\N	NEW	\N	\N	\N	\N
87083	79	D5170C00002/tiny.path.1/file-5693.pdf	\N	D5170C00002-0df23476-8319-11eb-be00-fd6b1824122a-5693	\N	NEW	\N	\N	\N	\N
84142	79	D5170C00002/tiny.path.1/file-2752.pdf	\N	D5170C00002-0e1deac9-8317-11eb-be00-c774bb45cb06-2752	\N	NEW	\N	\N	\N	\N
87084	79	D5170C00002/tiny.path.1/file-5694.pdf	\N	D5170C00002-0e3b4b67-8319-11eb-be00-df6fa5386146-5694	\N	NEW	\N	\N	\N	\N
84143	79	D5170C00002/tiny.path.1/file-2753.pdf	\N	D5170C00002-0e7c5e7a-8317-11eb-be00-5f29633aa471-2753	\N	NEW	\N	\N	\N	\N
82750	79	D5170C00002/tiny.path.1/file-1360.pdf	\N	D5170C00002-0e894bc9-8316-11eb-be00-29e27c8a830b-1360	\N	NEW	\N	\N	\N	\N
87085	79	D5170C00002/tiny.path.1/file-5695.pdf	\N	D5170C00002-0e983878-8319-11eb-be00-2909e05a420a-5695	\N	NEW	\N	\N	\N	\N
87086	79	D5170C00002/tiny.path.1/file-5696.pdf	\N	D5170C00002-0ea6de79-8319-11eb-be00-13d122ad2733-5696	\N	NEW	\N	\N	\N	\N
84144	79	D5170C00002/tiny.path.1/file-2754.pdf	\N	D5170C00002-0eb71d8b-8317-11eb-be00-ab3785145314-2754	\N	NEW	\N	\N	\N	\N
87087	79	D5170C00002/tiny.path.1/file-5697.pdf	\N	D5170C00002-0ed4a53a-8319-11eb-be00-0f0c33da7048-5697	\N	NEW	\N	\N	\N	\N
84145	79	D5170C00002/tiny.path.1/file-2755.pdf	\N	D5170C00002-0ed6655c-8317-11eb-be00-69dda5819874-2755	\N	NEW	\N	\N	\N	\N
85718	79	D5170C00002/tiny.path.1/file-4328.xlsx	\N	D5170C00002-0ee58a41-8318-11eb-be00-c921350bd88e-4328	\N	NEW	\N	\N	\N	\N
82751	79	D5170C00002/tiny.path.1/file-1361.pdf	\N	D5170C00002-0ef505ea-8316-11eb-be00-3551c2dc4959-1361	\N	NEW	\N	\N	\N	\N
87088	79	D5170C00002/tiny.path.1/file-5698.pdf	\N	D5170C00002-0f0467cb-8319-11eb-be00-e5256b1c7ab5-5698	\N	NEW	\N	\N	\N	\N
85719	79	D5170C00002/tiny.path.1/file-4329.xlsx	\N	D5170C00002-0f117c42-8318-11eb-be00-412711997add-4329	\N	NEW	\N	\N	\N	\N
82752	79	D5170C00002/tiny.path.1/file-1362.pdf	\N	D5170C00002-0f13153b-8316-11eb-be00-6586e92a71b2-1362	\N	NEW	\N	\N	\N	\N
84146	79	D5170C00002/tiny.path.1/file-2756.pdf	\N	D5170C00002-0f14a6dd-8317-11eb-be00-0d3a93b13183-2756	\N	NEW	\N	\N	\N	\N
87089	79	D5170C00002/tiny.path.1/file-5699.pdf	\N	D5170C00002-0f2f6f6c-8319-11eb-be00-45129488855e-5699	\N	NEW	\N	\N	\N	\N
84147	79	D5170C00002/tiny.path.1/file-2757.pdf	\N	D5170C00002-0f31569e-8317-11eb-be00-9d85800076c8-2757	\N	NEW	\N	\N	\N	\N
84148	79	D5170C00002/tiny.path.1/file-2758.pdf	\N	D5170C00002-0f4f65ef-8317-11eb-be00-8bf0ff229938-2758	\N	NEW	\N	\N	\N	\N
87090	79	D5170C00002/tiny.path.1/file-5700.pdf	\N	D5170C00002-0f5016cd-8319-11eb-be00-c95f87b88fa6-5700	\N	NEW	\N	\N	\N	\N
84149	79	D5170C00002/tiny.path.1/file-2759.pdf	\N	D5170C00002-0f6e86b0-8317-11eb-be00-0f19fb7afdeb-2759	\N	NEW	\N	\N	\N	\N
87091	79	D5170C00002/tiny.path.1/file-5701.pdf	\N	D5170C00002-0f8c0e5e-8319-11eb-be00-17b996567e5e-5701	\N	NEW	\N	\N	\N	\N
84150	79	D5170C00002/tiny.path.1/file-2760.pdf	\N	D5170C00002-0f9d5ee1-8317-11eb-be00-6704fa07b3ba-2760	\N	NEW	\N	\N	\N	\N
84151	79	D5170C00002/tiny.path.1/file-2761.pdf	\N	D5170C00002-0fb92442-8317-11eb-be00-97164f25a4e7-2761	\N	NEW	\N	\N	\N	\N
84152	79	D5170C00002/tiny.path.1/file-2762.pdf	\N	D5170C00002-0fc8b4a3-8317-11eb-be00-1d6f3cedb522-2762	\N	NEW	\N	\N	\N	\N
85720	79	D5170C00002/tiny.path.1/file-4330.pdf	\N	D5170C00002-0fc9a8b3-8318-11eb-be00-e739f26cc43c-4330	\N	NEW	\N	\N	\N	\N
82753	79	D5170C00002/tiny.path.1/file-1363.pdf	\N	D5170C00002-0fca303c-8316-11eb-be00-2b2df3688dd2-1363	\N	NEW	\N	\N	\N	\N
84153	79	D5170C00002/tiny.path.1/file-2763.pdf	\N	D5170C00002-0fcb73c4-8317-11eb-be00-cdbdf8772954-2763	\N	NEW	\N	\N	\N	\N
87092	79	D5170C00002/tiny.path.1/file-5702.pdf	\N	D5170C00002-0fd76f3f-8319-11eb-be00-cb8ed0c5a293-5702	\N	NEW	\N	\N	\N	\N
85721	79	D5170C00002/tiny.path.1/file-4331.pdf	\N	D5170C00002-0fe6a694-8318-11eb-be00-b541adba2c7e-4331	\N	NEW	\N	\N	\N	\N
84154	79	D5170C00002/tiny.path.1/file-2764.pdf	\N	D5170C00002-0fe7fc75-8317-11eb-be00-95d2c5f1c9e9-2764	\N	NEW	\N	\N	\N	\N
87093	79	D5170C00002/tiny.path.1/file-5703.pdf	\N	D5170C00002-0fe8ad50-8319-11eb-be00-dbd2c83f2f08-5703	\N	NEW	\N	\N	\N	\N
85722	79	D5170C00002/tiny.path.1/file-4332.pdf	\N	D5170C00002-0ff6d335-8318-11eb-be00-ab19423bc41e-4332	\N	NEW	\N	\N	\N	\N
82754	79	D5170C00002/tiny.path.1/file-1364.pdf	\N	D5170C00002-0ff9086d-8316-11eb-be00-255ae24d08ec-1364	\N	NEW	\N	\N	\N	\N
87094	79	D5170C00002/tiny.path.1/file-5704.pdf	\N	D5170C00002-1005d241-8319-11eb-be00-cdfb77bebdb0-5704	\N	NEW	\N	\N	\N	\N
85723	79	D5170C00002/tiny.path.1/file-4333.pdf	\N	D5170C00002-10068aa6-8318-11eb-be00-9102d79d6598-4333	\N	NEW	\N	\N	\N	\N
84155	79	D5170C00002/tiny.path.1/file-2765.pdf	\N	D5170C00002-10154e06-8317-11eb-be00-5b36fe167d6b-2765	\N	NEW	\N	\N	\N	\N
84156	79	D5170C00002/tiny.path.1/file-2766.pdf	\N	D5170C00002-1025c8c7-8317-11eb-be00-1bcb74f7fdad-2766	\N	NEW	\N	\N	\N	\N
87101	79	D5170C00002/tiny.path.1/file-5711.pdf	\N	D5170C00002-103323d2-8319-11eb-be00-57081aab00f3-5705	\N	NEW	\N	\N	\N	\N
85724	79	D5170C00002/tiny.path.1/file-4334.pdf	\N	D5170C00002-10342a57-8318-11eb-be00-6144070d7072-4334	\N	NEW	\N	\N	\N	\N
87102	79	D5170C00002/tiny.path.1/file-5712.pdf	\N	D5170C00002-104413c3-8319-11eb-be00-a136873a51f4-5706	\N	NEW	\N	\N	\N	\N
82755	79	D5170C00002/tiny.path.1/file-1365.pdf	\N	D5170C00002-105224ee-8316-11eb-be00-7fde6be34123-1365	\N	NEW	\N	\N	\N	\N
85725	79	D5170C00002/tiny.path.1/file-4335.pdf	\N	D5170C00002-10534b18-8318-11eb-be00-bdbc26a8fc14-4335	\N	NEW	\N	\N	\N	\N
84157	79	D5170C00002/tiny.path.1/file-2767.pdf	\N	D5170C00002-1054c808-8317-11eb-be00-b901f9e880d5-2767	\N	NEW	\N	\N	\N	\N
85726	79	D5170C00002/tiny.path.1/file-4336.pdf	\N	D5170C00002-105546e9-8318-11eb-be00-0fe65c474fd0-4336	\N	NEW	\N	\N	\N	\N
84158	79	D5170C00002/tiny.path.1/file-2768.pdf	\N	D5170C00002-1062aab9-8317-11eb-be00-c93348e9cc39-2768	\N	NEW	\N	\N	\N	\N
85727	79	D5170C00002/tiny.path.1/file-4337.pdf	\N	D5170C00002-1071cf9a-8318-11eb-be00-cba5789ba4a5-4337	\N	NEW	\N	\N	\N	\N
87095	79	D5170C00002/tiny.path.1/file-5705.pdf	\N	D5170C00002-10805974-8319-11eb-be00-b948d9d7eae4-5707	\N	NEW	\N	\N	\N	\N
84159	79	D5170C00002/tiny.path.1/file-2769.pdf	\N	D5170C00002-10904a6a-8317-11eb-be00-e73136bcdf53-2769	\N	NEW	\N	\N	\N	\N
85728	79	D5170C00002/tiny.path.1/file-4338.pdf	\N	D5170C00002-109201cb-8318-11eb-be00-49a4613a0362-4338	\N	NEW	\N	\N	\N	\N
87096	79	D5170C00002/tiny.path.1/file-5706.pdf	\N	D5170C00002-109e1aa5-8319-11eb-be00-d3164321bd44-5708	\N	NEW	\N	\N	\N	\N
87097	79	D5170C00002/tiny.path.1/file-5707.pdf	\N	D5170C00002-109fc856-8319-11eb-be00-fda14a3ffe5b-5709	\N	NEW	\N	\N	\N	\N
84160	79	D5170C00002/tiny.path.1/file-2770.pdf	\N	D5170C00002-10ae32ab-8317-11eb-be00-df52e0898cac-2770	\N	NEW	\N	\N	\N	\N
87098	79	D5170C00002/tiny.path.1/file-5708.pdf	\N	D5170C00002-10af31a7-8319-11eb-be00-bfdccc2a3844-5710	\N	NEW	\N	\N	\N	\N
82756	79	D5170C00002/tiny.path.1/file-1366.pdf	\N	D5170C00002-10afd54f-8316-11eb-be00-e15a96e281c0-1366	\N	NEW	\N	\N	\N	\N
84161	79	D5170C00002/tiny.path.1/file-2771.pdf	\N	D5170C00002-10bd4ddc-8317-11eb-be00-8952f7de5db0-2771	\N	NEW	\N	\N	\N	\N
85729	79	D5170C00002/tiny.path.1/file-4339.pdf	\N	D5170C00002-10cbfd8c-8318-11eb-be00-451c31316940-4339	\N	NEW	\N	\N	\N	\N
87099	79	D5170C00002/tiny.path.1/file-5709.pdf	\N	D5170C00002-10cca4b8-8319-11eb-be00-f945cf595b64-5711	\N	NEW	\N	\N	\N	\N
85730	79	D5170C00002/tiny.path.1/file-4340.pdf	\N	D5170C00002-10ce477d-8318-11eb-be00-9b502e2c8fb9-4340	\N	NEW	\N	\N	\N	\N
84162	79	D5170C00002/tiny.path.1/file-2772.pdf	\N	D5170C00002-10db361d-8317-11eb-be00-ebd57c39ce61-2772	\N	NEW	\N	\N	\N	\N
85731	79	D5170C00002/tiny.path.1/file-4341.pdf	\N	D5170C00002-10ea33ee-8318-11eb-be00-c9c613e632c2-4341	\N	NEW	\N	\N	\N	\N
87100	79	D5170C00002/tiny.path.1/file-5710.pdf	\N	D5170C00002-10f9a829-8319-11eb-be00-a108935ade2d-5712	\N	NEW	\N	\N	\N	\N
82757	79	D5170C00002/tiny.path.1/file-1367.pdf	\N	D5170C00002-10f9af90-8316-11eb-be00-738264a47e72-1367	\N	NEW	\N	\N	\N	\N
84163	79	D5170C00002/tiny.path.1/file-2773.pdf	\N	D5170C00002-10fbdd7e-8317-11eb-be00-c9f0272e3f3c-2773	\N	NEW	\N	\N	\N	\N
85732	79	D5170C00002/tiny.path.1/file-4342.pdf	\N	D5170C00002-1108df7f-8318-11eb-be00-45f69933dd40-4342	\N	NEW	\N	\N	\N	\N
82758	79	D5170C00002/tiny.path.1/file-1368.pdf	\N	D5170C00002-110bb0f1-8316-11eb-be00-ad368f9f4a2f-1368	\N	NEW	\N	\N	\N	\N
85733	79	D5170C00002/tiny.path.1/file-4343.pdf	\N	D5170C00002-1119f680-8318-11eb-be00-210ef6d036b5-4343	\N	NEW	\N	\N	\N	\N
84164	79	D5170C00002/tiny.path.1/file-2774.pdf	\N	D5170C00002-11364e6f-8317-11eb-be00-2da94a0818bd-2774	\N	NEW	\N	\N	\N	\N
85734	79	D5170C00002/tiny.path.1/file-4344.pdf	\N	D5170C00002-1137b7b1-8318-11eb-be00-e18efb8557b6-4344	\N	NEW	\N	\N	\N	\N
82759	79	D5170C00002/tiny.path.1/file-1369.pdf	\N	D5170C00002-1147a882-8316-11eb-be00-bdfaf9cc30a2-1369	\N	NEW	\N	\N	\N	\N
87103	79	D5170C00002/tiny.path.1/file-5713.pdf	\N	D5170C00002-115535aa-8319-11eb-be00-9f7499762a47-5713	\N	NEW	\N	\N	\N	\N
87104	79	D5170C00002/tiny.path.1/file-5714.pdf	\N	D5170C00002-1156471b-8319-11eb-be00-eb37e54e2571-5714	\N	NEW	\N	\N	\N	\N
87105	79	D5170C00002/tiny.path.1/file-5715.pdf	\N	D5170C00002-11577f9c-8319-11eb-be00-ddf278e47548-5715	\N	NEW	\N	\N	\N	\N
85735	79	D5170C00002/tiny.path.1/file-4345.pdf	\N	D5170C00002-1157c2d2-8318-11eb-be00-9539e00b4083-4345	\N	NEW	\N	\N	\N	\N
87106	79	D5170C00002/tiny.path.1/file-5716.pdf	\N	D5170C00002-1165624d-8319-11eb-be00-21dccefb1e5a-5716	\N	NEW	\N	\N	\N	\N
85736	79	D5170C00002/tiny.path.1/file-4346.pdf	\N	D5170C00002-1166de03-8318-11eb-be00-eb0c9070aecc-4346	\N	NEW	\N	\N	\N	\N
85737	79	D5170C00002/tiny.path.1/file-4347.pdf	\N	D5170C00002-11764754-8318-11eb-be00-f9b0c2e6c997-4347	\N	NEW	\N	\N	\N	\N
82760	79	D5170C00002/tiny.path.1/file-1370.pdf	\N	D5170C00002-11854dc3-8316-11eb-be00-6145eab75138-1370	\N	NEW	\N	\N	\N	\N
87107	79	D5170C00002/tiny.path.1/file-5717.pdf	\N	D5170C00002-1192b3de-8319-11eb-be00-a3a159c17970-5717	\N	NEW	\N	\N	\N	\N
84165	79	D5170C00002/tiny.path.1/file-2775.pdf	\N	D5170C00002-119388a0-8317-11eb-be00-151d70297baa-2775	\N	NEW	\N	\N	\N	\N
82761	79	D5170C00002/tiny.path.1/file-1371.pdf	\N	D5170C00002-11a22494-8316-11eb-be00-5dd55072894f-1371	\N	NEW	\N	\N	\N	\N
82762	79	D5170C00002/tiny.path.1/file-1372.pdf	\N	D5170C00002-11a49595-8316-11eb-be00-25024a6b2034-1372	\N	NEW	\N	\N	\N	\N
82763	79	D5170C00002/tiny.path.1/file-1373.pdf	\N	D5170C00002-11c0a916-8316-11eb-be00-39883ec5709d-1373	\N	NEW	\N	\N	\N	\N
87108	79	D5170C00002/tiny.path.1/file-5718.pdf	\N	D5170C00002-11c0efcf-8319-11eb-be00-d30222e38615-5718	\N	NEW	\N	\N	\N	\N
84166	79	D5170C00002/tiny.path.1/file-2776.pdf	\N	D5170C00002-11d12de1-8317-11eb-be00-972345f8b83d-2776	\N	NEW	\N	\N	\N	\N
87109	79	D5170C00002/tiny.path.1/file-5719.pdf	\N	D5170C00002-11d16a90-8319-11eb-be00-af03c85a8410-5719	\N	NEW	\N	\N	\N	\N
82764	79	D5170C00002/tiny.path.1/file-1374.pdf	\N	D5170C00002-11df2d97-8316-11eb-be00-f75ece6f1013-1374	\N	NEW	\N	\N	\N	\N
87110	79	D5170C00002/tiny.path.1/file-5720.pdf	\N	D5170C00002-11eda521-8319-11eb-be00-25f79747d2e4-5720	\N	NEW	\N	\N	\N	\N
85738	79	D5170C00002/tiny.path.1/file-4348.pdf	\N	D5170C00002-11edc145-8318-11eb-be00-898401898e46-4348	\N	NEW	\N	\N	\N	\N
84167	79	D5170C00002/tiny.path.1/file-2777.pdf	\N	D5170C00002-11f02792-8317-11eb-be00-2bd89aef601a-2777	\N	NEW	\N	\N	\N	\N
82765	79	D5170C00002/tiny.path.1/file-1375.pdf	\N	D5170C00002-11fdd928-8316-11eb-be00-b3b69fac546b-1375	\N	NEW	\N	\N	\N	\N
87111	79	D5170C00002/tiny.path.1/file-5721.pdf	\N	D5170C00002-11fe46f2-8319-11eb-be00-c10ca93aedc6-5721	\N	NEW	\N	\N	\N	\N
85739	79	D5170C00002/tiny.path.1/file-4349.pdf	\N	D5170C00002-11feff56-8318-11eb-be00-df3bac98b9d3-4349	\N	NEW	\N	\N	\N	\N
82766	79	D5170C00002/tiny.path.1/file-1376.pdf	\N	D5170C00002-12004a29-8316-11eb-be00-f5dbb56c661b-1376	\N	NEW	\N	\N	\N	\N
85740	79	D5170C00002/tiny.path.1/file-4350.pdf	\N	D5170C00002-121d5cc7-8318-11eb-be00-012c92388c19-4350	\N	NEW	\N	\N	\N	\N
82767	79	D5170C00002/tiny.path.1/file-1377.pdf	\N	D5170C00002-122c151a-8316-11eb-be00-c35fae526b4c-1377	\N	NEW	\N	\N	\N	\N
84168	79	D5170C00002/tiny.path.1/file-2778.pdf	\N	D5170C00002-123bfda3-8317-11eb-be00-6770f4ca7414-2778	\N	NEW	\N	\N	\N	\N
85741	79	D5170C00002/tiny.path.1/file-4351.pdf	\N	D5170C00002-1249eb08-8318-11eb-be00-d5388dd4f22d-4351	\N	NEW	\N	\N	\N	\N
87112	79	D5170C00002/tiny.path.1/file-5722.pdf	\N	D5170C00002-124a4413-8319-11eb-be00-adc5dd29aa4c-5722	\N	NEW	\N	\N	\N	\N
85742	79	D5170C00002/tiny.path.1/file-4352.pdf	\N	D5170C00002-125ab3e9-8318-11eb-be00-ef81dfb50534-4352	\N	NEW	\N	\N	\N	\N
85743	79	D5170C00002/tiny.path.1/file-4353.pdf	\N	D5170C00002-1276ee7a-8318-11eb-be00-ebbfcebdc3d9-4353	\N	NEW	\N	\N	\N	\N
84169	79	D5170C00002/tiny.path.1/file-2779.pdf	\N	D5170C00002-1277a714-8317-11eb-be00-053d9c86d741-2779	\N	NEW	\N	\N	\N	\N
85744	79	D5170C00002/tiny.path.1/file-4354.pdf	\N	D5170C00002-12871b1b-8318-11eb-be00-77f378ef85a4-4354	\N	NEW	\N	\N	\N	\N
82768	79	D5170C00002/tiny.path.1/file-1378.pdf	\N	D5170C00002-12877b8b-8316-11eb-be00-01c0bf7e8062-1378	\N	NEW	\N	\N	\N	\N
85745	79	D5170C00002/tiny.path.1/file-4355.pdf	\N	D5170C00002-1297bcec-8318-11eb-be00-cf28cc3b0192-4355	\N	NEW	\N	\N	\N	\N
82769	79	D5170C00002/tiny.path.1/file-1379.pdf	\N	D5170C00002-12b457ec-8316-11eb-be00-6f281720d49d-1379	\N	NEW	\N	\N	\N	\N
85746	79	D5170C00002/tiny.path.1/file-4356.pdf	\N	D5170C00002-12b5f34d-8318-11eb-be00-9df0003c0925-4356	\N	NEW	\N	\N	\N	\N
82770	79	D5170C00002/tiny.path.1/file-1380.pdf	\N	D5170C00002-12b73e1d-8316-11eb-be00-31946f7e001e-1380	\N	NEW	\N	\N	\N	\N
85747	79	D5170C00002/tiny.path.1/file-4357.pdf	\N	D5170C00002-12c3fd0e-8318-11eb-be00-ffea1bf683df-4357	\N	NEW	\N	\N	\N	\N
85748	79	D5170C00002/tiny.path.1/file-4358.pdf	\N	D5170C00002-12c5aabf-8318-11eb-be00-1fdc99b7f930-4358	\N	NEW	\N	\N	\N	\N
82771	79	D5170C00002/tiny.path.1/file-1381.pdf	\N	D5170C00002-12e21eae-8316-11eb-be00-c1ca9f57804c-1381	\N	NEW	\N	\N	\N	\N
85749	79	D5170C00002/tiny.path.1/file-4359.pdf	\N	D5170C00002-12e40830-8318-11eb-be00-57fcf13e7ebb-4359	\N	NEW	\N	\N	\N	\N
82772	79	D5170C00002/tiny.path.1/file-1382.pdf	\N	D5170C00002-12f24b4f-8316-11eb-be00-73fdb7f1816a-1382	\N	NEW	\N	\N	\N	\N
85750	79	D5170C00002/tiny.path.1/file-4360.pdf	\N	D5170C00002-13001bb1-8318-11eb-be00-8b0bed73ad41-4360	\N	NEW	\N	\N	\N	\N
84170	79	D5170C00002/tiny.path.1/file-2780.pdf	\N	D5170C00002-13014975-8317-11eb-be00-a3728493a9f4-2780	\N	NEW	\N	\N	\N	\N
87113	79	D5170C00002/tiny.path.1/file-5723.pdf	\N	D5170C00002-1301fb54-8319-11eb-be00-816a7a70baa9-5723	\N	NEW	\N	\N	\N	\N
87114	79	D5170C00002/tiny.path.1/file-5724.pdf	\N	D5170C00002-13305e55-8319-11eb-be00-c97aebb3a0fe-5724	\N	NEW	\N	\N	\N	\N
82773	79	D5170C00002/tiny.path.1/file-1383.pdf	\N	D5170C00002-13312910-8316-11eb-be00-7732cc37ff32-1383	\N	NEW	\N	\N	\N	\N
85751	79	D5170C00002/tiny.path.1/file-4361.pdf	\N	D5170C00002-133dc0f2-8318-11eb-be00-4fdf54ece5f1-4361	\N	NEW	\N	\N	\N	\N
82774	79	D5170C00002/tiny.path.1/file-1384.pdf	\N	D5170C00002-13404441-8316-11eb-be00-3fbcd4e4d959-1384	\N	NEW	\N	\N	\N	\N
81391	79	D5170C00002/tiny.path.1/file-0001.pdf	\N	D5170C00002-1342833a-8315-11eb-be00-cf284f026d29-1	\N	NEW	\N	\N	\N	\N
85752	79	D5170C00002/tiny.path.1/file-4362.pdf	\N	D5170C00002-134e14a3-8318-11eb-be00-073db7fe816f-4362	\N	NEW	\N	\N	\N	\N
85753	79	D5170C00002/tiny.path.1/file-4363.pdf	\N	D5170C00002-134f4d24-8318-11eb-be00-45b3bfece373-4363	\N	NEW	\N	\N	\N	\N
81392	79	D5170C00002/tiny.path.1/file-0002.pdf	\N	D5170C00002-135d372b-8315-11eb-be00-e993a93c25fa-2	\N	NEW	\N	\N	\N	\N
84171	79	D5170C00002/tiny.path.1/file-2781.pdf	\N	D5170C00002-135e84a6-8317-11eb-be00-f163be773397-2781	\N	NEW	\N	\N	\N	\N
85754	79	D5170C00002/tiny.path.1/file-4364.pdf	\N	D5170C00002-136b3995-8318-11eb-be00-d9cea9464460-4364	\N	NEW	\N	\N	\N	\N
85755	79	D5170C00002/tiny.path.1/file-4365.pdf	\N	D5170C00002-137b1816-8318-11eb-be00-31ef64bc483d-4365	\N	NEW	\N	\N	\N	\N
85756	79	D5170C00002/tiny.path.1/file-4366.pdf	\N	D5170C00002-138948e7-8318-11eb-be00-a572449aa3e2-4366	\N	NEW	\N	\N	\N	\N
87115	79	D5170C00002/tiny.path.1/file-5725.pdf	\N	D5170C00002-1389f006-8319-11eb-be00-0110b5f4d74a-5725	\N	NEW	\N	\N	\N	\N
81393	79	D5170C00002/tiny.path.1/file-0003.pdf	\N	D5170C00002-139955cc-8315-11eb-be00-41770d00a7e9-3	\N	NEW	\N	\N	\N	\N
82775	79	D5170C00002/tiny.path.1/file-1385.pdf	\N	D5170C00002-139b3582-8316-11eb-be00-ab9795ad6e99-1385	\N	NEW	\N	\N	\N	\N
85757	79	D5170C00002/tiny.path.1/file-4367.pdf	\N	D5170C00002-13a84298-8318-11eb-be00-531fa4f458fc-4367	\N	NEW	\N	\N	\N	\N
84172	79	D5170C00002/tiny.path.1/file-2782.pdf	\N	D5170C00002-13a9be77-8317-11eb-be00-33dfdf30d336-2782	\N	NEW	\N	\N	\N	\N
85758	79	D5170C00002/tiny.path.1/file-4368.pdf	\N	D5170C00002-13b95999-8318-11eb-be00-c98178dfd308-4368	\N	NEW	\N	\N	\N	\N
87116	79	D5170C00002/tiny.path.1/file-5726.pdf	\N	D5170C00002-13c7e367-8319-11eb-be00-b728f0f1e60b-5726	\N	NEW	\N	\N	\N	\N
85759	79	D5170C00002/tiny.path.1/file-4369.pdf	\N	D5170C00002-13d8534a-8318-11eb-be00-29bc40e1f6ee-4369	\N	NEW	\N	\N	\N	\N
82776	79	D5170C00002/tiny.path.1/file-1386.pdf	\N	D5170C00002-13d86593-8316-11eb-be00-63653e878056-1386	\N	NEW	\N	\N	\N	\N
82777	79	D5170C00002/tiny.path.1/file-1387.pdf	\N	D5170C00002-13e84414-8316-11eb-be00-29c057de9422-1387	\N	NEW	\N	\N	\N	\N
85760	79	D5170C00002/tiny.path.1/file-4370.pdf	\N	D5170C00002-13f63b8b-8318-11eb-be00-e594391c3e8f-4370	\N	NEW	\N	\N	\N	\N
82778	79	D5170C00002/tiny.path.1/file-1388.pdf	\N	D5170C00002-140541f5-8316-11eb-be00-af96f9fbd516-1388	\N	NEW	\N	\N	\N	\N
87117	79	D5170C00002/tiny.path.1/file-5727.pdf	\N	D5170C00002-14134448-8319-11eb-be00-c978d7831910-5727	\N	NEW	\N	\N	\N	\N
85761	79	D5170C00002/tiny.path.1/file-4371.pdf	\N	D5170C00002-1415aa6c-8318-11eb-be00-6101f338123e-4371	\N	NEW	\N	\N	\N	\N
85762	79	D5170C00002/tiny.path.1/file-4372.pdf	\N	D5170C00002-1432a84d-8318-11eb-be00-67af18a4cf1c-4372	\N	NEW	\N	\N	\N	\N
82779	79	D5170C00002/tiny.path.1/file-1389.pdf	\N	D5170C00002-144223e6-8316-11eb-be00-77d8989ddd65-1389	\N	NEW	\N	\N	\N	\N
85763	79	D5170C00002/tiny.path.1/file-4373.pdf	\N	D5170C00002-14434a1e-8318-11eb-be00-b1400fc80e12-4373	\N	NEW	\N	\N	\N	\N
87118	79	D5170C00002/tiny.path.1/file-5728.pdf	\N	D5170C00002-144f89f9-8319-11eb-be00-a3d7a18dfcd5-5728	\N	NEW	\N	\N	\N	\N
81394	79	D5170C00002/tiny.path.1/file-0004.pdf	\N	D5170C00002-146e31fd-8315-11eb-be00-7f84f229f1df-4	\N	NEW	\N	\N	\N	\N
85764	79	D5170C00002/tiny.path.1/file-4374.pdf	\N	D5170C00002-146f3c1f-8318-11eb-be00-e74539773e3c-4374	\N	NEW	\N	\N	\N	\N
82780	79	D5170C00002/tiny.path.1/file-1390.pdf	\N	D5170C00002-147011b7-8316-11eb-be00-c9d90c09c32b-1390	\N	NEW	\N	\N	\N	\N
85765	79	D5170C00002/tiny.path.1/file-4375.pdf	\N	D5170C00002-147d9400-8318-11eb-be00-cb4cb7538024-4375	\N	NEW	\N	\N	\N	\N
87119	79	D5170C00002/tiny.path.1/file-5729.pdf	\N	D5170C00002-147dc5ea-8319-11eb-be00-8bcedfdc4f2b-5729	\N	NEW	\N	\N	\N	\N
87120	79	D5170C00002/tiny.path.1/file-5730.pdf	\N	D5170C00002-148fa03b-8319-11eb-be00-ed696789dcc7-5730	\N	NEW	\N	\N	\N	\N
81395	79	D5170C00002/tiny.path.1/file-0005.pdf	\N	D5170C00002-148feace-8315-11eb-be00-0d5ba0ad545c-5	\N	NEW	\N	\N	\N	\N
84173	79	D5170C00002/tiny.path.1/file-2783.msg	\N	D5170C00002-149ea5c8-8317-11eb-be00-abb4543fac81-2783	\N	NEW	\N	\N	\N	\N
85766	79	D5170C00002/tiny.path.1/file-4376.pdf	\N	D5170C00002-14adcbc1-8318-11eb-be00-ebfdf3e0f3ae-4376	\N	NEW	\N	\N	\N	\N
81396	79	D5170C00002/tiny.path.1/file-0006.pdf	\N	D5170C00002-14adfa1f-8315-11eb-be00-f9071e7b08bc-6	\N	NEW	\N	\N	\N	\N
87121	79	D5170C00002/tiny.path.1/file-5731.pdf	\N	D5170C00002-14ba59bc-8319-11eb-be00-1132874a93d4-5731	\N	NEW	\N	\N	\N	\N
87122	79	D5170C00002/tiny.path.1/file-5732.pdf	\N	D5170C00002-14c99bfd-8319-11eb-be00-c113fca55b99-5732	\N	NEW	\N	\N	\N	\N
81397	79	D5170C00002/tiny.path.1/file-0007.pdf	\N	D5170C00002-14ca0da0-8315-11eb-be00-678fc64293cc-7	\N	NEW	\N	\N	\N	\N
82781	79	D5170C00002/tiny.path.1/file-1391.pdf	\N	D5170C00002-14cb9f38-8316-11eb-be00-2ddbdb00e031-1391	\N	NEW	\N	\N	\N	\N
85767	79	D5170C00002/tiny.path.1/file-4377.pdf	\N	D5170C00002-14d92182-8318-11eb-be00-61fcba3a9963-4377	\N	NEW	\N	\N	\N	\N
81398	79	D5170C00002/tiny.path.1/file-0008.pdf	\N	D5170C00002-14da6151-8315-11eb-be00-0f39d27558eb-8	\N	NEW	\N	\N	\N	\N
84174	79	D5170C00002/tiny.path.1/file-2784.msg	\N	D5170C00002-14daeb79-8317-11eb-be00-d503524ff6ec-2784	\N	NEW	\N	\N	\N	\N
85768	79	D5170C00002/tiny.path.1/file-4378.pdf	\N	D5170C00002-14daf643-8318-11eb-be00-3d018b4b7804-4378	\N	NEW	\N	\N	\N	\N
82782	79	D5170C00002/tiny.path.1/file-1392.pdf	\N	D5170C00002-14eb5c39-8316-11eb-be00-c5d530334b10-1392	\N	NEW	\N	\N	\N	\N
85769	79	D5170C00002/tiny.path.1/file-4379.pdf	\N	D5170C00002-14eb9814-8318-11eb-be00-d379d95db916-4379	\N	NEW	\N	\N	\N	\N
87123	79	D5170C00002/tiny.path.1/file-5733.pdf	\N	D5170C00002-14f7b0de-8319-11eb-be00-a366cfd51168-5733	\N	NEW	\N	\N	\N	\N
81399	79	D5170C00002/tiny.path.1/file-0009.pdf	\N	D5170C00002-14f7fb72-8315-11eb-be00-85989d1534e0-9	\N	NEW	\N	\N	\N	\N
85770	79	D5170C00002/tiny.path.1/file-4380.pdf	\N	D5170C00002-14f97ac5-8318-11eb-be00-f9230881a9a4-4380	\N	NEW	\N	\N	\N	\N
81400	79	D5170C00002/tiny.path.1/file-0010.pdf	\N	D5170C00002-1508eb63-8315-11eb-be00-b78a2b6ad65d-10	\N	NEW	\N	\N	\N	\N
82783	79	D5170C00002/tiny.path.1/file-1393.pdf	\N	D5170C00002-1509929a-8316-11eb-be00-ddbaa049c81b-1393	\N	NEW	\N	\N	\N	\N
87124	79	D5170C00002/tiny.path.1/file-5734.pdf	\N	D5170C00002-15160e4f-8319-11eb-be00-af4c2f072fa2-5734	\N	NEW	\N	\N	\N	\N
84175	79	D5170C00002/tiny.path.1/file-2785.msg	\N	D5170C00002-1517a65a-8317-11eb-be00-51df5be65d50-2785	\N	NEW	\N	\N	\N	\N
81401	79	D5170C00002/tiny.path.1/file-0011.pdf	\N	D5170C00002-15265e74-8315-11eb-be00-4311a5974462-11	\N	NEW	\N	\N	\N	\N
82784	79	D5170C00002/tiny.path.1/file-1394.pdf	\N	D5170C00002-152753cb-8316-11eb-be00-2b95cbbaf632-1394	\N	NEW	\N	\N	\N	\N
85771	79	D5170C00002/tiny.path.1/file-4381.pdf	\N	D5170C00002-1527ddc6-8318-11eb-be00-15f37698bc89-4381	\N	NEW	\N	\N	\N	\N
85772	79	D5170C00002/tiny.path.1/file-4382.pdf	\N	D5170C00002-15441857-8318-11eb-be00-c35bbd9996d2-4382	\N	NEW	\N	\N	\N	\N
81402	79	D5170C00002/tiny.path.1/file-0012.pdf	\N	D5170C00002-154446b5-8315-11eb-be00-1d752dbd95ed-12	\N	NEW	\N	\N	\N	\N
87125	79	D5170C00002/tiny.path.1/file-5735.pdf	\N	D5170C00002-15455bb0-8319-11eb-be00-ebeaa76e2568-5735	\N	NEW	\N	\N	\N	\N
81403	79	D5170C00002/tiny.path.1/file-0013.pdf	\N	D5170C00002-1546dec6-8315-11eb-be00-f7ecff14580e-13	\N	NEW	\N	\N	\N	\N
82785	79	D5170C00002/tiny.path.1/file-1395.pdf	\N	D5170C00002-1547d41c-8316-11eb-be00-b13f18bb3d0b-1395	\N	NEW	\N	\N	\N	\N
84176	79	D5170C00002/tiny.path.1/file-2786.msg	\N	D5170C00002-1562b91b-8317-11eb-be00-c95e8e269815-2786	\N	NEW	\N	\N	\N	\N
85773	79	D5170C00002/tiny.path.1/file-4383.pdf	\N	D5170C00002-15631208-8318-11eb-be00-ef350ee87195-4383	\N	NEW	\N	\N	\N	\N
81404	79	D5170C00002/tiny.path.1/file-0014.pdf	\N	D5170C00002-15636777-8315-11eb-be00-4d38f48acf55-14	\N	NEW	\N	\N	\N	\N
87126	79	D5170C00002/tiny.path.1/file-5736.pdf	\N	D5170C00002-15645561-8319-11eb-be00-f76a13e6d734-5736	\N	NEW	\N	\N	\N	\N
85774	79	D5170C00002/tiny.path.1/file-4384.pdf	\N	D5170C00002-157401f9-8318-11eb-be00-b7c004f9ce6a-4384	\N	NEW	\N	\N	\N	\N
82786	79	D5170C00002/tiny.path.1/file-1396.pdf	\N	D5170C00002-1574fe9d-8316-11eb-be00-53e4e690ea07-1396	\N	NEW	\N	\N	\N	\N
81405	79	D5170C00002/tiny.path.1/file-0015.pdf	\N	D5170C00002-158128a8-8315-11eb-be00-ad2d34e8e95e-15	\N	NEW	\N	\N	\N	\N
85775	79	D5170C00002/tiny.path.1/file-4385.pdf	\N	D5170C00002-1592d49a-8318-11eb-be00-b983eb4ce8cf-4385	\N	NEW	\N	\N	\N	\N
82787	79	D5170C00002/tiny.path.1/file-1397.msg	\N	D5170C00002-15a07b6e-8316-11eb-be00-532416d668dd-1397	\N	NEW	\N	\N	\N	\N
85776	79	D5170C00002/tiny.path.1/file-4386.pdf	\N	D5170C00002-15b0209b-8318-11eb-be00-b50759dfb8d4-4386	\N	NEW	\N	\N	\N	\N
87127	79	D5170C00002/tiny.path.1/file-5737.pdf	\N	D5170C00002-15b07992-8319-11eb-be00-4bb0c6c3aa3c-5737	\N	NEW	\N	\N	\N	\N
81406	79	D5170C00002/tiny.path.1/file-0016.pdf	\N	D5170C00002-15be58b9-8315-11eb-be00-8fede12f0241-16	\N	NEW	\N	\N	\N	\N
87128	79	D5170C00002/tiny.path.1/file-5738.pdf	\N	D5170C00002-15c07f23-8319-11eb-be00-c1ef25fcd308-5738	\N	NEW	\N	\N	\N	\N
82788	79	D5170C00002/tiny.path.1/file-1398.pdf	\N	D5170C00002-15cda5ef-8316-11eb-be00-1d7a4c35c495-1398	\N	NEW	\N	\N	\N	\N
87129	79	D5170C00002/tiny.path.1/file-5739.pdf	\N	D5170C00002-15dcb9b4-8319-11eb-be00-f13097911569-5739	\N	NEW	\N	\N	\N	\N
84177	79	D5170C00002/tiny.path.1/file-2787.msg	\N	D5170C00002-15df632c-8317-11eb-be00-f51eb5e2b6bc-2787	\N	NEW	\N	\N	\N	\N
85777	79	D5170C00002/tiny.path.1/file-4387.pdf	\N	D5170C00002-15ec664c-8318-11eb-be00-5711eeb19583-4387	\N	NEW	\N	\N	\N	\N
81407	79	D5170C00002/tiny.path.1/file-0017.pdf	\N	D5170C00002-15ecbbba-8315-11eb-be00-6952e23cabc1-17	\N	NEW	\N	\N	\N	\N
87130	79	D5170C00002/tiny.path.1/file-5740.pdf	\N	D5170C00002-15fac905-8319-11eb-be00-25798bb46d24-5740	\N	NEW	\N	\N	\N	\N
81408	79	D5170C00002/tiny.path.1/file-0018.pdf	\N	D5170C00002-15fb61bb-8315-11eb-be00-513497649303-18	\N	NEW	\N	\N	\N	\N
81409	79	D5170C00002/tiny.path.1/file-0019.pdf	\N	D5170C00002-160c038c-8315-11eb-be00-a9c956de927f-19	\N	NEW	\N	\N	\N	\N
85778	79	D5170C00002/tiny.path.1/file-4388.pdf	\N	D5170C00002-160c987d-8318-11eb-be00-5d317aaf35df-4388	\N	NEW	\N	\N	\N	\N
81410	79	D5170C00002/tiny.path.1/file-0020.pdf	\N	D5170C00002-1619710d-8315-11eb-be00-6be172a3438f-20	\N	NEW	\N	\N	\N	\N
87131	79	D5170C00002/tiny.path.1/file-5741.pdf	\N	D5170C00002-16199ba6-8319-11eb-be00-8f407677f847-5741	\N	NEW	\N	\N	\N	\N
82789	79	D5170C00002/tiny.path.1/file-1399.pdf	\N	D5170C00002-16293370-8316-11eb-be00-2b37e1343b42-1399	\N	NEW	\N	\N	\N	\N
85779	79	D5170C00002/tiny.path.1/file-4389.pdf	\N	D5170C00002-162aa7ce-8318-11eb-be00-67a8e49d9c68-4389	\N	NEW	\N	\N	\N	\N
81411	79	D5170C00002/tiny.path.1/file-0021.pdf	\N	D5170C00002-16386abe-8315-11eb-be00-6b1608338e5d-21	\N	NEW	\N	\N	\N	\N
85780	79	D5170C00002/tiny.path.1/file-4390.pdf	\N	D5170C00002-16388a7f-8318-11eb-be00-656366151ebf-4390	\N	NEW	\N	\N	\N	\N
87132	79	D5170C00002/tiny.path.1/file-5742.pdf	\N	D5170C00002-16476267-8319-11eb-be00-03730d8bcad4-5742	\N	NEW	\N	\N	\N	\N
81412	79	D5170C00002/tiny.path.1/file-0022.pdf	\N	D5170C00002-164785ef-8315-11eb-be00-b701a8cef6cd-22	\N	NEW	\N	\N	\N	\N
81413	79	D5170C00002/tiny.path.1/file-0023.pdf	\N	D5170C00002-1648e580-8315-11eb-be00-b1d4b2441a89-23	\N	NEW	\N	\N	\N	\N
85781	79	D5170C00002/tiny.path.1/file-4391.pdf	\N	D5170C00002-1656c0e0-8318-11eb-be00-e3e8a1864a00-4391	\N	NEW	\N	\N	\N	\N
84178	79	D5170C00002/tiny.path.1/file-2788.msg	\N	D5170C00002-1657524d-8317-11eb-be00-d930bfe86c5c-2788	\N	NEW	\N	\N	\N	\N
82790	79	D5170C00002/tiny.path.1/file-1400.pdf	\N	D5170C00002-16668a91-8316-11eb-be00-db8f53f663e7-1400	\N	NEW	\N	\N	\N	\N
85782	79	D5170C00002/tiny.path.1/file-4392.pdf	\N	D5170C00002-16671491-8318-11eb-be00-07cc0ffb703f-4392	\N	NEW	\N	\N	\N	\N
84179	79	D5170C00002/tiny.path.1/file-2789.msg	\N	D5170C00002-16753a8e-8317-11eb-be00-0bb9315cc3ac-2789	\N	NEW	\N	\N	\N	\N
81414	79	D5170C00002/tiny.path.1/file-0024.pdf	\N	D5170C00002-167573c1-8315-11eb-be00-fddf95962292-24	\N	NEW	\N	\N	\N	\N
87133	79	D5170C00002/tiny.path.1/file-5743.pdf	\N	D5170C00002-16866738-8319-11eb-be00-17c605b3bfdc-5743	\N	NEW	\N	\N	\N	\N
82791	79	D5170C00002/tiny.path.1/file-1401.pdf	\N	D5170C00002-1695b0e2-8316-11eb-be00-b96b83c0ec8e-1401	\N	NEW	\N	\N	\N	\N
84180	79	D5170C00002/tiny.path.1/file-2790.msg	\N	D5170C00002-16a487ef-8317-11eb-be00-4569b3353217-2790	\N	NEW	\N	\N	\N	\N
82792	79	D5170C00002/tiny.path.1/file-1402.pdf	\N	D5170C00002-16b3e743-8316-11eb-be00-f90b69bf406c-1402	\N	NEW	\N	\N	\N	\N
87134	79	D5170C00002/tiny.path.1/file-5744.pdf	\N	D5170C00002-16b4f149-8319-11eb-be00-81f81b2100a3-5744	\N	NEW	\N	\N	\N	\N
81415	79	D5170C00002/tiny.path.1/file-0025.pdf	\N	D5170C00002-16d260d2-8315-11eb-be00-d362e441ca31-25	\N	NEW	\N	\N	\N	\N
82793	79	D5170C00002/tiny.path.1/file-1403.pdf	\N	D5170C00002-16d2e0f4-8316-11eb-be00-299fd2df093b-1403	\N	NEW	\N	\N	\N	\N
81416	79	D5170C00002/tiny.path.1/file-0026.pdf	\N	D5170C00002-16ff3d33-8315-11eb-be00-d1aca6959e48-26	\N	NEW	\N	\N	\N	\N
82794	79	D5170C00002/tiny.path.1/file-1404.msg	\N	D5170C00002-170ed885-8316-11eb-be00-7376d89c860e-1404	\N	NEW	\N	\N	\N	\N
81417	79	D5170C00002/tiny.path.1/file-0027.pdf	\N	D5170C00002-170fdf04-8315-11eb-be00-3d434801a82f-27	\N	NEW	\N	\N	\N	\N
82795	79	D5170C00002/tiny.path.1/file-1405.msg	\N	D5170C00002-1720d9e6-8316-11eb-be00-475acd9c2dc8-1405	\N	NEW	\N	\N	\N	\N
81418	79	D5170C00002/tiny.path.1/file-0028.pdf	\N	D5170C00002-172eb1a5-8315-11eb-be00-dffc8f58d6e3-28	\N	NEW	\N	\N	\N	\N
84181	79	D5170C00002/tiny.path.1/file-2791.msg	\N	D5170C00002-173cf760-8317-11eb-be00-dd45fa930aac-2791	\N	NEW	\N	\N	\N	\N
81419	79	D5170C00002/tiny.path.1/file-0029.pdf	\N	D5170C00002-174ac526-8315-11eb-be00-39d51bcfbf82-29	\N	NEW	\N	\N	\N	\N
85783	79	D5170C00002/tiny.path.1/file-4393.pdf	\N	D5170C00002-174bf652-8318-11eb-be00-8186c74feefc-4393	\N	NEW	\N	\N	\N	\N
81420	79	D5170C00002/tiny.path.1/file-0030.pdf	\N	D5170C00002-175a5587-8315-11eb-be00-13e53c3286a7-30	\N	NEW	\N	\N	\N	\N
87135	79	D5170C00002/tiny.path.1/file-5745.pdf	\N	D5170C00002-175b918a-8319-11eb-be00-bfb139048fc9-5745	\N	NEW	\N	\N	\N	\N
84182	79	D5170C00002/tiny.path.1/file-2792.msg	\N	D5170C00002-175cb461-8317-11eb-be00-7d69c4d83ac2-2792	\N	NEW	\N	\N	\N	\N
82796	79	D5170C00002/tiny.path.1/file-1406.msg	\N	D5170C00002-176adb37-8316-11eb-be00-6177e3163122-1406	\N	NEW	\N	\N	\N	\N
81421	79	D5170C00002/tiny.path.1/file-0031.pdf	\N	D5170C00002-177a3998-8315-11eb-be00-ebac958639df-31	\N	NEW	\N	\N	\N	\N
84183	79	D5170C00002/tiny.path.1/file-2793.msg	\N	D5170C00002-17883132-8317-11eb-be00-4d13668454d4-2793	\N	NEW	\N	\N	\N	\N
84184	79	D5170C00002/tiny.path.1/file-2794.msg	\N	D5170C00002-17996f43-8317-11eb-be00-85657793b413-2794	\N	NEW	\N	\N	\N	\N
87136	79	D5170C00002/tiny.path.1/file-5746.pdf	\N	D5170C00002-17a6cb5b-8319-11eb-be00-d5592ccdc779-5746	\N	NEW	\N	\N	\N	\N
84185	79	D5170C00002/tiny.path.1/file-2795.msg	\N	D5170C00002-17a88a74-8317-11eb-be00-fd8771ca21e3-2795	\N	NEW	\N	\N	\N	\N
82797	79	D5170C00002/tiny.path.1/file-1407.msg	\N	D5170C00002-17b72678-8316-11eb-be00-a71ec2f687a0-1407	\N	NEW	\N	\N	\N	\N
84186	79	D5170C00002/tiny.path.1/file-2796.msg	\N	D5170C00002-17d5dc05-8317-11eb-be00-c74dd2ca6ab3-2796	\N	NEW	\N	\N	\N	\N
81422	79	D5170C00002/tiny.path.1/file-0032.pdf	\N	D5170C00002-17e55779-8315-11eb-be00-8fc114f93c1e-32	\N	NEW	\N	\N	\N	\N
84187	79	D5170C00002/tiny.path.1/file-2797.msg	\N	D5170C00002-17e656c6-8317-11eb-be00-cb32d734a8af-2797	\N	NEW	\N	\N	\N	\N
87137	79	D5170C00002/tiny.path.1/file-5747.pdf	\N	D5170C00002-1801bc9c-8319-11eb-be00-c956372ebeaa-5747	\N	NEW	\N	\N	\N	\N
84188	79	D5170C00002/tiny.path.1/file-2798.msg	\N	D5170C00002-1802df77-8317-11eb-be00-b15bc899a67a-2798	\N	NEW	\N	\N	\N	\N
81423	79	D5170C00002/tiny.path.1/file-0033.pdf	\N	D5170C00002-182323ca-8315-11eb-be00-95f97895dcbf-33	\N	NEW	\N	\N	\N	\N
84189	79	D5170C00002/tiny.path.1/file-2799.msg	\N	D5170C00002-182338b8-8317-11eb-be00-45e0723f5e7f-2799	\N	NEW	\N	\N	\N	\N
85784	79	D5170C00002/tiny.path.1/file-4394.pdf	\N	D5170C00002-182fedb3-8318-11eb-be00-39c9e5513331-4394	\N	NEW	\N	\N	\N	\N
84190	79	D5170C00002/tiny.path.1/file-2800.msg	\N	D5170C00002-18319099-8317-11eb-be00-ff981963c054-2800	\N	NEW	\N	\N	\N	\N
81424	79	D5170C00002/tiny.path.1/file-0034.pdf	\N	D5170C00002-184048bb-8315-11eb-be00-e7ea0e953c1d-34	\N	NEW	\N	\N	\N	\N
81425	79	D5170C00002/tiny.path.1/file-0035.pdf	\N	D5170C00002-184e798c-8315-11eb-be00-f3d7374e71b0-35	\N	NEW	\N	\N	\N	\N
84191	79	D5170C00002/tiny.path.1/file-2801.msg	\N	D5170C00002-18503c2a-8317-11eb-be00-ed704257c23c-2801	\N	NEW	\N	\N	\N	\N
85785	79	D5170C00002/tiny.path.1/file-4395.pdf	\N	D5170C00002-18602574-8318-11eb-be00-0f2aac971641-4395	\N	NEW	\N	\N	\N	\N
84192	79	D5170C00002/tiny.path.1/file-2802.msg	\N	D5170C00002-186daf3b-8317-11eb-be00-95555a12f564-2802	\N	NEW	\N	\N	\N	\N
81426	79	D5170C00002/tiny.path.1/file-0036.pdf	\N	D5170C00002-186f961d-8315-11eb-be00-8b6f1316c0d3-36	\N	NEW	\N	\N	\N	\N
81427	79	D5170C00002/tiny.path.1/file-0037.pdf	\N	D5170C00002-187d9fde-8315-11eb-be00-ef2da602910e-37	\N	NEW	\N	\N	\N	\N
82798	79	D5170C00002/tiny.path.1/file-1408.pdf	\N	D5170C00002-187dd1d9-8316-11eb-be00-9d38874dc9e1-1408	\N	NEW	\N	\N	\N	\N
84193	79	D5170C00002/tiny.path.1/file-2803.msg	\N	D5170C00002-188c5acc-8317-11eb-be00-f796465161b2-2803	\N	NEW	\N	\N	\N	\N
81428	79	D5170C00002/tiny.path.1/file-0038.pdf	\N	D5170C00002-188e1a9f-8315-11eb-be00-95f42f098d37-38	\N	NEW	\N	\N	\N	\N
82799	79	D5170C00002/tiny.path.1/file-1409.pdf	\N	D5170C00002-188e73aa-8316-11eb-be00-0d9a440bfe2c-1409	\N	NEW	\N	\N	\N	\N
87138	79	D5170C00002/tiny.path.1/file-5748.pdf	\N	D5170C00002-189c4eed-8319-11eb-be00-bdb96dab0046-5748	\N	NEW	\N	\N	\N	\N
84194	79	D5170C00002/tiny.path.1/file-2804.msg	\N	D5170C00002-189cd58d-8317-11eb-be00-5d3469f981f3-2804	\N	NEW	\N	\N	\N	\N
84195	79	D5170C00002/tiny.path.1/file-2805.msg	\N	D5170C00002-18b9d36e-8317-11eb-be00-15aafdeb5325-2805	\N	NEW	\N	\N	\N	\N
87139	79	D5170C00002/tiny.path.1/file-5749.pdf	\N	D5170C00002-18ba854e-8319-11eb-be00-cb92bbbe1f44-5749	\N	NEW	\N	\N	\N	\N
87140	79	D5170C00002/tiny.path.1/file-5750.pdf	\N	D5170C00002-18bb96bf-8319-11eb-be00-4f05e9dbf573-5750	\N	NEW	\N	\N	\N	\N
84196	79	D5170C00002/tiny.path.1/file-2806.msg	\N	D5170C00002-18c915af-8317-11eb-be00-c3aad99eba4b-2806	\N	NEW	\N	\N	\N	\N
82800	79	D5170C00002/tiny.path.1/file-1410.pdf	\N	D5170C00002-18c9a7eb-8316-11eb-be00-fb615f0da2a1-1410	\N	NEW	\N	\N	\N	\N
81429	79	D5170C00002/tiny.path.1/file-0039.pdf	\N	D5170C00002-18d86a10-8315-11eb-be00-932b63456f70-39	\N	NEW	\N	\N	\N	\N
82801	79	D5170C00002/tiny.path.1/file-1411.pdf	\N	D5170C00002-1906b0ec-8316-11eb-be00-a3763b546684-1411	\N	NEW	\N	\N	\N	\N
81430	79	D5170C00002/tiny.path.1/file-0040.pdf	\N	D5170C00002-19074241-8315-11eb-be00-4bf7121f35ee-40	\N	NEW	\N	\N	\N	\N
84197	79	D5170C00002/tiny.path.1/file-2807.msg	\N	D5170C00002-1915d620-8317-11eb-be00-373ff066b3cd-2807	\N	NEW	\N	\N	\N	\N
87141	79	D5170C00002/tiny.path.1/file-5751.pdf	\N	D5170C00002-191660f0-8319-11eb-be00-27b6188c9375-5751	\N	NEW	\N	\N	\N	\N
85786	79	D5170C00002/tiny.path.1/file-4396.pdf	\N	D5170C00002-19171965-8318-11eb-be00-69d8ae64d17b-4396	\N	NEW	\N	\N	\N	\N
81431	79	D5170C00002/tiny.path.1/file-0041.pdf	\N	D5170C00002-1924dc62-8315-11eb-be00-59bc2c1fca4f-41	\N	NEW	\N	\N	\N	\N
84198	79	D5170C00002/tiny.path.1/file-2808.msg	\N	D5170C00002-1925dbb1-8317-11eb-be00-29c4ddac01a5-2808	\N	NEW	\N	\N	\N	\N
87142	79	D5170C00002/tiny.path.1/file-5752.pdf	\N	D5170C00002-19347041-8319-11eb-be00-dd57b899ffdd-5752	\N	NEW	\N	\N	\N	\N
84199	79	D5170C00002/tiny.path.1/file-2809.msg	\N	D5170C00002-1934f6e2-8317-11eb-be00-abd1cdfd403f-2809	\N	NEW	\N	\N	\N	\N
87143	79	D5170C00002/tiny.path.1/file-5753.pdf	\N	D5170C00002-19514712-8319-11eb-be00-bfb9afe744db-5753	\N	NEW	\N	\N	\N	\N
84202	79	D5170C00002/tiny.path.1/file-2812.msg	\N	D5170C00002-1951f4c3-8317-11eb-be00-3103bc4ba559-2810	\N	NEW	\N	\N	\N	\N
84200	79	D5170C00002/tiny.path.1/file-2810.msg	\N	D5170C00002-19618524-8317-11eb-be00-53b8873add29-2811	\N	NEW	\N	\N	\N	\N
85787	79	D5170C00002/tiny.path.1/file-4397.pdf	\N	D5170C00002-19625336-8318-11eb-be00-efa2cd98f0cb-4397	\N	NEW	\N	\N	\N	\N
84201	79	D5170C00002/tiny.path.1/file-2811.msg	\N	D5170C00002-1970a055-8317-11eb-be00-391b4c7295b1-2812	\N	NEW	\N	\N	\N	\N
84203	79	D5170C00002/tiny.path.1/file-2813.msg	\N	D5170C00002-19731156-8317-11eb-be00-73495f64afa4-2813	\N	NEW	\N	\N	\N	\N
81432	79	D5170C00002/tiny.path.1/file-0042.pdf	\N	D5170C00002-19734a83-8315-11eb-be00-81ea68ed581c-42	\N	NEW	\N	\N	\N	\N
84204	79	D5170C00002/tiny.path.1/file-2814.msg	\N	D5170C00002-1980ccf7-8317-11eb-be00-8925a192bc4b-2814	\N	NEW	\N	\N	\N	\N
82802	79	D5170C00002/tiny.path.1/file-1412.pdf	\N	D5170C00002-1981110d-8316-11eb-be00-7d1eacbd4524-1412	\N	NEW	\N	\N	\N	\N
84205	79	D5170C00002/tiny.path.1/file-2815.msg	\N	D5170C00002-198ed6b8-8317-11eb-be00-af21b2b1dd32-2815	\N	NEW	\N	\N	\N	\N
87144	79	D5170C00002/tiny.path.1/file-5754.pdf	\N	D5170C00002-198ffdc3-8319-11eb-be00-e395018ca3b1-5754	\N	NEW	\N	\N	\N	\N
84206	79	D5170C00002/tiny.path.1/file-2816.msg	\N	D5170C00002-1991bce9-8317-11eb-be00-d364f07f74b9-2816	\N	NEW	\N	\N	\N	\N
81433	79	D5170C00002/tiny.path.1/file-0043.pdf	\N	D5170C00002-199e7934-8315-11eb-be00-9b9fccc7a7b7-43	\N	NEW	\N	\N	\N	\N
85788	79	D5170C00002/tiny.path.1/file-4398.pdf	\N	D5170C00002-199ee707-8318-11eb-be00-6da7c83a2f0a-4398	\N	NEW	\N	\N	\N	\N
87145	79	D5170C00002/tiny.path.1/file-5755.pdf	\N	D5170C00002-199f18f4-8319-11eb-be00-ada477e583e6-5755	\N	NEW	\N	\N	\N	\N
84207	79	D5170C00002/tiny.path.1/file-2817.msg	\N	D5170C00002-199fedba-8317-11eb-be00-9167abde9e90-2817	\N	NEW	\N	\N	\N	\N
87146	79	D5170C00002/tiny.path.1/file-5756.pdf	\N	D5170C00002-19acfba5-8319-11eb-be00-712191aee85b-5756	\N	NEW	\N	\N	\N	\N
82803	79	D5170C00002/tiny.path.1/file-1413.pdf	\N	D5170C00002-19aeb0be-8316-11eb-be00-49408048fae1-1413	\N	NEW	\N	\N	\N	\N
81434	79	D5170C00002/tiny.path.1/file-0044.pdf	\N	D5170C00002-19af6925-8315-11eb-be00-fd584f9724e4-44	\N	NEW	\N	\N	\N	\N
84208	79	D5170C00002/tiny.path.1/file-2818.msg	\N	D5170C00002-19bc766b-8317-11eb-be00-154d5932298c-2818	\N	NEW	\N	\N	\N	\N
81435	79	D5170C00002/tiny.path.1/file-0045.pdf	\N	D5170C00002-19bcd6a6-8315-11eb-be00-a953b33ea9a6-45	\N	NEW	\N	\N	\N	\N
84209	79	D5170C00002/tiny.path.1/file-2819.msg	\N	D5170C00002-19bf0e7c-8317-11eb-be00-ef44d28af026-2819	\N	NEW	\N	\N	\N	\N
81436	79	D5170C00002/tiny.path.1/file-0046.pdf	\N	D5170C00002-19dbd057-8315-11eb-be00-d556879edf37-46	\N	NEW	\N	\N	\N	\N
84210	79	D5170C00002/tiny.path.1/file-2820.msg	\N	D5170C00002-19dd6bed-8317-11eb-be00-f70675345d72-2820	\N	NEW	\N	\N	\N	\N
87147	79	D5170C00002/tiny.path.1/file-5757.pdf	\N	D5170C00002-19ebb256-8319-11eb-be00-71778161390c-5757	\N	NEW	\N	\N	\N	\N
84211	79	D5170C00002/tiny.path.1/file-2821.msg	\N	D5170C00002-19ec600e-8317-11eb-be00-1d45a571faa8-2821	\N	NEW	\N	\N	\N	\N
82804	79	D5170C00002/tiny.path.1/file-1414.pdf	\N	D5170C00002-19ec7d0f-8316-11eb-be00-9b594533d40a-1414	\N	NEW	\N	\N	\N	\N
87148	79	D5170C00002/tiny.path.1/file-5758.pdf	\N	D5170C00002-19f9e327-8319-11eb-be00-6799eb31a071-5758	\N	NEW	\N	\N	\N	\N
85789	79	D5170C00002/tiny.path.1/file-4399.pdf	\N	D5170C00002-19fac2a8-8318-11eb-be00-f1d301bca38a-4399	\N	NEW	\N	\N	\N	\N
84212	79	D5170C00002/tiny.path.1/file-2822.msg	\N	D5170C00002-19fc3e8f-8317-11eb-be00-438e0c388371-2822	\N	NEW	\N	\N	\N	\N
81437	79	D5170C00002/tiny.path.1/file-0047.pdf	\N	D5170C00002-1a0a5a68-8315-11eb-be00-555473078460-47	\N	NEW	\N	\N	\N	\N
84213	79	D5170C00002/tiny.path.1/file-2823.msg	\N	D5170C00002-1a0b32b0-8317-11eb-be00-397477df0b3d-2823	\N	NEW	\N	\N	\N	\N
87149	79	D5170C00002/tiny.path.1/file-5759.pdf	\N	D5170C00002-1a17f278-8319-11eb-be00-519f821119e1-5759	\N	NEW	\N	\N	\N	\N
81438	79	D5170C00002/tiny.path.1/file-0048.pdf	\N	D5170C00002-1a281b99-8315-11eb-be00-2dbe2469bf87-48	\N	NEW	\N	\N	\N	\N
87150	79	D5170C00002/tiny.path.1/file-5760.pdf	\N	D5170C00002-1a28e269-8319-11eb-be00-37f2e7eb757a-5760	\N	NEW	\N	\N	\N	\N
84214	79	D5170C00002/tiny.path.1/file-2824.pdf	\N	D5170C00002-1a388441-8317-11eb-be00-ed015de95158-2824	\N	NEW	\N	\N	\N	\N
81439	79	D5170C00002/tiny.path.1/file-0049.pdf	\N	D5170C00002-1a46790a-8315-11eb-be00-4708d778ff15-49	\N	NEW	\N	\N	\N	\N
84215	79	D5170C00002/tiny.path.1/file-2825.pdf	\N	D5170C00002-1a558222-8317-11eb-be00-f32ad19abac1-2825	\N	NEW	\N	\N	\N	\N
87151	79	D5170C00002/tiny.path.1/file-5761.pdf	\N	D5170C00002-1a56d03a-8319-11eb-be00-fbf0dbb63d58-5761	\N	NEW	\N	\N	\N	\N
82805	79	D5170C00002/tiny.path.1/file-1415.pdf	\N	D5170C00002-1a83db10-8316-11eb-be00-7573331df357-1415	\N	NEW	\N	\N	\N	\N
85790	79	D5170C00002/tiny.path.1/file-4400.pdf	\N	D5170C00002-1a854f69-8318-11eb-be00-a57307cfe937-4400	\N	NEW	\N	\N	\N	\N
84216	79	D5170C00002/tiny.path.1/file-2826.pdf	\N	D5170C00002-1a91eee3-8317-11eb-be00-dde4c7cc79d3-2826	\N	NEW	\N	\N	\N	\N
84217	79	D5170C00002/tiny.path.1/file-2827.pdf	\N	D5170C00002-1ab09a74-8317-11eb-be00-436702c8627c-2827	\N	NEW	\N	\N	\N	\N
87152	79	D5170C00002/tiny.path.1/file-5762.pdf	\N	D5170C00002-1abfa42b-8319-11eb-be00-2fa4286b01f6-5762	\N	NEW	\N	\N	\N	\N
81440	79	D5170C00002/tiny.path.1/file-0050.pdf	\N	D5170C00002-1ac03ceb-8315-11eb-be00-234c2c34c1eb-50	\N	NEW	\N	\N	\N	\N
82806	79	D5170C00002/tiny.path.1/file-1416.pdf	\N	D5170C00002-1ac1f581-8316-11eb-be00-0d789c7c50c2-1416	\N	NEW	\N	\N	\N	\N
84218	79	D5170C00002/tiny.path.1/file-2828.pdf	\N	D5170C00002-1ade6135-8317-11eb-be00-7356ec189a85-2828	\N	NEW	\N	\N	\N	\N
81441	79	D5170C00002/tiny.path.1/file-0051.pdf	\N	D5170C00002-1adf84bc-8315-11eb-be00-a9ced1ada12b-51	\N	NEW	\N	\N	\N	\N
87153	79	D5170C00002/tiny.path.1/file-5763.pdf	\N	D5170C00002-1afcd43c-8319-11eb-be00-41eb2bff0cc8-5763	\N	NEW	\N	\N	\N	\N
84219	79	D5170C00002/tiny.path.1/file-2829.pdf	\N	D5170C00002-1afeba76-8317-11eb-be00-df11225e0312-2829	\N	NEW	\N	\N	\N	\N
81442	79	D5170C00002/tiny.path.1/file-0052.pdf	\N	D5170C00002-1afecc8d-8315-11eb-be00-35ff80f55ef3-52	\N	NEW	\N	\N	\N	\N
82807	79	D5170C00002/tiny.path.1/file-1417.pdf	\N	D5170C00002-1b0d5662-8316-11eb-be00-8d4036c90027-1417	\N	NEW	\N	\N	\N	\N
87154	79	D5170C00002/tiny.path.1/file-5764.pdf	\N	D5170C00002-1b1cb84d-8319-11eb-be00-63e62d70295e-5764	\N	NEW	\N	\N	\N	\N
85791	79	D5170C00002/tiny.path.1/file-4401.pdf	\N	D5170C00002-1b1dbeda-8318-11eb-be00-43f44c140de7-4401	\N	NEW	\N	\N	\N	\N
84220	79	D5170C00002/tiny.path.1/file-2830.pdf	\N	D5170C00002-1b2c0c07-8317-11eb-be00-c1c61dd7d44d-2830	\N	NEW	\N	\N	\N	\N
81443	79	D5170C00002/tiny.path.1/file-0053.pdf	\N	D5170C00002-1b2da4be-8315-11eb-be00-a519022b85da-53	\N	NEW	\N	\N	\N	\N
87155	79	D5170C00002/tiny.path.1/file-5765.pdf	\N	D5170C00002-1b3b63de-8319-11eb-be00-d135ee1b9a58-5765	\N	NEW	\N	\N	\N	\N
84221	79	D5170C00002/tiny.path.1/file-2831.pdf	\N	D5170C00002-1b4909e8-8317-11eb-be00-45091c38c383-2831	\N	NEW	\N	\N	\N	\N
84222	79	D5170C00002/tiny.path.1/file-2832.pdf	\N	D5170C00002-1b49cd39-8317-11eb-be00-27657381683b-2832	\N	NEW	\N	\N	\N	\N
81444	79	D5170C00002/tiny.path.1/file-0054.pdf	\N	D5170C00002-1b4aa29f-8315-11eb-be00-15619ba6ffff-54	\N	NEW	\N	\N	\N	\N
84223	79	D5170C00002/tiny.path.1/file-2833.pdf	\N	D5170C00002-1b584c2a-8317-11eb-be00-0bd7d368c132-2833	\N	NEW	\N	\N	\N	\N
82808	79	D5170C00002/tiny.path.1/file-1418.pdf	\N	D5170C00002-1b5a16d3-8316-11eb-be00-47bf1e26359e-1418	\N	NEW	\N	\N	\N	\N
84224	79	D5170C00002/tiny.path.1/file-2834.pdf	\N	D5170C00002-1b5a20eb-8317-11eb-be00-314f328871bd-2834	\N	NEW	\N	\N	\N	\N
81445	79	D5170C00002/tiny.path.1/file-0055.pdf	\N	D5170C00002-1b5b9290-8315-11eb-be00-7105399e84bd-55	\N	NEW	\N	\N	\N	\N
84225	79	D5170C00002/tiny.path.1/file-2835.pdf	\N	D5170C00002-1b67b57c-8317-11eb-be00-eb80e2b8d797-2835	\N	NEW	\N	\N	\N	\N
84226	79	D5170C00002/tiny.path.1/file-2836.pdf	\N	D5170C00002-1b771ecd-8317-11eb-be00-3bbae69f2415-2836	\N	NEW	\N	\N	\N	\N
85792	79	D5170C00002/tiny.path.1/file-4402.pdf	\N	D5170C00002-1b779eab-8318-11eb-be00-55dcd95184fd-4402	\N	NEW	\N	\N	\N	\N
87156	79	D5170C00002/tiny.path.1/file-5766.pdf	\N	D5170C00002-1b86016f-8319-11eb-be00-77ab6e6a3e5c-5766	\N	NEW	\N	\N	\N	\N
84227	79	D5170C00002/tiny.path.1/file-2837.pdf	\N	D5170C00002-1b86d63e-8317-11eb-be00-3b38f1ff6794-2837	\N	NEW	\N	\N	\N	\N
85793	79	D5170C00002/tiny.path.1/file-4403.pdf	\N	D5170C00002-1b9538cc-8318-11eb-be00-f5b4c66dc919-4403	\N	NEW	\N	\N	\N	\N
87157	79	D5170C00002/tiny.path.1/file-5767.pdf	\N	D5170C00002-1ba437d0-8319-11eb-be00-731548c75423-5767	\N	NEW	\N	\N	\N	\N
82809	79	D5170C00002/tiny.path.1/file-1419.pdf	\N	D5170C00002-1ba59ec4-8316-11eb-be00-793eded6fd33-1419	\N	NEW	\N	\N	\N	\N
81446	79	D5170C00002/tiny.path.1/file-0056.pdf	\N	D5170C00002-1ba5e201-8315-11eb-be00-6bbde1443838-56	\N	NEW	\N	\N	\N	\N
84228	79	D5170C00002/tiny.path.1/file-2838.pdf	\N	D5170C00002-1ba77d9f-8317-11eb-be00-abd2a99f5600-2838	\N	NEW	\N	\N	\N	\N
84229	79	D5170C00002/tiny.path.1/file-2839.pdf	\N	D5170C00002-1bc42d60-8317-11eb-be00-37ab25695b26-2839	\N	NEW	\N	\N	\N	\N
85794	79	D5170C00002/tiny.path.1/file-4404.pdf	\N	D5170C00002-1bc4fb5d-8318-11eb-be00-ad2530fe0952-4404	\N	NEW	\N	\N	\N	\N
84230	79	D5170C00002/tiny.path.1/file-2840.pdf	\N	D5170C00002-1bd4a821-8317-11eb-be00-1be5e577185d-2840	\N	NEW	\N	\N	\N	\N
81447	79	D5170C00002/tiny.path.1/file-0057.pdf	\N	D5170C00002-1be200a2-8315-11eb-be00-7d7808daca68-57	\N	NEW	\N	\N	\N	\N
84231	79	D5170C00002/tiny.path.1/file-2841.pdf	\N	D5170C00002-1be32712-8317-11eb-be00-e3e9b56295df-2841	\N	NEW	\N	\N	\N	\N
87158	79	D5170C00002/tiny.path.1/file-5768.pdf	\N	D5170C00002-1be44e11-8319-11eb-be00-c562420bf238-5768	\N	NEW	\N	\N	\N	\N
82810	79	D5170C00002/tiny.path.1/file-1420.pdf	\N	D5170C00002-1bf1ea05-8316-11eb-be00-a3e3f13aad24-1420	\N	NEW	\N	\N	\N	\N
84232	79	D5170C00002/tiny.path.1/file-2842.pdf	\N	D5170C00002-1c0f6733-8317-11eb-be00-05b3222ebfeb-2842	\N	NEW	\N	\N	\N	\N
81448	79	D5170C00002/tiny.path.1/file-0058.pdf	\N	D5170C00002-1c10ffe3-8315-11eb-be00-4b661d4ed444-58	\N	NEW	\N	\N	\N	\N
87159	79	D5170C00002/tiny.path.1/file-5769.pdf	\N	D5170C00002-1c110362-8319-11eb-be00-29da7a6a6be0-5769	\N	NEW	\N	\N	\N	\N
82811	79	D5170C00002/tiny.path.1/file-1421.pdf	\N	D5170C00002-1c1f62a6-8316-11eb-be00-f335641fba37-1421	\N	NEW	\N	\N	\N	\N
84233	79	D5170C00002/tiny.path.1/file-2843.pdf	\N	D5170C00002-1c200904-8317-11eb-be00-d760a0451732-2843	\N	NEW	\N	\N	\N	\N
81449	79	D5170C00002/tiny.path.1/file-0059.pdf	\N	D5170C00002-1c21a1b4-8315-11eb-be00-27a9cd945320-59	\N	NEW	\N	\N	\N	\N
84234	79	D5170C00002/tiny.path.1/file-2844.pdf	\N	D5170C00002-1c2e87f5-8317-11eb-be00-9bdd75c65249-2844	\N	NEW	\N	\N	\N	\N
87160	79	D5170C00002/tiny.path.1/file-5770.pdf	\N	D5170C00002-1c2f39c3-8319-11eb-be00-e9da38d14c3b-5770	\N	NEW	\N	\N	\N	\N
84235	79	D5170C00002/tiny.path.1/file-2845.pdf	\N	D5170C00002-1c3d5506-8317-11eb-be00-e5b18a249932-2845	\N	NEW	\N	\N	\N	\N
81450	79	D5170C00002/tiny.path.1/file-0060.pdf	\N	D5170C00002-1c4e7e15-8315-11eb-be00-01e31e9b50b2-60	\N	NEW	\N	\N	\N	\N
84236	79	D5170C00002/tiny.path.1/file-2846.pdf	\N	D5170C00002-1c6b1bc7-8317-11eb-be00-417d198edf95-2846	\N	NEW	\N	\N	\N	\N
85825	79	D5170C00002/tiny.path.1/file-4435.pdf	\N	D5170C00002-1c6b4d7e-8318-11eb-be00-032e94766ad3-4405	\N	NEW	\N	\N	\N	\N
81451	79	D5170C00002/tiny.path.1/file-0061.pdf	\N	D5170C00002-1c6c1836-8315-11eb-be00-d5ef003a1dd4-61	\N	NEW	\N	\N	\N	\N
84237	79	D5170C00002/tiny.path.1/file-2847.pdf	\N	D5170C00002-1c6db3d8-8317-11eb-be00-918ed7c9eb96-2847	\N	NEW	\N	\N	\N	\N
84238	79	D5170C00002/tiny.path.1/file-2848.pdf	\N	D5170C00002-1c7aac29-8317-11eb-be00-d37688255613-2848	\N	NEW	\N	\N	\N	\N
84239	79	D5170C00002/tiny.path.1/file-2849.pdf	\N	D5170C00002-1c8a3c8a-8317-11eb-be00-3f265ee65ccc-2849	\N	NEW	\N	\N	\N	\N
84240	79	D5170C00002/tiny.path.1/file-2850.pdf	\N	D5170C00002-1c9b2c7b-8317-11eb-be00-6f0f18ae242d-2850	\N	NEW	\N	\N	\N	\N
81452	79	D5170C00002/tiny.path.1/file-0062.pdf	\N	D5170C00002-1ca7e8b7-8315-11eb-be00-fb2cb64cd09c-62	\N	NEW	\N	\N	\N	\N
84241	79	D5170C00002/tiny.path.1/file-2851.pdf	\N	D5170C00002-1cab320c-8317-11eb-be00-b746270bf164-2851	\N	NEW	\N	\N	\N	\N
87161	79	D5170C00002/tiny.path.1/file-5771.pdf	\N	D5170C00002-1cb75584-8319-11eb-be00-eb274ddf5dfd-5771	\N	NEW	\N	\N	\N	\N
81453	79	D5170C00002/tiny.path.1/file-0063.pdf	\N	D5170C00002-1cc77ea8-8315-11eb-be00-c1cb5891c9fe-63	\N	NEW	\N	\N	\N	\N
82812	79	D5170C00002/tiny.path.1/file-1422.pdf	\N	D5170C00002-1cd65697-8316-11eb-be00-2193ecd698f4-1422	\N	NEW	\N	\N	\N	\N
84242	79	D5170C00002/tiny.path.1/file-2852.pdf	\N	D5170C00002-1cd7240d-8317-11eb-be00-bdc6f7b79731-2852	\N	NEW	\N	\N	\N	\N
81454	79	D5170C00002/tiny.path.1/file-0064.pdf	\N	D5170C00002-1cd82079-8315-11eb-be00-5910db59a8ee-64	\N	NEW	\N	\N	\N	\N
85826	79	D5170C00002/tiny.path.1/file-4436.pdf	\N	D5170C00002-1ce697ff-8318-11eb-be00-9d25585c6496-4406	\N	NEW	\N	\N	\N	\N
82813	79	D5170C00002/tiny.path.1/file-1423.pdf	\N	D5170C00002-1ce7bbb8-8316-11eb-be00-af983a365d29-1423	\N	NEW	\N	\N	\N	\N
87162	79	D5170C00002/tiny.path.1/file-5772.pdf	\N	D5170C00002-1cf521d5-8319-11eb-be00-d192b440cd4e-5772	\N	NEW	\N	\N	\N	\N
81455	79	D5170C00002/tiny.path.1/file-0065.pdf	\N	D5170C00002-1cf608ba-8315-11eb-be00-d1182c6d33f2-65	\N	NEW	\N	\N	\N	\N
84243	79	D5170C00002/tiny.path.1/file-2853.pdf	\N	D5170C00002-1cf66bde-8317-11eb-be00-417f4e545ec9-2853	\N	NEW	\N	\N	\N	\N
82814	79	D5170C00002/tiny.path.1/file-1424.pdf	\N	D5170C00002-1cf6afd9-8316-11eb-be00-6b04eccbff1d-1424	\N	NEW	\N	\N	\N	\N
82815	79	D5170C00002/tiny.path.1/file-1425.pdf	\N	D5170C00002-1cf7732a-8316-11eb-be00-77c1413d5b67-1425	\N	NEW	\N	\N	\N	\N
82816	79	D5170C00002/tiny.path.1/file-1426.pdf	\N	D5170C00002-1d12ea6b-8316-11eb-be00-ff8ad69eab62-1426	\N	NEW	\N	\N	\N	\N
84244	79	D5170C00002/tiny.path.1/file-2854.pdf	\N	D5170C00002-1d13deef-8317-11eb-be00-5d0d074297bd-2854	\N	NEW	\N	\N	\N	\N
81456	79	D5170C00002/tiny.path.1/file-0066.pdf	\N	D5170C00002-1d14b44b-8315-11eb-be00-e15b84050b38-66	\N	NEW	\N	\N	\N	\N
82817	79	D5170C00002/tiny.path.1/file-1427.pdf	\N	D5170C00002-1d227acc-8316-11eb-be00-83d34ee7c36f-1427	\N	NEW	\N	\N	\N	\N
87163	79	D5170C00002/tiny.path.1/file-5773.pdf	\N	D5170C00002-1d242116-8319-11eb-be00-7f39b19cbae4-5773	\N	NEW	\N	\N	\N	\N
82818	79	D5170C00002/tiny.path.1/file-1428.pdf	\N	D5170C00002-1d32a76d-8316-11eb-be00-e7651749527a-1428	\N	NEW	\N	\N	\N	\N
82819	79	D5170C00002/tiny.path.1/file-1429.pdf	\N	D5170C00002-1d34551e-8316-11eb-be00-bfd135d641d0-1429	\N	NEW	\N	\N	\N	\N
84245	79	D5170C00002/tiny.path.1/file-2855.pdf	\N	D5170C00002-1d409440-8317-11eb-be00-89daade10b67-2855	\N	NEW	\N	\N	\N	\N
82820	79	D5170C00002/tiny.path.1/file-1430.pdf	\N	D5170C00002-1d43222f-8316-11eb-be00-898af162b60c-1430	\N	NEW	\N	\N	\N	\N
81457	79	D5170C00002/tiny.path.1/file-0067.pdf	\N	D5170C00002-1d43656c-8315-11eb-be00-15be562170b1-67	\N	NEW	\N	\N	\N	\N
82821	79	D5170C00002/tiny.path.1/file-1431.pdf	\N	D5170C00002-1d60e360-8316-11eb-be00-bd6eac3079d0-1431	\N	NEW	\N	\N	\N	\N
87164	79	D5170C00002/tiny.path.1/file-5774.pdf	\N	D5170C00002-1d6e7087-8319-11eb-be00-f7286b4094ea-5774	\N	NEW	\N	\N	\N	\N
81458	79	D5170C00002/tiny.path.1/file-0068.pdf	\N	D5170C00002-1d6ebb2d-8315-11eb-be00-9fd079a73fda-68	\N	NEW	\N	\N	\N	\N
82822	79	D5170C00002/tiny.path.1/file-1432.pdf	\N	D5170C00002-1d7dba31-8316-11eb-be00-bd42549a8b99-1432	\N	NEW	\N	\N	\N	\N
84246	79	D5170C00002/tiny.path.1/file-2856.pdf	\N	D5170C00002-1d7eaeb1-8317-11eb-be00-45d7b36dc4e5-2856	\N	NEW	\N	\N	\N	\N
85795	79	D5170C00002/tiny.path.1/file-4405.pdf	\N	D5170C00002-1d8d1130-8318-11eb-be00-cf3fe86ad452-4407	\N	NEW	\N	\N	\N	\N
82823	79	D5170C00002/tiny.path.1/file-1433.pdf	\N	D5170C00002-1d9c3eb2-8316-11eb-be00-6bafb4454a8c-1433	\N	NEW	\N	\N	\N	\N
81459	79	D5170C00002/tiny.path.1/file-0069.pdf	\N	D5170C00002-1d9c5ade-8315-11eb-be00-4d71ab344da9-69	\N	NEW	\N	\N	\N	\N
82824	79	D5170C00002/tiny.path.1/file-1434.pdf	\N	D5170C00002-1d9f4bf3-8316-11eb-be00-d75ec8f15d7d-1434	\N	NEW	\N	\N	\N	\N
85796	79	D5170C00002/tiny.path.1/file-4406.pdf	\N	D5170C00002-1dac0ae1-8318-11eb-be00-c5f1f790bcf9-4408	\N	NEW	\N	\N	\N	\N
81460	79	D5170C00002/tiny.path.1/file-0070.pdf	\N	D5170C00002-1dbd9e7f-8315-11eb-be00-87de5a740b35-70	\N	NEW	\N	\N	\N	\N
87165	79	D5170C00002/tiny.path.1/file-5775.pdf	\N	D5170C00002-1dc9afe8-8319-11eb-be00-1b9659b2d4a4-5775	\N	NEW	\N	\N	\N	\N
82825	79	D5170C00002/tiny.path.1/file-1435.pdf	\N	D5170C00002-1dca0574-8316-11eb-be00-47cfa483d1d7-1435	\N	NEW	\N	\N	\N	\N
82826	79	D5170C00002/tiny.path.1/file-1436.pdf	\N	D5170C00002-1dcd12b5-8316-11eb-be00-df772502f294-1436	\N	NEW	\N	\N	\N	\N
81461	79	D5170C00002/tiny.path.1/file-0071.pdf	\N	D5170C00002-1de8cd30-8315-11eb-be00-81b391828ef6-71	\N	NEW	\N	\N	\N	\N
84247	79	D5170C00002/tiny.path.1/file-2857.pdf	\N	D5170C00002-1de93052-8317-11eb-be00-d5c24ca2bbb4-2857	\N	NEW	\N	\N	\N	\N
82827	79	D5170C00002/tiny.path.1/file-1437.pdf	\N	D5170C00002-1deb4916-8316-11eb-be00-d14abf7e2d86-1437	\N	NEW	\N	\N	\N	\N
84248	79	D5170C00002/tiny.path.1/file-2858.pdf	\N	D5170C00002-1df90ed3-8317-11eb-be00-f726d673ece0-2858	\N	NEW	\N	\N	\N	\N
82828	79	D5170C00002/tiny.path.1/file-1438.pdf	\N	D5170C00002-1df9a0f7-8316-11eb-be00-b7b38305a997-1438	\N	NEW	\N	\N	\N	\N
81462	79	D5170C00002/tiny.path.1/file-0072.pdf	\N	D5170C00002-1e07edf1-8315-11eb-be00-053137ffb489-72	\N	NEW	\N	\N	\N	\N
82829	79	D5170C00002/tiny.path.1/file-1439.pdf	\N	D5170C00002-1e17d758-8316-11eb-be00-9be2ed798293-1439	\N	NEW	\N	\N	\N	\N
85797	79	D5170C00002/tiny.path.1/file-4407.pdf	\N	D5170C00002-1e25f5d2-8318-11eb-be00-03f1cf62bcdb-4409	\N	NEW	\N	\N	\N	\N
87166	79	D5170C00002/tiny.path.1/file-5776.pdf	\N	D5170C00002-1e26c409-8319-11eb-be00-bbcc4825d8b2-5776	\N	NEW	\N	\N	\N	\N
82830	79	D5170C00002/tiny.path.1/file-1440.pdf	\N	D5170C00002-1e459e19-8316-11eb-be00-c5755f4126ca-1440	\N	NEW	\N	\N	\N	\N
81463	79	D5170C00002/tiny.path.1/file-0073.pdf	\N	D5170C00002-1e539cf2-8315-11eb-be00-2132e8a0157e-73	\N	NEW	\N	\N	\N	\N
87167	79	D5170C00002/tiny.path.1/file-5777.pdf	\N	D5170C00002-1e55c34a-8319-11eb-be00-11252cce097c-5777	\N	NEW	\N	\N	\N	\N
87168	79	D5170C00002/tiny.path.1/file-5778.pdf	\N	D5170C00002-1e6330cb-8319-11eb-be00-05ad71e830ee-5778	\N	NEW	\N	\N	\N	\N
82831	79	D5170C00002/tiny.path.1/file-1441.pdf	\N	D5170C00002-1e72054a-8316-11eb-be00-c5394e6cc232-1441	\N	NEW	\N	\N	\N	\N
87169	79	D5170C00002/tiny.path.1/file-5779.pdf	\N	D5170C00002-1e82789c-8319-11eb-be00-2f6c9e9e96f9-5779	\N	NEW	\N	\N	\N	\N
87170	79	D5170C00002/tiny.path.1/file-5780.pdf	\N	D5170C00002-1e9193cd-8319-11eb-be00-49ead8707834-5780	\N	NEW	\N	\N	\N	\N
85798	79	D5170C00002/tiny.path.1/file-4408.pdf	\N	D5170C00002-1e933693-8318-11eb-be00-59eb1fd8b20a-4410	\N	NEW	\N	\N	\N	\N
84249	79	D5170C00002/tiny.path.1/file-2859.msg	\N	D5170C00002-1ea1d1f4-8317-11eb-be00-d3aadddcf366-2859	\N	NEW	\N	\N	\N	\N
87171	79	D5170C00002/tiny.path.1/file-5781.pdf	\N	D5170C00002-1ea1e77e-8319-11eb-be00-6d73c961dc59-5781	\N	NEW	\N	\N	\N	\N
81464	79	D5170C00002/tiny.path.1/file-0074.pdf	\N	D5170C00002-1eaf7893-8315-11eb-be00-e1f5d065c3c7-74	\N	NEW	\N	\N	\N	\N
81465	79	D5170C00002/tiny.path.1/file-0075.pdf	\N	D5170C00002-1eb19b74-8315-11eb-be00-3dc7899293b7-75	\N	NEW	\N	\N	\N	\N
85799	79	D5170C00002/tiny.path.1/file-4409.pdf	\N	D5170C00002-1ece1cb4-8318-11eb-be00-1f4d77f6a255-4411	\N	NEW	\N	\N	\N	\N
82832	79	D5170C00002/tiny.path.1/file-1442.pdf	\N	D5170C00002-1ece7d2b-8316-11eb-be00-4fa73c4c91b6-1442	\N	NEW	\N	\N	\N	\N
81466	79	D5170C00002/tiny.path.1/file-0076.pdf	\N	D5170C00002-1edca315-8315-11eb-be00-73f22a9e081e-76	\N	NEW	\N	\N	\N	\N
84250	79	D5170C00002/tiny.path.1/file-2860.msg	\N	D5170C00002-1edd2d45-8317-11eb-be00-91d1a38193ad-2860	\N	NEW	\N	\N	\N	\N
87172	79	D5170C00002/tiny.path.1/file-5782.pdf	\N	D5170C00002-1ede061f-8319-11eb-be00-691f00a93fe1-5782	\N	NEW	\N	\N	\N	\N
82833	79	D5170C00002/tiny.path.1/file-1443.pdf	\N	D5170C00002-1ede82bc-8316-11eb-be00-694effa3a3a9-1443	\N	NEW	\N	\N	\N	\N
82834	79	D5170C00002/tiny.path.1/file-1444.pdf	\N	D5170C00002-1efba7ad-8316-11eb-be00-776a93a83836-1444	\N	NEW	\N	\N	\N	\N
84251	79	D5170C00002/tiny.path.1/file-2861.msg	\N	D5170C00002-1efbffe6-8317-11eb-be00-c1a19005b06a-2861	\N	NEW	\N	\N	\N	\N
82835	79	D5170C00002/tiny.path.1/file-1445.pdf	\N	D5170C00002-1f1ac86e-8316-11eb-be00-d7174036de45-1445	\N	NEW	\N	\N	\N	\N
81467	79	D5170C00002/tiny.path.1/file-0077.pdf	\N	D5170C00002-1f291566-8315-11eb-be00-b9fce38b976b-77	\N	NEW	\N	\N	\N	\N
85800	79	D5170C00002/tiny.path.1/file-4410.pdf	\N	D5170C00002-1f29aa35-8318-11eb-be00-f58d08848e01-4412	\N	NEW	\N	\N	\N	\N
84252	79	D5170C00002/tiny.path.1/file-2862.msg	\N	D5170C00002-1f381e87-8317-11eb-be00-0bca81e503a9-2862	\N	NEW	\N	\N	\N	\N
82836	79	D5170C00002/tiny.path.1/file-1446.pdf	\N	D5170C00002-1f394cef-8316-11eb-be00-09f154dda311-1446	\N	NEW	\N	\N	\N	\N
81468	79	D5170C00002/tiny.path.1/file-0078.pdf	\N	D5170C00002-1f3b3dd7-8315-11eb-be00-4920080b6f16-78	\N	NEW	\N	\N	\N	\N
87173	79	D5170C00002/tiny.path.1/file-5783.pdf	\N	D5170C00002-1f481290-8319-11eb-be00-9db2364061cf-5783	\N	NEW	\N	\N	\N	\N
85801	79	D5170C00002/tiny.path.1/file-4411.pdf	\N	D5170C00002-1f48a3e6-8318-11eb-be00-25b755662844-4413	\N	NEW	\N	\N	\N	\N
81469	79	D5170C00002/tiny.path.1/file-0079.pdf	\N	D5170C00002-1f49e3d8-8315-11eb-be00-bf577fbd9dd8-79	\N	NEW	\N	\N	\N	\N
84253	79	D5170C00002/tiny.path.1/file-2863.msg	\N	D5170C00002-1f571838-8317-11eb-be00-73c60a2f2d4f-2863	\N	NEW	\N	\N	\N	\N
85802	79	D5170C00002/tiny.path.1/file-4412.pdf	\N	D5170C00002-1f5722d7-8318-11eb-be00-4dba33b2585e-4414	\N	NEW	\N	\N	\N	\N
82837	79	D5170C00002/tiny.path.1/file-1447.pdf	\N	D5170C00002-1f57aa60-8316-11eb-be00-3313065c6d95-1447	\N	NEW	\N	\N	\N	\N
85803	79	D5170C00002/tiny.path.1/file-4413.pdf	\N	D5170C00002-1f666518-8318-11eb-be00-cb541c0b56e0-4415	\N	NEW	\N	\N	\N	\N
85804	79	D5170C00002/tiny.path.1/file-4414.pdf	\N	D5170C00002-1f75a759-8318-11eb-be00-1b8aed707445-4416	\N	NEW	\N	\N	\N	\N
87174	79	D5170C00002/tiny.path.1/file-5784.pdf	\N	D5170C00002-1f8542a1-8319-11eb-be00-119626254111-5784	\N	NEW	\N	\N	\N	\N
81470	79	D5170C00002/tiny.path.1/file-0080.pdf	\N	D5170C00002-1f93be19-8315-11eb-be00-39d90469f4b1-80	\N	NEW	\N	\N	\N	\N
85805	79	D5170C00002/tiny.path.1/file-4415.pdf	\N	D5170C00002-1f942bda-8318-11eb-be00-2923ba509dde-4417	\N	NEW	\N	\N	\N	\N
84254	79	D5170C00002/tiny.path.1/file-2864.msg	\N	D5170C00002-1f950b99-8317-11eb-be00-bd0a0e5df20b-2864	\N	NEW	\N	\N	\N	\N
82838	79	D5170C00002/tiny.path.1/file-1448.pdf	\N	D5170C00002-1f95c4d1-8316-11eb-be00-3f7a41fe41aa-1448	\N	NEW	\N	\N	\N	\N
85806	79	D5170C00002/tiny.path.1/file-4416.pdf	\N	D5170C00002-1fa3470b-8318-11eb-be00-057269a88c10-4418	\N	NEW	\N	\N	\N	\N
84255	79	D5170C00002/tiny.path.1/file-2865.msg	\N	D5170C00002-1fa5383a-8317-11eb-be00-d1a8184b3818-2865	\N	NEW	\N	\N	\N	\N
87175	79	D5170C00002/tiny.path.1/file-5785.pdf	\N	D5170C00002-1fa54dc2-8319-11eb-be00-f71ac6b672e0-5785	\N	NEW	\N	\N	\N	\N
85807	79	D5170C00002/tiny.path.1/file-4417.pdf	\N	D5170C00002-1fb39abc-8318-11eb-be00-25c6fc1316e0-4419	\N	NEW	\N	\N	\N	\N
84256	79	D5170C00002/tiny.path.1/file-2866.msg	\N	D5170C00002-1fb4536b-8317-11eb-be00-99c64acc47d5-2866	\N	NEW	\N	\N	\N	\N
87176	79	D5170C00002/tiny.path.1/file-5786.pdf	\N	D5170C00002-1fc13a33-8319-11eb-be00-11df892ab261-5786	\N	NEW	\N	\N	\N	\N
82839	79	D5170C00002/tiny.path.1/file-1449.pdf	\N	D5170C00002-1fc2c842-8316-11eb-be00-47face8c6608-1449	\N	NEW	\N	\N	\N	\N
81471	79	D5170C00002/tiny.path.1/file-0081.pdf	\N	D5170C00002-1fd1ff9a-8315-11eb-be00-139e5cb8da05-81	\N	NEW	\N	\N	\N	\N
84257	79	D5170C00002/tiny.path.1/file-2867.msg	\N	D5170C00002-1fd3742c-8317-11eb-be00-071c160e3dfd-2867	\N	NEW	\N	\N	\N	\N
82840	79	D5170C00002/tiny.path.1/file-1450.pdf	\N	D5170C00002-1fe06263-8316-11eb-be00-b91bf852adfa-1450	\N	NEW	\N	\N	\N	\N
87177	79	D5170C00002/tiny.path.1/file-5787.pdf	\N	D5170C00002-1fe0a914-8319-11eb-be00-034d7c15ac93-5787	\N	NEW	\N	\N	\N	\N
85808	79	D5170C00002/tiny.path.1/file-4418.pdf	\N	D5170C00002-1fe1617d-8318-11eb-be00-05cb773e3bf4-4420	\N	NEW	\N	\N	\N	\N
87178	79	D5170C00002/tiny.path.1/file-5788.pdf	\N	D5170C00002-1fe19375-8319-11eb-be00-c90c8802f651-5788	\N	NEW	\N	\N	\N	\N
81472	79	D5170C00002/tiny.path.1/file-0082.pdf	\N	D5170C00002-1ff0f94b-8315-11eb-be00-df12ed49bd0c-82	\N	NEW	\N	\N	\N	\N
87179	79	D5170C00002/tiny.path.1/file-5789.pdf	\N	D5170C00002-1ffe1c26-8319-11eb-be00-e7f025af7d0d-5789	\N	NEW	\N	\N	\N	\N
82841	79	D5170C00002/tiny.path.1/file-1451.pdf	\N	D5170C00002-200e0214-8316-11eb-be00-11930d8b2b89-1451	\N	NEW	\N	\N	\N	\N
81473	79	D5170C00002/tiny.path.1/file-0083.pdf	\N	D5170C00002-20101a0c-8315-11eb-be00-a509bfcaa0d6-83	\N	NEW	\N	\N	\N	\N
87180	79	D5170C00002/tiny.path.1/file-5790.pdf	\N	D5170C00002-201d15d7-8319-11eb-be00-9780d838c183-5790	\N	NEW	\N	\N	\N	\N
84258	79	D5170C00002/tiny.path.1/file-2868.pdf	\N	D5170C00002-201d757d-8317-11eb-be00-4b2792cc6110-2868	\N	NEW	\N	\N	\N	\N
82842	79	D5170C00002/tiny.path.1/file-1452.pdf	\N	D5170C00002-201ef205-8316-11eb-be00-576ca2672cb3-1452	\N	NEW	\N	\N	\N	\N
84259	79	D5170C00002/tiny.path.1/file-2869.pdf	\N	D5170C00002-202c428e-8317-11eb-be00-1dcdce559667-2869	\N	NEW	\N	\N	\N	\N
87181	79	D5170C00002/tiny.path.1/file-5791.pdf	\N	D5170C00002-202c5818-8319-11eb-be00-ed4e9f3b99a7-5791	\N	NEW	\N	\N	\N	\N
85809	79	D5170C00002/tiny.path.1/file-4419.pdf	\N	D5170C00002-202d107e-8318-11eb-be00-dd1ee3ab364e-4421	\N	NEW	\N	\N	\N	\N
87182	79	D5170C00002/tiny.path.1/file-5792.pdf	\N	D5170C00002-202e05c9-8319-11eb-be00-cdf957fb2524-5792	\N	NEW	\N	\N	\N	\N
84260	79	D5170C00002/tiny.path.1/file-2870.pdf	\N	D5170C00002-202e8c7f-8317-11eb-be00-7bcd5dad30c5-2870	\N	NEW	\N	\N	\N	\N
81474	79	D5170C00002/tiny.path.1/file-0084.pdf	\N	D5170C00002-203e55fd-8315-11eb-be00-0d21477a041d-84	\N	NEW	\N	\N	\N	\N
87183	79	D5170C00002/tiny.path.1/file-5793.pdf	\N	D5170C00002-204a8e7a-8319-11eb-be00-f1acfdfda947-5793	\N	NEW	\N	\N	\N	\N
84261	79	D5170C00002/tiny.path.1/file-2871.pdf	\N	D5170C00002-204ac710-8317-11eb-be00-a394ced33841-2871	\N	NEW	\N	\N	\N	\N
85810	79	D5170C00002/tiny.path.1/file-4420.pdf	\N	D5170C00002-204af8bf-8318-11eb-be00-e7c387de6f0c-4422	\N	NEW	\N	\N	\N	\N
84262	79	D5170C00002/tiny.path.1/file-2872.pdf	\N	D5170C00002-205a0951-8317-11eb-be00-9105a40255ed-2872	\N	NEW	\N	\N	\N	\N
87184	79	D5170C00002/tiny.path.1/file-5794.pdf	\N	D5170C00002-205b575b-8319-11eb-be00-6d488704df93-5794	\N	NEW	\N	\N	\N	\N
85811	79	D5170C00002/tiny.path.1/file-4421.pdf	\N	D5170C00002-205c0fc0-8318-11eb-be00-9f5a6a4de4f8-4423	\N	NEW	\N	\N	\N	\N
84263	79	D5170C00002/tiny.path.1/file-2873.pdf	\N	D5170C00002-206a0ee2-8317-11eb-be00-3377eec453c2-2873	\N	NEW	\N	\N	\N	\N
81475	79	D5170C00002/tiny.path.1/file-0085.pdf	\N	D5170C00002-206ae43e-8315-11eb-be00-d1ac27a8066b-85	\N	NEW	\N	\N	\N	\N
85812	79	D5170C00002/tiny.path.1/file-4422.pdf	\N	D5170C00002-207a9441-8318-11eb-be00-89a60756abf0-4424	\N	NEW	\N	\N	\N	\N
87185	79	D5170C00002/tiny.path.1/file-5795.pdf	\N	D5170C00002-2096b2ac-8319-11eb-be00-e7875ca2cce9-5795	\N	NEW	\N	\N	\N	\N
84264	79	D5170C00002/tiny.path.1/file-2874.pdf	\N	D5170C00002-20973963-8317-11eb-be00-4b753c37a3c2-2874	\N	NEW	\N	\N	\N	\N
85813	79	D5170C00002/tiny.path.1/file-4423.pdf	\N	D5170C00002-209966e2-8318-11eb-be00-e90bdf396e16-4425	\N	NEW	\N	\N	\N	\N
81476	79	D5170C00002/tiny.path.1/file-0086.pdf	\N	D5170C00002-2099955f-8315-11eb-be00-f36555cb3773-86	\N	NEW	\N	\N	\N	\N
85814	79	D5170C00002/tiny.path.1/file-4424.pdf	\N	D5170C00002-20a88213-8318-11eb-be00-913e2403c123-4426	\N	NEW	\N	\N	\N	\N
87186	79	D5170C00002/tiny.path.1/file-5796.pdf	\N	D5170C00002-20b66fad-8319-11eb-be00-57db26d9c23f-5796	\N	NEW	\N	\N	\N	\N
85815	79	D5170C00002/tiny.path.1/file-4425.pdf	\N	D5170C00002-20b7eb64-8318-11eb-be00-cd6c87e37dea-4427	\N	NEW	\N	\N	\N	\N
81477	79	D5170C00002/tiny.path.1/file-0087.pdf	\N	D5170C00002-20c7f860-8315-11eb-be00-7f9ec37aefaa-87	\N	NEW	\N	\N	\N	\N
84265	79	D5170C00002/tiny.path.1/file-2875.pdf	\N	D5170C00002-20d46974-8317-11eb-be00-ebaafc23fd99-2875	\N	NEW	\N	\N	\N	\N
85816	79	D5170C00002/tiny.path.1/file-4426.pdf	\N	D5170C00002-20d4e945-8318-11eb-be00-9983f5494885-4428	\N	NEW	\N	\N	\N	\N
84266	79	D5170C00002/tiny.path.1/file-2876.pdf	\N	D5170C00002-20e3d2c5-8317-11eb-be00-472af0844981-2876	\N	NEW	\N	\N	\N	\N
82843	79	D5170C00002/tiny.path.1/file-1453.pdf	\N	D5170C00002-20e464e6-8316-11eb-be00-93b7177d4f1e-1453	\N	NEW	\N	\N	\N	\N
85817	79	D5170C00002/tiny.path.1/file-4427.pdf	\N	D5170C00002-20e4c7c6-8318-11eb-be00-1102cc998b81-4429	\N	NEW	\N	\N	\N	\N
87187	79	D5170C00002/tiny.path.1/file-5797.pdf	\N	D5170C00002-20f378ae-8319-11eb-be00-1bca921a5cbd-5797	\N	NEW	\N	\N	\N	\N
85818	79	D5170C00002/tiny.path.1/file-4428.pdf	\N	D5170C00002-20f3e2f7-8318-11eb-be00-890bfebb24a9-4430	\N	NEW	\N	\N	\N	\N
82844	79	D5170C00002/tiny.path.1/file-1454.pdf	\N	D5170C00002-21029b47-8316-11eb-be00-b9e14a8e109d-1454	\N	NEW	\N	\N	\N	\N
84267	79	D5170C00002/tiny.path.1/file-2877.pdf	\N	D5170C00002-2102cc76-8317-11eb-be00-711e0b7d9581-2877	\N	NEW	\N	\N	\N	\N
85819	79	D5170C00002/tiny.path.1/file-4429.pdf	\N	D5170C00002-21052108-8318-11eb-be00-49b4243598d9-4431	\N	NEW	\N	\N	\N	\N
81478	79	D5170C00002/tiny.path.1/file-0088.pdf	\N	D5170C00002-2112bd01-8315-11eb-be00-379a57a13292-88	\N	NEW	\N	\N	\N	\N
82845	79	D5170C00002/tiny.path.1/file-1455.pdf	\N	D5170C00002-21131608-8316-11eb-be00-4775f7566815-1455	\N	NEW	\N	\N	\N	\N
84268	79	D5170C00002/tiny.path.1/file-2878.pdf	\N	D5170C00002-21208da7-8317-11eb-be00-efa6e8c54e1b-2878	\N	NEW	\N	\N	\N	\N
85820	79	D5170C00002/tiny.path.1/file-4430.pdf	\N	D5170C00002-21209849-8318-11eb-be00-67601c00d024-4432	\N	NEW	\N	\N	\N	\N
85821	79	D5170C00002/tiny.path.1/file-4431.pdf	\N	D5170C00002-2122e23a-8318-11eb-be00-8f535b084869-4433	\N	NEW	\N	\N	\N	\N
87188	79	D5170C00002/tiny.path.1/file-5798.pdf	\N	D5170C00002-2130338f-8319-11eb-be00-e5df4f763c42-5798	\N	NEW	\N	\N	\N	\N
81479	79	D5170C00002/tiny.path.1/file-0089.pdf	\N	D5170C00002-2130cc52-8315-11eb-be00-bbc16ac6c0af-89	\N	NEW	\N	\N	\N	\N
84269	79	D5170C00002/tiny.path.1/file-2879.pdf	\N	D5170C00002-21317d98-8317-11eb-be00-470126d5534f-2879	\N	NEW	\N	\N	\N	\N
85822	79	D5170C00002/tiny.path.1/file-4432.pdf	\N	D5170C00002-21330edb-8318-11eb-be00-a5e55f905690-4434	\N	NEW	\N	\N	\N	\N
82846	79	D5170C00002/tiny.path.1/file-1456.pdf	\N	D5170C00002-213f2f19-8316-11eb-be00-57a9afe52fcf-1456	\N	NEW	\N	\N	\N	\N
85823	79	D5170C00002/tiny.path.1/file-4433.pdf	\N	D5170C00002-2140a36c-8318-11eb-be00-d1c9716aa5f0-4435	\N	NEW	\N	\N	\N	\N
82847	79	D5170C00002/tiny.path.1/file-1457.pdf	\N	D5170C00002-2151307a-8316-11eb-be00-2f1e9ad31546-1457	\N	NEW	\N	\N	\N	\N
87189	79	D5170C00002/tiny.path.1/file-5799.pdf	\N	D5170C00002-215e9690-8319-11eb-be00-7545a43b9174-5799	\N	NEW	\N	\N	\N	\N
84271	79	D5170C00002/tiny.path.1/file-2881.pdf	\N	D5170C00002-215fb989-8317-11eb-be00-3571be80fc6a-2880	\N	NEW	\N	\N	\N	\N
85824	79	D5170C00002/tiny.path.1/file-4434.pdf	\N	D5170C00002-2160606d-8318-11eb-be00-71884315941a-4436	\N	NEW	\N	\N	\N	\N
82848	79	D5170C00002/tiny.path.1/file-1458.pdf	\N	D5170C00002-217cd45b-8316-11eb-be00-65ac301c788e-1458	\N	NEW	\N	\N	\N	\N
81480	79	D5170C00002/tiny.path.1/file-0090.pdf	\N	D5170C00002-217d65b3-8315-11eb-be00-473691a2893d-90	\N	NEW	\N	\N	\N	\N
84270	79	D5170C00002/tiny.path.1/file-2880.pdf	\N	D5170C00002-218cbcfa-8317-11eb-be00-235e3c19079c-2881	\N	NEW	\N	\N	\N	\N
81481	79	D5170C00002/tiny.path.1/file-0091.pdf	\N	D5170C00002-219cad84-8315-11eb-be00-3733e649ff67-91	\N	NEW	\N	\N	\N	\N
82849	79	D5170C00002/tiny.path.1/file-1459.pdf	\N	D5170C00002-21aa4cfc-8316-11eb-be00-d34bde69e146-1459	\N	NEW	\N	\N	\N	\N
81482	79	D5170C00002/tiny.path.1/file-0092.pdf	\N	D5170C00002-21ac3de5-8315-11eb-be00-171472eb7f2b-92	\N	NEW	\N	\N	\N	\N
84272	79	D5170C00002/tiny.path.1/file-2882.pdf	\N	D5170C00002-21b94b3b-8317-11eb-be00-cd4a2573c06b-2882	\N	NEW	\N	\N	\N	\N
87190	79	D5170C00002/tiny.path.1/file-5800.pdf	\N	D5170C00002-21ca77c1-8319-11eb-be00-e56a065fd9ad-5800	\N	NEW	\N	\N	\N	\N
82850	79	D5170C00002/tiny.path.1/file-1460.pdf	\N	D5170C00002-21d7ecad-8316-11eb-be00-9d8c84dc456a-1460	\N	NEW	\N	\N	\N	\N
85827	79	D5170C00002/tiny.path.1/file-4437.pdf	\N	D5170C00002-21d8769e-8318-11eb-be00-bf5857358575-4437	\N	NEW	\N	\N	\N	\N
84273	79	D5170C00002/tiny.path.1/file-2883.pdf	\N	D5170C00002-21da19ac-8317-11eb-be00-f56b81b63f12-2883	\N	NEW	\N	\N	\N	\N
81483	79	D5170C00002/tiny.path.1/file-0093.pdf	\N	D5170C00002-21e88396-8315-11eb-be00-19160415f4f9-93	\N	NEW	\N	\N	\N	\N
85828	79	D5170C00002/tiny.path.1/file-4438.pdf	\N	D5170C00002-21e8f15f-8318-11eb-be00-d5320edc9dd0-4438	\N	NEW	\N	\N	\N	\N
84274	79	D5170C00002/tiny.path.1/file-2884.pdf	\N	D5170C00002-2205bd8d-8317-11eb-be00-a333598fd840-2884	\N	NEW	\N	\N	\N	\N
81484	79	D5170C00002/tiny.path.1/file-0094.pdf	\N	D5170C00002-22070817-8315-11eb-be00-ef8e69983c15-94	\N	NEW	\N	\N	\N	\N
82851	79	D5170C00002/tiny.path.1/file-1461.pdf	\N	D5170C00002-22084b7e-8316-11eb-be00-0f66244c6a5a-1461	\N	NEW	\N	\N	\N	\N
87191	79	D5170C00002/tiny.path.1/file-5801.pdf	\N	D5170C00002-22236d32-8319-11eb-be00-99b0a48f16e3-5801	\N	NEW	\N	\N	\N	\N
81485	79	D5170C00002/tiny.path.1/file-0095.pdf	\N	D5170C00002-22253e78-8315-11eb-be00-47d83c3f7922-95	\N	NEW	\N	\N	\N	\N
84275	79	D5170C00002/tiny.path.1/file-2885.pdf	\N	D5170C00002-2227283e-8317-11eb-be00-19301eea36c3-2885	\N	NEW	\N	\N	\N	\N
82852	79	D5170C00002/tiny.path.1/file-1462.pdf	\N	D5170C00002-2234648f-8316-11eb-be00-a33fefbffed2-1462	\N	NEW	\N	\N	\N	\N
82853	79	D5170C00002/tiny.path.1/file-1463.pdf	\N	D5170C00002-224358b0-8316-11eb-be00-afe04a003edc-1463	\N	NEW	\N	\N	\N	\N
84276	79	D5170C00002/tiny.path.1/file-2886.pdf	\N	D5170C00002-225479cf-8317-11eb-be00-1b1bb1911d57-2886	\N	NEW	\N	\N	\N	\N
87192	79	D5170C00002/tiny.path.1/file-5802.pdf	\N	D5170C00002-226187a3-8319-11eb-be00-1f182a2c3df5-5802	\N	NEW	\N	\N	\N	\N
82854	79	D5170C00002/tiny.path.1/file-1464.pdf	\N	D5170C00002-22620441-8316-11eb-be00-3b4d3d8c9cf2-1464	\N	NEW	\N	\N	\N	\N
82855	79	D5170C00002/tiny.path.1/file-1465.pdf	\N	D5170C00002-228061b2-8316-11eb-be00-c725db0d624c-1465	\N	NEW	\N	\N	\N	\N
84277	79	D5170C00002/tiny.path.1/file-2887.pdf	\N	D5170C00002-22810810-8317-11eb-be00-0913f5b07c03-2887	\N	NEW	\N	\N	\N	\N
82856	79	D5170C00002/tiny.path.1/file-1466.pdf	\N	D5170C00002-229e9813-8316-11eb-be00-4f599b214072-1466	\N	NEW	\N	\N	\N	\N
84278	79	D5170C00002/tiny.path.1/file-2888.pdf	\N	D5170C00002-229ea231-8317-11eb-be00-cd832272cd5c-2888	\N	NEW	\N	\N	\N	\N
87193	79	D5170C00002/tiny.path.1/file-5803.pdf	\N	D5170C00002-22ae2104-8319-11eb-be00-a96212403e2b-5803	\N	NEW	\N	\N	\N	\N
82857	79	D5170C00002/tiny.path.1/file-1467.pdf	\N	D5170C00002-22bd1c94-8316-11eb-be00-87ce0814a2a8-1467	\N	NEW	\N	\N	\N	\N
84279	79	D5170C00002/tiny.path.1/file-2889.pdf	\N	D5170C00002-22bdc2f2-8317-11eb-be00-a9586f041852-2889	\N	NEW	\N	\N	\N	\N
82858	79	D5170C00002/tiny.path.1/file-1468.pdf	\N	D5170C00002-22bea335-8316-11eb-be00-cdd4f157c7d2-1468	\N	NEW	\N	\N	\N	\N
82859	79	D5170C00002/tiny.path.1/file-1469.pdf	\N	D5170C00002-22ce81b6-8316-11eb-be00-13add2a26c82-1469	\N	NEW	\N	\N	\N	\N
82860	79	D5170C00002/tiny.path.1/file-1470.pdf	\N	D5170C00002-22de3927-8316-11eb-be00-edd1e2692832-1470	\N	NEW	\N	\N	\N	\N
84280	79	D5170C00002/tiny.path.1/file-2890.pdf	\N	D5170C00002-22ec25f3-8317-11eb-be00-33a9c7e6225a-2890	\N	NEW	\N	\N	\N	\N
87194	79	D5170C00002/tiny.path.1/file-5804.pdf	\N	D5170C00002-22f90cb5-8319-11eb-be00-5f09a69740ed-5804	\N	NEW	\N	\N	\N	\N
85829	79	D5170C00002/tiny.path.1/file-4439.pdf	\N	D5170C00002-22fa1340-8318-11eb-be00-2339f2e047da-4439	\N	NEW	\N	\N	\N	\N
82861	79	D5170C00002/tiny.path.1/file-1471.pdf	\N	D5170C00002-22fb8528-8316-11eb-be00-9995486e9b5b-1471	\N	NEW	\N	\N	\N	\N
84281	79	D5170C00002/tiny.path.1/file-2891.pdf	\N	D5170C00002-22fc5294-8317-11eb-be00-29dd2f2696f1-2891	\N	NEW	\N	\N	\N	\N
82862	79	D5170C00002/tiny.path.1/file-1472.pdf	\N	D5170C00002-231a57c9-8316-11eb-be00-ad7b36686384-1472	\N	NEW	\N	\N	\N	\N
84282	79	D5170C00002/tiny.path.1/file-2892.pdf	\N	D5170C00002-23278145-8317-11eb-be00-1714be7c7a40-2892	\N	NEW	\N	\N	\N	\N
85830	79	D5170C00002/tiny.path.1/file-4440.pdf	\N	D5170C00002-23374351-8318-11eb-be00-27951ba69b91-4440	\N	NEW	\N	\N	\N	\N
84283	79	D5170C00002/tiny.path.1/file-2893.pdf	\N	D5170C00002-23389846-8317-11eb-be00-898b58592765-2893	\N	NEW	\N	\N	\N	\N
87195	79	D5170C00002/tiny.path.1/file-5805.pdf	\N	D5170C00002-23558496-8319-11eb-be00-c9a76576b862-5805	\N	NEW	\N	\N	\N	\N
81486	79	D5170C00002/tiny.path.1/file-0096.pdf	\N	D5170C00002-23655f99-8315-11eb-be00-1f76fb8f2b86-96	\N	NEW	\N	\N	\N	\N
85831	79	D5170C00002/tiny.path.1/file-4441.pdf	\N	D5170C00002-236690b2-8318-11eb-be00-e521d7c09480-4441	\N	NEW	\N	\N	\N	\N
84284	79	D5170C00002/tiny.path.1/file-2894.pdf	\N	D5170C00002-2375a147-8317-11eb-be00-4b2cc6531adb-2894	\N	NEW	\N	\N	\N	\N
81487	79	D5170C00002/tiny.path.1/file-0097.pdf	\N	D5170C00002-23a1f36a-8315-11eb-be00-055cdb7a6022-97	\N	NEW	\N	\N	\N	\N
82863	79	D5170C00002/tiny.path.1/file-1473.pdf	\N	D5170C00002-23a24c7a-8316-11eb-be00-2305f867e0c1-1473	\N	NEW	\N	\N	\N	\N
84285	79	D5170C00002/tiny.path.1/file-2895.pdf	\N	D5170C00002-23c1c578-8317-11eb-be00-192a4eaba379-2895	\N	NEW	\N	\N	\N	\N
81488	79	D5170C00002/tiny.path.1/file-0098.pdf	\N	D5170C00002-23d0566b-8315-11eb-be00-cf957a24200e-98	\N	NEW	\N	\N	\N	\N
82864	79	D5170C00002/tiny.path.1/file-1474.pdf	\N	D5170C00002-23d0af7b-8316-11eb-be00-9f7905cba0ee-1474	\N	NEW	\N	\N	\N	\N
87196	79	D5170C00002/tiny.path.1/file-5806.pdf	\N	D5170C00002-23deffe7-8319-11eb-be00-893f7032fcde-5806	\N	NEW	\N	\N	\N	\N
81489	79	D5170C00002/tiny.path.1/file-0099.pdf	\N	D5170C00002-23ee179c-8315-11eb-be00-935f379b64be-99	\N	NEW	\N	\N	\N	\N
81490	79	D5170C00002/tiny.path.1/file-0100.pdf	\N	D5170C00002-23f0889d-8315-11eb-be00-4fbf56383a0c-100	\N	NEW	\N	\N	\N	\N
82865	79	D5170C00002/tiny.path.1/file-1475.pdf	\N	D5170C00002-240c7ffc-8316-11eb-be00-6d3f28dea56d-1475	\N	NEW	\N	\N	\N	\N
84286	79	D5170C00002/tiny.path.1/file-2896.pdf	\N	D5170C00002-240c8a19-8317-11eb-be00-c1744b213a37-2896	\N	NEW	\N	\N	\N	\N
87197	79	D5170C00002/tiny.path.1/file-5807.pdf	\N	D5170C00002-240c9f98-8319-11eb-be00-637c240e2c55-5807	\N	NEW	\N	\N	\N	\N
87198	79	D5170C00002/tiny.path.1/file-5808.pdf	\N	D5170C00002-241d1a59-8319-11eb-be00-cf24e5001895-5808	\N	NEW	\N	\N	\N	\N
82866	79	D5170C00002/tiny.path.1/file-1476.pdf	\N	D5170C00002-241ea86d-8316-11eb-be00-49aecca3746b-1476	\N	NEW	\N	\N	\N	\N
84287	79	D5170C00002/tiny.path.1/file-2897.pdf	\N	D5170C00002-243a77ea-8317-11eb-be00-5f96f37e0584-2897	\N	NEW	\N	\N	\N	\N
87199	79	D5170C00002/tiny.path.1/file-5809.pdf	\N	D5170C00002-24490c5a-8319-11eb-be00-6327fa125e40-5809	\N	NEW	\N	\N	\N	\N
85832	79	D5170C00002/tiny.path.1/file-4442.pdf	\N	D5170C00002-24586ac3-8318-11eb-be00-fd30c3b9a4ad-4442	\N	NEW	\N	\N	\N	\N
87200	79	D5170C00002/tiny.path.1/file-5810.pdf	\N	D5170C00002-246742bb-8319-11eb-be00-6b1ea4613b08-5810	\N	NEW	\N	\N	\N	\N
85833	79	D5170C00002/tiny.path.1/file-4443.pdf	\N	D5170C00002-2467ad04-8318-11eb-be00-8160849873fe-4443	\N	NEW	\N	\N	\N	\N
85834	79	D5170C00002/tiny.path.1/file-4444.pdf	\N	D5170C00002-24771655-8318-11eb-be00-e91617a8d75b-4444	\N	NEW	\N	\N	\N	\N
82867	79	D5170C00002/tiny.path.1/file-1477.pdf	\N	D5170C00002-2478883e-8316-11eb-be00-03f1b20fd491-1477	\N	NEW	\N	\N	\N	\N
84288	79	D5170C00002/tiny.path.1/file-2898.pdf	\N	D5170C00002-2487fbab-8317-11eb-be00-93568e8a031e-2898	\N	NEW	\N	\N	\N	\N
85835	79	D5170C00002/tiny.path.1/file-4445.pdf	\N	D5170C00002-24882d56-8318-11eb-be00-7fa62c3f81b9-4445	\N	NEW	\N	\N	\N	\N
81491	79	D5170C00002/tiny.path.1/file-0101.pdf	\N	D5170C00002-24a5f5ee-8315-11eb-be00-2d492c99894b-101	\N	NEW	\N	\N	\N	\N
87201	79	D5170C00002/tiny.path.1/file-5811.pdf	\N	D5170C00002-24a6478c-8319-11eb-be00-0fca48bf6bf8-5811	\N	NEW	\N	\N	\N	\N
84289	79	D5170C00002/tiny.path.1/file-2899.pdf	\N	D5170C00002-24b5c26c-8317-11eb-be00-2b0c1a1dab3d-2899	\N	NEW	\N	\N	\N	\N
84290	79	D5170C00002/tiny.path.1/file-2900.pdf	\N	D5170C00002-24c3a51d-8317-11eb-be00-295b021c9901-2900	\N	NEW	\N	\N	\N	\N
81492	79	D5170C00002/tiny.path.1/file-0102.pdf	\N	D5170C00002-24c516af-8315-11eb-be00-d30e80ee67c3-102	\N	NEW	\N	\N	\N	\N
82868	79	D5170C00002/tiny.path.1/file-1478.pdf	\N	D5170C00002-24c548af-8316-11eb-be00-1f9e342042ce-1478	\N	NEW	\N	\N	\N	\N
81493	79	D5170C00002/tiny.path.1/file-0103.pdf	\N	D5170C00002-24d51c40-8315-11eb-be00-5ded9a959589-103	\N	NEW	\N	\N	\N	\N
87202	79	D5170C00002/tiny.path.1/file-5812.pdf	\N	D5170C00002-24e154bd-8319-11eb-be00-6d63d774cea9-5812	\N	NEW	\N	\N	\N	\N
84291	79	D5170C00002/tiny.path.1/file-2901.pdf	\N	D5170C00002-24e2028e-8317-11eb-be00-f56f66e74744-2901	\N	NEW	\N	\N	\N	\N
85836	79	D5170C00002/tiny.path.1/file-4446.pdf	\N	D5170C00002-24f0da37-8318-11eb-be00-17ecdeb6e8a1-4446	\N	NEW	\N	\N	\N	\N
87203	79	D5170C00002/tiny.path.1/file-5813.pdf	\N	D5170C00002-24f15a4e-8319-11eb-be00-37c623a8827e-5813	\N	NEW	\N	\N	\N	\N
82869	79	D5170C00002/tiny.path.1/file-1479.pdf	\N	D5170C00002-24f24c20-8316-11eb-be00-1f876bd78195-1479	\N	NEW	\N	\N	\N	\N
81494	79	D5170C00002/tiny.path.1/file-0104.pdf	\N	D5170C00002-2500c021-8315-11eb-be00-75d21a6683fd-104	\N	NEW	\N	\N	\N	\N
84292	79	D5170C00002/tiny.path.1/file-2902.pdf	\N	D5170C00002-25014a5f-8317-11eb-be00-8b2ecbe8bd53-2902	\N	NEW	\N	\N	\N	\N
87204	79	D5170C00002/tiny.path.1/file-5814.pdf	\N	D5170C00002-2501adff-8319-11eb-be00-d796d0bc866b-5814	\N	NEW	\N	\N	\N	\N
87205	79	D5170C00002/tiny.path.1/file-5815.pdf	\N	D5170C00002-250f4290-8319-11eb-be00-e17bd88a34c0-5815	\N	NEW	\N	\N	\N	\N
82870	79	D5170C00002/tiny.path.1/file-1480.pdf	\N	D5170C00002-251f76a1-8316-11eb-be00-e9b402d06749-1480	\N	NEW	\N	\N	\N	\N
81518	79	D5170C00002/tiny.path.1/file-0128.pdf	\N	D5170C00002-251fb9d2-8315-11eb-be00-fde832a131c4-105	\N	NEW	\N	\N	\N	\N
84293	79	D5170C00002/tiny.path.1/file-2903.pdf	\N	D5170C00002-251ff5f0-8317-11eb-be00-f3d185b87a26-2903	\N	NEW	\N	\N	\N	\N
87206	79	D5170C00002/tiny.path.1/file-5816.pdf	\N	D5170C00002-2520f5d1-8319-11eb-be00-091afd6d79d0-5816	\N	NEW	\N	\N	\N	\N
85837	79	D5170C00002/tiny.path.1/file-4447.pdf	\N	D5170C00002-25213908-8318-11eb-be00-2fffba64ec70-4447	\N	NEW	\N	\N	\N	\N
84294	79	D5170C00002/tiny.path.1/file-2904.pdf	\N	D5170C00002-252e4dd1-8317-11eb-be00-95d03201e957-2904	\N	NEW	\N	\N	\N	\N
81495	79	D5170C00002/tiny.path.1/file-0105.pdf	\N	D5170C00002-254da7a3-8315-11eb-be00-5b705d036cd3-106	\N	NEW	\N	\N	\N	\N
85838	79	D5170C00002/tiny.path.1/file-4448.pdf	\N	D5170C00002-256aec39-8318-11eb-be00-b993610f1c69-4448	\N	NEW	\N	\N	\N	\N
81496	79	D5170C00002/tiny.path.1/file-0106.pdf	\N	D5170C00002-256dd9d4-8315-11eb-be00-f5954eca8c9c-107	\N	NEW	\N	\N	\N	\N
82871	79	D5170C00002/tiny.path.1/file-1481.pdf	\N	D5170C00002-257b0422-8316-11eb-be00-8f2401708d12-1481	\N	NEW	\N	\N	\N	\N
87207	79	D5170C00002/tiny.path.1/file-5817.pdf	\N	D5170C00002-25897ba2-8319-11eb-be00-0da8f672a127-5817	\N	NEW	\N	\N	\N	\N
85839	79	D5170C00002/tiny.path.1/file-4449.pdf	\N	D5170C00002-2589beda-8318-11eb-be00-056818d04ff1-4449	\N	NEW	\N	\N	\N	\N
81497	79	D5170C00002/tiny.path.1/file-0107.pdf	\N	D5170C00002-258a6285-8315-11eb-be00-1db6831576c9-108	\N	NEW	\N	\N	\N	\N
81498	79	D5170C00002/tiny.path.1/file-0108.pdf	\N	D5170C00002-2599f2e6-8315-11eb-be00-6151f700f76f-109	\N	NEW	\N	\N	\N	\N
85840	79	D5170C00002/tiny.path.1/file-4450.pdf	\N	D5170C00002-259afceb-8318-11eb-be00-0fd394f653dd-4450	\N	NEW	\N	\N	\N	\N
82872	79	D5170C00002/tiny.path.1/file-1482.pdf	\N	D5170C00002-259bd293-8316-11eb-be00-0b1a31201260-1482	\N	NEW	\N	\N	\N	\N
87208	79	D5170C00002/tiny.path.1/file-5818.pdf	\N	D5170C00002-25a7d913-8319-11eb-be00-d11b9f83f71f-5818	\N	NEW	\N	\N	\N	\N
84295	79	D5170C00002/tiny.path.1/file-2905.pdf	\N	D5170C00002-25a92322-8317-11eb-be00-75491075fac0-2905	\N	NEW	\N	\N	\N	\N
82873	79	D5170C00002/tiny.path.1/file-1483.pdf	\N	D5170C00002-25b797f4-8316-11eb-be00-41564f8be79a-1483	\N	NEW	\N	\N	\N	\N
81499	79	D5170C00002/tiny.path.1/file-0109.pdf	\N	D5170C00002-25b82947-8315-11eb-be00-259a302eab55-110	\N	NEW	\N	\N	\N	\N
85841	79	D5170C00002/tiny.path.1/file-4451.pdf	\N	D5170C00002-25b848ec-8318-11eb-be00-597c3694e1ba-4451	\N	NEW	\N	\N	\N	\N
87209	79	D5170C00002/tiny.path.1/file-5819.pdf	\N	D5170C00002-25b96544-8319-11eb-be00-17430ed79d25-5819	\N	NEW	\N	\N	\N	\N
84296	79	D5170C00002/tiny.path.1/file-2906.pdf	\N	D5170C00002-25ba6133-8317-11eb-be00-1da4df28b3ac-2906	\N	NEW	\N	\N	\N	\N
85842	79	D5170C00002/tiny.path.1/file-4452.pdf	\N	D5170C00002-25c6eeed-8318-11eb-be00-23c76d39dd44-4452	\N	NEW	\N	\N	\N	\N
85843	79	D5170C00002/tiny.path.1/file-4453.pdf	\N	D5170C00002-25d5bbfe-8318-11eb-be00-5304025de3b8-4453	\N	NEW	\N	\N	\N	\N
81500	79	D5170C00002/tiny.path.1/file-0110.pdf	\N	D5170C00002-25d686b8-8315-11eb-be00-7b09e8996311-111	\N	NEW	\N	\N	\N	\N
87210	79	D5170C00002/tiny.path.1/file-5820.pdf	\N	D5170C00002-25e50925-8319-11eb-be00-d13904b2f675-5820	\N	NEW	\N	\N	\N	\N
82874	79	D5170C00002/tiny.path.1/file-1484.pdf	\N	D5170C00002-25e62205-8316-11eb-be00-73313ab59678-1484	\N	NEW	\N	\N	\N	\N
85844	79	D5170C00002/tiny.path.1/file-4454.pdf	\N	D5170C00002-25e7e46f-8318-11eb-be00-6765f2ea8b55-4454	\N	NEW	\N	\N	\N	\N
84297	79	D5170C00002/tiny.path.1/file-2907.pdf	\N	D5170C00002-25f4ab14-8317-11eb-be00-53d006884eff-2907	\N	NEW	\N	\N	\N	\N
81501	79	D5170C00002/tiny.path.1/file-0111.pdf	\N	D5170C00002-25f4bd19-8315-11eb-be00-975bb0905c51-112	\N	NEW	\N	\N	\N	\N
85845	79	D5170C00002/tiny.path.1/file-4455.pdf	\N	D5170C00002-25f66360-8318-11eb-be00-77497bc12918-4455	\N	NEW	\N	\N	\N	\N
81502	79	D5170C00002/tiny.path.1/file-0112.pdf	\N	D5170C00002-2606705a-8315-11eb-be00-8f41f0fd1507-113	\N	NEW	\N	\N	\N	\N
82875	79	D5170C00002/tiny.path.1/file-1485.pdf	\N	D5170C00002-26067b46-8316-11eb-be00-038afa093f8f-1485	\N	NEW	\N	\N	\N	\N
87211	79	D5170C00002/tiny.path.1/file-5821.pdf	\N	D5170C00002-2612a8d6-8319-11eb-be00-09dbc01e76f8-5821	\N	NEW	\N	\N	\N	\N
81503	79	D5170C00002/tiny.path.1/file-0113.pdf	\N	D5170C00002-2623472b-8315-11eb-be00-dbb5df8183d2-114	\N	NEW	\N	\N	\N	\N
85846	79	D5170C00002/tiny.path.1/file-4456.pdf	\N	D5170C00002-26314981-8318-11eb-be00-5514309965a6-4456	\N	NEW	\N	\N	\N	\N
84298	79	D5170C00002/tiny.path.1/file-2908.pdf	\N	D5170C00002-26325055-8317-11eb-be00-71a3567de19b-2908	\N	NEW	\N	\N	\N	\N
87212	79	D5170C00002/tiny.path.1/file-5822.pdf	\N	D5170C00002-263265d7-8319-11eb-be00-b9d3fe7bd2d5-5822	\N	NEW	\N	\N	\N	\N
84299	79	D5170C00002/tiny.path.1/file-2909.pdf	\N	D5170C00002-26419296-8317-11eb-be00-7363c8713cb1-2909	\N	NEW	\N	\N	\N	\N
81504	79	D5170C00002/tiny.path.1/file-0114.pdf	\N	D5170C00002-2641f2bc-8315-11eb-be00-27a32ccac744-115	\N	NEW	\N	\N	\N	\N
82876	79	D5170C00002/tiny.path.1/file-1486.pdf	\N	D5170C00002-26430f17-8316-11eb-be00-25c6c22a73d7-1486	\N	NEW	\N	\N	\N	\N
84300	79	D5170C00002/tiny.path.1/file-2910.pdf	\N	D5170C00002-26501187-8317-11eb-be00-3940c183a600-2910	\N	NEW	\N	\N	\N	\N
84301	79	D5170C00002/tiny.path.1/file-2911.pdf	\N	D5170C00002-26523468-8317-11eb-be00-41e0653e6b9b-2911	\N	NEW	\N	\N	\N	\N
87213	79	D5170C00002/tiny.path.1/file-5823.pdf	\N	D5170C00002-265249e8-8319-11eb-be00-e17f982c93da-5823	\N	NEW	\N	\N	\N	\N
81505	79	D5170C00002/tiny.path.1/file-0115.pdf	\N	D5170C00002-2660502d-8315-11eb-be00-8333b270da41-116	\N	NEW	\N	\N	\N	\N
85847	79	D5170C00002/tiny.path.1/file-4457.pdf	\N	D5170C00002-2661a852-8318-11eb-be00-7525d748722b-4457	\N	NEW	\N	\N	\N	\N
84302	79	D5170C00002/tiny.path.1/file-2912.pdf	\N	D5170C00002-266e9609-8317-11eb-be00-2f13bc119bb5-2912	\N	NEW	\N	\N	\N	\N
87214	79	D5170C00002/tiny.path.1/file-5824.pdf	\N	D5170C00002-26703229-8319-11eb-be00-2d3a763c067e-5824	\N	NEW	\N	\N	\N	\N
81506	79	D5170C00002/tiny.path.1/file-0116.pdf	\N	D5170C00002-267055be-8315-11eb-be00-054c3f88182e-117	\N	NEW	\N	\N	\N	\N
82877	79	D5170C00002/tiny.path.1/file-1487.pdf	\N	D5170C00002-2670d5d8-8316-11eb-be00-c35e9c855c2a-1487	\N	NEW	\N	\N	\N	\N
84303	79	D5170C00002/tiny.path.1/file-2913.pdf	\N	D5170C00002-267db13a-8317-11eb-be00-17d08e1f9452-2913	\N	NEW	\N	\N	\N	\N
84304	79	D5170C00002/tiny.path.1/file-2914.pdf	\N	D5170C00002-267ee9bb-8317-11eb-be00-39b9ce62a3ad-2914	\N	NEW	\N	\N	\N	\N
81507	79	D5170C00002/tiny.path.1/file-0117.pdf	\N	D5170C00002-26816cbf-8315-11eb-be00-af7ffac1ce15-118	\N	NEW	\N	\N	\N	\N
87215	79	D5170C00002/tiny.path.1/file-5825.pdf	\N	D5170C00002-268d08fa-8319-11eb-be00-67c936cf7c4d-5825	\N	NEW	\N	\N	\N	\N
84305	79	D5170C00002/tiny.path.1/file-2915.pdf	\N	D5170C00002-268ea12c-8317-11eb-be00-67d74eed897a-2915	\N	NEW	\N	\N	\N	\N
82878	79	D5170C00002/tiny.path.1/file-1488.pdf	\N	D5170C00002-268fcf89-8316-11eb-be00-a1d1318dcfc3-1488	\N	NEW	\N	\N	\N	\N
87216	79	D5170C00002/tiny.path.1/file-5826.pdf	\N	D5170C00002-269bfd1b-8319-11eb-be00-99ae7367d2bf-5826	\N	NEW	\N	\N	\N	\N
81508	79	D5170C00002/tiny.path.1/file-0118.pdf	\N	D5170C00002-269d5930-8315-11eb-be00-732b5b83a622-119	\N	NEW	\N	\N	\N	\N
84306	79	D5170C00002/tiny.path.1/file-2916.pdf	\N	D5170C00002-26abed2d-8317-11eb-be00-43dfa3e47fe4-2916	\N	NEW	\N	\N	\N	\N
82879	79	D5170C00002/tiny.path.1/file-1489.pdf	\N	D5170C00002-26ad429a-8316-11eb-be00-2723f373ebf0-1489	\N	NEW	\N	\N	\N	\N
81509	79	D5170C00002/tiny.path.1/file-0119.pdf	\N	D5170C00002-26ad85d1-8315-11eb-be00-255d2f2e6e41-120	\N	NEW	\N	\N	\N	\N
84307	79	D5170C00002/tiny.path.1/file-2917.pdf	\N	D5170C00002-26bda06e-8317-11eb-be00-71724ad35ca4-2917	\N	NEW	\N	\N	\N	\N
82880	79	D5170C00002/tiny.path.1/file-1490.pdf	\N	D5170C00002-26bdbd5b-8316-11eb-be00-5545e02e570b-1490	\N	NEW	\N	\N	\N	\N
81510	79	D5170C00002/tiny.path.1/file-0120.pdf	\N	D5170C00002-26cad1d2-8315-11eb-be00-2bc291e81ebb-121	\N	NEW	\N	\N	\N	\N
87217	79	D5170C00002/tiny.path.1/file-5827.pdf	\N	D5170C00002-26cc0dcc-8319-11eb-be00-43dc0b798c4a-5827	\N	NEW	\N	\N	\N	\N
84308	79	D5170C00002/tiny.path.1/file-2918.pdf	\N	D5170C00002-26cc1f5f-8317-11eb-be00-db291fd6e39f-2918	\N	NEW	\N	\N	\N	\N
85848	79	D5170C00002/tiny.path.1/file-4458.pdf	\N	D5170C00002-26d94953-8318-11eb-be00-292d7f02911f-4458	\N	NEW	\N	\N	\N	\N
84309	79	D5170C00002/tiny.path.1/file-2919.pdf	\N	D5170C00002-26db3a90-8317-11eb-be00-c16f013dfd2d-2919	\N	NEW	\N	\N	\N	\N
87218	79	D5170C00002/tiny.path.1/file-5828.pdf	\N	D5170C00002-26e932bd-8319-11eb-be00-5ff666527e2d-5828	\N	NEW	\N	\N	\N	\N
81511	79	D5170C00002/tiny.path.1/file-0121.pdf	\N	D5170C00002-26e9a473-8315-11eb-be00-0bbc4b8acb20-122	\N	NEW	\N	\N	\N	\N
87219	79	D5170C00002/tiny.path.1/file-5829.pdf	\N	D5170C00002-26f826de-8319-11eb-be00-f5ee8b1064e9-5829	\N	NEW	\N	\N	\N	\N
84310	79	D5170C00002/tiny.path.1/file-2920.pdf	\N	D5170C00002-26f9bf11-8317-11eb-be00-f76b4a91be99-2920	\N	NEW	\N	\N	\N	\N
81512	79	D5170C00002/tiny.path.1/file-0122.pdf	\N	D5170C00002-26fabb74-8315-11eb-be00-cbdf4fa31bc4-123	\N	NEW	\N	\N	\N	\N
87220	79	D5170C00002/tiny.path.1/file-5830.pdf	\N	D5170C00002-2706a5cf-8319-11eb-be00-dd6092ecf9fc-5830	\N	NEW	\N	\N	\N	\N
82905	79	D5170C00002/tiny.path.1/file-1515.pdf	\N	D5170C00002-27080ccc-8316-11eb-be00-a5dc88fca1f1-1491	\N	NEW	\N	\N	\N	\N
84311	79	D5170C00002/tiny.path.1/file-2921.pdf	\N	D5170C00002-27166ed2-8317-11eb-be00-153c6718c83f-2921	\N	NEW	\N	\N	\N	\N
84312	79	D5170C00002/tiny.path.1/file-2922.pdf	\N	D5170C00002-272710a3-8317-11eb-be00-a3bd32f606ca-2922	\N	NEW	\N	\N	\N	\N
87221	79	D5170C00002/tiny.path.1/file-5831.pdf	\N	D5170C00002-27364150-8319-11eb-be00-1d443d2fb345-5831	\N	NEW	\N	\N	\N	\N
81513	79	D5170C00002/tiny.path.1/file-0123.pdf	\N	D5170C00002-27372835-8315-11eb-be00-c135fbc5ddbe-124	\N	NEW	\N	\N	\N	\N
81514	79	D5170C00002/tiny.path.1/file-0124.pdf	\N	D5170C00002-27472dc6-8315-11eb-be00-79d5099f66a8-125	\N	NEW	\N	\N	\N	\N
82881	79	D5170C00002/tiny.path.1/file-1491.msg	\N	D5170C00002-2755908d-8316-11eb-be00-adb3b9c9b6ba-1492	\N	NEW	\N	\N	\N	\N
85849	79	D5170C00002/tiny.path.1/file-4459.pdf	\N	D5170C00002-2763fd24-8318-11eb-be00-99f25cc524ad-4459	\N	NEW	\N	\N	\N	\N
85850	79	D5170C00002/tiny.path.1/file-4460.pdf	\N	D5170C00002-27655cb5-8318-11eb-be00-256a701e6d05-4460	\N	NEW	\N	\N	\N	\N
87222	79	D5170C00002/tiny.path.1/file-5832.pdf	\N	D5170C00002-27717591-8319-11eb-be00-73942d46d919-5832	\N	NEW	\N	\N	\N	\N
81515	79	D5170C00002/tiny.path.1/file-0125.pdf	\N	D5170C00002-277346d7-8315-11eb-be00-c1290ef9fec6-126	\N	NEW	\N	\N	\N	\N
87223	79	D5170C00002/tiny.path.1/file-5833.pdf	\N	D5170C00002-2781a232-8319-11eb-be00-3b4cb8cd0120-5833	\N	NEW	\N	\N	\N	\N
85851	79	D5170C00002/tiny.path.1/file-4461.pdf	\N	D5170C00002-278281a6-8318-11eb-be00-19d98ec61f75-4461	\N	NEW	\N	\N	\N	\N
81516	79	D5170C00002/tiny.path.1/file-0126.pdf	\N	D5170C00002-27928ea8-8315-11eb-be00-27b088dd613f-127	\N	NEW	\N	\N	\N	\N
81517	79	D5170C00002/tiny.path.1/file-0127.pdf	\N	D5170C00002-27b24ba9-8315-11eb-be00-afd66505a4c4-128	\N	NEW	\N	\N	\N	\N
85852	79	D5170C00002/tiny.path.1/file-4462.pdf	\N	D5170C00002-27be0407-8318-11eb-be00-efc903eb0a58-4462	\N	NEW	\N	\N	\N	\N
82882	79	D5170C00002/tiny.path.1/file-1492.msg	\N	D5170C00002-27cedf3e-8316-11eb-be00-8b9d1a17ef7a-1493	\N	NEW	\N	\N	\N	\N
85853	79	D5170C00002/tiny.path.1/file-4463.pdf	\N	D5170C00002-27dcd6a8-8318-11eb-be00-cbf0cc9cc22d-4463	\N	NEW	\N	\N	\N	\N
81519	79	D5170C00002/tiny.path.1/file-0129.pdf	\N	D5170C00002-27ddef8a-8315-11eb-be00-d107ad6bcdb8-129	\N	NEW	\N	\N	\N	\N
85854	79	D5170C00002/tiny.path.1/file-4464.pdf	\N	D5170C00002-27fb0d09-8318-11eb-be00-e50e13923702-4464	\N	NEW	\N	\N	\N	\N
81520	79	D5170C00002/tiny.path.1/file-0130.pdf	\N	D5170C00002-27fce93b-8315-11eb-be00-ed5f3f4c37ed-130	\N	NEW	\N	\N	\N	\N
85855	79	D5170C00002/tiny.path.1/file-4465.pdf	\N	D5170C00002-280b60ba-8318-11eb-be00-7f60662bfac8-4465	\N	NEW	\N	\N	\N	\N
85856	79	D5170C00002/tiny.path.1/file-4466.pdf	\N	D5170C00002-280d5c8b-8318-11eb-be00-35abe232e0f6-4466	\N	NEW	\N	\N	\N	\N
81521	79	D5170C00002/tiny.path.1/file-0131.pdf	\N	D5170C00002-281998fc-8315-11eb-be00-01b790ff198b-131	\N	NEW	\N	\N	\N	\N
81522	79	D5170C00002/tiny.path.1/file-0132.pdf	\N	D5170C00002-281cf45d-8315-11eb-be00-9f96283ead57-132	\N	NEW	\N	\N	\N	\N
81523	79	D5170C00002/tiny.path.1/file-0133.pdf	\N	D5170C00002-282a13be-8315-11eb-be00-e9a75a2505c0-133	\N	NEW	\N	\N	\N	\N
84313	79	D5170C00002/tiny.path.1/file-2923.pdf	\N	D5170C00002-282a9df4-8317-11eb-be00-e7638b950049-2923	\N	NEW	\N	\N	\N	\N
81524	79	D5170C00002/tiny.path.1/file-0134.pdf	\N	D5170C00002-28490d6f-8315-11eb-be00-8feaf8ab9e15-134	\N	NEW	\N	\N	\N	\N
85858	79	D5170C00002/tiny.path.1/file-4468.pdf	\N	D5170C00002-2856c19c-8318-11eb-be00-7d9486f97fcd-4467	\N	NEW	\N	\N	\N	\N
81525	79	D5170C00002/tiny.path.1/file-0135.pdf	\N	D5170C00002-28598830-8315-11eb-be00-ad0bda62556b-135	\N	NEW	\N	\N	\N	\N
82883	79	D5170C00002/tiny.path.1/file-1493.msg	\N	D5170C00002-2868601f-8316-11eb-be00-cd8d20903b10-1494	\N	NEW	\N	\N	\N	\N
81526	79	D5170C00002/tiny.path.1/file-0136.pdf	\N	D5170C00002-28850501-8315-11eb-be00-4326cf8a48fe-136	\N	NEW	\N	\N	\N	\N
87224	79	D5170C00002/tiny.path.1/file-5834.pdf	\N	D5170C00002-2885a4b3-8319-11eb-be00-b3ba79307bef-5834	\N	NEW	\N	\N	\N	\N
82884	79	D5170C00002/tiny.path.1/file-1494.msg	\N	D5170C00002-2885ab20-8316-11eb-be00-a59b737457f9-1495	\N	NEW	\N	\N	\N	\N
85857	79	D5170C00002/tiny.path.1/file-4467.pdf	\N	D5170C00002-2886360d-8318-11eb-be00-8d6a87d98a48-4468	\N	NEW	\N	\N	\N	\N
82885	79	D5170C00002/tiny.path.1/file-1495.msg	\N	D5170C00002-28a3ba71-8316-11eb-be00-af9e64053adf-1496	\N	NEW	\N	\N	\N	\N
87225	79	D5170C00002/tiny.path.1/file-5835.pdf	\N	D5170C00002-28a40224-8319-11eb-be00-df52ec7c3697-5835	\N	NEW	\N	\N	\N	\N
85860	79	D5170C00002/tiny.path.1/file-4470.pdf	\N	D5170C00002-28c1915e-8318-11eb-be00-515913cb6511-4469	\N	NEW	\N	\N	\N	\N
82886	79	D5170C00002/tiny.path.1/file-1496.msg	\N	D5170C00002-28c2db32-8316-11eb-be00-7f11ea55439c-1497	\N	NEW	\N	\N	\N	\N
81527	79	D5170C00002/tiny.path.1/file-0137.pdf	\N	D5170C00002-28d23aa2-8315-11eb-be00-0dee385b22c5-137	\N	NEW	\N	\N	\N	\N
82887	79	D5170C00002/tiny.path.1/file-1497.msg	\N	D5170C00002-28d46763-8316-11eb-be00-d5b52a4509b6-1498	\N	NEW	\N	\N	\N	\N
87226	79	D5170C00002/tiny.path.1/file-5836.pdf	\N	D5170C00002-28e15945-8319-11eb-be00-b59bc23a520e-5836	\N	NEW	\N	\N	\N	\N
87227	79	D5170C00002/tiny.path.1/file-5837.pdf	\N	D5170C00002-28ef8a16-8319-11eb-be00-4d91eb566d65-5837	\N	NEW	\N	\N	\N	\N
85859	79	D5170C00002/tiny.path.1/file-4469.pdf	\N	D5170C00002-28efa63f-8318-11eb-be00-f3f042a3be90-4470	\N	NEW	\N	\N	\N	\N
81528	79	D5170C00002/tiny.path.1/file-0138.pdf	\N	D5170C00002-29018803-8315-11eb-be00-09fdd4c7387f-138	\N	NEW	\N	\N	\N	\N
84314	79	D5170C00002/tiny.path.1/file-2924.pdf	\N	D5170C00002-290e4735-8317-11eb-be00-8303aa4e0172-2924	\N	NEW	\N	\N	\N	\N
87228	79	D5170C00002/tiny.path.1/file-5838.pdf	\N	D5170C00002-290eaad7-8319-11eb-be00-29b93f20728e-5838	\N	NEW	\N	\N	\N	\N
81529	79	D5170C00002/tiny.path.1/file-0139.pdf	\N	D5170C00002-2910a334-8315-11eb-be00-e330b03ae115-139	\N	NEW	\N	\N	\N	\N
85862	79	D5170C00002/tiny.path.1/file-4472.pdf	\N	D5170C00002-291d1ee0-8318-11eb-be00-0beaeca24bec-4471	\N	NEW	\N	\N	\N	\N
84315	79	D5170C00002/tiny.path.1/file-2925.pdf	\N	D5170C00002-291db086-8317-11eb-be00-cd6842281d16-2925	\N	NEW	\N	\N	\N	\N
87229	79	D5170C00002/tiny.path.1/file-5839.pdf	\N	D5170C00002-292c44f8-8319-11eb-be00-85df95fccb1b-5839	\N	NEW	\N	\N	\N	\N
81530	79	D5170C00002/tiny.path.1/file-0140.pdf	\N	D5170C00002-292c6895-8315-11eb-be00-ab190e925913-140	\N	NEW	\N	\N	\N	\N
82888	79	D5170C00002/tiny.path.1/file-1498.msg	\N	D5170C00002-292cc094-8316-11eb-be00-490defef0b02-1499	\N	NEW	\N	\N	\N	\N
84316	79	D5170C00002/tiny.path.1/file-2926.pdf	\N	D5170C00002-292f3cb7-8317-11eb-be00-cf2673bf6bdb-2926	\N	NEW	\N	\N	\N	\N
84317	79	D5170C00002/tiny.path.1/file-2927.pdf	\N	D5170C00002-293e09c8-8317-11eb-be00-bb313693ec58-2927	\N	NEW	\N	\N	\N	\N
81531	79	D5170C00002/tiny.path.1/file-0141.pdf	\N	D5170C00002-293eb816-8315-11eb-be00-9330cc3294ad-141	\N	NEW	\N	\N	\N	\N
87230	79	D5170C00002/tiny.path.1/file-5840.pdf	\N	D5170C00002-294a7b59-8319-11eb-be00-dbe374c07065-5840	\N	NEW	\N	\N	\N	\N
81532	79	D5170C00002/tiny.path.1/file-0142.pdf	\N	D5170C00002-295a2f57-8315-11eb-be00-c7f61ca2ab4e-142	\N	NEW	\N	\N	\N	\N
81533	79	D5170C00002/tiny.path.1/file-0143.pdf	\N	D5170C00002-295c0418-8315-11eb-be00-c19427183824-143	\N	NEW	\N	\N	\N	\N
81534	79	D5170C00002/tiny.path.1/file-0144.pdf	\N	D5170C00002-29792909-8315-11eb-be00-0f66b06f9a78-144	\N	NEW	\N	\N	\N	\N
85861	79	D5170C00002/tiny.path.1/file-4471.pdf	\N	D5170C00002-2979e4e1-8318-11eb-be00-65a343f4dcdd-4472	\N	NEW	\N	\N	\N	\N
82889	79	D5170C00002/tiny.path.1/file-1499.msg	\N	D5170C00002-297ab985-8316-11eb-be00-2149e2622a53-1500	\N	NEW	\N	\N	\N	\N
84318	79	D5170C00002/tiny.path.1/file-2928.pdf	\N	D5170C00002-297b12c9-8317-11eb-be00-7f0c7c63d9f0-2928	\N	NEW	\N	\N	\N	\N
82890	79	D5170C00002/tiny.path.1/file-1500.msg	\N	D5170C00002-29884e16-8316-11eb-be00-218c918ce003-1501	\N	NEW	\N	\N	\N	\N
81535	79	D5170C00002/tiny.path.1/file-0145.pdf	\N	D5170C00002-2999824a-8315-11eb-be00-df73ed621074-145	\N	NEW	\N	\N	\N	\N
85865	79	D5170C00002/tiny.path.1/file-4475.pdf	\N	D5170C00002-29b73c02-8318-11eb-be00-cf8bcbceae53-4473	\N	NEW	\N	\N	\N	\N
87231	79	D5170C00002/tiny.path.1/file-5841.pdf	\N	D5170C00002-29d3f6aa-8319-11eb-be00-33e25b814b4d-5841	\N	NEW	\N	\N	\N	\N
82891	79	D5170C00002/tiny.path.1/file-1501.msg	\N	D5170C00002-29d5d1d7-8316-11eb-be00-1fe0b68885b4-1502	\N	NEW	\N	\N	\N	\N
81536	79	D5170C00002/tiny.path.1/file-0146.pdf	\N	D5170C00002-29e3aaab-8315-11eb-be00-eba933d69192-146	\N	NEW	\N	\N	\N	\N
85863	79	D5170C00002/tiny.path.1/file-4473.pdf	\N	D5170C00002-29e3f153-8318-11eb-be00-adf91606dc28-4474	\N	NEW	\N	\N	\N	\N
82892	79	D5170C00002/tiny.path.1/file-1502.msg	\N	D5170C00002-29f5dcf8-8316-11eb-be00-5dcff4b45fd0-1503	\N	NEW	\N	\N	\N	\N
81537	79	D5170C00002/tiny.path.1/file-0147.pdf	\N	D5170C00002-2a02081c-8315-11eb-be00-c9264ad2fabb-147	\N	NEW	\N	\N	\N	\N
81538	79	D5170C00002/tiny.path.1/file-0148.pdf	\N	D5170C00002-2a114a5d-8315-11eb-be00-0b83df079b2a-148	\N	NEW	\N	\N	\N	\N
81539	79	D5170C00002/tiny.path.1/file-0149.pdf	\N	D5170C00002-2a13bb5e-8315-11eb-be00-73be890342b6-149	\N	NEW	\N	\N	\N	\N
81540	79	D5170C00002/tiny.path.1/file-0150.pdf	\N	D5170C00002-2a317c8f-8315-11eb-be00-7329ab0f07d1-150	\N	NEW	\N	\N	\N	\N
81541	79	D5170C00002/tiny.path.1/file-0151.pdf	\N	D5170C00002-2a4097c0-8315-11eb-be00-7dae232a63cc-151	\N	NEW	\N	\N	\N	\N
81542	79	D5170C00002/tiny.path.1/file-0152.pdf	\N	D5170C00002-2a4f16b1-8315-11eb-be00-c5d5015bdc7a-152	\N	NEW	\N	\N	\N	\N
82893	79	D5170C00002/tiny.path.1/file-1503.msg	\N	D5170C00002-2a4f95b9-8316-11eb-be00-1bbd62117fc3-1504	\N	NEW	\N	\N	\N	\N
84319	79	D5170C00002/tiny.path.1/file-2929.pdf	\N	D5170C00002-2a50b24a-8317-11eb-be00-93fa40cfd32a-2929	\N	NEW	\N	\N	\N	\N
84320	79	D5170C00002/tiny.path.1/file-2930.pdf	\N	D5170C00002-2a5f584b-8317-11eb-be00-31ccc8e3a65c-2930	\N	NEW	\N	\N	\N	\N
82894	79	D5170C00002/tiny.path.1/file-1504.msg	\N	D5170C00002-2a6da50a-8316-11eb-be00-59bc7dc2dab6-1505	\N	NEW	\N	\N	\N	\N
84321	79	D5170C00002/tiny.path.1/file-2931.pdf	\N	D5170C00002-2a6fabfc-8317-11eb-be00-07455bdd7985-2931	\N	NEW	\N	\N	\N	\N
85864	79	D5170C00002/tiny.path.1/file-4474.pdf	\N	D5170C00002-2a6fdda4-8318-11eb-be00-1138d5f35a2f-4475	\N	NEW	\N	\N	\N	\N
84337	79	D5170C00002/tiny.path.1/file-2947.pdf	\N	D5170C00002-2a8c82cd-8317-11eb-be00-2777729256f9-2932	\N	NEW	\N	\N	\N	\N
82895	79	D5170C00002/tiny.path.1/file-1505.msg	\N	D5170C00002-2a8db02b-8316-11eb-be00-972b0ac11ef0-1506	\N	NEW	\N	\N	\N	\N
84338	79	D5170C00002/tiny.path.1/file-2948.pdf	\N	D5170C00002-2a9cd67e-8317-11eb-be00-4daddad5d96b-2933	\N	NEW	\N	\N	\N	\N
85866	79	D5170C00002/tiny.path.1/file-4476.pdf	\N	D5170C00002-2aab38f5-8318-11eb-be00-2135e6b3170f-4476	\N	NEW	\N	\N	\N	\N
87232	79	D5170C00002/tiny.path.1/file-5842.pdf	\N	D5170C00002-2aab6aeb-8319-11eb-be00-376cefe569dd-5842	\N	NEW	\N	\N	\N	\N
84339	79	D5170C00002/tiny.path.1/file-2949.pdf	\N	D5170C00002-2ab9381f-8317-11eb-be00-7dfc7c9de25f-2934	\N	NEW	\N	\N	\N	\N
82896	79	D5170C00002/tiny.path.1/file-1506.msg	\N	D5170C00002-2abab39c-8316-11eb-be00-690b0ee8b905-1507	\N	NEW	\N	\N	\N	\N
82897	79	D5170C00002/tiny.path.1/file-1507.msg	\N	D5170C00002-2acb556d-8316-11eb-be00-877526a604ad-1508	\N	NEW	\N	\N	\N	\N
84322	79	D5170C00002/tiny.path.1/file-2932.pdf	\N	D5170C00002-2ad91c30-8317-11eb-be00-bd7a6092d6a1-2935	\N	NEW	\N	\N	\N	\N
84323	79	D5170C00002/tiny.path.1/file-2933.pdf	\N	D5170C00002-2ae948d1-8317-11eb-be00-df7b60f4cd15-2936	\N	NEW	\N	\N	\N	\N
82898	79	D5170C00002/tiny.path.1/file-1508.msg	\N	D5170C00002-2af7476e-8316-11eb-be00-6dce51b9e418-1509	\N	NEW	\N	\N	\N	\N
84324	79	D5170C00002/tiny.path.1/file-2934.pdf	\N	D5170C00002-2b05d182-8317-11eb-be00-9309a26e8c4d-2937	\N	NEW	\N	\N	\N	\N
84325	79	D5170C00002/tiny.path.1/file-2935.pdf	\N	D5170C00002-2b153ad3-8317-11eb-be00-99111a9728f8-2938	\N	NEW	\N	\N	\N	\N
84326	79	D5170C00002/tiny.path.1/file-2936.pdf	\N	D5170C00002-2b16e884-8317-11eb-be00-093ab9031210-2939	\N	NEW	\N	\N	\N	\N
81543	79	D5170C00002/tiny.path.1/file-0153.pdf	\N	D5170C00002-2b252b62-8315-11eb-be00-73c114f5d380-153	\N	NEW	\N	\N	\N	\N
84327	79	D5170C00002/tiny.path.1/file-2937.pdf	\N	D5170C00002-2b334a25-8317-11eb-be00-f7ba039c2dbd-2940	\N	NEW	\N	\N	\N	\N
87233	79	D5170C00002/tiny.path.1/file-5843.pdf	\N	D5170C00002-2b42a1dc-8319-11eb-be00-bb1af9fedca4-5843	\N	NEW	\N	\N	\N	\N
84328	79	D5170C00002/tiny.path.1/file-2938.pdf	\N	D5170C00002-2b4328a6-8317-11eb-be00-d1aea7b4b4b5-2941	\N	NEW	\N	\N	\N	\N
85867	79	D5170C00002/tiny.path.1/file-4477.pdf	\N	D5170C00002-2b433336-8318-11eb-be00-4799f53cfa4b-4477	\N	NEW	\N	\N	\N	\N
81544	79	D5170C00002/tiny.path.1/file-0154.pdf	\N	D5170C00002-2b44c153-8315-11eb-be00-6d09a4eb3e0c-154	\N	NEW	\N	\N	\N	\N
84329	79	D5170C00002/tiny.path.1/file-2939.pdf	\N	D5170C00002-2b53a367-8317-11eb-be00-c9c982a68d03-2942	\N	NEW	\N	\N	\N	\N
81545	79	D5170C00002/tiny.path.1/file-0155.pdf	\N	D5170C00002-2b61e644-8315-11eb-be00-37c4d9a55597-155	\N	NEW	\N	\N	\N	\N
84330	79	D5170C00002/tiny.path.1/file-2940.pdf	\N	D5170C00002-2b630cb8-8317-11eb-be00-056e575351bd-2943	\N	NEW	\N	\N	\N	\N
84331	79	D5170C00002/tiny.path.1/file-2941.pdf	\N	D5170C00002-2b73d599-8317-11eb-be00-190c3232a0c5-2944	\N	NEW	\N	\N	\N	\N
87234	79	D5170C00002/tiny.path.1/file-5844.pdf	\N	D5170C00002-2b7f83cd-8319-11eb-be00-756bf395ce72-5844	\N	NEW	\N	\N	\N	\N
84332	79	D5170C00002/tiny.path.1/file-2942.pdf	\N	D5170C00002-2b8efeba-8317-11eb-be00-9b4d8ea2277b-2945	\N	NEW	\N	\N	\N	\N
85868	79	D5170C00002/tiny.path.1/file-4478.pdf	\N	D5170C00002-2b8f7e77-8318-11eb-be00-9fde16599ff2-4478	\N	NEW	\N	\N	\N	\N
84333	79	D5170C00002/tiny.path.1/file-2943.pdf	\N	D5170C00002-2b90102b-8317-11eb-be00-87197e50f421-2946	\N	NEW	\N	\N	\N	\N
81546	79	D5170C00002/tiny.path.1/file-0156.pdf	\N	D5170C00002-2b9f3d65-8315-11eb-be00-4db26713d4e4-156	\N	NEW	\N	\N	\N	\N
84334	79	D5170C00002/tiny.path.1/file-2944.pdf	\N	D5170C00002-2b9feeac-8317-11eb-be00-c10153cce0dc-2947	\N	NEW	\N	\N	\N	\N
85869	79	D5170C00002/tiny.path.1/file-4479.pdf	\N	D5170C00002-2bad3fa8-8318-11eb-be00-6522f9d9e4cb-4479	\N	NEW	\N	\N	\N	\N
84335	79	D5170C00002/tiny.path.1/file-2945.pdf	\N	D5170C00002-2bae468d-8317-11eb-be00-4b737d1a5b33-2948	\N	NEW	\N	\N	\N	\N
84336	79	D5170C00002/tiny.path.1/file-2946.pdf	\N	D5170C00002-2baf7f0e-8317-11eb-be00-471453a3d9bc-2949	\N	NEW	\N	\N	\N	\N
87235	79	D5170C00002/tiny.path.1/file-5845.pdf	\N	D5170C00002-2bbd01fe-8319-11eb-be00-71bd774f0182-5845	\N	NEW	\N	\N	\N	\N
85870	79	D5170C00002/tiny.path.1/file-4480.pdf	\N	D5170C00002-2bcbc429-8318-11eb-be00-a31277834c47-4480	\N	NEW	\N	\N	\N	\N
81547	79	D5170C00002/tiny.path.1/file-0157.pdf	\N	D5170C00002-2bcd0426-8315-11eb-be00-15267a5b0494-157	\N	NEW	\N	\N	\N	\N
82899	79	D5170C00002/tiny.path.1/file-1509.msg	\N	D5170C00002-2bcdd14f-8316-11eb-be00-85464d7d378f-1510	\N	NEW	\N	\N	\N	\N
85871	79	D5170C00002/tiny.path.1/file-4481.pdf	\N	D5170C00002-2bdc8d0a-8318-11eb-be00-6bc72b8f1cec-4481	\N	NEW	\N	\N	\N	\N
87236	79	D5170C00002/tiny.path.1/file-5846.pdf	\N	D5170C00002-2bdce60f-8319-11eb-be00-5f79eb0a4584-5846	\N	NEW	\N	\N	\N	\N
82900	79	D5170C00002/tiny.path.1/file-1510.msg	\N	D5170C00002-2bddfdf0-8316-11eb-be00-23ed1d96244d-1511	\N	NEW	\N	\N	\N	\N
84340	79	D5170C00002/tiny.path.1/file-2950.pdf	\N	D5170C00002-2bec60ff-8317-11eb-be00-0543b1b2c82d-2950	\N	NEW	\N	\N	\N	\N
82901	79	D5170C00002/tiny.path.1/file-1511.msg	\N	D5170C00002-2bed1921-8316-11eb-be00-6fefbb7a0dbf-1512	\N	NEW	\N	\N	\N	\N
85872	79	D5170C00002/tiny.path.1/file-4482.pdf	\N	D5170C00002-2bed2edb-8318-11eb-be00-795d897754cc-4482	\N	NEW	\N	\N	\N	\N
82902	79	D5170C00002/tiny.path.1/file-1512.msg	\N	D5170C00002-2bfc3452-8316-11eb-be00-db919daf44d0-1513	\N	NEW	\N	\N	\N	\N
85873	79	D5170C00002/tiny.path.1/file-4483.pdf	\N	D5170C00002-2c09425c-8318-11eb-be00-176eb7d75bfa-4483	\N	NEW	\N	\N	\N	\N
85874	79	D5170C00002/tiny.path.1/file-4484.pdf	\N	D5170C00002-2c0a53cd-8318-11eb-be00-c32fa49d5b76-4484	\N	NEW	\N	\N	\N	\N
81548	79	D5170C00002/tiny.path.1/file-0158.pdf	\N	D5170C00002-2c0a8257-8315-11eb-be00-37d0980a38a1-158	\N	NEW	\N	\N	\N	\N
87237	79	D5170C00002/tiny.path.1/file-5847.pdf	\N	D5170C00002-2c186770-8319-11eb-be00-ad063a3ca8b8-5847	\N	NEW	\N	\N	\N	\N
85875	79	D5170C00002/tiny.path.1/file-4485.pdf	\N	D5170C00002-2c18abae-8318-11eb-be00-a721b10733ed-4485	\N	NEW	\N	\N	\N	\N
85876	79	D5170C00002/tiny.path.1/file-4486.pdf	\N	D5170C00002-2c2751af-8318-11eb-be00-09dcc1a202fd-4486	\N	NEW	\N	\N	\N	\N
81549	79	D5170C00002/tiny.path.1/file-0159.pdf	\N	D5170C00002-2c27f568-8315-11eb-be00-a153ae6f7db1-159	\N	NEW	\N	\N	\N	\N
85877	79	D5170C00002/tiny.path.1/file-4487.pdf	\N	D5170C00002-2c28ff60-8318-11eb-be00-3975f8780327-4487	\N	NEW	\N	\N	\N	\N
85878	79	D5170C00002/tiny.path.1/file-4488.pdf	\N	D5170C00002-2c2a37e1-8318-11eb-be00-179f2fddcc0a-4488	\N	NEW	\N	\N	\N	\N
84341	79	D5170C00002/tiny.path.1/file-2951.pdf	\N	D5170C00002-2c374cb0-8317-11eb-be00-a9bd57b6b618-2951	\N	NEW	\N	\N	\N	\N
85879	79	D5170C00002/tiny.path.1/file-4489.pdf	\N	D5170C00002-2c375742-8318-11eb-be00-69c06e1727f4-4489	\N	NEW	\N	\N	\N	\N
81550	79	D5170C00002/tiny.path.1/file-0160.pdf	\N	D5170C00002-2c37acd9-8315-11eb-be00-25e28a17b0b0-160	\N	NEW	\N	\N	\N	\N
85880	79	D5170C00002/tiny.path.1/file-4490.pdf	\N	D5170C00002-2c45af23-8318-11eb-be00-2b7a58692dab-4490	\N	NEW	\N	\N	\N	\N
85881	79	D5170C00002/tiny.path.1/file-4491.pdf	\N	D5170C00002-2c46e7a4-8318-11eb-be00-5b7a5da69423-4491	\N	NEW	\N	\N	\N	\N
85882	79	D5170C00002/tiny.path.1/file-4492.pdf	\N	D5170C00002-2c48e375-8318-11eb-be00-c100ed896f95-4492	\N	NEW	\N	\N	\N	\N
81551	79	D5170C00002/tiny.path.1/file-0161.pdf	\N	D5170C00002-2c560a4a-8315-11eb-be00-7b72dd68a6bd-161	\N	NEW	\N	\N	\N	\N
85883	79	D5170C00002/tiny.path.1/file-4493.pdf	\N	D5170C00002-2c569f16-8318-11eb-be00-d53990cafe5d-4493	\N	NEW	\N	\N	\N	\N
87238	79	D5170C00002/tiny.path.1/file-5848.pdf	\N	D5170C00002-2c646491-8319-11eb-be00-1729e2e69567-5848	\N	NEW	\N	\N	\N	\N
84342	79	D5170C00002/tiny.path.1/file-2952.pdf	\N	D5170C00002-2c747cc1-8317-11eb-be00-19964e4f11e7-2952	\N	NEW	\N	\N	\N	\N
81552	79	D5170C00002/tiny.path.1/file-0162.pdf	\N	D5170C00002-2c83d10b-8315-11eb-be00-23432c6578f8-162	\N	NEW	\N	\N	\N	\N
85884	79	D5170C00002/tiny.path.1/file-4494.msg	\N	D5170C00002-2c84b3f7-8318-11eb-be00-932013e6bc2b-4494	\N	NEW	\N	\N	\N	\N
87239	79	D5170C00002/tiny.path.1/file-5849.pdf	\N	D5170C00002-2c92eea2-8319-11eb-be00-f595fa152062-5849	\N	NEW	\N	\N	\N	\N
85885	79	D5170C00002/tiny.path.1/file-4495.msg	\N	D5170C00002-2c93f638-8318-11eb-be00-ad08d0a28d8f-4495	\N	NEW	\N	\N	\N	\N
81553	79	D5170C00002/tiny.path.1/file-0163.pdf	\N	D5170C00002-2c94c0fc-8315-11eb-be00-11e1e9d9050c-163	\N	NEW	\N	\N	\N	\N
84343	79	D5170C00002/tiny.path.1/file-2953.pdf	\N	D5170C00002-2ca1ce52-8317-11eb-be00-5dd0a993dfd8-2953	\N	NEW	\N	\N	\N	\N
82903	79	D5170C00002/tiny.path.1/file-1513.msg	\N	D5170C00002-2ca4a953-8316-11eb-be00-354c7eef6555-1514	\N	NEW	\N	\N	\N	\N
81554	79	D5170C00002/tiny.path.1/file-0164.pdf	\N	D5170C00002-2cb2f75d-8315-11eb-be00-71298acffa88-164	\N	NEW	\N	\N	\N	\N
87240	79	D5170C00002/tiny.path.1/file-5850.pdf	\N	D5170C00002-2cbfa3f3-8319-11eb-be00-b51b4d63884e-5850	\N	NEW	\N	\N	\N	\N
82904	79	D5170C00002/tiny.path.1/file-1514.msg	\N	D5170C00002-2cc0bcd4-8316-11eb-be00-afd39ab2dab2-1515	\N	NEW	\N	\N	\N	\N
85886	79	D5170C00002/tiny.path.1/file-4496.msg	\N	D5170C00002-2cc1bcf9-8318-11eb-be00-e5e2debed3c2-4496	\N	NEW	\N	\N	\N	\N
87241	79	D5170C00002/tiny.path.1/file-5851.pdf	\N	D5170C00002-2ccf5b64-8319-11eb-be00-a9e565a360de-5851	\N	NEW	\N	\N	\N	\N
81555	79	D5170C00002/tiny.path.1/file-0165.pdf	\N	D5170C00002-2ccf800e-8315-11eb-be00-f5c73b1751e7-165	\N	NEW	\N	\N	\N	\N
85887	79	D5170C00002/tiny.path.1/file-4497.msg	\N	D5170C00002-2cd14d5a-8318-11eb-be00-6dc775324fc3-4497	\N	NEW	\N	\N	\N	\N
85888	79	D5170C00002/tiny.path.1/file-4498.msg	\N	D5170C00002-2cdf7e2b-8318-11eb-be00-2b1576341919-4498	\N	NEW	\N	\N	\N	\N
82906	79	D5170C00002/tiny.path.1/file-1516.pdf	\N	D5170C00002-2ce02bb5-8316-11eb-be00-d5e833b7a3d4-1516	\N	NEW	\N	\N	\N	\N
81556	79	D5170C00002/tiny.path.1/file-0166.pdf	\N	D5170C00002-2ce06fff-8315-11eb-be00-7973bca3a615-166	\N	NEW	\N	\N	\N	\N
87242	79	D5170C00002/tiny.path.1/file-5852.pdf	\N	D5170C00002-2ced43a5-8319-11eb-be00-4bf92a49c91a-5852	\N	NEW	\N	\N	\N	\N
81557	79	D5170C00002/tiny.path.1/file-0167.pdf	\N	D5170C00002-2cee52b0-8315-11eb-be00-cffc07c9379e-167	\N	NEW	\N	\N	\N	\N
84344	79	D5170C00002/tiny.path.1/file-2954.pdf	\N	D5170C00002-2ceeb5d3-8317-11eb-be00-23ea55aa0802-2954	\N	NEW	\N	\N	\N	\N
82907	79	D5170C00002/tiny.path.1/file-1517.pdf	\N	D5170C00002-2d000fc6-8316-11eb-be00-47cab83d07d6-1517	\N	NEW	\N	\N	\N	\N
82908	79	D5170C00002/tiny.path.1/file-1518.pdf	\N	D5170C00002-2d1cbf87-8316-11eb-be00-5b3772322e89-1518	\N	NEW	\N	\N	\N	\N
81558	79	D5170C00002/tiny.path.1/file-0168.pdf	\N	D5170C00002-2d1dc721-8315-11eb-be00-c7d601bfc055-168	\N	NEW	\N	\N	\N	\N
85889	79	D5170C00002/tiny.path.1/file-4499.msg	\N	D5170C00002-2d1e34dc-8318-11eb-be00-758200178737-4499	\N	NEW	\N	\N	\N	\N
85890	79	D5170C00002/tiny.path.1/file-4500.msg	\N	D5170C00002-2d6799ed-8318-11eb-be00-3d70c76b9cdd-4500	\N	NEW	\N	\N	\N	\N
81559	79	D5170C00002/tiny.path.1/file-0169.pdf	\N	D5170C00002-2d67c872-8315-11eb-be00-d3e367cb7fe0-169	\N	NEW	\N	\N	\N	\N
87243	79	D5170C00002/tiny.path.1/file-5853.pdf	\N	D5170C00002-2d6818f6-8319-11eb-be00-2d1e1d1ed503-5853	\N	NEW	\N	\N	\N	\N
82909	79	D5170C00002/tiny.path.1/file-1519.pdf	\N	D5170C00002-2d684778-8316-11eb-be00-b38e1958cce3-1519	\N	NEW	\N	\N	\N	\N
87244	79	D5170C00002/tiny.path.1/file-5854.pdf	\N	D5170C00002-2d862847-8319-11eb-be00-c97e43bd1f6a-5854	\N	NEW	\N	\N	\N	\N
87245	79	D5170C00002/tiny.path.1/file-5855.pdf	\N	D5170C00002-2d97b478-8319-11eb-be00-59759d4a5f4e-5855	\N	NEW	\N	\N	\N	\N
85891	79	D5170C00002/tiny.path.1/file-4501.msg	\N	D5170C00002-2d97d1ae-8318-11eb-be00-6fb0ea577aec-4501	\N	NEW	\N	\N	\N	\N
84345	79	D5170C00002/tiny.path.1/file-2955.pdf	\N	D5170C00002-2db476d4-8317-11eb-be00-7160587ea248-2955	\N	NEW	\N	\N	\N	\N
84346	79	D5170C00002/tiny.path.1/file-2956.pdf	\N	D5170C00002-2dd2fb55-8317-11eb-be00-2dd7a6d0ae97-2956	\N	NEW	\N	\N	\N	\N
85892	79	D5170C00002/tiny.path.1/file-4502.msg	\N	D5170C00002-2dd528cf-8318-11eb-be00-6b20003342c3-4502	\N	NEW	\N	\N	\N	\N
81560	79	D5170C00002/tiny.path.1/file-0170.pdf	\N	D5170C00002-2df1e003-8315-11eb-be00-8b26deee9860-170	\N	NEW	\N	\N	\N	\N
84347	79	D5170C00002/tiny.path.1/file-2957.pdf	\N	D5170C00002-2df35496-8317-11eb-be00-f5629e2dbcea-2957	\N	NEW	\N	\N	\N	\N
85893	79	D5170C00002/tiny.path.1/file-4503.msg	\N	D5170C00002-2df3ad50-8318-11eb-be00-c54408e743cc-4503	\N	NEW	\N	\N	\N	\N
82910	79	D5170C00002/tiny.path.1/file-1520.pdf	\N	D5170C00002-2e00ddf9-8316-11eb-be00-9507bd3da04d-1520	\N	NEW	\N	\N	\N	\N
85894	79	D5170C00002/tiny.path.1/file-4504.msg	\N	D5170C00002-2e0141e1-8318-11eb-be00-7593695b5751-4504	\N	NEW	\N	\N	\N	\N
87246	79	D5170C00002/tiny.path.1/file-5856.pdf	\N	D5170C00002-2e0199d9-8319-11eb-be00-07c14138a13f-5856	\N	NEW	\N	\N	\N	\N
85895	79	D5170C00002/tiny.path.1/file-4505.msg	\N	D5170C00002-2e0fc0d2-8318-11eb-be00-95271f2fb018-4505	\N	NEW	\N	\N	\N	\N
84348	79	D5170C00002/tiny.path.1/file-2958.pdf	\N	D5170C00002-2e1163e7-8317-11eb-be00-39b5344199b3-2958	\N	NEW	\N	\N	\N	\N
85896	79	D5170C00002/tiny.path.1/file-4506.msg	\N	D5170C00002-2e119593-8318-11eb-be00-6dbe51aea94d-4506	\N	NEW	\N	\N	\N	\N
85897	79	D5170C00002/tiny.path.1/file-4507.msg	\N	D5170C00002-2e1f0314-8318-11eb-be00-f161e94ac384-4507	\N	NEW	\N	\N	\N	\N
87247	79	D5170C00002/tiny.path.1/file-5857.pdf	\N	D5170C00002-2e206c7a-8319-11eb-be00-65a13ddc9202-5857	\N	NEW	\N	\N	\N	\N
84349	79	D5170C00002/tiny.path.1/file-2959.pdf	\N	D5170C00002-2e20f448-8317-11eb-be00-43f47854cdb4-2959	\N	NEW	\N	\N	\N	\N
85898	79	D5170C00002/tiny.path.1/file-4508.msg	\N	D5170C00002-2e217415-8318-11eb-be00-8ddfb4be0ec7-4508	\N	NEW	\N	\N	\N	\N
87248	79	D5170C00002/tiny.path.1/file-5858.pdf	\N	D5170C00002-2e2fd5cb-8319-11eb-be00-470d270626a5-5858	\N	NEW	\N	\N	\N	\N
82911	79	D5170C00002/tiny.path.1/file-1521.pdf	\N	D5170C00002-2e30a08a-8316-11eb-be00-1b632f7db88a-1521	\N	NEW	\N	\N	\N	\N
85899	79	D5170C00002/tiny.path.1/file-4509.msg	\N	D5170C00002-2e3d6086-8318-11eb-be00-1be00b7f2b3c-4509	\N	NEW	\N	\N	\N	\N
85900	79	D5170C00002/tiny.path.1/file-4510.msg	\N	D5170C00002-2e3e71f7-8318-11eb-be00-d76fc6f976df-4510	\N	NEW	\N	\N	\N	\N
81561	79	D5170C00002/tiny.path.1/file-0171.pdf	\N	D5170C00002-2e3ea074-8315-11eb-be00-971f6c91ca3c-171	\N	NEW	\N	\N	\N	\N
84350	79	D5170C00002/tiny.path.1/file-2960.pdf	\N	D5170C00002-2e3f0399-8317-11eb-be00-9510528b475a-2960	\N	NEW	\N	\N	\N	\N
85901	79	D5170C00002/tiny.path.1/file-4511.msg	\N	D5170C00002-2e3f5c58-8318-11eb-be00-f5374f5df544-4511	\N	NEW	\N	\N	\N	\N
85902	79	D5170C00002/tiny.path.1/file-4512.msg	\N	D5170C00002-2e4c54a9-8318-11eb-be00-43749fe087ff-4512	\N	NEW	\N	\N	\N	\N
87249	79	D5170C00002/tiny.path.1/file-5859.pdf	\N	D5170C00002-2e4c5e7c-8319-11eb-be00-0d35a9a36d91-5859	\N	NEW	\N	\N	\N	\N
85903	79	D5170C00002/tiny.path.1/file-4513.msg	\N	D5170C00002-2e4d3f0a-8318-11eb-be00-6bb709f3b3fe-4513	\N	NEW	\N	\N	\N	\N
85904	79	D5170C00002/tiny.path.1/file-4514.msg	\N	D5170C00002-2e4e778b-8318-11eb-be00-d3c74f009dd1-4514	\N	NEW	\N	\N	\N	\N
85905	79	D5170C00002/tiny.path.1/file-4515.msg	\N	D5170C00002-2e5b96ec-8318-11eb-be00-635133d33edc-4515	\N	NEW	\N	\N	\N	\N
82912	79	D5170C00002/tiny.path.1/file-1522.pdf	\N	D5170C00002-2e5c6b7b-8316-11eb-be00-2be67299cb33-1522	\N	NEW	\N	\N	\N	\N
85906	79	D5170C00002/tiny.path.1/file-4516.msg	\N	D5170C00002-2e6c11ad-8318-11eb-be00-c3644d6b798e-4516	\N	NEW	\N	\N	\N	\N
85907	79	D5170C00002/tiny.path.1/file-4517.msg	\N	D5170C00002-2e6d231e-8318-11eb-be00-3b1e01ec3439-4517	\N	NEW	\N	\N	\N	\N
85908	79	D5170C00002/tiny.path.1/file-4518.msg	\N	D5170C00002-2e7ab7af-8318-11eb-be00-7b9300f22674-4518	\N	NEW	\N	\N	\N	\N
81562	79	D5170C00002/tiny.path.1/file-0172.pdf	\N	D5170C00002-2e7b8265-8315-11eb-be00-114983880cab-172	\N	NEW	\N	\N	\N	\N
85909	79	D5170C00002/tiny.path.1/file-4519.msg	\N	D5170C00002-2e7cda90-8318-11eb-be00-0343d498e40f-4519	\N	NEW	\N	\N	\N	\N
85910	79	D5170C00002/tiny.path.1/file-4520.msg	\N	D5170C00002-2e8b5981-8318-11eb-be00-a13ab01167eb-4520	\N	NEW	\N	\N	\N	\N
87250	79	D5170C00002/tiny.path.1/file-5860.pdf	\N	D5170C00002-2e9882ad-8319-11eb-be00-fdcc2de28870-5860	\N	NEW	\N	\N	\N	\N
85911	79	D5170C00002/tiny.path.1/file-4521.msg	\N	D5170C00002-2e993c32-8318-11eb-be00-c1158d7d7fb8-4521	\N	NEW	\N	\N	\N	\N
85912	79	D5170C00002/tiny.path.1/file-4522.msg	\N	D5170C00002-2e9a9bc3-8318-11eb-be00-2791fe2241f1-4522	\N	NEW	\N	\N	\N	\N
85913	79	D5170C00002/tiny.path.1/file-4523.msg	\N	D5170C00002-2ea85764-8318-11eb-be00-d5030cee6a7d-4523	\N	NEW	\N	\N	\N	\N
85914	79	D5170C00002/tiny.path.1/file-4524.msg	\N	D5170C00002-2eaa0515-8318-11eb-be00-953f02a82861-4524	\N	NEW	\N	\N	\N	\N
85915	79	D5170C00002/tiny.path.1/file-4525.msg	\N	D5170C00002-2eb77296-8318-11eb-be00-a9c481daccdc-4525	\N	NEW	\N	\N	\N	\N
85916	79	D5170C00002/tiny.path.1/file-4526.msg	\N	D5170C00002-2ec72a07-8318-11eb-be00-f19ba7a3066c-4526	\N	NEW	\N	\N	\N	\N
82913	79	D5170C00002/tiny.path.1/file-1523.msg	\N	D5170C00002-2ec7624c-8316-11eb-be00-af4cc3507ca7-1523	\N	NEW	\N	\N	\N	\N
84351	79	D5170C00002/tiny.path.1/file-2961.pdf	\N	D5170C00002-2ec857da-8317-11eb-be00-5de27a4fca76-2961	\N	NEW	\N	\N	\N	\N
85917	79	D5170C00002/tiny.path.1/file-4527.msg	\N	D5170C00002-2ec88998-8318-11eb-be00-252ad5bc5156-4527	\N	NEW	\N	\N	\N	\N
85918	79	D5170C00002/tiny.path.1/file-4528.msg	\N	D5170C00002-2ed7a4c9-8318-11eb-be00-b90fca93252f-4528	\N	NEW	\N	\N	\N	\N
84352	79	D5170C00002/tiny.path.1/file-2962.pdf	\N	D5170C00002-2ee52eab-8317-11eb-be00-d9dd5017d206-2962	\N	NEW	\N	\N	\N	\N
81563	79	D5170C00002/tiny.path.1/file-0173.pdf	\N	D5170C00002-2ee5dcf6-8315-11eb-be00-cda3afb02e55-173	\N	NEW	\N	\N	\N	\N
85919	79	D5170C00002/tiny.path.1/file-4529.msg	\N	D5170C00002-2ef47b9a-8318-11eb-be00-3d73d2143244-4529	\N	NEW	\N	\N	\N	\N
85920	79	D5170C00002/tiny.path.1/file-4530.msg	\N	D5170C00002-2f03bddb-8318-11eb-be00-a502ef4ec578-4530	\N	NEW	\N	\N	\N	\N
85921	79	D5170C00002/tiny.path.1/file-4531.msg	\N	D5170C00002-2f04f65c-8318-11eb-be00-23941303a493-4531	\N	NEW	\N	\N	\N	\N
84353	79	D5170C00002/tiny.path.1/file-2963.pdf	\N	D5170C00002-2f0560dc-8317-11eb-be00-6f4876ef1217-2963	\N	NEW	\N	\N	\N	\N
82914	79	D5170C00002/tiny.path.1/file-1524.msg	\N	D5170C00002-2f068e2d-8316-11eb-be00-fbdaed7350b3-1524	\N	NEW	\N	\N	\N	\N
87251	79	D5170C00002/tiny.path.1/file-5861.pdf	\N	D5170C00002-2f12e2ce-8319-11eb-be00-559bc9ff7111-5861	\N	NEW	\N	\N	\N	\N
85922	79	D5170C00002/tiny.path.1/file-4532.msg	\N	D5170C00002-2f154a0d-8318-11eb-be00-9db0cc13f703-4532	\N	NEW	\N	\N	\N	\N
84354	79	D5170C00002/tiny.path.1/file-2964.pdf	\N	D5170C00002-2f23491d-8317-11eb-be00-abe38ef9f73f-2964	\N	NEW	\N	\N	\N	\N
82915	79	D5170C00002/tiny.path.1/file-1525.msg	\N	D5170C00002-2f342dde-8316-11eb-be00-abf8593433a2-1525	\N	NEW	\N	\N	\N	\N
85923	79	D5170C00002/tiny.path.1/file-4533.msg	\N	D5170C00002-2f50302e-8318-11eb-be00-71e83ce0befb-4533	\N	NEW	\N	\N	\N	\N
84374	79	D5170C00002/tiny.path.1/file-2984.pdf	\N	D5170C00002-2f504c8e-8317-11eb-be00-3b1729f0802c-2965	\N	NEW	\N	\N	\N	\N
87252	79	D5170C00002/tiny.path.1/file-5862.pdf	\N	D5170C00002-2f56546f-8319-11eb-be00-752ea081ab3d-5862	\N	NEW	\N	\N	\N	\N
84355	79	D5170C00002/tiny.path.1/file-2965.msg	\N	D5170C00002-2f5fb5df-8317-11eb-be00-0dc9f748ab4d-2966	\N	NEW	\N	\N	\N	\N
84356	79	D5170C00002/tiny.path.1/file-2966.msg	\N	D5170C00002-2f624df0-8317-11eb-be00-799cd5db21f3-2967	\N	NEW	\N	\N	\N	\N
85924	79	D5170C00002/tiny.path.1/file-4534.msg	\N	D5170C00002-2f70d78f-8318-11eb-be00-7b7232d0145e-4534	\N	NEW	\N	\N	\N	\N
84357	79	D5170C00002/tiny.path.1/file-2967.msg	\N	D5170C00002-2f716921-8317-11eb-be00-4dca2105fc9a-2968	\N	NEW	\N	\N	\N	\N
84358	79	D5170C00002/tiny.path.1/file-2968.msg	\N	D5170C00002-2f7f99f2-8317-11eb-be00-276b4e4d446c-2969	\N	NEW	\N	\N	\N	\N
85925	79	D5170C00002/tiny.path.1/file-4535.msg	\N	D5170C00002-2f8d3930-8318-11eb-be00-6f220ab0ad8b-4535	\N	NEW	\N	\N	\N	\N
84359	79	D5170C00002/tiny.path.1/file-2969.msg	\N	D5170C00002-2f8dcac3-8317-11eb-be00-99bf9562353d-2970	\N	NEW	\N	\N	\N	\N
84360	79	D5170C00002/tiny.path.1/file-2970.msg	\N	D5170C00002-2f9e4584-8317-11eb-be00-df8a56d1f5b9-2971	\N	NEW	\N	\N	\N	\N
87253	79	D5170C00002/tiny.path.1/file-5863.pdf	\N	D5170C00002-2faba060-8319-11eb-be00-c1cd449e1123-5863	\N	NEW	\N	\N	\N	\N
84361	79	D5170C00002/tiny.path.1/file-2971.msg	\N	D5170C00002-2faec045-8317-11eb-be00-db4f43db14db-2972	\N	NEW	\N	\N	\N	\N
87254	79	D5170C00002/tiny.path.1/file-5864.pdf	\N	D5170C00002-2fd96721-8319-11eb-be00-05acbf0402ab-5864	\N	NEW	\N	\N	\N	\N
82916	79	D5170C00002/tiny.path.1/file-1526.pdf	\N	D5170C00002-2fd9e3bf-8316-11eb-be00-c9a84d72fed3-1526	\N	NEW	\N	\N	\N	\N
84362	79	D5170C00002/tiny.path.1/file-2972.msg	\N	D5170C00002-2ffb59a6-8317-11eb-be00-2b1f6650b771-2973	\N	NEW	\N	\N	\N	\N
87255	79	D5170C00002/tiny.path.1/file-5865.pdf	\N	D5170C00002-30086662-8319-11eb-be00-31c71b5f2800-5865	\N	NEW	\N	\N	\N	\N
82917	79	D5170C00002/tiny.path.1/file-1527.pdf	\N	D5170C00002-301984d0-8316-11eb-be00-4df9e087f31a-1527	\N	NEW	\N	\N	\N	\N
84363	79	D5170C00002/tiny.path.1/file-2973.msg	\N	D5170C00002-30261327-8317-11eb-be00-2b244e954b50-2974	\N	NEW	\N	\N	\N	\N
84364	79	D5170C00002/tiny.path.1/file-2974.msg	\N	D5170C00002-30288428-8317-11eb-be00-85768e891cbf-2975	\N	NEW	\N	\N	\N	\N
85926	79	D5170C00002/tiny.path.1/file-4536.msg	\N	D5170C00002-30356011-8318-11eb-be00-27a391215a52-4536	\N	NEW	\N	\N	\N	\N
84365	79	D5170C00002/tiny.path.1/file-2975.msg	\N	D5170C00002-30444989-8317-11eb-be00-59a06a63ff93-2976	\N	NEW	\N	\N	\N	\N
81564	79	D5170C00002/tiny.path.1/file-0174.pdf	\N	D5170C00002-30451ed7-8315-11eb-be00-ab04a15a0d2f-174	\N	NEW	\N	\N	\N	\N
82918	79	D5170C00002/tiny.path.1/file-1528.pdf	\N	D5170C00002-30461311-8316-11eb-be00-8f79ef95d41e-1528	\N	NEW	\N	\N	\N	\N
84366	79	D5170C00002/tiny.path.1/file-2976.msg	\N	D5170C00002-3046e19a-8317-11eb-be00-0f7d4a811a5d-2977	\N	NEW	\N	\N	\N	\N
87256	79	D5170C00002/tiny.path.1/file-5866.pdf	\N	D5170C00002-30537923-8319-11eb-be00-25c0300915ee-5866	\N	NEW	\N	\N	\N	\N
84367	79	D5170C00002/tiny.path.1/file-2977.msg	\N	D5170C00002-30549d3b-8317-11eb-be00-39c4ae41767e-2978	\N	NEW	\N	\N	\N	\N
87257	79	D5170C00002/tiny.path.1/file-5867.pdf	\N	D5170C00002-3064b734-8319-11eb-be00-13347a289b74-5867	\N	NEW	\N	\N	\N	\N
84368	79	D5170C00002/tiny.path.1/file-2978.msg	\N	D5170C00002-3065661c-8317-11eb-be00-57fafac1e2a9-2979	\N	NEW	\N	\N	\N	\N
84369	79	D5170C00002/tiny.path.1/file-2979.msg	\N	D5170C00002-30745a3d-8317-11eb-be00-198274b843e7-2980	\N	NEW	\N	\N	\N	\N
82919	79	D5170C00002/tiny.path.1/file-1529.pdf	\N	D5170C00002-308231b2-8316-11eb-be00-95cbcbab999b-1529	\N	NEW	\N	\N	\N	\N
81565	79	D5170C00002/tiny.path.1/file-0175.pdf	\N	D5170C00002-309fe908-8315-11eb-be00-1baa431892aa-175	\N	NEW	\N	\N	\N	\N
87258	79	D5170C00002/tiny.path.1/file-5868.pdf	\N	D5170C00002-30a0aec5-8319-11eb-be00-d58a6d6ea61f-5868	\N	NEW	\N	\N	\N	\N
82920	79	D5170C00002/tiny.path.1/file-1530.pdf	\N	D5170C00002-30a0dd43-8316-11eb-be00-990a07287692-1530	\N	NEW	\N	\N	\N	\N
85927	79	D5170C00002/tiny.path.1/file-4537.msg	\N	D5170C00002-30a0f322-8318-11eb-be00-910e8b407a6c-4537	\N	NEW	\N	\N	\N	\N
84370	79	D5170C00002/tiny.path.1/file-2980.msg	\N	D5170C00002-30a26f1e-8317-11eb-be00-df8fd55c14dd-2981	\N	NEW	\N	\N	\N	\N
84371	79	D5170C00002/tiny.path.1/file-2981.msg	\N	D5170C00002-30b0ee0f-8317-11eb-be00-df0d91a0ed46-2982	\N	NEW	\N	\N	\N	\N
81566	79	D5170C00002/tiny.path.1/file-0176.pdf	\N	D5170C00002-30bf09c9-8315-11eb-be00-7157d0b3e37c-176	\N	NEW	\N	\N	\N	\N
84372	79	D5170C00002/tiny.path.1/file-2982.msg	\N	D5170C00002-30c0a580-8317-11eb-be00-c937540a2134-2983	\N	NEW	\N	\N	\N	\N
85928	79	D5170C00002/tiny.path.1/file-4538.msg	\N	D5170C00002-30cd5a53-8318-11eb-be00-d3fa99c1a100-4538	\N	NEW	\N	\N	\N	\N
81567	79	D5170C00002/tiny.path.1/file-0177.pdf	\N	D5170C00002-30ce24fa-8315-11eb-be00-71769986049b-177	\N	NEW	\N	\N	\N	\N
82921	79	D5170C00002/tiny.path.1/file-1531.pdf	\N	D5170C00002-30cea404-8316-11eb-be00-e38d01c1ba78-1531	\N	NEW	\N	\N	\N	\N
84373	79	D5170C00002/tiny.path.1/file-2983.msg	\N	D5170C00002-30dce011-8317-11eb-be00-754ed8410f2d-2984	\N	NEW	\N	\N	\N	\N
85929	79	D5170C00002/tiny.path.1/file-4539.msg	\N	D5170C00002-30ddfc24-8318-11eb-be00-e7b970e86367-4539	\N	NEW	\N	\N	\N	\N
82922	79	D5170C00002/tiny.path.1/file-1532.pdf	\N	D5170C00002-30ed0175-8316-11eb-be00-8b426f0791dd-1532	\N	NEW	\N	\N	\N	\N
84375	79	D5170C00002/tiny.path.1/file-2985.pdf	\N	D5170C00002-30fb6492-8317-11eb-be00-c36b12d840cc-2985	\N	NEW	\N	\N	\N	\N
82923	79	D5170C00002/tiny.path.1/file-1533.pdf	\N	D5170C00002-30fe6696-8316-11eb-be00-ddbbe05756a4-1533	\N	NEW	\N	\N	\N	\N
87259	79	D5170C00002/tiny.path.1/file-5869.pdf	\N	D5170C00002-310c68e6-8319-11eb-be00-2ba66ce8394e-5869	\N	NEW	\N	\N	\N	\N
85930	79	D5170C00002/tiny.path.1/file-4540.msg	\N	D5170C00002-311a1ac5-8318-11eb-be00-cbb54af06cbe-4540	\N	NEW	\N	\N	\N	\N
81568	79	D5170C00002/tiny.path.1/file-0178.pdf	\N	D5170C00002-311a974b-8315-11eb-be00-abe80db20ec2-178	\N	NEW	\N	\N	\N	\N
82924	79	D5170C00002/tiny.path.1/file-1534.pdf	\N	D5170C00002-311ceb17-8316-11eb-be00-df5670595e0e-1534	\N	NEW	\N	\N	\N	\N
82925	79	D5170C00002/tiny.path.1/file-1535.pdf	\N	D5170C00002-312b42f8-8316-11eb-be00-4372c78c6361-1535	\N	NEW	\N	\N	\N	\N
87260	79	D5170C00002/tiny.path.1/file-5870.pdf	\N	D5170C00002-31391e37-8319-11eb-be00-83877beec365-5870	\N	NEW	\N	\N	\N	\N
84376	79	D5170C00002/tiny.path.1/file-2986.pdf	\N	D5170C00002-313ade93-8317-11eb-be00-1f3e35480723-2986	\N	NEW	\N	\N	\N	\N
85931	79	D5170C00002/tiny.path.1/file-4541.msg	\N	D5170C00002-31491a06-8318-11eb-be00-a58c947980d8-4541	\N	NEW	\N	\N	\N	\N
84377	79	D5170C00002/tiny.path.1/file-2987.pdf	\N	D5170C00002-31578e54-8317-11eb-be00-e3a5fdf5298f-2987	\N	NEW	\N	\N	\N	\N
82926	79	D5170C00002/tiny.path.1/file-1536.pdf	\N	D5170C00002-31597ee9-8316-11eb-be00-c53e240c8d67-1536	\N	NEW	\N	\N	\N	\N
87261	79	D5170C00002/tiny.path.1/file-5871.pdf	\N	D5170C00002-3165fa98-8319-11eb-be00-216f6da81dc9-5871	\N	NEW	\N	\N	\N	\N
82927	79	D5170C00002/tiny.path.1/file-1537.pdf	\N	D5170C00002-31690f4a-8316-11eb-be00-8dd48b25e10b-1537	\N	NEW	\N	\N	\N	\N
85932	79	D5170C00002/tiny.path.1/file-4542.msg	\N	D5170C00002-31777d07-8318-11eb-be00-3b0000997785-4542	\N	NEW	\N	\N	\N	\N
81569	79	D5170C00002/tiny.path.1/file-0179.pdf	\N	D5170C00002-318518ec-8315-11eb-be00-37d4ccfae6da-179	\N	NEW	\N	\N	\N	\N
87262	79	D5170C00002/tiny.path.1/file-5872.pdf	\N	D5170C00002-3186a1f9-8319-11eb-be00-ad3ed2046965-5872	\N	NEW	\N	\N	\N	\N
82928	79	D5170C00002/tiny.path.1/file-1538.pdf	\N	D5170C00002-31948c1b-8316-11eb-be00-ed0f4ee6681b-1538	\N	NEW	\N	\N	\N	\N
85933	79	D5170C00002/tiny.path.1/file-4543.msg	\N	D5170C00002-31a4ce98-8318-11eb-be00-f1439445d20e-4543	\N	NEW	\N	\N	\N	\N
87263	79	D5170C00002/tiny.path.1/file-5873.pdf	\N	D5170C00002-31b4b6da-8319-11eb-be00-f1d814a9243f-5873	\N	NEW	\N	\N	\N	\N
85934	79	D5170C00002/tiny.path.1/file-4544.msg	\N	D5170C00002-31c1f389-8318-11eb-be00-8bae1927d9d4-4544	\N	NEW	\N	\N	\N	\N
84378	79	D5170C00002/tiny.path.1/file-2988.pdf	\N	D5170C00002-31d1c765-8317-11eb-be00-55faa3954894-2988	\N	NEW	\N	\N	\N	\N
81570	79	D5170C00002/tiny.path.1/file-0180.pdf	\N	D5170C00002-31d2759d-8315-11eb-be00-63ae0668998c-180	\N	NEW	\N	\N	\N	\N
81571	79	D5170C00002/tiny.path.1/file-0181.pdf	\N	D5170C00002-31e0a66e-8315-11eb-be00-dd6f18650ffd-181	\N	NEW	\N	\N	\N	\N
82929	79	D5170C00002/tiny.path.1/file-1539.pdf	\N	D5170C00002-31e25dfc-8316-11eb-be00-df8f60407267-1539	\N	NEW	\N	\N	\N	\N
85935	79	D5170C00002/tiny.path.1/file-4545.msg	\N	D5170C00002-31ef933a-8318-11eb-be00-5bdbd23e226f-4545	\N	NEW	\N	\N	\N	\N
84379	79	D5170C00002/tiny.path.1/file-2989.pdf	\N	D5170C00002-31f247b6-8317-11eb-be00-1d9df3adb4b9-2989	\N	NEW	\N	\N	\N	\N
84380	79	D5170C00002/tiny.path.1/file-2990.pdf	\N	D5170C00002-320e8247-8317-11eb-be00-d3365ee3fd1a-2990	\N	NEW	\N	\N	\N	\N
85936	79	D5170C00002/tiny.path.1/file-4546.msg	\N	D5170C00002-320e8ceb-8318-11eb-be00-a37b3ba0a260-4546	\N	NEW	\N	\N	\N	\N
84381	79	D5170C00002/tiny.path.1/file-2991.pdf	\N	D5170C00002-32200e78-8317-11eb-be00-cb4bcf95e6e8-2991	\N	NEW	\N	\N	\N	\N
87264	79	D5170C00002/tiny.path.1/file-5874.pdf	\N	D5170C00002-322ea1cb-8319-11eb-be00-1b7502d5607e-5874	\N	NEW	\N	\N	\N	\N
85937	79	D5170C00002/tiny.path.1/file-4547.msg	\N	D5170C00002-323c058c-8318-11eb-be00-c3cdc7979eac-4547	\N	NEW	\N	\N	\N	\N
82930	79	D5170C00002/tiny.path.1/file-1540.pdf	\N	D5170C00002-323efced-8316-11eb-be00-7108f0b3e7f7-1540	\N	NEW	\N	\N	\N	\N
84382	79	D5170C00002/tiny.path.1/file-2992.pdf	\N	D5170C00002-324c0079-8317-11eb-be00-ab0ba081068c-2992	\N	NEW	\N	\N	\N	\N
87265	79	D5170C00002/tiny.path.1/file-5875.pdf	\N	D5170C00002-325c688c-8319-11eb-be00-23a32a198e1f-5875	\N	NEW	\N	\N	\N	\N
85938	79	D5170C00002/tiny.path.1/file-4548.msg	\N	D5170C00002-326a417d-8318-11eb-be00-f78de45aaa66-4548	\N	NEW	\N	\N	\N	\N
81572	79	D5170C00002/tiny.path.1/file-0182.pdf	\N	D5170C00002-32798b0f-8315-11eb-be00-bb39667a458a-182	\N	NEW	\N	\N	\N	\N
84383	79	D5170C00002/tiny.path.1/file-2993.pdf	\N	D5170C00002-327a3c6a-8317-11eb-be00-13dce4681056-2993	\N	NEW	\N	\N	\N	\N
82931	79	D5170C00002/tiny.path.1/file-1541.pdf	\N	D5170C00002-327b429e-8316-11eb-be00-83fb613023ea-1541	\N	NEW	\N	\N	\N	\N
85939	79	D5170C00002/tiny.path.1/file-4549.msg	\N	D5170C00002-328850ce-8318-11eb-be00-9bd13c4f19a5-4549	\N	NEW	\N	\N	\N	\N
87266	79	D5170C00002/tiny.path.1/file-5876.pdf	\N	D5170C00002-3288cfbd-8319-11eb-be00-6d56b2c0df15-5876	\N	NEW	\N	\N	\N	\N
85940	79	D5170C00002/tiny.path.1/file-4550.msg	\N	D5170C00002-329967cf-8318-11eb-be00-877c4833907c-4550	\N	NEW	\N	\N	\N	\N
87267	79	D5170C00002/tiny.path.1/file-5877.pdf	\N	D5170C00002-32a6b7fe-8319-11eb-be00-fba6e1f49723-5877	\N	NEW	\N	\N	\N	\N
82932	79	D5170C00002/tiny.path.1/file-1542.pdf	\N	D5170C00002-32b5da9f-8316-11eb-be00-ff9b5c6e5cef-1542	\N	NEW	\N	\N	\N	\N
81573	79	D5170C00002/tiny.path.1/file-0183.pdf	\N	D5170C00002-32b73050-8315-11eb-be00-dde723b7fb44-183	\N	NEW	\N	\N	\N	\N
84384	79	D5170C00002/tiny.path.1/file-2994.pdf	\N	D5170C00002-32b76c7b-8317-11eb-be00-85820026a09e-2994	\N	NEW	\N	\N	\N	\N
81574	79	D5170C00002/tiny.path.1/file-0184.pdf	\N	D5170C00002-32c7f931-8315-11eb-be00-31ae7ae687ae-184	\N	NEW	\N	\N	\N	\N
85941	79	D5170C00002/tiny.path.1/file-4551.msg	\N	D5170C00002-32d49c10-8318-11eb-be00-e9bb3ea6677b-4551	\N	NEW	\N	\N	\N	\N
87268	79	D5170C00002/tiny.path.1/file-5878.pdf	\N	D5170C00002-32d6537f-8319-11eb-be00-a93084144f7e-5878	\N	NEW	\N	\N	\N	\N
82933	79	D5170C00002/tiny.path.1/file-1543.pdf	\N	D5170C00002-32f2e3a0-8316-11eb-be00-59b43f5545f2-1543	\N	NEW	\N	\N	\N	\N
87269	79	D5170C00002/tiny.path.1/file-5879.pdf	\N	D5170C00002-32f462d0-8319-11eb-be00-1dc0ab316329-5879	\N	NEW	\N	\N	\N	\N
81575	79	D5170C00002/tiny.path.1/file-0185.pdf	\N	D5170C00002-32f571d2-8315-11eb-be00-2143756ac69d-185	\N	NEW	\N	\N	\N	\N
82934	79	D5170C00002/tiny.path.1/file-1544.pdf	\N	D5170C00002-3312a0a1-8316-11eb-be00-0d1d42c5c237-1544	\N	NEW	\N	\N	\N	\N
85942	79	D5170C00002/tiny.path.1/file-4552.msg	\N	D5170C00002-3313c7f1-8318-11eb-be00-81be259985c1-4552	\N	NEW	\N	\N	\N	\N
81576	79	D5170C00002/tiny.path.1/file-0186.pdf	\N	D5170C00002-333057f3-8315-11eb-be00-6fe5ddd37620-186	\N	NEW	\N	\N	\N	\N
84385	79	D5170C00002/tiny.path.1/file-2995.pdf	\N	D5170C00002-3331a58c-8317-11eb-be00-b92b33082982-2995	\N	NEW	\N	\N	\N	\N
85943	79	D5170C00002/tiny.path.1/file-4553.msg	\N	D5170C00002-3340f272-8318-11eb-be00-991b56bd5e8a-4553	\N	NEW	\N	\N	\N	\N
84386	79	D5170C00002/tiny.path.1/file-2996.pdf	\N	D5170C00002-334ef18d-8317-11eb-be00-13c2ec1474d1-2996	\N	NEW	\N	\N	\N	\N
81577	79	D5170C00002/tiny.path.1/file-0187.pdf	\N	D5170C00002-335e6cd4-8315-11eb-be00-4745e6802dda-187	\N	NEW	\N	\N	\N	\N
87270	79	D5170C00002/tiny.path.1/file-5880.pdf	\N	D5170C00002-335e9651-8319-11eb-be00-758397b9c805-5880	\N	NEW	\N	\N	\N	\N
84387	79	D5170C00002/tiny.path.1/file-2997.pdf	\N	D5170C00002-335f6c4e-8317-11eb-be00-294e5ba93a4d-2997	\N	NEW	\N	\N	\N	\N
85945	79	D5170C00002/tiny.path.1/file-4555.msg	\N	D5170C00002-336f0753-8318-11eb-be00-87c27ad45b3e-4554	\N	NEW	\N	\N	\N	\N
87271	79	D5170C00002/tiny.path.1/file-5881.pdf	\N	D5170C00002-337c0962-8319-11eb-be00-73b10ebf3717-5881	\N	NEW	\N	\N	\N	\N
85944	79	D5170C00002/tiny.path.1/file-4554.msg	\N	D5170C00002-337e97b4-8318-11eb-be00-854730e246ad-4555	\N	NEW	\N	\N	\N	\N
84388	79	D5170C00002/tiny.path.1/file-2998.pdf	\N	D5170C00002-338d0bff-8317-11eb-be00-93281dc67f9b-2998	\N	NEW	\N	\N	\N	\N
85946	79	D5170C00002/tiny.path.1/file-4556.msg	\N	D5170C00002-338d16a5-8318-11eb-be00-894931949e96-4556	\N	NEW	\N	\N	\N	\N
87272	79	D5170C00002/tiny.path.1/file-5882.pdf	\N	D5170C00002-339a66d3-8319-11eb-be00-734af4c7efa4-5882	\N	NEW	\N	\N	\N	\N
81578	79	D5170C00002/tiny.path.1/file-0188.pdf	\N	D5170C00002-339ad995-8315-11eb-be00-0112bab4c44a-188	\N	NEW	\N	\N	\N	\N
84389	79	D5170C00002/tiny.path.1/file-2999.pdf	\N	D5170C00002-339aeeb0-8317-11eb-be00-b7448f41d73d-2999	\N	NEW	\N	\N	\N	\N
82935	79	D5170C00002/tiny.path.1/file-1545.pdf	\N	D5170C00002-33a9fea2-8316-11eb-be00-55e1a22a0445-1545	\N	NEW	\N	\N	\N	\N
87273	79	D5170C00002/tiny.path.1/file-5883.pdf	\N	D5170C00002-33ab2fb4-8319-11eb-be00-d14d2a3c1b84-5883	\N	NEW	\N	\N	\N	\N
85947	79	D5170C00002/tiny.path.1/file-4557.msg	\N	D5170C00002-33c8c016-8318-11eb-be00-25936e714416-4557	\N	NEW	\N	\N	\N	\N
87274	79	D5170C00002/tiny.path.1/file-5884.pdf	\N	D5170C00002-33cac5a5-8319-11eb-be00-af9c4d454e4b-5884	\N	NEW	\N	\N	\N	\N
84390	79	D5170C00002/tiny.path.1/file-3000.pdf	\N	D5170C00002-33d7a991-8317-11eb-be00-a586e8927daa-3000	\N	NEW	\N	\N	\N	\N
81579	79	D5170C00002/tiny.path.1/file-0189.pdf	\N	D5170C00002-33d857c6-8315-11eb-be00-1181dc873944-189	\N	NEW	\N	\N	\N	\N
84391	79	D5170C00002/tiny.path.1/file-3001.pdf	\N	D5170C00002-33e8c092-8317-11eb-be00-cdfc2d8ef294-3001	\N	NEW	\N	\N	\N	\N
87275	79	D5170C00002/tiny.path.1/file-5885.pdf	\N	D5170C00002-33e8fc06-8319-11eb-be00-15a2f0bb4986-5885	\N	NEW	\N	\N	\N	\N
85948	79	D5170C00002/tiny.path.1/file-4558.msg	\N	D5170C00002-33f686d7-8318-11eb-be00-b1f9ce7fc037-4558	\N	NEW	\N	\N	\N	\N
82936	79	D5170C00002/tiny.path.1/file-1546.pdf	\N	D5170C00002-33f8bae3-8316-11eb-be00-418f0f7a3180-1546	\N	NEW	\N	\N	\N	\N
84392	79	D5170C00002/tiny.path.1/file-3002.pdf	\N	D5170C00002-341500b3-8317-11eb-be00-b3999140ef79-3002	\N	NEW	\N	\N	\N	\N
85949	79	D5170C00002/tiny.path.1/file-4559.msg	\N	D5170C00002-34258618-8318-11eb-be00-6f9c57df4562-4559	\N	NEW	\N	\N	\N	\N
87276	79	D5170C00002/tiny.path.1/file-5886.pdf	\N	D5170C00002-3425ddf7-8319-11eb-be00-efa728176bf9-5886	\N	NEW	\N	\N	\N	\N
82937	79	D5170C00002/tiny.path.1/file-1547.pdf	\N	D5170C00002-3426cfc4-8316-11eb-be00-57dfde9bca93-1547	\N	NEW	\N	\N	\N	\N
84393	79	D5170C00002/tiny.path.1/file-3003.msg	\N	D5170C00002-34335e24-8317-11eb-be00-b30d7adecb32-3003	\N	NEW	\N	\N	\N	\N
84394	79	D5170C00002/tiny.path.1/file-3004.msg	\N	D5170C00002-34431595-8317-11eb-be00-2b6869b15ba9-3004	\N	NEW	\N	\N	\N	\N
82938	79	D5170C00002/tiny.path.1/file-1548.pdf	\N	D5170C00002-344469e5-8316-11eb-be00-59f8f82a7a0e-1548	\N	NEW	\N	\N	\N	\N
84395	79	D5170C00002/tiny.path.1/file-3005.msg	\N	D5170C00002-3452a5f6-8317-11eb-be00-0d9d8e7a4b45-3005	\N	NEW	\N	\N	\N	\N
85950	79	D5170C00002/tiny.path.1/file-4560.msg	\N	D5170C00002-3452feb9-8318-11eb-be00-3fa5bd9099fc-4560	\N	NEW	\N	\N	\N	\N
84396	79	D5170C00002/tiny.path.1/file-3006.msg	\N	D5170C00002-34614bf7-8317-11eb-be00-cfc2029e6d33-3006	\N	NEW	\N	\N	\N	\N
81580	79	D5170C00002/tiny.path.1/file-0190.pdf	\N	D5170C00002-3461fa27-8315-11eb-be00-3b9d30d2ace1-190	\N	NEW	\N	\N	\N	\N
84397	79	D5170C00002/tiny.path.1/file-3007.msg	\N	D5170C00002-3470dc58-8317-11eb-be00-611055245d4b-3007	\N	NEW	\N	\N	\N	\N
82939	79	D5170C00002/tiny.path.1/file-1549.pdf	\N	D5170C00002-34720996-8316-11eb-be00-8b32dedd9eff-1549	\N	NEW	\N	\N	\N	\N
87277	79	D5170C00002/tiny.path.1/file-5887.pdf	\N	D5170C00002-34725048-8319-11eb-be00-53660447cb34-5887	\N	NEW	\N	\N	\N	\N
85951	79	D5170C00002/tiny.path.1/file-4561.msg	\N	D5170C00002-348f1d5a-8318-11eb-be00-59b252d7d230-4561	\N	NEW	\N	\N	\N	\N
87278	79	D5170C00002/tiny.path.1/file-5888.pdf	\N	D5170C00002-34901179-8319-11eb-be00-9f881596faab-5888	\N	NEW	\N	\N	\N	\N
84398	79	D5170C00002/tiny.path.1/file-3008.msg	\N	D5170C00002-349e54f9-8317-11eb-be00-61f35f7e67c6-3008	\N	NEW	\N	\N	\N	\N
82940	79	D5170C00002/tiny.path.1/file-1550.pdf	\N	D5170C00002-349e70c7-8316-11eb-be00-5557f33b7a8a-1550	\N	NEW	\N	\N	\N	\N
87279	79	D5170C00002/tiny.path.1/file-5889.pdf	\N	D5170C00002-34ad5d7a-8319-11eb-be00-735b0aefe88e-5889	\N	NEW	\N	\N	\N	\N
85952	79	D5170C00002/tiny.path.1/file-4562.msg	\N	D5170C00002-34af016b-8318-11eb-be00-cbbd50b2f5d9-4562	\N	NEW	\N	\N	\N	\N
84399	79	D5170C00002/tiny.path.1/file-3009.msg	\N	D5170C00002-34afe12a-8317-11eb-be00-555ae81f53c7-3009	\N	NEW	\N	\N	\N	\N
84400	79	D5170C00002/tiny.path.1/file-3010.msg	\N	D5170C00002-34be390b-8317-11eb-be00-09e8539a31de-3010	\N	NEW	\N	\N	\N	\N
87280	79	D5170C00002/tiny.path.1/file-5890.pdf	\N	D5170C00002-34be9b8b-8319-11eb-be00-9544ebfe0f59-5890	\N	NEW	\N	\N	\N	\N
85953	79	D5170C00002/tiny.path.1/file-4563.msg	\N	D5170C00002-34cc265c-8318-11eb-be00-53192a80bab3-4563	\N	NEW	\N	\N	\N	\N
81581	79	D5170C00002/tiny.path.1/file-0191.pdf	\N	D5170C00002-34cc7bc8-8315-11eb-be00-6df7374a5c8b-191	\N	NEW	\N	\N	\N	\N
87281	79	D5170C00002/tiny.path.1/file-5891.pdf	\N	D5170C00002-34cdb6bc-8319-11eb-be00-e368554c9ceb-5891	\N	NEW	\N	\N	\N	\N
85954	79	D5170C00002/tiny.path.1/file-4564.msg	\N	D5170C00002-34dbb6bd-8318-11eb-be00-55174ff3334d-4564	\N	NEW	\N	\N	\N	\N
82941	79	D5170C00002/tiny.path.1/file-1551.pdf	\N	D5170C00002-34ec42a8-8316-11eb-be00-f351ac9742db-1551	\N	NEW	\N	\N	\N	\N
85955	79	D5170C00002/tiny.path.1/file-4565.msg	\N	D5170C00002-34f9ed1e-8318-11eb-be00-2bcda83188e2-4565	\N	NEW	\N	\N	\N	\N
81582	79	D5170C00002/tiny.path.1/file-0192.pdf	\N	D5170C00002-34fb05d9-8315-11eb-be00-1559c7c1635e-192	\N	NEW	\N	\N	\N	\N
87282	79	D5170C00002/tiny.path.1/file-5892.pdf	\N	D5170C00002-3509ae4d-8319-11eb-be00-f3abd2a3af9b-5892	\N	NEW	\N	\N	\N	\N
84401	79	D5170C00002/tiny.path.1/file-3011.pdf	\N	D5170C00002-350be3dc-8317-11eb-be00-7d295a19da64-3011	\N	NEW	\N	\N	\N	\N
85956	79	D5170C00002/tiny.path.1/file-4566.msg	\N	D5170C00002-3518237f-8318-11eb-be00-ffad3bfc8491-4566	\N	NEW	\N	\N	\N	\N
87283	79	D5170C00002/tiny.path.1/file-5893.pdf	\N	D5170C00002-35198cce-8319-11eb-be00-0773b2a9c03d-5893	\N	NEW	\N	\N	\N	\N
85957	79	D5170C00002/tiny.path.1/file-4567.msg	\N	D5170C00002-352764c0-8318-11eb-be00-39e249068699-4567	\N	NEW	\N	\N	\N	\N
82942	79	D5170C00002/tiny.path.1/file-1552.pdf	\N	D5170C00002-3528fd89-8316-11eb-be00-7d26f6f60166-1552	\N	NEW	\N	\N	\N	\N
87284	79	D5170C00002/tiny.path.1/file-5894.pdf	\N	D5170C00002-3536639f-8319-11eb-be00-dfcf290b7836-5894	\N	NEW	\N	\N	\N	\N
85958	79	D5170C00002/tiny.path.1/file-4568.msg	\N	D5170C00002-3536a701-8318-11eb-be00-39609f9108e9-4568	\N	NEW	\N	\N	\N	\N
81583	79	D5170C00002/tiny.path.1/file-0193.pdf	\N	D5170C00002-35385cfa-8315-11eb-be00-01485296f27f-193	\N	NEW	\N	\N	\N	\N
85959	79	D5170C00002/tiny.path.1/file-4569.msg	\N	D5170C00002-3546fab2-8318-11eb-be00-070351cf3a5a-4569	\N	NEW	\N	\N	\N	\N
82943	79	D5170C00002/tiny.path.1/file-1553.pdf	\N	D5170C00002-35481e4a-8316-11eb-be00-094a90b929b0-1553	\N	NEW	\N	\N	\N	\N
84402	79	D5170C00002/tiny.path.1/file-3012.pdf	\N	D5170C00002-354877ad-8317-11eb-be00-69cdaaafac20-3012	\N	NEW	\N	\N	\N	\N
87285	79	D5170C00002/tiny.path.1/file-5895.pdf	\N	D5170C00002-35488c10-8319-11eb-be00-071f6d330e07-5895	\N	NEW	\N	\N	\N	\N
87286	79	D5170C00002/tiny.path.1/file-5896.pdf	\N	D5170C00002-3556bce1-8319-11eb-be00-ddbbc4642b24-5896	\N	NEW	\N	\N	\N	\N
85960	79	D5170C00002/tiny.path.1/file-4570.msg	\N	D5170C00002-35574e63-8318-11eb-be00-df9aefa6d126-4570	\N	NEW	\N	\N	\N	\N
84403	79	D5170C00002/tiny.path.1/file-3013.pdf	\N	D5170C00002-3564641e-8317-11eb-be00-7134ac711c8b-3013	\N	NEW	\N	\N	\N	\N
82944	79	D5170C00002/tiny.path.1/file-1554.pdf	\N	D5170C00002-35662d9b-8316-11eb-be00-5da8deb9113d-1554	\N	NEW	\N	\N	\N	\N
87287	79	D5170C00002/tiny.path.1/file-5897.pdf	\N	D5170C00002-3566e982-8319-11eb-be00-b7a3bd73b9e2-5897	\N	NEW	\N	\N	\N	\N
85961	79	D5170C00002/tiny.path.1/file-4571.msg	\N	D5170C00002-35672ce4-8318-11eb-be00-d1079703ca2e-4571	\N	NEW	\N	\N	\N	\N
81584	79	D5170C00002/tiny.path.1/file-0194.pdf	\N	D5170C00002-3567352b-8315-11eb-be00-834ce2ce0da0-194	\N	NEW	\N	\N	\N	\N
82945	79	D5170C00002/tiny.path.1/file-1555.pdf	\N	D5170C00002-3575bdfc-8316-11eb-be00-411171abfdf2-1555	\N	NEW	\N	\N	\N	\N
87288	79	D5170C00002/tiny.path.1/file-5898.pdf	\N	D5170C00002-3582fd03-8319-11eb-be00-9f8da1990072-5898	\N	NEW	\N	\N	\N	\N
84404	79	D5170C00002/tiny.path.1/file-3014.pdf	\N	D5170C00002-35830faf-8317-11eb-be00-f9eee1b80c71-3014	\N	NEW	\N	\N	\N	\N
85962	79	D5170C00002/tiny.path.1/file-4572.msg	\N	D5170C00002-35831955-8318-11eb-be00-3b1f757aa7b7-4572	\N	NEW	\N	\N	\N	\N
87289	79	D5170C00002/tiny.path.1/file-5899.pdf	\N	D5170C00002-35923f44-8319-11eb-be00-b32cdc2927ce-5899	\N	NEW	\N	\N	\N	\N
85963	79	D5170C00002/tiny.path.1/file-4573.msg	\N	D5170C00002-35925b96-8318-11eb-be00-0f2d775b1dbb-4573	\N	NEW	\N	\N	\N	\N
85964	79	D5170C00002/tiny.path.1/file-4574.msg	\N	D5170C00002-35a26127-8318-11eb-be00-3dbf8c7bb10d-4574	\N	NEW	\N	\N	\N	\N
87290	79	D5170C00002/tiny.path.1/file-5900.pdf	\N	D5170C00002-35a3a465-8319-11eb-be00-0d7939872ecd-5900	\N	NEW	\N	\N	\N	\N
82946	79	D5170C00002/tiny.path.1/file-1556.pdf	\N	D5170C00002-35b2c6fd-8316-11eb-be00-3f7bc2d0f9ae-1556	\N	NEW	\N	\N	\N	\N
84405	79	D5170C00002/tiny.path.1/file-3015.pdf	\N	D5170C00002-35b36e80-8317-11eb-be00-e70ee655f21e-3015	\N	NEW	\N	\N	\N	\N
87291	79	D5170C00002/tiny.path.1/file-5901.pdf	\N	D5170C00002-35bfdef6-8319-11eb-be00-17740fbc3480-5901	\N	NEW	\N	\N	\N	\N
85965	79	D5170C00002/tiny.path.1/file-4575.msg	\N	D5170C00002-35c07078-8318-11eb-be00-87af9b509b90-4575	\N	NEW	\N	\N	\N	\N
81585	79	D5170C00002/tiny.path.1/file-0195.pdf	\N	D5170C00002-35d1419c-8315-11eb-be00-09ae594a4825-195	\N	NEW	\N	\N	\N	\N
84406	79	D5170C00002/tiny.path.1/file-3016.pdf	\N	D5170C00002-35d156c1-8317-11eb-be00-53bc160ae243-3016	\N	NEW	\N	\N	\N	\N
85966	79	D5170C00002/tiny.path.1/file-4576.msg	\N	D5170C00002-35d18779-8318-11eb-be00-f1c1a3b6c782-4576	\N	NEW	\N	\N	\N	\N
84407	79	D5170C00002/tiny.path.1/file-3017.pdf	\N	D5170C00002-35edb862-8317-11eb-be00-6b724582f22a-3017	\N	NEW	\N	\N	\N	\N
82947	79	D5170C00002/tiny.path.1/file-1557.pdf	\N	D5170C00002-35edd42e-8316-11eb-be00-4b5fc196930d-1557	\N	NEW	\N	\N	\N	\N
85967	79	D5170C00002/tiny.path.1/file-4577.msg	\N	D5170C00002-35f0330a-8318-11eb-be00-d77673a4065b-4577	\N	NEW	\N	\N	\N	\N
87292	79	D5170C00002/tiny.path.1/file-5902.pdf	\N	D5170C00002-35f064d7-8319-11eb-be00-750ba9a72913-5902	\N	NEW	\N	\N	\N	\N
81586	79	D5170C00002/tiny.path.1/file-0196.pdf	\N	D5170C00002-35fda8cd-8315-11eb-be00-79727a10afd9-196	\N	NEW	\N	\N	\N	\N
85968	79	D5170C00002/tiny.path.1/file-4578.msg	\N	D5170C00002-35ff001b-8318-11eb-be00-65ffa6a1c206-4578	\N	NEW	\N	\N	\N	\N
85969	79	D5170C00002/tiny.path.1/file-4579.msg	\N	D5170C00002-360c468c-8318-11eb-be00-758bcce549f8-4579	\N	NEW	\N	\N	\N	\N
85970	79	D5170C00002/tiny.path.1/file-4580.msg	\N	D5170C00002-360e425d-8318-11eb-be00-df7f1ddbadab-4580	\N	NEW	\N	\N	\N	\N
85971	79	D5170C00002/tiny.path.1/file-4581.msg	\N	D5170C00002-361e47ee-8318-11eb-be00-d703508294f1-4581	\N	NEW	\N	\N	\N	\N
84408	79	D5170C00002/tiny.path.1/file-3018.pdf	\N	D5170C00002-362ac163-8317-11eb-be00-85ba5f33c302-3018	\N	NEW	\N	\N	\N	\N
82948	79	D5170C00002/tiny.path.1/file-1558.pdf	\N	D5170C00002-362cb1ef-8316-11eb-be00-c55371ef3d3b-1558	\N	NEW	\N	\N	\N	\N
87293	79	D5170C00002/tiny.path.1/file-5903.pdf	\N	D5170C00002-362d94e8-8319-11eb-be00-157d7ec9f563-5903	\N	NEW	\N	\N	\N	\N
84409	79	D5170C00002/tiny.path.1/file-3019.pdf	\N	D5170C00002-363aee04-8317-11eb-be00-dbb69b2e27f6-3019	\N	NEW	\N	\N	\N	\N
85972	79	D5170C00002/tiny.path.1/file-4582.msg	\N	D5170C00002-363b45cf-8318-11eb-be00-f31ae6f59180-4582	\N	NEW	\N	\N	\N	\N
82949	79	D5170C00002/tiny.path.1/file-1559.pdf	\N	D5170C00002-3649afd0-8316-11eb-be00-4342a1753f59-1559	\N	NEW	\N	\N	\N	\N
81587	79	D5170C00002/tiny.path.1/file-0197.pdf	\N	D5170C00002-364ba1be-8315-11eb-be00-8ff9e1435a56-197	\N	NEW	\N	\N	\N	\N
84410	79	D5170C00002/tiny.path.1/file-3020.pdf	\N	D5170C00002-3658af35-8317-11eb-be00-33d5a4bc8380-3020	\N	NEW	\N	\N	\N	\N
82950	79	D5170C00002/tiny.path.1/file-1560.pdf	\N	D5170C00002-365a51a1-8316-11eb-be00-35f510ab46af-1560	\N	NEW	\N	\N	\N	\N
81588	79	D5170C00002/tiny.path.1/file-0198.pdf	\N	D5170C00002-365ae3ff-8315-11eb-be00-2dfde1a6d5ca-198	\N	NEW	\N	\N	\N	\N
85973	79	D5170C00002/tiny.path.1/file-4583.msg	\N	D5170C00002-365b02d0-8318-11eb-be00-1964ccb7f063-4583	\N	NEW	\N	\N	\N	\N
84411	79	D5170C00002/tiny.path.1/file-3021.pdf	\N	D5170C00002-3667f176-8317-11eb-be00-698b60b8dd04-3021	\N	NEW	\N	\N	\N	\N
81589	79	D5170C00002/tiny.path.1/file-0199.pdf	\N	D5170C00002-36685180-8315-11eb-be00-a3cb55ad731a-199	\N	NEW	\N	\N	\N	\N
87294	79	D5170C00002/tiny.path.1/file-5904.pdf	\N	D5170C00002-36772109-8319-11eb-be00-cf6beedfccae-5904	\N	NEW	\N	\N	\N	\N
85974	79	D5170C00002/tiny.path.1/file-4584.msg	\N	D5170C00002-3677b291-8318-11eb-be00-498d1def2c11-4584	\N	NEW	\N	\N	\N	\N
84412	79	D5170C00002/tiny.path.1/file-3022.pdf	\N	D5170C00002-36869d07-8317-11eb-be00-1d759764e112-3022	\N	NEW	\N	\N	\N	\N
82951	79	D5170C00002/tiny.path.1/file-1561.pdf	\N	D5170C00002-3686b8d2-8316-11eb-be00-8f6c9663d83d-1561	\N	NEW	\N	\N	\N	\N
85975	79	D5170C00002/tiny.path.1/file-4585.msg	\N	D5170C00002-3686f4d2-8318-11eb-be00-7f41d37f8f16-4585	\N	NEW	\N	\N	\N	\N
81590	79	D5170C00002/tiny.path.1/file-0200.pdf	\N	D5170C00002-3689bc31-8315-11eb-be00-457b1d5339ad-200	\N	NEW	\N	\N	\N	\N
84413	79	D5170C00002/tiny.path.1/file-3023.pdf	\N	D5170C00002-3695df48-8317-11eb-be00-9740f4842f8f-3023	\N	NEW	\N	\N	\N	\N
85976	79	D5170C00002/tiny.path.1/file-4586.msg	\N	D5170C00002-36a50423-8318-11eb-be00-ab68476abf27-4586	\N	NEW	\N	\N	\N	\N
84414	79	D5170C00002/tiny.path.1/file-3024.pdf	\N	D5170C00002-36a5bdc9-8317-11eb-be00-dfa8f0c5a49d-3024	\N	NEW	\N	\N	\N	\N
85977	79	D5170C00002/tiny.path.1/file-4587.msg	\N	D5170C00002-36d2a3d4-8318-11eb-be00-e79127de3b0a-4587	\N	NEW	\N	\N	\N	\N
81591	79	D5170C00002/tiny.path.1/file-0201.pdf	\N	D5170C00002-36d3e492-8315-11eb-be00-ffc5a16a4dde-201	\N	NEW	\N	\N	\N	\N
82952	79	D5170C00002/tiny.path.1/file-1562.pdf	\N	D5170C00002-36d43c93-8316-11eb-be00-f126722ad47b-1562	\N	NEW	\N	\N	\N	\N
84415	79	D5170C00002/tiny.path.1/file-3025.pdf	\N	D5170C00002-36d5f58a-8317-11eb-be00-dd57a17ce70b-3025	\N	NEW	\N	\N	\N	\N
85978	79	D5170C00002/tiny.path.1/file-4588.msg	\N	D5170C00002-36f12855-8318-11eb-be00-f332a56beaff-4588	\N	NEW	\N	\N	\N	\N
81592	79	D5170C00002/tiny.path.1/file-0202.pdf	\N	D5170C00002-36f1ccd3-8315-11eb-be00-f98bca0a46f2-202	\N	NEW	\N	\N	\N	\N
84416	79	D5170C00002/tiny.path.1/file-3026.pdf	\N	D5170C00002-36f42beb-8317-11eb-be00-bf024da45157-3026	\N	NEW	\N	\N	\N	\N
81593	79	D5170C00002/tiny.path.1/file-0203.pdf	\N	D5170C00002-37030ae4-8315-11eb-be00-877d602776c4-203	\N	NEW	\N	\N	\N	\N
84417	79	D5170C00002/tiny.path.1/file-3027.pdf	\N	D5170C00002-37103f6c-8317-11eb-be00-d73354117893-3027	\N	NEW	\N	\N	\N	\N
87295	79	D5170C00002/tiny.path.1/file-5905.pdf	\N	D5170C00002-3710a1ea-8319-11eb-be00-8df7a375ed69-5905	\N	NEW	\N	\N	\N	\N
85979	79	D5170C00002/tiny.path.1/file-4589.msg	\N	D5170C00002-37118196-8318-11eb-be00-c75be59f2707-4589	\N	NEW	\N	\N	\N	\N
85980	79	D5170C00002/tiny.path.1/file-4590.msg	\N	D5170C00002-371eef17-8318-11eb-be00-39dbd6a0f39c-4590	\N	NEW	\N	\N	\N	\N
85981	79	D5170C00002/tiny.path.1/file-4591.msg	\N	D5170C00002-37213908-8318-11eb-be00-79404c653436-4591	\N	NEW	\N	\N	\N	\N
84418	79	D5170C00002/tiny.path.1/file-3028.pdf	\N	D5170C00002-372eeafd-8317-11eb-be00-ab8a72be321f-3028	\N	NEW	\N	\N	\N	\N
85982	79	D5170C00002/tiny.path.1/file-4592.msg	\N	D5170C00002-372f42c9-8318-11eb-be00-d75b78e05e7f-4592	\N	NEW	\N	\N	\N	\N
81594	79	D5170C00002/tiny.path.1/file-0204.pdf	\N	D5170C00002-373f2985-8315-11eb-be00-5d4576086464-204	\N	NEW	\N	\N	\N	\N
87296	79	D5170C00002/tiny.path.1/file-5906.pdf	\N	D5170C00002-374ce79b-8319-11eb-be00-295041a7fb12-5906	\N	NEW	\N	\N	\N	\N
85983	79	D5170C00002/tiny.path.1/file-4593.msg	\N	D5170C00002-374e638a-8318-11eb-be00-5d9d8d57a9b4-4593	\N	NEW	\N	\N	\N	\N
84419	79	D5170C00002/tiny.path.1/file-3029.pdf	\N	D5170C00002-374ea7fe-8317-11eb-be00-53a0ff6f30cc-3029	\N	NEW	\N	\N	\N	\N
81595	79	D5170C00002/tiny.path.1/file-0205.pdf	\N	D5170C00002-374eb9e6-8315-11eb-be00-63448055b82a-205	\N	NEW	\N	\N	\N	\N
82953	79	D5170C00002/tiny.path.1/file-1563.pdf	\N	D5170C00002-374f38f4-8316-11eb-be00-153166bcdedd-1563	\N	NEW	\N	\N	\N	\N
81596	79	D5170C00002/tiny.path.1/file-0206.pdf	\N	D5170C00002-375ee687-8315-11eb-be00-99e79c8a7364-206	\N	NEW	\N	\N	\N	\N
82954	79	D5170C00002/tiny.path.1/file-1564.pdf	\N	D5170C00002-376b4c75-8316-11eb-be00-07c28a98ba0f-1564	\N	NEW	\N	\N	\N	\N
85984	79	D5170C00002/tiny.path.1/file-4594.msg	\N	D5170C00002-376d362b-8318-11eb-be00-afd7466a6c54-4594	\N	NEW	\N	\N	\N	\N
87297	79	D5170C00002/tiny.path.1/file-5907.pdf	\N	D5170C00002-376d67ec-8319-11eb-be00-d7fab081a53f-5907	\N	NEW	\N	\N	\N	\N
84420	79	D5170C00002/tiny.path.1/file-3030.pdf	\N	D5170C00002-377cbcdf-8317-11eb-be00-1d8eabf71ede-3030	\N	NEW	\N	\N	\N	\N
85985	79	D5170C00002/tiny.path.1/file-4595.msg	\N	D5170C00002-378a0cfc-8318-11eb-be00-91139d03e51e-4595	\N	NEW	\N	\N	\N	\N
82955	79	D5170C00002/tiny.path.1/file-1565.pdf	\N	D5170C00002-379a72c6-8316-11eb-be00-0ff7494ae91d-1565	\N	NEW	\N	\N	\N	\N
81597	79	D5170C00002/tiny.path.1/file-0207.pdf	\N	D5170C00002-37a9f948-8315-11eb-be00-872651b1c987-207	\N	NEW	\N	\N	\N	\N
87298	79	D5170C00002/tiny.path.1/file-5908.pdf	\N	D5170C00002-37a9fbbd-8319-11eb-be00-7bb475c8067c-5908	\N	NEW	\N	\N	\N	\N
85986	79	D5170C00002/tiny.path.1/file-4596.msg	\N	D5170C00002-37ba1dad-8318-11eb-be00-ad433597521b-4596	\N	NEW	\N	\N	\N	\N
82956	79	D5170C00002/tiny.path.1/file-1566.pdf	\N	D5170C00002-37c72817-8316-11eb-be00-d1d0d1127dd0-1566	\N	NEW	\N	\N	\N	\N
85987	79	D5170C00002/tiny.path.1/file-4597.msg	\N	D5170C00002-37e54c5e-8318-11eb-be00-b14a0a8d5263-4597	\N	NEW	\N	\N	\N	\N
87299	79	D5170C00002/tiny.path.1/file-5909.pdf	\N	D5170C00002-37e5570e-8319-11eb-be00-457c219a2cfd-5909	\N	NEW	\N	\N	\N	\N
82957	79	D5170C00002/tiny.path.1/file-1567.pdf	\N	D5170C00002-37f515e8-8316-11eb-be00-a7fab10e3865-1567	\N	NEW	\N	\N	\N	\N
85988	79	D5170C00002/tiny.path.1/file-4598.msg	\N	D5170C00002-3804bb3f-8318-11eb-be00-d92b45ef10d3-4598	\N	NEW	\N	\N	\N	\N
82958	79	D5170C00002/tiny.path.1/file-1568.pdf	\N	D5170C00002-381436a9-8316-11eb-be00-c533c481f707-1568	\N	NEW	\N	\N	\N	\N
85989	79	D5170C00002/tiny.path.1/file-4599.msg	\N	D5170C00002-38220740-8318-11eb-be00-cb85dc0df317-4599	\N	NEW	\N	\N	\N	\N
81598	79	D5170C00002/tiny.path.1/file-0208.pdf	\N	D5170C00002-3822f9d9-8315-11eb-be00-65c821cedc2d-208	\N	NEW	\N	\N	\N	\N
85990	79	D5170C00002/tiny.path.1/file-4600.msg	\N	D5170C00002-38328201-8318-11eb-be00-d33672b850e8-4600	\N	NEW	\N	\N	\N	\N
87300	79	D5170C00002/tiny.path.1/file-5910.pdf	\N	D5170C00002-3840bd7f-8319-11eb-be00-25e2157a8e3e-5910	\N	NEW	\N	\N	\N	\N
85991	79	D5170C00002/tiny.path.1/file-4601.msg	\N	D5170C00002-38434ae2-8318-11eb-be00-978177f11c93-4601	\N	NEW	\N	\N	\N	\N
82959	79	D5170C00002/tiny.path.1/file-1569.pdf	\N	D5170C00002-38507c5a-8316-11eb-be00-01201b8f4f90-1569	\N	NEW	\N	\N	\N	\N
85992	79	D5170C00002/tiny.path.1/file-4602.msg	\N	D5170C00002-385fd393-8318-11eb-be00-e94b4bcebe30-4602	\N	NEW	\N	\N	\N	\N
87301	79	D5170C00002/tiny.path.1/file-5911.pdf	\N	D5170C00002-38618bf0-8319-11eb-be00-930d480834e5-5911	\N	NEW	\N	\N	\N	\N
81599	79	D5170C00002/tiny.path.1/file-0209.pdf	\N	D5170C00002-386f1e0a-8315-11eb-be00-ebb6938bea50-209	\N	NEW	\N	\N	\N	\N
85993	79	D5170C00002/tiny.path.1/file-4603.msg	\N	D5170C00002-38707564-8318-11eb-be00-e792b17748a6-4603	\N	NEW	\N	\N	\N	\N
82960	79	D5170C00002/tiny.path.1/file-1570.pdf	\N	D5170C00002-388d855b-8316-11eb-be00-4d999acd547b-1570	\N	NEW	\N	\N	\N	\N
87302	79	D5170C00002/tiny.path.1/file-5912.pdf	\N	D5170C00002-388edd81-8319-11eb-be00-0509b6a64256-5912	\N	NEW	\N	\N	\N	\N
85994	79	D5170C00002/tiny.path.1/file-4604.pdf	\N	D5170C00002-389ed865-8318-11eb-be00-81776b73b6a3-4604	\N	NEW	\N	\N	\N	\N
81600	79	D5170C00002/tiny.path.1/file-0210.pdf	\N	D5170C00002-38bcefeb-8315-11eb-be00-8f62c75361cc-210	\N	NEW	\N	\N	\N	\N
85995	79	D5170C00002/tiny.path.1/file-4605.pdf	\N	D5170C00002-38cced46-8318-11eb-be00-2dbebe0e9cca-4605	\N	NEW	\N	\N	\N	\N
82961	79	D5170C00002/tiny.path.1/file-1571.pdf	\N	D5170C00002-38db091c-8316-11eb-be00-a9024040ac4d-1571	\N	NEW	\N	\N	\N	\N
87303	79	D5170C00002/tiny.path.1/file-5913.pdf	\N	D5170C00002-38f8c2e2-8319-11eb-be00-f5a55b0badb3-5913	\N	NEW	\N	\N	\N	\N
85996	79	D5170C00002/tiny.path.1/file-4606.pdf	\N	D5170C00002-38f92d67-8318-11eb-be00-5d3e7761ac75-4606	\N	NEW	\N	\N	\N	\N
82962	79	D5170C00002/tiny.path.1/file-1572.pdf	\N	D5170C00002-38faed2d-8316-11eb-be00-69d13d4e970a-1572	\N	NEW	\N	\N	\N	\N
82963	79	D5170C00002/tiny.path.1/file-1573.pdf	\N	D5170C00002-3918874e-8316-11eb-be00-31829d3839ef-1573	\N	NEW	\N	\N	\N	\N
85997	79	D5170C00002/tiny.path.1/file-4607.pdf	\N	D5170C00002-39189c48-8318-11eb-be00-4b7efcd1e987-4607	\N	NEW	\N	\N	\N	\N
82964	79	D5170C00002/tiny.path.1/file-1574.pdf	\N	D5170C00002-39350fff-8316-11eb-be00-5f0a21460fc3-1574	\N	NEW	\N	\N	\N	\N
85998	79	D5170C00002/tiny.path.1/file-4608.pdf	\N	D5170C00002-393747d9-8318-11eb-be00-9b6dcec89fbb-4608	\N	NEW	\N	\N	\N	\N
87304	79	D5170C00002/tiny.path.1/file-5914.pdf	\N	D5170C00002-3943d5a3-8319-11eb-be00-c10ae25d51ac-5914	\N	NEW	\N	\N	\N	\N
85999	79	D5170C00002/tiny.path.1/file-4609.pdf	\N	D5170C00002-395445ba-8318-11eb-be00-83a919a1cdf8-4609	\N	NEW	\N	\N	\N	\N
87305	79	D5170C00002/tiny.path.1/file-5915.pdf	\N	D5170C00002-3962a844-8319-11eb-be00-27f4284caac5-5915	\N	NEW	\N	\N	\N	\N
81601	79	D5170C00002/tiny.path.1/file-0211.pdf	\N	D5170C00002-3963de4c-8315-11eb-be00-7bca5e17e90d-211	\N	NEW	\N	\N	\N	\N
82965	79	D5170C00002/tiny.path.1/file-1575.pdf	\N	D5170C00002-39735180-8316-11eb-be00-294adbfa02db-1575	\N	NEW	\N	\N	\N	\N
87306	79	D5170C00002/tiny.path.1/file-5916.pdf	\N	D5170C00002-3980dea5-8319-11eb-be00-ddb9a96c5566-5916	\N	NEW	\N	\N	\N	\N
81602	79	D5170C00002/tiny.path.1/file-0212.pdf	\N	D5170C00002-39921a3d-8315-11eb-be00-b9c585959826-212	\N	NEW	\N	\N	\N	\N
82966	79	D5170C00002/tiny.path.1/file-1576.pdf	\N	D5170C00002-39929951-8316-11eb-be00-195e61f00bbd-1576	\N	NEW	\N	\N	\N	\N
86000	79	D5170C00002/tiny.path.1/file-4610.pdf	\N	D5170C00002-399fa69b-8318-11eb-be00-bd986df2c92e-4610	\N	NEW	\N	\N	\N	\N
87307	79	D5170C00002/tiny.path.1/file-5917.pdf	\N	D5170C00002-399fff66-8319-11eb-be00-59ca7d191278-5917	\N	NEW	\N	\N	\N	\N
82967	79	D5170C00002/tiny.path.1/file-1577.pdf	\N	D5170C00002-39af4912-8316-11eb-be00-6dadac2959df-1577	\N	NEW	\N	\N	\N	\N
87327	79	D5170C00002/tiny.path.1/file-5937.pdf	\N	D5170C00002-39be35c7-8319-11eb-be00-173ce0f21b8a-5918	\N	NEW	\N	\N	\N	\N
81603	79	D5170C00002/tiny.path.1/file-0213.pdf	\N	D5170C00002-39bfb9ee-8315-11eb-be00-39447ffc2981-213	\N	NEW	\N	\N	\N	\N
86001	79	D5170C00002/tiny.path.1/file-4611.pdf	\N	D5170C00002-39c1385c-8318-11eb-be00-e7e555b27054-4611	\N	NEW	\N	\N	\N	\N
86002	79	D5170C00002/tiny.path.1/file-4612.pdf	\N	D5170C00002-39dd24cd-8318-11eb-be00-45d24585de35-4612	\N	NEW	\N	\N	\N	\N
87328	79	D5170C00002/tiny.path.1/file-5938.pdf	\N	D5170C00002-39ec4aa8-8319-11eb-be00-b99fac6856a5-5919	\N	NEW	\N	\N	\N	\N
82968	79	D5170C00002/tiny.path.1/file-1578.pdf	\N	D5170C00002-39ed1563-8316-11eb-be00-55a2bf843fee-1578	\N	NEW	\N	\N	\N	\N
86003	79	D5170C00002/tiny.path.1/file-4613.pdf	\N	D5170C00002-39fda51e-8318-11eb-be00-25316b9c6c28-4613	\N	NEW	\N	\N	\N	\N
82969	79	D5170C00002/tiny.path.1/file-1579.pdf	\N	D5170C00002-39fdde44-8316-11eb-be00-4d86091f1be9-1579	\N	NEW	\N	\N	\N	\N
87329	79	D5170C00002/tiny.path.1/file-5939.pdf	\N	D5170C00002-3a0a59f9-8319-11eb-be00-137ed572264f-5920	\N	NEW	\N	\N	\N	\N
82970	79	D5170C00002/tiny.path.1/file-1580.pdf	\N	D5170C00002-3a1b2a45-8316-11eb-be00-872ce42bf1ea-1580	\N	NEW	\N	\N	\N	\N
82971	79	D5170C00002/tiny.path.1/file-1581.pdf	\N	D5170C00002-3a2bf326-8316-11eb-be00-659a4d91843b-1581	\N	NEW	\N	\N	\N	\N
86004	79	D5170C00002/tiny.path.1/file-4614.pdf	\N	D5170C00002-3a39277f-8318-11eb-be00-6b5cc396bc4f-4614	\N	NEW	\N	\N	\N	\N
86005	79	D5170C00002/tiny.path.1/file-4615.pdf	\N	D5170C00002-3a4adac0-8318-11eb-be00-d19c1fe20285-4615	\N	NEW	\N	\N	\N	\N
87308	79	D5170C00002/tiny.path.1/file-5918.pdf	\N	D5170C00002-3a582bda-8319-11eb-be00-d399f258ff09-5921	\N	NEW	\N	\N	\N	\N
82972	79	D5170C00002/tiny.path.1/file-1582.pdf	\N	D5170C00002-3a58a877-8316-11eb-be00-250998b0e787-1582	\N	NEW	\N	\N	\N	\N
81604	79	D5170C00002/tiny.path.1/file-0214.pdf	\N	D5170C00002-3a59fe1f-8315-11eb-be00-e796e7998913-214	\N	NEW	\N	\N	\N	\N
86006	79	D5170C00002/tiny.path.1/file-4616.pdf	\N	D5170C00002-3a67d8a1-8318-11eb-be00-3bdb26c07f57-4616	\N	NEW	\N	\N	\N	\N
87309	79	D5170C00002/tiny.path.1/file-5919.pdf	\N	D5170C00002-3a84ba1b-8319-11eb-be00-2bfde50fe817-5922	\N	NEW	\N	\N	\N	\N
82973	79	D5170C00002/tiny.path.1/file-1583.pdf	\N	D5170C00002-3a94c718-8316-11eb-be00-8d0c8e0bc02e-1583	\N	NEW	\N	\N	\N	\N
86007	79	D5170C00002/tiny.path.1/file-4617.pdf	\N	D5170C00002-3a950322-8318-11eb-be00-070658a76730-4617	\N	NEW	\N	\N	\N	\N
86008	79	D5170C00002/tiny.path.1/file-4618.pdf	\N	D5170C00002-3ab29d43-8318-11eb-be00-7d5f8fba0804-4618	\N	NEW	\N	\N	\N	\N
86009	79	D5170C00002/tiny.path.1/file-4619.pdf	\N	D5170C00002-3ac2f0f4-8318-11eb-be00-5da18bc9e807-4619	\N	NEW	\N	\N	\N	\N
87310	79	D5170C00002/tiny.path.1/file-5920.pdf	\N	D5170C00002-3ac40d0c-8319-11eb-be00-c737be9461d9-5923	\N	NEW	\N	\N	\N	\N
82974	79	D5170C00002/tiny.path.1/file-1584.pdf	\N	D5170C00002-3ac4b0b9-8316-11eb-be00-c97b65f7e4b9-1584	\N	NEW	\N	\N	\N	\N
81605	79	D5170C00002/tiny.path.1/file-0215.pdf	\N	D5170C00002-3ad21350-8315-11eb-be00-e1539289af5c-215	\N	NEW	\N	\N	\N	\N
86010	79	D5170C00002/tiny.path.1/file-4620.pdf	\N	D5170C00002-3ae10045-8318-11eb-be00-5da48e8ac442-4620	\N	NEW	\N	\N	\N	\N
82975	79	D5170C00002/tiny.path.1/file-1585.pdf	\N	D5170C00002-3ae3aa6a-8316-11eb-be00-1942e8ea45f7-1585	\N	NEW	\N	\N	\N	\N
84421	79	D5170C00002/tiny.path.1/file-3031.pdf	\N	D5170C00002-3af05ed0-8317-11eb-be00-d1d1dfcb62df-3031	\N	NEW	\N	\N	\N	\N
87311	79	D5170C00002/tiny.path.1/file-5921.pdf	\N	D5170C00002-3affb67d-8319-11eb-be00-7bdd70ab9580-5924	\N	NEW	\N	\N	\N	\N
81606	79	D5170C00002/tiny.path.1/file-0216.pdf	\N	D5170C00002-3b007651-8315-11eb-be00-a97734f28f19-216	\N	NEW	\N	\N	\N	\N
86011	79	D5170C00002/tiny.path.1/file-4621.pdf	\N	D5170C00002-3b0e03b6-8318-11eb-be00-8dcf9aff3486-4621	\N	NEW	\N	\N	\N	\N
82976	79	D5170C00002/tiny.path.1/file-1586.pdf	\N	D5170C00002-3b1f53db-8316-11eb-be00-ed1aae38f430-1586	\N	NEW	\N	\N	\N	\N
86012	79	D5170C00002/tiny.path.1/file-4622.pdf	\N	D5170C00002-3b2d99a7-8318-11eb-be00-d13f90204d36-4622	\N	NEW	\N	\N	\N	\N
81607	79	D5170C00002/tiny.path.1/file-0217.pdf	\N	D5170C00002-3b2eb242-8315-11eb-be00-6dbf65c8ec2d-217	\N	NEW	\N	\N	\N	\N
87312	79	D5170C00002/tiny.path.1/file-5922.pdf	\N	D5170C00002-3b3bae0e-8319-11eb-be00-250a1c58eff7-5925	\N	NEW	\N	\N	\N	\N
82977	79	D5170C00002/tiny.path.1/file-1587.pdf	\N	D5170C00002-3b3ec2bc-8316-11eb-be00-cf8bcd143ada-1587	\N	NEW	\N	\N	\N	\N
86013	79	D5170C00002/tiny.path.1/file-4623.pdf	\N	D5170C00002-3b3ed7b8-8318-11eb-be00-c72088ce570d-4623	\N	NEW	\N	\N	\N	\N
81608	79	D5170C00002/tiny.path.1/file-0218.pdf	\N	D5170C00002-3b4ebd63-8315-11eb-be00-937ce79e955a-218	\N	NEW	\N	\N	\N	\N
86014	79	D5170C00002/tiny.path.1/file-4624.pdf	\N	D5170C00002-3b5b8779-8318-11eb-be00-abedc74e4c4c-4624	\N	NEW	\N	\N	\N	\N
82978	79	D5170C00002/tiny.path.1/file-1588.pdf	\N	D5170C00002-3b5d6e4d-8316-11eb-be00-1b983a11c2ee-1588	\N	NEW	\N	\N	\N	\N
87313	79	D5170C00002/tiny.path.1/file-5923.pdf	\N	D5170C00002-3b6aad4f-8319-11eb-be00-39022b401779-5926	\N	NEW	\N	\N	\N	\N
82979	79	D5170C00002/tiny.path.1/file-1589.pdf	\N	D5170C00002-3b884ede-8316-11eb-be00-27e7a30d9b15-1589	\N	NEW	\N	\N	\N	\N
81609	79	D5170C00002/tiny.path.1/file-0219.pdf	\N	D5170C00002-3b89a384-8315-11eb-be00-95736db0f0bf-219	\N	NEW	\N	\N	\N	\N
86015	79	D5170C00002/tiny.path.1/file-4625.pdf	\N	D5170C00002-3b8a389a-8318-11eb-be00-a92f81e30f46-4625	\N	NEW	\N	\N	\N	\N
86016	79	D5170C00002/tiny.path.1/file-4626.pdf	\N	D5170C00002-3b9a3e2b-8318-11eb-be00-8d9fb937a190-4626	\N	NEW	\N	\N	\N	\N
87314	79	D5170C00002/tiny.path.1/file-5924.pdf	\N	D5170C00002-3ba76830-8319-11eb-be00-a981683c8442-5927	\N	NEW	\N	\N	\N	\N
84422	79	D5170C00002/tiny.path.1/file-3032.pdf	\N	D5170C00002-3bb6e321-8317-11eb-be00-ad3473ccfb57-3032	\N	NEW	\N	\N	\N	\N
81610	79	D5170C00002/tiny.path.1/file-0220.pdf	\N	D5170C00002-3bb80685-8315-11eb-be00-b1769598a324-220	\N	NEW	\N	\N	\N	\N
87315	79	D5170C00002/tiny.path.1/file-5925.pdf	\N	D5170C00002-3bc4db41-8319-11eb-be00-93ee86dcd7e7-5928	\N	NEW	\N	\N	\N	\N
82980	79	D5170C00002/tiny.path.1/file-1590.pdf	\N	D5170C00002-3bc6694f-8316-11eb-be00-ad26193f481f-1590	\N	NEW	\N	\N	\N	\N
84423	79	D5170C00002/tiny.path.1/file-3033.pdf	\N	D5170C00002-3bd45632-8317-11eb-be00-f78780ab5109-3033	\N	NEW	\N	\N	\N	\N
86017	79	D5170C00002/tiny.path.1/file-4627.pdf	\N	D5170C00002-3bd5726c-8318-11eb-be00-fd248a033fa2-4627	\N	NEW	\N	\N	\N	\N
84424	79	D5170C00002/tiny.path.1/file-3034.pdf	\N	D5170C00002-3be39873-8317-11eb-be00-4d23dbe3ba84-3034	\N	NEW	\N	\N	\N	\N
81611	79	D5170C00002/tiny.path.1/file-0221.pdf	\N	D5170C00002-3be46db6-8315-11eb-be00-47e9d168f0dd-221	\N	NEW	\N	\N	\N	\N
86018	79	D5170C00002/tiny.path.1/file-4628.pdf	\N	D5170C00002-3bf4450d-8318-11eb-be00-25f6acb9d926-4628	\N	NEW	\N	\N	\N	\N
84425	79	D5170C00002/tiny.path.1/file-3035.pdf	\N	D5170C00002-3bf572c4-8317-11eb-be00-9baf40a4e9e8-3035	\N	NEW	\N	\N	\N	\N
87316	79	D5170C00002/tiny.path.1/file-5926.pdf	\N	D5170C00002-3c023262-8319-11eb-be00-5b20e26c55e9-5929	\N	NEW	\N	\N	\N	\N
84426	79	D5170C00002/tiny.path.1/file-3036.pdf	\N	D5170C00002-3c030755-8317-11eb-be00-3530d0fd07c7-3036	\N	NEW	\N	\N	\N	\N
81612	79	D5170C00002/tiny.path.1/file-0222.pdf	\N	D5170C00002-3c053c27-8315-11eb-be00-fb77387ce571-222	\N	NEW	\N	\N	\N	\N
82981	79	D5170C00002/tiny.path.1/file-1591.pdf	\N	D5170C00002-3c11f140-8316-11eb-be00-95c555cc82c7-1591	\N	NEW	\N	\N	\N	\N
84427	79	D5170C00002/tiny.path.1/file-3037.pdf	\N	D5170C00002-3c20ef96-8317-11eb-be00-9bd66e36411b-3037	\N	NEW	\N	\N	\N	\N
86019	79	D5170C00002/tiny.path.1/file-4629.pdf	\N	D5170C00002-3c220bce-8318-11eb-be00-2d685b43cd03-4629	\N	NEW	\N	\N	\N	\N
82982	79	D5170C00002/tiny.path.1/file-1592.pdf	\N	D5170C00002-3c230841-8316-11eb-be00-cbb32c854ae9-1592	\N	NEW	\N	\N	\N	\N
82983	79	D5170C00002/tiny.path.1/file-1593.pdf	\N	D5170C00002-3c309cd2-8316-11eb-be00-27eaa23dcdee-1593	\N	NEW	\N	\N	\N	\N
84428	79	D5170C00002/tiny.path.1/file-3038.pdf	\N	D5170C00002-3c30a707-8317-11eb-be00-bb1df5fbdbec-3038	\N	NEW	\N	\N	\N	\N
84429	79	D5170C00002/tiny.path.1/file-3039.pdf	\N	D5170C00002-3c3f25f8-8317-11eb-be00-970b3a58d8d7-3039	\N	NEW	\N	\N	\N	\N
84430	79	D5170C00002/tiny.path.1/file-3040.pdf	\N	D5170C00002-3c40fab9-8317-11eb-be00-1dbd62d80a9f-3040	\N	NEW	\N	\N	\N	\N
82984	79	D5170C00002/tiny.path.1/file-1594.pdf	\N	D5170C00002-3c411793-8316-11eb-be00-2f632fc17aa4-1594	\N	NEW	\N	\N	\N	\N
87317	79	D5170C00002/tiny.path.1/file-5927.pdf	\N	D5170C00002-3c4ea4b3-8319-11eb-be00-0520fdfb66c2-5930	\N	NEW	\N	\N	\N	\N
84431	79	D5170C00002/tiny.path.1/file-3041.pdf	\N	D5170C00002-3c519c8a-8317-11eb-be00-77c6de169704-3041	\N	NEW	\N	\N	\N	\N
81613	79	D5170C00002/tiny.path.1/file-0223.pdf	\N	D5170C00002-3c602d68-8315-11eb-be00-ed92a918d7ca-223	\N	NEW	\N	\N	\N	\N
86020	79	D5170C00002/tiny.path.1/file-4630.pdf	\N	D5170C00002-3c609b6f-8318-11eb-be00-25ba5fbc0f96-4630	\N	NEW	\N	\N	\N	\N
84432	79	D5170C00002/tiny.path.1/file-3042.pdf	\N	D5170C00002-3c7c560b-8317-11eb-be00-270ff98262e3-3042	\N	NEW	\N	\N	\N	\N
87318	79	D5170C00002/tiny.path.1/file-5928.pdf	\N	D5170C00002-3c7e4034-8319-11eb-be00-f729550f61c0-5931	\N	NEW	\N	\N	\N	\N
82985	79	D5170C00002/tiny.path.1/file-1595.pdf	\N	D5170C00002-3c7e95c4-8316-11eb-be00-4b0de134b356-1595	\N	NEW	\N	\N	\N	\N
86021	79	D5170C00002/tiny.path.1/file-4631.pdf	\N	D5170C00002-3c7f1ff0-8318-11eb-be00-6f415e5108c9-4631	\N	NEW	\N	\N	\N	\N
84433	79	D5170C00002/tiny.path.1/file-3043.pdf	\N	D5170C00002-3c7f3c3c-8317-11eb-be00-099aeb397046-3043	\N	NEW	\N	\N	\N	\N
81614	79	D5170C00002/tiny.path.1/file-0224.pdf	\N	D5170C00002-3c8c4679-8315-11eb-be00-2550744dd2c7-224	\N	NEW	\N	\N	\N	\N
84434	79	D5170C00002/tiny.path.1/file-3044.pdf	\N	D5170C00002-3c8cd0cd-8317-11eb-be00-7528f38cab31-3044	\N	NEW	\N	\N	\N	\N
84435	79	D5170C00002/tiny.path.1/file-3045.pdf	\N	D5170C00002-3c9bebfe-8317-11eb-be00-1d64bc8e8b73-3045	\N	NEW	\N	\N	\N	\N
82986	79	D5170C00002/tiny.path.1/file-1596.pdf	\N	D5170C00002-3c9c08d5-8316-11eb-be00-a37b6f97ec0c-1596	\N	NEW	\N	\N	\N	\N
84436	79	D5170C00002/tiny.path.1/file-3046.pdf	\N	D5170C00002-3c9e0edf-8317-11eb-be00-118479c07d79-3046	\N	NEW	\N	\N	\N	\N
87319	79	D5170C00002/tiny.path.1/file-5929.pdf	\N	D5170C00002-3caaf585-8319-11eb-be00-0fda11a1d292-5932	\N	NEW	\N	\N	\N	\N
81615	79	D5170C00002/tiny.path.1/file-0225.pdf	\N	D5170C00002-3cb9980a-8315-11eb-be00-59f6487bbbdc-225	\N	NEW	\N	\N	\N	\N
84437	79	D5170C00002/tiny.path.1/file-3047.pdf	\N	D5170C00002-3cbba900-8317-11eb-be00-cd240151f76b-3047	\N	NEW	\N	\N	\N	\N
86022	79	D5170C00002/tiny.path.1/file-4632.pdf	\N	D5170C00002-3ccaf601-8318-11eb-be00-2d0470b46536-4632	\N	NEW	\N	\N	\N	\N
87320	79	D5170C00002/tiny.path.1/file-5930.pdf	\N	D5170C00002-3cd7f8f6-8319-11eb-be00-e7b2cf21384f-5933	\N	NEW	\N	\N	\N	\N
82987	79	D5170C00002/tiny.path.1/file-1597.pdf	\N	D5170C00002-3ce9b3a6-8316-11eb-be00-53456e6b241e-1597	\N	NEW	\N	\N	\N	\N
87321	79	D5170C00002/tiny.path.1/file-5931.pdf	\N	D5170C00002-3cf7b5f7-8319-11eb-be00-c56c09992bd5-5934	\N	NEW	\N	\N	\N	\N
84438	79	D5170C00002/tiny.path.1/file-3048.pdf	\N	D5170C00002-3cf99c61-8317-11eb-be00-f154f8d9675a-3048	\N	NEW	\N	\N	\N	\N
82988	79	D5170C00002/tiny.path.1/file-1598.pdf	\N	D5170C00002-3d17a177-8316-11eb-be00-5fe655ee0d73-1598	\N	NEW	\N	\N	\N	\N
81616	79	D5170C00002/tiny.path.1/file-0226.pdf	\N	D5170C00002-3d24dcfb-8315-11eb-be00-ad367b0b9ca6-226	\N	NEW	\N	\N	\N	\N
86023	79	D5170C00002/tiny.path.1/file-4633.pdf	\N	D5170C00002-3d271fc2-8318-11eb-be00-3baaab954fba-4633	\N	NEW	\N	\N	\N	\N
84439	79	D5170C00002/tiny.path.1/file-3049.pdf	\N	D5170C00002-3d348282-8317-11eb-be00-a39152c55af4-3049	\N	NEW	\N	\N	\N	\N
87322	79	D5170C00002/tiny.path.1/file-5932.pdf	\N	D5170C00002-3d42a1a8-8319-11eb-be00-eb214ac0f1e7-5935	\N	NEW	\N	\N	\N	\N
84440	79	D5170C00002/tiny.path.1/file-3050.pdf	\N	D5170C00002-3d4376a3-8317-11eb-be00-f9b29afb33b9-3050	\N	NEW	\N	\N	\N	\N
81617	79	D5170C00002/tiny.path.1/file-0227.pdf	\N	D5170C00002-3d43d6ac-8315-11eb-be00-21cf7d1cc790-227	\N	NEW	\N	\N	\N	\N
81618	79	D5170C00002/tiny.path.1/file-0228.pdf	\N	D5170C00002-3d61e5fd-8315-11eb-be00-7dc665aeb76c-228	\N	NEW	\N	\N	\N	\N
82989	79	D5170C00002/tiny.path.1/file-1599.pdf	\N	D5170C00002-3d61f0e8-8316-11eb-be00-31b199dc6120-1599	\N	NEW	\N	\N	\N	\N
84441	79	D5170C00002/tiny.path.1/file-3051.pdf	\N	D5170C00002-3d62e584-8317-11eb-be00-95e5a5ddef8f-3051	\N	NEW	\N	\N	\N	\N
84442	79	D5170C00002/tiny.path.1/file-3052.pdf	\N	D5170C00002-3d8142f5-8317-11eb-be00-49079b6f2177-3052	\N	NEW	\N	\N	\N	\N
82990	79	D5170C00002/tiny.path.1/file-1600.pdf	\N	D5170C00002-3d82e669-8316-11eb-be00-a37b565604b7-1600	\N	NEW	\N	\N	\N	\N
81619	79	D5170C00002/tiny.path.1/file-0229.pdf	\N	D5170C00002-3d8f378e-8315-11eb-be00-c5f6e67c436f-229	\N	NEW	\N	\N	\N	\N
86024	79	D5170C00002/tiny.path.1/file-4634.pdf	\N	D5170C00002-3d901ac3-8318-11eb-be00-0df7884310c5-4634	\N	NEW	\N	\N	\N	\N
84443	79	D5170C00002/tiny.path.1/file-3053.pdf	\N	D5170C00002-3d908536-8317-11eb-be00-bd3537d1d197-3053	\N	NEW	\N	\N	\N	\N
87323	79	D5170C00002/tiny.path.1/file-5933.pdf	\N	D5170C00002-3d924849-8319-11eb-be00-c7f8af32147b-5936	\N	NEW	\N	\N	\N	\N
84444	79	D5170C00002/tiny.path.1/file-3054.pdf	\N	D5170C00002-3d9fa067-8317-11eb-be00-5503c2fe3f6c-3054	\N	NEW	\N	\N	\N	\N
81620	79	D5170C00002/tiny.path.1/file-0230.pdf	\N	D5170C00002-3daf1b9f-8315-11eb-be00-75588a3e81a5-230	\N	NEW	\N	\N	\N	\N
86025	79	D5170C00002/tiny.path.1/file-4635.pdf	\N	D5170C00002-3dbe2fa4-8318-11eb-be00-df7467fd9cf0-4635	\N	NEW	\N	\N	\N	\N
81621	79	D5170C00002/tiny.path.1/file-0231.pdf	\N	D5170C00002-3dbf4840-8315-11eb-be00-d548c43aa82b-231	\N	NEW	\N	\N	\N	\N
84445	79	D5170C00002/tiny.path.1/file-3055.pdf	\N	D5170C00002-3dcc0798-8317-11eb-be00-d70ff0d6bebe-3055	\N	NEW	\N	\N	\N	\N
87324	79	D5170C00002/tiny.path.1/file-5934.pdf	\N	D5170C00002-3dcc6b1a-8319-11eb-be00-115fa49705aa-5937	\N	NEW	\N	\N	\N	\N
81622	79	D5170C00002/tiny.path.1/file-0232.pdf	\N	D5170C00002-3dce8a81-8315-11eb-be00-d1093c80667a-232	\N	NEW	\N	\N	\N	\N
82991	79	D5170C00002/tiny.path.1/file-1601.pdf	\N	D5170C00002-3dddd7aa-8316-11eb-be00-1bc8e16505ae-1601	\N	NEW	\N	\N	\N	\N
87325	79	D5170C00002/tiny.path.1/file-5935.pdf	\N	D5170C00002-3deac88b-8319-11eb-be00-3b4d1fe86bb1-5938	\N	NEW	\N	\N	\N	\N
84446	79	D5170C00002/tiny.path.1/file-3056.pdf	\N	D5170C00002-3dfa4389-8317-11eb-be00-8fb58082f25f-3056	\N	NEW	\N	\N	\N	\N
86026	79	D5170C00002/tiny.path.1/file-4636.pdf	\N	D5170C00002-3dfa7555-8318-11eb-be00-c7b247cdf973-4636	\N	NEW	\N	\N	\N	\N
87326	79	D5170C00002/tiny.path.1/file-5936.pdf	\N	D5170C00002-3dfaf52c-8319-11eb-be00-e9ba0580178e-5939	\N	NEW	\N	\N	\N	\N
84447	79	D5170C00002/tiny.path.1/file-3057.pdf	\N	D5170C00002-3dfc666a-8317-11eb-be00-b5e274d04a9d-3057	\N	NEW	\N	\N	\N	\N
82992	79	D5170C00002/tiny.path.1/file-1602.pdf	\N	D5170C00002-3e1896bb-8316-11eb-be00-791d3ca6df0b-1602	\N	NEW	\N	\N	\N	\N
84448	79	D5170C00002/tiny.path.1/file-3058.pdf	\N	D5170C00002-3e28586b-8317-11eb-be00-8f982cdb5f16-3058	\N	NEW	\N	\N	\N	\N
86027	79	D5170C00002/tiny.path.1/file-4637.pdf	\N	D5170C00002-3e2a5ef6-8318-11eb-be00-81baa6aa7e74-4637	\N	NEW	\N	\N	\N	\N
84449	79	D5170C00002/tiny.path.1/file-3059.pdf	\N	D5170C00002-3e39214c-8317-11eb-be00-9bdcf5c21316-3059	\N	NEW	\N	\N	\N	\N
82993	79	D5170C00002/tiny.path.1/file-1603.pdf	\N	D5170C00002-3e491c9c-8316-11eb-be00-1b4677a7a9f0-1603	\N	NEW	\N	\N	\N	\N
84450	79	D5170C00002/tiny.path.1/file-3060.pdf	\N	D5170C00002-3e65616d-8317-11eb-be00-b9b5796c2e22-3060	\N	NEW	\N	\N	\N	\N
81623	79	D5170C00002/tiny.path.1/file-0233.pdf	\N	D5170C00002-3e660f92-8315-11eb-be00-87055af007f8-233	\N	NEW	\N	\N	\N	\N
86028	79	D5170C00002/tiny.path.1/file-4638.pdf	\N	D5170C00002-3e75e6e7-8318-11eb-be00-0f1e6ddb822e-4638	\N	NEW	\N	\N	\N	\N
82994	79	D5170C00002/tiny.path.1/file-1604.pdf	\N	D5170C00002-3e77588d-8316-11eb-be00-3500f2350339-1604	\N	NEW	\N	\N	\N	\N
87330	79	D5170C00002/tiny.path.1/file-5940.pdf	\N	D5170C00002-3e835f0d-8319-11eb-be00-13204731119c-5940	\N	NEW	\N	\N	\N	\N
84451	79	D5170C00002/tiny.path.1/file-3061.pdf	\N	D5170C00002-3e8370be-8317-11eb-be00-afd1837be800-3061	\N	NEW	\N	\N	\N	\N
84452	79	D5170C00002/tiny.path.1/file-3062.pdf	\N	D5170C00002-3e85457f-8317-11eb-be00-cf6ee21b4319-3062	\N	NEW	\N	\N	\N	\N
86029	79	D5170C00002/tiny.path.1/file-4639.pdf	\N	D5170C00002-3e944458-8318-11eb-be00-0d28b44dac30-4639	\N	NEW	\N	\N	\N	\N
81624	79	D5170C00002/tiny.path.1/file-0234.pdf	\N	D5170C00002-3e950ed3-8315-11eb-be00-07f30916bed8-234	\N	NEW	\N	\N	\N	\N
84453	79	D5170C00002/tiny.path.1/file-3063.msg	\N	D5170C00002-3ea21c50-8317-11eb-be00-2b91770a89a0-3063	\N	NEW	\N	\N	\N	\N
82995	79	D5170C00002/tiny.path.1/file-1605.pdf	\N	D5170C00002-3ea2ae4e-8316-11eb-be00-831de44cf7c3-1605	\N	NEW	\N	\N	\N	\N
84454	79	D5170C00002/tiny.path.1/file-3064.msg	\N	D5170C00002-3eb0e961-8317-11eb-be00-c9e1b9349d85-3064	\N	NEW	\N	\N	\N	\N
87331	79	D5170C00002/tiny.path.1/file-5941.pdf	\N	D5170C00002-3eb173ee-8319-11eb-be00-93b95018b947-5941	\N	NEW	\N	\N	\N	\N
81625	79	D5170C00002/tiny.path.1/file-0235.pdf	\N	D5170C00002-3eb25ad4-8315-11eb-be00-679e2912330e-235	\N	NEW	\N	\N	\N	\N
86030	79	D5170C00002/tiny.path.1/file-4640.pdf	\N	D5170C00002-3eb2c8d9-8318-11eb-be00-19a331e7d69c-4640	\N	NEW	\N	\N	\N	\N
84455	79	D5170C00002/tiny.path.1/file-3065.msg	\N	D5170C00002-3ec079c2-8317-11eb-be00-43c7e4097387-3065	\N	NEW	\N	\N	\N	\N
81626	79	D5170C00002/tiny.path.1/file-0236.pdf	\N	D5170C00002-3ec17605-8315-11eb-be00-2ba4c367e789-236	\N	NEW	\N	\N	\N	\N
86031	79	D5170C00002/tiny.path.1/file-4641.pdf	\N	D5170C00002-3ed08a0a-8318-11eb-be00-153b71a3edf0-4641	\N	NEW	\N	\N	\N	\N
84456	79	D5170C00002/tiny.path.1/file-3066.msg	\N	D5170C00002-3ed1b7d3-8317-11eb-be00-0dab1c4b4929-3066	\N	NEW	\N	\N	\N	\N
82996	79	D5170C00002/tiny.path.1/file-1606.pdf	\N	D5170C00002-3ed1d49f-8316-11eb-be00-f96151497618-1606	\N	NEW	\N	\N	\N	\N
87332	79	D5170C00002/tiny.path.1/file-5942.pdf	\N	D5170C00002-3eed6b7f-8319-11eb-be00-57afb8a71d80-5942	\N	NEW	\N	\N	\N	\N
84457	79	D5170C00002/tiny.path.1/file-3067.msg	\N	D5170C00002-3eee1974-8317-11eb-be00-95950d952d05-3067	\N	NEW	\N	\N	\N	\N
84458	79	D5170C00002/tiny.path.1/file-3068.msg	\N	D5170C00002-3efd82c5-8317-11eb-be00-2d5e46930108-3068	\N	NEW	\N	\N	\N	\N
81627	79	D5170C00002/tiny.path.1/file-0237.pdf	\N	D5170C00002-3efe57f6-8315-11eb-be00-67267c3cee24-237	\N	NEW	\N	\N	\N	\N
82997	79	D5170C00002/tiny.path.1/file-1607.pdf	\N	D5170C00002-3eff2630-8316-11eb-be00-572dabf6d747-1607	\N	NEW	\N	\N	\N	\N
84459	79	D5170C00002/tiny.path.1/file-3069.msg	\N	D5170C00002-3effccb6-8317-11eb-be00-a52215a953dd-3069	\N	NEW	\N	\N	\N	\N
87333	79	D5170C00002/tiny.path.1/file-5943.pdf	\N	D5170C00002-3f0c3e20-8319-11eb-be00-058a54f153c7-5943	\N	NEW	\N	\N	\N	\N
84460	79	D5170C00002/tiny.path.1/file-3070.msg	\N	D5170C00002-3f0dd677-8317-11eb-be00-a7b853f72a05-3070	\N	NEW	\N	\N	\N	\N
84461	79	D5170C00002/tiny.path.1/file-3071.msg	\N	D5170C00002-3f1be038-8317-11eb-be00-37e3bd3bbc31-3071	\N	NEW	\N	\N	\N	\N
84462	79	D5170C00002/tiny.path.1/file-3072.msg	\N	D5170C00002-3f2b4989-8317-11eb-be00-3fbe84fe485b-3072	\N	NEW	\N	\N	\N	\N
81628	79	D5170C00002/tiny.path.1/file-0238.pdf	\N	D5170C00002-3f2bf7a7-8315-11eb-be00-f33974c40833-238	\N	NEW	\N	\N	\N	\N
82998	79	D5170C00002/tiny.path.1/file-1608.pdf	\N	D5170C00002-3f2c50b1-8316-11eb-be00-6574f6b20cbd-1608	\N	NEW	\N	\N	\N	\N
86032	79	D5170C00002/tiny.path.1/file-4642.pdf	\N	D5170C00002-3f2cb3cb-8318-11eb-be00-b94e5e8c1f8e-4642	\N	NEW	\N	\N	\N	\N
87334	79	D5170C00002/tiny.path.1/file-5944.pdf	\N	D5170C00002-3f494721-8319-11eb-be00-efca0b54e437-5944	\N	NEW	\N	\N	\N	\N
86033	79	D5170C00002/tiny.path.1/file-4643.pdf	\N	D5170C00002-3f4b5f5c-8318-11eb-be00-c57ec4ca9137-4643	\N	NEW	\N	\N	\N	\N
87335	79	D5170C00002/tiny.path.1/file-5945.pdf	\N	D5170C00002-3f692b32-8319-11eb-be00-57c2780ecc16-5945	\N	NEW	\N	\N	\N	\N
86034	79	D5170C00002/tiny.path.1/file-4644.pdf	\N	D5170C00002-3f696ead-8318-11eb-be00-1b74b6d20760-4644	\N	NEW	\N	\N	\N	\N
84463	79	D5170C00002/tiny.path.1/file-3073.msg	\N	D5170C00002-3f69d92a-8317-11eb-be00-354ea5847128-3073	\N	NEW	\N	\N	\N	\N
82999	79	D5170C00002/tiny.path.1/file-1609.pdf	\N	D5170C00002-3f78ea12-8316-11eb-be00-ff860a231b11-1609	\N	NEW	\N	\N	\N	\N
86035	79	D5170C00002/tiny.path.1/file-4645.pdf	\N	D5170C00002-3f79e96e-8318-11eb-be00-6317e76381a9-4645	\N	NEW	\N	\N	\N	\N
81629	79	D5170C00002/tiny.path.1/file-0239.pdf	\N	D5170C00002-3f7a17a8-8315-11eb-be00-7ffc262648ba-239	\N	NEW	\N	\N	\N	\N
84464	79	D5170C00002/tiny.path.1/file-3074.msg	\N	D5170C00002-3f86d70b-8317-11eb-be00-47c031569f6e-3074	\N	NEW	\N	\N	\N	\N
87336	79	D5170C00002/tiny.path.1/file-5946.pdf	\N	D5170C00002-3f962ea3-8319-11eb-be00-0bae4eafbfd6-5946	\N	NEW	\N	\N	\N	\N
86036	79	D5170C00002/tiny.path.1/file-4646.pdf	\N	D5170C00002-3f96721f-8318-11eb-be00-9ba5bc7a0f52-4646	\N	NEW	\N	\N	\N	\N
84465	79	D5170C00002/tiny.path.1/file-3075.msg	\N	D5170C00002-3f98633c-8317-11eb-be00-b32099e31e17-3075	\N	NEW	\N	\N	\N	\N
83000	79	D5170C00002/tiny.path.1/file-1610.pdf	\N	D5170C00002-3f994353-8316-11eb-be00-8df4f53f1891-1610	\N	NEW	\N	\N	\N	\N
81630	79	D5170C00002/tiny.path.1/file-0240.pdf	\N	D5170C00002-3fa6a5e9-8315-11eb-be00-09d92569b5d6-240	\N	NEW	\N	\N	\N	\N
84466	79	D5170C00002/tiny.path.1/file-3076.msg	\N	D5170C00002-3fb49dcd-8317-11eb-be00-1faba8ad308a-3076	\N	NEW	\N	\N	\N	\N
86037	79	D5170C00002/tiny.path.1/file-4647.pdf	\N	D5170C00002-3fb4cf90-8318-11eb-be00-d5c22d625aeb-4647	\N	NEW	\N	\N	\N	\N
81631	79	D5170C00002/tiny.path.1/file-0241.pdf	\N	D5170C00002-3fb720aa-8315-11eb-be00-5be823383e01-241	\N	NEW	\N	\N	\N	\N
86038	79	D5170C00002/tiny.path.1/file-4648.pdf	\N	D5170C00002-3fc3eac1-8318-11eb-be00-95d24745db75-4648	\N	NEW	\N	\N	\N	\N
83001	79	D5170C00002/tiny.path.1/file-1611.pdf	\N	D5170C00002-3fc44af4-8316-11eb-be00-d58adbc4a32c-1611	\N	NEW	\N	\N	\N	\N
87337	79	D5170C00002/tiny.path.1/file-5947.msg	\N	D5170C00002-3fc5f134-8319-11eb-be00-bf13eeefb483-5947	\N	NEW	\N	\N	\N	\N
86039	79	D5170C00002/tiny.path.1/file-4649.pdf	\N	D5170C00002-3fd41762-8318-11eb-be00-c59072b41c99-4649	\N	NEW	\N	\N	\N	\N
87338	79	D5170C00002/tiny.path.1/file-5948.msg	\N	D5170C00002-3fe1dda5-8319-11eb-be00-e92ef9497f11-5948	\N	NEW	\N	\N	\N	\N
84467	79	D5170C00002/tiny.path.1/file-3077.pdf	\N	D5170C00002-3fe23d7e-8317-11eb-be00-c74342f4b8c1-3077	\N	NEW	\N	\N	\N	\N
86040	79	D5170C00002/tiny.path.1/file-4650.pdf	\N	D5170C00002-3fe3a7c3-8318-11eb-be00-931b93e6c09b-4650	\N	NEW	\N	\N	\N	\N
83002	79	D5170C00002/tiny.path.1/file-1612.pdf	\N	D5170C00002-3fe45615-8316-11eb-be00-53ae95c4abfe-1612	\N	NEW	\N	\N	\N	\N
87339	79	D5170C00002/tiny.path.1/file-5949.msg	\N	D5170C00002-3ff31bb6-8319-11eb-be00-69330f01a934-5949	\N	NEW	\N	\N	\N	\N
87341	79	D5170C00002/tiny.path.1/file-5951.msg	\N	D5170C00002-40028507-8319-11eb-be00-7f93aa9493d6-5950	\N	NEW	\N	\N	\N	\N
84468	79	D5170C00002/tiny.path.1/file-3078.pdf	\N	D5170C00002-40102b4f-8317-11eb-be00-611e2d99bf57-3078	\N	NEW	\N	\N	\N	\N
83003	79	D5170C00002/tiny.path.1/file-1613.pdf	\N	D5170C00002-40204da6-8316-11eb-be00-45e414e5105a-1613	\N	NEW	\N	\N	\N	\N
84469	79	D5170C00002/tiny.path.1/file-3079.pdf	\N	D5170C00002-402e61b0-8317-11eb-be00-d70e53a7d0d4-3079	\N	NEW	\N	\N	\N	\N
81632	79	D5170C00002/tiny.path.1/file-0242.pdf	\N	D5170C00002-4030484b-8315-11eb-be00-ffa92615f1d1-242	\N	NEW	\N	\N	\N	\N
83004	79	D5170C00002/tiny.path.1/file-1614.pdf	\N	D5170C00002-4030ef77-8316-11eb-be00-453d94adedd0-1614	\N	NEW	\N	\N	\N	\N
86041	79	D5170C00002/tiny.path.1/file-4651.pdf	\N	D5170C00002-40312b84-8318-11eb-be00-cda215c93daa-4651	\N	NEW	\N	\N	\N	\N
84470	79	D5170C00002/tiny.path.1/file-3080.pdf	\N	D5170C00002-404cbf21-8317-11eb-be00-2782f5cd239a-3080	\N	NEW	\N	\N	\N	\N
81633	79	D5170C00002/tiny.path.1/file-0243.pdf	\N	D5170C00002-404cf80c-8315-11eb-be00-8ba2aa8c1bdc-243	\N	NEW	\N	\N	\N	\N
83005	79	D5170C00002/tiny.path.1/file-1615.pdf	\N	D5170C00002-404d5118-8316-11eb-be00-db5925f369cb-1615	\N	NEW	\N	\N	\N	\N
87340	79	D5170C00002/tiny.path.1/file-5950.msg	\N	D5170C00002-404e3408-8319-11eb-be00-09399f1b1896-5951	\N	NEW	\N	\N	\N	\N
84471	79	D5170C00002/tiny.path.1/file-3081.pdf	\N	D5170C00002-405c2872-8317-11eb-be00-f92f8673d37b-3081	\N	NEW	\N	\N	\N	\N
84472	79	D5170C00002/tiny.path.1/file-3082.pdf	\N	D5170C00002-405ee793-8317-11eb-be00-8570c794c653-3082	\N	NEW	\N	\N	\N	\N
86042	79	D5170C00002/tiny.path.1/file-4652.pdf	\N	D5170C00002-405f4065-8318-11eb-be00-15e2ede04677-4652	\N	NEW	\N	\N	\N	\N
83006	79	D5170C00002/tiny.path.1/file-1616.pdf	\N	D5170C00002-406ce709-8316-11eb-be00-aff6fd88f545-1616	\N	NEW	\N	\N	\N	\N
84473	79	D5170C00002/tiny.path.1/file-3083.pdf	\N	D5170C00002-407a85e4-8317-11eb-be00-956ee93fdcdc-3083	\N	NEW	\N	\N	\N	\N
87342	79	D5170C00002/tiny.path.1/file-5952.msg	\N	D5170C00002-407c21d9-8319-11eb-be00-952c2a0ac42b-5952	\N	NEW	\N	\N	\N	\N
84474	79	D5170C00002/tiny.path.1/file-3084.pdf	\N	D5170C00002-407d1df5-8317-11eb-be00-fdc49d4e5550-3084	\N	NEW	\N	\N	\N	\N
86043	79	D5170C00002/tiny.path.1/file-4653.pdf	\N	D5170C00002-408c6ae6-8318-11eb-be00-3f31b7f2ca6f-4653	\N	NEW	\N	\N	\N	\N
83007	79	D5170C00002/tiny.path.1/file-1617.pdf	\N	D5170C00002-408ca40a-8316-11eb-be00-5fc3b496497d-1617	\N	NEW	\N	\N	\N	\N
84475	79	D5170C00002/tiny.path.1/file-3085.pdf	\N	D5170C00002-409a42e6-8317-11eb-be00-b5277fb28244-3085	\N	NEW	\N	\N	\N	\N
83008	79	D5170C00002/tiny.path.1/file-1618.pdf	\N	D5170C00002-40a8de9b-8316-11eb-be00-37113ae1c4c9-1618	\N	NEW	\N	\N	\N	\N
86044	79	D5170C00002/tiny.path.1/file-4654.pdf	\N	D5170C00002-40aa2c17-8318-11eb-be00-6f8dcc447e9d-4654	\N	NEW	\N	\N	\N	\N
81634	79	D5170C00002/tiny.path.1/file-0244.pdf	\N	D5170C00002-40b83cfd-8315-11eb-be00-39c8e96397f5-244	\N	NEW	\N	\N	\N	\N
84476	79	D5170C00002/tiny.path.1/file-3086.pdf	\N	D5170C00002-40c71f47-8317-11eb-be00-ebadf00745e1-3086	\N	NEW	\N	\N	\N	\N
86045	79	D5170C00002/tiny.path.1/file-4655.pdf	\N	D5170C00002-40d77da8-8318-11eb-be00-6fde120d5be0-4655	\N	NEW	\N	\N	\N	\N
81635	79	D5170C00002/tiny.path.1/file-0245.pdf	\N	D5170C00002-40d7abde-8315-11eb-be00-1b519c7ffab6-245	\N	NEW	\N	\N	\N	\N
84477	79	D5170C00002/tiny.path.1/file-3087.pdf	\N	D5170C00002-40e52e98-8317-11eb-be00-ad6d8f8b3195-3087	\N	NEW	\N	\N	\N	\N
83009	79	D5170C00002/tiny.path.1/file-1619.pdf	\N	D5170C00002-40f577fc-8316-11eb-be00-ed172dcdf631-1619	\N	NEW	\N	\N	\N	\N
81636	79	D5170C00002/tiny.path.1/file-0246.pdf	\N	D5170C00002-40f6a58f-8315-11eb-be00-1f50df4904ac-246	\N	NEW	\N	\N	\N	\N
87343	79	D5170C00002/tiny.path.1/file-5953.msg	\N	D5170C00002-40f6a90a-8319-11eb-be00-a73628cdea81-5953	\N	NEW	\N	\N	\N	\N
84478	79	D5170C00002/tiny.path.1/file-3088.pdf	\N	D5170C00002-40f77e19-8317-11eb-be00-e9c966a42b88-3088	\N	NEW	\N	\N	\N	\N
83010	79	D5170C00002/tiny.path.1/file-1620.pdf	\N	D5170C00002-4114238d-8316-11eb-be00-db4fc157c973-1620	\N	NEW	\N	\N	\N	\N
87344	79	D5170C00002/tiny.path.1/file-5954.msg	\N	D5170C00002-412225db-8319-11eb-be00-01f8cc75da7c-5954	\N	NEW	\N	\N	\N	\N
81637	79	D5170C00002/tiny.path.1/file-0247.pdf	\N	D5170C00002-41224970-8315-11eb-be00-4519f9d5dcb2-247	\N	NEW	\N	\N	\N	\N
86046	79	D5170C00002/tiny.path.1/file-4656.pdf	\N	D5170C00002-41230599-8318-11eb-be00-5be193f91dbc-4656	\N	NEW	\N	\N	\N	\N
84479	79	D5170C00002/tiny.path.1/file-3089.pdf	\N	D5170C00002-4124336a-8317-11eb-be00-1f7a72f525a1-3089	\N	NEW	\N	\N	\N	\N
81638	79	D5170C00002/tiny.path.1/file-0248.pdf	\N	D5170C00002-41318bb1-8315-11eb-be00-e98a2644fa37-248	\N	NEW	\N	\N	\N	\N
83011	79	D5170C00002/tiny.path.1/file-1621.pdf	\N	D5170C00002-41320bce-8316-11eb-be00-593847e433e7-1621	\N	NEW	\N	\N	\N	\N
87345	79	D5170C00002/tiny.path.1/file-5955.msg	\N	D5170C00002-41344e4c-8319-11eb-be00-f5d4fea4e4bd-5955	\N	NEW	\N	\N	\N	\N
81639	79	D5170C00002/tiny.path.1/file-0249.pdf	\N	D5170C00002-41520c02-8315-11eb-be00-5d5d634398be-249	\N	NEW	\N	\N	\N	\N
87346	79	D5170C00002/tiny.path.1/file-5956.msg	\N	D5170C00002-415ff22d-8319-11eb-be00-5ba22db14675-5956	\N	NEW	\N	\N	\N	\N
83012	79	D5170C00002/tiny.path.1/file-1622.pdf	\N	D5170C00002-416eedbf-8316-11eb-be00-4b8ead62eb9c-1622	\N	NEW	\N	\N	\N	\N
84480	79	D5170C00002/tiny.path.1/file-3090.pdf	\N	D5170C00002-416f1f1b-8317-11eb-be00-abc5f88ce747-3090	\N	NEW	\N	\N	\N	\N
84481	79	D5170C00002/tiny.path.1/file-3091.pdf	\N	D5170C00002-4170f3dc-8317-11eb-be00-d1997af4dbb6-3091	\N	NEW	\N	\N	\N	\N
87347	79	D5170C00002/tiny.path.1/file-5957.msg	\N	D5170C00002-417f610e-8319-11eb-be00-a78c77ce0691-5957	\N	NEW	\N	\N	\N	\N
81640	79	D5170C00002/tiny.path.1/file-0250.pdf	\N	D5170C00002-418d1933-8315-11eb-be00-8f9be92c3a90-250	\N	NEW	\N	\N	\N	\N
86047	79	D5170C00002/tiny.path.1/file-4657.pdf	\N	D5170C00002-418dfc6a-8318-11eb-be00-79d7ad58de4e-4657	\N	NEW	\N	\N	\N	\N
83013	79	D5170C00002/tiny.path.1/file-1623.pdf	\N	D5170C00002-418e3590-8316-11eb-be00-77037d6878e1-1623	\N	NEW	\N	\N	\N	\N
84482	79	D5170C00002/tiny.path.1/file-3092.pdf	\N	D5170C00002-418f032d-8317-11eb-be00-2b28f3c29c63-3092	\N	NEW	\N	\N	\N	\N
84483	79	D5170C00002/tiny.path.1/file-3093.pdf	\N	D5170C00002-419e1e5e-8317-11eb-be00-8536541966eb-3093	\N	NEW	\N	\N	\N	\N
83014	79	D5170C00002/tiny.path.1/file-1624.pdf	\N	D5170C00002-41abf6c1-8316-11eb-be00-07ef04e9e1d9-1624	\N	NEW	\N	\N	\N	\N
87348	79	D5170C00002/tiny.path.1/file-5958.msg	\N	D5170C00002-41ad27cf-8319-11eb-be00-5b4ffe22d107-5958	\N	NEW	\N	\N	\N	\N
86048	79	D5170C00002/tiny.path.1/file-4658.pdf	\N	D5170C00002-41bc114b-8318-11eb-be00-93b51590163b-4658	\N	NEW	\N	\N	\N	\N
83015	79	D5170C00002/tiny.path.1/file-1625.pdf	\N	D5170C00002-41bc4a72-8316-11eb-be00-096a648266de-1625	\N	NEW	\N	\N	\N	\N
83016	79	D5170C00002/tiny.path.1/file-1626.pdf	\N	D5170C00002-41ca5433-8316-11eb-be00-f9a406651ebe-1626	\N	NEW	\N	\N	\N	\N
81641	79	D5170C00002/tiny.path.1/file-0251.pdf	\N	D5170C00002-41cb0c94-8315-11eb-be00-7d187be211c8-251	\N	NEW	\N	\N	\N	\N
81642	79	D5170C00002/tiny.path.1/file-0252.pdf	\N	D5170C00002-41e8a6b5-8315-11eb-be00-37c6da960564-252	\N	NEW	\N	\N	\N	\N
83017	79	D5170C00002/tiny.path.1/file-1627.pdf	\N	D5170C00002-41e8ffc4-8316-11eb-be00-9307a5e08742-1627	\N	NEW	\N	\N	\N	\N
84484	79	D5170C00002/tiny.path.1/file-3094.pdf	\N	D5170C00002-41ea1b7f-8317-11eb-be00-adc66f1d1686-3094	\N	NEW	\N	\N	\N	\N
86049	79	D5170C00002/tiny.path.1/file-4659.pdf	\N	D5170C00002-41f87e0c-8318-11eb-be00-29495bc29703-4659	\N	NEW	\N	\N	\N	\N
87349	79	D5170C00002/tiny.path.1/file-5959.pdf	\N	D5170C00002-42072eb0-8319-11eb-be00-9f4388bfa9bf-5959	\N	NEW	\N	\N	\N	\N
84485	79	D5170C00002/tiny.path.1/file-3095.pdf	\N	D5170C00002-420a4db0-8317-11eb-be00-a5e0e35ddaac-3095	\N	NEW	\N	\N	\N	\N
86050	79	D5170C00002/tiny.path.1/file-4660.pdf	\N	D5170C00002-42179ecd-8318-11eb-be00-6ffc594287bf-4660	\N	NEW	\N	\N	\N	\N
86051	79	D5170C00002/tiny.path.1/file-4661.pdf	\N	D5170C00002-42277d4e-8318-11eb-be00-71b08128783a-4661	\N	NEW	\N	\N	\N	\N
83018	79	D5170C00002/tiny.path.1/file-1628.pdf	\N	D5170C00002-4237e315-8316-11eb-be00-bfcf6eacdb85-1628	\N	NEW	\N	\N	\N	\N
87350	79	D5170C00002/tiny.path.1/file-5960.pdf	\N	D5170C00002-423802b1-8319-11eb-be00-274bad20e125-5960	\N	NEW	\N	\N	\N	\N
81643	79	D5170C00002/tiny.path.1/file-0253.pdf	\N	D5170C00002-4245bad6-8315-11eb-be00-ededb0170058-253	\N	NEW	\N	\N	\N	\N
83019	79	D5170C00002/tiny.path.1/file-1629.pdf	\N	D5170C00002-4255f266-8316-11eb-be00-37298ae84457-1629	\N	NEW	\N	\N	\N	\N
84486	79	D5170C00002/tiny.path.1/file-3096.pdf	\N	D5170C00002-42647ba1-8317-11eb-be00-3900238f8b9d-3096	\N	NEW	\N	\N	\N	\N
87351	79	D5170C00002/tiny.path.1/file-5961.pdf	\N	D5170C00002-4264df12-8319-11eb-be00-3bc0dbb21928-5961	\N	NEW	\N	\N	\N	\N
86052	79	D5170C00002/tiny.path.1/file-4662.pdf	\N	D5170C00002-426570af-8318-11eb-be00-197626c2d1c8-4662	\N	NEW	\N	\N	\N	\N
83020	79	D5170C00002/tiny.path.1/file-1630.pdf	\N	D5170C00002-42749df7-8316-11eb-be00-1bfe4f087903-1630	\N	NEW	\N	\N	\N	\N
84487	79	D5170C00002/tiny.path.1/file-3097.pdf	\N	D5170C00002-4282b202-8317-11eb-be00-f7b2e8523996-3097	\N	NEW	\N	\N	\N	\N
86053	79	D5170C00002/tiny.path.1/file-4663.pdf	\N	D5170C00002-42935e80-8318-11eb-be00-85fa8fd32c90-4663	\N	NEW	\N	\N	\N	\N
84488	79	D5170C00002/tiny.path.1/file-3098.pdf	\N	D5170C00002-42a10f73-8317-11eb-be00-572c07641ab8-3098	\N	NEW	\N	\N	\N	\N
83021	79	D5170C00002/tiny.path.1/file-1631.pdf	\N	D5170C00002-42a1ef88-8316-11eb-be00-436953038a12-1631	\N	NEW	\N	\N	\N	\N
81644	79	D5170C00002/tiny.path.1/file-0254.pdf	\N	D5170C00002-42a2f607-8315-11eb-be00-0b4e76d4d240-254	\N	NEW	\N	\N	\N	\N
86054	79	D5170C00002/tiny.path.1/file-4664.pdf	\N	D5170C00002-42b194e1-8318-11eb-be00-67f9e7b0d176-4664	\N	NEW	\N	\N	\N	\N
84489	79	D5170C00002/tiny.path.1/file-3099.pdf	\N	D5170C00002-42be3464-8317-11eb-be00-cbe4fb7ae2ca-3099	\N	NEW	\N	\N	\N	\N
83022	79	D5170C00002/tiny.path.1/file-1632.pdf	\N	D5170C00002-42c07409-8316-11eb-be00-65955233bbc5-1632	\N	NEW	\N	\N	\N	\N
81645	79	D5170C00002/tiny.path.1/file-0255.pdf	\N	D5170C00002-42ce24b8-8315-11eb-be00-67f2bcfdc7a8-255	\N	NEW	\N	\N	\N	\N
86055	79	D5170C00002/tiny.path.1/file-4665.pdf	\N	D5170C00002-42ce6bb2-8318-11eb-be00-8565b8466cea-4665	\N	NEW	\N	\N	\N	\N
84490	79	D5170C00002/tiny.path.1/file-3100.pdf	\N	D5170C00002-42dcb8e5-8317-11eb-be00-0b0d79240189-3100	\N	NEW	\N	\N	\N	\N
87352	79	D5170C00002/tiny.path.1/file-5962.pdf	\N	D5170C00002-42dd6a73-8319-11eb-be00-dbd47beefd3b-5962	\N	NEW	\N	\N	\N	\N
83023	79	D5170C00002/tiny.path.1/file-1633.pdf	\N	D5170C00002-42df46aa-8316-11eb-be00-d9349035d453-1633	\N	NEW	\N	\N	\N	\N
86056	79	D5170C00002/tiny.path.1/file-4666.pdf	\N	D5170C00002-42df82b3-8318-11eb-be00-45767f7f293b-4666	\N	NEW	\N	\N	\N	\N
81646	79	D5170C00002/tiny.path.1/file-0256.pdf	\N	D5170C00002-42ee56e9-8315-11eb-be00-939f09259cc6-256	\N	NEW	\N	\N	\N	\N
83024	79	D5170C00002/tiny.path.1/file-1634.pdf	\N	D5170C00002-42feb58b-8316-11eb-be00-d9fa712642e3-1634	\N	NEW	\N	\N	\N	\N
81647	79	D5170C00002/tiny.path.1/file-0257.pdf	\N	D5170C00002-430d027a-8315-11eb-be00-35a5073e5d6e-257	\N	NEW	\N	\N	\N	\N
86057	79	D5170C00002/tiny.path.1/file-4667.pdf	\N	D5170C00002-430d7084-8318-11eb-be00-95ff3712b0fa-4667	\N	NEW	\N	\N	\N	\N
83025	79	D5170C00002/tiny.path.1/file-1635.pdf	\N	D5170C00002-431bb36c-8316-11eb-be00-d3a1cb5f0d8d-1635	\N	NEW	\N	\N	\N	\N
86058	79	D5170C00002/tiny.path.1/file-4668.pdf	\N	D5170C00002-43298405-8318-11eb-be00-43fab2373f74-4668	\N	NEW	\N	\N	\N	\N
87353	79	D5170C00002/tiny.path.1/file-5963.pdf	\N	D5170C00002-43385bb4-8319-11eb-be00-9dc2b2a3b523-5963	\N	NEW	\N	\N	\N	\N
83026	79	D5170C00002/tiny.path.1/file-1636.pdf	\N	D5170C00002-433b977d-8316-11eb-be00-911c74319605-1636	\N	NEW	\N	\N	\N	\N
86059	79	D5170C00002/tiny.path.1/file-4669.pdf	\N	D5170C00002-4348cbd6-8318-11eb-be00-15b59e68d41c-4669	\N	NEW	\N	\N	\N	\N
81648	79	D5170C00002/tiny.path.1/file-0258.pdf	\N	D5170C00002-4356dcbb-8315-11eb-be00-f7947bd18e23-258	\N	NEW	\N	\N	\N	\N
87354	79	D5170C00002/tiny.path.1/file-5964.pdf	\N	D5170C00002-4356e035-8319-11eb-be00-d5668b33daf5-5964	\N	NEW	\N	\N	\N	\N
86060	79	D5170C00002/tiny.path.1/file-4670.pdf	\N	D5170C00002-4359bbc7-8318-11eb-be00-ab78ae8aceea-4670	\N	NEW	\N	\N	\N	\N
83027	79	D5170C00002/tiny.path.1/file-1637.pdf	\N	D5170C00002-43669f1e-8316-11eb-be00-9163c90eb09d-1637	\N	NEW	\N	\N	\N	\N
84491	79	D5170C00002/tiny.path.1/file-3101.pdf	\N	D5170C00002-43852de6-8317-11eb-be00-f9df1542cb52-3101	\N	NEW	\N	\N	\N	\N
83028	79	D5170C00002/tiny.path.1/file-1638.pdf	\N	D5170C00002-43854aaf-8316-11eb-be00-8345114c7f90-1638	\N	NEW	\N	\N	\N	\N
86061	79	D5170C00002/tiny.path.1/file-4671.pdf	\N	D5170C00002-4394a1e8-8318-11eb-be00-d5f6f8f56960-4671	\N	NEW	\N	\N	\N	\N
81649	79	D5170C00002/tiny.path.1/file-0259.pdf	\N	D5170C00002-439656bc-8315-11eb-be00-a1311eb4a338-259	\N	NEW	\N	\N	\N	\N
83029	79	D5170C00002/tiny.path.1/file-1639.pdf	\N	D5170C00002-43a3a820-8316-11eb-be00-5fe222c1b86c-1639	\N	NEW	\N	\N	\N	\N
84492	79	D5170C00002/tiny.path.1/file-3102.pdf	\N	D5170C00002-43a3b267-8317-11eb-be00-4f56a82e0003-3102	\N	NEW	\N	\N	\N	\N
83030	79	D5170C00002/tiny.path.1/file-1640.pdf	\N	D5170C00002-43a555d1-8316-11eb-be00-130aebcbe1d7-1640	\N	NEW	\N	\N	\N	\N
87355	79	D5170C00002/tiny.path.1/file-5965.pdf	\N	D5170C00002-43b2bbd6-8319-11eb-be00-e312176245fe-5965	\N	NEW	\N	\N	\N	\N
84493	79	D5170C00002/tiny.path.1/file-3103.pdf	\N	D5170C00002-43b51788-8317-11eb-be00-ef913662d09e-3103	\N	NEW	\N	\N	\N	\N
83031	79	D5170C00002/tiny.path.1/file-1641.pdf	\N	D5170C00002-43c20592-8316-11eb-be00-c55c5c9fe2eb-1641	\N	NEW	\N	\N	\N	\N
86062	79	D5170C00002/tiny.path.1/file-4672.pdf	\N	D5170C00002-43c2b6c9-8318-11eb-be00-8d47cec6f27c-4672	\N	NEW	\N	\N	\N	\N
84494	79	D5170C00002/tiny.path.1/file-3104.pdf	\N	D5170C00002-43e06d49-8317-11eb-be00-856ea0f16591-3104	\N	NEW	\N	\N	\N	\N
83032	79	D5170C00002/tiny.path.1/file-1642.pdf	\N	D5170C00002-43e0b123-8316-11eb-be00-19392e895e05-1642	\N	NEW	\N	\N	\N	\N
81650	79	D5170C00002/tiny.path.1/file-0260.pdf	\N	D5170C00002-43e1dead-8315-11eb-be00-8133ea07bdf4-260	\N	NEW	\N	\N	\N	\N
83033	79	D5170C00002/tiny.path.1/file-1643.pdf	\N	D5170C00002-43e2fb14-8316-11eb-be00-3dd6198acaf9-1643	\N	NEW	\N	\N	\N	\N
84495	79	D5170C00002/tiny.path.1/file-3105.pdf	\N	D5170C00002-43effdaa-8317-11eb-be00-67dbcc3fa523-3105	\N	NEW	\N	\N	\N	\N
83034	79	D5170C00002/tiny.path.1/file-1644.pdf	\N	D5170C00002-43f1a115-8316-11eb-be00-83424d237224-1644	\N	NEW	\N	\N	\N	\N
86063	79	D5170C00002/tiny.path.1/file-4673.pdf	\N	D5170C00002-43ff98ba-8318-11eb-be00-6fdde9bb951b-4673	\N	NEW	\N	\N	\N	\N
87356	79	D5170C00002/tiny.path.1/file-5966.pdf	\N	D5170C00002-43fff177-8319-11eb-be00-d58c2ddfc695-5966	\N	NEW	\N	\N	\N	\N
84496	79	D5170C00002/tiny.path.1/file-3106.pdf	\N	D5170C00002-4400c68b-8317-11eb-be00-1bcb2d9ab2e0-3106	\N	NEW	\N	\N	\N	\N
84497	79	D5170C00002/tiny.path.1/file-3107.pdf	\N	D5170C00002-441008cc-8317-11eb-be00-31c3c8898956-3107	\N	NEW	\N	\N	\N	\N
87357	79	D5170C00002/tiny.path.1/file-5967.pdf	\N	D5170C00002-44101e18-8319-11eb-be00-9337014463f8-5967	\N	NEW	\N	\N	\N	\N
81651	79	D5170C00002/tiny.path.1/file-0261.pdf	\N	D5170C00002-441d39fe-8315-11eb-be00-45c6cae49e31-261	\N	NEW	\N	\N	\N	\N
83035	79	D5170C00002/tiny.path.1/file-1645.pdf	\N	D5170C00002-441e5666-8316-11eb-be00-a9f324a5bb0f-1645	\N	NEW	\N	\N	\N	\N
84498	79	D5170C00002/tiny.path.1/file-3108.pdf	\N	D5170C00002-441f4b0d-8317-11eb-be00-a982de3e79ee-3108	\N	NEW	\N	\N	\N	\N
87358	79	D5170C00002/tiny.path.1/file-5968.pdf	\N	D5170C00002-442c58a9-8319-11eb-be00-31c167f21ff2-5968	\N	NEW	\N	\N	\N	\N
83036	79	D5170C00002/tiny.path.1/file-1646.pdf	\N	D5170C00002-442e0dd7-8316-11eb-be00-aff713cd2d5f-1646	\N	NEW	\N	\N	\N	\N
84499	79	D5170C00002/tiny.path.1/file-3109.pdf	\N	D5170C00002-442eb45e-8317-11eb-be00-295a5fe9363a-3109	\N	NEW	\N	\N	\N	\N
81652	79	D5170C00002/tiny.path.1/file-0262.pdf	\N	D5170C00002-443c5abf-8315-11eb-be00-abea85447ca7-262	\N	NEW	\N	\N	\N	\N
86064	79	D5170C00002/tiny.path.1/file-4674.pdf	\N	D5170C00002-443d8c1b-8318-11eb-be00-f999deb91cfd-4674	\N	NEW	\N	\N	\N	\N
84500	79	D5170C00002/tiny.path.1/file-3110.pdf	\N	D5170C00002-443e1daf-8317-11eb-be00-b7604ab456bd-3110	\N	NEW	\N	\N	\N	\N
86065	79	D5170C00002/tiny.path.1/file-4675.pdf	\N	D5170C00002-445cd3ec-8318-11eb-be00-873ab776d73b-4675	\N	NEW	\N	\N	\N	\N
87359	79	D5170C00002/tiny.path.1/file-5969.pdf	\N	D5170C00002-44693a9a-8319-11eb-be00-ef321943f6af-5969	\N	NEW	\N	\N	\N	\N
84501	79	D5170C00002/tiny.path.1/file-3111.pdf	\N	D5170C00002-4469c190-8317-11eb-be00-57d179bbebb9-3111	\N	NEW	\N	\N	\N	\N
84502	79	D5170C00002/tiny.path.1/file-3112.pdf	\N	D5170C00002-446c80b1-8317-11eb-be00-9110787171bc-3112	\N	NEW	\N	\N	\N	\N
84503	79	D5170C00002/tiny.path.1/file-3113.pdf	\N	D5170C00002-447b26b2-8317-11eb-be00-f9c5458f9379-3113	\N	NEW	\N	\N	\N	\N
86066	79	D5170C00002/tiny.path.1/file-4676.pdf	\N	D5170C00002-4489140d-8318-11eb-be00-0d1abbbfd2ba-4676	\N	NEW	\N	\N	\N	\N
84504	79	D5170C00002/tiny.path.1/file-3114.pdf	\N	D5170C00002-4489ccb3-8317-11eb-be00-159ddf2a5313-3114	\N	NEW	\N	\N	\N	\N
84505	79	D5170C00002/tiny.path.1/file-3115.pdf	\N	D5170C00002-4497fd84-8317-11eb-be00-c9974932d07a-3115	\N	NEW	\N	\N	\N	\N
83037	79	D5170C00002/tiny.path.1/file-1647.pdf	\N	D5170C00002-449904a8-8316-11eb-be00-072766afa8f0-1647	\N	NEW	\N	\N	\N	\N
81653	79	D5170C00002/tiny.path.1/file-0263.pdf	\N	D5170C00002-44a8b120-8315-11eb-be00-79f74e322990-263	\N	NEW	\N	\N	\N	\N
86067	79	D5170C00002/tiny.path.1/file-4677.pdf	\N	D5170C00002-44b8af8e-8318-11eb-be00-49753ec64756-4677	\N	NEW	\N	\N	\N	\N
81654	79	D5170C00002/tiny.path.1/file-0264.pdf	\N	D5170C00002-44c539d1-8315-11eb-be00-3dd168bee064-264	\N	NEW	\N	\N	\N	\N
86068	79	D5170C00002/tiny.path.1/file-4678.pdf	\N	D5170C00002-44d7f75f-8318-11eb-be00-e728618090a4-4678	\N	NEW	\N	\N	\N	\N
81655	79	D5170C00002/tiny.path.1/file-0265.pdf	\N	D5170C00002-44e4a8b2-8315-11eb-be00-430249880af3-265	\N	NEW	\N	\N	\N	\N
86069	79	D5170C00002/tiny.path.1/file-4679.pdf	\N	D5170C00002-44f3bcc0-8318-11eb-be00-130c363f77c6-4679	\N	NEW	\N	\N	\N	\N
83038	79	D5170C00002/tiny.path.1/file-1648.pdf	\N	D5170C00002-44f44409-8316-11eb-be00-f19adbe0007e-1648	\N	NEW	\N	\N	\N	\N
81656	79	D5170C00002/tiny.path.1/file-0266.pdf	\N	D5170C00002-4504dae3-8315-11eb-be00-2103665134df-266	\N	NEW	\N	\N	\N	\N
87360	79	D5170C00002/tiny.path.1/file-5970.pdf	\N	D5170C00002-4511fdbb-8319-11eb-be00-ab9a9caefec3-5970	\N	NEW	\N	\N	\N	\N
81657	79	D5170C00002/tiny.path.1/file-0267.pdf	\N	D5170C00002-453f99f4-8315-11eb-be00-d780e9c46246-267	\N	NEW	\N	\N	\N	\N
83039	79	D5170C00002/tiny.path.1/file-1649.pdf	\N	D5170C00002-455f13ca-8316-11eb-be00-890315de7a6e-1649	\N	NEW	\N	\N	\N	\N
87361	79	D5170C00002/tiny.path.1/file-5971.pdf	\N	D5170C00002-457ccd7c-8319-11eb-be00-e32b169dd110-5971	\N	NEW	\N	\N	\N	\N
87362	79	D5170C00002/tiny.path.1/file-5972.pdf	\N	D5170C00002-459b2aed-8319-11eb-be00-2d3b2c0c9a4f-5972	\N	NEW	\N	\N	\N	\N
81658	79	D5170C00002/tiny.path.1/file-0268.pdf	\N	D5170C00002-45aa42a5-8315-11eb-be00-9507b226c63a-268	\N	NEW	\N	\N	\N	\N
86070	79	D5170C00002/tiny.path.1/file-4680.pdf	\N	D5170C00002-45ba1a01-8318-11eb-be00-3d54da5bf39d-4680	\N	NEW	\N	\N	\N	\N
87363	79	D5170C00002/tiny.path.1/file-5973.pdf	\N	D5170C00002-45c82e5e-8319-11eb-be00-b55bac941d63-5973	\N	NEW	\N	\N	\N	\N
83040	79	D5170C00002/tiny.path.1/file-1650.pdf	\N	D5170C00002-45ca31ab-8316-11eb-be00-cd761843bc2d-1650	\N	NEW	\N	\N	\N	\N
83041	79	D5170C00002/tiny.path.1/file-1651.pdf	\N	D5170C00002-45f6e6fc-8316-11eb-be00-290eac7114e8-1651	\N	NEW	\N	\N	\N	\N
83042	79	D5170C00002/tiny.path.1/file-1652.pdf	\N	D5170C00002-4626345d-8316-11eb-be00-1b5bca665bf6-1652	\N	NEW	\N	\N	\N	\N
81659	79	D5170C00002/tiny.path.1/file-0269.pdf	\N	D5170C00002-46340c16-8315-11eb-be00-d57ed2330d41-269	\N	NEW	\N	\N	\N	\N
83043	79	D5170C00002/tiny.path.1/file-1653.pdf	\N	D5170C00002-4644dfee-8316-11eb-be00-8768102b1e8f-1653	\N	NEW	\N	\N	\N	\N
87364	79	D5170C00002/tiny.path.1/file-5974.pdf	\N	D5170C00002-4655050f-8319-11eb-be00-5982828bb90d-5974	\N	NEW	\N	\N	\N	\N
83044	79	D5170C00002/tiny.path.1/file-1654.pdf	\N	D5170C00002-46716e2f-8316-11eb-be00-9fa75303c87a-1654	\N	NEW	\N	\N	\N	\N
81660	79	D5170C00002/tiny.path.1/file-0270.pdf	\N	D5170C00002-46724d97-8315-11eb-be00-a38a97aced54-270	\N	NEW	\N	\N	\N	\N
87365	79	D5170C00002/tiny.path.1/file-5975.pdf	\N	D5170C00002-467fbe90-8319-11eb-be00-77e4bee13f11-5975	\N	NEW	\N	\N	\N	\N
81661	79	D5170C00002/tiny.path.1/file-0271.pdf	\N	D5170C00002-469f7818-8315-11eb-be00-f787e35c0394-271	\N	NEW	\N	\N	\N	\N
83045	79	D5170C00002/tiny.path.1/file-1655.pdf	\N	D5170C00002-469faa20-8316-11eb-be00-3dabb19ce851-1655	\N	NEW	\N	\N	\N	\N
86071	79	D5170C00002/tiny.path.1/file-4681.pdf	\N	D5170C00002-46bda752-8318-11eb-be00-43aece9fa5d5-4681	\N	NEW	\N	\N	\N	\N
86072	79	D5170C00002/tiny.path.1/file-4682.pdf	\N	D5170C00002-46de0093-8318-11eb-be00-e16cf80693cc-4682	\N	NEW	\N	\N	\N	\N
81662	79	D5170C00002/tiny.path.1/file-0272.pdf	\N	D5170C00002-46df4039-8315-11eb-be00-69eb47b3f13d-272	\N	NEW	\N	\N	\N	\N
83046	79	D5170C00002/tiny.path.1/file-1656.pdf	\N	D5170C00002-46ec91a1-8316-11eb-be00-058bbb314c2c-1656	\N	NEW	\N	\N	\N	\N
81663	79	D5170C00002/tiny.path.1/file-0273.pdf	\N	D5170C00002-47090f5a-8315-11eb-be00-09f229298078-273	\N	NEW	\N	\N	\N	\N
87366	79	D5170C00002/tiny.path.1/file-5976.pdf	\N	D5170C00002-47193f71-8319-11eb-be00-7336f199840f-5976	\N	NEW	\N	\N	\N	\N
81664	79	D5170C00002/tiny.path.1/file-0274.pdf	\N	D5170C00002-4728090b-8315-11eb-be00-d73c5a369880-274	\N	NEW	\N	\N	\N	\N
83047	79	D5170C00002/tiny.path.1/file-1657.pdf	\N	D5170C00002-4746e6a2-8316-11eb-be00-eb4c93c1ca8d-1657	\N	NEW	\N	\N	\N	\N
86073	79	D5170C00002/tiny.path.1/file-4683.pdf	\N	D5170C00002-4746fb94-8318-11eb-be00-8f905f6c2ae1-4683	\N	NEW	\N	\N	\N	\N
81665	79	D5170C00002/tiny.path.1/file-0275.pdf	\N	D5170C00002-4748895c-8315-11eb-be00-8f875618e00f-275	\N	NEW	\N	\N	\N	\N
87367	79	D5170C00002/tiny.path.1/file-5977.pdf	\N	D5170C00002-47647942-8319-11eb-be00-ab8a5c6ef745-5977	\N	NEW	\N	\N	\N	\N
81666	79	D5170C00002/tiny.path.1/file-0276.pdf	\N	D5170C00002-4764c3ed-8315-11eb-be00-ab42a73d77c6-276	\N	NEW	\N	\N	\N	\N
86074	79	D5170C00002/tiny.path.1/file-4684.pdf	\N	D5170C00002-476531f5-8318-11eb-be00-6d8542f8fa5e-4684	\N	NEW	\N	\N	\N	\N
83048	79	D5170C00002/tiny.path.1/file-1658.pdf	\N	D5170C00002-4767b513-8316-11eb-be00-f1e6efb64bae-1658	\N	NEW	\N	\N	\N	\N
87368	79	D5170C00002/tiny.path.1/file-5978.pdf	\N	D5170C00002-47856ec3-8319-11eb-be00-e9da189c0135-5978	\N	NEW	\N	\N	\N	\N
83049	79	D5170C00002/tiny.path.1/file-1659.pdf	\N	D5170C00002-47861284-8316-11eb-be00-93fa1eb36e9f-1659	\N	NEW	\N	\N	\N	\N
81667	79	D5170C00002/tiny.path.1/file-0277.pdf	\N	D5170C00002-4794385e-8315-11eb-be00-b75fbb8f4107-277	\N	NEW	\N	\N	\N	\N
81668	79	D5170C00002/tiny.path.1/file-0278.pdf	\N	D5170C00002-47a2b74f-8315-11eb-be00-498abf26c6cb-278	\N	NEW	\N	\N	\N	\N
87369	79	D5170C00002/tiny.path.1/file-5979.pdf	\N	D5170C00002-47b09d74-8319-11eb-be00-5d6410708e3d-5979	\N	NEW	\N	\N	\N	\N
83050	79	D5170C00002/tiny.path.1/file-1660.pdf	\N	D5170C00002-47b1dd75-8316-11eb-be00-cd526a8d1c72-1660	\N	NEW	\N	\N	\N	\N
81669	79	D5170C00002/tiny.path.1/file-0279.pdf	\N	D5170C00002-47b2bce0-8315-11eb-be00-6f8095d17733-279	\N	NEW	\N	\N	\N	\N
87370	79	D5170C00002/tiny.path.1/file-5980.pdf	\N	D5170C00002-47bfb8a5-8319-11eb-be00-8d7b948ebf3c-5980	\N	NEW	\N	\N	\N	\N
83051	79	D5170C00002/tiny.path.1/file-1661.pdf	\N	D5170C00002-47c05c66-8316-11eb-be00-096ece801006-1661	\N	NEW	\N	\N	\N	\N
81670	79	D5170C00002/tiny.path.1/file-0280.pdf	\N	D5170C00002-47c2c271-8315-11eb-be00-bbcdf49c1977-280	\N	NEW	\N	\N	\N	\N
87371	79	D5170C00002/tiny.path.1/file-5981.pdf	\N	D5170C00002-47cf9726-8319-11eb-be00-971848fb0dcc-5981	\N	NEW	\N	\N	\N	\N
81671	79	D5170C00002/tiny.path.1/file-0281.pdf	\N	D5170C00002-47ded5f2-8315-11eb-be00-9d2c9dd2729d-281	\N	NEW	\N	\N	\N	\N
87372	79	D5170C00002/tiny.path.1/file-5982.pdf	\N	D5170C00002-47e06007-8319-11eb-be00-ff5eb3a161b5-5982	\N	NEW	\N	\N	\N	\N
81672	79	D5170C00002/tiny.path.1/file-0282.pdf	\N	D5170C00002-47edca13-8315-11eb-be00-f5d56cbd48a7-282	\N	NEW	\N	\N	\N	\N
83052	79	D5170C00002/tiny.path.1/file-1662.pdf	\N	D5170C00002-47eee677-8316-11eb-be00-2fc51524498f-1662	\N	NEW	\N	\N	\N	\N
81673	79	D5170C00002/tiny.path.1/file-0283.pdf	\N	D5170C00002-47fda894-8315-11eb-be00-b9c06a2120eb-283	\N	NEW	\N	\N	\N	\N
87373	79	D5170C00002/tiny.path.1/file-5983.pdf	\N	D5170C00002-480c7918-8319-11eb-be00-198a02d3ff2d-5983	\N	NEW	\N	\N	\N	\N
86075	79	D5170C00002/tiny.path.1/file-4685.pdf	\N	D5170C00002-481cc226-8318-11eb-be00-7f9350aa281f-4685	\N	NEW	\N	\N	\N	\N
81674	79	D5170C00002/tiny.path.1/file-0284.pdf	\N	D5170C00002-482b2135-8315-11eb-be00-dd983a201b92-284	\N	NEW	\N	\N	\N	\N
83053	79	D5170C00002/tiny.path.1/file-1663.pdf	\N	D5170C00002-482d4f08-8316-11eb-be00-5b848c8bf13c-1663	\N	NEW	\N	\N	\N	\N
87374	79	D5170C00002/tiny.path.1/file-5984.pdf	\N	D5170C00002-483a18c9-8319-11eb-be00-0b2bda7ba6fe-5984	\N	NEW	\N	\N	\N	\N
87375	79	D5170C00002/tiny.path.1/file-5985.pdf	\N	D5170C00002-484b7dea-8319-11eb-be00-d9538f20c1d1-5985	\N	NEW	\N	\N	\N	\N
81675	79	D5170C00002/tiny.path.1/file-0285.pdf	\N	D5170C00002-484c16b6-8315-11eb-be00-471ad028150c-285	\N	NEW	\N	\N	\N	\N
81676	79	D5170C00002/tiny.path.1/file-0286.pdf	\N	D5170C00002-4869d7e7-8315-11eb-be00-bb9622e35cd5-286	\N	NEW	\N	\N	\N	\N
86076	79	D5170C00002/tiny.path.1/file-4686.pdf	\N	D5170C00002-4876f017-8318-11eb-be00-5b50146ad380-4686	\N	NEW	\N	\N	\N	\N
87376	79	D5170C00002/tiny.path.1/file-5986.pdf	\N	D5170C00002-48868b1b-8319-11eb-be00-43da67be1b35-5986	\N	NEW	\N	\N	\N	\N
81677	79	D5170C00002/tiny.path.1/file-0287.pdf	\N	D5170C00002-48888378-8315-11eb-be00-570a302f6fa8-287	\N	NEW	\N	\N	\N	\N
83054	79	D5170C00002/tiny.path.1/file-1664.pdf	\N	D5170C00002-4895fbe9-8316-11eb-be00-0ba5dd4aa6e2-1664	\N	NEW	\N	\N	\N	\N
86077	79	D5170C00002/tiny.path.1/file-4687.pdf	\N	D5170C00002-48977068-8318-11eb-be00-bb1f7929fea5-4687	\N	NEW	\N	\N	\N	\N
87377	79	D5170C00002/tiny.path.1/file-5987.pdf	\N	D5170C00002-48a4c17c-8319-11eb-be00-d38e16eaee88-5987	\N	NEW	\N	\N	\N	\N
86078	79	D5170C00002/tiny.path.1/file-4688.pdf	\N	D5170C00002-48b3f919-8318-11eb-be00-0da1904d413e-4688	\N	NEW	\N	\N	\N	\N
81678	79	D5170C00002/tiny.path.1/file-0288.pdf	\N	D5170C00002-48b586e9-8315-11eb-be00-c3f39db8fcbf-288	\N	NEW	\N	\N	\N	\N
81679	79	D5170C00002/tiny.path.1/file-0289.pdf	\N	D5170C00002-48c53e5a-8315-11eb-be00-db6efb6f5db5-289	\N	NEW	\N	\N	\N	\N
87378	79	D5170C00002/tiny.path.1/file-5988.pdf	\N	D5170C00002-48d2883d-8319-11eb-be00-11c2ec4d6827-5988	\N	NEW	\N	\N	\N	\N
83055	79	D5170C00002/tiny.path.1/file-1665.pdf	\N	D5170C00002-48d527ca-8316-11eb-be00-ef4f07fcfa29-1665	\N	NEW	\N	\N	\N	\N
86079	79	D5170C00002/tiny.path.1/file-4689.pdf	\N	D5170C00002-48e1bfda-8318-11eb-be00-159df02168a4-4689	\N	NEW	\N	\N	\N	\N
87379	79	D5170C00002/tiny.path.1/file-5989.pdf	\N	D5170C00002-48e3782e-8319-11eb-be00-31a8c42759cd-5989	\N	NEW	\N	\N	\N	\N
81680	79	D5170C00002/tiny.path.1/file-0290.pdf	\N	D5170C00002-48f241cb-8315-11eb-be00-a580bd59098d-290	\N	NEW	\N	\N	\N	\N
87380	79	D5170C00002/tiny.path.1/file-5990.pdf	\N	D5170C00002-490027ef-8319-11eb-be00-ed5ee2e8d54a-5990	\N	NEW	\N	\N	\N	\N
81681	79	D5170C00002/tiny.path.1/file-0291.pdf	\N	D5170C00002-4900c0bc-8315-11eb-be00-17f0b4b86fd8-291	\N	NEW	\N	\N	\N	\N
81682	79	D5170C00002/tiny.path.1/file-0292.pdf	\N	D5170C00002-49102a0d-8315-11eb-be00-7f9018b38be8-292	\N	NEW	\N	\N	\N	\N
87381	79	D5170C00002/tiny.path.1/file-5991.pdf	\N	D5170C00002-4910c9c0-8319-11eb-be00-7d7cb7355a6a-5991	\N	NEW	\N	\N	\N	\N
86080	79	D5170C00002/tiny.path.1/file-4690.pdf	\N	D5170C00002-4912baeb-8318-11eb-be00-b11bb72c5cff-4690	\N	NEW	\N	\N	\N	\N
81683	79	D5170C00002/tiny.path.1/file-0293.pdf	\N	D5170C00002-4921410e-8315-11eb-be00-fb1250192e64-293	\N	NEW	\N	\N	\N	\N
83056	79	D5170C00002/tiny.path.1/file-1666.pdf	\N	D5170C00002-493f0d2b-8316-11eb-be00-33009ec5025f-1666	\N	NEW	\N	\N	\N	\N
87382	79	D5170C00002/tiny.path.1/file-5992.pdf	\N	D5170C00002-494cc151-8319-11eb-be00-b36226016d40-5992	\N	NEW	\N	\N	\N	\N
81684	79	D5170C00002/tiny.path.1/file-0294.pdf	\N	D5170C00002-494d0bff-8315-11eb-be00-bf7f2dbe675e-294	\N	NEW	\N	\N	\N	\N
86081	79	D5170C00002/tiny.path.1/file-4691.pdf	\N	D5170C00002-494f009c-8318-11eb-be00-2b1a926cec10-4691	\N	NEW	\N	\N	\N	\N
81685	79	D5170C00002/tiny.path.1/file-0295.pdf	\N	D5170C00002-496b6970-8315-11eb-be00-ff965dacbab2-295	\N	NEW	\N	\N	\N	\N
87383	79	D5170C00002/tiny.path.1/file-5993.pdf	\N	D5170C00002-496cf382-8319-11eb-be00-635ca1b37b05-5993	\N	NEW	\N	\N	\N	\N
81686	79	D5170C00002/tiny.path.1/file-0296.pdf	\N	D5170C00002-496db361-8315-11eb-be00-b5efd97fd0be-296	\N	NEW	\N	\N	\N	\N
84506	79	D5170C00002/tiny.path.1/file-3116.pdf	\N	D5170C00002-497ae7e5-8317-11eb-be00-7f60b94a0647-3116	\N	NEW	\N	\N	\N	\N
83057	79	D5170C00002/tiny.path.1/file-1667.pdf	\N	D5170C00002-497bef1c-8316-11eb-be00-a90e3ab3d663-1667	\N	NEW	\N	\N	\N	\N
81687	79	D5170C00002/tiny.path.1/file-0297.pdf	\N	D5170C00002-498a1502-8315-11eb-be00-e1433a06b3bc-297	\N	NEW	\N	\N	\N	\N
87384	79	D5170C00002/tiny.path.1/file-5994.pdf	\N	D5170C00002-498c1443-8319-11eb-be00-1d70cb9170cb-5994	\N	NEW	\N	\N	\N	\N
81688	79	D5170C00002/tiny.path.1/file-0298.pdf	\N	D5170C00002-49995743-8315-11eb-be00-c3193a36b6d1-298	\N	NEW	\N	\N	\N	\N
86082	79	D5170C00002/tiny.path.1/file-4692.pdf	\N	D5170C00002-499bc10d-8318-11eb-be00-95ec3991ec2e-4692	\N	NEW	\N	\N	\N	\N
84507	79	D5170C00002/tiny.path.1/file-3117.pdf	\N	D5170C00002-499c0476-8317-11eb-be00-376585ec0362-3117	\N	NEW	\N	\N	\N	\N
81689	79	D5170C00002/tiny.path.1/file-0299.pdf	\N	D5170C00002-49aa2024-8315-11eb-be00-affe3778d99a-299	\N	NEW	\N	\N	\N	\N
87385	79	D5170C00002/tiny.path.1/file-5995.pdf	\N	D5170C00002-49b82d54-8319-11eb-be00-1b2e04a2dbe7-5995	\N	NEW	\N	\N	\N	\N
83058	79	D5170C00002/tiny.path.1/file-1668.pdf	\N	D5170C00002-49ba098d-8316-11eb-be00-0562d7f681e7-1668	\N	NEW	\N	\N	\N	\N
81690	79	D5170C00002/tiny.path.1/file-0300.pdf	\N	D5170C00002-49c7ba45-8315-11eb-be00-0d3db2e329aa-300	\N	NEW	\N	\N	\N	\N
87386	79	D5170C00002/tiny.path.1/file-5996.pdf	\N	D5170C00002-49d61595-8319-11eb-be00-4d128ee3550b-5996	\N	NEW	\N	\N	\N	\N
81691	79	D5170C00002/tiny.path.1/file-0301.pdf	\N	D5170C00002-49d68756-8315-11eb-be00-91f77f4cfb83-301	\N	NEW	\N	\N	\N	\N
83059	79	D5170C00002/tiny.path.1/file-1669.pdf	\N	D5170C00002-49d7cabe-8316-11eb-be00-f1dcb1ee1854-1669	\N	NEW	\N	\N	\N	\N
84508	79	D5170C00002/tiny.path.1/file-3118.pdf	\N	D5170C00002-49d8e667-8317-11eb-be00-2b1e156237ce-3118	\N	NEW	\N	\N	\N	\N
87387	79	D5170C00002/tiny.path.1/file-5997.pdf	\N	D5170C00002-49e509b6-8319-11eb-be00-cf95601e53be-5997	\N	NEW	\N	\N	\N	\N
86083	79	D5170C00002/tiny.path.1/file-4693.pdf	\N	D5170C00002-49e5261e-8318-11eb-be00-cd779fe25cf9-4693	\N	NEW	\N	\N	\N	\N
83060	79	D5170C00002/tiny.path.1/file-1670.pdf	\N	D5170C00002-49e8939f-8316-11eb-be00-5ffc5974fa53-1670	\N	NEW	\N	\N	\N	\N
81692	79	D5170C00002/tiny.path.1/file-0302.pdf	\N	D5170C00002-49f64457-8315-11eb-be00-99e452ccded8-302	\N	NEW	\N	\N	\N	\N
84509	79	D5170C00002/tiny.path.1/file-3119.pdf	\N	D5170C00002-4a0574a8-8317-11eb-be00-fb20d195e628-3119	\N	NEW	\N	\N	\N	\N
87388	79	D5170C00002/tiny.path.1/file-5998.pdf	\N	D5170C00002-4a058a07-8319-11eb-be00-37683a4b6408-5998	\N	NEW	\N	\N	\N	\N
83061	79	D5170C00002/tiny.path.1/file-1671.pdf	\N	D5170C00002-4a067be0-8316-11eb-be00-19dd9f87d96e-1671	\N	NEW	\N	\N	\N	\N
86084	79	D5170C00002/tiny.path.1/file-4694.xlsx	\N	D5170C00002-4a12ecdf-8318-11eb-be00-e52eda8e5a1d-4694	\N	NEW	\N	\N	\N	\N
84510	79	D5170C00002/tiny.path.1/file-3120.pdf	\N	D5170C00002-4a14ddf9-8317-11eb-be00-abfec50a4711-3120	\N	NEW	\N	\N	\N	\N
81693	79	D5170C00002/tiny.path.1/file-0303.pdf	\N	D5170C00002-4a14efe8-8315-11eb-be00-854df6a281fd-303	\N	NEW	\N	\N	\N	\N
83068	79	D5170C00002/tiny.path.1/file-1678.pdf	\N	D5170C00002-4a2352b1-8316-11eb-be00-b31197931d68-1672	\N	NEW	\N	\N	\N	\N
81694	79	D5170C00002/tiny.path.1/file-0304.pdf	\N	D5170C00002-4a240b19-8315-11eb-be00-8b5d4793e92f-304	\N	NEW	\N	\N	\N	\N
87389	79	D5170C00002/tiny.path.1/file-5999.pdf	\N	D5170C00002-4a240e88-8319-11eb-be00-a7a327ea48b4-5999	\N	NEW	\N	\N	\N	\N
84511	79	D5170C00002/tiny.path.1/file-3121.pdf	\N	D5170C00002-4a32781a-8317-11eb-be00-855c0fc66428-3121	\N	NEW	\N	\N	\N	\N
83062	79	D5170C00002/tiny.path.1/file-1672.pdf	\N	D5170C00002-4a352d02-8316-11eb-be00-a7b2b3cf9e6b-1673	\N	NEW	\N	\N	\N	\N
86085	79	D5170C00002/tiny.path.1/file-4695.xlsx	\N	D5170C00002-4a40b3a0-8318-11eb-be00-bf1545046af6-4695	\N	NEW	\N	\N	\N	\N
81695	79	D5170C00002/tiny.path.1/file-0305.pdf	\N	D5170C00002-4a4108fa-8315-11eb-be00-b9dcbb9d53f1-305	\N	NEW	\N	\N	\N	\N
87390	79	D5170C00002/tiny.path.1/file-6000.pdf	\N	D5170C00002-4a415a89-8319-11eb-be00-d7dbae83163f-6000	\N	NEW	\N	\N	\N	\N
84515	79	D5170C00002/tiny.path.1/file-3125.pdf	\N	D5170C00002-4a422f8b-8317-11eb-be00-1b13687af7f4-3122	\N	NEW	\N	\N	\N	\N
81696	79	D5170C00002/tiny.path.1/file-0306.pdf	\N	D5170C00002-4a5f8d7b-8315-11eb-be00-8d1222606b14-306	\N	NEW	\N	\N	\N	\N
83063	79	D5170C00002/tiny.path.1/file-1673.pdf	\N	D5170C00002-4a6034a3-8316-11eb-be00-915f1c4a9185-1674	\N	NEW	\N	\N	\N	\N
84512	79	D5170C00002/tiny.path.1/file-3122.pdf	\N	D5170C00002-4a6ebdcc-8317-11eb-be00-f156d7a3c0a3-3123	\N	NEW	\N	\N	\N	\N
87391	79	D5170C00002/tiny.path.1/file-6001.pdf	\N	D5170C00002-4a6f485a-8319-11eb-be00-afdda6a29f37-6001	\N	NEW	\N	\N	\N	\N
81697	79	D5170C00002/tiny.path.1/file-0307.pdf	\N	D5170C00002-4a71dcfc-8315-11eb-be00-6fa4977f606c-307	\N	NEW	\N	\N	\N	\N
87392	79	D5170C00002/tiny.path.1/file-6002.pdf	\N	D5170C00002-4a7dee5b-8319-11eb-be00-afc3723b2095-6002	\N	NEW	\N	\N	\N	\N
83064	79	D5170C00002/tiny.path.1/file-1674.pdf	\N	D5170C00002-4a7f7c74-8316-11eb-be00-5d99c0647027-1675	\N	NEW	\N	\N	\N	\N
87393	79	D5170C00002/tiny.path.1/file-6003.pdf	\N	D5170C00002-4a80113c-8319-11eb-be00-259e0c6cd9df-6003	\N	NEW	\N	\N	\N	\N
81698	79	D5170C00002/tiny.path.1/file-0308.pdf	\N	D5170C00002-4a8f771d-8315-11eb-be00-fd1c848f2b02-308	\N	NEW	\N	\N	\N	\N
84513	79	D5170C00002/tiny.path.1/file-3123.pdf	\N	D5170C00002-4a90769d-8317-11eb-be00-c34021915d9f-3124	\N	NEW	\N	\N	\N	\N
83065	79	D5170C00002/tiny.path.1/file-1675.pdf	\N	D5170C00002-4a9dd9e5-8316-11eb-be00-59a9b528b815-1676	\N	NEW	\N	\N	\N	\N
87394	79	D5170C00002/tiny.path.1/file-6004.pdf	\N	D5170C00002-4a9df97d-8319-11eb-be00-c78a43a0daa8-6004	\N	NEW	\N	\N	\N	\N
84514	79	D5170C00002/tiny.path.1/file-3124.pdf	\N	D5170C00002-4aab9fbe-8317-11eb-be00-1d0093d0d959-3125	\N	NEW	\N	\N	\N	\N
86086	79	D5170C00002/tiny.path.1/file-4696.pdf	\N	D5170C00002-4aad0a01-8318-11eb-be00-7bcddfda8ccc-4696	\N	NEW	\N	\N	\N	\N
87395	79	D5170C00002/tiny.path.1/file-6005.pdf	\N	D5170C00002-4aad62ce-8319-11eb-be00-a196772e14de-6005	\N	NEW	\N	\N	\N	\N
81699	79	D5170C00002/tiny.path.1/file-0309.pdf	\N	D5170C00002-4aae49be-8315-11eb-be00-830c894558aa-309	\N	NEW	\N	\N	\N	\N
83066	79	D5170C00002/tiny.path.1/file-1676.pdf	\N	D5170C00002-4abcac86-8316-11eb-be00-69dcd554a6f0-1677	\N	NEW	\N	\N	\N	\N
84516	79	D5170C00002/tiny.path.1/file-3126.pdf	\N	D5170C00002-4aca4b4f-8317-11eb-be00-3789773baad7-3126	\N	NEW	\N	\N	\N	\N
81700	79	D5170C00002/tiny.path.1/file-0310.pdf	\N	D5170C00002-4acbbccf-8315-11eb-be00-9f6e258830bd-310	\N	NEW	\N	\N	\N	\N
84517	79	D5170C00002/tiny.path.1/file-3127.pdf	\N	D5170C00002-4ad9b4a0-8317-11eb-be00-d9007e499ccf-3127	\N	NEW	\N	\N	\N	\N
87396	79	D5170C00002/tiny.path.1/file-6006.pdf	\N	D5170C00002-4ad9c9ff-8319-11eb-be00-334bac4e11d1-6006	\N	NEW	\N	\N	\N	\N
83067	79	D5170C00002/tiny.path.1/file-1677.pdf	\N	D5170C00002-4adabbd7-8316-11eb-be00-fdbd37f507cf-1678	\N	NEW	\N	\N	\N	\N
83069	79	D5170C00002/tiny.path.1/file-1679.pdf	\N	D5170C00002-4ae8eca8-8316-11eb-be00-7f898343f21c-1679	\N	NEW	\N	\N	\N	\N
86087	79	D5170C00002/tiny.path.1/file-4697.pdf	\N	D5170C00002-4ae90192-8318-11eb-be00-bb518b7be8d7-4697	\N	NEW	\N	\N	\N	\N
81701	79	D5170C00002/tiny.path.1/file-0311.pdf	\N	D5170C00002-4ae9f330-8315-11eb-be00-d753fdb87de9-311	\N	NEW	\N	\N	\N	\N
84518	79	D5170C00002/tiny.path.1/file-3128.pdf	\N	D5170C00002-4af7eb01-8317-11eb-be00-a53fee5a0a81-3128	\N	NEW	\N	\N	\N	\N
84519	79	D5170C00002/tiny.path.1/file-3129.pdf	\N	D5170C00002-4b072d42-8317-11eb-be00-1132fe5bae4d-3129	\N	NEW	\N	\N	\N	\N
83070	79	D5170C00002/tiny.path.1/file-1680.pdf	\N	D5170C00002-4b083479-8316-11eb-be00-9159d18b9f21-1680	\N	NEW	\N	\N	\N	\N
84520	79	D5170C00002/tiny.path.1/file-3130.pdf	\N	D5170C00002-4b170bc3-8317-11eb-be00-15c1a656872a-3130	\N	NEW	\N	\N	\N	\N
81702	79	D5170C00002/tiny.path.1/file-0312.pdf	\N	D5170C00002-4b171db1-8315-11eb-be00-83487f49719f-312	\N	NEW	\N	\N	\N	\N
83071	79	D5170C00002/tiny.path.1/file-1681.pdf	\N	D5170C00002-4b17289a-8316-11eb-be00-8ddd033bcf6d-1681	\N	NEW	\N	\N	\N	\N
87397	79	D5170C00002/tiny.path.1/file-6007.pdf	\N	D5170C00002-4b1880b0-8319-11eb-be00-fd5ccf908d41-6007	\N	NEW	\N	\N	\N	\N
86088	79	D5170C00002/tiny.path.1/file-4698.pdf	\N	D5170C00002-4b193953-8318-11eb-be00-3f5cec5a12da-4698	\N	NEW	\N	\N	\N	\N
84521	79	D5170C00002/tiny.path.1/file-3131.pdf	\N	D5170C00002-4b26c334-8317-11eb-be00-c5dfab9d3b07-3131	\N	NEW	\N	\N	\N	\N
86089	79	D5170C00002/tiny.path.1/file-4699.pdf	\N	D5170C00002-4b359af4-8318-11eb-be00-43b081443957-4699	\N	NEW	\N	\N	\N	\N
81703	79	D5170C00002/tiny.path.1/file-0313.pdf	\N	D5170C00002-4b366582-8315-11eb-be00-af103a662521-313	\N	NEW	\N	\N	\N	\N
84522	79	D5170C00002/tiny.path.1/file-3132.pdf	\N	D5170C00002-4b36a1b5-8317-11eb-be00-39c20e84fa8c-3132	\N	NEW	\N	\N	\N	\N
87398	79	D5170C00002/tiny.path.1/file-6008.pdf	\N	D5170C00002-4b453601-8319-11eb-be00-298809d6785c-6008	\N	NEW	\N	\N	\N	\N
84523	79	D5170C00002/tiny.path.1/file-3133.pdf	\N	D5170C00002-4b474386-8317-11eb-be00-099fd6a5517a-3133	\N	NEW	\N	\N	\N	\N
86090	79	D5170C00002/tiny.path.1/file-4700.pdf	\N	D5170C00002-4b557f05-8318-11eb-be00-8d8ca048bf93-4700	\N	NEW	\N	\N	\N	\N
81704	79	D5170C00002/tiny.path.1/file-0314.pdf	\N	D5170C00002-4b562283-8315-11eb-be00-2fdd14f12b89-314	\N	NEW	\N	\N	\N	\N
84524	79	D5170C00002/tiny.path.1/file-3134.pdf	\N	D5170C00002-4b635707-8317-11eb-be00-77787cbf2d35-3134	\N	NEW	\N	\N	\N	\N
87399	79	D5170C00002/tiny.path.1/file-6009.pdf	\N	D5170C00002-4b64cbf2-8319-11eb-be00-87db1b72aa9a-6009	\N	NEW	\N	\N	\N	\N
81705	79	D5170C00002/tiny.path.1/file-0315.pdf	\N	D5170C00002-4b73bca4-8315-11eb-be00-7b17c39ce3b4-315	\N	NEW	\N	\N	\N	\N
87400	79	D5170C00002/tiny.path.1/file-6010.pdf	\N	D5170C00002-4b828d23-8319-11eb-be00-8fdf7dbe3f27-6010	\N	NEW	\N	\N	\N	\N
84525	79	D5170C00002/tiny.path.1/file-3135.pdf	\N	D5170C00002-4b83fe68-8317-11eb-be00-bbc9714ffa7a-3135	\N	NEW	\N	\N	\N	\N
81706	79	D5170C00002/tiny.path.1/file-0316.pdf	\N	D5170C00002-4b928f45-8315-11eb-be00-39f14672941c-316	\N	NEW	\N	\N	\N	\N
87401	79	D5170C00002/tiny.path.1/file-6011.pdf	\N	D5170C00002-4ba138b4-8319-11eb-be00-9f2ce65fdf16-6011	\N	NEW	\N	\N	\N	\N
81707	79	D5170C00002/tiny.path.1/file-0317.pdf	\N	D5170C00002-4ba21fa6-8315-11eb-be00-13b6c219f12d-317	\N	NEW	\N	\N	\N	\N
86091	79	D5170C00002/tiny.path.1/file-4701.pdf	\N	D5170C00002-4baf5ed6-8318-11eb-be00-15afb1aaf0aa-4701	\N	NEW	\N	\N	\N	\N
83072	79	D5170C00002/tiny.path.1/file-1682.pdf	\N	D5170C00002-4bafe62b-8316-11eb-be00-d3cdee81b22b-1682	\N	NEW	\N	\N	\N	\N
81708	79	D5170C00002/tiny.path.1/file-0318.pdf	\N	D5170C00002-4bbf4497-8315-11eb-be00-87c925566588-318	\N	NEW	\N	\N	\N	\N
83073	79	D5170C00002/tiny.path.1/file-1683.pdf	\N	D5170C00002-4bbf9d9c-8316-11eb-be00-d999f49c2dbe-1683	\N	NEW	\N	\N	\N	\N
84526	79	D5170C00002/tiny.path.1/file-3136.pdf	\N	D5170C00002-4bbfcee9-8317-11eb-be00-299cb4b7723c-3136	\N	NEW	\N	\N	\N	\N
83074	79	D5170C00002/tiny.path.1/file-1684.pdf	\N	D5170C00002-4bce91bd-8316-11eb-be00-b5d7497dae94-1684	\N	NEW	\N	\N	\N	\N
86092	79	D5170C00002/tiny.path.1/file-4702.pdf	\N	D5170C00002-4bd02d47-8318-11eb-be00-4948be21ea5f-4702	\N	NEW	\N	\N	\N	\N
81709	79	D5170C00002/tiny.path.1/file-0319.pdf	\N	D5170C00002-4bd0a9b8-8315-11eb-be00-451376b4907e-319	\N	NEW	\N	\N	\N	\N
87402	79	D5170C00002/tiny.path.1/file-6012.pdf	\N	D5170C00002-4bde41b5-8319-11eb-be00-d3f389545230-6012	\N	NEW	\N	\N	\N	\N
81710	79	D5170C00002/tiny.path.1/file-0320.pdf	\N	D5170C00002-4bdf9dd9-8315-11eb-be00-952ba9fa4443-320	\N	NEW	\N	\N	\N	\N
83075	79	D5170C00002/tiny.path.1/file-1685.pdf	\N	D5170C00002-4bed645e-8316-11eb-be00-b55d321288e3-1685	\N	NEW	\N	\N	\N	\N
87403	79	D5170C00002/tiny.path.1/file-6013.pdf	\N	D5170C00002-4bedab06-8319-11eb-be00-57c6bc0df781-6013	\N	NEW	\N	\N	\N	\N
81711	79	D5170C00002/tiny.path.1/file-0321.pdf	\N	D5170C00002-4bfc4d9a-8315-11eb-be00-c941988ef355-321	\N	NEW	\N	\N	\N	\N
87404	79	D5170C00002/tiny.path.1/file-6014.pdf	\N	D5170C00002-4bfd3b67-8319-11eb-be00-b9c66358ee48-6014	\N	NEW	\N	\N	\N	\N
84527	79	D5170C00002/tiny.path.1/file-3137.pdf	\N	D5170C00002-4c0b56da-8317-11eb-be00-3b9fe759cd8a-3137	\N	NEW	\N	\N	\N	\N
81712	79	D5170C00002/tiny.path.1/file-0322.pdf	\N	D5170C00002-4c0c7a3b-8315-11eb-be00-2b22d018729d-322	\N	NEW	\N	\N	\N	\N
87405	79	D5170C00002/tiny.path.1/file-6015.pdf	\N	D5170C00002-4c19c418-8319-11eb-be00-5f52ba5e0526-6015	\N	NEW	\N	\N	\N	\N
83076	79	D5170C00002/tiny.path.1/file-1686.pdf	\N	D5170C00002-4c1ba04f-8316-11eb-be00-c9a986a63576-1686	\N	NEW	\N	\N	\N	\N
87406	79	D5170C00002/tiny.path.1/file-6016.pdf	\N	D5170C00002-4c290659-8319-11eb-be00-0daab127a792-6016	\N	NEW	\N	\N	\N	\N
83077	79	D5170C00002/tiny.path.1/file-1687.pdf	\N	D5170C00002-4c2cb750-8316-11eb-be00-6be455d2e378-1687	\N	NEW	\N	\N	\N	\N
81713	79	D5170C00002/tiny.path.1/file-0323.pdf	\N	D5170C00002-4c39569c-8315-11eb-be00-f1cbc5a38377-323	\N	NEW	\N	\N	\N	\N
87407	79	D5170C00002/tiny.path.1/file-6017.pdf	\N	D5170C00002-4c47d8fa-8319-11eb-be00-67e9350c36d5-6017	\N	NEW	\N	\N	\N	\N
86093	79	D5170C00002/tiny.path.1/file-4703.pdf	\N	D5170C00002-4c47f558-8318-11eb-be00-69c106ba1d89-4703	\N	NEW	\N	\N	\N	\N
81714	79	D5170C00002/tiny.path.1/file-0324.pdf	\N	D5170C00002-4c48e6fd-8315-11eb-be00-054af075bd7c-324	\N	NEW	\N	\N	\N	\N
81715	79	D5170C00002/tiny.path.1/file-0325.pdf	\N	D5170C00002-4c5765ee-8315-11eb-be00-8f87a6878df4-325	\N	NEW	\N	\N	\N	\N
87408	79	D5170C00002/tiny.path.1/file-6018.pdf	\N	D5170C00002-4c75519b-8319-11eb-be00-8541376c3132-6018	\N	NEW	\N	\N	\N	\N
83078	79	D5170C00002/tiny.path.1/file-1688.pdf	\N	D5170C00002-4c766a81-8316-11eb-be00-0b09fd1b93ca-1688	\N	NEW	\N	\N	\N	\N
87409	79	D5170C00002/tiny.path.1/file-6019.pdf	\N	D5170C00002-4c76b12c-8319-11eb-be00-2f832716204f-6019	\N	NEW	\N	\N	\N	\N
87410	79	D5170C00002/tiny.path.1/file-6020.pdf	\N	D5170C00002-4c7810bd-8319-11eb-be00-4f5c986d5282-6020	\N	NEW	\N	\N	\N	\N
87411	79	D5170C00002/tiny.path.1/file-6021.pdf	\N	D5170C00002-4ca49efe-8319-11eb-be00-396e9c90d0e5-6021	\N	NEW	\N	\N	\N	\N
81716	79	D5170C00002/tiny.path.1/file-0326.pdf	\N	D5170C00002-4ca6222f-8315-11eb-be00-9304e17a1602-326	\N	NEW	\N	\N	\N	\N
83081	79	D5170C00002/tiny.path.1/file-1691.pdf	\N	D5170C00002-4ca6c952-8316-11eb-be00-c7b48d64f818-1689	\N	NEW	\N	\N	\N	\N
83082	79	D5170C00002/tiny.path.1/file-1692.pdf	\N	D5170C00002-4cc3a023-8316-11eb-be00-7bfae17e694a-1690	\N	NEW	\N	\N	\N	\N
87412	79	D5170C00002/tiny.path.1/file-6022.pdf	\N	D5170C00002-4cc40ddf-8319-11eb-be00-d9140a55b126-6022	\N	NEW	\N	\N	\N	\N
87413	79	D5170C00002/tiny.path.1/file-6023.pdf	\N	D5170C00002-4cd35020-8319-11eb-be00-95c76b459a5f-6023	\N	NEW	\N	\N	\N	\N
84528	79	D5170C00002/tiny.path.1/file-3138.pdf	\N	D5170C00002-4ce0a83b-8317-11eb-be00-75ffd428e071-3138	\N	NEW	\N	\N	\N	\N
81717	79	D5170C00002/tiny.path.1/file-0327.pdf	\N	D5170C00002-4ce1a490-8315-11eb-be00-a5f4bb219785-327	\N	NEW	\N	\N	\N	\N
83083	79	D5170C00002/tiny.path.1/file-1693.pdf	\N	D5170C00002-4ce1af74-8316-11eb-be00-5df08634ef13-1691	\N	NEW	\N	\N	\N	\N
87414	79	D5170C00002/tiny.path.1/file-6024.pdf	\N	D5170C00002-4cef63a1-8319-11eb-be00-5f226e43c94a-6024	\N	NEW	\N	\N	\N	\N
87415	79	D5170C00002/tiny.path.1/file-6025.pdf	\N	D5170C00002-4cff1b12-8319-11eb-be00-1ff247f6197d-6025	\N	NEW	\N	\N	\N	\N
84529	79	D5170C00002/tiny.path.1/file-3139.pdf	\N	D5170C00002-4d0e20dc-8317-11eb-be00-4948d82323ff-3139	\N	NEW	\N	\N	\N	\N
87416	79	D5170C00002/tiny.path.1/file-6026.pdf	\N	D5170C00002-4d0f47b3-8319-11eb-be00-710d53e1f8e6-6026	\N	NEW	\N	\N	\N	\N
83079	79	D5170C00002/tiny.path.1/file-1689.pdf	\N	D5170C00002-4d1f0695-8316-11eb-be00-592fb9ce22b3-1692	\N	NEW	\N	\N	\N	\N
87417	79	D5170C00002/tiny.path.1/file-6027.pdf	\N	D5170C00002-4d2c6ca4-8319-11eb-be00-11240436992e-6027	\N	NEW	\N	\N	\N	\N
87418	79	D5170C00002/tiny.path.1/file-6028.pdf	\N	D5170C00002-4d2eb695-8319-11eb-be00-fb5b2953bc72-6028	\N	NEW	\N	\N	\N	\N
86094	79	D5170C00002/tiny.path.1/file-4704.pdf	\N	D5170C00002-4d2f6f29-8318-11eb-be00-bb4cacd39bf6-4704	\N	NEW	\N	\N	\N	\N
81718	79	D5170C00002/tiny.path.1/file-0328.pdf	\N	D5170C00002-4d3ce3f1-8315-11eb-be00-bf2cf680f923-328	\N	NEW	\N	\N	\N	\N
87419	79	D5170C00002/tiny.path.1/file-6029.pdf	\N	D5170C00002-4d3e46f6-8319-11eb-be00-bf4040eae50b-6029	\N	NEW	\N	\N	\N	\N
83080	79	D5170C00002/tiny.path.1/file-1690.pdf	\N	D5170C00002-4d4d90a6-8316-11eb-be00-296b39994164-1693	\N	NEW	\N	\N	\N	\N
87420	79	D5170C00002/tiny.path.1/file-6030.pdf	\N	D5170C00002-4d5b1dc7-8319-11eb-be00-034225622334-6030	\N	NEW	\N	\N	\N	\N
86095	79	D5170C00002/tiny.path.1/file-4705.pdf	\N	D5170C00002-4d6991fa-8318-11eb-be00-45a8c60d24b6-4705	\N	NEW	\N	\N	\N	\N
83084	79	D5170C00002/tiny.path.1/file-1694.pdf	\N	D5170C00002-4d6a1957-8316-11eb-be00-bb4807a30e8b-1694	\N	NEW	\N	\N	\N	\N
84530	79	D5170C00002/tiny.path.1/file-3140.pdf	\N	D5170C00002-4d6a71ad-8317-11eb-be00-4b4200180aa9-3140	\N	NEW	\N	\N	\N	\N
87421	79	D5170C00002/tiny.path.1/file-6031.pdf	\N	D5170C00002-4d79c958-8319-11eb-be00-e1d97c3c8690-6031	\N	NEW	\N	\N	\N	\N
86096	79	D5170C00002/tiny.path.1/file-4706.pdf	\N	D5170C00002-4d87ef6b-8318-11eb-be00-ed0e725ac4d1-4706	\N	NEW	\N	\N	\N	\N
86097	79	D5170C00002/tiny.path.1/file-4707.pdf	\N	D5170C00002-4d98df5c-8318-11eb-be00-6d1b83bc2830-4707	\N	NEW	\N	\N	\N	\N
84531	79	D5170C00002/tiny.path.1/file-3141.pdf	\N	D5170C00002-4da7a1be-8317-11eb-be00-7181a298b8a6-3141	\N	NEW	\N	\N	\N	\N
86098	79	D5170C00002/tiny.path.1/file-4708.pdf	\N	D5170C00002-4db6c79d-8318-11eb-be00-6bb3ef3e8fbd-4708	\N	NEW	\N	\N	\N	\N
81719	79	D5170C00002/tiny.path.1/file-0329.pdf	\N	D5170C00002-4db76b22-8315-11eb-be00-f77f80929ed9-329	\N	NEW	\N	\N	\N	\N
87422	79	D5170C00002/tiny.path.1/file-6032.pdf	\N	D5170C00002-4dc72609-8319-11eb-be00-21c761fc444e-6032	\N	NEW	\N	\N	\N	\N
84532	79	D5170C00002/tiny.path.1/file-3142.pdf	\N	D5170C00002-4dc8702f-8317-11eb-be00-efedaeaeb4da-3142	\N	NEW	\N	\N	\N	\N
83085	79	D5170C00002/tiny.path.1/file-1695.pdf	\N	D5170C00002-4dd5d378-8316-11eb-be00-6369b61b0204-1695	\N	NEW	\N	\N	\N	\N
86099	79	D5170C00002/tiny.path.1/file-4709.pdf	\N	D5170C00002-4de37cee-8318-11eb-be00-77d937b4da3d-4709	\N	NEW	\N	\N	\N	\N
86100	79	D5170C00002/tiny.path.1/file-4710.pdf	\N	D5170C00002-4df4baff-8318-11eb-be00-cf8b29f88a36-4710	\N	NEW	\N	\N	\N	\N
84533	79	D5170C00002/tiny.path.1/file-3143.pdf	\N	D5170C00002-4e037d60-8317-11eb-be00-fdbaa31f8bee-3143	\N	NEW	\N	\N	\N	\N
87423	79	D5170C00002/tiny.path.1/file-6033.pdf	\N	D5170C00002-4e11c39a-8319-11eb-be00-89e314a74a22-6033	\N	NEW	\N	\N	\N	\N
86101	79	D5170C00002/tiny.path.1/file-4711.pdf	\N	D5170C00002-4e125520-8318-11eb-be00-8f0a9520b35c-4711	\N	NEW	\N	\N	\N	\N
83086	79	D5170C00002/tiny.path.1/file-1696.pdf	\N	D5170C00002-4e139fc9-8316-11eb-be00-b9bea906f0fb-1696	\N	NEW	\N	\N	\N	\N
86102	79	D5170C00002/tiny.path.1/file-4712.pdf	\N	D5170C00002-4e22cfe1-8318-11eb-be00-99c27ba75c71-4712	\N	NEW	\N	\N	\N	\N
81720	79	D5170C00002/tiny.path.1/file-0330.pdf	\N	D5170C00002-4e31a433-8315-11eb-be00-41a15091a8cb-330	\N	NEW	\N	\N	\N	\N
83087	79	D5170C00002/tiny.path.1/file-1697.pdf	\N	D5170C00002-4e31fd3a-8316-11eb-be00-279f6bb097d4-1697	\N	NEW	\N	\N	\N	\N
84534	79	D5170C00002/tiny.path.1/file-3144.pdf	\N	D5170C00002-4e423411-8317-11eb-be00-b1b43b3b3479-3144	\N	NEW	\N	\N	\N	\N
86103	79	D5170C00002/tiny.path.1/file-4713.pdf	\N	D5170C00002-4e4ee8f2-8318-11eb-be00-d588ea567dbc-4713	\N	NEW	\N	\N	\N	\N
83088	79	D5170C00002/tiny.path.1/file-1698.pdf	\N	D5170C00002-4e511dfb-8316-11eb-be00-ad2b6839ea01-1698	\N	NEW	\N	\N	\N	\N
84535	79	D5170C00002/tiny.path.1/file-3145.pdf	\N	D5170C00002-4e5e6ea2-8317-11eb-be00-6909ff73913b-3145	\N	NEW	\N	\N	\N	\N
87424	79	D5170C00002/tiny.path.1/file-6034.pdf	\N	D5170C00002-4e5f204b-8319-11eb-be00-fdf8646f0f6d-6034	\N	NEW	\N	\N	\N	\N
86104	79	D5170C00002/tiny.path.1/file-4714.pdf	\N	D5170C00002-4e7d7303-8318-11eb-be00-e5272027b550-4714	\N	NEW	\N	\N	\N	\N
83089	79	D5170C00002/tiny.path.1/file-1699.pdf	\N	D5170C00002-4e7f32dc-8316-11eb-be00-57a7686f06ac-1699	\N	NEW	\N	\N	\N	\N
84536	79	D5170C00002/tiny.path.1/file-3146.pdf	\N	D5170C00002-4e8d1fc3-8317-11eb-be00-8f4037d405fa-3146	\N	NEW	\N	\N	\N	\N
86105	79	D5170C00002/tiny.path.1/file-4715.pdf	\N	D5170C00002-4e8d5184-8318-11eb-be00-4791c248acc3-4715	\N	NEW	\N	\N	\N	\N
83090	79	D5170C00002/tiny.path.1/file-1700.pdf	\N	D5170C00002-4e9b947d-8316-11eb-be00-c146302cb096-1700	\N	NEW	\N	\N	\N	\N
83091	79	D5170C00002/tiny.path.1/file-1701.pdf	\N	D5170C00002-4e9d693e-8316-11eb-be00-5f44d68499b8-1701	\N	NEW	\N	\N	\N	\N
86106	79	D5170C00002/tiny.path.1/file-4716.pdf	\N	D5170C00002-4eab12b5-8318-11eb-be00-5d3cfcc14b5c-4716	\N	NEW	\N	\N	\N	\N
87425	79	D5170C00002/tiny.path.1/file-6035.pdf	\N	D5170C00002-4ec8425c-8319-11eb-be00-716dd81d117b-6035	\N	NEW	\N	\N	\N	\N
86107	79	D5170C00002/tiny.path.1/file-4717.pdf	\N	D5170C00002-4ec8d3e6-8318-11eb-be00-4fe7d908d9f7-4717	\N	NEW	\N	\N	\N	\N
84537	79	D5170C00002/tiny.path.1/file-3147.pdf	\N	D5170C00002-4ed80b74-8317-11eb-be00-5bf6618d8598-3147	\N	NEW	\N	\N	\N	\N
86108	79	D5170C00002/tiny.path.1/file-4718.pdf	\N	D5170C00002-4eda3907-8318-11eb-be00-c5a0280f262c-4718	\N	NEW	\N	\N	\N	\N
84538	79	D5170C00002/tiny.path.1/file-3148.pdf	\N	D5170C00002-4ee88635-8317-11eb-be00-572f0ded2139-3148	\N	NEW	\N	\N	\N	\N
86109	79	D5170C00002/tiny.path.1/file-4719.pdf	\N	D5170C00002-4ef6e8c8-8318-11eb-be00-b5ecc8562c4f-4719	\N	NEW	\N	\N	\N	\N
83092	79	D5170C00002/tiny.path.1/file-1702.pdf	\N	D5170C00002-4ef7972f-8316-11eb-be00-37183ac06811-1702	\N	NEW	\N	\N	\N	\N
81721	79	D5170C00002/tiny.path.1/file-0331.pdf	\N	D5170C00002-4f07dff4-8315-11eb-be00-4343a2f0a880-331	\N	NEW	\N	\N	\N	\N
84539	79	D5170C00002/tiny.path.1/file-3149.pdf	\N	D5170C00002-4f07f516-8317-11eb-be00-db9090ee8450-3149	\N	NEW	\N	\N	\N	\N
87426	79	D5170C00002/tiny.path.1/file-6036.pdf	\N	D5170C00002-4f14b4ad-8319-11eb-be00-a10eb88a32b0-6036	\N	NEW	\N	\N	\N	\N
86110	79	D5170C00002/tiny.path.1/file-4720.pdf	\N	D5170C00002-4f14f819-8318-11eb-be00-6987932e430a-4720	\N	NEW	\N	\N	\N	\N
84540	79	D5170C00002/tiny.path.1/file-3150.pdf	\N	D5170C00002-4f16e937-8317-11eb-be00-150edbf9443e-3150	\N	NEW	\N	\N	\N	\N
86111	79	D5170C00002/tiny.path.1/file-4721.pdf	\N	D5170C00002-4f24616a-8318-11eb-be00-35d504e1faac-4721	\N	NEW	\N	\N	\N	\N
84541	79	D5170C00002/tiny.path.1/file-3151.pdf	\N	D5170C00002-4f258f38-8317-11eb-be00-eba516be8905-3151	\N	NEW	\N	\N	\N	\N
86112	79	D5170C00002/tiny.path.1/file-4722.pdf	\N	D5170C00002-4f265d3b-8318-11eb-be00-d98821f6e6b1-4722	\N	NEW	\N	\N	\N	\N
81722	79	D5170C00002/tiny.path.1/file-0332.pdf	\N	D5170C00002-4f33d1f5-8315-11eb-be00-575e5973554c-332	\N	NEW	\N	\N	\N	\N
83093	79	D5170C00002/tiny.path.1/file-1703.pdf	\N	D5170C00002-4f35d8b0-8316-11eb-be00-efe29180175e-1703	\N	NEW	\N	\N	\N	\N
86113	79	D5170C00002/tiny.path.1/file-4723.pdf	\N	D5170C00002-4f52011c-8318-11eb-be00-65b2d12d297a-4723	\N	NEW	\N	\N	\N	\N
84542	79	D5170C00002/tiny.path.1/file-3152.pdf	\N	D5170C00002-4f521d79-8317-11eb-be00-2118fd792696-3152	\N	NEW	\N	\N	\N	\N
81723	79	D5170C00002/tiny.path.1/file-0333.pdf	\N	D5170C00002-4f63e2a6-8315-11eb-be00-038e1862374e-333	\N	NEW	\N	\N	\N	\N
87427	79	D5170C00002/tiny.path.1/file-6037.pdf	\N	D5170C00002-4f70693e-8319-11eb-be00-c9af54682d87-6037	\N	NEW	\N	\N	\N	\N
83094	79	D5170C00002/tiny.path.1/file-1704.pdf	\N	D5170C00002-4f70e5e1-8316-11eb-be00-1bed76939035-1704	\N	NEW	\N	\N	\N	\N
86114	79	D5170C00002/tiny.path.1/file-4724.pdf	\N	D5170C00002-4f725a5d-8318-11eb-be00-3973d451c69e-4724	\N	NEW	\N	\N	\N	\N
84543	79	D5170C00002/tiny.path.1/file-3153.pdf	\N	D5170C00002-4f733a0a-8317-11eb-be00-f980deda7663-3153	\N	NEW	\N	\N	\N	\N
86115	79	D5170C00002/tiny.path.1/file-4725.pdf	\N	D5170C00002-4f901b8e-8318-11eb-be00-c16b3c877872-4725	\N	NEW	\N	\N	\N	\N
84544	79	D5170C00002/tiny.path.1/file-3154.pdf	\N	D5170C00002-4f9e1a9b-8317-11eb-be00-4da9dd5f5723-3154	\N	NEW	\N	\N	\N	\N
86116	79	D5170C00002/tiny.path.1/file-4726.pdf	\N	D5170C00002-4f9e4c5f-8318-11eb-be00-078efe32ec36-4726	\N	NEW	\N	\N	\N	\N
87428	79	D5170C00002/tiny.path.1/file-6038.pdf	\N	D5170C00002-4fa004bf-8319-11eb-be00-75c9eb513bbe-6038	\N	NEW	\N	\N	\N	\N
81724	79	D5170C00002/tiny.path.1/file-0334.pdf	\N	D5170C00002-4fa2c067-8315-11eb-be00-17fce9376b68-334	\N	NEW	\N	\N	\N	\N
86117	79	D5170C00002/tiny.path.1/file-4727.pdf	\N	D5170C00002-4fad6790-8318-11eb-be00-5760c7545056-4727	\N	NEW	\N	\N	\N	\N
86118	79	D5170C00002/tiny.path.1/file-4728.pdf	\N	D5170C00002-4faf1541-8318-11eb-be00-239de26320e1-4728	\N	NEW	\N	\N	\N	\N
83095	79	D5170C00002/tiny.path.1/file-1705.pdf	\N	D5170C00002-4fb05fe2-8316-11eb-be00-614ff9d113be-1705	\N	NEW	\N	\N	\N	\N
86119	79	D5170C00002/tiny.path.1/file-4729.pdf	\N	D5170C00002-4fcbc502-8318-11eb-be00-6d83997a2634-4729	\N	NEW	\N	\N	\N	\N
84545	79	D5170C00002/tiny.path.1/file-3155.pdf	\N	D5170C00002-4fccf2cc-8317-11eb-be00-a37dff051905-3155	\N	NEW	\N	\N	\N	\N
83096	79	D5170C00002/tiny.path.1/file-1706.pdf	\N	D5170C00002-4fcebd53-8316-11eb-be00-87ac2ee85bdb-1706	\N	NEW	\N	\N	\N	\N
86120	79	D5170C00002/tiny.path.1/file-4730.pdf	\N	D5170C00002-4fdb5563-8318-11eb-be00-2596acdf1a2c-4730	\N	NEW	\N	\N	\N	\N
81774	79	D5170C00002/tiny.path.1/file-0384.pdf	\N	D5170C00002-4ffaa468-8315-11eb-be00-1bccc9bb807e-335	\N	NEW	\N	\N	\N	\N
86121	79	D5170C00002/tiny.path.1/file-4731.pdf	\N	D5170C00002-4ffaeb54-8318-11eb-be00-3bc0460e7ca6-4731	\N	NEW	\N	\N	\N	\N
84546	79	D5170C00002/tiny.path.1/file-3156.pdf	\N	D5170C00002-4ffc191d-8317-11eb-be00-63c11d91a3ca-3156	\N	NEW	\N	\N	\N	\N
83097	79	D5170C00002/tiny.path.1/file-1707.pdf	\N	D5170C00002-4ffc5d04-8316-11eb-be00-176d8fc771d2-1707	\N	NEW	\N	\N	\N	\N
86122	79	D5170C00002/tiny.path.1/file-4732.pdf	\N	D5170C00002-5008f515-8318-11eb-be00-cbdece0615fd-4732	\N	NEW	\N	\N	\N	\N
87429	79	D5170C00002/tiny.path.1/file-6039.pdf	\N	D5170C00002-500a8660-8319-11eb-be00-5d766ecfaa43-6039	\N	NEW	\N	\N	\N	\N
83098	79	D5170C00002/tiny.path.1/file-1708.pdf	\N	D5170C00002-500bc655-8316-11eb-be00-7b4dcb5e4086-1708	\N	NEW	\N	\N	\N	\N
81775	79	D5170C00002/tiny.path.1/file-0385.pdf	\N	D5170C00002-501b72d9-8315-11eb-be00-151b6de04ae7-336	\N	NEW	\N	\N	\N	\N
83099	79	D5170C00002/tiny.path.1/file-1709.pdf	\N	D5170C00002-5036f506-8316-11eb-be00-c5efdb364d56-1709	\N	NEW	\N	\N	\N	\N
87430	79	D5170C00002/tiny.path.1/file-6040.pdf	\N	D5170C00002-50391071-8319-11eb-be00-07f508a87fc4-6040	\N	NEW	\N	\N	\N	\N
86123	79	D5170C00002/tiny.path.1/file-4733.pdf	\N	D5170C00002-503953e6-8318-11eb-be00-47b844f087c9-4733	\N	NEW	\N	\N	\N	\N
84547	79	D5170C00002/tiny.path.1/file-3157.pdf	\N	D5170C00002-5046417e-8317-11eb-be00-49ea57ae0c7f-3157	\N	NEW	\N	\N	\N	\N
86124	79	D5170C00002/tiny.path.1/file-4734.pdf	\N	D5170C00002-5047abc7-8318-11eb-be00-dbecc7d1d81c-4734	\N	NEW	\N	\N	\N	\N
86125	79	D5170C00002/tiny.path.1/file-4735.pdf	\N	D5170C00002-5055b588-8318-11eb-be00-71e4b970a5bf-4735	\N	NEW	\N	\N	\N	\N
83100	79	D5170C00002/tiny.path.1/file-1710.pdf	\N	D5170C00002-5055c7a7-8316-11eb-be00-67e106855467-1710	\N	NEW	\N	\N	\N	\N
83101	79	D5170C00002/tiny.path.1/file-1711.pdf	\N	D5170C00002-505838a8-8316-11eb-be00-99ce5d3711db-1711	\N	NEW	\N	\N	\N	\N
83102	79	D5170C00002/tiny.path.1/file-1712.pdf	\N	D5170C00002-5074c159-8316-11eb-be00-c17c6ad2d274-1712	\N	NEW	\N	\N	\N	\N
81776	79	D5170C00002/tiny.path.1/file-0386.pdf	\N	D5170C00002-50841fba-8315-11eb-be00-778eb965edc5-337	\N	NEW	\N	\N	\N	\N
86126	79	D5170C00002/tiny.path.1/file-4736.pdf	\N	D5170C00002-50857819-8318-11eb-be00-09858493e3e6-4736	\N	NEW	\N	\N	\N	\N
87431	79	D5170C00002/tiny.path.1/file-6041.pdf	\N	D5170C00002-50933e62-8319-11eb-be00-c184234c273c-6041	\N	NEW	\N	\N	\N	\N
83103	79	D5170C00002/tiny.path.1/file-1713.pdf	\N	D5170C00002-509345da-8316-11eb-be00-f1048c56d66d-1713	\N	NEW	\N	\N	\N	\N
84548	79	D5170C00002/tiny.path.1/file-3158.pdf	\N	D5170C00002-50b249bf-8317-11eb-be00-23988fb3c602-3158	\N	NEW	\N	\N	\N	\N
81725	79	D5170C00002/tiny.path.1/file-0335.pdf	\N	D5170C00002-50c03e5b-8315-11eb-be00-b9dfae39065e-338	\N	NEW	\N	\N	\N	\N
86127	79	D5170C00002/tiny.path.1/file-4737.pdf	\N	D5170C00002-50d0b1ea-8318-11eb-be00-23c26826d9c2-4737	\N	NEW	\N	\N	\N	\N
84549	79	D5170C00002/tiny.path.1/file-3159.pdf	\N	D5170C00002-50dfc260-8317-11eb-be00-d3f4d0ad29ff-3159	\N	NEW	\N	\N	\N	\N
86128	79	D5170C00002/tiny.path.1/file-4738.pdf	\N	D5170C00002-50ee24fb-8318-11eb-be00-25133c5ef8ef-4738	\N	NEW	\N	\N	\N	\N
87432	79	D5170C00002/tiny.path.1/file-6042.pdf	\N	D5170C00002-50ee7dc3-8319-11eb-be00-af64dabc31d9-6042	\N	NEW	\N	\N	\N	\N
81726	79	D5170C00002/tiny.path.1/file-0336.pdf	\N	D5170C00002-50f0c43c-8315-11eb-be00-27a889337345-339	\N	NEW	\N	\N	\N	\N
86129	79	D5170C00002/tiny.path.1/file-4739.pdf	\N	D5170C00002-50fd673c-8318-11eb-be00-27795433f60b-4739	\N	NEW	\N	\N	\N	\N
84550	79	D5170C00002/tiny.path.1/file-3160.pdf	\N	D5170C00002-50fe6df1-8317-11eb-be00-e305a467349f-3160	\N	NEW	\N	\N	\N	\N
86130	79	D5170C00002/tiny.path.1/file-4740.pdf	\N	D5170C00002-50ff8a1d-8318-11eb-be00-37db722f6f59-4740	\N	NEW	\N	\N	\N	\N
81727	79	D5170C00002/tiny.path.1/file-0337.pdf	\N	D5170C00002-510ed38d-8315-11eb-be00-71c7d13f08d6-340	\N	NEW	\N	\N	\N	\N
86131	79	D5170C00002/tiny.path.1/file-4741.pdf	\N	D5170C00002-511de78e-8318-11eb-be00-8f38d7b732f0-4741	\N	NEW	\N	\N	\N	\N
84551	79	D5170C00002/tiny.path.1/file-3161.pdf	\N	D5170C00002-511e2af2-8317-11eb-be00-3fcf4a084024-3161	\N	NEW	\N	\N	\N	\N
86132	79	D5170C00002/tiny.path.1/file-4742.pdf	\N	D5170C00002-512d02bf-8318-11eb-be00-454b42863de4-4742	\N	NEW	\N	\N	\N	\N
86133	79	D5170C00002/tiny.path.1/file-4743.pdf	\N	D5170C00002-513bcfd0-8318-11eb-be00-8127435e431d-4743	\N	NEW	\N	\N	\N	\N
81728	79	D5170C00002/tiny.path.1/file-0338.pdf	\N	D5170C00002-513c251e-8315-11eb-be00-9b6b86e69649-341	\N	NEW	\N	\N	\N	\N
87433	79	D5170C00002/tiny.path.1/file-6043.pdf	\N	D5170C00002-514b6ad4-8319-11eb-be00-f9598e3fd023-6043	\N	NEW	\N	\N	\N	\N
86134	79	D5170C00002/tiny.path.1/file-4744.pdf	\N	D5170C00002-5158cdb1-8318-11eb-be00-4f32d3ab53d9-4744	\N	NEW	\N	\N	\N	\N
86135	79	D5170C00002/tiny.path.1/file-4745.pdf	\N	D5170C00002-51680ff2-8318-11eb-be00-a5badcd75a84-4745	\N	NEW	\N	\N	\N	\N
81729	79	D5170C00002/tiny.path.1/file-0339.pdf	\N	D5170C00002-516a39ff-8315-11eb-be00-938c21516735-342	\N	NEW	\N	\N	\N	\N
86136	79	D5170C00002/tiny.path.1/file-4746.pdf	\N	D5170C00002-51777943-8318-11eb-be00-01369aed4882-4746	\N	NEW	\N	\N	\N	\N
81730	79	D5170C00002/tiny.path.1/file-0340.pdf	\N	D5170C00002-51786ad0-8315-11eb-be00-058da077a587-343	\N	NEW	\N	\N	\N	\N
86137	79	D5170C00002/tiny.path.1/file-4747.pdf	\N	D5170C00002-5178d8d4-8318-11eb-be00-71d8542d0a0d-4747	\N	NEW	\N	\N	\N	\N
87434	79	D5170C00002/tiny.path.1/file-6044.pdf	\N	D5170C00002-5186ed35-8319-11eb-be00-430cc1826467-6044	\N	NEW	\N	\N	\N	\N
86138	79	D5170C00002/tiny.path.1/file-4748.pdf	\N	D5170C00002-518757c5-8318-11eb-be00-29b23e4fd6c5-4748	\N	NEW	\N	\N	\N	\N
84552	79	D5170C00002/tiny.path.1/file-3162.pdf	\N	D5170C00002-5195cbf3-8317-11eb-be00-3f9d347ed347-3162	\N	NEW	\N	\N	\N	\N
81731	79	D5170C00002/tiny.path.1/file-0341.pdf	\N	D5170C00002-5196c841-8315-11eb-be00-f938fe6d52bc-344	\N	NEW	\N	\N	\N	\N
81732	79	D5170C00002/tiny.path.1/file-0342.pdf	\N	D5170C00002-51b46262-8315-11eb-be00-2d13d93e33f1-345	\N	NEW	\N	\N	\N	\N
84553	79	D5170C00002/tiny.path.1/file-3163.pdf	\N	D5170C00002-51b6e884-8317-11eb-be00-67dac3cb82ae-3163	\N	NEW	\N	\N	\N	\N
87435	79	D5170C00002/tiny.path.1/file-6045.pdf	\N	D5170C00002-51d33876-8319-11eb-be00-69868e402b2f-6045	\N	NEW	\N	\N	\N	\N
84554	79	D5170C00002/tiny.path.1/file-3164.pdf	\N	D5170C00002-51d3bf55-8317-11eb-be00-fdacd9bc6676-3164	\N	NEW	\N	\N	\N	\N
81733	79	D5170C00002/tiny.path.1/file-0343.pdf	\N	D5170C00002-51e25033-8315-11eb-be00-33dc046ef5ca-346	\N	NEW	\N	\N	\N	\N
81734	79	D5170C00002/tiny.path.1/file-0344.pdf	\N	D5170C00002-5200d4b4-8315-11eb-be00-692f80546aa4-347	\N	NEW	\N	\N	\N	\N
81735	79	D5170C00002/tiny.path.1/file-0345.pdf	\N	D5170C00002-52036cc5-8315-11eb-be00-7732a061d8ef-348	\N	NEW	\N	\N	\N	\N
81736	79	D5170C00002/tiny.path.1/file-0346.pdf	\N	D5170C00002-521f8046-8315-11eb-be00-f5827701be12-349	\N	NEW	\N	\N	\N	\N
81737	79	D5170C00002/tiny.path.1/file-0347.pdf	\N	D5170C00002-52307037-8315-11eb-be00-df1486bc0bf7-350	\N	NEW	\N	\N	\N	\N
81738	79	D5170C00002/tiny.path.1/file-0348.pdf	\N	D5170C00002-524ea698-8315-11eb-be00-87078b118448-351	\N	NEW	\N	\N	\N	\N
84555	79	D5170C00002/tiny.path.1/file-3165.pdf	\N	D5170C00002-524ff436-8317-11eb-be00-9f60593fe08d-3165	\N	NEW	\N	\N	\N	\N
87436	79	D5170C00002/tiny.path.1/file-6046.pdf	\N	D5170C00002-526c4427-8319-11eb-be00-356a799f5576-6046	\N	NEW	\N	\N	\N	\N
86139	79	D5170C00002/tiny.path.1/file-4749.pdf	\N	D5170C00002-527ab876-8318-11eb-be00-9798a79e7ee7-4749	\N	NEW	\N	\N	\N	\N
81739	79	D5170C00002/tiny.path.1/file-0349.pdf	\N	D5170C00002-527abfa9-8315-11eb-be00-4f1664a1a7bc-352	\N	NEW	\N	\N	\N	\N
84556	79	D5170C00002/tiny.path.1/file-3166.pdf	\N	D5170C00002-527b9817-8317-11eb-be00-ffaee332f9a1-3166	\N	NEW	\N	\N	\N	\N
83104	79	D5170C00002/tiny.path.1/file-1714.pdf	\N	D5170C00002-528b454b-8316-11eb-be00-95ac47d9cc93-1714	\N	NEW	\N	\N	\N	\N
87437	79	D5170C00002/tiny.path.1/file-6047.pdf	\N	D5170C00002-528c7658-8319-11eb-be00-03933735d2e9-6047	\N	NEW	\N	\N	\N	\N
84557	79	D5170C00002/tiny.path.1/file-3167.pdf	\N	D5170C00002-529a43a8-8317-11eb-be00-dd69e4394fed-3167	\N	NEW	\N	\N	\N	\N
83105	79	D5170C00002/tiny.path.1/file-1715.pdf	\N	D5170C00002-529ad5ac-8316-11eb-be00-1be988bbef8d-1715	\N	NEW	\N	\N	\N	\N
86140	79	D5170C00002/tiny.path.1/file-4750.pdf	\N	D5170C00002-52a990a7-8318-11eb-be00-c588705339bf-4750	\N	NEW	\N	\N	\N	\N
87438	79	D5170C00002/tiny.path.1/file-6048.pdf	\N	D5170C00002-52b8dd89-8319-11eb-be00-2f34ad362f17-6048	\N	NEW	\N	\N	\N	\N
84558	79	D5170C00002/tiny.path.1/file-3168.pdf	\N	D5170C00002-52ba75d9-8317-11eb-be00-753583e908b6-3168	\N	NEW	\N	\N	\N	\N
81740	79	D5170C00002/tiny.path.1/file-0350.pdf	\N	D5170C00002-52c7590a-8315-11eb-be00-a33e83fb8e12-353	\N	NEW	\N	\N	\N	\N
86141	79	D5170C00002/tiny.path.1/file-4751.pdf	\N	D5170C00002-52c86348-8318-11eb-be00-b70b8324454a-4751	\N	NEW	\N	\N	\N	\N
87439	79	D5170C00002/tiny.path.1/file-6049.pdf	\N	D5170C00002-52d7b02a-8319-11eb-be00-13fb4c33329a-6049	\N	NEW	\N	\N	\N	\N
84559	79	D5170C00002/tiny.path.1/file-3169.pdf	\N	D5170C00002-52d7c1da-8317-11eb-be00-1b86a1c982d7-3169	\N	NEW	\N	\N	\N	\N
86142	79	D5170C00002/tiny.path.1/file-4752.pdf	\N	D5170C00002-52d88fe9-8318-11eb-be00-39c220aa5c09-4752	\N	NEW	\N	\N	\N	\N
83106	79	D5170C00002/tiny.path.1/file-1716.pdf	\N	D5170C00002-52d9172d-8316-11eb-be00-61833ccff96f-1716	\N	NEW	\N	\N	\N	\N
84560	79	D5170C00002/tiny.path.1/file-3170.pdf	\N	D5170C00002-52e7ee7b-8317-11eb-be00-2b6a33f274ec-3170	\N	NEW	\N	\N	\N	\N
87440	79	D5170C00002/tiny.path.1/file-6050.pdf	\N	D5170C00002-52f5e68b-8319-11eb-be00-57e9fcd8cbec-6050	\N	NEW	\N	\N	\N	\N
87441	79	D5170C00002/tiny.path.1/file-6051.pdf	\N	D5170C00002-5303c93c-8319-11eb-be00-4f248a99396f-6051	\N	NEW	\N	\N	\N	\N
81741	79	D5170C00002/tiny.path.1/file-0351.pdf	\N	D5170C00002-5304b02b-8315-11eb-be00-b54ba508db70-354	\N	NEW	\N	\N	\N	\N
83107	79	D5170C00002/tiny.path.1/file-1717.pdf	\N	D5170C00002-5313d63e-8316-11eb-be00-8b0b4b3eeff6-1717	\N	NEW	\N	\N	\N	\N
81742	79	D5170C00002/tiny.path.1/file-0352.pdf	\N	D5170C00002-53152aec-8315-11eb-be00-5187d5405f5c-355	\N	NEW	\N	\N	\N	\N
87442	79	D5170C00002/tiny.path.1/file-6052.pdf	\N	D5170C00002-5315ca9d-8319-11eb-be00-1b4d7d0a7093-6052	\N	NEW	\N	\N	\N	\N
84561	79	D5170C00002/tiny.path.1/file-3171.pdf	\N	D5170C00002-53162a6c-8317-11eb-be00-a94660f777a2-3171	\N	NEW	\N	\N	\N	\N
87443	79	D5170C00002/tiny.path.1/file-6053.pdf	\N	D5170C00002-532497ae-8319-11eb-be00-1121dfea1496-6053	\N	NEW	\N	\N	\N	\N
81743	79	D5170C00002/tiny.path.1/file-0353.pdf	\N	D5170C00002-5333fd8d-8315-11eb-be00-f17dfae16235-356	\N	NEW	\N	\N	\N	\N
84562	79	D5170C00002/tiny.path.1/file-3172.pdf	\N	D5170C00002-5341591d-8317-11eb-be00-9999f572b266-3172	\N	NEW	\N	\N	\N	\N
87444	79	D5170C00002/tiny.path.1/file-6054.pdf	\N	D5170C00002-53416e7f-8319-11eb-be00-ef9302d13132-6054	\N	NEW	\N	\N	\N	\N
86143	79	D5170C00002/tiny.path.1/file-4753.pdf	\N	D5170C00002-5351425a-8318-11eb-be00-a3ff25c54da6-4753	\N	NEW	\N	\N	\N	\N
87445	79	D5170C00002/tiny.path.1/file-6055.pdf	\N	D5170C00002-53519b20-8319-11eb-be00-2dda294ad7fe-6055	\N	NEW	\N	\N	\N	\N
81744	79	D5170C00002/tiny.path.1/file-0354.pdf	\N	D5170C00002-5351bebe-8315-11eb-be00-d14ad07ee1a9-357	\N	NEW	\N	\N	\N	\N
84563	79	D5170C00002/tiny.path.1/file-3173.pdf	\N	D5170C00002-53624e9e-8317-11eb-be00-ff5ceac85cf3-3173	\N	NEW	\N	\N	\N	\N
83108	79	D5170C00002/tiny.path.1/file-1718.pdf	\N	D5170C00002-537222df-8316-11eb-be00-7fd6e1898be6-1718	\N	NEW	\N	\N	\N	\N
84564	79	D5170C00002/tiny.path.1/file-3174.pdf	\N	D5170C00002-538e67af-8317-11eb-be00-d3b1e1ca6ded-3174	\N	NEW	\N	\N	\N	\N
81745	79	D5170C00002/tiny.path.1/file-0355.pdf	\N	D5170C00002-538eeecf-8315-11eb-be00-715fbcf36f0d-358	\N	NEW	\N	\N	\N	\N
87446	79	D5170C00002/tiny.path.1/file-6056.pdf	\N	D5170C00002-539051d1-8319-11eb-be00-e72009f71711-6056	\N	NEW	\N	\N	\N	\N
83109	79	D5170C00002/tiny.path.1/file-1719.pdf	\N	D5170C00002-539e14e0-8316-11eb-be00-19b110160349-1719	\N	NEW	\N	\N	\N	\N
87447	79	D5170C00002/tiny.path.1/file-6057.pdf	\N	D5170C00002-53ac3e42-8319-11eb-be00-53b95dd9718d-6057	\N	NEW	\N	\N	\N	\N
81746	79	D5170C00002/tiny.path.1/file-0356.pdf	\N	D5170C00002-53acfe20-8315-11eb-be00-870b5bf90165-359	\N	NEW	\N	\N	\N	\N
87448	79	D5170C00002/tiny.path.1/file-6058.pdf	\N	D5170C00002-53bb8083-8319-11eb-be00-39c7af14e9f3-6058	\N	NEW	\N	\N	\N	\N
81747	79	D5170C00002/tiny.path.1/file-0357.pdf	\N	D5170C00002-53cabf51-8315-11eb-be00-8d1538bb5b62-360	\N	NEW	\N	\N	\N	\N
87449	79	D5170C00002/tiny.path.1/file-6059.pdf	\N	D5170C00002-53cb37f4-8319-11eb-be00-374e1231317a-6059	\N	NEW	\N	\N	\N	\N
87450	79	D5170C00002/tiny.path.1/file-6060.pdf	\N	D5170C00002-53d968c5-8319-11eb-be00-d19084743a2d-6060	\N	NEW	\N	\N	\N	\N
84565	79	D5170C00002/tiny.path.1/file-3175.pdf	\N	D5170C00002-53db0110-8317-11eb-be00-1d5168e6b290-3175	\N	NEW	\N	\N	\N	\N
87451	79	D5170C00002/tiny.path.1/file-6061.pdf	\N	D5170C00002-53e8f926-8319-11eb-be00-297a3dda92c0-6061	\N	NEW	\N	\N	\N	\N
81748	79	D5170C00002/tiny.path.1/file-0358.pdf	\N	D5170C00002-53eaa362-8315-11eb-be00-5dcc80d1ee14-361	\N	NEW	\N	\N	\N	\N
87452	79	D5170C00002/tiny.path.1/file-6062.pdf	\N	D5170C00002-54092b57-8319-11eb-be00-85fb00e990cf-6062	\N	NEW	\N	\N	\N	\N
84566	79	D5170C00002/tiny.path.1/file-3176.pdf	\N	D5170C00002-54180a11-8317-11eb-be00-852d65009199-3176	\N	NEW	\N	\N	\N	\N
84567	79	D5170C00002/tiny.path.1/file-3177.pdf	\N	D5170C00002-54280fa2-8317-11eb-be00-d5ae048b072d-3177	\N	NEW	\N	\N	\N	\N
83110	79	D5170C00002/tiny.path.1/file-1720.pdf	\N	D5170C00002-54354bd1-8316-11eb-be00-25c3bdefe732-1720	\N	NEW	\N	\N	\N	\N
84568	79	D5170C00002/tiny.path.1/file-3178.pdf	\N	D5170C00002-54361963-8317-11eb-be00-c566c8dd620b-3178	\N	NEW	\N	\N	\N	\N
81749	79	D5170C00002/tiny.path.1/file-0359.pdf	\N	D5170C00002-54367973-8315-11eb-be00-b7fd090a740d-362	\N	NEW	\N	\N	\N	\N
87453	79	D5170C00002/tiny.path.1/file-6063.pdf	\N	D5170C00002-5443ea68-8319-11eb-be00-f3cfb975daf5-6063	\N	NEW	\N	\N	\N	\N
87454	79	D5170C00002/tiny.path.1/file-6064.pdf	\N	D5170C00002-54460d49-8319-11eb-be00-955cb734ff93-6064	\N	NEW	\N	\N	\N	\N
84569	79	D5170C00002/tiny.path.1/file-3179.pdf	\N	D5170C00002-5455d664-8317-11eb-be00-9388d46b67ba-3179	\N	NEW	\N	\N	\N	\N
83111	79	D5170C00002/tiny.path.1/file-1721.pdf	\N	D5170C00002-546339a2-8316-11eb-be00-6167bedafa42-1721	\N	NEW	\N	\N	\N	\N
84570	79	D5170C00002/tiny.path.1/file-3180.pdf	\N	D5170C00002-5464a375-8317-11eb-be00-e5af054db613-3180	\N	NEW	\N	\N	\N	\N
87455	79	D5170C00002/tiny.path.1/file-6065.pdf	\N	D5170C00002-5465551a-8319-11eb-be00-3d14e2b61491-6065	\N	NEW	\N	\N	\N	\N
83112	79	D5170C00002/tiny.path.1/file-1722.pdf	\N	D5170C00002-5472f113-8316-11eb-be00-f9704928adec-1722	\N	NEW	\N	\N	\N	\N
84571	79	D5170C00002/tiny.path.1/file-3181.pdf	\N	D5170C00002-54745ae6-8317-11eb-be00-e18c7e5e0b77-3181	\N	NEW	\N	\N	\N	\N
81750	79	D5170C00002/tiny.path.1/file-0360.pdf	\N	D5170C00002-54753024-8315-11eb-be00-3578fb5b153a-363	\N	NEW	\N	\N	\N	\N
83113	79	D5170C00002/tiny.path.1/file-1723.pdf	\N	D5170C00002-54828174-8316-11eb-be00-d5c17f18c3be-1723	\N	NEW	\N	\N	\N	\N
87481	79	D5170C00002/tiny.path.1/file-6091.pdf	\N	D5170C00002-549083cb-8319-11eb-be00-e18fe6a22dab-6066	\N	NEW	\N	\N	\N	\N
81751	79	D5170C00002/tiny.path.1/file-0361.pdf	\N	D5170C00002-5490f585-8315-11eb-be00-bf08207bb5fe-364	\N	NEW	\N	\N	\N	\N
84572	79	D5170C00002/tiny.path.1/file-3182.pdf	\N	D5170C00002-54a073f7-8317-11eb-be00-037ccc0d9430-3182	\N	NEW	\N	\N	\N	\N
83191	79	D5170C00002/tiny.path.1/file-1801.pdf	\N	D5170C00002-54a1f055-8316-11eb-be00-9757104ea96b-1724	\N	NEW	\N	\N	\N	\N
87482	79	D5170C00002/tiny.path.1/file-6092.pdf	\N	D5170C00002-54aee13c-8319-11eb-be00-27c53a62641a-6067	\N	NEW	\N	\N	\N	\N
84573	79	D5170C00002/tiny.path.1/file-3183.pdf	\N	D5170C00002-54b0eeb8-8317-11eb-be00-1b0364ce8c65-3183	\N	NEW	\N	\N	\N	\N
81752	79	D5170C00002/tiny.path.1/file-0362.pdf	\N	D5170C00002-54b175d6-8315-11eb-be00-ebdebf738395-365	\N	NEW	\N	\N	\N	\N
87483	79	D5170C00002/tiny.path.1/file-6093.pdf	\N	D5170C00002-54ce772d-8319-11eb-be00-79a9a7df629e-6068	\N	NEW	\N	\N	\N	\N
83192	79	D5170C00002/tiny.path.1/file-1802.pdf	\N	D5170C00002-54ceccb6-8316-11eb-be00-6f1ef76a5ad5-1725	\N	NEW	\N	\N	\N	\N
84574	79	D5170C00002/tiny.path.1/file-3184.pdf	\N	D5170C00002-54ced6f9-8317-11eb-be00-f5de9717d4b9-3184	\N	NEW	\N	\N	\N	\N
81753	79	D5170C00002/tiny.path.1/file-0363.pdf	\N	D5170C00002-54cfac37-8315-11eb-be00-0b33cd30bdef-366	\N	NEW	\N	\N	\N	\N
86144	79	D5170C00002/tiny.path.1/file-4754.pdf	\N	D5170C00002-54dd609b-8318-11eb-be00-b704f2a1d7a8-4754	\N	NEW	\N	\N	\N	\N
83193	79	D5170C00002/tiny.path.1/file-1803.pdf	\N	D5170C00002-54ecb4f7-8316-11eb-be00-e15bbb11460d-1726	\N	NEW	\N	\N	\N	\N
84575	79	D5170C00002/tiny.path.1/file-3185.pdf	\N	D5170C00002-54ed828a-8317-11eb-be00-4bef3c4d49a4-3185	\N	NEW	\N	\N	\N	\N
81754	79	D5170C00002/tiny.path.1/file-0364.pdf	\N	D5170C00002-54fbec58-8315-11eb-be00-853666df8db6-367	\N	NEW	\N	\N	\N	\N
87456	79	D5170C00002/tiny.path.1/file-6066.pdf	\N	D5170C00002-550a95ce-8319-11eb-be00-699628408b84-6069	\N	NEW	\N	\N	\N	\N
83194	79	D5170C00002/tiny.path.1/file-1804.pdf	\N	D5170C00002-550b6088-8316-11eb-be00-2d4b442d6277-1727	\N	NEW	\N	\N	\N	\N
84576	79	D5170C00002/tiny.path.1/file-3186.pdf	\N	D5170C00002-551afb2b-8317-11eb-be00-6b7b72906cfb-3186	\N	NEW	\N	\N	\N	\N
86145	79	D5170C00002/tiny.path.1/file-4755.pdf	\N	D5170C00002-551b05dc-8318-11eb-be00-87c0736d21af-4755	\N	NEW	\N	\N	\N	\N
87457	79	D5170C00002/tiny.path.1/file-6067.pdf	\N	D5170C00002-551b379f-8319-11eb-be00-2b1cd23890bd-6070	\N	NEW	\N	\N	\N	\N
81755	79	D5170C00002/tiny.path.1/file-0365.pdf	\N	D5170C00002-552b87d9-8315-11eb-be00-37394cbc036d-368	\N	NEW	\N	\N	\N	\N
83195	79	D5170C00002/tiny.path.1/file-1805.pdf	\N	D5170C00002-5539ea99-8316-11eb-be00-85c1af8b9c2a-1728	\N	NEW	\N	\N	\N	\N
87458	79	D5170C00002/tiny.path.1/file-6068.pdf	\N	D5170C00002-553af4a0-8319-11eb-be00-a5bad1101f29-6071	\N	NEW	\N	\N	\N	\N
87459	79	D5170C00002/tiny.path.1/file-6069.pdf	\N	D5170C00002-55581991-8319-11eb-be00-d53c1d0f6110-6072	\N	NEW	\N	\N	\N	\N
86146	79	D5170C00002/tiny.path.1/file-4756.pdf	\N	D5170C00002-5558ab1d-8318-11eb-be00-99bc213251aa-4756	\N	NEW	\N	\N	\N	\N
84577	79	D5170C00002/tiny.path.1/file-3187.pdf	\N	D5170C00002-5559b1dc-8317-11eb-be00-699fb16babd5-3187	\N	NEW	\N	\N	\N	\N
83196	79	D5170C00002/tiny.path.1/file-1806.pdf	\N	D5170C00002-555a6aea-8316-11eb-be00-83a130d42bec-1729	\N	NEW	\N	\N	\N	\N
81756	79	D5170C00002/tiny.path.1/file-0366.pdf	\N	D5170C00002-5566950a-8315-11eb-be00-493a0cb3b6b8-369	\N	NEW	\N	\N	\N	\N
87460	79	D5170C00002/tiny.path.1/file-6070.pdf	\N	D5170C00002-55756592-8319-11eb-be00-4be2246a6311-6073	\N	NEW	\N	\N	\N	\N
81757	79	D5170C00002/tiny.path.1/file-0367.pdf	\N	D5170C00002-5575b03b-8315-11eb-be00-659e8f965746-370	\N	NEW	\N	\N	\N	\N
84578	79	D5170C00002/tiny.path.1/file-3188.pdf	\N	D5170C00002-5577c12d-8317-11eb-be00-e5fb30c67e3c-3188	\N	NEW	\N	\N	\N	\N
81758	79	D5170C00002/tiny.path.1/file-0368.pdf	\N	D5170C00002-5584f27c-8315-11eb-be00-294201a3c8db-371	\N	NEW	\N	\N	\N	\N
86147	79	D5170C00002/tiny.path.1/file-4757.pdf	\N	D5170C00002-5585fcae-8318-11eb-be00-7db627c08d09-4757	\N	NEW	\N	\N	\N	\N
87461	79	D5170C00002/tiny.path.1/file-6071.pdf	\N	D5170C00002-5586cab3-8319-11eb-be00-c9632cf22228-6074	\N	NEW	\N	\N	\N	\N
81759	79	D5170C00002/tiny.path.1/file-0369.pdf	\N	D5170C00002-5586ee4d-8315-11eb-be00-a5ec52163c2e-372	\N	NEW	\N	\N	\N	\N
84579	79	D5170C00002/tiny.path.1/file-3189.pdf	\N	D5170C00002-559470ee-8317-11eb-be00-272eeaa4f3ea-3189	\N	NEW	\N	\N	\N	\N
81760	79	D5170C00002/tiny.path.1/file-0370.pdf	\N	D5170C00002-55a3ec2e-8315-11eb-be00-d7709d478cb3-373	\N	NEW	\N	\N	\N	\N
86148	79	D5170C00002/tiny.path.1/file-4758.pdf	\N	D5170C00002-55a4330f-8318-11eb-be00-4730d337baf2-4758	\N	NEW	\N	\N	\N	\N
84580	79	D5170C00002/tiny.path.1/file-3190.pdf	\N	D5170C00002-55a539cf-8317-11eb-be00-9f9e1c2d5edd-3190	\N	NEW	\N	\N	\N	\N
87462	79	D5170C00002/tiny.path.1/file-6072.pdf	\N	D5170C00002-55b358f4-8319-11eb-be00-03cc13eaa49f-6075	\N	NEW	\N	\N	\N	\N
81761	79	D5170C00002/tiny.path.1/file-0371.pdf	\N	D5170C00002-55b3caaf-8315-11eb-be00-4d5a23634549-374	\N	NEW	\N	\N	\N	\N
86149	79	D5170C00002/tiny.path.1/file-4759.pdf	\N	D5170C00002-55c46540-8318-11eb-be00-89bd149d9133-4759	\N	NEW	\N	\N	\N	\N
84581	79	D5170C00002/tiny.path.1/file-3191.pdf	\N	D5170C00002-55c4a8b0-8317-11eb-be00-57594f37a94c-3191	\N	NEW	\N	\N	\N	\N
87463	79	D5170C00002/tiny.path.1/file-6073.pdf	\N	D5170C00002-55d22b95-8319-11eb-be00-bf7b26414c2b-6076	\N	NEW	\N	\N	\N	\N
81762	79	D5170C00002/tiny.path.1/file-0372.pdf	\N	D5170C00002-55d33990-8315-11eb-be00-395ba1dda512-375	\N	NEW	\N	\N	\N	\N
87464	79	D5170C00002/tiny.path.1/file-6074.pdf	\N	D5170C00002-55ef5086-8319-11eb-be00-99fdb5a17cf5-6077	\N	NEW	\N	\N	\N	\N
81763	79	D5170C00002/tiny.path.1/file-0373.pdf	\N	D5170C00002-55f05e81-8315-11eb-be00-a781d730ddd2-376	\N	NEW	\N	\N	\N	\N
86150	79	D5170C00002/tiny.path.1/file-4760.pdf	\N	D5170C00002-56005cd1-8318-11eb-be00-2d5d44c2b6f9-4760	\N	NEW	\N	\N	\N	\N
81764	79	D5170C00002/tiny.path.1/file-0374.pdf	\N	D5170C00002-5600b232-8315-11eb-be00-67b9e7a26789-377	\N	NEW	\N	\N	\N	\N
83114	79	D5170C00002/tiny.path.1/file-1724.pdf	\N	D5170C00002-560e9fbb-8316-11eb-be00-39e1b5e18ac4-1730	\N	NEW	\N	\N	\N	\N
81765	79	D5170C00002/tiny.path.1/file-0375.pdf	\N	D5170C00002-560ee303-8315-11eb-be00-9773bc942c3d-378	\N	NEW	\N	\N	\N	\N
84582	79	D5170C00002/tiny.path.1/file-3192.pdf	\N	D5170C00002-56116921-8317-11eb-be00-d3c5805391b9-3192	\N	NEW	\N	\N	\N	\N
87465	79	D5170C00002/tiny.path.1/file-6075.pdf	\N	D5170C00002-561cf037-8319-11eb-be00-85c027beff62-6078	\N	NEW	\N	\N	\N	\N
81766	79	D5170C00002/tiny.path.1/file-0376.pdf	\N	D5170C00002-561ec184-8315-11eb-be00-ad182caa64d4-379	\N	NEW	\N	\N	\N	\N
84583	79	D5170C00002/tiny.path.1/file-3193.pdf	\N	D5170C00002-562d2e82-8317-11eb-be00-9f67ca70f96f-3193	\N	NEW	\N	\N	\N	\N
86151	79	D5170C00002/tiny.path.1/file-4761.pdf	\N	D5170C00002-562e4aa2-8318-11eb-be00-8d00816bd08d-4761	\N	NEW	\N	\N	\N	\N
84584	79	D5170C00002/tiny.path.1/file-3194.pdf	\N	D5170C00002-563c97d3-8317-11eb-be00-c573c12993d1-3194	\N	NEW	\N	\N	\N	\N
83115	79	D5170C00002/tiny.path.1/file-1725.pdf	\N	D5170C00002-563d77ec-8316-11eb-be00-a57b5b041b80-1731	\N	NEW	\N	\N	\N	\N
84585	79	D5170C00002/tiny.path.1/file-3195.pdf	\N	D5170C00002-563f2fe4-8317-11eb-be00-37c269216826-3195	\N	NEW	\N	\N	\N	\N
87466	79	D5170C00002/tiny.path.1/file-6076.pdf	\N	D5170C00002-564ade08-8319-11eb-be00-f998ca458f83-6079	\N	NEW	\N	\N	\N	\N
81767	79	D5170C00002/tiny.path.1/file-0377.pdf	\N	D5170C00002-564b9de5-8315-11eb-be00-4bc9689cfb0a-380	\N	NEW	\N	\N	\N	\N
86152	79	D5170C00002/tiny.path.1/file-4762.pdf	\N	D5170C00002-565bea53-8318-11eb-be00-b1c7c5644b11-4762	\N	NEW	\N	\N	\N	\N
87467	79	D5170C00002/tiny.path.1/file-6077.pdf	\N	D5170C00002-565bf509-8319-11eb-be00-bdc7b3f94062-6080	\N	NEW	\N	\N	\N	\N
83116	79	D5170C00002/tiny.path.1/file-1726.pdf	\N	D5170C00002-566b65bd-8316-11eb-be00-7f46b9bed1b0-1732	\N	NEW	\N	\N	\N	\N
87468	79	D5170C00002/tiny.path.1/file-6078.pdf	\N	D5170C00002-5678f2ea-8319-11eb-be00-7fc0f6f2a7ac-6081	\N	NEW	\N	\N	\N	\N
81768	79	D5170C00002/tiny.path.1/file-0378.pdf	\N	D5170C00002-56793d96-8315-11eb-be00-53cabe0cf8c5-381	\N	NEW	\N	\N	\N	\N
84586	79	D5170C00002/tiny.path.1/file-3196.pdf	\N	D5170C00002-567ab245-8317-11eb-be00-15fc049bebda-3196	\N	NEW	\N	\N	\N	\N
81769	79	D5170C00002/tiny.path.1/file-0379.pdf	\N	D5170C00002-568a5497-8315-11eb-be00-d5119adf0c79-382	\N	NEW	\N	\N	\N	\N
83117	79	D5170C00002/tiny.path.1/file-1727.pdf	\N	D5170C00002-568a867e-8316-11eb-be00-71faab803b26-1733	\N	NEW	\N	\N	\N	\N
87469	79	D5170C00002/tiny.path.1/file-6079.pdf	\N	D5170C00002-56a6447b-8319-11eb-be00-6d635079c0d3-6082	\N	NEW	\N	\N	\N	\N
84587	79	D5170C00002/tiny.path.1/file-3197.pdf	\N	D5170C00002-56a6f266-8317-11eb-be00-713b8e314ec6-3197	\N	NEW	\N	\N	\N	\N
81770	79	D5170C00002/tiny.path.1/file-0380.pdf	\N	D5170C00002-56a72b68-8315-11eb-be00-6725d77378da-383	\N	NEW	\N	\N	\N	\N
83118	79	D5170C00002/tiny.path.1/file-1728.pdf	\N	D5170C00002-56a90aff-8316-11eb-be00-712e61dc884d-1734	\N	NEW	\N	\N	\N	\N
84588	79	D5170C00002/tiny.path.1/file-3198.pdf	\N	D5170C00002-56b7bb47-8317-11eb-be00-8106f4b52edc-3198	\N	NEW	\N	\N	\N	\N
87470	79	D5170C00002/tiny.path.1/file-6080.pdf	\N	D5170C00002-56b86cec-8319-11eb-be00-97538adb13d0-6083	\N	NEW	\N	\N	\N	\N
87471	79	D5170C00002/tiny.path.1/file-6081.pdf	\N	D5170C00002-56d4324d-8319-11eb-be00-d1db37219f99-6084	\N	NEW	\N	\N	\N	\N
81771	79	D5170C00002/tiny.path.1/file-0381.pdf	\N	D5170C00002-56d4f229-8315-11eb-be00-d58edd13d5f7-384	\N	NEW	\N	\N	\N	\N
83119	79	D5170C00002/tiny.path.1/file-1729.pdf	\N	D5170C00002-56d52410-8316-11eb-be00-871b0f82c081-1735	\N	NEW	\N	\N	\N	\N
87472	79	D5170C00002/tiny.path.1/file-6082.pdf	\N	D5170C00002-56d6552e-8319-11eb-be00-9509d8381d56-6085	\N	NEW	\N	\N	\N	\N
87473	79	D5170C00002/tiny.path.1/file-6083.pdf	\N	D5170C00002-56f28fbf-8319-11eb-be00-6b25d9983566-6086	\N	NEW	\N	\N	\N	\N
84589	79	D5170C00002/tiny.path.1/file-3199.pdf	\N	D5170C00002-56f47628-8317-11eb-be00-c711e96b2388-3199	\N	NEW	\N	\N	\N	\N
83120	79	D5170C00002/tiny.path.1/file-1730.pdf	\N	D5170C00002-56f5f281-8316-11eb-be00-e1891a916545-1736	\N	NEW	\N	\N	\N	\N
87474	79	D5170C00002/tiny.path.1/file-6084.pdf	\N	D5170C00002-57044300-8319-11eb-be00-9f63ee36bc21-6087	\N	NEW	\N	\N	\N	\N
84590	79	D5170C00002/tiny.path.1/file-3200.pdf	\N	D5170C00002-57123759-8317-11eb-be00-7b1547b8a8f6-3200	\N	NEW	\N	\N	\N	\N
81772	79	D5170C00002/tiny.path.1/file-0382.pdf	\N	D5170C00002-5712494a-8315-11eb-be00-156e8d2c98db-385	\N	NEW	\N	\N	\N	\N
86153	79	D5170C00002/tiny.path.1/file-4763.pdf	\N	D5170C00002-572099e4-8318-11eb-be00-e1e17e99f551-4763	\N	NEW	\N	\N	\N	\N
83121	79	D5170C00002/tiny.path.1/file-1731.pdf	\N	D5170C00002-5721bd72-8316-11eb-be00-1f4490797772-1737	\N	NEW	\N	\N	\N	\N
87475	79	D5170C00002/tiny.path.1/file-6085.pdf	\N	D5170C00002-5730d141-8319-11eb-be00-a154193c07be-6088	\N	NEW	\N	\N	\N	\N
84591	79	D5170C00002/tiny.path.1/file-3201.pdf	\N	D5170C00002-573f88ea-8317-11eb-be00-097621aa4e2e-3201	\N	NEW	\N	\N	\N	\N
87476	79	D5170C00002/tiny.path.1/file-6086.pdf	\N	D5170C00002-57401382-8319-11eb-be00-09427065e689-6089	\N	NEW	\N	\N	\N	\N
84592	79	D5170C00002/tiny.path.1/file-3202.pdf	\N	D5170C00002-574ecb2b-8317-11eb-be00-d975d6ab6a43-3202	\N	NEW	\N	\N	\N	\N
83122	79	D5170C00002/tiny.path.1/file-1732.pdf	\N	D5170C00002-574f3613-8316-11eb-be00-3b82320c3929-1738	\N	NEW	\N	\N	\N	\N
81773	79	D5170C00002/tiny.path.1/file-0383.pdf	\N	D5170C00002-574f524b-8315-11eb-be00-1d6b68c3b0cf-386	\N	NEW	\N	\N	\N	\N
87477	79	D5170C00002/tiny.path.1/file-6087.pdf	\N	D5170C00002-575d8693-8319-11eb-be00-f97dfd991e39-6090	\N	NEW	\N	\N	\N	\N
87478	79	D5170C00002/tiny.path.1/file-6088.pdf	\N	D5170C00002-576e9d94-8319-11eb-be00-298df1cd77a7-6091	\N	NEW	\N	\N	\N	\N
86154	79	D5170C00002/tiny.path.1/file-4764.pdf	\N	D5170C00002-576ff265-8318-11eb-be00-f5029681bc59-4764	\N	NEW	\N	\N	\N	\N
83123	79	D5170C00002/tiny.path.1/file-1733.pdf	\N	D5170C00002-57702b94-8316-11eb-be00-b34f7ffacaf6-1739	\N	NEW	\N	\N	\N	\N
84593	79	D5170C00002/tiny.path.1/file-3203.pdf	\N	D5170C00002-577d2e2c-8317-11eb-be00-b5c00eb27855-3203	\N	NEW	\N	\N	\N	\N
84594	79	D5170C00002/tiny.path.1/file-3204.pdf	\N	D5170C00002-578bd42d-8317-11eb-be00-93825c303342-3204	\N	NEW	\N	\N	\N	\N
87479	79	D5170C00002/tiny.path.1/file-6089.pdf	\N	D5170C00002-578e3385-8319-11eb-be00-f9e97d5dc6f0-6092	\N	NEW	\N	\N	\N	\N
83124	79	D5170C00002/tiny.path.1/file-1734.pdf	\N	D5170C00002-579cb9d5-8316-11eb-be00-8ba20b44f73a-1740	\N	NEW	\N	\N	\N	\N
81777	79	D5170C00002/tiny.path.1/file-0387.pdf	\N	D5170C00002-57ac3f5c-8315-11eb-be00-0330ef8e11dd-387	\N	NEW	\N	\N	\N	\N
83125	79	D5170C00002/tiny.path.1/file-1735.pdf	\N	D5170C00002-57c8d2e6-8316-11eb-be00-b313f08d666c-1741	\N	NEW	\N	\N	\N	\N
87480	79	D5170C00002/tiny.path.1/file-6090.pdf	\N	D5170C00002-57d79896-8319-11eb-be00-db0c918dd542-6093	\N	NEW	\N	\N	\N	\N
84595	79	D5170C00002/tiny.path.1/file-3205.pdf	\N	D5170C00002-58060d3e-8317-11eb-be00-2121f42fcc40-3205	\N	NEW	\N	\N	\N	\N
87484	79	D5170C00002/tiny.path.1/file-6094.pdf	\N	D5170C00002-58147a87-8319-11eb-be00-979c46cfe907-6094	\N	NEW	\N	\N	\N	\N
87485	79	D5170C00002/tiny.path.1/file-6095.pdf	\N	D5170C00002-5823e3d8-8319-11eb-be00-dbea36dd375a-6095	\N	NEW	\N	\N	\N	\N
83131	79	D5170C00002/tiny.path.1/file-1741.pdf	\N	D5170C00002-5827bbc7-8316-11eb-be00-81c61f8039f8-1742	\N	NEW	\N	\N	\N	\N
81778	79	D5170C00002/tiny.path.1/file-0388.pdf	\N	D5170C00002-5834340d-8315-11eb-be00-d939f52b2b5d-388	\N	NEW	\N	\N	\N	\N
84596	79	D5170C00002/tiny.path.1/file-3206.pdf	\N	D5170C00002-5835338f-8317-11eb-be00-13bd1808c7ba-3206	\N	NEW	\N	\N	\N	\N
84597	79	D5170C00002/tiny.path.1/file-3207.pdf	\N	D5170C00002-5851e350-8317-11eb-be00-1910b8d7cf0e-3207	\N	NEW	\N	\N	\N	\N
87486	79	D5170C00002/tiny.path.1/file-6096.pdf	\N	D5170C00002-58537f59-8319-11eb-be00-dbcaa499b776-6096	\N	NEW	\N	\N	\N	\N
84598	79	D5170C00002/tiny.path.1/file-3208.pdf	\N	D5170C00002-5862ac31-8317-11eb-be00-2d0489dc6f08-3208	\N	NEW	\N	\N	\N	\N
87487	79	D5170C00002/tiny.path.1/file-6097.pdf	\N	D5170C00002-5871b5ba-8319-11eb-be00-67c7e92198ec-6097	\N	NEW	\N	\N	\N	\N
87488	79	D5170C00002/tiny.path.1/file-6098.pdf	\N	D5170C00002-588fc50b-8319-11eb-be00-ddf8d8a8b3a5-6098	\N	NEW	\N	\N	\N	\N
83126	79	D5170C00002/tiny.path.1/file-1736.pdf	\N	D5170C00002-588ff378-8316-11eb-be00-c931905238d3-1743	\N	NEW	\N	\N	\N	\N
87489	79	D5170C00002/tiny.path.1/file-6099.pdf	\N	D5170C00002-5891249c-8319-11eb-be00-b17c061fc397-6099	\N	NEW	\N	\N	\N	\N
84599	79	D5170C00002/tiny.path.1/file-3209.pdf	\N	D5170C00002-589e2e92-8317-11eb-be00-a7e8d80dfbb9-3209	\N	NEW	\N	\N	\N	\N
81779	79	D5170C00002/tiny.path.1/file-0389.pdf	\N	D5170C00002-589eb5ae-8315-11eb-be00-63961278dd4b-389	\N	NEW	\N	\N	\N	\N
83127	79	D5170C00002/tiny.path.1/file-1737.pdf	\N	D5170C00002-589ff909-8316-11eb-be00-8549ff61ca95-1744	\N	NEW	\N	\N	\N	\N
87490	79	D5170C00002/tiny.path.1/file-6100.pdf	\N	D5170C00002-58ad110d-8319-11eb-be00-c7cbcff46c19-6100	\N	NEW	\N	\N	\N	\N
87491	79	D5170C00002/tiny.path.1/file-6101.pdf	\N	D5170C00002-58af0cde-8319-11eb-be00-f3660e6e5051-6101	\N	NEW	\N	\N	\N	\N
87492	79	D5170C00002/tiny.path.1/file-6102.pdf	\N	D5170C00002-58bd64bf-8319-11eb-be00-29733e636504-6102	\N	NEW	\N	\N	\N	\N
84600	79	D5170C00002/tiny.path.1/file-3210.pdf	\N	D5170C00002-58bd7663-8317-11eb-be00-9df308edd40a-3210	\N	NEW	\N	\N	\N	\N
83128	79	D5170C00002/tiny.path.1/file-1738.pdf	\N	D5170C00002-58be085a-8316-11eb-be00-211313b9d3a2-1745	\N	NEW	\N	\N	\N	\N
83129	79	D5170C00002/tiny.path.1/file-1739.pdf	\N	D5170C00002-58ceaa2b-8316-11eb-be00-d1a0db4355a2-1746	\N	NEW	\N	\N	\N	\N
83130	79	D5170C00002/tiny.path.1/file-1740.pdf	\N	D5170C00002-58ea969c-8316-11eb-be00-93cbe833d34e-1747	\N	NEW	\N	\N	\N	\N
81780	79	D5170C00002/tiny.path.1/file-0390.pdf	\N	D5170C00002-58eb4f0f-8315-11eb-be00-c588d6a01a70-390	\N	NEW	\N	\N	\N	\N
87493	79	D5170C00002/tiny.path.1/file-6103.msg	\N	D5170C00002-58fa1ea0-8319-11eb-be00-61dcc789332a-6103	\N	NEW	\N	\N	\N	\N
83132	79	D5170C00002/tiny.path.1/file-1742.pdf	\N	D5170C00002-5909693d-8316-11eb-be00-31996bebba2c-1748	\N	NEW	\N	\N	\N	\N
87494	79	D5170C00002/tiny.path.1/file-6104.msg	\N	D5170C00002-590a7251-8319-11eb-be00-837f93bc69c3-6104	\N	NEW	\N	\N	\N	\N
81781	79	D5170C00002/tiny.path.1/file-0391.pdf	\N	D5170C00002-590ba850-8315-11eb-be00-fbc7f65ddb53-391	\N	NEW	\N	\N	\N	\N
87495	79	D5170C00002/tiny.path.1/file-6105.msg	\N	D5170C00002-59272212-8319-11eb-be00-4dbd1eaf946f-6105	\N	NEW	\N	\N	\N	\N
83133	79	D5170C00002/tiny.path.1/file-1743.pdf	\N	D5170C00002-5927edbe-8316-11eb-be00-f3f2bcff4c74-1749	\N	NEW	\N	\N	\N	\N
87496	79	D5170C00002/tiny.path.1/file-6106.msg	\N	D5170C00002-59383913-8319-11eb-be00-716417f7a042-6106	\N	NEW	\N	\N	\N	\N
84601	79	D5170C00002/tiny.path.1/file-3211.pdf	\N	D5170C00002-5939f964-8317-11eb-be00-f33490b366f7-3211	\N	NEW	\N	\N	\N	\N
87497	79	D5170C00002/tiny.path.1/file-6107.msg	\N	D5170C00002-59470624-8319-11eb-be00-c9bbd76e0867-6107	\N	NEW	\N	\N	\N	\N
83136	79	D5170C00002/tiny.path.1/file-1746.pdf	\N	D5170C00002-5949a68f-8316-11eb-be00-15066a40604f-1750	\N	NEW	\N	\N	\N	\N
87498	79	D5170C00002/tiny.path.1/file-6108.msg	\N	D5170C00002-59651575-8319-11eb-be00-c57952711d6b-6108	\N	NEW	\N	\N	\N	\N
81782	79	D5170C00002/tiny.path.1/file-0392.pdf	\N	D5170C00002-59656111-8315-11eb-be00-8da410c93039-392	\N	NEW	\N	\N	\N	\N
83134	79	D5170C00002/tiny.path.1/file-1744.pdf	\N	D5170C00002-597410f0-8316-11eb-be00-739f1b6d2391-1751	\N	NEW	\N	\N	\N	\N
87499	79	D5170C00002/tiny.path.1/file-6109.msg	\N	D5170C00002-59760566-8319-11eb-be00-5371a914ccea-6109	\N	NEW	\N	\N	\N	\N
83135	79	D5170C00002/tiny.path.1/file-1745.pdf	\N	D5170C00002-5992e391-8316-11eb-be00-6fc72151e9c2-1752	\N	NEW	\N	\N	\N	\N
83141	79	D5170C00002/tiny.path.1/file-1751.pdf	\N	D5170C00002-59a24ce2-8316-11eb-be00-9def893dfa85-1753	\N	NEW	\N	\N	\N	\N
81783	79	D5170C00002/tiny.path.1/file-0393.pdf	\N	D5170C00002-59b332f2-8315-11eb-be00-15c6959dede4-393	\N	NEW	\N	\N	\N	\N
83137	79	D5170C00002/tiny.path.1/file-1747.pdf	\N	D5170C00002-59b363e3-8316-11eb-be00-27ec4e9a1387-1754	\N	NEW	\N	\N	\N	\N
83138	79	D5170C00002/tiny.path.1/file-1748.pdf	\N	D5170C00002-59d17334-8316-11eb-be00-ab754b7cdd28-1755	\N	NEW	\N	\N	\N	\N
83139	79	D5170C00002/tiny.path.1/file-1749.pdf	\N	D5170C00002-59eee645-8316-11eb-be00-c506fa7e1ffd-1756	\N	NEW	\N	\N	\N	\N
87500	79	D5170C00002/tiny.path.1/file-6110.msg	\N	D5170C00002-59f01767-8319-11eb-be00-f121579fa5f0-6110	\N	NEW	\N	\N	\N	\N
84602	79	D5170C00002/tiny.path.1/file-3212.pdf	\N	D5170C00002-59f07825-8317-11eb-be00-013968085ff6-3212	\N	NEW	\N	\N	\N	\N
81784	79	D5170C00002/tiny.path.1/file-0394.pdf	\N	D5170C00002-59f08a13-8315-11eb-be00-1b4c5e19d22e-394	\N	NEW	\N	\N	\N	\N
83140	79	D5170C00002/tiny.path.1/file-1750.pdf	\N	D5170C00002-59fffd46-8316-11eb-be00-61424728397b-1757	\N	NEW	\N	\N	\N	\N
84603	79	D5170C00002/tiny.path.1/file-3213.pdf	\N	D5170C00002-5a0d4ef6-8317-11eb-be00-73726d034caf-3213	\N	NEW	\N	\N	\N	\N
81785	79	D5170C00002/tiny.path.1/file-0395.pdf	\N	D5170C00002-5a1e29c4-8315-11eb-be00-bd587ef2b4a7-395	\N	NEW	\N	\N	\N	\N
86155	79	D5170C00002/tiny.path.1/file-4765.pdf	\N	D5170C00002-5a2d64b6-8318-11eb-be00-f783f80597aa-4765	\N	NEW	\N	\N	\N	\N
87501	79	D5170C00002/tiny.path.1/file-6111.pdf	\N	D5170C00002-5a3b2a28-8319-11eb-be00-933d14132f32-6111	\N	NEW	\N	\N	\N	\N
84604	79	D5170C00002/tiny.path.1/file-3214.pdf	\N	D5170C00002-5a5a5d87-8317-11eb-be00-f5f22a26a3cc-3214	\N	NEW	\N	\N	\N	\N
83145	79	D5170C00002/tiny.path.1/file-1755.pdf	\N	D5170C00002-5a5bd8e7-8316-11eb-be00-894f37c90ae3-1758	\N	NEW	\N	\N	\N	\N
87502	79	D5170C00002/tiny.path.1/file-6112.pdf	\N	D5170C00002-5a67df79-8319-11eb-be00-97b8a2fafbe2-6112	\N	NEW	\N	\N	\N	\N
83146	79	D5170C00002/tiny.path.1/file-1756.pdf	\N	D5170C00002-5a786198-8316-11eb-be00-85ea31692215-1759	\N	NEW	\N	\N	\N	\N
83147	79	D5170C00002/tiny.path.1/file-1757.pdf	\N	D5170C00002-5a9697f9-8316-11eb-be00-735a1eafe66f-1760	\N	NEW	\N	\N	\N	\N
81786	79	D5170C00002/tiny.path.1/file-0396.pdf	\N	D5170C00002-5aa55b25-8315-11eb-be00-8302134633b8-396	\N	NEW	\N	\N	\N	\N
83148	79	D5170C00002/tiny.path.1/file-1758.pdf	\N	D5170C00002-5aa6ebaa-8316-11eb-be00-0d0d80d18db5-1761	\N	NEW	\N	\N	\N	\N
86156	79	D5170C00002/tiny.path.1/file-4766.pdf	\N	D5170C00002-5aa79dc7-8318-11eb-be00-65dbb4719a85-4766	\N	NEW	\N	\N	\N	\N
83149	79	D5170C00002/tiny.path.1/file-1759.pdf	\N	D5170C00002-5ab4f56b-8316-11eb-be00-11ec49916e9a-1762	\N	NEW	\N	\N	\N	\N
86157	79	D5170C00002/tiny.path.1/file-4767.pdf	\N	D5170C00002-5ac3ff68-8318-11eb-be00-958350c7693a-4767	\N	NEW	\N	\N	\N	\N
81787	79	D5170C00002/tiny.path.1/file-0397.pdf	\N	D5170C00002-5ac56646-8315-11eb-be00-b98a99fd86c7-397	\N	NEW	\N	\N	\N	\N
83150	79	D5170C00002/tiny.path.1/file-1760.pdf	\N	D5170C00002-5ac6a8ac-8316-11eb-be00-5f0131cd86dd-1763	\N	NEW	\N	\N	\N	\N
87503	79	D5170C00002/tiny.path.1/file-6113.pdf	\N	D5170C00002-5ad2af3a-8319-11eb-be00-070a609f2c53-6113	\N	NEW	\N	\N	\N	\N
83151	79	D5170C00002/tiny.path.1/file-1761.pdf	\N	D5170C00002-5ae246fd-8316-11eb-be00-23002464711d-1764	\N	NEW	\N	\N	\N	\N
81788	79	D5170C00002/tiny.path.1/file-0398.pdf	\N	D5170C00002-5ae30067-8315-11eb-be00-0f9cbfa1f496-398	\N	NEW	\N	\N	\N	\N
86158	79	D5170C00002/tiny.path.1/file-4768.pdf	\N	D5170C00002-5ae3e379-8318-11eb-be00-d5262978f602-4768	\N	NEW	\N	\N	\N	\N
86159	79	D5170C00002/tiny.path.1/file-4769.pdf	\N	D5170C00002-5af2d79a-8318-11eb-be00-f3a250ec1f77-4769	\N	NEW	\N	\N	\N	\N
81789	79	D5170C00002/tiny.path.1/file-0399.pdf	\N	D5170C00002-5b10a018-8315-11eb-be00-d9f9efb364df-399	\N	NEW	\N	\N	\N	\N
86160	79	D5170C00002/tiny.path.1/file-4770.pdf	\N	D5170C00002-5b209e5b-8318-11eb-be00-f30163d086dd-4770	\N	NEW	\N	\N	\N	\N
87504	79	D5170C00002/tiny.path.1/file-6114.pdf	\N	D5170C00002-5b21b99b-8319-11eb-be00-f310672b58c8-6114	\N	NEW	\N	\N	\N	\N
83142	79	D5170C00002/tiny.path.1/file-1752.pdf	\N	D5170C00002-5b3066fe-8316-11eb-be00-d9ae547ad88a-1765	\N	NEW	\N	\N	\N	\N
83143	79	D5170C00002/tiny.path.1/file-1753.pdf	\N	D5170C00002-5b3dd47f-8316-11eb-be00-51ce02b458eb-1766	\N	NEW	\N	\N	\N	\N
83144	79	D5170C00002/tiny.path.1/file-1754.pdf	\N	D5170C00002-5b4f39a0-8316-11eb-be00-31c884cd577d-1767	\N	NEW	\N	\N	\N	\N
86161	79	D5170C00002/tiny.path.1/file-4771.pdf	\N	D5170C00002-5b5cbcfc-8318-11eb-be00-1505855c54dd-4771	\N	NEW	\N	\N	\N	\N
81790	79	D5170C00002/tiny.path.1/file-0400.pdf	\N	D5170C00002-5b5d1269-8315-11eb-be00-e1710be868dd-400	\N	NEW	\N	\N	\N	\N
83159	79	D5170C00002/tiny.path.1/file-1769.pdf	\N	D5170C00002-5b6c3781-8316-11eb-be00-f577d0f83817-1768	\N	NEW	\N	\N	\N	\N
84605	79	D5170C00002/tiny.path.1/file-3215.pdf	\N	D5170C00002-5b8d8658-8317-11eb-be00-e118c286a68b-3215	\N	NEW	\N	\N	\N	\N
87505	79	D5170C00002/tiny.path.1/file-6115.pdf	\N	D5170C00002-5ba827ac-8319-11eb-be00-8d55ef3ebfcd-6115	\N	NEW	\N	\N	\N	\N
86162	79	D5170C00002/tiny.path.1/file-4772.pdf	\N	D5170C00002-5ba844ed-8318-11eb-be00-2d74f3fb59a0-4772	\N	NEW	\N	\N	\N	\N
83152	79	D5170C00002/tiny.path.1/file-1762.pdf	\N	D5170C00002-5bc74fd2-8316-11eb-be00-b324e13fccce-1769	\N	NEW	\N	\N	\N	\N
87506	79	D5170C00002/tiny.path.1/file-6116.pdf	\N	D5170C00002-5bd5ee6d-8319-11eb-be00-4736072449d1-6116	\N	NEW	\N	\N	\N	\N
84606	79	D5170C00002/tiny.path.1/file-3216.pdf	\N	D5170C00002-5be654b9-8317-11eb-be00-e16133937d85-3216	\N	NEW	\N	\N	\N	\N
86163	79	D5170C00002/tiny.path.1/file-4773.pdf	\N	D5170C00002-5bf4902e-8318-11eb-be00-e51f505c1f0f-4773	\N	NEW	\N	\N	\N	\N
83153	79	D5170C00002/tiny.path.1/file-1763.pdf	\N	D5170C00002-5c051c23-8316-11eb-be00-59b4fbc37ea6-1770	\N	NEW	\N	\N	\N	\N
83154	79	D5170C00002/tiny.path.1/file-1764.pdf	\N	D5170C00002-5c073f04-8316-11eb-be00-8101d64c91c9-1771	\N	NEW	\N	\N	\N	\N
83155	79	D5170C00002/tiny.path.1/file-1765.pdf	\N	D5170C00002-5c15e505-8316-11eb-be00-8f531d86a5e4-1772	\N	NEW	\N	\N	\N	\N
83156	79	D5170C00002/tiny.path.1/file-1766.pdf	\N	D5170C00002-5c3246a6-8316-11eb-be00-475baa9817cf-1773	\N	NEW	\N	\N	\N	\N
86164	79	D5170C00002/tiny.path.1/file-4774.pdf	\N	D5170C00002-5c3394ff-8318-11eb-be00-89d8feab255f-4774	\N	NEW	\N	\N	\N	\N
84607	79	D5170C00002/tiny.path.1/file-3217.pdf	\N	D5170C00002-5c40f7da-8317-11eb-be00-139d907677a4-3217	\N	NEW	\N	\N	\N	\N
86165	79	D5170C00002/tiny.path.1/file-4775.pdf	\N	D5170C00002-5c439a90-8318-11eb-be00-93a25c7e88a1-4775	\N	NEW	\N	\N	\N	\N
83157	79	D5170C00002/tiny.path.1/file-1767.pdf	\N	D5170C00002-5c529fe7-8316-11eb-be00-b1d31e3c1885-1774	\N	NEW	\N	\N	\N	\N
81791	79	D5170C00002/tiny.path.1/file-0401.pdf	\N	D5170C00002-5c52bd0a-8315-11eb-be00-a96057d271bb-401	\N	NEW	\N	\N	\N	\N
83158	79	D5170C00002/tiny.path.1/file-1768.pdf	\N	D5170C00002-5c6145e8-8316-11eb-be00-1de0352ff91f-1775	\N	NEW	\N	\N	\N	\N
86166	79	D5170C00002/tiny.path.1/file-4776.pdf	\N	D5170C00002-5c615bc1-8318-11eb-be00-d5c86d083629-4776	\N	NEW	\N	\N	\N	\N
83163	79	D5170C00002/tiny.path.1/file-1773.pdf	\N	D5170C00002-5c712469-8316-11eb-be00-ff7d14b46609-1776	\N	NEW	\N	\N	\N	\N
81792	79	D5170C00002/tiny.path.1/file-0402.pdf	\N	D5170C00002-5c7fe78b-8315-11eb-be00-fd84625202ae-402	\N	NEW	\N	\N	\N	\N
87507	79	D5170C00002/tiny.path.1/file-6117.pdf	\N	D5170C00002-5c8e1ade-8319-11eb-be00-c990207d5746-6117	\N	NEW	\N	\N	\N	\N
86167	79	D5170C00002/tiny.path.1/file-4777.pdf	\N	D5170C00002-5c9cde22-8318-11eb-be00-05eff1b3e281-4777	\N	NEW	\N	\N	\N	\N
84608	79	D5170C00002/tiny.path.1/file-3218.pdf	\N	D5170C00002-5c9ea83b-8317-11eb-be00-edf4bcf2118f-3218	\N	NEW	\N	\N	\N	\N
83164	79	D5170C00002/tiny.path.1/file-1774.pdf	\N	D5170C00002-5c9f123a-8316-11eb-be00-237a5a65b6b5-1777	\N	NEW	\N	\N	\N	\N
87508	79	D5170C00002/tiny.path.1/file-6118.pdf	\N	D5170C00002-5cabdc0f-8319-11eb-be00-85f5b9e757d2-6118	\N	NEW	\N	\N	\N	\N
83165	79	D5170C00002/tiny.path.1/file-1775.pdf	\N	D5170C00002-5cae065b-8316-11eb-be00-e30bd92ce3cc-1778	\N	NEW	\N	\N	\N	\N
87509	79	D5170C00002/tiny.path.1/file-6119.pdf	\N	D5170C00002-5cbca4f0-8319-11eb-be00-6f6b22166504-6119	\N	NEW	\N	\N	\N	\N
81793	79	D5170C00002/tiny.path.1/file-0403.pdf	\N	D5170C00002-5cbe01fc-8315-11eb-be00-9fddbc8a21a6-403	\N	NEW	\N	\N	\N	\N
86168	79	D5170C00002/tiny.path.1/file-4778.pdf	\N	D5170C00002-5cbe21c3-8318-11eb-be00-3592c52b0f5c-4778	\N	NEW	\N	\N	\N	\N
83160	79	D5170C00002/tiny.path.1/file-1770.pdf	\N	D5170C00002-5ccadd2c-8316-11eb-be00-c701d98fc5aa-1779	\N	NEW	\N	\N	\N	\N
86169	79	D5170C00002/tiny.path.1/file-4779.pdf	\N	D5170C00002-5cdc0a04-8318-11eb-be00-8f62a73282ae-4779	\N	NEW	\N	\N	\N	\N
81794	79	D5170C00002/tiny.path.1/file-0404.pdf	\N	D5170C00002-5ce957bd-8315-11eb-be00-096206c2085f-404	\N	NEW	\N	\N	\N	\N
83161	79	D5170C00002/tiny.path.1/file-1771.pdf	\N	D5170C00002-5ce988bd-8316-11eb-be00-bb780248b905-1780	\N	NEW	\N	\N	\N	\N
84609	79	D5170C00002/tiny.path.1/file-3219.pdf	\N	D5170C00002-5cfaf90c-8317-11eb-be00-4fc8d3fcac55-3219	\N	NEW	\N	\N	\N	\N
86170	79	D5170C00002/tiny.path.1/file-4780.pdf	\N	D5170C00002-5d07ade5-8318-11eb-be00-f9741d02485d-4780	\N	NEW	\N	\N	\N	\N
87510	79	D5170C00002/tiny.path.1/file-6120.pdf	\N	D5170C00002-5d165db1-8319-11eb-be00-43dfc8e09aa8-6120	\N	NEW	\N	\N	\N	\N
86171	79	D5170C00002/tiny.path.1/file-4781.pdf	\N	D5170C00002-5d18c4e6-8318-11eb-be00-e17b5dab5edd-4781	\N	NEW	\N	\N	\N	\N
87511	79	D5170C00002/tiny.path.1/file-6121.pdf	\N	D5170C00002-5d259ff2-8319-11eb-be00-336c5f0abde0-6121	\N	NEW	\N	\N	\N	\N
83162	79	D5170C00002/tiny.path.1/file-1772.pdf	\N	D5170C00002-5d266aae-8316-11eb-be00-6fb2c8262321-1781	\N	NEW	\N	\N	\N	\N
81795	79	D5170C00002/tiny.path.1/file-0405.pdf	\N	D5170C00002-5d27c04e-8315-11eb-be00-4b8185673951-405	\N	NEW	\N	\N	\N	\N
84610	79	D5170C00002/tiny.path.1/file-3220.pdf	\N	D5170C00002-5d28238d-8317-11eb-be00-298af06200de-3220	\N	NEW	\N	\N	\N	\N
87512	79	D5170C00002/tiny.path.1/file-6122.pdf	\N	D5170C00002-5d353053-8319-11eb-be00-0f1c7c299bf8-6122	\N	NEW	\N	\N	\N	\N
86172	79	D5170C00002/tiny.path.1/file-4782.pdf	\N	D5170C00002-5d36d437-8318-11eb-be00-0be3835d581d-4782	\N	NEW	\N	\N	\N	\N
83169	79	D5170C00002/tiny.path.1/file-1779.pdf	\N	D5170C00002-5d45b27f-8316-11eb-be00-a34ea21c1090-1782	\N	NEW	\N	\N	\N	\N
87513	79	D5170C00002/tiny.path.1/file-6123.pdf	\N	D5170C00002-5d45f934-8319-11eb-be00-5dc0da48237c-6123	\N	NEW	\N	\N	\N	\N
84611	79	D5170C00002/tiny.path.1/file-3221.pdf	\N	D5170C00002-5d53a05e-8317-11eb-be00-59668be0887a-3221	\N	NEW	\N	\N	\N	\N
81796	79	D5170C00002/tiny.path.1/file-0406.pdf	\N	D5170C00002-5d54277f-8315-11eb-be00-bd81b945e361-406	\N	NEW	\N	\N	\N	\N
87514	79	D5170C00002/tiny.path.1/file-6124.pdf	\N	D5170C00002-5d558995-8319-11eb-be00-af6583d1f2a3-6124	\N	NEW	\N	\N	\N	\N
86173	79	D5170C00002/tiny.path.1/file-4783.pdf	\N	D5170C00002-5d564318-8318-11eb-be00-47e660788bb0-4783	\N	NEW	\N	\N	\N	\N
87515	79	D5170C00002/tiny.path.1/file-6125.pdf	\N	D5170C00002-5d64f2e6-8319-11eb-be00-797d2e1ca09c-6125	\N	NEW	\N	\N	\N	\N
83170	79	D5170C00002/tiny.path.1/file-1780.pdf	\N	D5170C00002-5d654870-8316-11eb-be00-29967e64a1f8-1783	\N	NEW	\N	\N	\N	\N
84612	79	D5170C00002/tiny.path.1/file-3222.pdf	\N	D5170C00002-5d74e3ff-8317-11eb-be00-2bc00294f8ba-3222	\N	NEW	\N	\N	\N	\N
83171	79	D5170C00002/tiny.path.1/file-1781.pdf	\N	D5170C00002-5d754e01-8316-11eb-be00-f732ab9250ae-1784	\N	NEW	\N	\N	\N	\N
87516	79	D5170C00002/tiny.path.1/file-6126.pdf	\N	D5170C00002-5d91cf47-8319-11eb-be00-4f66b5104783-6126	\N	NEW	\N	\N	\N	\N
86174	79	D5170C00002/tiny.path.1/file-4784.pdf	\N	D5170C00002-5d934c19-8318-11eb-be00-9bce43bfce3a-4784	\N	NEW	\N	\N	\N	\N
83166	79	D5170C00002/tiny.path.1/file-1776.pdf	\N	D5170C00002-5da2c6a2-8316-11eb-be00-75dd50598d07-1785	\N	NEW	\N	\N	\N	\N
84613	79	D5170C00002/tiny.path.1/file-3223.pdf	\N	D5170C00002-5db129b0-8317-11eb-be00-df5b0a1c6f44-3223	\N	NEW	\N	\N	\N	\N
83167	79	D5170C00002/tiny.path.1/file-1777.pdf	\N	D5170C00002-5dc087d3-8316-11eb-be00-7316ee1fcb13-1786	\N	NEW	\N	\N	\N	\N
87517	79	D5170C00002/tiny.path.1/file-6127.pdf	\N	D5170C00002-5dcd9fc8-8319-11eb-be00-f95e82b2f095-6127	\N	NEW	\N	\N	\N	\N
83168	79	D5170C00002/tiny.path.1/file-1778.pdf	\N	D5170C00002-5ddd3794-8316-11eb-be00-4f2ca29fb918-1787	\N	NEW	\N	\N	\N	\N
87518	79	D5170C00002/tiny.path.1/file-6128.pdf	\N	D5170C00002-5debaf19-8319-11eb-be00-ff02ea342e52-6128	\N	NEW	\N	\N	\N	\N
86175	79	D5170C00002/tiny.path.1/file-4785.xlsx	\N	D5170C00002-5dec1a7a-8318-11eb-be00-dd5e595e348f-4785	\N	NEW	\N	\N	\N	\N
83187	79	D5170C00002/tiny.path.1/file-1797.pdf	\N	D5170C00002-5def11e5-8316-11eb-be00-ebd514fc9489-1788	\N	NEW	\N	\N	\N	\N
86176	79	D5170C00002/tiny.path.1/file-4786.xlsx	\N	D5170C00002-5e0a9efb-8318-11eb-be00-07157d1fa389-4786	\N	NEW	\N	\N	\N	\N
81797	79	D5170C00002/tiny.path.1/file-0407.pdf	\N	D5170C00002-5e0b4280-8315-11eb-be00-834e8773c741-407	\N	NEW	\N	\N	\N	\N
83184	79	D5170C00002/tiny.path.1/file-1794.pdf	\N	D5170C00002-5e29d0f6-8316-11eb-be00-dfe2672607b2-1789	\N	NEW	\N	\N	\N	\N
84614	79	D5170C00002/tiny.path.1/file-3224.pdf	\N	D5170C00002-5e2aed91-8317-11eb-be00-6f2490af5bc2-3224	\N	NEW	\N	\N	\N	\N
84615	79	D5170C00002/tiny.path.1/file-3225.pdf	\N	D5170C00002-5e3af322-8317-11eb-be00-29a5a5f1c139-3225	\N	NEW	\N	\N	\N	\N
87519	79	D5170C00002/tiny.path.1/file-6129.pdf	\N	D5170C00002-5e3ba3da-8319-11eb-be00-6584bc4453e0-6129	\N	NEW	\N	\N	\N	\N
86177	79	D5170C00002/tiny.path.1/file-4787.pdf	\N	D5170C00002-5e48b96c-8318-11eb-be00-cff1d537ee0e-4787	\N	NEW	\N	\N	\N	\N
81798	79	D5170C00002/tiny.path.1/file-0408.pdf	\N	D5170C00002-5e48c0b1-8315-11eb-be00-9366534f9b50-408	\N	NEW	\N	\N	\N	\N
84616	79	D5170C00002/tiny.path.1/file-3226.pdf	\N	D5170C00002-5e497213-8317-11eb-be00-939beeff5c59-3226	\N	NEW	\N	\N	\N	\N
84617	79	D5170C00002/tiny.path.1/file-3227.pdf	\N	D5170C00002-5e572db4-8317-11eb-be00-fb24949045cb-3227	\N	NEW	\N	\N	\N	\N
84618	79	D5170C00002/tiny.path.1/file-3228.pdf	\N	D5170C00002-5e6648e5-8317-11eb-be00-49161ab61c9e-3228	\N	NEW	\N	\N	\N	\N
83185	79	D5170C00002/tiny.path.1/file-1795.pdf	\N	D5170C00002-5e66b2e7-8316-11eb-be00-1d458695ae28-1790	\N	NEW	\N	\N	\N	\N
87520	79	D5170C00002/tiny.path.1/file-6130.pdf	\N	D5170C00002-5e752a6b-8319-11eb-be00-6755c5bc9201-6130	\N	NEW	\N	\N	\N	\N
86178	79	D5170C00002/tiny.path.1/file-4788.pdf	\N	D5170C00002-5e86108d-8318-11eb-be00-b503d9a03d31-4788	\N	NEW	\N	\N	\N	\N
84619	79	D5170C00002/tiny.path.1/file-3229.pdf	\N	D5170C00002-5e87b396-8317-11eb-be00-671575ab964c-3229	\N	NEW	\N	\N	\N	\N
83186	79	D5170C00002/tiny.path.1/file-1796.pdf	\N	D5170C00002-5e9515e8-8316-11eb-be00-b98dfaa897bc-1791	\N	NEW	\N	\N	\N	\N
86179	79	D5170C00002/tiny.path.1/file-4789.pdf	\N	D5170C00002-5e95ef0e-8318-11eb-be00-d74a13badfc9-4789	\N	NEW	\N	\N	\N	\N
87521	79	D5170C00002/tiny.path.1/file-6131.pdf	\N	D5170C00002-5eb31dcc-8319-11eb-be00-e1ccf833b682-6131	\N	NEW	\N	\N	\N	\N
81799	79	D5170C00002/tiny.path.1/file-0409.pdf	\N	D5170C00002-5eb4f002-8315-11eb-be00-5b3d7757ebbf-409	\N	NEW	\N	\N	\N	\N
86180	79	D5170C00002/tiny.path.1/file-4790.pdf	\N	D5170C00002-5ec53c6f-8318-11eb-be00-191d4c9d1d1a-4790	\N	NEW	\N	\N	\N	\N
83172	79	D5170C00002/tiny.path.1/file-1782.pdf	\N	D5170C00002-5ed30949-8316-11eb-be00-75f9afa61b37-1792	\N	NEW	\N	\N	\N	\N
84620	79	D5170C00002/tiny.path.1/file-3230.xlsx	\N	D5170C00002-5ee081f7-8317-11eb-be00-859a8dfaa94a-3230	\N	NEW	\N	\N	\N	\N
81800	79	D5170C00002/tiny.path.1/file-0410.pdf	\N	D5170C00002-5effdbb3-8315-11eb-be00-4facabd64bd0-410	\N	NEW	\N	\N	\N	\N
84621	79	D5170C00002/tiny.path.1/file-3231.pdf	\N	D5170C00002-5f106b98-8317-11eb-be00-27fe09b363b2-3231	\N	NEW	\N	\N	\N	\N
86181	79	D5170C00002/tiny.path.1/file-4791.pdf	\N	D5170C00002-5f2e1060-8318-11eb-be00-d991086cfd57-4791	\N	NEW	\N	\N	\N	\N
84622	79	D5170C00002/tiny.path.1/file-3232.pdf	\N	D5170C00002-5f3c84a9-8317-11eb-be00-1108d9a47706-3232	\N	NEW	\N	\N	\N	\N
84623	79	D5170C00002/tiny.path.1/file-3233.pdf	\N	D5170C00002-5f4d749a-8317-11eb-be00-d5b6243ba3e4-3233	\N	NEW	\N	\N	\N	\N
83173	79	D5170C00002/tiny.path.1/file-1783.pdf	\N	D5170C00002-5f5ad6ea-8316-11eb-be00-8b7309f62f0f-1793	\N	NEW	\N	\N	\N	\N
86182	79	D5170C00002/tiny.path.1/file-4792.pdf	\N	D5170C00002-5f6af251-8318-11eb-be00-9d70b538e415-4792	\N	NEW	\N	\N	\N	\N
84624	79	D5170C00002/tiny.path.1/file-3234.pdf	\N	D5170C00002-5f79669b-8317-11eb-be00-7b37ccff4b58-3234	\N	NEW	\N	\N	\N	\N
81801	79	D5170C00002/tiny.path.1/file-0411.pdf	\N	D5170C00002-5f7a89f4-8315-11eb-be00-65ad799d6f5c-411	\N	NEW	\N	\N	\N	\N
84625	79	D5170C00002/tiny.path.1/file-3235.pdf	\N	D5170C00002-5f896c2c-8317-11eb-be00-4589394b5b93-3235	\N	NEW	\N	\N	\N	\N
84626	79	D5170C00002/tiny.path.1/file-3236.pdf	\N	D5170C00002-5f8b40ed-8317-11eb-be00-4329853edfa2-3236	\N	NEW	\N	\N	\N	\N
87522	79	D5170C00002/tiny.path.1/file-6132.pdf	\N	D5170C00002-5f973c3d-8319-11eb-be00-8553dc084916-6132	\N	NEW	\N	\N	\N	\N
84627	79	D5170C00002/tiny.path.1/file-3237.pdf	\N	D5170C00002-5f98ae6e-8317-11eb-be00-b5fa95fe3936-3237	\N	NEW	\N	\N	\N	\N
83174	79	D5170C00002/tiny.path.1/file-1784.pdf	\N	D5170C00002-5f9a29db-8316-11eb-be00-4b0f3d053212-1794	\N	NEW	\N	\N	\N	\N
84628	79	D5170C00002/tiny.path.1/file-3238.pdf	\N	D5170C00002-5fa7064f-8317-11eb-be00-83c2f8ad6342-3238	\N	NEW	\N	\N	\N	\N
81802	79	D5170C00002/tiny.path.1/file-0412.pdf	\N	D5170C00002-5fa73f45-8315-11eb-be00-9159aab31335-412	\N	NEW	\N	\N	\N	\N
84629	79	D5170C00002/tiny.path.1/file-3239.pdf	\N	D5170C00002-5fa83ed0-8317-11eb-be00-85589820d8c2-3239	\N	NEW	\N	\N	\N	\N
87523	79	D5170C00002/tiny.path.1/file-6133.pdf	\N	D5170C00002-5fc4dbee-8319-11eb-be00-739cc9f34ccc-6133	\N	NEW	\N	\N	\N	\N
81803	79	D5170C00002/tiny.path.1/file-0413.pdf	\N	D5170C00002-5fc59cb6-8315-11eb-be00-07b3dfb936a7-413	\N	NEW	\N	\N	\N	\N
87524	79	D5170C00002/tiny.path.1/file-6134.pdf	\N	D5170C00002-5fd6410f-8319-11eb-be00-4d5fe4d06c94-6134	\N	NEW	\N	\N	\N	\N
84630	79	D5170C00002/tiny.path.1/file-3240.pdf	\N	D5170C00002-5fd71701-8317-11eb-be00-7926d8474373-3240	\N	NEW	\N	\N	\N	\N
81804	79	D5170C00002/tiny.path.1/file-0414.pdf	\N	D5170C00002-5fe3fa27-8315-11eb-be00-4f2cb1cfbe32-414	\N	NEW	\N	\N	\N	\N
83175	79	D5170C00002/tiny.path.1/file-1785.pdf	\N	D5170C00002-5fe4523c-8316-11eb-be00-a1236c53a1a7-1795	\N	NEW	\N	\N	\N	\N
87525	79	D5170C00002/tiny.path.1/file-6135.pdf	\N	D5170C00002-5ff38d10-8319-11eb-be00-21eb7f2df39d-6135	\N	NEW	\N	\N	\N	\N
84631	79	D5170C00002/tiny.path.1/file-3241.pdf	\N	D5170C00002-5ff3c6c2-8317-11eb-be00-afd4624a5015-3241	\N	NEW	\N	\N	\N	\N
83176	79	D5170C00002/tiny.path.1/file-1786.pdf	\N	D5170C00002-5ff6057d-8316-11eb-be00-0dc3c6d5426e-1796	\N	NEW	\N	\N	\N	\N
86183	79	D5170C00002/tiny.path.1/file-4793.pdf	\N	D5170C00002-60027762-8318-11eb-be00-6381006ee15f-4793	\N	NEW	\N	\N	\N	\N
84632	79	D5170C00002/tiny.path.1/file-3242.pdf	\N	D5170C00002-60030903-8317-11eb-be00-fd6a38179c44-3242	\N	NEW	\N	\N	\N	\N
87526	79	D5170C00002/tiny.path.1/file-6136.pdf	\N	D5170C00002-60047d01-8319-11eb-be00-b76ca772e2cd-6136	\N	NEW	\N	\N	\N	\N
84633	79	D5170C00002/tiny.path.1/file-3243.pdf	\N	D5170C00002-60130e94-8317-11eb-be00-59e595f9956b-3243	\N	NEW	\N	\N	\N	\N
81805	79	D5170C00002/tiny.path.1/file-0415.pdf	\N	D5170C00002-60134788-8315-11eb-be00-1f2ba59b9445-415	\N	NEW	\N	\N	\N	\N
87527	79	D5170C00002/tiny.path.1/file-6137.pdf	\N	D5170C00002-60140d62-8319-11eb-be00-db6d035f2f69-6137	\N	NEW	\N	\N	\N	\N
83177	79	D5170C00002/tiny.path.1/file-1787.pdf	\N	D5170C00002-6022bace-8316-11eb-be00-0dce49ac7cb7-1797	\N	NEW	\N	\N	\N	\N
81806	79	D5170C00002/tiny.path.1/file-0416.pdf	\N	D5170C00002-60232609-8315-11eb-be00-bdce9563f050-416	\N	NEW	\N	\N	\N	\N
84634	79	D5170C00002/tiny.path.1/file-3244.pdf	\N	D5170C00002-6030a8b5-8317-11eb-be00-a78a93bf5d2d-3244	\N	NEW	\N	\N	\N	\N
87528	79	D5170C00002/tiny.path.1/file-6138.pdf	\N	D5170C00002-60313253-8319-11eb-be00-7fe0591c416a-6138	\N	NEW	\N	\N	\N	\N
84635	79	D5170C00002/tiny.path.1/file-3245.pdf	\N	D5170C00002-60417196-8317-11eb-be00-554edf10db1f-3245	\N	NEW	\N	\N	\N	\N
83178	79	D5170C00002/tiny.path.1/file-1788.pdf	\N	D5170C00002-604eaccf-8316-11eb-be00-4fecf2bbbb4d-1798	\N	NEW	\N	\N	\N	\N
87529	79	D5170C00002/tiny.path.1/file-6139.pdf	\N	D5170C00002-604fdde4-8319-11eb-be00-5d3f6aa1bc40-6139	\N	NEW	\N	\N	\N	\N
87530	79	D5170C00002/tiny.path.1/file-6140.pdf	\N	D5170C00002-606d9f15-8319-11eb-be00-9995a0ca9bd9-6140	\N	NEW	\N	\N	\N	\N
84636	79	D5170C00002/tiny.path.1/file-3246.pdf	\N	D5170C00002-606eea37-8317-11eb-be00-1bf575b9c9c7-3246	\N	NEW	\N	\N	\N	\N
81807	79	D5170C00002/tiny.path.1/file-0417.pdf	\N	D5170C00002-607c90aa-8315-11eb-be00-97ef4ec5fb50-417	\N	NEW	\N	\N	\N	\N
86184	79	D5170C00002/tiny.path.1/file-4794.pdf	\N	D5170C00002-607cd783-8318-11eb-be00-5f6495314965-4794	\N	NEW	\N	\N	\N	\N
87531	79	D5170C00002/tiny.path.1/file-6141.pdf	\N	D5170C00002-607e8f06-8319-11eb-be00-716efd86f217-6141	\N	NEW	\N	\N	\N	\N
84637	79	D5170C00002/tiny.path.1/file-3247.pdf	\N	D5170C00002-608d47a8-8317-11eb-be00-7507c86afc7c-3247	\N	NEW	\N	\N	\N	\N
87532	79	D5170C00002/tiny.path.1/file-6142.pdf	\N	D5170C00002-608df857-8319-11eb-be00-ed541ed69052-6142	\N	NEW	\N	\N	\N	\N
84638	79	D5170C00002/tiny.path.1/file-3248.pdf	\N	D5170C00002-608e3209-8317-11eb-be00-b91f0eb008a1-3248	\N	NEW	\N	\N	\N	\N
81808	79	D5170C00002/tiny.path.1/file-0418.pdf	\N	D5170C00002-609bd87b-8315-11eb-be00-ed00e3ff9ed7-418	\N	NEW	\N	\N	\N	\N
84639	79	D5170C00002/tiny.path.1/file-3249.pdf	\N	D5170C00002-609d744a-8317-11eb-be00-5d03606299b3-3249	\N	NEW	\N	\N	\N	\N
86185	79	D5170C00002/tiny.path.1/file-4795.pdf	\N	D5170C00002-60aac554-8318-11eb-be00-1573b0aa56c2-4795	\N	NEW	\N	\N	\N	\N
87533	79	D5170C00002/tiny.path.1/file-6143.pdf	\N	D5170C00002-60b9ea58-8319-11eb-be00-6bd345d1b5fa-6143	\N	NEW	\N	\N	\N	\N
84640	79	D5170C00002/tiny.path.1/file-3250.pdf	\N	D5170C00002-60b9fcfb-8317-11eb-be00-99b31c04015d-3250	\N	NEW	\N	\N	\N	\N
83179	79	D5170C00002/tiny.path.1/file-1789.pdf	\N	D5170C00002-60badc20-8316-11eb-be00-27c05c260723-1799	\N	NEW	\N	\N	\N	\N
87534	79	D5170C00002/tiny.path.1/file-6144.pdf	\N	D5170C00002-60cab339-8319-11eb-be00-2fd6a5b8a766-6144	\N	NEW	\N	\N	\N	\N
84641	79	D5170C00002/tiny.path.1/file-3251.pdf	\N	D5170C00002-60cac5dc-8317-11eb-be00-a3f70efc780f-3251	\N	NEW	\N	\N	\N	\N
84642	79	D5170C00002/tiny.path.1/file-3252.pdf	\N	D5170C00002-60d9b9fd-8317-11eb-be00-257e243c34fd-3252	\N	NEW	\N	\N	\N	\N
86186	79	D5170C00002/tiny.path.1/file-4796.pdf	\N	D5170C00002-60da12b5-8318-11eb-be00-ddaedfeb02a4-4796	\N	NEW	\N	\N	\N	\N
83180	79	D5170C00002/tiny.path.1/file-1790.pdf	\N	D5170C00002-60dac031-8316-11eb-be00-210b242cae5e-1800	\N	NEW	\N	\N	\N	\N
84643	79	D5170C00002/tiny.path.1/file-3253.pdf	\N	D5170C00002-60e94a5e-8317-11eb-be00-cfa7b16a6c1e-3253	\N	NEW	\N	\N	\N	\N
87535	79	D5170C00002/tiny.path.1/file-6145.pdf	\N	D5170C00002-60f6571a-8319-11eb-be00-b377691053fd-6145	\N	NEW	\N	\N	\N	\N
81809	79	D5170C00002/tiny.path.1/file-0419.pdf	\N	D5170C00002-60f8ec9c-8315-11eb-be00-713b1465fb84-419	\N	NEW	\N	\N	\N	\N
84644	79	D5170C00002/tiny.path.1/file-3254.pdf	\N	D5170C00002-60f928df-8317-11eb-be00-75cbc052e728-3254	\N	NEW	\N	\N	\N	\N
86187	79	D5170C00002/tiny.path.1/file-4797.pdf	\N	D5170C00002-610679e6-8318-11eb-be00-07bbaccb0957-4797	\N	NEW	\N	\N	\N	\N
81810	79	D5170C00002/tiny.path.1/file-0420.pdf	\N	D5170C00002-6106cf4d-8315-11eb-be00-4d5a6c5a154a-420	\N	NEW	\N	\N	\N	\N
83181	79	D5170C00002/tiny.path.1/file-1791.pdf	\N	D5170C00002-61077582-8316-11eb-be00-85d0e4ae630e-1801	\N	NEW	\N	\N	\N	\N
81811	79	D5170C00002/tiny.path.1/file-0421.pdf	\N	D5170C00002-61154e3e-8315-11eb-be00-07f0fd506db8-421	\N	NEW	\N	\N	\N	\N
87536	79	D5170C00002/tiny.path.1/file-6146.pdf	\N	D5170C00002-6124930b-8319-11eb-be00-45cff364e68d-6146	\N	NEW	\N	\N	\N	\N
81812	79	D5170C00002/tiny.path.1/file-0422.pdf	\N	D5170C00002-6125c8ff-8315-11eb-be00-c3ee7fdadd8d-422	\N	NEW	\N	\N	\N	\N
83182	79	D5170C00002/tiny.path.1/file-1792.pdf	\N	D5170C00002-61275993-8316-11eb-be00-5dd25b83ae1c-1802	\N	NEW	\N	\N	\N	\N
87537	79	D5170C00002/tiny.path.1/file-6147.pdf	\N	D5170C00002-61453a6c-8319-11eb-be00-ab75d2113f6a-6147	\N	NEW	\N	\N	\N	\N
81813	79	D5170C00002/tiny.path.1/file-0423.pdf	\N	D5170C00002-61525740-8315-11eb-be00-5b0e79e2046d-423	\N	NEW	\N	\N	\N	\N
86188	79	D5170C00002/tiny.path.1/file-4798.pdf	\N	D5170C00002-6154e807-8318-11eb-be00-5f18bf9f07b0-4798	\N	NEW	\N	\N	\N	\N
87538	79	D5170C00002/tiny.path.1/file-6148.pdf	\N	D5170C00002-6171055d-8319-11eb-be00-2b92d1f6dea0-6148	\N	NEW	\N	\N	\N	\N
81814	79	D5170C00002/tiny.path.1/file-0424.pdf	\N	D5170C00002-618f6041-8315-11eb-be00-1146861d770d-424	\N	NEW	\N	\N	\N	\N
86189	79	D5170C00002/tiny.path.1/file-4799.pdf	\N	D5170C00002-618ff538-8318-11eb-be00-afdf034a0087-4799	\N	NEW	\N	\N	\N	\N
83183	79	D5170C00002/tiny.path.1/file-1793.pdf	\N	D5170C00002-61916604-8316-11eb-be00-2bdd7e505248-1803	\N	NEW	\N	\N	\N	\N
87539	79	D5170C00002/tiny.path.1/file-6149.pdf	\N	D5170C00002-619ecc1e-8319-11eb-be00-7f3fa7e78aaa-6149	\N	NEW	\N	\N	\N	\N
81815	79	D5170C00002/tiny.path.1/file-0425.pdf	\N	D5170C00002-61bdea52-8315-11eb-be00-bb55db3ee8ec-425	\N	NEW	\N	\N	\N	\N
87540	79	D5170C00002/tiny.path.1/file-6150.pdf	\N	D5170C00002-61cc1daf-8319-11eb-be00-ed322aeac0a5-6150	\N	NEW	\N	\N	\N	\N
83188	79	D5170C00002/tiny.path.1/file-1798.pdf	\N	D5170C00002-61cee435-8316-11eb-be00-c7bb57a1eda1-1804	\N	NEW	\N	\N	\N	\N
81816	79	D5170C00002/tiny.path.1/file-0426.pdf	\N	D5170C00002-61dc6ed3-8315-11eb-be00-433e84b74e44-426	\N	NEW	\N	\N	\N	\N
83189	79	D5170C00002/tiny.path.1/file-1799.pdf	\N	D5170C00002-61fa6106-8316-11eb-be00-63a481c61f99-1805	\N	NEW	\N	\N	\N	\N
86190	79	D5170C00002/tiny.path.1/file-4800.pdf	\N	D5170C00002-61fa76d9-8318-11eb-be00-457741b0d268-4800	\N	NEW	\N	\N	\N	\N
87541	79	D5170C00002/tiny.path.1/file-6151.pdf	\N	D5170C00002-6208b180-8319-11eb-be00-39e5155f7b97-6151	\N	NEW	\N	\N	\N	\N
84645	79	D5170C00002/tiny.path.1/file-3255.pdf	\N	D5170C00002-6209ae80-8317-11eb-be00-3f1cf12341eb-3255	\N	NEW	\N	\N	\N	\N
81817	79	D5170C00002/tiny.path.1/file-0427.pdf	\N	D5170C00002-620c3164-8315-11eb-be00-e126ebaac1e3-427	\N	NEW	\N	\N	\N	\N
83190	79	D5170C00002/tiny.path.1/file-1800.pdf	\N	D5170C00002-621aba47-8316-11eb-be00-9d5c8942f95a-1806	\N	NEW	\N	\N	\N	\N
84646	79	D5170C00002/tiny.path.1/file-3256.pdf	\N	D5170C00002-6227e4e1-8317-11eb-be00-e1cab52e1864-3256	\N	NEW	\N	\N	\N	\N
86191	79	D5170C00002/tiny.path.1/file-4801.pdf	\N	D5170C00002-6227ef7a-8318-11eb-be00-57a79596625f-4801	\N	NEW	\N	\N	\N	\N
84647	79	D5170C00002/tiny.path.1/file-3257.pdf	\N	D5170C00002-62374e32-8317-11eb-be00-11a31e297ce9-3257	\N	NEW	\N	\N	\N	\N
87542	79	D5170C00002/tiny.path.1/file-6152.pdf	\N	D5170C00002-6238c231-8319-11eb-be00-3ddc314c73aa-6152	\N	NEW	\N	\N	\N	\N
84648	79	D5170C00002/tiny.path.1/file-3258.pdf	\N	D5170C00002-62464253-8317-11eb-be00-fb5eed1b4495-3258	\N	NEW	\N	\N	\N	\N
81818	79	D5170C00002/tiny.path.1/file-0428.pdf	\N	D5170C00002-6246a255-8315-11eb-be00-571511c5b887-428	\N	NEW	\N	\N	\N	\N
84649	79	D5170C00002/tiny.path.1/file-3259.pdf	\N	D5170C00002-62483e24-8317-11eb-be00-4bd7c2ab4c30-3259	\N	NEW	\N	\N	\N	\N
84650	79	D5170C00002/tiny.path.1/file-3260.pdf	\N	D5170C00002-62656315-8317-11eb-be00-1d577700e221-3260	\N	NEW	\N	\N	\N	\N
86192	79	D5170C00002/tiny.path.1/file-4802.pdf	\N	D5170C00002-627413ab-8318-11eb-be00-f119608ee499-4802	\N	NEW	\N	\N	\N	\N
81819	79	D5170C00002/tiny.path.1/file-0429.pdf	\N	D5170C00002-62744206-8315-11eb-be00-41c1e25c0eb0-429	\N	NEW	\N	\N	\N	\N
84651	79	D5170C00002/tiny.path.1/file-3261.pdf	\N	D5170C00002-629302c6-8317-11eb-be00-079e26e8d2d0-3261	\N	NEW	\N	\N	\N	\N
81820	79	D5170C00002/tiny.path.1/file-0430.pdf	\N	D5170C00002-629314a7-8315-11eb-be00-bfe5378f8309-430	\N	NEW	\N	\N	\N	\N
87543	79	D5170C00002/tiny.path.1/file-6153.pdf	\N	D5170C00002-62931732-8319-11eb-be00-0bdc0f74efd7-6153	\N	NEW	\N	\N	\N	\N
86193	79	D5170C00002/tiny.path.1/file-4803.pdf	\N	D5170C00002-6295574c-8318-11eb-be00-05dcb7aad6b2-4803	\N	NEW	\N	\N	\N	\N
84652	79	D5170C00002/tiny.path.1/file-3262.pdf	\N	D5170C00002-62a30857-8317-11eb-be00-571d4b02d2a3-3262	\N	NEW	\N	\N	\N	\N
83197	79	D5170C00002/tiny.path.1/file-1807.pdf	\N	D5170C00002-62b1a318-8316-11eb-be00-29dd445d9783-1807	\N	NEW	\N	\N	\N	\N
86194	79	D5170C00002/tiny.path.1/file-4804.pdf	\N	D5170C00002-62c0ad0d-8318-11eb-be00-018edd82493f-4804	\N	NEW	\N	\N	\N	\N
87544	79	D5170C00002/tiny.path.1/file-6154.pdf	\N	D5170C00002-62c0b6e3-8319-11eb-be00-635bf6345bbf-6154	\N	NEW	\N	\N	\N	\N
83198	79	D5170C00002/tiny.path.1/file-1808.pdf	\N	D5170C00002-62c1cfb9-8316-11eb-be00-e94d592fc0d4-1808	\N	NEW	\N	\N	\N	\N
84653	79	D5170C00002/tiny.path.1/file-3263.pdf	\N	D5170C00002-62c22918-8317-11eb-be00-53f94d170b5f-3263	\N	NEW	\N	\N	\N	\N
86195	79	D5170C00002/tiny.path.1/file-4805.pdf	\N	D5170C00002-62d08b8e-8318-11eb-be00-8747660475c2-4805	\N	NEW	\N	\N	\N	\N
87545	79	D5170C00002/tiny.path.1/file-6155.pdf	\N	D5170C00002-62e04cd4-8319-11eb-be00-0ffcd5869f65-6155	\N	NEW	\N	\N	\N	\N
83199	79	D5170C00002/tiny.path.1/file-1809.pdf	\N	D5170C00002-62e13e9a-8316-11eb-be00-e7332c44dd5e-1809	\N	NEW	\N	\N	\N	\N
84654	79	D5170C00002/tiny.path.1/file-3264.pdf	\N	D5170C00002-62e197f9-8317-11eb-be00-a3c696e9cef5-3264	\N	NEW	\N	\N	\N	\N
86196	79	D5170C00002/tiny.path.1/file-4806.pdf	\N	D5170C00002-62edd78f-8318-11eb-be00-17d9267033c0-4806	\N	NEW	\N	\N	\N	\N
87546	79	D5170C00002/tiny.path.1/file-6156.pdf	\N	D5170C00002-62f05265-8319-11eb-be00-1df4553f5737-6156	\N	NEW	\N	\N	\N	\N
86197	79	D5170C00002/tiny.path.1/file-4807.pdf	\N	D5170C00002-62fec780-8318-11eb-be00-395e2aaecefa-4807	\N	NEW	\N	\N	\N	\N
84655	79	D5170C00002/tiny.path.1/file-3265.pdf	\N	D5170C00002-62ff0b0a-8317-11eb-be00-ffbd8baee157-3265	\N	NEW	\N	\N	\N	\N
81821	79	D5170C00002/tiny.path.1/file-0431.pdf	\N	D5170C00002-630e8638-8315-11eb-be00-ff2a71218965-431	\N	NEW	\N	\N	\N	\N
84656	79	D5170C00002/tiny.path.1/file-3266.pdf	\N	D5170C00002-630f37ab-8317-11eb-be00-7bb1e39198b9-3266	\N	NEW	\N	\N	\N	\N
86198	79	D5170C00002/tiny.path.1/file-4808.pdf	\N	D5170C00002-631bc561-8318-11eb-be00-c35dba9589d2-4808	\N	NEW	\N	\N	\N	\N
83200	79	D5170C00002/tiny.path.1/file-1810.pdf	\N	D5170C00002-631c24bb-8316-11eb-be00-f19e0b203c87-1810	\N	NEW	\N	\N	\N	\N
86199	79	D5170C00002/tiny.path.1/file-4809.pdf	\N	D5170C00002-632c4022-8318-11eb-be00-617aa6d0c09b-4809	\N	NEW	\N	\N	\N	\N
87547	79	D5170C00002/tiny.path.1/file-6157.pdf	\N	D5170C00002-633b1706-8319-11eb-be00-1f4b8c5b3676-6157	\N	NEW	\N	\N	\N	\N
84657	79	D5170C00002/tiny.path.1/file-3267.pdf	\N	D5170C00002-633b50bc-8317-11eb-be00-a77768553fe0-3267	\N	NEW	\N	\N	\N	\N
86200	79	D5170C00002/tiny.path.1/file-4810.pdf	\N	D5170C00002-634bd613-8318-11eb-be00-39375f91df4c-4810	\N	NEW	\N	\N	\N	\N
87548	79	D5170C00002/tiny.path.1/file-6158.pdf	\N	D5170C00002-63588a17-8319-11eb-be00-81c93ae4136b-6158	\N	NEW	\N	\N	\N	\N
86201	79	D5170C00002/tiny.path.1/file-4811.pdf	\N	D5170C00002-635b8d84-8318-11eb-be00-39eb62dbc8db-4811	\N	NEW	\N	\N	\N	\N
81822	79	D5170C00002/tiny.path.1/file-0432.pdf	\N	D5170C00002-63686609-8315-11eb-be00-2d4684256593-432	\N	NEW	\N	\N	\N	\N
84658	79	D5170C00002/tiny.path.1/file-3268.pdf	\N	D5170C00002-63693e8d-8317-11eb-be00-e5c7d2b79c3f-3268	\N	NEW	\N	\N	\N	\N
87549	79	D5170C00002/tiny.path.1/file-6159.pdf	\N	D5170C00002-63793178-8319-11eb-be00-49686b3b9ce8-6159	\N	NEW	\N	\N	\N	\N
83201	79	D5170C00002/tiny.path.1/file-1811.pdf	\N	D5170C00002-637986fc-8316-11eb-be00-6d47d036c44f-1811	\N	NEW	\N	\N	\N	\N
84659	79	D5170C00002/tiny.path.1/file-3269.pdf	\N	D5170C00002-63879bfe-8317-11eb-be00-7b7513c6981f-3269	\N	NEW	\N	\N	\N	\N
86202	79	D5170C00002/tiny.path.1/file-4812.pdf	\N	D5170C00002-63881bc5-8318-11eb-be00-e508cd8b7d38-4812	\N	NEW	\N	\N	\N	\N
84660	79	D5170C00002/tiny.path.1/file-3270.pdf	\N	D5170C00002-638a0cff-8317-11eb-be00-4974c9ab895c-3270	\N	NEW	\N	\N	\N	\N
81823	79	D5170C00002/tiny.path.1/file-0433.pdf	\N	D5170C00002-6396f01a-8315-11eb-be00-b79393d91955-433	\N	NEW	\N	\N	\N	\N
84661	79	D5170C00002/tiny.path.1/file-3271.pdf	\N	D5170C00002-6397c8a0-8317-11eb-be00-e180628289c7-3271	\N	NEW	\N	\N	\N	\N
86203	79	D5170C00002/tiny.path.1/file-4813.pdf	\N	D5170C00002-63a6ee66-8318-11eb-be00-696e36081996-4813	\N	NEW	\N	\N	\N	\N
84662	79	D5170C00002/tiny.path.1/file-3272.pdf	\N	D5170C00002-63b71071-8317-11eb-be00-ad5e64747b3c-3272	\N	NEW	\N	\N	\N	\N
87550	79	D5170C00002/tiny.path.1/file-6160.pdf	\N	D5170C00002-63c4b969-8319-11eb-be00-634731c8916f-6160	\N	NEW	\N	\N	\N	\N
81824	79	D5170C00002/tiny.path.1/file-0434.pdf	\N	D5170C00002-63c6648b-8315-11eb-be00-85eee82c4781-434	\N	NEW	\N	\N	\N	\N
81825	79	D5170C00002/tiny.path.1/file-0435.pdf	\N	D5170C00002-63d57fbc-8315-11eb-be00-cbe33912d6d0-435	\N	NEW	\N	\N	\N	\N
83202	79	D5170C00002/tiny.path.1/file-1812.pdf	\N	D5170C00002-63d589ad-8316-11eb-be00-8b1f9060ffe2-1812	\N	NEW	\N	\N	\N	\N
84663	79	D5170C00002/tiny.path.1/file-3273.pdf	\N	D5170C00002-63e26632-8317-11eb-be00-7981927ffb03-3273	\N	NEW	\N	\N	\N	\N
84664	79	D5170C00002/tiny.path.1/file-3274.pdf	\N	D5170C00002-63e46203-8317-11eb-be00-4166b2c8d256-3274	\N	NEW	\N	\N	\N	\N
87551	79	D5170C00002/tiny.path.1/file-6161.xlsx	\N	D5170C00002-63f2802a-8319-11eb-be00-89ede2310b7f-6161	\N	NEW	\N	\N	\N	\N
84665	79	D5170C00002/tiny.path.1/file-3275.pdf	\N	D5170C00002-63f32f14-8317-11eb-be00-49ad6d1ff4da-3275	\N	NEW	\N	\N	\N	\N
81826	79	D5170C00002/tiny.path.1/file-0436.pdf	\N	D5170C00002-63f4525d-8315-11eb-be00-3130f5ae06aa-436	\N	NEW	\N	\N	\N	\N
84666	79	D5170C00002/tiny.path.1/file-3276.pdf	\N	D5170C00002-64035bb5-8317-11eb-be00-f19219814d51-3276	\N	NEW	\N	\N	\N	\N
84667	79	D5170C00002/tiny.path.1/file-3277.pdf	\N	D5170C00002-6411b396-8317-11eb-be00-f1e76b5b56b0-3277	\N	NEW	\N	\N	\N	\N
84668	79	D5170C00002/tiny.path.1/file-3278.pdf	\N	D5170C00002-641fe467-8317-11eb-be00-199e1a029e79-3278	\N	NEW	\N	\N	\N	\N
83203	79	D5170C00002/tiny.path.1/file-1813.pdf	\N	D5170C00002-6421119e-8316-11eb-be00-5561ca46a44c-1813	\N	NEW	\N	\N	\N	\N
86204	79	D5170C00002/tiny.path.1/file-4814.pdf	\N	D5170C00002-642ebc07-8318-11eb-be00-d74e2d824ccf-4814	\N	NEW	\N	\N	\N	\N
81827	79	D5170C00002/tiny.path.1/file-0437.pdf	\N	D5170C00002-6431826e-8315-11eb-be00-77be989aefb4-437	\N	NEW	\N	\N	\N	\N
81828	79	D5170C00002/tiny.path.1/file-0438.pdf	\N	D5170C00002-643f8c2f-8315-11eb-be00-014a120d18df-438	\N	NEW	\N	\N	\N	\N
83204	79	D5170C00002/tiny.path.1/file-1814.pdf	\N	D5170C00002-644d78cf-8316-11eb-be00-8fc2acbb5d98-1814	\N	NEW	\N	\N	\N	\N
81829	79	D5170C00002/tiny.path.1/file-0439.pdf	\N	D5170C00002-645c3bf0-8315-11eb-be00-8f49eb273c81-439	\N	NEW	\N	\N	\N	\N
81830	79	D5170C00002/tiny.path.1/file-0440.pdf	\N	D5170C00002-645f7041-8315-11eb-be00-d75e62470d3c-440	\N	NEW	\N	\N	\N	\N
83205	79	D5170C00002/tiny.path.1/file-1815.pdf	\N	D5170C00002-646bd640-8316-11eb-be00-b3eab061916b-1815	\N	NEW	\N	\N	\N	\N
81831	79	D5170C00002/tiny.path.1/file-0441.pdf	\N	D5170C00002-647c6e22-8315-11eb-be00-bf991cf8775b-441	\N	NEW	\N	\N	\N	\N
83206	79	D5170C00002/tiny.path.1/file-1816.pdf	\N	D5170C00002-64994ee1-8316-11eb-be00-db4a514bf84a-1816	\N	NEW	\N	\N	\N	\N
87552	79	D5170C00002/tiny.path.1/file-6162.pdf	\N	D5170C00002-649a31db-8319-11eb-be00-3d64ab2d8648-6162	\N	NEW	\N	\N	\N	\N
81832	79	D5170C00002/tiny.path.1/file-0442.pdf	\N	D5170C00002-64aad123-8315-11eb-be00-35bb69e771a2-442	\N	NEW	\N	\N	\N	\N
83207	79	D5170C00002/tiny.path.1/file-1817.pdf	\N	D5170C00002-64c7b1e2-8316-11eb-be00-5de49238d555-1817	\N	NEW	\N	\N	\N	\N
83208	79	D5170C00002/tiny.path.1/file-1818.pdf	\N	D5170C00002-64d657e3-8316-11eb-be00-c5b2d82f063d-1818	\N	NEW	\N	\N	\N	\N
86205	79	D5170C00002/tiny.path.1/file-4815.pdf	\N	D5170C00002-64d694c8-8318-11eb-be00-95e827baa8e3-4815	\N	NEW	\N	\N	\N	\N
81833	79	D5170C00002/tiny.path.1/file-0443.pdf	\N	D5170C00002-64d822b4-8315-11eb-be00-81ff605652fa-443	\N	NEW	\N	\N	\N	\N
83209	79	D5170C00002/tiny.path.1/file-1819.pdf	\N	D5170C00002-64e68484-8316-11eb-be00-510afefdfd38-1819	\N	NEW	\N	\N	\N	\N
87553	79	D5170C00002/tiny.path.1/file-6163.pdf	\N	D5170C00002-64f60d7c-8319-11eb-be00-6b27834d9d38-6163	\N	NEW	\N	\N	\N	\N
84669	79	D5170C00002/tiny.path.1/file-3279.pdf	\N	D5170C00002-64f7a6c8-8317-11eb-be00-893c7e978f52-3279	\N	NEW	\N	\N	\N	\N
83210	79	D5170C00002/tiny.path.1/file-1820.pdf	\N	D5170C00002-65055725-8316-11eb-be00-a7f8b6d670fe-1820	\N	NEW	\N	\N	\N	\N
83211	79	D5170C00002/tiny.path.1/file-1821.pdf	\N	D5170C00002-65155cb6-8316-11eb-be00-b9df1d41070b-1821	\N	NEW	\N	\N	\N	\N
86206	79	D5170C00002/tiny.path.1/file-4816.pdf	\N	D5170C00002-65230719-8318-11eb-be00-0f5842593bc8-4816	\N	NEW	\N	\N	\N	\N
83212	79	D5170C00002/tiny.path.1/file-1822.pdf	\N	D5170C00002-653281a7-8316-11eb-be00-f7a02a506981-1822	\N	NEW	\N	\N	\N	\N
83213	79	D5170C00002/tiny.path.1/file-1823.pdf	\N	D5170C00002-65421208-8316-11eb-be00-f1a1a95d8684-1823	\N	NEW	\N	\N	\N	\N
87554	79	D5170C00002/tiny.path.1/file-6164.pdf	\N	D5170C00002-65514cdd-8319-11eb-be00-67378ff24103-6164	\N	NEW	\N	\N	\N	\N
81834	79	D5170C00002/tiny.path.1/file-0444.pdf	\N	D5170C00002-655fc945-8315-11eb-be00-1d294b804db4-444	\N	NEW	\N	\N	\N	\N
86207	79	D5170C00002/tiny.path.1/file-4817.pdf	\N	D5170C00002-656fa07a-8318-11eb-be00-7d00eaab1b27-4817	\N	NEW	\N	\N	\N	\N
83214	79	D5170C00002/tiny.path.1/file-1824.pdf	\N	D5170C00002-65711149-8316-11eb-be00-5b459b198758-1824	\N	NEW	\N	\N	\N	\N
81835	79	D5170C00002/tiny.path.1/file-0445.pdf	\N	D5170C00002-657ffb76-8315-11eb-be00-2150978804e0-445	\N	NEW	\N	\N	\N	\N
86208	79	D5170C00002/tiny.path.1/file-4818.pdf	\N	D5170C00002-658e9a2b-8318-11eb-be00-1b1da6d2d355-4818	\N	NEW	\N	\N	\N	\N
87555	79	D5170C00002/tiny.path.1/file-6165.pdf	\N	D5170C00002-659de63e-8319-11eb-be00-6b7e65d00502-6165	\N	NEW	\N	\N	\N	\N
86209	79	D5170C00002/tiny.path.1/file-4819.pdf	\N	D5170C00002-659ec6cc-8318-11eb-be00-d5922dd2d3e9-4819	\N	NEW	\N	\N	\N	\N
87556	79	D5170C00002/tiny.path.1/file-6166.pdf	\N	D5170C00002-65ad016f-8319-11eb-be00-a9fdcb4d366b-6166	\N	NEW	\N	\N	\N	\N
84670	79	D5170C00002/tiny.path.1/file-3280.pdf	\N	D5170C00002-65aee8d9-8317-11eb-be00-cb6ee43afa1a-3280	\N	NEW	\N	\N	\N	\N
83215	79	D5170C00002/tiny.path.1/file-1825.msg	\N	D5170C00002-65bb87ca-8316-11eb-be00-152bffa08092-1825	\N	NEW	\N	\N	\N	\N
81836	79	D5170C00002/tiny.path.1/file-0446.pdf	\N	D5170C00002-65bd0477-8315-11eb-be00-3b3541ff148f-446	\N	NEW	\N	\N	\N	\N
87557	79	D5170C00002/tiny.path.1/file-6167.pdf	\N	D5170C00002-65c9ff50-8319-11eb-be00-2d8d45bc1e69-6167	\N	NEW	\N	\N	\N	\N
86210	79	D5170C00002/tiny.path.1/file-4820.pdf	\N	D5170C00002-65ca91bd-8318-11eb-be00-dde8543cb1a5-4820	\N	NEW	\N	\N	\N	\N
87558	79	D5170C00002/tiny.path.1/file-6168.pdf	\N	D5170C00002-65cce581-8319-11eb-be00-4d8e5c9aba8a-6168	\N	NEW	\N	\N	\N	\N
83216	79	D5170C00002/tiny.path.1/file-1826.msg	\N	D5170C00002-65cd13fb-8316-11eb-be00-8dc10309212c-1826	\N	NEW	\N	\N	\N	\N
87559	79	D5170C00002/tiny.path.1/file-6169.pdf	\N	D5170C00002-65dc00b2-8319-11eb-be00-7d3a81296baa-6169	\N	NEW	\N	\N	\N	\N
86211	79	D5170C00002/tiny.path.1/file-4821.pdf	\N	D5170C00002-65e8c81e-8318-11eb-be00-abde21899e7f-4821	\N	NEW	\N	\N	\N	\N
87560	79	D5170C00002/tiny.path.1/file-6170.pdf	\N	D5170C00002-65e99543-8319-11eb-be00-1b0c66cb764c-6170	\N	NEW	\N	\N	\N	\N
84671	79	D5170C00002/tiny.path.1/file-3281.pdf	\N	D5170C00002-65ea924a-8317-11eb-be00-a329913cff8b-3281	\N	NEW	\N	\N	\N	\N
83217	79	D5170C00002/tiny.path.1/file-1827.msg	\N	D5170C00002-65f92d0c-8316-11eb-be00-751fe59d3b43-1827	\N	NEW	\N	\N	\N	\N
86212	79	D5170C00002/tiny.path.1/file-4822.pdf	\N	D5170C00002-65faf08f-8318-11eb-be00-6f283c11d928-4822	\N	NEW	\N	\N	\N	\N
81837	79	D5170C00002/tiny.path.1/file-0447.pdf	\N	D5170C00002-6607f028-8315-11eb-be00-61bb51c19b6c-447	\N	NEW	\N	\N	\N	\N
83218	79	D5170C00002/tiny.path.1/file-1828.msg	\N	D5170C00002-6608bd6d-8316-11eb-be00-a55cabb09bf2-1828	\N	NEW	\N	\N	\N	\N
86213	79	D5170C00002/tiny.path.1/file-4823.pdf	\N	D5170C00002-6609bca0-8318-11eb-be00-5d5e8c61ca81-4823	\N	NEW	\N	\N	\N	\N
83219	79	D5170C00002/tiny.path.1/file-1829.msg	\N	D5170C00002-6617636e-8316-11eb-be00-13973be65f08-1829	\N	NEW	\N	\N	\N	\N
87561	79	D5170C00002/tiny.path.1/file-6171.pdf	\N	D5170C00002-6617f844-8319-11eb-be00-abc6c1a2c796-6171	\N	NEW	\N	\N	\N	\N
86214	79	D5170C00002/tiny.path.1/file-4824.pdf	\N	D5170C00002-661889b1-8318-11eb-be00-477b8a0d984b-4824	\N	NEW	\N	\N	\N	\N
86215	79	D5170C00002/tiny.path.1/file-4825.pdf	\N	D5170C00002-66353972-8318-11eb-be00-f1f9e5b2a936-4825	\N	NEW	\N	\N	\N	\N
86216	79	D5170C00002/tiny.path.1/file-4826.pdf	\N	D5170C00002-66456613-8318-11eb-be00-fde6e63990aa-4826	\N	NEW	\N	\N	\N	\N
87562	79	D5170C00002/tiny.path.1/file-6172.pdf	\N	D5170C00002-664597f5-8319-11eb-be00-cf292ecb3244-6172	\N	NEW	\N	\N	\N	\N
83220	79	D5170C00002/tiny.path.1/file-1830.msg	\N	D5170C00002-6646b0cf-8316-11eb-be00-09f3a3159239-1830	\N	NEW	\N	\N	\N	\N
86217	79	D5170C00002/tiny.path.1/file-4827.pdf	\N	D5170C00002-6649d2e4-8318-11eb-be00-93b726f02a57-4827	\N	NEW	\N	\N	\N	\N
86218	79	D5170C00002/tiny.path.1/file-4828.pdf	\N	D5170C00002-6656a425-8318-11eb-be00-8f88b3e8ef3c-4828	\N	NEW	\N	\N	\N	\N
83221	79	D5170C00002/tiny.path.1/file-1831.msg	\N	D5170C00002-666387a0-8316-11eb-be00-d9c4f56b11ce-1831	\N	NEW	\N	\N	\N	\N
86219	79	D5170C00002/tiny.path.1/file-4829.pdf	\N	D5170C00002-666486d6-8318-11eb-be00-c1efefc54922-4829	\N	NEW	\N	\N	\N	\N
86220	79	D5170C00002/tiny.path.1/file-4830.pdf	\N	D5170C00002-666682a7-8318-11eb-be00-6f81088dcc3c-4830	\N	NEW	\N	\N	\N	\N
86221	79	D5170C00002/tiny.path.1/file-4831.pdf	\N	D5170C00002-66741738-8318-11eb-be00-adf494a45f8b-4831	\N	NEW	\N	\N	\N	\N
87563	79	D5170C00002/tiny.path.1/file-6173.pdf	\N	D5170C00002-66747026-8319-11eb-be00-3de2c979cc2a-6173	\N	NEW	\N	\N	\N	\N
86222	79	D5170C00002/tiny.path.1/file-4832.pdf	\N	D5170C00002-6681d2d9-8318-11eb-be00-b115a5472edd-4832	\N	NEW	\N	\N	\N	\N
83222	79	D5170C00002/tiny.path.1/file-1832.msg	\N	D5170C00002-66825a41-8316-11eb-be00-c78a0ec689fb-1832	\N	NEW	\N	\N	\N	\N
86223	79	D5170C00002/tiny.path.1/file-4833.pdf	\N	D5170C00002-66929bba-8318-11eb-be00-43336a6bd50f-4833	\N	NEW	\N	\N	\N	\N
83223	79	D5170C00002/tiny.path.1/file-1833.msg	\N	D5170C00002-66a12ce2-8316-11eb-be00-7b50e4288f51-1833	\N	NEW	\N	\N	\N	\N
84672	79	D5170C00002/tiny.path.1/file-3282.pdf	\N	D5170C00002-66a1ad4b-8317-11eb-be00-f9d5a7977296-3282	\N	NEW	\N	\N	\N	\N
86224	79	D5170C00002/tiny.path.1/file-4834.pdf	\N	D5170C00002-66a2c85b-8318-11eb-be00-87df5f24c8c2-4834	\N	NEW	\N	\N	\N	\N
83224	79	D5170C00002/tiny.path.1/file-1834.msg	\N	D5170C00002-66a328b3-8316-11eb-be00-3d07f5e79b71-1834	\N	NEW	\N	\N	\N	\N
84673	79	D5170C00002/tiny.path.1/file-3283.pdf	\N	D5170C00002-66b24f1c-8317-11eb-be00-4f204eff7f61-3283	\N	NEW	\N	\N	\N	\N
83225	79	D5170C00002/tiny.path.1/file-1835.msg	\N	D5170C00002-66b2e024-8316-11eb-be00-c38a32d8388b-1835	\N	NEW	\N	\N	\N	\N
87564	79	D5170C00002/tiny.path.1/file-6174.pdf	\N	D5170C00002-66be7177-8319-11eb-be00-9f119bcb4bcc-6174	\N	NEW	\N	\N	\N	\N
86225	79	D5170C00002/tiny.path.1/file-4835.pdf	\N	D5170C00002-66bf29fc-8318-11eb-be00-5d1915621cd0-4835	\N	NEW	\N	\N	\N	\N
83226	79	D5170C00002/tiny.path.1/file-1836.msg	\N	D5170C00002-66cf8fe5-8316-11eb-be00-b9bb7ce5fd95-1836	\N	NEW	\N	\N	\N	\N
87565	79	D5170C00002/tiny.path.1/file-6175.pdf	\N	D5170C00002-66de0768-8319-11eb-be00-ad3efc9df370-6175	\N	NEW	\N	\N	\N	\N
87566	79	D5170C00002/tiny.path.1/file-6176.pdf	\N	D5170C00002-66eea939-8319-11eb-be00-6d69d264e4d9-6176	\N	NEW	\N	\N	\N	\N
83227	79	D5170C00002/tiny.path.1/file-1837.msg	\N	D5170C00002-66efe926-8316-11eb-be00-2d5cb7473f5d-1837	\N	NEW	\N	\N	\N	\N
87567	79	D5170C00002/tiny.path.1/file-6177.pdf	\N	D5170C00002-66fe128a-8319-11eb-be00-e7c32aba9e05-6177	\N	NEW	\N	\N	\N	\N
83228	79	D5170C00002/tiny.path.1/file-1838.msg	\N	D5170C00002-670b3957-8316-11eb-be00-c39818da6518-1838	\N	NEW	\N	\N	\N	\N
87568	79	D5170C00002/tiny.path.1/file-6178.pdf	\N	D5170C00002-671c6ffb-8319-11eb-be00-b54a5cbd713e-6178	\N	NEW	\N	\N	\N	\N
84674	79	D5170C00002/tiny.path.1/file-3284.pdf	\N	D5170C00002-673bca6d-8317-11eb-be00-d97c861d6bd5-3284	\N	NEW	\N	\N	\N	\N
83229	79	D5170C00002/tiny.path.1/file-1839.msg	\N	D5170C00002-674a3e28-8316-11eb-be00-b7c4ac957e40-1839	\N	NEW	\N	\N	\N	\N
83230	79	D5170C00002/tiny.path.1/file-1840.pdf	\N	D5170C00002-6767ff59-8316-11eb-be00-63c7df0de29c-1840	\N	NEW	\N	\N	\N	\N
84675	79	D5170C00002/tiny.path.1/file-3285.pdf	\N	D5170C00002-6776144e-8317-11eb-be00-536f570caf87-3285	\N	NEW	\N	\N	\N	\N
87569	79	D5170C00002/tiny.path.1/file-6179.pdf	\N	D5170C00002-67773a2c-8319-11eb-be00-33b571b44bda-6179	\N	NEW	\N	\N	\N	\N
83231	79	D5170C00002/tiny.path.1/file-1841.pdf	\N	D5170C00002-67865cca-8316-11eb-be00-131f0db794e6-1841	\N	NEW	\N	\N	\N	\N
81838	79	D5170C00002/tiny.path.1/file-0448.pdf	\N	D5170C00002-678679d9-8315-11eb-be00-db57e04f9c0a-448	\N	NEW	\N	\N	\N	\N
86226	79	D5170C00002/tiny.path.1/file-4836.pdf	\N	D5170C00002-6787aa1d-8318-11eb-be00-b1944ee7f8a3-4836	\N	NEW	\N	\N	\N	\N
87570	79	D5170C00002/tiny.path.1/file-6180.pdf	\N	D5170C00002-6795bead-8319-11eb-be00-cf40ac0169f3-6180	\N	NEW	\N	\N	\N	\N
84676	79	D5170C00002/tiny.path.1/file-3286.pdf	\N	D5170C00002-67a365df-8317-11eb-be00-9d6144725ca6-3286	\N	NEW	\N	\N	\N	\N
83232	79	D5170C00002/tiny.path.1/file-1842.pdf	\N	D5170C00002-67a4450b-8316-11eb-be00-df43bc5f9968-1842	\N	NEW	\N	\N	\N	\N
81839	79	D5170C00002/tiny.path.1/file-0449.pdf	\N	D5170C00002-67c2987a-8315-11eb-be00-d5400b0d0859-449	\N	NEW	\N	\N	\N	\N
84677	79	D5170C00002/tiny.path.1/file-3287.pdf	\N	D5170C00002-67c4cf90-8317-11eb-be00-157cbfcbfd68-3287	\N	NEW	\N	\N	\N	\N
84678	79	D5170C00002/tiny.path.1/file-3288.pdf	\N	D5170C00002-67d45ff1-8317-11eb-be00-7dbd0ab1b582-3288	\N	NEW	\N	\N	\N	\N
84679	79	D5170C00002/tiny.path.1/file-3289.pdf	\N	D5170C00002-67e32d02-8317-11eb-be00-bf0e06744d2c-3289	\N	NEW	\N	\N	\N	\N
87571	79	D5170C00002/tiny.path.1/file-6181.pdf	\N	D5170C00002-67f013ae-8319-11eb-be00-1b9a3ba919de-6181	\N	NEW	\N	\N	\N	\N
83233	79	D5170C00002/tiny.path.1/file-1843.pdf	\N	D5170C00002-67f3285c-8316-11eb-be00-adf455b48834-1843	\N	NEW	\N	\N	\N	\N
84714	79	D5170C00002/tiny.path.1/file-3324.pdf	\N	D5170C00002-68016363-8317-11eb-be00-29206202dda0-3290	\N	NEW	\N	\N	\N	\N
83234	79	D5170C00002/tiny.path.1/file-1844.pdf	\N	D5170C00002-680fb10d-8316-11eb-be00-dbbc8209c101-1844	\N	NEW	\N	\N	\N	\N
87572	79	D5170C00002/tiny.path.1/file-6182.pdf	\N	D5170C00002-6811092f-8319-11eb-be00-61fe777fe3d8-6182	\N	NEW	\N	\N	\N	\N
83235	79	D5170C00002/tiny.path.1/file-1845.pdf	\N	D5170C00002-682dc05e-8316-11eb-be00-9bbec4e76f2a-1845	\N	NEW	\N	\N	\N	\N
84686	79	D5170C00002/tiny.path.1/file-3296.pdf	\N	D5170C00002-682fc664-8317-11eb-be00-33aa24cc2083-3291	\N	NEW	\N	\N	\N	\N
81840	79	D5170C00002/tiny.path.1/file-0450.pdf	\N	D5170C00002-683c5c5b-8315-11eb-be00-03ad7a35d5c6-450	\N	NEW	\N	\N	\N	\N
84680	79	D5170C00002/tiny.path.1/file-3290.pdf	\N	D5170C00002-684c00f5-8317-11eb-be00-0126bd1b068a-3292	\N	NEW	\N	\N	\N	\N
86227	79	D5170C00002/tiny.path.1/file-4837.pdf	\N	D5170C00002-684c329e-8318-11eb-be00-0bbf6024ee7d-4837	\N	NEW	\N	\N	\N	\N
87573	79	D5170C00002/tiny.path.1/file-6183.pdf	\N	D5170C00002-684c8b90-8319-11eb-be00-b50ec0aed6aa-6183	\N	NEW	\N	\N	\N	\N
83236	79	D5170C00002/tiny.path.1/file-1846.pdf	\N	D5170C00002-684c92ff-8316-11eb-be00-43d92788c614-1846	\N	NEW	\N	\N	\N	\N
84681	79	D5170C00002/tiny.path.1/file-3291.pdf	\N	D5170C00002-685ca2c6-8317-11eb-be00-f7893e005d00-3293	\N	NEW	\N	\N	\N	\N
83237	79	D5170C00002/tiny.path.1/file-1847.pdf	\N	D5170C00002-6869df00-8316-11eb-be00-e1952fe2fb15-1847	\N	NEW	\N	\N	\N	\N
83238	79	D5170C00002/tiny.path.1/file-1848.pdf	\N	D5170C00002-686c01e1-8316-11eb-be00-b19a364ddf6d-1848	\N	NEW	\N	\N	\N	\N
86228	79	D5170C00002/tiny.path.1/file-4838.pdf	\N	D5170C00002-686c16af-8318-11eb-be00-0578269622b2-4838	\N	NEW	\N	\N	\N	\N
84682	79	D5170C00002/tiny.path.1/file-3292.pdf	\N	D5170C00002-686ccf67-8317-11eb-be00-850f1931e6b4-3294	\N	NEW	\N	\N	\N	\N
84683	79	D5170C00002/tiny.path.1/file-3293.pdf	\N	D5170C00002-68895818-8317-11eb-be00-cd9d1e6a2091-3295	\N	NEW	\N	\N	\N	\N
84684	79	D5170C00002/tiny.path.1/file-3294.pdf	\N	D5170C00002-68984c39-8317-11eb-be00-d58e32b2bfb3-3296	\N	NEW	\N	\N	\N	\N
87574	79	D5170C00002/tiny.path.1/file-6184.pdf	\N	D5170C00002-689af9b1-8319-11eb-be00-9793dacbdd6f-6184	\N	NEW	\N	\N	\N	\N
83239	79	D5170C00002/tiny.path.1/file-1849.pdf	\N	D5170C00002-68a78442-8316-11eb-be00-bfc656d161e5-1849	\N	NEW	\N	\N	\N	\N
84685	79	D5170C00002/tiny.path.1/file-3295.pdf	\N	D5170C00002-68a9151a-8317-11eb-be00-1b575f6e5b76-3297	\N	NEW	\N	\N	\N	\N
87575	79	D5170C00002/tiny.path.1/file-6185.pdf	\N	D5170C00002-68c7af02-8319-11eb-be00-57024a8d397c-6185	\N	NEW	\N	\N	\N	\N
83240	79	D5170C00002/tiny.path.1/file-1850.pdf	\N	D5170C00002-68c7b673-8316-11eb-be00-a7bbeb982671-1850	\N	NEW	\N	\N	\N	\N
84691	79	D5170C00002/tiny.path.1/file-3301.pdf	\N	D5170C00002-68d52e2b-8317-11eb-be00-23f9b9b278bf-3298	\N	NEW	\N	\N	\N	\N
87576	79	D5170C00002/tiny.path.1/file-6186.pdf	\N	D5170C00002-68e37463-8319-11eb-be00-eb8f8a0c2b73-6186	\N	NEW	\N	\N	\N	\N
86229	79	D5170C00002/tiny.path.1/file-4839.pdf	\N	D5170C00002-68e58c70-8318-11eb-be00-956980687718-4839	\N	NEW	\N	\N	\N	\N
84687	79	D5170C00002/tiny.path.1/file-3297.pdf	\N	D5170C00002-68e5cffc-8317-11eb-be00-75daafdf9357-3299	\N	NEW	\N	\N	\N	\N
86230	79	D5170C00002/tiny.path.1/file-4840.pdf	\N	D5170C00002-68f4ceb1-8318-11eb-be00-7ffbb98a0993-4840	\N	NEW	\N	\N	\N	\N
83241	79	D5170C00002/tiny.path.1/file-1851.pdf	\N	D5170C00002-68f5f264-8316-11eb-be00-3d46afb45eb5-1851	\N	NEW	\N	\N	\N	\N
84688	79	D5170C00002/tiny.path.1/file-3298.pdf	\N	D5170C00002-6902a6cd-8317-11eb-be00-1543a95165aa-3300	\N	NEW	\N	\N	\N	\N
81841	79	D5170C00002/tiny.path.1/file-0451.pdf	\N	D5170C00002-69052a9c-8315-11eb-be00-b14f405ff84c-451	\N	NEW	\N	\N	\N	\N
84689	79	D5170C00002/tiny.path.1/file-3299.pdf	\N	D5170C00002-69145a0e-8317-11eb-be00-736d00edc966-3301	\N	NEW	\N	\N	\N	\N
84690	79	D5170C00002/tiny.path.1/file-3300.pdf	\N	D5170C00002-6924117f-8317-11eb-be00-59d65d0f4949-3302	\N	NEW	\N	\N	\N	\N
87577	79	D5170C00002/tiny.path.1/file-6187.pdf	\N	D5170C00002-6932f3f4-8319-11eb-be00-9b3307067e0f-6187	\N	NEW	\N	\N	\N	\N
84692	79	D5170C00002/tiny.path.1/file-3302.pdf	\N	D5170C00002-69404c10-8317-11eb-be00-5d32a2dc3eda-3303	\N	NEW	\N	\N	\N	\N
84693	79	D5170C00002/tiny.path.1/file-3303.pdf	\N	D5170C00002-694220d1-8317-11eb-be00-2fbc3231a619-3304	\N	NEW	\N	\N	\N	\N
87578	79	D5170C00002/tiny.path.1/file-6188.pdf	\N	D5170C00002-696f60b5-8319-11eb-be00-bdaaa8ba22dd-6188	\N	NEW	\N	\N	\N	\N
81842	79	D5170C00002/tiny.path.1/file-0452.pdf	\N	D5170C00002-697ddd0d-8315-11eb-be00-b3cf44c2ad56-452	\N	NEW	\N	\N	\N	\N
86231	79	D5170C00002/tiny.path.1/file-4841.pdf	\N	D5170C00002-697e7112-8318-11eb-be00-0959694f83c5-4841	\N	NEW	\N	\N	\N	\N
83242	79	D5170C00002/tiny.path.1/file-1852.pdf	\N	D5170C00002-697fe2e5-8316-11eb-be00-ebc9caa815a3-1852	\N	NEW	\N	\N	\N	\N
83243	79	D5170C00002/tiny.path.1/file-1853.pdf	\N	D5170C00002-699b8136-8316-11eb-be00-6991054fd1ca-1853	\N	NEW	\N	\N	\N	\N
84694	79	D5170C00002/tiny.path.1/file-3304.pdf	\N	D5170C00002-69acf092-8317-11eb-be00-35a271cc8ff3-3305	\N	NEW	\N	\N	\N	\N
87579	79	D5170C00002/tiny.path.1/file-6189.pdf	\N	D5170C00002-69ba4c66-8319-11eb-be00-c7e194242da7-6189	\N	NEW	\N	\N	\N	\N
81843	79	D5170C00002/tiny.path.1/file-0453.pdf	\N	D5170C00002-69cb39be-8315-11eb-be00-513f2709cc3b-453	\N	NEW	\N	\N	\N	\N
83244	79	D5170C00002/tiny.path.1/file-1854.pdf	\N	D5170C00002-69d94d87-8316-11eb-be00-13f90dc65f24-1854	\N	NEW	\N	\N	\N	\N
84695	79	D5170C00002/tiny.path.1/file-3305.pdf	\N	D5170C00002-6a07e1d3-8317-11eb-be00-098e0fa7c22e-3306	\N	NEW	\N	\N	\N	\N
81844	79	D5170C00002/tiny.path.1/file-0454.pdf	\N	D5170C00002-6a15fe5f-8315-11eb-be00-0b1c06bbde29-454	\N	NEW	\N	\N	\N	\N
87580	79	D5170C00002/tiny.path.1/file-6190.pdf	\N	D5170C00002-6a24a6f7-8319-11eb-be00-87b03fb2d6f4-6190	\N	NEW	\N	\N	\N	\N
83245	79	D5170C00002/tiny.path.1/file-1855.pdf	\N	D5170C00002-6a348ce8-8316-11eb-be00-33911f3c058e-1855	\N	NEW	\N	\N	\N	\N
81845	79	D5170C00002/tiny.path.1/file-0455.pdf	\N	D5170C00002-6a4328e0-8315-11eb-be00-2fc404b6eac6-455	\N	NEW	\N	\N	\N	\N
86232	79	D5170C00002/tiny.path.1/file-4842.pdf	\N	D5170C00002-6a443213-8318-11eb-be00-f73168e03857-4842	\N	NEW	\N	\N	\N	\N
81846	79	D5170C00002/tiny.path.1/file-0456.pdf	\N	D5170C00002-6a532e71-8315-11eb-be00-31280f2d7af9-456	\N	NEW	\N	\N	\N	\N
84696	79	D5170C00002/tiny.path.1/file-3306.pdf	\N	D5170C00002-6a61e8b4-8317-11eb-be00-2d05994af35b-3307	\N	NEW	\N	\N	\N	\N
87581	79	D5170C00002/tiny.path.1/file-6191.pdf	\N	D5170C00002-6a627348-8319-11eb-be00-a7a2c74cb8e0-6191	\N	NEW	\N	\N	\N	\N
83246	79	D5170C00002/tiny.path.1/file-1856.pdf	\N	D5170C00002-6a62efe9-8316-11eb-be00-e7950f68026a-1856	\N	NEW	\N	\N	\N	\N
81847	79	D5170C00002/tiny.path.1/file-0457.pdf	\N	D5170C00002-6a633402-8315-11eb-be00-d5725522bc48-457	\N	NEW	\N	\N	\N	\N
83247	79	D5170C00002/tiny.path.1/file-1857.pdf	\N	D5170C00002-6a808a0a-8316-11eb-be00-4f99a6c178cc-1857	\N	NEW	\N	\N	\N	\N
86233	79	D5170C00002/tiny.path.1/file-4843.pdf	\N	D5170C00002-6a9203f4-8318-11eb-be00-630f46be91a7-4843	\N	NEW	\N	\N	\N	\N
84697	79	D5170C00002/tiny.path.1/file-3307.pdf	\N	D5170C00002-6a9ecaa5-8317-11eb-be00-1dafb2aff992-3308	\N	NEW	\N	\N	\N	\N
81848	79	D5170C00002/tiny.path.1/file-0458.pdf	\N	D5170C00002-6aadd193-8315-11eb-be00-3562762c2c13-458	\N	NEW	\N	\N	\N	\N
83248	79	D5170C00002/tiny.path.1/file-1858.pdf	\N	D5170C00002-6aae02ab-8316-11eb-be00-a39717639cf7-1858	\N	NEW	\N	\N	\N	\N
81849	79	D5170C00002/tiny.path.1/file-0459.pdf	\N	D5170C00002-6acd6784-8315-11eb-be00-e99230d8e900-459	\N	NEW	\N	\N	\N	\N
84698	79	D5170C00002/tiny.path.1/file-3308.pdf	\N	D5170C00002-6acdf0f6-8317-11eb-be00-c1693cbc3986-3309	\N	NEW	\N	\N	\N	\N
81850	79	D5170C00002/tiny.path.1/file-0460.pdf	\N	D5170C00002-6addbb35-8315-11eb-be00-c970ce92368a-460	\N	NEW	\N	\N	\N	\N
87582	79	D5170C00002/tiny.path.1/file-6192.pdf	\N	D5170C00002-6aea67f9-8319-11eb-be00-3b84fb373f60-6192	\N	NEW	\N	\N	\N	\N
87583	79	D5170C00002/tiny.path.1/file-6193.pdf	\N	D5170C00002-6aecd8fa-8319-11eb-be00-27a64ae13c6f-6193	\N	NEW	\N	\N	\N	\N
81851	79	D5170C00002/tiny.path.1/file-0461.pdf	\N	D5170C00002-6aed99b6-8315-11eb-be00-ef38d4095427-461	\N	NEW	\N	\N	\N	\N
83249	79	D5170C00002/tiny.path.1/file-1859.pdf	\N	D5170C00002-6afaea2c-8316-11eb-be00-2116b2767929-1859	\N	NEW	\N	\N	\N	\N
87584	79	D5170C00002/tiny.path.1/file-6194.pdf	\N	D5170C00002-6b08ec7b-8319-11eb-be00-015541b85a5a-6194	\N	NEW	\N	\N	\N	\N
86234	79	D5170C00002/tiny.path.1/file-4844.pdf	\N	D5170C00002-6b092fc5-8318-11eb-be00-b3228f8630fa-4844	\N	NEW	\N	\N	\N	\N
81852	79	D5170C00002/tiny.path.1/file-0462.pdf	\N	D5170C00002-6b095f17-8315-11eb-be00-edcd0191cbd6-462	\N	NEW	\N	\N	\N	\N
83250	79	D5170C00002/tiny.path.1/file-1860.pdf	\N	D5170C00002-6b0c283d-8316-11eb-be00-752527795092-1860	\N	NEW	\N	\N	\N	\N
81853	79	D5170C00002/tiny.path.1/file-0463.pdf	\N	D5170C00002-6b18ef78-8315-11eb-be00-47067aa2fe98-463	\N	NEW	\N	\N	\N	\N
81854	79	D5170C00002/tiny.path.1/file-0464.pdf	\N	D5170C00002-6b1b3969-8315-11eb-be00-816f76d19366-464	\N	NEW	\N	\N	\N	\N
83251	79	D5170C00002/tiny.path.1/file-1861.pdf	\N	D5170C00002-6b28b0ee-8316-11eb-be00-c1ec2f3a5e68-1861	\N	NEW	\N	\N	\N	\N
87585	79	D5170C00002/tiny.path.1/file-6195.pdf	\N	D5170C00002-6b28d08c-8319-11eb-be00-87aa17e837d9-6195	\N	NEW	\N	\N	\N	\N
81855	79	D5170C00002/tiny.path.1/file-0465.pdf	\N	D5170C00002-6b29b85a-8315-11eb-be00-915993c9d0eb-465	\N	NEW	\N	\N	\N	\N
84699	79	D5170C00002/tiny.path.1/file-3309.pdf	\N	D5170C00002-6b378837-8317-11eb-be00-1764eb5e8756-3310	\N	NEW	\N	\N	\N	\N
86235	79	D5170C00002/tiny.path.1/file-4845.pdf	\N	D5170C00002-6b38a436-8318-11eb-be00-7dd034c5b16a-4845	\N	NEW	\N	\N	\N	\N
87586	79	D5170C00002/tiny.path.1/file-6196.pdf	\N	D5170C00002-6b47ca3d-8319-11eb-be00-7b8330db7aad-6196	\N	NEW	\N	\N	\N	\N
81856	79	D5170C00002/tiny.path.1/file-0466.pdf	\N	D5170C00002-6b48b20b-8315-11eb-be00-8d0f5fa04dfd-466	\N	NEW	\N	\N	\N	\N
83252	79	D5170C00002/tiny.path.1/file-1862.pdf	\N	D5170C00002-6b497f5f-8316-11eb-be00-3dbf46df5ddb-1862	\N	NEW	\N	\N	\N	\N
87587	79	D5170C00002/tiny.path.1/file-6197.pdf	\N	D5170C00002-6b56e56e-8319-11eb-be00-31995056aef8-6197	\N	NEW	\N	\N	\N	\N
84700	79	D5170C00002/tiny.path.1/file-3310.pdf	\N	D5170C00002-6b582f98-8317-11eb-be00-1995fbe53004-3311	\N	NEW	\N	\N	\N	\N
84701	79	D5170C00002/tiny.path.1/file-3311.pdf	\N	D5170C00002-6b6771d9-8317-11eb-be00-3d4c324de7ff-3312	\N	NEW	\N	\N	\N	\N
81857	79	D5170C00002/tiny.path.1/file-0467.pdf	\N	D5170C00002-6b7455ec-8315-11eb-be00-33f12ffebe46-467	\N	NEW	\N	\N	\N	\N
87588	79	D5170C00002/tiny.path.1/file-6198.pdf	\N	D5170C00002-6b74a69f-8319-11eb-be00-4bd6d60f166b-6198	\N	NEW	\N	\N	\N	\N
83253	79	D5170C00002/tiny.path.1/file-1863.pdf	\N	D5170C00002-6b7634b0-8316-11eb-be00-a592edd91bd1-1863	\N	NEW	\N	\N	\N	\N
87589	79	D5170C00002/tiny.path.1/file-6199.pdf	\N	D5170C00002-6b839ac0-8319-11eb-be00-75562304ac7b-6199	\N	NEW	\N	\N	\N	\N
84702	79	D5170C00002/tiny.path.1/file-3312.pdf	\N	D5170C00002-6b84219a-8317-11eb-be00-dda807a2f02c-3313	\N	NEW	\N	\N	\N	\N
84703	79	D5170C00002/tiny.path.1/file-3313.pdf	\N	D5170C00002-6b861d6b-8317-11eb-be00-09dfb4135d80-3314	\N	NEW	\N	\N	\N	\N
81858	79	D5170C00002/tiny.path.1/file-0468.pdf	\N	D5170C00002-6b93c4cd-8315-11eb-be00-4bb7a15ffff0-468	\N	NEW	\N	\N	\N	\N
84704	79	D5170C00002/tiny.path.1/file-3314.pdf	\N	D5170C00002-6ba257fc-8317-11eb-be00-9971c23a59ab-3315	\N	NEW	\N	\N	\N	\N
81859	79	D5170C00002/tiny.path.1/file-0469.pdf	\N	D5170C00002-6ba48dae-8315-11eb-be00-17de4cf5863c-469	\N	NEW	\N	\N	\N	\N
87590	79	D5170C00002/tiny.path.1/file-6200.pdf	\N	D5170C00002-6bb224d1-8319-11eb-be00-934f07f52629-6200	\N	NEW	\N	\N	\N	\N
81860	79	D5170C00002/tiny.path.1/file-0470.pdf	\N	D5170C00002-6bb30c9f-8315-11eb-be00-a7db8c3c8c2a-470	\N	NEW	\N	\N	\N	\N
84705	79	D5170C00002/tiny.path.1/file-3315.pdf	\N	D5170C00002-6bc08e5d-8317-11eb-be00-e1e726a26b12-3316	\N	NEW	\N	\N	\N	\N
81861	79	D5170C00002/tiny.path.1/file-0471.pdf	\N	D5170C00002-6bc31130-8315-11eb-be00-b727000606f1-471	\N	NEW	\N	\N	\N	\N
81862	79	D5170C00002/tiny.path.1/file-0472.pdf	\N	D5170C00002-6bd22c61-8315-11eb-be00-41c1121ef8ac-472	\N	NEW	\N	\N	\N	\N
84706	79	D5170C00002/tiny.path.1/file-3316.pdf	\N	D5170C00002-6bdeebce-8317-11eb-be00-c7dcf5d20ac9-3317	\N	NEW	\N	\N	\N	\N
86251	79	D5170C00002/tiny.path.1/file-4861.pdf	\N	D5170C00002-6bdfb9a7-8318-11eb-be00-23d8c175c91d-4846	\N	NEW	\N	\N	\N	\N
83254	79	D5170C00002/tiny.path.1/file-1864.pdf	\N	D5170C00002-6be08f41-8316-11eb-be00-d305c66dd374-1864	\N	NEW	\N	\N	\N	\N
87591	79	D5170C00002/tiny.path.1/file-6201.pdf	\N	D5170C00002-6be1e762-8319-11eb-be00-e146e5e18727-6201	\N	NEW	\N	\N	\N	\N
84707	79	D5170C00002/tiny.path.1/file-3317.pdf	\N	D5170C00002-6bef186f-8317-11eb-be00-edc82c786439-3318	\N	NEW	\N	\N	\N	\N
81863	79	D5170C00002/tiny.path.1/file-0473.pdf	\N	D5170C00002-6bf062c2-8315-11eb-be00-77054cbebc03-473	\N	NEW	\N	\N	\N	\N
83255	79	D5170C00002/tiny.path.1/file-1865.pdf	\N	D5170C00002-6c00c172-8316-11eb-be00-b165b9261e7e-1865	\N	NEW	\N	\N	\N	\N
84708	79	D5170C00002/tiny.path.1/file-3318.pdf	\N	D5170C00002-6c0dc400-8317-11eb-be00-7742d7f9f3ef-3319	\N	NEW	\N	\N	\N	\N
81864	79	D5170C00002/tiny.path.1/file-0474.pdf	\N	D5170C00002-6c0f3563-8315-11eb-be00-ffe9e7f5acf7-474	\N	NEW	\N	\N	\N	\N
86236	79	D5170C00002/tiny.path.1/file-4846.pdf	\N	D5170C00002-6c1c9b98-8318-11eb-be00-4f4baf516ca7-4847	\N	NEW	\N	\N	\N	\N
84709	79	D5170C00002/tiny.path.1/file-3319.pdf	\N	D5170C00002-6c1df0a1-8317-11eb-be00-bd5d0830c512-3320	\N	NEW	\N	\N	\N	\N
86237	79	D5170C00002/tiny.path.1/file-4847.pdf	\N	D5170C00002-6c2cef49-8318-11eb-be00-018fb78f790c-4848	\N	NEW	\N	\N	\N	\N
83256	79	D5170C00002/tiny.path.1/file-1866.pdf	\N	D5170C00002-6c2d28a3-8316-11eb-be00-3bc00e77eef9-1866	\N	NEW	\N	\N	\N	\N
81865	79	D5170C00002/tiny.path.1/file-0475.pdf	\N	D5170C00002-6c3a8b24-8315-11eb-be00-a1814b78fda6-475	\N	NEW	\N	\N	\N	\N
87592	79	D5170C00002/tiny.path.1/file-6202.pdf	\N	D5170C00002-6c3b2af3-8319-11eb-be00-799612531772-6202	\N	NEW	\N	\N	\N	\N
86238	79	D5170C00002/tiny.path.1/file-4848.pdf	\N	D5170C00002-6c49c61a-8318-11eb-be00-29a39dba152e-4849	\N	NEW	\N	\N	\N	\N
86239	79	D5170C00002/tiny.path.1/file-4849.pdf	\N	D5170C00002-6c58ba3b-8318-11eb-be00-a76fcf355949-4850	\N	NEW	\N	\N	\N	\N
84710	79	D5170C00002/tiny.path.1/file-3320.pdf	\N	D5170C00002-6c594bf2-8317-11eb-be00-635341a08fc0-3321	\N	NEW	\N	\N	\N	\N
86240	79	D5170C00002/tiny.path.1/file-4850.pdf	\N	D5170C00002-6c5a19cc-8318-11eb-be00-15d599120a5e-4851	\N	NEW	\N	\N	\N	\N
87593	79	D5170C00002/tiny.path.1/file-6203.pdf	\N	D5170C00002-6c680754-8319-11eb-be00-97e49c13a084-6203	\N	NEW	\N	\N	\N	\N
81866	79	D5170C00002/tiny.path.1/file-0476.pdf	\N	D5170C00002-6c68a005-8315-11eb-be00-2783c0ac0458-476	\N	NEW	\N	\N	\N	\N
84711	79	D5170C00002/tiny.path.1/file-3321.pdf	\N	D5170C00002-6c68b543-8317-11eb-be00-b1f0d08de370-3322	\N	NEW	\N	\N	\N	\N
84712	79	D5170C00002/tiny.path.1/file-3322.pdf	\N	D5170C00002-6c6a62f4-8317-11eb-be00-15869a2aa54b-3323	\N	NEW	\N	\N	\N	\N
86241	79	D5170C00002/tiny.path.1/file-4851.pdf	\N	D5170C00002-6c773ebd-8318-11eb-be00-475e8d02c888-4852	\N	NEW	\N	\N	\N	\N
87594	79	D5170C00002/tiny.path.1/file-6204.pdf	\N	D5170C00002-6c774995-8319-11eb-be00-4bd07495d5a6-6204	\N	NEW	\N	\N	\N	\N
81867	79	D5170C00002/tiny.path.1/file-0477.pdf	\N	D5170C00002-6c78a596-8315-11eb-be00-617a713471ac-477	\N	NEW	\N	\N	\N	\N
84713	79	D5170C00002/tiny.path.1/file-3323.pdf	\N	D5170C00002-6c7a6885-8317-11eb-be00-5b0ee834ce3d-3324	\N	NEW	\N	\N	\N	\N
86242	79	D5170C00002/tiny.path.1/file-4852.pdf	\N	D5170C00002-6c89672e-8318-11eb-be00-cb8384b4e2d1-4853	\N	NEW	\N	\N	\N	\N
83257	79	D5170C00002/tiny.path.1/file-1867.pdf	\N	D5170C00002-6c970e04-8316-11eb-be00-6999416c506d-1867	\N	NEW	\N	\N	\N	\N
87595	79	D5170C00002/tiny.path.1/file-6205.pdf	\N	D5170C00002-6c9754b6-8319-11eb-be00-0db999e33ac4-6205	\N	NEW	\N	\N	\N	\N
86243	79	D5170C00002/tiny.path.1/file-4853.pdf	\N	D5170C00002-6ca4de6f-8318-11eb-be00-7d40ed581b78-4854	\N	NEW	\N	\N	\N	\N
81868	79	D5170C00002/tiny.path.1/file-0478.pdf	\N	D5170C00002-6ca581f7-8315-11eb-be00-099cd31147cd-478	\N	NEW	\N	\N	\N	\N
81869	79	D5170C00002/tiny.path.1/file-0479.pdf	\N	D5170C00002-6cb4c438-8315-11eb-be00-09ce33e7454f-479	\N	NEW	\N	\N	\N	\N
84715	79	D5170C00002/tiny.path.1/file-3325.pdf	\N	D5170C00002-6cb72366-8317-11eb-be00-ff18e0ae342e-3325	\N	NEW	\N	\N	\N	\N
81870	79	D5170C00002/tiny.path.1/file-0480.pdf	\N	D5170C00002-6cc3df69-8315-11eb-be00-a199ca88f4e7-480	\N	NEW	\N	\N	\N	\N
87596	79	D5170C00002/tiny.path.1/file-6206.pdf	\N	D5170C00002-6cc3e2f7-8319-11eb-be00-3dae4012284f-6206	\N	NEW	\N	\N	\N	\N
86244	79	D5170C00002/tiny.path.1/file-4854.pdf	\N	D5170C00002-6cd3ddb0-8318-11eb-be00-f536556f765c-4855	\N	NEW	\N	\N	\N	\N
84716	79	D5170C00002/tiny.path.1/file-3326.pdf	\N	D5170C00002-6cd61d17-8317-11eb-be00-6794defb6395-3326	\N	NEW	\N	\N	\N	\N
81871	79	D5170C00002/tiny.path.1/file-0481.pdf	\N	D5170C00002-6ce28afa-8315-11eb-be00-9bc74c2ddd0e-481	\N	NEW	\N	\N	\N	\N
87597	79	D5170C00002/tiny.path.1/file-6207.pdf	\N	D5170C00002-6cf10d78-8319-11eb-be00-53f9c052c84e-6207	\N	NEW	\N	\N	\N	\N
86245	79	D5170C00002/tiny.path.1/file-4855.pdf	\N	D5170C00002-6cf1c5f1-8318-11eb-be00-97ba80463bde-4856	\N	NEW	\N	\N	\N	\N
83258	79	D5170C00002/tiny.path.1/file-1868.pdf	\N	D5170C00002-6cf24d65-8316-11eb-be00-1728ecab06a8-1868	\N	NEW	\N	\N	\N	\N
87598	79	D5170C00002/tiny.path.1/file-6208.pdf	\N	D5170C00002-6d01fd69-8319-11eb-be00-734885527d2b-6208	\N	NEW	\N	\N	\N	\N
86246	79	D5170C00002/tiny.path.1/file-4856.pdf	\N	D5170C00002-6d028ed2-8318-11eb-be00-4d629910c00d-4857	\N	NEW	\N	\N	\N	\N
81872	79	D5170C00002/tiny.path.1/file-0482.pdf	\N	D5170C00002-6d02e43b-8315-11eb-be00-17eec3886c86-482	\N	NEW	\N	\N	\N	\N
87599	79	D5170C00002/tiny.path.1/file-6209.pdf	\N	D5170C00002-6d1efb4a-8319-11eb-be00-63ac1237ed58-6209	\N	NEW	\N	\N	\N	\N
86247	79	D5170C00002/tiny.path.1/file-4857.pdf	\N	D5170C00002-6d1f1783-8318-11eb-be00-dd48c07497b8-4858	\N	NEW	\N	\N	\N	\N
81873	79	D5170C00002/tiny.path.1/file-0483.pdf	\N	D5170C00002-6d1f93fc-8315-11eb-be00-61a4d5c30d08-483	\N	NEW	\N	\N	\N	\N
87630	79	D5170C00002/tiny.path.1/file-6240.pdf	\N	D5170C00002-6d216c4b-8319-11eb-be00-290fe4b02957-6210	\N	NEW	\N	\N	\N	\N
81874	79	D5170C00002/tiny.path.1/file-0484.pdf	\N	D5170C00002-6d22531d-8315-11eb-be00-dda6b537a715-484	\N	NEW	\N	\N	\N	\N
83259	79	D5170C00002/tiny.path.1/file-1869.pdf	\N	D5170C00002-6d2f2f56-8316-11eb-be00-5157e8ef7dd7-1869	\N	NEW	\N	\N	\N	\N
86248	79	D5170C00002/tiny.path.1/file-4858.pdf	\N	D5170C00002-6d30f1d4-8318-11eb-be00-1d87b95dba7f-4859	\N	NEW	\N	\N	\N	\N
81875	79	D5170C00002/tiny.path.1/file-0485.pdf	\N	D5170C00002-6d3e187e-8315-11eb-be00-91f9d6ef01b5-485	\N	NEW	\N	\N	\N	\N
87600	79	D5170C00002/tiny.path.1/file-6210.pdf	\N	D5170C00002-6d3eb84c-8319-11eb-be00-6510f2493773-6211	\N	NEW	\N	\N	\N	\N
87601	79	D5170C00002/tiny.path.1/file-6211.pdf	\N	D5170C00002-6d4c9afd-8319-11eb-be00-2f0fe93430c0-6212	\N	NEW	\N	\N	\N	\N
84717	79	D5170C00002/tiny.path.1/file-3327.pdf	\N	D5170C00002-6d4de528-8317-11eb-be00-376bda52a967-3327	\N	NEW	\N	\N	\N	\N
86249	79	D5170C00002/tiny.path.1/file-4859.pdf	\N	D5170C00002-6d4f9d65-8318-11eb-be00-f77f6632adc9-4860	\N	NEW	\N	\N	\N	\N
87602	79	D5170C00002/tiny.path.1/file-6212.pdf	\N	D5170C00002-6d4fa83e-8319-11eb-be00-bdecaab978e9-6213	\N	NEW	\N	\N	\N	\N
81876	79	D5170C00002/tiny.path.1/file-0486.pdf	\N	D5170C00002-6d5c75ef-8315-11eb-be00-3fa1f26ed108-486	\N	NEW	\N	\N	\N	\N
87603	79	D5170C00002/tiny.path.1/file-6213.pdf	\N	D5170C00002-6d5c797f-8319-11eb-be00-1186a0930996-6214	\N	NEW	\N	\N	\N	\N
87604	79	D5170C00002/tiny.path.1/file-6214.pdf	\N	D5170C00002-6d5d63e0-8319-11eb-be00-213e3f8a48d2-6215	\N	NEW	\N	\N	\N	\N
87605	79	D5170C00002/tiny.path.1/file-6215.pdf	\N	D5170C00002-6d5ec371-8319-11eb-be00-f9749f69b6d8-6216	\N	NEW	\N	\N	\N	\N
81877	79	D5170C00002/tiny.path.1/file-0487.pdf	\N	D5170C00002-6d6bdf40-8315-11eb-be00-699f5921cdec-487	\N	NEW	\N	\N	\N	\N
87606	79	D5170C00002/tiny.path.1/file-6216.pdf	\N	D5170C00002-6d6d6972-8319-11eb-be00-6fd4a360c857-6217	\N	NEW	\N	\N	\N	\N
86250	79	D5170C00002/tiny.path.1/file-4860.pdf	\N	D5170C00002-6d6e21e6-8318-11eb-be00-2b657f31a3d0-4861	\N	NEW	\N	\N	\N	\N
81878	79	D5170C00002/tiny.path.1/file-0488.pdf	\N	D5170C00002-6d7b2181-8315-11eb-be00-a3897dbbd19f-488	\N	NEW	\N	\N	\N	\N
84718	79	D5170C00002/tiny.path.1/file-3328.pdf	\N	D5170C00002-6d7bd2f9-8317-11eb-be00-c7ca651a3ca2-3328	\N	NEW	\N	\N	\N	\N
87607	79	D5170C00002/tiny.path.1/file-6217.pdf	\N	D5170C00002-6d7c84a3-8319-11eb-be00-55eed1b94787-6218	\N	NEW	\N	\N	\N	\N
87608	79	D5170C00002/tiny.path.1/file-6218.pdf	\N	D5170C00002-6d7d47f4-8319-11eb-be00-4f502193e457-6219	\N	NEW	\N	\N	\N	\N
84719	79	D5170C00002/tiny.path.1/file-3329.pdf	\N	D5170C00002-6d8ac71a-8317-11eb-be00-ff0b5dd38b5b-3329	\N	NEW	\N	\N	\N	\N
83260	79	D5170C00002/tiny.path.1/file-1870.pdf	\N	D5170C00002-6d8c6a87-8316-11eb-be00-096809feec35-1870	\N	NEW	\N	\N	\N	\N
87609	79	D5170C00002/tiny.path.1/file-6219.pdf	\N	D5170C00002-6d990d55-8319-11eb-be00-b1355635fa2a-6220	\N	NEW	\N	\N	\N	\N
86252	79	D5170C00002/tiny.path.1/file-4862.pdf	\N	D5170C00002-6d99ecd7-8318-11eb-be00-3bd3254881d4-4862	\N	NEW	\N	\N	\N	\N
83261	79	D5170C00002/tiny.path.1/file-1871.pdf	\N	D5170C00002-6da8a518-8316-11eb-be00-4543fa2a9ebb-1871	\N	NEW	\N	\N	\N	\N
86253	79	D5170C00002/tiny.path.1/file-4863.pdf	\N	D5170C00002-6da97d38-8318-11eb-be00-1d5df5d306b3-4863	\N	NEW	\N	\N	\N	\N
84720	79	D5170C00002/tiny.path.1/file-3330.pdf	\N	D5170C00002-6daa841b-8317-11eb-be00-49b557cb43ff-3330	\N	NEW	\N	\N	\N	\N
87610	79	D5170C00002/tiny.path.1/file-6220.pdf	\N	D5170C00002-6db9b4b6-8319-11eb-be00-9ba29cac8d0b-6221	\N	NEW	\N	\N	\N	\N
81879	79	D5170C00002/tiny.path.1/file-0489.pdf	\N	D5170C00002-6db9d832-8315-11eb-be00-090a1bf8e100-489	\N	NEW	\N	\N	\N	\N
83262	79	D5170C00002/tiny.path.1/file-1872.pdf	\N	D5170C00002-6dc88929-8316-11eb-be00-2d47e3778325-1872	\N	NEW	\N	\N	\N	\N
86254	79	D5170C00002/tiny.path.1/file-4864.pdf	\N	D5170C00002-6dd6f5d9-8318-11eb-be00-297b7d58f437-4864	\N	NEW	\N	\N	\N	\N
83263	79	D5170C00002/tiny.path.1/file-1873.pdf	\N	D5170C00002-6dd92afa-8316-11eb-be00-c344cf7171ad-1873	\N	NEW	\N	\N	\N	\N
86255	79	D5170C00002/tiny.path.1/file-4865.pdf	\N	D5170C00002-6de5e9fa-8318-11eb-be00-63cf7a03e4c9-4865	\N	NEW	\N	\N	\N	\N
87611	79	D5170C00002/tiny.path.1/file-6221.pdf	\N	D5170C00002-6df4c1e7-8319-11eb-be00-6fb20d30df89-6222	\N	NEW	\N	\N	\N	\N
84721	79	D5170C00002/tiny.path.1/file-3331.msg	\N	D5170C00002-6df76b9c-8317-11eb-be00-7136f32aa4c2-3331	\N	NEW	\N	\N	\N	\N
83264	79	D5170C00002/tiny.path.1/file-1874.pdf	\N	D5170C00002-6e04cedb-8316-11eb-be00-6f8ad63a484b-1874	\N	NEW	\N	\N	\N	\N
86256	79	D5170C00002/tiny.path.1/file-4866.pdf	\N	D5170C00002-6e13b0bb-8318-11eb-be00-7b82899f9604-4866	\N	NEW	\N	\N	\N	\N
87612	79	D5170C00002/tiny.path.1/file-6222.pdf	\N	D5170C00002-6e13bb98-8319-11eb-be00-d1b6aa8993ab-6223	\N	NEW	\N	\N	\N	\N
83265	79	D5170C00002/tiny.path.1/file-1875.pdf	\N	D5170C00002-6e1597bc-8316-11eb-be00-f7b519e132e0-1875	\N	NEW	\N	\N	\N	\N
84722	79	D5170C00002/tiny.path.1/file-3332.msg	\N	D5170C00002-6e230f7d-8317-11eb-be00-db3de255854b-3332	\N	NEW	\N	\N	\N	\N
87613	79	D5170C00002/tiny.path.1/file-6223.pdf	\N	D5170C00002-6e31f1f9-8319-11eb-be00-279b3d0c4e1a-6224	\N	NEW	\N	\N	\N	\N
81880	79	D5170C00002/tiny.path.1/file-0490.pdf	\N	D5170C00002-6e345f63-8315-11eb-be00-1f4be4c02c09-490	\N	NEW	\N	\N	\N	\N
86257	79	D5170C00002/tiny.path.1/file-4867.pdf	\N	D5170C00002-6e40db3c-8318-11eb-be00-19f8c512a6fd-4867	\N	NEW	\N	\N	\N	\N
87614	79	D5170C00002/tiny.path.1/file-6224.pdf	\N	D5170C00002-6e415b4a-8319-11eb-be00-9512b7be2467-6225	\N	NEW	\N	\N	\N	\N
83266	79	D5170C00002/tiny.path.1/file-1876.pdf	\N	D5170C00002-6e43d3ad-8316-11eb-be00-7f06bb6e486e-1876	\N	NEW	\N	\N	\N	\N
84723	79	D5170C00002/tiny.path.1/file-3333.msg	\N	D5170C00002-6e51245e-8317-11eb-be00-ddd772abac51-3333	\N	NEW	\N	\N	\N	\N
83267	79	D5170C00002/tiny.path.1/file-1877.pdf	\N	D5170C00002-6e51683e-8316-11eb-be00-aba7b4ab5741-1877	\N	NEW	\N	\N	\N	\N
87615	79	D5170C00002/tiny.path.1/file-6225.pdf	\N	D5170C00002-6e52724b-8319-11eb-be00-d5904ad2fbf2-6226	\N	NEW	\N	\N	\N	\N
84724	79	D5170C00002/tiny.path.1/file-3334.msg	\N	D5170C00002-6e60187f-8317-11eb-be00-27ddf596001d-3334	\N	NEW	\N	\N	\N	\N
87616	79	D5170C00002/tiny.path.1/file-6226.pdf	\N	D5170C00002-6e61666c-8319-11eb-be00-4bcb23cd0b51-6227	\N	NEW	\N	\N	\N	\N
81881	79	D5170C00002/tiny.path.1/file-0491.pdf	\N	D5170C00002-6e6189e4-8315-11eb-be00-f5d1bc675c91-491	\N	NEW	\N	\N	\N	\N
84725	79	D5170C00002/tiny.path.1/file-3335.msg	\N	D5170C00002-6e628980-8317-11eb-be00-d54ce813bda2-3335	\N	NEW	\N	\N	\N	\N
83268	79	D5170C00002/tiny.path.1/file-1878.pdf	\N	D5170C00002-6e7fcb3f-8316-11eb-be00-aba485883eb4-1878	\N	NEW	\N	\N	\N	\N
84726	79	D5170C00002/tiny.path.1/file-3336.msg	\N	D5170C00002-6e8023a1-8317-11eb-be00-9b2c529de0f3-3336	\N	NEW	\N	\N	\N	\N
81882	79	D5170C00002/tiny.path.1/file-0492.pdf	\N	D5170C00002-6e8eb465-8315-11eb-be00-1bbf98bbde3b-492	\N	NEW	\N	\N	\N	\N
87617	79	D5170C00002/tiny.path.1/file-6227.pdf	\N	D5170C00002-6e90178d-8319-11eb-be00-d363bd9c8e80-6228	\N	NEW	\N	\N	\N	\N
84727	79	D5170C00002/tiny.path.1/file-3337.msg	\N	D5170C00002-6e909e62-8317-11eb-be00-87a2fab95498-3337	\N	NEW	\N	\N	\N	\N
84728	79	D5170C00002/tiny.path.1/file-3338.msg	\N	D5170C00002-6eac8ad3-8317-11eb-be00-77ceffcfdc32-3338	\N	NEW	\N	\N	\N	\N
81883	79	D5170C00002/tiny.path.1/file-0493.pdf	\N	D5170C00002-6eadfc36-8315-11eb-be00-b919a155ec43-493	\N	NEW	\N	\N	\N	\N
86258	79	D5170C00002/tiny.path.1/file-4868.msg	\N	D5170C00002-6eaeb83d-8318-11eb-be00-eb658c3a3269-4868	\N	NEW	\N	\N	\N	\N
87618	79	D5170C00002/tiny.path.1/file-6228.pdf	\N	D5170C00002-6eaec31e-8319-11eb-be00-23aa3f5a7f0a-6229	\N	NEW	\N	\N	\N	\N
83269	79	D5170C00002/tiny.path.1/file-1879.pdf	\N	D5170C00002-6ebd4970-8316-11eb-be00-abc6fe282b7f-1879	\N	NEW	\N	\N	\N	\N
87619	79	D5170C00002/tiny.path.1/file-6229.pdf	\N	D5170C00002-6ecaaf8f-8319-11eb-be00-81f863c00c72-6230	\N	NEW	\N	\N	\N	\N
84729	79	D5170C00002/tiny.path.1/file-3339.msg	\N	D5170C00002-6ecc47d4-8317-11eb-be00-61b624f486dc-3339	\N	NEW	\N	\N	\N	\N
81884	79	D5170C00002/tiny.path.1/file-0494.pdf	\N	D5170C00002-6edad897-8315-11eb-be00-91809637f840-494	\N	NEW	\N	\N	\N	\N
83270	79	D5170C00002/tiny.path.1/file-1880.pdf	\N	D5170C00002-6ee93b71-8316-11eb-be00-1568ceab4de6-1880	\N	NEW	\N	\N	\N	\N
87620	79	D5170C00002/tiny.path.1/file-6230.pdf	\N	D5170C00002-6ee9a940-8319-11eb-be00-813c543d88a8-6231	\N	NEW	\N	\N	\N	\N
84730	79	D5170C00002/tiny.path.1/file-3340.msg	\N	D5170C00002-6eeb1a75-8317-11eb-be00-d76433b0d159-3340	\N	NEW	\N	\N	\N	\N
87621	79	D5170C00002/tiny.path.1/file-6231.pdf	\N	D5170C00002-6ef80121-8319-11eb-be00-e938781c75fc-6232	\N	NEW	\N	\N	\N	\N
86259	79	D5170C00002/tiny.path.1/file-4869.msg	\N	D5170C00002-6ef86b6e-8318-11eb-be00-a3671554a569-4869	\N	NEW	\N	\N	\N	\N
81885	79	D5170C00002/tiny.path.1/file-0495.pdf	\N	D5170C00002-6ef872b8-8315-11eb-be00-c5074e1538c1-495	\N	NEW	\N	\N	\N	\N
84731	79	D5170C00002/tiny.path.1/file-3341.msg	\N	D5170C00002-6f083f66-8317-11eb-be00-fd646115aa0b-3341	\N	NEW	\N	\N	\N	\N
87622	79	D5170C00002/tiny.path.1/file-6232.pdf	\N	D5170C00002-6f16fad2-8319-11eb-be00-e186c068d028-6233	\N	NEW	\N	\N	\N	\N
84732	79	D5170C00002/tiny.path.1/file-3342.msg	\N	D5170C00002-6f170c77-8317-11eb-be00-699d4e406892-3342	\N	NEW	\N	\N	\N	\N
87623	79	D5170C00002/tiny.path.1/file-6233.pdf	\N	D5170C00002-6f26b243-8319-11eb-be00-e76d4f6db008-6234	\N	NEW	\N	\N	\N	\N
84733	79	D5170C00002/tiny.path.1/file-3343.msg	\N	D5170C00002-6f35b808-8317-11eb-be00-bf1ac9edef85-3343	\N	NEW	\N	\N	\N	\N
86260	79	D5170C00002/tiny.path.1/file-4870.msg	\N	D5170C00002-6f4504cf-8318-11eb-be00-c1dcad7cda7e-4870	\N	NEW	\N	\N	\N	\N
87624	79	D5170C00002/tiny.path.1/file-6234.pdf	\N	D5170C00002-6f455dd4-8319-11eb-be00-d7224b029c40-6235	\N	NEW	\N	\N	\N	\N
81886	79	D5170C00002/tiny.path.1/file-0496.pdf	\N	D5170C00002-6f5538b9-8315-11eb-be00-cf79edbfd1a7-496	\N	NEW	\N	\N	\N	\N
87625	79	D5170C00002/tiny.path.1/file-6235.pdf	\N	D5170C00002-6f631f05-8319-11eb-be00-5d63188ff864-6236	\N	NEW	\N	\N	\N	\N
84734	79	D5170C00002/tiny.path.1/file-3344.msg	\N	D5170C00002-6f644219-8317-11eb-be00-0d41b0cfc2bc-3344	\N	NEW	\N	\N	\N	\N
83271	79	D5170C00002/tiny.path.1/file-1881.pdf	\N	D5170C00002-6f657052-8316-11eb-be00-5fb59f9e3d3a-1881	\N	NEW	\N	\N	\N	\N
87626	79	D5170C00002/tiny.path.1/file-6236.pdf	\N	D5170C00002-6f72d676-8319-11eb-be00-91c221c7cc32-6237	\N	NEW	\N	\N	\N	\N
86261	79	D5170C00002/tiny.path.1/file-4871.msg	\N	D5170C00002-6f81bfb0-8318-11eb-be00-13162255d4eb-4871	\N	NEW	\N	\N	\N	\N
87627	79	D5170C00002/tiny.path.1/file-6237.pdf	\N	D5170C00002-6f8218b7-8319-11eb-be00-5be2eab5f712-6238	\N	NEW	\N	\N	\N	\N
84735	79	D5170C00002/tiny.path.1/file-3345.msg	\N	D5170C00002-6f91baba-8317-11eb-be00-595d33f73da2-3345	\N	NEW	\N	\N	\N	\N
87628	79	D5170C00002/tiny.path.1/file-6238.pdf	\N	D5170C00002-6f929378-8319-11eb-be00-e9d6c35002ff-6239	\N	NEW	\N	\N	\N	\N
86262	79	D5170C00002/tiny.path.1/file-4872.msg	\N	D5170C00002-6fa06b41-8318-11eb-be00-510cc6c4b097-4872	\N	NEW	\N	\N	\N	\N
87629	79	D5170C00002/tiny.path.1/file-6239.pdf	\N	D5170C00002-6fa18799-8319-11eb-be00-d1b6f00e31cf-6240	\N	NEW	\N	\N	\N	\N
81887	79	D5170C00002/tiny.path.1/file-0497.pdf	\N	D5170C00002-6fbef70a-8315-11eb-be00-eddcdd1cf413-497	\N	NEW	\N	\N	\N	\N
84736	79	D5170C00002/tiny.path.1/file-3346.msg	\N	D5170C00002-6fbf5a6b-8317-11eb-be00-bddb57920ae2-3346	\N	NEW	\N	\N	\N	\N
86263	79	D5170C00002/tiny.path.1/file-4873.msg	\N	D5170C00002-6fce0af2-8318-11eb-be00-29c7d4c173d5-4873	\N	NEW	\N	\N	\N	\N
86264	79	D5170C00002/tiny.path.1/file-4874.msg	\N	D5170C00002-6fdcd803-8318-11eb-be00-2bf55f35b8e1-4874	\N	NEW	\N	\N	\N	\N
86265	79	D5170C00002/tiny.path.1/file-4875.msg	\N	D5170C00002-6fde1084-8318-11eb-be00-d700a89624ad-4875	\N	NEW	\N	\N	\N	\N
81888	79	D5170C00002/tiny.path.1/file-0498.pdf	\N	D5170C00002-6fde65eb-8315-11eb-be00-c5805cdd0350-498	\N	NEW	\N	\N	\N	\N
86266	79	D5170C00002/tiny.path.1/file-4876.msg	\N	D5170C00002-6fdf21f5-8318-11eb-be00-1bb7159d16a7-4876	\N	NEW	\N	\N	\N	\N
84737	79	D5170C00002/tiny.path.1/file-3347.msg	\N	D5170C00002-6fdfb3ac-8317-11eb-be00-b341557a29f2-3347	\N	NEW	\N	\N	\N	\N
87631	79	D5170C00002/tiny.path.1/file-6241.pdf	\N	D5170C00002-6fec734a-8319-11eb-be00-638d7eb97bca-6241	\N	NEW	\N	\N	\N	\N
86267	79	D5170C00002/tiny.path.1/file-4877.msg	\N	D5170C00002-6fecdd96-8318-11eb-be00-c15068da6b8c-4877	\N	NEW	\N	\N	\N	\N
81889	79	D5170C00002/tiny.path.1/file-0499.pdf	\N	D5170C00002-6fefa3fc-8315-11eb-be00-81e531ac9e20-499	\N	NEW	\N	\N	\N	\N
86268	79	D5170C00002/tiny.path.1/file-4878.msg	\N	D5170C00002-6ffc46e7-8318-11eb-be00-eff2cafbb3bd-4878	\N	NEW	\N	\N	\N	\N
87632	79	D5170C00002/tiny.path.1/file-6242.pdf	\N	D5170C00002-700a829b-8319-11eb-be00-2d835a548c9a-6242	\N	NEW	\N	\N	\N	\N
84738	79	D5170C00002/tiny.path.1/file-3348.msg	\N	D5170C00002-700def9d-8317-11eb-be00-3192b4cdb6b6-3348	\N	NEW	\N	\N	\N	\N
86269	79	D5170C00002/tiny.path.1/file-4879.msg	\N	D5170C00002-701a0818-8318-11eb-be00-0df227dfa983-4879	\N	NEW	\N	\N	\N	\N
81926	79	D5170C00002/tiny.path.1/file-0536.pdf	\N	D5170C00002-701b95fd-8315-11eb-be00-8dcc97e52a71-500	\N	NEW	\N	\N	\N	\N
87633	79	D5170C00002/tiny.path.1/file-6243.pdf	\N	D5170C00002-7029071c-8319-11eb-be00-17962b4ed269-6243	\N	NEW	\N	\N	\N	\N
86270	79	D5170C00002/tiny.path.1/file-4880.msg	\N	D5170C00002-70299879-8318-11eb-be00-817bb2d71aa0-4880	\N	NEW	\N	\N	\N	\N
84739	79	D5170C00002/tiny.path.1/file-3349.msg	\N	D5170C00002-702a513e-8317-11eb-be00-a56f60001a24-3349	\N	NEW	\N	\N	\N	\N
83272	79	D5170C00002/tiny.path.1/file-1882.pdf	\N	D5170C00002-702a6e03-8316-11eb-be00-a71aeca0b5cd-1882	\N	NEW	\N	\N	\N	\N
86271	79	D5170C00002/tiny.path.1/file-4881.msg	\N	D5170C00002-70394fea-8318-11eb-be00-afcfe81938a8-4881	\N	NEW	\N	\N	\N	\N
86272	79	D5170C00002/tiny.path.1/file-4882.msg	\N	D5170C00002-70481cfb-8318-11eb-be00-9b552e004bb4-4882	\N	NEW	\N	\N	\N	\N
84740	79	D5170C00002/tiny.path.1/file-3350.msg	\N	D5170C00002-704b1faf-8317-11eb-be00-77676940effd-3350	\N	NEW	\N	\N	\N	\N
86273	79	D5170C00002/tiny.path.1/file-4883.msg	\N	D5170C00002-7058499c-8318-11eb-be00-fb93dee6288c-4883	\N	NEW	\N	\N	\N	\N
81927	79	D5170C00002/tiny.path.1/file-0537.pdf	\N	D5170C00002-705a259e-8315-11eb-be00-6b44e038ceb9-501	\N	NEW	\N	\N	\N	\N
87634	79	D5170C00002/tiny.path.1/file-6244.pdf	\N	D5170C00002-706796bd-8319-11eb-be00-7f1488b2002f-6244	\N	NEW	\N	\N	\N	\N
86274	79	D5170C00002/tiny.path.1/file-4884.msg	\N	D5170C00002-7069127d-8318-11eb-be00-4d8fa8659ce8-4884	\N	NEW	\N	\N	\N	\N
87635	79	D5170C00002/tiny.path.1/file-6245.pdf	\N	D5170C00002-708530de-8319-11eb-be00-f97c38bc7d9a-6245	\N	NEW	\N	\N	\N	\N
86275	79	D5170C00002/tiny.path.1/file-4885.msg	\N	D5170C00002-70859b2e-8318-11eb-be00-052f794cb39a-4885	\N	NEW	\N	\N	\N	\N
86276	79	D5170C00002/tiny.path.1/file-4886.msg	\N	D5170C00002-7093f30f-8318-11eb-be00-e331c83e5542-4886	\N	NEW	\N	\N	\N	\N
81928	79	D5170C00002/tiny.path.1/file-0538.pdf	\N	D5170C00002-709580ef-8315-11eb-be00-67c1b3bee884-502	\N	NEW	\N	\N	\N	\N
86277	79	D5170C00002/tiny.path.1/file-4887.msg	\N	D5170C00002-709615f0-8318-11eb-be00-bf6e9f39de2e-4887	\N	NEW	\N	\N	\N	\N
84741	79	D5170C00002/tiny.path.1/file-3351.msg	\N	D5170C00002-70a46340-8317-11eb-be00-1582766dda0c-3351	\N	NEW	\N	\N	\N	\N
87636	79	D5170C00002/tiny.path.1/file-6246.pdf	\N	D5170C00002-70a5630f-8319-11eb-be00-b18f1b971904-6246	\N	NEW	\N	\N	\N	\N
86278	79	D5170C00002/tiny.path.1/file-4888.msg	\N	D5170C00002-70b2c5b1-8318-11eb-be00-7b73b0b204fa-4888	\N	NEW	\N	\N	\N	\N
81929	79	D5170C00002/tiny.path.1/file-0539.pdf	\N	D5170C00002-70b516e0-8315-11eb-be00-9f5557e6d07c-503	\N	NEW	\N	\N	\N	\N
86279	79	D5170C00002/tiny.path.1/file-4889.msg	\N	D5170C00002-70c25612-8318-11eb-be00-abd48bf58595-4889	\N	NEW	\N	\N	\N	\N
84742	79	D5170C00002/tiny.path.1/file-3352.msg	\N	D5170C00002-70c46e61-8317-11eb-be00-536341c8377d-3352	\N	NEW	\N	\N	\N	\N
87637	79	D5170C00002/tiny.path.1/file-6247.pdf	\N	D5170C00002-70d1f150-8319-11eb-be00-dfdc87423a90-6247	\N	NEW	\N	\N	\N	\N
87638	79	D5170C00002/tiny.path.1/file-6248.pdf	\N	D5170C00002-70d3c611-8319-11eb-be00-2b6a0ca6f11d-6248	\N	NEW	\N	\N	\N	\N
81930	79	D5170C00002/tiny.path.1/file-0540.pdf	\N	D5170C00002-70e24161-8315-11eb-be00-7f468a4eb158-504	\N	NEW	\N	\N	\N	\N
87639	79	D5170C00002/tiny.path.1/file-6249.pdf	\N	D5170C00002-70e29322-8319-11eb-be00-dd00723c7f7b-6249	\N	NEW	\N	\N	\N	\N
83273	79	D5170C00002/tiny.path.1/file-1883.pdf	\N	D5170C00002-70f007f4-8316-11eb-be00-4d0a7790c131-1883	\N	NEW	\N	\N	\N	\N
86280	79	D5170C00002/tiny.path.1/file-4890.pdf	\N	D5170C00002-70f01cd3-8318-11eb-be00-0169b127ae08-4890	\N	NEW	\N	\N	\N	\N
87640	79	D5170C00002/tiny.path.1/file-6250.pdf	\N	D5170C00002-70f24a93-8319-11eb-be00-6d70d37933cb-6250	\N	NEW	\N	\N	\N	\N
84743	79	D5170C00002/tiny.path.1/file-3353.msg	\N	D5170C00002-70ff2d72-8317-11eb-be00-51888e909e69-3353	\N	NEW	\N	\N	\N	\N
87641	79	D5170C00002/tiny.path.1/file-6251.pdf	\N	D5170C00002-70ff9104-8319-11eb-be00-7db009ba80f3-6251	\N	NEW	\N	\N	\N	\N
87642	79	D5170C00002/tiny.path.1/file-6252.pdf	\N	D5170C00002-710e5e15-8319-11eb-be00-db629f33aad9-6252	\N	NEW	\N	\N	\N	\N
83274	79	D5170C00002/tiny.path.1/file-1884.pdf	\N	D5170C00002-710e8c75-8316-11eb-be00-81146210fea9-1884	\N	NEW	\N	\N	\N	\N
84744	79	D5170C00002/tiny.path.1/file-3354.msg	\N	D5170C00002-710f0bf3-8317-11eb-be00-d98d80d46bf0-3354	\N	NEW	\N	\N	\N	\N
86281	79	D5170C00002/tiny.path.1/file-4891.pdf	\N	D5170C00002-71104f04-8318-11eb-be00-79bcc832c8e3-4891	\N	NEW	\N	\N	\N	\N
81931	79	D5170C00002/tiny.path.1/file-0541.pdf	\N	D5170C00002-711f2352-8315-11eb-be00-7fe0f40b02ff-505	\N	NEW	\N	\N	\N	\N
86282	79	D5170C00002/tiny.path.1/file-4892.pdf	\N	D5170C00002-712e1035-8318-11eb-be00-0586a31b9845-4892	\N	NEW	\N	\N	\N	\N
87643	79	D5170C00002/tiny.path.1/file-6253.pdf	\N	D5170C00002-712e1b16-8319-11eb-be00-67dd9522b8f7-6253	\N	NEW	\N	\N	\N	\N
83275	79	D5170C00002/tiny.path.1/file-1885.pdf	\N	D5170C00002-712e9796-8316-11eb-be00-47ccdffd391a-1885	\N	NEW	\N	\N	\N	\N
84745	79	D5170C00002/tiny.path.1/file-3355.msg	\N	D5170C00002-714c8a24-8317-11eb-be00-bb8938a5d0c2-3355	\N	NEW	\N	\N	\N	\N
86283	79	D5170C00002/tiny.path.1/file-4893.pdf	\N	D5170C00002-715bfe06-8318-11eb-be00-73dadc55a725-4893	\N	NEW	\N	\N	\N	\N
87644	79	D5170C00002/tiny.path.1/file-6254.pdf	\N	D5170C00002-71697667-8319-11eb-be00-fb8492ec724d-6254	\N	NEW	\N	\N	\N	\N
87645	79	D5170C00002/tiny.path.1/file-6255.pdf	\N	D5170C00002-71884908-8319-11eb-be00-d36955f2fa2a-6255	\N	NEW	\N	\N	\N	\N
81890	79	D5170C00002/tiny.path.1/file-0500.pdf	\N	D5170C00002-71897de3-8315-11eb-be00-1f79230fffbf-506	\N	NEW	\N	\N	\N	\N
84746	79	D5170C00002/tiny.path.1/file-3356.msg	\N	D5170C00002-71b8b975-8317-11eb-be00-1dab7a4b928a-3356	\N	NEW	\N	\N	\N	\N
81891	79	D5170C00002/tiny.path.1/file-0501.pdf	\N	D5170C00002-71b8f254-8315-11eb-be00-8b9d3ebad385-507	\N	NEW	\N	\N	\N	\N
86284	79	D5170C00002/tiny.path.1/file-4894.pdf	\N	D5170C00002-71d525a7-8318-11eb-be00-e16def99f5d7-4894	\N	NEW	\N	\N	\N	\N
83276	79	D5170C00002/tiny.path.1/file-1886.pdf	\N	D5170C00002-71d5d417-8316-11eb-be00-d975b7ff36aa-1886	\N	NEW	\N	\N	\N	\N
81892	79	D5170C00002/tiny.path.1/file-0502.pdf	\N	D5170C00002-71e55985-8315-11eb-be00-21d08d06bdbd-508	\N	NEW	\N	\N	\N	\N
86285	79	D5170C00002/tiny.path.1/file-4895.pdf	\N	D5170C00002-71f3aa28-8318-11eb-be00-f3cbc4888371-4895	\N	NEW	\N	\N	\N	\N
87646	79	D5170C00002/tiny.path.1/file-6256.pdf	\N	D5170C00002-71f3b509-8319-11eb-be00-875448a0658c-6256	\N	NEW	\N	\N	\N	\N
81893	79	D5170C00002/tiny.path.1/file-0503.pdf	\N	D5170C00002-7205b2c6-8315-11eb-be00-556322abfb67-509	\N	NEW	\N	\N	\N	\N
84748	79	D5170C00002/tiny.path.1/file-3358.msg	\N	D5170C00002-722277c6-8317-11eb-be00-93577e89b744-3357	\N	NEW	\N	\N	\N	\N
87647	79	D5170C00002/tiny.path.1/file-6257.pdf	\N	D5170C00002-7222b44a-8319-11eb-be00-33c1b763d6f9-6257	\N	NEW	\N	\N	\N	\N
81894	79	D5170C00002/tiny.path.1/file-0504.pdf	\N	D5170C00002-72234ce7-8315-11eb-be00-5180bf33ffcd-510	\N	NEW	\N	\N	\N	\N
83277	79	D5170C00002/tiny.path.1/file-1887.pdf	\N	D5170C00002-723224e8-8316-11eb-be00-0f41004bbeb2-1887	\N	NEW	\N	\N	\N	\N
87648	79	D5170C00002/tiny.path.1/file-6258.pdf	\N	D5170C00002-725f963b-8319-11eb-be00-9b14a77d35d4-6258	\N	NEW	\N	\N	\N	\N
84749	79	D5170C00002/tiny.path.1/file-3359.msg	\N	D5170C00002-7260e057-8317-11eb-be00-0f89c6e79050-3358	\N	NEW	\N	\N	\N	\N
81895	79	D5170C00002/tiny.path.1/file-0505.pdf	\N	D5170C00002-726dea78-8315-11eb-be00-1bd122702e96-511	\N	NEW	\N	\N	\N	\N
83278	79	D5170C00002/tiny.path.1/file-1888.pdf	\N	D5170C00002-726e91a9-8316-11eb-be00-13abbdadd9c7-1888	\N	NEW	\N	\N	\N	\N
84747	79	D5170C00002/tiny.path.1/file-3357.msg	\N	D5170C00002-727d9018-8317-11eb-be00-b1278905eebf-3359	\N	NEW	\N	\N	\N	\N
87649	79	D5170C00002/tiny.path.1/file-6259.pdf	\N	D5170C00002-728c99ac-8319-11eb-be00-d340bd50b24c-6259	\N	NEW	\N	\N	\N	\N
84750	79	D5170C00002/tiny.path.1/file-3360.msg	\N	D5170C00002-729e1069-8317-11eb-be00-c9db4c1c4cb3-3360	\N	NEW	\N	\N	\N	\N
84751	79	D5170C00002/tiny.path.1/file-3361.msg	\N	D5170C00002-72ba720a-8317-11eb-be00-4909b703c840-3361	\N	NEW	\N	\N	\N	\N
81896	79	D5170C00002/tiny.path.1/file-0506.pdf	\N	D5170C00002-72baf909-8315-11eb-be00-cf31c8160c18-512	\N	NEW	\N	\N	\N	\N
83279	79	D5170C00002/tiny.path.1/file-1889.msg	\N	D5170C00002-72d89e1a-8316-11eb-be00-77d3d9bd1e6f-1889	\N	NEW	\N	\N	\N	\N
84752	79	D5170C00002/tiny.path.1/file-3362.msg	\N	D5170C00002-72e886eb-8317-11eb-be00-25074f361187-3362	\N	NEW	\N	\N	\N	\N
81897	79	D5170C00002/tiny.path.1/file-0507.pdf	\N	D5170C00002-73060bca-8315-11eb-be00-13acae12ce6e-513	\N	NEW	\N	\N	\N	\N
84753	79	D5170C00002/tiny.path.1/file-3363.msg	\N	D5170C00002-7307327c-8317-11eb-be00-af21a397bcd1-3363	\N	NEW	\N	\N	\N	\N
87673	79	D5170C00002/tiny.path.1/file-6283.pdf	\N	D5170C00002-7316631d-8319-11eb-be00-5bc0dcd8909a-6260	\N	NEW	\N	\N	\N	\N
83280	79	D5170C00002/tiny.path.1/file-1890.msg	\N	D5170C00002-73172dbb-8316-11eb-be00-f332d320e472-1890	\N	NEW	\N	\N	\N	\N
84754	79	D5170C00002/tiny.path.1/file-3364.msg	\N	D5170C00002-7324a58d-8317-11eb-be00-5df372d5eb63-3364	\N	NEW	\N	\N	\N	\N
86286	79	D5170C00002/tiny.path.1/file-4896.pdf	\N	D5170C00002-73252549-8318-11eb-be00-03e6452e418b-4896	\N	NEW	\N	\N	\N	\N
81898	79	D5170C00002/tiny.path.1/file-0508.pdf	\N	D5170C00002-733495db-8315-11eb-be00-8b26297381b1-514	\N	NEW	\N	\N	\N	\N
83281	79	D5170C00002/tiny.path.1/file-1891.msg	\N	D5170C00002-734605ec-8316-11eb-be00-b1d68141bb2a-1891	\N	NEW	\N	\N	\N	\N
87674	79	D5170C00002/tiny.path.1/file-6284.pdf	\N	D5170C00002-7352a8ce-8319-11eb-be00-afa8727a5263-6261	\N	NEW	\N	\N	\N	\N
81899	79	D5170C00002/tiny.path.1/file-0509.pdf	\N	D5170C00002-73531a5c-8315-11eb-be00-c382dee076ce-515	\N	NEW	\N	\N	\N	\N
86287	79	D5170C00002/tiny.path.1/file-4897.pdf	\N	D5170C00002-7362a37a-8318-11eb-be00-59f5777f87e7-4897	\N	NEW	\N	\N	\N	\N
87650	79	D5170C00002/tiny.path.1/file-6260.msg	\N	D5170C00002-736434ff-8319-11eb-be00-014e41ac97d3-6262	\N	NEW	\N	\N	\N	\N
83282	79	D5170C00002/tiny.path.1/file-1892.msg	\N	D5170C00002-73737e8d-8316-11eb-be00-d9a92b16685d-1892	\N	NEW	\N	\N	\N	\N
87651	79	D5170C00002/tiny.path.1/file-6261.msg	\N	D5170C00002-737fac40-8319-11eb-be00-0ffe58df7ce3-6263	\N	NEW	\N	\N	\N	\N
84755	79	D5170C00002/tiny.path.1/file-3365.msg	\N	D5170C00002-7380330e-8317-11eb-be00-474973a28bd1-3365	\N	NEW	\N	\N	\N	\N
87652	79	D5170C00002/tiny.path.1/file-6262.msg	\N	D5170C00002-7380e4c1-8319-11eb-be00-a1c1237a08b5-6264	\N	NEW	\N	\N	\N	\N
87653	79	D5170C00002/tiny.path.1/file-6263.msg	\N	D5170C00002-738f3ca2-8319-11eb-be00-b3dbaa73e14a-6265	\N	NEW	\N	\N	\N	\N
81900	79	D5170C00002/tiny.path.1/file-0510.pdf	\N	D5170C00002-73a028ed-8315-11eb-be00-8d2a0b5b5881-516	\N	NEW	\N	\N	\N	\N
86288	79	D5170C00002/tiny.path.1/file-4898.pdf	\N	D5170C00002-73ad8f2b-8318-11eb-be00-ff2d459bcc4a-4898	\N	NEW	\N	\N	\N	\N
87654	79	D5170C00002/tiny.path.1/file-6264.msg	\N	D5170C00002-73ade833-8319-11eb-be00-6906539e1661-6266	\N	NEW	\N	\N	\N	\N
83283	79	D5170C00002/tiny.path.1/file-1893.msg	\N	D5170C00002-73adef7e-8316-11eb-be00-d54a1f4d3e36-1893	\N	NEW	\N	\N	\N	\N
84756	79	D5170C00002/tiny.path.1/file-3366.msg	\N	D5170C00002-73bf85ff-8317-11eb-be00-4f26637bd55c-3366	\N	NEW	\N	\N	\N	\N
81901	79	D5170C00002/tiny.path.1/file-0511.pdf	\N	D5170C00002-73c0340e-8315-11eb-be00-ad1e6a7e1c0a-517	\N	NEW	\N	\N	\N	\N
87655	79	D5170C00002/tiny.path.1/file-6265.msg	\N	D5170C00002-73ce1a64-8319-11eb-be00-b78772e14ecc-6267	\N	NEW	\N	\N	\N	\N
83284	79	D5170C00002/tiny.path.1/file-1894.msg	\N	D5170C00002-73dc527f-8316-11eb-be00-4b91ed3fb008-1894	\N	NEW	\N	\N	\N	\N
81902	79	D5170C00002/tiny.path.1/file-0512.pdf	\N	D5170C00002-73ecc24f-8315-11eb-be00-5166332abdf0-518	\N	NEW	\N	\N	\N	\N
87656	79	D5170C00002/tiny.path.1/file-6266.msg	\N	D5170C00002-73fa0c65-8319-11eb-be00-313b6e08e2d6-6268	\N	NEW	\N	\N	\N	\N
83285	79	D5170C00002/tiny.path.1/file-1895.msg	\N	D5170C00002-73fafe10-8316-11eb-be00-a1a13db1e0e1-1895	\N	NEW	\N	\N	\N	\N
81903	79	D5170C00002/tiny.path.1/file-0513.pdf	\N	D5170C00002-740a8380-8315-11eb-be00-571072e9e757-519	\N	NEW	\N	\N	\N	\N
86289	79	D5170C00002/tiny.path.1/file-4899.pdf	\N	D5170C00002-740aca5c-8318-11eb-be00-678772b074b3-4899	\N	NEW	\N	\N	\N	\N
84758	79	D5170C00002/tiny.path.1/file-3368.msg	\N	D5170C00002-741965d0-8317-11eb-be00-a351ff1cb9ac-3367	\N	NEW	\N	\N	\N	\N
81904	79	D5170C00002/tiny.path.1/file-0514.pdf	\N	D5170C00002-74199eb1-8315-11eb-be00-733a2387b3e9-520	\N	NEW	\N	\N	\N	\N
87657	79	D5170C00002/tiny.path.1/file-6267.msg	\N	D5170C00002-7427fa36-8319-11eb-be00-8dd1b58bc208-6269	\N	NEW	\N	\N	\N	\N
84757	79	D5170C00002/tiny.path.1/file-3367.msg	\N	D5170C00002-743970f1-8317-11eb-be00-a71da290f734-3368	\N	NEW	\N	\N	\N	\N
81905	79	D5170C00002/tiny.path.1/file-0515.pdf	\N	D5170C00002-743a1f02-8315-11eb-be00-d1f41738e837-521	\N	NEW	\N	\N	\N	\N
81906	79	D5170C00002/tiny.path.1/file-0516.pdf	\N	D5170C00002-74571ce3-8315-11eb-be00-259c4625ee26-522	\N	NEW	\N	\N	\N	\N
86290	79	D5170C00002/tiny.path.1/file-4900.pdf	\N	D5170C00002-7464d13d-8318-11eb-be00-2fe84fbddf92-4900	\N	NEW	\N	\N	\N	\N
87658	79	D5170C00002/tiny.path.1/file-6268.msg	\N	D5170C00002-7464dc27-8319-11eb-be00-2d906c8fa0f5-6270	\N	NEW	\N	\N	\N	\N
81907	79	D5170C00002/tiny.path.1/file-0517.pdf	\N	D5170C00002-747441d4-8315-11eb-be00-cd97a1111c63-523	\N	NEW	\N	\N	\N	\N
84759	79	D5170C00002/tiny.path.1/file-3369.msg	\N	D5170C00002-74747e22-8317-11eb-be00-35fb6d91c1ee-3369	\N	NEW	\N	\N	\N	\N
86291	79	D5170C00002/tiny.path.1/file-4901.pdf	\N	D5170C00002-748355be-8318-11eb-be00-61817633bbb1-4901	\N	NEW	\N	\N	\N	\N
81908	79	D5170C00002/tiny.path.1/file-0518.pdf	\N	D5170C00002-7485ce05-8315-11eb-be00-c1a92be90279-524	\N	NEW	\N	\N	\N	\N
86292	79	D5170C00002/tiny.path.1/file-4902.pdf	\N	D5170C00002-7494badf-8318-11eb-be00-83cb8b66d77e-4902	\N	NEW	\N	\N	\N	\N
87659	79	D5170C00002/tiny.path.1/file-6269.msg	\N	D5170C00002-74a1be18-8319-11eb-be00-dba9b3e2fefb-6271	\N	NEW	\N	\N	\N	\N
84760	79	D5170C00002/tiny.path.1/file-3370.msg	\N	D5170C00002-74a30833-8317-11eb-be00-d35210e3fbcc-3370	\N	NEW	\N	\N	\N	\N
84761	79	D5170C00002/tiny.path.1/file-3371.msg	\N	D5170C00002-74c3af94-8317-11eb-be00-3d7dc3a1b0ac-3371	\N	NEW	\N	\N	\N	\N
81909	79	D5170C00002/tiny.path.1/file-0519.pdf	\N	D5170C00002-74cfcf56-8315-11eb-be00-8f7e0d6d802d-525	\N	NEW	\N	\N	\N	\N
87660	79	D5170C00002/tiny.path.1/file-6270.msg	\N	D5170C00002-74cffa09-8319-11eb-be00-a5b99dabf5ce-6272	\N	NEW	\N	\N	\N	\N
86293	79	D5170C00002/tiny.path.1/file-4903.pdf	\N	D5170C00002-74d06450-8318-11eb-be00-538b563c3997-4903	\N	NEW	\N	\N	\N	\N
83286	79	D5170C00002/tiny.path.1/file-1896.pdf	\N	D5170C00002-74d1d611-8316-11eb-be00-3f0304f3ab81-1896	\N	NEW	\N	\N	\N	\N
86294	79	D5170C00002/tiny.path.1/file-4904.pdf	\N	D5170C00002-74dfa691-8318-11eb-be00-eb6a68cb1378-4904	\N	NEW	\N	\N	\N	\N
84762	79	D5170C00002/tiny.path.1/file-3372.msg	\N	D5170C00002-74efc8a5-8317-11eb-be00-b948b29fc568-3372	\N	NEW	\N	\N	\N	\N
81910	79	D5170C00002/tiny.path.1/file-0520.pdf	\N	D5170C00002-74f076b7-8315-11eb-be00-35c3fa74d47e-526	\N	NEW	\N	\N	\N	\N
86295	79	D5170C00002/tiny.path.1/file-4905.pdf	\N	D5170C00002-74ffffd2-8318-11eb-be00-1d7a296e0f78-4905	\N	NEW	\N	\N	\N	\N
87661	79	D5170C00002/tiny.path.1/file-6271.msg	\N	D5170C00002-750cb4ea-8319-11eb-be00-39076b435e73-6273	\N	NEW	\N	\N	\N	\N
81911	79	D5170C00002/tiny.path.1/file-0521.pdf	\N	D5170C00002-750f2248-8315-11eb-be00-db1b969b15d1-527	\N	NEW	\N	\N	\N	\N
86296	79	D5170C00002/tiny.path.1/file-4906.pdf	\N	D5170C00002-751bec43-8318-11eb-be00-c542d11e1544-4906	\N	NEW	\N	\N	\N	\N
84763	79	D5170C00002/tiny.path.1/file-3373.msg	\N	D5170C00002-751ca506-8317-11eb-be00-837047ba33d0-3373	\N	NEW	\N	\N	\N	\N
86297	79	D5170C00002/tiny.path.1/file-4907.pdf	\N	D5170C00002-751ef984-8318-11eb-be00-0329819ee012-4907	\N	NEW	\N	\N	\N	\N
81912	79	D5170C00002/tiny.path.1/file-0522.pdf	\N	D5170C00002-752c6e49-8315-11eb-be00-891057a08678-528	\N	NEW	\N	\N	\N	\N
81913	79	D5170C00002/tiny.path.1/file-0523.pdf	\N	D5170C00002-754b19da-8315-11eb-be00-0174e44e4243-529	\N	NEW	\N	\N	\N	\N
86298	79	D5170C00002/tiny.path.1/file-4908.pdf	\N	D5170C00002-755b8d55-8318-11eb-be00-95b165661d35-4908	\N	NEW	\N	\N	\N	\N
87662	79	D5170C00002/tiny.path.1/file-6272.msg	\N	D5170C00002-756905bb-8319-11eb-be00-c1ebc909a512-6274	\N	NEW	\N	\N	\N	\N
81914	79	D5170C00002/tiny.path.1/file-0524.pdf	\N	D5170C00002-7569503b-8315-11eb-be00-9749a7ff9780-530	\N	NEW	\N	\N	\N	\N
84764	79	D5170C00002/tiny.path.1/file-3374.msg	\N	D5170C00002-756a01b7-8317-11eb-be00-e7a1370e92df-3374	\N	NEW	\N	\N	\N	\N
87663	79	D5170C00002/tiny.path.1/file-6273.msg	\N	D5170C00002-7586c6ec-8319-11eb-be00-6df002775d56-6275	\N	NEW	\N	\N	\N	\N
81915	79	D5170C00002/tiny.path.1/file-0525.pdf	\N	D5170C00002-758870fc-8315-11eb-be00-c1134baf0a2b-531	\N	NEW	\N	\N	\N	\N
83287	79	D5170C00002/tiny.path.1/file-1897.pdf	\N	D5170C00002-75965e92-8316-11eb-be00-1910c9559148-1897	\N	NEW	\N	\N	\N	\N
86299	79	D5170C00002/tiny.path.1/file-4909.pdf	\N	D5170C00002-75967376-8318-11eb-be00-07efdde349f9-4909	\N	NEW	\N	\N	\N	\N
84765	79	D5170C00002/tiny.path.1/file-3375.msg	\N	D5170C00002-75c47dc8-8317-11eb-be00-9ff3a619df8e-3375	\N	NEW	\N	\N	\N	\N
81916	79	D5170C00002/tiny.path.1/file-0526.pdf	\N	D5170C00002-75c48f9d-8315-11eb-be00-59a98ba79a2e-532	\N	NEW	\N	\N	\N	\N
86300	79	D5170C00002/tiny.path.1/file-4910.pdf	\N	D5170C00002-75d3ca97-8318-11eb-be00-8d1522845489-4910	\N	NEW	\N	\N	\N	\N
87664	79	D5170C00002/tiny.path.1/file-6274.msg	\N	D5170C00002-75e2546d-8319-11eb-be00-1fcc8577c60b-6276	\N	NEW	\N	\N	\N	\N
81917	79	D5170C00002/tiny.path.1/file-0527.pdf	\N	D5170C00002-75e2c5fe-8315-11eb-be00-b188cda54c5f-533	\N	NEW	\N	\N	\N	\N
81918	79	D5170C00002/tiny.path.1/file-0528.pdf	\N	D5170C00002-75f3b5ef-8315-11eb-be00-eb5400e720a7-534	\N	NEW	\N	\N	\N	\N
84766	79	D5170C00002/tiny.path.1/file-3376.msg	\N	D5170C00002-76011199-8317-11eb-be00-ad0938113ed6-3376	\N	NEW	\N	\N	\N	\N
87665	79	D5170C00002/tiny.path.1/file-6275.msg	\N	D5170C00002-761f0f4e-8319-11eb-be00-b3ca69624d91-6277	\N	NEW	\N	\N	\N	\N
86301	79	D5170C00002/tiny.path.1/file-4911.pdf	\N	D5170C00002-761f5288-8318-11eb-be00-8352f3cfe0b5-4911	\N	NEW	\N	\N	\N	\N
81919	79	D5170C00002/tiny.path.1/file-0529.pdf	\N	D5170C00002-761f59d0-8315-11eb-be00-5f156c24cd78-535	\N	NEW	\N	\N	\N	\N
84767	79	D5170C00002/tiny.path.1/file-3377.msg	\N	D5170C00002-7620596a-8317-11eb-be00-29d7d960c6f7-3377	\N	NEW	\N	\N	\N	\N
83288	79	D5170C00002/tiny.path.1/file-1898.pdf	\N	D5170C00002-76300683-8316-11eb-be00-dfeaa35bd957-1898	\N	NEW	\N	\N	\N	\N
86302	79	D5170C00002/tiny.path.1/file-4912.pdf	\N	D5170C00002-76306989-8318-11eb-be00-753306a975f0-4912	\N	NEW	\N	\N	\N	\N
81920	79	D5170C00002/tiny.path.1/file-0530.pdf	\N	D5170C00002-763e2c71-8315-11eb-be00-2f1bff4478b2-536	\N	NEW	\N	\N	\N	\N
84768	79	D5170C00002/tiny.path.1/file-3378.msg	\N	D5170C00002-763f2c0b-8317-11eb-be00-753e4833f077-3378	\N	NEW	\N	\N	\N	\N
87666	79	D5170C00002/tiny.path.1/file-6276.msg	\N	D5170C00002-764f470f-8319-11eb-be00-7bc6b3dab338-6278	\N	NEW	\N	\N	\N	\N
81921	79	D5170C00002/tiny.path.1/file-0531.pdf	\N	D5170C00002-766cb682-8315-11eb-be00-5f219b46851c-537	\N	NEW	\N	\N	\N	\N
87667	79	D5170C00002/tiny.path.1/file-6277.msg	\N	D5170C00002-766d2f50-8319-11eb-be00-2151f58be6d4-6279	\N	NEW	\N	\N	\N	\N
84769	79	D5170C00002/tiny.path.1/file-3379.msg	\N	D5170C00002-766d40ec-8317-11eb-be00-57b1d8295c33-3379	\N	NEW	\N	\N	\N	\N
86303	79	D5170C00002/tiny.path.1/file-4913.pdf	\N	D5170C00002-767c188a-8318-11eb-be00-9d70ae7393cd-4913	\N	NEW	\N	\N	\N	\N
81922	79	D5170C00002/tiny.path.1/file-0532.pdf	\N	D5170C00002-767cbc13-8315-11eb-be00-b183ffdd1100-538	\N	NEW	\N	\N	\N	\N
87668	79	D5170C00002/tiny.path.1/file-6278.msg	\N	D5170C00002-7689df11-8319-11eb-be00-1b38a25cd23d-6280	\N	NEW	\N	\N	\N	\N
86304	79	D5170C00002/tiny.path.1/file-4914.pdf	\N	D5170C00002-768c452b-8318-11eb-be00-0b413c978c2a-4914	\N	NEW	\N	\N	\N	\N
86305	79	D5170C00002/tiny.path.1/file-4915.pdf	\N	D5170C00002-76a858ac-8318-11eb-be00-a521dd782dcd-4915	\N	NEW	\N	\N	\N	\N
83289	79	D5170C00002/tiny.path.1/file-1899.pdf	\N	D5170C00002-76aab4c4-8316-11eb-be00-8d86e13315d5-1899	\N	NEW	\N	\N	\N	\N
81923	79	D5170C00002/tiny.path.1/file-0533.pdf	\N	D5170C00002-76b86584-8315-11eb-be00-2f1441be7a09-539	\N	NEW	\N	\N	\N	\N
87669	79	D5170C00002/tiny.path.1/file-6279.msg	\N	D5170C00002-76b9c8b2-8319-11eb-be00-65d1fd754e86-6281	\N	NEW	\N	\N	\N	\N
84770	79	D5170C00002/tiny.path.1/file-3380.pdf	\N	D5170C00002-76b9da4d-8317-11eb-be00-37816c6cee48-3380	\N	NEW	\N	\N	\N	\N
86306	79	D5170C00002/tiny.path.1/file-4916.pdf	\N	D5170C00002-76c815ad-8318-11eb-be00-ebe24f681bac-4916	\N	NEW	\N	\N	\N	\N
84771	79	D5170C00002/tiny.path.1/file-3381.pdf	\N	D5170C00002-76d6ff3e-8317-11eb-be00-3da02615294d-3381	\N	NEW	\N	\N	\N	\N
87670	79	D5170C00002/tiny.path.1/file-6280.msg	\N	D5170C00002-76e6f333-8319-11eb-be00-cdb0b93f48c9-6282	\N	NEW	\N	\N	\N	\N
84772	79	D5170C00002/tiny.path.1/file-3382.pdf	\N	D5170C00002-76f6952f-8317-11eb-be00-ab1fd7a7064e-3382	\N	NEW	\N	\N	\N	\N
81924	79	D5170C00002/tiny.path.1/file-0534.pdf	\N	D5170C00002-7704b0c5-8315-11eb-be00-0155518aa4f8-540	\N	NEW	\N	\N	\N	\N
84773	79	D5170C00002/tiny.path.1/file-3383.pdf	\N	D5170C00002-7704c600-8317-11eb-be00-992faa763155-3383	\N	NEW	\N	\N	\N	\N
87671	79	D5170C00002/tiny.path.1/file-6281.msg	\N	D5170C00002-770550a4-8319-11eb-be00-b7b84ebd4558-6283	\N	NEW	\N	\N	\N	\N
86307	79	D5170C00002/tiny.path.1/file-4917.pdf	\N	D5170C00002-7714af0e-8318-11eb-be00-c5fae7f38cbc-4917	\N	NEW	\N	\N	\N	\N
83290	79	D5170C00002/tiny.path.1/file-1900.pdf	\N	D5170C00002-7714e845-8316-11eb-be00-6fa170e6827b-1900	\N	NEW	\N	\N	\N	\N
87672	79	D5170C00002/tiny.path.1/file-6282.msg	\N	D5170C00002-7731b7d5-8319-11eb-be00-297d797fad52-6284	\N	NEW	\N	\N	\N	\N
87675	79	D5170C00002/tiny.path.1/file-6285.pdf	\N	D5170C00002-77508a76-8319-11eb-be00-6724a87335df-6285	\N	NEW	\N	\N	\N	\N
84774	79	D5170C00002/tiny.path.1/file-3384.pdf	\N	D5170C00002-7751ad81-8317-11eb-be00-09cc6a73d078-3384	\N	NEW	\N	\N	\N	\N
81925	79	D5170C00002/tiny.path.1/file-0535.pdf	\N	D5170C00002-77603e46-8315-11eb-be00-5ba832af6fda-541	\N	NEW	\N	\N	\N	\N
84775	79	D5170C00002/tiny.path.1/file-3385.pdf	\N	D5170C00002-77705912-8317-11eb-be00-0fb0f9f5b00b-3385	\N	NEW	\N	\N	\N	\N
87676	79	D5170C00002/tiny.path.1/file-6286.pdf	\N	D5170C00002-77724347-8319-11eb-be00-2df3c995d17b-6286	\N	NEW	\N	\N	\N	\N
83291	79	D5170C00002/tiny.path.1/file-1901.pdf	\N	D5170C00002-778e36f6-8316-11eb-be00-21c784a15ecb-1901	\N	NEW	\N	\N	\N	\N
84776	79	D5170C00002/tiny.path.1/file-3386.pdf	\N	D5170C00002-778e8f73-8317-11eb-be00-9581d3c4411f-3386	\N	NEW	\N	\N	\N	\N
87677	79	D5170C00002/tiny.path.1/file-6287.pdf	\N	D5170C00002-779d9908-8319-11eb-be00-c32a12ad9c7b-6287	\N	NEW	\N	\N	\N	\N
84777	79	D5170C00002/tiny.path.1/file-3387.pdf	\N	D5170C00002-779e6df4-8317-11eb-be00-f1057e3e5094-3387	\N	NEW	\N	\N	\N	\N
84778	79	D5170C00002/tiny.path.1/file-3388.pdf	\N	D5170C00002-77ae7385-8317-11eb-be00-13a09a765b55-3388	\N	NEW	\N	\N	\N	\N
86308	79	D5170C00002/tiny.path.1/file-4918.pdf	\N	D5170C00002-77bb765f-8318-11eb-be00-1d4eecf96b31-4918	\N	NEW	\N	\N	\N	\N
84779	79	D5170C00002/tiny.path.1/file-3389.pdf	\N	D5170C00002-77dc3a46-8317-11eb-be00-61453b6e2384-3389	\N	NEW	\N	\N	\N	\N
87678	79	D5170C00002/tiny.path.1/file-6288.pdf	\N	D5170C00002-77e8f9e9-8319-11eb-be00-f71032cb9247-6288	\N	NEW	\N	\N	\N	\N
83292	79	D5170C00002/tiny.path.1/file-1902.pdf	\N	D5170C00002-77ea1297-8316-11eb-be00-490c21bc74d7-1902	\N	NEW	\N	\N	\N	\N
86309	79	D5170C00002/tiny.path.1/file-4919.pdf	\N	D5170C00002-77f83140-8318-11eb-be00-b1def1830603-4919	\N	NEW	\N	\N	\N	\N
84780	79	D5170C00002/tiny.path.1/file-3390.pdf	\N	D5170C00002-77f8c2f7-8317-11eb-be00-7d0e755e4feb-3390	\N	NEW	\N	\N	\N	\N
81932	79	D5170C00002/tiny.path.1/file-0542.pdf	\N	D5170C00002-78086527-8315-11eb-be00-71139d297a1a-542	\N	NEW	\N	\N	\N	\N
83293	79	D5170C00002/tiny.path.1/file-1903.pdf	\N	D5170C00002-78178b38-8316-11eb-be00-a7813ce5a1f2-1903	\N	NEW	\N	\N	\N	\N
81933	79	D5170C00002/tiny.path.1/file-0543.pdf	\N	D5170C00002-7826c298-8315-11eb-be00-c9cd29192d67-543	\N	NEW	\N	\N	\N	\N
87679	79	D5170C00002/tiny.path.1/file-6289.pdf	\N	D5170C00002-7826c63a-8319-11eb-be00-5b5fd9233496-6289	\N	NEW	\N	\N	\N	\N
84781	79	D5170C00002/tiny.path.1/file-3391.pdf	\N	D5170C00002-78357dd8-8317-11eb-be00-259b871c3828-3391	\N	NEW	\N	\N	\N	\N
83294	79	D5170C00002/tiny.path.1/file-1904.pdf	\N	D5170C00002-78541f09-8316-11eb-be00-2f053dc0125a-1904	\N	NEW	\N	\N	\N	\N
87680	79	D5170C00002/tiny.path.1/file-6290.pdf	\N	D5170C00002-7855022b-8319-11eb-be00-537ce039238a-6290	\N	NEW	\N	\N	\N	\N
83295	79	D5170C00002/tiny.path.1/file-1905.pdf	\N	D5170C00002-7863614a-8316-11eb-be00-f578c301eb4b-1905	\N	NEW	\N	\N	\N	\N
84782	79	D5170C00002/tiny.path.1/file-3392.pdf	\N	D5170C00002-7864cb39-8317-11eb-be00-dd051f00f0af-3392	\N	NEW	\N	\N	\N	\N
84783	79	D5170C00002/tiny.path.1/file-3393.pdf	\N	D5170C00002-7865b59a-8317-11eb-be00-51aea47812ed-3393	\N	NEW	\N	\N	\N	\N
87681	79	D5170C00002/tiny.path.1/file-6291.pdf	\N	D5170C00002-7872000c-8319-11eb-be00-21be5389aaad-6291	\N	NEW	\N	\N	\N	\N
84784	79	D5170C00002/tiny.path.1/file-3394.pdf	\N	D5170C00002-7872d4fb-8317-11eb-be00-e593373f407f-3394	\N	NEW	\N	\N	\N	\N
84785	79	D5170C00002/tiny.path.1/file-3395.pdf	\N	D5170C00002-7873984c-8317-11eb-be00-b1a0d70af690-3395	\N	NEW	\N	\N	\N	\N
84786	79	D5170C00002/tiny.path.1/file-3396.pdf	\N	D5170C00002-78751eed-8317-11eb-be00-cb9ba5efcf4a-3396	\N	NEW	\N	\N	\N	\N
83296	79	D5170C00002/tiny.path.1/file-1906.pdf	\N	D5170C00002-7882f73b-8316-11eb-be00-a3f24f00a939-1906	\N	NEW	\N	\N	\N	\N
84787	79	D5170C00002/tiny.path.1/file-3397.pdf	\N	D5170C00002-7883ebfe-8317-11eb-be00-8595a29326fd-3397	\N	NEW	\N	\N	\N	\N
87682	79	D5170C00002/tiny.path.1/file-6292.pdf	\N	D5170C00002-78844f8d-8319-11eb-be00-4bf9478c2bfc-6292	\N	NEW	\N	\N	\N	\N
83297	79	D5170C00002/tiny.path.1/file-1907.pdf	\N	D5170C00002-789100fc-8316-11eb-be00-ad5561c2132c-1907	\N	NEW	\N	\N	\N	\N
81934	79	D5170C00002/tiny.path.1/file-0544.pdf	\N	D5170C00002-78a197e9-8315-11eb-be00-8f7f4acca0e1-544	\N	NEW	\N	\N	\N	\N
84788	79	D5170C00002/tiny.path.1/file-3398.pdf	\N	D5170C00002-78a2978f-8317-11eb-be00-2d9667dea737-3398	\N	NEW	\N	\N	\N	\N
86310	79	D5170C00002/tiny.path.1/file-4920.pdf	\N	D5170C00002-78af7351-8318-11eb-be00-bdd4e594d3c9-4920	\N	NEW	\N	\N	\N	\N
83298	79	D5170C00002/tiny.path.1/file-1908.pdf	\N	D5170C00002-78af857d-8316-11eb-be00-19b61005bf1d-1908	\N	NEW	\N	\N	\N	\N
81935	79	D5170C00002/tiny.path.1/file-0545.pdf	\N	D5170C00002-78b1eb9a-8315-11eb-be00-7949b1c2fdec-545	\N	NEW	\N	\N	\N	\N
83299	79	D5170C00002/tiny.path.1/file-1909.pdf	\N	D5170C00002-78ce09fe-8316-11eb-be00-632e2452188d-1909	\N	NEW	\N	\N	\N	\N
87683	79	D5170C00002/tiny.path.1/file-6293.pdf	\N	D5170C00002-78ce9efe-8319-11eb-be00-455c1c2f197b-6293	\N	NEW	\N	\N	\N	\N
84789	79	D5170C00002/tiny.path.1/file-3399.pdf	\N	D5170C00002-78ced7b0-8317-11eb-be00-67fd446ba3d9-3399	\N	NEW	\N	\N	\N	\N
81936	79	D5170C00002/tiny.path.1/file-0546.pdf	\N	D5170C00002-78cfd3db-8315-11eb-be00-490a8341bd8d-546	\N	NEW	\N	\N	\N	\N
83300	79	D5170C00002/tiny.path.1/file-1910.pdf	\N	D5170C00002-78df6f1f-8316-11eb-be00-9763c81dfc90-1910	\N	NEW	\N	\N	\N	\N
81937	79	D5170C00002/tiny.path.1/file-0547.pdf	\N	D5170C00002-78e04e9c-8315-11eb-be00-a3004490e807-547	\N	NEW	\N	\N	\N	\N
84790	79	D5170C00002/tiny.path.1/file-3400.pdf	\N	D5170C00002-78edaa51-8317-11eb-be00-99a4ab697934-3400	\N	NEW	\N	\N	\N	\N
86311	79	D5170C00002/tiny.path.1/file-4921.pdf	\N	D5170C00002-78ef3b72-8318-11eb-be00-99f6a3831e20-4921	\N	NEW	\N	\N	\N	\N
83301	79	D5170C00002/tiny.path.1/file-1911.pdf	\N	D5170C00002-78fbd0c0-8316-11eb-be00-312eaae21c9d-1911	\N	NEW	\N	\N	\N	\N
81938	79	D5170C00002/tiny.path.1/file-0548.pdf	\N	D5170C00002-78fe5ded-8315-11eb-be00-19a26460f2e0-548	\N	NEW	\N	\N	\N	\N
87684	79	D5170C00002/tiny.path.1/file-6294.pdf	\N	D5170C00002-7919d8cf-8319-11eb-be00-57c4388e58fa-6294	\N	NEW	\N	\N	\N	\N
84791	79	D5170C00002/tiny.path.1/file-3401.pdf	\N	D5170C00002-791b4a02-8317-11eb-be00-2ded0e66cd8b-3401	\N	NEW	\N	\N	\N	\N
81939	79	D5170C00002/tiny.path.1/file-0549.pdf	\N	D5170C00002-791c6d3e-8315-11eb-be00-f15416bd1972-549	\N	NEW	\N	\N	\N	\N
83302	79	D5170C00002/tiny.path.1/file-1912.pdf	\N	D5170C00002-7929e5a1-8316-11eb-be00-d788af320ddb-1912	\N	NEW	\N	\N	\N	\N
86312	79	D5170C00002/tiny.path.1/file-4922.pdf	\N	D5170C00002-793963d3-8318-11eb-be00-2dd9191e9167-4922	\N	NEW	\N	\N	\N	\N
81940	79	D5170C00002/tiny.path.1/file-0550.pdf	\N	D5170C00002-7939b93f-8315-11eb-be00-47bf7f9dac5b-550	\N	NEW	\N	\N	\N	\N
86313	79	D5170C00002/tiny.path.1/file-4923.xlsx	\N	D5170C00002-793a2724-8318-11eb-be00-ad2b20d33ae6-4923	\N	NEW	\N	\N	\N	\N
84792	79	D5170C00002/tiny.path.1/file-3402.pdf	\N	D5170C00002-793b2e13-8317-11eb-be00-d7c97ea51a3c-3402	\N	NEW	\N	\N	\N	\N
86314	79	D5170C00002/tiny.path.1/file-4924.xlsx	\N	D5170C00002-7947bbb5-8318-11eb-be00-1357c4754c0a-4924	\N	NEW	\N	\N	\N	\N
81941	79	D5170C00002/tiny.path.1/file-0551.pdf	\N	D5170C00002-79485f40-8315-11eb-be00-ffa0a0bbac18-551	\N	NEW	\N	\N	\N	\N
84793	79	D5170C00002/tiny.path.1/file-3403.pdf	\N	D5170C00002-795804e4-8317-11eb-be00-7bca86b15d2a-3403	\N	NEW	\N	\N	\N	\N
86315	79	D5170C00002/tiny.path.1/file-4925.pdf	\N	D5170C00002-795920d6-8318-11eb-be00-93f88a2bf060-4925	\N	NEW	\N	\N	\N	\N
81942	79	D5170C00002/tiny.path.1/file-0552.pdf	\N	D5170C00002-795a3991-8315-11eb-be00-2902d30c8247-552	\N	NEW	\N	\N	\N	\N
84794	79	D5170C00002/tiny.path.1/file-3404.pdf	\N	D5170C00002-79672015-8317-11eb-be00-6b565538f85b-3404	\N	NEW	\N	\N	\N	\N
87685	79	D5170C00002/tiny.path.1/file-6295.pdf	\N	D5170C00002-79778930-8319-11eb-be00-a37b667b24fd-6295	\N	NEW	\N	\N	\N	\N
81943	79	D5170C00002/tiny.path.1/file-0553.pdf	\N	D5170C00002-7978be12-8315-11eb-be00-077714b9123b-553	\N	NEW	\N	\N	\N	\N
81944	79	D5170C00002/tiny.path.1/file-0554.pdf	\N	D5170C00002-7986c7d3-8315-11eb-be00-c78171f2513c-554	\N	NEW	\N	\N	\N	\N
86316	79	D5170C00002/tiny.path.1/file-4926.pdf	\N	D5170C00002-7994f157-8318-11eb-be00-bb79664e6ce7-4926	\N	NEW	\N	\N	\N	\N
84795	79	D5170C00002/tiny.path.1/file-3405.pdf	\N	D5170C00002-79964666-8317-11eb-be00-97fda0483f79-3405	\N	NEW	\N	\N	\N	\N
84796	79	D5170C00002/tiny.path.1/file-3406.pdf	\N	D5170C00002-79a5fdd7-8317-11eb-be00-5150ae2b6e8b-3406	\N	NEW	\N	\N	\N	\N
83303	79	D5170C00002/tiny.path.1/file-1913.pdf	\N	D5170C00002-79b360f2-8316-11eb-be00-d548ea418faa-1913	\N	NEW	\N	\N	\N	\N
81945	79	D5170C00002/tiny.path.1/file-0555.pdf	\N	D5170C00002-79b3f254-8315-11eb-be00-171523a1d052-555	\N	NEW	\N	\N	\N	\N
84797	79	D5170C00002/tiny.path.1/file-3407.pdf	\N	D5170C00002-79b47cc8-8317-11eb-be00-7970b0f086d0-3407	\N	NEW	\N	\N	\N	\N
86317	79	D5170C00002/tiny.path.1/file-4927.pdf	\N	D5170C00002-79c242e8-8318-11eb-be00-d5c0bcd296ce-4927	\N	NEW	\N	\N	\N	\N
84798	79	D5170C00002/tiny.path.1/file-3408.pdf	\N	D5170C00002-79c2fbb9-8317-11eb-be00-0d9aabc3c0ed-3408	\N	NEW	\N	\N	\N	\N
87686	79	D5170C00002/tiny.path.1/file-6296.pdf	\N	D5170C00002-79c3fb81-8319-11eb-be00-1ff70377cff8-6296	\N	NEW	\N	\N	\N	\N
84799	79	D5170C00002/tiny.path.1/file-3409.pdf	\N	D5170C00002-79c56cba-8317-11eb-be00-0d159dcced92-3409	\N	NEW	\N	\N	\N	\N
81946	79	D5170C00002/tiny.path.1/file-0556.pdf	\N	D5170C00002-79d201a5-8315-11eb-be00-d9969075428e-556	\N	NEW	\N	\N	\N	\N
84800	79	D5170C00002/tiny.path.1/file-3410.pdf	\N	D5170C00002-79d3014b-8317-11eb-be00-6141b5bbfb33-3410	\N	NEW	\N	\N	\N	\N
84801	79	D5170C00002/tiny.path.1/file-3411.pdf	\N	D5170C00002-79d460dc-8317-11eb-be00-f3276e09895e-3411	\N	NEW	\N	\N	\N	\N
81947	79	D5170C00002/tiny.path.1/file-0557.pdf	\N	D5170C00002-79e143e6-8315-11eb-be00-4d7a988bb67b-557	\N	NEW	\N	\N	\N	\N
84802	79	D5170C00002/tiny.path.1/file-3412.pdf	\N	D5170C00002-79e1803d-8317-11eb-be00-a7f77d70c594-3412	\N	NEW	\N	\N	\N	\N
84803	79	D5170C00002/tiny.path.1/file-3413.pdf	\N	D5170C00002-79e2b8be-8317-11eb-be00-31666a6a9e13-3413	\N	NEW	\N	\N	\N	\N
86318	79	D5170C00002/tiny.path.1/file-4928.pdf	\N	D5170C00002-79e2ea49-8318-11eb-be00-437dcc982bbc-4928	\N	NEW	\N	\N	\N	\N
87687	79	D5170C00002/tiny.path.1/file-6297.pdf	\N	D5170C00002-79ef7852-8319-11eb-be00-3ba0817ccb53-6297	\N	NEW	\N	\N	\N	\N
84804	79	D5170C00002/tiny.path.1/file-3414.xlsx	\N	D5170C00002-79ff1a5f-8317-11eb-be00-a5a68886ffae-3414	\N	NEW	\N	\N	\N	\N
84805	79	D5170C00002/tiny.path.1/file-3415.xlsx	\N	D5170C00002-7a002bd0-8317-11eb-be00-9fde6db3841e-3415	\N	NEW	\N	\N	\N	\N
81948	79	D5170C00002/tiny.path.1/file-0558.pdf	\N	D5170C00002-7a014f07-8315-11eb-be00-838402874383-558	\N	NEW	\N	\N	\N	\N
84806	79	D5170C00002/tiny.path.1/file-3416.pdf	\N	D5170C00002-7a0227a1-8317-11eb-be00-492d93992361-3416	\N	NEW	\N	\N	\N	\N
86319	79	D5170C00002/tiny.path.1/file-4929.pdf	\N	D5170C00002-7a1089fa-8318-11eb-be00-35e24134b8cc-4929	\N	NEW	\N	\N	\N	\N
84807	79	D5170C00002/tiny.path.1/file-3417.pdf	\N	D5170C00002-7a212152-8317-11eb-be00-47b353ca58bf-3417	\N	NEW	\N	\N	\N	\N
81949	79	D5170C00002/tiny.path.1/file-0559.pdf	\N	D5170C00002-7a215a28-8315-11eb-be00-b52bd7a87044-559	\N	NEW	\N	\N	\N	\N
87688	79	D5170C00002/tiny.path.1/file-6298.pdf	\N	D5170C00002-7a2d1d93-8319-11eb-be00-7d93cce53d5c-6298	\N	NEW	\N	\N	\N	\N
81950	79	D5170C00002/tiny.path.1/file-0560.pdf	\N	D5170C00002-7a2e7989-8315-11eb-be00-f5e1b758a884-560	\N	NEW	\N	\N	\N	\N
84808	79	D5170C00002/tiny.path.1/file-3418.pdf	\N	D5170C00002-7a2fc753-8317-11eb-be00-adf37a866d05-3418	\N	NEW	\N	\N	\N	\N
87689	79	D5170C00002/tiny.path.1/file-6299.pdf	\N	D5170C00002-7a3d4a34-8319-11eb-be00-87d44da09c56-6299	\N	NEW	\N	\N	\N	\N
84809	79	D5170C00002/tiny.path.1/file-3419.pdf	\N	D5170C00002-7a3d5be4-8317-11eb-be00-2759d2e14aad-3419	\N	NEW	\N	\N	\N	\N
84810	79	D5170C00002/tiny.path.1/file-3420.pdf	\N	D5170C00002-7a3f30a5-8317-11eb-be00-0b89e2fdc559-3420	\N	NEW	\N	\N	\N	\N
81951	79	D5170C00002/tiny.path.1/file-0561.pdf	\N	D5170C00002-7a4cd6fa-8315-11eb-be00-2dd2c5da0889-561	\N	NEW	\N	\N	\N	\N
84811	79	D5170C00002/tiny.path.1/file-3421.pdf	\N	D5170C00002-7a4d8886-8317-11eb-be00-c94a7c4a78da-3421	\N	NEW	\N	\N	\N	\N
87690	79	D5170C00002/tiny.path.1/file-6300.pdf	\N	D5170C00002-7a5b0b65-8319-11eb-be00-b5dd1a08962b-6300	\N	NEW	\N	\N	\N	\N
86320	79	D5170C00002/tiny.path.1/file-4930.pdf	\N	D5170C00002-7a5b4e9b-8318-11eb-be00-f924be884781-4930	\N	NEW	\N	\N	\N	\N
87691	79	D5170C00002/tiny.path.1/file-6301.pdf	\N	D5170C00002-7a6a74b6-8319-11eb-be00-abe7f745d203-6301	\N	NEW	\N	\N	\N	\N
84812	79	D5170C00002/tiny.path.1/file-3422.pdf	\N	D5170C00002-7a6ca947-8317-11eb-be00-2984800da4ea-3422	\N	NEW	\N	\N	\N	\N
87692	79	D5170C00002/tiny.path.1/file-6302.pdf	\N	D5170C00002-7a7b3d97-8319-11eb-be00-fd2109d16d99-6302	\N	NEW	\N	\N	\N	\N
87693	79	D5170C00002/tiny.path.1/file-6303.pdf	\N	D5170C00002-7a975118-8319-11eb-be00-67debb3d3e5f-6303	\N	NEW	\N	\N	\N	\N
84813	79	D5170C00002/tiny.path.1/file-3423.pdf	\N	D5170C00002-7a993788-8317-11eb-be00-cbb2bec4188e-3423	\N	NEW	\N	\N	\N	\N
87694	79	D5170C00002/tiny.path.1/file-6304.pdf	\N	D5170C00002-7a99c219-8319-11eb-be00-b3837d65bfb4-6304	\N	NEW	\N	\N	\N	\N
84814	79	D5170C00002/tiny.path.1/file-3424.pdf	\N	D5170C00002-7a9a9719-8317-11eb-be00-83f51cb347b3-3424	\N	NEW	\N	\N	\N	\N
83304	79	D5170C00002/tiny.path.1/file-1914.pdf	\N	D5170C00002-7aa84843-8316-11eb-be00-8fb53d0d4093-1914	\N	NEW	\N	\N	\N	\N
84815	79	D5170C00002/tiny.path.1/file-3425.pdf	\N	D5170C00002-7aa9160a-8317-11eb-be00-a119bb407643-3425	\N	NEW	\N	\N	\N	\N
87695	79	D5170C00002/tiny.path.1/file-6305.pdf	\N	D5170C00002-7ab671da-8319-11eb-be00-2791a98d7e51-6305	\N	NEW	\N	\N	\N	\N
84816	79	D5170C00002/tiny.path.1/file-3426.pdf	\N	D5170C00002-7ab8313b-8317-11eb-be00-ff994326c202-3426	\N	NEW	\N	\N	\N	\N
81952	79	D5170C00002/tiny.path.1/file-0562.pdf	\N	D5170C00002-7ab842fb-8315-11eb-be00-2b90970debeb-562	\N	NEW	\N	\N	\N	\N
86321	79	D5170C00002/tiny.path.1/file-4931.pdf	\N	D5170C00002-7ac55b0c-8318-11eb-be00-238c68a20ea5-4931	\N	NEW	\N	\N	\N	\N
87696	79	D5170C00002/tiny.path.1/file-6306.pdf	\N	D5170C00002-7ad4cf4b-8319-11eb-be00-1da32091402a-6306	\N	NEW	\N	\N	\N	\N
84817	79	D5170C00002/tiny.path.1/file-3427.pdf	\N	D5170C00002-7ad5562c-8317-11eb-be00-7ba170425b70-3427	\N	NEW	\N	\N	\N	\N
83305	79	D5170C00002/tiny.path.1/file-1915.pdf	\N	D5170C00002-7ad5e7f4-8316-11eb-be00-11a845cf6fbf-1915	\N	NEW	\N	\N	\N	\N
87697	79	D5170C00002/tiny.path.1/file-6307.pdf	\N	D5170C00002-7ad6a40c-8319-11eb-be00-534b3163cf6e-6307	\N	NEW	\N	\N	\N	\N
84818	79	D5170C00002/tiny.path.1/file-3428.pdf	\N	D5170C00002-7ae6461d-8317-11eb-be00-d568201490f9-3428	\N	NEW	\N	\N	\N	\N
87698	79	D5170C00002/tiny.path.1/file-6308.pdf	\N	D5170C00002-7af3f00d-8319-11eb-be00-6f7de3105b1b-6308	\N	NEW	\N	\N	\N	\N
81953	79	D5170C00002/tiny.path.1/file-0563.pdf	\N	D5170C00002-7af5730c-8315-11eb-be00-cf9af1dc5849-563	\N	NEW	\N	\N	\N	\N
84819	79	D5170C00002/tiny.path.1/file-3429.pdf	\N	D5170C00002-7af5885e-8317-11eb-be00-396e56f4ba45-3429	\N	NEW	\N	\N	\N	\N
83306	79	D5170C00002/tiny.path.1/file-1916.pdf	\N	D5170C00002-7b1254b5-8316-11eb-be00-0f2fa18d8a1c-1916	\N	NEW	\N	\N	\N	\N
84820	79	D5170C00002/tiny.path.1/file-3430.pdf	\N	D5170C00002-7b12863f-8317-11eb-be00-6dfb4af47faf-3430	\N	NEW	\N	\N	\N	\N
84821	79	D5170C00002/tiny.path.1/file-3431.pdf	\N	D5170C00002-7b1397b0-8317-11eb-be00-c3bb14114567-3431	\N	NEW	\N	\N	\N	\N
87699	79	D5170C00002/tiny.path.1/file-6309.pdf	\N	D5170C00002-7b22ef4e-8319-11eb-be00-8d6524873794-6309	\N	NEW	\N	\N	\N	\N
86322	79	D5170C00002/tiny.path.1/file-4932.pdf	\N	D5170C00002-7b309ffd-8318-11eb-be00-416ce5e31770-4932	\N	NEW	\N	\N	\N	\N
81954	79	D5170C00002/tiny.path.1/file-0564.pdf	\N	D5170C00002-7b31dfcd-8315-11eb-be00-3b08112d1e9f-564	\N	NEW	\N	\N	\N	\N
87700	79	D5170C00002/tiny.path.1/file-6310.pdf	\N	D5170C00002-7b3f77ff-8319-11eb-be00-83810a0edabd-6310	\N	NEW	\N	\N	\N	\N
84822	79	D5170C00002/tiny.path.1/file-3432.pdf	\N	D5170C00002-7b3fd7d1-8317-11eb-be00-b59daf6841b3-3432	\N	NEW	\N	\N	\N	\N
84823	79	D5170C00002/tiny.path.1/file-3433.pdf	\N	D5170C00002-7b4248d2-8317-11eb-be00-3f5164b5c702-3433	\N	NEW	\N	\N	\N	\N
83307	79	D5170C00002/tiny.path.1/file-1917.pdf	\N	D5170C00002-7b504816-8316-11eb-be00-b12a97d4a301-1917	\N	NEW	\N	\N	\N	\N
81955	79	D5170C00002/tiny.path.1/file-0565.pdf	\N	D5170C00002-7b50644e-8315-11eb-be00-9936ec1cd9fd-565	\N	NEW	\N	\N	\N	\N
87701	79	D5170C00002/tiny.path.1/file-6311.pdf	\N	D5170C00002-7b508f00-8319-11eb-be00-c7a5267922e1-6311	\N	NEW	\N	\N	\N	\N
84824	79	D5170C00002/tiny.path.1/file-3434.pdf	\N	D5170C00002-7b518b13-8317-11eb-be00-5f32b4c6af58-3434	\N	NEW	\N	\N	\N	\N
84825	79	D5170C00002/tiny.path.1/file-3435.pdf	\N	D5170C00002-7b600a04-8317-11eb-be00-4546478a02ee-3435	\N	NEW	\N	\N	\N	\N
87702	79	D5170C00002/tiny.path.1/file-6312.pdf	\N	D5170C00002-7b7ca811-8319-11eb-be00-95091147903b-6312	\N	NEW	\N	\N	\N	\N
84826	79	D5170C00002/tiny.path.1/file-3436.pdf	\N	D5170C00002-7b7f51d5-8317-11eb-be00-6da77235c428-3436	\N	NEW	\N	\N	\N	\N
84827	79	D5170C00002/tiny.path.1/file-3437.pdf	\N	D5170C00002-7b8e45f6-8317-11eb-be00-a9d624cec78c-3437	\N	NEW	\N	\N	\N	\N
83308	79	D5170C00002/tiny.path.1/file-1918.pdf	\N	D5170C00002-7b8f25d7-8316-11eb-be00-8313e3f96f74-1918	\N	NEW	\N	\N	\N	\N
87703	79	D5170C00002/tiny.path.1/file-6313.pdf	\N	D5170C00002-7b9ade72-8319-11eb-be00-1180ad79f6e7-6313	\N	NEW	\N	\N	\N	\N
84828	79	D5170C00002/tiny.path.1/file-3438.pdf	\N	D5170C00002-7b9d3a17-8317-11eb-be00-172d9f762e79-3438	\N	NEW	\N	\N	\N	\N
87704	79	D5170C00002/tiny.path.1/file-6314.pdf	\N	D5170C00002-7baa95e3-8319-11eb-be00-57b731620d82-6314	\N	NEW	\N	\N	\N	\N
81956	79	D5170C00002/tiny.path.1/file-0566.pdf	\N	D5170C00002-7baae05f-8315-11eb-be00-999f6dcd78cb-566	\N	NEW	\N	\N	\N	\N
84829	79	D5170C00002/tiny.path.1/file-3439.pdf	\N	D5170C00002-7baaf5b8-8317-11eb-be00-9db5cf24ee1a-3439	\N	NEW	\N	\N	\N	\N
84830	79	D5170C00002/tiny.path.1/file-3440.pdf	\N	D5170C00002-7bb9c2c9-8317-11eb-be00-f1e1acf2ae9a-3440	\N	NEW	\N	\N	\N	\N
87705	79	D5170C00002/tiny.path.1/file-6315.pdf	\N	D5170C00002-7bbb10a4-8319-11eb-be00-a59d9fe4ba71-6315	\N	NEW	\N	\N	\N	\N
83309	79	D5170C00002/tiny.path.1/file-1919.pdf	\N	D5170C00002-7bbc2948-8316-11eb-be00-d52dc601d9dd-1919	\N	NEW	\N	\N	\N	\N
84831	79	D5170C00002/tiny.path.1/file-3441.pdf	\N	D5170C00002-7bbc5ada-8317-11eb-be00-eb138eee59d3-3441	\N	NEW	\N	\N	\N	\N
84832	79	D5170C00002/tiny.path.1/file-3442.pdf	\N	D5170C00002-7bc97a3b-8317-11eb-be00-030505083117-3442	\N	NEW	\N	\N	\N	\N
86323	79	D5170C00002/tiny.path.1/file-4933.pdf	\N	D5170C00002-7bcb806e-8318-11eb-be00-2d316563b9cb-4933	\N	NEW	\N	\N	\N	\N
84833	79	D5170C00002/tiny.path.1/file-3443.pdf	\N	D5170C00002-7bd90a9c-8317-11eb-be00-eb3de619afb5-3443	\N	NEW	\N	\N	\N	\N
87706	79	D5170C00002/tiny.path.1/file-6316.pdf	\N	D5170C00002-7be729b5-8319-11eb-be00-55907ef1fc20-6316	\N	NEW	\N	\N	\N	\N
83310	79	D5170C00002/tiny.path.1/file-1920.pdf	\N	D5170C00002-7be8b789-8316-11eb-be00-ad2ddba577d1-1920	\N	NEW	\N	\N	\N	\N
81957	79	D5170C00002/tiny.path.1/file-0567.pdf	\N	D5170C00002-7be921e0-8315-11eb-be00-a5bc99c38a98-567	\N	NEW	\N	\N	\N	\N
84834	79	D5170C00002/tiny.path.1/file-3444.pdf	\N	D5170C00002-7bea6fbd-8317-11eb-be00-8d5c12fe25ac-3444	\N	NEW	\N	\N	\N	\N
84835	79	D5170C00002/tiny.path.1/file-3445.pdf	\N	D5170C00002-7bf8797e-8317-11eb-be00-19c1f720be5c-3445	\N	NEW	\N	\N	\N	\N
83311	79	D5170C00002/tiny.path.1/file-1921.pdf	\N	D5170C00002-7bf9324a-8316-11eb-be00-8f4fddf940d1-1921	\N	NEW	\N	\N	\N	\N
86324	79	D5170C00002/tiny.path.1/file-4934.pdf	\N	D5170C00002-7c05ca4f-8318-11eb-be00-fdd98dec6522-4934	\N	NEW	\N	\N	\N	\N
87707	79	D5170C00002/tiny.path.1/file-6317.pdf	\N	D5170C00002-7c0782f6-8319-11eb-be00-29d2c3ae84e8-6317	\N	NEW	\N	\N	\N	\N
87708	79	D5170C00002/tiny.path.1/file-6318.pdf	\N	D5170C00002-7c14f077-8319-11eb-be00-f3b381df948c-6318	\N	NEW	\N	\N	\N	\N
84836	79	D5170C00002/tiny.path.1/file-3446.pdf	\N	D5170C00002-7c15293f-8317-11eb-be00-413db7618c3b-3446	\N	NEW	\N	\N	\N	\N
81958	79	D5170C00002/tiny.path.1/file-0568.pdf	\N	D5170C00002-7c164c61-8315-11eb-be00-9b495b66bbe4-568	\N	NEW	\N	\N	\N	\N
87709	79	D5170C00002/tiny.path.1/file-6319.pdf	\N	D5170C00002-7c240ba8-8319-11eb-be00-4fb7ed0c7d8d-6319	\N	NEW	\N	\N	\N	\N
84837	79	D5170C00002/tiny.path.1/file-3447.pdf	\N	D5170C00002-7c347110-8317-11eb-be00-293d99712de5-3447	\N	NEW	\N	\N	\N	\N
87710	79	D5170C00002/tiny.path.1/file-6320.pdf	\N	D5170C00002-7c34fb99-8319-11eb-be00-09345162c465-6320	\N	NEW	\N	\N	\N	\N
86325	79	D5170C00002/tiny.path.1/file-4935.pdf	\N	D5170C00002-7c42d350-8318-11eb-be00-c9932bba0a35-4935	\N	NEW	\N	\N	\N	\N
83312	79	D5170C00002/tiny.path.1/file-1922.pdf	\N	D5170C00002-7c5498bb-8316-11eb-be00-d9a488120992-1922	\N	NEW	\N	\N	\N	\N
87711	79	D5170C00002/tiny.path.1/file-6321.pdf	\N	D5170C00002-7c54b89a-8319-11eb-be00-9f021ae6f91c-6321	\N	NEW	\N	\N	\N	\N
87712	79	D5170C00002/tiny.path.1/file-6322.pdf	\N	D5170C00002-7c7056eb-8319-11eb-be00-6b529c6dd27a-6322	\N	NEW	\N	\N	\N	\N
86326	79	D5170C00002/tiny.path.1/file-4936.pdf	\N	D5170C00002-7c80edc1-8318-11eb-be00-db3352a6d0b7-4936	\N	NEW	\N	\N	\N	\N
84838	79	D5170C00002/tiny.path.1/file-3448.pdf	\N	D5170C00002-7c82df31-8317-11eb-be00-993e84b76cb1-3448	\N	NEW	\N	\N	\N	\N
84839	79	D5170C00002/tiny.path.1/file-3449.pdf	\N	D5170C00002-7c91ac42-8317-11eb-be00-531c921b28be-3449	\N	NEW	\N	\N	\N	\N
87713	79	D5170C00002/tiny.path.1/file-6323.pdf	\N	D5170C00002-7c9f080c-8319-11eb-be00-b99bbb2189b0-6323	\N	NEW	\N	\N	\N	\N
81959	79	D5170C00002/tiny.path.1/file-0569.pdf	\N	D5170C00002-7c9fa0a2-8315-11eb-be00-3b1b196dc2f8-569	\N	NEW	\N	\N	\N	\N
84840	79	D5170C00002/tiny.path.1/file-3450.pdf	\N	D5170C00002-7ca0ee83-8317-11eb-be00-cd18223d4428-3450	\N	NEW	\N	\N	\N	\N
83313	79	D5170C00002/tiny.path.1/file-1923.pdf	\N	D5170C00002-7caf14cc-8316-11eb-be00-85e6e36bc6ac-1923	\N	NEW	\N	\N	\N	\N
84841	79	D5170C00002/tiny.path.1/file-3451.pdf	\N	D5170C00002-7cbdc554-8317-11eb-be00-4bed498088d7-3451	\N	NEW	\N	\N	\N	\N
86327	79	D5170C00002/tiny.path.1/file-4937.pdf	\N	D5170C00002-7cbfcb82-8318-11eb-be00-7156b82008f1-4937	\N	NEW	\N	\N	\N	\N
84842	79	D5170C00002/tiny.path.1/file-3452.pdf	\N	D5170C00002-7cc00f45-8317-11eb-be00-edc6f0d1ddd8-3452	\N	NEW	\N	\N	\N	\N
83314	79	D5170C00002/tiny.path.1/file-1924.pdf	\N	D5170C00002-7ccd4b2d-8316-11eb-be00-6548b47158c5-1924	\N	NEW	\N	\N	\N	\N
87714	79	D5170C00002/tiny.path.1/file-6324.pdf	\N	D5170C00002-7cdb74cd-8319-11eb-be00-0d1f1387cbb8-6324	\N	NEW	\N	\N	\N	\N
81960	79	D5170C00002/tiny.path.1/file-0570.pdf	\N	D5170C00002-7ceb76b3-8315-11eb-be00-4b86bdc2cb80-570	\N	NEW	\N	\N	\N	\N
83315	79	D5170C00002/tiny.path.1/file-1925.pdf	\N	D5170C00002-7cfa75ae-8316-11eb-be00-1bc6803a9c1c-1925	\N	NEW	\N	\N	\N	\N
83316	79	D5170C00002/tiny.path.1/file-1926.pdf	\N	D5170C00002-7cfc988f-8316-11eb-be00-0700259da95c-1926	\N	NEW	\N	\N	\N	\N
86328	79	D5170C00002/tiny.path.1/file-4938.pdf	\N	D5170C00002-7d0957a3-8318-11eb-be00-79f2cc7ab2fa-4938	\N	NEW	\N	\N	\N	\N
86329	79	D5170C00002/tiny.path.1/file-4939.pdf	\N	D5170C00002-7d19f974-8318-11eb-be00-bd3e531f49a4-4939	\N	NEW	\N	\N	\N	\N
84843	79	D5170C00002/tiny.path.1/file-3453.pdf	\N	D5170C00002-7d27f8d6-8317-11eb-be00-5d26f336df83-3453	\N	NEW	\N	\N	\N	\N
81961	79	D5170C00002/tiny.path.1/file-0571.pdf	\N	D5170C00002-7d29b834-8315-11eb-be00-cd47dce5d3b8-571	\N	NEW	\N	\N	\N	\N
86330	79	D5170C00002/tiny.path.1/file-4940.pdf	\N	D5170C00002-7d371e65-8318-11eb-be00-db790612df48-4940	\N	NEW	\N	\N	\N	\N
87715	79	D5170C00002/tiny.path.1/file-6325.pdf	\N	D5170C00002-7d383ace-8319-11eb-be00-390861459603-6325	\N	NEW	\N	\N	\N	\N
84844	79	D5170C00002/tiny.path.1/file-3454.pdf	\N	D5170C00002-7d39ac17-8317-11eb-be00-777e7555a1aa-3454	\N	NEW	\N	\N	\N	\N
83317	79	D5170C00002/tiny.path.1/file-1927.pdf	\N	D5170C00002-7d475d30-8316-11eb-be00-9de758a4ebc2-1927	\N	NEW	\N	\N	\N	\N
86331	79	D5170C00002/tiny.path.1/file-4941.pdf	\N	D5170C00002-7d557bd6-8318-11eb-be00-0bcfb0c3bbde-4941	\N	NEW	\N	\N	\N	\N
81962	79	D5170C00002/tiny.path.1/file-0572.pdf	\N	D5170C00002-7d566d85-8315-11eb-be00-030593a6790e-572	\N	NEW	\N	\N	\N	\N
84845	79	D5170C00002/tiny.path.1/file-3455.pdf	\N	D5170C00002-7d576d48-8317-11eb-be00-29d374538126-3455	\N	NEW	\N	\N	\N	\N
86332	79	D5170C00002/tiny.path.1/file-4942.pdf	\N	D5170C00002-7d66b9e7-8318-11eb-be00-234d8331888c-4942	\N	NEW	\N	\N	\N	\N
81963	79	D5170C00002/tiny.path.1/file-0573.pdf	\N	D5170C00002-7d74f206-8315-11eb-be00-07d2c5308cb5-573	\N	NEW	\N	\N	\N	\N
84846	79	D5170C00002/tiny.path.1/file-3456.pdf	\N	D5170C00002-7d75f1c9-8317-11eb-be00-f9e0a34f361d-3456	\N	NEW	\N	\N	\N	\N
83318	79	D5170C00002/tiny.path.1/file-1928.pdf	\N	D5170C00002-7d868911-8316-11eb-be00-0da7cd8f338e-1928	\N	NEW	\N	\N	\N	\N
84847	79	D5170C00002/tiny.path.1/file-3457.pdf	\N	D5170C00002-7d933dca-8317-11eb-be00-f92408e79db9-3457	\N	NEW	\N	\N	\N	\N
81964	79	D5170C00002/tiny.path.1/file-0574.pdf	\N	D5170C00002-7d9487f7-8315-11eb-be00-1142d28e3fb6-574	\N	NEW	\N	\N	\N	\N
86333	79	D5170C00002/tiny.path.1/file-4943.pdf	\N	D5170C00002-7da3e9f8-8318-11eb-be00-654854f89305-4943	\N	NEW	\N	\N	\N	\N
81965	79	D5170C00002/tiny.path.1/file-0575.pdf	\N	D5170C00002-7da48d88-8315-11eb-be00-6fb357f3dde8-575	\N	NEW	\N	\N	\N	\N
84848	79	D5170C00002/tiny.path.1/file-3458.pdf	\N	D5170C00002-7db2facb-8317-11eb-be00-9bb0c62273a0-3458	\N	NEW	\N	\N	\N	\N
84849	79	D5170C00002/tiny.path.1/file-3459.pdf	\N	D5170C00002-7dc0684c-8317-11eb-be00-51e271b79bd0-3459	\N	NEW	\N	\N	\N	\N
87716	79	D5170C00002/tiny.path.1/file-6326.pdf	\N	D5170C00002-7dc07d9f-8319-11eb-be00-e301400c0375-6326	\N	NEW	\N	\N	\N	\N
81966	79	D5170C00002/tiny.path.1/file-0576.pdf	\N	D5170C00002-7dc0ef29-8315-11eb-be00-3bc601ee7551-576	\N	NEW	\N	\N	\N	\N
83319	79	D5170C00002/tiny.path.1/file-1929.pdf	\N	D5170C00002-7dc25992-8316-11eb-be00-af7151fec8d3-1929	\N	NEW	\N	\N	\N	\N
86334	79	D5170C00002/tiny.path.1/file-4944.pdf	\N	D5170C00002-7dc2e3a9-8318-11eb-be00-b9098abea770-4944	\N	NEW	\N	\N	\N	\N
81967	79	D5170C00002/tiny.path.1/file-0577.pdf	\N	D5170C00002-7dd0587a-8315-11eb-be00-570dae14b849-577	\N	NEW	\N	\N	\N	\N
84850	79	D5170C00002/tiny.path.1/file-3460.pdf	\N	D5170C00002-7dd0e30d-8317-11eb-be00-b7bbce5efde0-3460	\N	NEW	\N	\N	\N	\N
84851	79	D5170C00002/tiny.path.1/file-3461.pdf	\N	D5170C00002-7dd1cd6e-8317-11eb-be00-3fa1a6ce5579-3461	\N	NEW	\N	\N	\N	\N
84852	79	D5170C00002/tiny.path.1/file-3462.pdf	\N	D5170C00002-7dd290bf-8317-11eb-be00-8ffce94e93b6-3462	\N	NEW	\N	\N	\N	\N
81968	79	D5170C00002/tiny.path.1/file-0578.pdf	\N	D5170C00002-7de1486b-8315-11eb-be00-294bc32736fd-578	\N	NEW	\N	\N	\N	\N
84853	79	D5170C00002/tiny.path.1/file-3463.pdf	\N	D5170C00002-7de1d300-8317-11eb-be00-1d8cde4545c2-3463	\N	NEW	\N	\N	\N	\N
84854	79	D5170C00002/tiny.path.1/file-3464.pdf	\N	D5170C00002-7df051f1-8317-11eb-be00-03246a7e8552-3464	\N	NEW	\N	\N	\N	\N
84855	79	D5170C00002/tiny.path.1/file-3465.pdf	\N	D5170C00002-7dfd7152-8317-11eb-be00-a364e7733311-3465	\N	NEW	\N	\N	\N	\N
86335	79	D5170C00002/tiny.path.1/file-4945.pdf	\N	D5170C00002-7dfdf0da-8318-11eb-be00-fbd49ff5af18-4945	\N	NEW	\N	\N	\N	\N
81969	79	D5170C00002/tiny.path.1/file-0579.pdf	\N	D5170C00002-7e00903c-8315-11eb-be00-f7bcf345c579-579	\N	NEW	\N	\N	\N	\N
84856	79	D5170C00002/tiny.path.1/file-3466.pdf	\N	D5170C00002-7e0d76e3-8317-11eb-be00-05d555940b4f-3466	\N	NEW	\N	\N	\N	\N
84857	79	D5170C00002/tiny.path.1/file-3467.pdf	\N	D5170C00002-7e0e6144-8317-11eb-be00-3d4993a76393-3467	\N	NEW	\N	\N	\N	\N
81970	79	D5170C00002/tiny.path.1/file-0580.pdf	\N	D5170C00002-7e0f363d-8315-11eb-be00-8d5c04eaf7d9-580	\N	NEW	\N	\N	\N	\N
84858	79	D5170C00002/tiny.path.1/file-3468.pdf	\N	D5170C00002-7e1c1ce5-8317-11eb-be00-63571ca2a54b-3468	\N	NEW	\N	\N	\N	\N
86336	79	D5170C00002/tiny.path.1/file-4946.pdf	\N	D5170C00002-7e1c4e4b-8318-11eb-be00-6bc6158bb259-4946	\N	NEW	\N	\N	\N	\N
84859	79	D5170C00002/tiny.path.1/file-3469.pdf	\N	D5170C00002-7e2b3816-8317-11eb-be00-81066a26b26b-3469	\N	NEW	\N	\N	\N	\N
81971	79	D5170C00002/tiny.path.1/file-0581.pdf	\N	D5170C00002-7e2be5fe-8315-11eb-be00-2b0c81807102-581	\N	NEW	\N	\N	\N	\N
84860	79	D5170C00002/tiny.path.1/file-3470.pdf	\N	D5170C00002-7e2da917-8317-11eb-be00-f7d9cc4bff2f-3470	\N	NEW	\N	\N	\N	\N
86337	79	D5170C00002/tiny.path.1/file-4947.pdf	\N	D5170C00002-7e2dda7c-8318-11eb-be00-359c262f5be8-4947	\N	NEW	\N	\N	\N	\N
87717	79	D5170C00002/tiny.path.1/file-6327.pdf	\N	D5170C00002-7e3b7a00-8319-11eb-be00-639677e38b99-6327	\N	NEW	\N	\N	\N	\N
84861	79	D5170C00002/tiny.path.1/file-3471.pdf	\N	D5170C00002-7e3c7628-8317-11eb-be00-ed81fba7e69d-3471	\N	NEW	\N	\N	\N	\N
86338	79	D5170C00002/tiny.path.1/file-4948.pdf	\N	D5170C00002-7e4978cd-8318-11eb-be00-d9659742a9b3-4948	\N	NEW	\N	\N	\N	\N
81972	79	D5170C00002/tiny.path.1/file-0582.pdf	\N	D5170C00002-7e4c664f-8315-11eb-be00-81c78cdf4ed6-582	\N	NEW	\N	\N	\N	\N
83320	79	D5170C00002/tiny.path.1/file-1930.pdf	\N	D5170C00002-7e4c9833-8316-11eb-be00-834801cc2829-1930	\N	NEW	\N	\N	\N	\N
86339	79	D5170C00002/tiny.path.1/file-4949.pdf	\N	D5170C00002-7e5b2c0e-8318-11eb-be00-59ba0dc2cb87-4949	\N	NEW	\N	\N	\N	\N
87718	79	D5170C00002/tiny.path.1/file-6328.pdf	\N	D5170C00002-7e680841-8319-11eb-be00-03409c396d41-6328	\N	NEW	\N	\N	\N	\N
86340	79	D5170C00002/tiny.path.1/file-4950.pdf	\N	D5170C00002-7e773f8f-8318-11eb-be00-115337c469aa-4950	\N	NEW	\N	\N	\N	\N
83321	79	D5170C00002/tiny.path.1/file-1931.pdf	\N	D5170C00002-7e783c14-8316-11eb-be00-416af34978cd-1931	\N	NEW	\N	\N	\N	\N
81973	79	D5170C00002/tiny.path.1/file-0583.pdf	\N	D5170C00002-7e78f490-8315-11eb-be00-619567ff9bdf-583	\N	NEW	\N	\N	\N	\N
86341	79	D5170C00002/tiny.path.1/file-4951.pdf	\N	D5170C00002-7e8919e0-8318-11eb-be00-516d4b6cf0e4-4951	\N	NEW	\N	\N	\N	\N
81974	79	D5170C00002/tiny.path.1/file-0584.pdf	\N	D5170C00002-7e8a32a1-8315-11eb-be00-436f0ff584ac-584	\N	NEW	\N	\N	\N	\N
87719	79	D5170C00002/tiny.path.1/file-6329.pdf	\N	D5170C00002-7e95f612-8319-11eb-be00-494a7be7bc6d-6329	\N	NEW	\N	\N	\N	\N
86342	79	D5170C00002/tiny.path.1/file-4952.pdf	\N	D5170C00002-7e9798d1-8318-11eb-be00-eb27c29812d0-4952	\N	NEW	\N	\N	\N	\N
83322	79	D5170C00002/tiny.path.1/file-1932.pdf	\N	D5170C00002-7e989555-8316-11eb-be00-b34650aaa015-1932	\N	NEW	\N	\N	\N	\N
84862	79	D5170C00002/tiny.path.1/file-3472.pdf	\N	D5170C00002-7e989fe9-8317-11eb-be00-a925b0f44b35-3472	\N	NEW	\N	\N	\N	\N
86343	79	D5170C00002/tiny.path.1/file-4953.pdf	\N	D5170C00002-7ea52d62-8318-11eb-be00-37518f05fee0-4953	\N	NEW	\N	\N	\N	\N
81975	79	D5170C00002/tiny.path.1/file-0585.pdf	\N	D5170C00002-7ea7a5b2-8315-11eb-be00-91d2a21506b4-585	\N	NEW	\N	\N	\N	\N
83323	79	D5170C00002/tiny.path.1/file-1933.pdf	\N	D5170C00002-7ec54aa6-8316-11eb-be00-6d018e42ec6c-1933	\N	NEW	\N	\N	\N	\N
86344	79	D5170C00002/tiny.path.1/file-4954.pdf	\N	D5170C00002-7ec5adb3-8318-11eb-be00-29f9458d62e2-4954	\N	NEW	\N	\N	\N	\N
81976	79	D5170C00002/tiny.path.1/file-0586.pdf	\N	D5170C00002-7ec5b503-8315-11eb-be00-335a7bf55c64-586	\N	NEW	\N	\N	\N	\N
86345	79	D5170C00002/tiny.path.1/file-4955.pdf	\N	D5170C00002-7ed4a1d4-8318-11eb-be00-7d5c2021cfbc-4955	\N	NEW	\N	\N	\N	\N
81977	79	D5170C00002/tiny.path.1/file-0587.pdf	\N	D5170C00002-7ee32814-8315-11eb-be00-313b95d5450c-587	\N	NEW	\N	\N	\N	\N
86346	79	D5170C00002/tiny.path.1/file-4956.pdf	\N	D5170C00002-7ee40b25-8318-11eb-be00-518eee0d4404-4956	\N	NEW	\N	\N	\N	\N
86347	79	D5170C00002/tiny.path.1/file-4957.pdf	\N	D5170C00002-7ef15196-8318-11eb-be00-7505e9c0ba75-4957	\N	NEW	\N	\N	\N	\N
83324	79	D5170C00002/tiny.path.1/file-1934.pdf	\N	D5170C00002-7ef3d4b7-8316-11eb-be00-8b5a76a62230-1934	\N	NEW	\N	\N	\N	\N
86348	79	D5170C00002/tiny.path.1/file-4958.pdf	\N	D5170C00002-7f00bae7-8318-11eb-be00-052eefe88790-4958	\N	NEW	\N	\N	\N	\N
83325	79	D5170C00002/tiny.path.1/file-1935.pdf	\N	D5170C00002-7f03b338-8316-11eb-be00-9b5939846720-1935	\N	NEW	\N	\N	\N	\N
86349	79	D5170C00002/tiny.path.1/file-4959.pdf	\N	D5170C00002-7f0fd618-8318-11eb-be00-bdad1d103556-4959	\N	NEW	\N	\N	\N	\N
81978	79	D5170C00002/tiny.path.1/file-0588.pdf	\N	D5170C00002-7f11b225-8315-11eb-be00-0d3f3acfa24f-588	\N	NEW	\N	\N	\N	\N
83326	79	D5170C00002/tiny.path.1/file-1936.pdf	\N	D5170C00002-7f125939-8316-11eb-be00-ff53cf0a93e4-1936	\N	NEW	\N	\N	\N	\N
86350	79	D5170C00002/tiny.path.1/file-4960.pdf	\N	D5170C00002-7f1f1859-8318-11eb-be00-5bf8ee695508-4960	\N	NEW	\N	\N	\N	\N
83327	79	D5170C00002/tiny.path.1/file-1937.pdf	\N	D5170C00002-7f21c28a-8316-11eb-be00-f559aaa20a68-1937	\N	NEW	\N	\N	\N	\N
87720	79	D5170C00002/tiny.path.1/file-6330.pdf	\N	D5170C00002-7f2f9e03-8319-11eb-be00-77d1e294056e-6330	\N	NEW	\N	\N	\N	\N
83328	79	D5170C00002/tiny.path.1/file-1938.pdf	\N	D5170C00002-7f3179fb-8316-11eb-be00-f5a1dbd6cc8f-1938	\N	NEW	\N	\N	\N	\N
83329	79	D5170C00002/tiny.path.1/file-1939.pdf	\N	D5170C00002-7f40bc3c-8316-11eb-be00-07486f605fce-1939	\N	NEW	\N	\N	\N	\N
87721	79	D5170C00002/tiny.path.1/file-6331.pdf	\N	D5170C00002-7f5c0534-8319-11eb-be00-33a0ef03aa2e-6331	\N	NEW	\N	\N	\N	\N
81979	79	D5170C00002/tiny.path.1/file-0589.pdf	\N	D5170C00002-7f5d6126-8315-11eb-be00-27de118d6bf6-589	\N	NEW	\N	\N	\N	\N
83330	79	D5170C00002/tiny.path.1/file-1940.pdf	\N	D5170C00002-7f5e083d-8316-11eb-be00-1f759f2f41c6-1940	\N	NEW	\N	\N	\N	\N
86351	79	D5170C00002/tiny.path.1/file-4961.pdf	\N	D5170C00002-7f6d385a-8318-11eb-be00-77d4084f50f2-4961	\N	NEW	\N	\N	\N	\N
83331	79	D5170C00002/tiny.path.1/file-1941.pdf	\N	D5170C00002-7f6dbfae-8316-11eb-be00-07e9d934f467-1941	\N	NEW	\N	\N	\N	\N
83332	79	D5170C00002/tiny.path.1/file-1942.pdf	\N	D5170C00002-7f8a967f-8316-11eb-be00-d37c1a14d7e4-1942	\N	NEW	\N	\N	\N	\N
87722	79	D5170C00002/tiny.path.1/file-6332.pdf	\N	D5170C00002-7f995c55-8319-11eb-be00-fd5e7f36f64e-6332	\N	NEW	\N	\N	\N	\N
87723	79	D5170C00002/tiny.path.1/file-6333.pdf	\N	D5170C00002-7f9b0a06-8319-11eb-be00-a3064b70ba29-6333	\N	NEW	\N	\N	\N	\N
86352	79	D5170C00002/tiny.path.1/file-4962.pdf	\N	D5170C00002-7f9bc26b-8318-11eb-be00-457ae721b833-4962	\N	NEW	\N	\N	\N	\N
83333	79	D5170C00002/tiny.path.1/file-1943.pdf	\N	D5170C00002-7f9c22b0-8316-11eb-be00-9197b2805bfe-1943	\N	NEW	\N	\N	\N	\N
81980	79	D5170C00002/tiny.path.1/file-0590.pdf	\N	D5170C00002-7faa6fb7-8315-11eb-be00-0f6555c261b4-590	\N	NEW	\N	\N	\N	\N
83334	79	D5170C00002/tiny.path.1/file-1944.pdf	\N	D5170C00002-7fab3de1-8316-11eb-be00-6b3d277aac13-1944	\N	NEW	\N	\N	\N	\N
83335	79	D5170C00002/tiny.path.1/file-1945.pdf	\N	D5170C00002-7fb995c2-8316-11eb-be00-772a2e521483-1945	\N	NEW	\N	\N	\N	\N
87724	79	D5170C00002/tiny.path.1/file-6334.pdf	\N	D5170C00002-7fb9b597-8319-11eb-be00-79c293d0b702-6334	\N	NEW	\N	\N	\N	\N
87725	79	D5170C00002/tiny.path.1/file-6335.pdf	\N	D5170C00002-7fc945f8-8319-11eb-be00-d5807d9adf99-6335	\N	NEW	\N	\N	\N	\N
83336	79	D5170C00002/tiny.path.1/file-1946.pdf	\N	D5170C00002-7fc99b53-8316-11eb-be00-8d1850a71999-1946	\N	NEW	\N	\N	\N	\N
81981	79	D5170C00002/tiny.path.1/file-0591.pdf	\N	D5170C00002-7fca7ad8-8315-11eb-be00-976c5c731fa9-591	\N	NEW	\N	\N	\N	\N
81982	79	D5170C00002/tiny.path.1/file-0592.pdf	\N	D5170C00002-7fe70389-8315-11eb-be00-99b10e7de9a9-592	\N	NEW	\N	\N	\N	\N
86353	79	D5170C00002/tiny.path.1/file-4963.pdf	\N	D5170C00002-7fe7bf8c-8318-11eb-be00-1f04cbb5bb78-4963	\N	NEW	\N	\N	\N	\N
83337	79	D5170C00002/tiny.path.1/file-1947.pdf	\N	D5170C00002-7fe81fd4-8316-11eb-be00-5ba638ba467d-1947	\N	NEW	\N	\N	\N	\N
87726	79	D5170C00002/tiny.path.1/file-6336.pdf	\N	D5170C00002-7fe866b9-8319-11eb-be00-338efda16c78-6336	\N	NEW	\N	\N	\N	\N
87727	79	D5170C00002/tiny.path.1/file-6337.pdf	\N	D5170C00002-7ff70cba-8319-11eb-be00-759ee1e61b74-6337	\N	NEW	\N	\N	\N	\N
86354	79	D5170C00002/tiny.path.1/file-4964.pdf	\N	D5170C00002-800580bd-8318-11eb-be00-a3b97305e731-4964	\N	NEW	\N	\N	\N	\N
84863	79	D5170C00002/tiny.path.1/file-3473.pdf	\N	D5170C00002-800639aa-8317-11eb-be00-dfe1a3f68586-3473	\N	NEW	\N	\N	\N	\N
86355	79	D5170C00002/tiny.path.1/file-4965.pdf	\N	D5170C00002-8015ad5e-8318-11eb-be00-77e0d6bfc1d6-4965	\N	NEW	\N	\N	\N	\N
86356	79	D5170C00002/tiny.path.1/file-4966.pdf	\N	D5170C00002-803458ef-8318-11eb-be00-3bcdc689e605-4966	\N	NEW	\N	\N	\N	\N
86357	79	D5170C00002/tiny.path.1/file-4967.pdf	\N	D5170C00002-80528f50-8318-11eb-be00-a1b8c0d021c6-4967	\N	NEW	\N	\N	\N	\N
83338	79	D5170C00002/tiny.path.1/file-1948.pdf	\N	D5170C00002-80614775-8316-11eb-be00-b97b9bf60433-1948	\N	NEW	\N	\N	\N	\N
83339	79	D5170C00002/tiny.path.1/file-1949.pdf	\N	D5170C00002-80717416-8316-11eb-be00-f9bf3b2bb3ff-1949	\N	NEW	\N	\N	\N	\N
83340	79	D5170C00002/tiny.path.1/file-1950.pdf	\N	D5170C00002-807e6c67-8316-11eb-be00-b16b3fa2a566-1950	\N	NEW	\N	\N	\N	\N
86358	79	D5170C00002/tiny.path.1/file-4968.pdf	\N	D5170C00002-807e8151-8318-11eb-be00-51b3b577c4c3-4968	\N	NEW	\N	\N	\N	\N
87728	79	D5170C00002/tiny.path.1/file-6338.pdf	\N	D5170C00002-807f769b-8319-11eb-be00-190c765693fa-6338	\N	NEW	\N	\N	\N	\N
87729	79	D5170C00002/tiny.path.1/file-6339.pdf	\N	D5170C00002-808039ec-8319-11eb-be00-1d5e30cebc83-6339	\N	NEW	\N	\N	\N	\N
83341	79	D5170C00002/tiny.path.1/file-1951.pdf	\N	D5170C00002-80808f48-8316-11eb-be00-b3e59192932e-1951	\N	NEW	\N	\N	\N	\N
87730	79	D5170C00002/tiny.path.1/file-6340.pdf	\N	D5170C00002-808e43ad-8319-11eb-be00-dd7546f9f7da-6340	\N	NEW	\N	\N	\N	\N
87731	79	D5170C00002/tiny.path.1/file-6341.pdf	\N	D5170C00002-80a01dfe-8319-11eb-be00-dfdb40638051-6341	\N	NEW	\N	\N	\N	\N
87732	79	D5170C00002/tiny.path.1/file-6342.pdf	\N	D5170C00002-80adb28f-8319-11eb-be00-8fcf9278bcb3-6342	\N	NEW	\N	\N	\N	\N
83342	79	D5170C00002/tiny.path.1/file-1952.pdf	\N	D5170C00002-80ae2ef9-8316-11eb-be00-cd246f3ec239-1952	\N	NEW	\N	\N	\N	\N
81983	79	D5170C00002/tiny.path.1/file-0593.pdf	\N	D5170C00002-80ae4b2a-8315-11eb-be00-d72c57b08a30-593	\N	NEW	\N	\N	\N	\N
83343	79	D5170C00002/tiny.path.1/file-1953.pdf	\N	D5170C00002-80bd713a-8316-11eb-be00-f77edd1416db-1953	\N	NEW	\N	\N	\N	\N
86359	79	D5170C00002/tiny.path.1/file-4969.pdf	\N	D5170C00002-80bdad32-8318-11eb-be00-15c695cf74ae-4969	\N	NEW	\N	\N	\N	\N
83344	79	D5170C00002/tiny.path.1/file-1954.pdf	\N	D5170C00002-80cadebb-8316-11eb-be00-df13179b1641-1954	\N	NEW	\N	\N	\N	\N
87733	79	D5170C00002/tiny.path.1/file-6343.pdf	\N	D5170C00002-80ccd350-8319-11eb-be00-c5e599bed517-6343	\N	NEW	\N	\N	\N	\N
83345	79	D5170C00002/tiny.path.1/file-1955.pdf	\N	D5170C00002-80cd76cc-8316-11eb-be00-07834e8fd293-1955	\N	NEW	\N	\N	\N	\N
86360	79	D5170C00002/tiny.path.1/file-4970.pdf	\N	D5170C00002-80ebe923-8318-11eb-be00-af95bda2a317-4970	\N	NEW	\N	\N	\N	\N
87734	79	D5170C00002/tiny.path.1/file-6344.pdf	\N	D5170C00002-80f82911-8319-11eb-be00-bbfb37356ff8-6344	\N	NEW	\N	\N	\N	\N
83346	79	D5170C00002/tiny.path.1/file-1956.pdf	\N	D5170C00002-80fa2c1d-8316-11eb-be00-3506bbfe379c-1956	\N	NEW	\N	\N	\N	\N
83347	79	D5170C00002/tiny.path.1/file-1957.pdf	\N	D5170C00002-81179f2e-8316-11eb-be00-1183bb9183a4-1957	\N	NEW	\N	\N	\N	\N
87735	79	D5170C00002/tiny.path.1/file-6345.pdf	\N	D5170C00002-8117e612-8319-11eb-be00-750650b222ce-6345	\N	NEW	\N	\N	\N	\N
87736	79	D5170C00002/tiny.path.1/file-6346.pdf	\N	D5170C00002-81350b03-8319-11eb-be00-9f6e856b2ddf-6346	\N	NEW	\N	\N	\N	\N
84864	79	D5170C00002/tiny.path.1/file-3474.pdf	\N	D5170C00002-8136553b-8317-11eb-be00-f70c751bc4fa-3474	\N	NEW	\N	\N	\N	\N
83348	79	D5170C00002/tiny.path.1/file-1958.pdf	\N	D5170C00002-8137aa4f-8316-11eb-be00-7521bc697ae7-1958	\N	NEW	\N	\N	\N	\N
81984	79	D5170C00002/tiny.path.1/file-0594.pdf	\N	D5170C00002-8145821b-8315-11eb-be00-6fca91e4fb14-594	\N	NEW	\N	\N	\N	\N
83349	79	D5170C00002/tiny.path.1/file-1959.pdf	\N	D5170C00002-814788d0-8316-11eb-be00-51558318e945-1959	\N	NEW	\N	\N	\N	\N
87737	79	D5170C00002/tiny.path.1/file-6347.pdf	\N	D5170C00002-81538f84-8319-11eb-be00-753781066388-6347	\N	NEW	\N	\N	\N	\N
86361	79	D5170C00002/tiny.path.1/file-4971.pdf	\N	D5170C00002-81555954-8318-11eb-be00-c1e3ec2e006d-4971	\N	NEW	\N	\N	\N	\N
87738	79	D5170C00002/tiny.path.1/file-6348.pdf	\N	D5170C00002-81639515-8319-11eb-be00-b7bcf3a6cf67-6348	\N	NEW	\N	\N	\N	\N
83350	79	D5170C00002/tiny.path.1/file-1960.pdf	\N	D5170C00002-8163c361-8316-11eb-be00-cd18e4f3b629-1960	\N	NEW	\N	\N	\N	\N
87739	79	D5170C00002/tiny.path.1/file-6349.pdf	\N	D5170C00002-81726226-8319-11eb-be00-290f1f42c202-6349	\N	NEW	\N	\N	\N	\N
87740	79	D5170C00002/tiny.path.1/file-6350.pdf	\N	D5170C00002-81752147-8319-11eb-be00-3d4b18dbb26e-6350	\N	NEW	\N	\N	\N	\N
83351	79	D5170C00002/tiny.path.1/file-1961.pdf	\N	D5170C00002-81835952-8316-11eb-be00-db121990375c-1961	\N	NEW	\N	\N	\N	\N
81985	79	D5170C00002/tiny.path.1/file-0595.pdf	\N	D5170C00002-818486ec-8315-11eb-be00-ab9465f0538e-595	\N	NEW	\N	\N	\N	\N
87741	79	D5170C00002/tiny.path.1/file-6351.pdf	\N	D5170C00002-81909888-8319-11eb-be00-43b0235b6203-6351	\N	NEW	\N	\N	\N	\N
84865	79	D5170C00002/tiny.path.1/file-3475.pdf	\N	D5170C00002-8193de8c-8317-11eb-be00-a16a9174b293-3475	\N	NEW	\N	\N	\N	\N
83352	79	D5170C00002/tiny.path.1/file-1962.pdf	\N	D5170C00002-81a18fb3-8316-11eb-be00-4f34d7d0944e-1962	\N	NEW	\N	\N	\N	\N
87742	79	D5170C00002/tiny.path.1/file-6352.pdf	\N	D5170C00002-81a24bc9-8319-11eb-be00-dd2f5b0936a3-6352	\N	NEW	\N	\N	\N	\N
86362	79	D5170C00002/tiny.path.1/file-4972.pdf	\N	D5170C00002-81a35245-8318-11eb-be00-7dce62158432-4972	\N	NEW	\N	\N	\N	\N
84866	79	D5170C00002/tiny.path.1/file-3476.pdf	\N	D5170C00002-81afcafd-8317-11eb-be00-218a554e0157-3476	\N	NEW	\N	\N	\N	\N
84867	79	D5170C00002/tiny.path.1/file-3477.pdf	\N	D5170C00002-81b1c6ce-8317-11eb-be00-19a7caaaa066-3477	\N	NEW	\N	\N	\N	\N
83353	79	D5170C00002/tiny.path.1/file-1963.pdf	\N	D5170C00002-81b2a6b4-8316-11eb-be00-d52ff5812bac-1963	\N	NEW	\N	\N	\N	\N
84868	79	D5170C00002/tiny.path.1/file-3478.pdf	\N	D5170C00002-81bf826f-8317-11eb-be00-797e2256f6e4-3478	\N	NEW	\N	\N	\N	\N
81986	79	D5170C00002/tiny.path.1/file-0596.pdf	\N	D5170C00002-81bfe23d-8315-11eb-be00-bd859928d723-596	\N	NEW	\N	\N	\N	\N
87743	79	D5170C00002/tiny.path.1/file-6353.pdf	\N	D5170C00002-81c0d04a-8319-11eb-be00-23d5352a1c63-6353	\N	NEW	\N	\N	\N	\N
81987	79	D5170C00002/tiny.path.1/file-0597.pdf	\N	D5170C00002-81d1204e-8315-11eb-be00-b98252ee80b8-597	\N	NEW	\N	\N	\N	\N
86363	79	D5170C00002/tiny.path.1/file-4973.pdf	\N	D5170C00002-81ded4a6-8318-11eb-be00-95e64e608d96-4973	\N	NEW	\N	\N	\N	\N
84869	79	D5170C00002/tiny.path.1/file-3479.pdf	\N	D5170C00002-81ed4930-8317-11eb-be00-b3a3d81970ce-3479	\N	NEW	\N	\N	\N	\N
84870	79	D5170C00002/tiny.path.1/file-3480.pdf	\N	D5170C00002-81fbc821-8317-11eb-be00-0d817af8735a-3480	\N	NEW	\N	\N	\N	\N
86364	79	D5170C00002/tiny.path.1/file-4974.pdf	\N	D5170C00002-81fbd287-8318-11eb-be00-a9392fc46a58-4974	\N	NEW	\N	\N	\N	\N
81988	79	D5170C00002/tiny.path.1/file-0598.pdf	\N	D5170C00002-81fc4eff-8315-11eb-be00-99c59d1b94b2-598	\N	NEW	\N	\N	\N	\N
81989	79	D5170C00002/tiny.path.1/file-0599.pdf	\N	D5170C00002-820bb850-8315-11eb-be00-2d1b9d7aace6-599	\N	NEW	\N	\N	\N	\N
86365	79	D5170C00002/tiny.path.1/file-4975.pdf	\N	D5170C00002-820c7458-8318-11eb-be00-2b1c7ddc1598-4975	\N	NEW	\N	\N	\N	\N
84871	79	D5170C00002/tiny.path.1/file-3481.pdf	\N	D5170C00002-820e17a2-8317-11eb-be00-2739db638375-3481	\N	NEW	\N	\N	\N	\N
87744	79	D5170C00002/tiny.path.1/file-6354.pdf	\N	D5170C00002-821afe3b-8319-11eb-be00-d5405c95abd2-6354	\N	NEW	\N	\N	\N	\N
84872	79	D5170C00002/tiny.path.1/file-3482.pdf	\N	D5170C00002-822967d3-8317-11eb-be00-2f640b4920e1-3482	\N	NEW	\N	\N	\N	\N
81990	79	D5170C00002/tiny.path.1/file-0600.pdf	\N	D5170C00002-822a15c1-8315-11eb-be00-85e2d488af14-600	\N	NEW	\N	\N	\N	\N
84873	79	D5170C00002/tiny.path.1/file-3483.pdf	\N	D5170C00002-822bd8d4-8317-11eb-be00-018b258ab6e3-3483	\N	NEW	\N	\N	\N	\N
86366	79	D5170C00002/tiny.path.1/file-4976.pdf	\N	D5170C00002-822c5869-8318-11eb-be00-13982a4c00ea-4976	\N	NEW	\N	\N	\N	\N
83354	79	D5170C00002/tiny.path.1/file-1964.pdf	\N	D5170C00002-823b5eb5-8316-11eb-be00-ab3535355037-1964	\N	NEW	\N	\N	\N	\N
86367	79	D5170C00002/tiny.path.1/file-4977.pdf	\N	D5170C00002-824892fa-8318-11eb-be00-7db616817ca7-4977	\N	NEW	\N	\N	\N	\N
84891	79	D5170C00002/tiny.path.1/file-3501.pdf	\N	D5170C00002-82494be5-8317-11eb-be00-1d93a4b98e4f-3484	\N	NEW	\N	\N	\N	\N
86368	79	D5170C00002/tiny.path.1/file-4978.pdf	\N	D5170C00002-8249f28b-8318-11eb-be00-4be3b6673a13-4978	\N	NEW	\N	\N	\N	\N
87745	79	D5170C00002/tiny.path.1/file-6355.pdf	\N	D5170C00002-8249fd7c-8319-11eb-be00-af29777e6859-6355	\N	NEW	\N	\N	\N	\N
83355	79	D5170C00002/tiny.path.1/file-1965.pdf	\N	D5170C00002-824a52d6-8316-11eb-be00-f3ef4b8b0bf8-1965	\N	NEW	\N	\N	\N	\N
86369	79	D5170C00002/tiny.path.1/file-4979.pdf	\N	D5170C00002-82590dbc-8318-11eb-be00-bdd445ad1e2d-4979	\N	NEW	\N	\N	\N	\N
83356	79	D5170C00002/tiny.path.1/file-1966.pdf	\N	D5170C00002-82679ed7-8316-11eb-be00-952c1f74deef-1966	\N	NEW	\N	\N	\N	\N
81991	79	D5170C00002/tiny.path.1/file-0601.pdf	\N	D5170C00002-82687e52-8315-11eb-be00-13438979c37a-601	\N	NEW	\N	\N	\N	\N
84874	79	D5170C00002/tiny.path.1/file-3484.pdf	\N	D5170C00002-82692ff6-8317-11eb-be00-b130a15e1153-3485	\N	NEW	\N	\N	\N	\N
86370	79	D5170C00002/tiny.path.1/file-4980.pdf	\N	D5170C00002-8277e05d-8318-11eb-be00-e13a8c9c6966-4980	\N	NEW	\N	\N	\N	\N
81992	79	D5170C00002/tiny.path.1/file-0602.pdf	\N	D5170C00002-8277e7a3-8315-11eb-be00-edaf1c8ed791-602	\N	NEW	\N	\N	\N	\N
81993	79	D5170C00002/tiny.path.1/file-0603.pdf	\N	D5170C00002-8285ca54-8315-11eb-be00-f39abb17aa70-603	\N	NEW	\N	\N	\N	\N
87746	79	D5170C00002/tiny.path.1/file-6356.pdf	\N	D5170C00002-82861c1d-8319-11eb-be00-2d9420d641fe-6356	\N	NEW	\N	\N	\N	\N
84875	79	D5170C00002/tiny.path.1/file-3485.pdf	\N	D5170C00002-82876657-8317-11eb-be00-d3b7e2c27e94-3486	\N	NEW	\N	\N	\N	\N
86371	79	D5170C00002/tiny.path.1/file-4981.pdf	\N	D5170C00002-8295054e-8318-11eb-be00-c9a5d4c569a8-4981	\N	NEW	\N	\N	\N	\N
84876	79	D5170C00002/tiny.path.1/file-3486.pdf	\N	D5170C00002-8296f6b8-8317-11eb-be00-db29d0a86f36-3487	\N	NEW	\N	\N	\N	\N
86372	79	D5170C00002/tiny.path.1/file-4982.pdf	\N	D5170C00002-82a3d25f-8318-11eb-be00-71f26ff847c7-4982	\N	NEW	\N	\N	\N	\N
81994	79	D5170C00002/tiny.path.1/file-0604.pdf	\N	D5170C00002-82a400b5-8315-11eb-be00-bd547314bdd3-604	\N	NEW	\N	\N	\N	\N
83357	79	D5170C00002/tiny.path.1/file-1967.pdf	\N	D5170C00002-82a59238-8316-11eb-be00-e9954b3b00db-1967	\N	NEW	\N	\N	\N	\N
86373	79	D5170C00002/tiny.path.1/file-4983.pdf	\N	D5170C00002-82b2c680-8318-11eb-be00-971c650d56b8-4983	\N	NEW	\N	\N	\N	\N
84877	79	D5170C00002/tiny.path.1/file-3487.pdf	\N	D5170C00002-82b33149-8317-11eb-be00-9bcbe0cd6e67-3488	\N	NEW	\N	\N	\N	\N
87747	79	D5170C00002/tiny.path.1/file-6357.pdf	\N	D5170C00002-82b3469e-8319-11eb-be00-ef24bb4ce6c1-6357	\N	NEW	\N	\N	\N	\N
81995	79	D5170C00002/tiny.path.1/file-0605.pdf	\N	D5170C00002-82b36a06-8315-11eb-be00-5159e7bcca59-605	\N	NEW	\N	\N	\N	\N
84878	79	D5170C00002/tiny.path.1/file-3488.pdf	\N	D5170C00002-82c24c7a-8317-11eb-be00-9347d87967a7-3489	\N	NEW	\N	\N	\N	\N
86374	79	D5170C00002/tiny.path.1/file-4984.pdf	\N	D5170C00002-82c34141-8318-11eb-be00-4f42f777f339-4984	\N	NEW	\N	\N	\N	\N
81996	79	D5170C00002/tiny.path.1/file-0606.pdf	\N	D5170C00002-82c432e7-8315-11eb-be00-11cf2ed00c97-606	\N	NEW	\N	\N	\N	\N
84879	79	D5170C00002/tiny.path.1/file-3489.pdf	\N	D5170C00002-82d203eb-8317-11eb-be00-fb488f57266c-3490	\N	NEW	\N	\N	\N	\N
86375	79	D5170C00002/tiny.path.1/file-4985.pdf	\N	D5170C00002-82d31fc2-8318-11eb-be00-d756db4f3653-4985	\N	NEW	\N	\N	\N	\N
83358	79	D5170C00002/tiny.path.1/file-1968.pdf	\N	D5170C00002-82d3a719-8316-11eb-be00-0710c8d081e0-1968	\N	NEW	\N	\N	\N	\N
81997	79	D5170C00002/tiny.path.1/file-0607.pdf	\N	D5170C00002-82e130c8-8315-11eb-be00-85f6ddd9d06c-607	\N	NEW	\N	\N	\N	\N
84880	79	D5170C00002/tiny.path.1/file-3490.pdf	\N	D5170C00002-82e1944c-8317-11eb-be00-2163c1db022d-3491	\N	NEW	\N	\N	\N	\N
86376	79	D5170C00002/tiny.path.1/file-4986.pdf	\N	D5170C00002-82e2d733-8318-11eb-be00-c3584c1fc8e3-4986	\N	NEW	\N	\N	\N	\N
84881	79	D5170C00002/tiny.path.1/file-3491.pdf	\N	D5170C00002-82f0af7d-8317-11eb-be00-03f9cca85283-3492	\N	NEW	\N	\N	\N	\N
81998	79	D5170C00002/tiny.path.1/file-0608.pdf	\N	D5170C00002-82f0e839-8315-11eb-be00-9f0421b4cd9f-608	\N	NEW	\N	\N	\N	\N
81999	79	D5170C00002/tiny.path.1/file-0609.pdf	\N	D5170C00002-830ef78a-8315-11eb-be00-cb1b3e7d5837-609	\N	NEW	\N	\N	\N	\N
84882	79	D5170C00002/tiny.path.1/file-3492.pdf	\N	D5170C00002-830f33fe-8317-11eb-be00-b36a3e479b1c-3493	\N	NEW	\N	\N	\N	\N
83359	79	D5170C00002/tiny.path.1/file-1969.pdf	\N	D5170C00002-830fecca-8316-11eb-be00-b353e195153e-1969	\N	NEW	\N	\N	\N	\N
84883	79	D5170C00002/tiny.path.1/file-3493.pdf	\N	D5170C00002-831dd9ff-8317-11eb-be00-49da99cce233-3494	\N	NEW	\N	\N	\N	\N
84884	79	D5170C00002/tiny.path.1/file-3494.pdf	\N	D5170C00002-831eeb70-8317-11eb-be00-ddf77f4358ca-3495	\N	NEW	\N	\N	\N	\N
84885	79	D5170C00002/tiny.path.1/file-3495.pdf	\N	D5170C00002-83204b01-8317-11eb-be00-2dc5fa66824f-3496	\N	NEW	\N	\N	\N	\N
84886	79	D5170C00002/tiny.path.1/file-3496.pdf	\N	D5170C00002-832e54c2-8317-11eb-be00-2f74a2cd8de0-3497	\N	NEW	\N	\N	\N	\N
87748	79	D5170C00002/tiny.path.1/file-6358.pdf	\N	D5170C00002-832fc99f-8319-11eb-be00-ab40059ce51d-6358	\N	NEW	\N	\N	\N	\N
83360	79	D5170C00002/tiny.path.1/file-1970.pdf	\N	D5170C00002-83301efb-8316-11eb-be00-57717c7fdef5-1970	\N	NEW	\N	\N	\N	\N
84887	79	D5170C00002/tiny.path.1/file-3497.pdf	\N	D5170C00002-833de523-8317-11eb-be00-77dbca2a2c26-3498	\N	NEW	\N	\N	\N	\N
84888	79	D5170C00002/tiny.path.1/file-3498.pdf	\N	D5170C00002-835abbf4-8317-11eb-be00-135bbe4353e3-3499	\N	NEW	\N	\N	\N	\N
83361	79	D5170C00002/tiny.path.1/file-1971.pdf	\N	D5170C00002-835de5bc-8316-11eb-be00-f9341c528e83-1971	\N	NEW	\N	\N	\N	\N
84889	79	D5170C00002/tiny.path.1/file-3499.pdf	\N	D5170C00002-8369d725-8317-11eb-be00-f70b64218d1f-3500	\N	NEW	\N	\N	\N	\N
84890	79	D5170C00002/tiny.path.1/file-3500.pdf	\N	D5170C00002-83794076-8317-11eb-be00-e9eab2bfe651-3501	\N	NEW	\N	\N	\N	\N
84892	79	D5170C00002/tiny.path.1/file-3502.pdf	\N	D5170C00002-838a3067-8317-11eb-be00-5b6d0ea1943b-3502	\N	NEW	\N	\N	\N	\N
83362	79	D5170C00002/tiny.path.1/file-1972.pdf	\N	D5170C00002-839856ad-8316-11eb-be00-57b912899914-1972	\N	NEW	\N	\N	\N	\N
84893	79	D5170C00002/tiny.path.1/file-3503.pdf	\N	D5170C00002-8399e7d8-8317-11eb-be00-fdfbf5c53476-3503	\N	NEW	\N	\N	\N	\N
82000	79	D5170C00002/tiny.path.1/file-0610.pdf	\N	D5170C00002-83a82a4b-8315-11eb-be00-436c75b1d2ce-610	\N	NEW	\N	\N	\N	\N
84894	79	D5170C00002/tiny.path.1/file-3504.pdf	\N	D5170C00002-83b64979-8317-11eb-be00-e3be1c716439-3504	\N	NEW	\N	\N	\N	\N
87749	79	D5170C00002/tiny.path.1/file-6359.pdf	\N	D5170C00002-83c52ad0-8319-11eb-be00-6b8063d1ab1b-6359	\N	NEW	\N	\N	\N	\N
84895	79	D5170C00002/tiny.path.1/file-3505.pdf	\N	D5170C00002-83c600ea-8317-11eb-be00-1d5b70135d50-3505	\N	NEW	\N	\N	\N	\N
83363	79	D5170C00002/tiny.path.1/file-1973.pdf	\N	D5170C00002-83d70d5e-8316-11eb-be00-f5a9c924c0e1-1973	\N	NEW	\N	\N	\N	\N
84896	79	D5170C00002/tiny.path.1/file-3506.pdf	\N	D5170C00002-83e3e92b-8317-11eb-be00-9f5de5dad3dd-3506	\N	NEW	\N	\N	\N	\N
82001	79	D5170C00002/tiny.path.1/file-0611.pdf	\N	D5170C00002-83e66bcc-8315-11eb-be00-67ae400911dc-611	\N	NEW	\N	\N	\N	\N
87750	79	D5170C00002/tiny.path.1/file-6360.pdf	\N	D5170C00002-83f33fb1-8319-11eb-be00-3b52e43013ee-6360	\N	NEW	\N	\N	\N	\N
83364	79	D5170C00002/tiny.path.1/file-1974.pdf	\N	D5170C00002-83f3e42f-8316-11eb-be00-8353a0b8b1fd-1974	\N	NEW	\N	\N	\N	\N
83365	79	D5170C00002/tiny.path.1/file-1975.pdf	\N	D5170C00002-84146480-8316-11eb-be00-510debea1e0f-1975	\N	NEW	\N	\N	\N	\N
82002	79	D5170C00002/tiny.path.1/file-0612.pdf	\N	D5170C00002-8421a00d-8315-11eb-be00-915b19bd4443-612	\N	NEW	\N	\N	\N	\N
84897	79	D5170C00002/tiny.path.1/file-3507.pdf	\N	D5170C00002-8422edfc-8317-11eb-be00-5dec728754a2-3507	\N	NEW	\N	\N	\N	\N
82003	79	D5170C00002/tiny.path.1/file-0613.pdf	\N	D5170C00002-8431ccae-8315-11eb-be00-b1d2f362eaa2-613	\N	NEW	\N	\N	\N	\N
83366	79	D5170C00002/tiny.path.1/file-1976.pdf	\N	D5170C00002-84400861-8316-11eb-be00-0580528e57e5-1976	\N	NEW	\N	\N	\N	\N
82004	79	D5170C00002/tiny.path.1/file-0614.pdf	\N	D5170C00002-84410eef-8315-11eb-be00-0d5b142268d7-614	\N	NEW	\N	\N	\N	\N
87751	79	D5170C00002/tiny.path.1/file-6361.pdf	\N	D5170C00002-844ef442-8319-11eb-be00-d9fbaf5f6c25-6361	\N	NEW	\N	\N	\N	\N
84898	79	D5170C00002/tiny.path.1/file-3508.pdf	\N	D5170C00002-844f070d-8317-11eb-be00-990e0ec5312b-3508	\N	NEW	\N	\N	\N	\N
84899	79	D5170C00002/tiny.path.1/file-3509.pdf	\N	D5170C00002-845102de-8317-11eb-be00-394ebcc7874d-3509	\N	NEW	\N	\N	\N	\N
82005	79	D5170C00002/tiny.path.1/file-0615.pdf	\N	D5170C00002-845ea910-8315-11eb-be00-bbc810747de7-615	\N	NEW	\N	\N	\N	\N
84900	79	D5170C00002/tiny.path.1/file-3510.pdf	\N	D5170C00002-84601e0f-8317-11eb-be00-4dc34c31bfca-3510	\N	NEW	\N	\N	\N	\N
84901	79	D5170C00002/tiny.path.1/file-3511.pdf	\N	D5170C00002-846eeb20-8317-11eb-be00-e90da4d45621-3511	\N	NEW	\N	\N	\N	\N
82006	79	D5170C00002/tiny.path.1/file-0616.pdf	\N	D5170C00002-847d7bb1-8315-11eb-be00-bb4631955792-616	\N	NEW	\N	\N	\N	\N
83367	79	D5170C00002/tiny.path.1/file-1977.pdf	\N	D5170C00002-847dada2-8316-11eb-be00-e1429efdb987-1977	\N	NEW	\N	\N	\N	\N
84902	79	D5170C00002/tiny.path.1/file-3512.msg	\N	D5170C00002-849d7531-8317-11eb-be00-9f346c2bf0d7-3512	\N	NEW	\N	\N	\N	\N
87752	79	D5170C00002/tiny.path.1/file-6362.pdf	\N	D5170C00002-849d8973-8319-11eb-be00-ffb16faf4a04-6362	\N	NEW	\N	\N	\N	\N
82007	79	D5170C00002/tiny.path.1/file-0617.pdf	\N	D5170C00002-849dade2-8315-11eb-be00-55324ac6c993-617	\N	NEW	\N	\N	\N	\N
87753	79	D5170C00002/tiny.path.1/file-6363.pdf	\N	D5170C00002-84aca4a4-8319-11eb-be00-b58807e30c72-6363	\N	NEW	\N	\N	\N	\N
84903	79	D5170C00002/tiny.path.1/file-3513.msg	\N	D5170C00002-84ad2ca2-8317-11eb-be00-53090c15b045-3513	\N	NEW	\N	\N	\N	\N
82008	79	D5170C00002/tiny.path.1/file-0618.pdf	\N	D5170C00002-84baabc3-8315-11eb-be00-e371356850ca-618	\N	NEW	\N	\N	\N	\N
83368	79	D5170C00002/tiny.path.1/file-1978.pdf	\N	D5170C00002-84bc6453-8316-11eb-be00-792570bf8336-1978	\N	NEW	\N	\N	\N	\N
84904	79	D5170C00002/tiny.path.1/file-3514.msg	\N	D5170C00002-84c8caf3-8317-11eb-be00-41f864400eb7-3514	\N	NEW	\N	\N	\N	\N
87754	79	D5170C00002/tiny.path.1/file-6364.pdf	\N	D5170C00002-84c97b75-8319-11eb-be00-a19b3397016b-6364	\N	NEW	\N	\N	\N	\N
84905	79	D5170C00002/tiny.path.1/file-3515.msg	\N	D5170C00002-84cb6304-8317-11eb-be00-c706ccafb601-3515	\N	NEW	\N	\N	\N	\N
83369	79	D5170C00002/tiny.path.1/file-1979.pdf	\N	D5170C00002-84da2584-8316-11eb-be00-55e13bca1d3e-1979	\N	NEW	\N	\N	\N	\N
84906	79	D5170C00002/tiny.path.1/file-3516.msg	\N	D5170C00002-84e812c5-8317-11eb-be00-05e1c26c4b52-3516	\N	NEW	\N	\N	\N	\N
82009	79	D5170C00002/tiny.path.1/file-0619.pdf	\N	D5170C00002-84e87284-8315-11eb-be00-3f0f9fa8fcc6-619	\N	NEW	\N	\N	\N	\N
84907	79	D5170C00002/tiny.path.1/file-3517.msg	\N	D5170C00002-84f706e6-8317-11eb-be00-c953fe82711e-3517	\N	NEW	\N	\N	\N	\N
83370	79	D5170C00002/tiny.path.1/file-1980.pdf	\N	D5170C00002-84f85be5-8316-11eb-be00-e9f5eb4b0b06-1980	\N	NEW	\N	\N	\N	\N
84908	79	D5170C00002/tiny.path.1/file-3518.msg	\N	D5170C00002-8508ba27-8317-11eb-be00-13a79a8c2448-3518	\N	NEW	\N	\N	\N	\N
84909	79	D5170C00002/tiny.path.1/file-3519.msg	\N	D5170C00002-85169cd8-8317-11eb-be00-1528059e65e9-3519	\N	NEW	\N	\N	\N	\N
87755	79	D5170C00002/tiny.path.1/file-6365.xlsx	\N	D5170C00002-8524e1e6-8319-11eb-be00-49a949693da7-6365	\N	NEW	\N	\N	\N	\N
84910	79	D5170C00002/tiny.path.1/file-3520.msg	\N	D5170C00002-85340fe9-8317-11eb-be00-c1773d3e1b12-3520	\N	NEW	\N	\N	\N	\N
87756	79	D5170C00002/tiny.path.1/file-6366.pdf	\N	D5170C00002-8543db97-8319-11eb-be00-afeaef6fbd9a-6366	\N	NEW	\N	\N	\N	\N
82010	79	D5170C00002/tiny.path.1/file-0620.pdf	\N	D5170C00002-8552f425-8315-11eb-be00-0368713a9757-620	\N	NEW	\N	\N	\N	\N
84911	79	D5170C00002/tiny.path.1/file-3521.msg	\N	D5170C00002-8554421a-8317-11eb-be00-43abb8390528-3521	\N	NEW	\N	\N	\N	\N
82011	79	D5170C00002/tiny.path.1/file-0621.pdf	\N	D5170C00002-85623666-8315-11eb-be00-0799fd07ea1d-621	\N	NEW	\N	\N	\N	\N
84912	79	D5170C00002/tiny.path.1/file-3522.msg	\N	D5170C00002-8570f1db-8317-11eb-be00-bd280c723960-3522	\N	NEW	\N	\N	\N	\N
87757	79	D5170C00002/tiny.path.1/file-6367.pdf	\N	D5170C00002-85717b48-8319-11eb-be00-5f329441f00d-6367	\N	NEW	\N	\N	\N	\N
82012	79	D5170C00002/tiny.path.1/file-0622.pdf	\N	D5170C00002-857214e7-8315-11eb-be00-a74db13e1356-622	\N	NEW	\N	\N	\N	\N
84913	79	D5170C00002/tiny.path.1/file-3523.msg	\N	D5170C00002-8580341c-8317-11eb-be00-e3e4c2887b31-3523	\N	NEW	\N	\N	\N	\N
83371	79	D5170C00002/tiny.path.1/file-1981.pdf	\N	D5170C00002-8581b026-8316-11eb-be00-b58321597d8d-1981	\N	NEW	\N	\N	\N	\N
87758	79	D5170C00002/tiny.path.1/file-6368.pdf	\N	D5170C00002-8582b959-8319-11eb-be00-171bcfd8d6a9-6368	\N	NEW	\N	\N	\N	\N
84914	79	D5170C00002/tiny.path.1/file-3524.msg	\N	D5170C00002-858f765d-8317-11eb-be00-8370a04b4cde-3524	\N	NEW	\N	\N	\N	\N
82013	79	D5170C00002/tiny.path.1/file-0623.pdf	\N	D5170C00002-8592e358-8315-11eb-be00-615ef29e298b-623	\N	NEW	\N	\N	\N	\N
84915	79	D5170C00002/tiny.path.1/file-3525.msg	\N	D5170C00002-859e918e-8317-11eb-be00-c9c18dafa96d-3525	\N	NEW	\N	\N	\N	\N
87759	79	D5170C00002/tiny.path.1/file-6369.pdf	\N	D5170C00002-85a0c8aa-8319-11eb-be00-4f96c3231062-6369	\N	NEW	\N	\N	\N	\N
84916	79	D5170C00002/tiny.path.1/file-3526.msg	\N	D5170C00002-85adacbf-8317-11eb-be00-c7e4b394872c-3526	\N	NEW	\N	\N	\N	\N
84917	79	D5170C00002/tiny.path.1/file-3527.msg	\N	D5170C00002-85af3360-8317-11eb-be00-1b75377e0d5d-3527	\N	NEW	\N	\N	\N	\N
84918	79	D5170C00002/tiny.path.1/file-3528.msg	\N	D5170C00002-85b0ba01-8317-11eb-be00-adb07f04e655-3528	\N	NEW	\N	\N	\N	\N
87760	79	D5170C00002/tiny.path.1/file-6370.pdf	\N	D5170C00002-85bded9b-8319-11eb-be00-cd7a449527bb-6370	\N	NEW	\N	\N	\N	\N
82014	79	D5170C00002/tiny.path.1/file-0624.pdf	\N	D5170C00002-85bf4a89-8315-11eb-be00-1d597ef7cb36-624	\N	NEW	\N	\N	\N	\N
84919	79	D5170C00002/tiny.path.1/file-3529.msg	\N	D5170C00002-85cca672-8317-11eb-be00-25a8e0b96220-3529	\N	NEW	\N	\N	\N	\N
82015	79	D5170C00002/tiny.path.1/file-0625.pdf	\N	D5170C00002-85ce8cca-8315-11eb-be00-2d959933ebe6-625	\N	NEW	\N	\N	\N	\N
84920	79	D5170C00002/tiny.path.1/file-3530.msg	\N	D5170C00002-85dcfa23-8317-11eb-be00-49cda874acf9-3530	\N	NEW	\N	\N	\N	\N
82016	79	D5170C00002/tiny.path.1/file-0626.pdf	\N	D5170C00002-85eb157b-8315-11eb-be00-2f51b51a16e0-626	\N	NEW	\N	\N	\N	\N
84921	79	D5170C00002/tiny.path.1/file-3531.msg	\N	D5170C00002-85ec1554-8317-11eb-be00-c33d0a152a64-3531	\N	NEW	\N	\N	\N	\N
82017	79	D5170C00002/tiny.path.1/file-0627.pdf	\N	D5170C00002-85edfbac-8315-11eb-be00-576f3d1c557b-627	\N	NEW	\N	\N	\N	\N
83372	79	D5170C00002/tiny.path.1/file-1982.pdf	\N	D5170C00002-85fb4cf7-8316-11eb-be00-a1961738d8dd-1982	\N	NEW	\N	\N	\N	\N
82018	79	D5170C00002/tiny.path.1/file-0628.pdf	\N	D5170C00002-85fd64fd-8315-11eb-be00-4180ad9ed17f-628	\N	NEW	\N	\N	\N	\N
87761	79	D5170C00002/tiny.path.1/file-6371.pdf	\N	D5170C00002-861869ac-8319-11eb-be00-91189ed76e00-6371	\N	NEW	\N	\N	\N	\N
84922	79	D5170C00002/tiny.path.1/file-3532.msg	\N	D5170C00002-8619b505-8317-11eb-be00-1b64671f6268-3532	\N	NEW	\N	\N	\N	\N
82019	79	D5170C00002/tiny.path.1/file-0629.pdf	\N	D5170C00002-861a62de-8315-11eb-be00-a7a08f5cedaa-629	\N	NEW	\N	\N	\N	\N
87762	79	D5170C00002/tiny.path.1/file-6372.pdf	\N	D5170C00002-8627fa0d-8319-11eb-be00-9b21b6cc19ba-6372	\N	NEW	\N	\N	\N	\N
84923	79	D5170C00002/tiny.path.1/file-3533.msg	\N	D5170C00002-86399916-8317-11eb-be00-a99de37dbc9f-3533	\N	NEW	\N	\N	\N	\N
84924	79	D5170C00002/tiny.path.1/file-3534.msg	\N	D5170C00002-8646df87-8317-11eb-be00-63419c5cb9f8-3534	\N	NEW	\N	\N	\N	\N
82020	79	D5170C00002/tiny.path.1/file-0630.xlsx	\N	D5170C00002-86473f3f-8315-11eb-be00-ad14ac16263d-630	\N	NEW	\N	\N	\N	\N
87763	79	D5170C00002/tiny.path.1/file-6373.pdf	\N	D5170C00002-864768ee-8319-11eb-be00-cf89b70378ad-6373	\N	NEW	\N	\N	\N	\N
83373	79	D5170C00002/tiny.path.1/file-1983.pdf	\N	D5170C00002-86491ed8-8316-11eb-be00-f14d7525ffd5-1983	\N	NEW	\N	\N	\N	\N
84925	79	D5170C00002/tiny.path.1/file-3535.msg	\N	D5170C00002-8656e518-8317-11eb-be00-0d969f44041c-3535	\N	NEW	\N	\N	\N	\N
82021	79	D5170C00002/tiny.path.1/file-0631.xlsx	\N	D5170C00002-86672350-8315-11eb-be00-61b90f040144-631	\N	NEW	\N	\N	\N	\N
84926	79	D5170C00002/tiny.path.1/file-3536.msg	\N	D5170C00002-86747f39-8317-11eb-be00-a56d9cc48dd5-3536	\N	NEW	\N	\N	\N	\N
87764	79	D5170C00002/tiny.path.1/file-6374.pdf	\N	D5170C00002-8675a4df-8319-11eb-be00-3f4d7f5d6780-6374	\N	NEW	\N	\N	\N	\N
86377	79	D5170C00002/tiny.path.1/file-4987.pdf	\N	D5170C00002-86774894-8318-11eb-be00-a1e50b3d7dfb-4987	\N	NEW	\N	\N	\N	\N
82022	79	D5170C00002/tiny.path.1/file-0632.xlsx	\N	D5170C00002-8683d311-8315-11eb-be00-871a9d3b4af1-632	\N	NEW	\N	\N	\N	\N
83374	79	D5170C00002/tiny.path.1/file-1984.pdf	\N	D5170C00002-868675f9-8316-11eb-be00-8b63ba29cc1f-1984	\N	NEW	\N	\N	\N	\N
82023	79	D5170C00002/tiny.path.1/file-0633.xlsx	\N	D5170C00002-8694ea12-8315-11eb-be00-ab320ee7ef01-633	\N	NEW	\N	\N	\N	\N
84927	79	D5170C00002/tiny.path.1/file-3537.msg	\N	D5170C00002-86a245fa-8317-11eb-be00-0d896b3a6700-3537	\N	NEW	\N	\N	\N	\N
82024	79	D5170C00002/tiny.path.1/file-0634.xlsx	\N	D5170C00002-86a25793-8315-11eb-be00-a9380abf044e-634	\N	NEW	\N	\N	\N	\N
87765	79	D5170C00002/tiny.path.1/file-6375.pdf	\N	D5170C00002-86a392b0-8319-11eb-be00-71a483aadfd2-6375	\N	NEW	\N	\N	\N	\N
84928	79	D5170C00002/tiny.path.1/file-3538.msg	\N	D5170C00002-86a41abb-8317-11eb-be00-79e6962cc444-3538	\N	NEW	\N	\N	\N	\N
82025	79	D5170C00002/tiny.path.1/file-0635.xlsx	\N	D5170C00002-86b1e7f4-8315-11eb-be00-21e7f17828e1-635	\N	NEW	\N	\N	\N	\N
83375	79	D5170C00002/tiny.path.1/file-1985.pdf	\N	D5170C00002-86b3a07a-8316-11eb-be00-f50f1c68b7f3-1985	\N	NEW	\N	\N	\N	\N
84929	79	D5170C00002/tiny.path.1/file-3539.msg	\N	D5170C00002-86c0ca7c-8317-11eb-be00-3ffe9005b51b-3539	\N	NEW	\N	\N	\N	\N
87766	79	D5170C00002/tiny.path.1/file-6376.pdf	\N	D5170C00002-86c328a1-8319-11eb-be00-d74e37c1b3ec-6376	\N	NEW	\N	\N	\N	\N
82026	79	D5170C00002/tiny.path.1/file-0636.pdf	\N	D5170C00002-86d0e1a5-8315-11eb-be00-a51b6bba6c56-636	\N	NEW	\N	\N	\N	\N
84930	79	D5170C00002/tiny.path.1/file-3540.pdf	\N	D5170C00002-86d256ad-8317-11eb-be00-4542a747c841-3540	\N	NEW	\N	\N	\N	\N
82027	79	D5170C00002/tiny.path.1/file-0637.pdf	\N	D5170C00002-86e13556-8315-11eb-be00-2f9ade580e08-637	\N	NEW	\N	\N	\N	\N
87767	79	D5170C00002/tiny.path.1/file-6377.pdf	\N	D5170C00002-86ee7e62-8319-11eb-be00-e182fc81a2f0-6377	\N	NEW	\N	\N	\N	\N
84931	79	D5170C00002/tiny.path.1/file-3541.pdf	\N	D5170C00002-86f08d0e-8317-11eb-be00-178d09304163-3541	\N	NEW	\N	\N	\N	\N
87768	79	D5170C00002/tiny.path.1/file-6378.pdf	\N	D5170C00002-86fe83f3-8319-11eb-be00-e51431ba7426-6378	\N	NEW	\N	\N	\N	\N
82028	79	D5170C00002/tiny.path.1/file-0638.pdf	\N	D5170C00002-86ff92c7-8315-11eb-be00-db2f15e96263-638	\N	NEW	\N	\N	\N	\N
84932	79	D5170C00002/tiny.path.1/file-3542.pdf	\N	D5170C00002-870ceeaf-8317-11eb-be00-e7c3d2c8f63b-3542	\N	NEW	\N	\N	\N	\N
83376	79	D5170C00002/tiny.path.1/file-1986.pdf	\N	D5170C00002-870d322b-8316-11eb-be00-75def780b8a4-1986	\N	NEW	\N	\N	\N	\N
84933	79	D5170C00002/tiny.path.1/file-3543.pdf	\N	D5170C00002-870dff20-8317-11eb-be00-e57fc6db901d-3543	\N	NEW	\N	\N	\N	\N
82029	79	D5170C00002/tiny.path.1/file-0639.pdf	\N	D5170C00002-871c1b78-8315-11eb-be00-8d7e11581aff-639	\N	NEW	\N	\N	\N	\N
83377	79	D5170C00002/tiny.path.1/file-1987.pdf	\N	D5170C00002-871ebe5c-8316-11eb-be00-4d6086c57f2a-1987	\N	NEW	\N	\N	\N	\N
87769	79	D5170C00002/tiny.path.1/file-6379.pdf	\N	D5170C00002-872aeb24-8319-11eb-be00-cf26d6091910-6379	\N	NEW	\N	\N	\N	\N
82030	79	D5170C00002/tiny.path.1/file-0640.pdf	\N	D5170C00002-872c4819-8315-11eb-be00-d38ef65a193c-640	\N	NEW	\N	\N	\N	\N
84934	79	D5170C00002/tiny.path.1/file-3544.pdf	\N	D5170C00002-872cf8d1-8317-11eb-be00-23f9b5408724-3544	\N	NEW	\N	\N	\N	\N
87770	79	D5170C00002/tiny.path.1/file-6380.pdf	\N	D5170C00002-873a2d65-8319-11eb-be00-c531cb2bae82-6380	\N	NEW	\N	\N	\N	\N
84935	79	D5170C00002/tiny.path.1/file-3545.pdf	\N	D5170C00002-873a8d62-8317-11eb-be00-d1656b5e75a4-3545	\N	NEW	\N	\N	\N	\N
83378	79	D5170C00002/tiny.path.1/file-1988.pdf	\N	D5170C00002-873b6e1d-8316-11eb-be00-2354f4509bb7-1988	\N	NEW	\N	\N	\N	\N
86378	79	D5170C00002/tiny.path.1/file-4988.pdf	\N	D5170C00002-873c9465-8318-11eb-be00-55fd1a4294a9-4988	\N	NEW	\N	\N	\N	\N
82031	79	D5170C00002/tiny.path.1/file-0641.pdf	\N	D5170C00002-874c533a-8315-11eb-be00-7703f2d4876e-641	\N	NEW	\N	\N	\N	\N
84936	79	D5170C00002/tiny.path.1/file-3546.pdf	\N	D5170C00002-876a01d3-8317-11eb-be00-0fc47c16a92d-3546	\N	NEW	\N	\N	\N	\N
86379	79	D5170C00002/tiny.path.1/file-4989.pdf	\N	D5170C00002-876af766-8318-11eb-be00-37499d78381c-4989	\N	NEW	\N	\N	\N	\N
87771	79	D5170C00002/tiny.path.1/file-6381.pdf	\N	D5170C00002-87793236-8319-11eb-be00-1565fc119e08-6381	\N	NEW	\N	\N	\N	\N
83379	79	D5170C00002/tiny.path.1/file-1989.pdf	\N	D5170C00002-87793a6e-8316-11eb-be00-f1ad4e6bb0d0-1989	\N	NEW	\N	\N	\N	\N
82032	79	D5170C00002/tiny.path.1/file-0642.pdf	\N	D5170C00002-8787395b-8315-11eb-be00-8d4ee1a4d726-642	\N	NEW	\N	\N	\N	\N
87772	79	D5170C00002/tiny.path.1/file-6382.pdf	\N	D5170C00002-878937c7-8319-11eb-be00-97f0169d4ad3-6382	\N	NEW	\N	\N	\N	\N
86380	79	D5170C00002/tiny.path.1/file-4990.pdf	\N	D5170C00002-87969b47-8318-11eb-be00-ff072cd41ef0-4990	\N	NEW	\N	\N	\N	\N
83380	79	D5170C00002/tiny.path.1/file-1990.pdf	\N	D5170C00002-879749bf-8316-11eb-be00-771dfff05c3c-1990	\N	NEW	\N	\N	\N	\N
84937	79	D5170C00002/tiny.path.1/file-3547.pdf	\N	D5170C00002-87977a74-8317-11eb-be00-b9a05680e38d-3547	\N	NEW	\N	\N	\N	\N
82033	79	D5170C00002/tiny.path.1/file-0643.pdf	\N	D5170C00002-87a6330c-8315-11eb-be00-a9099f6d2b7e-643	\N	NEW	\N	\N	\N	\N
84938	79	D5170C00002/tiny.path.1/file-3548.pdf	\N	D5170C00002-87c47de5-8317-11eb-be00-a570edea6b99-3548	\N	NEW	\N	\N	\N	\N
83381	79	D5170C00002/tiny.path.1/file-1991.pdf	\N	D5170C00002-87c5d3d0-8316-11eb-be00-0f0114924db2-1991	\N	NEW	\N	\N	\N	\N
82034	79	D5170C00002/tiny.path.1/file-0644.pdf	\N	D5170C00002-87c7017d-8315-11eb-be00-79feb09dc46e-644	\N	NEW	\N	\N	\N	\N
86381	79	D5170C00002/tiny.path.1/file-4991.pdf	\N	D5170C00002-87d37d38-8318-11eb-be00-fb4aae99f910-4991	\N	NEW	\N	\N	\N	\N
82035	79	D5170C00002/tiny.path.1/file-0645.pdf	\N	D5170C00002-87e2c6de-8315-11eb-be00-c5b7166f4306-645	\N	NEW	\N	\N	\N	\N
84939	79	D5170C00002/tiny.path.1/file-3549.pdf	\N	D5170C00002-87f21d96-8317-11eb-be00-af8a13de061a-3549	\N	NEW	\N	\N	\N	\N
82036	79	D5170C00002/tiny.path.1/file-0646.pdf	\N	D5170C00002-87f4530f-8315-11eb-be00-61ec56fd8a94-646	\N	NEW	\N	\N	\N	\N
86382	79	D5170C00002/tiny.path.1/file-4992.pdf	\N	D5170C00002-880143f9-8318-11eb-be00-291e72521671-4992	\N	NEW	\N	\N	\N	\N
83382	79	D5170C00002/tiny.path.1/file-1992.pdf	\N	D5170C00002-88104a51-8316-11eb-be00-b30f43eaaeb7-1992	\N	NEW	\N	\N	\N	\N
87773	79	D5170C00002/tiny.path.1/file-6383.pdf	\N	D5170C00002-88106928-8319-11eb-be00-af7e69149683-6383	\N	NEW	\N	\N	\N	\N
82037	79	D5170C00002/tiny.path.1/file-0647.pdf	\N	D5170C00002-881ff6f0-8315-11eb-be00-d759ef304c4b-647	\N	NEW	\N	\N	\N	\N
83383	79	D5170C00002/tiny.path.1/file-1993.pdf	\N	D5170C00002-882272c2-8316-11eb-be00-81307ccb1ee2-1993	\N	NEW	\N	\N	\N	\N
82038	79	D5170C00002/tiny.path.1/file-0648.pdf	\N	D5170C00002-88313501-8315-11eb-be00-e9a6f6d7cd7c-648	\N	NEW	\N	\N	\N	\N
87774	79	D5170C00002/tiny.path.1/file-6384.pdf	\N	D5170C00002-883ea519-8319-11eb-be00-19b6bf46ebce-6384	\N	NEW	\N	\N	\N	\N
83384	79	D5170C00002/tiny.path.1/file-1994.pdf	\N	D5170C00002-883efb73-8316-11eb-be00-7f1f22363014-1994	\N	NEW	\N	\N	\N	\N
84940	79	D5170C00002/tiny.path.1/file-3550.pdf	\N	D5170C00002-883fef77-8317-11eb-be00-d12391d30081-3550	\N	NEW	\N	\N	\N	\N
84941	79	D5170C00002/tiny.path.1/file-3551.pdf	\N	D5170C00002-884df938-8317-11eb-be00-bbe5fa22348c-3551	\N	NEW	\N	\N	\N	\N
83385	79	D5170C00002/tiny.path.1/file-1995.pdf	\N	D5170C00002-88506094-8316-11eb-be00-b9b330729dd8-1995	\N	NEW	\N	\N	\N	\N
84942	79	D5170C00002/tiny.path.1/file-3552.pdf	\N	D5170C00002-885d3b79-8317-11eb-be00-31dfc038c2f2-3552	\N	NEW	\N	\N	\N	\N
83386	79	D5170C00002/tiny.path.1/file-1996.pdf	\N	D5170C00002-88601805-8316-11eb-be00-85f51f98c011-1996	\N	NEW	\N	\N	\N	\N
84943	79	D5170C00002/tiny.path.1/file-3553.pdf	\N	D5170C00002-886d19fa-8317-11eb-be00-157060e71187-3553	\N	NEW	\N	\N	\N	\N
86383	79	D5170C00002/tiny.path.1/file-4993.pdf	\N	D5170C00002-886d252a-8318-11eb-be00-23a1d7319758-4993	\N	NEW	\N	\N	\N	\N
83387	79	D5170C00002/tiny.path.1/file-1997.pdf	\N	D5170C00002-887b8f46-8316-11eb-be00-479955fea51e-1997	\N	NEW	\N	\N	\N	\N
87775	79	D5170C00002/tiny.path.1/file-6385.pdf	\N	D5170C00002-887c716a-8319-11eb-be00-65fc94f1151e-6385	\N	NEW	\N	\N	\N	\N
84944	79	D5170C00002/tiny.path.1/file-3554.pdf	\N	D5170C00002-887dbbcb-8317-11eb-be00-89834c1876e4-3554	\N	NEW	\N	\N	\N	\N
82039	79	D5170C00002/tiny.path.1/file-0649.pdf	\N	D5170C00002-888a9fa2-8315-11eb-be00-bbe6821a69ce-649	\N	NEW	\N	\N	\N	\N
84945	79	D5170C00002/tiny.path.1/file-3555.pdf	\N	D5170C00002-888b9e7c-8317-11eb-be00-977463b21f7f-3555	\N	NEW	\N	\N	\N	\N
83388	79	D5170C00002/tiny.path.1/file-1998.pdf	\N	D5170C00002-888d1b77-8316-11eb-be00-753eeb196c6c-1998	\N	NEW	\N	\N	\N	\N
83389	79	D5170C00002/tiny.path.1/file-1999.pdf	\N	D5170C00002-889b4c48-8316-11eb-be00-39f908455e64-1999	\N	NEW	\N	\N	\N	\N
84946	79	D5170C00002/tiny.path.1/file-3556.pdf	\N	D5170C00002-88aa4a0d-8317-11eb-be00-7d03f7ba4502-3556	\N	NEW	\N	\N	\N	\N
83390	79	D5170C00002/tiny.path.1/file-2000.pdf	\N	D5170C00002-88ab2ac9-8316-11eb-be00-11bb6c0c0c9b-2000	\N	NEW	\N	\N	\N	\N
87776	79	D5170C00002/tiny.path.1/file-6386.pdf	\N	D5170C00002-88bab2eb-8319-11eb-be00-01c97c9a0b5c-6386	\N	NEW	\N	\N	\N	\N
82040	79	D5170C00002/tiny.path.1/file-0650.pdf	\N	D5170C00002-88c7a8a3-8315-11eb-be00-e9f536c35b50-650	\N	NEW	\N	\N	\N	\N
86384	79	D5170C00002/tiny.path.1/file-4994.pdf	\N	D5170C00002-88d77fbb-8318-11eb-be00-8df9988cd63d-4994	\N	NEW	\N	\N	\N	\N
83391	79	D5170C00002/tiny.path.1/file-2001.pdf	\N	D5170C00002-88d9b4da-8316-11eb-be00-d9fbd3c10fa0-2001	\N	NEW	\N	\N	\N	\N
84947	79	D5170C00002/tiny.path.1/file-3557.pdf	\N	D5170C00002-88e5cc6e-8317-11eb-be00-d147c9b93b17-3557	\N	NEW	\N	\N	\N	\N
82041	79	D5170C00002/tiny.path.1/file-0651.pdf	\N	D5170C00002-88e67b44-8315-11eb-be00-27003272152a-651	\N	NEW	\N	\N	\N	\N
83392	79	D5170C00002/tiny.path.1/file-2002.pdf	\N	D5170C00002-88e8a8fb-8316-11eb-be00-250587ba77d7-2002	\N	NEW	\N	\N	\N	\N
87777	79	D5170C00002/tiny.path.1/file-6387.pdf	\N	D5170C00002-8905025c-8319-11eb-be00-1d8e877e0aab-6387	\N	NEW	\N	\N	\N	\N
82042	79	D5170C00002/tiny.path.1/file-0652.pdf	\N	D5170C00002-89149025-8315-11eb-be00-c7c01227ca94-652	\N	NEW	\N	\N	\N	\N
83393	79	D5170C00002/tiny.path.1/file-2003.pdf	\N	D5170C00002-89149afc-8316-11eb-be00-19e73fc60e11-2003	\N	NEW	\N	\N	\N	\N
86385	79	D5170C00002/tiny.path.1/file-4995.pdf	\N	D5170C00002-89154c0c-8318-11eb-be00-bbc486a52868-4995	\N	NEW	\N	\N	\N	\N
82043	79	D5170C00002/tiny.path.1/file-0653.pdf	\N	D5170C00002-89244796-8315-11eb-be00-959866a33605-653	\N	NEW	\N	\N	\N	\N
83394	79	D5170C00002/tiny.path.1/file-2004.pdf	\N	D5170C00002-89258aed-8316-11eb-be00-891445513029-2004	\N	NEW	\N	\N	\N	\N
84948	79	D5170C00002/tiny.path.1/file-3558.pdf	\N	D5170C00002-893217af-8317-11eb-be00-a1679be5d7d3-3558	\N	NEW	\N	\N	\N	\N
87778	79	D5170C00002/tiny.path.1/file-6388.pdf	\N	D5170C00002-8941e44d-8319-11eb-be00-23fb99645130-6388	\N	NEW	\N	\N	\N	\N
83395	79	D5170C00002/tiny.path.1/file-2005.pdf	\N	D5170C00002-8942139e-8316-11eb-be00-a79d7256ed85-2005	\N	NEW	\N	\N	\N	\N
82044	79	D5170C00002/tiny.path.1/file-0654.pdf	\N	D5170C00002-894256e7-8315-11eb-be00-e947112b87f4-654	\N	NEW	\N	\N	\N	\N
82045	79	D5170C00002/tiny.path.1/file-0655.pdf	\N	D5170C00002-89523568-8315-11eb-be00-539d8e4593b0-655	\N	NEW	\N	\N	\N	\N
84949	79	D5170C00002/tiny.path.1/file-3559.pdf	\N	D5170C00002-895270f0-8317-11eb-be00-bf520295e9ed-3559	\N	NEW	\N	\N	\N	\N
86386	79	D5170C00002/tiny.path.1/file-4996.pdf	\N	D5170C00002-89533f6d-8318-11eb-be00-b3b320fad46b-4996	\N	NEW	\N	\N	\N	\N
83396	79	D5170C00002/tiny.path.1/file-2006.pdf	\N	D5170C00002-8960bf2f-8316-11eb-be00-0f2d0365f040-2006	\N	NEW	\N	\N	\N	\N
87779	79	D5170C00002/tiny.path.1/file-6389.pdf	\N	D5170C00002-8961c85e-8319-11eb-be00-69414da563dd-6389	\N	NEW	\N	\N	\N	\N
82046	79	D5170C00002/tiny.path.1/file-0656.pdf	\N	D5170C00002-89623af9-8315-11eb-be00-3d1898f6e9e5-656	\N	NEW	\N	\N	\N	\N
84950	79	D5170C00002/tiny.path.1/file-3560.pdf	\N	D5170C00002-897e3be1-8317-11eb-be00-6f20e249e9cd-3560	\N	NEW	\N	\N	\N	\N
82047	79	D5170C00002/tiny.path.1/file-0657.pdf	\N	D5170C00002-897eeaba-8315-11eb-be00-690116f76c9c-657	\N	NEW	\N	\N	\N	\N
83397	79	D5170C00002/tiny.path.1/file-2007.pdf	\N	D5170C00002-89807b30-8316-11eb-be00-6d16de06d6fb-2007	\N	NEW	\N	\N	\N	\N
87780	79	D5170C00002/tiny.path.1/file-6390.pdf	\N	D5170C00002-899c876f-8319-11eb-be00-d78b0479d503-6390	\N	NEW	\N	\N	\N	\N
83398	79	D5170C00002/tiny.path.1/file-2008.pdf	\N	D5170C00002-899d7911-8316-11eb-be00-858861729c49-2008	\N	NEW	\N	\N	\N	\N
83399	79	D5170C00002/tiny.path.1/file-2009.pdf	\N	D5170C00002-89bc99d2-8316-11eb-be00-6daa111deb7c-2009	\N	NEW	\N	\N	\N	\N
84951	79	D5170C00002/tiny.path.1/file-3561.pdf	\N	D5170C00002-89cb7182-8317-11eb-be00-01d4687bda4e-3561	\N	NEW	\N	\N	\N	\N
87781	79	D5170C00002/tiny.path.1/file-6391.pdf	\N	D5170C00002-89cbfbe0-8319-11eb-be00-51b030b7439d-6391	\N	NEW	\N	\N	\N	\N
83400	79	D5170C00002/tiny.path.1/file-2010.pdf	\N	D5170C00002-89cdb0d3-8316-11eb-be00-0d2ed321ce5e-2010	\N	NEW	\N	\N	\N	\N
83401	79	D5170C00002/tiny.path.1/file-2011.pdf	\N	D5170C00002-89e9c454-8316-11eb-be00-0f0df0379ff0-2011	\N	NEW	\N	\N	\N	\N
86404	79	D5170C00002/tiny.path.1/file-5014.pdf	\N	D5170C00002-89ebfcfe-8318-11eb-be00-5141a0e2d5d5-4997	\N	NEW	\N	\N	\N	\N
83402	79	D5170C00002/tiny.path.1/file-2012.pdf	\N	D5170C00002-89fb0265-8316-11eb-be00-fb2b4aa069c1-2012	\N	NEW	\N	\N	\N	\N
87782	79	D5170C00002/tiny.path.1/file-6392.pdf	\N	D5170C00002-8a077e41-8319-11eb-be00-031c7a6b1eaf-6392	\N	NEW	\N	\N	\N	\N
84952	79	D5170C00002/tiny.path.1/file-3562.xlsx	\N	D5170C00002-8a093dd3-8317-11eb-be00-3302845ee422-3562	\N	NEW	\N	\N	\N	\N
87783	79	D5170C00002/tiny.path.1/file-6393.pdf	\N	D5170C00002-8a1783d2-8319-11eb-be00-df21cb5537b5-6393	\N	NEW	\N	\N	\N	\N
83403	79	D5170C00002/tiny.path.1/file-2013.pdf	\N	D5170C00002-8a178b16-8316-11eb-be00-934ead1ba7e0-2013	\N	NEW	\N	\N	\N	\N
84953	79	D5170C00002/tiny.path.1/file-3563.xlsx	\N	D5170C00002-8a18a724-8317-11eb-be00-3da8cbec1001-3563	\N	NEW	\N	\N	\N	\N
83404	79	D5170C00002/tiny.path.1/file-2014.pdf	\N	D5170C00002-8a2805d7-8316-11eb-be00-7f351d111310-2014	\N	NEW	\N	\N	\N	\N
83405	79	D5170C00002/tiny.path.1/file-2015.pdf	\N	D5170C00002-8a391cd8-8316-11eb-be00-47ad29c1006e-2015	\N	NEW	\N	\N	\N	\N
84954	79	D5170C00002/tiny.path.1/file-3564.pdf	\N	D5170C00002-8a45aa95-8317-11eb-be00-cf532b0d3017-3564	\N	NEW	\N	\N	\N	\N
87784	79	D5170C00002/tiny.path.1/file-6394.pdf	\N	D5170C00002-8a53a273-8319-11eb-be00-bfbe74807980-6394	\N	NEW	\N	\N	\N	\N
83406	79	D5170C00002/tiny.path.1/file-2016.pdf	\N	D5170C00002-8a555769-8316-11eb-be00-1f9b4790abf7-2016	\N	NEW	\N	\N	\N	\N
82048	79	D5170C00002/tiny.path.1/file-0658.pdf	\N	D5170C00002-8a56ad1b-8315-11eb-be00-e9c3b28e45b9-658	\N	NEW	\N	\N	\N	\N
87785	79	D5170C00002/tiny.path.1/file-6395.pdf	\N	D5170C00002-8a6380f4-8319-11eb-be00-1dff3d2b34e6-6395	\N	NEW	\N	\N	\N	\N
83407	79	D5170C00002/tiny.path.1/file-2017.pdf	\N	D5170C00002-8a63883a-8316-11eb-be00-81bcd69c5a56-2017	\N	NEW	\N	\N	\N	\N
83408	79	D5170C00002/tiny.path.1/file-2018.pdf	\N	D5170C00002-8a666e6b-8316-11eb-be00-2bfba209ba89-2018	\N	NEW	\N	\N	\N	\N
87786	79	D5170C00002/tiny.path.1/file-6396.pdf	\N	D5170C00002-8a73fbb5-8319-11eb-be00-affd817ceed9-6396	\N	NEW	\N	\N	\N	\N
83409	79	D5170C00002/tiny.path.1/file-2019.pdf	\N	D5170C00002-8a74782c-8316-11eb-be00-a5c8a7df94da-2019	\N	NEW	\N	\N	\N	\N
83410	79	D5170C00002/tiny.path.1/file-2020.pdf	\N	D5170C00002-8a919d1d-8316-11eb-be00-99a94306102b-2020	\N	NEW	\N	\N	\N	\N
82049	79	D5170C00002/tiny.path.1/file-0659.pdf	\N	D5170C00002-8aa171bc-8315-11eb-be00-e3cf0baab0b8-659	\N	NEW	\N	\N	\N	\N
87787	79	D5170C00002/tiny.path.1/file-6397.pdf	\N	D5170C00002-8aaf5706-8319-11eb-be00-015fe0ae256a-6397	\N	NEW	\N	\N	\N	\N
83411	79	D5170C00002/tiny.path.1/file-2021.pdf	\N	D5170C00002-8ab048ae-8316-11eb-be00-59ede721c0b5-2021	\N	NEW	\N	\N	\N	\N
84955	79	D5170C00002/tiny.path.1/file-3565.pdf	\N	D5170C00002-8ab0ef86-8317-11eb-be00-dfa1c2db4265-3565	\N	NEW	\N	\N	\N	\N
83412	79	D5170C00002/tiny.path.1/file-2022.pdf	\N	D5170C00002-8ab21d6f-8316-11eb-be00-bfc41081ed77-2022	\N	NEW	\N	\N	\N	\N
84956	79	D5170C00002/tiny.path.1/file-3566.pdf	\N	D5170C00002-8ac11c27-8317-11eb-be00-15f47c6d6714-3566	\N	NEW	\N	\N	\N	\N
87788	79	D5170C00002/tiny.path.1/file-6398.pdf	\N	D5170C00002-8aceecf7-8319-11eb-be00-f74b8471f38f-6398	\N	NEW	\N	\N	\N	\N
84957	79	D5170C00002/tiny.path.1/file-3567.pdf	\N	D5170C00002-8adda4d8-8317-11eb-be00-7972d25ae2e2-3567	\N	NEW	\N	\N	\N	\N
83413	79	D5170C00002/tiny.path.1/file-2023.pdf	\N	D5170C00002-8addc150-8316-11eb-be00-fbf13491b278-2023	\N	NEW	\N	\N	\N	\N
84958	79	D5170C00002/tiny.path.1/file-3568.pdf	\N	D5170C00002-8aedd179-8317-11eb-be00-4dfe7690e6b5-3568	\N	NEW	\N	\N	\N	\N
83414	79	D5170C00002/tiny.path.1/file-2024.pdf	\N	D5170C00002-8aef2671-8316-11eb-be00-ff94e151b05b-2024	\N	NEW	\N	\N	\N	\N
82050	79	D5170C00002/tiny.path.1/file-0660.pdf	\N	D5170C00002-8afe85dd-8315-11eb-be00-6bc08daa969d-660	\N	NEW	\N	\N	\N	\N
84959	79	D5170C00002/tiny.path.1/file-3569.pdf	\N	D5170C00002-8b0c7d0a-8317-11eb-be00-1ff0c342e203-3569	\N	NEW	\N	\N	\N	\N
87789	79	D5170C00002/tiny.path.1/file-6399.pdf	\N	D5170C00002-8b1c49a8-8319-11eb-be00-8f3a0d3233cf-6399	\N	NEW	\N	\N	\N	\N
83415	79	D5170C00002/tiny.path.1/file-2025.pdf	\N	D5170C00002-8b2aa8d2-8316-11eb-be00-1b3aea8b4413-2025	\N	NEW	\N	\N	\N	\N
84960	79	D5170C00002/tiny.path.1/file-3570.pdf	\N	D5170C00002-8b2caf3b-8317-11eb-be00-6563b0e1100c-3570	\N	NEW	\N	\N	\N	\N
83416	79	D5170C00002/tiny.path.1/file-2026.pdf	\N	D5170C00002-8b3b4aa3-8316-11eb-be00-b93c6695dfac-2026	\N	NEW	\N	\N	\N	\N
87790	79	D5170C00002/tiny.path.1/file-6400.pdf	\N	D5170C00002-8b483ba9-8319-11eb-be00-837828935bfc-6400	\N	NEW	\N	\N	\N	\N
83417	79	D5170C00002/tiny.path.1/file-2027.pdf	\N	D5170C00002-8b4adb04-8316-11eb-be00-bf61fca7f428-2027	\N	NEW	\N	\N	\N	\N
84961	79	D5170C00002/tiny.path.1/file-3571.pdf	\N	D5170C00002-8b58ef5c-8317-11eb-be00-715384992fe9-3571	\N	NEW	\N	\N	\N	\N
83418	79	D5170C00002/tiny.path.1/file-2028.pdf	\N	D5170C00002-8b682705-8316-11eb-be00-ad32977e2645-2028	\N	NEW	\N	\N	\N	\N
87791	79	D5170C00002/tiny.path.1/file-6401.pdf	\N	D5170C00002-8b75db5a-8319-11eb-be00-039e4ce39c1a-6401	\N	NEW	\N	\N	\N	\N
84962	79	D5170C00002/tiny.path.1/file-3572.pdf	\N	D5170C00002-8b78101d-8317-11eb-be00-3f2fa008194a-3572	\N	NEW	\N	\N	\N	\N
82051	79	D5170C00002/tiny.path.1/file-0661.pdf	\N	D5170C00002-8b86537e-8315-11eb-be00-95173d575f12-661	\N	NEW	\N	\N	\N	\N
83419	79	D5170C00002/tiny.path.1/file-2029.pdf	\N	D5170C00002-8b95edc6-8316-11eb-be00-cbe5c9632477-2029	\N	NEW	\N	\N	\N	\N
87792	79	D5170C00002/tiny.path.1/file-6402.pdf	\N	D5170C00002-8b96a9cb-8319-11eb-be00-05729419cb40-6402	\N	NEW	\N	\N	\N	\N
86387	79	D5170C00002/tiny.path.1/file-4997.pdf	\N	D5170C00002-8ba3e62f-8318-11eb-be00-bb188449f642-4998	\N	NEW	\N	\N	\N	\N
82052	79	D5170C00002/tiny.path.1/file-0662.pdf	\N	D5170C00002-8ba65e9f-8315-11eb-be00-7b35475d650b-662	\N	NEW	\N	\N	\N	\N
83420	79	D5170C00002/tiny.path.1/file-2030.pdf	\N	D5170C00002-8bb49957-8316-11eb-be00-b7c57f214b52-2030	\N	NEW	\N	\N	\N	\N
83421	79	D5170C00002/tiny.path.1/file-2031.pdf	\N	D5170C00002-8bb5d1d8-8316-11eb-be00-75c5689a1fbf-2031	\N	NEW	\N	\N	\N	\N
86388	79	D5170C00002/tiny.path.1/file-4998.pdf	\N	D5170C00002-8bc2b8d0-8318-11eb-be00-1dc6346e7985-4999	\N	NEW	\N	\N	\N	\N
82053	79	D5170C00002/tiny.path.1/file-0663.pdf	\N	D5170C00002-8bd20280-8315-11eb-be00-31d93dedc09e-663	\N	NEW	\N	\N	\N	\N
83422	79	D5170C00002/tiny.path.1/file-2032.pdf	\N	D5170C00002-8bd42f49-8316-11eb-be00-bdfcc2269345-2032	\N	NEW	\N	\N	\N	\N
84963	79	D5170C00002/tiny.path.1/file-3573.pdf	\N	D5170C00002-8be291be-8317-11eb-be00-cdcd37d7290a-3573	\N	NEW	\N	\N	\N	\N
83423	79	D5170C00002/tiny.path.1/file-2033.pdf	\N	D5170C00002-8be3236a-8316-11eb-be00-0d0c1a96b642-2033	\N	NEW	\N	\N	\N	\N
82054	79	D5170C00002/tiny.path.1/file-0664.pdf	\N	D5170C00002-8be3b5c1-8315-11eb-be00-d5f289b61ff0-664	\N	NEW	\N	\N	\N	\N
83424	79	D5170C00002/tiny.path.1/file-2034.pdf	\N	D5170C00002-8bf3c53b-8316-11eb-be00-2793f86df579-2034	\N	NEW	\N	\N	\N	\N
86389	79	D5170C00002/tiny.path.1/file-4999.pdf	\N	D5170C00002-8bffc1d1-8318-11eb-be00-09db8fba5c28-5000	\N	NEW	\N	\N	\N	\N
84964	79	D5170C00002/tiny.path.1/file-3574.pdf	\N	D5170C00002-8bffddbf-8317-11eb-be00-4d80040284a8-3574	\N	NEW	\N	\N	\N	\N
87793	79	D5170C00002/tiny.path.1/file-6403.pdf	\N	D5170C00002-8bfff2ec-8319-11eb-be00-3976c094764f-6403	\N	NEW	\N	\N	\N	\N
83425	79	D5170C00002/tiny.path.1/file-2035.pdf	\N	D5170C00002-8c01f60c-8316-11eb-be00-43c7433cbabc-2035	\N	NEW	\N	\N	\N	\N
84965	79	D5170C00002/tiny.path.1/file-3575.pdf	\N	D5170C00002-8c0e83c0-8317-11eb-be00-df26b7906f56-3575	\N	NEW	\N	\N	\N	\N
84966	79	D5170C00002/tiny.path.1/file-3576.pdf	\N	D5170C00002-8c1142e1-8317-11eb-be00-759c02d869be-3576	\N	NEW	\N	\N	\N	\N
86390	79	D5170C00002/tiny.path.1/file-5000.pdf	\N	D5170C00002-8c1f30b2-8318-11eb-be00-97251055ce73-5001	\N	NEW	\N	\N	\N	\N
84967	79	D5170C00002/tiny.path.1/file-3577.pdf	\N	D5170C00002-8c2da482-8317-11eb-be00-f749fadff270-3577	\N	NEW	\N	\N	\N	\N
83426	79	D5170C00002/tiny.path.1/file-2036.pdf	\N	D5170C00002-8c2de80d-8316-11eb-be00-cb687ac57b39-2036	\N	NEW	\N	\N	\N	\N
87794	79	D5170C00002/tiny.path.1/file-6404.pdf	\N	D5170C00002-8c2ef22d-8319-11eb-be00-5dd875d22c64-6404	\N	NEW	\N	\N	\N	\N
83427	79	D5170C00002/tiny.path.1/file-2037.pdf	\N	D5170C00002-8c3ded9e-8316-11eb-be00-7f8378c52d51-2037	\N	NEW	\N	\N	\N	\N
84968	79	D5170C00002/tiny.path.1/file-3578.pdf	\N	D5170C00002-8c3ebb83-8317-11eb-be00-4d5805153f81-3578	\N	NEW	\N	\N	\N	\N
86391	79	D5170C00002/tiny.path.1/file-5001.pdf	\N	D5170C00002-8c4d6ca3-8318-11eb-be00-b79baa6d197f-5002	\N	NEW	\N	\N	\N	\N
84969	79	D5170C00002/tiny.path.1/file-3579.pdf	\N	D5170C00002-8c5acf04-8317-11eb-be00-0568ca32608b-3579	\N	NEW	\N	\N	\N	\N
83428	79	D5170C00002/tiny.path.1/file-2038.pdf	\N	D5170C00002-8c5baecf-8316-11eb-be00-51bf13614778-2038	\N	NEW	\N	\N	\N	\N
83429	79	D5170C00002/tiny.path.1/file-2039.pdf	\N	D5170C00002-8c5df8c0-8316-11eb-be00-9952f0b67527-2039	\N	NEW	\N	\N	\N	\N
84970	79	D5170C00002/tiny.path.1/file-3580.pdf	\N	D5170C00002-8c6a8675-8317-11eb-be00-f7f626b0ff57-3580	\N	NEW	\N	\N	\N	\N
86392	79	D5170C00002/tiny.path.1/file-5002.pdf	\N	D5170C00002-8c6c6654-8318-11eb-be00-3b0b7956197c-5003	\N	NEW	\N	\N	\N	\N
86393	79	D5170C00002/tiny.path.1/file-5003.pdf	\N	D5170C00002-8c88a0e5-8318-11eb-be00-c742377b450d-5004	\N	NEW	\N	\N	\N	\N
84971	79	D5170C00002/tiny.path.1/file-3581.pdf	\N	D5170C00002-8c8b06c6-8317-11eb-be00-1f8b7f4e0bd5-3581	\N	NEW	\N	\N	\N	\N
86394	79	D5170C00002/tiny.path.1/file-5004.pdf	\N	D5170C00002-8c980a36-8318-11eb-be00-97b428dcfeed-5005	\N	NEW	\N	\N	\N	\N
86395	79	D5170C00002/tiny.path.1/file-5005.pdf	\N	D5170C00002-8ca72567-8318-11eb-be00-af571ecece81-5006	\N	NEW	\N	\N	\N	\N
82055	79	D5170C00002/tiny.path.1/file-0665.pdf	\N	D5170C00002-8ca9c4e2-8315-11eb-be00-41bc821a4309-665	\N	NEW	\N	\N	\N	\N
84972	79	D5170C00002/tiny.path.1/file-3582.pdf	\N	D5170C00002-8cb6f8c7-8317-11eb-be00-5f6c84083a82-3582	\N	NEW	\N	\N	\N	\N
86396	79	D5170C00002/tiny.path.1/file-5006.pdf	\N	D5170C00002-8cc64628-8318-11eb-be00-57cce85dc085-5007	\N	NEW	\N	\N	\N	\N
87795	79	D5170C00002/tiny.path.1/file-6405.pdf	\N	D5170C00002-8cd5444e-8319-11eb-be00-df5df0f19c85-6405	\N	NEW	\N	\N	\N	\N
86397	79	D5170C00002/tiny.path.1/file-5007.pdf	\N	D5170C00002-8cd624a9-8318-11eb-be00-1b1d13092bdf-5008	\N	NEW	\N	\N	\N	\N
84973	79	D5170C00002/tiny.path.1/file-3583.pdf	\N	D5170C00002-8cd7a028-8317-11eb-be00-a97617d7acff-3583	\N	NEW	\N	\N	\N	\N
86398	79	D5170C00002/tiny.path.1/file-5008.pdf	\N	D5170C00002-8ce4075a-8318-11eb-be00-81984778a9a5-5009	\N	NEW	\N	\N	\N	\N
83430	79	D5170C00002/tiny.path.1/file-2040.pdf	\N	D5170C00002-8ce57841-8316-11eb-be00-ad3f566e631e-2040	\N	NEW	\N	\N	\N	\N
83431	79	D5170C00002/tiny.path.1/file-2041.pdf	\N	D5170C00002-8ce74d02-8316-11eb-be00-3963853f429a-2041	\N	NEW	\N	\N	\N	\N
84974	79	D5170C00002/tiny.path.1/file-3584.pdf	\N	D5170C00002-8cf44fe9-8317-11eb-be00-d995b0cf2d50-3584	\N	NEW	\N	\N	\N	\N
82056	79	D5170C00002/tiny.path.1/file-0666.pdf	\N	D5170C00002-8cf46273-8315-11eb-be00-b3dd67279c4e-666	\N	NEW	\N	\N	\N	\N
86399	79	D5170C00002/tiny.path.1/file-5009.pdf	\N	D5170C00002-8cf5456b-8318-11eb-be00-6365dea00956-5010	\N	NEW	\N	\N	\N	\N
87796	79	D5170C00002/tiny.path.1/file-6406.pdf	\N	D5170C00002-8d04dfcf-8319-11eb-be00-f987d8fb7193-6406	\N	NEW	\N	\N	\N	\N
84975	79	D5170C00002/tiny.path.1/file-3585.pdf	\N	D5170C00002-8d0518ca-8317-11eb-be00-67f53f5ed43e-3585	\N	NEW	\N	\N	\N	\N
86400	79	D5170C00002/tiny.path.1/file-5010.pdf	\N	D5170C00002-8d0523ec-8318-11eb-be00-75c60cb745fa-5011	\N	NEW	\N	\N	\N	\N
83432	79	D5170C00002/tiny.path.1/file-2042.pdf	\N	D5170C00002-8d13b433-8316-11eb-be00-8b65dd8d31c2-2042	\N	NEW	\N	\N	\N	\N
86401	79	D5170C00002/tiny.path.1/file-5011.pdf	\N	D5170C00002-8d20e94d-8318-11eb-be00-6151ca363874-5012	\N	NEW	\N	\N	\N	\N
83433	79	D5170C00002/tiny.path.1/file-2043.pdf	\N	D5170C00002-8d231d84-8316-11eb-be00-b3d61920d27c-2043	\N	NEW	\N	\N	\N	\N
84976	79	D5170C00002/tiny.path.1/file-3586.pdf	\N	D5170C00002-8d306e8b-8317-11eb-be00-991fbf4c8b40-3586	\N	NEW	\N	\N	\N	\N
83434	79	D5170C00002/tiny.path.1/file-2044.pdf	\N	D5170C00002-8d32fc05-8316-11eb-be00-f5c30841a10b-2044	\N	NEW	\N	\N	\N	\N
86402	79	D5170C00002/tiny.path.1/file-5012.pdf	\N	D5170C00002-8d4efe2e-8318-11eb-be00-17d51947049f-5013	\N	NEW	\N	\N	\N	\N
87797	79	D5170C00002/tiny.path.1/file-6407.pdf	\N	D5170C00002-8d4f2f40-8319-11eb-be00-31606d282b47-6407	\N	NEW	\N	\N	\N	\N
86403	79	D5170C00002/tiny.path.1/file-5013.pdf	\N	D5170C00002-8d6d348f-8318-11eb-be00-27a7f993caef-5014	\N	NEW	\N	\N	\N	\N
83461	79	D5170C00002/tiny.path.1/file-2071.pdf	\N	D5170C00002-8d6de226-8316-11eb-be00-c9ea1ede2e8b-2045	\N	NEW	\N	\N	\N	\N
84977	79	D5170C00002/tiny.path.1/file-3587.pdf	\N	D5170C00002-8d8c4a2c-8317-11eb-be00-6958894e6e12-3587	\N	NEW	\N	\N	\N	\N
83435	79	D5170C00002/tiny.path.1/file-2045.pdf	\N	D5170C00002-8d8d02e7-8316-11eb-be00-5177746c63a3-2046	\N	NEW	\N	\N	\N	\N
82057	79	D5170C00002/tiny.path.1/file-0667.pdf	\N	D5170C00002-8d8f42e4-8315-11eb-be00-b15e023a7761-667	\N	NEW	\N	\N	\N	\N
83436	79	D5170C00002/tiny.path.1/file-2046.pdf	\N	D5170C00002-8d9cba58-8316-11eb-be00-ed45be9c9def-2047	\N	NEW	\N	\N	\N	\N
83437	79	D5170C00002/tiny.path.1/file-2047.pdf	\N	D5170C00002-8dab8769-8316-11eb-be00-5f71a9cdac99-2048	\N	NEW	\N	\N	\N	\N
84978	79	D5170C00002/tiny.path.1/file-3588.pdf	\N	D5170C00002-8db9e9dd-8317-11eb-be00-596efcba16ac-3588	\N	NEW	\N	\N	\N	\N
87798	79	D5170C00002/tiny.path.1/file-6408.pdf	\N	D5170C00002-8db9ff01-8319-11eb-be00-d769ad546c09-6408	\N	NEW	\N	\N	\N	\N
83438	79	D5170C00002/tiny.path.1/file-2048.pdf	\N	D5170C00002-8dbac9aa-8316-11eb-be00-0de3b8e529da-2049	\N	NEW	\N	\N	\N	\N
83439	79	D5170C00002/tiny.path.1/file-2049.pdf	\N	D5170C00002-8dcb6b7b-8316-11eb-be00-4f3a5d2f54ca-2050	\N	NEW	\N	\N	\N	\N
87799	79	D5170C00002/tiny.path.1/file-6409.pdf	\N	D5170C00002-8de99a82-8319-11eb-be00-eba10ff25be3-6409	\N	NEW	\N	\N	\N	\N
83440	79	D5170C00002/tiny.path.1/file-2050.pdf	\N	D5170C00002-8de9effc-8316-11eb-be00-93298c5fddaf-2051	\N	NEW	\N	\N	\N	\N
87800	79	D5170C00002/tiny.path.1/file-6410.pdf	\N	D5170C00002-8e064a43-8319-11eb-be00-d38fb4e59fc9-6410	\N	NEW	\N	\N	\N	\N
84979	79	D5170C00002/tiny.path.1/file-3589.pdf	\N	D5170C00002-8e06833e-8317-11eb-be00-c9425ef1ba12-3589	\N	NEW	\N	\N	\N	\N
86405	79	D5170C00002/tiny.path.1/file-5015.pdf	\N	D5170C00002-8e06b570-8318-11eb-be00-1b45d9bf9587-5015	\N	NEW	\N	\N	\N	\N
83441	79	D5170C00002/tiny.path.1/file-2051.pdf	\N	D5170C00002-8e0714ed-8316-11eb-be00-4dfb0a45b2b9-2052	\N	NEW	\N	\N	\N	\N
82058	79	D5170C00002/tiny.path.1/file-0668.pdf	\N	D5170C00002-8e08b8a5-8315-11eb-be00-6f11a2fbf0d3-668	\N	NEW	\N	\N	\N	\N
83442	79	D5170C00002/tiny.path.1/file-2052.pdf	\N	D5170C00002-8e095ede-8316-11eb-be00-938ab263ad59-2053	\N	NEW	\N	\N	\N	\N
83443	79	D5170C00002/tiny.path.1/file-2053.pdf	\N	D5170C00002-8e24fd2f-8316-11eb-be00-0d4340a51d5f-2054	\N	NEW	\N	\N	\N	\N
83444	79	D5170C00002/tiny.path.1/file-2054.pdf	\N	D5170C00002-8e26f900-8316-11eb-be00-07e7861691b3-2055	\N	NEW	\N	\N	\N	\N
84980	79	D5170C00002/tiny.path.1/file-3590.pdf	\N	D5170C00002-8e35827f-8317-11eb-be00-a193335a222f-3590	\N	NEW	\N	\N	\N	\N
83445	79	D5170C00002/tiny.path.1/file-2055.pdf	\N	D5170C00002-8e36d781-8316-11eb-be00-458a5f2b8aac-2056	\N	NEW	\N	\N	\N	\N
86406	79	D5170C00002/tiny.path.1/file-5016.pdf	\N	D5170C00002-8e44f6f1-8318-11eb-be00-bd3b9688827a-5016	\N	NEW	\N	\N	\N	\N
84981	79	D5170C00002/tiny.path.1/file-3591.pdf	\N	D5170C00002-8e61e9b0-8317-11eb-be00-51a493fc8dc8-3591	\N	NEW	\N	\N	\N	\N
87801	79	D5170C00002/tiny.path.1/file-6411.pdf	\N	D5170C00002-8e70a4d4-8319-11eb-be00-17f881807a7a-6411	\N	NEW	\N	\N	\N	\N
82059	79	D5170C00002/tiny.path.1/file-0669.pdf	\N	D5170C00002-8e822e66-8315-11eb-be00-aff11eede3d9-669	\N	NEW	\N	\N	\N	\N
83446	79	D5170C00002/tiny.path.1/file-2056.pdf	\N	D5170C00002-8e8322c2-8316-11eb-be00-af00ff74ce4c-2057	\N	NEW	\N	\N	\N	\N
83447	79	D5170C00002/tiny.path.1/file-2057.pdf	\N	D5170C00002-8e9fab73-8316-11eb-be00-e51526ba2973-2058	\N	NEW	\N	\N	\N	\N
87802	79	D5170C00002/tiny.path.1/file-6412.pdf	\N	D5170C00002-8e9fcb25-8319-11eb-be00-8d6008abcb57-6412	\N	NEW	\N	\N	\N	\N
86407	79	D5170C00002/tiny.path.1/file-5017.pdf	\N	D5170C00002-8e9fe832-8318-11eb-be00-fd20d2822137-5017	\N	NEW	\N	\N	\N	\N
87803	79	D5170C00002/tiny.path.1/file-6413.pdf	\N	D5170C00002-8eafd0b6-8319-11eb-be00-c753efdcf872-6413	\N	NEW	\N	\N	\N	\N
82060	79	D5170C00002/tiny.path.1/file-0670.pdf	\N	D5170C00002-8ebd89b7-8315-11eb-be00-2b730dbdc12c-670	\N	NEW	\N	\N	\N	\N
87804	79	D5170C00002/tiny.path.1/file-6414.pdf	\N	D5170C00002-8ebe0187-8319-11eb-be00-ad912a07696a-6414	\N	NEW	\N	\N	\N	\N
84982	79	D5170C00002/tiny.path.1/file-3592.pdf	\N	D5170C00002-8ebed6c1-8317-11eb-be00-71e0316b73ec-3592	\N	NEW	\N	\N	\N	\N
83448	79	D5170C00002/tiny.path.1/file-2058.pdf	\N	D5170C00002-8eccfd04-8316-11eb-be00-c9cc69a55a63-2059	\N	NEW	\N	\N	\N	\N
84983	79	D5170C00002/tiny.path.1/file-3593.pdf	\N	D5170C00002-8ecf0362-8317-11eb-be00-7368b2ba6bd7-3593	\N	NEW	\N	\N	\N	\N
86408	79	D5170C00002/tiny.path.1/file-5018.pdf	\N	D5170C00002-8edb6a93-8318-11eb-be00-c5cba5e9ca88-5018	\N	NEW	\N	\N	\N	\N
87805	79	D5170C00002/tiny.path.1/file-6415.pdf	\N	D5170C00002-8ede33b8-8319-11eb-be00-8d43c9a9647b-6415	\N	NEW	\N	\N	\N	\N
84984	79	D5170C00002/tiny.path.1/file-3594.pdf	\N	D5170C00002-8eeb6503-8317-11eb-be00-f169beabdcdd-3594	\N	NEW	\N	\N	\N	\N
83449	79	D5170C00002/tiny.path.1/file-2059.pdf	\N	D5170C00002-8eec1dc5-8316-11eb-be00-8132a3056f35-2060	\N	NEW	\N	\N	\N	\N
82061	79	D5170C00002/tiny.path.1/file-0671.pdf	\N	D5170C00002-8eec61e8-8315-11eb-be00-732fe6031402-671	\N	NEW	\N	\N	\N	\N
87806	79	D5170C00002/tiny.path.1/file-6416.pdf	\N	D5170C00002-8eed27d9-8319-11eb-be00-95e0603fe798-6416	\N	NEW	\N	\N	\N	\N
82062	79	D5170C00002/tiny.path.1/file-0672.pdf	\N	D5170C00002-8efc1959-8315-11eb-be00-f1876025c81a-672	\N	NEW	\N	\N	\N	\N
87807	79	D5170C00002/tiny.path.1/file-6417.pdf	\N	D5170C00002-8efc912a-8319-11eb-be00-d7021817fd30-6417	\N	NEW	\N	\N	\N	\N
86409	79	D5170C00002/tiny.path.1/file-5019.pdf	\N	D5170C00002-8f093154-8318-11eb-be00-91bafeb3d4dc-5019	\N	NEW	\N	\N	\N	\N
82063	79	D5170C00002/tiny.path.1/file-0673.pdf	\N	D5170C00002-8f09adea-8315-11eb-be00-cbab0c41f043-673	\N	NEW	\N	\N	\N	\N
87808	79	D5170C00002/tiny.path.1/file-6418.pdf	\N	D5170C00002-8f0ae90b-8319-11eb-be00-bf2674472b29-6418	\N	NEW	\N	\N	\N	\N
84985	79	D5170C00002/tiny.path.1/file-3595.pdf	\N	D5170C00002-8f0c0c64-8317-11eb-be00-399dd3096059-3595	\N	NEW	\N	\N	\N	\N
83450	79	D5170C00002/tiny.path.1/file-2060.pdf	\N	D5170C00002-8f1b9236-8316-11eb-be00-27853c1bdc33-2061	\N	NEW	\N	\N	\N	\N
87809	79	D5170C00002/tiny.path.1/file-6419.pdf	\N	D5170C00002-8f2798cc-8319-11eb-be00-fd45fb6f1fd3-6419	\N	NEW	\N	\N	\N	\N
87810	79	D5170C00002/tiny.path.1/file-6420.pdf	\N	D5170C00002-8f3888bd-8319-11eb-be00-5b82291bda70-6420	\N	NEW	\N	\N	\N	\N
83451	79	D5170C00002/tiny.path.1/file-2061.pdf	\N	D5170C00002-8f6656d7-8316-11eb-be00-cb8beb2b1b0d-2062	\N	NEW	\N	\N	\N	\N
86410	79	D5170C00002/tiny.path.1/file-5020.pdf	\N	D5170C00002-8f740115-8318-11eb-be00-91a09c3939e7-5020	\N	NEW	\N	\N	\N	\N
83452	79	D5170C00002/tiny.path.1/file-2062.pdf	\N	D5170C00002-8f843f18-8316-11eb-be00-97c434cf00b7-2063	\N	NEW	\N	\N	\N	\N
87811	79	D5170C00002/tiny.path.1/file-6421.pdf	\N	D5170C00002-8f85974e-8319-11eb-be00-f16b0160c73d-6421	\N	NEW	\N	\N	\N	\N
82064	79	D5170C00002/tiny.path.1/file-0674.pdf	\N	D5170C00002-8f93293b-8315-11eb-be00-df61f7f2cd7f-674	\N	NEW	\N	\N	\N	\N
83453	79	D5170C00002/tiny.path.1/file-2063.pdf	\N	D5170C00002-8f933339-8316-11eb-be00-ad8d70214449-2064	\N	NEW	\N	\N	\N	\N
83454	79	D5170C00002/tiny.path.1/file-2064.pdf	\N	D5170C00002-8fa4985a-8316-11eb-be00-8d32a393bab6-2065	\N	NEW	\N	\N	\N	\N
84986	79	D5170C00002/tiny.path.1/file-3596.pdf	\N	D5170C00002-8fa53f25-8317-11eb-be00-a3a3d64c64c4-3596	\N	NEW	\N	\N	\N	\N
87812	79	D5170C00002/tiny.path.1/file-6422.pdf	\N	D5170C00002-8fb1623f-8319-11eb-be00-a36cb27fe05a-6422	\N	NEW	\N	\N	\N	\N
83455	79	D5170C00002/tiny.path.1/file-2065.pdf	\N	D5170C00002-8fd210fb-8316-11eb-be00-2ff59a7c6932-2066	\N	NEW	\N	\N	\N	\N
82065	79	D5170C00002/tiny.path.1/file-0675.pdf	\N	D5170C00002-8fdf4d6c-8315-11eb-be00-b501b0960034-675	\N	NEW	\N	\N	\N	\N
87813	79	D5170C00002/tiny.path.1/file-6423.pdf	\N	D5170C00002-8fdf5010-8319-11eb-be00-03a1a7ce259a-6423	\N	NEW	\N	\N	\N	\N
86428	79	D5170C00002/tiny.path.1/file-5038.pdf	\N	D5170C00002-8fdf6d16-8318-11eb-be00-cfb9a49333a6-5021	\N	NEW	\N	\N	\N	\N
87814	79	D5170C00002/tiny.path.1/file-6424.pdf	\N	D5170C00002-8fee9251-8319-11eb-be00-2f0941595133-6424	\N	NEW	\N	\N	\N	\N
84987	79	D5170C00002/tiny.path.1/file-3597.pdf	\N	D5170C00002-8ffdbf66-8317-11eb-be00-6552023ad2d2-3597	\N	NEW	\N	\N	\N	\N
83456	79	D5170C00002/tiny.path.1/file-2066.pdf	\N	D5170C00002-8ffe511c-8316-11eb-be00-5f42fa0f64be-2067	\N	NEW	\N	\N	\N	\N
83457	79	D5170C00002/tiny.path.1/file-2067.pdf	\N	D5170C00002-900025dd-8316-11eb-be00-7d2b8c6340e2-2068	\N	NEW	\N	\N	\N	\N
87815	79	D5170C00002/tiny.path.1/file-6425.pdf	\N	D5170C00002-900e4f52-8319-11eb-be00-434f6ce842e9-6425	\N	NEW	\N	\N	\N	\N
82066	79	D5170C00002/tiny.path.1/file-0676.pdf	\N	D5170C00002-901c7d7d-8315-11eb-be00-ad07ef686acd-676	\N	NEW	\N	\N	\N	\N
87816	79	D5170C00002/tiny.path.1/file-6426.pdf	\N	D5170C00002-902b2623-8319-11eb-be00-719921306f8e-6426	\N	NEW	\N	\N	\N	\N
84988	79	D5170C00002/tiny.path.1/file-3598.pdf	\N	D5170C00002-902b8627-8317-11eb-be00-7df14385b5f7-3598	\N	NEW	\N	\N	\N	\N
86411	79	D5170C00002/tiny.path.1/file-5021.msg	\N	D5170C00002-902c5497-8318-11eb-be00-59823ceb79f4-5022	\N	NEW	\N	\N	\N	\N
82067	79	D5170C00002/tiny.path.1/file-0677.pdf	\N	D5170C00002-902e09ae-8315-11eb-be00-33e6a85321e0-677	\N	NEW	\N	\N	\N	\N
86412	79	D5170C00002/tiny.path.1/file-5022.msg	\N	D5170C00002-903b6fc8-8318-11eb-be00-b53d58171b84-5023	\N	NEW	\N	\N	\N	\N
82068	79	D5170C00002/tiny.path.1/file-0678.pdf	\N	D5170C00002-903d72ff-8315-11eb-be00-2db850964514-678	\N	NEW	\N	\N	\N	\N
87817	79	D5170C00002/tiny.path.1/file-6427.pdf	\N	D5170C00002-90498394-8319-11eb-be00-db8bab4a3f0d-6427	\N	NEW	\N	\N	\N	\N
83458	79	D5170C00002/tiny.path.1/file-2068.pdf	\N	D5170C00002-904b118e-8316-11eb-be00-b93cc12c8017-2069	\N	NEW	\N	\N	\N	\N
82069	79	D5170C00002/tiny.path.1/file-0679.pdf	\N	D5170C00002-90595f70-8315-11eb-be00-63ea8d68e202-679	\N	NEW	\N	\N	\N	\N
87818	79	D5170C00002/tiny.path.1/file-6428.pdf	\N	D5170C00002-905a2565-8319-11eb-be00-3b351af457ee-6428	\N	NEW	\N	\N	\N	\N
86413	79	D5170C00002/tiny.path.1/file-5023.msg	\N	D5170C00002-905b53d9-8318-11eb-be00-59237c57f4b4-5024	\N	NEW	\N	\N	\N	\N
84989	79	D5170C00002/tiny.path.1/file-3599.pdf	\N	D5170C00002-9068b638-8317-11eb-be00-9db6992f6c34-3599	\N	NEW	\N	\N	\N	\N
87819	79	D5170C00002/tiny.path.1/file-6429.pdf	\N	D5170C00002-906aee46-8319-11eb-be00-cb127c7448ca-6429	\N	NEW	\N	\N	\N	\N
86414	79	D5170C00002/tiny.path.1/file-5024.msg	\N	D5170C00002-9077dc8a-8318-11eb-be00-fd74991e8539-5025	\N	NEW	\N	\N	\N	\N
83459	79	D5170C00002/tiny.path.1/file-2069.pdf	\N	D5170C00002-9078ff5f-8316-11eb-be00-37ca73723126-2070	\N	NEW	\N	\N	\N	\N
83460	79	D5170C00002/tiny.path.1/file-2070.pdf	\N	D5170C00002-90888fc0-8316-11eb-be00-ffcc185eed5c-2071	\N	NEW	\N	\N	\N	\N
84990	79	D5170C00002/tiny.path.1/file-3600.pdf	\N	D5170C00002-9088e869-8317-11eb-be00-dddba4252ca4-3600	\N	NEW	\N	\N	\N	\N
87822	79	D5170C00002/tiny.path.1/file-6432.pdf	\N	D5170C00002-9095a7c7-8319-11eb-be00-4fb863028bd8-6430	\N	NEW	\N	\N	\N	\N
86415	79	D5170C00002/tiny.path.1/file-5025.msg	\N	D5170C00002-9096610b-8318-11eb-be00-69dadb9b3781-5026	\N	NEW	\N	\N	\N	\N
82070	79	D5170C00002/tiny.path.1/file-0680.pdf	\N	D5170C00002-90983d31-8315-11eb-be00-3793a4f312d0-680	\N	NEW	\N	\N	\N	\N
87823	79	D5170C00002/tiny.path.1/file-6433.pdf	\N	D5170C00002-90b42c48-8319-11eb-be00-216b111c4994-6431	\N	NEW	\N	\N	\N	\N
86416	79	D5170C00002/tiny.path.1/file-5026.msg	\N	D5170C00002-90b4e58c-8318-11eb-be00-b99b6747accd-5027	\N	NEW	\N	\N	\N	\N
82071	79	D5170C00002/tiny.path.1/file-0681.pdf	\N	D5170C00002-90b64c82-8315-11eb-be00-039713da3d15-681	\N	NEW	\N	\N	\N	\N
86417	79	D5170C00002/tiny.path.1/file-5027.msg	\N	D5170C00002-90b6e15d-8318-11eb-be00-d343d72a7f2a-5028	\N	NEW	\N	\N	\N	\N
87824	79	D5170C00002/tiny.path.1/file-6434.pdf	\N	D5170C00002-90c3bca9-8319-11eb-be00-a9587cb6fc46-6432	\N	NEW	\N	\N	\N	\N
86418	79	D5170C00002/tiny.path.1/file-5028.msg	\N	D5170C00002-90d2f4de-8318-11eb-be00-afb8fe6d5bdf-5029	\N	NEW	\N	\N	\N	\N
87825	79	D5170C00002/tiny.path.1/file-6435.pdf	\N	D5170C00002-90d2feea-8319-11eb-be00-ab88f43aa6f0-6433	\N	NEW	\N	\N	\N	\N
86419	79	D5170C00002/tiny.path.1/file-5029.msg	\N	D5170C00002-90d53ecf-8318-11eb-be00-53e7541049b8-5030	\N	NEW	\N	\N	\N	\N
82072	79	D5170C00002/tiny.path.1/file-0682.pdf	\N	D5170C00002-90e301d3-8315-11eb-be00-055dc1d98d17-682	\N	NEW	\N	\N	\N	\N
86420	79	D5170C00002/tiny.path.1/file-5030.msg	\N	D5170C00002-90e45a00-8318-11eb-be00-71218859c03c-5031	\N	NEW	\N	\N	\N	\N
83462	79	D5170C00002/tiny.path.1/file-2072.pdf	\N	D5170C00002-90e4b981-8316-11eb-be00-7def08fb9ec9-2072	\N	NEW	\N	\N	\N	\N
86421	79	D5170C00002/tiny.path.1/file-5031.msg	\N	D5170C00002-90f34e21-8318-11eb-be00-cda2a69975a8-5032	\N	NEW	\N	\N	\N	\N
87826	79	D5170C00002/tiny.path.1/file-6436.pdf	\N	D5170C00002-9100778b-8319-11eb-be00-e76a2258b9e0-6434	\N	NEW	\N	\N	\N	\N
86422	79	D5170C00002/tiny.path.1/file-5032.msg	\N	D5170C00002-9100e2b2-8318-11eb-be00-7de245c0ee9c-5033	\N	NEW	\N	\N	\N	\N
83463	79	D5170C00002/tiny.path.1/file-2073.pdf	\N	D5170C00002-91027ab2-8316-11eb-be00-57c467dfdc7e-2073	\N	NEW	\N	\N	\N	\N
86423	79	D5170C00002/tiny.path.1/file-5033.msg	\N	D5170C00002-9102b773-8318-11eb-be00-157437f4ec5d-5034	\N	NEW	\N	\N	\N	\N
87827	79	D5170C00002/tiny.path.1/file-6437.pdf	\N	D5170C00002-910fb9cc-8319-11eb-be00-79f9c1b3aa16-6435	\N	NEW	\N	\N	\N	\N
82073	79	D5170C00002/tiny.path.1/file-0683.pdf	\N	D5170C00002-9112eb74-8315-11eb-be00-27ad57d62d9c-683	\N	NEW	\N	\N	\N	\N
87828	79	D5170C00002/tiny.path.1/file-6438.pdf	\N	D5170C00002-911f231d-8319-11eb-be00-114948cc4d86-6436	\N	NEW	\N	\N	\N	\N
86424	79	D5170C00002/tiny.path.1/file-5034.msg	\N	D5170C00002-91213bf4-8318-11eb-be00-85c64fec0545-5035	\N	NEW	\N	\N	\N	\N
83464	79	D5170C00002/tiny.path.1/file-2074.pdf	\N	D5170C00002-91219b73-8316-11eb-be00-c186f7e2d515-2074	\N	NEW	\N	\N	\N	\N
82074	79	D5170C00002/tiny.path.1/file-0684.pdf	\N	D5170C00002-912f9b35-8315-11eb-be00-b399326f713b-684	\N	NEW	\N	\N	\N	\N
83465	79	D5170C00002/tiny.path.1/file-2075.pdf	\N	D5170C00002-912ff354-8316-11eb-be00-31b457aea7ec-2075	\N	NEW	\N	\N	\N	\N
87829	79	D5170C00002/tiny.path.1/file-6439.pdf	\N	D5170C00002-913e1cce-8319-11eb-be00-f5f63d2d48c9-6437	\N	NEW	\N	\N	\N	\N
82075	79	D5170C00002/tiny.path.1/file-0685.pdf	\N	D5170C00002-913e8f56-8315-11eb-be00-b901b334d82b-685	\N	NEW	\N	\N	\N	\N
86425	79	D5170C00002/tiny.path.1/file-5035.msg	\N	D5170C00002-913fe785-8318-11eb-be00-4d83d5690e5d-5036	\N	NEW	\N	\N	\N	\N
87830	79	D5170C00002/tiny.path.1/file-6440.pdf	\N	D5170C00002-915eeb3f-8319-11eb-be00-c9d6026462fc-6438	\N	NEW	\N	\N	\N	\N
82076	79	D5170C00002/tiny.path.1/file-0686.pdf	\N	D5170C00002-916eee27-8315-11eb-be00-8726f321c5db-686	\N	NEW	\N	\N	\N	\N
87831	79	D5170C00002/tiny.path.1/file-6441.pdf	\N	D5170C00002-917ab0a0-8319-11eb-be00-df5d162d9f3a-6439	\N	NEW	\N	\N	\N	\N
83466	79	D5170C00002/tiny.path.1/file-2076.pdf	\N	D5170C00002-917d9e25-8316-11eb-be00-f3a51dcc6189-2076	\N	NEW	\N	\N	\N	\N
87832	79	D5170C00002/tiny.path.1/file-6442.pdf	\N	D5170C00002-918b5271-8319-11eb-be00-4bf457f99cc9-6440	\N	NEW	\N	\N	\N	\N
87833	79	D5170C00002/tiny.path.1/file-6443.pdf	\N	D5170C00002-91a8c582-8319-11eb-be00-6144604d32eb-6441	\N	NEW	\N	\N	\N	\N
83467	79	D5170C00002/tiny.path.1/file-2077.pdf	\N	D5170C00002-91aa0556-8316-11eb-be00-cf2e5d60de0d-2077	\N	NEW	\N	\N	\N	\N
87834	79	D5170C00002/tiny.path.1/file-6444.pdf	\N	D5170C00002-91b8a403-8319-11eb-be00-05caeb958e60-6442	\N	NEW	\N	\N	\N	\N
82077	79	D5170C00002/tiny.path.1/file-0687.pdf	\N	D5170C00002-91ba00e8-8315-11eb-be00-d16f730fb2ea-687	\N	NEW	\N	\N	\N	\N
84991	79	D5170C00002/tiny.path.1/file-3601.pdf	\N	D5170C00002-91bb26da-8317-11eb-be00-713962b7d4a6-3601	\N	NEW	\N	\N	\N	\N
87835	79	D5170C00002/tiny.path.1/file-6445.pdf	\N	D5170C00002-91ca3034-8319-11eb-be00-5dc53281d1dd-6443	\N	NEW	\N	\N	\N	\N
87836	79	D5170C00002/tiny.path.1/file-6446.pdf	\N	D5170C00002-91d79db5-8319-11eb-be00-ef6834e7e37e-6444	\N	NEW	\N	\N	\N	\N
83468	79	D5170C00002/tiny.path.1/file-2078.pdf	\N	D5170C00002-91e67217-8316-11eb-be00-5dc9b79b9143-2078	\N	NEW	\N	\N	\N	\N
87820	79	D5170C00002/tiny.path.1/file-6430.pdf	\N	D5170C00002-91e75526-8319-11eb-be00-c33b1239fad6-6445	\N	NEW	\N	\N	\N	\N
83469	79	D5170C00002/tiny.path.1/file-2079.pdf	\N	D5170C00002-91e86de8-8316-11eb-be00-273a3e8fe505-2079	\N	NEW	\N	\N	\N	\N
82078	79	D5170C00002/tiny.path.1/file-0688.pdf	\N	D5170C00002-91e90029-8315-11eb-be00-15a1847ced33-688	\N	NEW	\N	\N	\N	\N
84992	79	D5170C00002/tiny.path.1/file-3602.pdf	\N	D5170C00002-91e914ab-8317-11eb-be00-b7ec69a681e8-3602	\N	NEW	\N	\N	\N	\N
83470	79	D5170C00002/tiny.path.1/file-2080.pdf	\N	D5170C00002-91f58d49-8316-11eb-be00-47708b5bf8cf-2080	\N	NEW	\N	\N	\N	\N
83471	79	D5170C00002/tiny.path.1/file-2081.pdf	\N	D5170C00002-91f7891a-8316-11eb-be00-abf7a440a68d-2081	\N	NEW	\N	\N	\N	\N
84993	79	D5170C00002/tiny.path.1/file-3603.pdf	\N	D5170C00002-91f856ec-8317-11eb-be00-7d3874964de5-3603	\N	NEW	\N	\N	\N	\N
87821	79	D5170C00002/tiny.path.1/file-6431.pdf	\N	D5170C00002-92045307-8319-11eb-be00-bd1d9e95741c-6446	\N	NEW	\N	\N	\N	\N
84994	79	D5170C00002/tiny.path.1/file-3604.pdf	\N	D5170C00002-9214917d-8317-11eb-be00-35178067a8ab-3604	\N	NEW	\N	\N	\N	\N
83472	79	D5170C00002/tiny.path.1/file-2082.pdf	\N	D5170C00002-9214ae0b-8316-11eb-be00-b9f530aef987-2082	\N	NEW	\N	\N	\N	\N
82079	79	D5170C00002/tiny.path.1/file-0689.pdf	\N	D5170C00002-9223711a-8315-11eb-be00-b9b007e10188-689	\N	NEW	\N	\N	\N	\N
87837	79	D5170C00002/tiny.path.1/file-6447.pdf	\N	D5170C00002-9231a498-8319-11eb-be00-d9419c56b043-6447	\N	NEW	\N	\N	\N	\N
83473	79	D5170C00002/tiny.path.1/file-2083.pdf	\N	D5170C00002-9232482c-8316-11eb-be00-ff91fbe18e21-2083	\N	NEW	\N	\N	\N	\N
86426	79	D5170C00002/tiny.path.1/file-5036.msg	\N	D5170C00002-9232abf6-8318-11eb-be00-377cbcc00eaf-5037	\N	NEW	\N	\N	\N	\N
82080	79	D5170C00002/tiny.path.1/file-0690.pdf	\N	D5170C00002-9232b35b-8315-11eb-be00-45f8da4658bc-690	\N	NEW	\N	\N	\N	\N
87838	79	D5170C00002/tiny.path.1/file-6448.pdf	\N	D5170C00002-9240bfc9-8319-11eb-be00-b5a991c9ff56-6448	\N	NEW	\N	\N	\N	\N
83474	79	D5170C00002/tiny.path.1/file-2084.pdf	\N	D5170C00002-9241d88d-8316-11eb-be00-21f658cbb5f9-2084	\N	NEW	\N	\N	\N	\N
84995	79	D5170C00002/tiny.path.1/file-3605.pdf	\N	D5170C00002-9243429e-8317-11eb-be00-c9088b0ae8ab-3605	\N	NEW	\N	\N	\N	\N
82081	79	D5170C00002/tiny.path.1/file-0691.pdf	\N	D5170C00002-9252e58c-8315-11eb-be00-71ed8ea2a5c4-691	\N	NEW	\N	\N	\N	\N
87839	79	D5170C00002/tiny.path.1/file-6449.pdf	\N	D5170C00002-92535d6a-8319-11eb-be00-59d09b762caa-6449	\N	NEW	\N	\N	\N	\N
83475	79	D5170C00002/tiny.path.1/file-2085.pdf	\N	D5170C00002-92627fee-8316-11eb-be00-a7834cf9208a-2085	\N	NEW	\N	\N	\N	\N
82082	79	D5170C00002/tiny.path.1/file-0692.pdf	\N	D5170C00002-926f954d-8315-11eb-be00-33c2cc763f61-692	\N	NEW	\N	\N	\N	\N
87840	79	D5170C00002/tiny.path.1/file-6450.pdf	\N	D5170C00002-927defdb-8319-11eb-be00-8f130171e95b-6450	\N	NEW	\N	\N	\N	\N
84996	79	D5170C00002/tiny.path.1/file-3606.pdf	\N	D5170C00002-9280248f-8317-11eb-be00-a5579c2873fd-3606	\N	NEW	\N	\N	\N	\N
83476	79	D5170C00002/tiny.path.1/file-2086.pdf	\N	D5170C00002-9280682f-8316-11eb-be00-870012c433d4-2086	\N	NEW	\N	\N	\N	\N
87841	79	D5170C00002/tiny.path.1/file-6451.pdf	\N	D5170C00002-928d321c-8319-11eb-be00-03204682f181-6451	\N	NEW	\N	\N	\N	\N
83477	79	D5170C00002/tiny.path.1/file-2087.pdf	\N	D5170C00002-928f0e30-8316-11eb-be00-4f1b5593bb6b-2087	\N	NEW	\N	\N	\N	\N
87842	79	D5170C00002/tiny.path.1/file-6452.pdf	\N	D5170C00002-928f7c0d-8319-11eb-be00-0dfeea691d45-6452	\N	NEW	\N	\N	\N	\N
84997	79	D5170C00002/tiny.path.1/file-3607.pdf	\N	D5170C00002-92900310-8317-11eb-be00-791ff0c9f7ea-3607	\N	NEW	\N	\N	\N	\N
82083	79	D5170C00002/tiny.path.1/file-0693.pdf	\N	D5170C00002-92ac773e-8315-11eb-be00-b55f0d32ae25-693	\N	NEW	\N	\N	\N	\N
84998	79	D5170C00002/tiny.path.1/file-3608.pdf	\N	D5170C00002-92adeb51-8317-11eb-be00-1f52ecc7ddff-3608	\N	NEW	\N	\N	\N	\N
82084	79	D5170C00002/tiny.path.1/file-0694.pdf	\N	D5170C00002-92bbb97f-8315-11eb-be00-97abd197510f-694	\N	NEW	\N	\N	\N	\N
85007	79	D5170C00002/tiny.path.1/file-3617.pdf	\N	D5170C00002-92cce502-8317-11eb-be00-8b3ded59aedd-3609	\N	NEW	\N	\N	\N	\N
82085	79	D5170C00002/tiny.path.1/file-0695.pdf	\N	D5170C00002-92cd1ea0-8315-11eb-be00-e7d1b42547b6-695	\N	NEW	\N	\N	\N	\N
87843	79	D5170C00002/tiny.path.1/file-6453.msg	\N	D5170C00002-92cd214e-8319-11eb-be00-7b42986c6791-6453	\N	NEW	\N	\N	\N	\N
82086	79	D5170C00002/tiny.path.1/file-0696.pdf	\N	D5170C00002-92da8c21-8315-11eb-be00-332e05b6ba94-696	\N	NEW	\N	\N	\N	\N
87844	79	D5170C00002/tiny.path.1/file-6454.msg	\N	D5170C00002-92e8e6af-8319-11eb-be00-9f23d3671f97-6454	\N	NEW	\N	\N	\N	\N
82087	79	D5170C00002/tiny.path.1/file-0697.pdf	\N	D5170C00002-92ea6aa2-8315-11eb-be00-ed1a770a2bc0-697	\N	NEW	\N	\N	\N	\N
84999	79	D5170C00002/tiny.path.1/file-3609.pdf	\N	D5170C00002-92f888e3-8317-11eb-be00-4f135d6387f5-3610	\N	NEW	\N	\N	\N	\N
83478	79	D5170C00002/tiny.path.1/file-2088.pdf	\N	D5170C00002-92f8a571-8316-11eb-be00-5ff42e572f7b-2088	\N	NEW	\N	\N	\N	\N
87845	79	D5170C00002/tiny.path.1/file-6455.msg	\N	D5170C00002-92f98880-8319-11eb-be00-f9e368a0e055-6455	\N	NEW	\N	\N	\N	\N
82088	79	D5170C00002/tiny.path.1/file-0698.pdf	\N	D5170C00002-930a0093-8315-11eb-be00-cbdf0aad3425-698	\N	NEW	\N	\N	\N	\N
87846	79	D5170C00002/tiny.path.1/file-6456.msg	\N	D5170C00002-93168661-8319-11eb-be00-53de8d662bec-6456	\N	NEW	\N	\N	\N	\N
82089	79	D5170C00002/tiny.path.1/file-0699.pdf	\N	D5170C00002-931a0624-8315-11eb-be00-a7a235647115-699	\N	NEW	\N	\N	\N	\N
87847	79	D5170C00002/tiny.path.1/file-6457.msg	\N	D5170C00002-93263dd2-8319-11eb-be00-f1f9179af0c0-6457	\N	NEW	\N	\N	\N	\N
85000	79	D5170C00002/tiny.path.1/file-3610.pdf	\N	D5170C00002-93278824-8317-11eb-be00-07563d5c49f8-3611	\N	NEW	\N	\N	\N	\N
87848	79	D5170C00002/tiny.path.1/file-6458.msg	\N	D5170C00002-9328aed3-8319-11eb-be00-4dbd80e8b94c-6458	\N	NEW	\N	\N	\N	\N
83479	79	D5170C00002/tiny.path.1/file-2089.pdf	\N	D5170C00002-9328b622-8316-11eb-be00-fbbe8f1d0b60-2089	\N	NEW	\N	\N	\N	\N
87849	79	D5170C00002/tiny.path.1/file-6459.msg	\N	D5170C00002-93447434-8319-11eb-be00-07b0fa2d639f-6459	\N	NEW	\N	\N	\N	\N
82090	79	D5170C00002/tiny.path.1/file-0700.pdf	\N	D5170C00002-934534d5-8315-11eb-be00-b917993f4364-700	\N	NEW	\N	\N	\N	\N
85001	79	D5170C00002/tiny.path.1/file-3611.pdf	\N	D5170C00002-9345be85-8317-11eb-be00-1939568058ac-3612	\N	NEW	\N	\N	\N	\N
83480	79	D5170C00002/tiny.path.1/file-2090.pdf	\N	D5170C00002-934761b3-8316-11eb-be00-13fce19e085f-2090	\N	NEW	\N	\N	\N	\N
87850	79	D5170C00002/tiny.path.1/file-6460.msg	\N	D5170C00002-93553d15-8319-11eb-be00-7f8cb546f61d-6460	\N	NEW	\N	\N	\N	\N
82091	79	D5170C00002/tiny.path.1/file-0701.pdf	\N	D5170C00002-935672e6-8315-11eb-be00-1d1e449fb864-701	\N	NEW	\N	\N	\N	\N
87851	79	D5170C00002/tiny.path.1/file-6461.msg	\N	D5170C00002-93647f56-8319-11eb-be00-672302fc11bb-6461	\N	NEW	\N	\N	\N	\N
86427	79	D5170C00002/tiny.path.1/file-5037.msg	\N	D5170C00002-9372f427-8318-11eb-be00-19fba89a9411-5038	\N	NEW	\N	\N	\N	\N
82092	79	D5170C00002/tiny.path.1/file-0702.pdf	\N	D5170C00002-9372fb97-8315-11eb-be00-972f1d9e97d4-702	\N	NEW	\N	\N	\N	\N
87852	79	D5170C00002/tiny.path.1/file-6462.msg	\N	D5170C00002-93740fb7-8319-11eb-be00-33ce4f9353c6-6462	\N	NEW	\N	\N	\N	\N
85002	79	D5170C00002/tiny.path.1/file-3612.pdf	\N	D5170C00002-93742186-8317-11eb-be00-751d92c7f4e0-3613	\N	NEW	\N	\N	\N	\N
82093	79	D5170C00002/tiny.path.1/file-0703.pdf	\N	D5170C00002-938264e8-8315-11eb-be00-a97beff1d0a0-703	\N	NEW	\N	\N	\N	\N
87853	79	D5170C00002/tiny.path.1/file-6463.msg	\N	D5170C00002-939182c8-8319-11eb-be00-6d2d9fc4a6a8-6463	\N	NEW	\N	\N	\N	\N
87854	79	D5170C00002/tiny.path.1/file-6464.msg	\N	D5170C00002-93926d29-8319-11eb-be00-5f1d5472f4a6-6464	\N	NEW	\N	\N	\N	\N
87855	79	D5170C00002/tiny.path.1/file-6465.msg	\N	D5170C00002-93a09dfa-8319-11eb-be00-9f639c0b330e-6465	\N	NEW	\N	\N	\N	\N
82094	79	D5170C00002/tiny.path.1/file-0704.pdf	\N	D5170C00002-93a248f9-8315-11eb-be00-831ed06e17b2-704	\N	NEW	\N	\N	\N	\N
85003	79	D5170C00002/tiny.path.1/file-3613.pdf	\N	D5170C00002-93a28487-8317-11eb-be00-816cafa86005-3614	\N	NEW	\N	\N	\N	\N
87856	79	D5170C00002/tiny.path.1/file-6466.pdf	\N	D5170C00002-93a299cb-8319-11eb-be00-21e34bd23642-6466	\N	NEW	\N	\N	\N	\N
83481	79	D5170C00002/tiny.path.1/file-2091.pdf	\N	D5170C00002-93b2a6a4-8316-11eb-be00-47afd9770a84-2091	\N	NEW	\N	\N	\N	\N
82095	79	D5170C00002/tiny.path.1/file-0705.pdf	\N	D5170C00002-93c11b9a-8315-11eb-be00-f1d5f4899690-705	\N	NEW	\N	\N	\N	\N
87857	79	D5170C00002/tiny.path.1/file-6467.pdf	\N	D5170C00002-93c1455c-8319-11eb-be00-e9df4ad46502-6467	\N	NEW	\N	\N	\N	\N
83482	79	D5170C00002/tiny.path.1/file-2092.pdf	\N	D5170C00002-93c173b5-8316-11eb-be00-47e642f0156f-2092	\N	NEW	\N	\N	\N	\N
86429	79	D5170C00002/tiny.path.1/file-5039.pdf	\N	D5170C00002-93cecfc8-8318-11eb-be00-69100b5bfeac-5039	\N	NEW	\N	\N	\N	\N
85004	79	D5170C00002/tiny.path.1/file-3614.pdf	\N	D5170C00002-93cf12c8-8317-11eb-be00-894ac4f2bcd8-3615	\N	NEW	\N	\N	\N	\N
83483	79	D5170C00002/tiny.path.1/file-2093.pdf	\N	D5170C00002-93d067d6-8316-11eb-be00-c7d267602fbf-2093	\N	NEW	\N	\N	\N	\N
82096	79	D5170C00002/tiny.path.1/file-0706.pdf	\N	D5170C00002-93df03db-8315-11eb-be00-b7703884f963-706	\N	NEW	\N	\N	\N	\N
85005	79	D5170C00002/tiny.path.1/file-3615.pdf	\N	D5170C00002-93df8d89-8317-11eb-be00-e3357f1941a9-3616	\N	NEW	\N	\N	\N	\N
86430	79	D5170C00002/tiny.path.1/file-5040.pdf	\N	D5170C00002-93eda269-8318-11eb-be00-51fb4538265c-5040	\N	NEW	\N	\N	\N	\N
83484	79	D5170C00002/tiny.path.1/file-2094.msg	\N	D5170C00002-93ef8897-8316-11eb-be00-dd851328669d-2094	\N	NEW	\N	\N	\N	\N
85006	79	D5170C00002/tiny.path.1/file-3616.pdf	\N	D5170C00002-93fd75ca-8317-11eb-be00-55dc271e0016-3617	\N	NEW	\N	\N	\N	\N
86431	79	D5170C00002/tiny.path.1/file-5041.pdf	\N	D5170C00002-93fdcf0a-8318-11eb-be00-216e4e6c295c-5041	\N	NEW	\N	\N	\N	\N
87858	79	D5170C00002/tiny.path.1/file-6468.pdf	\N	D5170C00002-940aaa6d-8319-11eb-be00-9bce1bd125d4-6468	\N	NEW	\N	\N	\N	\N
87859	79	D5170C00002/tiny.path.1/file-6469.pdf	\N	D5170C00002-941cd2de-8319-11eb-be00-0f5c4a48e484-6469	\N	NEW	\N	\N	\N	\N
86432	79	D5170C00002/tiny.path.1/file-5042.pdf	\N	D5170C00002-942972eb-8318-11eb-be00-d9001d42c029-5042	\N	NEW	\N	\N	\N	\N
82097	79	D5170C00002/tiny.path.1/file-0707.pdf	\N	D5170C00002-942c879c-8315-11eb-be00-2b7298828244-707	\N	NEW	\N	\N	\N	\N
86433	79	D5170C00002/tiny.path.1/file-5043.pdf	\N	D5170C00002-94399f8c-8318-11eb-be00-ed654d46f9c7-5043	\N	NEW	\N	\N	\N	\N
85008	79	D5170C00002/tiny.path.1/file-3618.pdf	\N	D5170C00002-943b421b-8317-11eb-be00-27f3dfabddc4-3618	\N	NEW	\N	\N	\N	\N
83485	79	D5170C00002/tiny.path.1/file-2095.msg	\N	D5170C00002-944bb258-8316-11eb-be00-bb5e997022c5-2095	\N	NEW	\N	\N	\N	\N
87860	79	D5170C00002/tiny.path.1/file-6470.pdf	\N	D5170C00002-9458a35f-8319-11eb-be00-2da0cc77a2fb-6470	\N	NEW	\N	\N	\N	\N
82098	79	D5170C00002/tiny.path.1/file-0708.pdf	\N	D5170C00002-9459d92d-8315-11eb-be00-997914326c1a-708	\N	NEW	\N	\N	\N	\N
85009	79	D5170C00002/tiny.path.1/file-3619.pdf	\N	D5170C00002-9459edac-8317-11eb-be00-d1f2054f64a6-3619	\N	NEW	\N	\N	\N	\N
87861	79	D5170C00002/tiny.path.1/file-6471.pdf	\N	D5170C00002-9475ef60-8319-11eb-be00-31af81bef5a9-6471	\N	NEW	\N	\N	\N	\N
85010	79	D5170C00002/tiny.path.1/file-3620.pdf	\N	D5170C00002-9478722d-8317-11eb-be00-ad6866c702da-3620	\N	NEW	\N	\N	\N	\N
87862	79	D5170C00002/tiny.path.1/file-6472.pdf	\N	D5170C00002-94869131-8319-11eb-be00-57b4840df02f-6472	\N	NEW	\N	\N	\N	\N
82099	79	D5170C00002/tiny.path.1/file-0709.pdf	\N	D5170C00002-94883c2e-8315-11eb-be00-69a02dcdd824-709	\N	NEW	\N	\N	\N	\N
83486	79	D5170C00002/tiny.path.1/file-2096.msg	\N	D5170C00002-94a4f5e9-8316-11eb-be00-4fc48c7e1b6e-2096	\N	NEW	\N	\N	\N	\N
87863	79	D5170C00002/tiny.path.1/file-6473.pdf	\N	D5170C00002-94a563d2-8319-11eb-be00-759831703f62-6473	\N	NEW	\N	\N	\N	\N
86434	79	D5170C00002/tiny.path.1/file-5044.pdf	\N	D5170C00002-94b3b18d-8318-11eb-be00-d5a7b52b6973-5044	\N	NEW	\N	\N	\N	\N
85011	79	D5170C00002/tiny.path.1/file-3621.pdf	\N	D5170C00002-94b3cd7e-8317-11eb-be00-ebf8bfbaf3f4-3621	\N	NEW	\N	\N	\N	\N
87864	79	D5170C00002/tiny.path.1/file-6474.pdf	\N	D5170C00002-94b3e2c3-8319-11eb-be00-a12ee4e5fee5-6474	\N	NEW	\N	\N	\N	\N
85012	79	D5170C00002/tiny.path.1/file-3622.pdf	\N	D5170C00002-94b505ff-8317-11eb-be00-cb7849adb0f8-3622	\N	NEW	\N	\N	\N	\N
87865	79	D5170C00002/tiny.path.1/file-6475.pdf	\N	D5170C00002-94b56964-8319-11eb-be00-cb973d332058-6475	\N	NEW	\N	\N	\N	\N
82100	79	D5170C00002/tiny.path.1/file-0710.pdf	\N	D5170C00002-94b58dbf-8315-11eb-be00-a563a21d79de-710	\N	NEW	\N	\N	\N	\N
85013	79	D5170C00002/tiny.path.1/file-3623.pdf	\N	D5170C00002-94c22560-8317-11eb-be00-b9e210c5c699-3623	\N	NEW	\N	\N	\N	\N
86435	79	D5170C00002/tiny.path.1/file-5045.pdf	\N	D5170C00002-94c4a17e-8318-11eb-be00-27fb4ed436fe-5045	\N	NEW	\N	\N	\N	\N
85014	79	D5170C00002/tiny.path.1/file-3624.pdf	\N	D5170C00002-94d18eb1-8317-11eb-be00-175987809c30-3624	\N	NEW	\N	\N	\N	\N
87866	79	D5170C00002/tiny.path.1/file-6476.pdf	\N	D5170C00002-94d43c05-8319-11eb-be00-45acafaab639-6476	\N	NEW	\N	\N	\N	\N
82101	79	D5170C00002/tiny.path.1/file-0711.pdf	\N	D5170C00002-94e131a0-8315-11eb-be00-45792bde3515-711	\N	NEW	\N	\N	\N	\N
83487	79	D5170C00002/tiny.path.1/file-2097.msg	\N	D5170C00002-94f056ca-8316-11eb-be00-992a4d0ee1b9-2097	\N	NEW	\N	\N	\N	\N
87867	79	D5170C00002/tiny.path.1/file-6477.pdf	\N	D5170C00002-94f18806-8319-11eb-be00-ed64b14684a0-6477	\N	NEW	\N	\N	\N	\N
82102	79	D5170C00002/tiny.path.1/file-0712.pdf	\N	D5170C00002-94f30bf1-8315-11eb-be00-2d0bb7d96fb5-712	\N	NEW	\N	\N	\N	\N
86436	79	D5170C00002/tiny.path.1/file-5046.pdf	\N	D5170C00002-94ff126f-8318-11eb-be00-3341cc286622-5046	\N	NEW	\N	\N	\N	\N
85015	79	D5170C00002/tiny.path.1/file-3625.pdf	\N	D5170C00002-94fff1b2-8317-11eb-be00-e7de407b4304-3625	\N	NEW	\N	\N	\N	\N
87868	79	D5170C00002/tiny.path.1/file-6478.pdf	\N	D5170C00002-950efb17-8319-11eb-be00-1dcaf1a8476b-6478	\N	NEW	\N	\N	\N	\N
86437	79	D5170C00002/tiny.path.1/file-5047.pdf	\N	D5170C00002-95102970-8318-11eb-be00-278994960dfa-5047	\N	NEW	\N	\N	\N	\N
85016	79	D5170C00002/tiny.path.1/file-3626.msg	\N	D5170C00002-95109383-8317-11eb-be00-9190e200e016-3626	\N	NEW	\N	\N	\N	\N
87869	79	D5170C00002/tiny.path.1/file-6479.pdf	\N	D5170C00002-951d52f8-8319-11eb-be00-e196c82c2838-6479	\N	NEW	\N	\N	\N	\N
85017	79	D5170C00002/tiny.path.1/file-3627.msg	\N	D5170C00002-951f3984-8317-11eb-be00-d597c2c7dc85-3627	\N	NEW	\N	\N	\N	\N
82103	79	D5170C00002/tiny.path.1/file-0713.pdf	\N	D5170C00002-951fc142-8315-11eb-be00-b1b0d80e2345-713	\N	NEW	\N	\N	\N	\N
86438	79	D5170C00002/tiny.path.1/file-5048.pdf	\N	D5170C00002-952f2321-8318-11eb-be00-c3b4837a47a3-5048	\N	NEW	\N	\N	\N	\N
85018	79	D5170C00002/tiny.path.1/file-3628.msg	\N	D5170C00002-953c5e75-8317-11eb-be00-79bfeba7cc06-3628	\N	NEW	\N	\N	\N	\N
87870	79	D5170C00002/tiny.path.1/file-6480.pdf	\N	D5170C00002-953d0ff9-8319-11eb-be00-6b63f7576943-6480	\N	NEW	\N	\N	\N	\N
82104	79	D5170C00002/tiny.path.1/file-0714.pdf	\N	D5170C00002-953d3453-8315-11eb-be00-69f9cd1291e3-714	\N	NEW	\N	\N	\N	\N
83488	79	D5170C00002/tiny.path.1/file-2098.msg	\N	D5170C00002-953d655b-8316-11eb-be00-9f69dbf5e4a8-2098	\N	NEW	\N	\N	\N	\N
87871	79	D5170C00002/tiny.path.1/file-6481.pdf	\N	D5170C00002-954c041a-8319-11eb-be00-67ed8f882f3e-6481	\N	NEW	\N	\N	\N	\N
85019	79	D5170C00002/tiny.path.1/file-3629.msg	\N	D5170C00002-954d2756-8317-11eb-be00-eb07e9a62493-3629	\N	NEW	\N	\N	\N	\N
86439	79	D5170C00002/tiny.path.1/file-5049.pdf	\N	D5170C00002-954d5982-8318-11eb-be00-673096e8adb1-5049	\N	NEW	\N	\N	\N	\N
87872	79	D5170C00002/tiny.path.1/file-6482.pdf	\N	D5170C00002-95699e3b-8319-11eb-be00-97b26a67240c-6482	\N	NEW	\N	\N	\N	\N
86440	79	D5170C00002/tiny.path.1/file-5050.pdf	\N	D5170C00002-9569e233-8318-11eb-be00-07ebc8ecdb19-5050	\N	NEW	\N	\N	\N	\N
82105	79	D5170C00002/tiny.path.1/file-0715.pdf	\N	D5170C00002-956a5ed4-8315-11eb-be00-d7c537214252-715	\N	NEW	\N	\N	\N	\N
85020	79	D5170C00002/tiny.path.1/file-3630.msg	\N	D5170C00002-956a7357-8317-11eb-be00-cf6da8d9c003-3630	\N	NEW	\N	\N	\N	\N
85021	79	D5170C00002/tiny.path.1/file-3631.msg	\N	D5170C00002-9579b598-8317-11eb-be00-d33feb9268e6-3631	\N	NEW	\N	\N	\N	\N
86441	79	D5170C00002/tiny.path.1/file-5051.pdf	\N	D5170C00002-957a35e4-8318-11eb-be00-77e77199e458-5051	\N	NEW	\N	\N	\N	\N
87873	79	D5170C00002/tiny.path.1/file-6483.pdf	\N	D5170C00002-957a671c-8319-11eb-be00-99827134e839-6483	\N	NEW	\N	\N	\N	\N
83489	79	D5170C00002/tiny.path.1/file-2099.msg	\N	D5170C00002-957b0a9c-8316-11eb-be00-13b323f87dac-2099	\N	NEW	\N	\N	\N	\N
87874	79	D5170C00002/tiny.path.1/file-6484.pdf	\N	D5170C00002-958822bd-8319-11eb-be00-d7dc9f6c67f6-6484	\N	NEW	\N	\N	\N	\N
87875	79	D5170C00002/tiny.path.1/file-6485.pdf	\N	D5170C00002-959764fe-8319-11eb-be00-c763b0289a40-6485	\N	NEW	\N	\N	\N	\N
83490	79	D5170C00002/tiny.path.1/file-2100.pdf	\N	D5170C00002-9598a4bd-8316-11eb-be00-25f690506199-2100	\N	NEW	\N	\N	\N	\N
82106	79	D5170C00002/tiny.path.1/file-0716.pdf	\N	D5170C00002-9599fa55-8315-11eb-be00-650cf287e07b-716	\N	NEW	\N	\N	\N	\N
85022	79	D5170C00002/tiny.path.1/file-3632.msg	\N	D5170C00002-959a5cf9-8317-11eb-be00-d91800dd6ca8-3632	\N	NEW	\N	\N	\N	\N
87876	79	D5170C00002/tiny.path.1/file-6486.pdf	\N	D5170C00002-95a8f12f-8319-11eb-be00-07af333a9a26-6486	\N	NEW	\N	\N	\N	\N
86442	79	D5170C00002/tiny.path.1/file-5052.pdf	\N	D5170C00002-95a9aa55-8318-11eb-be00-bb843136911f-5052	\N	NEW	\N	\N	\N	\N
85023	79	D5170C00002/tiny.path.1/file-3633.msg	\N	D5170C00002-95a9ed5a-8317-11eb-be00-9b38ea6e637e-3633	\N	NEW	\N	\N	\N	\N
83491	79	D5170C00002/tiny.path.1/file-2101.pdf	\N	D5170C00002-95aa7f0e-8316-11eb-be00-655dbaa2ace9-2101	\N	NEW	\N	\N	\N	\N
85024	79	D5170C00002/tiny.path.1/file-3634.msg	\N	D5170C00002-95c58bab-8317-11eb-be00-219621e16d96-3634	\N	NEW	\N	\N	\N	\N
86443	79	D5170C00002/tiny.path.1/file-5053.pdf	\N	D5170C00002-95c60bf6-8318-11eb-be00-f18fc5765aee-5053	\N	NEW	\N	\N	\N	\N
83492	79	D5170C00002/tiny.path.1/file-2102.pdf	\N	D5170C00002-95c6e0af-8316-11eb-be00-67e40f6bcb6d-2102	\N	NEW	\N	\N	\N	\N
87877	79	D5170C00002/tiny.path.1/file-6487.pdf	\N	D5170C00002-95c7eae0-8319-11eb-be00-3fe5ffa2bdc8-6487	\N	NEW	\N	\N	\N	\N
82107	79	D5170C00002/tiny.path.1/file-0717.pdf	\N	D5170C00002-95c83646-8315-11eb-be00-53dad395144e-717	\N	NEW	\N	\N	\N	\N
86444	79	D5170C00002/tiny.path.1/file-5054.pdf	\N	D5170C00002-95d6adc7-8318-11eb-be00-2730f2098518-5054	\N	NEW	\N	\N	\N	\N
87878	79	D5170C00002/tiny.path.1/file-6488.pdf	\N	D5170C00002-95d6b7f1-8319-11eb-be00-935499796f9c-6488	\N	NEW	\N	\N	\N	\N
83493	79	D5170C00002/tiny.path.1/file-2103.pdf	\N	D5170C00002-95d7f7b0-8316-11eb-be00-19c59c4993b3-2103	\N	NEW	\N	\N	\N	\N
87879	79	D5170C00002/tiny.path.1/file-6489.pdf	\N	D5170C00002-95e4e8c2-8319-11eb-be00-31bb902ef5e9-6489	\N	NEW	\N	\N	\N	\N
83494	79	D5170C00002/tiny.path.1/file-2104.pdf	\N	D5170C00002-95e5da61-8316-11eb-be00-5b6ba74f792b-2104	\N	NEW	\N	\N	\N	\N
87880	79	D5170C00002/tiny.path.1/file-6490.pdf	\N	D5170C00002-9602d103-8319-11eb-be00-999dccfe5bb7-6490	\N	NEW	\N	\N	\N	\N
83495	79	D5170C00002/tiny.path.1/file-2105.pdf	\N	D5170C00002-9602d842-8316-11eb-be00-d9e6723daf41-2105	\N	NEW	\N	\N	\N	\N
85025	79	D5170C00002/tiny.path.1/file-3635.msg	\N	D5170C00002-9603f43c-8317-11eb-be00-891b46be5c5c-3635	\N	NEW	\N	\N	\N	\N
82108	79	D5170C00002/tiny.path.1/file-0718.pdf	\N	D5170C00002-96125ea7-8315-11eb-be00-d72d1360491d-718	\N	NEW	\N	\N	\N	\N
85026	79	D5170C00002/tiny.path.1/file-3636.msg	\N	D5170C00002-9621b56d-8317-11eb-be00-51b3662f6ed9-3636	\N	NEW	\N	\N	\N	\N
83496	79	D5170C00002/tiny.path.1/file-2106.pdf	\N	D5170C00002-9630ed23-8316-11eb-be00-1ff2b99ffaa3-2106	\N	NEW	\N	\N	\N	\N
82109	79	D5170C00002/tiny.path.1/file-0719.pdf	\N	D5170C00002-96313148-8315-11eb-be00-37d7d91d62a5-719	\N	NEW	\N	\N	\N	\N
85027	79	D5170C00002/tiny.path.1/file-3637.msg	\N	D5170C00002-964039ee-8317-11eb-be00-5b77933c06e9-3637	\N	NEW	\N	\N	\N	\N
82110	79	D5170C00002/tiny.path.1/file-0720.pdf	\N	D5170C00002-96424849-8315-11eb-be00-e71324b23c31-720	\N	NEW	\N	\N	\N	\N
85028	79	D5170C00002/tiny.path.1/file-3638.msg	\N	D5170C00002-965129df-8317-11eb-be00-91a1ddb1bc48-3638	\N	NEW	\N	\N	\N	\N
82111	79	D5170C00002/tiny.path.1/file-0721.pdf	\N	D5170C00002-9660a5ba-8315-11eb-be00-c11683aaec34-721	\N	NEW	\N	\N	\N	\N
87881	79	D5170C00002/tiny.path.1/file-6491.pdf	\N	D5170C00002-966d2b94-8319-11eb-be00-4bc796d31b6d-6491	\N	NEW	\N	\N	\N	\N
86445	79	D5170C00002/tiny.path.1/file-5055.xlsx	\N	D5170C00002-966d4878-8318-11eb-be00-8355514319f7-5055	\N	NEW	\N	\N	\N	\N
82112	79	D5170C00002/tiny.path.1/file-0722.pdf	\N	D5170C00002-966e133b-8315-11eb-be00-4b6ba53b6951-722	\N	NEW	\N	\N	\N	\N
85029	79	D5170C00002/tiny.path.1/file-3639.msg	\N	D5170C00002-966e9cf0-8317-11eb-be00-af7961219526-3639	\N	NEW	\N	\N	\N	\N
85030	79	D5170C00002/tiny.path.1/file-3640.msg	\N	D5170C00002-96704aa1-8317-11eb-be00-79cbcab74791-3640	\N	NEW	\N	\N	\N	\N
83497	79	D5170C00002/tiny.path.1/file-2107.pdf	\N	D5170C00002-967dfbb4-8316-11eb-be00-310257a11fde-2107	\N	NEW	\N	\N	\N	\N
85031	79	D5170C00002/tiny.path.1/file-3641.msg	\N	D5170C00002-968c1002-8317-11eb-be00-995f98ef63c7-3641	\N	NEW	\N	\N	\N	\N
87882	79	D5170C00002/tiny.path.1/file-6492.pdf	\N	D5170C00002-968d36b5-8319-11eb-be00-fdb8b6a8a7be-6492	\N	NEW	\N	\N	\N	\N
87883	79	D5170C00002/tiny.path.1/file-6493.pdf	\N	D5170C00002-969b6786-8319-11eb-be00-959a08936452-6493	\N	NEW	\N	\N	\N	\N
85032	79	D5170C00002/tiny.path.1/file-3642.msg	\N	D5170C00002-969ba063-8317-11eb-be00-4d7b03b39124-3642	\N	NEW	\N	\N	\N	\N
86446	79	D5170C00002/tiny.path.1/file-5056.xlsx	\N	D5170C00002-969dce59-8318-11eb-be00-0d8bf7678f43-5056	\N	NEW	\N	\N	\N	\N
87884	79	D5170C00002/tiny.path.1/file-6494.pdf	\N	D5170C00002-96c8b917-8319-11eb-be00-a5980740b7fc-6494	\N	NEW	\N	\N	\N	\N
85033	79	D5170C00002/tiny.path.1/file-3643.pdf	\N	D5170C00002-96c94014-8317-11eb-be00-0b71e0dd63be-3643	\N	NEW	\N	\N	\N	\N
83498	79	D5170C00002/tiny.path.1/file-2108.pdf	\N	D5170C00002-96cabc25-8316-11eb-be00-6757eca311a3-2108	\N	NEW	\N	\N	\N	\N
87885	79	D5170C00002/tiny.path.1/file-6495.pdf	\N	D5170C00002-96d7d448-8319-11eb-be00-29f82d79931b-6495	\N	NEW	\N	\N	\N	\N
85034	79	D5170C00002/tiny.path.1/file-3644.pdf	\N	D5170C00002-96daf355-8317-11eb-be00-614b77439918-3644	\N	NEW	\N	\N	\N	\N
86447	79	D5170C00002/tiny.path.1/file-5057.xlsx	\N	D5170C00002-96f69cba-8318-11eb-be00-5f4cd2477e38-5057	\N	NEW	\N	\N	\N	\N
82113	79	D5170C00002/tiny.path.1/file-0723.pdf	\N	D5170C00002-96f7677c-8315-11eb-be00-450a649f562e-723	\N	NEW	\N	\N	\N	\N
85035	79	D5170C00002/tiny.path.1/file-3645.pdf	\N	D5170C00002-96f950c6-8317-11eb-be00-556298871e2d-3645	\N	NEW	\N	\N	\N	\N
83499	79	D5170C00002/tiny.path.1/file-2109.pdf	\N	D5170C00002-97079e16-8316-11eb-be00-d9795491a6e9-2109	\N	NEW	\N	\N	\N	\N
85036	79	D5170C00002/tiny.path.1/file-3646.pdf	\N	D5170C00002-9726c967-8317-11eb-be00-835999c34dbf-3646	\N	NEW	\N	\N	\N	\N
87886	79	D5170C00002/tiny.path.1/file-6496.pdf	\N	D5170C00002-9726dea9-8319-11eb-be00-49500837e3d5-6496	\N	NEW	\N	\N	\N	\N
86448	79	D5170C00002/tiny.path.1/file-5058.xlsx	\N	D5170C00002-9742e7fb-8318-11eb-be00-6f7bacb4283f-5058	\N	NEW	\N	\N	\N	\N
85037	79	D5170C00002/tiny.path.1/file-3647.pdf	\N	D5170C00002-97435218-8317-11eb-be00-bb8f1605d308-3647	\N	NEW	\N	\N	\N	\N
87887	79	D5170C00002/tiny.path.1/file-6497.pdf	\N	D5170C00002-976176aa-8319-11eb-be00-1df15a4606fc-6497	\N	NEW	\N	\N	\N	\N
83500	79	D5170C00002/tiny.path.1/file-2110.pdf	\N	D5170C00002-9772e307-8316-11eb-be00-51d012e6b09f-2110	\N	NEW	\N	\N	\N	\N
86449	79	D5170C00002/tiny.path.1/file-5059.xlsx	\N	D5170C00002-9780180c-8318-11eb-be00-01970b91278a-5059	\N	NEW	\N	\N	\N	\N
87888	79	D5170C00002/tiny.path.1/file-6498.pdf	\N	D5170C00002-9782ba4b-8319-11eb-be00-652cb4db3e07-6498	\N	NEW	\N	\N	\N	\N
82114	79	D5170C00002/tiny.path.1/file-0724.pdf	\N	D5170C00002-979fb56d-8315-11eb-be00-458aa42a5767-724	\N	NEW	\N	\N	\N	\N
83501	79	D5170C00002/tiny.path.1/file-2111.pdf	\N	D5170C00002-979fe678-8316-11eb-be00-a302003981fc-2111	\N	NEW	\N	\N	\N	\N
86450	79	D5170C00002/tiny.path.1/file-5060.pdf	\N	D5170C00002-97a0714d-8318-11eb-be00-01bfdb275790-5060	\N	NEW	\N	\N	\N	\N
85038	79	D5170C00002/tiny.path.1/file-3648.pdf	\N	D5170C00002-97bffc29-8317-11eb-be00-5bf3e4f4558e-3648	\N	NEW	\N	\N	\N	\N
82115	79	D5170C00002/tiny.path.1/file-0725.pdf	\N	D5170C00002-97c00eae-8315-11eb-be00-792173c6a0d1-725	\N	NEW	\N	\N	\N	\N
86451	79	D5170C00002/tiny.path.1/file-5061.pdf	\N	D5170C00002-97cd269e-8318-11eb-be00-df58ce210cc6-5061	\N	NEW	\N	\N	\N	\N
83502	79	D5170C00002/tiny.path.1/file-2112.pdf	\N	D5170C00002-97cee5b9-8316-11eb-be00-394bf40f28b2-2112	\N	NEW	\N	\N	\N	\N
82116	79	D5170C00002/tiny.path.1/file-0726.pdf	\N	D5170C00002-97dc975f-8315-11eb-be00-790c341effee-726	\N	NEW	\N	\N	\N	\N
83503	79	D5170C00002/tiny.path.1/file-2113.pdf	\N	D5170C00002-97de761a-8316-11eb-be00-1b3402ae96cb-2113	\N	NEW	\N	\N	\N	\N
86452	79	D5170C00002/tiny.path.1/file-5062.pdf	\N	D5170C00002-97fac64f-8318-11eb-be00-914e1a7dd3fb-5062	\N	NEW	\N	\N	\N	\N
85039	79	D5170C00002/tiny.path.1/file-3649.pdf	\N	D5170C00002-9809d66a-8317-11eb-be00-1b63b3bf16e7-3649	\N	NEW	\N	\N	\N	\N
83504	79	D5170C00002/tiny.path.1/file-2114.pdf	\N	D5170C00002-980a19fb-8316-11eb-be00-5dfca25c3d4a-2114	\N	NEW	\N	\N	\N	\N
82117	79	D5170C00002/tiny.path.1/file-0727.pdf	\N	D5170C00002-980a5d20-8315-11eb-be00-434d01efd01f-727	\N	NEW	\N	\N	\N	\N
87889	79	D5170C00002/tiny.path.1/file-6499.pdf	\N	D5170C00002-9827fafc-8319-11eb-be00-5336ddad10a1-6499	\N	NEW	\N	\N	\N	\N
83505	79	D5170C00002/tiny.path.1/file-2115.pdf	\N	D5170C00002-9828505c-8316-11eb-be00-f30b87b6061a-2115	\N	NEW	\N	\N	\N	\N
82118	79	D5170C00002/tiny.path.1/file-0728.pdf	\N	D5170C00002-98292fc1-8315-11eb-be00-535ea3f329b3-728	\N	NEW	\N	\N	\N	\N
82119	79	D5170C00002/tiny.path.1/file-0729.pdf	\N	D5170C00002-9846f0f2-8315-11eb-be00-832e0117db99-729	\N	NEW	\N	\N	\N	\N
83506	79	D5170C00002/tiny.path.1/file-2116.pdf	\N	D5170C00002-9858610d-8316-11eb-be00-830876fe5bf3-2116	\N	NEW	\N	\N	\N	\N
86453	79	D5170C00002/tiny.path.1/file-5063.pdf	\N	D5170C00002-985876b0-8318-11eb-be00-21c5ba365264-5063	\N	NEW	\N	\N	\N	\N
85040	79	D5170C00002/tiny.path.1/file-3650.pdf	\N	D5170C00002-9865b20b-8317-11eb-be00-23efd8d79317-3650	\N	NEW	\N	\N	\N	\N
86454	79	D5170C00002/tiny.path.1/file-5064.pdf	\N	D5170C00002-986743c1-8318-11eb-be00-47b918774bb0-5064	\N	NEW	\N	\N	\N	\N
82120	79	D5170C00002/tiny.path.1/file-0730.pdf	\N	D5170C00002-9875f033-8315-11eb-be00-91026ad86456-730	\N	NEW	\N	\N	\N	\N
86455	79	D5170C00002/tiny.path.1/file-5065.pdf	\N	D5170C00002-98841a92-8318-11eb-be00-d766f8cce211-5065	\N	NEW	\N	\N	\N	\N
86456	79	D5170C00002/tiny.path.1/file-5066.pdf	\N	D5170C00002-988727d3-8318-11eb-be00-39f04737410c-5066	\N	NEW	\N	\N	\N	\N
85041	79	D5170C00002/tiny.path.1/file-3651.pdf	\N	D5170C00002-98a37e5c-8317-11eb-be00-09d4a2951f06-3651	\N	NEW	\N	\N	\N	\N
85042	79	D5170C00002/tiny.path.1/file-3652.pdf	\N	D5170C00002-98b35cdd-8317-11eb-be00-9114bdae9d5f-3652	\N	NEW	\N	\N	\N	\N
82121	79	D5170C00002/tiny.path.1/file-0731.pdf	\N	D5170C00002-98b3e394-8315-11eb-be00-a9bcfc1db375-731	\N	NEW	\N	\N	\N	\N
83507	79	D5170C00002/tiny.path.1/file-2117.pdf	\N	D5170C00002-98c2466e-8316-11eb-be00-99bfdcc98c46-2117	\N	NEW	\N	\N	\N	\N
86457	79	D5170C00002/tiny.path.1/file-5067.xlsx	\N	D5170C00002-98e155c4-8318-11eb-be00-7525a6b61c34-5067	\N	NEW	\N	\N	\N	\N
86458	79	D5170C00002/tiny.path.1/file-5068.pdf	\N	D5170C00002-98fe53a5-8318-11eb-be00-b9a8e1d226f9-5068	\N	NEW	\N	\N	\N	\N
83508	79	D5170C00002/tiny.path.1/file-2118.pdf	\N	D5170C00002-98ff9d8f-8316-11eb-be00-9de82ee82fc9-2118	\N	NEW	\N	\N	\N	\N
86459	79	D5170C00002/tiny.path.1/file-5069.pdf	\N	D5170C00002-992bcc46-8318-11eb-be00-cdf21f74d6cd-5069	\N	NEW	\N	\N	\N	\N
82126	79	D5170C00002/tiny.path.1/file-0736.pdf	\N	D5170C00002-992c9605-8315-11eb-be00-2f5e81dd2667-732	\N	NEW	\N	\N	\N	\N
86460	79	D5170C00002/tiny.path.1/file-5070.pdf	\N	D5170C00002-994a9ee7-8318-11eb-be00-91f791d5cb4d-5070	\N	NEW	\N	\N	\N	\N
82122	79	D5170C00002/tiny.path.1/file-0732.pdf	\N	D5170C00002-99594b56-8315-11eb-be00-6ff9c58993af-733	\N	NEW	\N	\N	\N	\N
83509	79	D5170C00002/tiny.path.1/file-2119.pdf	\N	D5170C00002-99882e80-8316-11eb-be00-33b7fa8c5d33-2119	\N	NEW	\N	\N	\N	\N
83510	79	D5170C00002/tiny.path.1/file-2120.pdf	\N	D5170C00002-999722a1-8316-11eb-be00-f16fd48882d5-2120	\N	NEW	\N	\N	\N	\N
82123	79	D5170C00002/tiny.path.1/file-0733.pdf	\N	D5170C00002-99a632d7-8315-11eb-be00-c7513bb65b99-734	\N	NEW	\N	\N	\N	\N
86461	79	D5170C00002/tiny.path.1/file-5071.pdf	\N	D5170C00002-99b4d268-8318-11eb-be00-533a6b10388b-5071	\N	NEW	\N	\N	\N	\N
87890	79	D5170C00002/tiny.path.1/file-6500.pdf	\N	D5170C00002-99b7267d-8319-11eb-be00-2f2cb56e8741-6500	\N	NEW	\N	\N	\N	\N
83511	79	D5170C00002/tiny.path.1/file-2121.msg	\N	D5170C00002-99c47432-8316-11eb-be00-0d1b6c843c2f-2121	\N	NEW	\N	\N	\N	\N
82124	79	D5170C00002/tiny.path.1/file-0734.pdf	\N	D5170C00002-99d495d8-8315-11eb-be00-c1c5987e9eb7-735	\N	NEW	\N	\N	\N	\N
83512	79	D5170C00002/tiny.path.1/file-2122.msg	\N	D5170C00002-99d4c7e3-8316-11eb-be00-a179fe5ad13d-2122	\N	NEW	\N	\N	\N	\N
83513	79	D5170C00002/tiny.path.1/file-2123.msg	\N	D5170C00002-99f39a84-8316-11eb-be00-c39bb364484d-2123	\N	NEW	\N	\N	\N	\N
82125	79	D5170C00002/tiny.path.1/file-0735.pdf	\N	D5170C00002-9a020e79-8315-11eb-be00-db53dedee4a2-736	\N	NEW	\N	\N	\N	\N
87891	79	D5170C00002/tiny.path.1/file-6501.pdf	\N	D5170C00002-9a123ece-8319-11eb-be00-8341cdae6990-6501	\N	NEW	\N	\N	\N	\N
83514	79	D5170C00002/tiny.path.1/file-2124.msg	\N	D5170C00002-9a124615-8316-11eb-be00-b9db87ee6691-2124	\N	NEW	\N	\N	\N	\N
86462	79	D5170C00002/tiny.path.1/file-5072.xlsx	\N	D5170C00002-9a1f5409-8318-11eb-be00-a79d0b55afab-5072	\N	NEW	\N	\N	\N	\N
83515	79	D5170C00002/tiny.path.1/file-2125.msg	\N	D5170C00002-9a1f8c86-8316-11eb-be00-252cf0ff171e-2125	\N	NEW	\N	\N	\N	\N
87892	79	D5170C00002/tiny.path.1/file-6502.pdf	\N	D5170C00002-9a31116f-8319-11eb-be00-77875aef815d-6502	\N	NEW	\N	\N	\N	\N
82127	79	D5170C00002/tiny.path.1/file-0737.pdf	\N	D5170C00002-9a4e0b9a-8315-11eb-be00-ef5e801f0ee7-737	\N	NEW	\N	\N	\N	\N
83516	79	D5170C00002/tiny.path.1/file-2126.msg	\N	D5170C00002-9a5dce07-8316-11eb-be00-1d5d822e7c7c-2126	\N	NEW	\N	\N	\N	\N
87893	79	D5170C00002/tiny.path.1/file-6503.pdf	\N	D5170C00002-9a997030-8319-11eb-be00-232d2347ca7e-6503	\N	NEW	\N	\N	\N	\N
86463	79	D5170C00002/tiny.path.1/file-5073.xlsx	\N	D5170C00002-9aa8f66a-8318-11eb-be00-a793dc80c738-5073	\N	NEW	\N	\N	\N	\N
85043	79	D5170C00002/tiny.path.1/file-3653.pdf	\N	D5170C00002-9aa9396e-8317-11eb-be00-337e5ccd8bac-3653	\N	NEW	\N	\N	\N	\N
82128	79	D5170C00002/tiny.path.1/file-0738.pdf	\N	D5170C00002-9ab8b44b-8315-11eb-be00-738fb3fd13e7-738	\N	NEW	\N	\N	\N	\N
87894	79	D5170C00002/tiny.path.1/file-6504.pdf	\N	D5170C00002-9ab8b801-8319-11eb-be00-3fe3bed68a21-6504	\N	NEW	\N	\N	\N	\N
83517	79	D5170C00002/tiny.path.1/file-2127.pdf	\N	D5170C00002-9ad6ce98-8316-11eb-be00-c500e1e6bb47-2127	\N	NEW	\N	\N	\N	\N
85044	79	D5170C00002/tiny.path.1/file-3654.pdf	\N	D5170C00002-9ad7002f-8317-11eb-be00-a19a75c36c1b-3654	\N	NEW	\N	\N	\N	\N
82129	79	D5170C00002/tiny.path.1/file-0739.pdf	\N	D5170C00002-9ad982bc-8315-11eb-be00-8d3d50a3f1c3-739	\N	NEW	\N	\N	\N	\N
85045	79	D5170C00002/tiny.path.1/file-3655.pdf	\N	D5170C00002-9ae77af0-8317-11eb-be00-41285bf7971a-3655	\N	NEW	\N	\N	\N	\N
85046	79	D5170C00002/tiny.path.1/file-3656.pdf	\N	D5170C00002-9b0478d1-8317-11eb-be00-e5277379b899-3656	\N	NEW	\N	\N	\N	\N
82130	79	D5170C00002/tiny.path.1/file-0740.pdf	\N	D5170C00002-9b059bcd-8315-11eb-be00-83d2e062d5bb-740	\N	NEW	\N	\N	\N	\N
85047	79	D5170C00002/tiny.path.1/file-3657.pdf	\N	D5170C00002-9b139402-8317-11eb-be00-ed8968877aea-3657	\N	NEW	\N	\N	\N	\N
83518	79	D5170C00002/tiny.path.1/file-2128.pdf	\N	D5170C00002-9b13d799-8316-11eb-be00-1b36651c84ba-2128	\N	NEW	\N	\N	\N	\N
83519	79	D5170C00002/tiny.path.1/file-2129.pdf	\N	D5170C00002-9b14e90a-8316-11eb-be00-3f112faea82a-2129	\N	NEW	\N	\N	\N	\N
85048	79	D5170C00002/tiny.path.1/file-3658.pdf	\N	D5170C00002-9b1541b3-8317-11eb-be00-fda23ff1eb84-3658	\N	NEW	\N	\N	\N	\N
85049	79	D5170C00002/tiny.path.1/file-3659.pdf	\N	D5170C00002-9b346274-8317-11eb-be00-9d116a57cbd0-3659	\N	NEW	\N	\N	\N	\N
87895	79	D5170C00002/tiny.path.1/file-6505.pdf	\N	D5170C00002-9b5fcd72-8319-11eb-be00-cb9d36769d08-6505	\N	NEW	\N	\N	\N	\N
85050	79	D5170C00002/tiny.path.1/file-3660.pdf	\N	D5170C00002-9b60f0b5-8317-11eb-be00-15fdeb544166-3660	\N	NEW	\N	\N	\N	\N
87896	79	D5170C00002/tiny.path.1/file-6506.pdf	\N	D5170C00002-9b626583-8319-11eb-be00-3dece89a1afc-6506	\N	NEW	\N	\N	\N	\N
83520	79	D5170C00002/tiny.path.1/file-2130.pdf	\N	D5170C00002-9b7160eb-8316-11eb-be00-87614f297328-2130	\N	NEW	\N	\N	\N	\N
85051	79	D5170C00002/tiny.path.1/file-3661.pdf	\N	D5170C00002-9b7f9c46-8317-11eb-be00-175199ca19c4-3661	\N	NEW	\N	\N	\N	\N
87897	79	D5170C00002/tiny.path.1/file-6507.pdf	\N	D5170C00002-9b7fffa4-8319-11eb-be00-d320587305d9-6507	\N	NEW	\N	\N	\N	\N
82131	79	D5170C00002/tiny.path.1/file-0741.pdf	\N	D5170C00002-9b8e2cbe-8315-11eb-be00-697d07807c74-741	\N	NEW	\N	\N	\N	\N
85052	79	D5170C00002/tiny.path.1/file-3662.pdf	\N	D5170C00002-9b8fa1d7-8317-11eb-be00-7f920a23c946-3662	\N	NEW	\N	\N	\N	\N
87898	79	D5170C00002/tiny.path.1/file-6508.pdf	\N	D5170C00002-9b9e0ef5-8319-11eb-be00-773561ac04db-6508	\N	NEW	\N	\N	\N	\N
85053	79	D5170C00002/tiny.path.1/file-3663.pdf	\N	D5170C00002-9b9e20c8-8317-11eb-be00-c9612da47dcd-3663	\N	NEW	\N	\N	\N	\N
82132	79	D5170C00002/tiny.path.1/file-0742.pdf	\N	D5170C00002-9b9ef59f-8315-11eb-be00-65694ba5b7bf-742	\N	NEW	\N	\N	\N	\N
86464	79	D5170C00002/tiny.path.1/file-5074.xlsx	\N	D5170C00002-9b9f645b-8318-11eb-be00-9b85412b21c3-5074	\N	NEW	\N	\N	\N	\N
87899	79	D5170C00002/tiny.path.1/file-6509.pdf	\N	D5170C00002-9bad9f56-8319-11eb-be00-599acae0cec3-6509	\N	NEW	\N	\N	\N	\N
83521	79	D5170C00002/tiny.path.1/file-2131.msg	\N	D5170C00002-9bae69ec-8316-11eb-be00-d78e43081c40-2131	\N	NEW	\N	\N	\N	\N
82133	79	D5170C00002/tiny.path.1/file-0743.pdf	\N	D5170C00002-9baf7060-8315-11eb-be00-2b33b0c7a79e-743	\N	NEW	\N	\N	\N	\N
83522	79	D5170C00002/tiny.path.1/file-2132.msg	\N	D5170C00002-9bbe6f7d-8316-11eb-be00-ef17195a1cfb-2132	\N	NEW	\N	\N	\N	\N
85054	79	D5170C00002/tiny.path.1/file-3664.pdf	\N	D5170C00002-9bcafd29-8317-11eb-be00-7b64e37e050d-3664	\N	NEW	\N	\N	\N	\N
87900	79	D5170C00002/tiny.path.1/file-6510.pdf	\N	D5170C00002-9bdc0257-8319-11eb-be00-3fd6b124c74a-6510	\N	NEW	\N	\N	\N	\N
83523	79	D5170C00002/tiny.path.1/file-2133.msg	\N	D5170C00002-9bdc099e-8316-11eb-be00-030d8b93a743-2133	\N	NEW	\N	\N	\N	\N
82134	79	D5170C00002/tiny.path.1/file-0744.pdf	\N	D5170C00002-9beb67f1-8315-11eb-be00-d5e9c98e8d77-744	\N	NEW	\N	\N	\N	\N
87901	79	D5170C00002/tiny.path.1/file-6511.pdf	\N	D5170C00002-9beb92b8-8319-11eb-be00-2d9e1fa89b0d-6511	\N	NEW	\N	\N	\N	\N
85055	79	D5170C00002/tiny.path.1/file-3665.pdf	\N	D5170C00002-9bf9fc6a-8317-11eb-be00-a1711d63a29e-3665	\N	NEW	\N	\N	\N	\N
83524	79	D5170C00002/tiny.path.1/file-2134.msg	\N	D5170C00002-9bfb034f-8316-11eb-be00-e1bcbf255584-2134	\N	NEW	\N	\N	\N	\N
82135	79	D5170C00002/tiny.path.1/file-0745.pdf	\N	D5170C00002-9c083ec2-8315-11eb-be00-ffae1dac7f07-745	\N	NEW	\N	\N	\N	\N
87902	79	D5170C00002/tiny.path.1/file-6512.pdf	\N	D5170C00002-9c0a6559-8319-11eb-be00-e7021e9ed7a9-6512	\N	NEW	\N	\N	\N	\N
85056	79	D5170C00002/tiny.path.1/file-3666.pdf	\N	D5170C00002-9c18a7fb-8317-11eb-be00-01aa360b5dfa-3666	\N	NEW	\N	\N	\N	\N
87903	79	D5170C00002/tiny.path.1/file-6513.pdf	\N	D5170C00002-9c35e22a-8319-11eb-be00-458cb2a6a957-6513	\N	NEW	\N	\N	\N	\N
82136	79	D5170C00002/tiny.path.1/file-0746.pdf	\N	D5170C00002-9c3653a3-8315-11eb-be00-89822c7a274a-746	\N	NEW	\N	\N	\N	\N
83525	79	D5170C00002/tiny.path.1/file-2135.pdf	\N	D5170C00002-9c452bb0-8316-11eb-be00-47041182f650-2135	\N	NEW	\N	\N	\N	\N
87904	79	D5170C00002/tiny.path.1/file-6514.pdf	\N	D5170C00002-9c53f17b-8319-11eb-be00-b7c08c0e5e2b-6514	\N	NEW	\N	\N	\N	\N
85057	79	D5170C00002/tiny.path.1/file-3667.pdf	\N	D5170C00002-9c54516c-8317-11eb-be00-33e5adbb9423-3667	\N	NEW	\N	\N	\N	\N
86465	79	D5170C00002/tiny.path.1/file-5075.pdf	\N	D5170C00002-9c56313c-8318-11eb-be00-d92b02dff4a2-5075	\N	NEW	\N	\N	\N	\N
85058	79	D5170C00002/tiny.path.1/file-3668.pdf	\N	D5170C00002-9c65415d-8317-11eb-be00-ff62b70635fc-3668	\N	NEW	\N	\N	\N	\N
87905	79	D5170C00002/tiny.path.1/file-6515.pdf	\N	D5170C00002-9c724eec-8319-11eb-be00-cd3514014560-6515	\N	NEW	\N	\N	\N	\N
82137	79	D5170C00002/tiny.path.1/file-0747.pdf	\N	D5170C00002-9c82c5f4-8315-11eb-be00-c54038f896db-747	\N	NEW	\N	\N	\N	\N
86466	79	D5170C00002/tiny.path.1/file-5076.pdf	\N	D5170C00002-9c84461d-8318-11eb-be00-ed5a3b158f29-5076	\N	NEW	\N	\N	\N	\N
87906	79	D5170C00002/tiny.path.1/file-6516.pdf	\N	D5170C00002-9c9232fd-8319-11eb-be00-97adf2aea32c-6516	\N	NEW	\N	\N	\N	\N
85059	79	D5170C00002/tiny.path.1/file-3669.pdf	\N	D5170C00002-9ca09cae-8317-11eb-be00-2557778d71fb-3669	\N	NEW	\N	\N	\N	\N
87907	79	D5170C00002/tiny.path.1/file-6517.pdf	\N	D5170C00002-9ca1000e-8319-11eb-be00-bb05e39b9441-6517	\N	NEW	\N	\N	\N	\N
87908	79	D5170C00002/tiny.path.1/file-6518.pdf	\N	D5170C00002-9cb0424f-8319-11eb-be00-577118faa6dd-6518	\N	NEW	\N	\N	\N	\N
83526	79	D5170C00002/tiny.path.1/file-2136.pdf	\N	D5170C00002-9cb133f1-8316-11eb-be00-e7fee7df48aa-2136	\N	NEW	\N	\N	\N	\N
85060	79	D5170C00002/tiny.path.1/file-3670.xlsx	\N	D5170C00002-9cc080bf-8317-11eb-be00-ad5c3cb7c5a2-3670	\N	NEW	\N	\N	\N	\N
87909	79	D5170C00002/tiny.path.1/file-6519.pdf	\N	D5170C00002-9cc09600-8319-11eb-be00-5524a4f7bce7-6519	\N	NEW	\N	\N	\N	\N
87910	79	D5170C00002/tiny.path.1/file-6520.pdf	\N	D5170C00002-9ccf8a21-8319-11eb-be00-599d587f200b-6520	\N	NEW	\N	\N	\N	\N
83527	79	D5170C00002/tiny.path.1/file-2137.pdf	\N	D5170C00002-9ccfdf82-8316-11eb-be00-f3003e3ec60d-2137	\N	NEW	\N	\N	\N	\N
82138	79	D5170C00002/tiny.path.1/file-0748.pdf	\N	D5170C00002-9cd022a5-8315-11eb-be00-59918cbd01a5-748	\N	NEW	\N	\N	\N	\N
85061	79	D5170C00002/tiny.path.1/file-3671.xlsx	\N	D5170C00002-9cdd5790-8317-11eb-be00-f5333aa6003b-3671	\N	NEW	\N	\N	\N	\N
87911	79	D5170C00002/tiny.path.1/file-6521.pdf	\N	D5170C00002-9cddbaf2-8319-11eb-be00-cb5927343d62-6521	\N	NEW	\N	\N	\N	\N
83528	79	D5170C00002/tiny.path.1/file-2138.pdf	\N	D5170C00002-9cdefab3-8316-11eb-be00-85d0828c2cca-2138	\N	NEW	\N	\N	\N	\N
82139	79	D5170C00002/tiny.path.1/file-0749.pdf	\N	D5170C00002-9cecd266-8315-11eb-be00-1d41bccacee9-749	\N	NEW	\N	\N	\N	\N
87912	79	D5170C00002/tiny.path.1/file-6522.pdf	\N	D5170C00002-9cecfd33-8319-11eb-be00-9f1d7c80d3f0-6522	\N	NEW	\N	\N	\N	\N
86467	79	D5170C00002/tiny.path.1/file-5077.pdf	\N	D5170C00002-9cfbc00e-8318-11eb-be00-dfa5fc454dbe-5077	\N	NEW	\N	\N	\N	\N
83529	79	D5170C00002/tiny.path.1/file-2139.pdf	\N	D5170C00002-9cfbf894-8316-11eb-be00-111232913edc-2139	\N	NEW	\N	\N	\N	\N
82140	79	D5170C00002/tiny.path.1/file-0750.pdf	\N	D5170C00002-9cfc89d7-8315-11eb-be00-f971ddbb10d7-750	\N	NEW	\N	\N	\N	\N
82141	79	D5170C00002/tiny.path.1/file-0751.pdf	\N	D5170C00002-9cfefad8-8315-11eb-be00-89685898093b-751	\N	NEW	\N	\N	\N	\N
87913	79	D5170C00002/tiny.path.1/file-6523.pdf	\N	D5170C00002-9d0bf6e4-8319-11eb-be00-6bd0f4576982-6523	\N	NEW	\N	\N	\N	\N
85062	79	D5170C00002/tiny.path.1/file-3672.pdf	\N	D5170C00002-9d0e2b91-8317-11eb-be00-ef4a2255d3a9-3672	\N	NEW	\N	\N	\N	\N
86468	79	D5170C00002/tiny.path.1/file-5078.pdf	\N	D5170C00002-9d0e369f-8318-11eb-be00-63643ad3b801-5078	\N	NEW	\N	\N	\N	\N
82142	79	D5170C00002/tiny.path.1/file-0752.pdf	\N	D5170C00002-9d0e3d19-8315-11eb-be00-9f10f5cb6cd6-752	\N	NEW	\N	\N	\N	\N
87914	79	D5170C00002/tiny.path.1/file-6524.pdf	\N	D5170C00002-9d2942e5-8319-11eb-be00-61bda7bc70b4-6524	\N	NEW	\N	\N	\N	\N
87915	79	D5170C00002/tiny.path.1/file-6525.pdf	\N	D5170C00002-9d392166-8319-11eb-be00-2fb968cc1b14-6525	\N	NEW	\N	\N	\N	\N
85063	79	D5170C00002/tiny.path.1/file-3673.pdf	\N	D5170C00002-9d3ae0e2-8317-11eb-be00-f7204a9ba340-3673	\N	NEW	\N	\N	\N	\N
87916	79	D5170C00002/tiny.path.1/file-6526.pdf	\N	D5170C00002-9d481587-8319-11eb-be00-61f83bb1a41e-6526	\N	NEW	\N	\N	\N	\N
87917	79	D5170C00002/tiny.path.1/file-6527.pdf	\N	D5170C00002-9d5730b8-8319-11eb-be00-b9435883d807-6527	\N	NEW	\N	\N	\N	\N
86469	79	D5170C00002/tiny.path.1/file-5079.pdf	\N	D5170C00002-9d579ab0-8318-11eb-be00-fffd639ca2a8-5079	\N	NEW	\N	\N	\N	\N
85064	79	D5170C00002/tiny.path.1/file-3674.pdf	\N	D5170C00002-9d5a28b3-8317-11eb-be00-6dbd53cfce68-3674	\N	NEW	\N	\N	\N	\N
87918	79	D5170C00002/tiny.path.1/file-6528.pdf	\N	D5170C00002-9d675d59-8319-11eb-be00-f33414d09a7b-6528	\N	NEW	\N	\N	\N	\N
82143	79	D5170C00002/tiny.path.1/file-0753.pdf	\N	D5170C00002-9d764dba-8315-11eb-be00-e193a2a2c981-753	\N	NEW	\N	\N	\N	\N
85065	79	D5170C00002/tiny.path.1/file-3675.pdf	\N	D5170C00002-9d78d444-8317-11eb-be00-d1da2ec2e07f-3675	\N	NEW	\N	\N	\N	\N
87919	79	D5170C00002/tiny.path.1/file-6529.pdf	\N	D5170C00002-9d86570a-8319-11eb-be00-a375bcf86116-6529	\N	NEW	\N	\N	\N	\N
85066	79	D5170C00002/tiny.path.1/file-3676.pdf	\N	D5170C00002-9d8864a5-8317-11eb-be00-310e3b81f996-3676	\N	NEW	\N	\N	\N	\N
82144	79	D5170C00002/tiny.path.1/file-0754.pdf	\N	D5170C00002-9d95476b-8315-11eb-be00-03cc04bfd476-754	\N	NEW	\N	\N	\N	\N
85067	79	D5170C00002/tiny.path.1/file-3677.pdf	\N	D5170C00002-9da51466-8317-11eb-be00-15c2220f7836-3677	\N	NEW	\N	\N	\N	\N
87920	79	D5170C00002/tiny.path.1/file-6530.pdf	\N	D5170C00002-9da5c5eb-8319-11eb-be00-5983a145da5e-6530	\N	NEW	\N	\N	\N	\N
82145	79	D5170C00002/tiny.path.1/file-0755.pdf	\N	D5170C00002-9da6d39c-8315-11eb-be00-0d646451451b-755	\N	NEW	\N	\N	\N	\N
82146	79	D5170C00002/tiny.path.1/file-0756.pdf	\N	D5170C00002-9dc3353d-8315-11eb-be00-f7ea90870e66-756	\N	NEW	\N	\N	\N	\N
85068	79	D5170C00002/tiny.path.1/file-3678.pdf	\N	D5170C00002-9dc54697-8317-11eb-be00-7919d564436b-3678	\N	NEW	\N	\N	\N	\N
87921	79	D5170C00002/tiny.path.1/file-6531.pdf	\N	D5170C00002-9dd169cc-8319-11eb-be00-8533e4e742c5-6531	\N	NEW	\N	\N	\N	\N
83530	79	D5170C00002/tiny.path.1/file-2140.pdf	\N	D5170C00002-9dd4a555-8316-11eb-be00-47de7fc017d0-2140	\N	NEW	\N	\N	\N	\N
87922	79	D5170C00002/tiny.path.1/file-6532.pdf	\N	D5170C00002-9de1966d-8319-11eb-be00-89fa7275a6e7-6532	\N	NEW	\N	\N	\N	\N
87923	79	D5170C00002/tiny.path.1/file-6533.pdf	\N	D5170C00002-9df2383e-8319-11eb-be00-23af586e3b08-6533	\N	NEW	\N	\N	\N	\N
87924	79	D5170C00002/tiny.path.1/file-6534.pdf	\N	D5170C00002-9e0f5d2f-8319-11eb-be00-0b02b32c0861-6534	\N	NEW	\N	\N	\N	\N
82147	79	D5170C00002/tiny.path.1/file-0757.pdf	\N	D5170C00002-9e1e4d8e-8315-11eb-be00-d3da683a41b2-757	\N	NEW	\N	\N	\N	\N
85069	79	D5170C00002/tiny.path.1/file-3679.pdf	\N	D5170C00002-9e3e2018-8317-11eb-be00-61e6e662df53-3679	\N	NEW	\N	\N	\N	\N
83531	79	D5170C00002/tiny.path.1/file-2141.pdf	\N	D5170C00002-9e3e8ab6-8316-11eb-be00-e51741ed45dc-2141	\N	NEW	\N	\N	\N	\N
87925	79	D5170C00002/tiny.path.1/file-6535.pdf	\N	D5170C00002-9e4c8d40-8319-11eb-be00-c5a2dbb50189-6535	\N	NEW	\N	\N	\N	\N
85070	79	D5170C00002/tiny.path.1/file-3680.pdf	\N	D5170C00002-9e5c5679-8317-11eb-be00-69ba9affe956-3680	\N	NEW	\N	\N	\N	\N
86470	79	D5170C00002/tiny.path.1/file-5080.xlsx	\N	D5170C00002-9e5c8791-8318-11eb-be00-456a9b913aed-5080	\N	NEW	\N	\N	\N	\N
87926	79	D5170C00002/tiny.path.1/file-6536.pdf	\N	D5170C00002-9e6bd511-8319-11eb-be00-793aa5f80a3b-6536	\N	NEW	\N	\N	\N	\N
83532	79	D5170C00002/tiny.path.1/file-2142.pdf	\N	D5170C00002-9e6c7887-8316-11eb-be00-cd022c7f5b09-2142	\N	NEW	\N	\N	\N	\N
82148	79	D5170C00002/tiny.path.1/file-0758.pdf	\N	D5170C00002-9e6dcd1f-8315-11eb-be00-a59e7d8b6465-758	\N	NEW	\N	\N	\N	\N
85071	79	D5170C00002/tiny.path.1/file-3681.pdf	\N	D5170C00002-9e79a27a-8317-11eb-be00-07feab97e6cb-3681	\N	NEW	\N	\N	\N	\N
87927	79	D5170C00002/tiny.path.1/file-6537.pdf	\N	D5170C00002-9e7bdaa2-8319-11eb-be00-f93ea68907c8-6537	\N	NEW	\N	\N	\N	\N
85072	79	D5170C00002/tiny.path.1/file-3682.pdf	\N	D5170C00002-9e8a444b-8317-11eb-be00-c1e4bc37df7e-3682	\N	NEW	\N	\N	\N	\N
87928	79	D5170C00002/tiny.path.1/file-6538.pdf	\N	D5170C00002-9eb735f3-8319-11eb-be00-21400e056a1f-6538	\N	NEW	\N	\N	\N	\N
85073	79	D5170C00002/tiny.path.1/file-3683.pdf	\N	D5170C00002-9ec7745c-8317-11eb-be00-cd8642aff0ba-3683	\N	NEW	\N	\N	\N	\N
82149	79	D5170C00002/tiny.path.1/file-0759.pdf	\N	D5170C00002-9ed62be0-8315-11eb-be00-3d8059156d01-759	\N	NEW	\N	\N	\N	\N
87929	79	D5170C00002/tiny.path.1/file-6539.pdf	\N	D5170C00002-9ee571e4-8319-11eb-be00-0f45f9bcbba8-6539	\N	NEW	\N	\N	\N	\N
85074	79	D5170C00002/tiny.path.1/file-3684.pdf	\N	D5170C00002-9ee5f8dd-8317-11eb-be00-414964afeb56-3684	\N	NEW	\N	\N	\N	\N
83533	79	D5170C00002/tiny.path.1/file-2143.pdf	\N	D5170C00002-9ee66378-8316-11eb-be00-83040dc60e17-2143	\N	NEW	\N	\N	\N	\N
85075	79	D5170C00002/tiny.path.1/file-3685.pdf	\N	D5170C00002-9ef38d6e-8317-11eb-be00-cbe2ddd4d0e7-3685	\N	NEW	\N	\N	\N	\N
82150	79	D5170C00002/tiny.path.1/file-0760.pdf	\N	D5170C00002-9ef65e11-8315-11eb-be00-d1809d75f39f-760	\N	NEW	\N	\N	\N	\N
85076	79	D5170C00002/tiny.path.1/file-3686.pdf	\N	D5170C00002-9f031dcf-8317-11eb-be00-c3ea6fa487f5-3686	\N	NEW	\N	\N	\N	\N
87930	79	D5170C00002/tiny.path.1/file-6540.pdf	\N	D5170C00002-9f1338a5-8319-11eb-be00-d1b79120a890-6540	\N	NEW	\N	\N	\N	\N
82151	79	D5170C00002/tiny.path.1/file-0761.pdf	\N	D5170C00002-9f238892-8315-11eb-be00-9b26c0782356-761	\N	NEW	\N	\N	\N	\N
85077	79	D5170C00002/tiny.path.1/file-3687.pdf	\N	D5170C00002-9f309670-8317-11eb-be00-5b698706e858-3687	\N	NEW	\N	\N	\N	\N
87931	79	D5170C00002/tiny.path.1/file-6541.pdf	\N	D5170C00002-9f3120e6-8319-11eb-be00-51eda1487ed1-6541	\N	NEW	\N	\N	\N	\N
83534	79	D5170C00002/tiny.path.1/file-2144.pdf	\N	D5170C00002-9f321279-8316-11eb-be00-852fe91994d5-2144	\N	NEW	\N	\N	\N	\N
82152	79	D5170C00002/tiny.path.1/file-0762.pdf	\N	D5170C00002-9f405f63-8315-11eb-be00-bdd90b84f15b-762	\N	NEW	\N	\N	\N	\N
87932	79	D5170C00002/tiny.path.1/file-6542.pdf	\N	D5170C00002-9f5068b7-8319-11eb-be00-450622af952f-6542	\N	NEW	\N	\N	\N	\N
85078	79	D5170C00002/tiny.path.1/file-3688.pdf	\N	D5170C00002-9f5eab51-8317-11eb-be00-0f4719c61912-3688	\N	NEW	\N	\N	\N	\N
87933	79	D5170C00002/tiny.path.1/file-6543.pdf	\N	D5170C00002-9f6d1878-8319-11eb-be00-f90da1b00d97-6543	\N	NEW	\N	\N	\N	\N
85079	79	D5170C00002/tiny.path.1/file-3689.pdf	\N	D5170C00002-9f6ded92-8317-11eb-be00-3506766c3f2a-3689	\N	NEW	\N	\N	\N	\N
87934	79	D5170C00002/tiny.path.1/file-6544.pdf	\N	D5170C00002-9f7d1e09-8319-11eb-be00-75ae006d9ab3-6544	\N	NEW	\N	\N	\N	\N
85080	79	D5170C00002/tiny.path.1/file-3690.pdf	\N	D5170C00002-9f7e8f63-8317-11eb-be00-9d2d599d700a-3690	\N	NEW	\N	\N	\N	\N
83535	79	D5170C00002/tiny.path.1/file-2145.pdf	\N	D5170C00002-9f7ed2ea-8316-11eb-be00-2b10dc9d8a5f-2145	\N	NEW	\N	\N	\N	\N
86471	79	D5170C00002/tiny.path.1/file-5081.xlsx	\N	D5170C00002-9f8d6672-8318-11eb-be00-8b9434537500-5081	\N	NEW	\N	\N	\N	\N
82153	79	D5170C00002/tiny.path.1/file-0763.pdf	\N	D5170C00002-9f8d6df4-8315-11eb-be00-0f2e6e3108de-763	\N	NEW	\N	\N	\N	\N
85081	79	D5170C00002/tiny.path.1/file-3691.pdf	\N	D5170C00002-9f9dd734-8317-11eb-be00-1df2396de5f4-3691	\N	NEW	\N	\N	\N	\N
87935	79	D5170C00002/tiny.path.1/file-6545.pdf	\N	D5170C00002-9faba81a-8319-11eb-be00-13f0ed616e4f-6545	\N	NEW	\N	\N	\N	\N
82154	79	D5170C00002/tiny.path.1/file-0764.pdf	\N	D5170C00002-9fad2af5-8315-11eb-be00-4140e15343a8-764	\N	NEW	\N	\N	\N	\N
85082	79	D5170C00002/tiny.path.1/file-3692.pdf	\N	D5170C00002-9fba86f5-8317-11eb-be00-afa6e20e8532-3692	\N	NEW	\N	\N	\N	\N
87936	79	D5170C00002/tiny.path.1/file-6546.pdf	\N	D5170C00002-9fc87eeb-8319-11eb-be00-4b7825da131d-6546	\N	NEW	\N	\N	\N	\N
82155	79	D5170C00002/tiny.path.1/file-0765.pdf	\N	D5170C00002-9fcb3a46-8315-11eb-be00-d7a15375c3ac-765	\N	NEW	\N	\N	\N	\N
85083	79	D5170C00002/tiny.path.1/file-3693.pdf	\N	D5170C00002-9fdb5566-8317-11eb-be00-4d2cf5a95fa1-3693	\N	NEW	\N	\N	\N	\N
87937	79	D5170C00002/tiny.path.1/file-6547.pdf	\N	D5170C00002-9fe83bec-8319-11eb-be00-6bc7df876726-6547	\N	NEW	\N	\N	\N	\N
82156	79	D5170C00002/tiny.path.1/file-0766.pdf	\N	D5170C00002-a0089167-8315-11eb-be00-4bba195d261a-766	\N	NEW	\N	\N	\N	\N
85084	79	D5170C00002/tiny.path.1/file-3694.pdf	\N	D5170C00002-a0250897-8317-11eb-be00-35956b041609-3694	\N	NEW	\N	\N	\N	\N
82157	79	D5170C00002/tiny.path.1/file-0767.pdf	\N	D5170C00002-a034d188-8315-11eb-be00-1b804484cc98-767	\N	NEW	\N	\N	\N	\N
85085	79	D5170C00002/tiny.path.1/file-3695.pdf	\N	D5170C00002-a0353538-8317-11eb-be00-23bfb969dd58-3695	\N	NEW	\N	\N	\N	\N
85086	79	D5170C00002/tiny.path.1/file-3696.pdf	\N	D5170C00002-a035f889-8317-11eb-be00-c3dd431d4944-3696	\N	NEW	\N	\N	\N	\N
85087	79	D5170C00002/tiny.path.1/file-3697.pdf	\N	D5170C00002-a0438d1a-8317-11eb-be00-a1fbb1d88064-3697	\N	NEW	\N	\N	\N	\N
83536	79	D5170C00002/tiny.path.1/file-2146.pdf	\N	D5170C00002-a0529dab-8316-11eb-be00-e7e365031f8f-2146	\N	NEW	\N	\N	\N	\N
85088	79	D5170C00002/tiny.path.1/file-3698.pdf	\N	D5170C00002-a052f66b-8317-11eb-be00-bb9ef7506c94-3698	\N	NEW	\N	\N	\N	\N
87938	79	D5170C00002/tiny.path.1/file-6548.pdf	\N	D5170C00002-a0541d1d-8319-11eb-be00-e91de9bd0130-6548	\N	NEW	\N	\N	\N	\N
85089	79	D5170C00002/tiny.path.1/file-3699.pdf	\N	D5170C00002-a0542eec-8317-11eb-be00-9dbcd850b9be-3699	\N	NEW	\N	\N	\N	\N
82158	79	D5170C00002/tiny.path.1/file-0768.pdf	\N	D5170C00002-a054b599-8315-11eb-be00-ad3a06e18dc7-768	\N	NEW	\N	\N	\N	\N
85090	79	D5170C00002/tiny.path.1/file-3700.pdf	\N	D5170C00002-a055194d-8317-11eb-be00-e7d0d3e877f8-3700	\N	NEW	\N	\N	\N	\N
83537	79	D5170C00002/tiny.path.1/file-2147.pdf	\N	D5170C00002-a063668c-8316-11eb-be00-eb25e15a6da9-2147	\N	NEW	\N	\N	\N	\N
85091	79	D5170C00002/tiny.path.1/file-3701.pdf	\N	D5170C00002-a0645b8e-8317-11eb-be00-5720d51373f2-3701	\N	NEW	\N	\N	\N	\N
87939	79	D5170C00002/tiny.path.1/file-6549.xlsx	\N	D5170C00002-a0707ebe-8319-11eb-be00-ef126efa62d7-6549	\N	NEW	\N	\N	\N	\N
83538	79	D5170C00002/tiny.path.1/file-2148.pdf	\N	D5170C00002-a0808b7d-8316-11eb-be00-3f10c44d571a-2148	\N	NEW	\N	\N	\N	\N
82159	79	D5170C00002/tiny.path.1/file-0769.pdf	\N	D5170C00002-a080f5ba-8315-11eb-be00-81f153e78887-769	\N	NEW	\N	\N	\N	\N
85092	79	D5170C00002/tiny.path.1/file-3702.pdf	\N	D5170C00002-a0810b4f-8317-11eb-be00-a1f270679ec7-3702	\N	NEW	\N	\N	\N	\N
86472	79	D5170C00002/tiny.path.1/file-5082.xlsx	\N	D5170C00002-a081b183-8318-11eb-be00-57a80c20899a-5082	\N	NEW	\N	\N	\N	\N
87940	79	D5170C00002/tiny.path.1/file-6550.pdf	\N	D5170C00002-a09e457f-8319-11eb-be00-691478ddaaf3-6550	\N	NEW	\N	\N	\N	\N
83539	79	D5170C00002/tiny.path.1/file-2149.pdf	\N	D5170C00002-a0a0bdae-8316-11eb-be00-093e699c3805-2149	\N	NEW	\N	\N	\N	\N
85093	79	D5170C00002/tiny.path.1/file-3703.pdf	\N	D5170C00002-a0a13d80-8317-11eb-be00-4d681a99635c-3703	\N	NEW	\N	\N	\N	\N
87941	79	D5170C00002/tiny.path.1/file-6551.pdf	\N	D5170C00002-a0bcf110-8319-11eb-be00-e1515988e042-6551	\N	NEW	\N	\N	\N	\N
83540	79	D5170C00002/tiny.path.1/file-2150.pdf	\N	D5170C00002-a0bf693f-8316-11eb-be00-6b009c729013-2150	\N	NEW	\N	\N	\N	\N
85094	79	D5170C00002/tiny.path.1/file-3704.pdf	\N	D5170C00002-a0c03731-8317-11eb-be00-337cf39b6d1c-3704	\N	NEW	\N	\N	\N	\N
87942	79	D5170C00002/tiny.path.1/file-6552.pdf	\N	D5170C00002-a0cca881-8319-11eb-be00-a7edb2cc5cc9-6552	\N	NEW	\N	\N	\N	\N
82160	79	D5170C00002/tiny.path.1/file-0770.pdf	\N	D5170C00002-a0cddd3b-8315-11eb-be00-612defdefb3f-770	\N	NEW	\N	\N	\N	\N
86473	79	D5170C00002/tiny.path.1/file-5083.pdf	\N	D5170C00002-a0cdfcc4-8318-11eb-be00-0112493505b4-5083	\N	NEW	\N	\N	\N	\N
85095	79	D5170C00002/tiny.path.1/file-3705.pdf	\N	D5170C00002-a0de1f72-8317-11eb-be00-1f5b26c65771-3705	\N	NEW	\N	\N	\N	\N
83541	79	D5170C00002/tiny.path.1/file-2151.pdf	\N	D5170C00002-a0eb5b40-8316-11eb-be00-1b6d9aa635eb-2151	\N	NEW	\N	\N	\N	\N
87943	79	D5170C00002/tiny.path.1/file-6553.pdf	\N	D5170C00002-a0ec1762-8319-11eb-be00-d99a7c94b7ea-6553	\N	NEW	\N	\N	\N	\N
87944	79	D5170C00002/tiny.path.1/file-6554.pdf	\N	D5170C00002-a0fba7c3-8319-11eb-be00-e75975b7f9bd-6554	\N	NEW	\N	\N	\N	\N
86474	79	D5170C00002/tiny.path.1/file-5084.pdf	\N	D5170C00002-a0fc11a5-8318-11eb-be00-973799069382-5084	\N	NEW	\N	\N	\N	\N
82161	79	D5170C00002/tiny.path.1/file-0771.pdf	\N	D5170C00002-a0fd78bc-8315-11eb-be00-fb300c3b3d17-771	\N	NEW	\N	\N	\N	\N
83542	79	D5170C00002/tiny.path.1/file-2152.pdf	\N	D5170C00002-a10af131-8316-11eb-be00-413c80476056-2152	\N	NEW	\N	\N	\N	\N
85096	79	D5170C00002/tiny.path.1/file-3706.pdf	\N	D5170C00002-a10c3453-8317-11eb-be00-cf6b3d2b5ad4-3706	\N	NEW	\N	\N	\N	\N
87945	79	D5170C00002/tiny.path.1/file-6555.pdf	\N	D5170C00002-a11aef94-8319-11eb-be00-2bda275af06b-6555	\N	NEW	\N	\N	\N	\N
83543	79	D5170C00002/tiny.path.1/file-2153.pdf	\N	D5170C00002-a11af6c2-8316-11eb-be00-f1722aacb944-2153	\N	NEW	\N	\N	\N	\N
82162	79	D5170C00002/tiny.path.1/file-0772.pdf	\N	D5170C00002-a11c244d-8315-11eb-be00-01e141031aab-772	\N	NEW	\N	\N	\N	\N
83544	79	D5170C00002/tiny.path.1/file-2154.pdf	\N	D5170C00002-a137a683-8316-11eb-be00-e36ed0c11ba8-2154	\N	NEW	\N	\N	\N	\N
83545	79	D5170C00002/tiny.path.1/file-2155.pdf	\N	D5170C00002-a13a1784-8316-11eb-be00-5fac9be375ac-2155	\N	NEW	\N	\N	\N	\N
85097	79	D5170C00002/tiny.path.1/file-3707.pdf	\N	D5170C00002-a13a4934-8317-11eb-be00-d5920fa036f2-3707	\N	NEW	\N	\N	\N	\N
83546	79	D5170C00002/tiny.path.1/file-2156.pdf	\N	D5170C00002-a147fa35-8316-11eb-be00-dff62e139239-2156	\N	NEW	\N	\N	\N	\N
82163	79	D5170C00002/tiny.path.1/file-0773.pdf	\N	D5170C00002-a148646e-8315-11eb-be00-9391cb735e9a-773	\N	NEW	\N	\N	\N	\N
85098	79	D5170C00002/tiny.path.1/file-3708.pdf	\N	D5170C00002-a1579535-8317-11eb-be00-3327ce2cccb9-3708	\N	NEW	\N	\N	\N	\N
82164	79	D5170C00002/tiny.path.1/file-0774.pdf	\N	D5170C00002-a1581bdf-8315-11eb-be00-e37b54d9bc3a-774	\N	NEW	\N	\N	\N	\N
83547	79	D5170C00002/tiny.path.1/file-2157.pdf	\N	D5170C00002-a165e276-8316-11eb-be00-edbdb143008d-2157	\N	NEW	\N	\N	\N	\N
87946	79	D5170C00002/tiny.path.1/file-6556.pdf	\N	D5170C00002-a1665075-8319-11eb-be00-d9dd95452934-6556	\N	NEW	\N	\N	\N	\N
85099	79	D5170C00002/tiny.path.1/file-3709.pdf	\N	D5170C00002-a1752f56-8317-11eb-be00-d3db2b93ea0d-3709	\N	NEW	\N	\N	\N	\N
82165	79	D5170C00002/tiny.path.1/file-0775.pdf	\N	D5170C00002-a1767950-8315-11eb-be00-071108dc808f-775	\N	NEW	\N	\N	\N	\N
83548	79	D5170C00002/tiny.path.1/file-2158.pdf	\N	D5170C00002-a18466f7-8316-11eb-be00-f5a8879f1e99-2158	\N	NEW	\N	\N	\N	\N
87947	79	D5170C00002/tiny.path.1/file-6557.pdf	\N	D5170C00002-a185e666-8319-11eb-be00-3f15a148375a-6557	\N	NEW	\N	\N	\N	\N
82166	79	D5170C00002/tiny.path.1/file-0776.pdf	\N	D5170C00002-a1941371-8315-11eb-be00-2d3e61f90b19-776	\N	NEW	\N	\N	\N	\N
86475	79	D5170C00002/tiny.path.1/file-5085.xlsx	\N	D5170C00002-a1945a06-8318-11eb-be00-91181a5d55bd-5085	\N	NEW	\N	\N	\N	\N
83549	79	D5170C00002/tiny.path.1/file-2159.pdf	\N	D5170C00002-a1a387b8-8316-11eb-be00-59fe311a7233-2159	\N	NEW	\N	\N	\N	\N
87948	79	D5170C00002/tiny.path.1/file-6558.pdf	\N	D5170C00002-a1b13c27-8319-11eb-be00-17030b171421-6558	\N	NEW	\N	\N	\N	\N
85100	79	D5170C00002/tiny.path.1/file-3710.pdf	\N	D5170C00002-a1b28677-8317-11eb-be00-395a1f12bb10-3710	\N	NEW	\N	\N	\N	\N
85101	79	D5170C00002/tiny.path.1/file-3711.pdf	\N	D5170C00002-a1b48248-8317-11eb-be00-cb6fe5eb86f7-3711	\N	NEW	\N	\N	\N	\N
86476	79	D5170C00002/tiny.path.1/file-5086.xlsx	\N	D5170C00002-a1b79977-8318-11eb-be00-41307bdd3405-5086	\N	NEW	\N	\N	\N	\N
82167	79	D5170C00002/tiny.path.1/file-0777.pdf	\N	D5170C00002-a1c16502-8315-11eb-be00-75af85fe149a-777	\N	NEW	\N	\N	\N	\N
85102	79	D5170C00002/tiny.path.1/file-3712.pdf	\N	D5170C00002-a1cfd279-8317-11eb-be00-cb02dc34479e-3712	\N	NEW	\N	\N	\N	\N
83550	79	D5170C00002/tiny.path.1/file-2160.pdf	\N	D5170C00002-a1d03d09-8316-11eb-be00-e3ecf52e4609-2160	\N	NEW	\N	\N	\N	\N
82168	79	D5170C00002/tiny.path.1/file-0778.pdf	\N	D5170C00002-a1d08033-8315-11eb-be00-e7ae2ea7bef4-778	\N	NEW	\N	\N	\N	\N
83551	79	D5170C00002/tiny.path.1/file-2161.pdf	\N	D5170C00002-a1dfcd6a-8316-11eb-be00-e57cd89fe9cc-2161	\N	NEW	\N	\N	\N	\N
82169	79	D5170C00002/tiny.path.1/file-0779.pdf	\N	D5170C00002-a1e037a4-8315-11eb-be00-f18a060415be-779	\N	NEW	\N	\N	\N	\N
87949	79	D5170C00002/tiny.path.1/file-6559.pdf	\N	D5170C00002-a1e06278-8319-11eb-be00-93355cdd31f7-6559	\N	NEW	\N	\N	\N	\N
83552	79	D5170C00002/tiny.path.1/file-2162.pdf	\N	D5170C00002-a1e1a22b-8316-11eb-be00-51e1cedde643-2162	\N	NEW	\N	\N	\N	\N
82170	79	D5170C00002/tiny.path.1/file-0780.pdf	\N	D5170C00002-a1f03d35-8315-11eb-be00-d77ef999653c-780	\N	NEW	\N	\N	\N	\N
85103	79	D5170C00002/tiny.path.1/file-3713.pdf	\N	D5170C00002-a1f052ca-8317-11eb-be00-1599c04b80e7-3713	\N	NEW	\N	\N	\N	\N
86477	79	D5170C00002/tiny.path.1/file-5087.pdf	\N	D5170C00002-a1f25888-8318-11eb-be00-516206bd8267-5087	\N	NEW	\N	\N	\N	\N
82171	79	D5170C00002/tiny.path.1/file-0781.pdf	\N	D5170C00002-a2001bb6-8315-11eb-be00-2f7af10ae36b-781	\N	NEW	\N	\N	\N	\N
86478	79	D5170C00002/tiny.path.1/file-5088.pdf	\N	D5170C00002-a2006249-8318-11eb-be00-4f1dd5f35101-5088	\N	NEW	\N	\N	\N	\N
86479	79	D5170C00002/tiny.path.1/file-5089.pdf	\N	D5170C00002-a2108eea-8318-11eb-be00-f30049487c81-5089	\N	NEW	\N	\N	\N	\N
87950	79	D5170C00002/tiny.path.1/file-6560.pdf	\N	D5170C00002-a21bbdc9-8319-11eb-be00-01b9835b39ea-6560	\N	NEW	\N	\N	\N	\N
82172	79	D5170C00002/tiny.path.1/file-0782.pdf	\N	D5170C00002-a21cf287-8315-11eb-be00-3947a5cd69fb-782	\N	NEW	\N	\N	\N	\N
86480	79	D5170C00002/tiny.path.1/file-5090.pdf	\N	D5170C00002-a21dd55b-8318-11eb-be00-eb067c987284-5090	\N	NEW	\N	\N	\N	\N
86481	79	D5170C00002/tiny.path.1/file-5091.pdf	\N	D5170C00002-a222b75c-8318-11eb-be00-2f94fc1ac3f9-5091	\N	NEW	\N	\N	\N	\N
82173	79	D5170C00002/tiny.path.1/file-0783.pdf	\N	D5170C00002-a22bbf98-8315-11eb-be00-73010133214d-783	\N	NEW	\N	\N	\N	\N
85104	79	D5170C00002/tiny.path.1/file-3714.pdf	\N	D5170C00002-a22ce69b-8317-11eb-be00-9737fd3d768d-3714	\N	NEW	\N	\N	\N	\N
83553	79	D5170C00002/tiny.path.1/file-2163.pdf	\N	D5170C00002-a23b81fc-8316-11eb-be00-ad0c60672f0b-2163	\N	NEW	\N	\N	\N	\N
82174	79	D5170C00002/tiny.path.1/file-0784.pdf	\N	D5170C00002-a23caf89-8315-11eb-be00-5904d655f648-784	\N	NEW	\N	\N	\N	\N
87951	79	D5170C00002/tiny.path.1/file-6561.pdf	\N	D5170C00002-a249848a-8319-11eb-be00-b91aff764730-6561	\N	NEW	\N	\N	\N	\N
85105	79	D5170C00002/tiny.path.1/file-3715.pdf	\N	D5170C00002-a24bb93c-8317-11eb-be00-5b6e866240ec-3715	\N	NEW	\N	\N	\N	\N
86482	79	D5170C00002/tiny.path.1/file-5092.pdf	\N	D5170C00002-a24d97ed-8318-11eb-be00-f3a8f2e6fb87-5092	\N	NEW	\N	\N	\N	\N
86483	79	D5170C00002/tiny.path.1/file-5093.pdf	\N	D5170C00002-a25befce-8318-11eb-be00-73fd6048d727-5093	\N	NEW	\N	\N	\N	\N
82175	79	D5170C00002/tiny.path.1/file-0785.pdf	\N	D5170C00002-a25c939a-8315-11eb-be00-9dcb4138c5b5-785	\N	NEW	\N	\N	\N	\N
85106	79	D5170C00002/tiny.path.1/file-3716.pdf	\N	D5170C00002-a268900d-8317-11eb-be00-9b01a0104183-3716	\N	NEW	\N	\N	\N	\N
82176	79	D5170C00002/tiny.path.1/file-0786.pdf	\N	D5170C00002-a26b399b-8315-11eb-be00-b903f6fa03c8-786	\N	NEW	\N	\N	\N	\N
87952	79	D5170C00002/tiny.path.1/file-6562.pdf	\N	D5170C00002-a277725b-8319-11eb-be00-19b6cad3e487-6562	\N	NEW	\N	\N	\N	\N
85107	79	D5170C00002/tiny.path.1/file-3717.pdf	\N	D5170C00002-a2786e8e-8317-11eb-be00-6d00853c522c-3717	\N	NEW	\N	\N	\N	\N
82177	79	D5170C00002/tiny.path.1/file-0787.pdf	\N	D5170C00002-a279b88c-8315-11eb-be00-f973f54b5091-787	\N	NEW	\N	\N	\N	\N
82178	79	D5170C00002/tiny.path.1/file-0788.pdf	\N	D5170C00002-a28948ed-8315-11eb-be00-9327a2ef3d31-788	\N	NEW	\N	\N	\N	\N
85108	79	D5170C00002/tiny.path.1/file-3718.pdf	\N	D5170C00002-a289fabf-8317-11eb-be00-3d4eaec6f441-3718	\N	NEW	\N	\N	\N	\N
86484	79	D5170C00002/tiny.path.1/file-5094.pdf	\N	D5170C00002-a28a79df-8318-11eb-be00-c70a11464458-5094	\N	NEW	\N	\N	\N	\N
86485	79	D5170C00002/tiny.path.1/file-5095.pdf	\N	D5170C00002-a2983580-8318-11eb-be00-8121df9366b3-5095	\N	NEW	\N	\N	\N	\N
82179	79	D5170C00002/tiny.path.1/file-0789.pdf	\N	D5170C00002-a298b23e-8315-11eb-be00-fff4f338a694-789	\N	NEW	\N	\N	\N	\N
87953	79	D5170C00002/tiny.path.1/file-6563.pdf	\N	D5170C00002-a2a5120c-8319-11eb-be00-253b49a6a472-6563	\N	NEW	\N	\N	\N	\N
85109	79	D5170C00002/tiny.path.1/file-3719.pdf	\N	D5170C00002-a2a6f8a0-8317-11eb-be00-d7a2b8c91bfd-3719	\N	NEW	\N	\N	\N	\N
83554	79	D5170C00002/tiny.path.1/file-2164.pdf	\N	D5170C00002-a2b545dd-8316-11eb-be00-673d16695dc0-2164	\N	NEW	\N	\N	\N	\N
86486	79	D5170C00002/tiny.path.1/file-5096.pdf	\N	D5170C00002-a2b6e111-8318-11eb-be00-fbdc05dd95dc-5096	\N	NEW	\N	\N	\N	\N
85110	79	D5170C00002/tiny.path.1/file-3720.pdf	\N	D5170C00002-a2b74c51-8317-11eb-be00-e586be14cc89-3720	\N	NEW	\N	\N	\N	\N
87954	79	D5170C00002/tiny.path.1/file-6564.pdf	\N	D5170C00002-a2d4867d-8319-11eb-be00-39efbc1586d0-6564	\N	NEW	\N	\N	\N	\N
83555	79	D5170C00002/tiny.path.1/file-2165.pdf	\N	D5170C00002-a2d550fe-8316-11eb-be00-55c5767b97f6-2165	\N	NEW	\N	\N	\N	\N
86487	79	D5170C00002/tiny.path.1/file-5097.pdf	\N	D5170C00002-a2d5dac2-8318-11eb-be00-77414abecf41-5097	\N	NEW	\N	\N	\N	\N
86488	79	D5170C00002/tiny.path.1/file-5098.pdf	\N	D5170C00002-a2f374e3-8318-11eb-be00-014b17643129-5098	\N	NEW	\N	\N	\N	\N
87955	79	D5170C00002/tiny.path.1/file-6565.pdf	\N	D5170C00002-a300c69e-8319-11eb-be00-1d0a3205cd9e-6565	\N	NEW	\N	\N	\N	\N
85111	79	D5170C00002/tiny.path.1/file-3721.pdf	\N	D5170C00002-a3019bc2-8317-11eb-be00-a93e97a36be4-3721	\N	NEW	\N	\N	\N	\N
86489	79	D5170C00002/tiny.path.1/file-5099.pdf	\N	D5170C00002-a3130ad4-8318-11eb-be00-0145692a0806-5099	\N	NEW	\N	\N	\N	\N
87956	79	D5170C00002/tiny.path.1/file-6566.pdf	\N	D5170C00002-a3216dff-8319-11eb-be00-6972afa1d9d1-6566	\N	NEW	\N	\N	\N	\N
86490	79	D5170C00002/tiny.path.1/file-5100.pdf	\N	D5170C00002-a34d2da5-8318-11eb-be00-7348f89c6e57-5100	\N	NEW	\N	\N	\N	\N
87957	79	D5170C00002/tiny.path.1/file-6567.pdf	\N	D5170C00002-a34ee6a0-8319-11eb-be00-671b0207905b-6567	\N	NEW	\N	\N	\N	\N
85112	79	D5170C00002/tiny.path.1/file-3722.pdf	\N	D5170C00002-a34fbbc3-8317-11eb-be00-bb85f4366664-3722	\N	NEW	\N	\N	\N	\N
87958	79	D5170C00002/tiny.path.1/file-6568.pdf	\N	D5170C00002-a35e01d1-8319-11eb-be00-9396f9d59f7a-6568	\N	NEW	\N	\N	\N	\N
86491	79	D5170C00002/tiny.path.1/file-5101.pdf	\N	D5170C00002-a35e1d96-8318-11eb-be00-b7c7570df7cf-5101	\N	NEW	\N	\N	\N	\N
82180	79	D5170C00002/tiny.path.1/file-0790.pdf	\N	D5170C00002-a35e251f-8315-11eb-be00-9dd2bf4d095e-790	\N	NEW	\N	\N	\N	\N
87959	79	D5170C00002/tiny.path.1/file-6569.pdf	\N	D5170C00002-a37ad8a2-8319-11eb-be00-27d86b88a0b3-6569	\N	NEW	\N	\N	\N	\N
83556	79	D5170C00002/tiny.path.1/file-2166.pdf	\N	D5170C00002-a37b54ff-8316-11eb-be00-b10fb5d41376-2166	\N	NEW	\N	\N	\N	\N
85113	79	D5170C00002/tiny.path.1/file-3723.pdf	\N	D5170C00002-a37c22f4-8317-11eb-be00-339086f91cc6-3723	\N	NEW	\N	\N	\N	\N
86492	79	D5170C00002/tiny.path.1/file-5102.pdf	\N	D5170C00002-a37c7b07-8318-11eb-be00-479d24273367-5102	\N	NEW	\N	\N	\N	\N
87960	79	D5170C00002/tiny.path.1/file-6570.pdf	\N	D5170C00002-a38a1ae3-8319-11eb-be00-c31b4d7083f4-6570	\N	NEW	\N	\N	\N	\N
86493	79	D5170C00002/tiny.path.1/file-5103.pdf	\N	D5170C00002-a39b4da8-8318-11eb-be00-0b250fff1f5b-5103	\N	NEW	\N	\N	\N	\N
83557	79	D5170C00002/tiny.path.1/file-2167.pdf	\N	D5170C00002-a39bfc60-8316-11eb-be00-bb49cb3b2c4d-2167	\N	NEW	\N	\N	\N	\N
87961	79	D5170C00002/tiny.path.1/file-6571.pdf	\N	D5170C00002-a3a89f64-8319-11eb-be00-29a317453430-6571	\N	NEW	\N	\N	\N	\N
85114	79	D5170C00002/tiny.path.1/file-3724.pdf	\N	D5170C00002-a3aa10c5-8317-11eb-be00-fb50b2b159c4-3724	\N	NEW	\N	\N	\N	\N
86494	79	D5170C00002/tiny.path.1/file-5104.pdf	\N	D5170C00002-a3aade09-8318-11eb-be00-053d32667597-5104	\N	NEW	\N	\N	\N	\N
87962	79	D5170C00002/tiny.path.1/file-6572.pdf	\N	D5170C00002-a3c6fcd5-8319-11eb-be00-4bd2a42b5266-6572	\N	NEW	\N	\N	\N	\N
86495	79	D5170C00002/tiny.path.1/file-5105.pdf	\N	D5170C00002-a3d681ea-8318-11eb-be00-1b56b63842fa-5105	\N	NEW	\N	\N	\N	\N
83558	79	D5170C00002/tiny.path.1/file-2168.pdf	\N	D5170C00002-a3d86921-8316-11eb-be00-113356fcb8be-2168	\N	NEW	\N	\N	\N	\N
82181	79	D5170C00002/tiny.path.1/file-0791.pdf	\N	D5170C00002-a3d94890-8315-11eb-be00-b5387a07f4f1-791	\N	NEW	\N	\N	\N	\N
83559	79	D5170C00002/tiny.path.1/file-2169.pdf	\N	D5170C00002-a3e70f22-8316-11eb-be00-7ff442dd512e-2169	\N	NEW	\N	\N	\N	\N
83560	79	D5170C00002/tiny.path.1/file-2170.pdf	\N	D5170C00002-a3f789e3-8316-11eb-be00-5be993c8b5ed-2170	\N	NEW	\N	\N	\N	\N
87963	79	D5170C00002/tiny.path.1/file-6573.pdf	\N	D5170C00002-a4047b06-8319-11eb-be00-cb07eee49aab-6573	\N	NEW	\N	\N	\N	\N
82182	79	D5170C00002/tiny.path.1/file-0792.pdf	\N	D5170C00002-a415dc61-8315-11eb-be00-8d9ea7c333a8-792	\N	NEW	\N	\N	\N	\N
83569	79	D5170C00002/tiny.path.1/file-2179.pdf	\N	D5170C00002-a415e754-8316-11eb-be00-db1a2e5c1829-2171	\N	NEW	\N	\N	\N	\N
85115	79	D5170C00002/tiny.path.1/file-3725.pdf	\N	D5170C00002-a415f1f6-8317-11eb-be00-310f519a41df-3725	\N	NEW	\N	\N	\N	\N
87964	79	D5170C00002/tiny.path.1/file-6574.pdf	\N	D5170C00002-a422d877-8319-11eb-be00-0b4547052249-6574	\N	NEW	\N	\N	\N	\N
86496	79	D5170C00002/tiny.path.1/file-5106.pdf	\N	D5170C00002-a423907b-8318-11eb-be00-835a6555b0b7-5106	\N	NEW	\N	\N	\N	\N
85116	79	D5170C00002/tiny.path.1/file-3726.pdf	\N	D5170C00002-a426bad7-8317-11eb-be00-0fadfbb3545f-3726	\N	NEW	\N	\N	\N	\N
87965	79	D5170C00002/tiny.path.1/file-6575.pdf	\N	D5170C00002-a4335338-8319-11eb-be00-d758524887ec-6575	\N	NEW	\N	\N	\N	\N
82183	79	D5170C00002/tiny.path.1/file-0793.pdf	\N	D5170C00002-a434fd22-8315-11eb-be00-c3fec7b36585-793	\N	NEW	\N	\N	\N	\N
86497	79	D5170C00002/tiny.path.1/file-5107.pdf	\N	D5170C00002-a44178bc-8318-11eb-be00-4da1e7cab878-5107	\N	NEW	\N	\N	\N	\N
87966	79	D5170C00002/tiny.path.1/file-6576.pdf	\N	D5170C00002-a45f6c49-8319-11eb-be00-375c50c36146-6576	\N	NEW	\N	\N	\N	\N
86498	79	D5170C00002/tiny.path.1/file-5108.pdf	\N	D5170C00002-a460244d-8318-11eb-be00-932acc3c3a11-5108	\N	NEW	\N	\N	\N	\N
83561	79	D5170C00002/tiny.path.1/file-2171.pdf	\N	D5170C00002-a4612125-8316-11eb-be00-4b4f99cbe6ac-2172	\N	NEW	\N	\N	\N	\N
86499	79	D5170C00002/tiny.path.1/file-5109.pdf	\N	D5170C00002-a462201e-8318-11eb-be00-89dd14ed9026-5109	\N	NEW	\N	\N	\N	\N
85117	79	D5170C00002/tiny.path.1/file-3727.pdf	\N	D5170C00002-a4701fe8-8317-11eb-be00-09c08bf27600-3727	\N	NEW	\N	\N	\N	\N
86500	79	D5170C00002/tiny.path.1/file-5110.pdf	\N	D5170C00002-a471896f-8318-11eb-be00-b75dcaedb5ec-5110	\N	NEW	\N	\N	\N	\N
87967	79	D5170C00002/tiny.path.1/file-6577.pdf	\N	D5170C00002-a47e8d0a-8319-11eb-be00-5fbef9edc34d-6577	\N	NEW	\N	\N	\N	\N
86501	79	D5170C00002/tiny.path.1/file-5111.pdf	\N	D5170C00002-a47f6c20-8318-11eb-be00-0761fb884860-5111	\N	NEW	\N	\N	\N	\N
86502	79	D5170C00002/tiny.path.1/file-5112.pdf	\N	D5170C00002-a4807d91-8318-11eb-be00-d78eca138342-5112	\N	NEW	\N	\N	\N	\N
86503	79	D5170C00002/tiny.path.1/file-5113.pdf	\N	D5170C00002-a48d9cf2-8318-11eb-be00-2531be8bd92e-5113	\N	NEW	\N	\N	\N	\N
86504	79	D5170C00002/tiny.path.1/file-5114.pdf	\N	D5170C00002-a48fbfd3-8318-11eb-be00-e92d2e561c91-5114	\N	NEW	\N	\N	\N	\N
87968	79	D5170C00002/tiny.path.1/file-6578.pdf	\N	D5170C00002-a48ff22b-8319-11eb-be00-39319559d746-6578	\N	NEW	\N	\N	\N	\N
87969	79	D5170C00002/tiny.path.1/file-6579.pdf	\N	D5170C00002-a49e4a0c-8319-11eb-be00-47523e0ff2fd-6579	\N	NEW	\N	\N	\N	\N
86505	79	D5170C00002/tiny.path.1/file-5115.pdf	\N	D5170C00002-a4ac96a4-8318-11eb-be00-b5da754b8792-5115	\N	NEW	\N	\N	\N	\N
82184	79	D5170C00002/tiny.path.1/file-0794.pdf	\N	D5170C00002-a4ac9e23-8315-11eb-be00-cfa4a1203b8a-794	\N	NEW	\N	\N	\N	\N
83562	79	D5170C00002/tiny.path.1/file-2172.pdf	\N	D5170C00002-a4acd026-8316-11eb-be00-4d3c96c5936a-2173	\N	NEW	\N	\N	\N	\N
85118	79	D5170C00002/tiny.path.1/file-3728.pdf	\N	D5170C00002-a4aefda9-8317-11eb-be00-7371b5880ca7-3728	\N	NEW	\N	\N	\N	\N
87970	79	D5170C00002/tiny.path.1/file-6580.pdf	\N	D5170C00002-a4be070d-8319-11eb-be00-b1328fa1c67f-6580	\N	NEW	\N	\N	\N	\N
86506	79	D5170C00002/tiny.path.1/file-5116.pdf	\N	D5170C00002-a4cbde75-8318-11eb-be00-2716e85f7132-5116	\N	NEW	\N	\N	\N	\N
87971	79	D5170C00002/tiny.path.1/file-6581.pdf	\N	D5170C00002-a4da1a8e-8319-11eb-be00-13b63bb85908-6581	\N	NEW	\N	\N	\N	\N
86507	79	D5170C00002/tiny.path.1/file-5117.pdf	\N	D5170C00002-a4e97896-8318-11eb-be00-51e949c976ce-5117	\N	NEW	\N	\N	\N	\N
85119	79	D5170C00002/tiny.path.1/file-3729.pdf	\N	D5170C00002-a4eb6a6a-8317-11eb-be00-f10842d68275-3729	\N	NEW	\N	\N	\N	\N
87972	79	D5170C00002/tiny.path.1/file-6582.pdf	\N	D5170C00002-a4f8c61f-8319-11eb-be00-87fc908aea0e-6582	\N	NEW	\N	\N	\N	\N
86508	79	D5170C00002/tiny.path.1/file-5118.pdf	\N	D5170C00002-a4f93007-8318-11eb-be00-93fb7634ca64-5118	\N	NEW	\N	\N	\N	\N
83563	79	D5170C00002/tiny.path.1/file-2173.pdf	\N	D5170C00002-a4faa207-8316-11eb-be00-933a51129476-2174	\N	NEW	\N	\N	\N	\N
87973	79	D5170C00002/tiny.path.1/file-6583.pdf	\N	D5170C00002-a5085680-8319-11eb-be00-dd71d3dd2ec6-6583	\N	NEW	\N	\N	\N	\N
87974	79	D5170C00002/tiny.path.1/file-6584.pdf	\N	D5170C00002-a518aa31-8319-11eb-be00-a7dffaa013f5-6584	\N	NEW	\N	\N	\N	\N
86509	79	D5170C00002/tiny.path.1/file-5119.pdf	\N	D5170C00002-a5287d68-8318-11eb-be00-6345a094df10-5119	\N	NEW	\N	\N	\N	\N
87975	79	D5170C00002/tiny.path.1/file-6585.pdf	\N	D5170C00002-a53559f2-8319-11eb-be00-252487ede34a-6585	\N	NEW	\N	\N	\N	\N
83564	79	D5170C00002/tiny.path.1/file-2174.pdf	\N	D5170C00002-a5362468-8316-11eb-be00-436f46e0e7c9-2175	\N	NEW	\N	\N	\N	\N
82185	79	D5170C00002/tiny.path.1/file-0795.pdf	\N	D5170C00002-a5364084-8315-11eb-be00-8db8292572e5-795	\N	NEW	\N	\N	\N	\N
85120	79	D5170C00002/tiny.path.1/file-3730.pdf	\N	D5170C00002-a53803cb-8317-11eb-be00-230e5f7de354-3730	\N	NEW	\N	\N	\N	\N
86510	79	D5170C00002/tiny.path.1/file-5120.pdf	\N	D5170C00002-a544b7f9-8318-11eb-be00-8d14a84f5137-5120	\N	NEW	\N	\N	\N	\N
87976	79	D5170C00002/tiny.path.1/file-6586.pdf	\N	D5170C00002-a546e623-8319-11eb-be00-fb60a6e32d70-6586	\N	NEW	\N	\N	\N	\N
86511	79	D5170C00002/tiny.path.1/file-5121.pdf	\N	D5170C00002-a563b1aa-8318-11eb-be00-f57cd9f29477-5121	\N	NEW	\N	\N	\N	\N
87977	79	D5170C00002/tiny.path.1/file-6587.pdf	\N	D5170C00002-a564a754-8319-11eb-be00-c7e11301d4be-6587	\N	NEW	\N	\N	\N	\N
83565	79	D5170C00002/tiny.path.1/file-2175.pdf	\N	D5170C00002-a5654ab9-8316-11eb-be00-012366ee3c98-2176	\N	NEW	\N	\N	\N	\N
82186	79	D5170C00002/tiny.path.1/file-0796.pdf	\N	D5170C00002-a572d455-8315-11eb-be00-f54c0253d7bf-796	\N	NEW	\N	\N	\N	\N
87978	79	D5170C00002/tiny.path.1/file-6588.pdf	\N	D5170C00002-a574d3f5-8319-11eb-be00-d593ec22816a-6588	\N	NEW	\N	\N	\N	\N
86512	79	D5170C00002/tiny.path.1/file-5122.pdf	\N	D5170C00002-a57516cb-8318-11eb-be00-bb220e23f3eb-5122	\N	NEW	\N	\N	\N	\N
82187	79	D5170C00002/tiny.path.1/file-0797.pdf	\N	D5170C00002-a5756c66-8315-11eb-be00-5192271083c3-797	\N	NEW	\N	\N	\N	\N
86513	79	D5170C00002/tiny.path.1/file-5123.pdf	\N	D5170C00002-a582ab5c-8318-11eb-be00-dddca7bc0bbd-5123	\N	NEW	\N	\N	\N	\N
87979	79	D5170C00002/tiny.path.1/file-6589.pdf	\N	D5170C00002-a5910e86-8319-11eb-be00-f33f8eefb853-6589	\N	NEW	\N	\N	\N	\N
83566	79	D5170C00002/tiny.path.1/file-2176.pdf	\N	D5170C00002-a591b1ea-8316-11eb-be00-97b593fcb141-2177	\N	NEW	\N	\N	\N	\N
87980	79	D5170C00002/tiny.path.1/file-6590.pdf	\N	D5170C00002-a5935877-8319-11eb-be00-9dd4e065672b-6590	\N	NEW	\N	\N	\N	\N
86514	79	D5170C00002/tiny.path.1/file-5124.pdf	\N	D5170C00002-a5a0457d-8318-11eb-be00-034ed8d09d27-5124	\N	NEW	\N	\N	\N	\N
85121	79	D5170C00002/tiny.path.1/file-3731.pdf	\N	D5170C00002-a5a0b0ac-8317-11eb-be00-b19dca34092d-3731	\N	NEW	\N	\N	\N	\N
85122	79	D5170C00002/tiny.path.1/file-3732.pdf	\N	D5170C00002-a5b1a09d-8317-11eb-be00-bd591245b2e1-3732	\N	NEW	\N	\N	\N	\N
87981	79	D5170C00002/tiny.path.1/file-6591.pdf	\N	D5170C00002-a5be8728-8319-11eb-be00-cb1341c79022-6591	\N	NEW	\N	\N	\N	\N
82192	79	D5170C00002/tiny.path.1/file-0802.pdf	\N	D5170C00002-a5c03107-8315-11eb-be00-c94583e36a02-798	\N	NEW	\N	\N	\N	\N
85123	79	D5170C00002/tiny.path.1/file-3733.pdf	\N	D5170C00002-a5c130fe-8317-11eb-be00-cfe6f30a3472-3733	\N	NEW	\N	\N	\N	\N
83567	79	D5170C00002/tiny.path.1/file-2177.pdf	\N	D5170C00002-a5c1747b-8316-11eb-be00-f3bb6d9dc039-2178	\N	NEW	\N	\N	\N	\N
86515	79	D5170C00002/tiny.path.1/file-5125.pdf	\N	D5170C00002-a5ddc3ae-8318-11eb-be00-796eb2d7559e-5125	\N	NEW	\N	\N	\N	\N
85124	79	D5170C00002/tiny.path.1/file-3734.pdf	\N	D5170C00002-a5de7cff-8317-11eb-be00-4bfcd4b2b2ea-3734	\N	NEW	\N	\N	\N	\N
83568	79	D5170C00002/tiny.path.1/file-2178.pdf	\N	D5170C00002-a5ee77ec-8316-11eb-be00-239fb41eeb25-2179	\N	NEW	\N	\N	\N	\N
86516	79	D5170C00002/tiny.path.1/file-5126.pdf	\N	D5170C00002-a5fd328f-8318-11eb-be00-07196cea66bc-5126	\N	NEW	\N	\N	\N	\N
85125	79	D5170C00002/tiny.path.1/file-3735.pdf	\N	D5170C00002-a60b8070-8317-11eb-be00-2bcc8c7b144a-3735	\N	NEW	\N	\N	\N	\N
87982	79	D5170C00002/tiny.path.1/file-6592.pdf	\N	D5170C00002-a60cce39-8319-11eb-be00-871dc9854380-6592	\N	NEW	\N	\N	\N	\N
86517	79	D5170C00002/tiny.path.1/file-5127.pdf	\N	D5170C00002-a61a5780-8318-11eb-be00-331a4ea21abb-5127	\N	NEW	\N	\N	\N	\N
85126	79	D5170C00002/tiny.path.1/file-3736.pdf	\N	D5170C00002-a61d5ac1-8317-11eb-be00-317631879f57-3736	\N	NEW	\N	\N	\N	\N
82188	79	D5170C00002/tiny.path.1/file-0798.pdf	\N	D5170C00002-a62a1668-8315-11eb-be00-73806a72d82a-799	\N	NEW	\N	\N	\N	\N
86518	79	D5170C00002/tiny.path.1/file-5128.pdf	\N	D5170C00002-a62b6e81-8318-11eb-be00-278aed8e43f9-5128	\N	NEW	\N	\N	\N	\N
83570	79	D5170C00002/tiny.path.1/file-2180.pdf	\N	D5170C00002-a62bcf0d-8316-11eb-be00-3fe173205902-2180	\N	NEW	\N	\N	\N	\N
85127	79	D5170C00002/tiny.path.1/file-3737.pdf	\N	D5170C00002-a62d1232-8317-11eb-be00-5916738bb318-3737	\N	NEW	\N	\N	\N	\N
82189	79	D5170C00002/tiny.path.1/file-0799.pdf	\N	D5170C00002-a639f4e9-8315-11eb-be00-1983f717716b-800	\N	NEW	\N	\N	\N	\N
85128	79	D5170C00002/tiny.path.1/file-3738.pdf	\N	D5170C00002-a63a3193-8317-11eb-be00-9b3798f97ac8-3738	\N	NEW	\N	\N	\N	\N
82190	79	D5170C00002/tiny.path.1/file-0800.pdf	\N	D5170C00002-a648c1fa-8315-11eb-be00-e70a8e516184-801	\N	NEW	\N	\N	\N	\N
86519	79	D5170C00002/tiny.path.1/file-5129.pdf	\N	D5170C00002-a64a1a12-8318-11eb-be00-c5f0c04c54e6-5129	\N	NEW	\N	\N	\N	\N
86520	79	D5170C00002/tiny.path.1/file-5130.pdf	\N	D5170C00002-a6578793-8318-11eb-be00-0f30047dda0d-5130	\N	NEW	\N	\N	\N	\N
85129	79	D5170C00002/tiny.path.1/file-3739.pdf	\N	D5170C00002-a657cbb4-8317-11eb-be00-9bbf7a936b5e-3739	\N	NEW	\N	\N	\N	\N
87983	79	D5170C00002/tiny.path.1/file-6593.pdf	\N	D5170C00002-a6582f1a-8319-11eb-be00-21e55538b5a9-6593	\N	NEW	\N	\N	\N	\N
82191	79	D5170C00002/tiny.path.1/file-0801.pdf	\N	D5170C00002-a65a000b-8315-11eb-be00-4dce5e1e5a9b-802	\N	NEW	\N	\N	\N	\N
83571	79	D5170C00002/tiny.path.1/file-2181.pdf	\N	D5170C00002-a66862de-8316-11eb-be00-3bf884b3293e-2181	\N	NEW	\N	\N	\N	\N
87984	79	D5170C00002/tiny.path.1/file-6594.pdf	\N	D5170C00002-a67701bb-8319-11eb-be00-0b14fd46b49d-6594	\N	NEW	\N	\N	\N	\N
85130	79	D5170C00002/tiny.path.1/file-3740.pdf	\N	D5170C00002-a67824f5-8317-11eb-be00-37c80bfab602-3740	\N	NEW	\N	\N	\N	\N
82193	79	D5170C00002/tiny.path.1/file-0803.pdf	\N	D5170C00002-a686673c-8315-11eb-be00-cf720c2c6baa-803	\N	NEW	\N	\N	\N	\N
83572	79	D5170C00002/tiny.path.1/file-2182.pdf	\N	D5170C00002-a6875c8f-8316-11eb-be00-bd73947bb007-2182	\N	NEW	\N	\N	\N	\N
85131	79	D5170C00002/tiny.path.1/file-3741.pdf	\N	D5170C00002-a694d4b6-8317-11eb-be00-e93df543844c-3741	\N	NEW	\N	\N	\N	\N
83573	79	D5170C00002/tiny.path.1/file-2183.pdf	\N	D5170C00002-a6a62f30-8316-11eb-be00-0bc0f7a8507d-2183	\N	NEW	\N	\N	\N	\N
82194	79	D5170C00002/tiny.path.1/file-0804.pdf	\N	D5170C00002-a6a6725d-8315-11eb-be00-7b7d52a1b007-804	\N	NEW	\N	\N	\N	\N
87985	79	D5170C00002/tiny.path.1/file-6595.pdf	\N	D5170C00002-a6c1ed6c-8319-11eb-be00-bdacc08d16eb-6595	\N	NEW	\N	\N	\N	\N
82195	79	D5170C00002/tiny.path.1/file-0805.pdf	\N	D5170C00002-a6c2acee-8315-11eb-be00-41c110d2cafa-805	\N	NEW	\N	\N	\N	\N
85132	79	D5170C00002/tiny.path.1/file-3742.pdf	\N	D5170C00002-a6c2e997-8317-11eb-be00-eb86e20a0df0-3742	\N	NEW	\N	\N	\N	\N
82196	79	D5170C00002/tiny.path.1/file-0806.pdf	\N	D5170C00002-a6d2b27f-8315-11eb-be00-b3e7a2a84d09-806	\N	NEW	\N	\N	\N	\N
85133	79	D5170C00002/tiny.path.1/file-3743.pdf	\N	D5170C00002-a6d36458-8317-11eb-be00-fb69739e41bf-3743	\N	NEW	\N	\N	\N	\N
82197	79	D5170C00002/tiny.path.1/file-0807.pdf	\N	D5170C00002-a6f0c1d0-8315-11eb-be00-038149be66ea-807	\N	NEW	\N	\N	\N	\N
86521	79	D5170C00002/tiny.path.1/file-5131.pdf	\N	D5170C00002-a6f12f84-8318-11eb-be00-5b1defb703e7-5131	\N	NEW	\N	\N	\N	\N
83574	79	D5170C00002/tiny.path.1/file-2184.pdf	\N	D5170C00002-a6f141f1-8316-11eb-be00-3953a067a24e-2184	\N	NEW	\N	\N	\N	\N
85134	79	D5170C00002/tiny.path.1/file-3744.pdf	\N	D5170C00002-a6f2fa49-8317-11eb-be00-71c569bee5ca-3744	\N	NEW	\N	\N	\N	\N
82198	79	D5170C00002/tiny.path.1/file-0808.pdf	\N	D5170C00002-a7011581-8315-11eb-be00-a3a96f5a44cd-808	\N	NEW	\N	\N	\N	\N
85135	79	D5170C00002/tiny.path.1/file-3745.pdf	\N	D5170C00002-a711099a-8317-11eb-be00-05266616f32e-3745	\N	NEW	\N	\N	\N	\N
87986	79	D5170C00002/tiny.path.1/file-6596.pdf	\N	D5170C00002-a71f289d-8319-11eb-be00-233fe11f1b57-6596	\N	NEW	\N	\N	\N	\N
85136	79	D5170C00002/tiny.path.1/file-3746.pdf	\N	D5170C00002-a72024cb-8317-11eb-be00-4924635634bb-3746	\N	NEW	\N	\N	\N	\N
82199	79	D5170C00002/tiny.path.1/file-0809.pdf	\N	D5170C00002-a720ab72-8315-11eb-be00-d7ee12a13b84-809	\N	NEW	\N	\N	\N	\N
83575	79	D5170C00002/tiny.path.1/file-2185.pdf	\N	D5170C00002-a73d3f12-8316-11eb-be00-7decd6bcdfc5-2185	\N	NEW	\N	\N	\N	\N
82200	79	D5170C00002/tiny.path.1/file-0810.pdf	\N	D5170C00002-a73d5b33-8315-11eb-be00-7fa9dfd6481a-810	\N	NEW	\N	\N	\N	\N
85137	79	D5170C00002/tiny.path.1/file-3747.pdf	\N	D5170C00002-a73ea94c-8317-11eb-be00-5fbc8675f447-3747	\N	NEW	\N	\N	\N	\N
87987	79	D5170C00002/tiny.path.1/file-6597.pdf	\N	D5170C00002-a73f0cae-8319-11eb-be00-23fb2853feef-6597	\N	NEW	\N	\N	\N	\N
83576	79	D5170C00002/tiny.path.1/file-2186.pdf	\N	D5170C00002-a74db9d3-8316-11eb-be00-6d69be9c31d6-2186	\N	NEW	\N	\N	\N	\N
82201	79	D5170C00002/tiny.path.1/file-0811.pdf	\N	D5170C00002-a75b6a84-8315-11eb-be00-05a6db385ee6-811	\N	NEW	\N	\N	\N	\N
85138	79	D5170C00002/tiny.path.1/file-3748.pdf	\N	D5170C00002-a75bce3d-8317-11eb-be00-79c88f13624a-3748	\N	NEW	\N	\N	\N	\N
82202	79	D5170C00002/tiny.path.1/file-0812.pdf	\N	D5170C00002-a76a85b5-8315-11eb-be00-55212f9bc18e-812	\N	NEW	\N	\N	\N	\N
87988	79	D5170C00002/tiny.path.1/file-6598.pdf	\N	D5170C00002-a76b9aef-8319-11eb-be00-59d7ec6099ad-6598	\N	NEW	\N	\N	\N	\N
82203	79	D5170C00002/tiny.path.1/file-0813.pdf	\N	D5170C00002-a779c7f6-8315-11eb-be00-51f4e7c20846-813	\N	NEW	\N	\N	\N	\N
82204	79	D5170C00002/tiny.path.1/file-0814.pdf	\N	D5170C00002-a788e327-8315-11eb-be00-27dd70b5d279-814	\N	NEW	\N	\N	\N	\N
85139	79	D5170C00002/tiny.path.1/file-3749.pdf	\N	D5170C00002-a789bc0e-8317-11eb-be00-a777baa811bd-3749	\N	NEW	\N	\N	\N	\N
87989	79	D5170C00002/tiny.path.1/file-6599.pdf	\N	D5170C00002-a7982930-8319-11eb-be00-2d66bf40759b-6599	\N	NEW	\N	\N	\N	\N
87990	79	D5170C00002/tiny.path.1/file-6600.pdf	\N	D5170C00002-a79a2501-8319-11eb-be00-97f4e158f93c-6600	\N	NEW	\N	\N	\N	\N
85140	79	D5170C00002/tiny.path.1/file-3750.pdf	\N	D5170C00002-a7a72f1f-8317-11eb-be00-bb6bb44b0484-3750	\N	NEW	\N	\N	\N	\N
87991	79	D5170C00002/tiny.path.1/file-6601.pdf	\N	D5170C00002-a7a82ec2-8319-11eb-be00-8736ebaa316c-6601	\N	NEW	\N	\N	\N	\N
85141	79	D5170C00002/tiny.path.1/file-3751.pdf	\N	D5170C00002-a7b6e690-8317-11eb-be00-2387d0bea5a2-3751	\N	NEW	\N	\N	\N	\N
87992	79	D5170C00002/tiny.path.1/file-6602.pdf	\N	D5170C00002-a7b6fbd3-8319-11eb-be00-bbf2af18095d-6602	\N	NEW	\N	\N	\N	\N
86522	79	D5170C00002/tiny.path.1/file-5132.pdf	\N	D5170C00002-a7b85015-8318-11eb-be00-dd7f9fd801a2-5132	\N	NEW	\N	\N	\N	\N
87993	79	D5170C00002/tiny.path.1/file-6603.pdf	\N	D5170C00002-a7c5a1d4-8319-11eb-be00-dd4cf2f802ab-6603	\N	NEW	\N	\N	\N	\N
82205	79	D5170C00002/tiny.path.1/file-0815.pdf	\N	D5170C00002-a7c5ec28-8315-11eb-be00-139cdbcba202-815	\N	NEW	\N	\N	\N	\N
83577	79	D5170C00002/tiny.path.1/file-2187.pdf	\N	D5170C00002-a7c70884-8316-11eb-be00-c9904e3839f2-2187	\N	NEW	\N	\N	\N	\N
82206	79	D5170C00002/tiny.path.1/file-0816.pdf	\N	D5170C00002-a7c799d9-8315-11eb-be00-bddd20554a68-816	\N	NEW	\N	\N	\N	\N
87994	79	D5170C00002/tiny.path.1/file-6604.pdf	\N	D5170C00002-a7c839e5-8319-11eb-be00-f9d4d327e0d2-6604	\N	NEW	\N	\N	\N	\N
85142	79	D5170C00002/tiny.path.1/file-3752.pdf	\N	D5170C00002-a7d56b11-8317-11eb-be00-41c8d6265a82-3752	\N	NEW	\N	\N	\N	\N
82207	79	D5170C00002/tiny.path.1/file-0817.pdf	\N	D5170C00002-a7d6dc1a-8315-11eb-be00-cfd45737e39b-817	\N	NEW	\N	\N	\N	\N
87995	79	D5170C00002/tiny.path.1/file-6605.pdf	\N	D5170C00002-a7e42656-8319-11eb-be00-218611d566f7-6605	\N	NEW	\N	\N	\N	\N
82208	79	D5170C00002/tiny.path.1/file-0818.pdf	\N	D5170C00002-a7e66c7b-8315-11eb-be00-f7fa8bc55853-818	\N	NEW	\N	\N	\N	\N
85143	79	D5170C00002/tiny.path.1/file-3753.pdf	\N	D5170C00002-a7f5eb62-8317-11eb-be00-e7306cfb4717-3753	\N	NEW	\N	\N	\N	\N
87996	79	D5170C00002/tiny.path.1/file-6606.pdf	\N	D5170C00002-a8119ef7-8319-11eb-be00-f5733f0d0ba9-6606	\N	NEW	\N	\N	\N	\N
85144	79	D5170C00002/tiny.path.1/file-3754.pdf	\N	D5170C00002-a8131053-8317-11eb-be00-c9af9640bbe5-3754	\N	NEW	\N	\N	\N	\N
83578	79	D5170C00002/tiny.path.1/file-2188.pdf	\N	D5170C00002-a821f9c5-8316-11eb-be00-6fa630da6fcc-2188	\N	NEW	\N	\N	\N	\N
85145	79	D5170C00002/tiny.path.1/file-3755.pdf	\N	D5170C00002-a830f894-8317-11eb-be00-659f8444a285-3755	\N	NEW	\N	\N	\N	\N
82209	79	D5170C00002/tiny.path.1/file-0819.pdf	\N	D5170C00002-a831311c-8315-11eb-be00-0376e671b1c5-819	\N	NEW	\N	\N	\N	\N
87997	79	D5170C00002/tiny.path.1/file-6607.pdf	\N	D5170C00002-a83309a8-8319-11eb-be00-9f6fbd8c2dc7-6607	\N	NEW	\N	\N	\N	\N
85146	79	D5170C00002/tiny.path.1/file-3756.pdf	\N	D5170C00002-a842d2e5-8317-11eb-be00-21e7e1123918-3756	\N	NEW	\N	\N	\N	\N
82210	79	D5170C00002/tiny.path.1/file-0820.pdf	\N	D5170C00002-a843327d-8315-11eb-be00-d5f043bdb602-820	\N	NEW	\N	\N	\N	\N
86523	79	D5170C00002/tiny.path.1/file-5133.pdf	\N	D5170C00002-a84f38e6-8318-11eb-be00-e359e17d7ec5-5133	\N	NEW	\N	\N	\N	\N
83579	79	D5170C00002/tiny.path.1/file-2189.pdf	\N	D5170C00002-a8500ea6-8316-11eb-be00-dd21508aa2e7-2189	\N	NEW	\N	\N	\N	\N
87998	79	D5170C00002/tiny.path.1/file-6608.pdf	\N	D5170C00002-a85e3859-8319-11eb-be00-09d4067a91f5-6608	\N	NEW	\N	\N	\N	\N
85147	79	D5170C00002/tiny.path.1/file-3757.pdf	\N	D5170C00002-a85ebf56-8317-11eb-be00-a9f3a0b4cca6-3757	\N	NEW	\N	\N	\N	\N
82211	79	D5170C00002/tiny.path.1/file-0821.pdf	\N	D5170C00002-a85ef7de-8315-11eb-be00-85907b304d96-821	\N	NEW	\N	\N	\N	\N
85148	79	D5170C00002/tiny.path.1/file-3758.pdf	\N	D5170C00002-a86f8837-8317-11eb-be00-fd0666f5c76a-3758	\N	NEW	\N	\N	\N	\N
86524	79	D5170C00002/tiny.path.1/file-5134.pdf	\N	D5170C00002-a87cffa7-8318-11eb-be00-55ffa1b08394-5134	\N	NEW	\N	\N	\N	\N
85149	79	D5170C00002/tiny.path.1/file-3759.pdf	\N	D5170C00002-a87e0728-8317-11eb-be00-630707db2fa9-3759	\N	NEW	\N	\N	\N	\N
82212	79	D5170C00002/tiny.path.1/file-0822.pdf	\N	D5170C00002-a88da8ff-8315-11eb-be00-3bd9359fef04-822	\N	NEW	\N	\N	\N	\N
87999	79	D5170C00002/tiny.path.1/file-6609.pdf	\N	D5170C00002-a88dfaea-8319-11eb-be00-6bccbc79fce0-6609	\N	NEW	\N	\N	\N	\N
85150	79	D5170C00002/tiny.path.1/file-3760.pdf	\N	D5170C00002-a88e0cb9-8317-11eb-be00-cf379ff572b8-3760	\N	NEW	\N	\N	\N	\N
83580	79	D5170C00002/tiny.path.1/file-2190.pdf	\N	D5170C00002-a89c80f7-8316-11eb-be00-b7163b5bff04-2190	\N	NEW	\N	\N	\N	\N
85151	79	D5170C00002/tiny.path.1/file-3761.pdf	\N	D5170C00002-a89e395a-8317-11eb-be00-57094e4933f4-3761	\N	NEW	\N	\N	\N	\N
82213	79	D5170C00002/tiny.path.1/file-0823.pdf	\N	D5170C00002-a8ac2d80-8315-11eb-be00-0f9315337237-823	\N	NEW	\N	\N	\N	\N
85152	79	D5170C00002/tiny.path.1/file-3762.pdf	\N	D5170C00002-a8ad7b9b-8317-11eb-be00-9bfa61379b84-3762	\N	NEW	\N	\N	\N	\N
88000	79	D5170C00002/tiny.path.1/file-6610.pdf	\N	D5170C00002-a8bbe8bb-8319-11eb-be00-d30b0ebb6dd9-6610	\N	NEW	\N	\N	\N	\N
82214	79	D5170C00002/tiny.path.1/file-0824.pdf	\N	D5170C00002-a8bd1d71-8315-11eb-be00-a329248d7c1d-824	\N	NEW	\N	\N	\N	\N
86525	79	D5170C00002/tiny.path.1/file-5135.pdf	\N	D5170C00002-a8ca0e38-8318-11eb-be00-c5c93caaa107-5135	\N	NEW	\N	\N	\N	\N
83581	79	D5170C00002/tiny.path.1/file-2191.pdf	\N	D5170C00002-a8ca47b8-8316-11eb-be00-87d833bb4da4-2191	\N	NEW	\N	\N	\N	\N
88001	79	D5170C00002/tiny.path.1/file-6611.pdf	\N	D5170C00002-a8e7b3ac-8319-11eb-be00-2f6f16d9dd85-6611	\N	NEW	\N	\N	\N	\N
82215	79	D5170C00002/tiny.path.1/file-0825.pdf	\N	D5170C00002-a8e9f9d2-8315-11eb-be00-a3aaec763134-825	\N	NEW	\N	\N	\N	\N
88002	79	D5170C00002/tiny.path.1/file-6612.pdf	\N	D5170C00002-a8f8557d-8319-11eb-be00-2506b94b2114-6612	\N	NEW	\N	\N	\N	\N
86526	79	D5170C00002/tiny.path.1/file-5136.pdf	\N	D5170C00002-a8f982a9-8318-11eb-be00-a58a8cd34edd-5136	\N	NEW	\N	\N	\N	\N
82216	79	D5170C00002/tiny.path.1/file-0826.pdf	\N	D5170C00002-a9068283-8315-11eb-be00-23a24ba1aa55-826	\N	NEW	\N	\N	\N	\N
88003	79	D5170C00002/tiny.path.1/file-6613.pdf	\N	D5170C00002-a917763e-8319-11eb-be00-bfcda7e6a550-6613	\N	NEW	\N	\N	\N	\N
82217	79	D5170C00002/tiny.path.1/file-0827.pdf	\N	D5170C00002-a92729e4-8315-11eb-be00-f758012aa467-827	\N	NEW	\N	\N	\N	\N
86527	79	D5170C00002/tiny.path.1/file-5137.pdf	\N	D5170C00002-a933a57a-8318-11eb-be00-d9e90ed0651c-5137	\N	NEW	\N	\N	\N	\N
86528	79	D5170C00002/tiny.path.1/file-5138.pdf	\N	D5170C00002-a9357a3b-8318-11eb-be00-91441a1bfa44-5138	\N	NEW	\N	\N	\N	\N
88004	79	D5170C00002/tiny.path.1/file-6614.pdf	\N	D5170C00002-a935d3af-8319-11eb-be00-83575c3c98b9-6614	\N	NEW	\N	\N	\N	\N
83582	79	D5170C00002/tiny.path.1/file-2192.pdf	\N	D5170C00002-a9439669-8316-11eb-be00-e5662e7d6c12-2192	\N	NEW	\N	\N	\N	\N
88005	79	D5170C00002/tiny.path.1/file-6615.pdf	\N	D5170C00002-a944c6d0-8319-11eb-be00-a7e06a894797-6615	\N	NEW	\N	\N	\N	\N
82218	79	D5170C00002/tiny.path.1/file-0828.pdf	\N	D5170C00002-a9715245-8315-11eb-be00-6371ff5bc2be-828	\N	NEW	\N	\N	\N	\N
83583	79	D5170C00002/tiny.path.1/file-2193.pdf	\N	D5170C00002-a971ab4a-8316-11eb-be00-71c54370c6f3-2193	\N	NEW	\N	\N	\N	\N
88006	79	D5170C00002/tiny.path.1/file-6616.pdf	\N	D5170C00002-a9807041-8319-11eb-be00-c366d14743f0-6616	\N	NEW	\N	\N	\N	\N
85153	79	D5170C00002/tiny.path.1/file-3763.pdf	\N	D5170C00002-a98257cc-8317-11eb-be00-0f04f4473b71-3763	\N	NEW	\N	\N	\N	\N
82219	79	D5170C00002/tiny.path.1/file-0829.pdf	\N	D5170C00002-a99295e6-8315-11eb-be00-6b24db4994c1-829	\N	NEW	\N	\N	\N	\N
86529	79	D5170C00002/tiny.path.1/file-5139.pdf	\N	D5170C00002-a99f86ac-8318-11eb-be00-357a18dafde5-5139	\N	NEW	\N	\N	\N	\N
85154	79	D5170C00002/tiny.path.1/file-3764.pdf	\N	D5170C00002-a9aff77d-8317-11eb-be00-335b5fcf27aa-3764	\N	NEW	\N	\N	\N	\N
83584	79	D5170C00002/tiny.path.1/file-2194.pdf	\N	D5170C00002-a9b013db-8316-11eb-be00-d9a6d2e61af2-2194	\N	NEW	\N	\N	\N	\N
88007	79	D5170C00002/tiny.path.1/file-6617.pdf	\N	D5170C00002-a9bed8d2-8319-11eb-be00-cd5bb57cbfd1-6617	\N	NEW	\N	\N	\N	\N
85155	79	D5170C00002/tiny.path.1/file-3765.pdf	\N	D5170C00002-a9ce7bfe-8317-11eb-be00-ef842f0b3bbd-3765	\N	NEW	\N	\N	\N	\N
83585	79	D5170C00002/tiny.path.1/file-2195.pdf	\N	D5170C00002-a9dca21c-8316-11eb-be00-5bba8b950bb7-2195	\N	NEW	\N	\N	\N	\N
86530	79	D5170C00002/tiny.path.1/file-5140.pdf	\N	D5170C00002-a9dcddcd-8318-11eb-be00-b53f3dec9bfb-5140	\N	NEW	\N	\N	\N	\N
82220	79	D5170C00002/tiny.path.1/file-0830.pdf	\N	D5170C00002-a9ec9cc7-8315-11eb-be00-85dea0eb0614-830	\N	NEW	\N	\N	\N	\N
88008	79	D5170C00002/tiny.path.1/file-6618.pdf	\N	D5170C00002-a9ec9f93-8319-11eb-be00-b37f00eac1ab-6618	\N	NEW	\N	\N	\N	\N
85156	79	D5170C00002/tiny.path.1/file-3766.pdf	\N	D5170C00002-a9ecd96f-8317-11eb-be00-f5ac267040dd-3766	\N	NEW	\N	\N	\N	\N
86531	79	D5170C00002/tiny.path.1/file-5141.pdf	\N	D5170C00002-a9fa02be-8318-11eb-be00-9d77850aacb3-5141	\N	NEW	\N	\N	\N	\N
86532	79	D5170C00002/tiny.path.1/file-5142.pdf	\N	D5170C00002-aa0a084f-8318-11eb-be00-812cdfa6ea94-5142	\N	NEW	\N	\N	\N	\N
88009	79	D5170C00002/tiny.path.1/file-6619.pdf	\N	D5170C00002-aa0b2414-8319-11eb-be00-a72f354f69f6-6619	\N	NEW	\N	\N	\N	\N
85157	79	D5170C00002/tiny.path.1/file-3767.pdf	\N	D5170C00002-aa0bac10-8317-11eb-be00-1da05e883775-3767	\N	NEW	\N	\N	\N	\N
82221	79	D5170C00002/tiny.path.1/file-0831.pdf	\N	D5170C00002-aa0bbd88-8315-11eb-be00-491c8788f5a9-831	\N	NEW	\N	\N	\N	\N
88010	79	D5170C00002/tiny.path.1/file-6620.pdf	\N	D5170C00002-aa1a8d65-8319-11eb-be00-67cf3a485284-6620	\N	NEW	\N	\N	\N	\N
82222	79	D5170C00002/tiny.path.1/file-0832.pdf	\N	D5170C00002-aa28e279-8315-11eb-be00-038047072488-832	\N	NEW	\N	\N	\N	\N
86535	79	D5170C00002/tiny.path.1/file-5145.pdf	\N	D5170C00002-aa3732d0-8318-11eb-be00-7d16159fa013-5143	\N	NEW	\N	\N	\N	\N
83586	79	D5170C00002/tiny.path.1/file-2196.pdf	\N	D5170C00002-aa37ba6d-8316-11eb-be00-07a2b5e95821-2196	\N	NEW	\N	\N	\N	\N
88011	79	D5170C00002/tiny.path.1/file-6621.pdf	\N	D5170C00002-aa396006-8319-11eb-be00-0350cee649e7-6621	\N	NEW	\N	\N	\N	\N
82223	79	D5170C00002/tiny.path.1/file-0833.pdf	\N	D5170C00002-aa489f7a-8315-11eb-be00-3129934d6006-833	\N	NEW	\N	\N	\N	\N
88012	79	D5170C00002/tiny.path.1/file-6622.pdf	\N	D5170C00002-aa56ac07-8319-11eb-be00-65e566eba2b3-6622	\N	NEW	\N	\N	\N	\N
86536	79	D5170C00002/tiny.path.1/file-5146.pdf	\N	D5170C00002-aa589d81-8318-11eb-be00-91bbb1d333d1-5144	\N	NEW	\N	\N	\N	\N
85158	79	D5170C00002/tiny.path.1/file-3768.pdf	\N	D5170C00002-aa660111-8317-11eb-be00-4b4dbcc369ae-3768	\N	NEW	\N	\N	\N	\N
88013	79	D5170C00002/tiny.path.1/file-6623.pdf	\N	D5170C00002-aa74e268-8319-11eb-be00-c3ed821198c5-6623	\N	NEW	\N	\N	\N	\N
83587	79	D5170C00002/tiny.path.1/file-2197.pdf	\N	D5170C00002-aa770d5e-8316-11eb-be00-97ecb3298f77-2197	\N	NEW	\N	\N	\N	\N
86533	79	D5170C00002/tiny.path.1/file-5143.pdf	\N	D5170C00002-aa8552d2-8318-11eb-be00-bd7ca9c22c6a-5145	\N	NEW	\N	\N	\N	\N
82224	79	D5170C00002/tiny.path.1/file-0834.pdf	\N	D5170C00002-aa866bcb-8315-11eb-be00-e3129659c207-834	\N	NEW	\N	\N	\N	\N
83588	79	D5170C00002/tiny.path.1/file-2198.pdf	\N	D5170C00002-aa93960f-8316-11eb-be00-29f9f256d46f-2198	\N	NEW	\N	\N	\N	\N
82225	79	D5170C00002/tiny.path.1/file-0835.pdf	\N	D5170C00002-aaa2f47c-8315-11eb-be00-23bef704ab3e-835	\N	NEW	\N	\N	\N	\N
83589	79	D5170C00002/tiny.path.1/file-2199.pdf	\N	D5170C00002-aaa437e0-8316-11eb-be00-45ae4727bbdd-2199	\N	NEW	\N	\N	\N	\N
86534	79	D5170C00002/tiny.path.1/file-5144.pdf	\N	D5170C00002-aab144d3-8318-11eb-be00-8312cca6ac2a-5146	\N	NEW	\N	\N	\N	\N
82226	79	D5170C00002/tiny.path.1/file-0836.pdf	\N	D5170C00002-aab2abed-8315-11eb-be00-0736be2bb28d-836	\N	NEW	\N	\N	\N	\N
82227	79	D5170C00002/tiny.path.1/file-0837.pdf	\N	D5170C00002-aac326ae-8315-11eb-be00-9f4d0101c597-837	\N	NEW	\N	\N	\N	\N
85159	79	D5170C00002/tiny.path.1/file-3769.pdf	\N	D5170C00002-aac33c42-8317-11eb-be00-b3e5aa927407-3769	\N	NEW	\N	\N	\N	\N
85160	79	D5170C00002/tiny.path.1/file-3770.pdf	\N	D5170C00002-aad20953-8317-11eb-be00-4baf0a0eef32-3770	\N	NEW	\N	\N	\N	\N
86537	79	D5170C00002/tiny.path.1/file-5147.pdf	\N	D5170C00002-aad324b4-8318-11eb-be00-fb32c1db1d34-5147	\N	NEW	\N	\N	\N	\N
85161	79	D5170C00002/tiny.path.1/file-3771.pdf	\N	D5170C00002-aae12484-8317-11eb-be00-c7932bf50a28-3771	\N	NEW	\N	\N	\N	\N
85194	79	D5170C00002/tiny.path.1/file-3804.pdf	\N	D5170C00002-aafee5b5-8317-11eb-be00-ffdbf40f57a4-3772	\N	NEW	\N	\N	\N	\N
86538	79	D5170C00002/tiny.path.1/file-5148.pdf	\N	D5170C00002-aaff8be5-8318-11eb-be00-2fb8f1efc1c7-5148	\N	NEW	\N	\N	\N	\N
82228	79	D5170C00002/tiny.path.1/file-0838.pdf	\N	D5170C00002-ab0d761f-8315-11eb-be00-e3eaee0e1a2d-838	\N	NEW	\N	\N	\N	\N
88014	79	D5170C00002/tiny.path.1/file-6624.pdf	\N	D5170C00002-ab2baf49-8319-11eb-be00-11bb95527a5e-6624	\N	NEW	\N	\N	\N	\N
85162	79	D5170C00002/tiny.path.1/file-3772.pdf	\N	D5170C00002-ab2d6fc6-8317-11eb-be00-ddf98ccd89a6-3773	\N	NEW	\N	\N	\N	\N
86539	79	D5170C00002/tiny.path.1/file-5149.pdf	\N	D5170C00002-ab2da0c6-8318-11eb-be00-6b9819b10cde-5149	\N	NEW	\N	\N	\N	\N
85163	79	D5170C00002/tiny.path.1/file-3773.pdf	\N	D5170C00002-ab3cb207-8317-11eb-be00-9987944b9e03-3774	\N	NEW	\N	\N	\N	\N
85164	79	D5170C00002/tiny.path.1/file-3774.pdf	\N	D5170C00002-ab59d6f8-8317-11eb-be00-33683b4e3ff9-3775	\N	NEW	\N	\N	\N	\N
82229	79	D5170C00002/tiny.path.1/file-0839.pdf	\N	D5170C00002-ab5b4800-8315-11eb-be00-ef15c041159f-839	\N	NEW	\N	\N	\N	\N
88015	79	D5170C00002/tiny.path.1/file-6625.pdf	\N	D5170C00002-ab5bbffa-8319-11eb-be00-e75341f61560-6625	\N	NEW	\N	\N	\N	\N
85165	79	D5170C00002/tiny.path.1/file-3775.pdf	\N	D5170C00002-ab77e649-8317-11eb-be00-0747fda76d72-3776	\N	NEW	\N	\N	\N	\N
83590	79	D5170C00002/tiny.path.1/file-2200.pdf	\N	D5170C00002-ab871dd1-8316-11eb-be00-73fd18bcf00e-2200	\N	NEW	\N	\N	\N	\N
82230	79	D5170C00002/tiny.path.1/file-0840.pdf	\N	D5170C00002-ab876111-8315-11eb-be00-7594d174a722-840	\N	NEW	\N	\N	\N	\N
85166	79	D5170C00002/tiny.path.1/file-3776.pdf	\N	D5170C00002-ab88881a-8317-11eb-be00-7bb7bed8e2d2-3777	\N	NEW	\N	\N	\N	\N
85167	79	D5170C00002/tiny.path.1/file-3777.pdf	\N	D5170C00002-aba6705b-8317-11eb-be00-8dc57825720f-3778	\N	NEW	\N	\N	\N	\N
85168	79	D5170C00002/tiny.path.1/file-3778.pdf	\N	D5170C00002-abb5647c-8317-11eb-be00-718a2fb9aa71-3779	\N	NEW	\N	\N	\N	\N
88016	79	D5170C00002/tiny.path.1/file-6626.pdf	\N	D5170C00002-abb6ff5b-8319-11eb-be00-6b65a3e2d7db-6626	\N	NEW	\N	\N	\N	\N
85169	79	D5170C00002/tiny.path.1/file-3779.pdf	\N	D5170C00002-abb7122d-8317-11eb-be00-d541da099cc2-3780	\N	NEW	\N	\N	\N	\N
86540	79	D5170C00002/tiny.path.1/file-5150.pdf	\N	D5170C00002-abc3c647-8318-11eb-be00-b7c25fc0f91b-5150	\N	NEW	\N	\N	\N	\N
83591	79	D5170C00002/tiny.path.1/file-2201.pdf	\N	D5170C00002-abc5fb92-8316-11eb-be00-a37c46947d7d-2201	\N	NEW	\N	\N	\N	\N
88017	79	D5170C00002/tiny.path.1/file-6627.pdf	\N	D5170C00002-abd3880c-8319-11eb-be00-fb0481a0465d-6627	\N	NEW	\N	\N	\N	\N
85170	79	D5170C00002/tiny.path.1/file-3780.pdf	\N	D5170C00002-abd4853e-8317-11eb-be00-8902fad7a0c5-3781	\N	NEW	\N	\N	\N	\N
83592	79	D5170C00002/tiny.path.1/file-2202.pdf	\N	D5170C00002-abe56a73-8316-11eb-be00-8dec7c3608d1-2202	\N	NEW	\N	\N	\N	\N
88018	79	D5170C00002/tiny.path.1/file-6628.pdf	\N	D5170C00002-abf31dfd-8319-11eb-be00-b953f30184e0-6628	\N	NEW	\N	\N	\N	\N
82231	79	D5170C00002/tiny.path.1/file-0841.pdf	\N	D5170C00002-abf40592-8315-11eb-be00-9b90b9084ff5-841	\N	NEW	\N	\N	\N	\N
83593	79	D5170C00002/tiny.path.1/file-2203.pdf	\N	D5170C00002-ac109924-8316-11eb-be00-a1b8b7c06f6f-2203	\N	NEW	\N	\N	\N	\N
83594	79	D5170C00002/tiny.path.1/file-2204.pdf	\N	D5170C00002-ac1fb455-8316-11eb-be00-a5bf6a85045c-2204	\N	NEW	\N	\N	\N	\N
82232	79	D5170C00002/tiny.path.1/file-0842.pdf	\N	D5170C00002-ac210903-8315-11eb-be00-0ff74ab10d46-842	\N	NEW	\N	\N	\N	\N
86541	79	D5170C00002/tiny.path.1/file-5151.pdf	\N	D5170C00002-ac22af28-8318-11eb-be00-2f8d78f9cde4-5151	\N	NEW	\N	\N	\N	\N
83595	79	D5170C00002/tiny.path.1/file-2205.pdf	\N	D5170C00002-ac22c196-8316-11eb-be00-d10df358fcf8-2205	\N	NEW	\N	\N	\N	\N
88019	79	D5170C00002/tiny.path.1/file-6629.pdf	\N	D5170C00002-ac2e794e-8319-11eb-be00-ddc637497ef3-6629	\N	NEW	\N	\N	\N	\N
82233	79	D5170C00002/tiny.path.1/file-0843.pdf	\N	D5170C00002-ac4029c4-8315-11eb-be00-4b052eb8fae1-843	\N	NEW	\N	\N	\N	\N
83596	79	D5170C00002/tiny.path.1/file-2206.pdf	\N	D5170C00002-ac4f4fd7-8316-11eb-be00-43a214a93232-2206	\N	NEW	\N	\N	\N	\N
83597	79	D5170C00002/tiny.path.1/file-2207.pdf	\N	D5170C00002-ac6c4db8-8316-11eb-be00-9d2cfed1345b-2207	\N	NEW	\N	\N	\N	\N
86542	79	D5170C00002/tiny.path.1/file-5152.pdf	\N	D5170C00002-ac6d4cb9-8318-11eb-be00-4b161cc35f1d-5152	\N	NEW	\N	\N	\N	\N
82234	79	D5170C00002/tiny.path.1/file-0844.pdf	\N	D5170C00002-ac6da265-8315-11eb-be00-f12236e5e881-844	\N	NEW	\N	\N	\N	\N
83598	79	D5170C00002/tiny.path.1/file-2208.pdf	\N	D5170C00002-ac7e2809-8316-11eb-be00-c1907ad9ffb1-2208	\N	NEW	\N	\N	\N	\N
83599	79	D5170C00002/tiny.path.1/file-2209.pdf	\N	D5170C00002-ac8d433a-8316-11eb-be00-6b054f3fa89d-2209	\N	NEW	\N	\N	\N	\N
88020	79	D5170C00002/tiny.path.1/file-6630.pdf	\N	D5170C00002-ac8d893f-8319-11eb-be00-53891b28fb8f-6630	\N	NEW	\N	\N	\N	\N
83600	79	D5170C00002/tiny.path.1/file-2210.pdf	\N	D5170C00002-aca9a4db-8316-11eb-be00-e318aa4be044-2210	\N	NEW	\N	\N	\N	\N
83601	79	D5170C00002/tiny.path.1/file-2211.pdf	\N	D5170C00002-acb8c00c-8316-11eb-be00-858d0fac4796-2211	\N	NEW	\N	\N	\N	\N
83602	79	D5170C00002/tiny.path.1/file-2212.pdf	\N	D5170C00002-acca252d-8316-11eb-be00-afecf9d2c419-2212	\N	NEW	\N	\N	\N	\N
86543	79	D5170C00002/tiny.path.1/file-5153.pdf	\N	D5170C00002-acca39ca-8318-11eb-be00-37bada6a749f-5153	\N	NEW	\N	\N	\N	\N
88021	79	D5170C00002/tiny.path.1/file-6631.pdf	\N	D5170C00002-acd91130-8319-11eb-be00-9b4b7b472f32-6631	\N	NEW	\N	\N	\N	\N
82235	79	D5170C00002/tiny.path.1/file-0845.pdf	\N	D5170C00002-ace6a2f6-8315-11eb-be00-fb258325f216-845	\N	NEW	\N	\N	\N	\N
83603	79	D5170C00002/tiny.path.1/file-2213.pdf	\N	D5170C00002-ace6adde-8316-11eb-be00-e9a7399c3561-2213	\N	NEW	\N	\N	\N	\N
88022	79	D5170C00002/tiny.path.1/file-6632.pdf	\N	D5170C00002-acf795b1-8319-11eb-be00-533eeb5d48c7-6632	\N	NEW	\N	\N	\N	\N
83604	79	D5170C00002/tiny.path.1/file-2214.pdf	\N	D5170C00002-ad05807f-8316-11eb-be00-45e82adf702f-2214	\N	NEW	\N	\N	\N	\N
83605	79	D5170C00002/tiny.path.1/file-2215.pdf	\N	D5170C00002-ad14e9d0-8316-11eb-be00-e5d1d9cb50df-2215	\N	NEW	\N	\N	\N	\N
83606	79	D5170C00002/tiny.path.1/file-2216.pdf	\N	D5170C00002-ad25d9c1-8316-11eb-be00-2359c72c40fe-2216	\N	NEW	\N	\N	\N	\N
82236	79	D5170C00002/tiny.path.1/file-0846.pdf	\N	D5170C00002-ad32c727-8315-11eb-be00-019f5d5a17ca-846	\N	NEW	\N	\N	\N	\N
83607	79	D5170C00002/tiny.path.1/file-2217.pdf	\N	D5170C00002-ad34a6d2-8316-11eb-be00-814fbda144fd-2217	\N	NEW	\N	\N	\N	\N
86544	79	D5170C00002/tiny.path.1/file-5154.pdf	\N	D5170C00002-ad43616b-8318-11eb-be00-855f59cbc441-5154	\N	NEW	\N	\N	\N	\N
83608	79	D5170C00002/tiny.path.1/file-2218.pdf	\N	D5170C00002-ad517da3-8316-11eb-be00-c7a59463e490-2218	\N	NEW	\N	\N	\N	\N
85171	79	D5170C00002/tiny.path.1/file-3781.pdf	\N	D5170C00002-ad629f4f-8317-11eb-be00-f17b47ba432a-3782	\N	NEW	\N	\N	\N	\N
88023	79	D5170C00002/tiny.path.1/file-6633.pdf	\N	D5170C00002-ad6f36b2-8319-11eb-be00-850e0d3d8853-6633	\N	NEW	\N	\N	\N	\N
83609	79	D5170C00002/tiny.path.1/file-2219.pdf	\N	D5170C00002-ad70c574-8316-11eb-be00-7bc718593d3c-2219	\N	NEW	\N	\N	\N	\N
86545	79	D5170C00002/tiny.path.1/file-5155.pdf	\N	D5170C00002-ad801c4c-8318-11eb-be00-11c411ce5a62-5155	\N	NEW	\N	\N	\N	\N
82238	79	D5170C00002/tiny.path.1/file-0848.pdf	\N	D5170C00002-ad8071f8-8315-11eb-be00-7b4c06cb7d48-847	\N	NEW	\N	\N	\N	\N
88024	79	D5170C00002/tiny.path.1/file-6634.pdf	\N	D5170C00002-ad9cfd73-8319-11eb-be00-75b377ddde08-6634	\N	NEW	\N	\N	\N	\N
83610	79	D5170C00002/tiny.path.1/file-2220.pdf	\N	D5170C00002-ada0d625-8316-11eb-be00-f97c6cfda0a6-2220	\N	NEW	\N	\N	\N	\N
85172	79	D5170C00002/tiny.path.1/file-3782.pdf	\N	D5170C00002-adae2740-8317-11eb-be00-91fef0f91517-3783	\N	NEW	\N	\N	\N	\N
86546	79	D5170C00002/tiny.path.1/file-5156.pdf	\N	D5170C00002-adbcfe3d-8318-11eb-be00-bf1e0620e96e-5156	\N	NEW	\N	\N	\N	\N
83611	79	D5170C00002/tiny.path.1/file-2221.pdf	\N	D5170C00002-adcb6896-8316-11eb-be00-efbef7a2e843-2221	\N	NEW	\N	\N	\N	\N
85173	79	D5170C00002/tiny.path.1/file-3783.pdf	\N	D5170C00002-adccf9e1-8317-11eb-be00-c7ec6d9b36cf-3784	\N	NEW	\N	\N	\N	\N
82237	79	D5170C00002/tiny.path.1/file-0847.pdf	\N	D5170C00002-adcdcea9-8315-11eb-be00-7f37be09d8bd-848	\N	NEW	\N	\N	\N	\N
85174	79	D5170C00002/tiny.path.1/file-3784.pdf	\N	D5170C00002-addb51c2-8317-11eb-be00-75bef84af81e-3785	\N	NEW	\N	\N	\N	\N
83612	79	D5170C00002/tiny.path.1/file-2222.pdf	\N	D5170C00002-addb6e27-8316-11eb-be00-33b3f71af99a-2222	\N	NEW	\N	\N	\N	\N
88025	79	D5170C00002/tiny.path.1/file-6635.pdf	\N	D5170C00002-adea3314-8319-11eb-be00-a3126b733b04-6635	\N	NEW	\N	\N	\N	\N
83613	79	D5170C00002/tiny.path.1/file-2223.pdf	\N	D5170C00002-adebc1d8-8316-11eb-be00-ab79ffd9bf2f-2223	\N	NEW	\N	\N	\N	\N
85175	79	D5170C00002/tiny.path.1/file-3785.pdf	\N	D5170C00002-adfb0ec3-8317-11eb-be00-b3961eb598c3-3786	\N	NEW	\N	\N	\N	\N
86547	79	D5170C00002/tiny.path.1/file-5157.pdf	\N	D5170C00002-ae0810fe-8318-11eb-be00-e73828742309-5157	\N	NEW	\N	\N	\N	\N
88035	79	D5170C00002/tiny.path.1/file-6645.pdf	\N	D5170C00002-ae0a3e35-8319-11eb-be00-33233713d657-6636	\N	NEW	\N	\N	\N	\N
85176	79	D5170C00002/tiny.path.1/file-3786.pdf	\N	D5170C00002-ae194524-8317-11eb-be00-fde6530d4031-3787	\N	NEW	\N	\N	\N	\N
88036	79	D5170C00002/tiny.path.1/file-6646.pdf	\N	D5170C00002-ae19ce96-8319-11eb-be00-3b3e083246a0-6637	\N	NEW	\N	\N	\N	\N
83614	79	D5170C00002/tiny.path.1/file-2224.pdf	\N	D5170C00002-ae28f1e9-8316-11eb-be00-3d6f8825a386-2224	\N	NEW	\N	\N	\N	\N
88037	79	D5170C00002/tiny.path.1/file-6647.pdf	\N	D5170C00002-ae35bb07-8319-11eb-be00-2b48358e9ea3-6638	\N	NEW	\N	\N	\N	\N
85177	79	D5170C00002/tiny.path.1/file-3787.pdf	\N	D5170C00002-ae35f4e5-8317-11eb-be00-d9a45d555d45-3788	\N	NEW	\N	\N	\N	\N
82239	79	D5170C00002/tiny.path.1/file-0849.pdf	\N	D5170C00002-ae362d6a-8315-11eb-be00-9304ba0697e0-849	\N	NEW	\N	\N	\N	\N
86548	79	D5170C00002/tiny.path.1/file-5158.pdf	\N	D5170C00002-ae37fa9f-8318-11eb-be00-c11fefa90b8a-5158	\N	NEW	\N	\N	\N	\N
83615	79	D5170C00002/tiny.path.1/file-2225.pdf	\N	D5170C00002-ae47013a-8316-11eb-be00-9d3f008ec133-2225	\N	NEW	\N	\N	\N	\N
85178	79	D5170C00002/tiny.path.1/file-3788.pdf	\N	D5170C00002-ae470be6-8317-11eb-be00-23a9d1ee7d13-3789	\N	NEW	\N	\N	\N	\N
88026	79	D5170C00002/tiny.path.1/file-6636.pdf	\N	D5170C00002-ae53f168-8319-11eb-be00-c1cfbf503ff9-6639	\N	NEW	\N	\N	\N	\N
88027	79	D5170C00002/tiny.path.1/file-6637.pdf	\N	D5170C00002-ae6619d9-8319-11eb-be00-e9fc884ce783-6640	\N	NEW	\N	\N	\N	\N
83616	79	D5170C00002/tiny.path.1/file-2226.pdf	\N	D5170C00002-ae66be3b-8316-11eb-be00-9b16169bf311-2226	\N	NEW	\N	\N	\N	\N
86549	79	D5170C00002/tiny.path.1/file-5159.pdf	\N	D5170C00002-ae72e0c0-8318-11eb-be00-11c42a3b9af5-5159	\N	NEW	\N	\N	\N	\N
88028	79	D5170C00002/tiny.path.1/file-6638.pdf	\N	D5170C00002-ae73fc8a-8319-11eb-be00-43994f02342b-6641	\N	NEW	\N	\N	\N	\N
85179	79	D5170C00002/tiny.path.1/file-3789.pdf	\N	D5170C00002-ae74d2a7-8317-11eb-be00-2be5abf64925-3790	\N	NEW	\N	\N	\N	\N
82240	79	D5170C00002/tiny.path.1/file-0850.pdf	\N	D5170C00002-ae74e41b-8315-11eb-be00-bb3fc5161bbf-850	\N	NEW	\N	\N	\N	\N
88029	79	D5170C00002/tiny.path.1/file-6639.pdf	\N	D5170C00002-ae74e6eb-8319-11eb-be00-15b70e4b1f00-6642	\N	NEW	\N	\N	\N	\N
88030	79	D5170C00002/tiny.path.1/file-6640.pdf	\N	D5170C00002-ae84503c-8319-11eb-be00-c5eab76f8161-6643	\N	NEW	\N	\N	\N	\N
83617	79	D5170C00002/tiny.path.1/file-2227.pdf	\N	D5170C00002-ae84a67c-8316-11eb-be00-8336d0b5ef78-2227	\N	NEW	\N	\N	\N	\N
85180	79	D5170C00002/tiny.path.1/file-3790.pdf	\N	D5170C00002-ae9245b8-8317-11eb-be00-3da6b6ba845a-3791	\N	NEW	\N	\N	\N	\N
86550	79	D5170C00002/tiny.path.1/file-5160.pdf	\N	D5170C00002-ae9312f1-8318-11eb-be00-e3cd2716e670-5160	\N	NEW	\N	\N	\N	\N
88031	79	D5170C00002/tiny.path.1/file-6641.pdf	\N	D5170C00002-ae931d4d-8319-11eb-be00-f3a6f84b44f7-6644	\N	NEW	\N	\N	\N	\N
86551	79	D5170C00002/tiny.path.1/file-5161.pdf	\N	D5170C00002-aea25532-8318-11eb-be00-89187747a3e6-5161	\N	NEW	\N	\N	\N	\N
83618	79	D5170C00002/tiny.path.1/file-2228.pdf	\N	D5170C00002-aea28ebd-8316-11eb-be00-818568ecb4b4-2228	\N	NEW	\N	\N	\N	\N
82241	79	D5170C00002/tiny.path.1/file-0851.pdf	\N	D5170C00002-aea36e2c-8315-11eb-be00-79e6042485a0-851	\N	NEW	\N	\N	\N	\N
88032	79	D5170C00002/tiny.path.1/file-6642.pdf	\N	D5170C00002-aeaf57de-8319-11eb-be00-7b52092f4b33-6645	\N	NEW	\N	\N	\N	\N
88033	79	D5170C00002/tiny.path.1/file-6643.pdf	\N	D5170C00002-aebf847f-8319-11eb-be00-75f787ee8276-6646	\N	NEW	\N	\N	\N	\N
85181	79	D5170C00002/tiny.path.1/file-3791.pdf	\N	D5170C00002-aebfbe59-8317-11eb-be00-65c00836fd68-3792	\N	NEW	\N	\N	\N	\N
86552	79	D5170C00002/tiny.path.1/file-5162.pdf	\N	D5170C00002-aece2023-8318-11eb-be00-dd618ec0542d-5162	\N	NEW	\N	\N	\N	\N
83619	79	D5170C00002/tiny.path.1/file-2229.pdf	\N	D5170C00002-aececede-8316-11eb-be00-e708cd47cc90-2229	\N	NEW	\N	\N	\N	\N
88034	79	D5170C00002/tiny.path.1/file-6644.pdf	\N	D5170C00002-aecfd830-8319-11eb-be00-6d3a6d27c315-6647	\N	NEW	\N	\N	\N	\N
82242	79	D5170C00002/tiny.path.1/file-0852.pdf	\N	D5170C00002-aed098ad-8315-11eb-be00-3dd09ef1b2c4-852	\N	NEW	\N	\N	\N	\N
83620	79	D5170C00002/tiny.path.1/file-2230.pdf	\N	D5170C00002-aed0a39f-8316-11eb-be00-07b5849d760b-2230	\N	NEW	\N	\N	\N	\N
83621	79	D5170C00002/tiny.path.1/file-2231.pdf	\N	D5170C00002-aeed2c50-8316-11eb-be00-21b5bb6881d8-2231	\N	NEW	\N	\N	\N	\N
86553	79	D5170C00002/tiny.path.1/file-5163.pdf	\N	D5170C00002-aefef424-8318-11eb-be00-47eb8e66941b-5163	\N	NEW	\N	\N	\N	\N
83622	79	D5170C00002/tiny.path.1/file-2232.pdf	\N	D5170C00002-af0d5e81-8316-11eb-be00-416d7b5c6264-2232	\N	NEW	\N	\N	\N	\N
88038	79	D5170C00002/tiny.path.1/file-6648.pdf	\N	D5170C00002-af0dcb91-8319-11eb-be00-ebc01a2791bb-6648	\N	NEW	\N	\N	\N	\N
85182	79	D5170C00002/tiny.path.1/file-3792.pdf	\N	D5170C00002-af0e056a-8317-11eb-be00-a1b4330a6d45-3793	\N	NEW	\N	\N	\N	\N
83623	79	D5170C00002/tiny.path.1/file-2233.pdf	\N	D5170C00002-af1acc02-8316-11eb-be00-6ddfd7be81cc-2233	\N	NEW	\N	\N	\N	\N
88039	79	D5170C00002/tiny.path.1/file-6649.pdf	\N	D5170C00002-af1cbfb2-8319-11eb-be00-251e8c336757-6649	\N	NEW	\N	\N	\N	\N
83624	79	D5170C00002/tiny.path.1/file-2234.pdf	\N	D5170C00002-af29e733-8316-11eb-be00-f1d292155884-2234	\N	NEW	\N	\N	\N	\N
88040	79	D5170C00002/tiny.path.1/file-6650.pdf	\N	D5170C00002-af2b65b3-8319-11eb-be00-cb81b2d4c1c2-6650	\N	NEW	\N	\N	\N	\N
85183	79	D5170C00002/tiny.path.1/file-3793.pdf	\N	D5170C00002-af2c62db-8317-11eb-be00-557778ed33df-3794	\N	NEW	\N	\N	\N	\N
86554	79	D5170C00002/tiny.path.1/file-5164.pdf	\N	D5170C00002-af39b335-8318-11eb-be00-7518db47815b-5164	\N	NEW	\N	\N	\N	\N
86555	79	D5170C00002/tiny.path.1/file-5165.pdf	\N	D5170C00002-af3b60e6-8318-11eb-be00-1f1c5dd300d2-5165	\N	NEW	\N	\N	\N	\N
82243	79	D5170C00002/tiny.path.1/file-0853.pdf	\N	D5170C00002-af48d5ee-8315-11eb-be00-d31083de1494-853	\N	NEW	\N	\N	\N	\N
83625	79	D5170C00002/tiny.path.1/file-2235.pdf	\N	D5170C00002-af57d504-8316-11eb-be00-dd8fe78c2f8d-2235	\N	NEW	\N	\N	\N	\N
85184	79	D5170C00002/tiny.path.1/file-3794.pdf	\N	D5170C00002-af59664c-8317-11eb-be00-67a0e7f167bb-3795	\N	NEW	\N	\N	\N	\N
88041	79	D5170C00002/tiny.path.1/file-6651.pdf	\N	D5170C00002-af673634-8319-11eb-be00-d5053d399127-6651	\N	NEW	\N	\N	\N	\N
83626	79	D5170C00002/tiny.path.1/file-2236.pdf	\N	D5170C00002-af693a25-8316-11eb-be00-3b31f366ea2f-2236	\N	NEW	\N	\N	\N	\N
88042	79	D5170C00002/tiny.path.1/file-6652.pdf	\N	D5170C00002-af769f85-8319-11eb-be00-cde97bfe0602-6652	\N	NEW	\N	\N	\N	\N
86556	79	D5170C00002/tiny.path.1/file-5166.pdf	\N	D5170C00002-af76bc37-8318-11eb-be00-215e15d059b8-5166	\N	NEW	\N	\N	\N	\N
85185	79	D5170C00002/tiny.path.1/file-3795.pdf	\N	D5170C00002-af85a66d-8317-11eb-be00-776a4b548e7f-3796	\N	NEW	\N	\N	\N	\N
83627	79	D5170C00002/tiny.path.1/file-2237.pdf	\N	D5170C00002-af885ae6-8316-11eb-be00-e390e1b506f7-2237	\N	NEW	\N	\N	\N	\N
88043	79	D5170C00002/tiny.path.1/file-6653.pdf	\N	D5170C00002-af94aed6-8319-11eb-be00-ad722a875af0-6653	\N	NEW	\N	\N	\N	\N
86557	79	D5170C00002/tiny.path.1/file-5167.pdf	\N	D5170C00002-af94cb88-8318-11eb-be00-6bd6864a5164-5167	\N	NEW	\N	\N	\N	\N
82244	79	D5170C00002/tiny.path.1/file-0854.pdf	\N	D5170C00002-af94fa1f-8315-11eb-be00-e96b653c07f7-854	\N	NEW	\N	\N	\N	\N
85186	79	D5170C00002/tiny.path.1/file-3796.pdf	\N	D5170C00002-af96965e-8317-11eb-be00-31d3caf46c56-3797	\N	NEW	\N	\N	\N	\N
86558	79	D5170C00002/tiny.path.1/file-5168.pdf	\N	D5170C00002-afa3bfa9-8318-11eb-be00-9dbefbee8e30-5168	\N	NEW	\N	\N	\N	\N
88044	79	D5170C00002/tiny.path.1/file-6654.pdf	\N	D5170C00002-afa59ec7-8319-11eb-be00-a395d0793e1f-6654	\N	NEW	\N	\N	\N	\N
86559	79	D5170C00002/tiny.path.1/file-5169.pdf	\N	D5170C00002-afa6ccea-8318-11eb-be00-c779a4e2a412-5169	\N	NEW	\N	\N	\N	\N
83628	79	D5170C00002/tiny.path.1/file-2238.pdf	\N	D5170C00002-afb3d7b7-8316-11eb-be00-55c8547c1f3a-2238	\N	NEW	\N	\N	\N	\N
88045	79	D5170C00002/tiny.path.1/file-6655.pdf	\N	D5170C00002-afc22778-8319-11eb-be00-b35596787516-6655	\N	NEW	\N	\N	\N	\N
83629	79	D5170C00002/tiny.path.1/file-2239.pdf	\N	D5170C00002-afc563e8-8316-11eb-be00-3d70090d7fbe-2239	\N	NEW	\N	\N	\N	\N
83630	79	D5170C00002/tiny.path.1/file-2240.pdf	\N	D5170C00002-afe12949-8316-11eb-be00-01d8383b87bb-2240	\N	NEW	\N	\N	\N	\N
88046	79	D5170C00002/tiny.path.1/file-6656.pdf	\N	D5170C00002-afe1bd69-8319-11eb-be00-b914bcbd7b30-6656	\N	NEW	\N	\N	\N	\N
86560	79	D5170C00002/tiny.path.1/file-5170.pdf	\N	D5170C00002-aff16a7b-8318-11eb-be00-ad292529f3ae-5170	\N	NEW	\N	\N	\N	\N
85187	79	D5170C00002/tiny.path.1/file-3797.pdf	\N	D5170C00002-aff24aef-8317-11eb-be00-b714d2a2fb28-3798	\N	NEW	\N	\N	\N	\N
82245	79	D5170C00002/tiny.path.1/file-0855.pdf	\N	D5170C00002-aff2aa80-8315-11eb-be00-7526c22e4da5-855	\N	NEW	\N	\N	\N	\N
83631	79	D5170C00002/tiny.path.1/file-2241.pdf	\N	D5170C00002-aff2b57a-8316-11eb-be00-95c9d81c1b28-2241	\N	NEW	\N	\N	\N	\N
85188	79	D5170C00002/tiny.path.1/file-3798.pdf	\N	D5170C00002-b000eff0-8317-11eb-be00-5fab308ea6fc-3799	\N	NEW	\N	\N	\N	\N
83632	79	D5170C00002/tiny.path.1/file-2242.pdf	\N	D5170C00002-b00f3e2b-8316-11eb-be00-7731769d33e3-2242	\N	NEW	\N	\N	\N	\N
83633	79	D5170C00002/tiny.path.1/file-2243.pdf	\N	D5170C00002-b01e324c-8316-11eb-be00-4f09985ace43-2243	\N	NEW	\N	\N	\N	\N
82246	79	D5170C00002/tiny.path.1/file-0856.pdf	\N	D5170C00002-b01ec391-8315-11eb-be00-8b79d553b908-856	\N	NEW	\N	\N	\N	\N
83634	79	D5170C00002/tiny.path.1/file-2244.pdf	\N	D5170C00002-b01fb8ed-8316-11eb-be00-05af828d2428-2244	\N	NEW	\N	\N	\N	\N
86561	79	D5170C00002/tiny.path.1/file-5171.pdf	\N	D5170C00002-b02042ac-8318-11eb-be00-d191d808d3c8-5171	\N	NEW	\N	\N	\N	\N
85189	79	D5170C00002/tiny.path.1/file-3799.pdf	\N	D5170C00002-b02d5721-8317-11eb-be00-7742159f4936-3800	\N	NEW	\N	\N	\N	\N
88047	79	D5170C00002/tiny.path.1/file-6657.pdf	\N	D5170C00002-b02d6c6a-8319-11eb-be00-274677672e81-6657	\N	NEW	\N	\N	\N	\N
85190	79	D5170C00002/tiny.path.1/file-3800.pdf	\N	D5170C00002-b04cc602-8317-11eb-be00-658ee0c8c6ed-3801	\N	NEW	\N	\N	\N	\N
86562	79	D5170C00002/tiny.path.1/file-5172.pdf	\N	D5170C00002-b05ab39d-8318-11eb-be00-73ef0575f37b-5172	\N	NEW	\N	\N	\N	\N
83635	79	D5170C00002/tiny.path.1/file-2245.pdf	\N	D5170C00002-b05c73ce-8316-11eb-be00-bfce9a1d28f3-2245	\N	NEW	\N	\N	\N	\N
82247	79	D5170C00002/tiny.path.1/file-0857.pdf	\N	D5170C00002-b06cbc82-8315-11eb-be00-9dc62d6c00dc-857	\N	NEW	\N	\N	\N	\N
85191	79	D5170C00002/tiny.path.1/file-3801.pdf	\N	D5170C00002-b07c8893-8317-11eb-be00-c3677be01332-3802	\N	NEW	\N	\N	\N	\N
86563	79	D5170C00002/tiny.path.1/file-5173.pdf	\N	D5170C00002-b088534e-8318-11eb-be00-152690f6fa33-5173	\N	NEW	\N	\N	\N	\N
88048	79	D5170C00002/tiny.path.1/file-6658.msg	\N	D5170C00002-b09a5f0b-8319-11eb-be00-9b28c4f7786c-6658	\N	NEW	\N	\N	\N	\N
85192	79	D5170C00002/tiny.path.1/file-3802.pdf	\N	D5170C00002-b0a98c04-8317-11eb-be00-013ffb5920cd-3803	\N	NEW	\N	\N	\N	\N
86564	79	D5170C00002/tiny.path.1/file-5174.pdf	\N	D5170C00002-b0b61a0f-8318-11eb-be00-abcf1c8af4c3-5174	\N	NEW	\N	\N	\N	\N
88049	79	D5170C00002/tiny.path.1/file-6659.msg	\N	D5170C00002-b0c7898c-8319-11eb-be00-d3204b4c7f4d-6659	\N	NEW	\N	\N	\N	\N
86565	79	D5170C00002/tiny.path.1/file-5175.pdf	\N	D5170C00002-b0e47d10-8318-11eb-be00-7bf86f3b6a62-5175	\N	NEW	\N	\N	\N	\N
86566	79	D5170C00002/tiny.path.1/file-5176.pdf	\N	D5170C00002-b0f51ee1-8318-11eb-be00-c754bca14f7c-5176	\N	NEW	\N	\N	\N	\N
82248	79	D5170C00002/tiny.path.1/file-0858.pdf	\N	D5170C00002-b0f6d413-8315-11eb-be00-6d27fd04428a-858	\N	NEW	\N	\N	\N	\N
88050	79	D5170C00002/tiny.path.1/file-6660.msg	\N	D5170C00002-b112000d-8319-11eb-be00-55b26f2e932b-6660	\N	NEW	\N	\N	\N	\N
82249	79	D5170C00002/tiny.path.1/file-0859.pdf	\N	D5170C00002-b1129974-8315-11eb-be00-b39b37190b27-859	\N	NEW	\N	\N	\N	\N
85193	79	D5170C00002/tiny.path.1/file-3803.pdf	\N	D5170C00002-b112ae15-8317-11eb-be00-59211480c977-3804	\N	NEW	\N	\N	\N	\N
82250	79	D5170C00002/tiny.path.1/file-0860.pdf	\N	D5170C00002-b1249ad5-8315-11eb-be00-f7feeb21719c-860	\N	NEW	\N	\N	\N	\N
88051	79	D5170C00002/tiny.path.1/file-6661.msg	\N	D5170C00002-b14f7e3e-8319-11eb-be00-69085df7dfbe-6661	\N	NEW	\N	\N	\N	\N
82251	79	D5170C00002/tiny.path.1/file-0861.pdf	\N	D5170C00002-b15fcf16-8315-11eb-be00-c57a616acd61-861	\N	NEW	\N	\N	\N	\N
82252	79	D5170C00002/tiny.path.1/file-0862.pdf	\N	D5170C00002-b17f16e7-8315-11eb-be00-eba4c307bf42-862	\N	NEW	\N	\N	\N	\N
88052	79	D5170C00002/tiny.path.1/file-6662.msg	\N	D5170C00002-b1aabd9f-8319-11eb-be00-57082d8c57b2-6662	\N	NEW	\N	\N	\N	\N
82253	79	D5170C00002/tiny.path.1/file-0863.pdf	\N	D5170C00002-b1bc46f8-8315-11eb-be00-6721de7fffc5-863	\N	NEW	\N	\N	\N	\N
85195	79	D5170C00002/tiny.path.1/file-3805.pdf	\N	D5170C00002-b1cada86-8317-11eb-be00-4bffb53acbd1-3805	\N	NEW	\N	\N	\N	\N
88053	79	D5170C00002/tiny.path.1/file-6663.msg	\N	D5170C00002-b1d9e3f0-8319-11eb-be00-050437b62e07-6663	\N	NEW	\N	\N	\N	\N
85196	79	D5170C00002/tiny.path.1/file-3806.pdf	\N	D5170C00002-b1f7ddf7-8317-11eb-be00-89ff3cbf8787-3806	\N	NEW	\N	\N	\N	\N
82254	79	D5170C00002/tiny.path.1/file-0864.pdf	\N	D5170C00002-b21626c9-8315-11eb-be00-0de79273c059-864	\N	NEW	\N	\N	\N	\N
86567	79	D5170C00002/tiny.path.1/file-5177.pdf	\N	D5170C00002-b2169472-8318-11eb-be00-fb494d59b9cf-5177	\N	NEW	\N	\N	\N	\N
88054	79	D5170C00002/tiny.path.1/file-6664.msg	\N	D5170C00002-b2169ed1-8319-11eb-be00-9fd6ea1b2a34-6664	\N	NEW	\N	\N	\N	\N
83636	79	D5170C00002/tiny.path.1/file-2246.pdf	\N	D5170C00002-b226d38f-8316-11eb-be00-89867435f655-2246	\N	NEW	\N	\N	\N	\N
86568	79	D5170C00002/tiny.path.1/file-5178.pdf	\N	D5170C00002-b2465703-8318-11eb-be00-b72017c2a403-5178	\N	NEW	\N	\N	\N	\N
88055	79	D5170C00002/tiny.path.1/file-6665.msg	\N	D5170C00002-b2541d02-8319-11eb-be00-27144dd57608-6665	\N	NEW	\N	\N	\N	\N
82255	79	D5170C00002/tiny.path.1/file-0865.pdf	\N	D5170C00002-b25579ba-8315-11eb-be00-3fa1d548cbe8-865	\N	NEW	\N	\N	\N	\N
85197	79	D5170C00002/tiny.path.1/file-3807.pdf	\N	D5170C00002-b262d4c8-8317-11eb-be00-5d728e7be3f9-3807	\N	NEW	\N	\N	\N	\N
88056	79	D5170C00002/tiny.path.1/file-6666.msg	\N	D5170C00002-b2719013-8319-11eb-be00-73f9f294e3d0-6666	\N	NEW	\N	\N	\N	\N
82256	79	D5170C00002/tiny.path.1/file-0866.pdf	\N	D5170C00002-b2733aeb-8315-11eb-be00-3b1dc0cc996f-866	\N	NEW	\N	\N	\N	\N
86569	79	D5170C00002/tiny.path.1/file-5179.pdf	\N	D5170C00002-b280a0e4-8318-11eb-be00-2304f5512e56-5179	\N	NEW	\N	\N	\N	\N
88057	79	D5170C00002/tiny.path.1/file-6667.msg	\N	D5170C00002-b2834354-8319-11eb-be00-09410ffd0241-6667	\N	NEW	\N	\N	\N	\N
83637	79	D5170C00002/tiny.path.1/file-2247.pdf	\N	D5170C00002-b2923f90-8316-11eb-be00-53e8c8210206-2247	\N	NEW	\N	\N	\N	\N
88058	79	D5170C00002/tiny.path.1/file-6668.msg	\N	D5170C00002-b29f08b5-8319-11eb-be00-8f49ceaebd15-6668	\N	NEW	\N	\N	\N	\N
85198	79	D5170C00002/tiny.path.1/file-3808.pdf	\N	D5170C00002-b2aef8f9-8317-11eb-be00-e739d76eecd6-3808	\N	NEW	\N	\N	\N	\N
82257	79	D5170C00002/tiny.path.1/file-0867.pdf	\N	D5170C00002-b2bdd87c-8315-11eb-be00-33a8407b2489-867	\N	NEW	\N	\N	\N	\N
88059	79	D5170C00002/tiny.path.1/file-6669.msg	\N	D5170C00002-b2be2976-8319-11eb-be00-c9abbf806f35-6669	\N	NEW	\N	\N	\N	\N
86570	79	D5170C00002/tiny.path.1/file-5180.pdf	\N	D5170C00002-b2ccec25-8318-11eb-be00-2f6504cbc3a6-5180	\N	NEW	\N	\N	\N	\N
83638	79	D5170C00002/tiny.path.1/file-2248.pdf	\N	D5170C00002-b2cd73d1-8316-11eb-be00-2bb9ca4aeeec-2248	\N	NEW	\N	\N	\N	\N
88060	79	D5170C00002/tiny.path.1/file-6670.msg	\N	D5170C00002-b2ce7d27-8319-11eb-be00-5997d877b485-6670	\N	NEW	\N	\N	\N	\N
86571	79	D5170C00002/tiny.path.1/file-5181.pdf	\N	D5170C00002-b2eb97b6-8318-11eb-be00-f56dd9e35455-5181	\N	NEW	\N	\N	\N	\N
82258	79	D5170C00002/tiny.path.1/file-0868.pdf	\N	D5170C00002-b2eb9f3d-8315-11eb-be00-e3e1613bc992-868	\N	NEW	\N	\N	\N	\N
82259	79	D5170C00002/tiny.path.1/file-0869.pdf	\N	D5170C00002-b2fb088e-8315-11eb-be00-939452cdff74-869	\N	NEW	\N	\N	\N	\N
86572	79	D5170C00002/tiny.path.1/file-5182.pdf	\N	D5170C00002-b30a4347-8318-11eb-be00-9748830138c0-5182	\N	NEW	\N	\N	\N	\N
82260	79	D5170C00002/tiny.path.1/file-0870.pdf	\N	D5170C00002-b30c6daf-8315-11eb-be00-311d7c19c436-870	\N	NEW	\N	\N	\N	\N
88061	79	D5170C00002/tiny.path.1/file-6671.msg	\N	D5170C00002-b31968d8-8319-11eb-be00-0f9e2a8e5c90-6671	\N	NEW	\N	\N	\N	\N
85199	79	D5170C00002/tiny.path.1/file-3809.pdf	\N	D5170C00002-b319c8ba-8317-11eb-be00-3f8be2157424-3809	\N	NEW	\N	\N	\N	\N
88062	79	D5170C00002/tiny.path.1/file-6672.msg	\N	D5170C00002-b32a0aa9-8319-11eb-be00-49945ee9748e-6672	\N	NEW	\N	\N	\N	\N
83639	79	D5170C00002/tiny.path.1/file-2249.pdf	\N	D5170C00002-b32a87f2-8316-11eb-be00-41abc50ed1ff-2249	\N	NEW	\N	\N	\N	\N
86573	79	D5170C00002/tiny.path.1/file-5183.pdf	\N	D5170C00002-b348d2e8-8318-11eb-be00-f5e06b9375e0-5183	\N	NEW	\N	\N	\N	\N
83640	79	D5170C00002/tiny.path.1/file-2250.pdf	\N	D5170C00002-b3562bd3-8316-11eb-be00-47b1ab3cfcf5-2250	\N	NEW	\N	\N	\N	\N
86574	79	D5170C00002/tiny.path.1/file-5184.pdf	\N	D5170C00002-b365a9b9-8318-11eb-be00-1d9ce3335cda-5184	\N	NEW	\N	\N	\N	\N
88063	79	D5170C00002/tiny.path.1/file-6673.pdf	\N	D5170C00002-b366505a-8319-11eb-be00-0955612048b1-6673	\N	NEW	\N	\N	\N	\N
83641	79	D5170C00002/tiny.path.1/file-2251.pdf	\N	D5170C00002-b374b054-8316-11eb-be00-737681dd5d51-2251	\N	NEW	\N	\N	\N	\N
86575	79	D5170C00002/tiny.path.1/file-5185.pdf	\N	D5170C00002-b375af4a-8318-11eb-be00-b34f7e30e821-5185	\N	NEW	\N	\N	\N	\N
85200	79	D5170C00002/tiny.path.1/file-3810.pdf	\N	D5170C00002-b3855bcb-8317-11eb-be00-79bbb1a037f1-3810	\N	NEW	\N	\N	\N	\N
86576	79	D5170C00002/tiny.path.1/file-5186.pdf	\N	D5170C00002-b392ad2b-8318-11eb-be00-cbec0b59b037-5186	\N	NEW	\N	\N	\N	\N
88064	79	D5170C00002/tiny.path.1/file-6674.pdf	\N	D5170C00002-b393f00b-8319-11eb-be00-6140f770f438-6674	\N	NEW	\N	\N	\N	\N
83642	79	D5170C00002/tiny.path.1/file-2252.pdf	\N	D5170C00002-b393f825-8316-11eb-be00-656ff840633d-2252	\N	NEW	\N	\N	\N	\N
86577	79	D5170C00002/tiny.path.1/file-5187.pdf	\N	D5170C00002-b39433cc-8318-11eb-be00-618ec8e869f6-5187	\N	NEW	\N	\N	\N	\N
88065	79	D5170C00002/tiny.path.1/file-6675.pdf	\N	D5170C00002-b3b1631c-8319-11eb-be00-e57be9d131b5-6675	\N	NEW	\N	\N	\N	\N
83643	79	D5170C00002/tiny.path.1/file-2253.pdf	\N	D5170C00002-b3b22e86-8316-11eb-be00-49ea7a9152e1-2253	\N	NEW	\N	\N	\N	\N
86578	79	D5170C00002/tiny.path.1/file-5188.pdf	\N	D5170C00002-b3b2431d-8318-11eb-be00-1d75fe5c80cc-5188	\N	NEW	\N	\N	\N	\N
85201	79	D5170C00002/tiny.path.1/file-3811.pdf	\N	D5170C00002-b3b3228c-8317-11eb-be00-4951841f7211-3811	\N	NEW	\N	\N	\N	\N
82261	79	D5170C00002/tiny.path.1/file-0871.pdf	\N	D5170C00002-b3b35c10-8315-11eb-be00-23dfec8241cc-871	\N	NEW	\N	\N	\N	\N
88066	79	D5170C00002/tiny.path.1/file-6676.pdf	\N	D5170C00002-b3b3ad0d-8319-11eb-be00-6193589c8d2a-6676	\N	NEW	\N	\N	\N	\N
86579	79	D5170C00002/tiny.path.1/file-5189.pdf	\N	D5170C00002-b3df6d9e-8318-11eb-be00-5729e01e6529-5189	\N	NEW	\N	\N	\N	\N
88067	79	D5170C00002/tiny.path.1/file-6677.pdf	\N	D5170C00002-b3eff2be-8319-11eb-be00-69aacea55b8b-6677	\N	NEW	\N	\N	\N	\N
86580	79	D5170C00002/tiny.path.1/file-5190.pdf	\N	D5170C00002-b3ff2a9f-8318-11eb-be00-656d28fd2f13-5190	\N	NEW	\N	\N	\N	\N
85202	79	D5170C00002/tiny.path.1/file-3812.pdf	\N	D5170C00002-b400582d-8317-11eb-be00-8f394e93f304-3812	\N	NEW	\N	\N	\N	\N
82262	79	D5170C00002/tiny.path.1/file-0872.pdf	\N	D5170C00002-b40091b1-8315-11eb-be00-41c88e833653-872	\N	NEW	\N	\N	\N	\N
86581	79	D5170C00002/tiny.path.1/file-5191.pdf	\N	D5170C00002-b40e93f0-8318-11eb-be00-5d7ba6ce662a-5191	\N	NEW	\N	\N	\N	\N
88068	79	D5170C00002/tiny.path.1/file-6678.pdf	\N	D5170C00002-b41e2eaf-8319-11eb-be00-e92ee6aa762f-6678	\N	NEW	\N	\N	\N	\N
85203	79	D5170C00002/tiny.path.1/file-3813.pdf	\N	D5170C00002-b42b86de-8317-11eb-be00-1d9523f7338b-3813	\N	NEW	\N	\N	\N	\N
83644	79	D5170C00002/tiny.path.1/file-2254.pdf	\N	D5170C00002-b42c1977-8316-11eb-be00-81b88aa1a1e3-2254	\N	NEW	\N	\N	\N	\N
86582	79	D5170C00002/tiny.path.1/file-5192.pdf	\N	D5170C00002-b42c7c31-8318-11eb-be00-ef3c7c85bae0-5192	\N	NEW	\N	\N	\N	\N
85204	79	D5170C00002/tiny.path.1/file-3814.pdf	\N	D5170C00002-b43b3e4f-8317-11eb-be00-cd6dc1c6820e-3814	\N	NEW	\N	\N	\N	\N
88069	79	D5170C00002/tiny.path.1/file-6679.pdf	\N	D5170C00002-b43befe0-8319-11eb-be00-0f35dc8ee5db-6679	\N	NEW	\N	\N	\N	\N
82263	79	D5170C00002/tiny.path.1/file-0873.pdf	\N	D5170C00002-b44ba472-8315-11eb-be00-45656138a8dd-873	\N	NEW	\N	\N	\N	\N
86583	79	D5170C00002/tiny.path.1/file-5193.pdf	\N	D5170C00002-b459f4d2-8318-11eb-be00-15dd867da0e9-5193	\N	NEW	\N	\N	\N	\N
85205	79	D5170C00002/tiny.path.1/file-3815.pdf	\N	D5170C00002-b468b6f0-8317-11eb-be00-8dab7ec572ea-3815	\N	NEW	\N	\N	\N	\N
82264	79	D5170C00002/tiny.path.1/file-0874.pdf	\N	D5170C00002-b46965a3-8315-11eb-be00-7b31761af341-874	\N	NEW	\N	\N	\N	\N
83645	79	D5170C00002/tiny.path.1/file-2255.pdf	\N	D5170C00002-b46a8208-8316-11eb-be00-3301aebe4953-2255	\N	NEW	\N	\N	\N	\N
86584	79	D5170C00002/tiny.path.1/file-5194.pdf	\N	D5170C00002-b46b32e3-8318-11eb-be00-d933f94435c2-5194	\N	NEW	\N	\N	\N	\N
83646	79	D5170C00002/tiny.path.1/file-2256.pdf	\N	D5170C00002-b47a3979-8316-11eb-be00-e145d4616f07-2256	\N	NEW	\N	\N	\N	\N
86585	79	D5170C00002/tiny.path.1/file-5195.pdf	\N	D5170C00002-b4874664-8318-11eb-be00-4d3ce275416e-5195	\N	NEW	\N	\N	\N	\N
88070	79	D5170C00002/tiny.path.1/file-6680.pdf	\N	D5170C00002-b489c1c1-8319-11eb-be00-f3813b5d38ae-6680	\N	NEW	\N	\N	\N	\N
83647	79	D5170C00002/tiny.path.1/file-2257.pdf	\N	D5170C00002-b4975e6a-8316-11eb-be00-a7088cb6699e-2257	\N	NEW	\N	\N	\N	\N
86586	79	D5170C00002/tiny.path.1/file-5196.pdf	\N	D5170C00002-b4a68e35-8318-11eb-be00-ad60369f0799-5196	\N	NEW	\N	\N	\N	\N
82265	79	D5170C00002/tiny.path.1/file-0875.pdf	\N	D5170C00002-b4a731f4-8315-11eb-be00-d978a2035f38-875	\N	NEW	\N	\N	\N	\N
88071	79	D5170C00002/tiny.path.1/file-6681.pdf	\N	D5170C00002-b4a782f2-8319-11eb-be00-59a4d3e97fd0-6681	\N	NEW	\N	\N	\N	\N
88072	79	D5170C00002/tiny.path.1/file-6682.pdf	\N	D5170C00002-b4b6ec43-8319-11eb-be00-455c0e51639e-6682	\N	NEW	\N	\N	\N	\N
83648	79	D5170C00002/tiny.path.1/file-2258.pdf	\N	D5170C00002-b4b71b6b-8316-11eb-be00-c587977f6fe9-2258	\N	NEW	\N	\N	\N	\N
88073	79	D5170C00002/tiny.path.1/file-6683.pdf	\N	D5170C00002-b4c65594-8319-11eb-be00-d33234324180-6683	\N	NEW	\N	\N	\N	\N
86587	79	D5170C00002/tiny.path.1/file-5197.pdf	\N	D5170C00002-b4d4f136-8318-11eb-be00-f70348ea6ded-5197	\N	NEW	\N	\N	\N	\N
85206	79	D5170C00002/tiny.path.1/file-3816.pdf	\N	D5170C00002-b4d66ce1-8317-11eb-be00-d9c59e0434a6-3816	\N	NEW	\N	\N	\N	\N
82266	79	D5170C00002/tiny.path.1/file-0876.pdf	\N	D5170C00002-b4d67f55-8315-11eb-be00-b58dd114d0c1-876	\N	NEW	\N	\N	\N	\N
86588	79	D5170C00002/tiny.path.1/file-5198.pdf	\N	D5170C00002-b4f23d37-8318-11eb-be00-2ddbf3991843-5198	\N	NEW	\N	\N	\N	\N
86589	79	D5170C00002/tiny.path.1/file-5199.pdf	\N	D5170C00002-b501a688-8318-11eb-be00-b507808c6072-5199	\N	NEW	\N	\N	\N	\N
85207	79	D5170C00002/tiny.path.1/file-3817.pdf	\N	D5170C00002-b50237d2-8317-11eb-be00-55224eb5f0fe-3817	\N	NEW	\N	\N	\N	\N
83649	79	D5170C00002/tiny.path.1/file-2259.pdf	\N	D5170C00002-b502ca6c-8316-11eb-be00-553227cea4a3-2259	\N	NEW	\N	\N	\N	\N
88074	79	D5170C00002/tiny.path.1/file-6684.msg	\N	D5170C00002-b502e965-8319-11eb-be00-39245b7f6d66-6684	\N	NEW	\N	\N	\N	\N
82267	79	D5170C00002/tiny.path.1/file-0877.pdf	\N	D5170C00002-b50382c6-8315-11eb-be00-4d703bf81173-877	\N	NEW	\N	\N	\N	\N
86590	79	D5170C00002/tiny.path.1/file-5200.pdf	\N	D5170C00002-b511ac19-8318-11eb-be00-43f5880d71fe-5200	\N	NEW	\N	\N	\N	\N
86591	79	D5170C00002/tiny.path.1/file-5201.pdf	\N	D5170C00002-b51fb5da-8318-11eb-be00-47ac010b5e6f-5201	\N	NEW	\N	\N	\N	\N
82268	79	D5170C00002/tiny.path.1/file-0878.pdf	\N	D5170C00002-b520cec7-8315-11eb-be00-fb7c3c235a4b-878	\N	NEW	\N	\N	\N	\N
83650	79	D5170C00002/tiny.path.1/file-2260.pdf	\N	D5170C00002-b52100cd-8316-11eb-be00-8f2ee9986d09-2260	\N	NEW	\N	\N	\N	\N
86592	79	D5170C00002/tiny.path.1/file-5202.pdf	\N	D5170C00002-b52ea9fb-8318-11eb-be00-4f80256da3bc-5202	\N	NEW	\N	\N	\N	\N
88075	79	D5170C00002/tiny.path.1/file-6685.pdf	\N	D5170C00002-b54d11c6-8319-11eb-be00-3510cd27c400-6685	\N	NEW	\N	\N	\N	\N
86593	79	D5170C00002/tiny.path.1/file-5203.pdf	\N	D5170C00002-b5503bbc-8318-11eb-be00-7fae25d8ad0d-5203	\N	NEW	\N	\N	\N	\N
88076	79	D5170C00002/tiny.path.1/file-6686.pdf	\N	D5170C00002-b55cc937-8319-11eb-be00-df203329f1f3-6686	\N	NEW	\N	\N	\N	\N
82276	79	D5170C00002/tiny.path.1/file-0886.pdf	\N	D5170C00002-b55dd7c8-8315-11eb-be00-cb3addfbd35d-879	\N	NEW	\N	\N	\N	\N
88077	79	D5170C00002/tiny.path.1/file-6687.pdf	\N	D5170C00002-b55f3a38-8319-11eb-be00-abc749beceab-6687	\N	NEW	\N	\N	\N	\N
86594	79	D5170C00002/tiny.path.1/file-5204.pdf	\N	D5170C00002-b56c4f3d-8318-11eb-be00-2b6f039358ac-5204	\N	NEW	\N	\N	\N	\N
83651	79	D5170C00002/tiny.path.1/file-2261.pdf	\N	D5170C00002-b56dc13e-8316-11eb-be00-07dc7df2ddfd-2261	\N	NEW	\N	\N	\N	\N
83652	79	D5170C00002/tiny.path.1/file-2262.pdf	\N	D5170C00002-b58b5b5f-8316-11eb-be00-913176fd5b7c-2262	\N	NEW	\N	\N	\N	\N
82269	79	D5170C00002/tiny.path.1/file-0879.pdf	\N	D5170C00002-b58d4c39-8315-11eb-be00-8314139cf5b4-880	\N	NEW	\N	\N	\N	\N
82270	79	D5170C00002/tiny.path.1/file-0880.pdf	\N	D5170C00002-b5abd0ba-8315-11eb-be00-852d1a7baa2e-881	\N	NEW	\N	\N	\N	\N
83653	79	D5170C00002/tiny.path.1/file-2263.pdf	\N	D5170C00002-b5b85dd0-8316-11eb-be00-e7b4fb81510d-2263	\N	NEW	\N	\N	\N	\N
88078	79	D5170C00002/tiny.path.1/file-6688.pdf	\N	D5170C00002-b5b8a4d9-8319-11eb-be00-afff5acef020-6688	\N	NEW	\N	\N	\N	\N
88079	79	D5170C00002/tiny.path.1/file-6689.pdf	\N	D5170C00002-b5c74ada-8319-11eb-be00-53233be6ad5c-6689	\N	NEW	\N	\N	\N	\N
83654	79	D5170C00002/tiny.path.1/file-2264.pdf	\N	D5170C00002-b5c7ee31-8316-11eb-be00-bb64c1317d74-2264	\N	NEW	\N	\N	\N	\N
82271	79	D5170C00002/tiny.path.1/file-0881.pdf	\N	D5170C00002-b5c8807b-8315-11eb-be00-3528b9e56a13-882	\N	NEW	\N	\N	\N	\N
83655	79	D5170C00002/tiny.path.1/file-2265.pdf	\N	D5170C00002-b5ca1112-8316-11eb-be00-bd6665ccf9f1-2265	\N	NEW	\N	\N	\N	\N
88080	79	D5170C00002/tiny.path.1/file-6690.pdf	\N	D5170C00002-b5d68d1b-8319-11eb-be00-fb348afa5041-6690	\N	NEW	\N	\N	\N	\N
83656	79	D5170C00002/tiny.path.1/file-2266.pdf	\N	D5170C00002-b5e64ba3-8316-11eb-be00-9fbac522d7c9-2266	\N	NEW	\N	\N	\N	\N
83657	79	D5170C00002/tiny.path.1/file-2267.pdf	\N	D5170C00002-b5e78424-8316-11eb-be00-45b087d6e8b1-2267	\N	NEW	\N	\N	\N	\N
85208	79	D5170C00002/tiny.path.1/file-3818.msg	\N	D5170C00002-b5f54a63-8317-11eb-be00-e362fa3c773b-3818	\N	NEW	\N	\N	\N	\N
83658	79	D5170C00002/tiny.path.1/file-2268.pdf	\N	D5170C00002-b5f58de5-8316-11eb-be00-31f4a05e7c63-2268	\N	NEW	\N	\N	\N	\N
83659	79	D5170C00002/tiny.path.1/file-2269.pdf	\N	D5170C00002-b6056c66-8316-11eb-be00-73c68308f641-2269	\N	NEW	\N	\N	\N	\N
88081	79	D5170C00002/tiny.path.1/file-6691.pdf	\N	D5170C00002-b606289c-8319-11eb-be00-55e0311e5322-6691	\N	NEW	\N	\N	\N	\N
82272	79	D5170C00002/tiny.path.1/file-0882.pdf	\N	D5170C00002-b607fa7c-8315-11eb-be00-43d34839f236-883	\N	NEW	\N	\N	\N	\N
83660	79	D5170C00002/tiny.path.1/file-2270.pdf	\N	D5170C00002-b613eb57-8316-11eb-be00-3d0433f0832a-2270	\N	NEW	\N	\N	\N	\N
83661	79	D5170C00002/tiny.path.1/file-2271.pdf	\N	D5170C00002-b624b438-8316-11eb-be00-31a264417b43-2271	\N	NEW	\N	\N	\N	\N
82273	79	D5170C00002/tiny.path.1/file-0883.pdf	\N	D5170C00002-b625467d-8315-11eb-be00-21c99e72fec1-884	\N	NEW	\N	\N	\N	\N
88082	79	D5170C00002/tiny.path.1/file-6692.pdf	\N	D5170C00002-b625495d-8319-11eb-be00-b164b3beef62-6692	\N	NEW	\N	\N	\N	\N
88083	79	D5170C00002/tiny.path.1/file-6693.pdf	\N	D5170C00002-b634648e-8319-11eb-be00-69b641d46ad5-6693	\N	NEW	\N	\N	\N	\N
82274	79	D5170C00002/tiny.path.1/file-0884.pdf	\N	D5170C00002-b642b98e-8315-11eb-be00-b70cab39e551-885	\N	NEW	\N	\N	\N	\N
88084	79	D5170C00002/tiny.path.1/file-6694.pdf	\N	D5170C00002-b65225bf-8319-11eb-be00-bfc1cb01a4fa-6694	\N	NEW	\N	\N	\N	\N
82275	79	D5170C00002/tiny.path.1/file-0885.pdf	\N	D5170C00002-b662768f-8315-11eb-be00-752a102bc787-886	\N	NEW	\N	\N	\N	\N
83662	79	D5170C00002/tiny.path.1/file-2272.pdf	\N	D5170C00002-b670d869-8316-11eb-be00-fd26389c2d34-2272	\N	NEW	\N	\N	\N	\N
88085	79	D5170C00002/tiny.path.1/file-6695.pdf	\N	D5170C00002-b670f860-8319-11eb-be00-9392c826fbad-6695	\N	NEW	\N	\N	\N	\N
85209	79	D5170C00002/tiny.path.1/file-3819.msg	\N	D5170C00002-b68ecb44-8317-11eb-be00-ad9b667fe650-3819	\N	NEW	\N	\N	\N	\N
83663	79	D5170C00002/tiny.path.1/file-2273.pdf	\N	D5170C00002-b68ee7ba-8316-11eb-be00-2375440caecd-2273	\N	NEW	\N	\N	\N	\N
88086	79	D5170C00002/tiny.path.1/file-6696.pdf	\N	D5170C00002-b69c9c41-8319-11eb-be00-9d06e31db235-6696	\N	NEW	\N	\N	\N	\N
82277	79	D5170C00002/tiny.path.1/file-0887.pdf	\N	D5170C00002-b69f3170-8315-11eb-be00-256cd7e40407-887	\N	NEW	\N	\N	\N	\N
85210	79	D5170C00002/tiny.path.1/file-3820.msg	\N	D5170C00002-b6ad01a5-8317-11eb-be00-4115a94b6695-3820	\N	NEW	\N	\N	\N	\N
86595	79	D5170C00002/tiny.path.1/file-5205.pdf	\N	D5170C00002-b6bdfc8e-8318-11eb-be00-e3be6ee4d4b1-5205	\N	NEW	\N	\N	\N	\N
82278	79	D5170C00002/tiny.path.1/file-0888.pdf	\N	D5170C00002-b6cb7191-8315-11eb-be00-b139a56c1b66-888	\N	NEW	\N	\N	\N	\N
83664	79	D5170C00002/tiny.path.1/file-2274.pdf	\N	D5170C00002-b6cd775b-8316-11eb-be00-b9c5e6ed5c00-2274	\N	NEW	\N	\N	\N	\N
85211	79	D5170C00002/tiny.path.1/file-3821.msg	\N	D5170C00002-b6db1686-8317-11eb-be00-77f445331771-3821	\N	NEW	\N	\N	\N	\N
88087	79	D5170C00002/tiny.path.1/file-6697.pdf	\N	D5170C00002-b6e9f8f2-8319-11eb-be00-7b0179a9f8d9-6697	\N	NEW	\N	\N	\N	\N
88088	79	D5170C00002/tiny.path.1/file-6698.pdf	\N	D5170C00002-b6eb3173-8319-11eb-be00-21704aee3ec1-6698	\N	NEW	\N	\N	\N	\N
82279	79	D5170C00002/tiny.path.1/file-0889.pdf	\N	D5170C00002-b6eb55a2-8315-11eb-be00-eba498516acb-889	\N	NEW	\N	\N	\N	\N
88089	79	D5170C00002/tiny.path.1/file-6699.pdf	\N	D5170C00002-b6fa9ac4-8319-11eb-be00-e302093ac6dc-6699	\N	NEW	\N	\N	\N	\N
88090	79	D5170C00002/tiny.path.1/file-6700.pdf	\N	D5170C00002-b708a485-8319-11eb-be00-e12910de88ba-6700	\N	NEW	\N	\N	\N	\N
88091	79	D5170C00002/tiny.path.1/file-6701.pdf	\N	D5170C00002-b718d126-8319-11eb-be00-474f49504701-6701	\N	NEW	\N	\N	\N	\N
82280	79	D5170C00002/tiny.path.1/file-0890.pdf	\N	D5170C00002-b71aa303-8315-11eb-be00-37631691a42d-890	\N	NEW	\N	\N	\N	\N
83665	79	D5170C00002/tiny.path.1/file-2275.pdf	\N	D5170C00002-b727a54c-8316-11eb-be00-690f5dcf8862-2275	\N	NEW	\N	\N	\N	\N
88092	79	D5170C00002/tiny.path.1/file-6702.pdf	\N	D5170C00002-b73580e7-8319-11eb-be00-a78233c0ba8c-6702	\N	NEW	\N	\N	\N	\N
88093	79	D5170C00002/tiny.path.1/file-6703.pdf	\N	D5170C00002-b7451148-8319-11eb-be00-21c1d3266a53-6703	\N	NEW	\N	\N	\N	\N
83666	79	D5170C00002/tiny.path.1/file-2276.pdf	\N	D5170C00002-b74650dd-8316-11eb-be00-b9e7a7a26d48-2276	\N	NEW	\N	\N	\N	\N
82281	79	D5170C00002/tiny.path.1/file-0891.pdf	\N	D5170C00002-b7569a94-8315-11eb-be00-ad85065dcf40-891	\N	NEW	\N	\N	\N	\N
88094	79	D5170C00002/tiny.path.1/file-6704.pdf	\N	D5170C00002-b764ce49-8319-11eb-be00-9590109c4e29-6704	\N	NEW	\N	\N	\N	\N
83667	79	D5170C00002/tiny.path.1/file-2277.pdf	\N	D5170C00002-b7660dde-8316-11eb-be00-d3dd154017c8-2277	\N	NEW	\N	\N	\N	\N
82282	79	D5170C00002/tiny.path.1/file-0892.pdf	\N	D5170C00002-b766c735-8315-11eb-be00-579e7fed60b4-892	\N	NEW	\N	\N	\N	\N
86596	79	D5170C00002/tiny.path.1/file-5206.pdf	\N	D5170C00002-b77342cf-8318-11eb-be00-c72a7fccd7ea-5206	\N	NEW	\N	\N	\N	\N
88095	79	D5170C00002/tiny.path.1/file-6705.pdf	\N	D5170C00002-b773e97a-8319-11eb-be00-39bd471ede86-6705	\N	NEW	\N	\N	\N	\N
82283	79	D5170C00002/tiny.path.1/file-0893.pdf	\N	D5170C00002-b7756d36-8315-11eb-be00-2d05ac35b96c-893	\N	NEW	\N	\N	\N	\N
88096	79	D5170C00002/tiny.path.1/file-6706.pdf	\N	D5170C00002-b7926dfb-8319-11eb-be00-b3c3b5683248-6706	\N	NEW	\N	\N	\N	\N
82284	79	D5170C00002/tiny.path.1/file-0894.pdf	\N	D5170C00002-b7a13827-8315-11eb-be00-a1cd7a8fbdf6-894	\N	NEW	\N	\N	\N	\N
83668	79	D5170C00002/tiny.path.1/file-2278.pdf	\N	D5170C00002-b7a27a9f-8316-11eb-be00-fb618df9b344-2278	\N	NEW	\N	\N	\N	\N
88097	79	D5170C00002/tiny.path.1/file-6707.pdf	\N	D5170C00002-b7af6bdc-8319-11eb-be00-b789b41659cf-6707	\N	NEW	\N	\N	\N	\N
82285	79	D5170C00002/tiny.path.1/file-0895.pdf	\N	D5170C00002-b7c058e8-8315-11eb-be00-d3226749ba5f-895	\N	NEW	\N	\N	\N	\N
88098	79	D5170C00002/tiny.path.1/file-6708.pdf	\N	D5170C00002-b7dff1bd-8319-11eb-be00-3b7e47d35566-6708	\N	NEW	\N	\N	\N	\N
86597	79	D5170C00002/tiny.path.1/file-5207.pdf	\N	D5170C00002-b7ed06b0-8318-11eb-be00-b5d3ed55488d-5207	\N	NEW	\N	\N	\N	\N
88099	79	D5170C00002/tiny.path.1/file-6709.pdf	\N	D5170C00002-b81c376e-8319-11eb-be00-ddd5c348c47e-6709	\N	NEW	\N	\N	\N	\N
85212	79	D5170C00002/tiny.path.1/file-3822.msg	\N	D5170C00002-b81c9737-8317-11eb-be00-69663697d62c-3822	\N	NEW	\N	\N	\N	\N
86598	79	D5170C00002/tiny.path.1/file-5208.pdf	\N	D5170C00002-b82a5dd1-8318-11eb-be00-bb0605157d9f-5208	\N	NEW	\N	\N	\N	\N
88100	79	D5170C00002/tiny.path.1/file-6710.pdf	\N	D5170C00002-b838e72f-8319-11eb-be00-75b9a3cb1223-6710	\N	NEW	\N	\N	\N	\N
88101	79	D5170C00002/tiny.path.1/file-6711.pdf	\N	D5170C00002-b849d720-8319-11eb-be00-7f2e3cdbed86-6711	\N	NEW	\N	\N	\N	\N
86599	79	D5170C00002/tiny.path.1/file-5209.pdf	\N	D5170C00002-b84a9002-8318-11eb-be00-69313e3a7ac1-5209	\N	NEW	\N	\N	\N	\N
85213	79	D5170C00002/tiny.path.1/file-3823.msg	\N	D5170C00002-b858dce8-8317-11eb-be00-0b912a1bb0c6-3823	\N	NEW	\N	\N	\N	\N
85214	79	D5170C00002/tiny.path.1/file-3824.msg	\N	D5170C00002-b868bb69-8317-11eb-be00-3560905cf4a3-3824	\N	NEW	\N	\N	\N	\N
86600	79	D5170C00002/tiny.path.1/file-5210.pdf	\N	D5170C00002-b8782fb3-8318-11eb-be00-095160c97e34-5210	\N	NEW	\N	\N	\N	\N
86601	79	D5170C00002/tiny.path.1/file-5211.pdf	\N	D5170C00002-b894b864-8318-11eb-be00-edc272ccb192-5211	\N	NEW	\N	\N	\N	\N
86602	79	D5170C00002/tiny.path.1/file-5212.pdf	\N	D5170C00002-b8a46fd5-8318-11eb-be00-3d687e97d985-5212	\N	NEW	\N	\N	\N	\N
83669	79	D5170C00002/tiny.path.1/file-2279.pdf	\N	D5170C00002-b8a71960-8316-11eb-be00-059aefa7bd67-2279	\N	NEW	\N	\N	\N	\N
86603	79	D5170C00002/tiny.path.1/file-5213.pdf	\N	D5170C00002-b8b5ade6-8318-11eb-be00-a3c0513b396a-5213	\N	NEW	\N	\N	\N	\N
88102	79	D5170C00002/tiny.path.1/file-6712.pdf	\N	D5170C00002-b8b5b851-8319-11eb-be00-6dda5ce921b9-6712	\N	NEW	\N	\N	\N	\N
82286	79	D5170C00002/tiny.path.1/file-0896.pdf	\N	D5170C00002-b8b651a9-8315-11eb-be00-47214f2c604c-896	\N	NEW	\N	\N	\N	\N
88103	79	D5170C00002/tiny.path.1/file-6713.pdf	\N	D5170C00002-b8c4ac72-8319-11eb-be00-d13c565d3c6d-6713	\N	NEW	\N	\N	\N	\N
85215	79	D5170C00002/tiny.path.1/file-3825.msg	\N	D5170C00002-b8c50c3a-8317-11eb-be00-1374e9475035-3825	\N	NEW	\N	\N	\N	\N
86604	79	D5170C00002/tiny.path.1/file-5214.pdf	\N	D5170C00002-b8e1c6f7-8318-11eb-be00-89590c0352e9-5214	\N	NEW	\N	\N	\N	\N
82287	79	D5170C00002/tiny.path.1/file-0897.pdf	\N	D5170C00002-b8e43f7a-8315-11eb-be00-33afe414ed4b-897	\N	NEW	\N	\N	\N	\N
83670	79	D5170C00002/tiny.path.1/file-2280.pdf	\N	D5170C00002-b8f27a41-8316-11eb-be00-2f12353fb951-2280	\N	NEW	\N	\N	\N	\N
88104	79	D5170C00002/tiny.path.1/file-6714.pdf	\N	D5170C00002-b900f223-8319-11eb-be00-f30e96d53027-6714	\N	NEW	\N	\N	\N	\N
85216	79	D5170C00002/tiny.path.1/file-3826.msg	\N	D5170C00002-b902635b-8317-11eb-be00-37b2758ebf9b-3826	\N	NEW	\N	\N	\N	\N
86614	79	D5170C00002/tiny.path.1/file-5224.pdf	\N	D5170C00002-b910ed48-8318-11eb-be00-9f58ceeedfaa-5215	\N	NEW	\N	\N	\N	\N
82288	79	D5170C00002/tiny.path.1/file-0898.pdf	\N	D5170C00002-b92eb5fb-8315-11eb-be00-e1c3d5cd3860-898	\N	NEW	\N	\N	\N	\N
83671	79	D5170C00002/tiny.path.1/file-2281.pdf	\N	D5170C00002-b94d4472-8316-11eb-be00-f54420c8b04f-2281	\N	NEW	\N	\N	\N	\N
86605	79	D5170C00002/tiny.path.1/file-5215.pdf	\N	D5170C00002-b94d8119-8318-11eb-be00-372f0607b4e6-5216	\N	NEW	\N	\N	\N	\N
85217	79	D5170C00002/tiny.path.1/file-3827.msg	\N	D5170C00002-b95b58cc-8317-11eb-be00-d7a0f7ee7b1f-3827	\N	NEW	\N	\N	\N	\N
86606	79	D5170C00002/tiny.path.1/file-5216.pdf	\N	D5170C00002-b96a30da-8318-11eb-be00-8182f4a24085-5217	\N	NEW	\N	\N	\N	\N
86607	79	D5170C00002/tiny.path.1/file-5217.pdf	\N	D5170C00002-b988b55b-8318-11eb-be00-79052f4eb0f5-5218	\N	NEW	\N	\N	\N	\N
88105	79	D5170C00002/tiny.path.1/file-6715.pdf	\N	D5170C00002-b9980204-8319-11eb-be00-f9114efa02e2-6715	\N	NEW	\N	\N	\N	\N
86608	79	D5170C00002/tiny.path.1/file-5218.pdf	\N	D5170C00002-b9986ccc-8318-11eb-be00-f900bce7c461-5219	\N	NEW	\N	\N	\N	\N
83672	79	D5170C00002/tiny.path.1/file-2282.pdf	\N	D5170C00002-b9994193-8316-11eb-be00-47ddab42a449-2282	\N	NEW	\N	\N	\N	\N
86609	79	D5170C00002/tiny.path.1/file-5219.pdf	\N	D5170C00002-b9a8243d-8318-11eb-be00-1762644b0b00-5220	\N	NEW	\N	\N	\N	\N
82289	79	D5170C00002/tiny.path.1/file-0899.pdf	\N	D5170C00002-b9c63b0c-8315-11eb-be00-cd45b951ba3c-899	\N	NEW	\N	\N	\N	\N
88106	79	D5170C00002/tiny.path.1/file-6716.pdf	\N	D5170C00002-b9d4bce5-8319-11eb-be00-b9dea8bffe6b-6716	\N	NEW	\N	\N	\N	\N
86610	79	D5170C00002/tiny.path.1/file-5220.pdf	\N	D5170C00002-b9d54ebe-8318-11eb-be00-395a55c4b7ce-5221	\N	NEW	\N	\N	\N	\N
85218	79	D5170C00002/tiny.path.1/file-3828.msg	\N	D5170C00002-b9d6a34d-8317-11eb-be00-2f7234f9e95e-3828	\N	NEW	\N	\N	\N	\N
83673	79	D5170C00002/tiny.path.1/file-2283.pdf	\N	D5170C00002-b9d6e6d4-8316-11eb-be00-99f0c9ee12c6-2283	\N	NEW	\N	\N	\N	\N
83674	79	D5170C00002/tiny.path.1/file-2284.pdf	\N	D5170C00002-b9e4f095-8316-11eb-be00-09ab79cd9c26-2284	\N	NEW	\N	\N	\N	\N
86611	79	D5170C00002/tiny.path.1/file-5221.pdf	\N	D5170C00002-b9e701ff-8318-11eb-be00-b7607e2befdf-5222	\N	NEW	\N	\N	\N	\N
83675	79	D5170C00002/tiny.path.1/file-2285.pdf	\N	D5170C00002-b9e788a6-8316-11eb-be00-43ee45b09d9e-2285	\N	NEW	\N	\N	\N	\N
86612	79	D5170C00002/tiny.path.1/file-5222.pdf	\N	D5170C00002-ba049c20-8318-11eb-be00-b56e269d4d86-5223	\N	NEW	\N	\N	\N	\N
85219	79	D5170C00002/tiny.path.1/file-3829.msg	\N	D5170C00002-ba1225ae-8317-11eb-be00-19762ec65973-3829	\N	NEW	\N	\N	\N	\N
88107	79	D5170C00002/tiny.path.1/file-6717.pdf	\N	D5170C00002-ba148506-8319-11eb-be00-21432bc8feb5-6717	\N	NEW	\N	\N	\N	\N
86613	79	D5170C00002/tiny.path.1/file-5223.pdf	\N	D5170C00002-ba228461-8318-11eb-be00-7dee55b0ac3a-5224	\N	NEW	\N	\N	\N	\N
83676	79	D5170C00002/tiny.path.1/file-2286.pdf	\N	D5170C00002-ba241c77-8316-11eb-be00-319844bd2e49-2286	\N	NEW	\N	\N	\N	\N
88108	79	D5170C00002/tiny.path.1/file-6718.pdf	\N	D5170C00002-ba418877-8319-11eb-be00-5f30862093c2-6718	\N	NEW	\N	\N	\N	\N
85220	79	D5170C00002/tiny.path.1/file-3830.msg	\N	D5170C00002-ba420f4f-8317-11eb-be00-6b9bcc3b25de-3830	\N	NEW	\N	\N	\N	\N
82290	79	D5170C00002/tiny.path.1/file-0900.pdf	\N	D5170C00002-ba4221cd-8315-11eb-be00-3da5f40df2e0-900	\N	NEW	\N	\N	\N	\N
86615	79	D5170C00002/tiny.path.1/file-5225.pdf	\N	D5170C00002-ba4f39b2-8318-11eb-be00-a37299d648ce-5225	\N	NEW	\N	\N	\N	\N
86616	79	D5170C00002/tiny.path.1/file-5226.pdf	\N	D5170C00002-ba5eca13-8318-11eb-be00-f3a23c3c029b-5226	\N	NEW	\N	\N	\N	\N
85221	79	D5170C00002/tiny.path.1/file-3831.msg	\N	D5170C00002-ba5f5b50-8317-11eb-be00-432da4e75064-3831	\N	NEW	\N	\N	\N	\N
85222	79	D5170C00002/tiny.path.1/file-3832.msg	\N	D5170C00002-ba60e1f1-8317-11eb-be00-1508575da1ad-3832	\N	NEW	\N	\N	\N	\N
86617	79	D5170C00002/tiny.path.1/file-5227.pdf	\N	D5170C00002-ba611404-8318-11eb-be00-0394d49fa132-5227	\N	NEW	\N	\N	\N	\N
82291	79	D5170C00002/tiny.path.1/file-0901.pdf	\N	D5170C00002-ba7f03be-8315-11eb-be00-9d1778bd8b42-901	\N	NEW	\N	\N	\N	\N
83677	79	D5170C00002/tiny.path.1/file-2287.pdf	\N	D5170C00002-ba7f5bd8-8316-11eb-be00-c75bd618c956-2287	\N	NEW	\N	\N	\N	\N
85223	79	D5170C00002/tiny.path.1/file-3833.msg	\N	D5170C00002-ba7fb492-8317-11eb-be00-0f81e576657e-3833	\N	NEW	\N	\N	\N	\N
85224	79	D5170C00002/tiny.path.1/file-3834.msg	\N	D5170C00002-ba9bef23-8317-11eb-be00-b1bc6eb684f7-3834	\N	NEW	\N	\N	\N	\N
86618	79	D5170C00002/tiny.path.1/file-5228.pdf	\N	D5170C00002-ba9d0b95-8318-11eb-be00-d10cd64e9d91-5228	\N	NEW	\N	\N	\N	\N
88109	79	D5170C00002/tiny.path.1/file-6719.pdf	\N	D5170C00002-baab46c8-8319-11eb-be00-dda18abf5b74-6719	\N	NEW	\N	\N	\N	\N
85225	79	D5170C00002/tiny.path.1/file-3835.msg	\N	D5170C00002-bac967c4-8317-11eb-be00-7f78c58f2867-3835	\N	NEW	\N	\N	\N	\N
83678	79	D5170C00002/tiny.path.1/file-2288.pdf	\N	D5170C00002-bacb8009-8316-11eb-be00-b50f22479a31-2288	\N	NEW	\N	\N	\N	\N
85226	79	D5170C00002/tiny.path.1/file-3836.msg	\N	D5170C00002-bada30a5-8317-11eb-be00-c55ff4ab5276-3836	\N	NEW	\N	\N	\N	\N
85227	79	D5170C00002/tiny.path.1/file-3837.msg	\N	D5170C00002-baf72e86-8317-11eb-be00-75fbc807f7ac-3837	\N	NEW	\N	\N	\N	\N
88110	79	D5170C00002/tiny.path.1/file-6720.pdf	\N	D5170C00002-baf918a9-8319-11eb-be00-85e2f18ee77b-6720	\N	NEW	\N	\N	\N	\N
86619	79	D5170C00002/tiny.path.1/file-5229.pdf	\N	D5170C00002-bb067bc6-8318-11eb-be00-552eee10eda6-5229	\N	NEW	\N	\N	\N	\N
83679	79	D5170C00002/tiny.path.1/file-2289.pdf	\N	D5170C00002-bb079eaa-8316-11eb-be00-0570641061a2-2289	\N	NEW	\N	\N	\N	\N
85228	79	D5170C00002/tiny.path.1/file-3838.msg	\N	D5170C00002-bb167657-8317-11eb-be00-2502f43cee54-3838	\N	NEW	\N	\N	\N	\N
82292	79	D5170C00002/tiny.path.1/file-0902.pdf	\N	D5170C00002-bb17e85f-8315-11eb-be00-2d012117810e-902	\N	NEW	\N	\N	\N	\N
83680	79	D5170C00002/tiny.path.1/file-2290.pdf	\N	D5170C00002-bb18b5ab-8316-11eb-be00-315a0f077fea-2290	\N	NEW	\N	\N	\N	\N
88111	79	D5170C00002/tiny.path.1/file-6721.pdf	\N	D5170C00002-bb26432a-8319-11eb-be00-938ad6f17128-6721	\N	NEW	\N	\N	\N	\N
82293	79	D5170C00002/tiny.path.1/file-0903.pdf	\N	D5170C00002-bb27edf0-8315-11eb-be00-cd550e8292a8-903	\N	NEW	\N	\N	\N	\N
83681	79	D5170C00002/tiny.path.1/file-2291.pdf	\N	D5170C00002-bb3676dc-8316-11eb-be00-6161744e303c-2291	\N	NEW	\N	\N	\N	\N
82294	79	D5170C00002/tiny.path.1/file-0904.pdf	\N	D5170C00002-bb458811-8315-11eb-be00-89637544c45d-904	\N	NEW	\N	\N	\N	\N
85229	79	D5170C00002/tiny.path.1/file-3839.msg	\N	D5170C00002-bb4638e8-8317-11eb-be00-1d0f02d38212-3839	\N	NEW	\N	\N	\N	\N
83682	79	D5170C00002/tiny.path.1/file-2292.pdf	\N	D5170C00002-bb54fb5d-8316-11eb-be00-0d0ab54bb60b-2292	\N	NEW	\N	\N	\N	\N
86620	79	D5170C00002/tiny.path.1/file-5230.pdf	\N	D5170C00002-bb638fe7-8318-11eb-be00-fd365ed0ab00-5230	\N	NEW	\N	\N	\N	\N
88112	79	D5170C00002/tiny.path.1/file-6722.pdf	\N	D5170C00002-bb64f9db-8319-11eb-be00-1f1a273b278e-6722	\N	NEW	\N	\N	\N	\N
85230	79	D5170C00002/tiny.path.1/file-3840.msg	\N	D5170C00002-bb716799-8317-11eb-be00-ffab43dc6f8f-3840	\N	NEW	\N	\N	\N	\N
86621	79	D5170C00002/tiny.path.1/file-5231.pdf	\N	D5170C00002-bb72ab18-8318-11eb-be00-e70f687bf273-5231	\N	NEW	\N	\N	\N	\N
83683	79	D5170C00002/tiny.path.1/file-2293.pdf	\N	D5170C00002-bb813b7e-8316-11eb-be00-198631c2b0be-2293	\N	NEW	\N	\N	\N	\N
88113	79	D5170C00002/tiny.path.1/file-6723.pdf	\N	D5170C00002-bb8f3e2c-8319-11eb-be00-2f87dd95a377-6723	\N	NEW	\N	\N	\N	\N
86622	79	D5170C00002/tiny.path.1/file-5232.pdf	\N	D5170C00002-bb904539-8318-11eb-be00-0957cd9090e3-5232	\N	NEW	\N	\N	\N	\N
83684	79	D5170C00002/tiny.path.1/file-2294.pdf	\N	D5170C00002-bb90f2ef-8316-11eb-be00-37a62b9ea790-2294	\N	NEW	\N	\N	\N	\N
85231	79	D5170C00002/tiny.path.1/file-3841.msg	\N	D5170C00002-bb9f074a-8317-11eb-be00-cbea8038324c-3841	\N	NEW	\N	\N	\N	\N
86623	79	D5170C00002/tiny.path.1/file-5233.pdf	\N	D5170C00002-bbaf3eea-8318-11eb-be00-49bc7bbf8453-5233	\N	NEW	\N	\N	\N	\N
83685	79	D5170C00002/tiny.path.1/file-2295.pdf	\N	D5170C00002-bbb0aff0-8316-11eb-be00-3d29b515d67f-2295	\N	NEW	\N	\N	\N	\N
85232	79	D5170C00002/tiny.path.1/file-3842.msg	\N	D5170C00002-bbbe280b-8317-11eb-be00-4f3a10ccd1e2-3842	\N	NEW	\N	\N	\N	\N
86624	79	D5170C00002/tiny.path.1/file-5234.pdf	\N	D5170C00002-bbbfe0bb-8318-11eb-be00-1dd4bd259bdf-5234	\N	NEW	\N	\N	\N	\N
82295	79	D5170C00002/tiny.path.1/file-0905.pdf	\N	D5170C00002-bbce1902-8315-11eb-be00-2990ecc033f9-905	\N	NEW	\N	\N	\N	\N
88114	79	D5170C00002/tiny.path.1/file-6724.pdf	\N	D5170C00002-bbceb82d-8319-11eb-be00-f78d2f14fc16-6724	\N	NEW	\N	\N	\N	\N
82296	79	D5170C00002/tiny.path.1/file-0906.pdf	\N	D5170C00002-bbdc97f3-8315-11eb-be00-875abfc676d3-906	\N	NEW	\N	\N	\N	\N
85233	79	D5170C00002/tiny.path.1/file-3843.msg	\N	D5170C00002-bbde332c-8317-11eb-be00-fd848b81c24c-3843	\N	NEW	\N	\N	\N	\N
82297	79	D5170C00002/tiny.path.1/file-0907.pdf	\N	D5170C00002-bbedd604-8315-11eb-be00-199eed738f42-907	\N	NEW	\N	\N	\N	\N
83686	79	D5170C00002/tiny.path.1/file-2296.pdf	\N	D5170C00002-bbfad851-8316-11eb-be00-e761c1fb5169-2296	\N	NEW	\N	\N	\N	\N
85234	79	D5170C00002/tiny.path.1/file-3844.msg	\N	D5170C00002-bbfcb7ad-8317-11eb-be00-63a78c897eb6-3844	\N	NEW	\N	\N	\N	\N
88115	79	D5170C00002/tiny.path.1/file-6725.pdf	\N	D5170C00002-bbfd694e-8319-11eb-be00-e74a029f84ee-6725	\N	NEW	\N	\N	\N	\N
82298	79	D5170C00002/tiny.path.1/file-0908.pdf	\N	D5170C00002-bbfdb485-8315-11eb-be00-fb3876e5d488-908	\N	NEW	\N	\N	\N	\N
86625	79	D5170C00002/tiny.path.1/file-5235.pdf	\N	D5170C00002-bc096cdc-8318-11eb-be00-f7ff2ccd9170-5235	\N	NEW	\N	\N	\N	\N
88116	79	D5170C00002/tiny.path.1/file-6726.pdf	\N	D5170C00002-bc1a190f-8319-11eb-be00-61225e0a19b4-6726	\N	NEW	\N	\N	\N	\N
85235	79	D5170C00002/tiny.path.1/file-3845.msg	\N	D5170C00002-bc28347e-8317-11eb-be00-4d52643dfe5b-3845	\N	NEW	\N	\N	\N	\N
86626	79	D5170C00002/tiny.path.1/file-5236.pdf	\N	D5170C00002-bc28dbbd-8318-11eb-be00-b1e95d0a0bff-5236	\N	NEW	\N	\N	\N	\N
83687	79	D5170C00002/tiny.path.1/file-2297.pdf	\N	D5170C00002-bc2a25b2-8316-11eb-be00-a986179de067-2297	\N	NEW	\N	\N	\N	\N
85236	79	D5170C00002/tiny.path.1/file-3846.msg	\N	D5170C00002-bc38882f-8317-11eb-be00-2d48c18dc534-3846	\N	NEW	\N	\N	\N	\N
88117	79	D5170C00002/tiny.path.1/file-6727.pdf	\N	D5170C00002-bc3a7250-8319-11eb-be00-61fb41dee64e-6727	\N	NEW	\N	\N	\N	\N
85237	79	D5170C00002/tiny.path.1/file-3847.msg	\N	D5170C00002-bc477c50-8317-11eb-be00-1509244362c2-3847	\N	NEW	\N	\N	\N	\N
86627	79	D5170C00002/tiny.path.1/file-5237.pdf	\N	D5170C00002-bc47874e-8318-11eb-be00-678201668693-5237	\N	NEW	\N	\N	\N	\N
83688	79	D5170C00002/tiny.path.1/file-2298.pdf	\N	D5170C00002-bc494673-8316-11eb-be00-af9d1b4fb274-2298	\N	NEW	\N	\N	\N	\N
85238	79	D5170C00002/tiny.path.1/file-3848.msg	\N	D5170C00002-bc586c41-8317-11eb-be00-f7847f73b1e7-3848	\N	NEW	\N	\N	\N	\N
86628	79	D5170C00002/tiny.path.1/file-5238.pdf	\N	D5170C00002-bc58773f-8318-11eb-be00-61ef8973e917-5238	\N	NEW	\N	\N	\N	\N
86629	79	D5170C00002/tiny.path.1/file-5239.pdf	\N	D5170C00002-bc66cf20-8318-11eb-be00-1d7d6b086a43-5239	\N	NEW	\N	\N	\N	\N
86630	79	D5170C00002/tiny.path.1/file-5240.pdf	\N	D5170C00002-bc748ac1-8318-11eb-be00-fbe9bb828260-5240	\N	NEW	\N	\N	\N	\N
85239	79	D5170C00002/tiny.path.1/file-3849.msg	\N	D5170C00002-bc76f0c2-8317-11eb-be00-01e7387f2981-3849	\N	NEW	\N	\N	\N	\N
83689	79	D5170C00002/tiny.path.1/file-2299.pdf	\N	D5170C00002-bc847ab4-8316-11eb-be00-cf9eedd693a1-2299	\N	NEW	\N	\N	\N	\N
86631	79	D5170C00002/tiny.path.1/file-5241.pdf	\N	D5170C00002-bc857ab2-8318-11eb-be00-598fa3661cc2-5241	\N	NEW	\N	\N	\N	\N
82299	79	D5170C00002/tiny.path.1/file-0909.pdf	\N	D5170C00002-bc953996-8315-11eb-be00-4d86e2795f4a-909	\N	NEW	\N	\N	\N	\N
85240	79	D5170C00002/tiny.path.1/file-3850.msg	\N	D5170C00002-bca294a3-8317-11eb-be00-8f3924fb790c-3850	\N	NEW	\N	\N	\N	\N
86632	79	D5170C00002/tiny.path.1/file-5242.pdf	\N	D5170C00002-bcb193c3-8318-11eb-be00-69d7a01c0ab3-5242	\N	NEW	\N	\N	\N	\N
83690	79	D5170C00002/tiny.path.1/file-2300.pdf	\N	D5170C00002-bcb3ef25-8316-11eb-be00-dfcc380db75a-2300	\N	NEW	\N	\N	\N	\N
82300	79	D5170C00002/tiny.path.1/file-0910.pdf	\N	D5170C00002-bcc10487-8315-11eb-be00-8132d9a2f50f-910	\N	NEW	\N	\N	\N	\N
85241	79	D5170C00002/tiny.path.1/file-3851.msg	\N	D5170C00002-bcc1dc74-8317-11eb-be00-e5cf9f87a711-3851	\N	NEW	\N	\N	\N	\N
86633	79	D5170C00002/tiny.path.1/file-5243.pdf	\N	D5170C00002-bcc1e774-8318-11eb-be00-5ba96c378244-5243	\N	NEW	\N	\N	\N	\N
88118	79	D5170C00002/tiny.path.1/file-6728.pdf	\N	D5170C00002-bcc2b521-8319-11eb-be00-e3bbe171ba53-6728	\N	NEW	\N	\N	\N	\N
86634	79	D5170C00002/tiny.path.1/file-5244.pdf	\N	D5170C00002-bccff135-8318-11eb-be00-951adfcb085f-5244	\N	NEW	\N	\N	\N	\N
83691	79	D5170C00002/tiny.path.1/file-2301.pdf	\N	D5170C00002-bcd2c1c6-8316-11eb-be00-259c5f32ca8b-2301	\N	NEW	\N	\N	\N	\N
82301	79	D5170C00002/tiny.path.1/file-0911.pdf	\N	D5170C00002-bcd2ded8-8315-11eb-be00-8ff77e4637b9-911	\N	NEW	\N	\N	\N	\N
85242	79	D5170C00002/tiny.path.1/file-3852.msg	\N	D5170C00002-bcdf7695-8317-11eb-be00-05f896305279-3852	\N	NEW	\N	\N	\N	\N
82302	79	D5170C00002/tiny.path.1/file-0912.pdf	\N	D5170C00002-bce29649-8315-11eb-be00-e7a8a164d790-912	\N	NEW	\N	\N	\N	\N
85243	79	D5170C00002/tiny.path.1/file-3853.msg	\N	D5170C00002-bcef06f6-8317-11eb-be00-e3c397efbaf2-3853	\N	NEW	\N	\N	\N	\N
82303	79	D5170C00002/tiny.path.1/file-0913.pdf	\N	D5170C00002-bcf02ada-8315-11eb-be00-8fd034c37324-913	\N	NEW	\N	\N	\N	\N
86636	79	D5170C00002/tiny.path.1/file-5246.pdf	\N	D5170C00002-bcfe0616-8318-11eb-be00-f708697d80de-5245	\N	NEW	\N	\N	\N	\N
85244	79	D5170C00002/tiny.path.1/file-3854.msg	\N	D5170C00002-bcfe2227-8317-11eb-be00-5b053663686f-3854	\N	NEW	\N	\N	\N	\N
82304	79	D5170C00002/tiny.path.1/file-0914.pdf	\N	D5170C00002-bd00095b-8315-11eb-be00-d966b897bb22-914	\N	NEW	\N	\N	\N	\N
85245	79	D5170C00002/tiny.path.1/file-3855.msg	\N	D5170C00002-bd0d8b78-8317-11eb-be00-6f079e90594e-3855	\N	NEW	\N	\N	\N	\N
86635	79	D5170C00002/tiny.path.1/file-5245.pdf	\N	D5170C00002-bd0e32b7-8318-11eb-be00-1f5057a47c9d-5246	\N	NEW	\N	\N	\N	\N
82305	79	D5170C00002/tiny.path.1/file-0915.pdf	\N	D5170C00002-bd0fe7dc-8315-11eb-be00-1fb1c11f0604-915	\N	NEW	\N	\N	\N	\N
85246	79	D5170C00002/tiny.path.1/file-3856.msg	\N	D5170C00002-bd1c7f99-8317-11eb-be00-41237faa7bf1-3856	\N	NEW	\N	\N	\N	\N
85247	79	D5170C00002/tiny.path.1/file-3857.msg	\N	D5170C00002-bd2e59ea-8317-11eb-be00-133b1481f9c1-3857	\N	NEW	\N	\N	\N	\N
88119	79	D5170C00002/tiny.path.1/file-6729.pdf	\N	D5170C00002-bd3c51f2-8319-11eb-be00-93299642f96f-6729	\N	NEW	\N	\N	\N	\N
82306	79	D5170C00002/tiny.path.1/file-0916.pdf	\N	D5170C00002-bd4a58cd-8315-11eb-be00-ad1b505512d4-916	\N	NEW	\N	\N	\N	\N
85248	79	D5170C00002/tiny.path.1/file-3858.msg	\N	D5170C00002-bd4a6d6b-8317-11eb-be00-d53d356ec274-3858	\N	NEW	\N	\N	\N	\N
83692	79	D5170C00002/tiny.path.1/file-2302.pdf	\N	D5170C00002-bd4b9b47-8316-11eb-be00-59f9dc6d5c9a-2302	\N	NEW	\N	\N	\N	\N
86637	79	D5170C00002/tiny.path.1/file-5247.pdf	\N	D5170C00002-bd594578-8318-11eb-be00-f523038b73d8-5247	\N	NEW	\N	\N	\N	\N
85249	79	D5170C00002/tiny.path.1/file-3859.msg	\N	D5170C00002-bd59d6bc-8317-11eb-be00-6b115b496f11-3859	\N	NEW	\N	\N	\N	\N
82307	79	D5170C00002/tiny.path.1/file-0917.pdf	\N	D5170C00002-bd5b21ae-8315-11eb-be00-3b45e0c4e055-917	\N	NEW	\N	\N	\N	\N
85250	79	D5170C00002/tiny.path.1/file-3860.msg	\N	D5170C00002-bd69400d-8317-11eb-be00-51c52f550688-3860	\N	NEW	\N	\N	\N	\N
86638	79	D5170C00002/tiny.path.1/file-5248.pdf	\N	D5170C00002-bd6a0e59-8318-11eb-be00-b15636dc9908-5248	\N	NEW	\N	\N	\N	\N
83693	79	D5170C00002/tiny.path.1/file-2303.pdf	\N	D5170C00002-bd6b3138-8316-11eb-be00-b5ca338a8d31-2303	\N	NEW	\N	\N	\N	\N
85251	79	D5170C00002/tiny.path.1/file-3861.msg	\N	D5170C00002-bd79e1de-8317-11eb-be00-b10722705f33-3861	\N	NEW	\N	\N	\N	\N
82308	79	D5170C00002/tiny.path.1/file-0918.pdf	\N	D5170C00002-bd7a1b5f-8315-11eb-be00-17819a9ad23b-918	\N	NEW	\N	\N	\N	\N
86639	79	D5170C00002/tiny.path.1/file-5249.pdf	\N	D5170C00002-bd7a891a-8318-11eb-be00-6d105446659f-5249	\N	NEW	\N	\N	\N	\N
85252	79	D5170C00002/tiny.path.1/file-3862.msg	\N	D5170C00002-bd894b2f-8317-11eb-be00-bf0d980ae4fb-3862	\N	NEW	\N	\N	\N	\N
83694	79	D5170C00002/tiny.path.1/file-2304.pdf	\N	D5170C00002-bd96ae09-8316-11eb-be00-73855120e0db-2304	\N	NEW	\N	\N	\N	\N
86640	79	D5170C00002/tiny.path.1/file-5250.pdf	\N	D5170C00002-bd96c3ab-8318-11eb-be00-890008fb79cc-5250	\N	NEW	\N	\N	\N	\N
82309	79	D5170C00002/tiny.path.1/file-0919.pdf	\N	D5170C00002-bd974050-8315-11eb-be00-c5e209ac84a4-919	\N	NEW	\N	\N	\N	\N
82310	79	D5170C00002/tiny.path.1/file-0920.pdf	\N	D5170C00002-bd996331-8315-11eb-be00-6d067ab74804-920	\N	NEW	\N	\N	\N	\N
85253	79	D5170C00002/tiny.path.1/file-3863.msg	\N	D5170C00002-bd9977d0-8317-11eb-be00-3712a3bc4fc7-3863	\N	NEW	\N	\N	\N	\N
88120	79	D5170C00002/tiny.path.1/file-6730.pdf	\N	D5170C00002-bda65e63-8319-11eb-be00-412026683b3a-6730	\N	NEW	\N	\N	\N	\N
83695	79	D5170C00002/tiny.path.1/file-2305.pdf	\N	D5170C00002-bda8132a-8316-11eb-be00-19c66090ed14-2305	\N	NEW	\N	\N	\N	\N
85254	79	D5170C00002/tiny.path.1/file-3864.msg	\N	D5170C00002-bdb4c801-8317-11eb-be00-abde78d2ba7f-3864	\N	NEW	\N	\N	\N	\N
86641	79	D5170C00002/tiny.path.1/file-5251.pdf	\N	D5170C00002-bdb5482c-8318-11eb-be00-05ae9ab8f588-5251	\N	NEW	\N	\N	\N	\N
82311	79	D5170C00002/tiny.path.1/file-0921.pdf	\N	D5170C00002-bdb576b2-8315-11eb-be00-5de6c97165af-921	\N	NEW	\N	\N	\N	\N
85255	79	D5170C00002/tiny.path.1/file-3865.msg	\N	D5170C00002-bdc4f4a2-8317-11eb-be00-492c2a2bce35-3865	\N	NEW	\N	\N	\N	\N
86642	79	D5170C00002/tiny.path.1/file-5252.pdf	\N	D5170C00002-bdc59bdd-8318-11eb-be00-e5751f58c9a6-5252	\N	NEW	\N	\N	\N	\N
85256	79	D5170C00002/tiny.path.1/file-3866.msg	\N	D5170C00002-bde28ec3-8317-11eb-be00-eb4bf66c3d0c-3866	\N	NEW	\N	\N	\N	\N
86643	79	D5170C00002/tiny.path.1/file-5253.pdf	\N	D5170C00002-bde2c0ce-8318-11eb-be00-2d8e9a019bac-5253	\N	NEW	\N	\N	\N	\N
83696	79	D5170C00002/tiny.path.1/file-2306.pdf	\N	D5170C00002-bde5915b-8316-11eb-be00-33233f15dffa-2306	\N	NEW	\N	\N	\N	\N
85257	79	D5170C00002/tiny.path.1/file-3867.msg	\N	D5170C00002-bdf21f24-8317-11eb-be00-8be6c85e4516-3867	\N	NEW	\N	\N	\N	\N
82312	79	D5170C00002/tiny.path.1/file-0922.pdf	\N	D5170C00002-bdf39123-8315-11eb-be00-bb74100fd1bc-922	\N	NEW	\N	\N	\N	\N
85258	79	D5170C00002/tiny.path.1/file-3868.msg	\N	D5170C00002-bdf3a5c5-8317-11eb-be00-95683a6392ac-3868	\N	NEW	\N	\N	\N	\N
88121	79	D5170C00002/tiny.path.1/file-6731.pdf	\N	D5170C00002-bdf47e64-8319-11eb-be00-dd45d1bd4117-6731	\N	NEW	\N	\N	\N	\N
86644	79	D5170C00002/tiny.path.1/file-5254.pdf	\N	D5170C00002-be12353f-8318-11eb-be00-ef4896d3f087-5254	\N	NEW	\N	\N	\N	\N
83697	79	D5170C00002/tiny.path.1/file-2307.pdf	\N	D5170C00002-be1309fc-8316-11eb-be00-fb0f7e091676-2307	\N	NEW	\N	\N	\N	\N
85259	79	D5170C00002/tiny.path.1/file-3869.msg	\N	D5170C00002-be219396-8317-11eb-be00-718580e873bc-3869	\N	NEW	\N	\N	\N	\N
88122	79	D5170C00002/tiny.path.1/file-6732.pdf	\N	D5170C00002-be2f3d75-8319-11eb-be00-115a11cb2e9a-6732	\N	NEW	\N	\N	\N	\N
82313	79	D5170C00002/tiny.path.1/file-0923.pdf	\N	D5170C00002-be30e844-8315-11eb-be00-81fdb55df647-923	\N	NEW	\N	\N	\N	\N
86645	79	D5170C00002/tiny.path.1/file-5255.pdf	\N	D5170C00002-be315600-8318-11eb-be00-bb6f87e6229e-5255	\N	NEW	\N	\N	\N	\N
85260	79	D5170C00002/tiny.path.1/file-3870.msg	\N	D5170C00002-be401817-8317-11eb-be00-89312d25f9f1-3870	\N	NEW	\N	\N	\N	\N
85261	79	D5170C00002/tiny.path.1/file-3871.msg	\N	D5170C00002-be4f8168-8317-11eb-be00-5dce4add1b52-3871	\N	NEW	\N	\N	\N	\N
85262	79	D5170C00002/tiny.path.1/file-3872.msg	\N	D5170C00002-be6c5839-8317-11eb-be00-4b1cd703f4a8-3872	\N	NEW	\N	\N	\N	\N
82314	79	D5170C00002/tiny.path.1/file-0924.pdf	\N	D5170C00002-be6cb8c5-8315-11eb-be00-57074e5c94c6-924	\N	NEW	\N	\N	\N	\N
88123	79	D5170C00002/tiny.path.1/file-6733.pdf	\N	D5170C00002-be6da606-8319-11eb-be00-8fe8dd60bddb-6733	\N	NEW	\N	\N	\N	\N
83698	79	D5170C00002/tiny.path.1/file-2308.pdf	\N	D5170C00002-be7bb6dd-8316-11eb-be00-a3ef98427353-2308	\N	NEW	\N	\N	\N	\N
85263	79	D5170C00002/tiny.path.1/file-3873.msg	\N	D5170C00002-be8adcba-8317-11eb-be00-35a72b738bad-3873	\N	NEW	\N	\N	\N	\N
88124	79	D5170C00002/tiny.path.1/file-6734.pdf	\N	D5170C00002-be8b1917-8319-11eb-be00-f9c77463fdfa-6734	\N	NEW	\N	\N	\N	\N
83699	79	D5170C00002/tiny.path.1/file-2309.pdf	\N	D5170C00002-be9a897e-8316-11eb-be00-a5252a7353a0-2309	\N	NEW	\N	\N	\N	\N
86646	79	D5170C00002/tiny.path.1/file-5256.pdf	\N	D5170C00002-be9bfeb1-8318-11eb-be00-3d6fe9029048-5256	\N	NEW	\N	\N	\N	\N
85264	79	D5170C00002/tiny.path.1/file-3874.msg	\N	D5170C00002-beaa4b9b-8317-11eb-be00-bdda98c3114c-3874	\N	NEW	\N	\N	\N	\N
83700	79	D5170C00002/tiny.path.1/file-2310.pdf	\N	D5170C00002-beca24ff-8316-11eb-be00-657b9f5bcaea-2310	\N	NEW	\N	\N	\N	\N
83701	79	D5170C00002/tiny.path.1/file-2311.pdf	\N	D5170C00002-bf234180-8316-11eb-be00-67f35983e3dc-2311	\N	NEW	\N	\N	\N	\N
82315	79	D5170C00002/tiny.path.1/file-0925.pdf	\N	D5170C00002-bf2644c6-8315-11eb-be00-3bde95573e02-925	\N	NEW	\N	\N	\N	\N
83702	79	D5170C00002/tiny.path.1/file-2312.pdf	\N	D5170C00002-bf530411-8316-11eb-be00-994f63eaf152-2312	\N	NEW	\N	\N	\N	\N
88125	79	D5170C00002/tiny.path.1/file-6735.pdf	\N	D5170C00002-bf604368-8319-11eb-be00-f56367704429-6735	\N	NEW	\N	\N	\N	\N
83703	79	D5170C00002/tiny.path.1/file-2313.pdf	\N	D5170C00002-bf707722-8316-11eb-be00-d9d47b455f35-2313	\N	NEW	\N	\N	\N	\N
82316	79	D5170C00002/tiny.path.1/file-0926.pdf	\N	D5170C00002-bf7241e7-8315-11eb-be00-e9c5d0346e0c-926	\N	NEW	\N	\N	\N	\N
83704	79	D5170C00002/tiny.path.1/file-2314.pdf	\N	D5170C00002-bf900d13-8316-11eb-be00-4d34a01f720d-2314	\N	NEW	\N	\N	\N	\N
82317	79	D5170C00002/tiny.path.1/file-0927.pdf	\N	D5170C00002-bf905138-8315-11eb-be00-fb45fbf0d218-927	\N	NEW	\N	\N	\N	\N
88126	79	D5170C00002/tiny.path.1/file-6736.pdf	\N	D5170C00002-bf9e5dd9-8319-11eb-be00-9b49dad74836-6736	\N	NEW	\N	\N	\N	\N
86647	79	D5170C00002/tiny.path.1/file-5257.pdf	\N	D5170C00002-bfac8452-8318-11eb-be00-358b03dfdb36-5257	\N	NEW	\N	\N	\N	\N
83705	79	D5170C00002/tiny.path.1/file-2315.pdf	\N	D5170C00002-bfaeb8a4-8316-11eb-be00-b7c3b28f6b0a-2315	\N	NEW	\N	\N	\N	\N
88127	79	D5170C00002/tiny.path.1/file-6737.pdf	\N	D5170C00002-bfbb82ca-8319-11eb-be00-ab131d7e107a-6737	\N	NEW	\N	\N	\N	\N
85265	79	D5170C00002/tiny.path.1/file-3875.msg	\N	D5170C00002-bfda8e3c-8317-11eb-be00-03ed20f1512b-3875	\N	NEW	\N	\N	\N	\N
83706	79	D5170C00002/tiny.path.1/file-2316.pdf	\N	D5170C00002-bfdc7f65-8316-11eb-be00-0f73c3f091ea-2316	\N	NEW	\N	\N	\N	\N
85266	79	D5170C00002/tiny.path.1/file-3876.msg	\N	D5170C00002-bff8ebad-8317-11eb-be00-e79958fbb4ae-3876	\N	NEW	\N	\N	\N	\N
88128	79	D5170C00002/tiny.path.1/file-6738.pdf	\N	D5170C00002-bffa126b-8319-11eb-be00-79457cb92977-6738	\N	NEW	\N	\N	\N	\N
82318	79	D5170C00002/tiny.path.1/file-0928.pdf	\N	D5170C00002-c00ab159-8315-11eb-be00-d974af4416ea-928	\N	NEW	\N	\N	\N	\N
83707	79	D5170C00002/tiny.path.1/file-2317.pdf	\N	D5170C00002-c00ae266-8316-11eb-be00-a1200b280daa-2317	\N	NEW	\N	\N	\N	\N
86648	79	D5170C00002/tiny.path.1/file-5258.pdf	\N	D5170C00002-c0188c93-8318-11eb-be00-65962b6498c5-5258	\N	NEW	\N	\N	\N	\N
85267	79	D5170C00002/tiny.path.1/file-3877.msg	\N	D5170C00002-c027279e-8317-11eb-be00-1dddadd3634a-3877	\N	NEW	\N	\N	\N	\N
83708	79	D5170C00002/tiny.path.1/file-2318.pdf	\N	D5170C00002-c0279227-8316-11eb-be00-9dd36f1c4579-2318	\N	NEW	\N	\N	\N	\N
82319	79	D5170C00002/tiny.path.1/file-0929.pdf	\N	D5170C00002-c027af3a-8315-11eb-be00-073fec46d729-929	\N	NEW	\N	\N	\N	\N
88129	79	D5170C00002/tiny.path.1/file-6739.pdf	\N	D5170C00002-c02938bc-8319-11eb-be00-7f67508cdaf1-6739	\N	NEW	\N	\N	\N	\N
86649	79	D5170C00002/tiny.path.1/file-5259.pdf	\N	D5170C00002-c0375f34-8318-11eb-be00-3f305c80ff86-5259	\N	NEW	\N	\N	\N	\N
85268	79	D5170C00002/tiny.path.1/file-3878.msg	\N	D5170C00002-c046485f-8317-11eb-be00-85a64b8564dd-3878	\N	NEW	\N	\N	\N	\N
82320	79	D5170C00002/tiny.path.1/file-0930.pdf	\N	D5170C00002-c047e16b-8315-11eb-be00-f934ee7cd980-930	\N	NEW	\N	\N	\N	\N
85269	79	D5170C00002/tiny.path.1/file-3879.msg	\N	D5170C00002-c0553c80-8317-11eb-be00-1dc479e0cc47-3879	\N	NEW	\N	\N	\N	\N
88130	79	D5170C00002/tiny.path.1/file-6740.pdf	\N	D5170C00002-c05578dd-8319-11eb-be00-114b8f2463ab-6740	\N	NEW	\N	\N	\N	\N
88131	79	D5170C00002/tiny.path.1/file-6741.pdf	\N	D5170C00002-c063f7ce-8319-11eb-be00-318b4101def8-6741	\N	NEW	\N	\N	\N	\N
85270	79	D5170C00002/tiny.path.1/file-3880.msg	\N	D5170C00002-c072fdb1-8317-11eb-be00-edc2a107687a-3880	\N	NEW	\N	\N	\N	\N
86650	79	D5170C00002/tiny.path.1/file-5260.pdf	\N	D5170C00002-c0741a15-8318-11eb-be00-21af73040cfc-5260	\N	NEW	\N	\N	\N	\N
88132	79	D5170C00002/tiny.path.1/file-6742.pdf	\N	D5170C00002-c082553f-8319-11eb-be00-1d8f85ab4c16-6742	\N	NEW	\N	\N	\N	\N
85271	79	D5170C00002/tiny.path.1/file-3881.msg	\N	D5170C00002-c0918232-8317-11eb-be00-1b490db129df-3881	\N	NEW	\N	\N	\N	\N
83709	79	D5170C00002/tiny.path.1/file-2319.pdf	\N	D5170C00002-c091ecb8-8316-11eb-be00-85ba884e33f4-2319	\N	NEW	\N	\N	\N	\N
88133	79	D5170C00002/tiny.path.1/file-6743.pdf	\N	D5170C00002-c092f710-8319-11eb-be00-d7f24dbb8813-6743	\N	NEW	\N	\N	\N	\N
88134	79	D5170C00002/tiny.path.1/file-6744.pdf	\N	D5170C00002-c0a21241-8319-11eb-be00-959413716710-6744	\N	NEW	\N	\N	\N	\N
85272	79	D5170C00002/tiny.path.1/file-3882.msg	\N	D5170C00002-c0a24b13-8317-11eb-be00-b768c7488eb0-3882	\N	NEW	\N	\N	\N	\N
82321	79	D5170C00002/tiny.path.1/file-0931.pdf	\N	D5170C00002-c0b1519c-8315-11eb-be00-3be62c2e0b11-931	\N	NEW	\N	\N	\N	\N
83710	79	D5170C00002/tiny.path.1/file-2320.pdf	\N	D5170C00002-c0b29419-8316-11eb-be00-13f59cda1245-2320	\N	NEW	\N	\N	\N	\N
88135	79	D5170C00002/tiny.path.1/file-6745.pdf	\N	D5170C00002-c0be9af2-8319-11eb-be00-6befb58462ca-6745	\N	NEW	\N	\N	\N	\N
86651	79	D5170C00002/tiny.path.1/file-5261.pdf	\N	D5170C00002-c0ce4806-8318-11eb-be00-e36479155808-5261	\N	NEW	\N	\N	\N	\N
85273	79	D5170C00002/tiny.path.1/file-3883.msg	\N	D5170C00002-c0cf0064-8317-11eb-be00-ab1e44866e3c-3883	\N	NEW	\N	\N	\N	\N
88136	79	D5170C00002/tiny.path.1/file-6746.pdf	\N	D5170C00002-c0cfb1f3-8319-11eb-be00-e9fa64c2046d-6746	\N	NEW	\N	\N	\N	\N
82322	79	D5170C00002/tiny.path.1/file-0932.pdf	\N	D5170C00002-c0d183cd-8315-11eb-be00-37b4a8b83b26-932	\N	NEW	\N	\N	\N	\N
86652	79	D5170C00002/tiny.path.1/file-5262.pdf	\N	D5170C00002-c0dd6337-8318-11eb-be00-55656b24efcc-5262	\N	NEW	\N	\N	\N	\N
88137	79	D5170C00002/tiny.path.1/file-6747.pdf	\N	D5170C00002-c0ee8494-8319-11eb-be00-a7a18fe87a09-6747	\N	NEW	\N	\N	\N	\N
85274	79	D5170C00002/tiny.path.1/file-3884.msg	\N	D5170C00002-c0ef0b85-8317-11eb-be00-27f7c920de7d-3884	\N	NEW	\N	\N	\N	\N
86653	79	D5170C00002/tiny.path.1/file-5263.pdf	\N	D5170C00002-c10b7818-8318-11eb-be00-039d32f1c2a0-5263	\N	NEW	\N	\N	\N	\N
85275	79	D5170C00002/tiny.path.1/file-3885.msg	\N	D5170C00002-c10ca5a6-8317-11eb-be00-d359fa85e9f6-3885	\N	NEW	\N	\N	\N	\N
88138	79	D5170C00002/tiny.path.1/file-6748.pdf	\N	D5170C00002-c11b12d5-8319-11eb-be00-cf3f4812fe54-6748	\N	NEW	\N	\N	\N	\N
85276	79	D5170C00002/tiny.path.1/file-3886.msg	\N	D5170C00002-c11d9597-8317-11eb-be00-b5759cbb8de4-3886	\N	NEW	\N	\N	\N	\N
82323	79	D5170C00002/tiny.path.1/file-0933.pdf	\N	D5170C00002-c11e1d2e-8315-11eb-be00-e90c23e1795e-933	\N	NEW	\N	\N	\N	\N
88139	79	D5170C00002/tiny.path.1/file-6749.pdf	\N	D5170C00002-c129dfe6-8319-11eb-be00-9f86976ef83a-6749	\N	NEW	\N	\N	\N	\N
86654	79	D5170C00002/tiny.path.1/file-5264.pdf	\N	D5170C00002-c12bf869-8318-11eb-be00-cb60e0de48c8-5264	\N	NEW	\N	\N	\N	\N
88140	79	D5170C00002/tiny.path.1/file-6750.pdf	\N	D5170C00002-c13a81b7-8319-11eb-be00-d98293aecff2-6750	\N	NEW	\N	\N	\N	\N
85277	79	D5170C00002/tiny.path.1/file-3887.msg	\N	D5170C00002-c1491268-8317-11eb-be00-e54bcf63a163-3887	\N	NEW	\N	\N	\N	\N
88141	79	D5170C00002/tiny.path.1/file-6751.pdf	\N	D5170C00002-c1577f98-8319-11eb-be00-81f5cf8efb2a-6751	\N	NEW	\N	\N	\N	\N
86655	79	D5170C00002/tiny.path.1/file-5265.pdf	\N	D5170C00002-c1585f9a-8318-11eb-be00-a7a33d390a44-5265	\N	NEW	\N	\N	\N	\N
82324	79	D5170C00002/tiny.path.1/file-0934.pdf	\N	D5170C00002-c15a14bf-8315-11eb-be00-a50b2a150da9-934	\N	NEW	\N	\N	\N	\N
88142	79	D5170C00002/tiny.path.1/file-6752.pdf	\N	D5170C00002-c166e8e9-8319-11eb-be00-fbce7c684a97-6752	\N	NEW	\N	\N	\N	\N
85278	79	D5170C00002/tiny.path.1/file-3888.msg	\N	D5170C00002-c16748c9-8317-11eb-be00-3511dbd2bc37-3888	\N	NEW	\N	\N	\N	\N
85279	79	D5170C00002/tiny.path.1/file-3889.msg	\N	D5170C00002-c1785fca-8317-11eb-be00-1bea79ba4d66-3889	\N	NEW	\N	\N	\N	\N
83711	79	D5170C00002/tiny.path.1/file-2321.pdf	\N	D5170C00002-c179186a-8316-11eb-be00-21e2d17b4e4a-2321	\N	NEW	\N	\N	\N	\N
88143	79	D5170C00002/tiny.path.1/file-6753.pdf	\N	D5170C00002-c185465a-8319-11eb-be00-a7b62e5c9cad-6753	\N	NEW	\N	\N	\N	\N
82325	79	D5170C00002/tiny.path.1/file-0935.pdf	\N	D5170C00002-c185b8a0-8315-11eb-be00-a1923f5e208e-935	\N	NEW	\N	\N	\N	\N
88144	79	D5170C00002/tiny.path.1/file-6754.pdf	\N	D5170C00002-c194d6bb-8319-11eb-be00-65edea143228-6754	\N	NEW	\N	\N	\N	\N
82326	79	D5170C00002/tiny.path.1/file-0936.pdf	\N	D5170C00002-c1954901-8315-11eb-be00-212e655d0ef2-936	\N	NEW	\N	\N	\N	\N
88145	79	D5170C00002/tiny.path.1/file-6755.pdf	\N	D5170C00002-c1a418fc-8319-11eb-be00-a5439e763adb-6755	\N	NEW	\N	\N	\N	\N
85280	79	D5170C00002/tiny.path.1/file-3890.msg	\N	D5170C00002-c1a478db-8317-11eb-be00-abdb1f987747-3890	\N	NEW	\N	\N	\N	\N
86656	79	D5170C00002/tiny.path.1/file-5266.pdf	\N	D5170C00002-c1a6f4cb-8318-11eb-be00-b554016aa325-5266	\N	NEW	\N	\N	\N	\N
85281	79	D5170C00002/tiny.path.1/file-3891.msg	\N	D5170C00002-c1b36cfc-8317-11eb-be00-a1984f5328c8-3891	\N	NEW	\N	\N	\N	\N
85282	79	D5170C00002/tiny.path.1/file-3892.msg	\N	D5170C00002-c1c2611d-8317-11eb-be00-596fd904dd0a-3892	\N	NEW	\N	\N	\N	\N
83712	79	D5170C00002/tiny.path.1/file-2322.pdf	\N	D5170C00002-c1d2d12b-8316-11eb-be00-999cf3ae1cb5-2322	\N	NEW	\N	\N	\N	\N
86657	79	D5170C00002/tiny.path.1/file-5267.pdf	\N	D5170C00002-c1e2772c-8318-11eb-be00-194bf217b70e-5267	\N	NEW	\N	\N	\N	\N
85283	79	D5170C00002/tiny.path.1/file-3893.msg	\N	D5170C00002-c1f09d0e-8317-11eb-be00-8938e65f5a63-3893	\N	NEW	\N	\N	\N	\N
82327	79	D5170C00002/tiny.path.1/file-0937.pdf	\N	D5170C00002-c1f14bb2-8315-11eb-be00-192c90752dd8-937	\N	NEW	\N	\N	\N	\N
85284	79	D5170C00002/tiny.path.1/file-3894.msg	\N	D5170C00002-c2013edf-8317-11eb-be00-2bea44e47247-3894	\N	NEW	\N	\N	\N	\N
82328	79	D5170C00002/tiny.path.1/file-0938.pdf	\N	D5170C00002-c20f33f3-8315-11eb-be00-c56785a3d5a3-938	\N	NEW	\N	\N	\N	\N
85285	79	D5170C00002/tiny.path.1/file-3895.msg	\N	D5170C00002-c20f48a0-8317-11eb-be00-c1a886e99392-3895	\N	NEW	\N	\N	\N	\N
86658	79	D5170C00002/tiny.path.1/file-5268.pdf	\N	D5170C00002-c210da2d-8318-11eb-be00-e7c4860b9405-5268	\N	NEW	\N	\N	\N	\N
86659	79	D5170C00002/tiny.path.1/file-5269.pdf	\N	D5170C00002-c22d14be-8318-11eb-be00-357993a12ef9-5269	\N	NEW	\N	\N	\N	\N
85286	79	D5170C00002/tiny.path.1/file-3896.msg	\N	D5170C00002-c22da611-8317-11eb-be00-992f3311665c-3896	\N	NEW	\N	\N	\N	\N
83713	79	D5170C00002/tiny.path.1/file-2323.pdf	\N	D5170C00002-c23cb68c-8316-11eb-be00-bd1c97f2d3b5-2323	\N	NEW	\N	\N	\N	\N
85287	79	D5170C00002/tiny.path.1/file-3897.msg	\N	D5170C00002-c23daba2-8317-11eb-be00-ed2b9543686b-3897	\N	NEW	\N	\N	\N	\N
82329	79	D5170C00002/tiny.path.1/file-0939.pdf	\N	D5170C00002-c23ea864-8315-11eb-be00-496e9d27a4aa-939	\N	NEW	\N	\N	\N	\N
85288	79	D5170C00002/tiny.path.1/file-3898.msg	\N	D5170C00002-c23f0b33-8317-11eb-be00-97316fb72b05-3898	\N	NEW	\N	\N	\N	\N
86660	79	D5170C00002/tiny.path.1/file-5270.pdf	\N	D5170C00002-c25c892f-8318-11eb-be00-91b17b7d4c82-5270	\N	NEW	\N	\N	\N	\N
82330	79	D5170C00002/tiny.path.1/file-0940.pdf	\N	D5170C00002-c25dc925-8315-11eb-be00-cbe51f203487-940	\N	NEW	\N	\N	\N	\N
85289	79	D5170C00002/tiny.path.1/file-3899.msg	\N	D5170C00002-c25dddd4-8317-11eb-be00-b7995eafaaf1-3899	\N	NEW	\N	\N	\N	\N
85290	79	D5170C00002/tiny.path.1/file-3900.msg	\N	D5170C00002-c27a1865-8317-11eb-be00-37c5a39832ac-3900	\N	NEW	\N	\N	\N	\N
83714	79	D5170C00002/tiny.path.1/file-2324.pdf	\N	D5170C00002-c27ad0fd-8316-11eb-be00-3fd0edc53dcf-2324	\N	NEW	\N	\N	\N	\N
85291	79	D5170C00002/tiny.path.1/file-3901.msg	\N	D5170C00002-c28981b6-8317-11eb-be00-719233197a23-3901	\N	NEW	\N	\N	\N	\N
82331	79	D5170C00002/tiny.path.1/file-0941.pdf	\N	D5170C00002-c29b9576-8315-11eb-be00-37df5d18a0de-941	\N	NEW	\N	\N	\N	\N
85292	79	D5170C00002/tiny.path.1/file-3902.msg	\N	D5170C00002-c2a7b817-8317-11eb-be00-770ed14e93c4-3902	\N	NEW	\N	\N	\N	\N
83715	79	D5170C00002/tiny.path.1/file-2325.pdf	\N	D5170C00002-c2c7434e-8316-11eb-be00-ad384ed14657-2325	\N	NEW	\N	\N	\N	\N
85293	79	D5170C00002/tiny.path.1/file-3903.msg	\N	D5170C00002-c2c83868-8317-11eb-be00-0dcfae0afcf9-3903	\N	NEW	\N	\N	\N	\N
85294	79	D5170C00002/tiny.path.1/file-3904.msg	\N	D5170C00002-c2e70b09-8317-11eb-be00-e573b0373626-3904	\N	NEW	\N	\N	\N	\N
83716	79	D5170C00002/tiny.path.1/file-2326.pdf	\N	D5170C00002-c2f446bf-8316-11eb-be00-dd93049fc087-2326	\N	NEW	\N	\N	\N	\N
82332	79	D5170C00002/tiny.path.1/file-0942.pdf	\N	D5170C00002-c2f48ae7-8315-11eb-be00-75fd8c774a28-942	\N	NEW	\N	\N	\N	\N
85295	79	D5170C00002/tiny.path.1/file-3905.msg	\N	D5170C00002-c313994a-8317-11eb-be00-ff92c21742db-3905	\N	NEW	\N	\N	\N	\N
88146	79	D5170C00002/tiny.path.1/file-6756.pdf	\N	D5170C00002-c31498ed-8319-11eb-be00-657f0130907e-6756	\N	NEW	\N	\N	\N	\N
82333	79	D5170C00002/tiny.path.1/file-0943.pdf	\N	D5170C00002-c3220388-8315-11eb-be00-eb36e6c1ce2b-943	\N	NEW	\N	\N	\N	\N
82334	79	D5170C00002/tiny.path.1/file-0944.pdf	\N	D5170C00002-c3311eb9-8315-11eb-be00-91b534f2230a-944	\N	NEW	\N	\N	\N	\N
85296	79	D5170C00002/tiny.path.1/file-3906.msg	\N	D5170C00002-c34f69cb-8317-11eb-be00-abbb322d0f8f-3906	\N	NEW	\N	\N	\N	\N
88147	79	D5170C00002/tiny.path.1/file-6757.pdf	\N	D5170C00002-c3512cbe-8319-11eb-be00-9791d762e507-6757	\N	NEW	\N	\N	\N	\N
82335	79	D5170C00002/tiny.path.1/file-0945.pdf	\N	D5170C00002-c35f339a-8315-11eb-be00-5f6da46f756f-945	\N	NEW	\N	\N	\N	\N
85297	79	D5170C00002/tiny.path.1/file-3907.msg	\N	D5170C00002-c36f26cc-8317-11eb-be00-2b40bc3611b9-3907	\N	NEW	\N	\N	\N	\N
88148	79	D5170C00002/tiny.path.1/file-6758.pdf	\N	D5170C00002-c37cf7af-8319-11eb-be00-7fe6ec59721f-6758	\N	NEW	\N	\N	\N	\N
82336	79	D5170C00002/tiny.path.1/file-0946.pdf	\N	D5170C00002-c37e063b-8315-11eb-be00-d725da46b895-946	\N	NEW	\N	\N	\N	\N
86661	79	D5170C00002/tiny.path.1/file-5271.pdf	\N	D5170C00002-c37e73f0-8318-11eb-be00-4df59fe2ef0f-5271	\N	NEW	\N	\N	\N	\N
85298	79	D5170C00002/tiny.path.1/file-3908.msg	\N	D5170C00002-c39bb50d-8317-11eb-be00-9f47b0c3c8b0-3908	\N	NEW	\N	\N	\N	\N
88149	79	D5170C00002/tiny.path.1/file-6759.pdf	\N	D5170C00002-c39bf160-8319-11eb-be00-a16a07f29545-6759	\N	NEW	\N	\N	\N	\N
85299	79	D5170C00002/tiny.path.1/file-3909.msg	\N	D5170C00002-c3aaf74e-8317-11eb-be00-5fc13fd9be4f-3909	\N	NEW	\N	\N	\N	\N
88150	79	D5170C00002/tiny.path.1/file-6760.pdf	\N	D5170C00002-c3ab33a1-8319-11eb-be00-6999d1ae3186-6760	\N	NEW	\N	\N	\N	\N
86662	79	D5170C00002/tiny.path.1/file-5272.pdf	\N	D5170C00002-c3bb55e1-8318-11eb-be00-719d5f494324-5272	\N	NEW	\N	\N	\N	\N
88151	79	D5170C00002/tiny.path.1/file-6761.pdf	\N	D5170C00002-c3caf0a2-8319-11eb-be00-d1139c885c30-6761	\N	NEW	\N	\N	\N	\N
85300	79	D5170C00002/tiny.path.1/file-3910.msg	\N	D5170C00002-c3cb297f-8317-11eb-be00-6ffd281c389e-3910	\N	NEW	\N	\N	\N	\N
82337	79	D5170C00002/tiny.path.1/file-0947.pdf	\N	D5170C00002-c3cc263c-8315-11eb-be00-1b7ad7ca5a5d-947	\N	NEW	\N	\N	\N	\N
86663	79	D5170C00002/tiny.path.1/file-5273.pdf	\N	D5170C00002-c3d9b352-8318-11eb-be00-0f5752b5fc20-5273	\N	NEW	\N	\N	\N	\N
86664	79	D5170C00002/tiny.path.1/file-5274.pdf	\N	D5170C00002-c3e7bd13-8318-11eb-be00-95e337240275-5274	\N	NEW	\N	\N	\N	\N
86665	79	D5170C00002/tiny.path.1/file-5275.pdf	\N	D5170C00002-c3ea0704-8318-11eb-be00-efbbc4abd55c-5275	\N	NEW	\N	\N	\N	\N
88152	79	D5170C00002/tiny.path.1/file-6762.pdf	\N	D5170C00002-c3ead4b3-8319-11eb-be00-39588d78e372-6762	\N	NEW	\N	\N	\N	\N
83717	79	D5170C00002/tiny.path.1/file-2327.pdf	\N	D5170C00002-c3f785f0-8316-11eb-be00-c57eef5223ba-2327	\N	NEW	\N	\N	\N	\N
86666	79	D5170C00002/tiny.path.1/file-5276.pdf	\N	D5170C00002-c4075305-8318-11eb-be00-5d6b7af76fbd-5276	\N	NEW	\N	\N	\N	\N
82338	79	D5170C00002/tiny.path.1/file-0948.pdf	\N	D5170C00002-c40892fd-8315-11eb-be00-9f07be375c61-948	\N	NEW	\N	\N	\N	\N
86667	79	D5170C00002/tiny.path.1/file-5277.pdf	\N	D5170C00002-c415d1f6-8318-11eb-be00-413a052a86ae-5277	\N	NEW	\N	\N	\N	\N
88153	79	D5170C00002/tiny.path.1/file-6763.pdf	\N	D5170C00002-c415dc54-8319-11eb-be00-dfe561bcda95-6763	\N	NEW	\N	\N	\N	\N
88162	79	D5170C00002/tiny.path.1/file-6772.pdf	\N	D5170C00002-c417ff35-8319-11eb-be00-2f55809eab81-6764	\N	NEW	\N	\N	\N	\N
85301	79	D5170C00002/tiny.path.1/file-3911.msg	\N	D5170C00002-c4253060-8317-11eb-be00-d7441ed9e911-3911	\N	NEW	\N	\N	\N	\N
86668	79	D5170C00002/tiny.path.1/file-5278.pdf	\N	D5170C00002-c425b077-8318-11eb-be00-3569d34fa0c9-5278	\N	NEW	\N	\N	\N	\N
88163	79	D5170C00002/tiny.path.1/file-6773.pdf	\N	D5170C00002-c4267e26-8319-11eb-be00-b70998347872-6765	\N	NEW	\N	\N	\N	\N
88154	79	D5170C00002/tiny.path.1/file-6764.pdf	\N	D5170C00002-c4432de7-8319-11eb-be00-072a7f03bba6-6766	\N	NEW	\N	\N	\N	\N
82339	79	D5170C00002/tiny.path.1/file-0949.pdf	\N	D5170C00002-c445ea1e-8315-11eb-be00-cb8f1c9c1cd7-949	\N	NEW	\N	\N	\N	\N
85302	79	D5170C00002/tiny.path.1/file-3912.msg	\N	D5170C00002-c45456b1-8317-11eb-be00-3f43ba675ca4-3912	\N	NEW	\N	\N	\N	\N
88155	79	D5170C00002/tiny.path.1/file-6765.pdf	\N	D5170C00002-c4549308-8319-11eb-be00-1dd2df23f61e-6767	\N	NEW	\N	\N	\N	\N
83718	79	D5170C00002/tiny.path.1/file-2328.pdf	\N	D5170C00002-c46255b1-8316-11eb-be00-ad2d4aadb7c2-2328	\N	NEW	\N	\N	\N	\N
88156	79	D5170C00002/tiny.path.1/file-6766.pdf	\N	D5170C00002-c4633909-8319-11eb-be00-45cbfca046a2-6768	\N	NEW	\N	\N	\N	\N
82340	79	D5170C00002/tiny.path.1/file-0950.pdf	\N	D5170C00002-c464478f-8315-11eb-be00-6b2368172e08-950	\N	NEW	\N	\N	\N	\N
88157	79	D5170C00002/tiny.path.1/file-6767.pdf	\N	D5170C00002-c48f521a-8319-11eb-be00-55eef4df4444-6769	\N	NEW	\N	\N	\N	\N
83719	79	D5170C00002/tiny.path.1/file-2329.pdf	\N	D5170C00002-c48fce52-8316-11eb-be00-3f6b70ba627b-2329	\N	NEW	\N	\N	\N	\N
83720	79	D5170C00002/tiny.path.1/file-2330.pdf	\N	D5170C00002-c4a10c63-8316-11eb-be00-e976bda38d98-2330	\N	NEW	\N	\N	\N	\N
86669	79	D5170C00002/tiny.path.1/file-5279.pdf	\N	D5170C00002-c4a14918-8318-11eb-be00-9951d9e6dc0c-5279	\N	NEW	\N	\N	\N	\N
85303	79	D5170C00002/tiny.path.1/file-3913.msg	\N	D5170C00002-c4ae5d92-8317-11eb-be00-779086f25299-3913	\N	NEW	\N	\N	\N	\N
83721	79	D5170C00002/tiny.path.1/file-2331.pdf	\N	D5170C00002-c4b04ea4-8316-11eb-be00-fd61cd313088-2331	\N	NEW	\N	\N	\N	\N
88158	79	D5170C00002/tiny.path.1/file-6768.pdf	\N	D5170C00002-c4be9f7b-8319-11eb-be00-0b163a30e690-6770	\N	NEW	\N	\N	\N	\N
86670	79	D5170C00002/tiny.path.1/file-5280.pdf	\N	D5170C00002-c4bebc29-8318-11eb-be00-01fa11ac7a1f-5280	\N	NEW	\N	\N	\N	\N
88159	79	D5170C00002/tiny.path.1/file-6769.pdf	\N	D5170C00002-c4ce08cc-8319-11eb-be00-35f4dcdd58cb-6771	\N	NEW	\N	\N	\N	\N
85304	79	D5170C00002/tiny.path.1/file-3914.msg	\N	D5170C00002-c4dc4b63-8317-11eb-be00-134a74cbdcd2-3914	\N	NEW	\N	\N	\N	\N
83722	79	D5170C00002/tiny.path.1/file-2332.pdf	\N	D5170C00002-c4dc67b5-8316-11eb-be00-37f1c7fb0e54-2332	\N	NEW	\N	\N	\N	\N
86671	79	D5170C00002/tiny.path.1/file-5281.pdf	\N	D5170C00002-c4dd8eca-8318-11eb-be00-41bb5123d14a-5281	\N	NEW	\N	\N	\N	\N
82341	79	D5170C00002/tiny.path.1/file-0951.pdf	\N	D5170C00002-c4ebee20-8315-11eb-be00-33e5ff87df9b-951	\N	NEW	\N	\N	\N	\N
86672	79	D5170C00002/tiny.path.1/file-5282.pdf	\N	D5170C00002-c4ec82eb-8318-11eb-be00-ad5cb2adf7b5-5282	\N	NEW	\N	\N	\N	\N
83723	79	D5170C00002/tiny.path.1/file-2333.pdf	\N	D5170C00002-c4ec9456-8316-11eb-be00-0b84f0ee8589-2333	\N	NEW	\N	\N	\N	\N
86673	79	D5170C00002/tiny.path.1/file-5283.pdf	\N	D5170C00002-c4fc616c-8318-11eb-be00-8baa7e616529-5283	\N	NEW	\N	\N	\N	\N
83724	79	D5170C00002/tiny.path.1/file-2334.pdf	\N	D5170C00002-c4fd3627-8316-11eb-be00-8da6445f9115-2334	\N	NEW	\N	\N	\N	\N
82342	79	D5170C00002/tiny.path.1/file-0952.pdf	\N	D5170C00002-c50bab21-8315-11eb-be00-fb3c689b175f-952	\N	NEW	\N	\N	\N	\N
86674	79	D5170C00002/tiny.path.1/file-5284.pdf	\N	D5170C00002-c50c3fed-8318-11eb-be00-a1ec83845969-5284	\N	NEW	\N	\N	\N	\N
83725	79	D5170C00002/tiny.path.1/file-2335.pdf	\N	D5170C00002-c51ad048-8316-11eb-be00-71bb262ce8c6-2335	\N	NEW	\N	\N	\N	\N
85305	79	D5170C00002/tiny.path.1/file-3915.msg	\N	D5170C00002-c5282174-8317-11eb-be00-c92ee1609ae9-3915	\N	NEW	\N	\N	\N	\N
82343	79	D5170C00002/tiny.path.1/file-0953.pdf	\N	D5170C00002-c52881f2-8315-11eb-be00-115e9af531f6-953	\N	NEW	\N	\N	\N	\N
86675	79	D5170C00002/tiny.path.1/file-5285.pdf	\N	D5170C00002-c537e3ce-8318-11eb-be00-5f66b78c9280-5285	\N	NEW	\N	\N	\N	\N
82344	79	D5170C00002/tiny.path.1/file-0954.pdf	\N	D5170C00002-c537eb43-8315-11eb-be00-632807dcb8cb-954	\N	NEW	\N	\N	\N	\N
82345	79	D5170C00002/tiny.path.1/file-0955.pdf	\N	D5170C00002-c53aaa64-8315-11eb-be00-c3131279b1a9-955	\N	NEW	\N	\N	\N	\N
86676	79	D5170C00002/tiny.path.1/file-5286.pdf	\N	D5170C00002-c547e95f-8318-11eb-be00-8765cb25abfe-5286	\N	NEW	\N	\N	\N	\N
86677	79	D5170C00002/tiny.path.1/file-5287.pdf	\N	D5170C00002-c5568f60-8318-11eb-be00-856759451dc6-5287	\N	NEW	\N	\N	\N	\N
88160	79	D5170C00002/tiny.path.1/file-6770.pdf	\N	D5170C00002-c558476d-8319-11eb-be00-af95698d1dfb-6772	\N	NEW	\N	\N	\N	\N
82346	79	D5170C00002/tiny.path.1/file-0956.pdf	\N	D5170C00002-c558b9b5-8315-11eb-be00-4788c4b8e865-956	\N	NEW	\N	\N	\N	\N
82347	79	D5170C00002/tiny.path.1/file-0957.pdf	\N	D5170C00002-c5675fb6-8315-11eb-be00-1711c6471813-957	\N	NEW	\N	\N	\N	\N
85306	79	D5170C00002/tiny.path.1/file-3916.msg	\N	D5170C00002-c5677465-8317-11eb-be00-cb345633a29f-3916	\N	NEW	\N	\N	\N	\N
83726	79	D5170C00002/tiny.path.1/file-2336.pdf	\N	D5170C00002-c576fa09-8316-11eb-be00-b9ca18da5371-2336	\N	NEW	\N	\N	\N	\N
83727	79	D5170C00002/tiny.path.1/file-2337.pdf	\N	D5170C00002-c584b5aa-8316-11eb-be00-71cf894a3fd1-2337	\N	NEW	\N	\N	\N	\N
86678	79	D5170C00002/tiny.path.1/file-5288.pdf	\N	D5170C00002-c5858ea1-8318-11eb-be00-e99d5b09573c-5288	\N	NEW	\N	\N	\N	\N
82348	79	D5170C00002/tiny.path.1/file-0958.pdf	\N	D5170C00002-c585bd27-8315-11eb-be00-198f4ca9a526-958	\N	NEW	\N	\N	\N	\N
88161	79	D5170C00002/tiny.path.1/file-6771.pdf	\N	D5170C00002-c595ecae-8319-11eb-be00-6bbac33267d2-6773	\N	NEW	\N	\N	\N	\N
85307	79	D5170C00002/tiny.path.1/file-3917.msg	\N	D5170C00002-c595fe76-8317-11eb-be00-c50bf6753146-3917	\N	NEW	\N	\N	\N	\N
86679	79	D5170C00002/tiny.path.1/file-5289.pdf	\N	D5170C00002-c5a26572-8318-11eb-be00-ffd81aa643d7-5289	\N	NEW	\N	\N	\N	\N
83728	79	D5170C00002/tiny.path.1/file-2338.pdf	\N	D5170C00002-c5a276db-8316-11eb-be00-97cc5e4a86f7-2338	\N	NEW	\N	\N	\N	\N
86680	79	D5170C00002/tiny.path.1/file-5290.pdf	\N	D5170C00002-c5b1f5d3-8318-11eb-be00-7bb53c00c171-5290	\N	NEW	\N	\N	\N	\N
86681	79	D5170C00002/tiny.path.1/file-5291.pdf	\N	D5170C00002-c5b3f1a4-8318-11eb-be00-1f328d871c03-5291	\N	NEW	\N	\N	\N	\N
82349	79	D5170C00002/tiny.path.1/file-0959.pdf	\N	D5170C00002-c5b44738-8315-11eb-be00-357e790d19d0-959	\N	NEW	\N	\N	\N	\N
83729	79	D5170C00002/tiny.path.1/file-2339.pdf	\N	D5170C00002-c5c31e3c-8316-11eb-be00-8b61a60df117-2339	\N	NEW	\N	\N	\N	\N
86684	79	D5170C00002/tiny.path.1/file-5294.pdf	\N	D5170C00002-c5d22805-8318-11eb-be00-53c07bc87d18-5292	\N	NEW	\N	\N	\N	\N
85308	79	D5170C00002/tiny.path.1/file-3918.msg	\N	D5170C00002-c5d2b957-8317-11eb-be00-bfba4899cc10-3918	\N	NEW	\N	\N	\N	\N
82350	79	D5170C00002/tiny.path.1/file-0960.pdf	\N	D5170C00002-c5df9cf9-8315-11eb-be00-7fc761dce40c-960	\N	NEW	\N	\N	\N	\N
86685	79	D5170C00002/tiny.path.1/file-5295.pdf	\N	D5170C00002-c5eefed6-8318-11eb-be00-9367cf4d8bac-5293	\N	NEW	\N	\N	\N	\N
83730	79	D5170C00002/tiny.path.1/file-2340.pdf	\N	D5170C00002-c5f06fcd-8316-11eb-be00-754fa32bda22-2340	\N	NEW	\N	\N	\N	\N
82351	79	D5170C00002/tiny.path.1/file-0961.pdf	\N	D5170C00002-c5fe217a-8315-11eb-be00-8ff5b8ff5b28-961	\N	NEW	\N	\N	\N	\N
82352	79	D5170C00002/tiny.path.1/file-0962.pdf	\N	D5170C00002-c5fff63b-8315-11eb-be00-f91c6e06fa68-962	\N	NEW	\N	\N	\N	\N
83731	79	D5170C00002/tiny.path.1/file-2341.pdf	\N	D5170C00002-c60ea62e-8316-11eb-be00-39e10a3047c8-2341	\N	NEW	\N	\N	\N	\N
82353	79	D5170C00002/tiny.path.1/file-0963.pdf	\N	D5170C00002-c61ca5fc-8315-11eb-be00-dd60b96224a4-963	\N	NEW	\N	\N	\N	\N
88164	79	D5170C00002/tiny.path.1/file-6774.pdf	\N	D5170C00002-c61e568f-8319-11eb-be00-c92322c312b9-6774	\N	NEW	\N	\N	\N	\N
86682	79	D5170C00002/tiny.path.1/file-5292.pdf	\N	D5170C00002-c61e7347-8318-11eb-be00-8fc763063f64-5294	\N	NEW	\N	\N	\N	\N
82354	79	D5170C00002/tiny.path.1/file-0964.pdf	\N	D5170C00002-c61f3e0d-8315-11eb-be00-fb990079a2e2-964	\N	NEW	\N	\N	\N	\N
86683	79	D5170C00002/tiny.path.1/file-5293.pdf	\N	D5170C00002-c63b4a18-8318-11eb-be00-e5a2886ccfa0-5295	\N	NEW	\N	\N	\N	\N
82355	79	D5170C00002/tiny.path.1/file-0965.pdf	\N	D5170C00002-c63cd82e-8315-11eb-be00-8f1c16c349b7-965	\N	NEW	\N	\N	\N	\N
83732	79	D5170C00002/tiny.path.1/file-2342.pdf	\N	D5170C00002-c64bd63f-8316-11eb-be00-f9cedeee576e-2342	\N	NEW	\N	\N	\N	\N
83733	79	D5170C00002/tiny.path.1/file-2343.pdf	\N	D5170C00002-c659e000-8316-11eb-be00-2504ffd37d1d-2343	\N	NEW	\N	\N	\N	\N
82356	79	D5170C00002/tiny.path.1/file-0966.pdf	\N	D5170C00002-c65a4b3f-8315-11eb-be00-abb06c928b46-966	\N	NEW	\N	\N	\N	\N
85309	79	D5170C00002/tiny.path.1/file-3919.msg	\N	D5170C00002-c65bbf78-8317-11eb-be00-d5fccb272534-3919	\N	NEW	\N	\N	\N	\N
82357	79	D5170C00002/tiny.path.1/file-0967.pdf	\N	D5170C00002-c66ac600-8315-11eb-be00-9f36c4d14476-967	\N	NEW	\N	\N	\N	\N
88165	79	D5170C00002/tiny.path.1/file-6775.pdf	\N	D5170C00002-c67995f0-8319-11eb-be00-ab15081f7a87-6775	\N	NEW	\N	\N	\N	\N
86686	79	D5170C00002/tiny.path.1/file-5296.pdf	\N	D5170C00002-c6a6dd29-8318-11eb-be00-65baeba186b7-5296	\N	NEW	\N	\N	\N	\N
82359	79	D5170C00002/tiny.path.1/file-0969.pdf	\N	D5170C00002-c6a89251-8315-11eb-be00-6fc6cdf426db-968	\N	NEW	\N	\N	\N	\N
85310	79	D5170C00002/tiny.path.1/file-3920.msg	\N	D5170C00002-c6b59f49-8317-11eb-be00-7723245fe5c7-3920	\N	NEW	\N	\N	\N	\N
83734	79	D5170C00002/tiny.path.1/file-2344.pdf	\N	D5170C00002-c6e3f791-8316-11eb-be00-05666c4beaae-2344	\N	NEW	\N	\N	\N	\N
83735	79	D5170C00002/tiny.path.1/file-2345.pdf	\N	D5170C00002-c6f535a2-8316-11eb-be00-773b754e730f-2345	\N	NEW	\N	\N	\N	\N
88166	79	D5170C00002/tiny.path.1/file-6776.pdf	\N	D5170C00002-c7033851-8319-11eb-be00-99d682d26240-6776	\N	NEW	\N	\N	\N	\N
85311	79	D5170C00002/tiny.path.1/file-3921.msg	\N	D5170C00002-c710b79a-8317-11eb-be00-893515528249-3921	\N	NEW	\N	\N	\N	\N
83736	79	D5170C00002/tiny.path.1/file-2346.pdf	\N	D5170C00002-c710fb03-8316-11eb-be00-5db9d7ffacad-2346	\N	NEW	\N	\N	\N	\N
82358	79	D5170C00002/tiny.path.1/file-0968.pdf	\N	D5170C00002-c7136212-8315-11eb-be00-cfcd47587c9b-969	\N	NEW	\N	\N	\N	\N
88167	79	D5170C00002/tiny.path.1/file-6777.pdf	\N	D5170C00002-c72147a2-8319-11eb-be00-d9af71a4166f-6777	\N	NEW	\N	\N	\N	\N
83737	79	D5170C00002/tiny.path.1/file-2347.pdf	\N	D5170C00002-c72f5874-8316-11eb-be00-f92e671bb11f-2347	\N	NEW	\N	\N	\N	\N
82360	79	D5170C00002/tiny.path.1/file-0970.pdf	\N	D5170C00002-c731bf83-8315-11eb-be00-4f070e06aa36-970	\N	NEW	\N	\N	\N	\N
83738	79	D5170C00002/tiny.path.1/file-2348.pdf	\N	D5170C00002-c7323ea5-8316-11eb-be00-59d7cd5d84f7-2348	\N	NEW	\N	\N	\N	\N
88168	79	D5170C00002/tiny.path.1/file-6778.pdf	\N	D5170C00002-c73ebab3-8319-11eb-be00-937b10728fac-6778	\N	NEW	\N	\N	\N	\N
86687	79	D5170C00002/tiny.path.1/file-5297.pdf	\N	D5170C00002-c7400fea-8318-11eb-be00-0f940d6729ce-5297	\N	NEW	\N	\N	\N	\N
83739	79	D5170C00002/tiny.path.1/file-2349.pdf	\N	D5170C00002-c7406f76-8316-11eb-be00-8d68f80bfa58-2349	\N	NEW	\N	\N	\N	\N
85312	79	D5170C00002/tiny.path.1/file-3922.msg	\N	D5170C00002-c74e83eb-8317-11eb-be00-d5bb4b66644e-3922	\N	NEW	\N	\N	\N	\N
82361	79	D5170C00002/tiny.path.1/file-0971.pdf	\N	D5170C00002-c75d3c54-8315-11eb-be00-dfa7343ce119-971	\N	NEW	\N	\N	\N	\N
83740	79	D5170C00002/tiny.path.1/file-2350.pdf	\N	D5170C00002-c75de287-8316-11eb-be00-bd37591f84cb-2350	\N	NEW	\N	\N	\N	\N
86688	79	D5170C00002/tiny.path.1/file-5298.pdf	\N	D5170C00002-c75ebb7b-8318-11eb-be00-9fbcfbcc7c51-5298	\N	NEW	\N	\N	\N	\N
85313	79	D5170C00002/tiny.path.1/file-3923.msg	\N	D5170C00002-c76e67fc-8317-11eb-be00-1fbc77de80fa-3923	\N	NEW	\N	\N	\N	\N
82362	79	D5170C00002/tiny.path.1/file-0972.pdf	\N	D5170C00002-c77cf955-8315-11eb-be00-9b9f548ee80a-972	\N	NEW	\N	\N	\N	\N
86689	79	D5170C00002/tiny.path.1/file-5299.pdf	\N	D5170C00002-c77d3ffc-8318-11eb-be00-d3f00a9fc099-5299	\N	NEW	\N	\N	\N	\N
88169	79	D5170C00002/tiny.path.1/file-6779.pdf	\N	D5170C00002-c77d9874-8319-11eb-be00-f92f35349345-6779	\N	NEW	\N	\N	\N	\N
85314	79	D5170C00002/tiny.path.1/file-3924.msg	\N	D5170C00002-c78af0ad-8317-11eb-be00-1305fa8c9212-3924	\N	NEW	\N	\N	\N	\N
83741	79	D5170C00002/tiny.path.1/file-2351.pdf	\N	D5170C00002-c78da518-8316-11eb-be00-b1c2e76da061-2351	\N	NEW	\N	\N	\N	\N
82363	79	D5170C00002/tiny.path.1/file-0973.pdf	\N	D5170C00002-c79b08a6-8315-11eb-be00-bffaf3ecd393-973	\N	NEW	\N	\N	\N	\N
88170	79	D5170C00002/tiny.path.1/file-6780.pdf	\N	D5170C00002-c79b80b5-8319-11eb-be00-9761680e320f-6780	\N	NEW	\N	\N	\N	\N
88171	79	D5170C00002/tiny.path.1/file-6781.pdf	\N	D5170C00002-c7ab1116-8319-11eb-be00-cb606c6627f5-6781	\N	NEW	\N	\N	\N	\N
83742	79	D5170C00002/tiny.path.1/file-2352.pdf	\N	D5170C00002-c7ab3f39-8316-11eb-be00-3fa582fbf30c-2352	\N	NEW	\N	\N	\N	\N
82364	79	D5170C00002/tiny.path.1/file-0974.pdf	\N	D5170C00002-c7b8c9d7-8315-11eb-be00-ed8be386974e-974	\N	NEW	\N	\N	\N	\N
83743	79	D5170C00002/tiny.path.1/file-2353.pdf	\N	D5170C00002-c7bb1dba-8316-11eb-be00-49235f3aa883-2353	\N	NEW	\N	\N	\N	\N
86690	79	D5170C00002/tiny.path.1/file-5300.pdf	\N	D5170C00002-c7bb335d-8318-11eb-be00-1b3fd54e8929-5300	\N	NEW	\N	\N	\N	\N
82366	79	D5170C00002/tiny.path.1/file-0976.pdf	\N	D5170C00002-c7c85a38-8315-11eb-be00-69d73317a245-975	\N	NEW	\N	\N	\N	\N
85315	79	D5170C00002/tiny.path.1/file-3925.msg	\N	D5170C00002-c7d714de-8317-11eb-be00-69bb6645bcb5-3925	\N	NEW	\N	\N	\N	\N
83744	79	D5170C00002/tiny.path.1/file-2354.pdf	\N	D5170C00002-c7d842ab-8316-11eb-be00-bdf58f97ad92-2354	\N	NEW	\N	\N	\N	\N
88172	79	D5170C00002/tiny.path.1/file-6782.pdf	\N	D5170C00002-c7e88f47-8319-11eb-be00-e180ec87cc2f-6782	\N	NEW	\N	\N	\N	\N
86691	79	D5170C00002/tiny.path.1/file-5301.pdf	\N	D5170C00002-c7f5a44e-8318-11eb-be00-752497112358-5301	\N	NEW	\N	\N	\N	\N
83745	79	D5170C00002/tiny.path.1/file-2355.pdf	\N	D5170C00002-c7f651fc-8316-11eb-be00-21e48d02b2c4-2355	\N	NEW	\N	\N	\N	\N
82365	79	D5170C00002/tiny.path.1/file-0975.pdf	\N	D5170C00002-c7f7f5b9-8315-11eb-be00-ef393cc76c7d-976	\N	NEW	\N	\N	\N	\N
88173	79	D5170C00002/tiny.path.1/file-6783.pdf	\N	D5170C00002-c8056618-8319-11eb-be00-d5af3867de38-6783	\N	NEW	\N	\N	\N	\N
85316	79	D5170C00002/tiny.path.1/file-3926.msg	\N	D5170C00002-c805c5ff-8317-11eb-be00-296e9b0d834e-3926	\N	NEW	\N	\N	\N	\N
86692	79	D5170C00002/tiny.path.1/file-5302.pdf	\N	D5170C00002-c8061f0f-8318-11eb-be00-8f92ac31774e-5302	\N	NEW	\N	\N	\N	\N
83746	79	D5170C00002/tiny.path.1/file-2356.pdf	\N	D5170C00002-c815249d-8316-11eb-be00-f5506b8c06ee-2356	\N	NEW	\N	\N	\N	\N
85317	79	D5170C00002/tiny.path.1/file-3927.msg	\N	D5170C00002-c815a480-8317-11eb-be00-9fab52d02685-3927	\N	NEW	\N	\N	\N	\N
88174	79	D5170C00002/tiny.path.1/file-6784.pdf	\N	D5170C00002-c816a429-8319-11eb-be00-330e1805b503-6784	\N	NEW	\N	\N	\N	\N
83747	79	D5170C00002/tiny.path.1/file-2357.pdf	\N	D5170C00002-c824dc0e-8316-11eb-be00-3530374d92d1-2357	\N	NEW	\N	\N	\N	\N
82368	79	D5170C00002/tiny.path.1/file-0978.pdf	\N	D5170C00002-c825956a-8315-11eb-be00-df72c8939748-977	\N	NEW	\N	\N	\N	\N
88175	79	D5170C00002/tiny.path.1/file-6785.pdf	\N	D5170C00002-c8321b6a-8319-11eb-be00-7f7ed7dd82a1-6785	\N	NEW	\N	\N	\N	\N
86693	79	D5170C00002/tiny.path.1/file-5303.pdf	\N	D5170C00002-c832ad50-8318-11eb-be00-6f9692f04810-5303	\N	NEW	\N	\N	\N	\N
85318	79	D5170C00002/tiny.path.1/file-3928.msg	\N	D5170C00002-c8338cc1-8317-11eb-be00-ed98548080f0-3928	\N	NEW	\N	\N	\N	\N
88176	79	D5170C00002/tiny.path.1/file-6786.pdf	\N	D5170C00002-c841abcb-8319-11eb-be00-a164aa526b81-6786	\N	NEW	\N	\N	\N	\N
82367	79	D5170C00002/tiny.path.1/file-0977.pdf	\N	D5170C00002-c843f2db-8315-11eb-be00-d9ea23cc9eed-978	\N	NEW	\N	\N	\N	\N
88177	79	D5170C00002/tiny.path.1/file-6787.pdf	\N	D5170C00002-c84443dc-8319-11eb-be00-5be3aa354945-6787	\N	NEW	\N	\N	\N	\N
83748	79	D5170C00002/tiny.path.1/file-2358.pdf	\N	D5170C00002-c84471ff-8316-11eb-be00-31cc9fbc6e16-2358	\N	NEW	\N	\N	\N	\N
85319	79	D5170C00002/tiny.path.1/file-3929.msg	\N	D5170C00002-c85126e2-8317-11eb-be00-29bb5bcc8ca4-3929	\N	NEW	\N	\N	\N	\N
86706	79	D5170C00002/tiny.path.1/file-5316.pdf	\N	D5170C00002-c853a2d1-8318-11eb-be00-1542c3622d97-5304	\N	NEW	\N	\N	\N	\N
88178	79	D5170C00002/tiny.path.1/file-6788.pdf	\N	D5170C00002-c853fb4d-8319-11eb-be00-953c0aa66ffe-6788	\N	NEW	\N	\N	\N	\N
88179	79	D5170C00002/tiny.path.1/file-6789.pdf	\N	D5170C00002-c8622c1e-8319-11eb-be00-83d5fd5535ee-6789	\N	NEW	\N	\N	\N	\N
83749	79	D5170C00002/tiny.path.1/file-2359.pdf	\N	D5170C00002-c87015e0-8316-11eb-be00-bb270700195e-2359	\N	NEW	\N	\N	\N	\N
86694	79	D5170C00002/tiny.path.1/file-5304.pdf	\N	D5170C00002-c87115e2-8318-11eb-be00-c9aa65388812-5305	\N	NEW	\N	\N	\N	\N
82369	79	D5170C00002/tiny.path.1/file-0979.pdf	\N	D5170C00002-c87f753c-8315-11eb-be00-5bb28b2224b0-979	\N	NEW	\N	\N	\N	\N
83750	79	D5170C00002/tiny.path.1/file-2360.pdf	\N	D5170C00002-c87fcd51-8316-11eb-be00-9d438af63a0e-2360	\N	NEW	\N	\N	\N	\N
88180	79	D5170C00002/tiny.path.1/file-6790.pdf	\N	D5170C00002-c88125cf-8319-11eb-be00-a312e29af5b6-6790	\N	NEW	\N	\N	\N	\N
86695	79	D5170C00002/tiny.path.1/file-5305.pdf	\N	D5170C00002-c88e13c3-8318-11eb-be00-c7790d48eeed-5306	\N	NEW	\N	\N	\N	\N
86700	79	D5170C00002/tiny.path.1/file-5310.pdf	\N	D5170C00002-c89e1954-8318-11eb-be00-89ed2b0a8a8b-5307	\N	NEW	\N	\N	\N	\N
88181	79	D5170C00002/tiny.path.1/file-6791.pdf	\N	D5170C00002-c89e23b0-8319-11eb-be00-bbfff579f704-6791	\N	NEW	\N	\N	\N	\N
82370	79	D5170C00002/tiny.path.1/file-0980.pdf	\N	D5170C00002-c89e47dd-8315-11eb-be00-ddab004411b9-980	\N	NEW	\N	\N	\N	\N
85320	79	D5170C00002/tiny.path.1/file-3930.msg	\N	D5170C00002-c89fbc13-8317-11eb-be00-85ae48c78076-3930	\N	NEW	\N	\N	\N	\N
83751	79	D5170C00002/tiny.path.1/file-2361.pdf	\N	D5170C00002-c8ade232-8316-11eb-be00-fb403de7a7e0-2361	\N	NEW	\N	\N	\N	\N
86701	79	D5170C00002/tiny.path.1/file-5311.pdf	\N	D5170C00002-c8af0945-8318-11eb-be00-75bd00fab009-5308	\N	NEW	\N	\N	\N	\N
85321	79	D5170C00002/tiny.path.1/file-3931.msg	\N	D5170C00002-c8bda454-8317-11eb-be00-4fa6cb65c273-3931	\N	NEW	\N	\N	\N	\N
85322	79	D5170C00002/tiny.path.1/file-3932.msg	\N	D5170C00002-c8cb11d5-8317-11eb-be00-3b5bf57ac92d-3932	\N	NEW	\N	\N	\N	\N
86702	79	D5170C00002/tiny.path.1/file-5312.pdf	\N	D5170C00002-c8cb6ae6-8318-11eb-be00-7d5e4781d036-5309	\N	NEW	\N	\N	\N	\N
88182	79	D5170C00002/tiny.path.1/file-6792.pdf	\N	D5170C00002-c8cc3891-8319-11eb-be00-25d14d821995-6792	\N	NEW	\N	\N	\N	\N
83752	79	D5170C00002/tiny.path.1/file-2362.pdf	\N	D5170C00002-c8cc66b3-8316-11eb-be00-5b8bbc65b238-2362	\N	NEW	\N	\N	\N	\N
85323	79	D5170C00002/tiny.path.1/file-3933.msg	\N	D5170C00002-c8daa236-8317-11eb-be00-4dbaaf505f59-3933	\N	NEW	\N	\N	\N	\N
82371	79	D5170C00002/tiny.path.1/file-0981.pdf	\N	D5170C00002-c8dab49e-8315-11eb-be00-fdef633bdf35-981	\N	NEW	\N	\N	\N	\N
86703	79	D5170C00002/tiny.path.1/file-5313.pdf	\N	D5170C00002-c8dafb47-8318-11eb-be00-858aa0445fd9-5310	\N	NEW	\N	\N	\N	\N
82372	79	D5170C00002/tiny.path.1/file-0982.pdf	\N	D5170C00002-c8ecb5ff-8315-11eb-be00-8700d448ba53-982	\N	NEW	\N	\N	\N	\N
86704	79	D5170C00002/tiny.path.1/file-5314.pdf	\N	D5170C00002-c8f931a8-8318-11eb-be00-71b96cf20e99-5311	\N	NEW	\N	\N	\N	\N
85324	79	D5170C00002/tiny.path.1/file-3934.msg	\N	D5170C00002-c90868f7-8317-11eb-be00-d757dce583cd-3934	\N	NEW	\N	\N	\N	\N
86705	79	D5170C00002/tiny.path.1/file-5315.pdf	\N	D5170C00002-c9098559-8318-11eb-be00-f3cce45ff5fa-5312	\N	NEW	\N	\N	\N	\N
88183	79	D5170C00002/tiny.path.1/file-6793.pdf	\N	D5170C00002-c9174b52-8319-11eb-be00-85d07cb90fc3-6793	\N	NEW	\N	\N	\N	\N
86696	79	D5170C00002/tiny.path.1/file-5306.pdf	\N	D5170C00002-c91915ba-8318-11eb-be00-0deac15f57e2-5313	\N	NEW	\N	\N	\N	\N
83753	79	D5170C00002/tiny.path.1/file-2363.pdf	\N	D5170C00002-c9194e34-8316-11eb-be00-53c737ec6c40-2363	\N	NEW	\N	\N	\N	\N
88184	79	D5170C00002/tiny.path.1/file-6794.pdf	\N	D5170C00002-c92925a3-8319-11eb-be00-91faf0488361-6794	\N	NEW	\N	\N	\N	\N
86697	79	D5170C00002/tiny.path.1/file-5307.pdf	\N	D5170C00002-c935ec8b-8318-11eb-be00-3bfa96b77eb4-5314	\N	NEW	\N	\N	\N	\N
85325	79	D5170C00002/tiny.path.1/file-3935.msg	\N	D5170C00002-c93608a8-8317-11eb-be00-7dcea8f7d69b-3935	\N	NEW	\N	\N	\N	\N
88185	79	D5170C00002/tiny.path.1/file-6795.pdf	\N	D5170C00002-c9377d84-8319-11eb-be00-bb28ce8560db-6795	\N	NEW	\N	\N	\N	\N
83754	79	D5170C00002/tiny.path.1/file-2364.pdf	\N	D5170C00002-c93847e5-8316-11eb-be00-9b07086b0283-2364	\N	NEW	\N	\N	\N	\N
85326	79	D5170C00002/tiny.path.1/file-3936.msg	\N	D5170C00002-c9454ae9-8317-11eb-be00-038f7cf5c26d-3936	\N	NEW	\N	\N	\N	\N
86698	79	D5170C00002/tiny.path.1/file-5308.pdf	\N	D5170C00002-c945cb0c-8318-11eb-be00-538f49aa07ec-5315	\N	NEW	\N	\N	\N	\N
82373	79	D5170C00002/tiny.path.1/file-0983.pdf	\N	D5170C00002-c9461fa0-8315-11eb-be00-679d67ffae8a-983	\N	NEW	\N	\N	\N	\N
85327	79	D5170C00002/tiny.path.1/file-3937.msg	\N	D5170C00002-c946d18a-8317-11eb-be00-45a07e0ffb49-3937	\N	NEW	\N	\N	\N	\N
88186	79	D5170C00002/tiny.path.1/file-6796.pdf	\N	D5170C00002-c9547b65-8319-11eb-be00-d767cdcc2a9b-6796	\N	NEW	\N	\N	\N	\N
85328	79	D5170C00002/tiny.path.1/file-3938.msg	\N	D5170C00002-c956b00b-8317-11eb-be00-e9b2280fee0e-3938	\N	NEW	\N	\N	\N	\N
86699	79	D5170C00002/tiny.path.1/file-5309.pdf	\N	D5170C00002-c964016d-8318-11eb-be00-7fba9f596445-5316	\N	NEW	\N	\N	\N	\N
83755	79	D5170C00002/tiny.path.1/file-2365.pdf	\N	D5170C00002-c96439e6-8316-11eb-be00-91864c82ab79-2365	\N	NEW	\N	\N	\N	\N
85329	79	D5170C00002/tiny.path.1/file-3939.msg	\N	D5170C00002-c97311ac-8317-11eb-be00-6fbcc07ae371-3939	\N	NEW	\N	\N	\N	\N
88187	79	D5170C00002/tiny.path.1/file-6797.pdf	\N	D5170C00002-c97549d6-8319-11eb-be00-0f76c954d326-6797	\N	NEW	\N	\N	\N	\N
83756	79	D5170C00002/tiny.path.1/file-2366.pdf	\N	D5170C00002-c984ba37-8316-11eb-be00-99f3d9ae1b9f-2366	\N	NEW	\N	\N	\N	\N
85330	79	D5170C00002/tiny.path.1/file-3940.msg	\N	D5170C00002-c985130d-8317-11eb-be00-21c54029a36c-3940	\N	NEW	\N	\N	\N	\N
82374	79	D5170C00002/tiny.path.1/file-0984.pdf	\N	D5170C00002-c99243d1-8315-11eb-be00-3d7e81dd5558-984	\N	NEW	\N	\N	\N	\N
86707	79	D5170C00002/tiny.path.1/file-5317.pdf	\N	D5170C00002-c99327be-8318-11eb-be00-6723f21f0a2b-5317	\N	NEW	\N	\N	\N	\N
86708	79	D5170C00002/tiny.path.1/file-5318.pdf	\N	D5170C00002-c9a3545f-8318-11eb-be00-11a4c220a44f-5318	\N	NEW	\N	\N	\N	\N
85331	79	D5170C00002/tiny.path.1/file-3941.msg	\N	D5170C00002-c9b041be-8317-11eb-be00-2fc761bdccb6-3941	\N	NEW	\N	\N	\N	\N
83757	79	D5170C00002/tiny.path.1/file-2367.pdf	\N	D5170C00002-c9b0ac38-8316-11eb-be00-2b60f0ce0612-2367	\N	NEW	\N	\N	\N	\N
83758	79	D5170C00002/tiny.path.1/file-2368.pdf	\N	D5170C00002-c9bf5239-8316-11eb-be00-8fe10b6d0ac3-2368	\N	NEW	\N	\N	\N	\N
88188	79	D5170C00002/tiny.path.1/file-6798.pdf	\N	D5170C00002-c9bf7237-8319-11eb-be00-2db2f77d73e8-6798	\N	NEW	\N	\N	\N	\N
86709	79	D5170C00002/tiny.path.1/file-5319.pdf	\N	D5170C00002-c9c0c770-8318-11eb-be00-85e3051bb5ba-5319	\N	NEW	\N	\N	\N	\N
85332	79	D5170C00002/tiny.path.1/file-3942.msg	\N	D5170C00002-c9c10a9f-8317-11eb-be00-6f450b63120a-3942	\N	NEW	\N	\N	\N	\N
86710	79	D5170C00002/tiny.path.1/file-5320.pdf	\N	D5170C00002-c9c18ac1-8318-11eb-be00-5f31475b4349-5320	\N	NEW	\N	\N	\N	\N
82375	79	D5170C00002/tiny.path.1/file-0985.pdf	\N	D5170C00002-c9c19132-8315-11eb-be00-99569e8ef36b-985	\N	NEW	\N	\N	\N	\N
83759	79	D5170C00002/tiny.path.1/file-2369.pdf	\N	D5170C00002-c9cfccfa-8316-11eb-be00-5d444c6b84df-2369	\N	NEW	\N	\N	\N	\N
86711	79	D5170C00002/tiny.path.1/file-5321.pdf	\N	D5170C00002-c9d030c2-8318-11eb-be00-953dc8ff02a7-5321	\N	NEW	\N	\N	\N	\N
85333	79	D5170C00002/tiny.path.1/file-3943.msg	\N	D5170C00002-c9dde170-8317-11eb-be00-8564edfca499-3943	\N	NEW	\N	\N	\N	\N
86712	79	D5170C00002/tiny.path.1/file-5322.pdf	\N	D5170C00002-c9df24e3-8318-11eb-be00-4927e1901e8b-5322	\N	NEW	\N	\N	\N	\N
86713	79	D5170C00002/tiny.path.1/file-5323.pdf	\N	D5170C00002-c9e03654-8318-11eb-be00-c3a08af85023-5323	\N	NEW	\N	\N	\N	\N
82376	79	D5170C00002/tiny.path.1/file-0986.pdf	\N	D5170C00002-c9eee2c3-8315-11eb-be00-01b5e6a4454e-986	\N	NEW	\N	\N	\N	\N
86714	79	D5170C00002/tiny.path.1/file-5324.pdf	\N	D5170C00002-c9fbfbb5-8318-11eb-be00-8d5d1d9d49e0-5324	\N	NEW	\N	\N	\N	\N
85334	79	D5170C00002/tiny.path.1/file-3944.msg	\N	D5170C00002-c9fe3ab1-8317-11eb-be00-5d7bfe4d6a1d-3944	\N	NEW	\N	\N	\N	\N
83760	79	D5170C00002/tiny.path.1/file-2370.pdf	\N	D5170C00002-ca0bc48b-8316-11eb-be00-c569a4ce35bc-2370	\N	NEW	\N	\N	\N	\N
88189	79	D5170C00002/tiny.path.1/file-6799.pdf	\N	D5170C00002-ca0c32a8-8319-11eb-be00-97860f859a99-6799	\N	NEW	\N	\N	\N	\N
85335	79	D5170C00002/tiny.path.1/file-3945.msg	\N	D5170C00002-ca0d7cf2-8317-11eb-be00-1b03bb381e3b-3945	\N	NEW	\N	\N	\N	\N
86715	79	D5170C00002/tiny.path.1/file-5325.pdf	\N	D5170C00002-ca0daef6-8318-11eb-be00-4be54de67ca1-5325	\N	NEW	\N	\N	\N	\N
82377	79	D5170C00002/tiny.path.1/file-0987.pdf	\N	D5170C00002-ca0ddc74-8315-11eb-be00-8d1ad55f6882-987	\N	NEW	\N	\N	\N	\N
85336	79	D5170C00002/tiny.path.1/file-3946.msg	\N	D5170C00002-ca2aa1e3-8317-11eb-be00-9b822babcc88-3946	\N	NEW	\N	\N	\N	\N
86716	79	D5170C00002/tiny.path.1/file-5326.pdf	\N	D5170C00002-ca2ad3e7-8318-11eb-be00-6b6a571d4ddf-5326	\N	NEW	\N	\N	\N	\N
88190	79	D5170C00002/tiny.path.1/file-6800.pdf	\N	D5170C00002-ca2c64d9-8319-11eb-be00-c1f57c795caa-6800	\N	NEW	\N	\N	\N	\N
82378	79	D5170C00002/tiny.path.1/file-0988.pdf	\N	D5170C00002-ca2d2445-8315-11eb-be00-ab64bac6c2bf-988	\N	NEW	\N	\N	\N	\N
86717	79	D5170C00002/tiny.path.1/file-5327.pdf	\N	D5170C00002-ca3979e8-8318-11eb-be00-233b48753144-5327	\N	NEW	\N	\N	\N	\N
85337	79	D5170C00002/tiny.path.1/file-3947.msg	\N	D5170C00002-ca3af594-8317-11eb-be00-297d444ad59f-3947	\N	NEW	\N	\N	\N	\N
88191	79	D5170C00002/tiny.path.1/file-6801.pdf	\N	D5170C00002-ca48032a-8319-11eb-be00-47ad4637abb1-6801	\N	NEW	\N	\N	\N	\N
83761	79	D5170C00002/tiny.path.1/file-2371.pdf	\N	D5170C00002-ca48a67c-8316-11eb-be00-17c342e3ed7e-2371	\N	NEW	\N	\N	\N	\N
86718	79	D5170C00002/tiny.path.1/file-5328.pdf	\N	D5170C00002-ca495869-8318-11eb-be00-a716b6dd9a94-5328	\N	NEW	\N	\N	\N	\N
86719	79	D5170C00002/tiny.path.1/file-5329.pdf	\N	D5170C00002-ca57893a-8318-11eb-be00-db79f7ad4c1f-5329	\N	NEW	\N	\N	\N	\N
88192	79	D5170C00002/tiny.path.1/file-6802.pdf	\N	D5170C00002-ca57938b-8319-11eb-be00-59081a729b9d-6802	\N	NEW	\N	\N	\N	\N
86720	79	D5170C00002/tiny.path.1/file-5330.pdf	\N	D5170C00002-ca584c8b-8318-11eb-be00-6327a05cbe93-5330	\N	NEW	\N	\N	\N	\N
88193	79	D5170C00002/tiny.path.1/file-6803.pdf	\N	D5170C00002-ca5856dc-8319-11eb-be00-f5ebaf9628de-6803	\N	NEW	\N	\N	\N	\N
86721	79	D5170C00002/tiny.path.1/file-5331.pdf	\N	D5170C00002-ca5936ec-8318-11eb-be00-3914f8253613-5331	\N	NEW	\N	\N	\N	\N
82379	79	D5170C00002/tiny.path.1/file-0989.pdf	\N	D5170C00002-ca5a00a6-8315-11eb-be00-2784543cfef7-989	\N	NEW	\N	\N	\N	\N
88194	79	D5170C00002/tiny.path.1/file-6804.pdf	\N	D5170C00002-ca5a52ad-8319-11eb-be00-5312f145d7b9-6804	\N	NEW	\N	\N	\N	\N
82380	79	D5170C00002/tiny.path.1/file-0990.pdf	\N	D5170C00002-ca676e27-8315-11eb-be00-f7414d4725c7-990	\N	NEW	\N	\N	\N	\N
83762	79	D5170C00002/tiny.path.1/file-2372.pdf	\N	D5170C00002-ca76944d-8316-11eb-be00-7d36e309840a-2372	\N	NEW	\N	\N	\N	\N
82381	79	D5170C00002/tiny.path.1/file-0991.pdf	\N	D5170C00002-ca76b068-8315-11eb-be00-3974d67490df-991	\N	NEW	\N	\N	\N	\N
86722	79	D5170C00002/tiny.path.1/file-5332.pdf	\N	D5170C00002-ca76f81d-8318-11eb-be00-39aff41e0dc4-5332	\N	NEW	\N	\N	\N	\N
88195	79	D5170C00002/tiny.path.1/file-6805.pdf	\N	D5170C00002-ca779eae-8319-11eb-be00-03f1fe2639f1-6805	\N	NEW	\N	\N	\N	\N
82382	79	D5170C00002/tiny.path.1/file-0992.pdf	\N	D5170C00002-ca88b1c9-8315-11eb-be00-33ab95e7868e-992	\N	NEW	\N	\N	\N	\N
88196	79	D5170C00002/tiny.path.1/file-6806.pdf	\N	D5170C00002-ca944e6f-8319-11eb-be00-3f24e141c985-6806	\N	NEW	\N	\N	\N	\N
83763	79	D5170C00002/tiny.path.1/file-2373.pdf	\N	D5170C00002-ca9518ce-8316-11eb-be00-a96dead5174a-2373	\N	NEW	\N	\N	\N	\N
83764	79	D5170C00002/tiny.path.1/file-2374.pdf	\N	D5170C00002-ca97149f-8316-11eb-be00-d177db29196c-2374	\N	NEW	\N	\N	\N	\N
82383	79	D5170C00002/tiny.path.1/file-0993.pdf	\N	D5170C00002-caa5afaa-8315-11eb-be00-ad1341bce7df-993	\N	NEW	\N	\N	\N	\N
82384	79	D5170C00002/tiny.path.1/file-0994.pdf	\N	D5170C00002-cab5400b-8315-11eb-be00-5352cc51dac6-994	\N	NEW	\N	\N	\N	\N
88197	79	D5170C00002/tiny.path.1/file-6807.pdf	\N	D5170C00002-cab62e50-8319-11eb-be00-e5a79338734b-6807	\N	NEW	\N	\N	\N	\N
88198	79	D5170C00002/tiny.path.1/file-6808.pdf	\N	D5170C00002-cac2d881-8319-11eb-be00-4d06e2e4a31c-6808	\N	NEW	\N	\N	\N	\N
83765	79	D5170C00002/tiny.path.1/file-2375.pdf	\N	D5170C00002-cac4b450-8316-11eb-be00-7da8785bb3b0-2375	\N	NEW	\N	\N	\N	\N
86723	79	D5170C00002/tiny.path.1/file-5333.pdf	\N	D5170C00002-cad25e8e-8318-11eb-be00-61731ebcd981-5333	\N	NEW	\N	\N	\N	\N
82385	79	D5170C00002/tiny.path.1/file-0995.pdf	\N	D5170C00002-cad3013c-8315-11eb-be00-d94a0efcd2c9-995	\N	NEW	\N	\N	\N	\N
82386	79	D5170C00002/tiny.path.1/file-0996.pdf	\N	D5170C00002-cae1a73d-8315-11eb-be00-99979a83f68a-996	\N	NEW	\N	\N	\N	\N
83766	79	D5170C00002/tiny.path.1/file-2376.pdf	\N	D5170C00002-cae29c91-8316-11eb-be00-e74bf2939a41-2376	\N	NEW	\N	\N	\N	\N
85338	79	D5170C00002/tiny.path.1/file-3948.msg	\N	D5170C00002-cae2a745-8317-11eb-be00-6fd361030d46-3948	\N	NEW	\N	\N	\N	\N
86724	79	D5170C00002/tiny.path.1/file-5334.pdf	\N	D5170C00002-caf17f4f-8318-11eb-be00-49a07683d3d2-5334	\N	NEW	\N	\N	\N	\N
88199	79	D5170C00002/tiny.path.1/file-6809.pdf	\N	D5170C00002-caffba72-8319-11eb-be00-a3e4e51461d6-6809	\N	NEW	\N	\N	\N	\N
82389	79	D5170C00002/tiny.path.1/file-0999.pdf	\N	D5170C00002-cb0052ce-8315-11eb-be00-1baa236f623c-997	\N	NEW	\N	\N	\N	\N
83767	79	D5170C00002/tiny.path.1/file-2377.pdf	\N	D5170C00002-cb012112-8316-11eb-be00-b1160163e857-2377	\N	NEW	\N	\N	\N	\N
85339	79	D5170C00002/tiny.path.1/file-3949.msg	\N	D5170C00002-cb01a0f6-8317-11eb-be00-673730c4fa85-3949	\N	NEW	\N	\N	\N	\N
86725	79	D5170C00002/tiny.path.1/file-5335.pdf	\N	D5170C00002-cb10c620-8318-11eb-be00-87f616fe5dbd-5335	\N	NEW	\N	\N	\N	\N
83768	79	D5170C00002/tiny.path.1/file-2378.pdf	\N	D5170C00002-cb114db3-8316-11eb-be00-fb7966b930d7-2378	\N	NEW	\N	\N	\N	\N
88200	79	D5170C00002/tiny.path.1/file-6810.pdf	\N	D5170C00002-cb116db3-8319-11eb-be00-6daaad4677a3-6810	\N	NEW	\N	\N	\N	\N
82387	79	D5170C00002/tiny.path.1/file-0997.pdf	\N	D5170C00002-cb1190df-8315-11eb-be00-1901954d88db-998	\N	NEW	\N	\N	\N	\N
85340	79	D5170C00002/tiny.path.1/file-3950.msg	\N	D5170C00002-cb1e0297-8317-11eb-be00-13acdda0b08d-3950	\N	NEW	\N	\N	\N	\N
86726	79	D5170C00002/tiny.path.1/file-5336.pdf	\N	D5170C00002-cb2d27c1-8318-11eb-be00-41beb9e9c8cc-5336	\N	NEW	\N	\N	\N	\N
82388	79	D5170C00002/tiny.path.1/file-0998.pdf	\N	D5170C00002-cb2da460-8315-11eb-be00-eb1eb1b02da2-999	\N	NEW	\N	\N	\N	\N
85341	79	D5170C00002/tiny.path.1/file-3951.msg	\N	D5170C00002-cb2f1998-8317-11eb-be00-f1b71382cff2-3951	\N	NEW	\N	\N	\N	\N
86727	79	D5170C00002/tiny.path.1/file-5337.pdf	\N	D5170C00002-cb3d7b72-8318-11eb-be00-8b43b45e7666-5337	\N	NEW	\N	\N	\N	\N
82390	79	D5170C00002/tiny.path.1/file-1000.pdf	\N	D5170C00002-cb3da9f1-8315-11eb-be00-ef4857237ed5-1000	\N	NEW	\N	\N	\N	\N
88201	79	D5170C00002/tiny.path.1/file-6811.pdf	\N	D5170C00002-cb4dda74-8319-11eb-be00-2fd87f37acfe-6811	\N	NEW	\N	\N	\N	\N
82391	79	D5170C00002/tiny.path.1/file-1001.pdf	\N	D5170C00002-cb4e99e2-8315-11eb-be00-c915620872a0-1001	\N	NEW	\N	\N	\N	\N
85342	79	D5170C00002/tiny.path.1/file-3952.msg	\N	D5170C00002-cb5b59b9-8317-11eb-be00-a929bcc9b760-3952	\N	NEW	\N	\N	\N	\N
86728	79	D5170C00002/tiny.path.1/file-5338.pdf	\N	D5170C00002-cb5d1163-8318-11eb-be00-d928521624f9-5338	\N	NEW	\N	\N	\N	\N
88202	79	D5170C00002/tiny.path.1/file-6812.pdf	\N	D5170C00002-cb5d1cb5-8319-11eb-be00-2771bb18b817-6812	\N	NEW	\N	\N	\N	\N
86729	79	D5170C00002/tiny.path.1/file-5339.pdf	\N	D5170C00002-cb6a30c4-8318-11eb-be00-2dca00d1d0f0-5339	\N	NEW	\N	\N	\N	\N
83769	79	D5170C00002/tiny.path.1/file-2379.pdf	\N	D5170C00002-cb6c8d14-8316-11eb-be00-1337067fc35a-2379	\N	NEW	\N	\N	\N	\N
86730	79	D5170C00002/tiny.path.1/file-5340.pdf	\N	D5170C00002-cb797305-8318-11eb-be00-6d71cdc8d27d-5340	\N	NEW	\N	\N	\N	\N
85343	79	D5170C00002/tiny.path.1/file-3953.msg	\N	D5170C00002-cb79901a-8317-11eb-be00-6b8816b8ee30-3953	\N	NEW	\N	\N	\N	\N
88203	79	D5170C00002/tiny.path.1/file-6813.pdf	\N	D5170C00002-cb7b2c06-8319-11eb-be00-1f9e9f9248eb-6813	\N	NEW	\N	\N	\N	\N
86731	79	D5170C00002/tiny.path.1/file-5341.pdf	\N	D5170C00002-cb7c8046-8318-11eb-be00-4db8387eebd2-5341	\N	NEW	\N	\N	\N	\N
88204	79	D5170C00002/tiny.path.1/file-6814.pdf	\N	D5170C00002-cb8a9557-8319-11eb-be00-37dc2f3456d9-6814	\N	NEW	\N	\N	\N	\N
85344	79	D5170C00002/tiny.path.1/file-3954.msg	\N	D5170C00002-cb8b435b-8317-11eb-be00-bb1daf06ee4c-3954	\N	NEW	\N	\N	\N	\N
83770	79	D5170C00002/tiny.path.1/file-2380.pdf	\N	D5170C00002-cb98cd35-8316-11eb-be00-6d80fdb45ec4-2380	\N	NEW	\N	\N	\N	\N
88205	79	D5170C00002/tiny.path.1/file-6815.pdf	\N	D5170C00002-cb993b58-8319-11eb-be00-c121a42be81d-6815	\N	NEW	\N	\N	\N	\N
82392	79	D5170C00002/tiny.path.1/file-1002.pdf	\N	D5170C00002-cb995e83-8315-11eb-be00-61826f4b4675-1002	\N	NEW	\N	\N	\N	\N
86732	79	D5170C00002/tiny.path.1/file-5342.pdf	\N	D5170C00002-cba93597-8318-11eb-be00-0dabd6bdf5bd-5342	\N	NEW	\N	\N	\N	\N
83771	79	D5170C00002/tiny.path.1/file-2381.pdf	\N	D5170C00002-cbaa5966-8316-11eb-be00-7b924e908853-2381	\N	NEW	\N	\N	\N	\N
82393	79	D5170C00002/tiny.path.1/file-1003.pdf	\N	D5170C00002-cbaa7584-8315-11eb-be00-d7931ece613a-1003	\N	NEW	\N	\N	\N	\N
88206	79	D5170C00002/tiny.path.1/file-6816.pdf	\N	D5170C00002-cbb63939-8319-11eb-be00-134b6bfb93d4-6816	\N	NEW	\N	\N	\N	\N
85345	79	D5170C00002/tiny.path.1/file-3955.msg	\N	D5170C00002-cbb6c02c-8317-11eb-be00-318de4e0e948-3955	\N	NEW	\N	\N	\N	\N
86733	79	D5170C00002/tiny.path.1/file-5343.pdf	\N	D5170C00002-cbb8ed08-8318-11eb-be00-4d9e427b63f3-5343	\N	NEW	\N	\N	\N	\N
85346	79	D5170C00002/tiny.path.1/file-3956.msg	\N	D5170C00002-cbc89a7d-8317-11eb-be00-63d0f5d57668-3956	\N	NEW	\N	\N	\N	\N
88207	79	D5170C00002/tiny.path.1/file-6817.pdf	\N	D5170C00002-cbd496aa-8319-11eb-be00-8354b6cafdd2-6817	\N	NEW	\N	\N	\N	\N
82394	79	D5170C00002/tiny.path.1/file-1004.pdf	\N	D5170C00002-cbd5a435-8315-11eb-be00-fd7f632cee3a-1004	\N	NEW	\N	\N	\N	\N
85347	79	D5170C00002/tiny.path.1/file-3957.msg	\N	D5170C00002-cbd7b5ae-8317-11eb-be00-1149d2d4cb92-3957	\N	NEW	\N	\N	\N	\N
82395	79	D5170C00002/tiny.path.1/file-1005.pdf	\N	D5170C00002-cbd88a66-8315-11eb-be00-cb9f5ccc0d54-1005	\N	NEW	\N	\N	\N	\N
86734	79	D5170C00002/tiny.path.1/file-5344.pdf	\N	D5170C00002-cbe5a259-8318-11eb-be00-294cc478c42c-5344	\N	NEW	\N	\N	\N	\N
85348	79	D5170C00002/tiny.path.1/file-3958.msg	\N	D5170C00002-cbf43e5f-8317-11eb-be00-ed94c258ec89-3958	\N	NEW	\N	\N	\N	\N
88208	79	D5170C00002/tiny.path.1/file-6818.pdf	\N	D5170C00002-cbf453ab-8319-11eb-be00-2f5de1188664-6818	\N	NEW	\N	\N	\N	\N
85349	79	D5170C00002/tiny.path.1/file-3959.msg	\N	D5170C00002-cc035990-8317-11eb-be00-f19120ba2023-3959	\N	NEW	\N	\N	\N	\N
86735	79	D5170C00002/tiny.path.1/file-5345.pdf	\N	D5170C00002-cc03ffca-8318-11eb-be00-f799f48713e8-5345	\N	NEW	\N	\N	\N	\N
88209	79	D5170C00002/tiny.path.1/file-6819.pdf	\N	D5170C00002-cc134d5c-8319-11eb-be00-1bd8e409182f-6819	\N	NEW	\N	\N	\N	\N
88210	79	D5170C00002/tiny.path.1/file-6820.pdf	\N	D5170C00002-cc1437bd-8319-11eb-be00-89082942715f-6820	\N	NEW	\N	\N	\N	\N
83772	79	D5170C00002/tiny.path.1/file-2382.pdf	\N	D5170C00002-cc21fa67-8316-11eb-be00-9bcb88dd8a31-2382	\N	NEW	\N	\N	\N	\N
82396	79	D5170C00002/tiny.path.1/file-1006.pdf	\N	D5170C00002-cc237617-8315-11eb-be00-99ce1c94be18-1006	\N	NEW	\N	\N	\N	\N
85350	79	D5170C00002/tiny.path.1/file-3960.msg	\N	D5170C00002-cc247621-8317-11eb-be00-8968354bd9e2-3960	\N	NEW	\N	\N	\N	\N
86736	79	D5170C00002/tiny.path.1/file-5346.pdf	\N	D5170C00002-cc30dc2b-8318-11eb-be00-f1e3e304575d-5346	\N	NEW	\N	\N	\N	\N
86737	79	D5170C00002/tiny.path.1/file-5347.pdf	\N	D5170C00002-cc33261c-8318-11eb-be00-95727f58ac6c-5347	\N	NEW	\N	\N	\N	\N
83773	79	D5170C00002/tiny.path.1/file-2383.pdf	\N	D5170C00002-cc333878-8316-11eb-be00-2b89be362a2b-2383	\N	NEW	\N	\N	\N	\N
88211	79	D5170C00002/tiny.path.1/file-6821.pdf	\N	D5170C00002-cc4002ae-8319-11eb-be00-eff122b83552-6821	\N	NEW	\N	\N	\N	\N
85351	79	D5170C00002/tiny.path.1/file-3961.msg	\N	D5170C00002-cc406292-8317-11eb-be00-af4cdc15ae5d-3961	\N	NEW	\N	\N	\N	\N
86738	79	D5170C00002/tiny.path.1/file-5348.pdf	\N	D5170C00002-cc50992d-8318-11eb-be00-0716073e2ca5-5348	\N	NEW	\N	\N	\N	\N
88212	79	D5170C00002/tiny.path.1/file-6822.pdf	\N	D5170C00002-cc5140bf-8319-11eb-be00-391cf6040a91-6822	\N	NEW	\N	\N	\N	\N
85352	79	D5170C00002/tiny.path.1/file-3962.msg	\N	D5170C00002-cc601f93-8317-11eb-be00-97c05e9b1d2e-3962	\N	NEW	\N	\N	\N	\N
88213	79	D5170C00002/tiny.path.1/file-6823.pdf	\N	D5170C00002-cc6034e0-8319-11eb-be00-972dccf62e08-6823	\N	NEW	\N	\N	\N	\N
86739	79	D5170C00002/tiny.path.1/file-5349.pdf	\N	D5170C00002-cc7d276e-8318-11eb-be00-6fe1723f070b-5349	\N	NEW	\N	\N	\N	\N
83774	79	D5170C00002/tiny.path.1/file-2384.pdf	\N	D5170C00002-cc7d39c9-8316-11eb-be00-6d4879c495d1-2384	\N	NEW	\N	\N	\N	\N
88214	79	D5170C00002/tiny.path.1/file-6824.pdf	\N	D5170C00002-cc7ee071-8319-11eb-be00-812ea12fd0ee-6824	\N	NEW	\N	\N	\N	\N
86740	79	D5170C00002/tiny.path.1/file-5350.pdf	\N	D5170C00002-cc8c69af-8318-11eb-be00-f14c018d5d8e-5350	\N	NEW	\N	\N	\N	\N
88215	79	D5170C00002/tiny.path.1/file-6825.pdf	\N	D5170C00002-cc9b1b02-8319-11eb-be00-559e41002e20-6825	\N	NEW	\N	\N	\N	\N
86741	79	D5170C00002/tiny.path.1/file-5351.pdf	\N	D5170C00002-cc9bfa10-8318-11eb-be00-7b69ac8d8eb5-5351	\N	NEW	\N	\N	\N	\N
85353	79	D5170C00002/tiny.path.1/file-3963.msg	\N	D5170C00002-cc9c1724-8317-11eb-be00-c761636952c3-3963	\N	NEW	\N	\N	\N	\N
88216	79	D5170C00002/tiny.path.1/file-6826.pdf	\N	D5170C00002-cc9cefc3-8319-11eb-be00-1539d7933432-6826	\N	NEW	\N	\N	\N	\N
85354	79	D5170C00002/tiny.path.1/file-3964.msg	\N	D5170C00002-ccabf5a5-8317-11eb-be00-eb5ceee9d780-3964	\N	NEW	\N	\N	\N	\N
82397	79	D5170C00002/tiny.path.1/file-1007.pdf	\N	D5170C00002-ccaca348-8315-11eb-be00-ff87da2ac8ea-1007	\N	NEW	\N	\N	\N	\N
86742	79	D5170C00002/tiny.path.1/file-5352.pdf	\N	D5170C00002-ccad8641-8318-11eb-be00-3fb8190b9193-5352	\N	NEW	\N	\N	\N	\N
88217	79	D5170C00002/tiny.path.1/file-6827.pdf	\N	D5170C00002-ccba3bc4-8319-11eb-be00-ef5561933c95-6827	\N	NEW	\N	\N	\N	\N
86743	79	D5170C00002/tiny.path.1/file-5353.pdf	\N	D5170C00002-ccc972b2-8318-11eb-be00-6766b1f849ee-5353	\N	NEW	\N	\N	\N	\N
82398	79	D5170C00002/tiny.path.1/file-1008.pdf	\N	D5170C00002-ccc9c839-8315-11eb-be00-bb98b30edb91-1008	\N	NEW	\N	\N	\N	\N
88218	79	D5170C00002/tiny.path.1/file-6828.pdf	\N	D5170C00002-ccca4155-8319-11eb-be00-8ba49f677799-6828	\N	NEW	\N	\N	\N	\N
83775	79	D5170C00002/tiny.path.1/file-2385.pdf	\N	D5170C00002-ccccb95a-8316-11eb-be00-3fcf8d54168e-2385	\N	NEW	\N	\N	\N	\N
82399	79	D5170C00002/tiny.path.1/file-1009.pdf	\N	D5170C00002-ccd97faa-8315-11eb-be00-a1a4be148ee9-1009	\N	NEW	\N	\N	\N	\N
88219	79	D5170C00002/tiny.path.1/file-6829.pdf	\N	D5170C00002-ccd98396-8319-11eb-be00-3fa22ce22df0-6829	\N	NEW	\N	\N	\N	\N
85355	79	D5170C00002/tiny.path.1/file-3965.msg	\N	D5170C00002-ccdaa6c6-8317-11eb-be00-317a32b34a52-3965	\N	NEW	\N	\N	\N	\N
86744	79	D5170C00002/tiny.path.1/file-5354.pdf	\N	D5170C00002-cce86c63-8318-11eb-be00-a123d9fc9cf1-5354	\N	NEW	\N	\N	\N	\N
88220	79	D5170C00002/tiny.path.1/file-6830.pdf	\N	D5170C00002-ccf94097-8319-11eb-be00-a50de0d3473d-6830	\N	NEW	\N	\N	\N	\N
82417	79	D5170C00002/tiny.path.1/file-1027.pdf	\N	D5170C00002-cd06d13b-8315-11eb-be00-635392dae570-1010	\N	NEW	\N	\N	\N	\N
85356	79	D5170C00002/tiny.path.1/file-3966.msg	\N	D5170C00002-cd073507-8317-11eb-be00-bd4d79923542-3966	\N	NEW	\N	\N	\N	\N
86745	79	D5170C00002/tiny.path.1/file-5355.pdf	\N	D5170C00002-cd073f04-8318-11eb-be00-31cd190b5e69-5355	\N	NEW	\N	\N	\N	\N
82418	79	D5170C00002/tiny.path.1/file-1028.pdf	\N	D5170C00002-cd09905c-8315-11eb-be00-0bb5d916875f-1011	\N	NEW	\N	\N	\N	\N
86746	79	D5170C00002/tiny.path.1/file-5356.pdf	\N	D5170C00002-cd16a855-8318-11eb-be00-899252dc28af-5356	\N	NEW	\N	\N	\N	\N
82419	79	D5170C00002/tiny.path.1/file-1029.pdf	\N	D5170C00002-cd18ab8d-8315-11eb-be00-5f8f7f59d078-1012	\N	NEW	\N	\N	\N	\N
85357	79	D5170C00002/tiny.path.1/file-3967.msg	\N	D5170C00002-cd18c138-8317-11eb-be00-354c24f2b186-3967	\N	NEW	\N	\N	\N	\N
88221	79	D5170C00002/tiny.path.1/file-6831.pdf	\N	D5170C00002-cd249658-8319-11eb-be00-89748d959fb2-6831	\N	NEW	\N	\N	\N	\N
83776	79	D5170C00002/tiny.path.1/file-2386.pdf	\N	D5170C00002-cd25128b-8316-11eb-be00-6b583d883957-2386	\N	NEW	\N	\N	\N	\N
86747	79	D5170C00002/tiny.path.1/file-5357.pdf	\N	D5170C00002-cd283486-8318-11eb-be00-551f1e15619d-5357	\N	NEW	\N	\N	\N	\N
85358	79	D5170C00002/tiny.path.1/file-3968.msg	\N	D5170C00002-cd363449-8317-11eb-be00-3746554b2cea-3968	\N	NEW	\N	\N	\N	\N
86748	79	D5170C00002/tiny.path.1/file-5358.pdf	\N	D5170C00002-cd43f9e7-8318-11eb-be00-9941dfd56b98-5358	\N	NEW	\N	\N	\N	\N
85359	79	D5170C00002/tiny.path.1/file-3969.msg	\N	D5170C00002-cd53322a-8317-11eb-be00-39e751d601bd-3969	\N	NEW	\N	\N	\N	\N
82400	79	D5170C00002/tiny.path.1/file-1010.pdf	\N	D5170C00002-cd542dee-8315-11eb-be00-edc6a21a2fb8-1013	\N	NEW	\N	\N	\N	\N
86749	79	D5170C00002/tiny.path.1/file-5359.pdf	\N	D5170C00002-cd544d98-8318-11eb-be00-4966d091ef1b-5359	\N	NEW	\N	\N	\N	\N
86750	79	D5170C00002/tiny.path.1/file-5360.pdf	\N	D5170C00002-cd5537f9-8318-11eb-be00-cf71bd89a4bb-5360	\N	NEW	\N	\N	\N	\N
88222	79	D5170C00002/tiny.path.1/file-6832.pdf	\N	D5170C00002-cd617849-8319-11eb-be00-3df77d7e71f2-6832	\N	NEW	\N	\N	\N	\N
85360	79	D5170C00002/tiny.path.1/file-3970.msg	\N	D5170C00002-cd61d82b-8317-11eb-be00-a7ba8e1c0ccd-3970	\N	NEW	\N	\N	\N	\N
82401	79	D5170C00002/tiny.path.1/file-1011.pdf	\N	D5170C00002-cd645a8f-8315-11eb-be00-99e83c4aa238-1014	\N	NEW	\N	\N	\N	\N
86751	79	D5170C00002/tiny.path.1/file-5361.pdf	\N	D5170C00002-cd7283fa-8318-11eb-be00-83a83d76aa37-5361	\N	NEW	\N	\N	\N	\N
82402	79	D5170C00002/tiny.path.1/file-1012.pdf	\N	D5170C00002-cd739cd0-8315-11eb-be00-7d980510e30e-1015	\N	NEW	\N	\N	\N	\N
85361	79	D5170C00002/tiny.path.1/file-3971.msg	\N	D5170C00002-cd74009c-8317-11eb-be00-57a6cab9c962-3971	\N	NEW	\N	\N	\N	\N
83777	79	D5170C00002/tiny.path.1/file-2387.pdf	\N	D5170C00002-cd80c71c-8316-11eb-be00-35584900e061-2387	\N	NEW	\N	\N	\N	\N
86752	79	D5170C00002/tiny.path.1/file-5362.pdf	\N	D5170C00002-cd8f81db-8318-11eb-be00-e56af60fd27c-5362	\N	NEW	\N	\N	\N	\N
82403	79	D5170C00002/tiny.path.1/file-1013.pdf	\N	D5170C00002-cd8fd761-8315-11eb-be00-05c02365821b-1016	\N	NEW	\N	\N	\N	\N
86753	79	D5170C00002/tiny.path.1/file-5363.pdf	\N	D5170C00002-cd91569c-8318-11eb-be00-9300792f7fb6-5363	\N	NEW	\N	\N	\N	\N
82404	79	D5170C00002/tiny.path.1/file-1014.pdf	\N	D5170C00002-cd918512-8315-11eb-be00-198720077f34-1017	\N	NEW	\N	\N	\N	\N
85362	79	D5170C00002/tiny.path.1/file-3972.msg	\N	D5170C00002-cd91e8dd-8317-11eb-be00-fb27c57f5f88-3972	\N	NEW	\N	\N	\N	\N
88223	79	D5170C00002/tiny.path.1/file-6833.pdf	\N	D5170C00002-cd91fe2a-8319-11eb-be00-ef63dd315412-6833	\N	NEW	\N	\N	\N	\N
86754	79	D5170C00002/tiny.path.1/file-5364.pdf	\N	D5170C00002-cd9219ed-8318-11eb-be00-873ecf22924f-5364	\N	NEW	\N	\N	\N	\N
83778	79	D5170C00002/tiny.path.1/file-2388.pdf	\N	D5170C00002-cda0841d-8316-11eb-be00-c5a078a88669-2388	\N	NEW	\N	\N	\N	\N
86755	79	D5170C00002/tiny.path.1/file-5365.pdf	\N	D5170C00002-cdae065e-8318-11eb-be00-cf199d683377-5365	\N	NEW	\N	\N	\N	\N
85363	79	D5170C00002/tiny.path.1/file-3973.msg	\N	D5170C00002-cdae989e-8317-11eb-be00-53a869f4e664-3973	\N	NEW	\N	\N	\N	\N
82405	79	D5170C00002/tiny.path.1/file-1015.pdf	\N	D5170C00002-cdaed113-8315-11eb-be00-a5b7529cdb43-1018	\N	NEW	\N	\N	\N	\N
86756	79	D5170C00002/tiny.path.1/file-5366.pdf	\N	D5170C00002-cdafb40f-8318-11eb-be00-4140e9cb14cd-5366	\N	NEW	\N	\N	\N	\N
82406	79	D5170C00002/tiny.path.1/file-1016.pdf	\N	D5170C00002-cdb0a5d4-8315-11eb-be00-5530a54d8427-1019	\N	NEW	\N	\N	\N	\N
82407	79	D5170C00002/tiny.path.1/file-1017.pdf	\N	D5170C00002-cdbd9e25-8315-11eb-be00-49fa3b7bd7af-1020	\N	NEW	\N	\N	\N	\N
85364	79	D5170C00002/tiny.path.1/file-3974.msg	\N	D5170C00002-cdbdb3cf-8317-11eb-be00-53954c8ea2ac-3974	\N	NEW	\N	\N	\N	\N
86757	79	D5170C00002/tiny.path.1/file-5367.pdf	\N	D5170C00002-cdbef650-8318-11eb-be00-9fbf398578a2-5367	\N	NEW	\N	\N	\N	\N
82408	79	D5170C00002/tiny.path.1/file-1018.pdf	\N	D5170C00002-cdc08456-8315-11eb-be00-4d1e9cec9c8f-1021	\N	NEW	\N	\N	\N	\N
88224	79	D5170C00002/tiny.path.1/file-6834.pdf	\N	D5170C00002-cdcce44b-8319-11eb-be00-b797442e0459-6834	\N	NEW	\N	\N	\N	\N
85365	79	D5170C00002/tiny.path.1/file-3975.msg	\N	D5170C00002-cdcea3c0-8317-11eb-be00-3d055a52633e-3975	\N	NEW	\N	\N	\N	\N
83779	79	D5170C00002/tiny.path.1/file-2389.pdf	\N	D5170C00002-cddc7bae-8316-11eb-be00-f5ccd3a2e795-2389	\N	NEW	\N	\N	\N	\N
82409	79	D5170C00002/tiny.path.1/file-1019.pdf	\N	D5170C00002-cddc97d7-8315-11eb-be00-f1f1ce469109-1022	\N	NEW	\N	\N	\N	\N
82410	79	D5170C00002/tiny.path.1/file-1020.pdf	\N	D5170C00002-cded87c8-8315-11eb-be00-fd726c50abaf-1023	\N	NEW	\N	\N	\N	\N
85366	79	D5170C00002/tiny.path.1/file-3976.msg	\N	D5170C00002-cdee60c1-8317-11eb-be00-b9a782433e31-3976	\N	NEW	\N	\N	\N	\N
86758	79	D5170C00002/tiny.path.1/file-5368.pdf	\N	D5170C00002-cdfc9b91-8318-11eb-be00-efe1312c821a-5368	\N	NEW	\N	\N	\N	\N
82411	79	D5170C00002/tiny.path.1/file-1021.pdf	\N	D5170C00002-cdfca2f9-8315-11eb-be00-817e8ae19e0e-1024	\N	NEW	\N	\N	\N	\N
88225	79	D5170C00002/tiny.path.1/file-6835.pdf	\N	D5170C00002-cdfd6a2c-8319-11eb-be00-7d2262197cb8-6835	\N	NEW	\N	\N	\N	\N
82412	79	D5170C00002/tiny.path.1/file-1022.pdf	\N	D5170C00002-ce0be53a-8315-11eb-be00-8d5e1a895e05-1025	\N	NEW	\N	\N	\N	\N
85367	79	D5170C00002/tiny.path.1/file-3977.msg	\N	D5170C00002-ce0c7012-8317-11eb-be00-8dbca6adeb34-3977	\N	NEW	\N	\N	\N	\N
82413	79	D5170C00002/tiny.path.1/file-1023.pdf	\N	D5170C00002-ce192bab-8315-11eb-be00-cd8b213bb740-1026	\N	NEW	\N	\N	\N	\N
85368	79	D5170C00002/tiny.path.1/file-3978.msg	\N	D5170C00002-ce1a52c3-8317-11eb-be00-932df030d810-3978	\N	NEW	\N	\N	\N	\N
86759	79	D5170C00002/tiny.path.1/file-5369.pdf	\N	D5170C00002-ce286682-8318-11eb-be00-31141966a632-5369	\N	NEW	\N	\N	\N	\N
83780	79	D5170C00002/tiny.path.1/file-2390.pdf	\N	D5170C00002-ce2878cf-8316-11eb-be00-c389265fc10c-2390	\N	NEW	\N	\N	\N	\N
82414	79	D5170C00002/tiny.path.1/file-1024.pdf	\N	D5170C00002-ce2894fc-8315-11eb-be00-5b553d11de83-1027	\N	NEW	\N	\N	\N	\N
88226	79	D5170C00002/tiny.path.1/file-6836.pdf	\N	D5170C00002-ce295c2d-8319-11eb-be00-01c9c1f523f8-6836	\N	NEW	\N	\N	\N	\N
85369	79	D5170C00002/tiny.path.1/file-3979.msg	\N	D5170C00002-ce2a0a34-8317-11eb-be00-a9c593594290-3979	\N	NEW	\N	\N	\N	\N
82415	79	D5170C00002/tiny.path.1/file-1025.pdf	\N	D5170C00002-ce3984ed-8315-11eb-be00-d1ac1c702f00-1028	\N	NEW	\N	\N	\N	\N
86760	79	D5170C00002/tiny.path.1/file-5370.pdf	\N	D5170C00002-ce3a19c3-8318-11eb-be00-3125ee772aa4-5370	\N	NEW	\N	\N	\N	\N
88227	79	D5170C00002/tiny.path.1/file-6837.pdf	\N	D5170C00002-ce46f64e-8319-11eb-be00-75ebcd7ba48f-6837	\N	NEW	\N	\N	\N	\N
82416	79	D5170C00002/tiny.path.1/file-1026.pdf	\N	D5170C00002-ce48c72e-8315-11eb-be00-d51d1b2bb74f-1029	\N	NEW	\N	\N	\N	\N
85370	79	D5170C00002/tiny.path.1/file-3980.msg	\N	D5170C00002-ce584625-8317-11eb-be00-9baf5e12755a-3980	\N	NEW	\N	\N	\N	\N
88228	79	D5170C00002/tiny.path.1/file-6838.pdf	\N	D5170C00002-ce58827f-8319-11eb-be00-b1230bf6e1b5-6838	\N	NEW	\N	\N	\N	\N
86761	79	D5170C00002/tiny.path.1/file-5371.pdf	\N	D5170C00002-ce67e084-8318-11eb-be00-f57ee3fdd5f0-5371	\N	NEW	\N	\N	\N	\N
88229	79	D5170C00002/tiny.path.1/file-6839.pdf	\N	D5170C00002-ce766ac0-8319-11eb-be00-9f990f8d61bd-6839	\N	NEW	\N	\N	\N	\N
82420	79	D5170C00002/tiny.path.1/file-1030.pdf	\N	D5170C00002-ce768def-8315-11eb-be00-e198c732ef37-1030	\N	NEW	\N	\N	\N	\N
85371	79	D5170C00002/tiny.path.1/file-3981.msg	\N	D5170C00002-ce76f1b6-8317-11eb-be00-4d7fb1605c3d-3981	\N	NEW	\N	\N	\N	\N
82421	79	D5170C00002/tiny.path.1/file-1031.pdf	\N	D5170C00002-ce77c670-8315-11eb-be00-a96630d544c6-1031	\N	NEW	\N	\N	\N	\N
83781	79	D5170C00002/tiny.path.1/file-2391.pdf	\N	D5170C00002-ce84c9a0-8316-11eb-be00-d16f8045197b-2391	\N	NEW	\N	\N	\N	\N
85372	79	D5170C00002/tiny.path.1/file-3982.msg	\N	D5170C00002-ce865b07-8317-11eb-be00-b5afc3a00827-3982	\N	NEW	\N	\N	\N	\N
88230	79	D5170C00002/tiny.path.1/file-6840.pdf	\N	D5170C00002-ce94a121-8319-11eb-be00-1bce4a9aecdb-6840	\N	NEW	\N	\N	\N	\N
86762	79	D5170C00002/tiny.path.1/file-5372.pdf	\N	D5170C00002-cea33bd5-8318-11eb-be00-414cbb7519e6-5372	\N	NEW	\N	\N	\N	\N
88231	79	D5170C00002/tiny.path.1/file-6841.pdf	\N	D5170C00002-cea3e362-8319-11eb-be00-1566892dc345-6841	\N	NEW	\N	\N	\N	\N
83782	79	D5170C00002/tiny.path.1/file-2392.pdf	\N	D5170C00002-cea4adb1-8316-11eb-be00-4d0a083c17b2-2392	\N	NEW	\N	\N	\N	\N
82422	79	D5170C00002/tiny.path.1/file-1032.pdf	\N	D5170C00002-ceb321c1-8315-11eb-be00-99175b3ce333-1032	\N	NEW	\N	\N	\N	\N
88232	79	D5170C00002/tiny.path.1/file-6842.pdf	\N	D5170C00002-cec06c13-8319-11eb-be00-293888a42aa7-6842	\N	NEW	\N	\N	\N	\N
82423	79	D5170C00002/tiny.path.1/file-1033.pdf	\N	D5170C00002-cec15292-8315-11eb-be00-6b1de2e47b99-1033	\N	NEW	\N	\N	\N	\N
88233	79	D5170C00002/tiny.path.1/file-6843.pdf	\N	D5170C00002-cecffc74-8319-11eb-be00-c77fe238b491-6843	\N	NEW	\N	\N	\N	\N
86763	79	D5170C00002/tiny.path.1/file-5373.pdf	\N	D5170C00002-ced03f46-8318-11eb-be00-037327e3172c-5373	\N	NEW	\N	\N	\N	\N
88234	79	D5170C00002/tiny.path.1/file-6844.pdf	\N	D5170C00002-ced1d135-8319-11eb-be00-ef9354ad4d4c-6844	\N	NEW	\N	\N	\N	\N
82424	79	D5170C00002/tiny.path.1/file-1034.pdf	\N	D5170C00002-cedffe23-8315-11eb-be00-e7192e33686a-1034	\N	NEW	\N	\N	\N	\N
88235	79	D5170C00002/tiny.path.1/file-6845.pdf	\N	D5170C00002-cee11376-8319-11eb-be00-8fa63509f166-6845	\N	NEW	\N	\N	\N	\N
83783	79	D5170C00002/tiny.path.1/file-2393.pdf	\N	D5170C00002-ceef7252-8316-11eb-be00-0b9a0aa413e0-2393	\N	NEW	\N	\N	\N	\N
88236	79	D5170C00002/tiny.path.1/file-6846.pdf	\N	D5170C00002-cf000d27-8319-11eb-be00-e12436260a8e-6846	\N	NEW	\N	\N	\N	\N
86764	79	D5170C00002/tiny.path.1/file-5374.pdf	\N	D5170C00002-cf0e80c7-8318-11eb-be00-6923edc46bdb-5374	\N	NEW	\N	\N	\N	\N
82425	79	D5170C00002/tiny.path.1/file-1035.pdf	\N	D5170C00002-cf0fc0b4-8315-11eb-be00-8dc43b876a81-1035	\N	NEW	\N	\N	\N	\N
83784	79	D5170C00002/tiny.path.1/file-2394.pdf	\N	D5170C00002-cf1d1203-8316-11eb-be00-77b45cb17912-2394	\N	NEW	\N	\N	\N	\N
86765	79	D5170C00002/tiny.path.1/file-5375.pdf	\N	D5170C00002-cf2da188-8318-11eb-be00-f31c6faf9f0d-5375	\N	NEW	\N	\N	\N	\N
88237	79	D5170C00002/tiny.path.1/file-6847.pdf	\N	D5170C00002-cf3b8f88-8319-11eb-be00-51b247f1d793-6847	\N	NEW	\N	\N	\N	\N
82426	79	D5170C00002/tiny.path.1/file-1036.msg	\N	D5170C00002-cf5be4e5-8315-11eb-be00-e906377c2deb-1036	\N	NEW	\N	\N	\N	\N
83785	79	D5170C00002/tiny.path.1/file-2395.pdf	\N	D5170C00002-cf693634-8316-11eb-be00-35edfd99a155-2395	\N	NEW	\N	\N	\N	\N
82427	79	D5170C00002/tiny.path.1/file-1037.msg	\N	D5170C00002-cf6a8ae6-8315-11eb-be00-a30aee1318e3-1037	\N	NEW	\N	\N	\N	\N
86766	79	D5170C00002/tiny.path.1/file-5376.pdf	\N	D5170C00002-cf6b6dd9-8318-11eb-be00-8519d541d753-5376	\N	NEW	\N	\N	\N	\N
83786	79	D5170C00002/tiny.path.1/file-2396.pdf	\N	D5170C00002-cf96fcf5-8316-11eb-be00-87c4e02f6e56-2396	\N	NEW	\N	\N	\N	\N
82428	79	D5170C00002/tiny.path.1/file-1038.msg	\N	D5170C00002-cf97dc77-8315-11eb-be00-552b392450f2-1038	\N	NEW	\N	\N	\N	\N
86767	79	D5170C00002/tiny.path.1/file-5377.pdf	\N	D5170C00002-cfa7b38a-8318-11eb-be00-0d5711ad0130-5377	\N	NEW	\N	\N	\N	\N
83787	79	D5170C00002/tiny.path.1/file-2397.pdf	\N	D5170C00002-cfb5a886-8316-11eb-be00-5f58ebb90d4c-2397	\N	NEW	\N	\N	\N	\N
82429	79	D5170C00002/tiny.path.1/file-1039.msg	\N	D5170C00002-cfb660f8-8315-11eb-be00-bb9a88e9ce1f-1039	\N	NEW	\N	\N	\N	\N
83788	79	D5170C00002/tiny.path.1/file-2398.pdf	\N	D5170C00002-cfc47597-8316-11eb-be00-8dafd46e0525-2398	\N	NEW	\N	\N	\N	\N
88238	79	D5170C00002/tiny.path.1/file-6848.pdf	\N	D5170C00002-cfc5f539-8319-11eb-be00-b569dc5ad97a-6848	\N	NEW	\N	\N	\N	\N
82430	79	D5170C00002/tiny.path.1/file-1040.msg	\N	D5170C00002-cfc777f9-8315-11eb-be00-e9ead25604b8-1040	\N	NEW	\N	\N	\N	\N
88239	79	D5170C00002/tiny.path.1/file-6849.pdf	\N	D5170C00002-cfe31a2a-8319-11eb-be00-f9a578b41a1b-6849	\N	NEW	\N	\N	\N	\N
82431	79	D5170C00002/tiny.path.1/file-1041.msg	\N	D5170C00002-cfe49cea-8315-11eb-be00-337e448170b7-1041	\N	NEW	\N	\N	\N	\N
86768	79	D5170C00002/tiny.path.1/file-5378.pdf	\N	D5170C00002-cff2782b-8318-11eb-be00-9385601bc470-5378	\N	NEW	\N	\N	\N	\N
88240	79	D5170C00002/tiny.path.1/file-6850.pdf	\N	D5170C00002-d001779b-8319-11eb-be00-6739fb2b2403-6850	\N	NEW	\N	\N	\N	\N
82432	79	D5170C00002/tiny.path.1/file-1042.msg	\N	D5170C00002-d0112b2b-8315-11eb-be00-91e9b8613703-1042	\N	NEW	\N	\N	\N	\N
86769	79	D5170C00002/tiny.path.1/file-5379.pdf	\N	D5170C00002-d012352c-8318-11eb-be00-f3b017bbdb26-5379	\N	NEW	\N	\N	\N	\N
82433	79	D5170C00002/tiny.path.1/file-1043.msg	\N	D5170C00002-d02157cc-8315-11eb-be00-1de5ef061400-1043	\N	NEW	\N	\N	\N	\N
85373	79	D5170C00002/tiny.path.1/file-3983.msg	\N	D5170C00002-d022f408-8317-11eb-be00-6939e2e785f1-3983	\N	NEW	\N	\N	\N	\N
83789	79	D5170C00002/tiny.path.1/file-2399.pdf	\N	D5170C00002-d031dd68-8316-11eb-be00-a3d76db2a1fb-2399	\N	NEW	\N	\N	\N	\N
88241	79	D5170C00002/tiny.path.1/file-6851.pdf	\N	D5170C00002-d03ea7ac-8319-11eb-be00-83570051992f-6851	\N	NEW	\N	\N	\N	\N
85374	79	D5170C00002/tiny.path.1/file-3984.msg	\N	D5170C00002-d04e22b9-8317-11eb-be00-15a1d11435b3-3984	\N	NEW	\N	\N	\N	\N
82434	79	D5170C00002/tiny.path.1/file-1044.msg	\N	D5170C00002-d04fe1dd-8315-11eb-be00-3fb05eba7aa5-1044	\N	NEW	\N	\N	\N	\N
86770	79	D5170C00002/tiny.path.1/file-5380.pdf	\N	D5170C00002-d05e595d-8318-11eb-be00-edb5c457d835-5380	\N	NEW	\N	\N	\N	\N
83790	79	D5170C00002/tiny.path.1/file-2400.pdf	\N	D5170C00002-d05ff249-8316-11eb-be00-77d4fe82cde2-2400	\N	NEW	\N	\N	\N	\N
82435	79	D5170C00002/tiny.path.1/file-1045.msg	\N	D5170C00002-d07b85be-8315-11eb-be00-739d9794b45c-1045	\N	NEW	\N	\N	\N	\N
83791	79	D5170C00002/tiny.path.1/file-2401.pdf	\N	D5170C00002-d07cf02a-8316-11eb-be00-81a157c6d783-2401	\N	NEW	\N	\N	\N	\N
82436	79	D5170C00002/tiny.path.1/file-1046.msg	\N	D5170C00002-d08e235f-8315-11eb-be00-05be46507630-1046	\N	NEW	\N	\N	\N	\N
83792	79	D5170C00002/tiny.path.1/file-2402.pdf	\N	D5170C00002-d099ee0b-8316-11eb-be00-1bd691a80292-2402	\N	NEW	\N	\N	\N	\N
86771	79	D5170C00002/tiny.path.1/file-5381.pdf	\N	D5170C00002-d09a77fe-8318-11eb-be00-336d24d3c8a8-5381	\N	NEW	\N	\N	\N	\N
85375	79	D5170C00002/tiny.path.1/file-3985.msg	\N	D5170C00002-d09c1baa-8317-11eb-be00-cdc500616a76-3985	\N	NEW	\N	\N	\N	\N
82437	79	D5170C00002/tiny.path.1/file-1047.msg	\N	D5170C00002-d0abbd80-8315-11eb-be00-9981f88d179d-1047	\N	NEW	\N	\N	\N	\N
88242	79	D5170C00002/tiny.path.1/file-6852.pdf	\N	D5170C00002-d0abe86d-8319-11eb-be00-bd4064ef1957-6852	\N	NEW	\N	\N	\N	\N
83793	79	D5170C00002/tiny.path.1/file-2403.pdf	\N	D5170C00002-d0c8c63c-8316-11eb-be00-31b1be1f6b6a-2403	\N	NEW	\N	\N	\N	\N
86772	79	D5170C00002/tiny.path.1/file-5382.pdf	\N	D5170C00002-d0c9c55f-8318-11eb-be00-bf6b5e378877-5382	\N	NEW	\N	\N	\N	\N
82438	79	D5170C00002/tiny.path.1/file-1048.msg	\N	D5170C00002-d0d73a51-8315-11eb-be00-85ee71a0a53f-1048	\N	NEW	\N	\N	\N	\N
88243	79	D5170C00002/tiny.path.1/file-6853.pdf	\N	D5170C00002-d0d84f9e-8319-11eb-be00-cd56e7d5c72d-6853	\N	NEW	\N	\N	\N	\N
83794	79	D5170C00002/tiny.path.1/file-2404.pdf	\N	D5170C00002-d0e8833d-8316-11eb-be00-6522bb3ff7ce-2404	\N	NEW	\N	\N	\N	\N
86773	79	D5170C00002/tiny.path.1/file-5383.pdf	\N	D5170C00002-d0f7b330-8318-11eb-be00-4ddfc40f8dc0-5383	\N	NEW	\N	\N	\N	\N
83795	79	D5170C00002/tiny.path.1/file-2405.pdf	\N	D5170C00002-d104bdce-8316-11eb-be00-47720414c8a1-2405	\N	NEW	\N	\N	\N	\N
85376	79	D5170C00002/tiny.path.1/file-3986.msg	\N	D5170C00002-d1064f2b-8317-11eb-be00-cf24186b9748-3986	\N	NEW	\N	\N	\N	\N
88244	79	D5170C00002/tiny.path.1/file-6854.pdf	\N	D5170C00002-d115a6bf-8319-11eb-be00-69cf11a804b5-6854	\N	NEW	\N	\N	\N	\N
83796	79	D5170C00002/tiny.path.1/file-2406.pdf	\N	D5170C00002-d1242caf-8316-11eb-be00-39a210b5913a-2406	\N	NEW	\N	\N	\N	\N
85377	79	D5170C00002/tiny.path.1/file-3987.msg	\N	D5170C00002-d141d18c-8317-11eb-be00-798051ab6b2f-3987	\N	NEW	\N	\N	\N	\N
83814	79	D5170C00002/tiny.path.1/file-2424.pdf	\N	D5170C00002-d1423c00-8316-11eb-be00-cf172a0c66f9-2407	\N	NEW	\N	\N	\N	\N
82439	79	D5170C00002/tiny.path.1/file-1049.msg	\N	D5170C00002-d143b7c2-8315-11eb-be00-4f9c10bab293-1049	\N	NEW	\N	\N	\N	\N
83797	79	D5170C00002/tiny.path.1/file-2407.pdf	\N	D5170C00002-d1543d61-8316-11eb-be00-afc2797545db-2408	\N	NEW	\N	\N	\N	\N
83798	79	D5170C00002/tiny.path.1/file-2408.pdf	\N	D5170C00002-d1713b42-8316-11eb-be00-4328ebd1af79-2409	\N	NEW	\N	\N	\N	\N
83799	79	D5170C00002/tiny.path.1/file-2409.pdf	\N	D5170C00002-d17273c3-8316-11eb-be00-3360aea71450-2410	\N	NEW	\N	\N	\N	\N
88250	79	D5170C00002/tiny.path.1/file-6860.pdf	\N	D5170C00002-d1804f70-8319-11eb-be00-092d54b10308-6855	\N	NEW	\N	\N	\N	\N
85378	79	D5170C00002/tiny.path.1/file-3988.msg	\N	D5170C00002-d19d37fd-8317-11eb-be00-0d39c9b7afd0-3988	\N	NEW	\N	\N	\N	\N
83800	79	D5170C00002/tiny.path.1/file-2410.pdf	\N	D5170C00002-d19da274-8316-11eb-be00-e959af1c7a7c-2411	\N	NEW	\N	\N	\N	\N
82440	79	D5170C00002/tiny.path.1/file-1050.msg	\N	D5170C00002-d19ef723-8315-11eb-be00-af54559262c8-1050	\N	NEW	\N	\N	\N	\N
83801	79	D5170C00002/tiny.path.1/file-2411.pdf	\N	D5170C00002-d1a01375-8316-11eb-be00-172e0a69eb20-2412	\N	NEW	\N	\N	\N	\N
83802	79	D5170C00002/tiny.path.1/file-2412.pdf	\N	D5170C00002-d1af2ea6-8316-11eb-be00-3300ff10fa75-2413	\N	NEW	\N	\N	\N	\N
85379	79	D5170C00002/tiny.path.1/file-3989.msg	\N	D5170C00002-d1bbbc7e-8317-11eb-be00-2390ef8baf5e-3989	\N	NEW	\N	\N	\N	\N
83803	79	D5170C00002/tiny.path.1/file-2413.pdf	\N	D5170C00002-d1cb9047-8316-11eb-be00-bfe05db1c384-2414	\N	NEW	\N	\N	\N	\N
83804	79	D5170C00002/tiny.path.1/file-2414.pdf	\N	D5170C00002-d1ccefd8-8316-11eb-be00-09fa8767a692-2415	\N	NEW	\N	\N	\N	\N
83805	79	D5170C00002/tiny.path.1/file-2415.pdf	\N	D5170C00002-d1dc5929-8316-11eb-be00-bde238f43cb2-2416	\N	NEW	\N	\N	\N	\N
82441	79	D5170C00002/tiny.path.1/file-1051.msg	\N	D5170C00002-d1dc7554-8315-11eb-be00-95cf543786bf-1051	\N	NEW	\N	\N	\N	\N
83806	79	D5170C00002/tiny.path.1/file-2416.pdf	\N	D5170C00002-d1ebe98a-8316-11eb-be00-49ecdebf327f-2417	\N	NEW	\N	\N	\N	\N
88245	79	D5170C00002/tiny.path.1/file-6855.pdf	\N	D5170C00002-d1f865a1-8319-11eb-be00-e9d1d19d9c84-6856	\N	NEW	\N	\N	\N	\N
86774	79	D5170C00002/tiny.path.1/file-5384.pdf	\N	D5170C00002-d1f91da1-8318-11eb-be00-01af3660d2eb-5384	\N	NEW	\N	\N	\N	\N
83807	79	D5170C00002/tiny.path.1/file-2417.pdf	\N	D5170C00002-d1f9cc3b-8316-11eb-be00-c1a92465982f-2418	\N	NEW	\N	\N	\N	\N
83808	79	D5170C00002/tiny.path.1/file-2418.pdf	\N	D5170C00002-d208241c-8316-11eb-be00-052c36d1ba46-2419	\N	NEW	\N	\N	\N	\N
88246	79	D5170C00002/tiny.path.1/file-6856.pdf	\N	D5170C00002-d2089242-8319-11eb-be00-71aa6e157608-6857	\N	NEW	\N	\N	\N	\N
85380	79	D5170C00002/tiny.path.1/file-3990.msg	\N	D5170C00002-d208cb0f-8317-11eb-be00-2162e7da5518-3990	\N	NEW	\N	\N	\N	\N
88247	79	D5170C00002/tiny.path.1/file-6857.pdf	\N	D5170C00002-d2173843-8319-11eb-be00-ab808447cace-6858	\N	NEW	\N	\N	\N	\N
83809	79	D5170C00002/tiny.path.1/file-2419.pdf	\N	D5170C00002-d217b47d-8316-11eb-be00-0f58434eff43-2420	\N	NEW	\N	\N	\N	\N
88248	79	D5170C00002/tiny.path.1/file-6858.pdf	\N	D5170C00002-d2265374-8319-11eb-be00-13f8412184f8-6859	\N	NEW	\N	\N	\N	\N
88249	79	D5170C00002/tiny.path.1/file-6859.pdf	\N	D5170C00002-d2287655-8319-11eb-be00-135490cb5126-6860	\N	NEW	\N	\N	\N	\N
83810	79	D5170C00002/tiny.path.1/file-2420.pdf	\N	D5170C00002-d228a46e-8316-11eb-be00-57762254c5e2-2421	\N	NEW	\N	\N	\N	\N
85381	79	D5170C00002/tiny.path.1/file-3991.msg	\N	D5170C00002-d23643b0-8317-11eb-be00-3d7249085388-3991	\N	NEW	\N	\N	\N	\N
83811	79	D5170C00002/tiny.path.1/file-2421.pdf	\N	D5170C00002-d2380dbf-8316-11eb-be00-b7778420d04e-2422	\N	NEW	\N	\N	\N	\N
83812	79	D5170C00002/tiny.path.1/file-2422.pdf	\N	D5170C00002-d2477710-8316-11eb-be00-85ddfabe16b1-2423	\N	NEW	\N	\N	\N	\N
86775	79	D5170C00002/tiny.path.1/file-5385.pdf	\N	D5170C00002-d2556e72-8318-11eb-be00-bb1f668eb7b8-5385	\N	NEW	\N	\N	\N	\N
88251	79	D5170C00002/tiny.path.1/file-6861.pdf	\N	D5170C00002-d25579c6-8319-11eb-be00-c948c197f5a5-6861	\N	NEW	\N	\N	\N	\N
83813	79	D5170C00002/tiny.path.1/file-2423.pdf	\N	D5170C00002-d2561d11-8316-11eb-be00-83a377b9da91-2424	\N	NEW	\N	\N	\N	\N
82442	79	D5170C00002/tiny.path.1/file-1052.msg	\N	D5170C00002-d2572395-8315-11eb-be00-ef731fce3014-1052	\N	NEW	\N	\N	\N	\N
88252	79	D5170C00002/tiny.path.1/file-6862.pdf	\N	D5170C00002-d273b027-8319-11eb-be00-6d0d790d59e6-6862	\N	NEW	\N	\N	\N	\N
83815	79	D5170C00002/tiny.path.1/file-2425.pdf	\N	D5170C00002-d2828442-8316-11eb-be00-a9a42f063c00-2425	\N	NEW	\N	\N	\N	\N
85382	79	D5170C00002/tiny.path.1/file-3992.msg	\N	D5170C00002-d28463b1-8317-11eb-be00-1ff5f96a9fd6-3992	\N	NEW	\N	\N	\N	\N
88253	79	D5170C00002/tiny.path.1/file-6863.pdf	\N	D5170C00002-d292a9d8-8319-11eb-be00-df935bf09dc2-6863	\N	NEW	\N	\N	\N	\N
88254	79	D5170C00002/tiny.path.1/file-6864.pdf	\N	D5170C00002-d2b23fc9-8319-11eb-be00-3d48dcd666cb-6864	\N	NEW	\N	\N	\N	\N
83816	79	D5170C00002/tiny.path.1/file-2426.pdf	\N	D5170C00002-d2bfb453-8316-11eb-be00-3541372816ca-2426	\N	NEW	\N	\N	\N	\N
88255	79	D5170C00002/tiny.path.1/file-6865.pdf	\N	D5170C00002-d2c1a91a-8319-11eb-be00-d7edc496b2c5-6865	\N	NEW	\N	\N	\N	\N
86776	79	D5170C00002/tiny.path.1/file-5386.pdf	\N	D5170C00002-d2cf5963-8318-11eb-be00-ed6dcc07205b-5386	\N	NEW	\N	\N	\N	\N
82443	79	D5170C00002/tiny.path.1/file-1053.pdf	\N	D5170C00002-d2def136-8315-11eb-be00-6f5f8b7431ef-1053	\N	NEW	\N	\N	\N	\N
83817	79	D5170C00002/tiny.path.1/file-2427.pdf	\N	D5170C00002-d2e034a4-8316-11eb-be00-dbfe8f933323-2427	\N	NEW	\N	\N	\N	\N
83818	79	D5170C00002/tiny.path.1/file-2428.pdf	\N	D5170C00002-d2fc6f35-8316-11eb-be00-f19803c85304-2428	\N	NEW	\N	\N	\N	\N
85383	79	D5170C00002/tiny.path.1/file-3993.msg	\N	D5170C00002-d2fcef12-8317-11eb-be00-3bf0a2db45dc-3993	\N	NEW	\N	\N	\N	\N
88256	79	D5170C00002/tiny.path.1/file-6866.pdf	\N	D5170C00002-d2fd799b-8319-11eb-be00-7b982953b7e6-6866	\N	NEW	\N	\N	\N	\N
82444	79	D5170C00002/tiny.path.1/file-1054.pdf	\N	D5170C00002-d2ff2367-8315-11eb-be00-0741981d677b-1054	\N	NEW	\N	\N	\N	\N
88257	79	D5170C00002/tiny.path.1/file-6867.pdf	\N	D5170C00002-d31b3acc-8319-11eb-be00-73ef24974a2d-6867	\N	NEW	\N	\N	\N	\N
88258	79	D5170C00002/tiny.path.1/file-6868.pdf	\N	D5170C00002-d32b676d-8319-11eb-be00-2325c9517ce9-6868	\N	NEW	\N	\N	\N	\N
83819	79	D5170C00002/tiny.path.1/file-2429.pdf	\N	D5170C00002-d32b9586-8316-11eb-be00-99d466c2ebd4-2429	\N	NEW	\N	\N	\N	\N
82445	79	D5170C00002/tiny.path.1/file-1055.pdf	\N	D5170C00002-d33aa5c8-8315-11eb-be00-eb8f4eacb4a2-1055	\N	NEW	\N	\N	\N	\N
83820	79	D5170C00002/tiny.path.1/file-2430.pdf	\N	D5170C00002-d33c5e67-8316-11eb-be00-3185e3fa8907-2430	\N	NEW	\N	\N	\N	\N
85384	79	D5170C00002/tiny.path.1/file-3994.msg	\N	D5170C00002-d349af83-8317-11eb-be00-9122fb27fee3-3994	\N	NEW	\N	\N	\N	\N
88259	79	D5170C00002/tiny.path.1/file-6869.pdf	\N	D5170C00002-d34ad64e-8319-11eb-be00-cfd3d7735f8c-6869	\N	NEW	\N	\N	\N	\N
88260	79	D5170C00002/tiny.path.1/file-6870.pdf	\N	D5170C00002-d367860f-8319-11eb-be00-2d004bfcc949-6870	\N	NEW	\N	\N	\N	\N
83821	79	D5170C00002/tiny.path.1/file-2431.pdf	\N	D5170C00002-d3685068-8316-11eb-be00-cf0774a5eb71-2431	\N	NEW	\N	\N	\N	\N
82446	79	D5170C00002/tiny.path.1/file-1056.pdf	\N	D5170C00002-d36a6859-8315-11eb-be00-37787c960291-1056	\N	NEW	\N	\N	\N	\N
85385	79	D5170C00002/tiny.path.1/file-3995.msg	\N	D5170C00002-d3794b04-8317-11eb-be00-230a09c94e7b-3995	\N	NEW	\N	\N	\N	\N
83822	79	D5170C00002/tiny.path.1/file-2432.pdf	\N	D5170C00002-d3872309-8316-11eb-be00-151ba5197a17-2432	\N	NEW	\N	\N	\N	\N
88261	79	D5170C00002/tiny.path.1/file-6871.pdf	\N	D5170C00002-d39747a0-8319-11eb-be00-9f56171f8ea9-6871	\N	NEW	\N	\N	\N	\N
83823	79	D5170C00002/tiny.path.1/file-2433.pdf	\N	D5170C00002-d3a420ea-8316-11eb-be00-adac42873c16-2433	\N	NEW	\N	\N	\N	\N
85386	79	D5170C00002/tiny.path.1/file-3996.msg	\N	D5170C00002-d3a42b95-8317-11eb-be00-3da2c8093cc8-3996	\N	NEW	\N	\N	\N	\N
86777	79	D5170C00002/tiny.path.1/file-5387.pdf	\N	D5170C00002-d3a742d4-8318-11eb-be00-8192c62893da-5387	\N	NEW	\N	\N	\N	\N
85387	79	D5170C00002/tiny.path.1/file-3997.pdf	\N	D5170C00002-d3c4fa06-8317-11eb-be00-35f81805d407-3997	\N	NEW	\N	\N	\N	\N
83824	79	D5170C00002/tiny.path.1/file-2434.pdf	\N	D5170C00002-d3d1e7ab-8316-11eb-be00-cfd4d8f4187b-2434	\N	NEW	\N	\N	\N	\N
82447	79	D5170C00002/tiny.path.1/file-1057.pdf	\N	D5170C00002-d3d5863a-8315-11eb-be00-795b78653e62-1057	\N	NEW	\N	\N	\N	\N
85388	79	D5170C00002/tiny.path.1/file-3998.pdf	\N	D5170C00002-d3e41ac7-8317-11eb-be00-47f7057bfc73-3998	\N	NEW	\N	\N	\N	\N
83825	79	D5170C00002/tiny.path.1/file-2435.pdf	\N	D5170C00002-d3f1086c-8316-11eb-be00-918634a8290d-2435	\N	NEW	\N	\N	\N	\N
88262	79	D5170C00002/tiny.path.1/file-6872.pdf	\N	D5170C00002-d3f2fc31-8319-11eb-be00-f135ef2b45e5-6872	\N	NEW	\N	\N	\N	\N
83826	79	D5170C00002/tiny.path.1/file-2436.pdf	\N	D5170C00002-d401832d-8316-11eb-be00-f1ce1aa02125-2436	\N	NEW	\N	\N	\N	\N
85389	79	D5170C00002/tiny.path.1/file-3999.pdf	\N	D5170C00002-d402c658-8317-11eb-be00-dfbd754e8920-3999	\N	NEW	\N	\N	\N	\N
82448	79	D5170C00002/tiny.path.1/file-1058.pdf	\N	D5170C00002-d411a4db-8315-11eb-be00-b17aac613fd5-1058	\N	NEW	\N	\N	\N	\N
83827	79	D5170C00002/tiny.path.1/file-2437.pdf	\N	D5170C00002-d41e810e-8316-11eb-be00-c7ad8ffd5002-2437	\N	NEW	\N	\N	\N	\N
83828	79	D5170C00002/tiny.path.1/file-2438.pdf	\N	D5170C00002-d43d058f-8316-11eb-be00-eb79b05362fa-2438	\N	NEW	\N	\N	\N	\N
82449	79	D5170C00002/tiny.path.1/file-1059.pdf	\N	D5170C00002-d43dbdec-8315-11eb-be00-e7529476e369-1059	\N	NEW	\N	\N	\N	\N
85390	79	D5170C00002/tiny.path.1/file-4000.pdf	\N	D5170C00002-d43e96d9-8317-11eb-be00-e90dea58f5ca-4000	\N	NEW	\N	\N	\N	\N
83829	79	D5170C00002/tiny.path.1/file-2439.pdf	\N	D5170C00002-d44cbd00-8316-11eb-be00-95d1a5230ffb-2439	\N	NEW	\N	\N	\N	\N
82450	79	D5170C00002/tiny.path.1/file-1060.pdf	\N	D5170C00002-d45c908d-8315-11eb-be00-c3c25e68bf7b-1060	\N	NEW	\N	\N	\N	\N
85391	79	D5170C00002/tiny.path.1/file-4001.pdf	\N	D5170C00002-d45d908a-8317-11eb-be00-27f45b6747c0-4001	\N	NEW	\N	\N	\N	\N
86778	79	D5170C00002/tiny.path.1/file-5388.pdf	\N	D5170C00002-d45e0fb5-8318-11eb-be00-93d4217d4610-5388	\N	NEW	\N	\N	\N	\N
88263	79	D5170C00002/tiny.path.1/file-6873.pdf	\N	D5170C00002-d46b1262-8319-11eb-be00-1fb676f8fb93-6873	\N	NEW	\N	\N	\N	\N
85392	79	D5170C00002/tiny.path.1/file-4002.pdf	\N	D5170C00002-d488e64b-8317-11eb-be00-d35e40d5f966-4002	\N	NEW	\N	\N	\N	\N
88264	79	D5170C00002/tiny.path.1/file-6874.pdf	\N	D5170C00002-d48af673-8319-11eb-be00-fb94f007bf02-6874	\N	NEW	\N	\N	\N	\N
85393	79	D5170C00002/tiny.path.1/file-4003.pdf	\N	D5170C00002-d4989dbc-8317-11eb-be00-1f5fc4fac060-4003	\N	NEW	\N	\N	\N	\N
88265	79	D5170C00002/tiny.path.1/file-6875.pdf	\N	D5170C00002-d4997564-8319-11eb-be00-f965215da2f7-6875	\N	NEW	\N	\N	\N	\N
88266	79	D5170C00002/tiny.path.1/file-6876.pdf	\N	D5170C00002-d49a5fc5-8319-11eb-be00-5d8a1897224b-6876	\N	NEW	\N	\N	\N	\N
83830	79	D5170C00002/tiny.path.1/file-2440.pdf	\N	D5170C00002-d49a8ee1-8316-11eb-be00-8771e197dcbe-2440	\N	NEW	\N	\N	\N	\N
83831	79	D5170C00002/tiny.path.1/file-2441.pdf	\N	D5170C00002-d4a7fc62-8316-11eb-be00-3bbc9b35193e-2441	\N	NEW	\N	\N	\N	\N
88267	79	D5170C00002/tiny.path.1/file-6877.pdf	\N	D5170C00002-d4b6c166-8319-11eb-be00-ddde10b1c3d3-6877	\N	NEW	\N	\N	\N	\N
86779	79	D5170C00002/tiny.path.1/file-5389.pdf	\N	D5170C00002-d4c64766-8318-11eb-be00-2f6cbacb43bc-5389	\N	NEW	\N	\N	\N	\N
83832	79	D5170C00002/tiny.path.1/file-2442.pdf	\N	D5170C00002-d4c82e93-8316-11eb-be00-cdff62088ed7-2442	\N	NEW	\N	\N	\N	\N
88268	79	D5170C00002/tiny.path.1/file-6878.pdf	\N	D5170C00002-d4d5e227-8319-11eb-be00-4500fb55bfdd-6878	\N	NEW	\N	\N	\N	\N
88269	79	D5170C00002/tiny.path.1/file-6879.pdf	\N	D5170C00002-d4f502e8-8319-11eb-be00-b3e1420f6163-6879	\N	NEW	\N	\N	\N	\N
83833	79	D5170C00002/tiny.path.1/file-2443.pdf	\N	D5170C00002-d514ef04-8316-11eb-be00-fdd7b6e24ec8-2443	\N	NEW	\N	\N	\N	\N
88270	79	D5170C00002/tiny.path.1/file-6880.pdf	\N	D5170C00002-d5150e09-8319-11eb-be00-891c2904ae1f-6880	\N	NEW	\N	\N	\N	\N
88271	79	D5170C00002/tiny.path.1/file-6881.pdf	\N	D5170C00002-d5320bea-8319-11eb-be00-3509190ef104-6881	\N	NEW	\N	\N	\N	\N
88272	79	D5170C00002/tiny.path.1/file-6882.pdf	\N	D5170C00002-d540b1eb-8319-11eb-be00-a3b0fa7f417c-6882	\N	NEW	\N	\N	\N	\N
85394	79	D5170C00002/tiny.path.1/file-4004.pdf	\N	D5170C00002-d55054fd-8317-11eb-be00-3f0fa69d6d1a-4004	\N	NEW	\N	\N	\N	\N
88273	79	D5170C00002/tiny.path.1/file-6883.pdf	\N	D5170C00002-d5512cac-8319-11eb-be00-9314e7b63674-6883	\N	NEW	\N	\N	\N	\N
88274	79	D5170C00002/tiny.path.1/file-6884.pdf	\N	D5170C00002-d55ff9bd-8319-11eb-be00-e5660cf11e09-6884	\N	NEW	\N	\N	\N	\N
88275	79	D5170C00002/tiny.path.1/file-6885.pdf	\N	D5170C00002-d560bd0e-8319-11eb-be00-ed75369bdfe7-6885	\N	NEW	\N	\N	\N	\N
82451	79	D5170C00002/tiny.path.1/file-1061.pdf	\N	D5170C00002-d561f29e-8315-11eb-be00-cbca3e15e3e2-1061	\N	NEW	\N	\N	\N	\N
88276	79	D5170C00002/tiny.path.1/file-6886.pdf	\N	D5170C00002-d56f14ef-8319-11eb-be00-070eec43c20a-6886	\N	NEW	\N	\N	\N	\N
83834	79	D5170C00002/tiny.path.1/file-2444.pdf	\N	D5170C00002-d56f1cf5-8316-11eb-be00-0fb2c9504a0d-2444	\N	NEW	\N	\N	\N	\N
88277	79	D5170C00002/tiny.path.1/file-6887.pdf	\N	D5170C00002-d57fb6c0-8319-11eb-be00-bf83515b2f13-6887	\N	NEW	\N	\N	\N	\N
85395	79	D5170C00002/tiny.path.1/file-4005.pdf	\N	D5170C00002-d58d0fde-8317-11eb-be00-15f7fa2122e0-4005	\N	NEW	\N	\N	\N	\N
88278	79	D5170C00002/tiny.path.1/file-6888.pdf	\N	D5170C00002-d58dc081-8319-11eb-be00-5f4daa63cc6a-6888	\N	NEW	\N	\N	\N	\N
88279	79	D5170C00002/tiny.path.1/file-6889.pdf	\N	D5170C00002-d5abf6e2-8319-11eb-be00-7958f8d25e9a-6889	\N	NEW	\N	\N	\N	\N
86780	79	D5170C00002/tiny.path.1/file-5390.pdf	\N	D5170C00002-d5ba9277-8318-11eb-be00-85d683bdc27a-5390	\N	NEW	\N	\N	\N	\N
83835	79	D5170C00002/tiny.path.1/file-2445.pdf	\N	D5170C00002-d5bb6836-8316-11eb-be00-49f4d84716b4-2445	\N	NEW	\N	\N	\N	\N
88280	79	D5170C00002/tiny.path.1/file-6890.pdf	\N	D5170C00002-d5bc2383-8319-11eb-be00-914a003e7254-6890	\N	NEW	\N	\N	\N	\N
88281	79	D5170C00002/tiny.path.1/file-6891.pdf	\N	D5170C00002-d5c8f4c4-8319-11eb-be00-f99c30876ac5-6891	\N	NEW	\N	\N	\N	\N
88282	79	D5170C00002/tiny.path.1/file-6892.pdf	\N	D5170C00002-d5da32d5-8319-11eb-be00-c755468b58b3-6892	\N	NEW	\N	\N	\N	\N
88283	79	D5170C00002/tiny.path.1/file-6893.pdf	\N	D5170C00002-d5e99c26-8319-11eb-be00-3dbc077754f8-6893	\N	NEW	\N	\N	\N	\N
86781	79	D5170C00002/tiny.path.1/file-5391.pdf	\N	D5170C00002-d5ea06e8-8318-11eb-be00-3de8b2e555d7-5391	\N	NEW	\N	\N	\N	\N
88284	79	D5170C00002/tiny.path.1/file-6894.pdf	\N	D5170C00002-d5ea5f77-8319-11eb-be00-39ad23879eb8-6894	\N	NEW	\N	\N	\N	\N
82452	79	D5170C00002/tiny.path.1/file-1062.pdf	\N	D5170C00002-d5f88d4f-8315-11eb-be00-7d3829edba1e-1062	\N	NEW	\N	\N	\N	\N
88285	79	D5170C00002/tiny.path.1/file-6895.pdf	\N	D5170C00002-d5f89048-8319-11eb-be00-c15ab15a1bf9-6895	\N	NEW	\N	\N	\N	\N
86782	79	D5170C00002/tiny.path.1/file-5392.pdf	\N	D5170C00002-d5f8fb09-8318-11eb-be00-c3168dc60852-5392	\N	NEW	\N	\N	\N	\N
88286	79	D5170C00002/tiny.path.1/file-6896.pdf	\N	D5170C00002-d605fdc9-8319-11eb-be00-09bccdf332e4-6896	\N	NEW	\N	\N	\N	\N
88287	79	D5170C00002/tiny.path.1/file-6897.pdf	\N	D5170C00002-d60820aa-8319-11eb-be00-4d81c6597749-6897	\N	NEW	\N	\N	\N	\N
86783	79	D5170C00002/tiny.path.1/file-5393.pdf	\N	D5170C00002-d608b27a-8318-11eb-be00-4135a82ffc03-5393	\N	NEW	\N	\N	\N	\N
85396	79	D5170C00002/tiny.path.1/file-4006.pdf	\N	D5170C00002-d60992df-8317-11eb-be00-1f44d30ac099-4006	\N	NEW	\N	\N	\N	\N
88288	79	D5170C00002/tiny.path.1/file-6898.pdf	\N	D5170C00002-d615400b-8319-11eb-be00-39c9aca13fdb-6898	\N	NEW	\N	\N	\N	\N
88289	79	D5170C00002/tiny.path.1/file-6899.pdf	\N	D5170C00002-d624a95c-8319-11eb-be00-d37134cecb3d-6899	\N	NEW	\N	\N	\N	\N
83836	79	D5170C00002/tiny.path.1/file-2446.pdf	\N	D5170C00002-d62574a7-8316-11eb-be00-a1e06bdf5410-2446	\N	NEW	\N	\N	\N	\N
88290	79	D5170C00002/tiny.path.1/file-6900.pdf	\N	D5170C00002-d6262ffd-8319-11eb-be00-6734c1740612-6900	\N	NEW	\N	\N	\N	\N
88291	79	D5170C00002/tiny.path.1/file-6901.pdf	\N	D5170C00002-d627416e-8319-11eb-be00-e706cb812912-6901	\N	NEW	\N	\N	\N	\N
83837	79	D5170C00002/tiny.path.1/file-2447.pdf	\N	D5170C00002-d6277078-8316-11eb-be00-85216775e892-2447	\N	NEW	\N	\N	\N	\N
85397	79	D5170C00002/tiny.path.1/file-4007.pdf	\N	D5170C00002-d6350fb0-8317-11eb-be00-590c0d7fabe0-4007	\N	NEW	\N	\N	\N	\N
86784	79	D5170C00002/tiny.path.1/file-5394.pdf	\N	D5170C00002-d635b5eb-8318-11eb-be00-9b8f62833d6b-5394	\N	NEW	\N	\N	\N	\N
88292	79	D5170C00002/tiny.path.1/file-6902.pdf	\N	D5170C00002-d636358f-8319-11eb-be00-e1f766d3dbce-6902	\N	NEW	\N	\N	\N	\N
88293	79	D5170C00002/tiny.path.1/file-6903.pdf	\N	D5170C00002-d6437c00-8319-11eb-be00-b171f8664d21-6903	\N	NEW	\N	\N	\N	\N
83838	79	D5170C00002/tiny.path.1/file-2448.pdf	\N	D5170C00002-d64383f9-8316-11eb-be00-cf545dd4c998-2448	\N	NEW	\N	\N	\N	\N
88294	79	D5170C00002/tiny.path.1/file-6904.pdf	\N	D5170C00002-d6443f51-8319-11eb-be00-a188e241754b-6904	\N	NEW	\N	\N	\N	\N
88295	79	D5170C00002/tiny.path.1/file-6905.pdf	\N	D5170C00002-d64550c2-8319-11eb-be00-fbcc1e0b49f3-6905	\N	NEW	\N	\N	\N	\N
88296	79	D5170C00002/tiny.path.1/file-6906.pdf	\N	D5170C00002-d6533373-8319-11eb-be00-612433449e45-6906	\N	NEW	\N	\N	\N	\N
86785	79	D5170C00002/tiny.path.1/file-5395.pdf	\N	D5170C00002-d654135c-8318-11eb-be00-958ef79ea838-5395	\N	NEW	\N	\N	\N	\N
88297	79	D5170C00002/tiny.path.1/file-6907.pdf	\N	D5170C00002-d6552f44-8319-11eb-be00-2bb1443ade7b-6907	\N	NEW	\N	\N	\N	\N
88298	79	D5170C00002/tiny.path.1/file-6908.pdf	\N	D5170C00002-d6633905-8319-11eb-be00-a7f30d6d2b6f-6908	\N	NEW	\N	\N	\N	\N
88299	79	D5170C00002/tiny.path.1/file-6909.pdf	\N	D5170C00002-d6711bb6-8319-11eb-be00-bbd737f118c1-6909	\N	NEW	\N	\N	\N	\N
86786	79	D5170C00002/tiny.path.1/file-5396.pdf	\N	D5170C00002-d671866d-8318-11eb-be00-71a1491b259c-5396	\N	NEW	\N	\N	\N	\N
88300	79	D5170C00002/tiny.path.1/file-6910.pdf	\N	D5170C00002-d6727b47-8319-11eb-be00-91e656aa18f1-6910	\N	NEW	\N	\N	\N	\N
82453	79	D5170C00002/tiny.path.1/file-1063.pdf	\N	D5170C00002-d673b0c0-8315-11eb-be00-ef0a1dc72511-1063	\N	NEW	\N	\N	\N	\N
83839	79	D5170C00002/tiny.path.1/file-2449.pdf	\N	D5170C00002-d674cd2a-8316-11eb-be00-d30b1ba92f8d-2449	\N	NEW	\N	\N	\N	\N
86787	79	D5170C00002/tiny.path.1/file-5397.pdf	\N	D5170C00002-d6829d6e-8318-11eb-be00-a1ba1b66fb61-5397	\N	NEW	\N	\N	\N	\N
88301	79	D5170C00002/tiny.path.1/file-6911.pdf	\N	D5170C00002-d6901568-8319-11eb-be00-c191fe4d3832-6911	\N	NEW	\N	\N	\N	\N
85398	79	D5170C00002/tiny.path.1/file-4008.pdf	\N	D5170C00002-d6907621-8317-11eb-be00-5d33c32dd371-4008	\N	NEW	\N	\N	\N	\N
86788	79	D5170C00002/tiny.path.1/file-5398.pdf	\N	D5170C00002-d691b89f-8318-11eb-be00-3bc2ef70497c-5398	\N	NEW	\N	\N	\N	\N
88302	79	D5170C00002/tiny.path.1/file-6912.pdf	\N	D5170C00002-d6923849-8319-11eb-be00-e592a271045b-6912	\N	NEW	\N	\N	\N	\N
88303	79	D5170C00002/tiny.path.1/file-6913.pdf	\N	D5170C00002-d6a0691a-8319-11eb-be00-edbcda732ba7-6913	\N	NEW	\N	\N	\N	\N
83840	79	D5170C00002/tiny.path.1/file-2450.pdf	\N	D5170C00002-d6a15b6b-8316-11eb-be00-c91245c7fa6c-2450	\N	NEW	\N	\N	\N	\N
83841	79	D5170C00002/tiny.path.1/file-2451.pdf	\N	D5170C00002-d6be805c-8316-11eb-be00-d7a1c64bd6ef-2451	\N	NEW	\N	\N	\N	\N
88304	79	D5170C00002/tiny.path.1/file-6914.pdf	\N	D5170C00002-d6bfff0b-8319-11eb-be00-cb03b2b5cc0d-6914	\N	NEW	\N	\N	\N	\N
85399	79	D5170C00002/tiny.path.1/file-4009.pdf	\N	D5170C00002-d6c038b2-8317-11eb-be00-0ddedf6d0586-4009	\N	NEW	\N	\N	\N	\N
88305	79	D5170C00002/tiny.path.1/file-6915.pdf	\N	D5170C00002-d6ce2fdc-8319-11eb-be00-61d81b9cc7a2-6915	\N	NEW	\N	\N	\N	\N
86789	79	D5170C00002/tiny.path.1/file-5399.pdf	\N	D5170C00002-d6dd4090-8318-11eb-be00-9de748ab72c1-5399	\N	NEW	\N	\N	\N	\N
88306	79	D5170C00002/tiny.path.1/file-6916.pdf	\N	D5170C00002-d6dde74d-8319-11eb-be00-2d9943975981-6916	\N	NEW	\N	\N	\N	\N
83842	79	D5170C00002/tiny.path.1/file-2452.pdf	\N	D5170C00002-d6eb83cd-8316-11eb-be00-1d9100513227-2452	\N	NEW	\N	\N	\N	\N
88307	79	D5170C00002/tiny.path.1/file-6917.pdf	\N	D5170C00002-d6ecdb6e-8319-11eb-be00-81c9a75b74e8-6917	\N	NEW	\N	\N	\N	\N
82454	79	D5170C00002/tiny.path.1/file-1064.pdf	\N	D5170C00002-d6ee5f01-8315-11eb-be00-f9458c3f3d16-1064	\N	NEW	\N	\N	\N	\N
85400	79	D5170C00002/tiny.path.1/file-4010.pdf	\N	D5170C00002-d6fb45e3-8317-11eb-be00-fd6500fba147-4010	\N	NEW	\N	\N	\N	\N
88308	79	D5170C00002/tiny.path.1/file-6918.pdf	\N	D5170C00002-d6fbcf8f-8319-11eb-be00-6d0df936e7d6-6918	\N	NEW	\N	\N	\N	\N
86790	79	D5170C00002/tiny.path.1/file-5400.pdf	\N	D5170C00002-d70a4401-8318-11eb-be00-6dd1fedd3e38-5400	\N	NEW	\N	\N	\N	\N
82455	79	D5170C00002/tiny.path.1/file-1065.pdf	\N	D5170C00002-d70c2032-8315-11eb-be00-b336f23c24de-1065	\N	NEW	\N	\N	\N	\N
88309	79	D5170C00002/tiny.path.1/file-6919.pdf	\N	D5170C00002-d71969b0-8319-11eb-be00-77e786aa2925-6919	\N	NEW	\N	\N	\N	\N
88310	79	D5170C00002/tiny.path.1/file-6920.pdf	\N	D5170C00002-d71b6581-8319-11eb-be00-a9348665bdb8-6920	\N	NEW	\N	\N	\N	\N
88311	79	D5170C00002/tiny.path.1/file-6921.pdf	\N	D5170C00002-d72884e2-8319-11eb-be00-1160ddfc0bb5-6921	\N	NEW	\N	\N	\N	\N
88312	79	D5170C00002/tiny.path.1/file-6922.pdf	\N	D5170C00002-d72aa7c3-8319-11eb-be00-e1ff00dd62b0-6922	\N	NEW	\N	\N	\N	\N
82456	79	D5170C00002/tiny.path.1/file-1066.pdf	\N	D5170C00002-d7383943-8315-11eb-be00-23c5502a9e36-1066	\N	NEW	\N	\N	\N	\N
88313	79	D5170C00002/tiny.path.1/file-6923.pdf	\N	D5170C00002-d755af64-8319-11eb-be00-d52dec3b2815-6923	\N	NEW	\N	\N	\N	\N
82457	79	D5170C00002/tiny.path.1/file-1067.pdf	\N	D5170C00002-d7578114-8315-11eb-be00-995982381e97-1067	\N	NEW	\N	\N	\N	\N
82458	79	D5170C00002/tiny.path.1/file-1068.pdf	\N	D5170C00002-d7759065-8315-11eb-be00-a1c4ac324c69-1068	\N	NEW	\N	\N	\N	\N
86791	79	D5170C00002/tiny.path.1/file-5401.pdf	\N	D5170C00002-d784f242-8318-11eb-be00-5d27c958ca59-5401	\N	NEW	\N	\N	\N	\N
83843	79	D5170C00002/tiny.path.1/file-2453.pdf	\N	D5170C00002-d78504ae-8316-11eb-be00-11c225c25495-2453	\N	NEW	\N	\N	\N	\N
86792	79	D5170C00002/tiny.path.1/file-5402.pdf	\N	D5170C00002-d7932313-8318-11eb-be00-c10b4ccd59cd-5402	\N	NEW	\N	\N	\N	\N
85401	79	D5170C00002/tiny.path.1/file-4011.pdf	\N	D5170C00002-d7942a84-8317-11eb-be00-49ce2eb2dca8-4011	\N	NEW	\N	\N	\N	\N
88314	79	D5170C00002/tiny.path.1/file-6924.pdf	\N	D5170C00002-d7a1d395-8319-11eb-be00-69599c56ca06-6924	\N	NEW	\N	\N	\N	\N
86793	79	D5170C00002/tiny.path.1/file-5403.pdf	\N	D5170C00002-d7a48834-8318-11eb-be00-319fae1a58e2-5403	\N	NEW	\N	\N	\N	\N
88315	79	D5170C00002/tiny.path.1/file-6925.pdf	\N	D5170C00002-d7b24e56-8319-11eb-be00-cb12b4f13871-6925	\N	NEW	\N	\N	\N	\N
82459	79	D5170C00002/tiny.path.1/file-1069.pdf	\N	D5170C00002-d7c42596-8315-11eb-be00-031df1e6cf43-1069	\N	NEW	\N	\N	\N	\N
88316	79	D5170C00002/tiny.path.1/file-6926.pdf	\N	D5170C00002-d7d05da7-8319-11eb-be00-79d1caf2a35b-6926	\N	NEW	\N	\N	\N	\N
86794	79	D5170C00002/tiny.path.1/file-5404.pdf	\N	D5170C00002-d7d0a145-8318-11eb-be00-1b8e64c3806b-5404	\N	NEW	\N	\N	\N	\N
86795	79	D5170C00002/tiny.path.1/file-5405.pdf	\N	D5170C00002-d7e14316-8318-11eb-be00-857d539399c8-5405	\N	NEW	\N	\N	\N	\N
85402	79	D5170C00002/tiny.path.1/file-4012.pdf	\N	D5170C00002-d7e1d555-8317-11eb-be00-8b37fc7a5b1a-4012	\N	NEW	\N	\N	\N	\N
86796	79	D5170C00002/tiny.path.1/file-5406.pdf	\N	D5170C00002-d7e25487-8318-11eb-be00-eddfa542b367-5406	\N	NEW	\N	\N	\N	\N
88317	79	D5170C00002/tiny.path.1/file-6927.pdf	\N	D5170C00002-d7eee228-8319-11eb-be00-5de6491d4a1d-6927	\N	NEW	\N	\N	\N	\N
88318	79	D5170C00002/tiny.path.1/file-6928.pdf	\N	D5170C00002-d7f12c19-8319-11eb-be00-452052e81122-6928	\N	NEW	\N	\N	\N	\N
86797	79	D5170C00002/tiny.path.1/file-5407.pdf	\N	D5170C00002-d7fe19e8-8318-11eb-be00-7b9fcac3c661-5407	\N	NEW	\N	\N	\N	\N
85403	79	D5170C00002/tiny.path.1/file-4013.pdf	\N	D5170C00002-d7fe5e06-8317-11eb-be00-9b86dc034756-4013	\N	NEW	\N	\N	\N	\N
82460	79	D5170C00002/tiny.path.1/file-1070.pdf	\N	D5170C00002-d7febd97-8315-11eb-be00-f96b6fdbe99a-1070	\N	NEW	\N	\N	\N	\N
86798	79	D5170C00002/tiny.path.1/file-5408.pdf	\N	D5170C00002-d7ff0449-8318-11eb-be00-17ff43b63cad-5408	\N	NEW	\N	\N	\N	\N
88319	79	D5170C00002/tiny.path.1/file-6929.pdf	\N	D5170C00002-d80d3f9a-8319-11eb-be00-45f58768487c-6929	\N	NEW	\N	\N	\N	\N
83844	79	D5170C00002/tiny.path.1/file-2454.pdf	\N	D5170C00002-d80d477f-8316-11eb-be00-3d654d6f8f20-2454	\N	NEW	\N	\N	\N	\N
88320	79	D5170C00002/tiny.path.1/file-6930.pdf	\N	D5170C00002-d80eed4b-8319-11eb-be00-bf5eda4415f6-6930	\N	NEW	\N	\N	\N	\N
82461	79	D5170C00002/tiny.path.1/file-1071.pdf	\N	D5170C00002-d80fd498-8315-11eb-be00-c1e77d0ba354-1071	\N	NEW	\N	\N	\N	\N
82462	79	D5170C00002/tiny.path.1/file-1072.pdf	\N	D5170C00002-d81e2c79-8315-11eb-be00-e35447d44ae9-1072	\N	NEW	\N	\N	\N	\N
83845	79	D5170C00002/tiny.path.1/file-2455.pdf	\N	D5170C00002-d81e3770-8316-11eb-be00-2b49d2e593f5-2455	\N	NEW	\N	\N	\N	\N
88321	79	D5170C00002/tiny.path.1/file-6931.pdf	\N	D5170C00002-d82b75fc-8319-11eb-be00-813855090b76-6931	\N	NEW	\N	\N	\N	\N
85404	79	D5170C00002/tiny.path.1/file-4014.pdf	\N	D5170C00002-d82e47a7-8317-11eb-be00-59e3c06d3079-4014	\N	NEW	\N	\N	\N	\N
82463	79	D5170C00002/tiny.path.1/file-1073.pdf	\N	D5170C00002-d82ef55a-8315-11eb-be00-7197cf8706da-1073	\N	NEW	\N	\N	\N	\N
88322	79	D5170C00002/tiny.path.1/file-6932.pdf	\N	D5170C00002-d83a912d-8319-11eb-be00-0babe57e8682-6932	\N	NEW	\N	\N	\N	\N
83846	79	D5170C00002/tiny.path.1/file-2456.pdf	\N	D5170C00002-d83b0e41-8316-11eb-be00-135dfaeaeb77-2456	\N	NEW	\N	\N	\N	\N
88323	79	D5170C00002/tiny.path.1/file-6933.pdf	\N	D5170C00002-d83c3ede-8319-11eb-be00-29fb0c94350d-6933	\N	NEW	\N	\N	\N	\N
82464	79	D5170C00002/tiny.path.1/file-1074.pdf	\N	D5170C00002-d84ae1cb-8315-11eb-be00-5d79b7557cad-1074	\N	NEW	\N	\N	\N	\N
83847	79	D5170C00002/tiny.path.1/file-2457.pdf	\N	D5170C00002-d84bd722-8316-11eb-be00-c9af62e688e5-2457	\N	NEW	\N	\N	\N	\N
88324	79	D5170C00002/tiny.path.1/file-6934.pdf	\N	D5170C00002-d85915af-8319-11eb-be00-db2d82b8aab1-6934	\N	NEW	\N	\N	\N	\N
82465	79	D5170C00002/tiny.path.1/file-1075.pdf	\N	D5170C00002-d85b5c8c-8315-11eb-be00-fdd732134ceb-1075	\N	NEW	\N	\N	\N	\N
88325	79	D5170C00002/tiny.path.1/file-6935.pdf	\N	D5170C00002-d85bd4d0-8319-11eb-be00-53bc555e8c17-6935	\N	NEW	\N	\N	\N	\N
83848	79	D5170C00002/tiny.path.1/file-2458.pdf	\N	D5170C00002-d85bdcb3-8316-11eb-be00-d18c6359f012-2458	\N	NEW	\N	\N	\N	\N
86799	79	D5170C00002/tiny.path.1/file-5409.pdf	\N	D5170C00002-d86937ca-8318-11eb-be00-c52e1ef353ad-5409	\N	NEW	\N	\N	\N	\N
88326	79	D5170C00002/tiny.path.1/file-6936.pdf	\N	D5170C00002-d88751a1-8319-11eb-be00-711b21a04a65-6936	\N	NEW	\N	\N	\N	\N
88327	79	D5170C00002/tiny.path.1/file-6937.pdf	\N	D5170C00002-d8961eb2-8319-11eb-be00-5def11b3881c-6937	\N	NEW	\N	\N	\N	\N
83849	79	D5170C00002/tiny.path.1/file-2459.pdf	\N	D5170C00002-d896c2d4-8316-11eb-be00-3b167d12ed6f-2459	\N	NEW	\N	\N	\N	\N
88328	79	D5170C00002/tiny.path.1/file-6938.pdf	\N	D5170C00002-d8975733-8319-11eb-be00-39148850e600-6938	\N	NEW	\N	\N	\N	\N
88329	79	D5170C00002/tiny.path.1/file-6939.pdf	\N	D5170C00002-d898ddd4-8319-11eb-be00-89d175f12e96-6939	\N	NEW	\N	\N	\N	\N
82466	79	D5170C00002/tiny.path.1/file-1076.pdf	\N	D5170C00002-d8999e0d-8315-11eb-be00-bb190eee416d-1076	\N	NEW	\N	\N	\N	\N
86800	79	D5170C00002/tiny.path.1/file-5410.pdf	\N	D5170C00002-d8a68eeb-8318-11eb-be00-b994d211ae4b-5410	\N	NEW	\N	\N	\N	\N
83850	79	D5170C00002/tiny.path.1/file-2460.pdf	\N	D5170C00002-d8a7b2c5-8316-11eb-be00-a9d75f7c9a06-2460	\N	NEW	\N	\N	\N	\N
88330	79	D5170C00002/tiny.path.1/file-6940.pdf	\N	D5170C00002-d8b4ca45-8319-11eb-be00-17cb6bbacbca-6940	\N	NEW	\N	\N	\N	\N
88331	79	D5170C00002/tiny.path.1/file-6941.pdf	\N	D5170C00002-d8b78966-8319-11eb-be00-6b6e46e996ab-6941	\N	NEW	\N	\N	\N	\N
83851	79	D5170C00002/tiny.path.1/file-2461.pdf	\N	D5170C00002-d8b7b856-8316-11eb-be00-21104e13fba6-2461	\N	NEW	\N	\N	\N	\N
86801	79	D5170C00002/tiny.path.1/file-5411.pdf	\N	D5170C00002-d8c49e3c-8318-11eb-be00-ddd574da4484-5411	\N	NEW	\N	\N	\N	\N
88332	79	D5170C00002/tiny.path.1/file-6942.pdf	\N	D5170C00002-d8c65677-8319-11eb-be00-65ae1778677e-6942	\N	NEW	\N	\N	\N	\N
86802	79	D5170C00002/tiny.path.1/file-5412.pdf	\N	D5170C00002-d8d36b4d-8318-11eb-be00-d5cab736ea38-5412	\N	NEW	\N	\N	\N	\N
82467	79	D5170C00002/tiny.path.1/file-1077.pdf	\N	D5170C00002-d8d3c0de-8315-11eb-be00-af37784490ee-1077	\N	NEW	\N	\N	\N	\N
83852	79	D5170C00002/tiny.path.1/file-2462.pdf	\N	D5170C00002-d8d3f2e7-8316-11eb-be00-d174acd6f833-2462	\N	NEW	\N	\N	\N	\N
88333	79	D5170C00002/tiny.path.1/file-6943.pdf	\N	D5170C00002-d8d46038-8319-11eb-be00-81ead07f2afe-6943	\N	NEW	\N	\N	\N	\N
82468	79	D5170C00002/tiny.path.1/file-1078.pdf	\N	D5170C00002-d8e489bf-8315-11eb-be00-c126c280a0bc-1078	\N	NEW	\N	\N	\N	\N
86803	79	D5170C00002/tiny.path.1/file-5413.pdf	\N	D5170C00002-d8e4f77e-8318-11eb-be00-519ad53cc745-5413	\N	NEW	\N	\N	\N	\N
82469	79	D5170C00002/tiny.path.1/file-1079.pdf	\N	D5170C00002-d8f24560-8315-11eb-be00-11817921d213-1079	\N	NEW	\N	\N	\N	\N
88334	79	D5170C00002/tiny.path.1/file-6944.pdf	\N	D5170C00002-d8f24879-8319-11eb-be00-f955eeebcf54-6944	\N	NEW	\N	\N	\N	\N
88335	79	D5170C00002/tiny.path.1/file-6945.pdf	\N	D5170C00002-d8f4e08a-8319-11eb-be00-bfe31f0f16d6-6945	\N	NEW	\N	\N	\N	\N
83853	79	D5170C00002/tiny.path.1/file-2463.pdf	\N	D5170C00002-d901b9a8-8316-11eb-be00-e368b96f57db-2463	\N	NEW	\N	\N	\N	\N
86804	79	D5170C00002/tiny.path.1/file-5414.pdf	\N	D5170C00002-d90354ef-8318-11eb-be00-35a9147f500a-5414	\N	NEW	\N	\N	\N	\N
88336	79	D5170C00002/tiny.path.1/file-6946.pdf	\N	D5170C00002-d903fbbb-8319-11eb-be00-b3ff04bd469d-6946	\N	NEW	\N	\N	\N	\N
86805	79	D5170C00002/tiny.path.1/file-5415.pdf	\N	D5170C00002-d9133370-8318-11eb-be00-3fc78a0a20b2-5415	\N	NEW	\N	\N	\N	\N
82470	79	D5170C00002/tiny.path.1/file-1080.pdf	\N	D5170C00002-d920f681-8315-11eb-be00-6d6d0360e38f-1080	\N	NEW	\N	\N	\N	\N
88337	79	D5170C00002/tiny.path.1/file-6947.pdf	\N	D5170C00002-d920f99c-8319-11eb-be00-f55b57dd0e3e-6947	\N	NEW	\N	\N	\N	\N
83854	79	D5170C00002/tiny.path.1/file-2464.pdf	\N	D5170C00002-d9210179-8316-11eb-be00-27d57fb37ee5-2464	\N	NEW	\N	\N	\N	\N
88338	79	D5170C00002/tiny.path.1/file-6948.pdf	\N	D5170C00002-d9314d4d-8319-11eb-be00-11a294a6f818-6948	\N	NEW	\N	\N	\N	\N
83855	79	D5170C00002/tiny.path.1/file-2465.pdf	\N	D5170C00002-d9317c3a-8316-11eb-be00-ed4f6c1f9b96-2465	\N	NEW	\N	\N	\N	\N
88339	79	D5170C00002/tiny.path.1/file-6949.pdf	\N	D5170C00002-d9408f8e-8319-11eb-be00-f1c34e18badc-6949	\N	NEW	\N	\N	\N	\N
82471	79	D5170C00002/tiny.path.1/file-1081.pdf	\N	D5170C00002-d94128b2-8315-11eb-be00-2f7906d7ad82-1081	\N	NEW	\N	\N	\N	\N
85405	79	D5170C00002/tiny.path.1/file-4015.pdf	\N	D5170C00002-d94e84b8-8317-11eb-be00-b9eeabe54edc-4015	\N	NEW	\N	\N	\N	\N
88340	79	D5170C00002/tiny.path.1/file-6950.pdf	\N	D5170C00002-d94ec05f-8319-11eb-be00-05323a0b4a2d-6950	\N	NEW	\N	\N	\N	\N
82472	79	D5170C00002/tiny.path.1/file-1082.pdf	\N	D5170C00002-d95e2693-8315-11eb-be00-516ffe37b7e5-1082	\N	NEW	\N	\N	\N	\N
88341	79	D5170C00002/tiny.path.1/file-6951.pdf	\N	D5170C00002-d96ecb80-8319-11eb-be00-71097b0fd5fa-6951	\N	NEW	\N	\N	\N	\N
82473	79	D5170C00002/tiny.path.1/file-1083.pdf	\N	D5170C00002-d97cab14-8315-11eb-be00-9384f3a54c10-1083	\N	NEW	\N	\N	\N	\N
88342	79	D5170C00002/tiny.path.1/file-6952.pdf	\N	D5170C00002-d98a90e1-8319-11eb-be00-7bfa3d3abe0a-6952	\N	NEW	\N	\N	\N	\N
83856	79	D5170C00002/tiny.path.1/file-2466.pdf	\N	D5170C00002-d98b34fb-8316-11eb-be00-7bfe56d9bea1-2466	\N	NEW	\N	\N	\N	\N
88343	79	D5170C00002/tiny.path.1/file-6953.pdf	\N	D5170C00002-d98c65a2-8319-11eb-be00-9f10eab9f43b-6953	\N	NEW	\N	\N	\N	\N
83857	79	D5170C00002/tiny.path.1/file-2467.pdf	\N	D5170C00002-d99a9e4c-8316-11eb-be00-45a3118245d4-2467	\N	NEW	\N	\N	\N	\N
88344	79	D5170C00002/tiny.path.1/file-6954.pdf	\N	D5170C00002-d99b0ba3-8319-11eb-be00-6f5eb48ea659-6954	\N	NEW	\N	\N	\N	\N
82474	79	D5170C00002/tiny.path.1/file-1084.pdf	\N	D5170C00002-d99c8f25-8315-11eb-be00-e144037718d6-1084	\N	NEW	\N	\N	\N	\N
88345	79	D5170C00002/tiny.path.1/file-6955.pdf	\N	D5170C00002-d99c9244-8319-11eb-be00-a983f7a32d0f-6955	\N	NEW	\N	\N	\N	\N
88346	79	D5170C00002/tiny.path.1/file-6956.pdf	\N	D5170C00002-d9ab1135-8319-11eb-be00-ed28d22cfeed-6956	\N	NEW	\N	\N	\N	\N
82475	79	D5170C00002/tiny.path.1/file-1085.pdf	\N	D5170C00002-d9b917d6-8315-11eb-be00-2f0ad0c8f898-1085	\N	NEW	\N	\N	\N	\N
88347	79	D5170C00002/tiny.path.1/file-6957.pdf	\N	D5170C00002-d9b9de46-8319-11eb-be00-0f3c3d377b68-6957	\N	NEW	\N	\N	\N	\N
85406	79	D5170C00002/tiny.path.1/file-4016.pdf	\N	D5170C00002-d9badb19-8317-11eb-be00-6564a3567c90-4016	\N	NEW	\N	\N	\N	\N
83858	79	D5170C00002/tiny.path.1/file-2468.pdf	\N	D5170C00002-d9c8650d-8316-11eb-be00-c93fb1b348fc-2468	\N	NEW	\N	\N	\N	\N
88348	79	D5170C00002/tiny.path.1/file-6958.pdf	\N	D5170C00002-d9d7ed97-8319-11eb-be00-ff005f179cde-6958	\N	NEW	\N	\N	\N	\N
82476	79	D5170C00002/tiny.path.1/file-1086.pdf	\N	D5170C00002-d9d922f7-8315-11eb-be00-7308a77c2ac6-1086	\N	NEW	\N	\N	\N	\N
85407	79	D5170C00002/tiny.path.1/file-4017.pdf	\N	D5170C00002-d9e7424a-8317-11eb-be00-e52eda9b9106-4017	\N	NEW	\N	\N	\N	\N
83859	79	D5170C00002/tiny.path.1/file-2469.pdf	\N	D5170C00002-d9e75ebe-8316-11eb-be00-4f17dcc49ada-2469	\N	NEW	\N	\N	\N	\N
83860	79	D5170C00002/tiny.path.1/file-2470.pdf	\N	D5170C00002-d9e90c6f-8316-11eb-be00-41426c057264-2470	\N	NEW	\N	\N	\N	\N
82477	79	D5170C00002/tiny.path.1/file-1087.pdf	\N	D5170C00002-da05d848-8315-11eb-be00-f5cbc49db4ce-1087	\N	NEW	\N	\N	\N	\N
83861	79	D5170C00002/tiny.path.1/file-2471.pdf	\N	D5170C00002-da0769e0-8316-11eb-be00-57fffefc7e08-2471	\N	NEW	\N	\N	\N	\N
88349	79	D5170C00002/tiny.path.1/file-6959.pdf	\N	D5170C00002-da17b5b8-8319-11eb-be00-59e8abd81ee7-6959	\N	NEW	\N	\N	\N	\N
83862	79	D5170C00002/tiny.path.1/file-2472.pdf	\N	D5170C00002-da32e6b1-8316-11eb-be00-774798c98669-2472	\N	NEW	\N	\N	\N	\N
82478	79	D5170C00002/tiny.path.1/file-1088.pdf	\N	D5170C00002-da33c619-8315-11eb-be00-27d287196636-1088	\N	NEW	\N	\N	\N	\N
88350	79	D5170C00002/tiny.path.1/file-6960.pdf	\N	D5170C00002-da3528c9-8319-11eb-be00-a1471ad6868f-6960	\N	NEW	\N	\N	\N	\N
82479	79	D5170C00002/tiny.path.1/file-1089.pdf	\N	D5170C00002-da42ba3a-8315-11eb-be00-893b9f8b4e68-1089	\N	NEW	\N	\N	\N	\N
88351	79	D5170C00002/tiny.path.1/file-6961.pdf	\N	D5170C00002-da43328a-8319-11eb-be00-d7392dca1028-6961	\N	NEW	\N	\N	\N	\N
86806	79	D5170C00002/tiny.path.1/file-5416.pdf	\N	D5170C00002-da446071-8318-11eb-be00-bb0b94fcd4c9-5416	\N	NEW	\N	\N	\N	\N
88352	79	D5170C00002/tiny.path.1/file-6962.pdf	\N	D5170C00002-da52c2eb-8319-11eb-be00-51d2cbab6554-6962	\N	NEW	\N	\N	\N	\N
85408	79	D5170C00002/tiny.path.1/file-4018.pdf	\N	D5170C00002-da52d55b-8317-11eb-be00-17ba94f8c06f-4018	\N	NEW	\N	\N	\N	\N
83863	79	D5170C00002/tiny.path.1/file-2473.pdf	\N	D5170C00002-da70da12-8316-11eb-be00-41d3807d1527-2473	\N	NEW	\N	\N	\N	\N
82480	79	D5170C00002/tiny.path.1/file-1090.pdf	\N	D5170C00002-da72a3db-8315-11eb-be00-592a780933da-1090	\N	NEW	\N	\N	\N	\N
88353	79	D5170C00002/tiny.path.1/file-6963.pdf	\N	D5170C00002-da7eb4ec-8319-11eb-be00-ad74f34b4d7a-6963	\N	NEW	\N	\N	\N	\N
88354	79	D5170C00002/tiny.path.1/file-6964.pdf	\N	D5170C00002-da8fcbed-8319-11eb-be00-8f09a489510b-6964	\N	NEW	\N	\N	\N	\N
82481	79	D5170C00002/tiny.path.1/file-1091.pdf	\N	D5170C00002-da90da3c-8315-11eb-be00-bd1b8cfcf5ea-1091	\N	NEW	\N	\N	\N	\N
86807	79	D5170C00002/tiny.path.1/file-5417.pdf	\N	D5170C00002-da9d2ed2-8318-11eb-be00-3fd8f1d22c85-5417	\N	NEW	\N	\N	\N	\N
88355	79	D5170C00002/tiny.path.1/file-6965.pdf	\N	D5170C00002-da9e71ee-8319-11eb-be00-cbbbb8947fe7-6965	\N	NEW	\N	\N	\N	\N
85409	79	D5170C00002/tiny.path.1/file-4019.pdf	\N	D5170C00002-da9f6ebc-8317-11eb-be00-3d2342593650-4019	\N	NEW	\N	\N	\N	\N
83864	79	D5170C00002/tiny.path.1/file-2474.pdf	\N	D5170C00002-daa00063-8316-11eb-be00-db73a1c52633-2474	\N	NEW	\N	\N	\N	\N
82482	79	D5170C00002/tiny.path.1/file-1092.pdf	\N	D5170C00002-daaf85cd-8315-11eb-be00-773a8e10ee17-1092	\N	NEW	\N	\N	\N	\N
88366	79	D5170C00002/tiny.path.1/file-6976.pdf	\N	D5170C00002-dabbe4ff-8319-11eb-be00-dbf36043ca42-6966	\N	NEW	\N	\N	\N	\N
83865	79	D5170C00002/tiny.path.1/file-2475.pdf	\N	D5170C00002-dacb7d34-8316-11eb-be00-7d23d9f81e51-2475	\N	NEW	\N	\N	\N	\N
88356	79	D5170C00002/tiny.path.1/file-6966.pdf	\N	D5170C00002-dadab7a0-8319-11eb-be00-b558ffaa1055-6967	\N	NEW	\N	\N	\N	\N
82483	79	D5170C00002/tiny.path.1/file-1093.pdf	\N	D5170C00002-dadb50be-8315-11eb-be00-7918c27dd99c-1093	\N	NEW	\N	\N	\N	\N
82484	79	D5170C00002/tiny.path.1/file-1094.pdf	\N	D5170C00002-dadcd75f-8315-11eb-be00-014322dc6498-1094	\N	NEW	\N	\N	\N	\N
88357	79	D5170C00002/tiny.path.1/file-6967.pdf	\N	D5170C00002-daeb0b51-8319-11eb-be00-f38cd12aef17-6968	\N	NEW	\N	\N	\N	\N
85410	79	D5170C00002/tiny.path.1/file-4020.pdf	\N	D5170C00002-daebb9fd-8317-11eb-be00-4fd255a279d9-4020	\N	NEW	\N	\N	\N	\N
82485	79	D5170C00002/tiny.path.1/file-1095.pdf	\N	D5170C00002-daf98720-8315-11eb-be00-436e6b336f8b-1095	\N	NEW	\N	\N	\N	\N
88358	79	D5170C00002/tiny.path.1/file-6968.pdf	\N	D5170C00002-dafa9bb2-8319-11eb-be00-c9d1043542fe-6969	\N	NEW	\N	\N	\N	\N
88359	79	D5170C00002/tiny.path.1/file-6969.pdf	\N	D5170C00002-db07e223-8319-11eb-be00-df3ab28fa59f-6970	\N	NEW	\N	\N	\N	\N
88360	79	D5170C00002/tiny.path.1/file-6970.pdf	\N	D5170C00002-db185ce4-8319-11eb-be00-df686cef304f-6971	\N	NEW	\N	\N	\N	\N
88361	79	D5170C00002/tiny.path.1/file-6971.pdf	\N	D5170C00002-db261885-8319-11eb-be00-0583c011e389-6972	\N	NEW	\N	\N	\N	\N
88362	79	D5170C00002/tiny.path.1/file-6972.pdf	\N	D5170C00002-db281456-8319-11eb-be00-df37646c3ff0-6973	\N	NEW	\N	\N	\N	\N
83866	79	D5170C00002/tiny.path.1/file-2476.pdf	\N	D5170C00002-db367405-8316-11eb-be00-db1788a93e7a-2476	\N	NEW	\N	\N	\N	\N
85411	79	D5170C00002/tiny.path.1/file-4021.pdf	\N	D5170C00002-db38535e-8317-11eb-be00-87eff4718bf5-4021	\N	NEW	\N	\N	\N	\N
82486	79	D5170C00002/tiny.path.1/file-1096.pdf	\N	D5170C00002-db458441-8315-11eb-be00-abafb67b86c9-1096	\N	NEW	\N	\N	\N	\N
88363	79	D5170C00002/tiny.path.1/file-6973.pdf	\N	D5170C00002-db54a297-8319-11eb-be00-3b7a6939072d-6974	\N	NEW	\N	\N	\N	\N
82487	79	D5170C00002/tiny.path.1/file-1097.pdf	\N	D5170C00002-db54c682-8315-11eb-be00-0751fc982683-1097	\N	NEW	\N	\N	\N	\N
86808	79	D5170C00002/tiny.path.1/file-5418.pdf	\N	D5170C00002-db731c73-8318-11eb-be00-6772071de085-5418	\N	NEW	\N	\N	\N	\N
82488	79	D5170C00002/tiny.path.1/file-1098.pdf	\N	D5170C00002-db74f8b3-8315-11eb-be00-bf4110181d88-1098	\N	NEW	\N	\N	\N	\N
85412	79	D5170C00002/tiny.path.1/file-4022.pdf	\N	D5170C00002-db75aa7f-8317-11eb-be00-f5e96c511959-4022	\N	NEW	\N	\N	\N	\N
88364	79	D5170C00002/tiny.path.1/file-6974.pdf	\N	D5170C00002-db81cd18-8319-11eb-be00-fb3ffb86c17a-6975	\N	NEW	\N	\N	\N	\N
83867	79	D5170C00002/tiny.path.1/file-2477.pdf	\N	D5170C00002-db82e656-8316-11eb-be00-45fe19fa6abd-2477	\N	NEW	\N	\N	\N	\N
88365	79	D5170C00002/tiny.path.1/file-6975.pdf	\N	D5170C00002-db93a769-8319-11eb-be00-1ba0e3a026f5-6976	\N	NEW	\N	\N	\N	\N
83868	79	D5170C00002/tiny.path.1/file-2478.pdf	\N	D5170C00002-dbb037e7-8316-11eb-be00-a1c1492a03de-2478	\N	NEW	\N	\N	\N	\N
82489	79	D5170C00002/tiny.path.1/file-1099.pdf	\N	D5170C00002-dbc19214-8315-11eb-be00-37e821b615f6-1099	\N	NEW	\N	\N	\N	\N
85413	79	D5170C00002/tiny.path.1/file-4023.pdf	\N	D5170C00002-dbc1a7a0-8317-11eb-be00-fb0bfe47d7c4-4023	\N	NEW	\N	\N	\N	\N
85414	79	D5170C00002/tiny.path.1/file-4024.pdf	\N	D5170C00002-dbfded51-8317-11eb-be00-73d811a0d310-4024	\N	NEW	\N	\N	\N	\N
88367	79	D5170C00002/tiny.path.1/file-6977.pdf	\N	D5170C00002-dc0de07a-8319-11eb-be00-efc783840e32-6977	\N	NEW	\N	\N	\N	\N
82490	79	D5170C00002/tiny.path.1/file-1100.pdf	\N	D5170C00002-dc1b4ad5-8315-11eb-be00-bb0d6a30177a-1100	\N	NEW	\N	\N	\N	\N
88368	79	D5170C00002/tiny.path.1/file-6978.pdf	\N	D5170C00002-dc1bea3b-8319-11eb-be00-3bb0714f6c7b-6978	\N	NEW	\N	\N	\N	\N
85415	79	D5170C00002/tiny.path.1/file-4025.pdf	\N	D5170C00002-dc1d3522-8317-11eb-be00-af706276bd7f-4025	\N	NEW	\N	\N	\N	\N
88369	79	D5170C00002/tiny.path.1/file-6979.pdf	\N	D5170C00002-dc2c8c0c-8319-11eb-be00-89c3d0d550f0-6979	\N	NEW	\N	\N	\N	\N
85416	79	D5170C00002/tiny.path.1/file-4026.pdf	\N	D5170C00002-dc39bdd3-8317-11eb-be00-a51f74f8ac83-4026	\N	NEW	\N	\N	\N	\N
83869	79	D5170C00002/tiny.path.1/file-2479.pdf	\N	D5170C00002-dc4aca38-8316-11eb-be00-05438b33230b-2479	\N	NEW	\N	\N	\N	\N
88370	79	D5170C00002/tiny.path.1/file-6980.pdf	\N	D5170C00002-dc5856fd-8319-11eb-be00-3d7dd99691ad-6980	\N	NEW	\N	\N	\N	\N
82491	79	D5170C00002/tiny.path.1/file-1101.pdf	\N	D5170C00002-dc587ae6-8315-11eb-be00-8b84dcb7b37b-1101	\N	NEW	\N	\N	\N	\N
85417	79	D5170C00002/tiny.path.1/file-4027.pdf	\N	D5170C00002-dc5ab354-8317-11eb-be00-434f1d0a85dc-4027	\N	NEW	\N	\N	\N	\N
82492	79	D5170C00002/tiny.path.1/file-1102.pdf	\N	D5170C00002-dc67e437-8315-11eb-be00-37b4fc4512d5-1102	\N	NEW	\N	\N	\N	\N
88371	79	D5170C00002/tiny.path.1/file-6981.pdf	\N	D5170C00002-dc7750ae-8319-11eb-be00-4be7cb3d045f-6981	\N	NEW	\N	\N	\N	\N
83870	79	D5170C00002/tiny.path.1/file-2480.pdf	\N	D5170C00002-dc870fe9-8316-11eb-be00-9b8c96b9816b-2480	\N	NEW	\N	\N	\N	\N
85418	79	D5170C00002/tiny.path.1/file-4028.pdf	\N	D5170C00002-dc959975-8317-11eb-be00-21d97e09f5a5-4028	\N	NEW	\N	\N	\N	\N
82493	79	D5170C00002/tiny.path.1/file-1103.pdf	\N	D5170C00002-dc973198-8315-11eb-be00-6127acd8bb38-1103	\N	NEW	\N	\N	\N	\N
83871	79	D5170C00002/tiny.path.1/file-2481.pdf	\N	D5170C00002-dcd270ca-8316-11eb-be00-47c30abec7f3-2481	\N	NEW	\N	\N	\N	\N
86809	79	D5170C00002/tiny.path.1/file-5419.pdf	\N	D5170C00002-dcd2d384-8318-11eb-be00-1db613cbdf4a-5419	\N	NEW	\N	\N	\N	\N
82494	79	D5170C00002/tiny.path.1/file-1104.pdf	\N	D5170C00002-dcd4afc9-8315-11eb-be00-f53cf7521657-1104	\N	NEW	\N	\N	\N	\N
85419	79	D5170C00002/tiny.path.1/file-4029.pdf	\N	D5170C00002-dce2cf16-8317-11eb-be00-6be40f896508-4029	\N	NEW	\N	\N	\N	\N
86810	79	D5170C00002/tiny.path.1/file-5420.pdf	\N	D5170C00002-dcf305b5-8318-11eb-be00-932c0a049443-5420	\N	NEW	\N	\N	\N	\N
88372	79	D5170C00002/tiny.path.1/file-6982.pdf	\N	D5170C00002-dcf3105f-8319-11eb-be00-b7d3b335b754-6982	\N	NEW	\N	\N	\N	\N
83872	79	D5170C00002/tiny.path.1/file-2482.pdf	\N	D5170C00002-dcf33f3b-8316-11eb-be00-9969d96fed03-2482	\N	NEW	\N	\N	\N	\N
82495	79	D5170C00002/tiny.path.1/file-1105.pdf	\N	D5170C00002-dd007aba-8315-11eb-be00-13094b3b3cd5-1105	\N	NEW	\N	\N	\N	\N
86811	79	D5170C00002/tiny.path.1/file-5421.pdf	\N	D5170C00002-dd01abb6-8318-11eb-be00-b7bb6d6b208b-5421	\N	NEW	\N	\N	\N	\N
83873	79	D5170C00002/tiny.path.1/file-2483.pdf	\N	D5170C00002-dd1ebc0c-8316-11eb-be00-59e8b20b0873-2483	\N	NEW	\N	\N	\N	\N
82496	79	D5170C00002/tiny.path.1/file-1106.pdf	\N	D5170C00002-dd2da53b-8315-11eb-be00-97e56257aec8-1106	\N	NEW	\N	\N	\N	\N
86812	79	D5170C00002/tiny.path.1/file-5422.pdf	\N	D5170C00002-dd2f7277-8318-11eb-be00-497a922185ff-5422	\N	NEW	\N	\N	\N	\N
88373	79	D5170C00002/tiny.path.1/file-6983.pdf	\N	D5170C00002-dd3c7570-8319-11eb-be00-db9114c2ee70-6983	\N	NEW	\N	\N	\N	\N
86813	79	D5170C00002/tiny.path.1/file-5423.pdf	\N	D5170C00002-dd3c91d8-8318-11eb-be00-370ffa2fef35-5423	\N	NEW	\N	\N	\N	\N
83874	79	D5170C00002/tiny.path.1/file-2484.pdf	\N	D5170C00002-dd3ddccd-8316-11eb-be00-559226b901df-2484	\N	NEW	\N	\N	\N	\N
86814	79	D5170C00002/tiny.path.1/file-5424.pdf	\N	D5170C00002-dd4c7059-8318-11eb-be00-2f3685d31a9e-5424	\N	NEW	\N	\N	\N	\N
82497	79	D5170C00002/tiny.path.1/file-1107.pdf	\N	D5170C00002-dd5d40bc-8315-11eb-be00-496cb372f237-1107	\N	NEW	\N	\N	\N	\N
88374	79	D5170C00002/tiny.path.1/file-6984.pdf	\N	D5170C00002-dd6ad871-8319-11eb-be00-3bad0660fa69-6984	\N	NEW	\N	\N	\N	\N
83875	79	D5170C00002/tiny.path.1/file-2485.pdf	\N	D5170C00002-dd6b074e-8316-11eb-be00-9f808e571ef9-2485	\N	NEW	\N	\N	\N	\N
85420	79	D5170C00002/tiny.path.1/file-4030.pdf	\N	D5170C00002-dd6c4a67-8317-11eb-be00-8d68c6b0fedf-4030	\N	NEW	\N	\N	\N	\N
83876	79	D5170C00002/tiny.path.1/file-2486.pdf	\N	D5170C00002-dd7bf73f-8316-11eb-be00-9fcd71f9599d-2486	\N	NEW	\N	\N	\N	\N
82498	79	D5170C00002/tiny.path.1/file-1108.pdf	\N	D5170C00002-dd7c888d-8315-11eb-be00-5bf428968943-1108	\N	NEW	\N	\N	\N	\N
86815	79	D5170C00002/tiny.path.1/file-5425.pdf	\N	D5170C00002-dd89042a-8318-11eb-be00-b9d1b121ebdd-5425	\N	NEW	\N	\N	\N	\N
88375	79	D5170C00002/tiny.path.1/file-6985.pdf	\N	D5170C00002-dd8935e2-8319-11eb-be00-dba89aae3281-6985	\N	NEW	\N	\N	\N	\N
85421	79	D5170C00002/tiny.path.1/file-4031.pdf	\N	D5170C00002-dd899668-8317-11eb-be00-4baab65c8339-4031	\N	NEW	\N	\N	\N	\N
83877	79	D5170C00002/tiny.path.1/file-2487.pdf	\N	D5170C00002-dd8baeb0-8316-11eb-be00-adeb2b2b65fd-2487	\N	NEW	\N	\N	\N	\N
86816	79	D5170C00002/tiny.path.1/file-5426.pdf	\N	D5170C00002-dd8bc34b-8318-11eb-be00-23bafb73a89a-5426	\N	NEW	\N	\N	\N	\N
85422	79	D5170C00002/tiny.path.1/file-4032.pdf	\N	D5170C00002-dd98d8a9-8317-11eb-be00-5f3b09b3d020-4032	\N	NEW	\N	\N	\N	\N
86817	79	D5170C00002/tiny.path.1/file-5427.pdf	\N	D5170C00002-dda788ac-8318-11eb-be00-f94c4ec1d811-5427	\N	NEW	\N	\N	\N	\N
85423	79	D5170C00002/tiny.path.1/file-4033.pdf	\N	D5170C00002-dda7a5ba-8317-11eb-be00-b9d9b4f4e3aa-4033	\N	NEW	\N	\N	\N	\N
85424	79	D5170C00002/tiny.path.1/file-4034.pdf	\N	D5170C00002-dda8b72b-8317-11eb-be00-c50e8ad48636-4034	\N	NEW	\N	\N	\N	\N
82499	79	D5170C00002/tiny.path.1/file-1109.pdf	\N	D5170C00002-dda93dde-8315-11eb-be00-270e283b7dff-1109	\N	NEW	\N	\N	\N	\N
85425	79	D5170C00002/tiny.path.1/file-4035.pdf	\N	D5170C00002-dda97a7c-8317-11eb-be00-5d0f78cbfd30-4035	\N	NEW	\N	\N	\N	\N
85426	79	D5170C00002/tiny.path.1/file-4036.pdf	\N	D5170C00002-ddb7d25d-8317-11eb-be00-59d5e00a3adc-4036	\N	NEW	\N	\N	\N	\N
82500	79	D5170C00002/tiny.path.1/file-1110.pdf	\N	D5170C00002-ddb9918f-8315-11eb-be00-6dac5060c331-1110	\N	NEW	\N	\N	\N	\N
86818	79	D5170C00002/tiny.path.1/file-5428.pdf	\N	D5170C00002-ddc60d2d-8318-11eb-be00-ad93ae7abe40-5428	\N	NEW	\N	\N	\N	\N
85427	79	D5170C00002/tiny.path.1/file-4037.pdf	\N	D5170C00002-ddc762be-8317-11eb-be00-5948109c9e34-4037	\N	NEW	\N	\N	\N	\N
86819	79	D5170C00002/tiny.path.1/file-5429.pdf	\N	D5170C00002-ddd54f6e-8318-11eb-be00-d38eab01d0c5-5429	\N	NEW	\N	\N	\N	\N
88376	79	D5170C00002/tiny.path.1/file-6986.pdf	\N	D5170C00002-ddd7cb13-8319-11eb-be00-d7147327d3b0-6986	\N	NEW	\N	\N	\N	\N
82501	79	D5170C00002/tiny.path.1/file-1111.pdf	\N	D5170C00002-dde4c040-8315-11eb-be00-750cc582b686-1111	\N	NEW	\N	\N	\N	\N
85428	79	D5170C00002/tiny.path.1/file-4038.pdf	\N	D5170C00002-dde54aff-8317-11eb-be00-b1f9584ca193-4038	\N	NEW	\N	\N	\N	\N
88377	79	D5170C00002/tiny.path.1/file-6987.pdf	\N	D5170C00002-dde622f4-8319-11eb-be00-d50eefd8b9da-6987	\N	NEW	\N	\N	\N	\N
86820	79	D5170C00002/tiny.path.1/file-5430.pdf	\N	D5170C00002-ddf5819f-8318-11eb-be00-ad4d42e53a17-5430	\N	NEW	\N	\N	\N	\N
83878	79	D5170C00002/tiny.path.1/file-2488.pdf	\N	D5170C00002-ddf63051-8316-11eb-be00-4f8593c12647-2488	\N	NEW	\N	\N	\N	\N
85429	79	D5170C00002/tiny.path.1/file-4039.pdf	\N	D5170C00002-ddf66200-8317-11eb-be00-71271379f7f0-4039	\N	NEW	\N	\N	\N	\N
85430	79	D5170C00002/tiny.path.1/file-4040.pdf	\N	D5170C00002-de04e0f1-8317-11eb-be00-490fd9ae5995-4040	\N	NEW	\N	\N	\N	\N
86821	79	D5170C00002/tiny.path.1/file-5431.pdf	\N	D5170C00002-de22ac20-8318-11eb-be00-3f2d4797c3e1-5431	\N	NEW	\N	\N	\N	\N
85431	79	D5170C00002/tiny.path.1/file-4041.pdf	\N	D5170C00002-de231752-8317-11eb-be00-d75fb7d8d359-4041	\N	NEW	\N	\N	\N	\N
82502	79	D5170C00002/tiny.path.1/file-1112.pdf	\N	D5170C00002-de2328d1-8315-11eb-be00-197e587dc9d7-1112	\N	NEW	\N	\N	\N	\N
88378	79	D5170C00002/tiny.path.1/file-6988.pdf	\N	D5170C00002-de23a125-8319-11eb-be00-f9aca7d4147b-6988	\N	NEW	\N	\N	\N	\N
83879	79	D5170C00002/tiny.path.1/file-2489.pdf	\N	D5170C00002-de3200d2-8316-11eb-be00-93fb99557ed0-2489	\N	NEW	\N	\N	\N	\N
82503	79	D5170C00002/tiny.path.1/file-1113.pdf	\N	D5170C00002-de332e62-8315-11eb-be00-d719e07457f4-1113	\N	NEW	\N	\N	\N	\N
86822	79	D5170C00002/tiny.path.1/file-5432.pdf	\N	D5170C00002-de426921-8318-11eb-be00-01d8001aa4a4-5432	\N	NEW	\N	\N	\N	\N
85432	79	D5170C00002/tiny.path.1/file-4042.pdf	\N	D5170C00002-de4fcca3-8317-11eb-be00-1bf2c5623527-4042	\N	NEW	\N	\N	\N	\N
83880	79	D5170C00002/tiny.path.1/file-2490.pdf	\N	D5170C00002-de508553-8316-11eb-be00-bbdef4251d08-2490	\N	NEW	\N	\N	\N	\N
82504	79	D5170C00002/tiny.path.1/file-1114.pdf	\N	D5170C00002-de513db3-8315-11eb-be00-a370735fe86a-1114	\N	NEW	\N	\N	\N	\N
86823	79	D5170C00002/tiny.path.1/file-5433.pdf	\N	D5170C00002-de5e7ca2-8318-11eb-be00-0b538a6078a1-5433	\N	NEW	\N	\N	\N	\N
86824	79	D5170C00002/tiny.path.1/file-5434.pdf	\N	D5170C00002-de6e0d03-8318-11eb-be00-c7389dae56b2-5434	\N	NEW	\N	\N	\N	\N
85433	79	D5170C00002/tiny.path.1/file-4043.pdf	\N	D5170C00002-de704cf4-8317-11eb-be00-1773b2bcb0f5-4043	\N	NEW	\N	\N	\N	\N
86825	79	D5170C00002/tiny.path.1/file-5435.pdf	\N	D5170C00002-de70a514-8318-11eb-be00-474e0bf9b0f5-5435	\N	NEW	\N	\N	\N	\N
86826	79	D5170C00002/tiny.path.1/file-5436.pdf	\N	D5170C00002-de8c1c55-8318-11eb-be00-41b54626ebd2-5436	\N	NEW	\N	\N	\N	\N
85434	79	D5170C00002/tiny.path.1/file-4044.pdf	\N	D5170C00002-de8cae95-8317-11eb-be00-7d799501076d-4044	\N	NEW	\N	\N	\N	\N
86827	79	D5170C00002/tiny.path.1/file-5437.pdf	\N	D5170C00002-de9c21e6-8318-11eb-be00-cb9a3b683de6-5437	\N	NEW	\N	\N	\N	\N
83881	79	D5170C00002/tiny.path.1/file-2491.pdf	\N	D5170C00002-de9d1eb4-8316-11eb-be00-5349c9936369-2491	\N	NEW	\N	\N	\N	\N
82505	79	D5170C00002/tiny.path.1/file-1115.pdf	\N	D5170C00002-de9e4c44-8315-11eb-be00-f56208c17e0a-1115	\N	NEW	\N	\N	\N	\N
82506	79	D5170C00002/tiny.path.1/file-1116.pdf	\N	D5170C00002-dead6775-8315-11eb-be00-8f88c0731c37-1116	\N	NEW	\N	\N	\N	\N
86828	79	D5170C00002/tiny.path.1/file-5438.pdf	\N	D5170C00002-deadd527-8318-11eb-be00-5fd6d956ad92-5438	\N	NEW	\N	\N	\N	\N
88379	79	D5170C00002/tiny.path.1/file-6989.pdf	\N	D5170C00002-deb9c6a6-8319-11eb-be00-9597757cd68c-6989	\N	NEW	\N	\N	\N	\N
85435	79	D5170C00002/tiny.path.1/file-4045.pdf	\N	D5170C00002-debbd4e6-8317-11eb-be00-9fdae7228a60-4045	\N	NEW	\N	\N	\N	\N
85436	79	D5170C00002/tiny.path.1/file-4046.pdf	\N	D5170C00002-ded99617-8317-11eb-be00-032548d88efe-4046	\N	NEW	\N	\N	\N	\N
86829	79	D5170C00002/tiny.path.1/file-5439.pdf	\N	D5170C00002-deda3c58-8318-11eb-be00-573abed33c16-5439	\N	NEW	\N	\N	\N	\N
82507	79	D5170C00002/tiny.path.1/file-1117.pdf	\N	D5170C00002-deda91f6-8315-11eb-be00-573e2351d3a6-1117	\N	NEW	\N	\N	\N	\N
85437	79	D5170C00002/tiny.path.1/file-4047.pdf	\N	D5170C00002-def8dde8-8317-11eb-be00-87be86972719-4047	\N	NEW	\N	\N	\N	\N
86830	79	D5170C00002/tiny.path.1/file-5440.pdf	\N	D5170C00002-df06ca99-8318-11eb-be00-3bb4ad871add-5440	\N	NEW	\N	\N	\N	\N
83882	79	D5170C00002/tiny.path.1/file-2492.pdf	\N	D5170C00002-df07a055-8316-11eb-be00-67c42acaf2ec-2492	\N	NEW	\N	\N	\N	\N
82509	79	D5170C00002/tiny.path.1/file-1119.pdf	\N	D5170C00002-df16b097-8315-11eb-be00-c3f399dee237-1118	\N	NEW	\N	\N	\N	\N
85438	79	D5170C00002/tiny.path.1/file-4048.pdf	\N	D5170C00002-df176269-8317-11eb-be00-a9322ac91bde-4048	\N	NEW	\N	\N	\N	\N
83883	79	D5170C00002/tiny.path.1/file-2493.pdf	\N	D5170C00002-df177ed6-8316-11eb-be00-1d6919dd2b42-2493	\N	NEW	\N	\N	\N	\N
86831	79	D5170C00002/tiny.path.1/file-5441.pdf	\N	D5170C00002-df26126a-8318-11eb-be00-ed0dbd46e336-5441	\N	NEW	\N	\N	\N	\N
83884	79	D5170C00002/tiny.path.1/file-2494.pdf	\N	D5170C00002-df29a747-8316-11eb-be00-a17ff7280ea4-2494	\N	NEW	\N	\N	\N	\N
82508	79	D5170C00002/tiny.path.1/file-1118.pdf	\N	D5170C00002-df34e6f8-8315-11eb-be00-6f04f43706e3-1119	\N	NEW	\N	\N	\N	\N
85439	79	D5170C00002/tiny.path.1/file-4049.pdf	\N	D5170C00002-df35bfda-8317-11eb-be00-771869d0aefc-4049	\N	NEW	\N	\N	\N	\N
88380	79	D5170C00002/tiny.path.1/file-6990.pdf	\N	D5170C00002-df436907-8319-11eb-be00-51ae7fb73460-6990	\N	NEW	\N	\N	\N	\N
86832	79	D5170C00002/tiny.path.1/file-5442.pdf	\N	D5170C00002-df4421bb-8318-11eb-be00-e9905a7b4d63-5442	\N	NEW	\N	\N	\N	\N
82510	79	D5170C00002/tiny.path.1/file-1120.pdf	\N	D5170C00002-df45afd9-8315-11eb-be00-f5734ee8c4bc-1120	\N	NEW	\N	\N	\N	\N
83885	79	D5170C00002/tiny.path.1/file-2495.pdf	\N	D5170C00002-df624378-8316-11eb-be00-49ce71cef0ae-2495	\N	NEW	\N	\N	\N	\N
82511	79	D5170C00002/tiny.path.1/file-1121.pdf	\N	D5170C00002-df64345a-8315-11eb-be00-6b0b176c434b-1121	\N	NEW	\N	\N	\N	\N
86833	79	D5170C00002/tiny.path.1/file-5443.pdf	\N	D5170C00002-df72369c-8318-11eb-be00-fb48b4c733db-5443	\N	NEW	\N	\N	\N	\N
83886	79	D5170C00002/tiny.path.1/file-2496.pdf	\N	D5170C00002-df730c59-8316-11eb-be00-4f1699dd4ecd-2496	\N	NEW	\N	\N	\N	\N
82512	79	D5170C00002/tiny.path.1/file-1122.pdf	\N	D5170C00002-df81323b-8315-11eb-be00-c9170ffd1361-1122	\N	NEW	\N	\N	\N	\N
83887	79	D5170C00002/tiny.path.1/file-2497.pdf	\N	D5170C00002-df90cd8a-8316-11eb-be00-6944bdf2b791-2497	\N	NEW	\N	\N	\N	\N
88381	79	D5170C00002/tiny.path.1/file-6991.pdf	\N	D5170C00002-df9ecf78-8319-11eb-be00-49e5610851d7-6991	\N	NEW	\N	\N	\N	\N
82513	79	D5170C00002/tiny.path.1/file-1123.pdf	\N	D5170C00002-df9fb6bc-8315-11eb-be00-5df918bf82dd-1123	\N	NEW	\N	\N	\N	\N
83888	79	D5170C00002/tiny.path.1/file-2498.pdf	\N	D5170C00002-dfae67ab-8316-11eb-be00-73a1022b999a-2498	\N	NEW	\N	\N	\N	\N
86834	79	D5170C00002/tiny.path.1/file-5444.pdf	\N	D5170C00002-dfae7c4d-8318-11eb-be00-bfe12494191d-5444	\N	NEW	\N	\N	\N	\N
85440	79	D5170C00002/tiny.path.1/file-4050.pdf	\N	D5170C00002-dfb1a69b-8317-11eb-be00-8d801dcdf3bf-4050	\N	NEW	\N	\N	\N	\N
83889	79	D5170C00002/tiny.path.1/file-2499.pdf	\N	D5170C00002-dfbf097c-8316-11eb-be00-1b3db9b3cfb8-2499	\N	NEW	\N	\N	\N	\N
82514	79	D5170C00002/tiny.path.1/file-1124.pdf	\N	D5170C00002-dfbf259d-8315-11eb-be00-295ec95fae7f-1124	\N	NEW	\N	\N	\N	\N
83890	79	D5170C00002/tiny.path.1/file-2500.pdf	\N	D5170C00002-dfd0207d-8316-11eb-be00-f34cdf442fb2-2500	\N	NEW	\N	\N	\N	\N
86835	79	D5170C00002/tiny.path.1/file-5445.pdf	\N	D5170C00002-dfdda29e-8318-11eb-be00-0df3dc4da42a-5445	\N	NEW	\N	\N	\N	\N
82515	79	D5170C00002/tiny.path.1/file-1125.pdf	\N	D5170C00002-dfde6d6e-8315-11eb-be00-adc475f710f4-1125	\N	NEW	\N	\N	\N	\N
86836	79	D5170C00002/tiny.path.1/file-5446.pdf	\N	D5170C00002-dffaee9f-8318-11eb-be00-13291269d57a-5446	\N	NEW	\N	\N	\N	\N
85441	79	D5170C00002/tiny.path.1/file-4051.pdf	\N	D5170C00002-e01aefbc-8317-11eb-be00-13aa36fdcc64-4051	\N	NEW	\N	\N	\N	\N
83891	79	D5170C00002/tiny.path.1/file-2501.pdf	\N	D5170C00002-e01b333e-8316-11eb-be00-3d1ac0d93027-2501	\N	NEW	\N	\N	\N	\N
86837	79	D5170C00002/tiny.path.1/file-5447.pdf	\N	D5170C00002-e0286740-8318-11eb-be00-6d1dd35bfbe0-5447	\N	NEW	\N	\N	\N	\N
86838	79	D5170C00002/tiny.path.1/file-5448.pdf	\N	D5170C00002-e04712d1-8318-11eb-be00-61dc67f90568-5448	\N	NEW	\N	\N	\N	\N
82516	79	D5170C00002/tiny.path.1/file-1126.pdf	\N	D5170C00002-e04879df-8315-11eb-be00-858eed78ae9b-1126	\N	NEW	\N	\N	\N	\N
86839	79	D5170C00002/tiny.path.1/file-5449.pdf	\N	D5170C00002-e049aae2-8318-11eb-be00-09a93a1ca7ea-5449	\N	NEW	\N	\N	\N	\N
85442	79	D5170C00002/tiny.path.1/file-4052.pdf	\N	D5170C00002-e05894fd-8317-11eb-be00-eb0297b5bad7-4052	\N	NEW	\N	\N	\N	\N
86840	79	D5170C00002/tiny.path.1/file-5450.pdf	\N	D5170C00002-e0652223-8318-11eb-be00-63719ee9c86f-5450	\N	NEW	\N	\N	\N	\N
86841	79	D5170C00002/tiny.path.1/file-5451.pdf	\N	D5170C00002-e074b284-8318-11eb-be00-fd5930614dec-5451	\N	NEW	\N	\N	\N	\N
86842	79	D5170C00002/tiny.path.1/file-5452.pdf	\N	D5170C00002-e083cdb5-8318-11eb-be00-875af327ed46-5452	\N	NEW	\N	\N	\N	\N
83892	79	D5170C00002/tiny.path.1/file-2502.pdf	\N	D5170C00002-e08566bf-8316-11eb-be00-db0376558af7-2502	\N	NEW	\N	\N	\N	\N
86843	79	D5170C00002/tiny.path.1/file-5453.pdf	\N	D5170C00002-e0a27946-8318-11eb-be00-b90952fdf4c3-5453	\N	NEW	\N	\N	\N	\N
86844	79	D5170C00002/tiny.path.1/file-5454.pdf	\N	D5170C00002-e0a3d8d7-8318-11eb-be00-efdaa84d118b-5454	\N	NEW	\N	\N	\N	\N
82517	79	D5170C00002/tiny.path.1/file-1127.pdf	\N	D5170C00002-e0a5dc20-8315-11eb-be00-5db8f0cc215a-1127	\N	NEW	\N	\N	\N	\N
85443	79	D5170C00002/tiny.path.1/file-4053.pdf	\N	D5170C00002-e0b274ce-8317-11eb-be00-09fb9a90dad5-4053	\N	NEW	\N	\N	\N	\N
86845	79	D5170C00002/tiny.path.1/file-5455.pdf	\N	D5170C00002-e0c0afa8-8318-11eb-be00-8b087d1ee1b5-5455	\N	NEW	\N	\N	\N	\N
83893	79	D5170C00002/tiny.path.1/file-2503.pdf	\N	D5170C00002-e0c15e50-8316-11eb-be00-db87c57ae8db-2503	\N	NEW	\N	\N	\N	\N
86846	79	D5170C00002/tiny.path.1/file-5456.pdf	\N	D5170C00002-e0d04009-8318-11eb-be00-cb297a1f87b4-5456	\N	NEW	\N	\N	\N	\N
88382	79	D5170C00002/tiny.path.1/file-6992.pdf	\N	D5170C00002-e0d098b9-8319-11eb-be00-8be6252dbb3c-6992	\N	NEW	\N	\N	\N	\N
85444	79	D5170C00002/tiny.path.1/file-4054.pdf	\N	D5170C00002-e0e125ef-8317-11eb-be00-4b61e22b1601-4054	\N	NEW	\N	\N	\N	\N
82518	79	D5170C00002/tiny.path.1/file-1128.pdf	\N	D5170C00002-e10fe891-8315-11eb-be00-45dcc10f54fd-1128	\N	NEW	\N	\N	\N	\N
88383	79	D5170C00002/tiny.path.1/file-6993.pdf	\N	D5170C00002-e11d592a-8319-11eb-be00-b5a5ff465a96-6993	\N	NEW	\N	\N	\N	\N
88384	79	D5170C00002/tiny.path.1/file-6994.pdf	\N	D5170C00002-e12c745b-8319-11eb-be00-430a2b91d322-6994	\N	NEW	\N	\N	\N	\N
86847	79	D5170C00002/tiny.path.1/file-5457.pdf	\N	D5170C00002-e12c90da-8318-11eb-be00-756b159de89a-5457	\N	NEW	\N	\N	\N	\N
83894	79	D5170C00002/tiny.path.1/file-2504.pdf	\N	D5170C00002-e14b9cf1-8316-11eb-be00-2f29c53aa07e-2504	\N	NEW	\N	\N	\N	\N
82519	79	D5170C00002/tiny.path.1/file-1129.pdf	\N	D5170C00002-e14bb912-8315-11eb-be00-b5d024dc8adf-1129	\N	NEW	\N	\N	\N	\N
83895	79	D5170C00002/tiny.path.1/file-2505.pdf	\N	D5170C00002-e15a9112-8316-11eb-be00-496dc382f90b-2505	\N	NEW	\N	\N	\N	\N
85445	79	D5170C00002/tiny.path.1/file-4055.pdf	\N	D5170C00002-e15c4860-8317-11eb-be00-0b8722ed67c9-4055	\N	NEW	\N	\N	\N	\N
83896	79	D5170C00002/tiny.path.1/file-2506.pdf	\N	D5170C00002-e1698533-8316-11eb-be00-9b03bed5d73d-2506	\N	NEW	\N	\N	\N	\N
88385	79	D5170C00002/tiny.path.1/file-6995.pdf	\N	D5170C00002-e178717c-8319-11eb-be00-69373fd1db00-6995	\N	NEW	\N	\N	\N	\N
82520	79	D5170C00002/tiny.path.1/file-1130.pdf	\N	D5170C00002-e189d383-8315-11eb-be00-b9462d90f8eb-1130	\N	NEW	\N	\N	\N	\N
88386	79	D5170C00002/tiny.path.1/file-6996.pdf	\N	D5170C00002-e1976b2d-8319-11eb-be00-f52d57af4ba7-6996	\N	NEW	\N	\N	\N	\N
83897	79	D5170C00002/tiny.path.1/file-2507.pdf	\N	D5170C00002-e1a64014-8316-11eb-be00-e5bafac046e5-2507	\N	NEW	\N	\N	\N	\N
82521	79	D5170C00002/tiny.path.1/file-1131.pdf	\N	D5170C00002-e1a76da4-8315-11eb-be00-3da1cd647ab2-1131	\N	NEW	\N	\N	\N	\N
88387	79	D5170C00002/tiny.path.1/file-6997.pdf	\N	D5170C00002-e1b52c5e-8319-11eb-be00-1935b7ca03e7-6997	\N	NEW	\N	\N	\N	\N
86848	79	D5170C00002/tiny.path.1/file-5458.pdf	\N	D5170C00002-e1b6333b-8318-11eb-be00-490daa368fe0-5458	\N	NEW	\N	\N	\N	\N
85446	79	D5170C00002/tiny.path.1/file-4056.pdf	\N	D5170C00002-e1b739a1-8317-11eb-be00-892341067136-4056	\N	NEW	\N	\N	\N	\N
82522	79	D5170C00002/tiny.path.1/file-1132.pdf	\N	D5170C00002-e1b85d95-8315-11eb-be00-0fe0a59b571b-1132	\N	NEW	\N	\N	\N	\N
88388	79	D5170C00002/tiny.path.1/file-6998.pdf	\N	D5170C00002-e1e3413f-8319-11eb-be00-b927df5512b5-6998	\N	NEW	\N	\N	\N	\N
83898	79	D5170C00002/tiny.path.1/file-2508.msg	\N	D5170C00002-e1e59305-8316-11eb-be00-55ed889f562a-2508	\N	NEW	\N	\N	\N	\N
85457	79	D5170C00002/tiny.path.1/file-4067.pdf	\N	D5170C00002-e201fe42-8317-11eb-be00-038d1fa4560b-4057	\N	NEW	\N	\N	\N	\N
82523	79	D5170C00002/tiny.path.1/file-1133.pdf	\N	D5170C00002-e202fb26-8315-11eb-be00-53fdbb6a1f42-1133	\N	NEW	\N	\N	\N	\N
82524	79	D5170C00002/tiny.path.1/file-1134.pdf	\N	D5170C00002-e211a127-8315-11eb-be00-63a1cf368252-1134	\N	NEW	\N	\N	\N	\N
88389	79	D5170C00002/tiny.path.1/file-6999.pdf	\N	D5170C00002-e2215bb0-8319-11eb-be00-15ba0b48d49e-6999	\N	NEW	\N	\N	\N	\N
85447	79	D5170C00002/tiny.path.1/file-4057.pdf	\N	D5170C00002-e221e253-8317-11eb-be00-c75c8fc6f950-4058	\N	NEW	\N	\N	\N	\N
83899	79	D5170C00002/tiny.path.1/file-2509.msg	\N	D5170C00002-e22fbb66-8316-11eb-be00-376b0d216532-2509	\N	NEW	\N	\N	\N	\N
86849	79	D5170C00002/tiny.path.1/file-5459.pdf	\N	D5170C00002-e231cbdc-8318-11eb-be00-3d7b865144a4-5459	\N	NEW	\N	\N	\N	\N
85448	79	D5170C00002/tiny.path.1/file-4058.pdf	\N	D5170C00002-e23f5564-8317-11eb-be00-dd7181b5e1b5-4059	\N	NEW	\N	\N	\N	\N
88390	79	D5170C00002/tiny.path.1/file-7000.pdf	\N	D5170C00002-e23fb921-8319-11eb-be00-d30a74ca889d-7000	\N	NEW	\N	\N	\N	\N
86850	79	D5170C00002/tiny.path.1/file-5460.xlsx	\N	D5170C00002-e24023bd-8318-11eb-be00-790717486aac-5460	\N	NEW	\N	\N	\N	\N
85449	79	D5170C00002/tiny.path.1/file-4059.pdf	\N	D5170C00002-e2419f55-8317-11eb-be00-0ba5c53e3ef6-4060	\N	NEW	\N	\N	\N	\N
83900	79	D5170C00002/tiny.path.1/file-2510.msg	\N	D5170C00002-e24e18d7-8316-11eb-be00-b3fdfe207721-2510	\N	NEW	\N	\N	\N	\N
82525	79	D5170C00002/tiny.path.1/file-1135.pdf	\N	D5170C00002-e25d7738-8315-11eb-be00-972515ca3cdd-1135	\N	NEW	\N	\N	\N	\N
86851	79	D5170C00002/tiny.path.1/file-5461.pdf	\N	D5170C00002-e25f1d6e-8318-11eb-be00-c39947d929ea-5461	\N	NEW	\N	\N	\N	\N
85450	79	D5170C00002/tiny.path.1/file-4060.pdf	\N	D5170C00002-e26ddf76-8317-11eb-be00-fd01bfd4df96-4061	\N	NEW	\N	\N	\N	\N
82526	79	D5170C00002/tiny.path.1/file-1136.pdf	\N	D5170C00002-e27ce619-8315-11eb-be00-8176073a0f03-1136	\N	NEW	\N	\N	\N	\N
85451	79	D5170C00002/tiny.path.1/file-4061.pdf	\N	D5170C00002-e27dbdf7-8317-11eb-be00-b32730ea94f6-4062	\N	NEW	\N	\N	\N	\N
85452	79	D5170C00002/tiny.path.1/file-4062.pdf	\N	D5170C00002-e29ae2e8-8317-11eb-be00-0db63344611b-4063	\N	NEW	\N	\N	\N	\N
83901	79	D5170C00002/tiny.path.1/file-2511.msg	\N	D5170C00002-e29b7588-8316-11eb-be00-952fb44090e5-2511	\N	NEW	\N	\N	\N	\N
85453	79	D5170C00002/tiny.path.1/file-4063.pdf	\N	D5170C00002-e2aae879-8317-11eb-be00-8d890e0fb742-4064	\N	NEW	\N	\N	\N	\N
85454	79	D5170C00002/tiny.path.1/file-4064.pdf	\N	D5170C00002-e2bb8a4a-8317-11eb-be00-ad4ac1a9b88c-4065	\N	NEW	\N	\N	\N	\N
85455	79	D5170C00002/tiny.path.1/file-4065.pdf	\N	D5170C00002-e2d776bb-8317-11eb-be00-3feb45a8d009-4066	\N	NEW	\N	\N	\N	\N
85456	79	D5170C00002/tiny.path.1/file-4066.pdf	\N	D5170C00002-e2d9246c-8317-11eb-be00-fbfa6f86fc62-4067	\N	NEW	\N	\N	\N	\N
82527	79	D5170C00002/tiny.path.1/file-1137.pdf	\N	D5170C00002-e2e7dcea-8315-11eb-be00-7ff8f9eed2be-1137	\N	NEW	\N	\N	\N	\N
86852	79	D5170C00002/tiny.path.1/file-5462.pdf	\N	D5170C00002-e2f6f09f-8318-11eb-be00-297436258699-5462	\N	NEW	\N	\N	\N	\N
85458	79	D5170C00002/tiny.path.1/file-4068.pdf	\N	D5170C00002-e30675fd-8317-11eb-be00-3b3eca53e0e8-4068	\N	NEW	\N	\N	\N	\N
83902	79	D5170C00002/tiny.path.1/file-2512.msg	\N	D5170C00002-e323df69-8316-11eb-be00-15747317863e-2512	\N	NEW	\N	\N	\N	\N
85459	79	D5170C00002/tiny.path.1/file-4069.pdf	\N	D5170C00002-e3332b4e-8317-11eb-be00-856d699353ef-4069	\N	NEW	\N	\N	\N	\N
82528	79	D5170C00002/tiny.path.1/file-1138.pdf	\N	D5170C00002-e343917b-8315-11eb-be00-893ac8ff9566-1138	\N	NEW	\N	\N	\N	\N
85460	79	D5170C00002/tiny.path.1/file-4070.pdf	\N	D5170C00002-e344695f-8317-11eb-be00-dddeaa9a3d11-4070	\N	NEW	\N	\N	\N	\N
82529	79	D5170C00002/tiny.path.1/file-1139.pdf	\N	D5170C00002-e352377c-8315-11eb-be00-9d4bef5295c4-1139	\N	NEW	\N	\N	\N	\N
83903	79	D5170C00002/tiny.path.1/file-2513.msg	\N	D5170C00002-e361d2ca-8316-11eb-be00-85f99aac58d9-2513	\N	NEW	\N	\N	\N	\N
83904	79	D5170C00002/tiny.path.1/file-2514.msg	\N	D5170C00002-e37051bb-8316-11eb-be00-7d71839cacc5-2514	\N	NEW	\N	\N	\N	\N
86853	79	D5170C00002/tiny.path.1/file-5463.pdf	\N	D5170C00002-e37177d0-8318-11eb-be00-3365d765e158-5463	\N	NEW	\N	\N	\N	\N
82530	79	D5170C00002/tiny.path.1/file-1140.pdf	\N	D5170C00002-e371cd6d-8315-11eb-be00-1937b5e10a33-1140	\N	NEW	\N	\N	\N	\N
85461	79	D5170C00002/tiny.path.1/file-4071.pdf	\N	D5170C00002-e3814b50-8317-11eb-be00-510420ec6ac0-4071	\N	NEW	\N	\N	\N	\N
83905	79	D5170C00002/tiny.path.1/file-2515.msg	\N	D5170C00002-e3818fcc-8316-11eb-be00-cd45d62acfa6-2515	\N	NEW	\N	\N	\N	\N
83906	79	D5170C00002/tiny.path.1/file-2516.msg	\N	D5170C00002-e391473d-8316-11eb-be00-4f0481ba7e91-2516	\N	NEW	\N	\N	\N	\N
82531	79	D5170C00002/tiny.path.1/file-1141.pdf	\N	D5170C00002-e3a0a59e-8315-11eb-be00-5b5ebce9c59f-1141	\N	NEW	\N	\N	\N	\N
86854	79	D5170C00002/tiny.path.1/file-5464.pdf	\N	D5170C00002-e3ae80d1-8318-11eb-be00-9309e7215b23-5464	\N	NEW	\N	\N	\N	\N
83907	79	D5170C00002/tiny.path.1/file-2517.msg	\N	D5170C00002-e3bc75ee-8316-11eb-be00-a50fb469c864-2517	\N	NEW	\N	\N	\N	\N
82532	79	D5170C00002/tiny.path.1/file-1142.pdf	\N	D5170C00002-e3bcb91f-8315-11eb-be00-abd717b57d55-1142	\N	NEW	\N	\N	\N	\N
85462	79	D5170C00002/tiny.path.1/file-4072.pdf	\N	D5170C00002-e3bcf4c1-8317-11eb-be00-79c18d4fa55b-4072	\N	NEW	\N	\N	\N	\N
82533	79	D5170C00002/tiny.path.1/file-1143.pdf	\N	D5170C00002-e3cbfb60-8315-11eb-be00-892593c1ee87-1143	\N	NEW	\N	\N	\N	\N
82534	79	D5170C00002/tiny.path.1/file-1144.pdf	\N	D5170C00002-e3cdd021-8315-11eb-be00-034319d9b456-1144	\N	NEW	\N	\N	\N	\N
83908	79	D5170C00002/tiny.path.1/file-2518.msg	\N	D5170C00002-e3ce021f-8316-11eb-be00-0df2f7066223-2518	\N	NEW	\N	\N	\N	\N
86855	79	D5170C00002/tiny.path.1/file-5465.pdf	\N	D5170C00002-e3ce3dd2-8318-11eb-be00-01063768c309-5465	\N	NEW	\N	\N	\N	\N
86856	79	D5170C00002/tiny.path.1/file-5466.pdf	\N	D5170C00002-e3db5d33-8318-11eb-be00-b5534a4f35c4-5466	\N	NEW	\N	\N	\N	\N
82535	79	D5170C00002/tiny.path.1/file-1145.pdf	\N	D5170C00002-e3dc9d32-8315-11eb-be00-0128258b268b-1145	\N	NEW	\N	\N	\N	\N
86857	79	D5170C00002/tiny.path.1/file-5467.pdf	\N	D5170C00002-e3ea7864-8318-11eb-be00-71307ae1332d-5467	\N	NEW	\N	\N	\N	\N
82536	79	D5170C00002/tiny.path.1/file-1146.pdf	\N	D5170C00002-e3eb1c23-8315-11eb-be00-635c540d3c4f-1146	\N	NEW	\N	\N	\N	\N
86858	79	D5170C00002/tiny.path.1/file-5468.pdf	\N	D5170C00002-e3ec2615-8318-11eb-be00-c955abbefe40-5468	\N	NEW	\N	\N	\N	\N
83909	79	D5170C00002/tiny.path.1/file-2519.msg	\N	D5170C00002-e3ec5e90-8316-11eb-be00-9ddd62479435-2519	\N	NEW	\N	\N	\N	\N
86859	79	D5170C00002/tiny.path.1/file-5469.pdf	\N	D5170C00002-e3f96c86-8318-11eb-be00-9f4131b87a2a-5469	\N	NEW	\N	\N	\N	\N
82537	79	D5170C00002/tiny.path.1/file-1147.pdf	\N	D5170C00002-e3fbbdf4-8315-11eb-be00-8b64ab3ccfed-1147	\N	NEW	\N	\N	\N	\N
86860	79	D5170C00002/tiny.path.1/file-5470.pdf	\N	D5170C00002-e3fbdd87-8318-11eb-be00-f387238e41b5-5470	\N	NEW	\N	\N	\N	\N
85463	79	D5170C00002/tiny.path.1/file-4073.msg	\N	D5170C00002-e408cad2-8317-11eb-be00-39e2a040e2c4-4073	\N	NEW	\N	\N	\N	\N
82538	79	D5170C00002/tiny.path.1/file-1148.pdf	\N	D5170C00002-e40a3ce5-8315-11eb-be00-0393521e096f-1148	\N	NEW	\N	\N	\N	\N
86866	79	D5170C00002/tiny.path.1/file-5476.pdf	\N	D5170C00002-e40a8388-8318-11eb-be00-dfcb5b69be55-5471	\N	NEW	\N	\N	\N	\N
82539	79	D5170C00002/tiny.path.1/file-1149.pdf	\N	D5170C00002-e40b0036-8315-11eb-be00-dfdc3d0dde62-1149	\N	NEW	\N	\N	\N	\N
83910	79	D5170C00002/tiny.path.1/file-2520.msg	\N	D5170C00002-e40b3131-8316-11eb-be00-6767db594411-2520	\N	NEW	\N	\N	\N	\N
82540	79	D5170C00002/tiny.path.1/file-1150.pdf	\N	D5170C00002-e41846a7-8315-11eb-be00-d53aadc24ca7-1150	\N	NEW	\N	\N	\N	\N
85464	79	D5170C00002/tiny.path.1/file-4074.msg	\N	D5170C00002-e4270133-8317-11eb-be00-2320ba3bdba4-4074	\N	NEW	\N	\N	\N	\N
83911	79	D5170C00002/tiny.path.1/file-2521.msg	\N	D5170C00002-e427e0f2-8316-11eb-be00-fb74c88ddf74-2521	\N	NEW	\N	\N	\N	\N
82546	79	D5170C00002/tiny.path.1/file-1156.pdf	\N	D5170C00002-e4282528-8315-11eb-be00-4f028672ab13-1151	\N	NEW	\N	\N	\N	\N
86861	79	D5170C00002/tiny.path.1/file-5471.pdf	\N	D5170C00002-e4369c99-8318-11eb-be00-a95fc4c49ff0-5472	\N	NEW	\N	\N	\N	\N
82541	79	D5170C00002/tiny.path.1/file-1151.pdf	\N	D5170C00002-e436a419-8315-11eb-be00-95f5806124c3-1152	\N	NEW	\N	\N	\N	\N
83912	79	D5170C00002/tiny.path.1/file-2522.msg	\N	D5170C00002-e436ae03-8316-11eb-be00-6bd88c80dbf6-2522	\N	NEW	\N	\N	\N	\N
86862	79	D5170C00002/tiny.path.1/file-5472.pdf	\N	D5170C00002-e43786fa-8318-11eb-be00-b54a33789d62-5473	\N	NEW	\N	\N	\N	\N
86863	79	D5170C00002/tiny.path.1/file-5473.pdf	\N	D5170C00002-e438715b-8318-11eb-be00-69eade9c7e59-5474	\N	NEW	\N	\N	\N	\N
85465	79	D5170C00002/tiny.path.1/file-4075.msg	\N	D5170C00002-e4390294-8317-11eb-be00-d9d0a0e937cc-4075	\N	NEW	\N	\N	\N	\N
82542	79	D5170C00002/tiny.path.1/file-1152.pdf	\N	D5170C00002-e446829a-8315-11eb-be00-e355439b887a-1153	\N	NEW	\N	\N	\N	\N
83913	79	D5170C00002/tiny.path.1/file-2523.msg	\N	D5170C00002-e44776e4-8316-11eb-be00-fdda3c224119-2523	\N	NEW	\N	\N	\N	\N
85466	79	D5170C00002/tiny.path.1/file-4076.msg	\N	D5170C00002-e454a0e5-8317-11eb-be00-91ecab7ab4c6-4076	\N	NEW	\N	\N	\N	\N
86864	79	D5170C00002/tiny.path.1/file-5474.pdf	\N	D5170C00002-e455bd5c-8318-11eb-be00-7157992360ff-5475	\N	NEW	\N	\N	\N	\N
82543	79	D5170C00002/tiny.path.1/file-1153.pdf	\N	D5170C00002-e455c4db-8315-11eb-be00-6f005e9860d8-1154	\N	NEW	\N	\N	\N	\N
82544	79	D5170C00002/tiny.path.1/file-1154.pdf	\N	D5170C00002-e4585cec-8315-11eb-be00-3777f1e31493-1155	\N	NEW	\N	\N	\N	\N
85467	79	D5170C00002/tiny.path.1/file-4077.msg	\N	D5170C00002-e4640a36-8317-11eb-be00-57298775a6cd-4077	\N	NEW	\N	\N	\N	\N
83914	79	D5170C00002/tiny.path.1/file-2524.msg	\N	D5170C00002-e465d455-8316-11eb-be00-43ddf9714b13-2524	\N	NEW	\N	\N	\N	\N
82545	79	D5170C00002/tiny.path.1/file-1155.pdf	\N	D5170C00002-e465f17d-8315-11eb-be00-97fe05535f98-1156	\N	NEW	\N	\N	\N	\N
85468	79	D5170C00002/tiny.path.1/file-4078.msg	\N	D5170C00002-e4734c77-8317-11eb-be00-d1f03a23d773-4078	\N	NEW	\N	\N	\N	\N
86865	79	D5170C00002/tiny.path.1/file-5475.pdf	\N	D5170C00002-e4752c3d-8318-11eb-be00-a766fb604772-5476	\N	NEW	\N	\N	\N	\N
83915	79	D5170C00002/tiny.path.1/file-2525.msg	\N	D5170C00002-e47564b6-8316-11eb-be00-092c137dc55a-2525	\N	NEW	\N	\N	\N	\N
85469	79	D5170C00002/tiny.path.1/file-4079.msg	\N	D5170C00002-e482b5c8-8317-11eb-be00-b9920c0cb1e2-4079	\N	NEW	\N	\N	\N	\N
82547	79	D5170C00002/tiny.path.1/file-1157.pdf	\N	D5170C00002-e48475fe-8315-11eb-be00-b5db23b881cb-1157	\N	NEW	\N	\N	\N	\N
82548	79	D5170C00002/tiny.path.1/file-1158.pdf	\N	D5170C00002-e491e37f-8315-11eb-be00-33ecd9dbdc26-1158	\N	NEW	\N	\N	\N	\N
86867	79	D5170C00002/tiny.path.1/file-5477.pdf	\N	D5170C00002-e4933b8e-8318-11eb-be00-817b7c02f7e9-5477	\N	NEW	\N	\N	\N	\N
83916	79	D5170C00002/tiny.path.1/file-2526.msg	\N	D5170C00002-e4934cf7-8316-11eb-be00-b11ec90cc88f-2526	\N	NEW	\N	\N	\N	\N
85470	79	D5170C00002/tiny.path.1/file-4080.msg	\N	D5170C00002-e4935799-8317-11eb-be00-1123b778a64d-4080	\N	NEW	\N	\N	\N	\N
82549	79	D5170C00002/tiny.path.1/file-1159.pdf	\N	D5170C00002-e493b840-8315-11eb-be00-697a6da0e589-1159	\N	NEW	\N	\N	\N	\N
85471	79	D5170C00002/tiny.path.1/file-4081.msg	\N	D5170C00002-e4a3361a-8317-11eb-be00-23f72d9b7c09-4081	\N	NEW	\N	\N	\N	\N
82550	79	D5170C00002/tiny.path.1/file-1160.pdf	\N	D5170C00002-e4b08f11-8315-11eb-be00-8384986b10aa-1160	\N	NEW	\N	\N	\N	\N
85472	79	D5170C00002/tiny.path.1/file-4082.msg	\N	D5170C00002-e4c256db-8317-11eb-be00-6bad367216db-4082	\N	NEW	\N	\N	\N	\N
83917	79	D5170C00002/tiny.path.1/file-2527.msg	\N	D5170C00002-e4cef668-8316-11eb-be00-bf1eb4927e01-2527	\N	NEW	\N	\N	\N	\N
85473	79	D5170C00002/tiny.path.1/file-4083.msg	\N	D5170C00002-e4de434c-8317-11eb-be00-1d53a41ec229-4083	\N	NEW	\N	\N	\N	\N
82551	79	D5170C00002/tiny.path.1/file-1161.pdf	\N	D5170C00002-e4e00382-8315-11eb-be00-f5f66f5bd9c9-1161	\N	NEW	\N	\N	\N	\N
86868	79	D5170C00002/tiny.path.1/file-5478.pdf	\N	D5170C00002-e4eccd3f-8318-11eb-be00-d7fc55ca2af4-5478	\N	NEW	\N	\N	\N	\N
85474	79	D5170C00002/tiny.path.1/file-4084.msg	\N	D5170C00002-e4ff5fdd-8317-11eb-be00-0dde205bb40f-4084	\N	NEW	\N	\N	\N	\N
83918	79	D5170C00002/tiny.path.1/file-2528.msg	\N	D5170C00002-e50cc2b9-8316-11eb-be00-990a8d7d31bf-2528	\N	NEW	\N	\N	\N	\N
86869	79	D5170C00002/tiny.path.1/file-5479.pdf	\N	D5170C00002-e50d9bb0-8318-11eb-be00-b194494f2d4e-5479	\N	NEW	\N	\N	\N	\N
85475	79	D5170C00002/tiny.path.1/file-4085.msg	\N	D5170C00002-e51b4c4e-8317-11eb-be00-e79a9d33f3fb-4085	\N	NEW	\N	\N	\N	\N
82552	79	D5170C00002/tiny.path.1/file-1162.pdf	\N	D5170C00002-e51d5aa3-8315-11eb-be00-79cd2c8287c4-1162	\N	NEW	\N	\N	\N	\N
85476	79	D5170C00002/tiny.path.1/file-4086.msg	\N	D5170C00002-e52d269f-8317-11eb-be00-4f1dbf883234-4086	\N	NEW	\N	\N	\N	\N
86870	79	D5170C00002/tiny.path.1/file-5480.pdf	\N	D5170C00002-e53a5101-8318-11eb-be00-13a9b53e75b1-5480	\N	NEW	\N	\N	\N	\N
82553	79	D5170C00002/tiny.path.1/file-1163.pdf	\N	D5170C00002-e53d17a4-8315-11eb-be00-8724254ebb3b-1163	\N	NEW	\N	\N	\N	\N
85477	79	D5170C00002/tiny.path.1/file-4087.msg	\N	D5170C00002-e54ac0c0-8317-11eb-be00-29e751d3164b-4087	\N	NEW	\N	\N	\N	\N
83919	79	D5170C00002/tiny.path.1/file-2529.pdf	\N	D5170C00002-e559350a-8316-11eb-be00-95dbfc17f8fb-2529	\N	NEW	\N	\N	\N	\N
86871	79	D5170C00002/tiny.path.1/file-5481.pdf	\N	D5170C00002-e567f0b2-8318-11eb-be00-b1a4a9c86063-5481	\N	NEW	\N	\N	\N	\N
85478	79	D5170C00002/tiny.path.1/file-4088.msg	\N	D5170C00002-e56833d1-8317-11eb-be00-c90c64b5995e-4088	\N	NEW	\N	\N	\N	\N
82563	79	D5170C00002/tiny.path.1/file-1173.pdf	\N	D5170C00002-e5697ed5-8315-11eb-be00-c9f6e98c2905-1164	\N	NEW	\N	\N	\N	\N
82554	79	D5170C00002/tiny.path.1/file-1164.msg	\N	D5170C00002-e579ab76-8315-11eb-be00-e9a08f572272-1165	\N	NEW	\N	\N	\N	\N
85479	79	D5170C00002/tiny.path.1/file-4089.msg	\N	D5170C00002-e5864322-8317-11eb-be00-0707a702410e-4089	\N	NEW	\N	\N	\N	\N
86872	79	D5170C00002/tiny.path.1/file-5482.pdf	\N	D5170C00002-e587adb3-8318-11eb-be00-ed0ec5243741-5482	\N	NEW	\N	\N	\N	\N
82555	79	D5170C00002/tiny.path.1/file-1165.msg	\N	D5170C00002-e587b537-8315-11eb-be00-d54e5e46cc64-1166	\N	NEW	\N	\N	\N	\N
83920	79	D5170C00002/tiny.path.1/file-2530.pdf	\N	D5170C00002-e59553ab-8316-11eb-be00-059be2815a8b-2530	\N	NEW	\N	\N	\N	\N
85480	79	D5170C00002/tiny.path.1/file-4090.msg	\N	D5170C00002-e596e4f3-8317-11eb-be00-5fdeacbe09bf-4090	\N	NEW	\N	\N	\N	\N
82556	79	D5170C00002/tiny.path.1/file-1166.msg	\N	D5170C00002-e5976ca8-8315-11eb-be00-57a3f938959c-1167	\N	NEW	\N	\N	\N	\N
86873	79	D5170C00002/tiny.path.1/file-5483.pdf	\N	D5170C00002-e5a40f54-8318-11eb-be00-6d4ca015f9cb-5483	\N	NEW	\N	\N	\N	\N
82557	79	D5170C00002/tiny.path.1/file-1167.msg	\N	D5170C00002-e5a6d5f9-8315-11eb-be00-8b8fc0f05558-1168	\N	NEW	\N	\N	\N	\N
83921	79	D5170C00002/tiny.path.1/file-2531.pdf	\N	D5170C00002-e5b3d82c-8316-11eb-be00-eb6f7fad982c-2531	\N	NEW	\N	\N	\N	\N
85481	79	D5170C00002/tiny.path.1/file-4091.msg	\N	D5170C00002-e5b3e2d4-8317-11eb-be00-09e16ca7f8c4-4091	\N	NEW	\N	\N	\N	\N
83922	79	D5170C00002/tiny.path.1/file-2532.pdf	\N	D5170C00002-e5c31a6d-8316-11eb-be00-e94cc65ebb0b-2532	\N	NEW	\N	\N	\N	\N
85482	79	D5170C00002/tiny.path.1/file-4092.msg	\N	D5170C00002-e5c34c25-8317-11eb-be00-9542d907b787-4092	\N	NEW	\N	\N	\N	\N
86874	79	D5170C00002/tiny.path.1/file-5484.pdf	\N	D5170C00002-e5d29965-8318-11eb-be00-85af02eb81e1-5484	\N	NEW	\N	\N	\N	\N
85483	79	D5170C00002/tiny.path.1/file-4093.msg	\N	D5170C00002-e5d41506-8317-11eb-be00-0d875426be4e-4093	\N	NEW	\N	\N	\N	\N
85484	79	D5170C00002/tiny.path.1/file-4094.msg	\N	D5170C00002-e5e3a567-8317-11eb-be00-b143a94c8308-4094	\N	NEW	\N	\N	\N	\N
82558	79	D5170C00002/tiny.path.1/file-1168.msg	\N	D5170C00002-e5e4542a-8315-11eb-be00-334530b476a1-1169	\N	NEW	\N	\N	\N	\N
82559	79	D5170C00002/tiny.path.1/file-1169.msg	\N	D5170C00002-e5f1e8bb-8315-11eb-be00-d3a782639e57-1170	\N	NEW	\N	\N	\N	\N
85485	79	D5170C00002/tiny.path.1/file-4095.msg	\N	D5170C00002-e5f30eb8-8317-11eb-be00-b34409b50fcd-4095	\N	NEW	\N	\N	\N	\N
82560	79	D5170C00002/tiny.path.1/file-1170.msg	\N	D5170C00002-e602ffbc-8315-11eb-be00-2ffeabe5a14e-1171	\N	NEW	\N	\N	\N	\N
85486	79	D5170C00002/tiny.path.1/file-4096.msg	\N	D5170C00002-e60f9769-8317-11eb-be00-574b3db7a649-4096	\N	NEW	\N	\N	\N	\N
82561	79	D5170C00002/tiny.path.1/file-1171.msg	\N	D5170C00002-e612690d-8315-11eb-be00-cbfbc13f263c-1172	\N	NEW	\N	\N	\N	\N
86875	79	D5170C00002/tiny.path.1/file-5485.pdf	\N	D5170C00002-e63ca5d6-8318-11eb-be00-157ae232d5ba-5485	\N	NEW	\N	\N	\N	\N
83923	79	D5170C00002/tiny.path.1/file-2533.pdf	\N	D5170C00002-e63f4f4e-8316-11eb-be00-2f264d0fc914-2533	\N	NEW	\N	\N	\N	\N
85487	79	D5170C00002/tiny.path.1/file-4097.msg	\N	D5170C00002-e64e752a-8317-11eb-be00-35173e6a7e37-4097	\N	NEW	\N	\N	\N	\N
82562	79	D5170C00002/tiny.path.1/file-1172.msg	\N	D5170C00002-e65d2dae-8315-11eb-be00-ffaec60316dd-1173	\N	NEW	\N	\N	\N	\N
85488	79	D5170C00002/tiny.path.1/file-4098.msg	\N	D5170C00002-e66b4bfb-8317-11eb-be00-e70c932dfd08-4098	\N	NEW	\N	\N	\N	\N
82564	79	D5170C00002/tiny.path.1/file-1174.pdf	\N	D5170C00002-e6a951df-8315-11eb-be00-6f829448c748-1174	\N	NEW	\N	\N	\N	\N
82565	79	D5170C00002/tiny.path.1/file-1175.pdf	\N	D5170C00002-e6c7af50-8315-11eb-be00-9f50ce584696-1175	\N	NEW	\N	\N	\N	\N
82566	79	D5170C00002/tiny.path.1/file-1176.pdf	\N	D5170C00002-e6d5e021-8315-11eb-be00-eb4fbba4e3fc-1176	\N	NEW	\N	\N	\N	\N
86876	79	D5170C00002/tiny.path.1/file-5486.pdf	\N	D5170C00002-e702dc07-8318-11eb-be00-55e1c9cd3c1e-5486	\N	NEW	\N	\N	\N	\N
82567	79	D5170C00002/tiny.path.1/file-1177.pdf	\N	D5170C00002-e7133742-8315-11eb-be00-3195dbbf39f3-1177	\N	NEW	\N	\N	\N	\N
83924	79	D5170C00002/tiny.path.1/file-2534.pdf	\N	D5170C00002-e7158b0f-8316-11eb-be00-9948a573a510-2534	\N	NEW	\N	\N	\N	\N
86877	79	D5170C00002/tiny.path.1/file-5487.pdf	\N	D5170C00002-e7329e98-8318-11eb-be00-ff9e62d360ab-5487	\N	NEW	\N	\N	\N	\N
85489	79	D5170C00002/tiny.path.1/file-4099.msg	\N	D5170C00002-e734685c-8317-11eb-be00-2f40444ee62f-4099	\N	NEW	\N	\N	\N	\N
82568	79	D5170C00002/tiny.path.1/file-1178.pdf	\N	D5170C00002-e7414c23-8315-11eb-be00-1fa725785e97-1178	\N	NEW	\N	\N	\N	\N
83925	79	D5170C00002/tiny.path.1/file-2535.pdf	\N	D5170C00002-e74fade0-8316-11eb-be00-f5e707831da6-2535	\N	NEW	\N	\N	\N	\N
86878	79	D5170C00002/tiny.path.1/file-5488.pdf	\N	D5170C00002-e75038b9-8318-11eb-be00-ad2c43f3ca39-5488	\N	NEW	\N	\N	\N	\N
85490	79	D5170C00002/tiny.path.1/file-4100.msg	\N	D5170C00002-e75f21dd-8317-11eb-be00-95f3c2ad2bba-4100	\N	NEW	\N	\N	\N	\N
83926	79	D5170C00002/tiny.path.1/file-2536.pdf	\N	D5170C00002-e761af41-8316-11eb-be00-053349bb66b2-2536	\N	NEW	\N	\N	\N	\N
83927	79	D5170C00002/tiny.path.1/file-2537.pdf	\N	D5170C00002-e77efb42-8316-11eb-be00-5fdf0f1a69aa-2537	\N	NEW	\N	\N	\N	\N
86879	79	D5170C00002/tiny.path.1/file-5489.pdf	\N	D5170C00002-e77f37fa-8318-11eb-be00-7f8b58d6fa68-5489	\N	NEW	\N	\N	\N	\N
83928	79	D5170C00002/tiny.path.1/file-2538.pdf	\N	D5170C00002-e78eb2b3-8316-11eb-be00-95f40bdead2c-2538	\N	NEW	\N	\N	\N	\N
85491	79	D5170C00002/tiny.path.1/file-4101.msg	\N	D5170C00002-e79c78fe-8317-11eb-be00-47ce20496d7c-4101	\N	NEW	\N	\N	\N	\N
83929	79	D5170C00002/tiny.path.1/file-2539.pdf	\N	D5170C00002-e79e4314-8316-11eb-be00-615da3fb0740-2539	\N	NEW	\N	\N	\N	\N
82569	79	D5170C00002/tiny.path.1/file-1179.pdf	\N	D5170C00002-e79e8754-8315-11eb-be00-9b2398844b7f-1179	\N	NEW	\N	\N	\N	\N
83930	79	D5170C00002/tiny.path.1/file-2540.pdf	\N	D5170C00002-e7acc205-8316-11eb-be00-0981348a8052-2540	\N	NEW	\N	\N	\N	\N
82570	79	D5170C00002/tiny.path.1/file-1180.pdf	\N	D5170C00002-e7aeb3f5-8315-11eb-be00-ff538ca08386-1180	\N	NEW	\N	\N	\N	\N
83931	79	D5170C00002/tiny.path.1/file-2541.pdf	\N	D5170C00002-e7bc0446-8316-11eb-be00-a5859c301239-2541	\N	NEW	\N	\N	\N	\N
82571	79	D5170C00002/tiny.path.1/file-1181.pdf	\N	D5170C00002-e7bd8106-8315-11eb-be00-89cfed24aff1-1181	\N	NEW	\N	\N	\N	\N
82572	79	D5170C00002/tiny.path.1/file-1182.pdf	\N	D5170C00002-e7ccc347-8315-11eb-be00-7f43f7773d63-1182	\N	NEW	\N	\N	\N	\N
83932	79	D5170C00002/tiny.path.1/file-2542.pdf	\N	D5170C00002-e7d8db17-8316-11eb-be00-13f1bdf8cb7b-2542	\N	NEW	\N	\N	\N	\N
82573	79	D5170C00002/tiny.path.1/file-1183.pdf	\N	D5170C00002-e7db1b28-8315-11eb-be00-fd3a2770d4ea-1183	\N	NEW	\N	\N	\N	\N
82574	79	D5170C00002/tiny.path.1/file-1184.pdf	\N	D5170C00002-e7e888a9-8315-11eb-be00-cb0ac0efb166-1184	\N	NEW	\N	\N	\N	\N
86880	79	D5170C00002/tiny.path.1/file-5490.pdf	\N	D5170C00002-e7f7271b-8318-11eb-be00-9951581f4a8f-5490	\N	NEW	\N	\N	\N	\N
85492	79	D5170C00002/tiny.path.1/file-4102.pdf	\N	D5170C00002-e7f7432f-8317-11eb-be00-19c010664dcb-4102	\N	NEW	\N	\N	\N	\N
83933	79	D5170C00002/tiny.path.1/file-2543.pdf	\N	D5170C00002-e8098808-8316-11eb-be00-41d21ed4bc4c-2543	\N	NEW	\N	\N	\N	\N
86881	79	D5170C00002/tiny.path.1/file-5491.pdf	\N	D5170C00002-e81620cc-8318-11eb-be00-53dc7b1164ed-5491	\N	NEW	\N	\N	\N	\N
86882	79	D5170C00002/tiny.path.1/file-5492.pdf	\N	D5170C00002-e827acfd-8318-11eb-be00-0f1810e13808-5492	\N	NEW	\N	\N	\N	\N
82575	79	D5170C00002/tiny.path.1/file-1185.pdf	\N	D5170C00002-e836337a-8315-11eb-be00-5b477fe3fd8d-1185	\N	NEW	\N	\N	\N	\N
83934	79	D5170C00002/tiny.path.1/file-2544.pdf	\N	D5170C00002-e8363d59-8316-11eb-be00-9b168ade9c12-2544	\N	NEW	\N	\N	\N	\N
86883	79	D5170C00002/tiny.path.1/file-5493.pdf	\N	D5170C00002-e836ef3e-8318-11eb-be00-a1b30edf7687-5493	\N	NEW	\N	\N	\N	\N
83935	79	D5170C00002/tiny.path.1/file-2545.pdf	\N	D5170C00002-e845a6aa-8316-11eb-be00-adc55b9f53d8-2545	\N	NEW	\N	\N	\N	\N
86884	79	D5170C00002/tiny.path.1/file-5494.pdf	\N	D5170C00002-e8460a6f-8318-11eb-be00-fbdb8bfaed04-5494	\N	NEW	\N	\N	\N	\N
86885	79	D5170C00002/tiny.path.1/file-5495.pdf	\N	D5170C00002-e86419c0-8318-11eb-be00-29cf2a117044-5495	\N	NEW	\N	\N	\N	\N
83936	79	D5170C00002/tiny.path.1/file-2546.pdf	\N	D5170C00002-e872830b-8316-11eb-be00-fd63ddeeccd6-2546	\N	NEW	\N	\N	\N	\N
85493	79	D5170C00002/tiny.path.1/file-4103.pdf	\N	D5170C00002-e87302e0-8317-11eb-be00-d1fb33084b2d-4103	\N	NEW	\N	\N	\N	\N
82576	79	D5170C00002/tiny.path.1/file-1186.pdf	\N	D5170C00002-e873d8bb-8315-11eb-be00-77777991a938-1186	\N	NEW	\N	\N	\N	\N
86886	79	D5170C00002/tiny.path.1/file-5496.pdf	\N	D5170C00002-e8807b61-8318-11eb-be00-95d1bb97ff39-5496	\N	NEW	\N	\N	\N	\N
85494	79	D5170C00002/tiny.path.1/file-4104.pdf	\N	D5170C00002-e8826c31-8317-11eb-be00-2975d17d6816-4104	\N	NEW	\N	\N	\N	\N
86887	79	D5170C00002/tiny.path.1/file-5497.pdf	\N	D5170C00002-e8836192-8318-11eb-be00-6b07f16c7db0-5497	\N	NEW	\N	\N	\N	\N
85495	79	D5170C00002/tiny.path.1/file-4105.pdf	\N	D5170C00002-e88fd9b2-8317-11eb-be00-8fc929c58f36-4105	\N	NEW	\N	\N	\N	\N
83937	79	D5170C00002/tiny.path.1/file-2547.pdf	\N	D5170C00002-e890e07c-8316-11eb-be00-87a24ff2dee4-2547	\N	NEW	\N	\N	\N	\N
86888	79	D5170C00002/tiny.path.1/file-5498.pdf	\N	D5170C00002-e8911d33-8318-11eb-be00-f1f387b0a057-5498	\N	NEW	\N	\N	\N	\N
86889	79	D5170C00002/tiny.path.1/file-5499.pdf	\N	D5170C00002-e8922ea4-8318-11eb-be00-e39190032dcc-5499	\N	NEW	\N	\N	\N	\N
85496	79	D5170C00002/tiny.path.1/file-4106.pdf	\N	D5170C00002-e89f1bf3-8317-11eb-be00-eb86531c3e8f-4106	\N	NEW	\N	\N	\N	\N
85497	79	D5170C00002/tiny.path.1/file-4107.pdf	\N	D5170C00002-e8a07b84-8317-11eb-be00-79626f2343d4-4107	\N	NEW	\N	\N	\N	\N
83938	79	D5170C00002/tiny.path.1/file-2548.pdf	\N	D5170C00002-e8a10d1d-8316-11eb-be00-9d826c99cadd-2548	\N	NEW	\N	\N	\N	\N
85498	79	D5170C00002/tiny.path.1/file-4108.pdf	\N	D5170C00002-e8af4895-8317-11eb-be00-a558b086ec4d-4108	\N	NEW	\N	\N	\N	\N
86890	79	D5170C00002/tiny.path.1/file-5500.pdf	\N	D5170C00002-e8af5395-8318-11eb-be00-a14ff34c301f-5500	\N	NEW	\N	\N	\N	\N
86891	79	D5170C00002/tiny.path.1/file-5501.pdf	\N	D5170C00002-e8bfa746-8318-11eb-be00-0db58de56d67-5501	\N	NEW	\N	\N	\N	\N
82577	79	D5170C00002/tiny.path.1/file-1187.pdf	\N	D5170C00002-e8c023fc-8315-11eb-be00-2331ad4aa59f-1187	\N	NEW	\N	\N	\N	\N
86892	79	D5170C00002/tiny.path.1/file-5502.pdf	\N	D5170C00002-e8dc2ff7-8318-11eb-be00-9b89725ff295-5502	\N	NEW	\N	\N	\N	\N
85499	79	D5170C00002/tiny.path.1/file-4109.pdf	\N	D5170C00002-e8dc4c06-8317-11eb-be00-1fafee519f6b-4109	\N	NEW	\N	\N	\N	\N
86893	79	D5170C00002/tiny.path.1/file-5503.pdf	\N	D5170C00002-e8eb4b28-8318-11eb-be00-c55fdfe71cb0-5503	\N	NEW	\N	\N	\N	\N
86894	79	D5170C00002/tiny.path.1/file-5504.pdf	\N	D5170C00002-e8fa8d69-8318-11eb-be00-a5878502c4c6-5504	\N	NEW	\N	\N	\N	\N
83939	79	D5170C00002/tiny.path.1/file-2549.pdf	\N	D5170C00002-e8faecee-8316-11eb-be00-93e6e6124e50-2549	\N	NEW	\N	\N	\N	\N
82578	79	D5170C00002/tiny.path.1/file-1188.pdf	\N	D5170C00002-e90cbd5d-8315-11eb-be00-89c4c4c629c8-1188	\N	NEW	\N	\N	\N	\N
85500	79	D5170C00002/tiny.path.1/file-4110.pdf	\N	D5170C00002-e938eaf7-8317-11eb-be00-f3b6421e14c3-4110	\N	NEW	\N	\N	\N	\N
86895	79	D5170C00002/tiny.path.1/file-5505.pdf	\N	D5170C00002-e94726ca-8318-11eb-be00-6bd560bb707d-5505	\N	NEW	\N	\N	\N	\N
83940	79	D5170C00002/tiny.path.1/file-2550.pdf	\N	D5170C00002-e948499f-8316-11eb-be00-f191d11c0aec-2550	\N	NEW	\N	\N	\N	\N
82579	79	D5170C00002/tiny.path.1/file-1189.pdf	\N	D5170C00002-e9586c5e-8315-11eb-be00-6383d786029b-1189	\N	NEW	\N	\N	\N	\N
86896	79	D5170C00002/tiny.path.1/file-5506.pdf	\N	D5170C00002-e9858f5b-8318-11eb-be00-0dfc403aea63-5506	\N	NEW	\N	\N	\N	\N
83941	79	D5170C00002/tiny.path.1/file-2551.pdf	\N	D5170C00002-e994e300-8316-11eb-be00-79919975a082-2551	\N	NEW	\N	\N	\N	\N
82580	79	D5170C00002/tiny.path.1/file-1190.pdf	\N	D5170C00002-e995755f-8315-11eb-be00-77576ed3d32b-1190	\N	NEW	\N	\N	\N	\N
86897	79	D5170C00002/tiny.path.1/file-5507.pdf	\N	D5170C00002-e9b4678c-8318-11eb-be00-a7d70745f8e0-5507	\N	NEW	\N	\N	\N	\N
83942	79	D5170C00002/tiny.path.1/file-2552.pdf	\N	D5170C00002-e9b4a001-8316-11eb-be00-4b0e47aa87d9-2552	\N	NEW	\N	\N	\N	\N
83943	79	D5170C00002/tiny.path.1/file-2553.pdf	\N	D5170C00002-e9d19de2-8316-11eb-be00-ed03e955f45e-2553	\N	NEW	\N	\N	\N	\N
83944	79	D5170C00002/tiny.path.1/file-2554.pdf	\N	D5170C00002-ea1f21a3-8316-11eb-be00-db677b4049f7-2554	\N	NEW	\N	\N	\N	\N
86898	79	D5170C00002/tiny.path.1/file-5508.pdf	\N	D5170C00002-ea2db63d-8318-11eb-be00-3748364511b6-5508	\N	NEW	\N	\N	\N	\N
82581	79	D5170C00002/tiny.path.1/file-1191.pdf	\N	D5170C00002-ea2de4d0-8315-11eb-be00-df8bf72923d5-1191	\N	NEW	\N	\N	\N	\N
83945	79	D5170C00002/tiny.path.1/file-2555.pdf	\N	D5170C00002-ea2f0024-8316-11eb-be00-49db72d7b912-2555	\N	NEW	\N	\N	\N	\N
86899	79	D5170C00002/tiny.path.1/file-5509.pdf	\N	D5170C00002-ea59cf4e-8318-11eb-be00-bb09b1dd47a6-5509	\N	NEW	\N	\N	\N	\N
86900	79	D5170C00002/tiny.path.1/file-5510.pdf	\N	D5170C00002-ea7853cf-8318-11eb-be00-4b75a3914193-5510	\N	NEW	\N	\N	\N	\N
85501	79	D5170C00002/tiny.path.1/file-4111.pdf	\N	D5170C00002-ea793328-8317-11eb-be00-0b642cb0a4a3-4111	\N	NEW	\N	\N	\N	\N
83946	79	D5170C00002/tiny.path.1/file-2556.pdf	\N	D5170C00002-ea7e7fb5-8316-11eb-be00-5f6412cd14e4-2556	\N	NEW	\N	\N	\N	\N
85502	79	D5170C00002/tiny.path.1/file-4112.pdf	\N	D5170C00002-ea88c389-8317-11eb-be00-574cbc592a98-4112	\N	NEW	\N	\N	\N	\N
83947	79	D5170C00002/tiny.path.1/file-2557.pdf	\N	D5170C00002-ea99f6f6-8316-11eb-be00-6b290b31787f-2557	\N	NEW	\N	\N	\N	\N
83948	79	D5170C00002/tiny.path.1/file-2558.pdf	\N	D5170C00002-eab6f4d7-8316-11eb-be00-35653b3b4ea6-2558	\N	NEW	\N	\N	\N	\N
83949	79	D5170C00002/tiny.path.1/file-2559.pdf	\N	D5170C00002-eab82d58-8316-11eb-be00-dbc08a38c731-2559	\N	NEW	\N	\N	\N	\N
83950	79	D5170C00002/tiny.path.1/file-2560.pdf	\N	D5170C00002-ead467e9-8316-11eb-be00-21c8facfa1b6-2560	\N	NEW	\N	\N	\N	\N
86901	79	D5170C00002/tiny.path.1/file-5511.pdf	\N	D5170C00002-eae371b0-8318-11eb-be00-8738af53e71e-5511	\N	NEW	\N	\N	\N	\N
85503	79	D5170C00002/tiny.path.1/file-4113.pdf	\N	D5170C00002-eaf2f70a-8317-11eb-be00-d54f05e126ca-4113	\N	NEW	\N	\N	\N	\N
82582	79	D5170C00002/tiny.path.1/file-1192.pdf	\N	D5170C00002-eaf3a5d1-8315-11eb-be00-d78309afcede-1192	\N	NEW	\N	\N	\N	\N
83951	79	D5170C00002/tiny.path.1/file-2561.pdf	\N	D5170C00002-eb02079a-8316-11eb-be00-711689bf948f-2561	\N	NEW	\N	\N	\N	\N
86902	79	D5170C00002/tiny.path.1/file-5512.pdf	\N	D5170C00002-eb10ea51-8318-11eb-be00-75b071f4534c-5512	\N	NEW	\N	\N	\N	\N
86903	79	D5170C00002/tiny.path.1/file-5513.pdf	\N	D5170C00002-eb20efe2-8318-11eb-be00-4f1c738e7bf0-5513	\N	NEW	\N	\N	\N	\N
83952	79	D5170C00002/tiny.path.1/file-2562.pdf	\N	D5170C00002-eb214f6b-8316-11eb-be00-f3d634006f38-2562	\N	NEW	\N	\N	\N	\N
86904	79	D5170C00002/tiny.path.1/file-5514.pdf	\N	D5170C00002-eb30ce63-8318-11eb-be00-31190742895a-5514	\N	NEW	\N	\N	\N	\N
83953	79	D5170C00002/tiny.path.1/file-2563.pdf	\N	D5170C00002-eb317c0c-8316-11eb-be00-9b26ef05cf6f-2563	\N	NEW	\N	\N	\N	\N
86905	79	D5170C00002/tiny.path.1/file-5515.pdf	\N	D5170C00002-eb3fe994-8318-11eb-be00-e98130d45ebe-5515	\N	NEW	\N	\N	\N	\N
83954	79	D5170C00002/tiny.path.1/file-2564.pdf	\N	D5170C00002-eb5e586d-8316-11eb-be00-83fef416257f-2564	\N	NEW	\N	\N	\N	\N
86906	79	D5170C00002/tiny.path.1/file-5516.pdf	\N	D5170C00002-eb6c02a5-8318-11eb-be00-2b5e34b4ef92-5516	\N	NEW	\N	\N	\N	\N
83955	79	D5170C00002/tiny.path.1/file-2565.pdf	\N	D5170C00002-eb6c893e-8316-11eb-be00-f7d737eeb0fa-2565	\N	NEW	\N	\N	\N	\N
86907	79	D5170C00002/tiny.path.1/file-5517.pdf	\N	D5170C00002-eb7d19a6-8318-11eb-be00-215a370d5199-5517	\N	NEW	\N	\N	\N	\N
83956	79	D5170C00002/tiny.path.1/file-2566.pdf	\N	D5170C00002-eb8d098f-8316-11eb-be00-918e17c9cf83-2566	\N	NEW	\N	\N	\N	\N
85504	79	D5170C00002/tiny.path.1/file-4114.pdf	\N	D5170C00002-eb9aa8bb-8317-11eb-be00-bb25c83e5ff8-4114	\N	NEW	\N	\N	\N	\N
82583	79	D5170C00002/tiny.path.1/file-1193.pdf	\N	D5170C00002-eb9b3072-8315-11eb-be00-f7bd5e87f449-1193	\N	NEW	\N	\N	\N	\N
86908	79	D5170C00002/tiny.path.1/file-5518.pdf	\N	D5170C00002-eba9cef7-8318-11eb-be00-b50de8f1c96a-5518	\N	NEW	\N	\N	\N	\N
83957	79	D5170C00002/tiny.path.1/file-2567.pdf	\N	D5170C00002-ebab3ff0-8316-11eb-be00-ff236bee9f9f-2567	\N	NEW	\N	\N	\N	\N
86909	79	D5170C00002/tiny.path.1/file-5519.pdf	\N	D5170C00002-ebb84de8-8318-11eb-be00-ff900de369e4-5519	\N	NEW	\N	\N	\N	\N
86910	79	D5170C00002/tiny.path.1/file-5520.pdf	\N	D5170C00002-ebc7de49-8318-11eb-be00-138fc4e670cb-5520	\N	NEW	\N	\N	\N	\N
83958	79	D5170C00002/tiny.path.1/file-2568.pdf	\N	D5170C00002-ebd78011-8316-11eb-be00-23e554ae50ed-2568	\N	NEW	\N	\N	\N	\N
85505	79	D5170C00002/tiny.path.1/file-4115.pdf	\N	D5170C00002-ebd9867c-8317-11eb-be00-2116565f2a86-4115	\N	NEW	\N	\N	\N	\N
82584	79	D5170C00002/tiny.path.1/file-1194.pdf	\N	D5170C00002-ebda3543-8315-11eb-be00-0df5721c45fa-1194	\N	NEW	\N	\N	\N	\N
86911	79	D5170C00002/tiny.path.1/file-5521.pdf	\N	D5170C00002-ebf556ea-8318-11eb-be00-bf4d8f5aa6c2-5521	\N	NEW	\N	\N	\N	\N
83959	79	D5170C00002/tiny.path.1/file-2569.pdf	\N	D5170C00002-ebf5b672-8316-11eb-be00-3b4e75e048f4-2569	\N	NEW	\N	\N	\N	\N
85506	79	D5170C00002/tiny.path.1/file-4116.pdf	\N	D5170C00002-ec05c69d-8317-11eb-be00-2f369658b0bc-4116	\N	NEW	\N	\N	\N	\N
83960	79	D5170C00002/tiny.path.1/file-2570.pdf	\N	D5170C00002-ec060a23-8316-11eb-be00-33b0fb3e6f42-2570	\N	NEW	\N	\N	\N	\N
82585	79	D5170C00002/tiny.path.1/file-1195.pdf	\N	D5170C00002-ec064e54-8315-11eb-be00-d191a9391c39-1195	\N	NEW	\N	\N	\N	\N
86912	79	D5170C00002/tiny.path.1/file-5522.pdf	\N	D5170C00002-ec14027b-8318-11eb-be00-af396ae3aa1d-5522	\N	NEW	\N	\N	\N	\N
82586	79	D5170C00002/tiny.path.1/file-1196.pdf	\N	D5170C00002-ec14cd45-8315-11eb-be00-f94af3fb304a-1196	\N	NEW	\N	\N	\N	\N
85507	79	D5170C00002/tiny.path.1/file-4117.pdf	\N	D5170C00002-ec23fcfe-8317-11eb-be00-51bb86bdf60d-4117	\N	NEW	\N	\N	\N	\N
83961	79	D5170C00002/tiny.path.1/file-2571.pdf	\N	D5170C00002-ec2503d4-8316-11eb-be00-3d2714127fe5-2571	\N	NEW	\N	\N	\N	\N
83962	79	D5170C00002/tiny.path.1/file-2572.pdf	\N	D5170C00002-ec355785-8316-11eb-be00-d3a28ba16a26-2572	\N	NEW	\N	\N	\N	\N
85508	79	D5170C00002/tiny.path.1/file-4118.pdf	\N	D5170C00002-ec42817f-8317-11eb-be00-b1cb8e602845-4118	\N	NEW	\N	\N	\N	\N
86913	79	D5170C00002/tiny.path.1/file-5523.pdf	\N	D5170C00002-ec428c8c-8318-11eb-be00-6b6451a678b2-5523	\N	NEW	\N	\N	\N	\N
83963	79	D5170C00002/tiny.path.1/file-2573.pdf	\N	D5170C00002-ec519216-8316-11eb-be00-777558a070f6-2573	\N	NEW	\N	\N	\N	\N
82587	79	D5170C00002/tiny.path.1/file-1197.pdf	\N	D5170C00002-ec529996-8315-11eb-be00-e346ba29f169-1197	\N	NEW	\N	\N	\N	\N
85509	79	D5170C00002/tiny.path.1/file-4119.pdf	\N	D5170C00002-ec5434c0-8317-11eb-be00-b5733746f84b-4119	\N	NEW	\N	\N	\N	\N
83964	79	D5170C00002/tiny.path.1/file-2574.pdf	\N	D5170C00002-ec60fb67-8316-11eb-be00-2998c8491f1a-2574	\N	NEW	\N	\N	\N	\N
86914	79	D5170C00002/tiny.path.1/file-5524.pdf	\N	D5170C00002-ec61ad4d-8318-11eb-be00-29fcbbf59857-5524	\N	NEW	\N	\N	\N	\N
83965	79	D5170C00002/tiny.path.1/file-2575.pdf	\N	D5170C00002-ec61e5c8-8316-11eb-be00-5d63e90377c6-2575	\N	NEW	\N	\N	\N	\N
85510	79	D5170C00002/tiny.path.1/file-4120.pdf	\N	D5170C00002-ec7f6371-8317-11eb-be00-697d0402136b-4120	\N	NEW	\N	\N	\N	\N
86915	79	D5170C00002/tiny.path.1/file-5525.pdf	\N	D5170C00002-ec800abe-8318-11eb-be00-e918df4aa4b4-5525	\N	NEW	\N	\N	\N	\N
82588	79	D5170C00002/tiny.path.1/file-1198.pdf	\N	D5170C00002-ec825c27-8315-11eb-be00-0d294bfda40d-1198	\N	NEW	\N	\N	\N	\N
83966	79	D5170C00002/tiny.path.1/file-2576.pdf	\N	D5170C00002-ec826619-8316-11eb-be00-398372beb408-2576	\N	NEW	\N	\N	\N	\N
85511	79	D5170C00002/tiny.path.1/file-4121.pdf	\N	D5170C00002-ec8eccc2-8317-11eb-be00-a9c0286e20f5-4121	\N	NEW	\N	\N	\N	\N
85512	79	D5170C00002/tiny.path.1/file-4122.pdf	\N	D5170C00002-ec8f9013-8317-11eb-be00-5b5fca75bc42-4122	\N	NEW	\N	\N	\N	\N
86916	79	D5170C00002/tiny.path.1/file-5526.pdf	\N	D5170C00002-ec8f9b1f-8318-11eb-be00-e1addea0d4d2-5526	\N	NEW	\N	\N	\N	\N
83967	79	D5170C00002/tiny.path.1/file-2577.pdf	\N	D5170C00002-ec90e50a-8316-11eb-be00-7d408d26d0d2-2577	\N	NEW	\N	\N	\N	\N
85513	79	D5170C00002/tiny.path.1/file-4123.pdf	\N	D5170C00002-ec913dc4-8317-11eb-be00-7db65dbadcef-4123	\N	NEW	\N	\N	\N	\N
85514	79	D5170C00002/tiny.path.1/file-4124.pdf	\N	D5170C00002-ec9f95a5-8317-11eb-be00-a1d89a4e2715-4124	\N	NEW	\N	\N	\N	\N
86917	79	D5170C00002/tiny.path.1/file-5527.pdf	\N	D5170C00002-ecac71f0-8318-11eb-be00-5b437bb52860-5527	\N	NEW	\N	\N	\N	\N
83968	79	D5170C00002/tiny.path.1/file-2578.pdf	\N	D5170C00002-ecadbbdb-8316-11eb-be00-554d8bd8841f-2578	\N	NEW	\N	\N	\N	\N
82589	79	D5170C00002/tiny.path.1/file-1199.pdf	\N	D5170C00002-ecb022e8-8315-11eb-be00-0726acffb372-1199	\N	NEW	\N	\N	\N	\N
86918	79	D5170C00002/tiny.path.1/file-5528.pdf	\N	D5170C00002-ecbbb431-8318-11eb-be00-8dda270116a2-5528	\N	NEW	\N	\N	\N	\N
86919	79	D5170C00002/tiny.path.1/file-5529.pdf	\N	D5170C00002-eccaf672-8318-11eb-be00-f7a380b15f24-5529	\N	NEW	\N	\N	\N	\N
83969	79	D5170C00002/tiny.path.1/file-2579.pdf	\N	D5170C00002-eccd03ac-8316-11eb-be00-d3ecc4908da1-2579	\N	NEW	\N	\N	\N	\N
85515	79	D5170C00002/tiny.path.1/file-4125.pdf	\N	D5170C00002-eccdd196-8317-11eb-be00-df43c03cee2c-4125	\N	NEW	\N	\N	\N	\N
83970	79	D5170C00002/tiny.path.1/file-2580.pdf	\N	D5170C00002-eceb611d-8316-11eb-be00-338fe9c56b2b-2580	\N	NEW	\N	\N	\N	\N
83971	79	D5170C00002/tiny.path.1/file-2581.pdf	\N	D5170C00002-ecf943ce-8316-11eb-be00-3d05af73fdbd-2581	\N	NEW	\N	\N	\N	\N
83972	79	D5170C00002/tiny.path.1/file-2582.pdf	\N	D5170C00002-ed08ad1f-8316-11eb-be00-35e3aac7a484-2582	\N	NEW	\N	\N	\N	\N
82590	79	D5170C00002/tiny.path.1/file-1200.pdf	\N	D5170C00002-ed09b499-8315-11eb-be00-6154d365f604-1200	\N	NEW	\N	\N	\N	\N
85516	79	D5170C00002/tiny.path.1/file-4126.xlsx	\N	D5170C00002-ed26c707-8317-11eb-be00-afb48263716c-4126	\N	NEW	\N	\N	\N	\N
86920	79	D5170C00002/tiny.path.1/file-5530.pdf	\N	D5170C00002-ed26f923-8318-11eb-be00-7d04d7961755-5530	\N	NEW	\N	\N	\N	\N
83973	79	D5170C00002/tiny.path.1/file-2583.pdf	\N	D5170C00002-ed2a3ee0-8316-11eb-be00-9985cf9760c1-2583	\N	NEW	\N	\N	\N	\N
85517	79	D5170C00002/tiny.path.1/file-4127.xlsx	\N	D5170C00002-ed46d228-8317-11eb-be00-936896b8ca4b-4127	\N	NEW	\N	\N	\N	\N
83974	79	D5170C00002/tiny.path.1/file-2584.pdf	\N	D5170C00002-ed5657f1-8316-11eb-be00-9106e171a0b5-2584	\N	NEW	\N	\N	\N	\N
82591	79	D5170C00002/tiny.path.1/file-1201.pdf	\N	D5170C00002-ed57385a-8315-11eb-be00-b9d2003cda6a-1201	\N	NEW	\N	\N	\N	\N
86921	79	D5170C00002/tiny.path.1/file-5531.pdf	\N	D5170C00002-ed577f04-8318-11eb-be00-5b8a969ab50c-5531	\N	NEW	\N	\N	\N	\N
83975	79	D5170C00002/tiny.path.1/file-2585.pdf	\N	D5170C00002-ed82bf22-8316-11eb-be00-6f1d637fe619-2585	\N	NEW	\N	\N	\N	\N
85518	79	D5170C00002/tiny.path.1/file-4128.pdf	\N	D5170C00002-ed845059-8317-11eb-be00-8bacae51a26d-4128	\N	NEW	\N	\N	\N	\N
82592	79	D5170C00002/tiny.path.1/file-1202.pdf	\N	D5170C00002-eda2e75b-8315-11eb-be00-25a6f1a004e8-1202	\N	NEW	\N	\N	\N	\N
83976	79	D5170C00002/tiny.path.1/file-2586.pdf	\N	D5170C00002-eda36683-8316-11eb-be00-611cff5fddb5-2586	\N	NEW	\N	\N	\N	\N
86922	79	D5170C00002/tiny.path.1/file-5532.pdf	\N	D5170C00002-edb0c295-8318-11eb-be00-b19e09024ae1-5532	\N	NEW	\N	\N	\N	\N
82593	79	D5170C00002/tiny.path.1/file-1203.pdf	\N	D5170C00002-edb29ecc-8315-11eb-be00-6129bdcba660-1203	\N	NEW	\N	\N	\N	\N
83977	79	D5170C00002/tiny.path.1/file-2587.pdf	\N	D5170C00002-edb2a8c4-8316-11eb-be00-fd21380118a0-2587	\N	NEW	\N	\N	\N	\N
85519	79	D5170C00002/tiny.path.1/file-4129.pdf	\N	D5170C00002-edb2da6a-8317-11eb-be00-4fe7ff34fcd4-4129	\N	NEW	\N	\N	\N	\N
82594	79	D5170C00002/tiny.path.1/file-1204.pdf	\N	D5170C00002-edc11dbd-8315-11eb-be00-37c771754813-1204	\N	NEW	\N	\N	\N	\N
82595	79	D5170C00002/tiny.path.1/file-1205.pdf	\N	D5170C00002-edd14a5e-8315-11eb-be00-aff38258a20f-1205	\N	NEW	\N	\N	\N	\N
85520	79	D5170C00002/tiny.path.1/file-4130.pdf	\N	D5170C00002-eddde20b-8317-11eb-be00-f9598dc422e4-4130	\N	NEW	\N	\N	\N	\N
83978	79	D5170C00002/tiny.path.1/file-2588.pdf	\N	D5170C00002-edddfe85-8316-11eb-be00-0d8b0225257d-2588	\N	NEW	\N	\N	\N	\N
82596	79	D5170C00002/tiny.path.1/file-1206.pdf	\N	D5170C00002-eded5ddf-8315-11eb-be00-63b82f95d030-1206	\N	NEW	\N	\N	\N	\N
86923	79	D5170C00002/tiny.path.1/file-5533.pdf	\N	D5170C00002-eded7d76-8318-11eb-be00-49c31ba2ef22-5533	\N	NEW	\N	\N	\N	\N
85521	79	D5170C00002/tiny.path.1/file-4131.pdf	\N	D5170C00002-edee83dc-8317-11eb-be00-0d875e3e0c4f-4131	\N	NEW	\N	\N	\N	\N
83979	79	D5170C00002/tiny.path.1/file-2589.pdf	\N	D5170C00002-edfcd126-8316-11eb-be00-8394b92a6cf0-2589	\N	NEW	\N	\N	\N	\N
85522	79	D5170C00002/tiny.path.1/file-4132.pdf	\N	D5170C00002-edfcdbbd-8317-11eb-be00-b3fae03af75a-4132	\N	NEW	\N	\N	\N	\N
86924	79	D5170C00002/tiny.path.1/file-5534.pdf	\N	D5170C00002-edfe6d67-8318-11eb-be00-57c40629671d-5534	\N	NEW	\N	\N	\N	\N
82597	79	D5170C00002/tiny.path.1/file-1207.pdf	\N	D5170C00002-ee0c0970-8315-11eb-be00-4fdfcf0a93f1-1207	\N	NEW	\N	\N	\N	\N
85523	79	D5170C00002/tiny.path.1/file-4133.pdf	\N	D5170C00002-ee0c1dfe-8317-11eb-be00-1940f14f2934-4133	\N	NEW	\N	\N	\N	\N
82598	79	D5170C00002/tiny.path.1/file-1208.pdf	\N	D5170C00002-ee1d6e91-8315-11eb-be00-0ba4b2ec4d69-1208	\N	NEW	\N	\N	\N	\N
85524	79	D5170C00002/tiny.path.1/file-4134.pdf	\N	D5170C00002-ee2a7b6f-8317-11eb-be00-29890d9f2411-4134	\N	NEW	\N	\N	\N	\N
86925	79	D5170C00002/tiny.path.1/file-5535.pdf	\N	D5170C00002-ee2aad88-8318-11eb-be00-4f0e6002bd84-5535	\N	NEW	\N	\N	\N	\N
83980	79	D5170C00002/tiny.path.1/file-2590.pdf	\N	D5170C00002-ee2abef7-8316-11eb-be00-a531418ccaa8-2590	\N	NEW	\N	\N	\N	\N
82599	79	D5170C00002/tiny.path.1/file-1209.pdf	\N	D5170C00002-ee3b56d2-8315-11eb-be00-5f4235759639-1209	\N	NEW	\N	\N	\N	\N
86926	79	D5170C00002/tiny.path.1/file-5536.pdf	\N	D5170C00002-ee3c39b9-8318-11eb-be00-93c5a7ea450c-5536	\N	NEW	\N	\N	\N	\N
85525	79	D5170C00002/tiny.path.1/file-4135.pdf	\N	D5170C00002-ee494e10-8317-11eb-be00-83095644ffe7-4135	\N	NEW	\N	\N	\N	\N
82600	79	D5170C00002/tiny.path.1/file-1210.pdf	\N	D5170C00002-ee582da3-8315-11eb-be00-7bb775925bb9-1210	\N	NEW	\N	\N	\N	\N
85526	79	D5170C00002/tiny.path.1/file-4136.pdf	\N	D5170C00002-ee592c91-8317-11eb-be00-47249569222d-4136	\N	NEW	\N	\N	\N	\N
86927	79	D5170C00002/tiny.path.1/file-5537.pdf	\N	D5170C00002-ee67415a-8318-11eb-be00-a3158f04c3d5-5537	\N	NEW	\N	\N	\N	\N
85527	79	D5170C00002/tiny.path.1/file-4137.pdf	\N	D5170C00002-ee67ab82-8317-11eb-be00-4999617352d6-4137	\N	NEW	\N	\N	\N	\N
82601	79	D5170C00002/tiny.path.1/file-1211.pdf	\N	D5170C00002-ee69b9d4-8315-11eb-be00-f9cef5c63329-1211	\N	NEW	\N	\N	\N	\N
82602	79	D5170C00002/tiny.path.1/file-1212.pdf	\N	D5170C00002-ee7811b5-8315-11eb-be00-6f40830f0304-1212	\N	NEW	\N	\N	\N	\N
83981	79	D5170C00002/tiny.path.1/file-2591.pdf	\N	D5170C00002-ee797b38-8316-11eb-be00-cff0117e855e-2591	\N	NEW	\N	\N	\N	\N
85528	79	D5170C00002/tiny.path.1/file-4138.pdf	\N	D5170C00002-ee8852e3-8317-11eb-be00-ad046fb0c640-4138	\N	NEW	\N	\N	\N	\N
82603	79	D5170C00002/tiny.path.1/file-1213.pdf	\N	D5170C00002-ee973276-8315-11eb-be00-a3a25800f029-1213	\N	NEW	\N	\N	\N	\N
86928	79	D5170C00002/tiny.path.1/file-5538.pdf	\N	D5170C00002-eea3fc3b-8318-11eb-be00-6b18b7dfb5fe-5538	\N	NEW	\N	\N	\N	\N
85529	79	D5170C00002/tiny.path.1/file-4139.pdf	\N	D5170C00002-eea61414-8317-11eb-be00-1b95f385cace-4139	\N	NEW	\N	\N	\N	\N
85530	79	D5170C00002/tiny.path.1/file-4140.pdf	\N	D5170C00002-eeb38195-8317-11eb-be00-6bfcf16cdc7d-4140	\N	NEW	\N	\N	\N	\N
85531	79	D5170C00002/tiny.path.1/file-4141.pdf	\N	D5170C00002-eeb5cb86-8317-11eb-be00-0b9b1feb650f-4141	\N	NEW	\N	\N	\N	\N
82604	79	D5170C00002/tiny.path.1/file-1214.pdf	\N	D5170C00002-eeb60517-8315-11eb-be00-f5c143f0bd30-1214	\N	NEW	\N	\N	\N	\N
86929	79	D5170C00002/tiny.path.1/file-5539.pdf	\N	D5170C00002-eec36b1c-8318-11eb-be00-7f99b59619d6-5539	\N	NEW	\N	\N	\N	\N
85532	79	D5170C00002/tiny.path.1/file-4142.pdf	\N	D5170C00002-eec42367-8317-11eb-be00-11884eef6bf6-4142	\N	NEW	\N	\N	\N	\N
82605	79	D5170C00002/tiny.path.1/file-1215.pdf	\N	D5170C00002-eed23fa8-8315-11eb-be00-77abe9ebe0b7-1215	\N	NEW	\N	\N	\N	\N
86930	79	D5170C00002/tiny.path.1/file-5540.pdf	\N	D5170C00002-eee17a6d-8318-11eb-be00-ebdd095a8a24-5540	\N	NEW	\N	\N	\N	\N
85533	79	D5170C00002/tiny.path.1/file-4143.pdf	\N	D5170C00002-eee232b8-8317-11eb-be00-35e5c9352c97-4143	\N	NEW	\N	\N	\N	\N
82606	79	D5170C00002/tiny.path.1/file-1216.pdf	\N	D5170C00002-eee30889-8315-11eb-be00-db09fd31a1ad-1216	\N	NEW	\N	\N	\N	\N
82607	79	D5170C00002/tiny.path.1/file-1217.pdf	\N	D5170C00002-eef3d16a-8315-11eb-be00-45e0817257bd-1217	\N	NEW	\N	\N	\N	\N
85534	79	D5170C00002/tiny.path.1/file-4144.pdf	\N	D5170C00002-ef001af9-8317-11eb-be00-43055355e8e1-4144	\N	NEW	\N	\N	\N	\N
82608	79	D5170C00002/tiny.path.1/file-1218.pdf	\N	D5170C00002-ef02c58b-8315-11eb-be00-71a61b4f8dca-1218	\N	NEW	\N	\N	\N	\N
86931	79	D5170C00002/tiny.path.1/file-5541.pdf	\N	D5170C00002-ef1e5c5e-8318-11eb-be00-871622401523-5541	\N	NEW	\N	\N	\N	\N
85535	79	D5170C00002/tiny.path.1/file-4145.pdf	\N	D5170C00002-ef1ec68a-8317-11eb-be00-a1da73ad5774-4145	\N	NEW	\N	\N	\N	\N
82609	79	D5170C00002/tiny.path.1/file-1219.pdf	\N	D5170C00002-ef2dcd2c-8315-11eb-be00-9343a639aafc-1219	\N	NEW	\N	\N	\N	\N
86932	79	D5170C00002/tiny.path.1/file-5542.pdf	\N	D5170C00002-ef2e3adf-8318-11eb-be00-751e5d114f82-5542	\N	NEW	\N	\N	\N	\N
83982	79	D5170C00002/tiny.path.1/file-2592.pdf	\N	D5170C00002-ef2e9a69-8316-11eb-be00-2f13affd627c-2592	\N	NEW	\N	\N	\N	\N
85536	79	D5170C00002/tiny.path.1/file-4146.pdf	\N	D5170C00002-ef2ef32b-8317-11eb-be00-0164b7e478c6-4146	\N	NEW	\N	\N	\N	\N
85537	79	D5170C00002/tiny.path.1/file-4147.pdf	\N	D5170C00002-ef3d23fc-8317-11eb-be00-d39a85c74c22-4147	\N	NEW	\N	\N	\N	\N
86933	79	D5170C00002/tiny.path.1/file-5543.pdf	\N	D5170C00002-ef4c2320-8318-11eb-be00-d316d0604014-5543	\N	NEW	\N	\N	\N	\N
85538	79	D5170C00002/tiny.path.1/file-4148.pdf	\N	D5170C00002-ef4c3f2d-8317-11eb-be00-57edcc05bcea-4148	\N	NEW	\N	\N	\N	\N
82610	79	D5170C00002/tiny.path.1/file-1220.pdf	\N	D5170C00002-ef4c51ad-8315-11eb-be00-e34c59c8c7ff-1220	\N	NEW	\N	\N	\N	\N
85539	79	D5170C00002/tiny.path.1/file-4149.pdf	\N	D5170C00002-ef4e3afe-8317-11eb-be00-d3a21f8970bf-4149	\N	NEW	\N	\N	\N	\N
82611	79	D5170C00002/tiny.path.1/file-1221.pdf	\N	D5170C00002-ef5bbafe-8315-11eb-be00-dd9404345c36-1221	\N	NEW	\N	\N	\N	\N
85540	79	D5170C00002/tiny.path.1/file-4150.pdf	\N	D5170C00002-ef5c44bf-8317-11eb-be00-7f5614da2c37-4150	\N	NEW	\N	\N	\N	\N
85541	79	D5170C00002/tiny.path.1/file-4151.pdf	\N	D5170C00002-ef5dcb60-8317-11eb-be00-2d44ffb55123-4151	\N	NEW	\N	\N	\N	\N
86934	79	D5170C00002/tiny.path.1/file-5544.pdf	\N	D5170C00002-ef6ca371-8318-11eb-be00-410bacfc530d-5544	\N	NEW	\N	\N	\N	\N
85542	79	D5170C00002/tiny.path.1/file-4152.pdf	\N	D5170C00002-ef7a2d01-8317-11eb-be00-3fe802b512e1-4152	\N	NEW	\N	\N	\N	\N
83983	79	D5170C00002/tiny.path.1/file-2593.pdf	\N	D5170C00002-ef7b0cba-8316-11eb-be00-8bf96c758ce2-2593	\N	NEW	\N	\N	\N	\N
82612	79	D5170C00002/tiny.path.1/file-1222.pdf	\N	D5170C00002-ef7c896f-8315-11eb-be00-7368f2f46f49-1222	\N	NEW	\N	\N	\N	\N
86935	79	D5170C00002/tiny.path.1/file-5545.pdf	\N	D5170C00002-ef8a8bb2-8318-11eb-be00-f1c7a1838c25-5545	\N	NEW	\N	\N	\N	\N
85543	79	D5170C00002/tiny.path.1/file-4153.pdf	\N	D5170C00002-ef8b4402-8317-11eb-be00-db2cf66a20a0-4153	\N	NEW	\N	\N	\N	\N
86936	79	D5170C00002/tiny.path.1/file-5546.pdf	\N	D5170C00002-ef98bc83-8318-11eb-be00-638bb73d492c-5546	\N	NEW	\N	\N	\N	\N
85544	79	D5170C00002/tiny.path.1/file-4154.pdf	\N	D5170C00002-ef9a5f33-8317-11eb-be00-39e098b27731-4154	\N	NEW	\N	\N	\N	\N
86937	79	D5170C00002/tiny.path.1/file-5547.pdf	\N	D5170C00002-efaa48b4-8318-11eb-be00-bfb67979740e-5547	\N	NEW	\N	\N	\N	\N
85545	79	D5170C00002/tiny.path.1/file-4155.pdf	\N	D5170C00002-efb70ef4-8317-11eb-be00-619f48269afe-4155	\N	NEW	\N	\N	\N	\N
86938	79	D5170C00002/tiny.path.1/file-5548.pdf	\N	D5170C00002-efb85275-8318-11eb-be00-b94e26ff2536-5548	\N	NEW	\N	\N	\N	\N
82613	79	D5170C00002/tiny.path.1/file-1223.pdf	\N	D5170C00002-efb9b980-8315-11eb-be00-3f32c5e00135-1223	\N	NEW	\N	\N	\N	\N
86939	79	D5170C00002/tiny.path.1/file-5549.pdf	\N	D5170C00002-efd77336-8318-11eb-be00-319717983aac-5549	\N	NEW	\N	\N	\N	\N
83984	79	D5170C00002/tiny.path.1/file-2594.pdf	\N	D5170C00002-efd7d2bb-8316-11eb-be00-e93a96c53cac-2594	\N	NEW	\N	\N	\N	\N
85546	79	D5170C00002/tiny.path.1/file-4156.pdf	\N	D5170C00002-efd82b85-8317-11eb-be00-a3fdff5ebdda-4156	\N	NEW	\N	\N	\N	\N
85547	79	D5170C00002/tiny.path.1/file-4157.pdf	\N	D5170C00002-eff46616-8317-11eb-be00-9b0e264bdd0a-4157	\N	NEW	\N	\N	\N	\N
86940	79	D5170C00002/tiny.path.1/file-5550.pdf	\N	D5170C00002-eff645d7-8318-11eb-be00-d535a1a70b36-5550	\N	NEW	\N	\N	\N	\N
85548	79	D5170C00002/tiny.path.1/file-4158.pdf	\N	D5170C00002-f003f677-8317-11eb-be00-6567ce79b30d-4158	\N	NEW	\N	\N	\N	\N
86941	79	D5170C00002/tiny.path.1/file-5551.pdf	\N	D5170C00002-f014a348-8318-11eb-be00-b9a57dce3fc1-5551	\N	NEW	\N	\N	\N	\N
82614	79	D5170C00002/tiny.path.1/file-1224.pdf	\N	D5170C00002-f0246231-8315-11eb-be00-fb44614ebfad-1224	\N	NEW	\N	\N	\N	\N
85549	79	D5170C00002/tiny.path.1/file-4159.pdf	\N	D5170C00002-f0319628-8317-11eb-be00-4f52af482d40-4159	\N	NEW	\N	\N	\N	\N
86942	79	D5170C00002/tiny.path.1/file-5552.pdf	\N	D5170C00002-f0334ed9-8318-11eb-be00-b3f41e2d4501-5552	\N	NEW	\N	\N	\N	\N
86943	79	D5170C00002/tiny.path.1/file-5553.pdf	\N	D5170C00002-f041f4da-8318-11eb-be00-8baee817b5a2-5553	\N	NEW	\N	\N	\N	\N
82615	79	D5170C00002/tiny.path.1/file-1225.pdf	\N	D5170C00002-f0424a72-8315-11eb-be00-554557cc5f85-1225	\N	NEW	\N	\N	\N	\N
85550	79	D5170C00002/tiny.path.1/file-4160.pdf	\N	D5170C00002-f042fb49-8317-11eb-be00-d1149aa5b101-4160	\N	NEW	\N	\N	\N	\N
85551	79	D5170C00002/tiny.path.1/file-4161.pdf	\N	D5170C00002-f05068ca-8317-11eb-be00-55f13cbfc917-4161	\N	NEW	\N	\N	\N	\N
85552	79	D5170C00002/tiny.path.1/file-4162.pdf	\N	D5170C00002-f052b2bb-8317-11eb-be00-730cf5db629c-4162	\N	NEW	\N	\N	\N	\N
86944	79	D5170C00002/tiny.path.1/file-5554.pdf	\N	D5170C00002-f060042b-8318-11eb-be00-913a1c783b71-5554	\N	NEW	\N	\N	\N	\N
82616	79	D5170C00002/tiny.path.1/file-1226.pdf	\N	D5170C00002-f06e8a93-8315-11eb-be00-79dd501c6314-1226	\N	NEW	\N	\N	\N	\N
85553	79	D5170C00002/tiny.path.1/file-4163.pdf	\N	D5170C00002-f07025cc-8317-11eb-be00-533c92c45121-4163	\N	NEW	\N	\N	\N	\N
86945	79	D5170C00002/tiny.path.1/file-5555.pdf	\N	D5170C00002-f07f4bfc-8318-11eb-be00-091d3bbdb32a-5555	\N	NEW	\N	\N	\N	\N
83985	79	D5170C00002/tiny.path.1/file-2595.pdf	\N	D5170C00002-f07fd28c-8316-11eb-be00-bdd40b72dbb8-2595	\N	NEW	\N	\N	\N	\N
85554	79	D5170C00002/tiny.path.1/file-4164.pdf	\N	D5170C00002-f080044d-8317-11eb-be00-1d6c82b752ed-4164	\N	NEW	\N	\N	\N	\N
86946	79	D5170C00002/tiny.path.1/file-5556.pdf	\N	D5170C00002-f08e401d-8318-11eb-be00-89f01b7f6d2f-5556	\N	NEW	\N	\N	\N	\N
85555	79	D5170C00002/tiny.path.1/file-4165.pdf	\N	D5170C00002-f08ed15e-8317-11eb-be00-1d00a235ab47-4165	\N	NEW	\N	\N	\N	\N
86947	79	D5170C00002/tiny.path.1/file-5557.pdf	\N	D5170C00002-f09da96e-8318-11eb-be00-7d9d3379a9e1-5557	\N	NEW	\N	\N	\N	\N
85556	79	D5170C00002/tiny.path.1/file-4166.pdf	\N	D5170C00002-f0ab0bef-8317-11eb-be00-bb0a54c047f5-4166	\N	NEW	\N	\N	\N	\N
86948	79	D5170C00002/tiny.path.1/file-5558.pdf	\N	D5170C00002-f0ba321f-8318-11eb-be00-4f5dba61dc3e-5558	\N	NEW	\N	\N	\N	\N
86949	79	D5170C00002/tiny.path.1/file-5559.pdf	\N	D5170C00002-f0bcca30-8318-11eb-be00-f1da67b0f54f-5559	\N	NEW	\N	\N	\N	\N
85557	79	D5170C00002/tiny.path.1/file-4167.pdf	\N	D5170C00002-f0daa770-8317-11eb-be00-b9d4cb32aef8-4167	\N	NEW	\N	\N	\N	\N
82617	79	D5170C00002/tiny.path.1/file-1227.pdf	\N	D5170C00002-f0dab9e4-8315-11eb-be00-09542b59b78f-1227	\N	NEW	\N	\N	\N	\N
86950	79	D5170C00002/tiny.path.1/file-5560.pdf	\N	D5170C00002-f0e86e11-8318-11eb-be00-432d4f605815-5560	\N	NEW	\N	\N	\N	\N
82618	79	D5170C00002/tiny.path.1/file-1228.pdf	\N	D5170C00002-f0eb5bb5-8315-11eb-be00-9dd1524bbadd-1228	\N	NEW	\N	\N	\N	\N
82619	79	D5170C00002/tiny.path.1/file-1229.pdf	\N	D5170C00002-f11774c6-8315-11eb-be00-8de53ee6f75a-1229	\N	NEW	\N	\N	\N	\N
83986	79	D5170C00002/tiny.path.1/file-2596.pdf	\N	D5170C00002-f125615d-8316-11eb-be00-913c4fb102ed-2596	\N	NEW	\N	\N	\N	\N
86951	79	D5170C00002/tiny.path.1/file-5561.pdf	\N	D5170C00002-f1259e22-8318-11eb-be00-3917726ac0dc-5561	\N	NEW	\N	\N	\N	\N
83987	79	D5170C00002/tiny.path.1/file-2597.pdf	\N	D5170C00002-f1369f6e-8316-11eb-be00-c95d484359be-2597	\N	NEW	\N	\N	\N	\N
86952	79	D5170C00002/tiny.path.1/file-5562.pdf	\N	D5170C00002-f1372a53-8318-11eb-be00-5b6049fa087d-5562	\N	NEW	\N	\N	\N	\N
82620	79	D5170C00002/tiny.path.1/file-1230.pdf	\N	D5170C00002-f137a6f7-8315-11eb-be00-1b6de0e1be76-1230	\N	NEW	\N	\N	\N	\N
86953	79	D5170C00002/tiny.path.1/file-5563.pdf	\N	D5170C00002-f16406b4-8318-11eb-be00-81d86ebcd3e8-5563	\N	NEW	\N	\N	\N	\N
86954	79	D5170C00002/tiny.path.1/file-5564.pdf	\N	D5170C00002-f172fad5-8318-11eb-be00-bf8f605bb4d5-5564	\N	NEW	\N	\N	\N	\N
83988	79	D5170C00002/tiny.path.1/file-2598.pdf	\N	D5170C00002-f182c39f-8316-11eb-be00-25dc55195c20-2598	\N	NEW	\N	\N	\N	\N
86955	79	D5170C00002/tiny.path.1/file-5565.pdf	\N	D5170C00002-f19046d6-8318-11eb-be00-1d87c93a033d-5565	\N	NEW	\N	\N	\N	\N
86956	79	D5170C00002/tiny.path.1/file-5566.pdf	\N	D5170C00002-f1a1fa17-8318-11eb-be00-5d67271d200c-5566	\N	NEW	\N	\N	\N	\N
85558	79	D5170C00002/tiny.path.1/file-4168.pdf	\N	D5170C00002-f1bfb041-8317-11eb-be00-153d7e0f5795-4168	\N	NEW	\N	\N	\N	\N
82621	79	D5170C00002/tiny.path.1/file-1231.pdf	\N	D5170C00002-f1c05ef8-8315-11eb-be00-795d9b4a2025-1231	\N	NEW	\N	\N	\N	\N
82622	79	D5170C00002/tiny.path.1/file-1232.pdf	\N	D5170C00002-f1df3199-8315-11eb-be00-7570125335a0-1232	\N	NEW	\N	\N	\N	\N
85559	79	D5170C00002/tiny.path.1/file-4169.pdf	\N	D5170C00002-f1ebf062-8317-11eb-be00-513653f78229-4169	\N	NEW	\N	\N	\N	\N
86957	79	D5170C00002/tiny.path.1/file-5567.pdf	\N	D5170C00002-f1ebfb68-8318-11eb-be00-311e5f4baa4b-5567	\N	NEW	\N	\N	\N	\N
85560	79	D5170C00002/tiny.path.1/file-4170.pdf	\N	D5170C00002-f1fce053-8317-11eb-be00-e76ca0bf2696-4170	\N	NEW	\N	\N	\N	\N
84003	79	D5170C00002/tiny.path.1/file-2613.pdf	\N	D5170C00002-f1fd98f0-8316-11eb-be00-1d59d51fe417-2599	\N	NEW	\N	\N	\N	\N
82623	79	D5170C00002/tiny.path.1/file-1233.pdf	\N	D5170C00002-f20c0dfa-8315-11eb-be00-d7cdefb5866c-1233	\N	NEW	\N	\N	\N	\N
85561	79	D5170C00002/tiny.path.1/file-4171.pdf	\N	D5170C00002-f219de34-8317-11eb-be00-650a57a762fd-4171	\N	NEW	\N	\N	\N	\N
86958	79	D5170C00002/tiny.path.1/file-5568.pdf	\N	D5170C00002-f2292b79-8318-11eb-be00-81c1bef1ce46-5568	\N	NEW	\N	\N	\N	\N
85562	79	D5170C00002/tiny.path.1/file-4172.pdf	\N	D5170C00002-f22aa715-8317-11eb-be00-474f4dbeef69-4172	\N	NEW	\N	\N	\N	\N
82624	79	D5170C00002/tiny.path.1/file-1234.pdf	\N	D5170C00002-f24a286b-8315-11eb-be00-73846547bf2d-1234	\N	NEW	\N	\N	\N	\N
85563	79	D5170C00002/tiny.path.1/file-4173.pdf	\N	D5170C00002-f2669ea6-8317-11eb-be00-d57af4d341ec-4173	\N	NEW	\N	\N	\N	\N
85564	79	D5170C00002/tiny.path.1/file-4174.pdf	\N	D5170C00002-f2774077-8317-11eb-be00-8bbe149e6da4-4174	\N	NEW	\N	\N	\N	\N
83989	79	D5170C00002/tiny.path.1/file-2599.pdf	\N	D5170C00002-f2856691-8316-11eb-be00-8bc71752d2b3-2600	\N	NEW	\N	\N	\N	\N
82625	79	D5170C00002/tiny.path.1/file-1235.pdf	\N	D5170C00002-f2a47d6c-8315-11eb-be00-dbc0b9f8760b-1235	\N	NEW	\N	\N	\N	\N
83990	79	D5170C00002/tiny.path.1/file-2600.pdf	\N	D5170C00002-f2b32d52-8316-11eb-be00-75465ba140fb-2601	\N	NEW	\N	\N	\N	\N
86959	79	D5170C00002/tiny.path.1/file-5569.pdf	\N	D5170C00002-f2b4c9aa-8318-11eb-be00-a10051ed6b88-5569	\N	NEW	\N	\N	\N	\N
82626	79	D5170C00002/tiny.path.1/file-1236.pdf	\N	D5170C00002-f2d1cefd-8315-11eb-be00-d97fb9775ab5-1236	\N	NEW	\N	\N	\N	\N
85565	79	D5170C00002/tiny.path.1/file-4175.pdf	\N	D5170C00002-f2d20aa8-8317-11eb-be00-cbfadf2c3e3c-4175	\N	NEW	\N	\N	\N	\N
85575	79	D5170C00002/tiny.path.1/file-4185.pdf	\N	D5170C00002-f2eff2e9-8317-11eb-be00-93f85c4908f1-4176	\N	NEW	\N	\N	\N	\N
85566	79	D5170C00002/tiny.path.1/file-4176.pdf	\N	D5170C00002-f3006daa-8317-11eb-be00-3da8fe0ced0a-4177	\N	NEW	\N	\N	\N	\N
83991	79	D5170C00002/tiny.path.1/file-2601.pdf	\N	D5170C00002-f30e45a3-8316-11eb-be00-93d6fc2c3244-2602	\N	NEW	\N	\N	\N	\N
85567	79	D5170C00002/tiny.path.1/file-4177.pdf	\N	D5170C00002-f30fd6fb-8317-11eb-be00-d156358f3bbc-4178	\N	NEW	\N	\N	\N	\N
82627	79	D5170C00002/tiny.path.1/file-1237.pdf	\N	D5170C00002-f310107e-8315-11eb-be00-9973658c361d-1237	\N	NEW	\N	\N	\N	\N
85568	79	D5170C00002/tiny.path.1/file-4178.pdf	\N	D5170C00002-f32c389c-8317-11eb-be00-733e3e80d9af-4179	\N	NEW	\N	\N	\N	\N
83992	79	D5170C00002/tiny.path.1/file-2602.pdf	\N	D5170C00002-f32f6234-8316-11eb-be00-5fed41704f12-2603	\N	NEW	\N	\N	\N	\N
85569	79	D5170C00002/tiny.path.1/file-4179.pdf	\N	D5170C00002-f33b2cbd-8317-11eb-be00-d986ba4218e8-4180	\N	NEW	\N	\N	\N	\N
85570	79	D5170C00002/tiny.path.1/file-4180.pdf	\N	D5170C00002-f34a6efe-8317-11eb-be00-cfff02bc5c54-4181	\N	NEW	\N	\N	\N	\N
85571	79	D5170C00002/tiny.path.1/file-4181.pdf	\N	D5170C00002-f34ba77f-8317-11eb-be00-1bed72258e99-4182	\N	NEW	\N	\N	\N	\N
85572	79	D5170C00002/tiny.path.1/file-4182.pdf	\N	D5170C00002-f359b140-8317-11eb-be00-3311adb1e0bb-4183	\N	NEW	\N	\N	\N	\N
86960	79	D5170C00002/tiny.path.1/file-5570.pdf	\N	D5170C00002-f35b42db-8318-11eb-be00-ed4644705160-5570	\N	NEW	\N	\N	\N	\N
83993	79	D5170C00002/tiny.path.1/file-2603.pdf	\N	D5170C00002-f36a2145-8316-11eb-be00-5bd129621da3-2604	\N	NEW	\N	\N	\N	\N
85573	79	D5170C00002/tiny.path.1/file-4183.pdf	\N	D5170C00002-f36aef51-8317-11eb-be00-45f7e6ea5b00-4184	\N	NEW	\N	\N	\N	\N
82628	79	D5170C00002/tiny.path.1/file-1238.pdf	\N	D5170C00002-f3884dbf-8315-11eb-be00-d55fdf75325d-1238	\N	NEW	\N	\N	\N	\N
85574	79	D5170C00002/tiny.path.1/file-4184.pdf	\N	D5170C00002-f3972f72-8317-11eb-be00-33a792e7fd8f-4185	\N	NEW	\N	\N	\N	\N
83994	79	D5170C00002/tiny.path.1/file-2604.pdf	\N	D5170C00002-f397c0f6-8316-11eb-be00-6f45d70b6899-2605	\N	NEW	\N	\N	\N	\N
83995	79	D5170C00002/tiny.path.1/file-2605.pdf	\N	D5170C00002-f3c69927-8316-11eb-be00-ff176cc38528-2606	\N	NEW	\N	\N	\N	\N
86961	79	D5170C00002/tiny.path.1/file-5571.pdf	\N	D5170C00002-f3d4918c-8318-11eb-be00-594e60155341-5571	\N	NEW	\N	\N	\N	\N
85576	79	D5170C00002/tiny.path.1/file-4186.pdf	\N	D5170C00002-f3e37ab3-8317-11eb-be00-addf0aec5db0-4186	\N	NEW	\N	\N	\N	\N
86962	79	D5170C00002/tiny.path.1/file-5572.pdf	\N	D5170C00002-f402f48d-8318-11eb-be00-b34a825cb84d-5572	\N	NEW	\N	\N	\N	\N
83996	79	D5170C00002/tiny.path.1/file-2606.pdf	\N	D5170C00002-f430cca8-8316-11eb-be00-03030b3b834c-2607	\N	NEW	\N	\N	\N	\N
85577	79	D5170C00002/tiny.path.1/file-4187.pdf	\N	D5170C00002-f45f8884-8317-11eb-be00-c31881aaf9b2-4187	\N	NEW	\N	\N	\N	\N
83997	79	D5170C00002/tiny.path.1/file-2607.pdf	\N	D5170C00002-f47d6609-8316-11eb-be00-a3380bfb90aa-2608	\N	NEW	\N	\N	\N	\N
82629	79	D5170C00002/tiny.path.1/file-1239.pdf	\N	D5170C00002-f47d8230-8315-11eb-be00-07ddc0e266d2-1239	\N	NEW	\N	\N	\N	\N
85578	79	D5170C00002/tiny.path.1/file-4188.pdf	\N	D5170C00002-f47e3415-8317-11eb-be00-49c71853ed22-4188	\N	NEW	\N	\N	\N	\N
86963	79	D5170C00002/tiny.path.1/file-5573.pdf	\N	D5170C00002-f48ae93e-8318-11eb-be00-837f3c0a31bd-5573	\N	NEW	\N	\N	\N	\N
83998	79	D5170C00002/tiny.path.1/file-2608.pdf	\N	D5170C00002-f48c0c0a-8316-11eb-be00-9bc0171689c8-2609	\N	NEW	\N	\N	\N	\N
85579	79	D5170C00002/tiny.path.1/file-4189.pdf	\N	D5170C00002-f4a989d6-8317-11eb-be00-d9cf92e5a91b-4189	\N	NEW	\N	\N	\N	\N
83999	79	D5170C00002/tiny.path.1/file-2609.pdf	\N	D5170C00002-f4b95d9b-8316-11eb-be00-759f9a54f102-2610	\N	NEW	\N	\N	\N	\N
84000	79	D5170C00002/tiny.path.1/file-2610.pdf	\N	D5170C00002-f4cb37ec-8316-11eb-be00-131176696ed8-2611	\N	NEW	\N	\N	\N	\N
82630	79	D5170C00002/tiny.path.1/file-1240.pdf	\N	D5170C00002-f4d82551-8315-11eb-be00-974e04fd1553-1240	\N	NEW	\N	\N	\N	\N
85580	79	D5170C00002/tiny.path.1/file-4190.pdf	\N	D5170C00002-f4d8fe47-8317-11eb-be00-07fb4c57ff55-4190	\N	NEW	\N	\N	\N	\N
86964	79	D5170C00002/tiny.path.1/file-5574.pdf	\N	D5170C00002-f4f6a35f-8318-11eb-be00-bd76dd362ae6-5574	\N	NEW	\N	\N	\N	\N
82631	79	D5170C00002/tiny.path.1/file-1241.pdf	\N	D5170C00002-f4f8ccb2-8315-11eb-be00-2b810e622415-1241	\N	NEW	\N	\N	\N	\N
84001	79	D5170C00002/tiny.path.1/file-2611.pdf	\N	D5170C00002-f515604d-8316-11eb-be00-c78974a54354-2612	\N	NEW	\N	\N	\N	\N
82632	79	D5170C00002/tiny.path.1/file-1242.pdf	\N	D5170C00002-f5347623-8315-11eb-be00-6f7f29309e6c-1242	\N	NEW	\N	\N	\N	\N
84002	79	D5170C00002/tiny.path.1/file-2612.pdf	\N	D5170C00002-f5434e1e-8316-11eb-be00-d7eaff871fc9-2613	\N	NEW	\N	\N	\N	\N
82633	79	D5170C00002/tiny.path.1/file-1243.pdf	\N	D5170C00002-f5548144-8315-11eb-be00-613e443ef566-1243	\N	NEW	\N	\N	\N	\N
86965	79	D5170C00002/tiny.path.1/file-5575.pdf	\N	D5170C00002-f56061b0-8318-11eb-be00-850838a08c71-5575	\N	NEW	\N	\N	\N	\N
85581	79	D5170C00002/tiny.path.1/file-4191.msg	\N	D5170C00002-f5716db8-8317-11eb-be00-6d99d536de77-4191	\N	NEW	\N	\N	\N	\N
86966	79	D5170C00002/tiny.path.1/file-5576.pdf	\N	D5170C00002-f58045c1-8318-11eb-be00-bfc252a09f4e-5576	\N	NEW	\N	\N	\N	\N
84004	79	D5170C00002/tiny.path.1/file-2614.pdf	\N	D5170C00002-f581b6af-8316-11eb-be00-0d56ab627973-2614	\N	NEW	\N	\N	\N	\N
86967	79	D5170C00002/tiny.path.1/file-5577.pdf	\N	D5170C00002-f59e2e02-8318-11eb-be00-17bca9adb458-5577	\N	NEW	\N	\N	\N	\N
82634	79	D5170C00002/tiny.path.1/file-1244.pdf	\N	D5170C00002-f5bd0715-8315-11eb-be00-6b78fd4cc943-1244	\N	NEW	\N	\N	\N	\N
84005	79	D5170C00002/tiny.path.1/file-2615.pdf	\N	D5170C00002-f5bdae40-8316-11eb-be00-27da74bffb25-2615	\N	NEW	\N	\N	\N	\N
84006	79	D5170C00002/tiny.path.1/file-2616.pdf	\N	D5170C00002-f5cd65b1-8316-11eb-be00-677885688a90-2616	\N	NEW	\N	\N	\N	\N
86970	79	D5170C00002/tiny.path.1/file-5580.pdf	\N	D5170C00002-f5ce8cd3-8318-11eb-be00-9b7bf0215a32-5578	\N	NEW	\N	\N	\N	\N
85582	79	D5170C00002/tiny.path.1/file-4192.msg	\N	D5170C00002-f5e9f919-8317-11eb-be00-9582d7117ed8-4192	\N	NEW	\N	\N	\N	\N
84007	79	D5170C00002/tiny.path.1/file-2617.pdf	\N	D5170C00002-f5ea6392-8316-11eb-be00-1fbf037c9ead-2617	\N	NEW	\N	\N	\N	\N
84008	79	D5170C00002/tiny.path.1/file-2618.pdf	\N	D5170C00002-f6093633-8316-11eb-be00-850efbb0a339-2618	\N	NEW	\N	\N	\N	\N
86968	79	D5170C00002/tiny.path.1/file-5578.pdf	\N	D5170C00002-f60972f4-8318-11eb-be00-c55afb21b67e-5579	\N	NEW	\N	\N	\N	\N
82635	79	D5170C00002/tiny.path.1/file-1245.pdf	\N	D5170C00002-f60c3886-8315-11eb-be00-71696bc63b69-1245	\N	NEW	\N	\N	\N	\N
84009	79	D5170C00002/tiny.path.1/file-2619.pdf	\N	D5170C00002-f626f764-8316-11eb-be00-11b282a7397e-2619	\N	NEW	\N	\N	\N	\N
85583	79	D5170C00002/tiny.path.1/file-4193.msg	\N	D5170C00002-f627503a-8317-11eb-be00-413de12f5c10-4193	\N	NEW	\N	\N	\N	\N
86969	79	D5170C00002/tiny.path.1/file-5579.pdf	\N	D5170C00002-f6284595-8318-11eb-be00-47637cd49051-5580	\N	NEW	\N	\N	\N	\N
84010	79	D5170C00002/tiny.path.1/file-2620.pdf	\N	D5170C00002-f636aed5-8316-11eb-be00-818c495a4ad9-2620	\N	NEW	\N	\N	\N	\N
84011	79	D5170C00002/tiny.path.1/file-2621.pdf	\N	D5170C00002-f64813f6-8316-11eb-be00-ad783f559994-2621	\N	NEW	\N	\N	\N	\N
86971	79	D5170C00002/tiny.path.1/file-5581.pdf	\N	D5170C00002-f663ef06-8318-11eb-be00-5913c997ce01-5581	\N	NEW	\N	\N	\N	\N
84012	79	D5170C00002/tiny.path.1/file-2622.pdf	\N	D5170C00002-f6640067-8316-11eb-be00-47fcf9249047-2622	\N	NEW	\N	\N	\N	\N
85584	79	D5170C00002/tiny.path.1/file-4194.msg	\N	D5170C00002-f664804b-8317-11eb-be00-4f27a8f649d9-4194	\N	NEW	\N	\N	\N	\N
84013	79	D5170C00002/tiny.path.1/file-2623.pdf	\N	D5170C00002-f666bf88-8316-11eb-be00-1f9ac7696ff3-2623	\N	NEW	\N	\N	\N	\N
86972	79	D5170C00002/tiny.path.1/file-5582.pdf	\N	D5170C00002-f6741ba7-8318-11eb-be00-59bf1fa3ad11-5582	\N	NEW	\N	\N	\N	\N
84014	79	D5170C00002/tiny.path.1/file-2624.pdf	\N	D5170C00002-f682d309-8316-11eb-be00-db661fbb1807-2624	\N	NEW	\N	\N	\N	\N
82636	79	D5170C00002/tiny.path.1/file-1246.pdf	\N	D5170C00002-f683d987-8315-11eb-be00-95a9ede912fd-1246	\N	NEW	\N	\N	\N	\N
84015	79	D5170C00002/tiny.path.1/file-2625.pdf	\N	D5170C00002-f691c72a-8316-11eb-be00-d5820a634403-2625	\N	NEW	\N	\N	\N	\N
85585	79	D5170C00002/tiny.path.1/file-4195.msg	\N	D5170C00002-f691f8ec-8317-11eb-be00-13a7d9b714b5-4195	\N	NEW	\N	\N	\N	\N
86973	79	D5170C00002/tiny.path.1/file-5583.pdf	\N	D5170C00002-f69203e8-8318-11eb-be00-930d7ab8043b-5583	\N	NEW	\N	\N	\N	\N
84016	79	D5170C00002/tiny.path.1/file-2626.pdf	\N	D5170C00002-f694fb7b-8316-11eb-be00-bdae504d368d-2626	\N	NEW	\N	\N	\N	\N
84017	79	D5170C00002/tiny.path.1/file-2627.pdf	\N	D5170C00002-f6a241ec-8316-11eb-be00-5d70e933e460-2627	\N	NEW	\N	\N	\N	\N
84018	79	D5170C00002/tiny.path.1/file-2628.pdf	\N	D5170C00002-f6b358ed-8316-11eb-be00-69aeda708471-2628	\N	NEW	\N	\N	\N	\N
84019	79	D5170C00002/tiny.path.1/file-2629.pdf	\N	D5170C00002-f6cfba8e-8316-11eb-be00-6567bc63754b-2629	\N	NEW	\N	\N	\N	\N
84020	79	D5170C00002/tiny.path.1/file-2630.pdf	\N	D5170C00002-f6d1dd6f-8316-11eb-be00-930240372409-2630	\N	NEW	\N	\N	\N	\N
86974	79	D5170C00002/tiny.path.1/file-5584.pdf	\N	D5170C00002-f6de7639-8318-11eb-be00-d1b8340f7eb3-5584	\N	NEW	\N	\N	\N	\N
82637	79	D5170C00002/tiny.path.1/file-1247.pdf	\N	D5170C00002-f6df3ff8-8315-11eb-be00-494d0e65d759-1247	\N	NEW	\N	\N	\N	\N
84021	79	D5170C00002/tiny.path.1/file-2631.pdf	\N	D5170C00002-f6ed7bc0-8316-11eb-be00-659befc38165-2631	\N	NEW	\N	\N	\N	\N
85586	79	D5170C00002/tiny.path.1/file-4196.msg	\N	D5170C00002-f6ed866d-8317-11eb-be00-67cc8d518797-4196	\N	NEW	\N	\N	\N	\N
84022	79	D5170C00002/tiny.path.1/file-2632.pdf	\N	D5170C00002-f6fee0e1-8316-11eb-be00-27a12d3fdefb-2632	\N	NEW	\N	\N	\N	\N
82638	79	D5170C00002/tiny.path.1/file-1248.pdf	\N	D5170C00002-f70c6a79-8315-11eb-be00-c92aa04b68ff-1248	\N	NEW	\N	\N	\N	\N
85587	79	D5170C00002/tiny.path.1/file-4197.msg	\N	D5170C00002-f71b743e-8317-11eb-be00-092cf1567377-4197	\N	NEW	\N	\N	\N	\N
84023	79	D5170C00002/tiny.path.1/file-2633.pdf	\N	D5170C00002-f71e4fc2-8316-11eb-be00-61d92f764c3e-2633	\N	NEW	\N	\N	\N	\N
86975	79	D5170C00002/tiny.path.1/file-5585.pdf	\N	D5170C00002-f72d327a-8318-11eb-be00-8b21942e19f1-5585	\N	NEW	\N	\N	\N	\N
82639	79	D5170C00002/tiny.path.1/file-1249.pdf	\N	D5170C00002-f72d5ffa-8315-11eb-be00-65e62dfbea40-1249	\N	NEW	\N	\N	\N	\N
85588	79	D5170C00002/tiny.path.1/file-4198.msg	\N	D5170C00002-f73ae31f-8317-11eb-be00-bb8ace5bdd69-4198	\N	NEW	\N	\N	\N	\N
84024	79	D5170C00002/tiny.path.1/file-2634.pdf	\N	D5170C00002-f73cad33-8316-11eb-be00-0dbe95ef74a4-2634	\N	NEW	\N	\N	\N	\N
84025	79	D5170C00002/tiny.path.1/file-2635.pdf	\N	D5170C00002-f74ade04-8316-11eb-be00-e758f2dcfb4c-2635	\N	NEW	\N	\N	\N	\N
85589	79	D5170C00002/tiny.path.1/file-4199.msg	\N	D5170C00002-f74b84f0-8317-11eb-be00-dd2120d478cb-4199	\N	NEW	\N	\N	\N	\N
85590	79	D5170C00002/tiny.path.1/file-4200.msg	\N	D5170C00002-f75a7911-8317-11eb-be00-ad51bcded4d4-4200	\N	NEW	\N	\N	\N	\N
86976	79	D5170C00002/tiny.path.1/file-5586.pdf	\N	D5170C00002-f75a840b-8318-11eb-be00-9b8541e43a7b-5586	\N	NEW	\N	\N	\N	\N
82640	79	D5170C00002/tiny.path.1/file-1250.pdf	\N	D5170C00002-f767f7fb-8315-11eb-be00-e9024081d1c2-1250	\N	NEW	\N	\N	\N	\N
84026	79	D5170C00002/tiny.path.1/file-2636.pdf	\N	D5170C00002-f77919f5-8316-11eb-be00-c972ca1320e5-2636	\N	NEW	\N	\N	\N	\N
86977	79	D5170C00002/tiny.path.1/file-5587.pdf	\N	D5170C00002-f7864efc-8318-11eb-be00-4995c56d1be1-5587	\N	NEW	\N	\N	\N	\N
85591	79	D5170C00002/tiny.path.1/file-4201.msg	\N	D5170C00002-f7955f32-8317-11eb-be00-35de24dd2d56-4201	\N	NEW	\N	\N	\N	\N
82641	79	D5170C00002/tiny.path.1/file-1251.pdf	\N	D5170C00002-f7971e4c-8315-11eb-be00-d98a4d704b4a-1251	\N	NEW	\N	\N	\N	\N
84027	79	D5170C00002/tiny.path.1/file-2637.pdf	\N	D5170C00002-f7a5cf46-8316-11eb-be00-577e5cc6fe59-2637	\N	NEW	\N	\N	\N	\N
85592	79	D5170C00002/tiny.path.1/file-4202.msg	\N	D5170C00002-f7a69d43-8317-11eb-be00-6f1779607e36-4202	\N	NEW	\N	\N	\N	\N
85593	79	D5170C00002/tiny.path.1/file-4203.msg	\N	D5170C00002-f7b5b874-8317-11eb-be00-fbed2821f560-4203	\N	NEW	\N	\N	\N	\N
86978	79	D5170C00002/tiny.path.1/file-5588.pdf	\N	D5170C00002-f7c26d9d-8318-11eb-be00-136c0bc0ea6d-5588	\N	NEW	\N	\N	\N	\N
85594	79	D5170C00002/tiny.path.1/file-4204.msg	\N	D5170C00002-f7d24125-8317-11eb-be00-b3ecacda7d51-4204	\N	NEW	\N	\N	\N	\N
86979	79	D5170C00002/tiny.path.1/file-5589.pdf	\N	D5170C00002-f7d2732e-8318-11eb-be00-5f8f776775b5-5589	\N	NEW	\N	\N	\N	\N
85595	79	D5170C00002/tiny.path.1/file-4205.msg	\N	D5170C00002-f7e1aa76-8317-11eb-be00-ef97eae42a4f-4205	\N	NEW	\N	\N	\N	\N
84028	79	D5170C00002/tiny.path.1/file-2638.pdf	\N	D5170C00002-f7e1c6d7-8316-11eb-be00-71e2bb1665fc-2638	\N	NEW	\N	\N	\N	\N
85596	79	D5170C00002/tiny.path.1/file-4206.msg	\N	D5170C00002-f7e35827-8317-11eb-be00-df281b4aa9c3-4206	\N	NEW	\N	\N	\N	\N
85597	79	D5170C00002/tiny.path.1/file-4207.msg	\N	D5170C00002-f7e44288-8317-11eb-be00-83a57370274d-4207	\N	NEW	\N	\N	\N	\N
82642	79	D5170C00002/tiny.path.1/file-1252.pdf	\N	D5170C00002-f7e4a20d-8315-11eb-be00-175882efb68c-1252	\N	NEW	\N	\N	\N	\N
86980	79	D5170C00002/tiny.path.1/file-5590.pdf	\N	D5170C00002-f7f0827f-8318-11eb-be00-3d38c9c7d5f2-5590	\N	NEW	\N	\N	\N	\N
84029	79	D5170C00002/tiny.path.1/file-2639.pdf	\N	D5170C00002-f7f1f378-8316-11eb-be00-5d0f1d95165e-2639	\N	NEW	\N	\N	\N	\N
85598	79	D5170C00002/tiny.path.1/file-4208.msg	\N	D5170C00002-f7f24c49-8317-11eb-be00-6919b4910eed-4208	\N	NEW	\N	\N	\N	\N
86981	79	D5170C00002/tiny.path.1/file-5591.pdf	\N	D5170C00002-f8017170-8318-11eb-be00-3943e7bc8981-5591	\N	NEW	\N	\N	\N	\N
82643	79	D5170C00002/tiny.path.1/file-1253.pdf	\N	D5170C00002-f802ff7e-8315-11eb-be00-a12340834928-1253	\N	NEW	\N	\N	\N	\N
85599	79	D5170C00002/tiny.path.1/file-4209.msg	\N	D5170C00002-f8100d7a-8317-11eb-be00-f3b85e449912-4209	\N	NEW	\N	\N	\N	\N
84030	79	D5170C00002/tiny.path.1/file-2640.pdf	\N	D5170C00002-f810ed29-8316-11eb-be00-59432d94e26d-2640	\N	NEW	\N	\N	\N	\N
84031	79	D5170C00002/tiny.path.1/file-2641.pdf	\N	D5170C00002-f82dc3fa-8316-11eb-be00-bb5544912869-2641	\N	NEW	\N	\N	\N	\N
86982	79	D5170C00002/tiny.path.1/file-5592.pdf	\N	D5170C00002-f82dd8a1-8318-11eb-be00-15e3e7d626da-5592	\N	NEW	\N	\N	\N	\N
85600	79	D5170C00002/tiny.path.1/file-4210.pdf	\N	D5170C00002-f83dfb4b-8317-11eb-be00-873d6dd08da1-4210	\N	NEW	\N	\N	\N	\N
86983	79	D5170C00002/tiny.path.1/file-5593.pdf	\N	D5170C00002-f84c3612-8318-11eb-be00-51e789ac7fb4-5593	\N	NEW	\N	\N	\N	\N
84032	79	D5170C00002/tiny.path.1/file-2642.pdf	\N	D5170C00002-f84cbdab-8316-11eb-be00-93e47a420252-2642	\N	NEW	\N	\N	\N	\N
82644	79	D5170C00002/tiny.path.1/file-1254.pdf	\N	D5170C00002-f84cd9bf-8315-11eb-be00-5b08c3d21b7d-1254	\N	NEW	\N	\N	\N	\N
84033	79	D5170C00002/tiny.path.1/file-2643.pdf	\N	D5170C00002-f85c9c2c-8316-11eb-be00-c94b8dbc83fc-2643	\N	NEW	\N	\N	\N	\N
85601	79	D5170C00002/tiny.path.1/file-4211.pdf	\N	D5170C00002-f85e066c-8317-11eb-be00-fbb52e99f083-4211	\N	NEW	\N	\N	\N	\N
84034	79	D5170C00002/tiny.path.1/file-2644.pdf	\N	D5170C00002-f87a0f3d-8316-11eb-be00-4b81366c8ecf-2644	\N	NEW	\N	\N	\N	\N
82645	79	D5170C00002/tiny.path.1/file-1255.pdf	\N	D5170C00002-f87ac790-8315-11eb-be00-fbceb21ab53a-1255	\N	NEW	\N	\N	\N	\N
86984	79	D5170C00002/tiny.path.1/file-5594.pdf	\N	D5170C00002-f888f0f3-8318-11eb-be00-c79088196871-5594	\N	NEW	\N	\N	\N	\N
84035	79	D5170C00002/tiny.path.1/file-2645.pdf	\N	D5170C00002-f889c6ae-8316-11eb-be00-03e4fc31efbf-2645	\N	NEW	\N	\N	\N	\N
85602	79	D5170C00002/tiny.path.1/file-4212.pdf	\N	D5170C00002-f88c696d-8317-11eb-be00-b1bf68b898ce-4212	\N	NEW	\N	\N	\N	\N
84036	79	D5170C00002/tiny.path.1/file-2646.pdf	\N	D5170C00002-f8a9f8df-8316-11eb-be00-c1e863fa4750-2646	\N	NEW	\N	\N	\N	\N
82646	79	D5170C00002/tiny.path.1/file-1256.pdf	\N	D5170C00002-f8b9a551-8315-11eb-be00-05b9b80aaa14-1256	\N	NEW	\N	\N	\N	\N
84037	79	D5170C00002/tiny.path.1/file-2647.pdf	\N	D5170C00002-f8b9fe70-8316-11eb-be00-a9fbf957371c-2647	\N	NEW	\N	\N	\N	\N
86985	79	D5170C00002/tiny.path.1/file-5595.pdf	\N	D5170C00002-f8c73274-8318-11eb-be00-91bdd9a7f190-5595	\N	NEW	\N	\N	\N	\N
84038	79	D5170C00002/tiny.path.1/file-2648.pdf	\N	D5170C00002-f8d77181-8316-11eb-be00-d7b6043a294e-2648	\N	NEW	\N	\N	\N	\N
86986	79	D5170C00002/tiny.path.1/file-5596.pdf	\N	D5170C00002-f8d95ae5-8318-11eb-be00-d930867f2071-5596	\N	NEW	\N	\N	\N	\N
82647	79	D5170C00002/tiny.path.1/file-1257.pdf	\N	D5170C00002-f9049102-8315-11eb-be00-4b15dce430e8-1257	\N	NEW	\N	\N	\N	\N
86987	79	D5170C00002/tiny.path.1/file-5597.pdf	\N	D5170C00002-f904d7b6-8318-11eb-be00-dbdd889b9975-5597	\N	NEW	\N	\N	\N	\N
84039	79	D5170C00002/tiny.path.1/file-2649.pdf	\N	D5170C00002-f9136912-8316-11eb-be00-33d0dca90e94-2649	\N	NEW	\N	\N	\N	\N
82648	79	D5170C00002/tiny.path.1/file-1258.pdf	\N	D5170C00002-f9150bc3-8315-11eb-be00-f77154f9317c-1258	\N	NEW	\N	\N	\N	\N
84040	79	D5170C00002/tiny.path.1/file-2650.pdf	\N	D5170C00002-f9158bf3-8316-11eb-be00-87d0ab93a37a-2650	\N	NEW	\N	\N	\N	\N
84041	79	D5170C00002/tiny.path.1/file-2651.pdf	\N	D5170C00002-f9248014-8316-11eb-be00-4d5ac852cdd6-2651	\N	NEW	\N	\N	\N	\N
84042	79	D5170C00002/tiny.path.1/file-2652.pdf	\N	D5170C00002-f94156e5-8316-11eb-be00-99d28bc8f543-2652	\N	NEW	\N	\N	\N	\N
82649	79	D5170C00002/tiny.path.1/file-1259.pdf	\N	D5170C00002-f95018f4-8315-11eb-be00-d59be853f99b-1259	\N	NEW	\N	\N	\N	\N
84043	79	D5170C00002/tiny.path.1/file-2653.pdf	\N	D5170C00002-f951aa96-8316-11eb-be00-5f3fc617296b-2653	\N	NEW	\N	\N	\N	\N
85603	79	D5170C00002/tiny.path.1/file-4213.pdf	\N	D5170C00002-f961e1de-8317-11eb-be00-259c7776397b-4213	\N	NEW	\N	\N	\N	\N
82650	79	D5170C00002/tiny.path.1/file-1260.pdf	\N	D5170C00002-f96faee5-8315-11eb-be00-2729f818474e-1260	\N	NEW	\N	\N	\N	\N
86988	79	D5170C00002/tiny.path.1/file-5598.pdf	\N	D5170C00002-f98ccc67-8318-11eb-be00-e9270f084354-5598	\N	NEW	\N	\N	\N	\N
82651	79	D5170C00002/tiny.path.1/file-1261.pdf	\N	D5170C00002-f98d21f6-8315-11eb-be00-9db1796b92e6-1261	\N	NEW	\N	\N	\N	\N
82652	79	D5170C00002/tiny.path.1/file-1262.pdf	\N	D5170C00002-f9ab5857-8315-11eb-be00-a33b975f204f-1262	\N	NEW	\N	\N	\N	\N
85604	79	D5170C00002/tiny.path.1/file-4214.pdf	\N	D5170C00002-f9ae060f-8317-11eb-be00-b7ab1791fc2f-4214	\N	NEW	\N	\N	\N	\N
84044	79	D5170C00002/tiny.path.1/file-2654.pdf	\N	D5170C00002-f9baa597-8316-11eb-be00-9daf6acfa92f-2654	\N	NEW	\N	\N	\N	\N
82653	79	D5170C00002/tiny.path.1/file-1263.pdf	\N	D5170C00002-f9bcbd78-8315-11eb-be00-69f583062d44-1263	\N	NEW	\N	\N	\N	\N
86989	79	D5170C00002/tiny.path.1/file-5599.pdf	\N	D5170C00002-f9ccbb98-8318-11eb-be00-b18d7befb532-5599	\N	NEW	\N	\N	\N	\N
85605	79	D5170C00002/tiny.path.1/file-4215.pdf	\N	D5170C00002-f9d8bf90-8317-11eb-be00-0b6b9782e637-4215	\N	NEW	\N	\N	\N	\N
85606	79	D5170C00002/tiny.path.1/file-4216.pdf	\N	D5170C00002-f9e9af81-8317-11eb-be00-d173fd7f6386-4216	\N	NEW	\N	\N	\N	\N
86990	79	D5170C00002/tiny.path.1/file-5600.pdf	\N	D5170C00002-fa184389-8318-11eb-be00-2bf952b2ba0f-5600	\N	NEW	\N	\N	\N	\N
82654	79	D5170C00002/tiny.path.1/file-1264.pdf	\N	D5170C00002-fa18e739-8315-11eb-be00-e78398d490c9-1264	\N	NEW	\N	\N	\N	\N
85607	79	D5170C00002/tiny.path.1/file-4217.pdf	\N	D5170C00002-fa277bd2-8317-11eb-be00-43b1d3dcefbe-4217	\N	NEW	\N	\N	\N	\N
85608	79	D5170C00002/tiny.path.1/file-4218.pdf	\N	D5170C00002-fa46eab3-8317-11eb-be00-c505af51a7c2-4218	\N	NEW	\N	\N	\N	\N
86991	79	D5170C00002/tiny.path.1/file-5601.pdf	\N	D5170C00002-fa5377ca-8318-11eb-be00-c164a4c772ba-5601	\N	NEW	\N	\N	\N	\N
82655	79	D5170C00002/tiny.path.1/file-1265.xlsx	\N	D5170C00002-fa53a64a-8315-11eb-be00-4f6beff4d0a3-1265	\N	NEW	\N	\N	\N	\N
84045	79	D5170C00002/tiny.path.1/file-2655.msg	\N	D5170C00002-fa627e58-8316-11eb-be00-736eba3063b4-2655	\N	NEW	\N	\N	\N	\N
86992	79	D5170C00002/tiny.path.1/file-5602.pdf	\N	D5170C00002-fa91b94b-8318-11eb-be00-6f23c1d8e9fa-5602	\N	NEW	\N	\N	\N	\N
84046	79	D5170C00002/tiny.path.1/file-2656.msg	\N	D5170C00002-fa9fae69-8316-11eb-be00-dbe886c89b11-2656	\N	NEW	\N	\N	\N	\N
82656	79	D5170C00002/tiny.path.1/file-1266.pdf	\N	D5170C00002-faa2899b-8315-11eb-be00-2559072057d2-1266	\N	NEW	\N	\N	\N	\N
84047	79	D5170C00002/tiny.path.1/file-2657.msg	\N	D5170C00002-faafdb0a-8316-11eb-be00-0f4b7f63f7ae-2657	\N	NEW	\N	\N	\N	\N
85609	79	D5170C00002/tiny.path.1/file-4219.pdf	\N	D5170C00002-fab0f724-8317-11eb-be00-b97c7fec849e-4219	\N	NEW	\N	\N	\N	\N
86993	79	D5170C00002/tiny.path.1/file-5603.pdf	\N	D5170C00002-fabe6e9c-8318-11eb-be00-5b09c58879a5-5603	\N	NEW	\N	\N	\N	\N
84048	79	D5170C00002/tiny.path.1/file-2658.msg	\N	D5170C00002-fadcb76b-8316-11eb-be00-734de92fff95-2658	\N	NEW	\N	\N	\N	\N
85610	79	D5170C00002/tiny.path.1/file-4220.pdf	\N	D5170C00002-faddac75-8317-11eb-be00-17655a6832de-4220	\N	NEW	\N	\N	\N	\N
82657	79	D5170C00002/tiny.path.1/file-1267.pdf	\N	D5170C00002-faee389c-8315-11eb-be00-499dedb3ce95-1267	\N	NEW	\N	\N	\N	\N
84049	79	D5170C00002/tiny.path.1/file-2659.msg	\N	D5170C00002-faeeb8cc-8316-11eb-be00-0b755f3b0bd0-2659	\N	NEW	\N	\N	\N	\N
86994	79	D5170C00002/tiny.path.1/file-5604.pdf	\N	D5170C00002-fafab44d-8318-11eb-be00-d5fd84df993a-5604	\N	NEW	\N	\N	\N	\N
85611	79	D5170C00002/tiny.path.1/file-4221.pdf	\N	D5170C00002-fb0a88d6-8317-11eb-be00-6dc93eae2f71-4221	\N	NEW	\N	\N	\N	\N
84050	79	D5170C00002/tiny.path.1/file-2660.msg	\N	D5170C00002-fb0c2bdd-8316-11eb-be00-5513ce1935ad-2660	\N	NEW	\N	\N	\N	\N
84051	79	D5170C00002/tiny.path.1/file-2661.msg	\N	D5170C00002-fb299eee-8316-11eb-be00-eb12055c57d4-2661	\N	NEW	\N	\N	\N	\N
82658	79	D5170C00002/tiny.path.1/file-1268.pdf	\N	D5170C00002-fb29bafd-8315-11eb-be00-d35eff1f2df9-1268	\N	NEW	\N	\N	\N	\N
85612	79	D5170C00002/tiny.path.1/file-4222.pdf	\N	D5170C00002-fb3b35c7-8317-11eb-be00-657090ab3821-4222	\N	NEW	\N	\N	\N	\N
86995	79	D5170C00002/tiny.path.1/file-5605.pdf	\N	D5170C00002-fb4774be-8318-11eb-be00-63dfa6852467-5605	\N	NEW	\N	\N	\N	\N
82659	79	D5170C00002/tiny.path.1/file-1269.pdf	\N	D5170C00002-fb47ca4e-8315-11eb-be00-2d07d38c43f4-1269	\N	NEW	\N	\N	\N	\N
85613	79	D5170C00002/tiny.path.1/file-4223.pdf	\N	D5170C00002-fb58a8d8-8317-11eb-be00-d398f42a4d3f-4223	\N	NEW	\N	\N	\N	\N
84052	79	D5170C00002/tiny.path.1/file-2662.msg	\N	D5170C00002-fb67e06f-8316-11eb-be00-5d96ff8f7932-2662	\N	NEW	\N	\N	\N	\N
85614	79	D5170C00002/tiny.path.1/file-4224.pdf	\N	D5170C00002-fb686049-8317-11eb-be00-2dbcb11b9388-4224	\N	NEW	\N	\N	\N	\N
86996	79	D5170C00002/tiny.path.1/file-5606.pdf	\N	D5170C00002-fb84088f-8318-11eb-be00-3101bdff1c10-5606	\N	NEW	\N	\N	\N	\N
84053	79	D5170C00002/tiny.path.1/file-2663.msg	\N	D5170C00002-fb955910-8316-11eb-be00-d7c8bcda51e7-2663	\N	NEW	\N	\N	\N	\N
82660	79	D5170C00002/tiny.path.1/file-1270.pdf	\N	D5170C00002-fb95751f-8315-11eb-be00-75a109144db3-1270	\N	NEW	\N	\N	\N	\N
86997	79	D5170C00002/tiny.path.1/file-5607.pdf	\N	D5170C00002-fba35060-8318-11eb-be00-85057d52fed0-5607	\N	NEW	\N	\N	\N	\N
82661	79	D5170C00002/tiny.path.1/file-1271.pdf	\N	D5170C00002-fbc22a70-8315-11eb-be00-79e595f64ab6-1271	\N	NEW	\N	\N	\N	\N
86998	79	D5170C00002/tiny.path.1/file-5608.pdf	\N	D5170C00002-fbc3a9a1-8318-11eb-be00-77b8ddb388dc-5608	\N	NEW	\N	\N	\N	\N
86999	79	D5170C00002/tiny.path.1/file-5609.pdf	\N	D5170C00002-fbd24fa2-8318-11eb-be00-039944df604c-5609	\N	NEW	\N	\N	\N	\N
84054	79	D5170C00002/tiny.path.1/file-2664.msg	\N	D5170C00002-fbd2d741-8316-11eb-be00-d9d2e6dc6f9a-2664	\N	NEW	\N	\N	\N	\N
85615	79	D5170C00002/tiny.path.1/file-4225.pdf	\N	D5170C00002-fbdf8c1a-8317-11eb-be00-392064411925-4225	\N	NEW	\N	\N	\N	\N
85616	79	D5170C00002/tiny.path.1/file-4226.pdf	\N	D5170C00002-fbe2242b-8317-11eb-be00-efa4a5706b32-4226	\N	NEW	\N	\N	\N	\N
87000	79	D5170C00002/tiny.path.1/file-5610.pdf	\N	D5170C00002-fbe25533-8318-11eb-be00-4b3914908d8f-5610	\N	NEW	\N	\N	\N	\N
87001	79	D5170C00002/tiny.path.1/file-5611.pdf	\N	D5170C00002-fbf1be84-8318-11eb-be00-7b4d1cbaa99c-5611	\N	NEW	\N	\N	\N	\N
84055	79	D5170C00002/tiny.path.1/file-2665.msg	\N	D5170C00002-fbfea232-8316-11eb-be00-7d24c0bc90fd-2665	\N	NEW	\N	\N	\N	\N
85617	79	D5170C00002/tiny.path.1/file-4227.pdf	\N	D5170C00002-fbfeacdc-8317-11eb-be00-ff1fc3ccb7b7-4227	\N	NEW	\N	\N	\N	\N
82673	79	D5170C00002/tiny.path.1/file-1283.pdf	\N	D5170C00002-fc0044e1-8315-11eb-be00-6f16d64d17f6-1272	\N	NEW	\N	\N	\N	\N
84056	79	D5170C00002/tiny.path.1/file-2666.msg	\N	D5170C00002-fc1fbec3-8316-11eb-be00-fb204096b956-2666	\N	NEW	\N	\N	\N	\N
85618	79	D5170C00002/tiny.path.1/file-4228.pdf	\N	D5170C00002-fc2bd75d-8317-11eb-be00-6b131f7af8a9-4228	\N	NEW	\N	\N	\N	\N
87002	79	D5170C00002/tiny.path.1/file-5612.pdf	\N	D5170C00002-fc4b0215-8318-11eb-be00-155e2cb7b753-5612	\N	NEW	\N	\N	\N	\N
85619	79	D5170C00002/tiny.path.1/file-4229.pdf	\N	D5170C00002-fc4c57ae-8317-11eb-be00-4b9f75969e79-4229	\N	NEW	\N	\N	\N	\N
82662	79	D5170C00002/tiny.path.1/file-1272.pdf	\N	D5170C00002-fc698e02-8315-11eb-be00-69136f3b1dfb-1273	\N	NEW	\N	\N	\N	\N
82663	79	D5170C00002/tiny.path.1/file-1273.pdf	\N	D5170C00002-fc79e1b3-8315-11eb-be00-8fb17f02fe0e-1274	\N	NEW	\N	\N	\N	\N
85620	79	D5170C00002/tiny.path.1/file-4230.pdf	\N	D5170C00002-fc7b56ef-8317-11eb-be00-9d78bf156d59-4230	\N	NEW	\N	\N	\N	\N
84057	79	D5170C00002/tiny.path.1/file-2667.msg	\N	D5170C00002-fca78c64-8316-11eb-be00-111ace2947e5-2667	\N	NEW	\N	\N	\N	\N
87003	79	D5170C00002/tiny.path.1/file-5613.pdf	\N	D5170C00002-fca7ef26-8318-11eb-be00-f1c65567b0e7-5613	\N	NEW	\N	\N	\N	\N
82664	79	D5170C00002/tiny.path.1/file-1274.pdf	\N	D5170C00002-fca7f694-8315-11eb-be00-f1f41e603d33-1275	\N	NEW	\N	\N	\N	\N
87004	79	D5170C00002/tiny.path.1/file-5614.pdf	\N	D5170C00002-fcb70a57-8318-11eb-be00-67e7719eb88d-5614	\N	NEW	\N	\N	\N	\N
85621	79	D5170C00002/tiny.path.1/file-4231.pdf	\N	D5170C00002-fcb79ca0-8317-11eb-be00-ef0785e6569f-4231	\N	NEW	\N	\N	\N	\N
84058	79	D5170C00002/tiny.path.1/file-2668.msg	\N	D5170C00002-fcc574a5-8316-11eb-be00-7f00ce15e7ec-2668	\N	NEW	\N	\N	\N	\N
82665	79	D5170C00002/tiny.path.1/file-1275.pdf	\N	D5170C00002-fcd4d2f5-8315-11eb-be00-1f18bf663fae-1276	\N	NEW	\N	\N	\N	\N
85622	79	D5170C00002/tiny.path.1/file-4232.pdf	\N	D5170C00002-fcd4e8a1-8317-11eb-be00-3b5ef76a4714-4232	\N	NEW	\N	\N	\N	\N
85623	79	D5170C00002/tiny.path.1/file-4233.pdf	\N	D5170C00002-fce3b5b2-8317-11eb-be00-e9421ee5aee2-4233	\N	NEW	\N	\N	\N	\N
84059	79	D5170C00002/tiny.path.1/file-2669.msg	\N	D5170C00002-fce4bc76-8316-11eb-be00-bb64797dfa54-2669	\N	NEW	\N	\N	\N	\N
85624	79	D5170C00002/tiny.path.1/file-4234.pdf	\N	D5170C00002-fcf282c3-8317-11eb-be00-2bb706b47768-4234	\N	NEW	\N	\N	\N	\N
84060	79	D5170C00002/tiny.path.1/file-2670.msg	\N	D5170C00002-fcf53737-8316-11eb-be00-53939d14d3c1-2670	\N	NEW	\N	\N	\N	\N
87005	79	D5170C00002/tiny.path.1/file-5615.pdf	\N	D5170C00002-fd029248-8318-11eb-be00-6756354d4076-5615	\N	NEW	\N	\N	\N	\N
85625	79	D5170C00002/tiny.path.1/file-4235.pdf	\N	D5170C00002-fd10b924-8317-11eb-be00-3552fb51f120-4235	\N	NEW	\N	\N	\N	\N
82666	79	D5170C00002/tiny.path.1/file-1276.pdf	\N	D5170C00002-fd113fb6-8315-11eb-be00-ebdc7dc6d131-1277	\N	NEW	\N	\N	\N	\N
85626	79	D5170C00002/tiny.path.1/file-4236.pdf	\N	D5170C00002-fd130315-8317-11eb-be00-69b3d358b929-4236	\N	NEW	\N	\N	\N	\N
84061	79	D5170C00002/tiny.path.1/file-2671.msg	\N	D5170C00002-fd134688-8316-11eb-be00-cbe882163b15-2671	\N	NEW	\N	\N	\N	\N
85627	79	D5170C00002/tiny.path.1/file-4237.pdf	\N	D5170C00002-fd224556-8317-11eb-be00-c9ace2b8cc37-4237	\N	NEW	\N	\N	\N	\N
82667	79	D5170C00002/tiny.path.1/file-1277.pdf	\N	D5170C00002-fd308787-8315-11eb-be00-6fef292bf2a3-1278	\N	NEW	\N	\N	\N	\N
87006	79	D5170C00002/tiny.path.1/file-5616.pdf	\N	D5170C00002-fd3e89d9-8318-11eb-be00-33d7eec2422e-5616	\N	NEW	\N	\N	\N	\N
82668	79	D5170C00002/tiny.path.1/file-1278.pdf	\N	D5170C00002-fd3ff0d8-8315-11eb-be00-699a7afecfa4-1279	\N	NEW	\N	\N	\N	\N
85628	79	D5170C00002/tiny.path.1/file-4238.xlsx	\N	D5170C00002-fd4e3757-8317-11eb-be00-dd11245c24e8-4238	\N	NEW	\N	\N	\N	\N
84062	79	D5170C00002/tiny.path.1/file-2672.msg	\N	D5170C00002-fd4e53b9-8316-11eb-be00-0b93c91d618c-2672	\N	NEW	\N	\N	\N	\N
84063	79	D5170C00002/tiny.path.1/file-2673.msg	\N	D5170C00002-fd50769a-8316-11eb-be00-b96c3b795f8f-2673	\N	NEW	\N	\N	\N	\N
85629	79	D5170C00002/tiny.path.1/file-4239.xlsx	\N	D5170C00002-fd5eb218-8317-11eb-be00-a9221ce7e64a-4239	\N	NEW	\N	\N	\N	\N
82669	79	D5170C00002/tiny.path.1/file-1279.pdf	\N	D5170C00002-fd5f1199-8315-11eb-be00-db3fe3ab8e86-1280	\N	NEW	\N	\N	\N	\N
84064	79	D5170C00002/tiny.path.1/file-2674.msg	\N	D5170C00002-fd602e0b-8316-11eb-be00-63ad8052c58c-2674	\N	NEW	\N	\N	\N	\N
82670	79	D5170C00002/tiny.path.1/file-1280.pdf	\N	D5170C00002-fd6f3e3a-8315-11eb-be00-d14727890234-1281	\N	NEW	\N	\N	\N	\N
84065	79	D5170C00002/tiny.path.1/file-2675.msg	\N	D5170C00002-fd7def3c-8316-11eb-be00-953a4657aa5b-2675	\N	NEW	\N	\N	\N	\N
82671	79	D5170C00002/tiny.path.1/file-1281.pdf	\N	D5170C00002-fd8c632b-8315-11eb-be00-5d9c77b7a431-1282	\N	NEW	\N	\N	\N	\N
85630	79	D5170C00002/tiny.path.1/file-4240.pdf	\N	D5170C00002-fd9af7c9-8317-11eb-be00-ffe0e0584a4a-4240	\N	NEW	\N	\N	\N	\N
84066	79	D5170C00002/tiny.path.1/file-2676.msg	\N	D5170C00002-fd9b895d-8316-11eb-be00-c9a755446533-2676	\N	NEW	\N	\N	\N	\N
82672	79	D5170C00002/tiny.path.1/file-1282.pdf	\N	D5170C00002-fda9fd4c-8315-11eb-be00-413585733d0f-1283	\N	NEW	\N	\N	\N	\N
84067	79	D5170C00002/tiny.path.1/file-2677.msg	\N	D5170C00002-fdabb5fe-8316-11eb-be00-df57a675e5ba-2677	\N	NEW	\N	\N	\N	\N
84068	79	D5170C00002/tiny.path.1/file-2678.msg	\N	D5170C00002-fdb9e6cf-8316-11eb-be00-2bf5faa00e69-2678	\N	NEW	\N	\N	\N	\N
84069	79	D5170C00002/tiny.path.1/file-2679.msg	\N	D5170C00002-fdcafdd0-8316-11eb-be00-3d295a39425f-2679	\N	NEW	\N	\N	\N	\N
85631	79	D5170C00002/tiny.path.1/file-4241.pdf	\N	D5170C00002-fdd9876a-8317-11eb-be00-670e7233a166-4241	\N	NEW	\N	\N	\N	\N
84070	79	D5170C00002/tiny.path.1/file-2680.msg	\N	D5170C00002-fde75f71-8316-11eb-be00-594d41b16503-2680	\N	NEW	\N	\N	\N	\N
84071	79	D5170C00002/tiny.path.1/file-2681.msg	\N	D5170C00002-fe05bce2-8316-11eb-be00-153995f2f0c1-2681	\N	NEW	\N	\N	\N	\N
82674	79	D5170C00002/tiny.path.1/file-1284.pdf	\N	D5170C00002-fe14f41d-8315-11eb-be00-55a62ab1ed8b-1284	\N	NEW	\N	\N	\N	\N
85632	79	D5170C00002/tiny.path.1/file-4242.pdf	\N	D5170C00002-fe15cd1b-8317-11eb-be00-c35f2e462242-4242	\N	NEW	\N	\N	\N	\N
87007	79	D5170C00002/tiny.path.1/file-5617.pdf	\N	D5170C00002-fe262aba-8318-11eb-be00-3304797b2b06-5617	\N	NEW	\N	\N	\N	\N
82675	79	D5170C00002/tiny.path.1/file-1285.pdf	\N	D5170C00002-fe34d82e-8315-11eb-be00-3b0def053222-1285	\N	NEW	\N	\N	\N	\N
84072	79	D5170C00002/tiny.path.1/file-2682.msg	\N	D5170C00002-fe43fe63-8316-11eb-be00-61d418f0e2a7-2682	\N	NEW	\N	\N	\N	\N
85633	79	D5170C00002/tiny.path.1/file-4243.pdf	\N	D5170C00002-fe53e78c-8317-11eb-be00-5946ea3c0af8-4243	\N	NEW	\N	\N	\N	\N
84073	79	D5170C00002/tiny.path.1/file-2683.msg	\N	D5170C00002-fe542b04-8316-11eb-be00-83a204342202-2683	\N	NEW	\N	\N	\N	\N
82676	79	D5170C00002/tiny.path.1/file-1286.pdf	\N	D5170C00002-fe54952f-8315-11eb-be00-0bf2f963f18a-1286	\N	NEW	\N	\N	\N	\N
84074	79	D5170C00002/tiny.path.1/file-2684.msg	\N	D5170C00002-fe640985-8316-11eb-be00-d3158626c17e-2684	\N	NEW	\N	\N	\N	\N
82677	79	D5170C00002/tiny.path.1/file-1287.pdf	\N	D5170C00002-fe711de0-8315-11eb-be00-ad2be9337ad7-1287	\N	NEW	\N	\N	\N	\N
84075	79	D5170C00002/tiny.path.1/file-2685.msg	\N	D5170C00002-fe801d06-8316-11eb-be00-2f224b65b280-2685	\N	NEW	\N	\N	\N	\N
82678	79	D5170C00002/tiny.path.1/file-1288.pdf	\N	D5170C00002-fe8f0621-8315-11eb-be00-2173eb88cae4-1288	\N	NEW	\N	\N	\N	\N
85634	79	D5170C00002/tiny.path.1/file-4244.pdf	\N	D5170C00002-fe902d3d-8317-11eb-be00-f78a7976be13-4244	\N	NEW	\N	\N	\N	\N
82679	79	D5170C00002/tiny.path.1/file-1289.pdf	\N	D5170C00002-febc7ec2-8315-11eb-be00-2b4759fa487f-1289	\N	NEW	\N	\N	\N	\N
85635	79	D5170C00002/tiny.path.1/file-4245.pdf	\N	D5170C00002-febeb74e-8317-11eb-be00-9d4752fc3cf3-4245	\N	NEW	\N	\N	\N	\N
84076	79	D5170C00002/tiny.path.1/file-2686.msg	\N	D5170C00002-febefac7-8316-11eb-be00-95d125179505-2686	\N	NEW	\N	\N	\N	\N
82680	79	D5170C00002/tiny.path.1/file-1290.pdf	\N	D5170C00002-fedbeda3-8315-11eb-be00-69f32df73e4e-1290	\N	NEW	\N	\N	\N	\N
84077	79	D5170C00002/tiny.path.1/file-2687.msg	\N	D5170C00002-fedc1fb8-8316-11eb-be00-e707ed17cf8a-2687	\N	NEW	\N	\N	\N	\N
82681	79	D5170C00002/tiny.path.1/file-1291.pdf	\N	D5170C00002-feec8f74-8315-11eb-be00-f764bc31f257-1291	\N	NEW	\N	\N	\N	\N
85636	79	D5170C00002/tiny.path.1/file-4246.pdf	\N	D5170C00002-fefa60bf-8317-11eb-be00-554d32f38efc-4246	\N	NEW	\N	\N	\N	\N
84078	79	D5170C00002/tiny.path.1/file-2688.msg	\N	D5170C00002-fefa7d29-8316-11eb-be00-3bb7445622bd-2688	\N	NEW	\N	\N	\N	\N
87008	79	D5170C00002/tiny.path.1/file-5618.pdf	\N	D5170C00002-ff17688b-8318-11eb-be00-55f78a1bafe6-5618	\N	NEW	\N	\N	\N	\N
85637	79	D5170C00002/tiny.path.1/file-4247.pdf	\N	D5170C00002-ff190c50-8317-11eb-be00-bd3c6040b09d-4247	\N	NEW	\N	\N	\N	\N
82682	79	D5170C00002/tiny.path.1/file-1292.pdf	\N	D5170C00002-ff1af275-8315-11eb-be00-9792da5e73c6-1292	\N	NEW	\N	\N	\N	\N
84079	79	D5170C00002/tiny.path.1/file-2689.msg	\N	D5170C00002-ff28e02a-8316-11eb-be00-c9b3fa402f00-2689	\N	NEW	\N	\N	\N	\N
82683	79	D5170C00002/tiny.path.1/file-1293.pdf	\N	D5170C00002-ff388c96-8315-11eb-be00-b397367b460e-1293	\N	NEW	\N	\N	\N	\N
82684	79	D5170C00002/tiny.path.1/file-1294.pdf	\N	D5170C00002-ff551547-8315-11eb-be00-03eacc9fa8df-1294	\N	NEW	\N	\N	\N	\N
82685	79	D5170C00002/tiny.path.1/file-1295.pdf	\N	D5170C00002-ff74d248-8315-11eb-be00-87035c746200-1295	\N	NEW	\N	\N	\N	\N
84080	79	D5170C00002/tiny.path.1/file-2690.msg	\N	D5170C00002-ff8530fb-8316-11eb-be00-c577757c3909-2690	\N	NEW	\N	\N	\N	\N
85638	79	D5170C00002/tiny.path.1/file-4248.pdf	\N	D5170C00002-ff91bec1-8317-11eb-be00-d5b1e92f9687-4248	\N	NEW	\N	\N	\N	\N
82686	79	D5170C00002/tiny.path.1/file-1296.pdf	\N	D5170C00002-ff9356c9-8315-11eb-be00-1593ac62de1c-1296	\N	NEW	\N	\N	\N	\N
84081	79	D5170C00002/tiny.path.1/file-2691.msg	\N	D5170C00002-ffc239fc-8316-11eb-be00-a98a8c48c478-2691	\N	NEW	\N	\N	\N	\N
82687	79	D5170C00002/tiny.path.1/file-1297.pdf	\N	D5170C00002-ffc27d1a-8315-11eb-be00-ddc539eaa855-1297	\N	NEW	\N	\N	\N	\N
85639	79	D5170C00002/tiny.path.1/file-4249.pdf	\N	D5170C00002-ffde0a02-8317-11eb-be00-fba5be8bc044-4249	\N	NEW	\N	\N	\N	\N
85640	79	D5170C00002/tiny.path.1/file-4250.pdf	\N	D5170C00002-fffe6343-8317-11eb-be00-51c1af48f466-4250	\N	NEW	\N	\N	\N	\N
84082	79	D5170C00002/tiny.path.1/file-2692.msg	\N	D5170C00002-ffff911d-8316-11eb-be00-93c02cd3ea3c-2692	\N	NEW	\N	\N	\N	\N
82688	79	D5170C00002/tiny.path.1/file-1298.pdf	\N	D5170C00002-ffffd43b-8315-11eb-be00-a3294015d895-1298	\N	NEW	\N	\N	\N	\N
\.


--
-- Data for Name: playground; Type: TABLE DATA; Schema: public; Owner: postgres
--

COPY public.playground (equip_id, type, color, location, install_date) FROM stdin;
1	slide	blue	south	2017-04-28
2	swing	yellow	northwest	2018-08-16
\.


--
-- Name: playground_equip_id_seq; Type: SEQUENCE SET; Schema: public; Owner: postgres
--

SELECT pg_catalog.setval('public.playground_equip_id_seq', 2, true);


--
-- Name: playground playground_pkey; Type: CONSTRAINT; Schema: public; Owner: postgres
--

ALTER TABLE ONLY public.playground
    ADD CONSTRAINT playground_pkey PRIMARY KEY (equip_id);


--
-- PostgreSQL database dump complete
--
